id|nct_id|name|downcase_name
1735765|NCT03574311|CABG|cabg
1736383|NCT03389828|Focus Group|focus group
1736509|NCT03309020|OCT|oct
1736891|NCT03152760|Gut|gut
1737726|NCT01977534|CAD|cad
1738057|NCT01352949|HV|hv
1738400|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
1738401|NCT00016731|fMRI|fmri
1738402|NCT00016731|Healthy Volunteer|healthy volunteer
1738403|NCT00016731|HV|hv
1738404|NCT00016731|MRI|mri
1738405|NCT00013845|Seizures|seizures
1738406|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
1738407|NCT00013845|Pharmacotherapy|pharmacotherapy
1738408|NCT00013845|Neuropsychology|neuropsychology
1738409|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
1738410|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
1738412|NCT00013845|Grand Mal Seizures|grand mal seizures
1735783|NCT03574155|Anxiety|anxiety
1735981|NCT03572140|HCV|hcv
1736067|NCT03559075|eczema|eczema
1736246|NCT03479697|HIRREM|hirrem
1737134|NCT02936791|Kidney Institute|kidney institute
1737248|NCT02709226|GBM|gbm
1737327|NCT02620813|lipid|lipid
1738125|NCT01066663|CLL|cll
941749|NCT03534167|gay|gay
942750|NCT03527589|PAE|pae
936724|NCT03565939|IBD|ibd
943995|NCT03520348|dry eye|dry eye
937711|NCT03559985|Neuropathic pain|neuropathic pain
938343|NCT03555968|THC|thc
938552|NCT03554447|MDD|mdd
938653|NCT03553784|Cancer|cancer
938764|NCT03553173|App|app
938937|NCT03552003|CGA|cga
945696|NCT03510052|FI|fi
939141|NCT03550482|Oncoxin|oncoxin
946311|NCT03505866|HIV|hiv
946363|NCT03505476|Ileus|ileus
940327|NCT03543345|RCA|rca
947353|NCT03498924|CA125|ca125
947612|NCT03497130|dry|dry
940849|NCT03539796|DPE|dpe
948281|NCT03492541|MGD|mgd
948441|NCT03491579|AML|aml
937712|NCT03559985|Analgesic effect|analgesic effect
949259|NCT03486301|TLR|tlr
937714|NCT03559985|Biological parameters|biological parameters
937827|NCT03559127|criotherapy|criotherapy
949747|NCT03483233|fMRI|fmri
950127|NCT03480581|Gait|gait
943523|NCT03522870|FGMS|fgms
944253|NCT03518437|CT|ct
952270|NCT03467165|Hip|hip
945017|NCT03514017|CLL|cll
937828|NCT03559127|cold irrigation|cold irrigation
945521|NCT03511274|CMV|cmv
953893|NCT03456206|CID|cid
939056|NCT03551106|e-learning|e-learning
945975|NCT03507933|Hip|hip
946234|NCT03506438|anxiety|anxiety
946530|NCT03504358|survival|survival
947077|NCT03500731|BMT|bmt
947415|NCT03498508|Skills|skills
948010|NCT03494790|FGF-21|fgf-21
948139|NCT03493802|ADPKD|adpkd
948622|NCT03490474|massage|massage
939057|NCT03551106|web based learning module|web based learning module
948922|NCT03488966|Obesity|obesity
958392|NCT03428932|MRI|mri
949515|NCT03484793|CPOE|cpoe
959172|NCT03424356|LMA|lma
950361|NCT03479060|MIDAS|midas
950674|NCT03476902|CBT|cbt
960287|NCT03417284|MM|mm
960755|NCT03414411|HIV|hiv
960884|NCT03413579|Cervix|cervix
951383|NCT03472924|AMI|ami
961316|NCT03410992|PSO|pso
961392|NCT03410680|HIV|hiv
951750|NCT03470714|EMG|emg
961765|NCT03408171|FNA|fna
952342|NCT03466710|HPV|hpv
939058|NCT03551093|Ischemic Stroke|ischemic stroke
952872|NCT03463564|MDI|mdi
953821|NCT03456882|RNS60|rns60
964540|NCT03390569|GBM|gbm
964995|NCT03387709|Obesity|obesity
939059|NCT03551093|Mild Acute Ischemic Stroke|mild acute ischemic stroke
939060|NCT03551093|Safety|safety
939061|NCT03551093|Signal of Efficacy|signal of efficacy
955548|NCT03446118|EoE|eoe
939062|NCT03551080|Sickness behavior|sickness behavior
966860|NCT03375892|stage I|stage i
956111|NCT03442790|CXR|cxr
956786|NCT03438656|fMRI|fmri
939063|NCT03551080|Cytokines|cytokines
968473|NCT03365713|PEF|pef
968602|NCT03364855|Balance|balance
957632|NCT03434067|PTH|pth
969278|NCT03360617|IV|iv
958362|NCT03429075|mdd|mdd
958621|NCT03427515|Stress|stress
958821|NCT03426462|EEG|eeg
958925|NCT03425851|Infants|infants
971150|NCT03347994|AML|aml
959616|NCT03421535|GIRD|gird
939064|NCT03551080|Psychoneuroimmunology|psychoneuroimmunology
939065|NCT03551067|Dexmedetomidine|dexmedetomidine
973361|NCT03334240|HPV|hpv
961302|NCT03411057|Anxiety|anxiety
961418|NCT03410420|Hypoxia|hypoxia
961683|NCT03408678|sex|sex
961846|NCT03407729|EEG|eeg
974340|NCT03328078|MCL|mcl
975342|NCT03322046|CVD|cvd
963352|NCT03397446|LDX|ldx
976963|NCT03311412|PD1|pd1
964375|NCT03391765|PSP|psp
965051|NCT03387293|Diet|diet
978350|NCT03302481|liver|liver
965625|NCT03383692|ADC|adc
979103|NCT03297372|PhysIOL|physiol
939066|NCT03551067|Adenotonsillectomy|adenotonsillectomy
979511|NCT03294759|acl|acl
966218|NCT03379870|EAS|eas
966400|NCT03378570|F3|f3
980892|NCT03285854|CKD|ckd
939067|NCT03551067|Parental Separation|parental separation
968638|NCT03364686|BioRBCs|biorbcs
982977|NCT03272191|MI|mi
983291|NCT03270124|KAM|kam
983358|NCT03269721|COPD|copd
983522|NCT03268655|gut|gut
969933|NCT03356301|CMR|cmr
970177|NCT03354663|PAF|paf
970234|NCT03354286|670G|670g
985014|NCT03259139|gun|gun
970811|NCT03349905|IVF|ivf
986143|NCT03252171|GD2|gd2
986222|NCT03251521|pain|pain
971642|NCT03344978|Cot|cot
986798|NCT03247946|ear|ear
972488|NCT03339245|obesity|obesity
972697|NCT03338114|ALS|als
939068|NCT03551067|Face Mask Acceptance|face mask acceptance
973657|NCT03332537|IBS|ibs
974369|NCT03327831|pdt|pdt
940081|NCT03545022|pain|pain
940082|NCT03545022|edema|edema
940083|NCT03545022|trismus|trismus
940084|NCT03545022|anxiety|anxiety
976605|NCT03314155|PET|pet
940182|NCT03544242|Islet cell|islet cell
978436|NCT03301896|Phase I|phase i
940183|NCT03544242|Survival|survival
979058|NCT03297775|RA|ra
940184|NCT03544242|Pancreas|pancreas
979509|NCT03294759|amion|amion
996748|NCT03184779|Ski|ski
996906|NCT03183869|gut|gut
980393|NCT03289091|aging|aging
997910|NCT03177538|IVF|ivf
998409|NCT03174197|GBM|gbm
940185|NCT03544242|Liver|liver
999350|NCT03167593|Flu|flu
982027|NCT03278899|ALD|ald
982319|NCT03276767|e-mail|e-mail
982777|NCT03273465|IBD|ibd
982947|NCT03272321|EEG|eeg
983210|NCT03270709|HIV|hiv
1001591|NCT03153514|CLL|cll
983699|NCT03267316|Phase 2|phase 2
983812|NCT03266679|insight|insight
1002031|NCT03150953|MRI|mri
984055|NCT03264937|TTR|ttr
1002865|NCT03145129|IOP|iop
985385|NCT03257020|OCT|oct
985661|NCT03255148|EEG|eeg
985753|NCT03254719|PTSD|ptsd
1004504|NCT03133741|GIP|gip
1005624|NCT03126279|Pain|pain
1005769|NCT03125486|SLE|sle
1006246|NCT03121859|TENS|tens
987420|NCT03243682|Stones|stones
987711|NCT03241459|PTA|pta
1007371|NCT03114527|LMS|lms
1007502|NCT03113890|genomic|genomic
1007685|NCT03112785|Hip|hip
940186|NCT03544229|Drug Therapy|drug therapy
988969|NCT03234036|PK|pk
1008504|NCT03108118|Weaning|weaning
989147|NCT03233100|FMT|fmt
989633|NCT03229629|gender|gender
1009766|NCT03100136|PET|pet
1010401|NCT03096782|AML|aml
1010526|NCT03096301|pain|pain
991359|NCT03218943|ICU|icu
940187|NCT03544216|Contact Lens|contact lens
991952|NCT03215004|HIV|hiv
940188|NCT03544216|Multifocal|multifocal
993555|NCT03204617|HTI|hti
994110|NCT03201159|ASH|ash
994233|NCT03200457|MRI|mri
994421|NCT03199222|socket|socket
940189|NCT03544216|Accommodation|accommodation
994797|NCT03196908|ECG|ecg
994990|NCT03195452|HIV|hiv
940190|NCT03544216|Presbyopia|presbyopia
1017674|NCT03052283|Gut|gut
996517|NCT03186313|HCV|hcv
996609|NCT03185754|surgery|surgery
997306|NCT03181633|PNH|pnh
997628|NCT03179475|Opioids|opioids
995158|NCT03194659|DHA|dha
995159|NCT03194659|fatty acids|fatty acids
995465|NCT03192722|Reading|reading
940191|NCT03544203|intraabdominal infections|intraabdominal infections
940192|NCT03544203|peritonitis|peritonitis
999850|NCT03163862|IVF|ivf
1000106|NCT03162341|Gout|gout
995667|NCT03191474|Truvada|truvada
1001671|NCT03153085|HF10|hf10
1024809|NCT03007784|EEG|eeg
940193|NCT03544203|critically ill|critically ill
1002897|NCT03144934|HPV|hpv
940194|NCT03544177|mobility|mobility
1004073|NCT03136692|diet|diet
995968|NCT03189719|PD-L1|pd-l1
1004450|NCT03134183|D&E|d&e
1027959|NCT02987959|TAK-228|tak-228
995969|NCT03189706|Hu3F8|hu3f8
1005587|NCT03126539|aging|aging
995970|NCT03189706|Irinotecan|irinotecan
1006057|NCT03123172|co2 gap|co2 gap
996086|NCT03188887|NIgA|niga
1006363|NCT03121040|ATP|atp
1006645|NCT03119402|Reading|reading
1007146|NCT03116373|Posture|posture
1007325|NCT03114917|CBT|cbt
1007441|NCT03114189|Kneipp|kneipp
996393|NCT03187119|Pediatric|pediatric
996394|NCT03187119|Education|education
1008158|NCT03110354|ALL|all
1008272|NCT03109496|OME|ome
1008398|NCT03108703|RCC|rcc
1008469|NCT03108248|stent|stent
996692|NCT03185208|plaques|plaques
1009260|NCT03103347|EEG|eeg
996693|NCT03185208|tangles|tangles
1034726|NCT02946762|HIV|hiv
996694|NCT03185182|Diagnosis|diagnosis
996695|NCT03185182|Imaging|imaging
998120|NCT03176264|CMS4|cms4
1011167|NCT03092531|HIV|hiv
998418|NCT03174197|XRT|xrt
1011342|NCT03091192|AZD6094|azd6094
1036891|NCT02932501|Jaw|jaw
1011941|NCT03087500|Adults|adults
1012081|NCT03086564|HCC|hcc
940195|NCT03544177|exercise therapy|exercise therapy
940308|NCT03543436|Carbapenem|carbapenem
1037739|NCT02927587|TCI|tci
998527|NCT03173365|Brimonidine|brimonidine
1038255|NCT02924402|CLL|cll
940309|NCT03543436|ESBL infection|esbl infection
940310|NCT03543436|Urinary tract infection|urinary tract infection
940311|NCT03543423|Gut hormone secretion|gut hormone secretion
1014323|NCT03073265|IVD|ivd
1014530|NCT03072004|Leprosy|leprosy
940312|NCT03543423|Glucose absorption|glucose absorption
1014727|NCT03070938|PHMB|phmb
1015122|NCT03068585|CLI|cli
1015322|NCT03067402|Angina|angina
1041488|NCT02905032|Aid|aid
1015518|NCT03066388|fluid|fluid
998528|NCT03173365|Mirvaso|mirvaso
1042539|NCT02897427|HPV|hpv
1017333|NCT03054350|CKD|ckd
1017425|NCT03053908|Orexin|orexin
1044370|NCT02885766|CML|cml
940313|NCT03543423|early meal phase|early meal phase
942107|NCT03531645|PD-0332991|pd-0332991
1019081|NCT03043378|Surveys|surveys
1019566|NCT03040687|CS6|cs6
1019676|NCT03039907|Knee|knee
1020699|NCT03033420|CBT|cbt
1020751|NCT03033056|fMRI|fmri
942108|NCT03531645|Ibrance|ibrance
999326|NCT03167801|melatonin|melatonin
1021550|NCT03028181|smoke|smoke
999943|NCT03163355|pureed diet|pureed diet
999944|NCT03163355|dysphasia|dysphasia
999945|NCT03163342|Seasonal|seasonal
1050526|NCT02846935|THU|thu
1051526|NCT02840773|RANKL|rankl
1024430|NCT03010267|DP-R213|dp-r213
942109|NCT03531619|posturography|posturography
1025012|NCT03006302|IDO|ido
1054209|NCT02823886|MRI|mri
942110|NCT03531619|quality of life|quality of life
1025813|NCT03001557|sleep|sleep
1026030|NCT03000348|CF|cf
1026130|NCT02999945|growth|growth
999946|NCT03163303|Tobacco|tobacco
999947|NCT03163303|Cigarettes|cigarettes
1027510|NCT02990663|Stroke|stroke
1028188|NCT02986464|Burns|burns
1057830|NCT02801877|App|app
1028589|NCT02983838|Amyloid|amyloid
999948|NCT03163303|Alcohol|alcohol
1028890|NCT02982226|ReNu|renu
1028971|NCT02981602|Chronic|chronic
999949|NCT03163303|Cessation|cessation
942111|NCT03531619|pressure algometry|pressure algometry
1029957|NCT02976311|TNF|tnf
1030359|NCT02973945|HFNC|hfnc
1030523|NCT02972840|Btk|btk
942112|NCT03531619|cervicogenic dizziness|cervicogenic dizziness
1061971|NCT02779153|SLE|sle
1032236|NCT02961816|G-CSF|g-csf
1032429|NCT02960646|Fludara|fludara
942113|NCT03531593|MTX|mtx
942114|NCT03531593|IBD|ibd
1000053|NCT03162653|Allopurinol|allopurinol
1001326|NCT03155360|Migraine|migraine
1003591|NCT03140267|Weaning|weaning
1034672|NCT02947152|ADC|adc
1034727|NCT02946762|TB|tb
1003975|NCT03137290|Sugammadex|sugammadex
1035428|NCT02942212|CQ|cq
942115|NCT03531593|US Elastography|us elastography
1035785|NCT02939872|BVS|bvs
1067394|NCT02745600|RFA|rfa
1035997|NCT02938520|CAB|cab
1003976|NCT03137277|Colonoscopy|colonoscopy
1004492|NCT03133845|delirium|delirium
1036850|NCT02932774|SAR|sar
1037044|NCT02931721|MRI|mri
1004493|NCT03133845|elderly|elderly
1037912|NCT02926469|VR|vr
942116|NCT03531593|Liver Fibrosis|liver fibrosis
1004494|NCT03133845|lumbar|lumbar
1070899|NCT02724254|AGW|agw
1004495|NCT03133845|surgery|surgery
1004598|NCT03133221|NHL|nhl
1004696|NCT03132597|depression|depression
1005410|NCT03127800|Respiration|respiration
1039956|NCT02914964|Fatigue|fatigue
1040242|NCT02912936|MCT|mct
1040481|NCT02910934|IRS|irs
1040598|NCT02910284|HSV|hsv
1073533|NCT02708472|TMS|tms
1005609|NCT03126435|Gemcitabine|gemcitabine
1040952|NCT02908256|PVI|pvi
1005703|NCT03125850|inpatient|inpatient
1005803|NCT03125265|nutrition|nutrition
1041933|NCT02902159|Online|online
1006002|NCT03123536|high risk|high risk
1042637|NCT02896777|pH|ph
1006106|NCT03122860|SM04690|sm04690
1043213|NCT02893176|BOS|bos
942117|NCT03531567|Upper Extremity Hemiparesis|upper extremity hemiparesis
1044100|NCT02887690|MPL|mpl
1044303|NCT02886156|OSA|osa
1044762|NCT02883114|GSM|gsm
1044920|NCT02882321|AML|aml
1045083|NCT02881346|Spray|spray
1045468|NCT02878824|Child|child
1006306|NCT03121261|clonidine|clonidine
1045827|NCT02876796|DNL|dnl
1046087|NCT02874885|CRC|crc
1046284|NCT02873559|men|men
1006807|NCT03118362|Burns|burns
1081611|NCT02659241|DNA|dna
1047139|NCT02867839|S1|s1
1006907|NCT03117790|analgesia|analgesia
1007017|NCT03117114|resection|resection
1048319|NCT02860728|COPD|copd
1049731|NCT02851706|Glioma|glioma
1007215|NCT03115736|Hepatitis B|hepatitis b
1009273|NCT03103269|Prevention|prevention
1050824|NCT02845141|ACL|acl
1050985|NCT02844296|RCT|rct
1051315|NCT02842307|Nausea|nausea
1051496|NCT02841059|POP|pop
1051679|NCT02839798|TMS|tms
1051877|NCT02838498|EMS|ems
1052807|NCT02832401|EEG|eeg
1053012|NCT02831101|BIS|bis
1053119|NCT02830399|ECT|ect
942118|NCT03531567|Virtual Reality (VR)|virtual reality (vr)
1053419|NCT02829125|ERAS|eras
942217|NCT03530787|Curcumin|curcumin
1054297|NCT02823379|obese|obese
1054881|NCT02819518|PD1|pd1
1055382|NCT02816554|JECEVAX|jecevax
1092508|NCT02595190|VAS|vas
942218|NCT03530787|Zingerone|zingerone
943441|NCT03523403|Dysbiosis|dysbiosis
943442|NCT03523403|Type 2 diabetes risk|type 2 diabetes risk
1056280|NCT02811549|Adults|adults
1056563|NCT02809599|vertigo|vertigo
1009274|NCT03103269|Diet|diet
1009378|NCT03102437|FIX-HF-5CA|fix-hf-5ca
1009778|NCT03100058|Overweight|overweight
1057584|NCT02803307|DSP|dsp
1097471|NCT02566720|mri|mri
1009779|NCT03100045|HPV|hpv
1060414|NCT02787382|TORCH|torch
1060647|NCT02786342|HCC|hcc
1061186|NCT02783261|Y90|y90
943443|NCT03523403|Cardiovascular disease risk|cardiovascular disease risk
1736390|NCT03384576|Music|music
1062507|NCT02775903|Safety|safety
1101868|NCT02539680|CKD|ckd
1736391|NCT03384576|Emergency|emergency
1736392|NCT03384576|caregivers|caregivers
1063218|NCT02771626|RCC|rcc
1736591|NCT03259503|Rituxan|rituxan
1736592|NCT03259503|Caphosol|caphosol
1064124|NCT02765659|HIV|hiv
1736593|NCT03259503|Melphalan|melphalan
1736594|NCT03259503|Alkeran|alkeran
1736595|NCT03259503|Evomela|evomela
1736596|NCT03259503|Glutamine|glutamine
1065288|NCT02758977|ALPPS|alpps
1736597|NCT03259503|Enterex|enterex
1104927|NCT02520440|GIF|gif
1065567|NCT02757391|Cytoxan|cytoxan
1736598|NCT03259503|Glutapak-10|glutapak-10
1736599|NCT03259503|NutreStore|nutrestore
1736600|NCT03259503|Resource|resource
1736601|NCT03259503|GlutaSolve|glutasolve
1106293|NCT02512328|APP|app
1736602|NCT03259503|Sympt-X G.I|sympt-x g.i
1067261|NCT02746523|NHL|nhl
1736603|NCT03259503|Sympt-X|sympt-x
1067554|NCT02744833|DVT|dvt
1736604|NCT03259503|Gemcitabine|gemcitabine
1067845|NCT02743351|HSCT|hsct
1736605|NCT03259503|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1068732|NCT02737358|NAC|nac
1736606|NCT03259503|Gemzar|gemzar
1736607|NCT03259503|Busulfan|busulfan
1736608|NCT03259503|Busulfex|busulfex
1109820|NCT02492724|NDI|ndi
1069359|NCT02733263|fiber|fiber
1110571|NCT02487771|DHA|dha
1736609|NCT03259503|Myleran|myleran
1736610|NCT03259503|Pyridoxine|pyridoxine
1070598|NCT02725918|NSCLC|nsclc
1009780|NCT03100045|suppository|suppository
1009781|NCT03100045|Artesunate|artesunate
1009782|NCT03100045|artemisinin|artemisinin
1009886|NCT03099447|diplopia|diplopia
1112724|NCT02475395|Sperm|sperm
1010101|NCT03098459|Neurotrauma|neurotrauma
1010508|NCT03096379|TB|tb
1071900|NCT02718274|Malawi|malawi
1071999|NCT02717819|Frailty|frailty
1113619|NCT02470377|TMS|tms
1072428|NCT02715089|NGS|ngs
1010509|NCT03096379|CD|cd
1072895|NCT02712489|Tat|tat
1010510|NCT03096379|MRE|mre
1010511|NCT03096379|ileocecal|ileocecal
1011099|NCT03093051|Termination|termination
1011100|NCT03093051|Unpinning|unpinning
1073902|NCT02706015|Aura|aura
1116424|NCT02454400|RCT|rct
1011101|NCT03093051|Therapy|therapy
1011797|NCT03088514|Nitrate|nitrate
1075350|NCT02697227|SC|sc
1012083|NCT03086564|TACE|tace
1012179|NCT03086070|treatment|treatment
943444|NCT03523390|Metastatic Solid Tumors|metastatic solid tumors
943445|NCT03523390|Avelumab|avelumab
943446|NCT03523390|MSB0010718C|msb0010718c
1076813|NCT02689284|PD|pd
1076898|NCT02688712|5FU|5fu
1077321|NCT02685826|PD-L1|pd-l1
943447|NCT03523377|Fasting|fasting
943448|NCT03523377|18-199|18-199
1077877|NCT02682407|MN|mn
1012180|NCT03086070|adults|adults
1078633|NCT02677324|WM|wm
1012181|NCT03086057|PrEP|prep
1012182|NCT03086057|Prevention|prevention
1012384|NCT03084731|Microbiota|microbiota
1079456|NCT02671968|CGM|cgm
1079676|NCT02670356|DHA|dha
1012699|NCT03082534|PD-1|pd-1
1012700|NCT03082534|PD-L1|pd-l1
1080477|NCT02665104|TCD|tcd
1080754|NCT02663674|FLEET|fleet
1081659|NCT02659007|yoga|yoga
1081874|NCT02657980|MDD|mdd
1082052|NCT02657057|OAB|oab
1012903|NCT03081494|MMS|mms
1082363|NCT02655016|HRD|hrd
1126868|NCT02396524|Men|men
1012904|NCT03081494|CMS4|cms4
943449|NCT03523351|Palliative Radiation|palliative radiation
1083256|NCT02649660|Gb3|gb3
1083348|NCT02649088|outcome|outcome
943450|NCT03523351|18-196|18-196
1084320|NCT02643069|Frailty|frailty
1013006|NCT03080792|cancer|cancer
1038477|NCT02923141|HIV|hiv
1013007|NCT03080753|Sphinkeeper|sphinkeeper
1013644|NCT03077438|Meningitis|meningitis
1014150|NCT03074487|Monitoring|monitoring
1086015|NCT02633683|RLS|rls
1086080|NCT02633241|MRI|mri
1014151|NCT03074474|use of mesh|use of mesh
1014653|NCT03071406|Ipilimumab|ipilimumab
1086990|NCT02628678|FOS|fos
943451|NCT03523325|Tendinopathy|tendinopathy
1087561|NCT02625753|pain|pain
943452|NCT03523325|Tendon|tendon
1088398|NCT02620800|ABI-007|abi-007
1088502|NCT02620267|MMN|mmn
1134415|NCT02353143|AML|aml
1014755|NCT03070847|rhinoplasty|rhinoplasty
1089315|NCT02614820|DMD|dmd
1014958|NCT03069573|Diagnose|diagnose
1014959|NCT03069573|Biomarker|biomarker
1089898|NCT02611037|MPM|mpm
1015162|NCT03068299|Prevention|prevention
1090095|NCT02609737|CT scan|ct scan
943453|NCT03523325|Rehabilitation|rehabilitation
1015163|NCT03068299|Cognition|cognition
1090589|NCT02606487|CF|cf
1015164|NCT03068299|Aged care|aged care
1015165|NCT03068299|Caregivers|caregivers
1091210|NCT02602860|PET|pet
943454|NCT03523325|Exercise treatment|exercise treatment
1016105|NCT03063164|Visumax|visumax
1016201|NCT03062358|PDL1|pdl1
1016202|NCT03062358|PD-L1|pd-l1
1016203|NCT03062358|PDL2|pdl2
1016204|NCT03062345|Stroke|stroke
1093163|NCT02591459|Autism|autism
1017298|NCT03054675|Thoracotomy|thoracotomy
1093758|NCT02587832|ELBW|elbw
1017299|NCT03054662|Haemophilia|haemophilia
1093646|NCT02588586|HIV|hiv
1093818|NCT02587442|ARS|ars
1093920|NCT02586935|ASD|asd
1094064|NCT02585973|CRT|crt
1094154|NCT02585167|VAAFT|vaaft
1019591|NCT03040557|foot|foot
1094348|NCT02583854|VAS|vas
1022215|NCT03024125|protein|protein
943455|NCT03523312|Ablative Irradiation|ablative irradiation
1095251|NCT02578680|PD1|pd1
943456|NCT03523312|18-090|18-090
1095951|NCT02574871|Stress|stress
1022508|NCT03022253|PDA|pda
1022509|NCT03022253|Platelets|platelets
1096946|NCT02569476|B-cell|b-cell
1022702|NCT03021109|ultrasound|ultrasound
943457|NCT03523299|invasive ductal carcinoma|invasive ductal carcinoma
943561|NCT03522610|Parenting|parenting
1098296|NCT02561715|DBS|dbs
1098793|NCT02558790|ADD|add
943562|NCT03522597|Obesity|obesity
1098991|NCT02557399|Gel|gel
1099181|NCT02556372|JKB-122|jkb-122
1099299|NCT02555683|Asthma|asthma
1736611|NCT03259503|Autologous Stem-Cell Transplant|autologous stem-cell transplant
1736612|NCT03259503|ASCT|asct
1099707|NCT02552927|PDA|pda
1736613|NCT03259503|G-CSF|g-csf
1149013|NCT02270242|PCI|pci
1100432|NCT02548793|CPR|cpr
1100474|NCT02548572|TES|tes
1100852|NCT02546154|Iron|iron
1736614|NCT03259503|Filgrastim|filgrastim
1736615|NCT03259503|Neupogen|neupogen
1736616|NCT03258580|Pain|pain
1150243|NCT02262988|knee|knee
943673|NCT03522051|pulpotomy|pulpotomy
944415|NCT03517631|AIDS|aids
1151252|NCT02257242|Phase I|phase i
1102129|NCT02538094|MS|ms
1102323|NCT02536768|ART|art
944416|NCT03517631|Lentivirus|lentivirus
1102614|NCT02534389|omega-3|omega-3
1102712|NCT02533804|health|health
1102879|NCT02532907|HCV|hcv
1102905|NCT02532725|men|men
1152637|NCT02249715|TMS|tms
1103331|NCT02530476|AML|aml
1103443|NCT02530034|AML|aml
944417|NCT03517631|shRNA|shrna
1736617|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
944418|NCT03517631|Multiplex|multiplex
945838|NCT03509103|Partograpgh|partograpgh
945939|NCT03508284|Cognition|cognition
1154524|NCT02240784|AIP|aip
1104928|NCT02520440|MOF|mof
946137|NCT03507114|Depression|depression
1105162|NCT02519283|AHF|ahf
946138|NCT03507114|Anxiety|anxiety
946340|NCT03505697|exercise|exercise
946543|NCT03504267|exercise|exercise
947137|NCT03500250|Stroke|stroke
947138|NCT03500250|Feasibility|feasibility
1157197|NCT02228694|ADC|adc
947139|NCT03500237|anxiety|anxiety
1107002|NCT02508376|GLA-SE|gla-se
1157899|NCT02225496|SCC|scc
947140|NCT03500237|depression|depression
1158862|NCT02221596|MRS|mrs
1107988|NCT02502734|asthma|asthma
947239|NCT03499665|Myofascial|myofascial
1108175|NCT02501720|burn|burn
1108403|NCT02500602|AUD|aud
1108469|NCT02500316|r-hGH|r-hgh
947240|NCT03499665|Releasing|releasing
1736618|NCT03258580|Healthy Volunteer|healthy volunteer
1159814|NCT02217371|PSG|psg
1736619|NCT03258580|Social Cognition|social cognition
947341|NCT03499002|Simulation|simulation
1109411|NCT02494908|MRI|mri
948970|NCT03488498|follow-up|follow-up
1109662|NCT02493582|CIK|cik
949171|NCT03487237|Syncope|syncope
950337|NCT03479229|orgasm|orgasm
1736620|NCT03258580|Eye Movement|eye movement
950338|NCT03479216|Analgesia|analgesia
950339|NCT03479216|Anesthesia|anesthesia
950340|NCT03479216|Arthroscopy|arthroscopy
950341|NCT03479216|Bupivacaine|bupivacaine
951050|NCT03474653|Bulkamid|bulkamid
1736621|NCT03258606|Research Participants|research participants
1111539|NCT02482506|Adults|adults
1736622|NCT03258606|Retrospective Review|retrospective review
1163806|NCT02199054|Soy|soy
1736623|NCT03258606|Capacity Assignment|capacity assignment
951147|NCT03474172|Sham Tuina|sham tuina
1164169|NCT02197169|Brain|brain
951753|NCT03470662|Aged|aged
951754|NCT03470662|Care bundle|care bundle
1736624|NCT03258606|Cognitive Impairment|cognitive impairment
1736625|NCT03258606|Assent|assent
1165057|NCT02193425|PET|pet
1113044|NCT02473497|ALK|alk
952152|NCT03468036|ICU|icu
952153|NCT03468036|extubation|extubation
1113513|NCT02471092|satiety|satiety
1736626|NCT03253744|Image Guidance|image guidance
952553|NCT03465618|17-599|17-599
1114324|NCT02466958|MDD|mdd
1736627|NCT03253744|Dose Escalation|dose escalation
952653|NCT03465085|Heparin|heparin
954089|NCT03454841|VASP|vasp
954494|NCT03452943|children|children
1115019|NCT02462824|PAD|pad
1115142|NCT02462174|caudal|caudal
1115333|NCT02461017|airway|airway
1115425|NCT02460471|IMRT|imrt
955194|NCT03448276|Vibration|vibration
1116121|NCT02456363|NSAIDs|nsaids
1736628|NCT03253744|Radiotherapy|radiotherapy
955195|NCT03448276|Walking|walking
955196|NCT03448263|pain|pain
1736629|NCT03253744|Re-irradiation|re-irradiation
1170295|NCT02166879|OSA|osa
956095|NCT03442920|serum|serum
957104|NCT03436771|JCARH125|jcarh125
957207|NCT03436277|Overweight|overweight
1736630|NCT03253744|Quality of Life|quality of life
1736631|NCT03253718|Healthy Volunteers|healthy volunteers
957208|NCT03436277|Obesity|obesity
957209|NCT03436277|L-Carnitine|l-carnitine
957210|NCT03436277|Body weight|body weight
957312|NCT03435640|Metastatic|metastatic
957825|NCT03432767|pregnancy|pregnancy
1119772|NCT02434549|Adults|adults
1120102|NCT02432560|LAM|lam
959070|NCT03424889|Anaesthesia|anaesthesia
1120361|NCT02431351|KPT-330|kpt-330
1736632|NCT03253731|Brain Plasticity|brain plasticity
959783|NCT03420495|OCD|ocd
1120755|NCT02429310|IC|ic
1121042|NCT02427880|Edema|edema
1175665|NCT02142127|GFT505|gft505
959977|NCT03419403|radiation|radiation
1736633|NCT03253731|Healthy Volunteers|healthy volunteers
1176588|NCT02137915|AMD|amd
1736634|NCT03251989|Brain Tumor|brain tumor
960484|NCT03416335|DSP-0509|dsp-0509
1736635|NCT03251989|Central Nervous System|central nervous system
1178285|NCT02130193|PK|pk
1178705|NCT02128568|War|war
1736636|NCT03251989|CNS|cns
1123795|NCT02414269|CAR|car
1123951|NCT02413372|NASH|nash
1736637|NCT03248635|Survey|survey
1736638|NCT03248635|Pre-Test|pre-test
1124417|NCT02410733|RNA|rna
1736639|NCT03248622|Incidence|incidence
1179742|NCT02123498|ETD|etd
1124544|NCT02410057|growth|growth
1124995|NCT02407379|PMN|pmn
1181182|NCT02117375|MRI|mri
1125727|NCT02403271|NSCLC|nsclc
1736640|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
960485|NCT03416322|Adenoma|adenoma
960877|NCT03413631|parenthood|parenthood
961378|NCT03410771|Antibiotics|antibiotics
961379|NCT03410745|exercise|exercise
961380|NCT03410745|cytokines|cytokines
961381|NCT03410745|collagen|collagen
1127632|NCT02391831|SMA|sma
1736641|NCT03248622|Decompensation|decompensation
1183968|NCT02106013|HDL|hdl
961887|NCT03407430|Bone pain|bone pain
1129587|NCT02380963|Soy|soy
1129721|NCT02380391|HIV|hiv
1186964|NCT02092428|CAD|cad
1130514|NCT02376049|Eczema|eczema
962607|NCT03402828|Long-term|long-term
1131240|NCT02371590|CLL|cll
1188324|NCT02085538|AUC|auc
962608|NCT03402815|HIV|hiv
1736642|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
962810|NCT03401203|ISR|isr
1131804|NCT02368145|stroke|stroke
1131998|NCT02367235|robotic|robotic
962811|NCT03401203|ROTA|rota
1132293|NCT02365454|TAA|taa
962812|NCT03401203|DEB|deb
962813|NCT03401203|PCI|pci
962912|NCT03400514|concordance|concordance
1133379|NCT02359071|handoff|handoff
1736643|NCT03245619|Acute pancreatitis|acute pancreatitis
965011|NCT03387540|Anti-PD-1|anti-pd-1
965012|NCT03387540|Anti-PD-L1|anti-pd-l1
965013|NCT03387540|Anti CTLA-4|anti ctla-4
965301|NCT03385785|Monitoring|monitoring
965302|NCT03385785|Hemodynamic|hemodynamic
1134846|NCT02350452|AMH|amh
965503|NCT03384563|pediatric|pediatric
1135139|NCT02348788|Malaria|malaria
965504|NCT03384563|anesthesia|anesthesia
965607|NCT03383783|Caries|caries
1194031|NCT02059811|Diet|diet
1136132|NCT02343289|Healthy|healthy
1136520|NCT02341235|story|story
966300|NCT03379311|AKC|akc
966301|NCT03379311|PAC|pac
966302|NCT03379311|VKC|vkc
966715|NCT03376633|RCT|rct
1137339|NCT02336165|GBM|gbm
1736644|NCT03245619|Dose-escalation|dose-escalation
967015|NCT03374696|theater,|theater,
967209|NCT03373383|Epilepsy|epilepsy
1138498|NCT02328885|DLI|dli
967210|NCT03373383|Padsevonil|padsevonil
967211|NCT03373357|sleep apnea|sleep apnea
1138850|NCT02327065|EUS|eus
967309|NCT03372746|Biopsy|biopsy
1139215|NCT02325180|ACT|act
1139739|NCT02322307|PRO|pro
1139876|NCT02321761|TBI|tbi
1140049|NCT02321059|hernia|hernia
969395|NCT03359915|SGRQ|sgrq
1140474|NCT02318628|PWV|pwv
1140665|NCT02317536|DXA|dxa
1141353|NCT02313909|Xarelto|xarelto
969396|NCT03359915|LMIC|lmic
1141716|NCT02311699|Gender|gender
1141815|NCT02311166|Hip|hip
1141917|NCT02310568|safety|safety
1201936|NCT02024542|Obesity|obesity
1142411|NCT02307682|AMD|amd
1142613|NCT02306577|HIV|hiv
969501|NCT03359252|stent|stent
1142809|NCT02305758|ABT-888|abt-888
1736645|NCT03245619|Healthy subjects|healthy subjects
1736646|NCT03245619|GSK3335065|gsk3335065
969502|NCT03359239|PGV001|pgv001
1143289|NCT02302781|IVF|ivf
969697|NCT03357939|HLX03|hlx03
969698|NCT03357939|adalimumab|adalimumab
969900|NCT03356587|abemaciclib|abemaciclib
1204573|NCT02012413|PST|pst
1736647|NCT03234790|Diesel Exhaust|diesel exhaust
1736648|NCT03234790|Air Pollution|air pollution
1205065|NCT02010203|BCG|bcg
1144537|NCT02295592|PPH|pph
970096|NCT03355365|Bone Marrow|bone marrow
970407|NCT03352934|avelumab|avelumab
1145525|NCT02290496|CBT|cbt
1206702|NCT02002741|PDA|pda
1736649|NCT03234790|Airway Responsiveness|airway responsiveness
1146108|NCT02287116|BPD|bpd
1736650|NCT03234790|Proteomics|proteomics
1207469|NCT01999413|AML|aml
1736651|NCT03234790|Urine PAH Metabolites|urine pah metabolites
1736652|NCT03226704|CD19|cd19
1147068|NCT02281292|Retina|retina
1736653|NCT03226704|CD22|cd22
1736654|NCT03226704|CD19/22|cd19/22
970408|NCT03352934|anti-PD-L1|anti-pd-l1
1148350|NCT02274207|DMF|dmf
970802|NCT03350048|Diagnostics|diagnostics
1148903|NCT02271074|HIV|hiv
1148993|NCT02270359|CAD|cad
970803|NCT03350048|Biomarkers|biomarkers
1211541|NCT01980901|AAA|aaa
970804|NCT03349957|TACE|tace
970805|NCT03349944|exercise|exercise
1149926|NCT02265198|ARDS|ards
1150103|NCT02263950|LON002|lon002
970905|NCT03349450|Canada|canada
970906|NCT03349450|Ontario|ontario
1736655|NCT03226704|Immunotherapy|immunotherapy
1213847|NCT01970371|cUTI|cuti
1736656|NCT03226704|Apheresis|apheresis
1736657|NCT03225183|TOPMed|topmed
1214121|NCT01969240|Cardiac|cardiac
1736658|NCT03225183|Blood Pressure|blood pressure
1152073|NCT02252471|HIV|hiv
1152341|NCT02251015|splints|splints
971308|NCT03347123|melanoma|melanoma
971409|NCT03346382|Epilepsy|epilepsy
1152971|NCT02247869|HL|hl
1736659|NCT03225183|Long Noncoding RNA|long noncoding rna
1153462|NCT02245945|HIV|hiv
971613|NCT03345030|DNA damage|dna damage
1153835|NCT02244073|ICU|icu
1217611|NCT01953367|AUC|auc
1154434|NCT02241135|VNT|vnt
1154627|NCT02240160|Sativex|sativex
971614|NCT03345030|granulosa|granulosa
1218982|NCT01946828|FIM|fim
1155565|NCT02235883|FFR|ffr
1155624|NCT02235675|CLI|cli
1156408|NCT02231853|EBV|ebv
1157856|NCT02225600|BPD|bpd
971615|NCT03345030|IVF outcome|ivf outcome
971616|NCT03345004|Diamyd|diamyd
1159215|NCT02220088|TACE|tace
1159521|NCT02218762|asthma|asthma
1224260|NCT01922284|HIV|hiv
1160001|NCT02216591|HIV|hiv
971617|NCT03345004|Diabetes|diabetes
1225339|NCT01917682|PCI|pci
1161051|NCT02211599|fat|fat
1161579|NCT02208999|pain|pain
971915|NCT03343197|AG-120|ag-120
1161953|NCT02207413|Safety|safety
1162445|NCT02205216|FOG|fog
1162571|NCT02204683|AMD|amd
971916|NCT03343197|AG-881|ag-881
1164085|NCT02197702|RCT|rct
1164685|NCT02194881|CFTR|cftr
1231089|NCT01890811|CKD|ckd
1165171|NCT02192879|PCA|pca
1165479|NCT02191436|Anxiety|anxiety
1166187|NCT02188862|Oceania|oceania
972111|NCT03341806|LITT|litt
973318|NCT03334617|AZD9150|azd9150
1166906|NCT02185820|CPD|cpd
973319|NCT03334617|AZD6738|azd6738
1736660|NCT03225183|Gene Expression|gene expression
1167256|NCT02184455|Leg|leg
1736661|NCT03225183|MicroRNA|microrna
1168837|NCT02175004|FAP|fap
1736662|NCT03225170|BRCA1|brca1
1736663|NCT03225170|BRCA2|brca2
1736664|NCT03225170|Clinical Decision-Making|clinical decision-making
1237205|NCT01863381|ICP|icp
1169872|NCT02168933|laser|laser
1736665|NCT03225157|Audiogram|audiogram
1736666|NCT03225157|Statins|statins
1237877|NCT01860339|HD|hd
1170384|NCT02166502|HIV|hiv
1170705|NCT02164786|NMR|nmr
1170738|NCT02164630|TMD|tmd
1170984|NCT02163616|PPH|pph
1736667|NCT03225157|Drug Response|drug response
1239015|NCT01855451|HPV|hpv
973320|NCT03334617|Vistusertib|vistusertib
973321|NCT03334617|AZD2014|azd2014
1736668|NCT03225157|Cancer Treatment|cancer treatment
973424|NCT03333837|Memory loss|memory loss
1172378|NCT02157376|SUP|sup
1172876|NCT02155062|Wheat|wheat
973425|NCT03333837|Caregivers|caregivers
975328|NCT03322150|bradycardia|bradycardia
1174073|NCT02149394|Ice|ice
975715|NCT03319485|Pallidotomy|pallidotomy
1243385|NCT01836094|PVT|pvt
1243610|NCT01834911|HD|hd
1174837|NCT02145884|timolol|timolol
1175536|NCT02142894|TB|tb
975716|NCT03319472|malignant|malignant
1175937|NCT02140814|PKD|pkd
975717|NCT03319472|cancer|cancer
1176770|NCT02137057|DM|dm
1177243|NCT02134600|DHA|dha
975818|NCT03318887|Cirrhosis|cirrhosis
975918|NCT03318406|registry|registry
976403|NCT03315208|anxiety|anxiety
992702|NCT03210298|PITAC|pitac
1179239|NCT02126007|HIV|hiv
1180104|NCT02121951|Cancer|cancer
1180476|NCT02120352|RPV|rpv
977518|NCT03307811|hepatic|hepatic
1180909|NCT02118545|vWF|vwf
1182438|NCT02112396|CRAFT|craft
1253921|NCT01788241|BMI|bmi
1182955|NCT02110069|KHE|khe
1183048|NCT02109770|XXY|xxy
1183574|NCT02107495|CHF|chf
1184226|NCT02105012|Mild|mild
1184360|NCT02104219|HPP|hpp
977519|NCT03307811|EUS|eus
1256812|NCT01775319|Zinc|zinc
1185461|NCT02099266|MDS|mds
977935|NCT03305276|vitamin d|vitamin d
1736669|NCT03225157|Head and Neck Cancer|head and neck cancer
1186258|NCT02095678|HCC|hcc
1187371|NCT02090400|BMD|bmd
1260312|NCT01759615|SGA|sga
977936|NCT03305237|Weight loss|weight loss
1260678|NCT01757964|IBD|ibd
1188358|NCT02085356|HIV|hiv
1188732|NCT02083744|Spanish|spanish
1262130|NCT01750944|Toe|toe
1736670|NCT03225196|Extracellular RNA|extracellular rna
1189727|NCT02079402|ICU|icu
1189826|NCT02078960|CML|cml
1189936|NCT02078479|VDS|vds
1263815|NCT01743066|Arsenic|arsenic
1190603|NCT02075567|Glucose|glucose
1736671|NCT03225196|MicroRNA|microrna
1736769|NCT03157128|RET-PTC8|ret-ptc8
1736770|NCT03157128|HOOK3-RET|hook3-ret
1736771|NCT03157128|PCM1-RET|pcm1-ret
1736772|NCT03157128|TRIM24-RET|trim24-ret
1736773|NCT03157128|RET-PTC6|ret-ptc6
1191764|NCT02070133|Statins|statins
1191847|NCT02069691|stroke,|stroke,
1192272|NCT02067806|TNS|tns
1192343|NCT02067416|DDR|ddr
1736774|NCT03157128|TRIM27-RET|trim27-ret
1192739|NCT02065505|Posture|posture
1266817|NCT01729793|IL6|il6
1267109|NCT01728740|FDC|fdc
1736775|NCT03157128|TRIM33-RET|trim33-ret
1736776|NCT03157128|RET-PTC7|ret-ptc7
1193870|NCT02060513|KPC|kpc
1736777|NCT03157128|AKAP13-RET|akap13-ret
1194199|NCT02059031|HIV|hiv
1194519|NCT02057458|CF|cf
1194604|NCT02057146|PSC|psc
1194697|NCT02056873|DBS|dbs
1195379|NCT02053870|Wheezes|wheezes
1195669|NCT02052453|ICD|icd
1736778|NCT03157128|FKBP15-RET|fkbp15-ret
1736779|NCT03157128|SPECC1L-RET|specc1l-ret
1274265|NCT01697189|stress|stress
1198838|NCT02038868|BPH|bph
1199302|NCT02036710|PYY|pyy
1199618|NCT02035176|ADHD|adhd
1275898|NCT01690130|TMS|tms
1200716|NCT02029989|MTM|mtm
1201427|NCT02026674|bph|bph
1736780|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
1278306|NCT01679340|S-1|s-1
1736781|NCT03157128|BCR-RET|bcr-ret
1736782|NCT03157128|FGRF1OP-RET|fgrf1op-ret
1736783|NCT03157128|RFG8-RET|rfg8-ret
1736784|NCT03157128|RET-PTC9|ret-ptc9
1736785|NCT03157128|ACBD5-RET|acbd5-ret
1736786|NCT03157128|MYH13-RET|myh13-ret
1736787|NCT03157128|CUX1-RET|cux1-ret
978457|NCT03301740|Dialysis|dialysis
1736788|NCT03157128|KIAA1468-RET|kiaa1468-ret
1736789|NCT03157128|FRMD4A-RET|frmd4a-ret
1736790|NCT03157128|SQSTM1-RET|sqstm1-ret
1283709|NCT01654939|HIV|hiv
1206517|NCT02003742|LUTS|luts
1736791|NCT03157128|AFAP1L2-RET|afap1l2-ret
1736792|NCT03157128|PPFIBP2-RET|ppfibp2-ret
1206957|NCT02001649|SNP|snp
1285468|NCT01646333|Memory|memory
1207615|NCT01998646|ASP4058|asp4058
1736793|NCT03157128|EML4-RET|eml4-ret
1208210|NCT01996293|bipolar|bipolar
1208737|NCT01993849|Anxiety|anxiety
1208836|NCT01993316|EEG|eeg
1736794|NCT03157128|PARD3-RET|pard3-ret
1209200|NCT01991470|Sensor|sensor
1209293|NCT01990963|MALUNA;|maluna;
1209589|NCT01989455|Healthy|healthy
1288315|NCT01633060|HR+|hr+
1736795|NCT03157128|G533C|g533c
1736796|NCT03157128|C609F|c609f
1210783|NCT01983995|Fatigue|fatigue
1211753|NCT01979692|CLM|clm
1291060|NCT01620606|FAP|fap
1212085|NCT01978145|safety|safety
1736797|NCT03157128|C609G|c609g
1736798|NCT03157128|C609R|c609r
1736799|NCT03157128|C609S|c609s
1212806|NCT01974999|Kidney|kidney
1213239|NCT01973127|TMS|tms
1213615|NCT01971437|UTI|uti
1293454|NCT01610310|SC|sc
1213898|NCT01970150|EEG|eeg
1293764|NCT01609465|CAD|cad
1214202|NCT01968850|HIV|hiv
1736800|NCT03157128|C609Y|c609y
1736801|NCT03157128|C611F|c611f
1215371|NCT01963910|Pain|pain
1736802|NCT03157128|C611G|c611g
1215790|NCT01962311|ALS|als
1736803|NCT03157128|C611S|c611s
1216214|NCT01960244|FH|fh
1297424|NCT01594177|GBG|gbg
1217358|NCT01954472|soy|soy
1217488|NCT01953900|GD2|gd2
1217567|NCT01953575|EoE|eoe
1218218|NCT01950351|Gy|gy
1218276|NCT01950091|app|app
1218862|NCT01947270|Elderly|elderly
1736804|NCT03157128|C611Y|c611y
1220206|NCT01941251|rTMS|rtms
1220798|NCT01938495|ALS|als
1736805|NCT03157128|C611W|c611w
1221341|NCT01935674|HIV|hiv
1221691|NCT01934088|IBD|ibd
1222006|NCT01932710|AML|aml
1736806|NCT03157128|C618F|c618f
1736807|NCT03157128|C618R|c618r
1736808|NCT03157128|C618S|c618s
1305442|NCT01559844|HCC|hcc
1223348|NCT01926418|HIV|hiv
1736809|NCT03157128|C620F|c620f
1306069|NCT01557231|OA|oa
1223926|NCT01923909|Knee|knee
1224321|NCT01921933|AVF|avf
1224875|NCT01919697|CIC|cic
1736810|NCT03157128|C620R|c620r
1225000|NCT01919229|CDK|cdk
1736811|NCT03157128|C620S|c620s
1225196|NCT01918293|ASTHMA|asthma
1225298|NCT01917851|Hb|hb
1225380|NCT01917526|Oxygen|oxygen
1226321|NCT01912950|IPL|ipl
1736812|NCT03157128|C630R|c630r
1310635|NCT01538368|EUS|eus
1227256|NCT01908426|MET|met
1736813|NCT03157128|C630Y|c630y
1227643|NCT01906359|GIP|gip
1227726|NCT01905865|Coping|coping
1736814|NCT03157128|D631Y|d631y
1736815|NCT03157128|C634F|c634f
1312744|NCT01529073|HIV|hiv
1736816|NCT03157128|C634G|c634g
1229096|NCT01899651|EEG|eeg
1736817|NCT03157128|C634R|c634r
1229588|NCT01896973|BPH|bph
1229657|NCT01896609|Bon one|bon one
1736818|NCT03157128|C634S|c634s
1230410|NCT01893372|MDS|mds
1231045|NCT01890980|MPM|mpm
1231122|NCT01890720|Obesity|obesity
1231715|NCT01887834|gas|gas
1232398|NCT01884558|BAL8557|bal8557
1232623|NCT01883713|CPB|cpb
1736819|NCT03157128|C634W|c634w
1232972|NCT01882205|DALM|dalm
1736820|NCT03157128|C634Y|c634y
1736821|NCT03157128|K666E|k666e
1234482|NCT01875809|RDN|rdn
1736822|NCT03157128|E768D|e768d
1234979|NCT01873703|MDS|mds
1235273|NCT01872390|TB|tb
1321132|NCT01493427|OAG|oag
1736823|NCT03157128|L790F|l790f
1236216|NCT01867762|RV568|rv568
1736824|NCT03157128|V804L|v804l
1236915|NCT01864447|VTE|vte
1237530|NCT01861964|XOS|xos
1238494|NCT01857583|DU-176b|du-176b
1736825|NCT03157128|V804M|v804m
1238883|NCT01856127|SSRI|ssri
1239584|NCT01853384|ulcer|ulcer
1240396|NCT01849991|Crying|crying
1241002|NCT01847365|Okustim|okustim
1241099|NCT01846988|APAP|apap
1736826|NCT03157128|A883F|a883f
1241716|NCT01843998|CTCL|ctcl
1242342|NCT01840839|nap|nap
1242757|NCT01838941|PBD|pbd
1243042|NCT01837693|CIN|cin
1243146|NCT01837251|PLD|pld
1243285|NCT01836757|MSM|msm
1243562|NCT01835197|PK|pk
1244051|NCT01832935|NPH|nph
1244682|NCT01830231|TCCU|tccu
1244988|NCT01828762|DC|dc
1245195|NCT01827995|RCT|rct
1246676|NCT01821131|ALA|ala
1246797|NCT01820637|SFA|sfa
1736827|NCT03157128|S891A|s891a
1336367|NCT01431391|PSA|psa
1736828|NCT03157128|R912P|r912p
1247538|NCT01816867|hernia|hernia
1736829|NCT03157128|CLIP1-RET|clip1-ret
1247736|NCT01815970|dyspnea|dyspnea
1247834|NCT01815606|EUS-FNA|eus-fna
1247931|NCT01815333|MRI|mri
1248217|NCT01814033|LRU|lru
1248313|NCT01813552|HCV|hcv
1736830|NCT03157128|Y806C|y806c
1337684|NCT01426425|SVT|svt
1736831|NCT03157128|RET fusion|ret fusion
978657|NCT03300427|LVEF|lvef
978860|NCT03299257|CPAP|cpap
1250261|NCT01804452|MRI|mri
1250372|NCT01804244|Healthy|healthy
1736832|NCT03157128|RET alteration|ret alteration
1251173|NCT01800773|PTSD|ptsd
1251356|NCT01799889|WM|wm
1251476|NCT01799473|Tyvaso|tyvaso
1342295|NCT01408186|PPI|ppi
978861|NCT03299257|sleepiness|sleepiness
1736833|NCT03157128|RET mutation|ret mutation
1253751|NCT01788852|HPV|hpv
1253910|NCT01788241|Anxiety|anxiety
1345862|NCT01392820|PK|pk
1255197|NCT01782612|Stress|stress
1255400|NCT01781546|DEB|deb
1347734|NCT01384981|NIV|niv
1257130|NCT01773967|child|child
1736834|NCT03157128|RET rearrangement|ret rearrangement
1349827|NCT01376336|water|water
1736835|NCT03157128|RET translocation|ret translocation
1258481|NCT01768104|SET|set
1258580|NCT01767675|12-275|12-275
978862|NCT03299257|donepezil|donepezil
1259455|NCT01763645|NSCLC|nsclc
1259462|NCT01763619|DDD|ddd
978863|NCT03299231|COPD|copd
979165|NCT03297008|Rotavirus|rotavirus
1260320|NCT01759602|NMO|nmo
979669|NCT03293784|Infliximab|infliximab
1260523|NCT01758614|stroke|stroke
979763|NCT03293303|Homecare|homecare
1260805|NCT01757210|Survey|survey
979764|NCT03293303|Nursing|nursing
980655|NCT03287544|Linguistics|linguistics
1736836|NCT03157128|Neoplasms by Site|neoplasms by site
1262009|NCT01751464|youth|youth
1262177|NCT01750684|SCI|sci
1736837|NCT03157128|Neoplasms|neoplasms
980679|NCT03287401|EEG|eeg
982505|NCT03275415|surfactant|surfactant
1264787|NCT01739036|Malaria|malaria
1264893|NCT01738555|HIV|hiv
1358760|NCT01338987|FLT|flt
1736838|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
1359769|NCT01334879|eye|eye
982506|NCT03275415|budesonide|budesonide
1267145|NCT01728571|COPD|copd
983840|NCT03266523|MRI|mri
984439|NCT03262597|urine|urine
1267975|NCT01724944|IDS|ids
987303|NCT03244423|Pediatric|pediatric
987603|NCT03242382|advanced|advanced
1268639|NCT01721603|SRS|srs
987604|NCT03242382|sarcoma|sarcoma
1269267|NCT01718795|CPR|cpr
987605|NCT03242382|cdk4|cdk4
987995|NCT03239899|Brain|brain
988096|NCT03239288|Fiber|fiber
988202|NCT03238638|PD-L1|pd-l1
1271006|NCT01711294|PCL|pcl
1736839|NCT03157128|Lung Neoplasms|lung neoplasms
1271783|NCT01707927|EOA|eoa
1271847|NCT01707602|skin|skin
1272145|NCT01706419|iron|iron
1367892|NCT01301690|FNA|fna
1272484|NCT01704781|CD4|cd4
1737032|NCT03030391|Camp|camp
988203|NCT03238612|influenza|influenza
1737033|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
1737034|NCT03030391|Compartmental Analysis|compartmental analysis
1369799|NCT01293708|HRQOL|hrqol
1369916|NCT01293123|HIV|hiv
1274232|NCT01697319|LSD|lsd
1371053|NCT01288716|ASD|asd
1275305|NCT01692587|PSA|psa
1276008|NCT01689545|HIV|hiv
1276272|NCT01688336|5FU|5fu
1276326|NCT01688167|HIV|hiv
988204|NCT03238612|FFA|ffa
1737035|NCT03030027|Intergeneration|intergeneration
1279782|NCT01672879|HVPG|hvpg
1737036|NCT03030027|Reappraisal|reappraisal
1280500|NCT01669863|ARDS|ards
1280604|NCT01669278|sheath|sheath
1737037|NCT03030027|Caregiving|caregiving
1280893|NCT01668069|nausea|nausea
1280999|NCT01667627|IBS|ibs
1281175|NCT01666990|HIV|hiv
1281885|NCT01663467|Web|web
1282327|NCT01661439|aps|aps
1282480|NCT01660711|cancer|cancer
1282671|NCT01659697|BMI|bmi
1282766|NCT01659151|ACT|act
988494|NCT03236701|egg white|egg white
988897|NCT03234348|STEMI|stemi
1737038|NCT03028233|physical activity|physical activity
1284541|NCT01650987|uterus|uterus
1284756|NCT01649999|ASP015K|asp015k
1737039|NCT03028233|healthy eating|healthy eating
1285548|NCT01646060|blood|blood
1737040|NCT03028233|weight|weight
1737041|NCT03028233|families|families
1286107|NCT01643577|nausea|nausea
1286459|NCT01641796|CL|cl
1286592|NCT01641328|MCI|mci
1286842|NCT01640340|HEC|hec
1737042|NCT03028233|Community Health Worker|community health worker
1287130|NCT01638949|MCI|mci
1737043|NCT03028233|childhood obesity|childhood obesity
989278|NCT03231943|FTIH|ftih
1387564|NCT01216176|PK|pk
1737044|NCT03028233|built environment|built environment
1288195|NCT01633632|Yoga|yoga
935725|NCT03572595|FDG-PET/CT|fdg-pet/ct
989279|NCT03231943|Healthy|healthy
935726|NCT03572595|Staging and restaging|staging and restaging
935727|NCT03572569|Pediatrics|pediatrics
1391302|NCT01200537|IVF|ivf
989679|NCT03229317|Vitamin D|vitamin d
1291194|NCT01619956|RCT|rct
989680|NCT03229317|COPD|copd
1292182|NCT01616056|eye|eye
1292299|NCT01615601|HIV|hiv
1292552|NCT01614405|PBC|pbc
1292745|NCT01613586|ASP3652|asp3652
1293495|NCT01610180|ITP|itp
1293814|NCT01609244|bilevel|bilevel
1294573|NCT01605864|CAP|cap
1294633|NCT01605500|ICD|icd
935728|NCT03572569|Cardiomyopathy|cardiomyopathy
989681|NCT03229291|SM04755|sm04755
1397899|NCT01173510|HIV|hiv
989682|NCT03229291|topical|topical
1296475|NCT01597895|HIV|hiv
989683|NCT03229291|Samumed|samumed
1399119|NCT01168921|CLL|cll
1297231|NCT01594684|stent|stent
990093|NCT03226626|Prophylaxis|prophylaxis
990293|NCT03225534|Exposures|exposures
1297631|NCT01593241|RT|rt
1297716|NCT01593020|Cytoxan|cytoxan
1298343|NCT01590108|IPAH|ipah
1401019|NCT01160640|PID|pid
1298637|NCT01588782|CYP3A4|cyp3a4
1299095|NCT01586533|UC|uc
1299221|NCT01586065|CGM|cgm
1299966|NCT01583205|ALS|als
990423|NCT03224936|DISE|dise
1300910|NCT01579214|HIV|hiv
1301292|NCT01577537|BV|bv
1301301|NCT01577472|IVF|ivf
990424|NCT03224936|OSAS|osas
990425|NCT03224936|PSI|psi
935729|NCT03572569|Heart failure|heart failure
1302276|NCT01573429|HV|hv
1302629|NCT01572012|Safety|safety
935730|NCT03572569|Risk stratification|risk stratification
990745|NCT03222752|CES|ces
1303030|NCT01570426|MRI|mri
1303420|NCT01568749|otc|otc
1407236|NCT01135914|DME|dme
991036|NCT03221049|progression|progression
1304306|NCT01564953|QoL|qol
1304962|NCT01561729|pH|ph
1304997|NCT01561612|Asthma|asthma
935731|NCT03572569|Family screening|family screening
935732|NCT03572569|Genetics|genetics
935733|NCT03572517|Delirium|delirium
1306707|NCT01554527|child|child
935734|NCT03572517|Anesthesia|anesthesia
991139|NCT03220113|Migraine|migraine
1413054|NCT01112449|PSA|psa
992722|NCT03210155|Insomnia|insomnia
935735|NCT03572517|Surgical Oncology|surgical oncology
1309516|NCT01543035|patient|patient
1309799|NCT01541891|PRO-148|pro-148
935736|NCT03572465|Chronic liver disease|chronic liver disease
1415277|NCT01102790|HIT|hit
1415418|NCT01102088|SIB|sib
935737|NCT03572465|Fibrosis|fibrosis
1310480|NCT01538888|VO2|vo2
1310594|NCT01538459|Adult|adult
1311263|NCT01535339|mTBI|mtbi
992818|NCT03209401|Carboplatin|carboplatin
992819|NCT03209375|triage|triage
1312070|NCT01531842|CNV|cnv
1312348|NCT01530672|POC|poc
993430|NCT03205332|Anxiety|anxiety
1313137|NCT01527344|CAV|cav
1419132|NCT01087723|UFH|ufh
1313442|NCT01526044|insulin|insulin
1314255|NCT01522339|MRI|mri
994038|NCT03201679|Mortality|mortality
1315207|NCT01518374|AD|ad
1422064|NCT01076101|SLE|sle
1315906|NCT01515527|AML|aml
994933|NCT03195959|Hypoxia|hypoxia
1316195|NCT01514123|VGX-100|vgx-100
1317373|NCT01509209|vasomotor|vasomotor
1317681|NCT01507883|embryos|embryos
1318096|NCT01506232|EEG|eeg
1318184|NCT01505959|Apnea|apnea
1318655|NCT01504074|SD-OCT|sd-oct
1318754|NCT01503697|Imaging|imaging
1319008|NCT01502514|CHF|chf
1319526|NCT01500434|DES|des
1319722|NCT01499719|Disease|disease
994934|NCT03195959|Hyperoxia|hyperoxia
1320215|NCT01497470|cancer|cancer
1320496|NCT01496261|Phase 1|phase 1
1321193|NCT01493141|THA|tha
1321622|NCT01491555|DMD|dmd
1429733|NCT01046240|emesis|emesis
1429864|NCT01045655|Female|female
1322290|NCT01488773|ICS|ics
1430614|NCT01042600|Newborn|newborn
1323637|NCT01483183|A-fib|a-fib
1433252|NCT01031589|HIV|hiv
1325171|NCT01477138|SSS|sss
1434199|NCT01027767|MBI|mbi
1325317|NCT01476384|elderly|elderly
935738|NCT03572465|Elastography|elastography
935739|NCT03572465|Ultrasound|ultrasound
1329361|NCT01459822|sepsis|sepsis
1329293|NCT01460121|SpotOn|spoton
937506|NCT03560960|CSF pTau|csf ptau
1329882|NCT01457703|Obesity|obesity
994935|NCT03195933|Depression|depression
937507|NCT03560960|Cognitive evaluation|cognitive evaluation
937710|NCT03559985|Paracetamol|paracetamol
1331350|NCT01451489|CTX|ctx
1331443|NCT01451086|Safety|safety
1331637|NCT01450319|CRC|crc
995044|NCT03195179|disruption|disruption
1332456|NCT01446965|death|death
995045|NCT03195179|trauma|trauma
1333289|NCT01443637|CAD|cad
1022733|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
1444236|NCT00987987|adult|adult
1065113|NCT02760108|Genetics|genetics
1333674|NCT01442064|CNV|cnv
1022734|NCT03020849|prediction score|prediction score
1333965|NCT01440920|WT1|wt1
1065211|NCT02759588|imaging|imaging
1334261|NCT01439841|HIV|hiv
1334397|NCT01439347|ALL|all
1334752|NCT01437982|safety|safety
1065212|NCT02759588|carcinoma|carcinoma
1446548|NCT00979303|SVT|svt
1065213|NCT02759588|DNA virus|dna virus
1065214|NCT02759588|neoplasms|neoplasms
1447447|NCT00975845|ACL|acl
1336170|NCT01432171|HGG|hgg
1336226|NCT01432002|FDG|fdg
1022735|NCT03020849|severe trauma|severe trauma
1022736|NCT03020823|SCB01A|scb01a
1065614|NCT02757235|irrigation|irrigation
1337630|NCT01426646|S-1|s-1
1065615|NCT02757235|recurrence|recurrence
1338019|NCT01424982|ALL|all
1338105|NCT01424852|Caries|caries
1066619|NCT02750891|DIPG|dipg
1067029|NCT02748174|Curelator|curelator
1338609|NCT01422694|HLA-B27|hla-b27
1068944|NCT02735993|ADRC|adrc
1339128|NCT01420939|TBI|tbi
1069145|NCT02734602|PET|pet
1069240|NCT02734082|Berne|berne
1069241|NCT02734069|carboplatin|carboplatin
1339494|NCT01419522|TBI|tbi
1069343|NCT02733380|Chidamide|chidamide
1069946|NCT02729935|Parecoxib|parecoxib
1024349|NCT03010761|drug therapy|drug therapy
1452042|NCT00958204|RCT|rct
1339888|NCT01417637|TMD|tmd
1340078|NCT01416805|CBT|cbt
1340274|NCT01415986|SCC|scc
1070232|NCT02727855|Cholera|cholera
1340965|NCT01413178|MM|mm
1070233|NCT02727855|Vaccine|vaccine
1070234|NCT02727855|Strategy|strategy
1024350|NCT03010761|clinical trial|clinical trial
1454813|NCT00948961|NYESO1|nyeso1
1070740|NCT02725164|respiration|respiration
1342473|NCT01407627|human|human
1342560|NCT01407263|11-096|11-096
1342853|NCT01406171|ASP9766|asp9766
1343055|NCT01405209|EKG|ekg
1024351|NCT03010748|corneal morphology|corneal morphology
1070840|NCT02724618|Curcumin|curcumin
1343400|NCT01403766|GFR|gfr
1343688|NCT01402544|AMD|amd
1024352|NCT03010748|Chinese population|chinese population
1071367|NCT02721654|Plasma-Lyte|plasma-lyte
1344559|NCT01398813|HED|hed
1072074|NCT02717377|Micro bouts|micro bouts
1024353|NCT03010748|corneal curvature|corneal curvature
1345152|NCT01396135|927|927
1072183|NCT02716519|Diabetes|diabetes
1345439|NCT01394744|ion|ion
1345634|NCT01393834|Preterm|preterm
1346344|NCT01390974|ACS|acs
1072284|NCT02715895|Infant|infant
1072285|NCT02715895|Growth|growth
1346943|NCT01388257|Plug|plug
1072386|NCT02715336|IVF|ivf
1072780|NCT02713282|R092670|r092670
1073791|NCT02706873|Arthritis|arthritis
1347887|NCT01384162|ALS|als
1074014|NCT02705378|ICU|icu
1074122|NCT02704702|Fimasartan|fimasartan
1349159|NCT01378871|T Cell|t cell
1074123|NCT02704676|CA-125|ca-125
1022737|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1022738|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
1024354|NCT03010748|corneal thickness|corneal thickness
1074632|NCT02701816|Restenosis|restenosis
1074933|NCT02699736|coinfection|coinfection
1350370|NCT01373944|MPI|mpi
1075123|NCT02698501|Eosinophil|eosinophil
1465639|NCT00906399|MS|ms
1350934|NCT01371591|varix|varix
1351036|NCT01371110|OCD|ocd
1075124|NCT02698475|Psoriasis|psoriasis
1075125|NCT02698475|Ustekinumab|ustekinumab
1075126|NCT02698475|STELARA|stelara
1467160|NCT00900809|NK-92|nk-92
1352359|NCT01365676|PMS|pms
1352480|NCT01365169|CI|ci
1352650|NCT01364415|MTD|mtd
1022739|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
1352987|NCT01363128|CVC|cvc
1022740|NCT03020771|vaccine|vaccine
1022741|NCT03020771|human|human
1022742|NCT03020771|phase I|phase i
1075326|NCT02697305|Isoleucine|isoleucine
1022743|NCT03020745|Pharmacokinetics|pharmacokinetics
1022744|NCT03020745|Safety|safety
1353950|NCT01359488|IGF-I|igf-i
1469570|NCT00897715|CKD|ckd
1355391|NCT01352975|AMD|amd
1470587|NCT00894283|DVT|dvt
1075431|NCT02696954|Amodiaquine|amodiaquine
1075432|NCT02696954|Primaquine|primaquine
1022745|NCT03020745|Pharmacodynamics|pharmacodynamics
1022746|NCT03020745|Efficacy|efficacy
1356790|NCT01347320|MRI|mri
1357381|NCT01345019|SRE|sre
1075928|NCT02693964|Menopause|menopause
1022747|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
1022748|NCT03020745|GSK3389404|gsk3389404
1076137|NCT02692885|Phenotype|phenotype
1076448|NCT02691026|MPNST|mpnst
1358236|NCT01341132|HCC|hcc
1358537|NCT01339949|AMD|amd
1474882|NCT00877500|NST|nst
1076657|NCT02689973|body fat|body fat
1359588|NCT01335763|HbA1c|hba1c
1360074|NCT01333657|blood|blood
1076761|NCT02689440|Dasatinib|dasatinib
1076762|NCT02689440|BMS-354825|bms-354825
1360674|NCT01331044|RUTF|rutf
1360775|NCT01330615|EMLA|emla
1360863|NCT01330238|RCT|rct
1361063|NCT01329328|balance|balance
1076763|NCT02689440|Sprycel|sprycel
1022749|NCT03020732|growth factor|growth factor
1076764|NCT02689440|Venetoclax|venetoclax
1362358|NCT01323777|Toric|toric
1362794|NCT01322074|CRP|crp
1076765|NCT02689440|ABT-199|abt-199
1363751|NCT01318044|MRI|mri
1363831|NCT01317602|AF|af
1076766|NCT02689440|GDC-0199|gdc-0199
1076870|NCT02688959|exercise|exercise
1076871|NCT02688959|tai chi|tai chi
1076872|NCT02688959|ADHD|adhd
1333235|NCT01443923|HCV|hcv
1365002|NCT01313442|Samples|samples
1365080|NCT01313208|RA|ra
1365187|NCT01312714|Calcium|calcium
1078282|NCT02679859|Surgery|surgery
1078380|NCT02679157|ADL|adl
1078579|NCT02677636|Itching|itching
1365962|NCT01309334|MRI|mri
1022750|NCT03020732|mucogingival surgery|mucogingival surgery
1078580|NCT02677636|Rash|rash
1022751|NCT03020732|gingival recession|gingival recession
1484268|NCT00839436|ICL|icl
1484666|NCT00838097|CKD|ckd
1022752|NCT03020719|Growth Parameters|growth parameters
1078581|NCT02677636|Steroid|steroid
1079773|NCT02669667|Safety|safety
1367358|NCT01303796|AML|aml
1080498|NCT02665065|AML|aml
1080499|NCT02665065|BMT|bmt
1367913|NCT01301560|GKS|gks
1368095|NCT01300624|therapy|therapy
1368196|NCT01300182|ACLR|aclr
1368492|NCT01299103|wrinkle|wrinkle
1080799|NCT02663518|TTI-621|tti-621
1080800|NCT02663518|Solid Tumor|solid tumor
1080895|NCT02662907|Aspiration|aspiration
1081102|NCT02661789|human|human
1369575|NCT01294605|Td|td
1081103|NCT02661789|gender|gender
1369969|NCT01292954|FMD|fmd
1370243|NCT01291849|Cough|cough
1081104|NCT02661789|risk model|risk model
1022753|NCT03020719|Cystic Fibrosis|cystic fibrosis
1081314|NCT02660710|R-CHOP|r-chop
1081817|NCT02658292|spores|spores
1371252|NCT01287884|ABG|abg
1371418|NCT01287130|K-Ras|k-ras
1371723|NCT01285830|IgE|ige
1082523|NCT02654054|ABT-620|abt-620
1372120|NCT01283997|Velcade|velcade
1022754|NCT03020706|magnesium sulphate|magnesium sulphate
1491929|NCT00810693|PH|ph
1372682|NCT01281228|Satiety|satiety
1372775|NCT01280708|Urology|urology
1022755|NCT03020706|neostigmine|neostigmine
1373022|NCT01279499|BIS|bis
1373148|NCT01278953|RF|rf
1373253|NCT01278524|ICU|icu
1373484|NCT01277679|MRI|mri
1373837|NCT01276236|HIV|hiv
1373974|NCT01275625|hiv|hiv
1374138|NCT01275027|insulin|insulin
1374260|NCT01274598|LGG|lgg
1082723|NCT02652897|coagulation|coagulation
1082818|NCT02652494|Apremilast|apremilast
1495670|NCT00795886|ALL|all
1375773|NCT01268540|IOL|iol
1375977|NCT01267565|amylase|amylase
1376476|NCT01265498|FXR|fxr
1082819|NCT02652494|APRIL|april
1022756|NCT03020693|electrostimulation|electrostimulation
1083344|NCT02649127|exercise|exercise
1022757|NCT03020693|exercise program|exercise program
1378353|NCT01257022|HIV|hiv
1022758|NCT03020667|Cigarette|cigarette
1022759|NCT03020667|IQOS|iqos
1499434|NCT00781261|hip|hip
1378710|NCT01255371|Generic|generic
1379337|NCT01252641|HIV|hiv
1379592|NCT01251406|Stable|stable
1083345|NCT02649127|biomarker|biomarker
1022760|NCT03020667|Nicotine-containing product|nicotine-containing product
1501616|NCT00771771|ESD|esd
1022761|NCT03020667|Tobacco|tobacco
1380825|NCT01245790|RA|ra
1381301|NCT01243489|CML|cml
1024355|NCT03010748|higher order aberrations|higher order aberrations
1381488|NCT01242774|HDACi|hdaci
1024356|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
1024357|NCT03010735|Probiotics|probiotics
1382116|NCT01240161|PET|pet
1083447|NCT02648581|uveitis|uveitis
1024358|NCT03010735|Uremic toxins|uremic toxins
1083448|NCT02648581|ustekinumab|ustekinumab
1505096|NCT00756730|HIV|hiv
1383281|NCT01235598|CZP|czp
1383590|NCT01234194|Pain|pain
1383854|NCT01232933|PICC|picc
1383972|NCT01232361|HIV|hiv
1083449|NCT02648581|biologics|biologics
1384437|NCT01230281|C3G|c3g
1384638|NCT01229371|Virus|virus
1024359|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
1024744|NCT03008187|AML|aml
1083654|NCT02647411|Myopia|myopia
1024745|NCT03008174|tracheostomy|tracheostomy
1084233|NCT02643524|CAM boot|cam boot
1143673|NCT02300831|biomarker|biomarker
1084429|NCT02642380|ITP|itp
1024746|NCT03008174|quality of life|quality of life
1510052|NCT00738894|TIA|tia
1024747|NCT03008174|speaking valve|speaking valve
1387642|NCT01215851|EBA|eba
1022762|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
1388136|NCT01213498|NO|no
1388283|NCT01212978|Aging|aging
1388465|NCT01212315|Suture|suture
1024748|NCT03008174|speech|speech
1024947|NCT03006848|PD-L1|pd-l1
1084936|NCT02639338|Chronic|chronic
1084937|NCT02639325|Brain Tumor|brain tumor
1389104|NCT01209494|ECG|ecg
1389356|NCT01208519|ESBL|esbl
1389548|NCT01207583|vaccine|vaccine
1389672|NCT01207089|PK|pk
1389856|NCT01206192|Chinese|chinese
1390020|NCT01205438|SLE|sle
1390280|NCT01204515|IBS|ibs
1085435|NCT02636686|051-302|051-302
1391096|NCT01201382|Adolescents|adolescents
1391194|NCT01200966|ET|et
1391515|NCT01199861|MS|ms
1086029|NCT02633553|thymoma|thymoma
1024948|NCT03006848|Immunotherapy|immunotherapy
1025046|NCT03006068|Efficacy|efficacy
1516454|NCT00715806|MRI|mri
1025047|NCT03006042|bupivacaine|bupivacaine
1392658|NCT01194947|NEVUS|nevus
1392762|NCT01194466|Pain|pain
1392943|NCT01193517|CRC|crc
1393200|NCT01192685|TMS|tms
1086835|NCT02629328|FDA cleared|fda cleared
1393630|NCT01191021|breath|breath
1087337|NCT02626949|Mindfulness|mindfulness
1393807|NCT01190423|AN|an
1393910|NCT01189955|RLN|rln
1394289|NCT01188122|VAP|vap
1087752|NCT02624635|Hip|hip
1087963|NCT02623530|Nursing|nursing
1394968|NCT01185379|omega 3|omega 3
1395278|NCT01184170|obesity|obesity
1520416|NCT00699504|ECG|ecg
1520538|NCT00698997|autism|autism
1088494|NCT02620345|Fibroids|fibroids
1025048|NCT03006042|local anaesthetics|local anaesthetics
1090807|NCT02605187|cesarean|cesarean
1025049|NCT03006042|cesarean section|cesarean section
1025772|NCT03001908|shoulder|shoulder
1091828|NCT02599259|NOAC|noac
1093433|NCT02589782|clofazimine|clofazimine
1397418|NCT01175551|PTB|ptb
1093434|NCT02589782|pretomanid|pretomanid
1397604|NCT01174810|PD|pd
1398092|NCT01172652|Anxiety|anxiety
1094137|NCT02585310|CABGs|cabgs
1094854|NCT02580812|Sepsis|sepsis
1094855|NCT02580812|Prematurity|prematurity
1095058|NCT02579785|Abortion|abortion
1025773|NCT03001908|mobilization|mobilization
1095059|NCT02579785|mHealth|mhealth
1095557|NCT02576990|PD-L1|pd-l1
1095558|NCT02576977|PDL1|pdl1
1025774|NCT03001908|electromyography|electromyography
1400618|NCT01162330|CMV|cmv
1026174|NCT02999698|Psoriasis|psoriasis
1095559|NCT02576977|PD1|pd1
1095875|NCT02575339|Sorafenib|sorafenib
1096272|NCT02573324|ABT-414|abt-414
1096377|NCT02572843|lung cancer|lung cancer
1096378|NCT02572843|MEDI4736|medi4736
1403759|NCT01149044|PCI|pci
1096575|NCT02571725|BRCA|brca
1096577|NCT02571725|Olaparib|olaparib
1099285|NCT02555800|Cidofovir|cidofovir
1404705|NCT01145131|FSR|fsr
1099286|NCT02555800|Bevacizumab|bevacizumab
1148010|NCT02276417|Sepsis|sepsis
1100581|NCT02547896|diclofenac|diclofenac
1533867|NCT00645411|Flu|flu
1406041|NCT01139645|Calcium|calcium
1534271|NCT00643305|HIV|hiv
1406433|NCT01138111|MCI|mci
1025775|NCT03001908|imaging ultrasound|imaging ultrasound
1025776|NCT03001804|Multiple Myeloma|multiple myeloma
1407079|NCT01136629|Mealsma|mealsma
1407253|NCT01135875|GBM|gbm
1407473|NCT01134822|IPF|ipf
1408095|NCT01132534|OGD|ogd
1408338|NCT01131260|STAN|stan
1025777|NCT03001804|Revlimid|revlimid
1537937|NCT00628693|CPR|cpr
1409252|NCT01127321|SLE|sle
1409286|NCT01127217|stage 2|stage 2
1409413|NCT01126645|HCC|hcc
1409471|NCT01126320|VAP|vap
1409960|NCT01124318|itching|itching
1540264|NCT00619671|MG|mg
1025778|NCT03001804|Lenalidomide|lenalidomide
1540906|NCT00617383|MS|ms
1568386|NCT00506051|alimta|alimta
1411587|NCT01117662|kidney|kidney
1411891|NCT01116557|CARTO|carto
1102675|NCT02534077|cholestasis|cholestasis
1022763|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
1542938|NCT00609401|RCC|rcc
1022764|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
1543588|NCT00606931|PET|pet
1103411|NCT02530177|Alopecia|alopecia
1103412|NCT02530177|Skin Aging|skin aging
1022765|NCT03020628|Influenza Vaccines|influenza vaccines
1414301|NCT01106963|knee|knee
1545132|NCT00599937|APL|apl
1104918|NCT02520596|Metabolites|metabolites
1415248|NCT01102946|laser|laser
1415341|NCT01102439|Aspirin|aspirin
1022766|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
1104919|NCT02520557|Epilepsy|epilepsy
1416065|NCT01099956|CRP|crp
1022767|NCT03020628|Cell Culture-Derived|cell culture-derived
1416422|NCT01098513|HIV|hiv
1022768|NCT03020615|Sickle cell|sickle cell
1022769|NCT03020615|Hydroxyurea|hydroxyurea
1022770|NCT03020615|Infants|infants
1548923|NCT00583557|RA|ra
1106934|NCT02508532|BLUE-285|blue-285
1417897|NCT01092949|MRI|mri
1106935|NCT02508532|BLUE 285|blue 285
1106936|NCT02508532|Avapritinib|avapritinib
1418985|NCT01088295|HIV|hiv
1419274|NCT01087281|HV|hv
1022771|NCT03020589|Renal Transplant|renal transplant
1022772|NCT03020589|Tacrolimus|tacrolimus
1419995|NCT01084395|STD|std
1022774|NCT03020589|Phase IV|phase iv
1022775|NCT03020550|GERD|gerd
1420556|NCT01082172|TAA|taa
1022776|NCT03020550|Galvanic Skin Response|galvanic skin response
1421448|NCT01078493|PRP|prp
1107337|NCT02506140|clopidogrel|clopidogrel
1421932|NCT01076829|MDA|mda
1421947|NCT01076790|Surgery|surgery
1022777|NCT03020550|Heart Rate Variability|heart rate variability
1422159|NCT01075672|BDD|bdd
1107540|NCT02505165|Oncology|oncology
1555474|NCT00555282|cvc|cvc
1422591|NCT01074112|EMS|ems
1107541|NCT02505165|Pediatric|pediatric
1423483|NCT01070186|T2|t2
1107643|NCT02504671|DMARD-IR|dmard-ir
1107644|NCT02504671|GSK3196165|gsk3196165
1424161|NCT01067300|young|young
1107741|NCT02503969|Uptake|uptake
1107742|NCT02503969|Morbidity|morbidity
1558542|NCT00542152|IBD|ibd
1425125|NCT01063439|NHL|nhl
1425440|NCT01062100|MRI|mri
1108038|NCT02502487|Ropivacaine|ropivacaine
1425624|NCT01061255|Stress|stress
1426003|NCT01059669|Pain|pain
1426193|NCT01059019|Cornea|cornea
1426297|NCT01058603|IVF|ivf
1109154|NCT02496338|Menopause|menopause
1561695|NCT00530270|ACS|acs
1110158|NCT02490527|fatigue|fatigue
1561930|NCT00529399|T1D|t1d
1427785|NCT01052415|HIV|hiv
1110364|NCT02488915|Ischemic|ischemic
1110459|NCT02488473|Volunteers|volunteers
1110660|NCT02487277|Pancreatic|pancreatic
1110661|NCT02487251|Obesity|obesity
1564286|NCT00521196|tms|tms
1111682|NCT02481466|diabetes|diabetes
1111683|NCT02481466|exercise|exercise
1111891|NCT02480192|Vasomotor|vasomotor
1111892|NCT02480192|Symptoms|symptoms
1112102|NCT02479087|Hemorrhage|hemorrhage
1112991|NCT02473822|LCA|lca
1113191|NCT02472886|ledipasvir|ledipasvir
1431503|NCT01039272|EBV|ebv
1431625|NCT01038635|MDS|mds
1432294|NCT01035476|ALS|als
1432458|NCT01034709|CMV|cmv
1113192|NCT02472886|Hepatitis C|hepatitis c
1114008|NCT02468388|xylitol|xylitol
1432918|NCT01032603|IXT|ixt
1433350|NCT01031238|PUV|puv
1114827|NCT02464033|GAD-Alum|gad-alum
1433536|NCT01030536|NHL|nhl
1114923|NCT02463539|Vaccinology|vaccinology
1115237|NCT02461459|ASD|asd
1025779|NCT03001804|Non-transplantable|non-transplantable
1570724|NCT00499278|hip|hip
1025780|NCT03001791|CO2 laser|co2 laser
1115336|NCT02461004|CKD-391|ckd-391
1115946|NCT02457338|Microbiota|microbiota
1115947|NCT02457338|Gut|gut
1435471|NCT01022424|ADPKD|adpkd
1115948|NCT02457338|Breast milk|breast milk
1115949|NCT02457338|Vaginal|vaginal
1115950|NCT02457325|Articaine|articaine
1116950|NCT02450994|lung|lung
1116951|NCT02450994|treatment|treatment
1116952|NCT02450994|sleep|sleep
1117342|NCT02448706|hearing aid|hearing aid
1437605|NCT01013662|icu|icu
1437699|NCT01013259|E.coli|e.coli
1437820|NCT01012674|MRA|mra
1117540|NCT02447185|Ranibizumab|ranibizumab
1438089|NCT01011413|HIV|hiv
1117957|NCT02444897|laparoscopy|laparoscopy
1438472|NCT01009749|HIV|hiv
1438620|NCT01009294|DMD|dmd
1118363|NCT02442414|HER4|her4
1119758|NCT02434601|Adhesion|adhesion
1119759|NCT02434601|Restoration|restoration
1119760|NCT02434601|Sensitivity|sensitivity
1119761|NCT02434601|Prophylaxis|prophylaxis
1577370|NCT00474435|HIV|hiv
1025781|NCT03001791|thermal damage zone|thermal damage zone
1578015|NCT00471783|RCT|rct
1440280|NCT01002755|CLL|cll
1119762|NCT02434601|Randomized|randomized
1578382|NCT00470483|PET|pet
1440867|NCT01000428|Tarceva|tarceva
1441070|NCT00999609|AAV|aav
1441154|NCT00999336|Healthy|healthy
1121367|NCT02426034|Metastatic|metastatic
1441997|NCT00996229|Diet|diet
1022778|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
1022779|NCT03020537|Young children|young children
1581033|NCT00460902|TMS|tms
1121368|NCT02425995|ACL|acl
1022780|NCT03020537|Young adults|young adults
1121465|NCT02425397|oncology|oncology
1121571|NCT02424955|SABR|sabr
1582271|NCT00456183|TB|tb
1582407|NCT00455741|PET|pet
1444220|NCT00988039|aluvia|aluvia
1444413|NCT00987389|GPA|gpa
1122925|NCT02418728|obesity|obesity
1444924|NCT00985426|HBV|hbv
1123928|NCT02413489|Daratumumab|daratumumab
1022781|NCT03020511|Modern grains|modern grains
1584548|NCT00448292|MDD|mdd
1445733|NCT00982514|ALL|all
1446034|NCT00981318|HIV|hiv
1446212|NCT00980538|HIV|hiv
1446307|NCT00980239|Liver|liver
1585839|NCT00445341|MCL|mcl
1022784|NCT03020511|microbiota|microbiota
1446916|NCT00978068|HIV|hiv
1025782|NCT03001791|Er:YAG laser|er:yag laser
1124521|NCT02410161|flaxseed|flaxseed
1025783|NCT03001778|Physical Activity|physical activity
1587179|NCT00441376|RFA|rfa
1124522|NCT02410161|aging|aging
1124625|NCT02409628|EktoTherix|ektotherix
1448409|NCT00972400|fatigue|fatigue
1125028|NCT02407197|Outcome|outcome
1125029|NCT02407197|multicenter|multicenter
1125030|NCT02407184|Microbiota|microbiota
1125031|NCT02407184|Microbiome|microbiome
1450260|NCT00964873|ALL|all
1125032|NCT02407145|retropubic|retropubic
1025784|NCT03001778|Older Adults|older adults
1025983|NCT03000660|Amyloidosis|amyloidosis
1125234|NCT02405754|CVD|cvd
1450818|NCT00963248|EBV|ebv
1451294|NCT00961298|GAD|gad
1125235|NCT02405754|CHD|chd
1125336|NCT02405247|NSCLC|nsclc
1125337|NCT02405247|T790M|t790m
1125338|NCT02405247|EGFR|egfr
1125339|NCT02405247|TKI|tki
1125340|NCT02405247|Resistance|resistance
1126642|NCT02397928|Treatment|treatment
1594301|NCT00416299|elderly|elderly
1127969|NCT02389868|Lovastatin|lovastatin
1127970|NCT02389868|Proteome|proteome
1128069|NCT02389309|CCI-779|cci-779
1128070|NCT02389309|Torisel|torisel
1025984|NCT03000660|AL Amyloidosis|al amyloidosis
1026188|NCT02999529|Oncology|oncology
1128071|NCT02389309|Dasatinib|dasatinib
1454537|NCT00949416|genetic|genetic
1128072|NCT02389309|BMS-354825|bms-354825
1128073|NCT02389309|Sprycel|sprycel
1597213|NCT00405184|PID|pid
1128374|NCT02387710|tiagabine|tiagabine
1128479|NCT02387164|Children|children
1598098|NCT00401999|PET|pet
1128980|NCT02384512|Azilect®|azilect®
1026189|NCT02999503|adhd treatment|adhd treatment
1456838|NCT00941577|Asthma|asthma
1026190|NCT02999503|nutrition|nutrition
1022785|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
1128981|NCT02384512|Rasagiline|rasagiline
1457588|NCT00938236|Aerosol|aerosol
1457850|NCT00937287|HPV|hpv
1026191|NCT02999477|Breast Cancer|breast cancer
1458140|NCT00936273|SAS|sas
1026192|NCT02999464|stroke|stroke
1026193|NCT02999464|qigong|qigong
1458698|NCT00934505|FDG|fdg
1129407|NCT02381899|rituximab|rituximab
1129715|NCT02380430|Management|management
1459889|NCT00929214|RT|rt
1460732|NCT00925730|AD|ad
1026194|NCT02999464|randomized controlled trial|randomized controlled trial
1129817|NCT02379832|biomarkers|biomarkers
1461627|NCT00922662|CCTA|ccta
1129818|NCT02379832|serum|serum
1026195|NCT02999464|body-mind exercise|body-mind exercise
1026196|NCT02999464|balance|balance
1462354|NCT00919932|CBT|cbt
1462537|NCT00919321|CLL|cll
1463173|NCT00916643|FH|fh
1129819|NCT02379832|PAPP-A|papp-a
1129820|NCT02379832|PlGF|plgf
1608282|NCT00364390|CAD|cad
1026197|NCT02999464|quality of life|quality of life
1026198|NCT02999464|wellbeing|wellbeing
1609700|NCT00358956|MTC|mtc
1026298|NCT02998931|Glutamin|glutamin
1610063|NCT00357604|HIV|hiv
1129821|NCT02379832|sFlt-1|sflt-1
1026299|NCT02998931|Enteral Nutrition|enteral nutrition
1129822|NCT02379832|endoglin|endoglin
1130729|NCT02374671|Presbyopic|presbyopic
1130930|NCT02373332|DHA|dha
1026300|NCT02998931|Intensive Care Unit|intensive care unit
1130931|NCT02373332|EPA|epa
1612492|NCT00348933|Ataxia|ataxia
1130932|NCT02373332|12-LOX|12-lox
1131129|NCT02372253|beta cells|beta cells
1131734|NCT02368509|gustation|gustation
1131735|NCT02368509|taste|taste
1131736|NCT02368509|cancer|cancer
1132243|NCT02365766|MK-3475|mk-3475
1614345|NCT00341705|Cancer|cancer
1132244|NCT02365766|Gemcitabine|gemcitabine
1132245|NCT02365766|Cisplatin|cisplatin
1133746|NCT02357147|Pemetrexed|pemetrexed
1133747|NCT02357147|Cisplatin|cisplatin
1136242|NCT02342561|Drape|drape
1136243|NCT02342561|Ioban|ioban
1136848|NCT02339155|Raxibacumab|raxibacumab
1469328|NCT00897897|HIFU|hifu
1137342|NCT02336074|Vaccine|vaccine
1137343|NCT02336074|Cure|cure
1137642|NCT02334202|Humans|humans
1138548|NCT02328625|ADRCs|adrcs
1469655|NCT00897299|PgR|pgr
1618358|NCT00326209|UC|uc
1470181|NCT00895791|PCI|pci
1618829|NCT00324467|PET|pet
1140044|NCT02321072|hypoxia|hypoxia
1026301|NCT02998931|Critical Care Outcomes|critical care outcomes
1026302|NCT02998931|inflammatory|inflammatory
1140045|NCT02321072|hyperoxia|hyperoxia
1026303|NCT02998931|Immune System|immune system
1140247|NCT02319850|geriatrics|geriatrics
1472700|NCT00886470|pain|pain
1472025|NCT00889148|hip|hip
1140248|NCT02319850|muscle|muscle
1472427|NCT00887328|MRI|mri
1621647|NCT00313846|opioid|opioid
1140249|NCT02319850|aging|aging
1026304|NCT02998918|Inflammation|inflammation
1140455|NCT02318784|carfilzomib|carfilzomib
1140456|NCT02318784|Kyprolis|kyprolis
1623215|NCT00307502|HIV|hiv
1141259|NCT02314481|RET|ret
1141748|NCT02311569|Mirabegron|mirabegron
1623805|NCT00305643|pain|pain
1474625|NCT00878527|VAD|vad
1474831|NCT00877695|HIV|hiv
1624520|NCT00303264|CCK|cck
1475037|NCT00876941|Drug|drug
1625220|NCT00300820|BP|bp
1475903|NCT00873444|Hip|hip
1476163|NCT00872482|h-R3|h-r3
1141848|NCT02310984|Cosmesis|cosmesis
1141948|NCT02310321|Idarubicin|idarubicin
1477267|NCT00868088|AC|ac
1141949|NCT02310321|ASP2215|asp2215
1477830|NCT00866112|Stroke|stroke
1141950|NCT02310308|Xylitol|xylitol
1141951|NCT02310308|Magnolia|magnolia
1141952|NCT02310308|chewing gum|chewing gum
1142159|NCT02309177|NSCLC|nsclc
1479011|NCT00861172|3T MRI|3t mri
1142560|NCT02307019|Stroke|stroke
1142762|NCT02306031|diabetic|diabetic
1142867|NCT02305433|elderly|elderly
1142970|NCT02304822|prophylaxis|prophylaxis
1143668|NCT02300831|NSCLC|nsclc
1630725|NCT00281697|MBC|mbc
1480547|NCT00854516|3M|3m
1480782|NCT00853658|BNP|bnp
1481014|NCT00852696|Women|women
1481248|NCT00851799|ART|art
1481483|NCT00851058|Crime|crime
1143669|NCT02300831|Lung Cancer|lung cancer
1482080|NCT00848601|PIM|pim
1143670|NCT02300831|SELECT-1|select-1
1482671|NCT00846287|MRI|mri
1482881|NCT00845416|PID|pid
1143671|NCT02300831|SELECT-2|select-2
1143672|NCT02300831|selumetinib|selumetinib
1483141|NCT00844311|hCG|hcg
1026306|NCT02998918|Anti-inflammatory|anti-inflammatory
1026622|NCT02996864|diet|diet
1483883|NCT00841165|Carbon|carbon
1022786|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1022787|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
1023513|NCT03015753|Prophylaxis|prophylaxis
1029014|NCT02981368|PET/CT|pet/ct
1485305|NCT00835432|reentry|reentry
1485449|NCT00834782|PK|pk
1029015|NCT02981368|PyL|pyl
1485609|NCT00833820|ALS|als
1485788|NCT00833144|dyspnea|dyspnea
1486005|NCT00832325|09-001|09-001
1029016|NCT02981368|PSMA|psma
1029211|NCT02980302|Mutation|mutation
1023514|NCT03015753|Randomized controlled trial|randomized controlled trial
1023919|NCT03013595|Adolescent|adolescent
1023920|NCT03013595|Health services|health services
1023921|NCT03013595|Transition|transition
1487041|NCT00828178|SLE|sle
1029212|NCT02980302|Gene MYT1L|gene myt1l
1029402|NCT02978976|RDS|rds
1487583|NCT00826098|PRP|prp
1029506|NCT02978443|Anti-tumor|anti-tumor
1488183|NCT00823862|HCV|hcv
1029609|NCT02977923|Oculus rift|oculus rift
1029813|NCT02976974|function|function
1029814|NCT02976974|force|force
1488735|NCT00822146|CRT|crt
1030125|NCT02975258|Asthma|asthma
1030126|NCT02975258|Adiposity|adiposity
1489760|NCT00818389|ALS|als
1030433|NCT02973503|Hepatitis C|hepatitis c
1030434|NCT02973503|Genotype 1B|genotype 1b
1490299|NCT00816504|FSGS|fsgs
1490389|NCT00816374|CMM|cmm
1030648|NCT02971917|MTF|mtf
1491306|NCT00813124|CML|cml
1491504|NCT00812370|DVT|dvt
1023922|NCT03013595|Longitudinal cohort study|longitudinal cohort study
1491681|NCT00811590|Cancer|cancer
1024029|NCT03013023|Sleep|sleep
1492020|NCT00810368|GWI|gwi
1492222|NCT00809523|SAD|sad
1492299|NCT00809250|AML|aml
1492457|NCT00808756|Growth|growth
1492577|NCT00808353|CVD|cvd
1030649|NCT02971904|newborn|newborn
1030650|NCT02971904|prematurity|prematurity
1493194|NCT00805935|IVF|ivf
1030651|NCT02971904|preterm|preterm
1030652|NCT02971904|human milk|human milk
1034673|NCT02947152|maytansine|maytansine
1493834|NCT00803257|Splint|splint
1493974|NCT00802555|HCC|hcc
1034776|NCT02946372|vitrectomy|vitrectomy
1649256|NCT00200928|BCG|bcg
1035084|NCT02944344|stage 4|stage 4
1494640|NCT00800033|lipids|lipids
1035085|NCT02944344|metastatic|metastatic
1035086|NCT02944344|hospice|hospice
1035286|NCT02943213|Variability|variability
1495332|NCT00797316|stage 2|stage 2
1035287|NCT02943213|Variable|variable
1495803|NCT00795288|statin|statin
1495937|NCT00794586|CF|cf
1024030|NCT03013023|Salivary cortisol|salivary cortisol
1652290|NCT00183131|Alcohol|alcohol
1024031|NCT03013010|Randomized|randomized
1024032|NCT03013010|Open Label|open label
1024033|NCT03013010|Multicenter|multicenter
1024034|NCT03012984|elderly|elderly
1024035|NCT03012984|surgery|surgery
1654887|NCT00170391|PSG|psg
1498806|NCT00783848|CHF|chf
1498892|NCT00783406|COPD|copd
1024036|NCT03012984|analgesia|analgesia
1499102|NCT00782483|PWS|pws
1035288|NCT02943213|Absorption|absorption
1499306|NCT00781820|Placebo|placebo
1499506|NCT00780858|IUI|iui
1499609|NCT00780390|RSD|rsd
1035289|NCT02943213|USL Pharma|usl pharma
1035290|NCT02943213|USL|usl
1035291|NCT02943213|Healthy|healthy
1500651|NCT00775515|chronic|chronic
1035394|NCT02942316|Heart Rate|heart rate
1501171|NCT00773604|DBS|dbs
1501423|NCT00772486|17p|17p
1501792|NCT00770978|ICU|icu
1024037|NCT03012984|dexmedetomidine|dexmedetomidine
1024038|NCT03012984|delirium|delirium
1024039|NCT03012971|Elderly|elderly
1024040|NCT03012971|Surgery|surgery
1024041|NCT03012971|Analgesia|analgesia
1502389|NCT00769080|PSP|psp
1036100|NCT02937571|Carfilzomib|carfilzomib
1024042|NCT03012971|Dexmedetomidine|dexmedetomidine
1661658|NCT00137384|HV|hv
1661767|NCT00136825|cocaine|cocaine
1024043|NCT03012971|Long-term outcome|long-term outcome
1024044|NCT03012945|Elderly|elderly
1662164|NCT00135278|CSF|csf
1024045|NCT03012945|Cancer surgery|cancer surgery
1333132|NCT01444430|Asthma|asthma
1504608|NCT00759135|BPH|bph
1024339|NCT03010878|yoga|yoga
1505056|NCT00756925|CRH|crh
1505326|NCT00755781|Aerosol|aerosol
1024340|NCT03010878|chronic pain|chronic pain
1024341|NCT03010878|occupational therapy|occupational therapy
1036414|NCT02935504|Pregnancy|pregnancy
1022703|NCT03021109|pediatrics|pediatrics
1036415|NCT02935504|Postpartum|postpartum
1507106|NCT00749840|AIDS|aids
1036416|NCT02935491|TAVI|tavi
1036632|NCT02934243|Ventilation|ventilation
1672733|NCT00097669|prevention|prevention
1507697|NCT00747539|HCV|hcv
1667360|NCT00115791|RSD1235|rsd1235
1068509|NCT02738788|MMS|mms
1508189|NCT00745524|adult|adult
1036834|NCT02932852|keratoconus|keratoconus
1508491|NCT00744419|GERD|gerd
1036835|NCT02932852|scaffold|scaffold
1036836|NCT02932852|lamina|lamina
1509217|NCT00741832|dyspnea|dyspnea
1022704|NCT03021109|gastroenteritis|gastroenteritis
1036939|NCT02932280|16-878|16-878
1510080|NCT00738842|Uric|uric
1022705|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
1510267|NCT00738114|surgery|surgery
1036940|NCT02932267|Acne|acne
1024342|NCT03010878|self-management|self-management
1036941|NCT02932267|Dark skin|dark skin
1511405|NCT00734357|ct|ct
1511510|NCT00733993|cocaine|cocaine
1671976|NCT00100503|TMS|tms
1037636|NCT02928172|q-CON|q-con
1024343|NCT03010865|HDAC inhibitors|hdac inhibitors
1512364|NCT00730470|HER3|her3
1512550|NCT00729703|ICD|icd
1512659|NCT00729248|Assay|assay
1037637|NCT02928172|q-NOX|q-nox
1037638|NCT02928172|BIS|bis
1513548|NCT00726466|AMD|amd
1038237|NCT02924402|DLBCL|dlbcl
1024344|NCT03010865|Inflammation|inflammation
1038444|NCT02923323|MRI|mri
1024345|NCT03010852|Bariatric Surgery|bariatric surgery
1516022|NCT00717275|Temodar|temodar
1038545|NCT02922816|Infection|infection
1038746|NCT02921841|Adolescents|adolescents
1040219|NCT02913183|efficacy|efficacy
1040220|NCT02913183|safety|safety
1517457|NCT00712127|Obesity|obesity
1040325|NCT02912312|XRT|xrt
1024346|NCT03010852|Spirometry Monitoring|spirometry monitoring
1024347|NCT03010761|addiction|addiction
1022706|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
1022707|NCT03021083|Fentanyl|fentanyl
1519717|NCT00702494|Phase I|phase i
1519810|NCT00702078|COPD|copd
1024348|NCT03010761|betel-quid|betel-quid
1040733|NCT02909712|piperaquine|piperaquine
1726544|NCT00000781|Zidovudine|zidovudine
1521459|NCT00695136|Autism|autism
1521650|NCT00694330|vaccine|vaccine
1022708|NCT03021083|Opioid Analgesia|opioid analgesia
1022709|NCT03021070|Ante natal visit|ante natal visit
1682822|NCT00082550|OCD|ocd
1075104|NCT02698618|IMR|imr
1022710|NCT03021070|Facility delivery|facility delivery
1042235|NCT02900001|elderly|elderly
1042236|NCT02900001|deferred|deferred
1042237|NCT02899988|IL-23|il-23
1042238|NCT02899988|dermatology|dermatology
1042239|NCT02899975|Validation|validation
1524053|NCT00685373|NALP-3,|nalp-3,
1524411|NCT00683761|GBM|gbm
1524441|NCT00683709|BMI|bmi
1524730|NCT00682513|RDP|rdp
1042737|NCT02896140|Nutrition|nutrition
1042738|NCT02896140|Dairy|dairy
1043042|NCT02894190|Beliefs|beliefs
1043043|NCT02894190|Development|development
1043044|NCT02894190|Validation|validation
1525926|NCT00677885|AD|ad
1526022|NCT00677547|CMI|cmi
1022711|NCT03021070|Post natal visit|post natal visit
1526565|NCT00675415|EUS|eus
1526855|NCT00674479|ALL|all
1527002|NCT00673816|VHL|vhl
1527199|NCT00673127|KHAD|khad
1527601|NCT00671645|R04|r04
1527703|NCT00671255|Elderly|elderly
1043841|NCT02889666|docetaxel|docetaxel
1043842|NCT02889666|gemcitabine|gemcitabine
1022712|NCT03021070|Continuum of care|continuum of care
1022713|NCT03021070|Conditional cash transfer|conditional cash transfer
1022714|NCT03021070|Maternal and child health|maternal and child health
1044450|NCT02885246|Influenza B|influenza b
1044451|NCT02885246|Influenza A|influenza a
1044654|NCT02883842|Diabetes|diabetes
1690992|NCT00076752|Lupus|lupus
1044751|NCT02883153|imaging|imaging
1045440|NCT02879136|Gait|gait
1530185|NCT00661999|anemia|anemia
1530263|NCT00661661|550|550
1045441|NCT02879136|Balance|balance
1692443|NCT00073606|HV|hv
1045442|NCT02879136|PD|pd
1045547|NCT02878304|Spasticity|spasticity
1045548|NCT02878304|MRI|mri
1022715|NCT03021070|Cluster randomized trial|cluster randomized trial
1045549|NCT02878278|Chidamide|chidamide
1045653|NCT02877667|laser|laser
1046658|NCT02871128|antioxidant|antioxidant
1046659|NCT02871115|Cancer Care|cancer care
1046755|NCT02870491|Uganda|uganda
1046856|NCT02869763|Ethanol|ethanol
1047151|NCT02867800|Abatacept|abatacept
1533579|NCT00646555|IBC|ibc
1533877|NCT00645385|GBM|gbm
1534885|NCT00640887|HIV|hiv
1535064|NCT00640016|Asthma|asthma
1022716|NCT03021031|Parkinson's Disease|parkinson's disease
1535351|NCT00638768|pain|pain
1022717|NCT03021018|Epilepsy|epilepsy
1698121|NCT00061789|HV|hv
1047547|NCT02865356|topical|topical
1536495|NCT00634075|ICU|icu
1048247|NCT02861352|Zinc|zinc
1022718|NCT03021018|Brivaracetam|brivaracetam
1699074|NCT00060593|Balance|balance
1537072|NCT00631787|HV|hv
1537138|NCT00631527|RT|rt
1048350|NCT02860598|HSCT|hsct
1537717|NCT00629447|Heparin|heparin
1538113|NCT00628043|Cancer|cancer
1049791|NCT02851108|africa|africa
1538293|NCT00627263|ICD|icd
1050589|NCT02846610|anesthesia|anesthesia
1050692|NCT02846038|Relapse|relapse
1539408|NCT00623051|HIV|hiv
1050693|NCT02846038|Progression|progression
1540350|NCT00619541|HCC|hcc
1051101|NCT02843672|MIS|mis
1540786|NCT00617903|rosacea|rosacea
1051300|NCT02842398|gait|gait
1051301|NCT02842398|balance|balance
1022719|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
1541473|NCT00615043|TURBT|turbt
1051909|NCT02838160|RCT|rct
1052105|NCT02836665|Patients|patients
1022720|NCT03021018|Increased seizure activity|increased seizure activity
1022721|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
1022722|NCT03020992|axSpA|axspa
1542792|NCT00610012|VEGF|vegf
1543592|NCT00606931|PEM|pem
1052514|NCT02834117|fertility|fertility
1052515|NCT02834078|HbA1c|hba1c
1052809|NCT02832401|psychosis|psychosis
1054335|NCT02823145|epilepsy|epilepsy
1545282|NCT00599222|AMD|amd
1546127|NCT00595569|insulin|insulin
1546273|NCT00594893|Hip|hip
1547037|NCT00591474|VRE|vre
1547123|NCT00591058|GBM|gbm
1054336|NCT02823145|myoclonic|myoclonic
1547743|NCT00589225|PH|ph
1547791|NCT00588939|reflux|reflux
1548324|NCT00586599|IBD|ibd
1548407|NCT00586222|MRS|mrs
1054833|NCT02819882|advanced|advanced
1548804|NCT00584064|ovale|ovale
1548933|NCT00583505|VSD|vsd
1549217|NCT00582257|05-118|05-118
1549451|NCT00581191|SAD|sad
1549533|NCT00580814|PET|pet
1055138|NCT02817997|iMCD|imcd
1550024|NCT00578747|Seroma|seroma
1550213|NCT00577993|IFN|ifn
1550361|NCT00577681|HIV|hiv
1550529|NCT00576875|Elderly|elderly
1055139|NCT02817997|Castleman|castleman
1055331|NCT02816840|PET-CT/MRI|pet-ct/mri
1055332|NCT02816814|Menopause|menopause
1551568|NCT00572039|AMD|amd
1055333|NCT02816814|Diet|diet
1055733|NCT02814513|Adolescents|adolescents
1055734|NCT02814487|DAM|dam
1022723|NCT03020992|Anterior Uveitis|anterior uveitis
1055835|NCT02813850|pregnancy|pregnancy
1553605|NCT00563121|ROP|rop
1057148|NCT02806193|CMR|cmr
1022724|NCT03020992|Certolizumab Pegol|certolizumab pegol
1022725|NCT03020992|Cimzia|cimzia
1719404|NCT00029939|HV|hv
1555415|NCT00555490|Soy|soy
1555624|NCT00554762|dose,|dose,
1555706|NCT00554437|RCT|rct
1057149|NCT02806193|CT|ct
1555892|NCT00553631|human|human
1556047|NCT00552981|rct|rct
1057150|NCT02806193|ECG|ecg
1556618|NCT00550550|allergy|allergy
1556714|NCT00550082|Surgery|surgery
1556831|NCT00549523|HIV|hiv
1057863|NCT02801786|Breast|breast
1057864|NCT02801773|gingivitis|gingivitis
1057865|NCT02801773|probiotic|probiotic
1558606|NCT00541866|AML|aml
1059549|NCT02792569|IVA|iva
1558900|NCT00540332|KGF|kgf
1060258|NCT02788318|Serotonin|serotonin
1060357|NCT02787694|balance|balance
1060358|NCT02787694|exercise|exercise
1022726|NCT03020875|Acetaminophen|acetaminophen
1060660|NCT02786199|Backscatter|backscatter
1060973|NCT02784288|low-risk|low-risk
1726421|NCT00000802|Dapsone|dapsone
1727349|NCT00000647|IgG|igg
1061069|NCT02783794|Cisplatin|cisplatin
1063102|NCT02772406|Diagnosis|diagnosis
1022727|NCT03020875|Pain management|pain management
1022728|NCT03020862|Dietary nitrate|dietary nitrate
1561383|NCT00531791|COPD|copd
1063515|NCT02769754|RESECTION|resection
1561801|NCT00529919|Obesity|obesity
1063517|NCT02769741|Cashew|cashew
1022729|NCT03020862|Physical performance|physical performance
1562179|NCT00528411|CAD|cad
1562262|NCT00528138|CRP|crp
1063518|NCT02769741|Lipoprotein|lipoprotein
1562652|NCT00526578|FPC|fpc
1562829|NCT00526045|ER+|er+
1563073|NCT00525239|HDL|hdl
1563720|NCT00522964|normal|normal
1731418|NCT00001967|HIV|hiv
1564038|NCT00521859|ATG|atg
1564114|NCT00521508|IgA|iga
1063618|NCT02769143|Exercise|exercise
1063718|NCT02768467|Allograft|allograft
1064316|NCT02764554|Lenvatinib|lenvatinib
1564859|NCT00518570|PMS|pms
1022730|NCT03020862|Blood pressure|blood pressure
1565036|NCT00517764|MDD|mdd
1022731|NCT03020862|Nitrite|nitrite
1565344|NCT00516308|CLI|cli
1022732|NCT03020862|Exercise|exercise
1064317|NCT02764554|E7080|e7080
1064617|NCT02762747|Mesh Repair|mesh repair
1566533|NCT00512226|MRI|mri
1566725|NCT00511524|CB2,|cb2,
1566824|NCT00511095|HBV|hbv
1064722|NCT02762097|polyps|polyps
1567021|NCT00510367|5-Fluorouracil|5-fluorouracil
1567022|NCT00510367|5-FU|5-fu
1567023|NCT00510367|Adrucil|adrucil
1567024|NCT00510367|Efudex|efudex
1567025|NCT00510367|Cyclophosphamide|cyclophosphamide
1567026|NCT00510367|Cytoxan|cytoxan
1567027|NCT00510367|Neosar|neosar
1567028|NCT00510367|Pregnancy|pregnancy
1567029|NCT00510354|Progressive GIST|progressive gist
1567030|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
1567031|NCT00510341|Behavior Change Counseling|behavior change counseling
1567032|NCT00510341|Motivational Interviewing|motivational interviewing
1567033|NCT00510341|Chronic Care Model|chronic care model
1567034|NCT00510341|Communication|communication
1567039|NCT00510315|leukemia|leukemia
935664|NCT03573024|Venetoclax|venetoclax
935665|NCT03573024|Azacitidine|azacitidine
935666|NCT03573024|Non-Elderly|non-elderly
935667|NCT03573024|Previously Untreated|previously untreated
935668|NCT03573011|prostate cancer|prostate cancer
935669|NCT03573011|biochemical recurrence|biochemical recurrence
935670|NCT03573011|18F-PET imaging|18f-pet imaging
935764|NCT03572348|erectile function|erectile function
935765|NCT03572335|HIV|hiv
935766|NCT03572335|emphysema|emphysema
935767|NCT03572335|diffusing capacity|diffusing capacity
935768|NCT03572335|chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
935769|NCT03572309|trauma induced coagulopathy|trauma induced coagulopathy
935770|NCT03572309|multiple trauma|multiple trauma
935771|NCT03572309|fibrinogen|fibrinogen
935772|NCT03572296|Blackcurrant|blackcurrant
935773|NCT03572296|Polyphenols|polyphenols
935774|NCT03572296|Pulp|pulp
935775|NCT03572296|Fibre|fibre
935869|NCT03571672|Cardiac Magnetic Resonance|cardiac magnetic resonance
935870|NCT03571633|Pegfilgrastim|pegfilgrastim
935871|NCT03571633|Trastuzumab/Paclitaxel|trastuzumab/paclitaxel
935872|NCT03571633|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
935873|NCT03571581|Medication adherence|medication adherence
935874|NCT03571581|Heart failure|heart failure
935875|NCT03571581|Mindfulness interventions|mindfulness interventions
935876|NCT03571555|HIV|hiv
935877|NCT03571555|perinatal|perinatal
935878|NCT03571555|adolescent|adolescent
935879|NCT03571555|camp|camp
935880|NCT03571555|psychosocial|psychosocial
935881|NCT03571542|Children|children
935882|NCT03571542|transplanted|transplanted
935883|NCT03571542|kidney transplantation|kidney transplantation
935884|NCT03571542|respiratory function|respiratory function
935885|NCT03571542|pulmonary function tests|pulmonary function tests
935964|NCT03570931|INAD|inad
935968|NCT03570892|Non-Hodgkin's Lympoma|non-hodgkin's lympoma
936062|NCT03570281|Edoxaban|edoxaban
936063|NCT03570281|enoxaparine|enoxaparine
936064|NCT03570268|Falls prevention|falls prevention
936065|NCT03570268|Education|education
936066|NCT03570268|Neurological disease|neurological disease
936162|NCT03569722|Cognitive screen|cognitive screen
936163|NCT03569670|cost|cost
936164|NCT03569670|total knee replacement|total knee replacement
936165|NCT03569670|arthroplasty|arthroplasty
936166|NCT03569670|posterior stabilized|posterior stabilized
936167|NCT03569670|cruciate retaining|cruciate retaining
936168|NCT03569670|all-polyethylene|all-polyethylene
936169|NCT03569657|Caregivers|caregivers
936170|NCT03569644|quality of life, autoinflammatory diseases, qualitative study, children|quality of life, autoinflammatory diseases, qualitative study, children
936191|NCT03569605|young adult|young adult
936192|NCT03569605|cancer survivor|cancer survivor
936193|NCT03569592|HIV/AIDS|hiv/aids
936194|NCT03569592|naloxone|naloxone
936195|NCT03569592|incarceration|incarceration
936196|NCT03569566|Age|age
936197|NCT03569566|Genes|genes
936198|NCT03569566|Training volume|training volume
936199|NCT03569566|Training intensity|training intensity
936200|NCT03569566|Tick-bourne disease|tick-bourne disease
936203|NCT03569553|Anthrax|anthrax
936259|NCT03569280|enzalutamide|enzalutamide
936260|NCT03569280|prostate|prostate
936261|NCT03569280|cancer|cancer
936262|NCT03569280|metastatic|metastatic
936263|NCT03569254|infant, newborn|infant, newborn
936264|NCT03569254|devices|devices
936460|NCT03568084|physical activity|physical activity
936461|NCT03568084|exercise|exercise
936462|NCT03568084|frailty|frailty
936765|NCT03565692|Microbiota|microbiota
936766|NCT03565692|Mycobiota|mycobiota
936767|NCT03565692|Mycobiome|mycobiome
936768|NCT03565692|Deep-Sequencing|deep-sequencing
936769|NCT03565692|Cystic Fibrosis|cystic fibrosis
936770|NCT03565666|bionic pancreas|bionic pancreas
936771|NCT03565666|closed loop|closed loop
936772|NCT03565666|insulin|insulin
936773|NCT03565666|continuous glucose monitor|continuous glucose monitor
936774|NCT03565640|Buttock pain|buttock pain
936775|NCT03565640|Thigh pain|thigh pain
936776|NCT03565640|Sacrospinous ligament fixation|sacrospinous ligament fixation
936777|NCT03565627|mHealth, digital health, behavior change, exercise; mobile apps|mhealth, digital health, behavior change, exercise; mobile apps
936966|NCT03564587|AWAKE|awake
937150|NCT03563326|Gastric carcinoma|gastric carcinoma
937151|NCT03563326|Peritoneal metastasis|peritoneal metastasis
937158|NCT03563274|Hepatocellular Carcinoma,Holmium-166,SIRT,QuiremSpheres|hepatocellular carcinoma,holmium-166,sirt,quiremspheres
937159|NCT03563261|Older Adults|older adults
937160|NCT03563261|Collagen supplementation|collagen supplementation
937161|NCT03563261|Locomotor behaviour|locomotor behaviour
937243|NCT03562767|Diabetes|diabetes
937349|NCT03562000|Randomised study|randomised study
937350|NCT03562000|Cough assistance|cough assistance
937674|NCT03560154|Dyspnea|dyspnea
937752|NCT03559569|Infection|infection
937758|NCT03559530|osteomyelitis|osteomyelitis
937759|NCT03559530|Acinetobacter baumannii|acinetobacter baumannii
937760|NCT03559530|Anti-Infective Agents|anti-infective agents
937761|NCT03559504|electroencephalography|electroencephalography
937762|NCT03559504|general anesthesia|general anesthesia
937763|NCT03559504|sevoflurane|sevoflurane
937764|NCT03559491|steroid|steroid
937956|NCT03558503|T1|t1
938395|NCT03555643|TIA|tia
938460|NCT03555214|manual therapy|manual therapy
938461|NCT03555188|Diarrhoea|diarrhoea
938462|NCT03555162|Tool|tool
938463|NCT03555162|fMRI|fmri
938464|NCT03555162|neuroimaging|neuroimaging
938465|NCT03555162|Evolution|evolution
938558|NCT03554408|Dose Escalation|dose escalation
938958|NCT03551860|Fascia Iliaca Nerve Block|fascia iliaca nerve block
938959|NCT03551704|Smoking|smoking
939075|NCT03551002|HIV|hiv
939171|NCT03550352|HIV|hiv
939254|NCT03550066|Diabetes Mellitus|diabetes mellitus
939255|NCT03550040|radical prostatectomy|radical prostatectomy
939256|NCT03550040|laparoscopic prostatectomy|laparoscopic prostatectomy
939360|NCT03549546|CD4|cd4
939560|NCT03548467|NSCLC|nsclc
939712|NCT03547388|PET|pet
939762|NCT03547180|Panic|panic
940052|NCT03545178|white coat adherence|white coat adherence
940053|NCT03545178|continuous glucose monitoring|continuous glucose monitoring
940249|NCT03543813|CX-2029|cx-2029
940250|NCT03543813|PROBODY™ Therapeutic|probody™ therapeutic
940251|NCT03543813|Drug Conjugate|drug conjugate
940252|NCT03543813|Antibody drug conjugate|antibody drug conjugate
940253|NCT03543813|CD71|cd71
940254|NCT03543813|Transferrin receptor 1|transferrin receptor 1
940262|NCT03543774|Chronic kidney disease|chronic kidney disease
940347|NCT03543241|Strain|strain
940348|NCT03543228|Strain|strain
940349|NCT03543215|MRI|mri
940350|NCT03543215|Radiomics|radiomics
940351|NCT03543215|Texture features|texture features
940448|NCT03542487|Secure Messaging|secure messaging
940546|NCT03541785|NGAL|ngal
940547|NCT03541785|Renal Angina Index|renal angina index
940548|NCT03541772|Head Carcinoma|head carcinoma
940772|NCT03540277|parents|parents
941042|NCT03538691|MDD|mdd
941048|NCT03538652|CBT|cbt
941049|NCT03538652|Mindfulness|mindfulness
941050|NCT03538652|Opiates|opiates
941051|NCT03538652|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
941052|NCT03538652|Microrandomized Trial|microrandomized trial
941058|NCT03538626|Immune Cells|immune cells
941059|NCT03538626|bNAb|bnab
941060|NCT03538626|Plasma Cell|plasma cell
941061|NCT03538626|HIV|hiv
941062|NCT03538626|Immunotherapy|immunotherapy
941076|NCT03538548|Cocaine Abuse|cocaine abuse
941077|NCT03538548|Cocaine Use Disorder|cocaine use disorder
941078|NCT03538548|Substance-Related Disorders|substance-related disorders
941079|NCT03538535|reinforcement learning|reinforcement learning
941080|NCT03538535|computational models|computational models
941081|NCT03538535|neuroimaging|neuroimaging
941082|NCT03538457|Bariatric surgery|bariatric surgery
941083|NCT03538457|Gastrointestinal tract|gastrointestinal tract
941084|NCT03538457|Biological availability|biological availability
941085|NCT03538457|Pharmacokinetics|pharmacokinetics
941086|NCT03538457|Acetaminophen|acetaminophen
941087|NCT03538431|Autism Spectrum Disorder|autism spectrum disorder
941088|NCT03538431|ASD|asd
941089|NCT03538431|Anxiety|anxiety
941090|NCT03538418|Frailty|frailty
941430|NCT03536442|mental health|mental health
941432|NCT03536429|postural control|postural control
941535|NCT03535545|PET Imaging|pet imaging
941536|NCT03535545|Molecular Imaging|molecular imaging
941537|NCT03535532|resistant hypertension|resistant hypertension
941538|NCT03535532|Adrenal Disease|adrenal disease
941539|NCT03535532|medical treatment|medical treatment
941540|NCT03535532|laparoscopic adrenalectomy|laparoscopic adrenalectomy
941541|NCT03535506|Breast Cancer|breast cancer
941542|NCT03535506|DCIS|dcis
941544|NCT03535506|Palbociclib|palbociclib
941726|NCT03534336|Financial Incentives|financial incentives
941727|NCT03534336|Lifestyle Change|lifestyle change
941728|NCT03534323|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
941729|NCT03534310|obesity|obesity
942027|NCT03532100|lower limb prosthesis|lower limb prosthesis
942028|NCT03532100|transtibial amputation|transtibial amputation
942029|NCT03532100|below knee amputation|below knee amputation
942030|NCT03532100|biomechanics|biomechanics
942031|NCT03532100|gait|gait
942032|NCT03532087|Breast cancer|breast cancer
942033|NCT03532087|Denosumab|denosumab
942034|NCT03532087|Chemotherapy|chemotherapy
942035|NCT03532087|Immunity|immunity
942036|NCT03532087|Immune system|immune system
942037|NCT03532087|PERIDENO|perideno
942225|NCT03530696|Breast Cancer|breast cancer
942226|NCT03530696|HER2-positive|her2-positive
942227|NCT03530696|T-DM1|t-dm1
942228|NCT03530696|HER2-positive Breast Cancer|her2-positive breast cancer
942229|NCT03530696|Recurrent Breast Cancer|recurrent breast cancer
942237|NCT03530566|PnK Method|pnk method
942524|NCT03529084|nazartinib|nazartinib
942525|NCT03529084|erlotinib|erlotinib
942526|NCT03529084|gefitinib|gefitinib
942527|NCT03529071|communication|communication
942528|NCT03529071|patient activation|patient activation
942751|NCT03527589|BPH|bph
943528|NCT03522831|exercise endurance|exercise endurance
943529|NCT03522831|lung disease|lung disease
943530|NCT03522805|copd|copd
943531|NCT03522805|lung|lung
943634|NCT03522246|PARPi|parpi
943834|NCT03521180|Gluten|gluten
943835|NCT03521180|Immune Response|immune response
943836|NCT03521180|Challenge|challenge
943837|NCT03521154|Phase III|phase iii
943838|NCT03521154|Osimertinib|osimertinib
943839|NCT03521154|Non Small Cell Lung Cancer (Stage III)|non small cell lung cancer (stage iii)
943840|NCT03521154|Unresectable NSCLC|unresectable nsclc
943841|NCT03521154|EGFR|egfr
943842|NCT03521154|chemoradiation therapy|chemoradiation therapy
943843|NCT03521141|Tobacco Use Cessation|tobacco use cessation
943935|NCT03520621|sulfur amino acid|sulfur amino acid
943936|NCT03520556|EPA|epa
943937|NCT03520556|DHA|dha
943938|NCT03520556|low-grade inflammation|low-grade inflammation
943939|NCT03520556|CRP|crp
943940|NCT03520556|IL-6|il-6
943941|NCT03520556|TNF-alpha|tnf-alpha
944037|NCT03520088|Total Mesorectal Excision|total mesorectal excision
944038|NCT03520075|Neoplasms|neoplasms
944039|NCT03520075|Solid Tumors|solid tumors
944040|NCT03520075|Antineoplastic Agents|antineoplastic agents
944041|NCT03520075|MAPK|mapk
944175|NCT03519165|SVV|svv
944402|NCT03517761|CCJ|ccj
944831|NCT03515291|Progenitor|progenitor
944832|NCT03515291|Immunomodulatory|immunomodulatory
944926|NCT03514628|Valsalva Assist Device|valsalva assist device
944927|NCT03514576|gastric bypass|gastric bypass
944928|NCT03514576|hypoglycemia|hypoglycemia
944929|NCT03514576|hyperinsulinemia|hyperinsulinemia
944933|NCT03514563|3D|3d
945103|NCT03513601|PR|pr
945411|NCT03512002|Perimenopausal|perimenopausal
945412|NCT03512002|Postmenopausal|postmenopausal
945607|NCT03510650|Intensive care unit (ICU)|intensive care unit (icu)
945608|NCT03510637|Hepatitis C, Genotype 4, DAAs, Real life evaluation|hepatitis c, genotype 4, daas, real life evaluation
945609|NCT03510585|mucociliary clearance|mucociliary clearance
945610|NCT03510585|air pollution|air pollution
945611|NCT03510585|nasal lavage|nasal lavage
945612|NCT03510585|exhaled breath condensate|exhaled breath condensate
945613|NCT03510585|inflammation|inflammation
945615|NCT03510533|autoantibodies (autoAc) circulating|autoantibodies (autoac) circulating
945704|NCT03510013|low flow anesthesia|low flow anesthesia
945705|NCT03510013|wash-in|wash-in
945706|NCT03510013|sevoflurane|sevoflurane
945707|NCT03510000|T1DM|t1dm
945708|NCT03510000|artificial pancreas|artificial pancreas
946141|NCT03507062|pH|ph
946447|NCT03504904|ACT|act
946510|NCT03504462|Foot surgery|foot surgery
946511|NCT03504462|Regional Anesthesia|regional anesthesia
946902|NCT03501914|Care givers|care givers
946903|NCT03501914|Adults|adults
946909|NCT03501888|ACT|act
947003|NCT03501316|CRP|crp
947216|NCT03499834|IKC|ikc
947393|NCT03498742|asthma|asthma
947688|NCT03496688|Bone transplantation|bone transplantation
947689|NCT03496649|Primary Adductor tendinopathies|primary adductor tendinopathies
947690|NCT03496649|Pubalgia|pubalgia
947691|NCT03496649|Botulinum toxin type A|botulinum toxin type a
947992|NCT03494842|TENS|tens
948092|NCT03494218|vegetative state|vegetative state
948093|NCT03494218|minimally conscious state|minimally conscious state
948094|NCT03494218|consciousness|consciousness
948095|NCT03494218|pain assessment|pain assessment
948096|NCT03494218|nociception test|nociception test
948097|NCT03494205|Radiation Dermatitis|radiation dermatitis
948098|NCT03494205|Urtica comp.|urtica comp.
948307|NCT03492411|eHealth|ehealth
949290|NCT03486145|nitrates and nitrites|nitrates and nitrites
949291|NCT03486119|Non -small cell lung cancer|non -small cell lung cancer
949292|NCT03486093|Venous central catheter|venous central catheter
949294|NCT03486093|Port protector|port protector
949893|NCT03482258|Gut microbiota|gut microbiota
949894|NCT03482258|Short-chain fatty acids|short-chain fatty acids
949895|NCT03482258|Serotonin|serotonin
949896|NCT03482258|Cortisol|cortisol
949897|NCT03482245|pneumonia|pneumonia
949898|NCT03482245|appendicitis|appendicitis
949899|NCT03482245|diverticulitis|diverticulitis
949900|NCT03482245|circadian rhythms|circadian rhythms
949901|NCT03482245|blue light|blue light
950188|NCT03480165|Randomized controlled trial|randomized controlled trial
950189|NCT03480165|Double blind|double blind
950190|NCT03480165|Parallel group|parallel group
950191|NCT03480152|Metastatic Cancer|metastatic cancer
950192|NCT03480152|Immunotherapy|immunotherapy
950193|NCT03480152|Tumor Regression|tumor regression
950194|NCT03480152|Cancer Vaccine|cancer vaccine
950200|NCT03480100|rhinosinusitis|rhinosinusitis
950201|NCT03480100|nasal irrigation|nasal irrigation
950202|NCT03480100|nasal douche|nasal douche
950203|NCT03480100|Ectoin|ectoin
950204|NCT03480087|strain-rate echocardiography|strain-rate echocardiography
950205|NCT03480087|chemotherapy|chemotherapy
950206|NCT03480087|radiotherapy, mediastinal|radiotherapy, mediastinal
950207|NCT03480087|Lymphoma|lymphoma
950208|NCT03480087|Hodgkin|hodgkin
950289|NCT03479580|Myocardial ischemia|myocardial ischemia
950290|NCT03479554|antihypertensive treatment|antihypertensive treatment
950291|NCT03479541|mild traumatic brain injury|mild traumatic brain injury
950292|NCT03479541|vestibular impairment|vestibular impairment
950293|NCT03479541|balance and gait|balance and gait
950294|NCT03479541|dual-tasking|dual-tasking
950295|NCT03479541|veterans|veterans
950392|NCT03478839|Generalized Arterial Calcification of Infancy|generalized arterial calcification of infancy
950393|NCT03478839|Autosomal Recessive Hypophosphatemic Rickets|autosomal recessive hypophosphatemic rickets
950394|NCT03478839|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
950396|NCT03478826|ILD|ild
950671|NCT03476902|OCD|ocd
950974|NCT03475095|Tuina therapy|tuina therapy
950975|NCT03475095|lumbar disc herniation|lumbar disc herniation
950976|NCT03475095|central motion control|central motion control
950981|NCT03475069|Exercise|exercise
951294|NCT03473353|EHR|ehr
951747|NCT03470766|SCS|scs
952463|NCT03465969|Liver transplantation|liver transplantation
952464|NCT03465930|Lymphedema|lymphedema
952465|NCT03465930|Lymphatic collecting vessels|lymphatic collecting vessels
952664|NCT03465046|physical therapy|physical therapy
952665|NCT03465033|Orthognathic surgery|orthognathic surgery
952666|NCT03465033|Jaw rehabilitation|jaw rehabilitation
952667|NCT03465033|Jaw Physiotherapy|jaw physiotherapy
952668|NCT03465033|Pain|pain
952669|NCT03465033|Mandibular range of motion|mandibular range of motion
952673|NCT03465020|Purpura|purpura
953264|NCT03460561|Rectus sheath block|rectus sheath block
953265|NCT03460561|Major abdominal cancer surgery|major abdominal cancer surgery
953266|NCT03460535|Rythmia system|rythmia system
953267|NCT03460496|preterm infants|preterm infants
953268|NCT03460496|transition to home|transition to home
953306|NCT03460236|PRP|prp
953401|NCT03459677|CBT|cbt
953463|NCT03459170|leukemia|leukemia
953559|NCT03458572|Caesarean section|caesarean section
953560|NCT03458559|Bone metastases|bone metastases
953856|NCT03456661|Pectoral block|pectoral block
953857|NCT03456661|Ultrasound|ultrasound
953858|NCT03456661|Mastectomy|mastectomy
953863|NCT03456635|CDSS|cdss
953966|NCT03455699|GSV|gsv
954158|NCT03454451|Lung Cancer|lung cancer
954159|NCT03454451|Kidney Cancer|kidney cancer
954160|NCT03454451|Rectal Cancer|rectal cancer
954161|NCT03454451|Breast Cancer|breast cancer
954960|NCT03449745|Immune Checkpoint Ligand|immune checkpoint ligand
954961|NCT03449745|Flow Cytometry|flow cytometry
954962|NCT03449706|Reservoir|reservoir
955258|NCT03447821|MMX|mmx
955661|NCT03445351|Sleep;|sleep;
956372|NCT03441061|ALL|all
956780|NCT03438669|ETDRS|etdrs
957057|NCT03437122|lung, nasal mucosa, respiratory mucosa|lung, nasal mucosa, respiratory mucosa
957058|NCT03437083|Breast neoplasms|breast neoplasms
957059|NCT03437083|Metastatic breast cancer|metastatic breast cancer
957060|NCT03437083|E7389|e7389
957061|NCT03437070|Advanced Leiomyosarcoma|advanced leiomyosarcoma
957062|NCT03437070|Recurrent Leiomyosarcoma|recurrent leiomyosarcoma
957063|NCT03437057|ECL|ecl
957064|NCT03437057|Hematoma|hematoma
957133|NCT03436680|EEG|eeg
957554|NCT03434301|Pain|pain
957555|NCT03434288|Diabetes|diabetes
957556|NCT03434288|Diabetic foot|diabetic foot
957557|NCT03434288|Osteomyelitis|osteomyelitis
957558|NCT03434275|Total Knee Arthroplasty|total knee arthroplasty
957559|NCT03434275|Pain|pain
957854|NCT03432663|Intravenous Amiodarone|intravenous amiodarone
957855|NCT03432663|Drug safety profile|drug safety profile
957856|NCT03432663|Chemical cardioversion|chemical cardioversion
957858|NCT03432637|video assisted thoracic surgery|video assisted thoracic surgery
958054|NCT03430908|endotracheal tube|endotracheal tube
958055|NCT03430908|gastric tube|gastric tube
958056|NCT03430908|17-653|17-653
958057|NCT03430908|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
958058|NCT03430895|Durvalumab (MEDI4736)|durvalumab (medi4736)
958059|NCT03430895|Tremelimumab|tremelimumab
958060|NCT03430895|immunotherapy|immunotherapy
958061|NCT03430895|17-511|17-511
958062|NCT03430882|Solid tumor malignancy|solid tumor malignancy
958063|NCT03430882|TAK-228|tak-228
958064|NCT03430882|MLN0128|mln0128
958455|NCT03428490|Comorbidity|comorbidity
958551|NCT03427944|Calcium Dobesilate|calcium dobesilate
958552|NCT03427944|Non Dialysis Patients With CKD(3-5)|non dialysis patients with ckd(3-5)
958553|NCT03427944|Glomerular filtration rate|glomerular filtration rate
958554|NCT03427944|serum creatinine|serum creatinine
958555|NCT03427931|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
958558|NCT03427892|mood|mood
958751|NCT03426826|FMT|fmt
958855|NCT03426241|smoking|smoking
958944|NCT03425747|calcium carbonate|calcium carbonate
958945|NCT03425747|calcium citrate|calcium citrate
958946|NCT03425747|quality of life|quality of life
958947|NCT03425747|hypoparathyroidism|hypoparathyroidism
958948|NCT03425747|hypocalcemia|hypocalcemia
959018|NCT03425136|HIV|hiv
959136|NCT03424473|HER-2 Positive Breast Cancer|her-2 positive breast cancer
959137|NCT03424473|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
959138|NCT03424473|Recurrent Breast Carcinoma|recurrent breast carcinoma
959139|NCT03424473|Stage IV Breast Cancer|stage iv breast cancer
959835|NCT03420209|respiratory functions|respiratory functions
960234|NCT03417635|Older adults|older adults
960248|NCT03417531|Seniors|seniors
960431|NCT03416634|Obesity|obesity
960433|NCT03416621|Light Smoker|light smoker
960627|NCT03415529|Organ failure|organ failure
960628|NCT03415529|Hypercapnia|hypercapnia
960629|NCT03415503|anthocyanins|anthocyanins
960630|NCT03415503|dyslipidemias|dyslipidemias
960631|NCT03415503|Hyperglycemia|hyperglycemia
960856|NCT03413800|DLI|dli
960941|NCT03413306|ATG|atg
961011|NCT03412903|Pharmaceutical Services|pharmaceutical services
961016|NCT03412864|chondrocyte cells|chondrocyte cells
961017|NCT03412864|osteoarthritis|osteoarthritis
961018|NCT03412864|gene therapy|gene therapy
961142|NCT03411915|NET|net
961329|NCT03410927|MTD|mtd
961408|NCT03410563|Pain|pain
961824|NCT03407859|MRD|mrd
961907|NCT03407222|Personal health record|personal health record
961908|NCT03407222|Intervention|intervention
961909|NCT03407209|Epidural analgesia|epidural analgesia
961913|NCT03407196|Diabetes|diabetes
962019|NCT03406728|Balance|balance
962505|NCT03403530|Neonatal sepsis|neonatal sepsis
962506|NCT03403530|very low birth weight preterm|very low birth weight preterm
962507|NCT03403517|steroids|steroids
962508|NCT03403517|glucocorticoids|glucocorticoids
962755|NCT03401411|ICU|icu
962934|NCT03400397|CBT|cbt
963005|NCT03399708|apremilast|apremilast
963006|NCT03399708|PDE4 inhibition|pde4 inhibition
963007|NCT03399708|cardiometabolic|cardiometabolic
963008|NCT03399708|immune profile|immune profile
963009|NCT03399695|preoxygenation|preoxygenation
963010|NCT03399695|high flow oxygen|high flow oxygen
963011|NCT03399682|cystography|cystography
963012|NCT03399682|pediatry|pediatry
963013|NCT03399682|urinary infection|urinary infection
963028|NCT03399552|17-358|17-358
963191|NCT03398538|DFU|dfu
963681|NCT03395717|Gait Training|gait training
963682|NCT03395717|Rehabilitation|rehabilitation
963683|NCT03395717|Exoskeleton|exoskeleton
963684|NCT03395717|Functional Recovery|functional recovery
963885|NCT03394495|Exercise|exercise
963886|NCT03394495|Behavioral change|behavioral change
963887|NCT03394469|Obesity|obesity
963888|NCT03394469|Sarcopenia|sarcopenia
963889|NCT03394430|sevoflurane|sevoflurane
963890|NCT03394430|epileptiform EEG|epileptiform eeg
964370|NCT03391778|Safety|safety
964580|NCT03390296|AML|aml
964664|NCT03389867|Male sexual health|male sexual health
964665|NCT03389867|Erectile function|erectile function
964666|NCT03389841|home care services|home care services
964667|NCT03389841|comorbidity|comorbidity
964959|NCT03387917|doxorubicin|doxorubicin
965247|NCT03385967|upper extremity bone fracture|upper extremity bone fracture
965248|NCT03385954|nursing|nursing
965438|NCT03384875|cardiopulmonary bypass|cardiopulmonary bypass
965439|NCT03384875|Acute Kidney Injury|acute kidney injury
965930|NCT03381794|Keratoplasty Registry, PKP, DSAEK, DMEK, DALK|keratoplasty registry, pkp, dsaek, dmek, dalk
965931|NCT03381781|p53 mutation|p53 mutation
965933|NCT03381781|decitabine|decitabine
966328|NCT03379168|injection|injection
966529|NCT03377777|Metabolomics|metabolomics
966530|NCT03377777|Microbiome|microbiome
966531|NCT03377764|Spinal Anesthetic,|spinal anesthetic,
966532|NCT03377764|Ultrasound guided Neuroaxial block,|ultrasound guided neuroaxial block,
966533|NCT03377764|Anesthesia Trainees|anesthesia trainees
966534|NCT03377751|Catheter ablation|catheter ablation
966535|NCT03377751|Atrial fibrillation|atrial fibrillation
966536|NCT03377751|Low voltage area|low voltage area
966537|NCT03377738|Spirometry|spirometry
967215|NCT03373344|multiple sclerosis|multiple sclerosis
967315|NCT03372707|Cuff leak test|cuff leak test
967316|NCT03372707|Post-extubation airway obstruction|post-extubation airway obstruction
967317|NCT03372707|Laryngeal edema|laryngeal edema
967318|NCT03372681|Distal Gastrectomy|distal gastrectomy
967319|NCT03372681|Postoperative Reflux Rate|postoperative reflux rate
967320|NCT03372681|Gastric Cance|gastric cance
967321|NCT03372681|Laparoscopic Surgery|laparoscopic surgery
967814|NCT03369730|Screening|screening
967815|NCT03369730|Duration of Untreated Psychosis (DUP)|duration of untreated psychosis (dup)
967816|NCT03369730|Coordinated Specialty Care (CSC)|coordinated specialty care (csc)
967817|NCT03369730|First Episode Psychosis (FEP)|first episode psychosis (fep)
967818|NCT03369730|At Risk Mental State (ARMS)|at risk mental state (arms)
967819|NCT03369730|Clinical High Risk for Psychosis (CHR)|clinical high risk for psychosis (chr)
967820|NCT03369717|endoscopic sinus surgery|endoscopic sinus surgery
967821|NCT03369717|antibiotics|antibiotics
968221|NCT03367247|Symptom management|symptom management
968095|NCT03368053|gp120-NefTat/AS01B vaccine candidate|gp120-neftat/as01b vaccine candidate
968096|NCT03368053|V1V2|v1v2
968097|NCT03368040|body core temperature|body core temperature
968195|NCT03367442|mechanical ventilation|mechanical ventilation
968291|NCT03366779|Lumbar disc herniation, reherniation|lumbar disc herniation, reherniation
968292|NCT03366753|acute normovolemic hemodilution|acute normovolemic hemodilution
968293|NCT03366753|coronary artery bypass graft surgery|coronary artery bypass graft surgery
968294|NCT03366753|hydroxyethyl starch|hydroxyethyl starch
968404|NCT03366064|Non-small cell lung cancer|non-small cell lung cancer
968405|NCT03366064|Natural killer cells|natural killer cells
968406|NCT03366064|HLA-haploidentical family donor|hla-haploidentical family donor
968407|NCT03366051|Endometrial Cancer|endometrial cancer
968408|NCT03366051|Sentinel Lymph Node|sentinel lymph node
968409|NCT03366051|Lymphadenectomy|lymphadenectomy
968410|NCT03366038|pancreaticoduodenectomy|pancreaticoduodenectomy
968411|NCT03366038|pancreaticojejunostomy|pancreaticojejunostomy
968412|NCT03366038|pancreatic fistula|pancreatic fistula
968413|NCT03366012|Cytosponge|cytosponge
968414|NCT03366012|GERD|gerd
968415|NCT03365986|hereditary|hereditary
968416|NCT03365986|colorectal cancer|colorectal cancer
968431|NCT03365908|ACL|acl
968692|NCT03364374|Stroke rehabilitation|stroke rehabilitation
968693|NCT03364374|Upper extremity|upper extremity
968694|NCT03364374|Posture|posture
968695|NCT03364309|plaque psoriasis|plaque psoriasis
968696|NCT03364309|ixekizumab|ixekizumab
968697|NCT03364309|skin condition|skin condition
968698|NCT03364309|skin disease|skin disease
968699|NCT03364309|itching|itching
968700|NCT03364309|psoriasis vulgaris|psoriasis vulgaris
968897|NCT03363217|KIAA1549-BRAF|kiaa1549-braf
968898|NCT03363217|Mitogen-activated Protein Kinase (MEK) inhibitor|mitogen-activated protein kinase (mek) inhibitor
969184|NCT03361163|Group A Streptococcal Infection|group a streptococcal infection
969185|NCT03361163|Controlled human infection model|controlled human infection model
969186|NCT03361163|Challenge study|challenge study
969187|NCT03361150|prehabilitation|prehabilitation
969207|NCT03361072|egg|egg
969376|NCT03360006|Relapsing acute myeloid leukemia|relapsing acute myeloid leukemia
969377|NCT03360006|Remitting acute myeloid leukemia|remitting acute myeloid leukemia
969378|NCT03360006|Dose-limiting toxicity|dose-limiting toxicity
969670|NCT03358056|Emotion|emotion
970066|NCT03355586|Cancer|cancer
970167|NCT03354858|direct follicle aspiration|direct follicle aspiration
970168|NCT03354858|fertilization rate|fertilization rate
970169|NCT03354858|maturation|maturation
970170|NCT03354754|Intra-abdominal infection|intra-abdominal infection
970171|NCT03354754|LYS228|lys228
970266|NCT03354039|DMD|dmd
970663|NCT03351140|Diffuse Large B‐Cell (DLBCL)|diffuse large b‐cell (dlbcl)
970692|NCT03350828|CF|cf
970854|NCT03349658|spinal anesthesia|spinal anesthesia
970863|NCT03349554|anxiety|anxiety
971270|NCT03347370|Rebif®|rebif®
971547|NCT03345485|Small Cell Lung Cancer|small cell lung cancer
971548|NCT03345485|Breast Cancer|breast cancer
971549|NCT03345485|Ovarian Cancer|ovarian cancer
971588|NCT03345225|HCC|hcc
972058|NCT03342287|anxiety|anxiety
972237|NCT03340935|adjuvant treatment|adjuvant treatment
972238|NCT03340935|metastatic setting|metastatic setting
972339|NCT03340337|assessments, pain|assessments, pain
972832|NCT03337308|HeFH|hefh
973237|NCT03334968|Stroke|stroke
973438|NCT03333798|Community Lay Workers|community lay workers
973439|NCT03333785|Primary Care|primary care
973440|NCT03333785|Oncology|oncology
974275|NCT03328637|CBT|cbt
974319|NCT03328130|Adeno-associated virus|adeno-associated virus
974320|NCT03328130|AAV|aav
974321|NCT03328130|Retinitis Pigmentosa|retinitis pigmentosa
974322|NCT03328130|PDE6B|pde6b
974323|NCT03328130|Gene Therapy|gene therapy
974324|NCT03328130|Gene Transfer|gene transfer
974332|NCT03328104|T-ALL|t-all
974715|NCT03325894|Hyperactivity|hyperactivity
974716|NCT03325881|ADHD|adhd
974717|NCT03325881|Hyperactivity|hyperactivity
974718|NCT03325881|SHP465|shp465
974719|NCT03325868|heavy periods, painful periods, adenomyosis|heavy periods, painful periods, adenomyosis
974720|NCT03325855|FMT|fmt
974721|NCT03325855|CDI|cdi
974722|NCT03325855|Fecal Matter Transplant|fecal matter transplant
974911|NCT03324815|Morphine|morphine
974912|NCT03324815|Methadone|methadone
974936|NCT03324633|HIV|hiv
975017|NCT03324126|growth|growth
975603|NCT03320239|HIV|hiv
975793|NCT03318991|resection of the prostate|resection of the prostate
975794|NCT03318991|prostate hyperplasia|prostate hyperplasia
975904|NCT03318497|FLT|flt
976308|NCT03315650|ACS|acs
977276|NCT03309527|guided self-help|guided self-help
977277|NCT03309527|psychological treatment|psychological treatment
977278|NCT03309527|eCBTI|ecbti
977279|NCT03309527|internet|internet
977280|NCT03309527|Psychotherapy|psychotherapy
977286|NCT03309488|Egg allergy|egg allergy
977576|NCT03307473|Physical activity|physical activity
977577|NCT03307473|Bicycling|bicycling
977578|NCT03307473|Transportation|transportation
977579|NCT03307473|Public health|public health
977581|NCT03307434|Program|program
977681|NCT03306784|RAPID3|rapid3
977893|NCT03305536|AVD|avd
977982|NCT03304834|HIFU|hifu
977983|NCT03304834|High intensity focused ultrasound|high intensity focused ultrasound
977984|NCT03304821|Atherosclerotic peripheral artery disease|atherosclerotic peripheral artery disease
977985|NCT03304821|Granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
977986|NCT03304821|Atherosclerosis|atherosclerosis
977987|NCT03304821|Cardiology|cardiology
977988|NCT03304821|Vascular disease|vascular disease
977989|NCT03304808|premature ejaculation|premature ejaculation
977990|NCT03304808|cognitive-behavior|cognitive-behavior
978030|NCT03304600|OCD|ocd
978210|NCT03303547|MRI|mri
978581|NCT03301077|psychiatric disorders|psychiatric disorders
978583|NCT03301051|Influenza|influenza
978584|NCT03301051|Human|human
979182|NCT03296865|taping|taping
979473|NCT03295071|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
979474|NCT03295006|TheraSphere, hepatocellular carcinoma, dosimetry|therasphere, hepatocellular carcinoma, dosimetry
979476|NCT03294980|Observational study|observational study
979586|NCT03294304|UC|uc
980255|NCT03289936|nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
980256|NCT03289936|synchronization|synchronization
980258|NCT03289936|newborn|newborn
980358|NCT03289325|Cardiac surgery|cardiac surgery
980359|NCT03289325|Dexmedetomidine|dexmedetomidine
980360|NCT03289325|Long-term outcome|long-term outcome
980453|NCT03288610|Microcirculation|microcirculation
980454|NCT03288610|Inflammation|inflammation
980455|NCT03288610|Vasodilation|vasodilation
980456|NCT03288610|Cardiopulmonary bypass|cardiopulmonary bypass
980457|NCT03288597|positive rate|positive rate
980476|NCT03288545|CPI|cpi
980862|NCT03286270|mRUS|mrus
980964|NCT03285464|hip|hip
981057|NCT03284723|ADC|adc
981154|NCT03284008|Physiotherapy|physiotherapy
981155|NCT03284008|Rehabilitation|rehabilitation
981156|NCT03283982|Ventral Hernia|ventral hernia
981157|NCT03283982|Robotic|robotic
981158|NCT03283982|Laparoscopic|laparoscopic
981159|NCT03283982|Pain scores|pain scores
981160|NCT03283930|anxiety, cbt, abmt|anxiety, cbt, abmt
981357|NCT03282890|HIV|hiv
981457|NCT03282331|Electrical Impedance Tomography|electrical impedance tomography
981458|NCT03282331|Lung aeration|lung aeration
981465|NCT03282240|Influenza|influenza
981962|NCT03279198|breast cancer screening|breast cancer screening
981963|NCT03279198|colorectal cancer screening|colorectal cancer screening
981964|NCT03279198|cervical cancer screening|cervical cancer screening
981965|NCT03279198|cancer screening beliefs|cancer screening beliefs
982654|NCT03274375|Anti-NMDAR encephalitis|anti-nmdar encephalitis
982655|NCT03274375|IA adsorption|ia adsorption
982656|NCT03274375|Paediatric|paediatric
982657|NCT03274336|patient satisfaction|patient satisfaction
982855|NCT03272906|brain|brain
982885|NCT03272659|PDD|pdd
983460|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
983461|NCT03269019|Thrombosis|thrombosis
983463|NCT03269019|d-dimer|d-dimer
983652|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
983653|NCT03267797|Pregnancy Rate|pregnancy rate
983654|NCT03267797|Lymphocyte Therapy|lymphocyte therapy
983655|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
983656|NCT03267784|ABCB5|abcb5
984851|NCT03259776|Patient and Public Involvement|patient and public involvement
984852|NCT03259776|South West London Major Trauma Network|south west london major trauma network
984853|NCT03259776|Service Improvement|service improvement
984854|NCT03259776|Survey Questionnaire|survey questionnaire
984855|NCT03259776|Visitor Experiences|visitor experiences
984856|NCT03259763|Gastroenterostomy|gastroenterostomy
984857|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
984858|NCT03259763|Cancer|cancer
984859|NCT03259763|Endosonography|endosonography
984860|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
984861|NCT03259750|Sport|sport
984862|NCT03259750|Ankle and foot|ankle and foot
984863|NCT03259750|Injury|injury
984864|NCT03259711|Cardiotoxicity|cardiotoxicity
984865|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
984866|NCT03259711|aromatase inhibitors|aromatase inhibitors
984867|NCT03259711|hormone replacement therapy|hormone replacement therapy
984868|NCT03259711|estrogen|estrogen
984869|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
984870|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
984871|NCT03259685|Diet|diet
984872|NCT03259672|intubation|intubation
984873|NCT03259672|pharyngitis|pharyngitis
984874|NCT03259672|remifentanil|remifentanil
984875|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
984876|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
984877|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
984878|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
984879|NCT03259633|Selumetinib|selumetinib
984880|NCT03259633|Early Access|early access
984882|NCT03259607|Bioequivalence|bioequivalence
985044|NCT03258983|Nutritional epidemiology|nutritional epidemiology
985045|NCT03258970|vitamin supplement|vitamin supplement
985046|NCT03258970|Vitamin C|vitamin c
985047|NCT03258970|Vitamin E|vitamin e
985048|NCT03258905|transition-age youth|transition-age youth
985049|NCT03258905|mobile app|mobile app
985050|NCT03258905|grounding|grounding
985051|NCT03258905|Seeking Safety|seeking safety
985052|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
985055|NCT03258866|purpura|purpura
985347|NCT03257254|VLU|vlu
985928|NCT03253757|PrEP|prep
985929|NCT03253757|HIV|hiv
985938|NCT03253705|Assay Development|assay development
985939|NCT03253705|Gene Expression|gene expression
985940|NCT03253705|Metabolomics|metabolomics
985941|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
985942|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
985943|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
986121|NCT03252236|Dual-tasking|dual-tasking
986122|NCT03252236|Arterial compliance|arterial compliance
986127|NCT03252223|anovulation|anovulation
986602|NCT03249246|Sepsis|sepsis
986603|NCT03249246|ICU|icu
986604|NCT03249246|Point prevalence|point prevalence
986605|NCT03249207|Aneurysmal|aneurysmal
986606|NCT03249181|MTCT|mtct
986711|NCT03248479|CD47|cd47
987098|NCT03245892|Carboplatin|carboplatin
987099|NCT03245892|17-182|17-182
987100|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
987101|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
987103|NCT03245866|Neurosurgery|neurosurgery
987206|NCT03245151|E7080|e7080
987301|NCT03244449|myokine|myokine
987496|NCT03243084|tACS|tacs
987993|NCT03239912|RCT|rct
988579|NCT03236181|Satiety|satiety
988770|NCT03235349|Treatment-naïve|treatment-naïve
988771|NCT03235349|treatment-experienced|treatment-experienced
988772|NCT03235349|interferon|interferon
988773|NCT03235323|Vein Graft Failure|vein graft failure
988774|NCT03235323|Coronary Artery Bypass|coronary artery bypass
988867|NCT03234491|Insulin|insulin
990046|NCT03226873|women|women
990047|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
990048|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
990109|NCT03226574|RTX|rtx
990170|NCT03226158|Cancer|cancer
990344|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
990345|NCT03225222|Prostate cancer|prostate cancer
990346|NCT03225222|multivariate risk assessment|multivariate risk assessment
990347|NCT03225222|MRI|mri
990348|NCT03225222|biopsy|biopsy
990349|NCT03225222|screening|screening
990350|NCT03225222|multicenter|multicenter
990351|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
990352|NCT03225209|GLP-1|glp-1
990353|NCT03225209|Liraglutide|liraglutide
990354|NCT03225209|OPTIFAST|optifast
990370|NCT03225144|Motor Neuron Disease|motor neuron disease
990371|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
990546|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
990547|NCT03224000|Radiation Therapy|radiation therapy
990548|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
990549|NCT03224000|IMRT|imrt
990550|NCT03224000|Modified Barium Swallow|modified barium swallow
990551|NCT03224000|MBS|mbs
990552|NCT03224000|Swallowing questionnaire|swallowing questionnaire
990553|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
990554|NCT03224000|Symptom questionnaire|symptom questionnaire
990556|NCT03224000|Video-Strobe Procedure|video-strobe procedure
990641|NCT03223415|Asymptomatic carriage|asymptomatic carriage
991441|NCT03218423|plasma|plasma
991644|NCT03216980|PTSD|ptsd
992718|NCT03210155|Efficacy|efficacy
992935|NCT03208686|Men|men
993314|NCT03206125|Case-Control Study|case-control study
993315|NCT03206125|Risk Factors|risk factors
993316|NCT03206125|Epidemiology|epidemiology
993317|NCT03206112|Focal Dystonia|focal dystonia
993323|NCT03206099|Proband|proband
993906|NCT03202550|Oxycodone|oxycodone
993907|NCT03202524|Paracentesis|paracentesis
993908|NCT03202524|Albumin|albumin
993909|NCT03202524|Plasma|plasma
993914|NCT03202485|astigmatism|astigmatism
994422|NCT03199222|pressure|pressure
994735|NCT03197285|eye|eye
994912|NCT03196167|CABG|cabg
995003|NCT03195374|Analgesic opioids|analgesic opioids
995004|NCT03195374|Misuse|misuse
995005|NCT03195374|Use disorder|use disorder
995006|NCT03195374|Pain|pain
995007|NCT03195335|Cerebral Palsy|cerebral palsy
995010|NCT03195335|Validity|validity
995104|NCT03194945|Metformin|metformin
995105|NCT03194945|Linagliptin|linagliptin
995106|NCT03194919|online intervention|online intervention
995107|NCT03194919|e-Health|e-health
995108|NCT03194919|negotiating quit date|negotiating quit date
995110|NCT03194906|Brain tumor|brain tumor
995324|NCT03193671|HE4|he4
995524|NCT03192241|reading|reading
996011|NCT03189407|Herb-drug interaction|herb-drug interaction
996012|NCT03189394|HIV|hiv
996013|NCT03189394|gay couples|gay couples
996014|NCT03189394|relationships|relationships
996015|NCT03189394|dyads|dyads
996016|NCT03189381|Whole Brain Radiation|whole brain radiation
996017|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
996018|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
996112|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
996113|NCT03188705|pharmacogenetics|pharmacogenetics
996114|NCT03188705|carboxylesterase|carboxylesterase
996115|NCT03188705|Personalized Medicine|personalized medicine
996116|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
996122|NCT03188679|CMV|cmv
996261|NCT03187886|MRI|mri
996718|NCT03185078|ESWT|eswt
996982|NCT03183193|AHA|aha
997297|NCT03181711|diagnostic imaging|diagnostic imaging
997298|NCT03181685|Progesterone supplementation|progesterone supplementation
997299|NCT03181685|IVF|ivf
997300|NCT03181685|Preference expressed by the patient|preference expressed by the patient
997303|NCT03181659|Exercise|exercise
997505|NCT03180359|grafted children|grafted children
997506|NCT03180359|vaccine recommendation|vaccine recommendation
997507|NCT03180359|immunization efficacy|immunization efficacy
997508|NCT03180359|solid grafted children|solid grafted children
997537|NCT03180060|CMR|cmr
997806|NCT03178175|Balance|balance
997902|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
997903|NCT03177564|driving pressure|driving pressure
997904|NCT03177564|one-lung ventilation|one-lung ventilation
998295|NCT03174964|IVIg|ivig
998387|NCT03174392|Balance|balance
998388|NCT03174392|Resistance|resistance
998389|NCT03174392|Mobility|mobility
998390|NCT03174314|Visual Impairment|visual impairment
998391|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
998392|NCT03174275|durvalumab|durvalumab
998487|NCT03173677|Macronutrients|macronutrients
998878|NCT03170778|CHD|chd
999283|NCT03168061|advanced solid tumor|advanced solid tumor
999284|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
999285|NCT03168048|mobile application|mobile application
999286|NCT03168048|radiotherapy|radiotherapy
999383|NCT03167307|antidepressants|antidepressants
999577|NCT03165812|Diabetes Mellitus|diabetes mellitus
999578|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
999579|NCT03165786|self-management|self-management
999580|NCT03165786|glycemic control|glycemic control
999581|NCT03165786|glycemic variability|glycemic variability
999582|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
999583|NCT03165747|Probiotics|probiotics
999584|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
999598|NCT03165721|Renal Cancer|renal cancer
999599|NCT03165721|DNA Hypermethylation|dna hypermethylation
999600|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
999603|NCT03165708|Epidural technique|epidural technique
1000568|NCT03159364|EBV|ebv
1000769|NCT03158103|17-056|17-056
1000866|NCT03157557|Sheltered Housing|sheltered housing
1000867|NCT03157544|Chronic Neck Pain|chronic neck pain
1000868|NCT03157544|Chronic Back Pain|chronic back pain
1000869|NCT03157544|non-pharmacological|non-pharmacological
1000870|NCT03157544|pain relief|pain relief
1000871|NCT03157518|Asthma|asthma
1000872|NCT03157518|obesity|obesity
1000873|NCT03157518|micorbiome|micorbiome
1000874|NCT03157518|probiotics|probiotics
1000875|NCT03157492|Adult|adult
1000876|NCT03157492|Post-lingual|post-lingual
1000877|NCT03157492|Auditory training|auditory training
1000878|NCT03157492|Communication strategies|communication strategies
1000879|NCT03157492|Speech tracking|speech tracking
1000880|NCT03157492|Speech recognition|speech recognition
1000881|NCT03157492|Quality of Life|quality of life
1000882|NCT03157479|Mechanical ventilation|mechanical ventilation
1000883|NCT03157453|Evaluation scale|evaluation scale
1000884|NCT03157453|Brain injury|brain injury
1000885|NCT03157453|Severity of Brain Injury|severity of brain injury
1000886|NCT03157453|Initial Evaluation|initial evaluation
1000887|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
1000888|NCT03157388|inflammation|inflammation
1000889|NCT03157388|Macrophages|macrophages
1000890|NCT03157388|CD163|cd163
1000891|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
1000892|NCT03157349|Biofreeze|biofreeze
1000893|NCT03157349|Acute Neck Pain|acute neck pain
1000894|NCT03157349|Placebo|placebo
1000895|NCT03157349|chiropractic|chiropractic
1000896|NCT03157336|Cassava|cassava
1000897|NCT03157336|Konzo|konzo
1000898|NCT03157336|Cyanide|cyanide
1000899|NCT03157336|Cyanate|cyanate
1000900|NCT03157336|Thiocyanate|thiocyanate
1000901|NCT03157336|Carbamoylation|carbamoylation
1001065|NCT03157115|Kinocardiography|kinocardiography
1001066|NCT03157115|Cardiac contractility|cardiac contractility
1001067|NCT03157115|Heart kinetic energy|heart kinetic energy
1001068|NCT03157102|children|children
1001069|NCT03157102|status asthmaticus|status asthmaticus
1001070|NCT03157102|HFNC|hfnc
1001071|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
1001072|NCT03156998|CARE|care
1001073|NCT03156998|Paediatric asthma|paediatric asthma
1001074|NCT03156998|Compliance|compliance
1001075|NCT03156998|Home nebulizer|home nebulizer
1001076|NCT03156959|Eating disorders|eating disorders
1001077|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
1001078|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
1001079|NCT03156946|breastfeeding|breastfeeding
1001177|NCT03156387|diode laser|diode laser
1001196|NCT03156244|PROMIS|promis
1001474|NCT03154138|Stroke|stroke
1001675|NCT03153085|Ipilimumab|ipilimumab
1001676|NCT03153085|Intratumoral administration|intratumoral administration
1001977|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
1001978|NCT03151109|glenoid bone loss|glenoid bone loss
1001979|NCT03151083|Health Technology|health technology
1001980|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
1001981|NCT03151083|self-care|self-care
1001982|NCT03151083|Primary Care|primary care
1001983|NCT03151083|Mental Health|mental health
1001984|NCT03151057|Idelalisib|idelalisib
1001985|NCT03151057|Zydelig|zydelig
1001986|NCT03151057|Gilead|gilead
1001987|NCT03151057|allo transplant|allo transplant
1001988|NCT03151057|Gladstone|gladstone
1001989|NCT03151057|PI3K inhibitor|pi3k inhibitor
1001990|NCT03151057|post transplant maintenance therapy|post transplant maintenance therapy
1001991|NCT03151044|epirubicin|epirubicin
1001992|NCT03151044|high-dose|high-dose
1001993|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1001994|NCT03151044|medium/high-risk|medium/high-risk
1001995|NCT03151031|balance|balance
1001996|NCT03151031|college students|college students
1001997|NCT03151031|star excursion balance test|star excursion balance test
1001998|NCT03151018|coronary artery disease|coronary artery disease
1001999|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
1002000|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
1002001|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1002002|NCT03151005|Overweight|overweight
1002003|NCT03151005|Obesity|obesity
1002004|NCT03151005|GLP-1 Agonist|glp-1 agonist
1002005|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
1002006|NCT03151005|Metformin|metformin
1002007|NCT03151005|Reproductive Disorders|reproductive disorders
1002008|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
1002009|NCT03151005|Lipid Metabolism|lipid metabolism
1002763|NCT03145896|IBD|ibd
1003364|NCT03141723|Newborn|newborn
1003365|NCT03141723|Preterm|preterm
1003490|NCT03140722|CKD|ckd
1003581|NCT03140293|Pain|pain
1003665|NCT03139630|PCSK9|pcsk9
1003977|NCT03137277|ADR|adr
1004369|NCT03134794|risk|risk
1004717|NCT03132454|AML|aml
1004860|NCT03131700|Biosimilar|biosimilar
1004861|NCT03131700|Bevacizumab|bevacizumab
1004862|NCT03131700|Safety|safety
1004863|NCT03131674|Somatic tinnitus|somatic tinnitus
1004864|NCT03131635|Developmental|developmental
1004865|NCT03131596|intrauterine balloon|intrauterine balloon
1004866|NCT03131596|hysteroscopy|hysteroscopy
1004868|NCT03131570|Psoriasis|psoriasis
1005062|NCT03130114|Infant|infant
1005556|NCT03126786|Choroid|choroid
1006257|NCT03121794|humerus|humerus
1006676|NCT03119246|HD|hd
1006864|NCT03118050|muscle|muscle
1006946|NCT03117530|microglia|microglia
1006947|NCT03117530|cognition|cognition
1006948|NCT03117517|PCOS|pcos
1006950|NCT03117504|SUI|sui
1007529|NCT03113695|CLL|cll
1007853|NCT03112018|neonatal mortality|neonatal mortality
1007854|NCT03112018|premature infant|premature infant
1007855|NCT03112005|Diabetic Eye Disease|diabetic eye disease
1007856|NCT03111992|Myeloma,|myeloma,
1008045|NCT03111004|integrated care|integrated care
1008046|NCT03111004|MAST framework|mast framework
1008047|NCT03111004|organizational change|organizational change
1008048|NCT03111004|social care|social care
1008049|NCT03111004|elderly patients|elderly patients
1008050|NCT03110991|Depression|depression
1008051|NCT03110991|Depressive symptoms|depressive symptoms
1008052|NCT03110991|Prevention|prevention
1008053|NCT03110991|Non-professional caregivers|non-professional caregivers
1008054|NCT03110991|App|app
1008068|NCT03110913|Healthy|healthy
1008069|NCT03110913|Men|men
1008070|NCT03110913|Adults|adults
1008071|NCT03110913|Methionine|methionine
1008072|NCT03110887|Dynamic prediction model|dynamic prediction model
1008245|NCT03109743|Adherence Group Treatment|adherence group treatment
1008246|NCT03109717|Treatment Resistant Depression|treatment resistant depression
1008247|NCT03109704|scapular kinematics|scapular kinematics
1008248|NCT03109704|thoracic spine|thoracic spine
1008249|NCT03109704|thrust manipulation|thrust manipulation
1008250|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
1008569|NCT03107728|bracing|bracing
1008647|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
1008655|NCT03107065|Sweating|sweating
1009855|NCT03099564|TheraSphere®|therasphere®
1009856|NCT03099564|PD-1|pd-1
1009857|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
1009858|NCT03099551|Plaque|plaque
1009859|NCT03099551|oral hygiene|oral hygiene
1009925|NCT03099161|PD1|pd1
1009957|NCT03099031|urogenital neoplasms|urogenital neoplasms
1009958|NCT03099031|intestinal neoplasms|intestinal neoplasms
1009959|NCT03099031|digestive system neoplasms|digestive system neoplasms
1009960|NCT03099031|lymphoma|lymphoma
1010863|NCT03094455|ICT|ict
1010969|NCT03093987|Shock|shock
1011054|NCT03093376|Effortful Control|effortful control
1011055|NCT03093376|Preschool|preschool
1011056|NCT03093376|ERN|ern
1011502|NCT03090230|DTA|dta
1012043|NCT03086733|Cancer|cancer
1012425|NCT03084406|Substance Abuse|substance abuse
1012426|NCT03084406|Implementation Science|implementation science
1012427|NCT03084406|Evidence-based Practices|evidence-based practices
1012428|NCT03084393|non-cardiac surgery|non-cardiac surgery
1012429|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1012430|NCT03084354|pelvic floor|pelvic floor
1012431|NCT03084354|women's experiences|women's experiences
1012864|NCT03081780|AML|aml
1012929|NCT03081312|Quality of Life|quality of life
1012930|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
1012934|NCT03081273|Osteoblast|osteoblast
1013026|NCT03080584|AMH|amh
1013027|NCT03080584|ovarian reserve|ovarian reserve
1013028|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
1013059|NCT03080454|CVA|cva
1013533|NCT03077945|relapse|relapse
1013534|NCT03077945|cigarette|cigarette
1013535|NCT03077945|craving|craving
1013536|NCT03077945|self regulation|self regulation
1013537|NCT03077945|emotion regulation|emotion regulation
1013538|NCT03077945|stress response|stress response
1013539|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
1013540|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
1013541|NCT03077945|smoking cessation intervention|smoking cessation intervention
1013542|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
1013636|NCT03077503|Dexmedetomidine|dexmedetomidine
1013733|NCT03076840|hamstring tightness|hamstring tightness
1013734|NCT03076801|Choral Singing|choral singing
1013735|NCT03076801|Music|music
1013736|NCT03076801|Quality of Life|quality of life
1013927|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
1013928|NCT03075761|Thrombosis|thrombosis
1013929|NCT03075748|Vascular|vascular
1014328|NCT03073200|psoriasis treatment|psoriasis treatment
1014329|NCT03073200|adolescents|adolescents
1014330|NCT03073187|Asthma|asthma
1014331|NCT03073187|Sleep|sleep
1014428|NCT03072485|aging|aging
1014823|NCT03070418|DHS|dhs
1014977|NCT03069469|ALL|all
1015029|NCT03069235|HIV|hiv
1015224|NCT03068026|Non-invasive ventilation|non-invasive ventilation
1015934|NCT03064126|Atherosclerosis|atherosclerosis
1015935|NCT03064126|Arterial|arterial
1015936|NCT03064126|Peripheral|peripheral
1015937|NCT03064126|Plaque|plaque
1015938|NCT03064126|Angioplasty|angioplasty
1015939|NCT03064126|PTA|pta
1015940|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
1015941|NCT03064087|Self-Sampling|self-sampling
1015942|NCT03064087|HPV Testing|hpv testing
1015943|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
1015944|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1015945|NCT03064087|Urine|urine
1015949|NCT03064022|weight gain|weight gain
1016239|NCT03062202|Anxiety|anxiety
1016336|NCT03061474|Niacin|niacin
1017618|NCT03052751|Myasthenia Gravis|myasthenia gravis
1017915|NCT03050736|Glioma|glioma
1017916|NCT03050736|Glioblastoma|glioblastoma
1018023|NCT03050268|DNA|dna
1018312|NCT03048292|Mothership|mothership
1018313|NCT03048292|Trip and Treat|trip and treat
1018314|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
1019918|NCT03038061|EIT|eit
1020026|NCT03037385|M918T|m918t
1021094|NCT03030820|Periodontitis|periodontitis
1021095|NCT03030820|oral health|oral health
1021096|NCT03030820|gingivitis|gingivitis
1021192|NCT03030235|dapagliflozin|dapagliflozin
1021193|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
1021194|NCT03030222|diabetes|diabetes
1021494|NCT03028467|Methotrexate|methotrexate
1021495|NCT03028467|Monoclonal Antibody|monoclonal antibody
1021496|NCT03028467|Efficacy|efficacy
1021497|NCT03028467|Electrocardiogram|electrocardiogram
1021498|NCT03028467|Tolerability|tolerability
1021499|NCT03028467|Pharmacokinetics|pharmacokinetics
1021501|NCT03028441|Chikungunya|chikungunya
1021803|NCT03026764|cost|cost
1021995|NCT03025607|Autonomous motivation|autonomous motivation
1021996|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
1021997|NCT03025594|Gonyautoxin|gonyautoxin
1021998|NCT03025594|Post surgery pain management|post surgery pain management
1021999|NCT03025594|total knee arthroplasty|total knee arthroplasty
1022773|NCT03020589|UNC|unc
1022782|NCT03020511|ancient grains|ancient grains
1022783|NCT03020511|immunologic response|immunologic response
1022792|NCT03020433|Stroke|stroke
1022884|NCT03019861|Complementary medicine|complementary medicine
1022887|NCT03019835|mivacurium|mivacurium
1023282|NCT03017339|Chronic Pain|chronic pain
1023283|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
1023284|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
1023285|NCT03017274|celiac disease|celiac disease
1023286|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
1023335|NCT03016923|fes|fes
1023379|NCT03016650|Acetaminophen|acetaminophen
1023380|NCT03016650|Ibuprofen|ibuprofen
1023381|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
1023382|NCT03016637|EUS-FNA|eus-fna
1024099|NCT03012438|ICG|icg
1024481|NCT03009981|PSA|psa
1025312|NCT03004326|DIV|div
1025573|NCT03003078|brachytherapy|brachytherapy
1025574|NCT03003078|FOLFIRINOX|folfirinox
1025575|NCT03003078|gemcitabine|gemcitabine
1025576|NCT03003078|nab-paclitaxel|nab-paclitaxel
1025577|NCT03003078|Abraxane|abraxane
1025581|NCT03003052|dental implants|dental implants
1025582|NCT03003052|edentulous|edentulous
1025583|NCT03003052|dental hygiene|dental hygiene
1025973|NCT03000712|biostar|biostar
1026305|NCT02998918|HDL|hdl
1026489|NCT02997722|suicide|suicide
1026574|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
1026575|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
1026576|NCT02997137|Stress management|stress management
1026577|NCT02997137|Dietary supplement|dietary supplement
1026578|NCT02997124|Alveolar bone grafting|alveolar bone grafting
1026579|NCT02997124|delirium|delirium
1026580|NCT02997124|early ambulation|early ambulation
1026581|NCT02997098|Hepatectomy|hepatectomy
1026582|NCT02997085|Pain|pain
1026583|NCT02997085|Virtual Reality|virtual reality
1026584|NCT02997085|Opioid|opioid
1026585|NCT02997085|Prescription pain reliever|prescription pain reliever
1026586|NCT02997085|Treatment|treatment
1026587|NCT02997072|electrical impedance tomography|electrical impedance tomography
1027084|NCT02993367|VCIND|vcind
1027765|NCT02988947|Pain|pain
1027960|NCT02987959|MLN0128|mln0128
1028451|NCT02984787|3D|3d
1028752|NCT02983006|DR5|dr5
1029150|NCT02980536|TKI|tki
1029842|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
1029843|NCT02976766|Optical coherence tomography|optical coherence tomography
1029849|NCT02976740|lung cancer|lung cancer
1029850|NCT02976740|SBRT|sbrt
1029851|NCT02976740|rhGM-CSF|rhgm-csf
1029853|NCT02976727|Vitamin D|vitamin d
1030251|NCT02974712|MAP|map
1030345|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
1030346|NCT02973984|Frailty|frailty
1030347|NCT02973984|Elderly|elderly
1030439|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
1030440|NCT02973438|Spinal Cord Injuries|spinal cord injuries
1030445|NCT02973399|CLL|cll
1030642|NCT02971969|Hemophilia B|hemophilia b
1030643|NCT02971956|Esophageal Cancer|esophageal cancer
1030644|NCT02971917|Chest radiography|chest radiography
1030647|NCT02971917|Preprocessing|preprocessing
1030940|NCT02970552|HIV|hiv
1031268|NCT02968082|MVD|mvd
1032355|NCT02960893|SCA|sca
1032457|NCT02960555|SMM|smm
1032658|NCT02959554|RCC|rcc
1032831|NCT02958306|PRP|prp
1033185|NCT02956330|RVO|rvo
1033628|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
1033629|NCT02953717|Brain metastases|brain metastases
1033630|NCT02953717|Cognition|cognition
1033631|NCT02953717|Radiosurgery|radiosurgery
1033632|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
1033633|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
1033634|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
1033635|NCT02953717|Quality of Life|quality of life
1033636|NCT02953717|Fatigue|fatigue
1033637|NCT02953717|Anxiety|anxiety
1033638|NCT02953717|Depression|depression
1033639|NCT02953704|Myelofibrosis|myelofibrosis
1033645|NCT02953691|surgery|surgery
1034126|NCT02950389|PMMA|pmma
1034370|NCT02949011|Flu|flu
1034428|NCT02948673|glutathione supplementation|glutathione supplementation
1034429|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
1034430|NCT02948621|Excess weight loss|excess weight loss
1034814|NCT02946047|HIV|hiv
1035553|NCT02941406|Retina|retina
1035638|NCT02940808|Emotional Stroop|emotional stroop
1035639|NCT02940808|Global/local congruency|global/local congruency
1035694|NCT02940457|MCI|mci
1035839|NCT02939664|banded gastric bypass|banded gastric bypass
1035937|NCT02938975|insect repellents|insect repellents
1035938|NCT02938975|army personnel|army personnel
1035939|NCT02938975|cluster randomised trial|cluster randomised trial
1035943|NCT02938949|alirocumab|alirocumab
1036233|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
1036234|NCT02936713|flatulence|flatulence
1036236|NCT02936713|probiotics|probiotics
1036237|NCT02936713|fermented milk|fermented milk
1036238|NCT02936713|diet|diet
1036240|NCT02936700|Psychiatry|psychiatry
1036352|NCT02936037|MS|ms
1036431|NCT02935439|Mobile Phone|mobile phone
1036432|NCT02935439|Self-efficacy|self-efficacy
1036433|NCT02935439|Quality of Life|quality of life
1036434|NCT02935439|Knowledge|knowledge
1036477|NCT02935088|FFR|ffr
1037456|NCT02929017|IPF|ipf
1038232|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
1038233|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
1038234|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
1038235|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
1038236|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1038256|NCT02924402|SLL|sll
1038727|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
1038728|NCT02921984|genetic testing|genetic testing
1038736|NCT02921906|Insulin|insulin
1039518|NCT02917460|Rady|rady
1040202|NCT02913261|best available therapy (BAT)|best available therapy (bat)
1040204|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1040708|NCT02909829|Insulin|insulin
1042321|NCT02899286|AML|aml
1042547|NCT02897427|HRA|hra
1042808|NCT02895659|hemodynamics|hemodynamics
1042809|NCT02895659|buffered infusates|buffered infusates
1042810|NCT02895633|MR imaging|mr imaging
1042811|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
1042812|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
1042813|NCT02895633|CT perfusion|ct perfusion
1042814|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
1043002|NCT02894398|HR+|hr+
1043398|NCT02892097|tDCS|tdcs
1043493|NCT02891551|Non-interventional|non-interventional
1043494|NCT02891551|OCEAN|ocean
1043495|NCT02891551|Netherlands|netherlands
1043496|NCT02891551|azacitidine|azacitidine
1044914|NCT02882373|Placebo|placebo
1045213|NCT02880644|OCT-A|oct-a
1045700|NCT02877303|Cytoxan|cytoxan
1045993|NCT02875587|Calcium gluconate|calcium gluconate
1045995|NCT02875574|Isoniazid|isoniazid
1045996|NCT02875574|Drug Resistance|drug resistance
1045997|NCT02875535|Evidence-based|evidence-based
1047135|NCT02867891|AML|aml
1047780|NCT02864186|Pain|pain
1047985|NCT02862717|ESRD|esrd
1048472|NCT02859532|blood coagulation|blood coagulation
1048473|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
1048474|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
1048475|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
1048476|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
1048501|NCT02859415|Sarcoma|sarcoma
1048797|NCT02857790|CMR|cmr
1049017|NCT02855944|A4|a4
1049268|NCT02854579|neonate|neonate
1049269|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
1049270|NCT02854566|hip prosthesis|hip prosthesis
1049277|NCT02854514|endometrial -cytokines|endometrial -cytokines
1049278|NCT02854501|Homocysteine|homocysteine
1049377|NCT02853994|DCB|dcb
1049682|NCT02852135|laparoscopic surgery|laparoscopic surgery
1049683|NCT02852122|prostate cancer|prostate cancer
1049684|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
1049685|NCT02852122|staging|staging
1049686|NCT02852122|biochemical failure|biochemical failure
1050387|NCT02847715|PRO|pro
1051411|NCT02841696|GLS|gls
1052389|NCT02835027|Amputation free survival|amputation free survival
1052390|NCT02835027|Long time survival|long time survival
1052391|NCT02835027|Demographics|demographics
1052393|NCT02835014|Adolescents|adolescents
1052489|NCT02834260|dexamethasone|dexamethasone
1052490|NCT02834234|mesothelioma|mesothelioma
1052879|NCT02831946|glue (dermabond)|glue (dermabond)
1052887|NCT02831920|MRI|mri
1053409|NCT02829164|IgA|iga
1053488|NCT02828722|Mechanical ventilation|mechanical ventilation
1054194|NCT02824042|ECG thorough QTC|ecg thorough qtc
1054195|NCT02823977|ketamine|ketamine
1054227|NCT02823847|HIV|hiv
1054486|NCT02821975|Work|work
1055088|NCT02818361|Topical|topical
1055285|NCT02817152|periodontal treatment|periodontal treatment
1055551|NCT02815579|HIV|hiv
1056494|NCT02810171|anxiety|anxiety
1057492|NCT02803853|Schools|schools
1057493|NCT02803853|Worksite|worksite
1057494|NCT02803853|Social Media|social media
1057495|NCT02803853|Food Store|food store
1057496|NCT02803840|Large B-Cell|large b-cell
1057497|NCT02803840|Diffuse|diffuse
1058783|NCT02796898|PSA|psa
1058976|NCT02795962|Endovascular Procedures|endovascular procedures
1059007|NCT02795754|HIV|hiv
1059422|NCT02793154|GMA|gma
1059623|NCT02792114|CAR|car
1059786|NCT02791191|BACE inhibitor|bace inhibitor
1059787|NCT02791100|height|height
1059788|NCT02791100|weight|weight
1059789|NCT02791100|diet|diet
1059790|NCT02791100|complementary foods|complementary foods
1059791|NCT02791100|protein|protein
1059792|NCT02791100|calcium|calcium
1059921|NCT02790359|Air|air
1060375|NCT02787564|fruit, vegetables|fruit, vegetables
1060378|NCT02787538|Biologics|biologics
1061084|NCT02783742|burnout|burnout
1061293|NCT02782611|Health|health
1061501|NCT02781545|Surgery|surgery
1062004|NCT02778971|AD|ad
1062305|NCT02777060|gait|gait
1062435|NCT02776319|craving|craving
1063217|NCT02771639|outcome|outcome
1063417|NCT02770469|Quality of Life|quality of life
1063418|NCT02770469|Coping Skills|coping skills
1063422|NCT02770443|DCM|dcm
1063516|NCT02769754|SURGERY|surgery
1063929|NCT02766881|DSC|dsc
1064108|NCT02765815|TKA|tka
1064212|NCT02765282|Kinesia|kinesia
1064720|NCT02762149|Labour|labour
1066710|NCT02750267|Insulin Pump|insulin pump
1066711|NCT02750241|active video game|active video game
1066712|NCT02750241|mHealth|mhealth
1066713|NCT02750241|cancer survivor|cancer survivor
1066714|NCT02750241|women's health|women's health
1066715|NCT02750241|breast cancer|breast cancer
1067119|NCT02747667|Eye|eye
1067301|NCT02746107|shared decision making|shared decision making
1067796|NCT02743611|Refractory Myeloid Neoplasms|refractory myeloid neoplasms
1067799|NCT02743598|Obesity|obesity
1068545|NCT02738554|HBV|hbv
1068919|NCT02736188|GNEM|gnem
1069604|NCT02732015|Zofran|zofran
1069779|NCT02730884|MF|mf
1070451|NCT02726750|SMM|smm
1070725|NCT02725229|TENS|tens
1071000|NCT02723838|Reovirus|reovirus
1071001|NCT02723838|Oncolytic virus|oncolytic virus
1071002|NCT02723825|Distal tibia|distal tibia
1071003|NCT02723825|fractures|fractures
1071004|NCT02723825|epiphyses|epiphyses
1071005|NCT02723825|children|children
1071006|NCT02723812|Influenza|influenza
1071007|NCT02723812|GCFLU|gcflu
1071008|NCT02723812|vaccine|vaccine
1071009|NCT02723812|Vietnam|vietnam
1071010|NCT02723799|Hope|hope
1071011|NCT02723786|Delayed Graft Function|delayed graft function
1071705|NCT02719418|Innohep|innohep
1071909|NCT02718157|GBS|gbs
1072003|NCT02717819|Whey protein|whey protein
1072004|NCT02717819|Resistance training|resistance training
1072005|NCT02717819|Strength training|strength training
1072105|NCT02717065|Hearing|hearing
1072411|NCT02715245|Primary Health Care|primary health care
1072412|NCT02715245|Physiotherapy|physiotherapy
1072798|NCT02713217|alcohol-related disorders|alcohol-related disorders
1072799|NCT02713217|telemedicine|telemedicine
1072800|NCT02713217|rural health|rural health
1072801|NCT02713217|collaborative care|collaborative care
1072803|NCT02713191|Bronchoscopy|bronchoscopy
1072999|NCT02711956|XTANDI|xtandi
1073215|NCT02710500|LGMD2B|lgmd2b
1073385|NCT02709473|propofol|propofol
1073386|NCT02709473|remifentanil|remifentanil
1073387|NCT02709473|rocuronium|rocuronium
1073405|NCT02709408|Outcome|outcome
1073784|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
1073786|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
1073787|NCT02706886|RNAi therapeutic|rnai therapeutic
1073788|NCT02706886|siRNA|sirna
1073789|NCT02706886|AGT|agt
1073790|NCT02706873|Musculoskeletal disease|musculoskeletal disease
1073884|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
1073885|NCT02706132|Liver Transplantation|liver transplantation
1073886|NCT02706132|ABO blood group|abo blood group
1073887|NCT02706119|total parenteral nutrition|total parenteral nutrition
1073888|NCT02706119|glargine insulin|glargine insulin
1073987|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
1074086|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
1074087|NCT02704949|Urolithiasis|urolithiasis
1074088|NCT02704949|Fluoroscopy|fluoroscopy
1074089|NCT02704949|Radiation|radiation
1074288|NCT02703584|Double trigger|double trigger
1074289|NCT02703571|Trametinib|trametinib
1074290|NCT02703571|Ribociclib|ribociclib
1074291|NCT02703571|LEE011|lee011
1074787|NCT02700867|cadaver|cadaver
1075230|NCT02697734|UFC|ufc
1075770|NCT02694861|Angina, Stable|angina, stable
1075771|NCT02694861|Chest Pain|chest pain
1075775|NCT02694783|JC VIRUS|jc virus
1075777|NCT02694770|aGvHD|agvhd
1076173|NCT02692703|HCV Genotype 3|hcv genotype 3
1076174|NCT02692703|Without cirrhosis|without cirrhosis
1076186|NCT02692677|Healthy|healthy
1076592|NCT02690337|phase 1|phase 1
1076688|NCT02689843|Complement system proteins|complement system proteins
1076689|NCT02689843|Homocysteine|homocysteine
1076690|NCT02689843|C-Reactive Protein|c-reactive protein
1076801|NCT02689284|GEJ|gej
1077042|NCT02687789|BV|bv
1077514|NCT02684734|UC|uc
1077791|NCT02682836|fatigue|fatigue
1077886|NCT02682381|parenteral support|parenteral support
1077887|NCT02682381|Short Bowel Syndrome|short bowel syndrome
1077889|NCT02682381|short gut|short gut
1078413|NCT02678767|HIV|hiv
1079298|NCT02673112|child|child
1079675|NCT02670356|EPA|epa
1079975|NCT02668367|RSV|rsv
1079976|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
1079977|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1080077|NCT02667652|RCT|rct
1080337|NCT02666092|IgE|ige
1080375|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
1080376|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
1080377|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
1080378|NCT02665715|Diet|diet
1081179|NCT02661282|Temodar|temodar
1081487|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1082092|NCT02656745|Smoking|smoking
1082203|NCT02656017|PKD|pkd
1082783|NCT02652663|MRI|mri
1083183|NCT02649972|15-216|15-216
1083184|NCT02649959|Autism|autism
1083185|NCT02649933|pregnancy|pregnancy
1083186|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
1083187|NCT02649920|unfavorable cervix|unfavorable cervix
1083188|NCT02649920|obese pregnant women|obese pregnant women
1083189|NCT02649894|malignant pleural effusion|malignant pleural effusion
1083190|NCT02649881|macrophage|macrophage
1083191|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
1083192|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
1083193|NCT02649868|Thermal Ablation|thermal ablation
1083194|NCT02649868|Transarterial Embolization|transarterial embolization
1083195|NCT02649855|PSA|psa
1084133|NCT02644161|CAI|cai
1084580|NCT02641392|IBD|ibd
1084680|NCT02640820|HPV|hpv
1085172|NCT02637843|radial|radial
1086059|NCT02633319|Child maltreatment|child maltreatment
1086938|NCT02628912|HPV|hpv
1087092|NCT02628067|PD1|pd1
1087263|NCT02627456|Human|human
1087646|NCT02625298|MTA|mta
1087659|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
1087660|NCT02625181|Decision support|decision support
1087661|NCT02625181|Prediction models|prediction models
1087662|NCT02625181|PONV|ponv
1087663|NCT02625181|prophylaxis|prophylaxis
1087664|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
1087665|NCT02625181|Decision Support Techniques|decision support techniques
1087666|NCT02625168|Afatinib|afatinib
1087667|NCT02625168|Erlotinib|erlotinib
1087668|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
1087670|NCT02625168|Safety|safety
1088269|NCT02621502|Quinoa|quinoa
1088270|NCT02621502|Satiety|satiety
1088271|NCT02621502|Visual analogue scale|visual analogue scale
1088272|NCT02621502|Cross-over studies|cross-over studies
1088371|NCT02620891|helium oxygen mixture|helium oxygen mixture
1088372|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
1088373|NCT02620878|Artificial pancreas|artificial pancreas
1088476|NCT02620449|diet|diet
1088477|NCT02620436|Maternal & Child Health|maternal & child health
1088576|NCT02619825|Child|child
1088592|NCT02619695|gel|gel
1089474|NCT02613988|standard treatment|standard treatment
1089475|NCT02613949|fibromyalgia|fibromyalgia
1089476|NCT02613949|pain|pain
1089485|NCT02613923|sleep|sleep
1089685|NCT02612480|LPS|lps
1090291|NCT02608658|Ascites|ascites
1090971|NCT02604095|Acanthosis nigricans|acanthosis nigricans
1090972|NCT02604095|Obesity|obesity
1090973|NCT02604069|Breast reconstruction|breast reconstruction
1090974|NCT02604069|Breast cancer|breast cancer
1090975|NCT02604069|Microsurgery|microsurgery
1090976|NCT02604069|Continuous flap monitor|continuous flap monitor
1091488|NCT02601378|Phase I|phase i
1091890|NCT02599025|Cerebral palsy|cerebral palsy
1091891|NCT02599025|passive cycling|passive cycling
1091892|NCT02599025|autonomic control system|autonomic control system
1091893|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
1091901|NCT02598882|Elderly|elderly
1092380|NCT02595983|FAP|fap
1092499|NCT02595281|HE4|he4
1092668|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
1092669|NCT02594202|Molecular Mechanims|molecular mechanims
1092670|NCT02594202|Cell Lines|cell lines
1092676|NCT02594176|Osteoarthritis|osteoarthritis
1064827|NCT02761538|ICTs|icts
1064828|NCT02761538|Cost-effectiveness|cost-effectiveness
1064829|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
1064830|NCT02761486|aspirin|aspirin
1064831|NCT02761486|gut microbiome|gut microbiome
1064832|NCT02761486|inflammation|inflammation
1064833|NCT02761486|placebo|placebo
1064834|NCT02761486|circulating biomarker|circulating biomarker
1064835|NCT02761447|Motor control Laterality|motor control laterality
1064836|NCT02761447|Pain Perception|pain perception
1064837|NCT02761447|Lower Extremity|lower extremity
1064838|NCT02761447|Complementary Therapies|complementary therapies
1064839|NCT02761447|Physical Therapy Modalities|physical therapy modalities
1064840|NCT02761434|copeptin|copeptin
1064841|NCT02761434|vasopressin|vasopressin
1064842|NCT02761434|dehydration|dehydration
1064843|NCT02761434|insulin resistance|insulin resistance
1064844|NCT02761434|Diabetes|diabetes
1064845|NCT02761434|Glucose regulation|glucose regulation
1064846|NCT02761421|IOPD|iopd
1064847|NCT02761408|Head and neck cancer|head and neck cancer
1064848|NCT02761408|Asian|asian
1064849|NCT02761408|ALDH2|aldh2
1064850|NCT02761369|food addiction|food addiction
1064851|NCT02761369|obesity|obesity
1064852|NCT02761369|deep TMS|deep tms
1064853|NCT02761369|PAS|pas
1064854|NCT02761369|Food Stroop|food stroop
1064855|NCT02761369|brain laterality|brain laterality
1064856|NCT02761369|EEG|eeg
1064857|NCT02761369|INP|inp
1064858|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
1064859|NCT02761343|cardiac ablation|cardiac ablation
1064860|NCT02761343|congenital cardiac disease|congenital cardiac disease
1064861|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
1064862|NCT02761330|Anesthesia|anesthesia
1064863|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
1064864|NCT02761330|Delirium|delirium
1064865|NCT02761330|Electroencephalography|electroencephalography
1064866|NCT02761330|Seizures|seizures
1064867|NCT02761330|Depression|depression
1064868|NCT02761330|Ketamine|ketamine
1064869|NCT02761330|Etomidate|etomidate
1064870|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
1064871|NCT02761330|Pharmacologic Actions|pharmacologic actions
1064872|NCT02761330|Confusion|confusion
1064873|NCT02761330|Mental Disorders|mental disorders
1064874|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
1064875|NCT02761330|Signs and Symptoms|signs and symptoms
1064876|NCT02761330|Neurologic Manifestations|neurologic manifestations
1064877|NCT02761330|Cognitive Disorders|cognitive disorders
1064878|NCT02761317|bowel preparation|bowel preparation
1064879|NCT02761317|bisacodyl|bisacodyl
1064880|NCT02761317|polyethyleneglycol|polyethyleneglycol
1064881|NCT02761317|colorectal surgery|colorectal surgery
1064882|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1064883|NCT02761291|EB virus|eb virus
1064884|NCT02761291|metastasis|metastasis
1064885|NCT02761291|recurrence|recurrence
1064886|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
1064887|NCT02761291|gemcitabine|gemcitabine
1064888|NCT02761291|valproic acid|valproic acid
1064889|NCT02761291|ganciclovir|ganciclovir
1064890|NCT02761291|valganciclovir|valganciclovir
1064891|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
1064892|NCT02761265|Gait Analysis|gait analysis
1064893|NCT02761265|Balance Analysis|balance analysis
1064894|NCT02761265|Biomechanics|biomechanics
1064895|NCT02761265|Neuromuscular Control|neuromuscular control
1064896|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
1064897|NCT02761252|Bilastine|bilastine
1064898|NCT02761252|Montelukast|montelukast
1064899|NCT02761252|total symptom score|total symptom score
1064900|NCT02761252|AQLQ|aqlq
1064901|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
1064902|NCT02761239|innervation by EBSLN|innervation by ebsln
1064903|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
1064904|NCT02761226|platform switching|platform switching
1064905|NCT02761226|dental implant|dental implant
1064906|NCT02761226|crestal bone level|crestal bone level
1064907|NCT02761226|implant stability|implant stability
1064908|NCT02761226|postoperative complication|postoperative complication
1064909|NCT02761187|Drug Therapy|drug therapy
1064910|NCT02761174|Vascular lesions|vascular lesions
1064911|NCT02761174|inflammation|inflammation
1064912|NCT02761174|IPL|ipl
1064913|NCT02761161|PTSD|ptsd
1064914|NCT02761161|Sleep|sleep
1064915|NCT02761161|Refugee|refugee
1064916|NCT02761161|IRT|irt
1064917|NCT02761161|Mianserin|mianserin
1064918|NCT02761148|white matter hyperintensity|white matter hyperintensity
1064919|NCT02761148|brain network|brain network
1064920|NCT02761148|MRI|mri
1064921|NCT02761148|cognition|cognition
1064922|NCT02761148|emotion|emotion
1064923|NCT02761135|Biopsy technique|biopsy technique
1093856|NCT02587234|chronic|chronic
1093857|NCT02587234|human|human
1093858|NCT02587234|sensory|sensory
1094175|NCT02585024|smoking|smoking
1094566|NCT02582528|youth|youth
1094756|NCT02581384|Palliative Care|palliative care
1094757|NCT02581371|Cerebrolysin|cerebrolysin
1094758|NCT02581371|neuroplasticity|neuroplasticity
1094759|NCT02581371|upper limb|upper limb
1094760|NCT02581371|middle cerebral artery|middle cerebral artery
1094761|NCT02581371|NBS|nbs
1094762|NCT02581371|navigation brain stimulation|navigation brain stimulation
1095277|NCT02578537|CKD|ckd
1096086|NCT02574234|Surgery|surgery
1096495|NCT02572102|ECG|ecg
1097667|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
1097668|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
1097672|NCT02565485|hypotension|hypotension
1098174|NCT02562443|MDS|mds
1098423|NCT02561026|INR|inr
1098536|NCT02560350|small intestinal submucosa|small intestinal submucosa
1098537|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
1098538|NCT02560337|Ovarian cancer|ovarian cancer
1098639|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
1098733|NCT02559063|speed of processing|speed of processing
1098734|NCT02559063|neuroplasticity|neuroplasticity
1098735|NCT02559063|cognitive aging|cognitive aging
1098736|NCT02559037|acupuncture|acupuncture
1098737|NCT02559037|moxibustion|moxibustion
1098738|NCT02559037|intestinal microbiota|intestinal microbiota
1098739|NCT02559037|Mucosal immunity|mucosal immunity
1098924|NCT02557906|Autologous reconstruction|autologous reconstruction
1098925|NCT02557906|Biological mesh|biological mesh
1098926|NCT02557867|dexmedetomidine|dexmedetomidine
1098927|NCT02557867|pharmacokinetic|pharmacokinetic
1098928|NCT02557867|obesity|obesity
1099026|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
1099027|NCT02557204|Video laryngoscope|video laryngoscope
1099028|NCT02557204|success rate|success rate
1099029|NCT02557165|Muscle regeneration|muscle regeneration
1099117|NCT02556710|Osteoarthritis|osteoarthritis
1099118|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
1099122|NCT02556684|BSGI|bsgi
1099833|NCT02552329|Tai Chi|tai chi
1100221|NCT02549924|MAGE|mage
1100514|NCT02548273|Corneal endothelium|corneal endothelium
1100515|NCT02548273|phacoemulsification|phacoemulsification
1101109|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
1101110|NCT02544516|Schizophrenia|schizophrenia
1101111|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
1101112|NCT02544490|Sepsis|sepsis
1101664|NCT02541006|FVC|fvc
1101897|NCT02539524|Yoga|yoga
1101994|NCT02539043|Pilot Projects|pilot projects
1101995|NCT02539043|Subcutaneous Fat|subcutaneous fat
1101996|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
1101997|NCT02539043|Adiposity|adiposity
1101998|NCT02539030|Cartilage defect of knee|cartilage defect of knee
1103086|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
1103087|NCT02531971|Bioequivalence|bioequivalence
1103088|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
1103089|NCT02531945|topography|topography
1103090|NCT02531945|cobb angle|cobb angle
1103091|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
1103092|NCT02531919|tumor acidity|tumor acidity
1103093|NCT02531893|Irritability|irritability
1103094|NCT02531893|Disruptive Mood|disruptive mood
1103095|NCT02531893|Tantrums|tantrums
1103300|NCT02530515|CLL|cll
1103439|NCT02530034|MDS|mds
1103705|NCT02528643|MDV3100|mdv3100
1103800|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
1103801|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
1104503|NCT02523378|ESAS|esas
1104633|NCT02522585|p16|p16
1105593|NCT02516436|Induction|induction
1105599|NCT02516345|Children|children
1106239|NCT02512575|AZD9567|azd9567
1106607|NCT02510261|FAP|fap
1106829|NCT02509156|AIC|aic
1107204|NCT02506959|LBH589B|lbh589b
1107344|NCT02506062|(RP)|(rp)
1107606|NCT02504866|Aerobic Exercise Training|aerobic exercise training
1107607|NCT02504866|Balance|balance
1107803|NCT02503683|AAT|aat
1108604|NCT02499380|LVRC|lvrc
1108915|NCT02497456|HIV|hiv
1109527|NCT02494401|ssc|ssc
1109953|NCT02491879|gel|gel
1110023|NCT02491515|BMD|bmd
1110658|NCT02487290|AAA|aaa
1110723|NCT02487030|HCV|hcv
1111409|NCT02483156|HCV|hcv
1111619|NCT02481908|valsalva maneuver|valsalva maneuver
1111620|NCT02481908|systolic time intervals|systolic time intervals
1111621|NCT02481895|cognition|cognition
1111623|NCT02481869|Closed|closed
1111835|NCT02480725|CJD|cjd
1111937|NCT02479893|APC|apc
1112026|NCT02479464|Major depressive disorder|major depressive disorder
1112027|NCT02479451|End stage renal disease|end stage renal disease
1112028|NCT02479451|Olfaction|olfaction
1112029|NCT02479451|Dialysis|dialysis
1112030|NCT02479451|Hemodialysis|hemodialysis
1112031|NCT02479451|Malnutrition|malnutrition
1112327|NCT02477644|placebo|placebo
1112626|NCT02476058|Placebo|placebo
1112747|NCT02475187|TEG|teg
1113229|NCT02472691|MDS|mds
1113509|NCT02471131|Safety|safety
1113810|NCT02469415|5-azacitidine|5-azacitidine
1113811|NCT02469415|Azacitidine|azacitidine
1113812|NCT02469415|5-azacytidine|5-azacytidine
1113917|NCT02468843|Deep brain stimulation|deep brain stimulation
1113918|NCT02468843|DBS|dbs
1113919|NCT02468843|Dystonia|dystonia
1114020|NCT02468323|PONV|ponv
1114418|NCT02466243|JBT-101, lenabasum, dermatomyositis|jbt-101, lenabasum, dermatomyositis
1114419|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
1114420|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
1114421|NCT02466217|Auto-immune disease|auto-immune disease
1114422|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
1115028|NCT02462785|T1DM|t1dm
1115134|NCT02462239|FDG|fdg
1115462|NCT02460367|IDO|ido
1115530|NCT02459886|alpha synuclein|alpha synuclein
1115531|NCT02459886|PD|pd
1116537|NCT02453776|IBD|ibd
1116928|NCT02451124|Barrett|barrett
1117623|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
1117624|NCT02446704|SCLC|sclc
1117625|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
1117626|NCT02446678|emergency department|emergency department
1117665|NCT02446457|FL|fl
1117877|NCT02445300|TKA|tka
1118220|NCT02443168|Healthy|healthy
1118838|NCT02440256|HIV|hiv
1118922|NCT02439827|Obesity|obesity
1119118|NCT02438540|obesity|obesity
1119244|NCT02437773|OCD|ocd
1119819|NCT02434328|AMD|amd
1120324|NCT02431546|CVD|cvd
1121029|NCT02427919|G-CSF|g-csf
1121471|NCT02425358|BMC|bmc
1121829|NCT02423460|Healthy Controls|healthy controls
1121830|NCT02423460|Crohn's Disease|crohn's disease
1121831|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
1121832|NCT02423434|Diabetes Mellitus|diabetes mellitus
1122134|NCT02422017|wound|wound
1122443|NCT02420769|CA 125|ca 125
1122979|NCT02418533|PGS|pgs
1123467|NCT02416193|Diabetes|diabetes
1123468|NCT02416193|Cognition|cognition
1123469|NCT02416193|Functioning|functioning
1123869|NCT02413970|OSA|osa
1124958|NCT02407665|Tai Chi|tai chi
1125056|NCT02406924|pin|pin
1125162|NCT02406131|RCT|rct
1126077|NCT02401503|CLL|cll
1126266|NCT02400203|hemp|hemp
1127157|NCT02394626|Quality of life|quality of life
1127158|NCT02394613|Glaucoma|glaucoma
1127159|NCT02394613|DARC|darc
1127160|NCT02394613|Diagnosis|diagnosis
1127165|NCT02394587|SCD|scd
1127756|NCT02391181|Bioequivalence|bioequivalence
1127757|NCT02391181|Iron Status|iron status
1127758|NCT02391155|follicular flushing|follicular flushing
1127759|NCT02391155|IVF|ivf
1127760|NCT02391155|poor responders|poor responders
1127765|NCT02391090|asthma|asthma
1127873|NCT02390531|ROP|rop
1127963|NCT02389894|Embolic Protection Device|embolic protection device
1127964|NCT02389894|Stroke|stroke
1127966|NCT02389894|atheroma|atheroma
1128059|NCT02389335|IFN γ|ifn γ
1128814|NCT02385279|CAD|cad
1129065|NCT02384096|chronic pain|chronic pain
1129066|NCT02384096|leg pain|leg pain
1129067|NCT02384083|Multiple Myeloma|multiple myeloma
1129068|NCT02384083|Pethema|pethema
1129069|NCT02384083|Filanesib|filanesib
1129070|NCT02384083|Pomalidomide|pomalidomide
1129071|NCT02384044|Sensitivity|sensitivity
1129781|NCT02380053|Beta-blocker|beta-blocker
1129782|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1129885|NCT02379429|Specimen Collection|specimen collection
1129886|NCT02379429|Urine|urine
1129887|NCT02379429|Blood|blood
1130489|NCT02376231|Surgery|surgery
1130823|NCT02374099|ER+|er+
1130987|NCT02372890|PET/CT|pet/ct
1131187|NCT02371824|Hip|hip
1131482|NCT02370030|sepsis|sepsis
1131714|NCT02368756|dme|dme
1132624|NCT02363413|NIV|niv
1132844|NCT02362035|Btk|btk
1132889|NCT02361905|fibroid|fibroid
1133392|NCT02359032|ASP6858|asp6858
1134304|NCT02353949|PET|pet
1135196|NCT02348489|AML|aml
1135483|NCT02346708|TMS|tms
1135794|NCT02345109|BMI|bmi
1136212|NCT02342938|icEEG|iceeg
1136579|NCT02340923|DMD|dmd
1136680|NCT02340273|pain|pain
1137076|NCT02337790|Fluids|fluids
1137176|NCT02337140|TAVI|tavi
1137893|NCT02332668|PD1|pd1
1138194|NCT02330887|Nepal|nepal
1138265|NCT02330510|Transient Ischemic Attack|transient ischemic attack
1138266|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
1138336|NCT02330042|OCT|oct
1139253|NCT02325011|Sativex|sativex
1139658|NCT02322723|RA|ra
1139740|NCT02322307|Patient-centric|patient-centric
1139741|NCT02322307|HealthPROMISE|healthpromise
1139742|NCT02322294|Protein|protein
1139743|NCT02322294|mung bean|mung bean
1139744|NCT02322294|glucose|glucose
1139745|NCT02322294|triglycerides|triglycerides
1140254|NCT02319798|IBD|ibd
1140585|NCT02318030|EBV|ebv
1140654|NCT02317549|gut barrier breakdown|gut barrier breakdown
1140657|NCT02317549|MOF|mof
1141258|NCT02314481|ALK|alk
1141938|NCT02310399|ABI|abi
1142341|NCT02308111|PBC|pbc
1142546|NCT02307097|IAPT|iapt
1142657|NCT02306369|IBS|ibs
1142964|NCT02304848|DBS|dbs
1143142|NCT02303535|OPCS|opcs
1143341|NCT02302521|MRI|mri
1144137|NCT02298309|TB|tb
1144217|NCT02297737|Tai Chi|tai chi
1144341|NCT02296918|CLL|cll
1144796|NCT02294305|Social Anxiety|social anxiety
1144797|NCT02294305|Social Phobia|social phobia
1144798|NCT02294305|Major Depression|major depression
1144799|NCT02294305|Vortioxetine|vortioxetine
1144800|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
1144808|NCT02294214|malaria|malaria
1145224|NCT02292186|FAC|fac
1145500|NCT02290626|GER|ger
1146493|NCT02284815|T1D|t1d
1146867|NCT02282345|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
1147208|NCT02280525|CLL|cll
1148365|NCT02274116|walking|walking
1148660|NCT02272400|IGRT|igrt
1148761|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
1148762|NCT02271932|appendicitis|appendicitis
1148763|NCT02271932|non-operative management|non-operative management
1148764|NCT02271932|children|children
1148765|NCT02271932|pediatric|pediatric
1148778|NCT02271906|Lung Cancer|lung cancer
1148779|NCT02271906|Non small cell lung cancer|non small cell lung cancer
1148780|NCT02271906|NSCLC|nsclc
1148781|NCT02271906|Adenocarcinoma|adenocarcinoma
1148782|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
1149272|NCT02269085|MCL|mcl
1149940|NCT02265094|Memory|memory
1150332|NCT02262377|MBSR|mbsr
1150686|NCT02260193|CKD|ckd
1150720|NCT02259660|osa|osa
1151727|NCT02254577|ART|art
1151808|NCT02253706|safety|safety
1152010|NCT02252770|ASA|asa
1152158|NCT02252107|AML|aml
1152407|NCT02250820|Dexmedetomidine|dexmedetomidine
1152408|NCT02250820|Pentobarbital|pentobarbital
1152409|NCT02250807|Chronic hepatitis C|chronic hepatitis c
1152410|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
1152411|NCT02250807|Simeprevir|simeprevir
1152412|NCT02250807|Sofosbuvir|sofosbuvir
1152413|NCT02250794|diabetes mellitus|diabetes mellitus
1152414|NCT02250794|inpatient management|inpatient management
1152415|NCT02250794|metformin|metformin
1152416|NCT02250794|sitagliptin|sitagliptin
1152417|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
1152418|NCT02250755|MRI perfusion|mri perfusion
1152419|NCT02250755|therapeutic response|therapeutic response
1152420|NCT02250755|chemotherapy|chemotherapy
1152421|NCT02250755|brain metastases|brain metastases
1152515|NCT02250313|prostate cancer|prostate cancer
1152516|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1152517|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
1152518|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
1152519|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
1152520|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
1152521|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
1152522|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
1152525|NCT02250261|walking|walking
1152895|NCT02248285|PCR|pcr
1153784|NCT02244424|Infant|infant
1154095|NCT02242955|Relapse|relapse
1154281|NCT02241811|Foot|foot
1154684|NCT02239900|XRT|xrt
1154789|NCT02239393|MSC|msc
1155367|NCT02236650|Behavior|behavior
1155368|NCT02236650|Child Behavior|child behavior
1155369|NCT02236650|Child Development Disorders|child development disorders
1155371|NCT02236650|Caregivers|caregivers
1155400|NCT02236546|FDG|fdg
1155775|NCT02234895|knee|knee
1156593|NCT02231138|safety|safety
1156981|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
1156982|NCT02229513|severe hemorrhage|severe hemorrhage
1156983|NCT02229513|blood transfusion|blood transfusion
1156984|NCT02229513|obstetric emergencies|obstetric emergencies
1156985|NCT02229513|obstetrics|obstetrics
1157574|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1157575|NCT02226965|Lymphoma|lymphoma
1157576|NCT02226913|Buffered|buffered
1157577|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
1157578|NCT02226913|irreversible pulpitis|irreversible pulpitis
1157579|NCT02226913|local anesthesia|local anesthesia
1157775|NCT02226055|Sri Lanka|sri lanka
1157776|NCT02226055|CKDu|ckdu
1157777|NCT02226055|Arterial stiffness|arterial stiffness
1157778|NCT02226055|Cardiovascular risk|cardiovascular risk
1157779|NCT02226055|North Central Province|north central province
1157780|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
1157781|NCT02226016|ptosis|ptosis
1157782|NCT02226016|blepharochalasis|blepharochalasis
1157783|NCT02226016|dermatochalasis|dermatochalasis
1158376|NCT02223767|TMS|tms
1158486|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
1158487|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
1158488|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
1158489|NCT02223221|SNP array|snp array
1158490|NCT02223208|PTCL|ptcl
1158491|NCT02223208|PTCL-NOS|ptcl-nos
1158492|NCT02223208|AITL|aitl
1158493|NCT02223208|ALCL|alcl
1158494|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1158495|NCT02223195|Saliva|saliva
1158496|NCT02223182|Milk Allergy,|milk allergy,
1158497|NCT02223182|Viaskin Milk,|viaskin milk,
1158498|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
1158499|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
1158500|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
1158501|NCT02223169|Blood Pressure|blood pressure
1158502|NCT02223169|Hypertension|hypertension
1158503|NCT02223169|Cardiovascular disease|cardiovascular disease
1158504|NCT02223143|Lipid lowering therapy|lipid lowering therapy
1158505|NCT02223130|HIV|hiv
1158506|NCT02223130|Discrimination|discrimination
1158507|NCT02223130|Coping|coping
1158508|NCT02223130|Medical Mistrust|medical mistrust
1158509|NCT02223130|HIV Outcomes|hiv outcomes
1158510|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
1158511|NCT02223091|complementary therapies|complementary therapies
1158512|NCT02223091|consultants|consultants
1158513|NCT02223091|medical oncology|medical oncology
1158514|NCT02223091|breast-cancer|breast-cancer
1158515|NCT02223091|education|education
1158559|NCT02223039|Psoriasis|psoriasis
1158560|NCT02223039|Dermatology|dermatology
1158561|NCT02223039|Monoclonal antibody|monoclonal antibody
1158562|NCT02222935|Balance training|balance training
1158563|NCT02222935|low back pain|low back pain
1158564|NCT02222935|balance test|balance test
1158565|NCT02222935|routine back exercise|routine back exercise
1158905|NCT02221310|MDS|mds
1159103|NCT02220608|G-CSF|g-csf
1159906|NCT02217007|tic|tic
1160096|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
1160097|NCT02216253|L-methionine|l-methionine
1160098|NCT02216253|Placebo|placebo
1160099|NCT02216227|MRSA|mrsa
1160102|NCT02216214|Mirabegron|mirabegron
1160206|NCT02215538|ADHD|adhd
1160468|NCT02214212|TBI|tbi
1160496|NCT02214160|C7|c7
1162357|NCT02205437|RNA|rna
1162480|NCT02205177|Teen|teen
1162763|NCT02203773|AML|aml
1163646|NCT02199717|BMI|bmi
1163848|NCT02198859|PSA|psa
1163887|NCT02198664|OIT|oit
1164654|NCT02195011|90Y|90y
1166025|NCT02189395|NPH|nph
1166199|NCT02188810|PAL|pal
1166285|NCT02188420|PAS|pas
1167129|NCT02184949|PCI|pci
1167970|NCT02179892|surgery|surgery
1168479|NCT02176980|HCV|hcv
1168866|NCT02174848|PKAN|pkan
1169381|NCT02171286|ALK|alk
1169631|NCT02170025|Sweat Chloride|sweat chloride
1169633|NCT02170012|Multiple dose|multiple dose
1170414|NCT02166294|Foot|foot
1170813|NCT02164422|Alcohol|alcohol
1171015|NCT02163525|GFA|gfa
1171400|NCT02161874|T3|t3
1171841|NCT02159872|MDS|mds
1171925|NCT02159391|Adult|adult
1172694|NCT02155829|PTSD|ptsd
1172783|NCT02155569|Pain|pain
1172996|NCT02154425|CZP|czp
1173498|NCT02152085|Walking|walking
1173691|NCT02151032|Surveys|surveys
1174050|NCT02149498|EEG|eeg
1174687|NCT02146560|Surgery|surgery
1175077|NCT02144831|TIA|tia
1175169|NCT02144389|Schistosomiasis|schistosomiasis
1175170|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
1175171|NCT02144376|Constipation|constipation
1175172|NCT02144376|psyllium|psyllium
1175173|NCT02144376|ispaghula|ispaghula
1175174|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
1175175|NCT02144376|MRI|mri
1175176|NCT02144376|microbiota|microbiota
1175177|NCT02144363|Preterm|preterm
1175178|NCT02144363|RDS|rds
1175191|NCT02144311|MRI|mri
1175603|NCT02142530|NHL|nhl
1175980|NCT02140684|UK|uk
1176185|NCT02139774|Men|men
1176397|NCT02138786|CLL|cll
1176580|NCT02137954|cancer|cancer
1177949|NCT02131584|Fatigue|fatigue
1178071|NCT02130960|RMR|rmr
1178169|NCT02130635|PI3Kd|pi3kd
1178262|NCT02130271|MRI|mri
1178740|NCT02128334|PSA|psa
1178944|NCT02127424|HIV|hiv
1180118|NCT02121795|HIV|hiv
1181603|NCT02115542|biliary|biliary
1181900|NCT02114437|NI|ni
1182779|NCT02110927|Abdominal fat|abdominal fat
1182780|NCT02110927|Metabolic syndrome|metabolic syndrome
1182781|NCT02110927|Microcurrent|microcurrent
1183129|NCT02109367|HE4|he4
1183655|NCT02107248|Hip|hip
1185500|NCT02099032|milk|milk
1185501|NCT02099032|polar lipids|polar lipids
1185502|NCT02099032|cardiometabolic risk|cardiometabolic risk
1185503|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
1185510|NCT02098954|TKI|tki
1185862|NCT02097381|GUT|gut
1186319|NCT02095353|MRI|mri
1186639|NCT02093923|HAE|hae
1187087|NCT02091882|OPC-14597 Digital|opc-14597 digital
1187088|NCT02091882|Aripiprazole|aripiprazole
1187094|NCT02091817|oxytocin|oxytocin
1187473|NCT02090114|Testosterone|testosterone
1187474|NCT02090114|Enzalutamide|enzalutamide
1187524|NCT02089802|RCC|rcc
1187876|NCT02087852|DNA|dna
1188102|NCT02086630|HIV|hiv
1188152|NCT02086344|TLH|tlh
1188249|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1188250|NCT02085967|Healthy|healthy
1188251|NCT02085967|Metabolism|metabolism
1188252|NCT02085967|Drug-Drug Interactions|drug-drug interactions
1188841|NCT02083250|ALL|all
1189961|NCT02078310|Healthy|healthy
1190440|NCT02076243|SCC|scc
1190833|NCT02074657|NKAEs|nkaes
1191028|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
1191290|NCT02072447|AMS|ams
1191421|NCT02071823|Bial,|bial,
1192417|NCT02066948|DXA|dxa
1193042|NCT02064244|renal|renal
1193627|NCT02061553|TBI|tbi
1193735|NCT02061137|BDNF|bdnf
1193815|NCT02060773|Indocyanine Green|indocyanine green
1193816|NCT02060760|Prospective cohort study|prospective cohort study
1193817|NCT02060760|Diagnostic accuracy|diagnostic accuracy
1193819|NCT02060760|Gender|gender
1194217|NCT02058927|HIV|hiv
1194318|NCT02058563|Safety|safety
1194901|NCT02055872|Edema|edema
1195023|NCT02055443|ECG|ecg
1195123|NCT02055079|PKD|pkd
1195932|NCT02051283|RFA|rfa
1196289|NCT02049762|aspirin|aspirin
1196401|NCT02049255|All|all
1197199|NCT02045940|FTIH|ftih
1197306|NCT02045537|HIV|hiv
1197394|NCT02045186|Oropharynx|oropharynx
1197395|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
1197396|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
1197397|NCT02045186|Radiation Therapy|radiation therapy
1197398|NCT02045186|Chemotherapy|chemotherapy
1197402|NCT02045082|Flocked swab|flocked swab
1199151|NCT02037412|DES|des
1199301|NCT02036710|GLP-1|glp-1
1199690|NCT02034838|PK|pk
1200076|NCT02033213|tissue perfusion|tissue perfusion
1200077|NCT02033200|vision|vision
1200078|NCT02033200|Stendra|stendra
1200079|NCT02033200|avanafil|avanafil
1200088|NCT02033161|FGID|fgid
1200365|NCT02031666|Bioavailability|bioavailability
1200366|NCT02031653|Penile Cuff Test|penile cuff test
1200367|NCT02031640|asthma|asthma
1200368|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
1200369|NCT02031640|metered-dose inhaler|metered-dose inhaler
1200370|NCT02031627|lymphedema|lymphedema
1200371|NCT02031627|lymphoedema|lymphoedema
1200372|NCT02031627|leg lymphoedema|leg lymphoedema
1200375|NCT02031614|anemia|anemia
1200677|NCT02030080|Walking|walking
1201259|NCT02027571|Race/Ethnicity|race/ethnicity
1201260|NCT02027571|Offspring Cohort|offspring cohort
1201261|NCT02027571|African Americans|african americans
1201262|NCT02027571|Prediabetes Reversal|prediabetes reversal
1201263|NCT02027571|Lifestyle Intervention|lifestyle intervention
1201264|NCT02027571|Insulin Sensitivity|insulin sensitivity
1201265|NCT02027571|Beta-cell Function|beta-cell function
1201266|NCT02027571|Diabetes Prevention|diabetes prevention
1201267|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
1201268|NCT02027558|insomnia|insomnia
1201269|NCT02027558|apnea|apnea
1201271|NCT02027545|decision making|decision making
1202869|NCT02019927|TES|tes
1203824|NCT02015663|CF|cf
1203978|NCT02015065|GIST|gist
1203979|NCT02015065|Toxicity|toxicity
1203980|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
1203981|NCT02015065|Clinical Activity|clinical activity
1203982|NCT02015065|Survival|survival
1204081|NCT02014675|ICD|icd
1204469|NCT02012894|manometry|manometry
1204471|NCT02012868|weight loss|weight loss
1205264|NCT02009306|Hospice|hospice
1206167|NCT02005406|Wei JET|wei jet
1206554|NCT02003482|Head and Neck Cancer|head and neck cancer
1206557|NCT02003482|IMRT|imrt
1206655|NCT02003066|Fluid Therapy|fluid therapy
1206656|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
1206657|NCT02003066|Surgical Flaps|surgical flaps
1206658|NCT02003053|Critically ill|critically ill
1206659|NCT02003053|intubated|intubated
1206660|NCT02003053|safety|safety
1206661|NCT02003053|feasibility|feasibility
1206662|NCT02003053|inspiratory muscle training|inspiratory muscle training
1206758|NCT02002546|Angina|angina
1206885|NCT02001961|MRI|mri
1207142|NCT02000830|stannsoporfin|stannsoporfin
1207149|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
1207150|NCT02000791|cLMA|clma
1207151|NCT02000791|laryngoscopy|laryngoscopy
1207152|NCT02000791|fiberoptic|fiberoptic
1207254|NCT02000362|CD|cd
1207555|NCT01998971|IMiD|imid
1208036|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
1208037|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
1208038|NCT01996969|refractory|refractory
1208039|NCT01996969|regorafenib|regorafenib
1208131|NCT01996449|Eplerenone|eplerenone
1208132|NCT01996449|Amlodipine|amlodipine
1208133|NCT01996449|Primary aldosteronism|primary aldosteronism
1208134|NCT01996449|Exercise pressor reflex|exercise pressor reflex
1208135|NCT01996449|handgrip exercise|handgrip exercise
1208136|NCT01996449|passive arm cycling|passive arm cycling
1208137|NCT01996449|active arm cycling|active arm cycling
1208143|NCT01996423|vitamin D|vitamin d
1209417|NCT01990508|obesity prevention|obesity prevention
1209423|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1209424|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1209426|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
1209616|NCT01989286|Posture|posture
1210759|NCT01984060|HIV|hiv
1210986|NCT01983293|QLV|qlv
1211650|NCT01980303|Healthy|healthy
1212235|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
1212236|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1212237|NCT01977573|pharmacokinetics|pharmacokinetics
1212238|NCT01977573|GSK1278863|gsk1278863
1212239|NCT01977573|Anemia|anemia
1212240|NCT01977573|hemoglobin|hemoglobin
1212241|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1212242|NCT01977573|Chronic kidney disease|chronic kidney disease
1212243|NCT01977560|Type 2 diabetes|type 2 diabetes
1212244|NCT01977560|Exercise|exercise
1212245|NCT01977560|High protein|high protein
1212265|NCT01977508|Vascular access grafts|vascular access grafts
1212266|NCT01977508|Haemodialysis|haemodialysis
1212267|NCT01977495|Diabetes|diabetes
1212268|NCT01977495|Enrollment methods|enrollment methods
1212269|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
1212270|NCT01977495|Opt-in Enrollment|opt-in enrollment
1212272|NCT01977495|lottery|lottery
1212845|NCT01974804|MRI|mri
1213154|NCT01973439|HIV|hiv
1213349|NCT01972568|Placebo|placebo
1213661|NCT01971255|HAI|hai
1213866|NCT01970293|STI|sti
1214051|NCT01969500|SOS|sos
1214146|NCT01969097|Stroke|stroke
1214662|NCT01966848|tka|tka
1214744|NCT01966757|NCL|ncl
1215927|NCT01961648|CO2|co2
1216600|NCT01958125|VNS|vns
1217002|NCT01956032|LCIG|lcig
1217096|NCT01955473|Sym004|sym004
1217278|NCT01954797|MRI|mri
1217578|NCT01953523|copd|copd
1217932|NCT01951729|GIP|gip
1218983|NCT01946828|ATI|ati
1219667|NCT01943604|Glucose|glucose
1220043|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1220044|NCT01941875|gonadotropins|gonadotropins
1220045|NCT01941875|intrauterine insemination|intrauterine insemination
1220064|NCT01941849|RET|ret
1220754|NCT01938716|PK|pk
1221094|NCT01937091|HIV|hiv
1221535|NCT01934855|cancer|cancer
1221736|NCT01933854|women|women
1221940|NCT01933113|LHA|lha
1222573|NCT01930084|HIV|hiv
1222810|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
1223416|NCT01926028|candida|candida
1224046|NCT01923376|HE|he
1225019|NCT01919125|HCV|hcv
1225801|NCT01915511|IPF|ipf
1226292|NCT01913093|Folate|folate
1226530|NCT01911845|HCV|hcv
1226596|NCT01911559|Chronic constipation|chronic constipation
1227097|NCT01909232|TRMD|trmd
1227201|NCT01908686|ASD|asd
1227387|NCT01907724|HCV|hcv
1228277|NCT01903447|MRI|mri
1229353|NCT01898325|Fibrosis|fibrosis
1229354|NCT01898325|Gaucher disease|gaucher disease
1229569|NCT01897077|Peanut|peanut
1230353|NCT01893671|HOA|hoa
1230656|NCT01892371|AZA|aza
1230750|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
1230751|NCT01892033|PTSD|ptsd
1230752|NCT01892033|Aerobic Exercise|aerobic exercise
1230753|NCT01892033|Women|women
1231490|NCT01889004|EEG|eeg
1232939|NCT01882322|FK506|fk506
1233223|NCT01881282|Titanoreine|titanoreine
1233224|NCT01881256|Preterm birth|preterm birth
1233225|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
1233228|NCT01881230|Breast Cancer|breast cancer
1233530|NCT01880099|smoking|smoking
1234225|NCT01876992|bmi|bmi
1234330|NCT01876511|MSI|msi
1234531|NCT01875653|phase 3|phase 3
1234931|NCT01873911|MPS IH|mps ih
1235241|NCT01872533|obesity|obesity
1235421|NCT01871675|Rituxan|rituxan
1236793|NCT01864941|MS|ms
1236868|NCT01864681|PFS|pfs
1237688|NCT01861054|Novel targeted therapy|novel targeted therapy
1237689|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
1237690|NCT01861041|low dose|low dose
1237691|NCT01861041|different baricity|different baricity
1237692|NCT01861041|spinal anesthesia|spinal anesthesia
1237696|NCT01861002|Relapse|relapse
1239170|NCT01854853|HIV|hiv
1239931|NCT01852019|CAD|cad
1240021|NCT01851538|Heart failure|heart failure
1240022|NCT01851538|Biomarkers|biomarkers
1240023|NCT01851538|Echocardiography|echocardiography
1240024|NCT01851525|Atrial fibrillation|atrial fibrillation
1240025|NCT01851525|Ablation|ablation
1240026|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
1240027|NCT01851473|Cocaine|cocaine
1240033|NCT01851460|RFA|rfa
1241129|NCT01846793|LUTS secondary to BPH|luts secondary to bph
1241130|NCT01846793|LUTS/BPH|luts/bph
1241131|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
1241132|NCT01846793|BPO|bpo
1241133|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
1241134|NCT01846793|BOO|boo
1241135|NCT01846767|13CO2|13co2
1241136|NCT01846767|Breath test|breath test
1241137|NCT01846767|Glucose oxidation|glucose oxidation
1241138|NCT01846767|Diabetes mellitus|diabetes mellitus
1241139|NCT01846754|Hemodialysis|hemodialysis
1241140|NCT01846754|Fatigue|fatigue
1241141|NCT01846754|Muscle strength|muscle strength
1241142|NCT01846754|Metabolomics|metabolomics
1241143|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
1242033|NCT01842269|MMF|mmf
1242117|NCT01841840|Stroke|stroke
1242242|NCT01841216|TFL|tfl
1242333|NCT01840865|nap|nap
1242829|NCT01838655|Melanin|melanin
1243223|NCT01836939|ova|ova
1243995|NCT01833182|tailored home intervention|tailored home intervention
1243996|NCT01833169|Solid tumor|solid tumor
1243997|NCT01833169|malignancy|malignancy
1243998|NCT01833169|hematologic malignancy|hematologic malignancy
1244636|NCT01830439|PA-824|pa-824
1244830|NCT01829503|AML|aml
1244967|NCT01828827|PK|pk
1245153|NCT01828112|ALK|alk
1245945|NCT01824459|OS,|os,
1246864|NCT01820273|GIP|gip
1247045|NCT01819415|DHA|dha
1247329|NCT01817842|EMA|ema
1247833|NCT01815606|cancer|cancer
1248135|NCT01814449|Hypoxia|hypoxia
1248912|NCT01810718|cGVHD|cgvhd
1249127|NCT01809743|FFR|ffr
1249719|NCT01806870|HIV|hiv
1249906|NCT01805921|RSV|rsv
1250009|NCT01805570|stent|stent
1250306|NCT01804426|PTSD|ptsd
1250607|NCT01803386|EIM|eim
1250808|NCT01802515|cocaine|cocaine
1250914|NCT01802099|shock|shock
1251257|NCT01800344|LMA|lma
1253495|NCT01789983|Elderly|elderly
1253839|NCT01788527|CGM|cgm
1254092|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
1254093|NCT01787539|combined modality therapy|combined modality therapy
1254094|NCT01787539|gastrectomy|gastrectomy
1254095|NCT01787526|iron depletion|iron depletion
1254096|NCT01787526|donor safety|donor safety
1254097|NCT01787526|blood donation|blood donation
1254098|NCT01787526|transfusion medicine|transfusion medicine
1254099|NCT01787526|iron deficiency|iron deficiency
1254100|NCT01787526|intravenous iron|intravenous iron
1254101|NCT01787526|fatigue|fatigue
1254102|NCT01787526|restless legs syndrome|restless legs syndrome
1254103|NCT01787526|anemia|anemia
1254104|NCT01787500|Advanced Cancers|advanced cancers
1254105|NCT01787500|Advanced Solid Cancers|advanced solid cancers
1254106|NCT01787500|BRAF V600 Mutant Advanced Solid Malignancies|braf v600 mutant advanced solid malignancies
1255498|NCT01781000|MEG|meg
1255579|NCT01780649|IMSI|imsi
1255801|NCT01779622|GIP|gip
1256075|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
1256076|NCT01778543|Coloboma|coloboma
1256077|NCT01778530|Glioblastoma|glioblastoma
1256078|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
1256475|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
1256476|NCT01776866|Contrast Media|contrast media
1256477|NCT01776866|Radiation|radiation
1256478|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
1256479|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
1256480|NCT01776853|Fructose|fructose
1256481|NCT01776853|Fructans|fructans
1256482|NCT01776853|MRI|mri
1256483|NCT01776853|Fermentation|fermentation
1256484|NCT01776853|Breath Tests|breath tests
1256485|NCT01776853|Flatulence|flatulence
1256486|NCT01776853|Abdominal Pain|abdominal pain
1256487|NCT01776853|Diarrhoea|diarrhoea
1256488|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
1256489|NCT01776840|Ibrutinib|ibrutinib
1256490|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1256575|NCT01776398|Emphysema|emphysema
1256576|NCT01776398|Smoking|smoking
1256577|NCT01776398|Healthy Smoker|healthy smoker
1256578|NCT01776398|Smoker|smoker
1256579|NCT01776398|Non-smoker|non-smoker
1256580|NCT01776385|[C08.785.640]|[c08.785.640]
1256918|NCT01774825|IBS|ibs
1257097|NCT01774071|tracer|tracer
1258678|NCT01767311|BAN2401|ban2401
1258878|NCT01766323|Cancer|cancer
1259270|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
1259272|NCT01764451|Hispanic|hispanic
1260197|NCT01760148|HCV|hcv
1260645|NCT01758042|CKD|ckd
1261476|NCT01754155|RSA|rsa
1262452|NCT01749202|Lipids|lipids
1262950|NCT01747031|fractional flow reserve|fractional flow reserve
1262951|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
1262952|NCT01747018|Knee pain|knee pain
1262953|NCT01747018|osteoarthritis|osteoarthritis
1262954|NCT01747018|degenerative chondropathy|degenerative chondropathy
1262955|NCT01747018|Intraarticular injection|intraarticular injection
1262956|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
1262957|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
1262958|NCT01747005|inflammatory response|inflammatory response
1263659|NCT01743716|MDD|mdd
1263928|NCT01742611|CKD|ckd
1263956|NCT01742520|pain|pain
1264441|NCT01740557|TIL|til
1264878|NCT01738646|GBM|gbm
1265352|NCT01736904|FOLFIRI|folfiri
1265446|NCT01736462|Cornea|cornea
1265582|NCT01735955|CML|cml
1265923|NCT01734356|iPS|ips
1265942|NCT01734291|Family burden|family burden
1265944|NCT01734174|thermodilution|thermodilution
1266049|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
1266050|NCT01733706|Antismoke intervention|antismoke intervention
1266051|NCT01733693|Buprenorphine|buprenorphine
1266537|NCT01731327|550|550
1266910|NCT01729455|SLE|sle
1267356|NCT01727713|Tics|tics
1267440|NCT01727440|Roaccutane|roaccutane
1267441|NCT01727427|Unsuspected|unsuspected
1267442|NCT01727427|pulmonary embolism|pulmonary embolism
1267443|NCT01727427|cancer|cancer
1267444|NCT01727414|ADHD|adhd
1267445|NCT01727414|Inattention|inattention
1267446|NCT01727414|Methylphenidate|methylphenidate
1267447|NCT01727414|Pharmacogenetics|pharmacogenetics
1267448|NCT01727401|Fondaparinux|fondaparinux
1267549|NCT01726725|hemifacial spasm|hemifacial spasm
1267550|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
1268145|NCT01724086|TMC435|tmc435
1269564|NCT01717716|boys|boys
1270177|NCT01715051|cocaine|cocaine
1270659|NCT01712945|Thymus|thymus
1270660|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
1270661|NCT01712919|cetuximab|cetuximab
1270662|NCT01712919|chemoradiation|chemoradiation
1270663|NCT01712893|breast cancer|breast cancer
1270666|NCT01712854|COPD|copd
1271372|NCT01709695|fMRI|fmri
1272734|NCT01703988|SMA|sma
1272809|NCT01703650|CT|ct
1272887|NCT01703416|GOLD group C and D|gold group c and d
1272893|NCT01703390|mCRC|mcrc
1272980|NCT01702935|Ovarian Failure|ovarian failure
1272981|NCT01702935|Premature Ovarian Failure|premature ovarian failure
1272982|NCT01702935|Infertility|infertility
1272983|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
1273079|NCT01702493|SRT2104|srt2104
1273735|NCT01699724|ODT|odt
1273796|NCT01699477|FUS|fus
1273884|NCT01699165|doubleblind|doubleblind
1273885|NCT01699165|randomized|randomized
1273887|NCT01699165|placebo|placebo
1274106|NCT01698177|Cancer|cancer
1274200|NCT01697566|Obese|obese
1274490|NCT01696123|MLC601|mlc601
1275081|NCT01693471|asthma|asthma
1275374|NCT01692353|Inflammation|inflammation
1275375|NCT01692353|Cytokines|cytokines
1275376|NCT01692340|tomato|tomato
1275377|NCT01692340|prostate cancer|prostate cancer
1275378|NCT01692340|metabolism|metabolism
1275476|NCT01691924|Cancer|cancer
1276081|NCT01689298|Uterine contraction|uterine contraction
1276082|NCT01689298|Dose response|dose response
1276083|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
1276084|NCT01689298|Oxytocin|oxytocin
1276085|NCT01689298|Carbetocin|carbetocin
1276086|NCT01689285|bioequivalence|bioequivalence
1277323|NCT01683669|ALI|ali
1277988|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
1277989|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
1277990|NCT01680874|Yogurt|yogurt
1277991|NCT01680874|Probiotics|probiotics
1277993|NCT01680848|Dental caries,|dental caries,
1280008|NCT01672008|NOX-100|nox-100
1280724|NCT01668771|Affect|affect
1280858|NCT01668264|MRI|mri
1281044|NCT01667341|HSV|hsv
1281514|NCT01665261|Congenital heart disease|congenital heart disease
1281515|NCT01665261|Newborn|newborn
1281516|NCT01665261|Pulse oximetry|pulse oximetry
1281848|NCT01663636|SMS|sms
1283208|NCT01656993|Antiplatelet|antiplatelet
1283209|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
1283210|NCT01656967|LMA|lma
1283211|NCT01656967|Intubation|intubation
1283212|NCT01656967|AMBU|ambu
1283213|NCT01656967|AScope|ascope
1283214|NCT01656967|Aura-I|aura-i
1283215|NCT01656967|Fastrach|fastrach
1283216|NCT01656967|Fiberoptic|fiberoptic
1283892|NCT01653977|GDT|gdt
1285837|NCT01644591|SRS|srs
1286665|NCT01641016|HIV|hiv
1287039|NCT01639352|HCC|hcc
1287134|NCT01638936|Multiple Myeloma|multiple myeloma
1287135|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
1287136|NCT01638923|Efficacy|efficacy
1287137|NCT01638923|Safety|safety
1287944|NCT01635023|Phase I|phase i
1288100|NCT01634126|FIT|fit
1288217|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
1288218|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
1288219|NCT01633476|Valaciclovir|valaciclovir
1288220|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
1288222|NCT01633437|MAOI|maoi
1288454|NCT01632397|HIV|hiv
1289100|NCT01629472|Gender norms|gender norms
1289101|NCT01629472|Financial Autonomy|financial autonomy
1289102|NCT01629472|Economic Well-being|economic well-being
1289103|NCT01629459|exercise|exercise
1289307|NCT01628458|RFA|rfa
1289406|NCT01627938|MS|ms
1290150|NCT01624805|AA|aa
1290212|NCT01624636|AMD|amd
1290812|NCT01621724|Gene therapy|gene therapy
1290813|NCT01621724|WT1 TCR|wt1 tcr
1290814|NCT01621724|AML|aml
1290815|NCT01621724|CML|cml
1290816|NCT01621711|substance abuse|substance abuse
1291137|NCT01620177|Alcohol|alcohol
1291213|NCT01619878|malaria|malaria
1291836|NCT01617590|RA|ra
1292613|NCT01614197|ALL|all
1293215|NCT01611233|metal on metal|metal on metal
1293216|NCT01611233|hip replacement|hip replacement
1293217|NCT01611233|ASR|asr
1293218|NCT01611233|DePuy|depuy
1293219|NCT01611220|Anorexia Nervosa|anorexia nervosa
1293220|NCT01611220|Relapse prevention|relapse prevention
1293221|NCT01611220|Cognitive Dissonance|cognitive dissonance
1293222|NCT01611220|Inpatient treatment|inpatient treatment
1293223|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
1293224|NCT01611207|wound healing impairments,|wound healing impairments,
1293225|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
1293227|NCT01611207|germany|germany
1293975|NCT01608516|MRI|mri
1294059|NCT01608217|THC|thc
1294955|NCT01604213|hs-CRP|hs-crp
1295414|NCT01602159|SFA|sfa
1295902|NCT01600183|MTA|mta
1297948|NCT01592058|depo|depo
1298044|NCT01591629|Naloxone|naloxone
1298045|NCT01591629|THC|thc
1298046|NCT01591629|Psychotic Disorders|psychotic disorders
1298047|NCT01591590|Colorectal Cancer|colorectal cancer
1298048|NCT01591590|Cancer|cancer
1298049|NCT01591590|Colon Cancer|colon cancer
1298050|NCT01591590|Rectal Cancer|rectal cancer
1298051|NCT01591590|PET|pet
1298052|NCT01591590|PET-CT|pet-ct
1298053|NCT01591590|MRI|mri
1298054|NCT01591590|Diffusion MRI|diffusion mri
1298148|NCT01591096|Stroke|stroke
1298153|NCT01591057|fruit|fruit
1298247|NCT01590641|HBV|hbv
1298362|NCT01590095|Water|water
1298942|NCT01587144|GBM|gbm
1299641|NCT01584284|Genelux|genelux
1299733|NCT01583998|MDD|mdd
1300445|NCT01581073|renal anemia|renal anemia
1300446|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1301278|NCT01577589|AUC|auc
1302018|NCT01574352|BMI|bmi
1302494|NCT01572597|second-line eradication treatment|second-line eradication treatment
1302495|NCT01572584|Pneumothorax|pneumothorax
1302496|NCT01572584|Lung ultrasound|lung ultrasound
1303202|NCT01569685|PTSD|ptsd
1304189|NCT01565486|OS|os
1304486|NCT01564056|Breast cancer|breast cancer
1304487|NCT01564056|Elderly patients|elderly patients
1304488|NCT01564030|Pregnancy|pregnancy
1304489|NCT01564030|Respiratory aspiration|respiratory aspiration
1304529|NCT01563887|Web|web
1304588|NCT01563692|RSV|rsv
1306150|NCT01556841|5T4|5t4
1306313|NCT01556087|opioids|opioids
1306429|NCT01555684|MS|ms
1307046|NCT01553240|TMS|tms
1308094|NCT01548781|arm|arm
1308408|NCT01547572|Enhanced recovery|enhanced recovery
1308412|NCT01547533|lactation|lactation
1309075|NCT01544959|pain|pain
1309178|NCT01544504|Breast|breast
1310673|NCT01538212|Axona|axona
1311417|NCT01534819|AAA|aaa
1311446|NCT01534650|tremor|tremor
1315351|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
1315352|NCT01517880|GNE myopathies|gne myopathies
1315353|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
1315354|NCT01517880|Nonaka disease|nonaka disease
1315356|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
1315664|NCT01516619|NHL|nhl
1315946|NCT01515410|PD|pd
1317171|NCT01510132|OAG|oag
1317231|NCT01509859|pfna|pfna
1317640|NCT01508000|Colorectal Cancer|colorectal cancer
1317641|NCT01508000|KRAS wild type|kras wild type
1317642|NCT01508000|FOLFOX|folfox
1317643|NCT01508000|Bevacizumab|bevacizumab
1317644|NCT01508000|Panitumumab|panitumumab
1317645|NCT01508000|Randomized|randomized
1317646|NCT01508000|Phase II|phase ii
1317647|NCT01508000|Perioperative treatment|perioperative treatment
1317751|NCT01507597|T2DM|t2dm
1317948|NCT01506726|UAE|uae
1319629|NCT01500083|CLL|cll
1319861|NCT01499004|550|550
1320222|NCT01497405|HIV|hiv
1320590|NCT01495845|Plavix|plavix
1321031|NCT01493999|HPR|hpr
1321407|NCT01492348|OIF|oif
1322977|NCT01486017|ASP015K|asp015k
1323093|NCT01485575|ICG|icg
1323726|NCT01482715|HRD|hrd
1324888|NCT01478178|GBM|gbm
1325694|NCT01474811|HCV|hcv
1326294|NCT01472354|HIV|hiv
1326418|NCT01471717|PK|pk
1326821|NCT01470274|CVD|cvd
1327107|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
1327108|NCT01468948|Essential Tremor|essential tremor
1327109|NCT01468948|Tremor|tremor
1327110|NCT01468948|Octanol|octanol
1327111|NCT01468948|Octanoic Acid|octanoic acid
1327120|NCT01468922|Pazopanib|pazopanib
1327121|NCT01468922|Tivantinib|tivantinib
1327122|NCT01468922|MET Inhibitor|met inhibitor
1327637|NCT01466790|HCV|hcv
1327919|NCT01465828|ACS|acs
1327969|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
1328578|NCT01463046|AML|aml
1328691|NCT01462578|AML|aml
1328965|NCT01461408|Health Education|health education
1328966|NCT01461408|Sexual Health|sexual health
1328967|NCT01461395|IVF|ivf
1328980|NCT01461304|TFP|tfp
1329474|NCT01459315|DTG|dtg
1331093|NCT01452464|safety|safety
1331179|NCT01452139|STEMI|stemi
1331374|NCT01451320|TROIA|troia
1331628|NCT01450332|ACL|acl
1333090|NCT01444573|ILR|ilr
1334881|NCT01437475|HBV|hbv
1336466|NCT01431235|ADHD|adhd
1336560|NCT01430884|coronary aspirate blood|coronary aspirate blood
1336561|NCT01430884|particular debris / microemboli|particular debris / microemboli
1336562|NCT01430884|distal occlusion device|distal occlusion device
1336563|NCT01430858|Fracture|fracture
1336564|NCT01430858|Anabolic|anabolic
1336565|NCT01430858|Vibration|vibration
1336566|NCT01430858|Strain Gauge|strain gauge
1336567|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
1336574|NCT01430832|PTSD|ptsd
1336943|NCT01429363|TDD|tdd
1337650|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
1337651|NCT01426568|Mindfulness Meditation|mindfulness meditation
1337652|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
1338162|NCT01424618|IVF|ivf
1338239|NCT01424228|Constipation|constipation
1338240|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
1338550|NCT01423006|RFA|rfa
1339038|NCT01421212|HBV|hbv
1339142|NCT01420835|Stress|stress
1340323|NCT01415856|postoperative knee pain|postoperative knee pain
1340324|NCT01415856|knee replacement|knee replacement
1340325|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
1340326|NCT01415830|venom|venom
1340327|NCT01415830|efficacy|efficacy
1340328|NCT01415830|safety|safety
1340532|NCT01415063|RFA|rfa
1340719|NCT01414153|Avastin|avastin
1340929|NCT01413373|CT scan|ct scan
1341138|NCT01412567|HBsAg|hbsag
1341733|NCT01410318|Stroke|stroke
1341969|NCT01409226|MRI|mri
1342045|NCT01409148|Radioimmunoimaging|radioimmunoimaging
1342046|NCT01409148|AL Amyloidosis|al amyloidosis
1342047|NCT01409148|PET/CT|pet/ct
1342048|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
1342049|NCT01409135|Cancer|cancer
1342050|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
1342051|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
1342052|NCT01409135|Safety|safety
1342053|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
1342054|NCT01409135|ASG-22ME|asg-22me
1342055|NCT01409135|AGS-22M6E|ags-22m6e
1342056|NCT01409135|ASG-22CE|asg-22ce
1342057|NCT01409135|ASG-22C3|asg-22c3
1342058|NCT01409122|vasodilator|vasodilator
1342062|NCT01409122|PDE-5|pde-5
1342503|NCT01407497|HIV|hiv
1342582|NCT01407172|PAD|pad
1343127|NCT01404975|PCA|pca
1343533|NCT01403259|S-1|s-1
1343828|NCT01402076|Drug Interaction|drug interaction
1343829|NCT01402063|Brain Tumors|brain tumors
1343830|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
1343831|NCT01402063|GBM|gbm
1343833|NCT01402037|type 1 diabetes|type 1 diabetes
1343845|NCT01401985|OIC|oic
1344129|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1344130|NCT01400659|CSII|csii
1344131|NCT01400659|prandial insulin requirements|prandial insulin requirements
1344132|NCT01400659|bolus calculation|bolus calculation
1344133|NCT01400659|dual-wave bolus|dual-wave bolus
1344823|NCT01397656|fatigue|fatigue
1344976|NCT01396863|MRI|mri
1345056|NCT01396525|PAD|pad
1345526|NCT01394341|Uremia|uremia
1345616|NCT01393899|Xeljanz|xeljanz
1345942|NCT01392443|MF|mf
1346831|NCT01388725|sTREM-1|strem-1
1346971|NCT01388179|TMS|tms
1347028|NCT01387893|BPH|bph
1347809|NCT01384591|muscle|muscle
1349639|NCT01377064|HIV|hiv
1349901|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
1349902|NCT01375868|antibodies|antibodies
1350717|NCT01372293|PCOS|pcos
1350854|NCT01371734|MDD|mdd
1351309|NCT01369966|Smoking Cessation|smoking cessation
1351310|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
1351311|NCT01369966|fMRI|fmri
1351312|NCT01369966|Neural Circuits|neural circuits
1351313|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
1351668|NCT01368614|OHS|ohs
1351825|NCT01367938|TKA|tka
1352024|NCT01367015|SGA|sga
1352218|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1353424|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
1353425|NCT01361516|Sedation|sedation
1353426|NCT01361516|General Anaesthesia|general anaesthesia
1353427|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
1353430|NCT01361503|Adolescents|adolescents
1353712|NCT01360346|Conscious Sedation|conscious sedation
1353713|NCT01360346|Deep Sedation|deep sedation
1353714|NCT01360346|RASS|rass
1353715|NCT01360346|CAM-ICU|cam-icu
1353716|NCT01360346|VNR|vnr
1354489|NCT01356823|vaccine|vaccine
1354804|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
1354805|NCT01355536|PCOS|pcos
1354806|NCT01355536|Diabetes Mellitus|diabetes mellitus
1354807|NCT01355536|Hyperandrogenism|hyperandrogenism
1354808|NCT01355536|Hirsutism|hirsutism
1355306|NCT01353248|Rapid Virologic Response|rapid virologic response
1355307|NCT01353248|Sustained Virologic Response|sustained virologic response
1355308|NCT01353248|Direct Acting Antiviral|direct acting antiviral
1355411|NCT01352936|nephrotoxicity|nephrotoxicity
1355412|NCT01352936|hospital cost|hospital cost
1355413|NCT01352936|Staphylococcus aureus|staphylococcus aureus
1355414|NCT01352936|bacteremia|bacteremia
1355809|NCT01351194|RFA|rfa
1356865|NCT01347099|CBT|cbt
1357958|NCT01342471|TV|tv
1358697|NCT01339234|fatigue|fatigue
1359075|NCT01337700|ASD|asd
1359284|NCT01336907|CNV|cnv
1359903|NCT01334294|CNV|cnv
1359979|NCT01334086|AML|aml
1360433|NCT01332019|MS|ms
1360785|NCT01330576|NEC|nec
1361187|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
1361188|NCT01328769|renal plasma flow|renal plasma flow
1361189|NCT01328769|angiotensin II|angiotensin ii
1361190|NCT01328756|ADHD|adhd
1361192|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
1361927|NCT01325805|Obesity|obesity
1362090|NCT01325012|Pain|pain
1362703|NCT01322555|ASD|asd
1362992|NCT01321320|ICU|icu
1363100|NCT01320917|obesity|obesity
1364233|NCT01316718|IBS|ibs
1364295|NCT01316432|HF|hf
1365072|NCT01313247|opioids|opioids
1365319|NCT01312116|GAD|gad
1365415|NCT01311622|RA|ra
1366640|NCT01306578|IVIG|ivig
1367060|NCT01304966|RRP|rrp
1368334|NCT01299779|PEG-SD|peg-sd
1369708|NCT01294059|Pain|pain
1370030|NCT01292707|rdt|rdt
1370607|NCT01290406|mTOR,|mtor,
1372107|NCT01284036|safety|safety
1372882|NCT01280110|BAK|bak
1373555|NCT01277406|HDAC|hdac
1373743|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1373744|NCT01276613|Gemzar|gemzar
1373745|NCT01276587|sickle cell disease|sickle cell disease
1373746|NCT01276587|children|children
1373747|NCT01276587|vitamin D|vitamin d
1373748|NCT01276587|safety|safety
1373749|NCT01276574|PET/CT|pet/ct
1373750|NCT01276574|Ovarian cancer|ovarian cancer
1373751|NCT01276574|HE4|he4
1373752|NCT01276561|laparoscopy|laparoscopy
1373753|NCT01276561|splenectomy|splenectomy
1373754|NCT01276561|single site|single site
1374337|NCT01274260|infant|infant
1375802|NCT01268397|elderly|elderly
1376403|NCT01265888|PAH|pah
1376543|NCT01265199|AML|aml
1376718|NCT01264445|HIV|hiv
1377172|NCT01262391|Solifenacin suspension|solifenacin suspension
1377177|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
1377178|NCT01262339|interdermal injections|interdermal injections
1377278|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
1377279|NCT01262027|Stage IV disease|stage iv disease
1377280|NCT01262027|HER2-negative|her2-negative
1377791|NCT01259713|ALL|all
1378252|NCT01257542|placebo-controlled|placebo-controlled
1378253|NCT01257542|cough|cough
1378254|NCT01257542|efficacy|efficacy
1378751|NCT01255202|toxemia|toxemia
1379043|NCT01254032|CAT|cat
1379139|NCT01253551|VX-950.|vx-950.
1379549|NCT01251692|PTK|ptk
1380129|NCT01248962|10-184|10-184
1380420|NCT01247636|HLRQ|hlrq
1380899|NCT01245400|ACL|acl
1381613|NCT01242111|LSD|lsd
1382070|NCT01240395|MCS|mcs
1382206|NCT01239810|MRI|mri
1382413|NCT01238718|BIS|bis
1383188|NCT01235962|renal cell carcinoma|renal cell carcinoma
1383189|NCT01235962|pazopanib|pazopanib
1383190|NCT01235962|adjuvant therapy|adjuvant therapy
1383194|NCT01235949|Safety|safety
1383784|NCT01233271|ICU|icu
1384184|NCT01231503|EPI|epi
1384285|NCT01230944|LNF|lnf
1384465|NCT01230151|DBS|dbs
1384544|NCT01229761|Botswana|botswana
1384545|NCT01229761|Africa|africa
1384546|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
1384547|NCT01229761|adverse drug event|adverse drug event
1384548|NCT01229735|levetiracetam|levetiracetam
1384549|NCT01229735|topiramate|topiramate
1384555|NCT01229722|SMS|sms
1384745|NCT01228760|ASG-5ME|asg-5me
1384746|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
1384747|NCT01228747|Levetiracetam|levetiracetam
1384748|NCT01228747|epilepsy|epilepsy
1384749|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
1384756|NCT01228708|Implementation strategy|implementation strategy
1384757|NCT01228708|Chronic disease management programme|chronic disease management programme
1385302|NCT01226069|Nursing|nursing
1385813|NCT01223430|ICU|icu
1385888|NCT01223209|Cancer|cancer
1385991|NCT01222754|XRT|xrt
1386214|NCT01221805|D-dimer|d-dimer
1387074|NCT01218152|NF1|nf1
1388339|NCT01212835|Obesity|obesity
1388935|NCT01210378|HX4|hx4
1389168|NCT01209286|ALL|all
1389292|NCT01208740|IVF|ivf
1389333|NCT01208558|Cereals|cereals
1390134|NCT01204970|COPD|copd
1390433|NCT01203930|CLL|cll
1391793|NCT01198626|CABP|cabp
1392098|NCT01197274|allergy|allergy
1392290|NCT01196468|HIV|hiv
1393844|NCT01190202|Malaria|malaria
1394277|NCT01188174|AML|aml
1395027|NCT01185145|APBI|apbi
1395327|NCT01183962|CAD|cad
1395744|NCT01182298|HCV|hcv
1396039|NCT01181154|AHA|aha
1396128|NCT01180842|CF|cf
1396310|NCT01180114|economic empowerment model,|economic empowerment model,
1396311|NCT01180114|orphaned children and youth,|orphaned children and youth,
1396312|NCT01180114|Uganda,|uganda,
1396313|NCT01180114|sub-Saharan Africa|sub-saharan africa
1396823|NCT01177774|OCD|ocd
1398564|NCT01171105|Safety|safety
1398758|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
1398759|NCT01170221|TR-701|tr-701
1398966|NCT01169324|Tremor|tremor
1400108|NCT01164423|insulin|insulin
1400692|NCT01162109|ICU|icu
1401682|NCT01157533|PK|pk
1402023|NCT01156142|pain|pain
1402090|NCT01156051|ADD|add
1402672|NCT01153646|HIV|hiv
1402762|NCT01153152|acute pulpitis|acute pulpitis
1402763|NCT01153152|extraction|extraction
1402764|NCT01153152|pain|pain
1402766|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1403278|NCT01151033|DES|des
1403574|NCT01149915|AML|aml
1405678|NCT01141192|PTH|pth
1405994|NCT01139827|hsCRP|hscrp
1406702|NCT01137773|SAH|sah
1407072|NCT01136655|Foradil|foradil
1408343|NCT01131247|CLL|cll
1409507|NCT01126203|SLT|slt
1411524|NCT01117935|IMRT|imrt
1411535|NCT01117896|CPR|cpr
1411737|NCT01117142|CLL|cll
1411943|NCT01116375|OSA|osa
1412267|NCT01115387|AMD|amd
1412454|NCT01114737|PKU|pku
1412596|NCT01114217|IDA|ida
1413721|NCT01109498|LPLD|lpld
1414299|NCT01106976|PET|pet
1414515|NCT01106014|PAH|pah
1415992|NCT01100255|OCD|ocd
1416164|NCT01099410|Humans|humans
1417194|NCT01095692|Sub-urethral tape|sub-urethral tape
1417195|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
1417316|NCT01095237|PAD|pad
1417584|NCT01094171|tetanus|tetanus
1418065|NCT01092182|Microarray|microarray
1418066|NCT01092182|Toxicity|toxicity
1418067|NCT01092182|Therapeutic Index|therapeutic index
1418068|NCT01092182|HIV Positive|hiv positive
1418069|NCT01092182|HIV Negative|hiv negative
1418070|NCT01092182|Lymphoma|lymphoma
1418071|NCT01092182|Burkitt Lymphoma|burkitt lymphoma
1418073|NCT01092182|HIV Infections|hiv infections
1418276|NCT01091272|safety|safety
1419037|NCT01088152|Sweden|sweden
1419396|NCT01086995|weaning|weaning
1419592|NCT01086046|ASD|asd
1419687|NCT01085708|Japan|japan
1419799|NCT01085279|melasma|melasma
1419974|NCT01084447|obesity|obesity
1420552|NCT01082185|AAA|aaa
1421225|NCT01079455|Hip|hip
1422158|NCT01075672|OCD|ocd
1422439|NCT01074749|AF|af
1422913|NCT01072734|Lupus|lupus
1422914|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
1422915|NCT01072734|Influenza vaccine|influenza vaccine
1422916|NCT01072721|Liver|liver
1424288|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
1424289|NCT01066741|Hypopharynx|hypopharynx
1425171|NCT01063205|NAC|nac
1426749|NCT01056562|GU|gu
1426917|NCT01055847|CF|cf
1427380|NCT01053975|RSR|rsr
1428989|NCT01047826|43-A|43-a
1430857|NCT01041612|CBD|cbd
1430873|NCT01041560|Stroke|stroke
1431058|NCT01040949|Latino community|latino community
1431061|NCT01040936|intervention|intervention
1431773|NCT01038076|HIV|hiv
1431889|NCT01037686|PD|pd
1433280|NCT01031498|AML|aml
1434179|NCT01027845|Safety|safety
1435740|NCT01021293|IPV|ipv
1436011|NCT01020175|GvHD|gvhd
1436209|NCT01019317|CML|cml
1436844|NCT01016340|MCS|mcs
1437146|NCT01015495|CNV|cnv
1437657|NCT01013389|DDD|ddd
1438126|NCT01011205|Liver|liver
1439154|NCT01007448|MF|mf
1439390|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
1439391|NCT01006473|Exercise Movement Techniques|exercise movement techniques
1439392|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
1439393|NCT01006447|tai chi|tai chi
1439797|NCT01004744|ER+|er+
1440408|NCT01002326|BDD|bdd
1440472|NCT01002066|ACT|act
1441748|NCT00997087|OCD|ocd
1441981|NCT00996307|Flu|flu
1442382|NCT00995007|Glioma|glioma
1443185|NCT00992173|MIBG|mibg
1443486|NCT00991068|Pain|pain
1444582|NCT00986661|mUM|mum
1444749|NCT00986089|post-placental|post-placental
1444751|NCT00986089|Copper IUD|copper iud
1444752|NCT00986089|cesarean section|cesarean section
1444753|NCT00986089|immediate post-partum|immediate post-partum
1444754|NCT00986089|continuation|continuation
1444755|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
1444756|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
1444757|NCT00986076|Intraocular infusion|intraocular infusion
1444956|NCT00985244|COPD|copd
1445489|NCT00983619|Cancer|cancer
1446075|NCT00981136|SILS|sils
1446758|NCT00978510|Disease transmission|disease transmission
1446759|NCT00978510|Exposure to biological agents|exposure to biological agents
1446760|NCT00978510|Health personnel|health personnel
1446866|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
1446867|NCT00978237|treatment experienced|treatment experienced
1446868|NCT00978224|dietary supplement|dietary supplement
1446869|NCT00978224|hemodialysis|hemodialysis
1446870|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
1446871|NCT00978224|Viusid|viusid
1446872|NCT00978211|DOTATOC|dotatoc
1447369|NCT00976131|CAM|cam
1447654|NCT00975000|Mimpara|mimpara
1447773|NCT00974558|fan|fan
1448174|NCT00973388|VX-950|vx-950
1449072|NCT00969423|VATS|vats
1449421|NCT00968253|ALL|all
1449575|NCT00967668|Diet|diet
1449767|NCT00967044|NHL|nhl
1450259|NCT00964873|AML|aml
1450362|NCT00964795|AMD|amd
1450865|NCT00963079|IVF|ivf
1450952|NCT00962715|CLL|cll
1452249|NCT00957684|refractory|refractory
1452250|NCT00957684|partial|partial
1452251|NCT00957684|epilepsy|epilepsy
1452258|NCT00957658|Osteoarthritis|osteoarthritis
1452259|NCT00957645|Central post-stroke pain|central post-stroke pain
1452260|NCT00957645|post-stroke pain|post-stroke pain
1452261|NCT00957645|shoulder pain|shoulder pain
1452869|NCT00955630|OHS|ohs
1453139|NCT00954564|stage I breast cancer|stage i breast cancer
1453140|NCT00954564|stage II breast cancer|stage ii breast cancer
1453141|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
1453142|NCT00954525|Pancreatic Cancer|pancreatic cancer
1453143|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
1453356|NCT00953290|Thigh|thigh
1453565|NCT00952354|MLU|mlu
1454094|NCT00951106|Peru|peru
1453988|NCT00951548|VSL#3|vsl#3
1454850|NCT00948857|POF|pof
1454881|NCT00948766|Alzheimer's type|alzheimer's type
1454882|NCT00948753|Graft-versus-host disease|graft-versus-host disease
1454883|NCT00948753|GVHD|gvhd
1454884|NCT00948753|Maraviroc|maraviroc
1454887|NCT00948740|vitamin D|vitamin d
1455180|NCT00947596|Aerosol|aerosol
1455748|NCT00945516|Safety|safety
1456033|NCT00944476|Sarcoma|sarcoma
1456208|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1456209|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1456210|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1456215|NCT00943670|MBC|mbc
1456216|NCT00943670|TDM1|tdm1
1456308|NCT00943306|MTP|mtp
1457822|NCT00937404|IPV|ipv
1458128|NCT00936325|SCLS|scls
1459139|NCT00932373|MBC|mbc
1460573|NCT00926458|coronary angiography|coronary angiography
1460574|NCT00926458|coronary artery disease|coronary artery disease
1460575|NCT00926445|Pain behavior|pain behavior
1460576|NCT00926432|Balance|balance
1460577|NCT00926432|Spine disorders|spine disorders
1460578|NCT00926432|equilibrium|equilibrium
1460579|NCT00926419|Varicella|varicella
1460580|NCT00926419|Hepatitis A|hepatitis a
1461665|NCT00922441|24hour ABPM|24hour abpm
1461666|NCT00922441|Population PK|population pk
1461667|NCT00922428|rheumatism|rheumatism
1461668|NCT00922428|arthralgia|arthralgia
1461669|NCT00922428|myalgia|myalgia
1461784|NCT00921973|influenza|influenza
1461785|NCT00921973|universal influenza vaccine|universal influenza vaccine
1461786|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
1461787|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
1461788|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
1461789|NCT00921960|Myocardial Infarction|myocardial infarction
1461790|NCT00921960|Hypertension|hypertension
1461791|NCT00921960|Diabetes|diabetes
1461792|NCT00921960|Obesity|obesity
1461793|NCT00921960|Dyslipidaemia|dyslipidaemia
1461794|NCT00921960|Heart Failure|heart failure
1463794|NCT00914225|HIV|hiv
1464667|NCT00910429|sGC|sgc
1465976|NCT00905034|ALL|all
1468201|NCT00899717|TMD|tmd
1470082|NCT00896285|cancer|cancer
1470512|NCT00894569|CUP|cup
1470584|NCT00894296|MEG|meg
1470869|NCT00892944|Phase 1|phase 1
1472256|NCT00888030|outcome|outcome
1472451|NCT00887198|CB7630|cb7630
1473608|NCT00882817|ILD|ild
1474684|NCT00878267|EHR|ehr
1474819|NCT00877747|PET|pet
1474919|NCT00877344|IUC|iuc
1475006|NCT00877045|GIST|gist
1476071|NCT00872794|Hip|hip
1477057|NCT00869128|sleep|sleep
1477533|NCT00867048|HIV|hiv
1477846|NCT00866073|AML|aml
1478042|NCT00865306|Anxiety|anxiety
1478208|NCT00864578|IOP|iop
1478539|NCT00863070|anatomy|anatomy
1478934|NCT00861471|PSA|psa
1479155|NCT00860639|AML|aml
1480105|NCT00856401|PTH|pth
1480232|NCT00855907|IBD|ibd
1481364|NCT00851318|Cimzia|cimzia
1481748|NCT00849979|GI|gi
1482033|NCT00848822|Sleep|sleep
1484281|NCT00839410|cohort|cohort
1484829|NCT00837408|Type 2 Diabetes|type 2 diabetes
1484830|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
1485810|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
1485811|NCT00832988|pacing thresholds|pacing thresholds
1485905|NCT00832676|Self-management|self-management
1485906|NCT00832676|Patient education|patient education
1485907|NCT00832663|Muscle regeneration|muscle regeneration
1485908|NCT00832663|Satellite cells|satellite cells
1485909|NCT00832663|electrical stimulation|electrical stimulation
1485910|NCT00832663|eccentric contractions|eccentric contractions
1486221|NCT00831311|Tetanus|tetanus
1486324|NCT00830947|Device|device
1486632|NCT00829686|abscess|abscess
1487184|NCT00827580|HFS|hfs
1487821|NCT00825331|graduated scheme|graduated scheme
1487822|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
1487823|NCT00825318|End-stage renal disease|end-stage renal disease
1487824|NCT00825318|Chronic kidney disease|chronic kidney disease
1488691|NCT00822315|HIV|hiv
1490290|NCT00816530|somo v|somo v
1490560|NCT00815711|IPF|ipf
1491018|NCT00813969|MSC|msc
1491272|NCT00813228|DDP-4|ddp-4
1491555|NCT00812175|HCC|hcc
1143674|NCT02300831|NIS|nis
1143675|NCT02300831|Observational study|observational study
1143676|NCT02300831|Disease registry|disease registry
1143677|NCT02300831|Clinical Outcomes|clinical outcomes
1143678|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
1143679|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
1143680|NCT02300792|honey, hepatitis A|honey, hepatitis a
1143681|NCT02300779|Colonoscopy|colonoscopy
1143682|NCT02300779|Diabetes Mellitus|diabetes mellitus
1143683|NCT02300779|Diet|diet
1143684|NCT02300779|Polyethylene glycols|polyethylene glycols
1143685|NCT02300779|Efficacy|efficacy
1143686|NCT02300779|Personal satisfaction|personal satisfaction
1143687|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
1143688|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
1143689|NCT02300766|Pediatric cancer|pediatric cancer
1143690|NCT02300766|Neurosurgical techniques|neurosurgical techniques
1143691|NCT02300727|Mucositis|mucositis
1143692|NCT02300727|Neoplasms|neoplasms
1143693|NCT02300727|CANCER|cancer
1143694|NCT02300727|Curcumin|curcumin
1143695|NCT02300727|Drug Therapy|drug therapy
1143696|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
1143697|NCT02300675|therapeutic patient education|therapeutic patient education
1143698|NCT02300675|patient adherence|patient adherence
1143699|NCT02300675|empowerment|empowerment
1143700|NCT02300675|breast cancer|breast cancer
1143701|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
1143702|NCT02300675|side effects|side effects
1143703|NCT02300636|Knee joint|knee joint
1143704|NCT02300636|Muscle strength|muscle strength
1143705|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
1143706|NCT02300610|Ureteral Diseases|ureteral diseases
1143707|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
1143708|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
1143709|NCT02300610|Bladder|bladder
1143710|NCT02300610|Carcinoma|carcinoma
1143711|NCT02300610|Renal|renal
1143712|NCT02300610|Pelvis|pelvis
1143713|NCT02300610|Ureter|ureter
1143714|NCT02300610|Urethra|urethra
1143715|NCT02300597|ADHD|adhd
1143716|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
1143717|NCT02300597|controlled|controlled
1143718|NCT02300597|Internet based|internet based
1143719|NCT02300597|coaching|coaching
1143720|NCT02300558|Type 3 long QT syndrome (LQT3)|type 3 long qt syndrome (lqt3)
1143721|NCT02300558|Long QT syndrome|long qt syndrome
1143722|NCT02300558|Congenital long QT|congenital long qt
1143723|NCT02300558|Sudden cardiac death|sudden cardiac death
1143724|NCT02300532|Malignant Glioma|malignant glioma
1143725|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
1143726|NCT02300519|Haemophilia|haemophilia
1143727|NCT02300519|numerical models|numerical models
1143728|NCT02300519|thrombin generation|thrombin generation
1143729|NCT02300519|volunteers|volunteers
1143730|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
1143731|NCT02300506|Malignant Glioma|malignant glioma
1143732|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
1143733|NCT02300493|among college students|among college students
1143734|NCT02300480|pain|pain
1143735|NCT02300480|calot's triangle|calot's triangle
1143736|NCT02300480|local block|local block
1143737|NCT02300480|analgesia|analgesia
1143738|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
1143739|NCT02300454|in-stent restenosis|in-stent restenosis
1143740|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
1143741|NCT02300454|balloon|balloon
1143742|NCT02300428|iron deficiency|iron deficiency
1143743|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
1143744|NCT02300376|GFR|gfr
1143745|NCT02300376|Bayesian model|bayesian model
1143746|NCT02300376|plasma clearance|plasma clearance
1143747|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
1143748|NCT02300376|Inulin|inulin
1143749|NCT02300337|laryngeal tube|laryngeal tube
1143750|NCT02300337|cuff pressure|cuff pressure
1143751|NCT02300337|leakage|leakage
1143752|NCT02300337|laryngeal mask|laryngeal mask
1143753|NCT02300324|bioavailability|bioavailability
1143754|NCT02300324|Beneforte|beneforte
1143755|NCT02300324|sulforaphane|sulforaphane
1143756|NCT02300272|Practice-related learning|practice-related learning
1143757|NCT02300272|Sleep|sleep
1143758|NCT02300272|Pain|pain
1143759|NCT02300272|Circadian Rhythm|circadian rhythm
1143760|NCT02300272|Older Adults|older adults
1143761|NCT02300246|alveolar socket preservation|alveolar socket preservation
1143762|NCT02300246|tooth extraction|tooth extraction
1143763|NCT02300246|platelet concentrates|platelet concentrates
1143764|NCT02300246|growth factors|growth factors
1143765|NCT02300207|Electroacupuncture|electroacupuncture
1143766|NCT02300207|Cardiovascular function|cardiovascular function
1492694|NCT00807833|SAH|sah
1494046|NCT00802256|MTA|mta
1494917|NCT00798902|DDD|ddd
1495028|NCT00798538|HIV|hiv
1495510|NCT00796562|MDS|mds
1495840|NCT00795093|PPI|ppi
1496002|NCT00794352|HV|hv
1496103|NCT00793975|Tumors|tumors
1497820|NCT00787644|Fat|fat
1499099|NCT00782548|fed|fed
1499167|NCT00782353|HCV|hcv
1499389|NCT00781469|RNA|rna
1499884|NCT00779259|humans|humans
1500741|NCT00775125|HCV|hcv
1502313|NCT00769483|MK-0646|mk-0646
1503164|NCT00765453|adult stem cells|adult stem cells
1503165|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
1503863|NCT00762320|HIV|hiv
1504398|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
1504499|NCT00759655|ReFacto|refacto
1504500|NCT00759655|moroctocog alfa|moroctocog alfa
1504501|NCT00759655|bleeding disorder|bleeding disorder
1505123|NCT00756639|PCI|pci
1505193|NCT00756353|Heroin|heroin
1505337|NCT00755742|TNF|tnf
1505458|NCT00755326|OA|oa
1506739|NCT00750555|SCCHN|scchn
1507494|NCT00748280|MTA|mta
1507608|NCT00747851|PMNs|pmns
1507835|NCT00746941|PML|pml
1507918|NCT00746616|Young,|young,
1508614|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
1508615|NCT00743951|patient decision aids|patient decision aids
1508616|NCT00743951|patient preferences|patient preferences
1508617|NCT00743951|osteoarthritis|osteoarthritis
1508618|NCT00743951|joint replacement|joint replacement
1508619|NCT00743951|waiting times|waiting times
1508620|NCT00743925|Unstable Angina|unstable angina
1508621|NCT00743925|STEMI|stemi
1508622|NCT00743925|NSTEMI|nstemi
1508623|NCT00743925|ACS|acs
1508624|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
1508625|NCT00743925|C14.280.647.124|c14.280.647.124
1508626|NCT00743925|C14.280.647.500|c14.280.647.500
1508627|NCT00743912|rifaximin|rifaximin
1509325|NCT00741494|ICSI|icsi
1509441|NCT00741091|Stent|stent
1509908|NCT00739401|Type I|type i
1511343|NCT00734539|Candida|candida
1511470|NCT00734084|UKA|uka
1511658|NCT00733356|ADD|add
1512623|NCT00729391|HIV|hiv
1512909|NCT00728559|pain|pain
1514211|NCT00723775|HIV|hiv
1514957|NCT00720785|Colon Cancer|colon cancer
1514958|NCT00720785|Kidney Cancer|kidney cancer
1514959|NCT00720785|Pancreatic Cancer|pancreatic cancer
1514960|NCT00720785|Leukemia|leukemia
1514961|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1514963|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1514964|NCT00720785|SLL|sll
1515494|NCT00719472|NHL|nhl
1515538|NCT00719277|ECG|ecg
1517066|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1517072|NCT00713479|methamphetamine|methamphetamine
1517073|NCT00713479|varenicline|varenicline
1517107|NCT00713414|HV|hv
1517473|NCT00712088|HIV|hiv
1519353|NCT00703898|HIV|hiv
1521394|NCT00695396|MDS|mds
1521476|NCT00695097|B cells|b cells
1521784|NCT00693758|MRI|mri
1522134|NCT00692432|MIF|mif
1522371|NCT00691444|sleep|sleep
1523001|NCT00689338|ICU|icu
1523324|NCT00688311|HIV|hiv
1523527|NCT00687544|HIV|hiv
1524077|NCT00685308|Stent|stent
1524553|NCT00683189|MLD|mld
1524856|NCT00682058|fat|fat
1525315|NCT00680199|ERP|erp
1525503|NCT00679549|OSA|osa
1525552|NCT00679341|HER2+|her2+
1525755|NCT00678509|TTK|ttk
1526834|NCT00674544|fitness|fitness
1527825|NCT00670917|pain|pain
1528010|NCT00669994|UTI|uti
1529081|NCT00666172|Obesity|obesity
1529485|NCT00664443|CPR|cpr
1531213|NCT00657683|GBS|gbs
1531303|NCT00657202|NF1|nf1
1531864|NCT00654953|relapse|relapse
1532038|NCT00654433|MLD|mld
1532240|NCT00653822|Amevive|amevive
1532337|NCT00653471|osa|osa
1532654|NCT00652015|EPC|epc
1532843|NCT00651651|Asthma|asthma
1533568|NCT00646568|IVF|ivf
1533634|NCT00646295|TRO|tro
1533694|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1533695|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1533696|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1533697|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1533698|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1533984|NCT00644735|Nexium|nexium
1535514|NCT00638040|pH|ph
1535842|NCT00637013|RCT|rct
1536187|NCT00635518|Child|child
1537504|NCT00630331|Flu|flu
1537655|NCT00629746|EMG|emg
1537849|NCT00628966|ICD|icd
1538159|NCT00627796|GH|gh
1538249|NCT00627406|hCG|hcg
1538493|NCT00626522|Chronic|chronic
1539853|NCT00621257|IBD|ibd
1539945|NCT00621023|MDS|mds
1540328|NCT00619619|Child|child
1540368|NCT00619502|Polio|polio
1540472|NCT00619138|Anxiety|anxiety
1540856|NCT00617617|soy|soy
1541230|NCT00616161|PST2744|pst2744
1541331|NCT00615784|AML|aml
1541721|NCT00613808|venous|venous
1542219|NCT00612079|PPI|ppi
1542298|NCT00611767|Alcohol|alcohol
1542482|NCT00611325|GBM|gbm
1542577|NCT00610805|SLE|sle
1542747|NCT00610129|MK-0646|mk-0646
1543278|NCT00608153|ARB|arb
1543384|NCT00607815|CPT|cpt
1543478|NCT00607386|MPS II|mps ii
1543591|NCT00606931|FDG|fdg
1543979|NCT00604786|IgE|ige
1544385|NCT00603174|NAVA|nava
1544686|NCT00601653|BED|bed
1545047|NCT00600327|TIA|tia
1545192|NCT00599664|Calculi|calculi
1545274|NCT00599274|Multiple Sclerosis|multiple sclerosis
1545275|NCT00599274|Interferon beta 1a|interferon beta 1a
1545377|NCT00598650|E2020|e2020
1545976|NCT00596362|Melanoma|melanoma
1545977|NCT00596362|Eye|eye
1545978|NCT00596362|Avastin|avastin
1545979|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
1546469|NCT00593944|CLL|cll
1546803|NCT00592306|ATG|atg
1547278|NCT00590408|statin|statin
1548084|NCT00587691|TCV|tcv
1550398|NCT00577382|Sutent|sutent
1550350|NCT00577759|diet|diet
1551258|NCT00573378|CML|cml
1551375|NCT00572897|ATG|atg
1551637|NCT00571701|HPV|hpv
1552903|NCT00566423|PAH|pah
1553276|NCT00564759|CGD|cgd
1553351|NCT00564330|OCT|oct
1553839|NCT00562289|Stroke|stroke
1554164|NCT00560989|CBD|cbd
1554801|NCT00558103|RECIST|recist
1554991|NCT00557375|Survey|survey
1555207|NCT00556348|AMD|amd
1555307|NCT00555919|mBC|mbc
1555961|NCT00553358|ErbB2+|erbb2+
1556802|NCT00549666|Latuda|latuda
1556803|NCT00549666|schizophenia|schizophenia
1556804|NCT00549653|GW856553,|gw856553,
1556805|NCT00549653|drug-drug interactions,|drug-drug interactions,
1556899|NCT00549159|menorrhagia|menorrhagia
1556916|NCT00549081|IVF|ivf
1561244|NCT00532389|LBH589|lbh589
1562389|NCT00527683|GVG|gvg
1563368|NCT00524290|isolate|isolate
1564624|NCT00519506|PE|pe
1565009|NCT00517946|MRI,|mri,
1565198|NCT00516958|ulcer|ulcer
1565691|NCT00515099|ATG|atg
1565779|NCT00514696|CLL|cll
1566034|NCT00513734|eye|eye
1566343|NCT00512889|CTL|ctl
1566723|NCT00511524|brain,|brain,
1566827|NCT00511056|HIV|hiv
1566931|NCT00510692|FAP|fap
1567726|NCT00508352|breast|breast
1568235|NCT00506571|S-1|s-1
1568331|NCT00506207|S-1|s-1
1569096|NCT00503867|HCC|hcc
1569278|NCT00503256|CLL|cll
1569894|NCT00501137|HPV|hpv
1571160|NCT00497562|IGF-1|igf-1
1571892|NCT00494936|HIV|hiv
1572441|NCT00492882|FSH|fsh
1572725|NCT00491842|HD|hd
1572889|NCT00491075|Alimta|alimta
1573389|NCT00489151|HBV|hbv
1573695|NCT00487955|REE|ree
1574452|NCT00484991|PKU|pku
1575652|NCT00480506|assay|assay
1575882|NCT00479687|HA|ha
1576166|NCT00478478|Stroke|stroke
1576522|NCT00477230|AF|af
1576569|NCT00477113|MS|ms
1576754|NCT00476567|labor|labor
1577194|NCT00475046|TTM|ttm
1577870|NCT00472446|Surgery|surgery
1577976|NCT00472030|IgE|ige
1578050|NCT00471666|Malaria|malaria
1578155|NCT00471445|pain|pain
1579342|NCT00467090|Gene|gene
1580228|NCT00463840|5FU|5fu
1580481|NCT00462956|ErbB2|erbb2
1581648|NCT00458666|D-dimer|d-dimer
1581874|NCT00457860|CLL|cll
1584559|NCT00448214|Stroke|stroke
1584684|NCT00448084|HV|hv
1584768|NCT00447759|MEMO|memo
1584866|NCT00447317|diet|diet
1585070|NCT00446459|HLA|hla
1586811|NCT00442832|cSSSI|csssi
1588390|NCT00437073|TYKERB|tykerb
1588571|NCT00436501|TXT|txt
1589564|NCT00433108|ALT|alt
1590206|NCT00430768|AAV|aav
1590496|NCT00429559|Cancer;|cancer;
1590890|NCT00428233|CLL|cll
1591465|NCT00426296|HIV|hiv
1593253|NCT00419562|DPT-1|dpt-1
1593643|NCT00417794|ADHD|adhd
1594319|NCT00416247|TMS|tms
1594356|NCT00416052|PTH|pth
1595292|NCT00413023|MDD|mdd
1595857|NCT00410761|MTC|mtc
1596185|NCT00409786|Obesity|obesity
1596699|NCT00407602|RP|rp
1596885|NCT00406640|MDD|mdd
1597894|NCT00402610|HIV|hiv
1599564|NCT00395928|Smoking|smoking
1600450|NCT00392743|SPECT|spect
1600728|NCT00391469|mild hypothermia|mild hypothermia
1600729|NCT00391456|animal-assisted therapy|animal-assisted therapy
1600730|NCT00391456|dog hospital visit|dog hospital visit
1600731|NCT00391456|heart failure|heart failure
1600732|NCT00391443|BUILD 3|build 3
1600733|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1600734|NCT00391443|Tracleer|tracleer
1600735|NCT00391443|Interstitial Lung Disease|interstitial lung disease
1601137|NCT00390091|SLE|sle
1601498|NCT00388687|PET|pet
1602691|NCT00384163|PVR|pvr
1602790|NCT00383669|HIV|hiv
1603252|NCT00381927|Breast Cancer Risk|breast cancer risk
1603253|NCT00381927|Counseling|counseling
1603963|NCT00378976|MSM|msm
1604433|NCT00377949|PHROS|phros
1604849|NCT00376870|PCI|pci
1605796|NCT00373542|RLS|rls
1606662|NCT00370357|SPL7013|spl7013
1607031|NCT00369031|HIV|hiv
1607322|NCT00367874|Opiate dependence|opiate dependence
1607323|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
1607420|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
1607422|NCT00367497|rituximab|rituximab
1607828|NCT00365612|HIV|hiv
1608661|NCT00362726|HIV|hiv
1609913|NCT00358202|nhap|nhap
1610998|NCT00354445|macugen|macugen
1611174|NCT00353834|pulse wave analysis|pulse wave analysis
1611175|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
1611176|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
1611184|NCT00353795|MESA|mesa
1611185|NCT00353795|MRI|mri
1611186|NCT00353795|Cardiovascular|cardiovascular
1611187|NCT00353795|Cardiac|cardiac
1611188|NCT00353795|Coronary|coronary
1611189|NCT00353795|Atherosclerosis|atherosclerosis
1611951|NCT00351312|socks|socks
1612684|NCT00347880|ANP|anp
1613397|NCT00345202|GFR|gfr
1613580|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1613581|NCT00344422|DOXIL|doxil
1613582|NCT00344422|drug resistant myeloma|drug resistant myeloma
1613583|NCT00344409|darbepoetin alfa|darbepoetin alfa
1613584|NCT00344409|anemia|anemia
1613585|NCT00344409|cancer patients|cancer patients
1613586|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
1613587|NCT00344383|oral contraceptive|oral contraceptive
1613864|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1613866|NCT00343356|Carcinoma;|carcinoma;
1614185|NCT00342186|HBV|hbv
1614618|NCT00341029|Chromosomal Effects|chromosomal effects
1614619|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
1614620|NCT00341029|Micronuclei|micronuclei
1614621|NCT00341029|Stimulants|stimulants
1614623|NCT00341029|ADHD|adhd
1614838|NCT00340431|Human|human
1615042|NCT00339781|Twins|twins
1616259|NCT00334906|MRI|mri
1616486|NCT00334074|AML|aml
1616613|NCT00333567|COX189|cox189
1616966|NCT00331708|Malaria|malaria
1617067|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1617068|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1617069|NCT00331318|Motor Learning|motor learning
1617072|NCT00331318|HV|hv
1617695|NCT00328783|ABC|abc
1618205|NCT00326859|pain|pain
1619298|NCT00322907|malaria|malaria
1619675|NCT00321243|triage|triage
1620020|NCT00319930|CLL|cll
1620064|NCT00319748|852A|852a
1620376|NCT00318409|HIV|hiv
1621002|NCT00316173|recurrent|recurrent
1621003|NCT00316173|relapsed|relapsed
1621004|NCT00316173|carboplatin|carboplatin
1621005|NCT00316173|topotecan|topotecan
1621006|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
1621007|NCT00316160|sexual dysfunction|sexual dysfunction
1621008|NCT00316160|Depression|depression
1621009|NCT00316160|MDD|mdd
1621064|NCT00316056|HV|hv
1621240|NCT00315406|PAN|pan
1622428|NCT00310726|HIV|hiv
1622733|NCT00309777|kowa|kowa
1622963|NCT00308633|CAD|cad
1623262|NCT00307385|HV|hv
1623467|NCT00306592|MS|ms
1623851|NCT00305500|OCD|ocd
1623863|NCT00305461|Asthma|asthma
1624296|NCT00303914|pain|pain
1624583|NCT00303121|Therapy|therapy
1624691|NCT00302614|snoring|snoring
1625272|NCT00300638|Emotion|emotion
1625365|NCT00300196|Stroke|stroke
1625982|NCT00297882|Safety|safety
1626066|NCT00297531|PDD|pdd
1626183|NCT00297167|CF|cf
1626846|NCT00295581|HV|hv
1627031|NCT00294749|Biopsy,|biopsy,
1627146|NCT00294320|Aldara|aldara
1627995|NCT00291278|HV|hv
1628119|NCT00290771|GBM|gbm
1628542|NCT00290121|fMRI|fmri
1628735|NCT00289237|CHD|chd
1628844|NCT00288704|CIAS1|cias1
1629105|NCT00287677|Growth Hormone|growth hormone
1629106|NCT00287677|HIV-1|hiv-1
1629107|NCT00287677|Vaccination|vaccination
1629108|NCT00287677|Thymopoiesis|thymopoiesis
1629109|NCT00287677|HIV-specific responses|hiv-specific responses
1629112|NCT00287664|terlipressin|terlipressin
1629289|NCT00286832|PET|pet
1630231|NCT00282581|HIV|hiv
1631185|NCT00279539|DNA|dna
1631281|NCT00279110|HIV|hiv
1632013|NCT00276159|IRM|irm
1631584|NCT00278135|DHA|dha
1631683|NCT00277784|OCT|oct
1632715|NCT00273078|Speech,|speech,
1634399|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
1634401|NCT00266396|THA|tha
1634821|NCT00265057|Neoplasms;|neoplasms;
1634822|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
1634823|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
1634928|NCT00264498|NSCLC|nsclc
1635309|NCT00262574|PCI|pci
1635593|NCT00261118|colitis|colitis
1635987|NCT00259610|RA|ra
1636753|NCT00256490|FDG|fdg
1637181|NCT00255593|Kidney|kidney
1637266|NCT00255112|SAD|sad
1637467|NCT00254306|Ecstasy|ecstasy
1640226|NCT00244335|PTSD|ptsd
1640595|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
1640596|NCT00242749|Cancer of the Neck|cancer of the neck
1640597|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
1640604|NCT00242710|Endometrium|endometrium
1640605|NCT00242710|Uterus|uterus
1640606|NCT00242710|Menopause|menopause
1641021|NCT00240552|HIV|hiv
1641481|NCT00238082|COPD|copd
1641712|NCT00237536|BPH|bph
1642297|NCT00235378|SLE|sle
1642525|NCT00234143|MDS|mds
1642634|NCT00233701|NPH|nph
1643077|NCT00231322|Uganda|uganda
1643589|NCT00228995|Anemia|anemia
1644852|NCT00223067|TAIZ|taiz
1645345|NCT00221039|ECP|ecp
1645444|NCT00220571|AMI|ami
1645778|NCT00218712|HIV|hiv
1647603|NCT00209638|S-1,|s-1,
1647693|NCT00209313|HIV-1|hiv-1
1648195|NCT00206934|PPI|ppi
1648499|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1648500|NCT00204945|arterial stiffness|arterial stiffness
1648501|NCT00204945|echocardiography|echocardiography
1648502|NCT00204945|nesiritide|nesiritide
1649324|NCT00200694|ARB|arb
1650164|NCT00196716|GL3|gl3
1650768|NCT00193635|GFR|gfr
1650830|NCT00192803|niddm|niddm
1651712|NCT00186927|Vaccine|vaccine
1652167|NCT00183547|CBT|cbt
1652455|NCT00182585|HIV|hiv
1652899|NCT00180388|veins|veins
1653711|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1653799|NCT00176111|saline|saline
1654476|NCT00172133|PTH|pth
1654754|NCT00171132|women|women
1654940|NCT00170105|Stable|stable
1655132|NCT00169234|PPV23|ppv23
1656551|NCT00162617|Outcome|outcome
1658119|NCT00155311|OPG|opg
1658200|NCT00154856|FEM|fem
1659048|NCT00150111|thyroid|thyroid
1659848|NCT00146679|ICD|icd
1660542|NCT00142961|ADHD|adhd
1662183|NCT00135174|routine|routine
1665194|NCT00123708|CP|cp
1665897|NCT00120965|CPR|cpr
1666821|NCT00117637|RCC|rcc
1667900|NCT00114127|SNRI|snri
1668143|NCT00113334|ABT-510|abt-510
1668420|NCT00112307|MRI|mri
1669373|NCT00109772|Celgene|celgene
1669674|NCT00108810|OA|oa
1669999|NCT00107679|HIV|hiv
1670244|NCT00106795|Lipodystrophy|lipodystrophy
1670245|NCT00106795|HIV Positive|hiv positive
1670246|NCT00106795|Healthy Volunteer|healthy volunteer
1670761|NCT00104871|NTCTCSG|ntctcsg
1670993|NCT00104039|ADHD|adhd
1672221|NCT00099541|NTX|ntx
1672613|NCT00098072|HV|hv
1672921|NCT00097097|Zambia|zambia
1674101|NCT00092222|HIV|hiv
1675104|NCT00090623|AMD|amd
1675196|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675762|NCT00089804|Lupus|lupus
1675884|NCT00089778|IL-2|il-2
1677300|NCT00088517|MIRD|mird
1677334|NCT00088400|GBM|gbm
1678460|NCT00087763|AMD|amd
1678920|NCT00086541|SVR|svr
1678952|NCT00086567|Testing|testing
1679233|NCT00086086|CHF|chf
1679453|NCT00085995|AS|as
1679863|NCT00085696|NHL|nhl
1683433|NCT00082147|MRI|mri
1683700|NCT00082043|MRMD|mrmd
1687641|NCT00080002|cancer|cancer
1688065|NCT00004109|XRT|xrt
1688138|NCT00079768|IBM|ibm
1689239|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689292|NCT00078546|CARCINOMA|carcinoma
1690068|NCT00078013|AMI|ami
1690441|NCT00077922|CLL|cll
1691072|NCT00076635|IPF|ipf
1692484|NCT00073580|HIT|hit
1692751|NCT00073008|BAC|bac
1693004|NCT00072059|anemia|anemia
1695249|NCT00067496|Pain|pain
1695337|NCT00067223|HV|hv
1696145|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1696146|NCT00065832|Reading disabilities|reading disabilities
1696147|NCT00065832|Inner-city|inner-city
1696148|NCT00065832|Urban|urban
1696149|NCT00065819|HIV|hiv
1696150|NCT00065819|African American|african american
1697294|NCT00063245|HV|hv
1700277|NCT00058825|Campath|campath
1700628|NCT00057538|HIV|hiv
1700828|NCT00056849|AS|as
1700932|NCT00012454|Stroke|stroke
1701215|NCT00055588|HV|hv
1701266|NCT00055380|Gene Expression|gene expression
1701267|NCT00055380|Pharmacodynamics|pharmacodynamics
1701268|NCT00055380|Surrogate Markers|surrogate markers
1701269|NCT00055380|Targeted Therapy|targeted therapy
1701270|NCT00055380|Buccal Mucosa|buccal mucosa
1701271|NCT00055380|Pharmacogenomics|pharmacogenomics
1701272|NCT00055380|Oral Mucosa|oral mucosa
1701273|NCT00055354|Acupuncture|acupuncture
1701274|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
1701275|NCT00055302|vaginal bleeding|vaginal bleeding
1701276|NCT00055302|advanced bone age|advanced bone age
1701277|NCT00055302|fibrous dysplasia|fibrous dysplasia
1701278|NCT00055302|MAS|mas
1701279|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
1701287|NCT00055289|HV|hv
1701370|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
1701371|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
1701372|NCT00055042|Vitamin E|vitamin e
1701471|NCT00054730|Autism|autism
1702253|NCT00053001|anemia|anemia
1702457|NCT00052195|BCG|bcg
1710385|NCT00004917|anemia|anemia
1714097|NCT00051142|OAG|oag
1713903|NCT00052052|IPF|ipf
1714004|NCT00051701|NHL|nhl
1714670|NCT00001763|MAC|mac
1715619|NCT00001142|DXA|dxa
1716646|NCT00044005|Latuda|latuda
1717073|NCT00042016|CML|cml
1717188|NCT00041730|KLH|klh
1717707|NCT00038649|CML|cml
1717924|NCT00037960|CVA|cva
1719069|NCT00032396|AMD|amd
1719894|NCT00028067|Drug Therapy, Combination|drug therapy, combination
1719895|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
1719896|NCT00028067|RNA, Viral|rna, viral
1719897|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719898|NCT00028067|Viral Load|viral load
1719899|NCT00028067|BMS 232632|bms 232632
1719900|NCT00027482|T Cell|t cell
1719901|NCT00027482|B Cell|b cell
1719902|NCT00027482|Flow Cytometry|flow cytometry
1721440|NCT00006153|remune|remune
1722218|NCT00002389|HIV-1|hiv-1
1725911|NCT00000885|HIV-1|hiv-1
1727561|NCT00023075|HV|hv
1728076|NCT00017914|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
1728077|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
1728078|NCT00017914|Disease Assessment|disease assessment
1728079|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
1728080|NCT00017914|Idiopathic Inflammatory Myopathy|idiopathic inflammatory myopathy
1728081|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1728082|NCT00017875|Intracortical Inhibition|intracortical inhibition
1728083|NCT00017875|Dystonia|dystonia
1728381|NCT00014976|EMG|emg
1728479|NCT00013949|particulate exposure|particulate exposure
1728480|NCT00013936|Instrument Development|instrument development
1728481|NCT00013936|Psychophysical Methods|psychophysical methods
1728482|NCT00013936|ETDRS|etdrs
1728483|NCT00013936|Computer-Based Methods|computer-based methods
1728484|NCT00013936|Validation Study|validation study
1728485|NCT00013936|Visual Acuity|visual acuity
1728486|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
1728487|NCT00013936|Psychophysics|psychophysics
1728497|NCT00013884|HIV|hiv
1728983|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
1728984|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
1728985|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
1728986|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1728987|NCT00009633|Prematurity|prematurity
1728992|NCT00009620|Prematurity|prematurity
1729085|NCT00009178|Primary Care|primary care
1729086|NCT00009178|Fluoxetine|fluoxetine
1729087|NCT00009009|Immune System|immune system
1729088|NCT00009009|Biopsy|biopsy
1729089|NCT00009009|AIDS|aids
1729090|NCT00009009|HIV|hiv
1729091|NCT00009009|End Stage Renal Disease|end stage renal disease
1729095|NCT00008892|Twin Study|twin study
1729276|NCT00007163|Recombinant IgG1|recombinant igg1
1729277|NCT00007163|Apoptosis|apoptosis
1730166|NCT00005907|B Cell|b cell
1730281|NCT00005785|HIV|hiv
1730464|NCT00005569|Age|age
1731279|NCT00004556|Affect|affect
1731583|NCT00000390|Human|human
1731702|NCT00001912|MRI|mri
1731786|NCT00001883|Normal Volunteers|normal volunteers
1731787|NCT00001880|Graft-Versus-Tumor|graft-versus-tumor
1731788|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
1731789|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
1731885|NCT00001862|Immunosuppression|immunosuppression
1731886|NCT00001862|Joint|joint
1731887|NCT00001862|Inflammation|inflammation
1731991|NCT00001837|Premenopause|premenopause
1731992|NCT00001836|Coronary Artery Disease|coronary artery disease
1731993|NCT00001836|EBCT|ebct
1731994|NCT00001836|Volumetric Scan|volumetric scan
1731995|NCT00001836|Coronary Artery Calcium|coronary artery calcium
1731996|NCT00001836|Prospective Gating|prospective gating
1731997|NCT00001835|Renal Dysfunction|renal dysfunction
1731998|NCT00001835|Pharmacokinetics|pharmacokinetics
1731999|NCT00001835|Platinum Analogues|platinum analogues
1732000|NCT00001835|Renal Cancer|renal cancer
1732001|NCT00001835|Kidney Cancer|kidney cancer
1732203|NCT00001734|Retinitis|retinitis
1732204|NCT00001734|Keratitis|keratitis
1732205|NCT00001734|Screening Protocol|screening protocol
1732206|NCT00001734|Ocular Immunology|ocular immunology
1732207|NCT00001734|Inflammation|inflammation
1732307|NCT00001713|rtPA|rtpa
1732517|NCT00001638|Myocardial Perfusion|myocardial perfusion
1732518|NCT00001638|Myocardial Function|myocardial function
1732519|NCT00001638|Cardiovascular Disease|cardiovascular disease
1732520|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
1732521|NCT00001637|Engraftment|engraftment
1732522|NCT00001637|Fludarabine|fludarabine
1732523|NCT00001637|Nonmyeloablative|nonmyeloablative
1732524|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
1732525|NCT00001637|Graft vs. Host Disease|graft vs. host disease
1732526|NCT00001637|Cyclophosphamide|cyclophosphamide
1732527|NCT00001637|Donor Apheresis|donor apheresis
1732528|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
1732529|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1732530|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1732720|NCT00001595|Cushing Syndrome|cushing syndrome
1732721|NCT00001595|Homeobox-Containing Genes|homeobox-containing genes
1732722|NCT00001595|Developmental Defect|developmental defect
1732723|NCT00001595|Pituitary Gland|pituitary gland
1732724|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
1732819|NCT00001550|Rigidity|rigidity
1732820|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
1732821|NCT00001550|Episodic Spasms|episodic spasms
1732822|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
1732823|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
1732831|NCT00001549|PSP|psp
1732920|NCT00001526|Uveitis|uveitis
1732921|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
1733023|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
1733024|NCT00001486|Compensation|compensation
1733025|NCT00001486|Schizophrenia|schizophrenia
1733026|NCT00001486|Schizoaffective Disorder|schizoaffective disorder
1733027|NCT00001486|Psychosis|psychosis
1733028|NCT00001486|Manic-Depression|manic-depression
1733029|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
1733030|NCT00001483|Antidepressants|antidepressants
1733031|NCT00001483|Re-Randomization|re-randomization
1733032|NCT00001483|Continuation|continuation
1733033|NCT00001483|Ratings|ratings
1733034|NCT00001483|Bipolar Illness|bipolar illness
1733035|NCT00001483|Depression|depression
1733040|NCT00001481|Mood|mood
1733432|NCT00001353|Protease Inhibitor|protease inhibitor
1733433|NCT00001353|Interleukin-2|interleukin-2
1733434|NCT00001353|Indinavir|indinavir
1733435|NCT00001352|Cryptococcus Neoformans|cryptococcus neoformans
1733436|NCT00001352|Cryptococcosis|cryptococcosis
1733437|NCT00001352|CD4|cd4
1733933|NCT00001206|CSF|csf
1733942|NCT00001204|Hypercholesterolemia|hypercholesterolemia
1733943|NCT00001204|Atherosclerosis|atherosclerosis
1733944|NCT00001203|Desferal|desferal
1733945|NCT00001203|Thalassemia|thalassemia
1733946|NCT00001203|Liver Iron Concentration|liver iron concentration
1733947|NCT00001203|Endocrine Evaluation|endocrine evaluation
1733948|NCT00001203|Diabetes Mellitus|diabetes mellitus
1734362|NCT00000411|MRI|mri
1567169|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1567170|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1567171|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1567172|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1567173|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1567174|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1567175|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1567176|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1567177|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1567178|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1567179|NCT00509691|primary myelofibrosis|primary myelofibrosis
1567180|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1567181|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1567182|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1567183|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1567184|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
1567185|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1567737|NCT00508339|Survey|survey
1570190|NCT00500123|AAT|aat
1570234|NCT00499902|AIS|ais
1570730|NCT00499239|CLL|cll
1571442|NCT00496587|RCC|rcc
1571599|NCT00495976|flu|flu
1572344|NCT00493272|HES|hes
1572635|NCT00492141|Temodar|temodar
1572727|NCT00491816|breast|breast
1573282|NCT00489541|PES|pes
1573742|NCT00487838|AMD|amd
1573827|NCT00487461|SAH|sah
1574359|NCT00485394|AMD|amd
1574561|NCT00484627|HIV|hiv
1576027|NCT00478998|stents|stents
1576318|NCT00477919|fatigue|fatigue
1576627|NCT00476918|steroid|steroid
1576833|NCT00476294|AMD3100|amd3100
1577637|NCT00473447|Arm|arm
1578222|NCT00471250|HV|hv
1579451|NCT00466674|Myeloma|myeloma
1579995|NCT00464555|T1D|t1d
1580376|NCT00463294|CABG|cabg
1580683|NCT00462267|Obesity|obesity
1580759|NCT00461994|OBESITY|obesity
1582639|NCT00454662|Elderly|elderly
1582441|NCT00455585|HIV|hiv
1582748|NCT00454324|LCCC|lccc
1582822|NCT00454038|sinus|sinus
1583670|NCT00451451|oral|oral
1584307|NCT00448903|foot|foot
1587182|NCT00441376|HCC|hcc
1587220|NCT00441298|HIV|hiv
1587640|NCT00439803|CMV|cmv
1587739|NCT00439387|HV|hv
1588580|NCT00436462|IVF|ivf
1588656|NCT00436345|ICU|icu
1588864|NCT00435331|PPH|pph
1589575|NCT00433056|STI|sti
1589858|NCT00432055|Adult|adult
1590830|NCT00428454|QCA|qca
1591314|NCT00426829|PT|pt
1591494|NCT00426218|ACZ885|acz885
1592216|NCT00423813|FMS|fms
1592591|NCT00422565|Stent|stent
1592883|NCT00421213|APL|apl
1595411|NCT00412490|Smoking|smoking
1595963|NCT00410644|pain|pain
1596059|NCT00410384|SLE|sle
1596642|NCT00407836|HIV|hiv
1597384|NCT00404482|jia|jia
1598104|NCT00401999|HV|hv
1598812|NCT00398996|CD4|cd4
1599942|NCT00394446|Brain|brain
1600088|NCT00393926|CVA|cva
1600641|NCT00391872|ACS|acs
1601270|NCT00389493|OCD|ocd
1601957|NCT00387205|solid|solid
1602080|NCT00386763|Malaria|malaria
1602769|NCT00383786|Placebo|placebo
1603505|NCT00381108|BPH|bph
1603591|NCT00380575|YM087|ym087
1603888|NCT00379210|ERP|erp
1605069|NCT00376194|ASD|asd
1606008|NCT00372801|VAS|vas
1606049|NCT00372645|Healthy|healthy
1606120|NCT00372489|CKD|ckd
1608351|NCT00364013|EGFr|egfr
1609029|NCT00361140|AUC|auc
1609366|NCT00360152|FNA|fna
1609640|NCT00359164|AMD|amd
1610615|NCT00355732|ICU|icu
1610675|NCT00355524|HIV-1|hiv-1
1610976|NCT00354523|MTC|mtc
1611150|NCT00353899|HV|hv
1611788|NCT00351910|MDD|mdd
1613398|NCT00345202|RPF|rpf
1613593|NCT00344344|Asthma|asthma
1613779|NCT00343668|S-1|s-1
1615203|NCT00339326|KSHV|kshv
1616440|NCT00334230|HV|hv
1617021|NCT00331474|BCG|bcg
1618655|NCT00325013|PSC|psc
1619149|NCT00323557|CLL|cll
1619582|NCT00321581|AML|aml
1620321|NCT00318669|SAD|sad
1620422|NCT00318188|HAQ|haq
1621743|NCT00313573|pain|pain
1621905|NCT00312832|d4T|d4t
1622216|NCT00311571|bedrest|bedrest
1625682|NCT00299208|Malaria|malaria
1627156|NCT00294294|vaccine|vaccine
1627256|NCT00293930|Safety|safety
1628109|NCT00290823|Taenia|taenia
1628679|NCT00289549|CLL|cll
1628774|NCT00288990|MS|ms
1630040|NCT00283465|epoetin|epoetin
1630233|NCT00282581|MVA|mva
1631220|NCT00279357|NBI|nbi
1631509|NCT00278265|anemia|anemia
1632047|NCT00276042|AOM|aom
1632980|NCT00271908|HIV|hiv
1633579|NCT00269945|Anemia|anemia
1634067|NCT00267930|AF|af
1634714|NCT00265499|Flow|flow
1635666|NCT00260832|Dacogen|dacogen
1636375|NCT00258193|C-IBS|c-ibs
1637326|NCT00254852|DBM|dbm
1637431|NCT00254397|Lupron|lupron
1638557|NCT00250094|Phase I|phase i
1638083|NCT00252239|TNK|tnk
1641498|NCT00238004|Niacin|niacin
1642966|NCT00231699|Cotton|cotton
1644043|NCT00226668|edema|edema
1644210|NCT00225862|RLS|rls
1644251|NCT00225654|stent|stent
1644379|NCT00225160|HIV|hiv
1646304|NCT00215566|IBS|ibs
1646399|NCT00215202|Iressa|iressa
1646691|NCT00213382|EMG|emg
1647477|NCT00210301|MS|ms
1647890|NCT00208364|Hip|hip
1648547|NCT00204490|soy|soy
1649259|NCT00200902|MDD|mdd
1650037|NCT00197366|HIV|hiv
1650391|NCT00195624|SAA|saa
1650744|NCT00193739|Surgery|surgery
1652117|NCT00183716|Women|women
1652330|NCT00183053|Frailty|frailty
1652547|NCT00182247|DVT|dvt
1652813|NCT00181064|Atkins|atkins
1653118|NCT00179517|Men|men
1653222|NCT00178906|suicide|suicide
1653532|NCT00177268|eczema|eczema
1653753|NCT00176280|RCC|rcc
1654590|NCT00171821|MDS|mds
1654716|NCT00171275|Statins|statins
1656596|NCT00161980|Seroma|seroma
1656953|NCT00161148|PSC|psc
1657068|NCT00160563|EPAAC|epaac
1657156|NCT00160082|PPS|pps
1657759|NCT00156871|fatigue|fatigue
1657886|NCT00156351|Women|women
1657950|NCT00156026|HPV|hpv
1659707|NCT00147290|ATP|atp
1660707|NCT00142246|malaria|malaria
1661338|NCT00138853|RSA|rsa
1662062|NCT00135668|safety|safety
1663710|NCT00129363|Child|child
1663917|NCT00128752|diet|diet
1664523|NCT00126308|HIV|hiv
1664868|NCT00125177|SUI|sui
1665446|NCT00122538|HIV|hiv
1666753|NCT00117845|ATL|atl
1667464|NCT00115401|Walking|walking
1667942|NCT00113997|HV|hv
1669498|NCT00024635|HV|hv
1669621|NCT00109018|CAD|cad
1670253|NCT00106782|FHD|fhd
1670663|NCT00105066|HDL|hdl
1670763|NCT00104871|velcade|velcade
1670996|NCT00104039|HV|hv
1671459|NCT00102336|ITP|itp
1673338|NCT00095732|Enzymes|enzymes
1673421|NCT00095355|HD|hd
1674816|NCT00090831|HV|hv
1675765|NCT00089804|SLE|sle
1675887|NCT00089765|Tumor|tumor
1676350|NCT00004215|anemia|anemia
1677136|NCT00088569|HV|hv
1679327|NCT00085969|Amylin|amylin
1693154|NCT00071838|MS|ms
1680031|NCT00084825|bone metastases|bone metastases
1680567|NCT00083876|Doxorubicin|doxorubicin
1680502|NCT00084097|IgE|ige
1680824|NCT00083616|Abgenix|abgenix
1681420|NCT00003580|oral complications|oral complications
1681657|NCT00002780|stage IV breast cancer|stage iv breast cancer
1682024|NCT00002673|infection|infection
1682368|NCT00083317|Bargaining Games|bargaining games
1682408|NCT00083213|ovarian sarcoma|ovarian sarcoma
1682916|NCT00082329|PBSC's|pbsc's
1683211|NCT00005021|intraocular lymphoma|intraocular lymphoma
1683434|NCT00082147|Biopsy|biopsy
1683556|NCT00081926|CML|cml
1683928|NCT00003887|testicular teratoma|testicular teratoma
1684227|NCT00003270|Burkitt lymphoma|burkitt lymphoma
1685008|NCT00081549|Pancreas Cancer|pancreas cancer
1696484|NCT00065156|Celgene|celgene
1685508|NCT00014391|stage IV breast cancer|stage iv breast cancer
1686106|NCT00080912|pain|pain
1687382|NCT00080119|Treatment Naive|treatment naive
1686552|NCT00080470|Incontinence|incontinence
1687668|NCT00003647|cancer|cancer
1688148|NCT00079677|Nuvigil|nuvigil
1690443|NCT00077922|Oncology|oncology
1688492|NCT00079612|RCC|rcc
1714416|NCT00004576|Glutamate|glutamate
1689430|NCT00025012|melanoma|melanoma
1689673|NCT00078364|Pain Mechanisms|pain mechanisms
1690017|NCT00078091|BBS|bbs
1690796|NCT00077038|HV|hv
1690461|NCT00077896|Dementia|dementia
1690705|NCT00077584|Scleroderma|scleroderma
1690790|NCT00077012|BPH|bph
1690994|NCT00076752|SLE|sle
1691084|NCT00076674|PD|pd
1691590|NCT00075335|Mozobil|mozobil
1691746|NCT00074997|OZ1|oz1
1693127|NCT00071903|PTC|ptc
1693358|NCT00071227|AMD|amd
1693458|NCT00070993|ALS|als
1694038|NCT00069719|ocular|ocular
1694498|NCT00068926|HV|hv
1696171|NCT00065741|HIV|hiv
1697522|NCT00062556|PAD|pad
1698184|NCT00061607|SMA|sma
1698245|NCT00061568|SCA|sca
1699944|NCT00059358|HIV|hiv
1700210|NCT00058968|pain|pain
1700655|NCT00057460|EEG|eeg
1700969|NCT00056420|HV|hv
1703818|NCT00042939|EGF-r|egf-r
1705487|NCT00025662|MDS|mds
1714099|NCT00051129|AMD|amd
1714472|NCT00001944|Pgp|pgp
1714912|NCT00001624|BQ-123|bq-123
1715207|NCT00001443|AIDS|aids
1715440|NCT00001298|DAMPA|dampa
1716169|NCT00047580|Stroke|stroke
1716704|NCT00043979|Sarcoma|sarcoma
1717442|NCT00039923|PNH|pnh
1717657|NCT00038805|ALL|all
1717759|NCT00038558|DTIC|dtic
1719129|NCT00031408|Blood|blood
1719349|NCT00030199|HV|hv
1719868|NCT00028106|PET|pet
1720117|NCT00026832|PET|pet
1720226|NCT00026598|PD|pd
1721241|NCT00006442|HIV-1|hiv-1
1725924|NCT00000884|HIV-1|hiv-1
1725990|NCT00000876|PRO 542|pro 542
1727210|NCT00000675|IgG|igg
1728717|NCT00011791|CAH|cah
1728745|NCT00011752|PET|pet
1728942|NCT00010725|CVD|cvd
1730168|NCT00005907|T Cell|t cell
1732194|NCT00001737|Eye|eye
1732396|NCT00001666|TMS|tms
1733079|NCT00001471|HIV|hiv
1733168|NCT00001442|Taxol|taxol
1733598|NCT00001307|PET|pet
1733958|NCT00001201|EMG|emg
1734995|NCT00004449|autism|autism
1735764|NCT03573102|proteinuria , SGLT2 inhibitors , diabetes|proteinuria , sglt2 inhibitors , diabetes
1735766|NCT03574311|cardiac surgery|cardiac surgery
1735767|NCT03574311|blood transfusion|blood transfusion
1735768|NCT03574311|intravenous iron|intravenous iron
1735769|NCT03574311|postoperative infection|postoperative infection
1735770|NCT03574298|Radical prostatectomy|radical prostatectomy
1735771|NCT03574298|urinary incontinence|urinary incontinence
1735772|NCT03574298|pelvic floor muscle|pelvic floor muscle
1735773|NCT03574298|reaction time|reaction time
1735774|NCT03574272|mobile IoT technology|mobile iot technology
1735775|NCT03574272|Patient Transfer Monitoring System|patient transfer monitoring system
1735776|NCT03574220|pembrolizumab|pembrolizumab
1735777|NCT03574220|radiotherapy|radiotherapy
1735778|NCT03574220|immunotherapy|immunotherapy
1735779|NCT03574181|Wrist watch blood alcohol level|wrist watch blood alcohol level
1735780|NCT03574181|Blood alcohol|blood alcohol
1735781|NCT03574181|Objective alcohol measure|objective alcohol measure
1735782|NCT03574155|Gynecological cancer|gynecological cancer
1735784|NCT03574155|Pre-operative counseling|pre-operative counseling
1735785|NCT03574142|Pharmacokinetics|pharmacokinetics
1735786|NCT03574142|Safety|safety
1735787|NCT03574142|Tolerability|tolerability
1735788|NCT03574142|Epanova|epanova
1735789|NCT03574142|Omega-3 carboxylic acids|omega-3 carboxylic acids
1735790|NCT03574142|Chinese|chinese
1735791|NCT03574116|Sarcopenia|sarcopenia
1735792|NCT03574116|jejunostomy|jejunostomy
1735793|NCT03574116|oesogastric adenocarcinoma|oesogastric adenocarcinoma
1735794|NCT03574116|scanography|scanography
1735795|NCT03574103|Obesity|obesity
1735796|NCT03574103|Overweight|overweight
1735797|NCT03574103|Weight loss|weight loss
1735798|NCT03574103|Fasting|fasting
1735799|NCT03574090|topical antibiotic|topical antibiotic
1735800|NCT03574090|surgical wound infection|surgical wound infection
1735801|NCT03574090|prevention of surgical wound infection|prevention of surgical wound infection
1735802|NCT03574051|oral microbiota|oral microbiota
1735803|NCT03574051|16S rRNA gene|16s rrna gene
1735804|NCT03574051|thyroid cancer|thyroid cancer
1735805|NCT03574051|iodine 131 treatment|iodine 131 treatment
1735806|NCT03574051|fecal microbiota|fecal microbiota
1735807|NCT03574051|radiotherapy|radiotherapy
1735808|NCT03574025|Observational, Paediatric, Cardiac Arrest, PICU,|observational, paediatric, cardiac arrest, picu,
1735809|NCT03573999|mannitol|mannitol
1735810|NCT03573999|hypertonic saline|hypertonic saline
1735811|NCT03573999|brain metabolism|brain metabolism
1735812|NCT03573999|brain oxygenation|brain oxygenation
1735813|NCT03573973|Dietary inequalities|dietary inequalities
1735814|NCT03573973|Public Health|public health
1735815|NCT03573973|Choice architecture|choice architecture
1735816|NCT03573973|Supermarkets|supermarkets
1735817|NCT03573960|Lenvatinib, E7080, Refractory Differentiated Thyroid Cancer|lenvatinib, e7080, refractory differentiated thyroid cancer
1735818|NCT03573947|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
1735819|NCT03573947|nivolumab|nivolumab
1735820|NCT03573947|ipilimumab|ipilimumab
1735821|NCT03573947|paclitaxel|paclitaxel
1735822|NCT03573947|immunotherapy|immunotherapy
1735823|NCT03573921|Paediatrics|paediatrics
1735824|NCT03573921|Gastrografin|gastrografin
1735825|NCT03573882|Open Label Extension|open label extension
1735826|NCT03573843|Delirium|delirium
1735827|NCT03573843|Prevention|prevention
1735828|NCT03573843|Cognitive stimulation|cognitive stimulation
1735829|NCT03573830|Child Passenger Injury|child passenger injury
1735830|NCT03573830|Child Restraint Systems|child restraint systems
1735831|NCT03573830|Traffic Accidents|traffic accidents
1735832|NCT03573817|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1735833|NCT03573817|Pulmonary Function|pulmonary function
1735834|NCT03573817|COPD|copd
1735835|NCT03573804|Breast Cancer Locator|breast cancer locator
1735836|NCT03573778|health|health
1735837|NCT03573778|quality of life|quality of life
1735838|NCT03573778|safety|safety
1735839|NCT03573778|health promotion|health promotion
1735840|NCT03573778|intimate partner violence|intimate partner violence
1735841|NCT03573778|domestic violence|domestic violence
1735842|NCT03573778|confidence|confidence
1735843|NCT03573778|control|control
1735844|NCT03573778|nursing intervention|nursing intervention
1735845|NCT03573765|epidemiology|epidemiology
1735846|NCT03573765|upper limb|upper limb
1735847|NCT03573765|hand surgery|hand surgery
1735848|NCT03573765|wrist surgery|wrist surgery
1735849|NCT03573765|shoulder surgery|shoulder surgery
1735850|NCT03573765|elbow surgery|elbow surgery
1735851|NCT03573765|outcomes|outcomes
1735852|NCT03573765|complications|complications
1735853|NCT03573765|revision surgery|revision surgery
1735854|NCT03573752|Laparoscopic Promontofixation|laparoscopic promontofixation
1735855|NCT03573752|Outpatient management|outpatient management
1735856|NCT03573713|Hygiene practices|hygiene practices
1735857|NCT03573713|Sanitation|sanitation
1735858|NCT03573713|Nutrition|nutrition
1735859|NCT03573713|Interpersonal Psychotherapy|interpersonal psychotherapy
1735860|NCT03573713|Maternal depression|maternal depression
1735861|NCT03573713|clustered randomized controlled trial|clustered randomized controlled trial
1735862|NCT03573700|Leukemia|leukemia
1735863|NCT03573700|Leukemia, lymphoid|leukemia, lymphoid
1735864|NCT03573700|Leukemia, B-cell|leukemia, b-cell
1735865|NCT03573700|Relapsed|relapsed
1735866|NCT03573700|Refractory|refractory
1735867|NCT03573700|Pediatric|pediatric
1735868|NCT03573700|Chimeric antigen receptor|chimeric antigen receptor
1735869|NCT03573700|CAR|car
1735870|NCT03573700|CAR T cell|car t cell
1735871|NCT03573700|Anti-CD19|anti-cd19
1735872|NCT03573700|CD19|cd19
1735873|NCT03573687|protein|protein
1735874|NCT03573687|lipolysis|lipolysis
1735875|NCT03573687|fat oxidation|fat oxidation
1735876|NCT03573687|resistance training|resistance training
1735877|NCT03573687|nutrient timing|nutrient timing
1735878|NCT03573674|Working conditions,|working conditions,
1735879|NCT03573674|cognitive load|cognitive load
1735880|NCT03573674|disruptions|disruptions
1735881|NCT03573674|interruptions|interruptions
1735882|NCT03573674|information overload|information overload
1735883|NCT03573674|Mental contrasting with implementation intentions MCII|mental contrasting with implementation intentions mcii
1735884|NCT03573674|Cognitive ergonomics|cognitive ergonomics
1735885|NCT03573661|Breast Conserving Surgery|breast conserving surgery
1735886|NCT03573661|Breast Imaging|breast imaging
1735887|NCT03573661|Breast Cancer Locator|breast cancer locator
1735888|NCT03573661|Supine MRI|supine mri
1735889|NCT03573596|CML|cml
1735890|NCT03573596|second stop|second stop
1735891|NCT03573596|dasatinib|dasatinib
1735892|NCT03573583|muscle mass|muscle mass
1735893|NCT03573583|muscle loss|muscle loss
1735894|NCT03573583|Deuterated creatine (D3Cr) dilution|deuterated creatine (d3cr) dilution
1735895|NCT03573583|older adults|older adults
1735896|NCT03573583|resistance training|resistance training
1735897|NCT03573583|physical function|physical function
1735898|NCT03573544|mAbs|mabs
1735899|NCT03573544|monoclonal antibodies|monoclonal antibodies
1735900|NCT03573531|donor human milk|donor human milk
1735901|NCT03573531|lipid peroxidation|lipid peroxidation
1735902|NCT03573531|neonate|neonate
1735903|NCT03573531|omega-3 fatty acids|omega-3 fatty acids
1735904|NCT03573531|omega-6 fatty acids|omega-6 fatty acids
1735905|NCT03573531|preterm infants|preterm infants
1735906|NCT03573531|malondialdehyde|malondialdehyde
1735907|NCT03573479|rehabilitation|rehabilitation
1735908|NCT03573479|critical care|critical care
1735909|NCT03573479|child health|child health
1735910|NCT03573479|quality improvement|quality improvement
1735911|NCT03573466|ALS|als
1735912|NCT03573466|Motor Neuron|motor neuron
1735913|NCT03573466|Neuromuscular Junction|neuromuscular junction
1735914|NCT03573453|Critical Care|critical care
1735915|NCT03573453|Enteral Nutrition|enteral nutrition
1735916|NCT03573453|Ventilator Associated Pneumonia|ventilator associated pneumonia
1735917|NCT03573453|Gastric Residual Volume|gastric residual volume
1735918|NCT03573401|ALA-PDT|ala-pdt
1735919|NCT03573388|Intermediate coronary lesions|intermediate coronary lesions
1735920|NCT03573388|Fractional flow reserve|fractional flow reserve
1735921|NCT03573388|Optical coherence tomography|optical coherence tomography
1735922|NCT03573375|Questionnaires|questionnaires
1735923|NCT03573375|Surveys|surveys
1735924|NCT03573362|sarcoidosis|sarcoidosis
1735925|NCT03573362|ebus|ebus
1735926|NCT03573362|endobronchial ultrasound|endobronchial ultrasound
1735927|NCT03573323|biologic|biologic
1735928|NCT03573323|biologic therapy|biologic therapy
1735929|NCT03573284|cough variant asthma|cough variant asthma
1735930|NCT03573284|chronic cough|chronic cough
1735931|NCT03573284|fractional exhaled nitric oxide|fractional exhaled nitric oxide
1735932|NCT03573284|impulse oscillometry|impulse oscillometry
1735933|NCT03573284|forced mid-expiratory flow|forced mid-expiratory flow
1735934|NCT03573271|facial wrinkles|facial wrinkles
1735935|NCT03573271|skin laxity|skin laxity
1735936|NCT03573271|sagging skin|sagging skin
1735937|NCT03573232|Parkinson Disease|parkinson disease
1735938|NCT03573232|Pisa Syndrome|pisa syndrome
1735939|NCT03573232|Camptocormia|camptocormia
1735940|NCT03573232|Antecollis|antecollis
1735941|NCT03573232|Striatal deformities|striatal deformities
1735942|NCT03573219|Short-Wave Diathermy|short-wave diathermy
1735943|NCT03573219|Transient muscle pain|transient muscle pain
1735944|NCT03573219|Non-invasive pain model|non-invasive pain model
1735945|NCT03573206|vessel closure|vessel closure
1735946|NCT03573206|venous access site|venous access site
1735947|NCT03573206|femoral venotomy|femoral venotomy
1735948|NCT03573206|medium bore|medium bore
1735949|NCT03573206|multiple access sites|multiple access sites
1735950|NCT03573193|xenograft bone|xenograft bone
1735951|NCT03573193|synthetic bone substitutes|synthetic bone substitutes
1735952|NCT03573180|CAST index, prevalence of caries, primary dentition caries|cast index, prevalence of caries, primary dentition caries
1735953|NCT03573154|nicotine|nicotine
1735954|NCT03573154|e-cigarette|e-cigarette
1735955|NCT03573154|exhaled breath|exhaled breath
1735956|NCT03573154|pharmacokinetic model|pharmacokinetic model
1735957|NCT03573115|Optical Coherence Tomography|optical coherence tomography
1735958|NCT03573115|Reflectance Confocal Microscopy|reflectance confocal microscopy
1735959|NCT03573115|Gold microparticles|gold microparticles
1735960|NCT03573115|Adapalene|adapalene
1735961|NCT03573115|Benzoyl Peroxide|benzoyl peroxide
1735962|NCT03573089|Renal dialysis|renal dialysis
1735963|NCT03573089|Randomised controlled trial|randomised controlled trial
1735964|NCT03573089|Bone markers|bone markers
1735965|NCT03573089|Cardiovascular risk factors|cardiovascular risk factors
1735966|NCT03573089|Phosphate lowering agent|phosphate lowering agent
1735967|NCT03573089|End stage kidney disease|end stage kidney disease
1735968|NCT03573089|Hyperphosphatemia|hyperphosphatemia
1735969|NCT03573063|starvation|starvation
1735970|NCT03573063|androgens|androgens
1735971|NCT03573063|healthy women|healthy women
1735972|NCT03573063|PCOS|pcos
1735973|NCT03571815|Fluoride varnish|fluoride varnish
1735974|NCT03571815|clinical trial|clinical trial
1735975|NCT03571815|dental caries|dental caries
1735976|NCT03572153|Hot Flashes|hot flashes
1735977|NCT03572153|Postmenopausal Symptoms|postmenopausal symptoms
1735978|NCT03572153|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
1735979|NCT03572153|Mind Body|mind body
1735980|NCT03572153|Hypnosis|hypnosis
1735982|NCT03572140|Sofosbuvir|sofosbuvir
1735983|NCT03572140|Safety|safety
1735984|NCT03572140|RAVs|ravs
1735985|NCT03572140|Daclatasvir|daclatasvir
1735986|NCT03572374|Workforce|workforce
1735987|NCT03572374|Employers|employers
1735988|NCT03572374|Talking to Employers and Medical Staff About Work (TEAMWork)|talking to employers and medical staff about work (teamwork)
1735989|NCT03572374|18-217|18-217
1735990|NCT03571191|Bone Diseases|bone diseases
1735991|NCT03571191|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
1735992|NCT03571191|Bone Turnover|bone turnover
1735993|NCT03571464|obsessive compulsive disorder|obsessive compulsive disorder
1735994|NCT03571464|cognitive therapy|cognitive therapy
1735995|NCT03571464|maladaptive beliefs|maladaptive beliefs
1735996|NCT03571464|mobile app|mobile app
1735997|NCT03571386|Mindfulness|mindfulness
1735998|NCT03571386|Depression|depression
1735999|NCT03571386|Anxiety|anxiety
1736000|NCT03571386|stress|stress
1736001|NCT03571204|Treatment Interruption|treatment interruption
1736002|NCT03571204|Neutralizing Monoclonal Antibody|neutralizing monoclonal antibody
1736003|NCT03571165|carers|carers
1736004|NCT03571165|quality of life|quality of life
1736005|NCT03571165|dementia|dementia
1736006|NCT03571165|web-based intervention|web-based intervention
1736007|NCT03571035|Mandibular deviation|mandibular deviation
1736008|NCT03571035|mandibular movement recording|mandibular movement recording
1736009|NCT03570489|Cardiovascular fitness, refractory epilepsy,|cardiovascular fitness, refractory epilepsy,
1736010|NCT03569956|Razor bumps|razor bumps
1736011|NCT03569956|Skin Irritation|skin irritation
1736012|NCT03569956|Shaving|shaving
1736013|NCT03569943|Robot based procedure|robot based procedure
1736014|NCT03569943|RobOtol|robotol
1736015|NCT03569943|Tympanic drain|tympanic drain
1736016|NCT03569631|Phosphodiesterase Type 4D|phosphodiesterase type 4d
1736017|NCT03569631|PDE4D|pde4d
1736018|NCT03569631|Cognitive Dysfunction|cognitive dysfunction
1736019|NCT03569631|Neurocognitive Disorders|neurocognitive disorders
1736020|NCT03569631|Fragile X Syndrome|fragile x syndrome
1736021|NCT03569631|Fragile X|fragile x
1736022|NCT03569631|FXS|fxs
1736023|NCT03569631|Brain Diseases|brain diseases
1736024|NCT03569631|Central Nervous System Diseases|central nervous system diseases
1736025|NCT03569631|Nervous System Diseases|nervous system diseases
1736026|NCT03569631|Mental Disorders|mental disorders
1736027|NCT03569631|Cognition Disorders|cognition disorders
1736028|NCT03569631|Enzyme Inhibitors|enzyme inhibitors
1736029|NCT03569631|Nootropic Agents|nootropic agents
1736030|NCT03569631|Developmental Disorder|developmental disorder
1736031|NCT03569631|Autism|autism
1736032|NCT03569631|Autistic Spectrum Disorder|autistic spectrum disorder
1736033|NCT03569631|Genetic Disease|genetic disease
1736034|NCT03569631|Behavioral Disorder|behavioral disorder
1736035|NCT03569631|Learning Disorder|learning disorder
1736036|NCT03568916|Direct oral anticoagulants|direct oral anticoagulants
1736037|NCT03568916|Safety|safety
1736038|NCT03568916|Atrial fibrillation|atrial fibrillation
1736039|NCT03568916|Ischemic stroke|ischemic stroke
1736040|NCT03568916|Systemic embolization|systemic embolization
1736041|NCT03567772|Video-game assisted rehabilitation|video-game assisted rehabilitation
1736042|NCT03567772|COPD|copd
1736043|NCT03567772|Exercise tolerance|exercise tolerance
1736044|NCT03565328|Mitochondrial bioenergetic dysfunction|mitochondrial bioenergetic dysfunction
1736045|NCT03565328|Mitochondrial oxidative phosphorylation in sceletal muscles|mitochondrial oxidative phosphorylation in sceletal muscles
1736046|NCT03565328|Hyperacetylation of mitochondrial bioenergetic enzymes|hyperacetylation of mitochondrial bioenergetic enzymes
1736047|NCT03565328|NAD+ dependent sirtuin enzymes|nad+ dependent sirtuin enzymes
1736048|NCT03565328|NAD+/NADH ratio|nad+/nadh ratio
1736049|NCT03565315|HIV Prevention|hiv prevention
1736050|NCT03565315|Broadly Neutralizing Monoclonal Antibodies|broadly neutralizing monoclonal antibodies
1736051|NCT03565315|First in Human Study|first in human study
1736052|NCT03565315|Anti-Drug Antibody Response to 10E8VLS or VRC07-523LS|anti-drug antibody response to 10e8vls or vrc07-523ls
1736053|NCT03563313|Artificial Pancreas (AP)|artificial pancreas (ap)
1736054|NCT03563313|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1736055|NCT03563313|Insulin Pump|insulin pump
1736056|NCT03563313|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1736057|NCT03563313|Closed Loop Control (CLC)|closed loop control (clc)
1736058|NCT03563313|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
1736059|NCT03562481|Healthy pediatric volunteers|healthy pediatric volunteers
1736060|NCT03561987|ADIPOSE TISSUE, CARDIOVASCULAR, OBESE PATIENTS|adipose tissue, cardiovascular, obese patients
1736061|NCT03559543|Nutritional supplement|nutritional supplement
1736062|NCT03559543|Metastatic colorectal Cancer|metastatic colorectal cancer
1736063|NCT03559543|Oxidative Stress|oxidative stress
1736064|NCT03559543|Ocoxin Viusid|ocoxin viusid
1736065|NCT03559543|Antioxidant|antioxidant
1736066|NCT03559075|atopic dermatitis|atopic dermatitis
1736068|NCT03559075|children|children
1736069|NCT03554473|Chemosensitivity|chemosensitivity
1736070|NCT03554473|DNA Damage and Replication|dna damage and replication
1736071|NCT03554473|PD-1/PD-L1|pd-1/pd-l1
1736072|NCT03554473|Solid Tumors|solid tumors
1736073|NCT03554473|Checkpoint Inhibitors|checkpoint inhibitors
1736074|NCT03553823|Psoriasis|psoriasis
1736075|NCT03551353|video feedback|video feedback
1736076|NCT03551353|checkout prosedures|checkout prosedures
1736077|NCT03549754|Registry|registry
1736078|NCT03549754|Type 2 Diabetes|type 2 diabetes
1736079|NCT03549754|T2DM|t2dm
1736080|NCT03549754|Adult population|adult population
1736081|NCT03545204|Neonatal Mortality & Neurodevelopment of an Infant.|neonatal mortality & neurodevelopment of an infant.
1736082|NCT03545126|Tauopathies|tauopathies
1736083|NCT03543787|Referral networks|referral networks
1736084|NCT03543787|low and middle income countries|low and middle income countries
1736085|NCT03543787|PRECEDE-PROCEED|precede-proceed
1736086|NCT03543787|implementation research|implementation research
1736087|NCT03543787|hypertension|hypertension
1736088|NCT03543787|cardiovascular disease|cardiovascular disease
1736089|NCT03543787|process evaluation|process evaluation
1736090|NCT03542877|Cabozantinib|cabozantinib
1736091|NCT03542877|Progression Free Survival|progression free survival
1736092|NCT03542877|Metastatic Colorectal Cancer|metastatic colorectal cancer
1736093|NCT03542877|Tumor|tumor
1736094|NCT03541798|traditional sitting position|traditional sitting position
1736095|NCT03541798|combine spinal-epidural anesthesia|combine spinal-epidural anesthesia
1736096|NCT03541798|orthopedic surgery|orthopedic surgery
1736097|NCT03538613|Adoptive Cell Therapy|adoptive cell therapy
1736098|NCT03538613|Immunotherapy|immunotherapy
1736099|NCT03538613|Gene Therapy|gene therapy
1736100|NCT03538665|Endometrial Cancer|endometrial cancer
1736101|NCT03538665|Somatic Mutations|somatic mutations
1736102|NCT03538665|Early Detection|early detection
1736103|NCT03538665|Tampon Sampling|tampon sampling
1736104|NCT03538665|Tissue Discovery|tissue discovery
1736105|NCT03538639|Etiology of Rare and Orphan Diseases with Vascular Phenotype|etiology of rare and orphan diseases with vascular phenotype
1736106|NCT03538639|Natural History of Rare and Orphan Diseases with Vascular Phenotype|natural history of rare and orphan diseases with vascular phenotype
1736107|NCT03538639|Pathophysiology of Uncommon Vascular Diseases|pathophysiology of uncommon vascular diseases
1736108|NCT03538639|Undiagnosed Diseases|undiagnosed diseases
1736109|NCT03538639|Rare Human Diseases with Vascular Features|rare human diseases with vascular features
1736110|NCT03538600|Blood|blood
1736111|NCT03538600|Microbiome Analysis|microbiome analysis
1736112|NCT03538600|Stool|stool
1736113|NCT03538600|Saliva|saliva
1736114|NCT03538600|Skin|skin
1736115|NCT03538587|high-grade astrocytoma|high-grade astrocytoma
1736116|NCT03538587|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
1736117|NCT03538587|Glioblastoma Multiforme|glioblastoma multiforme
1736118|NCT03538587|Meditation|meditation
1736119|NCT03538587|Quality of Life|quality of life
1736120|NCT03535571|Energy increase|energy increase
1736121|NCT03535571|Energy|energy
1736122|NCT03535571|Healthy|healthy
1736123|NCT03535571|anti-inflammatory|anti-inflammatory
1736124|NCT03535571|Open-label|open-label
1736125|NCT03535571|Salmon protein|salmon protein
1736126|NCT03535571|Natural health product|natural health product
1736127|NCT03535571|Dietary supplement|dietary supplement
1736128|NCT03535129|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1736129|NCT03535129|Neurofeedback|neurofeedback
1736130|NCT03535129|Drug Relapse|drug relapse
1736131|NCT03534245|Mosquito Salivary Protein|mosquito salivary protein
1736132|NCT03534245|Dengue Fever|dengue fever
1736133|NCT03534245|Zika|zika
1736134|NCT03534245|Chikungunya|chikungunya
1736135|NCT03534245|Kampong Speu|kampong speu
1736136|NCT03531827|Androgen Receptor Antagonist|androgen receptor antagonist
1736137|NCT03531827|PSA|psa
1736138|NCT03531827|Hormonal Therapy|hormonal therapy
1736139|NCT03531827|Nanoparticle Drug|nanoparticle drug
1736140|NCT03531827|Antitumor|antitumor
1736141|NCT03531814|Plexiform Neurofibromas|plexiform neurofibromas
1736142|NCT03531814|Medication Event Monitoring Systems|medication event monitoring systems
938603|NCT03554109|TNBC|tnbc
1736143|NCT03531814|Oral Medication|oral medication
1736144|NCT03531840|DNA Mismatch Repair|dna mismatch repair
1736145|NCT03531840|BAP1|bap1
1736146|NCT03531840|BRCA|brca
1736147|NCT03530683|Neoplasms|neoplasms
1736148|NCT03530683|Lymphoma|lymphoma
1736149|NCT03530683|Myeloma|myeloma
1736150|NCT03530267|colorectal cancer|colorectal cancer
1736151|NCT03530267|5-FU|5-fu
1736152|NCT03530267|Aflibercept|aflibercept
1736153|NCT03530267|Oxaliplatin|oxaliplatin
1736154|NCT03528694|Durvalumab|durvalumab
1736155|NCT03528694|BCG|bcg
1736156|NCT03528694|MEDI4736|medi4736
1736157|NCT03528694|NMIBC|nmibc
1736158|NCT03528694|PD-L1|pd-l1
1736159|NCT03528694|DFS|dfs
1736160|NCT03528694|OS|os
1736161|NCT03522298|newly diagnosed|newly diagnosed
1736162|NCT03522298|unmethylated O6 methylguanine-methyltransferase (MGMT) promoter status|unmethylated o6 methylguanine-methyltransferase (mgmt) promoter status
1736163|NCT03520660|Natural History|natural history
1736164|NCT03520660|Hepatitis C Virus|hepatitis c virus
1736165|NCT03520660|Hepatocellular Carcinoma|hepatocellular carcinoma
1736166|NCT03520660|Fibrosis|fibrosis
1736167|NCT03520660|Immune Response|immune response
1736168|NCT03520647|Haploidentical CD34+cells|haploidentical cd34+cells
1736169|NCT03520647|Non-Myeloablative|non-myeloablative
1736170|NCT03520946|colorectal cancer|colorectal cancer
1736171|NCT03520946|ramucirumab|ramucirumab
1736172|NCT03520946|tas102|tas102
1736173|NCT03520530|second stage|second stage
1736174|NCT03520530|spontaneous vaginal delivery|spontaneous vaginal delivery
1736175|NCT03520114|Retropubic sling|retropubic sling
1736176|NCT03520114|Single-incision sling|single-incision sling
1736177|NCT03520114|Vaginal repair|vaginal repair
1736178|NCT03520114|Management|management
1736179|NCT03519464|Gardasil 9|gardasil 9
1736180|NCT03519464|Seroconversion|seroconversion
1736181|NCT03519464|Humoral immune response|humoral immune response
1736182|NCT03519464|Cellular Immune Response|cellular immune response
1736183|NCT03519464|Mucosal Lesions|mucosal lesions
1736184|NCT03515161|closedloop|closedloop
1736185|NCT03515161|vasopressor|vasopressor
1736186|NCT03514368|Immune checkpoint modulation|immune checkpoint modulation
1736187|NCT03514368|Tumor antigens|tumor antigens
1736188|NCT03514368|Adaptive immune responses|adaptive immune responses
1736189|NCT03514368|Tumor molecular signature|tumor molecular signature
1736190|NCT03511794|Hepatitis B Reactivation|hepatitis b reactivation
1736191|NCT03511794|Allogenic Stem Cell Transplant|allogenic stem cell transplant
1736192|NCT03510455|Renal Phosphate Wasting|renal phosphate wasting
1736193|NCT03510455|Phosphaturic Mesenchymal Tumors|phosphaturic mesenchymal tumors
1736194|NCT03510455|Fibroblast Growth Factor (FGF23)|fibroblast growth factor (fgf23)
1736195|NCT03510455|FGFR Inhibitors|fgfr inhibitors
1736196|NCT03510455|Hypophosphatemia|hypophosphatemia
1736197|NCT03510481|Infection|infection
1736198|NCT03510481|Malaria|malaria
1736199|NCT03510481|Transmission|transmission
1736200|NCT03510481|Treatment|treatment
1736201|NCT03510481|Disease|disease
1736202|NCT03509467|skin cancer prevention|skin cancer prevention
1736203|NCT03509467|educational materials|educational materials
1736204|NCT03509467|skin cancer risk|skin cancer risk
1736205|NCT03509467|questionnaire|questionnaire
1736206|NCT03509467|MC1R genotype|mc1r genotype
1736207|NCT03504163|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
1736208|NCT03504163|17-602|17-602
1736209|NCT03501511|Diabetes MellitusType1;Fasting;Health Education;Hypoglycemia|diabetes mellitustype1;fasting;health education;hypoglycemia
1736210|NCT03496519|Durvalumab|durvalumab
1736211|NCT03496519|Trabectedin|trabectedin
1736212|NCT03496519|Maximum Tolerated Dose|maximum tolerated dose
1736213|NCT03496519|Lung Cancer|lung cancer
1736214|NCT03496519|Sarcoma|sarcoma
1736215|NCT03496207|PAH|pah
1736216|NCT03493958|Alcohol Dependence|alcohol dependence
1736217|NCT03493958|Alcohol use Disorder|alcohol use disorder
1736218|NCT03493958|Insomnia|insomnia
1736219|NCT03493932|Glioblastoma|glioblastoma
1736220|NCT03493932|Glioma|glioma
1736221|NCT03493932|Brain Tumor|brain tumor
1736222|NCT03493932|Immune Therapy|immune therapy
1736223|NCT03493932|Checkpoint Inhibition|checkpoint inhibition
1736224|NCT03486067|Multiple Myeloma|multiple myeloma
1736225|NCT03486067|BCMA X CD3 T Cell|bcma x cd3 t cell
1736226|NCT03486067|Antibody|antibody
1736227|NCT03486067|CC-93269|cc-93269
1736228|NCT03486067|Relapsed and Refractory|relapsed and refractory
1736229|NCT03481829|American Indians|american indians
1736230|NCT03481829|Obesity|obesity
1736231|NCT03481829|Pregnancy|pregnancy
1736232|NCT03481829|Diabetes|diabetes
1736233|NCT03481829|Children|children
1736234|NCT03481816|mCRPC|mcrpc
1736235|NCT03481816|Therapeutic Cancer Vaccines|therapeutic cancer vaccines
1736236|NCT03481816|ETBX-071|etbx-071
1736237|NCT03481816|ETBX-061|etbx-061
1736238|NCT03481816|ETBX-051|etbx-051
1736239|NCT03480139|Prematurity|prematurity
1736240|NCT03480139|Perinatal Mortality|perinatal mortality
1736241|NCT03480139|Pregnancy Complications|pregnancy complications
1736242|NCT03480139|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
1736243|NCT03480139|Premature Rupture of Membranes|premature rupture of membranes
1736244|NCT03478904|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1736245|NCT03478904|Androgen Receptor|androgen receptor
1736247|NCT03479697|Neurotechnology|neurotechnology
1736248|NCT03479697|Closed-Loop|closed-loop
1736249|NCT03479697|Allostasis|allostasis
1736250|NCT03479697|Stress|stress
1736251|NCT03479697|Autonomic Dysregulation|autonomic dysregulation
1736252|NCT03479697|Hyperarousal|hyperarousal
1736253|NCT03479697|Brain Electrical Activity|brain electrical activity
1736254|NCT03479697|Acoustic Stimulation|acoustic stimulation
1736255|NCT03479697|Primary Hypertension|primary hypertension
1736256|NCT03479697|High Blood Pressure|high blood pressure
1736257|NCT03478917|Vasoocclusive Crisis|vasoocclusive crisis
1736258|NCT03478917|Sickle Cell Disease|sickle cell disease
1736259|NCT03478917|Acute Chest Syndrome|acute chest syndrome
1736260|NCT03478917|Pulmonary Syndrome|pulmonary syndrome
1736261|NCT03478917|Pneumonia|pneumonia
1736262|NCT03478852|Seizure Disorder|seizure disorder
1736263|NCT03478852|Seizures|seizures
1736264|NCT03478852|Antiepileptic Drug|antiepileptic drug
1736265|NCT03478852|Natural History Study|natural history study
1736266|NCT03478852|Screening Protocol|screening protocol
1736267|NCT03475004|Pembrolizumab|pembrolizumab
1736268|NCT03475004|Binimetinib|binimetinib
1736269|NCT03475004|Bevacizumab|bevacizumab
1736270|NCT03475004|Combination Therapy|combination therapy
1736271|NCT03464383|Neurologic Disorders|neurologic disorders
1736272|NCT03464383|Chronic Care|chronic care
1736273|NCT03464383|Management|management
1736274|NCT03464383|Treatment|treatment
1736275|NCT03464383|SSRI Medication|ssri medication
1736276|NCT03464383|SNRI Medication|snri medication
1736277|NCT03464383|Learning Healthcare System|learning healthcare system
1736278|NCT03465800|overweight|overweight
1736279|NCT03465800|obesity|obesity
1736280|NCT03465800|physical activity|physical activity
1736281|NCT03465800|exercise|exercise
1736282|NCT03460444|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
1736283|NCT03460444|Caspase 1|caspase 1
1736284|NCT03460444|3-Hydroxybutyric Acid|3-hydroxybutyric acid
1736285|NCT03460444|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1736286|NCT03460444|MCT Oil|mct oil
1736287|NCT03458585|ionising radiation|ionising radiation
1736288|NCT03458585|patient awareness|patient awareness
1736289|NCT03458585|patient knowledge|patient knowledge
1736290|NCT03456076|NSCLC, alectinib, ALK positive,adjuvant treatment, platinum based chemotherapy, complete resection, Stage IB-IIIA.|nsclc, alectinib, alk positive,adjuvant treatment, platinum based chemotherapy, complete resection, stage ib-iiia.
1736291|NCT03454126|Chronic pain|chronic pain
1736292|NCT03454126|Neuropathic pain|neuropathic pain
1736293|NCT03454126|Neuralgia|neuralgia
1736294|NCT03454126|Healthy volunteers|healthy volunteers
1736295|NCT03449303|breast cancer|breast cancer
1736296|NCT03449303|CIPN|cipn
1736297|NCT03449303|Pain|pain
1736298|NCT03449303|QOL|qol
1736299|NCT03449303|Essential Oils|essential oils
1736300|NCT03436745|Insomnia|insomnia
1736301|NCT03436745|Enzyme Expression|enzyme expression
1736302|NCT03436745|PSA|psa
1736303|NCT03436745|TESTOSTERONE|testosterone
1736304|NCT03436745|Recommended Dose|recommended dose
1736305|NCT03436992|Estrogen, Diabetes|estrogen, diabetes
1736306|NCT03436732|Immunotoxin|immunotoxin
1736307|NCT03436732|Rapamycin|rapamycin
1736308|NCT03436732|Targeted Therapy|targeted therapy
1736309|NCT03436732|Mesothelin|mesothelin
1736310|NCT03434093|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
1736311|NCT03434093|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1736312|NCT03434093|Electrical Field Modeling|electrical field modeling
1736313|NCT03434093|Working Memory|working memory
1736314|NCT03432494|Transcather|transcather
1736315|NCT03432494|Transcaval|transcaval
1736316|NCT03432494|Bioprosthesis|bioprosthesis
1736317|NCT03432494|Closure Device|closure device
1736318|NCT03432494|Aortic Stenosis|aortic stenosis
1736319|NCT03430843|Unresectable|unresectable
1736320|NCT03430843|metastatic|metastatic
1736321|NCT03430843|second-line|second-line
1736322|NCT03430843|squamous|squamous
1736323|NCT03430843|esophagus|esophagus
1736324|NCT03430843|chemotherapy|chemotherapy
1736325|NCT03430843|paclitaxel|paclitaxel
1736326|NCT03430843|docetaxel|docetaxel
1736327|NCT03430843|irinotecan|irinotecan
1736328|NCT03430427|BNET|bnet
1736329|NCT03430427|Brain Networks|brain networks
1736330|NCT03430427|Mobility Function|mobility function
1736331|NCT03430427|SMCCS|smccs
1736332|NCT03428373|Multiple Myeloma|multiple myeloma
1736333|NCT03427424|Opioid use Disorder|opioid use disorder
1736334|NCT03427424|Alcohol use Disorder|alcohol use disorder
1736335|NCT03427424|Physician Health Program|physician health program
1736336|NCT03427424|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1736337|NCT03427424|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1736338|NCT03425682|Anterior Cervical Discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
938859|NCT03552523|CGM|cgm
1626176|NCT00297180|hunger|hunger
1736339|NCT03425682|Transforaminal Lumbar Interbody Fusion (TLIF)|transforaminal lumbar interbody fusion (tlif)
1736340|NCT03425682|Posterior Lumbar Interbody Fusion (PLIF)|posterior lumbar interbody fusion (plif)
1736341|NCT03423940|Functional communication training|functional communication training
1736342|NCT03423940|Reinforcement Schedule Thinning|reinforcement schedule thinning
1736343|NCT03423940|Resurgence|resurgence
1736344|NCT03423940|Treatment Dosage|treatment dosage
1736345|NCT03423940|Treatment Relapse|treatment relapse
1736346|NCT03419897|Advanced liver cancer|advanced liver cancer
1736347|NCT03417466|Diabetes Type I Type II|diabetes type i type ii
1736348|NCT03416452|Gait|gait
1736349|NCT03416452|Parkinson's Disease|parkinson's disease
1736350|NCT03414840|coronary artery disease|coronary artery disease
1736351|NCT03414840|coronary computed tomography angiography|coronary computed tomography angiography
1736352|NCT03414840|statins|statins
1736353|NCT03414840|coronary atherosclerosis|coronary atherosclerosis
1736354|NCT03412877|Gene Therapy|gene therapy
1736355|NCT03412877|Immunotherapy|immunotherapy
1736356|NCT03412877|Cell Therapy|cell therapy
1736357|NCT03412877|Adoptive Cell Therapy|adoptive cell therapy
1736358|NCT03407066|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1736359|NCT03407066|MEG|meg
1736360|NCT03407066|Color Vision|color vision
1736361|NCT03407066|Neuroimaging|neuroimaging
1736362|NCT03403075|blood cancer|blood cancer
1736363|NCT03403075|exercise|exercise
1736364|NCT03403075|therapeutic education|therapeutic education
1736365|NCT03403075|fatigue|fatigue
1736366|NCT03403075|feasibility|feasibility
1736367|NCT03399604|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1736368|NCT03399604|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1736369|NCT03399604|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
1736370|NCT03399604|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
1736371|NCT03399604|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
1736372|NCT03399604|Connective tissue disease|connective tissue disease
1736373|NCT03395340|cGVHD|cgvhd
1736374|NCT03395340|Epidermal|epidermal
1736375|NCT03395340|JAK Inhibitors|jak inhibitors
1736376|NCT03395340|Skin|skin
1736377|NCT03395340|JAK-STAT|jak-stat
1736378|NCT03394066|Repetitive TMS (rTMS)|repetitive tms (rtms)
1736379|NCT03394066|Simultaneous TMS and MRI|simultaneous tms and mri
1736380|NCT03394040|Diarrhea|diarrhea
1736381|NCT03394040|Point-of-Need|point-of-need
1736382|NCT03394040|Pathogen Identification|pathogen identification
1736384|NCT03389828|Health Disparities|health disparities
1736385|NCT03389828|Occupational Health|occupational health
1736386|NCT03389828|Behaviors|behaviors
1736387|NCT03387397|Co-morbidities|co-morbidities
1736388|NCT03385798|Endo-GIA Stapler|endo-gia stapler
1736389|NCT03385798|Endowrist Stapler|endowrist stapler
1736393|NCT03381274|EGFR mutated, CD73, A2AR, oleclumab, MEDI9447, AZD4635, osimertinib, NSCLC, immunotherapy|egfr mutated, cd73, a2ar, oleclumab, medi9447, azd4635, osimertinib, nsclc, immunotherapy
1736394|NCT03377634|Older Adults|older adults
1736395|NCT03377634|Physical Activity|physical activity
1736396|NCT03377634|MORPH|morph
1736397|NCT03377634|Telecoaching|telecoaching
1736398|NCT03377634|mHealth|mhealth
1736399|NCT03377634|Weight Loss|weight loss
1736400|NCT03377634|Sedentary Behavior|sedentary behavior
1736401|NCT03377634|Pain|pain
1736402|NCT03377634|Design|design
1736403|NCT03377634|RCT|rct
1736404|NCT03377634|Randomized Controlled Trial|randomized controlled trial
1736405|NCT03378479|Influenza|influenza
1736406|NCT03372733|Omega-7|omega-7
1736407|NCT03372733|Palmitoleic Acid|palmitoleic acid
1736408|NCT03372733|Monounsaturated Fatty Acids|monounsaturated fatty acids
1736409|NCT03372733|Lipoproteins|lipoproteins
1736410|NCT03372733|Satiety|satiety
1736411|NCT03372057|Lymphoma|lymphoma
1736412|NCT03372057|T-cell Lymphoma|t-cell lymphoma
1736413|NCT03372057|Relapse|relapse
1736414|NCT03372057|Refractory|refractory
1736415|NCT03372057|PI3K-δ,γ|pi3k-δ,γ
1736416|NCT03369236|factor D|factor d
1736417|NCT03369236|fD|fd
1736418|NCT03369236|alternative pathway|alternative pathway
1736419|NCT03369236|complement mediated disease|complement mediated disease
1736420|NCT03369236|Membranoproliferative Glomerulonephritis|membranoproliferative glomerulonephritis
1736421|NCT03369236|Primary MPGN|primary mpgn
1736422|NCT03369236|MPGN|mpgn
1736423|NCT03369236|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
1736424|NCT03369236|idiopathic MPGN|idiopathic mpgn
1736425|NCT03369236|DDD|ddd
1736426|NCT03369236|C3GN|c3gn
1736427|NCT03367754|Immunotherapy|immunotherapy
1736428|NCT03367754|Immunologic Non-Responder|immunologic non-responder
1736429|NCT03367754|Immunologic Response|immunologic response
1736430|NCT03367754|Randomized|randomized
1736431|NCT03367754|PD-1|pd-1
1736432|NCT03366168|Diabetes|diabetes
1736433|NCT03366168|Fungiform Papillae|fungiform papillae
1736434|NCT03366168|Insulin|insulin
1736435|NCT03366142|Autosomal Recessive Disorder|autosomal recessive disorder
1736436|NCT03366142|Bacterial Infections|bacterial infections
1736437|NCT03366142|Gingival|gingival
1736438|NCT03366142|Oral Ulcer|oral ulcer
1736439|NCT03366142|Cytokine Expression|cytokine expression
1736440|NCT03366129|CEREBROVASCULAR DISEASE|cerebrovascular disease
1736441|NCT03366129|Vascular Cognitive Impairment|vascular cognitive impairment
1736442|NCT03366129|Stroke|stroke
1736443|NCT03366129|Permeability Imaging|permeability imaging
1736444|NCT03366116|Pharmacodynamics|pharmacodynamics
1736445|NCT03366116|DNA Methylation|dna methylation
1736446|NCT03366116|Pharmacokinetics|pharmacokinetics
1736447|NCT03366116|NUCLEOSIDE ANALOG|nucleoside analog
1736448|NCT03366116|Epigenetics|epigenetics
1736449|NCT03366155|Unresectable Liver Tumor|unresectable liver tumor
1736450|NCT03366155|Response Rates|response rates
1736451|NCT03366155|Progression-Free Survival|progression-free survival
1736452|NCT03366155|Patient Survival|patient survival
1736453|NCT03363945|kidney transplant|kidney transplant
1736454|NCT03363945|cellular therapy|cellular therapy
1736455|NCT03363945|anti-rejection therapy|anti-rejection therapy
1736456|NCT03363945|living donor|living donor
1736457|NCT03363945|HLA-matched|hla-matched
1736458|NCT03363945|hematopoietic stem cells (HSC)|hematopoietic stem cells (hsc)
1736459|NCT03363945|CD34+|cd34+
1736460|NCT03363945|CD3+|cd3+
1736461|NCT03363945|T cells|t cells
1736462|NCT03362814|HCV|hcv
1736463|NCT03362814|Ravidasvir|ravidasvir
1736464|NCT03362814|SVR12|svr12
1736465|NCT03360721|mCRPC|mcrpc
1736466|NCT03360721|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
1736467|NCT03360721|nonsteroidal antiandrogen|nonsteroidal antiandrogen
1736468|NCT03360721|androgen signaling|androgen signaling
1736469|NCT03359642|Microbiota|microbiota
1736470|NCT03359642|inflammatory bowel disease|inflammatory bowel disease
1736471|NCT03359642|inflammation|inflammation
1736472|NCT03359642|anti-TNF alpha|anti-tnf alpha
1736473|NCT03354390|genetically modified lymphocytes|genetically modified lymphocytes
1736474|NCT03354390|tumor antigens|tumor antigens
1736475|NCT03354390|T cell receptor immunotherapy|t cell receptor immunotherapy
1736476|NCT03354390|genomic retroviral elements|genomic retroviral elements
1736477|NCT03350620|child, myopia, nearsightedness|child, myopia, nearsightedness
1736478|NCT03349151|Postoperative maternal feeding, cesarean section|postoperative maternal feeding, cesarean section
1736479|NCT03347214|dbGaP|dbgap
1736480|NCT03345095|Marizomib|marizomib
1736481|NCT03345095|Temozolomide|temozolomide
1736482|NCT03345095|Glioblastoma|glioblastoma
1736483|NCT03345095|Phase III|phase iii
1736484|NCT03340727|Moderate preterm infant|moderate preterm infant
1736485|NCT03340727|Caffeine citrate|caffeine citrate
1736486|NCT03340220|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1736487|NCT03333694|Cutaneous Squamous Cell Carcinoma (cSCC) in situ, mTOR kinase inhibitors, PI3K inhibitor.|cutaneous squamous cell carcinoma (cscc) in situ, mtor kinase inhibitors, pi3k inhibitor.
1736488|NCT03327883|Diagnostic Imaging|diagnostic imaging
1736489|NCT03327883|Review of Patients Records|review of patients records
1736490|NCT03327883|PET MRI|pet mri
1736491|NCT03327883|Treatment Responses|treatment responses
1736492|NCT03327870|Sjogren's Syndrome|sjogren's syndrome
1736493|NCT03327870|Sicca|sicca
1736494|NCT03325582|Perianal Fistula Crohn's disease, MRI|perianal fistula crohn's disease, mri
1736495|NCT03325439|Electroencephalographic neonatal seizures|electroencephalographic neonatal seizures
1736496|NCT03325439|Brivaracetam|brivaracetam
1736497|NCT03325439|Epilepsy|epilepsy
1736498|NCT03325439|ENS|ens
1736499|NCT03325439|Newborns|newborns
1736500|NCT03325439|Pharmacokinetic|pharmacokinetic
1736501|NCT03324516|pterional incision|pterional incision
1736502|NCT03324516|Temporal hollowing|temporal hollowing
1736503|NCT03318939|EGFR|egfr
1736504|NCT03318939|HER2|her2
1736505|NCT03318939|Exon 20 insertion mutation|exon 20 insertion mutation
1736506|NCT03309033|Vaccine Efficacy|vaccine efficacy
1736507|NCT03309033|Immune Response|immune response
1736508|NCT03309033|Long-Term Protection|long-term protection
1736510|NCT03309020|Cataracts|cataracts
1736511|NCT03309020|Visual Acuity|visual acuity
1736512|NCT03307317|Near Infrared Spectroscopy|near infrared spectroscopy
1736513|NCT03307317|EEG|eeg
1736514|NCT03307317|Functional Brain Activity|functional brain activity
1736515|NCT03307317|Neurodevelopment|neurodevelopment
1736516|NCT03304665|Healthy Volunteers|healthy volunteers
1736517|NCT03304665|Mental Health|mental health
1736518|NCT03304665|Common Data Elements|common data elements
1736519|NCT03304704|Assays|assays
1736520|NCT03304704|Direct Skin Feeds|direct skin feeds
1736521|NCT03304704|Infection|infection
1736522|NCT03304704|Parasite|parasite
1736523|NCT03304704|Gametocyte|gametocyte
1736524|NCT03304691|Malaria|malaria
1736525|NCT03304691|Parasitemia|parasitemia
1736526|NCT03304691|Anemia|anemia
1736527|NCT03304691|Ligand|ligand
1736528|NCT03304691|Anopheles gambiae|anopheles gambiae
1736529|NCT03300856|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1736530|NCT03300856|Electrophysiology|electrophysiology
1736531|NCT03294460|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1736532|NCT03294460|Alcohol Use|alcohol use
1736533|NCT03294460|Polymorphism, Genetic|polymorphism, genetic
1736534|NCT03294460|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1736535|NCT03289923|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1736536|NCT03289923|Major Depressive Disorder|major depressive disorder
1736537|NCT03289923|Cognitive Therapy|cognitive therapy
1736538|NCT03288220|Stroke|stroke
1736539|NCT03288207|Community-Based Participatory Research|community-based participatory research
1736540|NCT03288207|Obesity|obesity
1736541|NCT03288207|Cardiovascular Disease Risk|cardiovascular disease risk
1736542|NCT03288207|Social Determinants of Health|social determinants of health
1736543|NCT03288714|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1736544|NCT03288714|TMS|tms
1736545|NCT03288714|sTMS|stms
1736546|NCT03283917|Amyloid light chain (AL) amyloidosis|amyloid light chain (al) amyloidosis
1736547|NCT03283917|Daratumumab|daratumumab
1736548|NCT03283917|Ixazomib|ixazomib
1736549|NCT03283917|Dexamethasone|dexamethasone
1736550|NCT03283917|MLN 9708|mln 9708
1736551|NCT03283917|MLN9708|mln9708
1736552|NCT03283917|Decadron|decadron
1736553|NCT03282318|Bladder Pain Syndrome|bladder pain syndrome
1736554|NCT03282318|Interstitial Cystitis|interstitial cystitis
1736555|NCT03282318|ASP6294|asp6294
1736556|NCT03278912|Inflammatory Bowel Disease|inflammatory bowel disease
1736557|NCT03278912|Chronic Granulomatous Disease|chronic granulomatous disease
1736558|NCT03278912|Dysbiosis|dysbiosis
1736559|NCT03278912|Microbiome|microbiome
1736560|NCT03278912|Immunodeficiency|immunodeficiency
1736561|NCT03273907|CyPass Micro-Stent|cypass micro-stent
1736562|NCT03273751|Remote Ischemic Preconditioning|remote ischemic preconditioning
1736563|NCT03273751|Partial nephrectomy|partial nephrectomy
1736564|NCT03273751|Acute kidney injury|acute kidney injury
1736565|NCT03272503|Pimozide|pimozide
1736566|NCT03269032|Mediterranean diet|mediterranean diet
1736567|NCT03269032|gut microbiome|gut microbiome
1736568|NCT03269032|gastrointestinal|gastrointestinal
1736569|NCT03267277|Calcinosis|calcinosis
1736570|NCT03267277|Dermatomyositis|dermatomyositis
1736571|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
1736572|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
1736573|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
1736574|NCT03259503|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
1736575|NCT03259503|Lymphoma|lymphoma
1736576|NCT03259503|Refractory|refractory
1736577|NCT03259503|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1736578|NCT03259503|DLBCL|dlbcl
1736579|NCT03259503|Palifermin|palifermin
1736580|NCT03259503|Kepivance|kepivance
1736581|NCT03259503|Olaparib|olaparib
1736582|NCT03259503|Lynparza|lynparza
1736583|NCT03259503|Vorinostat|vorinostat
1736584|NCT03259503|SAHA|saha
1736585|NCT03259503|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1736586|NCT03259503|MSK-390|msk-390
1736587|NCT03259503|Zolinza|zolinza
1736588|NCT03259503|Dexamethasone|dexamethasone
1736589|NCT03259503|Decadron|decadron
1736590|NCT03259503|Rituximab|rituximab
1736672|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1736673|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1736674|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
1736675|NCT03223636|Magnetoencephalogram|magnetoencephalogram
1736676|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
1736677|NCT03223610|Monoclonal Antibody|monoclonal antibody
1736678|NCT03223610|Dose-Finding|dose-finding
1736679|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
1736680|NCT03223662|Esophagectomy|esophagectomy
1736681|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
1736682|NCT03223038|Nutrition|nutrition
1736683|NCT03209609|Coronary artery bypass|coronary artery bypass
1736684|NCT03206086|DNA Repair|dna repair
1736685|NCT03206086|Bone Marrow|bone marrow
1736686|NCT03206086|Hematopoiesis|hematopoiesis
1736687|NCT03206086|Pancytopenia|pancytopenia
1736688|NCT03206086|Thrombocytopenia|thrombocytopenia
1736689|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
1736690|NCT03202498|Fibrosis, Liver|fibrosis, liver
1736691|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
1736692|NCT03202498|Liver Fibrosis|liver fibrosis
1736693|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1736694|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
1736695|NCT03195322|Pain Control|pain control
1736696|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
1736697|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
1736698|NCT03194854|e-Health|e-health
1736699|NCT03194854|self-efficacy theory|self-efficacy theory
1736700|NCT03194854|mixture modeling|mixture modeling
1736701|NCT03194854|mobile health|mobile health
1736702|NCT03194854|complier average causal effect estimation|complier average causal effect estimation
1736703|NCT03188991|pancreatic cystic neoplasm|pancreatic cystic neoplasm
1736704|NCT03188991|pancreatic cyst|pancreatic cyst
1736705|NCT03188991|pancreatic mucinous cyst|pancreatic mucinous cyst
1736706|NCT03188991|pancreatic neoplasms|pancreatic neoplasms
1736707|NCT03188991|digestive system neoplasms|digestive system neoplasms
1736708|NCT03188991|pancreatic diseases|pancreatic diseases
1736709|NCT03188991|mucinous cystic neoplasm|mucinous cystic neoplasm
1736710|NCT03188419|Prospective Donors|prospective donors
1736711|NCT03188419|Immunodeficiency|immunodeficiency
1736712|NCT03188406|Intestinal Metaplasia|intestinal metaplasia
1736713|NCT03188406|Epidemiology|epidemiology
1736714|NCT03188406|Risk Stratification|risk stratification
1736715|NCT03188406|Helicobacter Pylori|helicobacter pylori
1736716|NCT03180034|Human Papillomavirus|human papillomavirus
1736717|NCT03180034|Cervical Cancer|cervical cancer
1736718|NCT03180034|Costa Rica|costa rica
1736719|NCT03180034|Fewer Doses|fewer doses
1736720|NCT03180034|HPV-Associated Cancers|hpv-associated cancers
1736721|NCT03181321|nutrition|nutrition
1736722|NCT03181321|fitness|fitness
1736723|NCT03181321|cardiovascular disease|cardiovascular disease
1736724|NCT03181321|firefighters|firefighters
1736725|NCT03181321|obesity|obesity
1736726|NCT03181321|injury|injury
1736727|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
1736728|NCT03177109|Fluoride varnish|fluoride varnish
1736729|NCT03177109|Desensitizing agents|desensitizing agents
1736730|NCT03173573|Cystic Fibrosis|cystic fibrosis
1736731|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
1736732|NCT03173963|Kidney Biopsy|kidney biopsy
1736733|NCT03173963|Morphometry|morphometry
1736734|NCT03173963|American Indians|american indians
1736735|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
1736736|NCT03167450|CRISPR|crispr
1736737|NCT03167450|Gene Editing|gene editing
1736738|NCT03167450|Qualitative|qualitative
1736739|NCT03167450|Participation Clinical Trials|participation clinical trials
1736740|NCT03167450|Genetic Literacy|genetic literacy
1736741|NCT03165734|myelofibrosis|myelofibrosis
1736742|NCT03165734|pacritinib|pacritinib
1736743|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1736744|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1736745|NCT03165734|Ruxolitinib|ruxolitinib
1736746|NCT03165734|Bone Marrow Disease|bone marrow disease
1736747|NCT03165734|Hematologic Diseases|hematologic diseases
1736748|NCT03165734|Blood Platelet Disorders|blood platelet disorders
1736749|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
1736750|NCT03165734|Splenomegaly|splenomegaly
1736751|NCT03165734|Anemia|anemia
1736752|NCT03165734|Spleen volume|spleen volume
1736753|NCT03165734|Spleen|spleen
1736754|NCT03157128|LOXO-292|loxo-292
1736755|NCT03157128|KIF5B-RET|kif5b-ret
1736756|NCT03157128|M918T|m918t
1736757|NCT03157128|CCDC6-RET|ccdc6-ret
1736758|NCT03157128|RET-PTC1|ret-ptc1
1736759|NCT03157128|NCOA4-RET|ncoa4-ret
1736760|NCT03157128|RET-PTC|ret-ptc
1736761|NCT03157128|RET-PTC3|ret-ptc3
1736762|NCT03157128|RET-PTC4|ret-ptc4
1736763|NCT03157128|PRKAR1A-RET|prkar1a-ret
1736764|NCT03157128|RET-PTC2|ret-ptc2
1736765|NCT03157128|GOLGA5-RET|golga5-ret
1736766|NCT03157128|RET-PTC5|ret-ptc5
1736767|NCT03157128|ERC1-RET|erc1-ret
1736768|NCT03157128|KTN1-RET|ktn1-ret
1736840|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1736841|NCT03157128|Cancer of Lung|cancer of lung
1736842|NCT03157128|Cancer of the Lung|cancer of the lung
1736843|NCT03157128|Lung Cancer|lung cancer
1736844|NCT03157128|Neoplasms, Lung|neoplasms, lung
1736845|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
1736846|NCT03157128|Pulmonary Cancer|pulmonary cancer
1736847|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
1736848|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
1736849|NCT03157128|Lung Diseases|lung diseases
1736850|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
1736851|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1736852|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
1736853|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
1736854|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
1736855|NCT03157128|Thyroid Diseases|thyroid diseases
1736856|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
1736857|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
1736858|NCT03157128|Cancer of Thyroid|cancer of thyroid
1736859|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
1736860|NCT03157128|Thyroid Ademona|thyroid ademona
1736861|NCT03157128|Thyroid Cancer|thyroid cancer
1736862|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
1736863|NCT03157128|Endocrine System Diseases|endocrine system diseases
1736864|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
1736865|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
1736866|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
1736867|NCT03157128|CNS tumor|cns tumor
1736868|NCT03157128|Primary CNS tumor|primary cns tumor
1736869|NCT03157128|Cancer of Colon|cancer of colon
1736870|NCT03157128|Cancer of the Colon|cancer of the colon
1736871|NCT03157128|Colon Cancer|colon cancer
1736872|NCT03157128|Colon Neoplasms|colon neoplasms
1736873|NCT03157128|Colonic Cancer|colonic cancer
1736874|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
1736875|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
1736876|NCT03157128|Mammary Cancer|mammary cancer
1736877|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
1736878|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
1736879|NCT03157128|Neoplasms, Breast|neoplasms, breast
1736880|NCT03157128|Tumors, Breast|tumors, breast
1736881|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
1736882|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
1736883|NCT03157128|Breast Carcinoma|breast carcinoma
1736884|NCT03157128|Breast Tumors|breast tumors
1736885|NCT03157128|Cancer of the Breast|cancer of the breast
1736886|NCT03157128|Breast Neoplasms|breast neoplasms
1736887|NCT03157128|Breast Cancer|breast cancer
1736888|NCT03152760|Alcoholism|alcoholism
1736889|NCT03152760|Healthy Volunteers|healthy volunteers
1736890|NCT03152760|Craving|craving
1736892|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
1736893|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
1736894|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
1736895|NCT03150862|astrocytoma|astrocytoma
1736896|NCT03150862|neuroepithelial|neuroepithelial
1736897|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
1736898|NCT03150862|germ cell and embryonal|germ cell and embryonal
1736899|NCT03150862|antineoplastic agents|antineoplastic agents
1736900|NCT03150862|glandular and epithelial|glandular and epithelial
1736901|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
1736902|NCT03150862|temozolomide|temozolomide
1736903|NCT03150862|BGB-290|bgb-290
1736904|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
1736905|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
1736906|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
1736907|NCT03150862|enzyme inhibitors|enzyme inhibitors
1736908|NCT03150810|Ovarian cancer|ovarian cancer
1736909|NCT03150810|Triple negative breast cancer|triple negative breast cancer
1736910|NCT03150810|Small cell lung cancer|small cell lung cancer
1736911|NCT03150810|Prostate cancer,|prostate cancer,
1736912|NCT03150810|Gastric cancer|gastric cancer
1736913|NCT03150810|neoplasms|neoplasms
1736914|NCT03150810|temozolomide|temozolomide
1736915|NCT03150810|BGB-290|bgb-290
1736916|NCT03150810|antineoplastic agents|antineoplastic agents
1736917|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
1736918|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
1736919|NCT03150810|enzyme inhibitors|enzyme inhibitors
1736920|NCT03141671|Prostate Cancer|prostate cancer
1736921|NCT03131544|BPH|bph
1736922|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1736923|NCT03131544|MRI|mri
1736924|NCT03131544|Prostate|prostate
1736925|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1736926|NCT03131544|Nocturia|nocturia
1736927|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
1736928|NCT03131362|COPD|copd
1736929|NCT03117309|Nivolumab|nivolumab
1736930|NCT03117309|Ipilimumab|ipilimumab
1736931|NCT03117309|OPDIVO|opdivo
1736932|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
1736933|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
1736934|NCT03111745|VIRAL INFECTION|viral infection
1736935|NCT03111745|Lymphoproliferation|lymphoproliferation
1333106|NCT01444469|Asthma exacerbations|asthma exacerbations
1736936|NCT03110978|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
1736937|NCT03110978|Non-small Cell Lung Cancer|non-small cell lung cancer
1736938|NCT03110978|NSCLC|nsclc
1736939|NCT03110978|Squamous cell carcinoma|squamous cell carcinoma
1736940|NCT03110978|Adenocarcinoma|adenocarcinoma
1736941|NCT03110978|Large cell carcinoma|large cell carcinoma
1736942|NCT03110978|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
1736943|NCT03110978|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1736944|NCT03110978|SABR|sabr
1736945|NCT03110978|Nivolumab|nivolumab
1736946|NCT03110978|BMS-936558|bms-936558
1736947|NCT03110978|Opdivo|opdivo
1736948|NCT03110978|Immunotherapy|immunotherapy
1736949|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
1736950|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
1736951|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
1736952|NCT03109288|Targeted Therapy|targeted therapy
1736953|NCT03109288|Multiple Sclerosis|multiple sclerosis
1736954|NCT03109288|Biomarkers|biomarkers
1736955|NCT03109288|Combination Therapy|combination therapy
1736956|NCT03107026|Binge eating Disorder|binge eating disorder
1736957|NCT03107026|dasotraline|dasotraline
1736958|NCT03099096|SB240563|sb240563
1736959|NCT03099096|Mepolizumab|mepolizumab
1736960|NCT03099096|self-administration|self-administration
1736961|NCT03099096|eosinophilic asthma|eosinophilic asthma
1736962|NCT03099096|autoinjector|autoinjector
1736963|NCT03098862|Ebola Virus|ebola virus
1736964|NCT03098862|Genome-Wide Association Study|genome-wide association study
1736965|NCT03098862|Liberia|liberia
1736966|NCT03098862|Ebola Survivors|ebola survivors
1736967|NCT03098862|Ebola Contacts|ebola contacts
1736968|NCT03092687|Mental Illness|mental illness
1736969|NCT03092687|Aging|aging
1736970|NCT03092687|Normal Development|normal development
1736971|NCT03083873|LN-145|ln-145
1736972|NCT03083873|Cell Therapy|cell therapy
1736973|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
1736974|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
1736975|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
1736976|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1736977|NCT03083873|TIL|til
1736978|NCT03083873|IL-2|il-2
1736979|NCT03080714|no known ocular pathology|no known ocular pathology
1736980|NCT03080714|Glaucoma|glaucoma
1736981|NCT03080714|Retinal Disease|retinal disease
1736982|NCT03080493|Abortion|abortion
1736983|NCT03080493|Osmotic dilators|osmotic dilators
1736984|NCT03080493|Gabapentin|gabapentin
1736985|NCT03080493|Text message|text message
1736986|NCT03077685|pancreatic neoplasms|pancreatic neoplasms
1736987|NCT03077685|digestive system neoplasms|digestive system neoplasms
1736988|NCT03077685|pancreatic diseases|pancreatic diseases
1736989|NCT03077685|digestive system diseases|digestive system diseases
1736990|NCT03077685|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1736991|NCT03077685|pancreatic cancer|pancreatic cancer
1736992|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
1736993|NCT03077542|Host-Donor Chimerism|host-donor chimerism
1736994|NCT03077542|Graft Versus Host Disease|graft versus host disease
1736995|NCT03077542|Haploidentical|haploidentical
1736996|NCT03077542|Donor Apheresis|donor apheresis
1736997|NCT03076567|Epidemiology|epidemiology
1736998|NCT03076567|Cancer|cancer
1736999|NCT03076567|Methylation|methylation
1737000|NCT03076567|Genetics|genetics
1737001|NCT03076567|Screening|screening
1737002|NCT03075150|PVI|pvi
1737003|NCT03075150|Dynamic Cardiac Monitors|dynamic cardiac monitors
1737004|NCT03075150|SVV|svv
1737005|NCT03075150|PPV|ppv
1737006|NCT03072966|Distress|distress
1737007|NCT03072966|Exercise|exercise
1737008|NCT03072966|Wearable device|wearable device
1737009|NCT03072966|Smartphone|smartphone
1737010|NCT03070145|Prostate Cancer|prostate cancer
1737011|NCT03067675|no known ocular pathology|no known ocular pathology
1737012|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
1737013|NCT03063437|VRE|vre
1737014|NCT03063437|decolonization|decolonization
1737015|NCT03063437|VRE colonization|vre colonization
1737016|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
1737017|NCT03063437|FMT|fmt
1737018|NCT03063437|FMT capsule|fmt capsule
1737019|NCT03063437|capsule|capsule
1737020|NCT03063437|antimicrobial resistance|antimicrobial resistance
1737021|NCT03063437|antibiotic resistance|antibiotic resistance
1737022|NCT03063437|MDRO|mdro
1737023|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
1737024|NCT03063437|OpenBiome|openbiome
1737025|NCT03052517|Asthma, QAW039|asthma, qaw039
1737026|NCT03050541|MDMA|mdma
1737027|NCT03050541|adult|adult
1737028|NCT03047707|ultrasound elastography|ultrasound elastography
1737029|NCT03047707|S-Shearwave|s-shearwave
1737030|NCT03047707|liver|liver
1737031|NCT03047707|fibrosis|fibrosis
1737045|NCT03025256|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
1737046|NCT03025256|Leptomeningeal disease|leptomeningeal disease
1737047|NCT03025256|LMD|lmd
1737048|NCT03025256|Nivolumab|nivolumab
1737049|NCT03025256|BMS-936558|bms-936558
1737050|NCT03025256|Opdivo|opdivo
1737051|NCT03020134|pharmacokinetics|pharmacokinetics
1737052|NCT03020134|Danoprevir/r|danoprevir/r
1737053|NCT03020134|Ravidasvir|ravidasvir
1737054|NCT03019419|sporadic ALS|sporadic als
1737055|NCT03019419|perampanel|perampanel
1737056|NCT03016975|Edwards Cardioband|edwards cardioband
1737057|NCT03016975|Mitral Valve|mitral valve
1737058|NCT03016975|Transcatheter|transcatheter
1737059|NCT03016975|Mitral repair|mitral repair
1737060|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
1737061|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
1737062|NCT03016975|Annuloplasty|annuloplasty
1737063|NCT03016572|Suicide|suicide
1737064|NCT03016572|Adolescent|adolescent
1737065|NCT03016572|Intervention|intervention
1737066|NCT03016572|Crisis|crisis
1737067|NCT03016572|Follow-Up|follow-up
1737068|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
1737069|NCT03003065|Photodynamic therapy|photodynamic therapy
1737070|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1737071|NCT03002974|Gout|gout
1737072|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
1737073|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
1737074|NCT02996773|high-risk malignancies|high-risk malignancies
1737075|NCT02996773|Lymphoma|lymphoma
1737076|NCT02996773|Haploidentical|haploidentical
1737077|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
1737078|NCT02996773|Post-transplant|post-transplant
1737079|NCT02996773|myeloablative (MAC)|myeloablative (mac)
1737080|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
1737081|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
1737082|NCT02996773|Leukemia|leukemia
1737083|NCT02996695|Chemoprophylaxis|chemoprophylaxis
1737084|NCT02996695|Chloroquine|chloroquine
1737085|NCT02996695|Cryopreserved|cryopreserved
1737086|NCT02996695|Malaria|malaria
1737087|NCT02996695|Plasmodium|plasmodium
1737088|NCT02996695|Sporozoites|sporozoites
1737089|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
1737090|NCT02976753|Hematologic Diseases|hematologic diseases
1737091|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
1737092|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
1737093|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
1737094|NCT02973958|Penis|penis
1737095|NCT02973958|Pain|pain
1737096|NCT02973958|Ketorolac|ketorolac
1737097|NCT02973958|Circumcision|circumcision
1737098|NCT02973048|Cesarean delivery|cesarean delivery
1737099|NCT02973048|Spinal anesthesia|spinal anesthesia
1737100|NCT02973048|Local anesthetics|local anesthetics
1737101|NCT02971618|dapagliflozin,|dapagliflozin,
1737102|NCT02971618|Russia,|russia,
1737103|NCT02971618|retrospective study,|retrospective study,
1737104|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
1737105|NCT02953561|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
1737106|NCT02953561|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
1737107|NCT02953561|Acute Myeloid Leukemia|acute myeloid leukemia
1737108|NCT02953561|AML|aml
1737109|NCT02953561|Avelumab|avelumab
1737110|NCT02953561|antiPDL1|antipdl1
1737111|NCT02953561|5-azacytidine|5-azacytidine
1737112|NCT02953561|Azacitidine|azacitidine
1737113|NCT02953561|5-aza|5-aza
1737114|NCT02953561|Vidaza|vidaza
1737115|NCT02953561|5-AZC|5-azc
1737116|NCT02953561|AZA-CR|aza-cr
1737117|NCT02953561|Ladakamycin|ladakamycin
1737118|NCT02953561|NSC-102816|nsc-102816
1737119|NCT02953561|Azacytidine|azacytidine
1737120|NCT02948413|Traumatic Stress|traumatic stress
1737121|NCT02948413|Oncology|oncology
1737122|NCT02948413|Lymphoma|lymphoma
1737123|NCT02948413|Leukemia|leukemia
1737124|NCT02940626|Pneumonia|pneumonia
1737125|NCT02940626|S. aureus|s. aureus
1737126|NCT02940626|Mechanically ventilated|mechanically ventilated
1737127|NCT02939183|Multiple Myeloma|multiple myeloma
1737128|NCT02938598|maternal depression|maternal depression
1737129|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
1737130|NCT02938598|maternal health services|maternal health services
1737131|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1737132|NCT02936791|ADPKD|adpkd
1737133|NCT02936791|PKD biomarkers|pkd biomarkers
1626177|NCT00297180|obesity|obesity
1737135|NCT02936791|University of Kansas Medical Center|university of kansas medical center
1737136|NCT02935231|minimal cessation advice|minimal cessation advice
1737137|NCT02935231|proactive|proactive
1737138|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
1737139|NCT02935231|smoking hotspots|smoking hotspots
1737140|NCT02924129|Chronic Pain|chronic pain
1737141|NCT02924129|Back Pain|back pain
1737142|NCT02924129|Leg Pain|leg pain
1737143|NCT02924129|Pain|pain
1737144|NCT02924129|Neurologic Manifestations|neurologic manifestations
1737145|NCT02924129|Nervous System Diseases|nervous system diseases
1737146|NCT02924129|Signs and Symptoms|signs and symptoms
1737147|NCT02924129|SCS|scs
1737148|NCT02924129|Closed Loop|closed loop
1737149|NCT02921737|metastatic|metastatic
1737150|NCT02921737|pancreatic|pancreatic
1737151|NCT02921737|adenocarcinoma|adenocarcinoma
1737152|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1737153|NCT02913105|NASH|nash
1737154|NCT02913105|Fatty liver disease|fatty liver disease
1737155|NCT02895386|Hypertension|hypertension
1737156|NCT02895386|High Blood Pressure|high blood pressure
1737157|NCT02895386|Systolic Blood Pressure|systolic blood pressure
1737158|NCT02895386|Uncontrolled Hypertension|uncontrolled hypertension
1737159|NCT02895386|Essential Hypertension|essential hypertension
1737160|NCT02895386|Resistant Hypertension|resistant hypertension
1737161|NCT02895386|Vascular Disease|vascular disease
1737162|NCT02891070|Cranial Surgery|cranial surgery
1737163|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
1737164|NCT02891070|Tisseel|tisseel
1737165|NCT02875223|Safety|safety
1737166|NCT02875223|CC-90011|cc-90011
1737167|NCT02875223|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
1737168|NCT02875223|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
1737169|NCT02859350|Plasmodium falciparum|plasmodium falciparum
1737170|NCT02859350|PfSPZ Vaccine|pfspz vaccine
1737171|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
1737172|NCT02859350|CHMI|chmi
1737173|NCT02859350|Chloroquine|chloroquine
1737174|NCT02859350|Chemoprophylaxis|chemoprophylaxis
1737175|NCT02859350|PfSPZ-CVac|pfspz-cvac
1737176|NCT02854540|hyperhidrosis|hyperhidrosis
1737177|NCT02854540|palmar|palmar
1737178|NCT02854540|sweating|sweating
1737179|NCT02854540|iontophoresis|iontophoresis
1737180|NCT02854540|sweat gland diseases|sweat gland diseases
1737181|NCT02854540|skin diseases|skin diseases
1737182|NCT02851407|stem cell transplant|stem cell transplant
1737183|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1737184|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
1737185|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
1737186|NCT02834884|rare cancer|rare cancer
1737187|NCT02834884|biomarker|biomarker
1737188|NCT02834884|molecular screening|molecular screening
1737189|NCT02834884|cancer|cancer
1737190|NCT02834884|biobanking|biobanking
1737191|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
1737192|NCT02831699|Zika|zika
1737193|NCT02831699|Guillain Barré|guillain barré
1737194|NCT02828592|SAA|saa
1737195|NCT02828384|fodmap diet|fodmap diet
1737196|NCT02823769|clinical study|clinical study
1737197|NCT02823769|dental fillings|dental fillings
1737198|NCT02821416|asthma|asthma
1737199|NCT02816697|Smoking Habits|smoking habits
1737200|NCT02803411|Coronary Heart Disease|coronary heart disease
1737201|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
1737202|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
1737203|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
1737204|NCT02795936|rehabilitation|rehabilitation
1737205|NCT02795936|exercise|exercise
1737206|NCT02790996|sepsis|sepsis
1737207|NCT02790996|neonate|neonate
1737208|NCT02790996|vancomycin|vancomycin
1737209|NCT02790736|propranolol|propranolol
1737210|NCT02790736|public speaking anxiety|public speaking anxiety
1737211|NCT02790710|propanolol|propanolol
1737212|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
1737213|NCT02787369|Refractory Leukemia|refractory leukemia
1737214|NCT02787369|Leukemia|leukemia
1737215|NCT02771197|AML|aml
1737216|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
1737217|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
1737218|NCT02749877|Pediatric Cancer|pediatric cancer
1737219|NCT02749877|Training|training
1737220|NCT02749877|Working Memory|working memory
1737221|NCT02749877|Physical Activity|physical activity
1737222|NCT02749877|Brain Tumor|brain tumor
1737223|NCT02749877|Physical Exercise|physical exercise
1737224|NCT02746003|drinking water|drinking water
1737225|NCT02746003|salinity|salinity
1737226|NCT02743377|GsI+/-|gsi+/-
1737227|NCT02743377|Camp|camp
1737228|NCT02743377|GNAS|gnas
1737229|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1737230|NCT02723331|Perioperative Therapy|perioperative therapy
940016|NCT03545373|TB|tb
1737231|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
1737232|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
1737233|NCT02723331|Nab-paclitaxel|nab-paclitaxel
1737234|NCT02723331|Abraxane|abraxane
1737235|NCT02723331|Gemcitabine|gemcitabine
1737236|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
1737237|NCT02723331|Adjuvant Therapy|adjuvant therapy
1737238|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1737239|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
1737240|NCT02717104|femoropopliteal|femoropopliteal
1737747|NCT01881048|Surgery|surgery
1737241|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1737242|NCT02715011|JNJ-63709178|jnj-63709178
1737243|NCT02713022|DEXA Scan|dexa scan
1737244|NCT02713022|15-235|15-235
1737245|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
1737246|NCT02709226|Brain Tumor|brain tumor
1737247|NCT02709226|Astrocytoma|astrocytoma
1737249|NCT02709226|Radiation Therapy|radiation therapy
1737250|NCT02706353|Melanoma|melanoma
1737251|NCT02706353|Metastatic Melanoma|metastatic melanoma
1737252|NCT02706353|Intratumoral APX005M|intratumoral apx005m
1737253|NCT02706353|Pembrolizumab|pembrolizumab
1737254|NCT02706353|Keytruda|keytruda
1737255|NCT02706353|MK-3475|mk-3475
1737256|NCT02706353|SCH-900475|sch-900475
1737257|NCT02705482|Advanced solid tumors|advanced solid tumors
1737258|NCT02705482|MEDI0562|medi0562
1737259|NCT02705482|durvalumab|durvalumab
1737260|NCT02705482|tremelimumab|tremelimumab
1737261|NCT02705482|OX40|ox40
1737262|NCT02705482|PD-L1|pd-l1
1737263|NCT02705482|CTLA-4|ctla-4
1737264|NCT02705482|immuno-oncology|immuno-oncology
1737265|NCT02705482|Cancer|cancer
1737266|NCT02704624|Crohn Disease|crohn disease
1737267|NCT02704624|Fatigue|fatigue
1737268|NCT02704624|Osteopenia|osteopenia
1737269|NCT02704624|Exercise Tolerance|exercise tolerance
1737270|NCT02704624|Vitamin d|vitamin d
1737271|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1737272|NCT02703272|Ibrutinib|ibrutinib
1737273|NCT02703272|JNJ-54179060|jnj-54179060
1737274|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
1737275|NCT02694796|Connected devices|connected devices
1737276|NCT02694796|Balneotherapy|balneotherapy
1737277|NCT02692560|Sedentary time|sedentary time
1737278|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
1737279|NCT02689817|Pressure ulcer|pressure ulcer
1737280|NCT02689817|Monitoring|monitoring
1737281|NCT02689817|Pressure|pressure
1737282|NCT02689817|Physiologic feedback|physiologic feedback
1737283|NCT02682368|Surgeon performed ultrasound|surgeon performed ultrasound
1737284|NCT02682368|Point of care ultrasound|point of care ultrasound
1737285|NCT02668354|Childhood Cancer|childhood cancer
1737286|NCT02668354|Pediatric Oncology|pediatric oncology
1737287|NCT02668354|Infant tumors|infant tumors
1737288|NCT02665676|Childhood Cancer|childhood cancer
1737289|NCT02665676|Pediatric Oncology|pediatric oncology
1737290|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
1737291|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
1737292|NCT02665676|Embryonic Tumors|embryonic tumors
1737293|NCT02665676|Embryonal Tumors|embryonal tumors
1737294|NCT02659813|Orthodontic wires|orthodontic wires
1737295|NCT02649764|Acute Myelogenous Leukemia|acute myelogenous leukemia
1737296|NCT02649764|AML|aml
1737297|NCT02649764|Relapsed/Refractory|relapsed/refractory
1737298|NCT02649764|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1737299|NCT02649764|HRMDS|hrmds
1737300|NCT02649764|LY2606368|ly2606368
1737301|NCT02649764|Fludarabine|fludarabine
1737302|NCT02649764|Fludarabine Phosphate|fludarabine phosphate
1737303|NCT02649764|Fludara|fludara
1737304|NCT02649764|Cytarabine|cytarabine
1737305|NCT02649764|Ara-C|ara-c
1737306|NCT02649764|Cytosar|cytosar
1737307|NCT02649764|DepoCyt|depocyt
1737308|NCT02649764|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1737309|NCT02633306|trigeminal region pain|trigeminal region pain
1737310|NCT02624869|Hypercholesterolemia|hypercholesterolemia
1737311|NCT02624869|Elevated Cholesterol|elevated cholesterol
1737312|NCT02624869|High Cholesterol|high cholesterol
1737313|NCT02624869|PCSK9 mutations|pcsk9 mutations
1737314|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
1737315|NCT02624869|evolocumab|evolocumab
1737316|NCT02624869|Repatha|repatha
1737317|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1737318|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1737319|NCT02624869|Pediatric|pediatric
1737320|NCT02624869|Paediatric|paediatric
1737321|NCT02621021|Melanoma|melanoma
1737322|NCT02621021|Skin Cancer|skin cancer
1737323|NCT02621021|Immunotherapy|immunotherapy
1737324|NCT02621021|Cell Therapy|cell therapy
1737325|NCT02620813|acne|acne
1737326|NCT02620813|sebaceous gland|sebaceous gland
940101|NCT03544762|PET|pet
1737328|NCT02620813|sebum|sebum
1737329|NCT02619838|Double Arthrodesis|double arthrodesis
1737330|NCT02619838|Triple Arthrodesis|triple arthrodesis
1737331|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
1737332|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
1737333|NCT02613169|isoniazid|isoniazid
1737334|NCT02613169|HIV-exposed infants|hiv-exposed infants
1737335|NCT02603887|Smoldering Multiple Myeloma|smoldering multiple myeloma
1737336|NCT02603887|SMM|smm
1737337|NCT02603887|Intermediate or high-risk|intermediate or high-risk
1737338|NCT02603887|Pembrolizumab|pembrolizumab
1737339|NCT02603887|Keytruda|keytruda
1737340|NCT02603887|MK-3475|mk-3475
1737341|NCT02603887|SCH-900475|sch-900475
1737342|NCT02598518|Integrating Combined Therapies|integrating combined therapies
1737343|NCT02598518|Alcohol Use Disorder|alcohol use disorder
1737344|NCT02598518|Mental Health Disorder|mental health disorder
1737345|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
1737346|NCT02598661|Imetelstat|imetelstat
1737347|NCT02594189|Influenza A|influenza a
1737348|NCT02594189|H3N2|h3n2
1737349|NCT02594189|Challenge Model|challenge model
1737350|NCT02594189|Influenza|influenza
1737351|NCT02594189|Human Challenge|human challenge
1737352|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
1737353|NCT02586857|GBM|gbm
1737354|NCT02581007|CML|cml
1737355|NCT02581007|AML|aml
1737356|NCT02581007|MDS|mds
1737357|NCT02581007|ALL|all
1737358|NCT02581007|CLL/CPL|cll/cpl
1737359|NCT02581007|HD|hd
1737360|NCT02581007|NHL|nhl
1737361|NCT02581007|MPS|mps
1737362|NCT02581007|CMML|cmml
1737363|NCT02581007|MM|mm
1737364|NCT02564991|Alcoholism|alcoholism
1737365|NCT02564991|MRI|mri
1737366|NCT02564991|Structural MRI|structural mri
1737367|NCT02564991|Cerebellum|cerebellum
1737368|NCT02560129|recovery|recovery
1737369|NCT02560129|ICU|icu
1737370|NCT02560129|clinic|clinic
1737371|NCT02560129|survivor|survivor
1737372|NCT02560129|physical function|physical function
1737373|NCT02559427|sleep apnea|sleep apnea
1737374|NCT02559427|Venous Insufficiency|venous insufficiency
1737375|NCT02559427|SPA treatment|spa treatment
1737376|NCT02558647|therapy|therapy
1737377|NCT02558647|CBT-I|cbt-i
1737378|NCT02558647|internet-based|internet-based
1737379|NCT02558647|online|online
1737380|NCT02558647|short-term benefits|short-term benefits
1737381|NCT02558647|medium-term outcomes|medium-term outcomes
1737382|NCT02558647|health resource use|health resource use
1737383|NCT02558647|sick leave|sick leave
1737384|NCT02557243|Childhood Cancer|childhood cancer
1737385|NCT02557243|Soft Tissue Tumors|soft tissue tumors
1737386|NCT02557243|Bone Tumors|bone tumors
1737387|NCT02557243|Extremity Tumor|extremity tumor
1737388|NCT02557243|Pediatric Oncology|pediatric oncology
1737389|NCT02557230|Childhood Cancer|childhood cancer
1737390|NCT02557230|Genitourinary tumors|genitourinary tumors
1737391|NCT02557230|urogenital tumors|urogenital tumors
1737392|NCT02557230|Pediatric Oncology|pediatric oncology
1737393|NCT02556229|Aflibercept|aflibercept
1737394|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
1737395|NCT02556229|young patient|young patient
1737396|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
1737397|NCT02544048|Immune|immune
1737398|NCT02544048|Parasitemia|parasitemia
1737399|NCT02544048|Menactra|menactra
1737400|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
1737401|NCT02544048|Coartem|coartem
1737402|NCT02538965|Lenalidomide|lenalidomide
1737403|NCT02538965|Revlimid|revlimid
1737404|NCT02538965|Pediatric|pediatric
1737405|NCT02538965|Relapsed or Refractory|relapsed or refractory
1737406|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
1737407|NCT02538965|Leukemia|leukemia
1737408|NCT02531516|Prostatic neoplasms|prostatic neoplasms
1737409|NCT02531516|Prostate Cancer|prostate cancer
1737410|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
1737411|NCT02531516|JNJ-56021927|jnj-56021927
1737412|NCT02531516|Apalutamide|apalutamide
1737413|NCT02531516|ATLAS|atlas
1737414|NCT02531516|Radiation|radiation
1737415|NCT02531516|Long-term hormone therapy|long-term hormone therapy
1737416|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
1737417|NCT02531516|Janssen|janssen
1737418|NCT02527460|Inflammation|inflammation
1737419|NCT02527460|Cognitive Function|cognitive function
1737420|NCT02527460|HIV|hiv
1737421|NCT02516241|Urothelial Cancer|urothelial cancer
1737422|NCT02516241|Phase III|phase iii
1737423|NCT02504879|Osteosclerosis|osteosclerosis
1737424|NCT02504879|Hyperostosis|hyperostosis
1737425|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1737426|NCT02481570|Scoliosis surgery|scoliosis surgery
1737427|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
1737428|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
1737429|NCT02479321|Fluid therapy|fluid therapy
1737430|NCT02479321|Aged|aged
1737431|NCT02479321|Perioperative complications|perioperative complications
1737432|NCT02479321|Survival|survival
1737433|NCT02468869|Recall|recall
1737434|NCT02468869|Discharge communication|discharge communication
1737435|NCT02468869|Satisfaction|satisfaction
1737436|NCT02468869|Adherence|adherence
1737437|NCT02468869|Information structuring|information structuring
1737438|NCT02468869|Empathy skills|empathy skills
1737439|NCT02465983|Pancreatic Cancer|pancreatic cancer
1737440|NCT02465983|CAR / CART|car / cart
1737441|NCT02465983|T cells|t cells
1737442|NCT02465983|Immunotherapy|immunotherapy
1737443|NCT02465983|Gene therapy|gene therapy
1737444|NCT02465983|Redirected T cells|redirected t cells
1737445|NCT02465983|Autologous T cells|autologous t cells
1737446|NCT02459418|Afolia|afolia
1737447|NCT02459418|Follitropin|follitropin
1737448|NCT02446626|Lyme Disease|lyme disease
1737449|NCT02446626|Ixodes scapularis|ixodes scapularis
1737450|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
1737451|NCT02446626|Post treatment|post treatment
1737452|NCT02446626|Infection|infection
1737453|NCT02423083|Neuroprotection|neuroprotection
1737454|NCT02423083|Multiple Sclerosis|multiple sclerosis
1737455|NCT02423083|Clinical Trial|clinical trial
1737456|NCT02423083|Safety and Tolerability|safety and tolerability
1737457|NCT02416206|Multiple myeloma|multiple myeloma
1737458|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1737459|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
1737460|NCT02394210|IMW Consensus Panel|imw consensus panel
1737461|NCT02394210|anti-MM therapy|anti-mm therapy
1737462|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
1737463|NCT02390752|Dose Escalation|dose escalation
1737464|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1737465|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
1737466|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
1737467|NCT02383472|Concussion|concussion
1737468|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
1737469|NCT02383472|MTBI|mtbi
1737470|NCT02383472|LED|led
1737471|NCT02383472|Light Emitting Diode|light emitting diode
1737472|NCT02383472|Headache|headache
1737473|NCT02383472|Brain Concussion|brain concussion
1737474|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
1737475|NCT02379442|Corticosteroids|corticosteroids
1737476|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
1737477|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
1737478|NCT02330211|Colitis|colitis
1737479|NCT02330211|Fecal Microbiota Transplant|fecal microbiota transplant
1737480|NCT02330211|Crohn's Disease|crohn's disease
1737481|NCT02330211|inflammatory bowel disease|inflammatory bowel disease
1737482|NCT02322203|Niacin|niacin
1737483|NCT02322203|Cholesterol|cholesterol
1737484|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
1737485|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
1737486|NCT02322203|Lipoproteins|lipoproteins
1737487|NCT02317354|X-Linked|x-linked
1737488|NCT02317354|Retinoschisis|retinoschisis
1737489|NCT02294227|AIN457|ain457
1737490|NCT02294227|psoriatic arthritis|psoriatic arthritis
1737491|NCT02294227|chronic inflammatory disease|chronic inflammatory disease
1737492|NCT02294227|loading regimen|loading regimen
1737493|NCT02294227|secukinumab|secukinumab
1737494|NCT02294227|self-injection|self-injection
1737495|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
1737496|NCT02271919|Cancer Prevention|cancer prevention
1737497|NCT02271919|Tobacco Use Cessation|tobacco use cessation
1737498|NCT02271919|Nicotine replacement therapy|nicotine replacement therapy
1737499|NCT02271919|NRT|nrt
1737500|NCT02271919|Varenicline|varenicline
1737501|NCT02271919|Chantix|chantix
1737502|NCT02271919|Nicotine lozenge|nicotine lozenge
1737503|NCT02271919|Placebo tablet|placebo tablet
1737504|NCT02271919|Placebo patch|placebo patch
1737505|NCT02271919|Questionnaire|questionnaire
1737506|NCT02271919|Survey|survey
1737507|NCT02271919|Counseling|counseling
1737508|NCT02250326|Cancer of the lung|cancer of the lung
1737509|NCT02250326|lung neoplasm|lung neoplasm
1737510|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
1737511|NCT02250326|Nonsquamou|nonsquamou
1737512|NCT02250326|squamous|squamous
1737513|NCT02250326|squamous NSCLC|squamous nsclc
1737514|NCT02250326|Tumor|tumor
1737515|NCT02250326|locally advanced NSCLC|locally advanced nsclc
1737516|NCT02250326|metastatic NSCLC|metastatic nsclc
1737517|NCT02250326|advanced lung cancer|advanced lung cancer
1737518|NCT02250326|metastatic lung cancer|metastatic lung cancer
1737519|NCT02250326|non-squamous NSCLC|non-squamous nsclc
1737520|NCT02250326|lung cancer|lung cancer
1737521|NCT02250326|Abraxane|abraxane
1737522|NCT02250326|ABI-007|abi-007
1737523|NCT02250326|nab-paclitaxel|nab-paclitaxel
1737524|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
1737525|NCT02250326|taxanes|taxanes
1737526|NCT02250326|CC-486|cc-486
1737527|NCT02250326|oral azacitidine|oral azacitidine
1737528|NCT02250326|azacitidine|azacitidine
1737529|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
1737530|NCT02250326|second line treatment|second line treatment
1737531|NCT02250326|Celgene|celgene
1737532|NCT02250326|abound.2L|abound.2l
1737533|NCT02250326|third line treatment|third line treatment
1737534|NCT02250326|durvalumab|durvalumab
1737535|NCT02250326|immunotherapy|immunotherapy
1737536|NCT02250326|MEDI4736|medi4736
1737537|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
1737538|NCT02236637|Registry|registry
1737539|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1737540|NCT02229227|switch study|switch study
1737541|NCT02229227|albiglutide|albiglutide
1737542|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
1737543|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
1737544|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
1737545|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1737546|NCT02226861|MDS|mds
1737547|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1737548|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1737549|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1737550|NCT02225847|Gardening|gardening
1737551|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
1737552|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1737553|NCT02225847|Psychometric Assessment|psychometric assessment
1737554|NCT02225847|Stress|stress
1737555|NCT02225847|Depression|depression
1737556|NCT02225847|Anxiety|anxiety
1737557|NCT02225847|Quality of Life|quality of life
1737558|NCT02225847|Wellness|wellness
1737559|NCT02223052|CC-486|cc-486
1737560|NCT02223052|Oral Azacitidine|oral azacitidine
1737561|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
1737562|NCT02223052|Hematological Malignancy|hematological malignancy
1737563|NCT02223052|Leukemia|leukemia
1737564|NCT02223052|Lymphoma|lymphoma
1737565|NCT02223052|Multiple Myeloma|multiple myeloma
1737566|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
1737567|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
1737568|NCT02223052|Neoplasms|neoplasms
1737569|NCT02223052|Melanoma|melanoma
1737570|NCT02223052|Breast Cancer|breast cancer
1737571|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
1737572|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
1737573|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
1737574|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
1737575|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
1737576|NCT02223052|Brain Cancer|brain cancer
1737577|NCT02223052|Kidney Cancer|kidney cancer
1737578|NCT02223052|Lung cancer|lung cancer
1737579|NCT02223052|Blood Cancer|blood cancer
1737580|NCT02223052|Thyroid Cancer|thyroid cancer
1737581|NCT02223052|Bone Cancer|bone cancer
1737582|NCT02223052|Bone Metastasis|bone metastasis
1737583|NCT02223052|Testicular Cancer|testicular cancer
1737584|NCT02223052|Prostate Cancer|prostate cancer
1737585|NCT02223052|Bladder Cancer|bladder cancer
1737586|NCT02223052|Ovarian Cancer|ovarian cancer
1737587|NCT02223052|Skin Cancer|skin cancer
1737588|NCT02223052|Cancer general|cancer general
1737589|NCT02223052|Survival|survival
1737590|NCT02223052|Chemotherapy|chemotherapy
1737591|NCT02223052|Targeted Therapy|targeted therapy
1737592|NCT02223052|Genitourinary|genitourinary
1737593|NCT02223052|MM|mm
1737594|NCT02223052|MDS|mds
1737595|NCT02223052|AML|aml
1737596|NCT02223052|NHL|nhl
1737597|NCT02223052|HL|hl
1737598|NCT02223052|MBC|mbc
1737599|NCT02223052|NSCLC|nsclc
1737600|NCT02223052|SCLC|sclc
1737601|NCT02223052|GBM|gbm
1737602|NCT02215551|laminectomy|laminectomy
1737603|NCT02215707|PfSPZ Vaccine|pfspz vaccine
1737604|NCT02215707|Plasmodium falciparum|plasmodium falciparum
1737605|NCT02215707|Malaria|malaria
1737606|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
1737607|NCT02169791|hematologic malignancies|hematologic malignancies
1737608|NCT02144233|Pain|pain
1737609|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
1737610|NCT02144233|Occlusal adjustment|occlusal adjustment
1737611|NCT02144233|Therapy|therapy
1737612|NCT02144233|Randomized clinical trial|randomized clinical trial
1737613|NCT02144233|Mastication|mastication
1737614|NCT02144233|Habitual chewing side|habitual chewing side
1737615|NCT02144233|Handedness preference|handedness preference
1737616|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
1737617|NCT02110641|Breast Cancer|breast cancer
1737618|NCT02110641|Survivorship|survivorship
1737619|NCT02110641|Weight Loss|weight loss
1737620|NCT02098993|Sickle cell disease|sickle cell disease
1737621|NCT02098993|Acute chest syndrome|acute chest syndrome
1737622|NCT02098993|Hemoglobinopathy|hemoglobinopathy
1737623|NCT02098993|Hemolytic anemia|hemolytic anemia
1737624|NCT02098993|Heparin|heparin
1737625|NCT02098993|Anticoagulant|anticoagulant
1737626|NCT02091869|Adolescents|adolescents
1737627|NCT02091869|Asthma|asthma
1627612|NCT00293176|Memory Loss|memory loss
1737628|NCT02091869|Asthma Symptoms|asthma symptoms
1737629|NCT02089776|Stroke|stroke
1737630|NCT02089776|fMRI|fmri
1737631|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
1737632|NCT02085785|weight loss|weight loss
1737633|NCT02085785|exercise|exercise
1737634|NCT02085785|home-based|home-based
1737635|NCT02085785|lower extremity amputation|lower extremity amputation
1737636|NCT02085785|pilot study|pilot study
1737637|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
1737638|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
1737639|NCT02060487|pulmonary hypertension|pulmonary hypertension
1737640|NCT02060487|PAH|pah
1737641|NCT02060487|sildenafil|sildenafil
1737642|NCT02060487|revatio|revatio
1737643|NCT02045017|Multiple Myeloma|multiple myeloma
1737644|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
1737645|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
1737646|NCT02045017|Renal Insufficiency|renal insufficiency
1737647|NCT02045017|Pomalidomide|pomalidomide
1737648|NCT02045017|Dexamethasone|dexamethasone
1737649|NCT02032823|Breast Cancer|breast cancer
1737650|NCT02032823|Adjuvant|adjuvant
1737651|NCT02032823|Olaparib|olaparib
1737652|NCT02032823|BRCA 1/2|brca 1/2
1737653|NCT02032823|HER2|her2
1737654|NCT02031419|CC-122|cc-122
1737655|NCT02031419|CC-223|cc-223
1737656|NCT02031419|CC-292|cc-292
1737657|NCT02031419|Rituximab|rituximab
1737658|NCT02031419|Lymphoma|lymphoma
1737659|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1737660|NCT02031419|Lenalidomide naïve Follicular Lymphoma|lenalidomide naïve follicular lymphoma
1737661|NCT02031419|Lenalidomide exposed Follicular Lymphoma|lenalidomide exposed follicular lymphoma
1737662|NCT02027428|Nab-paclitaxel|nab-paclitaxel
1737663|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
1737664|NCT02027428|Taxanes|taxanes
1737665|NCT02027428|Maintenance trials|maintenance trials
1737666|NCT02027428|Celgene|celgene
1737667|NCT02027428|Abraxane|abraxane
1737668|NCT02027428|ABI-007|abi-007
1737669|NCT02027428|NSCLC|nsclc
1737670|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
1737671|NCT02027428|Cancer of the Lung|cancer of the lung
1737672|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
1737673|NCT02027428|Lung Neoplasms|lung neoplasms
1737674|NCT02027428|Abound.sqm|abound.sqm
1737675|NCT02015026|Biospecimen Repository|biospecimen repository
1737676|NCT02015026|Disease Progression Pattern|disease progression pattern
1737677|NCT02015026|Specimen Analysis|specimen analysis
1737678|NCT02015026|Genetic Analysis|genetic analysis
1737679|NCT02012790|Migraine disorders|migraine disorders
1737680|NCT02002884|Upper limb spasticity|upper limb spasticity
1737681|NCT02002884|lower limb spasticity|lower limb spasticity
1737682|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
1737683|NCT02003092|Metastatic|metastatic
1737684|NCT02003092|Rexahn|rexahn
1737685|NCT02003092|Phase 1|phase 1
1737686|NCT02003092|Triple Negative Breast Cancer|triple negative breast cancer
1737687|NCT02003092|Phase 2|phase 2
1737688|NCT02003092|Relapsed|relapsed
1737689|NCT02000817|Beta Cell|beta cell
1737690|NCT02000817|Monoclonal Antibody|monoclonal antibody
1737691|NCT02000817|Otelixizumab|otelixizumab
1737692|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
1737693|NCT02000817|Epstein-Barr Virus|epstein-barr virus
1737694|NCT02000817|Diabetes Mellitus|diabetes mellitus
1737695|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
1737696|NCT01996254|electrical stimulation|electrical stimulation
1737697|NCT01996254|neurostimulation|neurostimulation
1737698|NCT01996254|neuromodulation|neuromodulation
1737699|NCT01996254|post-amputation pain|post-amputation pain
1737700|NCT01996254|phantom limb pain|phantom limb pain
1737701|NCT01996254|residual limb pain|residual limb pain
1737702|NCT01996254|neuropathic pain|neuropathic pain
1737703|NCT01996254|amputee pain|amputee pain
1737704|NCT01990495|Renal failure|renal failure
1737705|NCT01990495|Exercise testing|exercise testing
1737706|NCT01990495|Exercise training|exercise training
1737707|NCT01990495|Protein signaling|protein signaling
1737708|NCT01990495|Skeletal muscle|skeletal muscle
1737709|NCT01977547|Red blood cell transfusions|red blood cell transfusions
1737710|NCT01977547|Red blood cell storage age|red blood cell storage age
1737711|NCT01977547|Pediatrics|pediatrics
1737712|NCT01977547|Critical Care|critical care
1737713|NCT01977534|Bioabsorbable|bioabsorbable
1737714|NCT01977534|Coronary Stent|coronary stent
1737715|NCT01977534|Everolimus|everolimus
1737716|NCT01977534|drug eluting stents|drug eluting stents
1737717|NCT01977534|stents|stents
1737718|NCT01977534|angioplasty|angioplasty
1737719|NCT01977534|coronary artery disease|coronary artery disease
1737720|NCT01977534|total coronary occlusion|total coronary occlusion
1737721|NCT01977534|coronary artery restenosis|coronary artery restenosis
1737722|NCT01977534|stent thrombosis|stent thrombosis
1737723|NCT01977534|vascular disease|vascular disease
1737724|NCT01977534|myocardial ischemia|myocardial ischemia
1737725|NCT01977534|coronary artery stenosis|coronary artery stenosis
1737727|NCT01977534|CAOD|caod
1737728|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
1737729|NCT01941433|self-management|self-management
1737730|NCT01941433|online|online
1737731|NCT01941433|patient passport|patient passport
1737732|NCT01928758|Smoking|smoking
1737733|NCT01928758|Nicotine|nicotine
1737734|NCT01911208|Minority|minority
1737735|NCT01911208|Recruitment|recruitment
1737736|NCT01898117|Triple negative|triple negative
1737737|NCT01898117|Metastatic|metastatic
1737738|NCT01891994|Cytokine|cytokine
1737739|NCT01891994|Hematopoiesis|hematopoiesis
1737740|NCT01891994|Autoimmunity|autoimmunity
1737741|NCT01891994|Thrombocytopenia|thrombocytopenia
1737742|NCT01891994|Neutropenia|neutropenia
1737743|NCT01881048|Breast cancer|breast cancer
1737744|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
1737745|NCT01881048|Celecoxib|celecoxib
1737746|NCT01881048|Celebrex|celebrex
1737748|NCT01860937|T cell Immunotherapy|t cell immunotherapy
1737749|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
1737750|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
1737751|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
1737752|NCT01860937|13-052|13-052
1737753|NCT01851447|Muscle|muscle
1737754|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
1737755|NCT01851447|Exercise|exercise
1737756|NCT01851447|Biomarkers|biomarkers
1737757|NCT01851447|Predictors of Outcome|predictors of outcome
1737758|NCT01851356|PBR28|pbr28
1737759|NCT01851356|Depression|depression
1737760|NCT01851356|PET Imaging|pet imaging
1737761|NCT01851356|Neuroinflammation|neuroinflammation
1737762|NCT01846611|Ovarian neoplasms|ovarian neoplasms
1737763|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
1737764|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
1737765|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
1737766|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
1737767|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
1737768|NCT01846611|Trabectedin|trabectedin
1737769|NCT01846611|Yondelis|yondelis
1737770|NCT01846611|Doxil|doxil
1737771|NCT01846611|Caelyx|caelyx
1737772|NCT01846611|Platinum sensitive|platinum sensitive
1737773|NCT01846611|Tthird-line|tthird-line
1737774|NCT01846611|BRCA|brca
1737775|NCT01846611|Patient related outcome|patient related outcome
1737776|NCT01833117|Dry eye|dry eye
1737777|NCT01833117|Tear film|tear film
1737778|NCT01833117|Tear break-up time|tear break-up time
1737779|NCT01833117|Ocular surface|ocular surface
1737780|NCT01833117|Eye drops|eye drops
1737781|NCT01803126|atherosclerosis|atherosclerosis
1737782|NCT01787474|Leukemia|leukemia
1737783|NCT01787474|Acute Myeloid Leukemia|acute myeloid leukemia
1737784|NCT01787474|Blood And Marrow Transplantation|blood and marrow transplantation
1737785|NCT01787474|Natural killer cells|natural killer cells
1737786|NCT01787474|NK|nk
1737787|NCT01787474|mbIL21-expanded haploidentical NK cells|mbil21-expanded haploidentical nk cells
1737788|NCT01787474|G-CSF|g-csf
1737789|NCT01787474|Filgrastim|filgrastim
1737790|NCT01787474|Neupogen|neupogen
1737791|NCT01787474|Fludarabine monophosphate|fludarabine monophosphate
1737792|NCT01787474|Fludarabine Phosphate|fludarabine phosphate
1737793|NCT01787474|Fludara|fludara
1737794|NCT01787474|Cytarabine|cytarabine
1737795|NCT01787474|Ara-C|ara-c
1737796|NCT01787474|Cytosar|cytosar
1737797|NCT01787474|DepoCyt|depocyt
1737798|NCT01787474|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1737799|NCT01778478|Anxiety|anxiety
1737800|NCT01778478|Depression|depression
1737801|NCT01778478|Adolescents and Adults|adolescents and adults
1737802|NCT01778478|Cancer Diagnosis|cancer diagnosis
1737803|NCT01776424|Cardiovascular events|cardiovascular events
1737804|NCT01776424|Rivaroxaban|rivaroxaban
1737805|NCT01776424|Xarelto|xarelto
1737806|NCT01776424|anticoagulant|anticoagulant
1737807|NCT01776424|blood thinner|blood thinner
1737808|NCT01776424|aspirin|aspirin
1737809|NCT01776424|ASA|asa
1737810|NCT01776424|CAD|cad
1737811|NCT01776424|coronary disease|coronary disease
1737812|NCT01776424|artery disease|artery disease
1737813|NCT01776424|coronary artery bypass graft|coronary artery bypass graft
1737814|NCT01776424|stroke|stroke
1737815|NCT01776424|heart attack|heart attack
1737816|NCT01776424|angina|angina
1737817|NCT01776424|arterial vascular disease|arterial vascular disease
1737818|NCT01776424|transient ischemic attack|transient ischemic attack
1737819|NCT01776424|TIA|tia
1737820|NCT01776424|heart disease|heart disease
1737821|NCT01775930|Kidney Cancer|kidney cancer
1737822|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
1737823|NCT01775930|RCC|rcc
1737824|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
1737825|NCT01775930|Carfilzomib|carfilzomib
1737826|NCT01764321|Certolizumab Pegol|certolizumab pegol
1737827|NCT01764321|Cimzia®|cimzia®
1737828|NCT01764321|TNF inhibitor|tnf inhibitor
1737829|NCT01764321|DMARD|dmard
1737830|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
1737831|NCT01746836|Leukemia|leukemia
1737832|NCT01746836|Chronic Myeloid Leukemia|chronic myeloid leukemia
1737833|NCT01746836|CML|cml
1737834|NCT01746836|Imatinib-resistant or intolerant|imatinib-resistant or intolerant
1737835|NCT01746836|Imatinib failure|imatinib failure
1737836|NCT01746836|Ph-positive (by cytogenetics or FISH)|ph-positive (by cytogenetics or fish)
1737837|NCT01746836|BCR-ABL-positive (by PCR) CML in chronic phase|bcr-abl-positive (by pcr) cml in chronic phase
1737838|NCT01746836|Ponatinib|ponatinib
1737839|NCT01746836|AP24534|ap24534
1737840|NCT01733732|Dry eye|dry eye
1737841|NCT01733732|Lipid deficiency|lipid deficiency
1737842|NCT01733732|Inflammatory markers|inflammatory markers
1737843|NCT01733745|dry eye|dry eye
1737844|NCT01733745|lipid deficiency|lipid deficiency
1737845|NCT01733745|meibomian gland|meibomian gland
1737846|NCT01726738|Melanoma|melanoma
1737847|NCT01726738|Stage III|stage iii
1737848|NCT01726738|Stage IV|stage iv
1737946|NCT01547390|Aspirin|aspirin
1737849|NCT01726738|Unresectable|unresectable
1737850|NCT01726738|BRAF Mutant|braf mutant
1737851|NCT01726738|Dabrafenib|dabrafenib
1737852|NCT01726738|Trametinib|trametinib
1737853|NCT01726738|Kinome|kinome
1737854|NCT01726738|Resistance|resistance
1737855|NCT01726738|Sequencing|sequencing
1737856|NCT01726738|Mutations|mutations
1737857|NCT01726738|Kinases|kinases
1737858|NCT01726738|Mechanism|mechanism
1737859|NCT01712789|Multiple Myeloma|multiple myeloma
1737860|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
1737861|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1737862|NCT01712789|Pomalidomide|pomalidomide
1737863|NCT01712789|Dexamethasone|dexamethasone
1737864|NCT01702961|Lymphoma|lymphoma
1737865|NCT01702961|Hodgkin's Disease|hodgkin's disease
1737866|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1737867|NCT01702948|Nicotine|nicotine
1737868|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
1737869|NCT01702948|fMRI|fmri
1737870|NCT01699087|PRK|prk
1737871|NCT01699087|myopia|myopia
1737872|NCT01699087|astigmatism|astigmatism
1737873|NCT01692236|MRI|mri
1737874|NCT01692236|HIV|hiv
1737875|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
1737876|NCT01692236|Major Depression|major depression
1737877|NCT01692236|Vasculopathy|vasculopathy
1737878|NCT01688726|Dry eye|dry eye
1737879|NCT01688726|Ocular surface|ocular surface
1737880|NCT01688726|Vision complaint|vision complaint
1737881|NCT01688726|Tear film stability|tear film stability
1737882|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
1737883|NCT01688726|Tear film kinetics|tear film kinetics
1737884|NCT01680783|noninvasive ventilation|noninvasive ventilation
1737885|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
1737886|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
1737887|NCT01680783|shock|shock
1737888|NCT01664923|prostate cancer|prostate cancer
1737889|NCT01664923|enzalutamide|enzalutamide
1737890|NCT01664923|MDV3100|mdv3100
1737891|NCT01656941|neonate|neonate
1737892|NCT01656941|congenital heart disease|congenital heart disease
1737893|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
1737894|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
1737895|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
1737896|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
1737897|NCT01638559|liver transplant|liver transplant
1737898|NCT01638559|allograft function|allograft function
1737899|NCT01638559|anti-rejection|anti-rejection
1737900|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
1737901|NCT01633229|Immune Suppression|immune suppression
1737902|NCT01633229|BMSC|bmsc
1737903|NCT01633229|GVHD|gvhd
1737904|NCT01633229|Marrow Failure|marrow failure
1737905|NCT01633229|Regimen Related Toxicity|regimen related toxicity
1737906|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
1737907|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
1737908|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1737909|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
1737910|NCT01621607|fMRI|fmri
1737911|NCT01621607|Monoamines|monoamines
1737912|NCT01621607|Environment|environment
1737913|NCT01621607|Genes|genes
1737914|NCT01621607|Reward Learning|reward learning
1737915|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1737916|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
1737917|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
1737918|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
1737919|NCT01611090|Ibrutinib|ibrutinib
1737920|NCT01611090|PCI-32765|pci-32765
1737921|NCT01611090|JNJ-54179060|jnj-54179060
1737922|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1737923|NCT01611090|Bendamustine|bendamustine
1737924|NCT01611090|Rituximab|rituximab
1737925|NCT01591356|Advanced Cancers|advanced cancers
1737926|NCT01591356|Advanced solid tumors|advanced solid tumors
1737927|NCT01591356|siRNA/EphA2|sirna/epha2
1737928|NCT01591122|Prostate cancer|prostate cancer
1737929|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1737930|NCT01591122|Abiraterone acetate|abiraterone acetate
1737931|NCT01591122|Prednisone|prednisone
1737932|NCT01591122|Zytiga|zytiga
1737933|NCT01591265|Compensatory dental extraction|compensatory dental extraction
1737934|NCT01591265|Children 7-11 years old|children 7-11 years old
1737935|NCT01580982|Oncogenes|oncogenes
1737936|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
1737937|NCT01572428|Proximal Colon Cancer|proximal colon cancer
1737938|NCT01572428|Serrated Colon Lesions|serrated colon lesions
1737939|NCT01572428|Narrow Band Imaging|narrow band imaging
1737940|NCT01563913|Parkinsons disease|parkinsons disease
1737941|NCT01563913|supplement|supplement
1737942|NCT01563913|DHA|dha
1737943|NCT01563913|dyskinesia|dyskinesia
1737944|NCT01563913|abnormal movements|abnormal movements
1737945|NCT01547390|preeclampsia|preeclampsia
1737947|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1737948|NCT01517802|Metastatic breast cancer|metastatic breast cancer
1737949|NCT01517802|Abiraterone acetate|abiraterone acetate
1737950|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
1737951|NCT01517802|Long-term access|long-term access
1737952|NCT01507662|Bone Density|bone density
1737953|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
1737954|NCT01507662|Osteoporosis|osteoporosis
1737955|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
1737956|NCT01507662|Patient Education as Topic|patient education as topic
1737957|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
1737958|NCT01468935|Uterus|uterus
1737959|NCT01468935|Endometrium|endometrium
1737960|NCT01468935|Bone Marrow Transplant|bone marrow transplant
1737961|NCT01468935|Gynecology|gynecology
1737962|NCT01468935|Healthy Volunteer|healthy volunteer
1737963|NCT01468935|HV|hv
1737964|NCT01468935|Stem Cell Transplant|stem cell transplant
1737965|NCT01468935|Endometriosis|endometriosis
1737966|NCT01465334|17p Deletion CLL|17p deletion cll
1737967|NCT01461070|Breast Cancer|breast cancer
1737968|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
1737969|NCT01461070|Fecal Microbes|fecal microbes
1737970|NCT01430845|GDD|gdd
1737971|NCT01430845|CP|cp
1737972|NCT01430845|MR|mr
1737973|NCT01430845|PDD|pdd
1737974|NCT01430845|ASD|asd
1737975|NCT01430845|BSID|bsid
1737976|NCT01430741|Implementation Science|implementation science
1737977|NCT01430741|Supportive Housing|supportive housing
1737978|NCT01430741|Co-occurring disorders|co-occurring disorders
1737979|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
1737980|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
1737981|NCT01426542|brain injury|brain injury
1737982|NCT01426542|stroke|stroke
1737983|NCT01426542|cerebral palsy|cerebral palsy
1737984|NCT01426542|seizures|seizures
1737985|NCT01424189|Cataract surgery|cataract surgery
1737986|NCT01424189|Intraocular lens|intraocular lens
1737987|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1737988|NCT01415674|pre operative treatment|pre operative treatment
1737989|NCT01415674|Afatinib|afatinib
1737990|NCT01415674|BIBW2992|bibw2992
1737991|NCT01415674|Biological markers|biological markers
1737992|NCT01409161|Leukemia|leukemia
1737993|NCT01409161|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1737994|NCT01409161|APL|apl
1737995|NCT01409161|ATRA|atra
1737996|NCT01409161|Tretinoin|tretinoin
1737997|NCT01409161|All-trans retinoic acid|all-trans retinoic acid
1737998|NCT01409161|Vesanoid|vesanoid
1737999|NCT01409161|ATO|ato
1738000|NCT01409161|Arsenic trioxide|arsenic trioxide
1738001|NCT01409161|Trisenox|trisenox
1738002|NCT01409161|GO|go
1738003|NCT01409161|Gemtuzumab|gemtuzumab
1738004|NCT01409161|Mylotarg|mylotarg
1738005|NCT01409161|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
1738006|NCT01409161|Methylprednisolone|methylprednisolone
1738007|NCT01409161|Depo-Medrol|depo-medrol
1738008|NCT01409161|Medrol|medrol
1738009|NCT01409161|Solu-Medrol|solu-medrol
1738010|NCT01401907|Palliative care|palliative care
1738011|NCT01401907|Lung|lung
1738012|NCT01401907|Gastric|gastric
1738013|NCT01401907|Liver|liver
1738014|NCT01401907|Pancreatic|pancreatic
1738015|NCT01401907|Esophageal|esophageal
1738016|NCT01401907|Caregiver|caregiver
1738017|NCT01400373|Hypothermia, induced|hypothermia, induced
1738018|NCT01400373|Intra-arrest cooling|intra-arrest cooling
1738019|NCT01400373|Cardiac arrest|cardiac arrest
1738020|NCT01400373|Prehospital emergency care|prehospital emergency care
1738021|NCT01400373|Emergency Medical Services|emergency medical services
1738022|NCT01375621|Farming|farming
1738023|NCT01375621|Antibiotic Resistant|antibiotic resistant
1738024|NCT01375621|Bacteria|bacteria
1738025|NCT01369901|Exercise|exercise
1738026|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
1738027|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
1738028|NCT01369901|SBMA|sbma
1738029|NCT01369901|Motor Neuron Disease|motor neuron disease
1738030|NCT01365845|Proton Radiation|proton radiation
1738031|NCT01365845|Breast Cancer|breast cancer
1738032|NCT01361217|Fluoxetine|fluoxetine
1738033|NCT01361217|CYP3A4|cyp3a4
1738034|NCT01361217|CYP2D6|cyp2d6
1738035|NCT01361217|CYP2C19|cyp2c19
1738036|NCT01361217|Drug-Drug Interaction|drug-drug interaction
1738037|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
1738038|NCT01360112|Mosquito|mosquito
1738039|NCT01360112|Membrane|membrane
1738040|NCT01360112|Feeding|feeding
1738041|NCT01360112|Parasites|parasites
1738042|NCT01360112|Infection|infection
1738043|NCT01360112|Malaria|malaria
1738044|NCT01355406|FlexStent|flexstent
1738045|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
1738046|NCT01355406|Self Expanding Stent|self expanding stent
1738047|NCT01355406|Stent|stent
1738048|NCT01355406|Bare Metal Stent|bare metal stent
1738049|NCT01352949|Anthropometry|anthropometry
1738250|NCT00713492|Alcohol|alcohol
1738050|NCT01352949|Stereophotogrammetry|stereophotogrammetry
1738051|NCT01352949|Torso|torso
1738052|NCT01352949|Spinal Deformity|spinal deformity
1738053|NCT01352949|Chest Wall Deformity|chest wall deformity
1738054|NCT01352949|Overweight|overweight
1738055|NCT01352949|Obese|obese
1738056|NCT01352949|Healthy Volunteer|healthy volunteer
1738058|NCT01328587|Eltrombopag|eltrombopag
1738059|NCT01328587|Aplastic Anemia|aplastic anemia
1738060|NCT01328587|Aplastic Anemia Treatment|aplastic anemia treatment
1738061|NCT01328587|Moderate Aplastic Anemia|moderate aplastic anemia
1738062|NCT01328587|Moderate Aplastic Anemia Treatment|moderate aplastic anemia treatment
1738063|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
1738064|NCT01276470|Antibody|antibody
1738065|NCT01276470|Autoimmune Diseases|autoimmune diseases
1738066|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
1738067|NCT01276470|Environmental Risk Factors|environmental risk factors
1738068|NCT01276470|Dermatomyositis|dermatomyositis
1738069|NCT01276470|Polymyositis|polymyositis
1738070|NCT01276470|Juvenile Dermatomyositis|juvenile dermatomyositis
1738071|NCT01276470|Juvenile Polymyositis|juvenile polymyositis
1738072|NCT01276470|Myositis|myositis
1738073|NCT01262365|Lupus|lupus
1738074|NCT01262365|Monoclonal antibody|monoclonal antibody
1738075|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
1738076|NCT01262365|Epratuzumab|epratuzumab
1738077|NCT01261793|Lupus|lupus
1738078|NCT01261793|Monoclonal antibody|monoclonal antibody
1738079|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
1738080|NCT01261793|Epratuzumab|epratuzumab
1738081|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1738082|NCT01257100|Epstein-Barr Virus|epstein-barr virus
1738083|NCT01257100|NPC|npc
1738084|NCT01235910|Hypertension|hypertension
1738085|NCT01235910|Cardiac transplantation|cardiac transplantation
1738086|NCT01235910|Aliskiren|aliskiren
1738087|NCT01235910|Cyclosporine|cyclosporine
1738088|NCT01229644|Glioma|glioma
1738089|NCT01229644|Brain Cancer|brain cancer
1738090|NCT01229644|Recurrent glioma|recurrent glioma
1738091|NCT01229644|Low grade glioma|low grade glioma
1738092|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
1738093|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
1738094|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
1738095|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
1738096|NCT01228734|RAS wild type|ras wild type
1738097|NCT01228734|Cetuximab|cetuximab
1738098|NCT01228734|First line treatment|first line treatment
1738099|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
1738100|NCT01228734|status|status
1738101|NCT01179867|Medication reconciliation|medication reconciliation
1738102|NCT01179867|Adverse drug events|adverse drug events
1738103|NCT01179867|Hospital readmission|hospital readmission
1738104|NCT01179867|Medication management|medication management
1738105|NCT01170117|Eating Disorders|eating disorders
1738106|NCT01170117|Anorexia Nervosa|anorexia nervosa
1738107|NCT01153035|Breast Conservation Therapy|breast conservation therapy
1738108|NCT01153035|Lumpectomy|lumpectomy
1738109|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
1738110|NCT01153035|Radiation|radiation
1738111|NCT01095354|pediatric|pediatric
1738112|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
1738113|NCT01092195|Women's Health|women's health
1738114|NCT01092195|Genital Precancer|genital precancer
1738115|NCT01092195|Stem Cell Donor|stem cell donor
1738116|NCT01092195|Cervical Cytology|cervical cytology
1738117|NCT01092195|Healthy Volunteers|healthy volunteers
1738118|NCT01092195|Stem Cell Transplant|stem cell transplant
1738119|NCT01092195|Healthy Volunteer|healthy volunteer
1738120|NCT01092195|HV|hv
1738121|NCT01072370|Umbilical Cord Blood|umbilical cord blood
1738122|NCT01072370|Stem Cells|stem cells
1738123|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
1738124|NCT01072370|Cerebral Palsy|cerebral palsy
1738126|NCT01066663|SLL|sll
1738127|NCT01066663|relapsed|relapsed
1738128|NCT01066663|pyrimethamine|pyrimethamine
1738129|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
1738130|NCT01006109|MEG|meg
1738131|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
1738132|NCT01006109|Decision-Making|decision-making
1738133|NCT01006109|Healthy Volunteers|healthy volunteers
1738134|NCT01006109|HV|hv
1738135|NCT01006109|Healthy Volunteer|healthy volunteer
1738136|NCT00985881|Artificial limbs|artificial limbs
1738137|NCT00985881|Gait|gait
1738138|NCT00985881|Posture|posture
1738139|NCT00985881|Prosthesis|prosthesis
1738140|NCT00985881|Vibration|vibration
1738141|NCT00985842|Artificial limbs|artificial limbs
1738142|NCT00985842|Gait|gait
1738143|NCT00985842|Oximetry|oximetry
1738144|NCT00985842|Prosthesis|prosthesis
1738145|NCT00985842|Rehabilitation|rehabilitation
1738146|NCT00978250|DNA Methylation|dna methylation
1738147|NCT00978250|Advanced Cancer|advanced cancer
1738148|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
1738149|NCT00978250|Epigenetics|epigenetics
1738150|NCT00978250|Gene Re-Expression|gene re-expression
935724|NCT03572608|pregnancy|pregnancy
1738151|NCT00978250|Breast Cancer|breast cancer
1738152|NCT00978250|Head and Neck Cancer|head and neck cancer
1738153|NCT00978250|Lung Cancer|lung cancer
1738154|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
1738155|NCT00978250|Bladder Cancer|bladder cancer
1738156|NCT00957671|TBI|tbi
1738157|NCT00957671|Traumatic Brain injury|traumatic brain injury
1738158|NCT00957671|Growth hormone deficiency|growth hormone deficiency
1738159|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
1738160|NCT00957671|Recombinant human growth Hormone|recombinant human growth hormone
1738161|NCT00957671|Genotropin|genotropin
1738162|NCT00954226|Head & Neck squamous cell carcinoma|head & neck squamous cell carcinoma
1738163|NCT00954226|HN cancer|hn cancer
1738164|NCT00954226|Surgery|surgery
1738165|NCT00954226|Erlotinib|erlotinib
1738166|NCT00954226|Biomarkers|biomarkers
1738167|NCT00954226|Phosphorylation of AKT|phosphorylation of akt
1738168|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
1738169|NCT00948675|Advanced Lung Cancer|advanced lung cancer
1738170|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
1738171|NCT00948675|Lung Cancer|lung cancer
1738172|NCT00943436|Exercise|exercise
1738173|NCT00943436|Sedentary|sedentary
1738174|NCT00943436|Energy Expenditure|energy expenditure
1738175|NCT00943436|Energy Balance|energy balance
1738176|NCT00943436|Macronutrient Intake|macronutrient intake
1738177|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
1738178|NCT00943436|Exercise and Energy Balance|exercise and energy balance
1738179|NCT00926380|osteoporosis|osteoporosis
1738180|NCT00926380|postmenopausal|postmenopausal
1738181|NCT00926380|denosumab|denosumab
1738182|NCT00926380|teriparatide|teriparatide
1738183|NCT00926380|Forteo®|forteo®
1738184|NCT00926380|DXA|dxa
1738185|NCT00926380|Bone Mineral Density|bone mineral density
1738186|NCT00926380|pQCT|pqct
1738187|NCT00921986|genetics|genetics
1738188|NCT00921986|biorepository|biorepository
1738189|NCT00921986|cardiac death|cardiac death
1738190|NCT00921986|atrial fibrillation|atrial fibrillation
1738191|NCT00921986|ventricular fibrillation|ventricular fibrillation
1738192|NCT00921986|ventricular tachycardia|ventricular tachycardia
1738193|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
1738194|NCT00921986|premature ventricular complexes|premature ventricular complexes
1738195|NCT00921986|premature atrial complexes|premature atrial complexes
1738196|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
1738197|NCT00921986|sinus node dysfunction|sinus node dysfunction
1738198|NCT00921986|syncope|syncope
1738199|NCT00921986|vasovagal reactivity|vasovagal reactivity
1738200|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
1738201|NCT00837122|Diabetes|diabetes
1738202|NCT00837122|Genetics|genetics
1738203|NCT00837122|Type 2 Diabetes|type 2 diabetes
1738204|NCT00832637|Liver|liver
1738205|NCT00832637|Gallbladder|gallbladder
1738206|NCT00832637|Bile duct|bile duct
1738207|NCT00832637|Gemzar|gemzar
1738208|NCT00832637|Eloxatin|eloxatin
1738209|NCT00832637|Tarceva|tarceva
1738210|NCT00832637|erlotinib|erlotinib
1738211|NCT00832637|Gem-ox|gem-ox
1738212|NCT00832871|Mifepristone|mifepristone
1738213|NCT00832871|RU-486|ru-486
1738214|NCT00832871|Compassionate Use|compassionate use
1738215|NCT00832871|Antiprogesterone|antiprogesterone
1738216|NCT00824941|Abdominal Pain|abdominal pain
1738217|NCT00824941|Women's Health and Disease|women's health and disease
1738218|NCT00824941|Gut|gut
1738219|NCT00824941|Symptoms|symptoms
1738220|NCT00824941|Brain|brain
1738221|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
1738222|NCT00765375|acne|acne
941244|NCT03537521|PCC|pcc
1738223|NCT00765375|Botox|botox
1738224|NCT00765375|cosmetic treatments|cosmetic treatments
1738225|NCT00759889|venous leg ulcer|venous leg ulcer
1738226|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
1738227|NCT00759499|open wound|open wound
1738228|NCT00743730|developmental delay|developmental delay
1738229|NCT00743730|cognitive impairment|cognitive impairment
1738230|NCT00743730|pain control|pain control
1738231|NCT00743730|post operative pain|post operative pain
1738232|NCT00743730|opioid|opioid
1738233|NCT00743730|pain assessment|pain assessment
1738234|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
1738235|NCT00743730|patient controlled analgesic|patient controlled analgesic
1738236|NCT00743730|children|children
1738237|NCT00743730|pain|pain
1738238|NCT00743730|analgesic|analgesic
1738239|NCT00743730|safety|safety
1738240|NCT00743730|parent satisfaction|parent satisfaction
1738241|NCT00743730|nurse satisfaction|nurse satisfaction
1738242|NCT00743730|Pediatric|pediatric
1738243|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
1738244|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
1738245|NCT00720460|Transcatheter Therapeutics|transcatheter therapeutics
1738246|NCT00720460|Healthy Volunteers|healthy volunteers
1738247|NCT00720460|Gadolinium Contrast|gadolinium contrast
1738248|NCT00720460|Healthy Volunteer|healthy volunteer
1738249|NCT00720460|HV|hv
1738251|NCT00713492|Self -Administration|self -administration
1738252|NCT00713492|Intoxication|intoxication
1738253|NCT00713492|Healthy Volunteer|healthy volunteer
1738254|NCT00713492|HV|hv
1738255|NCT00646022|Neuroendocrine|neuroendocrine
1738256|NCT00646022|PET|pet
1738257|NCT00646022|Gastrointestinal|gastrointestinal
1738258|NCT00646022|Serotonin|serotonin
1738259|NCT00646022|Carcinoid Tumor|carcinoid tumor
1738260|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
1738261|NCT00646022|Familial Cancer Tumor|familial cancer tumor
1738262|NCT00599118|Atrial Fibrillation|atrial fibrillation
1738263|NCT00599118|Genetics|genetics
1738264|NCT00596011|prostate cancer|prostate cancer
1738265|NCT00596011|PIN|pin
1738266|NCT00596011|polyphenon E|polyphenon e
1738267|NCT00596011|EGCG|egcg
1738268|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
1738269|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
937840|NCT03559101|Aging|aging
1738270|NCT00549172|Menisci, Medial|menisci, medial
1738271|NCT00549172|Placebo Effect|placebo effect
1738272|NCT00549172|Treatment Efficacy|treatment efficacy
1738273|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
1738274|NCT00391170|Topical Dexamethasone|topical dexamethasone
1738275|NCT00391170|Tissue Markers|tissue markers
1738276|NCT00391170|Salivary Proteomics|salivary proteomics
1738277|NCT00391170|Quality of Life|quality of life
1738278|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
1738279|NCT00391170|Oral Pain|oral pain
1738280|NCT00391170|Mouth Pain|mouth pain
1738281|NCT00381966|Prostate Cancer|prostate cancer
1738282|NCT00381966|Brachytherapy|brachytherapy
1738283|NCT00367523|Echocardiogram|echocardiogram
1738284|NCT00367523|Nigeria|nigeria
1738285|NCT00367523|Screening|screening
1738286|NCT00367523|Sickle Cell Disease|sickle cell disease
1738287|NCT00367523|Genetics|genetics
1738288|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
1738289|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
1738290|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
1738291|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1738292|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
1738293|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
1738294|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
1738295|NCT00344266|Obesity|obesity
1738296|NCT00344266|Adipose Tissue|adipose tissue
1738297|NCT00344266|Microarrays|microarrays
1738298|NCT00344266|Cytokines|cytokines
1738299|NCT00344266|Eicosanoids|eicosanoids
1738300|NCT00344266|Gene Expression|gene expression
1738301|NCT00344266|Adipokines|adipokines
1738302|NCT00344266|Inflammation|inflammation
1738303|NCT00344266|Weight Loss|weight loss
1738304|NCT00344266|Lipid Products|lipid products
1738305|NCT00340938|Adherence|adherence
1738306|NCT00340938|Education|education
1738307|NCT00340938|Problem Solving|problem solving
1738308|NCT00340938|Motivation|motivation
1738309|NCT00340938|Locus of Responsibility|locus of responsibility
1738310|NCT00342875|Bladder Cancer|bladder cancer
1738311|NCT00342875|Exposure|exposure
1738312|NCT00342875|Drinking Water|drinking water
1738313|NCT00331331|Uveitis|uveitis
1738314|NCT00331331|Intermediate Uveitis|intermediate uveitis
1738315|NCT00331331|Pars Planitis|pars planitis
1738316|NCT00331331|Macular Edema|macular edema
1738317|NCT00331331|Vasculitis|vasculitis
1738318|NCT00331331|Ocular Inflammatory Disease|ocular inflammatory disease
1738319|NCT00316069|Erythropoiesis|erythropoiesis
1738320|NCT00316069|Leukapheresis|leukapheresis
1738321|NCT00316069|G-CSF|g-csf
1738322|NCT00316069|Mobilization|mobilization
1738323|NCT00316069|Stem Cells|stem cells
1738324|NCT00316069|Apheresis|apheresis
1738325|NCT00316069|Blood Donation|blood donation
1738326|NCT00316069|Healthy Volunteer|healthy volunteer
1738327|NCT00316069|HV|hv
1738328|NCT00287495|AIDS|aids
1738329|NCT00287495|HIV|hiv
1738330|NCT00287495|Antiangiogenesis|antiangiogenesis
1738331|NCT00287495|VEGF|vegf
1738332|NCT00287495|AIDS Malignancy|aids malignancy
1738333|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
1738334|NCT00287495|KS|ks
1738335|NCT00266110|stage IV breast cancer|stage iv breast cancer
1738336|NCT00266110|recurrent breast cancer|recurrent breast cancer
1738337|NCT00264849|Asthma|asthma
1738338|NCT00264849|omalizumab|omalizumab
1738339|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
1738340|NCT00242723|Lung Cancers|lung cancers
1738341|NCT00242723|Esophageal Cancer|esophageal cancer
1738342|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1738343|NCT00242723|Biopsy|biopsy
1738344|NCT00242723|Staging Studies|staging studies
1738345|NCT00242723|Lung Cancer|lung cancer
1738346|NCT00204477|soy diet|soy diet
1738347|NCT00204477|breast cancer|breast cancer
1738348|NCT00204477|ovarian hormones|ovarian hormones
1738349|NCT00204477|breast density|breast density
1738350|NCT00204477|prevention|prevention
1738351|NCT00176371|Physical fitness|physical fitness
1738352|NCT00106743|Usher Syndrome|usher syndrome
1738353|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
1738354|NCT00106743|Congenital Deafness|congenital deafness
1738355|NCT00090285|anogenital warts|anogenital warts
1738356|NCT00078559|Immunosuppression|immunosuppression
1738357|NCT00078559|Renal Failure|renal failure
1738358|NCT00065676|Hyperglycemia|hyperglycemia
1738359|NCT00065676|Hyperinsulinemia|hyperinsulinemia
1738360|NCT00065676|OGTT|ogtt
1738361|NCT00065676|GLUT2|glut2
1738362|NCT00065676|Post-Prandial|post-prandial
1738363|NCT00065676|Type 2 Diabetes|type 2 diabetes
1738364|NCT00065676|Obesity|obesity
1738365|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
1738366|NCT00055055|Microarray Analyses|microarray analyses
1738367|NCT00055055|Microchimerism|microchimerism
1738368|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
1738369|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
1738370|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
1738371|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
1738372|NCT00055055|Systemic Sclerosis|systemic sclerosis
1738373|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
1738374|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
1738375|NCT00055055|Dermatomyositis|dermatomyositis
1738376|NCT00055055|Scleroderma|scleroderma
1738377|NCT00055055|SLE|sle
1738378|NCT00055055|Lupus|lupus
1738379|NCT00055055|Rheumatic Disease|rheumatic disease
1738380|NCT00055055|RA|ra
1738381|NCT00055055|Healthy Volunteer|healthy volunteer
1738382|NCT00055055|HV|hv
1738383|NCT00027274|Fanconi's Anemia|fanconi's anemia
1738384|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
1738385|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
1738386|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
1738387|NCT00027274|Hereditary|hereditary
1738388|NCT00027274|Bone Marrow|bone marrow
1738389|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
1738390|NCT00027274|IBMFS|ibmfs
1738391|NCT00027274|Familial Cancer|familial cancer
1738392|NCT00016731|Depression|depression
1738393|NCT00016731|Anxiety|anxiety
1738394|NCT00016731|CAH|cah
1738395|NCT00016731|Adults|adults
1738396|NCT00016731|FMPP|fmpp
1738397|NCT00016731|Emotion|emotion
1738398|NCT00016731|Cushing's Syndrome|cushing's syndrome
1738399|NCT00016731|Adolescence|adolescence
1738411|NCT00013845|Complex Partial Seizures|complex partial seizures
1738413|NCT00013845|Generalized Seizures|generalized seizures
1738414|NCT00013845|Epilepsy|epilepsy
1738415|NCT00009243|Brain Scans|brain scans
1738416|NCT00009243|Brain Imaging|brain imaging
1738417|NCT00009243|Brain|brain
1738418|NCT00009243|Alteplase|alteplase
1738419|NCT00009243|Acute Stroke|acute stroke
1738420|NCT00009243|Stroke|stroke
1738421|NCT00009243|TIA|tia
1738422|NCT00009035|Brain|brain
1738423|NCT00009035|Tumor|tumor
1738424|NCT00009035|Chemotherapy|chemotherapy
1738425|NCT00009035|Antiangiogenesis|antiangiogenesis
1738426|NCT00009035|Radiation|radiation
1738427|NCT00009035|CNS Tumor|cns tumor
1738428|NCT00009035|Glioma|glioma
1738429|NCT00009035|Medulloblastoma|medulloblastoma
1738430|NCT00009035|Astrocytoma|astrocytoma
1738431|NCT00009035|Glioblastoma|glioblastoma
1738432|NCT00006505|Islet Isolation|islet isolation
1738433|NCT00006505|Diabetes|diabetes
1738434|NCT00001183|Computed Tomography|computed tomography
1738435|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
1738436|NCT00001183|Pulmonary Function Testing|pulmonary function testing
1738437|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
1738438|NCT00001183|Allergen Skin Testing|allergen skin testing
1738439|NCT00001183|Chronic Lung Disease|chronic lung disease
1738440|NCT00001872|Volunteer|volunteer
1738441|NCT00001872|Leukocyte Donors|leukocyte donors
1738442|NCT00001872|Family Members|family members
1738443|NCT00001872|Leukocyte Collection|leukocyte collection
1738444|NCT00001872|No Reimbursement|no reimbursement
1738445|NCT00001852|Xerostomia|xerostomia
1738446|NCT00001852|Oral Dryness|oral dryness
1738447|NCT00001852|Salivary Function|salivary function
1738448|NCT00001807|CNS directed therapy|cns directed therapy
1738449|NCT00001807|Neurotoxicity|neurotoxicity
1738450|NCT00001807|H-NMRS|h-nmrs
1738451|NCT00001807|MRI|mri
1738452|NCT00001345|Hypercalcemia|hypercalcemia
1738453|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
1738454|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
1738455|NCT00001345|Hyperparathyroidism|hyperparathyroidism
1738456|NCT00001345|Linkage Analysis|linkage analysis
1738457|NCT00001715|Consultation|consultation
1738458|NCT00001715|Training|training
1738459|NCT00001715|Referral|referral
1738460|NCT00001715|Fellowship Program|fellowship program
1738461|NCT00001715|Outpatient|outpatient
1738462|NCT00001715|Blood Disorder|blood disorder
1738463|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
1738464|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
1738465|NCT00001623|Graft vs. Host Disease|graft vs. host disease
1738466|NCT00001623|Whole Body Irradiation|whole body irradiation
1738467|NCT00001623|Donor Apheresis|donor apheresis
1738468|NCT00001623|Cyclophosphamide|cyclophosphamide
1738469|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
1738470|NCT00001623|Leukemic Relapse|leukemic relapse
1738471|NCT00001623|Multiple Myeloma|multiple myeloma
1738472|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1738473|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1738474|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1738475|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
1738476|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1738477|NCT00001563|Lymphomagenesis|lymphomagenesis
1738478|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
1738479|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
1738480|NCT00001563|AIDS-related NHL|aids-related nhl
1738481|NCT00001529|G-CSF|g-csf
1738482|NCT00001529|Donor Apheresis|donor apheresis
1738483|NCT00001529|Graft vs. Host Disease|graft vs. host disease
1738484|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
1738485|NCT00001529|Dexamethasone|dexamethasone
1738486|NCT00001529|Transient Lymphopenia|transient lymphopenia
1738487|NCT00001529|Improved T-Cell Depletion|improved t-cell depletion
1738488|NCT00001529|Normal Volunteer|normal volunteer
1738489|NCT00001458|Exercise Testing|exercise testing
1738490|NCT00001458|Echocardiography|echocardiography
1738491|NCT00001458|Cardiac Catheterization|cardiac catheterization
1738492|NCT00001458|Radionuclide Stress Testing|radionuclide stress testing
1738493|NCT00001458|Holter Monitoring|holter monitoring
1738494|NCT00001458|Heart Disease|heart disease
1738495|NCT00001458|Muscle Leg Pain|muscle leg pain
1738496|NCT00001458|Leg Pain|leg pain
1738497|NCT00001458|Circulation|circulation
1738498|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
1738499|NCT00001458|Intermittent Claudication|intermittent claudication
1738500|NCT00001458|Renal Vascular Disease|renal vascular disease
1738501|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
1738502|NCT00001806|Genetic Testing|genetic testing
1738503|NCT00001806|Genetic Counseling|genetic counseling
1738504|NCT00001806|BRCA1/BRCA2|brca1/brca2
1738505|NCT00001806|Genetic Education|genetic education
1738506|NCT00001806|Informed Consent|informed consent
1738507|NCT00001806|Breast Cancer|breast cancer
1738508|NCT00001806|Ovarian Cancer|ovarian cancer
1738509|NCT00001806|Known Family Mutation|known family mutation
940318|NCT03543397|MRI|mri
935671|NCT03572933|refractory seizures|refractory seizures
935672|NCT03572933|genetic pediatric encephalopathies|genetic pediatric encephalopathies
935673|NCT03572933|epilepsy in children|epilepsy in children
935674|NCT03572933|seizure disorder|seizure disorder
935675|NCT03572920|Sleep|sleep
935676|NCT03572920|Actigraphy|actigraphy
935677|NCT03572920|Pain|pain
935678|NCT03572920|Patients|patients
935679|NCT03572920|Hospitalization|hospitalization
935680|NCT03572920|Hip Replacement|hip replacement
935681|NCT03572920|Knee Replacement|knee replacement
935682|NCT03572920|Arthroplasty|arthroplasty
935683|NCT03572881|Brugada syndrome|brugada syndrome
935684|NCT03572881|ventricular arrhythmia|ventricular arrhythmia
935685|NCT03572881|sudden death|sudden death
935686|NCT03572803|ntratissue Percutaneous Electrolysis|ntratissue percutaneous electrolysis
935687|NCT03572803|Dry needling|dry needling
935688|NCT03572803|Eccentric exercise|eccentric exercise
935689|NCT03572803|Lateral epicondyle|lateral epicondyle
935690|NCT03572790|5-HT4|5-ht4
935691|NCT03572790|Prucalopride|prucalopride
935692|NCT03572790|Resolor|resolor
935693|NCT03572790|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
935694|NCT03572790|Emotional Processing|emotional processing
935695|NCT03572790|Healthy Volunteers|healthy volunteers
935696|NCT03572777|Helicobacter pylori, eradication, hybrid therapy, concomitant therapy|helicobacter pylori, eradication, hybrid therapy, concomitant therapy
935697|NCT03572751|Sensor|sensor
935698|NCT03572751|Wearable|wearable
935699|NCT03572738|acne inversa|acne inversa
935700|NCT03572738|HS|hs
935701|NCT03572738|Verneuil's Disease|verneuil's disease
935702|NCT03572712|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
935703|NCT03572712|Non Invasive Ventilation|non invasive ventilation
935704|NCT03572712|Transcutaneous capnography|transcutaneous capnography
935705|NCT03572686|supraclavicular nerve block|supraclavicular nerve block
935706|NCT03572686|dexamethasone|dexamethasone
935707|NCT03572686|Ropivacaine|ropivacaine
935708|NCT03572660|stem cell|stem cell
935709|NCT03572660|circulatory support|circulatory support
935710|NCT03572647|Erythropoeitin|erythropoeitin
935711|NCT03572647|Chronic Kidney Disease|chronic kidney disease
935712|NCT03572647|Anaemia|anaemia
935713|NCT03572634|Tolero|tolero
935714|NCT03572634|Phase 1/2|phase 1/2
935715|NCT03572634|First in human|first in human
935716|NCT03572634|Previously treated Chronic Lymphocytic Leukemia (CLL)|previously treated chronic lymphocytic leukemia (cll)
935717|NCT03572634|Previously treated Small Lymphocytic Lymphoma (SLL)|previously treated small lymphocytic lymphoma (sll)
935718|NCT03572634|AXL inhibitor|axl inhibitor
935719|NCT03572634|Cancer|cancer
935720|NCT03572634|Advanced Cancer|advanced cancer
935721|NCT03572621|Prostatectomy|prostatectomy
935722|NCT03572608|acupuncture|acupuncture
935723|NCT03572608|infertility|infertility
935740|NCT03572465|Magnetic resonance elastography|magnetic resonance elastography
935741|NCT03572465|Diagnostic performance|diagnostic performance
935742|NCT03572465|Sensitivity and specificity|sensitivity and specificity
935743|NCT03572439|epidural|epidural
935744|NCT03572439|sensory block level|sensory block level
935745|NCT03572439|dermatome|dermatome
935746|NCT03572413|Laparoscopic surgery|laparoscopic surgery
935747|NCT03572413|Deep neuromuscular block|deep neuromuscular block
935748|NCT03572413|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
935749|NCT03572413|Postoperative immune suppression|postoperative immune suppression
935750|NCT03572387|Prostate Neoplasms|prostate neoplasms
935751|NCT03572387|Prostatic Neoplasms|prostatic neoplasms
935752|NCT03572387|5-Azacitidine|5-azacitidine
935753|NCT03572387|all-trans retinoic acid|all-trans retinoic acid
935754|NCT03572387|PSA|psa
935759|NCT03572348|urethral stricture|urethral stricture
935760|NCT03572348|urethroplasty|urethroplasty
935761|NCT03572348|bulbar urethra|bulbar urethra
935762|NCT03572348|reconstructive surgery|reconstructive surgery
935763|NCT03572348|lower urinary tract symptoms|lower urinary tract symptoms
935776|NCT03572296|Glucose|glucose
935777|NCT03572296|Postprandial|postprandial
935778|NCT03572296|Metabolism|metabolism
935779|NCT03572296|Cognition|cognition
935780|NCT03572283|Pancreas|pancreas
935781|NCT03572283|pancreatic adenocarcinoma|pancreatic adenocarcinoma
935782|NCT03572283|adenocarcinoma|adenocarcinoma
935783|NCT03572283|bethanechol|bethanechol
935784|NCT03572283|parasympathetic|parasympathetic
935785|NCT03572270|HIV|hiv
935786|NCT03572270|Ovarian reserve|ovarian reserve
935787|NCT03572270|Fertility preservation|fertility preservation
935788|NCT03572270|Anti HIV agents|anti hiv agents
935789|NCT03572244|Laser-Lok|laser-lok
935790|NCT03572244|Crevicular fluid|crevicular fluid
935791|NCT03572244|Machined|machined
935792|NCT03572244|Abutment|abutment
935793|NCT03572231|Betmiga|betmiga
935794|NCT03572231|OAB|oab
935795|NCT03572231|YM178|ym178
935796|NCT03572231|Overactive Bladder|overactive bladder
935797|NCT03572231|mirabegron|mirabegron
935798|NCT03572205|Nutrigenetics|nutrigenetics
935799|NCT03572179|3d printed positioning tray|3d printed positioning tray
935800|NCT03572166|Copeptin|copeptin
935811|NCT03572127|Protein|protein
935812|NCT03572127|Resistance Exercise|resistance exercise
935813|NCT03572127|Skeletal Muscle|skeletal muscle
935814|NCT03572127|Mycoprotein|mycoprotein
935815|NCT03572127|Sustainability|sustainability
935816|NCT03572101|colorectal cancer|colorectal cancer
935817|NCT03572101|palliative care|palliative care
935818|NCT03572101|patients|patients
935819|NCT03572101|caregivers|caregivers
935820|NCT03572101|quality of life|quality of life
935821|NCT03572062|Respiratory tract infection, RSV, Adjuvant, vaccine|respiratory tract infection, rsv, adjuvant, vaccine
935822|NCT03572036|Outcomes Assessment|outcomes assessment
935823|NCT03572036|Sickle Cell Disease|sickle cell disease
935824|NCT03572023|acute coronary syndrome|acute coronary syndrome
935825|NCT03572023|non-obstructive coronary artery atherosclerosis|non-obstructive coronary artery atherosclerosis
935826|NCT03571984|Breast cancer|breast cancer
935827|NCT03571984|depression|depression
935828|NCT03571984|Moving on ABC Plus|moving on abc plus
935829|NCT03571984|Pakistan|pakistan
935830|NCT03571919|Lidocaine infusion|lidocaine infusion
935831|NCT03571906|Rehabilitation|rehabilitation
935832|NCT03571867|Adenotonsillectomy|adenotonsillectomy
935833|NCT03571867|Severity of Agitation|severity of agitation
935834|NCT03571867|Sugammadex|sugammadex
935835|NCT03571841|Breast Cancer Survivors|breast cancer survivors
935836|NCT03571841|Sexual Function Disturbances|sexual function disturbances
935837|NCT03571841|Ovarian Suppression Treatment|ovarian suppression treatment
935841|NCT03571802|pharmacokinetics|pharmacokinetics
935842|NCT03571802|simvastatin|simvastatin
935843|NCT03571802|bariatric surgery|bariatric surgery
935844|NCT03571802|laporoscopic sleeve gastrectomy|laporoscopic sleeve gastrectomy
935845|NCT03571789|AF|af
935846|NCT03571763|Cerebral Hemorrhage|cerebral hemorrhage
935847|NCT03571763|anti-thrombosis|anti-thrombosis
935848|NCT03571750|Suicide|suicide
935849|NCT03571750|Prevention|prevention
935850|NCT03571750|Risk Factor|risk factor
935851|NCT03571750|Intervention|intervention
935852|NCT03571750|Military|military
935853|NCT03571737|acute pain|acute pain
935854|NCT03571737|muscle strain|muscle strain
935855|NCT03571737|muscle sprain|muscle sprain
935856|NCT03571737|injury|injury
935857|NCT03571737|emergency department|emergency department
935858|NCT03571724|Very Low Nicotine|very low nicotine
935859|NCT03571724|Cigarette|cigarette
935860|NCT03571724|VLN|vln
935861|NCT03571698|Knee Osteoarthritis|knee osteoarthritis
935862|NCT03571698|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
935863|NCT03571698|Exercise|exercise
935864|NCT03571698|Pain|pain
935865|NCT03571698|Function|function
935866|NCT03571672|Left Ventricular Ejection Fraction|left ventricular ejection fraction
935867|NCT03571672|DEFINITY|definity
935868|NCT03571672|Enhanced Echocardiogram|enhanced echocardiogram
935886|NCT03571542|respiratory disease|respiratory disease
936570|NCT03567252|Appalachia|appalachia
935887|NCT03571542|immunosuppression|immunosuppression
935888|NCT03571529|EMG driven exoskeleton|emg driven exoskeleton
935889|NCT03571529|hand rehabilitation|hand rehabilitation
935890|NCT03571529|hand function|hand function
935891|NCT03571529|upper extremity outcome|upper extremity outcome
935892|NCT03571516|Short bowel syndrome|short bowel syndrome
935893|NCT03571516|Teduglutide|teduglutide
935894|NCT03571503|Complementary Therapies|complementary therapies
935895|NCT03571503|Exercise|exercise
935896|NCT03571503|Acupuncture|acupuncture
935897|NCT03571477|Sleep apnea diagnosis|sleep apnea diagnosis
935898|NCT03571477|Sleep apnea monitoring|sleep apnea monitoring
935903|NCT03571451|peritoneal dialysis|peritoneal dialysis
935904|NCT03571451|survival rate|survival rate
935905|NCT03571451|technique survival rate|technique survival rate
935906|NCT03571451|risk factors|risk factors
935907|NCT03571451|end stage renal disease|end stage renal disease
935908|NCT03571412|Depression|depression
935909|NCT03571412|Major Depressive Disorder|major depressive disorder
935914|NCT03571360|Immunotherapy|immunotherapy
935915|NCT03571347|distress|distress
935916|NCT03571347|post-traumatic stress disorder|post-traumatic stress disorder
935917|NCT03571347|prevention|prevention
935918|NCT03571347|asylum seekers|asylum seekers
935919|NCT03571347|refugees|refugees
935920|NCT03571347|Self Help Plus|self help plus
935921|NCT03571347|Europe|europe
935922|NCT03571308|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
935923|NCT03571308|Acalabrunitib|acalabrunitib
935924|NCT03571308|Bruton Tyrosine Kinase|bruton tyrosine kinase
935925|NCT03571308|R-CHOP|r-chop
935926|NCT03571308|Molecular Profiling|molecular profiling
935927|NCT03571308|Chemoimmunotherapy|chemoimmunotherapy
935928|NCT03571295|pediatric airway management|pediatric airway management
935929|NCT03571295|learning curve|learning curve
935930|NCT03571282|conbercept|conbercept
935931|NCT03571282|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
935932|NCT03571282|safety|safety
935933|NCT03571282|effectiveness|effectiveness
935934|NCT03571230|Helicobacter Pylori Infection|helicobacter pylori infection
935935|NCT03571230|Antimicrobial Susceptibility testing(AST)|antimicrobial susceptibility testing(ast)
935936|NCT03571217|Type 2 diabetes mellitus|type 2 diabetes mellitus
935937|NCT03571217|diabetic retinopathy|diabetic retinopathy
935938|NCT03571217|visual impairment|visual impairment
935939|NCT03571217|diabetic choroidopathy|diabetic choroidopathy
935949|NCT03571152|Caregivers|caregivers
935950|NCT03571152|Educational videos|educational videos
935951|NCT03571152|Subacute phase|subacute phase
935952|NCT03571139|OCT angiography|oct angiography
935953|NCT03571139|Diabetic retinopathy|diabetic retinopathy
935954|NCT03571139|Cataract surgery|cataract surgery
935955|NCT03571113|cardiac arrest, OHCA survival score, predicting survival, German Resuscitation Registry|cardiac arrest, ohca survival score, predicting survival, german resuscitation registry
935956|NCT03571061|water-aided colonoscopy; difficult colonoscopy|water-aided colonoscopy; difficult colonoscopy
935959|NCT03570996|esophageal cancer|esophageal cancer
935960|NCT03570996|transversus abdominis plane catheter|transversus abdominis plane catheter
935961|NCT03570996|epidural|epidural
935962|NCT03570996|pain, postoperative|pain, postoperative
935963|NCT03570944|Postoperative Complications|postoperative complications
935965|NCT03570931|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
935966|NCT03570918|HIV, Latent HIV-1 infection, HIV therapy, antibody-based therapy|hiv, latent hiv-1 infection, hiv therapy, antibody-based therapy
935967|NCT03570905|acute, displaced distal radius fracture|acute, displaced distal radius fracture
935969|NCT03570892|B-Cell Lymphoma|b-cell lymphoma
935970|NCT03570892|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
935971|NCT03570892|High Grade B-cell Lymphoma|high grade b-cell lymphoma
935972|NCT03570892|Follicular Lymphoma grade 3B|follicular lymphoma grade 3b
935973|NCT03570892|CAR-T|car-t
935974|NCT03570892|Tisagenlecleucel|tisagenlecleucel
935975|NCT03570892|Kymriah|kymriah
935976|NCT03570892|Immunotherapy|immunotherapy
935977|NCT03570892|Cellular therapy|cellular therapy
935978|NCT03570892|CTL019|ctl019
935979|NCT03570879|Laparoscopy|laparoscopy
935980|NCT03570879|Power morcellation|power morcellation
935981|NCT03570879|Transvaginal extraction|transvaginal extraction
935982|NCT03570866|Endometrial cancer|endometrial cancer
935983|NCT03570866|Positron emission tomography|positron emission tomography
935984|NCT03570853|Resiliency|resiliency
935985|NCT03570840|pediatric metabolic syndrome|pediatric metabolic syndrome
935986|NCT03570801|Lumbar Spondylolisthesis|lumbar spondylolisthesis
935987|NCT03570801|Grade 1 Spondylolisthesis|grade 1 spondylolisthesis
935988|NCT03570801|Lumbar Spinal Stenosis|lumbar spinal stenosis
935989|NCT03570801|Degenerative Spondylolisthesis|degenerative spondylolisthesis
935990|NCT03570775|hyperbilirubinemia|hyperbilirubinemia
935991|NCT03570775|treatment|treatment
935992|NCT03570775|devices|devices
935993|NCT03570775|newborn|newborn
935994|NCT03570775|phototherapy|phototherapy
935995|NCT03570762|bioresorbable vascular scaffold|bioresorbable vascular scaffold
935996|NCT03570710|cesarean section|cesarean section
935997|NCT03570710|placenta accreta spectrum|placenta accreta spectrum
935998|NCT03570710|tranexamic acid|tranexamic acid
935999|NCT03570697|Optical coherence tomography (OCT)|optical coherence tomography (oct)
936000|NCT03570697|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
936001|NCT03570697|Coronary angiography|coronary angiography
936002|NCT03570697|Coronary artery disease|coronary artery disease
936003|NCT03570697|Cardiovascular events|cardiovascular events
936004|NCT03570697|Coronary atherosclerotic plaques|coronary atherosclerotic plaques
936005|NCT03570697|Lipid-lowering therapy|lipid-lowering therapy
936006|NCT03570697|Statin|statin
936007|NCT03570697|Maximally tolerated statin therapy|maximally tolerated statin therapy
936008|NCT03570671|MDCTA|mdcta
936009|NCT03570671|Coronary artery spasm|coronary artery spasm
936010|NCT03570619|Metastatic Cancer|metastatic cancer
936011|NCT03570619|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
936012|NCT03570619|mCRPC|mcrpc
936013|NCT03570619|Immunotherapy|immunotherapy
936014|NCT03570619|CDK12|cdk12
936015|NCT03570580|Sleep Apnea, Obstructive, Mass Screening|sleep apnea, obstructive, mass screening
936016|NCT03570541|Colon cancer|colon cancer
936017|NCT03570541|nerve block|nerve block
936018|NCT03570541|ultra-sound|ultra-sound
936019|NCT03570541|opioids|opioids
936020|NCT03570541|surgical stress|surgical stress
936022|NCT03570450|Cell therapy|cell therapy
936023|NCT03570450|stem cell|stem cell
936024|NCT03570450|transplantation|transplantation
936025|NCT03570450|graft|graft
936026|NCT03570450|recovery|recovery
936027|NCT03570450|repair|repair
936028|NCT03570450|stroke|stroke
936029|NCT03570450|msesenchymal stem cell|msesenchymal stem cell
936030|NCT03570450|regenerative|regenerative
936031|NCT03570437|Endometrial|endometrial
936032|NCT03570437|Cancer|cancer
936033|NCT03570437|Paclitaxel|paclitaxel
936034|NCT03570437|Cediranib|cediranib
936035|NCT03570437|Olaparib|olaparib
936036|NCT03570424|Organelle Biogenesis|organelle biogenesis
936037|NCT03570424|Adaptation, Physiological|adaptation, physiological
936038|NCT03570424|Whey Proteins|whey proteins
936039|NCT03570424|Protein Hydrolysates|protein hydrolysates
936040|NCT03570372|Life quality|life quality
936041|NCT03570372|ASD|asd
936042|NCT03570372|Internet based treatment|internet based treatment
936043|NCT03570372|Autism|autism
936044|NCT03570372|ICBT|icbt
936045|NCT03570359|COPD|copd
936046|NCT03570333|gingival recession|gingival recession
936047|NCT03570333|gingival graft|gingival graft
936048|NCT03570333|Palate|palate
936049|NCT03570333|Gingival mesenchymal stem cells|gingival mesenchymal stem cells
936050|NCT03570333|molar|molar
936051|NCT03570333|premolar|premolar
936052|NCT03570320|opioid|opioid
936053|NCT03570320|narcotic|narcotic
936054|NCT03570320|postoperative|postoperative
936055|NCT03570320|prescription|prescription
936056|NCT03570320|refill|refill
936057|NCT03570320|upper extremity surgery|upper extremity surgery
936058|NCT03570307|MISCARRAGE, CURATTAGE MISOPROSTOL|miscarrage, curattage misoprostol
936059|NCT03570281|cancer-related stroke|cancer-related stroke
936060|NCT03570281|coagulopathy|coagulopathy
936061|NCT03570281|D-dimer|d-dimer
936067|NCT03570242|gynecologic cancer|gynecologic cancer
936068|NCT03570242|WB-EMS|wb-ems
936069|NCT03570242|whole-body electromyostimulation|whole-body electromyostimulation
936070|NCT03570242|nutrition|nutrition
936071|NCT03570242|protein|protein
936072|NCT03570242|exercise|exercise
936073|NCT03570242|cancer cachexia|cancer cachexia
936074|NCT03570229|Quality of life (QOL)|quality of life (qol)
936075|NCT03570229|Hyperbaric oxygen treatment (HBOT)|hyperbaric oxygen treatment (hbot)
936076|NCT03570229|Late radiation tissue injury (LRTI)|late radiation tissue injury (lrti)
936077|NCT03570229|Longitudinal|longitudinal
936078|NCT03570229|Mixed methods|mixed methods
936079|NCT03570229|Patient experiences|patient experiences
936080|NCT03570216|acute exercise|acute exercise
936081|NCT03570216|High-intensity interval exercise|high-intensity interval exercise
936082|NCT03570216|feasibility|feasibility
936083|NCT03570216|arterial stiffness|arterial stiffness
936084|NCT03570203|Hyponatremia|hyponatremia
936085|NCT03570203|Dysnatremia|dysnatremia
936086|NCT03570203|Neurosurgery|neurosurgery
936087|NCT03570203|Neurointensive Care|neurointensive care
936088|NCT03570177|osteoporotic fractures|osteoporotic fractures
936089|NCT03570177|QCT|qct
936090|NCT03570177|BND|bnd
936091|NCT03570177|automatic measurement|automatic measurement
936092|NCT03570138|Freestyle libre|freestyle libre
936093|NCT03570138|Type 2 diabetes|type 2 diabetes
936094|NCT03570138|Hypoglycemia-induced cardiac arrhythmias|hypoglycemia-induced cardiac arrhythmias
936095|NCT03570138|Flash Continuous Glucose Monitoring|flash continuous glucose monitoring
936096|NCT03570099|opioid overdose|opioid overdose
936097|NCT03570099|mortality|mortality
936098|NCT03570099|naloxone|naloxone
936099|NCT03570099|substance use disorder|substance use disorder
936100|NCT03570099|prevention|prevention
936101|NCT03570047|Non-valvular atrial fibrillation, NVAF|non-valvular atrial fibrillation, nvaf
936102|NCT03570008|prevention|prevention
936103|NCT03570008|bone|bone
936104|NCT03570008|physical activity|physical activity
936105|NCT03570008|spa bath|spa bath
936106|NCT03570008|women|women
936107|NCT03569982|Integrative medicine|integrative medicine
936108|NCT03569982|Peri-operative anxiety|peri-operative anxiety
936109|NCT03569982|Pain|pain
936110|NCT03569982|MOHS surgery|mohs surgery
936111|NCT03569969|amniotic membrane|amniotic membrane
936112|NCT03569969|Tympanic Membrane Perforation|tympanic membrane perforation
936119|NCT03569930|Flavonoid-based supplements|flavonoid-based supplements
936120|NCT03569930|Centella asiatica|centella asiatica
936121|NCT03569930|Hemorrhoids|hemorrhoids
936122|NCT03569930|defecation|defecation
936123|NCT03569930|bleeding|bleeding
936124|NCT03569930|pain|pain
936125|NCT03569904|Cystic fibrosis|cystic fibrosis
936126|NCT03569904|Pulmonary Dysbiosis|pulmonary dysbiosis
936127|NCT03569904|pulmonary exacerbation|pulmonary exacerbation
936128|NCT03569904|Fungal bacterial pulmonary dysbiosis|fungal bacterial pulmonary dysbiosis
936129|NCT03569904|Viral bacterial pulmonary dysbiosis|viral bacterial pulmonary dysbiosis
936130|NCT03569904|Microbiota|microbiota
936131|NCT03569891|Gene therapy|gene therapy
936132|NCT03569891|FIX|fix
936133|NCT03569891|Factor IX|factor ix
936134|NCT03569891|Bleeding|bleeding
936135|NCT03569891|Viral vector|viral vector
936136|NCT03569891|Padua|padua
936137|NCT03569891|Hemophilia|hemophilia
936138|NCT03569891|AAV (adeno-associated virus)|aav (adeno-associated virus)
936139|NCT03569891|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
936140|NCT03569891|serotype 5|serotype 5
936141|NCT03569878|PTSD|ptsd
936142|NCT03569878|Physical Injury|physical injury
936143|NCT03569878|Patient Concerns|patient concerns
936144|NCT03569878|Emergency Department Utilization|emergency department utilization
936145|NCT03569813|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
936146|NCT03569813|Home-based monitoring|home-based monitoring
936147|NCT03569800|Levothyrox®|levothyrox®
936148|NCT03569800|thyroid hormones|thyroid hormones
936149|NCT03569800|bioequivalent|bioequivalent
936150|NCT03569761|colorectal cancer screening|colorectal cancer screening
936151|NCT03569761|decision aids|decision aids
936152|NCT03569761|American Indians|american indians
936153|NCT03569748|smoking|smoking
936154|NCT03569748|harm reduction|harm reduction
936155|NCT03569748|electronic cigarette|electronic cigarette
936156|NCT03569748|heated tobacco product|heated tobacco product
936157|NCT03569735|Prospective Cohort Study|prospective cohort study
936158|NCT03569735|Nutrition|nutrition
936159|NCT03569735|Chronic diseases|chronic diseases
936160|NCT03569735|Nanshan|nanshan
936161|NCT03569735|Chinese|chinese
936459|NCT03568084|elderly|elderly
936201|NCT03569566|Endurance performance|endurance performance
936202|NCT03569566|Elite endurance athletes|elite endurance athletes
936204|NCT03569553|Bacillus anthracis|bacillus anthracis
936205|NCT03569553|Inhalational anthrax|inhalational anthrax
936206|NCT03569553|Bacterial infection|bacterial infection
936207|NCT03569553|AIGIV|aigiv
936208|NCT03569553|Anthrasil|anthrasil
936209|NCT03569553|Anthrax immune globulin|anthrax immune globulin
936210|NCT03569553|Anti toxin|anti toxin
936211|NCT03569553|Poluclonal antibodies|poluclonal antibodies
936212|NCT03569540|Subarachnoid hemorrhage|subarachnoid hemorrhage
936213|NCT03569540|Glibenclamide|glibenclamide
936214|NCT03569527|Kiwifruit|kiwifruit
936215|NCT03569514|Anthrax|anthrax
936216|NCT03569514|Bacillus anthracis|bacillus anthracis
936217|NCT03569514|Bacterial infection|bacterial infection
936218|NCT03569514|AIGIV|aigiv
936219|NCT03569514|Anthrax immune globulin|anthrax immune globulin
936220|NCT03569514|Anti toxin|anti toxin
936221|NCT03569514|Polyclonal antibodies|polyclonal antibodies
936222|NCT03569501|gestational diabetes mellitus|gestational diabetes mellitus
936223|NCT03569501|oat|oat
936224|NCT03569501|docosahexaenoic acid|docosahexaenoic acid
936225|NCT03569501|glycemic control|glycemic control
936226|NCT03569501|intestinal flora|intestinal flora
936227|NCT03569501|newborn|newborn
936228|NCT03569501|leptin|leptin
936229|NCT03569462|HIV self-testing|hiv self-testing
936230|NCT03569462|Mobile Health|mobile health
936231|NCT03569462|Men who have sex with men|men who have sex with men
936232|NCT03569462|China|china
936233|NCT03569449|Family navigation|family navigation
936234|NCT03569449|Family partners|family partners
936235|NCT03569449|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
936236|NCT03569449|Pediatric Symptom Checklist-17|pediatric symptom checklist-17
936237|NCT03569449|Survey of Wellbeing of Young children (SWYC)|survey of wellbeing of young children (swyc)
936238|NCT03569449|Family Resource Scale|family resource scale
936239|NCT03569449|Federally qualified community health center|federally qualified community health center
936240|NCT03569410|peritoneal dialysis|peritoneal dialysis
936241|NCT03569410|albumin|albumin
936242|NCT03569410|end stage renal disease|end stage renal disease
936243|NCT03569371|Hidradenitis suppurativa (HS)|hidradenitis suppurativa (hs)
936244|NCT03569371|Janus kinase (JAK)|janus kinase (jak)
936245|NCT03569371|Janus kinase 1 (JAK1) inhibitor|janus kinase 1 (jak1) inhibitor
936246|NCT03569358|Randomised Controlled Study|randomised controlled study
936247|NCT03569358|Unblinded|unblinded
936248|NCT03569358|Electroencephalogram|electroencephalogram
936249|NCT03569358|Feasibility|feasibility
936250|NCT03569332|Incentive Spirometer|incentive spirometer
936251|NCT03569319|Mediterranean Diet|mediterranean diet
936252|NCT03569319|Lifestyle|lifestyle
936253|NCT03569306|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
936254|NCT03569306|peripheral pulmonary nodules|peripheral pulmonary nodules
936255|NCT03569306|diagnostic yield|diagnostic yield
936256|NCT03569293|Atopic Dermatitis|atopic dermatitis
936257|NCT03569293|Upadacitinib|upadacitinib
936258|NCT03569280|KPG-121|kpg-121
936265|NCT03569254|treatment|treatment
936266|NCT03569254|hyperbilirubinemia|hyperbilirubinemia
936267|NCT03569241|Radiotherapy|radiotherapy
936268|NCT03569241|metastasis-directed therapy|metastasis-directed therapy
936269|NCT03569228|hearing loss|hearing loss
936270|NCT03569228|hearing aids|hearing aids
936271|NCT03569202|Lubricant Eye Drops|lubricant eye drops
936272|NCT03569202|Moderate or Severe Dry Eye|moderate or severe dry eye
936273|NCT03569202|Hyaluronic Acid|hyaluronic acid
936274|NCT03569202|Trehalose|trehalose
936275|NCT03569202|Disaccharides|disaccharides
936276|NCT03569202|Polysaccharides|polysaccharides
936277|NCT03569202|Fatty Acids, Omega-3|fatty acids, omega-3
936278|NCT03569202|Tears|tears
936279|NCT03569202|Osmolar Concentration|osmolar concentration
936280|NCT03569202|Anterior Eye Segment|anterior eye segment
936281|NCT03569202|Severity of Illness Index|severity of illness index
936282|NCT03569176|mobile health, autism, ASD, mobile therapy|mobile health, autism, asd, mobile therapy
936283|NCT03569150|palliative care|palliative care
936284|NCT03569150|end-of-life care|end-of-life care
936285|NCT03569150|advance care planning|advance care planning
936286|NCT03569150|communication|communication
936287|NCT03569150|health literacy|health literacy
936288|NCT03569150|serious life-limiting illness|serious life-limiting illness
936289|NCT03569137|Gut Microbiome|gut microbiome
936290|NCT03569137|hematologic malignancies B|hematologic malignancies b
936291|NCT03569137|biomarkers|biomarkers
936292|NCT03569137|targeted therapy|targeted therapy
936293|NCT03569137|Gut microbiota|gut microbiota
936294|NCT03569111|Lung Nodule|lung nodule
936295|NCT03569111|Bronchoscopy|bronchoscopy
936296|NCT03569111|Ablation, Microwave|ablation, microwave
936297|NCT03569059|Stroke|stroke
936298|NCT03569059|Virtual Environment|virtual environment
936299|NCT03569059|Robotics|robotics
936300|NCT03569059|Upper Extremity|upper extremity
936301|NCT03569059|Hand|hand
936302|NCT03569059|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
936303|NCT03569020|Diet|diet
936304|NCT03569020|Nutrition|nutrition
936305|NCT03569020|DASH|dash
936306|NCT03569020|Gout|gout
936307|NCT03569020|Hyperuricemia|hyperuricemia
936308|NCT03569020|Potassium|potassium
936309|NCT03569020|Uric acid|uric acid
936310|NCT03569020|Trial|trial
936311|NCT03569020|Blood pressure|blood pressure
936312|NCT03569020|Glucose|glucose
936313|NCT03569020|Lipid|lipid
936314|NCT03569020|Cholesterol|cholesterol
936315|NCT03569020|Weight|weight
936316|NCT03569020|Arthritis|arthritis
936317|NCT03569020|BMI|bmi
936318|NCT03569020|Body mass index|body mass index
936319|NCT03569020|Fruit|fruit
936320|NCT03569020|Vegetable|vegetable
936321|NCT03569020|Low fat dairy|low fat dairy
936322|NCT03569020|Lean meat|lean meat
936323|NCT03569020|Fiber|fiber
936324|NCT03568968|Parkinson's Disease|parkinson's disease
936325|NCT03568968|NAD metabolism|nad metabolism
936326|NCT03568968|Mitochondria|mitochondria
936327|NCT03568968|Nicotinamide Riboside|nicotinamide riboside
936328|NCT03568955|assessment|assessment
936329|NCT03568955|validation|validation
936330|NCT03568955|prolonged grief disorder|prolonged grief disorder
936331|NCT03568955|cross cultural|cross cultural
936332|NCT03568955|questionnaire|questionnaire
936338|NCT03568903|Parkinson Disease|parkinson disease
936339|NCT03568903|Gait|gait
936340|NCT03568903|Physical therapy|physical therapy
936341|NCT03568903|functional performance|functional performance
936342|NCT03568903|group therapy|group therapy
936343|NCT03568890|Left Atrial Appendage Closure|left atrial appendage closure
936344|NCT03568890|Anticoagulation therapy|anticoagulation therapy
936345|NCT03568890|Antiplatelet therapy|antiplatelet therapy
936346|NCT03568825|Two-dimensional randomized response surface pathway design|two-dimensional randomized response surface pathway design
936347|NCT03568825|Osteopathic Manual Therapy|osteopathic manual therapy
936348|NCT03568825|OMT in treatment of GERD|omt in treatment of gerd
936349|NCT03568825|Dose-response|dose-response
936350|NCT03568812|HIV|hiv
936351|NCT03568812|immunological non responder|immunological non responder
936352|NCT03568812|gut inflammation|gut inflammation
936353|NCT03568786|end-inspiratory pause|end-inspiratory pause
936354|NCT03568786|lung protection|lung protection
936355|NCT03568786|intraoperative ventilation|intraoperative ventilation
936356|NCT03568786|lung compliance|lung compliance
936357|NCT03568760|Anomia|anomia
936358|NCT03568734|microbiome|microbiome
936359|NCT03568734|transplant|transplant
936360|NCT03568734|infant|infant
936361|NCT03568734|newborn|newborn
936362|NCT03568721|pain|pain
936363|NCT03568721|orthodontics|orthodontics
936571|NCT03567252|Exercise|exercise
936364|NCT03568708|Primary Ovarian Insufficiency|primary ovarian insufficiency
936365|NCT03568708|Hormone Replacement Therapy|hormone replacement therapy
936366|NCT03568708|Estrogen Deficiency|estrogen deficiency
936367|NCT03568695|pooled analysis|pooled analysis
936368|NCT03568695|sensitivity|sensitivity
936369|NCT03568695|men who have sex with men|men who have sex with men
936370|NCT03568682|food insecurity|food insecurity
936371|NCT03568682|nutrition|nutrition
936372|NCT03568682|treatment adherence|treatment adherence
936373|NCT03568669|NIH Toolbox|nih toolbox
936374|NCT03568669|Toolbox|toolbox
936375|NCT03568669|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
936376|NCT03568669|CCHS|cchs
936377|NCT03568669|Autonomic Nervous System Dysregulation|autonomic nervous system dysregulation
936378|NCT03568669|PHOX2B|phox2b
936379|NCT03568617|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
936380|NCT03568617|Migraine Disorders|migraine disorders
936381|NCT03568617|Prophylaxis|prophylaxis
936382|NCT03568617|Treatment Outcome|treatment outcome
936383|NCT03568617|Brain|brain
936384|NCT03568604|vulvovaginal atrophy|vulvovaginal atrophy
936385|NCT03568604|dyspareunia|dyspareunia
936386|NCT03568604|prasterone|prasterone
936387|NCT03568604|vulvoscopy|vulvoscopy
936388|NCT03568591|Psychosensory Therapy|psychosensory therapy
936389|NCT03568591|Trauma, Psychological|trauma, psychological
936390|NCT03568591|DS14|ds14
936391|NCT03568591|CD-RISC|cd-risc
936392|NCT03568591|Resilience|resilience
936393|NCT03568591|Psychosomatic Medicine|psychosomatic medicine
936394|NCT03568591|Type D Personality|type d personality
936395|NCT03568591|Salivary Cortisol|salivary cortisol
936396|NCT03568591|Blood Pressure|blood pressure
936397|NCT03568591|Havening Techniques|havening techniques
936398|NCT03568578|Fibrosis|fibrosis
936399|NCT03568578|Liver Cirrhosis|liver cirrhosis
936400|NCT03568578|non-invasive biopsy|non-invasive biopsy
936401|NCT03568578|hepatitis B virus|hepatitis b virus
936402|NCT03568552|Opioid Use Disorder (OUD)|opioid use disorder (oud)
936403|NCT03568552|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
936404|NCT03568552|Patient Decision Aid|patient decision aid
936405|NCT03568539|Advanced/metastatic solid malignancies, TMB high|advanced/metastatic solid malignancies, tmb high
936406|NCT03568513|Curcumin|curcumin
936407|NCT03568513|IBS and microbiota|ibs and microbiota
936408|NCT03568500|Digital Medicine System|digital medicine system
936409|NCT03568487|scapular dyskinesis|scapular dyskinesis
936410|NCT03568487|EMG biofeedback|emg biofeedback
936411|NCT03568487|scapulometer|scapulometer
936412|NCT03568461|Refractory or relapsed Follicular Lymphoma|refractory or relapsed follicular lymphoma
936413|NCT03568461|Refractory|refractory
936414|NCT03568461|Relapsed|relapsed
936415|NCT03568461|Follicular lymphoma|follicular lymphoma
936416|NCT03568461|CTL019|ctl019
936417|NCT03568461|Tisagenlecleucel|tisagenlecleucel
936418|NCT03568461|Chimeric antigen receptor|chimeric antigen receptor
936419|NCT03568448|HER2 negative breast cancer|her2 negative breast cancer
936420|NCT03568396|Nociceptive stimulation|nociceptive stimulation
936421|NCT03568383|Tuberculosis|tuberculosis
936422|NCT03568383|Multidrug Resistance|multidrug resistance
936423|NCT03568383|Prevention|prevention
936424|NCT03568383|Household Contact|household contact
936425|NCT03568357|tetralogy of Fallot|tetralogy of fallot
936426|NCT03568344|Severe malaria|severe malaria
936427|NCT03568344|Mortality|mortality
936428|NCT03568344|Referral|referral
936429|NCT03568344|Rectal artesunate|rectal artesunate
936430|NCT03568344|iCCM|iccm
936431|NCT03568344|Community based treatment|community based treatment
936432|NCT03568331|Chronic Pruritus|chronic pruritus
936433|NCT03568331|Eczema|eczema
936434|NCT03568318|Atopic Dermatitis|atopic dermatitis
936435|NCT03568318|Upadacitinib|upadacitinib
936436|NCT03568305|asthma|asthma
936437|NCT03568305|occupational asthma|occupational asthma
936438|NCT03568253|Bulk composite|bulk composite
936439|NCT03568253|High viscisity glassionomer|high viscisity glassionomer
936440|NCT03568253|Cambra application (Caries management by risk assessment)|cambra application (caries management by risk assessment)
936441|NCT03568253|E-dentistry|e-dentistry
936442|NCT03568227|Hypnosis|hypnosis
936443|NCT03568227|Neurophysiology|neurophysiology
936444|NCT03568227|fMRI|fmri
936445|NCT03568227|Resting-State|resting-state
936446|NCT03568227|Hypnotic Sub-States|hypnotic sub-states
936447|NCT03568214|Primary Prevention|primary prevention
936448|NCT03568201|Diagnosis|diagnosis
936449|NCT03568201|Peripheral artery disease|peripheral artery disease
936450|NCT03568201|Sports|sports
936451|NCT03568188|prostate cancer|prostate cancer
936452|NCT03568188|HIFU focal|hifu focal
936453|NCT03568188|adverse effect|adverse effect
936454|NCT03568188|intermediate risk|intermediate risk
936455|NCT03568162|GRB 830 for the treatment of moderate to severe atopic dermatitis|grb 830 for the treatment of moderate to severe atopic dermatitis
936456|NCT03568136|neurodermatitis|neurodermatitis
936584|NCT03567187|iovera|iovera
936457|NCT03568136|moderate to severe inflammatory reaction of the skin|moderate to severe inflammatory reaction of the skin
936458|NCT03568136|Skin and Connective Tissue Diseases|skin and connective tissue diseases
936463|NCT03568058|immunotherapy|immunotherapy
936464|NCT03568058|personalized cancer vaccine|personalized cancer vaccine
936465|NCT03568058|personalized immunotherapy|personalized immunotherapy
936466|NCT03568058|pembrolizumab|pembrolizumab
936467|NCT03568058|Keytruda|keytruda
936468|NCT03568058|cancer|cancer
936469|NCT03568045|circadian misalignment|circadian misalignment
936470|NCT03568045|entrainment|entrainment
936471|NCT03568045|zeitgeber|zeitgeber
936472|NCT03568045|bright light|bright light
936473|NCT03568045|critical illness|critical illness
936474|NCT03568032|intima media thickness|intima media thickness
936475|NCT03568006|subacromial impingement|subacromial impingement
936476|NCT03568006|pain|pain
936477|NCT03568006|shoulder|shoulder
936478|NCT03568006|passive mobilization|passive mobilization
936479|NCT03567993|mhealth|mhealth
936480|NCT03567993|Tobacco cessation|tobacco cessation
936481|NCT03567993|Vietnam|vietnam
936482|NCT03567993|Smoking cessation|smoking cessation
936483|NCT03567967|nutrition|nutrition
936484|NCT03567967|fruits and vegetables|fruits and vegetables
936485|NCT03567967|sugar-sweetened beverages|sugar-sweetened beverages
936486|NCT03567954|Diagnostic ultrasound|diagnostic ultrasound
936487|NCT03567902|C-MAC|c-mac
936488|NCT03567876|Mantle cell lymphoma|mantle cell lymphoma
936489|NCT03567876|Elderly patients|elderly patients
936490|NCT03567876|First line|first line
936491|NCT03567785|Therapy adherence|therapy adherence
936495|NCT03567746|Colonic Polyp|colonic polyp
936496|NCT03567746|Endoscopic mucosal resection|endoscopic mucosal resection
936497|NCT03567733|Dual antiplatelet treatment|dual antiplatelet treatment
936498|NCT03567733|Elderly patients|elderly patients
936499|NCT03567720|Metastatic|metastatic
936500|NCT03567720|Inoperable Locally Advanced|inoperable locally advanced
936501|NCT03567720|TNBC|tnbc
936502|NCT03567720|pIL-12|pil-12
936503|NCT03567720|tavokinogene telseplasmid|tavokinogene telseplasmid
936504|NCT03567720|pembrolizumab|pembrolizumab
936505|NCT03567707|Vaginal seeding|vaginal seeding
936506|NCT03567707|Immune responses|immune responses
936507|NCT03567707|Allergen sensitization|allergen sensitization
936508|NCT03567694|asthma, allergic rhinitis, HA115, CRTH2 antagonists|asthma, allergic rhinitis, ha115, crth2 antagonists
936509|NCT03567694|CT133|ct133
936510|NCT03567655|medroxyprogestrone acetate|medroxyprogestrone acetate
936511|NCT03567642|Osimertinib|osimertinib
936512|NCT03567642|Platinum|platinum
936513|NCT03567642|Etoposide|etoposide
936514|NCT03567642|EGFR Mutant|egfr mutant
936515|NCT03567642|18-211|18-211
936516|NCT03567629|Irinotecan|irinotecan
936517|NCT03567629|Oxaliplatin|oxaliplatin
936518|NCT03567629|refractory|refractory
936519|NCT03567629|mCRC|mcrc
936520|NCT03567616|Cancer|cancer
936521|NCT03567616|Multiple Myeloma (MM)|multiple myeloma (mm)
936522|NCT03567616|Relapsed or Refractory (R/R)|relapsed or refractory (r/r)
936523|NCT03567616|venetoclax|venetoclax
936524|NCT03567616|pomalidomide|pomalidomide
936525|NCT03567616|dexamethasone|dexamethasone
936526|NCT03567590|Cluster Headache, pulsed radiofrequency|cluster headache, pulsed radiofrequency
936527|NCT03567564|abdominal muscles|abdominal muscles
936528|NCT03567564|spontaneous breathing trial|spontaneous breathing trial
936529|NCT03567564|critically ill patients|critically ill patients
936530|NCT03567551|Preeclampsia|preeclampsia
936531|NCT03567551|Pregnancy|pregnancy
936532|NCT03567551|Complications|complications
936533|NCT03567551|Eclampsia|eclampsia
936534|NCT03567551|Aquaporin|aquaporin
936535|NCT03567551|Aquaporin 4|aquaporin 4
936536|NCT03567538|Thoracic surgery|thoracic surgery
936537|NCT03567538|Lung surgery|lung surgery
936538|NCT03567538|Epidemiologic Methods|epidemiologic methods
936539|NCT03567499|Pro-arrhythmic|pro-arrhythmic
936540|NCT03567499|Holter ECG|holter ecg
936541|NCT03567499|SAP|sap
936542|NCT03567499|Cardiac telemetry|cardiac telemetry
936543|NCT03567499|Benign arrhythmic|benign arrhythmic
936544|NCT03567447|Parkinsons Disease|parkinsons disease
936545|NCT03567447|PD|pd
936546|NCT03567447|Patient Falls|patient falls
936547|NCT03567447|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
936548|NCT03567421|stone disease|stone disease
936549|NCT03567421|ureteral stent|ureteral stent
936550|NCT03567421|stenting|stenting
936551|NCT03567421|ureteroscopy treatment|ureteroscopy treatment
936552|NCT03567421|stent placement|stent placement
936553|NCT03567421|postoperative ureteral stenting|postoperative ureteral stenting
936554|NCT03567421|Société Internationale d'Urologie|société internationale d'urologie
936555|NCT03567421|uCARE|ucare
936556|NCT03567369|Third molar|third molar
936557|NCT03567369|Surgery|surgery
936558|NCT03567369|Swelling|swelling
936559|NCT03567343|sleep|sleep
936560|NCT03567317|CPAP|cpap
936561|NCT03567317|Weight Gain|weight gain
936562|NCT03567317|obstructive sleep apnea|obstructive sleep apnea
936563|NCT03567304|HIV|hiv
936564|NCT03567304|Neurocognitive disorder|neurocognitive disorder
936565|NCT03567304|Efavirenz|efavirenz
936566|NCT03567304|Rilpivirine|rilpivirine
936567|NCT03567291|adolescents|adolescents
936568|NCT03567291|children|children
936569|NCT03567278|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
936572|NCT03567239|Rehabilitation Engineering|rehabilitation engineering
936573|NCT03567239|Adaptive Devices|adaptive devices
936574|NCT03567239|Assistive Technology|assistive technology
936575|NCT03567213|Tetraplegia|tetraplegia
936576|NCT03567213|ALS|als
936577|NCT03567213|Locked-in Syndrome|locked-in syndrome
936578|NCT03567213|Brainstem stroke|brainstem stroke
936579|NCT03567213|Brain Computer Interface|brain computer interface
936580|NCT03567213|Rehabilitation|rehabilitation
936581|NCT03567213|Stroke|stroke
936582|NCT03567213|Hopkins|hopkins
936583|NCT03567187|Cryoneurolysis|cryoneurolysis
936585|NCT03567187|Superficial nerve treatment|superficial nerve treatment
936586|NCT03567174|hepatitis C|hepatitis c
936587|NCT03567148|Graft|graft
936588|NCT03567148|Pain|pain
936589|NCT03567148|Palate|palate
936590|NCT03567148|Wound healing|wound healing
936591|NCT03567135|Temozolomide|temozolomide
936592|NCT03567135|Apatinib|apatinib
936593|NCT03567135|Radiotherapy|radiotherapy
936594|NCT03567122|Cranio-cervical|cranio-cervical
936595|NCT03567122|Motor Control|motor control
936596|NCT03567122|Deep Flexor muscles|deep flexor muscles
936597|NCT03567096|Cardiac resynchronization therapy|cardiac resynchronization therapy
936598|NCT03567096|MultiPoint Pacing|multipoint pacing
936599|NCT03567083|Refugees|refugees
936600|NCT03567083|Mental Health Problems|mental health problems
936601|NCT03567031|Pediatric Anesthesia|pediatric anesthesia
936602|NCT03567031|Near-Infrared Spectroscopy|near-infrared spectroscopy
936603|NCT03567031|End-Tidal CO2|end-tidal co2
936604|NCT03567031|Cerebral Blood Flow|cerebral blood flow
936605|NCT03566966|hepatitis C virus infection|hepatitis c virus infection
936606|NCT03566966|non-organ-specific antibodies|non-organ-specific antibodies
936607|NCT03566966|prognostic value|prognostic value
936608|NCT03566966|sustained virological response|sustained virological response
936609|NCT03566953|Dental Decay|dental decay
936610|NCT03566927|Arteriovenous Fistula|arteriovenous fistula
936611|NCT03566927|Vascular Fistula|vascular fistula
936612|NCT03566927|Scoring|scoring
936613|NCT03566927|Fistula|fistula
936614|NCT03566927|Cardiovascular Disease|cardiovascular disease
936615|NCT03566901|Balance, Gait, Rehabilitation, Stroke, Robotics, Postural|balance, gait, rehabilitation, stroke, robotics, postural
936616|NCT03566875|TKA robot assisted with the Stryker's MAKO™ system|tka robot assisted with the stryker's mako™ system
936617|NCT03566875|surgery precision|surgery precision
936618|NCT03566849|Volleyball|volleyball
936619|NCT03566849|Shoulder impingement|shoulder impingement
936620|NCT03566849|Scapular dyskinesis|scapular dyskinesis
936621|NCT03566849|Kinetic chain|kinetic chain
936622|NCT03566836|Smart Watch|smart watch
936623|NCT03566836|Garmin|garmin
936624|NCT03566836|Wearable|wearable
936625|NCT03566836|Cardioversion|cardioversion
936626|NCT03566810|Diabetes Mellitus|diabetes mellitus
936627|NCT03566810|Glucophage Extended Release (GXR)|glucophage extended release (gxr)
936628|NCT03566810|Bioequivalence Study|bioequivalence study
936629|NCT03566784|inguinal hernia repair|inguinal hernia repair
936630|NCT03566784|electrocoagulation|electrocoagulation
936631|NCT03566784|postoperative pain|postoperative pain
936632|NCT03566784|thermal injury|thermal injury
936633|NCT03566784|neuralgia|neuralgia
936634|NCT03566771|Mobile Health|mobile health
936635|NCT03566771|Self-Monitoring|self-monitoring
936636|NCT03566771|Behavioural Treatment|behavioural treatment
936637|NCT03566732|questionnaire survey|questionnaire survey
936638|NCT03566732|care for dying patients|care for dying patients
936639|NCT03566719|Prevention|prevention
936640|NCT03566719|Active Ageing|active ageing
936641|NCT03566719|Fall|fall
936642|NCT03566719|Fall Risk|fall risk
936643|NCT03566719|Exercise Programs|exercise programs
936644|NCT03566667|Beta-blockers|beta-blockers
936645|NCT03566654|remote ischemic conditioning|remote ischemic conditioning
936646|NCT03566628|Cerebral Angiography|cerebral angiography
936647|NCT03566628|Shivering|shivering
936648|NCT03566628|Anaesthesia|anaesthesia
936649|NCT03566628|Warmed solutions|warmed solutions
936650|NCT03566615|colonoscopy|colonoscopy
936651|NCT03566615|adenoma detection rate|adenoma detection rate
936652|NCT03566615|caps|caps
936653|NCT03566563|Community Screening|community screening
936654|NCT03566563|Halfway house|halfway house
936655|NCT03566563|People who inject drugs|people who inject drugs
936656|NCT03566563|Substance users|substance users
936657|NCT03566563|Released prisoners|released prisoners
936658|NCT03566511|diabetes|diabetes
936659|NCT03566511|type 2 diabetes|type 2 diabetes
936660|NCT03566511|insulin resistance|insulin resistance
936661|NCT03566511|diazoxide|diazoxide
936662|NCT03566511|MRI|mri
936663|NCT03566459|Opioid Use Disorder (OUD)|opioid use disorder (oud)
936664|NCT03566459|Medication Assisted Treatment (MAT)|medication assisted treatment (mat)
936665|NCT03566459|Telemedicine|telemedicine
936666|NCT03566459|Veteran|veteran
936667|NCT03566446|CALR mutation|calr mutation
936668|NCT03566381|Wearable sensor, sweat sensor|wearable sensor, sweat sensor
936669|NCT03566368|Cardiac Dysfunction|cardiac dysfunction
936670|NCT03566368|Traumatic Brain Injury|traumatic brain injury
936786|NCT03565588|Risk perception|risk perception
936671|NCT03566355|Lung Metastasis, Curative Proton Beam Therapy|lung metastasis, curative proton beam therapy
936672|NCT03566329|craniotomy- Emergence- hypertension|craniotomy- emergence- hypertension
936673|NCT03566303|Valve Heart Disease|valve heart disease
936674|NCT03566303|Rivaroxaban|rivaroxaban
936675|NCT03566303|Warfarin|warfarin
936676|NCT03566251|Multiple Sclerosis|multiple sclerosis
936677|NCT03566251|Balance|balance
936678|NCT03566251|Core Stability|core stability
936679|NCT03566251|Proprioception|proprioception
936680|NCT03566251|Functional Mobility|functional mobility
936681|NCT03566238|Pediatric|pediatric
936682|NCT03566238|Cholestasis|cholestasis
936683|NCT03566212|Anxiety|anxiety
936684|NCT03566212|Camouflaged syringe|camouflaged syringe
936685|NCT03566212|Conventional syringe|conventional syringe
936686|NCT03566186|Photobiomodulation|photobiomodulation
936687|NCT03566186|Autonomic nervous system|autonomic nervous system
936688|NCT03566186|Heart rate variability|heart rate variability
936689|NCT03566186|Recovery of function|recovery of function
936690|NCT03566186|Super-pulsed laser|super-pulsed laser
936691|NCT03566186|Led light|led light
936692|NCT03566095|Rural|rural
936693|NCT03566095|Food Policy Councils|food policy councils
936694|NCT03566095|Food Pantry|food pantry
936695|NCT03566095|Community Coaching|community coaching
936696|NCT03566069|Oxytocin|oxytocin
936697|NCT03566069|Psychotherapy|psychotherapy
936698|NCT03566069|Depression|depression
936699|NCT03566069|Anxiety|anxiety
936700|NCT03566069|Therapeutic working Alliance|therapeutic working alliance
936701|NCT03566043|MPS II|mps ii
936702|NCT03566043|gene therapy|gene therapy
936703|NCT03566043|Hunter|hunter
936704|NCT03566030|Hepatitis B|hepatitis b
936705|NCT03566030|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
936706|NCT03566030|Tenofovir Alafenamide|tenofovir alafenamide
936707|NCT03566030|Switch|switch
936708|NCT03566017|Glomerular filtration rate|glomerular filtration rate
936709|NCT03566017|Proteinuria|proteinuria
936710|NCT03566017|PRX-102|prx-102
936711|NCT03566017|pegunigalsidase alfa|pegunigalsidase alfa
936712|NCT03566017|Fabry disease|fabry disease
936713|NCT03565991|BRCA, ATM|brca, atm
936714|NCT03565965|Randomized clinical trial|randomized clinical trial
936715|NCT03565965|Parkinson's disease|parkinson's disease
936716|NCT03565965|Gait disorders|gait disorders
936717|NCT03565965|Locomotor imagery training|locomotor imagery training
936718|NCT03565952|Menopausal women|menopausal women
936719|NCT03565952|Insomnia|insomnia
936720|NCT03565939|Ulcerative Colitis|ulcerative colitis
936721|NCT03565939|Trichuris suis|trichuris suis
936722|NCT03565939|Trichuris suis ova|trichuris suis ova
936723|NCT03565939|Probiotic|probiotic
936725|NCT03565939|Inflammatory bowel diseases|inflammatory bowel diseases
936726|NCT03565939|Anti inflammatory|anti inflammatory
936727|NCT03565939|Hygiene Hypothesis|hygiene hypothesis
936728|NCT03565939|Helminths|helminths
936729|NCT03565939|Microbiome|microbiome
936730|NCT03565939|MAYO|mayo
936731|NCT03565926|low back pain|low back pain
936732|NCT03565926|manual therapy|manual therapy
936733|NCT03565926|hypopressive therapeutic exercises|hypopressive therapeutic exercises
936734|NCT03565848|Laparoscopy|laparoscopy
936735|NCT03565848|Colorectal resection|colorectal resection
936736|NCT03565848|Deep infiltrating endometriosis|deep infiltrating endometriosis
936737|NCT03565848|Constipation|constipation
936738|NCT03565835|abiraterone|abiraterone
936739|NCT03565835|prostate cancer|prostate cancer
936740|NCT03565835|androgen deprivation therapy|androgen deprivation therapy
936741|NCT03565822|Oesophageal Atresia|oesophageal atresia
936742|NCT03565822|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
936743|NCT03565822|Short Bowel Syndrome|short bowel syndrome
936744|NCT03565809|Diabetus mellitus|diabetus mellitus
936745|NCT03565809|Alzheimer Disease or related disorders|alzheimer disease or related disorders
936746|NCT03565796|Smoking cessation|smoking cessation
936747|NCT03565796|Quit to Win|quit to win
936748|NCT03565796|Brief intervention|brief intervention
936749|NCT03565796|Financial incentive|financial incentive
936750|NCT03565796|Active referral|active referral
936751|NCT03565796|AWARD model|award model
936752|NCT03565770|child|child
936753|NCT03565770|coaching|coaching
936754|NCT03565770|telemedicine|telemedicine
936755|NCT03565770|nurses|nurses
936756|NCT03565770|individual follow-up|individual follow-up
936757|NCT03565757|Stress Management|stress management
936758|NCT03565757|Resilience|resilience
936759|NCT03565744|obesity|obesity
936760|NCT03565744|adolescents|adolescents
936761|NCT03565744|school-based|school-based
936762|NCT03565744|weight management|weight management
936763|NCT03565744|wellness|wellness
936764|NCT03565692|Microbiome|microbiome
936778|NCT03565614|reablement|reablement
936779|NCT03565614|older people|older people
936780|NCT03565614|personal care services|personal care services
936781|NCT03565614|rehabilitation|rehabilitation
936782|NCT03565614|multimorbidity|multimorbidity
936783|NCT03565614|disability|disability
936784|NCT03565588|Voluntary medical male circumcision|voluntary medical male circumcision
936785|NCT03565588|HIV prevention|hiv prevention
936787|NCT03565575|Pre-Exposure Prophylaxis (PrEP) for HIV|pre-exposure prophylaxis (prep) for hiv
936788|NCT03565575|Risk perception|risk perception
936789|NCT03565575|HIV|hiv
936790|NCT03565562|Health promotion|health promotion
936791|NCT03565562|Local authorities involvement|local authorities involvement
936792|NCT03565562|Suicide and attempted suicide|suicide and attempted suicide
936793|NCT03565562|Primary prevention|primary prevention
936794|NCT03565562|Psychological Distress|psychological distress
936795|NCT03565549|Brain|brain
936796|NCT03565549|Trauma|trauma
936797|NCT03565549|Medical education|medical education
936798|NCT03565549|Emergency department|emergency department
936799|NCT03565536|Nexavar|nexavar
936800|NCT03565536|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
936801|NCT03565536|Neoadjuvant Treatment|neoadjuvant treatment
936802|NCT03565510|High-protein diet|high-protein diet
936803|NCT03565510|Energy metabolism|energy metabolism
936804|NCT03565484|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
936805|NCT03565484|Rescue Therapy|rescue therapy
936806|NCT03565471|Atrial Septal Defect|atrial septal defect
936807|NCT03565471|Exercise Capacity|exercise capacity
936808|NCT03565471|Pulmonary Hypertension|pulmonary hypertension
936809|NCT03565471|Heart Rate Variability|heart rate variability
936810|NCT03565471|Congenital Heart Disease|congenital heart disease
936811|NCT03565445|NSCLC|nsclc
936812|NCT03565445|Tumors|tumors
936813|NCT03565445|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
936814|NCT03565445|Oncology|oncology
936815|NCT03565445|breast cancer|breast cancer
936816|NCT03565445|ASP1948|asp1948
936817|NCT03565445|mCRPC|mcrpc
936818|NCT03565445|melanoma|melanoma
936819|NCT03565445|ovarian cancer|ovarian cancer
1333107|NCT01444469|Respiratory disease|respiratory disease
936820|NCT03565445|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
936821|NCT03565445|Advanced solid tumors|advanced solid tumors
936822|NCT03565432|work disability|work disability
936823|NCT03565432|quality of life|quality of life
936824|NCT03565432|psychosocial distress|psychosocial distress
936825|NCT03565393|Tolerability|tolerability
936826|NCT03565393|Acceptability|acceptability
936827|NCT03565393|Fibersol-2|fibersol-2
936828|NCT03565393|Children|children
936829|NCT03565380|Tai Chi|tai chi
936830|NCT03565380|Fall|fall
936831|NCT03565380|Balance|balance
936832|NCT03565380|Post operative|post operative
936833|NCT03565380|Elderly|elderly
936834|NCT03565354|Patient blood management|patient blood management
936961|NCT03564613|Antiretroviral|antiretroviral
936844|NCT03565302|Proteome|proteome
936845|NCT03565302|VO2max|vo2max
936846|NCT03565302|Muscle function|muscle function
936847|NCT03565302|Exercise performance|exercise performance
936848|NCT03565302|Skeletal muscle|skeletal muscle
936849|NCT03565302|Doping|doping
936850|NCT03565302|Anti-Doping|anti-doping
936851|NCT03565302|Enantiomeric analysis|enantiomeric analysis
936852|NCT03565276|Post partum hemorrhage|post partum hemorrhage
936853|NCT03565276|Tranexamic acid|tranexamic acid
936854|NCT03565276|TXA|txa
936855|NCT03565276|Dose-finding|dose-finding
936856|NCT03565276|Prevention|prevention
936857|NCT03565250|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
936858|NCT03565250|Self concept|self concept
936859|NCT03565250|Child|child
936860|NCT03565250|Neuropsychology|neuropsychology
936861|NCT03565224|Cervical vertebrae|cervical vertebrae
936862|NCT03565224|Postoperative complications|postoperative complications
936863|NCT03565224|Radiography|radiography
936864|NCT03565224|Spinal fusion|spinal fusion
936865|NCT03565224|Coating|coating
936866|NCT03565211|Progesterone vaginal ring (PVR)|progesterone vaginal ring (pvr)
936867|NCT03565211|Vaginal progesterone ring|vaginal progesterone ring
936868|NCT03565211|Assisted reproductive technology (ART)|assisted reproductive technology (art)
936869|NCT03565211|Infertility|infertility
936870|NCT03565172|cerebral palsy|cerebral palsy
936871|NCT03565172|stretching|stretching
936872|NCT03565172|isokinetic dynamometer|isokinetic dynamometer
936873|NCT03565172|ultrasound|ultrasound
936874|NCT03565172|ankle|ankle
936875|NCT03565172|children|children
936876|NCT03565107|Epigenetic|epigenetic
936877|NCT03565107|Female age|female age
936878|NCT03565107|Gene regulation|gene regulation
936879|NCT03565107|Methylation pattern|methylation pattern
936880|NCT03565081|Prader-Willi Syndrome|prader-willi syndrome
936881|NCT03565081|Resistance Training|resistance training
936882|NCT03565081|Body Composition|body composition
936883|NCT03565042|Arthritis, Psoriatic|arthritis, psoriatic
936884|NCT03565042|Mechanism of Action|mechanism of action
936885|NCT03565042|Ustekinumab|ustekinumab
936886|NCT03565042|anti-p40|anti-p40
936887|NCT03565042|anti-IL23/Il12 p40|anti-il23/il12 p40
936888|NCT03565029|rectal cancer|rectal cancer
936889|NCT03565029|neoadjuvant|neoadjuvant
936890|NCT03565029|non operative management|non operative management
936891|NCT03565016|Alcohol use disorders|alcohol use disorders
936892|NCT03565016|agitation|agitation
936893|NCT03565016|intensive care unit|intensive care unit
936894|NCT03565016|restlessness|restlessness
936895|NCT03565016|alcohol withdrawal syndrome|alcohol withdrawal syndrome
936896|NCT03565016|alcohol-dependence|alcohol-dependence
936897|NCT03565016|heavy drinking|heavy drinking
936898|NCT03564977|CAR-T|car-t
936899|NCT03564977|minimal residual disease|minimal residual disease
936900|NCT03564977|B cell maliganacy|b cell maliganacy
936901|NCT03564964|SUVN-502|suvn-502
936902|NCT03564964|Expanded Access|expanded access
936903|NCT03564938|metastatic colorectal cancer|metastatic colorectal cancer
936904|NCT03564938|mCRC|mcrc
936905|NCT03564925|Atrial Fibrillation|atrial fibrillation
936906|NCT03564925|CryoAblation|cryoablation
936907|NCT03564925|pulmonary vein isolation|pulmonary vein isolation
936908|NCT03564925|wide area circumferential ablation|wide area circumferential ablation
936909|NCT03564925|contact force|contact force
936910|NCT03564899|Breast cancer|breast cancer
936911|NCT03564899|Survivorship|survivorship
936912|NCT03564899|Physical activity intervention|physical activity intervention
936913|NCT03564899|Activity trackers|activity trackers
936914|NCT03564899|Sedentary time|sedentary time
936915|NCT03564873|Omacetaxine|omacetaxine
936916|NCT03564873|Azacitidine|azacitidine
936917|NCT03564873|Previously Untreated|previously untreated
936918|NCT03564873|Phase I/II|phase i/ii
936919|NCT03564873|Dose Escalation|dose escalation
936920|NCT03564873|Maximum Tolerated Dose|maximum tolerated dose
936921|NCT03564847|Learning Through Play Plus|learning through play plus
936922|NCT03564847|Cognitive Behavior Therapy|cognitive behavior therapy
936923|NCT03564847|Parenting Intervention|parenting intervention
936924|NCT03564847|Low and middle-income country|low and middle-income country
936925|NCT03564834|Elderly patients|elderly patients
936926|NCT03564834|Open gastrectomy|open gastrectomy
936927|NCT03564834|Laparoscopic gastrectomy|laparoscopic gastrectomy
936928|NCT03564821|myeloid neoplasms|myeloid neoplasms
936929|NCT03564808|Contour defects, Pigmentation, Enriched fat grafting|contour defects, pigmentation, enriched fat grafting
936930|NCT03564795|Wound Dressing|wound dressing
936931|NCT03564795|Keratin|keratin
936932|NCT03564795|Hydrogel|hydrogel
936933|NCT03564795|Burn Dressing|burn dressing
936934|NCT03564782|PVSRIPO|pvsripo
936935|NCT03564782|Triple Negative Breast Cancer|triple negative breast cancer
936936|NCT03564769|screening|screening
936937|NCT03564756|Anemia|anemia
936938|NCT03564756|Pregnancy|pregnancy
936939|NCT03564756|Iron|iron
936940|NCT03564756|Vitamin C|vitamin c
936941|NCT03564743|Spondyloarthritis|spondyloarthritis
936942|NCT03564743|ASAS criteria|asas criteria
936943|NCT03564743|Diagnosis criteria|diagnosis criteria
936944|NCT03564743|Classification criteria|classification criteria
936945|NCT03564730|Bilateral, staged, simultaneous|bilateral, staged, simultaneous
936946|NCT03564691|PD1|pd1
936947|NCT03564691|PD-1|pd-1
936948|NCT03564691|PDL1|pdl1
936949|NCT03564691|PD-L1|pd-l1
936950|NCT03564678|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
936951|NCT03564678|ALL|all
936952|NCT03564678|Levocarnitine|levocarnitine
936953|NCT03564678|Vitamin B complex|vitamin b complex
936954|NCT03564678|Hyperbilirubinemia|hyperbilirubinemia
936955|NCT03564613|HIV|hiv
936956|NCT03564613|Dolutegravir|dolutegravir
936957|NCT03564613|Europe|europe
936958|NCT03564613|NEAT ID|neat id
936959|NCT03564613|pregnancy|pregnancy
936960|NCT03564613|Safety|safety
936962|NCT03564600|low back pain|low back pain
936963|NCT03564587|Cancer Survivors|cancer survivors
936964|NCT03564587|Adolescent|adolescent
936965|NCT03564587|Achieving Wellness After Kancer in Early Life|achieving wellness after kancer in early life
936967|NCT03564587|Health-Promoting Behaviors|health-promoting behaviors
936968|NCT03564561|glycogen storage disease type II, adult|glycogen storage disease type ii, adult
936969|NCT03564561|Pompe disease|pompe disease
936970|NCT03564561|clinical evolution|clinical evolution
936971|NCT03564561|molecular evolution|molecular evolution
936972|NCT03564561|follow-up|follow-up
936973|NCT03564561|c.-32-13T>G mutation|c.-32-13t>g mutation
936974|NCT03564561|antisense oligonucleotide treatment|antisense oligonucleotide treatment
936975|NCT03564561|in vitro|in vitro
936976|NCT03564535|Adult|adult
936977|NCT03564535|Inguinal hernia|inguinal hernia
936978|NCT03564535|Inflammatory|inflammatory
936979|NCT03564535|Surgical Mesh|surgical mesh
936980|NCT03564535|Laparoscopy/Methods|laparoscopy/methods
936981|NCT03564535|Postoperative pain|postoperative pain
936982|NCT03564535|Recurrence|recurrence
936983|NCT03564535|Randomized Controlled Trials|randomized controlled trials
936984|NCT03564535|Double-Blind Method|double-blind method
936985|NCT03564535|Pain|pain
936986|NCT03564535|Chronic pain|chronic pain
936987|NCT03564535|Seroma|seroma
936988|NCT03564535|Total extraperitoneal repair|total extraperitoneal repair
936989|NCT03564535|Tacker|tacker
936990|NCT03564535|Mesh fixation|mesh fixation
936991|NCT03564535|Self gripping|self gripping
936992|NCT03564509|Human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
936993|NCT03564509|Recombinant Human Chorionic Gonadotropin (rhCG)|recombinant human chorionic gonadotropin (rhcg)
936994|NCT03564509|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
936995|NCT03564509|Assisted Reproductive Technologies (ART)|assisted reproductive technologies (art)
936996|NCT03564496|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
936997|NCT03564470|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
936998|NCT03564470|Ph-like|ph-like
936999|NCT03564470|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
937000|NCT03564470|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
937001|NCT03564444|Bivalent.|bivalent.
937002|NCT03564444|Influenza.|influenza.
937003|NCT03564444|FluMist Quadrivalent.|flumist quadrivalent.
937004|NCT03564444|Vaccine Prevention in Healthy Adults.|vaccine prevention in healthy adults.
937005|NCT03564353|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
937006|NCT03564353|memory|memory
937007|NCT03564314|Acute kidney injury|acute kidney injury
937008|NCT03564314|Major surgery|major surgery
937009|NCT03564314|Clinical decision support|clinical decision support
937010|NCT03564301|Peri-implantitis|peri-implantitis
937011|NCT03564301|antibiotics|antibiotics
937012|NCT03564301|Metronidazole|metronidazole
937013|NCT03564301|non- surgical treatment|non- surgical treatment
937014|NCT03564275|Radiation Therapy|radiation therapy
937015|NCT03564275|Proton Therapy|proton therapy
937016|NCT03564223|Adolescent|adolescent
937017|NCT03564223|Parental concerns|parental concerns
937018|NCT03564223|Child Health|child health
937019|NCT03564223|Paediatrician Concerns|paediatrician concerns
937020|NCT03564210|screen time|screen time
937021|NCT03564197|EGFR WT|egfr wt
937022|NCT03564197|negative EML4-ALK fusion|negative eml4-alk fusion
937023|NCT03564197|eligible for nivolumab treatment|eligible for nivolumab treatment
937024|NCT03564184|Parent-infant bonding|parent-infant bonding
937025|NCT03564184|Music therapy|music therapy
937026|NCT03564132|Yigansan|yigansan
937027|NCT03564132|YGTSS|ygtss
937028|NCT03564119|papulopustular rosacea|papulopustular rosacea
937029|NCT03564106|chronic sacroilitis,radiofrequancy,intraarticular steroids injection|chronic sacroilitis,radiofrequancy,intraarticular steroids injection
937030|NCT03564093|pediatrics|pediatrics
937031|NCT03564093|sedation|sedation
937032|NCT03564093|emergency room sedation|emergency room sedation
937033|NCT03564093|intranasal sedation|intranasal sedation
937034|NCT03564093|dexmedetomidine|dexmedetomidine
937035|NCT03564093|intranasal dexmedetomidine|intranasal dexmedetomidine
937036|NCT03564093|children|children
937037|NCT03564093|pediatric|pediatric
937038|NCT03564093|pediatric sedation|pediatric sedation
937039|NCT03564080|exercise rehabilitation|exercise rehabilitation
937040|NCT03564080|supervised exercise programmes|supervised exercise programmes
937041|NCT03564067|TRD, tDCS, cCBT, Home-based tDCS-cCBT|trd, tdcs, ccbt, home-based tdcs-ccbt
937042|NCT03564054|non small cell lung cancer|non small cell lung cancer
937043|NCT03564054|photodynamic therapy|photodynamic therapy
937044|NCT03564054|argon plasma coagulation|argon plasma coagulation
937045|NCT03564054|endobronchial obstruction|endobronchial obstruction
937046|NCT03564041|depression|depression
937047|NCT03564041|late-life|late-life
937048|NCT03564041|executive functioning|executive functioning
937049|NCT03564041|sahaj samadhi|sahaj samadhi
937050|NCT03564041|meditation|meditation
937051|NCT03564041|treatment-resistant|treatment-resistant
937052|NCT03564028|COPD|copd
937053|NCT03564028|daily activity|daily activity
937054|NCT03564028|stair climbing|stair climbing
937055|NCT03564028|rehabilitation|rehabilitation
937056|NCT03563989|Chronic total occlusion|chronic total occlusion
937057|NCT03563989|Self-expandable stent|self-expandable stent
937058|NCT03563989|Percutaneous coronary intervention|percutaneous coronary intervention
937059|NCT03563989|Coronary artery disease|coronary artery disease
937060|NCT03563976|Early Stage Lung Cancer|early stage lung cancer
937061|NCT03563872|hypertension|hypertension
937062|NCT03563872|team-based|team-based
937063|NCT03563872|guidelines|guidelines
937064|NCT03563872|implementation|implementation
937065|NCT03563833|Minimal Flow Anesthesia|minimal flow anesthesia
937066|NCT03563833|Thiol/disulfide balance|thiol/disulfide balance
937067|NCT03563833|Tissue oxygen saturation|tissue oxygen saturation
937068|NCT03563833|hypotensive anesthesia|hypotensive anesthesia
937069|NCT03563820|Positive Psychology|positive psychology
937070|NCT03563820|Resilience|resilience
937071|NCT03563820|Well-Being|well-being
937072|NCT03563781|ovarian cancer|ovarian cancer
937073|NCT03563781|laparoscopy|laparoscopy
937074|NCT03563781|sentinel node|sentinel node
937075|NCT03563781|lymphadenectomy|lymphadenectomy
937076|NCT03563768|coronary artery disease|coronary artery disease
937077|NCT03563768|aortic atherosclerotic disease|aortic atherosclerotic disease
937078|NCT03563768|one-stop|one-stop
937079|NCT03563768|endovascular aortic repair|endovascular aortic repair
937080|NCT03563768|percutaneous coronary intervention|percutaneous coronary intervention
937081|NCT03563742|Treatment-naive|treatment-naive
937082|NCT03563742|rilpivirine|rilpivirine
937083|NCT03563742|India|india
937084|NCT03563729|Immune therapy|immune therapy
937085|NCT03563729|checkpoint inhibitor|checkpoint inhibitor
937086|NCT03563729|pembrolizumab|pembrolizumab
937087|NCT03563729|ipilimumab|ipilimumab
937088|NCT03563729|nivolumab|nivolumab
937089|NCT03563729|steroid|steroid
937090|NCT03563729|brain metastasis|brain metastasis
937091|NCT03563703|Catheterization, Peripheral|catheterization, peripheral
937092|NCT03563703|Ultrasound|ultrasound
937093|NCT03563703|Near Infrared Light|near infrared light
937094|NCT03563690|KOA|koa
937095|NCT03563690|Acupuncture treatment|acupuncture treatment
937096|NCT03563690|Multi-center RCT|multi-center rct
937097|NCT03563677|psychosomatic|psychosomatic
937098|NCT03563677|unclear diagnosis|unclear diagnosis
937099|NCT03563625|Local anesthetic|local anesthetic
937100|NCT03563625|Hernioraphy|hernioraphy
937101|NCT03563625|Wound healing|wound healing
937102|NCT03563612|one lung ventilation|one lung ventilation
937103|NCT03563612|continuous positive airway pressure|continuous positive airway pressure
937104|NCT03563612|differential lung ventilation|differential lung ventilation
937105|NCT03563586|oral antibiotic|oral antibiotic
937106|NCT03563586|mechanical bowel preparation|mechanical bowel preparation
937107|NCT03563586|colorectal cancer|colorectal cancer
937108|NCT03563586|surgical site infection|surgical site infection
937109|NCT03563573|Conditions in which lidocaine is ineffective|conditions in which lidocaine is ineffective
937110|NCT03563560|Newly diagnosed AML|newly diagnosed aml
937111|NCT03563560|Relapsed/refractory AML|relapsed/refractory aml
937112|NCT03563560|Alvocidib|alvocidib
937113|NCT03563547|LDL-Cholesterol|ldl-cholesterol
937114|NCT03563547|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
937115|NCT03563547|Paediatrics|paediatrics
937116|NCT03563547|Dietary Treatment|dietary treatment
937117|NCT03563534|Silver diamine fluoride, dental caries children|silver diamine fluoride, dental caries children
937118|NCT03563521|severe asthma|severe asthma
937119|NCT03563521|inflammatory phenotypes|inflammatory phenotypes
937120|NCT03563521|serum cytokines|serum cytokines
937121|NCT03563521|eosinophilia|eosinophilia
937122|NCT03563521|atopy|atopy
937123|NCT03563521|chronic rhinosinusitis with nasal polyposis|chronic rhinosinusitis with nasal polyposis
937124|NCT03563508|cone beam computed tomography|cone beam computed tomography
937125|NCT03563508|maxillary premolars|maxillary premolars
937126|NCT03563508|root canal anatomy|root canal anatomy
937127|NCT03563508|root canal morphology|root canal morphology
937128|NCT03563508|Egyptian population|egyptian population
937129|NCT03563495|tissue engineering.|tissue engineering.
937130|NCT03563495|stem cells.|stem cells.
937131|NCT03563495|autogenous grafts.|autogenous grafts.
937132|NCT03563456|structured exercise|structured exercise
937133|NCT03563456|glycemic control|glycemic control
937134|NCT03563456|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
937135|NCT03563456|interval training|interval training
937136|NCT03563456|resistance training|resistance training
937137|NCT03563456|oxydative stress|oxydative stress
937138|NCT03563456|physical fitness|physical fitness
937139|NCT03563443|Bladder Cancer|bladder cancer
937140|NCT03563443|Genomic imprinting|genomic imprinting
937141|NCT03563443|Urine biomarker|urine biomarker
937142|NCT03563443|Diagnosis|diagnosis
937143|NCT03563443|Surveillance|surveillance
937144|NCT03563430|foam roller|foam roller
937145|NCT03563430|electrical stimulation|electrical stimulation
937146|NCT03563430|low intensity aerobic training|low intensity aerobic training
937147|NCT03563430|lactate removal|lactate removal
937148|NCT03563326|Epithelial Cell Adhesion Molecule|epithelial cell adhesion molecule
937149|NCT03563326|Chimeric Antigen Receptor-modified T cell|chimeric antigen receptor-modified t cell
937162|NCT03563248|Pancreatic Cancer|pancreatic cancer
937163|NCT03563235|Osteoporosis|osteoporosis
937164|NCT03563235|kidney deficiency and blood stasis syndrome|kidney deficiency and blood stasis syndrome
937165|NCT03563235|Xuling Jiangu Granules|xuling jiangu granules
937166|NCT03563222|Parenteral nutrition|parenteral nutrition
937167|NCT03563222|Pediatrics|pediatrics
937168|NCT03563222|Malnutrition|malnutrition
937169|NCT03563222|Nutritional needs|nutritional needs
937170|NCT03563209|Elbow spasticity|elbow spasticity
937171|NCT03563209|Stroke|stroke
937172|NCT03563183|immunogenicity|immunogenicity
937173|NCT03563183|Herpes Zoster|herpes zoster
937174|NCT03563183|efficacy|efficacy
937175|NCT03563183|safety|safety
937176|NCT03563183|frailty|frailty
937177|NCT03563183|Shingles vaccine|shingles vaccine
937178|NCT03563170|HCC|hcc
937179|NCT03563157|Colorectal Cancer|colorectal cancer
937180|NCT03563131|Osteoarthritis|osteoarthritis
937181|NCT03563131|Knee|knee
937182|NCT03563131|Arthroplasties|arthroplasties
937183|NCT03563118|Prolidase Activity|prolidase activity
937184|NCT03563118|Obstructive Sleep-Apnea Syndrome|obstructive sleep-apnea syndrome
937185|NCT03563105|tissue oxygen saturation|tissue oxygen saturation
937186|NCT03563092|Complete Inguinal Hernia|complete inguinal hernia
937187|NCT03563092|Inguinoscrotal Hernia|inguinoscrotal hernia
937188|NCT03563092|Laparoscopic hernia repair|laparoscopic hernia repair
937189|NCT03563079|Handling, Musculoskeletal|handling, musculoskeletal
937190|NCT03563079|Tissue, Subcutaneous|tissue, subcutaneous
937191|NCT03563079|Myofascial Release|myofascial release
937192|NCT03563079|Instrument-Mobilized Soft Tissue Mobilization|instrument-mobilized soft tissue mobilization
937193|NCT03563066|Skin Lesions|skin lesions
937194|NCT03563066|Benralizumab|benralizumab
937195|NCT03563066|Eosinophils|eosinophils
937196|NCT03563066|Intra-dermal challenge|intra-dermal challenge
937197|NCT03563066|Anti-inflammatory agents|anti-inflammatory agents
937198|NCT03563066|Physiological Effects of Drugs|physiological effects of drugs
937199|NCT03563027|Physical activity|physical activity
937200|NCT03563027|Incentive|incentive
937201|NCT03563027|Wearable device|wearable device
937202|NCT03563027|Gamification|gamification
937203|NCT03563014|Radium-223|radium-223
937204|NCT03563014|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
937205|NCT03563014|CRPC|crpc
937206|NCT03563014|Phase IV|phase iv
937207|NCT03563001|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
937208|NCT03563001|asthma-chronic obstructive pulmonary disease overlap|asthma-chronic obstructive pulmonary disease overlap
937209|NCT03563001|small airway|small airway
937210|NCT03563001|quality of life|quality of life
937211|NCT03562962|Functional Analytic Psychotherapy|functional analytic psychotherapy
937212|NCT03562962|Process-Outcome Psychotherapies|process-outcome psychotherapies
937213|NCT03562962|Mechanism of change|mechanism of change
937214|NCT03562962|Interpersonal Functioning|interpersonal functioning
937215|NCT03562962|Psychological Distress|psychological distress
937216|NCT03562962|Contingencies of reinforcement|contingencies of reinforcement
937217|NCT03562936|LSS,DS|lss,ds
937218|NCT03562897|Dietary supplements|dietary supplements
937219|NCT03562897|Ocoxin-Viusid|ocoxin-viusid
937220|NCT03562897|Nutritional supplement|nutritional supplement
937221|NCT03562897|Ovarian Cancer|ovarian cancer
937222|NCT03562897|Metastasis|metastasis
937223|NCT03562871|PD-1|pd-1
937224|NCT03562871|PD-L1|pd-l1
937225|NCT03562871|Programmed Cell Death 1|programmed cell death 1
937226|NCT03562871|Chemotherapy|chemotherapy
937227|NCT03562871|Pemetrexed|pemetrexed
937228|NCT03562871|Carboplatin|carboplatin
937229|NCT03562871|Pembrolizumab|pembrolizumab
937230|NCT03562871|Immunotherapy|immunotherapy
937231|NCT03562871|IO102|io102
937232|NCT03562871|Keytruda|keytruda
937233|NCT03562832|PARP inhibitor|parp inhibitor
937234|NCT03562832|Drug Response Prediction (DRP)|drug response prediction (drp)
937235|NCT03562832|Tankyrase 1/2 inhibitor|tankyrase 1/2 inhibitor
937236|NCT03562832|mRNA biomarker|mrna biomarker
937237|NCT03562819|Epidermal Growth Factor Receptor|epidermal growth factor receptor
937238|NCT03562793|pain|pain
937239|NCT03562793|healthcare disparities|healthcare disparities
937240|NCT03562793|communication|communication
937241|NCT03562767|Culturally-Tailored Cognitive Behavior intervention (CT-CB)|culturally-tailored cognitive behavior intervention (ct-cb)
937242|NCT03562767|Family Practice|family practice
937244|NCT03562728|Transplant|transplant
937245|NCT03562728|ECMO|ecmo
937246|NCT03562728|Sarcopenia|sarcopenia
937247|NCT03562728|Deconditioning|deconditioning
937248|NCT03562728|Physical therapy|physical therapy
937249|NCT03562715|microRNAs|micrornas
937250|NCT03562715|exosomes|exosomes
937251|NCT03562715|preeclampsia|preeclampsia
937252|NCT03562715|mesenchymal stem cells|mesenchymal stem cells
937253|NCT03562702|vomiting|vomiting
937254|NCT03562702|diarrhea|diarrhea
937255|NCT03562689|Sepsis|sepsis
937256|NCT03562689|Encephalopathy|encephalopathy
937257|NCT03562689|Delirium|delirium
937258|NCT03562689|ICU|icu
937259|NCT03562689|EEG|eeg
937260|NCT03562689|MRI|mri
937261|NCT03562689|Cognitive tests|cognitive tests
937262|NCT03562663|robotics|robotics
937263|NCT03562663|transcranial direct current stimulation|transcranial direct current stimulation
937264|NCT03562663|neurorehabilitation|neurorehabilitation
937265|NCT03562663|transcranial magnetic stimulation|transcranial magnetic stimulation
937266|NCT03562637|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
937267|NCT03562637|Adjuvant chemotherapy|adjuvant chemotherapy
937268|NCT03562637|TNBC|tnbc
937269|NCT03562611|postoperative pain|postoperative pain
937270|NCT03562611|general anesthesia|general anesthesia
937271|NCT03562611|postoperative discomfort|postoperative discomfort
937272|NCT03562585|Chronic hepatitis B|chronic hepatitis b
937273|NCT03562585|Alanine Aminotransferase|alanine aminotransferase
937274|NCT03562585|Aspartate Aminotransferase|aspartate aminotransferase
937275|NCT03562559|Total Knee Arthroplasty|total knee arthroplasty
937276|NCT03562559|Adductor Canal Block|adductor canal block
937277|NCT03562546|CVI|cvi
937278|NCT03562546|Calf Muscle Pump Function|calf muscle pump function
937279|NCT03562546|Structured Exercise|structured exercise
937280|NCT03562546|Varicose Veins|varicose veins
937281|NCT03562520|Aerobic fitness|aerobic fitness
937282|NCT03562520|Aerobic exercise|aerobic exercise
937283|NCT03562520|Behavior change counseling|behavior change counseling
937284|NCT03562507|ESK981|esk981
937285|NCT03562494|PD, Parkinson's disease|pd, parkinson's disease
937286|NCT03562494|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
937287|NCT03562494|AADC|aadc
937288|NCT03562494|AAV2-AADC|aav2-aadc
937289|NCT03562494|AAV2|aav2
937290|NCT03562494|VY-AADC|vy-aadc
937291|NCT03562494|AAV2-hAADC|aav2-haadc
937293|NCT03562468|Nicotinamide riboside|nicotinamide riboside
937294|NCT03562468|NAD|nad
937295|NCT03562455|Virtual Reality|virtual reality
937296|NCT03562455|Wheelchairs|wheelchairs
937297|NCT03562403|deep brain stimulation|deep brain stimulation
937298|NCT03562364|anti-gravity|anti-gravity
937299|NCT03562338|chronic nonspecific neck pain|chronic nonspecific neck pain
937300|NCT03562338|disability|disability
937301|NCT03562338|predictive model|predictive model
937302|NCT03562338|rehabilitation|rehabilitation
937303|NCT03562338|pain intensity|pain intensity
937304|NCT03562312|MPA|mpa
937305|NCT03562312|Music Performance Anxiety|music performance anxiety
937306|NCT03562312|HIIT|hiit
937307|NCT03562312|Exercise|exercise
937308|NCT03562312|Cortisol|cortisol
937309|NCT03562312|HRV|hrv
937310|NCT03562312|Heart Rate|heart rate
937311|NCT03562286|Open spina bifida|open spina bifida
937312|NCT03562286|spinal dysraphism|spinal dysraphism
937313|NCT03562273|Breast Nomogram|breast nomogram
937314|NCT03562273|Breast Cancer Quality of Life|breast cancer quality of life
937315|NCT03562273|GammaPod Registry|gammapod registry
937316|NCT03562221|coeliac disease|coeliac disease
937317|NCT03562221|celiac disease autoimmunity|celiac disease autoimmunity
937318|NCT03562208|Diabetes Mellitus|diabetes mellitus
937319|NCT03562208|Bone Marrow|bone marrow
937320|NCT03562208|Transplant|transplant
937321|NCT03562195|Eosinophilic inflammation|eosinophilic inflammation
937322|NCT03562195|Mepolizumab|mepolizumab
937323|NCT03562195|Asthma|asthma
937324|NCT03562143|Iron|iron
937325|NCT03562143|Deficiency|deficiency
937326|NCT03562143|Anemia|anemia
937327|NCT03562143|Supplementation|supplementation
937328|NCT03562143|Pregnancy|pregnancy
937329|NCT03562130|Teduglutide|teduglutide
937330|NCT03562130|Short Bowel Syndrome|short bowel syndrome
937331|NCT03562130|Parenteral nutrition|parenteral nutrition
937332|NCT03562130|Intestinal failure|intestinal failure
937333|NCT03562117|Child-Pugh classification|child-pugh classification
937334|NCT03562117|Open label|open label
937335|NCT03562117|Hepatic Impairment|hepatic impairment
937336|NCT03562117|Gepotidacin|gepotidacin
937337|NCT03562078|Tai Chi Quan|tai chi quan
937338|NCT03562078|HbA1c|hba1c
937339|NCT03562078|quality of life|quality of life
937340|NCT03562052|Cancer|cancer
937341|NCT03562052|Lung|lung
937342|NCT03562052|Occupational carcinogens|occupational carcinogens
937343|NCT03562052|Tobacco smoking|tobacco smoking
937344|NCT03562052|Screening|screening
937345|NCT03562052|Chest CT Scan|chest ct scan
937346|NCT03562052|Asbestos|asbestos
937347|NCT03562000|ICU|icu
937348|NCT03562000|Cough|cough
937351|NCT03562000|Medical device|medical device
937352|NCT03562000|Physiotherapy|physiotherapy
937354|NCT03561948|intraperitoneal chemotherapy|intraperitoneal chemotherapy
937355|NCT03561948|Peritoneal Carcinomatosis|peritoneal carcinomatosis
937356|NCT03561948|Colonic Diseases|colonic diseases
937357|NCT03561922|Retinal Degeneration|retinal degeneration
937358|NCT03561922|Artificial Vision|artificial vision
937359|NCT03561922|Retinal Prosthesis|retinal prosthesis
937360|NCT03561922|Subretinal Implant|subretinal implant
937361|NCT03561922|Inherited Retinal Dystrophy|inherited retinal dystrophy
937362|NCT03561922|Vision Restoration|vision restoration
937363|NCT03561922|Bionic Eye|bionic eye
937364|NCT03561922|Bionic Vision|bionic vision
937365|NCT03561922|Retinitis Pigmentosa|retinitis pigmentosa
937366|NCT03561922|Artificial Retina|artificial retina
937367|NCT03561922|Retina Implant|retina implant
937368|NCT03561922|Cone-Rod Dystrophy|cone-rod dystrophy
937369|NCT03561922|Choroideremia|choroideremia
937370|NCT03561922|Retinopathia Pigmentosa|retinopathia pigmentosa
937371|NCT03561896|Radation therapy|radation therapy
937372|NCT03561896|sterotactic radiosurgery|sterotactic radiosurgery
937373|NCT03561896|quality of life|quality of life
937374|NCT03561896|solid cancer|solid cancer
937375|NCT03561896|palliation|palliation
937376|NCT03561896|neurologic functionning|neurologic functionning
937377|NCT03561883|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
937378|NCT03561883|GERD|gerd
937379|NCT03561883|Proton Pump Inhibitor|proton pump inhibitor
937380|NCT03561883|IW-3718|iw-3718
937381|NCT03561870|IDH-mutant|idh-mutant
937382|NCT03561870|recurrent|recurrent
937383|NCT03561870|glioma|glioma
937384|NCT03561805|TAVI|tavi
937385|NCT03561805|ECG monitoring|ecg monitoring
937386|NCT03561779|Osteoarthritis|osteoarthritis
937387|NCT03561753|Tuberculosis|tuberculosis
937388|NCT03561740|breast cancer|breast cancer
937389|NCT03561740|HER2-positive|her2-positive
937390|NCT03561740|metronomic chemotherapy|metronomic chemotherapy
937391|NCT03561740|capecitabine|capecitabine
937392|NCT03561740|high-risk|high-risk
937393|NCT03561727|incisional hernia|incisional hernia
937394|NCT03561727|malignancy|malignancy
937395|NCT03561727|transverse incision|transverse incision
937396|NCT03561727|abdominal closure|abdominal closure
937397|NCT03561727|surgical technique|surgical technique
937398|NCT03561727|insicion|insicion
937399|NCT03561727|surgery|surgery
937400|NCT03561688|Biomechanics|biomechanics
937401|NCT03561688|Pain|pain
937402|NCT03561688|Gait|gait
937403|NCT03561688|Foot orthotics|foot orthotics
937404|NCT03561688|Rheumatoid Arthritis|rheumatoid arthritis
937405|NCT03561675|healthy participants older than 40 years|healthy participants older than 40 years
937406|NCT03561675|altitude|altitude
937407|NCT03561675|prevention|prevention
937408|NCT03561675|acetazolamide|acetazolamide
937409|NCT03561662|soya|soya
937410|NCT03561662|menopause|menopause
937411|NCT03561662|cognitive function|cognitive function
937412|NCT03561662|isoflavones|isoflavones
937413|NCT03561649|TNF inhibitor|tnf inhibitor
937414|NCT03561649|Adalimumab|adalimumab
937415|NCT03561649|Spondyloarthritis|spondyloarthritis
937416|NCT03561649|Biomarkers analysis|biomarkers analysis
937417|NCT03561649|Personalized medicine|personalized medicine
937418|NCT03561636|Health literacy|health literacy
937419|NCT03561610|cancer cachexia|cancer cachexia
937420|NCT03561610|malnutrition|malnutrition
937421|NCT03561610|nutritional supplement|nutritional supplement
937422|NCT03561610|sip feed|sip feed
937423|NCT03561610|nutritional risk|nutritional risk
937424|NCT03561597|stepped care|stepped care
937425|NCT03561597|mobile application|mobile application
937426|NCT03561584|Sclerosing|sclerosing
937427|NCT03561584|Cholangitis|cholangitis
937428|NCT03561571|chylomicrons|chylomicrons
937429|NCT03561571|Very Low Density Lipoprotein|very low density lipoprotein
937430|NCT03561571|saturated fat|saturated fat
937431|NCT03561571|platelet function|platelet function
937432|NCT03561571|type 2 diabetes|type 2 diabetes
937433|NCT03561571|post prandial phase|post prandial phase
1628454|NCT00290433|DepoCyt|depocyt
937434|NCT03561558|Bioequivalence|bioequivalence
937435|NCT03561441|Endoscopic retrograde pancreatocholangiography|endoscopic retrograde pancreatocholangiography
937436|NCT03561441|Pancreatitis|pancreatitis
937437|NCT03561441|Lactate ringer's solution|lactate ringer's solution
937438|NCT03561441|Tailored therapy|tailored therapy
937439|NCT03561428|lichen sclerosus|lichen sclerosus
937440|NCT03561415|Lung transplant, prophylaxis, pre-emptive|lung transplant, prophylaxis, pre-emptive
937441|NCT03561402|biomarker|biomarker
937442|NCT03561402|teriflunomide|teriflunomide
937443|NCT03561402|activity|activity
937444|NCT03561376|Scar|scar
937445|NCT03561363|insulin sensitivity|insulin sensitivity
937446|NCT03561363|high-fat diet|high-fat diet
937447|NCT03561350|Microsatellite Instability|microsatellite instability
937448|NCT03561350|Circulating Tumor DNA|circulating tumor dna
937449|NCT03561350|Colorectal Neoplasms|colorectal neoplasms
937450|NCT03561298|Pharmacokinetics|pharmacokinetics
937451|NCT03561298|Healthy subjects|healthy subjects
937452|NCT03561259|Iobenguane Avid High-risk Neuroblastoma|iobenguane avid high-risk neuroblastoma
937453|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine
937454|NCT03561259|Radiopharmaceutical|radiopharmaceutical
937455|NCT03561246|Stroke|stroke
937456|NCT03561246|Rehabilitation|rehabilitation
937457|NCT03561246|Walking|walking
937458|NCT03561246|Biomechanics|biomechanics
937459|NCT03561220|Prostate Cancer|prostate cancer
937460|NCT03561220|Proton Radiation|proton radiation
937461|NCT03561220|Photon Radiation|photon radiation
937462|NCT03561220|Cancer of the Prostate|cancer of the prostate
937463|NCT03561168|Pediatric|pediatric
937464|NCT03561168|MRI Indications|mri indications
937465|NCT03561168|Anesthesia|anesthesia
937466|NCT03561168|Anesthetic Neurotoxicity|anesthetic neurotoxicity
937467|NCT03561168|MRI Diagnostic Yield|mri diagnostic yield
937468|NCT03561155|Upper Extremity|upper extremity
937469|NCT03561155|Recovery|recovery
937470|NCT03561116|Metabolic Syndrome|metabolic syndrome
937471|NCT03561116|Xanthohumol|xanthohumol
937472|NCT03561116|Glucose metabolism|glucose metabolism
937473|NCT03561116|DNA damage|dna damage
937474|NCT03561090|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
937475|NCT03561090|GERD|gerd
937476|NCT03561090|Proton Pump Inhibitors|proton pump inhibitors
937477|NCT03561090|IW-3718|iw-3718
937478|NCT03561077|Pain|pain
937479|NCT03561077|Pediatrics|pediatrics
937480|NCT03561077|Mindfulness|mindfulness
937481|NCT03561077|Adolescents|adolescents
937482|NCT03561064|cancer|cancer
937483|NCT03561064|insomnia|insomnia
937484|NCT03561064|CBT|cbt
937485|NCT03561064|CBT-I|cbt-i
937486|NCT03561064|cognitive behavioral therapy|cognitive behavioral therapy
937487|NCT03561051|T-MACS|t-macs
937488|NCT03561051|Pre-hospital environment|pre-hospital environment
937489|NCT03561025|Diagnostic Imaging|diagnostic imaging
937490|NCT03561025|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
937491|NCT03561025|Magnetic Resonance Imaging|magnetic resonance imaging
937492|NCT03561012|health|health
937493|NCT03561012|nutrition|nutrition
937494|NCT03561012|pregnancy|pregnancy
937495|NCT03561012|infant|infant
937496|NCT03561012|child|child
937497|NCT03560986|Neridronic Acid|neridronic acid
937498|NCT03560986|Neridronate|neridronate
937499|NCT03560986|CRPS|crps
937500|NCT03560986|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
937501|NCT03560960|Early AD diagnosis|early ad diagnosis
937502|NCT03560960|Pramlintide challenge test|pramlintide challenge test
937503|NCT03560960|Amyloid|amyloid
937504|NCT03560960|Amyloid PET imaging|amyloid pet imaging
937505|NCT03560960|CSF Aβ|csf aβ
937508|NCT03560947|chronic nonspecific neck pain|chronic nonspecific neck pain
937509|NCT03560947|exercise|exercise
937510|NCT03560947|manual therapy|manual therapy
937511|NCT03560921|biomarkers|biomarkers
937512|NCT03560908|leukemia,myeloid, acute|leukemia,myeloid, acute
937513|NCT03560908|relapse|relapse
937514|NCT03560908|mutation|mutation
937515|NCT03560908|KIT|kit
937516|NCT03560908|dasatinib|dasatinib
937517|NCT03560882|atorvastatin|atorvastatin
937518|NCT03560882|p53|p53
937519|NCT03560882|tumor resection|tumor resection
937520|NCT03560869|Dehydration|dehydration
937521|NCT03560843|MBSR, TBI, insomnia|mbsr, tbi, insomnia
937522|NCT03560817|QALY|qaly
937523|NCT03560817|Cost-utility analysis|cost-utility analysis
937524|NCT03560817|Time-trade-off method|time-trade-off method
937525|NCT03560817|Discrete choice experiment method|discrete choice experiment method
937526|NCT03560804|olmesartan|olmesartan
937527|NCT03560804|chlorthalidone|chlorthalidone
937528|NCT03560804|hemodynamics|hemodynamics
937529|NCT03560778|Urinary Bladder, Overactive|urinary bladder, overactive
937530|NCT03560778|Urinary Incontinence, Urge|urinary incontinence, urge
937531|NCT03560778|Urodynamics|urodynamics
937532|NCT03560765|Rehabilitation|rehabilitation
937533|NCT03560765|Assistive technology|assistive technology
1629724|NCT00284752|Metastatic|metastatic
937534|NCT03560739|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
937535|NCT03560739|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
937536|NCT03560739|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
937537|NCT03560739|Bioequivalence|bioequivalence
937538|NCT03560739|Pharmacokinetics|pharmacokinetics
937539|NCT03560739|Neurofilament light chain|neurofilament light chain
937540|NCT03560739|Pre-filled Syringe|pre-filled syringe
937541|NCT03560739|Auto-injector|auto-injector
937542|NCT03560687|Anemia|anemia
937543|NCT03560687|Heart Surgery|heart surgery
937544|NCT03560687|Iron Supplementation|iron supplementation
937545|NCT03560674|Dental trauma|dental trauma
937546|NCT03560674|emergency management|emergency management
937547|NCT03560674|traumatic injures.|traumatic injures.
937548|NCT03560661|Acoustic and perceptual markers|acoustic and perceptual markers
937549|NCT03560661|Dysarthria|dysarthria
937650|NCT03560232|Gentamicin|gentamicin
937550|NCT03560661|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
937551|NCT03560661|Primitive lateral sclerosis|primitive lateral sclerosis
937552|NCT03560661|Kennedy's disease|kennedy's disease
937553|NCT03560648|muscle aging|muscle aging
937554|NCT03560648|sarcopenia|sarcopenia
937555|NCT03560648|neuromuscular dysfunction|neuromuscular dysfunction
937556|NCT03560635|weight loss maintenance|weight loss maintenance
937557|NCT03560635|reverse diet|reverse diet
937558|NCT03560635|body composition|body composition
937559|NCT03560635|metabolic rate|metabolic rate
937560|NCT03560635|dietary adherence|dietary adherence
937561|NCT03560635|resting energy expenditure|resting energy expenditure
937562|NCT03560635|weight loss|weight loss
937563|NCT03560635|weight regain|weight regain
937564|NCT03560622|focused ultrasound|focused ultrasound
937565|NCT03560622|fMRI|fmri
937566|NCT03560596|Latino|latino
937567|NCT03560570|stroke-like|stroke-like
937568|NCT03560570|thrombosis|thrombosis
937569|NCT03560570|haemorrhages|haemorrhages
937570|NCT03560557|Pharmacokinetics|pharmacokinetics
937571|NCT03560557|Meropenem|meropenem
937572|NCT03560557|Critical illness|critical illness
937573|NCT03560557|Capillary leak|capillary leak
937574|NCT03560557|Augmented renal clearance|augmented renal clearance
937575|NCT03560531|Estrogen receptor|estrogen receptor
937576|NCT03560531|Hormone receptor|hormone receptor
937577|NCT03560531|Selective estrogen receptor degrader|selective estrogen receptor degrader
937578|NCT03560531|Hormone sensitive|hormone sensitive
937579|NCT03560531|Phase 1|phase 1
937580|NCT03560518|Depression|depression
937581|NCT03560505|Ultrasound reference material|ultrasound reference material
937582|NCT03560505|Sensitivity|sensitivity
937583|NCT03560505|Specificity|specificity
937713|NCT03559985|Pharmacogenetics|pharmacogenetics
937584|NCT03560505|Common fibular compression neuropathy|common fibular compression neuropathy
937585|NCT03560505|Type 2 diabetes polyneuropathy|type 2 diabetes polyneuropathy
937586|NCT03560505|Intra-rater reliability|intra-rater reliability
937587|NCT03560505|Inter-rater reliability|inter-rater reliability
937588|NCT03560492|posture|posture
937589|NCT03560492|cervical pain|cervical pain
937590|NCT03560492|exercise|exercise
937591|NCT03560479|First-in human|first-in human
937592|NCT03560479|Phase 1|phase 1
937593|NCT03560479|Phase 2|phase 2
937594|NCT03560479|Safety|safety
937595|NCT03560479|Tolerability|tolerability
937596|NCT03560479|Cancer|cancer
937597|NCT03560479|Bladder cancer|bladder cancer
937598|NCT03560479|Clinical trial|clinical trial
937599|NCT03560479|Anti-cancer|anti-cancer
937600|NCT03560479|Antineoplastic|antineoplastic
937601|NCT03560479|alpha1H|alpha1h
937602|NCT03560479|HAMLET|hamlet
937603|NCT03560479|Urothelial|urothelial
937604|NCT03560479|Malignant|malignant
937605|NCT03560479|Papillary|papillary
937606|NCT03560479|Transurethral|transurethral
937607|NCT03560479|Non-muscle invasive|non-muscle invasive
937608|NCT03560479|Instillation|instillation
937609|NCT03560479|Intravesical|intravesical
937610|NCT03560453|Autism|autism
937611|NCT03560453|ASD|asd
937612|NCT03560453|Competitive Integrated Employment|competitive integrated employment
937613|NCT03560453|Project SEARCH|project search
937614|NCT03560453|Outcomes|outcomes
937615|NCT03560453|Support Intensity|support intensity
937616|NCT03560440|Vancomycin|vancomycin
937617|NCT03560440|Pharmacokinetics|pharmacokinetics
937618|NCT03560440|Trough level|trough level
937619|NCT03560440|Pediatric|pediatric
937620|NCT03560401|Bracing; transforaminal lumbar interbody fusion (TLIF); outcome; fusion rate|bracing; transforaminal lumbar interbody fusion (tlif); outcome; fusion rate
937621|NCT03560388|Integrative medicine|integrative medicine
937622|NCT03560388|Acupuncture|acupuncture
937623|NCT03560388|Gynecological oncology|gynecological oncology
937624|NCT03560388|Surgery|surgery
937625|NCT03560388|Analgesia|analgesia
937626|NCT03560388|Pain|pain
937627|NCT03560388|Anxiety|anxiety
937628|NCT03560375|Weight loss; Diabetes; Frailty; Sarcopenia|weight loss; diabetes; frailty; sarcopenia
937629|NCT03560362|bupivacaine|bupivacaine
1630029|NCT00283465|Anemia|anemia
937630|NCT03560362|lipossomal extended release bupivacaine|lipossomal extended release bupivacaine
937631|NCT03560362|Intercostal nerve block|intercostal nerve block
937632|NCT03560362|thoracic surgery|thoracic surgery
937633|NCT03560362|minimally invasive surgery|minimally invasive surgery
937634|NCT03560323|Ketone Body Metabolism|ketone body metabolism
937635|NCT03560323|Myocardial Glucose Uptake|myocardial glucose uptake
937636|NCT03560323|Positron Emission Tomography|positron emission tomography
937637|NCT03560323|Myocardial Function|myocardial function
937638|NCT03560310|Coronary Bypass Grafting|coronary bypass grafting
937639|NCT03560310|Antiplatelet treatment|antiplatelet treatment
937640|NCT03560284|Marathon|marathon
937641|NCT03560284|Half Marathon|half marathon
937642|NCT03560284|Runners|runners
937643|NCT03560284|Ederly|ederly
937644|NCT03560284|Aging process|aging process
937645|NCT03560284|Sport Addiction|sport addiction
937646|NCT03560232|Open Fracture|open fracture
937647|NCT03560232|Wound Infection|wound infection
937648|NCT03560232|Antimicrobial Prophylaxis|antimicrobial prophylaxis
937649|NCT03560232|Cefazolin|cefazolin
937651|NCT03560232|Ceftriaxone|ceftriaxone
937652|NCT03560232|Ampicillin/Sulbactam|ampicillin/sulbactam
937653|NCT03560232|Clindamycin|clindamycin
937654|NCT03560232|Piperacillin/tazobactam|piperacillin/tazobactam
937655|NCT03560219|Atrial Fibrillation|atrial fibrillation
937656|NCT03560219|Atrial Fibrosis|atrial fibrosis
937657|NCT03560219|Genome Wide Association Studies|genome wide association studies
937658|NCT03560219|Biomarkers|biomarkers
937659|NCT03560219|Echocardiography|echocardiography
937660|NCT03560219|Magnetic Resonance Imaging|magnetic resonance imaging
937661|NCT03560219|Flow Mediated Dilatation|flow mediated dilatation
937662|NCT03560219|Thrombogenic Substrate|thrombogenic substrate
937663|NCT03560206|Diet, low-sodium|diet, low-sodium
937664|NCT03560206|caregivers|caregivers
937665|NCT03560193|Skin antisepsis|skin antisepsis
937666|NCT03560193|Chlorhexidine|chlorhexidine
937667|NCT03560193|Povidone Iodine|povidone iodine
937668|NCT03560193|Surgical site infection|surgical site infection
937669|NCT03560180|Anastomotic Leak|anastomotic leak
937670|NCT03560180|Colorectal Surgery|colorectal surgery
937671|NCT03560154|Pulmonary Function Test|pulmonary function test
937672|NCT03560154|Peripheral Muscle strength|peripheral muscle strength
937673|NCT03560154|Postural balance|postural balance
937675|NCT03560154|Pulmonary Muscle Strength|pulmonary muscle strength
937676|NCT03560154|Functional Capacity|functional capacity
937677|NCT03560154|Fatigue|fatigue
937678|NCT03560154|Quality of Life|quality of life
937679|NCT03560128|Colonoscopy|colonoscopy
937680|NCT03560115|Children|children
937681|NCT03560115|Heel|heel
937682|NCT03560115|Reliability|reliability
937683|NCT03560089|Parkinson's disease|parkinson's disease
937684|NCT03560089|Gait|gait
937685|NCT03560089|Rehabilitation|rehabilitation
937686|NCT03560089|Serious game|serious game
937687|NCT03560076|Acute Care|acute care
937688|NCT03560076|SBIRT|sbirt
937689|NCT03560076|Substance Use|substance use
937690|NCT03560076|Alcohol|alcohol
937691|NCT03560076|Opioid|opioid
937692|NCT03560076|Tobacco|tobacco
937693|NCT03560076|Nurse|nurse
937694|NCT03560076|Toolkit|toolkit
937695|NCT03560076|Implementation|implementation
937696|NCT03560063|arthroplasty|arthroplasty
937697|NCT03560063|dislocation|dislocation
937698|NCT03560063|templating|templating
937699|NCT03560050|early childhood education|early childhood education
937700|NCT03560050|family child care home|family child care home
937701|NCT03560050|food environment|food environment
937702|NCT03559998|Simulation training|simulation training
937703|NCT03559998|role-play|role-play
937704|NCT03559998|psychiatry|psychiatry
937705|NCT03559998|students|students
937706|NCT03559998|medical|medical
937707|NCT03559998|psychology|psychology
937708|NCT03559998|educational|educational
937709|NCT03559998|learning|learning
937715|NCT03559985|Cognitivo-emotional parameters|cognitivo-emotional parameters
937716|NCT03559946|Overactive Bladder Syndrome|overactive bladder syndrome
937717|NCT03559946|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
937718|NCT03559907|prevention|prevention
937719|NCT03559907|nutrition|nutrition
937720|NCT03559907|early childhood|early childhood
937721|NCT03559907|parent training|parent training
937722|NCT03559907|underserved|underserved
937723|NCT03559881|Skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer|skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer
937724|NCT03559816|Episiotomy|episiotomy
937725|NCT03559816|Vaginal delivery|vaginal delivery
937726|NCT03559816|Perineal trauma|perineal trauma
937727|NCT03559816|Laceration|laceration
937728|NCT03559816|Classification of second-degree laceration|classification of second-degree laceration
937729|NCT03559803|Cervical Cancer|cervical cancer
937730|NCT03559803|PD-L1|pd-l1
937731|NCT03559803|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
937732|NCT03559790|chronic hepatitis B|chronic hepatitis b
937733|NCT03559790|tenofovir alafenamide|tenofovir alafenamide
937734|NCT03559790|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
937735|NCT03559790|Safety|safety
937736|NCT03559790|Efficacy|efficacy
937737|NCT03559777|closed sinus lifiting|closed sinus lifiting
937738|NCT03559777|implant stability|implant stability
937739|NCT03559777|osteotome|osteotome
937740|NCT03559777|densah bur|densah bur
937741|NCT03559751|Abuse liability|abuse liability
937742|NCT03559725|Abuse liability|abuse liability
937743|NCT03559712|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
937744|NCT03559712|Collaborative Care|collaborative care
937745|NCT03559712|Telemedecine|telemedecine
937746|NCT03559712|Telemental Health|telemental health
937747|NCT03559608|arterial hypertension|arterial hypertension
937748|NCT03559608|male health|male health
937749|NCT03559608|Warmia-Masuria region|warmia-masuria region
937750|NCT03559569|Shock|shock
937751|NCT03559569|Cardiovascular Diseases|cardiovascular diseases
937765|NCT03559491|retinal vein occlusion|retinal vein occlusion
937766|NCT03559491|macular edema|macular edema
937767|NCT03559465|systemic sclerosis|systemic sclerosis
937768|NCT03559465|B lymphocyte|b lymphocyte
937769|NCT03559452|Muscle damage|muscle damage
937770|NCT03559452|Inflammation|inflammation
937771|NCT03559452|Immobilisation|immobilisation
937772|NCT03559426|antipsychotics|antipsychotics
937773|NCT03559426|schizophrenia|schizophrenia
937774|NCT03559426|reduction|reduction
937775|NCT03559413|Individualized peptide vaccination|individualized peptide vaccination
937776|NCT03559413|Immunotherapy|immunotherapy
937777|NCT03559413|Tumor-specific mutations|tumor-specific mutations
937778|NCT03559413|Neoantigens|neoantigens
937779|NCT03559374|Vanadis NIPT system|vanadis nipt system
937780|NCT03559348|in Elderly Patients|in elderly patients
937781|NCT03559335|Colorectal cancer|colorectal cancer
937782|NCT03559335|Biomarkers|biomarkers
937783|NCT03559335|Neutrophil CD64|neutrophil cd64
937784|NCT03559335|Monocyte Human Leukocyte Antigen - DR|monocyte human leukocyte antigen - dr
937785|NCT03559335|Postoperative Infectious Complications|postoperative infectious complications
937786|NCT03559335|C-reactive protein (CRP)|c-reactive protein (crp)
937787|NCT03559335|Procalcitonin (PCT)|procalcitonin (pct)
937788|NCT03559296|imaging|imaging
937789|NCT03559296|assessment|assessment
937790|NCT03559296|edema|edema
937791|NCT03559296|dermis|dermis
937792|NCT03559296|postmastectomy Lymphedema|postmastectomy lymphedema
937793|NCT03559296|reliability|reliability
937794|NCT03559296|ultrasound|ultrasound
937795|NCT03559296|grade|grade
937796|NCT03559283|stroke, dual-task, gait parameters, fNIRS|stroke, dual-task, gait parameters, fnirs
937797|NCT03559270|eczema|eczema
937798|NCT03559270|atopic eczema|atopic eczema
937799|NCT03559257|prevention|prevention
937800|NCT03559257|prophylaxis|prophylaxis
937801|NCT03559257|headache|headache
937802|NCT03559257|treatment-resistant|treatment-resistant
937803|NCT03559257|treatment resistant|treatment resistant
937804|NCT03559244|exercise|exercise
937805|NCT03559244|pectus carinatum|pectus carinatum
937806|NCT03559244|orthosis|orthosis
937807|NCT03559244|dynamic compression brace|dynamic compression brace
937808|NCT03559231|duodenal adenoma|duodenal adenoma
937809|NCT03559231|FTRD|ftrd
937810|NCT03559231|dFTRD|dftrd
937811|NCT03559231|EMR|emr
937812|NCT03559231|endoscopic mucosal resection|endoscopic mucosal resection
937813|NCT03559205|Musculoskeletal|musculoskeletal
937814|NCT03559205|MSK|msk
937815|NCT03559179|CDS|cds
937816|NCT03559179|Medication Assisted Therapy|medication assisted therapy
937817|NCT03559153|Office workers|office workers
937818|NCT03559153|Worker health|worker health
937819|NCT03559153|Work ability|work ability
937820|NCT03559153|Musculoskeletal disease|musculoskeletal disease
937821|NCT03559140|post-endodontic pain|post-endodontic pain
937822|NCT03559140|pain|pain
937823|NCT03559140|root canal treatment|root canal treatment
937824|NCT03559140|cryotherapy|cryotherapy
937825|NCT03559127|post-endodontic pain|post-endodontic pain
937826|NCT03559127|pain|pain
937829|NCT03559114|Sequential Compression Device|sequential compression device
937830|NCT03559114|Anticoagulant Thromboprophylaxis|anticoagulant thromboprophylaxis
937831|NCT03559114|Deep Vein Thrombosis|deep vein thrombosis
937832|NCT03559114|Sub Cutaneous|sub cutaneous
937833|NCT03559114|VTE|vte
937834|NCT03559101|Hydration|hydration
937835|NCT03559101|Plasma Volume|plasma volume
937836|NCT03559101|Amino acids|amino acids
937837|NCT03559101|Glucose|glucose
937838|NCT03559101|Electrolytes|electrolytes
937839|NCT03559101|Fluid Retention|fluid retention
937841|NCT03559101|Beverage Hydration Index|beverage hydration index
937842|NCT03559101|Dehydration|dehydration
937843|NCT03559101|Oral Rehydration|oral rehydration
937847|NCT03559036|Locomotor Training|locomotor training
937848|NCT03559036|Urodynamics|urodynamics
937849|NCT03559023|Thoracic epidural|thoracic epidural
937850|NCT03559010|Daily birth control|daily birth control
937851|NCT03558984|Surgical Site Infection (SSI), Cardiac Surgery, Open Heart Surgery, Infection|surgical site infection (ssi), cardiac surgery, open heart surgery, infection
937852|NCT03558971|Cortisol|cortisol
937853|NCT03558945|pancreatic tumor|pancreatic tumor
937854|NCT03558945|neoantigen|neoantigen
937855|NCT03558945|vaccine|vaccine
937856|NCT03558906|Periodontal disease|periodontal disease
937857|NCT03558906|Hypoxia|hypoxia
937858|NCT03558906|Cytokines|cytokines
937859|NCT03558906|Gingival crevicular fluid|gingival crevicular fluid
937860|NCT03558906|Saliva|saliva
937861|NCT03558893|circadian rhythm|circadian rhythm
937862|NCT03558867|Pre Diabetes|pre diabetes
937863|NCT03558867|Insulin resistance|insulin resistance
937864|NCT03558867|Metformin|metformin
937865|NCT03558867|Gut microbiota|gut microbiota
937866|NCT03558867|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
937867|NCT03558854|Systemic sclerosis|systemic sclerosis
937868|NCT03558854|Acetylsalicylic acid|acetylsalicylic acid
937869|NCT03558854|Vascular dysfunction|vascular dysfunction
937870|NCT03558841|gait|gait
937871|NCT03558841|mobility|mobility
937872|NCT03558841|geriatric|geriatric
937873|NCT03558841|rehabilitation|rehabilitation
937874|NCT03558841|inpatient|inpatient
937875|NCT03558828|physical activity|physical activity
937876|NCT03558828|women|women
937877|NCT03558828|sedentary|sedentary
937878|NCT03558828|accelerometer|accelerometer
937879|NCT03558828|text message|text message
937880|NCT03558828|group meeting|group meeting
937881|NCT03558828|personal call|personal call
937882|NCT03558828|workplace|workplace
937883|NCT03558828|cost-effectiveness|cost-effectiveness
937884|NCT03558828|Sequential Multiple Assignment Randomized Trial|sequential multiple assignment randomized trial
937885|NCT03558828|adaptive intervention|adaptive intervention
937886|NCT03558828|Actigraph|actigraph
937887|NCT03558828|Fitbit|fitbit
937888|NCT03558828|iCardia|icardia
937889|NCT03558815|intellectual disability|intellectual disability
937890|NCT03558815|psychotropic medication|psychotropic medication
937891|NCT03558815|mental health services evaluation|mental health services evaluation
937892|NCT03558776|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid
937893|NCT03558763|Monitoring|monitoring
937894|NCT03558737|non-invasive high frequency ventilation (nHFJV)|non-invasive high frequency ventilation (nhfjv)
937895|NCT03558737|nasal intermittent positive pressure ventilation (NIPPV)|nasal intermittent positive pressure ventilation (nippv)
937896|NCT03558724|Fluorescence|fluorescence
937897|NCT03558724|Endoscopy|endoscopy
937898|NCT03558724|Bevacizumab-800CW|bevacizumab-800cw
937899|NCT03558724|Locally advanced esophageal cancer|locally advanced esophageal cancer
937900|NCT03558711|prostate cancer|prostate cancer
937901|NCT03558711|biochemical recurrence|biochemical recurrence
937902|NCT03558711|18F-PET imaging|18f-pet imaging
937903|NCT03558698|cognition|cognition
937904|NCT03558698|sleep|sleep
937905|NCT03558698|carbon dioxide|carbon dioxide
937906|NCT03558698|bio effluents|bio effluents
937907|NCT03558672|Flexitouch|flexitouch
937908|NCT03558659|Stroke|stroke
937909|NCT03558659|Obstructive sleep apnea|obstructive sleep apnea
937910|NCT03558659|Positional therapy|positional therapy
937911|NCT03558646|Smoke inhalation injury|smoke inhalation injury
937912|NCT03558646|Acute kidney injury|acute kidney injury
937913|NCT03558646|Intensive care unit|intensive care unit
937914|NCT03558646|Burns|burns
937915|NCT03558646|Prognosis|prognosis
937916|NCT03558646|Hydroxocobalamin|hydroxocobalamin
937917|NCT03558633|Cricoid pressure|cricoid pressure
937918|NCT03558633|Paralaryngeal pressure|paralaryngeal pressure
937919|NCT03558633|Intubation|intubation
937920|NCT03558620|manual ventilation|manual ventilation
937921|NCT03558581|Nursing Process|nursing process
937922|NCT03558581|Nephrology Nursing|nephrology nursing
937923|NCT03558581|Education Health|education health
937924|NCT03558568|Parkinson's Disease|parkinson's disease
937925|NCT03558568|Deep Brain Stimulation|deep brain stimulation
937926|NCT03558568|Subthalamic Nucleus|subthalamic nucleus
937927|NCT03558568|DBS|dbs
937928|NCT03558568|STN|stn
937929|NCT03558568|Face|face
937930|NCT03558568|Facial expressions|facial expressions
937931|NCT03558568|Parkinson|parkinson
937932|NCT03558555|Acetaminophen|acetaminophen
937933|NCT03558555|Tylenol|tylenol
937934|NCT03558555|Intravenous versus oral|intravenous versus oral
937935|NCT03558529|relapse|relapse
937936|NCT03558529|early signs|early signs
937937|NCT03558529|basic symptoms|basic symptoms
937938|NCT03558529|smartphone app|smartphone app
937939|NCT03558529|mhealth|mhealth
937940|NCT03558516|Meningioma|meningioma
937941|NCT03558516|Magnesium sulphate|magnesium sulphate
937942|NCT03558516|Montreal cognitive assessment|montreal cognitive assessment
937943|NCT03558516|Intraoperative blood loss|intraoperative blood loss
937944|NCT03558503|UGN-102|ugn-102
937945|NCT03558503|UG-1 gel|ug-1 gel
944368|NCT03517982|MyOra|myora
937946|NCT03558503|Bladder cancer|bladder cancer
937947|NCT03558503|Gel|gel
937948|NCT03558503|Slow Release|slow release
937949|NCT03558503|Non Muscle Invasive Bladder Cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
937950|NCT03558503|Low grade (LG)|low grade (lg)
937951|NCT03558503|Prolonged Release|prolonged release
937952|NCT03558503|Mitomycin C|mitomycin c
937953|NCT03558503|Local|local
937954|NCT03558503|Intravesical|intravesical
937955|NCT03558503|Ta|ta
937957|NCT03558503|MMC|mmc
937958|NCT03558451|Primary health care|primary health care
937959|NCT03558425|CKD-381|ckd-381
937960|NCT03558425|D026|d026
937961|NCT03558412|Decitabine|decitabine
937962|NCT03558412|RR|rr
937963|NCT03558412|TTP|ttp
937964|NCT03558412|OS|os
937965|NCT03558412|MST|mst
937966|NCT03558399|Endometrial receptivity analysis|endometrial receptivity analysis
937967|NCT03558399|Window of implantation|window of implantation
937968|NCT03558399|Euploid|euploid
937969|NCT03558399|Infertility, Female|infertility, female
937970|NCT03558399|Implantation failure|implantation failure
937971|NCT03558399|Frozen embryo transfer FET|frozen embryo transfer fet
937972|NCT03558399|ERA|era
937973|NCT03558399|WOI|woi
937974|NCT03558399|FET|fet
937975|NCT03558399|Synchrony|synchrony
937976|NCT03558373|adherence|adherence
937977|NCT03558373|tacrolimus|tacrolimus
937978|NCT03558373|once-daily|once-daily
937979|NCT03558360|lean body mass|lean body mass
937980|NCT03558360|bariatric surgery|bariatric surgery
937981|NCT03558334|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
937982|NCT03558334|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
937983|NCT03558295|Percutaneous coronary intervention (PCI), oral anticoagulants, atrial fibrillation, DOAC.|percutaneous coronary intervention (pci), oral anticoagulants, atrial fibrillation, doac.
937984|NCT03558269|Autologous Umbilical cord blood infusion|autologous umbilical cord blood infusion
937985|NCT03558269|Congenital Heart Disease|congenital heart disease
937986|NCT03558269|Brain Injuries|brain injuries
937987|NCT03558269|Low Cardiac Output Syndrome|low cardiac output syndrome
937988|NCT03558269|Neonatal Disorder|neonatal disorder
937989|NCT03558256|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
937990|NCT03558243|radial artery occlusion|radial artery occlusion
937991|NCT03558243|prevention|prevention
937992|NCT03558243|patent hemostasis|patent hemostasis
937993|NCT03558243|transradial intervention|transradial intervention
937994|NCT03558243|ulnar compression|ulnar compression
937995|NCT03558230|pediatric|pediatric
937996|NCT03558230|hemiplegic|hemiplegic
937997|NCT03558230|hand function|hand function
937998|NCT03558217|total hip arthroplasty|total hip arthroplasty
937999|NCT03558217|collarless femoral implant|collarless femoral implant
938000|NCT03558217|collared femoral implant|collared femoral implant
938001|NCT03558217|direct anterior approach|direct anterior approach
938002|NCT03558217|direct lateral approach|direct lateral approach
938003|NCT03558191|Recurrent/Metastatic Nasopharyngeal Carcinoma|recurrent/metastatic nasopharyngeal carcinoma
938004|NCT03558191|PD-1|pd-1
938005|NCT03558126|silicone tube|silicone tube
938006|NCT03558126|miniature drainage device|miniature drainage device
938007|NCT03558126|POAG|poag
938008|NCT03558126|IOP|iop
938009|NCT03558100|obesity|obesity
938010|NCT03558100|gait|gait
938011|NCT03558100|bariatric surgery|bariatric surgery
938012|NCT03558100|walking|walking
938013|NCT03558100|obstacles|obstacles
938014|NCT03558087|muscle-invasive|muscle-invasive
938015|NCT03558074|Refractory wAMD|refractory wamd
938016|NCT03558048|Prostate Specific Antigen|prostate specific antigen
938017|NCT03558048|IBD|ibd
938018|NCT03558048|PSA|psa
938019|NCT03558035|Hypopharyngeal carcinoma|hypopharyngeal carcinoma
938020|NCT03558035|Locally advanced|locally advanced
938021|NCT03558035|Multi-disciplinary treatment|multi-disciplinary treatment
938022|NCT03558035|Functional MR|functional mr
938023|NCT03558035|Prognosis|prognosis
938024|NCT03558009|Hereditary and acquired C1-inhibitor deficiency|hereditary and acquired c1-inhibitor deficiency
938025|NCT03558009|C1 esterase inhibitor, hereditary angioedema,|c1 esterase inhibitor, hereditary angioedema,
938026|NCT03557931|aripiprazole|aripiprazole
938027|NCT03557931|ziprasidone|ziprasidone
938028|NCT03557931|lurasidone|lurasidone
938029|NCT03557931|schizophrenia|schizophrenia
938030|NCT03557931|ASP4345|asp4345
938031|NCT03557931|quetiapine|quetiapine
938032|NCT03557931|olanzapine|olanzapine
938033|NCT03557931|brexpiprazole|brexpiprazole
938034|NCT03557931|risperidone|risperidone
938035|NCT03557931|paliperidone|paliperidone
938036|NCT03557879|Hearing impairment|hearing impairment
938037|NCT03557879|familial|familial
938038|NCT03557866|foot posture|foot posture
938039|NCT03557866|running|running
938040|NCT03557866|foot index|foot index
938041|NCT03557840|temocillin|temocillin
938042|NCT03557840|free concentration|free concentration
938043|NCT03557840|total concentration|total concentration
938044|NCT03557840|pharmacokinetics|pharmacokinetics
938045|NCT03557840|pharmacodynamic|pharmacodynamic
938046|NCT03557840|probability of target attainment|probability of target attainment
938047|NCT03557840|non-ICU|non-icu
938048|NCT03557827|periodontitis|periodontitis
938049|NCT03557827|photodynamic therapy|photodynamic therapy
938050|NCT03557814|chronic periodontitis|chronic periodontitis
938051|NCT03557814|light-emitting diodes|light-emitting diodes
938052|NCT03557788|Rifaximin|rifaximin
938053|NCT03557762|Cancer survivors|cancer survivors
938054|NCT03557762|Smartphone app|smartphone app
938055|NCT03557762|Mindfulness|mindfulness
938056|NCT03557723|Community-dwellers,older adults, museum, art|community-dwellers,older adults, museum, art
938057|NCT03557710|eating|eating
938058|NCT03557710|overweight|overweight
938059|NCT03557710|obesity|obesity
938060|NCT03557710|cancer risk|cancer risk
938061|NCT03557710|translational neuroscience|translational neuroscience
938062|NCT03557710|cognitive reappraisal|cognitive reappraisal
938063|NCT03557710|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
938064|NCT03557710|vmPFC|vmpfc
938065|NCT03557710|inhibitory control|inhibitory control
938066|NCT03557710|valuation|valuation
938067|NCT03557697|Chinese Americans|chinese americans
938068|NCT03557697|SMS intervention|sms intervention
938069|NCT03557645|mechanical ventilation|mechanical ventilation
938070|NCT03557645|physiotherapy|physiotherapy
938071|NCT03557645|ventilator hyperinflation|ventilator hyperinflation
938072|NCT03557645|airway clearance technique|airway clearance technique
938073|NCT03557632|Opioid Dependence|opioid dependence
938074|NCT03557632|Injection Drug Use|injection drug use
938075|NCT03557632|Hispanics|hispanics
938076|NCT03557632|Mexican Americans|mexican americans
938077|NCT03557632|Virtual Reality Cue Exposure|virtual reality cue exposure
938078|NCT03557619|Cancer|cancer
938079|NCT03557619|Hematologic Malignancies, venetoclax|hematologic malignancies, venetoclax
938080|NCT03557619|ethinyl estradiol|ethinyl estradiol
938081|NCT03557619|relapsed or refractory non-Hodgkin's lymphoma|relapsed or refractory non-hodgkin's lymphoma
938082|NCT03557619|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
938083|NCT03557606|CCJ|ccj
938084|NCT03557606|Bone Marrow Concentrate|bone marrow concentrate
938085|NCT03557606|Stem Cell Therapy|stem cell therapy
938086|NCT03557606|Alar Ligament|alar ligament
938087|NCT03557606|Transverse Ligament|transverse ligament
938088|NCT03557593|Antipsychotic|antipsychotic
938089|NCT03557593|Nursing home|nursing home
938090|NCT03557593|Long-term care|long-term care
938091|NCT03557554|Massage|massage
938092|NCT03557554|Breast Cancer|breast cancer
938093|NCT03557554|Neuropathy|neuropathy
938094|NCT03557541|diabetes|diabetes
938095|NCT03557541|T2D|t2d
938096|NCT03557541|diet|diet
938097|NCT03557541|nutrition|nutrition
938098|NCT03557541|prediabetes|prediabetes
938099|NCT03557541|sardine|sardine
938100|NCT03557541|elderly|elderly
938101|NCT03557515|Depression|depression
938102|NCT03557515|Cognitive Behavioral Therapy|cognitive behavioral therapy
938103|NCT03557515|Coping|coping
938104|NCT03557515|Meditation|meditation
938105|NCT03557515|Anxiety|anxiety
938106|NCT03557502|Stage 1 hypertension|stage 1 hypertension
938107|NCT03557502|Arterial Stiffness|arterial stiffness
938108|NCT03557476|Octacosanol|octacosanol
938109|NCT03557476|Taekwondo|taekwondo
938110|NCT03557476|Lipid Profiles|lipid profiles
938111|NCT03557476|Oxidative Stress|oxidative stress
938112|NCT03557437|Helicobacter pylori Therapy|helicobacter pylori therapy
938113|NCT03557424|Polyglucosamine|polyglucosamine
938114|NCT03557424|Glucomannan|glucomannan
938115|NCT03557424|Weight reduction|weight reduction
938116|NCT03557424|Weight loss|weight loss
938117|NCT03557424|without change in lifestyle|without change in lifestyle
938118|NCT03557411|SHR-1210,radiotherapy,Oligometastases,NSCLC|shr-1210,radiotherapy,oligometastases,nsclc
938119|NCT03557398|Hyaluronic acid|hyaluronic acid
938120|NCT03557398|Post-menopause|post-menopause
938121|NCT03557385|Fractional Flow Reserve|fractional flow reserve
938122|NCT03557372|Recurrent glioblastoma|recurrent glioblastoma
938123|NCT03557372|Radiation Therapy|radiation therapy
938124|NCT03557359|Recurrent|recurrent
938125|NCT03557359|Progressive|progressive
938126|NCT03557359|High Grade Glioma|high grade glioma
938127|NCT03557359|IDH Mutant|idh mutant
938128|NCT03557320|environment|environment
938129|NCT03557320|pressure|pressure
938130|NCT03557320|temperature|temperature
938131|NCT03557320|case-crossover|case-crossover
938132|NCT03557307|Asthma|asthma
938133|NCT03557307|Severe Asthma|severe asthma
938134|NCT03557307|Oral Corticosteroids|oral corticosteroids
938135|NCT03557281|Early bactericidal activity|early bactericidal activity
938136|NCT03557281|Mycobacterium Tuberculosis|mycobacterium tuberculosis
938137|NCT03557281|GSK3036656|gsk3036656
938138|NCT03557281|Pulmonary tuberculosis|pulmonary tuberculosis
938139|NCT03557281|Colony forming units|colony forming units
938140|NCT03557229|Oxidative Stress|oxidative stress
938141|NCT03557229|Sepsis|sepsis
938142|NCT03557229|Treatment|treatment
938143|NCT03557229|Antioxidant therapy|antioxidant therapy
938144|NCT03557216|Diverticulitis|diverticulitis
938145|NCT03557216|Advanced colonic neoplasm|advanced colonic neoplasm
938146|NCT03557216|Colonoscopy|colonoscopy
938147|NCT03557203|Vernal Keratoconjunctivitis|vernal keratoconjunctivitis
938148|NCT03557203|Atopic Keratoconjunctivitis|atopic keratoconjunctivitis
938149|NCT03557203|tacrolimus|tacrolimus
938150|NCT03557190|VEGF inhibitors|vegf inhibitors
938151|NCT03557190|hypertension|hypertension
938152|NCT03557190|endothelial function|endothelial function
938153|NCT03557190|thrombosis|thrombosis
938154|NCT03557190|venous occlusion plethysmography|venous occlusion plethysmography
938155|NCT03557177|cisplatin|cisplatin
938254|NCT03556423|Arthritis|arthritis
938156|NCT03557177|flow mediated dilatation|flow mediated dilatation
938157|NCT03557138|SGLT2 inhibitor|sglt2 inhibitor
938158|NCT03557138|18F-FDG|18f-fdg
938159|NCT03557138|alpha-Methyl-4-18F-FDG|alpha-methyl-4-18f-fdg
938160|NCT03557112|Locally Advanced Nasopharyngeal Carcinoma|locally advanced nasopharyngeal carcinoma
938161|NCT03557112|nimotuzumab|nimotuzumab
938162|NCT03557112|chemoradiotherapy|chemoradiotherapy
938163|NCT03557112|cisplatin|cisplatin
938164|NCT03557099|SAA|saa
938165|NCT03557073|Hand injuries, Hand trauma, Patient reported outcomes|hand injuries, hand trauma, patient reported outcomes
938166|NCT03557060|Nucala|nucala
938167|NCT03557060|Drug use investigation|drug use investigation
938168|NCT03557060|EGPA|egpa
938169|NCT03557060|Long-term|long-term
938170|NCT03557034|pulmonary vein isolation|pulmonary vein isolation
938171|NCT03557034|atrial fibrillation|atrial fibrillation
938172|NCT03557034|remote monitoring|remote monitoring
938173|NCT03557034|heart rhythm monitor|heart rhythm monitor
938174|NCT03557008|Rabies Vaccine|rabies vaccine
938175|NCT03557008|Antibiotics|antibiotics
938176|NCT03557008|Biopsy|biopsy
938177|NCT03556982|Acute Myeloid Leukemia|acute myeloid leukemia
938178|NCT03556982|Relapsed|relapsed
938179|NCT03556982|Refractory|refractory
938180|NCT03556930|Non-sedated radiotherapy treatment|non-sedated radiotherapy treatment
938181|NCT03556878|Circadian rhythm disorders|circadian rhythm disorders
938182|NCT03556878|Sleep disorders|sleep disorders
938183|NCT03556878|Acceptability|acceptability
938184|NCT03556878|Adaptation|adaptation
938185|NCT03556878|Feasibility|feasibility
938186|NCT03556839|Cervix|cervix
938187|NCT03556839|Carcinoma|carcinoma
938188|NCT03556839|Atezolizumab|atezolizumab
938189|NCT03556813|Patient information|patient information
938190|NCT03556813|Natural Language Processing|natural language processing
938191|NCT03556813|Conversational agent|conversational agent
938192|NCT03556813|Chatbot|chatbot
938193|NCT03556800|Hypoestrogenism|hypoestrogenism
938194|NCT03556800|Menopausal hormone therapy|menopausal hormone therapy
938195|NCT03556761|Furosemide|furosemide
938196|NCT03556761|Postpartum|postpartum
938197|NCT03556761|Hypertension|hypertension
938198|NCT03556748|hematological malignancies|hematological malignancies
938199|NCT03556748|leukemia|leukemia
938200|NCT03556748|myeloma|myeloma
938201|NCT03556748|lymphoma|lymphoma
938202|NCT03556748|exercise|exercise
938203|NCT03556748|nutrition|nutrition
938204|NCT03556748|protein|protein
938205|NCT03556748|WB-EMS|wb-ems
938206|NCT03556748|whole-body electromyostimulation|whole-body electromyostimulation
938207|NCT03556735|Depression, unipolar|depression, unipolar
938208|NCT03556735|Treatment resistant|treatment resistant
938209|NCT03556735|PEMF|pemf
938210|NCT03556722|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
938211|NCT03556722|Transcranial Doppler|transcranial doppler
938212|NCT03556722|Neuromodulation|neuromodulation
938213|NCT03556722|Randomized Controlled Trials|randomized controlled trials
938214|NCT03556722|Pain|pain
938215|NCT03556722|Migraine prophylaxis|migraine prophylaxis
938216|NCT03556722|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
938217|NCT03556722|Protocol|protocol
938218|NCT03556696|general anesthesia|general anesthesia
938219|NCT03556696|analgesia/nociception balance monitoring|analgesia/nociception balance monitoring
938220|NCT03556696|expert system|expert system
938221|NCT03556683|asthma, hypertonic saline|asthma, hypertonic saline
938222|NCT03556657|Music Therapy|music therapy
938223|NCT03556657|Sickle Cell Disease|sickle cell disease
938224|NCT03556657|Quality of Life|quality of life
938225|NCT03556657|Chronic Pain|chronic pain
938226|NCT03556644|Near Infrared Spectroscopy|near infrared spectroscopy
938227|NCT03556644|Computed Tomography Coronary Angiography|computed tomography coronary angiography
938228|NCT03556644|Atherosclerosis|atherosclerosis
938229|NCT03556644|Endothelial Shear Stress|endothelial shear stress
938230|NCT03556566|ovary|ovary
938231|NCT03556566|ovarian|ovarian
938540|NCT03554512|Anxiety|anxiety
938232|NCT03556566|immunotherapy|immunotherapy
938233|NCT03556566|cancer|cancer
938234|NCT03556553|composite resin|composite resin
938235|NCT03556553|occlusal caries|occlusal caries
938236|NCT03556540|Chronic Kidney Disease|chronic kidney disease
938237|NCT03556540|Hemodialysis|hemodialysis
938238|NCT03556540|Exercise|exercise
938239|NCT03556527|osteotomy|osteotomy
938240|NCT03556527|reverse oblique sigmoid notch|reverse oblique sigmoid notch
1630030|NCT00283465|cancer|cancer
938241|NCT03556527|ulnar impaction syndrome|ulnar impaction syndrome
938242|NCT03556527|ulnar shortening|ulnar shortening
938243|NCT03556514|Locking Plate Fixaion|locking plate fixaion
938244|NCT03556488|Chest ultrasound|chest ultrasound
938245|NCT03556488|Pediatric community acquired pneumonia|pediatric community acquired pneumonia
938246|NCT03556488|Air bronchogram|air bronchogram
938247|NCT03556449|scapula/innervation*|scapula/innervation*
938248|NCT03556449|Thoracic Nerves/injuries*|thoracic nerves/injuries*
938249|NCT03556449|Peripheral Nerve Injuries|peripheral nerve injuries
938250|NCT03556449|Shoulder|shoulder
938251|NCT03556449|Musculoskeletal Diseases/diagnosis*|musculoskeletal diseases/diagnosis*
938252|NCT03556436|YH25448|yh25448
938253|NCT03556436|Non-Small Cell Lung Cancer|non-small cell lung cancer
938255|NCT03556423|Chronic pain|chronic pain
938256|NCT03556423|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
938257|NCT03556423|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
938258|NCT03556423|Conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
938259|NCT03556423|Clinical measures|clinical measures
938260|NCT03556423|Knee osteoarthritis|knee osteoarthritis
938261|NCT03556410|Sleep|sleep
938262|NCT03556410|Obesity|obesity
938263|NCT03556410|Metabolic Syndrome|metabolic syndrome
938264|NCT03556410|Physical Activity|physical activity
938265|NCT03556397|breast cancer|breast cancer
938266|NCT03556397|neoadjuvant therapy|neoadjuvant therapy
938267|NCT03556397|sentinel lymph node biopsy|sentinel lymph node biopsy
938268|NCT03556397|axillary dissection|axillary dissection
938269|NCT03556384|cancer|cancer
938270|NCT03556384|Temozolomide|temozolomide
938271|NCT03556384|GIST|gist
938272|NCT03556384|SDH-Mutant/Deficient|sdh-mutant/deficient
938273|NCT03556384|SDH|sdh
938274|NCT03556384|Succinate Dehydrogenase|succinate dehydrogenase
938275|NCT03556371|Cocaine|cocaine
938276|NCT03556371|Coca Paste|coca paste
938277|NCT03556371|N-Acetylcysteine|n-acetylcysteine
938278|NCT03556371|Craving|craving
938279|NCT03556371|Abstinence|abstinence
938280|NCT03556358|trastuzumab|trastuzumab
938281|NCT03556358|Herceptin|herceptin
938282|NCT03556345|RC48-ADC|rc48-adc
938283|NCT03556345|HER2 overexpression|her2 overexpression
938284|NCT03556345|Gastric cancer|gastric cancer
938285|NCT03556332|Carfilzomib|carfilzomib
938286|NCT03556332|Lenalidomide|lenalidomide
938287|NCT03556332|Dexamethasone|dexamethasone
938288|NCT03556332|Daratumumab|daratumumab
938289|NCT03556332|salvage autologous hematopoietic cell transplantation|salvage autologous hematopoietic cell transplantation
938290|NCT03556332|17-493|17-493
938291|NCT03556319|Multiple Dosage|multiple dosage
938292|NCT03556280|Dementia|dementia
938293|NCT03556280|Alzheimer's Disease|alzheimer's disease
938294|NCT03556280|Cognitive Impairment|cognitive impairment
938295|NCT03556254|Helicobacter pylori infection|helicobacter pylori infection
938296|NCT03556254|Genotypic resistance|genotypic resistance
938297|NCT03556254|Antimicrobial susceptibility|antimicrobial susceptibility
938298|NCT03556228|TrkA|trka
938299|NCT03556228|NTRK1|ntrk1
938300|NCT03556228|Thymic|thymic
938301|NCT03556228|Pancreatic|pancreatic
938302|NCT03556228|TNBC|tnbc
938303|NCT03556215|otitis media with effusion|otitis media with effusion
938304|NCT03556215|balloon tuboplasty|balloon tuboplasty
938305|NCT03556215|Eustachian tube|eustachian tube
938306|NCT03556215|Eustachian tube dysfunction|eustachian tube dysfunction
938307|NCT03556202|IL-23|il-23
938308|NCT03556202|Interleukin-23|interleukin-23
938309|NCT03556202|Psoriasis|psoriasis
938310|NCT03556176|Anxiety|anxiety
938311|NCT03556176|Mood|mood
938312|NCT03556176|Physical activity|physical activity
938313|NCT03556176|Polymorphisms|polymorphisms
938314|NCT03556163|Chronic periodontitis|chronic periodontitis
938315|NCT03556163|Modified Widman flap surgery|modified widman flap surgery
938316|NCT03556163|Suturing technique|suturing technique
938317|NCT03556137|PET/MRI|pet/mri
938318|NCT03556137|Chronic Pain|chronic pain
938319|NCT03556137|Pediatric|pediatric
938320|NCT03556124|Transcranial direct current stimulation|transcranial direct current stimulation
938321|NCT03556124|major depression|major depression
938322|NCT03556124|MRI|mri
938323|NCT03556111|implant , sticky bone|implant , sticky bone
938324|NCT03556098|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
938325|NCT03556098|Hypoglycemia|hypoglycemia
938326|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
938327|NCT03556098|Glucagon|glucagon
938328|NCT03556098|Incretin|incretin
938329|NCT03556085|idiopathic intracranial hypertension|idiopathic intracranial hypertension
938330|NCT03556085|venous sinus stenting|venous sinus stenting
938331|NCT03556072|ERCP|ercp
938332|NCT03556072|periampullary diverticula|periampullary diverticula
938333|NCT03556072|difficulty cannulation|difficulty cannulation
938334|NCT03556072|complication|complication
938335|NCT03556072|biliary disorder|biliary disorder
938336|NCT03556059|EOSS|eoss
938337|NCT03556059|Obesity and metabolic surgery|obesity and metabolic surgery
938338|NCT03556059|postoperative outcome|postoperative outcome
938339|NCT03556059|procedure selection|procedure selection
938340|NCT03556046|Clear Cell Renal Carcinoma|clear cell renal carcinoma
938341|NCT03556007|T regulatory cells|t regulatory cells
938342|NCT03555994|0382, T2DM|0382, t2dm
938344|NCT03555968|Alcohol|alcohol
938345|NCT03555968|Driving|driving
938346|NCT03555968|Dronabinol|dronabinol
938347|NCT03555929|Axillary block|axillary block
938348|NCT03555929|Dexamethasone|dexamethasone
938349|NCT03555929|anesthesia|anesthesia
938350|NCT03555916|BOTOX®-Allergan|botox®-allergan
938351|NCT03555916|PPTTN|ppttn
938352|NCT03555916|Pain measurements|pain measurements
938353|NCT03555890|Oral disintegrating tablet|oral disintegrating tablet
938354|NCT03555890|Levocetirizine|levocetirizine
938355|NCT03555890|Immediate release tablet|immediate release tablet
938459|NCT03555214|migraine|migraine
938356|NCT03555890|Bioequivalence|bioequivalence
938357|NCT03555890|Japanese subjects|japanese subjects
938358|NCT03555877|Ribociclib|ribociclib
938359|NCT03555877|Anti-hormonal maintainance treatment|anti-hormonal maintainance treatment
938360|NCT03555877|HR-positive|hr-positive
938361|NCT03555877|HER2-negative|her2-negative
938362|NCT03555812|Hip, Arthroplasty, pelvic inclination, ultrasound|hip, arthroplasty, pelvic inclination, ultrasound
938363|NCT03555773|perianal Crohn's disease|perianal crohn's disease
938364|NCT03555773|mesenchymal stromal cells|mesenchymal stromal cells
938365|NCT03555773|complex anal fistulas|complex anal fistulas
938366|NCT03555773|micro-fragmented adipose tissue|micro-fragmented adipose tissue
938367|NCT03555773|regenerative medicine|regenerative medicine
938368|NCT03555747|Canine distalization|canine distalization
938369|NCT03555747|Gingival crevicular fluid|gingival crevicular fluid
938370|NCT03555747|Cytokines|cytokines
938371|NCT03555747|Orthodontic force|orthodontic force
938372|NCT03555747|Periodontium|periodontium
938373|NCT03555747|Gingivitis|gingivitis
938374|NCT03555734|Pulses (beans, chickpeas, lentils, dry peas)|pulses (beans, chickpeas, lentils, dry peas)
938375|NCT03555734|Legumes|legumes
938376|NCT03555734|Cardiovascular disease|cardiovascular disease
938377|NCT03555734|Coronary heart disease|coronary heart disease
938378|NCT03555734|Stroke|stroke
938379|NCT03555734|Diabetes|diabetes
938380|NCT03555734|Hypertension|hypertension
938381|NCT03555734|Obesity|obesity
938382|NCT03555734|Prospective cohort studies|prospective cohort studies
938383|NCT03555734|Umbrella review|umbrella review
938384|NCT03555734|Systematic review and meta-analysis|systematic review and meta-analysis
938385|NCT03555708|Gait Training|gait training
938386|NCT03555708|Power Training|power training
938387|NCT03555708|Action-Perception Training|action-perception training
938388|NCT03555708|Brain Imaging|brain imaging
938389|NCT03555708|Mobility|mobility
938390|NCT03555695|karate|karate
938391|NCT03555695|exercise|exercise
938392|NCT03555682|Multiple Dosage|multiple dosage
938393|NCT03555669|Implementation Science|implementation science
938394|NCT03555669|Malawi|malawi
938396|NCT03555643|Stroke|stroke
938397|NCT03555643|Ischemia|ischemia
938398|NCT03555643|MRI|mri
938399|NCT03555643|FLAIR|flair
938400|NCT03555643|hyperintense acute reperfusion marker|hyperintense acute reperfusion marker
938401|NCT03555617|healthy volunteers|healthy volunteers
938402|NCT03555617|drug-drug interaction|drug-drug interaction
938403|NCT03555617|itraconazole|itraconazole
938404|NCT03555617|CYP3A|cyp3a
938405|NCT03555617|P-gp|p-gp
938406|NCT03555617|Inflammatory Bowel Disease|inflammatory bowel disease
938407|NCT03555617|IBD|ibd
938408|NCT03555617|Irritable Bowel Syndrome|irritable bowel syndrome
938409|NCT03555617|IBS|ibs
938410|NCT03555539|Hepatic Impairment|hepatic impairment
938411|NCT03555539|ACH-0144471|ach-0144471
938412|NCT03555500|Fasting|fasting
938413|NCT03555500|Non fasting|non fasting
938414|NCT03555500|Cardiac catheterization|cardiac catheterization
938415|NCT03555487|Hyperparathyroidism|hyperparathyroidism
938416|NCT03555487|18F choline|18f choline
938417|NCT03555487|PET|pet
938418|NCT03555487|Tc-99m sestaMIBI|tc-99m sestamibi
938419|NCT03555487|SPECT|spect
938420|NCT03555448|Immunosuppression|immunosuppression
938421|NCT03555435|Problem-solving|problem-solving
938422|NCT03555435|World Wide Web|world wide web
938423|NCT03555435|Peer support|peer support
938424|NCT03555435|Online mental health program|online mental health program
938425|NCT03555383|bloodless transplantation|bloodless transplantation
938426|NCT03555383|hemostasis reserve capacity|hemostasis reserve capacity
938427|NCT03555383|surgery|surgery
938428|NCT03555370|adolescent|adolescent
938429|NCT03555370|concussion|concussion
938430|NCT03555357|Abdomen|abdomen
938431|NCT03555357|Abdominoplasty|abdominoplasty
938432|NCT03555357|Scar Therapy|scar therapy
938433|NCT03555357|Scar|scar
939053|NCT03551132|elderly|elderly
938434|NCT03555331|responsive parenting|responsive parenting
938435|NCT03555318|Heart failure|heart failure
938436|NCT03555318|Frailty|frailty
938437|NCT03555318|Outcome|outcome
938438|NCT03555318|Hospitalization|hospitalization
938439|NCT03555318|Mortality|mortality
938440|NCT03555292|11C-PIB|11c-pib
938441|NCT03555292|Parkinson's disease|parkinson's disease
938442|NCT03555292|dementia|dementia
938443|NCT03555292|mild cognitive impairment|mild cognitive impairment
938444|NCT03555279|HIV Prevention|hiv prevention
938445|NCT03555279|Juvenile Justice|juvenile justice
938446|NCT03555279|Sexual Health|sexual health
938447|NCT03555279|Evidence Based Intervention|evidence based intervention
938448|NCT03555266|Pain Therapy|pain therapy
938449|NCT03555266|Auricular Therapy|auricular therapy
938450|NCT03555253|Resilience|resilience
938451|NCT03555253|Telehealth|telehealth
938452|NCT03555253|Well-being|well-being
938453|NCT03555253|Support|support
938454|NCT03555253|Caregiving|caregiving
938455|NCT03555240|Rheumatoid Arthritis|rheumatoid arthritis
938456|NCT03555227|breast cancer analgesia|breast cancer analgesia
938457|NCT03555227|pecs2 blocks|pecs2 blocks
938458|NCT03555227|ultrasound|ultrasound
938466|NCT03555110|EMDR Therapy|emdr therapy
938467|NCT03555110|Bariatric Surgery|bariatric surgery
938468|NCT03555110|Obesity|obesity
938469|NCT03555097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
938470|NCT03555097|Non-invasive Positive Pressure Ventilation|non-invasive positive pressure ventilation
938471|NCT03555097|Respiratory Mechanics|respiratory mechanics
938472|NCT03555097|Neural Respiratory Drive|neural respiratory drive
938473|NCT03555071|live attenuated varicella vaccine|live attenuated varicella vaccine
938474|NCT03555071|consistency|consistency
938475|NCT03555071|immunogenicity|immunogenicity
938476|NCT03555071|safety|safety
938477|NCT03555071|children|children
938478|NCT03555019|Brain maturation|brain maturation
938479|NCT03555019|Postnatal growth|postnatal growth
938480|NCT03554993|Healthy Volunteer|healthy volunteer
938481|NCT03554993|Safety|safety
938482|NCT03554993|CC-99677|cc-99677
938483|NCT03554967|Oral Squamous Cell Carcinoma|oral squamous cell carcinoma
938484|NCT03554967|Toluidine Blue|toluidine blue
938485|NCT03554967|Frozen Section|frozen section
938486|NCT03554967|Tumor margin assessment|tumor margin assessment
938487|NCT03554954|Nutrients|nutrients
938488|NCT03554954|Diet|diet
938489|NCT03554954|Sleep Quality|sleep quality
938490|NCT03554954|Middle-aged adults|middle-aged adults
938491|NCT03554954|Older adults|older adults
938492|NCT03554915|Agitation, Ketamine, Midazolam, Emergency Medical Services|agitation, ketamine, midazolam, emergency medical services
938493|NCT03554902|Endoscopic gastric tubulization|endoscopic gastric tubulization
938494|NCT03554902|Weight loss|weight loss
938495|NCT03554902|Quality of life|quality of life
938496|NCT03554876|Biofilm|biofilm
938497|NCT03554876|peri-implantitis|peri-implantitis
938498|NCT03554876|metagenomic analysis|metagenomic analysis
938499|NCT03554876|abutment|abutment
938500|NCT03554863|Anesthesia genral, Oxygen|anesthesia genral, oxygen
938501|NCT03554837|safety|safety
938502|NCT03554837|effectiveness|effectiveness
938503|NCT03554837|low dose|low dose
938504|NCT03554759|Chronic Liver Disease|chronic liver disease
938505|NCT03554759|Low Platelet Count|low platelet count
938506|NCT03554733|self efficacy|self efficacy
938507|NCT03554733|participation|participation
938508|NCT03554733|satisfaction with life|satisfaction with life
938509|NCT03554707|Childhood CNS tumor|childhood cns tumor
938510|NCT03554707|Recurrent CNS malignancies|recurrent cns malignancies
938511|NCT03554707|Progressive CNS malignancies|progressive cns malignancies
938512|NCT03554707|Refractory CNS malignancies|refractory cns malignancies
938513|NCT03554681|Bayes Model|bayes model
938514|NCT03554655|Shared decision making|shared decision making
938515|NCT03554655|Patient activation|patient activation
938516|NCT03554655|Schizophrenia|schizophrenia
938517|NCT03554655|First-episode psychosis|first-episode psychosis
938518|NCT03554655|mHealth|mhealth
938519|NCT03554655|Randomized clinical trial|randomized clinical trial
938520|NCT03554603|Long term care|long term care
938521|NCT03554603|Urine culture|urine culture
938522|NCT03554590|carbohydrate counting|carbohydrate counting
938523|NCT03554590|insulin therapy|insulin therapy
938524|NCT03554564|peripheral artery disease|peripheral artery disease
938525|NCT03554564|claudication|claudication
938526|NCT03554564|supervised exercise therapy|supervised exercise therapy
938527|NCT03554564|walking|walking
938528|NCT03554564|quality of life|quality of life
938529|NCT03554551|Parasympathetic|parasympathetic
938530|NCT03554538|Shoulder impingement syndrome, exercise, web app, efficacy|shoulder impingement syndrome, exercise, web app, efficacy
938531|NCT03554525|Obesity|obesity
938532|NCT03554525|Overweight|overweight
938533|NCT03554525|Weight Loss|weight loss
938534|NCT03554525|Body weight maintenance|body weight maintenance
938535|NCT03554525|Weight Change, Body|weight change, body
938536|NCT03554525|Saccharomyces Cerevisiae|saccharomyces cerevisiae
938537|NCT03554525|Beta-glucans|beta-glucans
938538|NCT03554512|Neonatal Intensive Care|neonatal intensive care
938539|NCT03554512|Telehealth|telehealth
938541|NCT03554512|Self Efficacy|self efficacy
938542|NCT03554512|Parenting/psychology|parenting/psychology
938543|NCT03554499|Facial aging|facial aging
938544|NCT03554499|Buccal fat pad|buccal fat pad
938550|NCT03554447|Pentoxifylline|pentoxifylline
938551|NCT03554447|Anti-inflammatory|anti-inflammatory
938553|NCT03554447|phosphodiastrase inhibitors|phosphodiastrase inhibitors
938554|NCT03554421|Key Words: Anal Fissure, tibial nerve stimulation|key words: anal fissure, tibial nerve stimulation
938555|NCT03554408|10-1074-LS|10-1074-ls
938556|NCT03554408|3BNC117-LS|3bnc117-ls
938557|NCT03554408|First in Human|first in human
938559|NCT03554395|PD-1 activated CIK|pd-1 activated cik
938560|NCT03554395|MUC1|muc1
938561|NCT03554395|bispecific antibody|bispecific antibody
938562|NCT03554395|gastric cancer|gastric cancer
938563|NCT03554382|person-centred care (PCC)|person-centred care (pcc)
938564|NCT03554382|self-efficacy|self-efficacy
938565|NCT03554369|Prostate|prostate
938566|NCT03554369|Dose-Limiting Toxicity|dose-limiting toxicity
938567|NCT03554369|Maximum Tolerated Dose|maximum tolerated dose
938568|NCT03554369|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
938569|NCT03554343|newborn screening|newborn screening
938570|NCT03554330|pulmonary arterial hypertension|pulmonary arterial hypertension
938571|NCT03554330|balloon atrial septostomy|balloon atrial septostomy
938572|NCT03554330|radiofrequency catheter ablation|radiofrequency catheter ablation
938573|NCT03554330|spontaneous closure|spontaneous closure
938574|NCT03554317|Bipolar Androgen Therapy|bipolar androgen therapy
938575|NCT03554317|Testosterone|testosterone
938576|NCT03554317|Nivolumab|nivolumab
938577|NCT03554291|famotidine|famotidine
938578|NCT03554291|H2 blocker|h2 blocker
938579|NCT03554291|H2 antagonist|h2 antagonist
938580|NCT03554278|NEC|nec
938581|NCT03554278|transfusion|transfusion
938582|NCT03554278|microbiome|microbiome
938583|NCT03554278|premature|premature
938584|NCT03554265|growth hormone|growth hormone
938585|NCT03554265|Traumatic Brain injury|traumatic brain injury
938586|NCT03554265|concussion|concussion
938587|NCT03554265|mTBI|mtbi
938588|NCT03554265|fatigue|fatigue
938589|NCT03554265|cognitive impairment|cognitive impairment
938590|NCT03554265|BIAFAC|biafac
938591|NCT03554239|Genotyping techniques|genotyping techniques
938592|NCT03554239|Fungal infection|fungal infection
938593|NCT03554226|agitation|agitation
938594|NCT03554226|aggressivity|aggressivity
938595|NCT03554200|Empagliflozin|empagliflozin
938596|NCT03554200|acute heart failure|acute heart failure
938597|NCT03554200|cardiac output|cardiac output
938598|NCT03554200|left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
938599|NCT03554200|exercise capacity|exercise capacity
938600|NCT03554174|psilocybin|psilocybin
938601|NCT03554161|Tocilizumab|tocilizumab
938602|NCT03554161|Refractory uveitis|refractory uveitis
938604|NCT03554096|Multiple Dosage|multiple dosage
938605|NCT03554070|Prostate|prostate
938606|NCT03554070|BPH|bph
938607|NCT03554070|Laser|laser
938608|NCT03554070|Endoscopic Enucleation of the Prostate|endoscopic enucleation of the prostate
938609|NCT03554070|Thulium|thulium
938610|NCT03554070|Thulium Fiber Laser|thulium fiber laser
938611|NCT03554057|Angiogram, Coronary Computed Tomographic Angiography|angiogram, coronary computed tomographic angiography
938612|NCT03553992|Tobacco|tobacco
938613|NCT03553992|Gender Identity Minority|gender identity minority
938614|NCT03553992|Sexual Identity Minority|sexual identity minority
938615|NCT03553992|Cessation|cessation
938616|NCT03553992|Intervention|intervention
938617|NCT03553992|Young Adults|young adults
938618|NCT03553992|Social Media|social media
938619|NCT03553992|Internet|internet
938620|NCT03553992|Cigarette|cigarette
938621|NCT03553979|stress management|stress management
938622|NCT03553979|stress intervention|stress intervention
938623|NCT03553979|smoking intervention|smoking intervention
938624|NCT03553979|lower SES|lower ses
938625|NCT03553979|lower income|lower income
938626|NCT03553966|Dental caries|dental caries
938627|NCT03553966|Toothpaste|toothpaste
938628|NCT03553966|Fluoride|fluoride
938629|NCT03553966|Hydroxyapatite|hydroxyapatite
938630|NCT03553953|Anesthesia|anesthesia
938631|NCT03553953|Bispectral index (BIS™)|bispectral index (bis™)
938632|NCT03553940|H3N2 M2SR Prime|h3n2 m2sr prime
938633|NCT03553940|Immunogenicity|immunogenicity
938634|NCT03553940|Influenza|influenza
938635|NCT03553940|Pediatric|pediatric
938636|NCT03553940|QIV|qiv
938637|NCT03553940|Safety|safety
938638|NCT03553940|Vaccine|vaccine
938639|NCT03553888|Hidradenitis Suppurativa|hidradenitis suppurativa
938640|NCT03553888|Periodontal diseases|periodontal diseases
938641|NCT03553888|Multicenter cross-sectional study|multicenter cross-sectional study
938642|NCT03553888|Vibrational spectroscopies|vibrational spectroscopies
938643|NCT03553888|Salivary biomarkers|salivary biomarkers
938644|NCT03553875|Autism|autism
938645|NCT03553875|Massachusetts General Hospital|massachusetts general hospital
938646|NCT03553849|Very low calorie diet|very low calorie diet
938647|NCT03553849|General surgery|general surgery
938648|NCT03553836|Programmed Cell Death Receptor 1 (PD1)|programmed cell death receptor 1 (pd1)
938649|NCT03553836|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
938650|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PDL1)|programmed cell death receptor ligand 1 (pdl1)
938651|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
938654|NCT03553784|Therapy|therapy
938655|NCT03553771|aneurysm|aneurysm
938656|NCT03553771|endovascular|endovascular
938657|NCT03553732|active surveillance|active surveillance
938658|NCT03553732|health information technology|health information technology
938659|NCT03553732|patient safety|patient safety
938660|NCT03553732|adherence|adherence
938661|NCT03553732|ambulatory|ambulatory
938662|NCT03553732|outpatient|outpatient
938663|NCT03553732|human factors|human factors
938664|NCT03553732|systems engineering|systems engineering
938665|NCT03553732|vulnerable populations|vulnerable populations
938666|NCT03553732|chronic disease|chronic disease
938667|NCT03553706|growth restriction, nutritive status, comorbide disorders, Down Syndrome|growth restriction, nutritive status, comorbide disorders, down syndrome
938668|NCT03553693|HIV|hiv
938669|NCT03553693|Viral Load|viral load
938670|NCT03553693|Counseling|counseling
938671|NCT03553693|Costs and Costs Analysis|costs and costs analysis
938672|NCT03553693|Point-Of-Care Systems|point-of-care systems
938673|NCT03553667|Hemodynamic Monitoring|hemodynamic monitoring
938674|NCT03553667|Perioperative Care|perioperative care
938675|NCT03553667|Outcome Assessment|outcome assessment
938676|NCT03553641|capacity|capacity
938677|NCT03553641|clinical ethics|clinical ethics
938678|NCT03553641|autonomy|autonomy
938679|NCT03553641|competence|competence
938680|NCT03553628|dental caries|dental caries
938681|NCT03553628|propolis|propolis
938682|NCT03553628|chlorhexidine|chlorhexidine
938683|NCT03553628|clove oil|clove oil
938684|NCT03553628|bee wax|bee wax
938685|NCT03553602|Prostate Cancer|prostate cancer
938686|NCT03553602|HDR brachytherapy|hdr brachytherapy
938687|NCT03553602|Recurrent Prostate Cancer|recurrent prostate cancer
938688|NCT03553602|Oligometastasis|oligometastasis
938689|NCT03553602|Salvage Brachytherapy|salvage brachytherapy
938690|NCT03553602|Salvage Radiotherapy|salvage radiotherapy
938691|NCT03553589|metabolomics|metabolomics
938692|NCT03553589|proteomics|proteomics
938693|NCT03553589|early diagnosis|early diagnosis
938694|NCT03553589|prognosis|prognosis
938695|NCT03553576|Labor pain|labor pain
938696|NCT03553576|Epidural|epidural
938697|NCT03553576|Obstetric|obstetric
938698|NCT03553576|Labor Analgesia|labor analgesia
938699|NCT03553563|D961H|d961h
938700|NCT03553563|paediatric|paediatric
938701|NCT03553563|reflux esophagitis|reflux esophagitis
938702|NCT03553563|gastric ulcer|gastric ulcer
938703|NCT03553537|Peripheral T-cell Lymphoma, decitabine|peripheral t-cell lymphoma, decitabine
938704|NCT03553524|Type 2 Diabetes|type 2 diabetes
938705|NCT03553524|Insulin independent|insulin independent
938706|NCT03553524|HIIT|hiit
938707|NCT03553524|Male|male
938708|NCT03553524|CGM-based blood glucose|cgm-based blood glucose
938709|NCT03553511|Laparoscopy|laparoscopy
938710|NCT03553511|Hysterectomy|hysterectomy
938711|NCT03553511|Uterosacral ligaments suspension|uterosacral ligaments suspension
938712|NCT03553511|McCall culdoplasty|mccall culdoplasty
938713|NCT03553511|Post-hysterectomy vault prolapse|post-hysterectomy vault prolapse
938714|NCT03553498|pain|pain
938715|NCT03553498|opioid analgesics|opioid analgesics
938716|NCT03553498|Emergency Department|emergency department
938717|NCT03553498|adult|adult
938718|NCT03553498|randomized controlled trial|randomized controlled trial
938719|NCT03553459|fluid responsiveness|fluid responsiveness
938720|NCT03553459|trendelenburg|trendelenburg
938721|NCT03553459|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
938722|NCT03553446|Sevoflurane|sevoflurane
938723|NCT03553446|Motion|motion
938724|NCT03553446|Botulinum toxins|botulinum toxins
938725|NCT03553446|Cerebral palsy|cerebral palsy
938726|NCT03553433|apremilast|apremilast
938727|NCT03553433|quality of life|quality of life
938728|NCT03553433|pruritus|pruritus
938729|NCT03553433|oral drug|oral drug
938730|NCT03553433|placebo|placebo
938731|NCT03553420|lipodystrophy|lipodystrophy
938732|NCT03553407|Low level laser|low level laser
938733|NCT03553407|Pulpitis|pulpitis
938734|NCT03553407|Mandibular molars|mandibular molars
938735|NCT03553368|lung nodules|lung nodules
938736|NCT03553355|infrared laser moxibustion|infrared laser moxibustion
938737|NCT03553355|cancer-related fatigue|cancer-related fatigue
938738|NCT03553355|breast cancer|breast cancer
938739|NCT03553290|Dentistry|dentistry
938740|NCT03553290|Dentinal Hypersensitivity|dentinal hypersensitivity
938741|NCT03553290|lower-level laser therapy|lower-level laser therapy
938742|NCT03553277|Dengue|dengue
938743|NCT03553277|Zika|zika
938744|NCT03553277|Chikungunya|chikungunya
938745|NCT03553277|Spatial repellent|spatial repellent
938746|NCT03553277|transfluthrin|transfluthrin
938747|NCT03553251|Hypersensitivity|hypersensitivity
938748|NCT03553251|Beta Lactam Adverse Reaction|beta lactam adverse reaction
938749|NCT03553238|Early T-cell Precursor|early t-cell precursor
938750|NCT03553238|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
938751|NCT03553238|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
938752|NCT03553238|Chidamide|chidamide
938753|NCT03553225|vascular function|vascular function
938754|NCT03553225|endothelial function|endothelial function
938755|NCT03553225|polyphenols|polyphenols
938756|NCT03553225|Concord Grape|concord grape
938757|NCT03553212|Prostate cancer|prostate cancer
938758|NCT03553212|organ-confined|organ-confined
938759|NCT03553212|external beam Radiotherapy|external beam radiotherapy
938760|NCT03553212|Image-guided tomotherapy|image-guided tomotherapy
938761|NCT03553199|Tissue Retraction System|tissue retraction system
938762|NCT03553199|Colorectal polyps|colorectal polyps
938763|NCT03553173|Smoking Cessation|smoking cessation
938765|NCT03553173|Decision Support System|decision support system
938766|NCT03553147|denutrition screening tool|denutrition screening tool
938767|NCT03553147|SARC-F score|sarc-f score
938768|NCT03553147|denutrition in geriatric population|denutrition in geriatric population
938769|NCT03553147|sarc-f score associated with denutrition|sarc-f score associated with denutrition
938770|NCT03553121|gynecologic cancer|gynecologic cancer
938771|NCT03553121|postoperative bowel function|postoperative bowel function
938772|NCT03553121|walking|walking
938773|NCT03553121|debulking|debulking
938774|NCT03553108|Solid Tumor|solid tumor
938775|NCT03553056|alcohol|alcohol
938776|NCT03553056|hazardous drinking|hazardous drinking
938777|NCT03553056|mobile phone app|mobile phone app
938778|NCT03553056|clinical trial|clinical trial
938779|NCT03553043|consumer behaviour|consumer behaviour
938780|NCT03553043|alcohol labelling|alcohol labelling
938781|NCT03553043|energy labelling|energy labelling
938782|NCT03553017|Optical Coherence Tomography|optical coherence tomography
938783|NCT03553017|Automated|automated
938784|NCT03553017|Binocular|binocular
938785|NCT03553004|Metastatic pancreatic cancer|metastatic pancreatic cancer
938786|NCT03553004|germline mutation|germline mutation
938787|NCT03553004|somatic mutation|somatic mutation
938788|NCT03553004|Niraparib|niraparib
938789|NCT03553004|pancreas|pancreas
938790|NCT03552991|Dietary Fiber|dietary fiber
938791|NCT03552991|Microbiota|microbiota
938792|NCT03552991|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
938793|NCT03552991|Metformin|metformin
938794|NCT03552991|Sulfonylurea Compounds|sulfonylurea compounds
938795|NCT03552965|xerostomia|xerostomia
938796|NCT03552965|Robust photon radiotherapy|robust photon radiotherapy
938797|NCT03552965|Margin based radiotherapy|margin based radiotherapy
938798|NCT03552939|microbiota|microbiota
938799|NCT03552939|breast milk|breast milk
938800|NCT03552939|diet|diet
938801|NCT03552926|Small subcortical infarct|small subcortical infarct
938802|NCT03552926|Cerebrovascular disorders|cerebrovascular disorders
938803|NCT03552926|Neurocognitive and cardiovascular disorders|neurocognitive and cardiovascular disorders
938804|NCT03552926|Disability|disability
938805|NCT03552926|Dementia|dementia
938806|NCT03552926|Stroke|stroke
938807|NCT03552913|Enhanced Recovery After Surgery|enhanced recovery after surgery
938808|NCT03552913|Fast track|fast track
938809|NCT03552913|Surgery|surgery
938810|NCT03552913|Hysterectomy|hysterectomy
938811|NCT03552913|Left colectomy|left colectomy
938812|NCT03552913|Total knee arthroplasty|total knee arthroplasty
938813|NCT03552887|Adverse Event|adverse event
938814|NCT03552887|Physiotherapy|physiotherapy
938815|NCT03552887|Cardiac Surgery|cardiac surgery
938816|NCT03552861|Parkinson's disease|parkinson's disease
938817|NCT03552861|rTMS|rtms
938818|NCT03552861|Dorsal prefrontal cortex|dorsal prefrontal cortex
938819|NCT03552861|Depression|depression
938820|NCT03552861|Cognitive impairment|cognitive impairment
938821|NCT03552835|partial caries removal|partial caries removal
938822|NCT03552835|no caries removal|no caries removal
938823|NCT03552783|fathers|fathers
938824|NCT03552783|parenting|parenting
938825|NCT03552783|African American|african american
938826|NCT03552770|neovascular age-related macular degeneration|neovascular age-related macular degeneration
938827|NCT03552770|bevacizumab|bevacizumab
938828|NCT03552770|pro-re-nata regimens|pro-re-nata regimens
938829|NCT03552770|clinical governance|clinical governance
938830|NCT03552718|solid tumors|solid tumors
938831|NCT03552692|BCL-2 positive|bcl-2 positive
938832|NCT03552692|PTCL-NOS|ptcl-nos
938833|NCT03552692|angioimmunoblastic T-cell lymphoma (AITL)|angioimmunoblastic t-cell lymphoma (aitl)
938834|NCT03552692|T-follicular helper origin (TFH)|t-follicular helper origin (tfh)
938835|NCT03552692|Venetoclax|venetoclax
938836|NCT03552692|single agent|single agent
938837|NCT03552679|Right Heart Failure|right heart failure
938838|NCT03552679|Ventricular Assist Device|ventricular assist device
938839|NCT03552679|Mortality|mortality
938840|NCT03552679|ICU Stay|icu stay
938841|NCT03552679|Acute Kidney Injury|acute kidney injury
938842|NCT03552666|Vitamin D|vitamin d
938843|NCT03552640|Orthodontics|orthodontics
938844|NCT03552640|Digitized Models|digitized models
938845|NCT03552640|Root Position|root position
938846|NCT03552627|hyperoxia|hyperoxia
938847|NCT03552627|oxygen|oxygen
938848|NCT03552627|surgery|surgery
938849|NCT03552627|perioperative|perioperative
939055|NCT03551132|health|health
938850|NCT03552614|robot-assisted rehabilitation|robot-assisted rehabilitation
938851|NCT03552614|Armeo®Spring|armeo®spring
938852|NCT03552614|quantitative assessment|quantitative assessment
938853|NCT03552575|sacubritil|sacubritil
938854|NCT03552575|valsartan|valsartan
938855|NCT03552575|left ventricular remodelling|left ventricular remodelling
938856|NCT03552575|asymptomatic left ventricular systolic dysfunction|asymptomatic left ventricular systolic dysfunction
938857|NCT03552575|myocardial infarction|myocardial infarction
938858|NCT03552523|bionic pancreas|bionic pancreas
938860|NCT03552497|Radiomics|radiomics
938861|NCT03552497|Bosniak classification|bosniak classification
938862|NCT03552497|Renal cell carcinoma|renal cell carcinoma
938863|NCT03552497|Medical imaging|medical imaging
938864|NCT03552458|oral mucositis|oral mucositis
938865|NCT03552458|probiotics|probiotics
938866|NCT03552458|anti-neoplastic chemotherapy|anti-neoplastic chemotherapy
938867|NCT03552432|alirocumab|alirocumab
938868|NCT03552432|Thin-cap fIbroatheroma (TCFA)|thin-cap fibroatheroma (tcfa)
938869|NCT03552432|vulnerable plaque|vulnerable plaque
938870|NCT03552432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
938871|NCT03552419|Operating room leveling|operating room leveling
938872|NCT03552419|Obstetric anesthesia|obstetric anesthesia
938873|NCT03552419|Time to incision|time to incision
938874|NCT03552406|Solid tumor|solid tumor
938875|NCT03552406|Breast cancer|breast cancer
938876|NCT03552406|Head & Neck cancer|head & neck cancer
938877|NCT03552367|Obesity|obesity
938878|NCT03552367|Children|children
938879|NCT03552367|Non-alcoholic fatty acid liver disease|non-alcoholic fatty acid liver disease
938880|NCT03552367|Exercise|exercise
938881|NCT03552367|Metabolic syndrome|metabolic syndrome
938882|NCT03552367|Cardiovascular risk|cardiovascular risk
938883|NCT03552341|Iodine|iodine
938884|NCT03552341|Cognitive function|cognitive function
938885|NCT03552341|Birth outcomes|birth outcomes
938886|NCT03552341|Pregnancy|pregnancy
938887|NCT03552302|Yoga|yoga
938888|NCT03552302|Tinnitus|tinnitus
938889|NCT03552302|Sleep|sleep
938890|NCT03552289|Dialysis|dialysis
938891|NCT03552289|Renal|renal
938892|NCT03552289|Hemodialysis|hemodialysis
938893|NCT03552289|Stenosis(es)|stenosis(es)
938894|NCT03552289|Transluminal|transluminal
938895|NCT03552289|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
938896|NCT03552263|Acute mountain sickness|acute mountain sickness
938897|NCT03552250|Parenting Program|parenting program
938898|NCT03552224|Evoked auditory nerve activity|evoked auditory nerve activity
938899|NCT03552224|Hearing Loss|hearing loss
938900|NCT03552224|Tinnitus|tinnitus
938901|NCT03552211|Multiple Sclerosis|multiple sclerosis
938902|NCT03552211|Progressive Multiple Sclerosis|progressive multiple sclerosis
938903|NCT03552211|Biotin|biotin
938904|NCT03552211|Relapse|relapse
938905|NCT03552198|Air quality alerts|air quality alerts
938906|NCT03552198|Health behaviour change|health behaviour change
938907|NCT03552198|Adherence|adherence
938908|NCT03552185|Neurogenic Dysphagia|neurogenic dysphagia
938909|NCT03552185|Multiple Sclerosis|multiple sclerosis
938910|NCT03552146|sedation|sedation
938911|NCT03552133|variable deadspace|variable deadspace
938912|NCT03552133|rebreathe|rebreathe
938913|NCT03552133|hypercapnic side-effects|hypercapnic side-effects
938914|NCT03552107|Lorcaserin|lorcaserin
938915|NCT03552107|Belviq|belviq
938916|NCT03552094|Arbovirus|arbovirus
938917|NCT03552081|spermatogenesis|spermatogenesis
938918|NCT03552081|tobacco|tobacco
938919|NCT03552081|DNA Fragmentation Index|dna fragmentation index
938920|NCT03552068|Parkinson's disease|parkinson's disease
938921|NCT03552068|Impulse control disorder|impulse control disorder
938922|NCT03552068|Clonidine|clonidine
938923|NCT03552068|Noradrenergic system|noradrenergic system
938924|NCT03552055|placental proteins|placental proteins
938925|NCT03552029|Relapsed/Refractory|relapsed/refractory
938926|NCT03552029|Newly Diagnosed|newly diagnosed
938927|NCT03552029|Unfit for Chemotherapy|unfit for chemotherapy
938928|NCT03552029|Positive for FLT3 Biomarker|positive for flt3 biomarker
938929|NCT03552016|Myopia|myopia
938930|NCT03552016|Axial Myopia|axial myopia
938931|NCT03552016|Children|children
938932|NCT03552016|Refractive Error|refractive error
938933|NCT03552016|Riboflavin|riboflavin
938934|NCT03552016|Vitamin B2|vitamin b2
938935|NCT03552003|Hodgkin|hodgkin
938936|NCT03552003|Elderly patients|elderly patients
938938|NCT03551990|Whole-body electromyostimulation|whole-body electromyostimulation
938939|NCT03551990|WB-EMS|wb-ems
938940|NCT03551990|Cancer|cancer
938941|NCT03551990|Muscle atrophy|muscle atrophy
938942|NCT03551990|Muscle protein|muscle protein
938943|NCT03551990|Exercise|exercise
938944|NCT03551990|Muscle fiber|muscle fiber
938945|NCT03551964|Acute myocardial infarction|acute myocardial infarction
938946|NCT03551964|Cardiogenic shock|cardiogenic shock
938947|NCT03551964|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
938948|NCT03551964|Dual antiplatelet therapy|dual antiplatelet therapy
938949|NCT03551964|Cangrelor|cangrelor
938950|NCT03551964|Ticagrelor|ticagrelor
939054|NCT03551132|resistance training|resistance training
938951|NCT03551938|HIV, telehealth, HIV testing, YMSM, couples|hiv, telehealth, hiv testing, ymsm, couples
938952|NCT03551873|Breast milk|breast milk
938953|NCT03551873|Lactating|lactating
938954|NCT03551860|Total hip replacement|total hip replacement
938955|NCT03551860|Motor block post-operatively|motor block post-operatively
938956|NCT03551860|Morphine consumption post-operatively|morphine consumption post-operatively
938957|NCT03551860|Transmuscular Quadratus Nerve Block|transmuscular quadratus nerve block
938960|NCT03551704|Substance addiction|substance addiction
938961|NCT03551704|Cocaine|cocaine
938962|NCT03551704|Alcohol|alcohol
938963|NCT03551704|Behavioral treatment|behavioral treatment
938964|NCT03551691|fat absorption|fat absorption
938965|NCT03551691|pancreatic enzyme|pancreatic enzyme
938966|NCT03551665|Multiple Sclerosis|multiple sclerosis
938967|NCT03551665|Falls|falls
938968|NCT03551665|Posture|posture
938969|NCT03551665|Rehabilitation|rehabilitation
938970|NCT03551665|Cognition|cognition
938971|NCT03551665|Neuroimaging|neuroimaging
938972|NCT03551626|dabrafenib|dabrafenib
938973|NCT03551626|trametinib|trametinib
938974|NCT03551626|adjuvant|adjuvant
938975|NCT03551626|melanoma|melanoma
938976|NCT03551626|combination treatment|combination treatment
938977|NCT03551626|pyrexia|pyrexia
938978|NCT03551600|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
938979|NCT03551600|renal oxygen saturations|renal oxygen saturations
938980|NCT03551600|splanchnic oxygen saturations|splanchnic oxygen saturations
938981|NCT03551561|Chlorhexidine|chlorhexidine
938982|NCT03551561|Infection|infection
938983|NCT03551561|Orthopedics|orthopedics
938984|NCT03551561|Surgical rooms|surgical rooms
938985|NCT03551561|Antisepsis|antisepsis
938986|NCT03551561|Surgical Procedures.|surgical procedures.
938987|NCT03551535|Wearable technology|wearable technology
938988|NCT03551535|Pregnancy|pregnancy
938989|NCT03551535|Exercise|exercise
938990|NCT03551535|Mobile Health|mobile health
938991|NCT03551509|Rotator Cuff Tear|rotator cuff tear
938992|NCT03551509|Large Rotator Cuff Tear|large rotator cuff tear
938993|NCT03551509|Massive Rotator Cuff Tear|massive rotator cuff tear
938994|NCT03551509|ECM|ecm
938995|NCT03551509|Extracellular Matrix|extracellular matrix
938996|NCT03551509|ArthroFLEX|arthroflex
938997|NCT03551483|Arts-based Intervention|arts-based intervention
938998|NCT03551483|Mobile Health|mobile health
938999|NCT03551483|Online Recreation|online recreation
939000|NCT03551470|robotic|robotic
939001|NCT03551470|laparoscopy|laparoscopy
939002|NCT03551470|liver surgery|liver surgery
939003|NCT03551470|colorectal and synchronous liver metastases|colorectal and synchronous liver metastases
939004|NCT03551470|simultaneous surgery|simultaneous surgery
939005|NCT03551457|Patient Derived Xenograft|patient derived xenograft
939006|NCT03551457|Treatment Response Phenotype|treatment response phenotype
939007|NCT03551457|Personalised|personalised
939008|NCT03551392|Cognitive Aging|cognitive aging
939009|NCT03551392|Photobiomodulation|photobiomodulation
939010|NCT03551392|Low Level Light Therapy|low level light therapy
939011|NCT03551392|Near Infrared (NIR) Light|near infrared (nir) light
939012|NCT03551392|Neuromodulation|neuromodulation
939013|NCT03551379|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
939014|NCT03551366|Physical Activity|physical activity
939015|NCT03551366|Physical Education|physical education
939016|NCT03551366|Children|children
939017|NCT03551366|Pedagogy|pedagogy
939018|NCT03551366|Motor Competence|motor competence
939019|NCT03551366|Perceived Motor Competence|perceived motor competence
939020|NCT03551366|Self-perception|self-perception
939021|NCT03551366|Cognition|cognition
939022|NCT03551366|Fundamental Movement Skills|fundamental movement skills
939025|NCT03551340|Gastroenteritis, panel by PCR, antibiotic use|gastroenteritis, panel by pcr, antibiotic use
939026|NCT03551327|Post-stroke fatigue|post-stroke fatigue
939027|NCT03551314|Non-invasive ventilation|non-invasive ventilation
939028|NCT03551314|Preterm infant|preterm infant
939029|NCT03551314|Breathing pattern|breathing pattern
939030|NCT03551301|Substance Use Disorders|substance use disorders
939031|NCT03551301|Case Management|case management
939032|NCT03551301|Community Treatment|community treatment
939033|NCT03551301|Hospital discharge|hospital discharge
939034|NCT03551288|SUVN-911|suvn-911
939035|NCT03551288|Depression|depression
939036|NCT03551288|alpha4 beta2 receptor|alpha4 beta2 receptor
939037|NCT03551275|BCD-132|bcd-132
939038|NCT03551275|Multiple Sclerosis|multiple sclerosis
939039|NCT03551275|anti-CD20|anti-cd20
939040|NCT03551210|nemonoxacin|nemonoxacin
939041|NCT03551210|community-acquired pneumonia|community-acquired pneumonia
939042|NCT03551210|quinolones|quinolones
939043|NCT03551197|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
939044|NCT03551197|exercise|exercise
939045|NCT03551197|lung function|lung function
939046|NCT03551197|quality of life|quality of life
939047|NCT03551184|Sickness behavior|sickness behavior
939048|NCT03551184|Endotoxin|endotoxin
939049|NCT03551184|Lipopolysaccharide|lipopolysaccharide
939050|NCT03551184|Psychoneuroimmunology|psychoneuroimmunology
939051|NCT03551171|PARP inhibitor|parp inhibitor
939052|NCT03551171|BRCA mutation|brca mutation
939069|NCT03551041|depression, self-referential, neural representation|depression, self-referential, neural representation
939070|NCT03551015|Coronary Artery Bypass Grafting|coronary artery bypass grafting
939071|NCT03551015|Median sternotomy|median sternotomy
939072|NCT03551015|Post-operative outpatient review|post-operative outpatient review
939073|NCT03551015|Cardiac rehabilitation|cardiac rehabilitation
939074|NCT03551015|Quality of life|quality of life
939076|NCT03551002|Hepatitis C|hepatitis c
939077|NCT03551002|Direct acting antivirals|direct acting antivirals
939078|NCT03551002|Hepatitis C modeling|hepatitis c modeling
939079|NCT03550989|Environmental Aerosol Exposure|environmental aerosol exposure
939080|NCT03550989|Environmental Tobacco Smoke|environmental tobacco smoke
939081|NCT03550989|Indoor Air Quality|indoor air quality
939082|NCT03550898|Dynamic Ultrasonography|dynamic ultrasonography
939083|NCT03550898|Spinal Dysraphism|spinal dysraphism
939084|NCT03550885|microbiome, human|microbiome, human
939085|NCT03550885|bile acids and salts|bile acids and salts
939086|NCT03550885|diet, western|diet, western
939087|NCT03550872|heart failure, atrial fibrillation and exercise training|heart failure, atrial fibrillation and exercise training
939088|NCT03550846|Spinal Fusion|spinal fusion
939089|NCT03550833|Rheumatoid arthritis|rheumatoid arthritis
939090|NCT03550833|Stress|stress
939091|NCT03550820|pulmonary MAC|pulmonary mac
939092|NCT03550820|energy metabolism|energy metabolism
939093|NCT03550781|Takayasu Arteritis|takayasu arteritis
939094|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents
939095|NCT03550781|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
939096|NCT03550768|ERCP|ercp
939097|NCT03550768|anatomy of major duodenal papilla|anatomy of major duodenal papilla
939098|NCT03550755|cervix|cervix
939099|NCT03550755|uterus|uterus
939100|NCT03550742|Human Milk Oligosaccharides|human milk oligosaccharides
939101|NCT03550742|IBS-C|ibs-c
939102|NCT03550742|IBS-D|ibs-d
939103|NCT03550742|IBS-M|ibs-m
939104|NCT03550729|Exercise training|exercise training
939105|NCT03550729|Biomarkers|biomarkers
939106|NCT03550716|azoospermia|azoospermia
939107|NCT03550716|microdissection testicular sperm extraction|microdissection testicular sperm extraction
939108|NCT03550716|testicular sperm aspiration|testicular sperm aspiration
939109|NCT03550716|male infertility|male infertility
939110|NCT03550716|surgical sperm retrieval|surgical sperm retrieval
939111|NCT03550677|Ankle nerve block|ankle nerve block
939112|NCT03550677|post operative analgesia|post operative analgesia
939113|NCT03550677|patient satisfaction|patient satisfaction
939114|NCT03550677|foot surgery|foot surgery
939115|NCT03550651|Plaque|plaque
939116|NCT03550651|Plaque regrowth|plaque regrowth
939117|NCT03550651|Licorice extract|licorice extract
939118|NCT03550651|Mouthrinse|mouthrinse
939119|NCT03550651|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
939120|NCT03550651|Hypertonic salt solution|hypertonic salt solution
939121|NCT03550651|Essential oils|essential oils
939122|NCT03550573|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
939123|NCT03550573|sudden death|sudden death
939124|NCT03550573|3D mapping|3d mapping
939125|NCT03550560|Endoscopic Ultrasound-Guided|endoscopic ultrasound-guided
939126|NCT03550560|EUS-Guided|eus-guided
939127|NCT03550560|Transgastric plastic prostheses|transgastric plastic prostheses
939128|NCT03550547|Physical Activity|physical activity
939129|NCT03550547|Education|education
939130|NCT03550547|Dietary|dietary
939131|NCT03550547|Self-management|self-management
939132|NCT03550534|Calcium carbonate|calcium carbonate
939133|NCT03550534|Chronic kidney disease|chronic kidney disease
939134|NCT03550534|Normophosphatemia|normophosphatemia
939135|NCT03550534|FGF23|fgf23
939136|NCT03550534|Phosphate binder|phosphate binder
939137|NCT03550508|JMT103 in Patients with Bone Metastases from Tumors|jmt103 in patients with bone metastases from tumors
939138|NCT03550495|ICU delirium|icu delirium
939139|NCT03550495|prevention|prevention
939140|NCT03550495|psychiatry|psychiatry
939142|NCT03550482|Nutritional supplement|nutritional supplement
939143|NCT03550482|Chemotherapy|chemotherapy
939144|NCT03550482|Oxidative stress|oxidative stress
939145|NCT03550482|Antioxidant|antioxidant
939146|NCT03550469|hyperoxia|hyperoxia
939147|NCT03550469|hypoxia|hypoxia
939148|NCT03550456|Exercise Induced Asthma (EIA)|exercise induced asthma (eia)
939149|NCT03550456|Exercise Induced Laryngeal Obstruction (EILO)|exercise induced laryngeal obstruction (eilo)
939150|NCT03550456|Quality of life|quality of life
939151|NCT03550456|Exercise challenge in cold chamber (ECC)|exercise challenge in cold chamber (ecc)
939152|NCT03550456|Continous laryngoscopy while exercising (CLE)|continous laryngoscopy while exercising (cle)
939153|NCT03550443|Bardoxolone Methyl|bardoxolone methyl
939154|NCT03550443|Diabetic Kidney Disease|diabetic kidney disease
939155|NCT03550443|Diabetes Mellitus|diabetes mellitus
939156|NCT03550443|Kidney Diseases|kidney diseases
939157|NCT03550430|tinnitus distress|tinnitus distress
939158|NCT03550430|tinnitus intrusiveness|tinnitus intrusiveness
939159|NCT03550430|synchronization by loss of inhibition model (SLIM)|synchronization by loss of inhibition model (slim)
939160|NCT03550430|neurofeedback|neurofeedback
939161|NCT03550430|alpha/delta neurofeedback|alpha/delta neurofeedback
939778|NCT03547076|Support|support
939162|NCT03550430|beta/theta neurofeedback|beta/theta neurofeedback
939163|NCT03550430|electroencephalography (EEG)|electroencephalography (eeg)
939164|NCT03550430|tinnitus intensity|tinnitus intensity
939165|NCT03550430|tinnitus loudness|tinnitus loudness
939166|NCT03550417|disease management|disease management
939167|NCT03550417|best practice guidelines|best practice guidelines
939168|NCT03550378|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
939169|NCT03550378|MEDI0382|medi0382
939170|NCT03550378|Renal Impairment|renal impairment
939172|NCT03550352|Cannabinoids|cannabinoids
939173|NCT03550352|HIV reservoir|hiv reservoir
939174|NCT03550352|Microbiome|microbiome
939175|NCT03550352|CBD|cbd
939176|NCT03550352|THC|thc
939177|NCT03550352|Inflammation|inflammation
939178|NCT03550352|Immune activation|immune activation
939179|NCT03550339|obesity|obesity
939180|NCT03550339|appetite|appetite
939181|NCT03550339|food reward|food reward
939182|NCT03550339|hormonal responses|hormonal responses
939183|NCT03550339|psychophysiological responses|psychophysiological responses
939184|NCT03550339|implicit measures|implicit measures
939185|NCT03550339|explicit measures|explicit measures
939186|NCT03550326|anesthesia|anesthesia
939187|NCT03550326|difficult airway|difficult airway
939188|NCT03550326|supraglottic airway device|supraglottic airway device
939189|NCT03550326|difficult intubation|difficult intubation
939190|NCT03550326|airway complications|airway complications
939191|NCT03550274|Acute lateral ankle sprain|acute lateral ankle sprain
939192|NCT03550274|Acute ankle injury|acute ankle injury
939193|NCT03550274|Ankle sprain|ankle sprain
939194|NCT03550274|Exercise therapy|exercise therapy
939195|NCT03550274|App-based rehabilitation|app-based rehabilitation
939196|NCT03550274|Mixed-method|mixed-method
939197|NCT03550274|Pilot Study|pilot study
939198|NCT03550261|CAH|cah
939199|NCT03550261|Salt-wasting|salt-wasting
939200|NCT03550261|LC-MSMS|lc-msms
939201|NCT03550261|plasma and urine steroid profile|plasma and urine steroid profile
939202|NCT03550261|Fludrocortisone|fludrocortisone
939203|NCT03550248|Healthy Weights|healthy weights
939204|NCT03550248|Health Promotion|health promotion
939205|NCT03550248|Scale-up|scale-up
939206|NCT03550248|Family Health|family health
939207|NCT03550248|Prevention|prevention
939208|NCT03550248|Childhood Obesity|childhood obesity
939209|NCT03550248|Physical Activity|physical activity
939210|NCT03550248|Cooking Activity|cooking activity
939211|NCT03550248|Family education model|family education model
939212|NCT03550235|Heart failure|heart failure
939213|NCT03550235|dyspnea|dyspnea
939214|NCT03550235|stress test|stress test
939215|NCT03550222|Diaphragmatic dysfunction|diaphragmatic dysfunction
939216|NCT03550222|Mechanical Ventilation|mechanical ventilation
939217|NCT03550222|ICU acquired weakness|icu acquired weakness
939218|NCT03550222|Weaning|weaning
939219|NCT03550222|Skeletal muscles|skeletal muscles
939220|NCT03550222|Respiratory muscles|respiratory muscles
939221|NCT03550170|Fatigue|fatigue
939222|NCT03550170|Wellness|wellness
939223|NCT03550170|Multiple Sclerosis|multiple sclerosis
939224|NCT03550170|Quality of life|quality of life
939225|NCT03550157|Cellulite|cellulite
939226|NCT03550157|Cutaneous ultrasound|cutaneous ultrasound
939227|NCT03550157|PnKCelulitis® program|pnkcelulitis® program
939228|NCT03550144|Awe|awe
939229|NCT03550144|Compassion|compassion
939230|NCT03550144|Anxiety|anxiety
939231|NCT03550144|Positive emotions|positive emotions
939232|NCT03550144|Aging|aging
939233|NCT03550131|LGBT|lgbt
939234|NCT03550118|Prosthetic Socket|prosthetic socket
939235|NCT03550118|Amputee|amputee
939236|NCT03550118|Adjustable Socket|adjustable socket
939237|NCT03550105|Glucose|glucose
939238|NCT03550105|Diabetes|diabetes
939239|NCT03550105|Physical Activity|physical activity
939240|NCT03550105|Passive Exercise|passive exercise
939241|NCT03550105|Blood Pressure|blood pressure
939242|NCT03550105|Muscle Strength|muscle strength
939243|NCT03550105|Muscle Endurance|muscle endurance
939244|NCT03550105|Hypertension|hypertension
939245|NCT03550105|Physical Inactivity|physical inactivity
939246|NCT03550092|aphasia|aphasia
939247|NCT03550092|treatment|treatment
939248|NCT03550092|therapy|therapy
939249|NCT03550092|anomia|anomia
939250|NCT03550092|fMRI|fmri
939251|NCT03550092|neuroimaging|neuroimaging
939252|NCT03550092|semantics|semantics
939253|NCT03550066|Diabetes, gestational|diabetes, gestational
939257|NCT03550040|robot assisted prostatectomy|robot assisted prostatectomy
939258|NCT03550014|Low Back Pain|low back pain
939259|NCT03550014|Hip|hip
939260|NCT03550014|Physical Therapy|physical therapy
939261|NCT03550001|locally advanced rectal cancer|locally advanced rectal cancer
939262|NCT03550001|lymph node yeild|lymph node yeild
939263|NCT03550001|lymph node tracer|lymph node tracer
939264|NCT03550001|stage shift|stage shift
939265|NCT03550001|prognosis|prognosis
939266|NCT03549988|Ulcerative colitis|ulcerative colitis
939267|NCT03549988|Fecal calprotectin|fecal calprotectin
939268|NCT03549975|stroke|stroke
939269|NCT03549975|hand|hand
940077|NCT03545035|Idelalisib|idelalisib
939270|NCT03549975|botulinum toxin|botulinum toxin
939271|NCT03549975|functional electrical stimulation|functional electrical stimulation
939272|NCT03549962|Preoperative|preoperative
939273|NCT03549962|Nutritional Status|nutritional status
939274|NCT03549962|Arthroplasty|arthroplasty
939275|NCT03549962|Replacement|replacement
939276|NCT03549962|Osteoarthritis|osteoarthritis
939277|NCT03549962|Knee|knee
939278|NCT03549949|pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
939279|NCT03549936|NAS, low lactose formula|nas, low lactose formula
939280|NCT03549923|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
939281|NCT03549923|renal replacement therapy|renal replacement therapy
939282|NCT03549923|beta-blocker|beta-blocker
939283|NCT03549884|Early cord Clamping|early cord clamping
939284|NCT03549884|Delayed cord clamping|delayed cord clamping
939285|NCT03549884|Full term infant|full term infant
939286|NCT03549884|Elective cesarean section|elective cesarean section
939287|NCT03549884|Hematocrit|hematocrit
939288|NCT03549884|Postnatal adaptation|postnatal adaptation
939289|NCT03549871|RNAi therapeutic|rnai therapeutic
939290|NCT03549871|Hemophilia A|hemophilia a
939291|NCT03549871|Hemophilia B|hemophilia b
939292|NCT03549871|Hemophilia A, Severe|hemophilia a, severe
939293|NCT03549871|Hemophilia B, Severe|hemophilia b, severe
939294|NCT03549871|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
939295|NCT03549871|Blood Coagulation Disorders|blood coagulation disorders
939296|NCT03549871|Hematologic Diseases|hematologic diseases
939297|NCT03549871|Coagulation Protein Disorders|coagulation protein disorders
939298|NCT03549871|Hemorrhagic Disorders|hemorrhagic disorders
939299|NCT03549871|Genetic Diseases, Inborn|genetic diseases, inborn
939300|NCT03549871|Genetic Diseases, X-Linked|genetic diseases, x-linked
939301|NCT03549871|Factor VIII|factor viii
939302|NCT03549871|Factor IX|factor ix
939303|NCT03549871|Inhibitor|inhibitor
939304|NCT03549871|Coagulants|coagulants
939305|NCT03549871|Fitusiran|fitusiran
939306|NCT03549871|Prophylactic Treatment|prophylactic treatment
939307|NCT03549845|Healthcare Utilization|healthcare utilization
939308|NCT03549845|Emergency Department|emergency department
939309|NCT03549845|Hospitalization|hospitalization
939310|NCT03549845|Low Income|low income
939311|NCT03549845|Social Housing|social housing
939312|NCT03549845|Older Adults|older adults
939313|NCT03549845|Quality of Life|quality of life
939314|NCT03549832|HCV|hcv
939315|NCT03549832|DAAs|daas
939316|NCT03549832|Non-responder|non-responder
939317|NCT03549819|Anxiety Disorders|anxiety disorders
939318|NCT03549819|Cannabidiol|cannabidiol
939319|NCT03549819|Cannabis|cannabis
939320|NCT03549806|Atrium, tachyarrhythmias|atrium, tachyarrhythmias
939321|NCT03549780|Brooke Ileostomy|brooke ileostomy
939322|NCT03549780|stoma|stoma
939323|NCT03549780|ileostomy|ileostomy
939328|NCT03549728|endometriosis|endometriosis
939329|NCT03549728|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
939330|NCT03549728|recurrent implantation failure|recurrent implantation failure
939331|NCT03549676|FMT|fmt
939332|NCT03549676|GVHD|gvhd
939333|NCT03549676|HSCT|hsct
939334|NCT03549650|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
939335|NCT03549650|LUTS|luts
939336|NCT03549637|Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol|psychiatry, hypobetalipoproteinemia, ldl-cholesterol
939337|NCT03549611|ureteroscopy|ureteroscopy
939338|NCT03549611|opioids|opioids
939339|NCT03549611|narcotics|narcotics
939340|NCT03549611|text messaging|text messaging
939341|NCT03549611|real time data acquisition|real time data acquisition
939342|NCT03549611|ecologic momentary assessments|ecologic momentary assessments
939343|NCT03549611|pre-emptive analgesia|pre-emptive analgesia
939344|NCT03549611|gabapentin|gabapentin
939345|NCT03549611|meloxicam|meloxicam
939346|NCT03549611|tamsulosin|tamsulosin
939347|NCT03549611|kidney stones|kidney stones
939348|NCT03549611|lithotripsy|lithotripsy
939349|NCT03549611|nephrolithiasis|nephrolithiasis
939350|NCT03549585|End of life|end of life
939351|NCT03549585|Spotting|spotting
939352|NCT03549585|Emergency|emergency
939353|NCT03549585|criSTAL|cristal
939354|NCT03549546|Lymphopenia|lymphopenia
939355|NCT03549546|Lung cancer surgery|lung cancer surgery
939356|NCT03549546|TIM-3|tim-3
939357|NCT03549546|PD-1|pd-1
939358|NCT03549546|CTLA-4|ctla-4
939359|NCT03549546|lymphocytes|lymphocytes
939361|NCT03549546|CD8|cd8
939362|NCT03549533|Aluminum|aluminum
939363|NCT03549533|Sperm|sperm
939364|NCT03549533|DNA methylation|dna methylation
939365|NCT03549533|DNA fragmentation|dna fragmentation
939366|NCT03549533|Seminal plasma|seminal plasma
939367|NCT03549520|Ultrasound|ultrasound
939368|NCT03549507|Ultrasound|ultrasound
939369|NCT03549481|risk score|risk score
939370|NCT03549481|acute coronary syndrome|acute coronary syndrome
939371|NCT03549481|left ventricular remodelng|left ventricular remodelng
939372|NCT03549468|ischemic cardiomyopathy; neuromodulation; repolarization alternans|ischemic cardiomyopathy; neuromodulation; repolarization alternans
939373|NCT03549455|anxious|anxious
939374|NCT03549455|anxiety|anxiety
939375|NCT03549442|Multiple Myeloma|multiple myeloma
939376|NCT03549442|BCMA CART|bcma cart
939377|NCT03549442|huCART19|hucart19
939378|NCT03549416|Atopic dermatitis|atopic dermatitis
939379|NCT03549416|Dupilumab|dupilumab
939380|NCT03549416|Dupixent|dupixent
939381|NCT03549416|BioDay|bioday
939382|NCT03549416|Daily practice|daily practice
939383|NCT03549416|Real world|real world
939384|NCT03549416|Atopic Diseases Registry|atopic diseases registry
939385|NCT03549416|Registry|registry
939386|NCT03549416|Multi center|multi center
939387|NCT03549403|Telephone education|telephone education
939388|NCT03549403|Effectiveness|effectiveness
939389|NCT03549403|Health|health
939390|NCT03549403|Cost|cost
939391|NCT03549403|Day surgery|day surgery
939392|NCT03549403|Adult patient|adult patient
939393|NCT03549390|Type 2 diabetes|type 2 diabetes
939394|NCT03549390|ethnicity|ethnicity
939395|NCT03549390|physical activity|physical activity
939396|NCT03549390|yoga|yoga
939397|NCT03549377|Sleep|sleep
939398|NCT03549377|Academic functioning|academic functioning
939399|NCT03549377|Problem behaviors|problem behaviors
939400|NCT03549377|College age youth|college age youth
939401|NCT03549377|Self-regulation|self-regulation
939402|NCT03549351|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
939403|NCT03549351|measurable residual disease|measurable residual disease
939404|NCT03549351|surrogate endpoint|surrogate endpoint
939405|NCT03549351|multiparameter flow cytometry|multiparameter flow cytometry
939406|NCT03549338|Metastatic Colorectal Cancer|metastatic colorectal cancer
939407|NCT03549338|Colorectal Cancer|colorectal cancer
939408|NCT03549338|Carcinoma|carcinoma
939409|NCT03549325|Neisseria lactamica|neisseria lactamica
939410|NCT03549325|healthy volunteers|healthy volunteers
939411|NCT03549325|nasal inoculation|nasal inoculation
939412|NCT03549325|colonisation|colonisation
939413|NCT03549312|HIV|hiv
939414|NCT03549312|HCV|hcv
939415|NCT03549312|Hepatitis C|hepatitis c
939416|NCT03549312|Methadone|methadone
939417|NCT03549312|HIV/HCV Co-Infection|hiv/hcv co-infection
939418|NCT03549312|Opioid Substitution Therapy|opioid substitution therapy
939419|NCT03549312|Drug Abuse|drug abuse
939420|NCT03549299|limbal stem cell deficiency|limbal stem cell deficiency
939421|NCT03549299|ABCB5|abcb5
939422|NCT03549299|Limbal stem cells|limbal stem cells
939423|NCT03549299|LSCs|lscs
939424|NCT03549299|LSC|lsc
939425|NCT03549299|allogeneic|allogeneic
939426|NCT03549299|tissue engineered product|tissue engineered product
939427|NCT03549299|phase I/IIa|phase i/iia
939428|NCT03549286|Pregnancy|pregnancy
939429|NCT03549286|Down's syndrome|down's syndrome
939430|NCT03549286|non invasive prenatal testing|non invasive prenatal testing
939431|NCT03549273|carcinoma|carcinoma
939432|NCT03549273|intraepithelial cervix lesions|intraepithelial cervix lesions
939433|NCT03549273|Oxidative Stress|oxidative stress
939434|NCT03549273|Ocoxin Viusid|ocoxin viusid
939435|NCT03549273|Glizigen Spray|glizigen spray
939436|NCT03549260|low density lipoprotein cholesterol|low density lipoprotein cholesterol
939437|NCT03549260|PCSK9|pcsk9
939438|NCT03549247|OHIP-14|ohip-14
939439|NCT03549247|Periodontitis|periodontitis
939440|NCT03549234|Regional anesthesia|regional anesthesia
939441|NCT03549234|Paravertebral|paravertebral
939442|NCT03549234|Erector spinae|erector spinae
939443|NCT03549234|Nerve block|nerve block
939444|NCT03549221|total knee arthroplasty|total knee arthroplasty
939445|NCT03549221|multimodal anesthetic cocktail|multimodal anesthetic cocktail
939446|NCT03549221|adrenaline|adrenaline
939447|NCT03549221|morphine consumption|morphine consumption
939448|NCT03549221|blood loss|blood loss
939449|NCT03549221|Levobupivacaine|levobupivacaine
939450|NCT03549182|acute tryptophan depletion|acute tryptophan depletion
939451|NCT03549182|tryptophan hydroxylase 2 gene|tryptophan hydroxylase 2 gene
939452|NCT03549182|emotion|emotion
939453|NCT03549169|Intervention|intervention
939454|NCT03549169|Heart Failure|heart failure
939455|NCT03549169|Symptoms management|symptoms management
939456|NCT03549169|Selft-care|selft-care
939559|NCT03548467|melanoma|melanoma
939457|NCT03549156|Moderate Acute Malnutrition, Malnutrition|moderate acute malnutrition, malnutrition
939458|NCT03549143|IBS; Irritable Bowel Syndrome; spasmolytics; mebeverine; Duspatalin|ibs; irritable bowel syndrome; spasmolytics; mebeverine; duspatalin
939459|NCT03549104|fear of hypoglycemia|fear of hypoglycemia
939460|NCT03549104|glycemic control|glycemic control
939461|NCT03549104|glycemic variability|glycemic variability
939462|NCT03549104|self-management behavior|self-management behavior
939463|NCT03549065|Brain stimulation|brain stimulation
939464|NCT03549039|quality of life|quality of life
939465|NCT03549039|cleft lip|cleft lip
939466|NCT03549039|cleft palate|cleft palate
939467|NCT03549013|Tumor-related Trigeminal Neuralgia|tumor-related trigeminal neuralgia
939468|NCT03549013|Percutaneous Radiofrequency Thermocoagulation|percutaneous radiofrequency thermocoagulation
939469|NCT03549013|Three‐dimensional Computed Tomography|three‐dimensional computed tomography
939470|NCT03549000|NZV930|nzv930
939471|NCT03549000|PDR001|pdr001
939472|NCT03549000|NIR178|nir178
939473|NCT03549000|Immune checkpoint inhibitor|immune checkpoint inhibitor
939474|NCT03549000|immunotherapy|immunotherapy
939475|NCT03549000|CD73|cd73
939476|NCT03549000|PD-1|pd-1
939477|NCT03549000|PD-L1|pd-l1
939478|NCT03549000|A2aR|a2ar
939479|NCT03549000|Adenosine|adenosine
939480|NCT03548974|Multiple Sclerosis|multiple sclerosis
939481|NCT03548974|Spasticity|spasticity
939482|NCT03548974|MOTOmed training|motomed training
939483|NCT03548974|internet|internet
939484|NCT03548922|Risser|risser
939485|NCT03548922|Tanner|tanner
939486|NCT03548922|pressure of correction|pressure of correction
939487|NCT03548909|NT-proBNP|nt-probnp
939488|NCT03548896|implant|implant
939489|NCT03548857|Muscle dysfunction|muscle dysfunction
939490|NCT03548857|Cardiovascular regulation|cardiovascular regulation
939491|NCT03548857|Lung transplantation (LTx)|lung transplantation (ltx)
939492|NCT03548831|Minilaparotomy|minilaparotomy
939493|NCT03548831|Hysterectomy|hysterectomy
939494|NCT03548831|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
939495|NCT03548831|Benign|benign
939496|NCT03548831|Gynaecology|gynaecology
939497|NCT03548792|Arthroplasty Knee|arthroplasty knee
939498|NCT03548753|Angina|angina
939499|NCT03548753|Chest pain|chest pain
939500|NCT03548753|Diagnostic tests|diagnostic tests
939501|NCT03548714|Alcohol|alcohol
939502|NCT03548714|Alcoholic|alcoholic
939503|NCT03548714|Alcoholism|alcoholism
939504|NCT03548714|Alcohol abuse|alcohol abuse
939505|NCT03548714|Alcohol interaction|alcohol interaction
939506|NCT03548714|Alcohol Use Disorder|alcohol use disorder
939507|NCT03548714|Alcohol use|alcohol use
939508|NCT03548714|Alcohol dependence|alcohol dependence
939509|NCT03548714|Alcohol dependent|alcohol dependent
939510|NCT03548714|Ethanol abuse|ethanol abuse
939511|NCT03548714|Ethanol use|ethanol use
939512|NCT03548701|Thromboelastometry|thromboelastometry
939513|NCT03548701|Vaginal Bleeding|vaginal bleeding
939514|NCT03548701|Early Pregnancy|early pregnancy
939515|NCT03548688|Bladder Cancer|bladder cancer
939516|NCT03548688|Haematuria|haematuria
939517|NCT03548688|Collaborative study|collaborative study
939518|NCT03548675|Pharmacogenetics|pharmacogenetics
939519|NCT03548675|Antidepressive Agents|antidepressive agents
939520|NCT03548662|Rotator Cuff Tear|rotator cuff tear
939521|NCT03548662|Platelet Rich Plasma|platelet rich plasma
939522|NCT03548662|Ultrasound|ultrasound
939523|NCT03548662|Exercise|exercise
939524|NCT03548662|Hyaluronic Acid|hyaluronic acid
939525|NCT03548649|spinal cord injury|spinal cord injury
939526|NCT03548649|complete spinal cord injury|complete spinal cord injury
939527|NCT03548649|incomplete spinal cord injury|incomplete spinal cord injury
939528|NCT03548649|exoskeleton robot|exoskeleton robot
939529|NCT03548649|gait training|gait training
939530|NCT03548649|security testing|security testing
939531|NCT03548649|functional testing|functional testing
939532|NCT03548623|Hypertension|hypertension
939533|NCT03548623|renal denervation|renal denervation
939534|NCT03548623|preference|preference
939535|NCT03548623|shared decision making|shared decision making
939536|NCT03548610|nanofat|nanofat
939537|NCT03548610|tumor defect|tumor defect
939538|NCT03548584|Agitation|agitation
939539|NCT03548558|Early Childhood Development|early childhood development
939540|NCT03548558|Parenting Behaviors|parenting behaviors
939541|NCT03548558|Group-based curriculum|group-based curriculum
939542|NCT03548558|Kenya|kenya
939543|NCT03548558|Child Outcomes|child outcomes
939544|NCT03548558|Community Health Volunteers|community health volunteers
939545|NCT03548545|MDD|mdd
939546|NCT03548545|CBT|cbt
939547|NCT03548545|tDCS|tdcs
939548|NCT03548532|temperature|temperature
939549|NCT03548506|STN|stn
939550|NCT03548506|DBS|dbs
939551|NCT03548506|steering|steering
939552|NCT03548506|segmented electrode leads|segmented electrode leads
939553|NCT03548493|Magnesium sulphate|magnesium sulphate
939554|NCT03548493|Fentanyl|fentanyl
939555|NCT03548493|Conscious sedation|conscious sedation
939556|NCT03548493|chronic subdural haematoma|chronic subdural haematoma
939557|NCT03548493|Propofol|propofol
939558|NCT03548493|Burr hole|burr hole
939561|NCT03548467|clear renal cell carcinoma|clear renal cell carcinoma
939562|NCT03548467|urothelial cancer or SCCHN|urothelial cancer or scchn
939563|NCT03548428|Atezolizumab|atezolizumab
939564|NCT03548428|Oligometastatic Sarcomas|oligometastatic sarcomas
939565|NCT03548428|stereotactic body radiation therapy|stereotactic body radiation therapy
939566|NCT03548415|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
939567|NCT03548376|rehabilitation|rehabilitation
939568|NCT03548376|cerebral palsy|cerebral palsy
939569|NCT03548376|postural control|postural control
939570|NCT03548376|balance|balance
939571|NCT03548376|gross-motor function|gross-motor function
939572|NCT03548376|quality of life|quality of life
939573|NCT03548376|hippotherapy|hippotherapy
939574|NCT03548324|Feeding Tolerance|feeding tolerance
939575|NCT03548324|RDS|rds
939576|NCT03548324|HFNC|hfnc
939577|NCT03548324|NCPAP|ncpap
939578|NCT03548324|Preterm|preterm
939579|NCT03548324|NEC|nec
939580|NCT03548324|Enteral Nutrition|enteral nutrition
940078|NCT03545035|Rituximab|rituximab
939581|NCT03548324|Non Invasive Respiratory Support|non invasive respiratory support
939582|NCT03548324|Very Low Birth Weight Infant|very low birth weight infant
939583|NCT03548311|ALS|als
939584|NCT03548311|motor neuron disease|motor neuron disease
939585|NCT03548311|Lou Gehrig's disease|lou gehrig's disease
939586|NCT03548298|GERD, Hybrid-APC, efficacy, safety|gerd, hybrid-apc, efficacy, safety
939587|NCT03548298|ARAT|arat
939588|NCT03548272|dedicated bifurcation stent|dedicated bifurcation stent
939589|NCT03548272|non-LM bifurcation|non-lm bifurcation
939590|NCT03548272|sirolimus-eluting stent|sirolimus-eluting stent
939591|NCT03548259|Carpal Tunnel Syndrome|carpal tunnel syndrome
939592|NCT03548259|Platelet-rich plasma|platelet-rich plasma
939593|NCT03548259|Surgery|surgery
939594|NCT03548181|Tele-rehabilitation|tele-rehabilitation
939595|NCT03548155|schizophrenia；berberine；symptoms；inflammation|schizophrenia；berberine；symptoms；inflammation
939596|NCT03548142|Palliative Care|palliative care
939597|NCT03548142|advanced dementia|advanced dementia
939598|NCT03548142|life-prolonging treatment|life-prolonging treatment
939599|NCT03548142|patient will|patient will
939600|NCT03548142|advanced care planning|advanced care planning
939601|NCT03548116|Healthy Volunteer|healthy volunteer
939602|NCT03548116|Ultrasound|ultrasound
939603|NCT03548116|Insonification|insonification
939604|NCT03548116|Spleen|spleen
939605|NCT03548090|stroke rehabilitation|stroke rehabilitation
939606|NCT03548090|walking limitations|walking limitations
939607|NCT03548090|gait rehabilitation|gait rehabilitation
939608|NCT03548064|dmLT|dmlt
939609|NCT03548064|E. coli|e. coli
939610|NCT03548064|Enterotoxigenic Escherichia coli (ETEC)|enterotoxigenic escherichia coli (etec)
939611|NCT03548064|LTR192G/L211A|ltr192g/l211a
939612|NCT03548051|Clostridium difficle Associated Disease (CDAD)|clostridium difficle associated disease (cdad)
939613|NCT03548051|Efficacy|efficacy
939614|NCT03548051|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
939615|NCT03548051|Microbial Restoration|microbial restoration
939616|NCT03548051|Partially-Blinded|partially-blinded
939617|NCT03548051|Phase 1/2|phase 1/2
939618|NCT03548051|Placebo Controlled|placebo controlled
939619|NCT03548051|Safety|safety
939620|NCT03548038|taste perception|taste perception
939621|NCT03548038|bariatric surgery|bariatric surgery
939622|NCT03548038|taste preference|taste preference
939623|NCT03548038|weight loss surgery|weight loss surgery
939624|NCT03548012|Caregivers|caregivers
939625|NCT03548012|Support Needs|support needs
939626|NCT03548012|Intervention|intervention
939627|NCT03548012|Randomised controlled trial|randomised controlled trial
939628|NCT03547999|CV301 Vaccination|cv301 vaccination
939629|NCT03547999|mFOLFOX6|mfolfox6
939630|NCT03547999|Fowlpox (FP)-CV301|fowlpox (fp)-cv301
939631|NCT03547999|nivolumab|nivolumab
939632|NCT03547999|MVA-BN-CV301|mva-bn-cv301
939633|NCT03547986|flow-limiting dissection|flow-limiting dissection
939634|NCT03547986|residual stenosis|residual stenosis
939635|NCT03547934|Abdominal fat|abdominal fat
939636|NCT03547882|Opioid|opioid
939637|NCT03547882|Buprenorphine|buprenorphine
939638|NCT03547882|Naltrexone|naltrexone
939639|NCT03547882|methadone|methadone
939640|NCT03547869|Transcranial Direct Current Stimulation|transcranial direct current stimulation
939641|NCT03547869|Gulf War Illness|gulf war illness
939642|NCT03547869|Pain modulation|pain modulation
939643|NCT03547843|Behavior therapy|behavior therapy
939644|NCT03547843|Peer groups|peer groups
939645|NCT03547843|Patient satisfaction|patient satisfaction
939646|NCT03547843|Feasibility studies|feasibility studies
939647|NCT03547830|chronic granulomatous disease|chronic granulomatous disease
939648|NCT03547830|graft failure|graft failure
939649|NCT03547830|stem cell transplantation|stem cell transplantation
939650|NCT03547830|plerixafor|plerixafor
939651|NCT03547830|conditioning regimen|conditioning regimen
939652|NCT03547791|Antenatal corticosteroid|antenatal corticosteroid
939653|NCT03547791|Twin pregnancies|twin pregnancies
939654|NCT03547791|Respiratory morbidity|respiratory morbidity
939655|NCT03547791|Randomized controlled trial|randomized controlled trial
939656|NCT03547765|Obesity|obesity
939657|NCT03547765|Sexual Dysfunction|sexual dysfunction
939658|NCT03547752|motor imaginery|motor imaginery
939659|NCT03547752|mental training|mental training
939660|NCT03547687|Electrical stimulation|electrical stimulation
939661|NCT03547687|Intubation|intubation
939662|NCT03547687|ICU discharge|icu discharge
939663|NCT03547661|Premenstrual Syndrome|premenstrual syndrome
939664|NCT03547661|Open-Label Placebo Effect|open-label placebo effect
939665|NCT03547661|randomized controlled trial|randomized controlled trial
939666|NCT03547609|Kabuki Syndrome|kabuki syndrome
939667|NCT03547609|Intellectual Profile|intellectual profile
939668|NCT03547609|Memory|memory
939669|NCT03547596|Lower urinary tract symptoms|lower urinary tract symptoms
939670|NCT03547596|Erectile dysfunction|erectile dysfunction
939671|NCT03547596|Obstructive Sleep Apneas Syndrom|obstructive sleep apneas syndrom
939672|NCT03547570|Joint instability|joint instability
939673|NCT03547570|Hypermobility|hypermobility
939674|NCT03547570|Shoulder|shoulder
939675|NCT03547570|Strength training|strength training
939676|NCT03547557|Bone Tumors|bone tumors
939677|NCT03547544|helicobacter pylori|helicobacter pylori
939678|NCT03547544|urease test|urease test
939679|NCT03547544|helicotec|helicotec
939680|NCT03547518|Urinary Urgency|urinary urgency
939681|NCT03547518|Urinary Frequency|urinary frequency
939682|NCT03547518|Urge Incontinence|urge incontinence
939683|NCT03547505|Glide path|glide path
939684|NCT03547505|postoperative pain|postoperative pain
939685|NCT03547505|R-Pilot|r-pilot
939686|NCT03547505|ProGlider|proglider
939687|NCT03547492|language|language
939688|NCT03547492|LENA|lena
939689|NCT03547492|adolescent|adolescent
939690|NCT03547453|Menstrual cycles|menstrual cycles
939691|NCT03547453|Ultrasound|ultrasound
939692|NCT03547453|Ovary|ovary
939693|NCT03547453|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
939694|NCT03547440|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
939695|NCT03547440|immigrant|immigrant
939696|NCT03547440|microbiota|microbiota
939697|NCT03547440|bioindicator|bioindicator
939698|NCT03547440|Methanobrevibacter smithii|methanobrevibacter smithii
939699|NCT03547427|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
939700|NCT03547427|Pramlintide|pramlintide
939701|NCT03547427|Lispro Insulin|lispro insulin
939702|NCT03547427|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
939703|NCT03547427|Acetaminophen|acetaminophen
939704|NCT03547427|Hypoglycemia|hypoglycemia
939705|NCT03547427|Exercise|exercise
939706|NCT03547388|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
939707|NCT03547388|hyperthermia|hyperthermia
939708|NCT03547388|hypoxia|hypoxia
939709|NCT03547388|18f-fluoromisonidazole|18f-fluoromisonidazole
939710|NCT03547388|positron emission tomography|positron emission tomography
939711|NCT03547388|FMISO|fmiso
939713|NCT03547388|whole body hyperthermia|whole body hyperthermia
939714|NCT03547388|local recurrence|local recurrence
939715|NCT03547388|lymph node recurrence|lymph node recurrence
939716|NCT03547388|radiochemotherapy|radiochemotherapy
939717|NCT03547362|Amino acids|amino acids
939718|NCT03547362|Dairy proteins|dairy proteins
939719|NCT03547362|Postprandial|postprandial
939720|NCT03547362|Older adults|older adults
939721|NCT03547349|respiratory therapy|respiratory therapy
939722|NCT03547349|videogaming therapy|videogaming therapy
939723|NCT03547349|incentive spirometry|incentive spirometry
939724|NCT03547349|atelectases|atelectases
939725|NCT03547310|EMG|emg
939726|NCT03547310|Prosthesis control|prosthesis control
939727|NCT03547310|Neuromuscular rehabilitation|neuromuscular rehabilitation
939728|NCT03547310|Games for health|games for health
939729|NCT03547297|Acute Hepatic Porphyria|acute hepatic porphyria
939730|NCT03547297|Hepatic Porphyrias|hepatic porphyrias
939731|NCT03547297|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
939732|NCT03547297|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
939733|NCT03547297|Variegate Porphyria (VP)|variegate porphyria (vp)
939734|NCT03547297|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
939735|NCT03547297|Porphyria Acute|porphyria acute
939736|NCT03547271|Meningococcal meningitis|meningococcal meningitis
939737|NCT03547271|MenACYW conjugate vaccine|menacyw conjugate vaccine
939738|NCT03547271|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
939739|NCT03547258|AML|aml
939740|NCT03547258|Italian observational study|italian observational study
939741|NCT03547258|FLT3-ITD Mutation|flt3-itd mutation
939742|NCT03547258|FLT3-TKD Mutation|flt3-tkd mutation
939743|NCT03547232|Acute pancreatitis|acute pancreatitis
939744|NCT03547232|Indomethacin|indomethacin
939745|NCT03547232|Prognosis|prognosis
939746|NCT03547232|Organ dysfunction|organ dysfunction
939747|NCT03547219|Deprssion|deprssion
939748|NCT03547219|Adolescent|adolescent
939749|NCT03547219|Biomarker|biomarker
939750|NCT03547219|Inflammation|inflammation
939751|NCT03547219|BDNF|bdnf
939752|NCT03547219|Functional MRI|functional mri
939753|NCT03547219|Antidepressant|antidepressant
939754|NCT03547219|Machine learning|machine learning
939755|NCT03547206|NAION|naion
939756|NCT03547206|ischemic optic neuropathy|ischemic optic neuropathy
939757|NCT03547193|difficult laringoscopy|difficult laringoscopy
939758|NCT03547193|difficult airway|difficult airway
939759|NCT03547193|airway management|airway management
939760|NCT03547180|Respiration panic|respiration panic
939761|NCT03547180|Cognitions|cognitions
939763|NCT03547180|Treatment|treatment
939764|NCT03547180|Mediators|mediators
939765|NCT03547180|Moderators|moderators
939766|NCT03547128|fluoride|fluoride
939767|NCT03547128|genetics|genetics
939768|NCT03547128|physical activity|physical activity
939769|NCT03547128|diet|diet
939770|NCT03547115|B-Cell Malignancies, Voruciclib, Cyclin Dependent Kinase Inhibitor|b-cell malignancies, voruciclib, cyclin dependent kinase inhibitor
939771|NCT03547076|Pocket sized imaging device|pocket sized imaging device
939772|NCT03547076|Handheld ultrasound device|handheld ultrasound device
939773|NCT03547076|General practitioner|general practitioner
939774|NCT03547076|Nurse|nurse
939775|NCT03547076|Focused cardiac ultrasound|focused cardiac ultrasound
939776|NCT03547076|FoCUS|focus
939777|NCT03547076|Telemedicine|telemedicine
939779|NCT03547063|Obesity, appetite, taste, fMRI|obesity, appetite, taste, fmri
939780|NCT03547050|Epilepsy|epilepsy
939781|NCT03547050|Rolandic|rolandic
939782|NCT03547050|Genetics|genetics
939783|NCT03547050|Genomewide Association Study|genomewide association study
939784|NCT03547050|RE|re
939785|NCT03547050|Neurology|neurology
939786|NCT03547050|Pediatrics|pediatrics
939787|NCT03546998|epidermoid carcinoma|epidermoid carcinoma
939788|NCT03546998|esophageal achalasia|esophageal achalasia
939789|NCT03546998|risk factors|risk factors
939790|NCT03546972|Obesity and other hyperalimentation|obesity and other hyperalimentation
939791|NCT03546972|Questionnaires|questionnaires
939792|NCT03546972|Surveys|surveys
939793|NCT03546972|Hunger Training|hunger training
939794|NCT03546972|HT|ht
939795|NCT03546972|Diabetes Prevention Program|diabetes prevention program
939796|NCT03546972|DPP|dpp
939797|NCT03546972|Continuous glucose monitoring|continuous glucose monitoring
939798|NCT03546972|CGM|cgm
939799|NCT03546959|stroke|stroke
939800|NCT03546959|spasticity|spasticity
939801|NCT03546959|lycra|lycra
939802|NCT03546959|orthosis|orthosis
939803|NCT03546959|splint|splint
939804|NCT03546959|treatment|treatment
939805|NCT03546959|upper extremity|upper extremity
939806|NCT03546946|Attention|attention
939807|NCT03546946|Anxiety|anxiety
939808|NCT03546946|Adolescence|adolescence
939809|NCT03546894|Drug therapy|drug therapy
939810|NCT03546881|PAOD|paod
939811|NCT03546881|endovascular|endovascular
939812|NCT03546881|fusion|fusion
939813|NCT03546881|radiation|radiation
939814|NCT03546881|exposure|exposure
939815|NCT03546790|Cannabis|cannabis
939816|NCT03546777|Shoulder pain, coracoacromial ligament thickness|shoulder pain, coracoacromial ligament thickness
939817|NCT03546764|Percutatneous catheter|percutatneous catheter
939818|NCT03546764|chest tube|chest tube
939819|NCT03546764|trauma|trauma
939820|NCT03546764|hemothorax|hemothorax
939821|NCT03546751|Endothelial Dysfunction|endothelial dysfunction
939822|NCT03546751|Micro RNA|micro rna
939823|NCT03546738|Lumbar Vertebrae|lumbar vertebrae
939824|NCT03546738|Surgery|surgery
939825|NCT03546738|Postoperational Complications|postoperational complications
939826|NCT03546738|Spinal Cord Stimulation|spinal cord stimulation
939827|NCT03546712|Acuity|acuity
939828|NCT03546712|children|children
939829|NCT03546712|forearm|forearm
939830|NCT03546712|perception|perception
939831|NCT03546712|touch location|touch location
939832|NCT03546686|Hormone Receptor Negative|hormone receptor negative
939833|NCT03546686|Her2- Negative|her2- negative
939834|NCT03546686|Resectable Breast Cancer|resectable breast cancer
939835|NCT03546686|breast cancer|breast cancer
939836|NCT03546686|immunotherapy|immunotherapy
939837|NCT03546673|Chinese breast cancer survivors expressive writing|chinese breast cancer survivors expressive writing
939838|NCT03546634|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
939839|NCT03546634|Sabin strain|sabin strain
939840|NCT03546621|Hepatitis D|hepatitis d
939841|NCT03546608|Hepatic Impairment|hepatic impairment
939842|NCT03546608|Tepotinib|tepotinib
939843|NCT03546608|Pharmacokinetics|pharmacokinetics
939844|NCT03546595|Polycystic Ovary Syndrome|polycystic ovary syndrome
939845|NCT03546595|Insulin Resistance|insulin resistance
939846|NCT03546582|HNSCC|hnscc
939847|NCT03546582|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
939848|NCT03546582|KEYSTROKE|keystroke
939849|NCT03546517|myofascial trigger point|myofascial trigger point
939850|NCT03546517|dry needling|dry needling
939851|NCT03546517|spasticity|spasticity
939852|NCT03546517|stroke|stroke
939853|NCT03546504|child|child
939854|NCT03546504|dental|dental
939855|NCT03546504|oral health|oral health
939856|NCT03546504|sensory desensitization|sensory desensitization
939857|NCT03546504|sensory processing|sensory processing
939858|NCT03546504|occupational therapy|occupational therapy
939859|NCT03546478|SPECT/CT|spect/ct
939860|NCT03546478|HER2 imaging|her2 imaging
939861|NCT03546452|NSCLC|nsclc
939862|NCT03546452|malignant hydrothorax|malignant hydrothorax
939863|NCT03546452|prospective study|prospective study
939864|NCT03546439|atrial fibrillation|atrial fibrillation
939865|NCT03546439|vascular closure|vascular closure
939866|NCT03546426|Mesothelioma, Malignant|mesothelioma, malignant
939867|NCT03546426|PDL-1 negative|pdl-1 negative
939868|NCT03546426|advanced disease|advanced disease
939869|NCT03546426|progressive disease|progressive disease
939870|NCT03546413|food|food
939871|NCT03546413|peanut|peanut
939872|NCT03546413|allergy|allergy
939873|NCT03546413|prevention|prevention
939874|NCT03546387|18-126|18-126
939875|NCT03546387|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
939876|NCT03546322|head and neck cancer|head and neck cancer
939877|NCT03546322|health information technology|health information technology
939878|NCT03546322|patient safety|patient safety
939879|NCT03546322|adherence|adherence
939880|NCT03546322|ambulatory|ambulatory
939881|NCT03546322|outpatient|outpatient
939882|NCT03546322|human factors|human factors
940079|NCT03545022|third molar|third molar
939883|NCT03546322|vulnerable populations|vulnerable populations
939884|NCT03546322|chronic disease|chronic disease
939885|NCT03546309|pediatric moyamoya disease|pediatric moyamoya disease
939886|NCT03546309|remote ischemic conditioning|remote ischemic conditioning
939887|NCT03546309|revascularization therapy|revascularization therapy
939888|NCT03546296|Dietary Exposure|dietary exposure
939889|NCT03546296|gallbladder carcinoma|gallbladder carcinoma
939890|NCT03546270|Swimming|swimming
939891|NCT03546270|Arterial Stiffness|arterial stiffness
939892|NCT03546270|Blood Pressure|blood pressure
939893|NCT03546270|Muscular Strength|muscular strength
939894|NCT03546270|Cardiorespiratory Endurance|cardiorespiratory endurance
939895|NCT03546257|Early gastric cancer|early gastric cancer
939896|NCT03546257|Invasion depth|invasion depth
939897|NCT03546257|Narrow band imaging|narrow band imaging
939898|NCT03546257|Endoscopic ultrasonography|endoscopic ultrasonography
939899|NCT03546231|Tricuspid regurgitation|tricuspid regurgitation
939900|NCT03546231|tricuspid valve|tricuspid valve
939901|NCT03546231|surgery|surgery
939902|NCT03546231|outcome|outcome
939903|NCT03546231|prognosis|prognosis
939904|NCT03546231|mortality|mortality
939905|NCT03546231|right ventricle|right ventricle
939906|NCT03546231|asymptomatic|asymptomatic
939907|NCT03546192|Influenza|influenza
939908|NCT03546192|Influenza virus vaccine|influenza virus vaccine
939909|NCT03546192|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
939910|NCT03546179|PVI, Tidal volume challenge, hepatic resection|pvi, tidal volume challenge, hepatic resection
939911|NCT03546166|basal cell carcinoma|basal cell carcinoma
939912|NCT03546127|Next Generation Sequencing|next generation sequencing
939913|NCT03546127|Exome|exome
939914|NCT03546127|RNA sequencing|rna sequencing
939915|NCT03546127|Soft-tissue sarcoma|soft-tissue sarcoma
939916|NCT03546127|Colorectal carcinoma|colorectal carcinoma
939917|NCT03546114|Stereotypes|stereotypes
939918|NCT03546088|awake intubation|awake intubation
939919|NCT03546088|nasal fiberscope|nasal fiberscope
939920|NCT03546088|topical anesthesia|topical anesthesia
939921|NCT03546075|Cognition|cognition
939922|NCT03546075|Resveratrol|resveratrol
939923|NCT03546075|Whole body metabolism|whole body metabolism
939924|NCT03546049|ultrasound-guided percutaneous transhepatic biliary drainage|ultrasound-guided percutaneous transhepatic biliary drainage
939925|NCT03546049|endoscopic ultrasound-guided antegrade biliary drainage|endoscopic ultrasound-guided antegrade biliary drainage
939926|NCT03546049|endoscopic ultrasound-guided transhepatic biliary drainage|endoscopic ultrasound-guided transhepatic biliary drainage
939927|NCT03546049|endoscopic ultrasound-guided choledochal biliary drainage|endoscopic ultrasound-guided choledochal biliary drainage
939928|NCT03546049|self-expandable metal stent|self-expandable metal stent
939929|NCT03546049|malignant bile duct obstruction|malignant bile duct obstruction
939930|NCT03546023|Chronic cancer pain|chronic cancer pain
939931|NCT03546023|pain clinic|pain clinic
939932|NCT03546023|Brief Pain Inventory|brief pain inventory
939933|NCT03545997|Montelukast|montelukast
939934|NCT03545997|leukotriene pathway|leukotriene pathway
939935|NCT03545997|endothelial function|endothelial function
939936|NCT03545997|flux-mediated dilation|flux-mediated dilation
939937|NCT03545958|Older adults|older adults
939938|NCT03545958|Community-based|community-based
1333108|NCT01444469|Viral infection|viral infection
939939|NCT03545958|High-intensity interval training (HIT)|high-intensity interval training (hit)
939940|NCT03545958|Mind-motor training|mind-motor training
939941|NCT03545932|Hydrogymnastics|hydrogymnastics
939942|NCT03545932|Physical Condition|physical condition
939943|NCT03545932|Physical Activity and Health|physical activity and health
939944|NCT03545932|Gerontomotricity|gerontomotricity
939945|NCT03545919|respiratory viral infections|respiratory viral infections
939946|NCT03545919|chronic lung allograft dysfunction|chronic lung allograft dysfunction
939947|NCT03545919|lung microbiome|lung microbiome
939948|NCT03545867|postprandial|postprandial
939949|NCT03545867|glycemia|glycemia
939950|NCT03545867|lipemia|lipemia
939951|NCT03545867|macronutrient metabolism|macronutrient metabolism
939952|NCT03545867|physical activity|physical activity
939953|NCT03545815|mesothelin, CRISPR-Cas9, PD-1, TCR|mesothelin, crispr-cas9, pd-1, tcr
939954|NCT03545789|HV|hv
939955|NCT03545789|AD|ad
939956|NCT03545789|PSP|psp
939957|NCT03545763|Hypertension|hypertension
939958|NCT03545763|Social Determinants of Health|social determinants of health
939959|NCT03545763|Health Insurance|health insurance
939960|NCT03545763|Medicaid|medicaid
939961|NCT03545763|Affordable Care Act|affordable care act
939962|NCT03545750|Acute kidney injury|acute kidney injury
939963|NCT03545750|Continuous renal replacement therapy|continuous renal replacement therapy
939964|NCT03545750|Citrate|citrate
939965|NCT03545750|Heparin|heparin
939966|NCT03545672|Primary Biliary Cholangitis|primary biliary cholangitis
939967|NCT03545672|Cardiac impairment|cardiac impairment
939968|NCT03545672|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
939969|NCT03545646|Abdominal tissues|abdominal tissues
939970|NCT03545633|Abdominal tissues|abdominal tissues
939971|NCT03545620|difficult airway|difficult airway
939972|NCT03545620|difficult intubation|difficult intubation
940080|NCT03545022|acupuncture|acupuncture
939973|NCT03545620|videolaryngoscope|videolaryngoscope
939974|NCT03545620|exchange catheter|exchange catheter
939975|NCT03545620|fiberoptic bronchoscope|fiberoptic bronchoscope
939976|NCT03545620|Laryngeal subglottic airway device|laryngeal subglottic airway device
939977|NCT03545620|tracheostomy|tracheostomy
939978|NCT03545607|ischemic stroke|ischemic stroke
939979|NCT03545607|adult stem cells|adult stem cells
939980|NCT03545594|Randomized trial,|randomized trial,
939981|NCT03545594|Health care needs|health care needs
939982|NCT03545594|Traumatic brain injury|traumatic brain injury
939983|NCT03545594|Community|community
939984|NCT03545594|Goal attainment|goal attainment
939985|NCT03545581|Fructose|fructose
939986|NCT03545581|Uric acid|uric acid
939987|NCT03545581|Glucose homeostasis|glucose homeostasis
939988|NCT03545568|Sialic acid|sialic acid
939989|NCT03545568|Monosaccharide|monosaccharide
939990|NCT03545555|kale|kale
939991|NCT03545555|antioxidant capacity|antioxidant capacity
939992|NCT03545555|cholesterol|cholesterol
939993|NCT03545555|lipid status|lipid status
939994|NCT03545542|Microbiome|microbiome
939995|NCT03545542|Volatilome|volatilome
939996|NCT03545542|Neuroblastoma|neuroblastoma
939997|NCT03545516|Wound infiltration|wound infiltration
939998|NCT03545516|Post Cesarean|post cesarean
939999|NCT03545516|Pain management|pain management
940000|NCT03545516|bupivacaine|bupivacaine
940001|NCT03545516|dexmedetomidine|dexmedetomidine
940002|NCT03545516|postoperative pain|postoperative pain
940003|NCT03545503|Rapid Sequence Intubation|rapid sequence intubation
940004|NCT03545503|Hemodynamics|hemodynamics
940005|NCT03545503|Etomidate|etomidate
940006|NCT03545503|Ketamine|ketamine
940007|NCT03545477|gait rehabilitation|gait rehabilitation
940008|NCT03545477|curved walking training|curved walking training
940009|NCT03545477|lower limb|lower limb
940010|NCT03545464|Acute urticaria|acute urticaria
940011|NCT03545451|EEG, neurofeedback, fMRI, ALS, surgery, upper limbs|eeg, neurofeedback, fmri, als, surgery, upper limbs
940012|NCT03545425|Parkinson's Disease|parkinson's disease
940013|NCT03545425|Biomarker|biomarker
940014|NCT03545425|LRRK2|lrrk2
940015|NCT03545373|antimicrobial resistance|antimicrobial resistance
940017|NCT03545373|Cough|cough
940018|NCT03545373|antibiotics|antibiotics
940019|NCT03545373|anti-infective agents|anti-infective agents
940020|NCT03545347|Rehabilitation|rehabilitation
940021|NCT03545347|Physiotherapy|physiotherapy
940022|NCT03545347|Strength training|strength training
940023|NCT03545347|Anabolic steroids|anabolic steroids
940024|NCT03545347|Nutritional supplement|nutritional supplement
940025|NCT03545334|Transcutaneous, SLN, melanoma, Merkel cell carcinoma|transcutaneous, sln, melanoma, merkel cell carcinoma
940026|NCT03545321|Naloxone|naloxone
940027|NCT03545321|Community pharmacies|community pharmacies
940028|NCT03545321|MOON (Maximizing OpiOid safety with Naloxone)|moon (maximizing opioid safety with naloxone)
940029|NCT03545321|MOON+|moon+
940030|NCT03545321|RESPOND (Resources Encouraging Safe Prescription Opioid and Naloxone Dispensing)|respond (resources encouraging safe prescription opioid and naloxone dispensing)
940031|NCT03545308|Neuromuscular|neuromuscular
940032|NCT03545308|Deep Anesthesia|deep anesthesia
940033|NCT03545308|Rocuronium|rocuronium
940034|NCT03545282|Mental Health|mental health
940035|NCT03545282|Minority Health|minority health
940036|NCT03545282|Latina|latina
940037|NCT03545269|Degenerative Arthritis|degenerative arthritis
940038|NCT03545269|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
940039|NCT03545269|Cartilage defects|cartilage defects
940040|NCT03545269|Cartilage lesion|cartilage lesion
940041|NCT03545269|Arthritis|arthritis
940042|NCT03545256|Outpatient|outpatient
940043|NCT03545256|head neck cancer|head neck cancer
940044|NCT03545256|Lymph node metastasis|lymph node metastasis
940045|NCT03545256|surgery|surgery
940046|NCT03545256|Quality of life|quality of life
940047|NCT03545256|economical study|economical study
940048|NCT03545243|duodenum|duodenum
940049|NCT03545243|microbiome|microbiome
940050|NCT03545243|proton pump inhibitor|proton pump inhibitor
940054|NCT03545178|flash glucose monitoring|flash glucose monitoring
940055|NCT03545178|hypoglycemia prediction|hypoglycemia prediction
940056|NCT03545178|deep learning algorithm|deep learning algorithm
940057|NCT03545139|pulp revascularization|pulp revascularization
940058|NCT03545139|endodontic regeneration|endodontic regeneration
940059|NCT03545139|NeoMTA|neomta
940061|NCT03545113|graft|graft
940062|NCT03545113|fistula|fistula
940063|NCT03545113|hemodialysis|hemodialysis
940064|NCT03545113|Vascular access|vascular access
940065|NCT03545100|oral cancer|oral cancer
940066|NCT03545100|shoulder dysfunction|shoulder dysfunction
940067|NCT03545100|quality of life|quality of life
940068|NCT03545100|motor control|motor control
940069|NCT03545100|strengthening exercise|strengthening exercise
940070|NCT03545074|mindfulness|mindfulness
940071|NCT03545074|depression|depression
940072|NCT03545074|Spanish|spanish
940073|NCT03545048|web-based exercises|web-based exercises
940074|NCT03545048|Digital health|digital health
940075|NCT03545048|knee exercises|knee exercises
940076|NCT03545035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
940085|NCT03544996|Insulin, needle-less, transdermal|insulin, needle-less, transdermal
940086|NCT03544983|Breast Cancer|breast cancer
940087|NCT03544983|Ovarian Cancer|ovarian cancer
940088|NCT03544983|Prostate Cancer|prostate cancer
940089|NCT03544983|BRCA1|brca1
940090|NCT03544983|BRCA2|brca2
940091|NCT03544970|fetal MRI|fetal mri
940092|NCT03544970|Posterior fossa|posterior fossa
940093|NCT03544957|Screening instrument|screening instrument
940094|NCT03544944|bowel preparation|bowel preparation
940095|NCT03544892|Low carbohydrate diet|low carbohydrate diet
940096|NCT03544853|Prosthetic socket|prosthetic socket
940097|NCT03544853|Biomechanics|biomechanics
940098|NCT03544827|Atropine|atropine
940099|NCT03544788|mobile compression device|mobile compression device
940100|NCT03544762|breast cancer|breast cancer
940102|NCT03544762|[18F]FES|[18f]fes
940103|NCT03544762|estrogen receptor|estrogen receptor
940104|NCT03544762|hormone treatment|hormone treatment
940105|NCT03544762|personalized cancer care|personalized cancer care
940106|NCT03544736|Nivolumab|nivolumab
940107|NCT03544736|Immunotherapy|immunotherapy
940108|NCT03544710|surgical site infection|surgical site infection
940109|NCT03544671|Vitamin D|vitamin d
940110|NCT03544671|Nutritional deficiencies|nutritional deficiencies
940111|NCT03544671|Miconutrients|miconutrients
940112|NCT03544671|Children|children
940113|NCT03544671|Mexico|mexico
940114|NCT03544658|Tooth extrinsic stain|tooth extrinsic stain
940115|NCT03544658|Tooth color|tooth color
940116|NCT03544658|Dental prophylaxis|dental prophylaxis
940117|NCT03544658|Visual shade guide|visual shade guide
940118|NCT03544658|Dental spectrophotometer|dental spectrophotometer
940119|NCT03544645|Diabetic Education|diabetic education
940120|NCT03544645|audiovisual material|audiovisual material
940121|NCT03544645|Manual material|manual material
940122|NCT03544632|adipose-derived extracellular matrix (ECM)|adipose-derived extracellular matrix (ecm)
940123|NCT03544632|acellular adipose tissue (AAT)|acellular adipose tissue (aat)
940124|NCT03544580|dentin|dentin
940125|NCT03544580|immediate implant|immediate implant
940126|NCT03544580|buccal bone resorption|buccal bone resorption
940127|NCT03544580|crestal bone loss|crestal bone loss
940128|NCT03544554|Overactive bladder|overactive bladder
940129|NCT03544554|healthy lifestyle behaviors|healthy lifestyle behaviors
940130|NCT03544554|quality of life|quality of life
940131|NCT03544515|peri-implantitis|peri-implantitis
940132|NCT03544515|laser treatment|laser treatment
940133|NCT03544515|Biolase|biolase
940134|NCT03544515|Er,Cr:YSGG|er,cr:ysgg
940135|NCT03544502|music, anesthesia, surgery|music, anesthesia, surgery
940136|NCT03544476|mobile Health|mobile health
940137|NCT03544437|lymph node dissection|lymph node dissection
940138|NCT03544437|upper tract urothelial carcinoma|upper tract urothelial carcinoma
940139|NCT03544437|nephroureterectomy|nephroureterectomy
940140|NCT03544411|Olive oil|olive oil
940141|NCT03544411|Bran oil|bran oil
940142|NCT03544411|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
940143|NCT03544411|Antioxidant|antioxidant
940144|NCT03544411|glycemic control|glycemic control
940145|NCT03544411|lipid profile|lipid profile
940146|NCT03544372|concussion, rugby, self-report, concussion history, reliability|concussion, rugby, self-report, concussion history, reliability
940147|NCT03544359|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
940148|NCT03544359|functional magnetic resonance imaging (MRI)|functional magnetic resonance imaging (mri)
940248|NCT03543813|DLBCL|dlbcl
940149|NCT03544346|brain health, professional athlete, retired, neuropsychological assessment|brain health, professional athlete, retired, neuropsychological assessment
940150|NCT03544333|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
940151|NCT03544333|brain stimulation|brain stimulation
940152|NCT03544333|medication-free|medication-free
940153|NCT03544320|Pre-diabetes|pre-diabetes
940154|NCT03544320|diabetes|diabetes
940155|NCT03544320|wearable devices|wearable devices
940156|NCT03544320|mobile health|mobile health
940157|NCT03544307|Taekwondo|taekwondo
940158|NCT03544307|Menopause|menopause
940159|NCT03544307|Hypertension|hypertension
940160|NCT03544307|Arterial Stiffness|arterial stiffness
940161|NCT03544307|Blood Catecholamines|blood catecholamines
940162|NCT03544281|Relapsed / Refractory Multiple Myeloma|relapsed / refractory multiple myeloma
940163|NCT03544281|Dose escalation|dose escalation
940164|NCT03544281|Antibody-Drug Conjugate|antibody-drug conjugate
940165|NCT03544281|Dose expansion|dose expansion
940166|NCT03544268|ultrasound|ultrasound
940167|NCT03544268|breast|breast
940168|NCT03544268|angiography|angiography
940169|NCT03544255|pancreatic cancer|pancreatic cancer
940170|NCT03544255|EUS-FNA|eus-fna
940171|NCT03544255|organoid|organoid
940172|NCT03544242|Diabetes|diabetes
940173|NCT03544242|Insulin Resistance|insulin resistance
940174|NCT03544242|Nitrite|nitrite
940175|NCT03544242|Pancreatic islet cells|pancreatic islet cells
940176|NCT03544242|Autotransplantation|autotransplantation
940177|NCT03544242|Ischemia reperfusion injury|ischemia reperfusion injury
940178|NCT03544242|Mitigation|mitigation
940179|NCT03544242|Cure|cure
940180|NCT03544242|Nitric oxide|nitric oxide
940181|NCT03544242|Sodium nitrite|sodium nitrite
940196|NCT03544177|blood flow restricted exercise|blood flow restricted exercise
940197|NCT03544177|rehabilitation|rehabilitation
940198|NCT03544099|nasopharyngeal carcinoma|nasopharyngeal carcinoma
940199|NCT03544073|in-vitro fertilization|in-vitro fertilization
940200|NCT03544060|Familial Chylomicronemia|familial chylomicronemia
940201|NCT03544060|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
940202|NCT03544060|Hyperlipoproteinemias|hyperlipoproteinemias
940203|NCT03544060|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
940204|NCT03544060|Hyperlipoproteinemia Type 1|hyperlipoproteinemia type 1
940205|NCT03544060|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
940206|NCT03544060|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
940207|NCT03544060|Hyperlipidemias|hyperlipidemias
940208|NCT03544060|Dyslipidemias|dyslipidemias
940209|NCT03544060|Lipid Metabolism Disorders|lipid metabolism disorders
940210|NCT03544060|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
940211|NCT03544060|Metabolic Diseases|metabolic diseases
940212|NCT03544060|Metabolism, Inborn Errors|metabolism, inborn errors
940213|NCT03544060|Genetic Diseases, Inborn|genetic diseases, inborn
940214|NCT03544021|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
940215|NCT03544021|Relapsed|relapsed
940216|NCT03544021|Refractory|refractory
940217|NCT03543995|lower urinary tract symptoms|lower urinary tract symptoms
940218|NCT03543995|nocturnal enuresis|nocturnal enuresis
940219|NCT03543995|spina bifida occulta|spina bifida occulta
940220|NCT03543995|treatment response|treatment response
940221|NCT03543956|Silica|silica
940222|NCT03543956|Organic Solvents|organic solvents
940223|NCT03543956|Toxic substances exposure|toxic substances exposure
940224|NCT03543904|Abdomen|abdomen
940225|NCT03543904|Children|children
940226|NCT03543904|Chest physical therapy|chest physical therapy
940227|NCT03543904|Surgery|surgery
940228|NCT03543891|Gut microbiota|gut microbiota
940229|NCT03543891|16S rRNA gene|16s rrna gene
940230|NCT03543891|Thyroid cancer|thyroid cancer
940231|NCT03543891|Metabonomics|metabonomics
940232|NCT03543865|American Indian|american indian
940233|NCT03543865|Resilience|resilience
940234|NCT03543865|Native American|native american
940235|NCT03543852|Cancer survivor|cancer survivor
940236|NCT03543852|Health promotion|health promotion
940237|NCT03543852|Health education|health education
940238|NCT03543839|lupus|lupus
940239|NCT03543839|early lupus|early lupus
940240|NCT03543839|belimumab|belimumab
940241|NCT03543839|autoreactivity|autoreactivity
940242|NCT03543826|neostigmine|neostigmine
940243|NCT03543826|sugammadex|sugammadex
940244|NCT03543826|rocuronium|rocuronium
940245|NCT03543826|neuromuscular blocking agents|neuromuscular blocking agents
940246|NCT03543813|cancer|cancer
940247|NCT03543813|solid tumor|solid tumor
940263|NCT03543774|Lipid lowering therapy|lipid lowering therapy
940264|NCT03543774|Hypercholesterolemia|hypercholesterolemia
940265|NCT03543748|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
940266|NCT03543748|cognitive impairment|cognitive impairment
940267|NCT03543722|Veterans|veterans
940268|NCT03543722|Disability|disability
940269|NCT03543722|Employment|employment
940270|NCT03543722|Vocational Rehabilitation|vocational rehabilitation
940271|NCT03543722|Supported Employment|supported employment
940272|NCT03543709|Behcet's disease|behcet's disease
940273|NCT03543709|Fibromyalgia|fibromyalgia
940274|NCT03543709|Disease activity|disease activity
940275|NCT03543683|Non-Small Cell Lung Cancer|non-small cell lung cancer
940276|NCT03543683|Aspirin|aspirin
940277|NCT03543683|Osimertinib|osimertinib
940278|NCT03543683|EGFR-TKI|egfr-tki
940279|NCT03543683|T790M|t790m
940280|NCT03543644|Microbiome|microbiome
940281|NCT03543644|Sugar Sweetened Beverages|sugar sweetened beverages
940282|NCT03543644|Diet Beverages|diet beverages
940283|NCT03543644|Non-Nutritive Sweetened Beverages|non-nutritive sweetened beverages
940284|NCT03543644|Glucose response|glucose response
940285|NCT03543618|dental implant|dental implant
940286|NCT03543618|edentulous ridge|edentulous ridge
940287|NCT03543592|postmenopausal bleeding|postmenopausal bleeding
940288|NCT03543592|ultrasound|ultrasound
940289|NCT03543592|power doppler|power doppler
940290|NCT03543592|endometrium|endometrium
940291|NCT03543579|multiple myeloma|multiple myeloma
940292|NCT03543579|Carfilzomib|carfilzomib
940293|NCT03543579|Proteasome inhibition|proteasome inhibition
940294|NCT03543566|antimuscarinic medication|antimuscarinic medication
940295|NCT03543566|medical management|medical management
940296|NCT03543566|dual incontinence|dual incontinence
940297|NCT03543566|darifenacin|darifenacin
940298|NCT03543566|quality of life|quality of life
940299|NCT03543566|bowel diary|bowel diary
940300|NCT03543514|colon cancer, rectal cancer, prehabilitation|colon cancer, rectal cancer, prehabilitation
940301|NCT03543462|Ovarian Cancer|ovarian cancer
940302|NCT03543462|Diaphragm|diaphragm
940303|NCT03543462|Chest Drain|chest drain
940304|NCT03543462|Diaphragmatic Resection|diaphragmatic resection
940305|NCT03543462|Pleural Effusion|pleural effusion
940306|NCT03543436|Non-inferiority study|non-inferiority study
940307|NCT03543436|Temocillin|temocillin
940314|NCT03543423|Insulin and glucagon secretion|insulin and glucagon secretion
940315|NCT03543410|Depression, Depressive episode, Bipolar, Bipolar 1, Bipolar 1 depression|depression, depressive episode, bipolar, bipolar 1, bipolar 1 depression
940316|NCT03543397|ductal carcinomas|ductal carcinomas
940317|NCT03543397|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
940319|NCT03543384|facial neuritis|facial neuritis
940320|NCT03543384|T2 weighted gradient-echo|t2 weighted gradient-echo
940321|NCT03543384|fast imaging employing steady state acquisition (FIESTA-C)|fast imaging employing steady state acquisition (fiesta-c)
940322|NCT03543384|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
940323|NCT03543371|Neuropsychology|neuropsychology
940324|NCT03543358|rovalpituzumab tesirine|rovalpituzumab tesirine
940325|NCT03543358|rollover study|rollover study
940326|NCT03543358|cancer|cancer
940328|NCT03543345|PCI|pci
940329|NCT03543345|right ventricular function|right ventricular function
940330|NCT03543332|Physical training|physical training
940331|NCT03543332|Kinesiophobia|kinesiophobia
940332|NCT03543293|perilymphatic fistulas|perilymphatic fistulas
940333|NCT03543293|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
940334|NCT03543293|surgery|surgery
940335|NCT03543293|round window|round window
940336|NCT03543293|vertigo|vertigo
940337|NCT03543293|tinnitus|tinnitus
940338|NCT03543293|cophosis|cophosis
940339|NCT03543280|fatigability post stroke|fatigability post stroke
940340|NCT03543280|post stroke|post stroke
940341|NCT03543280|high-speed CT|high-speed ct
940342|NCT03543280|MRI|mri
940343|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a
940344|NCT03543254|Injections|injections
940345|NCT03543254|Cranial Sutures|cranial sutures
940346|NCT03543254|Head|head
940352|NCT03543215|Prognistication|prognistication
940353|NCT03543215|Endometrial cancer|endometrial cancer
940354|NCT03543202|Unilateral transversus abdominal plane block|unilateral transversus abdominal plane block
940355|NCT03543202|Local infiltration anesthesia|local infiltration anesthesia
940356|NCT03543202|Cholecystectomy|cholecystectomy
940357|NCT03543202|Postoperative analgesia|postoperative analgesia
940358|NCT03543189|Gleason Group 5|gleason group 5
940359|NCT03543189|PCa|pca
940360|NCT03543189|Advanced Stage Prostate Cancer|advanced stage prostate cancer
940361|NCT03543189|Immunotherapy|immunotherapy
940362|NCT03543189|Oligometastaic Disease|oligometastaic disease
940363|NCT03543189|Brachytherapy|brachytherapy
940364|NCT03543189|Androgen Deprivation Therapy|androgen deprivation therapy
940365|NCT03543176|Cohort|cohort
940366|NCT03543176|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
940367|NCT03543176|Observational|observational
940368|NCT03543176|GOLD|gold
940369|NCT03543176|Claims|claims
940370|NCT03543176|Health plan recruitment|health plan recruitment
940371|NCT03543163|buccal fat pad graft|buccal fat pad graft
940372|NCT03543163|sub-epithelial connective tissue graft|sub-epithelial connective tissue graft
940373|NCT03543150|Spasmodic Dysphonia|spasmodic dysphonia
940374|NCT03543150|VHI-10 scores|vhi-10 scores
940375|NCT03543150|BOTOX|botox
940376|NCT03543150|Drug use investigation|drug use investigation
940377|NCT03543124|colonoscopy|colonoscopy
940378|NCT03543124|pain|pain
940379|NCT03543124|water exchange|water exchange
940380|NCT03543124|cap|cap
940381|NCT03543098|Knee Injury|knee injury
940382|NCT03543098|Knee Injuries|knee injuries
940383|NCT03543098|Knee Surgery|knee surgery
940384|NCT03543098|Rehabilitation|rehabilitation
940385|NCT03543098|Knee Dislocation|knee dislocation
940386|NCT03543098|Multiple Ligament Knee Injury|multiple ligament knee injury
940387|NCT03543033|lumbar radiculopathy|lumbar radiculopathy
940388|NCT03543033|corticosteroid epidural injection|corticosteroid epidural injection
940389|NCT03543020|radiation induced alopecia|radiation induced alopecia
940390|NCT03543020|whole brain radiation|whole brain radiation
940391|NCT03543020|partial brain radiation|partial brain radiation
940392|NCT03543020|radiotherapy|radiotherapy
940393|NCT03542981|pain|pain
940394|NCT03542981|surgery|surgery
940395|NCT03542981|interferential current|interferential current
940396|NCT03542981|total knee arthroplasty|total knee arthroplasty
940397|NCT03542968|Congenital heart disease|congenital heart disease
940398|NCT03542968|Tetralogy of Fallot|tetralogy of fallot
940399|NCT03542968|Imaging by 4D Flow,|imaging by 4d flow,
940400|NCT03542968|Magnetic resonance imaging|magnetic resonance imaging
940401|NCT03542968|Prevention of ventricular dysfunction|prevention of ventricular dysfunction
940402|NCT03542942|locally advanced|locally advanced
940403|NCT03542942|radiotherapy|radiotherapy
940404|NCT03542942|DW-MRI|dw-mri
940405|NCT03542942|target volume|target volume
940406|NCT03542890|Anesthesia, General|anesthesia, general
940407|NCT03542890|Baska|baska
940408|NCT03542890|I-gel|i-gel
940413|NCT03542864|obesity|obesity
940414|NCT03542864|overweight|overweight
940415|NCT03542864|fat percentage|fat percentage
940416|NCT03542864|body fat|body fat
940417|NCT03542864|enteral feeding|enteral feeding
940418|NCT03542864|fat loss|fat loss
940419|NCT03542825|Iron|iron
940420|NCT03542825|Deficiency|deficiency
940421|NCT03542812|L-citrulline|l-citrulline
941983|NCT03532386|Infertility|infertility
940422|NCT03542812|Nitric oxide|nitric oxide
940423|NCT03542786|HIV-1|hiv-1
940424|NCT03542760|Methylene Blue|methylene blue
940425|NCT03542747|Airway|airway
940426|NCT03542747|extraglottic|extraglottic
940427|NCT03542747|simulation|simulation
940428|NCT03542747|laryngeal mask|laryngeal mask
940429|NCT03542721|chronic fatigue symptom|chronic fatigue symptom
940430|NCT03542721|blood circulation|blood circulation
940431|NCT03542656|Stroke|stroke
940432|NCT03542656|intracerebral hemorrhage|intracerebral hemorrhage
940433|NCT03542656|amyoid PET|amyoid pet
940434|NCT03542656|cerebral amyloid angiopathy|cerebral amyloid angiopathy
940435|NCT03542643|ADHD|adhd
940436|NCT03542643|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
940437|NCT03542643|children|children
940438|NCT03542643|adolescents|adolescents
940439|NCT03542513|Human Papillomavirus|human papillomavirus
940440|NCT03542513|Biomarker|biomarker
940441|NCT03542513|Self-sampling|self-sampling
940442|NCT03542513|First-void urine|first-void urine
940443|NCT03542513|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
940444|NCT03542513|LLETZ|lletz
940445|NCT03542487|Self Monitoring of Blood Glucose|self monitoring of blood glucose
940446|NCT03542487|Electronic Medical Records|electronic medical records
940447|NCT03542487|Nudge|nudge
940449|NCT03542487|Behavioral Economics|behavioral economics
940450|NCT03542461|Squamous NSCLC|squamous nsclc
940451|NCT03542461|Nivolumab|nivolumab
940452|NCT03542396|CBT|cbt
940453|NCT03542396|Endurance exercise|endurance exercise
940454|NCT03542383|Gulf War Illness|gulf war illness
940455|NCT03542383|Memory|memory
940456|NCT03542383|Word Finding|word finding
940457|NCT03542383|High Definition Transcranial Direct Current Stimulation|high definition transcranial direct current stimulation
940458|NCT03542383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
940459|NCT03542370|dietary approaches to stop hypertension|dietary approaches to stop hypertension
940460|NCT03542370|DASH|dash
940461|NCT03542370|cardiometabolic health|cardiometabolic health
940462|NCT03542370|Umbrella Review|umbrella review
940463|NCT03542370|GRADE|grade
940464|NCT03542370|Systematic review and meta-analysis|systematic review and meta-analysis
940465|NCT03542318|Pulmonary Rehabilitation|pulmonary rehabilitation
940466|NCT03542318|Functional outcomes|functional outcomes
940467|NCT03542318|Health Status|health status
940468|NCT03542318|Exercise|exercise
940469|NCT03542279|Autoimmune encephalitis, Plasma exchange, Immunotherapy, Outcome|autoimmune encephalitis, plasma exchange, immunotherapy, outcome
940470|NCT03542266|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
940471|NCT03542266|Azacitidine|azacitidine
940472|NCT03542266|Lymphoma|lymphoma
940473|NCT03542253|Early lung cancer,ground-glass nodule,CT,exosome|early lung cancer,ground-glass nodule,ct,exosome
940474|NCT03542240|curcumin|curcumin
940475|NCT03542240|microbiome|microbiome
940476|NCT03542240|dietary supplements|dietary supplements
940477|NCT03542240|gut bacteria|gut bacteria
940478|NCT03542227|Antibodies|antibodies
940479|NCT03542227|Vaccination|vaccination
940480|NCT03542227|Self-sampling|self-sampling
940481|NCT03542227|First-void urine|first-void urine
940482|NCT03542188|Large Vessel Occlusion|large vessel occlusion
940483|NCT03542188|Stroke|stroke
940484|NCT03542188|EVT|evt
940485|NCT03542175|Rucaparib|rucaparib
940486|NCT03542175|Radiotherapy|radiotherapy
940487|NCT03542175|Triple Negative Breast Cancer|triple negative breast cancer
940488|NCT03542175|18-002|18-002
940489|NCT03542162|Healaflow|healaflow
940490|NCT03542162|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
940491|NCT03542162|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
940492|NCT03542162|Minimally invasive surgery|minimally invasive surgery
940493|NCT03542162|Complications|complications
940494|NCT03542136|Polyneuropathy|polyneuropathy
940495|NCT03542136|Oxaliplatin|oxaliplatin
940496|NCT03542136|Colorectal cancer|colorectal cancer
940497|NCT03542123|Electrical Stimulation Therapy; Electrodes; Parasympathetic Nervous System; Sympathetic Fibers, Post Ganglionic; Congestive Heart Failure; Heart Failure|electrical stimulation therapy; electrodes; parasympathetic nervous system; sympathetic fibers, post ganglionic; congestive heart failure; heart failure
940498|NCT03542097|Ewing Sarcoma|ewing sarcoma
940499|NCT03542032|i-gel|i-gel
940500|NCT03542032|jaw-thrust|jaw-thrust
940501|NCT03541993|Resveratrol|resveratrol
940502|NCT03541993|Cerebral blood flow|cerebral blood flow
940503|NCT03541993|Cognition|cognition
940504|NCT03541993|Hypoxia|hypoxia
940505|NCT03541993|Polyphenols|polyphenols
940506|NCT03541980|sickle cell|sickle cell
940507|NCT03541980|acetaminophen in pain crises|acetaminophen in pain crises
940508|NCT03541980|opioid-sparing|opioid-sparing
940509|NCT03541967|bone conduction|bone conduction
940510|NCT03541954|sensitization|sensitization
940511|NCT03541954|pain thresholds|pain thresholds
940512|NCT03541941|Liposomal Bupivacaine|liposomal bupivacaine
940513|NCT03541941|Exparel|exparel
940514|NCT03541941|Transversus Abdominis Plane block|transversus abdominis plane block
940515|NCT03541941|Hernia|hernia
940516|NCT03541928|gene therapy|gene therapy
940517|NCT03541928|untreated prostate cancer|untreated prostate cancer
940627|NCT03541278|Internal Mammary Lymph Node|internal mammary lymph node
940518|NCT03541902|Malignant Neoplasms of Urinary Tract|malignant neoplasms of urinary tract
940519|NCT03541902|Renal cell carcinoma|renal cell carcinoma
940520|NCT03541902|Cabozantinib|cabozantinib
940521|NCT03541902|XL-184|xl-184
940522|NCT03541902|XL184|xl184
940523|NCT03541902|Sunitinib|sunitinib
940524|NCT03541902|Sunitinib Malate|sunitinib malate
940525|NCT03541902|SU011248|su011248
940526|NCT03541902|Sutent|sutent
940527|NCT03541876|children|children
940528|NCT03541876|treatment|treatment
940529|NCT03541876|observatory|observatory
940530|NCT03541863|Fulvestrant|fulvestrant
940531|NCT03541863|Progression|progression
940532|NCT03541863|Endocrine sensitivity|endocrine sensitivity
940533|NCT03541837|Bilateral ESP Catheter|bilateral esp catheter
940534|NCT03541837|Open heart surgery|open heart surgery
940535|NCT03541837|opioid free post op analgesia|opioid free post op analgesia
940536|NCT03541811|gait|gait
940537|NCT03541811|motion capture|motion capture
940538|NCT03541811|hemophilia joint health score|hemophilia joint health score
940539|NCT03541811|physical activity|physical activity
940540|NCT03541811|body composition|body composition
940541|NCT03541811|gait deviation index|gait deviation index
940542|NCT03541811|hemophilia|hemophilia
940549|NCT03541772|Neck Carcinoma|neck carcinoma
940550|NCT03541772|Chemotherapy|chemotherapy
940551|NCT03541772|Radiotherapy|radiotherapy
940552|NCT03541772|Oncoxin Viusid|oncoxin viusid
940553|NCT03541772|Nutritional supplement|nutritional supplement
1333202|NCT01444014|hypergastrinaemia|hypergastrinaemia
940554|NCT03541759|Elective shoulder surgery, hydromorphone, piritramide|elective shoulder surgery, hydromorphone, piritramide
940555|NCT03541733|magnetic resonance enterography|magnetic resonance enterography
940556|NCT03541733|bowel preparation|bowel preparation
940557|NCT03541707|TMS|tms
940558|NCT03541707|EEG|eeg
940559|NCT03541707|Depression|depression
940560|NCT03541707|adolescents|adolescents
940561|NCT03541694|Yellow fever|yellow fever
940562|NCT03541694|Stamaril®|stamaril®
940563|NCT03541681|Epidural Steroid Injections|epidural steroid injections
940564|NCT03541681|Cervical Epidural Injections|cervical epidural injections
940565|NCT03541681|Transforaminal Epidural Injections|transforaminal epidural injections
940566|NCT03541681|Steroids|steroids
940567|NCT03541681|Local Anesthetic|local anesthetic
940568|NCT03541655|total knee replacement|total knee replacement
940569|NCT03541655|pain|pain
940570|NCT03541655|celecoxib|celecoxib
940571|NCT03541655|intra-articular|intra-articular
940572|NCT03541603|PH-HFpEF|ph-hfpef
940573|NCT03541590|percutaneous biliary drainage|percutaneous biliary drainage
940574|NCT03541538|joint manipulation|joint manipulation
940575|NCT03541538|cervical|cervical
940576|NCT03541538|pressure pain|pressure pain
940577|NCT03541538|manual therapy|manual therapy
940578|NCT03541512|Mindfulness therapy|mindfulness therapy
940579|NCT03541512|Vulvodynia|vulvodynia
940580|NCT03541512|Vulvar pain|vulvar pain
940581|NCT03541499|B. pertussis Vaccine|b. pertussis vaccine
940582|NCT03541499|BPZE1|bpze1
940583|NCT03541499|Immunogenicity|immunogenicity
940584|NCT03541499|Safety|safety
940585|NCT03541486|ascorbic acid|ascorbic acid
940586|NCT03541486|ascorbate|ascorbate
940587|NCT03541486|sodium ascorbate|sodium ascorbate
940588|NCT03541486|radiotherapy|radiotherapy
940589|NCT03541486|radiotherapy, image-guided|radiotherapy, image-guided
940590|NCT03541486|gemcitabine|gemcitabine
940591|NCT03541460|centenarians|centenarians
940592|NCT03541460|epigenome|epigenome
940593|NCT03541460|longevity|longevity
940594|NCT03541460|healthy aging|healthy aging
940595|NCT03541460|epigenetic|epigenetic
940596|NCT03541447|ADPKD, Tolvaptan, Octrotide LAR|adpkd, tolvaptan, octrotide lar
940597|NCT03541434|obstructive sleep apnea|obstructive sleep apnea
940598|NCT03541434|tonsillitis|tonsillitis
940599|NCT03541434|middle ear effusion|middle ear effusion
940600|NCT03541434|pathophysiology|pathophysiology
940601|NCT03541434|score|score
940602|NCT03541382|HIV|hiv
940603|NCT03541382|HIV Self-Testing|hiv self-testing
940604|NCT03541382|Malawi|malawi
940605|NCT03541356|Parkinsons|parkinsons
940606|NCT03541356|L-dopa|l-dopa
940607|NCT03541356|levodopa|levodopa
940608|NCT03541356|ON|on
940609|NCT03541356|OFF|off
940610|NCT03541356|PD|pd
940611|NCT03541356|POD device|pod device
940612|NCT03541356|I231|i231
940613|NCT03541356|benserazide|benserazide
940614|NCT03541356|Precision olfactory delivery|precision olfactory delivery
940615|NCT03541356|MDS-UPDRS|mds-updrs
940616|NCT03541330|Siblings|siblings
940617|NCT03541330|information|information
940618|NCT03541330|malignant haemopathy|malignant haemopathy
940619|NCT03541317|Adaptive implementation|adaptive implementation
940620|NCT03541317|Coaching|coaching
940621|NCT03541317|Facilitation|facilitation
940622|NCT03541317|School mental health|school mental health
940623|NCT03541317|Implementation intervention|implementation intervention
940624|NCT03541304|high dose radiotherapy|high dose radiotherapy
940625|NCT03541304|rectal cancer|rectal cancer
940626|NCT03541278|Breast Cancer|breast cancer
942105|NCT03531645|Faslodex|faslodex
940628|NCT03541278|Internal Mammary Sentinel Lymph Node Biopsy|internal mammary sentinel lymph node biopsy
940629|NCT03541278|Detection Rate|detection rate
940630|NCT03541265|liposomal bupivacaine|liposomal bupivacaine
940631|NCT03541265|total knee arthroplasty|total knee arthroplasty
940632|NCT03541213|ferric carboxymaltose|ferric carboxymaltose
940633|NCT03541213|mitochondrial metabolism|mitochondrial metabolism
940634|NCT03541213|cardiomyocyte|cardiomyocyte
940635|NCT03541187|cockroach|cockroach
940636|NCT03541187|immunotherapy|immunotherapy
940637|NCT03541187|inner city asthma|inner city asthma
940638|NCT03541187|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
940639|NCT03541187|Nasal Allergen Challenge (NAC)|nasal allergen challenge (nac)
940640|NCT03541161|Early rehabilitation|early rehabilitation
940641|NCT03541161|Conventional protocol|conventional protocol
940642|NCT03541161|Tissue expander insertion|tissue expander insertion
940643|NCT03541148|Cutaneous malignant melanoma|cutaneous malignant melanoma
940644|NCT03541148|Nutritional supplement|nutritional supplement
940645|NCT03541148|survival|survival
940646|NCT03541148|Green tea|green tea
940647|NCT03541135|Cardiovascular health|cardiovascular health
940648|NCT03541135|Diet|diet
940649|NCT03541135|Functional limitations|functional limitations
940650|NCT03541135|Frailty|frailty
940651|NCT03541135|Older Adults|older adults
940652|NCT03541109|Cardiovascular disease|cardiovascular disease
940653|NCT03541109|fixed dose combination therapy|fixed dose combination therapy
940654|NCT03541109|cost effectiveness|cost effectiveness
940655|NCT03541070|kinesiology taping|kinesiology taping
940656|NCT03541070|balance|balance
940657|NCT03541070|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
940658|NCT03541018|TRV Reposition Chair|trv reposition chair
940659|NCT03541018|Epley Maneuvre|epley maneuvre
940660|NCT03541005|Overweight|overweight
940661|NCT03541005|Obesity|obesity
940662|NCT03541005|Nutritional supplement|nutritional supplement
940663|NCT03541005|Weight loss|weight loss
940664|NCT03541005|waist|waist
940665|NCT03540953|Endoscopic injection of Mitomycin C|endoscopic injection of mitomycin c
940666|NCT03540927|Well-being|well-being
940667|NCT03540927|Entrepreneurs|entrepreneurs
940668|NCT03540927|Conflict affected settings|conflict affected settings
940669|NCT03540927|Psychosocial intervention|psychosocial intervention
940670|NCT03540927|Psychological Capital|psychological capital
940671|NCT03540914|healthy participants older than 40 years|healthy participants older than 40 years
940672|NCT03540914|right heart function|right heart function
940673|NCT03540914|prevention|prevention
940674|NCT03540914|acetazolamide|acetazolamide
940675|NCT03540901|prevention|prevention
940676|NCT03540901|acetazolamide|acetazolamide
940677|NCT03540901|obstructive airway disease|obstructive airway disease
940678|NCT03540901|lung water|lung water
940679|NCT03540888|Dynamic Stretching|dynamic stretching
940680|NCT03540888|Static Stretching|static stretching
940681|NCT03540888|Manual Therapy|manual therapy
940682|NCT03540875|Anesthesia, general|anesthesia, general
940683|NCT03540875|Total intravenous anesthesia|total intravenous anesthesia
940684|NCT03540875|Closed loop anesthesia|closed loop anesthesia
940685|NCT03540875|Conox|conox
940686|NCT03540875|EEG monitoring|eeg monitoring
940687|NCT03540875|qCon|qcon
940688|NCT03540875|qNox|qnox
940689|NCT03540862|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
940690|NCT03540862|Maintenance Negative Pressure Ventilation- assisted pulmonary rehabilitation|maintenance negative pressure ventilation- assisted pulmonary rehabilitation
940691|NCT03540862|Six minute walk test|six minute walk test
940692|NCT03540862|Overall survival|overall survival
940693|NCT03540810|antiphospholipid syndrome|antiphospholipid syndrome
940694|NCT03540810|thrombosis|thrombosis
940695|NCT03540810|hydroxychloroquine|hydroxychloroquine
940696|NCT03540784|muscle weakness|muscle weakness
940697|NCT03540784|muscle mass|muscle mass
940698|NCT03540784|whole-body electromyostimulation|whole-body electromyostimulation
940699|NCT03540784|WB-EMS|wb-ems
940700|NCT03540784|nutrition|nutrition
940701|NCT03540784|protein|protein
940702|NCT03540784|crohn's disease|crohn's disease
940703|NCT03540784|ulcerative colitis|ulcerative colitis
940704|NCT03540771|palliative care|palliative care
940705|NCT03540771|hepatology|hepatology
940706|NCT03540758|type 2 diabetes|type 2 diabetes
940707|NCT03540758|diabetes|diabetes
940708|NCT03540758|insulin resistance|insulin resistance
940709|NCT03540758|diazoxide|diazoxide
940710|NCT03540719|classification|classification
940711|NCT03540719|questionnaires|questionnaires
940712|NCT03540719|open reduction|open reduction
940713|NCT03540719|internal fixation|internal fixation
940714|NCT03540706|Respiratory Infections|respiratory infections
940715|NCT03540706|C-reactive protein|c-reactive protein
940716|NCT03540706|antibiotic prescription|antibiotic prescription
940717|NCT03540693|Bariatric surgery|bariatric surgery
940718|NCT03540693|gastric bypass surgery|gastric bypass surgery
940719|NCT03540693|sleeve gastrectomy|sleeve gastrectomy
940720|NCT03540693|laparoscopic gastric banding|laparoscopic gastric banding
940721|NCT03540693|food preferences|food preferences
940722|NCT03540693|flavor perception|flavor perception
942106|NCT03531645|Palbociclib|palbociclib
940723|NCT03540667|Total hip arthroplasty|total hip arthroplasty
940724|NCT03540667|Total knee arthroplasty|total knee arthroplasty
940725|NCT03540667|Total joint arthroplasty|total joint arthroplasty
940726|NCT03540667|Low middle income country|low middle income country
940727|NCT03540667|Enhanced recovery pathway|enhanced recovery pathway
940728|NCT03540641|Binge Eating Disorder|binge eating disorder
940729|NCT03540641|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
940730|NCT03540641|Food Craving|food craving
940731|NCT03540602|Polyphenol rich supplementation|polyphenol rich supplementation
940732|NCT03540602|Tart cherry|tart cherry
940733|NCT03540602|Lifting|lifting
940734|NCT03540602|Recovery|recovery
940735|NCT03540563|ctDNA|ctdna
940736|NCT03540511|cardiac surgery|cardiac surgery
940737|NCT03540511|troponin|troponin
940738|NCT03540511|mortality|mortality
940739|NCT03540498|Oral health|oral health
940740|NCT03540498|Probiotics|probiotics
940741|NCT03540498|L. plantarum|l. plantarum
940742|NCT03540498|L. brevis|l. brevis
940743|NCT03540498|Periodontics|periodontics
940744|NCT03540472|tacrolimus|tacrolimus
940745|NCT03540472|refractory pure red cell aplasia|refractory pure red cell aplasia
940746|NCT03540472|prospective study|prospective study
940747|NCT03540420|Atezolizumab|atezolizumab
940748|NCT03540420|Chemoradiotherapy|chemoradiotherapy
940749|NCT03540420|Immunotherapy|immunotherapy
940750|NCT03540407|Cervical carcinoma|cervical carcinoma
940751|NCT03540407|Endometrial adenocarcinoma|endometrial adenocarcinoma
940752|NCT03540407|Oncoxin-Viusid|oncoxin-viusid
940753|NCT03540407|Nutritional supplement|nutritional supplement
940754|NCT03540407|Antioxidant|antioxidant
940755|NCT03540381|Neoatherosclerosis|neoatherosclerosis
940756|NCT03540381|Cholesterol Uptake Capacity|cholesterol uptake capacity
940757|NCT03540368|Gastrointestinal bleeding|gastrointestinal bleeding
940758|NCT03540368|Tranexamic acid|tranexamic acid
940759|NCT03540368|Clinical trial|clinical trial
940760|NCT03540342|coronary artery disease|coronary artery disease
940761|NCT03540342|aortic atherosclerotic disease|aortic atherosclerotic disease
940762|NCT03540342|one-stop|one-stop
940763|NCT03540342|percutaneous coronary intervention|percutaneous coronary intervention
940764|NCT03540342|endovascular aortic repair|endovascular aortic repair
940765|NCT03540329|osteogenesis|osteogenesis
940766|NCT03540329|distraction|distraction
940767|NCT03540329|Lower face asymmetry|lower face asymmetry
940768|NCT03540303|relapsed/refractory, B cell, lymphoma, CAR|relapsed/refractory, b cell, lymphoma, car
940769|NCT03540277|prevention program|prevention program
940770|NCT03540277|body-image|body-image
940771|NCT03540277|self-esteem|self-esteem
940773|NCT03540277|adolescents|adolescents
940774|NCT03540238|sedation|sedation
940775|NCT03540238|endoscopy|endoscopy
940776|NCT03540238|anesthesia|anesthesia
940777|NCT03540238|gastroenterologist|gastroenterologist
940778|NCT03540225|Progesterone|progesterone
940779|NCT03540199|activated CIK|activated cik
940780|NCT03540199|MUC1|muc1
940781|NCT03540199|bispecific antibody|bispecific antibody
940782|NCT03540199|kidney cancer|kidney cancer
940783|NCT03540147|blood flow restriction|blood flow restriction
940784|NCT03540147|blood pressure|blood pressure
940785|NCT03540147|yoga|yoga
940786|NCT03540134|DBS|dbs
940787|NCT03540121|video|video
940788|NCT03540121|contract|contract
940789|NCT03540121|patient education|patient education
940790|NCT03540108|hypercholesterolemia|hypercholesterolemia
940791|NCT03540108|bile acid synthesis|bile acid synthesis
940792|NCT03540108|cholesterol|cholesterol
940793|NCT03540108|bile salt hydrolysis|bile salt hydrolysis
940794|NCT03540108|vitamin D|vitamin d
940795|NCT03540082|Aging|aging
940796|NCT03540082|Older Adults|older adults
940797|NCT03540082|Fall prevention|fall prevention
940798|NCT03540082|Fall safety|fall safety
940799|NCT03540082|Safe landing|safe landing
940800|NCT03540056|varicocele|varicocele
940801|NCT03540056|testicular growth|testicular growth
940802|NCT03540043|Mild moderate atopic dermatitis|mild moderate atopic dermatitis
940803|NCT03540030|Primary Total Shoulder Arthroplasty|primary total shoulder arthroplasty
940804|NCT03540030|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
940805|NCT03540017|Ovarian Cancer|ovarian cancer
940806|NCT03540017|Fallopian Tube Cancer|fallopian tube cancer
940807|NCT03540017|Primary Peritoneal Cancer|primary peritoneal cancer
940808|NCT03539991|Tobacco counseling|tobacco counseling
940809|NCT03539991|e-Learning|e-learning
940810|NCT03539991|Smartphone App|smartphone app
940811|NCT03539991|Virtual meetings|virtual meetings
940812|NCT03539965|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
940813|NCT03539965|Predictive Biomarkers|predictive biomarkers
940814|NCT03539965|Prognostic Biomarkers|prognostic biomarkers
940815|NCT03539965|Complete Pathological Response|complete pathological response
940816|NCT03539965|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
940817|NCT03539965|PD-L1|pd-l1
940818|NCT03539965|PD-L2|pd-l2
940819|NCT03539939|Gingival crevicular fluid|gingival crevicular fluid
940820|NCT03539939|Gingival recession|gingival recession
940821|NCT03539939|Saliva|saliva
940822|NCT03539939|Smoking|smoking
940823|NCT03539939|Wound healing|wound healing
940824|NCT03539926|Cystinuria|cystinuria
940825|NCT03539926|pH Control|ph control
940826|NCT03539887|Ketamine|ketamine
940827|NCT03539887|Depression|depression
940828|NCT03539887|Suicidal Ideation|suicidal ideation
940829|NCT03539887|Alcohol Abuse|alcohol abuse
940830|NCT03539861|End Stage Renal Disease|end stage renal disease
940831|NCT03539861|Hemodialysis|hemodialysis
940832|NCT03539861|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
940833|NCT03539848|TBI|tbi
940834|NCT03539848|Community Setting|community setting
940835|NCT03539848|Mild TBI|mild tbi
940836|NCT03539835|Breast Cancer Survivors|breast cancer survivors
940837|NCT03539835|Resistance Training|resistance training
940838|NCT03539835|Fatigue|fatigue
940839|NCT03539835|Physical Function|physical function
940840|NCT03539835|Behavioral Function|behavioral function
940841|NCT03539835|Kynurenine metabolism|kynurenine metabolism
940842|NCT03539822|Cabozantinib|cabozantinib
940843|NCT03539822|Durvalumab|durvalumab
940844|NCT03539822|MEDI4736|medi4736
940845|NCT03539809|Branched Chain Amino Acids|branched chain amino acids
940846|NCT03539809|Direct Amino Acid Oxidation|direct amino acid oxidation
940847|NCT03539809|Stable isotopes|stable isotopes
940848|NCT03539796|dural puncture epidurals|dural puncture epidurals
940850|NCT03539796|combined-spinal epidural|combined-spinal epidural
940851|NCT03539796|CSE|cse
940852|NCT03539796|cesarean section|cesarean section
940853|NCT03539796|patient satisfaction|patient satisfaction
940854|NCT03539783|Endotype|endotype
940855|NCT03539783|Pediatric Acute Respiratory Distress Syndrome|pediatric acute respiratory distress syndrome
940856|NCT03539783|Gene Expression|gene expression
940857|NCT03539783|Transcriptomics|transcriptomics
940858|NCT03539770|Lung Development|lung development
940859|NCT03539770|Lung Regeneration|lung regeneration
940860|NCT03539770|Hyperpolarized Helium|hyperpolarized helium
940861|NCT03539757|Liver fibrosis|liver fibrosis
940862|NCT03539757|Fontan surgery|fontan surgery
940863|NCT03539757|MRI|mri
940864|NCT03539757|Novel Methods|novel methods
940865|NCT03539744|Cancer, Multiple Myeloma (MM), Relapsed or Refractory Multiple Myeloma (R/R MM), pharmacokinetics|cancer, multiple myeloma (mm), relapsed or refractory multiple myeloma (r/r mm), pharmacokinetics
940866|NCT03539679|Exercise, sickness absences, health, military fitness|exercise, sickness absences, health, military fitness
940867|NCT03539640|PEEP|peep
940868|NCT03539640|Diaphragm|diaphragm
940869|NCT03539627|diabetes mellitus|diabetes mellitus
940870|NCT03539627|Edarbi|edarbi
940871|NCT03539627|hypertension|hypertension
940872|NCT03539614|Prazosin|prazosin
940873|NCT03539614|Nightmares|nightmares
940874|NCT03539614|N-of-1|n-of-1
940875|NCT03539601|Atopic Dermatitis, Crisaborole ointment 2%, TCS, TCI|atopic dermatitis, crisaborole ointment 2%, tcs, tci
940876|NCT03539588|dry needling|dry needling
940877|NCT03539588|electrical stimulation|electrical stimulation
940878|NCT03539588|E-Stim|e-stim
940879|NCT03539588|LBP|lbp
940880|NCT03539588|low back pain|low back pain
940881|NCT03539588|trigger point|trigger point
940882|NCT03539588|chronic|chronic
940883|NCT03539588|subacute|subacute
940884|NCT03539575|K2|k2
940885|NCT03539575|Spice|spice
940886|NCT03539575|Synthetic Marijuana|synthetic marijuana
940887|NCT03539536|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
940888|NCT03539536|Cancer|cancer
940889|NCT03539536|Telisotuzumab vedotin|telisotuzumab vedotin
940890|NCT03539536|ABBV-399|abbv-399
940891|NCT03539536|c-Met, c-Met overexpression|c-met, c-met overexpression
940892|NCT03539536|metastatic|metastatic
940893|NCT03539523|L test|l test
940894|NCT03539523|cerebral palsy|cerebral palsy
940895|NCT03539523|children|children
940896|NCT03539523|validity|validity
940897|NCT03539523|reliability|reliability
940898|NCT03539497|biomarker|biomarker
940899|NCT03539445|AIS|ais
940900|NCT03539445|butylphthalide|butylphthalide
940901|NCT03539445|mechanical thrombectomy|mechanical thrombectomy
940902|NCT03539445|iv-rtPA|iv-rtpa
940903|NCT03539445|recovery of dysfunction|recovery of dysfunction
940904|NCT03539419|Psoriasis|psoriasis
940905|NCT03539419|Plaque Psoriasis|plaque psoriasis
940906|NCT03539419|Apremilast|apremilast
940907|NCT03539419|CC-10004|cc-10004
940908|NCT03539367|healthy participants older than 40 years|healthy participants older than 40 years
940909|NCT03539367|lung water|lung water
940910|NCT03539367|prevention|prevention
940911|NCT03539367|acetazolamide|acetazolamide
940912|NCT03539354|Atrial fibrillation|atrial fibrillation
940913|NCT03539354|Spinal cord stimulatoin|spinal cord stimulatoin
940914|NCT03539354|Coronary artery bypass grafting|coronary artery bypass grafting
940915|NCT03539302|Inhaled Flecainide|inhaled flecainide
940916|NCT03539289|IPF|ipf
940917|NCT03539289|Mitigating Adverse Events|mitigating adverse events
940918|NCT03539276|quality improvement|quality improvement
940919|NCT03539276|long term care|long term care
940920|NCT03539276|polypharmacy|polypharmacy
940921|NCT03539250|Radiation-induced temporal lobe injury;NPC|radiation-induced temporal lobe injury;npc
940922|NCT03539250|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
941023|NCT03538795|brain stimulation|brain stimulation
940923|NCT03539250|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
940924|NCT03539237|Video demonstration|video demonstration
940925|NCT03539237|Intensity levels|intensity levels
940926|NCT03539237|Physical activity|physical activity
940927|NCT03539237|Self-report|self-report
940928|NCT03539237|Accelerometer|accelerometer
940929|NCT03539185|Airtraq|airtraq
940930|NCT03539185|Fiberoptic|fiberoptic
940931|NCT03539185|Awake|awake
940932|NCT03539185|Tracheal intubation|tracheal intubation
940933|NCT03539185|laryngeal nerve blocks|laryngeal nerve blocks
940934|NCT03539185|sedation|sedation
940935|NCT03539185|remifentanil|remifentanil
940936|NCT03539159|Allogeneic serum eye drops|allogeneic serum eye drops
940937|NCT03539159|Micro eye drops|micro eye drops
940938|NCT03539159|Cross-over multicenter trial|cross-over multicenter trial
940939|NCT03539159|Ocular Surface Disease Index (OSDI)|ocular surface disease index (osdi)
940940|NCT03539146|byproducts|byproducts
940941|NCT03539146|functional yogurt|functional yogurt
940942|NCT03539146|satiety|satiety
940943|NCT03539146|sensory analysis|sensory analysis
940944|NCT03539146|sustainable health|sustainable health
940945|NCT03539146|novel food ingredient|novel food ingredient
940946|NCT03539133|STEMI|stemi
940947|NCT03539133|infarction|infarction
940948|NCT03539133|coronary artery disease|coronary artery disease
940949|NCT03539133|comorbidities|comorbidities
940950|NCT03539133|diabetes|diabetes
940951|NCT03539133|anemia|anemia
940952|NCT03539094|Multiple Sclerosis|multiple sclerosis
940953|NCT03539094|Intermittent fasting|intermittent fasting
940954|NCT03539094|western diet|western diet
940955|NCT03539094|microbiome|microbiome
940956|NCT03539081|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
940957|NCT03539081|Muscle Sympathetic Nerve Activity|muscle sympathetic nerve activity
940958|NCT03539081|Blood Flow|blood flow
940959|NCT03539068|Veteran|veteran
940960|NCT03539068|Mental Health|mental health
940961|NCT03539068|War|war
940962|NCT03539068|Shared decision-making|shared decision-making
940963|NCT03539068|Access to care|access to care
940964|NCT03539055|DRT|drt
940965|NCT03539055|Device related thrombus|device related thrombus
940966|NCT03539055|Dabigatran etexilate|dabigatran etexilate
940967|NCT03539055|Aspirin|aspirin
940968|NCT03539055|Watchman|watchman
940969|NCT03539042|DNA methylation|dna methylation
940970|NCT03539042|Physical activity|physical activity
940971|NCT03539042|Exercise capacity|exercise capacity
940972|NCT03539016|Chronic hepatitis B, Mother-to-child transmission|chronic hepatitis b, mother-to-child transmission
940973|NCT03538990|Nutrition|nutrition
940974|NCT03538990|Dietary Approaches to Stop Hypertension|dietary approaches to stop hypertension
940975|NCT03538990|Cardiometabolic Outcomes|cardiometabolic outcomes
940976|NCT03538990|Pulmonary Artery Pressure|pulmonary artery pressure
940977|NCT03538990|CardioMEMS|cardiomems
940978|NCT03538977|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
940979|NCT03538977|Hydrotherapy|hydrotherapy
940980|NCT03538977|Electromyography|electromyography
940981|NCT03538977|Pain|pain
940982|NCT03538977|Prematurity|prematurity
940983|NCT03538964|Cataract|cataract
940984|NCT03538964|Low Astigmatism|low astigmatism
940985|NCT03538951|actinic keratosis|actinic keratosis
940986|NCT03538951|efficacy|efficacy
940987|NCT03538951|safety|safety
940988|NCT03538951|VDA-1102|vda-1102
940989|NCT03538938|Smoking|smoking
940990|NCT03538938|Smoking cessation|smoking cessation
940991|NCT03538938|Quitline|quitline
940992|NCT03538938|Nicotine Replacement Therapy|nicotine replacement therapy
940993|NCT03538938|SmokefreeTXT text messages|smokefreetxt text messages
940994|NCT03538938|Financial incentives|financial incentives
940995|NCT03538912|empirical antifungal therapy|empirical antifungal therapy
940996|NCT03538912|invasive candidiasis|invasive candidiasis
940997|NCT03538912|biomarkers|biomarkers
940998|NCT03538912|de-escalation|de-escalation
940999|NCT03538912|ICU|icu
941000|NCT03538899|Artemis-deficient Severe Combined Immunodeficiency|artemis-deficient severe combined immunodeficiency
941001|NCT03538899|gene therapy|gene therapy
941002|NCT03538899|autologous stem cell transplant|autologous stem cell transplant
941003|NCT03538886|Coronary revascularization|coronary revascularization
941004|NCT03538873|Subsyndromic symptoms of depression|subsyndromic symptoms of depression
941005|NCT03538873|Subsyndromic symptoms of anxiety|subsyndromic symptoms of anxiety
941006|NCT03538873|Elderly|elderly
941007|NCT03538873|Physical activity|physical activity
941008|NCT03538873|Population-based study|population-based study
941009|NCT03538860|Telepsychiatry|telepsychiatry
941010|NCT03538860|AsynchronousTelepsychiatry|asynchronoustelepsychiatry
941011|NCT03538860|Automated Translation|automated translation
941012|NCT03538847|postoperative pain|postoperative pain
941013|NCT03538847|eye surgery|eye surgery
941014|NCT03538847|vitrectomy|vitrectomy
941015|NCT03538847|pain control protocol|pain control protocol
941016|NCT03538795|stroke|stroke
941017|NCT03538795|hemiplegia|hemiplegia
941018|NCT03538795|hemiparesis|hemiparesis
941019|NCT03538795|arm|arm
941020|NCT03538795|upper-extremity|upper-extremity
941021|NCT03538795|motor impairment|motor impairment
941022|NCT03538795|TMS|tms
941024|NCT03538795|neuroplasticity|neuroplasticity
941025|NCT03538782|percutaneous biliary drainage|percutaneous biliary drainage
941026|NCT03538782|radiation exposure|radiation exposure
941027|NCT03538756|Balance|balance
941028|NCT03538756|Peripheral Neuropathy|peripheral neuropathy
941029|NCT03538756|Neuropathy|neuropathy
941030|NCT03538743|Type 2 diabetes mellitus|type 2 diabetes mellitus
941031|NCT03538717|Axitinib,|axitinib,
941032|NCT03538717|Renal Carcinoma,|renal carcinoma,
941033|NCT03538717|Long responders|long responders
941034|NCT03538704|Endometrial cancer|endometrial cancer
941035|NCT03538704|Atypical hyperplasia|atypical hyperplasia
941036|NCT03538704|Fertility-preserving|fertility-preserving
941037|NCT03538704|Remission time|remission time
941038|NCT03538704|Recurrence|recurrence
941039|NCT03538704|Pregnancy|pregnancy
941040|NCT03538704|Progesterone receptor|progesterone receptor
941041|NCT03538691|Brexpiprazole|brexpiprazole
941091|NCT03538418|Wearable technology|wearable technology
941092|NCT03538418|Physical activity|physical activity
941093|NCT03538418|Behaviour change|behaviour change
941094|NCT03538405|harmonic techniques|harmonic techniques
941095|NCT03538405|supporting cushions|supporting cushions
941096|NCT03538405|intervention|intervention
941097|NCT03538379|Tourniquets|tourniquets
941098|NCT03538379|Bleeding Control Basic (B-Con) Course|bleeding control basic (b-con) course
941099|NCT03538379|Layperson training|layperson training
941100|NCT03538366|Ulcerative Colitis|ulcerative colitis
941101|NCT03538366|Inflammatory bowel disease|inflammatory bowel disease
941102|NCT03538366|Pouchitis|pouchitis
941103|NCT03538366|Fecal microbiota transplant|fecal microbiota transplant
941104|NCT03538366|Fecal microbiota treatment|fecal microbiota treatment
941105|NCT03538340|Thoracotomy|thoracotomy
941106|NCT03538340|Cryoanalgesia|cryoanalgesia
941107|NCT03538340|Pain|pain
941108|NCT03538327|essential hypertension|essential hypertension
941109|NCT03538327|insulin resistance|insulin resistance
941110|NCT03538327|silybin|silybin
941111|NCT03538262|SURE-PD3|sure-pd3
941112|NCT03538262|STEADY-PD III|steady-pd iii
941113|NCT03538262|Parkinson disease|parkinson disease
941114|NCT03538262|PD|pd
941115|NCT03538262|Parkinson Study Group (PSG)|parkinson study group (psg)
941116|NCT03538262|Telemedicine|telemedicine
941117|NCT03538262|Smartphone|smartphone
941118|NCT03538262|Disease progression|disease progression
941119|NCT03538262|Televisits|televisits
941120|NCT03538262|Patient-reported outcomes|patient-reported outcomes
941121|NCT03538249|Heart Failure|heart failure
941122|NCT03538249|Aerobic Exercise|aerobic exercise
941123|NCT03538249|Respiratory Muscle Training|respiratory muscle training
941124|NCT03538249|Strength Training|strength training
941125|NCT03538223|Music listening|music listening
941126|NCT03538223|Radiotherapy|radiotherapy
941127|NCT03538223|Breast cancer|breast cancer
941128|NCT03538223|Psychological rehabilitation|psychological rehabilitation
941129|NCT03538210|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis
941130|NCT03538197|suicide attempt|suicide attempt
941131|NCT03538197|suicide re attempt|suicide re attempt
941132|NCT03538158|Older adults|older adults
941133|NCT03538158|Physical well-being|physical well-being
941134|NCT03538158|Quality of life|quality of life
941135|NCT03538119|Cardiac Rehabilitation|cardiac rehabilitation
941136|NCT03538119|High Intensity Interval Training|high intensity interval training
942024|NCT03532113|Transfer|transfer
941137|NCT03538119|Exercise-based Rehabilitation|exercise-based rehabilitation
941138|NCT03538119|Secondary prevention|secondary prevention
941139|NCT03538119|Sedentary Behavior|sedentary behavior
941140|NCT03538106|Cesrean delivery|cesrean delivery
941141|NCT03538106|Risks factors|risks factors
941142|NCT03538106|Diabetes Type 1|diabetes type 1
941143|NCT03538093|arthrodesis|arthrodesis
941144|NCT03538093|core stabilization|core stabilization
941145|NCT03538093|physical therapy|physical therapy
941146|NCT03538080|venous disease|venous disease
941147|NCT03538080|peripheral vascular disease|peripheral vascular disease
941148|NCT03538080|vascular surgery|vascular surgery
941149|NCT03538080|ultrasound imaging|ultrasound imaging
941150|NCT03538067|percutaneous coronary intervention|percutaneous coronary intervention
941151|NCT03538067|stent apposition|stent apposition
941152|NCT03538067|stent deployment|stent deployment
941153|NCT03538067|stent expansion|stent expansion
941154|NCT03538067|intravascular ultrasound|intravascular ultrasound
941155|NCT03538054|Fibromyalgia|fibromyalgia
941156|NCT03538041|autoimmune hemolytic anemia|autoimmune hemolytic anemia
941157|NCT03538041|phosphatidylinositol 3-kinase (PI3K) inhibitor|phosphatidylinositol 3-kinase (pi3k) inhibitor
941158|NCT03538028|lymphocyte activation gene (LAG)|lymphocyte activation gene (lag)
941159|NCT03538028|LAG-3|lag-3
941160|NCT03538028|advanced solid tumor|advanced solid tumor
941161|NCT03538028|metastatic solid tumor|metastatic solid tumor
941162|NCT03538028|relapsed/refractory DLCBL|relapsed/refractory dlcbl
941163|NCT03538015|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
941164|NCT03538015|β-blocker|β-blocker
941165|NCT03538002|blue light filtering spectacle lens|blue light filtering spectacle lens
941578|NCT03535285|orthodontic|orthodontic
941166|NCT03537989|fluid therapy|fluid therapy
941167|NCT03537989|Restricted fluid therapy|restricted fluid therapy
941168|NCT03537989|saline|saline
941169|NCT03537963|HCT survivors|hct survivors
941170|NCT03537963|hematopoietic stem cell transplant (HCT)|hematopoietic stem cell transplant (hct)
941171|NCT03537963|survivors of hematopoietic stem cell transplant|survivors of hematopoietic stem cell transplant
941172|NCT03537950|Cannabidiol|cannabidiol
941173|NCT03537950|Cannabidivarin|cannabidivarin
941174|NCT03537950|E-I balance|e-i balance
941175|NCT03537950|pharmacological imaging|pharmacological imaging
941176|NCT03537924|healthy participants older than 40 years|healthy participants older than 40 years
941177|NCT03537924|right heart function during exercise|right heart function during exercise
941178|NCT03537924|prevention|prevention
941179|NCT03537924|acetazolamide|acetazolamide
941180|NCT03537898|balanced crystalloid|balanced crystalloid
941181|NCT03537898|crystalloid|crystalloid
941182|NCT03537898|isotonic|isotonic
941183|NCT03537898|acetate|acetate
941184|NCT03537898|non-acetate|non-acetate
941185|NCT03537898|lactated Ringer's|lactated ringer's
941186|NCT03537898|Normosol|normosol
941187|NCT03537859|hospitalized child|hospitalized child
941188|NCT03537859|salivary cortisol|salivary cortisol
941189|NCT03537859|augmented reality|augmented reality
941190|NCT03537807|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
941191|NCT03537807|ALS|als
941192|NCT03537807|Lou Gehrig Disease|lou gehrig disease
941193|NCT03537807|Lou Gehrig's Disease|lou gehrig's disease
941194|NCT03537807|Lou-Gehrigs Disease|lou-gehrigs disease
941195|NCT03537807|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
941196|NCT03537807|Riluzole|riluzole
941197|NCT03537807|Rilutek®|rilutek®
941198|NCT03537807|Sublingual|sublingual
941199|NCT03537807|Oral formulation|oral formulation
941200|NCT03537807|Neuroprotective Agents|neuroprotective agents
941201|NCT03537807|Administration, Sublingual|administration, sublingual
941202|NCT03537807|Administration, Oral|administration, oral
941203|NCT03537807|Biological Availability|biological availability
941204|NCT03537781|food choice, food labels|food choice, food labels
941205|NCT03537742|Heart Transplant|heart transplant
941206|NCT03537729|Alzheimer's disease|alzheimer's disease
941207|NCT03537729|Age related memory disorders|age related memory disorders
941208|NCT03537729|Environment design|environment design
941209|NCT03537729|Long term care|long term care
941210|NCT03537729|Dementia|dementia
941211|NCT03537716|Abdominal Fat|abdominal fat
941212|NCT03537703|Transcranial Direct Current Stimulation|transcranial direct current stimulation
941213|NCT03537703|tDCS|tdcs
941214|NCT03537703|Auditory Processing|auditory processing
941215|NCT03537703|tone matching|tone matching
941216|NCT03537664|Periapical Periodontitis|periapical periodontitis
941217|NCT03537664|Bacterial Infections|bacterial infections
941218|NCT03537664|Root Canal Preparation|root canal preparation
941219|NCT03537664|Calcium Hydroxide|calcium hydroxide
941220|NCT03537664|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
941221|NCT03537664|RNA-Directed DNA Polymerase|rna-directed dna polymerase
941222|NCT03537638|Lupus|lupus
941223|NCT03537638|Quality of life|quality of life
941224|NCT03537638|Multicomponent intervention|multicomponent intervention
941225|NCT03537638|Clinical Practice Guideline|clinical practice guideline
941226|NCT03537638|Computerized clinical decision support system|computerized clinical decision support system
941227|NCT03537638|Activity|activity
941228|NCT03537612|Post-operative pain|post-operative pain
941229|NCT03537573|Pragmatic clinical trial|pragmatic clinical trial
941230|NCT03537573|Primary care|primary care
941231|NCT03537573|Provider-targeted|provider-targeted
941232|NCT03537573|Behavioral intervention|behavioral intervention
941233|NCT03537573|Electronic health record|electronic health record
941234|NCT03537547|treatment naive|treatment naive
941235|NCT03537547|major depression|major depression
941236|NCT03537547|pharmacotherapy|pharmacotherapy
941237|NCT03537547|pharmacogenomic|pharmacogenomic
941238|NCT03537547|genomics|genomics
941239|NCT03537521|severe bleeding|severe bleeding
941240|NCT03537521|dabigatran|dabigatran
941241|NCT03537521|rivaroxaban|rivaroxaban
941242|NCT03537521|apixaban|apixaban
941243|NCT03537521|edoxaban|edoxaban
941245|NCT03537521|aPCC|apcc
941246|NCT03537521|rVIIa|rviia
941247|NCT03537521|hemodialysis|hemodialysis
941248|NCT03537521|antidots|antidots
941249|NCT03537521|idarucizumab|idarucizumab
941250|NCT03537521|urgent surgery|urgent surgery
941251|NCT03537521|andexanet alpha|andexanet alpha
941252|NCT03537508|Meningococcal meningitis|meningococcal meningitis
941253|NCT03537508|MenACYW conjugate vaccine|menacyw conjugate vaccine
941254|NCT03537508|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
941255|NCT03537495|tuberculous meningitis|tuberculous meningitis
941256|NCT03537495|linezolid|linezolid
941257|NCT03537495|pharmacokinetic study|pharmacokinetic study
941258|NCT03537456|Dermal Filler|dermal filler
941259|NCT03537456|Hyaluronic Acid|hyaluronic acid
941260|NCT03537443|Childhood|childhood
941261|NCT03537443|Vitamin D|vitamin d
941262|NCT03537443|Bone mineral density|bone mineral density
941263|NCT03537443|Bone mineral content|bone mineral content
941264|NCT03537430|Postoperative pain|postoperative pain
941265|NCT03537430|Tubeless Uniportal Video-assisted Thoracoscopic Surgery|tubeless uniportal video-assisted thoracoscopic surgery
941266|NCT03537430|Hospital costs|hospital costs
941267|NCT03537404|hepatitis C|hepatitis c
941268|NCT03537404|chronic|chronic
941269|NCT03537404|pharmacokinetics|pharmacokinetics
941270|NCT03537404|HIV|hiv
941271|NCT03537404|coinfection|coinfection
941272|NCT03537404|concomitant therapy|concomitant therapy
941273|NCT03537391|prostate cancer|prostate cancer
941274|NCT03537391|imaging of prostate cancer|imaging of prostate cancer
941275|NCT03537391|staging of prostate cancer|staging of prostate cancer
941276|NCT03537391|prostate specific membrane antigen (PSMA)|prostate specific membrane antigen (psma)
1630031|NCT00283465|neoplasm|neoplasm
941277|NCT03537391|positron emission tomography|positron emission tomography
941278|NCT03537391|bone scintigraphy|bone scintigraphy
941279|NCT03537391|whole body magnetic resonance imaging|whole body magnetic resonance imaging
941280|NCT03537391|whole body computer tomography|whole body computer tomography
941281|NCT03537391|single photon emission tomography (SPECT)|single photon emission tomography (spect)
941282|NCT03537378|Hybrid APC,Early Central Lung Cancer,|hybrid apc,early central lung cancer,
941283|NCT03537365|Human Milk Fortification|human milk fortification
941284|NCT03537365|Bovine Colostrum|bovine colostrum
941285|NCT03537365|Very Preterm Infants|very preterm infants
941286|NCT03537365|Enteral feeding|enteral feeding
941287|NCT03537365|Human Milk|human milk
941288|NCT03537365|Neonatology|neonatology
941289|NCT03537365|Colostrum|colostrum
941290|NCT03537326|doping|doping
941291|NCT03537261|Parent Training|parent training
941292|NCT03537261|Aggressive Behavior|aggressive behavior
941293|NCT03537235|Libramed|libramed
941294|NCT03537235|Policaptil Gel retard|policaptil gel retard
941295|NCT03537235|Overweigth|overweigth
941296|NCT03537235|Obesity|obesity
941297|NCT03537235|Medical Device|medical device
941298|NCT03537235|glycemic profile|glycemic profile
941299|NCT03537235|incretin|incretin
941300|NCT03537222|quality of life|quality of life
941301|NCT03537222|psychometrics|psychometrics
941302|NCT03537196|People who inject drugs|people who inject drugs
941303|NCT03537196|Hepatitis C|hepatitis c
941304|NCT03537196|Direct Acting Antiviral|direct acting antiviral
941305|NCT03537196|HCV Elimination|hcv elimination
941306|NCT03537196|Vietnam|vietnam
941307|NCT03537183|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
941308|NCT03537183|exercise training|exercise training
941309|NCT03537183|PCWP|pcwp
941310|NCT03537157|Crohn Disease recurrence|crohn disease recurrence
941311|NCT03537144|Patent ductus arteriosus|patent ductus arteriosus
941312|NCT03537144|acetaminophen|acetaminophen
941313|NCT03537144|indomethacin|indomethacin
941314|NCT03537131|diabetes|diabetes
941315|NCT03537131|dapagliflozin|dapagliflozin
941316|NCT03537131|exercise|exercise
941317|NCT03537131|hypoglycemia|hypoglycemia
941318|NCT03537105|cytokine|cytokine
941319|NCT03537105|skin inflammation|skin inflammation
941320|NCT03537079|hypoxia|hypoxia
941321|NCT03537079|exercise training|exercise training
941322|NCT03537079|heart failure|heart failure
941323|NCT03537079|cardiac remodeling|cardiac remodeling
941324|NCT03537053|Sedentary Lifestyle|sedentary lifestyle
941325|NCT03537027|vitamin D3|vitamin d3
941326|NCT03537027|cholecalciferol|cholecalciferol
941327|NCT03537027|calcidiol|calcidiol
941328|NCT03537027|25-hydroxyvitamin D|25-hydroxyvitamin d
941329|NCT03537027|gene expression|gene expression
941330|NCT03537027|vitamin D receptor|vitamin d receptor
941331|NCT03537027|adults|adults
941332|NCT03537027|clinical trial|clinical trial
941333|NCT03537001|Methoxyflurane|methoxyflurane
941334|NCT03537001|Penthrox|penthrox
941335|NCT03537001|anesthetic|anesthetic
941336|NCT03537001|analgesia|analgesia
941337|NCT03537001|acute|acute
941338|NCT03537001|traumatic|traumatic
941339|NCT03537001|pain|pain
941340|NCT03537001|prehospital setting|prehospital setting
941341|NCT03537001|visual numeric scale|visual numeric scale
941342|NCT03536988|Ulcerative Colitiis|ulcerative colitiis
941343|NCT03536988|Ileal pouch anal anastomosis|ileal pouch anal anastomosis
941344|NCT03536988|Transanal Minimally Invasive Surgery|transanal minimally invasive surgery
941345|NCT03536988|Postoperative Outcome|postoperative outcome
941346|NCT03536975|Dementia|dementia
941347|NCT03536975|Mild Dementia|mild dementia
941348|NCT03536975|Cognitive Impairment|cognitive impairment
941349|NCT03536923|Female|female
941350|NCT03536910|copeptin levels|copeptin levels
941351|NCT03536910|Cesarean section|cesarean section
941352|NCT03536910|general anesthesia|general anesthesia
941353|NCT03536910|spinal anesthesia|spinal anesthesia
941354|NCT03536897|breast cancer|breast cancer
941355|NCT03536897|invasive ductal carcinoma|invasive ductal carcinoma
941356|NCT03536897|intraoperative radiation therapy|intraoperative radiation therapy
941357|NCT03536897|iort|iort
941358|NCT03536884|Bimekizumab|bimekizumab
941359|NCT03536884|PSO|pso
941360|NCT03536884|Psoriasis|psoriasis
941361|NCT03536858|End Stage Renal Disease|end stage renal disease
941362|NCT03536858|Hemodialysis|hemodialysis
941363|NCT03536858|Social Network|social network
941364|NCT03536832|Cesarean Section; Complications|cesarean section; complications
941365|NCT03536832|suture material|suture material
941366|NCT03536806|Pharmacological cardioversion|pharmacological cardioversion
941367|NCT03536806|Canrenone|canrenone
941368|NCT03536793|Early detection of pancreatic cancer|early detection of pancreatic cancer
941369|NCT03536793|Endo180|endo180
941370|NCT03536793|Urinary tissue factor|urinary tissue factor
941371|NCT03536728|DFMO|dfmo
941372|NCT03536728|AMXT 1501|amxt 1501
941373|NCT03536689|Amniotic fluid index|amniotic fluid index
941374|NCT03536676|Breakfast|breakfast
941375|NCT03536676|Obesity|obesity
941376|NCT03536676|Mood|mood
941377|NCT03536676|Eating Behavior|eating behavior
941378|NCT03536676|Cognitive Function|cognitive function
941379|NCT03536650|Metabolic diseases|metabolic diseases
941380|NCT03536624|prevention|prevention
941381|NCT03536624|biomarkers|biomarkers
941382|NCT03536624|stress|stress
941383|NCT03536624|burn out|burn out
941384|NCT03536624|occupation|occupation
941385|NCT03536624|work|work
941386|NCT03536624|spa bath|spa bath
941387|NCT03536611|dabigatran|dabigatran
941388|NCT03536611|warfarin|warfarin
941389|NCT03536611|non-valve atrial fibrillation|non-valve atrial fibrillation
941390|NCT03536611|percutaneous coronary intervention|percutaneous coronary intervention
941391|NCT03536572|Sleep Apnea Syndromes|sleep apnea syndromes
941392|NCT03536572|Chronic Disease|chronic disease
941393|NCT03536572|Adherence|adherence
941394|NCT03536572|Self-Care|self-care
941395|NCT03536572|Patient Outcomes|patient outcomes
941396|NCT03536559|gold|gold
941397|NCT03536559|nanocrystal|nanocrystal
941398|NCT03536559|multifocal visual evoked potential|multifocal visual evoked potential
941399|NCT03536559|full field visual evoked potential|full field visual evoked potential
941400|NCT03536559|low contrast vision|low contrast vision
941401|NCT03536559|low contrast letter acuity|low contrast letter acuity
941402|NCT03536559|remyelination|remyelination
941403|NCT03536559|demyelination|demyelination
941404|NCT03536546|Veterans Health|veterans health
941405|NCT03536546|Intervention, Brief|intervention, brief
941406|NCT03536546|Peer|peer
941407|NCT03536520|healthy participants older than 40 years|healthy participants older than 40 years
941408|NCT03536520|cognition|cognition
941409|NCT03536520|visuo-motor learning performance|visuo-motor learning performance
941410|NCT03536520|prevention|prevention
941411|NCT03536520|acetazolamide|acetazolamide
941412|NCT03536507|healthy participants older than 40 years|healthy participants older than 40 years
941413|NCT03536507|sleep disordered breathing|sleep disordered breathing
941414|NCT03536507|periodic breathing|periodic breathing
941415|NCT03536507|prevention|prevention
941416|NCT03536507|acetazolamide|acetazolamide
941417|NCT03536494|Overactive bladder|overactive bladder
941418|NCT03536494|Mirabegron|mirabegron
941419|NCT03536494|Deprescribing|deprescribing
941420|NCT03536494|Persistence|persistence
941421|NCT03536494|Patient-Centered Care|patient-centered care
941422|NCT03536494|Inappropriate prescribing|inappropriate prescribing
941423|NCT03536468|Tooth loss, edentulousness, psychology, oral health-related|tooth loss, edentulousness, psychology, oral health-related
941424|NCT03536455|healthy participants older than 40 years|healthy participants older than 40 years
941425|NCT03536455|exercise performance|exercise performance
941426|NCT03536455|prevention|prevention
941427|NCT03536455|acetazolamide|acetazolamide
941428|NCT03536442|antenatal|antenatal
941429|NCT03536442|postpartum|postpartum
941431|NCT03536429|healthy participants older than 40 years|healthy participants older than 40 years
941433|NCT03536429|prevention|prevention
941434|NCT03536429|acetazolamide|acetazolamide
941435|NCT03536416|Self-management|self-management
941436|NCT03536416|Children and young people|children and young people
941437|NCT03536416|Schools|schools
941438|NCT03536377|Diabetes Mellitus Remission|diabetes mellitus remission
941439|NCT03536377|Prediabetic State|prediabetic state
941440|NCT03536377|caloric restriction|caloric restriction
941441|NCT03536377|weight loss|weight loss
941442|NCT03536377|diet|diet
941443|NCT03536377|Barbados|barbados
941444|NCT03536351|social skills|social skills
941445|NCT03536351|child|child
941446|NCT03536351|theory of mind|theory of mind
941447|NCT03536351|drama|drama
941448|NCT03536351|occupational therapy|occupational therapy
941449|NCT03536351|speech-language pathology|speech-language pathology
941450|NCT03536351|neural activation|neural activation
941451|NCT03536338|Sit-to-stand; Spinal Stimulation; transcutaneous|sit-to-stand; spinal stimulation; transcutaneous
941452|NCT03536299|Physical therapy|physical therapy
941453|NCT03536299|Gait training|gait training
941454|NCT03536299|Cognitive-motor interference|cognitive-motor interference
941455|NCT03536299|Rehabilitation|rehabilitation
941456|NCT03536273|sedentary|sedentary
941457|NCT03536273|pilates exercises|pilates exercises
941458|NCT03536273|functional movement screen|functional movement screen
941459|NCT03536273|posture|posture
941460|NCT03536273|quality of life|quality of life
941461|NCT03536247|bile duct stones|bile duct stones
941462|NCT03536247|choledocholithiasis|choledocholithiasis
941463|NCT03536247|ERCP|ercp
941464|NCT03536247|endoscopic retrograde cholangiopancreatograhy|endoscopic retrograde cholangiopancreatograhy
941465|NCT03536195|renal replacement therapy|renal replacement therapy
941466|NCT03536195|acute renal failure|acute renal failure
941467|NCT03536195|coagulation|coagulation
941468|NCT03536195|bleeding|bleeding
941469|NCT03536156|Dental implant|dental implant
941470|NCT03536156|Implant Emergence Profile|implant emergence profile
941471|NCT03536130|chest tube, lung resection, air leakage|chest tube, lung resection, air leakage
941472|NCT03536078|home phototherapy|home phototherapy
941473|NCT03536078|parental bonding|parental bonding
941474|NCT03536039|CNS lymphoma|cns lymphoma
941475|NCT03536039|BBB permeabilization|bbb permeabilization
941476|NCT03536039|R-CHOP|r-chop
941477|NCT03536039|TNF|tnf
941478|NCT03536000|Cardiac function|cardiac function
941479|NCT03536000|Fetal|fetal
941480|NCT03536000|Strain|strain
941481|NCT03535935|Chinese medicine|chinese medicine
941482|NCT03535935|Astragalus|astragalus
941483|NCT03535935|Pragmatic trial|pragmatic trial
941484|NCT03535922|Hemodialysis|hemodialysis
941485|NCT03535922|Chronic Kidney Disease|chronic kidney disease
941486|NCT03535909|CHF|chf
941487|NCT03535909|central venous pressure|central venous pressure
941488|NCT03535909|noninvasive|noninvasive
941489|NCT03535909|ADHF|adhf
941490|NCT03535909|stroke volume|stroke volume
941491|NCT03535857|overactive bladder|overactive bladder
941492|NCT03535857|OAB|oab
941493|NCT03535857|urge urinary incontinence|urge urinary incontinence
941494|NCT03535857|PTNS|ptns
941495|NCT03535844|Wolfberry (Goji berry)|wolfberry (goji berry)
941496|NCT03535844|Healthy diet|healthy diet
941497|NCT03535844|Cardiovascular diseases|cardiovascular diseases
941498|NCT03535844|Endothelial function|endothelial function
941499|NCT03535844|Lipidomics|lipidomics
941500|NCT03535844|Middle-aged and older adults|middle-aged and older adults
941501|NCT03535844|Oxidative stress|oxidative stress
941502|NCT03535844|Inflammation|inflammation
941503|NCT03535805|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
941504|NCT03535805|Children and Adolescents|children and adolescents
941505|NCT03535805|Community Health Care|community health care
941506|NCT03535805|Early Intervention|early intervention
941507|NCT03535740|Drug Therapy|drug therapy
941508|NCT03535714|Treatment|treatment
941509|NCT03535714|Psychotherapy|psychotherapy
941510|NCT03535714|Young Adult|young adult
941511|NCT03535714|Adolescence|adolescence
941512|NCT03535688|Chronic Pain|chronic pain
941513|NCT03535688|Low Back Pain|low back pain
941514|NCT03535688|D-cycloserine|d-cycloserine
941515|NCT03535649|Drug therapy|drug therapy
941516|NCT03535636|Polysomnography|polysomnography
941517|NCT03535636|Refugees|refugees
941518|NCT03535623|remote ischemic preconditioning|remote ischemic preconditioning
941519|NCT03535623|free flap reconstruction|free flap reconstruction
941520|NCT03535623|preoperative radiotherapy|preoperative radiotherapy
941521|NCT03535610|Embolization|embolization
941522|NCT03535610|Uterine Leiomyoma|uterine leiomyoma
941523|NCT03535610|Embospheres|embospheres
941524|NCT03535610|Microspheres|microspheres
941525|NCT03535597|Transradial Access|transradial access
941526|NCT03535597|Hemostasis|hemostasis
942025|NCT03532113|Inhibition|inhibition
941543|NCT03535506|Ductal Carcinoma In Situ|ductal carcinoma in situ
941545|NCT03535493|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
941546|NCT03535493|Burnout Syndrome|burnout syndrome
941547|NCT03535493|Float REST|float rest
941548|NCT03535493|Float Therapy|float therapy
941549|NCT03535493|Floatation Restricted Environmental Stimulation Therapy|floatation restricted environmental stimulation therapy
941550|NCT03535480|ovarian reserve|ovarian reserve
941551|NCT03535467|Caregivers|caregivers
941552|NCT03535467|Exoskeleton Device|exoskeleton device
941553|NCT03535467|Stroke Rehabilitation|stroke rehabilitation
941554|NCT03535454|Fibromyalgia|fibromyalgia
941555|NCT03535454|Musculoskeletal Diseases|musculoskeletal diseases
941556|NCT03535454|Work|work
941557|NCT03535441|hemorrhagic shock|hemorrhagic shock
941558|NCT03535441|HMGB1|hmgb1
941559|NCT03535376|Bariatric surgery|bariatric surgery
941560|NCT03535376|Gastrointestinal tract|gastrointestinal tract
941561|NCT03535376|Biological availability|biological availability
941562|NCT03535376|Pharmacokinetics|pharmacokinetics
941563|NCT03535376|Valsartan|valsartan
941564|NCT03535363|Osimertinib|osimertinib
941565|NCT03535350|ibrutinib|ibrutinib
941566|NCT03535350|temozolomide|temozolomide
941567|NCT03535350|brain cancer|brain cancer
941568|NCT03535337|Interventions|interventions
941569|NCT03535337|youth living with HIV|youth living with hiv
941570|NCT03535337|mHealth|mhealth
941571|NCT03535337|ART adherence|art adherence
941572|NCT03535337|adaptive intervention|adaptive intervention
941573|NCT03535337|cell phone|cell phone
941574|NCT03535337|text messaging|text messaging
941575|NCT03535285|periodontal ligament|periodontal ligament
941576|NCT03535285|dentoalveolar|dentoalveolar
941577|NCT03535285|distraction|distraction
941579|NCT03535259|hepatocellular carcinoma|hepatocellular carcinoma
941580|NCT03535259|intensity-modulated radiotherapy|intensity-modulated radiotherapy
941581|NCT03535259|sorafenib|sorafenib
941582|NCT03535259|portal vein thrombosis|portal vein thrombosis
941583|NCT03535259|lymph node metastasis|lymph node metastasis
941584|NCT03535246|immunotherapy|immunotherapy
941585|NCT03535246|T cell|t cell
941586|NCT03535246|Cancer|cancer
941587|NCT03535246|Gene therapy|gene therapy
1333109|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
1333203|NCT01444014|gastric carcinoids|gastric carcinoids
948860|NCT03489317|stool|stool
941588|NCT03535233|Alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, IL-23, TGFβ-1|alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, il-23, tgfβ-1
941589|NCT03535220|Multiple Myeloma|multiple myeloma
941590|NCT03535220|Sickle Cell Disease|sickle cell disease
941591|NCT03535194|Interleukin-23 (IL-23)|interleukin-23 (il-23)
941592|NCT03535168|Healthy volunteers|healthy volunteers
941593|NCT03535155|Ultrasound image, Neuraxial anesthesia, Landmark|ultrasound image, neuraxial anesthesia, landmark
941597|NCT03535090|Graves' Disease|graves' disease
941598|NCT03535090|Graves Ophthalmopathy|graves ophthalmopathy
941599|NCT03535090|Blood Coagulation|blood coagulation
941600|NCT03535090|Venous Thromboembolism|venous thromboembolism
941601|NCT03535090|Methylprednisolone|methylprednisolone
941602|NCT03535077|Melanoma|melanoma
941603|NCT03535077|Nevus|nevus
941604|NCT03535077|Mole|mole
941605|NCT03535077|Atypical Nevi|atypical nevi
941606|NCT03535064|HAND HYGIENE, HAND WASHING, INFLUENZA, SCHOOL ABSENCE, SCHOOL CHILDREN, UPPER RESPIRATORY INFECTIONS|hand hygiene, hand washing, influenza, school absence, school children, upper respiratory infections
941607|NCT03535051|vitiligo|vitiligo
941608|NCT03535051|fractional carbon dioxide laser|fractional carbon dioxide laser
941609|NCT03535051|tacrolimus|tacrolimus
941610|NCT03535051|drug delivery|drug delivery
941611|NCT03535038|Intravascular volume|intravascular volume
941612|NCT03535038|Inferior vena cava diameter|inferior vena cava diameter
941613|NCT03535038|Ultrasonography|ultrasonography
941614|NCT03535038|Vascular Pedicle Width|vascular pedicle width
941615|NCT03535038|Chest x-ray|chest x-ray
941616|NCT03534999|TENS,|tens,
941617|NCT03534999|VAS,|vas,
941618|NCT03534999|Oxford-Hip-score,|oxford-hip-score,
941619|NCT03534999|Hip-arthroplasthy,|hip-arthroplasthy,
941620|NCT03534999|Pain-intensity|pain-intensity
941621|NCT03534973|Cataract|cataract
941622|NCT03534973|Caffeine|caffeine
941623|NCT03534947|Neoadjuvant|neoadjuvant
941624|NCT03534947|Sonidegib|sonidegib
941625|NCT03534934|COPD|copd
941626|NCT03534934|Osteoporosis|osteoporosis
941627|NCT03534921|Diabetes mellitus|diabetes mellitus
941628|NCT03534921|Schizophrenia|schizophrenia
941629|NCT03534921|Schizoaffective disorder|schizoaffective disorder
941630|NCT03534921|Bipolar disorder|bipolar disorder
941631|NCT03534921|Severe mental illness|severe mental illness
941632|NCT03534895|midazolam|midazolam
941633|NCT03534895|ambulatory surgery|ambulatory surgery
941634|NCT03534882|anti-glaucoma medications|anti-glaucoma medications
941635|NCT03534882|glaucoma|glaucoma
941636|NCT03534882|prostaglandin analogues|prostaglandin analogues
941637|NCT03534882|medication washout|medication washout
941638|NCT03534869|auricular acupuncture|auricular acupuncture
941639|NCT03534869|episiotomy|episiotomy
941640|NCT03534869|acupuncture|acupuncture
941641|NCT03534869|pain relief|pain relief
941642|NCT03534869|analgesic therapy|analgesic therapy
941643|NCT03534843|Spontaneous rupture|spontaneous rupture
941644|NCT03534843|survival|survival
941645|NCT03534843|hepatocellular carcinoma|hepatocellular carcinoma
941646|NCT03534843|Child-Pugh|child-pugh
941647|NCT03534843|Albumin-bilirubin|albumin-bilirubin
941648|NCT03534817|Cardiac Rehabilitation|cardiac rehabilitation
941649|NCT03534817|Early Access Cardiac Rehabilitation|early access cardiac rehabilitation
941650|NCT03534817|Cardiac Rehabilitation Adherence|cardiac rehabilitation adherence
941651|NCT03534817|Myocardial Infarction|myocardial infarction
941652|NCT03534817|Ventricular Remodeling|ventricular remodeling
941653|NCT03534765|Laparotomy|laparotomy
941654|NCT03534765|Frailty|frailty
941655|NCT03534765|Sacropenia|sacropenia
941656|NCT03534752|Inborn errors of Metabolism|inborn errors of metabolism
941657|NCT03534752|Adulthood|adulthood
941658|NCT03534752|Clinical characteristics|clinical characteristics
941659|NCT03534739|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
941660|NCT03534739|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
941661|NCT03534739|massage|massage
941662|NCT03534739|hypoalgesia|hypoalgesia
941663|NCT03534713|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
941664|NCT03534713|Cervical Cancer|cervical cancer
941665|NCT03534713|Paraaortic Lymph Node Involvement|paraaortic lymph node involvement
941666|NCT03534713|Carboplatin|carboplatin
941667|NCT03534713|Paclitaxel|paclitaxel
941668|NCT03534700|sacrococcygeal pilonidal disease|sacrococcygeal pilonidal disease
941669|NCT03534687|RAGE|rage
941670|NCT03534687|ADAM10|adam10
941671|NCT03534687|Exercise|exercise
941672|NCT03534687|sRAGE|srage
941673|NCT03534635|metastatic melanoma|metastatic melanoma
941674|NCT03534635|tumor microenvironment|tumor microenvironment
941675|NCT03534635|pembrolizumab|pembrolizumab
941676|NCT03534635|PD1|pd1
941677|NCT03534596|cohort|cohort
941678|NCT03534596|surgery|surgery
941679|NCT03534596|adhesive small bowel obstruction|adhesive small bowel obstruction
941680|NCT03534557|spirometry|spirometry
941681|NCT03534544|artificial pancreas|artificial pancreas
941682|NCT03534544|pediatric|pediatric
941683|NCT03534544|parents|parents
941684|NCT03534544|adherence|adherence
941685|NCT03534505|Inguinal Herniorrhaphy|inguinal herniorrhaphy
941686|NCT03534505|Analgesic Effects of Local Wound|analgesic effects of local wound
941687|NCT03534492|urothelial|urothelial
941688|NCT03534492|bladder cancer|bladder cancer
941689|NCT03534492|olaparib|olaparib
941690|NCT03534492|durvalumab|durvalumab
941691|NCT03534466|treadmill|treadmill
941692|NCT03534466|infants|infants
941693|NCT03534466|neonatal encephalopathy|neonatal encephalopathy
941694|NCT03534466|neonatal brain injury|neonatal brain injury
941695|NCT03534453|ovarian cancer|ovarian cancer
941696|NCT03534453|PARP Inhibitor|parp inhibitor
941697|NCT03534453|Platinum sensitive|platinum sensitive
941698|NCT03534440|Diastolic Dysfunction|diastolic dysfunction
941699|NCT03534440|Anesthesia|anesthesia
941700|NCT03534440|Preoperative assessment|preoperative assessment
941701|NCT03534440|Postoperative care|postoperative care
941702|NCT03534440|TEVAR|tevar
941703|NCT03534427|arterial stiffness|arterial stiffness
941704|NCT03534427|endothelin-1|endothelin-1
941705|NCT03534427|c-reactive protein|c-reactive protein
941706|NCT03534427|adiposity|adiposity
941707|NCT03534427|exercise|exercise
941708|NCT03534427|jump rope|jump rope
941709|NCT03534414|dietary portfolio|dietary portfolio
941710|NCT03534414|plant sterols|plant sterols
941711|NCT03534414|plant protein|plant protein
941712|NCT03534414|viscous fibre|viscous fibre
941713|NCT03534414|nuts|nuts
941714|NCT03534401|Reproductive Coercion|reproductive coercion
941715|NCT03534401|Gender-based violence|gender-based violence
941716|NCT03534401|Contraception|contraception
941717|NCT03534401|Clinic-based screening for IPV|clinic-based screening for ipv
941718|NCT03534401|Clinic-based counseling|clinic-based counseling
941719|NCT03534362|Propel Stent|propel stent
941720|NCT03534362|Nasopore|nasopore
941721|NCT03534349|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
941722|NCT03534349|lower limb flexibility|lower limb flexibility
941723|NCT03534349|performance|performance
941724|NCT03534336|Weight Reduction|weight reduction
941725|NCT03534336|Health Literacy|health literacy
942026|NCT03532113|Updating|updating
941730|NCT03534310|sleeve-gastrectomy|sleeve-gastrectomy
941731|NCT03534310|liraglutide|liraglutide
941732|NCT03534310|Weight-loss|weight-loss
941733|NCT03534297|heart failure|heart failure
941734|NCT03534297|systolic heart failure|systolic heart failure
941735|NCT03534284|Hemodialysis|hemodialysis
941736|NCT03534284|Kidney disease|kidney disease
941737|NCT03534284|Trazodone|trazodone
941738|NCT03534284|Cognitive behavioral therapy|cognitive behavioral therapy
941744|NCT03534219|Earpopper|earpopper
941745|NCT03534219|Prophylaxis|prophylaxis
941746|NCT03534219|Randomized controlled trial|randomized controlled trial
941747|NCT03534167|depression|depression
941748|NCT03534167|anxiety|anxiety
941750|NCT03534167|youth|youth
941751|NCT03534167|Cognitive Behavior Therapy|cognitive behavior therapy
941752|NCT03534141|Hypothermia|hypothermia
941753|NCT03534141|NGAL - Neutrophil Gelatinase-associated Lipocalin|ngal - neutrophil gelatinase-associated lipocalin
941754|NCT03534128|Traumatic Brain Injury|traumatic brain injury
941755|NCT03534128|Spatial navigation|spatial navigation
941756|NCT03534128|Virtual Reality|virtual reality
941757|NCT03534128|Cues|cues
941758|NCT03534115|bleaching, toxicity, NAC|bleaching, toxicity, nac
941759|NCT03534102|Total Hip Arthroplasty|total hip arthroplasty
941760|NCT03534102|Total Knee Arthroplasty|total knee arthroplasty
941761|NCT03534102|Opioid Dependence|opioid dependence
941762|NCT03534102|Opioid Tapering|opioid tapering
941763|NCT03534063|Arthroplasty Surgery|arthroplasty surgery
941764|NCT03534063|Genotype-Guided Pain Management|genotype-guided pain management
941765|NCT03534050|Glioma|glioma
941766|NCT03534050|Low-Grade Glioma (LGG)|low-grade glioma (lgg)
941767|NCT03534050|Neurobehavioral Assessments|neurobehavioral assessments
941768|NCT03534050|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
941769|NCT03534050|Radiation Therapy (RT)|radiation therapy (rt)
941770|NCT03534050|Hippocampus|hippocampus
941771|NCT03534050|Progression-Free Survival (PFS)|progression-free survival (pfs)
941772|NCT03534037|Serum uric acid|serum uric acid
941773|NCT03534037|Metabolic syndrome|metabolic syndrome
941774|NCT03534037|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
941775|NCT03534037|Febuxostat|febuxostat
941776|NCT03534037|Benzbromarone|benzbromarone
941777|NCT03534011|Balloon occlusion|balloon occlusion
941778|NCT03534011|Air ambulances|air ambulances
941779|NCT03534011|Aorta|aorta
941780|NCT03534011|Resuscitation|resuscitation
941781|NCT03533985|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
941782|NCT03533985|Music therapy|music therapy
941783|NCT03533985|Attachment|attachment
941784|NCT03533985|Music medicine|music medicine
941785|NCT03533985|Multi-modal stimulation|multi-modal stimulation
941786|NCT03533959|in-stent neoatherosclerosis|in-stent neoatherosclerosis
941787|NCT03533959|alirocumab|alirocumab
941788|NCT03533933|collagen matrix|collagen matrix
941789|NCT03533933|connective tissue graft|connective tissue graft
941790|NCT03533933|histometry|histometry
941791|NCT03533933|xenograft|xenograft
941792|NCT03533933|periodontal regeneration|periodontal regeneration
941793|NCT03533933|biometry|biometry
941794|NCT03533881|collagen|collagen
941795|NCT03533881|volatile oils|volatile oils
941796|NCT03533881|metabolic syndrome|metabolic syndrome
941797|NCT03533881|insulin resistance|insulin resistance
941798|NCT03533868|Point-of-care|point-of-care
941799|NCT03533868|Viral load monitoring|viral load monitoring
941800|NCT03533868|Nigeria|nigeria
941801|NCT03533829|vaccination|vaccination
941802|NCT03533829|pre-syncope|pre-syncope
941803|NCT03533829|syncope prevention|syncope prevention
941804|NCT03533816|Gamma delta T-cells|gamma delta t-cells
941805|NCT03533816|Hematopoietic Stem Cell Transplantation (HCT)|hematopoietic stem cell transplantation (hct)
941806|NCT03533816|Post-transplant Cyclophosphamide (PTCy)|post-transplant cyclophosphamide (ptcy)
941807|NCT03533816|Expanded/Activated gamma delta (EAGD)|expanded/activated gamma delta (eagd)
941808|NCT03533816|Graft versus host disease (GVHD)|graft versus host disease (gvhd)
941809|NCT03533816|haploidentical|haploidentical
941810|NCT03533764|Asthma Self-Management for Adolescents (ASMA)|asthma self-management for adolescents (asma)
941811|NCT03533764|Community Health Workers (CHW)|community health workers (chw)
941812|NCT03533725|Initiation, Exclusivity, Duration|initiation, exclusivity, duration
941813|NCT03533647|high myopia|high myopia
941814|NCT03533647|ocular biometric parameters|ocular biometric parameters
941815|NCT03533647|adolescent|adolescent
941816|NCT03533647|children|children
941817|NCT03533634|midshaft clavicle fracture|midshaft clavicle fracture
941818|NCT03533634|functional outcome|functional outcome
941819|NCT03533634|anteroinferior plate|anteroinferior plate
941820|NCT03533634|superior plate|superior plate
941821|NCT03533634|reconstruction plate|reconstruction plate
941822|NCT03533608|PTSD|ptsd
941823|NCT03533608|Prolonged Exposure|prolonged exposure
941824|NCT03533608|Group Therapy|group therapy
941825|NCT03533569|pain|pain
941826|NCT03533569|inflammation|inflammation
941827|NCT03533543|Myocardial infarction|myocardial infarction
941828|NCT03533543|New-onset atrial fibrillation|new-onset atrial fibrillation
941829|NCT03533543|Retrospective|retrospective
941830|NCT03533543|Prognosis|prognosis
941831|NCT03533530|Electrical source imaging|electrical source imaging
941832|NCT03533504|pharmacokinetics|pharmacokinetics
941833|NCT03533504|hemophilia|hemophilia
941834|NCT03533504|factor VII|factor vii
941835|NCT03533504|factor IX|factor ix
941836|NCT03533504|population pharmacokinetics|population pharmacokinetics
941837|NCT03533478|Nutritional supplement|nutritional supplement
941838|NCT03533478|Diabetic Macular Edema|diabetic macular edema
941839|NCT03533478|Diabetes|diabetes
941840|NCT03533478|Alzer|alzer
941841|NCT03533478|Oxidative Stress|oxidative stress
941842|NCT03533478|Diamel|diamel
941843|NCT03533400|respiratory therapy|respiratory therapy
941844|NCT03533400|videogaming therapy|videogaming therapy
941845|NCT03533400|incentive spirometry|incentive spirometry
941846|NCT03533374|Accuracy|accuracy
941847|NCT03533374|Inter-ictal EEG Discharges|inter-ictal eeg discharges
941848|NCT03533374|Inter-rater agreement|inter-rater agreement
941849|NCT03533374|Long Term Monitoring|long term monitoring
941850|NCT03533374|Sensitivity|sensitivity
941851|NCT03533374|Sharp transients|sharp transients
941852|NCT03533374|Specificity|specificity
941853|NCT03533374|Source Space|source space
941854|NCT03533374|Voltage maps|voltage maps
941855|NCT03533361|expanded access program|expanded access program
941856|NCT03533361|radioiodine refractory|radioiodine refractory
941857|NCT03533361|differentiated|differentiated
941858|NCT03533361|lenvatinib|lenvatinib
941859|NCT03533335|Oral Hygiene|oral hygiene
941860|NCT03533335|Oral Sprays|oral sprays
941861|NCT03533335|Oral Health|oral health
941862|NCT03533335|Frail Elderly|frail elderly
941863|NCT03533335|Nursing Homes|nursing homes
941864|NCT03533335|Chlorhexidine|chlorhexidine
941865|NCT03533335|Chlorine Dioxide|chlorine dioxide
941866|NCT03533309|horizontal defect, Anterior maxillary|horizontal defect, anterior maxillary
941867|NCT03533244|Hyperemia|hyperemia
941868|NCT03533231|Pulp regeneration, intracanal medication|pulp regeneration, intracanal medication
941869|NCT03533218|endotracheal tube, point of care ultrasound|endotracheal tube, point of care ultrasound
941870|NCT03533179|Glucagon|glucagon
941871|NCT03533179|Beta-adrenergic antagonist|beta-adrenergic antagonist
941872|NCT03533179|poisoning|poisoning
941873|NCT03533166|Peri-implant mucositis|peri-implant mucositis
941874|NCT03533166|Chlorhexidine|chlorhexidine
941875|NCT03533166|CPC|cpc
941876|NCT03533166|Treatment|treatment
941877|NCT03533153|MSC|msc
941878|NCT03533101|Tocilizumab|tocilizumab
941879|NCT03533101|Haploidentical|haploidentical
941880|NCT03533101|Peripheral blood|peripheral blood
941881|NCT03533088|shoulder|shoulder
941882|NCT03533088|rotator cuff|rotator cuff
941883|NCT03533088|scapula|scapula
941884|NCT03533062|OAB , Botox , anticholinergics , quality of life|oab , botox , anticholinergics , quality of life
941885|NCT03533036|Virtual Reality|virtual reality
941886|NCT03533036|Anxiety|anxiety
941887|NCT03533023|Firefighters|firefighters
941888|NCT03533023|San Diego Fire and Rescue|san diego fire and rescue
941889|NCT03533023|Cardiometabolic Health|cardiometabolic health
941890|NCT03533023|First Responder|first responder
941891|NCT03533023|Shift Workers|shift workers
941892|NCT03533010|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
941893|NCT03533010|Bone Health|bone health
941894|NCT03533010|Treatment|treatment
941895|NCT03533010|Vitamin D|vitamin d
941896|NCT03533010|Calcium|calcium
941897|NCT03532971|BK virus|bk virus
941898|NCT03532971|BK polyomavirus|bk polyomavirus
941899|NCT03532971|hematopoietic-cell transplantation|hematopoietic-cell transplantation
941900|NCT03532932|Drug therapy|drug therapy
941901|NCT03532893|COPD incidence|copd incidence
941902|NCT03532893|Decline in FEV1|decline in fev1
941903|NCT03532893|Inflammatory biomarkers|inflammatory biomarkers
941904|NCT03532893|EBC|ebc
941905|NCT03532893|microRNA-23a|microrna-23a
941906|NCT03532880|Olaparib|olaparib
941907|NCT03532880|Radiation therapy|radiation therapy
941908|NCT03532880|18-195|18-195
941909|NCT03532880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
941910|NCT03532867|Exercise Test|exercise test
941911|NCT03532867|Blood Pressure|blood pressure
941912|NCT03532867|Choroid|choroid
941913|NCT03532815|Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial|cardiovascular diseases, framingham risk score, life style modification, randomized controlled trial
941914|NCT03532802|metoprolol|metoprolol
941915|NCT03532802|heart diseases|heart diseases
941916|NCT03532802|cardiovascular diseases|cardiovascular diseases
941917|NCT03532802|ventricular outflow obstruction|ventricular outflow obstruction
941918|NCT03532802|hemodynamics|hemodynamics
941919|NCT03532763|Inflammation|inflammation
941920|NCT03532763|Tocotrienols|tocotrienols
941921|NCT03532763|Cardiovascular disease|cardiovascular disease
941922|NCT03532737|head and neck cancer|head and neck cancer
941923|NCT03532737|check point inhibitor|check point inhibitor
941924|NCT03532737|Pembrolizumab|pembrolizumab
941925|NCT03532737|Chemoradiation|chemoradiation
941926|NCT03532724|Patient Self-management, Acenocoumarol, Warfarin|patient self-management, acenocoumarol, warfarin
941927|NCT03532698|lung cancer|lung cancer
941928|NCT03532698|Aspirin|aspirin
941929|NCT03532698|Osimertinib|osimertinib
941930|NCT03532698|EGFR-TKI|egfr-tki
941931|NCT03532698|resistance|resistance
941932|NCT03532685|Asthma|asthma
941933|NCT03532685|severity|severity
941934|NCT03532685|follow up|follow up
941935|NCT03532685|obesity|obesity
941936|NCT03532685|bariatric surgery|bariatric surgery
941937|NCT03532672|Acute fasting|acute fasting
941938|NCT03532672|Inflammatory response|inflammatory response
941939|NCT03532672|Energy Expenditure|energy expenditure
941940|NCT03532659|adolescents|adolescents
941941|NCT03532659|obesity|obesity
941942|NCT03532659|lung function|lung function
941943|NCT03532659|microcirculation|microcirculation
941944|NCT03532659|intima media thickness|intima media thickness
941945|NCT03532633|infant|infant
941946|NCT03532633|cord|cord
941947|NCT03532633|micronutrients|micronutrients
941948|NCT03532633|purine|purine
941949|NCT03532633|pyrimidine|pyrimidine
941950|NCT03532620|Pitavastatin|pitavastatin
941951|NCT03532620|Prediabetic State|prediabetic state
941952|NCT03532620|Hypertension|hypertension
941953|NCT03532620|Dyslipidemias|dyslipidemias
941954|NCT03532620|Cardiovascular Disease|cardiovascular disease
941955|NCT03532607|Chronic|chronic
941956|NCT03532594|Protamine|protamine
941957|NCT03532594|Heparin Antagonists|heparin antagonists
941958|NCT03532594|Cardiopulmonary Bypass|cardiopulmonary bypass
941959|NCT03532555|zinc|zinc
941960|NCT03532542|Duchenne muscular dystrophy|duchenne muscular dystrophy
941961|NCT03532542|Exon Skipping|exon skipping
941962|NCT03532542|DMD|dmd
941963|NCT03532542|Exon 53|exon 53
941964|NCT03532542|Exon 45|exon 45
941965|NCT03532503|pregnancy termination|pregnancy termination
941966|NCT03532503|second trimester|second trimester
941967|NCT03532503|foley catheter|foley catheter
941968|NCT03532477|Bariatric surgery|bariatric surgery
941969|NCT03532477|Gastrointestinal tract|gastrointestinal tract
941970|NCT03532477|Biological availability|biological availability
941971|NCT03532477|Pharmacokinetics|pharmacokinetics
941972|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride
941973|NCT03532464|Chlamydia Trachomatis|chlamydia trachomatis
941974|NCT03532464|Infection|infection
941975|NCT03532464|Vaginal|vaginal
941976|NCT03532464|Anal|anal
941977|NCT03532451|Muscle-Invasive|muscle-invasive
941978|NCT03532451|Cisplatin-Ineligible|cisplatin-ineligible
941979|NCT03532451|Nivolumab|nivolumab
941980|NCT03532451|Lirilumab|lirilumab
941981|NCT03532412|Polysomnography, Sleep apnea, Central sleep apnea|polysomnography, sleep apnea, central sleep apnea
941982|NCT03532399|Bivalirudin|bivalirudin
941984|NCT03532386|male factor infertility|male factor infertility
941985|NCT03532386|oligoasthenospermia|oligoasthenospermia
949451|NCT03485209|CRC|crc
941986|NCT03532386|vaginal hydrocele|vaginal hydrocele
941987|NCT03532334|19F MRI gas Ventilation|19f mri gas ventilation
941988|NCT03532334|133 XE ventilation Scintigraphy|133 xe ventilation scintigraphy
941989|NCT03532321|Stress|stress
941990|NCT03532321|occupational risks|occupational risks
941991|NCT03532321|hospital organization|hospital organization
941992|NCT03532321|longitudinal|longitudinal
941993|NCT03532308|Fermented Soy|fermented soy
941994|NCT03532269|sleep|sleep
941995|NCT03532269|nightmare|nightmare
941996|NCT03532269|app|app
941997|NCT03532256|Quality Improvement|quality improvement
941998|NCT03532256|Prescription Use|prescription use
941999|NCT03532256|Patient Experience|patient experience
942000|NCT03532256|SMS Messaging|sms messaging
942001|NCT03532256|Crowd Sourcing|crowd sourcing
942002|NCT03532243|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
942003|NCT03532243|inspiratory muscle training|inspiratory muscle training
942004|NCT03532243|Central Drive|central drive
942005|NCT03532230|Chronic Low Back Pain|chronic low back pain
942006|NCT03532230|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
942007|NCT03532204|Oligometastatis|oligometastatis
942008|NCT03532204|SBRT|sbrt
942009|NCT03532191|Quality Improvement|quality improvement
942010|NCT03532191|Healthcare Providers|healthcare providers
942011|NCT03532191|Health Disparity|health disparity
942012|NCT03532178|Electroconvulsive Therapy, Neuromuscular Blockade|electroconvulsive therapy, neuromuscular blockade
942013|NCT03532152|VR|vr
942014|NCT03532152|moderate stress|moderate stress
942015|NCT03532139|Ovarian Cancer|ovarian cancer
942016|NCT03532113|Cognitive intervention|cognitive intervention
942017|NCT03532113|Cognitive training|cognitive training
942018|NCT03532113|Aging|aging
942019|NCT03532113|Working memory|working memory
942020|NCT03532113|Cognitive reserve|cognitive reserve
942021|NCT03532113|Brain imaging|brain imaging
942022|NCT03532113|Brain plasticity|brain plasticity
942023|NCT03532113|Polymorphisms|polymorphisms
942038|NCT03532061|Familial Caregiver|familial caregiver
942039|NCT03532061|Cancer|cancer
942040|NCT03532061|Symptom Management|symptom management
942041|NCT03532061|COPE Principles|cope principles
942042|NCT03532061|Problem-solving Skills Training Program|problem-solving skills training program
942043|NCT03532048|Hispanic|hispanic
942044|NCT03532048|Fathers|fathers
942045|NCT03532048|Child|child
942046|NCT03532048|Obesity Prevention|obesity prevention
942047|NCT03532048|Cultural adaptation|cultural adaptation
942048|NCT03532048|Weight Loss|weight loss
942049|NCT03532009|Heart Failure|heart failure
942050|NCT03532009|Chronic Heart Failure|chronic heart failure
942051|NCT03532009|Hyperkalaemia|hyperkalaemia
942052|NCT03531996|Pulmonary Surfactant|pulmonary surfactant
942053|NCT03531996|Rare Lung Disease|rare lung disease
942054|NCT03531996|Registry|registry
942055|NCT03531983|gamma nail|gamma nail
942056|NCT03531970|inferior alveolar nerve block|inferior alveolar nerve block
942057|NCT03531970|irreversible pulpitis|irreversible pulpitis
942058|NCT03531970|local anesthesia|local anesthesia
942059|NCT03531970|dexamethasone|dexamethasone
942060|NCT03531957|eczema|eczema
942061|NCT03531905|diabetes|diabetes
942062|NCT03531905|cholesterolemia|cholesterolemia
942063|NCT03531905|type 2 diabetes|type 2 diabetes
942064|NCT03531905|LDL-C|ldl-c
942065|NCT03531905|T2D|t2d
942066|NCT03531905|diabetes mellitus|diabetes mellitus
942067|NCT03531892|Ulcerative Colitis|ulcerative colitis
942068|NCT03531892|Inflammatory Bowel Disease, Ulcerative Colitis Type|inflammatory bowel disease, ulcerative colitis type
942069|NCT03531892|Colitis|colitis
942070|NCT03531892|AJM300|ajm300
942082|NCT03531801|Referred pain|referred pain
942083|NCT03531801|pressure algometry|pressure algometry
942084|NCT03531801|pain mapping|pain mapping
942085|NCT03531788|dynamic arm support|dynamic arm support
942086|NCT03531788|mobile arm support|mobile arm support
942087|NCT03531788|rehabilitation|rehabilitation
942088|NCT03531788|occupational therapy|occupational therapy
942089|NCT03531775|upright MRI|upright mri
942090|NCT03531775|COPD with hyperinflation|copd with hyperinflation
942091|NCT03531775|Diaphragmatic weakness|diaphragmatic weakness
942092|NCT03531762|Proton Pump Inhibitor|proton pump inhibitor
942093|NCT03531762|Omeprazole|omeprazole
942094|NCT03531762|Tepotinib|tepotinib
942095|NCT03531762|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
942096|NCT03531762|Pharmacokinetics|pharmacokinetics
942097|NCT03531736|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
942098|NCT03531736|intensity conditioning regimen|intensity conditioning regimen
942099|NCT03531736|17-639|17-639
942100|NCT03531723|external ventricular derivation|external ventricular derivation
942101|NCT03531697|Loteprednol Etabonate|loteprednol etabonate
942102|NCT03531645|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
942103|NCT03531645|Advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas|advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas
942104|NCT03531645|Fulvestrant|fulvestrant
942119|NCT03531554|Fatty acid Oxidation Disorders|fatty acid oxidation disorders
942120|NCT03531554|ketone ester|ketone ester
942121|NCT03531554|VLCAD deficiency|vlcad deficiency
942122|NCT03531541|TENS|tens
942123|NCT03531541|cervical manipulation|cervical manipulation
942124|NCT03531541|pressure pain|pressure pain
942125|NCT03531502|tachycardia|tachycardia
942126|NCT03531502|defibrillator|defibrillator
942127|NCT03531502|arrythmia|arrythmia
942128|NCT03531476|Mindfulness|mindfulness
942129|NCT03531476|Chronic Pain|chronic pain
942130|NCT03531476|Disability|disability
942131|NCT03531476|Quality of Life|quality of life
942132|NCT03531476|Online|online
942133|NCT03531463|Displaced|displaced
942134|NCT03531463|Non-Operative treatment|non-operative treatment
942135|NCT03531463|Reversed Total Shoulder Prosthesis|reversed total shoulder prosthesis
942136|NCT03531450|Gastroparesis|gastroparesis
942137|NCT03531424|Coronary Stenosis|coronary stenosis
942138|NCT03531424|Percutaneous Coronary Intervention|percutaneous coronary intervention
942139|NCT03531424|Stents|stents
942140|NCT03531424|Computed Tomography Angiography|computed tomography angiography
942141|NCT03531424|Augmented Reality|augmented reality
942142|NCT03531385|Behcet's disease|behcet's disease
942143|NCT03531385|Central sensitisation|central sensitisation
942144|NCT03531385|Neuropathic pain|neuropathic pain
942145|NCT03531385|Sleep disturbance|sleep disturbance
942146|NCT03531346|Tear film|tear film
942147|NCT03531346|Tear osmolarity|tear osmolarity
942148|NCT03531346|Contact lenses|contact lenses
942149|NCT03531333|Glioma, intraoperative ultrasound, gross total resection, quality of life|glioma, intraoperative ultrasound, gross total resection, quality of life
942150|NCT03531307|Lactate|lactate
942151|NCT03531307|Ki-67|ki-67
942152|NCT03531307|Mitotic index|mitotic index
942153|NCT03531307|Brain tumor|brain tumor
942154|NCT03531268|Pharmacogenomic Analysis|pharmacogenomic analysis
942155|NCT03531268|Clinical Utility|clinical utility
942156|NCT03531268|Outcomes|outcomes
942157|NCT03531203|soursop|soursop
942158|NCT03531203|supplementation|supplementation
942159|NCT03531203|prehypertension|prehypertension
942160|NCT03531203|uric acid|uric acid
942161|NCT03531203|randomized controlled trial|randomized controlled trial
942162|NCT03531190|Head and neck cancer|head and neck cancer
942163|NCT03531190|wound healing|wound healing
942164|NCT03531190|pre and post-surgical nutrition|pre and post-surgical nutrition
942165|NCT03531190|zinc, arginine, vitamin C, protein, oral supplements|zinc, arginine, vitamin c, protein, oral supplements
942166|NCT03531177|type 2 diabetes|type 2 diabetes
942167|NCT03531177|Ethnicity|ethnicity
942168|NCT03531177|African-caribbean|african-caribbean
942169|NCT03531177|Education|education
942170|NCT03531177|Self-management|self-management
942171|NCT03531164|spinal cord injuries|spinal cord injuries
942172|NCT03531164|kayak|kayak
942173|NCT03531164|trunk control|trunk control
942174|NCT03531138|performance test|performance test
942175|NCT03531138|exercise capacity|exercise capacity
942176|NCT03531138|rehabilitation outcome|rehabilitation outcome
942177|NCT03531138|pulmonary rehabilitation|pulmonary rehabilitation
942178|NCT03531099|Prostate cancer|prostate cancer
942179|NCT03531099|HIFU focal|hifu focal
942180|NCT03531099|adverse effect|adverse effect
942181|NCT03531099|low risk|low risk
942182|NCT03531086|dopamine transporter binding|dopamine transporter binding
942183|NCT03531073|treat to target|treat to target
942184|NCT03531047|progressive|progressive
942185|NCT03531047|cross-linking|cross-linking
942186|NCT03531047|customised|customised
942187|NCT03531047|refractive|refractive
942188|NCT03531034|Blood Pressure Variability|blood pressure variability
942189|NCT03531034|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
942190|NCT03531034|Combined Exercise|combined exercise
942191|NCT03531021|type 1 diabetes|type 1 diabetes
942192|NCT03531021|cardiovascular risk factor|cardiovascular risk factor
942193|NCT03531021|teenager|teenager
942194|NCT03531008|focal;|focal;
942195|NCT03530956|AMPfoot|ampfoot
942196|NCT03530956|dual-task|dual-task
942197|NCT03530956|cognitive performance|cognitive performance
942198|NCT03530956|physical performance|physical performance
942199|NCT03530956|lower-limb prosthesis|lower-limb prosthesis
942200|NCT03530891|anterior mandible fracture|anterior mandible fracture
942201|NCT03530891|surgery computer assisted|surgery computer assisted
1630032|NCT00283465|transfusion|transfusion
949616|NCT03484156|Elderly|elderly
942202|NCT03530865|mandibular molars|mandibular molars
942203|NCT03530865|extra root|extra root
942204|NCT03530865|extra root canal|extra root canal
942205|NCT03530865|root morphology|root morphology
942206|NCT03530865|cbct endodontics|cbct endodontics
942207|NCT03530839|lesser toe deformity|lesser toe deformity
942208|NCT03530839|claw toe|claw toe
942209|NCT03530839|PIP joint|pip joint
942210|NCT03530839|arthrodesis|arthrodesis
942211|NCT03530839|resection arthroplasty|resection arthroplasty
942212|NCT03530813|School|school
942213|NCT03530813|Management|management
942214|NCT03530813|Technology|technology
942215|NCT03530813|Asthma Education|asthma education
942216|NCT03530787|Ginger|ginger
942219|NCT03530774|physical performance battery|physical performance battery
942220|NCT03530774|24-hour dietary recalls|24-hour dietary recalls
942221|NCT03530774|dual-energy X-ray absorptimetry|dual-energy x-ray absorptimetry
942222|NCT03530774|dietary supplement|dietary supplement
942223|NCT03530774|protein|protein
942224|NCT03530735|Fingerprick Autologous Blood|fingerprick autologous blood
942230|NCT03530696|Metastatic Breast Cancer|metastatic breast cancer
942234|NCT03530644|Non-invasive glucose monitoring|non-invasive glucose monitoring
942235|NCT03530605|PCNSL, primary central nervous system lymphoma|pcnsl, primary central nervous system lymphoma
942236|NCT03530579|Diabetes Prevention|diabetes prevention
942238|NCT03530566|obesity|obesity
942239|NCT03530566|very low calorie ketogenic diet|very low calorie ketogenic diet
942240|NCT03530566|Comorbidity|comorbidity
942241|NCT03530566|Bariatric Surgery|bariatric surgery
942242|NCT03530566|weight loss|weight loss
942243|NCT03530527|ERCP|ercp
942244|NCT03530527|Endoscopic ultrasound (EUS) guided biliary drainage|endoscopic ultrasound (eus) guided biliary drainage
942245|NCT03530501|microbiota|microbiota
942246|NCT03530501|obesity|obesity
942247|NCT03530462|episodic memory|episodic memory
942248|NCT03530462|executive control|executive control
942249|NCT03530462|fMRI|fmri
942250|NCT03530436|Bioavailability|bioavailability
942251|NCT03530436|Pharmacokinetics|pharmacokinetics
942252|NCT03530436|Curcumin|curcumin
942253|NCT03530436|Demethoxycurcumin|demethoxycurcumin
942254|NCT03530436|Bisdemethoxycurcumin|bisdemethoxycurcumin
942255|NCT03530397|Advanced solid tumors|advanced solid tumors
942256|NCT03530397|MEDI5752|medi5752
942257|NCT03530397|durvalumab|durvalumab
942258|NCT03530397|immuno-oncology|immuno-oncology
942259|NCT03530397|Cancer|cancer
942260|NCT03530397|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
942261|NCT03530397|PD-1|pd-1
942262|NCT03530397|CTLA-4|ctla-4
942263|NCT03530397|Bispecific|bispecific
942264|NCT03530397|Chemotherapy|chemotherapy
942265|NCT03530397|Pemetrexed|pemetrexed
942266|NCT03530397|Carboplatin|carboplatin
942267|NCT03530397|Pembrolizumab|pembrolizumab
942268|NCT03530358|Muscle Synergies|muscle synergies
942269|NCT03530358|MRI|mri
942270|NCT03530358|Virtual Reality|virtual reality
942271|NCT03530358|Robotics|robotics
942272|NCT03530345|Neridronic Acid|neridronic acid
942273|NCT03530345|Neridronate|neridronate
942274|NCT03530345|CRPS|crps
942275|NCT03530345|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
942276|NCT03530332|Preterm Birth|preterm birth
942277|NCT03530332|Prematurity Prevention Clinic|prematurity prevention clinic
942278|NCT03530332|Maternal-Fetal Medicine|maternal-fetal medicine
942279|NCT03530319|Mycoplasma pneumoniae|mycoplasma pneumoniae
942280|NCT03530319|Macrolide-resistance|macrolide-resistance
942281|NCT03530319|Children|children
942282|NCT03530280|pregabalin|pregabalin
942283|NCT03530280|adductor canal block|adductor canal block
942284|NCT03530280|postoperative pain|postoperative pain
942289|NCT03530254|Endometrial receptivity|endometrial receptivity
942290|NCT03530254|Preimplantation Genetic Diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
942291|NCT03530254|Preimplantation Genetic Testing for Aneuploidy (PGT-A)|preimplantation genetic testing for aneuploidy (pgt-a)
942292|NCT03530254|Embryo Transfer (ET)|embryo transfer (et)
942293|NCT03530254|Endometrial Receptivity Analysis (ERA)|endometrial receptivity analysis (era)
942294|NCT03530254|Endometrial Diagnosis|endometrial diagnosis
942295|NCT03530254|Live Newborn Rate (LBR)|live newborn rate (lbr)
942296|NCT03530241|fluorescence|fluorescence
942297|NCT03530241|cholangiography|cholangiography
942298|NCT03530241|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
942299|NCT03530215|Cardiotoxicity|cardiotoxicity
942300|NCT03530215|Antineoplastic and immunomodulating agents|antineoplastic and immunomodulating agents
942301|NCT03530202|muscle thickness|muscle thickness
942302|NCT03530202|strength|strength
942303|NCT03530202|power|power
942304|NCT03530202|functionality|functionality
942305|NCT03530189|Hyperglycemia;|hyperglycemia;
942306|NCT03530189|Hypoglycemia;|hypoglycemia;
942307|NCT03530189|Neurodevelopment;|neurodevelopment;
942308|NCT03530189|Prematurity|prematurity
942309|NCT03530163|Exercise|exercise
942310|NCT03530163|Aerobic|aerobic
1631721|NCT00277524|Pacemaker|pacemaker
942311|NCT03530163|Cognitive Function|cognitive function
942312|NCT03530150|Burns|burns
942313|NCT03530150|Partial-thickness burn wounds|partial-thickness burn wounds
942314|NCT03530150|Re-epithelization|re-epithelization
942315|NCT03530150|Second-Degree Wound|second-degree wound
942316|NCT03530150|Pirfenidone|pirfenidone
942317|NCT03530150|Wound Healing|wound healing
942318|NCT03530137|homelessness|homelessness
942319|NCT03530137|homeless children|homeless children
942320|NCT03530137|homeless families|homeless families
942321|NCT03530124|apnea following vaccination|apnea following vaccination
942322|NCT03530111|Adipose tissue|adipose tissue
942323|NCT03530111|Adipose turnover|adipose turnover
942324|NCT03530111|Adipose kinetics|adipose kinetics
942325|NCT03530111|Exercise|exercise
942326|NCT03530111|Deuterium|deuterium
942327|NCT03530098|Age Determination by Skeleton|age determination by skeleton
942328|NCT03530098|Machine Learning|machine learning
942329|NCT03530098|Deep Learning|deep learning
942330|NCT03530098|Artificial Intelligence|artificial intelligence
942331|NCT03530098|Prospective|prospective
942332|NCT03530098|Clinical Validation|clinical validation
942333|NCT03530059|Home-based training program|home-based training program
942334|NCT03530020|monolithic zirconia|monolithic zirconia
942335|NCT03530020|tooth wear|tooth wear
942336|NCT03530020|all ceramic crown|all ceramic crown
942337|NCT03529981|mindfulness, awareness|mindfulness, awareness
942338|NCT03529968|esophageal adenocarcinoma|esophageal adenocarcinoma
942339|NCT03529968|staging|staging
942340|NCT03529968|CT|ct
942341|NCT03529968|PET-CT|pet-ct
942342|NCT03529968|EUS|eus
942343|NCT03529955|dermatomyositis|dermatomyositis
942344|NCT03529955|apremilast|apremilast
942345|NCT03529955|recalcitrant cutaneous disease|recalcitrant cutaneous disease
942346|NCT03529942|Osteoarthritis|osteoarthritis
942347|NCT03529942|Knee|knee
942348|NCT03529942|Pain|pain
942349|NCT03529942|Intra-articular|intra-articular
942350|NCT03529942|Injection|injection
942351|NCT03529942|Corticosteroid|corticosteroid
942352|NCT03529929|glucocorticoids|glucocorticoids
942353|NCT03529929|aging|aging
942354|NCT03529929|NFKB|nfkb
942355|NCT03529929|Medrol|medrol
942356|NCT03529929|methylprednisolone|methylprednisolone
942357|NCT03529903|behavior change|behavior change
942358|NCT03529903|health coaching|health coaching
942359|NCT03529903|wearable activity tracker|wearable activity tracker
942360|NCT03529903|text messaging|text messaging
942361|NCT03529903|lifestyle-related chronic diseases|lifestyle-related chronic diseases
942362|NCT03529890|locally advanced urothelial carcinoma|locally advanced urothelial carcinoma
942363|NCT03529890|immunotherapy|immunotherapy
942364|NCT03529890|cystectomy|cystectomy
942365|NCT03529890|radiation|radiation
942366|NCT03529890|nivolumab|nivolumab
942367|NCT03529877|Epidermolysis Bullosa|epidermolysis bullosa
942368|NCT03529877|Epidermolysis Bullosa Dystrophica|epidermolysis bullosa dystrophica
942369|NCT03529877|Skin Abnormalities|skin abnormalities
942370|NCT03529877|Congenital Abnormalities|congenital abnormalities
942371|NCT03529877|Skin Diseases, Genetic|skin diseases, genetic
942372|NCT03529877|Somatic Cell Therapy|somatic cell therapy
942373|NCT03529877|Mesenchymal Stem Cells|mesenchymal stem cells
942374|NCT03529877|ABCB5|abcb5
942375|NCT03529877|Allogeneic|allogeneic
942376|NCT03529851|Patient reported outcomes|patient reported outcomes
942377|NCT03529851|Symptom monitoring|symptom monitoring
942378|NCT03529851|Follow-up|follow-up
942379|NCT03529838|Combined Exercise|combined exercise
942380|NCT03529838|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
942381|NCT03529838|Blood analysis|blood analysis
942382|NCT03529838|Salivary analysis|salivary analysis
942383|NCT03529838|Heart rate variability|heart rate variability
942384|NCT03529825|Rifaximin|rifaximin
942385|NCT03529825|Microbiome|microbiome
942386|NCT03529825|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
942387|NCT03529825|Blood stream infections|blood stream infections
942388|NCT03529825|Acute graft versus host disease|acute graft versus host disease
942389|NCT03529812|Behavioral intervention|behavioral intervention
942390|NCT03529812|Social intervention|social intervention
942391|NCT03529799|mTBI|mtbi
942392|NCT03529799|TBI|tbi
942393|NCT03529799|brain injury|brain injury
942394|NCT03529799|concussion|concussion
942395|NCT03529786|Hunter Syndrome|hunter syndrome
942396|NCT03529786|Natural History|natural history
942397|NCT03529786|Iduronate-2-sulfatase|iduronate-2-sulfatase
942398|NCT03529786|glycosaminoglycans|glycosaminoglycans
942399|NCT03529773|Respiratory tract infections, RSV, vaccine|respiratory tract infections, rsv, vaccine
942400|NCT03529760|Leukemia, occult hepatitis B virus infection|leukemia, occult hepatitis b virus infection
942401|NCT03529734|Anticipatory postural adjustments|anticipatory postural adjustments
942402|NCT03529734|Trunk muscles reflex responses|trunk muscles reflex responses
942403|NCT03529734|Sitting balance|sitting balance
942404|NCT03529734|Kinesthesia|kinesthesia
942405|NCT03529695|obesity|obesity
1632061|NCT00275951|Combination|combination
942406|NCT03529695|childhood obesity|childhood obesity
942407|NCT03529695|maternal and child health|maternal and child health
942408|NCT03529695|health disparities|health disparities
942409|NCT03529695|prevention|prevention
942410|NCT03529695|low-income|low-income
942411|NCT03529695|social network|social network
942412|NCT03529695|home environment|home environment
942413|NCT03529682|Circuit Exercise|circuit exercise
942414|NCT03529682|Trunk Control|trunk control
942415|NCT03529682|Functional Strength Training|functional strength training
942416|NCT03529669|Cancer|cancer
942417|NCT03529669|Oesophageal Cancer|oesophageal cancer
942418|NCT03529669|Gastrointestinal|gastrointestinal
942419|NCT03529656|Liver transplantation|liver transplantation
942420|NCT03529656|rehabilitation|rehabilitation
942421|NCT03529656|ICU acquired weakness|icu acquired weakness
942422|NCT03529604|Oral Cancer|oral cancer
942523|NCT03529084|EGF816|egf816
942423|NCT03529604|Potentially Malignant Oral Disorders|potentially malignant oral disorders
942424|NCT03529604|Saliva|saliva
942532|NCT03529032|methadone|methadone
942425|NCT03529604|Squamous cell carcinoma antigen 1|squamous cell carcinoma antigen 1
942426|NCT03529604|Squamous cell carcinoma antigen 2|squamous cell carcinoma antigen 2
942427|NCT03529604|Trophoblast cell surface antigen|trophoblast cell surface antigen
942428|NCT03529604|Diadenosine tetraphosphate|diadenosine tetraphosphate
942429|NCT03529578|Pressure Ulcer, Decubitus Ulcer|pressure ulcer, decubitus ulcer
942430|NCT03529539|neuroendocrine disease of the pancreas.|neuroendocrine disease of the pancreas.
942431|NCT03529500|dental caries|dental caries
942432|NCT03529500|saliva|saliva
942433|NCT03529500|child|child
942434|NCT03529461|severe obesity|severe obesity
942435|NCT03529461|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
942436|NCT03529461|endoscopy|endoscopy
942437|NCT03529461|hypoxia|hypoxia
942438|NCT03529461|bariatric surgery|bariatric surgery
942439|NCT03529461|sedation|sedation
942440|NCT03529461|adverse events|adverse events
942441|NCT03529461|BMI|bmi
942442|NCT03529461|anesthesia|anesthesia
942443|NCT03529461|complications|complications
942444|NCT03529448|Glioblastoma|glioblastoma
942445|NCT03529435|Posttraumatic Stress Disorder|posttraumatic stress disorder
942446|NCT03529435|PTSD|ptsd
942447|NCT03529435|Post-Traumatic Stress|post-traumatic stress
942448|NCT03529435|Trauma and Stressor Related Disorders|trauma and stressor related disorders
942449|NCT03529435|Trauma|trauma
942450|NCT03529435|Combat|combat
942451|NCT03529435|Military|military
942452|NCT03529435|Veterans|veterans
942453|NCT03529435|Prolonged Exposure|prolonged exposure
942454|NCT03529435|Exposure Therapy|exposure therapy
942455|NCT03529435|Behavior Therapy|behavior therapy
942456|NCT03529435|Psychological Treatment|psychological treatment
942457|NCT03529435|Psychotherapy|psychotherapy
942458|NCT03529422|Head and Neck|head and neck
942459|NCT03529422|Larynx|larynx
942460|NCT03529422|Lip|lip
942461|NCT03529422|Oral Cancer|oral cancer
942462|NCT03529409|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
942463|NCT03529409|Substance Use|substance use
942464|NCT03529409|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
942465|NCT03529409|Immune System Diseases|immune system diseases
942466|NCT03529409|Behavioral Symptoms|behavioral symptoms
942467|NCT03529409|RNA Virus Infections|rna virus infections
942468|NCT03529409|HIV Infections|hiv infections
942469|NCT03529409|Alcohol Use|alcohol use
942470|NCT03529409|Drug Use|drug use
942471|NCT03529396|G6PD deficiency|g6pd deficiency
942472|NCT03529396|Acute hemolytic anemia|acute hemolytic anemia
942473|NCT03529396|Vivax malaria|vivax malaria
942474|NCT03529396|Primaquine|primaquine
942475|NCT03529396|Weekly primaquine|weekly primaquine
942476|NCT03529396|Chloroquine|chloroquine
942477|NCT03529396|Weekly chloroquine|weekly chloroquine
942478|NCT03529396|Brazilian Amazon|brazilian amazon
942479|NCT03529396|Oxidative stress|oxidative stress
942480|NCT03529383|Localized breast cancer|localized breast cancer
942481|NCT03529383|Exercise|exercise
942482|NCT03529383|Adapted physical activity|adapted physical activity
942483|NCT03529383|Sedentary|sedentary
942484|NCT03529383|Connected device|connected device
942485|NCT03529383|Activity trackers|activity trackers
942486|NCT03529383|Therapeutic education|therapeutic education
942487|NCT03529383|Obesity|obesity
942488|NCT03529357|Biological Age|biological age
942489|NCT03529357|Motivation|motivation
942490|NCT03529331|Pain Medications, Analgesia, Emergency Medicine|pain medications, analgesia, emergency medicine
942491|NCT03529305|Stroke|stroke
942492|NCT03529305|rTMS|rtms
942493|NCT03529305|MRI|mri
942494|NCT03529253|Alirocumab|alirocumab
942495|NCT03529253|NIRS-IVUS|nirs-ivus
942496|NCT03529253|LCBI|lcbi
942497|NCT03529240|kinesiology taping|kinesiology taping
942498|NCT03529240|performance|performance
942499|NCT03529240|energy consumption|energy consumption
942500|NCT03529240|gait|gait
942501|NCT03529240|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
942502|NCT03529227|chlorambucil|chlorambucil
942503|NCT03529227|obinutuzumab|obinutuzumab
942504|NCT03529214|Quality Improvement|quality improvement
942505|NCT03529214|Program Evaluation|program evaluation
942506|NCT03529214|Quality Assurance|quality assurance
942507|NCT03529214|Feasibility|feasibility
942508|NCT03529214|Acceptability|acceptability
942509|NCT03529188|Diabetes type 1|diabetes type 1
942510|NCT03529188|Child ans teenager|child ans teenager
942511|NCT03529188|Fear of Hypoglycaemia|fear of hypoglycaemia
942512|NCT03529162|Biceps Tendinitis|biceps tendinitis
942513|NCT03529162|Subpectoral biceps tenodesis|subpectoral biceps tenodesis
942514|NCT03529162|Biceps tendon disorder|biceps tendon disorder
942515|NCT03529136|Mesenchymal Stem Cell|mesenchymal stem cell
942516|NCT03529136|MSC|msc
942517|NCT03529110|Breast Cancer|breast cancer
942518|NCT03529110|Metastatic breast cancer|metastatic breast cancer
942519|NCT03529110|DS-8201a|ds-8201a
942520|NCT03529084|Non small cell lung cancer|non small cell lung cancer
942521|NCT03529084|NSCLC|nsclc
942522|NCT03529084|EGFR mutation|egfr mutation
942529|NCT03529045|VNS|vns
942530|NCT03529045|VNS Therapy|vns therapy
942531|NCT03529045|Vagus Nerve Stimulation|vagus nerve stimulation
942533|NCT03529032|postoperative pain|postoperative pain
942534|NCT03529032|acute pain therapy|acute pain therapy
942535|NCT03529032|postoperative pain therapy|postoperative pain therapy
942536|NCT03529019|Enhanced Recovery After Surgery Protocol|enhanced recovery after surgery protocol
942537|NCT03529006|bioresorbable vascular scaffold|bioresorbable vascular scaffold
942538|NCT03529006|drug eluting balloon|drug eluting balloon
942539|NCT03528993|stroke, hippotherapy, balance, postural control, gait|stroke, hippotherapy, balance, postural control, gait
942540|NCT03528980|fertility|fertility
942541|NCT03528980|bariatric surgery|bariatric surgery
942542|NCT03528954|Emergence agitation|emergence agitation
942543|NCT03528954|Propofol|propofol
942544|NCT03528954|General anesthesia|general anesthesia
942545|NCT03528941|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
942546|NCT03528941|Hepatitis B|hepatitis b
942547|NCT03528941|Ibrutinib|ibrutinib
942548|NCT03528928|pelvic floor|pelvic floor
942549|NCT03528928|electrical stimulation|electrical stimulation
942550|NCT03528928|bladder|bladder
942551|NCT03528928|ultrasound|ultrasound
942552|NCT03528915|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's
942553|NCT03528876|gastric cancer|gastric cancer
942554|NCT03528876|esophageal cancer|esophageal cancer
942555|NCT03528876|adnocarcinoma|adnocarcinoma
942556|NCT03528876|FOLFIRI|folfiri
942557|NCT03528876|FOLFOX|folfox
942558|NCT03528876|Metastatic cancer|metastatic cancer
942559|NCT03528811|Diabetes|diabetes
942560|NCT03528811|Peripheral Vascular Disease|peripheral vascular disease
942561|NCT03528811|Microcirculation|microcirculation
942562|NCT03528785|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
942563|NCT03528785|Liposomial IrinoTecan|liposomial irinotecan
942564|NCT03528785|nal-IRI|nal-iri
942565|NCT03528785|Resectable pancreatic cancer|resectable pancreatic cancer
942566|NCT03528772|anal fissure, minoxidil, glycreyl trinitrate|anal fissure, minoxidil, glycreyl trinitrate
942567|NCT03528746|Patellar tendinopathy|patellar tendinopathy
942568|NCT03528720|Tomography, Optical Coherence|tomography, optical coherence
942569|NCT03528720|Fluorescein Angiography|fluorescein angiography
942570|NCT03528720|Fundus photographs|fundus photographs
942578|NCT03528655|separation care|separation care
942579|NCT03528655|rooming-in care|rooming-in care
942580|NCT03528655|patient decision aid|patient decision aid
942581|NCT03528629|pharmacokinetics|pharmacokinetics
942582|NCT03528629|tolerability|tolerability
942583|NCT03528629|safety|safety
942584|NCT03528629|ASP8951|asp8951
942585|NCT03528629|immunogenicity|immunogenicity
942586|NCT03528603|platelet, aggregation, phenolic, olive oil, oleocanthal|platelet, aggregation, phenolic, olive oil, oleocanthal
942587|NCT03528590|laryngeal mask airway|laryngeal mask airway
942588|NCT03528590|breast surgery|breast surgery
942589|NCT03528564|Preoperative Anemia|preoperative anemia
942590|NCT03528564|Intravenous Iron|intravenous iron
942591|NCT03528564|Erythropoietin|erythropoietin
942592|NCT03528538|Fenugreek|fenugreek
942593|NCT03528538|Aging Male Symptoms|aging male symptoms
942594|NCT03528538|Testosterone|testosterone
942595|NCT03528538|Supplementation|supplementation
942596|NCT03528538|Double Blind|double blind
942597|NCT03528538|Body Composition|body composition
942598|NCT03528525|Diseases|diseases
942599|NCT03528525|Children|children
942600|NCT03528525|Respiratory|respiratory
942601|NCT03528525|Monogenic diseases|monogenic diseases
942602|NCT03528525|China|china
942603|NCT03528512|Pediatric|pediatric
942604|NCT03528512|analgesia|analgesia
942605|NCT03528512|pain control|pain control
942606|NCT03528512|sedation|sedation
942607|NCT03528512|intranasal ketamine|intranasal ketamine
942608|NCT03528512|intranasal midazolam|intranasal midazolam
942609|NCT03528512|intranasal fentanyl|intranasal fentanyl
942610|NCT03528499|Scapula|scapula
942611|NCT03528499|Physical Therapy|physical therapy
942612|NCT03528499|Movement|movement
942613|NCT03528499|Rehabilitation|rehabilitation
942614|NCT03528460|Parkinson Disease|parkinson disease
942615|NCT03528460|Deep Brain Stimulation|deep brain stimulation
942616|NCT03528460|Subthalamic Nucleus|subthalamic nucleus
942617|NCT03528460|Predictive factors|predictive factors
942618|NCT03528447|lung transplantation|lung transplantation
942619|NCT03528447|cognition|cognition
942620|NCT03528447|MOCA|moca
942621|NCT03528447|exercise|exercise
942622|NCT03528447|pulmonary rehabilitation|pulmonary rehabilitation
942623|NCT03528434|Zinc|zinc
942624|NCT03528421|CAR-T|car-t
942625|NCT03528395|Balance|balance
942626|NCT03528395|Baropodometry|baropodometry
942627|NCT03528395|Video games|video games
942628|NCT03528395|Virtual reality|virtual reality
942629|NCT03528343|appendicitis|appendicitis
942630|NCT03528343|postoperative pain|postoperative pain
942631|NCT03528343|patient satisfaction|patient satisfaction
942632|NCT03528343|children|children
942633|NCT03528343|pediatric|pediatric
942634|NCT03528343|narcotic|narcotic
942635|NCT03528343|pain control|pain control
942636|NCT03528304|Obesity|obesity
942637|NCT03528304|Overweight|overweight
942638|NCT03528304|Current smoker|current smoker
943345|NCT03524209|fusion|fusion
942639|NCT03528304|American Indian/Alaska Native|american indian/alaska native
942640|NCT03528291|Human,|human,
942641|NCT03528291|adult,|adult,
942642|NCT03528291|intensive care unit,|intensive care unit,
942643|NCT03528291|cardiogenic shock,|cardiogenic shock,
942644|NCT03528291|Transient circulatory support,|transient circulatory support,
942645|NCT03528291|extra corporeal life support|extra corporeal life support
942646|NCT03528291|Impella|impella
942647|NCT03528265|lateral flow immunoassay|lateral flow immunoassay
942648|NCT03528265|validation|validation
942649|NCT03528252|cholesterol|cholesterol
942650|NCT03528252|LDL cholesterol|ldl cholesterol
942651|NCT03528252|Triglycerides|triglycerides
942652|NCT03528252|Diet|diet
942653|NCT03528252|Food|food
942654|NCT03528252|Lipoproteins|lipoproteins
942655|NCT03528226|Type 1 diabetes|type 1 diabetes
942656|NCT03528226|endothelial function|endothelial function
942657|NCT03528226|exercise training|exercise training
942658|NCT03528226|physical activity|physical activity
942659|NCT03528213|sepsis|sepsis
942660|NCT03528213|fluid balance|fluid balance
942661|NCT03528213|metabolism|metabolism
942662|NCT03528213|ischemia-reperfusion|ischemia-reperfusion
942663|NCT03528213|treatment|treatment
942664|NCT03528161|hypersensitive troponin|hypersensitive troponin
942665|NCT03528161|risk of serious adverse events|risk of serious adverse events
942666|NCT03528161|emergency|emergency
942667|NCT03528148|Post stroke|post stroke
942668|NCT03528148|Gait|gait
942669|NCT03528148|Elliptical cross bike.|elliptical cross bike.
942670|NCT03528148|Postural control|postural control
942671|NCT03528148|Balance|balance
942672|NCT03528122|amniotic membrane|amniotic membrane
942673|NCT03528122|retinal detachment|retinal detachment
942674|NCT03528122|Myopic|myopic
942675|NCT03528122|macular hole|macular hole
942676|NCT03528122|internal limiting membrane|internal limiting membrane
942677|NCT03528083|Bronchiolitis|bronchiolitis
942678|NCT03528083|Children|children
942679|NCT03528083|Hospital|hospital
942680|NCT03528070|Sarcoidosis|sarcoidosis
942681|NCT03528070|Tranilast|tranilast
942682|NCT03528070|skin|skin
942683|NCT03528070|lung|lung
942684|NCT03528057|Kidney|kidney
942685|NCT03528044|Bariatric surgery|bariatric surgery
942686|NCT03528044|Reward|reward
942687|NCT03528044|Cognition|cognition
942688|NCT03528044|Working memory|working memory
942689|NCT03528044|Grey matter|grey matter
942690|NCT03528044|GLP-1|glp-1
942691|NCT03528044|Inflammation|inflammation
942692|NCT03528044|Stress|stress
942693|NCT03528044|Follow-up|follow-up
942694|NCT03528044|Psychiatric|psychiatric
942695|NCT03528018|Virtual Reality|virtual reality
942696|NCT03528018|Rehabilitation|rehabilitation
942697|NCT03528018|Physical therapy|physical therapy
942698|NCT03528005|Integrated Health Care Systems|integrated health care systems
942699|NCT03528005|Multimorbid|multimorbid
942700|NCT03528005|Multi-domain intervention|multi-domain intervention
942701|NCT03528005|Clinical Trials, Randomized|clinical trials, randomized
942702|NCT03527992|Randomized Therapeutic trial|randomized therapeutic trial
942703|NCT03527992|Hypoxemic pneumonia|hypoxemic pneumonia
942704|NCT03527992|Automated oxygen therapy|automated oxygen therapy
942705|NCT03527992|Length of stay|length of stay
942706|NCT03527992|medico-economic cost|medico-economic cost
942707|NCT03527953|bulk-fill restorative resins, dental caries|bulk-fill restorative resins, dental caries
942708|NCT03527927|COPD|copd
942709|NCT03527914|Depression|depression
942710|NCT03527914|Psychosis|psychosis
942711|NCT03527914|Personality Disorder|personality disorder
942712|NCT03527914|Substance Abuse|substance abuse
942713|NCT03527901|aggressive periodontitis|aggressive periodontitis
942714|NCT03527901|healthy peri-implant|healthy peri-implant
942715|NCT03527901|chairside test|chairside test
942716|NCT03527901|chronic periodontitis|chronic periodontitis
942717|NCT03527849|Osteoarthritis|osteoarthritis
942718|NCT03527849|Knee Osteoarthritis|knee osteoarthritis
942719|NCT03527849|Knee Pain|knee pain
942720|NCT03527823|Fertilization in Vitro|fertilization in vitro
942721|NCT03527823|Granulosa Cells|granulosa cells
942722|NCT03527823|Apoptosis|apoptosis
942723|NCT03527810|sleeve gastrectomy|sleeve gastrectomy
942724|NCT03527810|hiatal interrogation|hiatal interrogation
942725|NCT03527810|GERD|gerd
942726|NCT03527797|Critical illness associated diaphragm weakness|critical illness associated diaphragm weakness
942727|NCT03527797|Mechanical ventilation|mechanical ventilation
942831|NCT03527264|Stage IIIA|stage iiia
942728|NCT03527797|Critical illness|critical illness
942729|NCT03527797|Respiratory muscle dysfunction|respiratory muscle dysfunction
942730|NCT03527784|rectal adenocarcinoma|rectal adenocarcinoma
942731|NCT03527784|abdominoperineal resection|abdominoperineal resection
942732|NCT03527784|hernia prophylaxis|hernia prophylaxis
942733|NCT03527758|Biomarkers|biomarkers
942734|NCT03527758|Hypotension|hypotension
942735|NCT03527758|Organ Protection|organ protection
942736|NCT03527758|Intraoperative|intraoperative
942737|NCT03527719|Hypertension|hypertension
942738|NCT03527719|Stroke|stroke
942739|NCT03527719|China|china
942740|NCT03527719|Protocol-based treatment|protocol-based treatment
942741|NCT03527693|Knee Chondropathy, Osteoarthritis, Micro-fragmented fat.|knee chondropathy, osteoarthritis, micro-fragmented fat.
942742|NCT03527628|Stage II B Classical Hodgkin Lymphoma|stage ii b classical hodgkin lymphoma
942743|NCT03527628|Stage III Classical Hodgkin Lymphoma|stage iii classical hodgkin lymphoma
942744|NCT03527628|Stage IV Classical Hodgkin Lymphoma|stage iv classical hodgkin lymphoma
942745|NCT03527602|Apical patency|apical patency
942746|NCT03527602|Endodontics|endodontics
942747|NCT03527589|Prostatic Artery Embolization|prostatic artery embolization
942748|NCT03527589|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
942749|NCT03527589|Lower Urinary Tract Symptoms|lower urinary tract symptoms
942752|NCT03527589|LUTS|luts
942753|NCT03527589|Embolization|embolization
942754|NCT03527589|Embolic|embolic
942755|NCT03527589|Embosphere Microsphere|embosphere microsphere
942756|NCT03527563|Hypertension|hypertension
942757|NCT03527550|impulsivity|impulsivity
942758|NCT03527550|Inhibition (Psychology)|inhibition (psychology)
942759|NCT03527550|Working memory|working memory
942760|NCT03527550|Cognitive Remediation|cognitive remediation
942761|NCT03527524|exercise|exercise
942762|NCT03527472|cognitive dysfunction|cognitive dysfunction
942763|NCT03527472|memantine|memantine
942764|NCT03527472|lupus|lupus
942765|NCT03527446|Metabolic flexibility|metabolic flexibility
942766|NCT03527446|Insulin sensitivity|insulin sensitivity
942767|NCT03527446|Sprint interval training|sprint interval training
942768|NCT03527446|Obesity|obesity
942769|NCT03527446|Exercise intensity|exercise intensity
942770|NCT03527433|Incisional hernia|incisional hernia
942771|NCT03527433|Wound infection|wound infection
942772|NCT03527433|Midline laparotomy|midline laparotomy
942773|NCT03527420|Obesity|obesity
942774|NCT03527420|DNA methylation|dna methylation
942775|NCT03527420|Exercise|exercise
942776|NCT03527420|Weight loss|weight loss
942777|NCT03527420|Bariatric|bariatric
942778|NCT03527420|Macrovascular|macrovascular
942779|NCT03527420|Microvascular|microvascular
942780|NCT03527420|Epigenetics|epigenetics
942781|NCT03527420|Adipose tissue|adipose tissue
942782|NCT03527420|Adipocytokines|adipocytokines
942783|NCT03527420|Inflammation|inflammation
942784|NCT03527420|Cardiovascular|cardiovascular
942785|NCT03527394|Obesity|obesity
942786|NCT03527394|Pediatric|pediatric
942787|NCT03527394|Parent|parent
942788|NCT03527394|Family|family
942789|NCT03527394|Motivational Interviewing|motivational interviewing
942790|NCT03527394|Lifestyle|lifestyle
942791|NCT03527394|Health Behavior|health behavior
942792|NCT03527381|Cardiopulmonary Bypass|cardiopulmonary bypass
942793|NCT03527381|Nitric Oxide|nitric oxide
942794|NCT03527381|Kidney Function Tests|kidney function tests
942795|NCT03527381|Renal Insufficiency|renal insufficiency
942796|NCT03527381|Protective Agents|protective agents
942797|NCT03527381|Coronary Artery Bypass|coronary artery bypass
942798|NCT03527381|Cardiac Surgery|cardiac surgery
942799|NCT03527355|Typhoid|typhoid
942800|NCT03527355|Vi-DT|vi-dt
942801|NCT03527355|Conjugate vaccine|conjugate vaccine
942802|NCT03527355|First in human|first in human
942803|NCT03527355|New vaccine|new vaccine
942804|NCT03527329|Prewarming|prewarming
942805|NCT03527329|Tympanic temperature|tympanic temperature
942806|NCT03527303|stress|stress
942807|NCT03527303|health|health
942808|NCT03527303|meditation|meditation
942809|NCT03527303|mindfulness|mindfulness
942810|NCT03527303|employees|employees
942811|NCT03527303|job strain|job strain
942812|NCT03527303|burnout|burnout
942813|NCT03527303|work|work
942814|NCT03527303|mood|mood
942815|NCT03527303|affect|affect
942816|NCT03527303|work related stress|work related stress
942817|NCT03527277|orange juice|orange juice
942818|NCT03527277|sugar-sweetened beverage|sugar-sweetened beverage
942819|NCT03527277|triglyceride|triglyceride
942820|NCT03527277|low density lipoprotein cholesterol|low density lipoprotein cholesterol
942821|NCT03527277|apolipoprotein B|apolipoprotein b
942822|NCT03527277|uric acid|uric acid
942823|NCT03527277|de novo lipogenesis|de novo lipogenesis
942824|NCT03527277|hepatic triglyceride|hepatic triglyceride
942825|NCT03527277|hepatic glucose production|hepatic glucose production
942826|NCT03527277|whole body insulin sensitivity|whole body insulin sensitivity
942827|NCT03527264|cervical cancer|cervical cancer
942828|NCT03527264|Stage IB|stage ib
942829|NCT03527264|Stage IIA|stage iia
942830|NCT03527264|Stage IIB|stage iib
942832|NCT03527264|Stage IIIB|stage iiib
942833|NCT03527264|Stage IVA|stage iva
942834|NCT03527251|clinical trial, phase I|clinical trial, phase i
942835|NCT03527251|CTLA-4 antibody|ctla-4 antibody
942836|NCT03527251|PD-1 antibody|pd-1 antibody
942837|NCT03527251|non-small cell lung cancer|non-small cell lung cancer
942838|NCT03527238|Phenotypic Precision Medicine (PPM)|phenotypic precision medicine (ppm)
942839|NCT03527238|Tacrolimus|tacrolimus
942840|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors
942841|NCT03527225|Music Therapy|music therapy
942842|NCT03527225|First Radiotherapy|first radiotherapy
942843|NCT03527225|Anxiety Reduction|anxiety reduction
943440|NCT03523403|Microbiota|microbiota
942844|NCT03527225|Psychosocial Functioning|psychosocial functioning
942845|NCT03527225|State - Trait Anxiety Inventory (STAI)|state - trait anxiety inventory (stai)
942846|NCT03527225|Symptom Distress Thermometer (SDT)|symptom distress thermometer (sdt)
942847|NCT03527212|Dry Eye Disease|dry eye disease
942848|NCT03527212|Corneal Epithelial Disorders|corneal epithelial disorders
942849|NCT03527212|Re-Epithelialization|re-epithelialization
942850|NCT03527173|Challenge|challenge
942851|NCT03527173|Efficacy|efficacy
942852|NCT03527173|Shigellosis|shigellosis
942853|NCT03527173|Vaccination|vaccination
942854|NCT03527160|AKI|aki
942855|NCT03527160|NGAL|ngal
942856|NCT03527147|Acalabrutinib|acalabrutinib
942857|NCT03527147|CALQUENCE®|calquence®
942858|NCT03527147|ACP-196|acp-196
942859|NCT03527147|Platform study|platform study
942860|NCT03527147|Master protocol|master protocol
942861|NCT03527147|PRISM|prism
942862|NCT03527121|Ankle|ankle
942863|NCT03527121|Exercise|exercise
942864|NCT03527121|Activities of daily living|activities of daily living
942865|NCT03527121|Treatment outcome|treatment outcome
942866|NCT03527108|Non-small cell lung cancer|non-small cell lung cancer
942867|NCT03527108|Immunotherapy|immunotherapy
942868|NCT03527095|Cystic Fibrosis|cystic fibrosis
942869|NCT03527082|mesh|mesh
942870|NCT03527082|erosion|erosion
942871|NCT03527082|transvaginal|transvaginal
942872|NCT03527082|prolapse|prolapse
942873|NCT03527082|laparoscopic|laparoscopic
942874|NCT03527082|tension free tape|tension free tape
942875|NCT03527056|CRE|cre
942876|NCT03527030|Tobacco Use|tobacco use
942877|NCT03527030|IQOS|iqos
942878|NCT03527017|Tobacco Use|tobacco use
942879|NCT03527017|IQOS|iqos
942880|NCT03527004|Tobacco Use|tobacco use
942881|NCT03527004|IQOS|iqos
942882|NCT03526991|Freezing of Gait|freezing of gait
942883|NCT03526991|Locomotion|locomotion
942884|NCT03526991|Spinal cord stimulation|spinal cord stimulation
942885|NCT03526978|Sabin strain|sabin strain
942886|NCT03526978|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
942887|NCT03526978|poliomyelitis|poliomyelitis
942888|NCT03526978|safety|safety
942889|NCT03526978|immunogenicity|immunogenicity
942890|NCT03526978|infant|infant
942891|NCT03526939|Persons who inject drugs|persons who inject drugs
942892|NCT03526939|HIV|hiv
942893|NCT03526939|Hepatitis C|hepatitis c
942894|NCT03526939|Vietnam|vietnam
942895|NCT03526939|Behavioral Intervention|behavioral intervention
942896|NCT03526926|newly-diagnosed t-AML or AML-MRC|newly-diagnosed t-aml or aml-mrc
942897|NCT03526913|chronic leg ulcers, PRP|chronic leg ulcers, prp
942898|NCT03526913|split-thickness skin graft|split-thickness skin graft
942899|NCT03526913|platelet-rich plasma|platelet-rich plasma
942900|NCT03526874|Pain|pain
942901|NCT03526874|Chronic Migraine|chronic migraine
942902|NCT03526874|Episodic Migraine|episodic migraine
942903|NCT03526874|Headache|headache
942904|NCT03526874|Nerve Block|nerve block
942905|NCT03526848|3BNC117|3bnc117
942906|NCT03526848|10-1074|10-1074
942907|NCT03526848|Broadly Neutralizing Antibody|broadly neutralizing antibody
942908|NCT03526835|Bispecific antibody|bispecific antibody
942909|NCT03526835|First-in-human|first-in-human
942910|NCT03526835|MCLA-158|mcla-158
942911|NCT03526835|Antibodies|antibodies
942912|NCT03526835|Bispecific|bispecific
942913|NCT03526835|immunologic factors|immunologic factors
942914|NCT03526835|Cytokines|cytokines
942915|NCT03526835|EGFR|egfr
942916|NCT03526835|LGR5|lgr5
942917|NCT03526809|Magnetic resonance imaging|magnetic resonance imaging
942918|NCT03526796|Pouchitis|pouchitis
942919|NCT03526796|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
942920|NCT03526783|Obesity Surgery|obesity surgery
1633783|NCT00269035|SB-773812|sb-773812
942921|NCT03526783|Failed Sleeve Gastrectomy|failed sleeve gastrectomy
942922|NCT03526783|Roux-en-Y gastric bypass|roux-en-y gastric bypass
942923|NCT03526783|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
942924|NCT03526770|pH of saliva|ph of saliva
942925|NCT03526770|carbonated drink|carbonated drink
942926|NCT03526770|buffering agent|buffering agent
942927|NCT03526770|oral hygiene|oral hygiene
942928|NCT03526757|Postural balance|postural balance
942929|NCT03526757|Pilates method|pilates method
942930|NCT03526757|Elderly|elderly
942931|NCT03526744|Dietary Supplements|dietary supplements
942932|NCT03526744|Fish Proteins|fish proteins
942933|NCT03526744|Protein Hydrolysates|protein hydrolysates
942934|NCT03526744|Aged|aged
942935|NCT03526718|Transmission|transmission
942936|NCT03526718|Genotyping|genotyping
942937|NCT03526718|Risk factors|risk factors
942938|NCT03526692|Mild cognitive impairment|mild cognitive impairment
942939|NCT03526692|Neurofeedback|neurofeedback
942940|NCT03526692|electroencephalography|electroencephalography
942941|NCT03526692|attention|attention
942942|NCT03526692|memory|memory
942943|NCT03526679|soft tissue sarcoma|soft tissue sarcoma
942944|NCT03526679|phase Ib/II|phase ib/ii
942945|NCT03526679|advanced cancer|advanced cancer
942946|NCT03526666|Vitamin C|vitamin c
942947|NCT03526666|Ascorbic Acid|ascorbic acid
942948|NCT03526666|Epigenetics|epigenetics
942949|NCT03526666|5-hydroxymethylcytosine|5-hydroxymethylcytosine
942950|NCT03526666|5-methylcytosine|5-methylcytosine
942951|NCT03526627|advanced care management, advanced heart failure|advanced care management, advanced heart failure
942952|NCT03526601|heart failure|heart failure
942953|NCT03526601|prevalence|prevalence
942954|NCT03526588|CDH|cdh
942955|NCT03526523|Mindfulness based stress reduction|mindfulness based stress reduction
942956|NCT03526523|Perimenopausal depression|perimenopausal depression
942957|NCT03526523|Menopause transition|menopause transition
942958|NCT03526510|High Risk Prostate Cancer|high risk prostate cancer
942959|NCT03526510|Radiotherapy|radiotherapy
942960|NCT03526497|Catheterization, Peripheral/methods|catheterization, peripheral/methods
942961|NCT03526497|Humans|humans
942962|NCT03526497|Acute Disease|acute disease
942963|NCT03526497|Aged|aged
942964|NCT03526497|Female|female
942965|NCT03526497|Male|male
942966|NCT03526497|Follow-Up Studies|follow-up studies
942967|NCT03526497|Heart Failure/physiopathology|heart failure/physiopathology
942968|NCT03526497|Prospective Studies|prospective studies
942969|NCT03526497|Stroke Volume/physiology|stroke volume/physiology
942970|NCT03526497|Venous Pressure/physiology|venous pressure/physiology
942971|NCT03526484|UTI|uti
942972|NCT03526484|Urinalysis|urinalysis
942973|NCT03526484|Urine Culture|urine culture
942974|NCT03526484|Cystoscopy|cystoscopy
942975|NCT03526484|BCG treatment|bcg treatment
942976|NCT03526484|Prostate Biopsy|prostate biopsy
942977|NCT03526471|Left Atrial Appendage|left atrial appendage
942978|NCT03526471|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
942979|NCT03526458|Holmium Laser|holmium laser
942980|NCT03526458|Laser setting|laser setting
942981|NCT03526458|Stone fragmentation|stone fragmentation
942982|NCT03526445|Glucagon|glucagon
942983|NCT03526445|Stable isotope|stable isotope
942984|NCT03526445|Energy expenditure|energy expenditure
942985|NCT03526445|Lipid metabolism|lipid metabolism
942986|NCT03526445|Glucose metabolism|glucose metabolism
942987|NCT03526445|Appetite|appetite
942988|NCT03526419|Liposomal bupivacaine|liposomal bupivacaine
942989|NCT03526419|TAP block|tap block
942990|NCT03526419|cesarean section|cesarean section
942991|NCT03526406|Cognition|cognition
942992|NCT03526406|Mood|mood
942993|NCT03526406|Flavonoid|flavonoid
942994|NCT03526406|Grape Seed|grape seed
942995|NCT03526406|Catechin|catechin
942996|NCT03526406|Epicatechin|epicatechin
942997|NCT03526406|Proanthocyanidin|proanthocyanidin
942998|NCT03526380|Drug overdose|drug overdose
942999|NCT03526380|Substance-Related Disorders|substance-related disorders
943000|NCT03526380|Chemically-Induced Disorders|chemically-induced disorders
943001|NCT03526380|Risk Reduction Behavior|risk reduction behavior
943002|NCT03526380|Harm Reduction|harm reduction
943003|NCT03526354|Schizophrenia|schizophrenia
943004|NCT03526354|Schizoaffective Disorder|schizoaffective disorder
943005|NCT03526354|Substance Use Disorders|substance use disorders
943006|NCT03526354|Alcohol Use Disorder|alcohol use disorder
943007|NCT03526354|Cannabis Use Disorder|cannabis use disorder
943008|NCT03526354|Cocaine Use Disorder|cocaine use disorder
943009|NCT03526354|Heroin Use Disorder|heroin use disorder
943010|NCT03526328|DCLK1|dclk1
943011|NCT03526328|Serum Biomarker|serum biomarker
943012|NCT03526328|Barrett's Esophagus|barrett's esophagus
943013|NCT03526328|Esophageal Adenocarcinoma|esophageal adenocarcinoma
943014|NCT03526328|Tumor Stem Cell Marker|tumor stem cell marker
943015|NCT03526315|CPP-ACP paste|cpp-acp paste
943016|NCT03526315|Fluoride toothpaste|fluoride toothpaste
943017|NCT03526315|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
943018|NCT03526315|MS reduction|ms reduction
943019|NCT03526315|Antibacterial|antibacterial
943020|NCT03526315|Children|children
943021|NCT03526276|Quantitative Laser Fluorescence (QLF)|quantitative laser fluorescence (qlf)
943022|NCT03526276|CPP-ACP paste|cpp-acp paste
943023|NCT03526276|Fluoride toothpaste|fluoride toothpaste
943024|NCT03526276|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
943025|NCT03526276|Primary teeth|primary teeth
943026|NCT03526263|Gastric Mucosal Devitalization|gastric mucosal devitalization
943027|NCT03526263|Obesity|obesity
943028|NCT03526263|Endoscopic Bariatric Therapies|endoscopic bariatric therapies
943029|NCT03526263|Bariatric surgery|bariatric surgery
943030|NCT03526237|diabetes|diabetes
943031|NCT03526237|prevention|prevention
943032|NCT03526237|risk|risk
943033|NCT03526237|obesity|obesity
943034|NCT03526237|weight loss|weight loss
943035|NCT03526237|community based|community based
943036|NCT03526211|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
943037|NCT03526211|Cycloergometer|cycloergometer
943038|NCT03526211|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
943039|NCT03526211|FES Cycling|fes cycling
943040|NCT03526198|Force plate|force plate
943041|NCT03526198|Center of mass|center of mass
943042|NCT03526159|Herlitz|herlitz
943043|NCT03526159|Laminin 332|laminin 332
943044|NCT03526159|Laminin beta 3|laminin beta 3
943045|NCT03526159|JEB|jeb
943046|NCT03526133|sleep apnea|sleep apnea
943047|NCT03526133|polygraph|polygraph
943048|NCT03526133|home sleep apnea test (HSAT)|home sleep apnea test (hsat)
943049|NCT03526133|apnea hypopnea index (AHI)|apnea hypopnea index (ahi)
943050|NCT03526133|oxygen desaturation index (ODI)|oxygen desaturation index (odi)
943051|NCT03526133|portable monitor|portable monitor
943052|NCT03526120|Human subjects|human subjects
943053|NCT03526120|Pistachio snack|pistachio snack
943054|NCT03526120|Body mass index|body mass index
943055|NCT03526120|Energy intake|energy intake
943056|NCT03526120|Fat mass|fat mass
943057|NCT03526107|flavanol|flavanol
943058|NCT03526107|ADME|adme
943059|NCT03526107|polyphenols|polyphenols
943060|NCT03526107|cocoa|cocoa
943061|NCT03526107|epicatechin|epicatechin
943062|NCT03526107|methylxanthine|methylxanthine
943063|NCT03526107|caffeine|caffeine
943064|NCT03526094|flavanol|flavanol
943065|NCT03526094|ADME|adme
943066|NCT03526094|polyphenols|polyphenols
943067|NCT03526094|Cocoa|cocoa
943068|NCT03526094|Banana|banana
943069|NCT03526094|epicatechin|epicatechin
943070|NCT03526081|flavone|flavone
943071|NCT03526081|ADME|adme
943072|NCT03526081|apigenin|apigenin
943073|NCT03526081|parsley|parsley
943074|NCT03526081|chamomile|chamomile
943075|NCT03526081|polyphenols|polyphenols
943076|NCT03526016|Sleep Apnea|sleep apnea
943077|NCT03526016|Acromegaly|acromegaly
943078|NCT03526016|Transsphenoidal surgery|transsphenoidal surgery
943079|NCT03526016|Respiratory polygraphy|respiratory polygraphy
943080|NCT03525964|Individualized treatment|individualized treatment
943081|NCT03525964|Functional outcome|functional outcome
943082|NCT03525847|Contrast endosonograpy|contrast endosonograpy
943083|NCT03525834|TSC|tsc
943084|NCT03525834|tuberous sclerosis complex|tuberous sclerosis complex
943085|NCT03525834|AML|aml
943086|NCT03525834|afinitor|afinitor
943087|NCT03525834|everolimus|everolimus
943088|NCT03525834|RAD001|rad001
943089|NCT03525834|mTOR|mtor
943090|NCT03525834|kidney|kidney
943091|NCT03525834|lymphangioleiomyomatosis|lymphangioleiomyomatosis
943092|NCT03525834|renal angiomyolipoma|renal angiomyolipoma
943093|NCT03525808|Pancreatic necrosis|pancreatic necrosis
943094|NCT03525795|Phase 1/2|phase 1/2
943095|NCT03525795|Oncology|oncology
943096|NCT03525795|EZH2 Inhibitor|ezh2 inhibitor
943097|NCT03525782|CAR-T cell therapy|car-t cell therapy
943098|NCT03525782|MUC+|muc+
943099|NCT03525782|PD-1 Knockout|pd-1 knockout
943100|NCT03525782|Non-small cell lung cancer|non-small cell lung cancer
943101|NCT03525756|cystogram|cystogram
943102|NCT03525756|Foley catheter|foley catheter
943103|NCT03525743|Intubation|intubation
943104|NCT03525730|HIV|hiv
943105|NCT03525730|Latency reversing agents|latency reversing agents
943106|NCT03525730|HDAC inhibitor|hdac inhibitor
943107|NCT03525730|BAF inhibitor|baf inhibitor
943108|NCT03525730|HIV reservoir|hiv reservoir
943109|NCT03525730|HIV cure|hiv cure
943110|NCT03525717|healthy volunteers|healthy volunteers
943111|NCT03525717|metabolism|metabolism
943112|NCT03525717|fat oxidation|fat oxidation
943113|NCT03525717|obesity|obesity
943114|NCT03525717|sleep|sleep
943115|NCT03525678|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
943116|NCT03525678|Antibody-drug conjugate|antibody-drug conjugate
943117|NCT03525678|Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events|patient-reported outcome version of the common term criteria for adverse events
943118|NCT03525678|Quality of Life Questionnaire 20-item Multiple Myeloma module|quality of life questionnaire 20-item multiple myeloma module
943119|NCT03525678|Multiple Myeloma|multiple myeloma
1333204|NCT01444001|Pneumococcal Infections|pneumococcal infections
943120|NCT03525678|Quality of Life Questionnaire 30-item Core module|quality of life questionnaire 30-item core module
943121|NCT03525665|Follicular lymphoma|follicular lymphoma
943122|NCT03525665|FDG-PET|fdg-pet
943123|NCT03525665|Relapse/progression|relapse/progression
943124|NCT03525652|Prostate Cancer|prostate cancer
943125|NCT03525652|Therapeutic vaccine|therapeutic vaccine
943126|NCT03525652|PD-1 knockout|pd-1 knockout
943127|NCT03525639|Cardiac Magnetic Resonance|cardiac magnetic resonance
943128|NCT03525639|Acute Myocarditis|acute myocarditis
943129|NCT03525639|Myocardial Inflammation|myocardial inflammation
943130|NCT03525626|Tic Disorders|tic disorders
943131|NCT03525626|Mindfulness|mindfulness
943132|NCT03525626|Meditation|meditation
943133|NCT03525626|Online|online
943134|NCT03525626|Internet-based|internet-based
943135|NCT03525626|Treatment|treatment
943136|NCT03525587|Quality Improvement|quality improvement
943137|NCT03525587|Quality of Life|quality of life
943425|NCT03523507|Military|military
943138|NCT03525587|Smartphone APP|smartphone app
943139|NCT03525522|Lichen sclerosus|lichen sclerosus
943140|NCT03525522|laser|laser
943141|NCT03525522|Nd:YAG|nd:yag
943142|NCT03525522|randomized controlled trial|randomized controlled trial
943143|NCT03525509|Methadone|methadone
943144|NCT03525509|Morphine|morphine
943145|NCT03525509|Quantitative sensory testing|quantitative sensory testing
943146|NCT03525509|Epidural|epidural
943147|NCT03525496|Iodinated contrast agents|iodinated contrast agents
943148|NCT03525496|Immediate hypersensitivity reactions|immediate hypersensitivity reactions
943149|NCT03525496|Reintroduction tests|reintroduction tests
943150|NCT03525483|ECMO|ecmo
943151|NCT03525483|Acute renal failure|acute renal failure
943152|NCT03525470|Hydration|hydration
943153|NCT03525470|Brain functioning|brain functioning
943154|NCT03525470|Heart-rate variability|heart-rate variability
943155|NCT03525457|Glomerular filtration rate|glomerular filtration rate
943156|NCT03525457|Periodontitis|periodontitis
943157|NCT03525457|Chronic kidney disease|chronic kidney disease
943158|NCT03525431|Exome|exome
943159|NCT03525431|Sequencing|sequencing
943160|NCT03525431|Clinical Utility|clinical utility
943161|NCT03525431|Pediatric|pediatric
943162|NCT03525431|Underrepresented|underrepresented
943163|NCT03525431|Underserved|underserved
943164|NCT03525418|Pediatrics|pediatrics
943165|NCT03525379|Skeletal Muscle Blood Flow|skeletal muscle blood flow
943166|NCT03525379|(calf muscle) targeted exercise|(calf muscle) targeted exercise
943167|NCT03525340|Engagement to care, peer navigation, transgender|engagement to care, peer navigation, transgender
943168|NCT03525327|Dance|dance
943169|NCT03525301|Short Course Radiotherapy|short course radiotherapy
943170|NCT03525301|Symptomatic brain metastases|symptomatic brain metastases
943171|NCT03525262|Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy|erectile dysfunction, neurovascular, prostate, rectal spacer, radiotherapy
943172|NCT03525223|23Na MRI|23na mri
943173|NCT03525197|Muscle Physiology|muscle physiology
943174|NCT03525197|Nutrition|nutrition
943175|NCT03525145|Platelet Reactivity|platelet reactivity
943176|NCT03525145|Thrombotic Events|thrombotic events
943177|NCT03525119|Vaccine|vaccine
943178|NCT03525054|Psychotic Disorders|psychotic disorders
943179|NCT03525054|Diagnosis, Psychiatric|diagnosis, psychiatric
943180|NCT03525054|Schizophrenia Prodromal|schizophrenia prodromal
943181|NCT03525054|Ultra High Risk|ultra high risk
943182|NCT03525054|Prediction Of Psychosis|prediction of psychosis
943183|NCT03525054|Machine Learning|machine learning
943184|NCT03525054|Automated Language Analysis|automated language analysis
943185|NCT03525054|Semantic Coherence|semantic coherence
943186|NCT03525054|Syntaxic Complexity|syntaxic complexity
943187|NCT03524989|hbot|hbot
943188|NCT03524989|hyperbaric oxygen|hyperbaric oxygen
943189|NCT03524989|sport|sport
943190|NCT03524989|mitochondria|mitochondria
943191|NCT03524989|athletes|athletes
943192|NCT03524989|aerobic|aerobic
943193|NCT03524976|endovascular treatment|endovascular treatment
943194|NCT03524976|liquid embolization|liquid embolization
943195|NCT03524950|stress|stress
943196|NCT03524950|dexmedetomidine|dexmedetomidine
943197|NCT03524937|Delirium|delirium
943198|NCT03524937|Mechanical ventilation|mechanical ventilation
943199|NCT03524937|Intensive care unit|intensive care unit
943200|NCT03524937|Prevention|prevention
943201|NCT03524937|Pharmacokinetics|pharmacokinetics
943202|NCT03524937|Melatonin|melatonin
943203|NCT03524924|atrial fibrillation|atrial fibrillation
943204|NCT03524924|elderly|elderly
943205|NCT03524924|edoxaban|edoxaban
943206|NCT03524924|frailty|frailty
943207|NCT03524924|SHARE-FI|share-fi
943208|NCT03524924|Stroke|stroke
943209|NCT03524924|Major bleeding|major bleeding
943210|NCT03524911|Nutrition education|nutrition education
943211|NCT03524911|Evaluation|evaluation
943212|NCT03524911|Child diet|child diet
943213|NCT03524911|EFNEP|efnep
943214|NCT03524898|Nab-Paclitaxel|nab-paclitaxel
943215|NCT03524898|Gemcitabine|gemcitabine
943216|NCT03524898|Advanced soft tissue sarcoma|advanced soft tissue sarcoma
943217|NCT03524898|Cancer|cancer
943218|NCT03524898|Sarcoma|sarcoma
943219|NCT03524898|Abraxane®|abraxane®
943220|NCT03524859|Cystic Fibrosis|cystic fibrosis
943221|NCT03524859|Sit-to-stand|sit-to-stand
943222|NCT03524859|Lung Function|lung function
943223|NCT03524859|Handgrip|handgrip
943224|NCT03524859|Walking Speed|walking speed
943225|NCT03524859|Power|power
943226|NCT03524859|Velocity|velocity
943227|NCT03524859|Gait Speed|gait speed
943228|NCT03524859|Chair rise|chair rise
943229|NCT03524846|Ascorbic acid|ascorbic acid
943230|NCT03524846|hemodialysis vascular access|hemodialysis vascular access
943231|NCT03524846|restenosis|restenosis
943232|NCT03524833|Lansoprazole, Amoxicillin, Metronidazole|lansoprazole, amoxicillin, metronidazole
943233|NCT03524820|cetuximab, colon cancer, RAS|cetuximab, colon cancer, ras
943234|NCT03524807|pelvic floor muscle electrophysiologic therapy|pelvic floor muscle electrophysiologic therapy
943235|NCT03524807|enhanced recovery|enhanced recovery
943236|NCT03524807|muscle soreness|muscle soreness
943237|NCT03524807|postoperative retention of urine|postoperative retention of urine
943238|NCT03524807|Intrauterine Adhesions|intrauterine adhesions
943239|NCT03524807|enhanced recovery after gynecologic surgery|enhanced recovery after gynecologic surgery
943240|NCT03524781|Anti-reflux surgery|anti-reflux surgery
943241|NCT03524781|Proton-pump inhibitors|proton-pump inhibitors
943242|NCT03524781|Upper endoscopy|upper endoscopy
943243|NCT03524768|endothelial function, microvascular|endothelial function, microvascular
943244|NCT03524768|laser speckle contrast imaging|laser speckle contrast imaging
943245|NCT03524768|capillaroscopy, skin|capillaroscopy, skin
943246|NCT03524742|Diet|diet
943247|NCT03524742|Cholesterol|cholesterol
943248|NCT03524729|Rocker bottom shoe|rocker bottom shoe
943249|NCT03524729|Ankle-foot orthosis|ankle-foot orthosis
943250|NCT03524729|Ankle osteoarthritis|ankle osteoarthritis
943251|NCT03524716|physical activity|physical activity
943252|NCT03524716|digital health|digital health
943253|NCT03524716|text messages|text messages
943254|NCT03524716|intervention|intervention
943255|NCT03524716|exercise|exercise
943256|NCT03524716|randomized|randomized
943257|NCT03524716|Fitbit|fitbit
943258|NCT03524703|dysphagia|dysphagia
943259|NCT03524703|anterior cervical fusion|anterior cervical fusion
943260|NCT03524703|chewing gum|chewing gum
943261|NCT03524677|pancreatic cancer|pancreatic cancer
943262|NCT03524677|liquid biopsy|liquid biopsy
943263|NCT03524677|borderline resectable|borderline resectable
943264|NCT03524651|Iron Deficiency Anemia|iron deficiency anemia
943265|NCT03524651|Fe-ASP|fe-asp
943266|NCT03524651|Casein|casein
943267|NCT03524651|Iron protein acetyl aspartylate|iron protein acetyl aspartylate
943268|NCT03524651|Restoration of decreased hemoglobin|restoration of decreased hemoglobin
943269|NCT03524651|Ferrous sulfate|ferrous sulfate
943270|NCT03524612|Thrombocytopenic|thrombocytopenic
943271|NCT03524612|Immune|immune
943272|NCT03524612|Platelets|platelets
943273|NCT03524612|Bleeding|bleeding
943274|NCT03524612|ITP|itp
943275|NCT03524612|eltrombopag|eltrombopag
943276|NCT03524612|ETB115|etb115
943277|NCT03524612|induce sustained remission|induce sustained remission
943278|NCT03524612|refractory or relapsed|refractory or relapsed
943279|NCT03524612|first-line steroids|first-line steroids
943280|NCT03524599|Heavy drinking|heavy drinking
943281|NCT03524599|Primary health care|primary health care
943282|NCT03524599|Training|training
943283|NCT03524599|Community|community
943284|NCT03524560|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio
943285|NCT03524482|culturally specific|culturally specific
943286|NCT03524456|home blood pressure monitoring|home blood pressure monitoring
943287|NCT03524456|sms|sms
943288|NCT03524456|primary care|primary care
943289|NCT03524443|Affective symptom|affective symptom
943290|NCT03524443|Art Therapy|art therapy
943291|NCT03524443|alexithymia|alexithymia
943292|NCT03524443|emotional disturbance|emotional disturbance
943293|NCT03524443|hyperphagia|hyperphagia
943294|NCT03524443|psychotherapy|psychotherapy
943295|NCT03524443|rehabilitation|rehabilitation
943296|NCT03524443|factor of resistance|factor of resistance
943297|NCT03524430|Early breast cancer|early breast cancer
943298|NCT03524417|Rabies immunoglobulin|rabies immunoglobulin
943299|NCT03524378|repetitive strain|repetitive strain
943300|NCT03524378|ergonomics|ergonomics
943301|NCT03524378|participatory ergonomics|participatory ergonomics
943302|NCT03524378|chronic low back pain|chronic low back pain
943303|NCT03524378|seafood workers|seafood workers
943304|NCT03524352|recurrent pouchitis|recurrent pouchitis
943305|NCT03524352|fecal microbiota transplant|fecal microbiota transplant
943306|NCT03524326|cetuximab|cetuximab
943307|NCT03524326|Lenvatinib|lenvatinib
943308|NCT03524326|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
943309|NCT03524326|17-635|17-635
943310|NCT03524313|cardiac output|cardiac output
943311|NCT03524313|end tidal carbon monoxide|end tidal carbon monoxide
943312|NCT03524313|echocardiography|echocardiography
943313|NCT03524313|intensive care|intensive care
943314|NCT03524300|Stomach Neoplasm|stomach neoplasm
943315|NCT03524300|Robotic Surgery|robotic surgery
943316|NCT03524300|Total Gastrectomy|total gastrectomy
943317|NCT03524287|Stomach Neoplasms|stomach neoplasms
943318|NCT03524287|Robotic Surgery|robotic surgery
943319|NCT03524287|Spleen-Preserving|spleen-preserving
943320|NCT03524287|No.10 Lymph Node Dissection|no.10 lymph node dissection
943321|NCT03524274|PD-1 activated CIK|pd-1 activated cik
943322|NCT03524274|MUC1|muc1
943323|NCT03524274|bispecific antibody|bispecific antibody
943324|NCT03524274|Colorectal Cancer|colorectal cancer
943325|NCT03524261|activated CIK|activated cik
943326|NCT03524261|MUC1|muc1
943327|NCT03524261|bispecific antibody|bispecific antibody
943328|NCT03524261|breast cancer|breast cancer
943329|NCT03524235|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
943330|NCT03524235|Multiple Myeloma|multiple myeloma
943331|NCT03524235|CLL|cll
943332|NCT03524235|Bendamustine|bendamustine
943333|NCT03524235|Haploidentical Stem Cell Transplantation|haploidentical stem cell transplantation
943334|NCT03524235|GVHD|gvhd
943426|NCT03523468|VATS|vats
943335|NCT03524235|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
943336|NCT03524235|Natural Killer Cell|natural killer cell
943337|NCT03524235|CliniMACS|clinimacs
943338|NCT03524235|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
943339|NCT03524235|Donor Lymphocyte Infusion|donor lymphocyte infusion
943340|NCT03524235|Minimal Residual Disease|minimal residual disease
943341|NCT03524209|Spondylodiscitis|spondylodiscitis
943342|NCT03524209|spinal infection|spinal infection
943343|NCT03524209|back pain|back pain
943344|NCT03524209|quality of life|quality of life
943346|NCT03524209|minimal invasive surgery|minimal invasive surgery
943347|NCT03524209|brace treatment|brace treatment
943348|NCT03524170|Malignant neoplasm of breast|malignant neoplasm of breast
943349|NCT03524170|Metastatic HR+/HER2- breast cancer|metastatic hr+/her2- breast cancer
943350|NCT03524170|M7824|m7824
943351|NCT03524170|MSB0011359C|msb0011359c
943352|NCT03524170|Radiation therapy|radiation therapy
943353|NCT03524170|XRT|xrt
943354|NCT03524170|External beam radiation therapy|external beam radiation therapy
943355|NCT03524157|Humylub PF|humylub pf
943356|NCT03524157|artificial tears|artificial tears
943357|NCT03524157|Ophthalmic lubricant|ophthalmic lubricant
943358|NCT03524157|Chondroitin sulfate|chondroitin sulfate
943359|NCT03524157|Sodium hyaluronate|sodium hyaluronate
943360|NCT03524105|Socio Economic Adversity|socio economic adversity
943361|NCT03524105|Child Development|child development
943362|NCT03524105|Poverty|poverty
943363|NCT03524105|racial disparity|racial disparity
943364|NCT03524105|ethnic disparity|ethnic disparity
943365|NCT03524092|Interleukin-23 (IL-23)|interleukin-23 (il-23)
943366|NCT03524092|IL-23p19|il-23p19
943367|NCT03524092|Inflammatory Bowel Disease|inflammatory bowel disease
943368|NCT03524040|Selective Photothermolysis|selective photothermolysis
943369|NCT03524040|Reflectance Confocal Microscopy|reflectance confocal microscopy
943370|NCT03524040|Optical Coherence Tomography|optical coherence tomography
943371|NCT03524040|Pilosebaceous Unit|pilosebaceous unit
943372|NCT03524040|Gold Microparticles|gold microparticles
943373|NCT03524027|Vertebral Column Resection|vertebral column resection
943374|NCT03524027|Congenital Spinal Deformity|congenital spinal deformity
943375|NCT03524027|Congenital Thoracolumbar Kyphoscoliosis|congenital thoracolumbar kyphoscoliosis
943376|NCT03523988|Pre-emptive analgesics|pre-emptive analgesics
943377|NCT03523988|Acetaminophen|acetaminophen
943378|NCT03523988|Ibuprofen|ibuprofen
943379|NCT03523962|Surgical Site Infection|surgical site infection
943380|NCT03523962|Open Fracture|open fracture
943381|NCT03523962|Lower Extremity Fracture|lower extremity fracture
943382|NCT03523962|Pelvis; Fracture|pelvis; fracture
943383|NCT03523962|DuraPrep|duraprep
943384|NCT03523962|ChloraPrep|chloraprep
943385|NCT03523962|Peri-operative Preparation Solutions|peri-operative preparation solutions
943386|NCT03523949|Pain Neuroscience Education|pain neuroscience education
943387|NCT03523949|Elderly|elderly
943388|NCT03523949|Pain Education|pain education
943389|NCT03523936|antibiotics, prebiotics, dysbiosis|antibiotics, prebiotics, dysbiosis
943390|NCT03523923|Collaborative Care|collaborative care
943391|NCT03523923|Effectiveness Study|effectiveness study
943392|NCT03523845|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"
943393|NCT03523819|Solid Tumors|solid tumors
943394|NCT03523793|Outpatient Physical Therapy|outpatient physical therapy
943395|NCT03523754|Induction of labor|induction of labor
943396|NCT03523754|isosorbide mononitrate|isosorbide mononitrate
943397|NCT03523754|misoprostol|misoprostol
943398|NCT03523741|genetic polymorphism|genetic polymorphism
943399|NCT03523741|pharmacodynamic variability|pharmacodynamic variability
943400|NCT03523741|personalized pharmacotherapy|personalized pharmacotherapy
943401|NCT03523741|adverse drug reaction|adverse drug reaction
943402|NCT03523741|quality of life|quality of life
1633784|NCT00269035|SPECT|spect
943403|NCT03523689|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
943404|NCT03523689|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
943405|NCT03523689|EBUS-TBNA|ebus-tbna
943406|NCT03523624|factor XIII|factor xiii
943407|NCT03523624|intramyocardial haemorrhage|intramyocardial haemorrhage
943408|NCT03523624|microvascular injury|microvascular injury
943409|NCT03523624|STEMI|stemi
943410|NCT03523624|cardiac magnetic resonance|cardiac magnetic resonance
943411|NCT03523611|lung cancer|lung cancer
943412|NCT03523611|Ventricular Failure|ventricular failure
943413|NCT03523585|Breast Cancer|breast cancer
943414|NCT03523585|Metastatic breast cancer|metastatic breast cancer
943415|NCT03523585|DS 8201a|ds 8201a
943416|NCT03523572|Human epidermal growth factor receptor-2|human epidermal growth factor receptor-2
943417|NCT03523572|HER2|her2
943418|NCT03523572|Refractory|refractory
943419|NCT03523572|Metastatic|metastatic
943420|NCT03523572|Urothelial cancer|urothelial cancer
943421|NCT03523572|Breast Cancer|breast cancer
943422|NCT03523520|constipation|constipation
943423|NCT03523520|opioid|opioid
943424|NCT03523507|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
943427|NCT03523468|Lung Cancer|lung cancer
943428|NCT03523455|Iron|iron
943429|NCT03523455|Exercise Performance|exercise performance
943430|NCT03523455|Fatigue|fatigue
943431|NCT03523403|Obesity|obesity
943432|NCT03523403|Diet|diet
943433|NCT03523403|Apples|apples
943434|NCT03523403|Polyphenols|polyphenols
943435|NCT03523403|Soluble fibre|soluble fibre
943436|NCT03523403|Blood lipids|blood lipids
943437|NCT03523403|Lipid digestion|lipid digestion
943438|NCT03523403|Inflammation|inflammation
943439|NCT03523403|Cytokines|cytokines
943458|NCT03523299|breast cancer|breast cancer
943459|NCT03523299|cryoablation|cryoablation
943460|NCT03523286|Catheter ablation|catheter ablation
943461|NCT03523286|ECG imaging|ecg imaging
943462|NCT03523247|Cholesterol|cholesterol
943463|NCT03523247|LDL|ldl
943464|NCT03523247|HDL|hdl
943465|NCT03523247|triglycerides|triglycerides
943466|NCT03523247|c-reactive protein|c-reactive protein
943467|NCT03523247|whole food diet|whole food diet
943468|NCT03523247|plant based diet|plant based diet
943469|NCT03523247|community based enrollment|community based enrollment
943470|NCT03523234|neoadjuvant therapy|neoadjuvant therapy
943471|NCT03523234|surgery|surgery
943472|NCT03523182|Micronutrient supplementation|micronutrient supplementation
943473|NCT03523182|Home fortification|home fortification
943474|NCT03523182|Spirulina|spirulina
943475|NCT03523182|Zambia|zambia
943476|NCT03523169|Septic associated encephalopathy|septic associated encephalopathy
943477|NCT03523169|Cerebral oxygenation|cerebral oxygenation
943478|NCT03523169|Prognosis|prognosis
943479|NCT03523169|Passive leg raising|passive leg raising
943480|NCT03523156|Antibiotics|antibiotics
943481|NCT03523156|Infectious diseases|infectious diseases
943482|NCT03523156|Tropical medicine|tropical medicine
943483|NCT03523156|Public health|public health
943484|NCT03523143|early screening|early screening
943485|NCT03523143|early intervention|early intervention
943486|NCT03523143|gestational diabetes mellitus|gestational diabetes mellitus
943487|NCT03523143|pregnancy outcomes|pregnancy outcomes
943488|NCT03523143|randomized controlled trial|randomized controlled trial
943489|NCT03523130|Macrophage-specific inflammation|macrophage-specific inflammation
943490|NCT03523130|Arterial inflammation|arterial inflammation
943491|NCT03523130|Neuroinflammation|neuroinflammation
943492|NCT03523130|SPECT/CT|spect/ct
943493|NCT03523130|Tilmanocept|tilmanocept
943494|NCT03523091|OnabotulinumtoxinA|onabotulinumtoxina
943495|NCT03523091|Bladder Injections|bladder injections
943496|NCT03523039|Cardiac Arrest|cardiac arrest
943497|NCT03523039|Cytokine Hemoadsorption|cytokine hemoadsorption
943498|NCT03523026|Metabolic Syndrome|metabolic syndrome
943499|NCT03523026|Coronary Artery Patients|coronary artery patients
943500|NCT03523026|Neuromuscular Electrical Stimulation,|neuromuscular electrical stimulation,
943501|NCT03523026|Respiratory Muscle Training|respiratory muscle training
943502|NCT03523026|Peripheral Muscle Training|peripheral muscle training
943503|NCT03523000|intractable chronic low back pain|intractable chronic low back pain
943504|NCT03523000|lumbar post-laminectomy syndrome|lumbar post-laminectomy syndrome
943505|NCT03523000|vertebral compression fracture|vertebral compression fracture
943506|NCT03523000|intrathecal drug delivery system|intrathecal drug delivery system
943507|NCT03522987|Neurologic Disorders|neurologic disorders
943508|NCT03522987|Chronic Care|chronic care
943509|NCT03522987|Management|management
943510|NCT03522987|Treatment|treatment
943511|NCT03522987|SSRI Medication|ssri medication
943512|NCT03522987|SNRI Medication|snri medication
943513|NCT03522987|Learning Healthcare System|learning healthcare system
943514|NCT03522948|heavy drinking|heavy drinking
943515|NCT03522948|sexual risk behavior|sexual risk behavior
943516|NCT03522922|Acne scars|acne scars
943517|NCT03522922|dermaroller|dermaroller
943518|NCT03522922|vitamin C|vitamin c
943519|NCT03522909|obstetric anesthesia|obstetric anesthesia
943520|NCT03522909|telemedicine|telemedicine
943521|NCT03522883|Martial Arts|martial arts
943522|NCT03522870|Flash glucose monitoring system|flash glucose monitoring system
943524|NCT03522844|mindfulness|mindfulness
943525|NCT03522844|escitalopram|escitalopram
943526|NCT03522844|anxiety|anxiety
943527|NCT03522831|dyspnea|dyspnea
943630|NCT03522259|Rivaroxaban|rivaroxaban
943532|NCT03522805|non-invasive ventilation|non-invasive ventilation
943533|NCT03522805|hypercapnia|hypercapnia
943534|NCT03522805|hypoventilation|hypoventilation
943535|NCT03522792|food intake|food intake
943536|NCT03522792|appetite|appetite
943537|NCT03522792|obesity treatment|obesity treatment
943538|NCT03522792|neurotensin|neurotensin
943539|NCT03522792|gastrointestinal|gastrointestinal
943540|NCT03522792|peptide|peptide
943541|NCT03522740|Chronic Kidney Disease|chronic kidney disease
943542|NCT03522740|Chronic Kidney Failure|chronic kidney failure
943543|NCT03522740|Palliative Care|palliative care
943544|NCT03522740|Dialysis|dialysis
943545|NCT03522740|End-of-life care|end-of-life care
943546|NCT03522740|Decision making|decision making
943547|NCT03522714|support surface, pressure ulcer, flap closure|support surface, pressure ulcer, flap closure
943548|NCT03522701|Adolescents|adolescents
943549|NCT03522701|Youth|youth
943550|NCT03522701|Insomnia|insomnia
943551|NCT03522688|dexmedetomidine|dexmedetomidine
943552|NCT03522688|acute kidney injury|acute kidney injury
943553|NCT03522688|liver transplantation|liver transplantation
943554|NCT03522649|CRC|crc
943555|NCT03522636|Prehospital transfusion|prehospital transfusion
943556|NCT03522636|Trauma|trauma
943557|NCT03522636|Trauma induced coagulopathy|trauma induced coagulopathy
943558|NCT03522623|colitis, costs, Crohn, pediatrics|colitis, costs, crohn, pediatrics
943559|NCT03522610|Prevention|prevention
943560|NCT03522610|Military Families|military families
943563|NCT03522597|Gestational Diabetes|gestational diabetes
943564|NCT03522597|Breast Milk|breast milk
943565|NCT03522597|Microbiome|microbiome
943566|NCT03522597|Infant Growth|infant growth
943567|NCT03522545|treatment-resistant bipolar depression|treatment-resistant bipolar depression
943568|NCT03522545|bipolar disorder|bipolar disorder
943569|NCT03522545|manic depression|manic depression
943570|NCT03522532|dental restorations|dental restorations
943571|NCT03522532|gingival crevicular fluid|gingival crevicular fluid
943572|NCT03522532|glutathione|glutathione
943573|NCT03522532|lipid peroxidation|lipid peroxidation
943574|NCT03522532|superoxide dismutase|superoxide dismutase
943575|NCT03522519|Physical Activity|physical activity
943576|NCT03522519|Upper Extremity|upper extremity
943577|NCT03522519|Movement Sensors|movement sensors
943578|NCT03522519|Prognosis|prognosis
943579|NCT03522519|Observational Cohort Study|observational cohort study
943580|NCT03522506|Drug Therapy|drug therapy
943581|NCT03522480|cystic fibrosis|cystic fibrosis
943582|NCT03522480|autogenic drainage|autogenic drainage
943583|NCT03522480|respiratory therapy|respiratory therapy
943584|NCT03522480|videogaming therapy|videogaming therapy
943585|NCT03522467|Cannabis oil|cannabis oil
943586|NCT03522467|Cannabis|cannabis
943587|NCT03522467|Pain|pain
943588|NCT03522467|Cancer|cancer
943589|NCT03522454|Frailty|frailty
943590|NCT03522454|TAVR|tavr
943591|NCT03522428|vitamin b12|vitamin b12
943592|NCT03522428|pregnancy|pregnancy
943593|NCT03522428|anemia|anemia
943594|NCT03522402|head position|head position
943595|NCT03522402|obstructive airway|obstructive airway
943596|NCT03522402|minimum alveolar concentration(MACendotracheal intubation)|minimum alveolar concentration(macendotracheal intubation)
943597|NCT03522402|sevoflurane concentration|sevoflurane concentration
943598|NCT03522389|Action Observation Training|action observation training
943599|NCT03522389|Gait|gait
943600|NCT03522363|oral health|oral health
943601|NCT03522363|Streptococcus dentisani|streptococcus dentisani
943602|NCT03522350|Infertility|infertility
943603|NCT03522350|Embryo develpoment|embryo develpoment
943604|NCT03522350|IVF|ivf
943605|NCT03522350|ICSI|icsi
943606|NCT03522350|EmbryoScope|embryoscope
943607|NCT03522337|preschool children|preschool children
943608|NCT03522337|special needs|special needs
943609|NCT03522337|tooth brushing|tooth brushing
943610|NCT03522337|social story|social story
943611|NCT03522337|visual pedagogy|visual pedagogy
943612|NCT03522324|Cannabis|cannabis
943613|NCT03522324|Pain|pain
943614|NCT03522324|Cytokines|cytokines
943615|NCT03522324|Inflammation|inflammation
943616|NCT03522324|Cognition|cognition
943619|NCT03522285|hip arthroplasty|hip arthroplasty
943620|NCT03522285|chronic renal diseases|chronic renal diseases
943621|NCT03522272|denture|denture
943622|NCT03522272|removable partial denture|removable partial denture
943623|NCT03522272|denture cleansers|denture cleansers
943624|NCT03522272|ultrasonics|ultrasonics
943625|NCT03522272|cetylpyridinium chloride|cetylpyridinium chloride
943626|NCT03522272|Staphylococcus aureus|staphylococcus aureus
943627|NCT03522272|Gram negative bacilli|gram negative bacilli
943628|NCT03522272|Candida|candida
943629|NCT03522272|yeast|yeast
943631|NCT03522259|Thromboembolic prophylaxis|thromboembolic prophylaxis
943632|NCT03522259|Venous thromboembolism|venous thromboembolism
943633|NCT03522246|PARP inhibitor|parp inhibitor
943635|NCT03522246|HRD|hrd
943636|NCT03522246|ATHENA|athena
943637|NCT03522246|homologous recombination|homologous recombination
943638|NCT03522246|DNA repair|dna repair
943639|NCT03522246|LOH|loh
943640|NCT03522246|DNA defect|dna defect
943641|NCT03522246|DNA anomaly|dna anomaly
943642|NCT03522246|Rucaparib|rucaparib
943643|NCT03522246|Nivolumab|nivolumab
943644|NCT03522246|PD-1|pd-1
943645|NCT03522246|Immuno-|immuno-
943646|NCT03522246|oncology|oncology
943647|NCT03522246|Tumor|tumor
943648|NCT03522246|mutational|mutational
943649|NCT03522246|burden|burden
943650|NCT03522246|BRCA|brca
943651|NCT03522155|Conjoint Analysis|conjoint analysis
943652|NCT03522155|Life Expectancy|life expectancy
943653|NCT03522155|Patient-centered|patient-centered
943654|NCT03522142|Advanced solid tumors|advanced solid tumors
943655|NCT03522142|AXL|axl
943656|NCT03522142|MER|mer
943657|NCT03522142|AXL/MER|axl/mer
943658|NCT03522129|Alzheimer's Disease|alzheimer's disease
943659|NCT03522103|Cannabis|cannabis
943660|NCT03522103|Marijuana|marijuana
943661|NCT03522103|Cognition|cognition
943662|NCT03522077|Angiogram|angiogram
943663|NCT03522077|Hemostatic|hemostatic
943664|NCT03522077|Activated clotting time|activated clotting time
943665|NCT03522077|Quality of Life|quality of life
943666|NCT03522064|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
943667|NCT03522064|bipolar androgen therapy|bipolar androgen therapy
943668|NCT03522064|homologous recombination deficiency|homologous recombination deficiency
943669|NCT03522064|BRCA|brca
943670|NCT03522051|teeth|teeth
943671|NCT03522051|pulpitis|pulpitis
943672|NCT03522051|deep caries|deep caries
943674|NCT03522051|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
943675|NCT03522038|coronary chronic total occlusion|coronary chronic total occlusion
943676|NCT03522038|functional evaluation|functional evaluation
943677|NCT03522012|Pharmacokinetics|pharmacokinetics
943678|NCT03522012|Tocilizumab|tocilizumab
943679|NCT03521999|PTSD|ptsd
943680|NCT03521999|peer resource|peer resource
943681|NCT03521999|Veterans|veterans
943682|NCT03521999|web-based intervention|web-based intervention
943683|NCT03521999|digital story telling|digital story telling
943684|NCT03521986|Mediastinal Neoplasms|mediastinal neoplasms
943685|NCT03521986|Pain|pain
943686|NCT03521986|Quality of life|quality of life
943687|NCT03521973|Plasmodium falciparum|plasmodium falciparum
943688|NCT03521973|PfSPZ Vaccine|pfspz vaccine
943689|NCT03521960|Buspirone|buspirone
943690|NCT03521947|MCP|mcp
943691|NCT03521856|spinal cord injuries|spinal cord injuries
943692|NCT03521856|SCI|sci
943693|NCT03521843|femoropopliteal occlusive disease|femoropopliteal occlusive disease
943694|NCT03521843|local drug delivery|local drug delivery
943695|NCT03521843|endovascular treatment|endovascular treatment
943696|NCT03521804|Chronic Total Occlusion|chronic total occlusion
943697|NCT03521804|coronary|coronary
943698|NCT03521804|SoundBite™ Crossing System|soundbite™ crossing system
943699|NCT03521804|CTO|cto
943700|NCT03521804|distal cap|distal cap
943701|NCT03521804|true lumen|true lumen
943702|NCT03521804|Active wire|active wire
943703|NCT03521804|Device|device
943704|NCT03521804|Procedure|procedure
943705|NCT03521804|Stenosis|stenosis
943706|NCT03521804|CAD|cad
943707|NCT03521804|Coronary Artery Disease|coronary artery disease
943708|NCT03521791|zebesten|zebesten
943709|NCT03521791|ocular anti-inflammatory|ocular anti-inflammatory
943710|NCT03521791|ocular analgesic|ocular analgesic
943711|NCT03521791|pterygium|pterygium
943712|NCT03521791|anti-inflammatory non-steroidal ophthalmic|anti-inflammatory non-steroidal ophthalmic
943713|NCT03521765|quality of life|quality of life
943714|NCT03521765|occupational therapy|occupational therapy
943715|NCT03521752|BALANCE|balance
943716|NCT03521752|INSTITUTIONALIZED ELDERLY PEOPLE|institutionalized elderly people
943717|NCT03521752|THERAPEUTIC EXERCISE|therapeutic exercise
943718|NCT03521752|FUNCTIONAL CAPACITY|functional capacity
943719|NCT03521739|blood pressure|blood pressure
943720|NCT03521739|pulse wave velocity|pulse wave velocity
943721|NCT03521739|ankle brachial index|ankle brachial index
943722|NCT03521739|cardiovascular events|cardiovascular events
943723|NCT03521726|Rabeprazole|rabeprazole
943724|NCT03521726|Amoxicillin|amoxicillin
943725|NCT03521726|Helicobacter Pylori|helicobacter pylori
943726|NCT03521700|Renal Artery Obstruction|renal artery obstruction
943727|NCT03521700|Stents|stents
943728|NCT03521700|Glomerular filtration rate|glomerular filtration rate
943729|NCT03521687|Central centrifugal cicatricial alopecia|central centrifugal cicatricial alopecia
943730|NCT03521687|open-label pilot study|open-label pilot study
943731|NCT03521674|second trimester pregnancy termination|second trimester pregnancy termination
943732|NCT03521674|double-balloon catheter|double-balloon catheter
943733|NCT03521674|foley catheter|foley catheter
943734|NCT03521661|Vertebral fracture|vertebral fracture
943735|NCT03521661|Kyphotic deformity|kyphotic deformity
943736|NCT03521661|Kyphoplasty|kyphoplasty
943737|NCT03521661|Vertebroplasty|vertebroplasty
943738|NCT03521648|Prostatic Artery Embolization|prostatic artery embolization
943739|NCT03521648|Transurethral Prostate Resection|transurethral prostate resection
943740|NCT03521648|Transurethral Electroresection of Prostate|transurethral electroresection of prostate
943741|NCT03521648|Contact Laser Ablation of Prostate|contact laser ablation of prostate
943742|NCT03521648|Laser Enucleation of Prostate|laser enucleation of prostate
943743|NCT03521648|Open prostatectomy|open prostatectomy
943744|NCT03521622|counseling|counseling
943745|NCT03521622|behavioral therapy|behavioral therapy
943746|NCT03521622|tobacco|tobacco
943747|NCT03521622|alcohol drinking|alcohol drinking
943748|NCT03521596|IgM monoclonal gammopathy|igm monoclonal gammopathy
943749|NCT03521596|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
943750|NCT03521596|Minimal residual disease|minimal residual disease
943751|NCT03521596|Clonal evolution|clonal evolution
943752|NCT03521583|von Willebrand disease|von willebrand disease
943753|NCT03521583|von Willebrand factor|von willebrand factor
943754|NCT03521583|Nationwide study|nationwide study
943755|NCT03521583|Prospective study|prospective study
943756|NCT03521531|Quality of Life|quality of life
943757|NCT03521531|Sarcoma|sarcoma
943758|NCT03521531|Patient Reported Outcomes|patient reported outcomes
943759|NCT03521505|Sedation|sedation
943760|NCT03521505|dexmedetomidine|dexmedetomidine
943761|NCT03521505|brain perfusion|brain perfusion
943762|NCT03521505|bronchoscopy|bronchoscopy
943763|NCT03521492|Early childhood caries, Vitamin D deficiency, Parathyroid hormone, Calcium|early childhood caries, vitamin d deficiency, parathyroid hormone, calcium
943764|NCT03521479|Squaric Acid|squaric acid
943765|NCT03521479|SADBE|sadbe
943766|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester
943767|NCT03521466|Smoking cessation counselling|smoking cessation counselling
944208|NCT03518749|Depression|depression
943768|NCT03521466|Medical Students|medical students
943769|NCT03521466|India|india
943770|NCT03521440|Therapeutic relaxation|therapeutic relaxation
943771|NCT03521440|Elderly|elderly
943772|NCT03521440|Community dwelling|community dwelling
943773|NCT03521427|Intensive Therapy|intensive therapy
943774|NCT03521427|Cerebral Palsy|cerebral palsy
943775|NCT03521414|Bispectral index|bispectral index
943776|NCT03521414|Glasgow Coma Scale|glasgow coma scale
943777|NCT03521414|intracranial pathology|intracranial pathology
943778|NCT03521401|Adverse Childhood Experiences|adverse childhood experiences
943779|NCT03521401|Exercise Intervention|exercise intervention
943780|NCT03521401|Inflammation|inflammation
943781|NCT03521401|Resilience|resilience
943782|NCT03521401|Health|health
943783|NCT03521388|depression|depression
943784|NCT03521388|adolescence|adolescence
943785|NCT03521388|prevention|prevention
943786|NCT03521388|early intervention|early intervention
943787|NCT03521388|internet-based|internet-based
943788|NCT03521375|lung|lung
943789|NCT03521375|cancer|cancer
943790|NCT03521375|lobectomy|lobectomy
943791|NCT03521362|mHealth|mhealth
943792|NCT03521362|Adolescent|adolescent
943793|NCT03521349|Electroencephalography|electroencephalography
943794|NCT03521349|Executive Function|executive function
943795|NCT03521349|Egg|egg
943796|NCT03521349|Diet|diet
943797|NCT03521336|Spinal cord injury|spinal cord injury
943798|NCT03521336|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
943799|NCT03521323|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
943800|NCT03521323|spinal cord injury|spinal cord injury
943801|NCT03521310|IPISTOSS|ipistoss
943802|NCT03521310|Skin to skin|skin to skin
943803|NCT03521310|SSC|ssc
943804|NCT03521310|Neonatal|neonatal
943805|NCT03521284|perinatal period|perinatal period
943806|NCT03521271|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
943807|NCT03521271|Upper limb|upper limb
943808|NCT03521271|Hand functions|hand functions
943809|NCT03521271|Performance|performance
943810|NCT03521271|Grip Strength|grip strength
943811|NCT03521245|breast cancer|breast cancer
943812|NCT03521245|epidermal growth factor receptor|epidermal growth factor receptor
943813|NCT03521245|HER2|her2
943814|NCT03521245|EGFR|egfr
943815|NCT03521245|biomarkers|biomarkers
943816|NCT03521245|targeted therapy|targeted therapy
943817|NCT03521245|NGS|ngs
943818|NCT03521245|RNAseq|rnaseq
943819|NCT03521245|mRNA|mrna
943820|NCT03521245|transcriptome analysis|transcriptome analysis
943821|NCT03521245|signaling pathway|signaling pathway
943822|NCT03521245|intracellular molecular pathway|intracellular molecular pathway
943823|NCT03521245|OncoBox|oncobox
943824|NCT03521245|trastuzumab|trastuzumab
943825|NCT03521206|Advance directives|advance directives
943826|NCT03521206|Effectiveness|effectiveness
943827|NCT03521206|Process evaluation|process evaluation
943828|NCT03521206|Care staff|care staff
943829|NCT03521193|Migraine;|migraine;
943830|NCT03521193|PFO|pfo
943831|NCT03521193|platelet reactivity|platelet reactivity
943832|NCT03521193|aura|aura
943833|NCT03521180|Celiac Disease|celiac disease
943844|NCT03521141|Precision Medicine|precision medicine
943845|NCT03521089|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
943846|NCT03521089|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
943847|NCT03521076|Botulinum Toxin Injections|botulinum toxin injections
943848|NCT03521076|Virtual Reality|virtual reality
943849|NCT03521063|bronchopulmonary dysplasia|bronchopulmonary dysplasia
943850|NCT03521063|respiratory distress syndrome|respiratory distress syndrome
943851|NCT03521063|budesonide|budesonide
943852|NCT03521063|poractant alfa|poractant alfa
943853|NCT03521037|rucaparib|rucaparib
943854|NCT03521037|CO-338|co-338
943855|NCT03521037|Clovis|clovis
943856|NCT03521037|Clovis Oncology|clovis oncology
943857|NCT03521037|PARP inhibitor|parp inhibitor
943858|NCT03521037|hepatic impairment|hepatic impairment
943859|NCT03521024|Zirconia implants|zirconia implants
943860|NCT03521024|PEKK crowns|pekk crowns
943861|NCT03521024|high performance polymer crowns|high performance polymer crowns
943862|NCT03520985|refractory Multiple Myeloma|refractory multiple myeloma
943863|NCT03520985|Phase II|phase ii
943864|NCT03520985|Pomalidomide|pomalidomide
943865|NCT03520985|OptiPOM|optipom
943866|NCT03520959|Synovate Study|synovate study
943867|NCT03520959|NY-ESO-1|ny-eso-1
943868|NCT03520959|cancer vaccine|cancer vaccine
943869|NCT03520959|Sarcoma|sarcoma
943870|NCT03520959|soft tissue sarcoma|soft tissue sarcoma
943871|NCT03520959|immunotherapy|immunotherapy
943875|NCT03520933|Embryo|embryo
943876|NCT03520933|Blastocyst|blastocyst
943877|NCT03520933|Non-invasive|non-invasive
943878|NCT03520933|PGT-A|pgt-a
943879|NCT03520933|Chromosome|chromosome
943880|NCT03520933|Aneuploidy|aneuploidy
943881|NCT03520933|Spent culture medium|spent culture medium
943882|NCT03520933|Trophectoderm biopsy|trophectoderm biopsy
943883|NCT03520907|transversalis fascia|transversalis fascia
943884|NCT03520907|ilioinguinal/iliohypogastric nerve|ilioinguinal/iliohypogastric nerve
943885|NCT03520907|inguinal hernia repair|inguinal hernia repair
943886|NCT03520907|children|children
943887|NCT03520881|asthma|asthma
943888|NCT03520855|Type 1 Diabetes|type 1 diabetes
943889|NCT03520855|Paediatrics patients|paediatrics patients
943890|NCT03520816|Fibronectin|fibronectin
943891|NCT03520816|Prealbumin|prealbumin
943892|NCT03520816|Physiotherapy|physiotherapy
943893|NCT03520816|Major Burns|major burns
943894|NCT03520816|biochemical parameters|biochemical parameters
943895|NCT03520803|obesity|obesity
943896|NCT03520803|bariatric surgery|bariatric surgery
943897|NCT03520803|enhanced recovery after surgery|enhanced recovery after surgery
943898|NCT03520803|sleeve gastrectomy|sleeve gastrectomy
943899|NCT03520803|gastric bypass|gastric bypass
943900|NCT03520790|Pancreatic Cancer|pancreatic cancer
943901|NCT03520751|CMT1A|cmt1a
943902|NCT03520751|scAAV1.tMCK.NTF3|scaav1.tmck.ntf3
943903|NCT03520751|NTF3|ntf3
943904|NCT03520725|antioxidant capacity|antioxidant capacity
943905|NCT03520712|Hemophilia A|hemophilia a
943906|NCT03520712|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
943907|NCT03520712|Blood Coagulation Disorders|blood coagulation disorders
943908|NCT03520712|Hematologic Diseases|hematologic diseases
943909|NCT03520712|Coagulation Protein Disorders|coagulation protein disorders
943910|NCT03520712|Hemorrhagic Disorders|hemorrhagic disorders
943911|NCT03520712|Genetic Diseases, Inborn|genetic diseases, inborn
943912|NCT03520712|Factor VIII|factor viii
943913|NCT03520712|Coagulants|coagulants
943914|NCT03520712|AAV5 antibodies|aav5 antibodies
943915|NCT03520699|metabolic surgery|metabolic surgery
943916|NCT03520699|metabolic disease|metabolic disease
943917|NCT03520686|Pembrolizumab|pembrolizumab
943918|NCT03520686|ALT-803|alt-803
943919|NCT03520686|Non-Small Cell Lung Cancer|non-small cell lung cancer
943920|NCT03520686|Immunotherapy|immunotherapy
943921|NCT03520673|Lower Urinary Tract Symptoms|lower urinary tract symptoms
943922|NCT03520673|Primary Care|primary care
943923|NCT03520673|Urology|urology
943931|NCT03520634|Melanoma|melanoma
943932|NCT03520634|PD-L1|pd-l1
943933|NCT03520634|Brain metastases|brain metastases
943934|NCT03520634|PET imaging|pet imaging
943942|NCT03520556|adiponectin|adiponectin
943943|NCT03520556|randomized controlled trials|randomized controlled trials
943944|NCT03520556|systematic review and meta-analysis|systematic review and meta-analysis
943945|NCT03520543|PET imaging|pet imaging
943946|NCT03520543|Noradrenaline|noradrenaline
943947|NCT03520543|Radiotracer|radiotracer
943950|NCT03520517|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
943951|NCT03520517|ALS|als
943952|NCT03520517|Biohaven|biohaven
943953|NCT03520517|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
943954|NCT03520517|Lou Gehrig's Disease|lou gehrig's disease
943955|NCT03520517|Lou-Gehrigs Disease|lou-gehrigs disease
943956|NCT03520517|Lou Gehrig Disease|lou gehrig disease
943957|NCT03520517|Riluzole|riluzole
943958|NCT03520517|Rilutek®|rilutek®
943959|NCT03520517|Neuroprotective Agents|neuroprotective agents
943960|NCT03520517|Administration, Sublingual|administration, sublingual
943961|NCT03520517|Administration, Oral|administration, oral
943962|NCT03520517|Biological Availability|biological availability
943963|NCT03520504|Proton Radiation|proton radiation
943964|NCT03520504|craniospinal irradiation (CSI)|craniospinal irradiation (csi)
943965|NCT03520504|18-205|18-205
943966|NCT03520491|Immunotherapy|immunotherapy
943967|NCT03520491|Nivolumab|nivolumab
943968|NCT03520491|Ipilimumab|ipilimumab
943969|NCT03520491|18-042|18-042
943970|NCT03520478|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
943971|NCT03520478|SHR3680|shr3680
943972|NCT03520478|Anti-androgen receptor|anti-androgen receptor
943973|NCT03520439|Adenomyosis|adenomyosis
943974|NCT03520439|mifepristone|mifepristone
943975|NCT03520439|the selective progesterone receptor modulators|the selective progesterone receptor modulators
943976|NCT03520439|treatment|treatment
943977|NCT03520413|Complex Care|complex care
943978|NCT03520413|Outcomes|outcomes
943979|NCT03520413|Telemedicine|telemedicine
943980|NCT03520413|Rural Health|rural health
943981|NCT03520413|Diabetes|diabetes
943982|NCT03520400|Cardiovascular Disease|cardiovascular disease
943983|NCT03520400|Percutaneous Intervention|percutaneous intervention
943984|NCT03520400|coronary artery disease|coronary artery disease
943985|NCT03520400|exercise therapy|exercise therapy
943986|NCT03520387|Randomized controlled trial|randomized controlled trial
943987|NCT03520387|Chronic pain|chronic pain
943988|NCT03520374|ultrasound|ultrasound
943989|NCT03520374|gastric contents|gastric contents
943990|NCT03520361|Colonoscopy|colonoscopy
943991|NCT03520361|Bowel preparation|bowel preparation
943992|NCT03520361|Oral sulfate solution|oral sulfate solution
943993|NCT03520361|Polyethylene glycol|polyethylene glycol
943994|NCT03520361|Ascorbic acid|ascorbic acid
943996|NCT03520348|eye lubricants|eye lubricants
943997|NCT03520348|eye lubricant gel|eye lubricant gel
943998|NCT03520348|PRO-167|pro-167
943999|NCT03520335|stroke|stroke
944000|NCT03520335|conjugated eye deviation|conjugated eye deviation
944001|NCT03520335|prehospital|prehospital
944002|NCT03520335|stroke scale|stroke scale
944003|NCT03520335|large vessel occlusion|large vessel occlusion
944004|NCT03520309|Diagnosis|diagnosis
944005|NCT03520309|Visual inspection|visual inspection
944006|NCT03520309|Quality of Life|quality of life
944007|NCT03520309|Restorations|restorations
944008|NCT03520244|Microbiome|microbiome
944009|NCT03520244|High intensity interval training|high intensity interval training
944010|NCT03520244|Exercise|exercise
944011|NCT03520244|Holistic education|holistic education
944012|NCT03520244|Quality of life|quality of life
944013|NCT03520244|Fatigue|fatigue
944014|NCT03520205|stress response|stress response
944015|NCT03520205|kidney donor|kidney donor
944016|NCT03520205|Cellular Imunological Function|cellular imunological function
944017|NCT03520205|quadratus lumborum block|quadratus lumborum block
944018|NCT03520192|Paediatric|paediatric
944019|NCT03520192|Critical care|critical care
944020|NCT03520192|Transport|transport
944021|NCT03520166|urgency|urgency
944022|NCT03520166|frequency|frequency
944023|NCT03520166|overactive bladder|overactive bladder
944024|NCT03520166|LUTS|luts
944025|NCT03520166|pelvic pain|pelvic pain
944026|NCT03520166|electrostimulation|electrostimulation
944027|NCT03520140|Familial hypercholesterolemia|familial hypercholesterolemia
944028|NCT03520140|Coronary artery disease|coronary artery disease
944033|NCT03520088|Rectal cancer|rectal cancer
944034|NCT03520088|Sexual dysfunction|sexual dysfunction
944035|NCT03520088|Urinary dysfunction|urinary dysfunction
944036|NCT03520088|Rectal nerves damage|rectal nerves damage
944042|NCT03520075|ERK|erk
944043|NCT03520062|Amylase|amylase
944044|NCT03520062|Lipase|lipase
944045|NCT03520062|GLP-1|glp-1
944046|NCT03520049|Thrombocytopenia|thrombocytopenia
944047|NCT03520049|ITP|itp
944048|NCT03520049|Platelets|platelets
944049|NCT03520049|Bleeding|bleeding
944050|NCT03520049|Immune|immune
944051|NCT03520049|Oseltamivir|oseltamivir
944052|NCT03520049|Glycoprotein|glycoprotein
944053|NCT03520049|Sialylation|sialylation
944054|NCT03520049|Antibody|antibody
944055|NCT03520049|Autoantibody|autoantibody
944056|NCT03519971|Locally Advanced, Unresectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-Small-Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer, nsclc, carcinoma, non-small-cell lung cancer
944057|NCT03519945|Inflammatory Bowel Disease|inflammatory bowel disease
944058|NCT03519906|Bariatric surgery|bariatric surgery
944059|NCT03519906|Gastrointestinal tract|gastrointestinal tract
944060|NCT03519906|Biological availability|biological availability
944061|NCT03519906|Pharmacokinetics|pharmacokinetics
944062|NCT03519906|Metoprolol|metoprolol
944063|NCT03519893|Bariatric surgery|bariatric surgery
944064|NCT03519893|Gastrointestinal tract|gastrointestinal tract
944065|NCT03519893|Biological availability|biological availability
944066|NCT03519893|Pharmacokinetics|pharmacokinetics
944067|NCT03519893|Losartan|losartan
944068|NCT03519880|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3D-printing|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3d-printing
944069|NCT03519841|Non-invasive glucose monitoring|non-invasive glucose monitoring
944070|NCT03519815|dry eye|dry eye
944071|NCT03519815|eye spray|eye spray
944072|NCT03519802|Cognitive functions|cognitive functions
944073|NCT03519802|MoCA test|moca test
944074|NCT03519789|Change blindness|change blindness
944075|NCT03519789|Eye tracking|eye tracking
944076|NCT03519789|Implicit response|implicit response
944077|NCT03519750|Melatonin|melatonin
944078|NCT03519750|Safety|safety
944079|NCT03519750|Pharmacokinetics|pharmacokinetics
944080|NCT03519737|Stroke|stroke
944081|NCT03519737|Acute Stroke|acute stroke
944082|NCT03519685|Contraception|contraception
944083|NCT03519685|Hormonal contraception|hormonal contraception
944084|NCT03519685|Long-acting reversible contraception|long-acting reversible contraception
944085|NCT03519685|Condoms|condoms
944086|NCT03519685|Emergency contraception|emergency contraception
944087|NCT03519685|Family planning services|family planning services
944088|NCT03519646|Enzyme Replacement Therapy|enzyme replacement therapy
944089|NCT03519646|Eliglustat (Cerdelga®)|eliglustat (cerdelga®)
944090|NCT03519607|Infertility|infertility
944091|NCT03519607|Distress|distress
944092|NCT03519607|Coping|coping
944093|NCT03519607|Men|men
944094|NCT03519594|angioembolization|angioembolization
944095|NCT03519594|computed tomography|computed tomography
944096|NCT03519581|DME|dme
944097|NCT03519581|micropulse laser|micropulse laser
944098|NCT03519529|sex hormone-binding globulin|sex hormone-binding globulin
944099|NCT03519516|ocular antibiotic|ocular antibiotic
944100|NCT03519516|quinolone|quinolone
944101|NCT03519516|levofloxacin|levofloxacin
944102|NCT03519516|ophthalmic antibiotic|ophthalmic antibiotic
944103|NCT03519516|antibiotic in drops|antibiotic in drops
944104|NCT03519503|HIV|hiv
944105|NCT03519503|Neuropsychological tests|neuropsychological tests
944106|NCT03519503|PMTCT|pmtct
944107|NCT03519503|PreP|prep
944108|NCT03519490|Myopia|myopia
944109|NCT03519490|Myopia Control|myopia control
944110|NCT03519490|Bifocal Contact Lenses|bifocal contact lenses
944313|NCT03518125|Vaccines|vaccines
944111|NCT03519490|Multifocal Contact Lenses|multifocal contact lenses
944112|NCT03519490|Hybrid Contact Lenses|hybrid contact lenses
944113|NCT03519490|Randomized Controlled Clinical Trial|randomized controlled clinical trial
944114|NCT03519490|Distance Center Multifocal Contact Lens|distance center multifocal contact lens
944115|NCT03519490|Near Center Multifocal Contact Lens|near center multifocal contact lens
944116|NCT03519477|clinical decision support|clinical decision support
944117|NCT03519477|drug levels in blood|drug levels in blood
944118|NCT03519477|therapeutic drug monitoring|therapeutic drug monitoring
944119|NCT03519477|medication adherence|medication adherence
944120|NCT03519477|medication therapy management|medication therapy management
944126|NCT03519451|Smartphone mobile app|smartphone mobile app
944127|NCT03519451|Questionnaires|questionnaires
944128|NCT03519451|Surveys|surveys
944129|NCT03519451|Phone calls|phone calls
944130|NCT03519451|Interview|interview
944131|NCT03519451|Tobacco cessation|tobacco cessation
944132|NCT03519425|Tuberculosis|tuberculosis
944133|NCT03519425|HIV|hiv
944134|NCT03519425|Randomised controlled trial|randomised controlled trial
944135|NCT03519425|Africa|africa
944136|NCT03519425|Public Health|public health
944137|NCT03519425|Screening|screening
944138|NCT03519412|DNA Mismatch Repair|dna mismatch repair
944139|NCT03519412|Pembrolizumab|pembrolizumab
944140|NCT03519399|Bile Acids, Fetal ECG, Stillbirth,|bile acids, fetal ecg, stillbirth,
944141|NCT03519360|arrythmia|arrythmia
944142|NCT03519360|hemodialysis|hemodialysis
944143|NCT03519334|Employment|employment
944144|NCT03519334|Return to work|return to work
944145|NCT03519334|Career Mobility|career mobility
944146|NCT03519334|Employment supported|employment supported
944147|NCT03519334|Workplace|workplace
944148|NCT03519334|Chronic disease|chronic disease
944149|NCT03519321|Early Onset Scoliosis (EOS)|early onset scoliosis (eos)
1333205|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
944150|NCT03519295|Epidermoid Cancers of the Anal Canal|epidermoid cancers of the anal canal
944151|NCT03519269|total knee replacement|total knee replacement
944152|NCT03519269|robotic surgery|robotic surgery
944153|NCT03519191|teen dating violence|teen dating violence
944154|NCT03519191|sexual assault|sexual assault
944155|NCT03519191|reproductive coercion|reproductive coercion
944156|NCT03519178|Hormone Receptor (HR) Positive Breast Cancer|hormone receptor (hr) positive breast cancer
944157|NCT03519178|Estrogen receptor (ER) positive|estrogen receptor (er) positive
944158|NCT03519178|Progesterone receptor (PR) positive|progesterone receptor (pr) positive
944159|NCT03519178|Cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
944160|NCT03519178|Human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
944161|NCT03519178|Advanced breast cancer|advanced breast cancer
944162|NCT03519178|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
944163|NCT03519178|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
944164|NCT03519178|Epithelial ovarian cancer (EOC)|epithelial ovarian cancer (eoc)
944165|NCT03519178|Fallopian tube cancer|fallopian tube cancer
944166|NCT03519178|Primary peritoneal cancer (PPC)|primary peritoneal cancer (ppc)
944167|NCT03519178|CDK4/6 inhibitor|cdk4/6 inhibitor
944168|NCT03519178|Endocrine Therapy (ET)|endocrine therapy (et)
944169|NCT03519178|Measurable disease|measurable disease
944170|NCT03519178|Luteinizing Hormone Releasing Hormone (LHRH) Agonist|luteinizing hormone releasing hormone (lhrh) agonist
944171|NCT03519178|Goserelin|goserelin
944172|NCT03519178|Leuprolide acetate|leuprolide acetate
944173|NCT03519165|Ovarian cancer|ovarian cancer
944174|NCT03519165|goal-directed fluid therapy|goal-directed fluid therapy
944176|NCT03519139|Geriatric patients, nutritional counselling, homevisit|geriatric patients, nutritional counselling, homevisit
944177|NCT03519126|Urinary Bladder, Overactive; Electric Stimulation|urinary bladder, overactive; electric stimulation
944178|NCT03519113|HBV-related liver transplantation|hbv-related liver transplantation
944179|NCT03519113|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
944180|NCT03519035|borderline|borderline
944181|NCT03519035|hallucinations|hallucinations
944182|NCT03519035|dissociation|dissociation
944183|NCT03519035|post-traumatic stress disorder|post-traumatic stress disorder
944184|NCT03519009|Employment|employment
944185|NCT03518970|uncertainty|uncertainty
944186|NCT03518970|caregivers|caregivers
944187|NCT03518970|palliative care|palliative care
944188|NCT03518970|nursing|nursing
944189|NCT03518970|Hospice and Palliative Care Nursing|hospice and palliative care nursing
944190|NCT03518918|Premature ovarian insufficiency|premature ovarian insufficiency
944191|NCT03518918|Diagnosis standard|diagnosis standard
944192|NCT03518918|Risk factors|risk factors
944193|NCT03518892|Resting Metabolic Rate|resting metabolic rate
944194|NCT03518879|informatics|informatics
944195|NCT03518879|asthma|asthma
944196|NCT03518827|asymmetry|asymmetry
944197|NCT03518827|pain|pain
944198|NCT03518827|sport|sport
944199|NCT03518827|injury|injury
944200|NCT03518827|risk factor|risk factor
944201|NCT03518814|Melanoma stage IV|melanoma stage iv
944202|NCT03518814|Remission|remission
944203|NCT03518814|Quality of life|quality of life
944204|NCT03518801|cannabidiol|cannabidiol
944205|NCT03518801|CBD|cbd
944206|NCT03518801|PTSD|ptsd
944207|NCT03518801|Veterans|veterans
944209|NCT03518749|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
944210|NCT03518723|Muscle dysfunction|muscle dysfunction
944211|NCT03518710|child|child
944212|NCT03518710|reading|reading
944213|NCT03518710|vision|vision
944214|NCT03518710|attention|attention
944215|NCT03518710|therapeutical perspectives|therapeutical perspectives
944216|NCT03518697|Exercise|exercise
944217|NCT03518697|Physical fitness|physical fitness
944218|NCT03518697|Physical activity|physical activity
944219|NCT03518697|Accelerometer|accelerometer
944220|NCT03518697|Sleep|sleep
944221|NCT03518671|head and neck cancer|head and neck cancer
944222|NCT03518671|body image disturbance|body image disturbance
944223|NCT03518671|cognitive behavioral therapy|cognitive behavioral therapy
944224|NCT03518671|survivorship|survivorship
944225|NCT03518658|remote monitoring|remote monitoring
944226|NCT03518658|transmission compliance|transmission compliance
944227|NCT03518658|patient engagement|patient engagement
944228|NCT03518645|Coronary Artery Disease|coronary artery disease
944229|NCT03518645|OPN NC|opn nc
944230|NCT03518645|Angina|angina
944231|NCT03518645|Stable|stable
944232|NCT03518645|Unstable|unstable
944233|NCT03518632|Exercise|exercise
944234|NCT03518632|Adapted physical activity|adapted physical activity
944235|NCT03518632|preoperative|preoperative
944236|NCT03518632|liver resection|liver resection
944237|NCT03518632|hepatectomy|hepatectomy
944238|NCT03518606|Advanced solid tumours|advanced solid tumours
944239|NCT03518606|Durvalumab|durvalumab
944240|NCT03518606|Tremelimumab|tremelimumab
944241|NCT03518606|Metronomic vinorelbine|metronomic vinorelbine
944242|NCT03518606|High mutational load malignancies|high mutational load malignancies
1633785|NCT00269035|D2 RO|d2 ro
944243|NCT03518606|Immunotherapy|immunotherapy
944244|NCT03518606|Early phase|early phase
944245|NCT03518606|Combination study|combination study
944246|NCT03518580|mobile technology|mobile technology
944247|NCT03518580|real-time assessment|real-time assessment
944248|NCT03518580|active life engagement|active life engagement
944249|NCT03518515|nutrition intervention|nutrition intervention
944250|NCT03518515|potato consumption|potato consumption
944251|NCT03518515|energy balance|energy balance
944252|NCT03518437|coronary artery disease|coronary artery disease
944254|NCT03518437|MACE|mace
944255|NCT03518424|Association football|association football
944256|NCT03518424|Soccer|soccer
944257|NCT03518424|Injury|injury
944258|NCT03518424|Epidemiology|epidemiology
944259|NCT03518398|Intense pulsed light|intense pulsed light
944260|NCT03518398|Meibomian gland dysfunction|meibomian gland dysfunction
944261|NCT03518398|Dry eye|dry eye
944262|NCT03518398|cytokines|cytokines
944263|NCT03518372|Hypoxia|hypoxia
944264|NCT03518372|Myocardial Injury|myocardial injury
944265|NCT03518372|Surgery--Complications|surgery--complications
944266|NCT03518372|Tissue Oximetry|tissue oximetry
944267|NCT03518372|Near-infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
944268|NCT03518359|Residents|residents
944269|NCT03518359|Stress|stress
944270|NCT03518359|Well-being|well-being
944271|NCT03518320|Bladder Cancer|bladder cancer
944272|NCT03518320|Urothelial Carcinoma|urothelial carcinoma
944273|NCT03518320|Cystectomy|cystectomy
944274|NCT03518320|Radical Cystectomy|radical cystectomy
944275|NCT03518307|Merkel carcinoma|merkel carcinoma
944276|NCT03518294|NAFLD|nafld
944277|NCT03518294|NASH|nash
944278|NCT03518268|probiotics|probiotics
944279|NCT03518268|aromatase inhibitors|aromatase inhibitors
944280|NCT03518268|bone mass|bone mass
944281|NCT03518268|postmenopausal|postmenopausal
944282|NCT03518255|Nursing Care|nursing care
944283|NCT03518255|Complementary therapies|complementary therapies
944284|NCT03518255|Oncological Nursing|oncological nursing
944285|NCT03518255|Photography|photography
944286|NCT03518229|cancer prevention|cancer prevention
944287|NCT03518229|sunburn|sunburn
944288|NCT03518216|cognitive behavioral therapy|cognitive behavioral therapy
944289|NCT03518216|mindfulness meditation|mindfulness meditation
944290|NCT03518216|fMRI|fmri
944291|NCT03518216|neuroimaging|neuroimaging
944292|NCT03518203|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
944293|NCT03518164|ACDF|acdf
944294|NCT03518164|allograft|allograft
944295|NCT03518164|autograft|autograft
944296|NCT03518164|cervical fusion|cervical fusion
944297|NCT03518164|NDI|ndi
944298|NCT03518164|EQ-5D|eq-5d
944299|NCT03518164|PROMIS-PF|promis-pf
944300|NCT03518164|DSQ|dsq
944301|NCT03518151|public health|public health
944302|NCT03518151|dietary inequalities|dietary inequalities
944303|NCT03518151|environment design|environment design
944304|NCT03518125|Anthrax|anthrax
944305|NCT03518125|Bacillaceae Infections|bacillaceae infections
944306|NCT03518125|Gram-Positive Bacterial Infections|gram-positive bacterial infections
944307|NCT03518125|Bacterial Infections|bacterial infections
944308|NCT03518125|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
944309|NCT03518125|BioThrax|biothrax
944310|NCT03518125|AV7909|av7909
944311|NCT03518125|CPG 7909|cpg 7909
944312|NCT03518125|Adjuvant|adjuvant
944314|NCT03518125|Post-exposure Prophylaxis|post-exposure prophylaxis
944315|NCT03518112|Leukemia|leukemia
944316|NCT03518112|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
944317|NCT03518112|ALL|all
944318|NCT03518112|Relapsed/Refractory|relapsed/refractory
944319|NCT03518112|Philadelphia Chromosome Negative|philadelphia chromosome negative
944320|NCT03518112|Cyclophosphamide|cyclophosphamide
944321|NCT03518112|Cytoxan|cytoxan
944322|NCT03518112|Neosar|neosar
944323|NCT03518112|Mesna|mesna
944324|NCT03518112|Mesnex|mesnex
944325|NCT03518112|Vincristine|vincristine
944326|NCT03518112|Dexamethasone|dexamethasone
944327|NCT03518112|Decadron|decadron
944328|NCT03518112|G-CSF|g-csf
944329|NCT03518112|Filgrastim|filgrastim
944330|NCT03518112|Neupogen|neupogen
944331|NCT03518112|Methotrexate|methotrexate
944332|NCT03518112|Cytarabine|cytarabine
944333|NCT03518112|Ara-C|ara-c
944334|NCT03518112|Cytosar|cytosar
944335|NCT03518112|DepoCyt|depocyt
944336|NCT03518112|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
944337|NCT03518112|Rituximab|rituximab
944338|NCT03518112|Rituxan|rituxan
944339|NCT03518112|Blinatumomab|blinatumomab
944340|NCT03518086|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
944341|NCT03518086|IL-23p19|il-23p19
944342|NCT03518073|Memory problems|memory problems
944343|NCT03518073|Cognitive impairment|cognitive impairment
944344|NCT03518073|PERISCOPE-ALZ|periscope-alz
944345|NCT03518073|Dementia|dementia
944346|NCT03518073|Tauopathy|tauopathy
944347|NCT03518073|Neurofibrillary tangles|neurofibrillary tangles
944348|NCT03518060|2 drug regimen|2 drug regimen
944349|NCT03518060|Juluca|juluca
944350|NCT03518060|Rilpivirine|rilpivirine
944351|NCT03518060|Dolutegravir|dolutegravir
944352|NCT03518060|Antiretroviral|antiretroviral
944353|NCT03518060|One pill regimen|one pill regimen
944354|NCT03518047|Plaque Psoriasis|plaque psoriasis
944355|NCT03518034|hypogonadism|hypogonadism
944356|NCT03518034|cardiovascular (CV) disease|cardiovascular (cv) disease
944357|NCT03518034|AndroGel|androgel
944358|NCT03518034|testosterone replacement therapy (TRT)|testosterone replacement therapy (trt)
944359|NCT03518021|Naloxone|naloxone
944360|NCT03518021|Administration, Intranasal|administration, intranasal
944361|NCT03518021|Injections, Intramuscular|injections, intramuscular
944362|NCT03518021|Narcotic Antagonists|narcotic antagonists
944363|NCT03517995|primary bladder tumor|primary bladder tumor
944364|NCT03517995|non-muscle invasive bladder tumor|non-muscle invasive bladder tumor
944365|NCT03517995|muscle invasive bladder tumor|muscle invasive bladder tumor
944366|NCT03517995|sulforaphane|sulforaphane
944367|NCT03517995|chemoprevention|chemoprevention
944369|NCT03517982|Mycophenolate Mofetil|mycophenolate mofetil
944370|NCT03517982|End stage renal disease|end stage renal disease
944371|NCT03517982|De novo Renal transplant|de novo renal transplant
944372|NCT03517982|Post authorization safety study|post authorization safety study
944373|NCT03517982|Immunosuppressant|immunosuppressant
944374|NCT03517982|Cohort study|cohort study
944375|NCT03517956|Phase I|phase i
944376|NCT03517956|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
944377|NCT03517956|Urothelial cancer|urothelial cancer
944378|NCT03517956|FGFR inhibitor|fgfr inhibitor
944379|NCT03517943|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
944380|NCT03517930|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
944381|NCT03517904|Femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy|femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy
944382|NCT03517891|Physical activity|physical activity
944383|NCT03517891|Sleep pattern|sleep pattern
944384|NCT03517891|Nutrition|nutrition
944385|NCT03517891|Education|education
944386|NCT03517878|Community Health Worker|community health worker
944387|NCT03517878|Pregnancy|pregnancy
944388|NCT03517878|Breast Feeding|breast feeding
944389|NCT03517878|Child Development|child development
944390|NCT03517878|Home Visits|home visits
944391|NCT03517878|Infants|infants
944392|NCT03517839|Dyspnea|dyspnea
944393|NCT03517839|Inspiratory Muscle Training|inspiratory muscle training
944394|NCT03517839|Kinesiophobia|kinesiophobia
944395|NCT03517826|COPD|copd
944396|NCT03517826|Dyspnea|dyspnea
944397|NCT03517826|Kinesiophobia|kinesiophobia
944398|NCT03517800|Embolization|embolization
944399|NCT03517800|surgery|surgery
944400|NCT03517800|hysterectomy|hysterectomy
944401|NCT03517800|arterial ligation|arterial ligation
944403|NCT03517761|Bone Marrow Concentrate|bone marrow concentrate
944404|NCT03517761|Stem Cell Therapy|stem cell therapy
944405|NCT03517761|Alar Ligament|alar ligament
944406|NCT03517761|Transverse Ligament|transverse ligament
944407|NCT03517670|Cerebral vasospasm|cerebral vasospasm
944408|NCT03517670|Subarachnoid hemorrhage|subarachnoid hemorrhage
944409|NCT03517670|Milrinone|milrinone
944410|NCT03517670|Hemodynamic tolerance|hemodynamic tolerance
944411|NCT03517657|upper limb|upper limb
944412|NCT03517657|occupational therapy|occupational therapy
944413|NCT03517657|bilateral priming|bilateral priming
944414|NCT03517631|HIV|hiv
944419|NCT03517631|Gene therapy|gene therapy
944420|NCT03517618|A phase II study|a phase ii study
944421|NCT03517618|Heavily pre-treated metastatic colorectal cancer|heavily pre-treated metastatic colorectal cancer
944422|NCT03517618|S-1|s-1
944423|NCT03517618|oral leucovrin|oral leucovrin
944424|NCT03517605|Cardiac Rehabilitation|cardiac rehabilitation
944425|NCT03517605|Quality of Life|quality of life
944426|NCT03517605|Rehabilitation Nursing|rehabilitation nursing
944427|NCT03517566|atopic dermatitis, AD, eczema, atopic eczema, itch, pruritus, histamine 4 receptor|atopic dermatitis, ad, eczema, atopic eczema, itch, pruritus, histamine 4 receptor
944428|NCT03517566|antagonist, H4R, ZPL389, ZPL389A2203, dermatitis|antagonist, h4r, zpl389, zpl389a2203, dermatitis
944429|NCT03517553|electrical muscle stimulation|electrical muscle stimulation
944430|NCT03517540|Steatohepatitis|steatohepatitis
944431|NCT03517540|NASH|nash
944432|NCT03517540|NAFLD|nafld
944433|NCT03517540|Fatty Liver Disease|fatty liver disease
944434|NCT03517540|Liver|liver
944435|NCT03517527|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
944436|NCT03517527|Metabolic Control|metabolic control
944437|NCT03517527|Walking Exercise|walking exercise
944438|NCT03517527|Transtheoretical Model|transtheoretical model
944439|NCT03517527|Nurse|nurse
944440|NCT03517514|Heart Failure|heart failure
1634347|NCT00266604|seizures|seizures
944441|NCT03517514|Physical Therapy|physical therapy
944442|NCT03517514|Hospital Readmission|hospital readmission
944443|NCT03517488|DUET-2|duet-2
944444|NCT03517488|Melanoma|melanoma
944445|NCT03517488|Triple Negative Breast Cancer|triple negative breast cancer
944446|NCT03517488|Hepatocellular|hepatocellular
944447|NCT03517488|Urothelial Cancer|urothelial cancer
944448|NCT03517488|Bladder Cancer|bladder cancer
944449|NCT03517488|Renal Cell Cancer|renal cell cancer
944450|NCT03517488|Head and Neck Cancer|head and neck cancer
944451|NCT03517488|MSI-high Colorectal Cancer|msi-high colorectal cancer
944452|NCT03517488|MSI-high Endometrial Cancer|msi-high endometrial cancer
944453|NCT03517488|Non-small Cell Lung Cancer|non-small cell lung cancer
944454|NCT03517488|Gastric Cancer|gastric cancer
944455|NCT03517488|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
944456|NCT03517462|mass drug administration|mass drug administration
944457|NCT03517462|ophthalmology|ophthalmology
944458|NCT03517449|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
944459|NCT03517449|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
944460|NCT03517449|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
944461|NCT03517449|vascular endothelial growth factor (VEGF) receptors|vascular endothelial growth factor (vegf) receptors
944462|NCT03517449|lenvatinib|lenvatinib
944463|NCT03517449|pembrolizumab|pembrolizumab
944464|NCT03517449|doxorubicin|doxorubicin
944465|NCT03517449|paclitaxel|paclitaxel
944466|NCT03517449|phase 3 endometrial cancer|phase 3 endometrial cancer
944467|NCT03517436|THV|thv
944468|NCT03517436|Transcatheter Heart Valve|transcatheter heart valve
944469|NCT03517436|CENTERA|centera
944470|NCT03517436|self-expanding|self-expanding
944471|NCT03517423|brivaracetam|brivaracetam
944472|NCT03517423|post-marketing observational study|post-marketing observational study
944473|NCT03517410|Mechanical Low Back Pain|mechanical low back pain
944474|NCT03517410|Smart phone|smart phone
944475|NCT03517410|Low Back Pain|low back pain
944476|NCT03517410|Chronic Mechanical Low Back Pain|chronic mechanical low back pain
944477|NCT03517410|CLBP|clbp
944478|NCT03517397|Smoking Cessation|smoking cessation
944479|NCT03517397|Socioeconomic Disadvantage|socioeconomic disadvantage
944480|NCT03517397|Contingency Management|contingency management
944481|NCT03517397|Financial Incentives|financial incentives
944482|NCT03517397|Mobile Health|mobile health
944483|NCT03517397|Biochemical Verification|biochemical verification
944484|NCT03517371|Parkinson disease|parkinson disease
944485|NCT03517371|Walking|walking
944486|NCT03517371|Exercise|exercise
944487|NCT03517371|Mobile Health|mobile health
944488|NCT03517371|Physical Therapy|physical therapy
944489|NCT03517371|Cognitive Behavioral|cognitive behavioral
944490|NCT03517345|Bariatric surgery|bariatric surgery
944491|NCT03517345|Prebiotics|prebiotics
944492|NCT03517345|gut microbiota|gut microbiota
944493|NCT03517345|GLP-1|glp-1
944494|NCT03517345|PYY|pyy
944495|NCT03517306|lung cancer, FDG, PET/CT, radiomics|lung cancer, fdg, pet/ct, radiomics
944496|NCT03517280|Malnutrition|malnutrition
944497|NCT03517280|Childhood Cancer|childhood cancer
944498|NCT03517280|Nutrition Aspect of Cancer|nutrition aspect of cancer
944499|NCT03517280|Child Malnutrition|child malnutrition
944500|NCT03517280|Brazil|brazil
944501|NCT03517280|Sao Paolo|sao paolo
944502|NCT03517254|Glutamine,|glutamine,
944503|NCT03517228|Robotic Uterine Manipulator|robotic uterine manipulator
944504|NCT03517228|18-173|18-173
944505|NCT03517202|Urologic surgery|urologic surgery
944506|NCT03517202|Urinary incontinence|urinary incontinence
944507|NCT03517202|Tension Free Vaginal Tape|tension free vaginal tape
944508|NCT03517202|Post-operative urinary retention|post-operative urinary retention
944509|NCT03517202|Outpatient surgery|outpatient surgery
944510|NCT03517163|Asperger's|asperger's
944511|NCT03517163|autism|autism
944512|NCT03517163|autism spectrum disorder|autism spectrum disorder
944513|NCT03517163|ASD|asd
944514|NCT03517137|advanced Hodgkin lymphoma|advanced hodgkin lymphoma
944515|NCT03517137|brentuximab vedotin|brentuximab vedotin
944516|NCT03517137|phase 2|phase 2
944517|NCT03517124|Zirconium oxide|zirconium oxide
944518|NCT03517124|surface treatment|surface treatment
944519|NCT03517124|resin cement|resin cement
944520|NCT03517098|Enhanced recovery after surgery|enhanced recovery after surgery
944521|NCT03517098|Desflurane|desflurane
944522|NCT03517098|Total hip arthroplasty|total hip arthroplasty
944523|NCT03517098|Total knee arthroplasty|total knee arthroplasty
944524|NCT03517085|glycogen storage disorder Ia|glycogen storage disorder ia
944525|NCT03517085|AAV|aav
944526|NCT03517085|gene therapy|gene therapy
944527|NCT03517085|von Gierke disease|von gierke disease
944528|NCT03517085|glucose metabolism disorder|glucose metabolism disorder
944529|NCT03517059|Levodopa|levodopa
944530|NCT03517059|axial symptoms|axial symptoms
944531|NCT03517046|Arthritis|arthritis
944532|NCT03517046|Articular Cartilage|articular cartilage
944533|NCT03517046|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
944534|NCT03517046|Degenerative Arthritis|degenerative arthritis
1636599|NCT00257114|Retreatment|retreatment
944535|NCT03517046|Cartilage Lesion|cartilage lesion
944536|NCT03517046|Cartilage Defect|cartilage defect
944537|NCT03517007|antibiotic de-escalation|antibiotic de-escalation
944538|NCT03517007|sepsis|sepsis
944539|NCT03517007|antimicrobial stewardship|antimicrobial stewardship
944540|NCT03516994|Advance Care Planning|advance care planning
944541|NCT03516994|Disparities|disparities
944542|NCT03516994|Palliative Care|palliative care
944543|NCT03516994|End of Life Care|end of life care
944544|NCT03516994|African Americans|african americans
944545|NCT03516981|programmed cell death 1 (PD-1)|programmed cell death 1 (pd-1)
944546|NCT03516981|programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
944547|NCT03516981|anti-PD-1|anti-pd-1
944548|NCT03516981|anti PD-1|anti pd-1
944549|NCT03516968|Obesity|obesity
944550|NCT03516968|Vitamin D deficiency,|vitamin d deficiency,
944551|NCT03516968|supplementation,|supplementation,
944552|NCT03516968|Child|child
944553|NCT03516968|Adolescent|adolescent
944554|NCT03516955|Superstat|superstat
944555|NCT03516955|Rosuvastatin|rosuvastatin
944556|NCT03516955|Statins|statins
944557|NCT03516955|LDL-C|ldl-c
944558|NCT03516955|Cholesterol|cholesterol
944559|NCT03516955|Hypercholesterolemia|hypercholesterolemia
944560|NCT03516955|Dyslipidemia|dyslipidemia
944561|NCT03516955|Coronary Artery Disease|coronary artery disease
944562|NCT03516955|Cardiovascular Disease|cardiovascular disease
944563|NCT03516916|Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)|rectal cancer, hrqol, stoma, colostomy, patient reported outcome measure (prom)
944564|NCT03516903|Anterior myocardial infarction|anterior myocardial infarction
944565|NCT03516903|Methotrexate|methotrexate
944566|NCT03516903|Myocardial remodeling|myocardial remodeling
944567|NCT03516890|Partial hepatectomy|partial hepatectomy
944568|NCT03516890|Emergency|emergency
944569|NCT03516890|Staged|staged
944570|NCT03516890|Peritoneal dissemination|peritoneal dissemination
944571|NCT03516890|Propensity score matching|propensity score matching
944572|NCT03516877|Mindfulness-Bases Stress Reduction, Stress, Resilience, Well-being|mindfulness-bases stress reduction, stress, resilience, well-being
944573|NCT03516864|tissue oxygenation|tissue oxygenation
944574|NCT03516864|near-infrared|near-infrared
944575|NCT03516864|diabetic foot ulcer (DFU)|diabetic foot ulcer (dfu)
944576|NCT03516864|diabetes|diabetes
944577|NCT03516864|vascularity|vascularity
944578|NCT03516851|Moyamoya Disease|moyamoya disease
944579|NCT03516851|multimodal neuronavigation|multimodal neuronavigation
944580|NCT03516851|flow800|flow800
944581|NCT03516851|direct revascularization|direct revascularization
944582|NCT03516838|Dental caries|dental caries
944583|NCT03516838|Class II|class ii
944584|NCT03516838|Primary molar|primary molar
944585|NCT03516838|Restorative material|restorative material
944586|NCT03516838|Bioactive material|bioactive material
944587|NCT03516838|Compomer|compomer
944588|NCT03516838|Activa bioactive|activa bioactive
944589|NCT03516838|Ryge criteria|ryge criteria
944590|NCT03516825|Musical Neglect Training|musical neglect training
944591|NCT03516825|Neurologic Music Therapy|neurologic music therapy
944592|NCT03516825|unilateral visual neglect|unilateral visual neglect
944593|NCT03516825|hemispatial neglect|hemispatial neglect
944594|NCT03516825|stroke|stroke
944595|NCT03516825|spatial perception and attention|spatial perception and attention
944596|NCT03516825|music therapy|music therapy
944597|NCT03516799|pain management of adolescent and young adults with cancer|pain management of adolescent and young adults with cancer
944598|NCT03516773|Hypoparathyroidism, PTH(1-34), Parathyroid Hormone|hypoparathyroidism, pth(1-34), parathyroid hormone
944599|NCT03516747|cytology|cytology
944600|NCT03516747|parathyroidectomy|parathyroidectomy
944601|NCT03516747|parathyroid hormone level|parathyroid hormone level
944602|NCT03516734|Iron deficiency|iron deficiency
944603|NCT03516734|Food-based dietary intervention|food-based dietary intervention
944604|NCT03516695|Registry|registry
944605|NCT03516695|Liver Cancers|liver cancers
944606|NCT03516695|HCC|hcc
944607|NCT03516695|Dosimetry|dosimetry
944608|NCT03516695|Simplicit90Y™|simplicit90y™
944609|NCT03516695|TheraSphere®|therasphere®
944610|NCT03516682|Logistic Barriers to Vaccination|logistic barriers to vaccination
944611|NCT03516669|Lansoprazole, Amoxicillin, clarithromycin|lansoprazole, amoxicillin, clarithromycin
944612|NCT03516630|Trazodone|trazodone
944613|NCT03516630|QTc interval|qtc interval
944614|NCT03516630|Moxifloxacin|moxifloxacin
944615|NCT03516578|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
944616|NCT03516578|cardiac magnetic resonance|cardiac magnetic resonance
944617|NCT03516578|prognosis|prognosis
944618|NCT03516565|gingivitis|gingivitis
944619|NCT03516565|saliva|saliva
944620|NCT03516565|gingival crevicular fluid|gingival crevicular fluid
944621|NCT03516539|Videolaryngoscopy|videolaryngoscopy
944622|NCT03516526|natalizumab|natalizumab
944623|NCT03516487|PKU|pku
944624|NCT03516474|nir|nir
944625|NCT03516474|diabetes|diabetes
944626|NCT03516474|diabetic foot ulcer (DFU).|diabetic foot ulcer (dfu).
944627|NCT03516474|wound|wound
944628|NCT03516461|Gut Microbiota|gut microbiota
944629|NCT03516461|Selective Microbiota Transplantation|selective microbiota transplantation
944630|NCT03516461|Radiation Enteritis|radiation enteritis
944631|NCT03516435|Intravaginal electrical stimulation|intravaginal electrical stimulation
944632|NCT03516435|Parasacral transcutaneous electrical stimulation|parasacral transcutaneous electrical stimulation
944633|NCT03516422|ultrasound debridement|ultrasound debridement
944634|NCT03516422|diabetic foot ulcer|diabetic foot ulcer
944635|NCT03516422|chronic wound|chronic wound
944636|NCT03516422|biofilm|biofilm
944637|NCT03516409|probiotics|probiotics
944638|NCT03516409|prebiotics|prebiotics
944639|NCT03516409|diarrhoea|diarrhoea
944640|NCT03516396|Nepal|nepal
944641|NCT03516396|child growth|child growth
944642|NCT03516396|nutrition education|nutrition education
944643|NCT03516396|community development|community development
944644|NCT03516370|chronic periodontitis|chronic periodontitis
944645|NCT03516370|Sacchraomyces boulardii|sacchraomyces boulardii
944646|NCT03516370|probiotics|probiotics
944647|NCT03516344|Breathing Exercises|breathing exercises
944648|NCT03516344|Manipulation, Osteopathic|manipulation, osteopathic
944649|NCT03516344|Quantitative Ultrasonography|quantitative ultrasonography
944650|NCT03516344|Therapy, Soft Tissue|therapy, soft tissue
944651|NCT03516344|Portal Vein|portal vein
944652|NCT03516344|Venous flow|venous flow
944653|NCT03516331|Cystic Fibrosis|cystic fibrosis
944654|NCT03516318|HIV|hiv
944655|NCT03516318|Youth|youth
944656|NCT03516318|Social support|social support
944657|NCT03516318|Social media|social media
944658|NCT03516318|Retention|retention
944659|NCT03516292|overactive bladder|overactive bladder
944660|NCT03516292|biomarker|biomarker
944661|NCT03516292|nerve growth factor|nerve growth factor
944662|NCT03516292|vaginal prolapse|vaginal prolapse
944663|NCT03516292|urinary incontinence|urinary incontinence
944664|NCT03516266|Pelvic floor muscle strength|pelvic floor muscle strength
944665|NCT03516266|Premenopausal nullipara|premenopausal nullipara
944666|NCT03516266|Childbirth|childbirth
944667|NCT03516266|Postmenopausal|postmenopausal
944668|NCT03516214|Acquired resistance|acquired resistance
944669|NCT03516214|EGFR p.T790M-positive|egfr p.t790m-positive
944670|NCT03516201|bariatric surgery|bariatric surgery
944671|NCT03516201|Periodontitis|periodontitis
944672|NCT03516201|Caries|caries
944673|NCT03516201|erosive tooth wear|erosive tooth wear
944674|NCT03516201|Gingivitis|gingivitis
944675|NCT03516201|BMI|bmi
944676|NCT03516201|oral health|oral health
944677|NCT03516201|obesity|obesity
944678|NCT03516188|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
944679|NCT03516188|Acid pocket|acid pocket
944680|NCT03516188|Acid Reflux|acid reflux
944681|NCT03516188|Alginate antacid|alginate antacid
944682|NCT03516188|Obesity|obesity
944683|NCT03516162|Behaviour|behaviour
944684|NCT03516162|Brain Tumor|brain tumor
944685|NCT03516162|Hydrocephalus|hydrocephalus
944686|NCT03516162|Smartphone|smartphone
944687|NCT03516162|Big Data|big data
944688|NCT03516162|Neuropsychology|neuropsychology
944689|NCT03516162|Neuroradiology|neuroradiology
944690|NCT03516162|Neurosurgery|neurosurgery
944691|NCT03516162|Outcome Assessment|outcome assessment
944692|NCT03516162|Functional Impairment|functional impairment
944693|NCT03516162|Cognitive Function|cognitive function
944694|NCT03516162|Touchscreen|touchscreen
944695|NCT03516149|elbow|elbow
944696|NCT03516149|foam rolling|foam rolling
944697|NCT03516149|proprioception|proprioception
944698|NCT03516149|sensorimotor|sensorimotor
944699|NCT03516149|acute|acute
944700|NCT03516071|Hepatocellular Carcinoma, HCC, Brivanib|hepatocellular carcinoma, hcc, brivanib
944701|NCT03516045|18F-AlF-NOTA-neurotensin|18f-alf-nota-neurotensin
944702|NCT03516032|exercises therapy|exercises therapy
944703|NCT03516032|rehabilitation|rehabilitation
944704|NCT03516032|aged|aged
944705|NCT03516032|inpatients|inpatients
944706|NCT03516019|mHealth|mhealth
944707|NCT03516019|digital BP monitoring|digital bp monitoring
944708|NCT03516019|patient provider communication|patient provider communication
944709|NCT03516019|smart watch|smart watch
944710|NCT03516019|user engagement|user engagement
944711|NCT03516019|population health data|population health data
944712|NCT03515993|long-term survival|long-term survival
944713|NCT03515993|gynecologic cancer|gynecologic cancer
944714|NCT03515993|quality of life|quality of life
944715|NCT03515967|concussion, mild traumatic brain injury|concussion, mild traumatic brain injury
944716|NCT03515954|conjunctiva|conjunctiva
944717|NCT03515954|squamous neoplasia|squamous neoplasia
944718|NCT03515954|amniotic|amniotic
944719|NCT03515941|chemotherapy|chemotherapy
944720|NCT03515941|chemoradiation|chemoradiation
944721|NCT03515928|Ultrasound, Hearing|ultrasound, hearing
944722|NCT03515915|multiple myeloma|multiple myeloma
944723|NCT03515915|HDAC inhibitor|hdac inhibitor
944724|NCT03515915|Biomarker|biomarker
944725|NCT03515902|Dentine Hypersensitivity|dentine hypersensitivity
944726|NCT03515902|Toothpaste|toothpaste
944727|NCT03515902|Tooth erosion|tooth erosion
944728|NCT03515837|PD1|pd1
944729|NCT03515837|PD-1|pd-1
944730|NCT03515837|PDL1|pdl1
944731|NCT03515837|PD-L1|pd-l1
944732|NCT03515785|acute lymphoblastic leukemia|acute lymphoblastic leukemia
944733|NCT03515785|ponatinib|ponatinib
944734|NCT03515785|tyrosine kinase inhibitor|tyrosine kinase inhibitor
944735|NCT03515772|dolutegravir|dolutegravir
944736|NCT03515772|darunavir|darunavir
944737|NCT03515772|amlodipine|amlodipine
944738|NCT03515772|rosuvastatin|rosuvastatin
944739|NCT03515772|atorvastatin|atorvastatin
944740|NCT03515759|PREECLAMPSIA|preeclampsia
944741|NCT03515759|DOPPLER|doppler
944742|NCT03515759|IUGR|iugr
944743|NCT03515759|UMBILICAL ARTERY|umbilical artery
944744|NCT03515759|MIDDLE CEREBRAL ARTERY|middle cerebral artery
944745|NCT03515746|exergaming|exergaming
944746|NCT03515746|physiotherapy|physiotherapy
944747|NCT03515746|upper extremities|upper extremities
944748|NCT03515746|telerehabilitation|telerehabilitation
944749|NCT03515694|Bridion|bridion
944750|NCT03515694|Sugammadex|sugammadex
944751|NCT03515694|TOF|tof
944752|NCT03515681|Text messaging|text messaging
944753|NCT03515642|Gut microbiota|gut microbiota
944754|NCT03515642|Hepatic function|hepatic function
944755|NCT03515642|Obesity|obesity
944756|NCT03515642|Exercise|exercise
944757|NCT03515629|Stage IIIB|stage iiib
944758|NCT03515629|Stage IV|stage iv
944759|NCT03515629|Non-squamous NSCLC|non-squamous nsclc
944760|NCT03515629|Squamous NSCLC|squamous nsclc
944761|NCT03515551|Melanoma|melanoma
944762|NCT03515551|Lung Cancer|lung cancer
944763|NCT03515551|Bladder Cancer|bladder cancer
944764|NCT03515551|Sarcoma|sarcoma
944765|NCT03515551|IMCnyeso|imcnyeso
944766|NCT03515551|Immunotherapy|immunotherapy
944767|NCT03515538|head and neck cancer|head and neck cancer
944768|NCT03515538|squamous|squamous
944769|NCT03515538|neck cancer|neck cancer
944770|NCT03515538|oral cancer|oral cancer
944771|NCT03515538|mucositis|mucositis
944772|NCT03515538|sores|sores
944773|NCT03515538|mouth|mouth
944774|NCT03515525|Breast surgery|breast surgery
944775|NCT03515525|Closed-suction drains|closed-suction drains
944776|NCT03515512|Acute Myeloid Leukemia|acute myeloid leukemia
944777|NCT03515512|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
944778|NCT03515499|Adherence|adherence
944779|NCT03515499|Incentives|incentives
944780|NCT03515486|Stroke|stroke
944781|NCT03515486|Cerebellum|cerebellum
944782|NCT03515486|Depression|depression
944783|NCT03515486|Anxiety|anxiety
944784|NCT03515486|Mood|mood
944785|NCT03515486|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
944786|NCT03515473|cochlear implant|cochlear implant
944787|NCT03515473|CI532|ci532
944788|NCT03515473|CI512|ci512
944789|NCT03515473|CI522|ci522
944790|NCT03515473|electrode array|electrode array
944791|NCT03515473|perimodiolar|perimodiolar
944792|NCT03515473|electrophysiology|electrophysiology
944793|NCT03515460|vascular endothelial function|vascular endothelial function
944794|NCT03515460|systemic microvascular reactivity|systemic microvascular reactivity
944795|NCT03515460|dysglycemia|dysglycemia
944796|NCT03515460|dyslipidemia|dyslipidemia
944797|NCT03515447|transfusion saving strategy|transfusion saving strategy
944798|NCT03515447|heart or lung transplantation|heart or lung transplantation
944799|NCT03515447|assist device|assist device
944800|NCT03515447|Extra Corporal Life Support (ECLS)|extra corporal life support (ecls)
944801|NCT03515447|Left Ventricular Assist Device (LVAD )|left ventricular assist device (lvad )
944802|NCT03515447|Total artificial Heart|total artificial heart
944803|NCT03515408|fMRI|fmri
944804|NCT03515408|rTMS|rtms
944805|NCT03515408|functional connectivity|functional connectivity
944806|NCT03515395|exergaming|exergaming
944807|NCT03515395|hip fracture|hip fracture
944808|NCT03515395|training|training
944809|NCT03515395|acceptance|acceptance
944810|NCT03515369|hepatocellular carcinoma|hepatocellular carcinoma
944811|NCT03515369|tumor recurrence|tumor recurrence
944812|NCT03515369|adjuvant therapy|adjuvant therapy
944813|NCT03515369|traditional Chinese medicine|traditional chinese medicine
944814|NCT03515343|Cancer prevention|cancer prevention
944815|NCT03515343|Endoscopy|endoscopy
944816|NCT03515343|Gastroenterology|gastroenterology
944817|NCT03515330|mHealth|mhealth
944818|NCT03515330|liver transplantation|liver transplantation
944819|NCT03515330|medication adherence|medication adherence
944820|NCT03515330|video directly observed therapy|video directly observed therapy
944821|NCT03515317|Cognitive impairments|cognitive impairments
944822|NCT03515317|Low Resolution tomography|low resolution tomography
944823|NCT03515317|Neurofeedback|neurofeedback
944824|NCT03515317|Traumatic brain injury|traumatic brain injury
944825|NCT03515291|Heart|heart
944826|NCT03515291|CABG|cabg
944827|NCT03515291|Injection|injection
944828|NCT03515291|Scar|scar
944829|NCT03515291|Fibrosis|fibrosis
944830|NCT03515291|Cell|cell
944833|NCT03515291|MRI|mri
944834|NCT03515291|Randomized|randomized
944835|NCT03515278|Frozen shoulder|frozen shoulder
944836|NCT03515278|adhesive capsulitis|adhesive capsulitis
944837|NCT03515278|ultrasound-guided intervention|ultrasound-guided intervention
944838|NCT03515278|suprascapular nerve block|suprascapular nerve block
944839|NCT03515278|intra-articular injection|intra-articular injection
944840|NCT03515265|Fiber reinforced composite|fiber reinforced composite
944841|NCT03515265|Microhybrid composite|microhybrid composite
944842|NCT03515226|workforce development|workforce development
944843|NCT03515226|intelligent tutoring systems|intelligent tutoring systems
944844|NCT03515187|Dug induced dry eye|dug induced dry eye
944845|NCT03515187|meibomian gland dysfunction, MGD|meibomian gland dysfunction, mgd
944846|NCT03515187|Sodium hyaluronate ophthalmic solution|sodium hyaluronate ophthalmic solution
944847|NCT03515187|Sodium bromide hydrate eye drops|sodium bromide hydrate eye drops
944848|NCT03515187|Meibomian gland massage|meibomian gland massage
944849|NCT03515174|Adolescent and Young Adult Oncology|adolescent and young adult oncology
944850|NCT03515174|Carcinoma|carcinoma
944851|NCT03515174|Lymphoma|lymphoma
944852|NCT03515174|Sarcoma|sarcoma
944853|NCT03515174|Cancer|cancer
944856|NCT03515148|Achilles Tendinopathy|achilles tendinopathy
944857|NCT03515148|Rectus Abominis|rectus abominis
944858|NCT03515148|Vibration|vibration
944859|NCT03515148|Cryotherapy|cryotherapy
944860|NCT03515148|Eccentric Exercise|eccentric exercise
944861|NCT03515135|ADHD|adhd
944862|NCT03515135|executive function|executive function
944863|NCT03515135|preschool|preschool
944864|NCT03515135|intervention|intervention
944865|NCT03515122|Epidemiology|epidemiology
944866|NCT03515122|Rehabilitation|rehabilitation
944867|NCT03515122|Clinical protocols|clinical protocols
944868|NCT03515122|Middle aged|middle aged
944869|NCT03515109|stress incontinence|stress incontinence
944870|NCT03515109|female|female
944871|NCT03515109|altis|altis
944872|NCT03515109|transobturator tape|transobturator tape
944873|NCT03515109|minisling|minisling
944874|NCT03515096|rhTPO|rhtpo
944875|NCT03515096|HSCT|hsct
944876|NCT03515096|Thrombopoietin|thrombopoietin
944877|NCT03515083|apixaban|apixaban
944878|NCT03515083|atrial fibrillation|atrial fibrillation
944879|NCT03515070|Gastrointestinal Microbiome|gastrointestinal microbiome
944880|NCT03515070|Genetics|genetics
944881|NCT03515031|High Flow Nasal Cannula|high flow nasal cannula
944882|NCT03515031|Venturi mask|venturi mask
944883|NCT03515018|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
944884|NCT03515018|hydroxyurea|hydroxyurea
944885|NCT03515018|Imatinib Mesylate|imatinib mesylate
944886|NCT03515018|Pulse Therapy, Drug|pulse therapy, drug
944887|NCT03515005|Hypertension|hypertension
944888|NCT03515005|Community Health Workers|community health workers
944889|NCT03515005|Community-Based Participatory Research|community-based participatory research
944890|NCT03515005|Health Equity|health equity
944891|NCT03514992|Developmental Dysgraphia|developmental dysgraphia
944892|NCT03514992|Ambidexterity|ambidexterity
944893|NCT03514992|Outcom study|outcom study
944894|NCT03514966|Position change|position change
944895|NCT03514966|Gastric cleanliness|gastric cleanliness
944896|NCT03514966|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
944897|NCT03514914|LARC, contraception, family planning, India, male engagement|larc, contraception, family planning, india, male engagement
944898|NCT03514888|High-risk bladder cancer|high-risk bladder cancer
944899|NCT03514888|Urothelial cancer|urothelial cancer
944900|NCT03514888|HIPEC|hipec
944901|NCT03514888|Mitomycin|mitomycin
944902|NCT03514836|Castrate-resistant|castrate-resistant
944903|NCT03514810|Major depressive disorder|major depressive disorder
944904|NCT03514810|sertraline|sertraline
944905|NCT03514810|ketoprofen|ketoprofen
944906|NCT03514797|Tooth bleaching|tooth bleaching
944907|NCT03514797|Hydrogen peroxide|hydrogen peroxide
944908|NCT03514797|Carbamide peroxide|carbamide peroxide
944909|NCT03514797|Tooth Bleaching Agents|tooth bleaching agents
944910|NCT03514784|Autism Spectrum Disorder, Gastrointestinal Symptoms, Constipation, Diarrhea,|autism spectrum disorder, gastrointestinal symptoms, constipation, diarrhea,
944911|NCT03514719|89Zr-avelumab PET|89zr-avelumab pet
944912|NCT03514719|avelumab|avelumab
944913|NCT03514706|Extravascular lung water|extravascular lung water
944914|NCT03514706|one lung ventilation|one lung ventilation
944915|NCT03514706|volume controlled ventilation|volume controlled ventilation
944916|NCT03514706|pressure controlled ventilation|pressure controlled ventilation
944917|NCT03514693|Persistent atrial fibrillation|persistent atrial fibrillation
944918|NCT03514693|non-inferiority trial|non-inferiority trial
944919|NCT03514680|Cancer Care|cancer care
944920|NCT03514654|Breast Cancer|breast cancer
944921|NCT03514654|Mastectomy|mastectomy
944922|NCT03514654|Therapeutic Mammoplasty|therapeutic mammoplasty
944923|NCT03514654|Multiple Ipsilateral Breast Cancers|multiple ipsilateral breast cancers
944924|NCT03514628|Valsalva Manoeuvre|valsalva manoeuvre
944925|NCT03514628|SVT|svt
944930|NCT03514563|Cleft Lip and Palate|cleft lip and palate
944931|NCT03514563|Maxillofacial|maxillofacial
944932|NCT03514563|Growth|growth
944934|NCT03514498|anesthesia|anesthesia
944935|NCT03514485|asthma disparities|asthma disparities
944936|NCT03514485|community health worker|community health worker
944937|NCT03514485|childhood asthma|childhood asthma
944938|NCT03514472|Hb, Anemia,|hb, anemia,
944939|NCT03514433|Patient Navigation|patient navigation
944940|NCT03514433|Disparity|disparity
944941|NCT03514433|Social Determinants|social determinants
944942|NCT03514420|Lipodystrophy|lipodystrophy
944943|NCT03514420|Lipodystrophy, Familial Partial|lipodystrophy, familial partial
944944|NCT03514420|Lipid Metabolism Disorders|lipid metabolism disorders
944945|NCT03514420|Dyslipidemias|dyslipidemias
944946|NCT03514420|Kobberling-Dunnigan syndrome (type 1 and 2)|kobberling-dunnigan syndrome (type 1 and 2)
944947|NCT03514420|Lipoatrophic Diabetes|lipoatrophic diabetes
944948|NCT03514407|Relapsed Ewing sarcoma|relapsed ewing sarcoma
944949|NCT03514407|refractory Ewing sarcoma|refractory ewing sarcoma
944950|NCT03514407|bromodomain-containing protein (BRD) inhibitor|bromodomain-containing protein (brd) inhibitor
944951|NCT03514407|lysine demethylase 1 (LSD1) inhibitor|lysine demethylase 1 (lsd1) inhibitor
944952|NCT03514381|Soft Tissue Sarcoma|soft tissue sarcoma
944953|NCT03514381|Ifosfamide|ifosfamide
944954|NCT03514381|Aprepitant|aprepitant
944955|NCT03514381|Doxorubicin|doxorubicin
944960|NCT03514342|Heart rate variability|heart rate variability
944961|NCT03514342|Scotopic pupil size|scotopic pupil size
944962|NCT03514329|Non Small Cell Lung Cancer|non small cell lung cancer
944963|NCT03514329|Metastatic Lung Cancer|metastatic lung cancer
944964|NCT03514329|Lung Cancer|lung cancer
944965|NCT03514329|Vapor Ablation|vapor ablation
944966|NCT03514329|BTVA|btva
944967|NCT03514316|gingival overgrowth|gingival overgrowth
944968|NCT03514316|diode laser gingivectomy|diode laser gingivectomy
944969|NCT03514316|scalpel gingivectomy|scalpel gingivectomy
944970|NCT03514316|orthodontic treatment|orthodontic treatment
944971|NCT03514303|Skin test, Microarray test|skin test, microarray test
944972|NCT03514290|Laser|laser
944973|NCT03514290|Color|color
944974|NCT03514264|Endodontics|endodontics
944975|NCT03514264|Biomaterials|biomaterials
944976|NCT03514264|Dental pulp cavity|dental pulp cavity
944977|NCT03514264|Periapical abscess|periapical abscess
944978|NCT03514264|Root canal therapy|root canal therapy
944979|NCT03514264|Root canal obturation|root canal obturation
944980|NCT03514251|Thyroid Cancer|thyroid cancer
944981|NCT03514251|Hypoparathyroidism|hypoparathyroidism
944982|NCT03514251|parathyroid marker|parathyroid marker
944983|NCT03514238|Exercise|exercise
944984|NCT03514238|Physical Activity|physical activity
944985|NCT03514238|Cardio-metabolic Health|cardio-metabolic health
944986|NCT03514238|Myokines|myokines
944987|NCT03514238|Cardiorespiratory Fitness|cardiorespiratory fitness
944988|NCT03514238|Obesity|obesity
944989|NCT03514238|Type 2 Diabetes|type 2 diabetes
944990|NCT03514225|Metacognitive Therapy|metacognitive therapy
944991|NCT03514212|physical activity|physical activity
944992|NCT03514212|intervention|intervention
944993|NCT03514212|walking|walking
944994|NCT03514186|Aphasia|aphasia
944995|NCT03514186|Speech and Language Treatment|speech and language treatment
944996|NCT03514186|ICAP|icap
944997|NCT03514186|Intensive Comprehensive Aphasia Program|intensive comprehensive aphasia program
944998|NCT03514147|Women|women
944999|NCT03514147|Pelvic Floor Muscles|pelvic floor muscles
945000|NCT03514108|Heart failure|heart failure
945001|NCT03514108|Diabetes|diabetes
945002|NCT03514108|Insulin resistance|insulin resistance
945003|NCT03514108|Metformin|metformin
945004|NCT03514108|Hydralazine|hydralazine
945005|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate
945006|NCT03514069|ruxolitinib|ruxolitinib
945007|NCT03514069|radiation|radiation
945008|NCT03514069|temozolomide|temozolomide
945009|NCT03514056|Fibromyalgia|fibromyalgia
945010|NCT03514056|Behcet Disease|behcet disease
945011|NCT03514056|Trigger points|trigger points
945012|NCT03514043|Ambulatory care|ambulatory care
945013|NCT03514043|Emergency general surgery|emergency general surgery
945014|NCT03514043|Patient satisfaction|patient satisfaction
945015|NCT03514017|Lymphocytic|lymphocytic
945016|NCT03514017|Leukemia|leukemia
945018|NCT03514017|Blood disease|blood disease
945019|NCT03514017|White blood cells|white blood cells
945020|NCT03514017|Bone marrow disease|bone marrow disease
945021|NCT03514017|Immunotherapy|immunotherapy
945022|NCT03514004|Suicide prevention|suicide prevention
945023|NCT03514004|Information and Communication Technologies|information and communication technologies
945309|NCT03512483|Rural|rural
945024|NCT03514004|Cluster Randomized Controlled Trial|cluster randomized controlled trial
945025|NCT03514004|Latin America|latin america
945026|NCT03513991|human milk|human milk
945027|NCT03513991|infant formula with low protein|infant formula with low protein
945028|NCT03513991|alpha lactoalbumin|alpha lactoalbumin
945029|NCT03513991|growth velocity|growth velocity
945030|NCT03513991|gastrointestinal events|gastrointestinal events
945031|NCT03513978|Soccer|soccer
945032|NCT03513978|Prevention injury|prevention injury
945033|NCT03513965|food allergy|food allergy
945034|NCT03513965|oral immunotherapy|oral immunotherapy
945035|NCT03513965|mindsets|mindsets
945036|NCT03513965|patient experience|patient experience
953125|NCT03461510|MRI|mri
945037|NCT03513939|Type 1 Diabetes Mellitus, Diabetes, hypoglycemia|type 1 diabetes mellitus, diabetes, hypoglycemia
945038|NCT03513926|miRNA|mirna
945039|NCT03513926|Cardiovascular Risk|cardiovascular risk
945040|NCT03513926|CPAP|cpap
945041|NCT03513926|Obstructive Sleep Apnea|obstructive sleep apnea
945042|NCT03513926|Hypertension|hypertension
945043|NCT03513926|Molecular profile|molecular profile
945044|NCT03513913|in vitro fertilization|in vitro fertilization
945045|NCT03513913|intracytoplasmic sperm injection|intracytoplasmic sperm injection
945046|NCT03513913|fertilization|fertilization
945047|NCT03513913|Assisted reproduction|assisted reproduction
945048|NCT03513900|Cirrhosis|cirrhosis
945049|NCT03513900|Non-invasive methods|non-invasive methods
945050|NCT03513900|portal hypertensive gastropathy|portal hypertensive gastropathy
945051|NCT03513887|cirrhosis,varices,variceal bleeding, noninvasive tests,TE|cirrhosis,varices,variceal bleeding, noninvasive tests,te
945052|NCT03513861|Low and Middle Income Countries|low and middle income countries
945053|NCT03513861|Limited resource settings|limited resource settings
945054|NCT03513861|Early warning signs|early warning signs
945055|NCT03513822|KETAMINE|ketamine
945056|NCT03513822|CHRONIC PAIN|chronic pain
945057|NCT03513822|NEUROPATHIC PAIN|neuropathic pain
945058|NCT03513822|KYNURENINE|kynurenine
945059|NCT03513822|KYNURENINE PATHWAY|kynurenine pathway
945060|NCT03513822|BEDSORES|bedsores
945061|NCT03513822|ANTI-INFLAMMATORY|anti-inflammatory
945062|NCT03513822|ULCER PRESSURE|ulcer pressure
945063|NCT03513809|Acute Hypoxemic Respiratory Failure|acute hypoxemic respiratory failure
945064|NCT03513809|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
945065|NCT03513809|Electrical impedance tomography|electrical impedance tomography
945066|NCT03513809|Spontaneous breathing|spontaneous breathing
945067|NCT03513809|Ventilation induced-lung injury|ventilation induced-lung injury
945068|NCT03513809|Patient self-inflicted lung injury|patient self-inflicted lung injury
945069|NCT03513783|Spinal Cord Injury|spinal cord injury
945070|NCT03513783|tendon transfer|tendon transfer
945071|NCT03513783|muscle synergy|muscle synergy
945072|NCT03513783|muscle co-activation|muscle co-activation
945073|NCT03513783|electromyography|electromyography
945074|NCT03513770|venous distension reflex|venous distension reflex
945075|NCT03513744|human milk oligosaccharides|human milk oligosaccharides
945076|NCT03513744|infant formula|infant formula
945077|NCT03513718|Acute kidney injury, AKI|acute kidney injury, aki
945078|NCT03513705|implementation|implementation
945079|NCT03513705|randomized trial|randomized trial
945080|NCT03513705|pancreatic cancer|pancreatic cancer
945081|NCT03513705|nationwide|nationwide
945082|NCT03513705|survival|survival
945083|NCT03513705|quality of life|quality of life
945084|NCT03513653|acute heart failure|acute heart failure
945085|NCT03513653|global longitudinal strain|global longitudinal strain
945086|NCT03513653|ejection fraction|ejection fraction
945087|NCT03513653|echocardiography|echocardiography
945088|NCT03513653|mortality|mortality
945089|NCT03513627|periimplant soft tissue|periimplant soft tissue
945090|NCT03513627|gingiva|gingiva
945091|NCT03513627|human|human
945092|NCT03513627|microcirculation|microcirculation
945093|NCT03513614|Tailored Axillary Surgery|tailored axillary surgery
945094|NCT03513614|TAXIS|taxis
945095|NCT03513614|Breast Cancer|breast cancer
945096|NCT03513614|node-positive breast cancer|node-positive breast cancer
945097|NCT03513614|phase III trial|phase iii trial
945098|NCT03513614|IBCSG 57-18|ibcsg 57-18
945099|NCT03513614|ABCSG|abcsg
945100|NCT03513601|Curative effect evaluation|curative effect evaluation
945101|NCT03513601|Adverse reactions|adverse reactions
945102|NCT03513601|Clinical characteristics|clinical characteristics
945104|NCT03513601|PFS|pfs
945105|NCT03513601|OS|os
945106|NCT03513575|pH of saliva|ph of saliva
945107|NCT03513575|Flavored Milk|flavored milk
945108|NCT03513575|buffering agent|buffering agent
945109|NCT03513575|oral hygiene|oral hygiene
945110|NCT03513549|Agitation|agitation
945111|NCT03513549|Schizophrenia|schizophrenia
945112|NCT03513549|Bipolar I disorder|bipolar i disorder
945113|NCT03513536|Aromatherapy|aromatherapy
945114|NCT03513536|Essential Oils|essential oils
945115|NCT03513510|evidence-based programs|evidence-based programs
945116|NCT03513510|community-based participatory research|community-based participatory research
945117|NCT03513510|program adoption|program adoption
945118|NCT03513497|Teeth|teeth
945119|NCT03513497|Periodontal disease|periodontal disease
945120|NCT03513497|acute inflammatory response|acute inflammatory response
945121|NCT03513497|stent-induced biofilm overgrowth|stent-induced biofilm overgrowth
945122|NCT03513497|periodontal pathogens|periodontal pathogens
945123|NCT03513471|Late Phase Asthmatic Response|late phase asthmatic response
945124|NCT03513471|Allergen Challenge|allergen challenge
945125|NCT03513458|Late Phase Asthmatic Response|late phase asthmatic response
945126|NCT03513458|Allergen Challenge|allergen challenge
945127|NCT03513432|Gut microbiota|gut microbiota
945128|NCT03513432|Beer|beer
945129|NCT03513432|Alcohol|alcohol
945130|NCT03513432|Cardiovascular disease|cardiovascular disease
945131|NCT03513406|muscle function|muscle function
945132|NCT03513393|velpatasvir|velpatasvir
945133|NCT03513393|cola|cola
945134|NCT03513393|omeprazole|omeprazole
945135|NCT03513393|proton pump inhibitors|proton pump inhibitors
945136|NCT03513380|Exercise therapy|exercise therapy
945137|NCT03513380|Physical fitness|physical fitness
945138|NCT03513380|Gaming|gaming
945139|NCT03513380|Adult|adult
945140|NCT03513380|Healthy lifestyle|healthy lifestyle
945141|NCT03513380|Fitness testing|fitness testing
945142|NCT03513367|Duchenne Muscular Dystrophy,|duchenne muscular dystrophy,
945143|NCT03513367|Pediatric Quality of Life Inventory|pediatric quality of life inventory
945144|NCT03513367|disability paradox|disability paradox
945145|NCT03513354|Aging; Physical activity; Motor activity; Quality of life|aging; physical activity; motor activity; quality of life
945146|NCT03513341|Physical activity|physical activity
945147|NCT03513341|Sedentary behaviour|sedentary behaviour
945148|NCT03513341|Undergraduate|undergraduate
945149|NCT03513328|human leukocyte antigen (HLA)|human leukocyte antigen (hla)
945150|NCT03513315|Heat-related illnesses|heat-related illnesses
945151|NCT03513315|Heat Illnesses|heat illnesses
945152|NCT03513315|Community based interventions|community based interventions
945153|NCT03513315|heatwave|heatwave
945154|NCT03513315|Pakistan|pakistan
945155|NCT03513315|emergency preparedness|emergency preparedness
945156|NCT03513315|emergency medicine|emergency medicine
945157|NCT03513315|heat stroke|heat stroke
945158|NCT03513315|heat exhaustion|heat exhaustion
945159|NCT03513315|urban health|urban health
945160|NCT03513302|nitric oxide|nitric oxide
945161|NCT03513289|ICU delirium|icu delirium
945162|NCT03513289|post-intensive care syndrome|post-intensive care syndrome
945163|NCT03513289|critical illness myopathy|critical illness myopathy
945164|NCT03513211|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
945165|NCT03513211|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
945166|NCT03513198|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
945167|NCT03513198|endoscopic ultrasound elastography|endoscopic ultrasound elastography
945168|NCT03513198|tumor vascularity|tumor vascularity
945169|NCT03513198|prognostic|prognostic
945170|NCT03513185|somatic symptom disorder|somatic symptom disorder
945171|NCT03513185|the Somatic Symptom Scale-China|the somatic symptom scale-china
945172|NCT03513185|mental disorders management|mental disorders management
945173|NCT03513172|Intraocular Pressure|intraocular pressure
945174|NCT03513172|Anti-VEGF Agents|anti-vegf agents
945175|NCT03513172|alpha2-agonists|alpha2-agonists
945176|NCT03513159|transitional care, geriatric, readmission|transitional care, geriatric, readmission
945177|NCT03513133|working memory|working memory
945178|NCT03513133|cognitive rehabilitation|cognitive rehabilitation
945179|NCT03513133|functional neuroimaging|functional neuroimaging
945180|NCT03513120|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
945181|NCT03513120|Posterior Spinal Fusion|posterior spinal fusion
945182|NCT03513120|Return to Sport|return to sport
945183|NCT03513107|Osteoporosis|osteoporosis
945184|NCT03513094|Kinetics|kinetics
945185|NCT03513094|Transversus abdominis|transversus abdominis
945186|NCT03513081|food neophobia|food neophobia
945187|NCT03513081|preschool|preschool
945188|NCT03513081|children|children
945189|NCT03513068|COPD|copd
945190|NCT03513068|POC|poc
945191|NCT03513068|Oxygen|oxygen
945192|NCT03513068|QoL|qol
945193|NCT03513055|glucose excursions|glucose excursions
945194|NCT03513055|insulin technique|insulin technique
945195|NCT03513055|insulin antibodies|insulin antibodies
945196|NCT03513055|premixed insulin|premixed insulin
945197|NCT03513042|intensity-modulated proton therapy|intensity-modulated proton therapy
945198|NCT03513042|therapy response evaluation|therapy response evaluation
945199|NCT03513042|positron emission tomography (PET)|positron emission tomography (pet)
945200|NCT03513042|hypoxia|hypoxia
945201|NCT03513042|metabolism|metabolism
945202|NCT03513042|18F-fluoroazomycin-arabinoside (FAZA)|18f-fluoroazomycin-arabinoside (faza)
945203|NCT03513042|18F-2-fluoro-2-deoxy-D-glucose (FDG)|18f-2-fluoro-2-deoxy-d-glucose (fdg)
945204|NCT03513042|head and neck neoplasms|head and neck neoplasms
945205|NCT03513042|image-guided proton therapy|image-guided proton therapy
945206|NCT03513042|treatment outcome|treatment outcome
945207|NCT03513042|predictive biomarker|predictive biomarker
945208|NCT03513029|PAF|paf
945209|NCT03513029|atrial fibrillation|atrial fibrillation
945210|NCT03513029|ablation|ablation
945211|NCT03513029|low intensity collimated ultrasound|low intensity collimated ultrasound
945212|NCT03513016|Osteoarthritis|osteoarthritis
945213|NCT03513016|Painful Osteoarthritis|painful osteoarthritis
945214|NCT03513016|Osteoarthritis, Knee|osteoarthritis, knee
945215|NCT03513016|Senescence|senescence
945216|NCT03512990|Brachial Plexus Block|brachial plexus block
945217|NCT03512990|Superior Trunk|superior trunk
945218|NCT03512990|Phrenic Nerve|phrenic nerve
945219|NCT03512977|spinal anesthesia|spinal anesthesia
945220|NCT03512977|sphenopalatine ganglion block|sphenopalatine ganglion block
945221|NCT03512977|postspinal headache|postspinal headache
945222|NCT03512951|Hearing aids|hearing aids
945223|NCT03512951|Remote microphone systems|remote microphone systems
945224|NCT03512951|Roger technology|roger technology
945225|NCT03512951|Sound externalization|sound externalization
945226|NCT03512951|Auditory distance estimation|auditory distance estimation
945227|NCT03512938|Generalized aggressive periodontitis|generalized aggressive periodontitis
945480|NCT03511508|interdisciplinary|interdisciplinary
945228|NCT03512938|Non-surgical periodontal therapy|non-surgical periodontal therapy
945229|NCT03512938|Periodontopathogens|periodontopathogens
945230|NCT03512938|Smoking|smoking
945231|NCT03512938|Gingival crevicular fluid|gingival crevicular fluid
945232|NCT03512925|Coercion|coercion
945233|NCT03512925|Debriefing|debriefing
945234|NCT03512925|Mental health|mental health
945235|NCT03512925|Seclusion|seclusion
945236|NCT03512925|Mechanical restraint|mechanical restraint
945237|NCT03512899|implantable port|implantable port
945238|NCT03512886|Multiple sclerosis|multiple sclerosis
945239|NCT03512886|Multi-task training|multi-task training
945240|NCT03512886|Balance|balance
945241|NCT03512886|Mobility|mobility
945242|NCT03512886|Cognition|cognition
945243|NCT03512886|Upper extremity function|upper extremity function
945244|NCT03512873|Scleredema Diabeticorum|scleredema diabeticorum
945245|NCT03512873|Tranilast|tranilast
945246|NCT03512860|Estetrol|estetrol
945247|NCT03512860|Drospirenone|drospirenone
945248|NCT03512860|Uridine diphosphate glucuronosyltransferase-2B7|uridine diphosphate glucuronosyltransferase-2b7
945249|NCT03512860|Drug-drug interaction|drug-drug interaction
945250|NCT03512860|Valproic acid|valproic acid
945251|NCT03512847|liquid biopsy|liquid biopsy
945252|NCT03512847|genomic profiling|genomic profiling
945253|NCT03512847|ctDNA|ctdna
945254|NCT03512834|angiosarcoma|angiosarcoma
945255|NCT03512834|paclitaxel|paclitaxel
945256|NCT03512834|avelumab|avelumab
945257|NCT03512769|jaw support device, third molars, wisdom teeth, partially erupted or impacted|jaw support device, third molars, wisdom teeth, partially erupted or impacted
945258|NCT03512756|Pancreatic cancer|pancreatic cancer
945259|NCT03512756|Pancreas cancer|pancreas cancer
945260|NCT03512756|Pancreatic|pancreatic
945261|NCT03512756|Pancreas|pancreas
945262|NCT03512756|cancer|cancer
945263|NCT03512756|non- toxic|non- toxic
945264|NCT03512756|no toxicity|no toxicity
945265|NCT03512756|chemotherapy|chemotherapy
945266|NCT03512756|metastatic|metastatic
945267|NCT03512743|bone mineral density|bone mineral density
945268|NCT03512743|bone turnover markers|bone turnover markers
945269|NCT03512743|ferritin|ferritin
945270|NCT03512730|regenera|regenera
945271|NCT03512704|Heart failure|heart failure
945272|NCT03512704|clinical prediction rules|clinical prediction rules
945273|NCT03512704|health services research|health services research
945274|NCT03512691|Risk perceptions and attitudes, time preference, information|risk perceptions and attitudes, time preference, information
945275|NCT03512665|Pre-diabetes|pre-diabetes
945276|NCT03512665|cardiovascular risk|cardiovascular risk
945277|NCT03512665|lipids|lipids
945278|NCT03512665|insulin resistance|insulin resistance
945279|NCT03512665|obesity|obesity
945280|NCT03512665|overweight|overweight
945281|NCT03512639|Mastectomy, Breast Reconstruction, Homeopathic Treatment|mastectomy, breast reconstruction, homeopathic treatment
945282|NCT03512626|OptiVis|optivis
945283|NCT03512626|hybrid multifocal intraocular lens|hybrid multifocal intraocular lens
945284|NCT03512626|multifocal intraocular lens|multifocal intraocular lens
945285|NCT03512626|presbyopia|presbyopia
945286|NCT03512600|lithiasis|lithiasis
945287|NCT03512600|uric acid|uric acid
945288|NCT03512600|crystallization|crystallization
945289|NCT03512587|Personalized quantum sonotherapy|personalized quantum sonotherapy
945290|NCT03512587|Regional anesthesia|regional anesthesia
945291|NCT03512587|Peripheral nerve block|peripheral nerve block
945292|NCT03512574|pregabalin, dexmedetomidine, postoperative pain|pregabalin, dexmedetomidine, postoperative pain
945293|NCT03512522|chronic pain|chronic pain
945294|NCT03512522|pain self-management|pain self-management
945295|NCT03512522|remote delivery|remote delivery
945296|NCT03512522|workbook|workbook
945297|NCT03512522|online|online
945298|NCT03512496|Energy Drink|energy drink
945299|NCT03512496|Pediatric|pediatric
945300|NCT03512496|Metabolism|metabolism
945301|NCT03512496|Glucose|glucose
945302|NCT03512496|Caffeine|caffeine
945303|NCT03512496|Obesity|obesity
945304|NCT03512496|Nutrition|nutrition
945305|NCT03512496|Metabolomics|metabolomics
945306|NCT03512496|Health Behavior|health behavior
945307|NCT03512496|Glucose Intolerance|glucose intolerance
945308|NCT03512483|Atrial Fibrillation|atrial fibrillation
945310|NCT03512483|Virtual|virtual
945311|NCT03512483|Older Adults|older adults
945312|NCT03512470|surgical wound|surgical wound
945313|NCT03512470|Prevena System|prevena system
945314|NCT03512457|Melanoma|melanoma
945315|NCT03512457|Skin self-examination|skin self-examination
945316|NCT03512457|mammogram|mammogram
945317|NCT03512444|negative pressure therapy|negative pressure therapy
945318|NCT03512444|negative pressure|negative pressure
945319|NCT03512444|Wound therapy|wound therapy
945320|NCT03512444|NPWT|npwt
945321|NCT03512444|Vacuum therapy|vacuum therapy
945322|NCT03512444|VAC|vac
945323|NCT03512431|analytical method validation|analytical method validation
945324|NCT03512431|renal transplantation|renal transplantation
945325|NCT03512431|limited sampling strategy|limited sampling strategy
945326|NCT03512418|HIV prevention|hiv prevention
945327|NCT03512418|Pre-exposure prophylaxis|pre-exposure prophylaxis
945328|NCT03512418|Digital Pill|digital pill
945329|NCT03512418|Substance use disorder|substance use disorder
945330|NCT03512418|Stimulant use|stimulant use
945331|NCT03512392|fluid therapy|fluid therapy
945332|NCT03512392|furosemide|furosemide
945333|NCT03512392|diuretics|diuretics
945334|NCT03512392|Injections, Intravenous|injections, intravenous
945335|NCT03512392|Infusions, Intravenous|infusions, intravenous
945336|NCT03512392|Spironolactone|spironolactone
945337|NCT03512392|Indapamide|indapamide
945338|NCT03512379|robot-assisted surgery|robot-assisted surgery
945339|NCT03512379|pedicle screw|pedicle screw
945340|NCT03512379|spine|spine
945341|NCT03512366|inguinal hernia|inguinal hernia
945342|NCT03512366|lichtenstein's technique|lichtenstein's technique
945343|NCT03512366|desarda's technique|desarda's technique
945344|NCT03512366|local anaesthesia|local anaesthesia
945345|NCT03512340|CD47|cd47
945346|NCT03512340|SiRP α|sirp α
945347|NCT03512340|tumor microenvironment|tumor microenvironment
945348|NCT03512340|macrophage|macrophage
945349|NCT03512340|solid tumor|solid tumor
945350|NCT03512340|Phase 1|phase 1
945351|NCT03512340|safety|safety
945352|NCT03512340|efficacy|efficacy
945353|NCT03512340|hematologic malignancies|hematologic malignancies
945354|NCT03512340|SRF231|srf231
945355|NCT03512275|Hidradenitis Suppurativa|hidradenitis suppurativa
945356|NCT03512262|BA058|ba058
945357|NCT03512262|abaloparatide|abaloparatide
945358|NCT03512262|abaloparatide-SC|abaloparatide-sc
945359|NCT03512262|osteoporosis|osteoporosis
945360|NCT03512262|male osteoporosis|male osteoporosis
945361|NCT03512262|TYMLOS™|tymlos™
945362|NCT03512262|fracture|fracture
945363|NCT03512262|bone loss|bone loss
945364|NCT03512197|Newly diagnosed FLT3-mutation negative|newly diagnosed flt3-mutation negative
945365|NCT03512197|PKC412|pkc412
945366|NCT03512197|midostaurin|midostaurin
945367|NCT03512197|cytarabine|cytarabine
945368|NCT03512197|daunorubicin|daunorubicin
945369|NCT03512197|idarubicin|idarubicin
945370|NCT03512197|acute myeloid leukemia|acute myeloid leukemia
945371|NCT03512197|AML|aml
945372|NCT03512197|FLT3-MN (SR<0.05)|flt3-mn (sr<0.05)
945373|NCT03512197|combination treatment|combination treatment
945374|NCT03512197|induction failure|induction failure
945375|NCT03512197|event free survival|event free survival
945376|NCT03512197|EFS|efs
945377|NCT03512197|minimal residual disease|minimal residual disease
945378|NCT03512119|Cystic fibrosis|cystic fibrosis
945379|NCT03512119|Glucose tolerance abnormalities|glucose tolerance abnormalities
945380|NCT03512119|CFTR corrector and potentiator|cftr corrector and potentiator
945381|NCT03512106|Arterial Hypertension|arterial hypertension
945382|NCT03512106|Acupuncture|acupuncture
945383|NCT03512093|Preterm Infant|preterm infant
945384|NCT03512080|Warfarin|warfarin
945385|NCT03512080|Anticoagulation|anticoagulation
945386|NCT03512080|Clinical Dosing Algorithm|clinical dosing algorithm
945387|NCT03512080|Genetic Dosing Algorithm|genetic dosing algorithm
945388|NCT03512080|International Normalised Ratio|international normalised ratio
945389|NCT03512080|Uganda|uganda
945390|NCT03512080|Cape Town|cape town
945391|NCT03512080|Cardiovascular Disease|cardiovascular disease
945392|NCT03512080|Genome-wide Association Study|genome-wide association study
945393|NCT03512080|Stratified Medicine|stratified medicine
945394|NCT03512080|Pharmacogenetics|pharmacogenetics
945395|NCT03512067|Mechanical Ventilation|mechanical ventilation
945396|NCT03512067|Respiratory Support|respiratory support
945397|NCT03512054|Tracheostomy|tracheostomy
945398|NCT03512054|Decannulation|decannulation
945399|NCT03512054|Rehabilitation|rehabilitation
945400|NCT03512054|Brain injury|brain injury
945401|NCT03512054|Neurosurgery|neurosurgery
945402|NCT03512041|ischemic conditioning, motor learning|ischemic conditioning, motor learning
945403|NCT03512028|ischemic conditioning, motor learning, strength, cognition|ischemic conditioning, motor learning, strength, cognition
945404|NCT03512015|Lung Cancer|lung cancer
945405|NCT03512002|Neurotechnology|neurotechnology
945406|NCT03512002|Autonomic Dysregulation|autonomic dysregulation
945407|NCT03512002|Hyperarousal|hyperarousal
945408|NCT03512002|Brain Electrical Activity|brain electrical activity
945409|NCT03512002|HIRREM|hirrem
945410|NCT03512002|Acoustic Stimulation|acoustic stimulation
945413|NCT03512002|Hot Flashes|hot flashes
945414|NCT03512002|Night Sweats|night sweats
945415|NCT03512002|Vasomotor Symptoms|vasomotor symptoms
945416|NCT03512002|Allostatis|allostatis
945417|NCT03511937|Food and beverage purchases|food and beverage purchases
945418|NCT03511937|Sugar-sweetened beverages|sugar-sweetened beverages
945419|NCT03511937|Beverages|beverages
945420|NCT03511924|resistance training|resistance training
945421|NCT03511924|circulating microRNA´s|circulating microrna´s
945422|NCT03511924|muscle strength|muscle strength
945423|NCT03511911|Pelvic floor muscle strength|pelvic floor muscle strength
945424|NCT03511911|modified Oxford Grading Scale|modified oxford grading scale
945425|NCT03511911|Levator ani testing|levator ani testing
945426|NCT03511911|vaginal contraction pressure|vaginal contraction pressure
945427|NCT03511911|reliability|reliability
945428|NCT03511885|Cardiovascular|cardiovascular
945429|NCT03511885|Prevention|prevention
945430|NCT03511885|EUROASPIRE|euroaspire
945431|NCT03511872|Basic life support|basic life support
945432|NCT03511872|cardiopulmonary resuscitation|cardiopulmonary resuscitation
945433|NCT03511872|medical undergraduate students|medical undergraduate students
945434|NCT03511872|crisis|crisis
945435|NCT03511872|randomized controlled trial.|randomized controlled trial.
945436|NCT03511859|Breast cancer. Circulating tumor cells. CTCs. Cell free DNA. cfDNA|breast cancer. circulating tumor cells. ctcs. cell free dna. cfdna
945437|NCT03511846|Brain Freeze|brain freeze
945438|NCT03511846|Capsaicin|capsaicin
945439|NCT03511833|Intra nasal ketamine|intra nasal ketamine
945440|NCT03511833|IV morphine|iv morphine
945441|NCT03511833|acute traumatic pain|acute traumatic pain
945442|NCT03511820|Amphotericin B|amphotericin b
945443|NCT03511820|liposome|liposome
945444|NCT03511820|post marketing surveillance|post marketing surveillance
945447|NCT03511768|18F-AlF-NOTA-octreotide|18f-alf-nota-octreotide
945448|NCT03511729|Tau/P-Tau|tau/p-tau
945449|NCT03511729|biomarker|biomarker
945450|NCT03511729|neurocognitive|neurocognitive
945451|NCT03511729|outcomes|outcomes
945452|NCT03511729|children|children
945453|NCT03511716|Mitral Insufficiency|mitral insufficiency
945454|NCT03511716|Mitral Valve Incompetence|mitral valve incompetence
945455|NCT03511690|Latinas, African Americans|latinas, african americans
945456|NCT03511677|Insole|insole
945457|NCT03511677|Morton Neuroma|morton neuroma
945458|NCT03511677|Pain|pain
945459|NCT03511677|Function|function
945460|NCT03511664|mCRPC|mcrpc
945461|NCT03511664|177Lu-PSMA-617|177lu-psma-617
945462|NCT03511664|PSMA-617|psma-617
945463|NCT03511664|PSMA-11|psma-11
945464|NCT03511664|radioligand therapy|radioligand therapy
945465|NCT03511560|Envarsus XR|envarsus xr
945466|NCT03511560|Tacrolimus|tacrolimus
945467|NCT03511560|Kidney Transplantation|kidney transplantation
945468|NCT03511534|treatment, psychotherapy, pharmacotherapy|treatment, psychotherapy, pharmacotherapy
945469|NCT03511521|steroid|steroid
945470|NCT03511521|prednisone|prednisone
945471|NCT03511521|methylprednisolone|methylprednisolone
945472|NCT03511521|hyperglycemia|hyperglycemia
945473|NCT03511521|insulin|insulin
945474|NCT03511521|hypoglycemia|hypoglycemia
945475|NCT03511508|pregnancy|pregnancy
945476|NCT03511508|maternity Care|maternity care
945477|NCT03511508|complex intervention|complex intervention
945478|NCT03511508|interdisiplinary team|interdisiplinary team
945479|NCT03511508|chronic disease|chronic disease
945481|NCT03511508|midwifery|midwifery
945482|NCT03511469|Kontralateral Education, Bankart, Rehabilitation, Shoulder,|kontralateral education, bankart, rehabilitation, shoulder,
945483|NCT03511456|leg pain|leg pain
945484|NCT03511456|waist pain|waist pain
945485|NCT03511456|life quality|life quality
945486|NCT03511443|hsRDT|hsrdt
945487|NCT03511443|usRDT|usrdt
945488|NCT03511443|Reactive Case Detection (RCD)|reactive case detection (rcd)
945489|NCT03511443|High risk for malaria|high risk for malaria
945490|NCT03511430|Acute Coronary Syndrome|acute coronary syndrome
945491|NCT03511430|Heart Diseases|heart diseases
945492|NCT03511430|Cardiovascular Diseases|cardiovascular diseases
945493|NCT03511430|Vascular Diseases|vascular diseases
945494|NCT03511404|Non specific chronic low back pain|non specific chronic low back pain
945495|NCT03511404|surface electromyography (EMG)|surface electromyography (emg)
945496|NCT03511404|neuromuscular function|neuromuscular function
945497|NCT03511404|physiotherapy|physiotherapy
945498|NCT03511404|Numeric Pain Rating Scale|numeric pain rating scale
945499|NCT03511391|radiotherapy|radiotherapy
945500|NCT03511391|checkpoint inhibitors|checkpoint inhibitors
945501|NCT03511378|Breast Carcinoma|breast carcinoma
945502|NCT03511378|Breast neoplasms|breast neoplasms
945503|NCT03511378|Breast Tumors|breast tumors
945504|NCT03511378|Cancer of Breast|cancer of breast
945505|NCT03511378|Anti-Drug Antibodies (ADA)|anti-drug antibodies (ada)
945506|NCT03511378|Immunogenicity|immunogenicity
945507|NCT03511365|Probiotic|probiotic
945508|NCT03511365|Microbiome|microbiome
945509|NCT03511365|Inflammation|inflammation
945510|NCT03511365|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
945511|NCT03511326|field-treatment|field-treatment
945512|NCT03511313|Primary Hypertension|primary hypertension
945513|NCT03511313|Renal Denervation|renal denervation
945514|NCT03511300|Cognition|cognition
945515|NCT03511300|Apathy|apathy
945516|NCT03511287|inspiratory muscle training|inspiratory muscle training
945517|NCT03511287|advanced lung disease|advanced lung disease
945518|NCT03511287|maximal inspiratory pressure|maximal inspiratory pressure
945519|NCT03511287|inspiratory endurance|inspiratory endurance
945520|NCT03511274|Cytomegalovirus Congenital|cytomegalovirus congenital
945522|NCT03511274|Cytomegalovirus infections|cytomegalovirus infections
945523|NCT03511261|Oral submucous fibrosis|oral submucous fibrosis
945524|NCT03511261|curcumin|curcumin
945525|NCT03511261|potentially malignant disease|potentially malignant disease
945526|NCT03511248|Heart Failure|heart failure
945527|NCT03511248|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
945528|NCT03511248|Nitric Oxide|nitric oxide
945529|NCT03511248|Inorganic Nitrate|inorganic nitrate
945530|NCT03511209|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
945531|NCT03511209|Hypnotics and Sedatives|hypnotics and sedatives
945532|NCT03511196|stage IV castration sensitive prostate cancer|stage iv castration sensitive prostate cancer
945533|NCT03511196|advanced castration sensitive prostate cancer|advanced castration sensitive prostate cancer
945534|NCT03511157|ischemic preconditioning|ischemic preconditioning
945535|NCT03511131|HIV prevention|hiv prevention
945536|NCT03511131|Adolescent risk-taking behaviors|adolescent risk-taking behaviors
945537|NCT03511105|Lipopolysaccharide|lipopolysaccharide
945538|NCT03511105|Pharmacodynamics|pharmacodynamics
945539|NCT03511105|Healthy subjects|healthy subjects
945540|NCT03511105|GSK2798745|gsk2798745
945541|NCT03511105|Placebo|placebo
945542|NCT03511105|Segmental challenge|segmental challenge
945543|NCT03511092|Leucine metabolites|leucine metabolites
945544|NCT03511092|Resistance training|resistance training
945545|NCT03511092|Hypertrophy|hypertrophy
945546|NCT03511092|Strength|strength
945547|NCT03511092|Supplement|supplement
945548|NCT03511079|Music|music
945549|NCT03511066|efficacy|efficacy
945550|NCT03511066|safety|safety
945551|NCT03511027|Medication Adherence|medication adherence
945552|NCT03511027|Medication Dispensing|medication dispensing
945553|NCT03511027|Homecare|homecare
945554|NCT03511027|Elderly|elderly
945555|NCT03510975|behavioural therapy|behavioural therapy
945556|NCT03510975|mono symptomatic nocturnal enuresis|mono symptomatic nocturnal enuresis
945557|NCT03510975|compliance|compliance
945558|NCT03510975|response|response
945559|NCT03510962|pH of saliva|ph of saliva
945560|NCT03510962|Fruit juice|fruit juice
945561|NCT03510962|buffering agent|buffering agent
945562|NCT03510962|oral hygiene|oral hygiene
945563|NCT03510936|Probiotics|probiotics
945564|NCT03510936|Gut Microbiome|gut microbiome
945565|NCT03510936|Infants|infants
945566|NCT03510936|Jaundice|jaundice
945567|NCT03510923|Appendix|appendix
945568|NCT03510923|Appendectomy|appendectomy
945569|NCT03510923|Gallbladder|gallbladder
945570|NCT03510923|Cholecystectomy|cholecystectomy
945571|NCT03510923|Neoplasms|neoplasms
945572|NCT03510923|Pathology|pathology
945573|NCT03510923|Selective|selective
945574|NCT03510923|Routine|routine
945575|NCT03510897|MAKE|make
945576|NCT03510897|AKI|aki
945577|NCT03510871|neoadjuvant therapy|neoadjuvant therapy
945578|NCT03510819|Dental trauma|dental trauma
945579|NCT03510819|Emergency management|emergency management
945580|NCT03510819|Tooth avulsion|tooth avulsion
945581|NCT03510819|Knowledge|knowledge
945582|NCT03510819|Practice|practice
945583|NCT03510819|Traumatic injuries|traumatic injuries
945584|NCT03510819|Attitude|attitude
945585|NCT03510793|microcirculation; aortic aneurysm; anesthesia|microcirculation; aortic aneurysm; anesthesia
945586|NCT03510780|Platlet rich fibrin|platlet rich fibrin
945587|NCT03510780|Enamel Matrix Derivative|enamel matrix derivative
945588|NCT03510780|Bone graft|bone graft
945589|NCT03510780|Non-inferiority study|non-inferiority study
945590|NCT03510754|Endoscopic ultrasound|endoscopic ultrasound
945591|NCT03510754|Biliary drainage|biliary drainage
945592|NCT03510754|Endoscopic ultrasound guided biliary drainage|endoscopic ultrasound guided biliary drainage
945593|NCT03510741|Schizophrenia|schizophrenia
945594|NCT03510741|Sodium Benzoate|sodium benzoate
945595|NCT03510741|N-Acetylcysteine|n-acetylcysteine
945596|NCT03510741|NMDA receptor|nmda receptor
945597|NCT03510741|Psychopharmacology|psychopharmacology
945598|NCT03510741|Anti-oxidant|anti-oxidant
945599|NCT03510741|Inflammation|inflammation
945600|NCT03510728|Protective Behavioral Strategies|protective behavioral strategies
945601|NCT03510702|Epigenetic.|epigenetic.
945602|NCT03510702|microRNA.|microrna.
945603|NCT03510702|Periodontitis.|periodontitis.
945728|NCT03509766|rhinitis|rhinitis
945604|NCT03510650|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
945605|NCT03510650|Hemophagocytic syndrome (HPS)|hemophagocytic syndrome (hps)
945606|NCT03510650|critically ill|critically ill
945614|NCT03510572|[18F]PI-2620, tauopathy, positron emission computed tomography|[18f]pi-2620, tauopathy, positron emission computed tomography
945616|NCT03510533|neuropeptides (Ghrelin, l'α-MSH)|neuropeptides (ghrelin, l'α-msh)
945617|NCT03510533|potential digestive origin|potential digestive origin
945618|NCT03510520|Hemodialysis|hemodialysis
945619|NCT03510520|Haemodialysis|haemodialysis
945620|NCT03510520|Hemodiafiltration|hemodiafiltration
945621|NCT03510520|Haemodiafiltration|haemodiafiltration
945622|NCT03510520|Dialysis membrane|dialysis membrane
945623|NCT03510520|Endothelial Microvesicles|endothelial microvesicles
945624|NCT03510520|Pulse Wave Velocity|pulse wave velocity
945625|NCT03510507|Lyme arthritis|lyme arthritis
945626|NCT03510507|Borrelia burgdorferi|borrelia burgdorferi
945627|NCT03510507|vector tick|vector tick
945628|NCT03510507|Arthritis|arthritis
945629|NCT03510507|joints|joints
945635|NCT03510468|Antiretrovial Therapy|antiretrovial therapy
945636|NCT03510468|Human Immunodeficiency Virus|human immunodeficiency virus
945637|NCT03510468|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
945638|NCT03510468|Drug-Drug Interaction|drug-drug interaction
945639|NCT03510468|Rifamycin|rifamycin
945645|NCT03510442|Inflammation|inflammation
945646|NCT03510442|Fever|fever
945647|NCT03510442|Arthritis|arthritis
945648|NCT03510442|Sequencing|sequencing
945649|NCT03510416|apatinib，TACE， hepatocellular carcinoma|apatinib，tace， hepatocellular carcinoma
945650|NCT03510390|head and neck cancer|head and neck cancer
945651|NCT03510390|tissue hypoxia|tissue hypoxia
945652|NCT03510390|metformin|metformin
945653|NCT03510364|Subjective social status|subjective social status
945654|NCT03510364|Obesity|obesity
945655|NCT03510364|High calorie intake|high calorie intake
945656|NCT03510364|Energy balance|energy balance
945657|NCT03510364|Eating behavior|eating behavior
945658|NCT03510325|Schizophrenia; Antipsychotics；Cost-Effectiveness Analyses|schizophrenia; antipsychotics；cost-effectiveness analyses
945659|NCT03510286|proteinuria|proteinuria
945660|NCT03510286|preeclampsia|preeclampsia
945661|NCT03510286|diagnostic|diagnostic
945662|NCT03510286|dipstick|dipstick
945663|NCT03510286|protein|protein
945664|NCT03510286|urine|urine
945665|NCT03510286|creatinine|creatinine
945666|NCT03510273|Thermocoagulation|thermocoagulation
945667|NCT03510273|Treatment|treatment
945668|NCT03510273|Cervical precancer|cervical precancer
945669|NCT03510260|Cesarean, Consent, Electronic, Satisfaction|cesarean, consent, electronic, satisfaction
945670|NCT03510234|Pigmentary retinopathy|pigmentary retinopathy
945671|NCT03510234|Argus II retinal prosthesis|argus ii retinal prosthesis
945672|NCT03510234|Self-confidence|self-confidence
945673|NCT03510221|Hypertension|hypertension
945674|NCT03510221|Oxidative stress|oxidative stress
945675|NCT03510221|Antioxidant|antioxidant
945676|NCT03510221|Autonomic imbalance|autonomic imbalance
945677|NCT03510221|Insulin resistance|insulin resistance
945678|NCT03510221|Cytokines|cytokines
945679|NCT03510143|thyroid cancer|thyroid cancer
945680|NCT03510143|Neoveil|neoveil
945681|NCT03510143|seroma|seroma
945682|NCT03510143|chyle leakage|chyle leakage
945683|NCT03510117|Mindfulness|mindfulness
945684|NCT03510117|Patient reported outcomes measures|patient reported outcomes measures
945685|NCT03510117|PROMIS|promis
945686|NCT03510104|MerTK|mertk
945687|NCT03510078|Diabetes Mellitus|diabetes mellitus
945688|NCT03510078|hyperglycemic control|hyperglycemic control
945689|NCT03510078|hospitalization|hospitalization
945690|NCT03510078|internal medicine|internal medicine
945691|NCT03510065|hip arthroplasty|hip arthroplasty
945692|NCT03510065|revision arthroplasty|revision arthroplasty
945693|NCT03510065|survival|survival
945694|NCT03510052|diet|diet
945695|NCT03510052|Fecal Incontinence|fecal incontinence
945697|NCT03510052|ABL|abl
945698|NCT03510039|Involuntary commitment hospitalization|involuntary commitment hospitalization
945699|NCT03510039|close relative|close relative
945700|NCT03510026|internal thoracic artery harvesting|internal thoracic artery harvesting
945701|NCT03510026|arterial graft patency|arterial graft patency
945702|NCT03510026|electrosurgery|electrosurgery
945703|NCT03510026|arterial graft preparation|arterial graft preparation
945709|NCT03510000|insulin pump|insulin pump
945710|NCT03510000|empagliflozin|empagliflozin
945711|NCT03510000|SGLT2 inhibitor|sglt2 inhibitor
945712|NCT03510000|carbohydrate counting|carbohydrate counting
945713|NCT03509935|ultrasound,|ultrasound,
945714|NCT03509935|high-risk surgery|high-risk surgery
945715|NCT03509935|intensive care|intensive care
945716|NCT03509909|yoga|yoga
945717|NCT03509909|exercise|exercise
945718|NCT03509909|randomized controlled trial|randomized controlled trial
945719|NCT03509870|diabetes|diabetes
945720|NCT03509818|Klotho|klotho
945721|NCT03509818|Exercise|exercise
945722|NCT03509818|Physical Fitness|physical fitness
945723|NCT03509805|sleep apnea syndrome|sleep apnea syndrome
945724|NCT03509805|obesity|obesity
945725|NCT03509805|pregnancy|pregnancy
945726|NCT03509805|preeclampsia|preeclampsia
945727|NCT03509766|allergic|allergic
945729|NCT03509766|allergy|allergy
945730|NCT03509766|asthma|asthma
945731|NCT03509766|food allergy|food allergy
945732|NCT03509766|skin testing|skin testing
945733|NCT03509766|skin prick test|skin prick test
945734|NCT03509753|Prebiotic fiber|prebiotic fiber
945735|NCT03509701|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
1636600|NCT00257114|VELCADE|velcade
954014|NCT03455270|ER+|er+
945736|NCT03509701|Herpes zoster|herpes zoster
945737|NCT03509701|Varicella-zoster virus infection|varicella-zoster virus infection
945738|NCT03509688|entecavir|entecavir
945739|NCT03509688|resveratrol|resveratrol
945740|NCT03509688|thymosin|thymosin
945741|NCT03509688|hepatitis B|hepatitis b
945742|NCT03509675|Oral Ulceration|oral ulceration
945743|NCT03509662|Vitamin C|vitamin c
945744|NCT03509662|Cardiac Arrest|cardiac arrest
945745|NCT03509662|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
945746|NCT03509662|Oxidative stress|oxidative stress
945747|NCT03509623|neovascular age-related macular degeneration|neovascular age-related macular degeneration
945748|NCT03509623|aflibercept|aflibercept
945749|NCT03509623|intravitreal anti-VEGF|intravitreal anti-vegf
945750|NCT03509623|coagulation|coagulation
945751|NCT03509623|platelet count|platelet count
945752|NCT03509623|D-Dimer|d-dimer
945753|NCT03509623|Fibrinogen|fibrinogen
945754|NCT03509610|Physical Activity|physical activity
945755|NCT03509610|Nutrition|nutrition
945756|NCT03509610|Carbohydrates|carbohydrates
945757|NCT03509597|Cognitive remediation|cognitive remediation
945758|NCT03509597|Aerobic exercise|aerobic exercise
945759|NCT03509597|Physical exercise|physical exercise
945760|NCT03509597|Negative symptoms|negative symptoms
945761|NCT03509597|Functional outcome|functional outcome
945762|NCT03509597|Cognition|cognition
945763|NCT03509558|Spinal electrical stimulation|spinal electrical stimulation
945764|NCT03509545|natriuresis|natriuresis
945765|NCT03509519|neuromuscular electrical stimulation|neuromuscular electrical stimulation
945766|NCT03509519|physical activity|physical activity
945767|NCT03509519|muscular strength|muscular strength
945768|NCT03509493|Primary prevention|primary prevention
945769|NCT03509493|Secondary prevention|secondary prevention
945770|NCT03509493|Clinical practice|clinical practice
945776|NCT03509441|South Asian|south asian
945777|NCT03509441|Insulin Resistance|insulin resistance
945778|NCT03509441|Cardiac Fibrosis|cardiac fibrosis
945779|NCT03509441|MRI|mri
945780|NCT03509441|Diabetes|diabetes
945781|NCT03509441|Cardiomyopathy|cardiomyopathy
945782|NCT03509428|Exercise|exercise
945783|NCT03509428|mortality|mortality
945784|NCT03509428|morbidity|morbidity
945785|NCT03509428|surgery|surgery
945786|NCT03509428|colorectal|colorectal
945787|NCT03509428|upper gastrointestinal|upper gastrointestinal
945788|NCT03509428|hepatobiliary|hepatobiliary
945789|NCT03509428|urology|urology
945790|NCT03509428|lung|lung
945791|NCT03509428|nutrition|nutrition
945792|NCT03509428|psychology|psychology
945793|NCT03509415|Confocal|confocal
945794|NCT03509415|RCM|rcm
945795|NCT03509415|Imaging|imaging
945796|NCT03509415|Skin cancer|skin cancer
945797|NCT03509402|short dental implants|short dental implants
945798|NCT03509402|full-arch prosthesis|full-arch prosthesis
945799|NCT03509350|Vitamin C|vitamin c
945800|NCT03509350|Thiamine|thiamine
945801|NCT03509350|Corticosteroid|corticosteroid
945802|NCT03509337|Elastography, Nervous tissue, Muscle tonus|elastography, nervous tissue, muscle tonus
945803|NCT03509311|Asthma|asthma
945804|NCT03509311|Physical activity|physical activity
945805|NCT03509311|Cardiorespiratory fitness|cardiorespiratory fitness
945806|NCT03509311|Quality of life|quality of life
945807|NCT03509298|activated CIK|activated cik
945808|NCT03509298|MUC1|muc1
945809|NCT03509298|bispecific antibody|bispecific antibody
945810|NCT03509298|pancreatic cancer|pancreatic cancer
945811|NCT03509233|periodontitis|periodontitis
945812|NCT03509233|full mouth scaling|full mouth scaling
945813|NCT03509233|air abrasion|air abrasion
945814|NCT03509233|scaling|scaling
945815|NCT03509220|Colonoscopy|colonoscopy
945816|NCT03509220|PBK-1701TC|pbk-1701tc
945817|NCT03509220|Bowel cleansing|bowel cleansing
945818|NCT03509207|Uterine sarcoma|uterine sarcoma
945819|NCT03509207|Histone deacetylases|histone deacetylases
945820|NCT03509194|liver|liver
945821|NCT03509194|children|children
945822|NCT03509194|liver transplantation|liver transplantation
945823|NCT03509194|liver cirrhosis|liver cirrhosis
945824|NCT03509181|interpretation bias|interpretation bias
945825|NCT03509181|smartphone|smartphone
945826|NCT03509181|partial hospital|partial hospital
945827|NCT03509155|Infant and Young Child Feeding|infant and young child feeding
945828|NCT03509155|Program Evaluation|program evaluation
945829|NCT03509155|Food Supplementation|food supplementation
945830|NCT03509155|Biscuit|biscuit
945831|NCT03509155|wasting children|wasting children
945832|NCT03509116|patient experience|patient experience
945833|NCT03509116|disease-related malnutrition|disease-related malnutrition
945834|NCT03509116|nutritional care|nutritional care
945835|NCT03509116|dietetic consultation|dietetic consultation
945836|NCT03509116|older adults|older adults
945837|NCT03509116|oral nutritional support|oral nutritional support
945839|NCT03509090|regional anesthesia|regional anesthesia
945840|NCT03509090|erector spinae plane block|erector spinae plane block
945841|NCT03509090|postoperative pain|postoperative pain
945842|NCT03509077|geriatric|geriatric
945843|NCT03509077|addiction|addiction
945844|NCT03509064|Primary sjogren syndrome|primary sjogren syndrome
945845|NCT03509064|Small fiber neuropathy|small fiber neuropathy
945846|NCT03509064|Quality of life|quality of life
945847|NCT03509064|Medico-economic impact|medico-economic impact
945848|NCT03509051|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
945849|NCT03509012|Durvalumab|durvalumab
945850|NCT03509012|Chemotherapy|chemotherapy
945851|NCT03509012|Radiotherapy|radiotherapy
945852|NCT03509012|HNSCC|hnscc
945853|NCT03509012|NSCLC|nsclc
945854|NCT03509012|SCLC|sclc
945855|NCT03509012|locally-advanced|locally-advanced
945856|NCT03509012|limited stage|limited stage
945857|NCT03509012|first line|first line
945858|NCT03508934|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
945859|NCT03508934|hypoglycemia|hypoglycemia
945860|NCT03508934|Continuous Glucose Monitoring|continuous glucose monitoring
945861|NCT03508934|hospital|hospital
945862|NCT03508934|inpatient|inpatient
945863|NCT03508921|Onabotulinumtoxin|onabotulinumtoxin
945864|NCT03508908|HIV testing|hiv testing
945865|NCT03508908|ART|art
945866|NCT03508908|partner notification|partner notification
945867|NCT03508908|PrEP|prep
945868|NCT03508895|Hemp protein|hemp protein
945869|NCT03508895|Protein hydrolysate|protein hydrolysate
945870|NCT03508895|Bioactive peptides|bioactive peptides
945871|NCT03508895|Cannabis sativa|cannabis sativa
945872|NCT03508882|Eyelid|eyelid
945873|NCT03508882|Dystonia|dystonia
945874|NCT03508882|Botulinum injection|botulinum injection
945875|NCT03508882|Oculoplastics|oculoplastics
945876|NCT03508830|Liposomal Bupivacaine|liposomal bupivacaine
945877|NCT03508830|Intercostal Nerve Block|intercostal nerve block
945878|NCT03508830|Minimally Invasive Thoracic Surgery|minimally invasive thoracic surgery
945879|NCT03508817|Atropine, myopia, children|atropine, myopia, children
945880|NCT03508804|surgical abortion|surgical abortion
945881|NCT03508804|cervical anesthesia|cervical anesthesia
945882|NCT03508804|pain control|pain control
945883|NCT03508765|ASCT|asct
945884|NCT03508765|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
945885|NCT03508765|18-154|18-154
945886|NCT03508726|Sarcoma|sarcoma
945887|NCT03508726|Soft tissue|soft tissue
945888|NCT03508713|Rheumatoid Arthritis|rheumatoid arthritis
945889|NCT03508713|prognosis|prognosis
945890|NCT03508700|TNX-102 SL|tnx-102 sl
945891|NCT03508700|Bedtime|bedtime
945892|NCT03508700|Sublingual|sublingual
945893|NCT03508700|Safety|safety
945894|NCT03508700|PTSD|ptsd
945895|NCT03508661|Scleroderma|scleroderma
945896|NCT03508661|Systemic Sclerosis|systemic sclerosis
945897|NCT03508661|Support group|support group
945898|NCT03508661|Training|training
945899|NCT03508661|Feasibility|feasibility
945900|NCT03508635|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
945901|NCT03508583|mpoc|mpoc
945902|NCT03508583|Validity and Reliability|validity and reliability
945903|NCT03508518|Accessibility of health services|accessibility of health services
945904|NCT03508518|Access to psychiatric care|access to psychiatric care
945905|NCT03508518|Consultation-liaison|consultation-liaison
945906|NCT03508518|General practitioner and psychiatrist collaboration|general practitioner and psychiatrist collaboration
945907|NCT03508518|Care pathway|care pathway
945908|NCT03508505|Acute Heart Failure|acute heart failure
945909|NCT03508505|Low Output Heart Failure|low output heart failure
945910|NCT03508505|Cardiac Low Output|cardiac low output
945911|NCT03508505|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
945912|NCT03508505|ECMO|ecmo
945913|NCT03508505|Venoarterial Extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
945914|NCT03508505|Cardiac Surgery|cardiac surgery
945915|NCT03508466|hypersensitivity|hypersensitivity
945916|NCT03508453|monoclonal antibody|monoclonal antibody
945917|NCT03508427|Bipolar Disorder|bipolar disorder
945918|NCT03508427|Smartphone|smartphone
945919|NCT03508427|Self-monitoring|self-monitoring
945920|NCT03508427|Objective data|objective data
945921|NCT03508414|Relapse-remitting Multiple Sclerosis|relapse-remitting multiple sclerosis
945922|NCT03508401|superior vena cava|superior vena cava
945923|NCT03508388|Liver volume|liver volume
945924|NCT03508388|Alcoholic cirrhosis|alcoholic cirrhosis
945925|NCT03508388|Liver transplantation|liver transplantation
945926|NCT03508336|disorders of consciousness|disorders of consciousness
945927|NCT03508336|swallowing|swallowing
945928|NCT03508336|prognosis prediction|prognosis prediction
945929|NCT03508336|minimally conscious state|minimally conscious state
945930|NCT03508336|vegetative state|vegetative state
945931|NCT03508297|Confocal|confocal
945932|NCT03508297|RCM|rcm
945933|NCT03508297|Imaging|imaging
945934|NCT03508297|Skin cancer|skin cancer
945935|NCT03508284|Multiple sclerosis|multiple sclerosis
945936|NCT03508284|Dual-task|dual-task
945937|NCT03508284|Balance|balance
945938|NCT03508284|Mobility|mobility
945940|NCT03508245|Tourette Syndrome|tourette syndrome
945941|NCT03508245|Tourette's|tourette's
945942|NCT03508245|Tics|tics
945943|NCT03508245|Circadian|circadian
945944|NCT03508245|Sleep|sleep
945945|NCT03508219|Coronary Artery Disease (CAD)|coronary artery disease (cad)
945946|NCT03508219|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
945947|NCT03508219|Left Main Bifurcation|left main bifurcation
945948|NCT03508206|Students, cognitive functions, memory|students, cognitive functions, memory
945949|NCT03508180|Supportive care|supportive care
945950|NCT03508180|cancer|cancer
945951|NCT03508180|foot reflexology|foot reflexology
945952|NCT03508180|nausea|nausea
945953|NCT03508180|vomiting|vomiting
945954|NCT03508141|Fibrinogen Concentrate|fibrinogen concentrate
945955|NCT03508141|Cryoprecipitate|cryoprecipitate
945956|NCT03508102|remifentanil|remifentanil
945957|NCT03508102|bispectral index|bispectral index
945958|NCT03508102|Caesarean delivery|caesarean delivery
945959|NCT03508102|general anesthesia|general anesthesia
945960|NCT03508076|Vibrating Capsule|vibrating capsule
945961|NCT03508076|Efficacy and Safety|efficacy and safety
945962|NCT03508076|Chronic Constipation|chronic constipation
945963|NCT03508076|different vibrating modes|different vibrating modes
945964|NCT03508011|Breast Cancer|breast cancer
945965|NCT03508011|Ovarian Cancer|ovarian cancer
945966|NCT03508011|Prostate Cancer|prostate cancer
945967|NCT03508011|Advanced solid tumours|advanced solid tumours
945968|NCT03507985|morphine|morphine
945969|NCT03507985|attention disorders|attention disorders
945970|NCT03507972|ankle|ankle
945971|NCT03507972|diagnostic|diagnostic
945972|NCT03507972|ankle's ultrasound|ankle's ultrasound
945973|NCT03507972|traumatic lesion|traumatic lesion
945974|NCT03507933|villo-nodular synovitis|villo-nodular synovitis
945976|NCT03507933|Surgery|surgery
945977|NCT03507907|neck pain|neck pain
945978|NCT03507907|older adults|older adults
945979|NCT03507907|mobilization|mobilization
945980|NCT03507894|rehabilitation|rehabilitation
945981|NCT03507894|exercise|exercise
945982|NCT03507894|stroke|stroke
945983|NCT03507894|adherence|adherence
945984|NCT03507881|isthmic spondylolisthesis|isthmic spondylolisthesis
945985|NCT03507816|Tuberculosis|tuberculosis
945986|NCT03507816|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
945987|NCT03507816|Observational retrospective study|observational retrospective study
945988|NCT03507816|Clinical epidemiology|clinical epidemiology
945989|NCT03507816|Treatment outcome|treatment outcome
945990|NCT03507816|Migrant|migrant
945991|NCT03507816|Precarity|precarity
945992|NCT03507803|Gait training|gait training
945993|NCT03507803|Walking|walking
945994|NCT03507790|Alzheimer's Disease|alzheimer's disease
945995|NCT03507764|Treadmills|treadmills
945996|NCT03507764|Exercise|exercise
945997|NCT03507764|Number of steps|number of steps
945998|NCT03507764|Dispatchers|dispatchers
945999|NCT03507725|mind-body intervention|mind-body intervention
946000|NCT03507725|18-189|18-189
946001|NCT03507712|Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric|asymmetric, inferior oblique, overaction, surgery, symmetric
946002|NCT03507699|radiotherapy|radiotherapy
946003|NCT03507699|radiosurgery|radiosurgery
946004|NCT03507699|immunotherapy|immunotherapy
946005|NCT03507699|PD-1|pd-1
946006|NCT03507699|CTLA-4|ctla-4
946007|NCT03507699|TLR9|tlr9
946008|NCT03507686|NightstaRx|nightstarx
946009|NCT03507686|NSR-REP1|nsr-rep1
946010|NCT03507686|Choroideremia|choroideremia
946011|NCT03507686|CHM|chm
946012|NCT03507686|Gene Therapy|gene therapy
946013|NCT03507686|AAV|aav
946014|NCT03507686|REP1|rep1
946015|NCT03507660|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
946016|NCT03507647|randomized controlled trial|randomized controlled trial
946017|NCT03507647|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
946018|NCT03507647|clinical effectiveness|clinical effectiveness
946019|NCT03507647|cost-effectiveness|cost-effectiveness
946020|NCT03507647|working mechanisms|working mechanisms
946021|NCT03507634|Lidocaine|lidocaine
946022|NCT03507634|Dexmedetomidine|dexmedetomidine
946023|NCT03507634|Opioid Free|opioid free
946024|NCT03507634|Bariatric surgery|bariatric surgery
946025|NCT03507595|prostate specific membrane antigen(PMSA)|prostate specific membrane antigen(pmsa)
946026|NCT03507595|prostate cancer|prostate cancer
946027|NCT03507595|PET/CT|pet/ct
946028|NCT03507556|immature teeth, necrotic teeth|immature teeth, necrotic teeth
946029|NCT03507543|Breast Cancer|breast cancer
946030|NCT03507543|Ovarian Cancer|ovarian cancer
946031|NCT03507543|Prostate Cancer|prostate cancer
946032|NCT03507543|Advanced solid tumours|advanced solid tumours
946033|NCT03507543|primary peritoneal Cancer|primary peritoneal cancer
946034|NCT03507530|physiotherapy and rehabilitation|physiotherapy and rehabilitation
946035|NCT03507530|fear of falling|fear of falling
946036|NCT03507530|quality of life|quality of life
946037|NCT03507517|prevention|prevention
946038|NCT03507504|psychiatric aspects|psychiatric aspects
946039|NCT03507491|Pediatric|pediatric
946040|NCT03507491|Sarcoma|sarcoma
946041|NCT03507491|Neuroblastoma|neuroblastoma
946042|NCT03507491|Ewing sarcoma|ewing sarcoma
946043|NCT03507491|Osteosarcoma|osteosarcoma
946044|NCT03507491|Rhabdomyosarcoma|rhabdomyosarcoma
946045|NCT03507491|Wilms tumor|wilms tumor
946046|NCT03507491|Hepatoblastoma|hepatoblastoma
946047|NCT03507491|Adolescent and young adult|adolescent and young adult
946048|NCT03507491|Germ cell tumor|germ cell tumor
946049|NCT03507465|letrozole|letrozole
946050|NCT03507465|metronomic|metronomic
946051|NCT03507465|capecitabine|capecitabine
946052|NCT03507465|neoadjuvant|neoadjuvant
946053|NCT03507465|chemotherapy|chemotherapy
946054|NCT03507465|ER+/HER2-|er+/her2-
946055|NCT03507452|Malignant Mesothelioma|malignant mesothelioma
946056|NCT03507452|Malignant Pleural Epithelioid Mesothelioma|malignant pleural epithelioid mesothelioma
946057|NCT03507452|Malignant Peritoneal Epithelioid Mesothelioma|malignant peritoneal epithelioid mesothelioma
946058|NCT03507452|Serous Ovarian Cancer|serous ovarian cancer
946059|NCT03507439|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
946060|NCT03507439|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
946061|NCT03507426|Retrobulbar block|retrobulbar block
946062|NCT03507426|Ketamine|ketamine
946063|NCT03507426|Ocular enucleation|ocular enucleation
946064|NCT03507426|Analgesia|analgesia
946065|NCT03507413|abdominal aortic aneurysm|abdominal aortic aneurysm
946066|NCT03507413|metformin|metformin
946067|NCT03507413|non-diabetic|non-diabetic
946068|NCT03507413|placebo|placebo
946069|NCT03507400|Introvision: mental and emotional self-regulation technique|introvision: mental and emotional self-regulation technique
946070|NCT03507400|Mindfulness, perception technique|mindfulness, perception technique
946071|NCT03507400|Migraine|migraine
946072|NCT03507387|Intramuscular|intramuscular
946073|NCT03507387|Phenylephrine|phenylephrine
946074|NCT03507374|Stroke|stroke
946075|NCT03507374|alirocumab|alirocumab
946076|NCT03507374|Intracranial Atherosclerosis|intracranial atherosclerosis
946077|NCT03507374|Intraplaque Hemorrhage|intraplaque hemorrhage
946078|NCT03507374|atorvastatin|atorvastatin
946079|NCT03507374|praluent|praluent
946080|NCT03507348|Anti-HLA alloantibodies|anti-hla alloantibodies
946081|NCT03507348|Desensitization therapy|desensitization therapy
946082|NCT03507348|Tocilizumab|tocilizumab
946083|NCT03507348|Rituximab|rituximab
946084|NCT03507335|Arrhythmia Atrial|arrhythmia atrial
946085|NCT03507335|heart rate monitoring|heart rate monitoring
946086|NCT03507335|stroke|stroke
946087|NCT03507335|atrial fibrillation|atrial fibrillation
946088|NCT03507322|texturization|texturization
946089|NCT03507322|pregnancy rate|pregnancy rate
946090|NCT03507322|oocyte donation|oocyte donation
946091|NCT03507322|2D ultrasound|2d ultrasound
946092|NCT03507322|3D ultrasound|3d ultrasound
946093|NCT03507322|assisted reproductive technology (ART)|assisted reproductive technology (art)
946094|NCT03507283|Pterygium|pterygium
946095|NCT03507283|double-headed|double-headed
946096|NCT03507283|vertical|vertical
946097|NCT03507270|FABP|fabp
946098|NCT03507270|non ST Segment Elevation Myocardial Infarction|non st segment elevation myocardial infarction
946099|NCT03507257|Cognitively Normal|cognitively normal
946100|NCT03507257|Amyloid|amyloid
946101|NCT03507257|Plaques|plaques
946102|NCT03507257|Neuroimaging|neuroimaging
946103|NCT03507257|Biomarkers|biomarkers
946104|NCT03507257|Cognition Disorder|cognition disorder
946105|NCT03507257|Dementia|dementia
946106|NCT03507257|Tau|tau
946107|NCT03507257|Early Onset Alzheimer's Disease|early onset alzheimer's disease
946108|NCT03507257|Alzheimer's Disease|alzheimer's disease
946901|NCT03501927|Anesthesia|anesthesia
946109|NCT03507257|Mild Cognitive Impairment|mild cognitive impairment
946110|NCT03507244|Leptomeningeal metastasis|leptomeningeal metastasis
946111|NCT03507244|Malignant solid tumors|malignant solid tumors
946112|NCT03507244|Pemetrexed|pemetrexed
946113|NCT03507244|Intrathecal chemotherapy|intrathecal chemotherapy
946114|NCT03507244|Radiotherapy|radiotherapy
946115|NCT03507231|incentives|incentives
946116|NCT03507231|field study|field study
946117|NCT03507231|vaccination|vaccination
946118|NCT03507218|Obsessive Compulsive Disorder|obsessive compulsive disorder
946119|NCT03507218|Anxiety Disorder|anxiety disorder
946120|NCT03507218|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
946121|NCT03507218|Eating Disorders|eating disorders
946122|NCT03507205|Everolimus|everolimus
946123|NCT03507205|Sirolimus|sirolimus
946124|NCT03507205|Zotarolimus|zotarolimus
946125|NCT03507205|Biolimus|biolimus
946126|NCT03507205|Drug-eluting stent|drug-eluting stent
946127|NCT03507192|MCI, Alzheimer's disease, muscle relaxation|mci, alzheimer's disease, muscle relaxation
946128|NCT03507166|RC48-ADC|rc48-adc
946129|NCT03507166|HER2|her2
946130|NCT03507153|"Nylon denture base and PEEK partial denture"|"nylon denture base and peek partial denture"
946131|NCT03507140|cirrhosis|cirrhosis
946132|NCT03507140|hepatocellular carcinoma|hepatocellular carcinoma
946133|NCT03507140|Liver transplantation|liver transplantation
946134|NCT03507140|Microbiota|microbiota
946135|NCT03507114|Rumination|rumination
946136|NCT03507114|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
946139|NCT03507088|fulvestrant 500 mg|fulvestrant 500 mg
946140|NCT03507088|fluorine-18 fluoroestradiol PET-CT|fluorine-18 fluoroestradiol pet-ct
946142|NCT03507062|crystalloids|crystalloids
946143|NCT03507036|knee area|knee area
946144|NCT03507036|suprapatellar skin|suprapatellar skin
946145|NCT03507036|aging|aging
946146|NCT03507036|laxity|laxity
946147|NCT03507010|Radiotherapy|radiotherapy
946148|NCT03507010|Pain|pain
946149|NCT03506997|Immune checkpoint inhibitor|immune checkpoint inhibitor
946150|NCT03506997|Pembrolizumab|pembrolizumab
946151|NCT03506971|Young child's development|young child's development
946152|NCT03506971|Home visits|home visits
946153|NCT03506971|Early interactions|early interactions
946154|NCT03506971|attachment|attachment
946155|NCT03506971|parenthood|parenthood
946156|NCT03506932|blood sugar|blood sugar
946157|NCT03506932|insulin|insulin
946158|NCT03506932|peas|peas
946159|NCT03506932|bread|bread
946160|NCT03506932|metabolites|metabolites
946161|NCT03506906|Chronic hypoventilation syndrome|chronic hypoventilation syndrome
946162|NCT03506906|Polysomnography|polysomnography
946163|NCT03506906|Transcutaneous Capnometry|transcutaneous capnometry
946164|NCT03506906|Noninvasive Ventilation|noninvasive ventilation
946165|NCT03506906|home mechanical ventilation|home mechanical ventilation
946166|NCT03506906|Ventilator´s set-up|ventilator´s set-up
946167|NCT03506893|refractory ascite|refractory ascite
946168|NCT03506893|pump system|pump system
946169|NCT03506867|Health Equity|health equity
946170|NCT03506867|Community Based Participatory Action Research|community based participatory action research
946171|NCT03506867|Poverty Reduction|poverty reduction
946172|NCT03506815|Upper Extremity Deep Vein Thrombosis|upper extremity deep vein thrombosis
946173|NCT03506815|Thromboprophylaxis|thromboprophylaxis
946174|NCT03506815|Cancer|cancer
946175|NCT03506815|Randomized Trial|randomized trial
946176|NCT03506763|office hysteroscopy, pain measure|office hysteroscopy, pain measure
946177|NCT03506750|Conbercept|conbercept
946178|NCT03506750|PLGF|plgf
946179|NCT03506724|Hypertension, Pregnancy-induced|hypertension, pregnancy-induced
946180|NCT03506724|Pregnancy Induced Hypertension|pregnancy induced hypertension
946181|NCT03506724|Gestational Hypertension|gestational hypertension
946182|NCT03506724|Transient Hypertension, Pregnancy|transient hypertension, pregnancy
946183|NCT03506724|Pharmacogenetics|pharmacogenetics
946184|NCT03506711|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
946185|NCT03506711|MRI|mri
946186|NCT03506711|Isometric handgrip exercise|isometric handgrip exercise
946187|NCT03506711|Children|children
946188|NCT03506711|Adolescents|adolescents
946189|NCT03506698|Birth weight|birth weight
946190|NCT03506685|dry needling|dry needling
946191|NCT03506685|ACL reconstruction|acl reconstruction
946192|NCT03506685|knee ROM|knee rom
946193|NCT03506685|pain management|pain management
946194|NCT03506685|opioid use|opioid use
946195|NCT03506672|Behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
946196|NCT03506672|Psychosocial interventions|psychosocial interventions
946197|NCT03506672|Well-being|well-being
946198|NCT03506672|Long-term care facilities|long-term care facilities
946199|NCT03506672|Family and formal caregivers|family and formal caregivers
946200|NCT03506672|Partnership|partnership
946201|NCT03506620|femoroacetabular impingement|femoroacetabular impingement
946202|NCT03506620|hip arthroscopy|hip arthroscopy
946203|NCT03506620|QL nerve block|ql nerve block
946204|NCT03506607|exercise|exercise
946205|NCT03506607|cardiovascular|cardiovascular
946206|NCT03506607|normobaric hypoxia|normobaric hypoxia
946207|NCT03506568|Adherence|adherence
946208|NCT03506568|Medication|medication
946209|NCT03506568|Glaucoma|glaucoma
946210|NCT03506568|Device|device
946211|NCT03506555|Laparoscopy|laparoscopy
946212|NCT03506555|Hasson technique|hasson technique
946213|NCT03506555|Veress needle technique|veress needle technique
946214|NCT03506555|complications|complications
946215|NCT03506529|TEP|tep
946216|NCT03506529|hypermetabolism|hypermetabolism
946217|NCT03506516|alcohol, hangover|alcohol, hangover
946218|NCT03506503|nanofat|nanofat
946219|NCT03506503|hair loss|hair loss
946220|NCT03506503|prp|prp
946221|NCT03506477|skin of color|skin of color
946222|NCT03506477|psoriasis|psoriasis
946223|NCT03506477|Enstilar|enstilar
946224|NCT03506477|skin diseases|skin diseases
946225|NCT03506464|Plantar Fasciitis|plantar fasciitis
946226|NCT03506464|physical therapy|physical therapy
946227|NCT03506464|sonoelastography|sonoelastography
946228|NCT03506451|Financial toxicity|financial toxicity
946229|NCT03506438|critical illness|critical illness
946230|NCT03506438|palliative care|palliative care
946231|NCT03506438|mobile app|mobile app
946232|NCT03506438|psychological distress|psychological distress
946233|NCT03506438|depression|depression
946235|NCT03506438|informal caregiver|informal caregiver
946236|NCT03506412|Heart Failure|heart failure
946237|NCT03506412|HFpEF|hfpef
946238|NCT03506412|Entresto™|entresto™
946239|NCT03506412|Neprilysin|neprilysin
946240|NCT03506412|Diastolic Heart Failure|diastolic heart failure
946339|NCT03505697|rehabilitation|rehabilitation
946241|NCT03506386|Real World Evidence , Multiple Myeloma Profile, Brazil|real world evidence , multiple myeloma profile, brazil
946242|NCT03506321|colonoscopy|colonoscopy
946243|NCT03506321|Residual adenoma|residual adenoma
946244|NCT03506321|Recurrent adenoma|recurrent adenoma
946245|NCT03506282|Running biomechanics|running biomechanics
946246|NCT03506282|Vertical loading rate|vertical loading rate
946247|NCT03506282|Music exercise|music exercise
946248|NCT03506282|Gait analysis|gait analysis
946249|NCT03506256|urinary tract infection|urinary tract infection
946250|NCT03506256|Norfloxacin|norfloxacin
946251|NCT03506256|Fluroquinolone|fluroquinolone
946252|NCT03506256|Safety|safety
946253|NCT03506256|Pakistan|pakistan
946254|NCT03506243|IVF, rhFSH|ivf, rhfsh
946255|NCT03506230|Rewards|rewards
946256|NCT03506230|Medication Adherence|medication adherence
946257|NCT03506230|Health Behavior|health behavior
946258|NCT03506230|Diabetes Mellitus|diabetes mellitus
946259|NCT03506230|Copayments|copayments
946260|NCT03506217|mitral valve prolaps,|mitral valve prolaps,
946261|NCT03506217|chorda tendinea,|chorda tendinea,
946262|NCT03506217|cardiac output|cardiac output
946263|NCT03506204|Pelvic floor muscle strength|pelvic floor muscle strength
946264|NCT03506204|Pelvic floor dysfunction|pelvic floor dysfunction
946265|NCT03506204|Postpartum|postpartum
946266|NCT03506204|primipara|primipara
946267|NCT03506191|Stenotrophomonas maltophilia|stenotrophomonas maltophilia
946268|NCT03506191|Pneumonia|pneumonia
946269|NCT03506191|Intensive Care Unit|intensive care unit
946270|NCT03506178|Upper airway|upper airway
946271|NCT03506178|Obstructive sleep apnea|obstructive sleep apnea
946272|NCT03506178|Polysomnography|polysomnography
946273|NCT03506139|Radiotherapy|radiotherapy
946274|NCT03506139|Magnetic Resonance Imaging|magnetic resonance imaging
946275|NCT03506126|amino acid requirement|amino acid requirement
946276|NCT03506126|elderly|elderly
946277|NCT03506126|leucine|leucine
946278|NCT03506126|dietary requirement|dietary requirement
946279|NCT03506113|Gram staining|gram staining
946280|NCT03506113|Antimicrobial therapy|antimicrobial therapy
946281|NCT03506113|Empirical therapy|empirical therapy
946282|NCT03506113|Nosocomial infection|nosocomial infection
946283|NCT03506113|Mechanical ventilation|mechanical ventilation
946284|NCT03506113|Intensive care|intensive care
946285|NCT03506113|Sepsis|sepsis
946286|NCT03506100|Spirometry|spirometry
946287|NCT03506100|swimming|swimming
946288|NCT03506100|water walking|water walking
946289|NCT03506087|Advance Care Planning|advance care planning
946290|NCT03506087|Shared Decision Making|shared decision making
946291|NCT03506074|Obesity|obesity
946292|NCT03506074|Flavor|flavor
946293|NCT03506035|Shared epitope|shared epitope
946294|NCT03506035|HLA-DRB1|hla-drb1
946295|NCT03506035|Citrullinated peptides|citrullinated peptides
946296|NCT03506035|Autoantibodies|autoantibodies
946297|NCT03506022|Sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (CGMS )|sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (cgms )
946298|NCT03505983|Prosthetic Limb Design|prosthetic limb design
946299|NCT03505983|Prosthesis Fitting|prosthesis fitting
946300|NCT03505970|Physiological Phenomena|physiological phenomena
946301|NCT03505957|IV Dislodgement|iv dislodgement
946302|NCT03505931|Peripheral artery disease|peripheral artery disease
946303|NCT03505931|femoropopliteal|femoropopliteal
946304|NCT03505931|drug-eluting stent|drug-eluting stent
946305|NCT03505931|restenosis|restenosis
946306|NCT03505905|Pregnenolone|pregnenolone
946307|NCT03505892|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
946308|NCT03505892|Adalimumab|adalimumab
946309|NCT03505892|Humira|humira
946310|NCT03505879|Next Generation Sequencing|next generation sequencing
946312|NCT03505866|Anti-retroviral therapy|anti-retroviral therapy
946313|NCT03505866|Intervention|intervention
946314|NCT03505866|Mental Health|mental health
946315|NCT03505853|RNAi therapeutic|rnai therapeutic
946316|NCT03505853|Porphyria|porphyria
946317|NCT03505853|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
946318|NCT03505853|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
946319|NCT03505827|TECNIS Symfony|tecnis symfony
946320|NCT03505814|post extubation care|post extubation care
946321|NCT03505814|neonatal surgical critical care|neonatal surgical critical care
946322|NCT03505814|oxygen therapy|oxygen therapy
946323|NCT03505814|high nasal flow cannula|high nasal flow cannula
946324|NCT03505775|Hormone replacement|hormone replacement
946325|NCT03505775|Mineralocorticoids|mineralocorticoids
946326|NCT03505775|23Na-magnetic resonance imaging|23na-magnetic resonance imaging
946327|NCT03505775|Tissue sodium content|tissue sodium content
946328|NCT03505723|Noncardiac surgery|noncardiac surgery
946329|NCT03505723|Myocardial injury|myocardial injury
946330|NCT03505723|Perioperative myocardial infarction|perioperative myocardial infarction
946331|NCT03505723|Tranexamic Acid|tranexamic acid
946332|NCT03505723|Hypotension|hypotension
946333|NCT03505723|Hypertension|hypertension
946334|NCT03505710|HER2 over-expression|her2 over-expression
946335|NCT03505710|HER2 mutation|her2 mutation
946336|NCT03505710|Unresectable or metastatic|unresectable or metastatic
946337|NCT03505710|Non-squamous|non-squamous
946338|NCT03505710|NSCLC|nsclc
946341|NCT03505697|maximal inspiratory pressure|maximal inspiratory pressure
946342|NCT03505697|6-minute walk test|6-minute walk test
946343|NCT03505619|home care service|home care service
946344|NCT03505619|reablement service|reablement service
946345|NCT03505619|rehabilitation|rehabilitation
946346|NCT03505606|Amblyopia|amblyopia
946347|NCT03505606|Visual Acuity|visual acuity
946348|NCT03505606|Crowding|crowding
946349|NCT03505554|ALK|alk
946350|NCT03505554|relapsed|relapsed
946351|NCT03505554|lorlatinib|lorlatinib
946352|NCT03505528|Nanoparticle albumin-bound paclitaxel (Abraxane)|nanoparticle albumin-bound paclitaxel (abraxane)
946353|NCT03505528|Phenelzine Sulfate|phenelzine sulfate
946354|NCT03505528|Cancer stem cells|cancer stem cells
946355|NCT03505528|epigenetics|epigenetics
946356|NCT03505528|LSD1|lsd1
946357|NCT03505502|Cesarean Myomectomy|cesarean myomectomy
946358|NCT03505502|Tranexamic Acid|tranexamic acid
946359|NCT03505489|Mannitol|mannitol
946360|NCT03505489|Methacholine|methacholine
946361|NCT03505489|Deep inhalation|deep inhalation
946362|NCT03505489|Tidal breathing|tidal breathing
946364|NCT03505476|Abdominal surgery|abdominal surgery
946365|NCT03505476|Bowel obstruction|bowel obstruction
946366|NCT03505476|Postoperative Ileus|postoperative ileus
946367|NCT03505463|Spinal cord injury|spinal cord injury
946368|NCT03505463|Biomarkers|biomarkers
946369|NCT03505463|Inflammation|inflammation
946370|NCT03505463|Trauma|trauma
946371|NCT03505450|decision support tools,|decision support tools,
946372|NCT03505437|anxiety disorders|anxiety disorders
946373|NCT03505437|spider phobia|spider phobia
946374|NCT03505437|stress|stress
946375|NCT03505437|exposure therapy|exposure therapy
946376|NCT03505437|generalization|generalization
946377|NCT03505424|Premature Infant|premature infant
946378|NCT03505424|Premature Birth|premature birth
946379|NCT03505424|Smartphone App|smartphone app
946380|NCT03505424|NICU|nicu
946381|NCT03505411|Melatonin|melatonin
946382|NCT03505411|Glutathione|glutathione
946383|NCT03505411|Glutathione peroxidase|glutathione peroxidase
946384|NCT03505411|Malondialdehyde|malondialdehyde
946385|NCT03505411|Isoprostanes|isoprostanes
946386|NCT03505411|anti-ox-LDL|anti-ox-ldl
946387|NCT03505411|Superoxide dismutase|superoxide dismutase
946388|NCT03505411|Glutathione reductase|glutathione reductase
946389|NCT03505411|Interleukin-6|interleukin-6
946390|NCT03505411|C-reactive protein|c-reactive protein
946391|NCT03505411|Autonomic nervous system|autonomic nervous system
946392|NCT03505385|Co-creation|co-creation
946393|NCT03505385|Service-learning methodology|service-learning methodology
946394|NCT03505372|Atypical ductal hyperplasia|atypical ductal hyperplasia
946395|NCT03505372|ADH|adh
946396|NCT03505346|Positron Emission Tomography|positron emission tomography
946397|NCT03505346|nuclear medicine|nuclear medicine
946398|NCT03505346|prognosis|prognosis
946399|NCT03505320|oxaliplatin|oxaliplatin
946400|NCT03505320|fluorouracil|fluorouracil
946401|NCT03505320|IMAB362|imab362
946402|NCT03505320|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
946403|NCT03505320|Gastric cancer|gastric cancer
946404|NCT03505294|Multiple Sclerosis|multiple sclerosis
946405|NCT03505294|task-oriented training|task-oriented training
946406|NCT03505294|physical performance|physical performance
946407|NCT03505294|cognition|cognition
946607|NCT03503981|Mechanisms of change|mechanisms of change
946408|NCT03505268|Glycosylated hemoglobin A1c (HbA1c), Telemedicine|glycosylated hemoglobin a1c (hba1c), telemedicine
946409|NCT03505164|Doxorubicin|doxorubicin
946410|NCT03505164|suPAR|supar
946411|NCT03505164|Caridomyopathy|caridomyopathy
946412|NCT03505164|Heart Failure|heart failure
946413|NCT03505164|Breast Cancer|breast cancer
946414|NCT03505138|COPD|copd
946415|NCT03505138|hospitalization|hospitalization
946416|NCT03505138|telemedicine platform|telemedicine platform
946417|NCT03505112|Goal-directed therapy|goal-directed therapy
946418|NCT03505112|stroke volume index|stroke volume index
946419|NCT03505099|gene therapy|gene therapy
946420|NCT03505047|second trimester medical abortion|second trimester medical abortion
946421|NCT03505047|Immediate versus delayed insertion|immediate versus delayed insertion
946422|NCT03505047|copper intrauterine device|copper intrauterine device
946423|NCT03505034|Spinal cord injury，Umbilical Cord Mesenchymal Stem Cells|spinal cord injury，umbilical cord mesenchymal stem cells
946424|NCT03505008|Methotrexate|methotrexate
946425|NCT03505008|Adalimumab|adalimumab
946426|NCT03505008|Autoimmune Disease|autoimmune disease
946427|NCT03505008|Connective Tissue Diseases|connective tissue diseases
946428|NCT03505008|Rheumatic Disease|rheumatic disease
946429|NCT03505008|Rheumatoid Arthritis|rheumatoid arthritis
946430|NCT03504995|Prostate|prostate
946431|NCT03504995|Irreversible Electroporation|irreversible electroporation
946432|NCT03504995|Prostate Cancer|prostate cancer
946433|NCT03504982|Vericiguat|vericiguat
946434|NCT03504982|Stable CAD|stable cad
946435|NCT03504982|QT/QTc|qt/qtc
946436|NCT03504969|umbilical cord|umbilical cord
946437|NCT03504956|MRI technique|mri technique
946438|NCT03504956|High Resolution MRI Technique|high resolution mri technique
946439|NCT03504943|Exercise|exercise
946440|NCT03504943|Hemodialysis|hemodialysis
946441|NCT03504943|Intradialytic hypotension|intradialytic hypotension
946442|NCT03504930|Surgical|surgical
946443|NCT03504930|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
946444|NCT03504904|Chronic pain|chronic pain
946445|NCT03504904|Self-criticism|self-criticism
946446|NCT03504904|Internet-based treatment|internet-based treatment
946448|NCT03504904|CFT|cft
946449|NCT03504904|Guided self-help|guided self-help
946450|NCT03504904|Acceptance|acceptance
946451|NCT03504904|Compassion|compassion
946452|NCT03504865|Exparel|exparel
946453|NCT03504865|Bupivacaine|bupivacaine
946454|NCT03504852|psoriasis|psoriasis
946455|NCT03504852|weight|weight
946456|NCT03504852|secukinumab|secukinumab
946457|NCT03504839|defibrillator|defibrillator
946458|NCT03504826|adaptive robotics|adaptive robotics
946459|NCT03504826|locomotor training|locomotor training
946460|NCT03504826|Spinal Cord diseases|spinal cord diseases
946461|NCT03504826|walking rehabilitation|walking rehabilitation
946462|NCT03504826|Spinal Cord Injury|spinal cord injury
946463|NCT03504813|Elderly|elderly
946464|NCT03504813|Quality of life|quality of life
946465|NCT03504813|Wearables|wearables
946466|NCT03504813|Urinary incontinence|urinary incontinence
946467|NCT03504813|Insomnia|insomnia
946468|NCT03504813|Risk of falls|risk of falls
946469|NCT03504800|OCT|oct
946470|NCT03504800|Keratoconus|keratoconus
946471|NCT03504787|cerebral palsy|cerebral palsy
946472|NCT03504787|upper extremity|upper extremity
946473|NCT03504787|selective motor control|selective motor control
946474|NCT03504748|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
946475|NCT03504748|chronic pain|chronic pain
946476|NCT03504748|parkinson|parkinson
946477|NCT03504748|treatment|treatment
946478|NCT03504748|non-motor symptom|non-motor symptom
946479|NCT03504670|Labor induction|labor induction
946480|NCT03504670|Cesarean delivery|cesarean delivery
946481|NCT03504670|Preterm labor induction|preterm labor induction
946482|NCT03504670|Duration of labor induction|duration of labor induction
946483|NCT03504657|Vertebral Artery Stenosis|vertebral artery stenosis
946484|NCT03504657|Drug-coated balloon angioplasty|drug-coated balloon angioplasty
946485|NCT03504657|Stenting|stenting
946486|NCT03504631|tamoxifen|tamoxifen
946487|NCT03504631|breast cancer|breast cancer
946488|NCT03504631|Z-endoxifen|z-endoxifen
946489|NCT03504579|rt-fMRI|rt-fmri
946490|NCT03504579|MRI|mri
946491|NCT03504579|schizophrenia|schizophrenia
946492|NCT03504579|auditory hallucinations|auditory hallucinations
946493|NCT03504579|neurofeedback|neurofeedback
946494|NCT03504540|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
946495|NCT03504540|Age Related Macular Degeneration|age related macular degeneration
946496|NCT03504540|"Pseudo-drusen-like deposits"|"pseudo-drusen-like deposits"
946497|NCT03504527|ICS|ics
946498|NCT03504527|LABA|laba
946499|NCT03504527|LAMA|lama
946500|NCT03504527|therapy|therapy
946501|NCT03504527|asthma|asthma
946502|NCT03504527|COPD|copd
946503|NCT03504527|ACO|aco
946504|NCT03504514|non invasive ventilation|non invasive ventilation
946505|NCT03504514|invasive ventilation|invasive ventilation
946506|NCT03504514|neuromuscular disorder|neuromuscular disorder
946507|NCT03504514|phonation|phonation
946508|NCT03504514|speech|speech
946509|NCT03504501|RASopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation|rasopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation
946512|NCT03504462|Regional Analgesia|regional analgesia
946513|NCT03504462|Ultrasound|ultrasound
946514|NCT03504462|Distal block|distal block
946515|NCT03504462|Plantar nerve block|plantar nerve block
946516|NCT03504397|HER2|her2
946517|NCT03504397|IMAB362|imab362
946518|NCT03504397|leucovorin|leucovorin
946519|NCT03504397|fluorouracil|fluorouracil
946520|NCT03504397|Gastric cancer|gastric cancer
946521|NCT03504397|oxaliplatin|oxaliplatin
946522|NCT03504397|adenocarcinoma|adenocarcinoma
946523|NCT03504397|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
946524|NCT03504397|HER2 Negative mFOLFOX6|her2 negative mfolfox6
946525|NCT03504371|oesophageal surgeries-epidural-erector block|oesophageal surgeries-epidural-erector block
946526|NCT03504358|surgery|surgery
946527|NCT03504358|scoring system|scoring system
946528|NCT03504358|hepatocellular carcinoma|hepatocellular carcinoma
946529|NCT03504358|homogeneity and discriminatory ability|homogeneity and discriminatory ability
946531|NCT03504332|immature teeth, revascularization|immature teeth, revascularization
946532|NCT03504319|exercise|exercise
946533|NCT03504319|inflammation|inflammation
946534|NCT03504319|metabolic inflexibility|metabolic inflexibility
946535|NCT03504319|insulin resistance|insulin resistance
946536|NCT03504319|neonatal adiposity|neonatal adiposity
946537|NCT03504293|Endosonography|endosonography
946538|NCT03504293|Endoscopic retrograde choledochography|endoscopic retrograde choledochography
946539|NCT03504280|hypovitaminosis D|hypovitaminosis d
946540|NCT03504280|cholecalciferol|cholecalciferol
946541|NCT03504280|mehadose|mehadose
946542|NCT03504267|physical activity|physical activity
946544|NCT03504267|patient-provider communication|patient-provider communication
946545|NCT03504254|cervical spondylotic myelopathy|cervical spondylotic myelopathy
946546|NCT03504254|diffusion tensor imaging|diffusion tensor imaging
946547|NCT03504254|functional magnetic resonance imaging|functional magnetic resonance imaging
946548|NCT03504241|mesenchymal stromal cells (MSCs)|mesenchymal stromal cells (mscs)
946549|NCT03504241|anti-rejection drugs|anti-rejection drugs
946550|NCT03504241|operational tolerance|operational tolerance
946551|NCT03504215|extremely preterm|extremely preterm
946552|NCT03504215|young adults|young adults
946553|NCT03504215|term|term
946554|NCT03504215|exercise capacity|exercise capacity
946555|NCT03504215|pulmonary function|pulmonary function
946556|NCT03504215|muscle oxygenation|muscle oxygenation
946557|NCT03504189|Fetal monitoring, Prenatal monitoring|fetal monitoring, prenatal monitoring
946560|NCT03504137|mHealth|mhealth
946561|NCT03504137|kidney transplantation|kidney transplantation
946562|NCT03504137|medication adherence|medication adherence
946563|NCT03504137|video directly observed therapy|video directly observed therapy
946564|NCT03504098|One-carbon metabolism|one-carbon metabolism
946565|NCT03504098|Folate|folate
946566|NCT03504098|Choline|choline
946567|NCT03504098|metabolomic marker|metabolomic marker
946568|NCT03504098|Cancer risk|cancer risk
946569|NCT03504085|Chronic Low Back Pain|chronic low back pain
946570|NCT03504085|CLBP|clbp
946571|NCT03504085|Chronic Neck Pain|chronic neck pain
946572|NCT03504085|CNP|cnp
946573|NCT03504085|Chronic Pain|chronic pain
946574|NCT03504085|Military|military
946575|NCT03504085|Active Duty|active duty
946576|NCT03504085|Yoga|yoga
946577|NCT03504085|Mindbody|mindbody
946578|NCT03504072|Etanercept|etanercept
946579|NCT03504072|Infection|infection
946580|NCT03504072|Tofacitinib|tofacitinib
946581|NCT03504072|Tuberculosis|tuberculosis
946582|NCT03504072|Spondyloarthritis|spondyloarthritis
946583|NCT03504059|Obesity|obesity
946584|NCT03504059|Cardiovascular Diseases|cardiovascular diseases
946585|NCT03504059|Diabetes|diabetes
946586|NCT03504059|Adolescents|adolescents
946587|NCT03504059|Physical Activity|physical activity
946588|NCT03504059|Diet|diet
946589|NCT03504059|School-Based|school-based
946590|NCT03504046|artificial pancreas|artificial pancreas
946591|NCT03504046|hyperglycemia|hyperglycemia
946592|NCT03504046|hypoglycemia|hypoglycemia
946593|NCT03504033|Xenon|xenon
946594|NCT03504033|Liver resection|liver resection
946595|NCT03504033|post-operative liver failure|post-operative liver failure
946596|NCT03504033|anesthetics, inhalation|anesthetics, inhalation
946597|NCT03504033|Desflurane|desflurane
946598|NCT03504033|Randomized controlled trail|randomized controlled trail
946599|NCT03504033|RCT|rct
946600|NCT03504007|Deep Vein Thrombosis|deep vein thrombosis
946601|NCT03504007|Pulmonary Embolism|pulmonary embolism
946602|NCT03504007|Apixaban|apixaban
946603|NCT03504007|Rivaroxaban|rivaroxaban
946604|NCT03504007|Dabigatran|dabigatran
946605|NCT03504007|Edoxaban|edoxaban
946606|NCT03503981|Process-outcome study|process-outcome study
946608|NCT03503916|Accidental fall|accidental fall
946609|NCT03503916|Postural Balance|postural balance
946610|NCT03503903|Wet cupping therapy|wet cupping therapy
946611|NCT03503903|antioxidant capacity|antioxidant capacity
946612|NCT03503890|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme.|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme.
946613|NCT03503864|Neuroblastoma|neuroblastoma
946614|NCT03503864|Arsenic Trioxide|arsenic trioxide
946615|NCT03503864|Children|children
946616|NCT03503851|Mitral Regurgitation|mitral regurgitation
946617|NCT03503851|transcatheter mitral valve repair|transcatheter mitral valve repair
946618|NCT03503851|MitraClip|mitraclip
946619|NCT03503812|Randomized clinical trial|randomized clinical trial
946620|NCT03503812|Public Health Intervention|public health intervention
946621|NCT03503812|Behavioral Intervention|behavioral intervention
946622|NCT03503812|Exposure-Reduction Approaches|exposure-reduction approaches
946623|NCT03503812|Desert dust storm events|desert dust storm events
946624|NCT03503812|Climate change|climate change
946625|NCT03503812|Asthma in children|asthma in children
946626|NCT03503812|Atrial Fibrillation|atrial fibrillation
946627|NCT03503812|Air pollution|air pollution
946628|NCT03503799|breast cancer|breast cancer
946629|NCT03503799|EndoPredict®|endopredict®
946630|NCT03503799|endocrine therapy|endocrine therapy
946631|NCT03503786|PD-L1 Expression|pd-l1 expression
946632|NCT03503786|advanced endometrial cancer|advanced endometrial cancer
946633|NCT03503786|recurrent endometrial cancer|recurrent endometrial cancer
946634|NCT03503786|Patient reported outcomes|patient reported outcomes
946635|NCT03503773|Renal Denervation|renal denervation
946636|NCT03503773|Neurolysis|neurolysis
946637|NCT03503760|Extremely low magnetic field (ELF)|extremely low magnetic field (elf)
946638|NCT03503760|Fibromyalgia impact questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
946639|NCT03503760|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
946640|NCT03503760|Short Form-12 of Physical and Mental Health Summary (SF-12)|short form-12 of physical and mental health summary (sf-12)
946641|NCT03503760|"LIMFA Therapy® machine from Eywa Srl system"|"limfa therapy® machine from eywa srl system"
946642|NCT03503747|type 1 diabetes|type 1 diabetes
946643|NCT03503747|Infants|infants
946644|NCT03503747|INGR1D|ingr1d
946645|NCT03503721|BipolEP|bipolep
946646|NCT03503721|TURP|turp
946647|NCT03503695|auricular acupuncture|auricular acupuncture
946648|NCT03503695|battlefield acupuncture|battlefield acupuncture
946649|NCT03503695|insomnia|insomnia
946650|NCT03503695|chronic pain|chronic pain
946651|NCT03503695|randomized|randomized
946652|NCT03503682|Short Course Radiotherapy|short course radiotherapy
946653|NCT03503682|Complicated Bone Metastases|complicated bone metastases
946654|NCT03503669|Memory impairment|memory impairment
946655|NCT03503669|Meditation|meditation
946656|NCT03503669|Yoga|yoga
946657|NCT03503669|Memory Training|memory training
946658|NCT03503669|Mild Cognitive Impairment|mild cognitive impairment
946659|NCT03503669|MCI|mci
946660|NCT03503669|Geriatric|geriatric
946661|NCT03503669|fMRI|fmri
946662|NCT03503669|Alzheimer's disease|alzheimer's disease
946663|NCT03503669|Cardiovascular risk|cardiovascular risk
946664|NCT03503643|prostate cancer|prostate cancer
946665|NCT03503643|cryoablation|cryoablation
946666|NCT03503630|Locally advanced rectal cancer|locally advanced rectal cancer
946667|NCT03503630|Immunotherapy|immunotherapy
946668|NCT03503630|Short course radiation|short course radiation
946669|NCT03503630|Folfox|folfox
946670|NCT03503630|Response rate|response rate
946671|NCT03503604|mAb|mab
946672|NCT03503604|VEGF|vegf
946673|NCT03503604|antibody|antibody
946674|NCT03503604|phase1|phase1
946675|NCT03503591|tympanostomy|tympanostomy
946676|NCT03503591|myringotomy|myringotomy
946677|NCT03503591|otitis media|otitis media
946678|NCT03503591|ear tubes|ear tubes
946679|NCT03503591|ear infection|ear infection
946680|NCT03503565|one-lung ventilation|one-lung ventilation
946681|NCT03503565|thoracic surgery|thoracic surgery
946682|NCT03503565|atelectasis|atelectasis
946683|NCT03503565|postoperative pulmonary complication|postoperative pulmonary complication
946684|NCT03503500|Breastfeeding|breastfeeding
946685|NCT03503500|Laid-back position|laid-back position
946686|NCT03503500|Breast problems|breast problems
946687|NCT03503500|Exclusive breastfeeding|exclusive breastfeeding
946688|NCT03503461|Calcineurin inhibitors|calcineurin inhibitors
946689|NCT03503461|hypertension|hypertension
946690|NCT03503461|kidney transplant|kidney transplant
946691|NCT03503461|acidosis|acidosis
946692|NCT03503461|Gordon syndrome|gordon syndrome
946693|NCT03503448|surgically assisted rapid maxillary expansion|surgically assisted rapid maxillary expansion
946694|NCT03503448|surgically assisted rapid palatal expansion|surgically assisted rapid palatal expansion
946695|NCT03503448|Malocclusion|malocclusion
946696|NCT03503435|Heart Rate Variability|heart rate variability
946697|NCT03503435|Art Therapy|art therapy
946698|NCT03503435|Total Laryngectomy|total laryngectomy
946699|NCT03503396|drunk driving|drunk driving
946700|NCT03503396|alcohol impaired driving|alcohol impaired driving
946900|NCT03501927|Surgery|surgery
946701|NCT03503396|drinking and driving|drinking and driving
946702|NCT03503396|ambulatory assessment|ambulatory assessment
946703|NCT03503383|Hypertension with pregnancy|hypertension with pregnancy
946704|NCT03503383|anxiety|anxiety
946705|NCT03503383|depression|depression
946706|NCT03503383|preeclampsia|preeclampsia
946707|NCT03503383|mental health|mental health
946708|NCT03503370|topical chlorhexidine|topical chlorhexidine
946709|NCT03503370|prevention|prevention
946710|NCT03503370|clinical trial|clinical trial
946711|NCT03503357|Consciousness|consciousness
946712|NCT03503357|Electroencephalography|electroencephalography
946713|NCT03503357|Anesthesia|anesthesia
946714|NCT03503305|Adipose-derived stem cells|adipose-derived stem cells
946715|NCT03503305|osteoarthritis|osteoarthritis
946716|NCT03503292|Pharmacogenetics|pharmacogenetics
946717|NCT03503292|CYP2D6|cyp2d6
946718|NCT03503292|Ondansetron|ondansetron
946719|NCT03503292|Granisetron|granisetron
946720|NCT03503292|Bariatric surgery|bariatric surgery
946721|NCT03503266|Mass Balance Study with MT-7117|mass balance study with mt-7117
946722|NCT03503240|Quality of Life|quality of life
946723|NCT03503240|survey|survey
946724|NCT03503240|18-168|18-168
946725|NCT03503214|Acid-base equilibrium|acid-base equilibrium
946726|NCT03503214|Stewart's approach|stewart's approach
946727|NCT03503214|In vitro study|in vitro study
946728|NCT03503214|Respiratory acid-base derangements|respiratory acid-base derangements
946729|NCT03503162|bowel prepartion|bowel prepartion
946730|NCT03503136|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
946731|NCT03503136|Induction chemotherapy|induction chemotherapy
946732|NCT03503136|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
946733|NCT03503136|Nedaplatin|nedaplatin
946734|NCT03503136|Capecitabine|capecitabine
946735|NCT03503097|Prostate cancer|prostate cancer
946736|NCT03503097|metastatic|metastatic
946737|NCT03503097|genetic testing|genetic testing
946738|NCT03503097|cancer risk|cancer risk
946739|NCT03503097|BRCA1|brca1
946740|NCT03503097|BRCA2|brca2
946741|NCT03503084|Tai Chi Chuan|tai chi chuan
946742|NCT03503084|insulin resistance|insulin resistance
946743|NCT03503084|cholesterol|cholesterol
946744|NCT03503084|endothelin-1|endothelin-1
946745|NCT03503058|Plasmodium falciparum|plasmodium falciparum
946746|NCT03503058|Sporozoites|sporozoites
946747|NCT03503058|PfSPZ|pfspz
946748|NCT03503045|Diabetes Mellitus|diabetes mellitus
946749|NCT03503045|Polypharmacy|polypharmacy
946750|NCT03503045|Overtreatment|overtreatment
946751|NCT03503045|Undertreatment|undertreatment
946752|NCT03503032|Extracardiac Fontan|extracardiac fontan
946753|NCT03503032|Total cavo-pulmonary connection|total cavo-pulmonary connection
946754|NCT03503032|Fenestrated|fenestrated
946755|NCT03503032|Congenital heart defects|congenital heart defects
946756|NCT03503032|Pediatrics|pediatrics
946757|NCT03502993|children|children
946758|NCT03502980|Peripherally Inserted Central Catheter Line Insertion|peripherally inserted central catheter line insertion
946759|NCT03502980|Catheterization, Peripheral Venous|catheterization, peripheral venous
946760|NCT03502967|Traumatic Brain Injury|traumatic brain injury
946761|NCT03502967|TBI|tbi
946762|NCT03502915|breech presentation|breech presentation
946763|NCT03502915|nitrous oxide|nitrous oxide
946764|NCT03502915|analgesia|analgesia
946765|NCT03502915|pregnancy|pregnancy
946766|NCT03502889|Total Knee Arthroplasty|total knee arthroplasty
946767|NCT03502889|SPANK Block|spank block
946768|NCT03502889|Adductor Canal Block|adductor canal block
946769|NCT03502889|Regional Anesthesia|regional anesthesia
946770|NCT03502837|ERP;DOC;auditory|erp;doc;auditory
946771|NCT03502824|Chronic wounds|chronic wounds
946772|NCT03502824|PHMB|phmb
946773|NCT03502824|Pressure Ulcer|pressure ulcer
946774|NCT03502824|Wound Management|wound management
946775|NCT03502824|Collagen|collagen
946776|NCT03502824|Stage II|stage ii
946777|NCT03502824|Stage III|stage iii
946778|NCT03502824|Stage IV|stage iv
946779|NCT03502824|Pressure Injury|pressure injury
946780|NCT03502811|MitraClip|mitraclip
946781|NCT03502811|MitraClip NTR|mitraclip ntr
946782|NCT03502811|MitraClip XTR|mitraclip xtr
946783|NCT03502811|Mitral Regurgitation|mitral regurgitation
946784|NCT03502759|SUDEP|sudep
946785|NCT03502759|Epilepsy|epilepsy
946786|NCT03502681|Cisplatin-Ineligible|cisplatin-ineligible
946787|NCT03502681|Avelumab|avelumab
946788|NCT03502681|PD-L1 Monoclonal Antibody|pd-l1 monoclonal antibody
946789|NCT03502681|Eribulin Mesylate|eribulin mesylate
946790|NCT03502668|low risk myelodysplastic syndromes, MDS, ASTX727|low risk myelodysplastic syndromes, mds, astx727
946791|NCT03502655|Pain|pain
946792|NCT03502655|Peripheral intravenous catheter|peripheral intravenous catheter
946793|NCT03502655|Peripheral catheterization|peripheral catheterization
946794|NCT03502655|Communication|communication
946795|NCT03502655|Emergency Department|emergency department
946796|NCT03502642|Ropivacaine|ropivacaine
946797|NCT03502642|wound infusion|wound infusion
946798|NCT03502642|analgesia|analgesia
946799|NCT03502642|cesarean|cesarean
946800|NCT03502642|intrathecal morphine|intrathecal morphine
946801|NCT03502642|randomized controlled trial|randomized controlled trial
946802|NCT03502564|Posttraumatic stress disorder|posttraumatic stress disorder
946803|NCT03502564|Eating disorders|eating disorders
946804|NCT03502564|Cognitive behavior therapy|cognitive behavior therapy
946805|NCT03502564|Cognitive processing therapy|cognitive processing therapy
946806|NCT03502564|Randomized controlled trial|randomized controlled trial
946807|NCT03502551|ketamine|ketamine
946808|NCT03502551|suicide|suicide
946809|NCT03502512|Breast reconstruction|breast reconstruction
946810|NCT03502512|REVOLVE Tissue Process|revolve tissue process
946811|NCT03502512|PureGraft Tissue Process|puregraft tissue process
946812|NCT03502512|Questionnaires|questionnaires
946813|NCT03502512|Surveys|surveys
946814|NCT03502473|fat flanks|fat flanks
946815|NCT03502460|Lung ultrasonography|lung ultrasonography
946816|NCT03502460|fluid administration|fluid administration
946817|NCT03502460|limitation|limitation
946818|NCT03502460|stroke volume variation|stroke volume variation
946819|NCT03502460|esophageal Doppler|esophageal doppler
946820|NCT03502421|Ketamine|ketamine
1636601|NCT00257088|development|development
946821|NCT03502343|Pancreatic cancer|pancreatic cancer
946822|NCT03502343|Metastatic|metastatic
946823|NCT03502343|Modified|modified
946824|NCT03502343|Gemcitabine|gemcitabine
946825|NCT03502343|nab-Paclitaxel|nab-paclitaxel
946826|NCT03502317|Prehabilitation|prehabilitation
946827|NCT03502317|Gastrointestinal Cancer|gastrointestinal cancer
946828|NCT03502317|Physical Activity|physical activity
946829|NCT03502317|Exercise|exercise
946830|NCT03502317|Surgery|surgery
946831|NCT03502304|Metabolic syndrome|metabolic syndrome
946832|NCT03502304|Obesity|obesity
946833|NCT03502291|Human challenge models|human challenge models
946834|NCT03502291|Immunity|immunity
946835|NCT03502291|Streptococcus pneumoniae|streptococcus pneumoniae
946836|NCT03502291|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
946837|NCT03502278|refugee|refugee
946838|NCT03502252|early childhood development|early childhood development
946839|NCT03502252|social and emotional development|social and emotional development
947136|NCT03500250|Nursing|nursing
946840|NCT03502252|secure parenting relationships|secure parenting relationships
946841|NCT03502213|Prostate Cancer|prostate cancer
946842|NCT03502213|Localized Prostate Cancer|localized prostate cancer
946843|NCT03502213|Low Risk Prostate Cancer|low risk prostate cancer
946844|NCT03502213|Active Surveillance|active surveillance
946845|NCT03502213|Active Monitoring|active monitoring
946846|NCT03502213|OncotypeDX GPS|oncotypedx gps
946847|NCT03502213|Genomic Prostate Score|genomic prostate score
946848|NCT03502213|Genomic Test|genomic test
946849|NCT03502213|Molecular Test|molecular test
946850|NCT03502122|stroke|stroke
946851|NCT03502122|rehabilitation|rehabilitation
946852|NCT03502109|Medication review|medication review
946853|NCT03502109|Pharmacist|pharmacist
946854|NCT03502109|Medication therapy management|medication therapy management
946855|NCT03502109|Cardiovascular diseases|cardiovascular diseases
946856|NCT03502109|Economics|economics
946857|NCT03502109|Elderly|elderly
946858|NCT03502109|Primary Care|primary care
946859|NCT03502096|portion size|portion size
946860|NCT03502096|food intake|food intake
946861|NCT03502096|energy intake|energy intake
946862|NCT03502096|food choice|food choice
946863|NCT03502070|CF, Human Factors, TOBI® Podhaler™, user interface, IFU|cf, human factors, tobi® podhaler™, user interface, ifu
946864|NCT03502044|Myalgic Encephalomyelitis|myalgic encephalomyelitis
946865|NCT03502044|Chronic Fatigue Syndrome|chronic fatigue syndrome
946866|NCT03502044|Kinetic Oscillatory Stimulation in nasal cavity|kinetic oscillatory stimulation in nasal cavity
946867|NCT03502018|Exparel|exparel
946868|NCT03502018|Bupivacaine|bupivacaine
946869|NCT03502018|Intracapsular Fracture of the Femur|intracapsular fracture of the femur
946870|NCT03502018|Femoral Neck Fracture|femoral neck fracture
946871|NCT03502018|Hip Hemiarthroplasty|hip hemiarthroplasty
946872|NCT03501992|Papillomavirus vaccines|papillomavirus vaccines
946873|NCT03501992|Vaccination|vaccination
946874|NCT03501992|Patient acceptance of health care|patient acceptance of health care
946875|NCT03501992|Child|child
946876|NCT03501992|Parents|parents
946877|NCT03501992|Primary health care|primary health care
946878|NCT03501992|Health personnel|health personnel
946879|NCT03501992|Primary prevention|primary prevention
946880|NCT03501992|Neoplasms|neoplasms
946881|NCT03501979|HER2+|her2+
946882|NCT03501979|metastatic breast cancer|metastatic breast cancer
946883|NCT03501979|leptomeningeal disease|leptomeningeal disease
946884|NCT03501979|tucatinib|tucatinib
946885|NCT03501979|trastuzumab|trastuzumab
946886|NCT03501979|capecitabine|capecitabine
946887|NCT03501966|headache|headache
946888|NCT03501966|idiopathic intracranial hypertension (IIH)|idiopathic intracranial hypertension (iih)
946889|NCT03501966|shunt|shunt
946890|NCT03501966|fenestration|fenestration
946891|NCT03501966|acetazolamide|acetazolamide
946892|NCT03501966|visual loss|visual loss
946893|NCT03501966|diamox|diamox
946894|NCT03501953|Cognitive Change|cognitive change
946895|NCT03501953|Physical Activity|physical activity
946896|NCT03501953|Environmental Exposure|environmental exposure
946897|NCT03501953|Health Behavior|health behavior
946898|NCT03501927|Ultrasound|ultrasound
946899|NCT03501927|FOCUS|focus
946904|NCT03501914|Intellectual Disability|intellectual disability
946905|NCT03501914|Mindfulness|mindfulness
946906|NCT03501901|ESBL-producing enterobacteria|esbl-producing enterobacteria
946907|NCT03501901|hospital- and community-acquired urinary tract infections|hospital- and community-acquired urinary tract infections
946908|NCT03501888|Acceptance and Commitment Therapy|acceptance and commitment therapy
946910|NCT03501888|Cognitive Behavior Therapy|cognitive behavior therapy
946911|NCT03501888|CBT|cbt
946912|NCT03501888|Schizophrenia|schizophrenia
946913|NCT03501888|Psychoses|psychoses
946914|NCT03501862|Mindfulness|mindfulness
946915|NCT03501862|Cognitive therapy|cognitive therapy
946916|NCT03501849|Cancer prevention|cancer prevention
946917|NCT03501849|Cancer detection|cancer detection
946918|NCT03501849|Colonoscopy|colonoscopy
946919|NCT03501849|Polypectomy|polypectomy
946920|NCT03501849|Cold Snare|cold snare
946921|NCT03501849|Optivista|optivista
946922|NCT03501771|Acupuncture|acupuncture
946923|NCT03501771|Back pain|back pain
946924|NCT03501771|Low Back Pain|low back pain
946925|NCT03501771|Lumbago|lumbago
946926|NCT03501771|pulse diagnosis|pulse diagnosis
946927|NCT03501771|radial pressure pulse|radial pressure pulse
946928|NCT03501758|ulcerative colitis|ulcerative colitis
946929|NCT03501758|ultrasound|ultrasound
946930|NCT03501758|remission|remission
946931|NCT03501758|relapse|relapse
946932|NCT03501719|HIV|hiv
946933|NCT03501719|inflammation|inflammation
946934|NCT03501719|antiretroviral therapy|antiretroviral therapy
946935|NCT03501719|cohort studies|cohort studies
946936|NCT03501719|mortality|mortality
946937|NCT03501719|non-AIDS events|non-aids events
946938|NCT03501706|intertemporal tradeoffs|intertemporal tradeoffs
946939|NCT03501706|delayed gratification|delayed gratification
946940|NCT03501706|executive functioning|executive functioning
946941|NCT03501706|delay discounting|delay discounting
946942|NCT03501706|working memory|working memory
946943|NCT03501680|hyperlipidaemic pancreatitis|hyperlipidaemic pancreatitis
946944|NCT03501680|Plasmapheresis|plasmapheresis
946945|NCT03501680|insulin|insulin
946946|NCT03501654|Lenses, Intraocular|lenses, intraocular
946947|NCT03501641|cognitive load|cognitive load
946948|NCT03501641|competence|competence
946949|NCT03501641|heart rate variation|heart rate variation
946950|NCT03501641|learning|learning
946951|NCT03501641|otolaryngology|otolaryngology
946952|NCT03501641|video|video
946953|NCT03501641|virtual reality|virtual reality
946954|NCT03501615|Early Access, leukemia, hairy cell, Moxetumomab Pasudotox, PNA, Purine analog, BRAF Inhibitor, rituximab, Pseudomonas-immunotoxin naïve|early access, leukemia, hairy cell, moxetumomab pasudotox, pna, purine analog, braf inhibitor, rituximab, pseudomonas-immunotoxin naïve
946955|NCT03501602|aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope|aintree, lma protector; i-gel lma, fiberoptic bronchoscope
946956|NCT03501563|hypotensive anesthesia|hypotensive anesthesia
946957|NCT03501563|thiol / disulfide|thiol / disulfide
946958|NCT03501563|oxidative stress markers|oxidative stress markers
946959|NCT03501563|septoplasty|septoplasty
946960|NCT03501550|HCV|hcv
946961|NCT03501550|GT1|gt1
946963|NCT03501498|Intestinal Transit, Bile Salts, Gut Bacteria, Volatile Organic Compounds|intestinal transit, bile salts, gut bacteria, volatile organic compounds
946964|NCT03501472|pictorial warning labels|pictorial warning labels
946965|NCT03501472|risk knowledge|risk knowledge
946966|NCT03501472|emotion|emotion
946967|NCT03501472|memory|memory
946968|NCT03501472|risk perceptions|risk perceptions
946969|NCT03501472|quit intentions|quit intentions
946970|NCT03501472|numeracy|numeracy
946971|NCT03501446|PEEP optimization|peep optimization
946972|NCT03501446|Lung volumes|lung volumes
946973|NCT03501433|postpandial|postpandial
946974|NCT03501433|lipemia|lipemia
946975|NCT03501433|microvascular|microvascular
946976|NCT03501420|Belimumab|belimumab
946977|NCT03501420|Disease Specific Programme|disease specific programme
946978|NCT03501420|rheumatologist|rheumatologist
946979|NCT03501420|Benlysta|benlysta
946980|NCT03501420|Primary Sjögren's Syndrome|primary sjögren's syndrome
946981|NCT03501420|Adelphi pSS DSP|adelphi pss dsp
946982|NCT03501394|Magnetic Resonance Imaging|magnetic resonance imaging
946983|NCT03501394|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
946984|NCT03501368|cutaneous|cutaneous
946985|NCT03501368|refractory|refractory
946986|NCT03501368|melanoma|melanoma
946987|NCT03501368|ceritinib|ceritinib
946988|NCT03501355|pacemaker|pacemaker
946989|NCT03501355|inspiratory muscle training|inspiratory muscle training
946990|NCT03501355|exercise capacity|exercise capacity
946991|NCT03501355|Quality of Life|quality of life
946992|NCT03501355|Respiratory Muscle Strength|respiratory muscle strength
946993|NCT03501342|Multiple Sclerosis|multiple sclerosis
946994|NCT03501342|virtual reality|virtual reality
946995|NCT03501342|balance|balance
946996|NCT03501342|mobility|mobility
946997|NCT03501342|fatigue|fatigue
946998|NCT03501316|Root Surface Debridement|root surface debridement
947190|NCT03499964|randomized|randomized
946999|NCT03501316|Hand Instrumentation|hand instrumentation
947000|NCT03501316|Ultrasonic Instrumentation|ultrasonic instrumentation
947001|NCT03501316|Systemic|systemic
947002|NCT03501316|Immune|immune
947004|NCT03501290|Frailty|frailty
947005|NCT03501290|Malnutrition|malnutrition
947006|NCT03501290|Older adults|older adults
947007|NCT03501290|Oral Nutritional Supplements|oral nutritional supplements
947008|NCT03501290|Compliance|compliance
947009|NCT03501277|Drug therapy|drug therapy
947010|NCT03501199|immediate implant placement|immediate implant placement
947011|NCT03501186|Backward walking, stroke, gait training|backward walking, stroke, gait training
947012|NCT03501160|Regressive behaviors|regressive behaviors
947013|NCT03501160|Childish behaviors|childish behaviors
947014|NCT03501160|Affection expression socially inappropriate behaviors|affection expression socially inappropriate behaviors
947015|NCT03501160|Social Inappropriate Behaviors|social inappropriate behaviors
947016|NCT03501160|Social Impairment|social impairment
947017|NCT03501134|Pro000888900|pro000888900
947018|NCT03501134|Katherine Peters|katherine peters
947019|NCT03501134|Optune|optune
947020|NCT03501134|NovoTTF|novottf
947021|NCT03501134|ACTION|action
947022|NCT03501134|Quality of life|quality of life
947023|NCT03501134|Tumor treating fields|tumor treating fields
947024|NCT03501121|intra-operative radiation therapy|intra-operative radiation therapy
947025|NCT03501108|Polypharmacy|polypharmacy
947026|NCT03501108|Multi-morbidity|multi-morbidity
947027|NCT03501108|Deprescribing|deprescribing
947028|NCT03501108|Older people|older people
947029|NCT03501108|Elderly|elderly
947030|NCT03501082|Gut microbiome|gut microbiome
947031|NCT03501069|Drug Therapy|drug therapy
947032|NCT03501056|PD-1 activated CIK|pd-1 activated cik
947033|NCT03501056|MUC1|muc1
947034|NCT03501056|Bispecific antibody|bispecific antibody
947035|NCT03501056|lung cancer|lung cancer
947036|NCT03500991|CNS, CAR T cell, HER2-positive, brain tumor|cns, car t cell, her2-positive, brain tumor
947037|NCT03500991|pediatric, young adults|pediatric, young adults
947038|NCT03500965|pictorial warning labels|pictorial warning labels
947039|NCT03500965|risk knowledge|risk knowledge
947040|NCT03500965|emotion|emotion
947041|NCT03500965|memory|memory
947042|NCT03500965|risk perceptions|risk perceptions
947043|NCT03500965|quit intentions|quit intentions
947044|NCT03500913|Growth Hormone Deficiency|growth hormone deficiency
947045|NCT03500913|Adipose Tissue|adipose tissue
947046|NCT03500913|Inflammation|inflammation
947047|NCT03500900|gastric accommodation|gastric accommodation
947048|NCT03500900|food intake|food intake
947049|NCT03500900|gastrointestinal hormones|gastrointestinal hormones
947050|NCT03500861|headache characteristics, health-related quality of life.|headache characteristics, health-related quality of life.
947051|NCT03500848|Liver transplantation|liver transplantation
947052|NCT03500848|Sirolimus|sirolimus
947053|NCT03500848|Tacrolimus|tacrolimus
947054|NCT03500848|HCC recurrence free survival|hcc recurrence free survival
947055|NCT03500822|dynamic hyperinflation|dynamic hyperinflation
947056|NCT03500822|diastolic dysfunction|diastolic dysfunction
947057|NCT03500822|COPD|copd
947058|NCT03500822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
947059|NCT03500822|Metronome-paced Tachypnea|metronome-paced tachypnea
947060|NCT03500822|Expiratory-stenosis Breathing|expiratory-stenosis breathing
947061|NCT03500783|Cardioprotection|cardioprotection
947062|NCT03500783|Ischemia-reperfusion injury|ischemia-reperfusion injury
947063|NCT03500783|Nitric oxide|nitric oxide
947064|NCT03500783|Cardiopulmonary bypass|cardiopulmonary bypass
947065|NCT03500783|Coronary artery bypass grafting|coronary artery bypass grafting
947066|NCT03500770|Post Treatment Lyme Disease Syndrome|post treatment lyme disease syndrome
947067|NCT03500757|HoloLens|hololens
947068|NCT03500757|3D holographic guidance|3d holographic guidance
947069|NCT03500731|Lung Transplantation|lung transplantation
947070|NCT03500731|Stem Cell Transplantation|stem cell transplantation
947071|NCT03500731|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
947072|NCT03500731|Emphysema or COPD|emphysema or copd
947073|NCT03500731|Bone marrow transplantation|bone marrow transplantation
947074|NCT03500731|Cadaveric donor|cadaveric donor
947075|NCT03500731|Unrelated donor|unrelated donor
947076|NCT03500731|HLA-Mismatch|hla-mismatch
947078|NCT03500731|HSCT|hsct
947079|NCT03500731|IPF|ipf
947080|NCT03500731|Pulmonary fibrosis|pulmonary fibrosis
947081|NCT03500718|cochlear implant|cochlear implant
947082|NCT03500718|threshold of electrically evoked compound action potential|threshold of electrically evoked compound action potential
947083|NCT03500718|neural response telemetry|neural response telemetry
947084|NCT03500692|Mitral Valve Regurgitation|mitral valve regurgitation
947085|NCT03500692|MitraClip|mitraclip
947086|NCT03500692|MitraClip NT|mitraclip nt
947087|NCT03500692|Japan MitraClip NT Postmarketing Surveillance|japan mitraclip nt postmarketing surveillance
947088|NCT03500666|Thyroid carcinoma|thyroid carcinoma
947089|NCT03500666|Robot surgery|robot surgery
947090|NCT03500666|Endoscopic surgery|endoscopic surgery
947091|NCT03500640|Intervention|intervention
947092|NCT03500640|Prevention|prevention
947093|NCT03500640|Weight Management|weight management
947094|NCT03500640|Physical Activity|physical activity
947095|NCT03500640|Physical Function|physical function
947096|NCT03500627|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
947097|NCT03500627|Childhood Cerebral Adrenoleukodystrophy (ccALD)|childhood cerebral adrenoleukodystrophy (ccald)
947098|NCT03500627|OP-101|op-101
947099|NCT03500627|Dendrimer|dendrimer
947100|NCT03500627|N-Acetyl-Cysteine (NAC)|n-acetyl-cysteine (nac)
947101|NCT03500614|particulate matter|particulate matter
947102|NCT03500614|phthalates|phthalates
947103|NCT03500614|cytokines|cytokines
947104|NCT03500614|chemokines|chemokines
947105|NCT03500614|epigenetics|epigenetics
947106|NCT03500614|DNA methylation|dna methylation
947107|NCT03500614|peripheral blood mononuclear cells|peripheral blood mononuclear cells
947108|NCT03500614|immune function|immune function
947109|NCT03500601|Cognition|cognition
947110|NCT03500601|Metagenomics|metagenomics
947111|NCT03500601|Metabolomics|metabolomics
947112|NCT03500575|induction therapy, photopheresis|induction therapy, photopheresis
947113|NCT03500497|reticulocyte hemoglobin content (RetHe)|reticulocyte hemoglobin content (rethe)
947114|NCT03500497|perioperative|perioperative
947115|NCT03500497|colorectal surgery|colorectal surgery
947116|NCT03500497|anemia|anemia
947117|NCT03500471|Laparoscopic|laparoscopic
947118|NCT03500471|Robotic|robotic
947119|NCT03500471|Total Gastrectomy|total gastrectomy
947120|NCT03500471|AGC|agc
947121|NCT03500432|transperineal prostate biopsy|transperineal prostate biopsy
947122|NCT03500432|local anesthesia|local anesthesia
947123|NCT03500432|prostate cancer diagnosis|prostate cancer diagnosis
947124|NCT03500367|mammilian target of rapamycin inhibitor|mammilian target of rapamycin inhibitor
947125|NCT03500367|Rapamycin (sirolimus)|rapamycin (sirolimus)
947126|NCT03500367|Treatment|treatment
947127|NCT03500367|Complications|complications
947128|NCT03500354|malnutrition|malnutrition
947129|NCT03500276|yoga|yoga
947130|NCT03500276|health-related quality of life|health-related quality of life
947131|NCT03500276|proinflammatory genes|proinflammatory genes
947132|NCT03500276|inflammatory markers|inflammatory markers
947133|NCT03500276|rheumatoid arthritis|rheumatoid arthritis
947134|NCT03500250|Complex intervention|complex intervention
947135|NCT03500250|Depression|depression
947141|NCT03500237|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
947142|NCT03500237|randomized controlled trial|randomized controlled trial
947143|NCT03500237|patient-centered|patient-centered
947144|NCT03500237|knowledge implementation|knowledge implementation
947145|NCT03500237|mental health system|mental health system
947146|NCT03500237|therapist-assistance|therapist-assistance
947147|NCT03500224|Drug therapy|drug therapy
947148|NCT03500211|Cesarean section|cesarean section
947149|NCT03500211|Postoperative pain|postoperative pain
947150|NCT03500185|Physiotherapy|physiotherapy
947151|NCT03500185|Pelvic floor|pelvic floor
947152|NCT03500185|Urinary Incontinence|urinary incontinence
947153|NCT03500172|HIV|hiv
947154|NCT03500172|Female Sex Workers|female sex workers
947155|NCT03500172|Viral Suppression|viral suppression
947156|NCT03500172|South Africa|south africa
947157|NCT03500172|Decentralized care|decentralized care
947158|NCT03500172|Antiretroviral therapy|antiretroviral therapy
947159|NCT03500172|Differentiated care|differentiated care
947160|NCT03500133|Pediatric Hodgkin Lymphoma, therapy, reduced radiotherapy|pediatric hodgkin lymphoma, therapy, reduced radiotherapy
947161|NCT03500107|Blue Light Emitting Diode|blue light emitting diode
947162|NCT03500107|Women|women
947163|NCT03500094|Lysosomal storage disease|lysosomal storage disease
947164|NCT03500094|migalastat|migalastat
947165|NCT03500094|AT1001|at1001
947166|NCT03500068|Pancreatic cancer|pancreatic cancer
947167|NCT03500068|Organoids|organoids
947168|NCT03500042|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
947169|NCT03500042|inspiratory muscle training|inspiratory muscle training
947170|NCT03500042|expiratory muscle training|expiratory muscle training
947171|NCT03500042|Neural Respiratory Drive|neural respiratory drive
947172|NCT03500029|Depression|depression
947173|NCT03500029|Transcranial magnetic stimulation(TMS)|transcranial magnetic stimulation(tms)
947174|NCT03500029|Resting-state functional MRI(fMRI)|resting-state functional mri(fmri)
947175|NCT03500016|Insulin resistance|insulin resistance
947176|NCT03500016|Obesity|obesity
947177|NCT03500016|Type 2 diabetes|type 2 diabetes
947178|NCT03500016|Exercise training|exercise training
947179|NCT03500003|dairy products|dairy products
947180|NCT03500003|milk|milk
947181|NCT03500003|yogurt|yogurt
947182|NCT03500003|metabolomics|metabolomics
947183|NCT03500003|elderly|elderly
947184|NCT03499990|Adrenal crisis|adrenal crisis
947185|NCT03499990|Risk factors|risk factors
947186|NCT03499977|Physical Activity|physical activity
947187|NCT03499977|Executive function|executive function
947188|NCT03499977|Anti-saccade|anti-saccade
947189|NCT03499964|pivotal trial|pivotal trial
947191|NCT03499964|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
947192|NCT03499964|urethral stricture|urethral stricture
947193|NCT03499964|obstruction|obstruction
947194|NCT03499951|Quality of life|quality of life
947195|NCT03499951|Participation|participation
947196|NCT03499951|Training|training
947197|NCT03499938|Asthma|asthma
947198|NCT03499938|Bronchiolitis|bronchiolitis
947199|NCT03499938|Wheezing|wheezing
947200|NCT03499938|Structured Light Plethysmography|structured light plethysmography
947201|NCT03499925|mental health|mental health
947202|NCT03499925|intervention|intervention
947203|NCT03499925|pregnancy-related complications|pregnancy-related complications
947204|NCT03499912|Acute myeloid leukemia|acute myeloid leukemia
947205|NCT03499912|IDH1|idh1
947206|NCT03499912|IDH2|idh2
947207|NCT03499912|Genetic mutations|genetic mutations
947208|NCT03499912|Prognosis|prognosis
947209|NCT03499899|triple-negative breast cancer|triple-negative breast cancer
947210|NCT03499899|checkpoint inhibition|checkpoint inhibition
947211|NCT03499899|LAG525|lag525
947212|NCT03499899|spartalizumab|spartalizumab
947213|NCT03499899|PDR001|pdr001
947214|NCT03499899|carboplatin|carboplatin
947215|NCT03499834|Immune Cell Therapy|immune cell therapy
947217|NCT03499795|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
947218|NCT03499795|Human papillomavirus (HPV)|human papillomavirus (hpv)
947219|NCT03499795|HPV-16|hpv-16
947220|NCT03499795|HPV-18|hpv-18
947221|NCT03499795|Anal intraepithelial neoplasia 2 (AIN2)|anal intraepithelial neoplasia 2 (ain2)
947222|NCT03499795|Anal intraepithelial neoplasia 3 (AIN3)|anal intraepithelial neoplasia 3 (ain3)
947223|NCT03499795|Peri-anal intraepithelial neoplasia 2 (PAIN2)|peri-anal intraepithelial neoplasia 2 (pain2)
947224|NCT03499795|Peri-anal intraepithelial neoplasia 3 (PAIN3)|peri-anal intraepithelial neoplasia 3 (pain3)
947225|NCT03499782|Prognosis|prognosis
947226|NCT03499782|Surgery options|surgery options
947227|NCT03499782|Bayesian networks|bayesian networks
947228|NCT03499756|Postnatal depression, interpersonal psychotherapy|postnatal depression, interpersonal psychotherapy
947229|NCT03499730|Midazolam|midazolam
947230|NCT03499730|Inguinal hernia|inguinal hernia
947231|NCT03499717|Fall Risk|fall risk
947232|NCT03499717|Patient Falls|patient falls
947233|NCT03499717|Fall Prevention|fall prevention
947234|NCT03499717|Patient Safety|patient safety
947235|NCT03499704|Drug therapy|drug therapy
947236|NCT03499665|Bruxism|bruxism
947237|NCT03499665|Pain|pain
947238|NCT03499665|Exercises|exercises
947241|NCT03499613|Movement analysis|movement analysis
947242|NCT03499613|Spinal kinematics|spinal kinematics
947243|NCT03499613|Muscle activity|muscle activity
947244|NCT03499613|Pain-related fear|pain-related fear
947245|NCT03499613|Rehabilitation|rehabilitation
947246|NCT03499613|Spine|spine
947247|NCT03499600|Cultural assessment|cultural assessment
947248|NCT03499600|Engagement|engagement
947249|NCT03499600|Diverse Populations|diverse populations
947250|NCT03499548|Intensive|intensive
947251|NCT03499548|Cognitive Behavioral Therapy|cognitive behavioral therapy
947252|NCT03499548|Male prisoners|male prisoners
947253|NCT03499535|Risk Perception|risk perception
947254|NCT03499522|Hemophilic arthropathy|hemophilic arthropathy
947255|NCT03499522|Pain|pain
947256|NCT03499522|Functional Disease Present|functional disease present
947257|NCT03499522|Quality of life|quality of life
947258|NCT03499522|Anxiety|anxiety
947259|NCT03499522|Stress|stress
947260|NCT03499522|Coping strategies|coping strategies
947261|NCT03499496|plaques detection by ultrasound|plaques detection by ultrasound
947262|NCT03499483|Post Exposure Prophylaxis|post exposure prophylaxis
947263|NCT03499470|copd|copd
947264|NCT03499470|exacerbation|exacerbation
947265|NCT03499470|structured discharge|structured discharge
947266|NCT03499470|readmission|readmission
947267|NCT03499470|chronic respiratory failure|chronic respiratory failure
947268|NCT03499457|Penicillin Allergy|penicillin allergy
947269|NCT03499457|chalenge test|chalenge test
947270|NCT03499457|primary clinic|primary clinic
947271|NCT03499418|newborn|newborn
947272|NCT03499418|TTN|ttn
947273|NCT03499418|PPHN|pphn
947274|NCT03499405|development and health disparities and navigation|development and health disparities and navigation
947275|NCT03499392|psychological factors|psychological factors
947276|NCT03499379|Intrauterine device (IUD)|intrauterine device (iud)
947277|NCT03499379|Depression|depression
947278|NCT03499379|Stress hormones|stress hormones
947279|NCT03499379|Mood changes|mood changes
947280|NCT03499366|enterovirus D68|enterovirus d68
947281|NCT03499366|AFP|afp
947282|NCT03499366|AFM|afm
947283|NCT03499366|EV-D68|ev-d68
947284|NCT03499366|acute flaccid myelitis|acute flaccid myelitis
947285|NCT03499366|acute flaccid paresis|acute flaccid paresis
947286|NCT03499353|Neoadjuvant Therapy, Triple Negative Breast Cancer, BRACA Positive|neoadjuvant therapy, triple negative breast cancer, braca positive
947287|NCT03499340|pictorial warning labels|pictorial warning labels
947288|NCT03499340|risk knowledge|risk knowledge
947289|NCT03499340|emotion|emotion
947290|NCT03499340|memory|memory
947291|NCT03499340|risk perceptions|risk perceptions
947292|NCT03499340|quit intentions|quit intentions
947293|NCT03499327|vitamin D|vitamin d
947294|NCT03499327|ergosterol|ergosterol
947295|NCT03499327|7-dehydro-cholesterol|7-dehydro-cholesterol
947296|NCT03499327|wheat germ oil|wheat germ oil
947297|NCT03499314|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
947298|NCT03499301|Chronic pain|chronic pain
947299|NCT03499301|Emergency|emergency
947300|NCT03499301|Satisfaction|satisfaction
947301|NCT03499288|Cerebral Palsy|cerebral palsy
947302|NCT03499275|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
947303|NCT03499262|Social ABCs|social abcs
947304|NCT03499262|Early Intervention|early intervention
947305|NCT03499262|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
947306|NCT03499262|Toddler|toddler
947307|NCT03499262|Pivotal Response Treatment (PRT)|pivotal response treatment (prt)
947308|NCT03499262|Group Intervention|group intervention
947309|NCT03499262|Parent-Mediated|parent-mediated
947310|NCT03499262|Caregiver-Mediated|caregiver-mediated
947311|NCT03499262|Social Communication|social communication
947312|NCT03499262|Positive Affect|positive affect
947313|NCT03499262|Social Smiling|social smiling
947314|NCT03499262|Social Orienting|social orienting
947315|NCT03499262|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
947316|NCT03499262|NDBI|ndbi
947317|NCT03499262|Autism|autism
947318|NCT03499262|Early Identification|early identification
947319|NCT03499249|Biliary Atresia|biliary atresia
947320|NCT03499249|N-Acetylcysteine|n-acetylcysteine
947321|NCT03499249|Glutathione|glutathione
947322|NCT03499249|Kasai portoenterostomy|kasai portoenterostomy
947323|NCT03499249|Bile flow|bile flow
947324|NCT03499249|Serum bile acids|serum bile acids
947325|NCT03499249|Serum bilirubin|serum bilirubin
947326|NCT03499210|Stroke|stroke
947327|NCT03499210|Exoskeleton|exoskeleton
947328|NCT03499210|Hemiparesis|hemiparesis
947329|NCT03499210|Hemiplegia|hemiplegia
947330|NCT03499145|conjunctivitis|conjunctivitis
947331|NCT03499145|keratitis|keratitis
947332|NCT03499145|pterygium|pterygium
947333|NCT03499145|cataracts|cataracts
947334|NCT03499132|anesthesia, obstructive sleep apnea|anesthesia, obstructive sleep apnea
947335|NCT03499093|esthetics|esthetics
947336|NCT03499093|orofacial esthetic scale|orofacial esthetic scale
947337|NCT03499080|Medication free treatment, mental illness, outcome|medication free treatment, mental illness, outcome
947338|NCT03499054|Breathing exercises|breathing exercises
947339|NCT03499054|fatigue|fatigue
947340|NCT03499054|quality of life|quality of life
947342|NCT03499002|Medical Students|medical students
947343|NCT03499002|In Situ Simulation|in situ simulation
947344|NCT03498976|painful shoulder|painful shoulder
947345|NCT03498937|Borderline Personality Disorder|borderline personality disorder
947346|NCT03498937|Impulsive behavior|impulsive behavior
947347|NCT03498937|Suicidal behavior|suicidal behavior
947348|NCT03498937|Cognitive control|cognitive control
947349|NCT03498937|tDCS|tdcs
947350|NCT03498937|Noninvasive brain stimulation|noninvasive brain stimulation
947351|NCT03498924|tumor marker|tumor marker
947352|NCT03498924|HE4|he4
947354|NCT03498924|staging|staging
947355|NCT03498924|diagnosis|diagnosis
947356|NCT03498924|Endometrial Cancer|endometrial cancer
947357|NCT03498898|Beta adrenergic receptor blockers|beta adrenergic receptor blockers
947358|NCT03498898|Analgesia nociceptive index|analgesia nociceptive index
947359|NCT03498898|Total hip replacement|total hip replacement
947360|NCT03498885|Rectal Cancer|rectal cancer
947361|NCT03498885|inferior mesenteric artery|inferior mesenteric artery
947362|NCT03498885|Laparoscopic|laparoscopic
947363|NCT03498872|AMPfoot|ampfoot
947364|NCT03498872|Prosthetics|prosthetics
947365|NCT03498872|gait|gait
947366|NCT03498872|electro-encephalography|electro-encephalography
947367|NCT03498872|dual-task walking|dual-task walking
947368|NCT03498859|Rehabilitation|rehabilitation
947369|NCT03498833|domains|domains
947370|NCT03498833|item development|item development
947371|NCT03498833|osteoarthritis|osteoarthritis
947372|NCT03498833|scale formulation|scale formulation
947373|NCT03498833|test retest reliability|test retest reliability
947374|NCT03498820|Analgesia-Nociception Index (ANI)|analgesia-nociception index (ani)
947375|NCT03498820|General anesthesia|general anesthesia
947376|NCT03498820|Opioids|opioids
947377|NCT03498820|Remifentanil|remifentanil
947378|NCT03498820|Pain|pain
947379|NCT03498820|Monitoring|monitoring
947380|NCT03498807|ARDS|ards
947381|NCT03498807|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
947382|NCT03498807|PEEP|peep
947383|NCT03498807|pressure-volume loop|pressure-volume loop
947384|NCT03498807|Positive End-Expiratory Pressure|positive end-expiratory pressure
947385|NCT03498807|hysteresis|hysteresis
947386|NCT03498781|Exercise|exercise
947387|NCT03498755|fisheries|fisheries
947388|NCT03498755|Ghana|ghana
947389|NCT03498755|sub-Saharan Africa|sub-saharan africa
947390|NCT03498755|value chain|value chain
947391|NCT03498755|fish processing|fish processing
947392|NCT03498755|fish smoking|fish smoking
947394|NCT03498742|SABA|saba
947395|NCT03498729|Autoimmune Diseases|autoimmune diseases
947396|NCT03498690|online trial|online trial
947397|NCT03498690|decision analysis|decision analysis
947398|NCT03498677|online trial|online trial
947399|NCT03498677|decision analysis|decision analysis
947400|NCT03498664|EMR-C; EMR-S; LST|emr-c; emr-s; lst
947401|NCT03498651|Anxiety|anxiety
947402|NCT03498651|Cognitive bias|cognitive bias
947403|NCT03498651|Telemedicine|telemedicine
947404|NCT03498599|neuroimaging|neuroimaging
947405|NCT03498599|fear conditioning|fear conditioning
947406|NCT03498547|caudal block|caudal block
947407|NCT03498547|saddle block|saddle block
947408|NCT03498534|Treatment|treatment
947409|NCT03498534|Latent infection|latent infection
947410|NCT03498534|Tuberculosis|tuberculosis
947411|NCT03498534|Interferon gamma|interferon gamma
947412|NCT03498508|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
947413|NCT03498508|Knowledge|knowledge
947414|NCT03498508|In-hospital cardiac arrest|in-hospital cardiac arrest
947416|NCT03498469|reintegration, reunification, child development|reintegration, reunification, child development
947417|NCT03498430|Indolent Non-Hodgkin's Lymphoma (iNHL) (excluding CLL)|indolent non-hodgkin's lymphoma (inhl) (excluding cll)
947418|NCT03498378|Avelumab|avelumab
947419|NCT03498378|Palbociclib|palbociclib
947420|NCT03498378|Cetuximab|cetuximab
947421|NCT03498378|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
947422|NCT03498378|cancer|cancer
947423|NCT03498378|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
947424|NCT03498378|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
947425|NCT03498365|decision analysis|decision analysis
947426|NCT03498365|decision support|decision support
947427|NCT03498352|cardiopulmonary exercise testing, thoracic surgery|cardiopulmonary exercise testing, thoracic surgery
947428|NCT03498326|pancreatic cancer|pancreatic cancer
947429|NCT03498326|gemcitabine|gemcitabine
947430|NCT03498326|celecoxib|celecoxib
947431|NCT03498326|R0 resection|r0 resection
947432|NCT03498313|steroid hormones|steroid hormones
947433|NCT03498313|estradiol|estradiol
947434|NCT03498313|estrogen|estrogen
947435|NCT03498313|progesterone|progesterone
947436|NCT03498313|depression|depression
947437|NCT03498313|suicide|suicide
947438|NCT03498287|carpal tunnel syndrome|carpal tunnel syndrome
947439|NCT03498287|carpal tunnel|carpal tunnel
947440|NCT03498287|CTS|cts
947441|NCT03498287|musculoskeletal disorder|musculoskeletal disorder
947442|NCT03498287|peripheral neuropathy|peripheral neuropathy
947750|NCT03496363|Children|children
947443|NCT03498287|repetitive stress injury|repetitive stress injury
947444|NCT03498287|non-invasive device|non-invasive device
947445|NCT03498287|non-significant risk|non-significant risk
947446|NCT03498287|medical device|medical device
947447|NCT03498274|Fitting|fitting
947448|NCT03498235|sevoflurane|sevoflurane
947449|NCT03498235|propofol|propofol
947450|NCT03498235|intracranial pressure|intracranial pressure
947451|NCT03498235|optic nerve sheath diameter|optic nerve sheath diameter
947452|NCT03498196|muscle invasive bladder cancer|muscle invasive bladder cancer
947453|NCT03498196|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
947454|NCT03498196|radical cystectomy|radical cystectomy
947455|NCT03498196|monoclonal antibodies|monoclonal antibodies
947456|NCT03498196|Avelumab|avelumab
947457|NCT03498196|Invasive Resectable disease|invasive resectable disease
947458|NCT03498196|MIBC|mibc
947459|NCT03498196|NMIBC|nmibc
947460|NCT03498196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
947461|NCT03498170|Healthy Male Volunteers|healthy male volunteers
947462|NCT03498157|Prehabilitation|prehabilitation
947463|NCT03498157|Exercise|exercise
947464|NCT03498157|Breast Cancer|breast cancer
947465|NCT03498157|Physical Activity|physical activity
947466|NCT03498157|Surgery|surgery
947467|NCT03498144|acquired punctal stenosis|acquired punctal stenosis
947468|NCT03498144|epiphora|epiphora
947469|NCT03498144|lower punctum|lower punctum
947470|NCT03498144|AS-OCT|as-oct
947471|NCT03498131|Multiple Sclerosis|multiple sclerosis
947472|NCT03498131|MS|ms
947473|NCT03498131|Melatonin|melatonin
947474|NCT03498131|Supplement|supplement
947475|NCT03498118|Transversus Abdominis Plane Block|transversus abdominis plane block
947476|NCT03498118|Cesarean Delivery|cesarean delivery
947477|NCT03498105|Acute Chest Syndrome|acute chest syndrome
947478|NCT03498066|Myocardial Infarction|myocardial infarction
947479|NCT03498066|Beta-Blockers|beta-blockers
947480|NCT03498066|Stable Coronary Artery Disease|stable coronary artery disease
947481|NCT03497936|vaccine narratives|vaccine narratives
947482|NCT03497936|HPV prevention|hpv prevention
947483|NCT03497936|vaccine promotion|vaccine promotion
947484|NCT03497923|rocuronium, magnesium sulphate, neostigmine, sugammadex|rocuronium, magnesium sulphate, neostigmine, sugammadex
947485|NCT03497897|Acne, efficacy, safety|acne, efficacy, safety
947486|NCT03497884|fMRI|fmri
947487|NCT03497884|rTMS|rtms
947488|NCT03497884|functional connectivity|functional connectivity
947489|NCT03497871|Heart failure|heart failure
947490|NCT03497871|Self-management|self-management
947491|NCT03497871|Health-related quality of life|health-related quality of life
947492|NCT03497871|mHealth|mhealth
947493|NCT03497845|vaccine|vaccine
947494|NCT03497845|adjuvant|adjuvant
947495|NCT03497845|Influenza in Birds|influenza in birds
947496|NCT03497845|MF59|mf59
947497|NCT03497845|AS03|as03
947498|NCT03497832|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
947499|NCT03497819|CART|cart
947500|NCT03497819|Pancreatic Cancer|pancreatic cancer
947501|NCT03497819|artery infusion|artery infusion
947502|NCT03497780|Healthy Volunteers|healthy volunteers
947503|NCT03497780|ACL (Anterior Cruciate Ligament) tear|acl (anterior cruciate ligament) tear
947504|NCT03497767|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
947505|NCT03497767|EGFR mutation|egfr mutation
947506|NCT03497767|Osimertinib|osimertinib
947507|NCT03497767|Stereotactic Radiosurgery|stereotactic radiosurgery
947508|NCT03497754|ultrasound|ultrasound
947509|NCT03497754|cardiac output|cardiac output
947510|NCT03497754|Probefix|probefix
947511|NCT03497754|passive leg raising test|passive leg raising test
947512|NCT03497741|Intensive Care Unit|intensive care unit
947513|NCT03497689|pulmonary hypertension|pulmonary hypertension
947514|NCT03497689|treprostinil|treprostinil
947515|NCT03497689|pulmonary arterial hypertension|pulmonary arterial hypertension
947516|NCT03497689|PAH|pah
947517|NCT03497689|Remodulin|remodulin
947518|NCT03497689|Orenitram|orenitram
947519|NCT03497663|Familial high risk|familial high risk
947520|NCT03497663|offspring|offspring
947521|NCT03497663|schizophrenia|schizophrenia
947522|NCT03497663|bipolar disorder|bipolar disorder
947523|NCT03497663|recurrent depression|recurrent depression
947524|NCT03497663|early intervention|early intervention
947525|NCT03497663|parental training|parental training
947526|NCT03497663|family based intervention|family based intervention
947527|NCT03497611|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
947528|NCT03497611|Pacemaker|pacemaker
947529|NCT03497611|Aortic valve calcification|aortic valve calcification
947530|NCT03497611|PPI|ppi
947531|NCT03497598|D-mannose|d-mannose
947532|NCT03497585|Rehabilitation|rehabilitation
947533|NCT03497585|Pain Management|pain management
947534|NCT03497572|Leptospirosis|leptospirosis
947535|NCT03497546|Morbid obesity|morbid obesity
947536|NCT03497546|Exercise|exercise
947537|NCT03497546|Weight loss|weight loss
947538|NCT03497546|Cardiometabolic risk|cardiometabolic risk
947539|NCT03497546|Bariatric surgery|bariatric surgery
947540|NCT03497533|CD19|cd19
947541|NCT03497533|CAR-T|car-t
947542|NCT03497533|TriCAR-T-CD19|tricar-t-cd19
947543|NCT03497533|non-Hodgkin lymphoma|non-hodgkin lymphoma
947544|NCT03497533|NHL|nhl
947545|NCT03497520|surface EMG|surface emg
947546|NCT03497520|cobb angle|cobb angle
947547|NCT03497520|exercise|exercise
947548|NCT03497520|Spinal Curvatures|spinal curvatures
947549|NCT03497507|Shivering|shivering
947550|NCT03497507|Cesarean delivery|cesarean delivery
947551|NCT03497507|acupressure|acupressure
947552|NCT03497507|P6 acupoint|p6 acupoint
947553|NCT03497481|eye's anterior chamber fluid|eye's anterior chamber fluid
947554|NCT03497481|cerebrospinal fluid|cerebrospinal fluid
947555|NCT03497481|inflammatory pathology|inflammatory pathology
947556|NCT03497468|task-oriented training|task-oriented training
947557|NCT03497468|exercise training|exercise training
947558|NCT03497468|mobility|mobility
947559|NCT03497468|balance|balance
947560|NCT03497468|fatigue|fatigue
947561|NCT03497468|quality of life|quality of life
947562|NCT03497416|Preoperative Anemia|preoperative anemia
947563|NCT03497416|elderly|elderly
947564|NCT03497416|healthcare outcomes|healthcare outcomes
947565|NCT03497390|Type 2 diabetes|type 2 diabetes
947566|NCT03497390|Obesity|obesity
947567|NCT03497364|Cesarean Section|cesarean section
947568|NCT03497364|Hypotension|hypotension
947569|NCT03497364|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
947570|NCT03497312|Rehabilitation|rehabilitation
947571|NCT03497312|children with disabilities|children with disabilities
947572|NCT03497312|general anesthesia|general anesthesia
947573|NCT03497312|Children with special healthcare need|children with special healthcare need
947574|NCT03497312|handicapped children|handicapped children
947575|NCT03497312|full mouth rehabilitation|full mouth rehabilitation
947576|NCT03497299|Schizophrenia|schizophrenia
947577|NCT03497299|Smoking|smoking
947578|NCT03497299|Lapse|lapse
947579|NCT03497299|Varenicline|varenicline
947580|NCT03497299|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
947581|NCT03497286|maternal health|maternal health
947582|NCT03497286|maternal stress|maternal stress
947583|NCT03497286|infant health|infant health
947584|NCT03497273|JAK1 inhibitor|jak1 inhibitor
947585|NCT03497273|GVHD|gvhd
947586|NCT03497273|acute GVHD|acute gvhd
947587|NCT03497273|Japan|japan
947588|NCT03497273|corticosteroids|corticosteroids
947589|NCT03497260|Type 1 Diabetes, Fructose, Exercise, Hypoglycaemia, Degludec|type 1 diabetes, fructose, exercise, hypoglycaemia, degludec
947590|NCT03497221|Nursing Education|nursing education
947591|NCT03497208|Surgery|surgery
947592|NCT03497208|melanocytes|melanocytes
947593|NCT03497208|dermarolling system|dermarolling system
947594|NCT03497169|Bariatric surgery|bariatric surgery
947595|NCT03497169|Gastrointestinal tract|gastrointestinal tract
947596|NCT03497169|Biological availability|biological availability
947597|NCT03497169|Pharmacokinetics|pharmacokinetics
947598|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
947599|NCT03497156|Bariatric surgery|bariatric surgery
947600|NCT03497156|Gastrointestinal tract|gastrointestinal tract
947601|NCT03497156|Biological availability|biological availability
947602|NCT03497156|Pharmacokinetics|pharmacokinetics
947603|NCT03497156|Lercanidipine|lercanidipine
1638126|NCT00252070|pain|pain
947604|NCT03497143|Bariatric surgery|bariatric surgery
947605|NCT03497143|Gastrointestinal tract|gastrointestinal tract
947606|NCT03497143|Biological availability|biological availability
947607|NCT03497143|Pharmacokinetics|pharmacokinetics
947608|NCT03497143|Lamotrigine|lamotrigine
947609|NCT03497130|skin regimen|skin regimen
947610|NCT03497130|moisturizer|moisturizer
947611|NCT03497130|dry skin|dry skin
947613|NCT03497130|itchy skin|itchy skin
947614|NCT03497130|skin care|skin care
947615|NCT03497117|imaging|imaging
947616|NCT03497117|hyperpolarized|hyperpolarized
947617|NCT03497117|perfluorinated|perfluorinated
947618|NCT03497117|MRI|mri
947619|NCT03497117|lung|lung
947620|NCT03497117|multiple breath washout|multiple breath washout
947621|NCT03497117|lung clearance index|lung clearance index
947622|NCT03497078|collimator|collimator
947623|NCT03497078|bone scintigraphy|bone scintigraphy
947624|NCT03497078|image quality|image quality
947625|NCT03497078|scintigraphy|scintigraphy
947626|NCT03497065|Dental devices|dental devices
947627|NCT03497065|Home care|home care
947628|NCT03497065|Awareness|awareness
947629|NCT03497065|Peri-implant mucositis|peri-implant mucositis
947630|NCT03497065|Peri-implantitis|peri-implantitis
947631|NCT03497052|IVF culture media|ivf culture media
947632|NCT03497052|Blastocyst|blastocyst
947633|NCT03497052|Time-lapse microscopy|time-lapse microscopy
947634|NCT03497013|transcranial Direct Current Stimulation|transcranial direct current stimulation
947635|NCT03497013|Randomized Controlled Trial|randomized controlled trial
947636|NCT03497013|Schizophrenia|schizophrenia
947637|NCT03497013|Tardive Dyskinesia|tardive dyskinesia
947638|NCT03497013|Abnormal Involuntary Movements Scale|abnormal involuntary movements scale
947639|NCT03497013|Tardive Dyskinesia Rating Scale|tardive dyskinesia rating scale
947640|NCT03497013|Cognition|cognition
947641|NCT03497000|optical coherence tomography angiography|optical coherence tomography angiography
947852|NCT03495661|laminectomy|laminectomy
947642|NCT03497000|central serous chorioretinopathy|central serous chorioretinopathy
947643|NCT03497000|photodynamic therapy|photodynamic therapy
947644|NCT03496987|Pleural Effusion|pleural effusion
947645|NCT03496987|Pleural Drainage|pleural drainage
947646|NCT03496987|Thoracentesis|thoracentesis
947647|NCT03496961|Yan Nian Jiu Zhuan Fa|yan nian jiu zhuan fa
947648|NCT03496948|PAD|pad
947649|NCT03496948|Peripheral Artery Disease|peripheral artery disease
947650|NCT03496948|Peripheral Arterial Disease|peripheral arterial disease
947651|NCT03496935|Renal replacement therapy|renal replacement therapy
947652|NCT03496922|Unventilated Cigarettes|unventilated cigarettes
947653|NCT03496922|Experimental Tobacco Marketplace|experimental tobacco marketplace
947654|NCT03496922|Demand|demand
947655|NCT03496922|Delay Discounting|delay discounting
947656|NCT03496896|Randomized Controlled Trial|randomized controlled trial
947657|NCT03496896|Patient readmission|patient readmission
947658|NCT03496896|Patient transfer|patient transfer
947659|NCT03496896|Health care utilization|health care utilization
947660|NCT03496896|Prognosis|prognosis
947661|NCT03496896|Multimorbidity|multimorbidity
947662|NCT03496896|Internal medicine|internal medicine
947663|NCT03496857|labor pain|labor pain
947664|NCT03496831|Hospitalization|hospitalization
947665|NCT03496831|Infection|infection
947666|NCT03496805|Muscadine Grape Extract|muscadine grape extract
947667|NCT03496805|Androgen Deprivation Therapy|androgen deprivation therapy
947668|NCT03496792|venous distension reflex|venous distension reflex
947669|NCT03496779|Brentuximab Vedotin|brentuximab vedotin
947670|NCT03496779|T-cell lymphoma|t-cell lymphoma
947671|NCT03496753|nipple fissure|nipple fissure
947672|NCT03496740|Postoperative pain|postoperative pain
947673|NCT03496740|Ultrasound|ultrasound
947674|NCT03496740|Dorsal Penile Nerve Block|dorsal penile nerve block
947675|NCT03496740|Pudendal Block|pudendal block
947676|NCT03496740|Hypospadias|hypospadias
947677|NCT03496727|pain, VATS|pain, vats
947678|NCT03496714|Posttraumatic stress disorder|posttraumatic stress disorder
947679|NCT03496714|Safety behaviors|safety behaviors
947680|NCT03496714|Threat appraisal|threat appraisal
947681|NCT03496714|Secondary prevention|secondary prevention
947682|NCT03496714|Internet-based|internet-based
947683|NCT03496714|PTSD|ptsd
947684|NCT03496688|Sinus floor augmentation|sinus floor augmentation
947685|NCT03496688|Bone regeneration|bone regeneration
947686|NCT03496688|Histology|histology
947687|NCT03496688|Biocompatible materials|biocompatible materials
948788|NCT03489577|Sepsis|sepsis
947692|NCT03496636|Ovary|ovary
947693|NCT03496636|Transplant|transplant
947694|NCT03496623|Pulmonary Hypertension|pulmonary hypertension
947695|NCT03496623|COPD|copd
947696|NCT03496623|Inhaled Treprostinil|inhaled treprostinil
947697|NCT03496623|6-Minute Walk Test|6-minute walk test
947698|NCT03496623|Tyvaso|tyvaso
947699|NCT03496610|Bupivacaine|bupivacaine
947700|NCT03496610|Living donor nephrectomy|living donor nephrectomy
947701|NCT03496571|Eosinophilic Gastritis|eosinophilic gastritis
947702|NCT03496571|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
947703|NCT03496571|Eosinophil|eosinophil
947704|NCT03496571|EG|eg
947705|NCT03496571|EGE|ege
947706|NCT03496571|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
947707|NCT03496571|EGID|egid
947708|NCT03496558|lactogenesis, pregnant, TG, lipidic profile, breastfeeding.|lactogenesis, pregnant, tg, lipidic profile, breastfeeding.
947709|NCT03496545|fever|fever
947710|NCT03496545|central fever|central fever
947711|NCT03496545|neurogenic fever|neurogenic fever
947712|NCT03496545|hyperthermia|hyperthermia
947713|NCT03496545|bromocriptine|bromocriptine
947714|NCT03496545|subarachnoid hemorrhage|subarachnoid hemorrhage
947715|NCT03496545|SAH|sah
947716|NCT03496545|subdural hematoma|subdural hematoma
947717|NCT03496545|SDH|sdh
947718|NCT03496545|intracerebral hemorrhage|intracerebral hemorrhage
947719|NCT03496545|ICH|ich
947720|NCT03496545|traumatic brain injury|traumatic brain injury
947721|NCT03496545|TBI|tbi
947722|NCT03496545|ischemic stroke|ischemic stroke
947728|NCT03496506|selexipag|selexipag
947729|NCT03496506|clopidogrel|clopidogrel
947730|NCT03496493|perioperative|perioperative
947731|NCT03496493|monitoring|monitoring
947732|NCT03496493|plethysmography|plethysmography
947733|NCT03496493|pulse oximetery|pulse oximetery
947734|NCT03496480|ptsd|ptsd
947735|NCT03496480|stress|stress
947736|NCT03496480|traumatization|traumatization
947737|NCT03496467|Treatment of pain and inflammation after Cataract Surgery|treatment of pain and inflammation after cataract surgery
947738|NCT03496454|malaria|malaria
947739|NCT03496454|infection|infection
947740|NCT03496454|controlled|controlled
947741|NCT03496428|intra-oral scanner|intra-oral scanner
947742|NCT03496428|customized impression coping|customized impression coping
947743|NCT03496428|extra-oral scanner|extra-oral scanner
947744|NCT03496428|accuracy|accuracy
947745|NCT03496376|kinesio taping|kinesio taping
947746|NCT03496376|COPD|copd
947747|NCT03496376|functional capacity|functional capacity
947748|NCT03496376|pulmonary functions|pulmonary functions
947749|NCT03496376|pulmonary rehabilitation|pulmonary rehabilitation
947751|NCT03496337|activities of daily living|activities of daily living
947752|NCT03496337|assessment of motor and process skills|assessment of motor and process skills
947753|NCT03496337|validation study|validation study
947754|NCT03496337|responsiveness study|responsiveness study
947755|NCT03496259|Postoperative pain, on-Q pump, epidural, children|postoperative pain, on-q pump, epidural, children
947757|NCT03496181|fMRI|fmri
947758|NCT03496181|MRI|mri
947759|NCT03496181|18-121|18-121
947760|NCT03496181|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
947761|NCT03496168|Symptomatic|symptomatic
947762|NCT03496168|Obstructive|obstructive
947763|NCT03496168|Left ventricular outflow tract gradient|left ventricular outflow tract gradient
947764|NCT03496155|parent-teen communication|parent-teen communication
947765|NCT03496155|teen strengths|teen strengths
947766|NCT03496155|adolescence|adolescence
947767|NCT03496142|Prostate biopsy approach|prostate biopsy approach
947768|NCT03496142|Transrectal prostate biopsy|transrectal prostate biopsy
947769|NCT03496142|Transperineal prostate biopsy|transperineal prostate biopsy
947770|NCT03496142|Iatrogenic infection|iatrogenic infection
947771|NCT03496142|Prevention|prevention
947772|NCT03496090|Diverticulitis|diverticulitis
947773|NCT03496090|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
947774|NCT03496090|Free diet|free diet
947775|NCT03496090|Dietary restriction|dietary restriction
947776|NCT03496090|Acute Diverticulitis|acute diverticulitis
947777|NCT03496077|Dual Use|dual use
947778|NCT03496077|Little Cigars and Cigarillos|little cigars and cigarillos
947779|NCT03496077|Cigarettes|cigarettes
947780|NCT03496077|Flavored Tobacco Use|flavored tobacco use
947781|NCT03496077|Addiction Potential|addiction potential
947782|NCT03496064|Thrombectomy|thrombectomy
947783|NCT03496064|Eligibility|eligibility
947784|NCT03496064|Large vessel occlusion|large vessel occlusion
947785|NCT03496025|facial nerve palsy|facial nerve palsy
947786|NCT03496025|facial paralysis|facial paralysis
948890|NCT03489083|Diabetes|diabetes
947787|NCT03496025|functional electrical stimulation|functional electrical stimulation
947788|NCT03496025|facial pacing|facial pacing
947789|NCT03496012|NightstaRx|nightstarx
947790|NCT03496012|NSR-REP1|nsr-rep1
947791|NCT03496012|Choroideremia|choroideremia
947792|NCT03496012|CHM|chm
947793|NCT03496012|Gene Therapy|gene therapy
947794|NCT03496012|AAV|aav
947795|NCT03496012|REP1|rep1
947796|NCT03495999|Hyperuricemia|hyperuricemia
947797|NCT03495999|Metabolic syndrome|metabolic syndrome
947798|NCT03495999|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
947799|NCT03495999|Inflammation|inflammation
947800|NCT03495986|Functional Electrical Stimulation|functional electrical stimulation
947801|NCT03495986|Exercise|exercise
947802|NCT03495986|Body Composition|body composition
947803|NCT03495960|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
947804|NCT03495960|elderly|elderly
947805|NCT03495960|PCNSL|pcnsl
947806|NCT03495947|High Flow Nasal Cannula (HFNC).|high flow nasal cannula (hfnc).
947807|NCT03495947|Mechanical ventilation|mechanical ventilation
947808|NCT03495947|Extubation failure|extubation failure
947809|NCT03495921|ESFT|esft
947810|NCT03495921|Immunotherapy|immunotherapy
947811|NCT03495921|Phase 3|phase 3
947812|NCT03495908|VGo|vgo
947813|NCT03495908|Insulin|insulin
947814|NCT03495908|Type 2 Diabetes|type 2 diabetes
947815|NCT03495895|Disadvantaged families|disadvantaged families
947816|NCT03495895|Pregnancy|pregnancy
947817|NCT03495895|Intervention|intervention
947818|NCT03495895|Minding the Baby|minding the baby
947819|NCT03495856|Mindfulness-based stress reduction|mindfulness-based stress reduction
947820|NCT03495856|Mindfulness|mindfulness
947821|NCT03495856|chronic pain|chronic pain
947822|NCT03495856|Feasibility|feasibility
947823|NCT03495856|Intervention|intervention
947824|NCT03495804|CT enterography|ct enterography
947825|NCT03495804|oral contrast agent|oral contrast agent
947826|NCT03495791|RA|ra
947827|NCT03495791|Rheumatoid Arthritis|rheumatoid arthritis
947828|NCT03495791|Arthritis|arthritis
947829|NCT03495765|Diabetic macular oedema|diabetic macular oedema
947830|NCT03495765|Lucentis|lucentis
947831|NCT03495752|muscle performance|muscle performance
947832|NCT03495752|injury prevention|injury prevention
947833|NCT03495752|step down|step down
947834|NCT03495752|fatigue|fatigue
947835|NCT03495726|Contemplative|contemplative
947836|NCT03495726|Applications|applications
947837|NCT03495726|Well-being|well-being
947838|NCT03495687|Respiratory function|respiratory function
947839|NCT03495687|Spinal mobility|spinal mobility
947840|NCT03495687|Chest expansion|chest expansion
947841|NCT03495674|Lynch Syndrome|lynch syndrome
947842|NCT03495674|Cycling Exercise|cycling exercise
947843|NCT03495674|Lower GI Endoscopy|lower gi endoscopy
947844|NCT03495674|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
947845|NCT03495674|CPET|cpet
947846|NCT03495674|EKG|ekg
947847|NCT03495674|Questionnaires|questionnaires
947848|NCT03495674|Surveys|surveys
947849|NCT03495674|FITBIT|fitbit
947850|NCT03495661|lumbar spine stenosis|lumbar spine stenosis
947851|NCT03495661|decompression|decompression
947853|NCT03495661|physiotherapy|physiotherapy
947854|NCT03495661|physical therapy|physical therapy
947855|NCT03495661|electroneurography|electroneurography
947856|NCT03495661|ENG|eng
947857|NCT03495661|electromyography|electromyography
947858|NCT03495661|EMG|emg
947859|NCT03495661|Neurogenic Claudication|neurogenic claudication
947860|NCT03495661|Pseudoclaudication|pseudoclaudication
947861|NCT03495648|farmers market|farmers market
947862|NCT03495648|Appalachia|appalachia
947863|NCT03495648|physical activity|physical activity
947864|NCT03495648|fruit and vegetable voucher program|fruit and vegetable voucher program
947865|NCT03495635|mentoring|mentoring
947866|NCT03495635|prevention|prevention
947867|NCT03495622|Text messaging|text messaging
947868|NCT03495622|Community health worker|community health worker
947869|NCT03495622|Smoking cessation|smoking cessation
947870|NCT03495622|India|india
947871|NCT03495622|Cardiovascular mortality|cardiovascular mortality
947872|NCT03495583|Food allergy|food allergy
947873|NCT03495583|Child Health|child health
947874|NCT03495583|Oral tolerance induction|oral tolerance induction
947875|NCT03495583|Food allergic sensitisation|food allergic sensitisation
947876|NCT03495583|Obesity|obesity
947877|NCT03495570|immunological|immunological
947878|NCT03495557|Hernia|hernia
947879|NCT03495557|Cholecystectomy|cholecystectomy
947880|NCT03495557|Mesh fixation|mesh fixation
947881|NCT03495531|virtual reality|virtual reality
947882|NCT03495531|obstetrics|obstetrics
947883|NCT03495531|labor procedures|labor procedures
947884|NCT03495531|regional anesthesia|regional anesthesia
947885|NCT03495518|Cancer|cancer
947886|NCT03495518|Randomized Control Trial|randomized control trial
947887|NCT03495518|Children|children
947888|NCT03495518|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
947889|NCT03495518|Quality of Life|quality of life
947890|NCT03495505|WiSE-CRT|wise-crt
949190|NCT03487016|Metastatic|metastatic
947891|NCT03495505|Endocardial Pacing Optimisation|endocardial pacing optimisation
947892|NCT03495505|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
947893|NCT03495492|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
947894|NCT03495492|CLL|cll
947895|NCT03495492|Dermal Chelation|dermal chelation
947896|NCT03495492|Nutritional Therapy|nutritional therapy
947897|NCT03495479|Prostate Cancer|prostate cancer
947898|NCT03495479|PC|pc
947899|NCT03495479|Active Surveillance|active surveillance
947900|NCT03495479|Chemonaiive|chemonaiive
947901|NCT03495479|OMN54|omn54
947902|NCT03495479|Aneustat (TM)|aneustat (tm)
947903|NCT03495479|PSA|psa
947904|NCT03495479|BPH|bph
947905|NCT03495440|Emotional Security|emotional security
947906|NCT03495440|Intellectual Disability|intellectual disability
947907|NCT03495440|Developmental Disability|developmental disability
947908|NCT03495427|radioactive diagnostic imaging|radioactive diagnostic imaging
947909|NCT03495375|Impulsivity|impulsivity
947910|NCT03495375|Compulsivity|compulsivity
947911|NCT03495375|Aggression|aggression
947912|NCT03495375|Microbiome|microbiome
947913|NCT03495375|Probiotic|probiotic
947914|NCT03495375|Nutrition|nutrition
947915|NCT03495375|Psychiatric disorders|psychiatric disorders
947916|NCT03495375|Synbiotic2000Forte|synbiotic2000forte
947917|NCT03495362|Yeast Beta-glucan|yeast beta-glucan
947918|NCT03495362|Immune Function|immune function
947919|NCT03495362|Prediabetes|prediabetes
947920|NCT03495362|Gut Microbiota|gut microbiota
947921|NCT03495336|Boiled coffee|boiled coffee
947922|NCT03495336|Cardiovascular disease|cardiovascular disease
947923|NCT03495336|Cholesterol|cholesterol
947924|NCT03495336|Homocysteine|homocysteine
947925|NCT03495336|Turkish coffee|turkish coffee
947926|NCT03495336|Diterpenes|diterpenes
947927|NCT03495336|Unfiltered coffee|unfiltered coffee
947928|NCT03495323|Cancer Care|cancer care
947929|NCT03495297|subcutaneous implantable cardioverter defibrillator|subcutaneous implantable cardioverter defibrillator
947930|NCT03495297|Defibrillation testing|defibrillation testing
947931|NCT03495271|Hemodialysis|hemodialysis
947932|NCT03495271|Taste|taste
947933|NCT03495271|Blood|blood
947934|NCT03495271|Saliva|saliva
947935|NCT03495245|pain|pain
947936|NCT03495245|opioid|opioid
947937|NCT03495245|fibromyalgia|fibromyalgia
947938|NCT03495232|Total Knee Arthroplasty|total knee arthroplasty
947939|NCT03495232|Persona knee system|persona knee system
947940|NCT03495232|osteoarthrosis|osteoarthrosis
947941|NCT03495232|Knee|knee
947942|NCT03495193|exercise|exercise
947943|NCT03495128|muscle protein breakdown|muscle protein breakdown
947944|NCT03495128|inactivity|inactivity
947945|NCT03495128|bed rest|bed rest
947946|NCT03495115|Breast Cancer|breast cancer
947947|NCT03495089|Screening; Sudomotor reflex; DEC; Primary Care|screening; sudomotor reflex; dec; primary care
947948|NCT03495076|Tactile acuity|tactile acuity
947949|NCT03495076|Tactile dysfunction|tactile dysfunction
947950|NCT03495076|Sensory dissociation|sensory dissociation
947951|NCT03495076|Two-point discrimination|two-point discrimination
947952|NCT03495076|Perception|perception
947953|NCT03495050|Bicuspid|bicuspid
947954|NCT03495050|TAVI|tavi
947955|NCT03495050|TAVR|tavr
947956|NCT03495050|self-expanding|self-expanding
947957|NCT03495050|Evolut|evolut
947958|NCT03495037|Age-related cognitive changes|age-related cognitive changes
947959|NCT03495024|Schizophrenia|schizophrenia
947960|NCT03495024|Schizoaffective disorder|schizoaffective disorder
947961|NCT03495024|Antipsychotics|antipsychotics
947962|NCT03495024|Tobacco smoking|tobacco smoking
947963|NCT03495024|Tardive dyskinesia|tardive dyskinesia
947964|NCT03495024|Parkinsonism|parkinsonism
947965|NCT03495011|Ductal Carcinoma in Situ|ductal carcinoma in situ
947966|NCT03495011|MRI|mri
947967|NCT03495011|Oncotype Dx|oncotype dx
947968|NCT03494959|Pentaglobin|pentaglobin
947969|NCT03494959|Carbapenem-resistant Klebsiella pneumoniae|carbapenem-resistant klebsiella pneumoniae
947970|NCT03494959|Pseudomonas aeruginosa|pseudomonas aeruginosa
947971|NCT03494959|febrile neutropenia|febrile neutropenia
947972|NCT03494959|infection-related mortality|infection-related mortality
947973|NCT03494946|Liver metastasis|liver metastasis
947974|NCT03494946|Colorectal cancer|colorectal cancer
947975|NCT03494920|Stroke|stroke
947976|NCT03494920|Ischemia|ischemia
947977|NCT03494920|Cerebral Infarction|cerebral infarction
947978|NCT03494920|Cerebrovascular Disorders|cerebrovascular disorders
947979|NCT03494920|Brain Diseases|brain diseases
947980|NCT03494920|Central Nervous System Diseases|central nervous system diseases
947981|NCT03494920|Nervous System Diseases|nervous system diseases
947982|NCT03494920|Vascular Diseases|vascular diseases
947983|NCT03494920|Cardiovascular Diseases|cardiovascular diseases
947984|NCT03494920|Pathologic Processes|pathologic processes
947985|NCT03494920|Brain Infarction|brain infarction
947986|NCT03494920|Brain Ischemia|brain ischemia
947987|NCT03494920|Tissue Plasminogen Activator|tissue plasminogen activator
947988|NCT03494920|Plasminogen|plasminogen
947989|NCT03494920|Fibrinolytic Agents|fibrinolytic agents
947990|NCT03494920|Fibrin Modulating Agents|fibrin modulating agents
948091|NCT03494218|disorders of consciousness|disorders of consciousness
947991|NCT03494920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
947993|NCT03494842|pain relief|pain relief
947994|NCT03494842|STOP|stop
947995|NCT03494842|surgical abortion|surgical abortion
947996|NCT03494829|early onset scoliosis|early onset scoliosis
947997|NCT03494829|motor competence|motor competence
947998|NCT03494829|physical activity|physical activity
947999|NCT03494829|pulmonary function|pulmonary function
948000|NCT03494829|health related quality of life|health related quality of life
948001|NCT03494816|Neoadjuvant|neoadjuvant
948002|NCT03494816|Venous Tumour Thrombus|venous tumour thrombus
948003|NCT03494816|Axitinib|axitinib
948004|NCT03494816|Mayo Classification|mayo classification
948005|NCT03494816|Nephrectomy|nephrectomy
948006|NCT03494816|Thrombectomy|thrombectomy
948007|NCT03494790|MMP|mmp
948008|NCT03494790|Matrix metalloproteinase|matrix metalloproteinase
948009|NCT03494790|Metabolomics|metabolomics
948011|NCT03494790|Quick SOFA|quick sofa
948012|NCT03494790|Infection|infection
948013|NCT03494790|Triage|triage
948014|NCT03494777|ART adherence|art adherence
948015|NCT03494764|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
948016|NCT03494751|Monitoring|monitoring
948017|NCT03494751|Myocardial infarction|myocardial infarction
948018|NCT03494751|Clinical trial|clinical trial
948019|NCT03494738|Prenatal alcohol exposure|prenatal alcohol exposure
948020|NCT03494725|Probiotic|probiotic
948021|NCT03494725|Gut-brain axis|gut-brain axis
948022|NCT03494725|Stress|stress
948023|NCT03494725|Anxiety|anxiety
948024|NCT03494712|healthy volunteer|healthy volunteer
948025|NCT03494712|antimiR|antimir
948026|NCT03494712|single ascending dose|single ascending dose
948027|NCT03494686|conization|conization
948028|NCT03494686|LLETZ|lletz
948029|NCT03494686|randomized controlled trial|randomized controlled trial
948030|NCT03494686|loop excision|loop excision
948031|NCT03494686|general anaesthesia|general anaesthesia
948032|NCT03494686|local anaesthesia|local anaesthesia
948033|NCT03494673|White matter hyperintensity|white matter hyperintensity
948034|NCT03494673|Cerebrovascular reactivity|cerebrovascular reactivity
948035|NCT03494660|Subchondroplasty|subchondroplasty
948036|NCT03494660|Bone Marrow Lesion|bone marrow lesion
948037|NCT03494660|Arthroscopy|arthroscopy
948038|NCT03494660|Bone Substitute Material|bone substitute material
948039|NCT03494660|AccuFill|accufill
948040|NCT03494660|Subchondral Bone Defect|subchondral bone defect
948041|NCT03494608|cognitive function|cognitive function
948042|NCT03494608|quality of life|quality of life
948043|NCT03494608|anxiety|anxiety
948044|NCT03494608|depression|depression
948045|NCT03494608|neurological function|neurological function
948046|NCT03494595|Pediatric Liver Transplantation, Thromboelastometry|pediatric liver transplantation, thromboelastometry
948047|NCT03494543|Ampullary Adenoma|ampullary adenoma
948048|NCT03494543|Endoscopic Papillectomy|endoscopic papillectomy
948049|NCT03494543|Familial Adenomatous Polyposis|familial adenomatous polyposis
948050|NCT03494478|Cohort study|cohort study
948051|NCT03494478|Emotion dysregulation|emotion dysregulation
948052|NCT03494478|Questionnaires|questionnaires
948053|NCT03494478|Actimetry|actimetry
948054|NCT03494478|Neuropsychology|neuropsychology
948055|NCT03494452|electromyography, strength, strength endurance|electromyography, strength, strength endurance
948056|NCT03494400|Breast cancer|breast cancer
948057|NCT03494400|Physical exercise|physical exercise
948058|NCT03494400|Body mass|body mass
948059|NCT03494387|Antioxidant|antioxidant
948060|NCT03494387|Hyperoxia|hyperoxia
948061|NCT03494387|Troponin|troponin
948062|NCT03494387|MINS|mins
948063|NCT03494387|Ascorbic acid|ascorbic acid
948064|NCT03494387|N-acetylcysteine|n-acetylcysteine
948065|NCT03494374|pes planus|pes planus
948066|NCT03494374|UCBL|ucbl
948067|NCT03494374|exercise|exercise
948068|NCT03494361|deglutition disorders|deglutition disorders
948069|NCT03494361|electromyography|electromyography
948070|NCT03494348|Radiostereometry (RSA)|radiostereometry (rsa)
948071|NCT03494348|Total Knee Arthroplasty|total knee arthroplasty
948072|NCT03494309|Mandibular Subcondylar Fractures|mandibular subcondylar fractures
948073|NCT03494309|Mouth Opening|mouth opening
948074|NCT03494309|Open Reduction and Internal Fixation|open reduction and internal fixation
948075|NCT03494309|Closed Reduction with External Fixation|closed reduction with external fixation
948076|NCT03494283|CrossFit injuries|crossfit injuries
948077|NCT03494257|phacoemulsification|phacoemulsification
948078|NCT03494257|intraocular pressure|intraocular pressure
948079|NCT03494257|cataract|cataract
948080|NCT03494257|brinzolamide|brinzolamide
948081|NCT03494257|brimonidinde|brimonidinde
948082|NCT03494257|fixed combination|fixed combination
948083|NCT03494244|acellular dermal matrix|acellular dermal matrix
948084|NCT03494244|breast reconstruction|breast reconstruction
948085|NCT03494244|efficacy|efficacy
948086|NCT03494231|Metastatic|metastatic
948087|NCT03494231|Refractory|refractory
948088|NCT03494231|Cancer|cancer
948089|NCT03494231|Solid|solid
948090|NCT03494231|Tumor|tumor
948099|NCT03494192|acromiohumeral distance|acromiohumeral distance
948100|NCT03494192|pain|pain
948101|NCT03494192|functional level|functional level
948102|NCT03494192|Subacromial Impingement Syndrome|subacromial impingement syndrome
948103|NCT03494127|wheelchair seating|wheelchair seating
948104|NCT03494127|tissue health|tissue health
948105|NCT03494088|Autism|autism
948106|NCT03494088|Abdominal Pain|abdominal pain
948107|NCT03494075|Patients|patients
948108|NCT03494075|Caregivers|caregivers
948109|NCT03494036|synbiotic|synbiotic
948110|NCT03494036|probiotic|probiotic
948111|NCT03494036|lupus|lupus
948112|NCT03494036|connective tissue disease|connective tissue disease
948113|NCT03494010|Kidney Transplantation|kidney transplantation
948114|NCT03493971|carotid endarterectomy|carotid endarterectomy
948115|NCT03493971|carotid stenting|carotid stenting
948116|NCT03493971|autonomic function|autonomic function
948117|NCT03493971|computational fluid dynamic|computational fluid dynamic
948118|NCT03493971|cognitive function|cognitive function
948122|NCT03493945|Immunotherapy|immunotherapy
948123|NCT03493945|Combined Treatment|combined treatment
948124|NCT03493945|PD-1/PD-L1|pd-1/pd-l1
948125|NCT03493945|Tumor-Specific T Cells|tumor-specific t cells
948126|NCT03493945|Novel Cancer Vaccine|novel cancer vaccine
948132|NCT03493919|Immunological assays|immunological assays
948133|NCT03493919|Human blood donors|human blood donors
948134|NCT03493919|Meningococcal vaccination|meningococcal vaccination
948135|NCT03493919|Meningococcal disease|meningococcal disease
948136|NCT03493867|Non-invasive blood pressure monitoring|non-invasive blood pressure monitoring
948137|NCT03493867|Wearable device|wearable device
948138|NCT03493867|Medical device verification study|medical device verification study
948140|NCT03493802|Endothelial dysfunction|endothelial dysfunction
948141|NCT03493802|Oxidative stress|oxidative stress
948142|NCT03493802|NADPH oxidase 4 (NOX4)|nadph oxidase 4 (nox4)
948143|NCT03493802|Mitochondria|mitochondria
948144|NCT03493763|Recurrence Monitoring|recurrence monitoring
948145|NCT03493763|5-Hydroxymethylcytosine|5-hydroxymethylcytosine
948146|NCT03493763|Liquid biopsy|liquid biopsy
948147|NCT03493763|Cell-free DNA|cell-free dna
948148|NCT03493672|Phase I clinical trial|phase i clinical trial
948149|NCT03493672|Phase II clinical trial|phase ii clinical trial
948150|NCT03493672|Early trial discontinuation|early trial discontinuation
948151|NCT03493672|Objective smartphone measurements|objective smartphone measurements
948152|NCT03493672|Physical activity|physical activity
948153|NCT03493672|Physical fitness|physical fitness
948154|NCT03493659|Standing|standing
948155|NCT03493659|Sitting|sitting
948156|NCT03493659|Learning|learning
948157|NCT03493659|Problem-Based Learning|problem-based learning
948158|NCT03493659|Undergraduate|undergraduate
948159|NCT03493646|Myelodysplastic Syndrome|myelodysplastic syndrome
948160|NCT03493646|MDS|mds
948161|NCT03493646|Acute Myeloid Leukemia|acute myeloid leukemia
948162|NCT03493646|AML|aml
948163|NCT03493646|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
948164|NCT03493646|CMML|cmml
948165|NCT03493607|AMO-01|amo-01
948166|NCT03493607|Shank3|shank3
948167|NCT03493607|Clinical Trial|clinical trial
948168|NCT03493594|Early nutrition|early nutrition
948169|NCT03493594|Breastfeeding|breastfeeding
948170|NCT03493594|Infant growth|infant growth
948171|NCT03493529|Endometrial microbiome|endometrial microbiome
948172|NCT03493529|Obesity|obesity
948173|NCT03493529|Bacterial pathogens|bacterial pathogens
948174|NCT03493529|Dysbiosis|dysbiosis
948175|NCT03493529|Endometrial receptivity|endometrial receptivity
948176|NCT03493516|Positron Emission Tomography|positron emission tomography
948177|NCT03493516|Sympathetic Innervation|sympathetic innervation
948178|NCT03493516|Sudden Death|sudden death
948179|NCT03493516|Ventricular Fibrillation|ventricular fibrillation
948180|NCT03493516|LMI-1195|lmi-1195
948181|NCT03493516|Ischemic Cardiomyopathy|ischemic cardiomyopathy
948182|NCT03493516|Risk Prediction|risk prediction
948183|NCT03493490|Double-Blind Method|double-blind method
948184|NCT03493490|placebo-controlled|placebo-controlled
948185|NCT03493490|parallel-group|parallel-group
948186|NCT03493490|single-centre|single-centre
948187|NCT03493490|exploratory clinical study|exploratory clinical study
948188|NCT03493399|Gambling|gambling
948189|NCT03493399|Craving|craving
948190|NCT03493399|Urge|urge
948191|NCT03493399|Desire|desire
948192|NCT03493399|Interference|interference
948193|NCT03493399|Elaborated Intrusion Theory|elaborated intrusion theory
948194|NCT03493399|Treatment|treatment
948195|NCT03493399|Intervention|intervention
948196|NCT03493399|Clinical Sample|clinical sample
948197|NCT03493399|Single case|single case
948198|NCT03493386|Japan|japan
948199|NCT03493386|Crossover|crossover
948200|NCT03493386|Daprodustat|daprodustat
948201|NCT03493386|Bioequivalence|bioequivalence
948202|NCT03493386|Pharmacokinetics|pharmacokinetics
948203|NCT03493269|Rheumatoid Arthritis;|rheumatoid arthritis;
948204|NCT03493269|Psoriasis|psoriasis
948205|NCT03493243|Adolescent|adolescent
948206|NCT03493243|Post Traumatic Stress Disorder|post traumatic stress disorder
948207|NCT03493243|Terrorist Attack|terrorist attack
948208|NCT03493204|Hepatic Encephalopathy|hepatic encephalopathy
948209|NCT03493204|Ascites|ascites
948210|NCT03493204|Liver Diseases|liver diseases
948211|NCT03493204|Cirrhosis|cirrhosis
948212|NCT03493126|postpartum, local estrogen|postpartum, local estrogen
948213|NCT03493113|EEG|eeg
948214|NCT03493100|oral nutritional supplementation|oral nutritional supplementation
948215|NCT03493100|geriatrics|geriatrics
948216|NCT03493100|bone fracture|bone fracture
948217|NCT03493087|Dialysis, Vitamin-K, Malnutrition|dialysis, vitamin-k, malnutrition
948218|NCT03493035|Middle Cerebral Artery|middle cerebral artery
948219|NCT03493035|Aneurysm|aneurysm
948220|NCT03493035|computed tomography angiogram|computed tomography angiogram
948221|NCT03493035|hemodynamical theory|hemodynamical theory
948222|NCT03492983|Cocoa|cocoa
948223|NCT03492983|Vascular function|vascular function
948224|NCT03492983|Body composition|body composition
948225|NCT03492983|Quality of life|quality of life
948226|NCT03492983|Cognitive performance|cognitive performance
948227|NCT03492983|Postmenopausal women|postmenopausal women
948228|NCT03492957|physical activity|physical activity
948229|NCT03492957|exercise|exercise
948230|NCT03492957|non-ambulatory|non-ambulatory
948231|NCT03492957|feasibility|feasibility
948232|NCT03492957|mixed methods|mixed methods
948233|NCT03492931|Hb SS disease, Hb S Beta 0 Thalassemia|hb ss disease, hb s beta 0 thalassemia
948234|NCT03492892|acupuncture|acupuncture
948235|NCT03492892|hypertension|hypertension
948236|NCT03492892|targeted metabolome|targeted metabolome
948237|NCT03492892|pilot clinical trial|pilot clinical trial
948238|NCT03492814|impacted third molar|impacted third molar
948239|NCT03492814|suturing|suturing
948240|NCT03492814|post-operative morbidity|post-operative morbidity
948241|NCT03492788|cardiac resynchronization therapy|cardiac resynchronization therapy
948242|NCT03492788|electrocardiographic imaging|electrocardiographic imaging
948243|NCT03492775|indolent lymphoma|indolent lymphoma
948244|NCT03492775|Obinutuzumab|obinutuzumab
948245|NCT03492775|GA101|ga101
948246|NCT03492775|Bendamustine|bendamustine
948247|NCT03492775|medically non-fit patients|medically non-fit patients
948248|NCT03492684|nerve injury after total hip arthroplasty|nerve injury after total hip arthroplasty
948249|NCT03492671|Pancreatic Cancer|pancreatic cancer
948250|NCT03492658|abatacept|abatacept
948251|NCT03492658|ACPA expressing B cells|acpa expressing b cells
948252|NCT03492632|psoriasis|psoriasis
948253|NCT03492632|Anti mullerian hormone|anti mullerian hormone
948254|NCT03492632|ovarian reserve|ovarian reserve
948255|NCT03492632|antral follicle count|antral follicle count
948256|NCT03492619|obesity|obesity
948257|NCT03492619|food insecurity|food insecurity
948258|NCT03492619|depressive symptoms|depressive symptoms
948259|NCT03492619|empowerment|empowerment
948260|NCT03492593|carotenoids|carotenoids
948261|NCT03492593|vitamin E|vitamin e
948262|NCT03492593|digestion|digestion
948263|NCT03492593|stability|stability
948264|NCT03492593|metabolism|metabolism
948265|NCT03492567|Cystic fibrosis|cystic fibrosis
948266|NCT03492567|CFTR|cftr
948267|NCT03492567|CFTR modulators|cftr modulators
948268|NCT03492567|Monocyte|monocyte
948269|NCT03492567|Osteoclast|osteoclast
948270|NCT03492567|Osteoporosis|osteoporosis
948271|NCT03492541|mixed dry eye|mixed dry eye
948272|NCT03492541|aqueous-deficient dry eye|aqueous-deficient dry eye
948273|NCT03492541|lipid-deficient dry eye|lipid-deficient dry eye
948274|NCT03492541|evaporative dry eye|evaporative dry eye
948275|NCT03492541|tear film|tear film
948276|NCT03492541|eye drops|eye drops
948277|NCT03492541|artificial tears|artificial tears
948278|NCT03492541|lipid layer|lipid layer
948279|NCT03492541|eye symptoms|eye symptoms
948280|NCT03492541|meibomian gland dysfunction|meibomian gland dysfunction
948282|NCT03492541|SYSTANE|systane
948283|NCT03492541|SYSTANE Complete|systane complete
948284|NCT03492541|nanoemulsion|nanoemulsion
948285|NCT03492515|immune thrombocytopenia|immune thrombocytopenia
948286|NCT03492502|Fecal microbiota transplantation|fecal microbiota transplantation
948287|NCT03492502|allogeneic stem cell transplantation|allogeneic stem cell transplantation
948288|NCT03492502|microbiome|microbiome
948289|NCT03492476|Lymphedema of Upper Arm reduction|lymphedema of upper arm reduction
948290|NCT03492476|Lymphedema Upper Arm device|lymphedema upper arm device
948291|NCT03492463|Nicotine addiction|nicotine addiction
949694|NCT03483623|NATO Litter|nato litter
948292|NCT03492463|Cigarette smoking|cigarette smoking
948293|NCT03492463|Nicotine patches|nicotine patches
948294|NCT03492463|E-cigarettes|e-cigarettes
948295|NCT03492450|Treadmill training|treadmill training
948296|NCT03492450|Instrumented assessment|instrumented assessment
948297|NCT03492450|Disease progression|disease progression
948298|NCT03492437|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
948299|NCT03492437|P-glycoprotein|p-glycoprotein
948300|NCT03492437|Tepotinib|tepotinib
948301|NCT03492437|Dabigatran Etexilate|dabigatran etexilate
948302|NCT03492424|prostate cancer|prostate cancer
948303|NCT03492424|cryotherapy|cryotherapy
948304|NCT03492424|focal therapy|focal therapy
948305|NCT03492411|Breastfeeding|breastfeeding
948306|NCT03492411|Co-parenting|co-parenting
948308|NCT03492411|patient education|patient education
948309|NCT03492411|fathers|fathers
948310|NCT03492398|atopic dermatitis|atopic dermatitis
948311|NCT03492359|COPD, Structured Light Plethysmography, COPD severity|copd, structured light plethysmography, copd severity
948312|NCT03492346|LGMD2E|lgmd2e
948313|NCT03492346|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
948314|NCT03492346|sarcoglycanopathy|sarcoglycanopathy
948315|NCT03492346|β -sarcoglycan|β -sarcoglycan
948316|NCT03492346|Natural History|natural history
948317|NCT03492333|antigliadin, gluten free diet, transit|antigliadin, gluten free diet, transit
948318|NCT03492320|HRQoL|hrqol
948319|NCT03492320|Quality of Life|quality of life
948320|NCT03492320|End Stage Osteoarthritis|end stage osteoarthritis
948321|NCT03492320|Total Knee Arthroplasty|total knee arthroplasty
948322|NCT03492320|WOMAC|womac
948323|NCT03492320|SF 36|sf 36
948324|NCT03492320|Total Knee Replacement|total knee replacement
948325|NCT03492307|High Flow Nasal Cannula|high flow nasal cannula
948326|NCT03492294|disorders of consciousness|disorders of consciousness
948327|NCT03492294|music stimulation|music stimulation
948328|NCT03492294|functional magnetic resonance imaging|functional magnetic resonance imaging
948329|NCT03492281|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
948330|NCT03492281|Incontinence|incontinence
948331|NCT03492281|OAB|oab
948332|NCT03492281|Vibegron|vibegron
948333|NCT03492281|Urge urinary incontinence|urge urinary incontinence
948334|NCT03492281|Urinary bladder, overactive|urinary bladder, overactive
948335|NCT03492281|Urologic Diseases|urologic diseases
948336|NCT03492281|Lower Urinary Tract Symptoms|lower urinary tract symptoms
948337|NCT03492281|Urological Agents|urological agents
948338|NCT03492242|Anti-PD-1|anti-pd-1
948339|NCT03492242|Anti-PD-L1|anti-pd-l1
948340|NCT03492242|Anti-CTLA-4|anti-ctla-4
948341|NCT03492242|Immune checkpoint inhibitors|immune checkpoint inhibitors
948342|NCT03492242|Immune adverse drug reactions|immune adverse drug reactions
948343|NCT03492229|Gait|gait
948344|NCT03492229|Brain stimulation|brain stimulation
948345|NCT03492229|tDCS|tdcs
948346|NCT03492229|Walking|walking
948347|NCT03492203|Cognitive Remediation|cognitive remediation
948348|NCT03492203|Neurocognition|neurocognition
948349|NCT03492203|Severe mental illness|severe mental illness
948350|NCT03492203|Remote treatment|remote treatment
948351|NCT03492190|protein availability|protein availability
948352|NCT03492190|beans|beans
948353|NCT03492190|children|children
948354|NCT03492190|elderly|elderly
948355|NCT03492177|Pediatric|pediatric
948356|NCT03492151|Confocal laser endomicroscopy|confocal laser endomicroscopy
948357|NCT03492138|Multiple Myeloma|multiple myeloma
948358|NCT03492138|Relapsed and Refractory|relapsed and refractory
948359|NCT03492086|Rosmarinus officinalis L|rosmarinus officinalis l
948360|NCT03492086|alkylglycerols|alkylglycerols
948361|NCT03492086|immuno-nutrition|immuno-nutrition
948362|NCT03492086|colon cancer|colon cancer
948363|NCT03492073|Mindfulness|mindfulness
948364|NCT03492073|Oncology|oncology
948365|NCT03492073|Cancer|cancer
948366|NCT03492073|Emotional distress|emotional distress
948367|NCT03492073|Quality of life|quality of life
948368|NCT03492060|Gene Variant|gene variant
948369|NCT03492047|paclitaxel|paclitaxel
948370|NCT03492047|peripheral neuropathy|peripheral neuropathy
948371|NCT03492047|N-acetyl cysteine|n-acetyl cysteine
948372|NCT03492021|rehabilitative nutrition|rehabilitative nutrition
948373|NCT03492021|protein|protein
948374|NCT03492021|beef|beef
948375|NCT03492021|ACL reconstruction|acl reconstruction
948376|NCT03492021|protein synthesis|protein synthesis
948377|NCT03492021|proteolysis|proteolysis
948378|NCT03492021|muscle mass|muscle mass
948379|NCT03492021|muscle strength|muscle strength
948380|NCT03492008|nasogastric tube|nasogastric tube
948381|NCT03492008|general anesthesia|general anesthesia
948382|NCT03492008|head position|head position
948383|NCT03491982|Cardiac Rehabilitation|cardiac rehabilitation
948384|NCT03491930|Weight Loss|weight loss
948385|NCT03491930|Obesity|obesity
948386|NCT03491930|Pre-Diabetes|pre-diabetes
948387|NCT03491930|Metabolic Syndrome|metabolic syndrome
948388|NCT03491891|Very Late Stent Thrombosis|very late stent thrombosis
948389|NCT03491891|New generation DES|new generation des
948491|NCT03491280|Rare Diseases|rare diseases
948390|NCT03491774|memory impairment, montessori intervention, neurocognitive disorder|memory impairment, montessori intervention, neurocognitive disorder
948391|NCT03491761|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
948392|NCT03491761|Viscosupplementation|viscosupplementation
948393|NCT03491761|Knee Osteoarthritis|knee osteoarthritis
948394|NCT03491761|Hyaluronic Acid (HA)|hyaluronic acid (ha)
948395|NCT03491761|Supartz|supartz
948396|NCT03491761|WOMAC|womac
948397|NCT03491761|KOOS|koos
948398|NCT03491748|Pharmacokinetics|pharmacokinetics
948399|NCT03491748|ETX0282|etx0282
948400|NCT03491748|Single Ascending Dose|single ascending dose
948401|NCT03491748|Multiple Ascending Doses|multiple ascending doses
948402|NCT03491748|ETX1317|etx1317
948403|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil
948404|NCT03491748|Cefpodoxime|cefpodoxime
948405|NCT03491748|Enterobacteriaceae Infections|enterobacteriaceae infections
948406|NCT03491735|patterns|patterns
948407|NCT03491735|glaucoma|glaucoma
948408|NCT03491735|egypt|egypt
948409|NCT03491735|india|india
948410|NCT03491735|2018|2018
948411|NCT03491696|Depressive disorder|depressive disorder
948412|NCT03491696|Metyrapone|metyrapone
948413|NCT03491696|Dexamethasone Suppression Test|dexamethasone suppression test
948414|NCT03491696|Antidepressive association|antidepressive association
948415|NCT03491696|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
948416|NCT03491696|Cortisol|cortisol
948417|NCT03491696|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
948418|NCT03491696|Serotonin and Norepinephrine Reuptake Inhibitor|serotonin and norepinephrine reuptake inhibitor
948419|NCT03491683|Glioblastoma|glioblastoma
948420|NCT03491683|immunotherapy|immunotherapy
948421|NCT03491683|DNA therapy|dna therapy
948422|NCT03491683|checkpoint inhibitor|checkpoint inhibitor
948423|NCT03491657|virtual reality pain|virtual reality pain
948424|NCT03491657|opioid|opioid
948425|NCT03491657|pediatric burn|pediatric burn
948426|NCT03491657|wound care|wound care
948427|NCT03491644|Traumatic accident|traumatic accident
948428|NCT03491644|Oxygen|oxygen
948429|NCT03491644|Intensive Care|intensive care
948430|NCT03491644|Emergency|emergency
948431|NCT03491618|lumbar facet joint pain|lumbar facet joint pain
948432|NCT03491618|Lumbar Medial Branch Neurotomy|lumbar medial branch neurotomy
948433|NCT03491618|Chronic Low Back Pain|chronic low back pain
948434|NCT03491605|chronic EBV infection, hemophagocytic lymphohistiocytosis|chronic ebv infection, hemophagocytic lymphohistiocytosis
948435|NCT03491592|Physical Activity|physical activity
948436|NCT03491592|Latinas|latinas
948437|NCT03491592|Spanish-language|spanish-language
948438|NCT03491592|Text-Message|text-message
948439|NCT03491592|Exercise|exercise
948440|NCT03491592|Web-based|web-based
948442|NCT03491579|Epacadostat|epacadostat
948443|NCT03491579|Cladribine|cladribine
948444|NCT03491579|Cytarabine|cytarabine
948445|NCT03491540|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
948446|NCT03491540|Oral antibiotics|oral antibiotics
948447|NCT03491540|Rectal cancer surgery|rectal cancer surgery
948448|NCT03491540|Surgical site infection|surgical site infection
948449|NCT03491501|Industrial work|industrial work
948450|NCT03491501|physical effort|physical effort
948451|NCT03491501|mental effort|mental effort
948452|NCT03491501|questionnaires|questionnaires
948453|NCT03491501|ergonomic evaluation|ergonomic evaluation
948454|NCT03491488|executive function|executive function
948455|NCT03491488|Early childhood education|early childhood education
948456|NCT03491488|self regulation|self regulation
948457|NCT03491475|Ajmaline test|ajmaline test
948458|NCT03491462|arimoclomol|arimoclomol
948459|NCT03491462|ALS|als
948460|NCT03491449|Brain ischemia|brain ischemia
948461|NCT03491449|Cerebral ischemia|cerebral ischemia
948462|NCT03491410|Metastatic|metastatic
948463|NCT03491410|Active Surveillance|active surveillance
948464|NCT03491397|Microspheres|microspheres
948465|NCT03491397|Artery Embolization|artery embolization
948466|NCT03491397|Knee Osteoarthritis|knee osteoarthritis
948467|NCT03491397|Chronic Pain|chronic pain
948468|NCT03491397|Embozene|embozene
948469|NCT03491384|anxiety|anxiety
948470|NCT03491384|inflammation|inflammation
948471|NCT03491384|cannabis|cannabis
948472|NCT03491384|marijuana|marijuana
948473|NCT03491384|stress|stress
948474|NCT03491371|apatinib|apatinib
948475|NCT03491371|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
948476|NCT03491371|osteosarcoma|osteosarcoma
948477|NCT03491371|Ewing sarcoma|ewing sarcoma
948478|NCT03491371|chondrosarcoma|chondrosarcoma
948479|NCT03491371|soft-tissue sarcoma|soft-tissue sarcoma
948480|NCT03491358|vibrating mesh nebulizer|vibrating mesh nebulizer
948481|NCT03491358|allergen challenge|allergen challenge
948482|NCT03491319|Anesthetics, Local|anesthetics, local
948483|NCT03491319|Head-Down Tilt|head-down tilt
948484|NCT03491319|Anesthesia, Spinal|anesthesia, spinal
948485|NCT03491319|hypotension|hypotension
948486|NCT03491306|PEEK|peek
948487|NCT03491306|Breflex|breflex
948488|NCT03491293|internet|internet
948489|NCT03491293|behavioral weight loss|behavioral weight loss
948490|NCT03491293|obesity|obesity
948586|NCT03490708|Tranilast|tranilast
948492|NCT03491280|Genetic Predisposition|genetic predisposition
948493|NCT03491280|Omics Technology|omics technology
948494|NCT03491280|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
948495|NCT03491267|alopecia|alopecia
948496|NCT03491215|Graft versus host disease (GvHD)|graft versus host disease (gvhd)
948497|NCT03491215|acute graft versus host disease (aGvHD)|acute graft versus host disease (agvhd)
948498|NCT03491215|Steroid refractory acute graft versus host disease (SR-aGvHD)|steroid refractory acute graft versus host disease (sr-agvhd)
948499|NCT03491215|Ruxolitinib|ruxolitinib
948500|NCT03491215|INC424|inc424
948501|NCT03491215|allogeneic stem cell transplantation|allogeneic stem cell transplantation
948502|NCT03491176|Head and Neck Cancer|head and neck cancer
948503|NCT03491176|Magnetic resonance imaging|magnetic resonance imaging
948504|NCT03491176|MRI|mri
948505|NCT03491176|Biomarker testing|biomarker testing
948506|NCT03491176|Blood draws|blood draws
948507|NCT03491176|Questionnaires|questionnaires
948508|NCT03491176|Surveys|surveys
948509|NCT03491163|syndecan-1|syndecan-1
948510|NCT03491163|endothelial glycocalyx|endothelial glycocalyx
948511|NCT03491163|On-pump heart surgery|on-pump heart surgery
948512|NCT03491150|Dementia|dementia
948513|NCT03491150|Neurodegenerative Diseases|neurodegenerative diseases
948514|NCT03491150|Brain Diseases|brain diseases
948515|NCT03491150|Central Nervous System Diseases|central nervous system diseases
948516|NCT03491150|Nervous System Diseases|nervous system diseases
948517|NCT03491150|Tauopathies|tauopathies
948518|NCT03491150|Neurocognitive Disorders|neurocognitive disorders
948519|NCT03491150|Mental Disorders|mental disorders
948520|NCT03491137|Wireless monitoring, postoperative complications|wireless monitoring, postoperative complications
948521|NCT03491111|Cerebrovascular disease|cerebrovascular disease
948522|NCT03491111|respiratory muscle training|respiratory muscle training
948523|NCT03491111|spirometry|spirometry
948524|NCT03491111|peak flow|peak flow
948525|NCT03491111|maximal inspiratory pressure, maximal expiratory pressure|maximal inspiratory pressure, maximal expiratory pressure
948526|NCT03491098|Otitis Media with Effusion|otitis media with effusion
948527|NCT03491072|extracorporeal shock-wave Lithotripsy,|extracorporeal shock-wave lithotripsy,
948528|NCT03491072|pain relief during extracorporeal shock-wave Lithotripsy|pain relief during extracorporeal shock-wave lithotripsy
948529|NCT03491072|fentanyl|fentanyl
948530|NCT03491072|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
948531|NCT03491033|advanced-stage ovarian cancer|advanced-stage ovarian cancer
948532|NCT03491033|neoadjuvant chemotherapy|neoadjuvant chemotherapy
948533|NCT03491033|residual disease|residual disease
948534|NCT03491033|genomic profiling|genomic profiling
948535|NCT03491033|immunohistochemistry|immunohistochemistry
948536|NCT03491020|Emission Patterns|emission patterns
948537|NCT03491020|Respiratory|respiratory
948538|NCT03491020|Aerosolization|aerosolization
948539|NCT03491020|Airborne|airborne
948540|NCT03491007|PTSD|ptsd
948541|NCT03491007|DHEA|dhea
948542|NCT03490981|primary care|primary care
948543|NCT03490981|chronic pain|chronic pain
948544|NCT03490981|musculoskeletal pain|musculoskeletal pain
948545|NCT03490981|cognitive behavioral therapy|cognitive behavioral therapy
948546|NCT03490981|integrated primary care|integrated primary care
948547|NCT03490942|glucagon|glucagon
948548|NCT03490942|hypoglycemia counter-regulation|hypoglycemia counter-regulation
948549|NCT03490916|Acetazolamide|acetazolamide
948550|NCT03490916|High-altitude illness|high-altitude illness
948551|NCT03490916|High-altitude pulmonary edema|high-altitude pulmonary edema
948552|NCT03490916|Lung comets|lung comets
948553|NCT03490916|Lung ultrasound|lung ultrasound
948554|NCT03490916|Subclinical high-altitude pulmonary edema|subclinical high-altitude pulmonary edema
948555|NCT03490903|virtual reality|virtual reality
948556|NCT03490903|anxiety|anxiety
948557|NCT03490903|vasospasm|vasospasm
948558|NCT03490903|pain|pain
948559|NCT03490903|coronary artery angiography|coronary artery angiography
948560|NCT03490903|angiogram|angiogram
948561|NCT03490903|VR|vr
948562|NCT03490890|microwave ablation|microwave ablation
948563|NCT03490890|lung cancer|lung cancer
948667|NCT03490305|Mosul|mosul
948564|NCT03490890|ground glass nodules|ground glass nodules
948565|NCT03490877|Atopic Dermatitis|atopic dermatitis
948566|NCT03490877|Pruritus|pruritus
948567|NCT03490877|Sleep Disturbance|sleep disturbance
948568|NCT03490786|GT-001|gt-001
948569|NCT03490773|Cpeptide|cpeptide
948570|NCT03490773|Immunology|immunology
948571|NCT03490760|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
948572|NCT03490747|Physical Activity|physical activity
948573|NCT03490747|Pragmatic Evaluation|pragmatic evaluation
948574|NCT03490747|Exercise Referral|exercise referral
948575|NCT03490747|Mixed-methods|mixed-methods
948576|NCT03490747|Behaviour Change|behaviour change
948577|NCT03490747|Intervention|intervention
948578|NCT03490734|nutrition|nutrition
948579|NCT03490734|obesity|obesity
948580|NCT03490734|weight gain|weight gain
948581|NCT03490734|sugar|sugar
948582|NCT03490734|sugar sweetened beverage|sugar sweetened beverage
948583|NCT03490734|dopamine|dopamine
948584|NCT03490734|neurobehavioral adaptation|neurobehavioral adaptation
948585|NCT03490708|Mucinoses|mucinoses
948587|NCT03490643|Plantar Pressure Distribution|plantar pressure distribution
948588|NCT03490643|Posture|posture
948589|NCT03490643|Posturescreen Mobile|posturescreen mobile
948590|NCT03490643|RDC/TMD|rdc/tmd
948591|NCT03490643|TMD|tmd
948592|NCT03490630|patient reported outcome|patient reported outcome
948593|NCT03490630|postoperative pain|postoperative pain
948594|NCT03490630|pain related impairment|pain related impairment
948595|NCT03490630|quality of life|quality of life
948596|NCT03490630|prospective association study|prospective association study
948597|NCT03490617|Intrauterine device|intrauterine device
948598|NCT03490617|Misoprostol|misoprostol
948599|NCT03490617|Nulliparous women|nulliparous women
948600|NCT03490617|Contraception|contraception
948601|NCT03490591|Cerebral Palsy|cerebral palsy
948602|NCT03490591|Robotic rehabilitation|robotic rehabilitation
948603|NCT03490591|Hand function|hand function
948604|NCT03490591|Activities of Daily Living|activities of daily living
948605|NCT03490578|Parkinson Disease|parkinson disease
948606|NCT03490578|Gait|gait
948607|NCT03490578|Balance|balance
948608|NCT03490578|Rehabilitation|rehabilitation
948609|NCT03490578|Robot-assisted gait training|robot-assisted gait training
948610|NCT03490565|exercise training|exercise training
948611|NCT03490565|treatment tolerability|treatment tolerability
1638526|NCT00250198|Placebo|placebo
948612|NCT03490565|treatment complications|treatment complications
948613|NCT03490539|observational|observational
948614|NCT03490539|comparative effectiveness|comparative effectiveness
948615|NCT03490539|myasthenia gravis|myasthenia gravis
948616|NCT03490500|protein S100B|protein s100b
948617|NCT03490500|negative predictive value|negative predictive value
948618|NCT03490500|headache|headache
948619|NCT03490500|intracranial hemorrhage|intracranial hemorrhage
948620|NCT03490474|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
948621|NCT03490474|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
948623|NCT03490474|hypoalgesia|hypoalgesia
948624|NCT03490448|vitamin D|vitamin d
948625|NCT03490448|obesity|obesity
948626|NCT03490448|body composition|body composition
948627|NCT03490448|glucose metabolism|glucose metabolism
948628|NCT03490448|lipid metabolism|lipid metabolism
948629|NCT03490435|Per os invasions|per os invasions
948630|NCT03490435|Giardiasis|giardiasis
948631|NCT03490435|Toxoplasmosis|toxoplasmosis
948632|NCT03490435|Taeniasis|taeniasis
948633|NCT03490435|Cryptosporidiosis|cryptosporidiosis
948634|NCT03490435|Trichinosis|trichinosis
948635|NCT03490435|Ascariasis|ascariasis
948636|NCT03490435|Echinococcosis|echinococcosis
948637|NCT03490422|pulpotomy|pulpotomy
948638|NCT03490422|permanent teeth|permanent teeth
948639|NCT03490422|deep caries management|deep caries management
948640|NCT03490422|risk factors|risk factors
948641|NCT03490422|clinical indicators for pulpotomy|clinical indicators for pulpotomy
948642|NCT03490409|Arthroplasty|arthroplasty
948643|NCT03490409|Replacement|replacement
948644|NCT03490409|Knee|knee
948645|NCT03490409|Compression|compression
948646|NCT03490409|Edema|edema
948647|NCT03490409|Pain|pain
948648|NCT03490396|Oral Mucositis|oral mucositis
948649|NCT03490396|Stomatitis|stomatitis
948650|NCT03490396|Myeloablative|myeloablative
948651|NCT03490383|ERCP|ercp
948652|NCT03490383|CBD stone|cbd stone
948653|NCT03490383|Microbial Colonization|microbial colonization
948654|NCT03490344|bony plasmacytoma|bony plasmacytoma
948655|NCT03490344|extramedullary plasmacytoma|extramedullary plasmacytoma
948656|NCT03490344|Daratumumab|daratumumab
948657|NCT03490344|lenalidomide|lenalidomide
948658|NCT03490344|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
948659|NCT03490344|18-048|18-048
948660|NCT03490331|JEB|jeb
948661|NCT03490331|Stem cells|stem cells
948662|NCT03490331|Gene Therapy|gene therapy
948663|NCT03490305|War injury|war injury
948664|NCT03490305|Penetrating abdominal trauma|penetrating abdominal trauma
948665|NCT03490305|Exploratory laparotomy|exploratory laparotomy
948666|NCT03490305|Improvised explosive device|improvised explosive device
948668|NCT03490266|Ventral Hernia|ventral hernia
948669|NCT03490266|Hernia Repair|hernia repair
948670|NCT03490227|neonates|neonates
948671|NCT03490227|brown adipose tissue|brown adipose tissue
948672|NCT03490227|body composition|body composition
948673|NCT03490214|Optoacoustics|optoacoustics
948674|NCT03490214|MSOT|msot
948675|NCT03490214|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
948676|NCT03490175|genetic association study|genetic association study
948677|NCT03490175|postoperative nausea and vomiting|postoperative nausea and vomiting
948678|NCT03490175|patient reported outcome|patient reported outcome
948679|NCT03490175|antiemetics|antiemetics
948680|NCT03490162|Anti-Malarial|anti-malarial
948681|NCT03490162|DM1157|dm1157
948682|NCT03490162|Pharmacokinetics|pharmacokinetics
948683|NCT03490162|Safety|safety
948684|NCT03490149|ECT|ect
948685|NCT03490149|Electroconvulsive Therapy|electroconvulsive therapy
948686|NCT03490149|Depression|depression
948687|NCT03490149|Memory|memory
948688|NCT03490149|Memory Impairment|memory impairment
948689|NCT03490123|Azithromycin|azithromycin
948690|NCT03490123|Endemic treponematoses|endemic treponematoses
948691|NCT03490123|Mass drug administration|mass drug administration
948692|NCT03490123|Eradication|eradication
948693|NCT03490123|Papua New Guinea|papua new guinea
948694|NCT03490110|cognitive rehabilitation|cognitive rehabilitation
948695|NCT03490110|EEG|eeg
948696|NCT03490110|TBI|tbi
948697|NCT03490110|brain networks|brain networks
948698|NCT03490110|attention|attention
948699|NCT03490110|memory|memory
948700|NCT03490110|executive function|executive function
948701|NCT03490084|multiple myeloma|multiple myeloma
948702|NCT03490084|elderly patients|elderly patients
948703|NCT03490084|health outcomes|health outcomes
948704|NCT03490084|hospital-at-home|hospital-at-home
948705|NCT03490084|day hospitalization|day hospitalization
948706|NCT03490084|quality of life|quality of life
948707|NCT03490084|medico-economic evaluation|medico-economic evaluation
948708|NCT03490084|qualitative study|qualitative study
948709|NCT03490071|Longstanding hip and groin pain|longstanding hip and groin pain
948710|NCT03490071|Patient reported outcome|patient reported outcome
948711|NCT03490058|pre-exposure prophylaxis|pre-exposure prophylaxis
957763|NCT03433222|RCT|rct
948712|NCT03490058|young women|young women
948713|NCT03490058|delivery of health care|delivery of health care
948714|NCT03490058|HIV infections/prevention|hiv infections/prevention
948715|NCT03490045|Diaper Need|diaper need
948716|NCT03490045|Well-Child Care|well-child care
948717|NCT03490045|Infant Immunizations|infant immunizations
948718|NCT03490045|Incentives|incentives
948719|NCT03490045|Basic Needs|basic needs
948720|NCT03490006|regional anesthesia|regional anesthesia
948721|NCT03490006|postoperative pain|postoperative pain
948722|NCT03490006|mastectomy|mastectomy
948723|NCT03490006|erector spinae plane block|erector spinae plane block
948724|NCT03490006|paravertebral block|paravertebral block
948725|NCT03489993|FGF23|fgf23
948726|NCT03489993|Angiotensin-(1-7)|angiotensin-(1-7)
948727|NCT03489993|Hypophosphatemia|hypophosphatemia
948728|NCT03489980|STAI Questionnaire|stai questionnaire
948729|NCT03489980|ECTM2-Qa|ectm2-qa
948730|NCT03489967|Hypoglycemia, carbohydrates|hypoglycemia, carbohydrates
948731|NCT03489954|Non-specific Chronic Neck Pain|non-specific chronic neck pain
948732|NCT03489954|Balance Master|balance master
948733|NCT03489954|Joint Position Error|joint position error
948734|NCT03489954|Neck pain|neck pain
948735|NCT03489928|Labour|labour
948736|NCT03489928|Induction|induction
948737|NCT03489928|Misoprostol|misoprostol
948738|NCT03489928|Dinoprostone|dinoprostone
948739|NCT03489928|Oxytocin|oxytocin
948740|NCT03489889|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
948741|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid
948742|NCT03489876|Metatarsophalangeal Joint|metatarsophalangeal joint
948743|NCT03489876|Arthritis|arthritis
948744|NCT03489876|Synthetic Cartilage Implant|synthetic cartilage implant
948745|NCT03489876|Cartiva|cartiva
948746|NCT03489876|Osteochondral Autograft Transfer|osteochondral autograft transfer
948747|NCT03489863|clopidogrel|clopidogrel
948748|NCT03489863|prasugrel|prasugrel
948749|NCT03489863|ticagrelor|ticagrelor
948750|NCT03489811|Essential Oils|essential oils
948751|NCT03489811|Aromatherapy|aromatherapy
948752|NCT03489811|Anxiety|anxiety
948753|NCT03489811|Autism Spectrum Disorder|autism spectrum disorder
948754|NCT03489798|Induction of labor|induction of labor
948755|NCT03489798|Misoprostol|misoprostol
948756|NCT03489798|Failed induction|failed induction
948757|NCT03489785|Predicted factor|predicted factor
948758|NCT03489785|Motor Evoked Potentials|motor evoked potentials
948759|NCT03489759|Acute Kidney Injury|acute kidney injury
948760|NCT03489759|Oxidative Stress|oxidative stress
948761|NCT03489759|Renal Replacement Therapy|renal replacement therapy
948762|NCT03489759|Vitamine E-coated Polysulfone Membrane|vitamine e-coated polysulfone membrane
948763|NCT03489746|Inhaled corticosteroids|inhaled corticosteroids
948764|NCT03489746|Quality improvement|quality improvement
948765|NCT03489746|Cluster randomized Trial|cluster randomized trial
948766|NCT03489707|anal cancer|anal cancer
948767|NCT03489707|human papillomavirus|human papillomavirus
948768|NCT03489694|skin test endpoint|skin test endpoint
948769|NCT03489681|acupuncture, sciatica, default mode network|acupuncture, sciatica, default mode network
948770|NCT03489668|PCOS|pcos
948771|NCT03489668|Androgen|androgen
948772|NCT03489668|3D ultrasound|3d ultrasound
948773|NCT03489655|Healthy Homes|healthy homes
948774|NCT03489655|Asthma|asthma
948775|NCT03489655|Community Health Worker|community health worker
948776|NCT03489629|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
948777|NCT03489629|Early infection|early infection
948778|NCT03489629|Treatment|treatment
948779|NCT03489629|Forced Expiratory Volume in 1 Second (FEV1)|forced expiratory volume in 1 second (fev1)
948780|NCT03489603|Troponin|troponin
948781|NCT03489590|Lung|lung
948782|NCT03489590|imaging|imaging
948783|NCT03489590|hyperpolarized|hyperpolarized
948784|NCT03489590|perfluorinated|perfluorinated
948785|NCT03489590|MRI|mri
948786|NCT03489577|Inflammation|inflammation
948787|NCT03489577|Multiple Organ Failure|multiple organ failure
948789|NCT03489577|Wounds and Injuries|wounds and injuries
948790|NCT03489577|Pathologic Processes|pathologic processes
948791|NCT03489577|Shock|shock
948792|NCT03489577|Infection|infection
948793|NCT03489577|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
948794|NCT03489577|Neutrophils|neutrophils
948795|NCT03489577|PMN|pmn
948796|NCT03489577|Granulocytes|granulocytes
948797|NCT03489577|Innate immunity|innate immunity
948798|NCT03489577|ICU|icu
948799|NCT03489577|Intensive Care|intensive care
948800|NCT03489577|polytrauma|polytrauma
948801|NCT03489577|host-pathogen|host-pathogen
948802|NCT03489564|Pregnancy|pregnancy
948803|NCT03489564|Mitochondrial metabolism|mitochondrial metabolism
948804|NCT03489564|Placenta|placenta
948805|NCT03489538|bariatric surgery|bariatric surgery
948806|NCT03489538|gastric bypass|gastric bypass
948807|NCT03489538|homocysteine|homocysteine
948808|NCT03489538|folate|folate
948809|NCT03489538|vitamin b12|vitamin b12
948810|NCT03489525|multiple myeloma|multiple myeloma
948811|NCT03489525|relapsed/refractory|relapsed/refractory
948812|NCT03489525|open-label|open-label
948813|NCT03489499|postoperative pain|postoperative pain
948814|NCT03489499|analgesics|analgesics
948815|NCT03489499|patient reported outcome|patient reported outcome
948816|NCT03489499|pain related impairment|pain related impairment
948817|NCT03489499|genetic association study|genetic association study
948818|NCT03489486|Presepsin|presepsin
948819|NCT03489486|sCD14-ST|scd14-st
948820|NCT03489486|biomarker|biomarker
948821|NCT03489486|perioperative risk|perioperative risk
948822|NCT03489473|Hormonal therapy|hormonal therapy
948823|NCT03489473|FES PET scan|fes pet scan
948824|NCT03489473|Estrogen receptor|estrogen receptor
948825|NCT03489460|sleep health|sleep health
948826|NCT03489434|adolescents|adolescents
948827|NCT03489434|primary care|primary care
948828|NCT03489434|sexual assault|sexual assault
948829|NCT03489434|substance use|substance use
948830|NCT03489434|sexual risk behavior|sexual risk behavior
948831|NCT03489408|Proximal humerus fracture fixation|proximal humerus fracture fixation
948832|NCT03489382|self-harm|self-harm
948833|NCT03489382|problem-solving therapy|problem-solving therapy
948834|NCT03489382|emergency department|emergency department
948835|NCT03489382|e-therapy|e-therapy
948836|NCT03489382|suicide prevention|suicide prevention
948837|NCT03489369|Locally advanced/unresectable|locally advanced/unresectable
948838|NCT03489369|Metastatic solid tumor|metastatic solid tumor
948839|NCT03489369|Lymphoma|lymphoma
948840|NCT03489369|Anti-LAG-3|anti-lag-3
948841|NCT03489369|LAG-3|lag-3
948842|NCT03489369|LAG3|lag3
948843|NCT03489356|Addressing Behavior Change (ABC)|addressing behavior change (abc)
948844|NCT03489356|Addressing Behavior Change (ABC) Intervention|addressing behavior change (abc) intervention
948845|NCT03489356|Addressing Behavior Change (ABC) Intervention Method|addressing behavior change (abc) intervention method
948846|NCT03489343|Locally advanced/unresectable|locally advanced/unresectable
948847|NCT03489343|Metastatic solid tumor|metastatic solid tumor
948848|NCT03489343|Lymphoma|lymphoma
948849|NCT03489343|Anti-TIM-3|anti-tim-3
948850|NCT03489343|TIM-3|tim-3
948851|NCT03489343|TIM3|tim3
948852|NCT03489330|Anti-Bacterial Agents/therapeutic use|anti-bacterial agents/therapeutic use
948853|NCT03489330|Drug Utilization/statistics & numerical data|drug utilization/statistics & numerical data
948854|NCT03489330|Hospitals/statistics & numerical data|hospitals/statistics & numerical data
948855|NCT03489330|Data Analysis, Statistical|data analysis, statistical
948856|NCT03489330|Interpretation, Statistical Data|interpretation, statistical data
948857|NCT03489330|Antibiotic Stewardship|antibiotic stewardship
948858|NCT03489330|Electronic Medical Record|electronic medical record
948859|NCT03489317|gut microbiome|gut microbiome
948861|NCT03489304|Insomnia|insomnia
948862|NCT03489304|Zaleplon|zaleplon
948863|NCT03489291|Hemophilia,|hemophilia,
948864|NCT03489291|Gene Therapy|gene therapy
948865|NCT03489291|Bleeding|bleeding
948866|NCT03489291|Factor IX|factor ix
948867|NCT03489291|FIX|fix
948868|NCT03489291|viral vector|viral vector
948869|NCT03489291|Padua|padua
948870|NCT03489226|capsaicin|capsaicin
948871|NCT03489226|energy expenditure|energy expenditure
948872|NCT03489226|satiety|satiety
948873|NCT03489226|food intake|food intake
948874|NCT03489174|Opioid Substitution Therapy|opioid substitution therapy
948875|NCT03489174|Pregnancy Tests|pregnancy tests
948876|NCT03489148|Stress|stress
948877|NCT03489148|Relaxation|relaxation
948878|NCT03489148|Health promotion|health promotion
948879|NCT03489122|Depressive Disorder, Major|depressive disorder, major
948880|NCT03489122|yoga|yoga
948881|NCT03489122|breathing exercise|breathing exercise
948882|NCT03489122|parasympathetic|parasympathetic
948883|NCT03489122|anxiety|anxiety
948884|NCT03489122|Post Traumatic Stress Disorder|post traumatic stress disorder
948885|NCT03489122|polyvagal|polyvagal
948886|NCT03489109|Fasting|fasting
948887|NCT03489096|Cryoballoon Ablation|cryoballoon ablation
948888|NCT03489096|Persistent atrial fibrillation|persistent atrial fibrillation
948889|NCT03489096|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
948891|NCT03489083|Heat Shock Response|heat shock response
948892|NCT03489083|Aging|aging
948893|NCT03489083|Exercise|exercise
948894|NCT03489070|Liver resection|liver resection
948895|NCT03489070|Liver Hemorrhage|liver hemorrhage
948896|NCT03489070|Traumastem|traumastem
948897|NCT03489070|Surgicel|surgicel
948898|NCT03489057|symptom|symptom
948899|NCT03489057|family research|family research
948900|NCT03489057|self-management|self-management
948901|NCT03489057|caregiving|caregiving
948902|NCT03489057|social support|social support
948903|NCT03489057|mHealth|mhealth
948904|NCT03489057|healthy behavior|healthy behavior
948905|NCT03489057|self-efficacy|self-efficacy
948906|NCT03489057|quality of life|quality of life
948907|NCT03489057|care transition|care transition
948908|NCT03489044|Alzheimer|alzheimer
948909|NCT03489044|Seizure|seizure
948910|NCT03489044|Epilepsy|epilepsy
948911|NCT03489044|Anti-epileptic drug|anti-epileptic drug
948912|NCT03489044|Levetiracetam|levetiracetam
948913|NCT03489005|BIA 5-1058|bia 5-1058
948914|NCT03489005|Pulmonary arterial hypertension|pulmonary arterial hypertension
948915|NCT03489005|Heart failure|heart failure
948916|NCT03489005|Cardiovascular Disease|cardiovascular disease
948917|NCT03488992|dietary supplement, cardiovascular health, oxidative stress|dietary supplement, cardiovascular health, oxidative stress
948918|NCT03488979|Heart Failure|heart failure
948919|NCT03488979|Medication Adherence|medication adherence
948920|NCT03488966|Mindfulness|mindfulness
948921|NCT03488966|Bariatric Surgery|bariatric surgery
948923|NCT03488966|Group psychotherapy|group psychotherapy
948924|NCT03488953|Liver transplantation|liver transplantation
948925|NCT03488953|Two-stage hepatectomy|two-stage hepatectomy
948926|NCT03488953|Living donor liver transplantation|living donor liver transplantation
948927|NCT03488940|Sepsis|sepsis
948928|NCT03488940|intestinal dysfunction|intestinal dysfunction
948929|NCT03488940|enteral feeding|enteral feeding
948930|NCT03488927|Sexual Violence|sexual violence
948931|NCT03488927|Interpersonal Violence|interpersonal violence
948932|NCT03488927|Prevention|prevention
948933|NCT03488927|Mixed-Methods|mixed-methods
948934|NCT03488927|Randomized Controlled Trial|randomized controlled trial
948935|NCT03488927|Outcome Evaluation|outcome evaluation
948936|NCT03488927|College Students|college students
948937|NCT03488927|Post-traumatic Stress Disorder|post-traumatic stress disorder
948938|NCT03488927|Alcohol|alcohol
948939|NCT03488927|Sexual Assault|sexual assault
948940|NCT03488927|Disclosure|disclosure
948941|NCT03488927|Social Reactions|social reactions
948942|NCT03488927|Coping|coping
948943|NCT03488927|Depression|depression
948944|NCT03488927|Intervention|intervention
948945|NCT03488823|Endothelial Function|endothelial function
948946|NCT03488823|Flavonols|flavonols
948947|NCT03488823|Intima Injury|intima injury
948948|NCT03488810|Apalutamide Prostate Cancer Radiotherapy|apalutamide prostate cancer radiotherapy
948949|NCT03488771|kidney transplantation|kidney transplantation
948950|NCT03488771|rejection|rejection
948951|NCT03488771|infection|infection
948952|NCT03488771|immunosuppression|immunosuppression
948953|NCT03488667|resectable adenocarcinoma of Gastroesophageal Junction|resectable adenocarcinoma of gastroesophageal junction
948954|NCT03488667|resectable adenocarcinoma of Stomach|resectable adenocarcinoma of stomach
948955|NCT03488641|Biomarker|biomarker
948956|NCT03488641|Signal Transduction Pathway Deregulation|signal transduction pathway deregulation
948957|NCT03488641|Outcome|outcome
948958|NCT03488641|Drug sensitivity testing|drug sensitivity testing
948959|NCT03488641|Targeted Therapy|targeted therapy
948960|NCT03488641|Genomic landscape|genomic landscape
948961|NCT03488628|respiratory failure|respiratory failure
948962|NCT03488628|oxygen therapy|oxygen therapy
948963|NCT03488628|Noninvasive ventilation|noninvasive ventilation
948964|NCT03488563|Headache|headache
948965|NCT03488498|Balneotherapy|balneotherapy
948966|NCT03488498|Chronic low back pain|chronic low back pain
948967|NCT03488498|Controlled|controlled
948968|NCT03488498|Randomized trial|randomized trial
948969|NCT03488498|weight bath traction|weight bath traction
948971|NCT03488485|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
948972|NCT03488485|Direct antivirals, DAAs|direct antivirals, daas
948973|NCT03488485|Chronic hepatitis C|chronic hepatitis c
948974|NCT03488459|anxiety|anxiety
948975|NCT03488459|preoperative education|preoperative education
948976|NCT03488459|psychologist|psychologist
948977|NCT03488459|thoracotomy|thoracotomy
948978|NCT03488459|Ravitch procedure|ravitch procedure
948979|NCT03488459|postoperative pain|postoperative pain
948980|NCT03488446|Gastric Cancer|gastric cancer
948981|NCT03488446|Radiomics|radiomics
948982|NCT03488446|Computed Tomograpy|computed tomograpy
948983|NCT03488446|Lymph Node Metastasis|lymph node metastasis
948984|NCT03488446|Prediction|prediction
948985|NCT03488433|Postoperative shoulder immobilization|postoperative shoulder immobilization
948986|NCT03488433|Reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
948987|NCT03488433|Neutral rotation shoulder brace|neutral rotation shoulder brace
948988|NCT03488433|Antirotation sling|antirotation sling
948989|NCT03488407|Primary angioplasty|primary angioplasty
948990|NCT03488407|Radial access|radial access
948991|NCT03488407|STEMI|stemi
948992|NCT03488394|Mucopolysaccharidosis IH|mucopolysaccharidosis ih
948993|NCT03488394|Gene Therapy|gene therapy
948994|NCT03488394|Transplantation, Autologous|transplantation, autologous
948995|NCT03488394|Lentiviral vector|lentiviral vector
948996|NCT03488355|Catheter|catheter
948997|NCT03488342|Rives technique|rives technique
948998|NCT03488342|Lichtenstein repair|lichtenstein repair
948999|NCT03488329|Hospital readmissions|hospital readmissions
949000|NCT03488329|Seniors|seniors
949001|NCT03488290|Parents|parents
949002|NCT03488290|Young Children|young children
949003|NCT03488290|Trauma Focused Cognitive Behavior Therapy|trauma focused cognitive behavior therapy
949004|NCT03488290|Learning Through Play|learning through play
949005|NCT03488225|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
949006|NCT03488225|ALL|all
949007|NCT03488225|B-Cell Lineage|b-cell lineage
949008|NCT03488225|Cyclophosphamide|cyclophosphamide
949009|NCT03488225|Cytoxan|cytoxan
949010|NCT03488225|Neosar|neosar
949011|NCT03488225|Mesna|mesna
949012|NCT03488225|Mesnex|mesnex
949013|NCT03488225|Doxorubicin hydrochloride|doxorubicin hydrochloride
949014|NCT03488225|Adriamycin PFS|adriamycin pfs
949015|NCT03488225|Adriamycin RDF|adriamycin rdf
949016|NCT03488225|Rubex|rubex
949017|NCT03488225|Adriamycin|adriamycin
949018|NCT03488225|Doxorubicin|doxorubicin
949019|NCT03488225|Vincristine|vincristine
949020|NCT03488225|Ofatumumab|ofatumumab
949021|NCT03488225|Arzerra|arzerra
949022|NCT03488225|Rituximab|rituximab
949023|NCT03488225|Rituxan|rituxan
949024|NCT03488225|Pegfilgrastim|pegfilgrastim
949025|NCT03488225|Neulasta|neulasta
949026|NCT03488225|PEG-G-CSF|peg-g-csf
949027|NCT03488225|Filgrastim|filgrastim
949028|NCT03488225|G-CSF|g-csf
949029|NCT03488225|Neupogen|neupogen
949030|NCT03488225|Methotrexate|methotrexate
949031|NCT03488225|Cytarabine|cytarabine
949032|NCT03488225|Ara-C|ara-c
949033|NCT03488225|Cytosar|cytosar
949034|NCT03488225|DepoCyt|depocyt
949035|NCT03488225|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
949036|NCT03488225|Citrovorum|citrovorum
949037|NCT03488225|Leucovorin|leucovorin
949038|NCT03488225|Wellcovorin|wellcovorin
949039|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin
949040|NCT03488225|CMC-544|cmc-544
949041|NCT03488225|6-MP 6|6-mp 6
949042|NCT03488225|Mercaptopurine|mercaptopurine
949043|NCT03488225|Purinethol|purinethol
949044|NCT03488225|MTX|mtx
949045|NCT03488225|Prednisone|prednisone
949046|NCT03488160|lymphoma CAR-T|lymphoma car-t
949047|NCT03488147|Esomeprazole Magnesium|esomeprazole magnesium
949048|NCT03488147|Postoperative dysphagia|postoperative dysphagia
949049|NCT03488147|Gastroesophageal reflux disease|gastroesophageal reflux disease
949050|NCT03488147|Anterior cervical surgery|anterior cervical surgery
949051|NCT03488147|Proton pump inhibitor|proton pump inhibitor
949052|NCT03488134|Exosome|exosome
949053|NCT03488134|Anaplastic thyroid cancer|anaplastic thyroid cancer
949054|NCT03488134|Urine|urine
949055|NCT03488134|Biological marker|biological marker
949056|NCT03488134|Thyroglobuin|thyroglobuin
949057|NCT03488134|Galectin-3|galectin-3
949058|NCT03488095|Tobacco, smokeless, chewing, betel quid|tobacco, smokeless, chewing, betel quid
949059|NCT03488082|saccadic adaptation|saccadic adaptation
949060|NCT03488082|visual-spatial perception|visual-spatial perception
949061|NCT03488082|fMRI|fmri
949062|NCT03488069|critical care|critical care
949063|NCT03488069|sedation|sedation
949064|NCT03488069|practice|practice
949065|NCT03488069|survey|survey
949066|NCT03488056|Dental Caries, ICCMS, Risk Assessment|dental caries, iccms, risk assessment
949067|NCT03488043|Lung lesions|lung lesions
949068|NCT03488043|Pneumothorax|pneumothorax
949069|NCT03488043|CT-guided transthoracic biopsy|ct-guided transthoracic biopsy
949070|NCT03488043|Risk score|risk score
949071|NCT03488030|Drug therapy|drug therapy
949072|NCT03487991|autonomic balance|autonomic balance
949073|NCT03487991|sleep|sleep
949170|NCT03487263|anti-CD14|anti-cd14
949074|NCT03487991|endothelial function|endothelial function
949075|NCT03487991|behavior|behavior
949076|NCT03487991|stress|stress
949077|NCT03487965|dicarbonyl compounds|dicarbonyl compounds
949078|NCT03487965|skin elasticity|skin elasticity
949079|NCT03487965|glycation|glycation
949080|NCT03487952|Lung nodule|lung nodule
949081|NCT03487952|Computed tomography|computed tomography
949082|NCT03487952|Artificial intelligence|artificial intelligence
949083|NCT03487887|continuous glucose monitoring|continuous glucose monitoring
949084|NCT03487887|glycemic variability|glycemic variability
949085|NCT03487887|hypoglycemia|hypoglycemia
949086|NCT03487874|8th cervical nerve root block|8th cervical nerve root block
949087|NCT03487861|transglutaminase type 2|transglutaminase type 2
949088|NCT03487861|kidney transplantation|kidney transplantation
949089|NCT03487861|chronic allograft nephropathy|chronic allograft nephropathy
949090|NCT03487861|biomarker|biomarker
949091|NCT03487835|Athletic tape. Accidental Falls. Aging.|athletic tape. accidental falls. aging.
949092|NCT03487809|Asthma|asthma
949093|NCT03487809|Inhaled corticosteroid|inhaled corticosteroid
949094|NCT03487809|pharmacogenomics|pharmacogenomics
949095|NCT03487809|Therapeutic effect|therapeutic effect
949096|NCT03487783|Tourette|tourette
949097|NCT03487783|Aripiprazole Oral Solution|aripiprazole oral solution
949098|NCT03487770|Autistic|autistic
949099|NCT03487770|Aripiprazole Oral Solution|aripiprazole oral solution
949100|NCT03487744|Tube Feeding|tube feeding
949101|NCT03487744|Diarrhea|diarrhea
949102|NCT03487744|Enteral Nutrition|enteral nutrition
949103|NCT03487744|Critically Ill|critically ill
949104|NCT03487744|Surgical|surgical
949105|NCT03487744|Cardiovascular|cardiovascular
949106|NCT03487731|stem cells|stem cells
949107|NCT03487731|back pain|back pain
949108|NCT03487718|Platelet-Rich Fibrin|platelet-rich fibrin
949109|NCT03487718|high-density polytetrafluoroethylene membrane|high-density polytetrafluoroethylene membrane
949110|NCT03487692|diabetes|diabetes
949111|NCT03487692|group visit|group visit
949112|NCT03487692|shared medical appointment|shared medical appointment
949113|NCT03487692|text messaging|text messaging
949114|NCT03487679|Microbiome|microbiome
949115|NCT03487679|High Density Lipoprotein|high density lipoprotein
949116|NCT03487679|Inflammation|inflammation
949117|NCT03487666|Triple Negative Breast Cancer|triple negative breast cancer
949118|NCT03487666|Nivolumab|nivolumab
949119|NCT03487666|Capecitabine|capecitabine
949120|NCT03487640|constipation, surgery|constipation, surgery
949121|NCT03487627|adolescent|adolescent
949122|NCT03487627|parental support|parental support
949123|NCT03487627|parental coping|parental coping
949124|NCT03487614|pediatric obesity|pediatric obesity
949125|NCT03487614|preschool children|preschool children
949126|NCT03487614|non-responsive feeding|non-responsive feeding
949127|NCT03487614|body mass index|body mass index
949128|NCT03487614|parenting|parenting
949129|NCT03487601|docetaxel|docetaxel
949130|NCT03487601|Stage I - IV|stage i - iv
949131|NCT03487601|chemotherapy|chemotherapy
949132|NCT03487575|Adolescent|adolescent
949133|NCT03487575|Parental Support|parental support
949134|NCT03487575|Parental Coping|parental coping
949135|NCT03487523|Behavioural Economics|behavioural economics
949136|NCT03487510|treatment standards|treatment standards
949137|NCT03487510|diagnostical approaches|diagnostical approaches
949138|NCT03487510|descriptive|descriptive
949139|NCT03487497|gait analysis|gait analysis
949140|NCT03487497|electromyography|electromyography
949141|NCT03487497|strength test|strength test
949142|NCT03487497|walking|walking
949143|NCT03487419|left atrial echocardiography|left atrial echocardiography
949144|NCT03487419|new onset atrial fibrillation|new onset atrial fibrillation
949145|NCT03487419|coronary artery bypass grafting|coronary artery bypass grafting
949146|NCT03487419|speckle tracking echocardiography|speckle tracking echocardiography
949147|NCT03487393|facial nerve|facial nerve
949148|NCT03487393|magnetic stimulation|magnetic stimulation
949149|NCT03487393|cerebral blood flow|cerebral blood flow
949150|NCT03487367|spinocerebellar ataxia|spinocerebellar ataxia
949151|NCT03487367|ataxia|ataxia
949152|NCT03487367|ataxias|ataxias
949153|NCT03487367|SCA1|sca1
949154|NCT03487367|SCA3|sca3
949155|NCT03487367|spinocerebellar ataxia type 1|spinocerebellar ataxia type 1
949156|NCT03487367|spinocerebellar ataxia type 3|spinocerebellar ataxia type 3
949157|NCT03487367|READISCA|readisca
949158|NCT03487328|treatment|treatment
949159|NCT03487276|hidradenitis suppurativa|hidradenitis suppurativa
949160|NCT03487276|monoclonal antibody|monoclonal antibody
949161|NCT03487276|complement factor C5a|complement factor c5a
949162|NCT03487276|IFX-1|ifx-1
949163|NCT03487276|hidradenitis Suppurativa Clinical Response|hidradenitis suppurativa clinical response
949164|NCT03487276|Inflammation|inflammation
949165|NCT03487276|skin diseases|skin diseases
949166|NCT03487263|motor neurone disease|motor neurone disease
949167|NCT03487263|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
949168|NCT03487263|IC14 [anti-CD14 (cluster of differentiation 14) monoclonal antibody]|ic14 [anti-cd14 (cluster of differentiation 14) monoclonal antibody]
949169|NCT03487263|monoclonal antibody|monoclonal antibody
949172|NCT03487237|Pulmonary embolism|pulmonary embolism
949173|NCT03487237|emergency department|emergency department
949174|NCT03487237|clinical decision rule|clinical decision rule
949175|NCT03487224|Hoarding Disorder|hoarding disorder
949176|NCT03487211|Fibromyalgia treatment|fibromyalgia treatment
949177|NCT03487211|Duloxetine|duloxetine
949178|NCT03487211|Escitalopram|escitalopram
949179|NCT03487198|Major Depressive Disorder|major depressive disorder
949180|NCT03487198|Brexpiprazole|brexpiprazole
949181|NCT03487185|CPAP|cpap
949182|NCT03487185|Apnea|apnea
949183|NCT03487185|pregnancy|pregnancy
949184|NCT03487107|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
949185|NCT03487029|diabetes|diabetes
949186|NCT03487029|high intensity interval training|high intensity interval training
949187|NCT03487029|cardiorespiratory fitness|cardiorespiratory fitness
949188|NCT03487016|Pancreatic Cancer|pancreatic cancer
949189|NCT03487016|First line|first line
949191|NCT03487003|laryngeal mask airway|laryngeal mask airway
949192|NCT03487003|children, preschool|children, preschool
949193|NCT03487003|muscle relaxant|muscle relaxant
949194|NCT03486990|safety|safety
949195|NCT03486990|tolerability|tolerability
949196|NCT03486990|pharmacokinetics|pharmacokinetics
949197|NCT03486990|celiac|celiac
949198|NCT03486990|gliadin|gliadin
949199|NCT03486990|gluten|gluten
949200|NCT03486951|outpatient surgery|outpatient surgery
949201|NCT03486951|ambulatory surgery|ambulatory surgery
949202|NCT03486951|length of hospital stay|length of hospital stay
949203|NCT03486925|oxytocin, eye-tracking, attention inhibition|oxytocin, eye-tracking, attention inhibition
949204|NCT03486873|PD1|pd1
949205|NCT03486873|PD-1|pd-1
949206|NCT03486873|PDL1|pdl1
949207|NCT03486873|PD-L1|pd-l1
949208|NCT03486821|Radiation Therapy|radiation therapy
949209|NCT03486821|ultra-short Radiation|ultra-short radiation
949210|NCT03486821|SBRT|sbrt
949211|NCT03486821|prostate|prostate
949212|NCT03486821|quality of life|quality of life
949213|NCT03486821|financial toxicity|financial toxicity
949214|NCT03486808|transcranial direct current stimulation|transcranial direct current stimulation
949215|NCT03486808|motor function|motor function
949216|NCT03486795|transcranial direct current stimulation|transcranial direct current stimulation
949217|NCT03486795|motor function|motor function
949218|NCT03486782|transcranial direct current stimulation|transcranial direct current stimulation
949219|NCT03486782|dual stimulation|dual stimulation
949220|NCT03486769|transcranial direct current stimulation|transcranial direct current stimulation
949221|NCT03486769|dual stimulation|dual stimulation
949222|NCT03486756|Asthma|asthma
949223|NCT03486756|Anxiety|anxiety
949224|NCT03486756|Stress|stress
949225|NCT03486743|LARC contraception cultural acceptance|larc contraception cultural acceptance
949226|NCT03486678|BTC|btc
949227|NCT03486678|PD-1 antibody|pd-1 antibody
949228|NCT03486639|Urodynamics|urodynamics
949229|NCT03486639|Bladder sensation|bladder sensation
949230|NCT03486639|confounding factors|confounding factors
949231|NCT03486587|afatinib|afatinib
949232|NCT03486587|diarrhea|diarrhea
949233|NCT03486587|Bacillus Cereus|bacillus cereus
949234|NCT03486587|NSCLC|nsclc
949235|NCT03486561|Ranolazine|ranolazine
949236|NCT03486561|Pakistan|pakistan
949237|NCT03486561|Ischemic Heart Disease|ischemic heart disease
949238|NCT03486548|popliteal sciatic nerve block|popliteal sciatic nerve block
949239|NCT03486548|total knee artgroplasty|total knee artgroplasty
949240|NCT03486548|adductor canal block|adductor canal block
949241|NCT03486548|dexamethasone|dexamethasone
949242|NCT03486535|Diabetes mellitus|diabetes mellitus
949243|NCT03486535|Infraclavicular brachial plexus block|infraclavicular brachial plexus block
949244|NCT03486535|Block duration|block duration
949245|NCT03486535|Time-to-first pain|time-to-first pain
949246|NCT03486535|Postoperative analgesia|postoperative analgesia
949247|NCT03486522|termination of pregnancy|termination of pregnancy
949248|NCT03486509|afatinib|afatinib
949249|NCT03486496|Lung Adenocarcinoma|lung adenocarcinoma
949250|NCT03486496|EGFR mutation|egfr mutation
949251|NCT03486496|Gefitinib|gefitinib
949252|NCT03486496|Berberine|berberine
949253|NCT03486457|psoriatic arthritis|psoriatic arthritis
949254|NCT03486457|tofacitinib|tofacitinib
949255|NCT03486431|Stereotactic Ablative Body Radiotherapy (SABR)|stereotactic ablative body radiotherapy (sabr)
949256|NCT03486366|epilepsy, TSC, biomarkers, mTOR pathway|epilepsy, tsc, biomarkers, mtor pathway
949257|NCT03486353|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
949258|NCT03486314|Drug therapy|drug therapy
949260|NCT03486301|Immuno-oncology|immuno-oncology
949261|NCT03486288|delirium|delirium
949262|NCT03486288|postoperative cognitive dysfunction|postoperative cognitive dysfunction
949263|NCT03486288|spine surgery|spine surgery
949264|NCT03486288|elderly|elderly
949265|NCT03486288|neuroinflammation|neuroinflammation
949266|NCT03486288|magnetic resonance imaging|magnetic resonance imaging
949267|NCT03486288|resting state fmri|resting state fmri
949268|NCT03486288|cerebral vasculature|cerebral vasculature
949269|NCT03486288|quality of life|quality of life
949270|NCT03486275|GENERAL PRACTICE|general practice
949271|NCT03486275|SERIOUS GAME|serious game
949272|NCT03486275|EVIDENCE BASED MEDICINE|evidence based medicine
949273|NCT03486275|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
949274|NCT03486275|PEDAGOGY|pedagogy
949275|NCT03486262|Lung cancer; Idiopathic pulmonary fibrosis|lung cancer; idiopathic pulmonary fibrosis
949276|NCT03486249|diaphragm dysfunction|diaphragm dysfunction
949277|NCT03486249|ventilator weaning|ventilator weaning
949278|NCT03486249|pulmonary edema|pulmonary edema
949279|NCT03486171|difficult intubation|difficult intubation
949280|NCT03486171|prehospital emergency|prehospital emergency
949281|NCT03486171|risk factors|risk factors
949282|NCT03486158|Leukocyte L1 Antigen Complex|leukocyte l1 antigen complex
949283|NCT03486158|Feces|feces
949284|NCT03486158|Cell Phone|cell phone
949285|NCT03486158|Biomarkers|biomarkers
949286|NCT03486158|Recurrence|recurrence
949287|NCT03486158|Prognosis|prognosis
949288|NCT03486158|Clinical Chemistry Tests|clinical chemistry tests
949289|NCT03486145|beetroot juice|beetroot juice
949293|NCT03486093|Central line-associated bloodstream infections|central line-associated bloodstream infections
949295|NCT03486093|Respiratory semi-Intensive Care Unit|respiratory semi-intensive care unit
949301|NCT03486054|Anemia|anemia
949302|NCT03486054|Transfusion|transfusion
949303|NCT03486054|Pathogen inactivation|pathogen inactivation
949304|NCT03486054|low-resource|low-resource
949305|NCT03486054|Sub-saharan Africa|sub-saharan africa
949306|NCT03486054|Uganda|uganda
949307|NCT03486054|Transfusion-transmitted infection|transfusion-transmitted infection
949308|NCT03486054|dose escalation|dose escalation
949309|NCT03486054|Whole blood|whole blood
949310|NCT03486028|Patient-Centered Outcomes Research Institute (PCORI)|patient-centered outcomes research institute (pcori)
949311|NCT03486028|American Society of Addiction Medicine (ASAM)|american society of addiction medicine (asam)
949312|NCT03486028|substance use|substance use
949313|NCT03486028|addiction|addiction
949314|NCT03486028|treatment|treatment
949315|NCT03486028|RTI International|rti international
949316|NCT03486028|UCLA|ucla
949317|NCT03485989|hazelnuts|hazelnuts
949318|NCT03485989|vitamin E|vitamin e
949319|NCT03485989|aging|aging
949320|NCT03485976|Ixekizumab|ixekizumab
949321|NCT03485976|IL-17|il-17
949322|NCT03485976|Pityriasis Rubra Pilaris (PRP)|pityriasis rubra pilaris (prp)
949323|NCT03485950|Other infectious diseases|other infectious diseases
949324|NCT03485950|Febrile neutropenic adults with cancer|febrile neutropenic adults with cancer
949325|NCT03485950|Ceftolozane-Tazobactam|ceftolozane-tazobactam
949326|NCT03485950|Cefepime|cefepime
949327|NCT03485950|Meropenem|meropenem
949328|NCT03485950|Piperacillin/Tazobactam|piperacillin/tazobactam
949329|NCT03485937|anxiety|anxiety
949330|NCT03485937|patient satisfaction|patient satisfaction
949331|NCT03485937|video education|video education
949332|NCT03485937|skin cancer|skin cancer
949333|NCT03485937|linear closure on the face|linear closure on the face
949334|NCT03485911|BCX7353|bcx7353
949335|NCT03485898|UCC|ucc
949336|NCT03485898|mortality|mortality
949337|NCT03485898|alzheimer's disease|alzheimer's disease
949338|NCT03485898|longitudinal study|longitudinal study
949339|NCT03485885|anthocyanins, maqui berries, bioavailability|anthocyanins, maqui berries, bioavailability
949340|NCT03485846|hepatitis C|hepatitis c
949341|NCT03485846|chronic|chronic
949342|NCT03485846|1b genotype|1b genotype
949343|NCT03485846|oral treatment|oral treatment
949344|NCT03485833|end-expiratory occlusion test|end-expiratory occlusion test
949345|NCT03485833|end-inspiratory occlusion test|end-inspiratory occlusion test
949346|NCT03485833|transesophageal echocardiography|transesophageal echocardiography
949347|NCT03485833|passive legs raising|passive legs raising
949348|NCT03485833|fluid challenge|fluid challenge
949349|NCT03485820|environmental modifications|environmental modifications
949350|NCT03485820|activity performance|activity performance
949351|NCT03485807|stress|stress
949352|NCT03485807|mindfulness|mindfulness
949353|NCT03485807|active coping|active coping
949354|NCT03485781|EEG|eeg
949355|NCT03485781|Intensive Care|intensive care
949356|NCT03485781|Propofol|propofol
949357|NCT03485768|cervical vertigo|cervical vertigo
949358|NCT03485768|percutaneous disc decompression with coblation nucleoplasty|percutaneous disc decompression with coblation nucleoplasty
949359|NCT03485768|manual therapy|manual therapy
949360|NCT03485768|clinical efficacy|clinical efficacy
949361|NCT03485768|randomized controlled trial|randomized controlled trial
949362|NCT03485755|microflora|microflora
949363|NCT03485755|microbiome|microbiome
949364|NCT03485755|bacteria taxa|bacteria taxa
949365|NCT03485716|metabolism|metabolism
949366|NCT03485716|metabolome|metabolome
949367|NCT03485716|physical activity|physical activity
949368|NCT03485716|hypoxia|hypoxia
949369|NCT03485690|COPD|copd
949370|NCT03485690|Cohort study|cohort study
949371|NCT03485690|Prospective|prospective
949372|NCT03485651|adrexal mass|adrexal mass
949373|NCT03485651|ovarian cancer|ovarian cancer
949374|NCT03485651|fallopian tube cancer|fallopian tube cancer
949375|NCT03485651|peritoneal cancer|peritoneal cancer
949376|NCT03485612|Optic Nerve Sheath Diameter|optic nerve sheath diameter
949377|NCT03485612|Urological Anaesthesia|urological anaesthesia
949378|NCT03485612|point of care USG|point of care usg
949379|NCT03485586|cataract, higher order aberration,vitrectomy,diabetic retinopathy|cataract, higher order aberration,vitrectomy,diabetic retinopathy
949380|NCT03485560|chronic skin disease|chronic skin disease
949381|NCT03485560|psoriasis|psoriasis
949382|NCT03485560|Eczema|eczema
949383|NCT03485560|atopic dermatitis|atopic dermatitis
949384|NCT03485547|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
949385|NCT03485547|BPDCN|bpdcn
951170|NCT03474107|ASG-22ME|asg-22me
949386|NCT03485521|High Fidelity Simulation Training|high fidelity simulation training
949387|NCT03485521|physiotherapy|physiotherapy
949388|NCT03485521|tracheobronchial aspiration.|tracheobronchial aspiration.
949389|NCT03485482|Pharmacokinetic drug interaction|pharmacokinetic drug interaction
949390|NCT03485482|ivabtadine|ivabtadine
949391|NCT03485482|bisoprolol|bisoprolol
949392|NCT03485469|Obesity|obesity
949393|NCT03485469|bariatric surgery|bariatric surgery
949394|NCT03485469|Hypnosis|hypnosis
949395|NCT03485456|Dry powder inhalation|dry powder inhalation
949396|NCT03485456|Tobramycin|tobramycin
949397|NCT03485443|fluid infusion|fluid infusion
949398|NCT03485443|vomiting|vomiting
949399|NCT03485443|otorhinolaringology|otorhinolaringology
949400|NCT03485417|stimulant|stimulant
949401|NCT03485417|psychosis|psychosis
949402|NCT03485417|schizophrenia|schizophrenia
949403|NCT03485417|dependence|dependence
949404|NCT03485417|pharmacotherapy|pharmacotherapy
949405|NCT03485404|POCD|pocd
949406|NCT03485404|vitamin B12|vitamin b12
949407|NCT03485404|folic acid|folic acid
949408|NCT03485378|Stereotactic|stereotactic
949409|NCT03485378|Ablative|ablative
949410|NCT03485378|Radiation|radiation
949411|NCT03485365|Pain|pain
949412|NCT03485365|Osteoarthritis of the knee|osteoarthritis of the knee
949413|NCT03485365|Target engagement|target engagement
949414|NCT03485365|GSK3858279|gsk3858279
949415|NCT03485365|Pharmacokinetics|pharmacokinetics
949416|NCT03485365|Sequential|sequential
949417|NCT03485352|Bariatric Surgery|bariatric surgery
949418|NCT03485352|Sleep|sleep
949419|NCT03485352|Chronotype|chronotype
949420|NCT03485326|Osimertinib|osimertinib
949421|NCT03485326|Tagrisso|tagrisso
949422|NCT03485326|NSCLC|nsclc
949423|NCT03485326|Non-small cell lung cancer|non-small cell lung cancer
949424|NCT03485326|Safety|safety
949425|NCT03485313|Healthy|healthy
949426|NCT03485313|Volunteer|volunteer
949427|NCT03485313|Female|female
949428|NCT03485313|Pregnancy|pregnancy
949429|NCT03485287|PTSD|ptsd
949430|NCT03485287|MDMA|mdma
949431|NCT03485287|Psychotherapy|psychotherapy
949432|NCT03485274|Cannabis|cannabis
949433|NCT03485274|depression|depression
949434|NCT03485274|anxiety|anxiety
949435|NCT03485274|medication|medication
949436|NCT03485248|HIV/AIDS|hiv/aids
949437|NCT03485248|Arterial stiffness|arterial stiffness
949438|NCT03485248|Flow mediated-dilatation|flow mediated-dilatation
949439|NCT03485248|Muscle oxygenation|muscle oxygenation
949440|NCT03485248|Exercise performance|exercise performance
949441|NCT03485248|Dietary Nitrate|dietary nitrate
949442|NCT03485222|Cardiovascular diseases|cardiovascular diseases
949443|NCT03485222|Heart Failure|heart failure
949444|NCT03485222|LV remodeling|lv remodeling
949445|NCT03485222|SGLT-2 Inhibitors|sglt-2 inhibitors
949446|NCT03485222|Empagliflozin|empagliflozin
949447|NCT03485222|Cardiac MRI|cardiac mri
949448|NCT03485209|Colorectal cancer|colorectal cancer
949449|NCT03485209|NSCLC|nsclc
949450|NCT03485209|SCCHN|scchn
949452|NCT03485209|Pancreatic cancer|pancreatic cancer
949453|NCT03485209|Head and neck cancer|head and neck cancer
949454|NCT03485196|Microsatellite Instability|microsatellite instability
949455|NCT03485196|Fluorouracil|fluorouracil
949456|NCT03485196|Adjuvant chemotherapy|adjuvant chemotherapy
949457|NCT03485196|Efficacy|efficacy
949458|NCT03485196|Operation|operation
949459|NCT03485183|delirium|delirium
949460|NCT03485183|white noise|white noise
949461|NCT03485183|pink noise|pink noise
949462|NCT03485170|Hemophilia|hemophilia
949463|NCT03485170|Hemophilic arthropathy|hemophilic arthropathy
949464|NCT03485170|PET|pet
949465|NCT03485144|Dengue Vaccine|dengue vaccine
949466|NCT03485118|Previously untreated DLBCL|previously untreated dlbcl
949467|NCT03485105|Gastric cancer|gastric cancer
949468|NCT03485105|biomarker|biomarker
949469|NCT03485105|chemotherapy|chemotherapy
949470|NCT03485105|precise medicine|precise medicine
949471|NCT03485092|heart failure|heart failure
949472|NCT03485092|diabetes mellitus|diabetes mellitus
949473|NCT03485092|empagliflozin|empagliflozin
949474|NCT03485092|Randomised, placebo controlled trial|randomised, placebo controlled trial
949475|NCT03485040|Rehabilitation|rehabilitation
949476|NCT03485040|Neurorehabilitation|neurorehabilitation
949477|NCT03485040|Neurotechnology|neurotechnology
949478|NCT03485040|Neurorecovery|neurorecovery
949479|NCT03485040|Neurorestoration|neurorestoration
949480|NCT03484988|Polyunsaturated fatty acids|polyunsaturated fatty acids
949481|NCT03484988|Echium oil|echium oil
949482|NCT03484988|Hyperlipidemias|hyperlipidemias
949483|NCT03484988|Metabolites|metabolites
949484|NCT03484988|Gut Microbiota|gut microbiota
949485|NCT03484962|activated CIK|activated cik
949486|NCT03484962|MUC1|muc1
949487|NCT03484962|bispecific antibody|bispecific antibody
949488|NCT03484962|liver cancer|liver cancer
949489|NCT03484949|Gastric cancer|gastric cancer
949490|NCT03484949|Screening|screening
949491|NCT03484949|Risk assessment|risk assessment
949492|NCT03484936|Intracranial Hemorrhages|intracranial hemorrhages
951171|NCT03474107|ASG-22CE|asg-22ce
949493|NCT03484936|remote ischemic conditioning|remote ischemic conditioning
949494|NCT03484923|Unresectable|unresectable
949495|NCT03484923|melanoma|melanoma
949496|NCT03484923|metastatic melanoma|metastatic melanoma
949497|NCT03484923|advanced melanoma|advanced melanoma
949498|NCT03484923|spartalizumab|spartalizumab
949499|NCT03484923|PDR001|pdr001
949500|NCT03484923|LAG525|lag525
949501|NCT03484923|capmatinib|capmatinib
949502|NCT03484923|INC280|inc280
949503|NCT03484923|canakinumab|canakinumab
949504|NCT03484923|ACZ885|acz885
949505|NCT03484923|immunotherapy|immunotherapy
949506|NCT03484923|platform study|platform study
949507|NCT03484884|nodal metastases|nodal metastases
949508|NCT03484884|17-538|17-538
949509|NCT03484884|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
949510|NCT03484793|AESOP Model|aesop model
949511|NCT03484793|Big data|big data
949512|NCT03484793|medication error|medication error
949513|NCT03484793|data mining|data mining
949514|NCT03484793|patient safety|patient safety
949516|NCT03484793|CDSS|cdss
949517|NCT03484793|alarm fatigue|alarm fatigue
949518|NCT03484793|association rule mining.|association rule mining.
949519|NCT03484780|Implantable Heart Failure Device Therapy|implantable heart failure device therapy
949520|NCT03484780|Asymptomatic Diaphragmatic Stimulation|asymptomatic diaphragmatic stimulation
949521|NCT03484767|methylmalonic acidemia|methylmalonic acidemia
949522|NCT03484767|MMA|mma
949523|NCT03484767|organic acidemia|organic acidemia
949524|NCT03484767|mut deficiency|mut deficiency
949525|NCT03484767|inborn errors of metabolism|inborn errors of metabolism
949526|NCT03484767|mut0|mut0
949527|NCT03484767|mut-|mut-
949528|NCT03484767|PA|pa
949529|NCT03484767|PCCA|pcca
949530|NCT03484767|PCCB|pccb
949531|NCT03484767|propionic acidemia|propionic acidemia
949532|NCT03484728|Conditional pain modulation|conditional pain modulation
949533|NCT03484728|pain|pain
949534|NCT03484728|placebo|placebo
949535|NCT03484715|Physical Activity|physical activity
949536|NCT03484715|Nursing Home|nursing home
949537|NCT03484715|Feasibility|feasibility
949538|NCT03484715|Older Adults|older adults
949539|NCT03484702|Non-Hodgkin lymphoma|non-hodgkin lymphoma
949540|NCT03484702|Aggressive B-cell non-Hodgkin lymphoma|aggressive b-cell non-hodgkin lymphoma
949541|NCT03484702|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
949542|NCT03484702|Relapse / refractory lymphoma|relapse / refractory lymphoma
949543|NCT03484702|Transplant not eligible|transplant not eligible
949544|NCT03484702|Double-hit lymphoma|double-hit lymphoma
949545|NCT03484702|Triple-hit lymphoma|triple-hit lymphoma
949546|NCT03484702|Primary/secondary central nervous system lymphoma|primary/secondary central nervous system lymphoma
949547|NCT03484702|Richter's transformation/syndrome|richter's transformation/syndrome
949548|NCT03484702|Transformed follicular lymphoma|transformed follicular lymphoma
949549|NCT03484702|Follicular lymphoma Grade 3B|follicular lymphoma grade 3b
949550|NCT03484702|JCAR017|jcar017
949551|NCT03484702|CAR T cell therapy|car t cell therapy
949552|NCT03484702|CD19 targeted therapy.|cd19 targeted therapy.
949553|NCT03484702|Efficacy and safety|efficacy and safety
949554|NCT03484702|Europe / Japan|europe / japan
949555|NCT03484702|TPTD|tptd
949556|NCT03484689|Diabetes-related distress|diabetes-related distress
949557|NCT03484689|Mindfulness|mindfulness
949558|NCT03484637|motivation|motivation
949559|NCT03484637|Treatment adherence|treatment adherence
949560|NCT03484637|Waist circumference|waist circumference
949561|NCT03484637|obesity|obesity
949562|NCT03484637|overweight|overweight
949563|NCT03484624|Muscle; Fatigue|muscle; fatigue
949564|NCT03484624|Wearable hip assist robot|wearable hip assist robot
949565|NCT03484624|Metabolic energy expenditure|metabolic energy expenditure
949566|NCT03484585|Mass Balance, metabolism and excretion pattern|mass balance, metabolism and excretion pattern
949567|NCT03484559|In-hospital Cardiac Arrest|in-hospital cardiac arrest
949568|NCT03484546|ovarian reserve|ovarian reserve
949569|NCT03484546|endometriosis|endometriosis
949570|NCT03484546|endometrioma|endometrioma
949571|NCT03484520|Cancer, Acute Myeloid Leukemia (AML), venetoclax, dinaciclib, Relapsed/refractory AML, Pharmacokinetics, Venetoclax, Dinaciclib|cancer, acute myeloid leukemia (aml), venetoclax, dinaciclib, relapsed/refractory aml, pharmacokinetics, venetoclax, dinaciclib
949572|NCT03484494|Geriatric|geriatric
949573|NCT03484494|Low Field Magnetic Stimulation|low field magnetic stimulation
949574|NCT03484494|Antidepressant|antidepressant
949575|NCT03484494|fMRI|fmri
949576|NCT03484494|MRS|mrs
949577|NCT03484468|lasik|lasik
949578|NCT03484468|flap_thickness|flap_thickness
949579|NCT03484468|femtosecond|femtosecond
949580|NCT03484468|laser|laser
949581|NCT03484468|moria|moria
949582|NCT03484468|microkeratome|microkeratome
949583|NCT03484429|Neurostimulation|neurostimulation
949584|NCT03484429|Peripheral nerve stimulation|peripheral nerve stimulation
949585|NCT03484390|mindfulness|mindfulness
949586|NCT03484390|posttraumatic stress disorder|posttraumatic stress disorder
949587|NCT03484351|Falls|falls
949588|NCT03484325|Registry|registry
949589|NCT03484325|Joint Registry|joint registry
949590|NCT03484325|OA|oa
949591|NCT03484325|Osteoarthritis|osteoarthritis
949592|NCT03484325|Osteo arthritis|osteo arthritis
949593|NCT03484325|knee|knee
949594|NCT03484325|hip|hip
949595|NCT03484325|tka|tka
949596|NCT03484325|tha|tha
949597|NCT03484273|Tilt Table|tilt table
949598|NCT03484273|Compression|compression
949599|NCT03484273|Dysautonomia|dysautonomia
949600|NCT03484273|POTS|pots
949601|NCT03484260|Risk factors predicting the initiation of testosterone use|risk factors predicting the initiation of testosterone use
949602|NCT03484247|infraclavicular block|infraclavicular block
949603|NCT03484247|axillary block|axillary block
949604|NCT03484234|Drug eluting stent|drug eluting stent
949605|NCT03484234|everolimus eluting stent|everolimus eluting stent
949606|NCT03484234|sirolimus eluting stent|sirolimus eluting stent
949607|NCT03484182|Upper extremity|upper extremity
949608|NCT03484182|Stroke|stroke
949609|NCT03484182|Web-based program|web-based program
949610|NCT03484182|Home exercise training|home exercise training
949611|NCT03484169|Muscle Stretching Exercises|muscle stretching exercises
949612|NCT03484169|Pelvic Floor|pelvic floor
949613|NCT03484169|motor control|motor control
949614|NCT03484169|motor skill|motor skill
949615|NCT03484169|motor activity|motor activity
949617|NCT03484156|Frailty|frailty
949618|NCT03484156|Tele-monitoring|tele-monitoring
949619|NCT03484156|Disability|disability
949620|NCT03484143|Moderate to Severe Alzheimer's Disease,|moderate to severe alzheimer's disease,
949621|NCT03484130|primary aldosteronism|primary aldosteronism
949622|NCT03484104|Cardiopulmonary bypass|cardiopulmonary bypass
949623|NCT03484104|Hypothermic circulatory arrest|hypothermic circulatory arrest
949624|NCT03484104|Aortic arch surgery|aortic arch surgery
949625|NCT03484091|Hyruan-One|hyruan-one
949626|NCT03484091|Hylan G-F 20|hylan g-f 20
949627|NCT03484091|Hyaluronic acid|hyaluronic acid
949628|NCT03484091|Knee osteoarthritis|knee osteoarthritis
949629|NCT03484091|Pain level|pain level
949630|NCT03484065|Congenital fibrinogen disorders|congenital fibrinogen disorders
949631|NCT03484039|memory problems|memory problems
949632|NCT03484039|stress|stress
949633|NCT03484039|depression|depression
949634|NCT03484039|adherence|adherence
949635|NCT03484039|seizure documentation|seizure documentation
949636|NCT03484026|Iron Deficiency|iron deficiency
949637|NCT03484026|Anemia|anemia
949638|NCT03484026|Medical Food|medical food
949639|NCT03483987|Hepatitis c virus|hepatitis c virus
949640|NCT03483987|Direct acting antiviral drugs|direct acting antiviral drugs
949641|NCT03483987|Virological relapse|virological relapse
949642|NCT03483974|Hyperspectrum, excreta, neoplasm,|hyperspectrum, excreta, neoplasm,
949643|NCT03483909|gesture|gesture
949644|NCT03483909|rTMS|rtms
949645|NCT03483909|nonverbal communication|nonverbal communication
949646|NCT03483909|schizophrenia|schizophrenia
949647|NCT03483909|psychosis|psychosis
949648|NCT03483870|Granisetron, serum serotonin, morphine|granisetron, serum serotonin, morphine
949649|NCT03483857|Peer Navigation|peer navigation
949650|NCT03483844|scoliosis|scoliosis
949651|NCT03483844|low dose|low dose
949652|NCT03483844|arthrodesis|arthrodesis
949653|NCT03483844|dual-energy CT|dual-energy ct
949654|NCT03483818|Community Pharmacy|community pharmacy
949655|NCT03483818|Antiviral Therapy|antiviral therapy
949656|NCT03483805|synbiotic|synbiotic
949657|NCT03483805|nutrition|nutrition
949658|NCT03483805|permeability|permeability
949659|NCT03483805|gluten free diet|gluten free diet
949660|NCT03483805|quality of life|quality of life
949661|NCT03483805|digestive comfort|digestive comfort
949662|NCT03483792|PCOS|pcos
949663|NCT03483792|AMH|amh
949664|NCT03483792|Pregnancy|pregnancy
949665|NCT03483792|Heritability|heritability
949666|NCT03483792|LH|lh
949667|NCT03483753|Vasopressin|vasopressin
949668|NCT03483753|Norepinephrine|norepinephrine
949669|NCT03483753|Post-operative|post-operative
949670|NCT03483753|Critical Care|critical care
949671|NCT03483740|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
949672|NCT03483740|Cognitive remediation group therapy|cognitive remediation group therapy
949673|NCT03483740|Mutual aid group therapy|mutual aid group therapy
949674|NCT03483714|Manipulation|manipulation
949675|NCT03483714|Spinal|spinal
949676|NCT03483714|electromyography|electromyography
949677|NCT03483714|kinetics|kinetics
949678|NCT03483714|kinematic|kinematic
949679|NCT03483701|Cognitive Remediation Therapy|cognitive remediation therapy
949680|NCT03483688|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
949681|NCT03483688|Refractory|refractory
949682|NCT03483688|Relapsed|relapsed
949683|NCT03483662|hypertension|hypertension
949684|NCT03483662|blood pressure|blood pressure
950335|NCT03479229|desire|desire
949685|NCT03483662|medication adherence|medication adherence
949686|NCT03483662|lifestyle modification|lifestyle modification
949687|NCT03483662|blood pressure control|blood pressure control
949688|NCT03483662|implementation|implementation
949689|NCT03483636|Drug-alcohol interaction|drug-alcohol interaction
949690|NCT03483636|Lemborexant|lemborexant
949691|NCT03483636|E2006|e2006
949692|NCT03483636|Postural stability|postural stability
949693|NCT03483636|Cognitive performance|cognitive performance
949695|NCT03483623|Dolphin Fluid Immersion System|dolphin fluid immersion system
949696|NCT03483623|Raven 90C litter|raven 90c litter
949697|NCT03483623|Laser doppler pressure monitor|laser doppler pressure monitor
949698|NCT03483623|Transcutanous oxygenation|transcutanous oxygenation
949699|NCT03483623|WELP mattress|welp mattress
949700|NCT03483571|asymptomatic|asymptomatic
949701|NCT03483571|submicroscopic|submicroscopic
949702|NCT03483571|PCR|pcr
949703|NCT03483558|vegetable metabolite signature|vegetable metabolite signature
949704|NCT03483558|human serum/urinary metabolite|human serum/urinary metabolite
949705|NCT03483558|liquid chromatography mass spectrometry|liquid chromatography mass spectrometry
949706|NCT03483545|Ovarian Response|ovarian response
949707|NCT03483545|In vitro fertilization|in vitro fertilization
949708|NCT03483545|Controlled ovarian stimulation|controlled ovarian stimulation
949709|NCT03483532|lithiasis|lithiasis
949710|NCT03483532|uric acid|uric acid
949711|NCT03483532|crystallization|crystallization
949712|NCT03483493|Tic disorders|tic disorders
949713|NCT03483493|Tourette Syndrome|tourette syndrome
949714|NCT03483493|Online delivered therapy|online delivered therapy
949715|NCT03483454|exercise, fitness, sleep, children, obesity|exercise, fitness, sleep, children, obesity
949716|NCT03483402|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
949717|NCT03483402|Primary Open-angle Glaucoma|primary open-angle glaucoma
949718|NCT03483402|Micropulse Laser Trabeculoplasty|micropulse laser trabeculoplasty
949719|NCT03483402|Intraocular Pressure|intraocular pressure
949720|NCT03483376|black stain|black stain
949721|NCT03483376|dental plaque|dental plaque
949722|NCT03483376|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
949723|NCT03483376|curcumin|curcumin
949724|NCT03483376|tooth discoloration|tooth discoloration
949725|NCT03483337|(DW)-MRI|(dw)-mri
949726|NCT03483337|oncological biomarkers|oncological biomarkers
949727|NCT03483337|18-053|18-053
949728|NCT03483285|intubation|intubation
949729|NCT03483285|airtraq|airtraq
949730|NCT03483285|open heart surgery|open heart surgery
949731|NCT03483285|hemodynamic parameters|hemodynamic parameters
949732|NCT03483272|Terlipressin|terlipressin
949733|NCT03483272|Pharmacological respons|pharmacological respons
949734|NCT03483272|Magnetic Resonance Imaging|magnetic resonance imaging
949735|NCT03483272|Hemodynamic assessments|hemodynamic assessments
949736|NCT03483272|Echocardiography|echocardiography
949737|NCT03483272|Hepatorenal syndrome - acute kidney injury|hepatorenal syndrome - acute kidney injury
949738|NCT03483259|Pharmacokinetics|pharmacokinetics
949739|NCT03483259|Relative bioavailability|relative bioavailability
949740|NCT03483246|Ulcerative colitis|ulcerative colitis
949741|NCT03483246|Inflammatory bowel disease|inflammatory bowel disease
949742|NCT03483246|Fecal microbiota transplantation|fecal microbiota transplantation
949743|NCT03483233|Gyrus Cinguli|gyrus cinguli
949744|NCT03483233|Cognitive Control Process|cognitive control process
949745|NCT03483233|Check process|check process
949746|NCT03483233|Decision Making|decision making
949748|NCT03483220|Addiction, MRI, Decision making|addiction, mri, decision making
949749|NCT03483194|Therapeutic Virtual Reality|therapeutic virtual reality
949750|NCT03483194|Pain related medical procedure management|pain related medical procedure management
949751|NCT03483194|Anxiety management|anxiety management
949752|NCT03483194|Osteo-medullary biopsy|osteo-medullary biopsy
949753|NCT03483116|Dose ranging|dose ranging
949754|NCT03483116|Neonatal vaccine|neonatal vaccine
949755|NCT03483116|RV3-BB vaccine|rv3-bb vaccine
949756|NCT03483103|JCAR017|jcar017
949757|NCT03483103|lisocabtagene maraleucel|lisocabtagene maraleucel
949758|NCT03483103|NHL|nhl
949759|NCT03483103|chimeric antigen receptor|chimeric antigen receptor
949760|NCT03483103|CAR|car
949761|NCT03483103|CAR T cell|car t cell
949762|NCT03483103|autologous T cell therapy|autologous t cell therapy
949763|NCT03483103|immunotherapy|immunotherapy
949764|NCT03483103|cell therapy|cell therapy
949765|NCT03483103|liso-cel|liso-cel
949766|NCT03483090|mild|mild
949767|NCT03483090|moderate|moderate
949768|NCT03483090|krill oil|krill oil
949769|NCT03483090|pain|pain
949770|NCT03483090|osteoarthritis|osteoarthritis
949771|NCT03483090|supplement|supplement
949772|NCT03483051|aortic stenosis, aortic valve replacement|aortic stenosis, aortic valve replacement
949773|NCT03483038|pancreatic adenocarcinoma|pancreatic adenocarcinoma
949774|NCT03483038|neoadjuvant|neoadjuvant
949775|NCT03483038|ONIVYDE|onivyde
949776|NCT03483038|chemotherapy|chemotherapy
949777|NCT03483038|borderline resectable|borderline resectable
949778|NCT03483012|Breast Cancer|breast cancer
949779|NCT03482986|Diet|diet
949780|NCT03482986|Dietary Habits|dietary habits
949781|NCT03482986|Weight changes|weight changes
949782|NCT03482973|Cardiopulmonary Bypass|cardiopulmonary bypass
949783|NCT03482973|Cardiac Surgery|cardiac surgery
949784|NCT03482973|Sternotomy|sternotomy
949785|NCT03482960|imaging|imaging
949786|NCT03482960|hyperpolarized|hyperpolarized
949787|NCT03482960|perfluorinated|perfluorinated
949788|NCT03482960|MRI|mri
949789|NCT03482960|lung|lung
949790|NCT03482947|Dexmedetomidine|dexmedetomidine
949791|NCT03482947|pediatrics; postoperative;|pediatrics; postoperative;
951272|NCT03473483|SREC|srec
949792|NCT03482947|Analgesia; caudal|analgesia; caudal
949793|NCT03482908|Responsive parenting|responsive parenting
949794|NCT03482895|Gastric Bypass|gastric bypass
949795|NCT03482895|Intestinal Absorption|intestinal absorption
949796|NCT03482895|Gastrointestinal Hormones|gastrointestinal hormones
949797|NCT03482895|Enteroendocrine Cells|enteroendocrine cells
949798|NCT03482869|walking impairment|walking impairment
949799|NCT03482869|disability|disability
949800|NCT03482869|diabetes mellitus|diabetes mellitus
949801|NCT03482830|Inflammation|inflammation
949802|NCT03482830|Insulin-glucose homeostasis|insulin-glucose homeostasis
949803|NCT03482830|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
949804|NCT03482830|Endothelial function and damage|endothelial function and damage
949805|NCT03482830|Thyroid hormones|thyroid hormones
949806|NCT03482778|PROMIS|promis
949807|NCT03482778|AYA|aya
949808|NCT03482778|ONCOLOGY|oncology
949809|NCT03482778|HRQOL|hrqol
949810|NCT03482778|Adolescent and Young Adult|adolescent and young adult
949811|NCT03482778|Health Related Quality of Life Measurement|health related quality of life measurement
949812|NCT03482778|Patient-Reported Outcomes Measurement Information System|patient-reported outcomes measurement information system
949813|NCT03482739|HPV|hpv
949814|NCT03482739|Vaccine|vaccine
949815|NCT03482739|HIV|hiv
949816|NCT03482739|Solid organ transplantation|solid organ transplantation
949817|NCT03482726|bicycle|bicycle
949818|NCT03482726|cadence|cadence
949819|NCT03482726|cyclist|cyclist
949820|NCT03482726|modulation|modulation
949821|NCT03482700|COPD; GP Surgeries|copd; gp surgeries
949822|NCT03482687|adolescent behavior|adolescent behavior
949823|NCT03482687|interpersonal relationships|interpersonal relationships
949824|NCT03482687|intimate partner violence|intimate partner violence
949825|NCT03482687|violence/prevention & control|violence/prevention & control
949826|NCT03482687|program evaluation|program evaluation
949827|NCT03482687|teen dating violence|teen dating violence
949828|NCT03482674|Health literacy|health literacy
949829|NCT03482674|Innovation Fund|innovation fund
949830|NCT03482674|lifestyle intervention|lifestyle intervention
949831|NCT03482674|risk screening|risk screening
949832|NCT03482674|type 2 diabetes mellitus|type 2 diabetes mellitus
949833|NCT03482674|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
949834|NCT03482661|Magnetic steering|magnetic steering
949835|NCT03482661|MCE|mce
949836|NCT03482661|CECR|cecr
949837|NCT03482648|Pellino-1|pellino-1
949838|NCT03482622|Raman spectroscopy|raman spectroscopy
949839|NCT03482596|Sedentary Behaviour|sedentary behaviour
949840|NCT03482596|Prevention|prevention
949841|NCT03482583|Smoking, Cancer, Treatment|smoking, cancer, treatment
949842|NCT03482570|Activity behaviors|activity behaviors
949843|NCT03482570|Malignant pleural effusion|malignant pleural effusion
949844|NCT03482557|Breast Cancer|breast cancer
949845|NCT03482557|screening|screening
949846|NCT03482557|breast MRI|breast mri
949847|NCT03482557|contrast enhanced spectral mammography|contrast enhanced spectral mammography
949848|NCT03482544|pregabalin|pregabalin
949849|NCT03482544|ischemia reperfusion injury|ischemia reperfusion injury
949850|NCT03482544|muscle|muscle
949851|NCT03482531|limit nocturnal activity|limit nocturnal activity
949852|NCT03482531|cervical ripening|cervical ripening
949853|NCT03482492|Acetaminophen|acetaminophen
949854|NCT03482492|Tramadol|tramadol
949855|NCT03482492|Discogenic pain|discogenic pain
949856|NCT03482492|Lumbar Discectomy|lumbar discectomy
949857|NCT03482453|Drug Therapy|drug therapy
949858|NCT03482440|preeclampsia|preeclampsia
949859|NCT03482440|microvascular|microvascular
949860|NCT03482440|inflammation|inflammation
949861|NCT03482440|angiotensin II|angiotensin ii
949862|NCT03482414|stroke|stroke
949863|NCT03482414|upper limb rehabilitation|upper limb rehabilitation
949864|NCT03482414|neuro-rehabilitation|neuro-rehabilitation
949865|NCT03482401|Polyphenol|polyphenol
949866|NCT03482401|Methylxanthine|methylxanthine
949867|NCT03482401|Metabolism|metabolism
949868|NCT03482401|Breast tissue|breast tissue
949869|NCT03482401|Disposition|disposition
949870|NCT03482401|UPLC-QTOF|uplc-qtof
949871|NCT03482388|Hepatitis|hepatitis
949872|NCT03482388|Hepatitis B|hepatitis b
949873|NCT03482388|Hepatitis C|hepatitis c
949874|NCT03482388|Men who have sex with men|men who have sex with men
949875|NCT03482388|Crowdsourcing|crowdsourcing
949876|NCT03482388|China|china
949877|NCT03482388|Testing|testing
949878|NCT03482375|Gall Stones|gall stones
949879|NCT03482375|ERCP|ercp
949880|NCT03482375|Cholangioscopy|cholangioscopy
949881|NCT03482362|vinorelbine|vinorelbine
949882|NCT03482336|labeling|labeling
949883|NCT03482336|Front of pack|front of pack
949884|NCT03482336|nutrition|nutrition
949885|NCT03482336|nutrition facts panel|nutrition facts panel
949886|NCT03482310|Brain computer interface|brain computer interface
949887|NCT03482310|electric stimulation|electric stimulation
949888|NCT03482258|Stress|stress
949889|NCT03482258|Galactooligosaccharide|galactooligosaccharide
949890|NCT03482258|Prebiotic|prebiotic
949891|NCT03482258|Early life stress|early life stress
949892|NCT03482258|Emotional eating|emotional eating
949902|NCT03482245|sepsis|sepsis
949903|NCT03482232|patient safety|patient safety
949904|NCT03482232|quality assurance|quality assurance
949905|NCT03482232|overuse|overuse
949906|NCT03482167|blood pressure|blood pressure
949907|NCT03482167|arterial stiffness|arterial stiffness
949908|NCT03482167|cerebrovascular function|cerebrovascular function
949909|NCT03482167|cognitive function|cognitive function
949910|NCT03482128|transfusion|transfusion
949911|NCT03482128|coagulation|coagulation
949912|NCT03482128|cardiac surgery|cardiac surgery
949913|NCT03482115|coma|coma
949914|NCT03482115|traumatic brain injury|traumatic brain injury
949915|NCT03482115|anoxic encephalopathy|anoxic encephalopathy
949916|NCT03482115|brain connectome|brain connectome
949917|NCT03482115|neuroinflammation|neuroinflammation
949918|NCT03482115|prognosis|prognosis
949919|NCT03482102|Hepatocellular Carcinoma|hepatocellular carcinoma
949920|NCT03482102|Biliary Tract Cancer|biliary tract cancer
949921|NCT03482063|B vitamin|b vitamin
949922|NCT03482063|herbal supplement|herbal supplement
949923|NCT03482063|attention|attention
949924|NCT03482011|Psoriasis|psoriasis
949925|NCT03482011|IL-23|il-23
949926|NCT03481998|CDK4/6 inhibitor|cdk4/6 inhibitor
949927|NCT03481998|Breast cancer|breast cancer
949928|NCT03481998|Postmenopausal women|postmenopausal women
949929|NCT03481998|Hormone-receptor positive|hormone-receptor positive
949930|NCT03481998|HER2 negative|her2 negative
949931|NCT03481985|Fontan-associated liver disease|fontan-associated liver disease
949932|NCT03481959|TDAH|tdah
949933|NCT03481959|Methylphenidate|methylphenidate
949934|NCT03481959|Cannabis|cannabis
949935|NCT03481920|pancreatic cancer, inmunotherapy|pancreatic cancer, inmunotherapy
949936|NCT03481907|collagen powder|collagen powder
949937|NCT03481907|punch biopsy wound|punch biopsy wound
949938|NCT03481894|Parenteral nutrition|parenteral nutrition
949939|NCT03481894|Malnutrition|malnutrition
949940|NCT03481894|Pediatrics|pediatrics
949941|NCT03481894|nutritional needs|nutritional needs
949942|NCT03481881|pharmacokinetics|pharmacokinetics
949943|NCT03481868|chronic myeloid leukemia|chronic myeloid leukemia
949944|NCT03481868|epigenetic|epigenetic
949945|NCT03481868|leukemic stem cell|leukemic stem cell
949946|NCT03481842|Endometriosis|endometriosis
949947|NCT03481842|VEGF(R)|vegf(r)
949958|NCT03481803|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
949959|NCT03481790|iron deficiency anemia of pregnancy - lactoferrin|iron deficiency anemia of pregnancy - lactoferrin
949960|NCT03481777|Remote Ischemic Conditioning|remote ischemic conditioning
949961|NCT03481777|Neuroprotection|neuroprotection
949962|NCT03481764|febrile seizure|febrile seizure
949963|NCT03481764|HRC-test|hrc-test
949964|NCT03481764|genetic variation|genetic variation
949965|NCT03481764|epilepsy|epilepsy
949966|NCT03481751|Crohn Disease|crohn disease
949967|NCT03481751|Ultrasound|ultrasound
949968|NCT03481751|Monitoring|monitoring
949969|NCT03481751|Disease activity|disease activity
949970|NCT03481738|Glycolytic enzymopathy|glycolytic enzymopathy
949971|NCT03481738|Congenital Non-spherocytic hemolytic anemia (CNSA)|congenital non-spherocytic hemolytic anemia (cnsa)
949972|NCT03481699|Adolescence|adolescence
949973|NCT03481699|Prevention|prevention
949974|NCT03481699|Emotional disorders|emotional disorders
949975|NCT03481699|Aggressive behavior|aggressive behavior
949976|NCT03481686|Erythropoiesis|erythropoiesis
949977|NCT03481686|stimulating|stimulating
949978|NCT03481686|agents|agents
949979|NCT03481686|therapeutic|therapeutic
949980|NCT03481686|education|education
949981|NCT03481686|program|program
949982|NCT03481673|Childhood Asthma|childhood asthma
949983|NCT03481673|Childhood Anxiety|childhood anxiety
949984|NCT03481673|Childhood Depression|childhood depression
949985|NCT03481673|Childhood Quality of Life|childhood quality of life
949986|NCT03481660|Diabetic Macular Edema|diabetic macular edema
949987|NCT03481660|intravitreal injection|intravitreal injection
949988|NCT03481660|brolucizumab|brolucizumab
949989|NCT03481660|aflibercept|aflibercept
949990|NCT03481660|double-masked|double-masked
949991|NCT03481634|Diabetic Macular Edema|diabetic macular edema
949992|NCT03481634|intravitreal injection|intravitreal injection
949993|NCT03481634|brolucizumab|brolucizumab
949994|NCT03481634|aflibercept|aflibercept
949995|NCT03481634|double-masked|double-masked
949996|NCT03481621|Vulvodynia|vulvodynia
949997|NCT03481608|fatty acid|fatty acid
949998|NCT03481608|nutrition|nutrition
949999|NCT03481608|metabolism|metabolism
950000|NCT03481608|lauric acid|lauric acid
950001|NCT03481608|dilauroylphosphatidylcholine|dilauroylphosphatidylcholine
950002|NCT03481608|lrh-1|lrh-1
950003|NCT03481582|Nitroglycerin Trans-dermal Patch|nitroglycerin trans-dermal patch
950004|NCT03481543|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
950005|NCT03481543|Nebulization|nebulization
950006|NCT03481543|Respiratory failure|respiratory failure
950007|NCT03481543|Non-invasive ventilation(NIV)|non-invasive ventilation(niv)
950008|NCT03481517|adult|adult
950009|NCT03481517|appendectomy|appendectomy
950010|NCT03481517|appendicitis|appendicitis
950011|NCT03481517|local anesthesia|local anesthesia
950012|NCT03481517|pain|pain
950013|NCT03481491|Cerebellum|cerebellum
950014|NCT03481491|Striatum|striatum
950015|NCT03481491|Human|human
950016|NCT03481491|fMRI|fmri
950017|NCT03481491|Transcranial magnetic stimulation|transcranial magnetic stimulation
950018|NCT03481491|Genetic dystonia|genetic dystonia
950019|NCT03481478|occult|occult
950020|NCT03481478|proximal humeral neck fractures|proximal humeral neck fractures
950021|NCT03481478|greater tuberosity|greater tuberosity
950022|NCT03481478|shoulder dislocation|shoulder dislocation
950023|NCT03481465|Biomarkers|biomarkers
950024|NCT03481465|Hepatic dysfunction|hepatic dysfunction
950025|NCT03481465|Metabolic dysfunction|metabolic dysfunction
950026|NCT03481465|Endothelial dysfunction|endothelial dysfunction
950027|NCT03481465|Antipsychotics|antipsychotics
950028|NCT03481465|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
950029|NCT03481452|anxiety|anxiety
950030|NCT03481452|regulation of states|regulation of states
950031|NCT03481452|NBO|nbo
950032|NCT03481452|HAMA|hama
950033|NCT03481439|Pharmacist|pharmacist
950034|NCT03481439|Led medication review|led medication review
950035|NCT03481439|Orthopaedic surgery|orthopaedic surgery
950036|NCT03481439|Traumatology|traumatology
950037|NCT03481426|musculoskelelal disorder|musculoskelelal disorder
950038|NCT03481426|occupational health service|occupational health service
950039|NCT03481400|Calcitonin gene-related peptide|calcitonin gene-related peptide
950040|NCT03481361|Obstructive sleep apnoea (OSA)|obstructive sleep apnoea (osa)
950041|NCT03481361|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
950042|NCT03481361|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
950043|NCT03481361|Insulin-Dependent Diabetes Mellitus (IDDM)|insulin-dependent diabetes mellitus (iddm)
950044|NCT03481322|sodium chloride|sodium chloride
950045|NCT03481322|diet|diet
950046|NCT03481322|cooking|cooking
950047|NCT03481309|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
950048|NCT03481309|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
950049|NCT03481309|electroencephalography (EEG)|electroencephalography (eeg)
950050|NCT03481296|Colorectal Cancer Screening|colorectal cancer screening
950051|NCT03481296|Asian Americans|asian americans
950052|NCT03481296|Patient Navigation|patient navigation
950053|NCT03481296|Decision Counseling Program|decision counseling program
950054|NCT03481283|Amylin|amylin
950055|NCT03481218|Type 1 diabetes|type 1 diabetes
950056|NCT03481218|Quality of life|quality of life
950057|NCT03481218|Personality traits|personality traits
950058|NCT03481218|Young adults|young adults
950059|NCT03481205|remote limb ischemic conditioning|remote limb ischemic conditioning
950060|NCT03481205|large vessel occlusion|large vessel occlusion
950061|NCT03481205|helicopter transport|helicopter transport
950062|NCT03481179|Repetitive transcranial magnetic stimulation, Physiotherapy, Stroke, Spasticity|repetitive transcranial magnetic stimulation, physiotherapy, stroke, spasticity
950063|NCT03481166|pilot|pilot
950064|NCT03481166|randomized controlled trial|randomized controlled trial
950065|NCT03481166|prenatal education|prenatal education
950066|NCT03481166|anticipatory guidance|anticipatory guidance
950067|NCT03481114|radiation therapy|radiation therapy
950068|NCT03481114|chemotherapy|chemotherapy
950069|NCT03481114|PET Imaging|pet imaging
950070|NCT03481101|early response evaluation|early response evaluation
950071|NCT03481101|immunotherapy|immunotherapy
950072|NCT03481101|chemotherapy|chemotherapy
950073|NCT03481101|liquid biopsy|liquid biopsy
950074|NCT03481101|FDG-PET/CT|fdg-pet/ct
950075|NCT03481075|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
950076|NCT03481075|Imaging, Three-Dimensional|imaging, three-dimensional
950077|NCT03481075|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
950078|NCT03481075|Angiography, Digital Subtraction|angiography, digital subtraction
950079|NCT03481075|Endovascular Procedures|endovascular procedures
950080|NCT03481075|Radiography, Interventional|radiography, interventional
950081|NCT03481036|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
950082|NCT03481036|Direct acting antiviral agents (DAA)|direct acting antiviral agents (daa)
950083|NCT03481036|Chronic Hepatitis C|chronic hepatitis c
950084|NCT03481036|Pediatric population|pediatric population
950085|NCT03481036|Adolescent Chronic Hepatitis C|adolescent chronic hepatitis c
950086|NCT03481023|Atrial Fibrillation|atrial fibrillation
950087|NCT03481023|Esophageal Cooling Device|esophageal cooling device
950088|NCT03481023|Radiofrequency Ablation|radiofrequency ablation
950089|NCT03481023|Arrhythmia|arrhythmia
950090|NCT03480971|cisplatin toxicity|cisplatin toxicity
950091|NCT03480958|erector spinae plane block|erector spinae plane block
950092|NCT03480958|thoracic paravertebral block|thoracic paravertebral block
950093|NCT03480958|breast surgery|breast surgery
950094|NCT03480958|postoperative pain|postoperative pain
950095|NCT03480932|directly observed therapy|directly observed therapy
950096|NCT03480932|sofosbuvir|sofosbuvir
950097|NCT03480932|daclatasvir|daclatasvir
950098|NCT03480932|pegylated interferon|pegylated interferon
950099|NCT03480932|resource-limited setting|resource-limited setting
950100|NCT03480893|laminectomy|laminectomy
950101|NCT03480893|laminotomy|laminotomy
950102|NCT03480893|lumbar canal stenosis|lumbar canal stenosis
950103|NCT03480880|Bispectral Index|bispectral index
950104|NCT03480815|Asthma|asthma
950105|NCT03480815|Controlled Laminar Airflow Device|controlled laminar airflow device
950106|NCT03480815|Omalizumab|omalizumab
950107|NCT03480802|Conjugate pneumococcal vaccine, 15-valent, 22F, 33F|conjugate pneumococcal vaccine, 15-valent, 22f, 33f
950108|NCT03480750|Copper chelator|copper chelator
950109|NCT03480750|Epithelial ovarian cancer|epithelial ovarian cancer
950110|NCT03480750|Tubal cancer|tubal cancer
950111|NCT03480750|Peritoneal cancer|peritoneal cancer
950112|NCT03480750|Trientine|trientine
950113|NCT03480750|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
950114|NCT03480750|Carboplatin|carboplatin
950115|NCT03480711|subscleral trabeculectomy|subscleral trabeculectomy
950116|NCT03480711|extended subscleral tunnel|extended subscleral tunnel
950117|NCT03480711|mitomycinC|mitomycinc
950118|NCT03480698|acute ischemic stroke|acute ischemic stroke
950119|NCT03480646|Phase 1/2|phase 1/2
950120|NCT03480646|Oncology|oncology
950121|NCT03480646|EZH2 Inhibitor|ezh2 inhibitor
950122|NCT03480620|Telehealth|telehealth
950123|NCT03480620|Telerehabilitation|telerehabilitation
950124|NCT03480620|Chronic pain|chronic pain
950125|NCT03480620|Post-discharge care|post-discharge care
950126|NCT03480581|Neurological|neurological
950128|NCT03480581|Cardiorespiratory fitness|cardiorespiratory fitness
950129|NCT03480581|Rehabilitation|rehabilitation
950130|NCT03480581|Walking|walking
950131|NCT03480581|Locomotor training|locomotor training
950132|NCT03480581|Robotics|robotics
950133|NCT03480568|Alirocumab|alirocumab
950134|NCT03480529|adverse event|adverse event
950135|NCT03480529|arthritis|arthritis
950136|NCT03480529|Systemic Lupus Erythematosus|systemic lupus erythematosus
950137|NCT03480529|Capillary Leak Syndrome|capillary leak syndrome
950138|NCT03480516|Silver Diamine Fluoride|silver diamine fluoride
950139|NCT03480516|Sodium Fluoride Varnish|sodium fluoride varnish
950140|NCT03480516|Arrest caries|arrest caries
950141|NCT03480516|Caries prevention|caries prevention
950142|NCT03480503|Apelin12|apelin12
950143|NCT03480477|Adverse Childhood Experiences|adverse childhood experiences
950144|NCT03480412|Luteal Phase Stimulation|luteal phase stimulation
950145|NCT03480412|Poor Ovarian Response|poor ovarian response
950146|NCT03480412|In Vitro Fertilization|in vitro fertilization
950147|NCT03480399|retroperitoneal sarcoma|retroperitoneal sarcoma
950148|NCT03480399|quality of life|quality of life
950149|NCT03480399|morbidity|morbidity
950150|NCT03480399|surgery|surgery
950151|NCT03480386|Pulmonary Rehabilitation|pulmonary rehabilitation
950152|NCT03480373|Nicotine|nicotine
950153|NCT03480373|Nicotine addiction|nicotine addiction
950154|NCT03480373|Tobacco Use Disorder|tobacco use disorder
950155|NCT03480373|Pregnancy|pregnancy
950156|NCT03480373|Electronic cigarettes|electronic cigarettes
950157|NCT03480373|Cigarettes|cigarettes
950158|NCT03480373|Vaping|vaping
950159|NCT03480373|Carcinoma|carcinoma
950160|NCT03480373|Pregnant|pregnant
950161|NCT03480373|Birth Outcomes|birth outcomes
950162|NCT03480373|E-liquid|e-liquid
950163|NCT03480360|haploidentical|haploidentical
950164|NCT03480360|transplant|transplant
950165|NCT03480360|peripheral blood|peripheral blood
950166|NCT03480360|allogeneic|allogeneic
950167|NCT03480321|Peripheral Artery Disease|peripheral artery disease
950168|NCT03480321|Cilostazol|cilostazol
950169|NCT03480321|PMR|pmr
950170|NCT03480321|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
950171|NCT03480282|Life expectancy|life expectancy
950172|NCT03480282|Older adults|older adults
950173|NCT03480282|Primary care|primary care
950174|NCT03480282|Cancer screening|cancer screening
950175|NCT03480256|SHR6390|shr6390
950176|NCT03480256|Pyrotinib|pyrotinib
950177|NCT03480256|gastric cancer|gastric cancer
950178|NCT03480256|Her-2 positive|her-2 positive
950179|NCT03480243|Padsevonil|padsevonil
950180|NCT03480230|Non-small cell lung cancer|non-small cell lung cancer
950181|NCT03480230|Platinum doublet chemotherapy|platinum doublet chemotherapy
950182|NCT03480230|Neoadjuvant|neoadjuvant
950183|NCT03480217|hypertension|hypertension
950184|NCT03480217|screening|screening
950185|NCT03480217|guidelines|guidelines
950186|NCT03480217|implementation|implementation
950187|NCT03480217|randomized|randomized
950209|NCT03480022|prediabetes|prediabetes
950210|NCT03480022|PCOS|pcos
950211|NCT03480022|GLP-1 agonist|glp-1 agonist
950212|NCT03480022|weight loss|weight loss
950213|NCT03480009|medication abortion|medication abortion
950214|NCT03480009|dextromethorphan|dextromethorphan
950215|NCT03480009|pain control|pain control
950336|NCT03479229|lubrication|lubrication
950216|NCT03479983|Indian gooseberry|indian gooseberry
950217|NCT03479983|Total cholesterol|total cholesterol
950218|NCT03479983|Triglycerides|triglycerides
950219|NCT03479866|Gut microbiome|gut microbiome
950220|NCT03479866|Personalised Nutrition|personalised nutrition
950221|NCT03479866|Metabolic health|metabolic health
950222|NCT03479853|Ocular Rosacea|ocular rosacea
950223|NCT03479853|Keratoconjunctivitis|keratoconjunctivitis
950224|NCT03479853|Meibomian Gland|meibomian gland
950225|NCT03479853|Interferometry|interferometry
950226|NCT03479853|Child|child
950227|NCT03479840|SYNTAX score, PCI, elderly|syntax score, pci, elderly
950228|NCT03479814|rectal cancer|rectal cancer
950229|NCT03479814|neoadjuvant chemoradiation|neoadjuvant chemoradiation
950230|NCT03479814|IMRT-SIB|imrt-sib
950231|NCT03479814|adaptive radiotherapy|adaptive radiotherapy
950232|NCT03479788|sleep apnea, coronary artery, diabetes|sleep apnea, coronary artery, diabetes
950244|NCT03479684|warfarin|warfarin
950245|NCT03479684|gene|gene
950246|NCT03479658|HIIT|hiit
950247|NCT03479658|nutritional education|nutritional education
950248|NCT03479658|Dose-effect|dose-effect
950249|NCT03479658|school|school
950250|NCT03479658|children|children
950251|NCT03479658|cardiovascular|cardiovascular
950252|NCT03479658|adiposity|adiposity
950253|NCT03479658|blood pressure|blood pressure
950254|NCT03479658|fitness|fitness
950255|NCT03479645|Colon cancer|colon cancer
950256|NCT03479645|Bowel cancer|bowel cancer
950257|NCT03479645|Cancer screening|cancer screening
950258|NCT03479645|text message|text message
950259|NCT03479645|Fecal immunochemistry test (FIT)|fecal immunochemistry test (fit)
950260|NCT03479645|opt-out|opt-out
950261|NCT03479645|behavioral intervention|behavioral intervention
950262|NCT03479619|lancing device|lancing device
950263|NCT03479619|lancet|lancet
950264|NCT03479606|Traumatic Brain Injury|traumatic brain injury
950265|NCT03479606|TBI|tbi
950266|NCT03479606|Executive Dysfunction|executive dysfunction
950267|NCT03479606|Emotional Regulation|emotional regulation
950268|NCT03479606|Emotional Dysfunction|emotional dysfunction
950269|NCT03479606|Problem Solving|problem solving
950270|NCT03479606|Self-regulation|self-regulation
950271|NCT03479606|Cognitive Rehabilitation|cognitive rehabilitation
950272|NCT03479606|Metacognitive Strategies|metacognitive strategies
950273|NCT03479606|Cognitive-behavioral therapy|cognitive-behavioral therapy
950274|NCT03479606|Online Therapy|online therapy
950275|NCT03479606|GroupTherapy|grouptherapy
950276|NCT03479606|Group videoconference|group videoconference
950277|NCT03479606|Telehealth|telehealth
950278|NCT03479606|Telerehabilitation|telerehabilitation
950279|NCT03479593|NSTEMI|nstemi
950280|NCT03479593|Culprit|culprit
950281|NCT03479593|Cardiac magnetic resonance|cardiac magnetic resonance
950282|NCT03479593|Optical Coherence Tomography|optical coherence tomography
950283|NCT03479580|Cardiomyopathy|cardiomyopathy
950284|NCT03479580|Multimodal imaging|multimodal imaging
950285|NCT03479580|Coronary artery disease|coronary artery disease
950286|NCT03479580|Coronary microvascular disease|coronary microvascular disease
950287|NCT03479580|Prognosis|prognosis
950288|NCT03479580|Atherosclerosis|atherosclerosis
950296|NCT03479541|quality of life|quality of life
950297|NCT03479541|rehabilitation|rehabilitation
950298|NCT03479528|Dyspepsia,alarm symptoms，Roman IV|dyspepsia,alarm symptoms，roman iv
950299|NCT03479476|Congenital Abnormalities|congenital abnormalities
950300|NCT03479476|Metformin|metformin
950301|NCT03479476|Nervous System Diseases|nervous system diseases
950302|NCT03479476|Chromosome Disorders|chromosome disorders
950303|NCT03479437|Obesity|obesity
950304|NCT03479437|Melanocortin|melanocortin
950305|NCT03479437|TEMPO|tempo
950306|NCT03479437|MC4R|mc4r
950307|NCT03479437|Genetic Obesity|genetic obesity
950308|NCT03479437|hypothalamic|hypothalamic
950309|NCT03479437|POMC|pomc
950310|NCT03479437|LEPR|lepr
950311|NCT03479437|PCSK1|pcsk1
950312|NCT03479398|Fidelity|fidelity
950313|NCT03479398|Cognitive Behavioral Therapy|cognitive behavioral therapy
950314|NCT03479398|Mobile Application|mobile application
950315|NCT03479398|Routine Practice|routine practice
950316|NCT03479372|AMD|amd
950317|NCT03479372|wet AMD|wet amd
950318|NCT03479372|exudative AMD|exudative amd
950319|NCT03479372|macular degeneration|macular degeneration
950320|NCT03479359|Prostate cancer; Benign Prostatic Hyperplasia; Digital Rectal Examination; Accuracy|prostate cancer; benign prostatic hyperplasia; digital rectal examination; accuracy
950321|NCT03479346|Obesity|obesity
950322|NCT03479346|Metabolic syndrome|metabolic syndrome
950323|NCT03479346|Traditional Korean Medicine|traditional korean medicine
950324|NCT03479346|Galgeun-tang|galgeun-tang
950325|NCT03479255|Smartphone|smartphone
950326|NCT03479255|Exercise|exercise
950327|NCT03479255|Functional capacity|functional capacity
950328|NCT03479229|vaginal laxity|vaginal laxity
950329|NCT03479229|sexual function|sexual function
950330|NCT03479229|vaginal childbirth|vaginal childbirth
950331|NCT03479229|sexual dysfunction|sexual dysfunction
950332|NCT03479229|diminished sexual function|diminished sexual function
950333|NCT03479229|satisfaction|satisfaction
950334|NCT03479229|arousal|arousal
950342|NCT03479216|Dexmedetomidine|dexmedetomidine
950343|NCT03479216|Injections, Intra-Articular|injections, intra-articular
950344|NCT03479216|Magnesium|magnesium
950345|NCT03479216|Pain, Postoperative|pain, postoperative
950346|NCT03479203|Inflammation|inflammation
950347|NCT03479151|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
950348|NCT03479151|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
950349|NCT03479138|severe asthma|severe asthma
950350|NCT03479138|induced sputum|induced sputum
950351|NCT03479138|asthma phenotypes|asthma phenotypes
950352|NCT03479138|neutrophilic inflammation|neutrophilic inflammation
950353|NCT03479138|microbiome|microbiome
950354|NCT03479112|Tourniquets, Layperson, hemorrhage control, first responder|tourniquets, layperson, hemorrhage control, first responder
950355|NCT03479099|Lung cancer|lung cancer
950356|NCT03479099|Circulating Tumor Cell|circulating tumor cell
950357|NCT03479099|Cell-Free Tumor DNA|cell-free tumor dna
950358|NCT03479099|Liquid Biopsy|liquid biopsy
950359|NCT03479060|Wet cupping therapy|wet cupping therapy
950360|NCT03479060|Migraine|migraine
950362|NCT03479047|diaphragm ultrasound|diaphragm ultrasound
950363|NCT03479047|spontaneous breathing trial|spontaneous breathing trial
950364|NCT03479047|mechanical ventilation weaning|mechanical ventilation weaning
950365|NCT03479047|rapid shallow breathing index|rapid shallow breathing index
950366|NCT03479034|digital|digital
950367|NCT03479034|prescription|prescription
950368|NCT03479034|Application|application
950369|NCT03478995|Phase1b|phase1b
950377|NCT03478891|Ebola Virus|ebola virus
950378|NCT03478891|Immune Response|immune response
950379|NCT03478891|Filovirus|filovirus
950380|NCT03478891|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
950381|NCT03478891|First in Human|first in human
950382|NCT03478878|Eye Examinations|eye examinations
950383|NCT03478878|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
950384|NCT03478878|Retinal Pigment Epithelium|retinal pigment epithelium
950385|NCT03478865|Eye Examinations|eye examinations
950386|NCT03478865|Retinal Pigment Epithelium|retinal pigment epithelium
950395|NCT03478839|Idiopathic Infantile Arterial Calcification|idiopathic infantile arterial calcification
950397|NCT03478813|Intervention|intervention
950398|NCT03478813|Implementation|implementation
950399|NCT03478813|Children|children
950400|NCT03478813|Urotherapy|urotherapy
950401|NCT03478787|Plaque Psoriasis|plaque psoriasis
950402|NCT03478761|CYP24A1 mutation|cyp24a1 mutation
950403|NCT03478761|CYP24A1|cyp24a1
950404|NCT03478761|24-hydroxylase deficiency|24-hydroxylase deficiency
950405|NCT03478748|Dental caries|dental caries
950406|NCT03478748|Oral health literacy|oral health literacy
950407|NCT03478709|vasoplegia|vasoplegia
950408|NCT03478709|dynamic arterial elastance|dynamic arterial elastance
950409|NCT03478709|microcirculation|microcirculation
950410|NCT03478696|fluticasone furoate/umeclidinium/vilanterol|fluticasone furoate/umeclidinium/vilanterol
950411|NCT03478696|HRQoL|hrqol
950412|NCT03478696|COPD|copd
950413|NCT03478696|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
950414|NCT03478696|Tiotropium|tiotropium
950415|NCT03478696|Budesonide/formoterol|budesonide/formoterol
950416|NCT03478683|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
950417|NCT03478683|tiotropium|tiotropium
950418|NCT03478683|HRQoL|hrqol
950419|NCT03478683|Budesonide/formoterol|budesonide/formoterol
950420|NCT03478683|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
950421|NCT03478683|COPD|copd
950422|NCT03478670|gene therapy|gene therapy
950423|NCT03478670|retroviral vector|retroviral vector
950424|NCT03478670|inherited immune disorder|inherited immune disorder
950425|NCT03478670|ADA-SCID|ada-scid
950426|NCT03478670|GSK2696273|gsk2696273
950427|NCT03478670|Strimvelis|strimvelis
950428|NCT03478657|Asthma|asthma
950429|NCT03478657|Dry Powder Inhaler|dry powder inhaler
950430|NCT03478657|Metered Dose Inhaler|metered dose inhaler
950431|NCT03478657|Long Acting beta 2 Agonist|long acting beta 2 agonist
950432|NCT03478657|ELLIPTA|ellipta
950433|NCT03478631|nitrate|nitrate
950434|NCT03478631|vegetables|vegetables
950435|NCT03478605|olanzapine|olanzapine
950436|NCT03478605|aprepitant|aprepitant
950437|NCT03478605|CINV|cinv
950438|NCT03478605|nausea|nausea
950439|NCT03478605|vomiting|vomiting
950440|NCT03478605|nausea and vomiting|nausea and vomiting
950441|NCT03478605|antiemetics|antiemetics
950442|NCT03478592|Slow-freezing|slow-freezing
950443|NCT03478592|Vitrification|vitrification
950444|NCT03478592|Automated system|automated system
950445|NCT03478592|Embryos|embryos
950446|NCT03478592|Implantation|implantation
950447|NCT03478579|serious game|serious game
950448|NCT03478579|simulation|simulation
950449|NCT03478579|virtual emergency department|virtual emergency department
950450|NCT03478579|nontechnical skills|nontechnical skills
950451|NCT03478527|Probiotics|probiotics
950452|NCT03478527|Psychiatric Symptoms|psychiatric symptoms
950453|NCT03478527|Cognitive Function|cognitive function
950454|NCT03478527|Hippocampus|hippocampus
950455|NCT03478527|Oxytocin|oxytocin
950456|NCT03478527|Immunological Parameters|immunological parameters
950457|NCT03478514|mantle cell lymphoma|mantle cell lymphoma
950458|NCT03478514|B-cell lymphoma|b-cell lymphoma
950459|NCT03478501|firearm|firearm
950460|NCT03478501|lethal means|lethal means
950461|NCT03478501|decision aid|decision aid
950462|NCT03478475|Vitamin D|vitamin d
950463|NCT03478475|HOMA-IR|homa-ir
950464|NCT03478475|Glucose|glucose
950465|NCT03478475|HbA1C|hba1c
950466|NCT03478475|insulin resistance|insulin resistance
950467|NCT03478436|pharmacokinetics|pharmacokinetics
950468|NCT03478436|microdialysis|microdialysis
950469|NCT03478436|healthy volunteers|healthy volunteers
950470|NCT03478410|Epicardial fat|epicardial fat
950471|NCT03478397|cervical cancer prevention|cervical cancer prevention
950472|NCT03478397|self-collection HPV test|self-collection hpv test
950473|NCT03478397|mHealth|mhealth
950474|NCT03478397|Argentina|argentina
950475|NCT03478384|self-efficacy expectation|self-efficacy expectation
950476|NCT03478371|tampon|tampon
950477|NCT03478319|ACE-2494|ace-2494
950478|NCT03478241|Endodontic retreatment|endodontic retreatment
950479|NCT03478241|postoperative pain|postoperative pain
950480|NCT03478241|OneShape|oneshape
950481|NCT03478241|Revo-S|revo-s
950482|NCT03478241|WaveOne|waveone
950483|NCT03478228|fracture|fracture
950484|NCT03478228|rehabilitation|rehabilitation
950485|NCT03478228|wrist|wrist
950486|NCT03478228|sensation|sensation
950487|NCT03478228|exercise|exercise
950488|NCT03478215|kidney transplantation|kidney transplantation
950489|NCT03478215|graft rejection|graft rejection
950490|NCT03478176|Intraabdominal hypertension|intraabdominal hypertension
950491|NCT03478176|Kidney transplantation|kidney transplantation
950492|NCT03478163|Bakri|bakri
950493|NCT03478163|Intrauterine balloon tamponade|intrauterine balloon tamponade
950494|NCT03478163|Antibiotics|antibiotics
950495|NCT03478137|Cognition|cognition
950496|NCT03478137|Intervention|intervention
950497|NCT03478098|Gut hormones|gut hormones
950498|NCT03478098|Glucose excursions|glucose excursions
950499|NCT03478033|Tuberculosis|tuberculosis
950500|NCT03478033|AIDS|aids
950501|NCT03478033|Rifampicin|rifampicin
950502|NCT03478033|Rifabutin|rifabutin
950503|NCT03478007|Exercise Compliance|exercise compliance
950504|NCT03478007|Health Coaching|health coaching
950505|NCT03477994|dexmedetomidine, clonidine, postoperative, CABG|dexmedetomidine, clonidine, postoperative, cabg
950506|NCT03477955|spinopelvic alignment|spinopelvic alignment
950507|NCT03477955|short lumbosacral instrumentation|short lumbosacral instrumentation
950508|NCT03477955|PEEK|peek
950509|NCT03477955|silicon spacer|silicon spacer
950510|NCT03477929|In vitro fertilization|in vitro fertilization
950511|NCT03477929|gnrh antagonist|gnrh antagonist
950512|NCT03477929|pituitary suppression|pituitary suppression
950513|NCT03477903|Drug therapy|drug therapy
950514|NCT03477877|Intimate Partner Violence|intimate partner violence
950515|NCT03477877|Gender-Based violence|gender-based violence
950516|NCT03477877|Spouse Abuse|spouse abuse
950517|NCT03477877|Rwanda|rwanda
950518|NCT03477877|Heterosexual Couples|heterosexual couples
950519|NCT03477877|Activists|activists
950520|NCT03477877|Opinion Leaders|opinion leaders
950521|NCT03477877|Social Change|social change
950522|NCT03477877|Social-Ecological Model|social-ecological model
950523|NCT03477877|Diffusion of Innovation|diffusion of innovation
950524|NCT03477877|Cluster Randomized Controlled Trial|cluster randomized controlled trial
950525|NCT03477877|Community Randomized Controlled Trial|community randomized controlled trial
950526|NCT03477851|sciatic nerve block|sciatic nerve block
950527|NCT03477851|tramadol|tramadol
950528|NCT03477851|foot fracture|foot fracture
950529|NCT03477838|continuous glucose monitoring|continuous glucose monitoring
950530|NCT03477799|gambling disorder|gambling disorder
950531|NCT03477799|cognition|cognition
950532|NCT03477773|high-intensity interval training|high-intensity interval training
950533|NCT03477773|video games|video games
950534|NCT03477773|heart rate|heart rate
950535|NCT03477773|boxing|boxing
950536|NCT03477773|metabolic syndrome|metabolic syndrome
950537|NCT03477747|Microcurrent|microcurrent
950538|NCT03477747|Exercise training|exercise training
950539|NCT03477747|Hypertrophy|hypertrophy
950540|NCT03477747|Muscle damage|muscle damage
950541|NCT03477747|Recovery|recovery
950542|NCT03477747|Performance|performance
950543|NCT03477721|Agrin Fragment C-terminus (CAF)|agrin fragment c-terminus (caf)
950544|NCT03477669|Colic|colic
950545|NCT03477656|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
950546|NCT03477656|Desensitization|desensitization
950547|NCT03477656|Double Filtration PlasmaPherisis (DFPP)|double filtration plasmapherisis (dfpp)
950548|NCT03477656|Specific immunoadsorption|specific immunoadsorption
950549|NCT03477656|Living donor kidney transplantation|living donor kidney transplantation
950550|NCT03477630|gonarthrosis|gonarthrosis
950551|NCT03477604|Below the knee|below the knee
950552|NCT03477604|Stent|stent
950553|NCT03477591|Screening|screening
950554|NCT03477591|PSA testing|psa testing
950555|NCT03477591|Patient Decision Aid|patient decision aid
950556|NCT03477552|Sickle Cell Crisis|sickle cell crisis
950557|NCT03477552|intravenous catheter|intravenous catheter
950558|NCT03477552|transillumination|transillumination
950559|NCT03477526|pulmonary fibrosis|pulmonary fibrosis
950560|NCT03477526|COPD|copd
950561|NCT03477526|pulmonary rehabilitation|pulmonary rehabilitation
950562|NCT03477526|mental status (anxiety and depression)|mental status (anxiety and depression)
950563|NCT03477526|quality of life|quality of life
1640777|NCT00241618|Prospective|prospective
950564|NCT03477526|physical activity|physical activity
950565|NCT03477500|multiple sclerosis,|multiple sclerosis,
950566|NCT03477500|HSCT|hsct
950567|NCT03477500|alemtuzumab|alemtuzumab
950568|NCT03477500|RCT|rct
950569|NCT03477487|inflammation|inflammation
950570|NCT03477487|Cytokines|cytokines
950571|NCT03477487|Interleukin-10|interleukin-10
950572|NCT03477487|Gene therapy|gene therapy
950573|NCT03477474|Guardant Health|guardant health
950574|NCT03477435|smoking|smoking
950575|NCT03477435|tobacco dependence|tobacco dependence
950576|NCT03477435|quitline|quitline
950577|NCT03477435|smoking cessation|smoking cessation
950578|NCT03477422|CSE-1034 Double Blind Study|cse-1034 double blind study
950579|NCT03477422|Elores|elores
950580|NCT03477422|Meropenem|meropenem
950581|NCT03477422|PLEA-CT|plea-ct
950582|NCT03477422|Bacterial Infections|bacterial infections
950583|NCT03477422|ESBL|esbl
950584|NCT03477422|MBL|mbl
950585|NCT03477422|beta-lactamase|beta-lactamase
950586|NCT03477422|Anti-Infective Agents, Urinary|anti-infective agents, urinary
950587|NCT03477422|Anti-Infective Agents|anti-infective agents
951674|NCT03471078|CIT|cit
950588|NCT03477422|Urinary Tract Infections|urinary tract infections
950589|NCT03477422|Pyelonephritis|pyelonephritis
950590|NCT03477422|Infection|infection
950591|NCT03477422|Sulbactam|sulbactam
950592|NCT03477422|EDTA|edta
950593|NCT03477422|Disodium EDTA|disodium edta
950594|NCT03477422|Antibiotic Adjuvant Entity|antibiotic adjuvant entity
950595|NCT03477422|Antibiotic Resistance Breaker|antibiotic resistance breaker
950596|NCT03477409|plasticizers|plasticizers
950597|NCT03477409|medical devices|medical devices
950598|NCT03477409|neonates|neonates
950599|NCT03477409|exposition|exposition
950600|NCT03477383|diagnosis|diagnosis
950601|NCT03477383|economics|economics
950602|NCT03477383|cell-free DNA|cell-free dna
950603|NCT03477383|digital droplet PCR|digital droplet pcr
950604|NCT03477383|heart failure|heart failure
950605|NCT03477344|Cardiac Surgery|cardiac surgery
950606|NCT03477344|Delirium|delirium
950607|NCT03477344|Sleep deprivation|sleep deprivation
950608|NCT03477331|Direct oral anticoagulant|direct oral anticoagulant
950609|NCT03477331|P2Y12 inhibitors|p2y12 inhibitors
950610|NCT03477331|Physiologically-based pharmacokinetic model (PBPK)|physiologically-based pharmacokinetic model (pbpk)
950611|NCT03477331|Population-based pharmacokinetic model (POPPK)|population-based pharmacokinetic model (poppk)
950612|NCT03477318|colonoscopy, polyp, endoscopist|colonoscopy, polyp, endoscopist
950613|NCT03477305|older adults|older adults
950614|NCT03477305|community gardening|community gardening
950615|NCT03477305|cooperative extension|cooperative extension
950616|NCT03477279|couple HIV testing and counseling|couple hiv testing and counseling
950617|NCT03477279|disclosure|disclosure
950618|NCT03477279|Malawi|malawi
950619|NCT03477266|Postoperative ileus|postoperative ileus
950620|NCT03477266|mosapride|mosapride
950621|NCT03477266|mouth dissolving tablets|mouth dissolving tablets
950622|NCT03477266|Intraoperative vomiting|intraoperative vomiting
950623|NCT03477240|Cervical Cancer|cervical cancer
950624|NCT03477240|TELEPHONIC QUESTIONNAIRE|telephonic questionnaire
950625|NCT03477240|Follow up|follow up
950626|NCT03477227|compression stocking|compression stocking
950627|NCT03477227|elastic stocking|elastic stocking
950628|NCT03477227|endovenous radiofrequency ablation|endovenous radiofrequency ablation
950629|NCT03477227|compression therapy|compression therapy
950630|NCT03477188|Stroke|stroke
950631|NCT03477188|Vestibular|vestibular
950632|NCT03477188|Somatosensory|somatosensory
950633|NCT03477188|Rehabilitation|rehabilitation
950634|NCT03477188|Balance|balance
950635|NCT03477175|lenvatinib|lenvatinib
950636|NCT03477175|E7080|e7080
950637|NCT03477149|liquid embolics|liquid embolics
950638|NCT03477123|Incomplete spinal cord injury|incomplete spinal cord injury
950639|NCT03477123|Walking|walking
950640|NCT03477123|Rehabilitation|rehabilitation
950641|NCT03477123|Robotic exoskeleton|robotic exoskeleton
950642|NCT03477097|Frailty|frailty
950643|NCT03477097|Social Determinants|social determinants
950644|NCT03477097|Biological Risk Factors|biological risk factors
950645|NCT03477097|Intervention|intervention
950646|NCT03477097|Cost Effectiveness|cost effectiveness
950647|NCT03477071|Transplant renal artery stenosis|transplant renal artery stenosis
950648|NCT03477071|Endovascular repair|endovascular repair
950649|NCT03477071|Post-operative outcome|post-operative outcome
950650|NCT03477058|chronic pruritus|chronic pruritus
950651|NCT03477058|acute pruritus|acute pruritus
950652|NCT03477045|omega 3 polyunsaturated fatty acid|omega 3 polyunsaturated fatty acid
950653|NCT03477045|camelina sativa|camelina sativa
950654|NCT03477045|fatty acid composition|fatty acid composition
950655|NCT03477045|immune modulation|immune modulation
950656|NCT03477019|Ultrasonic Therapy|ultrasonic therapy
950657|NCT03477019|Liver|liver
950658|NCT03477019|Neoplasm Metastasis|neoplasm metastasis
950659|NCT03476993|primary biliary cholangitis|primary biliary cholangitis
950660|NCT03476993|IL-17 monoclonal antibody|il-17 monoclonal antibody
1333206|NCT01444001|pneumococcal protein|pneumococcal protein
950661|NCT03476980|Neurodevelopmental impairment, prematurity|neurodevelopmental impairment, prematurity
950662|NCT03476980|Disability|disability
950663|NCT03476980|Umbilical cord milking|umbilical cord milking
950664|NCT03476980|Delayed cord clamping|delayed cord clamping
950665|NCT03476967|optic disc topography|optic disc topography
950666|NCT03476967|panretinal photocoagulation|panretinal photocoagulation
950667|NCT03476967|confocal scanning laser ophthalmoscopy|confocal scanning laser ophthalmoscopy
950668|NCT03476967|stereoscopic disc photographs|stereoscopic disc photographs
950669|NCT03476967|diabetic retinopathy|diabetic retinopathy
950670|NCT03476967|optic nerve head parameters|optic nerve head parameters
950672|NCT03476902|Mobile|mobile
950673|NCT03476902|Technology|technology
950675|NCT03476902|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
950676|NCT03476876|acellular matrix|acellular matrix
950677|NCT03476837|secondhand smoke, African Americans, policies, tobacco use|secondhand smoke, african americans, policies, tobacco use
950678|NCT03476785|LVH|lvh
950679|NCT03476785|Ventricular Stiffness|ventricular stiffness
950680|NCT03476785|Fitness|fitness
950681|NCT03476785|HFpEF|hfpef
950682|NCT03476733|Drug related problem|drug related problem
950683|NCT03476733|inpatient|inpatient
950684|NCT03476733|Medication Error|medication error
950685|NCT03476733|Clinical Pharmacist|clinical pharmacist
950686|NCT03476681|NEO-201|neo-201
950687|NCT03476681|Monoclonal Antibody|monoclonal antibody
950688|NCT03476681|Colorectal Cancer|colorectal cancer
950689|NCT03476681|Pancreatic Cancer|pancreatic cancer
950690|NCT03476681|Adenocarcinoma of Lung|adenocarcinoma of lung
950691|NCT03476681|Squamous Cell Lung Cancer|squamous cell lung cancer
950692|NCT03476681|Breast Cancer|breast cancer
950693|NCT03476681|Mucinous Carcinoma of Ovary|mucinous carcinoma of ovary
950694|NCT03476681|Signet Ring Cell Carcinoma of Ovary|signet ring cell carcinoma of ovary
950695|NCT03476629|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
950696|NCT03476629|Rehabilitation|rehabilitation
950697|NCT03476629|Distance Traveled|distance traveled
950698|NCT03476629|Functional Capacity|functional capacity
950699|NCT03476629|Autonomic Nervous System|autonomic nervous system
950700|NCT03476616|Hypertension|hypertension
950701|NCT03476616|Obesity|obesity
950702|NCT03476616|Ambulatory Blood Pressure|ambulatory blood pressure
950703|NCT03476616|Eplerenone|eplerenone
950704|NCT03476616|Valsartan|valsartan
950705|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
950706|NCT03476616|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
950707|NCT03476603|Bariatric surgery|bariatric surgery
950708|NCT03476603|Gastrointestinal tract|gastrointestinal tract
950709|NCT03476603|Biological availability|biological availability
950710|NCT03476603|Pharmacokinetics|pharmacokinetics
950711|NCT03476603|Irbesartan|irbesartan
950712|NCT03476590|heart failure|heart failure
950713|NCT03476590|ambulatory care|ambulatory care
950714|NCT03476590|telemedicine|telemedicine
950715|NCT03476590|impedance cardiography|impedance cardiography
950716|NCT03476577|Bariatric surgery|bariatric surgery
950717|NCT03476577|Gastrointestinal tract|gastrointestinal tract
950718|NCT03476577|Biological availability|biological availability
950719|NCT03476577|Pharmacokinetics|pharmacokinetics
950720|NCT03476577|Ibuprofen|ibuprofen
950721|NCT03476564|assisted reproductive techniques|assisted reproductive techniques
950722|NCT03476551|Bariatric surgery|bariatric surgery
950723|NCT03476551|Gastrointestinal tract|gastrointestinal tract
950724|NCT03476551|Biological availability|biological availability
950725|NCT03476551|Pharmacokinetics|pharmacokinetics
950726|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide
950727|NCT03476538|Bariatric surgery|bariatric surgery
950728|NCT03476538|Gastrointestinal tract|gastrointestinal tract
950729|NCT03476538|Biological availability|biological availability
950730|NCT03476538|Pharmacokinetics|pharmacokinetics
950731|NCT03476538|Gabapentin|gabapentin
950732|NCT03476525|Bariatric surgery|bariatric surgery
950733|NCT03476525|Gastrointestinal tract|gastrointestinal tract
950734|NCT03476525|Biological availability|biological availability
950735|NCT03476525|Pharmacokinetics|pharmacokinetics
950736|NCT03476525|Fluoxetine|fluoxetine
950737|NCT03476512|Treatment adherence|treatment adherence
950738|NCT03476512|Ambulatory hypertensive patients|ambulatory hypertensive patients
950739|NCT03476512|Blood pressure|blood pressure
950740|NCT03476512|Non-pharmacological measures|non-pharmacological measures
950741|NCT03476473|Asthma|asthma
950742|NCT03476473|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
950743|NCT03476473|Spirometry|spirometry
950744|NCT03476473|Lung disease|lung disease
950745|NCT03476473|Smoke|smoke
950746|NCT03476460|Acute kidney failure|acute kidney failure
950747|NCT03476460|CT scan|ct scan
950748|NCT03476460|Iodine contrast|iodine contrast
950749|NCT03476460|Sodium chloride|sodium chloride
950847|NCT03475849|Obesity|obesity
950750|NCT03476434|sessile serrated polyp|sessile serrated polyp
950751|NCT03476434|chromoendoscopy|chromoendoscopy
950752|NCT03476434|indigo carmine|indigo carmine
950753|NCT03476382|Osteoarthritis|osteoarthritis
950754|NCT03476382|Knee|knee
950755|NCT03476382|Bone Growth Stimulators|bone growth stimulators
950756|NCT03476382|Rheumatic Diseases|rheumatic diseases
950757|NCT03476382|Musculoskeletal Diseases|musculoskeletal diseases
950758|NCT03476382|Joint Diseases|joint diseases
950759|NCT03476382|Arthritis|arthritis
950760|NCT03476343|NICU|nicu
950761|NCT03476343|MRI|mri
950762|NCT03476343|Neonatal|neonatal
950763|NCT03476343|Cincinnati|cincinnati
950764|NCT03476330|Hematopoietic cell transplantation|hematopoietic cell transplantation
950765|NCT03476291|macular diseases|macular diseases
950766|NCT03476291|screening|screening
950767|NCT03476291|OCT|oct
950768|NCT03476291|Deep learning|deep learning
950769|NCT03476291|AI|ai
950770|NCT03476278|Outcome Assessment (Health Care)|outcome assessment (health care)
950771|NCT03476278|Patient Satisfaction|patient satisfaction
950772|NCT03476278|Perioperative Period|perioperative period
950773|NCT03476278|Regional Anesthesia|regional anesthesia
950774|NCT03476278|Surveys and Questionnaires|surveys and questionnaires
950775|NCT03476239|Relapsed|relapsed
950776|NCT03476239|Refractory|refractory
950777|NCT03476239|B-precursor|b-precursor
950778|NCT03476239|Acute Lymphoblastic|acute lymphoblastic
950779|NCT03476239|Leukemia ALL|leukemia all
950780|NCT03476239|Blinatumomab|blinatumomab
950781|NCT03476239|Chinese Adult Subjects|chinese adult subjects
950782|NCT03476226|Quality of Life|quality of life
950783|NCT03476226|Cognitive Dysfunction|cognitive dysfunction
950784|NCT03476226|Breast Cancer|breast cancer
950785|NCT03476213|Anesthesia Awareness|anesthesia awareness
950786|NCT03476213|Dreaming in anesthesia|dreaming in anesthesia
950787|NCT03476213|Total intravenous anesthesia|total intravenous anesthesia
950788|NCT03476213|Target-controll infusion|target-controll infusion
950789|NCT03476200|Cognitive Behavioral Therapy|cognitive behavioral therapy
950790|NCT03476200|Hair Cortisol|hair cortisol
950791|NCT03476200|Hypothalamic Pituitary Adrenal Axis|hypothalamic pituitary adrenal axis
950792|NCT03476200|Stress|stress
950793|NCT03476200|Psychopathology|psychopathology
950794|NCT03476135|Meningococcal Meningitis|meningococcal meningitis
950795|NCT03476135|MenACYW conjugate vaccine|menacyw conjugate vaccine
950796|NCT03476135|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
950797|NCT03476122|Colorectal cancer|colorectal cancer
950798|NCT03476122|CRC|crc
950799|NCT03476122|Circulating tumor cells|circulating tumor cells
950800|NCT03476122|CTCs|ctcs
950801|NCT03476122|Early detection|early detection
950802|NCT03476122|Automated|automated
950803|NCT03476096|pregnancy|pregnancy
950804|NCT03476096|microcirculation|microcirculation
950805|NCT03476083|Mother to Child Transmission|mother to child transmission
950806|NCT03476083|Hepatitis B Infection|hepatitis b infection
950807|NCT03476083|Congenital Defects or Malformation|congenital defects or malformation
950808|NCT03476083|Hepatitis B Vaccine|hepatitis b vaccine
950809|NCT03476083|Hepatitis B Immunoglobulin|hepatitis b immunoglobulin
950810|NCT03476083|Pregnancy|pregnancy
950811|NCT03476083|Antiviral Treatment|antiviral treatment
950812|NCT03476070|Adolescents and Young Adults (AYA)|adolescents and young adults (aya)
950813|NCT03476070|breast cancer|breast cancer
950814|NCT03476070|lymphoma|lymphoma
950815|NCT03476070|germ cell tumor|germ cell tumor
950816|NCT03476070|cognitive impairment|cognitive impairment
950817|NCT03476070|survivorship|survivorship
950818|NCT03476070|Singapore|singapore
950819|NCT03476057|NGS|ngs
950820|NCT03476057|cfDNA|cfdna
950821|NCT03476057|OS|os
950822|NCT03475966|Nutrition|nutrition
950823|NCT03475966|Exercise|exercise
950824|NCT03475966|Relaxation techniques|relaxation techniques
950825|NCT03475966|Prehabilitation|prehabilitation
950826|NCT03475953|Advanced solid tumor|advanced solid tumor
950827|NCT03475953|Metastatic tumor|metastatic tumor
950828|NCT03475953|Phase Ib/II trial|phase ib/ii trial
950829|NCT03475953|Colorectal cancer not MSI-H or MMR-deficient|colorectal cancer not msi-h or mmr-deficient
950830|NCT03475953|GIST|gist
950831|NCT03475953|Oesophageal or Gastric Carcinoma|oesophageal or gastric carcinoma
950832|NCT03475953|Biliary Tract cancer|biliary tract cancer
950833|NCT03475953|Hepatocellular Carcinoma|hepatocellular carcinoma
950834|NCT03475914|Psoriasis Guttate, Psoriasis vulgaris|psoriasis guttate, psoriasis vulgaris
950835|NCT03475901|procedural anxiety|procedural anxiety
950836|NCT03475901|virtual reality|virtual reality
950837|NCT03475901|anxiolysis|anxiolysis
950838|NCT03475901|laceration repair|laceration repair
950839|NCT03475901|pediatric|pediatric
950840|NCT03475888|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
950841|NCT03475888|Ventricular Arrythmia|ventricular arrythmia
950842|NCT03475888|Sustained VT|sustained vt
950843|NCT03475888|Ventricular Fibrillation|ventricular fibrillation
950844|NCT03475888|Implantable loop recorder|implantable loop recorder
950845|NCT03475849|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
950846|NCT03475849|Bile Acid Circulation|bile acid circulation
950848|NCT03475849|Bariatric Surgery|bariatric surgery
950849|NCT03475836|Mentha|mentha
950850|NCT03475836|Mint|mint
950851|NCT03475836|Essential oil|essential oil
950852|NCT03475836|Cognition|cognition
950853|NCT03475836|Mood|mood
950854|NCT03475836|Humans|humans
950855|NCT03475810|VIRTUAL REALITY|virtual reality
950856|NCT03475810|ANXIETY|anxiety
950857|NCT03475810|SPINAL ANESTHESIA|spinal anesthesia
950858|NCT03475745|resting-state|resting-state
950859|NCT03475745|DTI|dti
950860|NCT03475745|aphasia|aphasia
950861|NCT03475745|stroke|stroke
950862|NCT03475732|XueBiJing injection|xuebijing injection
950863|NCT03475732|Sepsis|sepsis
950864|NCT03475732|Septic shock|septic shock
950865|NCT03475732|Pharmacokinetics|pharmacokinetics
950866|NCT03475706|overactive bladder|overactive bladder
950867|NCT03475706|urinary conditions|urinary conditions
950868|NCT03475706|urgency urinary incontinence|urgency urinary incontinence
950869|NCT03475706|urgency|urgency
950870|NCT03475706|micturitions|micturitions
950871|NCT03475680|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
950872|NCT03475680|Oral antibiotics|oral antibiotics
950873|NCT03475680|Colon cancer surgery|colon cancer surgery
950874|NCT03475680|Surgical site infection|surgical site infection
950875|NCT03475667|Septic Shock|septic shock
950876|NCT03475667|hemodynamic monitoring|hemodynamic monitoring
950877|NCT03475667|blood pressure determination|blood pressure determination
950878|NCT03475654|exercise|exercise
950879|NCT03475654|therapy|therapy
950880|NCT03475654|rehabilitation|rehabilitation
950881|NCT03475654|home|home
950882|NCT03475641|pain|pain
950883|NCT03475641|femoral nerve blockade|femoral nerve blockade
950884|NCT03475641|varicose vein|varicose vein
950885|NCT03475589|apatinib； Adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer|apatinib； adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer
950886|NCT03475576|elderly|elderly
950887|NCT03475576|caregiving|caregiving
950888|NCT03475576|needs|needs
950889|NCT03475576|support|support
950890|NCT03475563|Drug-eluting stent|drug-eluting stent
950891|NCT03475563|Dedicated bifurcation stent|dedicated bifurcation stent
950892|NCT03475563|Cobalt-chromium|cobalt-chromium
950893|NCT03475563|Sirolimus-eluting stent|sirolimus-eluting stent
950894|NCT03475485|Ingestion event marker|ingestion event marker
950895|NCT03475485|Ingestible sensor|ingestible sensor
950896|NCT03475485|Medication adherence|medication adherence
950897|NCT03475485|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
950898|NCT03475459|QTc prolongation effect|qtc prolongation effect
950899|NCT03475446|Cognitive Training|cognitive training
950900|NCT03475446|Memory Impairment|memory impairment
950901|NCT03475446|Mild Cognitive Impairment|mild cognitive impairment
950902|NCT03475446|Alzheimer's Disease|alzheimer's disease
950903|NCT03475446|tES|tes
950904|NCT03475446|tACS|tacs
950905|NCT03475446|tDCS|tdcs
950906|NCT03475433|Cancer|cancer
950907|NCT03475433|Questionnaire|questionnaire
950908|NCT03475433|Survey|survey
950909|NCT03475433|Sleep Disturbance|sleep disturbance
950910|NCT03475433|Sleep Quality|sleep quality
950911|NCT03475433|E-health|e-health
950912|NCT03475433|M-health|m-health
950913|NCT03475433|Actigraphy|actigraphy
950914|NCT03475433|Physical activity|physical activity
950915|NCT03475433|Dyssomnias Medical Subject Headings [MeSH]|dyssomnias medical subject headings [mesh]
950916|NCT03475433|Sleep Wake Disorders [MeSH]|sleep wake disorders [mesh]
950917|NCT03475433|Parasomnias [MeSH]|parasomnias [mesh]
950918|NCT03475433|Nervous System Diseases [MeSH]|nervous system diseases [mesh]
950919|NCT03475433|Mental Disorders [MeSH]|mental disorders [mesh]
950920|NCT03475433|Neurologic Manifestations [MeSH]|neurologic manifestations [mesh]
950921|NCT03475433|Signs and Symptoms [MeSH]|signs and symptoms [mesh]
950922|NCT03475433|Telemedicine [MeSH]|telemedicine [mesh]
950923|NCT03475433|Actigraphy [MeSH]|actigraphy [mesh]
950924|NCT03475433|Quality of Life [MeSH]|quality of life [mesh]
950925|NCT03475433|Motor Activity [MeSH]|motor activity [mesh]
950926|NCT03475433|Breast Neoplasms [MeSH]|breast neoplasms [mesh]
950927|NCT03475433|Prostatic Neoplasms [MeSH]|prostatic neoplasms [mesh]
950928|NCT03475433|Sleep Hygiene [MeSH]|sleep hygiene [mesh]
950929|NCT03475433|Neoplasms [MeSH]|neoplasms [mesh]
950930|NCT03475407|Diabetic macular edema|diabetic macular edema
950931|NCT03475407|cytokine|cytokine
950932|NCT03475407|dexamethasone|dexamethasone
950933|NCT03475394|Chlorhexidine gluconate|chlorhexidine gluconate
950934|NCT03475394|Morus alba|morus alba
950935|NCT03475394|Microbiology|microbiology
950936|NCT03475394|Gel|gel
950937|NCT03475394|Root planing|root planing
950938|NCT03475381|Cystic Fibrosis|cystic fibrosis
950939|NCT03475381|ivacaftor|ivacaftor
950940|NCT03475381|lumacaftor|lumacaftor
950941|NCT03475355|action observation|action observation
950942|NCT03475355|parkinson's disease|parkinson's disease
950943|NCT03475355|physical therapy|physical therapy
950944|NCT03475355|home-based|home-based
950945|NCT03475355|neural plasticity|neural plasticity
950946|NCT03475355|telerehabilitation|telerehabilitation
951049|NCT03474653|Bulking|bulking
950947|NCT03475342|prevention, postpartum haemorrhage|prevention, postpartum haemorrhage
950948|NCT03475342|moderate anaemia|moderate anaemia
950949|NCT03475342|severe anaemia|severe anaemia
950950|NCT03475342|antifibrinolytic|antifibrinolytic
950951|NCT03475342|tranexamic acid|tranexamic acid
950952|NCT03475342|pregnancy|pregnancy
950953|NCT03475329|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy
950954|NCT03475290|e-mental health|e-mental health
950955|NCT03475290|stress|stress
950956|NCT03475290|burnout|burnout
950957|NCT03475290|self-efficacy|self-efficacy
950958|NCT03475290|social support|social support
950959|NCT03475264|Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,|lung mri, bronchopulmonary dysplasia, hyperpolarized xenon,
950960|NCT03475238|critical care|critical care
950961|NCT03475225|Epilepsy|epilepsy
950962|NCT03475225|Drug-resistance|drug-resistance
950963|NCT03475225|Vitamin D deficiency|vitamin d deficiency
950964|NCT03475225|Metabolism|metabolism
950965|NCT03475225|Controlled study antiepileptic drugs|controlled study antiepileptic drugs
950966|NCT03475212|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
950967|NCT03475212|Primary Immune Deficiency Disease|primary immune deficiency disease
950968|NCT03475186|Memory|memory
950969|NCT03475186|Brain Cancer|brain cancer
950970|NCT03475186|Ramipril|ramipril
950971|NCT03475173|Optic Neuropathy|optic neuropathy
950972|NCT03475173|, Retinopathy|, retinopathy
950973|NCT03475095|Low Back Pain|low back pain
950977|NCT03475095|functional magnetic resonanceimaging|functional magnetic resonanceimaging
950978|NCT03475095|effect mechanism|effect mechanism
950979|NCT03475095|Chronic nonspecific low Back pain|chronic nonspecific low back pain
950980|NCT03475069|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
950982|NCT03475069|Physical Performance|physical performance
950983|NCT03475069|Physiological Cost Index|physiological cost index
950984|NCT03475056|Marburg virus|marburg virus
950985|NCT03475056|Marburg vaccine|marburg vaccine
950986|NCT03475056|cAd3-Marburg vaccine|cad3-marburg vaccine
950991|NCT03474965|SEG101|seg101
950992|NCT03474965|Sickle cell disease|sickle cell disease
950993|NCT03474965|crizanlizumab|crizanlizumab
950994|NCT03474965|pediatric|pediatric
950995|NCT03474965|pharmacokinetic|pharmacokinetic
950996|NCT03474965|P-selectin|p-selectin
950997|NCT03474952|remote ischemic preconditioning|remote ischemic preconditioning
950998|NCT03474952|free flap reconstruction|free flap reconstruction
950999|NCT03474952|tissue oxygen saturation|tissue oxygen saturation
951000|NCT03474926|urothelial cancer|urothelial cancer
951001|NCT03474926|nephroureterectomy|nephroureterectomy
951002|NCT03474926|Upper urinary tract|upper urinary tract
951003|NCT03474913|Prostate Cancer|prostate cancer
951004|NCT03474913|Magnetic Resonance Imaging|magnetic resonance imaging
951005|NCT03474913|case cross over|case cross over
951006|NCT03474913|diagnostic|diagnostic
951007|NCT03474913|clinical trial|clinical trial
951008|NCT03474913|prostate imaging|prostate imaging
951009|NCT03474913|PSA|psa
951010|NCT03474900|intramedullary nailing|intramedullary nailing
951011|NCT03474900|randomised controlled trial|randomised controlled trial
951012|NCT03474900|biodegradable|biodegradable
951013|NCT03474900|children|children
951014|NCT03474900|forearm shaft fractures|forearm shaft fractures
951015|NCT03474887|Telemedicine|telemedicine
951016|NCT03474887|Remote consultation|remote consultation
951017|NCT03474887|Mobile health|mobile health
951018|NCT03474887|Telehealth|telehealth
951019|NCT03474887|mhealth|mhealth
951020|NCT03474887|eVisits|evisits
951021|NCT03474887|eConsultation|econsultation
951022|NCT03474887|ehealth|ehealth
951023|NCT03474848|cerebral palsy|cerebral palsy
951024|NCT03474848|rehabilitation|rehabilitation
951025|NCT03474848|hand function|hand function
951026|NCT03474848|daily functioning|daily functioning
951027|NCT03474848|hand-arm bimanual intensive training|hand-arm bimanual intensive training
951028|NCT03474835|atherosclerosis|atherosclerosis
951029|NCT03474835|angiogenesis|angiogenesis
951030|NCT03474835|cardiooncology|cardiooncology
951031|NCT03474822|Advanced breast cancer|advanced breast cancer
951032|NCT03474822|advanced liver cancer|advanced liver cancer
951033|NCT03474822|Plasmodium immunotherapy|plasmodium immunotherapy
951034|NCT03474822|Plasmodiun vivax|plasmodiun vivax
951035|NCT03474809|Sepsis, PSP, Abionic|sepsis, psp, abionic
951036|NCT03474718|scalp|scalp
951037|NCT03474718|hair loss|hair loss
951038|NCT03474718|platelet-rich plasma therapy|platelet-rich plasma therapy
951039|NCT03474705|Clinical Pain|clinical pain
951040|NCT03474705|Hyperalgesia|hyperalgesia
951041|NCT03474705|Intervention|intervention
951042|NCT03474705|Musculoskeletal disorders|musculoskeletal disorders
951043|NCT03474705|Computer Work|computer work
951044|NCT03474705|Strength Training|strength training
951045|NCT03474666|Liver Transplantation|liver transplantation
951046|NCT03474666|Surgical Wound Infection|surgical wound infection
951047|NCT03474666|Hiperglycemia|hiperglycemia
1641754|NCT00237367|esophagus|esophagus
951048|NCT03474653|Stress urinary incontinence|stress urinary incontinence
951051|NCT03474640|immunotherapy|immunotherapy
951052|NCT03474640|check point inhibitor|check point inhibitor
951053|NCT03474640|PD-1 antibody|pd-1 antibody
951054|NCT03474640|solid tumor|solid tumor
951055|NCT03474640|esophageal carcinoma|esophageal carcinoma
951056|NCT03474640|gastric carcinoma|gastric carcinoma
951057|NCT03474640|nasopharyngeal carcinoma|nasopharyngeal carcinoma
951058|NCT03474640|endometrial cancer|endometrial cancer
951059|NCT03474640|soft tissue sarcoma|soft tissue sarcoma
951060|NCT03474640|orphan tumors|orphan tumors
951061|NCT03474640|phase 1 trial|phase 1 trial
951062|NCT03474601|Pituitary Diseases|pituitary diseases
951063|NCT03474601|Pituitary incidentaloma|pituitary incidentaloma
951064|NCT03474601|Central Diabetes Insipidus|central diabetes insipidus
951065|NCT03474601|Pituitary Neoplasms|pituitary neoplasms
951066|NCT03474575|homecare, COPD, Exacerbation|homecare, copd, exacerbation
951067|NCT03474549|Mechanical thrombectomy,|mechanical thrombectomy,
951068|NCT03474549|Brain|brain
951069|NCT03474549|Brain clot|brain clot
951070|NCT03474549|Brain infarction|brain infarction
951071|NCT03474549|Cerebral ischemia|cerebral ischemia
951072|NCT03474549|Neurovascular intervention|neurovascular intervention
951073|NCT03474549|Revascularization|revascularization
951074|NCT03474549|Reperfusion|reperfusion
951075|NCT03474549|Stent retriever|stent retriever
951076|NCT03474549|Tigertriever|tigertriever
951077|NCT03474549|Stroke|stroke
951078|NCT03474549|Rapid Medical|rapid medical
951079|NCT03474536|Lung transplantation|lung transplantation
951080|NCT03474536|HLA antibodies|hla antibodies
951081|NCT03474536|concentration|concentration
951082|NCT03474536|affinity|affinity
951083|NCT03474536|surface plasmon resonance|surface plasmon resonance
951084|NCT03474523|radio frequency diathermy|radio frequency diathermy
951085|NCT03474523|cavitation|cavitation
951086|NCT03474523|ultrasound|ultrasound
951087|NCT03474523|edemato-fibrosclerotic panniculopathy|edemato-fibrosclerotic panniculopathy
951088|NCT03474523|cellulitis|cellulitis
951089|NCT03474510|pain control|pain control
951090|NCT03474510|EXPAREL|exparel
951091|NCT03474510|shoulder surgery|shoulder surgery
951092|NCT03474510|continuous interscalene nerve block|continuous interscalene nerve block
951093|NCT03474484|Biomarkers|biomarkers
951094|NCT03474484|Sensitivity and Specificity|sensitivity and specificity
951095|NCT03474484|Clinical Deterioration|clinical deterioration
951096|NCT03474380|Caregiver|caregiver
951097|NCT03474380|Veterans|veterans
951098|NCT03474380|Skills training|skills training
951099|NCT03474380|Informal care|informal care
951100|NCT03474380|Days at home|days at home
951101|NCT03474367|Unplanned Peritoneal Dialysis|unplanned peritoneal dialysis
951102|NCT03474367|Unplanned Hemodialysis|unplanned hemodialysis
951103|NCT03474367|Cost-Benefit Analysis|cost-benefit analysis
951104|NCT03474367|Dialysis|dialysis
951105|NCT03474367|Peritoneal Dialysis|peritoneal dialysis
951106|NCT03474367|Hemodialysis|hemodialysis
951107|NCT03474354|chemoembolization|chemoembolization
951108|NCT03474354|drug eluting beads|drug eluting beads
951109|NCT03474341|Neoadjuvant chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
951110|NCT03474341|Pathologic complete response (pCR)|pathologic complete response (pcr)
951111|NCT03474341|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
951112|NCT03474341|PET-CT|pet-ct
951113|NCT03474341|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
951114|NCT03474341|endoscopy|endoscopy
951115|NCT03474315|Cardiac implantable electronic device|cardiac implantable electronic device
951116|NCT03474315|Cardiac resynchronization therapy|cardiac resynchronization therapy
951117|NCT03474315|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
951118|NCT03474315|Machine learning|machine learning
951119|NCT03474315|Mobile application|mobile application
951120|NCT03474315|Patient's assistance|patient's assistance
951121|NCT03474302|African American|african american
951122|NCT03474302|Aging|aging
951123|NCT03474302|Physical activity|physical activity
951124|NCT03474302|Cognition|cognition
951125|NCT03474276|Children|children
951126|NCT03474276|Africa|africa
951127|NCT03474276|Metagenomic|metagenomic
951128|NCT03474276|Prebiotic|prebiotic
951129|NCT03474276|Randomized Controlled Trial|randomized controlled trial
951130|NCT03474276|Pragmatic trial|pragmatic trial
951131|NCT03474276|Azithromycin|azithromycin
951132|NCT03474276|Cognitive impairment|cognitive impairment
951133|NCT03474263|Motor Neurone Disease (MND)|motor neurone disease (mnd)
951134|NCT03474263|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
951135|NCT03474237|algorithms|algorithms
951136|NCT03474237|adrenal adenoma|adrenal adenoma
951137|NCT03474237|cushing syndrome|cushing syndrome
951138|NCT03474237|pheochromocytoma|pheochromocytoma
951139|NCT03474237|adrenal incidentaloma|adrenal incidentaloma
951140|NCT03474237|adreocortical carcinoma|adreocortical carcinoma
951141|NCT03474237|primary hyperaldosteronism|primary hyperaldosteronism
951142|NCT03474224|stroke volume|stroke volume
951143|NCT03474224|goal directed therapy|goal directed therapy
951144|NCT03474224|major abdominal surgery|major abdominal surgery
951145|NCT03474172|Pediatric Tuina|pediatric tuina
951146|NCT03474172|Massage therapy|massage therapy
951148|NCT03474172|Sham massage|sham massage
951149|NCT03474172|Sham device|sham device
951150|NCT03474159|Bicuspid aortic valve|bicuspid aortic valve
951151|NCT03474159|aortic aneurysm|aortic aneurysm
951152|NCT03474159|stiffness|stiffness
951153|NCT03474159|Pulse wave velocity|pulse wave velocity
951154|NCT03474146|Mouthrinse|mouthrinse
951155|NCT03474146|Ocimum sanctum|ocimum sanctum
951156|NCT03474146|Periodontal Diseases|periodontal diseases
951157|NCT03474146|Tulsi|tulsi
951158|NCT03474133|Hodgkin's lymphoma|hodgkin's lymphoma
951159|NCT03474133|Hodgkin lymphoma|hodgkin lymphoma
951160|NCT03474133|relapsed|relapsed
951161|NCT03474133|refractory|refractory
951162|NCT03474133|brentuximab vedotin|brentuximab vedotin
951163|NCT03474133|autologous stem cell transplantation|autologous stem cell transplantation
951164|NCT03474120|Genetic causes|genetic causes
951165|NCT03474120|etiology|etiology
951166|NCT03474120|POI|poi
951167|NCT03474120|DOR|dor
951168|NCT03474107|antibody drug conjugate|antibody drug conjugate
951169|NCT03474107|enfortumab vedotin (EV)|enfortumab vedotin (ev)
951172|NCT03474107|urothelial cancer|urothelial cancer
951173|NCT03474094|Clinical Trial|clinical trial
951174|NCT03474094|randomized|randomized
951175|NCT03474094|phase II|phase ii
951176|NCT03474094|atezolizumab|atezolizumab
951177|NCT03474094|PD-L1|pd-l1
951178|NCT03474081|Umeclidinium|umeclidinium
951179|NCT03474081|Lung function|lung function
951180|NCT03474081|RESPIMAT|respimat
951181|NCT03474081|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
951182|NCT03474081|Triple Therapy|triple therapy
951183|NCT03474081|Vilanterol|vilanterol
951184|NCT03474081|HANDIHALER|handihaler
951185|NCT03474081|Tiotropium|tiotropium
951186|NCT03474081|Fluticasone furoate|fluticasone furoate
951187|NCT03474068|Emergency Medical Services, Stroke, Ambulances|emergency medical services, stroke, ambulances
951188|NCT03474055|Liquid rotavirus vaccine|liquid rotavirus vaccine
951189|NCT03474055|LBRV-PV|lbrv-pv
951190|NCT03474055|Gastroenteritis|gastroenteritis
951191|NCT03474055|Diarrhoea|diarrhoea
951192|NCT03474029|latent tuberculosis|latent tuberculosis
951193|NCT03474029|rifapentine|rifapentine
951194|NCT03474003|Score prediction|score prediction
951195|NCT03474003|Allograft survival|allograft survival
951196|NCT03473990|Home-based|home-based
951197|NCT03473990|Short-term|short-term
951198|NCT03473990|Randomised Control Trial|randomised control trial
951199|NCT03473951|Hyperuricemia|hyperuricemia
951200|NCT03473951|Metabolic syndrome|metabolic syndrome
951201|NCT03473951|Left ventricular hypertrophy|left ventricular hypertrophy
951202|NCT03473938|Obesity|obesity
951203|NCT03473938|Weight loss|weight loss
951204|NCT03473938|Intragastric balloons|intragastric balloons
951205|NCT03473938|Adjustable gastric balloon|adjustable gastric balloon
951206|NCT03473938|Weight loss plateau|weight loss plateau
951207|NCT03473938|Intolerance|intolerance
951208|NCT03473860|prognosis|prognosis
951209|NCT03473860|all-cause mortality|all-cause mortality
951210|NCT03473860|myocardial infarction|myocardial infarction
951211|NCT03473860|stroke|stroke
951212|NCT03473847|VHF digital ultrasound|vhf digital ultrasound
951213|NCT03473847|Optical coherence tomography|optical coherence tomography
951214|NCT03473847|Corneal thickness|corneal thickness
951215|NCT03473847|Epithelial thickness|epithelial thickness
951216|NCT03473847|LASIK|lasik
951217|NCT03473847|SMILE|smile
951218|NCT03473834|Parkinson's disease|parkinson's disease
951219|NCT03473834|Exercise|exercise
951220|NCT03473834|Rigidity|rigidity
951221|NCT03473834|Turning|turning
951222|NCT03473821|ACL Injury|acl injury
951223|NCT03473821|Return to Sport|return to sport
951224|NCT03473821|Mental Training|mental training
951225|NCT03473821|Motor Imagery|motor imagery
951226|NCT03473808|Hand Function|hand function
951227|NCT03473808|Occupational Therapy|occupational therapy
951228|NCT03473808|Physical Stimulation|physical stimulation
951229|NCT03473795|Patient Outcomes|patient outcomes
951230|NCT03473795|18-114|18-114
951231|NCT03473769|Hospital Admission|hospital admission
951232|NCT03473756|Locally advanced or metastatic urothelial carcinoma|locally advanced or metastatic urothelial carcinoma
951233|NCT03473756|Bladder cancer|bladder cancer
951234|NCT03473756|Checkpoint inhibition|checkpoint inhibition
951235|NCT03473756|FGFR inhibition|fgfr inhibition
951236|NCT03473730|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
951237|NCT03473730|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
951238|NCT03473730|Muscle invasive bladder cancer|muscle invasive bladder cancer
951239|NCT03473730|Daratumumab|daratumumab
951240|NCT03473717|pain|pain
951241|NCT03473717|Intrauterine device (IUD)|intrauterine device (iud)
951242|NCT03473717|Intrauterine system (IUS)|intrauterine system (ius)
951243|NCT03473717|Patient-Reported Outcome|patient-reported outcome
951244|NCT03473704|Type 1 diabetes|type 1 diabetes
951245|NCT03473704|Depression|depression
951246|NCT03473704|Telematic Program|telematic program
951247|NCT03473704|Treatment|treatment
951248|NCT03473704|Web-based|web-based
951249|NCT03473665|ankylsoing spondylitis|ankylsoing spondylitis
951250|NCT03473665|spondyloarthritis|spondyloarthritis
951251|NCT03473639|Residual invasive breast cancer|residual invasive breast cancer
951252|NCT03473639|Metastatic breast cancer|metastatic breast cancer
951253|NCT03473613|Calcium infusion|calcium infusion
951254|NCT03473613|Cabergoline|cabergoline
951255|NCT03473548|Childhood OSA|childhood osa
951256|NCT03473535|self-harm|self-harm
951257|NCT03473535|problem-solving therapy|problem-solving therapy
951258|NCT03473535|emergency department|emergency department
951259|NCT03473535|e-therapy|e-therapy
951260|NCT03473535|suicide prevention|suicide prevention
951261|NCT03473522|Transcranial Direct Current Stimulation|transcranial direct current stimulation
951262|NCT03473522|therapeutic exercises|therapeutic exercises
951263|NCT03473522|Parkinson|parkinson
951264|NCT03473496|BCMA-CART|bcma-cart
951265|NCT03473496|CD138-CART|cd138-cart
951266|NCT03473496|CD56-CART|cd56-cart
951267|NCT03473496|CD38-CART|cd38-cart
951268|NCT03473483|nicotine|nicotine
951269|NCT03473483|tobacco|tobacco
951270|NCT03473483|research electronic cigarette|research electronic cigarette
951271|NCT03473483|e-cigarette|e-cigarette
951273|NCT03473470|Maternal and Neonatal Hypothermia, cesarean delivery|maternal and neonatal hypothermia, cesarean delivery
951274|NCT03473457|CD38-CART|cd38-cart
951275|NCT03473457|CD33-CART|cd33-cart
951276|NCT03473457|CD56-CART|cd56-cart
951277|NCT03473457|CD123-CART|cd123-cart
951278|NCT03473457|CD117-CART|cd117-cart
951279|NCT03473457|CD133-CART|cd133-cart
951280|NCT03473457|CD34-CART|cd34-cart
951281|NCT03473457|Mucl-CART|mucl-cart
951282|NCT03473444|uric acid|uric acid
951283|NCT03473444|prevalence|prevalence
951284|NCT03473444|pakistan|pakistan
951285|NCT03473405|Total knee replacement|total knee replacement
951286|NCT03473405|Operating room airborne CFU|operating room airborne cfu
951287|NCT03473392|pre-treatment|pre-treatment
951288|NCT03473392|antibiotherapy|antibiotherapy
951289|NCT03473392|prosthetic joint infection|prosthetic joint infection
951290|NCT03473392|treatment failure|treatment failure
951291|NCT03473379|economic difficulty, financial toxicity|economic difficulty, financial toxicity
951292|NCT03473353|Medical Scribe|medical scribe
951293|NCT03473353|Outpatient|outpatient
951295|NCT03473340|CLAD|clad
951296|NCT03473340|Chronic Rejection|chronic rejection
951297|NCT03473340|Lung Transplant|lung transplant
951298|NCT03473327|colorectal neoplasms|colorectal neoplasms
951299|NCT03473327|Immunologic Factors|immunologic factors
951300|NCT03473327|Postoperative Period|postoperative period
951301|NCT03473314|Inhaled nitric oxide|inhaled nitric oxide
951302|NCT03473314|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
951303|NCT03473314|Drug resistant bacteria|drug resistant bacteria
951304|NCT03473314|Antimicrobial drug resistance|antimicrobial drug resistance
951305|NCT03473301|CP|cp
951306|NCT03473301|Cerebral Palsy|cerebral palsy
951307|NCT03473301|Stem Cell|stem cell
951308|NCT03473301|Cord Blood|cord blood
951309|NCT03473301|MSCs|mscs
951310|NCT03473275|Sympathetic nervous system|sympathetic nervous system
951311|NCT03473275|Blood oxygen level dependent|blood oxygen level dependent
951312|NCT03473275|Brainstem|brainstem
951313|NCT03473275|Contrast enhanced ultrasound|contrast enhanced ultrasound
951314|NCT03473275|Kidney function|kidney function
951315|NCT03473275|Hypertension|hypertension
951316|NCT03473275|Renal denervation|renal denervation
951317|NCT03473262|Type 2 diabetes|type 2 diabetes
951318|NCT03473262|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
951319|NCT03473262|Empagliflozin|empagliflozin
951320|NCT03473262|Insulin glargine|insulin glargine
951321|NCT03473171|nasal non-invasive ventilation|nasal non-invasive ventilation
951322|NCT03473171|RAM Cannula|ram cannula
951323|NCT03473171|Pediatric Complex Care|pediatric complex care
951324|NCT03473171|Tracheostomy Avoidance|tracheostomy avoidance
951325|NCT03473158|fetal reduction|fetal reduction
951326|NCT03473158|embryo reduction|embryo reduction
951327|NCT03473158|feticide|feticide
951328|NCT03473158|potassium chloride|potassium chloride
951329|NCT03473158|multiple pregnancy|multiple pregnancy
951330|NCT03473158|multifetal pregnancy|multifetal pregnancy
951331|NCT03473119|Sphingosine-1-phosphate|sphingosine-1-phosphate
951332|NCT03473106|Pneumatic Tourniquet|pneumatic tourniquet
951333|NCT03473106|Postoperative Muscle Dysfunction|postoperative muscle dysfunction
951334|NCT03473080|OCD|ocd
951335|NCT03473080|ASD|asd
951336|NCT03473080|Obsessive Compulsive Disorder|obsessive compulsive disorder
951337|NCT03473080|Autism Spectrum Disorder|autism spectrum disorder
951338|NCT03473080|ICBT|icbt
951339|NCT03473080|eHealth|ehealth
951340|NCT03473080|Internet|internet
951341|NCT03473080|CBT|cbt
951342|NCT03473080|Pediatric|pediatric
951343|NCT03473080|Adolescents|adolescents
951344|NCT03473080|Children|children
951345|NCT03473080|Internet-delivered|internet-delivered
951346|NCT03473054|Stroke|stroke
951347|NCT03473054|Cerebrovascular Accident|cerebrovascular accident
951348|NCT03473054|Stress|stress
951349|NCT03473054|Anxiety|anxiety
951350|NCT03473054|Depression|depression
951351|NCT03473054|Mindfulness|mindfulness
951352|NCT03473054|Family caregivers|family caregivers
951353|NCT03473054|Web-based|web-based
951354|NCT03473041|female stress incontinence|female stress incontinence
951355|NCT03473041|Transobturator tension free vaginal tape TVTO|transobturator tension free vaginal tape tvto
951356|NCT03473028|obesity|obesity
951357|NCT03473028|embryo transfer|embryo transfer
951358|NCT03473028|invitro fertilization|invitro fertilization
951359|NCT03473002|Immunogenicity|immunogenicity
951360|NCT03473002|Respiratory Syncytial Virus|respiratory syncytial virus
951361|NCT03473002|Safety|safety
951362|NCT03473002|Sendai Virus|sendai virus
951363|NCT03473002|Vaccine|vaccine
951364|NCT03472989|plantar fasciopathy|plantar fasciopathy
951365|NCT03472989|foot orthosis|foot orthosis
951366|NCT03472989|rESWT|reswt
951367|NCT03472989|exercise|exercise
951368|NCT03472976|A/H7N9 Vaccine|a/h7n9 vaccine
951369|NCT03472976|Adults|adults
951370|NCT03472976|Immunogenicity|immunogenicity
951371|NCT03472976|Influenza|influenza
951372|NCT03472976|Phase I|phase i
951373|NCT03472976|Reactogenicity|reactogenicity
951374|NCT03472976|Safety|safety
951375|NCT03472963|Post-Exposure Prophylaxis|post-exposure prophylaxis
951376|NCT03472963|Anti-Retroviral|anti-retroviral
951377|NCT03472963|Pharmacokinetics|pharmacokinetics
951378|NCT03472937|Mechanical cervical ripening|mechanical cervical ripening
951379|NCT03472937|Transcervical catheter|transcervical catheter
951380|NCT03472937|Foley catheter for labor induction|foley catheter for labor induction
951381|NCT03472937|Cervical ripening|cervical ripening
951382|NCT03472937|Induction of labor|induction of labor
951384|NCT03472885|PNH|pnh
951385|NCT03472885|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
951386|NCT03472885|ACH-0144471|ach-0144471
951387|NCT03472885|eculizumab|eculizumab
951388|NCT03472872|acetaminophen|acetaminophen
951389|NCT03472872|ketorolac|ketorolac
951390|NCT03472872|prochlorperazine|prochlorperazine
951391|NCT03472872|diphenhydramine|diphenhydramine
951392|NCT03472859|laser|laser
951393|NCT03472859|lasers|lasers
951394|NCT03472859|KTP|ktp
951395|NCT03472859|semiconductor|semiconductor
951396|NCT03472859|tgs|tgs
951397|NCT03472859|rosacea|rosacea
951398|NCT03472859|telangiectasia|telangiectasia
951399|NCT03472833|V|v
951400|NCT03472820|Diet|diet
951401|NCT03472820|Lifestyle|lifestyle
951402|NCT03472820|DNA methylation|dna methylation
951403|NCT03472768|ECMO|ecmo
951404|NCT03472755|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy
951405|NCT03472729|Social isolation|social isolation
951406|NCT03472729|Older adults|older adults
951407|NCT03472729|Technology|technology
951408|NCT03472716|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
951409|NCT03472716|βig-h3|βig-h3
951410|NCT03472716|Pronostic marker|pronostic marker
951411|NCT03472703|fMRI|fmri
951412|NCT03472703|Cognitive processes|cognitive processes
951413|NCT03472703|Inhibition|inhibition
951414|NCT03472703|Food reward|food reward
951415|NCT03472703|Appetite|appetite
951416|NCT03472690|Inflammatory Bowel Disease 1|inflammatory bowel disease 1
951417|NCT03472677|Osteoarthritis|osteoarthritis
951418|NCT03472677|Knee Pain|knee pain
951419|NCT03472664|Memory|memory
951420|NCT03472664|Diet|diet
951421|NCT03472664|ketogenic|ketogenic
951422|NCT03472612|OSA|osa
951423|NCT03472612|CPAP|cpap
951424|NCT03472612|upper airway collapse|upper airway collapse
951425|NCT03472612|neural respiratory drive|neural respiratory drive
951426|NCT03472599|Neurogenic bladder dysfunction|neurogenic bladder dysfunction
951427|NCT03472599|Genital Nerve Stimulation|genital nerve stimulation
951428|NCT03472599|Electrical Stimulation|electrical stimulation
951429|NCT03472599|Urinary Incontinence|urinary incontinence
951430|NCT03472599|Spinal cord injury|spinal cord injury
951431|NCT03472560|Cancer|cancer
951432|NCT03472560|non-small cell lung cancer|non-small cell lung cancer
951433|NCT03472560|non small cell lung cancer|non small cell lung cancer
951434|NCT03472560|NSCLC|nsclc
951435|NCT03472560|lung cancer|lung cancer
951436|NCT03472560|urothelial cancer|urothelial cancer
951437|NCT03472560|bladder cancer|bladder cancer
951438|NCT03472560|Avelumab|avelumab
951439|NCT03472560|Bavencio|bavencio
951440|NCT03472560|Axitinib|axitinib
951441|NCT03472560|Inlyta|inlyta
951442|NCT03472508|Folic acid|folic acid
951443|NCT03472508|Homocysteine|homocysteine
951444|NCT03472508|MTHFR C677T|mthfr c677t
951445|NCT03472508|RCT|rct
951446|NCT03472508|Precision treatment|precision treatment
951447|NCT03472495|Diltiazem|diltiazem
951448|NCT03472495|Atrial Fibrillation|atrial fibrillation
951449|NCT03472495|Atrial Flutter|atrial flutter
951450|NCT03472495|Emergency Medicine|emergency medicine
951451|NCT03472482|Alzheimer's disease|alzheimer's disease
951452|NCT03472482|Dementia|dementia
951453|NCT03472482|Lewy body disease|lewy body disease
951454|NCT03472482|Retina|retina
951455|NCT03472482|Retinal imaging|retinal imaging
951456|NCT03472482|Optical Coherence Tomography|optical coherence tomography
951457|NCT03472482|Hyperspectral imaging|hyperspectral imaging
951458|NCT03472482|Mild Cognitive Impairment|mild cognitive impairment
951459|NCT03472430|Oocyte Retrieval|oocyte retrieval
951460|NCT03472430|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
951461|NCT03472430|Pain relief|pain relief
951462|NCT03472430|Conscious sedation|conscious sedation
951463|NCT03472365|PD-1|pd-1
951464|NCT03472365|SHR-1210|shr-1210
951465|NCT03472365|Capecitabine|capecitabine
951466|NCT03472365|Oxaliplatin|oxaliplatin
951467|NCT03472365|Apatinib|apatinib
951468|NCT03472339|Acute limb injury, Diclofenac, pain management|acute limb injury, diclofenac, pain management
951469|NCT03472313|HV|hv
951470|NCT03472300|Knee Osteoarthritis|knee osteoarthritis
951471|NCT03472300|pain|pain
951472|NCT03472300|Complementary Therapies|complementary therapies
951473|NCT03472300|Survey|survey
951474|NCT03472300|questionnaire|questionnaire
951475|NCT03472261|cerebral palsy|cerebral palsy
951476|NCT03472261|botulinum toxin-A|botulinum toxin-a
951477|NCT03472261|pronator deformity|pronator deformity
951478|NCT03472248|Adolescents|adolescents
951479|NCT03472248|Acceptance and Commitment Therapy|acceptance and commitment therapy
951480|NCT03472248|Smartphone|smartphone
951481|NCT03472209|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
951482|NCT03472209|Gynecological Laparoscopic Surgery|gynecological laparoscopic surgery
951483|NCT03472209|End-tidal carbon dioxide|end-tidal carbon dioxide
951484|NCT03472183|Enteric nervous system|enteric nervous system
951485|NCT03472183|Alzheimer disease|alzheimer disease
951486|NCT03472183|biomarker|biomarker
951487|NCT03472183|colonic biopsies|colonic biopsies
951488|NCT03472183|neurodegenerative disease|neurodegenerative disease
951489|NCT03472170|bovine lactoferrin, late sepsis|bovine lactoferrin, late sepsis
951490|NCT03472157|Gastric bypass|gastric bypass
951491|NCT03472157|Sleeve gastrectomy|sleeve gastrectomy
951492|NCT03472157|Lifestyle therapy|lifestyle therapy
951493|NCT03472157|NASH|nash
951494|NCT03472157|Advanced fibrosis|advanced fibrosis
951495|NCT03472157|Cirrhosis|cirrhosis
951496|NCT03472131|Spondylodiscitis|spondylodiscitis
951497|NCT03472131|Titanium Cage|titanium cage
951498|NCT03472131|Posterolateral Debridement|posterolateral debridement
951499|NCT03472131|Immunosuppressed|immunosuppressed
951500|NCT03472131|Less Invasive|less invasive
951501|NCT03472131|Spine Infection|spine infection
951502|NCT03472118|Anesthesia, general|anesthesia, general
951503|NCT03472118|Adult|adult
951504|NCT03472118|Humans|humans
951505|NCT03472118|Apnea|apnea
951506|NCT03472118|Oxygen|oxygen
951507|NCT03472118|Carbon dioxide|carbon dioxide
951508|NCT03472118|Acidosis, respiratory|acidosis, respiratory
951509|NCT03472118|Administration, Intranals/methods|administration, intranals/methods
951510|NCT03472118|Airway management/methods|airway management/methods
951511|NCT03472118|Continuous positive airway pressure/methods|continuous positive airway pressure/methods
951512|NCT03472118|Insufflation/methods|insufflation/methods
951513|NCT03472118|Oxygen/administration&dosage|oxygen/administration&dosage
951514|NCT03472118|Laryngoscopy|laryngoscopy
951515|NCT03472118|Larynx/surgery|larynx/surgery
951516|NCT03472092|headache|headache
951517|NCT03472092|migraine|migraine
951518|NCT03472092|cognitive behavioral therapy|cognitive behavioral therapy
951519|NCT03472092|amitriptyline|amitriptyline
951520|NCT03472092|functional magnetic resonance imaging|functional magnetic resonance imaging
951521|NCT03472092|conditioned pain modulation|conditioned pain modulation
951522|NCT03472092|brain connectivity|brain connectivity
951523|NCT03472092|pediatrics|pediatrics
951524|NCT03472079|Acute kidney injury, septic shock, TIMP2*IGFBP7|acute kidney injury, septic shock, timp2*igfbp7
951525|NCT03472053|Lung cancer|lung cancer
951526|NCT03472053|non small cell|non small cell
951527|NCT03472053|metastasis|metastasis
951528|NCT03472040|BCX7353|bcx7353
951529|NCT03472040|Hereditary Angioedema|hereditary angioedema
951530|NCT03472040|HAE|hae
951531|NCT03471988|deep mycosis|deep mycosis
951532|NCT03471988|aspergillosis|aspergillosis
951533|NCT03471988|mucormycosis|mucormycosis
951534|NCT03471988|cryptococcosis|cryptococcosis
951535|NCT03471988|isavuconazonium sulfate|isavuconazonium sulfate
951536|NCT03471988|isavuconazole|isavuconazole
951537|NCT03471988|AK1820|ak1820
951538|NCT03471988|Cresemba|cresemba
951539|NCT03471975|Video laryngoscopy|video laryngoscopy
951540|NCT03471962|respiratory quotient (RQ), anaerobic metabolism, major surgery.|respiratory quotient (rq), anaerobic metabolism, major surgery.
951541|NCT03471936|Congenital Heart Disease|congenital heart disease
1642161|NCT00236041|Children|children
951542|NCT03471936|pressure-volume loops|pressure-volume loops
951543|NCT03471936|diastolic function|diastolic function
951544|NCT03471910|Chronic venous insufficiency|chronic venous insufficiency
951545|NCT03471910|Diosmin|diosmin
951546|NCT03471910|Hesperidin|hesperidin
951547|NCT03471897|glycosaminoglycans|glycosaminoglycans
951548|NCT03471897|biomarkers|biomarkers
951549|NCT03471897|diagnostics|diagnostics
951550|NCT03471897|prognostic|prognostic
951551|NCT03471897|liquid biopsy|liquid biopsy
951552|NCT03471884|Thoracoscopic surgery,Airway Management,Anesthesia|thoracoscopic surgery,airway management,anesthesia
951553|NCT03471871|Elderly Healthy Subjects|elderly healthy subjects
951752|NCT03470662|Delirium|delirium
951554|NCT03471871|Adult Healthy Subjects|adult healthy subjects
951555|NCT03471871|Lemborexant|lemborexant
951556|NCT03471871|Respiratory Safety|respiratory safety
951557|NCT03471871|Peripheral Oxygen Saturation|peripheral oxygen saturation
951558|NCT03471871|Total Sleep Time|total sleep time
951559|NCT03471858|caesarean, uterus|caesarean, uterus
951560|NCT03471845|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
951561|NCT03471845|Myocardial Infarction (MI)|myocardial infarction (mi)
951562|NCT03471845|Late Lumen Loss (LLL)|late lumen loss (lll)
951563|NCT03471845|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
951564|NCT03471845|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
951565|NCT03471845|Target Vessel Failure (TVF)|target vessel failure (tvf)
951566|NCT03471845|Target Lesion Failure (TLF)|target lesion failure (tlf)
951567|NCT03471845|Stent Thrombosis (ST)|stent thrombosis (st)
951568|NCT03471845|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
951569|NCT03471819|Atopic Dermatitis|atopic dermatitis
951570|NCT03471819|serotonin|serotonin
951571|NCT03471806|Bulimia Nervosa|bulimia nervosa
951572|NCT03471806|Eating disorder|eating disorder
951573|NCT03471806|Dopamine|dopamine
951574|NCT03471806|Food|food
951575|NCT03471806|Reward|reward
951576|NCT03471806|Positron Emission Tomography|positron emission tomography
951577|NCT03471806|Magnetic Resonance|magnetic resonance
951578|NCT03471806|Metabolic hormones|metabolic hormones
951579|NCT03471767|Smoking cessation|smoking cessation
951580|NCT03471767|Nicotine dependence|nicotine dependence
951581|NCT03471767|Bupropion|bupropion
951582|NCT03471767|DXM|dxm
951583|NCT03471767|Nicotine addiction|nicotine addiction
951584|NCT03471767|Cigarette smoking|cigarette smoking
951585|NCT03471767|Dextromethorphan|dextromethorphan
951586|NCT03471754|Depression, transcranial electronic stimulation, pilot, open label, safety, efficacy|depression, transcranial electronic stimulation, pilot, open label, safety, efficacy
951587|NCT03471741|breast cancer|breast cancer
951588|NCT03471741|radiotherapy|radiotherapy
951589|NCT03471741|cutaneous toxicity|cutaneous toxicity
951590|NCT03471741|subcutaneous toxicity|subcutaneous toxicity
951591|NCT03471741|local control|local control
951592|NCT03471741|IMRT|imrt
951593|NCT03471728|Linzess|linzess
951594|NCT03471728|Irritable Bowel Syndrome|irritable bowel syndrome
951595|NCT03471728|linaclotide|linaclotide
951596|NCT03471715|frequency fenesration dehiscence cbct population|frequency fenesration dehiscence cbct population
951597|NCT03471689|Multimodal|multimodal
951598|NCT03471689|Pain perception|pain perception
951599|NCT03471689|Regulation|regulation
951600|NCT03471689|Mindfulness|mindfulness
951601|NCT03471650|J17149|j17149
951602|NCT03471650|PSMA|psma
951603|NCT03471650|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
951604|NCT03471637|Chronic Pain|chronic pain
951605|NCT03471637|Compassion-Focused Therapy|compassion-focused therapy
951606|NCT03471637|Self-Compassion|self-compassion
951607|NCT03471637|Psychological Flexibility|psychological flexibility
951608|NCT03471624|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
951609|NCT03471585|THC|thc
951610|NCT03471585|adult|adult
951611|NCT03471572|BRCA, ovarian cancer, fallopian tube cancer|brca, ovarian cancer, fallopian tube cancer
951612|NCT03471546|Palliative Care|palliative care
951613|NCT03471546|Pro00091481|pro00091481
951614|NCT03471546|Malignant Glioma|malignant glioma
951615|NCT03471546|Katherine Peters|katherine peters
951616|NCT03471546|David Casarett|david casarett
951617|NCT03471494|Surgery|surgery
951618|NCT03471494|Quality|quality
951619|NCT03471494|Outcomes|outcomes
951620|NCT03471468|Microparticles|microparticles
951621|NCT03471468|Pancreatic cancer|pancreatic cancer
951622|NCT03471468|Gastric cancer|gastric cancer
951623|NCT03471468|Chemotherapy|chemotherapy
951624|NCT03471468|Venous thromboembolism|venous thromboembolism
951625|NCT03471429|Anxiety|anxiety
951626|NCT03471429|Dog|dog
951627|NCT03471429|Canine|canine
951628|NCT03471429|Therapy|therapy
951629|NCT03471429|Depression|depression
951630|NCT03471429|Pain|pain
951631|NCT03471416|Guatemala|guatemala
951632|NCT03471416|Guatemala City|guatemala city
951633|NCT03471416|Malnutrition|malnutrition
951634|NCT03471416|Leukemia|leukemia
951635|NCT03471416|Childhood Cancer|childhood cancer
951636|NCT03471403|Cold snare polypectomy|cold snare polypectomy
1642162|NCT00236041|Adolescents|adolescents
951637|NCT03471390|Nursing Home|nursing home
951638|NCT03471377|Planned Surgical Case|planned surgical case
951639|NCT03471377|Predictive Modeling|predictive modeling
951640|NCT03471377|18-115|18-115
951641|NCT03471351|Hodgkin lymphoma|hodgkin lymphoma
951642|NCT03471351|RP6530|rp6530
951643|NCT03471351|Pembrolizumab|pembrolizumab
951644|NCT03471351|Tenalisib|tenalisib
951645|NCT03471338|multiple sclerosis|multiple sclerosis
951646|NCT03471338|cognition|cognition
951647|NCT03471338|neuropsychology|neuropsychology
951648|NCT03471338|cognitive rehabilitation|cognitive rehabilitation
951649|NCT03471325|plaque removal|plaque removal
951650|NCT03471299|Ultrafiltration rate|ultrafiltration rate
951651|NCT03471260|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
951652|NCT03471260|Advanced hematologic malignancies|advanced hematologic malignancies
951653|NCT03471260|Acute myeloid leukemia|acute myeloid leukemia
951654|NCT03471260|AML|aml
951655|NCT03471260|IDH1 mutation|idh1 mutation
951656|NCT03471260|Relapsed/refractory|relapsed/refractory
951657|NCT03471260|Ivosidenib|ivosidenib
951658|NCT03471260|AG120|ag120
951659|NCT03471260|Venetoclax|venetoclax
951660|NCT03471260|AB-199|ab-199
951661|NCT03471260|GDC-0199|gdc-0199
951662|NCT03471234|coronary disease|coronary disease
951663|NCT03471234|drug eluting stent|drug eluting stent
951664|NCT03471234|Inspiron|inspiron
951665|NCT03471182|Cocaine Dependence|cocaine dependence
951666|NCT03471182|Cocaine Addiction|cocaine addiction
951667|NCT03471169|antithrombotic therapy|antithrombotic therapy
951668|NCT03471117|blood pressure|blood pressure
951669|NCT03471117|pioglitazone|pioglitazone
951670|NCT03471117|hypertension|hypertension
951671|NCT03471104|Diabetes-related distress|diabetes-related distress
951672|NCT03471104|Living with diabetes|living with diabetes
951673|NCT03471104|Patient-Reported Outcome Measures (PROMs)|patient-reported outcome measures (proms)
951675|NCT03471078|Thrombocytopenia|thrombocytopenia
951676|NCT03471065|Transcatheter|transcatheter
951677|NCT03471065|Transcatheter Valve Replacement|transcatheter valve replacement
951678|NCT03471065|SAPIEN 3 Ultra|sapien 3 ultra
951679|NCT03471013|schizophrenia|schizophrenia
951680|NCT03471013|beliefs|beliefs
951681|NCT03471013|caregiver|caregiver
951682|NCT03471000|implant|implant
951683|NCT03471000|dental implant|dental implant
951684|NCT03470987|obesity|obesity
951685|NCT03470987|periodontitis|periodontitis
951686|NCT03470987|cytokines|cytokines
951687|NCT03470961|Grafalon ATG SPK|grafalon atg spk
951688|NCT03470948|surgical apgar score, postoperative complication|surgical apgar score, postoperative complication
951689|NCT03470935|breast cancer|breast cancer
951690|NCT03470935|young women|young women
951691|NCT03470922|Cancer|cancer
951692|NCT03470922|Advanced Cancer|advanced cancer
951693|NCT03470909|Remaining breast tissue|remaining breast tissue
951694|NCT03470909|Skin-Sparing Mastectomy|skin-sparing mastectomy
951695|NCT03470909|Nipple-Sparing Mastectomy|nipple-sparing mastectomy
951696|NCT03470909|Prophylactic|prophylactic
951697|NCT03470896|preanesthesia teleconsultation|preanesthesia teleconsultation
951698|NCT03470896|video-conference|video-conference
951699|NCT03470896|ambulatory surgery|ambulatory surgery
951700|NCT03470896|telemedicine|telemedicine
951701|NCT03470883|endoscopic resection|endoscopic resection
951702|NCT03470883|colorectal adenomas|colorectal adenomas
951703|NCT03470883|Colorectal adenocarcinomas|colorectal adenocarcinomas
951704|NCT03470870|Enhanced recovery after surgery|enhanced recovery after surgery
951705|NCT03470870|gynecologic oncology surgery|gynecologic oncology surgery
951706|NCT03470870|Nomogram control|nomogram control
951707|NCT03470857|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
951708|NCT03470857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
951709|NCT03470857|Cancer|cancer
951710|NCT03470857|Superooxide Dismutase|superooxide dismutase
951711|NCT03470857|Catalase|catalase
951712|NCT03470857|Glutathione Peroxidase|glutathione peroxidase
951713|NCT03470857|Malondialdehyde|malondialdehyde
951714|NCT03470857|Conjugated Dienes|conjugated dienes
951715|NCT03470857|Acid Phosphatase|acid phosphatase
951716|NCT03470857|Cathepsin D|cathepsin d
951717|NCT03470857|Alpha-1-Antitrypsin|alpha-1-antitrypsin
951718|NCT03470857|Arylsulfatase|arylsulfatase
951719|NCT03470857|8-iso-Prostaglandin F2alpha|8-iso-prostaglandin f2alpha
951720|NCT03470857|4-Hydroxynonenal|4-hydroxynonenal
951721|NCT03470857|Total Antioxidant Capacity|total antioxidant capacity
951722|NCT03470857|Vitamin A|vitamin a
951723|NCT03470857|Vitamin E|vitamin e
951724|NCT03470844|Major burns|major burns
951725|NCT03470844|Intensive Care Medicine|intensive care medicine
951726|NCT03470844|Neurocognitive dysfunction|neurocognitive dysfunction
951727|NCT03470844|Functional magnetic resonance imaging|functional magnetic resonance imaging
951728|NCT03470844|Neuroinflammation|neuroinflammation
951729|NCT03470844|Long term quality of life|long term quality of life
951730|NCT03470818|Medical Education|medical education
951731|NCT03470818|Flipped Classroom|flipped classroom
951732|NCT03470818|Anxiety|anxiety
951733|NCT03470818|Simulation|simulation
951734|NCT03470818|Achievement Emotions|achievement emotions
951735|NCT03470792|Microcirculation, extracorporeal membrane oxygenation|microcirculation, extracorporeal membrane oxygenation
951736|NCT03470766|Neuromodulation|neuromodulation
951737|NCT03470766|HF10|hf10
951738|NCT03470766|HF-10|hf-10
951739|NCT03470766|Nevro|nevro
951740|NCT03470766|High-frequency|high-frequency
951741|NCT03470766|10kHz|10khz
951742|NCT03470766|Spinal Cord Stimulation|spinal cord stimulation
951743|NCT03470766|CNLBP|cnlbp
951744|NCT03470766|Chronic Neuropathic Low Back Pain|chronic neuropathic low back pain
951745|NCT03470766|Double blind randomised sham-controlled|double blind randomised sham-controlled
951746|NCT03470766|PANARC|panarc
951748|NCT03470714|Force Irradiation|force irradiation
951749|NCT03470714|Kinesiotaping|kinesiotaping
951751|NCT03470662|Hip fractures|hip fractures
951755|NCT03470623|hallux valgus|hallux valgus
951756|NCT03470623|chevron osteotomy|chevron osteotomy
951757|NCT03470623|bioabsorbable screw|bioabsorbable screw
951758|NCT03470623|steel screw|steel screw
951759|NCT03470610|Progesterone|progesterone
951760|NCT03470610|HRT|hrt
951761|NCT03470610|frozen embryo transfer|frozen embryo transfer
951762|NCT03470584|Diet, vegetarian|diet, vegetarian
951763|NCT03470584|Dementia|dementia
951764|NCT03470584|Depression|depression
951765|NCT03470584|Cardiovascular Diseases|cardiovascular diseases
951766|NCT03470584|Stroke|stroke
951767|NCT03470584|Gout|gout
951768|NCT03470584|Cataract|cataract
951769|NCT03470584|Gallstone|gallstone
951770|NCT03470584|Urinary Tract Infections|urinary tract infections
951771|NCT03470558|Diet|diet
951772|NCT03470558|Dietary Habits|dietary habits
951773|NCT03470558|Weight changes|weight changes
951872|NCT03469921|Young adults|young adults
951774|NCT03470545|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
951775|NCT03470428|Fontan|fontan
951776|NCT03470428|Single Ventricle|single ventricle
951777|NCT03470402|Breast Cancer Prevention|breast cancer prevention
951778|NCT03470402|Genetic Testing|genetic testing
951779|NCT03470402|Genetic Counseling|genetic counseling
951780|NCT03470402|Personalized Prevention|personalized prevention
951781|NCT03470402|Precision Prevention|precision prevention
951782|NCT03470402|Precision Medicine|precision medicine
951783|NCT03470402|Risk Assessment|risk assessment
951784|NCT03470402|Decision Making|decision making
951785|NCT03470402|Decision Aid|decision aid
951786|NCT03470376|cholesterol|cholesterol
951787|NCT03470376|nutraceutical|nutraceutical
951788|NCT03470376|HIV|hiv
951789|NCT03470376|PCSK9|pcsk9
951790|NCT03470376|hsCRP|hscrp
951791|NCT03470376|stiffness|stiffness
951792|NCT03470363|total knee arthroplasty|total knee arthroplasty
951793|NCT03470363|tourniquet|tourniquet
951794|NCT03470363|sevoflurane|sevoflurane
951795|NCT03470363|spinal anesthesia|spinal anesthesia
951796|NCT03470363|myeloperoxidase|myeloperoxidase
951797|NCT03470363|elastase|elastase
951798|NCT03470363|neutrophil|neutrophil
951799|NCT03470350|TGF-beta activatied|tgf-beta activatied
951800|NCT03470337|Thrombophlebitis|thrombophlebitis
951801|NCT03470324|Parkinson's disease|parkinson's disease
951802|NCT03470324|Dysphagia|dysphagia
951803|NCT03470324|Parkinsonian Disorders|parkinsonian disorders
951804|NCT03470324|Neurodegenerative Diseases|neurodegenerative diseases
951805|NCT03470324|Movement Disorders|movement disorders
951806|NCT03470324|Nervous System Diseases|nervous system diseases
951807|NCT03470324|Basal Ganglia Diseases|basal ganglia diseases
951808|NCT03470324|Brain Diseases|brain diseases
951809|NCT03470324|Central Nervous System Diseases|central nervous system diseases
951810|NCT03470324|Deep brain stimulation|deep brain stimulation
951811|NCT03470324|substantia nigra pars reticulata|substantia nigra pars reticulata
951812|NCT03470324|subthalamic nucleus|subthalamic nucleus
951813|NCT03470311|Eosinophils|eosinophils
951814|NCT03470311|asthma|asthma
951815|NCT03470311|inflammation|inflammation
951816|NCT03470311|prednisone|prednisone
951817|NCT03470298|Endometrial Scratching|endometrial scratching
951818|NCT03470298|Unexplained infertility|unexplained infertility
951819|NCT03470298|ICSI|icsi
951820|NCT03470285|Mulitparametric MR Imaging|mulitparametric mr imaging
951821|NCT03470285|Small solid renal tumors|small solid renal tumors
951822|NCT03470246|Accelerometer|accelerometer
951823|NCT03470246|Aortic valve replacement|aortic valve replacement
951824|NCT03470246|Aortic valve stenosis|aortic valve stenosis
951825|NCT03470246|Coronary artery bypass grafting|coronary artery bypass grafting
951826|NCT03470246|Coronary artery disease|coronary artery disease
951827|NCT03470246|eHealth|ehealth
951828|NCT03470246|Interactive guidance|interactive guidance
951829|NCT03470246|Mitral valve insufficiency|mitral valve insufficiency
951830|NCT03470246|Mitral valve repair|mitral valve repair
951831|NCT03470246|Rehabilitation|rehabilitation
951832|NCT03470194|Quality Care|quality care
951833|NCT03470194|Access to health care|access to health care
951834|NCT03470194|Interpretation services|interpretation services
951835|NCT03470181|Chronic nausea, intermittent vomiting, impaired accommodation|chronic nausea, intermittent vomiting, impaired accommodation
951836|NCT03470155|annuloplasty mitral valve|annuloplasty mitral valve
951837|NCT03470155|reduced LV function|reduced lv function
951838|NCT03470142|laparoscopy-assisted surgery|laparoscopy-assisted surgery
951839|NCT03470142|NOSES|noses
951840|NCT03470116|MacGrath MAC|macgrath mac
951841|NCT03470116|curarization|curarization
951842|NCT03470116|intubation|intubation
951843|NCT03470116|MacIntosh|macintosh
951844|NCT03470116|laryngoscope|laryngoscope
951845|NCT03470103|Wet age-related macular degeneration(wAMD)|wet age-related macular degeneration(wamd)
951846|NCT03470103|Diabetic macular edema(DME)|diabetic macular edema(dme)
951847|NCT03470090|Physical activity|physical activity
951848|NCT03470090|Function|function
951849|NCT03470090|Balance|balance
951850|NCT03470090|Neuromuscular exercises|neuromuscular exercises
951851|NCT03470090|Osteoarthritis|osteoarthritis
951852|NCT03470038|NGF-induced pain|ngf-induced pain
951853|NCT03470038|Ischemia-induced pain|ischemia-induced pain
951854|NCT03470038|Muscle hypersensitivity|muscle hypersensitivity
951855|NCT03470038|NGF pain model|ngf pain model
951856|NCT03470025|Rehabilitation|rehabilitation
951857|NCT03470025|Psychological Intervention|psychological intervention
951858|NCT03470025|Quality of life|quality of life
951859|NCT03469999|Botulinum toxin A|botulinum toxin a
951860|NCT03469999|Walking efficiency|walking efficiency
951861|NCT03469999|Spasticity|spasticity
951862|NCT03469999|Dysport|dysport
951863|NCT03469960|IFCT|ifct
951864|NCT03469960|DICIPLE|diciple
951865|NCT03469960|NSCLC|nsclc
951866|NCT03469947|Tranexamic Acid|tranexamic acid
951867|NCT03469947|TXA|txa
951868|NCT03469921|Malignant haemopathies|malignant haemopathies
951869|NCT03469921|Acute Leukemia|acute leukemia
951870|NCT03469921|Non-hodgkin Lymphoma|non-hodgkin lymphoma
951871|NCT03469921|Hodgkin Lymphoma|hodgkin lymphoma
951873|NCT03469921|Adolescent|adolescent
951874|NCT03469895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
951875|NCT03469895|Autoimmune Cytopenias|autoimmune cytopenias
951876|NCT03469895|BCR inhibitors|bcr inhibitors
951877|NCT03469882|Protein, exercise, critical illness, outcome,|protein, exercise, critical illness, outcome,
951878|NCT03469869|Obesity|obesity
951879|NCT03469843|Congenital Heart Disease|congenital heart disease
951880|NCT03469843|Cardiac denervation|cardiac denervation
951881|NCT03469843|123I-metaiodobenzylguanidine|123i-metaiodobenzylguanidine
951882|NCT03469843|Arterial switch operation|arterial switch operation
951883|NCT03469830|insert|insert
951884|NCT03469830|pressure therapy|pressure therapy
951885|NCT03469830|silicone gel|silicone gel
951886|NCT03469817|Bone apposition|bone apposition
951887|NCT03469817|Stryker|stryker
951888|NCT03469817|MRI|mri
951889|NCT03469817|Trident II|trident ii
951890|NCT03469817|Total Hip Replacement|total hip replacement
951891|NCT03469791|Degenerative Spondylolisthesis|degenerative spondylolisthesis
951892|NCT03469791|Treatment|treatment
951893|NCT03469791|Decompression alone|decompression alone
951894|NCT03469791|Instrumented fusion|instrumented fusion
951895|NCT03469791|Oswestry Disability Index|oswestry disability index
951896|NCT03469778|stroke|stroke
951897|NCT03469778|rehabilitation|rehabilitation
951898|NCT03469778|upper limb|upper limb
951899|NCT03469778|motor activity|motor activity
951900|NCT03469778|robotic|robotic
951901|NCT03469765|AKI|aki
951902|NCT03469752|Hispanic Latino families|hispanic latino families
951903|NCT03469739|Intimate Partner Violence|intimate partner violence
951904|NCT03469726|Liver metastases|liver metastases
951905|NCT03469726|Diffusion weighted MRI|diffusion weighted mri
951906|NCT03469674|Radiotherapy|radiotherapy
951907|NCT03469674|Vaginal brachytherapy|vaginal brachytherapy
951908|NCT03469674|Molecular risk factors|molecular risk factors
951909|NCT03469622|Adenoma|adenoma
951910|NCT03469622|Polyp|polyp
951911|NCT03469622|EndoRings|endorings
951912|NCT03469622|Colonoscopy|colonoscopy
951913|NCT03469622|Endoscopic device|endoscopic device
951914|NCT03469622|Colon cancer screening|colon cancer screening
951915|NCT03469609|infants|infants
951916|NCT03469609|necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
951917|NCT03469609|focal intestinal perforation (FIP)|focal intestinal perforation (fip)
951918|NCT03469609|enterostomy creation|enterostomy creation
951919|NCT03469609|bowel reanastomosis|bowel reanastomosis
951920|NCT03469609|enteral feeding|enteral feeding
951921|NCT03469609|caloric intake|caloric intake
951922|NCT03469609|parenteral nutrition|parenteral nutrition
951923|NCT03469609|complication rate|complication rate
951924|NCT03469609|reduction of hospital expenses|reduction of hospital expenses
951925|NCT03469609|length of hospital stay|length of hospital stay
951926|NCT03469570|Non-cardiac|non-cardiac
951927|NCT03469570|Non-Thoracic|non-thoracic
951928|NCT03469570|Fluid Management|fluid management
951929|NCT03469570|Perioperative Goal Directed Therapy|perioperative goal directed therapy
951930|NCT03469531|Cervical Cancer|cervical cancer
951931|NCT03469531|Radiation Therapy|radiation therapy
951932|NCT03469531|Chemotherapy|chemotherapy
951933|NCT03469531|Nimotuzumab|nimotuzumab
951934|NCT03469531|Cisplatin|cisplatin
951935|NCT03469518|beta-cryptoxanthin|beta-cryptoxanthin
951936|NCT03469518|cholesterol|cholesterol
951937|NCT03469518|Galactooligosaccharides|galactooligosaccharides
951938|NCT03469518|Plant Sterols|plant sterols
951939|NCT03469518|Cardiovascular risk|cardiovascular risk
951940|NCT03469518|Bone Turnover markers|bone turnover markers
951941|NCT03469518|Intestinal Inflammatory markers|intestinal inflammatory markers
951942|NCT03469518|Microbiota|microbiota
951943|NCT03469479|Neoadjuvant hepatic arterial infusion chemotherapy|neoadjuvant hepatic arterial infusion chemotherapy
951944|NCT03469479|BCLC A/B|bclc a/b
951945|NCT03469479|FOLFOX|folfox
951946|NCT03469479|Resection|resection
951947|NCT03469453|GAD|gad
951948|NCT03469453|Adolescents|adolescents
951949|NCT03469453|Internet-delivered Cognitive behavioral therapy|internet-delivered cognitive behavioral therapy
951950|NCT03469453|ICBT|icbt
951951|NCT03469453|CBT|cbt
951952|NCT03469440|lactate|lactate
951953|NCT03469440|central venous saturation|central venous saturation
951954|NCT03469440|Pediatric Cardiac Surgery|pediatric cardiac surgery
951955|NCT03469388|EVAR, central pressure, arterial stiffness, AAA, elective surgery|evar, central pressure, arterial stiffness, aaa, elective surgery
951956|NCT03469375|FOLFIRINOX|folfirinox
951957|NCT03469375|Pancreatic cancer|pancreatic cancer
951958|NCT03469375|Conversion surgery|conversion surgery
951959|NCT03469375|Overall survival|overall survival
951960|NCT03469349|Drug Therapy|drug therapy
951961|NCT03469336|Psoriasis|psoriasis
951962|NCT03469336|Topical|topical
951963|NCT03469323|Nonintubated video-assisted thoracic surgery (VATS)|nonintubated video-assisted thoracic surgery (vats)
951964|NCT03469310|endocrine surgery|endocrine surgery
951965|NCT03469310|opioid addiction|opioid addiction
951966|NCT03469310|pain management|pain management
951967|NCT03469310|analgesia|analgesia
951968|NCT03469284|Diseases of Oral Cavity Salivary Glands and Jaws|diseases of oral cavity salivary glands and jaws
951969|NCT03469284|Methylene Blue|methylene blue
951970|NCT03469284|MB|mb
951971|NCT03469284|Oral Mucositis|oral mucositis
951972|NCT03469271|Pneumonia|pneumonia
951973|NCT03469258|Pancreatic Cancer|pancreatic cancer
951974|NCT03469245|Endovascular|endovascular
951975|NCT03469245|Fenestrated endovascular repair|fenestrated endovascular repair
951976|NCT03469245|numerical simulation|numerical simulation
951977|NCT03469219|granulysin|granulysin
951978|NCT03469193|knee unicompartmental prosthesis|knee unicompartmental prosthesis
951979|NCT03469193|KneeKG system|kneekg system
951980|NCT03469193|robotic-assisted|robotic-assisted
951981|NCT03469193|alignment|alignment
951982|NCT03469193|implants positioning|implants positioning
951983|NCT03469193|International Knee Society|international knee society
951984|NCT03469193|Forgotten joint score|forgotten joint score
951985|NCT03469180|Treadmill Training|treadmill training
951986|NCT03469180|Whole Body Vibration Training|whole body vibration training
951987|NCT03469167|Bleeding|bleeding
951988|NCT03469154|Layperson|layperson
951989|NCT03469154|Paediatric Basic life Support|paediatric basic life support
951990|NCT03469154|education|education
951991|NCT03469141|Wheelchair|wheelchair
951992|NCT03469141|Pressure Relief|pressure relief
951993|NCT03469141|Activity|activity
951994|NCT03469141|Monitor|monitor
951995|NCT03469128|PTSD|ptsd
951996|NCT03469128|CPT|cpt
951997|NCT03469128|SUD|sud
951998|NCT03469102|Positron emission tomography|positron emission tomography
951999|NCT03469102|Texture indices|texture indices
952000|NCT03469102|Diagnostic performance|diagnostic performance
952001|NCT03469089|schizophrenia|schizophrenia
952002|NCT03469089|cognitive symptom|cognitive symptom
952003|NCT03469089|healthy volunteer|healthy volunteer
952004|NCT03469089|cognitive testing|cognitive testing
952005|NCT03469076|Acne, Comedonal, Mild to Moderate Papulopustular Acne|acne, comedonal, mild to moderate papulopustular acne
952006|NCT03469050|Recurrent acute diverticulitis|recurrent acute diverticulitis
952007|NCT03469050|Prevention|prevention
952008|NCT03469050|Diverticular complications|diverticular complications
952009|NCT03469050|Rifaximin delayed release|rifaximin delayed release
952010|NCT03469050|Diverticulitis|diverticulitis
952011|NCT03469050|SIBO|sibo
952012|NCT03469037|Dyspnea, High flow nasal cannula|dyspnea, high flow nasal cannula
952013|NCT03469024|Low back pain|low back pain
952014|NCT03469024|Electroanalgesia|electroanalgesia
952015|NCT03469024|Exercise program|exercise program
952016|NCT03469024|Randomized clinical trial|randomized clinical trial
952017|NCT03468998|Bone allograft|bone allograft
952018|NCT03468998|Particle size|particle size
952019|NCT03468998|Ridge preservation|ridge preservation
952020|NCT03468998|Ridge augmentation|ridge augmentation
952021|NCT03468998|Socket grafting|socket grafting
952022|NCT03468998|Histology|histology
952023|NCT03468998|New bone|new bone
952024|NCT03468972|IgA nephropathy|iga nephropathy
952025|NCT03468972|immunosuppression|immunosuppression
952026|NCT03468946|taste perception|taste perception
952027|NCT03468946|caries risk|caries risk
952028|NCT03468946|cariogram|cariogram
952029|NCT03468946|children|children
952030|NCT03468907|hepatitis B virus|hepatitis b virus
952031|NCT03468907|exacerbation|exacerbation
952032|NCT03468907|antiviral agents|antiviral agents
952033|NCT03468907|pregnancy|pregnancy
952034|NCT03468907|flare|flare
952035|NCT03468894|prolonged sitting|prolonged sitting
952036|NCT03468894|sedentary behaviour|sedentary behaviour
952037|NCT03468894|physical activity|physical activity
952038|NCT03468894|office workplace|office workplace
952039|NCT03468868|Multiple sclerosis|multiple sclerosis
952040|NCT03468868|Exercise|exercise
952041|NCT03468868|Physical activity|physical activity
952042|NCT03468868|Telerehabilitation|telerehabilitation
952043|NCT03468868|Comparative effectiveness study|comparative effectiveness study
952044|NCT03468868|Social cognitive theory|social cognitive theory
952045|NCT03468868|Health behavior change|health behavior change
952046|NCT03468842|Streptococcus dentisani|streptococcus dentisani
952047|NCT03468842|caries|caries
952048|NCT03468842|salivary pH|salivary ph
952049|NCT03468842|S. mutans|s. mutans
952050|NCT03468764|anesthesia|anesthesia
952051|NCT03468764|hemodynamic management|hemodynamic management
952052|NCT03468764|lung recruitment maneuver|lung recruitment maneuver
952053|NCT03468764|hypovolemia|hypovolemia
952054|NCT03468751|Metastatic; Refractory; Cancer; Solid; Tumor|metastatic; refractory; cancer; solid; tumor
952055|NCT03468725|Transcranial magnetic stimulation|transcranial magnetic stimulation
952056|NCT03468712|mortality|mortality
952057|NCT03468712|morbidity|morbidity
952058|NCT03468712|neoadjuvant chemotherapy|neoadjuvant chemotherapy
952059|NCT03468712|laparoscopic gastrectomy|laparoscopic gastrectomy
952060|NCT03468712|gastric cancer|gastric cancer
952061|NCT03468699|Autologous bone marrow Transplantation|autologous bone marrow transplantation
952062|NCT03468699|biliary atresia|biliary atresia
952063|NCT03468699|Kasai's operation|kasai's operation
952064|NCT03468699|liver cirrhosis|liver cirrhosis
952065|NCT03468673|AIDS|aids
952066|NCT03468673|HCV|hcv
952067|NCT03468673|Questionnaire|questionnaire
952068|NCT03468673|Qualitative analysis|qualitative analysis
952069|NCT03468673|Sexual Quality of Life|sexual quality of life
952070|NCT03468673|Psychometric validation|psychometric validation
952071|NCT03468660|Accented speech perception|accented speech perception
952072|NCT03468647|frailty|frailty
952073|NCT03468647|tele-monitoring|tele-monitoring
952074|NCT03468647|self-management|self-management
952075|NCT03468634|endoscopy|endoscopy
952076|NCT03468634|Raman spectroscopy|raman spectroscopy
952077|NCT03468621|woundclosure|woundclosure
952078|NCT03468621|technique|technique
952079|NCT03468621|surgical|surgical
952080|NCT03468621|site|site
952081|NCT03468621|infection|infection
952082|NCT03468621|intrademal|intrademal
952083|NCT03468621|transdermal|transdermal
952084|NCT03468621|suture|suture
952085|NCT03468608|procedural sedation|procedural sedation
952086|NCT03468608|paediatric|paediatric
952087|NCT03468608|parental satisfaction|parental satisfaction
952088|NCT03468595|Listerine, CHX|listerine, chx
952089|NCT03468569|Athletic Performance|athletic performance
952090|NCT03468569|Functional Movement Screen|functional movement screen
952091|NCT03468569|Handball Athletes|handball athletes
952092|NCT03468569|Injury Prevention|injury prevention
952093|NCT03468569|Injury History|injury history
952094|NCT03468517|General Anaesthesia|general anaesthesia
952095|NCT03468517|Preoperative Anxiety|preoperative anxiety
952096|NCT03468517|BATHE method|bathe method
952097|NCT03468465|Hyperactive Bladder Syndrome|hyperactive bladder syndrome
952098|NCT03468439|nerve block|nerve block
952099|NCT03468413|CP1050|cp1050
952100|NCT03468413|Phase 1|phase 1
952101|NCT03468413|Healthy subjects|healthy subjects
952102|NCT03468400|sleep disorders|sleep disorders
952103|NCT03468400|assessment|assessment
952104|NCT03468400|diagnosis|diagnosis
952105|NCT03468348|duloxetine|duloxetine
952106|NCT03468348|mastectomy|mastectomy
952107|NCT03468348|postoperative pain|postoperative pain
952108|NCT03468335|Second-line therapy|second-line therapy
952109|NCT03468335|Nal-IRI|nal-iri
952110|NCT03468335|failure gemcitabine/nab-paclitaxel|failure gemcitabine/nab-paclitaxel
952111|NCT03468335|predictive role of 1st-line therapy|predictive role of 1st-line therapy
952112|NCT03468309|polypharmacy|polypharmacy
952113|NCT03468309|drug interactions|drug interactions
952114|NCT03468309|DNA testing|dna testing
952115|NCT03468309|mental health diagnosis|mental health diagnosis
952116|NCT03468309|drug side effects|drug side effects
952117|NCT03468309|presciption treatment plans|presciption treatment plans
952118|NCT03468309|mental health medication treatment plans|mental health medication treatment plans
952119|NCT03468296|age-related macular degeneration|age-related macular degeneration
952120|NCT03468283|Mobile healthcare|mobile healthcare
952121|NCT03468283|Health Services Research|health services research
952122|NCT03468283|Community Health Services|community health services
952123|NCT03468283|Diabetes self-management education|diabetes self-management education
952124|NCT03468231|Hepatocellular Carcinoma|hepatocellular carcinoma
952125|NCT03468231|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
952126|NCT03468231|Sorafenib|sorafenib
952127|NCT03468231|Oxaliplatin plus Fluorouracil/Leucovorin|oxaliplatin plus fluorouracil/leucovorin
952128|NCT03468231|Oxaliplatin|oxaliplatin
952129|NCT03468205|breathlessness|breathlessness
952130|NCT03468205|dyspnea|dyspnea
952131|NCT03468205|measurement|measurement
952132|NCT03468179|Diet|diet
952133|NCT03468179|N-acyl-phosphatidylethanolamine|n-acyl-phosphatidylethanolamine
952134|NCT03468179|N-acyl-ethanolamine|n-acyl-ethanolamine
952135|NCT03468179|NAPE|nape
952136|NCT03468179|NAE|nae
952137|NCT03468179|Oatmeal|oatmeal
952138|NCT03468166|Motor function|motor function
952139|NCT03468166|Gait pattern|gait pattern
952140|NCT03468127|Soy protein|soy protein
952141|NCT03468127|LDL-Cholesterol|ldl-cholesterol
952142|NCT03468127|Total Cholesterol|total cholesterol
952143|NCT03468127|Cardiovascular disease|cardiovascular disease
952144|NCT03468101|COPD|copd
952145|NCT03468101|Dairy farmers|dairy farmers
952146|NCT03468101|Exposure Occupational|exposure occupational
952147|NCT03468101|FEV1|fev1
952148|NCT03468075|Sarcoma|sarcoma
952149|NCT03468075|Soft tissue|soft tissue
952150|NCT03468075|Ascorbate|ascorbate
952151|NCT03468036|critical illness|critical illness
952154|NCT03468036|respiratory failure|respiratory failure
952155|NCT03468023|Cast treatment|cast treatment
952156|NCT03468023|above-elbow cast|above-elbow cast
952157|NCT03468023|below-elbow cast|below-elbow cast
952158|NCT03468023|long arm cast|long arm cast
952159|NCT03468023|short arm cast|short arm cast
952160|NCT03467971|Metformin|metformin
952161|NCT03467971|Bioavailability|bioavailability
952162|NCT03467971|Food effect|food effect
952163|NCT03467971|Pharmacokinetics|pharmacokinetics
952164|NCT03467958|Crohn's Disease|crohn's disease
952165|NCT03467958|Crohn Disease|crohn disease
952166|NCT03467958|Oral|oral
952167|NCT03467958|Ozanimod|ozanimod
952168|NCT03467958|Moderately active|moderately active
952169|NCT03467958|Severely active|severely active
952170|NCT03467958|RPC01|rpc01
952171|NCT03467958|RPC01-3204|rpc01-3204
952172|NCT03467945|Metformin|metformin
952173|NCT03467945|Gliclazide|gliclazide
952174|NCT03467945|Bioequivalence|bioequivalence
952175|NCT03467945|Drug-drug Interaction|drug-drug interaction
952176|NCT03467945|Pharmacokinetics|pharmacokinetics
952177|NCT03467919|osteoarthritis|osteoarthritis
952178|NCT03467919|stem cell|stem cell
952179|NCT03467919|knee pain|knee pain
952180|NCT03467919|adipose derived stem cell|adipose derived stem cell
952181|NCT03467919|injection|injection
952182|NCT03467906|Diet|diet
952183|NCT03467906|Dietary Habits|dietary habits
952184|NCT03467906|Weight changes|weight changes
952185|NCT03467880|Impulse Oscillometry|impulse oscillometry
952186|NCT03467880|Chinese|chinese
952187|NCT03467880|Healthy Subjects|healthy subjects
952188|NCT03467880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
952189|NCT03467880|Asthma|asthma
952190|NCT03467880|Interstitial Lung Disease|interstitial lung disease
952191|NCT03467880|Upper Airway Obstruction|upper airway obstruction
952192|NCT03467880|Reference Values|reference values
952193|NCT03467867|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
952194|NCT03467867|Leukemia|leukemia
952195|NCT03467867|Venetoclax|venetoclax
952196|NCT03467867|Rituximab|rituximab
952197|NCT03467867|Lymphoid|lymphoid
952198|NCT03467867|Lymphoproliferative Disorders|lymphoproliferative disorders
952199|NCT03467867|Antineoplastic Agents|antineoplastic agents
952200|NCT03467867|Neoplasm|neoplasm
952201|NCT03467854|ECMO|ecmo
952202|NCT03467854|Antimicrobials|antimicrobials
952203|NCT03467815|Wireless monitoring|wireless monitoring
952204|NCT03467815|Continuous monitoring|continuous monitoring
952205|NCT03467815|Vital parameters|vital parameters
952206|NCT03467815|Clinical deterioration|clinical deterioration
952207|NCT03467802|Gingival Recession|gingival recession
952208|NCT03467802|Enamel Matrix Derivative|enamel matrix derivative
952209|NCT03467802|Porcine Collagen Matrix|porcine collagen matrix
952210|NCT03467789|Vitamin D|vitamin d
952211|NCT03467789|Photodynamic Therapy|photodynamic therapy
952212|NCT03467776|infants|infants
952213|NCT03467776|asthma|asthma
952214|NCT03467776|bronchial dilation test|bronchial dilation test
952215|NCT03467776|plethysmography|plethysmography
952216|NCT03467750|Adenotonsillectomy|adenotonsillectomy
952217|NCT03467750|Opioids|opioids
952218|NCT03467750|Post-surgical pain|post-surgical pain
952219|NCT03467750|Anesthesiology|anesthesiology
952220|NCT03467750|Pediatrics|pediatrics
952221|NCT03467724|Fractional Radiofrequency|fractional radiofrequency
952222|NCT03467698|Aging|aging
952223|NCT03467698|Memory|memory
952224|NCT03467698|Associative learning|associative learning
1333207|NCT01443988|Open angle glaucoma|open angle glaucoma
952225|NCT03467698|transcranial direct current stimulation|transcranial direct current stimulation
952226|NCT03467581|gastric sleeve|gastric sleeve
952227|NCT03467568|Mood Salt|mood salt
952228|NCT03467542|Fistula|fistula
952229|NCT03467542|Intracranial|intracranial
952230|NCT03467542|Dural|dural
952231|NCT03467542|Arteriovenous|arteriovenous
952232|NCT03467542|Liquid Embolic|liquid embolic
952233|NCT03467529|Superficial esophageal cancer|superficial esophageal cancer
952234|NCT03467529|Squamous cell cancer|squamous cell cancer
952235|NCT03467529|Mini invasive imaging|mini invasive imaging
952236|NCT03467529|Pre therapeutic assessment|pre therapeutic assessment
952237|NCT03467529|Optical coherence tomography|optical coherence tomography
952238|NCT03467516|Metastatic Uveal Melanoma|metastatic uveal melanoma
952239|NCT03467516|Uveal Diseases|uveal diseases
952240|NCT03467516|Melanoma|melanoma
952241|NCT03467464|Autism, EMDR; Children|autism, emdr; children
952242|NCT03467438|heartburn|heartburn
952243|NCT03467438|pyrosis|pyrosis
952244|NCT03467438|regurgitation|regurgitation
952245|NCT03467425|FF/VI/UMEC|ff/vi/umec
952246|NCT03467425|TRELEGY ELLIPTA|trelegy ellipta
952247|NCT03467425|COPD|copd
952248|NCT03467425|Effectiveness|effectiveness
952249|NCT03467347|Healthy Women|healthy women
952250|NCT03467347|Contraception|contraception
952251|NCT03467347|Vaginal Ring|vaginal ring
952252|NCT03467347|dapivirine|dapivirine
952253|NCT03467347|Levonorgestrel|levonorgestrel
952254|NCT03467334|Infant colic|infant colic
952255|NCT03467334|Bifidobacterium breve|bifidobacterium breve
952256|NCT03467334|Lactobacillus fermentum|lactobacillus fermentum
952257|NCT03467308|colorectal cancer|colorectal cancer
952258|NCT03467308|TIGAR|tigar
952259|NCT03467308|TRIM59|trim59
952260|NCT03467295|Cavernous Malformations, treatment.|cavernous malformations, treatment.
952261|NCT03467243|schizophrenia|schizophrenia
952262|NCT03467243|Veterans|veterans
952263|NCT03467243|depression|depression
952264|NCT03467243|peer specialist|peer specialist
952265|NCT03467243|social skills training|social skills training
952266|NCT03467217|Losartan|losartan
952267|NCT03467217|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
952268|NCT03467165|MRgFUS|mrgfus
952269|NCT03467165|Pain|pain
952271|NCT03467165|Trapeziometacarpal joint|trapeziometacarpal joint
952272|NCT03467165|Osteoarthritis|osteoarthritis
952273|NCT03467152|E2027|e2027
952274|NCT03467152|Montreal Cognitive Assessment|montreal cognitive assessment
952275|NCT03467152|Neuropsychiatric Inventory|neuropsychiatric inventory
952276|NCT03467152|Mini-Mental State Examination|mini-mental state examination
952277|NCT03467152|Cognitive Fluctuation Inventory|cognitive fluctuation inventory
952278|NCT03467139|Adhesive Capsulitis|adhesive capsulitis
952279|NCT03467139|Breathing exercises|breathing exercises
952280|NCT03467139|Pain|pain
952281|NCT03467139|Sleep quality|sleep quality
952282|NCT03467139|Quality of life|quality of life
952283|NCT03467126|Atrial Fibrillation|atrial fibrillation
952284|NCT03467113|Dravet Syndrome|dravet syndrome
952285|NCT03467113|LGS|lgs
952286|NCT03467087|Stem cell transplantation|stem cell transplantation
952287|NCT03467087|Chemotherapy|chemotherapy
952288|NCT03467087|Rehabilitation|rehabilitation
952289|NCT03467087|Electrical muscle stimulation|electrical muscle stimulation
952290|NCT03467022|alcohol withdrawal|alcohol withdrawal
952291|NCT03467022|scurvy|scurvy
952292|NCT03467022|vitamin C|vitamin c
952293|NCT03467022|tiredness|tiredness
952294|NCT03467009|cyber-victimization|cyber-victimization
952295|NCT03467009|text message|text message
952296|NCT03467009|mhealth|mhealth
952297|NCT03466996|Transition to adult care|transition to adult care
952298|NCT03466996|Telemedicine|telemedicine
952299|NCT03466996|Myelomeningocele|myelomeningocele
952300|NCT03466957|image guided brachytherapy|image guided brachytherapy
952301|NCT03466957|3D print|3d print
952302|NCT03466957|gynecological cancer|gynecological cancer
952303|NCT03466944|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
952304|NCT03466944|Leukaemia|leukaemia
952305|NCT03466944|Whole-Body DiffusionWeighted-Magnetic Resonance Imaging (WB DW-MRI)|whole-body diffusionweighted-magnetic resonance imaging (wb dw-mri)
952306|NCT03466944|Paediatrics|paediatrics
952307|NCT03466918|TAVI|tavi
952308|NCT03466918|TAVR|tavr
952309|NCT03466918|CHINA|china
952310|NCT03466918|SAPIEN 3|sapien 3
952311|NCT03466918|High Risk|high risk
952312|NCT03466918|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
952313|NCT03466918|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
952314|NCT03466892|Repetitive Negative Thinking|repetitive negative thinking
952315|NCT03466892|Rumination|rumination
952316|NCT03466892|Fibromyalgia|fibromyalgia
952317|NCT03466892|Chronic pain|chronic pain
952318|NCT03466892|Attentional Bias|attentional bias
952319|NCT03466840|Ridge Augmentation|ridge augmentation
952320|NCT03466840|Titanium mesh|titanium mesh
952321|NCT03466840|Flap advancement|flap advancement
952322|NCT03466801|prednisone alone|prednisone alone
952323|NCT03466801|methylprednisolone and cyclophosphamide|methylprednisolone and cyclophosphamide
952324|NCT03466801|membranous nephropathy in stage I|membranous nephropathy in stage i
952325|NCT03466775|Kidney transplantation|kidney transplantation
952326|NCT03466775|Allograft rejection|allograft rejection
952327|NCT03466775|Allograft survival|allograft survival
952328|NCT03466775|Anti-angiotensin II type 1 receptor antibody|anti-angiotensin ii type 1 receptor antibody
952329|NCT03466762|Quality of life|quality of life
952330|NCT03466762|Resilience|resilience
952331|NCT03466762|Cancer Survivors|cancer survivors
952332|NCT03466762|Life Satisfaction|life satisfaction
952333|NCT03466762|Post-Cancer Depression|post-cancer depression
952334|NCT03466762|Coping|coping
952335|NCT03466749|Coronary Disease|coronary disease
952336|NCT03466749|Drug eluting balloon|drug eluting balloon
952337|NCT03466749|De-novo lesions|de-novo lesions
952338|NCT03466736|practice effects|practice effects
952339|NCT03466736|amyloid imaging|amyloid imaging
952340|NCT03466710|Colposcopy|colposcopy
952341|NCT03466710|Uterine cervical neoplasm|uterine cervical neoplasm
952343|NCT03466710|Pap|pap
952344|NCT03466684|Trauma|trauma
952345|NCT03466684|Open abdomen|open abdomen
952346|NCT03466684|Fluid resuscitation|fluid resuscitation
952347|NCT03466684|Fascial closure|fascial closure
952348|NCT03466684|Bioelectrical impedance analysis|bioelectrical impedance analysis
952349|NCT03466645|SSI|ssi
952350|NCT03466645|elective Craniotomy|elective craniotomy
952351|NCT03466645|Vancomycin|vancomycin
952352|NCT03466645|Cefazolin|cefazolin
952353|NCT03466645|Antibiotic|antibiotic
952354|NCT03466593|Prehabilitation|prehabilitation
952355|NCT03466593|Recovery|recovery
952552|NCT03465618|Pet Scan|pet scan
952356|NCT03466593|Complications|complications
952357|NCT03466580|Caregivers|caregivers
952358|NCT03466580|Support needs|support needs
952359|NCT03466580|Intervention|intervention
952360|NCT03466580|Randomised controlled trial|randomised controlled trial
952361|NCT03466541|Alcohol consumption|alcohol consumption
952362|NCT03466541|Sick leave|sick leave
952363|NCT03466541|Workplace interventions|workplace interventions
952364|NCT03466541|Presenteeism|presenteeism
952365|NCT03466515|stem cells therapy|stem cells therapy
952366|NCT03466502|vancomycin|vancomycin
952367|NCT03466502|Clostridium difficile|clostridium difficile
952368|NCT03466502|Clostridium difficile infection|clostridium difficile infection
952369|NCT03466502|Recurrent Clostridium difficile infection|recurrent clostridium difficile infection
952370|NCT03466489|total joint arthroplasty|total joint arthroplasty
952371|NCT03466476|Wearable Technology|wearable technology
952762|NCT03464305|Neoplasms|neoplasms
952372|NCT03466476|Total Knee Arthroplasty|total knee arthroplasty
952373|NCT03466463|Crigler-Najjar|crigler-najjar
952374|NCT03466463|Adeno Associated Virus|adeno associated virus
952375|NCT03466450|glioblastoma|glioblastoma
952376|NCT03466450|glasdegib|glasdegib
952377|NCT03466450|temozolomide|temozolomide
952378|NCT03466450|combined therapy|combined therapy
952379|NCT03466424|Short-course radiotherapy|short-course radiotherapy
952380|NCT03466424|dose escalation|dose escalation
952381|NCT03466424|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
952382|NCT03466424|mFOLFOX6|mfolfox6
952383|NCT03466424|rectal cancer|rectal cancer
952384|NCT03466424|Phase I trial|phase i trial
952385|NCT03466398|Remote Patient Monitoring|remote patient monitoring
952386|NCT03466398|Adolescents|adolescents
952387|NCT03466385|Non-invasive ventilation|non-invasive ventilation
952388|NCT03466385|Nasal High Flow|nasal high flow
952389|NCT03466372|gait biofeedback|gait biofeedback
952390|NCT03466372|gait rehabilitation|gait rehabilitation
952391|NCT03466372|paretic propulsion|paretic propulsion
952392|NCT03466372|gait motor learning|gait motor learning
952393|NCT03466359|appetite control|appetite control
952394|NCT03466359|obesity|obesity
952395|NCT03466359|Adolescents|adolescents
952396|NCT03466359|Physical activity|physical activity
952397|NCT03466333|preterm pre-eclampsia|preterm pre-eclampsia
952398|NCT03466333|cardiovascular dysfunction|cardiovascular dysfunction
952399|NCT03466307|Nocturnal pain|nocturnal pain
952400|NCT03466307|shoulder pain|shoulder pain
952401|NCT03466307|ultrasonography|ultrasonography
952402|NCT03466307|resistive index|resistive index
952403|NCT03466307|quality of life|quality of life
952404|NCT03466307|anterior circumflex humeral artery|anterior circumflex humeral artery
952405|NCT03466294|Azacitidine|azacitidine
952406|NCT03466294|Venetoclax|venetoclax
952407|NCT03466294|AML|aml
952408|NCT03466268|Safety|safety
952409|NCT03466268|Tolerability|tolerability
952410|NCT03466268|Pharmacokinetics|pharmacokinetics
952411|NCT03466268|Anti-tumor activity|anti-tumor activity
952412|NCT03466242|intranasal dexmedetomidine|intranasal dexmedetomidine
952413|NCT03466229|sperm DNA strand breaks|sperm dna strand breaks
952414|NCT03466229|antioxidants|antioxidants
952415|NCT03466216|somatostatin receptor|somatostatin receptor
952416|NCT03466203|obesity|obesity
952417|NCT03466203|hypertriglyceridemia|hypertriglyceridemia
952418|NCT03466190|Mandibular body fractures, PEEK plates, titanium plates.|mandibular body fractures, peek plates, titanium plates.
952419|NCT03466177|Alzheimer's disease|alzheimer's disease
952420|NCT03466177|Dementia|dementia
952421|NCT03466177|Mild cognitive impairment|mild cognitive impairment
952422|NCT03466177|Optical coherence tomography|optical coherence tomography
952423|NCT03466177|Hyperspectral imaging|hyperspectral imaging
952424|NCT03466177|Multimodal retinal imaging|multimodal retinal imaging
952425|NCT03466151|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
952426|NCT03466151|Myocardial Infarction (MI)|myocardial infarction (mi)
952427|NCT03466151|Late Lumen Loss (LLL)|late lumen loss (lll)
952428|NCT03466151|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
952429|NCT03466151|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
952430|NCT03466151|Target Vessel Failure (TVF)|target vessel failure (tvf)
952431|NCT03466151|Target Lesion Failure (TLF)|target lesion failure (tlf)
952432|NCT03466151|Stent Thrombosis (ST)|stent thrombosis (st)
952433|NCT03466151|The Randomized Controlled Trial|the randomized controlled trial
952434|NCT03466151|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
952435|NCT03466112|exercise|exercise
952436|NCT03466073|recombinant human plasma gelsolin (rhu-pGSN)|recombinant human plasma gelsolin (rhu-pgsn)
952437|NCT03466073|severe community-acquired pneumonia (sCAP)|severe community-acquired pneumonia (scap)
952438|NCT03466073|adjunctive therapy|adjunctive therapy
952439|NCT03466034|TP53|tp53
952440|NCT03466034|Hypoxia|hypoxia
952441|NCT03466034|Endometriod and Mucinous Carcinomas|endometriod and mucinous carcinomas
952442|NCT03466034|Serous and Clear Cell Carcinomas|serous and clear cell carcinomas
952443|NCT03466034|Magnetic Resonance Imaging, MRI|magnetic resonance imaging, mri
952444|NCT03466021|GLP-1 receptor agonist|glp-1 receptor agonist
952445|NCT03466021|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
952446|NCT03466021|FDG/PET-CT|fdg/pet-ct
952447|NCT03466021|inflammation|inflammation
952448|NCT03466021|weightloss|weightloss
952449|NCT03466021|quality of life|quality of life
952450|NCT03466008|whole body cryotherapy|whole body cryotherapy
952451|NCT03466008|fibromyalgia|fibromyalgia
952452|NCT03466008|chronic pain|chronic pain
952453|NCT03466008|quality of life|quality of life
952454|NCT03466008|perceived health|perceived health
952455|NCT03465982|rectal cancer|rectal cancer
952456|NCT03465982|robotic rectal cancer resection|robotic rectal cancer resection
952457|NCT03465982|minimally invasive surgery|minimally invasive surgery
952458|NCT03465982|Colorectal Cancer|colorectal cancer
952459|NCT03465982|chemoradiation treatment rectal cancer|chemoradiation treatment rectal cancer
952460|NCT03465969|Kidney transplantation|kidney transplantation
952461|NCT03465969|A Bioanalytical Method Cross-validation|a bioanalytical method cross-validation
952462|NCT03465969|Advagraf|advagraf
952960|NCT03462810|HIV|hiv
952466|NCT03465930|Supermicrosurgery|supermicrosurgery
952467|NCT03465930|Lymphatic-venous anastomoses|lymphatic-venous anastomoses
952468|NCT03465930|Immunohistochemistry|immunohistochemistry
952469|NCT03465891|Advanced Stage Follicular Lymphoma|advanced stage follicular lymphoma
952470|NCT03465891|Relapsed|relapsed
952471|NCT03465891|Refractory|refractory
952472|NCT03465891|Atezolizumab|atezolizumab
952473|NCT03465891|Dose Local Radiotherapy (2 x 2Gy)|dose local radiotherapy (2 x 2gy)
952474|NCT03465891|17-360|17-360
952479|NCT03465787|Schizophrenia|schizophrenia
952480|NCT03465787|Acutely Psychotic Patients with Schizophrenia|acutely psychotic patients with schizophrenia
952481|NCT03465787|Latuda|latuda
952482|NCT03465787|Lurasidone|lurasidone
952483|NCT03465774|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
952484|NCT03465774|Pleural effusions|pleural effusions
952485|NCT03465774|Indwelling Pleural Catheter|indwelling pleural catheter
952486|NCT03465774|IPC|ipc
952487|NCT03465774|Fentanyl|fentanyl
952488|NCT03465774|Sublimaze|sublimaze
952489|NCT03465774|Doxycycline|doxycycline
952490|NCT03465774|Vibramycin|vibramycin
952491|NCT03465774|Periostat|periostat
952492|NCT03465774|Doryx|doryx
952493|NCT03465774|Questionnaires|questionnaires
952494|NCT03465774|Surveys|surveys
952495|NCT03465761|MRgFUS|mrgfus
952496|NCT03465761|ExAblate|exablate
952497|NCT03465761|Bilateral Essential Tremor|bilateral essential tremor
952498|NCT03465735|Deep|deep
952499|NCT03465735|Pulmonary|pulmonary
952500|NCT03465735|Venous|venous
952501|NCT03465735|Vascular|vascular
952502|NCT03465735|Post|post
952503|NCT03465735|Vein|vein
952504|NCT03465735|Thrombosis|thrombosis
952505|NCT03465735|Embolism|embolism
952506|NCT03465735|Thromboembolism|thromboembolism
952507|NCT03465735|Thrombotic|thrombotic
952508|NCT03465735|Syndrome|syndrome
952509|NCT03465722|Other Relapsed or Refractory Solid Tumors|other relapsed or refractory solid tumors
952510|NCT03465722|BLU-285|blu-285
952511|NCT03465722|BLU 285|blu 285
952512|NCT03465722|BLUE-285|blue-285
952513|NCT03465722|BLUE 285|blue 285
952514|NCT03465722|Avapritinib|avapritinib
952515|NCT03465722|GIST imatinib relapse|gist imatinib relapse
952516|NCT03465722|GIST gleevec relapse|gist gleevec relapse
952517|NCT03465722|GIST KIT|gist kit
952518|NCT03465722|GIST relapse|gist relapse
962541|NCT03403192|DLT|dlt
952519|NCT03465722|GIST refractory|gist refractory
952520|NCT03465722|GIST imatinib intolerance|gist imatinib intolerance
952521|NCT03465722|GIST TKI treatment|gist tki treatment
952522|NCT03465722|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
952523|NCT03465722|GIST TKI|gist tki
952524|NCT03465722|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
952525|NCT03465722|Advanced GIST|advanced gist
952526|NCT03465722|GIST mutations|gist mutations
952527|NCT03465722|GIST treatments|gist treatments
952528|NCT03465722|Blueprint GIST|blueprint gist
952529|NCT03465722|Relapsed GIST clinical trial|relapsed gist clinical trial
952530|NCT03465722|Refractory GIST clinical trial|refractory gist clinical trial
952531|NCT03465722|KIT-mutant GIST|kit-mutant gist
952532|NCT03465722|cancer gist|cancer gist
952533|NCT03465722|gastrointestinal stromal tumor|gastrointestinal stromal tumor
952534|NCT03465722|gist cancer|gist cancer
952535|NCT03465722|PDGFRA|pdgfra
952536|NCT03465696|psoriasis|psoriasis
952537|NCT03465696|biologics|biologics
952538|NCT03465696|treatment decision-making|treatment decision-making
952539|NCT03465670|chlorhexidine|chlorhexidine
952540|NCT03465670|hyaluronic acid|hyaluronic acid
952541|NCT03465670|tooth discoloration|tooth discoloration
952542|NCT03465657|Child Health|child health
952543|NCT03465657|Sodium intake|sodium intake
952544|NCT03465657|Food Sources|food sources
952545|NCT03465657|Blood Pressure|blood pressure
952546|NCT03465657|BMI|bmi
952547|NCT03465657|Urinary sodium excretion|urinary sodium excretion
952548|NCT03465644|antithrombotic strategy|antithrombotic strategy
952549|NCT03465644|dual antiplatelet therapy|dual antiplatelet therapy
952550|NCT03465631|stroke rehabilitation|stroke rehabilitation
952551|NCT03465618|89Zr-cRGDY Ultrasmall Silica Particle Tracers|89zr-crgdy ultrasmall silica particle tracers
952554|NCT03465579|Diagnosis Prostate Cancer|diagnosis prostate cancer
952555|NCT03465579|TNM staging|tnm staging
952556|NCT03465579|68Ga-PSMA PET/CT guided prostate biopsy|68ga-psma pet/ct guided prostate biopsy
952557|NCT03465579|mp-3TMRI guided prostate biopsy|mp-3tmri guided prostate biopsy
952558|NCT03465579|pre-surgical staging|pre-surgical staging
952559|NCT03465579|clinically-suspected prostate cancer|clinically-suspected prostate cancer
952560|NCT03465566|Emotion|emotion
952561|NCT03465566|Social cognition|social cognition
952562|NCT03465566|Childhood epilepsy|childhood epilepsy
952563|NCT03465553|palliative care|palliative care
952564|NCT03465553|thoracic cancer|thoracic cancer
952565|NCT03465553|radiotherapy|radiotherapy
952566|NCT03465553|pain|pain
952567|NCT03465553|quality of life|quality of life
952568|NCT03465540|Multiple Myeloma|multiple myeloma
952569|NCT03465540|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
952570|NCT03465540|Acute Myeloid Leukemia|acute myeloid leukemia
952571|NCT03465501|Anal Canal Cancer|anal canal cancer
952572|NCT03465501|brachytherapy|brachytherapy
952573|NCT03465488|parasitology|parasitology
952574|NCT03465488|helminth infections|helminth infections
952575|NCT03465488|diagnosis|diagnosis
952576|NCT03465488|drug resistance|drug resistance
952577|NCT03465488|albendazole|albendazole
952578|NCT03465488|benzimidazole drugs|benzimidazole drugs
952579|NCT03465488|Ascaris|ascaris
952580|NCT03465488|Trichuris|trichuris
952581|NCT03465488|hookworm|hookworm
952582|NCT03465488|qPCR|qpcr
952583|NCT03465488|microscopy|microscopy
952584|NCT03465475|Low flow anesthesia|low flow anesthesia
952585|NCT03465475|Desflurane|desflurane
952586|NCT03465475|Cost analysis|cost analysis
952587|NCT03465462|hypertension,|hypertension,
952588|NCT03465462|zinc|zinc
952589|NCT03465462|zinc supplementation|zinc supplementation
952590|NCT03465462|antihypertensive monotherapy|antihypertensive monotherapy
952591|NCT03465462|mineral status|mineral status
952592|NCT03465384|Parent-Child relations|parent-child relations
952593|NCT03465384|Parenting|parenting
952594|NCT03465384|Non-inferiority trial|non-inferiority trial
952595|NCT03465384|Externalizing behaviors|externalizing behaviors
952596|NCT03465384|Randomized controlled trial|randomized controlled trial
952597|NCT03465384|Cost-effectiveness|cost-effectiveness
952598|NCT03465332|blood eosinophil count|blood eosinophil count
952599|NCT03465332|COPD|copd
952600|NCT03465332|diagnostic test|diagnostic test
952601|NCT03465332|doctor's questionnaire|doctor's questionnaire
952602|NCT03465332|Lung specialist|lung specialist
952603|NCT03465319|oxygen concentration|oxygen concentration
952604|NCT03465319|volatile anesthetics concentration|volatile anesthetics concentration
952605|NCT03465319|prediction model|prediction model
952606|NCT03465306|Obesity|obesity
952607|NCT03465306|Cognitive Behavioral Therapy|cognitive behavioral therapy
952608|NCT03465293|Symptomatic diverticulosis|symptomatic diverticulosis
952609|NCT03465293|Microbiota|microbiota
952610|NCT03465293|Bowel preparation|bowel preparation
952611|NCT03465280|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
952612|NCT03465267|stroke|stroke
1333208|NCT01443988|POAG|poag
952613|NCT03465267|upper extremity rehabilitation robot|upper extremity rehabilitation robot
952614|NCT03465267|stroke rehabilitation|stroke rehabilitation
952615|NCT03465241|Non-Small Cell Lung Cancer|non-small cell lung cancer
952616|NCT03465241|stage II to IIIA|stage ii to iiia
952617|NCT03465241|circulating tumor DNA|circulating tumor dna
952618|NCT03465241|The next generation of high-throughput gene sequencing|the next generation of high-throughput gene sequencing
952619|NCT03465228|Low Back Pain|low back pain
952620|NCT03465228|Photobiomodulation|photobiomodulation
952621|NCT03465228|Deep Water Running|deep water running
952622|NCT03465228|Training|training
952623|NCT03465228|Running|running
952624|NCT03465202|Capecitabine|capecitabine
952625|NCT03465202|Pharmacokinetics|pharmacokinetics
952626|NCT03465202|Ageing|ageing
952627|NCT03465202|Frailty|frailty
952628|NCT03465202|Breast cancer|breast cancer
952629|NCT03465202|Colorectal cancer|colorectal cancer
952630|NCT03465176|aromatherapy|aromatherapy
952631|NCT03465176|fatigue|fatigue
952632|NCT03465176|hypothyroidism|hypothyroidism
952633|NCT03465176|essential oils|essential oils
952634|NCT03465150|Acne|acne
952635|NCT03465150|Cohort|cohort
952636|NCT03465150|prospective|prospective
952637|NCT03465150|risk factors|risk factors
952638|NCT03465137|Exposure therapy|exposure therapy
952639|NCT03465137|Behavioral therapy|behavioral therapy
952640|NCT03465137|fMRI|fmri
952641|NCT03465137|Extinction learning|extinction learning
952642|NCT03465137|Social anxiety|social anxiety
952643|NCT03465111|Scleritis|scleritis
952644|NCT03465111|anterior|anterior
952645|NCT03465111|adrenocorticotropic hormone|adrenocorticotropic hormone
952646|NCT03465111|ACTH|acth
952647|NCT03465111|Non-infectious|non-infectious
952648|NCT03465098|Infective endocarditis|infective endocarditis
952649|NCT03465098|PET/CT 18F-FDG|pet/ct 18f-fdg
952650|NCT03465098|Low carbohydrate diet as Atkins diet|low carbohydrate diet as atkins diet
952651|NCT03465085|ARDS|ards
952652|NCT03465085|Streptokinase|streptokinase
952654|NCT03465085|Nebulization|nebulization
952655|NCT03465085|Inhaled Thrombolytics|inhaled thrombolytics
952656|NCT03465085|Inhaled Anticoagulation|inhaled anticoagulation
952657|NCT03465059|BGB-3111|bgb-3111
952658|NCT03465059|Zanubrutinib|zanubrutinib
952659|NCT03465059|pharmacokinetics|pharmacokinetics
952660|NCT03465059|healthy subjects|healthy subjects
952661|NCT03465059|hepatic impairment|hepatic impairment
952662|NCT03465046|infantile hemiplegia|infantile hemiplegia
952663|NCT03465046|upper extremity|upper extremity
952670|NCT03465033|Sensorial disturbance|sensorial disturbance
952671|NCT03465020|Idiopathic|idiopathic
952672|NCT03465020|Thrombocytopenic|thrombocytopenic
952674|NCT03465007|hemodialysis|hemodialysis
952675|NCT03465007|cortisol|cortisol
952676|NCT03465007|Hydrocortisone|hydrocortisone
952677|NCT03464994|Hereditary ichthyosis|hereditary ichthyosis
952678|NCT03464994|keratoconus|keratoconus
952679|NCT03464968|second line|second line
952680|NCT03464968|FOLFOX|folfox
952681|NCT03464968|FOLFIRI|folfiri
952682|NCT03464916|CAR2 Anti-CD38 A2 CAR-T Cells|car2 anti-cd38 a2 car-t cells
952683|NCT03464903|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
952684|NCT03464903|progressive muscular atrophy|progressive muscular atrophy
952685|NCT03464903|motor neuron disease|motor neuron disease
952686|NCT03464903|ALS reversals|als reversals
952687|NCT03464903|whole genome sequencing|whole genome sequencing
952688|NCT03464851|carotid artery stenosis|carotid artery stenosis
952689|NCT03464851|plaque|plaque
952690|NCT03464851|carotid duplex|carotid duplex
952691|NCT03464851|ultrasound|ultrasound
952692|NCT03464851|fibromsucular dysplasia|fibromsucular dysplasia
952693|NCT03464851|carotid atherosclerosis|carotid atherosclerosis
952694|NCT03464812|Diabetes education|diabetes education
952695|NCT03464812|Psychosocial management of diabetes|psychosocial management of diabetes
952696|NCT03464747|Lactic Acid|lactic acid
952697|NCT03464708|Critical illness|critical illness
952698|NCT03464708|HMB|hmb
952699|NCT03464708|Nutrition|nutrition
952700|NCT03464708|Muscle wasting|muscle wasting
952701|NCT03464708|Recovery|recovery
952702|NCT03464695|closed-loop|closed-loop
952703|NCT03464695|oxygen treatment|oxygen treatment
952704|NCT03464656|semen|semen
952705|NCT03464656|male infertility|male infertility
952706|NCT03464656|semen quality|semen quality
952707|NCT03464656|sperm DNA fragmentation|sperm dna fragmentation
952708|NCT03464656|oxidation reduction potential|oxidation reduction potential
952709|NCT03464565|Large Vessel Occlusion|large vessel occlusion
952710|NCT03464565|Acute Ischemic Stroke|acute ischemic stroke
952711|NCT03464565|Mechanical Thrombectomy|mechanical thrombectomy
952712|NCT03464565|Penumbra System|penumbra system
952713|NCT03464565|3D Revascularization|3d revascularization
952714|NCT03464552|colposcopy - colposcopic directed biopsy - celecoxib|colposcopy - colposcopic directed biopsy - celecoxib
952715|NCT03464448|Teriflunomide|teriflunomide
952716|NCT03464448|B cell|b cell
952717|NCT03464448|T cell|t cell
952718|NCT03464448|cytokines|cytokines
952719|NCT03464435|Refractory Vernal Keratoconjunctivitis|refractory vernal keratoconjunctivitis
952720|NCT03464435|0.1% tacrolimus|0.1% tacrolimus
952721|NCT03464435|loteprednol etabonate 0.5%/tobramycin 0.3%|loteprednol etabonate 0.5%/tobramycin 0.3%
952722|NCT03464422|HIV|hiv
952723|NCT03464422|MSM|msm
952724|NCT03464409|Nerve Transfer Surgery|nerve transfer surgery
952725|NCT03464409|Tendon Transfer Surgery|tendon transfer surgery
952726|NCT03464409|Decision Support Intervention|decision support intervention
952727|NCT03464396|Periodic breathing|periodic breathing
952728|NCT03464396|Apnea of prematurity|apnea of prematurity
952729|NCT03464396|Chronic Lung disease|chronic lung disease
952730|NCT03464396|Prematurity|prematurity
952731|NCT03464396|Respiratory disease|respiratory disease
952732|NCT03464396|Hypoxia|hypoxia
952733|NCT03464396|Pulmonary Hypertension|pulmonary hypertension
952741|NCT03464370|amygdala enlargement|amygdala enlargement
952742|NCT03464370|temporal lobe epilepsy|temporal lobe epilepsy
952743|NCT03464370|stress|stress
952744|NCT03464370|attentional bias|attentional bias
952745|NCT03464370|anxiety|anxiety
952746|NCT03464370|depression|depression
952747|NCT03464370|PTSD|ptsd
952748|NCT03464357|functional MRI|functional mri
952749|NCT03464344|intracerebral hemorrhage|intracerebral hemorrhage
952750|NCT03464344|cerebral amyloid angiopathy|cerebral amyloid angiopathy
952751|NCT03464344|cortical superficial siderosis|cortical superficial siderosis
952752|NCT03464344|Magnetic Resonance Imaging|magnetic resonance imaging
952753|NCT03464318|idiopathic scoliosis|idiopathic scoliosis
952754|NCT03464318|radiographs|radiographs
952755|NCT03464318|low dose|low dose
952756|NCT03464305|Colonic Neoplasms|colonic neoplasms
952757|NCT03464305|Colorectal Neoplasms|colorectal neoplasms
952758|NCT03464305|Intestinal Neoplasms|intestinal neoplasms
952759|NCT03464305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
952760|NCT03464305|Digestive System Neoplasms|digestive system neoplasms
952761|NCT03464305|Neoplasms by Site|neoplasms by site
952763|NCT03464305|Colonic Diseases|colonic diseases
952764|NCT03464305|Aspirin|aspirin
952765|NCT03464305|Recurrence|recurrence
952766|NCT03464305|Digestive System Diseases|digestive system diseases
952767|NCT03464305|Intestinal Diseases|intestinal diseases
952768|NCT03464305|Disease Attributes|disease attributes
952769|NCT03464305|Pathologic Processes|pathologic processes
952770|NCT03464227|Phase 1|phase 1
952771|NCT03464227|UCB0107|ucb0107
952772|NCT03464214|Vibration|vibration
952773|NCT03464214|Cervical stabilization exercises|cervical stabilization exercises
952774|NCT03464214|Physiotherapy and rehabilitation|physiotherapy and rehabilitation
952775|NCT03464214|Sensory organization test|sensory organization test
952776|NCT03464214|Balance|balance
952777|NCT03464188|early palliative care|early palliative care
952778|NCT03464188|family caregiver|family caregiver
952779|NCT03464188|rural|rural
952780|NCT03464188|African-American|african-american
952781|NCT03464188|telehealth|telehealth
952782|NCT03464162|Social Network Meetings|social network meetings
952783|NCT03464162|First Episode Psychosis|first episode psychosis
952784|NCT03464162|OnTrackNY|ontrackny
952785|NCT03464097|Crohn's Disease|crohn's disease
952786|NCT03464097|Crohn Disease|crohn disease
952787|NCT03464097|Oral|oral
952788|NCT03464097|Ozanimod|ozanimod
952789|NCT03464097|Moderately active|moderately active
952790|NCT03464097|Severely active|severely active
952791|NCT03464097|RPC01|rpc01
952792|NCT03464097|RPC01-3203|rpc01-3203
952793|NCT03464071|sepsis|sepsis
952794|NCT03464071|biomarkers|biomarkers
952795|NCT03464071|lung injury|lung injury
952796|NCT03464058|Pharmacokinetics|pharmacokinetics
952797|NCT03464058|Food Effect|food effect
952798|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors
952799|NCT03464058|Drug Interaction|drug interaction
952800|NCT03464058|Oral Prototype Formulations|oral prototype formulations
952801|NCT03464019|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
952802|NCT03464019|cardiac monitoring|cardiac monitoring
952803|NCT03464019|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
952804|NCT03464019|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
952805|NCT03464019|calcium channel blocker|calcium channel blocker
952806|NCT03464019|conversion rate|conversion rate
952807|NCT03463980|Meditation|meditation
952808|NCT03463980|African American|african american
952809|NCT03463980|Randomized controlled trial|randomized controlled trial
952810|NCT03463967|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
952811|NCT03463967|obesity|obesity
952812|NCT03463967|dyslipidemia|dyslipidemia
952813|NCT03463967|diet|diet
952814|NCT03463967|children|children
952815|NCT03463967|adolescents|adolescents
952816|NCT03463954|less than or equal to 15 mm|less than or equal to 15 mm
952817|NCT03463941|African American|african american
952818|NCT03463941|Faith institutions|faith institutions
952819|NCT03463941|Dyads|dyads
952820|NCT03463941|Health disparities|health disparities
952821|NCT03463915|Interstitial cystitis|interstitial cystitis
952822|NCT03463915|Bladder pain syndrome|bladder pain syndrome
952823|NCT03463915|IC/BPS|ic/bps
952824|NCT03463915|Women|women
952825|NCT03463915|Pelvic pain|pelvic pain
952826|NCT03463915|Urologic pain|urologic pain
952827|NCT03463915|gabapentin|gabapentin
952828|NCT03463915|Antiepileptic|antiepileptic
952829|NCT03463902|Gesture|gesture
952830|NCT03463902|tDCS|tdcs
952831|NCT03463902|schizophrenia|schizophrenia
952832|NCT03463902|nonverbal communication|nonverbal communication
952833|NCT03463798|structured light plethysmography|structured light plethysmography
952834|NCT03463798|sonar|sonar
952835|NCT03463798|transdiaphragmatic pressure|transdiaphragmatic pressure
952836|NCT03463785|obstructive sleep apnea|obstructive sleep apnea
952837|NCT03463785|race|race
952838|NCT03463785|upper airway|upper airway
952839|NCT03463785|cone beam computed tomography|cone beam computed tomography
952840|NCT03463772|in vitro maturation|in vitro maturation
952841|NCT03463772|polycystic ovarian syndrome|polycystic ovarian syndrome
952842|NCT03463772|oocyte|oocyte
952843|NCT03463733|Glioma|glioma
952844|NCT03463733|Recurrent glioma|recurrent glioma
952845|NCT03463733|Glioblastoma multiforme|glioblastoma multiforme
952846|NCT03463733|Recurrent Glioblastoma multiforme|recurrent glioblastoma multiforme
952847|NCT03463733|Hydroxyurea|hydroxyurea
952848|NCT03463733|Temozolomide|temozolomide
952849|NCT03463668|duodenal stenosis|duodenal stenosis
952850|NCT03463668|pyloric stenosis|pyloric stenosis
952851|NCT03463668|digestive neoplasias|digestive neoplasias
952852|NCT03463668|non-digestive neoplasias|non-digestive neoplasias
952853|NCT03463668|duodenal prosthesis|duodenal prosthesis
952854|NCT03463655|palliative|palliative
952855|NCT03463655|solid tumor|solid tumor
952856|NCT03463655|ascites|ascites
952857|NCT03463629|Multidisciplinary Team|multidisciplinary team
952858|NCT03463629|Hispanic adults|hispanic adults
952859|NCT03463616|Rectal Cancer|rectal cancer
952860|NCT03463616|Liver Metastases|liver metastases
952861|NCT03463616|CT abdomen|ct abdomen
952862|NCT03463616|MRI Liver|mri liver
952863|NCT03463603|ischemic heart disease|ischemic heart disease
952864|NCT03463603|acute coronary syndrome|acute coronary syndrome
952865|NCT03463603|racial bias|racial bias
952866|NCT03463590|Habenula|habenula
953475|NCT03459144|ranibizumab|ranibizumab
952867|NCT03463590|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
952868|NCT03463590|Deep brain stimulation|deep brain stimulation
952869|NCT03463564|type 1 diabetes|type 1 diabetes
952870|NCT03463564|transition|transition
952871|NCT03463564|CSII|csii
952873|NCT03463564|glycemic control|glycemic control
952874|NCT03463564|glucose variability|glucose variability
952875|NCT03463525|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
952876|NCT03463486|outpatient cardiac rehabilitation, exercise training,|outpatient cardiac rehabilitation, exercise training,
952877|NCT03463447|Dynamometer|dynamometer
952878|NCT03463447|Handgrip|handgrip
952879|NCT03463447|children|children
952880|NCT03463434|pressure ulcer treatment|pressure ulcer treatment
952881|NCT03463434|wound healing|wound healing
952882|NCT03463421|Adherence to oral anticoagulation|adherence to oral anticoagulation
952883|NCT03463421|Persistence to oral anticoagulation|persistence to oral anticoagulation
952884|NCT03463421|AF patients|af patients
952885|NCT03463421|Previous ischemic stroke|previous ischemic stroke
952886|NCT03463408|Sarcoma|sarcoma
952887|NCT03463382|Pediatric Surgery|pediatric surgery
952888|NCT03463382|Postoperative Pain|postoperative pain
952889|NCT03463382|Erector spinae plane block|erector spinae plane block
952890|NCT03463382|quadratus lumborum block|quadratus lumborum block
952891|NCT03463317|Atrial Fibrillation|atrial fibrillation
952892|NCT03463317|Anticoagulation|anticoagulation
952893|NCT03463317|Left atrial appendage closure|left atrial appendage closure
952894|NCT03463317|Stroke|stroke
952895|NCT03463304|Gut Microbiota|gut microbiota
952896|NCT03463304|endocannabinoide|endocannabinoide
952897|NCT03463304|Metabolic health|metabolic health
952898|NCT03463304|Gastrointestinal health|gastrointestinal health
952899|NCT03463304|Mental wellbeing|mental wellbeing
952900|NCT03463239|Autologous tissue engineered corpora|autologous tissue engineered corpora
952901|NCT03463226|Testosterone Deficiency|testosterone deficiency
952902|NCT03463226|Sympathetic overactivity|sympathetic overactivity
952903|NCT03463226|Exercise Intolerance|exercise intolerance
952904|NCT03463213|health behavior|health behavior
952905|NCT03463213|chronic disease prevention|chronic disease prevention
952906|NCT03463213|healthy lifestyle|healthy lifestyle
952907|NCT03463200|bandage|bandage
952908|NCT03463200|low back pain|low back pain
952909|NCT03463200|muscle fatigue|muscle fatigue
952910|NCT03463200|electromyography|electromyography
952911|NCT03463174|overdenture|overdenture
952912|NCT03463174|edentulism|edentulism
952913|NCT03463174|dental implant|dental implant
952914|NCT03463174|cost-effectiveness|cost-effectiveness
952915|NCT03463174|economic analysis|economic analysis
952916|NCT03463174|effectiveness|effectiveness
952917|NCT03463122|stroke|stroke
952918|NCT03463122|neglect|neglect
952919|NCT03463122|virtual reality|virtual reality
952920|NCT03463122|head mount display|head mount display
952921|NCT03463122|rehabilitation|rehabilitation
952922|NCT03463109|Chronic low back pain|chronic low back pain
952923|NCT03463096|respiratory|respiratory
952924|NCT03463096|physiology|physiology
952925|NCT03463096|gravity|gravity
952926|NCT03463070|misoprostol|misoprostol
952927|NCT03463070|postpartum haemorrhage|postpartum haemorrhage
952928|NCT03463031|GSP 301 nasal spray for the treatment of Seasonal Allergic Rhinitis|gsp 301 nasal spray for the treatment of seasonal allergic rhinitis
952929|NCT03463018|Echinacea, Subthreshold Anxiety|echinacea, subthreshold anxiety
952930|NCT03462979|Gluten-free diet|gluten-free diet
952931|NCT03462979|Urine|urine
952932|NCT03462979|Stool|stool
952933|NCT03462979|home testing|home testing
952934|NCT03462966|Rifaximin|rifaximin
952935|NCT03462966|Xifaxan|xifaxan
952936|NCT03462940|Tauroursodeoxycholic acid (TUDCA)|tauroursodeoxycholic acid (tudca)
952937|NCT03462940|Endothelial function in humans|endothelial function in humans
952938|NCT03462940|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
952939|NCT03462901|Fixation of midshaft clavicular fracture by intramedullary|fixation of midshaft clavicular fracture by intramedullary
952940|NCT03462888|Rhabdomyosarcoma|rhabdomyosarcoma
952941|NCT03462888|Adolescents and young adults|adolescents and young adults
952942|NCT03462888|prognostic factors|prognostic factors
952943|NCT03462888|molecular profiling|molecular profiling
952944|NCT03462875|Crohn's Disease|crohn's disease
952945|NCT03462875|Microbiota|microbiota
952946|NCT03462875|Dietary Pattern|dietary pattern
952947|NCT03462875|Environmental factors|environmental factors
952948|NCT03462862|PEEK|peek
952949|NCT03462862|Breflex|breflex
952950|NCT03462849|ARDS|ards
952951|NCT03462849|expiratory flow limitation|expiratory flow limitation
952952|NCT03462849|trans-pulmonary pressure|trans-pulmonary pressure
952953|NCT03462849|airway closure|airway closure
952954|NCT03462823|ACL Reconstruction|acl reconstruction
952955|NCT03462823|Osteoconductive Scaffold|osteoconductive scaffold
952956|NCT03462823|Bone Tunnel Widening|bone tunnel widening
952957|NCT03462810|cabotegravir, CAB|cabotegravir, cab
952958|NCT03462810|GSK1265744|gsk1265744
952959|NCT03462810|Individual Patient Compassionate Use|individual patient compassionate use
952961|NCT03462771|elderly|elderly
952962|NCT03462771|sarcopenia|sarcopenia
952963|NCT03462771|dietary supplementation|dietary supplementation
952964|NCT03462771|omega-3 fatty acid|omega-3 fatty acid
952965|NCT03462758|Mirena|mirena
952966|NCT03462758|ParaGard|paragard
952967|NCT03462758|Skyla|skyla
952968|NCT03462758|Liletta|liletta
952969|NCT03462758|Kyleena|kyleena
952970|NCT03462758|Intrauterine Device|intrauterine device
952971|NCT03462758|Intrauterine System|intrauterine system
952972|NCT03462758|Postpartum|postpartum
952973|NCT03462758|Expulsion|expulsion
952974|NCT03462706|Polyp Resection|polyp resection
952975|NCT03462706|Cold Snare|cold snare
952976|NCT03462706|Hot Snare|hot snare
952977|NCT03462706|Cold Endoscopic Mucosal Resection (EMR)|cold endoscopic mucosal resection (emr)
952978|NCT03462706|Hot Endoscopic Mucosal Resection (EMR)|hot endoscopic mucosal resection (emr)
952979|NCT03462706|Colonoscopy|colonoscopy
952980|NCT03462654|Health promotion|health promotion
952981|NCT03462654|Behaviour change|behaviour change
952982|NCT03462654|Physical activity|physical activity
952983|NCT03462654|Fall prevention|fall prevention
952984|NCT03462641|Gait|gait
952985|NCT03462641|Balance|balance
952986|NCT03462641|Flumazenil|flumazenil
952987|NCT03462641|PET Imaging|pet imaging
952988|NCT03462641|MRI|mri
952989|NCT03462641|Mobility|mobility
952990|NCT03462641|Intravenous|intravenous
952991|NCT03462628|substrate modification|substrate modification
952992|NCT03462628|pulmonary vein isolation|pulmonary vein isolation
952993|NCT03462628|ablation|ablation
952994|NCT03462628|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
952995|NCT03462615|malaria|malaria
952996|NCT03462615|pregnancy|pregnancy
952997|NCT03462615|diagnosis|diagnosis
952998|NCT03462615|rapid diagnostic test|rapid diagnostic test
952999|NCT03462537|Aerobic Exercise|aerobic exercise
953000|NCT03462537|Lipolytic Laser|lipolytic laser
953001|NCT03462537|Lipid Profile|lipid profile
953002|NCT03462537|C-reactive protein|c-reactive protein
953003|NCT03462537|Lipolysis|lipolysis
953004|NCT03462511|Hydroxyurea|hydroxyurea
953005|NCT03462511|Community health worker (CHW)|community health worker (chw)
953006|NCT03462511|Text messages|text messages
953007|NCT03462511|Medication adherence|medication adherence
953008|NCT03462498|Acute Coronary Syndrome|acute coronary syndrome
953009|NCT03462498|Acute Myocardial Infarction|acute myocardial infarction
953010|NCT03462498|Coronary Artery Disease|coronary artery disease
953011|NCT03462498|Percutaneous Coronary Intervention|percutaneous coronary intervention
953012|NCT03462498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
953013|NCT03462446|Atrial fibrillation|atrial fibrillation
953014|NCT03462446|VKA|vka
953015|NCT03462446|Stroke|stroke
953016|NCT03462433|Ruptured Intracranial Aneurysms|ruptured intracranial aneurysms
953017|NCT03462433|Unruptured Intracranial Aneurysms|unruptured intracranial aneurysms
953018|NCT03462433|Prospective cohort study|prospective cohort study
953019|NCT03462433|China|china
953020|NCT03462420|Adhesive capsulitis|adhesive capsulitis
953021|NCT03462420|Frozen shoulder|frozen shoulder
953022|NCT03462420|Diabetes|diabetes
953023|NCT03462420|Physiotherapy|physiotherapy
953024|NCT03462329|Post-Lyme symptoms|post-lyme symptoms
953025|NCT03462329|Pretreatment expectations|pretreatment expectations
953026|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a
953027|NCT03462290|Injections|injections
953028|NCT03462290|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
953029|NCT03462251|Breast Cancer|breast cancer
953030|NCT03462251|HR positive|hr positive
953031|NCT03462251|HER2 negative|her2 negative
953032|NCT03462251|Mamma carcinoma|mamma carcinoma
953033|NCT03462199|Kiwi|kiwi
953034|NCT03462199|Constipation|constipation
953035|NCT03462199|Bowel Movements|bowel movements
953036|NCT03462199|Healthy|healthy
953037|NCT03462199|Functional Constipation|functional constipation
953038|NCT03462160|Urinary Tract Infection|urinary tract infection
953039|NCT03462160|prophylaxis|prophylaxis
953040|NCT03462160|probiotics|probiotics
953041|NCT03462121|Alzheimer's Disease,|alzheimer's disease,
953042|NCT03462121|Dementia|dementia
953043|NCT03462082|Parkinson's disease|parkinson's disease
953044|NCT03462082|axial motor dysfunction|axial motor dysfunction
953045|NCT03462082|asymmetric neuromodulation|asymmetric neuromodulation
953046|NCT03462082|subthalamic nucleus deep brain stimulation|subthalamic nucleus deep brain stimulation
953047|NCT03462030|food allergy|food allergy
953048|NCT03462030|oral immunotherapy|oral immunotherapy
953049|NCT03462004|Healthy Volunteer|healthy volunteer
953050|NCT03461965|3D printing|3d printing
953051|NCT03461965|Patient education|patient education
953052|NCT03461939|ePRIME|eprime
953053|NCT03461939|PRO|pro
953054|NCT03461939|PROM|prom
953055|NCT03461939|Adverse event|adverse event
953056|NCT03461939|QTool|qtool
953057|NCT03461939|Early phase|early phase
953058|NCT03461939|CTCAE|ctcae
953059|NCT03461926|Sedentary Behaviour|sedentary behaviour
953060|NCT03461926|Health Behaviour Change|health behaviour change
953061|NCT03461926|Health Action Process Approach|health action process approach
953062|NCT03461926|mHealth|mhealth
953063|NCT03461926|Intervention|intervention
953064|NCT03461926|Non-Sedentary Behaviours|non-sedentary behaviours
953065|NCT03461926|Break Frequency|break frequency
953066|NCT03461926|Break Duration|break duration
953067|NCT03461926|Action Planning|action planning
953068|NCT03461926|Coping Planning|coping planning
953069|NCT03461926|Work Performance|work performance
953070|NCT03461926|Health Outcomes|health outcomes
953071|NCT03461900|Septic shock|septic shock
953072|NCT03461900|Fluid optimisation|fluid optimisation
953073|NCT03461900|Minifluid challenge|minifluid challenge
953074|NCT03461900|Fluid overload|fluid overload
953075|NCT03461887|exercise|exercise
953076|NCT03461887|minimal equipment|minimal equipment
953077|NCT03461887|home-based|home-based
953078|NCT03461887|COPD|copd
953079|NCT03461874|High-Frequency Migraine without aura|high-frequency migraine without aura
953080|NCT03461874|ACT|act
953081|NCT03461861|Healthy|healthy
953082|NCT03461861|Adult|adult
953083|NCT03461861|Normal Memory|normal memory
953084|NCT03461861|APOE 4|apoe 4
953085|NCT03461861|Brain|brain
953086|NCT03461861|Magnetic Resonance Imaging|magnetic resonance imaging
953087|NCT03461861|MRI|mri
953088|NCT03461861|Alzheimer's disease|alzheimer's disease
953089|NCT03461861|Hippocampus|hippocampus
953090|NCT03461861|Genetic testing|genetic testing
953091|NCT03461861|Dementia|dementia
953092|NCT03461809|diplopia; ocular motor nerve palsy; acupuncture|diplopia; ocular motor nerve palsy; acupuncture
953093|NCT03461770|atelectasis|atelectasis
953094|NCT03461770|children|children
953095|NCT03461770|ultrasound|ultrasound
953096|NCT03461757|Acute Migraine|acute migraine
953097|NCT03461757|phonophobia|phonophobia
953098|NCT03461757|photophobia|photophobia
953099|NCT03461757|nausea|nausea
953100|NCT03461731|Low-Level Light Therapy|low-level light therapy
953101|NCT03461705|Coronary Artery Stenosis|coronary artery stenosis
953102|NCT03461705|Stenosis|stenosis
953103|NCT03461705|Resting Flow Reserve (RFR)|resting flow reserve (rfr)
953104|NCT03461705|Volcano Verrata Pressure Wire|volcano verrata pressure wire
953105|NCT03461666|Primary insomnia|primary insomnia
953106|NCT03461666|Behavioral treatment of primary insomnia|behavioral treatment of primary insomnia
953107|NCT03461666|Focus of attention|focus of attention
953108|NCT03461666|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
953109|NCT03461627|randomized|randomized
953110|NCT03461627|double-blind|double-blind
953111|NCT03461627|double-dummy|double-dummy
953112|NCT03461627|positive-controlled|positive-controlled
953113|NCT03461627|parallel-group|parallel-group
953114|NCT03461614|pulmonary function|pulmonary function
953115|NCT03461614|respiratory muscle strength|respiratory muscle strength
953116|NCT03461614|functional capacity|functional capacity
953117|NCT03461614|core exercises|core exercises
953118|NCT03461614|rehabilitation|rehabilitation
953119|NCT03461562|Aerobic Exercise|aerobic exercise
953120|NCT03461562|Whole Body Vibration Therapy|whole body vibration therapy
953121|NCT03461549|pressure sensor|pressure sensor
953122|NCT03461549|temperature sensor|temperature sensor
953123|NCT03461549|wearables|wearables
953124|NCT03461510|Cognition|cognition
953126|NCT03461510|Functional MRI|functional mri
953127|NCT03461510|Pediatric Obesity|pediatric obesity
953128|NCT03461510|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
953129|NCT03461510|Adolescents|adolescents
953130|NCT03461510|Continuous Glucose Monitoring|continuous glucose monitoring
953131|NCT03461510|Insulin Clamp|insulin clamp
953132|NCT03461497|Patient-Reported Outcome|patient-reported outcome
953133|NCT03461497|Patient Outcome Assessment|patient outcome assessment
953134|NCT03461497|Questionnaire|questionnaire
953135|NCT03461497|Self-Report|self-report
953136|NCT03461497|Abdominal Surgery|abdominal surgery
953137|NCT03461497|Postoperative Period|postoperative period
953138|NCT03461497|Recovery of Function|recovery of function
953139|NCT03461497|Psychometrics|psychometrics
953140|NCT03461497|Qualitative Research|qualitative research
953141|NCT03461497|Patient-Centered|patient-centered
953142|NCT03461458|Degenerative Disc Disease|degenerative disc disease
953143|NCT03461458|Musculoskeletal Diseases|musculoskeletal diseases
953144|NCT03461458|Lumbar|lumbar
953145|NCT03461445|Elderly|elderly
953146|NCT03461445|Neurotoxicity|neurotoxicity
953147|NCT03461445|Calcineurin inhibitors|calcineurin inhibitors
953148|NCT03461445|Tacrolimus|tacrolimus
953149|NCT03461432|Cognitive Remediation Therapy CRT|cognitive remediation therapy crt
953150|NCT03461419|Multiple Sclerosis|multiple sclerosis
953151|NCT03461419|Demyelinating Disease|demyelinating disease
953152|NCT03461419|Nervous System Degenerative Disease|nervous system degenerative disease
953153|NCT03461419|Autoimmune Disease|autoimmune disease
953154|NCT03461393|AMD|amd
953155|NCT03461393|Mobile Device|mobile device
953156|NCT03461393|Training|training
953157|NCT03461380|Cimicifuga, Rhodiola, Menopause Symptoms|cimicifuga, rhodiola, menopause symptoms
953158|NCT03461328|magnesium sulphate, chronic obstructive pulmonary diseases|magnesium sulphate, chronic obstructive pulmonary diseases
953159|NCT03461315|home care|home care
953160|NCT03461315|primary care|primary care
953161|NCT03461315|preventive home visits|preventive home visits
953162|NCT03461250|HCV infection|hcv infection
953163|NCT03461250|hemodialysis|hemodialysis
953164|NCT03461250|HCV genotype|hcv genotype
953165|NCT03461250|Liver Fibrosis stage|liver fibrosis stage
953166|NCT03461237|Second Hip Fracture|second hip fracture
953167|NCT03461237|Quantitative Computed Tomography|quantitative computed tomography
953168|NCT03461237|Bone structure|bone structure
953169|NCT03461237|Muscle|muscle
953170|NCT03461224|breast cancer|breast cancer
953171|NCT03461224|radiotherapy|radiotherapy
953172|NCT03461224|cutaneous toxicity|cutaneous toxicity
953173|NCT03461224|subcutaneous toxicity|subcutaneous toxicity
953174|NCT03461224|IMRT|imrt
953175|NCT03461172|surgery|surgery
953176|NCT03461172|breast cancer|breast cancer
953177|NCT03461159|operant conditioning|operant conditioning
953178|NCT03461159|H-reflex|h-reflex
953179|NCT03461159|motor evoked potential|motor evoked potential
953180|NCT03461159|transcranial magnetic stimulation|transcranial magnetic stimulation
953181|NCT03461159|motor control|motor control
953182|NCT03461042|Chronic insomnia|chronic insomnia
953183|NCT03461042|Ramelteon|ramelteon
953184|NCT03461042|Rozerem|rozerem
953185|NCT03461042|dose reduction|dose reduction
953186|NCT03461029|Sedation|sedation
953187|NCT03461016|Smartphones|smartphones
953188|NCT03461016|Exposure Therapy|exposure therapy
953189|NCT03461016|Dental Anxiety|dental anxiety
953190|NCT03460977|efficacy|efficacy
953191|NCT03460977|safety|safety
953192|NCT03460977|pharmacokinetics|pharmacokinetics
953193|NCT03460977|pharmacodynamics|pharmacodynamics
953194|NCT03460977|dose escalation|dose escalation
953195|NCT03460977|dose expansion|dose expansion
953196|NCT03460977|open-label|open-label
953197|NCT03460977|EZH2|ezh2
953198|NCT03460977|enhancer of zeste homolog 2|enhancer of zeste homolog 2
953199|NCT03460977|castrate resistant prostate cancer|castrate resistant prostate cancer
953200|NCT03460977|CRPC|crpc
953201|NCT03460977|small cell lung cancer|small cell lung cancer
953202|NCT03460977|SCLC|sclc
953203|NCT03460977|follicular lymphoma|follicular lymphoma
953204|NCT03460977|FL|fl
953205|NCT03460977|relapsed|relapsed
953206|NCT03460977|refractory|refractory
953207|NCT03460964|Sensor|sensor
953208|NCT03460964|Glucose|glucose
953209|NCT03460964|Sweat|sweat
953210|NCT03460951|Feasibility and reproductibility|feasibility and reproductibility
953211|NCT03460951|DTI parameters (Fractional Anisotropy, Apparent Diffusion Coefficient)|dti parameters (fractional anisotropy, apparent diffusion coefficient)
953212|NCT03460951|MRI morphological parameters (T1, STIR)|mri morphological parameters (t1, stir)
953213|NCT03460925|pancreatic cancer|pancreatic cancer
953214|NCT03460925|stereotactic body radiotherapy|stereotactic body radiotherapy
953215|NCT03460925|resectability|resectability
953216|NCT03460912|IONM|ionm
953217|NCT03460912|thyroidectomy|thyroidectomy
953218|NCT03460912|bipolar probe|bipolar probe
953219|NCT03460912|monopolar probe|monopolar probe
953220|NCT03460899|Hypoglycaemia|hypoglycaemia
953221|NCT03460899|Platelet activity|platelet activity
953222|NCT03460899|Type 2 diabetes mellitus|type 2 diabetes mellitus
953223|NCT03460886|transcranial direct current stimulation|transcranial direct current stimulation
953224|NCT03460834|Asthma|asthma
953225|NCT03460834|Obesity|obesity
953226|NCT03460834|Observational Study|observational study
953227|NCT03460808|steroid-resistant|steroid-resistant
953228|NCT03460808|refractory|refractory
953229|NCT03460808|Atorvastatin|atorvastatin
953230|NCT03460808|Acetylcysteine|acetylcysteine
953231|NCT03460808|Danazol|danazol
953232|NCT03460782|Ipilimumab|ipilimumab
953233|NCT03460782|Glioblastoma|glioblastoma
953234|NCT03460782|Glioma|glioma
953235|NCT03460769|Pancreatic Cancer|pancreatic cancer
953236|NCT03460769|Chronic Pancreatitis|chronic pancreatitis
953237|NCT03460769|Diabetes Mellitus Type 3c|diabetes mellitus type 3c
953238|NCT03460769|Data management|data management
953239|NCT03460756|Postpartum Care|postpartum care
953240|NCT03460756|Postpartum Depression|postpartum depression
953241|NCT03460743|hemagglutinin influenza vaccine|hemagglutinin influenza vaccine
953242|NCT03460743|recombinant influenza vaccine|recombinant influenza vaccine
953243|NCT03460730|Invasive Pneumococcal Disease|invasive pneumococcal disease
953244|NCT03460691|bariatric surgery|bariatric surgery
953245|NCT03460691|central sensitization|central sensitization
953246|NCT03460691|knee pain|knee pain
953247|NCT03460691|function|function
953248|NCT03460691|quality of life|quality of life
953249|NCT03460678|Generic Erlotinib|generic erlotinib
953250|NCT03460678|Generic Pemetrexed|generic pemetrexed
953251|NCT03460678|NSCLC|nsclc
953252|NCT03460678|Non-squamous|non-squamous
953253|NCT03460678|Randomized Study|randomized study
953254|NCT03460678|Maintenance Therapy|maintenance therapy
953255|NCT03460678|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
953256|NCT03460678|Antifolate antineoplastic agents|antifolate antineoplastic agents
953257|NCT03460639|Masseter muscle|masseter muscle
953258|NCT03460639|initial fatigue|initial fatigue
953259|NCT03460639|low-level laser|low-level laser
953260|NCT03460626|stress|stress
953261|NCT03460626|pharmacy students|pharmacy students
953262|NCT03460626|Saudi Arabia|saudi arabia
953263|NCT03460561|TEA|tea
953269|NCT03460496|advanced practice nurse|advanced practice nurse
953270|NCT03460496|cost-analysis|cost-analysis
953276|NCT03460392|Human microbiota|human microbiota
953277|NCT03460379|Bariatric surgery|bariatric surgery
953278|NCT03460379|Gastrointestinal tract|gastrointestinal tract
953279|NCT03460379|Biological availability|biological availability
953280|NCT03460379|Pharmacokinetics|pharmacokinetics
953281|NCT03460379|Citalopram|citalopram
953282|NCT03460366|Bariatric surgery|bariatric surgery
953283|NCT03460366|Gastrointestinal tract|gastrointestinal tract
953284|NCT03460366|Biological availability|biological availability
953285|NCT03460366|Pharmacokinetics|pharmacokinetics
953286|NCT03460366|Enalapril|enalapril
953287|NCT03460353|Bariatric surgery|bariatric surgery
953288|NCT03460353|Gastrointestinal tract|gastrointestinal tract
953289|NCT03460353|Biological availability|biological availability
953290|NCT03460353|Pharmacokinetics|pharmacokinetics
953291|NCT03460353|Dextroamphetamine|dextroamphetamine
953292|NCT03460340|dTMS|dtms
953293|NCT03460340|Fibromyalgia|fibromyalgia
953294|NCT03460327|Bariatric surgery|bariatric surgery
953295|NCT03460327|Gastrointestinal tract|gastrointestinal tract
953296|NCT03460327|Biological availability|biological availability
953297|NCT03460327|Pharmacokinetics|pharmacokinetics
953298|NCT03460327|Candesartan|candesartan
953299|NCT03460314|Bariatric surgery|bariatric surgery
953300|NCT03460314|Gastrointestinal tract|gastrointestinal tract
953301|NCT03460314|Biological availability|biological availability
953302|NCT03460314|Pharmacokinetics|pharmacokinetics
953303|NCT03460314|Buprenorphine|buprenorphine
953304|NCT03460288|Gambling, Problematic Gambling, Pathological Gambling|gambling, problematic gambling, pathological gambling
953305|NCT03460275|Osimertinib|osimertinib
953307|NCT03460236|osteoarthritis|osteoarthritis
953308|NCT03460236|MRI|mri
953309|NCT03460236|gait|gait
953310|NCT03460236|patient reported outcome|patient reported outcome
953311|NCT03460210|Bariatric surgery|bariatric surgery
953312|NCT03460210|Gastrointestinal tract|gastrointestinal tract
953313|NCT03460210|Biological availability|biological availability
953314|NCT03460210|Pharmacokinetics|pharmacokinetics
953315|NCT03460210|Atomoxetine hydrochloride|atomoxetine hydrochloride
953316|NCT03460197|Capillary technique|capillary technique
953317|NCT03460197|Wet technique|wet technique
953318|NCT03460197|Endoscopic Ultrasound-Guided Fine-Needle Aspiration|endoscopic ultrasound-guided fine-needle aspiration
953319|NCT03460171|Human Metapneumovirus|human metapneumovirus
953320|NCT03460171|Paramyxoviridae infections|paramyxoviridae infections
953321|NCT03460171|Lower-respiratory tract infections|lower-respiratory tract infections
953322|NCT03460171|Pneumonia|pneumonia
953323|NCT03460158|facial filler|facial filler
953324|NCT03460158|Retylane|retylane
953325|NCT03460158|aesthetic improvement|aesthetic improvement
953326|NCT03460158|volumizing fillers|volumizing fillers
953327|NCT03460145|Lavender Oil,|lavender oil,
953328|NCT03460145|Propofol|propofol
953329|NCT03460132|orthodontic miniscrews|orthodontic miniscrews
953330|NCT03460132|biological effect|biological effect
953331|NCT03460132|cytotoxicity|cytotoxicity
953332|NCT03460132|metal release|metal release
953333|NCT03460119|High Flow Nasal Cannula|high flow nasal cannula
953334|NCT03460119|Emergency department|emergency department
953335|NCT03460119|Respiratory care|respiratory care
953336|NCT03460106|Asthma Medical Adherence|asthma medical adherence
953337|NCT03460093|nerve blockade|nerve blockade
953338|NCT03460093|hypogastric plexus|hypogastric plexus
953339|NCT03460093|cesarean section|cesarean section
953340|NCT03460080|Hepatocellular carcinoma|hepatocellular carcinoma
953341|NCT03460080|AFP-L3|afp-l3
953342|NCT03460080|PIVKA-II|pivka-ii
953343|NCT03460067|omission of radiation|omission of radiation
953344|NCT03460067|trastuzumab|trastuzumab
953345|NCT03460067|pertuzumab|pertuzumab
953346|NCT03460067|biospecimen collection|biospecimen collection
953347|NCT03460067|lumpectomy|lumpectomy
953348|NCT03460015|COPD exacerbation|copd exacerbation
953349|NCT03460015|Sevoflurane|sevoflurane
953350|NCT03460015|Airway Resistance|airway resistance
953351|NCT03460002|Measles vaccine|measles vaccine
953352|NCT03460002|Oral polio vaccine|oral polio vaccine
953353|NCT03460002|Campaign|campaign
953354|NCT03460002|Child mortality|child mortality
953355|NCT03460002|Child morbidity|child morbidity
953356|NCT03460002|Non-specific effects|non-specific effects
953357|NCT03459989|hadlock|hadlock
953358|NCT03459989|thigh soft tissue|thigh soft tissue
953359|NCT03459963|catheter|catheter
953360|NCT03459963|cesarean section|cesarean section
953361|NCT03459963|urinary tract infection|urinary tract infection
953362|NCT03459963|patient's satisfaction|patient's satisfaction
953363|NCT03459937|obesity|obesity
953364|NCT03459937|yoga|yoga
953365|NCT03459937|mindfulness|mindfulness
953366|NCT03459937|weight loss|weight loss
953367|NCT03459937|physical activity|physical activity
953368|NCT03459924|Right ventricular function|right ventricular function
953369|NCT03459924|Liver transplantation|liver transplantation
953370|NCT03459924|Transesophageal echocardiography|transesophageal echocardiography
953371|NCT03459911|Bioequivalence|bioequivalence
953372|NCT03459872|acupuncture|acupuncture
953373|NCT03459872|quantitative data|quantitative data
953878|NCT03456323|Frailty|frailty
953374|NCT03459872|outcomes based rehabilitation|outcomes based rehabilitation
953375|NCT03459872|fine motor control|fine motor control
953376|NCT03459846|Urinary Bladder Neoplasms|urinary bladder neoplasms
953377|NCT03459833|premature ejaculation|premature ejaculation
953378|NCT03459833|IELT|ielt
953379|NCT03459833|hyaluronic acid|hyaluronic acid
953380|NCT03459833|glans penis augmentation|glans penis augmentation
953381|NCT03459807|Blood pressure|blood pressure
953382|NCT03459807|Hemodialysis|hemodialysis
953383|NCT03459807|End-stage-renal-disease|end-stage-renal-disease
953384|NCT03459807|Chronic kidney disease|chronic kidney disease
953385|NCT03459742|Obesity|obesity
953386|NCT03459742|Gamification|gamification
953387|NCT03459742|Schools|schools
953388|NCT03459742|Cluster Randomized Trial|cluster randomized trial
953389|NCT03459729|Anti-tumor B|anti-tumor b
953390|NCT03459729|ACAPHA|acapha
953391|NCT03459729|Pharmacokinetics|pharmacokinetics
953392|NCT03459716|Biomarkers|biomarkers
953393|NCT03459716|Endothelial microparticles|endothelial microparticles
953394|NCT03459690|Meditation, EEG|meditation, eeg
953395|NCT03459677|School Refusal|school refusal
953396|NCT03459677|Truancy|truancy
953397|NCT03459677|School Absenteeism|school absenteeism
953398|NCT03459677|Anxiety|anxiety
953399|NCT03459677|Depression|depression
953400|NCT03459677|Behavioral problems|behavioral problems
953402|NCT03459664|stepped care|stepped care
953403|NCT03459664|common mental disorders|common mental disorders
953404|NCT03459664|managed care|managed care
953405|NCT03459664|integrated care|integrated care
953406|NCT03459664|psychiatric disorders|psychiatric disorders
953407|NCT03459664|psychotherapy|psychotherapy
953408|NCT03459664|severe mental disorders|severe mental disorders
953409|NCT03459651|numeracy|numeracy
953410|NCT03459651|number sense|number sense
953411|NCT03459638|Screening|screening
953412|NCT03459599|Antibiotic|antibiotic
953413|NCT03459599|Endometritis|endometritis
953414|NCT03459599|Placental membranes|placental membranes
953415|NCT03459599|Prophylaxis|prophylaxis
953416|NCT03459599|Ragged membranes|ragged membranes
953417|NCT03459586|Parkinson|parkinson
953418|NCT03459560|antihypertensive agents|antihypertensive agents
953419|NCT03459560|acetylsalicylic acid|acetylsalicylic acid
953420|NCT03459560|atorvastatin|atorvastatin
953421|NCT03459508|Antiphospholipid Syndrome - Bad obstetric history - Ocular|antiphospholipid syndrome - bad obstetric history - ocular
953422|NCT03459495|migraine, therapeutic ultrasound, pain, disability|migraine, therapeutic ultrasound, pain, disability
953423|NCT03459456|OCD|ocd
1333209|NCT01443988|Ocular hypertension|ocular hypertension
953424|NCT03459456|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
953425|NCT03459430|trunk stability|trunk stability
953426|NCT03459430|accelerometer|accelerometer
953427|NCT03459430|smartphone|smartphone
953428|NCT03459430|core training|core training
953429|NCT03459430|isometric exercises|isometric exercises
953430|NCT03459391|Healthy volunteers|healthy volunteers
953431|NCT03459391|Phase I|phase i
953432|NCT03459391|PHARMENTERPRISES|pharmenterprises
953433|NCT03459352|Cancer|cancer
953434|NCT03459352|Patient Reported Outcomes|patient reported outcomes
953435|NCT03459352|Symptom management|symptom management
953436|NCT03459326|male sexuality|male sexuality
953437|NCT03459326|medical assisted to procreation|medical assisted to procreation
953438|NCT03459326|International Index of Erectile Function questionnaire|international index of erectile function questionnaire
953439|NCT03459300|actimetry|actimetry
953440|NCT03459287|INTERCEPT|intercept
953441|NCT03459287|Red Blood Cells|red blood cells
953442|NCT03459287|RBC|rbc
953443|NCT03459287|Pathogen Inactivation|pathogen inactivation
953444|NCT03459287|Cerus|cerus
953445|NCT03459287|Pathogen Reduction|pathogen reduction
953446|NCT03459287|Cardiovascular surgery|cardiovascular surgery
953447|NCT03459261|osteomyelitis|osteomyelitis
953448|NCT03459261|tibial fracture|tibial fracture
953449|NCT03459261|cytokines|cytokines
953450|NCT03459261|PCT|pct
953451|NCT03459261|CRP|crp
953452|NCT03459261|albumin|albumin
953453|NCT03459235|rectal cancer|rectal cancer
953454|NCT03459235|proctectomy|proctectomy
953455|NCT03459235|digestive sequelae|digestive sequelae
953456|NCT03459235|quality of life|quality of life
953457|NCT03459235|Urinary and Sexual sequelae|urinary and sexual sequelae
953458|NCT03459222|immunotherapy|immunotherapy
953459|NCT03459222|Relatlimab|relatlimab
953460|NCT03459196|Interventional|interventional
953461|NCT03459196|Radiofrequency Ablation|radiofrequency ablation
953462|NCT03459196|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
953464|NCT03459170|myelodysplastic syndrome|myelodysplastic syndrome
953465|NCT03459170|lymphoma|lymphoma
953466|NCT03459170|minimal residual disease|minimal residual disease
953467|NCT03459170|BPX-501|bpx-501
953468|NCT03459170|AP1903|ap1903
953469|NCT03459170|rimiducid|rimiducid
953470|NCT03459157|HIV infection|hiv infection
953471|NCT03459157|Men who have sex with men|men who have sex with men
953472|NCT03459157|Pre-exposure prophylaxis|pre-exposure prophylaxis
953473|NCT03459144|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
953474|NCT03459144|photodynamic therapy|photodynamic therapy
953476|NCT03459144|combination therapy|combination therapy
953477|NCT03459144|cost-benefit|cost-benefit
953478|NCT03459092|Botulinum toxin, strabismus surgery, binocular vision|botulinum toxin, strabismus surgery, binocular vision
953479|NCT03459066|Spasticity|spasticity
953480|NCT03459066|Stroke|stroke
953481|NCT03459066|Predictors|predictors
953482|NCT03459066|Functionality|functionality
953483|NCT03459066|Quality of life|quality of life
953484|NCT03459027|exercise hyperemia|exercise hyperemia
953485|NCT03459027|vasodilation|vasodilation
953486|NCT03459027|nitric oxide|nitric oxide
953487|NCT03459027|dietary nitrate|dietary nitrate
953488|NCT03459014|Robot-Assisted Gait Training|robot-assisted gait training
953489|NCT03459014|Virtual Reality|virtual reality
953490|NCT03459014|Optic Flow|optic flow
953491|NCT03459014|Active Participation|active participation
953492|NCT03458988|Blood pressure measuring|blood pressure measuring
953493|NCT03458975|microbubbles|microbubbles
953494|NCT03458975|sonoporation|sonoporation
953495|NCT03458975|hepatic metastases of colorectal cancer|hepatic metastases of colorectal cancer
953496|NCT03458962|Nicklaus Children's|nicklaus children's
953497|NCT03458962|Pediatric|pediatric
953498|NCT03458962|Genomic|genomic
953499|NCT03458962|Precision Medicine|precision medicine
953500|NCT03458962|Biorepository|biorepository
953501|NCT03458962|Rady Children's|rady children's
953502|NCT03458936|Depression|depression
953503|NCT03458936|Adolescence|adolescence
953504|NCT03458936|Resilience|resilience
953505|NCT03458936|Risk Factor|risk factor
953506|NCT03458936|Biomarker|biomarker
953507|NCT03458923|Diclofenac|diclofenac
953508|NCT03458923|Ranibizumab|ranibizumab
953509|NCT03458923|Diabetic Macular Edema|diabetic macular edema
953510|NCT03458910|heart rate variability, HRV|heart rate variability, hrv
953511|NCT03458897|bone marrow cellularity|bone marrow cellularity
953512|NCT03458897|bone marrow transplant|bone marrow transplant
953513|NCT03458884|Stroke|stroke
953514|NCT03458884|Fatigue|fatigue
953515|NCT03458884|PROBE design|probe design
953516|NCT03458884|Cardiorespiratory fitness|cardiorespiratory fitness
953517|NCT03458884|Cardiorespiratory training|cardiorespiratory training
953518|NCT03458871|electric stimulation|electric stimulation
953519|NCT03458845|Cirrhosis|cirrhosis
953520|NCT03458845|Sarcopenia|sarcopenia
953521|NCT03458845|Malnutrition|malnutrition
953522|NCT03458845|Inguinal hernia|inguinal hernia
953523|NCT03458845|Umbilical hernia|umbilical hernia
953524|NCT03458845|Undernutrition|undernutrition
953525|NCT03458832|muscular dystrophy.|muscular dystrophy.
953526|NCT03458832|FSHD|fshd
953527|NCT03458806|Auscultation|auscultation
953528|NCT03458806|Phonocardiogram|phonocardiogram
953529|NCT03458806|Machine Learning|machine learning
953530|NCT03458806|Heart Sounds|heart sounds
953531|NCT03458793|randomised controlled study|randomised controlled study
953532|NCT03458793|physical activity|physical activity
953533|NCT03458793|loneliness|loneliness
953534|NCT03458780|yellow fever vaccine|yellow fever vaccine
953535|NCT03458780|immune response|immune response
953536|NCT03458780|"droplet microfluidics single cell (inDrop) RNA-Seq"|"droplet microfluidics single cell (indrop) rna-seq"
953537|NCT03458767|Cognitive function|cognitive function
953538|NCT03458767|Physical activity|physical activity
953539|NCT03458767|Self-management|self-management
953540|NCT03458754|Peripheral Arterial Disease|peripheral arterial disease
953541|NCT03458754|Exercise capacity|exercise capacity
953542|NCT03458754|Physical activity|physical activity
953543|NCT03458754|Respiratory muscle strength|respiratory muscle strength
953544|NCT03458754|Peripheric muscle strength|peripheric muscle strength
953545|NCT03458728|Phase I: relapsed or refractory solid tumors or lymphoma|phase i: relapsed or refractory solid tumors or lymphoma
953546|NCT03458728|Phase II: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or Ewing sarcoma)|phase ii: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or ewing sarcoma)
953547|NCT03458715|SGLT2 inhibitor|sglt2 inhibitor
953548|NCT03458715|DPP4 inhibitor|dpp4 inhibitor
953549|NCT03458702|autonomic function|autonomic function
953550|NCT03458702|emotion|emotion
953551|NCT03458702|heart rate variability|heart rate variability
953552|NCT03458676|Advanced magnetic resonance imaging|advanced magnetic resonance imaging
953553|NCT03458676|AMRI|amri
953554|NCT03458624|FURESTEM-AD Inj.|furestem-ad inj.
953555|NCT03458624|Stem cells|stem cells
954157|NCT03454451|CRC|crc
953561|NCT03458559|Rhenium-188-HEDP|rhenium-188-hedp
953562|NCT03458559|Radium 223-chloride|radium 223-chloride
953563|NCT03458559|Survival|survival
953564|NCT03458559|Prostate cancer|prostate cancer
953565|NCT03458533|Pituitary|pituitary
953566|NCT03458533|Obesity|obesity
953567|NCT03458533|Overweight|overweight
953568|NCT03458533|Metabolic syndrome|metabolic syndrome
953569|NCT03458533|MRI|mri
953570|NCT03458507|Neuromuscular diseases|neuromuscular diseases
953571|NCT03458507|Non-invasive ventilation|non-invasive ventilation
953572|NCT03458507|Nasal mask|nasal mask
953573|NCT03458507|Oronasal mask|oronasal mask
953574|NCT03458507|Alveolar hypoventilation|alveolar hypoventilation
953575|NCT03458507|leaks|leaks
953576|NCT03458507|Sleep disorder breathing|sleep disorder breathing
953577|NCT03458507|Side effects|side effects
953578|NCT03458494|type 2 diabetes|type 2 diabetes
953579|NCT03458494|glucose|glucose
953580|NCT03458494|insulin|insulin
953581|NCT03458494|CRP|crp
953582|NCT03458494|Metabolomics|metabolomics
953583|NCT03458494|gene-diet interaction|gene-diet interaction
953584|NCT03458494|TCF7L2|tcf7l2
953585|NCT03458481|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
953586|NCT03458468|tranexamic acid|tranexamic acid
953587|NCT03458468|anterior shoulder instability|anterior shoulder instability
953588|NCT03458468|latarjet|latarjet
953589|NCT03458468|hematoma|hematoma
953590|NCT03458455|TREATMENT|treatment
953591|NCT03458455|Vessel Architectural Imaging|vessel architectural imaging
953592|NCT03458455|Brain Metastases|brain metastases
953593|NCT03458442|education|education
953594|NCT03458442|developing country|developing country
953595|NCT03458442|developing countries|developing countries
953596|NCT03458442|low-and middle-income country|low-and middle-income country
953597|NCT03458442|low-and middle-income countries|low-and middle-income countries
953598|NCT03458442|surgical training|surgical training
953599|NCT03458442|blindness|blindness
953600|NCT03458442|china|china
953601|NCT03458442|simulation|simulation
953602|NCT03458442|model|model
953603|NCT03458429|Young Donor Plasma|young donor plasma
953604|NCT03458429|Frailty|frailty
953605|NCT03458429|Aging|aging
953606|NCT03458429|Immune Function|immune function
953607|NCT03458429|G-CSF|g-csf
953608|NCT03458403|Digestive endoscopy|digestive endoscopy
953609|NCT03458403|Tracking motion|tracking motion
953610|NCT03458377|Colonoscopy|colonoscopy
953611|NCT03458377|Quality|quality
953612|NCT03458377|Telephone intervention|telephone intervention
953613|NCT03458364|Weaning; Noninvasive ventilation; High flow nasal cannula|weaning; noninvasive ventilation; high flow nasal cannula
953614|NCT03458351|platelet activation|platelet activation
953615|NCT03458351|remote ischemic preconditioning|remote ischemic preconditioning
953616|NCT03458338|chronic kidney disease|chronic kidney disease
953617|NCT03458338|communicable disease|communicable disease
953618|NCT03458338|sub-Saharan Africa|sub-saharan africa
953619|NCT03458338|Tanzania|tanzania
953620|NCT03458338|neglected disease|neglected disease
953621|NCT03458338|prevalence|prevalence
953622|NCT03458338|double burden|double burden
953623|NCT03458299|American Indian|american indian
1642163|NCT00236041|Analgesia|analgesia
953624|NCT03458286|Diabetic Foot Ulcers|diabetic foot ulcers
953625|NCT03458286|Chronic|chronic
953626|NCT03458286|Combined ultrasound and electric current stimulation|combined ultrasound and electric current stimulation
953627|NCT03458286|Adjunctive therapy|adjunctive therapy
953628|NCT03458273|Atrial Arrhythmia|atrial arrhythmia
953629|NCT03458273|Ventricular Arrythmia|ventricular arrythmia
953630|NCT03458273|ablation|ablation
953631|NCT03458273|fluoroscopy|fluoroscopy
953632|NCT03458260|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
953633|NCT03458260|relapsed or refractory|relapsed or refractory
953634|NCT03458247|Prostate Cancer|prostate cancer
953635|NCT03458247|Castration resistance|castration resistance
953636|NCT03458247|Drug monitoring|drug monitoring
953637|NCT03458247|Abiraterone acetate|abiraterone acetate
953638|NCT03458234|Focal therapy|focal therapy
953639|NCT03458234|Prostate cancer|prostate cancer
953640|NCT03458234|SBRT|sbrt
953641|NCT03458234|Intra-urethral transponder|intra-urethral transponder
953642|NCT03458221|ovarian carcinoma|ovarian carcinoma
953643|NCT03458221|Signal Transduction Pathway|signal transduction pathway
953644|NCT03458221|therapy|therapy
953645|NCT03458208|AUC|auc
953646|NCT03458208|Cmax|cmax
953647|NCT03458208|Pharmacokinetics|pharmacokinetics
953648|NCT03458208|metformin|metformin
953649|NCT03458208|fed|fed
953650|NCT03458208|fasting|fasting
953651|NCT03458195|ileo-caecal resection; post-operative recurrence|ileo-caecal resection; post-operative recurrence
953652|NCT03458143|ketamine|ketamine
953653|NCT03458143|remifentanil|remifentanil
953654|NCT03458078|Bupivacaine,|bupivacaine,
953655|NCT03458078|Anesthetics|anesthetics
953656|NCT03458078|Adjuvants|adjuvants
953657|NCT03458078|Analgesics|analgesics
953658|NCT03458078|Peripheral system|peripheral system
953659|NCT03458078|Central Nervous|central nervous
953660|NCT03458078|sensory system|sensory system
953661|NCT03458078|Agents|agents
953662|NCT03458078|Physiological effects of drugs|physiological effects of drugs
953663|NCT03458078|opioid|opioid
953664|NCT03458078|Pain|pain
953665|NCT03458078|Postoperative|postoperative
953666|NCT03458078|Signs and Symptoms|signs and symptoms
953667|NCT03458052|Intensive and critical care|intensive and critical care
953668|NCT03458052|Organ donation|organ donation
953669|NCT03458052|Knowledge|knowledge
953670|NCT03458039|mental health capacity building|mental health capacity building
953671|NCT03458039|low and middle-income country|low and middle-income country
953672|NCT03458039|train the trainer strategy|train the trainer strategy
953673|NCT03458039|technology-based training|technology-based training
953674|NCT03458026|activity|activity
953675|NCT03458026|Connected object|connected object
953676|NCT03458013|Mindfulness|mindfulness
953677|NCT03458013|Complementary Medicine|complementary medicine
953678|NCT03458013|Integrative Health|integrative health
953679|NCT03458013|Hand Therapy|hand therapy
953680|NCT03457987|protein load|protein load
953681|NCT03457987|cardiac surgery|cardiac surgery
953682|NCT03457974|saliva composition|saliva composition
953683|NCT03457974|antioxidant activity|antioxidant activity
953684|NCT03457974|caries risk factors|caries risk factors
953685|NCT03457974|congenital cardiac disease|congenital cardiac disease
953686|NCT03457961|Perampanel|perampanel
953687|NCT03457961|focal onset seizure|focal onset seizure
953688|NCT03457961|epilepsy|epilepsy
953689|NCT03457909|string|string
953690|NCT03457909|capsule endoscopy|capsule endoscopy
953691|NCT03457896|NSABP|nsabp
953692|NCT03457896|PUMA|puma
953693|NCT03457896|Neratinib|neratinib
953694|NCT03457896|Trastuzumab|trastuzumab
953695|NCT03457896|Cetuximab|cetuximab
953696|NCT03457896|RAS|ras
953697|NCT03457896|NRAS|nras
953698|NCT03457896|BRAF|braf
953699|NCT03457896|PIK3CA wild-type|pik3ca wild-type
953700|NCT03457896|Quadruple wild-type|quadruple wild-type
953701|NCT03457896|HER2 status|her2 status
953702|NCT03457883|Pelvic organ prolapse|pelvic organ prolapse
953703|NCT03457883|Vaginal mesh|vaginal mesh
953704|NCT03457883|biological graft|biological graft
953705|NCT03457883|Recurrence|recurrence
953706|NCT03457870|Intermittent fasting|intermittent fasting
953707|NCT03457870|Adult hippocampal neurogenesis|adult hippocampal neurogenesis
953708|NCT03457870|Mastication|mastication
953709|NCT03457870|Pattern separation|pattern separation
953710|NCT03457870|Recognition memory|recognition memory
953711|NCT03457870|Klotho|klotho
953712|NCT03457857|Microbiome|microbiome
953713|NCT03457857|Microbiota|microbiota
953714|NCT03457805|prostate cancer|prostate cancer
953715|NCT03457805|prostate|prostate
953716|NCT03457805|embolization|embolization
953717|NCT03457805|minimally invasive|minimally invasive
953718|NCT03457805|cytoreductive therapy|cytoreductive therapy
953719|NCT03457753|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
953720|NCT03457740|muscular strength|muscular strength
953721|NCT03457740|testosterone|testosterone
953722|NCT03457740|sexual function|sexual function
953723|NCT03457740|quality of life|quality of life
953724|NCT03457727|Danirixin|danirixin
953725|NCT03457727|Healthy|healthy
953726|NCT03457727|Food effect|food effect
953727|NCT03457727|Relative Bioavailability|relative bioavailability
953728|NCT03457727|Hydrobromide Salt|hydrobromide salt
953729|NCT03457714|spinal cord injuries|spinal cord injuries
953730|NCT03457714|anxiety|anxiety
953731|NCT03457714|depression|depression
953732|NCT03457714|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
953733|NCT03457714|pilot study|pilot study
953734|NCT03457675|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
953735|NCT03457675|Treatment Resistant OCD|treatment resistant ocd
953736|NCT03457675|Intractable OCD|intractable ocd
953737|NCT03457675|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
953738|NCT03457610|chronic cough|chronic cough
953739|NCT03457610|speech and language intervention|speech and language intervention
953740|NCT03457610|difficult-to-treat cough|difficult-to-treat cough
953741|NCT03457532|Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity|safety, tolerability, pharmacokinetics, anti-tumor activity
953742|NCT03457519|ChARM|charm
953743|NCT03457519|community health worker|community health worker
953744|NCT03457506|Cancer|cancer
953745|NCT03457506|Digital pet|digital pet
953746|NCT03457506|Conventional pet|conventional pet
953747|NCT03457480|Cancer Prevention|cancer prevention
953748|NCT03457480|Focus Group|focus group
953749|NCT03457480|Text messaging|text messaging
953750|NCT03457480|Questionnaires|questionnaires
953751|NCT03457480|Surveys|surveys
953752|NCT03457467|oligometacosis|oligometacosis
953753|NCT03457467|anti-angiogenic|anti-angiogenic
953754|NCT03457467|apatinib|apatinib
953755|NCT03457428|obstructive sleep apnea|obstructive sleep apnea
953756|NCT03457428|home sleep testing|home sleep testing
953757|NCT03457415|LDCT|ldct
953758|NCT03457415|Sputum|sputum
953759|NCT03457415|High-risk Smoker|high-risk smoker
953760|NCT03457415|Porphyrin|porphyrin
953761|NCT03457415|Early detection|early detection
953762|NCT03457402|delay discounting|delay discounting
953763|NCT03457402|shaping|shaping
953764|NCT03457389|Prolactinoma|prolactinoma
953765|NCT03457389|Cabergoline|cabergoline
953766|NCT03457389|Recurrence|recurrence
953767|NCT03457363|oxygen|oxygen
953768|NCT03457363|nasal cannula|nasal cannula
953769|NCT03457363|double trunk mask|double trunk mask
953770|NCT03457363|hypoxia|hypoxia
953771|NCT03457350|hysteroscopy|hysteroscopy
953772|NCT03457350|cervical stenosis|cervical stenosis
953773|NCT03457350|probing|probing
953774|NCT03457324|JCM-16021|jcm-16021
953775|NCT03457324|Trial|trial
953776|NCT03457324|Irritable Bowel Syndrome|irritable bowel syndrome
953777|NCT03457324|Chinese Medicine|chinese medicine
953778|NCT03457311|GSP, oral galactose single point (OGSP)|gsp, oral galactose single point (ogsp)
953879|NCT03456323|Palliative Care|palliative care
953779|NCT03457285|Ankylosing spondylitis; physiotherapy; Salaso|ankylosing spondylitis; physiotherapy; salaso
953780|NCT03457272|Patient Safety|patient safety
953781|NCT03457272|Risk Factors|risk factors
953782|NCT03457272|Quality Indicators, Health Care|quality indicators, health care
953783|NCT03457272|Risk Assessment|risk assessment
953784|NCT03457259|Midline catheter, peripheral venous catheter, central venous catheter, complication rate|midline catheter, peripheral venous catheter, central venous catheter, complication rate
953785|NCT03457246|solar lentigos|solar lentigos
953786|NCT03457246|physical Hyperpigmentation therapies|physical hyperpigmentation therapies
953787|NCT03457246|cosmetic topical depigmenting product|cosmetic topical depigmenting product
953788|NCT03457246|topical Hyperpigmentation therapies|topical hyperpigmentation therapies
953789|NCT03457194|Obesity|obesity
953790|NCT03457194|Vaccination|vaccination
953791|NCT03457194|Pregnancy|pregnancy
953792|NCT03457194|Influenza|influenza
953793|NCT03457194|Pertussis|pertussis
953794|NCT03457194|Maternal antibodies|maternal antibodies
953795|NCT03457168|Sleep-time hypertension|sleep-time hypertension
953796|NCT03457168|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
953797|NCT03457168|Hypertension chronotherapy|hypertension chronotherapy
953798|NCT03457168|Asleep blood pressure|asleep blood pressure
953799|NCT03457168|Cardiovascular risk|cardiovascular risk
953800|NCT03457168|Type 2 diabetes|type 2 diabetes
953801|NCT03457168|Chronic kidney disease|chronic kidney disease
953802|NCT03457129|Epilepsy|epilepsy
953803|NCT03457129|Epilepsy, partial onset|epilepsy, partial onset
953804|NCT03457129|Epilepsy, generalized onset|epilepsy, generalized onset
953805|NCT03457129|Fycompa|fycompa
953806|NCT03457129|perampanel|perampanel
953807|NCT03457090|neurologic complication, transcranial Doppler ultrasound|neurologic complication, transcranial doppler ultrasound
953808|NCT03457077|brief intervention|brief intervention
953809|NCT03457077|fMRI|fmri
953810|NCT03457038|Mannose-Binding Lectin, PAMPs,|mannose-binding lectin, pamps,
953811|NCT03457025|Oxygen Therapy|oxygen therapy
953812|NCT03457025|Bells Palsy|bells palsy
953813|NCT03456999|BKV, renal transplant, renal and kidney transplant|bkv, renal transplant, renal and kidney transplant
953814|NCT03456934|Protein requirements|protein requirements
953815|NCT03456934|Adiposity|adiposity
953816|NCT03456934|Body composition|body composition
953817|NCT03456934|Cardiovascular health|cardiovascular health
953818|NCT03456921|health games|health games
953819|NCT03456921|community engagement|community engagement
953820|NCT03456882|AMYOTROPHIC LATERAL SCLEROSIS|amyotrophic lateral sclerosis
953822|NCT03456882|Biomarkers|biomarkers
953823|NCT03456882|clinical trial|clinical trial
953824|NCT03456882|therapy|therapy
953825|NCT03456869|patient specific implant|patient specific implant
953826|NCT03456869|computer-aided surgery|computer-aided surgery
953827|NCT03456869|clinical accuracy|clinical accuracy
953828|NCT03456856|Cardiac|cardiac
953829|NCT03456856|Congestive|congestive
953830|NCT03456856|Decompensation|decompensation
953831|NCT03456856|Heart Failure|heart failure
953832|NCT03456856|Left-Sided|left-sided
953833|NCT03456856|Myocardial|myocardial
953834|NCT03456856|Corlanor|corlanor
953835|NCT03456856|Ivabradine|ivabradine
953836|NCT03456856|African American|african american
953837|NCT03456856|Black|black
953838|NCT03456856|Michigan|michigan
953839|NCT03456830|Kidney stones|kidney stones
953840|NCT03456830|Hyperoxaluria|hyperoxaluria
953841|NCT03456830|Enteric hyperoxaluria|enteric hyperoxaluria
953842|NCT03456830|Oxalate|oxalate
953843|NCT03456791|Epididymal secretory protein E4|epididymal secretory protein e4
953844|NCT03456791|Major epididymis specific protein E4|major epididymis specific protein e4
953845|NCT03456778|Sonographic imaging|sonographic imaging
953846|NCT03456778|Platelet-rich plasma (PRP) injection|platelet-rich plasma (prp) injection
953847|NCT03456778|Shear Wave Elastography|shear wave elastography
953848|NCT03456752|Inflammatory Bowel Diseases|inflammatory bowel diseases
953849|NCT03456752|Glucocorticosteroids|glucocorticosteroids
953850|NCT03456752|Postoperative Outcome|postoperative outcome
953851|NCT03456726|EZH2 gene mutation|ezh2 gene mutation
953852|NCT03456726|Tazemetostat|tazemetostat
953853|NCT03456726|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
953854|NCT03456726|Follicular lymphoma|follicular lymphoma
953855|NCT03456687|Exenatide|exenatide
953859|NCT03456661|Levobupivacaine|levobupivacaine
953860|NCT03456661|Dexmedetomidine|dexmedetomidine
953861|NCT03456635|antimicrobial|antimicrobial
953862|NCT03456635|prophylaxys|prophylaxys
953864|NCT03456622|G7|g7
953865|NCT03456596|CBPR|cbpr
953866|NCT03456596|RE-AIM|re-aim
953867|NCT03456583|Breast Biopsy|breast biopsy
953868|NCT03456583|Breast Biopsy Imaging|breast biopsy imaging
953869|NCT03456583|Stereotactic Imaging|stereotactic imaging
953870|NCT03456414|exercise|exercise
953871|NCT03456414|physical function|physical function
953872|NCT03456414|health related quality of life|health related quality of life
953873|NCT03456375|progesterone|progesterone
953874|NCT03456375|artificial endometrial preparation cycle|artificial endometrial preparation cycle
953875|NCT03456375|endometrial receptivity|endometrial receptivity
953876|NCT03456349|Alzheimer's disease|alzheimer's disease
953877|NCT03456323|Critical Illness|critical illness
953880|NCT03456297|Web-based clinical pedagogy program|web-based clinical pedagogy program
953881|NCT03456297|nurse preceptors|nurse preceptors
953882|NCT03456297|teaching competency|teaching competency
953883|NCT03456232|hemodialysis|hemodialysis
953884|NCT03456232|hemodiafiltration|hemodiafiltration
953885|NCT03456232|end-stage renal disease|end-stage renal disease
953886|NCT03456219|Food intake|food intake
953887|NCT03456219|Sleep|sleep
953888|NCT03456219|Shift work|shift work
953889|NCT03456219|Postprandial metabolic response|postprandial metabolic response
953890|NCT03456206|Life Style|life style
953891|NCT03456206|Diet|diet
953892|NCT03456206|Food|food
953894|NCT03456206|Disease risk|disease risk
953895|NCT03456180|septic shock|septic shock
953896|NCT03456180|microcirculation|microcirculation
953897|NCT03456180|acute renal failure|acute renal failure
953898|NCT03456180|renal replacement therapy|renal replacement therapy
953899|NCT03456180|haemoadsorption|haemoadsorption
953900|NCT03456167|telemedicine|telemedicine
953901|NCT03456167|mobile applications|mobile applications
953902|NCT03456167|ERAS|eras
953903|NCT03456167|postoperative care|postoperative care
953904|NCT03456167|patient satisfaction|patient satisfaction
953905|NCT03456167|breast reconstruction|breast reconstruction
953906|NCT03456167|gynecologic oncology|gynecologic oncology
953907|NCT03456167|mastectomy|mastectomy
953908|NCT03456128|Older Adult|older adult
953909|NCT03456128|Rehospitalization|rehospitalization
953910|NCT03456128|Physical function|physical function
953911|NCT03456115|nasal obstruction|nasal obstruction
953912|NCT03456115|nasal valve collapse|nasal valve collapse
953913|NCT03456089|urodynamics|urodynamics
953914|NCT03456089|neurogenic|neurogenic
953915|NCT03456089|bladder|bladder
953917|NCT03456037|HBsAg|hbsag
953918|NCT03456037|Anti-HCV,|anti-hcv,
953919|NCT03456037|seropositivity|seropositivity
953920|NCT03455998|morbid obesity|morbid obesity
953921|NCT03455998|gastric bypass|gastric bypass
953922|NCT03455998|pain|pain
953923|NCT03455998|symptoms|symptoms
953924|NCT03455959|Asthma|asthma
953925|NCT03455959|Allergic|allergic
953926|NCT03455959|Inflammation|inflammation
953927|NCT03455959|Airway|airway
953928|NCT03455946|Digital Health|digital health
953929|NCT03455946|Amazon Alexa|amazon alexa
953930|NCT03455907|Bevacizumab|bevacizumab
953931|NCT03455894|Fall detection|fall detection
953932|NCT03455894|Smart carpet|smart carpet
953933|NCT03455894|Elderly people|elderly people
953934|NCT03455881|TEF|tef
953935|NCT03455881|EA|ea
953936|NCT03455881|Tracheal Esophageal birth Defect (TED)|tracheal esophageal birth defect (ted)
953937|NCT03455855|Atherectomy|atherectomy
953938|NCT03455855|occlusive atherosclerotic lesions|occlusive atherosclerotic lesions
953939|NCT03455829|Lung Cancer|lung cancer
953940|NCT03455829|Non-small Cell Lung Cancer|non-small cell lung cancer
953941|NCT03455829|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
953942|NCT03455829|EGFR-Positive|egfr-positive
953943|NCT03455829|EGFR Mutation- Positive|egfr mutation- positive
953944|NCT03455829|T790M|t790m
953945|NCT03455829|EGFR Mutant|egfr mutant
953946|NCT03455816|mobile app|mobile app
953947|NCT03455790|Wheelchair Basketball,|wheelchair basketball,
953948|NCT03455790|Isokinetic|isokinetic
953949|NCT03455790|Anaerobic Capacity|anaerobic capacity
953950|NCT03455790|Shoulder Muscle Strength|shoulder muscle strength
953951|NCT03455790|Aerobic Capacity,|aerobic capacity,
953952|NCT03455790|Sportive Performance|sportive performance
953953|NCT03455764|Melanoma|melanoma
953954|NCT03455751|Pain Management|pain management
953955|NCT03455751|Pharmacogenomics|pharmacogenomics
953956|NCT03455738|Vasoplegia, norepinephrine, dynamic arterial elastance|vasoplegia, norepinephrine, dynamic arterial elastance
953957|NCT03455725|Cardiovascular Stem Cell Therapy|cardiovascular stem cell therapy
953958|NCT03455725|Bone Marrow Mononuclear Stem Cells|bone marrow mononuclear stem cells
953959|NCT03455725|Intramyocardial Injection|intramyocardial injection
953960|NCT03455712|Pregnancy|pregnancy
953961|NCT03455712|Gestational weight gain|gestational weight gain
953962|NCT03455712|Weight gain|weight gain
953963|NCT03455712|Patient education|patient education
953964|NCT03455712|Patient knowledge|patient knowledge
953965|NCT03455712|Institute of Medicine|institute of medicine
953967|NCT03455686|magnetic resonance imaging|magnetic resonance imaging
953968|NCT03455686|hyperpolarized xenon-129|hyperpolarized xenon-129
953969|NCT03455686|lung function|lung function
953970|NCT03455686|lung structure|lung structure
953971|NCT03455660|Cesarean|cesarean
953972|NCT03455660|C-Section|c-section
953973|NCT03455647|stunting|stunting
953974|NCT03455647|underweight|underweight
953975|NCT03455647|wasting|wasting
953976|NCT03455634|quality of life|quality of life
953977|NCT03455621|dental caries|dental caries
953978|NCT03455621|fluoride|fluoride
953979|NCT03455621|toothpaste|toothpaste
953980|NCT03455621|dentifrice|dentifrice
953981|NCT03455608|dysphagia|dysphagia
953982|NCT03455608|swallowing disorder|swallowing disorder
953983|NCT03455608|speech pathology|speech pathology
953984|NCT03455608|swallowing therapy|swallowing therapy
954088|NCT03454841|ticagrelor|ticagrelor
953985|NCT03455608|head and neck cancer|head and neck cancer
953986|NCT03455608|radiotherapy|radiotherapy
953987|NCT03455608|toxicity|toxicity
953988|NCT03455608|supportive care|supportive care
953989|NCT03455582|cognitive impairment|cognitive impairment
953990|NCT03455582|ecological assessment|ecological assessment
953991|NCT03455582|brain MRI|brain mri
953992|NCT03455569|Behavioral sleep management|behavioral sleep management
953993|NCT03455569|Alzheimer's disease|alzheimer's disease
953994|NCT03455569|Informal caregiver|informal caregiver
953995|NCT03455517|Chronic myeloid leukemia|chronic myeloid leukemia
953996|NCT03455517|Umutated IGVH|umutated igvh
953997|NCT03455517|Disrupted TP53|disrupted tp53
953998|NCT03455504|Acute myeloid leukemia|acute myeloid leukemia
953999|NCT03455504|Venetoclax|venetoclax
954000|NCT03455413|electrical impedance tomography|electrical impedance tomography
954001|NCT03455387|sFLt1|sflt1
954002|NCT03455387|PlGF|plgf
954003|NCT03455361|implant stability, dental implants, primary stability|implant stability, dental implants, primary stability
954004|NCT03455309|Als3|als3
954005|NCT03455309|SSTI|ssti
954006|NCT03455309|vaccine|vaccine
954007|NCT03455309|NDV-3A|ndv-3a
954008|NCT03455309|incident nasal colonization|incident nasal colonization
954009|NCT03455270|Breast Cancer|breast cancer
954010|NCT03455270|Oral SERD|oral serd
954011|NCT03455270|SERD|serd
954012|NCT03455270|HER2-Negative|her2-negative
954013|NCT03455270|ER-Positive|er-positive
954015|NCT03455270|HER2-|her2-
954016|NCT03455270|HER2 -ve|her2 -ve
954017|NCT03455270|ER +ve|er +ve
954018|NCT03455231|palliative care|palliative care
954019|NCT03455231|complicated bone metastases|complicated bone metastases
954020|NCT03455231|radiotherapy|radiotherapy
954021|NCT03455231|pain|pain
954022|NCT03455231|quality of life|quality of life
954023|NCT03455218|Cardiopulmonary Bypass|cardiopulmonary bypass
954024|NCT03455218|Infant|infant
954025|NCT03455218|Nitric Oxide|nitric oxide
954026|NCT03455218|Thrombocytopenia|thrombocytopenia
954027|NCT03455218|Blood Platelets|blood platelets
954028|NCT03455192|gingivitis|gingivitis
954029|NCT03455192|gingival crevicular fluid|gingival crevicular fluid
954030|NCT03455192|probiotics|probiotics
954031|NCT03455192|smoking|smoking
954032|NCT03455192|periodontal medicine|periodontal medicine
954033|NCT03455179|Older|older
954034|NCT03455179|Physical function|physical function
954035|NCT03455179|Power training|power training
954036|NCT03455179|Oxidative stress|oxidative stress
954037|NCT03455179|Elastic band|elastic band
954038|NCT03455179|OMNI-RES perceived exertion scale|omni-res perceived exertion scale
954039|NCT03455179|Strength training|strength training
954040|NCT03455153|Pulmonary Rehabilitation|pulmonary rehabilitation
954041|NCT03455153|Neutrophils|neutrophils
954042|NCT03455140|Arginine|arginine
954043|NCT03455140|Arginase|arginase
954044|NCT03455140|Children|children
954045|NCT03455140|Young Adult|young adult
954046|NCT03455127|Child Development|child development
954047|NCT03455127|Home Visiting|home visiting
954048|NCT03455127|Parenting Program|parenting program
954049|NCT03455127|Social Protection|social protection
954050|NCT03455127|Public Works|public works
954051|NCT03455101|Cardiovascular risk status|cardiovascular risk status
954052|NCT03455101|Optimal metabolic control|optimal metabolic control
954053|NCT03455075|Healthy Men|healthy men
954054|NCT03455075|Male Contraception|male contraception
954055|NCT03455075|Androgen|androgen
954056|NCT03455075|Dimethandrolone|dimethandrolone
954057|NCT03455075|Levonorgestrel|levonorgestrel
954058|NCT03455062|Transplant, fertility|transplant, fertility
954059|NCT03455036|whole body vibration, erythema, tryptase, unpleasantness|whole body vibration, erythema, tryptase, unpleasantness
954060|NCT03455023|Cancer pain|cancer pain
954061|NCT03455023|Pharmaceutical care|pharmaceutical care
954062|NCT03455010|Ambulatory load|ambulatory load
954063|NCT03455010|Biomarker|biomarker
954064|NCT03455010|Articular cartilage|articular cartilage
954065|NCT03454945|Mycosis fungoides|mycosis fungoides
954066|NCT03454945|Doxycycline|doxycycline
954067|NCT03454932|Rheumatoid Arthritis|rheumatoid arthritis
954068|NCT03454932|Psoriatic Arthritis|psoriatic arthritis
954069|NCT03454932|Spondylarthritis|spondylarthritis
954070|NCT03454932|Rheumatic diseases|rheumatic diseases
954071|NCT03454932|Inflammation|inflammation
954072|NCT03454932|Autoimmune diseases|autoimmune diseases
954073|NCT03454932|Osteoimmunology|osteoimmunology
954074|NCT03454906|hemodialysis|hemodialysis
954075|NCT03454906|hemoglobin variability|hemoglobin variability
954076|NCT03454906|mortality|mortality
954077|NCT03454906|nutrition|nutrition
954078|NCT03454906|inflammation|inflammation
954079|NCT03454880|Accelerometry|accelerometry
954080|NCT03454880|Wearable electronic devices|wearable electronic devices
954081|NCT03454854|risk evaluation|risk evaluation
954082|NCT03454854|individualized treatment|individualized treatment
954083|NCT03454854|coronary artery disease|coronary artery disease
954084|NCT03454854|antithrombotic therapy|antithrombotic therapy
954085|NCT03454854|Chinese people|chinese people
954086|NCT03454854|Application|application
954087|NCT03454841|prasugrel|prasugrel
954090|NCT03454841|platelet reactivity|platelet reactivity
954091|NCT03454841|STEMI|stemi
954092|NCT03454841|NSTEMI|nstemi
954093|NCT03454815|Apical Patency|apical patency
954094|NCT03454815|Root Canal Treatment|root canal treatment
954095|NCT03454789|brachial plexus block|brachial plexus block
954096|NCT03454789|local anesthetic mixture solution|local anesthetic mixture solution
954097|NCT03454789|axillary-supraclavicular approach|axillary-supraclavicular approach
954098|NCT03454789|outcome quality|outcome quality
954099|NCT03454789|lidocaine, bupivacaine|lidocaine, bupivacaine
954100|NCT03454789|onset time|onset time
954101|NCT03454789|duration action local anesthetic|duration action local anesthetic
954102|NCT03454789|postoperative analgesia|postoperative analgesia
954103|NCT03454763|sst2-positive tumors|sst2-positive tumors
954104|NCT03454763|Neuroendocrine Tumors|neuroendocrine tumors
954105|NCT03454763|radiolabelled somatostatin analogues (PRRT)|radiolabelled somatostatin analogues (prrt)
954106|NCT03454750|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
954107|NCT03454750|68Ga-PSMA PET/CT positive|68ga-psma pet/ct positive
954108|NCT03454724|BioResorbable Vascular Scaffold System|bioresorbable vascular scaffold system
954109|NCT03454711|Obesity|obesity
954110|NCT03454711|Food addictions|food addictions
954111|NCT03454711|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
954112|NCT03454711|Metabolomics|metabolomics
954113|NCT03454633|Hyperthermic circulatory arrest; Surgery|hyperthermic circulatory arrest; surgery
954114|NCT03454607|FREE|free
954115|NCT03454607|Robotic|robotic
954116|NCT03454594|hypertension|hypertension
954117|NCT03454594|high blood viscosity|high blood viscosity
954118|NCT03454581|Temporomandibular Diseases|temporomandibular diseases
954119|NCT03454581|Photobiomodulation|photobiomodulation
954120|NCT03454581|Low level laser|low level laser
954121|NCT03454581|Treatment|treatment
954122|NCT03454581|Manual Therapy|manual therapy
954123|NCT03454568|Stem Cell Transplant|stem cell transplant
954124|NCT03454555|Pragmatic Clinical Trial|pragmatic clinical trial
954125|NCT03454555|Comparative Effectiveness Research|comparative effectiveness research
954126|NCT03454555|Analgesics, Opioid|analgesics, opioid
954127|NCT03454555|Decision Making, Shared|decision making, shared
954128|NCT03454555|Motivational Interviewing|motivational interviewing
954129|NCT03454555|Cognitive Therapy|cognitive therapy
954130|NCT03454555|Patient Reported Outcome Measures|patient reported outcome measures
954131|NCT03454516|Hypertension|hypertension
954132|NCT03454516|Telemonitoring|telemonitoring
954133|NCT03454516|Digital Health|digital health
954134|NCT03454503|Imatinib|imatinib
954135|NCT03454503|Generic Imatinib|generic imatinib
954136|NCT03454503|Leukemia|leukemia
954137|NCT03454503|Chronic myeloid leukemia|chronic myeloid leukemia
954138|NCT03454503|Philadelphia chromosome-positive|philadelphia chromosome-positive
954139|NCT03454503|Chronic phase|chronic phase
954140|NCT03454503|Observational study|observational study
954141|NCT03454503|Switched patients|switched patients
954142|NCT03454503|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
954143|NCT03454490|Gingival graft|gingival graft
954144|NCT03454490|Pseudoaneurysm|pseudoaneurysm
954145|NCT03454490|Postoperative complication|postoperative complication
954146|NCT03454490|Gingival recession treatment|gingival recession treatment
954147|NCT03454490|Palatine mass|palatine mass
954148|NCT03454490|Palatine bleeding|palatine bleeding
954149|NCT03454477|Endoscopy|endoscopy
954150|NCT03454477|Robotics|robotics
954151|NCT03454477|Thyroidectomy|thyroidectomy
954152|NCT03454477|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
954153|NCT03454451|NSCLC|nsclc
954154|NCT03454451|RCC|rcc
954155|NCT03454451|TNBC|tnbc
954156|NCT03454451|mCRPC|mcrpc
954162|NCT03454451|Sarcoma|sarcoma
954163|NCT03454451|Endometrial|endometrial
954164|NCT03454451|Pancreatic|pancreatic
954165|NCT03454451|Ovarian|ovarian
954166|NCT03454451|SCCHN|scchn
954167|NCT03454438|Referral|referral
954168|NCT03454438|Primary care|primary care
954169|NCT03454438|Rheumatologist|rheumatologist
954170|NCT03454425|Parkinson's Disease|parkinson's disease
954171|NCT03454425|ExAblate|exablate
954172|NCT03454425|MRgFUS|mrgfus
954173|NCT03454425|Sub-Thalamotomy|sub-thalamotomy
954174|NCT03454412|Cerebral Palsy|cerebral palsy
954175|NCT03454412|Rehabilitation|rehabilitation
954176|NCT03454412|Hand|hand
954177|NCT03454386|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
954178|NCT03454386|Stress|stress
954179|NCT03454386|Resilience|resilience
954180|NCT03454386|Stress Management and Resilience Training Program (SMART)|stress management and resilience training program (smart)
954181|NCT03454373|HIV|hiv
954182|NCT03454373|Food Insecurities|food insecurities
954183|NCT03454373|Antiretroviral Therapy|antiretroviral therapy
954184|NCT03454360|TAVI|tavi
954185|NCT03454360|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
954186|NCT03454360|Transcatheter Aortic Valve|transcatheter aortic valve
954187|NCT03454360|Transapical Access|transapical access
954188|NCT03454321|Rotator cuff tendinopathy|rotator cuff tendinopathy
954189|NCT03454321|ultrasound|ultrasound
954190|NCT03454321|subacromial bursitis|subacromial bursitis
954191|NCT03454321|steroid injection|steroid injection
954192|NCT03454295|Cancer Caregivers|cancer caregivers
954193|NCT03454295|Caregiver|caregiver
954194|NCT03454295|Caregivers|caregivers
954195|NCT03454295|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
954196|NCT03454295|18-075|18-075
954197|NCT03454282|Breast|breast
954198|NCT03454282|Cancer|cancer
954199|NCT03454282|Malignant|malignant
954200|NCT03454282|Melanoma|melanoma
954201|NCT03454282|Fasting Mimicking Diet (FMD)|fasting mimicking diet (fmd)
954202|NCT03454282|Tumor|tumor
954203|NCT03454282|Immunity|immunity
954204|NCT03454282|Metabolic Effects|metabolic effects
954205|NCT03454282|Immunological Effects|immunological effects
954206|NCT03454269|Parkinson disease|parkinson disease
954207|NCT03454269|Visual Hallucinations|visual hallucinations
954208|NCT03454269|Illusions|illusions
954209|NCT03454269|Retina|retina
954210|NCT03454256|Virtual Reality|virtual reality
954211|NCT03454256|Total Knee Replacement|total knee replacement
954212|NCT03454256|Proprioception|proprioception
954213|NCT03454256|Balance|balance
954214|NCT03454256|Gait|gait
954215|NCT03454243|Solid Tumors|solid tumors
954216|NCT03454243|TYRO3|tyro3
954217|NCT03454243|AXL|axl
954218|NCT03454243|MER|mer
954219|NCT03454243|Receptor tyrosine kinases (RTKs)|receptor tyrosine kinases (rtks)
954220|NCT03454243|Checkpoint inhibitors|checkpoint inhibitors
954221|NCT03454243|Melanoma|melanoma
954222|NCT03454243|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
954223|NCT03454243|Squamous cell carcinoma|squamous cell carcinoma
954224|NCT03454243|Hodgkin lymphoma|hodgkin lymphoma
954225|NCT03454243|Urothelial carcinoma|urothelial carcinoma
954226|NCT03454243|Microsatellite instability-high carcinomas|microsatellite instability-high carcinomas
954227|NCT03454243|TAM Inhibitor|tam inhibitor
954228|NCT03454230|Intensive care unit|intensive care unit
954229|NCT03454230|ICU|icu
954230|NCT03454230|adult critical care patients|adult critical care patients
954231|NCT03454230|repositioning schedule|repositioning schedule
954232|NCT03454230|patient handling|patient handling
954233|NCT03454230|practical nursing|practical nursing
954234|NCT03454230|nursing care|nursing care
954235|NCT03454230|pressure ulcers|pressure ulcers
954236|NCT03454230|decubitus ulcers|decubitus ulcers
954237|NCT03454230|pressure injury|pressure injury
954238|NCT03454178|AOBP|aobp
954239|NCT03454178|ABPM|abpm
954240|NCT03454139|percutaneous nephrolithotomy|percutaneous nephrolithotomy
954241|NCT03454139|subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
954242|NCT03454139|pain|pain
954243|NCT03454139|paracetamol|paracetamol
954244|NCT03454139|tramadol|tramadol
954245|NCT03454139|morphine|morphine
954246|NCT03454139|nephrolithiasis|nephrolithiasis
954247|NCT03454139|lidocaine|lidocaine
954248|NCT03454139|bupivacaine|bupivacaine
954253|NCT03454113|dialysis autogenous arterio-venous fistula|dialysis autogenous arterio-venous fistula
954254|NCT03454087|enteral nutrition|enteral nutrition
954255|NCT03454087|inflammation|inflammation
954256|NCT03454087|incretin hormones|incretin hormones
954257|NCT03454087|microbiome|microbiome
954258|NCT03454074|healthy aging|healthy aging
954259|NCT03454074|behavior change|behavior change
954260|NCT03454074|older adults|older adults
954261|NCT03454061|sport|sport
954262|NCT03454061|physical activity|physical activity
954263|NCT03454061|education|education
954264|NCT03454061|fundamental motor skills|fundamental motor skills
954265|NCT03454061|childhood|childhood
954266|NCT03454061|exercise|exercise
954267|NCT03454061|health|health
954268|NCT03454061|training|training
954269|NCT03454061|intervention|intervention
954270|NCT03454061|gross motor development|gross motor development
954271|NCT03454009|multi-modal intervention;|multi-modal intervention;
954272|NCT03454009|office-based employees|office-based employees
954273|NCT03454009|hand hygiene|hand hygiene
954274|NCT03454009|hand sanitizer|hand sanitizer
954275|NCT03454009|hand sanitizer surface wipes|hand sanitizer surface wipes
954276|NCT03454009|self-reported infections|self-reported infections
954277|NCT03454009|absenteeism|absenteeism
954278|NCT03454009|presenteeism|presenteeism
954279|NCT03453996|acute kidney injury|acute kidney injury
954280|NCT03453996|heart disease|heart disease
954281|NCT03453996|cardiac catheterization|cardiac catheterization
954282|NCT03453983|Neurodevelopment|neurodevelopment
954283|NCT03453983|Pediatrics|pediatrics
954284|NCT03453983|Motor Learning|motor learning
954285|NCT03453983|Brain Imaging|brain imaging
954286|NCT03453983|Neuroscience|neuroscience
954287|NCT03453970|patient education|patient education
954288|NCT03453970|self-care|self-care
954289|NCT03453970|Controlled Trial|controlled trial
954290|NCT03453957|Practice based research|practice based research
954291|NCT03453944|Expiratory muscles|expiratory muscles
954292|NCT03453944|Mechanically ventilated patients|mechanically ventilated patients
954293|NCT03453944|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
954294|NCT03453944|Respiratory function|respiratory function
954493|NCT03452943|adolescents|adolescents
954295|NCT03453944|Ventilator-acquired muscle atrophy|ventilator-acquired muscle atrophy
954296|NCT03453931|Corticosteroids|corticosteroids
954297|NCT03453931|Arrhythmia|arrhythmia
954298|NCT03453931|Heart Rate Variability|heart rate variability
954299|NCT03453931|Albuminuria|albuminuria
954300|NCT03453918|Iron absorption|iron absorption
954301|NCT03453918|Polyphenols|polyphenols
954302|NCT03453918|Dysmetabolic iron overload syndrome|dysmetabolic iron overload syndrome
954303|NCT03453918|Metabolic syndrome X|metabolic syndrome x
954304|NCT03453918|Genetic Hemochromatosis|genetic hemochromatosis
954305|NCT03453918|Oxylipin|oxylipin
954306|NCT03453918|Lipidomic analysis|lipidomic analysis
954307|NCT03453905|CT-based Finite Element Analysis|ct-based finite element analysis
954308|NCT03453905|Randomized Controlled Study|randomized controlled study
954309|NCT03453905|Preventive bone fixation|preventive bone fixation
954310|NCT03453905|Randomized Controlled Trial|randomized controlled trial
954311|NCT03453892|Metastatic cancer|metastatic cancer
954312|NCT03453892|Radiotherapy|radiotherapy
954313|NCT03453892|Immunotherapy|immunotherapy
954314|NCT03453892|radioimmuno therapy|radioimmuno therapy
954315|NCT03453866|Hip Arthroscopy|hip arthroscopy
954316|NCT03453866|Warmed Fluids|warmed fluids
954317|NCT03453853|Percutaneous mitral valve repair|percutaneous mitral valve repair
954318|NCT03453853|Coronary sinus annuloplasty|coronary sinus annuloplasty
954319|NCT03453853|Mitral loop cerclage|mitral loop cerclage
954320|NCT03453853|atrial fibrillation|atrial fibrillation
954321|NCT03453853|Mitral Regurgitation|mitral regurgitation
954322|NCT03453840|malaria|malaria
954323|NCT03453840|HIV|hiv
954324|NCT03453840|Children|children
954325|NCT03453840|Efavirenz|efavirenz
954326|NCT03453840|artemether|artemether
954327|NCT03453840|lumefantrine|lumefantrine
1644348|NCT00225290|Phase III|phase iii
954328|NCT03453827|Pseudoexfoliation Syndrome|pseudoexfoliation syndrome
954329|NCT03453827|Cataract|cataract
954330|NCT03453827|Aberration|aberration
954331|NCT03453827|IOL decentration|iol decentration
954332|NCT03453827|IOL tilt|iol tilt
954333|NCT03453814|PICU|picu
954334|NCT03453814|critical care|critical care
954335|NCT03453814|music|music
954336|NCT03453814|music therapy|music therapy
954337|NCT03453814|agitation|agitation
954338|NCT03453801|Inactivated, influenza vaccine quadrivalent|inactivated, influenza vaccine quadrivalent
954339|NCT03453801|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
954340|NCT03453801|Young children|young children
954341|NCT03453801|Identical twins|identical twins
954342|NCT03453788|follow up|follow up
954343|NCT03453788|side effects|side effects
954344|NCT03453788|smartphone app|smartphone app
954345|NCT03453788|physical activity|physical activity
954346|NCT03453788|empowerment|empowerment
954347|NCT03453788|patient reported outcomes|patient reported outcomes
954348|NCT03453749|Traumatic brain injury|traumatic brain injury
954349|NCT03453749|Cerebral edema|cerebral edema
954350|NCT03453749|Microdialysis|microdialysis
954351|NCT03453749|Inflammatory cytokines|inflammatory cytokines
954352|NCT03453736|Robotic surgery|robotic surgery
954353|NCT03453736|theatre staff|theatre staff
954354|NCT03453736|teamwork|teamwork
954355|NCT03453736|patient safety|patient safety
954356|NCT03453723|hypnoanalgesia|hypnoanalgesia
954357|NCT03453723|lidocaine|lidocaine
954358|NCT03453723|propofol|propofol
954359|NCT03453723|children|children
954360|NCT03453710|Bankart Repair|bankart repair
954361|NCT03453710|Remplissage|remplissage
954362|NCT03453710|Latarjet coracoid transfer|latarjet coracoid transfer
954363|NCT03453697|Intermittent Hypoxemia|intermittent hypoxemia
954364|NCT03453697|diffusion tensor imaging|diffusion tensor imaging
954365|NCT03453697|oxidative stress|oxidative stress
954366|NCT03453658|Endodontics|endodontics
954367|NCT03453658|Primary Teeth|primary teeth
954368|NCT03453658|Reciprocating instrumentation|reciprocating instrumentation
954369|NCT03453658|Mechanized instrumentation|mechanized instrumentation
954370|NCT03453645|ablation|ablation
954371|NCT03453645|sudden death|sudden death
954372|NCT03453645|signal averaged ECG|signal averaged ecg
954373|NCT03453645|T wave alternans|t wave alternans
954374|NCT03453645|heart rate variability|heart rate variability
954375|NCT03453632|Dermatology|dermatology
954376|NCT03453632|Rare skin diseases|rare skin diseases
954377|NCT03453632|epidermolysis bullosa simplex|epidermolysis bullosa simplex
954378|NCT03453632|botulinic toxin|botulinic toxin
954379|NCT03453632|blisters|blisters
954380|NCT03453606|Pulmonary rehabilitation|pulmonary rehabilitation
954381|NCT03453606|home-based|home-based
954382|NCT03453593|Trauma|trauma
954383|NCT03453593|India|india
954384|NCT03453593|Computed tomography|computed tomography
954385|NCT03453567|TAVR|tavr
954386|NCT03453567|SAVR|savr
954387|NCT03453567|TAVI|tavi
954388|NCT03453567|Conventional AVR|conventional avr
954389|NCT03453567|Sutureless AVR|sutureless avr
954390|NCT03453554|technology|technology
954391|NCT03453554|activities of daily living|activities of daily living
954392|NCT03453554|everyday functioning|everyday functioning
954393|NCT03453554|quality of life|quality of life
954394|NCT03453554|memory impairment|memory impairment
954395|NCT03453528|mCRPC or advanced/metastatic solid tumors|mcrpc or advanced/metastatic solid tumors
954396|NCT03453528|Prostate-specific membrane antigen|prostate-specific membrane antigen
954397|NCT03453502|quality improvement|quality improvement
954398|NCT03453502|breast milk|breast milk
954399|NCT03453476|Photodynamic therapy|photodynamic therapy
954400|NCT03453476|Interleukin 1-beta|interleukin 1-beta
954401|NCT03453476|Tumour necrosis factor - alpha|tumour necrosis factor - alpha
954402|NCT03453476|Interleukin-6|interleukin-6
954403|NCT03453476|Interleukin-8|interleukin-8
954404|NCT03453476|Matrix metalloproteinase-8|matrix metalloproteinase-8
954405|NCT03453463|sarcopenia|sarcopenia
954406|NCT03453463|osteopenia|osteopenia
954407|NCT03453463|older men|older men
954408|NCT03453463|community dwelling|community dwelling
954409|NCT03453463|physical functioning|physical functioning
954410|NCT03453450|Primary Care|primary care
954411|NCT03453411|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO)|equimolar mixture of oxygen and nitrous oxide (emono)
954412|NCT03453411|Substance-Related Disorders|substance-related disorders
954413|NCT03453398|Chronotype|chronotype
954414|NCT03453398|Shift work|shift work
954415|NCT03453398|Health status|health status
954416|NCT03453385|Smoking|smoking
954417|NCT03453385|Nicotine|nicotine
954418|NCT03453385|Tobacco|tobacco
954419|NCT03453385|Electronic Cigarette|electronic cigarette
954420|NCT03453372|Osteoarthritis|osteoarthritis
954421|NCT03453372|Knee|knee
954422|NCT03453372|MRgFUS|mrgfus
954423|NCT03453372|ExAblate|exablate
954424|NCT03453372|Pain|pain
954425|NCT03453372|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
954426|NCT03453359|deep sedation|deep sedation
954427|NCT03453359|spontaneous ventilation|spontaneous ventilation
954428|NCT03453346|Hepatitis C virus|hepatitis c virus
954429|NCT03453346|Sofosbuvir|sofosbuvir
954430|NCT03453346|RNA polymerase inhibitor|rna polymerase inhibitor
954431|NCT03453346|Ribavirin|ribavirin
954432|NCT03453346|Genotype 2|genotype 2
954433|NCT03453346|Sustained virologic response|sustained virologic response
954434|NCT03453346|Confirmatory study|confirmatory study
954435|NCT03453307|Tumor Organoids|tumor organoids
954436|NCT03453307|Drug Sensitivity|drug sensitivity
954437|NCT03453307|NSCLC|nsclc
954438|NCT03453294|THRIVE|thrive
954439|NCT03453281|Aflibercept|aflibercept
954440|NCT03453281|Diabetic Macular Edema|diabetic macular edema
954441|NCT03453281|Electroretinogram|electroretinogram
954442|NCT03453281|Central Macular Thickness|central macular thickness
954443|NCT03453281|ETDRS|etdrs
954444|NCT03453268|Blood pressure|blood pressure
954445|NCT03453268|Aged|aged
954446|NCT03453268|Frailty|frailty
954447|NCT03453268|Polypharmacy|polypharmacy
954448|NCT03453255|AML, chidamide, decitabine|aml, chidamide, decitabine
954449|NCT03453242|Osteoporosis|osteoporosis
954450|NCT03453203|Chronic migraine|chronic migraine
954451|NCT03453203|Osteopathic manipulative treatment|osteopathic manipulative treatment
954452|NCT03453203|Cervicalgia|cervicalgia
954453|NCT03453164|Radiotherapy|radiotherapy
954454|NCT03453164|anti-PD-1 antibody|anti-pd-1 antibody
954455|NCT03453138|laryngel mask airway|laryngel mask airway
954456|NCT03453138|laparoscopic surgery|laparoscopic surgery
954457|NCT03453125|cognitive rehabilitation|cognitive rehabilitation
954458|NCT03453125|memory|memory
954561|NCT03452709|Cardiovascular Disease;|cardiovascular disease;
954459|NCT03453112|Peek Expiratory Flow (PEF) Lung function tests|peek expiratory flow (pef) lung function tests
954460|NCT03453099|propofol|propofol
954461|NCT03453099|anaesthetic dose|anaesthetic dose
954462|NCT03453099|sleep|sleep
954463|NCT03453099|caffeine|caffeine
954464|NCT03453099|anxiety|anxiety
954465|NCT03453099|induction|induction
954466|NCT03453073|Coronary heart disease|coronary heart disease
954467|NCT03453073|stroke|stroke
954468|NCT03453073|chocolate consumption|chocolate consumption
954469|NCT03453073|postmenopausal women|postmenopausal women
954470|NCT03453073|nutrition|nutrition
954471|NCT03453073|dietary intake|dietary intake
954472|NCT03453073|epidemiology|epidemiology
954473|NCT03453047|S100β|s100β
954474|NCT03453047|Neuron specific enolase|neuron specific enolase
954475|NCT03453047|Liver transplantation|liver transplantation
954476|NCT03453034|TQ-B3233|tq-b3233
954477|NCT03453034|tumor|tumor
954478|NCT03453034|toleration|toleration
954479|NCT03453034|pharmacokinetics|pharmacokinetics
954480|NCT03453021|asthma|asthma
954481|NCT03453021|mepolizumab|mepolizumab
954482|NCT03453021|corticosteroids|corticosteroids
954483|NCT03453008|Cerebrovascular Accident|cerebrovascular accident
954484|NCT03453008|Botulinum toxin A|botulinum toxin a
954485|NCT03453008|Stroke|stroke
954486|NCT03452982|SENTINEL LYMPH NODE|sentinel lymph node
954487|NCT03452969|visual outcomes|visual outcomes
954488|NCT03452969|mulitfocal intraocular lens|mulitfocal intraocular lens
954489|NCT03452969|patient satisfaction|patient satisfaction
954490|NCT03452969|spectacle independence|spectacle independence
954491|NCT03452969|contrast sensitivity|contrast sensitivity
954492|NCT03452943|Tourette Syndrome|tourette syndrome
954495|NCT03452930|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
954496|NCT03452930|Unmethylated Glioblastoma|unmethylated glioblastoma
954497|NCT03452930|nGBM|ngbm
954498|NCT03452930|Glioma|glioma
954499|NCT03452930|Gliosarcoma|gliosarcoma
954500|NCT03452930|EDO-S101|edo-s101
954501|NCT03452930|Radiation Therapy|radiation therapy
954502|NCT03452930|XRT|xrt
954503|NCT03452904|In suit coronary lesions|in suit coronary lesions
954504|NCT03452904|Drug-coated balloon|drug-coated balloon
954505|NCT03452904|Drug-eluting stent|drug-eluting stent
954506|NCT03452904|Restenosis|restenosis
954507|NCT03452878|Amygdala, neurosurgery, aggressive behavior|amygdala, neurosurgery, aggressive behavior
954508|NCT03452865|proton pump inhibitor|proton pump inhibitor
954509|NCT03452865|esomeprazole|esomeprazole
954510|NCT03452865|sepsis|sepsis
954511|NCT03452865|septic shock|septic shock
954512|NCT03452865|organ failure|organ failure
954513|NCT03452865|SOFA|sofa
954514|NCT03452865|mortality|mortality
954515|NCT03452852|Split thickness skin graft|split thickness skin graft
954516|NCT03452852|Lower leg|lower leg
954517|NCT03452852|Compression therapy|compression therapy
954518|NCT03452852|PICO|pico
954519|NCT03452852|Coban 2 lite|coban 2 lite
954520|NCT03452839|meropenem|meropenem
954521|NCT03452839|antibiotic resistance|antibiotic resistance
954522|NCT03452839|critical illness|critical illness
954523|NCT03452839|β-lactams|β-lactams
954524|NCT03452839|continuous antibacterial drug infusion|continuous antibacterial drug infusion
954525|NCT03452839|mortality|mortality
954526|NCT03452813|transitions of care|transitions of care
954527|NCT03452813|stroke disparities|stroke disparities
954528|NCT03452800|addiction|addiction
954529|NCT03452800|mental health|mental health
954530|NCT03452787|Body mass index|body mass index
954531|NCT03452787|genetics|genetics
954532|NCT03452787|diet|diet
954533|NCT03452787|saturated fat|saturated fat
954534|NCT03452774|artificial intelligence|artificial intelligence
954535|NCT03452774|virtual tumor board|virtual tumor board
954536|NCT03452774|clinical trial|clinical trial
954537|NCT03452774|clinical trial matching|clinical trial matching
954538|NCT03452774|electronic medical record|electronic medical record
954539|NCT03452774|machine learning|machine learning
954540|NCT03452774|cost of care|cost of care
954541|NCT03452774|targeted therapy|targeted therapy
954542|NCT03452774|immunotherapy|immunotherapy
954543|NCT03452774|precision medicine|precision medicine
954544|NCT03452774|precision oncology|precision oncology
954545|NCT03452774|cancer|cancer
954546|NCT03452774|value based care|value based care
954547|NCT03452774|real world data|real world data
954548|NCT03452774|data analytics|data analytics
954549|NCT03452761|exogenous ketone salts|exogenous ketone salts
954550|NCT03452761|ketosis|ketosis
954551|NCT03452761|safety|safety
954552|NCT03452761|comprehensive metabolic panel|comprehensive metabolic panel
954553|NCT03452761|complete blood count|complete blood count
954554|NCT03452761|lipid panel|lipid panel
954555|NCT03452761|insulin|insulin
954556|NCT03452735|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
954557|NCT03452735|Fertility|fertility
954558|NCT03452735|Procreation|procreation
954559|NCT03452722|secondary brain injury|secondary brain injury
954560|NCT03452722|neuroinflammation|neuroinflammation
954562|NCT03452709|primary prevention;|primary prevention;
954563|NCT03452709|physical activity;|physical activity;
954564|NCT03452709|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
954565|NCT03452670|Workplace|workplace
954566|NCT03452670|Applications|applications
954567|NCT03452670|Anxiety|anxiety
954568|NCT03452670|Burnout|burnout
954569|NCT03452670|Meditation|meditation
954570|NCT03452670|Mindfulness|mindfulness
954571|NCT03452644|US-CNB|us-cnb
954572|NCT03452644|Soft Tissue Mass|soft tissue mass
954573|NCT03452644|Soft Tissue Sarcoma|soft tissue sarcoma
954574|NCT03452644|Soft Tissue Neoplasm|soft tissue neoplasm
954575|NCT03452644|Soft Tissue Lesion|soft tissue lesion
954576|NCT03452631|Psoas hematomas|psoas hematomas
954577|NCT03452618|diagnostic criteria|diagnostic criteria
954578|NCT03452579|Nivolumab|nivolumab
954579|NCT03452579|Bevacizumab|bevacizumab
954580|NCT03452566|actinic cheilitis|actinic cheilitis
954581|NCT03452566|ingenol mebutate|ingenol mebutate
954582|NCT03452566|treatment|treatment
954583|NCT03452566|phase 1/2 clinical trial|phase 1/2 clinical trial
954584|NCT03452553|Liver Cancer|liver cancer
954585|NCT03452553|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
954586|NCT03452553|Trans Arterial Chemo Embolization (TACE)|trans arterial chemo embolization (tace)
954587|NCT03452553|Drug Eluting Beads (DEB)|drug eluting beads (deb)
954588|NCT03452553|Doxorubicin (DOX)|doxorubicin (dox)
954589|NCT03452501|Infliximab|infliximab
954590|NCT03452501|Remsima|remsima
954591|NCT03452501|Biosimilar|biosimilar
954592|NCT03452501|Inflammatory Bowel Diseases|inflammatory bowel diseases
954593|NCT03452501|Crohn's Disease|crohn's disease
954594|NCT03452501|Ulcerative Colitis|ulcerative colitis
954595|NCT03452501|Fistulizing Crohn's Disease|fistulizing crohn's disease
954596|NCT03452501|Observational|observational
954597|NCT03452501|Follow up|follow up
954598|NCT03452501|Safety|safety
954599|NCT03452501|Effectiveness|effectiveness
954600|NCT03452501|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
954601|NCT03452501|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
954602|NCT03452488|Sarcopenia|sarcopenia
954603|NCT03452488|Sarcopenic Obesity|sarcopenic obesity
954604|NCT03452488|6-minute walking distance|6-minute walking distance
954605|NCT03452488|400 meters walking test|400 meters walking test
954606|NCT03452488|Patient Reported Outcomes|patient reported outcomes
954607|NCT03452488|BIO101|bio101
954608|NCT03452488|SPPB|sppb
954609|NCT03452488|ALM; ALM/BMI|alm; alm/bmi
954610|NCT03452449|activity monitor|activity monitor
954611|NCT03452449|questionnaire|questionnaire
954612|NCT03452449|Oswestry Disability Index|oswestry disability index
954613|NCT03452436|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
954614|NCT03452436|Cognitive Dysfunction|cognitive dysfunction
954615|NCT03452436|Cognition Disorders|cognition disorders
954616|NCT03452436|Neurocognitive Disorder|neurocognitive disorder
954617|NCT03452436|Testosterone|testosterone
954618|NCT03452436|Endocrinology|endocrinology
954619|NCT03452436|Testicular Cancer|testicular cancer
954620|NCT03452436|Prostate Cancer|prostate cancer
954621|NCT03452423|Osteoarthritis of knees|osteoarthritis of knees
1333110|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
954622|NCT03452423|Arthroscopic cartilage regeneration facilitating procedure (ACRFP)|arthroscopic cartilage regeneration facilitating procedure (acrfp)
954623|NCT03452423|Foot pressure|foot pressure
954624|NCT03452423|Gait|gait
954625|NCT03452410|Vestibular neuritis|vestibular neuritis
954626|NCT03452410|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
954627|NCT03452410|Vertigo|vertigo
954628|NCT03452410|Fluid attenuated inversion recuperation (FLAIR)|fluid attenuated inversion recuperation (flair)
954629|NCT03452384|Acupuncture|acupuncture
954630|NCT03452384|Traditional chinese medicine|traditional chinese medicine
954631|NCT03452384|Major depressive disorder|major depressive disorder
954632|NCT03452371|Patient Navigation|patient navigation
954633|NCT03452371|Hospitalized smokers|hospitalized smokers
954634|NCT03452332|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
954635|NCT03452332|Cervical Cancer|cervical cancer
954636|NCT03452332|Vaginal Cancer|vaginal cancer
954637|NCT03452332|Vulvar Cancer|vulvar cancer
954638|NCT03452332|Durvalumab|durvalumab
954639|NCT03452332|MEDI4736|medi4736
954640|NCT03452332|Tremelimumab|tremelimumab
954641|NCT03452332|Ticilimumab|ticilimumab
954642|NCT03452332|CP-675,206|cp-675,206
954643|NCT03452332|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
954644|NCT03452332|SABR|sabr
954645|NCT03452332|Radiation therapy|radiation therapy
954646|NCT03452319|Thoracoabdominal surgery|thoracoabdominal surgery
954647|NCT03452319|Physical Therapy|physical therapy
954648|NCT03452319|Inspiratory Muscle Training|inspiratory muscle training
954649|NCT03452319|Physical Activity|physical activity
954650|NCT03452306|AUC|auc
954651|NCT03452306|Cmax|cmax
954652|NCT03452306|Pharmacokinetics|pharmacokinetics
954653|NCT03452306|metformin|metformin
954654|NCT03452306|fed|fed
954655|NCT03452306|fasting|fasting
954656|NCT03452254|Stroke|stroke
954657|NCT03452254|Upper Extremity Paresis|upper extremity paresis
954658|NCT03452254|Neuro Rehabilitation|neuro rehabilitation
954659|NCT03452254|tDCS|tdcs
954660|NCT03452254|mCIMT|mcimt
954661|NCT03452254|Occupational Therapy|occupational therapy
954662|NCT03452241|Screening, Brief Intervention, and Referral to Treatment|screening, brief intervention, and referral to treatment
954663|NCT03452241|Substance Use|substance use
954664|NCT03452215|Pregnancy|pregnancy
954665|NCT03452215|Mobile Phone Application|mobile phone application
954666|NCT03452202|Stroke|stroke
954667|NCT03452111|Healthy Men|healthy men
954668|NCT03452111|Couple|couple
954669|NCT03452111|Gel|gel
954670|NCT03452111|Male Contraception|male contraception
954671|NCT03452111|Nestorone|nestorone
954672|NCT03452111|Testosterone|testosterone
954673|NCT03452085|xerostomia|xerostomia
954674|NCT03452085|diabetes type II|diabetes type ii
954675|NCT03452085|salivary flow|salivary flow
954676|NCT03452085|antioxidant capacity of saliva|antioxidant capacity of saliva
954677|NCT03452085|aldiamed|aldiamed
954678|NCT03452059|Paralysis|paralysis
954679|NCT03452059|Lower Extremities|lower extremities
954680|NCT03452059|Ai-Robotics|ai-robotics
954681|NCT03452046|Ultrasound,inferior vena cava, positive pressure|ultrasound,inferior vena cava, positive pressure
954682|NCT03452033|glaucoma|glaucoma
954683|NCT03452007|Epidural Stimulation|epidural stimulation
954684|NCT03452007|Bladder dysfunction|bladder dysfunction
954685|NCT03452007|Spinal cord injury|spinal cord injury
954686|NCT03451981|surgical therapy|surgical therapy
954687|NCT03451981|laser|laser
954688|NCT03451981|air powder|air powder
954689|NCT03451968|amino acid|amino acid
954690|NCT03451968|stable isotope|stable isotope
954691|NCT03451968|critical care|critical care
954692|NCT03451955|gluten|gluten
954693|NCT03451955|gluten free diet|gluten free diet
954694|NCT03451955|blood brain barrier permeability|blood brain barrier permeability
954695|NCT03451955|intestinal permeability|intestinal permeability
954696|NCT03451955|neuroinflammation|neuroinflammation
954697|NCT03451955|autoimmunity|autoimmunity
954698|NCT03451929|primary healthcare|primary healthcare
954699|NCT03451929|cohort|cohort
954700|NCT03451903|stroke|stroke
954701|NCT03451903|thrombectomy|thrombectomy
954702|NCT03451903|procedure time|procedure time
954703|NCT03451903|revascularisation|revascularisation
954704|NCT03451903|thrombolytic therapy|thrombolytic therapy
954705|NCT03451890|Healthy participants|healthy participants
954706|NCT03451890|E2730|e2730
954707|NCT03451890|Pharmacokinetics|pharmacokinetics
954708|NCT03451877|High myopia|high myopia
954709|NCT03451877|TGFB1Gene Polymorphisms|tgfb1gene polymorphisms
954710|NCT03451877|LAMA1 Gene Polymorphisms|lama1 gene polymorphisms
954711|NCT03451825|Avelumab|avelumab
954712|NCT03451825|Anti PD-L1|anti pd-l1
954713|NCT03451825|Solid tumors|solid tumors
954714|NCT03451825|CNS tumors|cns tumors
954715|NCT03451825|Lymphoma|lymphoma
954716|NCT03451825|Pediatric subjects|pediatric subjects
954717|NCT03451812|prostate cancer|prostate cancer
954718|NCT03451812|metabolomics|metabolomics
954719|NCT03451812|molecular imaging|molecular imaging
954720|NCT03451812|PET|pet
954721|NCT03451812|MRI|mri
965246|NCT03385993|VR|vr
954722|NCT03451812|11C-choline tracer|11c-choline tracer
954723|NCT03451799|Glioblastoma|glioblastoma
954724|NCT03451799|Ketogenic diet|ketogenic diet
954725|NCT03451799|Keto diet|keto diet
954726|NCT03451799|GBM|gbm
954727|NCT03451773|TGF Ligand Trap|tgf ligand trap
954728|NCT03451773|Extracellular Domain of Human TGF Receptor II|extracellular domain of human tgf receptor ii
954729|NCT03451773|Avelumab|avelumab
954730|NCT03451773|Human IgG1 mAb Directed Against Human PD-L1|human igg1 mab directed against human pd-l1
954731|NCT03451773|Health-Related Quality of Life|health-related quality of life
954732|NCT03451747|hypertension|hypertension
954733|NCT03451747|female|female
954734|NCT03451643|colorectal cancer|colorectal cancer
954735|NCT03451643|liver metastases|liver metastases
954736|NCT03451643|stage IV|stage iv
954737|NCT03451591|Cerebral Small Vessel Diseases|cerebral small vessel diseases
954738|NCT03451591|Stroke, Lacunar|stroke, lacunar
954739|NCT03451591|Dementia|dementia
954740|NCT03451591|Alzheimer's disease|alzheimer's disease
954741|NCT03451578|macular degeneration|macular degeneration
954742|NCT03451578|blindness|blindness
954743|NCT03451565|Hypotension|hypotension
954744|NCT03451565|Systemic blood pressure|systemic blood pressure
954745|NCT03451552|Community Resources, Patient Navigator|community resources, patient navigator
954746|NCT03451539|Anaesthetist|anaesthetist
954747|NCT03451539|ICU|icu
954748|NCT03451539|Intensif care unit|intensif care unit
954749|NCT03451526|Chinese|chinese
954750|NCT03451526|real-world evidences|real-world evidences
954751|NCT03451526|NSCLC|nsclc
954752|NCT03451526|surgeries|surgeries
954753|NCT03451513|Prevention|prevention
954754|NCT03451513|Sexual minority men|sexual minority men
954755|NCT03451513|Internalization of the appearance ideal|internalization of the appearance ideal
954756|NCT03451513|Body dissatisfaction|body dissatisfaction
954757|NCT03451500|GPR 143|gpr 143
954758|NCT03451500|PEDF|pedf
954759|NCT03451500|VEGF|vegf
954760|NCT03451500|LDOPA|ldopa
954761|NCT03451487|acetaminophen|acetaminophen
954762|NCT03451487|acute liver failure|acute liver failure
954763|NCT03451461|Asynchronies|asynchronies
954764|NCT03451448|PET/MRI|pet/mri
954765|NCT03451448|ultra-small-superparamagnetic particles|ultra-small-superparamagnetic particles
954766|NCT03451422|AMG 592|amg 592
954767|NCT03451422|Systemic lupus erythematosus|systemic lupus erythematosus
954768|NCT03451422|Phase 1b/2a|phase 1b/2a
954769|NCT03451396|Dry eye|dry eye
954770|NCT03451396|Tear osmolarity|tear osmolarity
954771|NCT03451396|Lifitegrast|lifitegrast
954772|NCT03451383|breast cancer|breast cancer
954773|NCT03451383|cognitive decline|cognitive decline
954774|NCT03451370|Bevacizumab|bevacizumab
954775|NCT03451370|Capecitabine|capecitabine
954776|NCT03451370|Oxaliplatin|oxaliplatin
954777|NCT03451370|CRASH score|crash score
954778|NCT03451370|ECOG PS|ecog ps
954779|NCT03451370|G8 score|g8 score
954780|NCT03451357|stroke|stroke
954781|NCT03451357|dependence degree|dependence degree
954782|NCT03451357|social care|social care
954783|NCT03451357|health care|health care
954784|NCT03451357|disability|disability
954785|NCT03451344|Mobile Health|mobile health
954786|NCT03451344|Illicit drug use|illicit drug use
954787|NCT03451344|Rehabilitation|rehabilitation
954788|NCT03451344|Community|community
954789|NCT03451344|China|china
954790|NCT03451331|cisplatin-ineligible|cisplatin-ineligible
954791|NCT03451331|gemcitabine|gemcitabine
954792|NCT03451331|carboplatin|carboplatin
954793|NCT03451331|nivolumab|nivolumab
954794|NCT03451331|oxaliplatin|oxaliplatin
954795|NCT03451305|Compression fracture, postural reduction, vertebroplasty|compression fracture, postural reduction, vertebroplasty
954796|NCT03451266|preeclampsia|preeclampsia
954797|NCT03451266|vitamin C|vitamin c
954798|NCT03451266|lung ultrasound|lung ultrasound
954799|NCT03451240|Stress|stress
954800|NCT03451240|Resilience|resilience
954801|NCT03451227|Sedation, Analgesia|sedation, analgesia
954802|NCT03451201|Exercise|exercise
954803|NCT03451201|High-Intensity Interval Training|high-intensity interval training
954804|NCT03451201|Type 1 diabetes|type 1 diabetes
954805|NCT03451201|Endothelial Dysfunction|endothelial dysfunction
954806|NCT03451175|Overactive Detrusor|overactive detrusor
954807|NCT03451175|Multiple Sclerosis|multiple sclerosis
954808|NCT03451175|Reproductibility|reproductibility
954809|NCT03451175|Cystometry|cystometry
954810|NCT03451149|TIPS|tips
954811|NCT03451136|Placenta previa|placenta previa
954812|NCT03451136|Cervical length|cervical length
954813|NCT03451136|Antepartum haemorrhage|antepartum haemorrhage
954814|NCT03451110|Drug-Drug Interactions|drug-drug interactions
954815|NCT03451110|Lemborexant|lemborexant
954816|NCT03451110|Oral Contraceptive|oral contraceptive
954817|NCT03451110|Famotidine|famotidine
954818|NCT03451110|Fluconazole|fluconazole
954819|NCT03451110|Pharmacokinetics|pharmacokinetics
954820|NCT03451110|Proton pump inhibitors|proton pump inhibitors
954821|NCT03451110|CYP3A inhibitors|cyp3a inhibitors
954822|NCT03451084|AML, ASLAN, DHODH|aml, aslan, dhodh
965393|NCT03385161|BPH|bph
954823|NCT03451058|Traumatic brain injury, eye tracking, EEG, cognition|traumatic brain injury, eye tracking, eeg, cognition
954824|NCT03451045|Pulmonary exacerbation, lenabasum, JBT-101|pulmonary exacerbation, lenabasum, jbt-101
954825|NCT03451032|HIV exposition treatment|hiv exposition treatment
954826|NCT03451032|sexual risk|sexual risk
954827|NCT03451032|blood risk|blood risk
954828|NCT03451019|chronic kidney disease - mineral bone disorder, phosphate-binders|chronic kidney disease - mineral bone disorder, phosphate-binders
954829|NCT03450993|Mind-Body|mind-body
954830|NCT03450980|Double Vision, Amblyopia|double vision, amblyopia
954831|NCT03450928|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
954832|NCT03450928|Endoscopy|endoscopy
954833|NCT03450928|POEM|poem
954834|NCT03450928|Submucosal endoscopy|submucosal endoscopy
954835|NCT03450915|Influenza|influenza
954836|NCT03450915|vaccine|vaccine
954837|NCT03450915|universal|universal
954838|NCT03450915|M-001|m-001
954839|NCT03450915|Multimeric-001|multimeric-001
954840|NCT03450915|Flu|flu
954841|NCT03450902|Urinary incontinence, Chinese herb, Acupuncture|urinary incontinence, chinese herb, acupuncture
954842|NCT03450837|Coronary artery disease; HDL; anabolic steroids|coronary artery disease; hdl; anabolic steroids
954843|NCT03450824|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
954844|NCT03450824|Anterior Knee Pain|anterior knee pain
954845|NCT03450824|Knee Varus|knee varus
954846|NCT03450811|complication|complication
954847|NCT03450811|uroflowmetry|uroflowmetry
954848|NCT03450759|Heart failure.|heart failure.
954849|NCT03450759|Mineralocorticoid receptor modulator.|mineralocorticoid receptor modulator.
954850|NCT03450759|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
954851|NCT03450733|Metal-on-Metal|metal-on-metal
954852|NCT03450733|MOM|mom
954853|NCT03450733|Total Hip Arthroplasty|total hip arthroplasty
954854|NCT03450733|THA|tha
954855|NCT03450707|cardiac arrest|cardiac arrest
954856|NCT03450707|post-arrest|post-arrest
954857|NCT03450681|Pain Management|pain management
954858|NCT03450681|Knee Replacement Arthroplasty|knee replacement arthroplasty
954859|NCT03450681|Postoperative Pain|postoperative pain
954860|NCT03450681|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
954861|NCT03450668|neonatal, incubator, thermal-regulation|neonatal, incubator, thermal-regulation
954862|NCT03450590|heart rate variability|heart rate variability
954863|NCT03450590|intraarterial chemotherapy|intraarterial chemotherapy
954864|NCT03450590|ophthalmic arterial chemotherapy|ophthalmic arterial chemotherapy
954865|NCT03450538|Trauma|trauma
954866|NCT03450538|Computed tomography|computed tomography
954867|NCT03450538|India|india
954868|NCT03450512|Neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry|neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry
954869|NCT03450486|dynamic balance|dynamic balance
954870|NCT03450486|star excursion balance test|star excursion balance test
954871|NCT03450486|exercise|exercise
954872|NCT03450473|Mesh|mesh
954873|NCT03450460|peer support|peer support
954874|NCT03450460|feasibility trial|feasibility trial
954875|NCT03450460|mixed methods|mixed methods
954876|NCT03450447|Head and Neck Cancer|head and neck cancer
954877|NCT03450447|Esophageal Cancer|esophageal cancer
954878|NCT03450447|endoscopic submucosal dissection|endoscopic submucosal dissection
954879|NCT03450447|quality of life|quality of life
954880|NCT03450447|median survival time|median survival time
954881|NCT03450382|community health|community health
954882|NCT03450382|mental health|mental health
954883|NCT03450382|behavior change|behavior change
954884|NCT03450382|social support|social support
954885|NCT03450382|health promotion|health promotion
954886|NCT03450304|Multidetector Computed Tomography|multidetector computed tomography
954887|NCT03450304|Pulmonary Embolism|pulmonary embolism
954888|NCT03450304|Hypertension Pulmonary Secondary|hypertension pulmonary secondary
954889|NCT03450291|Computational|computational
954890|NCT03450252|HCM|hcm
954891|NCT03450252|Mid-cavity|mid-cavity
954892|NCT03450252|Pacing|pacing
954893|NCT03450239|MRI|mri
954894|NCT03450200|Diabetic Peripheral Neuropathy, Exercises|diabetic peripheral neuropathy, exercises
954895|NCT03450148|aversive therapy|aversive therapy
954896|NCT03450135|puberty|puberty
954897|NCT03450135|EEG|eeg
954898|NCT03450135|estradiol|estradiol
954899|NCT03450135|mood|mood
954900|NCT03450135|stress|stress
954901|NCT03450122|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
954902|NCT03450122|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
954903|NCT03450122|Synovial sarcoma|synovial sarcoma
954904|NCT03450122|Myxoid liposarcoma|myxoid liposarcoma
954905|NCT03450122|CD8+ antigen specific T cells|cd8+ antigen specific t cells
954906|NCT03450122|Cyclophosphamide|cyclophosphamide
954907|NCT03450122|Cytoxan|cytoxan
954908|NCT03450122|Neosar|neosar
954909|NCT03450122|IL-2|il-2
954910|NCT03450122|Aldesleukin|aldesleukin
954911|NCT03450122|Interleukin|interleukin
954912|NCT03450122|Proleukin|proleukin
954913|NCT03450122|LV305|lv305
954914|NCT03450122|ID-LV305|id-lv305
954915|NCT03450122|CMB305|cmb305
954916|NCT03450044|Chemotherapy|chemotherapy
954917|NCT03450044|Breast Cancer|breast cancer
954918|NCT03450044|Dendritic cells|dendritic cells
954919|NCT03450044|Immunotherapy|immunotherapy
954920|NCT03450044|Doxorubicine|doxorubicine
954921|NCT03450018|Gemcitabine|gemcitabine
954922|NCT03450018|SLC-0111|slc-0111
954923|NCT03450018|PDAC|pdac
954924|NCT03449979|tACS|tacs
954925|NCT03449979|transcranial alternating current stimulation|transcranial alternating current stimulation
954926|NCT03449979|stimulation|stimulation
954927|NCT03449979|heart rate variability|heart rate variability
954928|NCT03449979|electroencephalogram|electroencephalogram
954929|NCT03449979|EEG|eeg
954930|NCT03449966|pCLE|pcle
954931|NCT03449966|confocal|confocal
954932|NCT03449966|Advanced gastric cancer|advanced gastric cancer
954933|NCT03449966|chemotherapy|chemotherapy
954934|NCT03449940|Penile fracture|penile fracture
954935|NCT03449940|Delayed|delayed
954936|NCT03449940|Localized|localized
954937|NCT03449940|Repair|repair
954938|NCT03449927|Nutrition Tool|nutrition tool
954939|NCT03449927|Melphalan Autologous Transplant|melphalan autologous transplant
954940|NCT03449914|ECOG PS|ecog ps
954941|NCT03449914|Timed Up and Go test|timed up and go test
954942|NCT03449914|G8 score|g8 score
954943|NCT03449823|Renal Artery Doppler|renal artery doppler
954944|NCT03449810|Muscles Energy Technique, Low Back Pain|muscles energy technique, low back pain
954945|NCT03449797|aldosterone|aldosterone
954946|NCT03449797|cortisol|cortisol
954947|NCT03449797|adrenal vein sampling|adrenal vein sampling
954948|NCT03449797|primary aldosteronism|primary aldosteronism
954949|NCT03449784|dyslipidemia|dyslipidemia
954950|NCT03449784|lipid-lowering therapy|lipid-lowering therapy
954951|NCT03449784|cardiovascular risk|cardiovascular risk
954952|NCT03449784|diabetes|diabetes
954953|NCT03449784|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
954954|NCT03449771|HIV|hiv
954955|NCT03449771|Pre-exposure prophylaxis|pre-exposure prophylaxis
954956|NCT03449771|Recreational drugs|recreational drugs
954957|NCT03449771|Chemsex|chemsex
954958|NCT03449771|Mental disorders|mental disorders
954959|NCT03449745|Acute Myeloid Leukemia|acute myeloid leukemia
955057|NCT03449108|Fludara|fludara
954963|NCT03449680|hip arthroscopy|hip arthroscopy
954964|NCT03449680|femoral articular branch block|femoral articular branch block
954965|NCT03449615|Cutaneous melanoma|cutaneous melanoma
954966|NCT03449615|Sentinel node biopsy|sentinel node biopsy
954967|NCT03449602|thoracoscopy|thoracoscopy
954968|NCT03449602|pleuroscopy|pleuroscopy
954969|NCT03449602|metastatic cancer|metastatic cancer
954970|NCT03449602|lung cancer|lung cancer
954971|NCT03449602|malignant pleural effusion|malignant pleural effusion
954972|NCT03449602|tuberculosis|tuberculosis
954973|NCT03449576|PTSD|ptsd
954974|NCT03449576|neuroimaging|neuroimaging
954975|NCT03449576|fMRI|fmri
954976|NCT03449576|veterans|veterans
954977|NCT03449576|exposure therapy|exposure therapy
954978|NCT03449576|treatment|treatment
954979|NCT03449563|thoracic paravertebral block|thoracic paravertebral block
954980|NCT03449563|postoperative analgesia|postoperative analgesia
954981|NCT03449563|pulmonary lobectomy|pulmonary lobectomy
954982|NCT03449550|Child obstructive sleep apnea|child obstructive sleep apnea
954983|NCT03449550|Home Respiratory Polygraphy|home respiratory polygraphy
954984|NCT03449550|Diagnosis|diagnosis
954985|NCT03449550|Validity|validity
954986|NCT03449550|Polysomnography|polysomnography
954987|NCT03449524|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
954988|NCT03449524|Pulmonary Hypertension|pulmonary hypertension
954989|NCT03449524|PAH|pah
954990|NCT03449524|Connective Tissue Disease-Associated|connective tissue disease-associated
954991|NCT03449524|6 Minute Walk Test|6 minute walk test
954992|NCT03449524|6 Minute Walk Distance|6 minute walk distance
954993|NCT03449524|Pulmonary Vascular Resistance|pulmonary vascular resistance
954994|NCT03449524|Cardiac MRI|cardiac mri
954995|NCT03449524|Right Ventricular Function|right ventricular function
954996|NCT03449524|Hypertension|hypertension
954997|NCT03449524|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
954998|NCT03449524|Connective Tissue Diseases|connective tissue diseases
954999|NCT03449524|Vascular Diseases|vascular diseases
955000|NCT03449524|Cardiovascular Diseases|cardiovascular diseases
955001|NCT03449524|Hypertension, Pulmonary|hypertension, pulmonary
955002|NCT03449524|Lung Diseases|lung diseases
955003|NCT03449485|Bariatric surgery|bariatric surgery
955004|NCT03449485|Gastrointestinal tract|gastrointestinal tract
955005|NCT03449485|Biological availability|biological availability
955006|NCT03449485|Pharmacokinetics|pharmacokinetics
955007|NCT03449485|Chlorprothixene|chlorprothixene
955008|NCT03449472|Bariatric surgery|bariatric surgery
955009|NCT03449472|Gastrointestinal tract|gastrointestinal tract
955010|NCT03449472|Biological availability|biological availability
955011|NCT03449472|Pharmacokinetics|pharmacokinetics
955012|NCT03449472|Quetiapine fumarate|quetiapine fumarate
1649630|NCT00199342|Melanoma|melanoma
965623|NCT03383692|HER2|her2
955013|NCT03449459|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
955014|NCT03449459|aerosol inhaled amikacin|aerosol inhaled amikacin
955015|NCT03449459|oral probiotics|oral probiotics
955016|NCT03449459|combined influenza and pneumococcal vaccine inoculation|combined influenza and pneumococcal vaccine inoculation
955017|NCT03449459|bacterial decolonization in lower respiratory tract|bacterial decolonization in lower respiratory tract
955018|NCT03449420|thromboelastography|thromboelastography
955019|NCT03449407|Auditory hallucinations|auditory hallucinations
955020|NCT03449407|Psychosis|psychosis
955021|NCT03449407|Mood|mood
955022|NCT03449407|Brain imaging|brain imaging
955023|NCT03449407|Experience sampling method|experience sampling method
955024|NCT03449394|Psychosis|psychosis
955025|NCT03449394|Depression|depression
955026|NCT03449394|Metacognition|metacognition
955027|NCT03449394|Attribution|attribution
955028|NCT03449394|Emotions|emotions
955029|NCT03449355|sexuality|sexuality
955030|NCT03449355|mode of delivery|mode of delivery
955031|NCT03449355|quality of life|quality of life
955032|NCT03449316|Nebulizers and Vaporizers|nebulizers and vaporizers
955038|NCT03449251|Apelin|apelin
955039|NCT03449251|Relaxin|relaxin
955040|NCT03449212|SOD1|sod1
955041|NCT03449212|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
955042|NCT03449212|ALS|als
955043|NCT03449212|Kinetics|kinetics
955044|NCT03449212|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
955045|NCT03449212|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
955046|NCT03449186|periodontitis|periodontitis
955047|NCT03449186|postpartum|postpartum
955048|NCT03449121|Breathing|breathing
955049|NCT03449121|Mind-body|mind-body
955050|NCT03449108|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
955051|NCT03449108|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
955052|NCT03449108|Cyclophosphamide|cyclophosphamide
955053|NCT03449108|Cytoxan|cytoxan
955054|NCT03449108|Neosar|neosar
955055|NCT03449108|Fludarabine|fludarabine
955056|NCT03449108|Fludarabine phosphate|fludarabine phosphate
955058|NCT03449108|LN-145|ln-145
955059|NCT03449108|IL-2|il-2
955060|NCT03449108|Aldesleukin|aldesleukin
955061|NCT03449108|Interleukin|interleukin
955062|NCT03449108|Proleukin|proleukin
955063|NCT03449108|Mesna|mesna
955064|NCT03449108|Questionnaires|questionnaires
955065|NCT03449108|Surveys|surveys
955066|NCT03449082|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
955067|NCT03449082|allogeneic stem cell|allogeneic stem cell
955068|NCT03449030|Drug Therapy|drug therapy
955069|NCT03449017|nicotine|nicotine
955070|NCT03449017|alcohol|alcohol
955071|NCT03449017|vape|vape
955072|NCT03449017|electronic cigarette|electronic cigarette
955073|NCT03449004|Validation|validation
955074|NCT03449004|questionnaire|questionnaire
955075|NCT03449004|satisfaction|satisfaction
955076|NCT03449004|online information|online information
955077|NCT03448991|NPO time|npo time
955078|NCT03448991|Gastric content|gastric content
955079|NCT03448991|Gastric pH|gastric ph
955080|NCT03448939|papulopustular rosacea|papulopustular rosacea
955081|NCT03448926|DCIS|dcis
955082|NCT03448926|molecular testing|molecular testing
955083|NCT03448926|risk of recurrence|risk of recurrence
955084|NCT03448913|Anesthesia, Regional ;PECS block|anesthesia, regional ;pecs block
955085|NCT03448900|Cessation|cessation
955086|NCT03448900|College student|college student
955087|NCT03448900|Motivational Interview|motivational interview
955088|NCT03448900|Self-efficacy|self-efficacy
955089|NCT03448900|Intention|intention
955090|NCT03448900|Beliefs|beliefs
955091|NCT03448900|Young adult|young adult
955092|NCT03448887|End-stage renal disease|end-stage renal disease
955093|NCT03448887|Medium cut-off dialyzer|medium cut-off dialyzer
955094|NCT03448887|Hemodiafiltration|hemodiafiltration
955095|NCT03448887|Cardiovascular|cardiovascular
955096|NCT03448887|Pulse wave velocity|pulse wave velocity
955097|NCT03448835|short term immunotherapy|short term immunotherapy
955098|NCT03448835|surgical resection|surgical resection
955099|NCT03448835|atezolizumab|atezolizumab
955100|NCT03448835|capecitabine|capecitabine
955101|NCT03448835|oxaliplatin|oxaliplatin
955102|NCT03448835|docetaxel|docetaxel
955103|NCT03448809|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
955104|NCT03448809|Children and Adolescents|children and adolescents
955105|NCT03448809|Community Health Care|community health care
955106|NCT03448809|Early Intervention|early intervention
955107|NCT03448809|Feasibility Study|feasibility study
955108|NCT03448796|High tibial osteotomy|high tibial osteotomy
955109|NCT03448796|Osteoarthrosis|osteoarthrosis
955110|NCT03448796|Tomofix|tomofix
955111|NCT03448796|Randomized controlled trial|randomized controlled trial
955112|NCT03448783|Bariatric surgery|bariatric surgery
955113|NCT03448783|Gastrointestinal tract|gastrointestinal tract
955114|NCT03448783|Biological availability|biological availability
955115|NCT03448783|Pharmacokinetics|pharmacokinetics
955116|NCT03448783|Apixaban|apixaban
955117|NCT03448757|LEEF|leef
955118|NCT03448757|hemodynamic parameters|hemodynamic parameters
955119|NCT03448757|heart beat|heart beat
955120|NCT03448757|biofeedback effect|biofeedback effect
955121|NCT03448744|thymosin alpha|thymosin alpha
955122|NCT03448744|entecavir|entecavir
955123|NCT03448705|influenza|influenza
955124|NCT03448679|glycocalyx|glycocalyx
955125|NCT03448679|serum albumin|serum albumin
955126|NCT03448679|orthotopic liver transplantation|orthotopic liver transplantation
955127|NCT03448679|colloid osmotic pressure|colloid osmotic pressure
955128|NCT03448679|endothelial dysfunction|endothelial dysfunction
955129|NCT03448666|ECT|ect
955130|NCT03448666|pembrolizumab|pembrolizumab
955131|NCT03448666|advanced melanoma|advanced melanoma
955132|NCT03448627|stem cell transplantation|stem cell transplantation
955133|NCT03448627|Pulmonary Functions|pulmonary functions
955134|NCT03448627|muscle strength|muscle strength
955135|NCT03448627|exercise capacity|exercise capacity
955136|NCT03448614|skull base reconstrction|skull base reconstrction
955137|NCT03448601|Precision Medicine|precision medicine
955138|NCT03448575|Youth|youth
955139|NCT03448575|Mental Health|mental health
955140|NCT03448575|Psychotropic|psychotropic
955141|NCT03448575|Medication Safety|medication safety
955142|NCT03448575|Quality Improvement|quality improvement
955143|NCT03448562|Atrial Fibrillation|atrial fibrillation
955144|NCT03448562|Pulmonary Vein Isolation|pulmonary vein isolation
955145|NCT03448562|Catheter Ablation|catheter ablation
955146|NCT03448562|Substrate Modification|substrate modification
955147|NCT03448549|Tegafur，gimeracil and oteracil potassium|tegafur，gimeracil and oteracil potassium
955148|NCT03448549|Capecitabine|capecitabine
955149|NCT03448549|compliance|compliance
955150|NCT03448549|quality of life|quality of life
955151|NCT03448549|adverse reaction|adverse reaction
955152|NCT03448549|disease free survival|disease free survival
955153|NCT03448549|overall survival|overall survival
955154|NCT03448536|Primary dysmenorrhea of at least moderate severity|primary dysmenorrhea of at least moderate severity
955155|NCT03448510|lower urinary tract symptoms|lower urinary tract symptoms
955156|NCT03448510|male|male
955157|NCT03448510|benign prostatic obstruction|benign prostatic obstruction
955158|NCT03448510|irreversible electroporation|irreversible electroporation
955159|NCT03448510|urodynamics|urodynamics
955160|NCT03448471|stem cell transplantation|stem cell transplantation
955161|NCT03448471|Fatigue|fatigue
955162|NCT03448471|muscle strength|muscle strength
955163|NCT03448471|exercise capacity|exercise capacity
955164|NCT03448471|Depression|depression
955165|NCT03448471|Quality of Life|quality of life
955166|NCT03448445|High-risk|high-risk
955167|NCT03448445|Low-risk|low-risk
955168|NCT03448445|Alzheimer's disease|alzheimer's disease
955169|NCT03448445|Observational study|observational study
955170|NCT03448432|Pregnancy Anemia|pregnancy anemia
955171|NCT03448393|CD-19 expressing tumor|cd-19 expressing tumor
955172|NCT03448393|CD-22 Expressing Tumor|cd-22 expressing tumor
955173|NCT03448393|Adoptive Immunotherapy|adoptive immunotherapy
955174|NCT03448393|Philadelphia chromosome (Ph)+ ALL|philadelphia chromosome (ph)+ all
955175|NCT03448393|Lymphoma|lymphoma
955176|NCT03448354|HIPEC|hipec
955177|NCT03448354|Interval debulking surgery|interval debulking surgery
955178|NCT03448341|radiotherapy|radiotherapy
955179|NCT03448341|IMRT|imrt
955180|NCT03448341|dysphagia|dysphagia
955181|NCT03448341|Oropharynx|oropharynx
955182|NCT03448341|Nasopharynx|nasopharynx
955183|NCT03448341|FEES|fees
955184|NCT03448341|VFS|vfs
955185|NCT03448328|muscular strength|muscular strength
955186|NCT03448328|inflammation|inflammation
955187|NCT03448328|protein|protein
955188|NCT03448315|brain stimulation, tDCS, acute postoperative pain, chronic pain|brain stimulation, tdcs, acute postoperative pain, chronic pain
955189|NCT03448289|Postpartum|postpartum
955190|NCT03448289|Contraception|contraception
955191|NCT03448276|Osteoporosis|osteoporosis
955192|NCT03448276|Muscle Strength|muscle strength
955193|NCT03448276|Postural Balance|postural balance
955197|NCT03448263|post endodontic pain|post endodontic pain
955198|NCT03448263|root canal treatment|root canal treatment
955199|NCT03448198|total knee arthroplasty|total knee arthroplasty
955200|NCT03448198|patellar resurfacing|patellar resurfacing
955201|NCT03448198|patellar tracking|patellar tracking
955202|NCT03448198|patello-femoral joint kinematics|patello-femoral joint kinematics
955203|NCT03448198|surgical navigation|surgical navigation
955204|NCT03448198|computer-aided surgery|computer-aided surgery
955205|NCT03448159|Stroke|stroke
955206|NCT03448159|Exercise|exercise
955207|NCT03448159|Fluoxetine|fluoxetine
955208|NCT03448159|Randomized Control Trial|randomized control trial
955209|NCT03448159|Rehabilitation|rehabilitation
955210|NCT03448120|Muscle fatigue|muscle fatigue
955211|NCT03448120|Thermography|thermography
955212|NCT03448120|Acupuncture|acupuncture
955213|NCT03448120|Dry needling|dry needling
955214|NCT03448107|dental caries|dental caries
955215|NCT03448107|caries arrest|caries arrest
955216|NCT03448107|caries prevention|caries prevention
955217|NCT03448107|silver diamine fluoride|silver diamine fluoride
955218|NCT03448107|sealants|sealants
955219|NCT03448107|interim therapeutic restorations|interim therapeutic restorations
955220|NCT03448055|MCI, AD, MRI, GSH, Immunocal, brain health, neuropsychological evaluation|mci, ad, mri, gsh, immunocal, brain health, neuropsychological evaluation
955221|NCT03448029|Vascular Diseases|vascular diseases
955222|NCT03448029|Peripheral Artery Disease|peripheral artery disease
955223|NCT03448029|Revascularisation|revascularisation
955224|NCT03448029|Outcome|outcome
955225|NCT03448029|Quality Management|quality management
955226|NCT03448029|Registry|registry
955227|NCT03448029|Endovascular Intervention|endovascular intervention
955228|NCT03448029|Limb Amputation|limb amputation
955229|NCT03448003|Benign Neoplasms|benign neoplasms
955230|NCT03448003|Cancer prevention|cancer prevention
955231|NCT03448003|Online counseling|online counseling
955232|NCT03448003|Questionnaires|questionnaires
955233|NCT03448003|Surveys|surveys
955234|NCT03447977|neck pain|neck pain
955235|NCT03447977|manual therapy|manual therapy
955236|NCT03447977|respiratory function|respiratory function
955237|NCT03447964|sphingolipids|sphingolipids
955238|NCT03447964|hepatic steatosis|hepatic steatosis
955239|NCT03447964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
955240|NCT03447964|macrovascular complications|macrovascular complications
955241|NCT03447964|insulin resistance|insulin resistance
955242|NCT03447964|microvasclar complications|microvasclar complications
955243|NCT03447964|NAFLD|nafld
955244|NCT03447925|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents
955245|NCT03447912|Behavioral intervention|behavioral intervention
955246|NCT03447912|Social intervention|social intervention
955247|NCT03447912|Public health|public health
955248|NCT03447912|Smoking behavior|smoking behavior
955249|NCT03447886|Breast Cancer|breast cancer
955250|NCT03447873|Antiretroviral treatment|antiretroviral treatment
955251|NCT03447873|Treatment simplification|treatment simplification
955252|NCT03447873|Dual therapy|dual therapy
955253|NCT03447873|Immune recovery|immune recovery
956554|NCT03440164|Sylimarin|sylimarin
955254|NCT03447834|intracoronary cooling|intracoronary cooling
955255|NCT03447821|Infectious diarrhoea|infectious diarrhoea
955256|NCT03447821|rifamycin SV|rifamycin sv
955257|NCT03447821|rifamycin SV MMX|rifamycin sv mmx
955259|NCT03447782|New Daily Persistent Headache|new daily persistent headache
955260|NCT03447782|Chronic Headache|chronic headache
955261|NCT03447769|Non-Small Cell Lung Cancer|non-small cell lung cancer
955262|NCT03447769|NSCLC|nsclc
955263|NCT03447769|ACZ885|acz885
955264|NCT03447769|canakinumab|canakinumab
955265|NCT03447769|adjuvant|adjuvant
955266|NCT03447769|AJCC/UICC v. 8 stages II-IIIA and IIIB (T>5cm N2)|ajcc/uicc v. 8 stages ii-iiia and iiib (t>5cm n2)
955267|NCT03447717|hemiplegic gait|hemiplegic gait
955268|NCT03447717|peroneal nerve stimulation|peroneal nerve stimulation
955269|NCT03447717|gait analysis|gait analysis
955270|NCT03447704|Ankylosing Spondylitis|ankylosing spondylitis
955271|NCT03447704|interleukin 17|interleukin 17
955272|NCT03447704|monoclonal antibody|monoclonal antibody
955273|NCT03447665|Infant behavioral sleep intervention|infant behavioral sleep intervention
955274|NCT03447665|Infant sleep|infant sleep
955275|NCT03447665|Pediatric insomnia|pediatric insomnia
955276|NCT03447665|Infant night wakings|infant night wakings
955277|NCT03447639|Catheter associated UTI|catheter associated uti
955278|NCT03447639|Povidine iodine|povidine iodine
955279|NCT03447639|Bladder Irrigation|bladder irrigation
955280|NCT03447613|retinal nerve fiber layer|retinal nerve fiber layer
955281|NCT03447613|cerebrospinal fluid Aβ and Tau|cerebrospinal fluid aβ and tau
955282|NCT03447587|Randomized controlled trial|randomized controlled trial
955283|NCT03447587|Sleep|sleep
955284|NCT03447587|Traditional Chinese medicine|traditional chinese medicine
955285|NCT03447587|Oxidative stress|oxidative stress
955286|NCT03447561|Dopamine|dopamine
955287|NCT03447561|Food|food
955288|NCT03447561|Reward|reward
955289|NCT03447561|Anticipatory|anticipatory
955290|NCT03447561|Consummatory|consummatory
955291|NCT03447561|Positron Emission Tomography|positron emission tomography
955292|NCT03447561|Magnetic Resonance|magnetic resonance
955293|NCT03447561|Metabolic hormones|metabolic hormones
955294|NCT03447548|Cognitive training|cognitive training
955295|NCT03447548|Social function|social function
955296|NCT03447548|Processing speed|processing speed
955297|NCT03447535|Oppositional defiant disorder|oppositional defiant disorder
955298|NCT03447535|Family|family
955299|NCT03447535|Disruptive, impulse control and conduct disorders|disruptive, impulse control and conduct disorders
955300|NCT03447535|Anxiety disorder|anxiety disorder
955301|NCT03447535|Intrafamilial disruptive behaviours disorder|intrafamilial disruptive behaviours disorder
955302|NCT03447509|Spinal cord injury|spinal cord injury
955303|NCT03447509|neural control|neural control
955304|NCT03447509|motor function|motor function
955305|NCT03447509|hand movement|hand movement
955306|NCT03447483|Solid tumor|solid tumor
955307|NCT03447483|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
955308|NCT03447483|immune-related Adverse Event|immune-related adverse event
955309|NCT03447444|dignity|dignity
955310|NCT03447444|music therapy|music therapy
955311|NCT03447444|physical activity|physical activity
955312|NCT03447431|colorectal cancers|colorectal cancers
955313|NCT03447431|Microsatellite Instability|microsatellite instability
955314|NCT03447431|Tumor development|tumor development
955315|NCT03447418|Lung Clearance Index|lung clearance index
955316|NCT03447418|Breath Nitrogen Washout|breath nitrogen washout
955317|NCT03447418|Healthy subjects|healthy subjects
955318|NCT03447405|Music Therapy|music therapy
955319|NCT03447405|NICU|nicu
955320|NCT03447405|Infants|infants
955321|NCT03447405|multisensory processing|multisensory processing
955322|NCT03447392|Patient Education|patient education
955323|NCT03447392|Chinese Medicine|chinese medicine
955324|NCT03447353|driving|driving
955325|NCT03447353|Xanax|xanax
955326|NCT03447353|Norco|norco
955327|NCT03447353|simulation|simulation
955328|NCT03447314|GSK1795091|gsk1795091
955329|NCT03447314|Dose-escalation|dose-escalation
955330|NCT03447314|204686|204686
955331|NCT03447314|Immunotherapies|immunotherapies
955332|NCT03447314|Phase I|phase i
955333|NCT03447314|anticancer agent|anticancer agent
955334|NCT03447314|OX40|ox40
955335|NCT03447314|201212|201212
955336|NCT03447314|TLR4|tlr4
955337|NCT03447314|GSK3174998|gsk3174998
955338|NCT03447314|Advanced Solid Tumors|advanced solid tumors
955339|NCT03447301|Saudi Arabia, Extra Virgin Olive Oil, Blood Glucose|saudi arabia, extra virgin olive oil, blood glucose
955340|NCT03447288|Dyssynchrony|dyssynchrony
955341|NCT03447288|Breath-stacking|breath-stacking
955342|NCT03447288|Asynchrony|asynchrony
955343|NCT03447288|Reverse Triggering|reverse triggering
955344|NCT03447288|Mechanical Ventilation|mechanical ventilation
955345|NCT03447288|Sedation|sedation
955346|NCT03447236|Older people|older people
955347|NCT03447236|Cognitive training|cognitive training
955348|NCT03447236|MCI|mci
955349|NCT03447223|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
955350|NCT03447223|circulating metabolites|circulating metabolites
955351|NCT03447223|metagenome|metagenome
955352|NCT03447210|Persons who inject drugs (PWID)|persons who inject drugs (pwid)
955353|NCT03447210|Phylogenetics|phylogenetics
955354|NCT03447210|HIV testing|hiv testing
955355|NCT03447210|HCV testing|hcv testing
955356|NCT03447210|HIV care cascade|hiv care cascade
955357|NCT03447210|Assisted partner services|assisted partner services
955358|NCT03447171|Amblyopia|amblyopia
955359|NCT03447171|Myopia|myopia
955360|NCT03447171|Hyperopia|hyperopia
955361|NCT03447171|Risk Factors|risk factors
955362|NCT03447171|Amblyopia Risk Factors|amblyopia risk factors
955363|NCT03447171|Smartphone Application (App)|smartphone application (app)
955364|NCT03447171|Photoscreening|photoscreening
955365|NCT03447171|Vision Screening|vision screening
955366|NCT03447171|Mobile Vision Screening|mobile vision screening
955367|NCT03447171|Vision Screening App|vision screening app
955368|NCT03447171|Preschool children|preschool children
955369|NCT03447171|Objective vision screening|objective vision screening
955370|NCT03447132|Breast Cancer|breast cancer
955371|NCT03447132|Luminal|luminal
955372|NCT03447132|Neoadjuvant|neoadjuvant
955373|NCT03447132|pCR|pcr
955374|NCT03447132|Surgery|surgery
955375|NCT03447093|oral microbiota|oral microbiota
955376|NCT03447093|16S rRNA gene|16s rrna gene
955377|NCT03447093|Graves' disease|graves' disease
955378|NCT03447093|Methimazole|methimazole
955379|NCT03447093|Propylthiouracil|propylthiouracil
955380|NCT03447093|Hashimoto's thyroiditis|hashimoto's thyroiditis
955381|NCT03447054|Alcohol|alcohol
955382|NCT03447054|tDCS|tdcs
955383|NCT03447054|inhibition|inhibition
955384|NCT03447054|cognitive training|cognitive training
955385|NCT03447054|implicit cognition|implicit cognition
955386|NCT03447054|relapse|relapse
955387|NCT03447054|craving|craving
955388|NCT03447041|Keratopathy|keratopathy
955389|NCT03447041|Visual Quality|visual quality
955390|NCT03447041|Contrast Sensitivity Function|contrast sensitivity function
955391|NCT03447028|Triglyseride-Glucose index|triglyseride-glucose index
955392|NCT03447028|prostate cancer|prostate cancer
955393|NCT03447028|radical prostatectomy|radical prostatectomy
955394|NCT03447028|metabolic syndrome|metabolic syndrome
955395|NCT03447015|ambulation|ambulation
955396|NCT03447015|labour|labour
955397|NCT03447015|Randomized Controlled Trial|randomized controlled trial
955398|NCT03447015|Jordan|jordan
955399|NCT03447002|premature|premature
955400|NCT03447002|pvc|pvc
955401|NCT03446989|case management|case management
955402|NCT03446989|rheumatoid arthritis|rheumatoid arthritis
955403|NCT03446989|Effectiveness|effectiveness
955404|NCT03446989|Generalized Estimating Equations|generalized estimating equations
955405|NCT03446950|vaginal surgery|vaginal surgery
955406|NCT03446950|patient position|patient position
955407|NCT03446950|stirrups|stirrups
955408|NCT03446950|functional status|functional status
955409|NCT03446950|urogynecology|urogynecology
955410|NCT03446937|Antenal corticosteroids|antenal corticosteroids
955411|NCT03446937|Late preterm delivery|late preterm delivery
955412|NCT03446937|Neonatal morbidity|neonatal morbidity
955413|NCT03446924|Nutraceuticals|nutraceuticals
955414|NCT03446924|Muscle anabolism|muscle anabolism
955415|NCT03446924|Ageing|ageing
955416|NCT03446911|SABR|sabr
955417|NCT03446911|Immunotherapy|immunotherapy
955418|NCT03446859|Transcutaneous nerve electrical stimulation,|transcutaneous nerve electrical stimulation,
955419|NCT03446859|Pain intensity|pain intensity
955420|NCT03446859|Primary dysmenorrhea|primary dysmenorrhea
955421|NCT03446859|Female|female
955422|NCT03446859|Undergraduates|undergraduates
955423|NCT03446833|Parkinson's Disease|parkinson's disease
955424|NCT03446833|Deep Brain Stimulation|deep brain stimulation
955425|NCT03446807|fatigue|fatigue
955426|NCT03446807|Droxidopa|droxidopa
955427|NCT03446794|Left Atrial Appendage Closure|left atrial appendage closure
955428|NCT03446794|Watchman device|watchman device
955429|NCT03446768|COPD|copd
955430|NCT03446768|OSA|osa
955431|NCT03446742|Rehabilitation Service|rehabilitation service
955432|NCT03446742|Signals and symptons|signals and symptons
955433|NCT03446742|Heart Rate|heart rate
955434|NCT03446742|Blood pressure|blood pressure
955435|NCT03446742|Respiratory Muscles|respiratory muscles
955436|NCT03446742|autonomic modulation|autonomic modulation
955437|NCT03446742|exercise|exercise
955438|NCT03446742|risk measurement|risk measurement
955439|NCT03446742|muscle strength|muscle strength
955440|NCT03446742|inflammation|inflammation
955441|NCT03446742|cytosines|cytosines
955442|NCT03446703|social cognition|social cognition
955443|NCT03446703|psychotherapy|psychotherapy
955444|NCT03446703|rehabilitation|rehabilitation
955445|NCT03446703|theory of mind|theory of mind
955446|NCT03446690|Enamel decalcification|enamel decalcification
955447|NCT03446677|HIV|hiv
955448|NCT03446677|Balance|balance
955449|NCT03446677|Vestibular|vestibular
955450|NCT03446677|Somatosensory|somatosensory
955451|NCT03446677|postural stability|postural stability
955452|NCT03446677|center of pressure|center of pressure
955453|NCT03446651|Sodium Homeostasis|sodium homeostasis
955454|NCT03446638|myelodysplastic syndromes|myelodysplastic syndromes
955455|NCT03446638|MDS|mds
955456|NCT03446638|computational biology|computational biology
955457|NCT03446638|relapsed|relapsed
955458|NCT03446638|refractory|refractory
955459|NCT03446625|resveratrol|resveratrol
955460|NCT03446625|OHSS|ohss
955461|NCT03446625|PCOS|pcos
955462|NCT03446612|Daprodustat, Darbepoetin alfa, Efficacy and FBF-CKD|daprodustat, darbepoetin alfa, efficacy and fbf-ckd
955463|NCT03446599|cardiac surgery|cardiac surgery
955464|NCT03446599|vasoplegia|vasoplegia
955465|NCT03446599|cardiopulmonary bypass|cardiopulmonary bypass
955466|NCT03446573|Switch study|switch study
955467|NCT03446573|non-inferiority|non-inferiority
955468|NCT03446573|HIV-1|hiv-1
955469|NCT03446573|tenofovir alafenamide|tenofovir alafenamide
955470|NCT03446573|dolutegravir plus lamivudine|dolutegravir plus lamivudine
955471|NCT03446560|Compliance|compliance
955472|NCT03446560|Telemedicine|telemedicine
955473|NCT03446560|Patient related outcome measures|patient related outcome measures
955474|NCT03446547|SBRT|sbrt
955475|NCT03446547|Immunotherapy|immunotherapy
955476|NCT03446534|pneumonia|pneumonia
955477|NCT03446534|pre-school children|pre-school children
955478|NCT03446534|antibiotics|antibiotics
955479|NCT03446534|amoxicillin|amoxicillin
955480|NCT03446508|High definition transcranial direct stimulation|high definition transcranial direct stimulation
955481|NCT03446508|Mild Cognitive Impairment|mild cognitive impairment
955482|NCT03446508|Memory|memory
955483|NCT03446495|ovarian cancer, trabectedin, recurrent ovarian cancer|ovarian cancer, trabectedin, recurrent ovarian cancer
955484|NCT03446469|Chronic ankle instability|chronic ankle instability
955485|NCT03446469|Functional instability|functional instability
955486|NCT03446469|Ankle sprain|ankle sprain
955487|NCT03446469|postural sway|postural sway
955488|NCT03446469|Fascial Manipulation|fascial manipulation
955489|NCT03446456|Magnetic Resonance Imaging|magnetic resonance imaging
955490|NCT03446456|Healthy Volunteers|healthy volunteers
955491|NCT03446430|arterial stiffness|arterial stiffness
955492|NCT03446430|pulse wave velocity|pulse wave velocity
955493|NCT03446430|laser Doppler vibrometry|laser doppler vibrometry
955494|NCT03446365|Asthma|asthma
955495|NCT03446365|Latino children|latino children
955496|NCT03446365|middle school|middle school
955497|NCT03446365|peer models|peer models
955498|NCT03446365|educational intervention|educational intervention
955499|NCT03446365|high school students|high school students
955500|NCT03446352|Falls|falls
955501|NCT03446352|Elderly|elderly
955502|NCT03446352|Psychomotor exercise program|psychomotor exercise program
955503|NCT03446352|Whole body vibration|whole body vibration
955504|NCT03446326|pacemaker|pacemaker
955505|NCT03446326|stroke volume|stroke volume
955506|NCT03446326|cardiac output|cardiac output
955507|NCT03446326|heart rate|heart rate
955508|NCT03446300|High Myopia, fundus structure, early visual impairment|high myopia, fundus structure, early visual impairment
955509|NCT03446248|vibroacoustic stimulation|vibroacoustic stimulation
955510|NCT03446235|Obesity|obesity
955511|NCT03446235|Physical Activity|physical activity
955512|NCT03446235|Exercise|exercise
955513|NCT03446235|Wearable device|wearable device
955514|NCT03446196|Transplantation, Fluid Balance|transplantation, fluid balance
955515|NCT03446170|Young adults|young adults
955516|NCT03446170|Cigarette smoking|cigarette smoking
955517|NCT03446170|Warning labels|warning labels
955518|NCT03446157|colon cancer|colon cancer
955519|NCT03446157|metastatic colon cancer|metastatic colon cancer
955520|NCT03446157|palbociclib|palbociclib
955521|NCT03446157|cetuximab|cetuximab
955522|NCT03446144|Geographic Atrophy|geographic atrophy
955523|NCT03446144|Age Related Macular Degeneration|age related macular degeneration
955524|NCT03446144|IONIS-FB-Lrx|ionis-fb-lrx
955525|NCT03446144|Complement Factor B|complement factor b
955526|NCT03446131|transfemoral amputation|transfemoral amputation
955527|NCT03446131|limb salvage|limb salvage
955528|NCT03446131|bilateral amputation|bilateral amputation
955529|NCT03446131|Department of Defense|department of defense
955530|NCT03446131|orthosis|orthosis
955531|NCT03446131|prosthesis|prosthesis
955532|NCT03446131|rehabilitation|rehabilitation
955533|NCT03446131|military treatment facilities|military treatment facilities
955534|NCT03446131|military|military
955535|NCT03446131|injured lower extremity|injured lower extremity
955536|NCT03446131|prevent falls|prevent falls
955537|NCT03446131|trauma lower extremity|trauma lower extremity
955538|NCT03446131|service members|service members
955539|NCT03446131|retired service members|retired service members
955540|NCT03446131|active service members|active service members
955541|NCT03446131|unilateral lower extremity trauma|unilateral lower extremity trauma
955542|NCT03446131|limb amputation|limb amputation
955543|NCT03446131|limb preservation|limb preservation
955544|NCT03446131|preserved limb|preserved limb
955545|NCT03446131|trips|trips
955546|NCT03446131|slips|slips
955547|NCT03446131|transtibial amputation|transtibial amputation
955549|NCT03446105|Cancer survivor|cancer survivor
955550|NCT03446105|App-based intervention|app-based intervention
955551|NCT03446105|Behavioral intervention|behavioral intervention
955552|NCT03446092|Cancer|cancer
955553|NCT03446092|Mindfulness|mindfulness
955554|NCT03446092|Palliative care|palliative care
955555|NCT03446079|Genetic|genetic
955556|NCT03446079|Skin|skin
955557|NCT03446079|Anti Aging|anti aging
955558|NCT03446079|SNP|snp
955559|NCT03446053|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
955560|NCT03446053|Methicillin-Sensitive Staphylococcus Aureus|methicillin-sensitive staphylococcus aureus
955561|NCT03446053|N-Rephasin SAL200|n-rephasin sal200
955562|NCT03445962|Autonomic nervous system|autonomic nervous system
955563|NCT03445962|Heart rate variability|heart rate variability
955564|NCT03445962|Physical Activity|physical activity
955565|NCT03445962|exercise|exercise
955566|NCT03445962|biological parameters|biological parameters
955567|NCT03445962|cephalometry|cephalometry
955568|NCT03445962|body composition|body composition
955569|NCT03445962|actigraphy|actigraphy
955570|NCT03445962|motor capacity|motor capacity
955571|NCT03445962|physical fitness|physical fitness
955572|NCT03445962|aerobic capacity|aerobic capacity
955573|NCT03445962|seismocardiography|seismocardiography
955574|NCT03445949|atrial fibrillation, stroke, bleeding, left atrial appendage|atrial fibrillation, stroke, bleeding, left atrial appendage
955575|NCT03445936|loop-ileostomy reversal|loop-ileostomy reversal
955576|NCT03445936|hernia prevention|hernia prevention
955577|NCT03445910|human chorionic gonadotropin|human chorionic gonadotropin
955578|NCT03445884|positron emission tomography|positron emission tomography
955579|NCT03445884|nuclear medicine|nuclear medicine
955580|NCT03445884|prognosis|prognosis
955581|NCT03445871|Rheumatoid Arthritis|rheumatoid arthritis
955582|NCT03445871|Methotrexate|methotrexate
955583|NCT03445871|Erythrocyte polyglutamate|erythrocyte polyglutamate
955584|NCT03445871|Compliance Questionnaire Rheumatology|compliance questionnaire rheumatology
955585|NCT03445845|TNF blocker|tnf blocker
955586|NCT03445845|change of biotherapy|change of biotherapy
955587|NCT03445819|Patella Fracture, elderly|patella fracture, elderly
955588|NCT03445806|IOP fluctuations|iop fluctuations
955589|NCT03445806|iCare Home|icare home
955590|NCT03445806|Trabeculectomy|trabeculectomy
955591|NCT03445806|self-tonometry|self-tonometry
955592|NCT03445793|DeltaF508deletion (F508del) mutation in 2 copies|deltaf508deletion (f508del) mutation in 2 copies
955593|NCT03445767|Peri-operative care|peri-operative care
955594|NCT03445767|Medication management|medication management
955595|NCT03445741|Aerobic exercise|aerobic exercise
955596|NCT03445741|Metabolic syndrome|metabolic syndrome
955597|NCT03445741|Pedometer|pedometer
955598|NCT03445676|Hand Hygiene|hand hygiene
966367|NCT03378830|Pain|pain
955599|NCT03445676|WHO 5-moments|who 5-moments
955600|NCT03445663|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
955601|NCT03445663|Multiple Myeloma|multiple myeloma
955602|NCT03445663|Oncology/Hematology|oncology/hematology
955603|NCT03445663|Immunotherapy|immunotherapy
955604|NCT03445650|ADX-102, Sjögren-Larsson Syndrome|adx-102, sjögren-larsson syndrome
955605|NCT03445637|Metastatic breast cancer, safety, ibrance|metastatic breast cancer, safety, ibrance
955606|NCT03445598|depression|depression
955607|NCT03445598|anxiety|anxiety
955608|NCT03445598|CBT|cbt
955609|NCT03445598|psychotherapy|psychotherapy
955610|NCT03445598|e-health|e-health
955611|NCT03445598|CCBT|ccbt
955612|NCT03445572|Advanced Cancer|advanced cancer
955613|NCT03445572|Meditative Slow Breathing|meditative slow breathing
955614|NCT03445572|MSB|msb
955615|NCT03445572|Isha Kriya Meditation|isha kriya meditation
955616|NCT03445572|IK|ik
955617|NCT03445572|Questionnaires|questionnaires
955618|NCT03445572|Surveys|surveys
955619|NCT03445559|Prostate Cancer|prostate cancer
955620|NCT03445559|Imaging|imaging
955621|NCT03445559|Veterans Affairs|veterans affairs
955622|NCT03445559|Guideline Adherence|guideline adherence
955623|NCT03445559|Implementation|implementation
955624|NCT03445533|Melanoma|melanoma
955625|NCT03445533|PD1|pd1
955626|NCT03445533|PD-1|pd-1
955627|NCT03445533|refractory|refractory
955628|NCT03445533|metastatic|metastatic
955629|NCT03445533|IMO-2125|imo-2125
955630|NCT03445533|illuminate 301|illuminate 301
955631|NCT03445533|TLR9 agonist|tlr9 agonist
955632|NCT03445533|advanced melanoma|advanced melanoma
955633|NCT03445533|CTLA4|ctla4
955634|NCT03445533|CTLA-4|ctla-4
955635|NCT03445533|immunotherapy|immunotherapy
955636|NCT03445533|skin cancer|skin cancer
955637|NCT03445533|ILLUMINATE-301|illuminate-301
955638|NCT03445520|Transitions|transitions
955639|NCT03445520|Passport|passport
955640|NCT03445520|Building Better Bridges|building better bridges
955641|NCT03445520|Snapshot|snapshot
955642|NCT03445507|tobacco|tobacco
955643|NCT03445507|cessation|cessation
955644|NCT03445507|medical apps for smartphones|medical apps for smartphones
955645|NCT03445468|Influenza vaccine|influenza vaccine
955646|NCT03445468|Split influenza vaccine|split influenza vaccine
955647|NCT03445468|Seasonal influenza vaccine|seasonal influenza vaccine
955648|NCT03445442|Elderly|elderly
955649|NCT03445442|Native tissue repair|native tissue repair
955650|NCT03445442|Pelvic Organ Prolapse|pelvic organ prolapse
955651|NCT03445442|Sacrocolpopexy|sacrocolpopexy
955652|NCT03445442|Vaginal mesh repair|vaginal mesh repair
956957|NCT03437603|Eltrombopag|eltrombopag
955653|NCT03445403|Offset analgesia|offset analgesia
955654|NCT03445403|Quantitive sensory testing|quantitive sensory testing
955655|NCT03445364|Primary PCI|primary pci
955656|NCT03445364|Coronary injection pressure|coronary injection pressure
955657|NCT03445364|Reperfusion|reperfusion
955658|NCT03445364|Resolution of ST elevation|resolution of st elevation
955659|NCT03445364|Myocardial Blush Grade|myocardial blush grade
955660|NCT03445351|Exercise Therapy;|exercise therapy;
955662|NCT03445351|; Immune Markers;|; immune markers;
955663|NCT03445351|HIV|hiv
955664|NCT03445325|obesity|obesity
955665|NCT03445325|physical activity|physical activity
955666|NCT03445325|nutrition|nutrition
955667|NCT03445325|adolescents|adolescents
955668|NCT03445325|gamification|gamification
955669|NCT03445325|sedentary activity|sedentary activity
955670|NCT03445286|Gingivitis and geriatric patients|gingivitis and geriatric patients
955671|NCT03445286|Silver Diamine Fluoride and gingivitis|silver diamine fluoride and gingivitis
955672|NCT03445286|Sliver Diamine Fluoride|sliver diamine fluoride
955673|NCT03445247|Diabetic Nephropathies|diabetic nephropathies
955674|NCT03445247|Extracorporeal low intensity shockwave therapy|extracorporeal low intensity shockwave therapy
955675|NCT03445247|Proteinuria|proteinuria
955676|NCT03445234|exercise|exercise
955677|NCT03445234|innate immune function|innate immune function
955678|NCT03445234|metabolomics|metabolomics
955679|NCT03445234|inflammation|inflammation
955680|NCT03445221|Oral Immunonutrition|oral immunonutrition
955681|NCT03445221|Cardiac Patient|cardiac patient
955682|NCT03445221|Mitral Valve Replacement|mitral valve replacement
955683|NCT03445182|pain control|pain control
955684|NCT03445182|paediatric dental patients|paediatric dental patients
955685|NCT03445182|local anaesthesia|local anaesthesia
955686|NCT03445182|dentalvibe|dentalvibe
955687|NCT03445156|First-person shooter (FPS)|first-person shooter (fps)
955688|NCT03445156|Violent video game|violent video game
955689|NCT03445156|Headshot|headshot
955690|NCT03445156|Gun|gun
955691|NCT03445156|Operant conditioning theory|operant conditioning theory
955692|NCT03445130|Preoperative Anxiety|preoperative anxiety
955693|NCT03445130|Breast Surgery|breast surgery
955694|NCT03445130|Lavender Aromatherapy|lavender aromatherapy
955695|NCT03445117|influenza|influenza
955696|NCT03445117|pneumonia|pneumonia
955697|NCT03445117|vaccination|vaccination
955698|NCT03445117|education|education
955699|NCT03445117|public health|public health
955700|NCT03445104|Huperzine A|huperzine a
955701|NCT03445104|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
955702|NCT03445104|AChEI|achei
955703|NCT03445104|exercise|exercise
955704|NCT03445104|Physical performance|physical performance
955705|NCT03445104|cognitive function|cognitive function
955706|NCT03445104|rating of perceived exertion|rating of perceived exertion
955707|NCT03445104|RPE|rpe
955708|NCT03445091|compression socks|compression socks
955709|NCT03445091|venous insufficiency|venous insufficiency
955710|NCT03445091|compression stockings|compression stockings
955711|NCT03445091|compression|compression
955712|NCT03445091|compression therapy|compression therapy
955713|NCT03445052|Adherence|adherence
955714|NCT03445052|Behaviour change|behaviour change
955715|NCT03445052|Intervention|intervention
955716|NCT03445052|Photoprotection|photoprotection
955717|NCT03445052|Ultraviolet radiation|ultraviolet radiation
955718|NCT03445039|Dental implants, Trans-alveolar sinus floor elevation, Bone grafting|dental implants, trans-alveolar sinus floor elevation, bone grafting
955719|NCT03445000|RET-rearrangement|ret-rearrangement
955720|NCT03445000|advanced NSCLC|advanced nsclc
955721|NCT03444987|Uterine fibroid|uterine fibroid
955722|NCT03444987|FAP|fap
955723|NCT03444987|Autophagy|autophagy
955724|NCT03444974|drugs|drugs
955725|NCT03444974|youth|youth
955726|NCT03444974|adolescence|adolescence
955727|NCT03444974|abuse|abuse
955728|NCT03444974|dependency|dependency
955729|NCT03444974|Tetrahydrocannabinol (THC)|tetrahydrocannabinol (thc)
955730|NCT03444974|Methamphetamine (Crystal Meth)|methamphetamine (crystal meth)
955731|NCT03444974|Marihuana|marihuana
955732|NCT03444974|comorbidity|comorbidity
955733|NCT03444974|treatment|treatment
955734|NCT03444974|etiopathology|etiopathology
955735|NCT03444974|sociodemographics|sociodemographics
955736|NCT03444974|Saxony|saxony
955737|NCT03444961|Argus II Retinal Prosthesis System|argus ii retinal prosthesis system
955738|NCT03444961|Rehabilitation|rehabilitation
955739|NCT03444935|Phone|phone
955740|NCT03444935|Brief Contact Intervention|brief contact intervention
955741|NCT03444935|Caring Contact|caring contact
955742|NCT03444935|Follow-up|follow-up
955743|NCT03444935|Suicide|suicide
955744|NCT03444935|Suicidal Ideation|suicidal ideation
955745|NCT03444935|Suicidal Behaviour|suicidal behaviour
955746|NCT03444935|Suicide Attempt|suicide attempt
955747|NCT03444909|Monitoring|monitoring
955748|NCT03444857|Continuous Positive Airway Pressure|continuous positive airway pressure
955749|NCT03444857|Myocardial Salvage|myocardial salvage
955750|NCT03444857|Obstructive Sleep Apnea|obstructive sleep apnea
955751|NCT03444857|ST Elevation Myocardial Infarction|st elevation myocardial infarction
955752|NCT03444831|Functional Dyspepsia|functional dyspepsia
955753|NCT03444818|E6007|e6007
955754|NCT03444818|Pharmacokinetics|pharmacokinetics
955755|NCT03444818|Radioactivity|radioactivity
955756|NCT03444805|Autoimmune diseases|autoimmune diseases
955757|NCT03444805|Systemic sclerosis|systemic sclerosis
955758|NCT03444805|Autologous hematopoietic stem cell transplant (AHSCT)|autologous hematopoietic stem cell transplant (ahsct)
955759|NCT03444805|Post-AHSCT management|post-ahsct management
955760|NCT03444805|Immune reconstitution|immune reconstitution
955761|NCT03444727|vulvar biopsy|vulvar biopsy
955762|NCT03444727|ice|ice
955763|NCT03444727|anesthesia|anesthesia
955764|NCT03444727|pain|pain
955765|NCT03444727|vulva|vulva
955766|NCT03444714|intratumoral|intratumoral
955767|NCT03444701|Solid tumors|solid tumors
955768|NCT03444701|Her2-negative breast cancer|her2-negative breast cancer
955769|NCT03444701|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
955770|NCT03444688|Robotic Walker|robotic walker
955771|NCT03444675|Transplantation; intestine|transplantation; intestine
955772|NCT03444675|endoscopy|endoscopy
955773|NCT03444675|severity score|severity score
955774|NCT03444675|transplant rejection|transplant rejection
955775|NCT03444675|transplant; complications|transplant; complications
955776|NCT03444649|AML|aml
955777|NCT03444649|Epacadostat|epacadostat
955778|NCT03444649|Idarubicin|idarubicin
955779|NCT03444649|Cytarabine|cytarabine
955780|NCT03444636|Multimodal analgesia|multimodal analgesia
955781|NCT03444636|Thoracic epidural|thoracic epidural
955782|NCT03444636|Postoperative pain|postoperative pain
955783|NCT03444636|Postoperative Complications|postoperative complications
955784|NCT03444636|Patient Satisfaction|patient satisfaction
955785|NCT03444623|predictive factor|predictive factor
955786|NCT03444623|prognostic factor|prognostic factor
955787|NCT03444584|0382, T2DM|0382, t2dm
955788|NCT03444558|metabolic parameters|metabolic parameters
955789|NCT03444558|cardio-metabolic parameters|cardio-metabolic parameters
955790|NCT03444545|Cardiac output|cardiac output
955791|NCT03444545|Carbon dioxide|carbon dioxide
955792|NCT03444545|Intraoperative monitoring|intraoperative monitoring
955793|NCT03444545|Pulmonary blood flow|pulmonary blood flow
955794|NCT03444519|brain relaxation|brain relaxation
955795|NCT03444519|mannitol|mannitol
955796|NCT03444519|supratentorial tumours|supratentorial tumours
955797|NCT03444506|SAR|sar
955798|NCT03444454|Telerehabilitation|telerehabilitation
955799|NCT03444454|Virtual reality|virtual reality
955800|NCT03444454|Quality of life|quality of life
955801|NCT03444441|Foot|foot
955802|NCT03444441|Ankle|ankle
955803|NCT03444441|Finnish|finnish
955804|NCT03444441|Validation|validation
955805|NCT03444441|FAOS|faos
955806|NCT03444441|EFAS|efas
955807|NCT03444441|LEFS|lefs
955808|NCT03444441|FAAM|faam
955809|NCT03444441|VAS-FA|vas-fa
955810|NCT03444441|MOxFA|moxfa
955811|NCT03444415|Obesity|obesity
955812|NCT03444415|Children|children
955813|NCT03444415|Pregnancy|pregnancy
955814|NCT03444415|Motivational interview|motivational interview
955815|NCT03444415|Family Care|family care
955816|NCT03444415|Primary Care|primary care
955817|NCT03444402|CKD-381|ckd-381
955818|NCT03444402|Nexium|nexium
955819|NCT03444376|keytruda|keytruda
955820|NCT03444376|pembrolizumab|pembrolizumab
955821|NCT03444376|GX-188E|gx-188e
955822|NCT03444363|laser|laser
955823|NCT03444363|periodontal treatment|periodontal treatment
955824|NCT03444363|systemic inflammation|systemic inflammation
955825|NCT03444363|glycemic control|glycemic control
955826|NCT03444350|Periodontal treatment|periodontal treatment
955827|NCT03444350|Ozone|ozone
955828|NCT03444350|oxidative stress|oxidative stress
955829|NCT03444337|ablation|ablation
955830|NCT03444337|atrial fibrillation|atrial fibrillation
955831|NCT03444337|FIRM|firm
955832|NCT03444324|Fibrinogen|fibrinogen
955833|NCT03444311|microbiota|microbiota
955834|NCT03444311|ulcerative colitis|ulcerative colitis
955835|NCT03444311|fiber|fiber
955836|NCT03444311|probiotic|probiotic
955837|NCT03444285|Thermotherapy|thermotherapy
955838|NCT03444285|warm-up|warm-up
955839|NCT03444285|extensibility|extensibility
955840|NCT03444285|pain|pain
955841|NCT03444285|athletes|athletes
955842|NCT03444259|Atrial fibrillation|atrial fibrillation
955843|NCT03444259|Aortic stenosis|aortic stenosis
955844|NCT03444259|Coronary artery disease|coronary artery disease
955845|NCT03444259|Cardiac surgery|cardiac surgery
955846|NCT03444259|Atrial appendage|atrial appendage
955847|NCT03444207|obesity|obesity
955848|NCT03444207|inflammation|inflammation
955849|NCT03444207|C-reactive protein|c-reactive protein
955850|NCT03444207|training|training
955851|NCT03444207|tumor necrosis factor alfa|tumor necrosis factor alfa
955852|NCT03444194|liver metastasis|liver metastasis
955853|NCT03444194|chemotherapy|chemotherapy
955854|NCT03444194|liver biopsy|liver biopsy
955855|NCT03444194|colorectal caner|colorectal caner
955856|NCT03444168|lumbar spine surgery|lumbar spine surgery
957250|NCT03436004|Colonoscopy|colonoscopy
955857|NCT03444168|lumbar failed back surgery syndrome|lumbar failed back surgery syndrome
955858|NCT03444142|Diabetes|diabetes
955859|NCT03444142|Hyperglycemia|hyperglycemia
955860|NCT03444142|ABPM|abpm
955861|NCT03444142|Variability of blood pressure|variability of blood pressure
955862|NCT03444142|Exenatide LAR or Dulaglutide 0.75mg|exenatide lar or dulaglutide 0.75mg
955863|NCT03444142|Glucagon-like peptide analogues type 1 (GLP1).|glucagon-like peptide analogues type 1 (glp1).
955864|NCT03444103|IL-6 blockade|il-6 blockade
955865|NCT03444064|Islet transplantation|islet transplantation
955866|NCT03444064|Diabetes treatment|diabetes treatment
955867|NCT03444064|PolyTregs|polytregs
955868|NCT03444064|Immunotherapy|immunotherapy
955869|NCT03444051|EUS-FNB|eus-fnb
955870|NCT03444051|comparative study|comparative study
955871|NCT03443999|Coronary Artery Disease|coronary artery disease
955872|NCT03443999|Sirolimus-eluting Stent|sirolimus-eluting stent
955873|NCT03443999|Biodegradable Polymers|biodegradable polymers
955874|NCT03443986|Diabetes Mellitus|diabetes mellitus
955875|NCT03443986|Blood Flow Velocity|blood flow velocity
955876|NCT03443986|Skin Temperature|skin temperature
955877|NCT03443986|Postural Balance|postural balance
955878|NCT03443986|Combined Modality Therapy|combined modality therapy
955879|NCT03443986|Vibration|vibration
955880|NCT03443986|Resistance Training|resistance training
955881|NCT03443934|Hemodynamic assessments|hemodynamic assessments
955882|NCT03443934|Echocardiography|echocardiography
955883|NCT03443934|MR-Elastography|mr-elastography
955884|NCT03443934|Liver vein catheterization|liver vein catheterization
955885|NCT03443934|Liver Cirrhosis|liver cirrhosis
955886|NCT03443934|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
955887|NCT03443934|Cirrhotic complications|cirrhotic complications
955888|NCT03443934|Magnetic Resonance Imaging|magnetic resonance imaging
955889|NCT03443921|Artery Divestment Technique|artery divestment technique
955890|NCT03443921|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
955891|NCT03443921|Neoadjuvant Therapy|neoadjuvant therapy
956094|NCT03442920|saliva|saliva
955892|NCT03443921|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
955893|NCT03443908|lung cancer|lung cancer
955894|NCT03443908|non small cell lung cancer|non small cell lung cancer
955895|NCT03443908|nsclc|nsclc
955896|NCT03443908|small cell lung cancer|small cell lung cancer
955897|NCT03443908|sclc|sclc
955898|NCT03443908|metastic lung mass|metastic lung mass
955899|NCT03443908|sleep disordered breathing|sleep disordered breathing
955900|NCT03443908|sdb|sdb
955901|NCT03443908|obstructive sleep apnea|obstructive sleep apnea
955902|NCT03443830|Zika virus|zika virus
955903|NCT03443830|Tyzivumab|tyzivumab
955904|NCT03443830|Monoclonal antibody|monoclonal antibody
955905|NCT03443830|Infectious diseases|infectious diseases
955906|NCT03443830|Phase 1A first in human study|phase 1a first in human study
955907|NCT03443830|Singapore|singapore
955908|NCT03443817|Feasibility|feasibility
955909|NCT03443817|tele-rehabilitation|tele-rehabilitation
955910|NCT03443817|follow-up|follow-up
955911|NCT03443817|COPD|copd
955912|NCT03443791|CMV|cmv
955913|NCT03443791|Congenital Birth|congenital birth
955914|NCT03443791|Infectious Diseases|infectious diseases
955915|NCT03443778|tonsillectomy pain|tonsillectomy pain
955916|NCT03443778|dexamethasone|dexamethasone
955917|NCT03443778|bupivacaine|bupivacaine
955918|NCT03443739|Intermittent Fasting|intermittent fasting
955919|NCT03443739|Religious Fast|religious fast
955920|NCT03443739|Bahá'í|bahá'í
955921|NCT03443739|Hydration|hydration
955922|NCT03443739|Calorimetry|calorimetry
955923|NCT03443739|Microdialysis|microdialysis
955924|NCT03443739|circadian clock|circadian clock
955925|NCT03443739|circadian rhythm|circadian rhythm
955926|NCT03443739|spirituality|spirituality
955927|NCT03443739|self-efficacy|self-efficacy
955928|NCT03443726|Lower third molar extraction|lower third molar extraction
955929|NCT03443726|Infiltration anesthesia|infiltration anesthesia
955930|NCT03443726|Articaine|articaine
955931|NCT03443700|SCI|sci
955932|NCT03443700|gait|gait
955933|NCT03443700|incomplete motor SCI|incomplete motor sci
955934|NCT03443700|robotic gait training|robotic gait training
955935|NCT03443700|locomotor training|locomotor training
955936|NCT03443700|walking training|walking training
955937|NCT03443700|rehabilitation|rehabilitation
955938|NCT03443700|exoskeleton|exoskeleton
955939|NCT03443700|EKSO|ekso
955940|NCT03443700|EKSO-GT|ekso-gt
955941|NCT03443700|neuroplasticity|neuroplasticity
955942|NCT03443700|brain cortical plasticity|brain cortical plasticity
955943|NCT03443661|5-Fluorouracil|5-fluorouracil
955944|NCT03443661|rectal cancer|rectal cancer
955945|NCT03443661|irinotecan|irinotecan
955946|NCT03443661|oxaliplatin|oxaliplatin
955947|NCT03443661|neoadjuvant chemotherapy|neoadjuvant chemotherapy
955948|NCT03443622|SC-43|sc-43
955949|NCT03443622|refractory solid tumor|refractory solid tumor
955950|NCT03443622|Phase I|phase i
955951|NCT03443609|occult prostate cancer recurrence|occult prostate cancer recurrence
955952|NCT03443609|PSA|psa
955953|NCT03443609|68Ga-HBED-CC-PSMA PET / CT|68ga-hbed-cc-psma pet / ct
955954|NCT03443596|stroke|stroke
955955|NCT03443596|blood pressure|blood pressure
955956|NCT03443596|hemodynamic|hemodynamic
955957|NCT03443570|immune thrombocytopenia|immune thrombocytopenia
955958|NCT03443570|Thrombocytopenia|thrombocytopenia
955959|NCT03443557|Oral nutrition supplement|oral nutrition supplement
955960|NCT03443557|malnutrition|malnutrition
955961|NCT03443557|mortality|mortality
955962|NCT03443544|fournier's|fournier's
955963|NCT03443544|gangrene|gangrene
955964|NCT03443531|Bronchiectasis|bronchiectasis
955965|NCT03443531|Traditional Chinese Medicine|traditional chinese medicine
955966|NCT03443518|EVAR, analgesia|evar, analgesia
955967|NCT03443505|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
955968|NCT03443505|Acute exacerbation|acute exacerbation
955969|NCT03443505|Neural respiratory drive|neural respiratory drive
955970|NCT03443505|Parasternal electromyography|parasternal electromyography
955971|NCT03443505|Respiratory physiology|respiratory physiology
955972|NCT03443479|Non invasive ventilation|non invasive ventilation
955973|NCT03443479|BiPAP|bipap
955974|NCT03443479|High-Flow Oxygen Therapy|high-flow oxygen therapy
955975|NCT03443479|High-Flow Nasal Cannula|high-flow nasal cannula
955976|NCT03443479|COPD|copd
955977|NCT03443479|Hypercapnia|hypercapnia
955978|NCT03443479|Hypercapnic Respiratory failure|hypercapnic respiratory failure
955979|NCT03443479|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
955980|NCT03443466|Electric stimulation|electric stimulation
955981|NCT03443466|Cesarean section|cesarean section
955982|NCT03443427|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
955983|NCT03443427|Moraxella catarrhalis|moraxella catarrhalis
955984|NCT03443427|Safety|safety
955985|NCT03443427|Third vaccine dose|third vaccine dose
955986|NCT03443427|Vaccination|vaccination
955987|NCT03443427|Immunogenicity|immunogenicity
955988|NCT03443414|COPD, bronchodilation, FEV1|copd, bronchodilation, fev1
955989|NCT03443388|head injury from seizures|head injury from seizures
955990|NCT03443388|seizures resulting in fall|seizures resulting in fall
955991|NCT03443388|helmet for seizures|helmet for seizures
955992|NCT03443388|novel helmet design|novel helmet design
955993|NCT03443388|inflatable helmet|inflatable helmet
955994|NCT03443388|Hovding Inc|hovding inc
955995|NCT03443388|helmet|helmet
955996|NCT03443388|device|device
955997|NCT03443375|Older adults|older adults
955998|NCT03443375|Physical function|physical function
955999|NCT03443375|Muscle mass|muscle mass
956000|NCT03443375|Short-term memory|short-term memory
956001|NCT03443375|Executive function|executive function
956002|NCT03443375|Blood Pressure|blood pressure
956003|NCT03443375|Resistance training|resistance training
956004|NCT03443375|Exercise training|exercise training
956005|NCT03443375|Periodization|periodization
956006|NCT03443362|Chronic Urticaria|chronic urticaria
956007|NCT03443362|Endothelial cells|endothelial cells
956008|NCT03443349|Delivering Women|delivering women
956009|NCT03443323|Executive Function|executive function
956010|NCT03443323|Behavioral Research|behavioral research
956011|NCT03443323|Cost Analysis|cost analysis
956012|NCT03443323|Students|students
956013|NCT03443323|Schools|schools
956014|NCT03443323|Randomized Controlled Trial|randomized controlled trial
956015|NCT03443323|Behavior Therapy|behavior therapy
956016|NCT03443310|DVT|dvt
956017|NCT03443310|TKA|tka
956018|NCT03443310|THA|tha
956019|NCT03443310|Hip Fracture|hip fracture
956020|NCT03443310|High risk|high risk
956021|NCT03443310|Ultrasound|ultrasound
956022|NCT03443310|U/S|u/s
956023|NCT03443284|Total Knee Arthroplasty|total knee arthroplasty
956024|NCT03443284|Total Hip Arthroplasty|total hip arthroplasty
956025|NCT03443284|Total Knee Replacement|total knee replacement
956026|NCT03443284|Total Hip Replacement|total hip replacement
956027|NCT03443284|Hospital Care Plan|hospital care plan
956028|NCT03443284|mHealth|mhealth
956029|NCT03443271|transversus abdominis plane block|transversus abdominis plane block
956030|NCT03443271|abdominal hysterectomy|abdominal hysterectomy
956031|NCT03443271|stress response|stress response
956032|NCT03443219|Airway Management|airway management
956033|NCT03443219|Extraglottic airway device|extraglottic airway device
956034|NCT03443219|Laryngeal mask airway|laryngeal mask airway
956035|NCT03443219|Spritztube|spritztube
956036|NCT03443206|adolescent|adolescent
956037|NCT03443206|mental health|mental health
956038|NCT03443206|social media|social media
956039|NCT03443193|aerobic exercise training|aerobic exercise training
956040|NCT03443193|periodization|periodization
956041|NCT03443193|cerebral oxygenation and perfusion|cerebral oxygenation and perfusion
956042|NCT03443193|cognition|cognition
956043|NCT03443180|Siblings|siblings
956044|NCT03443167|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
956045|NCT03443167|Teaching Material|teaching material
956046|NCT03443167|Primary education|primary education
956047|NCT03443154|Cerclage|cerclage
956048|NCT03443154|Preterm birth|preterm birth
956049|NCT03443128|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
956050|NCT03443128|Recurrent|recurrent
956051|NCT03443128|Childhood|childhood
956052|NCT03443128|Adolescent|adolescent
956053|NCT03443128|Treatment|treatment
956054|NCT03443089|medroxyprogesterone acetate|medroxyprogesterone acetate
956055|NCT03443089|estradiol cypionate|estradiol cypionate
956056|NCT03443089|bioavailability|bioavailability
956057|NCT03443089|monthly contraceptive|monthly contraceptive
956058|NCT03443063|severe renal impairment|severe renal impairment
956059|NCT03443063|lemborexant|lemborexant
956060|NCT03443063|normal renal function|normal renal function
956061|NCT03443063|healthy participants|healthy participants
956062|NCT03443063|metabolites|metabolites
956063|NCT03443063|E2006|e2006
956064|NCT03443063|pharmacokinetics|pharmacokinetics
956065|NCT03443037|Coma|coma
956066|NCT03443037|Disability|disability
956067|NCT03443037|amantadine|amantadine
956068|NCT03443024|Eczema|eczema
956069|NCT03442985|Multiple osteochondromas|multiple osteochondromas
956070|NCT03442985|Osteochondroma|osteochondroma
956071|NCT03442985|Palovarotene|palovarotene
956072|NCT03442985|Hereditary multiple exostoses|hereditary multiple exostoses
956073|NCT03442985|HME|hme
956074|NCT03442985|MO|mo
956075|NCT03442985|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
956076|NCT03442985|Retinoic acid receptor agonist|retinoic acid receptor agonist
956077|NCT03442972|Intestinal lipoprotein|intestinal lipoprotein
956078|NCT03442972|Duodenal biopsy|duodenal biopsy
956079|NCT03442972|Gut Peptide|gut peptide
956080|NCT03442972|Chylomicrons|chylomicrons
956081|NCT03442959|Small intestine neuroendocrine tumor|small intestine neuroendocrine tumor
956082|NCT03442959|palliative surgery|palliative surgery
956083|NCT03442946|nutrition guidelines|nutrition guidelines
956084|NCT03442946|critical care|critical care
956085|NCT03442946|cardiovascular|cardiovascular
956086|NCT03442946|nutrition therapy|nutrition therapy
956087|NCT03442933|Muscle Fatigue|muscle fatigue
956088|NCT03442933|Cycling|cycling
956089|NCT03442933|MTB|mtb
956090|NCT03442933|Tensiomiography|tensiomiography
956091|NCT03442920|obesity|obesity
956092|NCT03442920|periodontal diseases|periodontal diseases
956093|NCT03442920|gingival crevicular fluid|gingival crevicular fluid
956096|NCT03442894|Shoulder pain|shoulder pain
956097|NCT03442894|Subacromial|subacromial
956098|NCT03442894|bursitis|bursitis
956099|NCT03442894|rotator cuff|rotator cuff
956100|NCT03442894|tendinopathy|tendinopathy
956101|NCT03442894|dry needling|dry needling
956102|NCT03442894|myofascial trigger point|myofascial trigger point
956103|NCT03442855|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
956104|NCT03442829|sweet taste, food preferences, food intake|sweet taste, food preferences, food intake
956105|NCT03442803|sedation|sedation
956106|NCT03442803|Emergency Department|emergency department
956107|NCT03442803|Target Controlled infusion|target controlled infusion
956108|NCT03442803|propofol|propofol
956109|NCT03442790|CVC confirmation|cvc confirmation
956110|NCT03442790|Agitated Saline|agitated saline
956112|NCT03442738|ADR|adr
956113|NCT03442738|adenoma|adenoma
956114|NCT03442738|polyp|polyp
956115|NCT03442738|colon|colon
956116|NCT03442738|screening|screening
956117|NCT03442738|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
956118|NCT03442738|cap|cap
956119|NCT03442738|endoscopy|endoscopy
956120|NCT03442738|colonoscopy|colonoscopy
956121|NCT03442738|private practice|private practice
956122|NCT03442712|obesity|obesity
956123|NCT03442712|weight loss|weight loss
956124|NCT03442712|ear acupressure|ear acupressure
956125|NCT03442712|smartphone application|smartphone application
956126|NCT03442699|cognitive behavioral therapy|cognitive behavioral therapy
956127|NCT03442699|suicidal ideology|suicidal ideology
956128|NCT03442699|suicidal behavior|suicidal behavior
956129|NCT03442673|Multiple Myeloma|multiple myeloma
956130|NCT03442673|Vinorelbine|vinorelbine
956131|NCT03442673|Gemcitabine|gemcitabine
956132|NCT03442673|G-CSF|g-csf
956133|NCT03442673|ASCT|asct
956134|NCT03442634|bowel movements|bowel movements
956135|NCT03442634|cesarean section|cesarean section
956136|NCT03442634|oral hydration|oral hydration
956137|NCT03442543|sentinel lymph node biopsy|sentinel lymph node biopsy
956138|NCT03442530|pregnancy, smoking cessation, tobacco, preterm birth, ToPIC|pregnancy, smoking cessation, tobacco, preterm birth, topic
956139|NCT03442517|group-based counseling|group-based counseling
956140|NCT03442517|phone counseling|phone counseling
956141|NCT03442517|conference calls|conference calls
956142|NCT03442504|metastatic Breast cancer|metastatic breast cancer
956143|NCT03442504|FES PET/CT|fes pet/ct
956144|NCT03442504|menopausal patients|menopausal patients
956145|NCT03442504|recurrence after a 1st line of hormone therapy|recurrence after a 1st line of hormone therapy
956146|NCT03442491|Postpartum Hemorrhage|postpartum hemorrhage
956147|NCT03442491|Hayman's Haemostatic Suture|hayman's haemostatic suture
956148|NCT03442465|18-014|18-014
956149|NCT03442465|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
956150|NCT03442439|Family Nurture Intervention|family nurture intervention
956151|NCT03442439|Martha G. Welch MD|martha g. welch md
956152|NCT03442439|Randomized Controlled Trial|randomized controlled trial
956153|NCT03442439|Preschool Intervention|preschool intervention
956154|NCT03442439|Pre-school Intervention|pre-school intervention
956353|NCT03441139|Musculoskeletal metastasis|musculoskeletal metastasis
956155|NCT03442439|Multiple Family Group Intervention|multiple family group intervention
956156|NCT03442439|Emotional Connection|emotional connection
956157|NCT03442439|Co-regulation|co-regulation
956158|NCT03442426|Primary Health Care|primary health care
956159|NCT03442426|Frail Elderly|frail elderly
956160|NCT03442426|Qualitative Methods|qualitative methods
956161|NCT03442426|Quantitative Methods|quantitative methods
956162|NCT03442426|Cost-Benefit Analysis|cost-benefit analysis
956163|NCT03442426|Patient Participation|patient participation
956164|NCT03442400|Coronary Artery Stenoses|coronary artery stenoses
956165|NCT03442400|Aortic Stenosis|aortic stenosis
956166|NCT03442374|Multifidus|multifidus
956167|NCT03442374|Muscle|muscle
956168|NCT03442374|Degeneration|degeneration
956169|NCT03442374|Lumbar Spine|lumbar spine
956170|NCT03442374|Disc|disc
956171|NCT03442348|Omega 3|omega 3
956172|NCT03442348|Fibre|fibre
956173|NCT03442348|Gut microbiome|gut microbiome
956174|NCT03442348|Metabolic profile|metabolic profile
956175|NCT03442348|Dietary intervention|dietary intervention
956176|NCT03442348|Randomised Control Trial|randomised control trial
956177|NCT03442335|embryo implantation|embryo implantation
956178|NCT03442335|endometrial receptivity|endometrial receptivity
956179|NCT03442335|chromohysteroscopy|chromohysteroscopy
956180|NCT03442335|transcriptomics|transcriptomics
956181|NCT03442335|proteomics|proteomics
956182|NCT03442335|metabolomics|metabolomics
956183|NCT03442335|implantation window|implantation window
956184|NCT03442335|luteal phase|luteal phase
956185|NCT03442322|long term care residents|long term care residents
956186|NCT03442322|nursing home care|nursing home care
956187|NCT03442309|dental caries|dental caries
956188|NCT03442309|caries arrest|caries arrest
956189|NCT03442309|caries prevention|caries prevention
956190|NCT03442309|quality of life|quality of life
956191|NCT03442309|silver diamine fluoride|silver diamine fluoride
956192|NCT03442309|sealants|sealants
956193|NCT03442309|interim therapeutic restorations|interim therapeutic restorations
956194|NCT03442309|student achievement|student achievement
956195|NCT03442309|school attendance|school attendance
956196|NCT03442283|Supplements, Cardiovascular Diseases, All-cause mortality, Meta-Analysis|supplements, cardiovascular diseases, all-cause mortality, meta-analysis
956197|NCT03442270|Serrated Adenoma, Colonoscopy|serrated adenoma, colonoscopy
956198|NCT03442257|Hypertension|hypertension
956199|NCT03442257|Text Messaging|text messaging
956200|NCT03442257|Primary Prevention|primary prevention
956201|NCT03442257|Cardiovascular Risk Factor|cardiovascular risk factor
956202|NCT03442257|Primary Health Care|primary health care
956203|NCT03442257|Health Promotion|health promotion
956204|NCT03442231|osteoarthritis|osteoarthritis
956205|NCT03442231|traumatic arthritis|traumatic arthritis
956206|NCT03442231|avascular necrosis|avascular necrosis
956207|NCT03442218|Cesarean|cesarean
956208|NCT03442218|Operative site infection|operative site infection
956209|NCT03442218|Vaginal wash|vaginal wash
956210|NCT03442218|Clorhexidine|clorhexidine
956211|NCT03442218|Endometritis|endometritis
956212|NCT03442205|Common Bile Duct Stone;|common bile duct stone;
956213|NCT03442205|Laparoscopic Common Bile Duct Exploration;|laparoscopic common bile duct exploration;
956214|NCT03442205|ERCP;|ercp;
956215|NCT03442192|PrEP|prep
956216|NCT03442192|virtual|virtual
956217|NCT03442192|adherence|adherence
956218|NCT03442192|retention|retention
956219|NCT03442179|Aging|aging
956220|NCT03442179|Anesthesia|anesthesia
956221|NCT03442179|EEG monitoring|eeg monitoring
956222|NCT03442179|Burst suppression|burst suppression
956223|NCT03442140|COPD|copd
956224|NCT03442140|Shortness of breath|shortness of breath
956225|NCT03442140|Harmonica|harmonica
956226|NCT03442114|shared decision making|shared decision making
956227|NCT03442114|parent-provider communication|parent-provider communication
956228|NCT03442114|hydroxyurea|hydroxyurea
956229|NCT03442114|sickle cell disease|sickle cell disease
956230|NCT03442075|Cancer of Prostate|cancer of prostate
956231|NCT03442075|Analgesic method|analgesic method
956232|NCT03442062|quality improvement|quality improvement
956233|NCT03442062|HPV vaccine|hpv vaccine
956234|NCT03442049|Multiple Sclerosis|multiple sclerosis
956235|NCT03442049|Gait|gait
956236|NCT03442049|Spinal Stabilization Exercises|spinal stabilization exercises
956237|NCT03442049|Plantar Pressure Distribution|plantar pressure distribution
956238|NCT03442049|Rehabilitation|rehabilitation
956239|NCT03442036|Regional Anesthesia|regional anesthesia
956240|NCT03442036|Sciatic Nerve Block|sciatic nerve block
956241|NCT03442036|Continuous Nerve Block|continuous nerve block
956242|NCT03442036|Perineural Catheter|perineural catheter
956243|NCT03442023|Chlorhexidine|chlorhexidine
956244|NCT03442023|Gram-negative|gram-negative
956245|NCT03442023|Colonization|colonization
956246|NCT03442010|Emergency department|emergency department
956247|NCT03442010|Clinical Pharmacist|clinical pharmacist
956248|NCT03442010|Adverse drug event|adverse drug event
956249|NCT03441997|exercise|exercise
956250|NCT03441997|low intensity exercise|low intensity exercise
956251|NCT03441997|pain|pain
956252|NCT03441997|fatigue|fatigue
956253|NCT03441997|sleep problems|sleep problems
956254|NCT03441984|Pediatric dispersible tablets|pediatric dispersible tablets
956255|NCT03441984|Bioavailability|bioavailability
956256|NCT03441958|hematopoietic stem cell transplant|hematopoietic stem cell transplant
956257|NCT03441958|Expanded cord blood|expanded cord blood
956258|NCT03441945|Magnetic|magnetic
956259|NCT03441945|Capsule Endoscopy|capsule endoscopy
956260|NCT03441945|enhance|enhance
956261|NCT03441945|gastric emptying|gastric emptying
956262|NCT03441932|Dysphagia|dysphagia
956263|NCT03441932|Pharyngeal residue scale|pharyngeal residue scale
956264|NCT03441932|Stroke|stroke
956265|NCT03441932|Pneumonia|pneumonia
956266|NCT03441893|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy
956267|NCT03441867|Cognitive Behavioral Therapy|cognitive behavioral therapy
956268|NCT03441867|Veterans|veterans
956269|NCT03441867|Quality of Life|quality of life
956270|NCT03441867|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
956271|NCT03441867|Convulsion, Non-Epileptic|convulsion, non-epileptic
956272|NCT03441867|civilians|civilians
956273|NCT03441854|Gas exchange|gas exchange
956274|NCT03441854|Non invasive ventilation|non invasive ventilation
956275|NCT03441854|Liver transplantation|liver transplantation
956276|NCT03441841|local anesthetics|local anesthetics
956277|NCT03441841|pharmacokinetics|pharmacokinetics
956278|NCT03441841|nanotechnology|nanotechnology
956279|NCT03441815|Healthy volunteers|healthy volunteers
956280|NCT03441815|Phase I|phase i
956281|NCT03441815|Histamine glutarimide|histamine glutarimide
956282|NCT03441815|PHARMENTERPRISES|pharmenterprises
956283|NCT03441776|TBI|tbi
956284|NCT03441776|Rehabilitation|rehabilitation
956285|NCT03441776|Vestibular|vestibular
956286|NCT03441776|Dizziness|dizziness
1650530|NCT00194701|exercise|exercise
956287|NCT03441763|Foot pressure, Obese, and normal Subjects|foot pressure, obese, and normal subjects
956288|NCT03441737|Aerobic exercise|aerobic exercise
956289|NCT03441737|Antisaccades|antisaccades
956290|NCT03441737|Urge to Smoke|urge to smoke
956291|NCT03441737|Adults|adults
956292|NCT03441672|Prenatal Screening|prenatal screening
956293|NCT03441672|Interactive educational technology|interactive educational technology
956294|NCT03441633|atrial fibrillation|atrial fibrillation
956295|NCT03441633|apixaban|apixaban
956296|NCT03441633|stroke|stroke
956297|NCT03441594|Food Insecurity|food insecurity
956298|NCT03441581|IBS-D|ibs-d
956299|NCT03441581|BAM|bam
956300|NCT03441555|Cancer|cancer
956301|NCT03441555|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
956302|NCT03441555|relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
956303|NCT03441555|refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
956304|NCT03441542|Care cascade|care cascade
956305|NCT03441542|Patient navigation services|patient navigation services
956306|NCT03441542|Injection drug users|injection drug users
956307|NCT03441542|Opioid substitution therapy|opioid substitution therapy
956308|NCT03441490|Learning Support|learning support
956309|NCT03441490|Chat|chat
956310|NCT03441490|Adolescents|adolescents
956311|NCT03441464|Fluorescence|fluorescence
956312|NCT03441464|Prostate|prostate
956313|NCT03441464|Cancer detection|cancer detection
956314|NCT03441451|Bariatric Surgery|bariatric surgery
956315|NCT03441438|alcohol sensitivity|alcohol sensitivity
956316|NCT03441438|red wine|red wine
956317|NCT03441438|aerd|aerd
956318|NCT03441425|CRM Skills|crm skills
956319|NCT03441425|ACLS|acls
956320|NCT03441425|Simulation|simulation
956321|NCT03441425|Stress|stress
956322|NCT03441399|Medication Adherence|medication adherence
956323|NCT03441360|eribulin mesylate|eribulin mesylate
956324|NCT03441360|pediatric|pediatric
956325|NCT03441347|Physical therapy|physical therapy
956326|NCT03441347|Occupational therapy|occupational therapy
956327|NCT03441347|Rehabilitation|rehabilitation
956328|NCT03441347|Motor control|motor control
956329|NCT03441308|Dieting|dieting
956330|NCT03441308|learning to eat|learning to eat
956331|NCT03441308|group treatment|group treatment
956332|NCT03441295|ACL|acl
956333|NCT03441269|Emergency Medicine|emergency medicine
956334|NCT03441269|Acute Pain|acute pain
956335|NCT03441269|Oral Ibuprofen|oral ibuprofen
956336|NCT03441230|stomach|stomach
956337|NCT03441230|motility|motility
956338|NCT03441217|Duration of labor|duration of labor
956339|NCT03441217|Hyoscine butylbromide|hyoscine butylbromide
956340|NCT03441204|COPD|copd
956341|NCT03441204|Long-term oxygen therapy (LTOT)|long-term oxygen therapy (ltot)
956342|NCT03441204|Registry|registry
956343|NCT03441204|Registry-based randomized controlled trial (R-RCT)|registry-based randomized controlled trial (r-rct)
956344|NCT03441204|Treatment duration|treatment duration
956345|NCT03441204|Mortality|mortality
956346|NCT03441165|ACL|acl
956347|NCT03441165|MAT|mat
956348|NCT03441165|REVISION|revision
956349|NCT03441165|LAXITY|laxity
956350|NCT03441152|Mild Cognitive Impairment|mild cognitive impairment
956351|NCT03441152|Neuromodulation|neuromodulation
956352|NCT03441139|Randomized controlled trial|randomized controlled trial
956354|NCT03441139|Cancer pain|cancer pain
956355|NCT03441139|Percutaneous cryotherapy|percutaneous cryotherapy
956356|NCT03441139|Medical supportive care|medical supportive care
956357|NCT03441126|Diagnostic Stewardship|diagnostic stewardship
956358|NCT03441126|Pediatric|pediatric
956359|NCT03441126|Blood Culture Test|blood culture test
956360|NCT03441100|T-Cell therapy|t-cell therapy
956361|NCT03441100|Immunotherapy|immunotherapy
956362|NCT03441100|Adoptive cellular therapy|adoptive cellular therapy
956363|NCT03441100|T-Cell Receptor|t-cell receptor
956364|NCT03441100|Cell Therapy|cell therapy
956365|NCT03441100|Cytotherapy|cytotherapy
956366|NCT03441100|IMA202|ima202
956367|NCT03441087|transvaginal ultrasonography|transvaginal ultrasonography
956368|NCT03441087|hysteroscopy|hysteroscopy
956369|NCT03441087|abnormal uterine bleeding|abnormal uterine bleeding
956370|NCT03441061|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
956371|NCT03441061|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
956373|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin
956374|NCT03441061|CMC-544|cmc-544
956375|NCT03441048|Acute myeloid leukemia|acute myeloid leukemia
956376|NCT03441048|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
956377|NCT03441048|CLAG-M|clag-m
956378|NCT03441048|Lintuzumab|lintuzumab
956379|NCT03441022|Cardioversion|cardioversion
956380|NCT03441022|BodyGuardian|bodyguardian
956381|NCT03441022|Amiigo Wristband|amiigo wristband
956382|NCT03441009|PSH, Rehabilitation, Medication, ANS|psh, rehabilitation, medication, ans
956383|NCT03440996|toothpaste|toothpaste
956384|NCT03440983|optimize the imaging protocols|optimize the imaging protocols
956385|NCT03440983|validate technical parameters in healthy volunteers|validate technical parameters in healthy volunteers
956386|NCT03440970|Chloride homeostasisH|chloride homeostasish
956387|NCT03440957|advanced cancer|advanced cancer
956388|NCT03440957|osteopathy|osteopathy
956389|NCT03440957|pain|pain
956390|NCT03440957|bedridden|bedridden
956391|NCT03440944|vascular access|vascular access
956392|NCT03440944|midline cather|midline cather
956393|NCT03440944|ultrasound guided IV|ultrasound guided iv
956394|NCT03440918|Infection|infection
956395|NCT03440892|survivin|survivin
956396|NCT03440892|biomarker of pharmacological response|biomarker of pharmacological response
956397|NCT03440892|antirheumatic treatment|antirheumatic treatment
956398|NCT03440892|methotrexate|methotrexate
956399|NCT03440892|sulfasalazin|sulfasalazin
956400|NCT03440892|abatacept|abatacept
956401|NCT03440892|tocilizumab|tocilizumab
956402|NCT03440892|tofacitinib/baricitinib|tofacitinib/baricitinib
956403|NCT03440827|low-flow vascular malformations, scale of life's quality|low-flow vascular malformations, scale of life's quality
956404|NCT03440814|PWS|pws
956405|NCT03440814|Prader-Willi Syndrome|prader-willi syndrome
956406|NCT03440762|Screening|screening
956407|NCT03440762|Education|education
956408|NCT03440762|AFib Awareness|afib awareness
956409|NCT03440762|Stroke prevention|stroke prevention
956410|NCT03440749|rhythm|rhythm
956411|NCT03440749|serial Reaction Time Task|serial reaction time task
956412|NCT03440736|Psoriasis|psoriasis
956413|NCT03440736|Metabolic syndrome|metabolic syndrome
956414|NCT03440736|Diabetes|diabetes
956415|NCT03440736|Obesity|obesity
956416|NCT03440736|Life-style|life-style
956417|NCT03440736|Life-style intervention|life-style intervention
956418|NCT03440736|Secukinumab|secukinumab
956419|NCT03440736|CAIN457A|cain457a
956420|NCT03440736|CAIN457ADE08|cain457ade08
956421|NCT03440736|AIN457A|ain457a
956422|NCT03440736|Skin condition|skin condition
956423|NCT03440736|skin disease|skin disease
956424|NCT03440736|itching condition|itching condition
956425|NCT03440736|psoriasis vulgaris|psoriasis vulgaris
956426|NCT03440736|relapsing/remitting psoriasis|relapsing/remitting psoriasis
956427|NCT03440736|immune-mediated systemic disease|immune-mediated systemic disease
956428|NCT03440736|skin lesions|skin lesions
956429|NCT03440736|red skin lesions|red skin lesions
956430|NCT03440736|scaly patches|scaly patches
956431|NCT03440736|papules|papules
956432|NCT03440736|plaques|plaques
956433|NCT03440736|itching|itching
956434|NCT03440723|Cervical Dilation|cervical dilation
956435|NCT03440723|Dilation|dilation
956436|NCT03440723|Sterile vaginal examination|sterile vaginal examination
956437|NCT03440697|Cardiovascular Disease|cardiovascular disease
956438|NCT03440684|Core stability, hand, function, balance, strength|core stability, hand, function, balance, strength
956439|NCT03440658|brachial plexus palsy|brachial plexus palsy
956440|NCT03440658|isokinetics|isokinetics
956441|NCT03440658|shoulder|shoulder
956442|NCT03440658|strenght|strenght
956443|NCT03440606|Randomized Wait-List Control Trial|randomized wait-list control trial
956444|NCT03440606|Mindful-Compassion Art Therapy Supervision|mindful-compassion art therapy supervision
956445|NCT03440606|End-of-Life Care|end-of-life care
956446|NCT03440606|Self-Care|self-care
956447|NCT03440593|sepsis|sepsis
956448|NCT03440593|nutrition|nutrition
956449|NCT03440593|indirect calorimetry|indirect calorimetry
956450|NCT03440593|muscle thickness|muscle thickness
956451|NCT03440580|physical activity|physical activity
956452|NCT03440580|serious game|serious game
956453|NCT03440580|school intervention|school intervention
956454|NCT03440580|children|children
956455|NCT03440554|Prostate Cancer|prostate cancer
956456|NCT03440554|Restriction spectrum imaging|restriction spectrum imaging
956457|NCT03440554|Magnetic resonance imaging|magnetic resonance imaging
956458|NCT03440554|MRI|mri
956459|NCT03440554|RSI|rsi
956460|NCT03440541|Amniotic membrane|amniotic membrane
956461|NCT03440541|Psoriasis|psoriasis
956462|NCT03440541|Treatment|treatment
956463|NCT03440528|Skin ulcer, Human amniotic membrane, Treatment|skin ulcer, human amniotic membrane, treatment
956464|NCT03440515|gastrointestinal stromal tumor|gastrointestinal stromal tumor
956465|NCT03440515|skin rash|skin rash
956466|NCT03440515|imatinib|imatinib
956467|NCT03440502|spinal anaesthesia|spinal anaesthesia
956468|NCT03440502|cesarean section|cesarean section
956469|NCT03440502|diabetes mellitus|diabetes mellitus
956470|NCT03440450|Liposomal gemcitabine|liposomal gemcitabine
956471|NCT03440437|FS118|fs118
956472|NCT03440437|Immuno-oncology|immuno-oncology
956473|NCT03440437|bispecific antibody|bispecific antibody
956474|NCT03440437|check-point inhibitor|check-point inhibitor
956475|NCT03440437|dose escalation|dose escalation
956476|NCT03440437|cohort expansion|cohort expansion
956477|NCT03440437|PK|pk
956478|NCT03440437|PD|pd
956479|NCT03440437|biomarker|biomarker
956480|NCT03440424|mild hepatic impairment|mild hepatic impairment
956481|NCT03440424|moderate hepatic impairment|moderate hepatic impairment
956482|NCT03440424|lemborexant|lemborexant
956483|NCT03440424|healthy participants|healthy participants
956484|NCT03440424|metabolites|metabolites
956485|NCT03440424|E2006|e2006
956486|NCT03440424|pharmacokinetics|pharmacokinetics
956487|NCT03440411|biochemical relapse|biochemical relapse
956488|NCT03440398|Robotic Mastectomy|robotic mastectomy
956489|NCT03440398|Nipple Sparing Mastectomy|nipple sparing mastectomy
956490|NCT03440398|Conservative mastectomy|conservative mastectomy
956491|NCT03440398|Breast reconstruction|breast reconstruction
956492|NCT03440385|Crohn's Disease|crohn's disease
956493|NCT03440385|Crohn Disease|crohn disease
956494|NCT03440385|Oral|oral
956495|NCT03440385|Ozanimod|ozanimod
956496|NCT03440385|Moderately active|moderately active
956497|NCT03440385|Severely active|severely active
956498|NCT03440385|RPC01|rpc01
956499|NCT03440385|RPC01-3202|rpc01-3202
956500|NCT03440372|Crohn's Disease|crohn's disease
956501|NCT03440372|Crohn Disease|crohn disease
956502|NCT03440372|Oral|oral
956503|NCT03440372|Ozanimod|ozanimod
956504|NCT03440372|Moderately active|moderately active
956505|NCT03440372|Severely active|severely active
956506|NCT03440372|RPC01|rpc01
956507|NCT03440372|RPC01-3201|rpc01-3201
956508|NCT03440359|PCOS, crinone, vaginal progesterone, ovulation induction|pcos, crinone, vaginal progesterone, ovulation induction
956509|NCT03440346|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
956510|NCT03440346|ADHD|adhd
956511|NCT03440346|child|child
956512|NCT03440346|human|human
956513|NCT03440346|diet|diet
956514|NCT03440346|few-foods diet|few-foods diet
956515|NCT03440346|brain|brain
956516|NCT03440346|gut|gut
956517|NCT03440346|microbiota|microbiota
956518|NCT03440320|Caregiving Dyad|caregiving dyad
956519|NCT03440320|Pain-related Disability|pain-related disability
956520|NCT03440294|windsurfer|windsurfer
956521|NCT03440294|neoprene suit|neoprene suit
956522|NCT03440294|spirometry|spirometry
956523|NCT03440294|cardiopulmonary exercise testing|cardiopulmonary exercise testing
956524|NCT03440268|cardiac surgery|cardiac surgery
956525|NCT03440268|post operatory complications|post operatory complications
956526|NCT03440268|Acute kidney injury|acute kidney injury
956527|NCT03440268|N-acetylcystein|n-acetylcystein
956528|NCT03440255|Transcutaneous Vagus nerve Stimulation|transcutaneous vagus nerve stimulation
956529|NCT03440255|Generalized Anxiety Disorder|generalized anxiety disorder
956530|NCT03440255|Chronic Pain|chronic pain
956531|NCT03440255|Irritable Bowel Syndrome|irritable bowel syndrome
956532|NCT03440255|Private Practice|private practice
956533|NCT03440216|temocillin|temocillin
956534|NCT03440216|ceftriaxone|ceftriaxone
956535|NCT03440216|meropenem|meropenem
956536|NCT03440216|pharmacokinetics|pharmacokinetics
956537|NCT03440216|pharmacodynamics|pharmacodynamics
956538|NCT03440216|Intensive Care|intensive care
956539|NCT03440216|dosing|dosing
956540|NCT03440216|total concentration|total concentration
956541|NCT03440216|free concentration|free concentration
956542|NCT03440190|Bariatric surgery|bariatric surgery
956543|NCT03440190|Gastrointestinal tract|gastrointestinal tract
956544|NCT03440190|Biological availability|biological availability
956545|NCT03440190|Pharmacokinetics|pharmacokinetics
956546|NCT03440190|Methylphenidate|methylphenidate
956547|NCT03440177|Bariatric surgery|bariatric surgery
956548|NCT03440177|Gastrointestinal tract|gastrointestinal tract
956549|NCT03440177|Biological availability|biological availability
956550|NCT03440177|Pharmacokinetics|pharmacokinetics
956551|NCT03440177|Ramipril|ramipril
956552|NCT03440164|liver fibrosis|liver fibrosis
956553|NCT03440164|Hepatoprotective|hepatoprotective
956555|NCT03440151|Tongue Squamous Cell Carcinoma,|tongue squamous cell carcinoma,
956556|NCT03440151|Contralateral Submental Flap|contralateral submental flap
956557|NCT03440151|Submental Flap|submental flap
956558|NCT03440151|oncological safety|oncological safety
956559|NCT03440125|Low Back Pain|low back pain
956560|NCT03440125|Capsicum|capsicum
956561|NCT03440125|Physical Therapy|physical therapy
956562|NCT03440125|Pain|pain
956563|NCT03440112|Gait|gait
956564|NCT03440112|Balance|balance
956565|NCT03440112|GABA|gaba
956566|NCT03440112|Clarithromycin|clarithromycin
956567|NCT03440112|PET Imaging|pet imaging
956568|NCT03440112|MRI|mri
956569|NCT03440112|Mobility|mobility
956570|NCT03440099|Resistance Training|resistance training
956571|NCT03440099|Sex Differences|sex differences
956572|NCT03440086|Laparoscopic surgery|laparoscopic surgery
956573|NCT03440086|Pain|pain
956574|NCT03440086|Jackson-Pratt drain|jackson-pratt drain
956575|NCT03440073|pregnancy|pregnancy
956576|NCT03440073|pain|pain
956577|NCT03440073|pelvis|pelvis
956578|NCT03440073|spine|spine
956579|NCT03440073|manual therapy|manual therapy
956580|NCT03440060|procalcitonin|procalcitonin
956581|NCT03440060|mechanical ventilation|mechanical ventilation
956582|NCT03440060|COPD exacerbation|copd exacerbation
956583|NCT03440047|endoscopic image|endoscopic image
956584|NCT03440047|Fujifilm|fujifilm
956585|NCT03440047|Blue light imaging|blue light imaging
956586|NCT03440034|IBM|ibm
956587|NCT03440034|inclusion body myositis|inclusion body myositis
956588|NCT03440021|Noradrenalin Agents|noradrenalin agents
956589|NCT03440021|Physiological Effects of Drugs|physiological effects of drugs
956590|NCT03440021|Mood disorders|mood disorders
956591|NCT03440021|Behavioral Symptoms|behavioral symptoms
956592|NCT03439982|Hepatic encephalopathy, fecal microbiota transplant|hepatic encephalopathy, fecal microbiota transplant
956593|NCT03439969|Gingivitis|gingivitis
956594|NCT03439969|SMS|sms
956595|NCT03439969|Text messages|text messages
956596|NCT03439969|Behavior change|behavior change
956597|NCT03439969|HAPA|hapa
956598|NCT03439969|Dental Hygiene|dental hygiene
956599|NCT03439956|Obstetric outcomes|obstetric outcomes
956600|NCT03439956|Transvaginal specimen extraction|transvaginal specimen extraction
956601|NCT03439956|Gynecological laparoscopy|gynecological laparoscopy
956602|NCT03439904|pharmaceutical care|pharmaceutical care
956603|NCT03439904|adherence|adherence
956604|NCT03439852|physical activity|physical activity
956605|NCT03439839|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,
956606|NCT03439839|hemolysis|hemolysis
956607|NCT03439813|stroke|stroke
956608|NCT03439813|transient ischemic attack|transient ischemic attack
956609|NCT03439813|anxiety|anxiety
956610|NCT03439813|psychotherapy|psychotherapy
956611|NCT03439787|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
956612|NCT03439787|Anesthetics, Local|anesthetics, local
956613|NCT03439787|Pain, Postoperative|pain, postoperative
956614|NCT03439787|Nerve Block|nerve block
956615|NCT03439787|Bupivacaine|bupivacaine
956616|NCT03439787|Epinephrine|epinephrine
956617|NCT03439735|Breast Cancer|breast cancer
956618|NCT03439735|Metastatic Breast Cancer|metastatic breast cancer
956619|NCT03439735|Aromatase Inhibitors|aromatase inhibitors
956620|NCT03439735|Palbociclib|palbociclib
956621|NCT03439735|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
956622|NCT03439722|cluster headache|cluster headache
956623|NCT03439722|sleep disturbances|sleep disturbances
956624|NCT03439709|acromegaly|acromegaly
956625|NCT03439709|pituitary adenoma|pituitary adenoma
956626|NCT03439709|gamma knife radiosurgery|gamma knife radiosurgery
956627|NCT03439709|adjuvant treatment|adjuvant treatment
956628|NCT03439696|Thoracoscopy|thoracoscopy
956629|NCT03439696|VATS|vats
956630|NCT03439696|Needlescopy|needlescopy
956631|NCT03439696|Uniportal|uniportal
956632|NCT03439670|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
956633|NCT03439670|Vamorolone|vamorolone
956634|NCT03439657|HZ|hz
956635|NCT03439657|Safety|safety
956636|NCT03439657|Immunogenicity|immunogenicity
956637|NCT03439657|Shingles|shingles
956638|NCT03439657|Adults|adults
956639|NCT03439657|Prevenar 13|prevenar 13
956640|NCT03439605|Troponin-T|troponin-t
956641|NCT03439605|Haemolysis|haemolysis
956642|NCT03439579|Telehealth|telehealth
956643|NCT03439579|Remote weight loss|remote weight loss
956644|NCT03439579|Self-monitoring|self-monitoring
956645|NCT03439579|Diet|diet
956646|NCT03439579|Physical activity|physical activity
956647|NCT03439566|pain measures|pain measures
956648|NCT03439566|prediction of pain|prediction of pain
956649|NCT03439566|pain management|pain management
956650|NCT03439540|Plantago major|plantago major
956651|NCT03439540|obesity|obesity
956652|NCT03439540|mineral content|mineral content
956653|NCT03439540|adipose tissue|adipose tissue
956654|NCT03439527|Muscle Precursor Cells|muscle precursor cells
956655|NCT03439514|cardiomyopathy|cardiomyopathy
956656|NCT03439514|Lamin Type A|lamin type a
956657|NCT03439514|heart failure|heart failure
956658|NCT03439514|ARRY-797|arry-797
956659|NCT03439488|First in Human|first in human
956660|NCT03439488|Healthy Volunteers|healthy volunteers
956661|NCT03439488|Hepatitis B Virus|hepatitis b virus
956662|NCT03439488|JNJ-64530440|jnj-64530440
956663|NCT03439449|History taking, Risk stratification|history taking, risk stratification
956664|NCT03439410|Internal medicine|internal medicine
956665|NCT03439410|Chronic disease|chronic disease
956666|NCT03439410|Healthcare expenditure|healthcare expenditure
956667|NCT03439371|Acute Myeloid Leukemia|acute myeloid leukemia
956668|NCT03439371|Micro-transplantation|micro-transplantation
956669|NCT03439371|Elderly|elderly
956670|NCT03439371|Graft-versus-leukemia|graft-versus-leukemia
956671|NCT03439358|Epidural top-up|epidural top-up
956672|NCT03439358|Shivering|shivering
956673|NCT03439358|Magnesium|magnesium
956674|NCT03439332|Highly infiltrative|highly infiltrative
956675|NCT03439332|Deeply invasive|deeply invasive
956676|NCT03439332|Strong vascular proliferation|strong vascular proliferation
956677|NCT03439332|Robust angiogenesis|robust angiogenesis
956678|NCT03439332|Vascular heterogeneity|vascular heterogeneity
956679|NCT03439332|Perfusion Biormarker|perfusion biormarker
956680|NCT03439332|Non-Invasive Biomarker|non-invasive biomarker
956681|NCT03439332|Predictor of overall survival|predictor of overall survival
956682|NCT03439332|Predictor of progression-free survival|predictor of progression-free survival
956683|NCT03439319|MyndMove|myndmove
956684|NCT03439319|Electrical neuromodulation|electrical neuromodulation
956685|NCT03439319|conventional therapy|conventional therapy
956686|NCT03439293|Drug Therapy|drug therapy
956687|NCT03439293|Ixazomib|ixazomib
956688|NCT03439293|Daratumumab|daratumumab
956689|NCT03439293|Dexamethasone|dexamethasone
956690|NCT03439280|Drug therapy|drug therapy
956691|NCT03439254|Compensated Cirrhosis|compensated cirrhosis
956692|NCT03439254|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
956693|NCT03439254|Fatty Liver Disease|fatty liver disease
956694|NCT03439254|NASH|nash
956695|NCT03439215|ROS1 positive, NSCLC|ros1 positive, nsclc
956696|NCT03439202|Hypoxia|hypoxia
956697|NCT03439202|Baro-reflex sensitivity|baro-reflex sensitivity
956698|NCT03439202|Low-intensity exercise|low-intensity exercise
956699|NCT03439202|Hear rate variability|hear rate variability
956700|NCT03439202|EEG|eeg
956701|NCT03439202|Concentration performance|concentration performance
956702|NCT03439150|Absolute flow measurement|absolute flow measurement
956703|NCT03439150|Microvascular resistance|microvascular resistance
956704|NCT03439150|Left ventricular function|left ventricular function
956705|NCT03439111|Lycium chinense fruit|lycium chinense fruit
956706|NCT03439085|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
956707|NCT03439085|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
956708|NCT03439085|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
956709|NCT03439085|Human Papilloma Virus|human papilloma virus
956710|NCT03439085|MEDI0457|medi0457
956711|NCT03439085|Durvalumab|durvalumab
956712|NCT03439085|MEDI4736|medi4736
956713|NCT03439085|Electroporation|electroporation
956714|NCT03439085|EP|ep
956715|NCT03439072|glucagon|glucagon
956716|NCT03439072|hypoglycemia|hypoglycemia
956717|NCT03439059|Older adults|older adults
956718|NCT03439059|Sedentary behaviour|sedentary behaviour
956719|NCT03439059|Assisted living facility|assisted living facility
956720|NCT03439059|cognitive function|cognitive function
956721|NCT03439046|HHR-positive HER2-negative|hhr-positive her2-negative
956722|NCT03439046|advanced breast cancer|advanced breast cancer
956723|NCT03439046|LEE011|lee011
956724|NCT03439046|ribociclib|ribociclib
956725|NCT03439046|letrozole|letrozole
956726|NCT03439046|CDK|cdk
956727|NCT03439046|CDK4|cdk4
956728|NCT03439046|CDK6|cdk6
956729|NCT03439046|CDK4/6|cdk4/6
956730|NCT03439046|Phase IIIb|phase iiib
956731|NCT03439046|ER-positive|er-positive
956732|NCT03439046|PR-positivel|pr-positivel
956733|NCT03439046|postmenopausal|postmenopausal
956734|NCT03439046|biomarker|biomarker
956735|NCT03439046|ctDNA|ctdna
956736|NCT03439046|liquid biopsy|liquid biopsy
956737|NCT03439033|prostate cancer|prostate cancer
956738|NCT03439007|Dehydration|dehydration
956739|NCT03438994|autism|autism
956740|NCT03438994|movement|movement
956741|NCT03438994|tablet|tablet
956742|NCT03438994|gameplay|gameplay
956743|NCT03438981|Pharmacokinetics|pharmacokinetics
956744|NCT03438981|Ceftriaxone|ceftriaxone
956745|NCT03438981|critical illness|critical illness
956746|NCT03438981|capillary leak|capillary leak
956747|NCT03438981|hypoalbuminemia|hypoalbuminemia
956748|NCT03438942|iron|iron
956749|NCT03438942|folate|folate
956750|NCT03438942|childbearing age|childbearing age
956751|NCT03438942|bioavailability|bioavailability
956752|NCT03438916|Non-selective beta-blocker|non-selective beta-blocker
956753|NCT03438916|Pharmacological respons|pharmacological respons
956754|NCT03438916|Magnetic Resonance Imaging|magnetic resonance imaging
956755|NCT03438916|Hemodynamic assessments|hemodynamic assessments
956756|NCT03438916|Echocardiography|echocardiography
956757|NCT03438916|MR-elastography|mr-elastography
956758|NCT03438916|Propranolol|propranolol
956759|NCT03438916|Liver vein catheterization|liver vein catheterization
956760|NCT03438864|Radius fracture, Interferential current, edema, pain|radius fracture, interferential current, edema, pain
956761|NCT03438838|Achalasia, LHM, Anterior fundoplication|achalasia, lhm, anterior fundoplication
956762|NCT03438773|Hispanic|hispanic
956763|NCT03438773|First time kidney recipients|first time kidney recipients
956764|NCT03438760|Language Disorders|language disorders
956765|NCT03438760|Communication Disorders|communication disorders
956766|NCT03438760|Neurobehavioral Manifestations|neurobehavioral manifestations
956767|NCT03438760|Developmental Language Disorder|developmental language disorder
956768|NCT03438760|Randomized Controlled Trial|randomized controlled trial
956769|NCT03438734|Bariatric surgery|bariatric surgery
956770|NCT03438734|Low flow anesthesia|low flow anesthesia
956771|NCT03438734|Bispectral index|bispectral index
956772|NCT03438734|Regional cerebral oximetry|regional cerebral oximetry
956773|NCT03438708|Renal Cell Carcinoma|renal cell carcinoma
956774|NCT03438708|Axitinib|axitinib
956775|NCT03438708|Nephrectomy|nephrectomy
956776|NCT03438708|Neoadjuvant|neoadjuvant
956777|NCT03438708|Clear Cell Renal Carcinoma|clear cell renal carcinoma
956778|NCT03438695|endoscopy, motorized spiral enteroscopy|endoscopy, motorized spiral enteroscopy
956779|NCT03438669|visual acuity|visual acuity
956781|NCT03438669|quality of life|quality of life
956782|NCT03438656|Depression|depression
956783|NCT03438656|Childhood adversity|childhood adversity
956784|NCT03438656|Behavioral Activation|behavioral activation
956785|NCT03438656|Reward Processing|reward processing
956787|NCT03438643|Graft versus host disease|graft versus host disease
956788|NCT03438643|Extracorporeal photopheresis|extracorporeal photopheresis
956789|NCT03438643|Immunomodulatory|immunomodulatory
956790|NCT03438630|socioeconomic factors|socioeconomic factors
956791|NCT03438630|comorbidity|comorbidity
956792|NCT03438630|replacement surgery|replacement surgery
956793|NCT03438617|Diabetes|diabetes
956794|NCT03438617|Self-Management|self-management
956795|NCT03438617|Primary Care|primary care
956796|NCT03438617|Community Health Center|community health center
956797|NCT03438617|Peer Support|peer support
956798|NCT03438617|Group Support|group support
956799|NCT03438617|Integrated Care|integrated care
956800|NCT03438617|China|china
956801|NCT03438617|Urban|urban
956802|NCT03438591|cerclage pacing|cerclage pacing
956803|NCT03438591|cerclage-CRT|cerclage-crt
956804|NCT03438591|wide QRS|wide qrs
956805|NCT03438578|Patient safety|patient safety
956806|NCT03438578|Postoperative care|postoperative care
956807|NCT03438578|Monitoring, physiologic|monitoring, physiologic
956808|NCT03438578|Safety management|safety management
956809|NCT03438565|Asahi Chikai Black 18 Neurovascular Guidewire|asahi chikai black 18 neurovascular guidewire
956810|NCT03438565|Prospective|prospective
956811|NCT03438565|Retrospective|retrospective
956812|NCT03438513|Caregivers|caregivers
956813|NCT03438513|Burden|burden
956814|NCT03438513|Coping|coping
956815|NCT03438513|Quality of life|quality of life
956816|NCT03438513|Problem solving therapy|problem solving therapy
956817|NCT03438448|Ultrasensitive Troponin T|ultrasensitive troponin t
956818|NCT03438448|MINS|mins
956819|NCT03438448|Cost-effectiveness|cost-effectiveness
956820|NCT03438448|Myocardial Ischemia|myocardial ischemia
956821|NCT03438383|Bi-PAP|bi-pap
956822|NCT03438383|BiPAP|bipap
956823|NCT03438383|morbid obesity|morbid obesity
956824|NCT03438383|anesthesia|anesthesia
956825|NCT03438383|bariatric surgery|bariatric surgery
956826|NCT03438383|sham Bi-PAP|sham bi-pap
956827|NCT03438383|sham BiPAP|sham bipap
956828|NCT03438383|postoperative complications|postoperative complications
956829|NCT03438331|Insomnia|insomnia
956830|NCT03438331|Depression|depression
956831|NCT03438331|Adolescents|adolescents
956832|NCT03438331|Youth|youth
956833|NCT03438292|Berberine|berberine
956834|NCT03438292|TPGS|tpgs
956835|NCT03438292|Pharmacokinetics|pharmacokinetics
956836|NCT03438292|Human intervention study|human intervention study
956837|NCT03438253|Intraoperative penile engorgement|intraoperative penile engorgement
956838|NCT03438253|Anaesthesia|anaesthesia
956839|NCT03438253|Urogenital surgery|urogenital surgery
956840|NCT03438227|Iron Deficiency Anemia of Pregnancy|iron deficiency anemia of pregnancy
956841|NCT03438227|oral iron supplementation|oral iron supplementation
956842|NCT03438227|parenteral iron supplementation|parenteral iron supplementation
956843|NCT03438227|maternal anemia|maternal anemia
956844|NCT03438214|Vancomycin infusion|vancomycin infusion
956845|NCT03438214|critical ill patients|critical ill patients
956846|NCT03438214|MRSA|mrsa
956847|NCT03438201|Cancer, ICU, Surgery, Protein, Physical Activity|cancer, icu, surgery, protein, physical activity
956848|NCT03438188|Nicotine Addiction|nicotine addiction
956849|NCT03438188|Quitting Smoking|quitting smoking
956850|NCT03438175|Post-traumatic Stress Disorder|post-traumatic stress disorder
956851|NCT03438175|Web-site|web-site
956852|NCT03438175|Communication|communication
956853|NCT03438175|Intensive Care Unit|intensive care unit
956854|NCT03438175|Comprehension|comprehension
956855|NCT03438149|microparticles|microparticles
956856|NCT03438149|cardiovascular outcomes|cardiovascular outcomes
956857|NCT03438110|Preterm birth|preterm birth
956858|NCT03438110|Neonatal death|neonatal death
956859|NCT03438110|Stillbirth|stillbirth
956860|NCT03438110|Asia|asia
956861|NCT03438110|Africa|africa
956862|NCT03438097|Fluid therapy|fluid therapy
956863|NCT03438097|Non-resuscitation fluids|non-resuscitation fluids
956864|NCT03438097|Septic shock|septic shock
956865|NCT03438084|Interesterified|interesterified
956866|NCT03438084|Postprandial|postprandial
956867|NCT03438084|Lipid|lipid
956868|NCT03438058|Solid Organ Transplantation|solid organ transplantation
956869|NCT03438058|Graft survival|graft survival
956870|NCT03438058|Rejection|rejection
956871|NCT03438058|Complement-activating anti-HLA DSA|complement-activating anti-hla dsa
956872|NCT03438058|Meta-analysis|meta-analysis
956873|NCT03438058|Prognosis|prognosis
956874|NCT03438045|Chinese American|chinese american
956875|NCT03438045|implementation science|implementation science
956876|NCT03438045|feasibility|feasibility
956877|NCT03438045|acceptability|acceptability
956878|NCT03438045|oral health|oral health
956879|NCT03438045|dental care|dental care
956880|NCT03438045|health equity|health equity
956881|NCT03438045|urban health|urban health
956882|NCT03438019|Maximal Respiratory Pressures, Inspiratory Muscle Training, TIRE, COPD|maximal respiratory pressures, inspiratory muscle training, tire, copd
956883|NCT03438006|Safety|safety
956884|NCT03438006|Human Papillomavirus Vaccine|human papillomavirus vaccine
956885|NCT03438006|Adverse Event Following Immunization|adverse event following immunization
956886|NCT03437993|ADHD|adhd
956887|NCT03437993|executive functioning|executive functioning
956888|NCT03437993|game|game
956889|NCT03437941|Prostate Cancer|prostate cancer
956890|NCT03437941|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
956891|NCT03437941|Glucocorticoid receptor|glucocorticoid receptor
956892|NCT03437941|Antagonist|antagonist
956893|NCT03437941|mCRPC|mcrpc
956894|NCT03437941|enzalutamide|enzalutamide
956895|NCT03437941|androgen receptor|androgen receptor
956896|NCT03437928|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
956897|NCT03437928|MDD|mdd
956898|NCT03437928|Neuromodulation|neuromodulation
956899|NCT03437928|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
956900|NCT03437928|DBS|dbs
956901|NCT03437928|Electrophysiology|electrophysiology
956902|NCT03437928|Imaging|imaging
956903|NCT03437902|Type 2 diabetes|type 2 diabetes
956904|NCT03437902|Rutin|rutin
956905|NCT03437902|Vitamin C|vitamin c
956906|NCT03437902|oxidative stress|oxidative stress
956907|NCT03437902|Insulin resistance|insulin resistance
956908|NCT03437902|lipid profile|lipid profile
956909|NCT03437889|epidural|epidural
956910|NCT03437876|HBV induced cirrhosis|hbv induced cirrhosis
956911|NCT03437876|intestinal microbiota transplantation|intestinal microbiota transplantation
956912|NCT03437876|microbiota|microbiota
956913|NCT03437863|self-management|self-management
956914|NCT03437863|health assets|health assets
956915|NCT03437863|Strengths|strengths
956916|NCT03437863|mHealth|mhealth
956917|NCT03437863|Feasibility|feasibility
956918|NCT03437811|airway clearance system|airway clearance system
956919|NCT03437811|cystic fibrosis|cystic fibrosis
956920|NCT03437811|lung secretion clearance|lung secretion clearance
956921|NCT03437798|Periodontal Disease|periodontal disease
956922|NCT03437798|Diabetes|diabetes
956923|NCT03437798|Osteoporosis|osteoporosis
956924|NCT03437798|Cardiovascular Risk Factor|cardiovascular risk factor
956925|NCT03437798|Genomic|genomic
956926|NCT03437785|Acute Gastritis|acute gastritis
956927|NCT03437785|Chronic Gastritis|chronic gastritis
956928|NCT03437785|Cinnamic acid|cinnamic acid
956929|NCT03437785|CKD-495|ckd-495
956930|NCT03437759|macular hole (MH)|macular hole (mh)
956931|NCT03437759|exosomes|exosomes
956932|NCT03437759|mesenchymal stem cells|mesenchymal stem cells
956933|NCT03437759|pars plana vitrectomy|pars plana vitrectomy
956934|NCT03437733|Radiofrequency Ablation|radiofrequency ablation
956935|NCT03437733|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
956936|NCT03437707|Postoperative pain|postoperative pain
956937|NCT03437707|Intravenous ibuprofen|intravenous ibuprofen
956938|NCT03437707|Intravenous paracetamol|intravenous paracetamol
956939|NCT03437707|Lumbar disc surgery|lumbar disc surgery
956940|NCT03437694|HIV|hiv
956941|NCT03437694|AIDS|aids
956942|NCT03437694|Diabetes Melliltus, Type 2|diabetes melliltus, type 2
956943|NCT03437694|Hypertension|hypertension
956944|NCT03437694|Pharmacist|pharmacist
956945|NCT03437694|Medication optimization|medication optimization
956946|NCT03437694|medication therapy management|medication therapy management
956947|NCT03437681|Sleep|sleep
956948|NCT03437681|Blood Sugar|blood sugar
956949|NCT03437668|Schizophrenia|schizophrenia
956950|NCT03437668|Withania Somnifera|withania somnifera
956951|NCT03437616|Rehabilitation|rehabilitation
956952|NCT03437616|Coronary heart disease|coronary heart disease
956953|NCT03437616|Cardiovascular diseases|cardiovascular diseases
956954|NCT03437616|Risk factors|risk factors
956955|NCT03437616|Life-style changes|life-style changes
956956|NCT03437616|Efficacy|efficacy
956958|NCT03437603|Allogenetic Hematopoietic Stem Cell Transplantation|allogenetic hematopoietic stem cell transplantation
956959|NCT03437603|Poor Graft Function|poor graft function
956960|NCT03437577|Kidney|kidney
956961|NCT03437577|Transplant|transplant
956962|NCT03437551|Diabetes Mellitus 1|diabetes mellitus 1
956963|NCT03437551|long-term intensified insulin therapy|long-term intensified insulin therapy
956964|NCT03437551|diabetic retinopathy|diabetic retinopathy
956965|NCT03437551|diabetic macular edema|diabetic macular edema
956966|NCT03437538|Dialysis|dialysis
956967|NCT03437538|MCO|mco
956968|NCT03437538|Middle molecules|middle molecules
956969|NCT03437538|High Retention Onset|high retention onset
956970|NCT03437538|Medium Cut-Off|medium cut-off
956971|NCT03437525|Diabetes|diabetes
956972|NCT03437525|Self-Management|self-management
956973|NCT03437525|Primary Care|primary care
956974|NCT03437525|Community Health Center|community health center
956975|NCT03437525|Peer Support|peer support
956976|NCT03437525|Group Support|group support
956977|NCT03437525|Integrated Care|integrated care
956978|NCT03437525|Insulin|insulin
956979|NCT03437525|China|china
956980|NCT03437525|Urban|urban
956981|NCT03437512|tDCS|tdcs
956982|NCT03437512|MRI|mri
956983|NCT03437512|Speech|speech
956984|NCT03437512|fluency|fluency
956985|NCT03437460|Productivity|productivity
956986|NCT03437460|Cognitive Function|cognitive function
956987|NCT03437460|Decision Making|decision making
956988|NCT03437460|Well-Being|well-being
956989|NCT03437460|Health|health
956990|NCT03437460|Labor|labor
956991|NCT03437447|Bioavailability|bioavailability
956992|NCT03437447|Bioequivalence|bioequivalence
956993|NCT03437447|Praziquantel|praziquantel
956994|NCT03437447|Cysticide|cysticide
956995|NCT03437447|Pharmacokinetics|pharmacokinetics
956996|NCT03437421|myocardial function|myocardial function
956997|NCT03437421|vitamin D|vitamin d
956998|NCT03437421|stress echocardiography|stress echocardiography
956999|NCT03437421|diabetes|diabetes
957000|NCT03437408|Ventricular Tachycardia|ventricular tachycardia
957001|NCT03437408|Catheter Ablation|catheter ablation
957002|NCT03437408|Late Potential|late potential
957003|NCT03437408|Ablation Index|ablation index
957004|NCT03437408|Pacing|pacing
957005|NCT03437395|Lumpectomy|lumpectomy
957006|NCT03437395|Unifocal Disease|unifocal disease
957007|NCT03437395|Stage 0 or 1 Disease|stage 0 or 1 disease
957008|NCT03437382|Hepatocellular carcinoma|hepatocellular carcinoma
957009|NCT03437382|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
957010|NCT03437382|Radioembolization|radioembolization
957011|NCT03437382|Quirem Spheres|quirem spheres
957012|NCT03437382|Selective internal radiation therapy|selective internal radiation therapy
957013|NCT03437369|Ivabradine, heart rate, acute heart failure|ivabradine, heart rate, acute heart failure
957014|NCT03437356|persistent atrial fibrillation|persistent atrial fibrillation
957015|NCT03437356|pulmonary vein isolation|pulmonary vein isolation
957016|NCT03437356|antiarrhythmic drug therapy|antiarrhythmic drug therapy
957017|NCT03437343|EOS|eos
957018|NCT03437343|total hip arthroplasty|total hip arthroplasty
957019|NCT03437343|performance of surgeons|performance of surgeons
957020|NCT03437343|leg length discrepancy|leg length discrepancy
957021|NCT03437343|HOOS|hoos
957022|NCT03437317|Social Anxiety|social anxiety
957023|NCT03437317|Threat processing|threat processing
957024|NCT03437317|Magnetoencephalography (MEG)|magnetoencephalography (meg)
957025|NCT03437304|Vaccine|vaccine
957026|NCT03437278|Anti-IgE|anti-ige
957027|NCT03437278|Chronic spontaneous urticaria,|chronic spontaneous urticaria,
957028|NCT03437252|COPD|copd
957029|NCT03437252|COPD exacerbation|copd exacerbation
957030|NCT03437252|COPD AE|copd ae
957031|NCT03437252|Physical activity|physical activity
957032|NCT03437252|Wearable arm device|wearable arm device
957033|NCT03437239|Bicep tenodesis|bicep tenodesis
957034|NCT03437226|Heart Failure, Levosimendan|heart failure, levosimendan
957035|NCT03437200|œsophageal cancer nivolumab ipilimumab|œsophageal cancer nivolumab ipilimumab
957036|NCT03437174|Hypoparathyroidism|hypoparathyroidism
957037|NCT03437174|Parathyroid Disease|parathyroid disease
957038|NCT03437174|Burden of Illness|burden of illness
957039|NCT03437174|SF-36|sf-36
957040|NCT03437174|Quality of Life|quality of life
957041|NCT03437161|Radiation|radiation
957042|NCT03437161|Prone position|prone position
957043|NCT03437161|Supine position|supine position
957044|NCT03437161|DIBH|dibh
957045|NCT03437161|Invasive Breast Carcinoma|invasive breast carcinoma
957046|NCT03437161|Ductal Breast Carcinoma In Situ|ductal breast carcinoma in situ
957047|NCT03437148|Pulmonary to systemic blood flow|pulmonary to systemic blood flow
957048|NCT03437148|Non-invasive measurement|non-invasive measurement
957049|NCT03437148|Inert gas rebreathing|inert gas rebreathing
957050|NCT03437148|Bioimpedance cardiograph|bioimpedance cardiograph
957051|NCT03437148|Atrial Septal Defect|atrial septal defect
957052|NCT03437148|Congenital heart disease|congenital heart disease
957053|NCT03437148|Cardiac Output|cardiac output
957054|NCT03437135|diabetes|diabetes
957055|NCT03437135|hearing problems|hearing problems
957056|NCT03437135|otoscopy|otoscopy
957251|NCT03436004|Adenoma|adenoma
957065|NCT03437057|Antiplatelet|antiplatelet
957066|NCT03437044|diabetes mellitus|diabetes mellitus
957067|NCT03437044|percutaneous coronary intervention|percutaneous coronary intervention
957068|NCT03437044|ticagrelor|ticagrelor
957069|NCT03437044|clopidogrel|clopidogrel
957070|NCT03437044|coronary artery disease|coronary artery disease
957071|NCT03437031|Labor Pain|labor pain
957072|NCT03437031|Virtual Reality|virtual reality
957073|NCT03437031|Alternative Medicine|alternative medicine
957074|NCT03437018|moderate diabetic retinopathy|moderate diabetic retinopathy
957075|NCT03437018|tele-expertise|tele-expertise
957076|NCT03437005|Human microbiome|human microbiome
957077|NCT03437005|Topical|topical
957078|NCT03437005|Steroid|steroid
957079|NCT03437005|Anti-fungal|anti-fungal
957081|NCT03436979|prolapse|prolapse
957082|NCT03436979|sacrospinous fixation|sacrospinous fixation
957083|NCT03436979|minimally invasive|minimally invasive
957084|NCT03436927|Multiple Sclerosis|multiple sclerosis
957085|NCT03436927|rehabilitation|rehabilitation
957086|NCT03436927|postural balance|postural balance
957087|NCT03436927|exercise|exercise
957088|NCT03436901|magnetic resonance imaging|magnetic resonance imaging
957089|NCT03436901|diffusion weighted imaging|diffusion weighted imaging
957090|NCT03436862|Nivolumab|nivolumab
957091|NCT03436862|Autologous Stem Cell Transplant|autologous stem cell transplant
957092|NCT03436862|Blood cancers|blood cancers
968335|NCT03366545|CRT|crt
957093|NCT03436849|ASP2693|asp2693
957094|NCT03436849|Pharmacodynamics|pharmacodynamics
957095|NCT03436849|Pharmacokinetics|pharmacokinetics
957096|NCT03436849|ESN364|esn364
957097|NCT03436849|Safety|safety
957098|NCT03436810|Motor Imagery|motor imagery
957099|NCT03436810|Task-Oriented Circuit Class Training|task-oriented circuit class training
957100|NCT03436810|Health Education|health education
957101|NCT03436771|long-term follow-up|long-term follow-up
957102|NCT03436771|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
957103|NCT03436771|JCAR017|jcar017
957105|NCT03436758|uterine fluids|uterine fluids
957106|NCT03436758|Biobank|biobank
957107|NCT03436758|culture medium|culture medium
957117|NCT03436719|Surgical Site Infection|surgical site infection
957118|NCT03436719|Rectal Cancer Surgery|rectal cancer surgery
957119|NCT03436719|Oral Antibiotic|oral antibiotic
957120|NCT03436719|Antibiotic Prophylaxis|antibiotic prophylaxis
957121|NCT03436693|Diabetic Nephropathy|diabetic nephropathy
957122|NCT03436693|Canagliflozin|canagliflozin
957123|NCT03436693|Canaglu|canaglu
957124|NCT03436693|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
957125|NCT03436680|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
957126|NCT03436680|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
957127|NCT03436680|CIPN|cipn
957128|NCT03436680|Home-based neurofeedback|home-based neurofeedback
957129|NCT03436680|HBNF|hbnf
957130|NCT03436680|Questionnaires|questionnaires
957131|NCT03436680|Surveys|surveys
957132|NCT03436680|Electroencephalogram|electroencephalogram
957134|NCT03436654|prostate cancer|prostate cancer
957135|NCT03436654|apalutamide|apalutamide
957136|NCT03436654|abiraterone acetate|abiraterone acetate
957137|NCT03436654|memorial sloan kettering cancer center|memorial sloan kettering cancer center
957138|NCT03436654|17-646|17-646
957139|NCT03436602|Personalized risk assessment|personalized risk assessment
957140|NCT03436602|Risk stratification model|risk stratification model
957141|NCT03436589|Supplemental Nutrition Assistance Program-Education|supplemental nutrition assistance program-education
957142|NCT03436589|nutrition education intervention|nutrition education intervention
957143|NCT03436576|Autologous serum|autologous serum
957144|NCT03436576|Concentration|concentration
957145|NCT03436576|Autologous serum 20%|autologous serum 20%
957146|NCT03436576|Autologous serum 50%|autologous serum 50%
957147|NCT03436576|Severe dry eye|severe dry eye
957148|NCT03436563|Adenocarcinoma of the colon|adenocarcinoma of the colon
957149|NCT03436563|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
957150|NCT03436563|Microsatellite instability-high metastatic colorectal cancer|microsatellite instability-high metastatic colorectal cancer
957151|NCT03436563|Treatment-refractory, consensus molecular subtype 4 (CMS4) mCRC|treatment-refractory, consensus molecular subtype 4 (cms4) mcrc
957152|NCT03436563|MSI-H non CRC solid tumors who have progressed on immune checkpoint blockade therapy|msi-h non crc solid tumors who have progressed on immune checkpoint blockade therapy
957153|NCT03436563|M7824|m7824
957154|NCT03436563|MSB0011359C|msb0011359c
957155|NCT03436550|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
957156|NCT03436550|Magnetic Resonance Imaging|magnetic resonance imaging
957157|NCT03436550|Acoustic Radiation Force Impulse|acoustic radiation force impulse
957158|NCT03436550|Elastography|elastography
957159|NCT03436550|Ultrasound|ultrasound
957160|NCT03436550|Liver Cirrhosis|liver cirrhosis
957161|NCT03436537|aesthetic|aesthetic
957162|NCT03436537|development|development
957163|NCT03436537|periodontal|periodontal
957164|NCT03436537|reliability|reliability
957165|NCT03436537|validity|validity
957166|NCT03436524|Early stage CLL|early stage cll
957167|NCT03436524|Binet A|binet a
957168|NCT03436524|Prognosis|prognosis
957169|NCT03436511|Health resource utilization|health resource utilization
957170|NCT03436511|Eosinophilic COPD|eosinophilic copd
957171|NCT03436511|Mepolizumab|mepolizumab
957172|NCT03436472|aged|aged
957173|NCT03436472|operative|operative
957174|NCT03436472|delirium|delirium
957175|NCT03436472|dexmedetomidine|dexmedetomidine
957176|NCT03436472|long-term outcome|long-term outcome
957177|NCT03436459|extracorporeal shock wave therapy (ESWT)|extracorporeal shock wave therapy (eswt)
957178|NCT03436459|Low level laser therapy (LLLT)|low level laser therapy (lllt)
957179|NCT03436459|Myofascial Pain Syndrome|myofascial pain syndrome
957180|NCT03436446|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
957181|NCT03436446|Social Incentives|social incentives
957182|NCT03436420|Pediatrics|pediatrics
957183|NCT03436420|Lipids|lipids
957184|NCT03436420|Liver Diseases|liver diseases
957185|NCT03436420|Obesity|obesity
957186|NCT03436394|Renal Impairment|renal impairment
957187|NCT03436394|Evobrutinib|evobrutinib
957188|NCT03436394|Pharmacokinetics|pharmacokinetics
957189|NCT03436368|Continuous spinal anesthesia|continuous spinal anesthesia
957190|NCT03436368|General anesthesia|general anesthesia
957191|NCT03436368|Renal transplantation|renal transplantation
957192|NCT03436368|Chronic renal failure|chronic renal failure
957193|NCT03436355|Behavioral|behavioral
957194|NCT03436355|Physical activity|physical activity
957195|NCT03436355|Intervention|intervention
957196|NCT03436355|School children|school children
957197|NCT03436329|Lung cancer|lung cancer
957198|NCT03436329|Surgical technique|surgical technique
957199|NCT03436329|vessel ligation|vessel ligation
957200|NCT03436329|Circulating tumor cell|circulating tumor cell
957201|NCT03436316|Phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
957202|NCT03436316|First-in-human (FiH) study|first-in-human (fih) study
957203|NCT03436303|Menopause Syndrome|menopause syndrome
957204|NCT03436303|low dose estrogen|low dose estrogen
957205|NCT03436303|progestin|progestin
957206|NCT03436290|Palliative Care|palliative care
957211|NCT03436277|Body fat percentage|body fat percentage
957212|NCT03436251|hyperthermia|hyperthermia
957213|NCT03436251|human papillomavirus virus|human papillomavirus virus
957214|NCT03436251|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
957215|NCT03436238|Perioperative|perioperative
957216|NCT03436238|Biomarkers|biomarkers
957217|NCT03436238|Troponin|troponin
957218|NCT03436238|Prodrenomedullin|prodrenomedullin
957219|NCT03436238|Endothelin|endothelin
957220|NCT03436238|Perioperative Complications|perioperative complications
957221|NCT03436225|steroid therapy.|steroid therapy.
957222|NCT03436186|Thyroidectomy|thyroidectomy
957223|NCT03436186|voice|voice
957224|NCT03436186|swallowing problems|swallowing problems
957225|NCT03436186|dysphagia|dysphagia
957226|NCT03436147|vaginal hysterectomy|vaginal hysterectomy
957227|NCT03436147|laparoscopic hysteropexy|laparoscopic hysteropexy
957228|NCT03436147|pelvic organ prolapse quantification|pelvic organ prolapse quantification
957229|NCT03436134|Donor-specific antibodies|donor-specific antibodies
957230|NCT03436134|Double-Filtration PlasmaPheresis (DFPP)|double-filtration plasmapheresis (dfpp)
957231|NCT03436134|Plasma Exchange (PE)|plasma exchange (pe)
957232|NCT03436095|Bundle|bundle
957233|NCT03436095|difficult ventilator weaning|difficult ventilator weaning
957234|NCT03436069|Breast cancer|breast cancer
957235|NCT03436069|biomarkers|biomarkers
957236|NCT03436069|prognostic|prognostic
957237|NCT03436069|ectopic gene expression|ectopic gene expression
957238|NCT03436069|expression profile|expression profile
957239|NCT03436069|tissue-specific genes|tissue-specific genes
957240|NCT03436069|response to treatment|response to treatment
957241|NCT03436056|Non-small-cell lunG cancer|non-small-cell lung cancer
957242|NCT03436056|NSCLC|nsclc
957243|NCT03436056|metastatic|metastatic
957244|NCT03436056|pembrolizumab|pembrolizumab
957245|NCT03436056|radiotherapy|radiotherapy
957246|NCT03436043|Walled of necrosis|walled of necrosis
957247|NCT03436017|adhd|adhd
957248|NCT03436017|metabolomics|metabolomics
957249|NCT03436017|child|child
957252|NCT03436004|Adenoma detection rate|adenoma detection rate
957253|NCT03435991|Experience Sampling Method|experience sampling method
957254|NCT03435991|Ecological Momentary Assessment|ecological momentary assessment
957255|NCT03435991|Momentary Symptom Assessment|momentary symptom assessment
957383|NCT03435185|Headache|headache
957256|NCT03435991|Patient Reported Outcome Measure|patient reported outcome measure
957257|NCT03435978|diet|diet
957258|NCT03435978|metabolic syndrome|metabolic syndrome
957259|NCT03435978|obese children|obese children
957260|NCT03435952|Pembrolizumab|pembrolizumab
957261|NCT03435952|Keytruda|keytruda
957262|NCT03435952|MK-3475|mk-3475
957263|NCT03435952|SCH-900475|sch-900475
957264|NCT03435952|Clostridium Novyi-NT|clostridium novyi-nt
957265|NCT03435952|C. novyi-NT|c. novyi-nt
957266|NCT03435952|Doxycycline|doxycycline
957267|NCT03435952|Vibramycin|vibramycin
957268|NCT03435952|Periostat|periostat
957269|NCT03435952|Doryx|doryx
957270|NCT03435952|Solid tumor malignancies|solid tumor malignancies
957271|NCT03435913|Mechanical ventilation|mechanical ventilation
957272|NCT03435913|Driving Pressure|driving pressure
957273|NCT03435913|Protective Lung VEntilation|protective lung ventilation
957274|NCT03435887|Point of Care Testing|point of care testing
957275|NCT03435887|HIV|hiv
957276|NCT03435887|Pediatric HIV-exposed infants|pediatric hiv-exposed infants
957277|NCT03435887|at-birth testing|at-birth testing
957278|NCT03435887|early infant diagnosis|early infant diagnosis
957279|NCT03435887|Kenya|kenya
957280|NCT03435848|Acute Myeloid Leukemia|acute myeloid leukemia
957281|NCT03435848|Unfit for standard induction therapy|unfit for standard induction therapy
957282|NCT03435848|Cytarabine|cytarabine
957283|NCT03435822|asthma|asthma
957284|NCT03435822|children|children
957285|NCT03435822|action plan|action plan
957286|NCT03435822|China|china
957287|NCT03435822|CCAAP|ccaap
957288|NCT03435796|Long-term follow up|long-term follow up
957289|NCT03435796|Gene-Modified T Cells|gene-modified t cells
957290|NCT03435796|CAR T Cell|car t cell
957291|NCT03435770|EUS-guided RFA|eus-guided rfa
957292|NCT03435770|Endoscopic ultrasound|endoscopic ultrasound
957293|NCT03435770|radio frequency ablation|radio frequency ablation
957294|NCT03435731|OSA|osa
957295|NCT03435731|Continous Positive Airway Pressure (CPAP)|continous positive airway pressure (cpap)
957296|NCT03435731|Mandibular Advancement Split (MAS)|mandibular advancement split (mas)
957297|NCT03435731|Mandibular Advancement Oral Appliance|mandibular advancement oral appliance
957298|NCT03435731|Dual Therapy|dual therapy
957299|NCT03435718|oxfendazole|oxfendazole
957300|NCT03435718|albendazole|albendazole
957301|NCT03435718|Trichuris trichiura|trichuris trichiura
957302|NCT03435679|infection|infection
957303|NCT03435679|knee arthroplasty|knee arthroplasty
957304|NCT03435679|surgical treatment|surgical treatment
957305|NCT03435679|one-stage|one-stage
957306|NCT03435679|two-stage|two-stage
957307|NCT03435679|outcome|outcome
957308|NCT03435640|NKTR-214|nktr-214
957309|NCT03435640|NKTR-262|nktr-262
957310|NCT03435640|Nivolumab|nivolumab
957311|NCT03435640|Opdivo|opdivo
957313|NCT03435640|Locally advanced|locally advanced
957314|NCT03435640|Relapsed/Refractory|relapsed/refractory
957315|NCT03435640|TLR7/8|tlr7/8
957316|NCT03435640|CD122|cd122
957317|NCT03435614|Opioid|opioid
957318|NCT03435614|Withdrawal|withdrawal
957319|NCT03435614|Critically ill adults|critically ill adults
957320|NCT03435614|Cortisol|cortisol
957321|NCT03435601|Rheumatoid Arthritis|rheumatoid arthritis
957322|NCT03435601|RA|ra
957323|NCT03435601|IFN-Signature|ifn-signature
957324|NCT03435601|Anifrolumab|anifrolumab
957325|NCT03435575|physical activity|physical activity
957326|NCT03435575|serious game|serious game
957327|NCT03435575|childhood obesity|childhood obesity
957328|NCT03435536|circulating tumor DNA|circulating tumor dna
957329|NCT03435536|kinetic|kinetic
957330|NCT03435536|pancreatic cancer|pancreatic cancer
957331|NCT03435536|pancreatoduodenectomy|pancreatoduodenectomy
957332|NCT03435536|Next Generation Sequencing|next generation sequencing
957333|NCT03435510|Live Donor Kidney Transplant|live donor kidney transplant
957334|NCT03435510|Education|education
957335|NCT03435510|Advocacy|advocacy
957336|NCT03435510|Live Donor|live donor
957337|NCT03435471|Prophylactic Swallowing Therapy|prophylactic swallowing therapy
957338|NCT03435458|Induced labor|induced labor
957339|NCT03435458|Maternal obesity|maternal obesity
957340|NCT03435445|obesity|obesity
957341|NCT03435445|overweight|overweight
957342|NCT03435445|telemedicine|telemedicine
957343|NCT03435445|ehealth|ehealth
957344|NCT03435419|cutaneous leishmaniasis|cutaneous leishmaniasis
957345|NCT03435419|RDT|rdt
957346|NCT03435419|LAMP|lamp
957347|NCT03435419|PCR|pcr
957348|NCT03435406|Hepatitis B, Chronic|hepatitis b, chronic
957349|NCT03435406|Cirrhosis|cirrhosis
957350|NCT03435406|Hepatopulmonary Syndrome|hepatopulmonary syndrome
957351|NCT03435380|Cancer Survivors|cancer survivors
957352|NCT03435380|Smartphone|smartphone
957353|NCT03435380|Mobile Applications|mobile applications
957455|NCT03434678|18-056|18-056
957354|NCT03435354|Physical activity|physical activity
957355|NCT03435354|Quality of life|quality of life
957356|NCT03435354|Activity motivation|activity motivation
957357|NCT03435354|Children|children
957358|NCT03435354|Adolescents|adolescents
957359|NCT03435354|Cluster-randomized trial|cluster-randomized trial
957360|NCT03435341|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
957361|NCT03435341|Observational|observational
957362|NCT03435341|Standard Clinical Practice|standard clinical practice
957363|NCT03435341|Survival|survival
957364|NCT03435341|Tolerability|tolerability
957365|NCT03435341|Spain|spain
957366|NCT03435328|TENS|tens
957367|NCT03435302|Mucosal Melanoma,Adjuvant Therapy,IFN-a2b,Temozolomide|mucosal melanoma,adjuvant therapy,ifn-a2b,temozolomide
957368|NCT03435289|Advanced Pancreatic Cancer|advanced pancreatic cancer
957369|NCT03435276|Heart failure.|heart failure.
957370|NCT03435276|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
957371|NCT03435276|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
957372|NCT03435263|premature rupture of membranes|premature rupture of membranes
957373|NCT03435250|MTAP|mtap
957374|NCT03435250|MTAP deletion|mtap deletion
957375|NCT03435250|CDKN2A deletion|cdkn2a deletion
957376|NCT03435250|MAT2A inhibitor|mat2a inhibitor
957377|NCT03435250|Advanced solid tumors|advanced solid tumors
957378|NCT03435250|Lymphoma|lymphoma
957379|NCT03435237|Optical Coherence Tomography|optical coherence tomography
957380|NCT03435237|Bronchial Thermoplasty|bronchial thermoplasty
957381|NCT03435185|Pain|pain
957382|NCT03435185|Nerve Blocks|nerve blocks
957384|NCT03435185|Local Anaesthetics|local anaesthetics
957385|NCT03435185|Migraine|migraine
957386|NCT03435172|Thermal Burn|thermal burn
957387|NCT03435172|Adipose Derived Regenerative Cells|adipose derived regenerative cells
957388|NCT03435172|Skin Graft|skin graft
957389|NCT03435159|Chiropractic, Manipulation, Vertebrobasilar Artery|chiropractic, manipulation, vertebrobasilar artery
957390|NCT03435146|3HP|3hp
957391|NCT03435146|LTBI|ltbi
957392|NCT03435146|IMPAACT4TB|impaact4tb
957393|NCT03435146|DDI|ddi
957394|NCT03435146|Pharmacokinetics|pharmacokinetics
957395|NCT03435146|Dolutegravir|dolutegravir
957396|NCT03435133|Primary angioplasty|primary angioplasty
957397|NCT03435133|Prasugrel|prasugrel
957398|NCT03435133|Ticagrelor|ticagrelor
957399|NCT03435133|STEMI|stemi
957400|NCT03435133|cardiac magnetic resonance|cardiac magnetic resonance
957401|NCT03435133|infarct size|infarct size
957402|NCT03435133|infarct injury|infarct injury
957403|NCT03435120|Breakthrough Cancer Pain|breakthrough cancer pain
957404|NCT03435120|Quality of life|quality of life
957405|NCT03435120|Medical Oncology|medical oncology
957406|NCT03435081|eczema|eczema
957407|NCT03435081|atopic eczema|atopic eczema
957408|NCT03435068|rotary|rotary
957409|NCT03435068|diode laser|diode laser
957410|NCT03435068|gingivectomy|gingivectomy
957411|NCT03435068|wound healing|wound healing
957412|NCT03435029|aging|aging
957413|NCT03435029|cognitive rehabilitation|cognitive rehabilitation
957414|NCT03435029|REHACOP|rehacop
957415|NCT03435003|Bariatric Procedure|bariatric procedure
957416|NCT03434990|spinal manipulative therapy|spinal manipulative therapy
957417|NCT03434990|Myofascial release|myofascial release
957418|NCT03434990|Low back pain|low back pain
957419|NCT03434938|Stroke|stroke
957420|NCT03434938|Geriatric|geriatric
957421|NCT03434938|Rehabilitation|rehabilitation
957422|NCT03434938|Functional recovery|functional recovery
957423|NCT03434938|Physical activity|physical activity
957424|NCT03434938|Motivational interviewing|motivational interviewing
957425|NCT03434938|Adherence|adherence
957426|NCT03434938|Clinical trial|clinical trial
957427|NCT03434925|colorectal neoplasia|colorectal neoplasia
957428|NCT03434925|adenoma|adenoma
957429|NCT03434925|colonoscopy|colonoscopy
957430|NCT03434925|gene mutation|gene mutation
957431|NCT03434925|follow-up|follow-up
957432|NCT03434925|recurrence|recurrence
957433|NCT03434925|multiparametric test|multiparametric test
957434|NCT03434873|magnetic stimulation, multiple sclerosis|magnetic stimulation, multiple sclerosis
957435|NCT03434821|Hyperoxemia|hyperoxemia
957436|NCT03434821|ventilator-associated|ventilator-associated
957437|NCT03434821|pneumonia|pneumonia
957438|NCT03434821|critical illness|critical illness
957439|NCT03434769|Cyclophosphamide|cyclophosphamide
957440|NCT03434769|Fludarabine|fludarabine
957441|NCT03434769|Chimeric antigen receptor T cells|chimeric antigen receptor t cells
957442|NCT03434756|ultrasound imaging|ultrasound imaging
957443|NCT03434756|propioception|propioception
957444|NCT03434756|training|training
957445|NCT03434743|oral feeding|oral feeding
957446|NCT03434743|early intervention|early intervention
957447|NCT03434743|premature infant|premature infant
957448|NCT03434743|sucking|sucking
957449|NCT03434730|tocilizumab|tocilizumab
957450|NCT03434730|17-616|17-616
957451|NCT03434730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
957452|NCT03434678|General Anesthesia|general anesthesia
957453|NCT03434678|Epidural|epidural
957454|NCT03434678|Pancreaticoduodenectomy|pancreaticoduodenectomy
957456|NCT03434665|Angiography|angiography
957457|NCT03434665|Bariatric embolization|bariatric embolization
957458|NCT03434665|Gastric artery|gastric artery
957459|NCT03434665|Obesity|obesity
957460|NCT03434665|Transradial|transradial
957461|NCT03434639|Gut permeability|gut permeability
957462|NCT03434639|Fluorescence|fluorescence
957463|NCT03434639|Spectroscopy|spectroscopy
957464|NCT03434639|Wearable sensor|wearable sensor
957465|NCT03434639|Leaky gut|leaky gut
957466|NCT03434587|fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT|fifth metacarpal neck, fracture, syndactyly, inmobilization, rct
957467|NCT03434574|(Poly)phenols|(poly)phenols
957468|NCT03434574|Aronia berry|aronia berry
957469|NCT03434574|Blood pressure|blood pressure
957470|NCT03434574|Vascular function|vascular function
957471|NCT03434561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
957472|NCT03434509|Motor Control|motor control
957473|NCT03434509|Attention|attention
957474|NCT03434509|Cognitive Control|cognitive control
957475|NCT03434496|PD; Gait training 3; treadmill.|pd; gait training 3; treadmill.
957476|NCT03434483|Microbiota|microbiota
957477|NCT03434483|Immunity|immunity
957478|NCT03434483|Genetics|genetics
957479|NCT03434483|Atherosclerosis|atherosclerosis
957480|NCT03434483|Diabetes|diabetes
957481|NCT03434470|Ultrasound|ultrasound
957482|NCT03434470|Shear wave elastography|shear wave elastography
957483|NCT03434470|SWE|swe
957484|NCT03434470|Hepatitis C|hepatitis c
957485|NCT03434470|HCV|hcv
957486|NCT03434457|Fetal growth retardation|fetal growth retardation
957487|NCT03434457|Early adversity|early adversity
957488|NCT03434457|Depressive Symptoms|depressive symptoms
957489|NCT03434444|propranolol|propranolol
957490|NCT03434444|oxytocin|oxytocin
957491|NCT03434444|uterine contraction|uterine contraction
957492|NCT03434431|metabolic adaptation|metabolic adaptation
957493|NCT03434431|weight regain|weight regain
957494|NCT03434431|reverse dieting|reverse dieting
957495|NCT03434418|EGFR Mutation|egfr mutation
957496|NCT03434418|osimertinib|osimertinib
957497|NCT03434418|exon 18 G719X|exon 18 g719x
957498|NCT03434418|exon 20 S7681|exon 20 s7681
957499|NCT03434418|exon 21 L861Q|exon 21 l861q
957500|NCT03434405|schizophrenia|schizophrenia
957501|NCT03434405|mindfulness|mindfulness
957502|NCT03434405|social cognition|social cognition
957503|NCT03434405|SocialMind|socialmind
957504|NCT03434405|AGES-Mind|ages-mind
957505|NCT03434392|Chronic Pain|chronic pain
957506|NCT03434392|Chronic Pancreatitis|chronic pancreatitis
957507|NCT03434392|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
957508|NCT03434392|Recurrent Acute Pancreatitis|recurrent acute pancreatitis
957509|NCT03434392|Chronic Abdominal Pain|chronic abdominal pain
957510|NCT03434392|Functional Dyspepsia|functional dyspepsia
957635|NCT03434054|emotional processing|emotional processing
957511|NCT03434366|Autism Spectrum Disorder|autism spectrum disorder
957512|NCT03434366|ketamine|ketamine
957513|NCT03434366|dexmedetomidine|dexmedetomidine
957514|NCT03434340|peppermint oil|peppermint oil
957515|NCT03434340|morphine|morphine
957516|NCT03434340|nausea and vomiting|nausea and vomiting
957517|NCT03434340|lower segment cesarean section|lower segment cesarean section
957518|NCT03434314|Paraplegia|paraplegia
957519|NCT03434314|Aortic Aneurysm Repair|aortic aneurysm repair
957520|NCT03434314|Staging|staging
957521|NCT03434314|Embolization|embolization
957522|NCT03434314|TAAA|taaa
957523|NCT03434314|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
957524|NCT03434314|MISACE|misace
957525|NCT03434314|Spinal cord ischemia|spinal cord ischemia
957526|NCT03434314|Spinal cord ischaemia|spinal cord ischaemia
957527|NCT03434314|Spinal cord injury|spinal cord injury
957528|NCT03434314|Spinal cord ischemic injury|spinal cord ischemic injury
957529|NCT03434314|Spinal cord ischaemic injury|spinal cord ischaemic injury
957530|NCT03434314|Permanent paraplegia|permanent paraplegia
957531|NCT03434314|Temporary paraplegia|temporary paraplegia
957532|NCT03434314|Paraparesis|paraparesis
957533|NCT03434314|SCI|sci
957534|NCT03434314|TAAA repair|taaa repair
957535|NCT03434314|Open TAAA repair|open taaa repair
957536|NCT03434314|Open surgical TAAA repair|open surgical taaa repair
957537|NCT03434314|Endovascular TAAA repair|endovascular taaa repair
957538|NCT03434314|TEVAR|tevar
957539|NCT03434314|Aortic surgery|aortic surgery
957540|NCT03434314|Thoracoabdominal aortic surgery|thoracoabdominal aortic surgery
957541|NCT03434314|Type B aortic dissection|type b aortic dissection
957542|NCT03434314|Chronic type B aortic dissection|chronic type b aortic dissection
957543|NCT03434314|Stanford type B aortic dissection|stanford type b aortic dissection
957544|NCT03434314|Collateral network|collateral network
957545|NCT03434314|Paraspinal collateral network|paraspinal collateral network
957546|NCT03434314|Paraspinous collateral network|paraspinous collateral network
957547|NCT03434314|Arteriogenesis|arteriogenesis
957548|NCT03434314|Intercostal arteries|intercostal arteries
957549|NCT03434301|Surgery|surgery
957550|NCT03434301|Laparotomy|laparotomy
957551|NCT03434301|Tack|tack
957552|NCT03434301|Non-absorbable Tack|non-absorbable tack
957553|NCT03434301|Absorbable Tack|absorbable tack
957560|NCT03434275|Analgesia|analgesia
957561|NCT03434275|N1539|n1539
957562|NCT03434275|Phase 3b|phase 3b
957563|NCT03434275|Knee Replacement|knee replacement
957564|NCT03434262|ATRT|atrt
957565|NCT03434262|Brain Tumors in Adolescents|brain tumors in adolescents
957566|NCT03434262|Brain Tumors in Children|brain tumors in children
957567|NCT03434262|Brain Tumors in Young Adults|brain tumors in young adults
957568|NCT03434262|CDK4 amplification|cdk4 amplification
957569|NCT03434262|CDK 4/6|cdk 4/6
957570|NCT03434262|CDK 4/6 inhibitor|cdk 4/6 inhibitor
957571|NCT03434262|CDK 4/6 pathway|cdk 4/6 pathway
957572|NCT03434262|CDK 4/6/cyclin/RB/E2F pathway|cdk 4/6/cyclin/rb/e2f pathway
957573|NCT03434262|CDK6 amplification|cdk6 amplification
957574|NCT03434262|CyclinD1|cyclind1
957575|NCT03434262|DAWN|dawn
957576|NCT03434262|D-type Cyclins|d-type cyclins
957577|NCT03434262|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
957578|NCT03434262|HGG|hgg
957579|NCT03434262|MAPK pathway|mapk pathway
957580|NCT03434262|MEK|mek
957581|NCT03434262|MEK inhibitor|mek inhibitor
957582|NCT03434262|MEK1|mek1
957583|NCT03434262|MEK2|mek2
957584|NCT03434262|Mekinist|mekinist
957585|NCT03434262|Molecular|molecular
957586|NCT03434262|Molecular therapy|molecular therapy
957587|NCT03434262|MYC amplification|myc amplification
957588|NCT03434262|PTCH1|ptch1
957589|NCT03434262|Rare brain tumor|rare brain tumor
957590|NCT03434262|Recurrent ATRT|recurrent atrt
957591|NCT03434262|Recurrent brain tumor|recurrent brain tumor
957592|NCT03434262|Recurrent ependymoma|recurrent ependymoma
957593|NCT03434262|Recurrent high grade glioma|recurrent high grade glioma
957594|NCT03434262|Recurrent malignant glioma|recurrent malignant glioma
957595|NCT03434262|Recurrent medulloblastoma|recurrent medulloblastoma
957596|NCT03434262|Refractory brain tumor|refractory brain tumor
957597|NCT03434262|Small molecule inhibitor|small molecule inhibitor
957598|NCT03434262|SMO antagonist|smo antagonist
957599|NCT03434262|Smoothened protein|smoothened protein
957600|NCT03434262|Sonic hedgehog|sonic hedgehog
957601|NCT03434262|Combination therapy|combination therapy
957602|NCT03434249|Bifidobacterium|bifidobacterium
957603|NCT03434236|omega-3|omega-3
957604|NCT03434236|specialized proresolving mediators|specialized proresolving mediators
957605|NCT03434210|schizophrenia|schizophrenia
957606|NCT03434210|violence risk|violence risk
957607|NCT03434210|long-acting antipsychotics|long-acting antipsychotics
957608|NCT03434210|community-based|community-based
957609|NCT03434197|Osteoarthritis Knee Pain|osteoarthritis knee pain
957610|NCT03434184|Walking analysis|walking analysis
957611|NCT03434184|spinal surgery|spinal surgery
957612|NCT03434184|scoliosis|scoliosis
957613|NCT03434184|pelvic fixation|pelvic fixation
957614|NCT03434158|Metastatic Prostate Cancer Resistant to Castration|metastatic prostate cancer resistant to castration
957615|NCT03434132|Open Radical Cystectomy|open radical cystectomy
957616|NCT03434132|Robotic Radical cystectomy|robotic radical cystectomy
957617|NCT03434132|Intracorporeal urinary diversion|intracorporeal urinary diversion
957618|NCT03434132|Prospective randdomized trial|prospective randdomized trial
957619|NCT03434106|meibomian gland dysfunction|meibomian gland dysfunction
957620|NCT03434106|Sjögren's syndrome|sjögren's syndrome
957621|NCT03434106|dry eye disease|dry eye disease
957626|NCT03434080|Pediatric|pediatric
957627|NCT03434080|Neuroimaging|neuroimaging
957628|NCT03434080|Brain Function|brain function
957629|NCT03434080|Voluntary Movement|voluntary movement
957630|NCT03434067|hyperthyroidism|hyperthyroidism
957631|NCT03434067|thyroidectomy|thyroidectomy
957633|NCT03434067|immunochromatographic assay|immunochromatographic assay
957634|NCT03434054|losartan|losartan
957636|NCT03434054|anxiety|anxiety
957637|NCT03434054|magnet resonance imaging|magnet resonance imaging
957638|NCT03434054|MRI|mri
957639|NCT03434028|Fluid management|fluid management
957640|NCT03434028|Sepsis-induced hypotension|sepsis-induced hypotension
957641|NCT03434028|vasopressors|vasopressors
957642|NCT03434015|Atrial fibrillation|atrial fibrillation
957643|NCT03434015|Left atrial septal closure|left atrial septal closure
957644|NCT03434002|Virtual Reality Simulation|virtual reality simulation
957645|NCT03434002|Teaching and Assessment|teaching and assessment
957646|NCT03434002|Anesthesia Crisis Management|anesthesia crisis management
957647|NCT03433989|Post-Traumatic Stress Disorder|post-traumatic stress disorder
957648|NCT03433989|Pregnancy loss|pregnancy loss
957649|NCT03433976|Caesarean section|caesarean section
957650|NCT03433976|spinal anesthesia|spinal anesthesia
957651|NCT03433976|Prilocaïne|prilocaïne
957652|NCT03433976|motor block|motor block
957653|NCT03433963|air pollution|air pollution
957654|NCT03433963|blood pressure|blood pressure
957655|NCT03433963|cardiac ischemia|cardiac ischemia
957656|NCT03433963|L-arginine|l-arginine
957657|NCT03433963|nitric oxide|nitric oxide
957658|NCT03433950|antiparkinson|antiparkinson
957659|NCT03433911|Permanent contraception|permanent contraception
957660|NCT03433911|Birth control|birth control
957661|NCT03433885|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
957662|NCT03433885|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
957663|NCT03433885|drusen|drusen
957664|NCT03433885|Chroidal neovascularization (CNV)|chroidal neovascularization (cnv)
957665|NCT03433885|lutein|lutein
957666|NCT03433885|zeaxanthin|zeaxanthin
957667|NCT03433872|Infant-toddler care|infant-toddler care
957668|NCT03433872|Early child development|early child development
957669|NCT03433872|Professional development|professional development
957670|NCT03433846|Sepsis|sepsis
957671|NCT03433846|Prematurity|prematurity
957672|NCT03433807|idebenone, DMD, Duchenne|idebenone, dmd, duchenne
957673|NCT03433781|ASCORBIC ACID|ascorbic acid
957674|NCT03433755|Evolocumab|evolocumab
957675|NCT03433755|Repatha|repatha
957676|NCT03433755|Statin|statin
957677|NCT03433755|Chinese|chinese
957678|NCT03433755|China|china
957679|NCT03433755|Hypercholesterolemia|hypercholesterolemia
957680|NCT03433755|Mixed Dyslipidemia|mixed dyslipidemia
957681|NCT03433755|High Cholesterol|high cholesterol
957682|NCT03433755|Lowering cholesterol|lowering cholesterol
957683|NCT03433742|metal ion levels, total hip replacement, Trident II cup.|metal ion levels, total hip replacement, trident ii cup.
957684|NCT03433729|Outpatient Clinics, Hospital|outpatient clinics, hospital
957685|NCT03433729|Humans|humans
957686|NCT03433729|Outcome Assessment (Health Care)|outcome assessment (health care)
957687|NCT03433729|Patient Outcome Assessment|patient outcome assessment
957688|NCT03433729|Patient satisfaction|patient satisfaction
957689|NCT03433729|Hospitalists|hospitalists
957690|NCT03433729|Secondary care|secondary care
957691|NCT03433716|Percutaneous Neuromodulation, radial nerve, pain|percutaneous neuromodulation, radial nerve, pain
957692|NCT03433703|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
957693|NCT03433703|Lenvatinib|lenvatinib
957694|NCT03433703|E7080|e7080
957695|NCT03433690|Child Obesity|child obesity
957696|NCT03433690|Adolescents|adolescents
957697|NCT03433690|High Intensity Interval Training|high intensity interval training
957698|NCT03433690|Moderate training|moderate training
957699|NCT03433677|insulin pump|insulin pump
957700|NCT03433664|CO2 laser|co2 laser
957701|NCT03433664|Ablative fractional laser|ablative fractional laser
957702|NCT03433651|depression|depression
957703|NCT03433638|Juvenile dermatomyositis|juvenile dermatomyositis
957704|NCT03433638|Inflammatory myopathy|inflammatory myopathy
957705|NCT03433638|Clinical features|clinical features
957706|NCT03433638|Treatment|treatment
957707|NCT03433625|Cognitive-behavioural therapy|cognitive-behavioural therapy
957708|NCT03433612|Anatomical Landmarks|anatomical landmarks
957709|NCT03433599|Intermittent Hypoxia|intermittent hypoxia
957710|NCT03433599|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
957711|NCT03433560|febrile neutropenia|febrile neutropenia
957712|NCT03433560|neutropenia|neutropenia
957713|NCT03433547|macular buckling|macular buckling
957714|NCT03433547|full-thickness macular hole|full-thickness macular hole
957715|NCT03433547|macular detachment|macular detachment
957716|NCT03433547|internal limiting membrane peeling|internal limiting membrane peeling
957717|NCT03433547|high myopia|high myopia
957718|NCT03433534|nivolumab|nivolumab
957719|NCT03433534|monoclonal antibody|monoclonal antibody
957720|NCT03433534|Opdivo|opdivo
957721|NCT03433534|antineoplastic agent|antineoplastic agent
957722|NCT03433534|ELISA|elisa
957723|NCT03433534|pharmacokinetic|pharmacokinetic
957724|NCT03433521|Spatio-Temporal Diagnostic Pattern|spatio-temporal diagnostic pattern
957725|NCT03433495|stroke|stroke
957726|NCT03433495|aphasia|aphasia
957727|NCT03433495|melodic intonation therapy|melodic intonation therapy
957728|NCT03433482|Meningococcal disease|meningococcal disease
957729|NCT03433482|Liquid formulation|liquid formulation
957730|NCT03433482|Meningitis|meningitis
957731|NCT03433456|obesity|obesity
957732|NCT03433456|low-income|low-income
957733|NCT03433456|health disparities|health disparities
957734|NCT03433456|home visitation|home visitation
957735|NCT03433456|prevention|prevention
957736|NCT03433456|childhood obesity|childhood obesity
957737|NCT03433456|habit|habit
957738|NCT03433443|Spinal Fusion|spinal fusion
957739|NCT03433443|Case Managers|case managers
957740|NCT03433443|Rehabilitation|rehabilitation
957741|NCT03433352|gut microbiota|gut microbiota
957742|NCT03433352|16S rRNA gene|16s rrna gene
957743|NCT03433352|Graves' disease|graves' disease
957744|NCT03433352|Methimazole|methimazole
957745|NCT03433352|Propylthiouracil|propylthiouracil
957746|NCT03433339|depression|depression
957747|NCT03433339|transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
957748|NCT03433339|non-invasive|non-invasive
957749|NCT03433339|major depressive disorder|major depressive disorder
957750|NCT03433248|Type 2 diabetes mellitus|type 2 diabetes mellitus
957751|NCT03433248|Diabetic kidney disease|diabetic kidney disease
957752|NCT03433248|Diabetic nephropathy|diabetic nephropathy
957753|NCT03433248|Renoprotection|renoprotection
957754|NCT03433248|SGLT2 inhibitor|sglt2 inhibitor
957755|NCT03433248|Empagliflozin|empagliflozin
957756|NCT03433248|DPP-4 inhibitor|dpp-4 inhibitor
957757|NCT03433248|Linagliptin|linagliptin
957758|NCT03433248|SU derivative|su derivative
957759|NCT03433248|Gliclazide|gliclazide
957760|NCT03433222|light emitting diode-red light|light emitting diode-red light
957761|NCT03433222|high fluence|high fluence
957762|NCT03433222|red light|red light
957764|NCT03433209|Advanced bipolar energy devices|advanced bipolar energy devices
957765|NCT03433209|ENSEAL|enseal
957766|NCT03433209|LigaSure|ligasure
957767|NCT03433209|Operative time|operative time
957768|NCT03433209|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
957769|NCT03433157|stainless stain crowns|stainless stain crowns
957770|NCT03433157|Hall technique|hall technique
957771|NCT03433157|children|children
957772|NCT03433118|fatigue|fatigue
957773|NCT03433118|health-related quality of life|health-related quality of life
957774|NCT03433105|oxygen uptake,prolonged mechanical ventilation,weaning|oxygen uptake,prolonged mechanical ventilation,weaning
957775|NCT03433092|Serum carotenoids|serum carotenoids
957776|NCT03433092|Gastrointestinal tract cancer|gastrointestinal tract cancer
957777|NCT03433092|Meta-analysis|meta-analysis
957778|NCT03433079|Acute Kidney Injury|acute kidney injury
957779|NCT03433079|Severe Trauma|severe trauma
957780|NCT03433079|NGAL|ngal
957781|NCT03433079|Tissue Hypoxia|tissue hypoxia
957782|NCT03433079|Inflammatory Response|inflammatory response
957783|NCT03433079|Rhabdomyolysis|rhabdomyolysis
957784|NCT03433066|advanced platelet-rich fibrin|advanced platelet-rich fibrin
957785|NCT03432988|Nursing Solution-Focused|nursing solution-focused
957786|NCT03432988|hemodialysis|hemodialysis
957787|NCT03432988|Psychosocial intervention|psychosocial intervention
957788|NCT03432988|Adherence|adherence
957789|NCT03432949|Radium-223|radium-223
957790|NCT03432949|Dexamethasone|dexamethasone
957791|NCT03432949|mCRPC|mcrpc
957792|NCT03432910|Forced Breath Technique|forced breath technique
957793|NCT03432910|auto-CPAP|auto-cpap
957794|NCT03432910|CPAP|cpap
957795|NCT03432910|Obstructive sleep apnea|obstructive sleep apnea
957796|NCT03432910|central sleep apnea|central sleep apnea
957797|NCT03432897|High risk|high risk
957798|NCT03432897|Defects|defects
957799|NCT03432897|prostate|prostate
957800|NCT03432884|Phase 1|phase 1
957801|NCT03432884|pharmacokinetics|pharmacokinetics
957802|NCT03432884|safety|safety
957803|NCT03432871|Mitochondria|mitochondria
957804|NCT03432871|Mitochondrial disease|mitochondrial disease
957805|NCT03432871|Nicotinamide Riboside|nicotinamide riboside
957806|NCT03432871|Niagen|niagen
957807|NCT03432871|PEO|peo
957808|NCT03432871|Single deletion|single deletion
957809|NCT03432871|mtDNA deletion|mtdna deletion
957810|NCT03432871|MELAS|melas
957811|NCT03432871|m.3243A>G|m.3243a>g
957812|NCT03432858|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
957813|NCT03432858|Prophylactic Antibiotics|prophylactic antibiotics
957814|NCT03432819|Latino, men who have sex with men|latino, men who have sex with men
957815|NCT03432806|Tissue samples|tissue samples
957816|NCT03432806|17-594|17-594
957817|NCT03432793|DDI|ddi
957818|NCT03432793|Itraconazole|itraconazole
957819|NCT03432793|Fluvoxamine|fluvoxamine
957820|NCT03432793|TD-9855|td-9855
957821|NCT03432793|Smoking|smoking
957822|NCT03432793|Caffeine|caffeine
957823|NCT03432793|CYP1A2|cyp1a2
957824|NCT03432793|CYP3A4|cyp3a4
957826|NCT03432767|postpartum hemorrhage|postpartum hemorrhage
957827|NCT03432767|vaginal delivery|vaginal delivery
957828|NCT03432767|shock index|shock index
957829|NCT03432767|hemoglobin|hemoglobin
957830|NCT03432754|Older adults|older adults
957831|NCT03432754|Mindfulness|mindfulness
957832|NCT03432754|Mind wandering|mind wandering
957833|NCT03432754|Health education|health education
957834|NCT03432754|Working memory|working memory
957835|NCT03432754|Cognitive functioning|cognitive functioning
957836|NCT03432754|Emotion regulation|emotion regulation
957837|NCT03432754|Emotional functioning|emotional functioning
957838|NCT03432728|Antioxidant Capacity|antioxidant capacity
957839|NCT03432715|School|school
957840|NCT03432715|Policy|policy
957841|NCT03432715|Nutrition|nutrition
957842|NCT03432715|Physical Activity|physical activity
957843|NCT03432715|Local Wellness Policy|local wellness policy
957844|NCT03432676|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
957845|NCT03432676|Homologous recombination repair deficiency|homologous recombination repair deficiency
957846|NCT03432676|HRD|hrd
957847|NCT03432676|Pembrolizumab|pembrolizumab
957848|NCT03432676|Keytruda|keytruda
957849|NCT03432676|MK-3475|mk-3475
957850|NCT03432676|SCH-900475|sch-900475
957851|NCT03432676|Epacadostat|epacadostat
957852|NCT03432676|INCB024360|incb024360
957853|NCT03432663|Atrial Fibrillation|atrial fibrillation
959039|NCT03425045|treatment|treatment
957857|NCT03432637|Complications, Postoperative/Perioperative|complications, postoperative/perioperative
957859|NCT03432637|non-intubated anaesthesia|non-intubated anaesthesia
957860|NCT03432611|mHealth|mhealth
957861|NCT03432611|dysmenorrhea|dysmenorrhea
957862|NCT03432611|acupressure|acupressure
957863|NCT03432611|self-management|self-management
957864|NCT03432611|self-care|self-care
957865|NCT03432585|feasibility|feasibility
957866|NCT03432585|attendance|attendance
957867|NCT03432585|conference|conference
957868|NCT03432559|endoscopy|endoscopy
957869|NCT03432533|Post-Menopausal osteoporosis|post-menopausal osteoporosis
957875|NCT03432481|Osteoarthritis, Knee|osteoarthritis, knee
957876|NCT03432468|Hypertension|hypertension
957877|NCT03432468|Left Ventricular Hypertrophy|left ventricular hypertrophy
957878|NCT03432468|Women|women
957879|NCT03432455|Incidence|incidence
957880|NCT03432455|prevalence|prevalence
957881|NCT03432455|epidemiology|epidemiology
957882|NCT03432455|juvenile dermatomyositis|juvenile dermatomyositis
957883|NCT03432455|inflammatory myopathy|inflammatory myopathy
957884|NCT03432429|Tumours|tumours
957885|NCT03432429|Breast conserving surgery|breast conserving surgery
957886|NCT03432429|Margin assessment technology|margin assessment technology
957887|NCT03432429|Mass spectrometry|mass spectrometry
957888|NCT03432416|Healthy Women|healthy women
957889|NCT03432416|Female Contraception|female contraception
957890|NCT03432416|Vaginal Ring|vaginal ring
957891|NCT03432416|Contraceptive Vaginal Ring|contraceptive vaginal ring
957892|NCT03432364|Beta thalassemia|beta thalassemia
957893|NCT03432364|Beta-thalassemia|beta-thalassemia
957894|NCT03432364|Thalassemia major|thalassemia major
957895|NCT03432364|Cooley's anemia|cooley's anemia
957896|NCT03432364|ZFN mediated genome editing|zfn mediated genome editing
957897|NCT03432364|zinc finger nuclease|zinc finger nuclease
957898|NCT03432351|EEG|eeg
957899|NCT03432351|Electroencephalography|electroencephalography
957900|NCT03432351|Pediatric anesthesia|pediatric anesthesia
957901|NCT03432299|Thyroid Diseases|thyroid diseases
957902|NCT03432299|Radiofrequency Ablation|radiofrequency ablation
957903|NCT03432260|Alcoholic Hepatitis|alcoholic hepatitis
957904|NCT03432260|acute alcoholic liver disease|acute alcoholic liver disease
957905|NCT03432260|progressive inflammatory liver injury|progressive inflammatory liver injury
957906|NCT03432260|IV infusion|iv infusion
957907|NCT03432247|music therapy|music therapy
957908|NCT03432247|bone pain|bone pain
957909|NCT03432247|pain management|pain management
957910|NCT03432247|advanced cancer|advanced cancer
957911|NCT03432234|COPD|copd
957912|NCT03432234|Microbiome|microbiome
957913|NCT03432234|Exacerbation|exacerbation
957914|NCT03432221|Cognition, antidepressants drugs, SNRI, hot cognition, functioning|cognition, antidepressants drugs, snri, hot cognition, functioning
957915|NCT03432182|Premature infant|premature infant
957916|NCT03432182|sleep state|sleep state
957917|NCT03432182|body movement|body movement
957918|NCT03432182|neurodevelopmental outcome|neurodevelopmental outcome
957919|NCT03432156|immunotherapy|immunotherapy
957920|NCT03432156|NSCLC|nsclc
957921|NCT03432143|Peer Review|peer review
957922|NCT03432143|Community-Based Research|community-based research
957923|NCT03432143|Community Perspectives|community perspectives
957924|NCT03432130|hip-hop dance, injuries, body fat|hip-hop dance, injuries, body fat
957925|NCT03432117|respiratory rehabilitation|respiratory rehabilitation
957926|NCT03432117|personalized mobile services|personalized mobile services
957927|NCT03432091|melatonin|melatonin
957928|NCT03432091|melatonin receptor agonist|melatonin receptor agonist
957929|NCT03432091|circadian-clock-related genes|circadian-clock-related genes
957930|NCT03432065|Autism Spectrum Disorders|autism spectrum disorders
957931|NCT03432065|Anxiety|anxiety
957932|NCT03432065|Pervasive Developmental Disorders|pervasive developmental disorders
957933|NCT03432065|Buspar|buspar
957934|NCT03432065|Buspirone|buspirone
957935|NCT03432052|centralization|centralization
957936|NCT03431987|Marijuana|marijuana
957937|NCT03431987|Alcohol|alcohol
957938|NCT03431987|THC|thc
957939|NCT03431987|fMRI|fmri
957940|NCT03431987|MRI|mri
957941|NCT03431987|Driving Simulation|driving simulation
957942|NCT03431987|Cannabis|cannabis
957943|NCT03431987|Intoxication|intoxication
957944|NCT03431974|Anti-folate|anti-folate
957945|NCT03431935|Health Care Transition|health care transition
957946|NCT03431935|Adolescent|adolescent
957947|NCT03431935|Young Adult|young adult
957948|NCT03431909|Human Urinary Kallidinogenase|human urinary kallidinogenase
957949|NCT03431909|Acute ischemic stroke|acute ischemic stroke
957950|NCT03431909|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
957951|NCT03431909|CT perfusion|ct perfusion
957952|NCT03431857|Shoulder arthroplasty|shoulder arthroplasty
957953|NCT03431857|Medical device|medical device
957954|NCT03431857|Shoulder prosthesis|shoulder prosthesis
957955|NCT03431857|Performance|performance
957956|NCT03431805|Randomized|randomized
957957|NCT03431805|double blind placebo controlled trial|double blind placebo controlled trial
957958|NCT03431805|prevention|prevention
957959|NCT03431805|tranexamic acid|tranexamic acid
957960|NCT03431805|postpartum hemorrhage|postpartum hemorrhage
957961|NCT03431805|cesarean|cesarean
957962|NCT03431792|CDH, FETO, fetal surgery, long tail FETO|cdh, feto, fetal surgery, long tail feto
957963|NCT03431766|chlorhexidine gel|chlorhexidine gel
957964|NCT03431766|dental implant|dental implant
957965|NCT03431753|STHLM3-test|sthlm3-test
957966|NCT03431753|prostate cancer|prostate cancer
957967|NCT03431753|MR-imaging|mr-imaging
957968|NCT03431753|MR-targeted biopsy|mr-targeted biopsy
957969|NCT03431753|MRI|mri
957970|NCT03431753|Novel biomarkers|novel biomarkers
957971|NCT03431753|Genetic screening|genetic screening
957972|NCT03431636|sports for people with disabilities|sports for people with disabilities
957973|NCT03431636|immersion therapy|immersion therapy
957974|NCT03431636|cryotherapy|cryotherapy
957975|NCT03431636|physiotherapy|physiotherapy
957976|NCT03431571|ReLEx|relex
957977|NCT03431571|SMILE|smile
957978|NCT03431571|Hyperopia|hyperopia
957979|NCT03431571|VisuMax|visumax
957980|NCT03431571|Small Incision Lenticule Extraction|small incision lenticule extraction
957981|NCT03431571|Lenticule|lenticule
957982|NCT03431571|Farsightedness|farsightedness
957983|NCT03431558|Bovine Lactoferrin, Neonatal infection, Low Birth Weight|bovine lactoferrin, neonatal infection, low birth weight
957984|NCT03431532|anesthesia|anesthesia
957985|NCT03431532|general anesthesia|general anesthesia
957986|NCT03431532|neuraxial anesthesia|neuraxial anesthesia
957987|NCT03431532|monocyte funtion|monocyte funtion
957988|NCT03431532|CD 14, HLA-DR|cd 14, hla-dr
957989|NCT03431532|Interleukines|interleukines
957990|NCT03431519|Thoracolumbar fractures|thoracolumbar fractures
957991|NCT03431519|PMMA|pmma
957992|NCT03431519|KIVA|kiva
957993|NCT03431519|PEEK|peek
957994|NCT03431480|cord blood stem cell|cord blood stem cell
957995|NCT03431480|Norwood heart surgery|norwood heart surgery
957996|NCT03431480|congenital|congenital
957997|NCT03431480|heart|heart
957998|NCT03431467|ECMO|ecmo
957999|NCT03431467|Heart Failure|heart failure
958000|NCT03431467|RCT|rct
958001|NCT03431467|Mechanical unloading|mechanical unloading
958002|NCT03431415|Lung|lung
958003|NCT03431415|Cancer|cancer
958004|NCT03431415|Early-Stage|early-stage
958005|NCT03431415|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
958006|NCT03431415|VATS|vats
958007|NCT03431415|SBRT|sbrt
958008|NCT03431415|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
958009|NCT03431376|potato consumption|potato consumption
958010|NCT03431376|hypertension|hypertension
958011|NCT03431376|CHNS|chns
958012|NCT03431311|MSI|msi
958013|NCT03431298|Knee osteoarthritis|knee osteoarthritis
958014|NCT03431298|Physical activity|physical activity
958015|NCT03431298|Exercise|exercise
958016|NCT03431272|contact lens, discomfort, dry eye|contact lens, discomfort, dry eye
958017|NCT03431233|protein-enriched bar|protein-enriched bar
958018|NCT03431233|food intake|food intake
958019|NCT03431233|appetite|appetite
958020|NCT03431233|satiety related hormones|satiety related hormones
958021|NCT03431194|Acute Kidney Injury|acute kidney injury
958022|NCT03431194|midodrine|midodrine
958023|NCT03431194|intensive care unit|intensive care unit
958024|NCT03431168|STI Prevention|sti prevention
958025|NCT03431168|Cameroon|cameroon
958026|NCT03431168|sub-Saharan Africa|sub-saharan africa
958027|NCT03431168|HIV pregnancy|hiv pregnancy
958028|NCT03431168|Malaria in pregnancy|malaria in pregnancy
958029|NCT03431155|children|children
958030|NCT03431155|cancer|cancer
958031|NCT03431155|mother|mother
958032|NCT03431155|uncertainty|uncertainty
958033|NCT03431155|nursing intervention|nursing intervention
958034|NCT03431155|education|education
958158|NCT03430297|Melanoma|melanoma
958035|NCT03431129|Xenon MRI, Lung, Radiation Induced Lung Injury,|xenon mri, lung, radiation induced lung injury,
958036|NCT03431103|overlap|overlap
958037|NCT03431103|exercise|exercise
958038|NCT03431103|inflammation|inflammation
958039|NCT03431051|Healthy Beverage Initiative, Sugar Sweetened Beverages|healthy beverage initiative, sugar sweetened beverages
958040|NCT03431012|Adherence, medication|adherence, medication
958041|NCT03431012|Pandemic Influenza|pandemic influenza
958042|NCT03430973|aggressive driving; road rage|aggressive driving; road rage
958043|NCT03430960|mCare|mcare
958044|NCT03430960|post surgery|post surgery
958045|NCT03430960|mobile|mobile
958046|NCT03430960|healthcare|healthcare
958047|NCT03430960|application|application
958048|NCT03430947|Stereotactic radiosurgery|stereotactic radiosurgery
958049|NCT03430947|BRAF inhibitor|braf inhibitor
958050|NCT03430947|MEK inhibitor|mek inhibitor
958051|NCT03430947|Vemurafenib|vemurafenib
958052|NCT03430947|Cobimetinib|cobimetinib
958053|NCT03430934|Mohs tumor|mohs tumor
959040|NCT03425045|placebo|placebo
958065|NCT03430882|TAK228|tak228
958066|NCT03430882|Paclitaxel|paclitaxel
958067|NCT03430882|Taxol|taxol
958068|NCT03430882|Carboplatin|carboplatin
958069|NCT03430882|Paraplatin|paraplatin
958070|NCT03430869|late-life depression|late-life depression
958071|NCT03430869|major depressive disorder|major depressive disorder
958072|NCT03430869|Alzheimer's disease dementia|alzheimer's disease dementia
958073|NCT03430869|neurodegeneration|neurodegeneration
958074|NCT03430869|amyloid plague, tau protein|amyloid plague, tau protein
958075|NCT03430856|Oral insulin|oral insulin
958085|NCT03430791|bevacizumab-naïve|bevacizumab-naïve
958086|NCT03430791|recurrent glioblastoma|recurrent glioblastoma
958087|NCT03430739|Deformational Plagiocephaly, Orthotics, Helmet|deformational plagiocephaly, orthotics, helmet
958088|NCT03430726|Probiotics; paediatrics; gut microbiota|probiotics; paediatrics; gut microbiota
958089|NCT03430713|tooth color|tooth color
958090|NCT03430713|measurement|measurement
958091|NCT03430713|accuracy|accuracy
958092|NCT03430713|shade guide|shade guide
958093|NCT03430713|spectrophotometer|spectrophotometer
958094|NCT03430700|platinum-resistant|platinum-resistant
958095|NCT03430648|Tau protein|tau protein
958096|NCT03430648|PET imaging|pet imaging
958097|NCT03430648|Alzheimer's disease|alzheimer's disease
958098|NCT03430609|endometrioma|endometrioma
958099|NCT03430609|laparoscopy|laparoscopy
958100|NCT03430609|ovarian reserve|ovarian reserve
958101|NCT03430609|anti-mullerian hormone|anti-mullerian hormone
958102|NCT03430583|Fontan|fontan
958103|NCT03430583|Ultrasound|ultrasound
958104|NCT03430583|Magnetic Resonance Imaging Elastography|magnetic resonance imaging elastography
958105|NCT03430570|Adolescent risk behavior|adolescent risk behavior
958106|NCT03430570|digital|digital
958107|NCT03430570|early adolescence|early adolescence
958108|NCT03430570|emotion regulation|emotion regulation
958109|NCT03430570|prevention|prevention
958110|NCT03430557|Endodontic surgery|endodontic surgery
958111|NCT03430544|cariprazine|cariprazine
958112|NCT03430544|fMRI|fmri
958113|NCT03430544|D3 receptor|d3 receptor
958114|NCT03430544|cocaine use disorder|cocaine use disorder
958115|NCT03430544|urine|urine
958116|NCT03430518|Durvalumab (MEDI4736) (Anti-PDL1)|durvalumab (medi4736) (anti-pdl1)
958117|NCT03430518|Eribulin|eribulin
958118|NCT03430518|Recurrent Ovarian cancer|recurrent ovarian cancer
958119|NCT03430518|Her2-negative Metastatic Breast Cancer|her2-negative metastatic breast cancer
958120|NCT03430518|Ovarian cancer|ovarian cancer
958121|NCT03430518|Metastatic Breast Cancer|metastatic breast cancer
958122|NCT03430505|Asthma, noninvasive ventilation|asthma, noninvasive ventilation
958123|NCT03430492|Psychological Resilience|psychological resilience
958124|NCT03430492|Biomarkers|biomarkers
958125|NCT03430492|Molecular Fingerprint|molecular fingerprint
958126|NCT03430492|Quality of Life (QoL)|quality of life (qol)
958127|NCT03430492|Body and Mind|body and mind
958128|NCT03430492|CD-RISC|cd-risc
958129|NCT03430492|SF-36|sf-36
958130|NCT03430453|Regional Anesthesia|regional anesthesia
958131|NCT03430453|Ultrasound guidance|ultrasound guidance
958132|NCT03430453|Nerve stimulation|nerve stimulation
958133|NCT03430453|Orthopedic surgery|orthopedic surgery
958138|NCT03430401|memory encoding|memory encoding
958139|NCT03430401|functional performance|functional performance
958140|NCT03430388|vaccine|vaccine
958141|NCT03430388|Yellow Fever|yellow fever
958142|NCT03430388|Rheumatic disease|rheumatic disease
958143|NCT03430375|wheelchair cushion|wheelchair cushion
958144|NCT03430375|pressure mapping|pressure mapping
958145|NCT03430375|pressure wounds|pressure wounds
958146|NCT03430349|IPV-primed|ipv-primed
958147|NCT03430349|adults|adults
958148|NCT03430349|vaccination|vaccination
958149|NCT03430349|containment|containment
958150|NCT03430349|shedding|shedding
958151|NCT03430349|genetic stability|genetic stability
958152|NCT03430349|safety|safety
958153|NCT03430349|neurovirulence|neurovirulence
958154|NCT03430349|novel polio vaccine candidates|novel polio vaccine candidates
958155|NCT03430297|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
958156|NCT03430297|the First Line Therapy|the first line therapy
958157|NCT03430297|Dacarbazine|dacarbazine
958159|NCT03430284|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
958160|NCT03430284|Diabetic Vascular Complications|diabetic vascular complications
958161|NCT03430284|Multifactorial Intervention|multifactorial intervention
958162|NCT03430284|Digital and Network Management|digital and network management
958163|NCT03430245|Circumference reduction|circumference reduction
958164|NCT03430219|AccuFill|accufill
958165|NCT03430219|Injectable Calcium Phosphate|injectable calcium phosphate
958166|NCT03430219|Subchondroplasty|subchondroplasty
958167|NCT03430206|high-flow|high-flow
958168|NCT03430206|nasal cannula|nasal cannula
958169|NCT03430206|laryngoscopy|laryngoscopy
958170|NCT03430206|otolaryngology|otolaryngology
958171|NCT03430206|oxygen|oxygen
958172|NCT03430206|desaturation|desaturation
958173|NCT03430206|anesthesia|anesthesia
958174|NCT03430206|pediatric|pediatric
958175|NCT03430193|rehabilitation|rehabilitation
958176|NCT03430193|multi-disciplinary rehabilitation|multi-disciplinary rehabilitation
958177|NCT03430193|clinical pathway|clinical pathway
958178|NCT03430193|Fragility|fragility
958179|NCT03430167|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
958180|NCT03430167|post operative physical therapy|post operative physical therapy
958181|NCT03430115|Obese|obese
958182|NCT03430115|Exercise|exercise
958183|NCT03430089|Influenza|influenza
958184|NCT03430089|Flu|flu
958185|NCT03430076|vascular prostheses|vascular prostheses
958186|NCT03430076|heparin|heparin
958187|NCT03430076|ischemia lesions|ischemia lesions
958188|NCT03430076|vascular|vascular
958189|NCT03430076|critical limb ischemia lesions|critical limb ischemia lesions
958190|NCT03430063|Advanced non-squamous NSCLC|advanced non-squamous nsclc
958191|NCT03430063|Advanced squamous NSCLC|advanced squamous nsclc
958192|NCT03430063|Metastatic non-squamous NSCLC|metastatic non-squamous nsclc
958193|NCT03430063|Metastatic squamous NSCLC|metastatic squamous nsclc
958194|NCT03430050|Progesterone|progesterone
958195|NCT03430050|Ovarian hormones|ovarian hormones
958196|NCT03430050|Gender|gender
958197|NCT03430050|Cannabis|cannabis
958198|NCT03430050|Withdrawal|withdrawal
958199|NCT03430050|Cognitive functioning|cognitive functioning
958200|NCT03430037|Inflammation|inflammation
958201|NCT03430037|Frailty|frailty
958202|NCT03430024|Myosin VI|myosin vi
958203|NCT03430024|Estrogen receptor|estrogen receptor
958204|NCT03430011|JCARH125|jcarh125
958205|NCT03430011|chimeric antigen receptor|chimeric antigen receptor
958206|NCT03430011|multiple myeloma|multiple myeloma
958207|NCT03430011|CAR T cells|car t cells
958208|NCT03430011|B-cell maturation antigen|b-cell maturation antigen
958209|NCT03430011|BCMA|bcma
958210|NCT03430011|autologous T-cell therapy|autologous t-cell therapy
958211|NCT03430011|immunotherapy|immunotherapy
958212|NCT03429998|cardiovascular risk|cardiovascular risk
958213|NCT03429998|evolocumab|evolocumab
958214|NCT03429998|LDL-apheresis|ldl-apheresis
958215|NCT03429985|Sexual and Reproductive Health|sexual and reproductive health
958216|NCT03429985|Parent-based Intervention|parent-based intervention
958217|NCT03429985|Sexual risk behavior|sexual risk behavior
958218|NCT03429985|Adolescent males|adolescent males
958219|NCT03429985|Father-son Intervention|father-son intervention
958220|NCT03429972|Paclitaxel|paclitaxel
958221|NCT03429972|Neuropathy|neuropathy
1650828|NCT00192829|Thrombosis|thrombosis
958222|NCT03429920|Fermented Soy|fermented soy
958223|NCT03429920|Cardiovascular Disease|cardiovascular disease
958224|NCT03429920|Inflammation|inflammation
958225|NCT03429920|DNA Methylation|dna methylation
958226|NCT03429907|Malignant neoplasm of breast|malignant neoplasm of breast
958227|NCT03429907|Mind-Body Exercises|mind-body exercises
958228|NCT03429907|Questionnaires|questionnaires
958229|NCT03429907|Surveys|surveys
958230|NCT03429868|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
958231|NCT03429868|Nead neck cancer|nead neck cancer
958232|NCT03429868|Prognosis|prognosis
958233|NCT03429868|PET|pet
958234|NCT03429868|MRI|mri
958235|NCT03429855|Physiotherapy|physiotherapy
958236|NCT03429855|Trunk control|trunk control
958237|NCT03429855|Bobath concept|bobath concept
958238|NCT03429855|Stroke rehabilitation|stroke rehabilitation
958239|NCT03429829|Caries|caries
958240|NCT03429829|Fluoride Varnish|fluoride varnish
958241|NCT03429829|Dental Health|dental health
958242|NCT03429803|low-grade glioma|low-grade glioma
958243|NCT03429790|caesarean section|caesarean section
958244|NCT03429790|cell salvage|cell salvage
958245|NCT03429790|blood transfusion|blood transfusion
958246|NCT03429777|Smartphone|smartphone
958247|NCT03429777|Medical application|medical application
958248|NCT03429777|Hearing-in-noise test|hearing-in-noise test
958249|NCT03429777|Digits-in-noise test|digits-in-noise test
958250|NCT03429777|Speech reception threshold|speech reception threshold
958251|NCT03429777|Hearing Loss|hearing loss
958252|NCT03429777|Hearing Disorders|hearing disorders
958253|NCT03429777|Hearing Abnormalities|hearing abnormalities
958254|NCT03429777|Tinnitus|tinnitus
958255|NCT03429777|Hearing aids|hearing aids
958256|NCT03429777|Cochlear implants|cochlear implants
958453|NCT03428490|Alcohol Use Disorder|alcohol use disorder
958257|NCT03429751|lung ultrasound, fluid, hysterectomy, B lines|lung ultrasound, fluid, hysterectomy, b lines
958258|NCT03429738|Ibuprofen|ibuprofen
958259|NCT03429738|phase-I-study|phase-i-study
958260|NCT03429738|pharmacokinetic|pharmacokinetic
958261|NCT03429738|combination therapy|combination therapy
958262|NCT03429738|bioavailability|bioavailability
958263|NCT03429738|bioequivalence|bioequivalence
958264|NCT03429738|pseudoephedrine hydrochloride|pseudoephedrine hydrochloride
958265|NCT03429712|CT Scan|ct scan
958266|NCT03429686|dementia|dementia
958267|NCT03429686|reminiscence therapy|reminiscence therapy
958268|NCT03429686|touch screen technology|touch screen technology
958269|NCT03429686|digital reminiscence therapy|digital reminiscence therapy
958270|NCT03429673|Chinese|chinese
958271|NCT03429673|real-world evidences|real-world evidences
958272|NCT03429673|NSCLC|nsclc
958273|NCT03429673|surgeries|surgeries
958274|NCT03429660|Disease epidemiology|disease epidemiology
958275|NCT03429660|Risk assessment|risk assessment
958276|NCT03429660|Drug utilisation study|drug utilisation study
958277|NCT03429660|Effectiveness evaluation|effectiveness evaluation
958278|NCT03429582|Human Papilloma Virus|human papilloma virus
958279|NCT03429582|Thermoablation|thermoablation
958280|NCT03429582|Thermocoagulation|thermocoagulation
958281|NCT03429582|Cryotherapy|cryotherapy
958282|NCT03429582|Cervica Pre-cancer|cervica pre-cancer
958283|NCT03429582|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
958284|NCT03429569|Keratoconus|keratoconus
958285|NCT03429569|Cross-linking|cross-linking
958286|NCT03429569|Confocal microscopy|confocal microscopy
958287|NCT03429569|Postoperative morphological|postoperative morphological
958288|NCT03429569|Iotonphoresis|iotonphoresis
958289|NCT03429556|pain, neurotoxin|pain, neurotoxin
958290|NCT03429517|HDL-C|hdl-c
958291|NCT03429517|Triglycerides|triglycerides
958292|NCT03429517|Non HDL-C and Acute coronary syndrome|non hdl-c and acute coronary syndrome
958293|NCT03429504|Obesity|obesity
958294|NCT03429504|Breast cancer|breast cancer
958295|NCT03429504|Body mass index|body mass index
958296|NCT03429478|Music|music
958297|NCT03429478|Laparoscopic Surgery|laparoscopic surgery
958298|NCT03429478|Sterile Inflammation|sterile inflammation
958299|NCT03429465|Digital Health Intervention|digital health intervention
958300|NCT03429465|Executive Function|executive function
958301|NCT03429465|Depression|depression
958302|NCT03429465|Anxiety|anxiety
958303|NCT03429452|structural heart abnormality|structural heart abnormality
958304|NCT03429452|spatial method|spatial method
958305|NCT03429452|echocardiography|echocardiography
958306|NCT03429452|electrocardiogram|electrocardiogram
958307|NCT03429452|mediterranean diet|mediterranean diet
958308|NCT03429452|exercise|exercise
958309|NCT03429452|social status|social status
958310|NCT03429452|rural|rural
958311|NCT03429439|chronic hepatitis B|chronic hepatitis b
958312|NCT03429439|intestinal microbiota transplantation|intestinal microbiota transplantation
958313|NCT03429439|microbiota|microbiota
958314|NCT03429439|antiviral therapy|antiviral therapy
958315|NCT03429426|Rheumatoid Arthritis|rheumatoid arthritis
958316|NCT03429426|High-resolution peripheral quantitative computed tomography|high-resolution peripheral quantitative computed tomography
958317|NCT03429426|Radiography|radiography
958318|NCT03429413|Health Information Technology (HIT)|health information technology (hit)
958319|NCT03429387|Diagnosis|diagnosis
958320|NCT03429348|Firefighter|firefighter
958321|NCT03429348|Post-Fire Rehabilitation|post-fire rehabilitation
958322|NCT03429348|Sauna|sauna
958323|NCT03429335|Transition|transition
958324|NCT03429335|Adolescents|adolescents
958325|NCT03429335|Smart phone|smart phone
958326|NCT03429322|traumatic brain injury|traumatic brain injury
958327|NCT03429322|pragmatic clinical trial|pragmatic clinical trial
958328|NCT03429322|telemedicine|telemedicine
958329|NCT03429322|cost|cost
958330|NCT03429309|telomere|telomere
958331|NCT03429309|propofol|propofol
958332|NCT03429309|anesthesia-induction|anesthesia-induction
958333|NCT03429296|Cancer|cancer
958334|NCT03429296|Autohypnosis|autohypnosis
958335|NCT03429296|Quality of life|quality of life
958336|NCT03429283|Epidemiology,|epidemiology,
958337|NCT03429283|Achromobacter xylosoxidans,|achromobacter xylosoxidans,
958338|NCT03429283|antibiotic resistance|antibiotic resistance
958339|NCT03429257|Aflatoxin B1|aflatoxin b1
958340|NCT03429257|Environmental Enteric Dysfunction|environmental enteric dysfunction
958341|NCT03429257|L:M Test|l:m test
958342|NCT03429257|Pregnancy|pregnancy
958343|NCT03429257|Linear Growth Faltering|linear growth faltering
958344|NCT03429257|Birth Outcomes|birth outcomes
958345|NCT03429257|Uganda|uganda
958346|NCT03429218|Tolero, Phase 1, First in Human, Solid Tumors, Advanced Malignancy, Cancer|tolero, phase 1, first in human, solid tumors, advanced malignancy, cancer
958347|NCT03429205|Sleeve gastrectomy|sleeve gastrectomy
958348|NCT03429205|Roux-Y gastric bypass|roux-y gastric bypass
958349|NCT03429205|Single anastomosis gastric bypass|single anastomosis gastric bypass
958350|NCT03429205|Hypothermia|hypothermia
958351|NCT03429205|External heating blanket|external heating blanket
959233|NCT03423914|coping|coping
958454|NCT03428490|Social Anxiety Disorder|social anxiety disorder
958352|NCT03429192|Chinese, real-world evidences, NSCLC, lymph skip metastases|chinese, real-world evidences, nsclc, lymph skip metastases
958353|NCT03429179|butorphanol|butorphanol
958354|NCT03429179|preoperative anxiety|preoperative anxiety
958355|NCT03429179|sedation|sedation
958356|NCT03429153|endocarditis|endocarditis
958357|NCT03429127|balanced fluids, neurosurgery, plasma osmolality|balanced fluids, neurosurgery, plasma osmolality
958358|NCT03429101|Poziotinib|poziotinib
958359|NCT03429101|HER2 Positive|her2 positive
958360|NCT03429101|T-DM1|t-dm1
958361|NCT03429075|depression|depression
958363|NCT03429075|major depression|major depression
958364|NCT03429075|major depressive disorder|major depressive disorder
958365|NCT03429075|unipolar depression|unipolar depression
958366|NCT03429075|psilocybin|psilocybin
958367|NCT03429075|psychedelics|psychedelics
958368|NCT03429075|psychedelic|psychedelic
958369|NCT03429075|escitalopram|escitalopram
958370|NCT03429075|ssri|ssri
958371|NCT03429062|balance|balance
958372|NCT03429062|gait|gait
958373|NCT03429062|Multiple Sclerosis|multiple sclerosis
958374|NCT03429036|Genomic DNA|genomic dna
958375|NCT03429036|DNA Banking|dna banking
958376|NCT03429036|Tissue Sample|tissue sample
958377|NCT03429036|Saliva|saliva
958378|NCT03429036|Blood Collection|blood collection
958379|NCT03429023|Mucormycosis|mucormycosis
958380|NCT03429010|Anesthesia|anesthesia
958381|NCT03429010|Hip Fracture|hip fracture
958382|NCT03428971|atrial fibrillation|atrial fibrillation
958383|NCT03428971|p-wave|p-wave
958384|NCT03428971|hospitalization|hospitalization
958385|NCT03428958|Relapsed metastatic adenocarcinoma of colon/rectum|relapsed metastatic adenocarcinoma of colon/rectum
958386|NCT03428945|TrialNet|trialnet
958387|NCT03428932|Insulin pump|insulin pump
958388|NCT03428932|Closed loop|closed loop
958389|NCT03428932|Brain development|brain development
958390|NCT03428932|Pediatric|pediatric
958391|NCT03428932|Type 1 Diabetes|type 1 diabetes
958393|NCT03428932|Cognitive development|cognitive development
958394|NCT03428919|ICSI|icsi
958395|NCT03428919|Conventional IVF|conventional ivf
958396|NCT03428919|Non-male factor|non-male factor
958397|NCT03428906|intranasal oxytocin|intranasal oxytocin
958398|NCT03428906|functional brain network|functional brain network
958399|NCT03428906|multiple tasks|multiple tasks
958400|NCT03428906|resting state|resting state
958401|NCT03428893|Exercise, mhealth, physical therapy|exercise, mhealth, physical therapy
958402|NCT03428880|quadratus lumborum block|quadratus lumborum block
958403|NCT03428880|cesarean section|cesarean section
958404|NCT03428880|spinal morphine|spinal morphine
958405|NCT03428880|ultrasound guidance|ultrasound guidance
958406|NCT03428841|audiometry|audiometry
958407|NCT03428841|dural puncture|dural puncture
958408|NCT03428841|epidural|epidural
958409|NCT03428828|Neurofeedback|neurofeedback
958410|NCT03428828|major depressive disorder|major depressive disorder
958411|NCT03428828|treatment resistant|treatment resistant
958412|NCT03428828|amygdala|amygdala
958413|NCT03428789|breast reconstruction|breast reconstruction
958414|NCT03428789|DIEP flap|diep flap
958415|NCT03428789|Nerve coaptation|nerve coaptation
958416|NCT03428789|Sensory recovery|sensory recovery
958417|NCT03428763|Arthritis, Rheumatoid|arthritis, rheumatoid
958418|NCT03428763|Telerehabilitation|telerehabilitation
958419|NCT03428763|controlled randomised trial|controlled randomised trial
958420|NCT03428737|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period
958421|NCT03428711|Superficial Venous Thrombosis of Leg|superficial venous thrombosis of leg
958422|NCT03428711|secondary prevention|secondary prevention
958423|NCT03428711|prophylaxis|prophylaxis
958424|NCT03428698|third molar extraction|third molar extraction
958425|NCT03428698|hyaluronic acid|hyaluronic acid
958426|NCT03428659|Motor function|motor function
958427|NCT03428659|Recovery|recovery
958428|NCT03428659|Gait|gait
958429|NCT03428659|Magnetic resonance imaging|magnetic resonance imaging
958430|NCT03428646|Eczema|eczema
958431|NCT03428620|Functional Performance|functional performance
958432|NCT03428620|Rehabilitation|rehabilitation
958433|NCT03428620|Manipulation|manipulation
958434|NCT03428581|Axillary|axillary
958435|NCT03428581|Lymph node|lymph node
958436|NCT03428581|Dissection|dissection
958437|NCT03428581|Reverse Mapping|reverse mapping
958438|NCT03428581|Lympho-venous Bypass|lympho-venous bypass
958439|NCT03428568|Herbal Melanin|herbal melanin
958440|NCT03428568|H.Pylori|h.pylori
958441|NCT03428542|yoga|yoga
958442|NCT03428542|stress|stress
958443|NCT03428542|anxiety|anxiety
958444|NCT03428542|depression|depression
958445|NCT03428542|sleep quality|sleep quality
958446|NCT03428542|physiological stress|physiological stress
958447|NCT03428542|biomarkers|biomarkers
958448|NCT03428503|paracetamol|paracetamol
958449|NCT03428503|dexketoprofen|dexketoprofen
958450|NCT03428503|emergency department|emergency department
958451|NCT03428503|musculoskeletal pain|musculoskeletal pain
958452|NCT03428490|Integrated Treatment|integrated treatment
958456|NCT03428490|Cognitive Behavioral Therapy|cognitive behavioral therapy
958457|NCT03428477|Liver metastases|liver metastases
958458|NCT03428477|Colon Cancer|colon cancer
958459|NCT03428451|TURP|turp
958460|NCT03428451|hypertonic saline|hypertonic saline
958461|NCT03428451|TURP syndrome|turp syndrome
958462|NCT03428451|hyponatraemia|hyponatraemia
958463|NCT03428412|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
958464|NCT03428412|Acute exacerbation|acute exacerbation
958465|NCT03428412|Traditional Chinese medicine|traditional chinese medicine
958466|NCT03428399|breast reconstruction|breast reconstruction
958467|NCT03428399|mastectomy|mastectomy
958469|NCT03428360|Seizure|seizure
958470|NCT03428347|Ebola|ebola
958471|NCT03428347|Ebola Virus Disease|ebola virus disease
958472|NCT03428347|Monoclonal antibody|monoclonal antibody
958473|NCT03428334|Sputum leukocyte density|sputum leukocyte density
958474|NCT03428321|Microwave ablation|microwave ablation
958475|NCT03428321|Percutaneous thermalablation|percutaneous thermalablation
958476|NCT03428321|High risk location|high risk location
958477|NCT03428321|Articifial pneumothorax|articifial pneumothorax
958478|NCT03428321|Lipiodol marked|lipiodol marked
958479|NCT03428321|Prognostic factor|prognostic factor
958480|NCT03428295|artificial pancreas|artificial pancreas
958481|NCT03428295|automated insulin delivery|automated insulin delivery
958482|NCT03428295|hybrid closed loop|hybrid closed loop
958483|NCT03428295|APDS|apds
958484|NCT03428295|fully automated closed loop|fully automated closed loop
958485|NCT03428269|simulation|simulation
958486|NCT03428269|clinical reasoning|clinical reasoning
958487|NCT03428269|patient deterioration|patient deterioration
958488|NCT03428217|Tumor Metabolism|tumor metabolism
958489|NCT03428217|RCC|rcc
958490|NCT03428217|Glutaminase Inhibitor|glutaminase inhibitor
958491|NCT03428217|CB-839|cb-839
958492|NCT03428217|CANTATA|cantata
958493|NCT03428217|TKI|tki
958494|NCT03428217|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
958495|NCT03428217|cabozantinib|cabozantinib
958496|NCT03428217|Cabometyx|cabometyx
958497|NCT03428217|Cometriq|cometriq
958498|NCT03428217|glutaminase|glutaminase
958499|NCT03428217|glutamine|glutamine
958500|NCT03428217|renal cell|renal cell
958501|NCT03428217|clear cell|clear cell
958502|NCT03428217|kidney cancer|kidney cancer
958503|NCT03428217|cMET|cmet
958504|NCT03428217|MET|met
958505|NCT03428217|HGFR|hgfr
958506|NCT03428191|dexmedetomidine|dexmedetomidine
958507|NCT03428191|remifentanil|remifentanil
958508|NCT03428191|prostate puncture and biopsy|prostate puncture and biopsy
958509|NCT03428178|Acute LHON|acute lhon
958510|NCT03428178|onset within three months|onset within three months
958511|NCT03428178|onset between 3 to 6 months|onset between 3 to 6 months
958512|NCT03428178|onset between 6 to 12 months|onset between 6 to 12 months
958513|NCT03428178|onset between 12 to 24 months|onset between 12 to 24 months
958514|NCT03428178|onset between 24 to 60 months|onset between 24 to 60 months
958515|NCT03428178|onset over 60 months|onset over 60 months
958516|NCT03428152|superior hypogastric plexus block|superior hypogastric plexus block
958517|NCT03428152|hysterectomy|hysterectomy
958518|NCT03428152|postoperative pain|postoperative pain
958519|NCT03428139|lumbosacral radicular pain|lumbosacral radicular pain
958520|NCT03428139|pulsed radiofrequency|pulsed radiofrequency
958521|NCT03428139|Alpha Lipoic acid|alpha lipoic acid
958522|NCT03428126|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
958523|NCT03428126|Colorectal Cancer|colorectal cancer
958524|NCT03428126|Colon Cancer|colon cancer
958525|NCT03428126|Durvalumab|durvalumab
958526|NCT03428126|MEDI4736|medi4736
958527|NCT03428126|Trametinib|trametinib
958528|NCT03428126|GSK1120212|gsk1120212
958529|NCT03428100|eczema|eczema
958530|NCT03428100|atopic eczema|atopic eczema
958531|NCT03428074|Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown|chinese, esophageal cancer, surgeries of ivor-lewis/mckeown
958532|NCT03428061|Prevention|prevention
958533|NCT03428061|Disease Management|disease management
958534|NCT03428061|Integrated care|integrated care
958535|NCT03428061|Primary Health Care|primary health care
958536|NCT03428035|Randomized controlled trial|randomized controlled trial
958537|NCT03428035|package insert|package insert
958538|NCT03428035|nocebo|nocebo
958539|NCT03428022|Apatinib|apatinib
958540|NCT03428022|EGFR-TKI resistance|egfr-tki resistance
958541|NCT03428022|slowly progress|slowly progress
958542|NCT03428009|Dystonia|dystonia
958543|NCT03428009|Control|control
958544|NCT03428009|Magnetic Resonance Imagine|magnetic resonance imagine
958545|NCT03428009|Genotype|genotype
958546|NCT03428009|Phenotype|phenotype
958547|NCT03427996|rotational atherectomy|rotational atherectomy
958548|NCT03427957|Hysteroscopy|hysteroscopy
958549|NCT03427957|Endometrial biopsy|endometrial biopsy
958550|NCT03427957|Menopause|menopause
959437|NCT03422783|Biomarker|biomarker
958556|NCT03427931|Islet Transplantation|islet transplantation
958557|NCT03427931|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
958559|NCT03427892|bipolar|bipolar
958560|NCT03427892|depression|depression
958561|NCT03427866|Myelofibrosis|myelofibrosis
958562|NCT03427840|Superior Hypogastric Plexus Block|superior hypogastric plexus block
958563|NCT03427840|Hysterectomy|hysterectomy
958564|NCT03427840|Minimally invasive surgery|minimally invasive surgery
958565|NCT03427840|Laparoscopy|laparoscopy
958566|NCT03427840|Pain|pain
958567|NCT03427840|Gynecologic Disease|gynecologic disease
958568|NCT03427827|PD-1 antibody|pd-1 antibody
958569|NCT03427827|Adjuvant treatment|adjuvant treatment
958570|NCT03427827|Immune checkpoint inhibitors|immune checkpoint inhibitors
958571|NCT03427814|BGB-290|bgb-290
958572|NCT03427814|PARP inhibitor|parp inhibitor
958573|NCT03427814|Phase 3|phase 3
958574|NCT03427814|maintenance therapy|maintenance therapy
958575|NCT03427814|gastric cancer|gastric cancer
958576|NCT03427814|oral treatment|oral treatment
958577|NCT03427801|erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
958578|NCT03427775|multimodal analgesia, quality of recovery, quality of pain management|multimodal analgesia, quality of recovery, quality of pain management
958579|NCT03427762|balance|balance
958580|NCT03427762|postural controll|postural controll
958581|NCT03427762|motor controll|motor controll
958582|NCT03427762|posturgraphy|posturgraphy
958583|NCT03427762|quality of life|quality of life
958584|NCT03427749|Myocardial Blood Flow|myocardial blood flow
958585|NCT03427749|SPECT|spect
958586|NCT03427723|Peripheral intravenous cannulation|peripheral intravenous cannulation
958587|NCT03427723|children|children
958588|NCT03427723|near-infrared light|near-infrared light
958589|NCT03427684|Gastric cancer|gastric cancer
958590|NCT03427684|Chemo-radiotherapy|chemo-radiotherapy
958591|NCT03427684|Phase I study|phase i study
958592|NCT03427684|Hypo-fractionated radiotherapy|hypo-fractionated radiotherapy
958593|NCT03427658|sweet taste|sweet taste
958594|NCT03427658|food preferences|food preferences
958595|NCT03427658|food intake|food intake
958596|NCT03427645|surrogate decision maker|surrogate decision maker
958597|NCT03427632|PVP|pvp
958598|NCT03427632|bone tumor|bone tumor
958599|NCT03427606|sacral colpopexy|sacral colpopexy
958600|NCT03427606|laparoscopy|laparoscopy
958601|NCT03427606|mesh fixation|mesh fixation
958602|NCT03427593|CVID|cvid
958603|NCT03427593|Neutropenia|neutropenia
958604|NCT03427593|Autoimmunity|autoimmunity
958605|NCT03427593|Lymphoproliferation|lymphoproliferation
958606|NCT03427580|Schizophrenia|schizophrenia
958607|NCT03427580|Psychotherapy|psychotherapy
958608|NCT03427580|Metacognitive abilities|metacognitive abilities
958609|NCT03427580|Session by session assessment|session by session assessment
958610|NCT03427580|Outcome|outcome
958611|NCT03427567|Chinese|chinese
958612|NCT03427567|real-world evidences|real-world evidences
958613|NCT03427567|NSCLC|nsclc
958614|NCT03427567|sublobar dissection|sublobar dissection
958615|NCT03427541|Chinese|chinese
958616|NCT03427541|non-small cell lung cancer|non-small cell lung cancer
958617|NCT03427541|oligometastases|oligometastases
958618|NCT03427515|Psychobiotics|psychobiotics
958619|NCT03427515|Probiotics|probiotics
958620|NCT03427515|Examination|examination
958622|NCT03427502|general anesthesia|general anesthesia
958623|NCT03427502|nasal surgery|nasal surgery
958624|NCT03427502|anterior ehtmoidal nerve block|anterior ehtmoidal nerve block
958625|NCT03427502|bupivacaine|bupivacaine
958626|NCT03427502|postoperative confusion|postoperative confusion
958627|NCT03427489|Biomarkers|biomarkers
958628|NCT03427489|Genetic Markers|genetic markers
958629|NCT03427489|Controls|controls
958630|NCT03427476|renal cell carcinoma|renal cell carcinoma
958631|NCT03427476|RCC|rcc
958632|NCT03427476|prostate specific membrane antigen|prostate specific membrane antigen
958633|NCT03427476|PSMA|psma
958634|NCT03427476|metastatic renal cancer|metastatic renal cancer
958635|NCT03427476|positron emission tomography|positron emission tomography
958636|NCT03427476|PET|pet
958637|NCT03427450|circulating tumor cells|circulating tumor cells
958638|NCT03427450|liquid biopsy|liquid biopsy
958639|NCT03427450|microfluidics|microfluidics
958640|NCT03427437|sacral canal|sacral canal
958641|NCT03427437|sacral hiatus|sacral hiatus
958642|NCT03427437|ultrasound|ultrasound
958648|NCT03427411|TGFR1 pathway signaling and overexpression|tgfr1 pathway signaling and overexpression
958649|NCT03427411|PD-1 inhibitors|pd-1 inhibitors
958650|NCT03427411|Manageable Safety Profile|manageable safety profile
958651|NCT03427411|Bifunctional Fusion Protein|bifunctional fusion protein
958652|NCT03427411|Refractory/Recurrent HPV Associated Malignancies|refractory/recurrent hpv associated malignancies
958653|NCT03427385|Neuromuscular blockade|neuromuscular blockade
958654|NCT03427359|nasopharyngeal carcinoma|nasopharyngeal carcinoma
958655|NCT03427359|induction chemotherapy|induction chemotherapy
958656|NCT03427359|cisplatin|cisplatin
958657|NCT03427359|capecitabine|capecitabine
958658|NCT03427359|chemoradiotherapy|chemoradiotherapy
958659|NCT03427346|Barrett Esophagus|barrett esophagus
958660|NCT03427346|ESD|esd
958661|NCT03427346|EMR|emr
958662|NCT03427346|Esophagus Neoplasm|esophagus neoplasm
958663|NCT03427346|endoscopic resection technique|endoscopic resection technique
958664|NCT03427346|ablation of esophageal mucosa|ablation of esophageal mucosa
958665|NCT03427333|VT|vt
958666|NCT03427333|Pacemaker Lead Extraction|pacemaker lead extraction
958667|NCT03427333|epicardial access|epicardial access
958668|NCT03427333|pericardial access|pericardial access
958669|NCT03427320|[131]I-IAZA Imaging study|[131]i-iaza imaging study
958670|NCT03427307|Lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
958671|NCT03427307|inflammation|inflammation
958672|NCT03427307|ASCVD|ascvd
958673|NCT03427255|superficial dyspareunia; CBT|superficial dyspareunia; cbt
958674|NCT03427242|biliary tract carcinoma|biliary tract carcinoma
958675|NCT03427242|apatinib|apatinib
958676|NCT03427229|fecal microbiota transplantation|fecal microbiota transplantation
958677|NCT03427229|Clostridium difficile infection|clostridium difficile infection
958678|NCT03427229|pseudomembranous colitis|pseudomembranous colitis
958679|NCT03427190|Suicide|suicide
958680|NCT03427190|Suicide attempted|suicide attempted
958681|NCT03427190|Secondary Prevention|secondary prevention
958682|NCT03427190|Relapse prevention|relapse prevention
958683|NCT03427190|Case Management|case management
958684|NCT03427190|Intervention Study|intervention study
958685|NCT03427164|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
958686|NCT03427164|TIPS|tips
958687|NCT03427164|cirrhosis|cirrhosis
958688|NCT03427164|hepatitis|hepatitis
958689|NCT03427164|portal vein thrombosis|portal vein thrombosis
958690|NCT03427164|Budd-Chiari Disease|budd-chiari disease
958691|NCT03427164|Elastography|elastography
958692|NCT03427086|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
958693|NCT03427086|Biotin|biotin
958694|NCT03427034|Urine|urine
958695|NCT03427034|Haematuria|haematuria
958696|NCT03427034|Flexible cystoscopy|flexible cystoscopy
958697|NCT03427034|Recurrence|recurrence
958698|NCT03427034|Cytology|cytology
958699|NCT03427008|mHealth|mhealth
958700|NCT03427008|kidney transplantation|kidney transplantation
958701|NCT03427008|medication adherence|medication adherence
958702|NCT03427008|video directly observed therapy|video directly observed therapy
958703|NCT03426969|Myelofibrosis|myelofibrosis
958704|NCT03426969|MF|mf
958705|NCT03426969|Haploidentical hematopoietic cell transplantation|haploidentical hematopoietic cell transplantation
958706|NCT03426969|Haplo-HCT|haplo-hct
958707|NCT03426969|Melphalan|melphalan
958708|NCT03426969|Alkeran|alkeran
958709|NCT03426969|Evomela|evomela
958710|NCT03426969|Fludarabine|fludarabine
958711|NCT03426969|Fludarabine phosphate|fludarabine phosphate
958712|NCT03426969|Fludara|fludara
958713|NCT03426969|Tacrolimus|tacrolimus
958714|NCT03426969|Prograf|prograf
958715|NCT03426969|Mycophenolate Mofetil|mycophenolate mofetil
958716|NCT03426969|MMF|mmf
958717|NCT03426969|CellCept|cellcept
958718|NCT03426969|G-CSF|g-csf
958719|NCT03426969|Filgrastim|filgrastim
958720|NCT03426969|Neupogen|neupogen
958721|NCT03426969|Total body irradiation|total body irradiation
958722|NCT03426969|TBI|tbi
958723|NCT03426969|External beam radiation therapy|external beam radiation therapy
958724|NCT03426956|Glucagon-like Peptide-1|glucagon-like peptide-1
958725|NCT03426956|Glucose|glucose
958726|NCT03426956|Gastric bypass|gastric bypass
958727|NCT03426956|Bariatric surgery|bariatric surgery
958728|NCT03426956|Obesity|obesity
958729|NCT03426956|Diabetes|diabetes
958730|NCT03426891|Immunotherapy|immunotherapy
958731|NCT03426891|Radiotherapy|radiotherapy
958732|NCT03426891|Glioblastoma|glioblastoma
958733|NCT03426878|Lynch syndrome|lynch syndrome
958734|NCT03426878|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
958735|NCT03426865|retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
958736|NCT03426865|testicular cancer|testicular cancer
958737|NCT03426865|testis cancer|testis cancer
958738|NCT03426865|germ cell tumor|germ cell tumor
958739|NCT03426865|PET scan|pet scan
958740|NCT03426865|Axumin|axumin
958741|NCT03426865|teratoma|teratoma
958742|NCT03426852|Biomechanical Phenomenon|biomechanical phenomenon
958743|NCT03426852|Gait|gait
958744|NCT03426852|Lumbar Disc Degeneration|lumbar disc degeneration
958745|NCT03426839|hemostatic techniques|hemostatic techniques
958746|NCT03426839|perioperative hemorrhage|perioperative hemorrhage
958747|NCT03426839|platelet function test|platelet function test
958748|NCT03426839|point of care technology|point of care technology
958749|NCT03426839|thromboelastometry|thromboelastometry
958750|NCT03426839|vascular surgical procedures|vascular surgical procedures
958752|NCT03426826|Gut Microbiome|gut microbiome
958753|NCT03426826|Fecal Microbiata Transplantation|fecal microbiata transplantation
958754|NCT03426826|Autism Spectrum Disorder|autism spectrum disorder
958755|NCT03426826|16s rRNA|16s rrna
958756|NCT03426826|Gastro-Intestinal Disorder|gastro-intestinal disorder
958757|NCT03426813|mobilization|mobilization
958758|NCT03426813|physiotherapy|physiotherapy
958759|NCT03426813|community-acquired pneumonia|community-acquired pneumonia
958760|NCT03426800|Acupuncture|acupuncture
958761|NCT03426800|Training|training
958762|NCT03426800|Children|children
958763|NCT03426800|Effect|effect
958764|NCT03426787|Patient Centered|patient centered
958765|NCT03426787|Pre-Post Design|pre-post design
958766|NCT03426787|Decision Support|decision support
958767|NCT03426787|Health Literacy|health literacy
958768|NCT03426748|Brachytherapy|brachytherapy
958769|NCT03426748|Quality of life|quality of life
958770|NCT03426748|High dose rate vs. low dose rate|high dose rate vs. low dose rate
958771|NCT03426748|Intermediate risk group|intermediate risk group
958772|NCT03426735|Iodine|iodine
958773|NCT03426735|Iodized|iodized
958774|NCT03426735|Computerized Tomography|computerized tomography
958775|NCT03426735|Extravasation|extravasation
958776|NCT03426735|contrast media|contrast media
958777|NCT03426709|Depression|depression
958778|NCT03426709|Multimorbidity|multimorbidity
958779|NCT03426709|Computer-delivered psychotherapy|computer-delivered psychotherapy
958780|NCT03426709|Randomized-controlled trial|randomized-controlled trial
958781|NCT03426709|Cost-effectiveness|cost-effectiveness
958782|NCT03426696|psychological status|psychological status
958783|NCT03426696|Related Factors|related factors
958784|NCT03426696|Thyroid Related Eye Disease|thyroid related eye disease
958785|NCT03426683|Inflammatory Bowel Disease(IBD)|inflammatory bowel disease(ibd)
958786|NCT03426683|Ulcerative colitis(UC)|ulcerative colitis(uc)
958787|NCT03426683|Crohn's disease(CD)|crohn's disease(cd)
958788|NCT03426683|intestinal microbiota transplantation|intestinal microbiota transplantation
958789|NCT03426683|microbiota|microbiota
958790|NCT03426670|HIV self-testing|hiv self-testing
958791|NCT03426670|Pre-exposure prophylaxis|pre-exposure prophylaxis
958792|NCT03426670|Sex workers|sex workers
958793|NCT03426644|Childhood sleep promotion|childhood sleep promotion
958794|NCT03426644|Sleep promotion|sleep promotion
958795|NCT03426644|Sleep|sleep
958796|NCT03426592|HIV|hiv
958797|NCT03426592|Inflammation|inflammation
958798|NCT03426592|Vitamin D|vitamin d
958799|NCT03426592|Immunomodulation|immunomodulation
958800|NCT03426592|Virus latency|virus latency
958801|NCT03426566|diabetic foot|diabetic foot
958802|NCT03426566|pedobarography|pedobarography
958803|NCT03426566|diabetic neuropathy|diabetic neuropathy
958804|NCT03426566|plantar pressure|plantar pressure
958805|NCT03426553|Patogen inactivation|patogen inactivation
958806|NCT03426553|Pathogen reduction|pathogen reduction
958807|NCT03426553|clinical use|clinical use
958808|NCT03426553|riboflavin+UV|riboflavin+uv
958809|NCT03426553|RBC transfusion|rbc transfusion
958810|NCT03426553|whole blood|whole blood
958811|NCT03426514|Colorectal cancer|colorectal cancer
958812|NCT03426514|Laparoscopic surgery|laparoscopic surgery
958813|NCT03426514|Three-port|three-port
958814|NCT03426501|heart rate variability|heart rate variability
958815|NCT03426501|prognosis|prognosis
958816|NCT03426475|nursing home residents|nursing home residents
958817|NCT03426475|interprofessional collaboration|interprofessional collaboration
958818|NCT03426475|reduction of hospitalisation|reduction of hospitalisation
958819|NCT03426462|Pharmacodynamic|pharmacodynamic
958820|NCT03426462|Permutation Entropy|permutation entropy
958822|NCT03426423|Gender|gender
958823|NCT03426423|Metabolism|metabolism
958824|NCT03426423|Microbiota|microbiota
958825|NCT03426397|Complete response|complete response
958826|NCT03426397|Organ preservation|organ preservation
958827|NCT03426397|Wait-and-See|wait-and-see
958828|NCT03426397|Watch-and-Wait|watch-and-wait
958829|NCT03426397|Watchful Waiting|watchful waiting
958830|NCT03426384|SLE|sle
958831|NCT03426384|FLARE|flare
958832|NCT03426384|Lupus|lupus
958833|NCT03426384|Digital Therapeutics|digital therapeutics
958834|NCT03426384|Health Coaching|health coaching
958835|NCT03426384|Smartphone App|smartphone app
958836|NCT03426358|Veno Occlusive Disease|veno occlusive disease
958837|NCT03426358|Sinusoidal Obstruction Syndrome|sinusoidal obstruction syndrome
958838|NCT03426358|HSCT|hsct
958839|NCT03426358|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
958840|NCT03426358|Stem Cell Transplant Complications|stem cell transplant complications
958841|NCT03426358|Liver Stiffness Measurement|liver stiffness measurement
958842|NCT03426358|Sinusoidal Obstructive Syndrome|sinusoidal obstructive syndrome
958843|NCT03426358|Transient Elastography|transient elastography
958844|NCT03426332|Adrenal Insufficiency|adrenal insufficiency
958845|NCT03426332|Adrenal crisis|adrenal crisis
958846|NCT03426332|Adrenal emergency|adrenal emergency
958847|NCT03426332|Glucocorticoid injection|glucocorticoid injection
958848|NCT03426319|Primary adrenal insufficiency|primary adrenal insufficiency
958849|NCT03426319|Cardiovascular status|cardiovascular status
958850|NCT03426319|Metabolic profile|metabolic profile
958851|NCT03426306|4-Dimensional Computed Tomography|4-dimensional computed tomography
958852|NCT03426293|heparin;ACT;non-cardiac vascular;peri-procedural|heparin;act;non-cardiac vascular;peri-procedural
958853|NCT03426254|Subcutaneously Talazoparib|subcutaneously talazoparib
958854|NCT03426241|chronic periodontitis|chronic periodontitis
958856|NCT03426241|mmp-2|mmp-2
958857|NCT03426241|mmp-9|mmp-9
958858|NCT03426228|IVF, Glucose Homeostasis, Metabolic Parameters|ivf, glucose homeostasis, metabolic parameters
958859|NCT03426202|modafinil|modafinil
958860|NCT03426202|emotion|emotion
958861|NCT03426202|cognitive processing|cognitive processing
958862|NCT03426189|HIV|hiv
958863|NCT03426189|Latent reservoir|latent reservoir
958864|NCT03426189|Leukapheresis|leukapheresis
958865|NCT03426189|Inguinal lymph node biopsy|inguinal lymph node biopsy
958866|NCT03426189|Immune checkpoint|immune checkpoint
958867|NCT03426189|PD1|pd1
958868|NCT03426189|CTLA4|ctla4
958869|NCT03426176|oxytocin|oxytocin
958870|NCT03426176|acute tryptophan depletion|acute tryptophan depletion
958871|NCT03426176|emotion|emotion
958872|NCT03426163|virtual reality|virtual reality
958873|NCT03426163|knee|knee
958874|NCT03426137|Oxycodone|oxycodone
958875|NCT03426137|Placebo|placebo
958876|NCT03426137|Expectancy Induced Analgesia|expectancy induced analgesia
958877|NCT03426137|NSAID|nsaid
958878|NCT03426124|venous thromboembolism|venous thromboembolism
958879|NCT03426111|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
958880|NCT03426111|NASH|nash
958881|NCT03426111|Obesity|obesity
958882|NCT03426111|Endoscopic gastric tubulization|endoscopic gastric tubulization
958883|NCT03426111|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
958884|NCT03426072|quality improvement|quality improvement
958885|NCT03426059|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
958886|NCT03426059|PMS|pms
958887|NCT03426059|Genotype|genotype
958888|NCT03426059|Phenotype|phenotype
958889|NCT03426059|Mapping|mapping
958890|NCT03426059|22q13 Deletion Syndrome|22q13 deletion syndrome
958891|NCT03426059|SHANK3|shank3
958892|NCT03426059|Autism Spectrum Disorder|autism spectrum disorder
958893|NCT03426059|ASD|asd
958894|NCT03426059|Intellectual Disability|intellectual disability
958895|NCT03426059|ID|id
958896|NCT03426046|Biodentine|biodentine
958897|NCT03426046|Cariously exposed pulp|cariously exposed pulp
958898|NCT03426046|MTA|mta
958899|NCT03426046|Partial pulpotomy|partial pulpotomy
958900|NCT03426046|Image J Software|image j software
958901|NCT03426020|Premedication|premedication
958902|NCT03426020|Pediatric patients|pediatric patients
958903|NCT03426020|Emergence agitation|emergence agitation
958904|NCT03426007|uterine lavage|uterine lavage
958905|NCT03426007|intrauterine insemination|intrauterine insemination
958906|NCT03426007|embryo|embryo
958907|NCT03426007|blastocyst|blastocyst
958908|NCT03426007|in vivo|in vivo
958909|NCT03426007|superovulation|superovulation
958910|NCT03425981|WB-EMS|wb-ems
958911|NCT03425981|Running economy|running economy
958912|NCT03425981|VO2max|vo2max
958913|NCT03425968|Injury rate|injury rate
958914|NCT03425942|Cognitive Behavioral Therapy|cognitive behavioral therapy
958915|NCT03425942|Applied Relaxation Techniques|applied relaxation techniques
958916|NCT03425942|Internet treatment|internet treatment
958917|NCT03425929|amygdala, fear, intrusion, oxytocin, trauma disclosure|amygdala, fear, intrusion, oxytocin, trauma disclosure
958918|NCT03425916|Hypopressive exercises|hypopressive exercises
958919|NCT03425916|Ultrasonography|ultrasonography
958920|NCT03425903|Fibromyalgia, Whole body cryotherapy|fibromyalgia, whole body cryotherapy
958921|NCT03425890|Upper Limb|upper limb
958922|NCT03425890|Self-exercise|self-exercise
958923|NCT03425877|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
958924|NCT03425851|Diaper need|diaper need
958926|NCT03425851|Well baby visits|well baby visits
958927|NCT03425851|Low-income families|low-income families
958928|NCT03425851|Caregiver stress|caregiver stress
958929|NCT03425838|CDK 4/6 inhibitor|cdk 4/6 inhibitor
958930|NCT03425825|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
958931|NCT03425812|Axial Spondyloarthritis|axial spondyloarthritis
958932|NCT03425812|Anti-Inflammatory Drugs|anti-inflammatory drugs
958933|NCT03425812|Flare|flare
958934|NCT03425773|HER2/neu|her2/neu
958935|NCT03425773|IHC 1+|ihc 1+
958936|NCT03425773|BVAC|bvac
958937|NCT03425773|Cellid|cellid
958938|NCT03425773|B-cell|b-cell
958939|NCT03425773|Monocyte|monocyte
958940|NCT03425773|Immunotherapeutic vaccine|immunotherapeutic vaccine
958941|NCT03425773|Breast cancer|breast cancer
958942|NCT03425773|Colorectal cancer|colorectal cancer
958943|NCT03425773|Pancreatic cancer|pancreatic cancer
958949|NCT03425708|Uric Acid|uric acid
958950|NCT03425708|Febuxostat|febuxostat
958951|NCT03425708|Chronic Renal Disease|chronic renal disease
958952|NCT03425695|Free gingival graft, Low level laser therapy, Shrinkage|free gingival graft, low level laser therapy, shrinkage
958956|NCT03425669|Acoustic and vestibular noise stimulation|acoustic and vestibular noise stimulation
958957|NCT03425656|breast cancer|breast cancer
958958|NCT03425656|AryoTrust™|aryotrust™
958959|NCT03425656|Herceptin®|herceptin®
958960|NCT03425656|non-Inferiority|non-inferiority
958961|NCT03425578|Monosodium glutamate|monosodium glutamate
958962|NCT03425578|Amino acids|amino acids
958963|NCT03425578|Glucose tolerance|glucose tolerance
958964|NCT03425526|Hematological Malignancies|hematological malignancies
958965|NCT03425526|Immunocompromised Patients|immunocompromised patients
958966|NCT03425526|Adenovirus Specific T Cells|adenovirus specific t cells
958967|NCT03425513|Belgium|belgium
958968|NCT03425513|Prevalence|prevalence
958969|NCT03425513|Risk factor|risk factor
958970|NCT03425513|Ethnicity|ethnicity
958971|NCT03425513|Linkage of care|linkage of care
958972|NCT03425487|Mindfulness|mindfulness
958973|NCT03425487|Compassion|compassion
959069|NCT03424889|Lignocaine|lignocaine
958974|NCT03425487|Mental Health Services|mental health services
958975|NCT03425422|Vagus nerve stimulation|vagus nerve stimulation
958976|NCT03425383|Cardiovascular disease, FMD, c-IMT|cardiovascular disease, fmd, c-imt
958977|NCT03425370|Surgical wounds|surgical wounds
958978|NCT03425370|Tissue adhesive|tissue adhesive
958979|NCT03425370|Sutures|sutures
958980|NCT03425370|Wound healing|wound healing
958981|NCT03425331|Non-Small Cell Lung Cancer|non-small cell lung cancer
958982|NCT03425305|Serum uric acid|serum uric acid
958983|NCT03425305|Cardiovascular disease|cardiovascular disease
958984|NCT03425305|Atherosclerosis|atherosclerosis
958985|NCT03425292|immunotherapy|immunotherapy
958986|NCT03425292|nivolumab|nivolumab
958987|NCT03425292|ipilimumab|ipilimumab
958988|NCT03425266|shared decision-making|shared decision-making
958989|NCT03425266|decision support tool|decision support tool
958990|NCT03425266|patient-provider communication|patient-provider communication
958991|NCT03425266|managing chronic pain|managing chronic pain
958992|NCT03425266|patient preferences|patient preferences
958993|NCT03425266|values clarification|values clarification
958994|NCT03425253|Lower Face Contouring|lower face contouring
958995|NCT03425240|Erectile Dysfunction|erectile dysfunction
958996|NCT03425240|Prostate Cancer|prostate cancer
958997|NCT03425240|Neuromodulation|neuromodulation
958998|NCT03425227|Frailty|frailty
958999|NCT03425227|Elderly People|elderly people
959000|NCT03425227|Exergame|exergame
959001|NCT03425227|Physical Activity|physical activity
959002|NCT03425227|Kinect|kinect
959003|NCT03425227|Biofeeback|biofeeback
959004|NCT03425214|functional MRI|functional mri
959005|NCT03425214|Reward system|reward system
959006|NCT03425214|REM sleep behaviour disorder|rem sleep behaviour disorder
959007|NCT03425214|Narco-cataplexy|narco-cataplexy
959008|NCT03425175|Non-relevant conversation|non-relevant conversation
959009|NCT03425175|Surgical safety|surgical safety
959010|NCT03425175|Audio recording|audio recording
959011|NCT03425162|quadratus lumborum block|quadratus lumborum block
959012|NCT03425162|pain|pain
959013|NCT03425162|ultrasound|ultrasound
959014|NCT03425162|percutaneous nephrolithotomy|percutaneous nephrolithotomy
959015|NCT03425149|vaccine|vaccine
959016|NCT03425149|prevention|prevention
959017|NCT03425136|Prevention of Mother-to-Child HIV Transmission|prevention of mother-to-child hiv transmission
959019|NCT03425136|PMTCT|pmtct
959020|NCT03425123|Regenerative endodontic procedure (REP)|regenerative endodontic procedure (rep)
959021|NCT03425123|Mineral Trioxide Aggregate (MTA) apexification|mineral trioxide aggregate (mta) apexification
959022|NCT03425123|Calcium Hydroxide -Ca(OH)2|calcium hydroxide -ca(oh)2
959023|NCT03425123|Permanent non-vital tooth|permanent non-vital tooth
959024|NCT03425123|Children 7-18 years of age|children 7-18 years of age
959025|NCT03425071|Tacrolimus|tacrolimus
959026|NCT03425071|T Lymphocytes|t lymphocytes
959027|NCT03425071|B lymphocytes|b lymphocytes
959028|NCT03425071|Monitoring, Immunologic|monitoring, immunologic
959029|NCT03425058|Molecular Evaluation|molecular evaluation
959030|NCT03425058|Locally Advanced Gastric Cancer|locally advanced gastric cancer
959031|NCT03425058|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
959032|NCT03425058|ctDNA|ctdna
959033|NCT03425058|CTC|ctc
959034|NCT03425058|dMMR/MSI|dmmr/msi
959035|NCT03425045|chronic tinnitus|chronic tinnitus
959036|NCT03425045|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
959037|NCT03425045|hypacusion|hypacusion
959038|NCT03425045|depression|depression
959041|NCT03425045|medication therapy|medication therapy
959042|NCT03425019|Knee Osteoarthritis|knee osteoarthritis
959043|NCT03425019|Chronic Pain|chronic pain
959044|NCT03425019|Osteoarthritis|osteoarthritis
959045|NCT03425019|Transcranial Direct Current Stimulation|transcranial direct current stimulation
959046|NCT03425019|tDCS|tdcs
959047|NCT03424993|Endothelium, vascular|endothelium, vascular
959048|NCT03424993|Cardiovascular Disease|cardiovascular disease
959049|NCT03424993|Hemodynamics|hemodynamics
959050|NCT03424993|Oxidative Stress|oxidative stress
959051|NCT03424993|Dietary Sodium|dietary sodium
959052|NCT03424993|Dietary Counseling|dietary counseling
959053|NCT03424980|Non-small cell lung cancer, Chinese, brain metastases|non-small cell lung cancer, chinese, brain metastases
959054|NCT03424967|attention-bias modification|attention-bias modification
959055|NCT03424967|statistical learning|statistical learning
959056|NCT03424967|social anxiety disorder|social anxiety disorder
959057|NCT03424967|treatment outcome|treatment outcome
959058|NCT03424941|Aortic Stenosis (AS)|aortic stenosis (as)
959059|NCT03424941|Multi Vessel Coronary Artery Disease (MVD)|multi vessel coronary artery disease (mvd)
959060|NCT03424941|TransCatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
959061|NCT03424941|Coronary Artery By-pass Grafting (CABG)|coronary artery by-pass grafting (cabg)
959062|NCT03424941|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
959063|NCT03424941|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
959064|NCT03424941|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
959065|NCT03424928|Pomalidomide|pomalidomide
959066|NCT03424928|Multiple myeloma|multiple myeloma
959067|NCT03424928|Bioequivalence|bioequivalence
959068|NCT03424889|Bronchoscopy|bronchoscopy
959071|NCT03424876|Sunitinib Imatinib|sunitinib imatinib
959072|NCT03424798|mechanical ventilation|mechanical ventilation
959073|NCT03424798|lung function|lung function
959074|NCT03424798|cardiopulmonary monitoring|cardiopulmonary monitoring
959075|NCT03424785|Aortic intramural hematoma|aortic intramural hematoma
959076|NCT03424785|Chinese patients|chinese patients
959077|NCT03424785|Clinical outcomes|clinical outcomes
959078|NCT03424733|demyelination|demyelination
959079|NCT03424733|relapse rate|relapse rate
959080|NCT03424733|Pegylated interferon beta-1a|pegylated interferon beta-1a
959081|NCT03424733|side effects|side effects
959082|NCT03424733|flu-like symptoms|flu-like symptoms
959083|NCT03424733|injection site reactions|injection site reactions
959084|NCT03424733|prednisone|prednisone
959085|NCT03424694|Brachytherapy|brachytherapy
959086|NCT03424694|Monotherapy|monotherapy
959087|NCT03424694|HDR Brachytherapy|hdr brachytherapy
959088|NCT03424694|Toxicity|toxicity
959089|NCT03424694|Quality of Life|quality of life
959090|NCT03424694|Progression Free Survival|progression free survival
959091|NCT03424668|nutrition|nutrition
959092|NCT03424668|physical activity|physical activity
959093|NCT03424668|lifestyle|lifestyle
959094|NCT03424668|smoking|smoking
959095|NCT03424655|post -endodontic pain|post -endodontic pain
959096|NCT03424655|endodontic pain|endodontic pain
959097|NCT03424655|pain|pain
959098|NCT03424642|prenatal depression|prenatal depression
959099|NCT03424642|prenatal anxiety|prenatal anxiety
959100|NCT03424642|prenatal mental disorders|prenatal mental disorders
959101|NCT03424642|interactive ultrasound examination|interactive ultrasound examination
959102|NCT03424642|maternal-fetal relations|maternal-fetal relations
959103|NCT03424629|psoriasis|psoriasis
959104|NCT03424629|UC-MSCs|uc-mscs
959105|NCT03424616|Opiate dependence|opiate dependence
959106|NCT03424616|Deep brain stimulation|deep brain stimulation
959107|NCT03424616|Nucleus accumbens|nucleus accumbens
959108|NCT03424577|H3B-6527|h3b-6527
959109|NCT03424577|Healthy Participants|healthy participants
959110|NCT03424577|Pharmacokinetics|pharmacokinetics
959111|NCT03424564|Perampanel|perampanel
959112|NCT03424564|Pharmacokinetics|pharmacokinetics
959113|NCT03424564|E2007|e2007
959114|NCT03424564|Chinese|chinese
959115|NCT03424551|vibration|vibration
959116|NCT03424551|muscle spindle|muscle spindle
959117|NCT03424551|H reflex|h reflex
959118|NCT03424551|tonic vibration reflex|tonic vibration reflex
959119|NCT03424538|multiple sclerosis|multiple sclerosis
959120|NCT03424538|posture|posture
959121|NCT03424538|neurorehabilitation|neurorehabilitation
959122|NCT03424538|balance|balance
959123|NCT03424499|neurogenic bladder|neurogenic bladder
959124|NCT03424499|intermittent urethral catheterization|intermittent urethral catheterization
959125|NCT03424499|Clean intermittent catheterization|clean intermittent catheterization
959126|NCT03424486|Cystic fibrosis|cystic fibrosis
959127|NCT03424486|Anxiety|anxiety
959128|NCT03424486|Depression|depression
959129|NCT03424486|Adolescence|adolescence
959130|NCT03424473|tucatinib|tucatinib
959131|NCT03424473|Breast Cancer|breast cancer
959132|NCT03424473|ARRY-380|arry-380
959133|NCT03424473|ONT-380|ont-380
959134|NCT03424473|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
959135|NCT03424473|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
959140|NCT03424473|Metastatic Breast Cancer|metastatic breast cancer
959141|NCT03424473|Breast Carcinoma|breast carcinoma
959142|NCT03424473|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
959143|NCT03424473|Brain Metastases in Breast Cancer|brain metastases in breast cancer
959144|NCT03424473|Breast Neoplasms|breast neoplasms
959145|NCT03424473|Neoplasms by Site|neoplasms by site
959146|NCT03424473|Neoplasms|neoplasms
959147|NCT03424473|Breast Diseases|breast diseases
959148|NCT03424460|Myotonic dystrophy 1|myotonic dystrophy 1
959149|NCT03424460|Venous thromboembolism|venous thromboembolism
959150|NCT03424460|Pulmonary embolism|pulmonary embolism
959151|NCT03424460|Deep vein thrombosis|deep vein thrombosis
959152|NCT03424460|Hypercoagulability|hypercoagulability
959153|NCT03424460|Thrombophilia|thrombophilia
959154|NCT03424460|RNA alternative splicing|rna alternative splicing
959155|NCT03424434|Occupational blood exposure|occupational blood exposure
959156|NCT03424434|underreporting|underreporting
959157|NCT03424434|medical|medical
959158|NCT03424434|hospital|hospital
959159|NCT03424421|Shoulder Joint|shoulder joint
959160|NCT03424421|Orthopedics|orthopedics
959161|NCT03424421|Arthroscopy|arthroscopy
959162|NCT03424395|personalized dietary and wellness program|personalized dietary and wellness program
959163|NCT03424395|oral protein glucose lipid tolerance test|oral protein glucose lipid tolerance test
959164|NCT03424395|metabolism|metabolism
959165|NCT03424395|behavior|behavior
959166|NCT03424395|health|health
959167|NCT03424395|body composition|body composition
959168|NCT03424395|single nucleotide polymorphisms|single nucleotide polymorphisms
959169|NCT03424395|genotype|genotype
959170|NCT03424395|dietary and wellness coaching/advice|dietary and wellness coaching/advice
959171|NCT03424395|liquid meal challenge test|liquid meal challenge test
959173|NCT03424356|Rocuronium bromur|rocuronium bromur
959174|NCT03424356|propofol|propofol
959175|NCT03424343|survivors|survivors
959176|NCT03424343|parents|parents
959177|NCT03424343|sibling|sibling
959178|NCT03424343|family environment|family environment
959179|NCT03424343|psychosocial functioning|psychosocial functioning
959180|NCT03424343|longitudinal|longitudinal
959181|NCT03424343|cancer|cancer
959182|NCT03424343|identity|identity
959183|NCT03424343|adolescence|adolescence
959184|NCT03424343|emerging adulthood|emerging adulthood
959185|NCT03424278|Low back pain|low back pain
959186|NCT03424278|Exercise|exercise
959187|NCT03424252|Cystic Fibrosis|cystic fibrosis
959188|NCT03424239|Roux-en-Y gastric bypass|roux-en-y gastric bypass
959189|NCT03424174|TKA, cytokine, coating|tka, cytokine, coating
959190|NCT03424122|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
959191|NCT03424122|follicular lymphoma (FL)|follicular lymphoma (fl)
959192|NCT03424122|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
959193|NCT03424122|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
959194|NCT03424122|phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase delta (pi3kδ) inhibitor
959195|NCT03424109|Emergency Department|emergency department
959196|NCT03424109|Palliative Care|palliative care
959197|NCT03424070|laryngoscopy|laryngoscopy
959198|NCT03424070|pediatric|pediatric
959199|NCT03424070|airway|airway
959200|NCT03424070|gel roll|gel roll
959201|NCT03424070|larynx|larynx
959202|NCT03424070|glottis|glottis
959203|NCT03424057|Karydakis modification|karydakis modification
959204|NCT03424057|pilonidal sinus|pilonidal sinus
959205|NCT03424057|seroma|seroma
959206|NCT03424044|glucagon|glucagon
959207|NCT03424044|closed-loop|closed-loop
959208|NCT03424044|Omnipod|omnipod
959209|NCT03424044|exercise|exercise
959210|NCT03424018|ACH|ach
959211|NCT03424018|Achondroplasia|achondroplasia
959212|NCT03424018|Bone Diseases|bone diseases
959213|NCT03424018|Bone Diseases, Developmental|bone diseases, developmental
959214|NCT03424018|Dwarfism|dwarfism
959215|NCT03424018|Genetic Diseases, Inborn|genetic diseases, inborn
959216|NCT03424018|Musculoskeletal Diseases|musculoskeletal diseases
959217|NCT03424018|Natriuretic Agents|natriuretic agents
1651130|NCT00189800|Solifenacin|solifenacin
959218|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
959219|NCT03424018|Osteochondrodysplasias|osteochondrodysplasias
959220|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs
959221|NCT03424018|Skeletal Dysplasias|skeletal dysplasias
959222|NCT03423979|BPH|bph
959223|NCT03423953|osteoarthritis|osteoarthritis
959224|NCT03423953|avascular necrosis|avascular necrosis
959225|NCT03423953|rheumatoid arthritis|rheumatoid arthritis
959231|NCT03423914|writing|writing
959232|NCT03423914|postraumatic stress|postraumatic stress
959234|NCT03423901|Complications|complications
959235|NCT03423888|Dyspnea|dyspnea
959236|NCT03423888|palliative care|palliative care
959237|NCT03423888|high-flow nasal oxygen|high-flow nasal oxygen
959238|NCT03423888|pilot study|pilot study
959239|NCT03423875|Delirium, Delirium Recognition|delirium, delirium recognition
959240|NCT03423823|Neovascularization|neovascularization
959241|NCT03423797|silver nitrate|silver nitrate
959242|NCT03423797|sodium fluoride|sodium fluoride
959243|NCT03423797|dental caries|dental caries
959244|NCT03423797|equivalence trial|equivalence trial
959245|NCT03423784|teething in infants and children|teething in infants and children
959246|NCT03423784|oral gels|oral gels
959247|NCT03423784|paediatric dentistry|paediatric dentistry
959248|NCT03423758|Pseudoexfoliation Glaucoma, Angle block glaucoma, Genetic|pseudoexfoliation glaucoma, angle block glaucoma, genetic
959249|NCT03423745|intubation|intubation
959250|NCT03423745|cardiopulmonary resuscitation|cardiopulmonary resuscitation
959251|NCT03423745|number of endotracheal intubation experience|number of endotracheal intubation experience
959252|NCT03423693|Small airway obstruction|small airway obstruction
959253|NCT03423693|Asthma|asthma
959254|NCT03423693|COPD|copd
959255|NCT03423693|ACOS|acos
959256|NCT03423667|N-acetylcysteine|n-acetylcysteine
959257|NCT03423667|Craving|craving
959258|NCT03423641|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
959259|NCT03423641|Antiviral Agents / Adverse Effects|antiviral agents / adverse effects
959260|NCT03423641|Antiviral Agents / Toxicity|antiviral agents / toxicity
959261|NCT03423641|Simeprevir|simeprevir
959262|NCT03423641|Sofosbuvir|sofosbuvir
959263|NCT03423641|Ledipasvir|ledipasvir
959264|NCT03423641|Ombitasvir|ombitasvir
959265|NCT03423641|Paritaprevir|paritaprevir
959266|NCT03423641|Ritonavir|ritonavir
959267|NCT03423641|Dasabuvir|dasabuvir
959268|NCT03423641|Daclatasvir|daclatasvir
959269|NCT03423641|Elbasvir|elbasvir
959270|NCT03423641|Grazoprevir|grazoprevir
959271|NCT03423641|Velpatasvir|velpatasvir
959272|NCT03423641|Ribavirin|ribavirin
959273|NCT03423628|glioblastoma|glioblastoma
959274|NCT03423628|brain metastases|brain metastases
959275|NCT03423628|Ataxia-telangiectasia mutated kinase (ATM) inhibition|ataxia-telangiectasia mutated kinase (atm) inhibition
959276|NCT03423628|radiation therapy|radiation therapy
959277|NCT03423615|School Health Services|school health services
959278|NCT03423615|Health Education|health education
959279|NCT03423615|Primary Schools|primary schools
959280|NCT03423615|Republic of India|republic of india
959281|NCT03423602|Percutaneous vascular closure device|percutaneous vascular closure device
959282|NCT03423602|Large hole closure device|large hole closure device
959283|NCT03423602|Arteriotomy closure|arteriotomy closure
959284|NCT03423602|Vascular closure device|vascular closure device
959285|NCT03423589|Siblings|siblings
959286|NCT03423576|health services|health services
959287|NCT03423576|FEV1|fev1
959288|NCT03423576|BMI|bmi
959289|NCT03423576|quality of life|quality of life
959290|NCT03423576|mental stress|mental stress
959291|NCT03423524|Intraocular lens|intraocular lens
959292|NCT03423524|Monofocal|monofocal
959293|NCT03423524|Hydrophobic|hydrophobic
959294|NCT03423511|MiStent|mistent
959295|NCT03423511|Coronary Artery Disease|coronary artery disease
959296|NCT03423511|Coronary Disease|coronary disease
959297|NCT03423511|Myocardial Ischemia|myocardial ischemia
959298|NCT03423511|Heart Disease|heart disease
959299|NCT03423511|Cardiovascular Diseases|cardiovascular diseases
959300|NCT03423511|Arteriosclerosis|arteriosclerosis
959301|NCT03423511|Arterial Occlusive Diseases|arterial occlusive diseases
959302|NCT03423511|Vascular Diseases|vascular diseases
959303|NCT03423498|hallux valgus,|hallux valgus,
959304|NCT03423498|toe-spread-out exercise|toe-spread-out exercise
959305|NCT03423498|abductor hallucis muscle|abductor hallucis muscle
959306|NCT03423498|surface electromyography|surface electromyography
959307|NCT03423485|Colorectal Surgery|colorectal surgery
959308|NCT03423472|Nutrition|nutrition
959309|NCT03423472|Women|women
959310|NCT03423472|Young children|young children
959311|NCT03423472|Ethiopia|ethiopia
959312|NCT03423472|Vitamin A|vitamin a
959313|NCT03423472|Orange flesh sweet potato|orange flesh sweet potato
959314|NCT03423433|Chronic|chronic
959315|NCT03423433|Stroke|stroke
959316|NCT03423433|Blood Pressure|blood pressure
959317|NCT03423433|Oxygen Perfusion|oxygen perfusion
959318|NCT03423433|Stroop|stroop
959319|NCT03423433|Cognitive Performance|cognitive performance
959320|NCT03423433|Cognition|cognition
1651131|NCT00189800|tolterodine|tolterodine
959321|NCT03423394|Motivational enhancement therapy|motivational enhancement therapy
959322|NCT03423368|Libramed|libramed
959323|NCT03423368|Policaptil Gel Retard|policaptil gel retard
959324|NCT03423368|Overweight|overweight
959325|NCT03423368|Obesity|obesity
959326|NCT03423368|Medical Device|medical device
959327|NCT03423368|glycemic profile|glycemic profile
959328|NCT03423368|lipid profile|lipid profile
959329|NCT03423342|nicotinamide riboside|nicotinamide riboside
959330|NCT03423342|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
959331|NCT03423303|Prostate cancer|prostate cancer
959332|NCT03423303|Screening|screening
959333|NCT03423303|Randomised trial|randomised trial
959334|NCT03423303|Kallikrein|kallikrein
959335|NCT03423303|Magnetic resonance imaging|magnetic resonance imaging
959336|NCT03423303|Prostate-specific antigen|prostate-specific antigen
959337|NCT03423264|HPV-related oropharyngeal cancer|hpv-related oropharyngeal cancer
959338|NCT03423264|oropharyngeal cancer|oropharyngeal cancer
959339|NCT03423264|HPV-related squamous cell carcinoma|hpv-related squamous cell carcinoma
959340|NCT03423264|prophylactic gabapentin|prophylactic gabapentin
959341|NCT03423264|Optima II study|optima ii study
959342|NCT03423238|Cardiac|cardiac
959343|NCT03423238|Rehab|rehab
959344|NCT03423238|Diet|diet
959345|NCT03423238|Exercise|exercise
959346|NCT03423238|Obese|obese
959347|NCT03423225|ADVAGRAF®|advagraf®
959348|NCT03423225|Liver Transplantation|liver transplantation
959349|NCT03423225|tacrolimus|tacrolimus
959350|NCT03423199|breast Cancer|breast cancer
959351|NCT03423199|palbociclib (PD-0332991)|palbociclib (pd-0332991)
959352|NCT03423199|tamoxifen|tamoxifen
959353|NCT03423199|goserelin|goserelin
959354|NCT03423199|any menopausal status|any menopausal status
959355|NCT03423199|hormone receptor positive|hormone receptor positive
959356|NCT03423199|HER2 negative|her2 negative
959357|NCT03423199|locally advanced|locally advanced
959358|NCT03423199|metastatic|metastatic
959359|NCT03423173|Vaccine|vaccine
959360|NCT03423147|Cesarean section|cesarean section
959361|NCT03423147|Labor|labor
959362|NCT03423147|Surgical Site Infections|surgical site infections
959363|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate
959364|NCT03423108|Exercise|exercise
959365|NCT03423108|Aging|aging
959366|NCT03423108|Elderly|elderly
959367|NCT03423108|Physical Activity|physical activity
959368|NCT03423108|Cardiovascular Disease|cardiovascular disease
959369|NCT03423069|Irritable bowel syndrome|irritable bowel syndrome
959370|NCT03423069|FODMAPs|fodmaps
959371|NCT03423069|Dietary advice|dietary advice
959372|NCT03423069|Gastrointestinal symptoms|gastrointestinal symptoms
959373|NCT03423069|Intestinal permeability|intestinal permeability
959374|NCT03423069|Gastrointestinal peptides|gastrointestinal peptides
959375|NCT03423069|Microbiome|microbiome
959376|NCT03423069|Lipidomic profile|lipidomic profile
959377|NCT03423056|Gastrointestinal Neoplasms|gastrointestinal neoplasms
959378|NCT03423056|Exercise|exercise
959379|NCT03423056|Preoperative Period|preoperative period
959380|NCT03423056|Preoperative Care|preoperative care
959381|NCT03423017|Pierre Robin sequence|pierre robin sequence
959382|NCT03423017|Brainstem|brainstem
959383|NCT03423017|pathogenesis|pathogenesis
959384|NCT03423017|swallowing|swallowing
959385|NCT03423017|apnea|apnea
959386|NCT03423004|psoriasis|psoriasis
959387|NCT03423004|IL-22|il-22
959388|NCT03423004|miR-21|mir-21
959389|NCT03422991|Heart Failure|heart failure
959390|NCT03422991|Heart Diseases|heart diseases
959391|NCT03422991|Cardiovascular Diseases|cardiovascular diseases
959392|NCT03422991|Vascular Diseases|vascular diseases
959393|NCT03422991|Cohort|cohort
959394|NCT03422978|Dexmedetomidine|dexmedetomidine
959395|NCT03422965|Retina|retina
959396|NCT03422965|OCT|oct
959397|NCT03422965|Optical Coherence Tomography|optical coherence tomography
959398|NCT03422965|Optical Coherence Tomography Angiography|optical coherence tomography angiography
959399|NCT03422965|Systemic|systemic
959400|NCT03422965|Blood|blood
959401|NCT03422965|Diabetes Mellitus|diabetes mellitus
959402|NCT03422965|Diabetic Retinopathy|diabetic retinopathy
959403|NCT03422939|FBDG|fbdg
959404|NCT03422939|dietitians|dietitians
959405|NCT03422939|portion sizes|portion sizes
959406|NCT03422939|time frame|time frame
959407|NCT03422939|visual references|visual references
959408|NCT03422887|postoperative pain|postoperative pain
959409|NCT03422887|general anesthesia|general anesthesia
959410|NCT03422887|postoperative discomfort|postoperative discomfort
959411|NCT03422874|Advanced Solid Tumors|advanced solid tumors
959412|NCT03422874|Lymphoma|lymphoma
959413|NCT03422874|Nelfinavir|nelfinavir
959414|NCT03422874|MLN9708|mln9708
959415|NCT03422874|proteasome inhibitor|proteasome inhibitor
959416|NCT03422861|Nabilone|nabilone
959417|NCT03422861|Inflammatory Bowel Disease|inflammatory bowel disease
959418|NCT03422861|Opioid|opioid
959419|NCT03422848|hydration|hydration
959420|NCT03422848|water|water
959421|NCT03422848|vasopressin|vasopressin
959422|NCT03422848|copeptin|copeptin
959423|NCT03422848|glucose|glucose
959424|NCT03422848|OGTT|ogtt
959425|NCT03422848|insulin|insulin
959426|NCT03422848|glucagon|glucagon
959427|NCT03422835|transanal surgery|transanal surgery
959428|NCT03422835|robotic surgery|robotic surgery
959429|NCT03422835|total mesorectal excision|total mesorectal excision
959430|NCT03422822|atopic dermatitis|atopic dermatitis
959431|NCT03422822|atopic eczema|atopic eczema
959432|NCT03422822|eczema|eczema
959433|NCT03422822|JAK|jak
959434|NCT03422822|janus kinase|janus kinase
959435|NCT03422809|Plasma volume, micronutrient, estrogen, progesterone|plasma volume, micronutrient, estrogen, progesterone
959436|NCT03422783|Monitoring|monitoring
959438|NCT03422783|Thoracoscopy|thoracoscopy
959439|NCT03422770|Myocardium|myocardium
959440|NCT03422770|Predictive Value of Tests|predictive value of tests
959441|NCT03422770|Prognosis|prognosis
959442|NCT03422770|Clinical Decision-making|clinical decision-making
959443|NCT03422770|Heart Ventricles|heart ventricles
959444|NCT03422770|Echocardiography|echocardiography
959445|NCT03422718|stroke|stroke
959446|NCT03422718|hypertension|hypertension
959447|NCT03422692|Resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.|resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.
959448|NCT03422679|advanced solid tumours|advanced solid tumours
959449|NCT03422679|haematological malignancies|haematological malignancies
959450|NCT03422679|phase I/II|phase i/ii
959451|NCT03422679|NOTCH pathway|notch pathway
959452|NCT03422679|pan-NOTCH inhibitor|pan-notch inhibitor
959453|NCT03422666|Intestinal lipoprotein|intestinal lipoprotein
959454|NCT03422666|Gut Peptide|gut peptide
959455|NCT03422666|Chylomicrons|chylomicrons
959456|NCT03422653|Hemodialysis|hemodialysis
959457|NCT03422640|Frontal Fibrosing Alopecia|frontal fibrosing alopecia
959458|NCT03422640|Apremilast|apremilast
959459|NCT03422549|diaphragm|diaphragm
959460|NCT03422549|non-invasive ventilation|non-invasive ventilation
959461|NCT03422549|high-frequency oscillation|high-frequency oscillation
959462|NCT03422549|CPAP|cpap
959463|NCT03422536|Head and Neck Cancer|head and neck cancer
959464|NCT03422536|Oropharyngeal Cancer|oropharyngeal cancer
959465|NCT03422536|Squamous Cell Carcinoma|squamous cell carcinoma
959466|NCT03422536|lip carcinoma|lip carcinoma
959467|NCT03422536|oral cavity carcinoma|oral cavity carcinoma
959468|NCT03422536|HNSCC|hnscc
959469|NCT03422536|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
959470|NCT03422536|AVEO|aveo
959471|NCT03422523|Refractory|refractory
959472|NCT03422523|Relapsed|relapsed
959473|NCT03422523|Hematological cancer|hematological cancer
959474|NCT03422510|FSGS|fsgs
959475|NCT03422510|Kidney Disease|kidney disease
959476|NCT03422510|Proteinuria|proteinuria
959477|NCT03422510|Nephrotic Syndrome|nephrotic syndrome
959478|NCT03422510|FIRSTx|firstx
959479|NCT03422510|Nitro fatty acids|nitro fatty acids
959480|NCT03422510|OA-NO2|oa-no2
959481|NCT03422510|10-nitro oleic acid|10-nitro oleic acid
959482|NCT03422510|Nitro oleic acid|nitro oleic acid
959483|NCT03422484|Internal medecine unit|internal medecine unit
959484|NCT03422484|Medication Error|medication error
959485|NCT03422484|Clinical Pharmacist|clinical pharmacist
959486|NCT03422484|Medication reconciliation|medication reconciliation
959487|NCT03422445|Apatinib|apatinib
959488|NCT03422445|Temozolomide|temozolomide
959489|NCT03422445|Advanced Melanoma|advanced melanoma
959490|NCT03422406|Iodine excess|iodine excess
959491|NCT03422406|Cause|cause
959492|NCT03422406|Pregnancy|pregnancy
959493|NCT03422406|Urinary iodine concentration|urinary iodine concentration
959494|NCT03422406|Serum iodine concentration|serum iodine concentration
959495|NCT03422406|Breast milk iodine concentration|breast milk iodine concentration
959496|NCT03422393|venetoclax|venetoclax
959497|NCT03422393|ibrutinib|ibrutinib
959498|NCT03422393|high-dose ibrutinib|high-dose ibrutinib
959499|NCT03422393|chronic lymphocytic leukemia|chronic lymphocytic leukemia
959500|NCT03422393|progressive disease|progressive disease
959501|NCT03422393|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
959502|NCT03422393|cancer|cancer
959503|NCT03422380|energy expenditure|energy expenditure
959504|NCT03422380|adaptive thermogenesis|adaptive thermogenesis
959505|NCT03422380|metabolic adaptation|metabolic adaptation
959506|NCT03422380|weight loss maintenance|weight loss maintenance
959507|NCT03422367|autism|autism
959508|NCT03422367|epilepsy|epilepsy
959509|NCT03422367|asd|asd
959510|NCT03422367|TSC|tsc
959511|NCT03422367|UCLA|ucla
959512|NCT03422367|Los Angeles|los angeles
959513|NCT03422367|JASPER|jasper
959514|NCT03422367|intervention|intervention
959515|NCT03422367|Boston|boston
959516|NCT03422367|BCH|bch
959517|NCT03422367|MGH|mgh
959518|NCT03422328|macitentan|macitentan
959519|NCT03422328|long-term safety|long-term safety
959520|NCT03422328|open-label|open-label
959521|NCT03422328|single-arm|single-arm
959522|NCT03422315|Propofol|propofol
1651426|NCT00188305|Behavioral|behavioral
959523|NCT03422315|Population pharmacokinetics|population pharmacokinetics
959524|NCT03422315|Individualized administration|individualized administration
959525|NCT03422302|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
959526|NCT03422302|Lung cancer|lung cancer
959527|NCT03422302|Continuous Positive Airway Pressure Device|continuous positive airway pressure device
959528|NCT03422302|CPAP|cpap
959529|NCT03422302|Deep inspiration breath hold|deep inspiration breath hold
959530|NCT03422302|DIBH|dibh
959531|NCT03422289|myo-inositol|myo-inositol
959532|NCT03422289|alpha-lactalbumin|alpha-lactalbumin
959533|NCT03422289|anovulation|anovulation
959534|NCT03422289|infertility|infertility
959535|NCT03422276|Transition|transition
959536|NCT03422276|Rehabilitation Discharge|rehabilitation discharge
959633|NCT03421457|Lateral Mesh Suspension|lateral mesh suspension
959537|NCT03422263|Type 2 diabetes mellitus, SGLT-2-Inhibitors, Empagliflozin, Canagliflozin, Dapagliflozin, 6-minute walk test.|type 2 diabetes mellitus, sglt-2-inhibitors, empagliflozin, canagliflozin, dapagliflozin, 6-minute walk test.
959538|NCT03422172|GSK1265744|gsk1265744
959539|NCT03422172|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
959540|NCT03422172|Human immunodeficiency virus|human immunodeficiency virus
959541|NCT03422172|Cabotegravir|cabotegravir
959542|NCT03422172|Pharmacokinetics|pharmacokinetics
959543|NCT03422120|Immune Suppression|immune suppression
959544|NCT03422120|Natural Killer Cell Mediated Immunity|natural killer cell mediated immunity
959545|NCT03422120|Natural Killer Cell Cytokine Production|natural killer cell cytokine production
959546|NCT03422120|Perioperative/Postoperative Complications|perioperative/postoperative complications
959547|NCT03422107|Peripheral Nerve Injuries|peripheral nerve injuries
959548|NCT03422107|Thoracic Surgery|thoracic surgery
959549|NCT03422107|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
959550|NCT03422081|endothelial dysfunction|endothelial dysfunction
959551|NCT03422081|doppler ultrasound examination|doppler ultrasound examination
959552|NCT03422081|nitric oxide|nitric oxide
959553|NCT03422055|safety 99mTc-Fucoïdane scintigraphy|safety 99mtc-fucoïdane scintigraphy
959554|NCT03422029|ORR|orr
959555|NCT03422029|Safety|safety
959556|NCT03422029|PFS|pfs
959557|NCT03422016|electroretinogram|electroretinogram
959558|NCT03422003|Breast Cancer|breast cancer
959559|NCT03422003|Radiation|radiation
959560|NCT03422003|Hypofractionation|hypofractionation
959561|NCT03422003|Randomization|randomization
959562|NCT03421951|spine|spine
959563|NCT03421951|lower limb|lower limb
959564|NCT03421938|total knee arthroplasty|total knee arthroplasty
959565|NCT03421938|walking exercises|walking exercises
959566|NCT03421938|uphill-downhill walking exercises|uphill-downhill walking exercises
959567|NCT03421938|functional level|functional level
959568|NCT03421912|Prevention strategy|prevention strategy
959569|NCT03421912|Cutaneous toxicity|cutaneous toxicity
959570|NCT03421912|Quality of life|quality of life
959571|NCT03421912|Patient satisfaction|patient satisfaction
959572|NCT03421912|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
959573|NCT03421912|Epidermal Repair Score (SCOREPI)|epidermal repair score (scorepi)
959574|NCT03421912|Topical treatment|topical treatment
959575|NCT03421899|Mitochondria|mitochondria
959576|NCT03421899|Mitochondrial dysfunction|mitochondrial dysfunction
959577|NCT03421899|Parkin|parkin
959578|NCT03421899|PINK1|pink1
959579|NCT03421860|Spinal anesthesia|spinal anesthesia
959580|NCT03421860|cardiac output|cardiac output
959581|NCT03421860|vasopressor|vasopressor
959582|NCT03421847|depression|depression
959583|NCT03421847|vestibular disorder|vestibular disorder
959584|NCT03421847|rotatory test|rotatory test
959585|NCT03421847|electronystagmography|electronystagmography
959586|NCT03421834|Ventricular Tachycardia|ventricular tachycardia
959587|NCT03421834|Ischemic Cardiomyopathy|ischemic cardiomyopathy
959588|NCT03421834|Primary prevention|primary prevention
959589|NCT03421834|Heart Failure|heart failure
959590|NCT03421821|quadratus lumborum block|quadratus lumborum block
959591|NCT03421821|anterior thoracolumbar fascia|anterior thoracolumbar fascia
959592|NCT03421821|subfascial injection|subfascial injection
959593|NCT03421821|extrafascial injection|extrafascial injection
959594|NCT03421808|TMS|tms
959595|NCT03421808|transcranial magnetic stimulation|transcranial magnetic stimulation
959596|NCT03421808|brain stimulation|brain stimulation
959597|NCT03421795|pain assessment/management|pain assessment/management
959598|NCT03421795|developmental disabilities|developmental disabilities
959599|NCT03421795|children|children
959600|NCT03421795|education|education
959601|NCT03421795|respite workers|respite workers
959602|NCT03421730|mild asthma|mild asthma
959603|NCT03421730|budesonide|budesonide
959604|NCT03421730|nebulizer|nebulizer
959605|NCT03421730|pediatric|pediatric
959606|NCT03421730|pharmacokinetics|pharmacokinetics
959607|NCT03421665|titanium wedge|titanium wedge
959608|NCT03421665|Evans|evans
959609|NCT03421665|Cotton|cotton
959610|NCT03421613|PHN, acute, herpes zoster|phn, acute, herpes zoster
959611|NCT03421600|image enhanced endoscopy|image enhanced endoscopy
959612|NCT03421600|colonoscopy|colonoscopy
959613|NCT03421600|colonic polyp|colonic polyp
959614|NCT03421600|colonic adenoma|colonic adenoma
959615|NCT03421535|Glenohumeral internal rotational deficit|glenohumeral internal rotational deficit
959617|NCT03421535|Sleeper stretch|sleeper stretch
959618|NCT03421535|SI joint stretch|si joint stretch
959619|NCT03421522|PPSP|ppsp
959620|NCT03421522|ICBN|icbn
959621|NCT03421509|cutaneous silent period|cutaneous silent period
959622|NCT03421509|spasticity|spasticity
959623|NCT03421509|stroke|stroke
959624|NCT03421483|Folate|folate
959625|NCT03421483|Absorption|absorption
959626|NCT03421483|Metabolism|metabolism
959627|NCT03421483|Colon|colon
959628|NCT03421483|Receptor|receptor
959629|NCT03421483|Enzyme|enzyme
959630|NCT03421457|Pelvic Organ Prolapse|pelvic organ prolapse
959631|NCT03421457|Translabial ultrasound|translabial ultrasound
959632|NCT03421457|Transperineal ultrasound|transperineal ultrasound
959634|NCT03421457|Descensus uteri|descensus uteri
959635|NCT03421457|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
959636|NCT03421457|Uterus preserving|uterus preserving
959637|NCT03421457|hysteropexy|hysteropexy
959638|NCT03421457|uterine-preserving|uterine-preserving
959639|NCT03421457|fertility-sparing|fertility-sparing
959640|NCT03421457|sacropexy|sacropexy
959641|NCT03421457|cervicopexy|cervicopexy
959642|NCT03421457|sacrocervicopexy|sacrocervicopexy
959643|NCT03421457|sacrohysteropexy|sacrohysteropexy
959644|NCT03421457|mesh prolapse surgery|mesh prolapse surgery
959645|NCT03421444|Children|children
959646|NCT03421444|Obesity|obesity
959647|NCT03421444|Metabolic Disease|metabolic disease
959648|NCT03421431|NASH|nash
959649|NCT03421431|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
959650|NCT03421392|constitutive thrombocytopenia|constitutive thrombocytopenia
959651|NCT03421392|central thrombocytopenia|central thrombocytopenia
959652|NCT03421392|platelets|platelets
959653|NCT03421392|sialylation|sialylation
959654|NCT03421392|flow cytometry|flow cytometry
959655|NCT03421366|posaconazole|posaconazole
959656|NCT03421353|AZD9150|azd9150
959657|NCT03421353|Durvalumab|durvalumab
959658|NCT03421353|NSCLC|nsclc
959659|NCT03421353|Non-small-cell lung cancer|non-small-cell lung cancer
959660|NCT03421353|Advanced solid malignancies|advanced solid malignancies
959661|NCT03421340|ERCP|ercp
959662|NCT03421340|DSC|dsc
959663|NCT03421340|Spy Glass|spy glass
959664|NCT03421340|Biliary Stones|biliary stones
959665|NCT03421340|Choledocholithiasis|choledocholithiasis
959666|NCT03421340|Non-Complex|non-complex
959667|NCT03421340|Stones|stones
959668|NCT03421301|gut microbiota|gut microbiota
959669|NCT03421301|functional foods|functional foods
959670|NCT03421301|branched chain amino acids|branched chain amino acids
959671|NCT03421301|TMAO|tmao
959672|NCT03421301|type 2 diabetes|type 2 diabetes
959673|NCT03421275|fentanyl|fentanyl
959674|NCT03421275|esketamine|esketamine
959675|NCT03421275|ketamine|ketamine
959676|NCT03421275|analgesia|analgesia
959677|NCT03421275|acute pain|acute pain
959678|NCT03421275|minor trauma|minor trauma
959679|NCT03421184|autoimmune disease|autoimmune disease
959680|NCT03421184|endocrine disruptors|endocrine disruptors
959681|NCT03421184|isoflavones|isoflavones
959682|NCT03421184|lignans|lignans
959683|NCT03421184|diet exposure|diet exposure
959684|NCT03421184|risk factor|risk factor
959685|NCT03421158|neonates|neonates
959686|NCT03421158|Non-pharmacological|non-pharmacological
959687|NCT03421119|type 2 diabetes|type 2 diabetes
959688|NCT03421119|liraglutide|liraglutide
959689|NCT03421119|efficacy|efficacy
959690|NCT03421119|safety|safety
959691|NCT03421106|Food insecurity|food insecurity
959692|NCT03421106|Food pantries|food pantries
959693|NCT03421093|Lung cancer|lung cancer
959694|NCT03421093|Chinese|chinese
959695|NCT03421093|surgeries|surgeries
959696|NCT03421093|adjuvant therapies|adjuvant therapies
959697|NCT03421015|localized prostate cancer|localized prostate cancer
959698|NCT03421015|prostatectomy|prostatectomy
959699|NCT03421015|biomarkers|biomarkers
959700|NCT03421015|metastatic recurrence|metastatic recurrence
959701|NCT03421015|genomic|genomic
959702|NCT03421002|candida meningitis|candida meningitis
959703|NCT03421002|Mycamine|mycamine
959704|NCT03421002|candidiasis, systemic|candidiasis, systemic
959705|NCT03421002|micafungin|micafungin
959706|NCT03420989|carob|carob
959707|NCT03420989|seaweed|seaweed
959708|NCT03420989|snack food|snack food
959709|NCT03420989|obese subjects|obese subjects
959710|NCT03420976|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
959711|NCT03420976|SIBO|sibo
959712|NCT03420963|Natural killer cells|natural killer cells
959713|NCT03420963|NK cells|nk cells
959714|NCT03420963|Cyclophosphamide|cyclophosphamide
959715|NCT03420963|Cytoxan|cytoxan
959716|NCT03420963|Neosar|neosar
959717|NCT03420963|Etoposide|etoposide
959718|NCT03420963|VePesid|vepesid
959719|NCT03420937|deep neuromuscular block|deep neuromuscular block
959720|NCT03420937|laparoscopic surgery|laparoscopic surgery
959721|NCT03420937|robotic surgery|robotic surgery
959722|NCT03420937|lung protective ventilation|lung protective ventilation
959723|NCT03420937|respiratory functions|respiratory functions
959724|NCT03420937|post-operative recovery|post-operative recovery
959725|NCT03420924|intraoperative hypothermia|intraoperative hypothermia
959726|NCT03420924|thermal suit|thermal suit
959727|NCT03420924|forced-air warming|forced-air warming
959728|NCT03420911|pain|pain
959729|NCT03420911|anxiety|anxiety
959730|NCT03420911|emergency department|emergency department
959731|NCT03420911|pain management|pain management
959732|NCT03420885|Ba Duan Jin|ba duan jin
959733|NCT03420885|Pulmonary Nodules|pulmonary nodules
959734|NCT03420885|Clinical Intervention|clinical intervention
959735|NCT03420872|Nutrition|nutrition
959736|NCT03420872|Nutrients|nutrients
959737|NCT03420872|Mixtures|mixtures
959738|NCT03420872|Neurodevelopment|neurodevelopment
959739|NCT03420872|Prenatal|prenatal
959740|NCT03420872|Children|children
959741|NCT03420820|intravitreal injection|intravitreal injection
959742|NCT03420820|povidone-iodine|povidone-iodine
959743|NCT03420820|ocular surface flora|ocular surface flora
959744|NCT03420820|endophthalmitis|endophthalmitis
959745|NCT03420820|betadine|betadine
959746|NCT03420781|diabetic gastroparesis|diabetic gastroparesis
959747|NCT03420781|vomiting|vomiting
959748|NCT03420742|Drug therapy, brigatinib, lung cancer, ALK, ROS1|drug therapy, brigatinib, lung cancer, alk, ros1
959749|NCT03420716|functional foods|functional foods
959750|NCT03420716|dairy foods|dairy foods
959751|NCT03420716|calcium absorption|calcium absorption
959752|NCT03420716|prebiotics and probiotics|prebiotics and probiotics
959753|NCT03420716|young women|young women
959754|NCT03420716|bone health|bone health
959755|NCT03420703|erector spinae plane block|erector spinae plane block
959756|NCT03420703|laparoscopic cholecystectomy|laparoscopic cholecystectomy
959757|NCT03420703|postoperative pain|postoperative pain
959758|NCT03420664|cast|cast
959759|NCT03420664|orthosis|orthosis
959760|NCT03420664|immobilisation|immobilisation
959761|NCT03420664|venous stasis|venous stasis
959762|NCT03420664|circulation|circulation
959763|NCT03420638|Adults|adults
959764|NCT03420638|Pain|pain
959885|NCT03419936|Stomach Neoplasms|stomach neoplasms
959765|NCT03420625|Intermittent Pneumatic Compression Devices|intermittent pneumatic compression devices
959766|NCT03420625|Electric Stimulation Therapy|electric stimulation therapy
959767|NCT03420625|Blood Flow Velocity|blood flow velocity
959768|NCT03420625|Hemodynamics|hemodynamics
959769|NCT03420599|Gut microbiota|gut microbiota
959770|NCT03420599|Splenectomy|splenectomy
959771|NCT03420599|Infection|infection
959772|NCT03420599|Immune|immune
959773|NCT03420599|Cytokines|cytokines
959774|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation
959775|NCT03420586|Anesthesia Recovery Period|anesthesia recovery period
959776|NCT03420586|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
959777|NCT03420586|Pain, Postoperative|pain, postoperative
959778|NCT03420508|Ensartinib|ensartinib
959779|NCT03420508|ALK Inhibitor|alk inhibitor
959780|NCT03420508|ALK Alterations|alk alterations
959781|NCT03420508|Aberrant ALK Expression|aberrant alk expression
959782|NCT03420508|17-471|17-471
959784|NCT03420495|Intolerance of Uncertainty|intolerance of uncertainty
959785|NCT03420482|Microbiome|microbiome
959786|NCT03420482|Fecal Microbiota Transplant|fecal microbiota transplant
959787|NCT03420443|radiotherapy, probiotics|radiotherapy, probiotics
959788|NCT03420417|Mechanical ventilation|mechanical ventilation
959789|NCT03420391|phototherapy|phototherapy
959790|NCT03420391|performance|performance
959791|NCT03420391|muscular recovery|muscular recovery
959792|NCT03420391|photobiomodulation therapy|photobiomodulation therapy
959793|NCT03420391|time-window|time-window
959794|NCT03420378|Central Sensitisation|central sensitisation
959795|NCT03420378|Cutaneous Silent Period|cutaneous silent period
959796|NCT03420378|Vitamin D Deficiency|vitamin d deficiency
959797|NCT03420339|stimulant medication|stimulant medication
959798|NCT03420339|behavioral function|behavioral function
959799|NCT03420339|preferences|preferences
959800|NCT03420339|delay discounting|delay discounting
959801|NCT03420326|Atrial Fibrillation|atrial fibrillation
959802|NCT03420326|Frailty status|frailty status
959803|NCT03420326|Body composition|body composition
959804|NCT03420326|Sarcopenia|sarcopenia
959805|NCT03420313|buprenorphine|buprenorphine
959806|NCT03420313|waitlist|waitlist
959807|NCT03420313|interim treatment|interim treatment
959808|NCT03420313|opioid use disorder|opioid use disorder
959809|NCT03420300|Hepatitis C virus|hepatitis c virus
959810|NCT03420300|Hemodialysis|hemodialysis
959811|NCT03420300|Direct acting antiviral agent|direct acting antiviral agent
959812|NCT03420274|Shared decision-making|shared decision-making
959813|NCT03420274|Prenatal genetic testing|prenatal genetic testing
959814|NCT03420274|Noninvasive prenatal testing (NIPT)|noninvasive prenatal testing (nipt)
959815|NCT03420274|Cell free fetal DNA (cfDNA)|cell free fetal dna (cfdna)
959816|NCT03420274|Informed consent|informed consent
959817|NCT03420261|Goal-directed therapy|goal-directed therapy
959818|NCT03420261|Fluid loading|fluid loading
959819|NCT03420261|Abdominal surgery|abdominal surgery
959820|NCT03420261|Postoperative morbidity|postoperative morbidity
959821|NCT03420261|Postoperative mortality|postoperative mortality
959822|NCT03420261|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
959823|NCT03420261|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
959824|NCT03420261|General Anesthesia|general anesthesia
959825|NCT03420261|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
959826|NCT03420235|quality of life|quality of life
959827|NCT03420235|eHealth|ehealth
959828|NCT03420235|patient-reported outcomes|patient-reported outcomes
959829|NCT03420235|home spirometry|home spirometry
959830|NCT03420235|cost-effectiveness|cost-effectiveness
959831|NCT03420235|home monitoring|home monitoring
959832|NCT03420222|Intermittent Explosive Disorder|intermittent explosive disorder
959833|NCT03420222|AVP-786|avp-786
959834|NCT03420209|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
959836|NCT03420209|elastic band|elastic band
959837|NCT03420209|posture|posture
959838|NCT03420196|low back pain|low back pain
959839|NCT03420196|physical therapy|physical therapy
959840|NCT03420196|randomized clinical trial|randomized clinical trial
959841|NCT03420196|exercise program|exercise program
959842|NCT03420183|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
959843|NCT03420183|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
959844|NCT03420183|Mantle cell lymphoma|mantle cell lymphoma
959845|NCT03420183|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
959846|NCT03420183|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
959847|NCT03420183|Leukemia, lymphoid|leukemia, lymphoid
959848|NCT03420183|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
959849|NCT03420183|Leukemia|leukemia
959850|NCT03420183|Lymphoma|lymphoma
959851|NCT03420183|Lymphoma, mantle cell|lymphoma, mantle cell
959852|NCT03420183|Neoplasms by histologic type|neoplasms by histologic type
959853|NCT03420183|Neoplasms|neoplasms
959854|NCT03420183|Lymphoproliferative Disorders|lymphoproliferative disorders
959855|NCT03420183|Lymphatic Diseases|lymphatic diseases
959856|NCT03420183|Immunoproliferative Disorders|immunoproliferative disorders
959857|NCT03420183|Immune System Diseases|immune system diseases
959858|NCT03420183|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
959859|NCT03420170|Spinal Cord Injuries|spinal cord injuries
959860|NCT03420170|Physical Fitness|physical fitness
959861|NCT03420170|Exercise Self-Efficacy|exercise self-efficacy
959862|NCT03420170|Physical Activity|physical activity
959863|NCT03420157|Cervical cancer screening|cervical cancer screening
959864|NCT03420157|vaginal self-sampling|vaginal self-sampling
959865|NCT03420157|Focus group|focus group
959866|NCT03420157|communication|communication
959867|NCT03420144|Growth hormone|growth hormone
959868|NCT03420144|cirrhosis|cirrhosis
959869|NCT03420131|instantaneous Flow Ratio|instantaneous flow ratio
959870|NCT03420131|Quantitative Flow Ratio|quantitative flow ratio
959871|NCT03420131|Fractional Flow Reserve|fractional flow reserve
959872|NCT03420092|vasoactive leukotrienes by leukocytes|vasoactive leukotrienes by leukocytes
959873|NCT03420092|bioavailability|bioavailability
959874|NCT03420053|PfSPZ Vaccine|pfspz vaccine
959875|NCT03420053|HIV+|hiv+
959876|NCT03420053|Plasmodium falciparum|plasmodium falciparum
959877|NCT03420053|Sporozoites|sporozoites
959878|NCT03420040|Glargine Insulin|glargine insulin
959879|NCT03420040|QS-M Needle Free Injector|qs-m needle free injector
959880|NCT03420027|predictive score|predictive score
959881|NCT03420027|difficult intubation|difficult intubation
959882|NCT03420001|VBAC, levator ani avulsion, quality of life|vbac, levator ani avulsion, quality of life
959883|NCT03419988|Nrf2|nrf2
959884|NCT03419949|pain|pain
959886|NCT03419936|Helicobacter pylori|helicobacter pylori
959887|NCT03419936|Subtotal gastrectomy|subtotal gastrectomy
959889|NCT03419871|economically stressed communities|economically stressed communities
959890|NCT03419858|Pain|pain
959891|NCT03419858|Slow-Breathing|slow-breathing
959892|NCT03419858|Mindfulness|mindfulness
959893|NCT03419858|Opioids|opioids
959894|NCT03419858|Placebo|placebo
959895|NCT03419832|ARIC|aric
959896|NCT03419819|Phenylketonuria|phenylketonuria
959897|NCT03419819|GMP|gmp
959898|NCT03419819|Sphere|sphere
959899|NCT03419819|Child|child
959900|NCT03419819|Adult|adult
959901|NCT03419819|Phenylalanine|phenylalanine
959902|NCT03419819|PKU|pku
959903|NCT03419819|Glycomacropeptide|glycomacropeptide
959904|NCT03419767|carotid stenosis|carotid stenosis
959905|NCT03419767|melatonin|melatonin
959906|NCT03419767|insulin resistance|insulin resistance
959907|NCT03419767|inflammation|inflammation
959908|NCT03419767|carotid revascularization|carotid revascularization
959909|NCT03419767|antioxidants|antioxidants
959910|NCT03419741|Cancer, Nicotine Addiction, Smoking Cessation|cancer, nicotine addiction, smoking cessation
1651427|NCT00188305|Screening|screening
959911|NCT03419728|Teen pregnancy prevention|teen pregnancy prevention
959912|NCT03419728|Long-acting reversible contraception (LARCs)|long-acting reversible contraception (larcs)
959913|NCT03419728|Healthy Families Healthy Futures|healthy families healthy futures
959914|NCT03419728|Home visiting|home visiting
959915|NCT03419715|migraine|migraine
959916|NCT03419715|headache|headache
959917|NCT03419715|bimatoprost|bimatoprost
959918|NCT03419676|Pancreatoduodenectomy|pancreatoduodenectomy
959919|NCT03419676|Postoperative pancreatic fistula|postoperative pancreatic fistula
959920|NCT03419676|Sealant|sealant
959921|NCT03419676|Hemopatch|hemopatch
959922|NCT03419663|cereal|cereal
959923|NCT03419663|whole grain|whole grain
959924|NCT03419663|refined grain|refined grain
959925|NCT03419663|gastric cancer|gastric cancer
959926|NCT03419663|meta analysis|meta analysis
959927|NCT03419650|PsA|psa
959928|NCT03419624|Dapagliflozin|dapagliflozin
959929|NCT03419624|Exenatide|exenatide
959930|NCT03419624|high-dose insulin therapy|high-dose insulin therapy
959931|NCT03419624|SGLT-2 inhibitor|sglt-2 inhibitor
960332|NCT03417206|Desflurane|desflurane
959932|NCT03419624|GLP-1 receptor agonist|glp-1 receptor agonist
959933|NCT03419611|Communication Intervention|communication intervention
959934|NCT03419598|virtual clinical trial|virtual clinical trial
959935|NCT03419598|high tibial osteotomy|high tibial osteotomy
959936|NCT03419598|3D|3d
959937|NCT03419598|computer simulation|computer simulation
959938|NCT03419598|finite element analysis|finite element analysis
959939|NCT03419598|medial unicompartmental knee osteoarthritis|medial unicompartmental knee osteoarthritis
959940|NCT03419559|LN-145|ln-145
959941|NCT03419559|Cell Therapy|cell therapy
959942|NCT03419559|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
959943|NCT03419559|Cellular Immuno-therapy|cellular immuno-therapy
959944|NCT03419559|TIL|til
959945|NCT03419559|IL-2|il-2
959946|NCT03419559|Durvalumab|durvalumab
959947|NCT03419520|Schoolchildren|schoolchildren
959948|NCT03419520|Overweight|overweight
959949|NCT03419520|Obesity|obesity
959950|NCT03419520|Polymorphisms|polymorphisms
959951|NCT03419520|Genetics|genetics
959952|NCT03419520|Nutritional counseling|nutritional counseling
959953|NCT03419520|Healthy strategies|healthy strategies
959954|NCT03419507|endotracheal tube introducer|endotracheal tube introducer
959955|NCT03419507|manikin|manikin
959956|NCT03419507|chest compression|chest compression
959957|NCT03419455|Obesity|obesity
959958|NCT03419455|Lifelong Obesity|lifelong obesity
959959|NCT03419455|Metabolic abnormalties|metabolic abnormalties
959960|NCT03419455|Low-grade chronic inflammation|low-grade chronic inflammation
959961|NCT03419455|Hyperinsulinemia|hyperinsulinemia
959962|NCT03419455|IGF signalling|igf signalling
959963|NCT03419455|Sex hormones|sex hormones
959964|NCT03419455|Inflammatory response|inflammatory response
959965|NCT03419455|Adipokines|adipokines
959966|NCT03419455|Diet|diet
959967|NCT03419442|Prostate cancer|prostate cancer
959968|NCT03419442|Bone metastases|bone metastases
959969|NCT03419442|Xofigo|xofigo
959970|NCT03419429|Guided tissue membranes|guided tissue membranes
959971|NCT03419429|EDTA|edta
959972|NCT03419429|Simvastatin|simvastatin
959973|NCT03419403|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
959974|NCT03419403|cancer|cancer
959975|NCT03419403|chemoradiation therapy|chemoradiation therapy
959976|NCT03419403|epidermal growth factor receptor-amplified glioblastoma|epidermal growth factor receptor-amplified glioblastoma
959978|NCT03419403|temozolomide|temozolomide
959979|NCT03419390|Hydra01|hydra01
959980|NCT03419377|Treatment|treatment
959981|NCT03419377|Quality of Life|quality of life
959982|NCT03419377|Sexology|sexology
959983|NCT03419377|Women|women
959984|NCT03419338|Maxillary Sinus|maxillary sinus
959985|NCT03419338|Sinus lifting|sinus lifting
959986|NCT03419338|Bone graft|bone graft
959987|NCT03419325|percutaneous coronary interventions (PCI)|percutaneous coronary interventions (pci)
959988|NCT03419325|secondary stroke prevention|secondary stroke prevention
959989|NCT03419325|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
959990|NCT03419312|Spinal Cord Stimulation|spinal cord stimulation
959991|NCT03419312|Burst Spinal Cord Stimulation|burst spinal cord stimulation
959992|NCT03419312|SCS|scs
959993|NCT03419260|seizures|seizures
959994|NCT03419260|status epilepticus|status epilepticus
959995|NCT03419260|EEG monitoring|eeg monitoring
959996|NCT03419221|Staphylococcus aureus|staphylococcus aureus
959997|NCT03419221|bloodstream infection|bloodstream infection
959998|NCT03419221|deep foci of infection|deep foci of infection
959999|NCT03419221|18 FDG PET/CT|18 fdg pet/ct
960000|NCT03419221|antibiotics|antibiotics
960001|NCT03419208|Systemic Sclerosis|systemic sclerosis
960002|NCT03419208|Scleroderma|scleroderma
960003|NCT03419208|Hand Function|hand function
960004|NCT03419208|Intervention|intervention
960005|NCT03419208|Exercise|exercise
960006|NCT03419208|Telerehabilitation|telerehabilitation
960007|NCT03419208|eHealth|ehealth
960008|NCT03419208|Physical Therapy|physical therapy
1651524|NCT00187889|Women|women
960009|NCT03419195|Type 2 Diabetes|type 2 diabetes
960010|NCT03419195|Overweight|overweight
960011|NCT03419195|Exercise Training|exercise training
960012|NCT03419195|Exercise Impairment|exercise impairment
960013|NCT03419195|Healthy Control|healthy control
960014|NCT03419195|Veteran|veteran
960015|NCT03419195|Blood Flow|blood flow
960016|NCT03419182|Geriatric|geriatric
960017|NCT03419182|Acetabular|acetabular
960018|NCT03419182|Arthroplasty|arthroplasty
960019|NCT03419169|Patient|patient
960020|NCT03419169|Rehabilitation|rehabilitation
960021|NCT03419169|Ligament reconstruction|ligament reconstruction
960022|NCT03419169|Surgery|surgery
960023|NCT03419156|text message|text message
960024|NCT03419156|telemedicine|telemedicine
960025|NCT03419104|bariatric surgery|bariatric surgery
960026|NCT03419104|extubation|extubation
960027|NCT03419091|ureteroscopy|ureteroscopy
960028|NCT03419091|lithovue|lithovue
960029|NCT03419091|nephrolithiasis|nephrolithiasis
960030|NCT03419091|single use ureteroscope|single use ureteroscope
960031|NCT03419078|enteral nutrition|enteral nutrition
960032|NCT03419078|parenteral nutrition|parenteral nutrition
960033|NCT03419078|artificial nutrition support|artificial nutrition support
960034|NCT03419078|non-relapse mortality|non-relapse mortality
960035|NCT03419078|survival|survival
960036|NCT03419039|Mild Cognitive Impairment|mild cognitive impairment
960037|NCT03419000|GTCS|gtcs
960038|NCT03419000|Epilepsies, Partial|epilepsies, partial
960039|NCT03419000|Drug Resistant Epilepsy|drug resistant epilepsy
960040|NCT03419000|Circulating MicroRNA|circulating microrna
960041|NCT03419000|Diagnostic|diagnostic
960042|NCT03418987|3D imaging|3d imaging
960043|NCT03418987|vertebral vector|vertebral vector
960044|NCT03418987|Scoliosis|scoliosis
960045|NCT03418974|Dyslipidemia|dyslipidemia
960046|NCT03418974|Cardiovascular Diseases|cardiovascular diseases
960047|NCT03418974|Hypertension|hypertension
960048|NCT03418974|LDL-C|ldl-c
960049|NCT03418935|obstructive jaundice, non-malignant|obstructive jaundice, non-malignant
960050|NCT03418935|mechanical jaundice, non-malignant|mechanical jaundice, non-malignant
960051|NCT03418935|Methionine|methionine
960052|NCT03418935|Succinic acid|succinic acid
960053|NCT03418883|Stroke|stroke
960054|NCT03418883|rehabilitation|rehabilitation
960055|NCT03418883|mirror therapy|mirror therapy
960056|NCT03418883|upper limb|upper limb
960057|NCT03418870|Intensive Care Units, Neonatal|intensive care units, neonatal
960058|NCT03418870|Parents|parents
960059|NCT03418870|Mobile application|mobile application
960060|NCT03418857|probiotics|probiotics
960061|NCT03418857|Human|human
960062|NCT03418857|obesity|obesity
960063|NCT03418857|non-pharmacologic therapy|non-pharmacologic therapy
960064|NCT03418857|gut health|gut health
960065|NCT03418857|microbiome|microbiome
960066|NCT03418857|inflammation|inflammation
960067|NCT03418831|negtive symptoms|negtive symptoms
960068|NCT03418831|cognitive function|cognitive function
960069|NCT03418818|hypoxia|hypoxia
960070|NCT03418818|sarcoma|sarcoma
960071|NCT03418818|FAZA|faza
960072|NCT03418818|PET Imaging|pet imaging
960073|NCT03418805|Ibuprofen|ibuprofen
960074|NCT03418805|Controlled-Release|controlled-release
960075|NCT03418805|pain control|pain control
960076|NCT03418805|Healthy Volunteers|healthy volunteers
960077|NCT03418805|Food Effect|food effect
960078|NCT03418779|IgA nephropathy|iga nephropathy
960079|NCT03418779|immunosuppressive therapy|immunosuppressive therapy
960080|NCT03418779|Yi-Qi-Qing-Jie herbal compound|yi-qi-qing-jie herbal compound
960081|NCT03418779|high-risk IgAN|high-risk igan
960082|NCT03418779|traditional chinese medicine|traditional chinese medicine
960083|NCT03418766|Right-to-left Shunt|right-to-left shunt
960084|NCT03418766|Brain White Matter Lesions|brain white matter lesions
960085|NCT03418766|Migraine|migraine
960086|NCT03418753|noninvasive diagnosis|noninvasive diagnosis
960087|NCT03418740|Friedreich|friedreich
960088|NCT03418740|Ataxia|ataxia
960089|NCT03418740|FRDA|frda
960090|NCT03418740|FA|fa
960091|NCT03418740|Friedrich Ataxia (FRDA)|friedrich ataxia (frda)
960092|NCT03418701|Women's health|women's health
960093|NCT03418662|Colonoscopy|colonoscopy
960094|NCT03418649|low back pain|low back pain
960095|NCT03418649|radicular pain|radicular pain
960096|NCT03418649|degenerative disc disease|degenerative disc disease
960097|NCT03418636|People who inject drugs|people who inject drugs
960098|NCT03418636|Hepatitis C prevention|hepatitis c prevention
960099|NCT03418636|Young adults|young adults
960100|NCT03418636|Behavioral interventions|behavioral interventions
960101|NCT03418623|Glutamate|glutamate
960102|NCT03418623|Alcohol use|alcohol use
960103|NCT03418623|GABA|gaba
960104|NCT03418623|GET73|get73
960105|NCT03418623|Non-treatment seeking|non-treatment seeking
960106|NCT03418610|Rosacea|rosacea
960107|NCT03418597|Virtual reality|virtual reality
960108|NCT03418597|Radio-guided biopsy|radio-guided biopsy
960109|NCT03418597|Pain|pain
960110|NCT03418597|Anxiety|anxiety
960111|NCT03418597|Patient's satisfaction|patient's satisfaction
960112|NCT03418584|argon plasma coagulation|argon plasma coagulation
960113|NCT03418584|submucosal injection|submucosal injection
960114|NCT03418584|Barrett Esophagus|barrett esophagus
960115|NCT03418558|HER2 AMPLIFICATION|her2 amplification
960116|NCT03418532|DARPin®protein|darpin®protein
960117|NCT03418532|MP0250|mp0250
960118|NCT03418532|VEGF|vegf
960119|NCT03418532|HGF|hgf
960120|NCT03418532|NSCLC|nsclc
960121|NCT03418532|EGFR mutated|egfr mutated
960122|NCT03418532|Osimertinib|osimertinib
960123|NCT03418506|Smokeless tobacco|smokeless tobacco
960124|NCT03418506|adolescent|adolescent
960125|NCT03418506|oral cancer|oral cancer
960126|NCT03418506|betal quid|betal quid
960127|NCT03418506|areca nut|areca nut
960128|NCT03418467|Tachycardiomyopathy|tachycardiomyopathy
960129|NCT03418467|atrial fibrillation|atrial fibrillation
960130|NCT03418467|EMID (enrichment of mitochondria at the intercalated discs)|emid (enrichment of mitochondria at the intercalated discs)
960131|NCT03418467|Biopsy|biopsy
960132|NCT03418467|empathy|empathy
960133|NCT03418441|Nationwide prospective observational cohort study|nationwide prospective observational cohort study
960134|NCT03418441|Epidemiology|epidemiology
960135|NCT03418441|Central Nervous System Infections|central nervous system infections
960136|NCT03418441|Meningitis|meningitis
960137|NCT03418441|Encephalitis|encephalitis
960138|NCT03418441|Brain abscess|brain abscess
960139|NCT03418441|Lyme disease|lyme disease
960140|NCT03418441|Neuroborreliosis|neuroborreliosis
960141|NCT03418441|Neurosyphilis|neurosyphilis
960142|NCT03418441|Tertiary syphilis|tertiary syphilis
960143|NCT03418363|Oral contraceptives|oral contraceptives
960144|NCT03418363|Venous thromboembolism|venous thromboembolism
960145|NCT03418363|androgenic combined oral contraception|androgenic combined oral contraception
960146|NCT03418337|cough, dexlansoprazole, GERD, globus, non-cardiac chest pain|cough, dexlansoprazole, gerd, globus, non-cardiac chest pain
960147|NCT03418324|Prostate Cancer|prostate cancer
960148|NCT03418324|Metastatic Prostate Cancer|metastatic prostate cancer
960149|NCT03418324|Castration Resistant Prostate Cancer|castration resistant prostate cancer
960150|NCT03418324|Metastatic Castration Resistant|metastatic castration resistant
960151|NCT03418311|Twin pregnancy|twin pregnancy
960152|NCT03418311|Cervical Pessary|cervical pessary
960153|NCT03418311|short cervix|short cervix
960154|NCT03418311|Prevention|prevention
960155|NCT03418272|ICU|icu
960156|NCT03418272|OR|or
960157|NCT03418272|Pneumonia|pneumonia
960158|NCT03418272|PICU|picu
960159|NCT03418272|Pediatric|pediatric
960160|NCT03418272|PCR|pcr
960161|NCT03418246|gingiva|gingiva
960162|NCT03418246|plaque|plaque
960163|NCT03418246|pocket depth|pocket depth
960164|NCT03418220|Age related Macular Degeneration|age related macular degeneration
960165|NCT03418220|Atrophy|atrophy
960166|NCT03418220|Inflammation|inflammation
960167|NCT03418220|Cytokines|cytokines
960168|NCT03418220|test LUMINEX®|test luminex®
960169|NCT03418207|TPS system|tps system
960170|NCT03418207|trans-perineal template-guided mapping biopsy|trans-perineal template-guided mapping biopsy
960171|NCT03418207|prostate cancer|prostate cancer
960172|NCT03418207|spatial distribution|spatial distribution
960173|NCT03418207|large tissue slice|large tissue slice
960174|NCT03418194|Anesthesia, General|anesthesia, general
960175|NCT03418181|Residual Kidney Function|residual kidney function
960176|NCT03418181|Haemodialysis|haemodialysis
960177|NCT03418181|Preserve Residual Kidney Function|preserve residual kidney function
960178|NCT03418129|Military Veterans|military veterans
960179|NCT03418051|Ankle Instability|ankle instability
960180|NCT03418051|Manual Therapy|manual therapy
960181|NCT03418051|Massage|massage
960182|NCT03418051|Ankle Joint Mobilization|ankle joint mobilization
960183|NCT03418051|Biomechanics|biomechanics
960184|NCT03418051|Neuromuscular|neuromuscular
960185|NCT03418012|Cervical Pessary|cervical pessary
960186|NCT03418012|Short Cervix|short cervix
960187|NCT03418012|Recurrent Preterm Birth|recurrent preterm birth
960188|NCT03418012|history of cervical surgery|history of cervical surgery
960189|NCT03418012|history of conisation|history of conisation
960190|NCT03417999|Intranasal|intranasal
960191|NCT03417999|Pharmacokinetic|pharmacokinetic
960192|NCT03417999|Pediatric|pediatric
960193|NCT03417986|Thiethylperazine|thiethylperazine
960194|NCT03417986|Alzheimer Disease|alzheimer disease
960195|NCT03417973|dorsal root ganglion|dorsal root ganglion
960196|NCT03417960|post partum depression|post partum depression
960197|NCT03417960|theta burst|theta burst
960198|NCT03417960|transcranial magnetic stimulation|transcranial magnetic stimulation
960199|NCT03417947|Bolus supplementation|bolus supplementation
960200|NCT03417947|Pilot randomised controlled trial|pilot randomised controlled trial
960201|NCT03417947|Vitamin D|vitamin d
960202|NCT03417908|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
960203|NCT03417908|Pulmonary Rehabilitation|pulmonary rehabilitation
960204|NCT03417908|muscle activation|muscle activation
960205|NCT03417908|COPD|copd
960206|NCT03417882|PD-L1+|pd-l1+
960207|NCT03417856|Ichthyosis|ichthyosis
960208|NCT03417856|Netherton Syndrome|netherton syndrome
1652707|NCT00181714|Concerta|concerta
960209|NCT03417843|ablation catheter|ablation catheter
960210|NCT03417843|pancreatic premalignant and early malignant cystic lesion|pancreatic premalignant and early malignant cystic lesion
960211|NCT03417830|miridesap|miridesap
960212|NCT03417830|GSK2315698|gsk2315698
960213|NCT03417830|89Zirconium labelled|89zirconium labelled
960214|NCT03417830|Positron Emission Tomography|positron emission tomography
960215|NCT03417830|Transthyretin cardiomyopathy|transthyretin cardiomyopathy
960216|NCT03417830|GSK2398852|gsk2398852
960217|NCT03417830|dezamizumab|dezamizumab
960218|NCT03417791|recovery|recovery
960219|NCT03417791|serum creatinine|serum creatinine
960220|NCT03417765|gastrointestinal mucositis|gastrointestinal mucositis
960221|NCT03417765|myeloablative chemotherapy|myeloablative chemotherapy
960222|NCT03417765|autologous transplantation|autologous transplantation
960223|NCT03417739|Uveal Melanoma|uveal melanoma
960224|NCT03417726|Cerebral Palsy|cerebral palsy
960225|NCT03417726|Balance|balance
960226|NCT03417700|vitamin D|vitamin d
960227|NCT03417700|exercise|exercise
960228|NCT03417700|training|training
960229|NCT03417700|aging|aging
960230|NCT03417648|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
960231|NCT03417635|Meditation|meditation
960232|NCT03417635|Cognitive assessment|cognitive assessment
960233|NCT03417635|Executive function|executive function
960235|NCT03417635|Randomized control trial|randomized control trial
960236|NCT03417635|Mobility|mobility
960237|NCT03417622|resection margin|resection margin
960238|NCT03417622|neoadjuvant therapy|neoadjuvant therapy
960239|NCT03417622|breast conservative surgery|breast conservative surgery
960240|NCT03417622|locally advanced breast cancer|locally advanced breast cancer
960241|NCT03417609|Sarcopenia|sarcopenia
960242|NCT03417609|Tongue strength|tongue strength
960243|NCT03417544|HER2-positive metastatic Breast Cancer|her2-positive metastatic breast cancer
960244|NCT03417544|Central Nervous System Metastases|central nervous system metastases
960245|NCT03417531|Protein supplementation|protein supplementation
960246|NCT03417531|Home exercise program|home exercise program
960247|NCT03417531|Falls prevention|falls prevention
960249|NCT03417531|Autonomy|autonomy
960250|NCT03417518|Oxidative stress|oxidative stress
960251|NCT03417518|Bariatric surgery|bariatric surgery
960252|NCT03417505|Contact lens discomfort|contact lens discomfort
960253|NCT03417505|Scleral lens|scleral lens
960254|NCT03417505|Tangible Hydra-PEG|tangible hydra-peg
960255|NCT03417492|TBI|tbi
960256|NCT03417492|CVR|cvr
960257|NCT03417492|Hypercapnia|hypercapnia
960258|NCT03417492|fNIRS|fnirs
960259|NCT03417492|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
960260|NCT03417492|American football|american football
960262|NCT03417453|normal patients|normal patients
960263|NCT03417453|eye drops dispensers|eye drops dispensers
960264|NCT03417453|aids|aids
960265|NCT03417453|glacuoma|glacuoma
960266|NCT03417453|cataract|cataract
960267|NCT03417440|smartphone app, physical activity, older adults|smartphone app, physical activity, older adults
960268|NCT03417427|acute myeloid leukemia|acute myeloid leukemia
960269|NCT03417427|Intermediate-risk|intermediate-risk
960270|NCT03417427|demethylation drug|demethylation drug
960271|NCT03417427|complete remission|complete remission
960272|NCT03417388|Coronary Angiography|coronary angiography
960273|NCT03417388|Coronary CT Angiogram|coronary ct angiogram
960274|NCT03417388|Ischemia|ischemia
960275|NCT03417388|Non-obstructive CAD|non-obstructive cad
960276|NCT03417362|education|education
960277|NCT03417362|audiovisual|audiovisual
960278|NCT03417362|information|information
960279|NCT03417362|acceptability|acceptability
960280|NCT03417349|Acute Ischemic Stroke|acute ischemic stroke
960281|NCT03417349|Thrombectomy|thrombectomy
960282|NCT03417349|Aspiration Thrombectomy|aspiration thrombectomy
960283|NCT03417349|Observational study|observational study
960284|NCT03417310|closed reduction|closed reduction
960285|NCT03417310|locked intramedullary nailing|locked intramedullary nailing
960286|NCT03417284|Multiple Myeloma|multiple myeloma
960288|NCT03417284|Evomela|evomela
960289|NCT03417284|Melphalan|melphalan
960290|NCT03417284|Alkeran|alkeran
960291|NCT03417284|G-CSF|g-csf
960292|NCT03417284|Filgrastim|filgrastim
960293|NCT03417284|Neupogen|neupogen
960294|NCT03417284|Stem cell transplant|stem cell transplant
960295|NCT03417258|phytoestrogens|phytoestrogens
960296|NCT03417258|isoflavones|isoflavones
960297|NCT03417258|adenomatous polyps|adenomatous polyps
960298|NCT03417258|microbiome|microbiome
960299|NCT03417245|RNAi therapeutic|rnai therapeutic
960300|NCT03417245|Hemophilia A|hemophilia a
960301|NCT03417245|Hemophilia B|hemophilia b
960302|NCT03417245|Hemophilia A, Severe|hemophilia a, severe
960303|NCT03417245|Hemophilia B, Severe|hemophilia b, severe
960304|NCT03417245|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
960305|NCT03417245|Blood Coagulation Disorders|blood coagulation disorders
960306|NCT03417245|Hematologic Diseases|hematologic diseases
960307|NCT03417245|Coagulation Protein Disorders|coagulation protein disorders
960308|NCT03417245|Hemorrhagic Disorders|hemorrhagic disorders
960309|NCT03417245|Genetic Diseases, Inborn|genetic diseases, inborn
960310|NCT03417245|Genetic Diseases, X-Linked|genetic diseases, x-linked
960311|NCT03417245|Factor VIII|factor viii
960312|NCT03417245|Factor IX|factor ix
960313|NCT03417245|Coagulants|coagulants
960314|NCT03417245|Fitusiran|fitusiran
960315|NCT03417232|gingival recession|gingival recession
960316|NCT03417232|coronally advanced flap|coronally advanced flap
960317|NCT03417232|complete root coverage|complete root coverage
960318|NCT03417232|flap elevation|flap elevation
960319|NCT03417232|flap thickness|flap thickness
960320|NCT03417219|Caregivers|caregivers
960321|NCT03417219|Family|family
960322|NCT03417219|Veterans|veterans
960323|NCT03417219|Alzheimer Disease|alzheimer disease
960324|NCT03417219|Memory|memory
960325|NCT03417206|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
960326|NCT03417206|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
960327|NCT03417206|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
960328|NCT03417206|Spectral Entropy (SE)|spectral entropy (se)
960329|NCT03417206|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
960330|NCT03417206|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
960331|NCT03417206|Sevoflurane|sevoflurane
960333|NCT03417193|Lidocaine|lidocaine
960334|NCT03417193|Dexmedetomidine|dexmedetomidine
960335|NCT03417193|Opioid-free|opioid-free
960336|NCT03417180|Surgical Pleth Index (SPI)|surgical pleth index (spi)
960337|NCT03417180|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
960338|NCT03417180|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
960339|NCT03417180|Spectral Entropy (SE)|spectral entropy (se)
960340|NCT03417180|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
960341|NCT03417180|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
960342|NCT03417180|Sevoflurane|sevoflurane
960343|NCT03417180|Desflurane|desflurane
960344|NCT03417167|synovial biopsy|synovial biopsy
960345|NCT03417167|US guided synovial biopsy|us guided synovial biopsy
960346|NCT03417154|AML|aml
960347|NCT03417154|MDS|mds
960348|NCT03417141|Valchor|valchor
960349|NCT03417115|Breast Cancer|breast cancer
960350|NCT03417115|Epidemiology|epidemiology
960351|NCT03417115|Registry|registry
960352|NCT03417115|Health Services Research|health services research
960353|NCT03417115|Germany|germany
960354|NCT03417115|Palliative Treatment|palliative treatment
960355|NCT03417102|RNAi therapeutic|rnai therapeutic
960356|NCT03417102|Hemophilia A|hemophilia a
960357|NCT03417102|Hemophilia B|hemophilia b
960358|NCT03417102|Hemophilia A, Severe|hemophilia a, severe
960359|NCT03417102|Hemophilia B, Severe|hemophilia b, severe
960360|NCT03417102|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
960361|NCT03417102|Blood Coagulation Disorders|blood coagulation disorders
960362|NCT03417102|Hematologic Diseases|hematologic diseases
960363|NCT03417102|Coagulation Protein Disorders|coagulation protein disorders
960364|NCT03417102|Hemorrhagic Disorders|hemorrhagic disorders
960365|NCT03417102|Genetic Diseases, Inborn|genetic diseases, inborn
960366|NCT03417102|Genetic Diseases, X-Linked|genetic diseases, x-linked
960367|NCT03417102|Factor VIII|factor viii
960368|NCT03417102|Factor IX|factor ix
960369|NCT03417102|Inhibitor|inhibitor
960370|NCT03417102|Bypassing agents|bypassing agents
960371|NCT03417102|Coagulants|coagulants
960372|NCT03417102|Fitusiran|fitusiran
960373|NCT03417063|Intracranial artery|intracranial artery
960374|NCT03417063|Atherosclerosis|atherosclerosis
960375|NCT03417063|Intracranial artery stenosis|intracranial artery stenosis
960376|NCT03417063|High-Resolution Magnetic Resonance|high-resolution magnetic resonance
960377|NCT03417050|coronary artery bypass grafting|coronary artery bypass grafting
960378|NCT03417050|percutaneous coronary intervention|percutaneous coronary intervention
960379|NCT03417050|drug eluting stent|drug eluting stent
960380|NCT03417050|survival status|survival status
960381|NCT03417050|long-term follow-up|long-term follow-up
960382|NCT03417050|complex coronary artery disease|complex coronary artery disease
960383|NCT03416998|Photherapy|photherapy
960384|NCT03416998|Photobiomodulation|photobiomodulation
960385|NCT03416998|Creatine Kinase|creatine kinase
960386|NCT03416998|Soccer|soccer
960387|NCT03416998|Muscle Recovery|muscle recovery
960388|NCT03416946|Total knee replacement|total knee replacement
960389|NCT03416933|ctDNA|ctdna
960390|NCT03416933|MAPK inhibition|mapk inhibition
960391|NCT03416933|BRAF(V600) mutated|braf(v600) mutated
960392|NCT03416907|Informed consent|informed consent
960393|NCT03416881|HIV infection|hiv infection
960394|NCT03416881|antiretroviral|antiretroviral
960395|NCT03416881|aging population|aging population
960396|NCT03416881|drug interactions|drug interactions
960397|NCT03416881|cross-sectional study|cross-sectional study
960398|NCT03416881|SNIIRAM|sniiram
960399|NCT03416868|Ambulatory|ambulatory
960400|NCT03416868|Biofeedback|biofeedback
960401|NCT03416868|Voice|voice
960402|NCT03416842|outpatient|outpatient
960403|NCT03416842|wearable sensors|wearable sensors
960404|NCT03416842|home exercise|home exercise
960405|NCT03416829|Ambulatory|ambulatory
960406|NCT03416829|Biofeedback|biofeedback
960407|NCT03416829|Voice|voice
960408|NCT03416816|DSP-0337|dsp-0337
960409|NCT03416790|Central Nervous System|central nervous system
960410|NCT03416790|HIV Persistence|hiv persistence
960411|NCT03416790|HIV Reservoirs|hiv reservoirs
960412|NCT03416777|vegetarian|vegetarian
960413|NCT03416777|meat|meat
960414|NCT03416777|fish|fish
960415|NCT03416764|PTSD, neurofeedback (NF)|ptsd, neurofeedback (nf)
960416|NCT03416712|Social Determinants of Health|social determinants of health
960417|NCT03416699|Transnal Total Mesorectal Excision|transnal total mesorectal excision
960418|NCT03416699|Rectal Cancer|rectal cancer
960419|NCT03416686|differentiated thyroid cancer|differentiated thyroid cancer
960420|NCT03416686|Radiofrequency|radiofrequency
960421|NCT03416660|Fractional laser|fractional laser
960422|NCT03416660|Postburn scar|postburn scar
960423|NCT03416660|Density|density
960424|NCT03416647|Superior Mesenteric Artery Syndrome|superior mesenteric artery syndrome
960425|NCT03416647|Chronic duodenal obstruction|chronic duodenal obstruction
960426|NCT03416647|Duodenojejunostomy|duodenojejunostomy
960427|NCT03416647|Wilkie's syndrome|wilkie's syndrome
960428|NCT03416634|Health promotion|health promotion
960429|NCT03416634|Behavioral research|behavioral research
960430|NCT03416634|Preventive medicine|preventive medicine
960432|NCT03416634|Cardiovascular disease|cardiovascular disease
960434|NCT03416608|ultrasound|ultrasound
960435|NCT03416608|patient experience|patient experience
960436|NCT03416608|diagnostic test|diagnostic test
960437|NCT03416608|general practice|general practice
960438|NCT03416608|family medicine|family medicine
960439|NCT03416595|probiotic|probiotic
960440|NCT03416595|Lactobacillus paracasei N1115|lactobacillus paracasei n1115
960441|NCT03416595|young children|young children
960442|NCT03416543|Rheumatoid arthritis|rheumatoid arthritis
960443|NCT03416543|Dendritics cells|dendritics cells
960444|NCT03416517|Ewing Sarcoma|ewing sarcoma
960445|NCT03416517|Anlotinib|anlotinib
960446|NCT03416517|Irinotecan|irinotecan
960447|NCT03416517|Refractory|refractory
960448|NCT03416517|Metastatic|metastatic
960449|NCT03416504|OCD|ocd
960450|NCT03416491|Chronic hepatitis C|chronic hepatitis c
960451|NCT03416491|Hepatitis C virus|hepatitis c virus
960452|NCT03416491|KW-136|kw-136
960453|NCT03416491|sofosbuvir|sofosbuvir
960454|NCT03416491|nonstructural protein 5A|nonstructural protein 5a
960455|NCT03416491|nonstructural protein 5B|nonstructural protein 5b
960456|NCT03416491|panogentypic regimen|panogentypic regimen
960457|NCT03416478|Colorectal Cancer|colorectal cancer
960458|NCT03416478|ctDNA|ctdna
960459|NCT03416478|Surveillance|surveillance
960460|NCT03416465|hospitalization|hospitalization
960461|NCT03416465|cancer|cancer
960462|NCT03416465|general practitioner|general practitioner
960465|NCT03416426|patent foramen ovale|patent foramen ovale
960466|NCT03416426|PFO closure|pfo closure
960467|NCT03416426|residual shunt|residual shunt
960468|NCT03416426|bubble contrast transesophageal echocardiography|bubble contrast transesophageal echocardiography
960469|NCT03416400|Vitrification|vitrification
960470|NCT03416400|In vitro maturation|in vitro maturation
960471|NCT03416400|Cytoskeleton|cytoskeleton
960472|NCT03416400|chromosomes|chromosomes
960473|NCT03416400|High resolution imaging|high resolution imaging
960474|NCT03416387|complex liver surgery|complex liver surgery
960475|NCT03416387|3D printing|3d printing
960476|NCT03416361|Left ventricular dysfunction|left ventricular dysfunction
960477|NCT03416361|Vitamin D|vitamin d
960478|NCT03416348|amputation|amputation
960479|NCT03416348|amputations|amputations
960480|NCT03416348|sweating|sweating
960481|NCT03416348|residual limb|residual limb
960482|NCT03416348|service members|service members
960483|NCT03416348|civilians|civilians
960486|NCT03416322|Adenoma detection rate|adenoma detection rate
960487|NCT03416322|Colorectal cancer|colorectal cancer
960488|NCT03416309|pharmacokinetics|pharmacokinetics
960489|NCT03416309|pharmacogenetics|pharmacogenetics
960490|NCT03416309|Time To Positivity|time to positivity
960491|NCT03416270|SGLT2 inhibtion|sglt2 inhibtion
960492|NCT03416270|Ertugliflozin|ertugliflozin
960493|NCT03416270|Type 2 Diabetes|type 2 diabetes
960494|NCT03416270|Heart Failure|heart failure
960495|NCT03416231|apatinib|apatinib
960496|NCT03416231|Docetaxel|docetaxel
960497|NCT03416218|STEM Skills|stem skills
960498|NCT03416192|Dialysis|dialysis
960499|NCT03416192|MCO|mco
960500|NCT03416192|Middle molecules|middle molecules
960501|NCT03416179|glasdegib;|glasdegib;
960502|NCT03416179|untreated;|untreated;
960503|NCT03416179|Hedgehog Inhibitor|hedgehog inhibitor
960504|NCT03416166|Tricuspid Valve|tricuspid valve
960505|NCT03416166|tricuspid regurgitation|tricuspid regurgitation
960506|NCT03416166|transcatheter tricuspid regurgitation|transcatheter tricuspid regurgitation
960507|NCT03416127|Diabetes Mellitus type 2|diabetes mellitus type 2
960508|NCT03416127|Glycemic control|glycemic control
960509|NCT03416127|Propolis|propolis
960510|NCT03416127|Metformin|metformin
960511|NCT03416114|rare headaches|rare headaches
960512|NCT03416114|epidemiology|epidemiology
960513|NCT03416101|esophageal cancer|esophageal cancer
960514|NCT03416101|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
960515|NCT03416101|esophageal surgery|esophageal surgery
960516|NCT03416088|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography
960517|NCT03416062|Jaundice, obstructive|jaundice, obstructive
960518|NCT03416062|Methionine|methionine
960519|NCT03416062|Succinic acid|succinic acid
960520|NCT03416049|ulcers|ulcers
960521|NCT03416049|leg ulcers|leg ulcers
960522|NCT03416049|venous stasis|venous stasis
960523|NCT03416049|ulcer treatment|ulcer treatment
960524|NCT03416049|leg ulcer treatment|leg ulcer treatment
960525|NCT03416049|venous stasis treatment|venous stasis treatment
960526|NCT03416049|non invasive treatment|non invasive treatment
960527|NCT03416049|pulsed electromagnetic|pulsed electromagnetic
960528|NCT03416049|pulsed electromagnetic therapy|pulsed electromagnetic therapy
960529|NCT03416049|pulsed electromagnetic treatment|pulsed electromagnetic treatment
960530|NCT03416049|pulsed magnetic|pulsed magnetic
961110|NCT03412227|Adolescents|adolescents
960531|NCT03416049|pulsed magnetic therapy|pulsed magnetic therapy
960532|NCT03416049|pulsed magnetic treatment|pulsed magnetic treatment
960533|NCT03416049|varicose Ulcer|varicose ulcer
960534|NCT03416049|ulcer pain|ulcer pain
960535|NCT03416023|Implant|implant
960536|NCT03416023|continence control|continence control
960537|NCT03416023|titanium|titanium
960538|NCT03416010|emotional distress pregnancy disparities minority depression|emotional distress pregnancy disparities minority depression
960539|NCT03415984|Parkinson Disease|parkinson disease
960540|NCT03415984|Age Related Macular Degeneration|age related macular degeneration
960541|NCT03415984|L-DOPA|l-dopa
960542|NCT03415958|prospective|prospective
960543|NCT03415958|adolescent|adolescent
960544|NCT03415958|displaced|displaced
960545|NCT03415958|clavicle|clavicle
960546|NCT03415958|fracture|fracture
960547|NCT03415958|mid-shaft|mid-shaft
960548|NCT03415906|angiotensin receptor blocker|angiotensin receptor blocker
960549|NCT03415906|neprilysin inhibition|neprilysin inhibition
960550|NCT03415906|sympathetic activity|sympathetic activity
960551|NCT03415906|baroreflex|baroreflex
960552|NCT03415906|microneurography|microneurography
960553|NCT03415906|functional MRI|functional mri
960554|NCT03415893|high-resolution manometry|high-resolution manometry
960555|NCT03415893|esophageal atresia|esophageal atresia
960556|NCT03415893|teenagers|teenagers
960557|NCT03415880|Diabetes mellitus|diabetes mellitus
960558|NCT03415880|Type2 Diabetes|type2 diabetes
960559|NCT03415880|Sedentary Lifestyle|sedentary lifestyle
960560|NCT03415880|Physical Activity|physical activity
960561|NCT03415880|Pulse wave velocity|pulse wave velocity
960562|NCT03415880|arterial stiffness|arterial stiffness
960563|NCT03415880|aortic stiffness|aortic stiffness
960564|NCT03415880|artery disease|artery disease
960565|NCT03415880|light intensity physical activity|light intensity physical activity
960566|NCT03415867|Graft-versus-host disease|graft-versus-host disease
960567|NCT03415867|Bone marrow transplantation|bone marrow transplantation
960568|NCT03415867|Hedgehog inhibitor|hedgehog inhibitor
960569|NCT03415841|Post MI|post mi
960570|NCT03415841|Cardiac Rehabilitation|cardiac rehabilitation
960571|NCT03415841|Wearable Devices|wearable devices
960572|NCT03415841|Smartphone-based Program|smartphone-based program
960573|NCT03415815|Chinese, real-world evidences, T1-T3 esophageal cancer|chinese, real-world evidences, t1-t3 esophageal cancer
960574|NCT03415802|Nab-Paclitaxel|nab-paclitaxel
960575|NCT03415802|S-1|s-1
960576|NCT03415802|Advanced Pancreatic Cancer|advanced pancreatic cancer
960577|NCT03415789|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
960578|NCT03415789|Cardiac thrombosis|cardiac thrombosis
960579|NCT03415789|Silent brain infarct|silent brain infarct
960580|NCT03415789|Fluid dynamics|fluid dynamics
960581|NCT03415789|Intracardiac blood flow|intracardiac blood flow
960582|NCT03415789|Echocardiography|echocardiography
960583|NCT03415776|Hemodialysis|hemodialysis
960584|NCT03415776|Sessions frequency|sessions frequency
960585|NCT03415776|Mortality|mortality
960586|NCT03415776|Morbidity|morbidity
960587|NCT03415763|Rectal Neoplasms|rectal neoplasms
960588|NCT03415763|Adjuvant Chemotherapy|adjuvant chemotherapy
960589|NCT03415763|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
960590|NCT03415750|Renal transplant|renal transplant
960591|NCT03415698|Regenerative medicine|regenerative medicine
960592|NCT03415672|Interleukin-2|interleukin-2
960593|NCT03415672|Hepatitis B Vaccines|hepatitis b vaccines
960594|NCT03415672|Non-responders|non-responders
960595|NCT03415672|Liver Diseases|liver diseases
960596|NCT03415672|Digestive system|digestive system
960597|NCT03415672|Vaccines|vaccines
960598|NCT03415659|HWH340|hwh340
960599|NCT03415659|pharmacokinetics|pharmacokinetics
960600|NCT03415659|dose-escalation|dose-escalation
960601|NCT03415659|safety|safety
960602|NCT03415659|tolerability|tolerability
960603|NCT03415646|erector spinae plane block|erector spinae plane block
960604|NCT03415646|breast surgery|breast surgery
960605|NCT03415646|postoperative pain|postoperative pain
960606|NCT03415633|Home Respiratory Polygraphy|home respiratory polygraphy
960607|NCT03415633|Standard Polysomnography|standard polysomnography
960608|NCT03415633|Validity|validity
960609|NCT03415633|Cost-effectiveness|cost-effectiveness
960610|NCT03415568|Postprandial lipid metabolism|postprandial lipid metabolism
960611|NCT03415568|Medium-chain triglycerides|medium-chain triglycerides
960612|NCT03415568|Diacylglycerols|diacylglycerols
960613|NCT03415568|Serum triglycerides|serum triglycerides
960614|NCT03415568|Chylomicron triglycerides|chylomicron triglycerides
960615|NCT03415555|Erector Spinae Plane blockade|erector spinae plane blockade
960616|NCT03415555|patient control anlagesia|patient control anlagesia
960617|NCT03415555|mitral valve replacement|mitral valve replacement
960618|NCT03415542|Attitudes|attitudes
960619|NCT03415542|Ecological momentary assessment|ecological momentary assessment
960620|NCT03415529|Lung|lung
960621|NCT03415529|ARDS|ards
960622|NCT03415529|Acute Respiratory Syndrome|acute respiratory syndrome
960623|NCT03415529|Prognosis|prognosis
960624|NCT03415529|Outcome Research|outcome research
960625|NCT03415529|Respiratory infection|respiratory infection
960626|NCT03415529|Sepsis|sepsis
960632|NCT03415490|general anesthesia|general anesthesia
960633|NCT03415490|self-adherent wrap|self-adherent wrap
960634|NCT03415490|pressure|pressure
960635|NCT03415477|aneurysmal bone cyst, denosumab, surgical treatment, complication|aneurysmal bone cyst, denosumab, surgical treatment, complication
960636|NCT03415451|cancer patients, Nutritional status|cancer patients, nutritional status
960637|NCT03415438|thoracolumbar fascia|thoracolumbar fascia
960638|NCT03415438|subacromial impingement syndrome|subacromial impingement syndrome
960639|NCT03415412|non-caries cervical lesion|non-caries cervical lesion
960640|NCT03415412|universal adhesives|universal adhesives
960641|NCT03415399|relapsed/refractory CD19+ Lymphomas, B-Cell|relapsed/refractory cd19+ lymphomas, b-cell
960642|NCT03415360|cryoablation|cryoablation
960643|NCT03415347|Pilonidal abscess|pilonidal abscess
960644|NCT03415347|Pilonidal disease|pilonidal disease
960645|NCT03415347|Pilonidal sinus|pilonidal sinus
960646|NCT03415334|Hepatitis C|hepatitis c
960647|NCT03415334|social marketing|social marketing
960648|NCT03415334|Communication for behavior development|communication for behavior development
960649|NCT03415321|Postpartum, Sense of Security, Mobile Support Application|postpartum, sense of security, mobile support application
960650|NCT03415308|Implicit Bias|implicit bias
960651|NCT03415308|Healthcare Equity|healthcare equity
960652|NCT03415295|Trimethylamine-N-oxide; Gestational diabetes mellitus|trimethylamine-n-oxide; gestational diabetes mellitus
960653|NCT03415269|acute|acute
960654|NCT03415191|ketamine, post-thoracotomy pain, analgesia|ketamine, post-thoracotomy pain, analgesia
960655|NCT03415152|Omacor|omacor
960656|NCT03415152|Omega-3-acid ethyl esters|omega-3-acid ethyl esters
960657|NCT03415152|patient adherence|patient adherence
960658|NCT03415152|patient reported outcomes|patient reported outcomes
960659|NCT03415126|KRAS mutant|kras mutant
960660|NCT03415126|NRAS mutant|nras mutant
960661|NCT03415126|BRAF mutant|braf mutant
960662|NCT03415126|HRAS mutant|hras mutant
960663|NCT03415126|ERK 1/2 inhibitor|erk 1/2 inhibitor
960664|NCT03415113|Medication reconciliation at discharge, potentially inappropriate medications, elderly.|medication reconciliation at discharge, potentially inappropriate medications, elderly.
960665|NCT03415074|low protein diet|low protein diet
960666|NCT03415074|Diabetic Kidney Disease|diabetic kidney disease
960667|NCT03415035|Venetoclax|venetoclax
960668|NCT03415035|Venclyxto|venclyxto
960669|NCT03415035|Cancer|cancer
960670|NCT03415035|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
960671|NCT03415022|SAD|sad
960672|NCT03415022|Social Anxiety|social anxiety
960673|NCT03415022|Social Phobia|social phobia
960674|NCT03415009|IL28B gene|il28b gene
960675|NCT03414996|Interval training|interval training
960676|NCT03414996|Autonomic nervous system|autonomic nervous system
960677|NCT03414996|Post-acute coronary syndrome|post-acute coronary syndrome
960678|NCT03414957|Malay women, PCOS, Metabolic Syndrome, Rotterdam criteria|malay women, pcos, metabolic syndrome, rotterdam criteria
960679|NCT03414944|Non-small cell lung cancer|non-small cell lung cancer
960680|NCT03414944|Brain metastases|brain metastases
960681|NCT03414944|SIB|sib
960682|NCT03414944|hippocampus avoidance|hippocampus avoidance
960683|NCT03414944|inner ear avoidance|inner ear avoidance
960684|NCT03414918|Macrolides, KCNJ5 potassium channel, aldosteronism|macrolides, kcnj5 potassium channel, aldosteronism
960685|NCT03414892|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
960686|NCT03414892|Glucokinase Activator|glucokinase activator
960687|NCT03414866|Thoracic Aorta|thoracic aorta
960688|NCT03414866|Dissection|dissection
960689|NCT03414866|Aneurysm|aneurysm
960690|NCT03414866|Frozen Elephant Trunk|frozen elephant trunk
960691|NCT03414853|Appendicitis, abdominal pain, free text prediction|appendicitis, abdominal pain, free text prediction
960696|NCT03414814|NSCLC|nsclc
960697|NCT03414814|Osimertinib|osimertinib
960698|NCT03414814|EGFR exon 20 insertion mutation|egfr exon 20 insertion mutation
972723|NCT03337906|HIV|hiv
960699|NCT03414801|Environmental Exposure Unit|environmental exposure unit
960700|NCT03414801|Cat Allergen|cat allergen
960701|NCT03414801|Rhinitis|rhinitis
960702|NCT03414801|Subject Validation|subject validation
960703|NCT03414788|Positron Emission Tomography (PET), Ulcerative Colitis, Safety, PKPlasma|positron emission tomography (pet), ulcerative colitis, safety, pkplasma
960704|NCT03414775|microbiome|microbiome
960705|NCT03414775|gastrointestinal microbiome|gastrointestinal microbiome
960706|NCT03414775|pediatrics|pediatrics
960707|NCT03414775|critical illness|critical illness
960708|NCT03414762|cesarean section|cesarean section
960709|NCT03414762|negative-pressure wound therapy|negative-pressure wound therapy
960710|NCT03414762|surgical wound dehiscence|surgical wound dehiscence
960711|NCT03414762|hospital readmission|hospital readmission
960712|NCT03414762|surgical site infection|surgical site infection
960713|NCT03414710|uptake of voluntary medical male circumcision|uptake of voluntary medical male circumcision
960714|NCT03414697|umbilical cord-derived mesenchymal stem cells|umbilical cord-derived mesenchymal stem cells
960715|NCT03414697|cerebral palsy|cerebral palsy
960716|NCT03414684|Breast Cancer|breast cancer
960717|NCT03414671|apnea|apnea
960718|NCT03414658|Breast Cancer|breast cancer
960719|NCT03414632|Heart Failure|heart failure
960720|NCT03414632|Diastolic Heart Failure|diastolic heart failure
960721|NCT03414632|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
960722|NCT03414632|Transthyretin Cardiac Amyloidosis|transthyretin cardiac amyloidosis
960723|NCT03414632|Amyloidosis|amyloidosis
960724|NCT03414619|OCD|ocd
960725|NCT03414619|GAD|gad
960726|NCT03414619|MDD|mdd
960727|NCT03414619|Rumination|rumination
960728|NCT03414619|Obsession|obsession
960729|NCT03414619|Worry|worry
960730|NCT03414593|preemptive analgic effect|preemptive analgic effect
960731|NCT03414593|popliteal sciatic nerve block|popliteal sciatic nerve block
960732|NCT03414593|Bilateral Hallux Valgus|bilateral hallux valgus
960733|NCT03414567|Follicular fluid|follicular fluid
960734|NCT03414567|nicotine|nicotine
960735|NCT03414567|cotinine|cotinine
960736|NCT03414567|Benzo(a)pyrene|benzo(a)pyrene
960737|NCT03414502|Methotrexate|methotrexate
960738|NCT03414489|Clinical Trial, Phase II|clinical trial, phase ii
960739|NCT03414489|Multicenter Trials|multicenter trials
960740|NCT03414489|Clinical Study|clinical study
960741|NCT03414489|Clinical Trials, Non-Randomized|clinical trials, non-randomized
960742|NCT03414489|Oral capsule|oral capsule
960743|NCT03414489|Single arm|single arm
960744|NCT03414489|Anti-cancer|anti-cancer
960745|NCT03414489|Anti-inflammatory|anti-inflammatory
960746|NCT03414489|ABC294640|abc294640
960747|NCT03414489|Expanded Access Program|expanded access program
960748|NCT03414489|Compassionate Use|compassionate use
960749|NCT03414489|Special Access Program|special access program
960750|NCT03414489|Yeliva ®|yeliva ®
960751|NCT03414463|Brain Injury|brain injury
960752|NCT03414450|Mnk kinase inhibitor, Mnk kinase|mnk kinase inhibitor, mnk kinase
960753|NCT03414424|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
960754|NCT03414424|transcranial magnetic stimulation|transcranial magnetic stimulation
960756|NCT03414411|Alcohol Use|alcohol use
960757|NCT03414411|Substance Use|substance use
960758|NCT03414411|Bone Disease|bone disease
960759|NCT03414411|Falls|falls
960760|NCT03414411|Fractures|fractures
960761|NCT03414372|MSM|msm
960762|NCT03414372|HIV|hiv
960763|NCT03414372|disclosure|disclosure
960764|NCT03414372|eHealth|ehealth
960765|NCT03414372|virtual reality|virtual reality
960766|NCT03414346|Cryotherapy|cryotherapy
960767|NCT03414346|Skin temperature|skin temperature
960768|NCT03414346|Physical therapy modalities|physical therapy modalities
960769|NCT03414346|Physical therapy|physical therapy
960770|NCT03414346|Thermography|thermography
960771|NCT03414346|Pain measurement|pain measurement
960772|NCT03414333|obesity|obesity
960773|NCT03414333|cognitive dysfunction|cognitive dysfunction
960774|NCT03414320|type 1 diabetes|type 1 diabetes
960775|NCT03414320|insulin pump|insulin pump
960776|NCT03414320|bolus calculator|bolus calculator
960777|NCT03414320|continuous glucose monitoring|continuous glucose monitoring
960778|NCT03414320|carbohydrate to insulin ratio|carbohydrate to insulin ratio
960779|NCT03414320|insulin sensitivity factor|insulin sensitivity factor
960780|NCT03414281|quadratus lumborum block, thoracic paravertebral block, nephrectomy|quadratus lumborum block, thoracic paravertebral block, nephrectomy
960781|NCT03414268|Chronic plantar fasciitis|chronic plantar fasciitis
960782|NCT03414268|Heel pain|heel pain
960783|NCT03414255|Chronic Achilles Tendonitis|chronic achilles tendonitis
960784|NCT03414229|Epacadostat|epacadostat
960785|NCT03414229|Pembrolizumab|pembrolizumab
960786|NCT03414229|17-508|17-508
960787|NCT03414203|Transcranial Direct Current Stimulation|transcranial direct current stimulation
960788|NCT03414203|Migraine Disorders|migraine disorders
960789|NCT03414203|Cognitive Symptoms|cognitive symptoms
960790|NCT03414190|Acute Coronary Syndrome|acute coronary syndrome
960791|NCT03414190|Text Messaging|text messaging
972839|NCT03337282|POCD|pocd
960792|NCT03414190|Risk Factors|risk factors
960793|NCT03414177|Telemedicine|telemedicine
960794|NCT03414177|Clinical follow up visits|clinical follow up visits
960795|NCT03414138|Pain|pain
960796|NCT03414138|Mindfulness|mindfulness
960797|NCT03414138|Meditation|meditation
960798|NCT03414138|fMRI|fmri
960799|NCT03414125|Colorectal Cancer|colorectal cancer
960800|NCT03414125|Colon Cancer|colon cancer
960801|NCT03414125|FIT Screening Strategy|fit screening strategy
960802|NCT03414125|Colon Screening Strategy|colon screening strategy
960803|NCT03414125|Colorectal Neoplasms|colorectal neoplasms
960804|NCT03414125|Mass Screening|mass screening
960805|NCT03414125|Health Services Research|health services research
960806|NCT03414125|Comparative Effectiveness Research|comparative effectiveness research
960807|NCT03414099|Pain|pain
960808|NCT03414099|Kratom|kratom
960809|NCT03414099|Ketum|ketum
960810|NCT03414099|mitragynine|mitragynine
960811|NCT03414086|PM|pm
960812|NCT03414086|DM|dm
960813|NCT03414073|dental floss|dental floss
961111|NCT03412227|CBT|cbt
960814|NCT03414073|gingival embrasure|gingival embrasure
960815|NCT03414073|oral hygiene|oral hygiene
960816|NCT03414073|interdental brush|interdental brush
960817|NCT03414060|obstetric fistula|obstetric fistula
960818|NCT03414060|vesicovaginal fistula|vesicovaginal fistula
960819|NCT03414060|menstrual cup|menstrual cup
960820|NCT03414060|pad test|pad test
960821|NCT03414060|non-surgical management|non-surgical management
960822|NCT03414060|feasibility|feasibility
960823|NCT03414060|acceptability|acceptability
960824|NCT03414060|innovation|innovation
960825|NCT03414047|DNA damage repair|dna damage repair
960826|NCT03414047|replication stress|replication stress
960827|NCT03414034|PLK1|plk1
960828|NCT03414034|PLK Inhibitor|plk inhibitor
960829|NCT03414021|Nuclear Medicine|nuclear medicine
960830|NCT03414021|SPECT-CT Scan|spect-ct scan
960831|NCT03414021|gamma-camera with semiconductor|gamma-camera with semiconductor
960832|NCT03413995|metastatic hormone sensitive|metastatic hormone sensitive
960833|NCT03413956|Chinese|chinese
960834|NCT03413956|T1 non-small cell lung cancer|t1 non-small cell lung cancer
960835|NCT03413956|Lymph metastases|lymph metastases
960836|NCT03413930|TaTME|tatme
960837|NCT03413930|Rectal cancer|rectal cancer
960838|NCT03413930|Laparoscopic Surgery|laparoscopic surgery
960839|NCT03413917|genomic markers|genomic markers
960840|NCT03413904|taTME|tatme
960841|NCT03413891|Anticoagulants|anticoagulants
960842|NCT03413891|Tranexamic Acid|tranexamic acid
960843|NCT03413878|snow|snow
960844|NCT03413878|avalanche|avalanche
960845|NCT03413878|hypercapnia|hypercapnia
960846|NCT03413878|work of breathing|work of breathing
960847|NCT03413839|Scoliosis|scoliosis
960848|NCT03413839|PSSE|psse
960849|NCT03413826|weight loss|weight loss
960850|NCT03413826|exercise|exercise
960851|NCT03413826|reinforcement|reinforcement
960852|NCT03413826|compensation|compensation
960853|NCT03413813|Magmaris|magmaris
960854|NCT03413800|hematopoietic stem cell transplant|hematopoietic stem cell transplant
960855|NCT03413800|lenalidomide|lenalidomide
960857|NCT03413722|Liver transplant|liver transplant
960858|NCT03413722|Cognitive function|cognitive function
960859|NCT03413709|Parenting Time, Father Involvement|parenting time, father involvement
960860|NCT03413696|HIV|hiv
960861|NCT03413696|Health literacy|health literacy
960862|NCT03413696|Hepatitis C|hepatitis c
960863|NCT03413696|Hepatitis C knowledge|hepatitis c knowledge
960864|NCT03413696|HIV knowledge|hiv knowledge
960865|NCT03413696|Hepatitis C treatment|hepatitis c treatment
960866|NCT03413644|Hematological diseases|hematological diseases
960867|NCT03413631|prenatal substance abuse|prenatal substance abuse
960868|NCT03413631|mentalization|mentalization
960869|NCT03413631|prenatal depression|prenatal depression
960870|NCT03413631|prenatal anxiety|prenatal anxiety
960871|NCT03413631|maternal-fetal attachment|maternal-fetal attachment
960872|NCT03413631|prenatal intervention|prenatal intervention
960873|NCT03413631|ultrasound|ultrasound
960874|NCT03413631|perinatal outcome|perinatal outcome
960875|NCT03413631|fetal exposure|fetal exposure
960876|NCT03413631|parenting|parenting
960878|NCT03413631|prenatal treatment|prenatal treatment
960879|NCT03413618|deep vein thrombosis|deep vein thrombosis
960880|NCT03413618|postthrombotic syndrome|postthrombotic syndrome
960881|NCT03413618|anticoagulation|anticoagulation
960882|NCT03413618|treatment|treatment
960883|NCT03413618|prevention|prevention
960885|NCT03413579|Oncology,|oncology,
960886|NCT03413579|hR3,|hr3,
960887|NCT03413579|Nimotuzumab,|nimotuzumab,
960888|NCT03413579|Chemotherapy,|chemotherapy,
960889|NCT03413579|Survival|survival
960890|NCT03413579|Monoclonal antibody|monoclonal antibody
960891|NCT03413579|RECIST|recist
960892|NCT03413579|Cisplatin|cisplatin
960893|NCT03413579|Vinorelbine|vinorelbine
960894|NCT03413579|Paclitaxel|paclitaxel
960895|NCT03413579|Carboplatine|carboplatine
960896|NCT03413579|Randomisation|randomisation
960897|NCT03413579|Placebo|placebo
960898|NCT03413579|cancer|cancer
960899|NCT03413566|Trends|trends
960900|NCT03413566|Prevalence|prevalence
960901|NCT03413566|Registries/statistics & numerical data|registries/statistics & numerical data
960902|NCT03413566|Epidemiology|epidemiology
960903|NCT03413553|immediate implant|immediate implant
960904|NCT03413553|connective tissue graft|connective tissue graft
960905|NCT03413540|jumping|jumping
960906|NCT03413540|bone health|bone health
960907|NCT03413527|rTMS|rtms
960908|NCT03413514|shared decision making|shared decision making
960909|NCT03413514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
960910|NCT03413514|cycle|cycle
960911|NCT03413514|MRI|mri
960912|NCT03413514|clinical response|clinical response
960913|NCT03413488|Shoulder impingement syndrome|shoulder impingement syndrome
960914|NCT03413488|Kinesio tape|kinesio tape
960915|NCT03413488|Round shoulder posture|round shoulder posture
960916|NCT03413475|Edentulism|edentulism
960917|NCT03413475|complete removable prosthesis|complete removable prosthesis
960918|NCT03413475|quality of life|quality of life
960919|NCT03413436|adjuvant chemotherapy|adjuvant chemotherapy
960920|NCT03413436|multicenter retrospective study|multicenter retrospective study
960921|NCT03413423|smoking|smoking
960922|NCT03413423|depression|depression
960923|NCT03413423|Behavioral Activation|behavioral activation
960924|NCT03413423|Mood management|mood management
960925|NCT03413423|Secondary Prevention|secondary prevention
960926|NCT03413384|Parkinson's Disease|parkinson's disease
960927|NCT03413384|Parkinson's Disease Dementia|parkinson's disease dementia
960928|NCT03413371|Surgical Pleth Index (SPI)|surgical pleth index (spi)
960929|NCT03413371|General Anaesthesia (GA),|general anaesthesia (ga),
960930|NCT03413371|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
960931|NCT03413371|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
960932|NCT03413371|Peribulbar Block (PBB)|peribulbar block (pbb)
960933|NCT03413371|bupivacaine|bupivacaine
960934|NCT03413371|ropivacaine|ropivacaine
960935|NCT03413371|lidocaine|lidocaine
960936|NCT03413332|Chinese American Women|chinese american women
960937|NCT03413332|Provider-patient Communication|provider-patient communication
960938|NCT03413332|Survivorship Care|survivorship care
960939|NCT03413306|aplastic anemia|aplastic anemia
960940|NCT03413306|immunosupressive therapy|immunosupressive therapy
960942|NCT03413306|eltrombopag|eltrombopag
960943|NCT03413280|preemptive analgic effect|preemptive analgic effect
960944|NCT03413280|Rectus Sheath Block|rectus sheath block
960945|NCT03413280|laparoscopic cholecystectomy|laparoscopic cholecystectomy
960946|NCT03413267|micronutrient|micronutrient
960947|NCT03413267|bioavailability|bioavailability
960948|NCT03413267|bioaccessibility|bioaccessibility
960949|NCT03413267|food structure|food structure
960950|NCT03413267|food texture|food texture
960951|NCT03413254|pT4 colon cancer|pt4 colon cancer
960952|NCT03413254|Peritoneal metastases|peritoneal metastases
960953|NCT03413254|Early detection|early detection
960954|NCT03413254|Diagnostic laparoscopy|diagnostic laparoscopy
960955|NCT03413254|Second look surgery|second look surgery
960956|NCT03413254|Third look surgery|third look surgery
960957|NCT03413241|High functioning autism spectrum disorder|high functioning autism spectrum disorder
960958|NCT03413202|butylphthalide(NBP)|butylphthalide(nbp)
960959|NCT03413202|large-artery atherosclerosis acute ischemic stroke|large-artery atherosclerosis acute ischemic stroke
960960|NCT03413202|dynamic Cerebral Autoregulation(dCA)|dynamic cerebral autoregulation(dca)
960961|NCT03413189|Exercise|exercise
960962|NCT03413189|Dosage|dosage
960963|NCT03413189|Function|function
960964|NCT03413176|VEGFR|vegfr
960965|NCT03413176|VEGF|vegf
960966|NCT03413176|antiangiogenics|antiangiogenics
960967|NCT03413176|angiogenesis|angiogenesis
960968|NCT03413163|Ultrasound Guided Erector Spinae Plane Block|ultrasound guided erector spinae plane block
960969|NCT03413163|postoperative pain|postoperative pain
960970|NCT03413163|retropubic radical prostatectomy|retropubic radical prostatectomy
960971|NCT03413137|Prostate cancer|prostate cancer
960972|NCT03413137|transperineal mp-MRI-fusion/TRUS biopsies|transperineal mp-mri-fusion/trus biopsies
960973|NCT03413137|mp-MRI fusion/TRUS transrectal biopsy|mp-mri fusion/trus transrectal biopsy
960974|NCT03413111|ERCP|ercp
960975|NCT03413111|double guidewire technique|double guidewire technique
960976|NCT03413085|Myopia control|myopia control
960977|NCT03413046|Regulatory T cell|regulatory t cell
960978|NCT03413046|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
960979|NCT03413046|Minimal residual disease|minimal residual disease
960980|NCT03413033|Semi-occluded vocal tract|semi-occluded vocal tract
960981|NCT03413033|resonance tubes|resonance tubes
960982|NCT03413033|tongue trill|tongue trill
960983|NCT03413033|voice therapy|voice therapy
960984|NCT03413020|Helicobacter pylori|helicobacter pylori
960985|NCT03413020|Rescue therapy|rescue therapy
960986|NCT03413020|Tailored therapy|tailored therapy
960987|NCT03413020|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
960988|NCT03412942|Comfort|comfort
960989|NCT03412942|Confidence|confidence
960990|NCT03412942|Usage outcomes|usage outcomes
960991|NCT03412916|Orthopaedic|orthopaedic
960992|NCT03412916|Orthopedic|orthopedic
960993|NCT03412903|Acute geriatric treatment|acute geriatric treatment
960994|NCT03412903|Inpatient treatment team|inpatient treatment team
960995|NCT03412903|Elderly|elderly
960996|NCT03412903|Pharmacist|pharmacist
960997|NCT03412903|Comprehensive pharmaceutical assessment|comprehensive pharmaceutical assessment
960998|NCT03412903|Medication history|medication history
960999|NCT03412903|Medication reconciliation|medication reconciliation
961000|NCT03412903|Adherence|adherence
961001|NCT03412903|Medication therapy management|medication therapy management
961002|NCT03412903|Pharmaceutical consultation|pharmaceutical consultation
961003|NCT03412903|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
961004|NCT03412903|Drug interactions|drug interactions
961005|NCT03412903|Pharmaceutical Council|pharmaceutical council
961006|NCT03412903|Drug regime acceptance|drug regime acceptance
961007|NCT03412903|Patient Care Team|patient care team
961008|NCT03412903|Hospital Pharmacy Service|hospital pharmacy service
961009|NCT03412903|Polypharmacy|polypharmacy
961010|NCT03412903|Hospitalization|hospitalization
961019|NCT03412851|Thrombectomy|thrombectomy
961020|NCT03412851|Stentriever|stentriever
961021|NCT03412851|ADAPT|adapt
961022|NCT03412838|Bone block allograft|bone block allograft
961023|NCT03412838|Bone density|bone density
961024|NCT03412838|Graft resorption|graft resorption
961025|NCT03412838|PRP|prp
961026|NCT03412838|RCT|rct
961027|NCT03412812|Brain Metastases|brain metastases
961028|NCT03412812|Stereotactic Radiosurgery|stereotactic radiosurgery
961029|NCT03412773|Advanced liver cancer|advanced liver cancer
961030|NCT03412760|hydrops fetalis|hydrops fetalis
961031|NCT03412760|birth defect|birth defect
961032|NCT03412760|fetal anomaly|fetal anomaly
961033|NCT03412760|whole exome sequencing|whole exome sequencing
961034|NCT03412747|Bimekizumab|bimekizumab
961035|NCT03412747|PSO|pso
961036|NCT03412747|Psoriasis|psoriasis
961037|NCT03412721|laser analgesia|laser analgesia
961038|NCT03412721|pediatric dentistry|pediatric dentistry
961039|NCT03412695|Disease-related malnutrition|disease-related malnutrition
961040|NCT03412695|eHealth|ehealth
961041|NCT03412695|Decision support system|decision support system
961042|NCT03412695|Clinical nutrition|clinical nutrition
961043|NCT03412682|Ulcerative colitis|ulcerative colitis
961044|NCT03412682|FE999315|fe999315
961045|NCT03412682|Mesalazine|mesalazine
961046|NCT03412682|Colitis|colitis
961047|NCT03412682|Colitis, Ulcerative|colitis, ulcerative
961048|NCT03412669|Addiction affected family members|addiction affected family members
961049|NCT03412669|Counselling|counselling
961050|NCT03412669|Psychosocial intervention|psychosocial intervention
961051|NCT03412669|Low and Middle Income Countries|low and middle income countries
961052|NCT03412669|India|india
961053|NCT03412669|Pilot Randomised Controlled Trial|pilot randomised controlled trial
961054|NCT03412656|CUFF|cuff
961055|NCT03412656|Soft Hand Pro|soft hand pro
961056|NCT03412656|SHP|shp
961057|NCT03412656|SH Pro|sh pro
961058|NCT03412656|SoftHand|softhand
961059|NCT03412617|Healthy Eating|healthy eating
961060|NCT03412617|Blood glucose|blood glucose
961061|NCT03412617|Bifidobacterium|bifidobacterium
961062|NCT03412617|Obese women|obese women
961063|NCT03412604|Alzheimer Disease|alzheimer disease
961064|NCT03412539|resistant pain|resistant pain
961065|NCT03412513|Overactive Bladder|overactive bladder
961066|NCT03412513|Parkinson Disease|parkinson disease
961067|NCT03412500|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
961068|NCT03412500|Vancomycin|vancomycin
961069|NCT03412474|suprazygomatic block, dexmedetomidine|suprazygomatic block, dexmedetomidine
961070|NCT03412461|Transition-aged youth|transition-aged youth
961071|NCT03412461|Mental Health|mental health
961072|NCT03412461|Accessibility|accessibility
961073|NCT03412448|chronic pain|chronic pain
961074|NCT03412448|cardiac surgery|cardiac surgery
961075|NCT03412448|opioids|opioids
961076|NCT03412435|Acute myocardial infarction|acute myocardial infarction
961077|NCT03412435|Myocardial infarction|myocardial infarction
961078|NCT03412422|Passive Leg Raise|passive leg raise
961079|NCT03412422|Fluid Challenge|fluid challenge
961080|NCT03412422|Common carotid artery|common carotid artery
961081|NCT03412409|RIC regimen|ric regimen
961082|NCT03412409|comorbidity|comorbidity
961083|NCT03412409|elderly|elderly
961084|NCT03412409|haploidentical|haploidentical
961085|NCT03412409|transplant-related mortality|transplant-related mortality
961086|NCT03412396|Prostate Cancer|prostate cancer
961087|NCT03412396|Apalutamide|apalutamide
961088|NCT03412396|ARN-509|arn-509
961089|NCT03412396|Prostatectomy|prostatectomy
961090|NCT03412396|Questionnaires|questionnaires
961091|NCT03412396|Surveys|surveys
961092|NCT03412396|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
961093|NCT03412357|pleurectomy/decortication|pleurectomy/decortication
961094|NCT03412357|indwelling pleural catheter|indwelling pleural catheter
961095|NCT03412344|clinical trial|clinical trial
961096|NCT03412344|patient|patient
961097|NCT03412344|questionnaire|questionnaire
961098|NCT03412305|Dental implants, antibiotic prophylaxis|dental implants, antibiotic prophylaxis
961099|NCT03412279|Chronic Low Back Pain|chronic low back pain
961100|NCT03412279|Oswestry Disability Index|oswestry disability index
961101|NCT03412279|Roland Morris Disability Questionnaire|roland morris disability questionnaire
961102|NCT03412279|SF-12 Health Survey|sf-12 health survey
961103|NCT03412279|Pain Catastrophizing Scale|pain catastrophizing scale
961104|NCT03412279|Back Beliefs Questionnaire|back beliefs questionnaire
961105|NCT03412266|RIC regimen; MDS; haplo-HSCT; survival|ric regimen; mds; haplo-hsct; survival
961106|NCT03412253|metabolic surgery, BMI 25-30 kg/m2, SAGB, T2DM remission.|metabolic surgery, bmi 25-30 kg/m2, sagb, t2dm remission.
961107|NCT03412227|Anxiety|anxiety
961108|NCT03412227|Depression|depression
961109|NCT03412227|Children|children
961112|NCT03412201|Disease management|disease management
961113|NCT03412201|Medication therapy management|medication therapy management
961114|NCT03412201|Biomarkers|biomarkers
961115|NCT03412188|Chronic ITP|chronic itp
961116|NCT03412188|persistent ITP|persistent itp
961117|NCT03412188|Eltrombopag|eltrombopag
961118|NCT03412188|GPVI receptor|gpvi receptor
961119|NCT03412162|Discrimination|discrimination
961120|NCT03412162|Cortisol|cortisol
961121|NCT03412162|Sleep|sleep
961122|NCT03412162|Identity|identity
961123|NCT03412149|Malabsorption, Mini Gastric Bypass, Roux en Y Gastric Bypass|malabsorption, mini gastric bypass, roux en y gastric bypass
961124|NCT03412136|Testosterone|testosterone
961125|NCT03412136|Food Intake|food intake
961126|NCT03412136|Appetite|appetite
961127|NCT03412110|chiropractic|chiropractic
961128|NCT03412097|chiropractic|chiropractic
961129|NCT03412084|Sedentary Lifestyle|sedentary lifestyle
961130|NCT03412084|physical function|physical function
961131|NCT03412058|PD-1|pd-1
961132|NCT03412058|PD-L1|pd-l1
961133|NCT03412019|Music|music
961134|NCT03412019|Patient Satisfaction|patient satisfaction
961135|NCT03412006|type II diabetes|type ii diabetes
961136|NCT03412006|diabetic kidney disease|diabetic kidney disease
961137|NCT03411980|Pharmacokinetics|pharmacokinetics
961138|NCT03411954|hippocampus avoidance|hippocampus avoidance
961139|NCT03411954|cognitive changes|cognitive changes
961140|NCT03411954|intensity modulated radiotherapy|intensity modulated radiotherapy
961141|NCT03411941|nAMD: neovascular Age-related Macular Degeneration|namd: neovascular age-related macular degeneration
961143|NCT03411915|GIST|gist
961144|NCT03411915|DUET-1|duet-1
961145|NCT03411902|Bone Health|bone health
961146|NCT03411876|IPF|ipf
961147|NCT03411876|Oxymizer|oxymizer
961148|NCT03411876|oxygen conserving device|oxygen conserving device
961149|NCT03411876|pulmonary disease|pulmonary disease
961150|NCT03411863|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
961151|NCT03411863|transcranial magnetic stimulation|transcranial magnetic stimulation
961152|NCT03411837|Atopic Dermatitis, dupilumab|atopic dermatitis, dupilumab
961153|NCT03411824|diagnosis|diagnosis
961154|NCT03411824|Point-of-Care-Ultrasound|point-of-care-ultrasound
961155|NCT03411824|lung ultrasound|lung ultrasound
961156|NCT03411811|tendinopathy|tendinopathy
961157|NCT03411811|wrist|wrist
961158|NCT03411811|chronic pain|chronic pain
961159|NCT03411811|sprain|sprain
961160|NCT03411798|ankylosing spondylitis(AS)|ankylosing spondylitis(as)
961161|NCT03411798|TNFi|tnfi
961162|NCT03411798|Yisaipu®|yisaipu®
961163|NCT03411798|Disease modifying anti-rheumatic drugs (DMARDs)|disease modifying anti-rheumatic drugs (dmards)
961164|NCT03411759|CYP2D6|cyp2d6
961165|NCT03411759|Chronic pain|chronic pain
961166|NCT03411759|Cytochrome P450|cytochrome p450
961167|NCT03411759|Opioids|opioids
961168|NCT03411733|acne vlugaris|acne vlugaris
961169|NCT03411733|prevalence|prevalence
961170|NCT03411733|Helicobacter Pylori|helicobacter pylori
961171|NCT03411707|Colorectal cancer screening|colorectal cancer screening
961172|NCT03411707|Stool DNA test|stool dna test
961173|NCT03411707|Blood mRNA test|blood mrna test
961174|NCT03411694|Survey|survey
961175|NCT03411694|Anesthesia|anesthesia
961176|NCT03411694|Anesthesiologist|anesthesiologist
961177|NCT03411694|Patient perspective|patient perspective
961178|NCT03411668|undergraduate nursing students|undergraduate nursing students
961179|NCT03411668|evidence based practice beliefs|evidence based practice beliefs
961180|NCT03411668|evidence based practice knowledge|evidence based practice knowledge
961181|NCT03411668|evidence based practice implementation|evidence based practice implementation
961279|NCT03411161|phase II|phase ii
961182|NCT03411668|Evidence based practice Education programme|evidence based practice education programme
961183|NCT03411642|Stroke, echocardiography|stroke, echocardiography
961184|NCT03411629|Necrotizing Pancreatitis|necrotizing pancreatitis
961185|NCT03411629|Critically ill|critically ill
961186|NCT03411629|Mortality|mortality
961187|NCT03411616|Eating behavior|eating behavior
961188|NCT03411616|Excessive weight|excessive weight
961189|NCT03411616|Food craving|food craving
961190|NCT03411616|Liver transplantation|liver transplantation
961191|NCT03411616|Obesity|obesity
961192|NCT03411616|Weight gain|weight gain
961193|NCT03411603|nutrient profiling|nutrient profiling
961194|NCT03411564|dating violence|dating violence
961195|NCT03411564|health promotion|health promotion
961196|NCT03411564|educational intervention|educational intervention
961197|NCT03411564|health assets|health assets
961198|NCT03411564|participation action research|participation action research
961199|NCT03411551|Intravenous anesthesia|intravenous anesthesia
961200|NCT03411551|Nerve Block|nerve block
961201|NCT03411551|Regional anesthesia|regional anesthesia
961202|NCT03411538|antibiotic-resistant infections|antibiotic-resistant infections
961203|NCT03411538|risk factors|risk factors
961204|NCT03411538|prospective surveillance|prospective surveillance
961205|NCT03411512|congenital heart defects|congenital heart defects
961206|NCT03411512|near-infrared spectroscopy|near-infrared spectroscopy
961207|NCT03411512|newborn|newborn
961208|NCT03411512|tissue oxygenation|tissue oxygenation
961209|NCT03411499|Adult|adult
961210|NCT03411499|Endocarditis/surgery|endocarditis/surgery
961211|NCT03411499|Embolism/prevention & control|embolism/prevention & control
961212|NCT03411499|Cardiovascular Diseases|cardiovascular diseases
961213|NCT03411499|Costs and Cost Analysis|costs and cost analysis
961214|NCT03411499|Quality of life|quality of life
961215|NCT03411447|vasoactive drug|vasoactive drug
961216|NCT03411447|mechanical ventilation|mechanical ventilation
961217|NCT03411447|early enteral nutrition|early enteral nutrition
961218|NCT03411447|intensive care unit|intensive care unit
961219|NCT03411447|early parenteral nutrition|early parenteral nutrition
961220|NCT03411447|critical care medicine|critical care medicine
961221|NCT03411447|nosocomial infection|nosocomial infection
961222|NCT03411447|mortality|mortality
961223|NCT03411447|shock|shock
961224|NCT03411434|oculomotor performances|oculomotor performances
961225|NCT03411434|neurocognition|neurocognition
961226|NCT03411434|methylphenidate|methylphenidate
961227|NCT03411408|Hypofractionated radiotherapy|hypofractionated radiotherapy
961228|NCT03411408|image - guided helical tomotherapy|image - guided helical tomotherapy
961229|NCT03411408|hyperbaric oxygen therapy|hyperbaric oxygen therapy
961230|NCT03411408|malignant glioma|malignant glioma
961231|NCT03411408|high grade glioma|high grade glioma
961232|NCT03411408|recurrent glioma|recurrent glioma
961233|NCT03411395|Diabetes|diabetes
961234|NCT03411395|Prediabetes|prediabetes
961235|NCT03411395|Blood sugar regulation|blood sugar regulation
961236|NCT03411369|Creatine, ribose, ischemic heart disease.|creatine, ribose, ischemic heart disease.
961237|NCT03411343|Postoperative Shoulder Analgesia|postoperative shoulder analgesia
961238|NCT03411343|Hemidiaphragmatic Paralysis|hemidiaphragmatic paralysis
961239|NCT03411343|Alternative blocks|alternative blocks
961240|NCT03411317|Aortic stenosis|aortic stenosis
961241|NCT03411317|progression|progression
961242|NCT03411317|Left ventricular remodeling|left ventricular remodeling
961243|NCT03411304|Aortic valvular replacement|aortic valvular replacement
961244|NCT03411304|Aortic stenosis|aortic stenosis
961245|NCT03411304|Left ventricular remodeling|left ventricular remodeling
961246|NCT03411304|biomarkers|biomarkers
961247|NCT03411291|Alzheimer's, magnetic resonance imaging|alzheimer's, magnetic resonance imaging
961248|NCT03411278|recovery|recovery
961249|NCT03411278|deep oscillation|deep oscillation
961250|NCT03411278|soccer|soccer
961251|NCT03411278|sports|sports
961252|NCT03411278|training|training
961253|NCT03411278|electrotherapy|electrotherapy
961254|NCT03411278|physical therapy|physical therapy
961255|NCT03411239|Airway pressure|airway pressure
961256|NCT03411239|Oesophageal pressure|oesophageal pressure
961257|NCT03411239|transpulmonary pressure|transpulmonary pressure
961258|NCT03411239|laparoscopic surgery|laparoscopic surgery
961259|NCT03411226|Inguinal Hernia|inguinal hernia
961260|NCT03411226|TREPP|trepp
961261|NCT03411226|Recurrence|recurrence
961262|NCT03411200|Older|older
961263|NCT03411200|Advanced Cancer|advanced cancer
961264|NCT03411200|Exercise|exercise
961265|NCT03411200|Resistance training|resistance training
961266|NCT03411200|Counseling|counseling
961267|NCT03411200|Mobilization|mobilization
961268|NCT03411187|Endoscopy|endoscopy
961269|NCT03411187|Thyroidectomy|thyroidectomy
961270|NCT03411187|Thyroid Cancer|thyroid cancer
961271|NCT03411174|breast cancer|breast cancer
961272|NCT03411174|hypofractionated partial breast irradiation|hypofractionated partial breast irradiation
961273|NCT03411161|Mps1|mps1
961274|NCT03411161|Mps1i|mps1i
961275|NCT03411161|S81694|s81694
961276|NCT03411161|breast cancer|breast cancer
961277|NCT03411161|triple negative breast cancer|triple negative breast cancer
961278|NCT03411161|phase I|phase i
961280|NCT03411148|fear avoidance|fear avoidance
961281|NCT03411148|cognitive behavioral therapy|cognitive behavioral therapy
961282|NCT03411148|physical therapy|physical therapy
961283|NCT03411148|prosthetic|prosthetic
961284|NCT03411148|fear of falling|fear of falling
961285|NCT03411148|gait|gait
961286|NCT03411122|Enzyme Inhibitors|enzyme inhibitors
1333210|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
961287|NCT03411122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers
961288|NCT03411109|intrathecal analgesia|intrathecal analgesia
961289|NCT03411109|colorectal|colorectal
961290|NCT03411109|enhanced recovery|enhanced recovery
961291|NCT03411083|Rehabilitation|rehabilitation
961292|NCT03411083|Recovery of function|recovery of function
961293|NCT03411083|Outcome Assessment (Health Care)|outcome assessment (health care)
961294|NCT03411083|Patient Reported outcome Measures|patient reported outcome measures
961295|NCT03411083|Treatment Outcome|treatment outcome
961296|NCT03411083|Pain, Postoperative|pain, postoperative
961297|NCT03411083|Pain Management|pain management
961298|NCT03411083|Orthopedic Surgery|orthopedic surgery
961299|NCT03411057|Mindfulness|mindfulness
961300|NCT03411057|Mindfulness Based Stress Reduction|mindfulness based stress reduction
961301|NCT03411057|Rheumatoid Arthritis|rheumatoid arthritis
961303|NCT03411057|Depression|depression
961304|NCT03411044|Total Hip Arthroplasty|total hip arthroplasty
961305|NCT03411044|Fitmore|fitmore
961505|NCT03409666|Performance|performance
961306|NCT03411044|Minimal Invasive Surgery|minimal invasive surgery
961307|NCT03411044|Short Stem|short stem
961308|NCT03411031|lenalidomide maintenance|lenalidomide maintenance
961309|NCT03411031|hematopoietic cell transplantation|hematopoietic cell transplantation
961310|NCT03411031|serologic relapse|serologic relapse
961311|NCT03411018|lung protective strategies|lung protective strategies
961312|NCT03411018|Less invasive respiratory support|less invasive respiratory support
961313|NCT03411018|preterm infant|preterm infant
961314|NCT03411005|Lysine, Adult, Protein Quality|lysine, adult, protein quality
961315|NCT03410992|Bimekizumab|bimekizumab
961317|NCT03410992|Psoriasis|psoriasis
961318|NCT03410940|Total Hip Arthroplasty|total hip arthroplasty
961319|NCT03410940|CLS Brevius|cls brevius
961320|NCT03410940|Kinectiv|kinectiv
961321|NCT03410940|Medical Device|medical device
961322|NCT03410940|Performance|performance
961323|NCT03410940|Safety|safety
961324|NCT03410940|Hip Prosthesis|hip prosthesis
961325|NCT03410927|Phase I|phase i
961326|NCT03410927|solid tumors|solid tumors
961327|NCT03410927|pharmacokinetics|pharmacokinetics
961328|NCT03410927|pharmacodynamics|pharmacodynamics
961330|NCT03410927|TAS0728|tas0728
961331|NCT03410927|HER2|her2
961332|NCT03410927|HER3 mutation|her3 mutation
961333|NCT03410927|amplification or overexpression|amplification or overexpression
961334|NCT03410927|Urothelial cancer with HER2 or HER3 mutation|urothelial cancer with her2 or her3 mutation
961335|NCT03410927|Biliary tract cancer with HER2 or HER3 mutation|biliary tract cancer with her2 or her3 mutation
961336|NCT03410927|MBC with HER2 amplification or overexpression or HER3 mutation|mbc with her2 amplification or overexpression or her3 mutation
961337|NCT03410927|NSCLC with HER2 or HER3 mutation|nsclc with her2 or her3 mutation
961338|NCT03410927|CRC with HER2 or HER3 mutation|crc with her2 or her3 mutation
961339|NCT03410927|amplification|amplification
961340|NCT03410914|Hemopatch|hemopatch
961341|NCT03410888|sciatic nerve block|sciatic nerve block
961342|NCT03410888|infragluteal approach|infragluteal approach
961343|NCT03410888|popliteal approach|popliteal approach
961344|NCT03410875|Leukemia|leukemia
961345|NCT03410875|Hairy Cell Leukemia|hairy cell leukemia
961346|NCT03410875|BRAF|braf
961347|NCT03410875|vemurafenib|vemurafenib
961348|NCT03410875|obinutuzumab|obinutuzumab
961349|NCT03410875|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
961350|NCT03410875|17-513|17-513
961351|NCT03410862|Elderberry|elderberry
961352|NCT03410862|Influenza|influenza
961353|NCT03410836|lidocaine|lidocaine
961354|NCT03410836|colorectal cancer|colorectal cancer
961355|NCT03410836|laparoscopy surgery|laparoscopy surgery
961356|NCT03410836|anesthesia|anesthesia
961357|NCT03410836|inflammation|inflammation
961358|NCT03410836|cytokine|cytokine
961359|NCT03410836|post-operative immunosuppression|post-operative immunosuppression
961360|NCT03410823|hip fracture|hip fracture
961361|NCT03410823|exercise|exercise
961362|NCT03410823|protein|protein
961363|NCT03410810|Prematurity|prematurity
961364|NCT03410810|Neuroimaging|neuroimaging
961365|NCT03410797|SOVT|sovt
961366|NCT03410797|semi occluded vocal tract|semi occluded vocal tract
961367|NCT03410797|voice disorder|voice disorder
961368|NCT03410797|voice therapy|voice therapy
961369|NCT03410797|muscle tension dysphonia|muscle tension dysphonia
961370|NCT03410797|MTD|mtd
961371|NCT03410797|vocal fold lesions|vocal fold lesions
961372|NCT03410797|vocal fold atrophy|vocal fold atrophy
961373|NCT03410784|PD-L1 Expression|pd-l1 expression
961374|NCT03410784|prognostic factors|prognostic factors
961375|NCT03410784|predictive factors|predictive factors
961376|NCT03410784|Patient reported outcomes|patient reported outcomes
961377|NCT03410771|Distribution Volume|distribution volume
961382|NCT03410732|dendritic cell|dendritic cell
961383|NCT03410732|immunotherapy|immunotherapy
961384|NCT03410732|tumor cell membrane proteins|tumor cell membrane proteins
961385|NCT03410706|Venous thromboembolism|venous thromboembolism
961386|NCT03410706|Anticoagulation|anticoagulation
961387|NCT03410706|Rivaroxaban|rivaroxaban
961388|NCT03410706|Observation study|observation study
961389|NCT03410693|Urothelial carcinoma|urothelial carcinoma
961390|NCT03410680|Antiretroviral Therapy|antiretroviral therapy
961391|NCT03410680|Adherence|adherence
961393|NCT03410680|Men who have sex with men|men who have sex with men
961394|NCT03410680|Sexual minorities|sexual minorities
961395|NCT03410680|habit-formation|habit-formation
961396|NCT03410680|gamification|gamification
961397|NCT03410641|cancer risk|cancer risk
961398|NCT03410641|randomised trial|randomised trial
961399|NCT03410641|intervention|intervention
961400|NCT03410641|smoking cessation|smoking cessation
961401|NCT03410641|dietary intervention|dietary intervention
961402|NCT03410641|weight loss|weight loss
961403|NCT03410602|Nonsurgical periodontal therapy|nonsurgical periodontal therapy
961404|NCT03410602|Orthodontic bands|orthodontic bands
961405|NCT03410576|Matrix metalloproteinase|matrix metalloproteinase
961406|NCT03410576|Carotid artery stenting|carotid artery stenting
961407|NCT03410576|Carotid endarterectomy|carotid endarterectomy
961409|NCT03410563|Auditory inputs|auditory inputs
961410|NCT03410524|Bowel wall visualization|bowel wall visualization
961411|NCT03410524|Intraluminal bubbles|intraluminal bubbles
961412|NCT03410524|Intraluminal foam|intraluminal foam
961413|NCT03410524|Simethicone|simethicone
961414|NCT03410485|NoL index|nol index
961415|NCT03410485|Bispectral index|bispectral index
961416|NCT03410485|Intraoperative monitoring|intraoperative monitoring
961417|NCT03410420|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
961419|NCT03410420|Ascending Aorta|ascending aorta
961420|NCT03410420|Hypoxyprobe|hypoxyprobe
961421|NCT03410420|Pimonidazole|pimonidazole
961422|NCT03410407|Acute Myeloid Leukemia|acute myeloid leukemia
961423|NCT03410407|Central Nervous System|central nervous system
961424|NCT03410407|Relapse|relapse
961425|NCT03410407|Prognostic factors|prognostic factors
961426|NCT03410394|adrenal|adrenal
961427|NCT03410394|thyroid|thyroid
961428|NCT03410394|parathyroid|parathyroid
961429|NCT03410394|endocrine pancreas|endocrine pancreas
961430|NCT03410394|endocrine digestive tube|endocrine digestive tube
961431|NCT03410381|Psychiatry|psychiatry
961432|NCT03410381|Suicide|suicide
961433|NCT03410381|Prediction|prediction
961434|NCT03410381|Smartphone application|smartphone application
961435|NCT03410381|Ecological Momentary Assessment|ecological momentary assessment
961436|NCT03410368|maintenance therapy|maintenance therapy
961437|NCT03410368|immunotherapy|immunotherapy
961438|NCT03410368|adoptive cell transfer|adoptive cell transfer
961439|NCT03410368|natural killer cell|natural killer cell
961440|NCT03410316|Obesity, common diseases, epidemiology, etiology|obesity, common diseases, epidemiology, etiology
961441|NCT03410225|Pregnancy Prevention|pregnancy prevention
961442|NCT03410225|Male Involvement|male involvement
961443|NCT03410212|Inferior alveolar nerve block|inferior alveolar nerve block
961444|NCT03410212|ketorolac|ketorolac
961445|NCT03410212|success|success
961446|NCT03410160|adrenal crisis|adrenal crisis
961447|NCT03410160|predisposing factors|predisposing factors
961448|NCT03410134|Permanent teeth|permanent teeth
961449|NCT03410134|Vital pulp therapy|vital pulp therapy
961450|NCT03410134|MTA|mta
961451|NCT03410043|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
961452|NCT03410043|Non-small cell lung cancer|non-small cell lung cancer
961453|NCT03410043|NSCLC|nsclc
961454|NCT03410043|Osimertinib|osimertinib
961455|NCT03410043|AZD9291|azd9291
961456|NCT03410043|Local consolidative therapy|local consolidative therapy
961457|NCT03410043|LCT|lct
961458|NCT03410043|Radiotherapy|radiotherapy
961459|NCT03410043|Surgical resection|surgical resection
961460|NCT03410017|Functional Listening Index|functional listening index
961461|NCT03409991|Psychiatric Rehabilitation|psychiatric rehabilitation
961462|NCT03409991|Career Counseling|career counseling
961463|NCT03409978|Infants, newborn|infants, newborn
961464|NCT03409978|General Movements|general movements
961465|NCT03409978|Video Recording|video recording
961466|NCT03409978|Mobile Applications|mobile applications
961467|NCT03409978|Prognosis|prognosis
961468|NCT03409978|Parents|parents
961469|NCT03409939|nutrition|nutrition
961470|NCT03409939|phenylalanine|phenylalanine
961471|NCT03409939|tyrosine|tyrosine
961472|NCT03409939|stable isotope|stable isotope
961473|NCT03409926|Heart Disease|heart disease
961474|NCT03409926|Cardiovascular Disease|cardiovascular disease
961475|NCT03409926|Diet|diet
961476|NCT03409926|Fiber|fiber
961477|NCT03409926|Microbiome|microbiome
961478|NCT03409913|positron emissions tomography|positron emissions tomography
961479|NCT03409913|diagnostic accuracy|diagnostic accuracy
961480|NCT03409913|case-control|case-control
961481|NCT03409900|Lumbar Plexus Block|lumbar plexus block
961482|NCT03409900|Quadratus Lumborum Block|quadratus lumborum block
961784|NCT03408054|Oxytocin|oxytocin
961483|NCT03409900|Direct Anterior Approach|direct anterior approach
961484|NCT03409900|Post-Operative|post-operative
961485|NCT03409900|Pain Management|pain management
961486|NCT03409887|root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
961487|NCT03409809|Implementation Support|implementation support
961488|NCT03409809|Eating Disorder|eating disorder
961489|NCT03409809|Dissemination|dissemination
961490|NCT03409809|Prevention|prevention
961491|NCT03409809|Peer Leader|peer leader
961492|NCT03409796|Gluten Challenge|gluten challenge
961493|NCT03409757|microbiome|microbiome
961494|NCT03409744|HoFH|hofh
961495|NCT03409731|Drug eluting Bio-resolvable Scaffold (BRS)|drug eluting bio-resolvable scaffold (brs)
961496|NCT03409731|Bio-resolvable Scaffold (BRS)|bio-resolvable scaffold (brs)
961497|NCT03409731|Real world|real world
961498|NCT03409718|Total Shoulder Arthroplasty|total shoulder arthroplasty
961499|NCT03409718|Medical Device|medical device
961500|NCT03409718|Performance|performance
961501|NCT03409718|Safety|safety
961502|NCT03409718|Shoulder Prosthesis|shoulder prosthesis
961503|NCT03409666|Total Hip Arthroplasty|total hip arthroplasty
961504|NCT03409666|Medical Device|medical device
961506|NCT03409666|Safety|safety
961507|NCT03409666|Hip prosthesis|hip prosthesis
961508|NCT03409666|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
961509|NCT03409627|retrograde coronary sinus infusion|retrograde coronary sinus infusion
961510|NCT03409627|DNA|dna
961511|NCT03409627|non-viral|non-viral
961512|NCT03409627|triple effector plasmid|triple effector plasmid
961513|NCT03409627|gene therapy|gene therapy
961514|NCT03409627|regenerative medicine|regenerative medicine
961515|NCT03409627|non-stem cell|non-stem cell
961516|NCT03409614|Stage IIIB|stage iiib
961517|NCT03409614|Stage IV|stage iv
961518|NCT03409614|Non-squamous NSCLC|non-squamous nsclc
961519|NCT03409614|Squamous NSCLC|squamous nsclc
961520|NCT03409601|Obesity, eating behavior, food, nutrition|obesity, eating behavior, food, nutrition
961521|NCT03409588|Chronic Thromboembolic Disease|chronic thromboembolic disease
961522|NCT03409588|CTED|cted
961523|NCT03409588|Treatment Post PEA surgery|treatment post pea surgery
961524|NCT03409575|neuromuscular electrical stimulation|neuromuscular electrical stimulation
961525|NCT03409575|geriatric population|geriatric population
961526|NCT03409575|physical function|physical function
961527|NCT03409575|quadriceps|quadriceps
961528|NCT03409575|fatigue|fatigue
961529|NCT03409562|low back pain|low back pain
961530|NCT03409562|pain neurophysiology education|pain neurophysiology education
961531|NCT03409562|motor control|motor control
961532|NCT03409536|SSEP Monitoring|ssep monitoring
961533|NCT03409536|Diagnostic threshold|diagnostic threshold
961534|NCT03409510|vitamin D|vitamin d
961535|NCT03409510|25(OH)D|25(oh)d
961536|NCT03409510|skin pigmentation|skin pigmentation
961537|NCT03409510|UVB|uvb
961538|NCT03409510|pigment genes|pigment genes
961539|NCT03409471|Urine|urine
961540|NCT03409471|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
961541|NCT03409471|Self-Sampling|self-sampling
961542|NCT03409471|HPV Testing|hpv testing
961543|NCT03409471|Cervical Cancer Screening|cervical cancer screening
961544|NCT03409471|ASCUS|ascus
961545|NCT03409471|LSIL|lsil
961546|NCT03409458|Advanced Solid Tumors|advanced solid tumors
961547|NCT03409458|NSCLC|nsclc
961548|NCT03409458|mUC|muc
961549|NCT03409458|mBC|mbc
961550|NCT03409458|CRPC|crpc
961551|NCT03409458|SCCHN|scchn
961552|NCT03409419|Advanced|advanced
961553|NCT03409419|Recurrent|recurrent
961554|NCT03409419|Immune Therapy|immune therapy
961555|NCT03409406|developmental disability|developmental disability
961556|NCT03409406|speech and language disorder|speech and language disorder
961557|NCT03409406|mobile health technology|mobile health technology
961558|NCT03409406|parent training|parent training
961559|NCT03409406|communication intervention|communication intervention
961560|NCT03409393|Human|human
961561|NCT03409393|Denmark|denmark
961562|NCT03409393|Adult|adult
961563|NCT03409393|Adolescent|adolescent
961564|NCT03409393|Young Adult|young adult
961565|NCT03409393|Male|male
961566|NCT03409393|Female|female
961567|NCT03409393|Physical Activity|physical activity
961568|NCT03409393|Maximum Oxygen Consumption|maximum oxygen consumption
961569|NCT03409393|Resistance Training|resistance training
961570|NCT03409393|High-Intensity Functional Training|high-intensity functional training
961571|NCT03409393|Aerobic Exercise|aerobic exercise
961572|NCT03409393|Motivation|motivation
961573|NCT03409393|Feasibility|feasibility
961574|NCT03409393|Relevance|relevance
961575|NCT03409393|Health Behavior|health behavior
961576|NCT03409380|growth hormone|growth hormone
961577|NCT03409367|Prevention|prevention
961578|NCT03409367|Emollient|emollient
961579|NCT03409367|Pragmatic clinical trial|pragmatic clinical trial
961580|NCT03409315|Centralized Therapeutic Drug Monitoring|centralized therapeutic drug monitoring
961581|NCT03409315|Fluoroquinolones|fluoroquinolones
961582|NCT03409302|ACT|act
961583|NCT03409302|digital intervention|digital intervention
961584|NCT03409302|web-based|web-based
961585|NCT03409302|adherence|adherence
961586|NCT03409289|Spontaneous Circulation (ROSC)|spontaneous circulation (rosc)
961587|NCT03409289|Shock and Hypotension (RUSH) exam|shock and hypotension (rush) exam
961588|NCT03409263|Cirrhosis|cirrhosis
961589|NCT03409263|Advanced chronic liver disease|advanced chronic liver disease
961590|NCT03409263|Ascites|ascites
961591|NCT03409263|Variceal hemorrhage|variceal hemorrhage
961592|NCT03409263|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
961593|NCT03409250|CNV due to Age Related Macular Degeneration|cnv due to age related macular degeneration
961594|NCT03409198|Neoplasms|neoplasms
961595|NCT03409185|Cataract surgery|cataract surgery
961596|NCT03409185|Intraocular lens|intraocular lens
961597|NCT03409185|Glistenings|glistenings
961598|NCT03409172|High intensity interval training|high intensity interval training
961599|NCT03409172|Inflammation|inflammation
961600|NCT03409172|Obesity|obesity
961601|NCT03409172|adipokines|adipokines
961602|NCT03409133|Prosthesis User|prosthesis user
961603|NCT03409133|Phantom Sensation|phantom sensation
961604|NCT03409133|Sensory Feedback|sensory feedback
961605|NCT03409120|Dystonia|dystonia
961606|NCT03409120|Parkinson's Disease|parkinson's disease
961607|NCT03409107|Non-Dialysis|non-dialysis
961608|NCT03409107|Anemia|anemia
961609|NCT03409107|Chronic kidney disease|chronic kidney disease
961610|NCT03409107|Recombinant human erythropoietin naïve|recombinant human erythropoietin naïve
961611|NCT03409107|Hemoglobin|hemoglobin
961612|NCT03409107|Daprodustat|daprodustat
961613|NCT03409081|Expanded Access|expanded access
961614|NCT03409081|FMS-like Tyrosine Kinase 3|fms-like tyrosine kinase 3
961615|NCT03409081|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
961616|NCT03409081|gilteritinib|gilteritinib
961617|NCT03409081|ASP2215|asp2215
961618|NCT03409068|Carotid thromboendarterectomy|carotid thromboendarterectomy
961619|NCT03409068|Carotidodynia|carotidodynia
961620|NCT03409042|Caloric compensation|caloric compensation
961621|NCT03409029|bladder|bladder
961622|NCT03409029|radiotherapy|radiotherapy
961623|NCT03409029|magnetic resonance imaging|magnetic resonance imaging
961624|NCT03409016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
961625|NCT03409016|Biomarkers|biomarkers
961626|NCT03409016|Immune Related Adverse Event|immune related adverse event
961627|NCT03409003|urea cycle disorder|urea cycle disorder
961628|NCT03408977|meal ingestion|meal ingestion
961629|NCT03408977|meal tolerance|meal tolerance
961630|NCT03408977|postprandial responses|postprandial responses
961631|NCT03408977|hedonic sensations|hedonic sensations
961632|NCT03408977|homeostatic sensations|homeostatic sensations
961633|NCT03408925|elite orienteering|elite orienteering
961634|NCT03408899|Microbicides|microbicides
961635|NCT03408886|fecal transplant|fecal transplant
961636|NCT03408886|fecal microbiota transplant|fecal microbiota transplant
961637|NCT03408886|microbiota transplant|microbiota transplant
961638|NCT03408886|vancomycin|vancomycin
961639|NCT03408886|moviprep|moviprep
961640|NCT03408873|Antipsychotic Drugs|antipsychotic drugs
961641|NCT03408873|Antipsychotics|antipsychotics
961642|NCT03408873|Injectables|injectables
961643|NCT03408873|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
961644|NCT03408873|Bipolar Disorder|bipolar disorder
961645|NCT03408873|Medication Adherence|medication adherence
961646|NCT03408873|Medication Non-Adherence|medication non-adherence
961647|NCT03408847|Ulcerative colitis|ulcerative colitis
961648|NCT03408847|UC|uc
961649|NCT03408847|Extra virgin olive oil|extra virgin olive oil
961650|NCT03408847|Polyphenols|polyphenols
961651|NCT03408834|NGAL|ngal
961652|NCT03408834|PVI|pvi
961653|NCT03408808|wrist|wrist
961654|NCT03408808|ganglion|ganglion
961655|NCT03408808|platelet rich plasma|platelet rich plasma
961656|NCT03408808|aspiration|aspiration
961657|NCT03408782|Surgical Site Infection|surgical site infection
961658|NCT03408782|Surgical drains|surgical drains
961659|NCT03408769|Cancer|cancer
961660|NCT03408769|Sexuality|sexuality
961661|NCT03408769|Quality of life|quality of life
961662|NCT03408769|Intimacy|intimacy
961663|NCT03408769|BISF-WBrief Index of Sexual Functioning for Women questionnaire|bisf-wbrief index of sexual functioning for women questionnaire
961664|NCT03408769|Quality of life questionnaire (EORTC QLQ-BR23):|quality of life questionnaire (eortc qlq-br23):
961665|NCT03408769|Partnership questionnaire (partnerschaftsfragebogen; PFB)|partnership questionnaire (partnerschaftsfragebogen; pfb)
961666|NCT03408743|Multiphase optimization strategy|multiphase optimization strategy
961667|NCT03408743|College students|college students
961668|NCT03408730|Hepatitis B Vaccines|hepatitis b vaccines
961669|NCT03408717|Breast cancer|breast cancer
961670|NCT03408717|Chronic pain|chronic pain
961671|NCT03408717|Acute Pain|acute pain
961672|NCT03408717|Depression|depression
961673|NCT03408717|Anxiety|anxiety
961674|NCT03408704|Streptococcus Pyogenes Infection|streptococcus pyogenes infection
961675|NCT03408704|Randomized Controlled Trial|randomized controlled trial
961676|NCT03408691|probiotic|probiotic
961677|NCT03408691|permeability|permeability
961678|NCT03408691|stress|stress
961679|NCT03408678|body composition|body composition
961680|NCT03408678|glucocorticoids|glucocorticoids
961681|NCT03408678|inflammation|inflammation
961682|NCT03408678|black African|black african
961684|NCT03408678|gonadal steroid hormones|gonadal steroid hormones
961685|NCT03408652|Bone Metastases|bone metastases
961686|NCT03408639|End-Stage Renal Disease, Anemia, Erythropoietin, Hemoglobine|end-stage renal disease, anemia, erythropoietin, hemoglobine
961687|NCT03408613|Obstructive Sleep Apnea|obstructive sleep apnea
961688|NCT03408613|Glucose Metabolism|glucose metabolism
961689|NCT03408600|Abdominal sepsis|abdominal sepsis
961690|NCT03408600|Secondary peritonitis|secondary peritonitis
961691|NCT03408600|Complicated intra-abdominal infections|complicated intra-abdominal infections
961692|NCT03408587|CVA21|cva21
961693|NCT03408587|CAVATAK|cavatak
961694|NCT03408587|Coxsackievirus|coxsackievirus
961695|NCT03408587|ocular|ocular
961696|NCT03408587|eye|eye
961697|NCT03408587|ipilimumab|ipilimumab
961698|NCT03408587|yervoy|yervoy
961699|NCT03408587|oncolytic|oncolytic
961700|NCT03408587|virus|virus
961701|NCT03408587|checkpoint|checkpoint
961702|NCT03408587|CTLA-4|ctla-4
961703|NCT03408574|nicotinic system|nicotinic system
961704|NCT03408574|cognitive aging|cognitive aging
961705|NCT03408574|working memory|working memory
961706|NCT03408574|fMRI|fmri
961707|NCT03408548|Bifidobacterium animalis subsp. lactis|bifidobacterium animalis subsp. lactis
961708|NCT03408548|Probiotic|probiotic
961709|NCT03408548|Periodontitis treatment|periodontitis treatment
961710|NCT03408548|Periodontitis|periodontitis
961711|NCT03408535|eHealth|ehealth
961712|NCT03408535|Online Rehabilitation|online rehabilitation
961713|NCT03408535|Hearing Problems|hearing problems
961714|NCT03408535|Adult|adult
961715|NCT03408535|Hearing Aids|hearing aids
961716|NCT03408496|Myofascial release|myofascial release
961717|NCT03408496|Pain|pain
961718|NCT03408496|Manual therapy|manual therapy
961719|NCT03408496|Muscle stretching|muscle stretching
961720|NCT03408496|Quality of life|quality of life
961721|NCT03408483|Quadratus Lumborum Block|quadratus lumborum block
961722|NCT03408470|Absolute Bioavailability|absolute bioavailability
961723|NCT03408470|ADME|adme
961724|NCT03408470|Healthy Normal Males|healthy normal males
961725|NCT03408457|Surgical wound infection|surgical wound infection
961726|NCT03408457|antibiotic concentration|antibiotic concentration
961727|NCT03408457|blood level|blood level
961728|NCT03408418|Platelet-rich fibrin|platelet-rich fibrin
961729|NCT03408418|Tooth Extraction|tooth extraction
961730|NCT03408418|Alveolar Bone Grafting|alveolar bone grafting
961731|NCT03408392|Single dose|single dose
961732|NCT03408392|Oral suspension|oral suspension
961733|NCT03408392|Bioequivalence|bioequivalence
961734|NCT03408392|Cefixime|cefixime
961735|NCT03408392|Two-way crossover|two-way crossover
961736|NCT03408379|intracranial aneurysms|intracranial aneurysms
961737|NCT03408379|ruptured aneurysm|ruptured aneurysm
961738|NCT03408379|platelet activity|platelet activity
961739|NCT03408366|Laparotomy|laparotomy
961740|NCT03408366|Surgical Incisions|surgical incisions
961741|NCT03408366|Wound Perfusion|wound perfusion
961742|NCT03408366|17-650|17-650
961743|NCT03408340|Anesthesiology|anesthesiology
961744|NCT03408340|Pediatric surgery|pediatric surgery
961745|NCT03408340|Anesthesia, Regional|anesthesia, regional
961746|NCT03408340|Anesthesia, Cardiac Procedures|anesthesia, cardiac procedures
961747|NCT03408340|Nerve Block|nerve block
961748|NCT03408327|Schizophrenia|schizophrenia
961749|NCT03408327|Physical Activity|physical activity
961750|NCT03408327|Health Promotion|health promotion
961751|NCT03408327|Wearable Technology|wearable technology
961752|NCT03408327|Fitness Wristband|fitness wristband
961753|NCT03408327|mobile health, mHealth|mobile health, mhealth
961754|NCT03408314|Advanced Cancer|advanced cancer
961755|NCT03408275|Dietary patterns|dietary patterns
961756|NCT03408275|Pregnancy|pregnancy
961757|NCT03408275|Woman|woman
961758|NCT03408275|Diet|diet
961759|NCT03408275|Lead|lead
961760|NCT03408275|ALSPAC|alspac
961761|NCT03408249|Crohn's disease, ulcerative colitis, fecal calprotectin|crohn's disease, ulcerative colitis, fecal calprotectin
961762|NCT03408197|inadvertent, intraoperative hypothermia, prewarming|inadvertent, intraoperative hypothermia, prewarming
961763|NCT03408171|liver biopsy|liver biopsy
961764|NCT03408171|endoscopic ultrasound guided liver biopsy|endoscopic ultrasound guided liver biopsy
961766|NCT03408171|FNB|fnb
961767|NCT03408158|HPA|hpa
961768|NCT03408158|Blood disease|blood disease
961769|NCT03408145|Stem Cell Therapy|stem cell therapy
961770|NCT03408145|Injection|injection
961771|NCT03408145|Hyaluronic Acid|hyaluronic acid
961772|NCT03408145|Synovial Fluid|synovial fluid
961773|NCT03408119|prune|prune
961774|NCT03408119|dried plum|dried plum
961775|NCT03408119|osteoporosis|osteoporosis
961776|NCT03408119|osteopenia|osteopenia
961777|NCT03408119|men|men
961778|NCT03408093|Interferon beta-1b (INFb-1b)|interferon beta-1b (infb-1b)
961779|NCT03408093|Multiple Sclerosis (MS)|multiple sclerosis (ms)
961780|NCT03408093|Relapsing-remitting MS (RRMS)|relapsing-remitting ms (rrms)
961781|NCT03408093|Secondary progressive MS (SPMS)|secondary progressive ms (spms)
961782|NCT03408093|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
961783|NCT03408054|Uterine contraction|uterine contraction
961785|NCT03408054|Nitroglycerin|nitroglycerin
961786|NCT03408041|Alzheimer Disease|alzheimer disease
961787|NCT03408041|Objective parameters|objective parameters
961788|NCT03408041|Scheltens index|scheltens index
961789|NCT03408028|Therapeutic code|therapeutic code
961790|NCT03408028|Geriatry|geriatry
961791|NCT03408015|dry eye disease|dry eye disease
961792|NCT03408015|neutrophil|neutrophil
961793|NCT03408015|T cell|t cell
961794|NCT03408015|lifitegrast|lifitegrast
961795|NCT03408015|contact lens discomfort|contact lens discomfort
961796|NCT03408015|ocular surface homeostasis|ocular surface homeostasis
961797|NCT03408002|preoperative anxiety|preoperative anxiety
961798|NCT03408002|self-efficacy|self-efficacy
961799|NCT03408002|psychophysiology|psychophysiology
961800|NCT03408002|psychotherapy|psychotherapy
961801|NCT03408002|pancreatic surgery|pancreatic surgery
961802|NCT03407950|Deficit Schizophrenia|deficit schizophrenia
961803|NCT03407950|long stay inpatients|long stay inpatients
961804|NCT03407950|cognitive remediation|cognitive remediation
962609|NCT03402815|Maraviroc|maraviroc
961805|NCT03407950|negative symptoms|negative symptoms
961806|NCT03407937|Hypnosis|hypnosis
961807|NCT03407937|Meditation|meditation
961808|NCT03407937|Conditioned pain modulation|conditioned pain modulation
961809|NCT03407937|Placebo|placebo
961810|NCT03407937|Endocannabinoids|endocannabinoids
961811|NCT03407937|Opioid peptides|opioid peptides
961812|NCT03407937|Norepinephrine|norepinephrine
961813|NCT03407937|Pain|pain
961814|NCT03407937|Analgesia|analgesia
961815|NCT03407937|Genes|genes
961816|NCT03407937|Heart rate variability|heart rate variability
961817|NCT03407911|Peri-implant pocket microbiota|peri-implant pocket microbiota
961818|NCT03407911|Periodontal pocket microbiota|periodontal pocket microbiota
961819|NCT03407859|CD19-CART|cd19-cart
961820|NCT03407859|CD20-CART|cd20-cart
961821|NCT03407859|CD10-CART|cd10-cart
961822|NCT03407859|CD22-CART|cd22-cart
961823|NCT03407859|Relapsed/Refractory B-ALL|relapsed/refractory b-all
961825|NCT03407807|Fetal Splenic cyst|fetal splenic cyst
961826|NCT03407807|Differential Diagnosis|differential diagnosis
961827|NCT03407807|Evolution and complication|evolution and complication
961828|NCT03407768|Premenopausal breast cancer|premenopausal breast cancer
961829|NCT03407768|Individualized interventions|individualized interventions
961830|NCT03407768|Exercise|exercise
961831|NCT03407768|Combination hormone therapy|combination hormone therapy
961832|NCT03407768|Massage therapy|massage therapy
961833|NCT03407768|Yoga|yoga
961834|NCT03407768|Acupuncture|acupuncture
961835|NCT03407768|Treatment tolerance|treatment tolerance
961836|NCT03407768|Treatment adherence|treatment adherence
961837|NCT03407768|Adverse effects|adverse effects
961838|NCT03407768|Quality of life|quality of life
961839|NCT03407755|Intraocular gas|intraocular gas
961840|NCT03407755|Positioning|positioning
961841|NCT03407755|DMEK|dmek
961842|NCT03407755|Endothelial keratoplasty|endothelial keratoplasty
961843|NCT03407729|Hypoxia, Brain|hypoxia, brain
961844|NCT03407729|Neural networks|neural networks
961845|NCT03407729|Magnetic Resonance Imaging|magnetic resonance imaging
961847|NCT03407703|genotype 1|genotype 1
961848|NCT03407703|genotype 4|genotype 4
961849|NCT03407638|Opioid Use Disorder|opioid use disorder
961850|NCT03407638|Primary Care|primary care
961851|NCT03407638|Buprenorphine|buprenorphine
961852|NCT03407638|Naltrexone|naltrexone
961853|NCT03407625|Pregnancy|pregnancy
961854|NCT03407625|Labor Induction|labor induction
961855|NCT03407625|Cervical Ripening|cervical ripening
961856|NCT03407612|continuous passive motion device|continuous passive motion device
961857|NCT03407612|HOS-ADL|hos-adl
961858|NCT03407612|hip arthroscopy|hip arthroscopy
961859|NCT03407586|point-of-care testing|point-of-care testing
961860|NCT03407586|sexually transmitted infections|sexually transmitted infections
961861|NCT03407586|expedited partner therapy|expedited partner therapy
961862|NCT03407586|genital inflammation|genital inflammation
961863|NCT03407560|bone substitute|bone substitute
961864|NCT03407560|spinal fusion|spinal fusion
961865|NCT03407560|lumbar spine disease|lumbar spine disease
961866|NCT03407547|upper limb|upper limb
961867|NCT03407547|recovery|recovery
961868|NCT03407547|somatosensory|somatosensory
961869|NCT03407547|impairment|impairment
961870|NCT03407547|electroencephalography|electroencephalography
961871|NCT03407547|acute phase|acute phase
961872|NCT03407534|Exocrine|exocrine
961873|NCT03407534|Pancreatic Insufficiency|pancreatic insufficiency
961874|NCT03407534|Diarrhea|diarrhea
961875|NCT03407534|Bloating|bloating
961876|NCT03407534|Loose Stool|loose stool
961877|NCT03407521|second trimester abortion|second trimester abortion
961878|NCT03407495|Hepatocellular Carcinoma|hepatocellular carcinoma
961879|NCT03407495|Magnetic Resonance Imaging|magnetic resonance imaging
961880|NCT03407469|Questionnaires|questionnaires
961881|NCT03407469|Surveys|surveys
961882|NCT03407469|Cancer-related Venous Thromboembolism|cancer-related venous thromboembolism
961883|NCT03407469|VTE|vte
961884|NCT03407443|mental health promotion campaign|mental health promotion campaign
961885|NCT03407443|veterans|veterans
961886|NCT03407430|Pregabalin|pregabalin
961888|NCT03407430|Pegfilgrastim|pegfilgrastim
961889|NCT03407430|Supportive care|supportive care
961890|NCT03407430|prevention|prevention
961891|NCT03407391|Picky eater|picky eater
961892|NCT03407391|Fussy eater|fussy eater
961893|NCT03407391|Faddy eater|faddy eater
961894|NCT03407391|Nutrition|nutrition
961895|NCT03407352|Exercise|exercise
961896|NCT03407352|Video Games|video games
961897|NCT03407352|Physical Activity|physical activity
961898|NCT03407352|Children|children
961899|NCT03407352|Appetite|appetite
961900|NCT03407326|severe acute malnutrition, SAM|severe acute malnutrition, sam
961901|NCT03407313|Submental fullness|submental fullness
961902|NCT03407313|Submental fat|submental fat
961903|NCT03407313|Loose skin|loose skin
961904|NCT03407300|Non-small Cell Lung Cancer (NSCLC), XH1|non-small cell lung cancer (nsclc), xh1
961905|NCT03407222|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
961906|NCT03407222|Physical Activity|physical activity
961910|NCT03407209|Patient Controlled Epidural Analgesia (PCEA)|patient controlled epidural analgesia (pcea)
961911|NCT03407209|Patient Epidural Intermittent Bolus (PEIB)|patient epidural intermittent bolus (peib)
961912|NCT03407209|Local anesthetics|local anesthetics
961914|NCT03407196|Dapagliflozin|dapagliflozin
961915|NCT03407196|Endocrinology|endocrinology
961916|NCT03407196|Internal diseases|internal diseases
961917|NCT03407196|Type II diabetes mellitus|type ii diabetes mellitus
961918|NCT03407196|HbA1c|hba1c
961919|NCT03407196|BMI|bmi
961920|NCT03407196|BP|bp
961921|NCT03407170|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
961922|NCT03407170|PD1|pd1
961923|NCT03407170|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
961924|NCT03407170|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
961925|NCT03407170|PDL1|pdl1
961926|NCT03407170|PDL2|pdl2
961927|NCT03407157|Probiotics|probiotics
961928|NCT03407157|Pregnancy|pregnancy
961929|NCT03407157|GBS|gbs
961930|NCT03407157|Group B Streptococcus|group b streptococcus
961931|NCT03407144|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
961932|NCT03407144|PD1|pd1
961933|NCT03407144|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
961934|NCT03407144|PDL1|pdl1
961935|NCT03407131|Intertrochanteric fracture, Medical complications|intertrochanteric fracture, medical complications
961936|NCT03407079|Drug Metabolism|drug metabolism
961937|NCT03407079|Artificial Sweetner|artificial sweetner
961938|NCT03407079|P-Glycoprotein|p-glycoprotein
961939|NCT03407079|Cytochrome P 450|cytochrome p 450
961940|NCT03407079|Microbiome|microbiome
961945|NCT03407053|Calories|calories
961946|NCT03407053|Food Intake|food intake
961947|NCT03407053|Glucose|glucose
961948|NCT03407053|Body Composition|body composition
961949|NCT03407053|Body Weight Regulation|body weight regulation
961950|NCT03407040|Blood|blood
961951|NCT03407040|Tissue|tissue
961952|NCT03407040|Immunotherapy|immunotherapy
961953|NCT03407040|Tumor|tumor
961954|NCT03407040|Somatic|somatic
961955|NCT03407027|Quadratus lumborum syndrome; ultrasound- guided infiltration|quadratus lumborum syndrome; ultrasound- guided infiltration
961956|NCT03407001|Diseases of liver|diseases of liver
961957|NCT03407001|Hepatocellular carcinoma|hepatocellular carcinoma
961958|NCT03407001|HCC|hcc
961959|NCT03407001|Lumason|lumason
961960|NCT03407001|Ultrasounds|ultrasounds
961961|NCT03406988|Systemic Sclerosis|systemic sclerosis
961962|NCT03406988|Digital Ulcer|digital ulcer
961963|NCT03406988|Autologous fat grafting|autologous fat grafting
961964|NCT03406988|Adipose tissue stem cells|adipose tissue stem cells
961965|NCT03406962|inherited metabolic disorders|inherited metabolic disorders
961966|NCT03406962|cerebral adrenoleukodystrophy|cerebral adrenoleukodystrophy
961967|NCT03406962|Hurler syndrome|hurler syndrome
961968|NCT03406962|globoid cell leukodystrophy|globoid cell leukodystrophy
961969|NCT03406962|Krabbe disease|krabbe disease
961970|NCT03406962|metachromatic leukodystrophy|metachromatic leukodystrophy
961971|NCT03406962|hematopoietic stem cells|hematopoietic stem cells
961972|NCT03406962|hematopoietic stem cell transplant|hematopoietic stem cell transplant
961973|NCT03406962|umbilical cord blood|umbilical cord blood
961974|NCT03406962|umbilical cord blood transplant|umbilical cord blood transplant
961975|NCT03406962|MGTA-456|mgta-456
961976|NCT03406962|myeloablative conditioning regimen|myeloablative conditioning regimen
961977|NCT03406962|bone marrow transplant|bone marrow transplant
961978|NCT03406962|mucopolysaccharidosis-1H|mucopolysaccharidosis-1h
961979|NCT03406923|Health literacy|health literacy
961980|NCT03406923|Self-efficacy|self-efficacy
961981|NCT03406923|Beliefs about diabetes|beliefs about diabetes
961982|NCT03406923|Beliefs in medicines|beliefs in medicines
961983|NCT03406910|egg|egg
961984|NCT03406910|meat|meat
961985|NCT03406910|western diet|western diet
961986|NCT03406910|type 2 diabetes|type 2 diabetes
961987|NCT03406910|Adventist Health Study|adventist health study
961988|NCT03406910|Vegetarian cohort|vegetarian cohort
961989|NCT03406910|Adventist|adventist
961990|NCT03406884|stem cells|stem cells
961991|NCT03406884|pediatric|pediatric
961992|NCT03406871|Regorafenib|regorafenib
961993|NCT03406871|Nivolumab|nivolumab
962390|NCT03404297|Kenya|kenya
961994|NCT03406871|Phase I clinical trial|phase i clinical trial
961995|NCT03406832|Prevention|prevention
961996|NCT03406832|Slow flow|slow flow
961997|NCT03406832|No reflow|no reflow
961998|NCT03406832|Nitroprusside|nitroprusside
961999|NCT03406832|Tirofiban|tirofiban
962000|NCT03406819|Prevention|prevention
962001|NCT03406819|Slow flow|slow flow
962002|NCT03406819|No reflow|no reflow
962003|NCT03406819|Nitroprusside|nitroprusside
962004|NCT03406819|Tirofiban|tirofiban
962005|NCT03406793|Zinc|zinc
962712|NCT03401866|brain tumor|brain tumor
962006|NCT03406793|Multiple micronutrient powders|multiple micronutrient powders
962007|NCT03406793|Diarrhea|diarrhea
962008|NCT03406793|Stunting|stunting
962009|NCT03406780|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
962010|NCT03406780|Cell Therapy|cell therapy
962011|NCT03406780|Performance of the Upper Limb|performance of the upper limb
962012|NCT03406780|Pulmonary Function|pulmonary function
962013|NCT03406780|Ambulatory|ambulatory
962014|NCT03406780|Non-Ambulatory|non-ambulatory
962015|NCT03406780|Glucocorticoids|glucocorticoids
962016|NCT03406728|Parkinson's Disease|parkinson's disease
962017|NCT03406728|Virtual Reality|virtual reality
962018|NCT03406728|Training|training
962020|NCT03406728|Falls|falls
962021|NCT03406728|PDSAFEX|pdsafex
962022|NCT03406715|SCLC|sclc
962023|NCT03406715|Lung Cancer|lung cancer
962024|NCT03406715|Lung Disease|lung disease
962025|NCT03406715|Relapsed SCLC|relapsed sclc
962026|NCT03406702|Epilepsy, Generalized Epileptic Syndromes, Absence Seizures|epilepsy, generalized epileptic syndromes, absence seizures
962027|NCT03406689|Pain|pain
962028|NCT03406689|Intravitreal Injection|intravitreal injection
962029|NCT03406689|Anti-VEGF|anti-vegf
962030|NCT03406689|Nepafenac eye drops|nepafenac eye drops
962031|NCT03406689|Short Form McGill Pain Questionnaire|short form mcgill pain questionnaire
962032|NCT03406676|Methylene blue; Peripheral vascular resistance|methylene blue; peripheral vascular resistance
962033|NCT03406663|Insulin|insulin
962034|NCT03406650|muscle invasive urothelial cancer|muscle invasive urothelial cancer
962035|NCT03406650|cancer|cancer
962036|NCT03406650|immunotherapy|immunotherapy
962037|NCT03406650|durvalumab|durvalumab
962038|NCT03406650|MEDI4736|medi4736
962039|NCT03406650|adjuvant|adjuvant
962040|NCT03406650|neoadjuvant|neoadjuvant
962041|NCT03406650|radical cystectomy|radical cystectomy
962042|NCT03406650|bladder|bladder
962043|NCT03406624|Modic changes|modic changes
962044|NCT03406624|biomarkers|biomarkers
962045|NCT03406624|low back pain|low back pain
962046|NCT03406598|Shock|shock
962047|NCT03406598|Microcirculation|microcirculation
962048|NCT03406598|Nurses|nurses
962049|NCT03406572|Acute on chronic respiratory failure|acute on chronic respiratory failure
962050|NCT03406572|High-Flow heated and humidified nasal oxygen therapy|high-flow heated and humidified nasal oxygen therapy
962051|NCT03406520|peritoneal dialysis|peritoneal dialysis
962052|NCT03406520|chlorhexidine|chlorhexidine
962053|NCT03406520|exit site infection|exit site infection
962054|NCT03406520|tunnel tract infection|tunnel tract infection
962055|NCT03406494|sepsis|sepsis
962056|NCT03406494|critical illness|critical illness
962057|NCT03406494|intensive care unit|intensive care unit
962058|NCT03406494|mechanical ventilation|mechanical ventilation
962059|NCT03406494|rehabilitation|rehabilitation
962060|NCT03406494|mortality|mortality
962061|NCT03406494|physical function|physical function
962062|NCT03406494|health-related quality of life|health-related quality of life
962063|NCT03406468|non small cell lung cancer|non small cell lung cancer
962064|NCT03406468|immune therapy|immune therapy
962065|NCT03406468|radiotherapy|radiotherapy
962066|NCT03406455|wearable|wearable
962067|NCT03406455|mhealth|mhealth
962068|NCT03406429|rTMS|rtms
962069|NCT03406429|PPA|ppa
962070|NCT03406390|contrast sensitivity|contrast sensitivity
962071|NCT03406390|Pterygium|pterygium
962072|NCT03406325|mast cell|mast cell
962073|NCT03406325|allergy|allergy
962074|NCT03406325|genomic|genomic
962075|NCT03406325|biomarkers|biomarkers
962076|NCT03406312|Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial|roux en y gastric bypass surgery, hypoglycemia, postprandial
962077|NCT03406299|SLOG|slog
962078|NCT03406286|Post Marketing Surveillance|post marketing surveillance
962079|NCT03406208|Psychiatry|psychiatry
962080|NCT03406208|Psychology|psychology
962081|NCT03406208|Psychosocial|psychosocial
962082|NCT03406208|Behavioral|behavioral
962083|NCT03406195|transcranial magnetic stimulation|transcranial magnetic stimulation
962084|NCT03406182|stunting|stunting
962085|NCT03406182|under-weight|under-weight
962086|NCT03406182|Pakistan|pakistan
962087|NCT03406182|infant|infant
962088|NCT03406182|time-use|time-use
962089|NCT03406182|women|women
962090|NCT03406182|body mass index|body mass index
962091|NCT03406182|growth|growth
962092|NCT03406169|penile rehabilitation|penile rehabilitation
962093|NCT03406156|Cancer|cancer
962094|NCT03406156|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
962095|NCT03406156|17p Deletion|17p deletion
962096|NCT03406156|debulking|debulking
962097|NCT03406156|obinutuzumab|obinutuzumab
962098|NCT03406156|bendamustine|bendamustine
962099|NCT03406156|tumor lysis syndrome|tumor lysis syndrome
962100|NCT03406156|venetoclax|venetoclax
962101|NCT03406104|Heredity Optic Atrophy|heredity optic atrophy
962102|NCT03406104|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
962103|NCT03406104|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
962104|NCT03406104|LHON|lhon
962105|NCT03406104|Eye Diseases|eye diseases
962106|NCT03406104|Hereditary Eye Diseases|hereditary eye diseases
962107|NCT03406104|Inborn Genetic Disease|inborn genetic disease
962108|NCT03406104|Gene Therapy|gene therapy
962109|NCT03406104|Intravitreal Injections|intravitreal injections
962110|NCT03406104|Mitochondrial Disease|mitochondrial disease
962111|NCT03406104|AAV2 Vectors|aav2 vectors
962112|NCT03406104|Nervous System Diseases|nervous system diseases
962113|NCT03406104|Neurodegenerative Disease|neurodegenerative disease
962114|NCT03406104|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
962115|NCT03406078|Asthma|asthma
962116|NCT03406065|Sodium bicarbonate|sodium bicarbonate
962117|NCT03406065|NaHCO3|nahco3
962118|NCT03406065|Combat Sports|combat sports
962119|NCT03406065|Physical capacity|physical capacity
962120|NCT03406065|Dummy test|dummy test
962121|NCT03406039|Alcohol Use Disorder|alcohol use disorder
962122|NCT03406039|Emotional Disorder|emotional disorder
962123|NCT03406039|Cognitive Behavioural Therapy|cognitive behavioural therapy
962124|NCT03406039|Motivational Interviewing|motivational interviewing
962125|NCT03406039|Online Intervention|online intervention
962126|NCT03406039|Randomized Controlled Trial|randomized controlled trial
962127|NCT03406026|Stroke|stroke
962128|NCT03406026|Balance rehabilitation|balance rehabilitation
962129|NCT03406026|Physiotherapy|physiotherapy
962130|NCT03405974|Osteonecrosis|osteonecrosis
962131|NCT03405974|Aspirin|aspirin
962132|NCT03405961|PAR scoring|par scoring
962133|NCT03405961|Digital study models|digital study models
962134|NCT03405909|contrast-enhanced ultrasound|contrast-enhanced ultrasound
962135|NCT03405909|non-invasive diagnosis|non-invasive diagnosis
962136|NCT03405909|focal liver lesion|focal liver lesion
962137|NCT03405909|liver cirrhosis|liver cirrhosis
962138|NCT03405909|standardised diagnostic algorithm|standardised diagnostic algorithm
962139|NCT03405909|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
962140|NCT03405909|ESCULAP|esculap
962141|NCT03405909|CEUS LI-RADS|ceus li-rads
962142|NCT03405909|imaging|imaging
962143|NCT03405909|hepatocellular carcinoma|hepatocellular carcinoma
962144|NCT03405909|MRI|mri
962145|NCT03405909|diagnostic accuracy|diagnostic accuracy
962146|NCT03405909|interobserver agreement|interobserver agreement
962147|NCT03405909|Erlanger Synopsis of CEUS for Liver lesion Assessment in Patients at risk|erlanger synopsis of ceus for liver lesion assessment in patients at risk
962148|NCT03405909|CEUS Liver Imaging Reporting and Data System|ceus liver imaging reporting and data system
962149|NCT03405870|cholesterol|cholesterol
962150|NCT03405870|lipids|lipids
962151|NCT03405870|total parenteral nutrition|total parenteral nutrition
962152|NCT03405857|mild cognitive impairment|mild cognitive impairment
962153|NCT03405857|cognitive training program|cognitive training program
962154|NCT03405844|Shoulder|shoulder
962155|NCT03405844|glenohumeral|glenohumeral
962156|NCT03405844|stretching|stretching
962157|NCT03405831|Heart transplantation|heart transplantation
962158|NCT03405831|Exercise capacity|exercise capacity
962159|NCT03405831|Heart rate|heart rate
962160|NCT03405831|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
962161|NCT03405818|Fungal infection of the nail|fungal infection of the nail
962162|NCT03405792|Tumor Treating Electric Fields (TTFields)|tumor treating electric fields (ttfields)
962163|NCT03405714|Epilepsy|epilepsy
962164|NCT03405714|Brivaracetam|brivaracetam
962165|NCT03405714|Briviact|briviact
962166|NCT03405714|Open-label|open-label
962167|NCT03405714|pediatric|pediatric
962168|NCT03405714|intravenous|intravenous
962169|NCT03405688|Sickle cell|sickle cell
962170|NCT03405688|Heterozygous|heterozygous
962171|NCT03405688|Blood donor|blood donor
962172|NCT03405675|Dementia|dementia
962173|NCT03405675|Mild cognitive impairment|mild cognitive impairment
962174|NCT03405675|Cognitive abilities and changes|cognitive abilities and changes
962175|NCT03405675|Functional change and disabilities|functional change and disabilities
962176|NCT03405675|Depression|depression
962177|NCT03405675|Health and social services utilization|health and social services utilization
962178|NCT03405675|Quality of life|quality of life
962179|NCT03405675|Adverse drug effects|adverse drug effects
962180|NCT03405675|Social network and support|social network and support
962181|NCT03405675|Self-rated health|self-rated health
962182|NCT03405675|Medical morbidities|medical morbidities
962183|NCT03405675|Falls|falls
962184|NCT03405675|Health risk behaviors|health risk behaviors
962185|NCT03405675|Nutrition|nutrition
962186|NCT03405675|Apo-E lipoprotein|apo-e lipoprotein
962187|NCT03405675|Phytochemicals|phytochemicals
962188|NCT03405675|B12|b12
962189|NCT03405675|Folate|folate
962190|NCT03405675|Homocysteine|homocysteine
962191|NCT03405675|Lifestyle|lifestyle
962192|NCT03405675|Physical activity|physical activity
962193|NCT03405675|Leisure activity|leisure activity
962194|NCT03405675|Successful ageing|successful ageing
962195|NCT03405675|Mortality|mortality
962196|NCT03405649|postpartum|postpartum
962197|NCT03405649|exercise|exercise
962198|NCT03405649|intervention|intervention
962199|NCT03405610|Psychiatry|psychiatry
962200|NCT03405610|Psychology|psychology
962201|NCT03405610|Psychosocial|psychosocial
962202|NCT03405610|Mind-Body|mind-body
962808|NCT03401216|synergy 48|synergy 48
962203|NCT03405584|Helicobacter pylori|helicobacter pylori
962204|NCT03405584|Therapy|therapy
962205|NCT03405506|Fractional Flow Reserve|fractional flow reserve
962206|NCT03405506|Quantitative Coronary Angiography|quantitative coronary angiography
962207|NCT03405506|Coronary artery disease|coronary artery disease
962208|NCT03405506|Quantitative Flow Ratio|quantitative flow ratio
962209|NCT03405506|Tandem lesion|tandem lesion
962210|NCT03405506|Virtual stenting|virtual stenting
962211|NCT03405493|Circadian Rhythm|circadian rhythm
962212|NCT03405493|Light Therapy|light therapy
962213|NCT03405493|Wake Therapy|wake therapy
962214|NCT03405493|Sleep Phase Advance|sleep phase advance
962215|NCT03405493|Major Depression|major depression
962216|NCT03405480|Pulmonary embolism|pulmonary embolism
962217|NCT03405480|Dyspnea|dyspnea
962218|NCT03405480|Post Pulmonary Embolism Syndrome|post pulmonary embolism syndrome
962219|NCT03405480|PPS|pps
962220|NCT03405480|Rehabilitation|rehabilitation
962221|NCT03405480|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
962222|NCT03405428|Ultrasonography|ultrasonography
962223|NCT03405428|Radial Artery Diameter|radial artery diameter
962224|NCT03405428|Allen Test|allen test
962225|NCT03405428|Arterial Cannulation|arterial cannulation
962226|NCT03405428|Doppler Ultrasonography|doppler ultrasonography
962227|NCT03405428|Ulnar Artery|ulnar artery
962228|NCT03405402|Sickle cell disease|sickle cell disease
962229|NCT03405402|Allo-immunization|allo-immunization
962230|NCT03405402|Blood transfusion|blood transfusion
962231|NCT03405389|mandibulo-maxillary fixation|mandibulo-maxillary fixation
962232|NCT03405389|malocclusion|malocclusion
962233|NCT03405324|brain stimulation, tDCS, nausea and vomiting|brain stimulation, tdcs, nausea and vomiting
962234|NCT03405311|Labor analgesia|labor analgesia
962235|NCT03405311|Ultrasound|ultrasound
962236|NCT03405311|Obesity, Morbid|obesity, morbid
962237|NCT03405311|Pregnancy|pregnancy
962238|NCT03405311|Labor Epidural Analgesia|labor epidural analgesia
962239|NCT03405285|Improved Bladder Management|improved bladder management
962240|NCT03405285|Neurogenic Lower Urinary Tract Dysfunction|neurogenic lower urinary tract dysfunction
962241|NCT03405285|Bladder function following Spinal Cord Injury|bladder function following spinal cord injury
962242|NCT03405285|Urinary Retention|urinary retention
962243|NCT03405272|Full human anti-EGFR monoclonal antibody (SCT200)|full human anti-egfr monoclonal antibody (sct200)
962244|NCT03405272|metastatic colorectal cancer （mCRC）|metastatic colorectal cancer （mcrc）
962245|NCT03405246|Childhood obesity|childhood obesity
962246|NCT03405246|Weight gain in children|weight gain in children
962247|NCT03405246|Diet intervention|diet intervention
962248|NCT03405233|ESRD|esrd
962249|NCT03405233|ePTFE|eptfe
962250|NCT03405233|neointemal hyperplasia|neointemal hyperplasia
962251|NCT03405220|smoking|smoking
962252|NCT03405220|self-affirmation|self-affirmation
962253|NCT03405220|mobile application|mobile application
962254|NCT03405220|cessation|cessation
962255|NCT03405194|HIV/AIDS|hiv/aids
962256|NCT03405194|Same-Day ART|same-day art
962257|NCT03405194|Genvoya|genvoya
962258|NCT03405194|Efavirenz|efavirenz
962259|NCT03405129|Smoking Cessation|smoking cessation
962260|NCT03405129|Smartphone App|smartphone app
962261|NCT03405129|Dynamic Treatment|dynamic treatment
962262|NCT03405103|self-management|self-management
962263|NCT03405103|m-Health|m-health
962264|NCT03405077|interpersonal psychotherapy|interpersonal psychotherapy
962265|NCT03405077|treatment|treatment
962266|NCT03405077|training|training
962267|NCT03405077|dissemination and implementation|dissemination and implementation
962268|NCT03405077|eating disorders|eating disorders
962269|NCT03405051|hypokalemia|hypokalemia
962270|NCT03405051|cardiac failure|cardiac failure
962271|NCT03404960|Platinum|platinum
962272|NCT03404960|chemotherapy|chemotherapy
962273|NCT03404960|Niraparib|niraparib
962274|NCT03404960|Ipilimumab|ipilimumab
962275|NCT03404960|Nivolumab|nivolumab
962276|NCT03404960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
962277|NCT03404960|PARP inhibitor|parp inhibitor
962278|NCT03404960|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
962279|NCT03404960|DDR|ddr
962280|NCT03404960|PDAC|pdac
962281|NCT03404947|Exercise|exercise
962282|NCT03404947|Metabolism|metabolism
962283|NCT03404947|Nutrition|nutrition
962284|NCT03404934|Adaptive anastomosis|adaptive anastomosis
962285|NCT03404934|C-REX|c-rex
962286|NCT03404934|Colorectal cancer|colorectal cancer
962287|NCT03404921|Endoscopic submucosal dissection|endoscopic submucosal dissection
962288|NCT03404921|Endoscopic submucosal tunnelling dissection|endoscopic submucosal tunnelling dissection
962289|NCT03404921|procedure time|procedure time
962290|NCT03404908|transversus abdominis plane block|transversus abdominis plane block
962291|NCT03404908|quadratus lumborum block|quadratus lumborum block
962292|NCT03404908|neuropathic pain|neuropathic pain
962293|NCT03404895|DFU|dfu
962294|NCT03404895|Vein|vein
962295|NCT03404895|Stent|stent
962296|NCT03404791|Bladder Cancer|bladder cancer
962297|NCT03404791|Urothelial Carcinoma|urothelial carcinoma
962298|NCT03404791|Cystectomy|cystectomy
962299|NCT03404791|Radical Cystectomy|radical cystectomy
962300|NCT03404778|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
962301|NCT03404778|Medical Device|medical device
962302|NCT03404778|Performance|performance
962303|NCT03404778|Safety|safety
962304|NCT03404778|Shoulder Prosthesis|shoulder prosthesis
962305|NCT03404778|Glenoid Erosion|glenoid erosion
962306|NCT03404765|Tai Chi|tai chi
962307|NCT03404765|Cognition|cognition
962308|NCT03404765|Instrumental activities of daily living|instrumental activities of daily living
962309|NCT03404765|Health-related Quality of Life|health-related quality of life
962310|NCT03404752|breast cancer|breast cancer
962311|NCT03404752|chemotherapy|chemotherapy
962312|NCT03404752|Neutropenia|neutropenia
962313|NCT03404752|Peg-filgrastim|peg-filgrastim
962314|NCT03404752|biosimilar|biosimilar
962315|NCT03404739|Antibiotic prophylaxis|antibiotic prophylaxis
962316|NCT03404739|Infectious complications|infectious complications
962317|NCT03404739|Peroral endoscopic myotomy|peroral endoscopic myotomy
962318|NCT03404726|Acute myeloid leukemia|acute myeloid leukemia
962319|NCT03404726|Myelodysplastic Syndromes|myelodysplastic syndromes
962320|NCT03404726|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
962321|NCT03404726|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
962322|NCT03404713|adolescence|adolescence
962323|NCT03404713|adolescent|adolescent
962324|NCT03404713|binge eating|binge eating
962325|NCT03404713|loss-of-control eating|loss-of-control eating
962326|NCT03404713|behavioral weight loss|behavioral weight loss
962327|NCT03404713|weight management|weight management
962328|NCT03404713|acceptance commitment therapy|acceptance commitment therapy
962329|NCT03404713|overweight|overweight
962330|NCT03404713|obesity|obesity
962331|NCT03404700|Eggs, saturated fat, insulin resistance,|eggs, saturated fat, insulin resistance,
962332|NCT03404674|ETEC|etec
962333|NCT03404674|Escherichia coli|escherichia coli
962334|NCT03404674|enteric|enteric
962335|NCT03404648|high risk|high risk
962336|NCT03404648|prostate cancer|prostate cancer
962337|NCT03404648|C11-choline|c11-choline
962338|NCT03404648|PET/MR|pet/mr
962339|NCT03404648|mpMRI|mpmri
962340|NCT03404596|cigarettes|cigarettes
962341|NCT03404596|quit smoking|quit smoking
962342|NCT03404596|nicotine|nicotine
962343|NCT03404596|mindfulness|mindfulness
962344|NCT03404596|mHealth|mhealth
962345|NCT03404596|mobile health|mobile health
962346|NCT03404583|Person-centred care|person-centred care
962347|NCT03404570|Sweaty Hands|sweaty hands
962348|NCT03404557|Crohn's Disease|crohn's disease
962349|NCT03404557|Ulcerative colitis|ulcerative colitis
962350|NCT03404557|Macrophages|macrophages
962351|NCT03404557|Adherent-Invasive Escherichia coli|adherent-invasive escherichia coli
962352|NCT03404557|Proteomic analysis|proteomic analysis
962353|NCT03404518|Thyroidectomy|thyroidectomy
962354|NCT03404518|Parotidectomy|parotidectomy
962355|NCT03404518|Tympanoplasty|tympanoplasty
962356|NCT03404518|Mastoidectomy|mastoidectomy
962357|NCT03404518|Septoplasty|septoplasty
962358|NCT03404518|Sinus Surgery|sinus surgery
962359|NCT03404518|Postoperative pain|postoperative pain
962360|NCT03404518|Outpatient surgery|outpatient surgery
962361|NCT03404505|infant|infant
962362|NCT03404505|play|play
962363|NCT03404505|parents|parents
962364|NCT03404479|Knee Osteoarthritis|knee osteoarthritis
962365|NCT03404479|Diacerein|diacerein
962366|NCT03404453|Airway prediction|airway prediction
962367|NCT03404453|Difficult airway|difficult airway
962368|NCT03404440|helicobacter pylori|helicobacter pylori
962369|NCT03404440|L. Reuteri|l. reuteri
962370|NCT03404440|Proton Pump Inhibitor|proton pump inhibitor
962371|NCT03404375|scheduled cesarean section|scheduled cesarean section
962372|NCT03404375|term pregnancy|term pregnancy
962373|NCT03404375|estimated blood loss|estimated blood loss
962374|NCT03404375|postpartum hemorrhage|postpartum hemorrhage
962375|NCT03404362|Bone Metastases|bone metastases
962376|NCT03404336|migraine|migraine
962377|NCT03404336|chronic|chronic
962378|NCT03404336|well-being therapy|well-being therapy
962379|NCT03404336|psychotherapy|psychotherapy
962380|NCT03404336|therapy|therapy
962509|NCT03403517|liver surgery|liver surgery
962381|NCT03404323|central retinal thickness|central retinal thickness
962382|NCT03404323|epiretinal membrane|epiretinal membrane
962383|NCT03404323|cataract surgery|cataract surgery
962384|NCT03404323|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
962385|NCT03404310|HPV|hpv
962386|NCT03404310|ASCUS|ascus
962387|NCT03404310|LSIL|lsil
962388|NCT03404310|Cervical Cancer|cervical cancer
962389|NCT03404297|compression therapy|compression therapy
962391|NCT03404297|Kaposi Sarcoma|kaposi sarcoma
962392|NCT03404297|Locally sourced|locally sourced
962393|NCT03404297|wrapping|wrapping
962394|NCT03404297|chronic leg ulcers|chronic leg ulcers
962395|NCT03404284|Immunization|immunization
962396|NCT03404245|Physical Activity|physical activity
962397|NCT03404245|Exercise|exercise
962398|NCT03404245|Rheumatoid|rheumatoid
962399|NCT03404245|Arthritis|arthritis
962400|NCT03404245|Self-management|self-management
962401|NCT03404245|Symptoms|symptoms
962402|NCT03404206|Postsurgical pain|postsurgical pain
962403|NCT03404193|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
962404|NCT03404193|Acute Myeloid Leukemia|acute myeloid leukemia
962405|NCT03404193|AML|aml
962406|NCT03404193|Myelodysplastic Syndrome|myelodysplastic syndrome
962407|NCT03404193|MDS|mds
962408|NCT03404193|Decitabine|decitabine
962409|NCT03404193|Dacogen|dacogen
962410|NCT03404193|Ventoclax|ventoclax
962411|NCT03404193|ABT-199|abt-199
962412|NCT03404193|GDC-0199|gdc-0199
962413|NCT03404167|ETX0914|etx0914
962414|NCT03404167|Plasma Pharmacokinetic|plasma pharmacokinetic
962415|NCT03404167|Safety|safety
962416|NCT03404167|Tolerability|tolerability
962417|NCT03404167|Zoliflodacin|zoliflodacin
962418|NCT03404141|Stress|stress
962419|NCT03404141|pregnancy|pregnancy
962420|NCT03404141|psychological therapy|psychological therapy
962421|NCT03404141|cortisol|cortisol
962422|NCT03404115|reproxalap|reproxalap
962423|NCT03404089|device drug monitoring|device drug monitoring
962424|NCT03404089|β-lactam antibiotic|β-lactam antibiotic
962425|NCT03404089|health care-associated infection|health care-associated infection
962426|NCT03404089|MON4STRAT|mon4strat
962427|NCT03404076|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
962428|NCT03404076|Dual Energy CT|dual energy ct
962429|NCT03404076|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
962430|NCT03404024|gene therapy|gene therapy
962431|NCT03403998|Pain|pain
962432|NCT03403998|Temporomandibular Disorders|temporomandibular disorders
962433|NCT03403998|Therapeutic exercises|therapeutic exercises
962434|NCT03403998|Musculoskeletal disorders|musculoskeletal disorders
962435|NCT03403998|Randomized controlled trial|randomized controlled trial
962436|NCT03403998|Imaging|imaging
962437|NCT03403998|Brain plasticity|brain plasticity
962438|NCT03403998|Clinical outcomes|clinical outcomes
962439|NCT03403998|Chronic pain|chronic pain
962440|NCT03403998|Neck|neck
962441|NCT03403972|pharmacokinetics|pharmacokinetics
962442|NCT03403972|simvastatin|simvastatin
962443|NCT03403972|vancomycin|vancomycin
962444|NCT03403972|gut microbiome|gut microbiome
962445|NCT03403959|pupillometry|pupillometry
962446|NCT03403959|light therapy|light therapy
962447|NCT03403959|visual impairment|visual impairment
962448|NCT03403959|melatonin|melatonin
962449|NCT03403959|ipRGC|iprgc
962450|NCT03403946|difficult airway|difficult airway
962451|NCT03403946|carvical collar|carvical collar
962452|NCT03403946|endotracheal intubation|endotracheal intubation
962453|NCT03403920|validity|validity
962454|NCT03403920|low back pain|low back pain
962455|NCT03403920|functional|functional
962456|NCT03403920|pain|pain
962457|NCT03403920|questionnaire|questionnaire
962458|NCT03403907|epilepsy|epilepsy
962459|NCT03403907|microbiota|microbiota
962460|NCT03403907|probiotics|probiotics
962461|NCT03403881|Exercise|exercise
962462|NCT03403881|Physical activity|physical activity
962463|NCT03403881|Behavioral change|behavioral change
962464|NCT03403881|Depression|depression
962465|NCT03403881|Major Depressive Disorder|major depressive disorder
962466|NCT03403881|Health promotion|health promotion
962467|NCT03403803|Glioblastoma|glioblastoma
962468|NCT03403803|Brain Tumor|brain tumor
962469|NCT03403790|Bipresso|bipresso
962470|NCT03403790|Drug use-results survey|drug use-results survey
962471|NCT03403790|Quetiapine|quetiapine
962472|NCT03403777|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
962473|NCT03403777|Avelumab|avelumab
962474|NCT03403777|Anti PD-L1|anti pd-l1
962475|NCT03403764|Intention|intention
962476|NCT03403764|Distant Healing|distant healing
962477|NCT03403764|Wellness|wellness
962478|NCT03403764|Distant Intentionality|distant intentionality
962479|NCT03403764|Distant Healing Intention|distant healing intention
962480|NCT03403751|Abdominal sepsis|abdominal sepsis
962481|NCT03403751|AKI|aki
962482|NCT03403725|Solid Tumors|solid tumors
962483|NCT03403725|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
962484|NCT03403725|NHL|nhl
962485|NCT03403725|MEN1309|men1309
962486|NCT03403725|CD205|cd205
962487|NCT03403725|Relapsed|relapsed
962488|NCT03403725|Refractory|refractory
962489|NCT03403725|R-R NHL|r-r nhl
962490|NCT03403725|ADC|adc
962491|NCT03403725|Antibody-Drug Coniugate|antibody-drug coniugate
962492|NCT03403725|Metastatic Tumors|metastatic tumors
962493|NCT03403699|inducible pluripotent stem cells|inducible pluripotent stem cells
962494|NCT03403686|Liver X receptor|liver x receptor
962606|NCT03402828|Topicals|topicals
962495|NCT03403686|Circulating angiogenic cells|circulating angiogenic cells
962496|NCT03403660|Attire|attire
962497|NCT03403660|White coat|white coat
962498|NCT03403660|Patient physician communication|patient physician communication
962499|NCT03403569|CD4 cell recovery|cd4 cell recovery
962500|NCT03403569|immune activation|immune activation
962501|NCT03403569|anti-inflammation|anti-inflammation
962502|NCT03403556|High ASCVD risk patients with type 2 diabetes|high ascvd risk patients with type 2 diabetes
962503|NCT03403530|IgM|igm
962504|NCT03403530|Immunoglobulin|immunoglobulin
962510|NCT03403517|hepatectomy|hepatectomy
962511|NCT03403478|Hemodynamics|hemodynamics
962512|NCT03403478|Aquatic exercise|aquatic exercise
962513|NCT03403478|Elderly|elderly
962514|NCT03403374|Evolocumab|evolocumab
962515|NCT03403374|Hypercholesterolemia|hypercholesterolemia
962516|NCT03403322|intervention|intervention
962517|NCT03403322|children|children
962518|NCT03403309|Multiple system atrophy|multiple system atrophy
962519|NCT03403309|Uric acid|uric acid
962520|NCT03403309|Inosine 5'-monophosphate|inosine 5'-monophosphate
962521|NCT03403309|Inosine monophosphate|inosine monophosphate
962522|NCT03403309|Inosinic acid|inosinic acid
962523|NCT03403270|Mobile App|mobile app
962524|NCT03403270|Sedentary Behaviour|sedentary behaviour
962525|NCT03403270|Workplace Wellness|workplace wellness
962526|NCT03403270|Sitting Time|sitting time
962527|NCT03403257|Caregiving|caregiving
962528|NCT03403257|Hispanic|hispanic
962529|NCT03403257|Mexican American|mexican american
962530|NCT03403257|Epidemiology|epidemiology
962531|NCT03403257|Community|community
962532|NCT03403231|Veterans|veterans
962533|NCT03403231|Type 2 diabetes mellitus|type 2 diabetes mellitus
962534|NCT03403231|Prediabetes|prediabetes
962535|NCT03403231|Secure Messaging|secure messaging
962536|NCT03403231|Health Promotion|health promotion
962537|NCT03403231|Prevention and Control|prevention and control
962538|NCT03403231|Motivation|motivation
962539|NCT03403218|balance, risk of falling|balance, risk of falling
962540|NCT03403192|EZ Blocker|ez blocker
962542|NCT03403192|Double Lumen Tube|double lumen tube
962543|NCT03403192|Thoracic Surgery|thoracic surgery
962544|NCT03403179|Cognition|cognition
962545|NCT03403179|Cognitive Remediation|cognitive remediation
962546|NCT03403179|Mood Disorder|mood disorder
962547|NCT03403179|Functional Impairment|functional impairment
962548|NCT03403179|Psychosocial intervention|psychosocial intervention
962549|NCT03403153|Parent-Child Relationship|parent-child relationship
962550|NCT03403153|military family|military family
962551|NCT03403153|veterans health|veterans health
962552|NCT03403153|stress disorders|stress disorders
962553|NCT03403114|Vaccine hesitancy|vaccine hesitancy
962554|NCT03403114|Hospital specialists (HS)|hospital specialists (hs)
962555|NCT03403114|Vaccination survey|vaccination survey
962556|NCT03403088|Non-carious cervical lesions|non-carious cervical lesions
962557|NCT03403088|dentin hypersensitivity|dentin hypersensitivity
962563|NCT03403062|Sepsis|sepsis
962564|NCT03403062|red cell distribution width (RDW)|red cell distribution width (rdw)
962565|NCT03403062|Late onset sepsis (LOS)|late onset sepsis (los)
962566|NCT03403062|Early onset sepsis (EOS)|early onset sepsis (eos)
962567|NCT03403049|pancreatic cancer|pancreatic cancer
962568|NCT03403049|pancreas|pancreas
962569|NCT03403049|cancer|cancer
962570|NCT03403049|locally advanced|locally advanced
962571|NCT03403049|unresectable|unresectable
962572|NCT03403049|radiation|radiation
962573|NCT03403049|radiation therapy|radiation therapy
962574|NCT03403049|radiotherapy|radiotherapy
962575|NCT03403049|carbon|carbon
962576|NCT03403049|carbon ion|carbon ion
962577|NCT03403049|ion|ion
962578|NCT03403036|Psoriasis|psoriasis
962579|NCT03403036|brodalumab|brodalumab
962580|NCT03403023|Dry Eye Disease|dry eye disease
962581|NCT03403023|Tear Film Imager|tear film imager
962582|NCT03403023|tear film|tear film
962583|NCT03403023|Cyclosporine|cyclosporine
962584|NCT03403023|dry eye syndrome|dry eye syndrome
962585|NCT03403023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
962586|NCT03402984|Gastric motility|gastric motility
962587|NCT03402984|Gastric emptying|gastric emptying
962588|NCT03402971|right heart|right heart
962589|NCT03402971|pregnancy|pregnancy
962590|NCT03402971|echocardiography|echocardiography
962591|NCT03402971|reference values|reference values
962592|NCT03402945|negative pressure wound management system|negative pressure wound management system
962593|NCT03402945|open-heart surgery|open-heart surgery
962594|NCT03402945|antibiotic prophylaxis|antibiotic prophylaxis
962595|NCT03402945|surgical site infection|surgical site infection
962596|NCT03402854|pediatric|pediatric
962597|NCT03402854|children|children
962598|NCT03402854|non-invasive brain stimulation|non-invasive brain stimulation
962599|NCT03402854|transcranial direct current stimulation|transcranial direct current stimulation
962600|NCT03402854|bimanual training|bimanual training
962601|NCT03402854|hand training|hand training
962602|NCT03402841|Ovarian cancer|ovarian cancer
962603|NCT03402841|non-gBRCA|non-gbrca
962604|NCT03402841|Platinum|platinum
962605|NCT03402841|Chemotherapy|chemotherapy
962610|NCT03402815|Atherosclerosis|atherosclerosis
962611|NCT03402802|eye drop|eye drop
962612|NCT03402789|Docosahexaenoic acid|docosahexaenoic acid
962613|NCT03402789|Long chain fatty acid|long chain fatty acid
962614|NCT03402776|haemopoietic stem cell transplantation|haemopoietic stem cell transplantation
962615|NCT03402776|vaccine|vaccine
962616|NCT03402776|diphteria|diphteria
962617|NCT03402776|tetanus|tetanus
962618|NCT03402776|haemophilus influenza|haemophilus influenza
962619|NCT03402776|poliomyelitis|poliomyelitis
962620|NCT03402776|hepatitis B|hepatitis b
962621|NCT03402763|Advance care planning|advance care planning
962622|NCT03402763|Older adults|older adults
962623|NCT03402763|Emergency department|emergency department
962624|NCT03402750|Adherence, Medication, Prescription|adherence, medication, prescription
962625|NCT03402737|Stereotactic body radiotherapy|stereotactic body radiotherapy
962626|NCT03402737|Immunomodulating systemic therapy|immunomodulating systemic therapy
962627|NCT03402711|ACS|acs
962628|NCT03402711|PCI|pci
962629|NCT03402711|Bleeding risk|bleeding risk
962630|NCT03402698|cholecalciferol|cholecalciferol
962631|NCT03402698|BMI|bmi
962632|NCT03402698|winter|winter
962633|NCT03402607|Unresectable|unresectable
962634|NCT03402594|High flow oxygen therapy|high flow oxygen therapy
962635|NCT03402594|Oxygen desaturation index|oxygen desaturation index
962636|NCT03402594|Acute ischemic stroke|acute ischemic stroke
962637|NCT03402568|alcohol|alcohol
962638|NCT03402568|targeted metabolomics|targeted metabolomics
962639|NCT03402568|lipid metabolites|lipid metabolites
962640|NCT03402568|amino acids|amino acids
962641|NCT03402568|acylcarnitines|acylcarnitines
962642|NCT03402529|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
962643|NCT03402516|hysteroscopic myomectomy|hysteroscopic myomectomy
962644|NCT03402516|26Fr resector|26fr resector
962645|NCT03402516|18.5Fr resector|18.5fr resector
962646|NCT03402490|Motivational interviewing|motivational interviewing
962647|NCT03402490|physical activity|physical activity
962648|NCT03402490|feasibility|feasibility
962649|NCT03402490|HFpEF|hfpef
962650|NCT03402477|locally advanced, neo-adjuvant treatment, Watch & Wait|locally advanced, neo-adjuvant treatment, watch & wait
962651|NCT03402425|FET|fet
962652|NCT03402425|PET/MRI|pet/mri
962653|NCT03402425|child|child
962654|NCT03402360|Virtual Reality|virtual reality
962655|NCT03402360|Rehabilitation|rehabilitation
962656|NCT03402360|Acquired Brain Injury|acquired brain injury
962657|NCT03402347|Ex vivo|ex vivo
962658|NCT03402347|Gastric bypass|gastric bypass
962659|NCT03402321|alveogyl, gelatin sponge, free gingival graft, palate, pain|alveogyl, gelatin sponge, free gingival graft, palate, pain
962660|NCT03402282|hemorrhoidal disease|hemorrhoidal disease
962661|NCT03402282|embolization|embolization
962662|NCT03402256|Mobile Technology|mobile technology
962663|NCT03402256|Alcohol|alcohol
962664|NCT03402256|Alcoholic Liver Disease|alcoholic liver disease
962665|NCT03402256|Ethyl Glucuronide|ethyl glucuronide
962666|NCT03402217|Contraception|contraception
962667|NCT03402217|Post Partum Contraception|post partum contraception
962668|NCT03402204|Simvastatin|simvastatin
962669|NCT03402204|Plaque stability|plaque stability
962670|NCT03402204|Acute ischemic stroke|acute ischemic stroke
962671|NCT03402178|E2082|e2082
962672|NCT03402178|male|male
962673|NCT03402178|single ascending dose|single ascending dose
962674|NCT03402178|multiple ascending dose|multiple ascending dose
962675|NCT03402152|Biomarker|biomarker
962676|NCT03402100|myopia|myopia
962677|NCT03402100|schoolchildren|schoolchildren
962678|NCT03402100|atropine|atropine
962679|NCT03402100|allergy|allergy
962680|NCT03402100|eye drops|eye drops
962681|NCT03402100|outdoor|outdoor
962682|NCT03402100|near work|near work
962683|NCT03402048|Lung Cancer|lung cancer
962684|NCT03402048|Elderly|elderly
962685|NCT03402048|First line|first line
962686|NCT03402048|Customized chemotherapy|customized chemotherapy
962687|NCT03402048|Pharmacogenomic-driven|pharmacogenomic-driven
962688|NCT03402048|NSCLC|nsclc
962689|NCT03402035|Whole Blood Resuscitation|whole blood resuscitation
962690|NCT03402022|Sport|sport
962691|NCT03402022|competition|competition
962692|NCT03402022|ultra-endurance|ultra-endurance
962693|NCT03402022|trail running|trail running
962694|NCT03402022|doping|doping
962695|NCT03402009|meditation|meditation
962696|NCT03402009|Mindfulness|mindfulness
962697|NCT03402009|stress|stress
962698|NCT03402009|anxiety|anxiety
962699|NCT03401983|exercise|exercise
962700|NCT03401983|pelvic floor|pelvic floor
962701|NCT03401983|stress urinary incontinence|stress urinary incontinence
962702|NCT03401970|Body composition|body composition
962703|NCT03401970|Internal body fat|internal body fat
962704|NCT03401970|Dietary pattern|dietary pattern
962705|NCT03401970|Dietary carbohydrate|dietary carbohydrate
962706|NCT03401957|colorectal cancer|colorectal cancer
962707|NCT03401957|cetuximab resistance|cetuximab resistance
962708|NCT03401957|liquid biopsy|liquid biopsy
962709|NCT03401957|RAS mutation|ras mutation
962710|NCT03401905|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
962711|NCT03401905|Myofascial trigger point|myofascial trigger point
962713|NCT03401840|Head and neck cancers|head and neck cancers
962714|NCT03401840|Radiation oncology|radiation oncology
962715|NCT03401840|Stereotactic radiotherapy|stereotactic radiotherapy
962716|NCT03401827|pancreatic cancer|pancreatic cancer
962717|NCT03401827|second line chemotherapy|second line chemotherapy
962718|NCT03401827|nab-paclitaxel|nab-paclitaxel
962719|NCT03401775|aging, computerized cognitive training|aging, computerized cognitive training
962720|NCT03401762|rehabilitation|rehabilitation
962721|NCT03401736|Sedatives and Hypnotics,Mechanical Ventilation|sedatives and hypnotics,mechanical ventilation
962722|NCT03401723|Validation study|validation study
962723|NCT03401723|Simulation|simulation
962724|NCT03401723|Endoscopy|endoscopy
962725|NCT03401710|Anemia, Acute Kidney injury, ESA, Erythropoietin|anemia, acute kidney injury, esa, erythropoietin
962726|NCT03401684|firefighters|firefighters
962727|NCT03401684|mental resiliency|mental resiliency
962728|NCT03401684|peer support|peer support
962729|NCT03401671|Lanadelumab|lanadelumab
962730|NCT03401632|Enteral nutrition|enteral nutrition
962731|NCT03401632|Vasoactive Drugs|vasoactive drugs
962732|NCT03401632|Critical Care|critical care
962733|NCT03401606|sedation|sedation
962734|NCT03401606|dexmedetomidine|dexmedetomidine
962735|NCT03401606|remifentanil|remifentanil
962736|NCT03401606|cataract surgery|cataract surgery
962737|NCT03401606|surgeon satisfaction|surgeon satisfaction
962738|NCT03401606|patient satisfaction|patient satisfaction
962739|NCT03401593|ablation|ablation
962740|NCT03401593|atrial fibrillation|atrial fibrillation
962741|NCT03401593|stroke|stroke
962742|NCT03401567|blood flow restriction|blood flow restriction
962743|NCT03401567|proprioception|proprioception
962744|NCT03401567|functional performance|functional performance
962745|NCT03401567|muscle strength|muscle strength
962746|NCT03401463|endotracheal tube cuff pressure|endotracheal tube cuff pressure
962747|NCT03401463|Ventilator-Induced Lung Injury|ventilator-induced lung injury
962748|NCT03401463|traning|traning
962749|NCT03401437|adverse effects|adverse effects
962750|NCT03401437|Salpingectomy|salpingectomy
962751|NCT03401437|Essure® device ablation|essure® device ablation
962752|NCT03401437|Cornual resection|cornual resection
962753|NCT03401424|congenital cyst of common bile duct|congenital cyst of common bile duct
962754|NCT03401424|Biliary enteric anastomosis|biliary enteric anastomosis
962756|NCT03401411|ICU Triage Practices|icu triage practices
962757|NCT03401411|Cancer Patients|cancer patients
962758|NCT03401411|Oncology ICU|oncology icu
962759|NCT03401398|hydrocortisone|hydrocortisone
962760|NCT03401398|refractory septic shock|refractory septic shock
962761|NCT03401398|sepsis|sepsis
962762|NCT03401398|new/progressive MODS|new/progressive mods
962763|NCT03401398|mortality|mortality
962764|NCT03401398|health-related quality of life|health-related quality of life
962765|NCT03401398|corticosteroid adverse events|corticosteroid adverse events
962766|NCT03401398|sepsis biomarkers|sepsis biomarkers
962767|NCT03401385|Non-small cell lung cancer|non-small cell lung cancer
962768|NCT03401385|NSCLC|nsclc
962769|NCT03401385|Other solid tumors|other solid tumors
962770|NCT03401372|Primary light chain amyloidosis|primary light chain amyloidosis
962771|NCT03401372|Doxycycline|doxycycline
962772|NCT03401372|Bortezomib|bortezomib
962773|NCT03401372|Prognosis|prognosis
962774|NCT03401372|Progression-free survival|progression-free survival
962775|NCT03401372|Overall survival|overall survival
962776|NCT03401372|Organ response|organ response
962777|NCT03401320|pharmacokinetics|pharmacokinetics
962778|NCT03401320|letrozole|letrozole
962779|NCT03401294|Metastatic colorectal cancer|metastatic colorectal cancer
962780|NCT03401294|Conversion therapy|conversion therapy
962781|NCT03401294|Liver Metastasectomy|liver metastasectomy
962782|NCT03401268|hypogammaglobulinemia|hypogammaglobulinemia
962783|NCT03401268|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
962784|NCT03401255|Placental alpha microglobulin-1|placental alpha microglobulin-1
962785|NCT03401255|PAMG-1|pamg-1
962786|NCT03401255|preterm labor|preterm labor
962787|NCT03401255|preterm delivery|preterm delivery
962788|NCT03401255|preterm birth|preterm birth
962789|NCT03401255|cervical length|cervical length
962790|NCT03401255|transvaginal ultrasound|transvaginal ultrasound
962791|NCT03401255|corticosteroid|corticosteroid
962792|NCT03401242|Carbapenemase|carbapenemase
962793|NCT03401242|Enterobacteriaceae|enterobacteriaceae
962794|NCT03401242|extended spectrum beta-lactamases|extended spectrum beta-lactamases
962795|NCT03401242|nursing homes|nursing homes
962796|NCT03401242|prevalence|prevalence
962797|NCT03401229|Polyps|polyps
962798|NCT03401229|Nasal polyps|nasal polyps
962799|NCT03401229|Nasal polyposis|nasal polyposis
962800|NCT03401229|Nose diseases|nose diseases
962801|NCT03401229|Respiratory tract diseases|respiratory tract diseases
962802|NCT03401229|Otorhinolaryngologic diseases|otorhinolaryngologic diseases
962803|NCT03401229|Benralizumab|benralizumab
962804|NCT03401229|Mometasone furoate|mometasone furoate
962805|NCT03401216|Optical coherence tomography|optical coherence tomography
962806|NCT03401216|Healing score|healing score
962807|NCT03401216|Neointimal coverage|neointimal coverage
962809|NCT03401216|long lesion|long lesion
962814|NCT03401151|Heart failure|heart failure
962815|NCT03401151|Skeletal muscle|skeletal muscle
962816|NCT03401151|Exercise capacity|exercise capacity
962817|NCT03401151|Lung function|lung function
962818|NCT03401151|Gene expression|gene expression
962819|NCT03401138|Peripheral perfusion|peripheral perfusion
962820|NCT03401138|Blood Volume|blood volume
962821|NCT03401138|Tissue Prefusion|tissue prefusion
962822|NCT03401138|Near-infrared spectroscopy|near-infrared spectroscopy
962823|NCT03401138|Hemodynamic monitoring|hemodynamic monitoring
962824|NCT03401138|Hemodynamic optimization|hemodynamic optimization
962825|NCT03401138|Preoperative resuscitation|preoperative resuscitation
962826|NCT03401125|Sickle cell disease|sickle cell disease
962827|NCT03401125|Allo-immunization|allo-immunization
962828|NCT03401099|Radiofrequency ablation|radiofrequency ablation
962829|NCT03401099|Cavo-tricuspid isthmus|cavo-tricuspid isthmus
962830|NCT03401099|Pulmonary Vein Isolation|pulmonary vein isolation
962831|NCT03401099|Cryoballoon ablation|cryoballoon ablation
962832|NCT03401073|small Fiber Neuropathy|small fiber neuropathy
962833|NCT03401073|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
962834|NCT03401073|IVIg|ivig
962835|NCT03401073|Gamunex-C|gamunex-c
962836|NCT03401060|Systemic mastocytosis|systemic mastocytosis
962837|NCT03401060|Osteoporosis|osteoporosis
962838|NCT03401060|Bone mineral density (BMD)|bone mineral density (bmd)
962839|NCT03401060|Denosumab|denosumab
962840|NCT03401060|RANKL|rankl
962841|NCT03401047|PCOS|pcos
962842|NCT03401021|intention to quit smoking|intention to quit smoking
962843|NCT03401021|male smoker|male smoker
962844|NCT03401021|smoking cessation|smoking cessation
962845|NCT03401021|planning for pregnancy|planning for pregnancy
962846|NCT03401008|Acromegaly|acromegaly
962847|NCT03401008|Oral manifestations|oral manifestations
962848|NCT03400969|Palliative|palliative
962849|NCT03400969|Moisturisers|moisturisers
962850|NCT03400969|Dry mouth|dry mouth
962851|NCT03400969|Xerostomia|xerostomia
962852|NCT03400956|Uterine fibroids|uterine fibroids
962853|NCT03400956|Heavy menstrual bleeding|heavy menstrual bleeding
962854|NCT03400943|Uterine fibroids|uterine fibroids
962855|NCT03400943|Heavy menstrual bleeding|heavy menstrual bleeding
962856|NCT03400930|Severe Acute Malnutrition|severe acute malnutrition
962857|NCT03400865|cabergoline|cabergoline
962858|NCT03400865|prolactinomas|prolactinomas
962859|NCT03400865|resistant|resistant
962860|NCT03400865|hydroxychloroquine|hydroxychloroquine
962861|NCT03400865|chloroquine|chloroquine
962862|NCT03400852|Muscular Dystrophy|muscular dystrophy
962863|NCT03400852|DMD|dmd
962864|NCT03400852|Duchenne|duchenne
962865|NCT03400839|Interstitial Lung disease|interstitial lung disease
962866|NCT03400839|prognosis|prognosis
962867|NCT03400839|clinical endpoints|clinical endpoints
962868|NCT03400839|association|association
962869|NCT03400826|simvastatin|simvastatin
962870|NCT03400826|fibroids|fibroids
962871|NCT03400826|medical management|medical management
962872|NCT03400826|uterine fibroids|uterine fibroids
962873|NCT03400826|leiomyoma|leiomyoma
962874|NCT03400813|Eye-Movement Desensitization|eye-movement desensitization
962875|NCT03400813|Reprocessing|reprocessing
962876|NCT03400800|Inclisiran sodium|inclisiran sodium
962877|NCT03400800|ASCVD|ascvd
962878|NCT03400800|LDL-C|ldl-c
962879|NCT03400748|Electrosurgery|electrosurgery
962880|NCT03400748|RF ablation|rf ablation
962881|NCT03400748|Minimally invasive|minimally invasive
962882|NCT03400748|Lung cancer|lung cancer
962883|NCT03400748|Lung metastasis|lung metastasis
962884|NCT03400748|Lung tumor|lung tumor
962885|NCT03400748|Primary|primary
962886|NCT03400748|Metastatic|metastatic
962887|NCT03400748|Endobronchial ultrasound|endobronchial ultrasound
962888|NCT03400748|EBUS|ebus
962889|NCT03400722|Suboptimal ovarian response|suboptimal ovarian response
962890|NCT03400722|Ovarian Stimulation|ovarian stimulation
962891|NCT03400722|Infertility, Female|infertility, female
962892|NCT03400722|In Vitro Fertilisation|in vitro fertilisation
962893|NCT03400709|Cisplatin|cisplatin
962894|NCT03400709|Ototoxicity|ototoxicity
962895|NCT03400709|N-acetylcisteine|n-acetylcisteine
962896|NCT03400696|nutrition, diet, genetics, physical activity, weight loss|nutrition, diet, genetics, physical activity, weight loss
962897|NCT03400670|NCPAP|ncpap
962898|NCT03400670|Respiratory Distress Syndrome|respiratory distress syndrome
962899|NCT03400644|open-door laminoplasty, laminoplasty, cervical collars|open-door laminoplasty, laminoplasty, cervical collars
962900|NCT03400631|Cytokine|cytokine
962901|NCT03400618|Carbohydrates|carbohydrates
962902|NCT03400618|Diet|diet
962903|NCT03400618|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
962904|NCT03400592|gastric adenocarcinoma|gastric adenocarcinoma
962905|NCT03400592|EGFR|egfr
962906|NCT03400592|Irinotecan|irinotecan
962907|NCT03400592|Nimotuzumab|nimotuzumab
962908|NCT03400592|biomarker|biomarker
962909|NCT03400579|Emergency Medical Services|emergency medical services
963004|NCT03399734|Japanese|japanese
962910|NCT03400540|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
962911|NCT03400514|Artificial intelligence|artificial intelligence
962913|NCT03400488|Coronary Artery Disease,|coronary artery disease,
962914|NCT03400488|Cardiovascular disease (CAD),|cardiovascular disease (cad),
962915|NCT03400488|5-lipoxygenase activating protein (FLAP) inhibitor,|5-lipoxygenase activating protein (flap) inhibitor,
962916|NCT03400488|Leukotrienes.|leukotrienes.
962917|NCT03400475|topical|topical
962918|NCT03400475|subgingival|subgingival
962919|NCT03400475|simvastatin|simvastatin
962920|NCT03400462|Dry needling, occlusal splint, NSAID, nimesulide|dry needling, occlusal splint, nsaid, nimesulide
962921|NCT03400423|Caffeine|caffeine
962922|NCT03400423|Caffeine Withdrawal|caffeine withdrawal
962923|NCT03400423|Acute Aerobic Exercise|acute aerobic exercise
962924|NCT03400423|Cognition|cognition
962925|NCT03400423|Working Memory|working memory
962926|NCT03400410|Contraception|contraception
962927|NCT03400410|Education|education
962928|NCT03400410|Male adolescents|male adolescents
962929|NCT03400410|Emergency Department|emergency department
962930|NCT03400410|Unintended pregnancy|unintended pregnancy
962931|NCT03400397|Anxiety|anxiety
962932|NCT03400397|Child|child
962933|NCT03400397|Cognitive behaviour therapy|cognitive behaviour therapy
962935|NCT03400397|effectiveness|effectiveness
962936|NCT03400397|treatment|treatment
962937|NCT03400397|Cool Kids|cool kids
962938|NCT03400384|Deprescribing|deprescribing
962939|NCT03400371|JME|jme
962940|NCT03400371|Epilepsy|epilepsy
962941|NCT03400371|Juvenile Myoclonic Epilepsy|juvenile myoclonic epilepsy
962942|NCT03400371|Genomewide Association Study|genomewide association study
962943|NCT03400371|Genetics|genetics
962944|NCT03400358|uterocervical angle|uterocervical angle
962945|NCT03400358|multiparous|multiparous
962946|NCT03400345|Hand Transplant|hand transplant
962947|NCT03400345|composite tissue allograft (CTA)|composite tissue allograft (cta)
962948|NCT03400345|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
962949|NCT03400345|Amputation|amputation
962950|NCT03400345|Upper Limb|upper limb
962951|NCT03400345|Immunosuppression|immunosuppression
962952|NCT03400319|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
962953|NCT03400319|Obstructive Sleep Apnea|obstructive sleep apnea
962954|NCT03400306|Cancer - Ovarian cancer|cancer - ovarian cancer
962955|NCT03400306|Bioavailability|bioavailability
962956|NCT03400306|Pharmacokinetics|pharmacokinetics
962957|NCT03400306|Bioequivalence|bioequivalence
962958|NCT03400293|Human Immunodeficiency virus|human immunodeficiency virus
962959|NCT03400293|Health Related Quality of Life|health related quality of life
962960|NCT03400293|Functional Assessment of HIV Infection|functional assessment of hiv infection
962961|NCT03400293|Mobile app|mobile app
962962|NCT03400280|Postoperative pancreatic fistula|postoperative pancreatic fistula
962963|NCT03400280|Pancreatic resection|pancreatic resection
962964|NCT03400228|Probiotics|probiotics
962965|NCT03400228|Chronic kidney disease|chronic kidney disease
962966|NCT03400228|Cardiovascular risk|cardiovascular risk
962967|NCT03400176|Ibrutinib|ibrutinib
962968|NCT03400176|VAY736|vay736
962969|NCT03400176|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
962970|NCT03400176|CLL|cll
962971|NCT03400176|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
962972|NCT03400176|BTK mutation|btk mutation
962973|NCT03400163|First Line Therapy|first line therapy
962974|NCT03400163|NASH|nash
962975|NCT03400085|mHealth|mhealth
962976|NCT03400085|living donor kidney transplant|living donor kidney transplant
962977|NCT03400085|follow-up|follow-up
962978|NCT03400085|health utilization|health utilization
962979|NCT03400059|Prophylaxis, Headache, Preventative Treatment|prophylaxis, headache, preventative treatment
1333211|NCT01443988|Naïve to treatment|naïve to treatment
962980|NCT03400033|CKD, EPO, rhEPO, Hemodialysis dependent, Daprodustat|ckd, epo, rhepo, hemodialysis dependent, daprodustat
962981|NCT03400007|dynamic floor magnetic resonance imaging|dynamic floor magnetic resonance imaging
962982|NCT03400007|colpocystodefecagraphy|colpocystodefecagraphy
962983|NCT03400007|prolapse surgery|prolapse surgery
962984|NCT03399968|shockwave|shockwave
962985|NCT03399968|ESWT|eswt
962986|NCT03399929|Rehabilitation|rehabilitation
962987|NCT03399929|Long term outcome|long term outcome
962988|NCT03399838|Procedural Sedation and Analgesia|procedural sedation and analgesia
962989|NCT03399838|Pediatric Emergency Department|pediatric emergency department
962990|NCT03399838|intranasal|intranasal
962991|NCT03399838|dexmedetomidine|dexmedetomidine
962992|NCT03399838|midazolam|midazolam
962993|NCT03399838|anxiety relief|anxiety relief
962994|NCT03399786|HoFH|hofh
962995|NCT03399760|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
962996|NCT03399760|alveolar bone height|alveolar bone height
962997|NCT03399760|canine root resorption|canine root resorption
962998|NCT03399760|bone density|bone density
962999|NCT03399760|cone-beam computed tomography|cone-beam computed tomography
963000|NCT03399734|Perampanel|perampanel
963001|NCT03399734|Bioequivalence|bioequivalence
963002|NCT03399734|fine granules|fine granules
963003|NCT03399734|E2007|e2007
963014|NCT03399630|Osteo Arthritis Knee|osteo arthritis knee
963015|NCT03399630|Autologous Adipose Tissue|autologous adipose tissue
963022|NCT03399591|Gait Disorders|gait disorders
963703|NCT03395587|vaccination|vaccination
963023|NCT03399591|Spatio-temporal parameters of walking|spatio-temporal parameters of walking
963024|NCT03399591|Alzheimer's disease|alzheimer's disease
963025|NCT03399591|Lewy body disease|lewy body disease
963026|NCT03399552|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
963027|NCT03399552|Avelumab Immunotherapy|avelumab immunotherapy
963029|NCT03399513|Ibrutinib|ibrutinib
963030|NCT03399500|Case Management|case management
963031|NCT03399500|Homelessness|homelessness
963032|NCT03399500|Smartphone|smartphone
963033|NCT03399500|Health Related Quality of Life|health related quality of life
963034|NCT03399500|Mental Health|mental health
963035|NCT03399500|Substance Use Disorders|substance use disorders
963036|NCT03399487|NSCLC|nsclc
963037|NCT03399487|ROS1 rearrangement|ros1 rearrangement
963038|NCT03399487|Ceritinib|ceritinib
963039|NCT03399487|LDK378|ldk378
963040|NCT03399474|Regional Anesthesia, Dexmedetomidine and lidocaine|regional anesthesia, dexmedetomidine and lidocaine
963041|NCT03399461|United States|united states
963042|NCT03399461|United Kingdom|united kingdom
963043|NCT03399461|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
963044|NCT03399461|Caregiver|caregiver
963045|NCT03399461|Interview|interview
963046|NCT03399461|immune deficiency|immune deficiency
963047|NCT03399461|France|france
963048|NCT03399435|Regional anesthesia|regional anesthesia
963049|NCT03399435|Brachial plexus blockade|brachial plexus blockade
963050|NCT03399435|Sensory and motor function testing|sensory and motor function testing
963051|NCT03399422|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
963052|NCT03399422|canine retraction|canine retraction
963053|NCT03399422|pain and discomfort|pain and discomfort
963054|NCT03399383|Adrenal Insufficiency|adrenal insufficiency
963055|NCT03399383|Adrenal crisis|adrenal crisis
963056|NCT03399383|Adherence|adherence
963057|NCT03399383|Standardized patient education|standardized patient education
963058|NCT03399370|Inclisiran sodium|inclisiran sodium
963059|NCT03399370|ASCVD|ascvd
963060|NCT03399370|LDL-C|ldl-c
963061|NCT03399331|honey, olive oil, oral mucositis, pain|honey, olive oil, oral mucositis, pain
963062|NCT03399318|HRP2|hrp2
963063|NCT03399292|Lipid based eye drops|lipid based eye drops
963064|NCT03399292|Tearfilm lipid layer thickness|tearfilm lipid layer thickness
963065|NCT03399279|nanohydroxyapatite|nanohydroxyapatite
963066|NCT03399279|Perforated membrane|perforated membrane
963067|NCT03399279|occlusive membrane|occlusive membrane
963068|NCT03399279|Aggressive periodontitis|aggressive periodontitis
963069|NCT03399266|Induction of labor|induction of labor
963070|NCT03399266|Previous cesarean delivery|previous cesarean delivery
963071|NCT03399266|Trial of labor after cesarean|trial of labor after cesarean
963072|NCT03399266|Prelabor rupture of membranes|prelabor rupture of membranes
963073|NCT03399266|balloon induction|balloon induction
963074|NCT03399253|Distal Gastric Cancer, Gastrectomy, Metastasectomy|distal gastric cancer, gastrectomy, metastasectomy
963075|NCT03399227|Bone microarchitecture|bone microarchitecture
963076|NCT03399188|Inflammatory Bowel Diseases, Fecal microbiota transplantation, microbiome|inflammatory bowel diseases, fecal microbiota transplantation, microbiome
963077|NCT03399175|Vogt-Koyanagi-Harada disease|vogt-koyanagi-harada disease
963078|NCT03399175|Immunosuppressive therapy|immunosuppressive therapy
963079|NCT03399175|Indocyanine green angiography|indocyanine green angiography
963080|NCT03399175|Enhanced depth imaging optical coherence tomography|enhanced depth imaging optical coherence tomography
963081|NCT03399175|Electroretinogram|electroretinogram
963082|NCT03399149|Respiratory Insufficiency|respiratory insufficiency
963083|NCT03399149|Hematologic Malignancy|hematologic malignancy
963084|NCT03399149|Intensive Care Unit|intensive care unit
963085|NCT03399136|Exercise training|exercise training
963086|NCT03399136|Intervention|intervention
963087|NCT03399136|Aerobic capacity|aerobic capacity
963088|NCT03399123|Laparoscopic hepatectomy|laparoscopic hepatectomy
963089|NCT03399123|Low tidal volume|low tidal volume
963090|NCT03399123|Blood loss|blood loss
963091|NCT03399110|Gastric cancer,Adjuvant chemtherapy|gastric cancer,adjuvant chemtherapy
963092|NCT03399097|Obesity|obesity
963093|NCT03399084|Ferric carboxymaltose|ferric carboxymaltose
963094|NCT03399084|Anemia|anemia
963095|NCT03399071|Gastric cancer|gastric cancer
963096|NCT03399071|Oesophageal cancer|oesophageal cancer
963097|NCT03399071|Gastro-oesophageal cancer|gastro-oesophageal cancer
963098|NCT03399071|Perioperative|perioperative
963099|NCT03399071|Immunotherapy|immunotherapy
963100|NCT03399071|Anti PDL1|anti pdl1
963101|NCT03399071|Avelumab|avelumab
963102|NCT03399071|FLOT|flot
963103|NCT03399032|caspofungin|caspofungin
963104|NCT03399032|pharmacokinetics|pharmacokinetics
963105|NCT03399019|Bispectral index monitor|bispectral index monitor
963106|NCT03398980|Childhood and Adolescent|childhood and adolescent
963107|NCT03398980|Survivors|survivors
963108|NCT03398980|Radiotherapy|radiotherapy
963109|NCT03398980|Late Sequelae|late sequelae
963110|NCT03398941|Pancreatic fistula|pancreatic fistula
963111|NCT03398915|robotic|robotic
963112|NCT03398915|robot-guided|robot-guided
963113|NCT03398915|navigated|navigated
963114|NCT03398915|computer-assisted|computer-assisted
963115|NCT03398915|pedicle screw|pedicle screw
963116|NCT03398915|instrumentation|instrumentation
963117|NCT03398915|thoracolumbar|thoracolumbar
963118|NCT03398902|sleep|sleep
963119|NCT03398902|sleep extension|sleep extension
963120|NCT03398902|sleep patterns|sleep patterns
963121|NCT03398902|type 2 diabetes|type 2 diabetes
963122|NCT03398902|glucose regulation|glucose regulation
963123|NCT03398902|behavioral intervention|behavioral intervention
963124|NCT03398902|adults|adults
963125|NCT03398889|intestinal microbiome|intestinal microbiome
963126|NCT03398889|atherosclerosis|atherosclerosis
963127|NCT03398889|nutrients|nutrients
963128|NCT03398889|renal function|renal function
963370|NCT03397394|Rucaparib|rucaparib
963129|NCT03398850|spontaneous coronary artery dissection|spontaneous coronary artery dissection
963130|NCT03398850|acute coronary syndrome|acute coronary syndrome
963131|NCT03398850|coronary angiography|coronary angiography
963132|NCT03398850|coronary tomography|coronary tomography
963133|NCT03398837|Scleroderma|scleroderma
963134|NCT03398837|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
963135|NCT03398837|anabasum|anabasum
963136|NCT03398837|JBT-101|jbt-101
963137|NCT03398837|lenabasum|lenabasum
963138|NCT03398824|Fanconi Anemia|fanconi anemia
963139|NCT03398824|Metformin|metformin
963140|NCT03398798|archwire dimension|archwire dimension
963141|NCT03398798|ligation method|ligation method
963142|NCT03398798|bracket type|bracket type
963143|NCT03398785|Primary Aldosteronism|primary aldosteronism
963144|NCT03398785|Hypertension|hypertension
963145|NCT03398785|Ablation|ablation
963146|NCT03398785|Adrenal Gland|adrenal gland
963147|NCT03398759|Butorphanol|butorphanol
963148|NCT03398759|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
963149|NCT03398759|Emergence agitation|emergence agitation
963150|NCT03398746|soft tissue infection|soft tissue infection
963151|NCT03398746|MRSA|mrsa
963152|NCT03398733|Obstructive Sleep Apnea|obstructive sleep apnea
963153|NCT03398733|heart valve replacement|heart valve replacement
963154|NCT03398733|CPAP treatment|cpap treatment
963155|NCT03398707|PICs|pics
963156|NCT03398707|diagnosis|diagnosis
963157|NCT03398707|prevention|prevention
963158|NCT03398707|outcome|outcome
963159|NCT03398681|Heart failure|heart failure
963160|NCT03398681|Iron deficiency|iron deficiency
963161|NCT03398681|Cardiac magnetic resonance|cardiac magnetic resonance
963162|NCT03398681|Ferric carboxymaltose|ferric carboxymaltose
963163|NCT03398681|Myocardial iron|myocardial iron
963164|NCT03398655|Recurrent Ovarian cancer|recurrent ovarian cancer
963165|NCT03398655|Platinum resistant ovarian cancer|platinum resistant ovarian cancer
963166|NCT03398655|Ovarian cancer|ovarian cancer
963167|NCT03398655|Ovarian carcinoma|ovarian carcinoma
963168|NCT03398655|Epithelial ovarian cancer|epithelial ovarian cancer
963169|NCT03398655|paclitaxel|paclitaxel
963170|NCT03398642|Occupational therapy|occupational therapy
963171|NCT03398642|Health promotion|health promotion
963172|NCT03398642|Life Style|life style
963173|NCT03398642|Quality of life|quality of life
963174|NCT03398642|Aging|aging
963175|NCT03398642|Aged|aged
963176|NCT03398642|Community participation|community participation
963177|NCT03398616|Retinal Bloodflow Pressure|retinal bloodflow pressure
963178|NCT03398603|"AMH measurement ElecSys"|"amh measurement elecsys"
963179|NCT03398590|Type 2 Diabetes|type 2 diabetes
963180|NCT03398590|Obesity|obesity
963181|NCT03398577|Coronary disease|coronary disease
963182|NCT03398577|diabetes|diabetes
963183|NCT03398577|SGLT2I|sglt2i
963184|NCT03398577|Inflammation Mediators|inflammation mediators
963185|NCT03398564|Erecror Spinae Plan Block|erecror spinae plan block
963186|NCT03398564|postoperative pain|postoperative pain
963187|NCT03398564|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
963188|NCT03398551|pregnancy|pregnancy
963189|NCT03398551|machine learning|machine learning
963190|NCT03398551|fetal Doppler echocardiography|fetal doppler echocardiography
963192|NCT03398538|Ulcer|ulcer
963193|NCT03398525|central venous catheter|central venous catheter
963194|NCT03398525|intensive care|intensive care
963195|NCT03398525|music therapy|music therapy
963196|NCT03398499|pain|pain
963197|NCT03398499|orthognathic surgery|orthognathic surgery
963198|NCT03398499|temporomandibular disorders (TMD)|temporomandibular disorders (tmd)
963199|NCT03398499|Electromagnetic Therapy|electromagnetic therapy
963200|NCT03398499|Light therapy|light therapy
963201|NCT03398486|Kinesiotaping, Manual therapy|kinesiotaping, manual therapy
963202|NCT03398486|Physiotherapy|physiotherapy
963203|NCT03398473|Epoetin Hospira|epoetin hospira
963204|NCT03398473|Pharmacokinetics|pharmacokinetics
963205|NCT03398434|MAA868|maa868
963206|NCT03398434|apixaban|apixaban
963207|NCT03398434|atrial fibrillation|atrial fibrillation
963208|NCT03398434|anticoagulant|anticoagulant
963209|NCT03398434|Factor XI|factor xi
963210|NCT03398434|D-dimer|d-dimer
963211|NCT03398434|systemic thromboembolic events|systemic thromboembolic events
963212|NCT03398421|Nemiralisib|nemiralisib
963213|NCT03398421|Pharmacokinetics|pharmacokinetics
963214|NCT03398421|Itraconazole|itraconazole
963215|NCT03398421|Drug-drug Interaction|drug-drug interaction
963216|NCT03398421|Cross-over|cross-over
963217|NCT03398382|Magnesium citrate|magnesium citrate
963218|NCT03398382|Trismus after surgical removal of the lower third molars|trismus after surgical removal of the lower third molars
963219|NCT03398382|Local anesthesia|local anesthesia
963220|NCT03398382|Analgesia after surgical removal of the lower third molars|analgesia after surgical removal of the lower third molars
963221|NCT03398382|Swelling after surgical removal of the lower third molars|swelling after surgical removal of the lower third molars
963222|NCT03398382|Surgical removal of the lower third molars|surgical removal of the lower third molars
963223|NCT03398382|Oral surgical procedures|oral surgical procedures
963224|NCT03398382|Placebo effect|placebo effect
963225|NCT03398356|prediabetes|prediabetes
963226|NCT03398356|impaired fasting glucose|impaired fasting glucose
963227|NCT03398356|impaired glucose tolerance|impaired glucose tolerance
963228|NCT03398356|metformin|metformin
963229|NCT03398356|nitric oxide|nitric oxide
963230|NCT03398317|SDF|sdf
963231|NCT03398317|DFI|dfi
963232|NCT03398317|sperm selection|sperm selection
963233|NCT03398317|PICSI|picsi
963234|NCT03398317|MACS|macs
963235|NCT03398239|respiratory failure, hypercapnia, BPAP, AVAPS|respiratory failure, hypercapnia, bpap, avaps
963236|NCT03398174|Rural individuals|rural individuals
963237|NCT03398174|Patient Education|patient education
963238|NCT03398174|Exercise|exercise
963239|NCT03398161|Mycosis Fungoides|mycosis fungoides
963240|NCT03398161|MF|mf
963241|NCT03398161|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
963242|NCT03398161|Radiation therapy|radiation therapy
963243|NCT03398161|XRT|xrt
963244|NCT03398161|Questionnaire|questionnaire
963245|NCT03398161|Survey|survey
963246|NCT03398161|Photographs|photographs
963247|NCT03398161|Microbiome Analysis|microbiome analysis
963248|NCT03398148|ABBV-066|abbv-066
963249|NCT03398148|BI 655066|bi 655066
963250|NCT03398135|ABBV-066|abbv-066
963251|NCT03398135|BI 655066|bi 655066
963252|NCT03398122|Apatinib|apatinib
963253|NCT03398122|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
963254|NCT03398070|Functional Neurological Disorder|functional neurological disorder
963255|NCT03398070|Functional Movement Disorder|functional movement disorder
963256|NCT03398070|Psychogenic Nonepileptic Seizures|psychogenic nonepileptic seizures
963257|NCT03398070|Functional Limb Weakness|functional limb weakness
963258|NCT03398057|Breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.|breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.
963259|NCT03398018|dry eye|dry eye
963260|NCT03398018|corticotropin|corticotropin
963261|NCT03398005|Omega-3 Fatty acids|omega-3 fatty acids
963262|NCT03398005|Triglycerides|triglycerides
963263|NCT03397979|atopic dermatitis|atopic dermatitis
963264|NCT03397979|bathing|bathing
963265|NCT03397979|baths|baths
963266|NCT03397966|obesity|obesity
963267|NCT03397966|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
963268|NCT03397966|metabolism|metabolism
963269|NCT03397966|Energy Metabolism|energy metabolism
963270|NCT03397953|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
963271|NCT03397953|Childhood|childhood
963272|NCT03397953|Adolescent|adolescent
963273|NCT03397953|Recurrent|recurrent
963274|NCT03397953|Treatment|treatment
963275|NCT03397927|ballet shoe|ballet shoe
963276|NCT03397927|orthosis|orthosis
963277|NCT03397927|pain|pain
963278|NCT03397901|chronic radiation proctitis|chronic radiation proctitis
963279|NCT03397901|rectal bleeding|rectal bleeding
963280|NCT03397901|transverse colostomy|transverse colostomy
963281|NCT03397901|refractory|refractory
963282|NCT03397901|moderate to severe anemia|moderate to severe anemia
963283|NCT03397849|Primary prevention|primary prevention
963284|NCT03397849|Lifestyle intervention|lifestyle intervention
963285|NCT03397849|Digital health|digital health
963286|NCT03397849|Cardiovascular disease prevention|cardiovascular disease prevention
963287|NCT03397836|Older adults|older adults
963288|NCT03397836|Optimal aging|optimal aging
963679|NCT03395717|Robot|robot
963289|NCT03397836|Primary health care|primary health care
963290|NCT03397836|Randomized control trial|randomized control trial
963291|NCT03397836|Integrated care|integrated care
963292|NCT03397836|Health care volunteers|health care volunteers
963293|NCT03397836|interdisciplinary health care teams|interdisciplinary health care teams
963294|NCT03397836|Implementation|implementation
963295|NCT03397836|Health services research|health services research
963296|NCT03397836|Patient centered care|patient centered care
963297|NCT03397810|cardiac amyloidosis|cardiac amyloidosis
963298|NCT03397810|radiotherapy|radiotherapy
963299|NCT03397797|muscle relaxant|muscle relaxant
963300|NCT03397784|Tidal volume challenge|tidal volume challenge
963301|NCT03397784|Fluid responsiveness|fluid responsiveness
963302|NCT03397784|Preload responsiveness|preload responsiveness
963303|NCT03397784|Functional hemodynamic monitoring|functional hemodynamic monitoring
963304|NCT03397784|Cardiac surgery|cardiac surgery
963305|NCT03397784|inferior vena cava variation|inferior vena cava variation
963306|NCT03397771|urinary incontinence, SSRI|urinary incontinence, ssri
963307|NCT03397745|bispectral index|bispectral index
963308|NCT03397745|lateral decubitus position|lateral decubitus position
963309|NCT03397745|one lung ventilation|one lung ventilation
963310|NCT03397732|Matrix metalloproteinase|matrix metalloproteinase
963311|NCT03397732|Tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase
963312|NCT03397732|Vascular surgery|vascular surgery
963313|NCT03397732|Aorta stent implantation|aorta stent implantation
963314|NCT03397732|Aorto-bifemoral bypass surgery|aorto-bifemoral bypass surgery
963315|NCT03397719|Autism Spectrum Disorder|autism spectrum disorder
963316|NCT03397719|Early Intervention|early intervention
963317|NCT03397719|Parent-Mediated Intervention|parent-mediated intervention
963318|NCT03397706|EBV+ post-transplant lymphoproliferative malignancy|ebv+ post-transplant lymphoproliferative malignancy
963319|NCT03397706|EBV-associated lymphoproliferative disorders associated with acquired immunodeficiency including HIV-positive|ebv-associated lymphoproliferative disorders associated with acquired immunodeficiency including hiv-positive
963320|NCT03397706|Relapsed, refractory, EBV+ lymphoid malignancy|relapsed, refractory, ebv+ lymphoid malignancy
963321|NCT03397693|PCOS|pcos
963322|NCT03397693|Unexplained infertiltiy|unexplained infertiltiy
963323|NCT03397693|3D Power Doppler|3d power doppler
963324|NCT03397693|Endometrial thickness|endometrial thickness
963325|NCT03397693|Subendometrial blood perfusion|subendometrial blood perfusion
963326|NCT03397680|Helicobacter Pylori infection|helicobacter pylori infection
963327|NCT03397680|Non-ulcer Dyspepsia|non-ulcer dyspepsia
963328|NCT03397680|Rabeprazole-Levofloxacin|rabeprazole-levofloxacin
963329|NCT03397602|atrial fibrillation|atrial fibrillation
963330|NCT03397602|exercise|exercise
963331|NCT03397576|Prisoner|prisoner
963332|NCT03397563|Continuous Positive Airway Pressure|continuous positive airway pressure
963333|NCT03397563|Sleep Apnea, Obstructive|sleep apnea, obstructive
963334|NCT03397563|Polysomnography|polysomnography
963335|NCT03397550|taste threshold|taste threshold
963336|NCT03397550|salt restriction|salt restriction
963337|NCT03397537|Breast Neoplasms Endocrine-responsive Neoadjuvant Duration Letrozole|breast neoplasms endocrine-responsive neoadjuvant duration letrozole
963338|NCT03397498|computerized cognitive training|computerized cognitive training
963339|NCT03397472|Insomnia|insomnia
963340|NCT03397472|Treatment|treatment
963341|NCT03397472|magnetic field modulation|magnetic field modulation
963342|NCT03397459|cervicobrachial neuralgia|cervicobrachial neuralgia
963343|NCT03397459|sagittal balance|sagittal balance
963344|NCT03397459|lordosis|lordosis
963345|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
963346|NCT03397446|Lisdexamfetamine|lisdexamfetamine
963347|NCT03397446|Vyvanse|vyvanse
963348|NCT03397446|Eating Disorders|eating disorders
963349|NCT03397446|Mental Disorders|mental disorders
963350|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants
963351|NCT03397446|Dextroamphetamine|dextroamphetamine
963353|NCT03397446|Binge Eating|binge eating
963354|NCT03397446|Purging|purging
963355|NCT03397446|Bulimia Nervosa|bulimia nervosa
963356|NCT03397433|Antibiotic Stewardship|antibiotic stewardship
963357|NCT03397433|Information Technology|information technology
963358|NCT03397433|Healthcare Outcomes|healthcare outcomes
963359|NCT03397433|Antibiotic Resistance|antibiotic resistance
963360|NCT03397433|Bacterial Infection|bacterial infection
963361|NCT03397394|PARP inhibitor|parp inhibitor
963362|NCT03397394|PARPi|parpi
963363|NCT03397394|HRD|hrd
963364|NCT03397394|ATLAS|atlas
963365|NCT03397394|homologous recombination|homologous recombination
963366|NCT03397394|DNA repair|dna repair
963367|NCT03397394|LOH|loh
963368|NCT03397394|DNA defect|dna defect
963369|NCT03397394|DNA anomaly|dna anomaly
963371|NCT03397394|MIBC|mibc
963372|NCT03397355|Pulmonary Nodule; Lung Cancer; Biopsy; Biomarker.|pulmonary nodule; lung cancer; biopsy; biomarker.
963373|NCT03397329|Healthy Volunteers|healthy volunteers
963374|NCT03397316|immediate implant|immediate implant
963375|NCT03397316|upper esthetic zone|upper esthetic zone
963376|NCT03397316|marginal bone loss|marginal bone loss
963377|NCT03397290|Chest X-ray|chest x-ray
963378|NCT03397290|Ultrasound|ultrasound
963379|NCT03397277|IPV|ipv
963380|NCT03397238|myeloid cell|myeloid cell
963381|NCT03397238|reprogramming|reprogramming
963382|NCT03397238|monocyte|monocyte
963383|NCT03397238|tumor-associated macrophage|tumor-associated macrophage
963384|NCT03397212|NADA|nada
963385|NCT03397173|Azacitidine|azacitidine
963386|NCT03397173|Ascorbic Acid|ascorbic acid
963387|NCT03397160|Prostate cancer|prostate cancer
963388|NCT03397160|Transformative Impact Award|transformative impact award
963389|NCT03397160|Early stage|early stage
963390|NCT03397160|Active surveillance|active surveillance
963391|NCT03397160|Decision aid|decision aid
963392|NCT03397160|Coaching session|coaching session
963393|NCT03397160|Personalized|personalized
963394|NCT03397160|University of California, San Francisco (UCSF)|university of california, san francisco (ucsf)
963395|NCT03397160|Validation|validation
963396|NCT03397121|HeFH|hefh
963397|NCT03397121|LDL-C|ldl-c
963398|NCT03397121|Inclisiran|inclisiran
963399|NCT03397108|Inflammatory Bowel Disease|inflammatory bowel disease
963400|NCT03397108|Crohn disease|crohn disease
963401|NCT03397108|Colitis|colitis
963402|NCT03397108|TNF|tnf
963403|NCT03397108|Breast milk|breast milk
964504|NCT03390855|Biomarkers|biomarkers
963404|NCT03397108|monoclonal antibody|monoclonal antibody
963405|NCT03397095|stem cells, ischemic heart failure.|stem cells, ischemic heart failure.
963406|NCT03397082|Endouterine manual aspiration|endouterine manual aspiration
963407|NCT03397082|Paracervical blockade|paracervical blockade
963408|NCT03397082|Lidocaine gel|lidocaine gel
963409|NCT03397069|peribubar block - midazolam|peribubar block - midazolam
963410|NCT03397056|Patient willingness|patient willingness
963411|NCT03397056|Participation|participation
963412|NCT03397030|Prostate Cancer|prostate cancer
963413|NCT03397030|Biomarkers|biomarkers
963414|NCT03397030|Exercise|exercise
963415|NCT03397004|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
963416|NCT03397004|HHT|hht
963417|NCT03397004|Doxycycline|doxycycline
963418|NCT03396991|Analgesia technique|analgesia technique
963419|NCT03396991|Pain control|pain control
963420|NCT03396939|Stroke|stroke
963421|NCT03396939|Rehabilitation|rehabilitation
963422|NCT03396939|Task oriented training|task oriented training
963423|NCT03396939|Motor recovery|motor recovery
963424|NCT03396939|Hand function|hand function
963425|NCT03396939|Arm function|arm function
963426|NCT03396913|Intense Pulsed Light|intense pulsed light
963427|NCT03396913|Meibomian Gland Dysfunction|meibomian gland dysfunction
963428|NCT03396913|Dry Eye Disease|dry eye disease
963429|NCT03396887|Alcohol Use Disorder|alcohol use disorder
963430|NCT03396887|Smartphone Application|smartphone application
963431|NCT03396861|macular edema|macular edema
963432|NCT03396861|pseudophakia|pseudophakia
963433|NCT03396861|pseudophakic macular edema|pseudophakic macular edema
963434|NCT03396861|retinal swelling|retinal swelling
963435|NCT03396861|aflibercept|aflibercept
963436|NCT03396861|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
963437|NCT03396861|subconjunctival injection|subconjunctival injection
963438|NCT03396848|Rehabilitation|rehabilitation
963439|NCT03396848|Online Clinic|online clinic
963440|NCT03396822|multiple sclerosis|multiple sclerosis
963441|NCT03396822|7T MRI|7t mri
963442|NCT03396822|Meningeal inflammation|meningeal inflammation
963443|NCT03396809|punctal plugs|punctal plugs
963444|NCT03396809|dry eye|dry eye
963445|NCT03396809|ocular surface disease index|ocular surface disease index
963446|NCT03396796|Vagus nerve|vagus nerve
963447|NCT03396796|Delayed gastric emptying|delayed gastric emptying
963448|NCT03396796|Cirrhosis|cirrhosis
963449|NCT03396796|Hypertension|hypertension
963450|NCT03396796|laparoscopy|laparoscopy
963451|NCT03396770|Urinary biomarkers|urinary biomarkers
963452|NCT03396770|Intensive Care Unit|intensive care unit
963453|NCT03396757|Acute Kidney Injury|acute kidney injury
963454|NCT03396757|Critical Care|critical care
963455|NCT03396757|Renal Replacement Therapy|renal replacement therapy
963456|NCT03396731|VLU|vlu
963457|NCT03396731|Venous Leg Ulcer|venous leg ulcer
963458|NCT03396731|Leg Ulcer|leg ulcer
963459|NCT03396731|Leg Wound|leg wound
963460|NCT03396718|Head and neck cancer|head and neck cancer
963461|NCT03396718|Oropharyngeal cancer|oropharyngeal cancer
963462|NCT03396718|postoperative|postoperative
963463|NCT03396718|radiotherapy|radiotherapy
963464|NCT03396718|radiochemotherapy|radiochemotherapy
963465|NCT03396718|de-intensification|de-intensification
963466|NCT03396718|HPV|hpv
963467|NCT03396679|Psoriatic arthritis|psoriatic arthritis
963468|NCT03396679|remission|remission
963469|NCT03396679|ultrasound|ultrasound
963470|NCT03396653|weight loss|weight loss
963471|NCT03396653|weight maintenance|weight maintenance
963472|NCT03396653|weight control|weight control
963473|NCT03396653|peer support|peer support
963474|NCT03396653|patient-provided care|patient-provided care
963475|NCT03396640|anteromedial|anteromedial
963476|NCT03396627|eyelid|eyelid
963477|NCT03396627|Muller|muller
963478|NCT03396588|Opiate use during pregnancy|opiate use during pregnancy
963479|NCT03396588|Clonidine|clonidine
963480|NCT03396588|Morphine|morphine
963481|NCT03396588|Prenatal opiate|prenatal opiate
963482|NCT03396588|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
963483|NCT03396588|Infant, Newborn, Diseases|infant, newborn, diseases
963484|NCT03396588|Substance-Related Disorders|substance-related disorders
963485|NCT03396588|Chemically-Induced Disorders|chemically-induced disorders
963486|NCT03396588|Opiate Alkaloids|opiate alkaloids
963487|NCT03396588|Mental Disorders|mental disorders
963488|NCT03396588|Narcotics|narcotics
963489|NCT03396588|Central Nervous System Depressants|central nervous system depressants
963490|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs
963491|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
963492|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists
963493|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
963494|NCT03396588|Antihypertensive Agents|antihypertensive agents
963495|NCT03396588|Analgesics|analgesics
963496|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents
963497|NCT03396588|Sympatholytics|sympatholytics
963498|NCT03396588|Autonomic Agents|autonomic agents
963499|NCT03396588|Neurotransmitter Agents|neurotransmitter agents
963704|NCT03395535|Primary Open Angle Glaucoma|primary open angle glaucoma
963500|NCT03396575|Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs)|total tumor mrna-pulsed autologous dendritic cells (dcs) (ttrna-dcs)
963501|NCT03396575|Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)|tumor-specific ex vivo expanded autologous lymphocyte transfer (ttrna-xalt)
963502|NCT03396575|Autologous G-CSF mobilized HSCs|autologous g-csf mobilized hscs
963503|NCT03396575|Temozolomide (TMZ)|temozolomide (tmz)
963504|NCT03396575|Cyclophosphamide (CTX)|cyclophosphamide (ctx)
963505|NCT03396575|Fludarabine (Flu)|fludarabine (flu)
963506|NCT03396575|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
963507|NCT03396575|Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte macrophage colony stimulating factor (gm-csf)
963508|NCT03396575|Tetanus Toxoid|tetanus toxoid
963509|NCT03396575|Mesna|mesna
963510|NCT03396562|body composition|body composition
963511|NCT03396562|klinefelter syndrome|klinefelter syndrome
963512|NCT03396562|XXY|xxy
963513|NCT03396562|Trisomy X|trisomy x
963514|NCT03396562|XXX|xxx
963515|NCT03396562|XYY|xyy
963516|NCT03396562|XXYY|xxyy
963517|NCT03396562|XXXY|xxxy
963518|NCT03396562|XXXXY|xxxxy
963519|NCT03396562|sex chromosome variation|sex chromosome variation
963520|NCT03396562|sex chromosome aneuploidy|sex chromosome aneuploidy
963521|NCT03396562|sex chromosome trisomy|sex chromosome trisomy
963522|NCT03396562|testosterone|testosterone
963523|NCT03396562|XYYY|xyyy
963524|NCT03396562|XXXX|xxxx
963525|NCT03396562|XXXXX|xxxxx
963526|NCT03396562|XXXYY|xxxyy
963527|NCT03396562|XXYYY|xxyyy
963528|NCT03396562|XYYYY|xyyyy
963529|NCT03396562|developmental delay|developmental delay
963530|NCT03396562|speech development|speech development
963531|NCT03396549|tDCS|tdcs
963532|NCT03396549|food craving|food craving
963533|NCT03396549|tDCS sham procedure|tdcs sham procedure
963534|NCT03396549|montage|montage
963535|NCT03396549|food intake|food intake
963536|NCT03396536|implant|implant
963537|NCT03396536|oral hygiene|oral hygiene
963538|NCT03396536|discomfort|discomfort
963539|NCT03396523|Losartan|losartan
963540|NCT03396523|Fear extinction|fear extinction
963541|NCT03396510|Cancer Care|cancer care
963542|NCT03396484|TrialNet|trialnet
963543|NCT03396458|Hepatitis B|hepatitis b
963544|NCT03396458|Disease prevalence|disease prevalence
963545|NCT03396458|Screening|screening
963546|NCT03396458|Migrant|migrant
963547|NCT03396458|Turkish|turkish
963548|NCT03396458|Belgium|belgium
963549|NCT03396432|laryngoscope|laryngoscope
963550|NCT03396432|intubation|intubation
963551|NCT03396432|first attempt success|first attempt success
963552|NCT03396432|oxygen saturation|oxygen saturation
963553|NCT03396432|airway management|airway management
963554|NCT03396432|Videolaryngoscopy|videolaryngoscopy
963555|NCT03396432|Direct laryngoscopy|direct laryngoscopy
963556|NCT03396406|trigeminal neuralgia, radiofrequency|trigeminal neuralgia, radiofrequency
963557|NCT03396393|Dihydroartemisinin;Systemic Lupus Erythematosus|dihydroartemisinin;systemic lupus erythematosus
963558|NCT03396367|Relationships|relationships
963559|NCT03396367|YMSM|ymsm
963560|NCT03396367|HIV/AIDS|hiv/aids
963561|NCT03396367|PrEP|prep
963562|NCT03396367|Drug Use|drug use
963563|NCT03396341|BRCA1/2 Mutations|brca1/2 mutations
963564|NCT03396341|17-489|17-489
963565|NCT03396315|premenopausal women|premenopausal women
963566|NCT03396302|Exercise|exercise
963567|NCT03396302|Nutrition|nutrition
963568|NCT03396302|Internet|internet
963569|NCT03396302|Obesity|obesity
963570|NCT03396302|Hypertension|hypertension
963571|NCT03396289|Cerebral Palsy|cerebral palsy
963572|NCT03396289|Balance|balance
963573|NCT03396289|Inspiratory Muscle Training|inspiratory muscle training
963574|NCT03396289|6-Minute Walk Test|6-minute walk test
963575|NCT03396289|Pulmonary Function Test|pulmonary function test
963576|NCT03396289|Postural Stability|postural stability
963577|NCT03396263|Personalised nutrition|personalised nutrition
963578|NCT03396263|Mobile web application|mobile web application
963680|NCT03395717|Hemiparesis|hemiparesis
963579|NCT03396224|Total hip arthroplasty|total hip arthroplasty
963580|NCT03396224|Hip implant|hip implant
963581|NCT03396211|Metastatic|metastatic
963582|NCT03396211|Unresectable|unresectable
963583|NCT03396198|Gastrointestinal Microbiome|gastrointestinal microbiome
963584|NCT03396198|Infants|infants
963585|NCT03396172|COPD|copd
963586|NCT03396172|Homecare|homecare
963587|NCT03396172|Oxygen|oxygen
963588|NCT03396172|Telemedicine|telemedicine
963589|NCT03396172|Automated oxygen adjustment|automated oxygen adjustment
963590|NCT03396172|Rehabilitation program|rehabilitation program
963591|NCT03396159|liver transplantation|liver transplantation
963592|NCT03396159|mini fluid challenge|mini fluid challenge
963593|NCT03396146|Pancreatic polypeptide|pancreatic polypeptide
963594|NCT03396146|Type 1 diabetes|type 1 diabetes
963595|NCT03396146|Chronic pancreatitis|chronic pancreatitis
963596|NCT03396133|Dyno|dyno
963597|NCT03396133|symptomatic arrhythmia|symptomatic arrhythmia
963598|NCT03396133|diagnosis|diagnosis
963599|NCT03396133|follow-up|follow-up
963705|NCT03395535|Glaucoma|glaucoma
963600|NCT03396094|high flow oxygenation, rapid sequence intubation|high flow oxygenation, rapid sequence intubation
963601|NCT03396081|Heart Failure|heart failure
963602|NCT03396081|Care pathway|care pathway
963603|NCT03396081|Transition program|transition program
963604|NCT03396081|Efficiency|efficiency
963605|NCT03396055|decompression surgery|decompression surgery
963606|NCT03396055|functional outcome|functional outcome
963607|NCT03396055|biomechanic|biomechanic
963608|NCT03396055|rehabilitation|rehabilitation
963609|NCT03396042|CEP290|cep290
963610|NCT03396042|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
963611|NCT03396042|LCA10|lca10
963612|NCT03396042|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
963613|NCT03396029|Lifestyle intervention|lifestyle intervention
963614|NCT03396029|Diet|diet
963615|NCT03396029|Smoking cessation|smoking cessation
963616|NCT03396029|Physical activity|physical activity
963617|NCT03396029|Alcohol|alcohol
963618|NCT03396029|Body mass index|body mass index
963619|NCT03396029|colorectal cancer screening|colorectal cancer screening
963620|NCT03396029|sigmoidoscopy|sigmoidoscopy
963621|NCT03395990|femoral nerve block|femoral nerve block
963622|NCT03395990|adductor canal block|adductor canal block
963623|NCT03395990|analgesia|analgesia
963624|NCT03395977|uric acid|uric acid
963625|NCT03395977|xanthin oxydoreductase|xanthin oxydoreductase
963626|NCT03395977|febuxostat|febuxostat
963627|NCT03395977|uricase|uricase
963628|NCT03395951|Mean Systemic Filling Pressure|mean systemic filling pressure
963629|NCT03395951|Diuretics|diuretics
963630|NCT03395951|Pressure for venous return|pressure for venous return
963631|NCT03395951|Fluid Balance|fluid balance
963632|NCT03395951|De-escalation fluid therapy|de-escalation fluid therapy
963633|NCT03395951|De-resuscitation|de-resuscitation
963634|NCT03395951|Guyton|guyton
963635|NCT03395951|Guytonian Approach|guytonian approach
963636|NCT03395951|Furosemide|furosemide
963637|NCT03395951|Cardiac Output|cardiac output
963638|NCT03395951|Cardiac Index|cardiac index
963639|NCT03395938|SCREENING|screening
963640|NCT03395925|Thyroid Nodule|thyroid nodule
963641|NCT03395925|Bipolar coagulation electrode|bipolar coagulation electrode
963642|NCT03395925|radiofrequency ablation|radiofrequency ablation
963643|NCT03395912|local anesthetics infiltration|local anesthetics infiltration
963644|NCT03395912|cesarean section pain relief|cesarean section pain relief
963645|NCT03395899|Atezolizumab|atezolizumab
963646|NCT03395899|Bevacizumab|bevacizumab
963647|NCT03395899|Cobimetinib|cobimetinib
963648|NCT03395899|Ipatasertib|ipatasertib
963649|NCT03395899|pre-operative|pre-operative
963650|NCT03395899|Window of opportunity|window of opportunity
963651|NCT03395886|noninvasive ventilation|noninvasive ventilation
963652|NCT03395886|remifentanil|remifentanil
963653|NCT03395886|dexmedetomidine|dexmedetomidine
963654|NCT03395886|cardiac surgery|cardiac surgery
963655|NCT03395860|GVHD|gvhd
963656|NCT03395860|ATG|atg
963657|NCT03395860|PTCy|ptcy
963658|NCT03395860|halo-HSCT|halo-hsct
963659|NCT03395847|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
963660|NCT03395847|Advanced gastroesophageal adenocarcinoma|advanced gastroesophageal adenocarcinoma
1652810|NCT00181090|seizures|seizures
963661|NCT03395847|Pembrolizumab|pembrolizumab
963662|NCT03395847|Keytruda|keytruda
963663|NCT03395847|MK-3475|mk-3475
963664|NCT03395847|Ramucirumab|ramucirumab
963665|NCT03395847|Ramucirumab DP|ramucirumab dp
963666|NCT03395847|IMC-1121B|imc-1121b
963667|NCT03395847|SCH-900475|sch-900475
963668|NCT03395821|competency-based education|competency-based education
963669|NCT03395821|gynecology|gynecology
963670|NCT03395821|laparoscopy|laparoscopy
963671|NCT03395821|resident education|resident education
963672|NCT03395821|simulation|simulation
963673|NCT03395821|surgical curriculum|surgical curriculum
963674|NCT03395795|Infantile Spinal Muscular Atrophy|infantile spinal muscular atrophy
963675|NCT03395795|Respiratory Decompensations|respiratory decompensations
963676|NCT03395756|Depot Medroxyprogesterone acetate|depot medroxyprogesterone acetate
963677|NCT03395756|Injectable birth control|injectable birth control
963678|NCT03395717|Stroke|stroke
963685|NCT03395691|axillary vein|axillary vein
963686|NCT03395691|central venous catheterization|central venous catheterization
963687|NCT03395691|ultrasound|ultrasound
963688|NCT03395691|cardiac surgery|cardiac surgery
963689|NCT03395691|complication|complication
963690|NCT03395678|Microneedling|microneedling
963691|NCT03395678|Nonablative fractional lasers|nonablative fractional lasers
963692|NCT03395678|Fitzpatrick skin types III-V|fitzpatrick skin types iii-v
963693|NCT03395678|Arophic acne scarring|arophic acne scarring
963694|NCT03395652|pregnancy, physical activity, fetal growth|pregnancy, physical activity, fetal growth
963695|NCT03395639|Children|children
963696|NCT03395639|Pediatrics|pediatrics
963697|NCT03395639|Cardiac disease with potential for thromboembolic complications|cardiac disease with potential for thromboembolic complications
963698|NCT03395639|Prophylactic treatment|prophylactic treatment
963699|NCT03395639|Anticoagulant drugs|anticoagulant drugs
963700|NCT03395587|glioblastoma,|glioblastoma,
963701|NCT03395587|immunotherapy|immunotherapy
963702|NCT03395587|dendritic cells|dendritic cells
963706|NCT03395535|Ocular Hypertension|ocular hypertension
963707|NCT03395535|POAG|poag
963708|NCT03395535|SLT|slt
963709|NCT03395535|Laser|laser
963710|NCT03395509|Mass screening|mass screening
963711|NCT03395509|cardiovascular disease|cardiovascular disease
963712|NCT03395509|diabetes|diabetes
963713|NCT03395496|pulpotomy|pulpotomy
963714|NCT03395496|pediatric dentistry|pediatric dentistry
963715|NCT03395496|primary molars|primary molars
963716|NCT03395483|peripheral perfusion|peripheral perfusion
963717|NCT03395483|Haemodynamic Instability|haemodynamic instability
963718|NCT03395483|mesenteric bloodflow|mesenteric bloodflow
963719|NCT03395431|Autologuous serum|autologuous serum
963720|NCT03395431|dry eyes disease|dry eyes disease
963721|NCT03395431|fingerprick blood|fingerprick blood
963722|NCT03395418|COPD|copd
963723|NCT03395418|Asthma|asthma
963724|NCT03395418|Inhaled Therapeutics|inhaled therapeutics
963725|NCT03395405|Efficacy|efficacy
963726|NCT03395405|Nitazoxanide|nitazoxanide
963727|NCT03395405|Norovirus|norovirus
963728|NCT03395405|Safety|safety
963729|NCT03395405|Treatment|treatment
963730|NCT03395379|Radiofrequency|radiofrequency
963731|NCT03395379|Thermal Protection|thermal protection
963732|NCT03395379|Percutaneous thermal ablation|percutaneous thermal ablation
963733|NCT03395379|Kidney neoplasms|kidney neoplasms
963734|NCT03395366|Hemodialysis|hemodialysis
963735|NCT03395366|End Stage Renal Disease|end stage renal disease
963741|NCT03395314|Borderline Personality Disorder|borderline personality disorder
963742|NCT03395314|Ketamine|ketamine
963743|NCT03395314|Suicide|suicide
963744|NCT03395314|Social Cognition|social cognition
963745|NCT03395301|hysteroscopy|hysteroscopy
963746|NCT03395301|fiber platinum coil|fiber platinum coil
963747|NCT03395301|tubal occlusion|tubal occlusion
963748|NCT03395288|UTI|uti
963749|NCT03395288|recurrent UTI|recurrent uti
963750|NCT03395249|safety|safety
963751|NCT03395249|tolerability|tolerability
963752|NCT03395249|pharmacokinetics|pharmacokinetics
963753|NCT03395249|SPR994|spr994
963754|NCT03395223|Acquired Methaemoglobinemia|acquired methaemoglobinemia
963755|NCT03395223|Methylene Blue|methylene blue
963756|NCT03395197|DDR (DNA damage repair), mCRPc (metastatic castration-resistant prostate cancer)|ddr (dna damage repair), mcrpc (metastatic castration-resistant prostate cancer)
963757|NCT03395119|Ozone exposure|ozone exposure
963758|NCT03395119|Healthy Adults|healthy adults
963759|NCT03395106|vaccine|vaccine
963760|NCT03395106|public health|public health
963761|NCT03395093|bronchoscopy|bronchoscopy
963762|NCT03395093|conscious sedation|conscious sedation
963763|NCT03395093|fentanyl|fentanyl
963764|NCT03395093|Bispectral Index|bispectral index
963765|NCT03395080|endometrioid histology|endometrioid histology
963766|NCT03395080|Wnt pathway|wnt pathway
963767|NCT03395080|DKK1|dkk1
963768|NCT03395067|Obesity|obesity
963769|NCT03395067|Infertility|infertility
963770|NCT03395067|In vitro fertilization|in vitro fertilization
963771|NCT03395054|neck pain|neck pain
963772|NCT03395054|pulmonary function test|pulmonary function test
963773|NCT03395054|respiratory muscle strength|respiratory muscle strength
963774|NCT03395054|cervical stabilization exercises|cervical stabilization exercises
963775|NCT03395041|vulnerable plaque, cardiac imaging, oral bacteria, inflammation|vulnerable plaque, cardiac imaging, oral bacteria, inflammation
963776|NCT03395028|Biliary Atresia|biliary atresia
963777|NCT03395028|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
963778|NCT03395028|GCSF|gcsf
963779|NCT03395015|Reconstructive surgical procedures|reconstructive surgical procedures
963780|NCT03395015|Therapy, soft tissue|therapy, soft tissue
963781|NCT03395015|Treatment outcome|treatment outcome
963782|NCT03395015|Outcome Assessment (Health Care)|outcome assessment (health care)
963783|NCT03395015|Photogrammetry|photogrammetry
963784|NCT03395015|Physical Appearance, Body|physical appearance, body
963785|NCT03395002|Tiotropium|tiotropium
963786|NCT03395002|Salmeterol|salmeterol
963787|NCT03395002|Fluticasone|fluticasone
963788|NCT03395002|COPD|copd
963789|NCT03395002|Bronchodilator effect|bronchodilator effect
963790|NCT03395002|Discair|discair
963791|NCT03395002|Diskus|diskus
963792|NCT03395002|Spirometry|spirometry
963793|NCT03394963|Food-Based Dietary guideline|food-based dietary guideline
963794|NCT03394963|Healthy Eating Index|healthy eating index
963795|NCT03394963|Healthy Diet|healthy diet
963796|NCT03394963|Protocol|protocol
963797|NCT03394963|Ethiopia|ethiopia
963798|NCT03394950|thrombolysis|thrombolysis
963799|NCT03394950|Butyphthalide|butyphthalide
963800|NCT03394924|PBC|pbc
963801|NCT03394924|Primary Ciliary Cholangitis (PBC)|primary ciliary cholangitis (pbc)
963802|NCT03394898|Chronic Pain|chronic pain
963803|NCT03394898|Body Mass Index|body mass index
963804|NCT03394898|Eating Habits|eating habits
963805|NCT03394872|Pleural effusion|pleural effusion
963806|NCT03394872|Mechanical Ventilation|mechanical ventilation
963807|NCT03394872|Ultrasonography|ultrasonography
963808|NCT03394872|Drainage|drainage
963809|NCT03394833|preoperative|preoperative
963810|NCT03394833|fluid therapy|fluid therapy
963811|NCT03394833|hemodynamics|hemodynamics
963812|NCT03394833|anesthesia induction|anesthesia induction
963813|NCT03394833|rapid sequence induction|rapid sequence induction
963814|NCT03394833|TCI|tci
963815|NCT03394820|Dexamethasone|dexamethasone
963816|NCT03394820|Supraclavicular block|supraclavicular block
963817|NCT03394794|anorectal physiology|anorectal physiology
963818|NCT03394794|therapies|therapies
963819|NCT03394794|quality fo life|quality fo life
963820|NCT03394755|thrombocytopenia|thrombocytopenia
963821|NCT03394755|bleeding|bleeding
963822|NCT03394742|Peer Group|peer group
963823|NCT03394742|Quality of Life|quality of life
963824|NCT03394729|Propole|propole
963825|NCT03394729|Xylitol|xylitol
963826|NCT03394729|Saliva|saliva
963827|NCT03394716|MRI|mri
963828|NCT03394716|Radiotherapy|radiotherapy
963829|NCT03394703|Lung cancer|lung cancer
963830|NCT03394703|screening|screening
963831|NCT03394703|Low-dose Computed Tomography|low-dose computed tomography
963832|NCT03394703|Smokers|smokers
963833|NCT03394664|Body composition|body composition
963834|NCT03394664|Feeding study|feeding study
963835|NCT03394664|Ketogenic diet|ketogenic diet
963836|NCT03394664|Weight loss|weight loss
963837|NCT03394664|Energy Expenditure|energy expenditure
963838|NCT03394651|male|male
963839|NCT03394651|lower urinary tract symptoms|lower urinary tract symptoms
963840|NCT03394651|comorbidities|comorbidities
963841|NCT03394651|chronic kidney diseases|chronic kidney diseases
963842|NCT03394651|urodynamics|urodynamics
963843|NCT03394651|medical therapy|medical therapy
963844|NCT03394651|surgical treatment|surgical treatment
963845|NCT03394638|eHealth|ehealth
963846|NCT03394638|Bariatric surgery|bariatric surgery
963847|NCT03394638|Obesity|obesity
963848|NCT03394638|Telemedicine|telemedicine
963849|NCT03394625|Socket Shield|socket shield
963850|NCT03394625|immediate implant|immediate implant
963851|NCT03394625|ridge preservation|ridge preservation
963852|NCT03394612|Scar|scar
963853|NCT03394612|Skin|skin
963854|NCT03394612|Wound Healing|wound healing
963855|NCT03394612|Tissue Engineering|tissue engineering
963856|NCT03394612|Dermis|dermis
963857|NCT03394612|Epidermis|epidermis
963858|NCT03394599|Physical Activity|physical activity
963859|NCT03394599|Rehabilitation|rehabilitation
963860|NCT03394599|Exercise|exercise
963861|NCT03394599|Engagement|engagement
963862|NCT03394599|Older Adults|older adults
963863|NCT03394586|Golimumab|golimumab
963864|NCT03394586|TNF-inhibitors|tnf-inhibitors
963865|NCT03394586|Clinical Response|clinical response
963866|NCT03394586|Clinical Remission|clinical remission
963867|NCT03394586|Ulcerative Colitis|ulcerative colitis
963868|NCT03394573|Diabetic macular edema|diabetic macular edema
963869|NCT03394560|Spinal Cord Injury|spinal cord injury
963870|NCT03394560|transcranial magnetic stimulation|transcranial magnetic stimulation
963871|NCT03394560|body weight-support treadmill training|body weight-support treadmill training
963872|NCT03394560|gait|gait
963873|NCT03394534|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
963874|NCT03394534|Frailty|frailty
963875|NCT03394534|electronic Frailty Index|electronic frailty index
963876|NCT03394534|eFI|efi
963877|NCT03394534|Care and Support plan|care and support plan
963878|NCT03394534|Primary Care|primary care
963879|NCT03394521|glaucoma suspect|glaucoma suspect
963880|NCT03394521|ocular hypertension|ocular hypertension
963881|NCT03394521|progression|progression
963882|NCT03394495|Fatigue|fatigue
963883|NCT03394495|Frailty|frailty
963884|NCT03394495|Cluster-RCT|cluster-rct
963891|NCT03394430|midazolam|midazolam
963892|NCT03394430|dexmedetomidine|dexmedetomidine
963893|NCT03394404|ECG-I Mapping Pulmonary Vein Isolation|ecg-i mapping pulmonary vein isolation
963894|NCT03394391|Adherence|adherence
963895|NCT03394391|Adolescents|adolescents
963896|NCT03394391|Antiretroviral therapy|antiretroviral therapy
963897|NCT03394391|HIV|hiv
963898|NCT03394391|Nigeria|nigeria
963899|NCT03394391|Randomized controlled trial|randomized controlled trial
963900|NCT03394391|Short message services|short message services
963901|NCT03394365|Solid organ transplant|solid organ transplant
963902|NCT03394365|EBV-PTLD|ebv-ptld
963903|NCT03394365|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
963904|NCT03394365|SOT|sot
963905|NCT03394365|Lymphoproliferative disorders|lymphoproliferative disorders
963906|NCT03394365|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
963907|NCT03394365|EBV-CTL|ebv-ctl
963908|NCT03394365|Epstein-Barr Virus|epstein-barr virus
963909|NCT03394365|Kidney transplant|kidney transplant
963910|NCT03394365|Renal transplant|renal transplant
963911|NCT03394365|Liver transplant|liver transplant
963912|NCT03394365|Heart transplant|heart transplant
963913|NCT03394365|Lung transplant|lung transplant
963914|NCT03394365|Intestinal transplant|intestinal transplant
963915|NCT03394365|Pancreas transplant|pancreas transplant
963916|NCT03394365|Organ transplant complications|organ transplant complications
963917|NCT03394365|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
963918|NCT03394365|EBV-LPD|ebv-lpd
963919|NCT03394365|Post-transplant lymphoma|post-transplant lymphoma
964210|NCT03392493|Stroke|stroke
963920|NCT03394365|Cancer after transplant|cancer after transplant
963921|NCT03394352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
963922|NCT03394352|Insulin pump|insulin pump
963923|NCT03394352|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
963924|NCT03394352|Exercise|exercise
963925|NCT03394352|Activity on Board|activity on board
963926|NCT03394352|Decision Support System|decision support system
963927|NCT03394339|Systematic review and meta-anaylsis|systematic review and meta-anaylsis
963928|NCT03394339|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
963929|NCT03394339|Dietary guidelines|dietary guidelines
963930|NCT03394339|Fruit|fruit
963931|NCT03394339|Vegetables|vegetables
963932|NCT03394313|Registry|registry
963933|NCT03394274|transfusion|transfusion
963934|NCT03394274|liberal|liberal
963935|NCT03394274|restrictive|restrictive
963936|NCT03394261|Opioid Use Disorder (OUD)|opioid use disorder (oud)
963937|NCT03394261|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
963938|NCT03394261|Patient Decision Aid|patient decision aid
963939|NCT03394248|Subconcussive head injury|subconcussive head injury
963940|NCT03394235|hair transplant|hair transplant
963941|NCT03394235|hairline|hairline
963942|NCT03394235|laser hair removal|laser hair removal
963943|NCT03394209|Favipiravir, Influenza, Human, Critical Illness, Pharmacokinetics|favipiravir, influenza, human, critical illness, pharmacokinetics
963944|NCT03394183|cardiac rehabilitation|cardiac rehabilitation
963945|NCT03394183|cardiorespiratory fitness|cardiorespiratory fitness
963946|NCT03394183|functional capacity|functional capacity
963947|NCT03394183|acute exercise response|acute exercise response
963948|NCT03394183|quality of life|quality of life
963949|NCT03394157|sleeve gastrectomy , MGB , type 2 diabetes , obesity , SASI|sleeve gastrectomy , mgb , type 2 diabetes , obesity , sasi
963950|NCT03394118|T790 mutation|t790 mutation
963951|NCT03394118|Liquid biopsy|liquid biopsy
963952|NCT03394105|Pleurodesis|pleurodesis
963953|NCT03394092|immunoglobulin G|immunoglobulin g
963954|NCT03394079|OCT|oct
963955|NCT03394079|IVUS|ivus
963956|NCT03394079|PCI|pci
963959|NCT03394053|PID|pid
963960|NCT03394053|Immune Deficiency|immune deficiency
963961|NCT03394053|Molecular Biology|molecular biology
963962|NCT03394053|T-Cell Lymphocytopenia|t-cell lymphocytopenia
963963|NCT03394053|Genetic Biology|genetic biology
963967|NCT03394027|Impiridones|impiridones
963968|NCT03394027|TNBC|tnbc
963969|NCT03394027|Metastatic|metastatic
963970|NCT03394027|Male Breast Cancer|male breast cancer
963971|NCT03393988|Transversus abdominis plane block,|transversus abdominis plane block,
963972|NCT03393988|Dexmedetomidine|dexmedetomidine
963973|NCT03393988|Fentanyl|fentanyl
963974|NCT03393988|Live liver donor|live liver donor
963975|NCT03393988|Liver transplantation|liver transplantation
963976|NCT03393962|Ovarian cancer|ovarian cancer
963977|NCT03393962|Cytotoxic lymphocyte|cytotoxic lymphocyte
963978|NCT03393962|Cancer specific antigen|cancer specific antigen
963979|NCT03393949|Methylprednisolone|methylprednisolone
963980|NCT03393949|Postoperative cognitive function|postoperative cognitive function
963981|NCT03393949|Immunological function|immunological function
963982|NCT03393897|fluid responsiveness|fluid responsiveness
963983|NCT03393897|cardiac surgery|cardiac surgery
963984|NCT03393832|Oral care|oral care
963985|NCT03393832|Oropharyngeal mother's milk|oropharyngeal mother's milk
963986|NCT03393819|antimicrobial skin solution|antimicrobial skin solution
963987|NCT03393819|skin preparation|skin preparation
963988|NCT03393806|Asthma Control Questionnaire|asthma control questionnaire
963989|NCT03393806|Allergic fungal airway disease|allergic fungal airway disease
963990|NCT03393806|Asthma Quality of Life Questionnaire|asthma quality of life questionnaire
963991|NCT03393806|Holter monitoring|holter monitoring
963992|NCT03393806|Asthma|asthma
963993|NCT03393793|Heart transplantation|heart transplantation
963994|NCT03393767|CNV|cnv
963995|NCT03393767|AMD|amd
963996|NCT03393767|ranibizumab|ranibizumab
963997|NCT03393754|Hepatitis B Vaccines|hepatitis b vaccines
963998|NCT03393741|Metastatic breast cancer|metastatic breast cancer
963999|NCT03393728|hyperthyroidism|hyperthyroidism
964000|NCT03393728|heart rate variability|heart rate variability
964001|NCT03393728|propanolol|propanolol
964002|NCT03393728|Africa|africa
964003|NCT03393715|Diabetes|diabetes
964004|NCT03393715|Hypertension|hypertension
964005|NCT03393715|Perindopril|perindopril
964006|NCT03393715|chronobiology|chronobiology
964007|NCT03393715|Africa|africa
964008|NCT03393702|Postoperative pain|postoperative pain
964009|NCT03393702|Anxiety|anxiety
964010|NCT03393702|Postoperative Complications|postoperative complications
964011|NCT03393702|Patient Satisfaction|patient satisfaction
964012|NCT03393689|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
964013|NCT03393689|Angiogenesis PET/MR|angiogenesis pet/mr
964014|NCT03393689|Acoustic Neuroma|acoustic neuroma
964015|NCT03393676|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
964016|NCT03393676|elderly patients|elderly patients
964017|NCT03393676|Preoperative Pain|preoperative pain
964018|NCT03393663|chronic kidney disease|chronic kidney disease
964019|NCT03393663|cardiovascular disease|cardiovascular disease
964020|NCT03393663|mortality|mortality
964021|NCT03393663|end stage renal disease|end stage renal disease
964022|NCT03393650|exercise|exercise
964023|NCT03393650|protein|protein
964024|NCT03393650|muscle function|muscle function
964025|NCT03393650|aging|aging
964026|NCT03393637|prenatal anxiety|prenatal anxiety
964027|NCT03393637|pregnancy|pregnancy
964028|NCT03393637|depression|depression
964029|NCT03393637|military|military
964030|NCT03393637|intervention|intervention
964031|NCT03393624|Dark circles|dark circles
964032|NCT03393624|Periorbital hyperchromia|periorbital hyperchromia
964033|NCT03393624|Sleep Quality|sleep quality
964034|NCT03393624|Facial aesthetics|facial aesthetics
964035|NCT03393585|Respiratory Rates|respiratory rates
964036|NCT03393546|pain|pain
964037|NCT03393546|acupressure|acupressure
964038|NCT03393546|alzheimer|alzheimer
964039|NCT03393533|Third molar;|third molar;
964040|NCT03393533|Oral surgery;|oral surgery;
964041|NCT03393533|Pain;|pain;
964042|NCT03393533|Edema;|edema;
964043|NCT03393533|Trismus.|trismus.
964044|NCT03393520|Agitation|agitation
964045|NCT03393520|Dementia of the Alzheimer's type|dementia of the alzheimer's type
964046|NCT03393520|Alzheimer's disease|alzheimer's disease
964047|NCT03393520|AVP-786|avp-786
964048|NCT03393520|Deudextromethorphan hydrobromide|deudextromethorphan hydrobromide
964049|NCT03393520|Quinidine sulfate|quinidine sulfate
964050|NCT03393507|ovarian cancer|ovarian cancer
964051|NCT03393481|biologic,|biologic,
964052|NCT03393481|venous thromboembolism,|venous thromboembolism,
964053|NCT03393481|unilateral knee arthroplasty|unilateral knee arthroplasty
964054|NCT03393455|Fetal pathology|fetal pathology
964055|NCT03393455|Obstetrical outcome|obstetrical outcome
964056|NCT03393455|Pediatric outcome|pediatric outcome
964057|NCT03393442|Magnetic Resonance Imaging|magnetic resonance imaging
964058|NCT03393442|Gd-based contrast media|gd-based contrast media
964059|NCT03393442|Gd-deposits|gd-deposits
964060|NCT03393442|brain imaging|brain imaging
964061|NCT03393442|breast cancer screening|breast cancer screening
964062|NCT03393416|MASCT-I|masct-i
964063|NCT03393403|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
964064|NCT03393377|arterial stiffness|arterial stiffness
964065|NCT03393377|endothelial dysfunction|endothelial dysfunction
964066|NCT03393377|fluvastatin|fluvastatin
964067|NCT03393377|valsartan|valsartan
964068|NCT03393377|inflammatory markers|inflammatory markers
964069|NCT03393377|oxidative stress|oxidative stress
964070|NCT03393377|SIRT1|sirt1
964071|NCT03393351|Shared Decision-Making|shared decision-making
964072|NCT03393351|Decision Making|decision making
964073|NCT03393351|Patient Participation|patient participation
964074|NCT03393351|Patient Centeredness|patient centeredness
964075|NCT03393351|Health Services Research|health services research
1653005|NCT00179829|leukemia|leukemia
964076|NCT03393351|Implementation Research|implementation research
964077|NCT03393351|Oncology|oncology
964078|NCT03393351|Stepped Wedge Design|stepped wedge design
964079|NCT03393351|Mixed Methods|mixed methods
964080|NCT03393338|Diabetes|diabetes
964081|NCT03393338|African American|african american
964082|NCT03393338|Emergency Department visits|emergency department visits
964083|NCT03393312|Transcranial direct current stimulation|transcranial direct current stimulation
964084|NCT03393312|Biological Psychiatry|biological psychiatry
964085|NCT03393312|Depression|depression
964086|NCT03393312|Decision-making|decision-making
964087|NCT03393299|elderly people|elderly people
964088|NCT03393299|geriatric short-stay|geriatric short-stay
964089|NCT03393299|STOPP/START criteria|stopp/start criteria
964090|NCT03393273|Stem Cell autologous graft|stem cell autologous graft
964091|NCT03393273|Elotuzumab|elotuzumab
964092|NCT03393273|Multiple myeloma|multiple myeloma
964093|NCT03393273|Elderly|elderly
964094|NCT03393260|cancer|cancer
964095|NCT03393260|emergency departments (ED)|emergency departments (ed)
964096|NCT03393247|infliximab|infliximab
964097|NCT03393247|azathioprine|azathioprine
964098|NCT03393234|Ultra-low rectal cancer|ultra-low rectal cancer
964099|NCT03393234|Intersphincteric resection|intersphincteric resection
964100|NCT03393234|IORT|iort
964101|NCT03393208|Diabetes Mellitus|diabetes mellitus
964102|NCT03393208|Glucophage Immediate Release (GIR)|glucophage immediate release (gir)
964103|NCT03393208|Bioequivalence Study|bioequivalence study
964104|NCT03393195|Weight loss|weight loss
964105|NCT03393195|Diet|diet
964106|NCT03393195|Time-restricted feeding|time-restricted feeding
964107|NCT03393143|Primary Health Care; Analgesics, Opioid; Medicaid|primary health care; analgesics, opioid; medicaid
964108|NCT03393130|Burns|burns
964109|NCT03393130|Young Adult|young adult
964110|NCT03393130|Cognitive Impairment|cognitive impairment
964111|NCT03393130|Apolipoprotein E, Deficiency or Defect of|apolipoprotein e, deficiency or defect of
964112|NCT03393130|Intensive Care Neurological Disorder|intensive care neurological disorder
964113|NCT03393130|Quality of Life|quality of life
964114|NCT03393130|Inflammation, Brain|inflammation, brain
964115|NCT03393117|Reconstruction|reconstruction
964116|NCT03393117|Bupivacaine|bupivacaine
964117|NCT03393117|Liposomal Bupivacaine|liposomal bupivacaine
964405|NCT03391557|Diagnosis|diagnosis
964118|NCT03393104|Chronic Low Back Pain|chronic low back pain
964119|NCT03393104|Motor Control Exercise|motor control exercise
964120|NCT03393104|Patient Education|patient education
964121|NCT03393065|lung ultrasounds|lung ultrasounds
964122|NCT03393065|fluid managements|fluid managements
964123|NCT03393065|critical care patients|critical care patients
964124|NCT03393052|L-RECORD|l-record
964125|NCT03393052|Radial|radial
964126|NCT03393052|Femoral|femoral
964127|NCT03393052|CABG|cabg
964128|NCT03393052|coronary artery bypass graft|coronary artery bypass graft
964129|NCT03393039|fMRI|fmri
964130|NCT03393039|Reward|reward
964131|NCT03393039|Food Choices|food choices
964132|NCT03393039|Negative Affect|negative affect
964133|NCT03393013|immunoproteasome inhibition|immunoproteasome inhibition
964134|NCT03393013|selective proteasome inhibition|selective proteasome inhibition
964135|NCT03393013|proteasome|proteasome
964136|NCT03392987|GSK2696274|gsk2696274
964137|NCT03392987|Cryopreserved formulation|cryopreserved formulation
964138|NCT03392987|Gene therapy|gene therapy
964139|NCT03392987|Metachromatic leukodystrophy|metachromatic leukodystrophy
964140|NCT03392974|Hemophilia A|hemophilia a
964141|NCT03392974|Gene Therapy|gene therapy
964142|NCT03392974|Clotting Disorders|clotting disorders
964143|NCT03392974|Blood Disorder|blood disorder
964144|NCT03392974|Blood Coagulation Disorders|blood coagulation disorders
964145|NCT03392974|Inherited Blood Coagulation Disorders|inherited blood coagulation disorders
964146|NCT03392974|Hematologic Diseases|hematologic diseases
964147|NCT03392974|Coagulation Protein Disorders|coagulation protein disorders
964148|NCT03392974|Hemorrhagic Disorders|hemorrhagic disorders
964149|NCT03392974|Genetic Diseases|genetic diseases
964150|NCT03392974|Inborn|inborn
964151|NCT03392974|Factor VIII|factor viii
964152|NCT03392974|Coagulants|coagulants
964153|NCT03392961|Oral insulin|oral insulin
964154|NCT03392961|Dosing time|dosing time
964155|NCT03392961|Insulin concentration|insulin concentration
964156|NCT03392961|Prandial insulin|prandial insulin
964157|NCT03392961|Post Prandial Glucose (PPG)|post prandial glucose (ppg)
964158|NCT03392948|atrial fibrillation|atrial fibrillation
964159|NCT03392948|prosthetic valves|prosthetic valves
964160|NCT03392948|pulmonary embolism|pulmonary embolism
964161|NCT03392948|venous thrombosis|venous thrombosis
964162|NCT03392948|percutaneous coronary interventions|percutaneous coronary interventions
964163|NCT03392948|chronic anticoagulant treatment|chronic anticoagulant treatment
964164|NCT03392909|Nonsense Mutations|nonsense mutations
964165|NCT03392883|Latin America|latin america
964166|NCT03392883|Depression|depression
964167|NCT03392883|mHealth|mhealth
964168|NCT03392883|Problematic Alcohol Use|problematic alcohol use
1653115|NCT00179517|Hormone|hormone
964169|NCT03392870|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
964170|NCT03392870|Transition program|transition program
964171|NCT03392857|Critical care|critical care
964172|NCT03392831|Central Venous Catheters|central venous catheters
964173|NCT03392831|Vascular Access Devices|vascular access devices
964174|NCT03392831|Nursing|nursing
964175|NCT03392831|Cost Effectiveness|cost effectiveness
964176|NCT03392831|PICC|picc
964177|NCT03392766|fibreoptic intubation|fibreoptic intubation
964178|NCT03392766|double lumen tube|double lumen tube
964179|NCT03392766|difficult intubation|difficult intubation
964180|NCT03392714|Bendamustine|bendamustine
964181|NCT03392714|CSF|csf
964182|NCT03392714|Pharmacokinetics|pharmacokinetics
964183|NCT03392714|PCNSL|pcnsl
964184|NCT03392714|Salvage therapy|salvage therapy
964185|NCT03392688|onset , hamstring muscles, patellofemoral pain|onset , hamstring muscles, patellofemoral pain
964186|NCT03392675|Breast and Nipple Pain|breast and nipple pain
964187|NCT03392675|Quantitative Sensory Testing|quantitative sensory testing
964188|NCT03392675|Genotyping|genotyping
964189|NCT03392675|Breastfeeding|breastfeeding
964190|NCT03392649|Postoperative Atrial Fibrillation|postoperative atrial fibrillation
964191|NCT03392649|Tragus Stimulation|tragus stimulation
964192|NCT03392623|Epigenetics, Malar melasma,|epigenetics, malar melasma,
964193|NCT03392610|Intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection|intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection
964194|NCT03392584|Locally advanced rectal cancer|locally advanced rectal cancer
964195|NCT03392584|Deep infection|deep infection
964196|NCT03392584|Microdialysis|microdialysis
964197|NCT03392584|Surgical site infection|surgical site infection
964198|NCT03392571|Resectable pancreatic cancer, NGC-triple regimen|resectable pancreatic cancer, ngc-triple regimen
964199|NCT03392545|recurrent GBM; radiation; immunotherapy|recurrent gbm; radiation; immunotherapy
964200|NCT03392532|Astigmatism|astigmatism
964201|NCT03392532|Axis orientation|axis orientation
964202|NCT03392519|Brain connectivity|brain connectivity
964203|NCT03392519|Magnetic resonance imaging|magnetic resonance imaging
964204|NCT03392519|Brain plasticity|brain plasticity
964205|NCT03392519|Recovery|recovery
964206|NCT03392506|CP-EBUS|cp-ebus
964207|NCT03392506|EBUS-TBNA|ebus-tbna
964208|NCT03392506|Real time elasticity|real time elasticity
964209|NCT03392506|Staging of lung cancer|staging of lung cancer
964211|NCT03392493|Robotic rehabilitation|robotic rehabilitation
964212|NCT03392493|Hand function|hand function
964213|NCT03392493|Activities of Daily Living|activities of daily living
964214|NCT03392454|Partial Trapeziectomy|partial trapeziectomy
964215|NCT03392454|Tendon Interposition|tendon interposition
964216|NCT03392454|Trapeziectomy|trapeziectomy
964217|NCT03392454|Thumb Carpometacarpal Joint|thumb carpometacarpal joint
964218|NCT03392441|dementia|dementia
964219|NCT03392441|cognition|cognition
964220|NCT03392441|insulin|insulin
964221|NCT03392441|adolescent|adolescent
964222|NCT03392415|chronic total occlusion|chronic total occlusion
964223|NCT03392415|CTO|cto
964224|NCT03392415|PCI|pci
964225|NCT03392415|percutaneus coronary intervention|percutaneus coronary intervention
964226|NCT03392402|Thyroid nodule|thyroid nodule
964227|NCT03392402|Indeterminate thyroid nodule|indeterminate thyroid nodule
964228|NCT03392402|Molecular biopsy|molecular biopsy
964229|NCT03392402|Gene expression classifier|gene expression classifier
964230|NCT03392389|mRNA-1653|mrna-1653
964231|NCT03392389|human metapneumovirus|human metapneumovirus
964232|NCT03392389|human parainfluenza vaccine|human parainfluenza vaccine
964233|NCT03392376|ICU Delirium|icu delirium
964234|NCT03392376|Haloperidol|haloperidol
964235|NCT03392324|atrophic macular degeneration|atrophic macular degeneration
964236|NCT03392324|geographic atrophy|geographic atrophy
964237|NCT03392324|retina implant|retina implant
964238|NCT03392324|retinal prosthesis|retinal prosthesis
964239|NCT03392324|visual prosthesis|visual prosthesis
964240|NCT03392324|macular degeneration|macular degeneration
964241|NCT03392324|dry macular degeneration|dry macular degeneration
964242|NCT03392324|AMD|amd
964243|NCT03392298|Thalassemia|thalassemia
964244|NCT03392298|Pregnancy|pregnancy
964245|NCT03392298|Globin expression|globin expression
964246|NCT03392298|Colla corii asini|colla corii asini
964247|NCT03392272|Ptosis|ptosis
964248|NCT03392272|Müller's Muscle-Conjunctival Resection (MMCR)|müller's muscle-conjunctival resection (mmcr)
964249|NCT03392272|Fibrin Glue|fibrin glue
964250|NCT03392246|Non-Small Cell Lung Cancer|non-small cell lung cancer
964251|NCT03392233|spinal metastases|spinal metastases
964252|NCT03392233|Stereotactic body radiation therapy(SBRT)|stereotactic body radiation therapy(sbrt)
964253|NCT03392233|breast cancer|breast cancer
964254|NCT03392233|prostate cancer|prostate cancer
964255|NCT03392233|non small cell lung cancer|non small cell lung cancer
964256|NCT03392220|clinically negative neck|clinically negative neck
964257|NCT03392220|regional control rate|regional control rate
964258|NCT03392194|Behavioral interventions|behavioral interventions
964259|NCT03392194|Sleep hygiene|sleep hygiene
964260|NCT03392194|Yoga|yoga
964261|NCT03392194|Community research|community research
964262|NCT03392194|Short sleep duration|short sleep duration
964263|NCT03392194|Low-income population|low-income population
964264|NCT03392168|Psoriasis|psoriasis
964265|NCT03392168|Plaque Psoriasis|plaque psoriasis
964266|NCT03392142|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
964267|NCT03392142|EBV-LPD|ebv-lpd
964364|NCT03391778|SPEAR T Cell|spear t cell
964268|NCT03392142|Lymphoproliferative Disorders|lymphoproliferative disorders
964269|NCT03392142|Epstein-Barr Virus|epstein-barr virus
964270|NCT03392142|EBV-PTLD|ebv-ptld
964271|NCT03392142|alloHCT|allohct
964272|NCT03392142|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
964273|NCT03392142|EBV-associated PTLD|ebv-associated ptld
964274|NCT03392142|Post-transplant lymphoma|post-transplant lymphoma
964275|NCT03392142|HCT|hct
964276|NCT03392142|HSCT|hsct
964277|NCT03392142|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
964278|NCT03392142|EBV-CTL|ebv-ctl
964279|NCT03392142|Hematopoietic Cell Transplant|hematopoietic cell transplant
964280|NCT03392142|Stem cell transplant|stem cell transplant
964281|NCT03392142|Bone marrow transplant complications|bone marrow transplant complications
964282|NCT03392142|Cancer after transplant|cancer after transplant
964283|NCT03392142|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
964284|NCT03392129|Asthma|asthma
964285|NCT03392129|Child|child
964286|NCT03392129|respiratory exercises|respiratory exercises
964287|NCT03392129|Hydrotherapy|hydrotherapy
964288|NCT03392129|Physical Therapy Specialty|physical therapy specialty
964289|NCT03392129|Sleep|sleep
964290|NCT03392129|Quality of life|quality of life
964291|NCT03392129|Anxiety|anxiety
964292|NCT03392129|Spirometry|spirometry
964293|NCT03392129|Clinical trial|clinical trial
964294|NCT03392103|Raltitrexed|raltitrexed
964295|NCT03392103|IMRT|imrt
964296|NCT03392090|Cancer|cancer
964297|NCT03392064|AMG 119|amg 119
964298|NCT03392064|CART|cart
964299|NCT03392064|DLL3|dll3
964300|NCT03392012|anesthesia, patient safety, respiratory complications|anesthesia, patient safety, respiratory complications
964301|NCT03391999|Mental Health, Physical Health|mental health, physical health
964302|NCT03391973|CUP|cup
964303|NCT03391973|Pembrolizumab|pembrolizumab
964304|NCT03391973|KEYTRUDA|keytruda
964305|NCT03391960|CLABSI|clabsi
964306|NCT03391960|Septicemia|septicemia
964307|NCT03391960|Bloodstream infection|bloodstream infection
964308|NCT03391960|Central line associated bloodstream infection|central line associated bloodstream infection
964309|NCT03391960|Catheter related bloodstream infection|catheter related bloodstream infection
964310|NCT03391960|Intravascular device|intravascular device
964311|NCT03391960|Catheter port|catheter port
964312|NCT03391947|gingival recession|gingival recession
964313|NCT03391947|semilunar coronally flap|semilunar coronally flap
964314|NCT03391947|coronally advanced flap|coronally advanced flap
964315|NCT03391934|RAS Wild-type|ras wild-type
964316|NCT03391934|Cetuximab|cetuximab
964317|NCT03391934|Metastatic Colorectal Cancer|metastatic colorectal cancer
964318|NCT03391921|vaccine|vaccine
964319|NCT03391921|woman|woman
964320|NCT03391908|vulnerable plaques, acute coronary syndromes, NSTEMI, vulnerable patient|vulnerable plaques, acute coronary syndromes, nstemi, vulnerable patient
964321|NCT03391895|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
964322|NCT03391895|Scoliosis|scoliosis
964323|NCT03391895|Inspiratory Muscle Training|inspiratory muscle training
964324|NCT03391895|Exercise Training|exercise training
964325|NCT03391895|Respiratory Exercise Training|respiratory exercise training
964326|NCT03391895|Pulmonary Function Test|pulmonary function test
964327|NCT03391895|6-Minute Walk test|6-minute walk test
964328|NCT03391895|Respiratory Muscle Strength|respiratory muscle strength
964329|NCT03391882|Parkinson's Disease|parkinson's disease
964330|NCT03391882|"Off Episodes"|"off episodes"
964331|NCT03391882|motor fluctuations associated with Parkinson's Disease|motor fluctuations associated with parkinson's disease
964332|NCT03391869|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
964333|NCT03391869|Non-small cell lung cancer|non-small cell lung cancer
964334|NCT03391869|NSCLC|nsclc
964335|NCT03391869|Ipilimumab|ipilimumab
964336|NCT03391869|Yervoy|yervoy
964337|NCT03391869|BMS-734016|bms-734016
964338|NCT03391869|MDX010|mdx010
964339|NCT03391869|Nivolumab|nivolumab
964340|NCT03391869|BMS-936558|bms-936558
964341|NCT03391869|Opdivo|opdivo
964342|NCT03391869|Local Consolidative Therapy|local consolidative therapy
964343|NCT03391869|LCT|lct
964344|NCT03391843|Local Advanced Rectal Cancer|local advanced rectal cancer
964345|NCT03391843|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
964346|NCT03391843|FOLFOXIRI|folfoxiri
964347|NCT03391843|Cetuximab|cetuximab
964348|NCT03391843|EGFR wild type|egfr wild type
964349|NCT03391804|Oxalate|oxalate
964350|NCT03391804|Kidney Stones|kidney stones
964351|NCT03391804|oxalate nephropathy|oxalate nephropathy
964352|NCT03391804|systemic oxalosis|systemic oxalosis
964353|NCT03391791|Cell Therapy|cell therapy
964354|NCT03391791|T Cell Therapy|t cell therapy
964355|NCT03391791|SPEAR T Cell|spear t cell
964356|NCT03391791|Immuno-oncology|immuno-oncology
964357|NCT03391791|Metastatic|metastatic
964358|NCT03391791|T Cell Receptor|t cell receptor
964359|NCT03391791|Long Term Follow Up|long term follow up
964360|NCT03391791|Genetically Engineered|genetically engineered
964361|NCT03391778|Solid and Hematological Malignancies|solid and hematological malignancies
964362|NCT03391778|Cell Therapy|cell therapy
964363|NCT03391778|T Cell Therapy|t cell therapy
964365|NCT03391778|Immuno-oncology|immuno-oncology
964366|NCT03391778|NY-ESO-1|ny-eso-1
964367|NCT03391778|Metastatic|metastatic
964368|NCT03391778|Previously Treated|previously treated
964369|NCT03391778|T Cell Receptor|t cell receptor
964371|NCT03391778|Long Term Follow Up|long term follow up
964372|NCT03391778|Genetically engineered|genetically engineered
964373|NCT03391765|tauopathy|tauopathy
964374|NCT03391765|Steele-Richardson-Olszewski Syndrome|steele-richardson-olszewski syndrome
964376|NCT03391752|malnutrition, screening, assessment, treatment|malnutrition, screening, assessment, treatment
964377|NCT03391713|awareness|awareness
964378|NCT03391713|poster|poster
964379|NCT03391713|stroke|stroke
964380|NCT03391700|muscle relaxant|muscle relaxant
964381|NCT03391687|Gastric Cancer|gastric cancer
964382|NCT03391687|Pancreatic Fistula|pancreatic fistula
964383|NCT03391687|Gastrectomy|gastrectomy
964384|NCT03391635|acupuncture|acupuncture
964385|NCT03391635|functional constipation|functional constipation
964386|NCT03391635|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
964387|NCT03391635|randomized controlled trial|randomized controlled trial
964388|NCT03391622|thrombin generation|thrombin generation
964389|NCT03391622|calibrated automated thrombogram|calibrated automated thrombogram
964390|NCT03391622|ischemic heart disease|ischemic heart disease
964391|NCT03391622|Percutaneous Coronary Intervention|percutaneous coronary intervention
964392|NCT03391596|Family caregivers|family caregivers
964393|NCT03391596|Depressive symptoms|depressive symptoms
964394|NCT03391596|Psychological wellbeing|psychological wellbeing
964395|NCT03391596|Internet-based intervention|internet-based intervention
964396|NCT03391596|Acceptance and Commitment Therapy|acceptance and commitment therapy
964397|NCT03391583|Education|education
964398|NCT03391583|Pain|pain
964399|NCT03391570|Laparoscopic surgery|laparoscopic surgery
964400|NCT03391570|COX-2 inhibitor|cox-2 inhibitor
964401|NCT03391570|Celecoxib|celecoxib
964402|NCT03391570|Prostanoid|prostanoid
964403|NCT03391557|Elastography|elastography
964404|NCT03391557|Lymph node|lymph node
964406|NCT03391531|surgery: laparoscopic cholecystectomy|surgery: laparoscopic cholecystectomy
964407|NCT03391531|analgesia: postoperative|analgesia: postoperative
964408|NCT03391531|locoregional analgesia: transversus abdominis plane block|locoregional analgesia: transversus abdominis plane block
964409|NCT03391531|opioid: side effects|opioid: side effects
964410|NCT03391505|Cognition|cognition
964411|NCT03391505|Physical activity|physical activity
964412|NCT03391505|Memory|memory
964413|NCT03391505|Health|health
964414|NCT03391492|ICU|icu
964415|NCT03391427|Lidocaine|lidocaine
964416|NCT03391427|Ketamine|ketamine
964417|NCT03391427|postoperative analgesia|postoperative analgesia
964418|NCT03391414|thick mucus|thick mucus
964419|NCT03391414|obstructive lung disease|obstructive lung disease
964420|NCT03391362|Small Cell Lung Cancer|small cell lung cancer
964421|NCT03391362|Brain Metastases|brain metastases
964422|NCT03391362|Brain metastasis|brain metastasis
964423|NCT03391362|Lung cancer|lung cancer
964424|NCT03391362|Stereotactic radiation|stereotactic radiation
964425|NCT03391362|Stereotactic radiosurgery|stereotactic radiosurgery
964426|NCT03391362|SRS|srs
964427|NCT03391362|Stereotactic|stereotactic
964428|NCT03391362|Radiation|radiation
964429|NCT03391362|Quality of life|quality of life
964430|NCT03391362|Neurocognitive|neurocognitive
964431|NCT03391362|Neurocognition|neurocognition
964432|NCT03391349|proteomes, chronic periodontitis|proteomes, chronic periodontitis
964433|NCT03391336|Carpal tunnel syndrome|carpal tunnel syndrome
964434|NCT03391336|Median nerve injury|median nerve injury
964435|NCT03391336|Steroids|steroids
964436|NCT03391336|Ultrasound|ultrasound
964437|NCT03391336|Injections|injections
964438|NCT03391297|PTSD; prolonged exposure; posttraumatic growth|ptsd; prolonged exposure; posttraumatic growth
964439|NCT03391258|Fibrin|fibrin
964440|NCT03391258|L-PRF|l-prf
964441|NCT03391258|growth-factors|growth-factors
964442|NCT03391258|bone-atrophy|bone-atrophy
964443|NCT03391258|guided-bone-regeneration|guided-bone-regeneration
964444|NCT03391206|Breast cancer related lymphedemas|breast cancer related lymphedemas
964445|NCT03391206|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
964446|NCT03391206|Axillary Lymph Node Dissection|axillary lymph node dissection
964447|NCT03391206|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
964448|NCT03391206|Dietary Fat|dietary fat
964449|NCT03391193|Influenza|influenza
964450|NCT03391193|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
964451|NCT03391193|Multi-dose Presentation|multi-dose presentation
964452|NCT03391141|obstructive sleep apnea|obstructive sleep apnea
964453|NCT03391141|sleep endoscopy|sleep endoscopy
964454|NCT03391141|drug induced sleep endoscopy|drug induced sleep endoscopy
964455|NCT03391141|diagnostic validation|diagnostic validation
964456|NCT03391115|Psychosocial|psychosocial
964457|NCT03391115|Underserved|underserved
964458|NCT03391115|Palliative|palliative
964459|NCT03391115|Electronic Health Record|electronic health record
964460|NCT03391115|Narrative|narrative
964461|NCT03391102|Epidemiology|epidemiology
964462|NCT03391102|Community-based study|community-based study
964463|NCT03391050|Melanoma|melanoma
964464|NCT03391050|Malignant melanoma|malignant melanoma
964465|NCT03391050|Skin cancer|skin cancer
964466|NCT03391050|Resistant cancer|resistant cancer
964467|NCT03391050|Unresectable cancer|unresectable cancer
964468|NCT03391050|Metastatic cancer|metastatic cancer
964469|NCT03391050|BRAF mutant|braf mutant
964470|NCT03390998|Pregnancy-related SCAD|pregnancy-related scad
964471|NCT03390998|Myocardial Infarction|myocardial infarction
964472|NCT03390972|Dexmedetomidine|dexmedetomidine
964473|NCT03390972|Swallowing function|swallowing function
964474|NCT03390972|Anesthetic sedation|anesthetic sedation
964475|NCT03390959|Proprioception|proprioception
964476|NCT03390959|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
964477|NCT03390959|Postural Balance|postural balance
964478|NCT03390959|Gait|gait
964479|NCT03390959|Posture|posture
964480|NCT03390946|four-drugs, interval-compression|four-drugs, interval-compression
964481|NCT03390920|regenerative medicine|regenerative medicine
964482|NCT03390920|arthritis|arthritis
964483|NCT03390920|amniotic|amniotic
964484|NCT03390920|stem cell|stem cell
964485|NCT03390920|growth factor|growth factor
964486|NCT03390920|cartilage|cartilage
964487|NCT03390907|Colon polyp|colon polyp
964488|NCT03390907|EMR|emr
964489|NCT03390907|Hybrid-APC|hybrid-apc
964490|NCT03390907|Laterally spreading tumor|laterally spreading tumor
964491|NCT03390894|Long-term Follow-Up|long-term follow-up
964492|NCT03390894|Invasive Breast Cancer Early Stages|invasive breast cancer early stages
964493|NCT03390894|Previous Neoadjuvant treatment|previous neoadjuvant treatment
964494|NCT03390894|Previous Adjuvant treatment|previous adjuvant treatment
964495|NCT03390881|breath acetone|breath acetone
964496|NCT03390881|energy balance|energy balance
964497|NCT03390868|Interaction|interaction
964498|NCT03390868|challenging behaviour|challenging behaviour
964499|NCT03390868|training|training
964500|NCT03390855|IL-6|il-6
964501|NCT03390855|Glucosinolate|glucosinolate
964502|NCT03390855|Brassica oleracea|brassica oleracea
964503|NCT03390855|Sulphoraphane|sulphoraphane
964505|NCT03390855|Bioavailability|bioavailability
964506|NCT03390855|Inflammation|inflammation
964507|NCT03390842|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
964508|NCT03390816|malnutrition|malnutrition
964509|NCT03390816|cancer|cancer
964510|NCT03390816|elderly|elderly
964511|NCT03390764|Incisional hernia|incisional hernia
964512|NCT03390764|4:1-technique|4:1-technique
964513|NCT03390764|RTL-suture|rtl-suture
964514|NCT03390751|atropinic drugs|atropinic drugs
964515|NCT03390751|confusion|confusion
964516|NCT03390751|elderly patients|elderly patients
964517|NCT03390725|Prevention, obesity, parenting, diet, physical activity|prevention, obesity, parenting, diet, physical activity
964518|NCT03390712|Paliperidone palmitate|paliperidone palmitate
964519|NCT03390712|Risperidone long-acting injection|risperidone long-acting injection
964520|NCT03390712|mirror-image|mirror-image
964521|NCT03390673|randomized|randomized
964522|NCT03390673|double-blind|double-blind
964523|NCT03390647|E6130|e6130
964524|NCT03390647|Healthy adult male participants|healthy adult male participants
964525|NCT03390647|Phase 1|phase 1
964526|NCT03390647|Pharmacokinetics|pharmacokinetics
964527|NCT03390621|parent feeding styles|parent feeding styles
964528|NCT03390621|dietary quality|dietary quality
964529|NCT03390621|dinner meal|dinner meal
964530|NCT03390621|preschool|preschool
964531|NCT03390621|low-income|low-income
964532|NCT03390595|Urothelial carcinoma|urothelial carcinoma
964533|NCT03390582|Gut Microbiota|gut microbiota
964534|NCT03390582|Hashimoto Thyroiditis|hashimoto thyroiditis
964535|NCT03390582|Graves' Disease|graves' disease
964536|NCT03390582|Methimazole|methimazole
964537|NCT03390582|Levothyroxine sodium|levothyroxine sodium
964538|NCT03390582|16S rRNA gene|16s rrna gene
964539|NCT03390582|Metabonomics|metabonomics
964541|NCT03390569|Glioblastoma|glioblastoma
964542|NCT03390569|Brain Cancer|brain cancer
964543|NCT03390569|High-Grade Glioma|high-grade glioma
964544|NCT03390569|Glioma|glioma
964545|NCT03390530|Thyroxine|thyroxine
964546|NCT03390530|Intraventricular hemorrhage|intraventricular hemorrhage
964547|NCT03390530|MRI with DTI,|mri with dti,
964548|NCT03390530|Neurodevelopmental outcome|neurodevelopmental outcome
1653217|NCT00178919|L-NMMA|l-nmma
964549|NCT03390517|fluorescence angiography|fluorescence angiography
964550|NCT03390517|indocyanine green|indocyanine green
964551|NCT03390517|anastomotic leakage|anastomotic leakage
964552|NCT03390478|Frailty|frailty
964553|NCT03390478|Aged|aged
964554|NCT03390478|Cognitive Stimulation|cognitive stimulation
964555|NCT03390478|Technology|technology
964556|NCT03390452|mHealth|mhealth
964557|NCT03390452|Oral Health|oral health
964558|NCT03390452|Primary School Children|primary school children
964559|NCT03390452|Mobile Phone Messaging|mobile phone messaging
964560|NCT03390439|Striae alba|striae alba
964561|NCT03390439|Microneedling|microneedling
964562|NCT03390439|Fractional nonablative laser|fractional nonablative laser
964563|NCT03390439|dermaroller|dermaroller
964564|NCT03390439|Nd-yap 1340nm laser|nd-yap 1340nm laser
964565|NCT03390439|Percutaneous Collagen Induction Therapy|percutaneous collagen induction therapy
964566|NCT03390426|Perifemoral|perifemoral
964567|NCT03390426|Tourniquet|tourniquet
964568|NCT03390426|Mepivacaine|mepivacaine
964569|NCT03390426|Tourniquet Hypertension|tourniquet hypertension
964570|NCT03390413|Cryoablation|cryoablation
964571|NCT03390413|Robot-assisted surgical resection|robot-assisted surgical resection
964572|NCT03390400|Laser Cataract Surgery|laser cataract surgery
964573|NCT03390387|Acute lymphoblastic leukemia, children, adolescents, treatment|acute lymphoblastic leukemia, children, adolescents, treatment
964574|NCT03390374|Nystatin|nystatin
964575|NCT03390374|Fungal colonization|fungal colonization
964576|NCT03390374|Systemic fungal infections|systemic fungal infections
964577|NCT03390361|Laser Cataract Surgery|laser cataract surgery
964578|NCT03390361|Prostaglandin|prostaglandin
964579|NCT03390296|Acute Myeloid Leukemia|acute myeloid leukemia
964581|NCT03390296|Relapsed/refractory|relapsed/refractory
964582|NCT03390296|RR|rr
964583|NCT03390296|PF-04518600|pf-04518600
964584|NCT03390296|Avelumab|avelumab
964585|NCT03390296|MSB0010718C|msb0010718c
964586|NCT03390296|Azacitidine|azacitidine
964587|NCT03390296|5-azacytidine|5-azacytidine
964588|NCT03390296|5-AZA|5-aza
964589|NCT03390296|Vidaza|vidaza
964590|NCT03390296|5-AZC|5-azc
964591|NCT03390296|AZA-CR|aza-cr
964592|NCT03390296|Ladakamycin|ladakamycin
964593|NCT03390296|NSC-102816|nsc-102816
964594|NCT03390296|Azacytidine|azacytidine
964595|NCT03390296|Utomilumab|utomilumab
964596|NCT03390296|PF-05082566|pf-05082566
964597|NCT03390296|Anti-CD137|anti-cd137
964598|NCT03390296|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
964599|NCT03390296|Gemtuzumab|gemtuzumab
964600|NCT03390296|Mylotarg|mylotarg
964601|NCT03390296|Glasdegib|glasdegib
964602|NCT03390296|PF-04449913|pf-04449913
964603|NCT03390283|Survey|survey
964604|NCT03390283|Questionnaire|questionnaire
964605|NCT03390270|intensive care units|intensive care units
964606|NCT03390270|critical care|critical care
964607|NCT03390270|risk assessment|risk assessment
964608|NCT03390270|electronic health records|electronic health records
964609|NCT03390257|Endoscopy, BSD|endoscopy, bsd
964610|NCT03390231|Stem Cell Educator|stem cell educator
964611|NCT03390231|Immune modulation|immune modulation
964612|NCT03390231|Diabetes|diabetes
964613|NCT03390231|Autoimmune|autoimmune
964614|NCT03390231|Insulin resistance|insulin resistance
964615|NCT03390231|Pancreatic islets|pancreatic islets
964616|NCT03390192|Noninvasive brain stimulation|noninvasive brain stimulation
964617|NCT03390192|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
964618|NCT03390192|Transcranial Direct Current Stimulation|transcranial direct current stimulation
964619|NCT03390179|diabetes|diabetes
964620|NCT03390179|anesthesia|anesthesia
964621|NCT03390179|surgery|surgery
964622|NCT03390179|glucose|glucose
964623|NCT03390166|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
964624|NCT03390166|Tri Fluvac vaccine|tri fluvac vaccine
964625|NCT03390140|Spinal Cord Injuries|spinal cord injuries
964626|NCT03390140|Group Intervention|group intervention
964627|NCT03390140|Self Efficacy|self efficacy
964628|NCT03390127|elderly|elderly
964629|NCT03390127|lithotomy position|lithotomy position
964630|NCT03390127|PEEP|peep
964631|NCT03390127|laryngeal mask airway|laryngeal mask airway
964632|NCT03390114|HIV|hiv
964633|NCT03390114|Insomnia|insomnia
964634|NCT03390114|Cognitive Behavioral Therapy|cognitive behavioral therapy
964635|NCT03390088|Heart failure|heart failure
964636|NCT03390075|shelf nutrition label, NuVal|shelf nutrition label, nuval
964637|NCT03390049|SmartXide 2 V 2 LR|smartxide 2 v 2 lr
964638|NCT03390049|MonaLisa Touch|monalisa touch
964639|NCT03390049|DEKA|deka
964640|NCT03390049|Fractional CO2 Laser|fractional co2 laser
964641|NCT03390049|Sham Laser|sham laser
964642|NCT03390049|Vulvodynia|vulvodynia
964643|NCT03390049|PVD|pvd
964644|NCT03390049|Provoked vestibulodynia|provoked vestibulodynia
964645|NCT03390023|Prenatal Care|prenatal care
964646|NCT03390023|Barriers|barriers
964647|NCT03390023|Clinical Trials|clinical trials
964648|NCT03389997|respiratory tract infections|respiratory tract infections
964649|NCT03389997|virus shedding|virus shedding
964650|NCT03389997|cancer|cancer
1653527|NCT00177294|Late-Life|late-life
964651|NCT03389997|Immunocompromised Host|immunocompromised host
964652|NCT03389958|intrauterine device|intrauterine device
964653|NCT03389958|postpartum contraception|postpartum contraception
964654|NCT03389958|repeat pregnancy|repeat pregnancy
964655|NCT03389958|adolescent pregnancy|adolescent pregnancy
964656|NCT03389945|Labor analgesia|labor analgesia
964657|NCT03389945|Dural puncture epidural|dural puncture epidural
964658|NCT03389945|Postdural puncture headache|postdural puncture headache
964659|NCT03389945|Neuraxial analgesia|neuraxial analgesia
964660|NCT03389893|randomized double-masked (blind) placebo-controlled trial|randomized double-masked (blind) placebo-controlled trial
964661|NCT03389893|Thelper2 (Th2) effect|thelper2 (th2) effect
964662|NCT03389893|cutaneous microbial community|cutaneous microbial community
964663|NCT03389893|skin barrier|skin barrier
964668|NCT03389841|heart failure|heart failure
964669|NCT03389841|caregivers|caregivers
964670|NCT03389841|health education|health education
964671|NCT03389841|patient admission|patient admission
964676|NCT03389789|pain|pain
964677|NCT03389789|infant|infant
964678|NCT03389789|near-infrared spectroscopy|near-infrared spectroscopy
964679|NCT03389789|non pharmacological analgesia|non pharmacological analgesia
964680|NCT03389763|Surgical Pleth Index (SPI)|surgical pleth index (spi)
964681|NCT03389763|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
964682|NCT03389763|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
964683|NCT03389763|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
964684|NCT03389763|Spectral Entropy (SE)|spectral entropy (se)
964685|NCT03389763|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
964686|NCT03389763|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
964687|NCT03389711|Rheumatoid Arthritis Mexico|rheumatoid arthritis mexico
964688|NCT03389711|Early Rheumatoid Arthritis Cohort Mexico|early rheumatoid arthritis cohort mexico
964689|NCT03389685|Platelet Rich Plasma|platelet rich plasma
964690|NCT03389672|patient safety|patient safety
964691|NCT03389672|residency training|residency training
964692|NCT03389659|mCRC|mcrc
964693|NCT03389659|oxaliplatin plus fluoropyrimidine|oxaliplatin plus fluoropyrimidine
964694|NCT03389620|CT-fluoroscopy|ct-fluoroscopy
964695|NCT03389620|Corticosteroid injection|corticosteroid injection
964696|NCT03389607|SCUBE-1|scube-1
964697|NCT03389594|Surgical guide|surgical guide
964698|NCT03389594|Computer guided implantology|computer guided implantology
964699|NCT03389594|CBCT voxel size|cbct voxel size
964700|NCT03389555|Sepsis|sepsis
964701|NCT03389555|Metabolic Resuscitation|metabolic resuscitation
964702|NCT03389503|Access site|access site
964703|NCT03389503|Transradial access|transradial access
964704|NCT03389503|Coronary artery disease|coronary artery disease
964705|NCT03389503|Learning curve|learning curve
964706|NCT03389451|68Ga-PSMA-11|68ga-psma-11
964707|NCT03389451|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
964708|NCT03389451|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
964709|NCT03389438|Immunotherapy|immunotherapy
964710|NCT03389399|Brigatinib|brigatinib
964711|NCT03389399|Early Onset Pulmonary Events|early onset pulmonary events
964712|NCT03389386|Congestive Heart Failure|congestive heart failure
964713|NCT03389386|Catestatin|catestatin
964714|NCT03389386|Chromogranin A|chromogranin a
964715|NCT03389386|Echocardiography|echocardiography
964716|NCT03389386|Biomarkers|biomarkers
964717|NCT03389386|Ventricular Dysfunction, Left|ventricular dysfunction, left
964718|NCT03389386|Comorbidity|comorbidity
964719|NCT03389373|Dental Caries|dental caries
964720|NCT03389321|pharmacokinetics|pharmacokinetics
964721|NCT03389321|macitentan|macitentan
964722|NCT03389321|riociguat|riociguat
964723|NCT03389308|Epidermolysis Bullosa Simplex|epidermolysis bullosa simplex
964724|NCT03389308|Epidermolysis Bullosa|epidermolysis bullosa
964725|NCT03389308|Skin Blister|skin blister
964726|NCT03389308|Erosions|erosions
964727|NCT03389295|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
964728|NCT03389295|Reduced Target Delineation|reduced target delineation
964729|NCT03389295|Sequential chemoradiotherapy|sequential chemoradiotherapy
964730|NCT03389282|Tear, Metabolite|tear, metabolite
964731|NCT03389256|apatinib|apatinib
964732|NCT03389256|T790 negative|t790 negative
964733|NCT03389256|NSCLC|nsclc
964734|NCT03389243|Surgical Pleth Index (SPI)|surgical pleth index (spi)
964735|NCT03389243|General Anaesthesia (GA),|general anaesthesia (ga),
964736|NCT03389243|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
964737|NCT03389243|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
964738|NCT03389243|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
964739|NCT03389243|paracetamol|paracetamol
964740|NCT03389243|metamizole|metamizole
964741|NCT03389230|chimeric antigen receptor|chimeric antigen receptor
964742|NCT03389230|glioblastoma|glioblastoma
964743|NCT03389217|Multiple Sclerosis|multiple sclerosis
964744|NCT03389217|Pain|pain
964745|NCT03389217|Transcranial Direct Current Stimulation|transcranial direct current stimulation
964746|NCT03389217|tDCS|tdcs
964747|NCT03389204|Breast surgery|breast surgery
964748|NCT03389204|Physiotherapy|physiotherapy
964749|NCT03389204|Breast Cancer|breast cancer
964750|NCT03389204|Shoulder pain|shoulder pain
964751|NCT03389204|Shoulder motion|shoulder motion
964752|NCT03389178|prenatal stress|prenatal stress
964753|NCT03389178|fetal autonomic nervous system|fetal autonomic nervous system
964754|NCT03389178|multidimensional FHR variability assessment|multidimensional fhr variability assessment
964755|NCT03389165|Wearable hip assist robot|wearable hip assist robot
964756|NCT03389165|Elderly adult|elderly adult
964757|NCT03389165|Metabolic energy expenditure|metabolic energy expenditure
964758|NCT03389165|Stair ascent|stair ascent
964759|NCT03389139|Cesarean|cesarean
964760|NCT03389139|newborn|newborn
964761|NCT03389139|cerebral and renal oxygenation|cerebral and renal oxygenation
964762|NCT03389139|anesthesia|anesthesia
964763|NCT03389100|diabetes|diabetes
964764|NCT03389100|hyperglycemia|hyperglycemia
964765|NCT03389100|tau|tau
964766|NCT03389061|Epclusa|epclusa
964767|NCT03389061|Pharmacokinetics|pharmacokinetics
964768|NCT03389061|Crushing|crushing
964769|NCT03389035|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
964770|NCT03389035|CAR-T|car-t
964771|NCT03389035|CARCIK|carcik
964772|NCT03389035|Transposon|transposon
964773|NCT03388983|Prehabilitation|prehabilitation
964774|NCT03388983|Physical activity|physical activity
964775|NCT03388983|Lumbar decompression surgery|lumbar decompression surgery
964776|NCT03388983|Randomized controlled trial|randomized controlled trial
964777|NCT03388970|vitamin K1|vitamin k1
964778|NCT03388970|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
964779|NCT03388970|effectiveness|effectiveness
964780|NCT03388970|outcome|outcome
964781|NCT03388931|Radiotherapy Dose Escalation|radiotherapy dose escalation
964782|NCT03388918|Quality of life|quality of life
964783|NCT03388918|Telerehabilitation|telerehabilitation
964784|NCT03388918|Cardiac patients|cardiac patients
964785|NCT03388918|Heart failure|heart failure
964786|NCT03388905|LifeVest wearable|lifevest wearable
964787|NCT03388905|cardioverter defibrillator|cardioverter defibrillator
964788|NCT03388905|LVEF|lvef
964789|NCT03388892|Angioplasty|angioplasty
964790|NCT03388892|Drug Eluting Balloon|drug eluting balloon
964791|NCT03388892|Arteriovenous Graft|arteriovenous graft
964792|NCT03388866|inhaled aeroallergens|inhaled aeroallergens
964793|NCT03388866|eczema|eczema
964794|NCT03388866|pruritus|pruritus
964795|NCT03388866|life quality|life quality
964796|NCT03388866|immunotheraphy|immunotheraphy
964797|NCT03388866|atopic dermatitis|atopic dermatitis
964798|NCT03388853|Acetylcysteine/Doxofylline|acetylcysteine/doxofylline
964799|NCT03388853|Acetylcysteine|acetylcysteine
964800|NCT03388853|Doxofylline|doxofylline
964801|NCT03388853|Effervescent Tablet|effervescent tablet
964802|NCT03388853|COPD|copd
964803|NCT03388840|platelet rich plasma|platelet rich plasma
964804|NCT03388840|adipose derived stem cells|adipose derived stem cells
964805|NCT03388840|follicular unit extraction|follicular unit extraction
964806|NCT03388840|hair transplantation|hair transplantation
964807|NCT03388814|PPBCS|ppbcs
964808|NCT03388814|Acute|acute
964907|NCT03388281|Pacemaker|pacemaker
964809|NCT03388814|Postoperative|postoperative
964810|NCT03388814|Mastectomy|mastectomy
964811|NCT03388814|Breast Reconstruction|breast reconstruction
964812|NCT03388775|deep vein thrombosis|deep vein thrombosis
964813|NCT03388775|assessment|assessment
964814|NCT03388775|risk factors|risk factors
964815|NCT03388762|Hyperglycemia|hyperglycemia
964816|NCT03388762|Prediabetes|prediabetes
964817|NCT03388762|Botanical|botanical
964818|NCT03388762|Phytochemicals|phytochemicals
964819|NCT03388762|Dietary Supplements|dietary supplements
964820|NCT03388762|Berberine|berberine
964821|NCT03388762|Fenugreek|fenugreek
964822|NCT03388762|American Ginseng|american ginseng
964823|NCT03388762|Gymnema|gymnema
964824|NCT03388762|Banaba|banaba
964825|NCT03388762|Kudzu|kudzu
964826|NCT03388762|Cinnamon|cinnamon
964827|NCT03388762|Glycated hemoglobin|glycated hemoglobin
964828|NCT03388762|Trigonella|trigonella
964829|NCT03388762|Blood Glucose|blood glucose
964830|NCT03388762|Panax|panax
964831|NCT03388762|Plant Extracts|plant extracts
964832|NCT03388762|Public Health|public health
964833|NCT03388762|Chronic Disease|chronic disease
964834|NCT03388736|preoperative|preoperative
964835|NCT03388736|anxiety|anxiety
964836|NCT03388736|orthognathic surgery|orthognathic surgery
964837|NCT03388736|lavender oil|lavender oil
964838|NCT03388723|Epigenetics|epigenetics
964839|NCT03388723|Cardiometabolic risk factors|cardiometabolic risk factors
964840|NCT03388710|airway, children, endotracheal tube, cuff|airway, children, endotracheal tube, cuff
964841|NCT03388658|Atrial Fibrillation; Cryoballoon; Ablation;|atrial fibrillation; cryoballoon; ablation;
964842|NCT03388645|RSV Shedding|rsv shedding
964843|NCT03388645|Immune Responses|immune responses
964844|NCT03388645|Neutralizing Antibody Titer|neutralizing antibody titer
964845|NCT03388645|Upper Respiratory Tract Infection|upper respiratory tract infection
964846|NCT03388632|Immunotherapy|immunotherapy
964847|NCT03388632|T Cells|t cells
964848|NCT03388632|Checkpoint Inhibitor|checkpoint inhibitor
964849|NCT03388632|IL-15|il-15
964850|NCT03388632|Combination Therapy|combination therapy
964851|NCT03388619|Rising PSA|rising psa
964852|NCT03388619|No evidence of metastatic disease|no evidence of metastatic disease
964853|NCT03388619|Entire Prostate Bed|entire prostate bed
964854|NCT03388619|Quality of Life|quality of life
964855|NCT03388619|Irradiation|irradiation
964856|NCT03388606|Mood Disorder|mood disorder
964857|NCT03388606|Teenagers|teenagers
964858|NCT03388606|Mechanism|mechanism
964859|NCT03388593|chronic heart failure|chronic heart failure
964860|NCT03388593|neuregulin|neuregulin
964861|NCT03388593|mortality|mortality
964862|NCT03388567|Dispensation|dispensation
964863|NCT03388567|Health Education|health education
964864|NCT03388567|Pharmacovigilance|pharmacovigilance
964865|NCT03388567|Pharmacists|pharmacists
964866|NCT03388528|Dysmotility|dysmotility
964867|NCT03388528|Microbiome|microbiome
964868|NCT03388528|Transit Time|transit time
964869|NCT03388528|Gastrointestinal|gastrointestinal
964870|NCT03388502|Total knee arthroplasty|total knee arthroplasty
964871|NCT03388502|Total hip arthroplasty|total hip arthroplasty
964872|NCT03388476|pulmonary hypertension|pulmonary hypertension
964873|NCT03388476|endtidal co2|endtidal co2
964874|NCT03388476|endtidal carbon dioxide|endtidal carbon dioxide
964875|NCT03388476|pulmonary arterial hypertension|pulmonary arterial hypertension
964876|NCT03388437|Non-invasive Neurally Adjusted Ventilatory Assist NI-NAVA|non-invasive neurally adjusted ventilatory assist ni-nava
964877|NCT03388437|Nasal Intermittent Positive Pressure Ventilation NIPPV|nasal intermittent positive pressure ventilation nippv
964878|NCT03388437|post extubation|post extubation
964879|NCT03388424|bacterial DNA, RNA16S gene|bacterial dna, rna16s gene
964880|NCT03388411|Microbiome|microbiome
964881|NCT03388411|Gut|gut
964882|NCT03388398|Mother-to-child transmission of HIV (MTCT)|mother-to-child transmission of hiv (mtct)
964883|NCT03388398|Prevention of mother-to-child HIV transmission (PMTCT)|prevention of mother-to-child hiv transmission (pmtct)
964884|NCT03388398|Antiretroviral therapy (ART)|antiretroviral therapy (art)
964885|NCT03388398|Antenatal care (ANC)|antenatal care (anc)
964886|NCT03388398|Pediatric infections|pediatric infections
964887|NCT03388398|Pregnancy|pregnancy
964888|NCT03388385|CKD, anemia, iron, endothelial dysfunction, oxidative stress|ckd, anemia, iron, endothelial dysfunction, oxidative stress
964889|NCT03388372|glioma|glioma
964890|NCT03388372|phase 2|phase 2
964891|NCT03388372|nimotozumab|nimotozumab
964892|NCT03388372|temozolomide|temozolomide
964893|NCT03388372|radiotherapy|radiotherapy
964894|NCT03388359|asthma|asthma
964895|NCT03388359|eosinophils|eosinophils
964896|NCT03388359|Extracellular matrix|extracellular matrix
964897|NCT03388359|airway smooth muscle|airway smooth muscle
964898|NCT03388359|airway remodelling|airway remodelling
964899|NCT03388359|fibroblast|fibroblast
964900|NCT03388346|68Ga-PSMA-11|68ga-psma-11
964901|NCT03388346|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
964902|NCT03388346|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
964903|NCT03388294|communication|communication
964904|NCT03388294|sensory|sensory
964905|NCT03388294|early intervention|early intervention
964906|NCT03388294|parent coaching|parent coaching
964908|NCT03388281|Gender differences|gender differences
964909|NCT03388281|Survival|survival
964910|NCT03388281|Retrospective|retrospective
964911|NCT03388268|Clostridium difficile|clostridium difficile
964912|NCT03388268|Diarrhea|diarrhea
964913|NCT03388255|Polydeoxyribonucletide|polydeoxyribonucletide
964914|NCT03388255|Placentex|placentex
964915|NCT03388255|PDRN|pdrn
964916|NCT03388229|Dietary pattern|dietary pattern
964917|NCT03388229|glycemic control|glycemic control
964918|NCT03388229|type 2 diabetes|type 2 diabetes
964919|NCT03388229|UAE|uae
964920|NCT03388203|25(OH)D|25(oh)d
964921|NCT03388203|PTH|pth
964922|NCT03388203|mass spectrometry|mass spectrometry
964923|NCT03388203|data mining|data mining
964924|NCT03388190|Colorectal|colorectal
964925|NCT03388190|Cancer|cancer
964926|NCT03388190|Neoplasm|neoplasm
964927|NCT03388190|Nivolumab|nivolumab
964928|NCT03388190|Fluorouracil|fluorouracil
964929|NCT03388190|Metastatic|metastatic
964930|NCT03388190|Oxaliplatin|oxaliplatin
964931|NCT03388190|Leucovorin|leucovorin
964932|NCT03388177|Depression|depression
964933|NCT03388177|Young adult women|young adult women
964934|NCT03388177|Yoga|yoga
964935|NCT03388112|Probiotics,Gut Microbiome,Antibiotics,Infants|probiotics,gut microbiome,antibiotics,infants
964936|NCT03388099|gonadotrophin receptor polymorphism|gonadotrophin receptor polymorphism
964937|NCT03388099|antimüllerian hormone|antimüllerian hormone
964938|NCT03388099|ovarian response|ovarian response
964939|NCT03388099|ovarian stimulation|ovarian stimulation
964940|NCT03388060|Oral Dissolution Therapy|oral dissolution therapy
964941|NCT03388060|Kidney stone|kidney stone
964942|NCT03388060|ESWL|eswl
964943|NCT03388047|Barrett Esophagus|barrett esophagus
964944|NCT03388047|Endoscopy|endoscopy
964945|NCT03388047|Adenocarcinoma|adenocarcinoma
964946|NCT03388021|limb ischemia|limb ischemia
964947|NCT03388021|completion angiography|completion angiography
964948|NCT03388021|thromboembolectomy|thromboembolectomy
964949|NCT03388008|donor-specific HLA antibodies|donor-specific hla antibodies
964950|NCT03388008|lung transplantation|lung transplantation
964951|NCT03387995|treatment outcome|treatment outcome
964952|NCT03387956|Postoperative Nuasea|postoperative nuasea
964953|NCT03387930|Low back pain|low back pain
964954|NCT03387930|lumbar multifidus|lumbar multifidus
964955|NCT03387930|Proprioception|proprioception
964956|NCT03387930|Elastography|elastography
964957|NCT03387930|Magnetic resonance imaging|magnetic resonance imaging
964958|NCT03387917|Advanced Solid Tumors|advanced solid tumors
964960|NCT03387917|TLD-1|tld-1
964961|NCT03387917|phase I|phase i
964962|NCT03387917|Talidox|talidox
964963|NCT03387917|Liposomal|liposomal
964964|NCT03387904|Anlotinib|anlotinib
964965|NCT03387865|banking, biological sampling, tumor tissue, tumor response|banking, biological sampling, tumor tissue, tumor response
964966|NCT03387826|ticagrelor|ticagrelor
964967|NCT03387826|prasugrel|prasugrel
964968|NCT03387813|Heart Failure|heart failure
964969|NCT03387813|Hemodynamic Monitoring|hemodynamic monitoring
964970|NCT03387813|CardioMEMS|cardiomems
964971|NCT03387813|Pulmonary Artery Pressure|pulmonary artery pressure
964972|NCT03387800|randomized controlled trial|randomized controlled trial
964973|NCT03387800|smoking cessation|smoking cessation
964974|NCT03387800|social support|social support
964975|NCT03387800|positive effect|positive effect
964976|NCT03387800|online social networking|online social networking
964977|NCT03387800|theory-based|theory-based
964978|NCT03387787|GlucoTab, Tresiba, Type 2 Diabetes|glucotab, tresiba, type 2 diabetes
964979|NCT03387774|Ulinastatin|ulinastatin
964980|NCT03387774|Radiation-induced acute oral mucositis|radiation-induced acute oral mucositis
964981|NCT03387774|Localregionally Advanced Nasopharyngeal Carcinoma|localregionally advanced nasopharyngeal carcinoma
964982|NCT03387774|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
964983|NCT03387761|Urothelial cancer|urothelial cancer
964984|NCT03387761|Bladder cancer|bladder cancer
964985|NCT03387761|Cancer|cancer
964986|NCT03387761|Resectable|resectable
964987|NCT03387761|Operable|operable
964988|NCT03387761|immunotherapy|immunotherapy
964989|NCT03387761|Ipilimumab|ipilimumab
964990|NCT03387761|Nivolumab|nivolumab
964991|NCT03387761|Neo-Adjuvant|neo-adjuvant
964992|NCT03387735|Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity|hypertension, hyperlipidemia, diabetes, arthritis, obesity
964993|NCT03387709|Nondiabetic|nondiabetic
964994|NCT03387709|Overweight|overweight
964996|NCT03387709|Men|men
964997|NCT03387709|Women|women
964998|NCT03387709|San Diego|san diego
964999|NCT03387709|Weight Loss|weight loss
965000|NCT03387696|Mucormycosis|mucormycosis
965001|NCT03387696|Intensive Care Medicine|intensive care medicine
965002|NCT03387631|Efficacy safety uncomplicated malaria AL|efficacy safety uncomplicated malaria al
965003|NCT03387592|Neuroendocrine Carcinoma|neuroendocrine carcinoma
965004|NCT03387592|second line therapy|second line therapy
965005|NCT03387592|PET imaging|pet imaging
965006|NCT03387592|FOLFIRI|folfiri
965007|NCT03387592|CAPTEM|captem
965008|NCT03387553|Immunotherapy|immunotherapy
965009|NCT03387553|Dendritic Cell Vaccine|dendritic cell vaccine
965010|NCT03387553|DC1|dc1
965014|NCT03387540|Immune checkpoint inhibitors|immune checkpoint inhibitors
965015|NCT03387527|Decision Aid|decision aid
965016|NCT03387514|Clear Cell|clear cell
965017|NCT03387514|Kidney Cancer|kidney cancer
965018|NCT03387514|RCC|rcc
965019|NCT03387475|efficacy|efficacy
965020|NCT03387475|safety|safety
965021|NCT03387462|Adherence|adherence
965022|NCT03387462|PrEP|prep
965023|NCT03387462|HIV Prevention|hiv prevention
965024|NCT03387462|Truvada|truvada
965025|NCT03387462|HIV Risk Reduction|hiv risk reduction
965026|NCT03387462|Mobile App|mobile app
965027|NCT03387436|Palliative care|palliative care
965028|NCT03387436|Advance care planning|advance care planning
965029|NCT03387436|psychological intervention|psychological intervention
965030|NCT03387410|Laparoscopic surgery|laparoscopic surgery
965031|NCT03387410|Fluorescence|fluorescence
965033|NCT03387371|chronic periodontitis, laser|chronic periodontitis, laser
965034|NCT03387358|intensive care unit|intensive care unit
965035|NCT03387358|nasal bridle securement device|nasal bridle securement device
965036|NCT03387358|small bore feeding tube|small bore feeding tube
965037|NCT03387358|adverse events|adverse events
965038|NCT03387358|enteral nutrition|enteral nutrition
965039|NCT03387345|glucose|glucose
965040|NCT03387345|dietary fiber|dietary fiber
965041|NCT03387345|glycemia|glycemia
965042|NCT03387345|whole grain|whole grain
965043|NCT03387332|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
965044|NCT03387319|Social stress|social stress
965045|NCT03387319|Inflammation|inflammation
965046|NCT03387306|serum bilirubin|serum bilirubin
965047|NCT03387306|normal-tension glaucoma|normal-tension glaucoma
965048|NCT03387306|oxidative stress|oxidative stress
1655255|NCT00168636|Vitamin A|vitamin a
965049|NCT03387293|Pediatric Obesity|pediatric obesity
965050|NCT03387293|Insulin Resistance|insulin resistance
965052|NCT03387280|acute myocardial infarction|acute myocardial infarction
965053|NCT03387280|electrocardiogram|electrocardiogram
965054|NCT03387280|coronary angiography|coronary angiography
965055|NCT03387254|virtual reality|virtual reality
965056|NCT03387254|brain stimulation|brain stimulation
965057|NCT03387241|moderate|moderate
965058|NCT03387241|severe|severe
965059|NCT03387241|persistent|persistent
965060|NCT03387241|reversible|reversible
965061|NCT03387241|Seretide|seretide
965062|NCT03387241|Flutiform|flutiform
965063|NCT03387228|back pain|back pain
965064|NCT03387228|low back pain|low back pain
965065|NCT03387228|Explain Pain|explain pain
965066|NCT03387228|Pain education|pain education
965067|NCT03387202|Pelvic Organ Prolapse|pelvic organ prolapse
965068|NCT03387202|Translabial ultrasound|translabial ultrasound
965069|NCT03387202|Transperineal ultrasound|transperineal ultrasound
965070|NCT03387202|Lateral Mesh Suspension|lateral mesh suspension
965071|NCT03387202|Descensus uteri|descensus uteri
965072|NCT03387202|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
965073|NCT03387163|Heart failure|heart failure
965074|NCT03387163|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
965075|NCT03387163|Chronic Systolic Heart failure|chronic systolic heart failure
965076|NCT03387163|Sacubitril /Valsartan|sacubitril /valsartan
965077|NCT03387163|Patient reported outcomes (PRO)|patient reported outcomes (pro)
965078|NCT03387163|Kansas City Cardiomyopathy Questionnaire (KCCQ)|kansas city cardiomyopathy questionnaire (kccq)
965079|NCT03387163|Patient Centered Outcomes Research Network (PCORNeT)|patient centered outcomes research network (pcornet)
965080|NCT03387163|Common Data Model (CDM)|common data model (cdm)
965081|NCT03387072|Mental stress|mental stress
965082|NCT03387072|Sudden cardiac death|sudden cardiac death
965083|NCT03387072|arrhythmias|arrhythmias
965084|NCT03387072|long QT syndrome|long qt syndrome
965085|NCT03387059|Infertility|infertility
965086|NCT03387059|Forielle|forielle
965087|NCT03387059|Assisted Reproductive Technique (ART)|assisted reproductive technique (art)
965088|NCT03387059|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
965089|NCT03387046|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
965090|NCT03387046|D-Aspartate|d-aspartate
965091|NCT03387046|interferon beta-1a|interferon beta-1a
965092|NCT03387007|adolescent|adolescent
965093|NCT03387007|mental health|mental health
965094|NCT03387007|hope|hope
965095|NCT03387007|psycho-social support|psycho-social support
965096|NCT03387007|school teachers|school teachers
965097|NCT03387007|earthquake|earthquake
965098|NCT03386981|Energy metabolism|energy metabolism
965099|NCT03386981|Homeostasis|homeostasis
965100|NCT03386981|Bone turnover markers|bone turnover markers
965101|NCT03386968|virtual reality|virtual reality
965102|NCT03386968|hemiplegia|hemiplegia
965103|NCT03386968|diplegia|diplegia
965104|NCT03386968|video gaming|video gaming
965105|NCT03386968|active video games|active video games
965106|NCT03386968|Playstation X-Box 360|playstation x-box 360
965107|NCT03386968|Rutgers V-Step|rutgers v-step
965108|NCT03386968|Microsoft Kinect|microsoft kinect
965109|NCT03386955|non-small cell lung cancer|non-small cell lung cancer
965110|NCT03386955|NSCLC|nsclc
965111|NCT03386942|Solid Tumors|solid tumors
965200|NCT03386370|Lower Limb|lower limb
965112|NCT03386942|Folate Receptor α (FRA)-Positive Triple Negative Breast Cancer|folate receptor α (fra)-positive triple negative breast cancer
965113|NCT03386942|FRA-Positive Type 2 Endometrial Carcinoma|fra-positive type 2 endometrial carcinoma
965114|NCT03386929|NSCLC|nsclc
965115|NCT03386929|tri-therapy|tri-therapy
965116|NCT03386929|avelumab|avelumab
965117|NCT03386929|axitinib|axitinib
965118|NCT03386929|palbociclib|palbociclib
965119|NCT03386929|dual matched normal and tumor biopsies|dual matched normal and tumor biopsies
965120|NCT03386929|SIMS algorithm|sims algorithm
965121|NCT03386929|Sequencing|sequencing
965122|NCT03386929|Gene expression|gene expression
965123|NCT03386916|Technology, Radiologic - Radiography, Interventional - Image-Guided Biopsy - Early Detection of Cancer - Carcinoma, Bronchogenic / diagnosis - Outpatients|technology, radiologic - radiography, interventional - image-guided biopsy - early detection of cancer - carcinoma, bronchogenic / diagnosis - outpatients
965124|NCT03386890|Non-invasive Assessment|non-invasive assessment
965125|NCT03386890|Transient Elastography|transient elastography
965126|NCT03386890|Controlled Attenuation Parameter|controlled attenuation parameter
965127|NCT03386864|Heart Failure, Diabetes Mellitus, Mitochondrial Respiration|heart failure, diabetes mellitus, mitochondrial respiration
965128|NCT03386825|Metastatic Colorectal Cancer|metastatic colorectal cancer
965129|NCT03386812|androgen deprivation therapy|androgen deprivation therapy
965130|NCT03386812|sarcopenia|sarcopenia
965131|NCT03386812|bone loss|bone loss
965132|NCT03386799|Power assistance device|power assistance device
965133|NCT03386799|Wheelchair|wheelchair
965134|NCT03386786|Total Knee Arthroplasty|total knee arthroplasty
965135|NCT03386786|Total Hip Arthroplasty|total hip arthroplasty
965136|NCT03386786|Total Knee Replacement|total knee replacement
965137|NCT03386786|Total Hip Replacement|total hip replacement
965138|NCT03386786|Hospital Care Plan|hospital care plan
965139|NCT03386786|mHealth|mhealth
965140|NCT03386773|patient generated health data|patient generated health data
965141|NCT03386773|patient reported outcome measures|patient reported outcome measures
965142|NCT03386773|health information technology|health information technology
965143|NCT03386773|mobile health|mobile health
965144|NCT03386773|consumer health informatics|consumer health informatics
965145|NCT03386760|tattoo|tattoo
965146|NCT03386747|child development|child development
965147|NCT03386747|neonatal mortality|neonatal mortality
965148|NCT03386708|Healing Poor After Uterus Injury, Mesenchymal Stem Cell|healing poor after uterus injury, mesenchymal stem cell
965337|NCT03385499|ELISPOT|elispot
965149|NCT03386695|Cervical Cancer and HPV infection|cervical cancer and hpv infection
965150|NCT03386669|18F-THK5351 PET|18f-thk5351 pet
965151|NCT03386669|Tauopathies|tauopathies
965152|NCT03386656|Osteoarthritis|osteoarthritis
965153|NCT03386656|Tranexamic acid|tranexamic acid
965154|NCT03386643|Oral lichen planus|oral lichen planus
965155|NCT03386643|Probiotics|probiotics
965156|NCT03386643|Immunomodulation.|immunomodulation.
965157|NCT03386604|Whey Protein|whey protein
965158|NCT03386539|heart transplantation|heart transplantation
965159|NCT03386539|children|children
965160|NCT03386539|everolimus|everolimus
965161|NCT03386539|tacrolimus|tacrolimus
965162|NCT03386539|mycophenolate mofetil|mycophenolate mofetil
965163|NCT03386539|randomized clinical trial|randomized clinical trial
965164|NCT03386526|IAP inhibitor|iap inhibitor
965165|NCT03386513|Antibody Drug Conjugate|antibody drug conjugate
965166|NCT03386513|Other Hematologic Malignancies|other hematologic malignancies
965167|NCT03386513|Myeloproliferative Neoplasms|myeloproliferative neoplasms
965168|NCT03386513|CD123|cd123
965169|NCT03386513|MDS|mds
965170|NCT03386513|Relapsed, Refractory|relapsed, refractory
965171|NCT03386513|Acute Lymphocytic Leukaemia|acute lymphocytic leukaemia
965172|NCT03386513|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
965173|NCT03386513|Acute Myeloid Leukemia|acute myeloid leukemia
965174|NCT03386474|double-masked, extension study|double-masked, extension study
965175|NCT03386474|neovascular age-related macular degeneration|neovascular age-related macular degeneration
965176|NCT03386474|intravitreal injection|intravitreal injection
965177|NCT03386474|brolucizumab|brolucizumab
965178|NCT03386474|aflibercept|aflibercept
965179|NCT03386461|elderly|elderly
965180|NCT03386461|exercise training|exercise training
965181|NCT03386461|adipose tissue|adipose tissue
965182|NCT03386461|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
965183|NCT03386461|inflammation|inflammation
965184|NCT03386461|diferentiation of preadipocytes|diferentiation of preadipocytes
965185|NCT03386435|remote ischemic preconditioning|remote ischemic preconditioning
965186|NCT03386435|liver donors|liver donors
965187|NCT03386422|Mindfulness|mindfulness
965188|NCT03386422|Self-Compassion|self-compassion
965189|NCT03386422|Chronic Pain|chronic pain
965190|NCT03386422|Psychological Intervention|psychological intervention
965191|NCT03386422|Cognitive-Behavioural therapy|cognitive-behavioural therapy
965192|NCT03386422|acceptance|acceptance
965193|NCT03386422|catastrophising|catastrophising
965194|NCT03386422|Self-Care|self-care
965195|NCT03386422|Quality of life|quality of life
965196|NCT03386409|Injury prevention|injury prevention
965197|NCT03386383|adolescent and young adult|adolescent and young adult
965198|NCT03386383|cancer survivor|cancer survivor
965199|NCT03386370|Acute ischemia|acute ischemia
965201|NCT03386318|concentration|concentration
965202|NCT03386292|prevalence|prevalence
965203|NCT03386292|urinary incontinence|urinary incontinence
965204|NCT03386292|anal incontinence|anal incontinence
965205|NCT03386292|risk factors|risk factors
965206|NCT03386292|women|women
965207|NCT03386279|healthy volunteers|healthy volunteers
965208|NCT03386266|Biomarkers|biomarkers
965209|NCT03386266|CMT1A|cmt1a
965210|NCT03386266|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
965211|NCT03386227|Assisted Reproductive Technology|assisted reproductive technology
965212|NCT03386227|Antibiotic Prophylaxis|antibiotic prophylaxis
965213|NCT03386227|Microbiome|microbiome
965214|NCT03386201|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
965215|NCT03386201|Fluorescence|fluorescence
965216|NCT03386162|Breast cancer, PI3K, alpelisib|breast cancer, pi3k, alpelisib
965217|NCT03386149|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
965218|NCT03386149|Low Back Pain|low back pain
965219|NCT03386149|Radiculopathy|radiculopathy
965220|NCT03386149|Bosinji|bosinji
965221|NCT03386149|Herbal Medicine|herbal medicine
965222|NCT03386136|bowel ischemia|bowel ischemia
965223|NCT03386136|bowel perforation|bowel perforation
965224|NCT03386123|Tinnitus|tinnitus
965225|NCT03386123|Insomnia|insomnia
965226|NCT03386123|Cognitive Behaviour Therapy|cognitive behaviour therapy
965227|NCT03386110|Couples|couples
965228|NCT03386110|MSM|msm
965229|NCT03386110|HIV|hiv
965230|NCT03386110|Drug Use|drug use
965231|NCT03386097|Cholesterol|cholesterol
965232|NCT03386097|Interstitial fluid|interstitial fluid
965233|NCT03386084|capacitive resistive diathermy|capacitive resistive diathermy
965234|NCT03386084|motor control|motor control
965235|NCT03386019|lymphatic massage|lymphatic massage
965236|NCT03386019|static stretching|static stretching
965237|NCT03386019|cold water immersion|cold water immersion
965238|NCT03386006|bariatric surgery|bariatric surgery
965239|NCT03386006|mobile health (mHealth)|mobile health (mhealth)
965240|NCT03386006|psychosocial functioning|psychosocial functioning
965241|NCT03386006|obesity|obesity
965242|NCT03386006|weight loss|weight loss
965243|NCT03386006|behavioral activation|behavioral activation
965244|NCT03385993|Delirium Prevention|delirium prevention
965245|NCT03385993|Virtual Reality|virtual reality
965338|NCT03385499|IgG|igg
965249|NCT03385954|distance|distance
965250|NCT03385954|education|education
965251|NCT03385954|RSI/WRMD|rsi/wrmd
965252|NCT03385928|ICH|ich
965253|NCT03385928|Stroke|stroke
965254|NCT03385928|Cerebrovascular Disorders|cerebrovascular disorders
965255|NCT03385928|Brain Diseases|brain diseases
965256|NCT03385928|Central Nervous System Diseases|central nervous system diseases
965257|NCT03385928|Nervous System Diseases|nervous system diseases
965258|NCT03385928|Vascular Diseases|vascular diseases
965259|NCT03385928|Cardiovascular Diseases|cardiovascular diseases
965260|NCT03385928|Tranexamic Acid|tranexamic acid
965261|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents
965262|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents
965263|NCT03385928|Pharmacologic Actions|pharmacologic actions
965264|NCT03385928|Cardiovascular Agents|cardiovascular agents
965265|NCT03385928|Therapeutic Uses|therapeutic uses
965266|NCT03385928|Hematologic Agents|hematologic agents
965267|NCT03385928|Hemostatics|hemostatics
965268|NCT03385928|Contrast Media|contrast media
965269|NCT03385928|Angiography|angiography
965270|NCT03385928|Cerebral Angiography|cerebral angiography
965271|NCT03385928|Tomography, X-Ray Computed|tomography, x-ray computed
965272|NCT03385915|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
965273|NCT03385915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
965274|NCT03385915|TAVI|tavi
965275|NCT03385915|TAVR|tavr
965276|NCT03385915|Aortic valve replacement|aortic valve replacement
965277|NCT03385915|Surgical aortic valve replacement|surgical aortic valve replacement
965278|NCT03385915|Sutureless|sutureless
965279|NCT03385902|advanced chronic kidney disease|advanced chronic kidney disease
965280|NCT03385902|timing of dialysis initiation|timing of dialysis initiation
965281|NCT03385902|hemodialysis|hemodialysis
965282|NCT03385902|fuzzy mathematics|fuzzy mathematics
965283|NCT03385902|glomerular filtration rate|glomerular filtration rate
965284|NCT03385889|Cervicogenic Headache|cervicogenic headache
965285|NCT03385889|Manual Therapy|manual therapy
965286|NCT03385889|Joint Position Sense|joint position sense
965287|NCT03385889|Balance|balance
965288|NCT03385876|Rady Children's|rady children's
965289|NCT03385876|Pediatric|pediatric
965290|NCT03385876|Genomic|genomic
965291|NCT03385876|Precision Medicine|precision medicine
965292|NCT03385876|Biorepository|biorepository
965293|NCT03385824|traumatic brain injury|traumatic brain injury
965294|NCT03385824|advocacy|advocacy
965295|NCT03385811|Professional quality of life, Medical Professionals, Job Involvement, Intention to Stay,|professional quality of life, medical professionals, job involvement, intention to stay,
965298|NCT03385785|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
965299|NCT03385785|Pressure Recording Analytical Method|pressure recording analytical method
965300|NCT03385785|Ventriculo-arterial coupling|ventriculo-arterial coupling
965303|NCT03385772|sphenopalatine block|sphenopalatine block
965304|NCT03385759|unicompartmental knee|unicompartmental knee
965305|NCT03385759|total knee arthroplasty|total knee arthroplasty
965306|NCT03385759|osteoarthritis|osteoarthritis
965307|NCT03385733|pulmonary hypertension|pulmonary hypertension
965308|NCT03385733|inspiratory muscle training|inspiratory muscle training
965309|NCT03385733|functional capacity|functional capacity
965310|NCT03385733|physical activity|physical activity
965311|NCT03385707|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
965312|NCT03385681|pediatric pain|pediatric pain
965313|NCT03385681|postoperative pain|postoperative pain
965314|NCT03385681|pain assessment|pain assessment
965315|NCT03385681|pain management|pain management
965316|NCT03385681|knowledge|knowledge
965317|NCT03385681|children|children
965318|NCT03385681|nurses|nurses
965319|NCT03385668|Pulmonary fibrosis|pulmonary fibrosis
965320|NCT03385668|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
965321|NCT03385668|Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|anti-neutrophil cytoplasmic antibody (anca)-associated vasculitis
965322|NCT03385668|Pirfenidone|pirfenidone
965323|NCT03385668|Microscopic Polyangiitis|microscopic polyangiitis
965324|NCT03385668|Interstitial lung disease|interstitial lung disease
965325|NCT03385629|Dental Care|dental care
965326|NCT03385629|Dental Caries|dental caries
965327|NCT03385629|Common Sense Model of Self-Regulation|common sense model of self-regulation
965328|NCT03385590|healthy|healthy
965329|NCT03385551|Vulvovaginal Atrophy|vulvovaginal atrophy
965330|NCT03385525|Healthy Volunteer|healthy volunteer
965331|NCT03385512|Virtual standardized patient coaching|virtual standardized patient coaching
965332|NCT03385512|Standardized patient instructor coaching|standardized patient instructor coaching
965333|NCT03385512|Patient centered communication|patient centered communication
965334|NCT03385499|Congenital toxoplasmosis|congenital toxoplasmosis
965335|NCT03385499|Neonatal biological diagnosis of congenital toxoplasmosis|neonatal biological diagnosis of congenital toxoplasmosis
965336|NCT03385499|neonatal diagnosis|neonatal diagnosis
965339|NCT03385486|Melanoma|melanoma
965340|NCT03385486|Resistant|resistant
965341|NCT03385486|Refractory|refractory
965342|NCT03385460|Overactive bladder|overactive bladder
965343|NCT03385460|Botulinum Toxin|botulinum toxin
965344|NCT03385460|low energy shock waves|low energy shock waves
965345|NCT03385460|Intravesical|intravesical
965346|NCT03385434|Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy|colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy
965347|NCT03385369|MEDI0382|medi0382
965348|NCT03385369|Safety|safety
965349|NCT03385369|Tolerability|tolerability
965350|NCT03385369|Pharmacokinetics|pharmacokinetics
965351|NCT03385369|Immunogenicity|immunogenicity
965352|NCT03385330|BPD|bpd
965353|NCT03385330|Prematurity|prematurity
965354|NCT03385330|Supplemental Oxygen|supplemental oxygen
965355|NCT03385330|Oximetry|oximetry
965356|NCT03385330|Infants|infants
965357|NCT03385304|Surgical Site Infection|surgical site infection
965358|NCT03385304|Open Fracture|open fracture
965359|NCT03385304|Povidone-iodine|povidone-iodine
965360|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate
965361|NCT03385304|Peri-operative Preparation Solutions|peri-operative preparation solutions
965362|NCT03385291|EEG;DOC;auditory|eeg;doc;auditory
965363|NCT03385278|TMS;DOC|tms;doc
965364|NCT03385252|complementary feeding|complementary feeding
965365|NCT03385252|eggs|eggs
965366|NCT03385252|infant growth|infant growth
965367|NCT03385252|stunting|stunting
965368|NCT03385252|cognitive development|cognitive development
965369|NCT03385252|choline|choline
965370|NCT03385252|vitamin B12|vitamin b12
965371|NCT03385252|microbiome|microbiome
965372|NCT03385239|AKCEA-APOCIII-LRx|akcea-apociii-lrx
965373|NCT03385239|IONIS-APOCIII-LRx|ionis-apociii-lrx
965374|NCT03385239|Dyslipidemia|dyslipidemia
965375|NCT03385239|Metabolic Disease|metabolic disease
965376|NCT03385239|Hyperlipidemia|hyperlipidemia
965377|NCT03385239|Cardiac Disease|cardiac disease
965378|NCT03385239|Lipid Metabolism Disorders|lipid metabolism disorders
965379|NCT03385239|Triglycerides High|triglycerides high
965380|NCT03385239|Vascular Diseases|vascular diseases
965381|NCT03385226|Relapsed|relapsed
965382|NCT03385226|Refractory|refractory
965383|NCT03385213|Microbiota|microbiota
965384|NCT03385213|colorectal cancer|colorectal cancer
965385|NCT03385213|relapse|relapse
965386|NCT03385213|surveillance|surveillance
965387|NCT03385200|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles
965388|NCT03385161|ethanol ablation of the prostate|ethanol ablation of the prostate
965389|NCT03385161|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
965390|NCT03385161|Prostate|prostate
965391|NCT03385161|Ethanol|ethanol
965392|NCT03385161|Transrectal|transrectal
965394|NCT03385161|onaBoNT-A|onabont-a
965395|NCT03385161|Botox|botox
965396|NCT03385161|Lower urinary tract symptoms|lower urinary tract symptoms
965397|NCT03385161|Botulinum toxin|botulinum toxin
965398|NCT03385161|OnabotulinumtoxinA|onabotulinumtoxina
965399|NCT03385161|Quality of life|quality of life
965400|NCT03385161|IPSS|ipss
965401|NCT03385161|Randomised controlled study|randomised controlled study
965402|NCT03385135|allopurinol|allopurinol
965403|NCT03385135|coronary artery disease|coronary artery disease
965404|NCT03385135|diabetes|diabetes
965405|NCT03385135|endothelial function|endothelial function
965406|NCT03385122|Cardiovascular disease|cardiovascular disease
965407|NCT03385109|Robotic|robotic
965408|NCT03385109|Laparoscopic|laparoscopic
965409|NCT03385044|Endotracheal tube|endotracheal tube
965410|NCT03385044|Intracuff pressure|intracuff pressure
965411|NCT03385044|Minimal occlusive volume technique|minimal occlusive volume technique
965412|NCT03385044|Spirometer|spirometer
965413|NCT03385044|Endotracheal sealing|endotracheal sealing
965414|NCT03385031|Dose-guided radiation therapy|dose-guided radiation therapy
965415|NCT03385031|CBCT|cbct
965416|NCT03385005|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
965417|NCT03385005|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
965418|NCT03385005|Healthy Volunteer|healthy volunteer
965419|NCT03385005|Spinal Cord Injury|spinal cord injury
965420|NCT03385005|Biomedical Engineering|biomedical engineering
965421|NCT03384992|Fear of Cancer Recurrence|fear of cancer recurrence
965422|NCT03384992|ehealth interventions|ehealth interventions
965423|NCT03384992|PROMIS|promis
965424|NCT03384992|FoR|for
965425|NCT03384940|Oncology|oncology
965426|NCT03384940|HER2|her2
965427|NCT03384940|Colorectal cancer|colorectal cancer
965428|NCT03384940|Antibody drug conjugate|antibody drug conjugate
965429|NCT03384940|ADC|adc
965430|NCT03384927|Treatment diary|treatment diary
965431|NCT03384914|axillary nodes|axillary nodes
965432|NCT03384914|HER-2 directed treatment|her-2 directed treatment
965433|NCT03384888|Fibromyalgia, Neurostimulation, TDCS|fibromyalgia, neurostimulation, tdcs
965434|NCT03384875|CytoSorb device|cytosorb device
965435|NCT03384875|Plasma free hemoglobin|plasma free hemoglobin
965436|NCT03384875|inflammation|inflammation
965437|NCT03384875|extracorporeal cardiopulmonary bypass|extracorporeal cardiopulmonary bypass
965440|NCT03384862|Arsenic exposure|arsenic exposure
965441|NCT03384849|Fiber-optic sensor system|fiber-optic sensor system
965442|NCT03384849|Magnetic resonance imaging|magnetic resonance imaging
965443|NCT03384849|Medical monitoring|medical monitoring
965444|NCT03384849|Physiological parameters|physiological parameters
965445|NCT03384836|Melanoma|melanoma
965446|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
965447|NCT03384836|Beta Adrenergic Blockers|beta adrenergic blockers
965448|NCT03384823|First-in-Human|first-in-human
965449|NCT03384823|Single Ascending Dose|single ascending dose
965450|NCT03384823|Multiple Ascending Dose|multiple ascending dose
965451|NCT03384810|CPR|cpr
965452|NCT03384810|cardiac arrest|cardiac arrest
965453|NCT03384810|inhospital|inhospital
965454|NCT03384797|blood|blood
965455|NCT03384797|biomarker|biomarker
965456|NCT03384797|Parkinson's disease|parkinson's disease
965457|NCT03384784|HIV|hiv
965458|NCT03384784|Neurocognition|neurocognition
965459|NCT03384784|Inflammation|inflammation
965460|NCT03384784|Galantamine|galantamine
965461|NCT03384784|Nicotine|nicotine
965462|NCT03384784|Tobacco Use|tobacco use
965463|NCT03384771|mindfulness, MBSR, teaching|mindfulness, mbsr, teaching
965464|NCT03384758|Compression therapy|compression therapy
965465|NCT03384758|Microcirculation|microcirculation
965466|NCT03384758|Diabetes mellitus|diabetes mellitus
965467|NCT03384758|Peripheral Arterial Disease|peripheral arterial disease
965468|NCT03384732|community-dwelling elderly|community-dwelling elderly
965469|NCT03384732|ICF|icf
965470|NCT03384732|core set development|core set development
965471|NCT03384732|geriatric|geriatric
965472|NCT03384732|functioning|functioning
965473|NCT03384732|health|health
965474|NCT03384732|ageing|ageing
965475|NCT03384719|Growth factor|growth factor
965476|NCT03384719|Protein|protein
965477|NCT03384719|Milk protein|milk protein
965478|NCT03384719|Plant protein|plant protein
965479|NCT03384719|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
965480|NCT03384719|Insulin|insulin
965481|NCT03384719|Insulin-like growth factor-binding protein-3 (IGFBP-3)|insulin-like growth factor-binding protein-3 (igfbp-3)
965482|NCT03384706|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
965483|NCT03384706|Clinical Trial|clinical trial
965484|NCT03384706|Psychotherapy|psychotherapy
965485|NCT03384706|Assessment|assessment
965486|NCT03384706|Effectiveness|effectiveness
965487|NCT03384693|hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
965488|NCT03384693|prophylactic defibrotide|prophylactic defibrotide
965489|NCT03384667|Maekmoondong-tang|maekmoondong-tang
965490|NCT03384667|Mai-men-dong-tang|mai-men-dong-tang
965491|NCT03384667|Bakumondo-to|bakumondo-to
965492|NCT03384628|Contact lens|contact lens
965493|NCT03384628|The Young Theory|the young theory
965494|NCT03384602|subjective cognitive decline|subjective cognitive decline
965495|NCT03384602|falls prevention|falls prevention
965496|NCT03384602|cognitive function|cognitive function
965497|NCT03384602|dalcroze eurhythmics|dalcroze eurhythmics
965498|NCT03384602|home exercise program|home exercise program
965499|NCT03384602|seniors|seniors
965505|NCT03384563|dexmedetomidine|dexmedetomidine
965506|NCT03384537|intra-oral microorganisms.|intra-oral microorganisms.
965507|NCT03384537|cariogenic microorganisms|cariogenic microorganisms
965508|NCT03384511|RGD PET-CT|rgd pet-ct
965509|NCT03384511|Apatinib|apatinib
965510|NCT03384498|Genetic epidemiology|genetic epidemiology
965511|NCT03384498|Antimalarial drug resistance|antimalarial drug resistance
965512|NCT03384472|Malaria Genetic Surveillance|malaria genetic surveillance
965513|NCT03384472|Cambodia|cambodia
965514|NCT03384459|vitiligo|vitiligo
965515|NCT03384459|308-nm excimer laser|308-nm excimer laser
965516|NCT03384459|maintenance therapy|maintenance therapy
965517|NCT03384459|recurrence|recurrence
965518|NCT03384420|Autologous stem cell transplantation|autologous stem cell transplantation
965519|NCT03384355|varicose veins|varicose veins
965520|NCT03384355|chronic venous disease|chronic venous disease
965521|NCT03384355|ecchymosis|ecchymosis
965522|NCT03384355|symptoms|symptoms
965523|NCT03384316|Combination Vaccine|combination vaccine
965524|NCT03384316|Adenoviral|adenoviral
965525|NCT03384316|ETBX-011|etbx-011
965526|NCT03384316|ETBX-061|etbx-061
965527|NCT03384316|ETBX-051|etbx-051
965528|NCT03384303|Incretines|incretines
965529|NCT03384303|Bile acids|bile acids
965530|NCT03384303|Gut hormones|gut hormones
965531|NCT03384303|Limb lengths|limb lengths
965532|NCT03384303|Biliopancreatic limb|biliopancreatic limb
965533|NCT03384303|Bariatric surgery|bariatric surgery
965534|NCT03384303|Gastric bypass|gastric bypass
965535|NCT03384290|Asthma|asthma
965536|NCT03384290|Anticalin|anticalin
965537|NCT03384290|PRS-060|prs-060
965538|NCT03384290|Healthy Volunteers|healthy volunteers
965539|NCT03384290|Pieris|pieris
965540|NCT03384290|IL-4 receptor alpha|il-4 receptor alpha
965541|NCT03384290|IL-13|il-13
965542|NCT03384290|IL-4|il-4
965543|NCT03384277|Acquired hemophilia A|acquired hemophilia a
965544|NCT03384277|Cyclophosphamide|cyclophosphamide
965545|NCT03384277|Rituximab|rituximab
965546|NCT03384277|Steroid|steroid
965547|NCT03384251|Adolescent pregnancy|adolescent pregnancy
965548|NCT03384251|Teenage pregnancy|teenage pregnancy
965549|NCT03384251|Prevention|prevention
965550|NCT03384251|Ghana|ghana
965551|NCT03384225|cladribine|cladribine
965552|NCT03384225|fludarabine|fludarabine
965553|NCT03384225|relapse|relapse
965554|NCT03384212|cladribine|cladribine
965555|NCT03384212|fludarabine|fludarabine
965556|NCT03384212|relapse|relapse
965557|NCT03384199|Localized Prostate|localized prostate
965558|NCT03384199|VMAT|vmat
965559|NCT03384199|Dose escalation|dose escalation
965560|NCT03384199|Fiducial marker|fiducial marker
965561|NCT03384199|Focal Lesion|focal lesion
965562|NCT03384199|Random error during dose escalation radiotherapy|random error during dose escalation radiotherapy
965563|NCT03384199|fiducial marker image guided technique|fiducial marker image guided technique
965564|NCT03384173|Near Infrared Spectroscopy|near infrared spectroscopy
965565|NCT03384173|Creatinine|creatinine
965566|NCT03384173|Urine Output|urine output
965567|NCT03384160|Pain|pain
965568|NCT03384160|Third molar|third molar
965569|NCT03384160|Articaine|articaine
965570|NCT03384160|Mepivacaine|mepivacaine
965571|NCT03384134|cancer|cancer
965572|NCT03384134|cognitive and behavioral skills training intervention|cognitive and behavioral skills training intervention
965573|NCT03384134|pain|pain
965574|NCT03384134|symptoms|symptoms
965575|NCT03384134|quality of life|quality of life
965576|NCT03384121|CYP24A1|cyp24a1
965577|NCT03384121|Nephrocalcinosis|nephrocalcinosis
965578|NCT03384121|Hypercalcemia|hypercalcemia
965579|NCT03384121|Hypercalcuria|hypercalcuria
965580|NCT03384095|Aromatase Inhibitors|aromatase inhibitors
965581|NCT03384069|Cognitive Impairment|cognitive impairment
965582|NCT03384069|Cognitive- behavioral therapy|cognitive- behavioral therapy
965583|NCT03384069|African Americans|african americans
965584|NCT03384030|Malodor|malodor
965585|NCT03384030|Stress|stress
965586|NCT03384030|STMST|stmst
965587|NCT03384004|Root Canal Treatment|root canal treatment
965588|NCT03383991|Humeral Fracture, Proximal|humeral fracture, proximal
965589|NCT03383991|Arthroplasty, Replacement, Shoulder|arthroplasty, replacement, shoulder
965590|NCT03383991|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
965591|NCT03383991|Shoulder Hemiarthroplasty|shoulder hemiarthroplasty
965592|NCT03383939|bronchiectasis|bronchiectasis
965593|NCT03383939|alpha1-antitrypsin|alpha1-antitrypsin
965594|NCT03383939|neutrophilic elastase|neutrophilic elastase
965595|NCT03383926|Longo|longo
965596|NCT03383926|Hemorrhoids|hemorrhoids
965597|NCT03383926|Rectal|rectal
965598|NCT03383926|Prolapse|prolapse
965599|NCT03383926|Anal|anal
965600|NCT03383913|Heart Rate Variability Biofeedback|heart rate variability biofeedback
965601|NCT03383835|Omega 3 supplement|omega 3 supplement
965602|NCT03383835|pre-menopausal|pre-menopausal
965603|NCT03383835|pregnancy|pregnancy
965604|NCT03383809|Self-reported healthy adults|self-reported healthy adults
965605|NCT03383796|Cholangiocarcinoma perihilar|cholangiocarcinoma perihilar
965606|NCT03383796|three dimension laparoscopic|three dimension laparoscopic
965608|NCT03383731|Operation mode|operation mode
965609|NCT03383731|Air tamponade|air tamponade
965610|NCT03383731|High myopia|high myopia
965611|NCT03383731|Macular hole retinal detachment|macular hole retinal detachment
965612|NCT03383718|Coronary Artery Disease|coronary artery disease
965613|NCT03383718|Fractional Flow Reserve|fractional flow reserve
965614|NCT03383718|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
965615|NCT03383718|Stable Coronary Artery Disease|stable coronary artery disease
965616|NCT03383718|Bystander Coronary Artery Disease|bystander coronary artery disease
965617|NCT03383718|Non-Culprit Lesions|non-culprit lesions
965618|NCT03383718|Acute Myocardial Infarction|acute myocardial infarction
965619|NCT03383705|Photoaged Skin|photoaged skin
965620|NCT03383692|Unresectable or metastatic solid malignant tumors|unresectable or metastatic solid malignant tumors
965621|NCT03383692|Solid malignant tumors|solid malignant tumors
965622|NCT03383692|Oncology|oncology
965624|NCT03383692|Antibody drug conjugate|antibody drug conjugate
965626|NCT03383666|Unruptured|unruptured
965627|NCT03383666|intracranial aneurysms|intracranial aneurysms
965628|NCT03383666|Endovascular|endovascular
965629|NCT03383653|Td Vaccine|td vaccine
965630|NCT03383653|Safety|safety
965631|NCT03383653|Pregnant|pregnant
965632|NCT03383653|Pregnant Women|pregnant women
965633|NCT03383627|Chronic Kidney Disease|chronic kidney disease
965634|NCT03383601|COPD|copd
965635|NCT03383601|Exacerbation of respiratory symptoms|exacerbation of respiratory symptoms
965636|NCT03383601|Functional exercise capacity|functional exercise capacity
965637|NCT03383601|Heated Tobacco Products|heated tobacco products
965638|NCT03383601|Respiratory symptoms|respiratory symptoms
965639|NCT03383575|Myelodysplastic Syndrome|myelodysplastic syndrome
965640|NCT03383575|MDS|mds
965641|NCT03383575|Enasidenib|enasidenib
965642|NCT03383575|AG-221|ag-221
965643|NCT03383575|IDHIFA|idhifa
965644|NCT03383575|Azacitidine|azacitidine
965645|NCT03383575|5-Azacytidine|5-azacytidine
965646|NCT03383575|Azacytidine|azacytidine
965647|NCT03383575|5-aza|5-aza
965648|NCT03383575|Vidaza|vidaza
965649|NCT03383575|5-AZC|5-azc
965650|NCT03383575|AZA-CR|aza-cr
965651|NCT03383575|Ladakamycin|ladakamycin
965652|NCT03383575|NSC-102816|nsc-102816
965653|NCT03383549|Telerehabilitation [E02.831.891]|telerehabilitation [e02.831.891]
965654|NCT03383549|Cognitive Aging [G07.345.124.260]|cognitive aging [g07.345.124.260]
965655|NCT03383549|Exercise Therapy [E02.760.169.063.500.387]|exercise therapy [e02.760.169.063.500.387]
965656|NCT03383536|fMRI|fmri
965657|NCT03383536|stress|stress
965658|NCT03383536|peptide|peptide
965659|NCT03383536|social|social
965660|NCT03383536|neuroimaging|neuroimaging
965661|NCT03383484|polycystic ovary syndrome|polycystic ovary syndrome
965662|NCT03383484|hyperandrogenism|hyperandrogenism
965663|NCT03383484|nonpharmacological|nonpharmacological
965664|NCT03383484|yoga|yoga
965665|NCT03383484|osteopathic manipulative medicine|osteopathic manipulative medicine
965666|NCT03383471|chondrocyte cells|chondrocyte cells
965667|NCT03383471|osteoarthritis|osteoarthritis
965668|NCT03383471|gene therapy|gene therapy
965669|NCT03383419|Heart Failure, Heart Transplant|heart failure, heart transplant
965670|NCT03383380|Activated PI3K-delta Syndrome|activated pi3k-delta syndrome
965671|NCT03383380|Immunodeficiency Primary|immunodeficiency primary
965672|NCT03383380|Akt/mTOR pathway|akt/mtor pathway
965673|NCT03383380|Rapamycin Therapy|rapamycin therapy
965674|NCT03383380|Hyperphosphorylation|hyperphosphorylation
965675|NCT03383367|mass screening|mass screening
965676|NCT03383367|colonoscopy surveillance|colonoscopy surveillance
965677|NCT03383367|high risk patients|high risk patients
965678|NCT03383341|gut microbiota|gut microbiota
965679|NCT03383341|cricket powder|cricket powder
965680|NCT03383341|prebiotic fiber|prebiotic fiber
965681|NCT03383341|inflammation|inflammation
965682|NCT03383341|dietary intervention|dietary intervention
965683|NCT03383328|Cataract|cataract
965684|NCT03383328|Cataract Surgery|cataract surgery
965685|NCT03383302|Non-small cell lung cancer|non-small cell lung cancer
965686|NCT03383302|NSCLC|nsclc
965687|NCT03383263|Humira®|humira®
965688|NCT03383263|polyarticular juvenile arthritis|polyarticular juvenile arthritis
965689|NCT03383263|Adalimumab|adalimumab
965690|NCT03383250|meal ingestion|meal ingestion
965691|NCT03383250|postprandial sensations|postprandial sensations
965692|NCT03383250|circulating metabolites|circulating metabolites
965693|NCT03383224|smoking cessation treatment|smoking cessation treatment
965694|NCT03383211|RNAseq|rnaseq
965695|NCT03383211|Next Generation Sequencing|next generation sequencing
965696|NCT03383211|Transcriptome|transcriptome
965697|NCT03383211|Peripheral blood transcripts|peripheral blood transcripts
965698|NCT03383211|Tempus Blood RNA Tubes|tempus blood rna tubes
965699|NCT03383185|contraception|contraception
965700|NCT03383185|Body mass index|body mass index
965701|NCT03383185|Metabolic Syndrome|metabolic syndrome
965702|NCT03383185|obesity|obesity
965703|NCT03383172|Prevention|prevention
965704|NCT03383172|Promotion|promotion
965705|NCT03383172|Mental Health|mental health
965706|NCT03383159|Microbiota|microbiota
965707|NCT03383159|Metachronous Adenoma|metachronous adenoma
965708|NCT03383159|Colorectal Cancer|colorectal cancer
965709|NCT03383159|Colonoscopy|colonoscopy
965710|NCT03383146|diabetic gastroparesis|diabetic gastroparesis
965711|NCT03383146|vomiting|vomiting
965712|NCT03383133|sulfotransferase|sulfotransferase
965713|NCT03383133|metabolism|metabolism
965714|NCT03383133|acetaminophen|acetaminophen
965715|NCT03383133|dehydroepiandrosterone|dehydroepiandrosterone
965716|NCT03383133|mefenamic acid|mefenamic acid
965717|NCT03383133|allostery|allostery
965718|NCT03383120|Peri-implantitis|peri-implantitis
965719|NCT03383120|Diode laser|diode laser
965720|NCT03383120|Surgical debridement|surgical debridement
965721|NCT03383094|cancer|cancer
965722|NCT03383094|Head and Neck|head and neck
965723|NCT03383094|Pembrolizumab|pembrolizumab
965724|NCT03383094|Cisplatin|cisplatin
965725|NCT03383094|Radiotherapy|radiotherapy
965726|NCT03383094|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
965727|NCT03383094|p16+|p16+
965728|NCT03383081|osteoarthritis, mesenchymal stem cell|osteoarthritis, mesenchymal stem cell
965729|NCT03383068|PCOS|pcos
965730|NCT03383068|imparied glucose tolerance|imparied glucose tolerance
965731|NCT03383029|Nutrition|nutrition
965732|NCT03383029|Behavioral|behavioral
965733|NCT03383016|Prostate cancer risk|prostate cancer risk
965734|NCT03383016|Environmental risk factors|environmental risk factors
965735|NCT03383016|Biomarkers|biomarkers
965736|NCT03383016|Inflammation and prostate cancer|inflammation and prostate cancer
965737|NCT03383003|Helicobacter pylori eradication|helicobacter pylori eradication
965738|NCT03383003|High dose proton pump inhibitor|high dose proton pump inhibitor
965739|NCT03383003|High dose Amoxicillin|high dose amoxicillin
965740|NCT03383003|Concomitant therapy|concomitant therapy
965741|NCT03382990|Atrial fibrillation|atrial fibrillation
965742|NCT03382990|Acute myocardial infarction|acute myocardial infarction
965743|NCT03382990|Drug-eluting stent|drug-eluting stent
965744|NCT03382977|GBM|gbm
965745|NCT03382977|Glioblastoma|glioblastoma
965746|NCT03382977|eVLP|evlp
965747|NCT03382977|VBI-1901|vbi-1901
965748|NCT03382977|vaccine|vaccine
965749|NCT03382977|immunotherapy|immunotherapy
965750|NCT03382977|CMV|cmv
965751|NCT03382977|CNS|cns
965752|NCT03382977|Brain|brain
965753|NCT03382977|Cancer|cancer
965754|NCT03382964|VLA1553|vla1553
965755|NCT03382964|Chikungunya|chikungunya
965756|NCT03382964|CHIKV|chikv
965757|NCT03382964|Live-attenuated Chikungunya virus vaccine|live-attenuated chikungunya virus vaccine
965758|NCT03382938|dexmedetomidine|dexmedetomidine
965759|NCT03382938|ropivacaine|ropivacaine
965760|NCT03382938|wound infiltration|wound infiltration
965761|NCT03382938|ceasarean section|ceasarean section
965762|NCT03382925|cervical epidural steroid injection|cervical epidural steroid injection
965763|NCT03382925|local anesthetic|local anesthetic
965764|NCT03382925|upper extremity weakness|upper extremity weakness
965765|NCT03382886|Advanced and/or metastatic|advanced and/or metastatic
965766|NCT03382873|Hyperglycemia|hyperglycemia
965767|NCT03382873|Obese|obese
965768|NCT03382873|Overweight|overweight
965769|NCT03382860|Intracranial Hypertension|intracranial hypertension
965770|NCT03382860|Intracranial pressure monitoring|intracranial pressure monitoring
965771|NCT03382860|Non-invasive point-of-care device|non-invasive point-of-care device
965772|NCT03382860|Normal pressure hydrocephalus|normal pressure hydrocephalus
965773|NCT03382821|cervical epidural steroid injection|cervical epidural steroid injection
965774|NCT03382821|transforaminal approach|transforaminal approach
965775|NCT03382821|epidural catheter targeted|epidural catheter targeted
965776|NCT03382821|interlaminar approach|interlaminar approach
965777|NCT03382821|cervical radicular pain|cervical radicular pain
965778|NCT03382795|Epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
965779|NCT03382795|Cytotoxic chemotherapy|cytotoxic chemotherapy
965780|NCT03382795|Epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
965781|NCT03382782|Obesity|obesity
965782|NCT03382782|Mental Disorder|mental disorder
965783|NCT03382782|Peer Navigator|peer navigator
965784|NCT03382782|Physical Health|physical health
965785|NCT03382782|Overweight|overweight
965786|NCT03382782|Serious Mental Illness|serious mental illness
965787|NCT03382743|office hysteroscopy|office hysteroscopy
965788|NCT03382743|Lidocaine spray|lidocaine spray
965789|NCT03382704|Peri-ocular|peri-ocular
965790|NCT03382678|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
965791|NCT03382665|Revision total hip arthroplasty|revision total hip arthroplasty
965792|NCT03382665|Medical Device|medical device
965793|NCT03382665|Post Market Surveillance Study|post market surveillance study
965794|NCT03382665|Primary total hip arthroplasty|primary total hip arthroplasty
965795|NCT03382652|Total hip arthroplasty|total hip arthroplasty
965796|NCT03382652|Medical Device|medical device
965797|NCT03382652|Post Market Surveillance Study|post market surveillance study
965798|NCT03382652|Performance|performance
965799|NCT03382652|Safety|safety
965800|NCT03382639|Drug therapy|drug therapy
965801|NCT03382626|Traumatic Brain Injury|traumatic brain injury
965802|NCT03382626|Transcranial Direct Current Stimulation|transcranial direct current stimulation
966200|NCT03380026|CTCL|ctcl
965803|NCT03382626|Computer-assisted training|computer-assisted training
965804|NCT03382626|Cognitive training|cognitive training
965805|NCT03382626|Cognitive function|cognitive function
965806|NCT03382626|Executive function|executive function
965807|NCT03382626|Working memory|working memory
965808|NCT03382626|Attention|attention
965809|NCT03382548|Ventilator Associated Pneumonia|ventilator associated pneumonia
965810|NCT03382548|Pneumonia|pneumonia
965811|NCT03382535|Voice disorder|voice disorder
965812|NCT03382535|Teacher's voice|teacher's voice
965813|NCT03382535|Voice SPL (Voice sound pressure level)|voice spl (voice sound pressure level)
1333212|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
965814|NCT03382535|Voice F0 (Voice fundamental frequency)|voice f0 (voice fundamental frequency)
965815|NCT03382535|Voice therapy|voice therapy
965816|NCT03382535|Voice accumulator|voice accumulator
965817|NCT03382535|Activity noise|activity noise
965818|NCT03382535|Classroom|classroom
965819|NCT03382522|bone scintigraphy|bone scintigraphy
965820|NCT03382522|quantification|quantification
965821|NCT03382522|prostate cancer|prostate cancer
965822|NCT03382522|prognosis|prognosis
965823|NCT03382457|Functional|functional
965824|NCT03382457|TR|tr
965825|NCT03382457|FTR|ftr
965826|NCT03382457|Transcatheter|transcatheter
965827|NCT03382457|Reconstruction|reconstruction
965828|NCT03382444|cognitive impairment|cognitive impairment
965829|NCT03382444|hemodialysis|hemodialysis
965830|NCT03382444|dementia|dementia
965831|NCT03382444|end stage renal disease|end stage renal disease
965832|NCT03382405|cytomegalovirus vaccine|cytomegalovirus vaccine
965833|NCT03382405|mRNA-1647|mrna-1647
965834|NCT03382405|mRNA-1443|mrna-1443
966126|NCT03380442|psilocybin|psilocybin
965835|NCT03382392|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
965836|NCT03382392|Resting energy expenditure|resting energy expenditure
965837|NCT03382392|Predictive equation|predictive equation
965838|NCT03382379|methamphetamine|methamphetamine
965839|NCT03382379|transcranial Direct Current Stimulation|transcranial direct current stimulation
965840|NCT03382379|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
965841|NCT03382379|amphetamine|amphetamine
965842|NCT03382379|drug craving|drug craving
965843|NCT03382366|Sarcopenia|sarcopenia
965844|NCT03382366|Risk of fall|risk of fall
965845|NCT03382366|Osteoporosis|osteoporosis
965846|NCT03382366|Muscle|muscle
965847|NCT03382366|DXA|dxa
965848|NCT03382366|MR|mr
965849|NCT03382366|Muscle metabolism|muscle metabolism
965850|NCT03382353|primary prevention|primary prevention
965851|NCT03382353|Subjective Cognitive Decline|subjective cognitive decline
965852|NCT03382353|Neuroimaging|neuroimaging
965853|NCT03382353|Alzheimer's disease|alzheimer's disease
965854|NCT03382353|nonpharmacological interventions|nonpharmacological interventions
965855|NCT03382353|multidomain lifestyle interventions|multidomain lifestyle interventions
965856|NCT03382327|Surgical planning|surgical planning
965857|NCT03382327|CT-scan|ct-scan
965858|NCT03382327|MRI|mri
965859|NCT03382327|3D model|3d model
965860|NCT03382327|Hepatocarcinoma eligible for surgical resection|hepatocarcinoma eligible for surgical resection
965861|NCT03382301|Ischemia reperfusion injuries|ischemia reperfusion injuries
965862|NCT03382301|Renal artery stenosis|renal artery stenosis
965863|NCT03382301|Renal functional imaging|renal functional imaging
965864|NCT03382262|Osteoarthritis|osteoarthritis
965865|NCT03382262|Shoulder|shoulder
965866|NCT03382262|Hip|hip
965867|NCT03382262|Pain|pain
965868|NCT03382262|Intra-articular|intra-articular
965869|NCT03382262|Injection|injection
965870|NCT03382262|Corticosteroid|corticosteroid
965871|NCT03382210|Enhanced Recovery Program|enhanced recovery program
965872|NCT03382197|aerosol therapy|aerosol therapy
965873|NCT03382197|positive pressure|positive pressure
965874|NCT03382197|electrical impedance tomography|electrical impedance tomography
965875|NCT03382197|pulmonary scintigraphy|pulmonary scintigraphy
965876|NCT03382158|pleuropulmonary blastoma|pleuropulmonary blastoma
965877|NCT03382158|PPB|ppb
965878|NCT03382158|DICER1|dicer1
965879|NCT03382158|Sertoli-Leydig cell tumor|sertoli-leydig cell tumor
965880|NCT03382158|cystic nephroma|cystic nephroma
965881|NCT03382119|liver stiffness Fontan|liver stiffness fontan
965882|NCT03382093|Anxiety Sensitivity|anxiety sensitivity
965883|NCT03382093|Tobacco|tobacco
965884|NCT03382093|Smoking|smoking
965885|NCT03382093|Anxiety|anxiety
965886|NCT03382093|Feedback|feedback
965887|NCT03382093|Stress|stress
965888|NCT03382080|randomized controlled trial|randomized controlled trial
965889|NCT03382080|drop out|drop out
965890|NCT03382080|upper secondary school|upper secondary school
965891|NCT03382080|psychosocial learning environments|psychosocial learning environments
965892|NCT03382028|developmental abnormalities|developmental abnormalities
965893|NCT03382028|psychomotor development|psychomotor development
965894|NCT03381989|TAVR|tavr
965895|NCT03381989|Native Aortic Valve Failure|native aortic valve failure
965896|NCT03381989|TAVR Associated Coronary Artery Obstruction|tavr associated coronary artery obstruction
965897|NCT03381989|Electrosurgery|electrosurgery
965898|NCT03381963|tamoxifen|tamoxifen
965899|NCT03381963|aromatase inhibitors|aromatase inhibitors
965900|NCT03381963|breast cancer|breast cancer
965901|NCT03381963|venous thromboembolism|venous thromboembolism
965902|NCT03381950|chronic kidney disease|chronic kidney disease
965903|NCT03381950|prospective cohort study|prospective cohort study
965904|NCT03381950|risk profile|risk profile
965905|NCT03381950|patient-reported-outcomes|patient-reported-outcomes
965906|NCT03381937|mechanical ventilation|mechanical ventilation
965907|NCT03381937|noninvasive ventilation|noninvasive ventilation
965908|NCT03381937|neuromuscular disorder|neuromuscular disorder
965909|NCT03381937|phonation|phonation
1655256|NCT00168636|Mortality|mortality
979353|NCT03295617|surgery|surgery
965910|NCT03381937|mouthpiece ventilation|mouthpiece ventilation
965911|NCT03381924|Migraine disorders|migraine disorders
965912|NCT03381924|Educational models|educational models
965913|NCT03381924|Neuroscience|neuroscience
965914|NCT03381898|Telehealth|telehealth
965915|NCT03381898|Physical therapy exercise|physical therapy exercise
965916|NCT03381898|Speech therapy Lee Silverman voice treatment|speech therapy lee silverman voice treatment
965917|NCT03381898|Pharmacy medication management|pharmacy medication management
965918|NCT03381872|Intravascular Imaging|intravascular imaging
965919|NCT03381872|Intravascular Ultrasound|intravascular ultrasound
965920|NCT03381872|Optical Coherence Tomography|optical coherence tomography
965921|NCT03381872|Complex Lesion|complex lesion
965922|NCT03381872|Percutaneous Coronary Intervention|percutaneous coronary intervention
965923|NCT03381859|Hepatitis C Virus|hepatitis c virus
965924|NCT03381859|Genotype 4|genotype 4
965925|NCT03381859|End Stage Renal Disease|end stage renal disease
965926|NCT03381820|music therapy|music therapy
965927|NCT03381820|hypertension|hypertension
965928|NCT03381820|Asian|asian
965929|NCT03381820|stage-2 hypertension|stage-2 hypertension
966127|NCT03380442|ketamine|ketamine
965932|NCT03381781|acute myeloid leukemia|acute myeloid leukemia
965934|NCT03381781|Arsenic trioxide|arsenic trioxide
965935|NCT03381781|cytarabine|cytarabine
965936|NCT03381768|PD-L1|pd-l1
965937|NCT03381768|PD-L2|pd-l2
965938|NCT03381768|peptide vaccine|peptide vaccine
965939|NCT03381729|Gene Transfer|gene transfer
965940|NCT03381729|Gene Therapy|gene therapy
965941|NCT03381729|Adeno-associated virus|adeno-associated virus
965942|NCT03381729|Survival Motor Neuron|survival motor neuron
965943|NCT03381729|SMN|smn
965944|NCT03381729|AAV9|aav9
965945|NCT03381716|aortic dissection|aortic dissection
965946|NCT03381716|sex|sex
965947|NCT03381716|treatment|treatment
965948|NCT03381703|Accelerated Mass Spectrometry|accelerated mass spectrometry
965949|NCT03381703|Microtracer|microtracer
965950|NCT03381703|Microdose|microdose
965951|NCT03381703|hAME|hame
965952|NCT03381703|Absolute bioavailability|absolute bioavailability
965953|NCT03381677|pedicle lengthening osteotomy|pedicle lengthening osteotomy
965954|NCT03381677|spinal stenosis|spinal stenosis
965955|NCT03381677|decompression|decompression
965956|NCT03381664|bioavailability|bioavailability
965957|NCT03381664|pharmacokinetics|pharmacokinetics
965958|NCT03381664|safety|safety
965959|NCT03381664|tolerability|tolerability
965960|NCT03381664|AVP-923|avp-923
965961|NCT03381664|dextromethorphan|dextromethorphan
965962|NCT03381664|quinidine|quinidine
965963|NCT03381651|Radiation dose|radiation dose
965964|NCT03381638|Concussion|concussion
965965|NCT03381638|TBI|tbi
965966|NCT03381638|Sports|sports
965967|NCT03381638|Medical Device|medical device
965968|NCT03381638|Fast|fast
965969|NCT03381612|Female circumcision, Young Women, Dysmenorrhea,Dysuria|female circumcision, young women, dysmenorrhea,dysuria
965970|NCT03381586|ALT-803|alt-803
965971|NCT03381586|PK|pk
965972|NCT03381560|LASSYC; COPD symptoms.|lassyc; copd symptoms.
965973|NCT03381534|vertebral artery origin|vertebral artery origin
965974|NCT03381534|angioplasty|angioplasty
965975|NCT03381534|distal embolic protection|distal embolic protection
965976|NCT03381521|nerve hydrodissection|nerve hydrodissection
965977|NCT03381508|CPAP|cpap
965978|NCT03381508|masks|masks
965979|NCT03381508|unintentional leak|unintentional leak
965980|NCT03381508|leakage|leakage
965981|NCT03381495|Epidural Labor Analgesia|epidural labor analgesia
965982|NCT03381495|length of labor stage|length of labor stage
965983|NCT03381495|fetal outcomes|fetal outcomes
965984|NCT03381495|maternal outcomes|maternal outcomes
965985|NCT03381482|Alzheimer disease|alzheimer disease
965986|NCT03381482|Extracellular vesicles|extracellular vesicles
965987|NCT03381482|Biomarker|biomarker
965988|NCT03381482|Tau|tau
965989|NCT03381482|CSF|csf
965990|NCT03381482|Plasma|plasma
965991|NCT03381404|Mass Balance Study with MT-8554|mass balance study with mt-8554
965992|NCT03381378|Vitamin D|vitamin d
965993|NCT03381378|s-25-hydroxyvitamin D|s-25-hydroxyvitamin d
965994|NCT03381378|hand grip strength|hand grip strength
965995|NCT03381378|myopathy|myopathy
965996|NCT03381378|muscle|muscle
965997|NCT03381352|Radiotherapy|radiotherapy
965998|NCT03381352|Anal cancer|anal cancer
965999|NCT03381352|IMRT|imrt
966000|NCT03381339|power toothbrush, oscillating rotating|power toothbrush, oscillating rotating
966001|NCT03381326|circulating tumor cells|circulating tumor cells
966002|NCT03381326|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
966003|NCT03381326|cabazitaxel|cabazitaxel
966004|NCT03381326|biomarker|biomarker
966005|NCT03381326|free DNA|free dna
966006|NCT03381326|stem cells|stem cells
966007|NCT03381326|EMT related antigens|emt related antigens
966009|NCT03381261|chronic migraine|chronic migraine
966010|NCT03381261|trigeminal neuralgia|trigeminal neuralgia
966011|NCT03381261|migraine surgery|migraine surgery
966012|NCT03381261|nerve decompression|nerve decompression
966013|NCT03381248|randomized clinical trial|randomized clinical trial
966014|NCT03381248|osteoarthritis|osteoarthritis
966015|NCT03381248|radiofrequency ablation|radiofrequency ablation
966016|NCT03381248|knee|knee
966017|NCT03381248|genicular|genicular
966018|NCT03381248|cross-over|cross-over
966019|NCT03381248|viscosupplemention|viscosupplemention
966020|NCT03381235|Exercise|exercise
966021|NCT03381235|Quality of life|quality of life
966022|NCT03381235|Progression of disease|progression of disease
966023|NCT03381235|Retinitis|retinitis
966024|NCT03381209|Sugammadex|sugammadex
966025|NCT03381209|morbidly obese patients|morbidly obese patients
966026|NCT03381209|bariatric surgery|bariatric surgery
966027|NCT03381209|neuromuscular blockade|neuromuscular blockade
966028|NCT03381170|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
966029|NCT03381157|general movements, fidgety movements, motor optimality score|general movements, fidgety movements, motor optimality score
966030|NCT03381105|Diagnostics, over-diagnosis|diagnostics, over-diagnosis
966031|NCT03381092|neoadjuvant chemotherapy|neoadjuvant chemotherapy
966032|NCT03381092|sentinel lymph node biopsy|sentinel lymph node biopsy
966033|NCT03381092|axillary lymph node dissection|axillary lymph node dissection
966034|NCT03381092|Predictive model|predictive model
966035|NCT03381066|NSCLC|nsclc
966036|NCT03381066|EGFR|egfr
966037|NCT03381066|adjuvant|adjuvant
966038|NCT03381066|gefitinib|gefitinib
966039|NCT03381066|intercalating|intercalating
966040|NCT03381053|GIST|gist
966041|NCT03381053|Grading and Staging|grading and staging
966042|NCT03381027|Infant Sleep|infant sleep
966043|NCT03381027|Baby Massage|baby massage
966044|NCT03381027|Neurodevelopmental Disorders|neurodevelopmental disorders
966045|NCT03381001|cryopreservation|cryopreservation
966046|NCT03381001|human embryos|human embryos
966047|NCT03381001|vitrification|vitrification
966048|NCT03381001|embryo culture|embryo culture
966049|NCT03381001|embryo transfer|embryo transfer
966050|NCT03381001|pregnancy rate|pregnancy rate
966051|NCT03380975|MAAP|maap
966052|NCT03380975|Asthma|asthma
966053|NCT03380975|Allergic rhinits|allergic rhinits
966054|NCT03380962|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
966055|NCT03380962|Kidney Transplantation|kidney transplantation
966056|NCT03380962|Donor Specific Antibody|donor specific antibody
966057|NCT03380949|Analgesia|analgesia
966058|NCT03380949|Monitoring|monitoring
966059|NCT03380949|Opioid|opioid
966060|NCT03380949|Sufentanil|sufentanil
966061|NCT03380949|Sevoflurane|sevoflurane
966062|NCT03380936|subclinical|subclinical
966063|NCT03380936|graft rejection|graft rejection
966064|NCT03380936|AMR (antibody-mediated rejection)|amr (antibody-mediated rejection)
966065|NCT03380936|AMBR (acute antibody-mediated rejection)|ambr (acute antibody-mediated rejection)
966066|NCT03380936|DSA (donor specific antibodies)|dsa (donor specific antibodies)
966067|NCT03380923|epigenetics|epigenetics
966068|NCT03380923|exercise dose-response|exercise dose-response
966069|NCT03380923|inter-individual response heterogeneity|inter-individual response heterogeneity
966070|NCT03380923|exercise training adaptations|exercise training adaptations
966071|NCT03380897|induction of labor|induction of labor
966072|NCT03380897|double balloon catheter|double balloon catheter
966073|NCT03380897|mechanical ripening|mechanical ripening
966074|NCT03380884|Distal Radius Fracture, Osteoporosis, Vibration Therapy|distal radius fracture, osteoporosis, vibration therapy
966075|NCT03380871|Personal Vaccine|personal vaccine
966076|NCT03380871|Neoantigen|neoantigen
966077|NCT03380871|Immunotherapy|immunotherapy
966078|NCT03380871|Poly-ICLC|poly-iclc
966079|NCT03380871|Peptide|peptide
966080|NCT03380871|Checkpoint Inhibitor|checkpoint inhibitor
966081|NCT03380806|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
966082|NCT03380806|conventional radiotherapy (CRT)|conventional radiotherapy (crt)
966083|NCT03380806|High risk prostate cancer|high risk prostate cancer
966084|NCT03380806|quality of life (QoL)|quality of life (qol)
966085|NCT03380806|The Expanded Prostate cancer Index Composite (EPIC-26)|the expanded prostate cancer index composite (epic-26)
966086|NCT03380806|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
966087|NCT03380767|trauma-induced coagulopathy|trauma-induced coagulopathy
966088|NCT03380754|Nausea|nausea
966089|NCT03380754|Vomiting|vomiting
966090|NCT03380754|Knee Arthroplasty|knee arthroplasty
966091|NCT03380754|PONV|ponv
966092|NCT03380754|TKA|tka
966093|NCT03380715|Sinusitis|sinusitis
966094|NCT03380715|Endoscopy|endoscopy
966095|NCT03380715|Rhinitis|rhinitis
966096|NCT03380702|colour|colour
966097|NCT03380702|dental aesthetics|dental aesthetics
966098|NCT03380702|perceptions|perceptions
966099|NCT03380702|quality of life|quality of life
966100|NCT03380702|tooth whitening|tooth whitening
966101|NCT03380663|blood flow restricted resistance exercise|blood flow restricted resistance exercise
966102|NCT03380663|remote ischemic conditioning|remote ischemic conditioning
966103|NCT03380663|miRNA|mirna
1333213|NCT01443975|Osteoarthritis|osteoarthritis
966104|NCT03380650|femoropopliteal occlusive disease|femoropopliteal occlusive disease
966105|NCT03380650|directional atherectomy|directional atherectomy
966106|NCT03380650|local drug delivery|local drug delivery
966107|NCT03380650|endovascular treatment|endovascular treatment
966108|NCT03380598|Mobile Health, Self-Monitoring, Behavioural Treatment|mobile health, self-monitoring, behavioural treatment
966109|NCT03380572|Robotic Surgery|robotic surgery
966110|NCT03380559|Epicondylitis|epicondylitis
966111|NCT03380559|Botulinum toxin|botulinum toxin
966112|NCT03380559|Corticoid|corticoid
966113|NCT03380546|Diabetes|diabetes
966114|NCT03380546|Pregnancy|pregnancy
966115|NCT03380546|Gestational|gestational
966116|NCT03380546|Acarbose|acarbose
966117|NCT03380507|Septic Shock|septic shock
966118|NCT03380507|Vitamin C|vitamin c
966119|NCT03380507|Thiamine|thiamine
966120|NCT03380507|Hydrocortisone|hydrocortisone
966121|NCT03380507|Critically Ill|critically ill
966122|NCT03380494|Overhead perturbation training; instability, glenohumeral joint|overhead perturbation training; instability, glenohumeral joint
966123|NCT03380468|Lung adenocarcinoma|lung adenocarcinoma
966124|NCT03380468|adjuvant chemotherapy|adjuvant chemotherapy
966125|NCT03380442|fMRI|fmri
966128|NCT03380442|biomarker|biomarker
966129|NCT03380442|rapid-acting antidepressants|rapid-acting antidepressants
966130|NCT03380429|Connected Inhaler System|connected inhaler system
966131|NCT03380429|Metered Dose Inhaler|metered dose inhaler
966132|NCT03380429|ELLIPTA|ellipta
966133|NCT03380429|RELVAR/BREO|relvar/breo
966134|NCT03380429|Dry Powder Inhaler|dry powder inhaler
966135|NCT03380429|Salbutamol|salbutamol
966136|NCT03380429|Asthma|asthma
966137|NCT03380403|diabetic foot|diabetic foot
966138|NCT03380403|Osteomyelitis|osteomyelitis
966139|NCT03380403|PACT|pact
966140|NCT03380403|PDT|pdt
966141|NCT03380403|Singlet oxygen|singlet oxygen
966142|NCT03380403|antimicrobial|antimicrobial
966143|NCT03380403|diabetes|diabetes
966144|NCT03380403|Wagner scale|wagner scale
966145|NCT03380377|kidney transplant|kidney transplant
966146|NCT03380377|Chronic antibody mediated rejection|chronic antibody mediated rejection
966147|NCT03380377|donor specific antibody|donor specific antibody
966148|NCT03380338|Gut microbiota|gut microbiota
966149|NCT03380325|Capillary recruitment|capillary recruitment
966150|NCT03380286|Firehawk|firehawk
966151|NCT03380286|Coronary Artery Disease|coronary artery disease
966152|NCT03380286|Drug Eluting Stent|drug eluting stent
966153|NCT03380247|Emergency, trauma pain, analgesia, Methoxyfurane|emergency, trauma pain, analgesia, methoxyfurane
966154|NCT03380234|Secondhand smoke|secondhand smoke
966155|NCT03380234|Thirdhand smoke|thirdhand smoke
966156|NCT03380234|Children|children
966157|NCT03380234|Cluster randomised controlled trial|cluster randomised controlled trial
966158|NCT03380182|acupuncture|acupuncture
966159|NCT03380182|acupressure|acupressure
966160|NCT03380143|Children|children
966161|NCT03380143|Cancer Prevention|cancer prevention
966162|NCT03380143|Population Health|population health
966163|NCT03380143|Rural|rural
966164|NCT03380143|Community|community
966165|NCT03380143|School|school
966166|NCT03380143|After School|after school
966167|NCT03380143|Youth Sport|youth sport
966168|NCT03380143|Intervention|intervention
966169|NCT03380143|Multilevel|multilevel
966170|NCT03380143|Systems|systems
966171|NCT03380130|Hepatocellular Carcinoma|hepatocellular carcinoma
966172|NCT03380130|Liver cancer|liver cancer
966173|NCT03380130|Hepatoma|hepatoma
966174|NCT03380117|Suicidal Ideation|suicidal ideation
966175|NCT03380117|Suicide Attempt|suicide attempt
966176|NCT03380117|Risk Screening|risk screening
966177|NCT03380117|Online Intervention|online intervention
966178|NCT03380117|Online Counseling|online counseling
966179|NCT03380117|College Students|college students
966180|NCT03380117|Motivational Interviewing|motivational interviewing
966181|NCT03380117|Linkage to Care|linkage to care
966182|NCT03380104|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
966183|NCT03380091|PCOS|pcos
966184|NCT03380091|Depression|depression
966185|NCT03380091|Vitamin D|vitamin d
966186|NCT03380091|Insulin Resistance|insulin resistance
966187|NCT03380091|Anxiety|anxiety
966188|NCT03380091|Quality of life|quality of life
966189|NCT03380091|Mood disorders|mood disorders
966190|NCT03380078|Implementation Mechanism|implementation mechanism
966191|NCT03380078|Autism Spectrum Disorder|autism spectrum disorder
966192|NCT03380078|Children's Mental Health Services|children's mental health services
966193|NCT03380078|School Services|school services
966194|NCT03380065|coronary angiogram|coronary angiogram
966195|NCT03380065|radial artery|radial artery
966196|NCT03380052|OLGA|olga
966197|NCT03380052|OLGIM|olgim
966198|NCT03380052|Helicobacter pylori|helicobacter pylori
966199|NCT03380052|Gastric cancer|gastric cancer
966201|NCT03380026|topical mechlorethamine|topical mechlorethamine
966202|NCT03380026|Valchlor|valchlor
966203|NCT03380026|contact dermatitis|contact dermatitis
966204|NCT03380026|triamcinolone|triamcinolone
966205|NCT03380026|MF|mf
966206|NCT03380026|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
966207|NCT03380013|hypothermia treatment|hypothermia treatment
966208|NCT03380013|OMT in infants|omt in infants
966209|NCT03380000|Dietary nitrate supplementation|dietary nitrate supplementation
966210|NCT03380000|Beetroot juice|beetroot juice
966211|NCT03379961|social categorization|social categorization
966212|NCT03379961|nurse sorting|nurse sorting
966213|NCT03379961|emergencies units|emergencies units
966214|NCT03379909|metformin|metformin
966215|NCT03379909|marker lesion|marker lesion
966216|NCT03379870|cochlear implant|cochlear implant
966217|NCT03379870|electric acoustic stimulation|electric acoustic stimulation
966219|NCT03379870|hearing loss|hearing loss
966220|NCT03379870|pediatric|pediatric
966221|NCT03379831|systemic right ventricle|systemic right ventricle
966222|NCT03379831|quality of life|quality of life
966223|NCT03379831|VO2|vo2
966224|NCT03379831|oxygen uptake|oxygen uptake
966225|NCT03379831|exercise test|exercise test
966226|NCT03379831|congenital heart disease|congenital heart disease
966227|NCT03379818|Shape bias|shape bias
966228|NCT03379818|Late Talkers|late talkers
966229|NCT03379792|Obesity|obesity
966230|NCT03379779|Microbiota|microbiota
966231|NCT03379779|Respiratory Failure|respiratory failure
966232|NCT03379779|Pneumonia|pneumonia
966233|NCT03379779|Lower Respiratory Tract Infection|lower respiratory tract infection
966234|NCT03379740|Reduced risk product|reduced risk product
966235|NCT03379727|Midostaurin|midostaurin
966236|NCT03379727|PKC412|pkc412
966237|NCT03379727|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
966238|NCT03379727|FLT3|flt3
966239|NCT03379727|Acute Myeloid Leukemia|acute myeloid leukemia
966240|NCT03379727|AML|aml
966241|NCT03379727|7+3 chemotherapy|7+3 chemotherapy
966242|NCT03379727|5+2 chemotherapy|5+2 chemotherapy
966243|NCT03379727|Daunorubicin|daunorubicin
966244|NCT03379727|Idarubicin|idarubicin
966245|NCT03379727|Cytarabine|cytarabine
966246|NCT03379701|chronic rhinosinusitis, nasal polyposis|chronic rhinosinusitis, nasal polyposis
966247|NCT03379662|Autism|autism
966248|NCT03379662|Autistic Disorder|autistic disorder
966249|NCT03379662|Autistic Spectrum Disorder|autistic spectrum disorder
966250|NCT03379662|Irritability|irritability
966251|NCT03379662|laser|laser
966252|NCT03379662|light therapy|light therapy
966253|NCT03379649|Recurrent implantation failure|recurrent implantation failure
966254|NCT03379636|Athletic tape|athletic tape
966255|NCT03379636|Electromyography|electromyography
966256|NCT03379636|Rehabilitation|rehabilitation
966257|NCT03379636|Shoulder|shoulder
966258|NCT03379597|Schizophrenia|schizophrenia
966259|NCT03379597|probiotics|probiotics
966260|NCT03379597|cognitive impairment|cognitive impairment
966261|NCT03379597|Metabolic syndrome|metabolic syndrome
966262|NCT03379597|clinical trail|clinical trail
966263|NCT03379597|Efficacy|efficacy
966264|NCT03379597|Safety|safety
966265|NCT03379584|Multiple myeloma|multiple myeloma
966266|NCT03379584|Antibody-drug conjugate|antibody-drug conjugate
966267|NCT03379571|Chronic kidney disease|chronic kidney disease
966268|NCT03379571|Competing-risk analysis|competing-risk analysis
966269|NCT03379571|Epidemiological study|epidemiological study
966270|NCT03379571|Incidence|incidence
966271|NCT03379571|Outcomes|outcomes
966272|NCT03379571|Risk factors|risk factors
966273|NCT03379493|relapsed/refractory CD19+ Lymphomas Non-Hodgkin's B-Cell|relapsed/refractory cd19+ lymphomas non-hodgkin's b-cell
966274|NCT03379480|Schizophrenia, Yoga, fMRI, self reflection, efficacy|schizophrenia, yoga, fmri, self reflection, efficacy
966275|NCT03379467|SMS Reminder|sms reminder
966276|NCT03379467|Two-way Reminder|two-way reminder
966277|NCT03379428|Breast Cancer|breast cancer
966278|NCT03379428|Metastatic Breast Cancer|metastatic breast cancer
966279|NCT03379428|HER2-amplified Metastatic Breast Cancer|her2-amplified metastatic breast cancer
966280|NCT03379428|HER2-positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
966281|NCT03379415|Meniscectomy|meniscectomy
966282|NCT03379415|Footwear|footwear
966283|NCT03379415|Osteoarthritis|osteoarthritis
966284|NCT03379402|causes of community-acquired sepsis|causes of community-acquired sepsis
966285|NCT03379402|diagnostic tests|diagnostic tests
966286|NCT03379363|cushing syndrome, hypercortisolism|cushing syndrome, hypercortisolism
966287|NCT03379350|lung cancer|lung cancer
966288|NCT03379350|surgery|surgery
966289|NCT03379350|chest tube clamping|chest tube clamping
966290|NCT03379350|duration of chest tube drainage|duration of chest tube drainage
966291|NCT03379350|postoperative stay|postoperative stay
966292|NCT03379337|Imaging|imaging
966293|NCT03379324|Rotator Cuff|rotator cuff
966294|NCT03379324|Human Amniotic Fluid|human amniotic fluid
966295|NCT03379324|Amniotic Fluid Allograft|amniotic fluid allograft
966296|NCT03379324|FlōGraft®|flōgraft®
966297|NCT03379324|Amniotic Fluid Biologic|amniotic fluid biologic
966298|NCT03379324|Fatty Atrophy|fatty atrophy
966299|NCT03379324|Fat Degeneration|fat degeneration
966303|NCT03379285|Gastro Intestinal Bleeding;|gastro intestinal bleeding;
966304|NCT03379285|Transfusion,|transfusion,
966305|NCT03379285|Outcomes|outcomes
966306|NCT03379272|Electroencephalography|electroencephalography
966307|NCT03379272|Epilepsy|epilepsy
966308|NCT03379272|EEG|eeg
966309|NCT03379233|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
966310|NCT03379233|Adherence|adherence
966311|NCT03379233|Dose Tracking|dose tracking
966312|NCT03379233|Concept2|concept2
966313|NCT03379233|Digital Adherence System|digital adherence system
966314|NCT03379233|Ultibro Breezhaler|ultibro breezhaler
966315|NCT03379207|Community-acquired Pneumonia|community-acquired pneumonia
966316|NCT03379207|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
966317|NCT03379207|Innate Immunity|innate immunity
966318|NCT03379207|Non Conventional T Lymphocytes|non conventional t lymphocytes
966319|NCT03379194|antibiotic prescriptions|antibiotic prescriptions
966320|NCT03379194|resistance|resistance
966321|NCT03379194|feedback|feedback
966322|NCT03379194|primary care|primary care
966323|NCT03379181|Brown adipose tissue (BAT)|brown adipose tissue (bat)
966324|NCT03379181|Hyperthyroidism|hyperthyroidism
966325|NCT03379168|knee osteoarthritis|knee osteoarthritis
966326|NCT03379168|mesenchymal stem cell|mesenchymal stem cell
966327|NCT03379168|adipose tissue|adipose tissue
966329|NCT03379168|nonoperative treatment|nonoperative treatment
966330|NCT03379142|Faith-Based; Community-engaged; Text messaging; Tobacco|faith-based; community-engaged; text messaging; tobacco
966331|NCT03379103|Blood Loss, Surgical|blood loss, surgical
966332|NCT03379103|Blood Transfusion|blood transfusion
966333|NCT03379103|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
966334|NCT03379077|Mothers|mothers
966335|NCT03379077|young children|young children
966336|NCT03379077|Implementation|implementation
966337|NCT03379077|Learning through play Plus|learning through play plus
966338|NCT03379077|Cognitive Behavior Therapy|cognitive behavior therapy
966339|NCT03379064|Irritable Bowel Syndrome, Low Income Country|irritable bowel syndrome, low income country
966340|NCT03379038|Cerebral Palsy|cerebral palsy
966341|NCT03379038|Spasticity|spasticity
966342|NCT03379038|Constipation|constipation
966343|NCT03379038|Gross Motor Functional Classification Scale|gross motor functional classification scale
966344|NCT03379038|Defecation Frequency|defecation frequency
966345|NCT03379038|Constipation Severity|constipation severity
966346|NCT03379025|electronic cigarettes; e-cigarettes|electronic cigarettes; e-cigarettes
966347|NCT03378973|motor evoked potentials|motor evoked potentials
966348|NCT03378947|EBV, DLBCL|ebv, dlbcl
966349|NCT03378934|Coronary Artery Disease|coronary artery disease
966350|NCT03378934|Percutaneous Coronary Intervention|percutaneous coronary intervention
966351|NCT03378934|Antiplatelet|antiplatelet
966352|NCT03378934|Berberine|berberine
966353|NCT03378921|FMT|fmt
966354|NCT03378908|medical therapy nutrition|medical therapy nutrition
966355|NCT03378908|meal|meal
966356|NCT03378908|carbohydrates|carbohydrates
966357|NCT03378908|intervention|intervention
966358|NCT03378908|food intake|food intake
966359|NCT03378882|Angiostrongylosis|angiostrongylosis
966360|NCT03378882|Hypereosinophilia|hypereosinophilia
966361|NCT03378882|Eosinophilic meningitis|eosinophilic meningitis
966362|NCT03378882|Meningoencephalitis|meningoencephalitis
966363|NCT03378882|Achatina fulica|achatina fulica
966364|NCT03378882|Angiostrongylus cantonensis|angiostrongylus cantonensis
966365|NCT03378882|Angiostrongylus costaricensis|angiostrongylus costaricensis
966366|NCT03378843|Polyamine, cardiovascular disease, cancer|polyamine, cardiovascular disease, cancer
966368|NCT03378830|Sleep Disordered Breathing|sleep disordered breathing
966369|NCT03378817|Extended criteria donor|extended criteria donor
966370|NCT03378817|Donation after brain death|donation after brain death
966371|NCT03378817|HOPE|hope
966372|NCT03378817|Kidney transplantation|kidney transplantation
966373|NCT03378804|PCEA|pcea
966374|NCT03378804|PIEB|pieb
966375|NCT03378804|epidural analgesia|epidural analgesia
966376|NCT03378752|Computer tomography|computer tomography
966377|NCT03378752|Liver tumor thermoablation|liver tumor thermoablation
966378|NCT03378739|cardiogenic|cardiogenic
966379|NCT03378739|shock|shock
966380|NCT03378713|Poor Ovarian Response|poor ovarian response
966381|NCT03378700|CKD|ckd
966382|NCT03378700|Hope Intervention|hope intervention
966383|NCT03378700|decision making|decision making
966384|NCT03378687|Status Epilepticus|status epilepticus
966385|NCT03378687|Children|children
966386|NCT03378687|Multi-center|multi-center
966387|NCT03378687|etiology|etiology
966388|NCT03378687|treatment|treatment
966389|NCT03378687|outcome|outcome
966390|NCT03378687|risk factor|risk factor
966391|NCT03378661|Chronic, Indeterminate|chronic, indeterminate
966392|NCT03378635|Glucagon|glucagon
966393|NCT03378596|Post-Exercise Hypotension|post-exercise hypotension
966394|NCT03378596|Exercise|exercise
966395|NCT03378596|Arginine|arginine
966396|NCT03378596|Citrulline|citrulline
966397|NCT03378570|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
966398|NCT03378570|rTMS|rtms
966399|NCT03378570|TMS|tms
966401|NCT03378570|5.5cm rule|5.5cm rule
966402|NCT03378570|Targeting|targeting
966403|NCT03378518|In-hospital Cardiac Arrest, mortality|in-hospital cardiac arrest, mortality
966405|NCT03378453|Narcolepsy|narcolepsy
966406|NCT03378453|Alzheimer|alzheimer
966407|NCT03378453|Orexin|orexin
966408|NCT03378453|Amyloid|amyloid
966409|NCT03378453|PET-amyloid imaging|pet-amyloid imaging
966410|NCT03378427|Tedizolid|tedizolid
966411|NCT03378427|Adverse effects|adverse effects
966412|NCT03378427|Efficacy|efficacy
966413|NCT03378427|prosthetic joint infection|prosthetic joint infection
966414|NCT03378414|Spinocerebellar Ataxia,Mesenchymal Stem Cells|spinocerebellar ataxia,mesenchymal stem cells
966415|NCT03378388|Drug therapy|drug therapy
966416|NCT03378323|upper extremity surgery|upper extremity surgery
966417|NCT03378297|Ovarian cancer|ovarian cancer
966418|NCT03378297|Phase 0|phase 0
966419|NCT03378297|Window-of-opportunity|window-of-opportunity
966420|NCT03378297|Suregry|suregry
966421|NCT03378297|Repurposing|repurposing
966422|NCT03378297|Metformin|metformin
966423|NCT03378297|Acetylsalicylic acid|acetylsalicylic acid
966424|NCT03378297|Olaparib|olaparib
966425|NCT03378297|Letrozol|letrozol
966426|NCT03378271|Continuous Glucose Monitoring|continuous glucose monitoring
966427|NCT03378271|Flash glucose Monitoring|flash glucose monitoring
966428|NCT03378271|Renal Impairment|renal impairment
966429|NCT03378271|Type 1 Diabetes|type 1 diabetes
966430|NCT03378271|Type 2 Diabetes|type 2 diabetes
966431|NCT03378258|meningococcal|meningococcal
966432|NCT03378258|neisseria meningitidis|neisseria meningitidis
966433|NCT03378258|sepsis|sepsis
966434|NCT03378258|meningitis|meningitis
966435|NCT03378258|procalcitonin|procalcitonin
966436|NCT03378258|PCT|pct
966437|NCT03378258|LAMP|lamp
966438|NCT03378258|loop-mediated-isothermal AMPlification|loop-mediated-isothermal amplification
966439|NCT03378232|DHA|dha
966440|NCT03378232|EPA|epa
966441|NCT03378232|fatty acids|fatty acids
966442|NCT03378232|blood pressure|blood pressure
966443|NCT03378232|resting metabolic rate|resting metabolic rate
966444|NCT03378232|blood lipids|blood lipids
966445|NCT03378232|muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
966446|NCT03378206|genu valgum or varum|genu valgum or varum
966447|NCT03378206|eight-plate|eight-plate
966448|NCT03378206|epiphysis arrest|epiphysis arrest
966449|NCT03378206|hemiepiphysiodesis|hemiepiphysiodesis
966450|NCT03378193|Squamous cell carcinoma|squamous cell carcinoma
966451|NCT03378193|FDG PET/CT|fdg pet/ct
966452|NCT03378193|Textural analysis|textural analysis
966453|NCT03378167|Paediatrics|paediatrics
966454|NCT03378167|Pediatrics|pediatrics
966455|NCT03378167|Crohn's|crohn's
966456|NCT03378167|Crohn|crohn
966457|NCT03378167|Microbiome|microbiome
966458|NCT03378167|Microbiota|microbiota
966459|NCT03378167|FMT|fmt
966460|NCT03378167|Fecal Transplant|fecal transplant
966461|NCT03378167|Fecal Microbiota Transplant|fecal microbiota transplant
966462|NCT03378167|IBD-U|ibd-u
966463|NCT03378167|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
966464|NCT03378167|Inflammatory Bowel Disease Indeterminate|inflammatory bowel disease indeterminate
966465|NCT03378167|IBD|ibd
966466|NCT03378167|Colitis|colitis
966467|NCT03378154|King vision|king vision
966468|NCT03378154|Difficult airway|difficult airway
966469|NCT03378154|Videolaryngoscope|videolaryngoscope
966470|NCT03378154|Paediatric intubation|paediatric intubation
966471|NCT03378128|debulking surgery|debulking surgery
966472|NCT03378128|Ovarian Cancer|ovarian cancer
966473|NCT03378102|T Cell Therapy|t cell therapy
966474|NCT03378102|Opportunistic Infection|opportunistic infection
966475|NCT03378089|Music Therapy|music therapy
966476|NCT03378076|Osteoarthritis|osteoarthritis
966477|NCT03378076|Knee|knee
966478|NCT03378076|Corticosteroid|corticosteroid
966479|NCT03378076|Bilateral|bilateral
966480|NCT03378076|Pain|pain
966481|NCT03378076|Intra-articular|intra-articular
966482|NCT03378076|Injection|injection
966483|NCT03378037|Brain Injuries, Traumatic|brain injuries, traumatic
966484|NCT03378037|Alzheimer's disease|alzheimer's disease
966485|NCT03378037|Magnetic resonance imaging|magnetic resonance imaging
966486|NCT03378037|white matter integrity|white matter integrity
966487|NCT03378037|beta-Amyloid|beta-amyloid
966488|NCT03378024|Oscillometric device|oscillometric device
966489|NCT03378024|repetitive Active Pedal Plantarflexion (APP) exercise test|repetitive active pedal plantarflexion (app) exercise test
966490|NCT03378024|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
966491|NCT03377959|dance|dance
966492|NCT03377959|ballet|ballet
966493|NCT03377959|Exercise Movement Techniques|exercise movement techniques
966494|NCT03377959|turnout|turnout
966495|NCT03377946|pre-diabetes,diabetes,probiotics|pre-diabetes,diabetes,probiotics
966496|NCT03377933|Helicobacter pylori|helicobacter pylori
966497|NCT03377933|Probiotics|probiotics
966498|NCT03377933|Efficacy|efficacy
966499|NCT03377933|Safety|safety
966500|NCT03377933|gastromicroecology|gastromicroecology
966501|NCT03377907|IVRA|ivra
966502|NCT03377907|hematoma block|hematoma block
966503|NCT03377842|apatinib|apatinib
966504|NCT03377829|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
966505|NCT03377829|Percutaneous Laser Ablation|percutaneous laser ablation
966506|NCT03377829|thyroidectomy|thyroidectomy
966507|NCT03377829|ultrasonography|ultrasonography
966508|NCT03377829|double-blind|double-blind
966509|NCT03377816|Emotion Processing|emotion processing
966510|NCT03377816|Art Therapy|art therapy
966511|NCT03377816|Breast Cancer|breast cancer
966512|NCT03377816|Cholinergic anti-inflammatory pathway|cholinergic anti-inflammatory pathway
966513|NCT03377803|Molluscum|molluscum
966514|NCT03377803|Skin Diseases|skin diseases
966515|NCT03377803|Poxviridae Infections|poxviridae infections
966516|NCT03377803|Skin Diseases; Infectious|skin diseases; infectious
966517|NCT03377803|Skin Diseases; Viral|skin diseases; viral
966518|NCT03377803|DNA Poxvirus|dna poxvirus
966519|NCT03377790|Molluscum|molluscum
966520|NCT03377790|Skin Diseases|skin diseases
966521|NCT03377790|Poxviridae Infections|poxviridae infections
966522|NCT03377790|Skin Diseases; Infectious|skin diseases; infectious
966523|NCT03377790|Skin Diseases; Viral|skin diseases; viral
966524|NCT03377790|DNA Poxvirus|dna poxvirus
966525|NCT03377777|Anemia|anemia
966526|NCT03377777|Iron-deficiency|iron-deficiency
966527|NCT03377777|Iron-deficiency anemia|iron-deficiency anemia
966528|NCT03377777|Infants|infants
966538|NCT03377738|Primary care|primary care
966539|NCT03377738|Smoking Cessations|smoking cessations
966540|NCT03377725|Myelodysplastic Syndromes|myelodysplastic syndromes
966541|NCT03377725|Decitabine|decitabine
966542|NCT03377725|Arsenic Trioxide|arsenic trioxide
966543|NCT03377725|P53 Mutations|p53 mutations
966544|NCT03377686|paediatrics|paediatrics
966545|NCT03377686|breath analysis|breath analysis
966546|NCT03377686|volatile organic compounds|volatile organic compounds
966547|NCT03377686|respiratory diseases|respiratory diseases
966548|NCT03377660|Esophagectomy|esophagectomy
966549|NCT03377660|Unintentional weight loss|unintentional weight loss
966550|NCT03377660|Gut hormones|gut hormones
966562|NCT03377621|whole body vibration|whole body vibration
966563|NCT03377621|sleep|sleep
966564|NCT03377621|apnea|apnea
966565|NCT03377608|tenofovir|tenofovir
966566|NCT03377608|microbiome|microbiome
966567|NCT03377608|inflammation|inflammation
966568|NCT03377582|cardiovascular diseases|cardiovascular diseases
966569|NCT03377582|cardiac rehabilitation|cardiac rehabilitation
966570|NCT03377582|sympathetic nervous system|sympathetic nervous system
966571|NCT03377582|heart rate|heart rate
966572|NCT03377582|blood pressure|blood pressure
966573|NCT03377582|clinical trial|clinical trial
966574|NCT03377582|virtual reality exposure therapy|virtual reality exposure therapy
966575|NCT03377582|barriers to cardiac rehabilitation|barriers to cardiac rehabilitation
966576|NCT03377582|motivation|motivation
966577|NCT03377582|adherence patient|adherence patient
966578|NCT03377582|engagement|engagement
966579|NCT03377582|perceived exertion|perceived exertion
966580|NCT03377582|oxygen saturation|oxygen saturation
966581|NCT03377569|Deep Brain Stimulation|deep brain stimulation
966582|NCT03377569|Polysomnography|polysomnography
966583|NCT03377569|Actigraphy|actigraphy
966584|NCT03377530|Bacillus Cereus|bacillus cereus
966585|NCT03377530|Premature neonates|premature neonates
966586|NCT03377504|complex regional pain syndrome|complex regional pain syndrome
966587|NCT03377504|mirror therapy|mirror therapy
966588|NCT03377504|rehabilitation|rehabilitation
966589|NCT03377491|Locally Advanced Pancreatic Adenocarcinoma|locally advanced pancreatic adenocarcinoma
966590|NCT03377491|TTFields|ttfields
966591|NCT03377491|Tumor Treating Fields|tumor treating fields
966592|NCT03377491|Gemcitabine|gemcitabine
966593|NCT03377491|nab-Paclitaxel|nab-paclitaxel
966594|NCT03377491|Minimal toxicity|minimal toxicity
966595|NCT03377491|TTF|ttf
966596|NCT03377491|Novocure|novocure
966597|NCT03377439|Platelet function|platelet function
966598|NCT03377439|Bleeding risk|bleeding risk
966599|NCT03377439|Immune Thrombocytopenia|immune thrombocytopenia
966600|NCT03377426|Urinary tract infection, LYS228, beta-lactam antibiotics, creatinine clearance, Enterobactericeae|urinary tract infection, lys228, beta-lactam antibiotics, creatinine clearance, enterobactericeae
966601|NCT03377387|Capecitabine|capecitabine
966602|NCT03377387|Neratinib|neratinib
966603|NCT03377387|HER2-Positive|her2-positive
966604|NCT03377387|17-585|17-585
966605|NCT03377335|Dapagliflozin|dapagliflozin
966606|NCT03377335|Type 2 diabetes mellitus|type 2 diabetes mellitus
966607|NCT03377335|Carotid intima-media thickness|carotid intima-media thickness
966608|NCT03377335|Endothelial dysfunction|endothelial dysfunction
966609|NCT03377335|Atherogenic lipoproteins|atherogenic lipoproteins
966610|NCT03377335|Inflammatory markers|inflammatory markers
966611|NCT03377335|microRNAs|micrornas
966612|NCT03377309|Safety|safety
966613|NCT03377309|Tolerability|tolerability
966614|NCT03377309|Perampanel|perampanel
966615|NCT03377270|Oropharyngeal Head and Neck Cancer|oropharyngeal head and neck cancer
966616|NCT03377270|dysphagia|dysphagia
1655257|NCT00168636|Morbidity|morbidity
966617|NCT03377270|Respiratory Swallow Training|respiratory swallow training
966618|NCT03377257|Cluster headache|cluster headache
966619|NCT03377257|zolmitriptan|zolmitriptan
966620|NCT03377257|Sublingual administration|sublingual administration
966621|NCT03377231|Pregnancy, Striae gravidarum, Striae distensae, Women's health|pregnancy, striae gravidarum, striae distensae, women's health
966622|NCT03377192|Impedance pneumography|impedance pneumography
966623|NCT03377192|Respiratory function|respiratory function
966624|NCT03377192|Asthma management|asthma management
966625|NCT03377179|Clinical Trial, Phase II|clinical trial, phase ii
966626|NCT03377179|Multicenter Trials|multicenter trials
966627|NCT03377179|Clinical Study|clinical study
966628|NCT03377179|Clinical Trials, Non-Randomized|clinical trials, non-randomized
966629|NCT03377179|Oral capsule|oral capsule
966630|NCT03377179|Single arm|single arm
966631|NCT03377179|Anti-cancer|anti-cancer
966632|NCT03377179|Anti-inflammatory|anti-inflammatory
966633|NCT03377179|ABC294640|abc294640
966634|NCT03377179|Yeliva ®|yeliva ®
966635|NCT03377127|diabetes|diabetes
966636|NCT03377127|pharmacy clinic|pharmacy clinic
966637|NCT03377127|education|education
966638|NCT03377127|diabetes complications|diabetes complications
966639|NCT03377127|hemoglobin A1c|hemoglobin a1c
966640|NCT03377127|health-care cost|health-care cost
966641|NCT03377127|'no show' rate|'no show' rate
966642|NCT03377127|compliance|compliance
966643|NCT03377127|diabetes core measures|diabetes core measures
966644|NCT03377114|Nasotracheal intubation|nasotracheal intubation
966645|NCT03377049|acetazolamide challenge|acetazolamide challenge
966646|NCT03377049|cerebral vasospasm|cerebral vasospasm
966647|NCT03377049|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
966648|NCT03377036|Breast Cancer|breast cancer
966649|NCT03377036|Population-based Screening|population-based screening
966650|NCT03377036|Digital Breast Tomosynthesis plus synthesized Mammography|digital breast tomosynthesis plus synthesized mammography
966651|NCT03377036|Reconstructed Mammography|reconstructed mammography
966652|NCT03377036|Full-Field Digital Mammography (FFDM)|full-field digital mammography (ffdm)
966653|NCT03377036|Multicentric Randomized Controlled Trial|multicentric randomized controlled trial
966654|NCT03377036|Diagnostic Performance|diagnostic performance
966655|NCT03377036|Recall Rate|recall rate
966656|NCT03377036|Interval Cancer|interval cancer
966657|NCT03377023|Nivolumab|nivolumab
966658|NCT03377023|Ipilimumab|ipilimumab
966659|NCT03377023|Nintedanib|nintedanib
966660|NCT03377023|Immunotherapy|immunotherapy
966661|NCT03377023|Advanced stage non-small cell lung cancer|advanced stage non-small cell lung cancer
966662|NCT03377023|Locally advanced non-small cell lung cancer|locally advanced non-small cell lung cancer
966663|NCT03376997|Bioavailability|bioavailability
966664|NCT03376997|Perampanel|perampanel
966665|NCT03376984|Root Canal Therapy|root canal therapy
966666|NCT03376971|Lesion|lesion
966667|NCT03376971|Lung|lung
966668|NCT03376971|Cancer|cancer
966669|NCT03376971|Diagnosis|diagnosis
966670|NCT03376971|Optical Biopsy|optical biopsy
966671|NCT03376971|Biopsy|biopsy
966672|NCT03376958|R/R DLBCL, DCR, OS, PFS|r/r dlbcl, dcr, os, pfs
966673|NCT03376945|n-3|n-3
966674|NCT03376945|Parenteral nutrition|parenteral nutrition
966675|NCT03376945|Jaundice|jaundice
966676|NCT03376945|Propensity score match|propensity score match
966677|NCT03376932|Vilanterol|vilanterol
966678|NCT03376932|Fluticasone furoate|fluticasone furoate
966679|NCT03376932|Connected Inhaler System|connected inhaler system
966680|NCT03376932|Dry powder inhaler|dry powder inhaler
966681|NCT03376932|Umeclidinium|umeclidinium
966682|NCT03376932|Asthma|asthma
966683|NCT03376919|wearable robotics|wearable robotics
966684|NCT03376919|Unilateral Lower Limb Amputation|unilateral lower limb amputation
966685|NCT03376919|gait efficiency|gait efficiency
966686|NCT03376906|Obesity|obesity
966687|NCT03376906|aerobic exercise|aerobic exercise
966688|NCT03376906|interval exercise|interval exercise
966689|NCT03376867|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
966690|NCT03376867|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
966691|NCT03376867|pressure pain threshold (PPT)|pressure pain threshold (ppt)
966692|NCT03376867|reference values|reference values
966693|NCT03376867|clinical decision rule|clinical decision rule
966694|NCT03376854|ARDS, temperature management, neuromuscular blockade|ards, temperature management, neuromuscular blockade
966695|NCT03376841|Liver insufficiency|liver insufficiency
966696|NCT03376841|Hepatic Impairment|hepatic impairment
966697|NCT03376841|Cenicriviroc|cenicriviroc
966698|NCT03376841|Pharmacokinetics|pharmacokinetics
966699|NCT03376828|laryngoscopy|laryngoscopy
966700|NCT03376828|videolaryngoscopy|videolaryngoscopy
966701|NCT03376828|hypertension|hypertension
966702|NCT03376815|Tumor ,landscape ,pathological diagnosis|tumor ,landscape ,pathological diagnosis
966703|NCT03376776|idiopathic macular hole|idiopathic macular hole
966704|NCT03376763|aripiprazole|aripiprazole
966705|NCT03376763|Long-Acting Injection|long-acting injection
966706|NCT03376750|telerehabilitation|telerehabilitation
966707|NCT03376750|occupational therapy|occupational therapy
966708|NCT03376750|RCT|rct
966709|NCT03376750|participation|participation
966710|NCT03376750|quality of life|quality of life
966711|NCT03376750|intervention|intervention
966712|NCT03376750|older adults|older adults
966713|NCT03376659|PD-L1|pd-l1
966714|NCT03376633|Randomized Controlled Trial|randomized controlled trial
966716|NCT03376633|Chicago Public Schools|chicago public schools
966717|NCT03376633|high school|high school
966718|NCT03376633|trauma-informed counseling|trauma-informed counseling
966719|NCT03376633|group-based counseling|group-based counseling
966720|NCT03376633|counseling|counseling
966721|NCT03376633|mentoring|mentoring
966722|NCT03376633|Cognitive Behavioral Therapy|cognitive behavioral therapy
966723|NCT03376633|CBT|cbt
966724|NCT03376633|adolescents|adolescents
966725|NCT03376633|females|females
966726|NCT03376633|trauma|trauma
966727|NCT03376633|stress|stress
966728|NCT03376633|PTSD|ptsd
966729|NCT03376633|anxiety|anxiety
966730|NCT03376633|depression|depression
966731|NCT03376633|graduation|graduation
966732|NCT03376620|Prevention of hypertrophic scar|prevention of hypertrophic scar
966733|NCT03376607|Primary Health Care|primary health care
966734|NCT03376607|Health Behavior|health behavior
966735|NCT03376607|Quality of Life|quality of life
966736|NCT03376607|Health Literacy|health literacy
966737|NCT03376607|Global Health|global health
966738|NCT03376607|Medication Adherence|medication adherence
966739|NCT03376594|Benjakul Extract|benjakul extract
966740|NCT03376594|Allergic Rhinitis|allergic rhinitis
966741|NCT03376594|Herbal Medicine|herbal medicine
966742|NCT03376568|polysomnographic|polysomnographic
966743|NCT03376568|multiple sleep latency test|multiple sleep latency test
966744|NCT03376568|fMRI|fmri
966745|NCT03376555|Sodium|sodium
966746|NCT03376555|Hypertension|hypertension
966747|NCT03376555|Blood Pressure|blood pressure
966748|NCT03376555|Cardiovascular Disease|cardiovascular disease
966749|NCT03376555|Nitric Oxide|nitric oxide
966750|NCT03376555|Skin|skin
966751|NCT03376555|Dairy|dairy
966752|NCT03376555|Cheese|cheese
966753|NCT03376555|Oxidative Stress|oxidative stress
966754|NCT03376555|Diet|diet
966755|NCT03376555|Flow Mediated Vasodilation|flow mediated vasodilation
966756|NCT03376555|Nitroglycerin|nitroglycerin
966757|NCT03376555|Superoxide|superoxide
966758|NCT03376555|Microcirculation|microcirculation
966759|NCT03376529|safety|safety
966760|NCT03376529|tolerability|tolerability
966761|NCT03376529|pharmacokinetics|pharmacokinetics
966762|NCT03376529|drug-drug interaction|drug-drug interaction
966763|NCT03376529|SPR741|spr741
966764|NCT03376529|antibiotic|antibiotic
966765|NCT03376477|Lenalidomide|lenalidomide
966766|NCT03376477|M-spike negative|m-spike negative
966767|NCT03376477|GVax|gvax
966768|NCT03376477|GM-CSF secreting myeloma vaccine|gm-csf secreting myeloma vaccine
966769|NCT03376464|Xeomin Cosmetic;|xeomin cosmetic;
966770|NCT03376464|Masseteric Hypertrophy|masseteric hypertrophy
966771|NCT03376425|Chest ultrasound,Lung tumor|chest ultrasound,lung tumor
966772|NCT03376399|Sleeve Gastrectomy|sleeve gastrectomy
966773|NCT03376399|Gastric Emptying|gastric emptying
966774|NCT03376399|Diabetic Gastroparesis|diabetic gastroparesis
966775|NCT03376399|Bariatric Surgery Candidate|bariatric surgery candidate
966776|NCT03376386|Adaptive|adaptive
966777|NCT03376386|Image-guided|image-guided
966778|NCT03376386|Radiotherapy|radiotherapy
966779|NCT03376386|Head and Neck cancer|head and neck cancer
966780|NCT03376360|prostate cancer|prostate cancer
966781|NCT03376360|Fcholine|fcholine
966782|NCT03376360|positron emission tomography|positron emission tomography
966783|NCT03376360|MRI|mri
966784|NCT03376347|intraoperative|intraoperative
966785|NCT03376347|hypotension|hypotension
966786|NCT03376347|Hypotension Probability Index|hypotension probability index
966787|NCT03376347|HPI|hpi
966788|NCT03376334|Mental motor imagery|mental motor imagery
966789|NCT03376334|SEBT|sebt
966790|NCT03376308|rocuronium|rocuronium
966791|NCT03376308|propofol|propofol
966792|NCT03376308|pain|pain
966793|NCT03376308|withdrawal|withdrawal
966794|NCT03376308|venous diameter|venous diameter
966795|NCT03376282|HBO|hbo
966796|NCT03376282|kidney functions|kidney functions
966797|NCT03376282|markers|markers
966798|NCT03376269|more than 1 year|more than 1 year
966799|NCT03376256|thoracic epidural|thoracic epidural
966800|NCT03376256|pressure measurement|pressure measurement
966801|NCT03376256|device|device
966802|NCT03376243|Atopic eczema, prevention|atopic eczema, prevention
966803|NCT03376230|Environmental risk factors|environmental risk factors
966804|NCT03376230|Xenobiotic detoxification|xenobiotic detoxification
966805|NCT03376217|malaria|malaria
966806|NCT03376217|malaria in pregnancy|malaria in pregnancy
966807|NCT03376217|intermittent preventive treatment in pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
966808|NCT03376217|community health workers|community health workers
966809|NCT03376217|Sulfadoxine-pyrimethamine (SP)|sulfadoxine-pyrimethamine (sp)
966810|NCT03376204|Bronchiectasis|bronchiectasis
966811|NCT03376204|Pain mechanisms|pain mechanisms
966812|NCT03376204|Pressure pain threshold|pressure pain threshold
966813|NCT03376204|Referred pain|referred pain
966814|NCT03376191|Apatinib|apatinib
966815|NCT03376191|lung cancer|lung cancer
966816|NCT03376191|angiogenesis inhibitors|angiogenesis inhibitors
966817|NCT03376191|efficacy|efficacy
966818|NCT03376191|safety|safety
967014|NCT03374696|condoms|condoms
966819|NCT03376178|multiorifice or endhole femoral nerve catheter|multiorifice or endhole femoral nerve catheter
966820|NCT03376165|prognosis|prognosis
966821|NCT03376165|translational research|translational research
966822|NCT03376139|Alcohol|alcohol
966823|NCT03376139|Alcoholic|alcoholic
966824|NCT03376139|Alcoholism|alcoholism
967021|NCT03374670|Zimura|zimura
966825|NCT03376139|Alcohol abuse|alcohol abuse
966826|NCT03376139|Alcohol Use Disorder|alcohol use disorder
966827|NCT03376139|Alcohol use|alcohol use
966828|NCT03376139|Alcohol dependence|alcohol dependence
966829|NCT03376139|Alcohol dependent|alcohol dependent
966830|NCT03376139|PTSD|ptsd
966831|NCT03376139|Post-Traumatic Stress Disorder|post-traumatic stress disorder
966832|NCT03376139|Veteran|veteran
966833|NCT03376126|isolated limb perfusion|isolated limb perfusion
966834|NCT03376113|self-harm|self-harm
966835|NCT03376113|psychological intervention|psychological intervention
966836|NCT03376087|Epilepsy|epilepsy
966837|NCT03376087|heart block|heart block
966838|NCT03376087|sudden cardiac death|sudden cardiac death
966839|NCT03376087|loop recorder|loop recorder
966840|NCT03376074|liver transplantation|liver transplantation
966841|NCT03376074|hypothermic machine liver perfusion|hypothermic machine liver perfusion
966842|NCT03376074|extended criteria liver grafts|extended criteria liver grafts
966843|NCT03376061|Tranexamic Acid|tranexamic acid
966844|NCT03376061|Cardiac surgery|cardiac surgery
966845|NCT03376022|Attitudes|attitudes
966846|NCT03376022|Knowledge|knowledge
966847|NCT03376022|Oral Health|oral health
966848|NCT03376022|Nursing personnel|nursing personnel
966849|NCT03376009|Biomarker|biomarker
966850|NCT03375983|Advanced cancer|advanced cancer
966851|NCT03375983|Plasmodium immunotherapy|plasmodium immunotherapy
966852|NCT03375983|Plasmodiun vivax|plasmodiun vivax
966853|NCT03375944|Cardiac tele-rehabilitation, Myocardial revascularization|cardiac tele-rehabilitation, myocardial revascularization
966854|NCT03375931|Quality of Recovery 40 Questionaries|quality of recovery 40 questionaries
966855|NCT03375918|Healthcare disparities|healthcare disparities
966856|NCT03375918|Racial Bias|racial bias
966857|NCT03375905|ethnic Japanese|ethnic japanese
966858|NCT03375892|radiation|radiation
966859|NCT03375892|Deep Inspiration Breath Hold|deep inspiration breath hold
966861|NCT03375892|stage II|stage ii
966862|NCT03375892|stage IIa|stage iia
966863|NCT03375879|Ptosis|ptosis
966864|NCT03375879|Blepharoptosis|blepharoptosis
966865|NCT03375879|bandage contact lens|bandage contact lens
966866|NCT03375879|fasanella servat procedure|fasanella servat procedure
966867|NCT03375853|Obesity|obesity
966868|NCT03375853|Dissonance|dissonance
966869|NCT03375853|Response Training|response training
966870|NCT03375853|Eating Disorder|eating disorder
966871|NCT03375853|Computer-based Training|computer-based training
966872|NCT03375840|pictorial warning labels|pictorial warning labels
966873|NCT03375840|risk knowledge|risk knowledge
966874|NCT03375840|emotion|emotion
966875|NCT03375840|memory|memory
966876|NCT03375840|risk perceptions|risk perceptions
966877|NCT03375840|quit intentions|quit intentions
966878|NCT03375827|Breast Cancer|breast cancer
966879|NCT03375814|Crocin, osteoarthritis, Inflammation, IL-17,T-helper,T-reg|crocin, osteoarthritis, inflammation, il-17,t-helper,t-reg
966880|NCT03375788|tesamorelin|tesamorelin
966881|NCT03375788|obesity|obesity
966882|NCT03375788|fatty liver|fatty liver
966883|NCT03375749|sitting|sitting
966884|NCT03375736|whole body vibration|whole body vibration
966885|NCT03375736|cerebral palsy|cerebral palsy
966886|NCT03375736|functional abilities|functional abilities
966887|NCT03375736|children|children
966888|NCT03375736|adults|adults
966889|NCT03375723|Pain measurement|pain measurement
966890|NCT03375723|Pain|pain
966891|NCT03375710|Heart Failure|heart failure
966892|NCT03375710|Heart Diseases|heart diseases
966893|NCT03375710|Cardiovascular Disease|cardiovascular disease
966894|NCT03375684|Cystic Fibrosis|cystic fibrosis
966895|NCT03375684|Inspiratory Muscle Training|inspiratory muscle training
966896|NCT03375684|Chest Physiotherapy|chest physiotherapy
966897|NCT03375684|Balance|balance
966898|NCT03375684|Postural Stability|postural stability
966899|NCT03375684|Pulmonary Function Test|pulmonary function test
966900|NCT03375684|6-Minute Walk Test|6-minute walk test
966901|NCT03375671|ketamine|ketamine
966902|NCT03375671|aggressive behaviour|aggressive behaviour
966903|NCT03375671|midazolam|midazolam
966904|NCT03375671|haloperidol|haloperidol
966905|NCT03375671|emergency department|emergency department
966906|NCT03375658|Information Science: Algorithms|information science: algorithms
966907|NCT03375658|Information Science: Informatics: Nursing Informatics|information science: informatics: nursing informatics
966908|NCT03375658|Information Science: Data Display: Computer graphics|information science: data display: computer graphics
966909|NCT03375658|Diagnosis: Diagnostic Techiques and Procedures: Monitoring, Physiologic|diagnosis: diagnostic techiques and procedures: monitoring, physiologic
966910|NCT03375658|Health care facilities, Manpower and services: Health services: Emergency Medical Services: Triage|health care facilities, manpower and services: health services: emergency medical services: triage
966911|NCT03375619|CAR-20/19 T-Cell Therapy|car-20/19 t-cell therapy
966912|NCT03375593|pain management|pain management
966913|NCT03375593|RCT|rct
966914|NCT03375554|esophageal steothoscope, tracheal intubation|esophageal steothoscope, tracheal intubation
966915|NCT03375528|Matrix metalloproteinase|matrix metalloproteinase
966916|NCT03375528|neointimal hyperplasia|neointimal hyperplasia
966917|NCT03375515|hydromorphone titration|hydromorphone titration
966918|NCT03375489|Lung Cancer palliative care|lung cancer palliative care
966919|NCT03375476|postoperative myocardial infraction|postoperative myocardial infraction
966920|NCT03375476|myocardial injury|myocardial injury
966921|NCT03375476|general anesthesia|general anesthesia
966922|NCT03375476|vascular surgery|vascular surgery
966923|NCT03375476|surgical stress|surgical stress
966924|NCT03375476|surgical plethysmographic index|surgical plethysmographic index
966925|NCT03375450|Epidemiology, Chronic Obstructive Disease, Comparative Effectiveness, Exacerbation|epidemiology, chronic obstructive disease, comparative effectiveness, exacerbation
966926|NCT03375437|Clinical Trial|clinical trial
966927|NCT03375437|Multicenter Trial|multicenter trial
966928|NCT03375437|NTRK1|ntrk1
966929|NCT03375437|NTRK2|ntrk2
966930|NCT03375437|NTRK3|ntrk3
966931|NCT03375437|ROS1|ros1
966932|NCT03375437|ALK|alk
966933|NCT03375437|RNAseq|rnaseq
966934|NCT03375437|entrectinib|entrectinib
966935|NCT03375437|STARTRK-2|startrk-2
966936|NCT03375424|Vedolizumab, Crohns disease, Ulcerative colitis, safety|vedolizumab, crohns disease, ulcerative colitis, safety
966937|NCT03375398|SUGARDOWN™|sugardown™
966938|NCT03375398|Galactomannan|galactomannan
966939|NCT03375398|Postprandial blood glucose|postprandial blood glucose
966940|NCT03375398|Insulin|insulin
966941|NCT03375346|Whole body vibration exercise|whole body vibration exercise
966942|NCT03375333|ultrasound|ultrasound
966943|NCT03375333|diagnostics|diagnostics
966944|NCT03375333|general practice|general practice
966945|NCT03375333|family medicine|family medicine
966946|NCT03375294|PTSD|ptsd
966947|NCT03375255|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
966948|NCT03375255|Exon Skipping|exon skipping
966949|NCT03375255|DMD|dmd
966950|NCT03375255|Exon 51|exon 51
966951|NCT03375255|Ambulatory|ambulatory
966952|NCT03375255|Pediatric|pediatric
966953|NCT03375229|Myofascial Pain|myofascial pain
966954|NCT03375229|Pain Pressure Threshold|pain pressure threshold
966955|NCT03375229|Low-Level Laser Therapy|low-level laser therapy
966956|NCT03375229|Dry Needling|dry needling
966957|NCT03375177|multiple sclerosis|multiple sclerosis
966958|NCT03375177|Argentina|argentina
966959|NCT03375177|epidemiology|epidemiology
966960|NCT03375177|registry|registry
966961|NCT03375164|Duchenne|duchenne
966962|NCT03375164|gene therapy|gene therapy
966963|NCT03375164|DMD|dmd
966964|NCT03375164|dystrophin|dystrophin
966965|NCT03375138|Healthy volunteers|healthy volunteers
966966|NCT03375112|Total Hip Arthroplasty|total hip arthroplasty
966967|NCT03375112|Fascia Iliaca|fascia iliaca
966968|NCT03375112|Nerve Block|nerve block
966969|NCT03375112|Pain Control|pain control
966970|NCT03375099|Firearms|firearms
966971|NCT03375099|Guns|guns
966972|NCT03375099|Suicide|suicide
966973|NCT03375099|Means Safety|means safety
966974|NCT03375099|Means Restriction|means restriction
966975|NCT03375099|Lethal Means Counseling|lethal means counseling
966976|NCT03375047|Cystic Fibrosis|cystic fibrosis
966977|NCT03375047|CF|cf
966978|NCT03375034|Chronic pain|chronic pain
966979|NCT03375034|Benzodiazepine|benzodiazepine
966980|NCT03375034|Central sensitization|central sensitization
966981|NCT03375034|Selective compound|selective compound
966982|NCT03375034|GABAA receptors|gabaa receptors
966983|NCT03375034|Antihyperalgesia|antihyperalgesia
966984|NCT03375034|RCT|rct
966985|NCT03375021|ADHD, ampakine, Phase II clinical trial|adhd, ampakine, phase ii clinical trial
966986|NCT03375008|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
966987|NCT03375008|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
966988|NCT03375008|Imaging diagnostic|imaging diagnostic
966989|NCT03374956|Pharmacological|pharmacological
966990|NCT03374956|Obesity Management|obesity management
966991|NCT03374956|Individualized|individualized
966992|NCT03374917|carbidopa|carbidopa
966993|NCT03374917|levodopa|levodopa
966994|NCT03374904|Parenting|parenting
966995|NCT03374904|Parental Mentalization|parental mentalization
966996|NCT03374904|Parental Reflective Function|parental reflective function
966997|NCT03374904|Child Psychopathology|child psychopathology
966998|NCT03374891|Shared Decision Making;|shared decision making;
966999|NCT03374891|Defibrillator|defibrillator
967000|NCT03374878|exercise|exercise
967001|NCT03374878|oral contraceptive|oral contraceptive
967002|NCT03374878|strength training|strength training
967003|NCT03374813|Bone graft substitutes|bone graft substitutes
967004|NCT03374813|Synthetic graft|synthetic graft
967005|NCT03374813|Xenograft|xenograft
967006|NCT03374813|Ridge preservation|ridge preservation
967007|NCT03374813|Alveolar defect|alveolar defect
967008|NCT03374761|child abuse|child abuse
967009|NCT03374761|parenting|parenting
967010|NCT03374761|low and middle income countries|low and middle income countries
967011|NCT03374761|child discipline|child discipline
967012|NCT03374761|Indonesia|indonesia
967013|NCT03374696|Chlamydia infections|chlamydia infections
967016|NCT03374696|sex education|sex education
967017|NCT03374683|Risky play|risky play
967018|NCT03374683|Physical activity|physical activity
967019|NCT03374683|Injury prevention|injury prevention
967020|NCT03374683|Outdoor play|outdoor play
967022|NCT03374670|ARC1905|arc1905
967023|NCT03374670|Eylea|eylea
967024|NCT03374670|aflibercept|aflibercept
967025|NCT03374670|IPCV|ipcv
967026|NCT03374670|avacincaptad pegol|avacincaptad pegol
967027|NCT03374670|complement factor C5 inhibitor|complement factor c5 inhibitor
967028|NCT03374657|Clinical trials, dark adaptation, gene therapy, RLBP1 mutation, retinitis pigmentosa.|clinical trials, dark adaptation, gene therapy, rlbp1 mutation, retinitis pigmentosa.
967029|NCT03374644|Correlation|correlation
967030|NCT03374644|ETCO2|etco2
967031|NCT03374644|PaCO2|paco2
967032|NCT03374644|nasal cannula|nasal cannula
967033|NCT03374644|Sentri Nasal Cannula|sentri nasal cannula
967034|NCT03374592|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
967035|NCT03374592|Volumetric intensity-modulated arc therapy|volumetric intensity-modulated arc therapy
967036|NCT03374592|Radiotherapy|radiotherapy
967037|NCT03374592|Pain|pain
967038|NCT03374592|Metastasis|metastasis
967039|NCT03374592|Quality of Life|quality of life
967040|NCT03374592|Acute Toxicity|acute toxicity
967041|NCT03374566|Epstein-Barr Virus Infections|epstein-barr virus infections
967042|NCT03374566|Immunodeficiency|immunodeficiency
967043|NCT03374566|Screening|screening
967044|NCT03374566|Immunologic Function|immunologic function
967045|NCT03374527|T-cells|t-cells
967046|NCT03374527|circulation|circulation
967047|NCT03374527|synovial fluid|synovial fluid
967048|NCT03374527|psoriasis|psoriasis
967049|NCT03374527|psoriatic arthritis|psoriatic arthritis
967050|NCT03374514|corticosteroids|corticosteroids
967051|NCT03374514|Electric impedance|electric impedance
967052|NCT03374501|Sugardown™|sugardown™
967053|NCT03374501|Galactomannan|galactomannan
967054|NCT03374501|Postprandial blood glucose|postprandial blood glucose
967055|NCT03374501|Insulin|insulin
967056|NCT03374488|Urothelial carcinoma|urothelial carcinoma
967057|NCT03374488|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
967058|NCT03374488|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
967059|NCT03374462|Pediatrics|pediatrics
967060|NCT03374449|Major surgery|major surgery
967061|NCT03374449|Postoperative morbidity and mortality|postoperative morbidity and mortality
967062|NCT03374449|Renin angiotensin system inhibitors|renin angiotensin system inhibitors
967063|NCT03374397|Laparoscopic unilateral ovarian cystectomy|laparoscopic unilateral ovarian cystectomy
967064|NCT03374397|SurgiGuard|surgiguard
967065|NCT03374397|Hemostasis|hemostasis
967066|NCT03374397|Ovarian function preservation|ovarian function preservation
967067|NCT03374397|Bipolar electrocauterization|bipolar electrocauterization
967068|NCT03374371|Staphylococcus epidermidis Infection|staphylococcus epidermidis infection
967069|NCT03374371|Staphylococcus epidermidis Contamination|staphylococcus epidermidis contamination
967070|NCT03374371|intravascular device|intravascular device
967071|NCT03374371|implanted material|implanted material
967072|NCT03374345|Cold Hypersensitivity|cold hypersensitivity
967073|NCT03374345|Korean medicine|korean medicine
967074|NCT03374345|Sipjeondaebo-tang|sipjeondaebo-tang
967075|NCT03374345|Cold intolerance|cold intolerance
967076|NCT03374332|Refractory|refractory
967077|NCT03374332|progression|progression
967078|NCT03374332|recurrence|recurrence
967079|NCT03374306|Myopia|myopia
967080|NCT03374306|Myopia control|myopia control
967081|NCT03374306|Atropine|atropine
967082|NCT03374306|Electroretinogram|electroretinogram
967083|NCT03374306|Multifocal Electroretinogram|multifocal electroretinogram
967084|NCT03374293|pancreatic cancer|pancreatic cancer
967085|NCT03374293|Radiation|radiation
967086|NCT03374293|Anti-PD-1 Antibody|anti-pd-1 antibody
967087|NCT03374280|non small cell lung cancer|non small cell lung cancer
967088|NCT03374280|Gefitinib|gefitinib
967089|NCT03374280|EGFR negative|egfr negative
967090|NCT03374280|Pemetrexed|pemetrexed
967091|NCT03374254|CRC, MSS, non-MSI-H, PD-1, anti-PD-1, anti PD-1, MEK, MEK inhibitor|crc, mss, non-msi-h, pd-1, anti-pd-1, anti pd-1, mek, mek inhibitor
967092|NCT03374215|Adrenal Adenoma|adrenal adenoma
967093|NCT03374215|Molecular Genetics|molecular genetics
967094|NCT03374215|African-American|african-american
967095|NCT03374215|Biomarkers|biomarkers
967096|NCT03374215|Primary Aldosteronism|primary aldosteronism
967097|NCT03374202|ARV Therapy|arv therapy
967098|NCT03374202|Broadly Neutralizing|broadly neutralizing
967099|NCT03374202|Gene Transfer|gene transfer
967100|NCT03374202|Monoclonal Antibody|monoclonal antibody
967101|NCT03374202|AAV8|aav8
967102|NCT03374176|periodontitis|periodontitis
967103|NCT03374176|diabetes mellitus|diabetes mellitus
967104|NCT03374176|systemic antimicrobials|systemic antimicrobials
967105|NCT03374163|infertility , implantion failure, intracytoplasmic sperm injection|infertility , implantion failure, intracytoplasmic sperm injection
967106|NCT03374150|Low-Calorie Diet|low-calorie diet
967107|NCT03374150|Diet, High-Protein|diet, high-protein
967108|NCT03374150|Obesity|obesity
967109|NCT03374150|weight cycling|weight cycling
967110|NCT03374150|body composition|body composition
967111|NCT03374150|high-sensitivity C-Reactive protein|high-sensitivity c-reactive protein
967112|NCT03374150|malondialdehyde|malondialdehyde
967113|NCT03374150|glutathione|glutathione
967114|NCT03374124|Chronic rhinosinusitis|chronic rhinosinusitis
967115|NCT03374124|Eosinophil|eosinophil
967116|NCT03374124|Surgery|surgery
967117|NCT03374124|Diagnosis|diagnosis
967118|NCT03374111|Thalassemia;|thalassemia;
967119|NCT03374111|the Syndrome of Blood Deficiency|the syndrome of blood deficiency
967120|NCT03374111|Anemia|anemia
967121|NCT03374111|Colla Corii Asini|colla corii asini
967122|NCT03374098|Medicaid|medicaid
967123|NCT03374098|Mississippi|mississippi
967124|NCT03374085|Multiple Myeloma|multiple myeloma
967125|NCT03374085|Safety|safety
967126|NCT03374085|Efficacy|efficacy
967127|NCT03374085|CC-92480|cc-92480
967128|NCT03374085|Relapsed|relapsed
967129|NCT03374085|Refractory|refractory
967130|NCT03374033|Preterm infants, growth, nutrition, physical activity|preterm infants, growth, nutrition, physical activity
967131|NCT03373994|FDG, perfusion, hypoxia, tumor, PET|fdg, perfusion, hypoxia, tumor, pet
967132|NCT03373955|T Cell repertoire|t cell repertoire
967133|NCT03373955|lung cancer|lung cancer
967134|NCT03373955|tumor mutation burden|tumor mutation burden
967135|NCT03373955|Circulating tumour DNA|circulating tumour dna
967136|NCT03373942|glaucoma|glaucoma
967137|NCT03373942|EDI OCT|edi oct
967138|NCT03373942|pseudoexfoliation|pseudoexfoliation
967139|NCT03373942|choroidal thickness|choroidal thickness
967140|NCT03373916|Peer Mentorship|peer mentorship
967141|NCT03373916|Psychiatric Hospitalization|psychiatric hospitalization
967142|NCT03373916|Suicide Risk|suicide risk
967143|NCT03373864|Unilateral spinal anesthesia|unilateral spinal anesthesia
967144|NCT03373864|general anesthesia|general anesthesia
967145|NCT03373864|hemodynamic stability|hemodynamic stability
967146|NCT03373864|MINS|mins
967147|NCT03373864|hip fracture|hip fracture
967148|NCT03373864|elderly|elderly
967149|NCT03373864|AKI|aki
967150|NCT03373825|overdose prevention|overdose prevention
967151|NCT03373825|opioid overdose|opioid overdose
967152|NCT03373825|risk behavior|risk behavior
967153|NCT03373825|harm reduction|harm reduction
967154|NCT03373799|rotator cuff|rotator cuff
967155|NCT03373799|physiotherapy|physiotherapy
967156|NCT03373799|video-based rehabilitation|video-based rehabilitation
967157|NCT03373799|exercise|exercise
967158|NCT03373786|Kidney disease|kidney disease
967159|NCT03373786|Nephritis|nephritis
967160|NCT03373786|Hereditary kidney disease|hereditary kidney disease
967161|NCT03373786|Hereditary nephritis|hereditary nephritis
967162|NCT03373773|pelvic reconstructive surgery|pelvic reconstructive surgery
967163|NCT03373773|foley catheter|foley catheter
967164|NCT03373773|Foley removal|foley removal
967165|NCT03373773|Urogynecology|urogynecology
967166|NCT03373773|Urinary Retention|urinary retention
967167|NCT03373773|Gynecologic surgery|gynecologic surgery
967168|NCT03373734|Online Cognitive Behavioural Therapy|online cognitive behavioural therapy
967169|NCT03373734|Pregnancy|pregnancy
967170|NCT03373734|Self-help|self-help
967171|NCT03373669|oral cholera vaccine|oral cholera vaccine
967172|NCT03373669|OCV|ocv
967173|NCT03373669|dose interval|dose interval
967174|NCT03373656|Vaccination|vaccination
967175|NCT03373656|Childhood|childhood
967176|NCT03373656|Hematologic Malignancy|hematologic malignancy
967177|NCT03373656|Solid Tumor|solid tumor
967178|NCT03373656|Immune Deficiency|immune deficiency
967179|NCT03373604|18F-MK-6240|18f-mk-6240
967180|NCT03373604|Cognitive Impairment|cognitive impairment
967181|NCT03373604|Alzheimer's|alzheimer's
967182|NCT03373591|bariatric surgery|bariatric surgery
967183|NCT03373591|liposomal bupivacaine|liposomal bupivacaine
967184|NCT03373578|sleep;|sleep;
967185|NCT03373578|Infant, Premature;|infant, premature;
967186|NCT03373578|Polysomnography;|polysomnography;
967187|NCT03373578|Ear Protective Devices|ear protective devices
967188|NCT03373552|Coronary Artery Disease; Clopidogrel; Polymorphism, genetic|coronary artery disease; clopidogrel; polymorphism, genetic
967189|NCT03373539|Biomarkers|biomarkers
967190|NCT03373539|Neurotrophins|neurotrophins
967191|NCT03373526|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
967192|NCT03373526|Aerobic Exercise|aerobic exercise
967193|NCT03373526|Breathing Exercises|breathing exercises
967194|NCT03373526|Inspiratory Capacity|inspiratory capacity
967195|NCT03373526|Muscle Strength|muscle strength
967196|NCT03373526|Exercise Tolerance|exercise tolerance
967197|NCT03373526|Autonomic Nervous System|autonomic nervous system
967198|NCT03373513|Return-to-work, Visual analogue pain score, Cosmesis|return-to-work, visual analogue pain score, cosmesis
967199|NCT03373461|glomerunephritis, complement driven, chronic kidney disease|glomerunephritis, complement driven, chronic kidney disease
967200|NCT03373409|Dry Powder Inhaler|dry powder inhaler
967201|NCT03373396|Chlordecone|chlordecone
967202|NCT03373396|fibrosis|fibrosis
967203|NCT03373396|cirrhosis|cirrhosis
967204|NCT03373396|chronic hepatitis B, C|chronic hepatitis b, c
967205|NCT03373396|alcohol|alcohol
967206|NCT03373396|viral hepatitis|viral hepatitis
967207|NCT03373396|transaminases|transaminases
967208|NCT03373396|fibroscan|fibroscan
967212|NCT03373357|arterial hypertension|arterial hypertension
967213|NCT03373357|cardiovascular risk|cardiovascular risk
967214|NCT03373344|emotional processing|emotional processing
967216|NCT03373344|cognition|cognition
967217|NCT03373331|Emotional Processing|emotional processing
967218|NCT03373331|Cognition|cognition
967219|NCT03373331|Traumatic Brain Injury|traumatic brain injury
967220|NCT03373331|Intervention|intervention
967221|NCT03373292|Stenting|stenting
967222|NCT03373292|Jugular vein stenosis|jugular vein stenosis
967223|NCT03373292|Intracranial hypertension|intracranial hypertension
967224|NCT03373292|Headache|headache
967225|NCT03373292|Tinnitus|tinnitus
967226|NCT03373292|Papilledema|papilledema
967227|NCT03373292|Visual impairment|visual impairment
967228|NCT03373279|Heart Transplant|heart transplant
967229|NCT03373240|Drug use Disorders|drug use disorders
967230|NCT03373240|Cognitive Remediation|cognitive remediation
967231|NCT03373227|Heart Transplant|heart transplant
967232|NCT03373214|Human Hookworm|human hookworm
967233|NCT03373214|Necator americanus|necator americanus
967234|NCT03373214|Hookworm|hookworm
967235|NCT03373214|Hookworm Disease|hookworm disease
967236|NCT03373214|Iron-deficiency anemia|iron-deficiency anemia
967237|NCT03373214|Soil-transmitted helminth infection|soil-transmitted helminth infection
967238|NCT03373214|Neglected Tropical Disease|neglected tropical disease
967239|NCT03373214|Na-GST-1|na-gst-1
967240|NCT03373214|CpG|cpg
967241|NCT03373175|Monitoring NIV, inspiratory muscular unloading, EMG|monitoring niv, inspiratory muscular unloading, emg
967242|NCT03373149|IVF|ivf
967243|NCT03373149|Growth hormone|growth hormone
967244|NCT03373149|Poor responders|poor responders
967245|NCT03373123|Esophageal Varices|esophageal varices
967246|NCT03373123|Variceal Hemorrhage|variceal hemorrhage
967247|NCT03373123|Endoscopy|endoscopy
967248|NCT03373123|Radiomics|radiomics
967249|NCT03373123|Hepatitis B Virus|hepatitis b virus
967250|NCT03373110|Online Therapy|online therapy
967251|NCT03373110|Fitbit|fitbit
967252|NCT03373110|Depression|depression
967253|NCT03373110|Cardiovascular Disease|cardiovascular disease
967254|NCT03373097|Neuroblastoma|neuroblastoma
967255|NCT03373097|GD2 CAR T cell|gd2 car t cell
967256|NCT03373097|CAR T|car t
967257|NCT03373084|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
967258|NCT03373084|Ultrasound|ultrasound
967259|NCT03373084|Sport|sport
967260|NCT03373084|Hamstring muscle|hamstring muscle
967261|NCT03373084|Injury|injury
967262|NCT03373071|CD19-CAR T cell|cd19-car t cell
967263|NCT03373071|CD19-malignancy|cd19-malignancy
967264|NCT03373071|CAR T cell|car t cell
967265|NCT03373071|CD19-ALL|cd19-all
967266|NCT03373071|CD19-LNH|cd19-lnh
967267|NCT03373058|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
967268|NCT03373058|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
967269|NCT03373058|Cytoreductive surgery|cytoreductive surgery
967270|NCT03373058|Postoperative Chemotherapy|postoperative chemotherapy
967271|NCT03373045|Severe asthma|severe asthma
967272|NCT03373045|Monoclonal antibody|monoclonal antibody
967273|NCT03373045|Corticosteroid|corticosteroid
967274|NCT03373045|Non-interventional|non-interventional
967275|NCT03373032|Physical Activity|physical activity
967276|NCT03373032|Sensory Neuropathy|sensory neuropathy
967277|NCT03373032|Acupuncture|acupuncture
967278|NCT03373019|chidamide|chidamide
967279|NCT03373019|R-GDP|r-gdp
967280|NCT03373019|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
967281|NCT03372980|Biomarkers|biomarkers
967282|NCT03372967|preventable disease|preventable disease
967283|NCT03372967|vaccine|vaccine
967284|NCT03372967|public health|public health
967285|NCT03372967|vaccine history|vaccine history
967286|NCT03372967|point-of-care|point-of-care
967287|NCT03372941|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
967288|NCT03372941|Hospital avoidance|hospital avoidance
967289|NCT03372941|Antibiotic therapy|antibiotic therapy
967290|NCT03372941|Dalbavancin|dalbavancin
967291|NCT03372941|Emergency department|emergency department
967292|NCT03372902|Breast imaging|breast imaging
967293|NCT03372902|17-598|17-598
967294|NCT03372889|Anterior Cruciate Ligament|anterior cruciate ligament
967295|NCT03372889|On-Q Catheter|on-q catheter
967296|NCT03372889|nerve block|nerve block
967297|NCT03372889|ACL reconstruction|acl reconstruction
967298|NCT03372889|patient education materials|patient education materials
967299|NCT03372837|Diffuse large B-cell lymphoma, rituximab, SyB L-0501, combination therapy|diffuse large b-cell lymphoma, rituximab, syb l-0501, combination therapy
967300|NCT03372824|mass screening|mass screening
967301|NCT03372798|catheter ablation|catheter ablation
967302|NCT03372798|intraprocedural left atrial wall thickness imaging|intraprocedural left atrial wall thickness imaging
967303|NCT03372785|coronary artery disease|coronary artery disease
967304|NCT03372785|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
967305|NCT03372785|Myocardial Stunning|myocardial stunning
967306|NCT03372785|Percutaneous Coronary Intervention|percutaneous coronary intervention
967307|NCT03372785|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
967308|NCT03372772|Fatigue, Levocarnitine,|fatigue, levocarnitine,
967322|NCT03372668|lower limb amputation|lower limb amputation
967323|NCT03372668|PLP|plp
967324|NCT03372616|aortic blood pressure|aortic blood pressure
967325|NCT03372616|diastolic dysfuntion|diastolic dysfuntion
967326|NCT03372616|echocardiography|echocardiography
967327|NCT03372616|left ventricular ejection fraction|left ventricular ejection fraction
967328|NCT03372603|GSK2798745, efficacy, safety, chronic cough, crossover study|gsk2798745, efficacy, safety, chronic cough, crossover study
967329|NCT03372590|general movement assessment|general movement assessment
967330|NCT03372538|placenta accreta|placenta accreta
967331|NCT03372499|Hepatic Encephalopathy|hepatic encephalopathy
967332|NCT03372499|Diet Management|diet management
967333|NCT03372499|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
967334|NCT03372460|Transcranial Direct Current Stimulation|transcranial direct current stimulation
967335|NCT03372460|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
967336|NCT03372460|Virtual Reality|virtual reality
967337|NCT03372460|Prefrontal Cortex|prefrontal cortex
967338|NCT03372460|Veterans|veterans
967339|NCT03372460|Quality of Life|quality of life
967340|NCT03372395|probiotics implementation|probiotics implementation
967341|NCT03372395|HPV infection|hpv infection
967342|NCT03372395|vaginosis|vaginosis
967343|NCT03372395|yeast vaginitis|yeast vaginitis
967344|NCT03372382|postpartum|postpartum
967345|NCT03372369|contraceptive knowledge|contraceptive knowledge
967346|NCT03372369|contraceptive use|contraceptive use
967347|NCT03372369|educational intervention|educational intervention
967348|NCT03372369|poster|poster
967349|NCT03372369|online survey|online survey
967350|NCT03372356|DT|dt
967351|NCT03372356|HADS|hads
967352|NCT03372356|SPBS|spbs
967353|NCT03372356|CD-RISC|cd-risc
967354|NCT03372356|Psychosocial Screening|psychosocial screening
967355|NCT03372330|peripheral artery disease|peripheral artery disease
967356|NCT03372330|sepsis|sepsis
967357|NCT03372317|Tau|tau
967358|NCT03372317|MK-6240|mk-6240
967359|NCT03372317|Cognition|cognition
967360|NCT03372304|Peripheral regional anesthesia|peripheral regional anesthesia
967361|NCT03372291|Acute Myeloid Leukemia|acute myeloid leukemia
967362|NCT03372278|Total hip arthroplasty|total hip arthroplasty
967363|NCT03372278|Medical Device|medical device
967364|NCT03372278|Safety|safety
967365|NCT03372278|Prothesis|prothesis
967366|NCT03372265|Peripheral regional anesthesia|peripheral regional anesthesia
967367|NCT03372239|Indoximod|indoximod
967368|NCT03372226|Gambling|gambling
967369|NCT03372226|Problematic Gambling|problematic gambling
967370|NCT03372226|Pathological Gambling|pathological gambling
967371|NCT03372187|diet|diet
967372|NCT03372187|MS|ms
967373|NCT03372187|Telehealth|telehealth
967374|NCT03372174|cardiac surgery|cardiac surgery
967375|NCT03372174|mechanical ventilation|mechanical ventilation
967376|NCT03372174|postoperative infections|postoperative infections
967377|NCT03372161|lumbosacral radicular pain|lumbosacral radicular pain
967378|NCT03372161|sciatica|sciatica
967379|NCT03372161|leg pain|leg pain
967380|NCT03372135|POCD|pocd
967381|NCT03372135|RARC|rarc
967382|NCT03372135|Trendelenburg Position|trendelenburg position
967383|NCT03372096|embolization|embolization
967384|NCT03372096|prostate|prostate
967385|NCT03372083|Iron Chelation Therapy|iron chelation therapy
967386|NCT03372083|Deferasirox|deferasirox
967387|NCT03372083|Asunra|asunra
967388|NCT03372083|Jadenu|jadenu
967389|NCT03372083|Exjade|exjade
967390|NCT03372083|ICL 670|icl 670
967391|NCT03372083|Pediatric|pediatric
967392|NCT03372070|primary snoring|primary snoring
967393|NCT03372070|bed partner|bed partner
967394|NCT03372070|home sleep testing|home sleep testing
967400|NCT03372044|Relative bioavailability|relative bioavailability
967401|NCT03372044|Modified release|modified release
967402|NCT03372044|Pharmacokinetics|pharmacokinetics
967403|NCT03372031|Music Supported Therapy|music supported therapy
967404|NCT03372031|plasticity|plasticity
967405|NCT03372031|multisensory integration|multisensory integration
967406|NCT03372031|bimanual coupling|bimanual coupling
967407|NCT03372031|auditory feedback|auditory feedback
967408|NCT03372031|dexterity|dexterity
967409|NCT03372031|piano therapy|piano therapy
967410|NCT03371992|immunotherapy|immunotherapy
967411|NCT03371992|anti-PD1|anti-pd1
967412|NCT03371992|anti-PDL1|anti-pdl1
967413|NCT03371992|biomarker|biomarker
967414|NCT03371992|drug mechanism|drug mechanism
967415|NCT03371966|Beetroot Juice|beetroot juice
967416|NCT03371966|Older Adults|older adults
967417|NCT03371966|Nitrate|nitrate
967418|NCT03371966|Nitrite|nitrite
967419|NCT03371966|Nitric Oxide|nitric oxide
967420|NCT03371953|vecuronium|vecuronium
967421|NCT03371953|atracurium|atracurium
967422|NCT03371953|combination|combination
967423|NCT03371927|Premature Infants|premature infants
967424|NCT03371927|SINC feeding protocol|sinc feeding protocol
967425|NCT03371914|costing|costing
967426|NCT03371914|behavioral intervention|behavioral intervention
967427|NCT03371914|management|management
967428|NCT03371901|Menisci, Tibial|menisci, tibial
968467|NCT03365739|Mango|mango
967429|NCT03371901|Cartilage, Articular|cartilage, articular
967430|NCT03371901|Blood Flow Restriction Training|blood flow restriction training
967431|NCT03371901|Resistance training|resistance training
967432|NCT03371901|Physical Therapy Modalities|physical therapy modalities
967433|NCT03371901|Feasibility Studies|feasibility studies
967434|NCT03371862|Liraglutide|liraglutide
967435|NCT03371862|Victoza|victoza
967436|NCT03371836|pediatrics|pediatrics
967437|NCT03371823|Hypertension|hypertension
967438|NCT03371823|Endothelin-1 receptor|endothelin-1 receptor
967439|NCT03371810|attention-deficit / hyperactivity disorder|attention-deficit / hyperactivity disorder
967440|NCT03371810|depression|depression
967441|NCT03371810|obesity|obesity
967442|NCT03371810|prevention|prevention
967443|NCT03371810|bright light therapy|bright light therapy
967444|NCT03371810|exercise|exercise
967445|NCT03371810|mobile healthy system|mobile healthy system
967446|NCT03371797|ALERT, MSSBP, MSDBP|alert, mssbp, msdbp
967447|NCT03371784|Acute myocardial infarction|acute myocardial infarction
967448|NCT03371784|Left ventricular remodeling|left ventricular remodeling
967449|NCT03371784|Coronary wedge pressure|coronary wedge pressure
967450|NCT03371784|Glucocorticoid therapy|glucocorticoid therapy
967451|NCT03371732|Psychological intervention Alcohol|psychological intervention alcohol
967452|NCT03371732|Tobacco consumption|tobacco consumption
967453|NCT03371732|Substance use|substance use
967454|NCT03371732|Health risk behavior|health risk behavior
967455|NCT03371732|Oncology setting|oncology setting
967456|NCT03371732|Women|women
967457|NCT03371732|Supportive care|supportive care
967458|NCT03371706|aphasia|aphasia
967459|NCT03371706|primary progressive aphasia|primary progressive aphasia
967460|NCT03371706|dementia|dementia
967461|NCT03371706|communication|communication
967462|NCT03371706|frontotemporal dementia|frontotemporal dementia
967463|NCT03371706|Alzheimer's disease|alzheimer's disease
967464|NCT03371693|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
967465|NCT03371693|epithelial ovarian cancer|epithelial ovarian cancer
967466|NCT03371667|Hematopoietic Stem Cell|hematopoietic stem cell
967467|NCT03371667|Methotrexate|methotrexate
967468|NCT03371667|Corticosteroids therapy|corticosteroids therapy
967469|NCT03371667|Acute GVHD|acute gvhd
967470|NCT03371667|Allogenic stem cell transplantation|allogenic stem cell transplantation
967471|NCT03371641|Fetal Alcohol Syndrome|fetal alcohol syndrome
967472|NCT03371641|Pregnancy|pregnancy
967473|NCT03371641|Biomarker|biomarker
967474|NCT03371641|PlGF|plgf
967475|NCT03371641|Cognitive development|cognitive development
967476|NCT03371641|Behavior troubles|behavior troubles
967477|NCT03371576|toric IOL|toric iol
967478|NCT03371550|Concurrent 3-D chemoradiotherapy,Docetaxel,Cisplatin,Chemotherapy ·|concurrent 3-d chemoradiotherapy,docetaxel,cisplatin,chemotherapy ·
967479|NCT03371511|Microbiota|microbiota
967480|NCT03371511|Microbiome|microbiome
967481|NCT03371485|Non-small cell lung cancer|non-small cell lung cancer
967482|NCT03371485|Immunotherapy|immunotherapy
967483|NCT03371485|Cancer vaccine|cancer vaccine
967484|NCT03371485|Dendritic cell vaccine|dendritic cell vaccine
967485|NCT03371485|Allogeneic vaccine|allogeneic vaccine
967486|NCT03371446|DNA Methylation. Smoking. SOCS-1 gene.|dna methylation. smoking. socs-1 gene.
967487|NCT03371433|Osteoporosis|osteoporosis
967488|NCT03371433|Hip Fractures|hip fractures
967489|NCT03371433|Soft Drinks|soft drinks
967490|NCT03371368|Obesity|obesity
967491|NCT03371368|Insulin Resistance|insulin resistance
967492|NCT03371368|Bariatric Surgery|bariatric surgery
967493|NCT03371368|Gastric Bypass|gastric bypass
967494|NCT03371368|Sleeve Gastrectomy|sleeve gastrectomy
967495|NCT03371355|Type 2 Diabetes|type 2 diabetes
967496|NCT03371355|Hepatic Steatosis|hepatic steatosis
967497|NCT03371355|Triglycerides|triglycerides
967498|NCT03371355|AKCEA-ANGPTL3-Lrx|akcea-angptl3-lrx
967499|NCT03371355|IONIS-ANGPTL3-Lrx|ionis-angptl3-lrx
967500|NCT03371355|Fatty Liver|fatty liver
967501|NCT03371355|Fatty Liver Without Mention of Alcohol|fatty liver without mention of alcohol
967502|NCT03371355|Liver Fat|liver fat
967503|NCT03371355|Liver Diseases|liver diseases
967504|NCT03371355|Diabetes Mellitus Type 2 in Nonobese|diabetes mellitus type 2 in nonobese
967505|NCT03371355|Diabetes Mellitus|diabetes mellitus
967506|NCT03371355|Triglycerides High|triglycerides high
967507|NCT03371355|High Triglycerides|high triglycerides
967508|NCT03371355|Metabolic Disease|metabolic disease
967812|NCT03369782|Rocuronium|rocuronium
967509|NCT03371355|Endocrine System Diseases|endocrine system diseases
967510|NCT03371355|Digestive System Disease|digestive system disease
967511|NCT03371355|Glucose Metabolism Disorders|glucose metabolism disorders
967512|NCT03371329|mesenchymal stem cell|mesenchymal stem cell
967513|NCT03371329|stroke|stroke
967514|NCT03371329|intracerebral hemorrhage|intracerebral hemorrhage
967515|NCT03371329|cell therapy|cell therapy
967516|NCT03371264|Liver transplantation|liver transplantation
967517|NCT03371264|Allocation process|allocation process
967518|NCT03371264|Extended-criteria donors|extended-criteria donors
967519|NCT03371264|Survival|survival
967520|NCT03371251|Adults|adults
967521|NCT03371251|BOS161721|bos161721
967522|NCT03371251|standard of care|standard of care
968671|NCT03364517|SPIA|spia
967523|NCT03371251|moderately to severely active Systemic Lupus Erythematosus|moderately to severely active systemic lupus erythematosus
967524|NCT03371212|Dual Mobility|dual mobility
967525|NCT03371212|Serum metal levels|serum metal levels
967526|NCT03371186|Implementation Research|implementation research
967527|NCT03371186|Maternal Mortality and Morbidity|maternal mortality and morbidity
967528|NCT03371186|Neonatal Mortality and Morbidity|neonatal mortality and morbidity
967529|NCT03371186|Infant Mortality and Morbidity|infant mortality and morbidity
967530|NCT03371186|Child Mortality and Morbidity|child mortality and morbidity
967531|NCT03371186|Community Health Workers|community health workers
967532|NCT03371186|Health Systems Strengthening|health systems strengthening
967533|NCT03371173|Pulmonary Hypertension|pulmonary hypertension
967534|NCT03371173|Iron Deficiency|iron deficiency
967535|NCT03371108|Diabetes|diabetes
967536|NCT03371108|Diabetes Type 2|diabetes type 2
967537|NCT03371108|Type 2|type 2
967538|NCT03371108|Basal|basal
967539|NCT03371108|Insulin|insulin
967540|NCT03371108|Glargine|glargine
967541|NCT03371108|T2DM|t2dm
967542|NCT03371108|Diabetes Mellitus|diabetes mellitus
967543|NCT03371095|Behcet's Disease|behcet's disease
967544|NCT03371095|Vasculitis|vasculitis
967545|NCT03371095|Biotherapy|biotherapy
967546|NCT03371095|immunosuppressant|immunosuppressant
967547|NCT03371095|Infliximab|infliximab
967548|NCT03371082|Diabetes|diabetes
967549|NCT03371082|Diabetes Type 1|diabetes type 1
967550|NCT03371082|Type 1|type 1
967551|NCT03371082|Basal|basal
967552|NCT03371082|Insulin|insulin
967553|NCT03371082|Glargine|glargine
967554|NCT03371082|T1DM|t1dm
967555|NCT03371082|Diabetes Mellitus|diabetes mellitus
967556|NCT03371082|Insulin Dependent Diabetes|insulin dependent diabetes
967557|NCT03371069|methylphenidate|methylphenidate
967558|NCT03371069|drug utilisation study|drug utilisation study
967559|NCT03371069|pediatrics|pediatrics
967560|NCT03371056|Neonatal infections|neonatal infections
967561|NCT03371056|maternal-fetal infection|maternal-fetal infection
967562|NCT03371056|group B streptococcus|group b streptococcus
967563|NCT03371056|vaginal sample|vaginal sample
967564|NCT03371056|antibiotic prophylaxis|antibiotic prophylaxis
967565|NCT03371056|bacterial resistance|bacterial resistance
967566|NCT03371043|analgesics|analgesics
967567|NCT03371043|opioids|opioids
967568|NCT03371043|outpatient drug use|outpatient drug use
967569|NCT03371043|pediatrics|pediatrics
967570|NCT03371030|distal radius fractures|distal radius fractures
967571|NCT03371030|pronator quadratus|pronator quadratus
967572|NCT03371030|osteosynthesis|osteosynthesis
967573|NCT03371004|DM-CHOC-PEN|dm-choc-pen
967574|NCT03371004|Radiation|radiation
967575|NCT03371004|Cancer|cancer
967576|NCT03370991|Blueberries|blueberries
967577|NCT03370991|Polyphenols|polyphenols
967578|NCT03370991|Cardiovascular Disease|cardiovascular disease
967579|NCT03370991|Atherosclerosis|atherosclerosis
967580|NCT03370991|Oxidative Stress|oxidative stress
967581|NCT03370991|Inflammmation|inflammmation
967582|NCT03370991|Endothelium|endothelium
967583|NCT03370991|Vasodilation|vasodilation
967584|NCT03370991|Blood Pressure|blood pressure
967585|NCT03370991|Menopause|menopause
967586|NCT03370991|Women's Health|women's health
967587|NCT03370991|Functional Food|functional food
967588|NCT03370991|Bioactive Compounds|bioactive compounds
967589|NCT03370991|Dietary Supplements|dietary supplements
967590|NCT03370991|Aging|aging
967591|NCT03370965|optic neuritis|optic neuritis
967592|NCT03370965|neuromyelitis optica|neuromyelitis optica
967593|NCT03370965|multiple sclerosis|multiple sclerosis
967594|NCT03370965|emergent treatment of optic neuritis|emergent treatment of optic neuritis
967595|NCT03370965|optic neuritis disease modifying therapy|optic neuritis disease modifying therapy
967596|NCT03370965|optic neuritis treatment trial|optic neuritis treatment trial
967597|NCT03370965|plasma exchange|plasma exchange
967598|NCT03370939|ischemic stroke|ischemic stroke
1655258|NCT00168636|OPV|opv
981472|NCT03282175|BDNF|bdnf
967599|NCT03370939|endovascular treatment|endovascular treatment
967600|NCT03370939|workflow|workflow
967601|NCT03370913|Gene Therapy|gene therapy
967602|NCT03370913|Clotting Disorders|clotting disorders
967603|NCT03370913|Blood Disorder|blood disorder
967604|NCT03370913|Blood Coagulation Disorders|blood coagulation disorders
967605|NCT03370913|Inherited Blood Coagulation disorders|inherited blood coagulation disorders
967606|NCT03370913|Hematologic Diseases|hematologic diseases
967813|NCT03369782|sugammadex|sugammadex
967607|NCT03370913|Coagulation Protein Disorders|coagulation protein disorders
967608|NCT03370913|Hemorrhagic Disorders|hemorrhagic disorders
967609|NCT03370913|Genetic Diseases|genetic diseases
967610|NCT03370913|Inborn|inborn
967611|NCT03370913|Factor VIII|factor viii
967612|NCT03370913|Coagulants|coagulants
967613|NCT03370900|Education (Medical); Retention;|education (medical); retention;
967614|NCT03370848|Niacin|niacin
967615|NCT03370848|Psyllium|psyllium
967616|NCT03370848|Dietary fiber|dietary fiber
967617|NCT03370835|Beta-Blocker|beta-blocker
967618|NCT03370835|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
967619|NCT03370835|COPD|copd
967620|NCT03370835|Cardioselective|cardioselective
967621|NCT03370822|Fetal monitoring|fetal monitoring
967622|NCT03370822|Acceptability|acceptability
967623|NCT03370822|Fetal Heart Rate|fetal heart rate
967624|NCT03370809|Frailty|frailty
967625|NCT03370809|Oncogeriatric|oncogeriatric
967626|NCT03370809|PET 18F-FDG|pet 18f-fdg
967627|NCT03370809|SPM (Statistical Parametric Mapping)|spm (statistical parametric mapping)
967628|NCT03370809|Neurology|neurology
967629|NCT03370796|dementia|dementia
967630|NCT03370796|cognitive impairment|cognitive impairment
967631|NCT03370796|cognition|cognition
967632|NCT03370796|quality of life|quality of life
967633|NCT03370796|depressive symptoms|depressive symptoms
967634|NCT03370796|Reminiscence Therapy|reminiscence therapy
967635|NCT03370744|subjective cognitive decline|subjective cognitive decline
967636|NCT03370744|brain network|brain network
967637|NCT03370744|multi-modality|multi-modality
967638|NCT03370744|magnetic resonance imaging|magnetic resonance imaging
967639|NCT03370731|pediatric|pediatric
967640|NCT03370731|obstructive sleep apnea|obstructive sleep apnea
967641|NCT03370731|polysomnography|polysomnography
967642|NCT03370731|quality of life|quality of life
967643|NCT03370731|adenotonsillectomy|adenotonsillectomy
967644|NCT03370718|Adrenocortical carcinoma|adrenocortical carcinoma
967645|NCT03370718|ACC|acc
967646|NCT03370718|Cabozantinib|cabozantinib
967647|NCT03370718|XL-184|xl-184
967648|NCT03370718|XL184|xl184
967649|NCT03370692|Outcome|outcome
967650|NCT03370692|Survival|survival
967651|NCT03370692|Prognostication|prognostication
967652|NCT03370679|Premature|premature
967653|NCT03370679|Ventricular|ventricular
967654|NCT03370679|Complexes|complexes
967655|NCT03370679|Beats|beats
967656|NCT03370679|Prognosis|prognosis
967657|NCT03370653|MPS VI|mps vi
967658|NCT03370653|Lysosomal disease|lysosomal disease
967659|NCT03370653|Glycoaminoglycans (GAG)|glycoaminoglycans (gag)
967660|NCT03370653|Odiparcil|odiparcil
967661|NCT03370627|Autoimmune Diseases|autoimmune diseases
967662|NCT03370627|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
967663|NCT03370627|Type I Interferons|type i interferons
967664|NCT03370627|Antibodies|antibodies
967665|NCT03370627|Anti-CD303|anti-cd303
967666|NCT03370614|PET|pet
967667|NCT03370614|MRI|mri
967668|NCT03370614|Irritable Bowel Syndrome|irritable bowel syndrome
967669|NCT03370614|Irritable Bowel|irritable bowel
967670|NCT03370614|Positron emission tomography|positron emission tomography
967671|NCT03370614|Magnetic resonance imaging|magnetic resonance imaging
967672|NCT03370614|FDG|fdg
967673|NCT03370614|Fluorodeoxyglucose|fluorodeoxyglucose
967674|NCT03370601|crohn's disease|crohn's disease
967675|NCT03370601|ulcerative colitis|ulcerative colitis
967676|NCT03370601|infliximab|infliximab
967677|NCT03370601|loss of response|loss of response
967678|NCT03370562|dexmedetomidine|dexmedetomidine
967679|NCT03370562|cesarean|cesarean
967680|NCT03370562|spinal anesthesia|spinal anesthesia
967681|NCT03370549|Mental health|mental health
967682|NCT03370549|Suicide|suicide
967683|NCT03370549|Sexual risk behaviors|sexual risk behaviors
967684|NCT03370536|Atrial Fibrillation|atrial fibrillation
967685|NCT03370536|Persistent Atrial Fibrillation|persistent atrial fibrillation
967686|NCT03370536|AFIB|afib
967687|NCT03370536|Arrhythmia|arrhythmia
967688|NCT03370471|aerobic exercise|aerobic exercise
967689|NCT03370471|learning|learning
967690|NCT03370471|language|language
967691|NCT03370471|cognition|cognition
967692|NCT03370432|Vitamin D|vitamin d
967693|NCT03370432|GC|gc
967694|NCT03370432|CYP2R1|cyp2r1
967695|NCT03370432|Gene-environment interaction|gene-environment interaction
967696|NCT03370432|prospective case-cohort study|prospective case-cohort study
967697|NCT03370432|single nucleotide polymorphisms|single nucleotide polymorphisms
967698|NCT03370432|colorectal cancer|colorectal cancer
967699|NCT03370419|Metabolic syndrome|metabolic syndrome
967700|NCT03370419|Habits|habits
967701|NCT03370419|African American|african american
967702|NCT03370419|Emergency Medicine|emergency medicine
967703|NCT03370406|Squamous Cell|squamous cell
967704|NCT03370406|Carcinoma|carcinoma
967705|NCT03370406|Lower Extremities|lower extremities
967706|NCT03370406|5-Fluorouracil|5-fluorouracil
967707|NCT03370406|Imiquimod|imiquimod
967708|NCT03370393|Reward-drive|reward-drive
967709|NCT03370393|Cogntiive-control|cogntiive-control
967710|NCT03370315|Parkinsonian Disorders|parkinsonian disorders
967711|NCT03370315|Dance Therapy|dance therapy
967712|NCT03370315|Rehabilitation|rehabilitation
967713|NCT03370315|Kinematics|kinematics
967714|NCT03370315|Locomotion|locomotion
967715|NCT03370315|Quality of Life|quality of life
967716|NCT03370302|Drug therapy|drug therapy
967717|NCT03370263|Benlysta, systemic lupus erythematosus, safety, efficacy|benlysta, systemic lupus erythematosus, safety, efficacy
967718|NCT03370250|immediate breast reconstruction|immediate breast reconstruction
967719|NCT03370250|free greater omentum|free greater omentum
967720|NCT03370250|breast-conserving surgery|breast-conserving surgery
967721|NCT03370250|luminal breast cancer|luminal breast cancer
967722|NCT03370237|Diabetic foot ulcer|diabetic foot ulcer
967723|NCT03370237|type 2 diabetes|type 2 diabetes
967724|NCT03370237|foot ulcer risk|foot ulcer risk
967725|NCT03370224|Memory|memory
967726|NCT03370224|Learning|learning
967727|NCT03370224|Cognition|cognition
967728|NCT03370224|Treatment|treatment
967729|NCT03370211|resistance training|resistance training
967730|NCT03370211|inflammatory markers|inflammatory markers
967731|NCT03370211|functional capacity|functional capacity
967732|NCT03370185|Leukemia|leukemia
967733|NCT03370185|Lymphoma|lymphoma
967734|NCT03370185|Refractory|refractory
967735|NCT03370185|Relapse|relapse
967736|NCT03370133|Bimekizumab|bimekizumab
967737|NCT03370133|PSO|pso
967738|NCT03370133|Psoriasis|psoriasis
967739|NCT03370120|Drug-Resistant Epilepsy|drug-resistant epilepsy
967740|NCT03370120|Padsevonil|padsevonil
967741|NCT03370081|Capnometry|capnometry
967742|NCT03370081|Capnography|capnography
967743|NCT03370081|ETCO2|etco2
967744|NCT03370081|Recovery room|recovery room
967745|NCT03370081|Post-anesthesia care unit|post-anesthesia care unit
967746|NCT03370068|ICSI|icsi
967747|NCT03370068|IVF|ivf
967748|NCT03370068|Infertility|infertility
967749|NCT03370068|non-male factor|non-male factor
967750|NCT03370068|intracytoplasmic sperm injection|intracytoplasmic sperm injection
967751|NCT03370068|In vitro fertilization|in vitro fertilization
967752|NCT03370055|Exposed tendon or bone|exposed tendon or bone
967753|NCT03370055|LeucoPatch|leucopatch
967754|NCT03370055|Plastic Surgery|plastic surgery
967755|NCT03370055|Granulation tissue|granulation tissue
967756|NCT03370055|Wound|wound
967757|NCT03370042|aesthetics|aesthetics
967758|NCT03370042|root coverage|root coverage
967759|NCT03370042|semilunar coronally positioned flap|semilunar coronally positioned flap
967760|NCT03370042|free gingival graft|free gingival graft
967761|NCT03370042|width of keratinised tissue|width of keratinised tissue
967762|NCT03370029|Exercise capacity|exercise capacity
967763|NCT03370029|Respiratory muscle strength|respiratory muscle strength
967764|NCT03370029|Physical inactivity|physical inactivity
967765|NCT03370029|Quality of life|quality of life
967766|NCT03370016|Radical Prostatectomy|radical prostatectomy
967767|NCT03370016|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
967768|NCT03369977|BioGlue Surgical Adhesive|bioglue surgical adhesive
967769|NCT03369977|Type A Aortic Dissection|type a aortic dissection
967770|NCT03369951|ACUMIN|acumin
967771|NCT03369951|Infusion|infusion
967772|NCT03369951|Injection|injection
967773|NCT03369951|Minocycline|minocycline
967774|NCT03369951|Pharmacokinetic|pharmacokinetic
967775|NCT03369951|PK|pk
967776|NCT03369938|left ventricular assist device|left ventricular assist device
967777|NCT03369938|exercise training|exercise training
967778|NCT03369912|Safety, efficacy|safety, efficacy
967779|NCT03369912|pregnant women|pregnant women
967780|NCT03369912|CSJ148|csj148
967781|NCT03369912|HCMV infection|hcmv infection
967782|NCT03369912|congenital HCMV|congenital hcmv
967783|NCT03369886|OCTA|octa
967784|NCT03369886|Angiography|angiography
967785|NCT03369886|Artificial neural network|artificial neural network
967786|NCT03369873|cardiac catheterization|cardiac catheterization
967787|NCT03369873|anxiety|anxiety
967788|NCT03369873|stress|stress
967789|NCT03369873|nursing orientation|nursing orientation
967790|NCT03369847|inhaled corticosteroids|inhaled corticosteroids
967791|NCT03369847|budesonide|budesonide
967792|NCT03369847|beclomethasone|beclomethasone
967793|NCT03369834|phototherapy|phototherapy
967794|NCT03369834|diabetes mellitus|diabetes mellitus
967795|NCT03369834|exercise|exercise
967796|NCT03369821|type 1 diabetes|type 1 diabetes
967797|NCT03369821|monogenic diabetes|monogenic diabetes
967798|NCT03369821|autoimmune diabetes|autoimmune diabetes
1655259|NCT00168636|Sex|sex
967799|NCT03369821|early-onset autoimmune diabetes|early-onset autoimmune diabetes
967800|NCT03369821|beta cell (β-cell) destruction|beta cell (β-cell) destruction
967801|NCT03369821|type 1 diabetes genetic risk|type 1 diabetes genetic risk
967802|NCT03369821|extremely early-onset Type 1 diabetes|extremely early-onset type 1 diabetes
967803|NCT03369821|neonatal diabetes|neonatal diabetes
967804|NCT03369808|H7N9|h7n9
967805|NCT03369795|methotrexate|methotrexate
967806|NCT03369795|add-on|add-on
967807|NCT03369795|schizophrenia|schizophrenia
967808|NCT03369795|schizoaffective|schizoaffective
967809|NCT03369782|Muscle Tension|muscle tension
967810|NCT03369782|Skeletal Muscle Relaxants|skeletal muscle relaxants
967811|NCT03369782|Arthroplasties, Hip Replacement|arthroplasties, hip replacement
967822|NCT03369704|cryptomeria, omalizumab, seasonal allergic rhinitis|cryptomeria, omalizumab, seasonal allergic rhinitis
967823|NCT03369678|Cultural Safety|cultural safety
967824|NCT03369678|Discrimination|discrimination
967825|NCT03369678|Emergency Departments|emergency departments
967826|NCT03369678|Health Equity|health equity
967827|NCT03369678|Indigenous Populations|indigenous populations
967828|NCT03369678|Marginalized Populations|marginalized populations
967829|NCT03369678|Patient Experiences of Care|patient experiences of care
967830|NCT03369678|Trauma- and Violence-Informed Care|trauma- and violence-informed care
967831|NCT03369678|Staff Engagement|staff engagement
967832|NCT03369678|Harm Reduction|harm reduction
967833|NCT03369665|Multiple sclerosis|multiple sclerosis
967834|NCT03369665|Mavenclad®|mavenclad®
967835|NCT03369665|Cladribine|cladribine
967836|NCT03369665|Health-related Quality of Life|health-related quality of life
967837|NCT03369639|late life|late life
967838|NCT03369639|THC|thc
967839|NCT03369639|depression|depression
967840|NCT03369639|anxiety|anxiety
967841|NCT03369639|dronabinol|dronabinol
967842|NCT03369587|Handwriting, Micrographia|handwriting, micrographia
967843|NCT03369548|Bile acids|bile acids
967844|NCT03369548|Lipid metabolism|lipid metabolism
967845|NCT03369548|Cholesterol|cholesterol
967846|NCT03369548|Probiotics|probiotics
967847|NCT03369548|Polyphenols|polyphenols
967848|NCT03369548|Prebiotics|prebiotics
967849|NCT03369548|Gut bacteria|gut bacteria
967850|NCT03369548|Gut microbiota|gut microbiota
967851|NCT03369535|hypertension|hypertension
967852|NCT03369522|seizure detection|seizure detection
967853|NCT03369509|Drug hypersensitivity, drug allergy, cross reaction|drug hypersensitivity, drug allergy, cross reaction
967854|NCT03369496|Social Capital|social capital
967855|NCT03369496|Social Support|social support
967856|NCT03369496|Neighborhood|neighborhood
967857|NCT03369496|Population Health|population health
967858|NCT03369496|Healthy Aging|healthy aging
967859|NCT03369496|Adult|adult
967860|NCT03369496|Canada|canada
967861|NCT03369431|Autism|autism
967862|NCT03369431|Gastrointestinal|gastrointestinal
967863|NCT03369431|behaviour|behaviour
967864|NCT03369431|constipation|constipation
967865|NCT03369431|diarrhoea|diarrhoea
967866|NCT03369431|probiotic|probiotic
967867|NCT03369431|sociability|sociability
967868|NCT03369405|periodontitis|periodontitis
967869|NCT03369405|hypothyroidism|hypothyroidism
967870|NCT03369379|Fibromyalgia|fibromyalgia
967871|NCT03369379|D Vitamin|d vitamin
967872|NCT03369366|Maxillofacial Defects|maxillofacial defects
967873|NCT03369366|Benign, large tumors requiring surgical resection|benign, large tumors requiring surgical resection
967874|NCT03369353|Bone Marrow Transplantation|bone marrow transplantation
967875|NCT03369353|Graft Vs Host Disease|graft vs host disease
967876|NCT03369353|Inflammatory Bowel Diseases|inflammatory bowel diseases
967877|NCT03369353|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
967878|NCT03369340|Nicotine|nicotine
967879|NCT03369340|Reduced risk product|reduced risk product
967880|NCT03369340|Nicotine-containing product|nicotine-containing product
967881|NCT03369275|Mesenchymal Stem Cells|mesenchymal stem cells
967882|NCT03369275|Mesenchymal Stromal Cells|mesenchymal stromal cells
967883|NCT03369275|Randomized Controlled Trial|randomized controlled trial
967884|NCT03369275|Cryopreserved|cryopreserved
967885|NCT03369275|Allogeneic|allogeneic
967886|NCT03369275|Phase II|phase ii
967887|NCT03369262|preterm labor|preterm labor
967888|NCT03369262|preterm birth|preterm birth
967889|NCT03369262|premature birth|premature birth
967890|NCT03369262|tocolysis|tocolysis
967891|NCT03369262|prostaglandin F2α antagonist|prostaglandin f2α antagonist
967892|NCT03369262|PGF2α|pgf2α
967904|NCT03369223|Antibodies|antibodies
967905|NCT03369223|Antineoplastic Agents|antineoplastic agents
967906|NCT03369223|Immunologic Factors|immunologic factors
967907|NCT03369223|Nivolumab|nivolumab
967908|NCT03369223|Antibodies, Monoclonal|antibodies, monoclonal
967909|NCT03369223|Physiological Effects of Drugs|physiological effects of drugs
967910|NCT03369197|procedural sedation|procedural sedation
968589|NCT03364894|Imaging|imaging
967911|NCT03369197|monitored anesthesia care|monitored anesthesia care
967912|NCT03369197|endoscopy|endoscopy
967913|NCT03369184|Coronary flow|coronary flow
967914|NCT03369184|Coronary vascular resistance|coronary vascular resistance
967915|NCT03369184|Supplemental oxygen|supplemental oxygen
967916|NCT03369145|Hepatokines|hepatokines
967917|NCT03369145|High Fat Diet|high fat diet
967918|NCT03369145|Glycaemic Control|glycaemic control
967919|NCT03369145|Fibroblast Growth Factor 21|fibroblast growth factor 21
967920|NCT03369145|Leukocyte Cell-derived Chemotaxin 2|leukocyte cell-derived chemotaxin 2
967921|NCT03369145|Fetuin-A|fetuin-a
967922|NCT03369145|Appetite|appetite
967923|NCT03369145|Ghrelin|ghrelin
967924|NCT03369145|Peptide YY|peptide yy
967925|NCT03369119|Acute asthma|acute asthma
967926|NCT03369119|Montelukast|montelukast
967927|NCT03369119|Hospitalized children|hospitalized children
967928|NCT03369119|Preschool children|preschool children
967929|NCT03369093|RCT|rct
967930|NCT03369093|severe pneumonia|severe pneumonia
967931|NCT03369093|amoxicillin|amoxicillin
967932|NCT03369093|under five|under five
967933|NCT03369080|Body Mass Index|body mass index
967934|NCT03369041|chemoembolization|chemoembolization
967935|NCT03369015|Reward Learning|reward learning
967936|NCT03369015|Decision Making|decision making
967937|NCT03369002|Hepatic Impairment|hepatic impairment
967938|NCT03368950|Anxiety|anxiety
967939|NCT03368950|Depression|depression
967940|NCT03368950|Stress|stress
967941|NCT03368937|Artificial Pancreas (AP)|artificial pancreas (ap)
967942|NCT03368937|Closed Loop Control (CLC)|closed loop control (clc)
967943|NCT03368937|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
968790|NCT03363815|Omeprazole|omeprazole
967944|NCT03368937|Insulin Pump|insulin pump
967945|NCT03368924|sickle cell anemia red blood cell oxidation|sickle cell anemia red blood cell oxidation
967946|NCT03368924|vaso-occlusive crises|vaso-occlusive crises
967947|NCT03368924|anti bande 3 antibodies|anti bande 3 antibodies
967948|NCT03368924|red blood cell oxidation|red blood cell oxidation
967949|NCT03368911|Hoarseness|hoarseness
967950|NCT03368911|Sore Throat|sore throat
967951|NCT03368911|Thyroidectomy|thyroidectomy
967952|NCT03368885|MIYCN -Maternal Infant Young Child Nutrition|miycn -maternal infant young child nutrition
967953|NCT03368885|CGPP - Core Group Polio Project|cgpp - core group polio project
967954|NCT03368885|A&T- Alive and Thrive|a&t- alive and thrive
967955|NCT03368885|PCI- Project Concern International|pci- project concern international
967956|NCT03368885|UP- Uttar Pradesh|up- uttar pradesh
967957|NCT03368885|VHSNC -Village Health, Sanitation and Nutrition Committee|vhsnc -village health, sanitation and nutrition committee
967958|NCT03368885|CMC- Community Mobilization Coordinator|cmc- community mobilization coordinator
967959|NCT03368872|Sarcopenia, muscle function, muscle endurance, fatigue|sarcopenia, muscle function, muscle endurance, fatigue
967960|NCT03368859|cancer|cancer
967961|NCT03368859|colorectal cancer|colorectal cancer
967962|NCT03368859|ABT-165|abt-165
967963|NCT03368859|FOLFIRI|folfiri
967964|NCT03368859|Bevacizumab|bevacizumab
967965|NCT03368859|bowel cancer|bowel cancer
967966|NCT03368859|metastatic colorectal cancer|metastatic colorectal cancer
967967|NCT03368859|metastatic colorectal|metastatic colorectal
967968|NCT03368820|lung neoplasms|lung neoplasms
967969|NCT03368820|cardiovascular co-morbidity|cardiovascular co-morbidity
967970|NCT03368781|Atrial Fibrillation|atrial fibrillation
967971|NCT03368768|Antimicrobial-resistant bacterial infection|antimicrobial-resistant bacterial infection
967972|NCT03368768|Questionaire|questionaire
967973|NCT03368729|metastatic breast cancer|metastatic breast cancer
967974|NCT03368729|HER2 positive|her2 positive
967975|NCT03368729|Poly (ADP-Ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
967976|NCT03368729|Niraparib|niraparib
967977|NCT03368729|Trastuzumab|trastuzumab
967978|NCT03368716|Pediatric Obesity|pediatric obesity
967979|NCT03368716|Executive Function|executive function
967980|NCT03368716|Behavioral Intervention|behavioral intervention
967981|NCT03368703|COPD|copd
967982|NCT03368703|Transcranial direct-current stimulation|transcranial direct-current stimulation
967983|NCT03368703|Transcranial magnetic stimulation|transcranial magnetic stimulation
967984|NCT03368703|Motor-evoked potentials|motor-evoked potentials
967985|NCT03368703|Inhibition|inhibition
967986|NCT03368703|Muscle weakness|muscle weakness
967987|NCT03368690|Polyphenolic extract from pine bark, Antioxidant, Attention deficit/hyperactivity disorder.|polyphenolic extract from pine bark, antioxidant, attention deficit/hyperactivity disorder.
967988|NCT03368638|Degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
967989|NCT03368638|Neural mobilization|neural mobilization
967990|NCT03368638|Hip extension mobilization|hip extension mobilization
967991|NCT03368638|Case series|case series
967992|NCT03368638|Neurogenic claudication|neurogenic claudication
967993|NCT03368625|Stereotactic Radiosurgery|stereotactic radiosurgery
967994|NCT03368625|Radiation|radiation
967995|NCT03368625|Surgery|surgery
967996|NCT03368586|Flash Glucose Monitoring|flash glucose monitoring
967997|NCT03368586|Children|children
967998|NCT03368586|Adolescents|adolescents
967999|NCT03368573|ADHD|adhd
968000|NCT03368573|Cognitive Assessment|cognitive assessment
968001|NCT03368573|QbTest|qbtest
968002|NCT03368573|Medication|medication
968003|NCT03368573|Feasibility|feasibility
968004|NCT03368560|Treatment-resistant Late Life Depression|treatment-resistant late life depression
968005|NCT03368560|Sudarshan Kriya Yoga|sudarshan kriya yoga
968006|NCT03368560|Glutathione|glutathione
968007|NCT03368508|Simulation|simulation
968008|NCT03368508|Physiotherapy training|physiotherapy training
968009|NCT03368508|360-degree video|360-degree video
968010|NCT03368495|yellow fever vaccine|yellow fever vaccine
968011|NCT03368495|MMR vaccine|mmr vaccine
968012|NCT03368495|immunogenicity|immunogenicity
968013|NCT03368482|cognition disorders|cognition disorders
968014|NCT03368482|frail elderly|frail elderly
968015|NCT03368482|human physical conditioning|human physical conditioning
968016|NCT03368482|institutionalization|institutionalization
968017|NCT03368482|physical activity|physical activity
968018|NCT03368469|Transcranial|transcranial
968019|NCT03368469|Stimulation|stimulation
968020|NCT03368456|mhealth|mhealth
968021|NCT03368456|preventive intervention|preventive intervention
968022|NCT03368456|primary health care|primary health care
968023|NCT03368443|Parkinson's disease|parkinson's disease
968024|NCT03368443|context-dependent learning|context-dependent learning
968025|NCT03368443|transcranial magnetic stimulation|transcranial magnetic stimulation
968026|NCT03368443|cognitive function|cognitive function
968027|NCT03368430|Melatonin; Chronic periodontitis; Host modulation therapy|melatonin; chronic periodontitis; host modulation therapy
968028|NCT03368417|Hypertension|hypertension
968029|NCT03368417|Wireless Home Blood Pressure Monitoring|wireless home blood pressure monitoring
968030|NCT03368417|Medication Adherence|medication adherence
968031|NCT03368417|Medication Titration|medication titration
968032|NCT03368417|Financial Incentives|financial incentives
968791|NCT03363815|Midazolam|midazolam
968033|NCT03368417|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
968034|NCT03368378|prostate cancer|prostate cancer
968035|NCT03368378|radical prostatectomy|radical prostatectomy
968036|NCT03368378|deep venous complex ligation|deep venous complex ligation
968037|NCT03368365|Monitoring|monitoring
968038|NCT03368365|Home|home
968039|NCT03368365|Lung|lung
968040|NCT03368365|Transplant|transplant
968041|NCT03368365|Hospitalization|hospitalization
968042|NCT03368365|Respiratory function at rest|respiratory function at rest
968043|NCT03368365|Monitoring modem|monitoring modem
968044|NCT03368352|Melatonin|melatonin
968045|NCT03368352|Altitude|altitude
968046|NCT03368352|Sleep|sleep
968047|NCT03368352|Ventilation|ventilation
968048|NCT03368352|Cognition|cognition
968049|NCT03368300|progressive supranuclear palsy|progressive supranuclear palsy
968050|NCT03368300|Caribbean atypical Parkinsonism|caribbean atypical parkinsonism
968051|NCT03368300|Annona Muricata|annona muricata
968052|NCT03368287|Total Knee Arthroplasty|total knee arthroplasty
968053|NCT03368287|steps|steps
968054|NCT03368287|rehabilitation|rehabilitation
968055|NCT03368287|activity tracker|activity tracker
968056|NCT03368261|Pulmonary arterial hypertension|pulmonary arterial hypertension
968057|NCT03368261|SCD|scd
968058|NCT03368261|Epidemiology|epidemiology
968059|NCT03368248|Palliative care|palliative care
968060|NCT03368248|Collegial meetings|collegial meetings
968061|NCT03368248|Neonatal resuscitation services|neonatal resuscitation services
968062|NCT03368248|Survey|survey
968063|NCT03368248|Medico-caring staff of the NICUs|medico-caring staff of the nicus
968064|NCT03368235|rheumatoid arthritis, swollen joints, tender joints, autoimmunity|rheumatoid arthritis, swollen joints, tender joints, autoimmunity
968065|NCT03368222|Non Small Cell Lung Cancer|non small cell lung cancer
968066|NCT03368222|NSCLC|nsclc
968067|NCT03368209|Non-invasive glucose monitoring|non-invasive glucose monitoring
968068|NCT03368196|Stomach cancer|stomach cancer
968069|NCT03368196|Cancer where the esophagus meets the stomach|cancer where the esophagus meets the stomach
968070|NCT03368196|Human epidermal growth factor 2|human epidermal growth factor 2
968071|NCT03368196|HER2|her2
968072|NCT03368196|Breast Cancer|breast cancer
968073|NCT03368196|Adenocarcinoma, Gastroesophageal Junction (GEJ)|adenocarcinoma, gastroesophageal junction (gej)
968074|NCT03368196|Gastric Cancer|gastric cancer
968075|NCT03368196|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
968076|NCT03368196|Oncology|oncology
968077|NCT03368170|Levodopa induced dyskinesia|levodopa induced dyskinesia
968078|NCT03368118|ABX464|abx464
968079|NCT03368118|Ulcerative Colitis|ulcerative colitis
968080|NCT03368105|Clostridium difficile Infection|clostridium difficile infection
968081|NCT03368105|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
968082|NCT03368105|organ transplantation|organ transplantation
968083|NCT03368105|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
968084|NCT03368092|severe trauma|severe trauma
968085|NCT03368092|acute respiratory distress syndrome|acute respiratory distress syndrome
968086|NCT03368092|damage-associated molecular patterns|damage-associated molecular patterns
968087|NCT03368092|neutrophil extracellular traps|neutrophil extracellular traps
968088|NCT03368092|dornase alfa|dornase alfa
968089|NCT03368079|Dysphagia|dysphagia
968090|NCT03368079|Oropharyngeal dysphagia|oropharyngeal dysphagia
968091|NCT03368079|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
968092|NCT03368053|gp120|gp120
968093|NCT03368053|HIV infections|hiv infections
968094|NCT03368053|RV144|rv144
968792|NCT03363815|Warfarin|warfarin
1655260|NCT00168623|Vitamin A|vitamin a
968098|NCT03368027|Vision Disorders; Stress, Psychological|vision disorders; stress, psychological
968099|NCT03368014|Sharing|sharing
968100|NCT03368014|Mind|mind
968101|NCT03368014|Enjoyment|enjoyment
968102|NCT03368001|Autism|autism
968103|NCT03367988|Opioid Dependence|opioid dependence
968104|NCT03367988|Analagesia|analagesia
968105|NCT03367988|Opioid-free Anesthesia|opioid-free anesthesia
968106|NCT03367962|PET-CT scan|pet-ct scan
968107|NCT03367962|[18F]F-AraG|[18f]f-arag
968108|NCT03367949|Surgical guide|surgical guide
968109|NCT03367949|impression inversion|impression inversion
968110|NCT03367949|stereolithographic surgical guides|stereolithographic surgical guides
968111|NCT03367936|mobile technology|mobile technology
968112|NCT03367936|feedback message|feedback message
968113|NCT03367936|self-monitoring|self-monitoring
968114|NCT03367910|Urinary tract infection|urinary tract infection
968115|NCT03367910|Multidrug resistant organism|multidrug resistant organism
968116|NCT03367910|Fecal microbiota transplantation|fecal microbiota transplantation
968117|NCT03367897|Helicobacter pylori|helicobacter pylori
968118|NCT03367897|peptic ulcer|peptic ulcer
968119|NCT03367897|erosions|erosions
968120|NCT03367897|bleeding|bleeding
968121|NCT03367897|Nsaids|nsaids
968122|NCT03367897|Noac|noac
968123|NCT03367884|Hypopharyngeal cancer|hypopharyngeal cancer
968124|NCT03367884|Neck dissection|neck dissection
968125|NCT03367884|Induction chemotherapy|induction chemotherapy
968126|NCT03367884|Cervical lymph node metastasis|cervical lymph node metastasis
968127|NCT03367884|definitive radiotherapy|definitive radiotherapy
968899|NCT03363217|Trametinib|trametinib
968128|NCT03367871|Recurrent Cervical Cancer|recurrent cervical cancer
968129|NCT03367871|Persistent Cervical Cancer|persistent cervical cancer
968130|NCT03367871|Metastatic Cervical Cancer|metastatic cervical cancer
968131|NCT03367845|Parent sensitivity|parent sensitivity
968132|NCT03367845|Fathers|fathers
968133|NCT03367845|Attachment|attachment
968134|NCT03367845|Marital communication|marital communication
968135|NCT03367780|Head-neck tumours|head-neck tumours
968136|NCT03367780|Radiotherapy|radiotherapy
968137|NCT03367780|Salivary gland toxicity|salivary gland toxicity
968138|NCT03367780|PSMA PET/CT|psma pet/ct
968139|NCT03367767|Blood Sample|blood sample
968140|NCT03367767|Medical History|medical history
968141|NCT03367767|Optical Imaging|optical imaging
968147|NCT03367728|Bariatric Surgery|bariatric surgery
968148|NCT03367728|Bariatrics|bariatrics
968149|NCT03367728|Ropivacaine|ropivacaine
968150|NCT03367728|Randomized Controlled Trial|randomized controlled trial
968151|NCT03367728|Enhanced Recovery After Bariatric Surgery|enhanced recovery after bariatric surgery
968152|NCT03367728|TAP Block|tap block
968153|NCT03367728|Rectus Sheath Block|rectus sheath block
968154|NCT03367676|trastuzumab|trastuzumab
968155|NCT03367676|adjuvant therapy|adjuvant therapy
968156|NCT03367650|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
968157|NCT03367650|epidemiology|epidemiology
968158|NCT03367650|genetic|genetic
968159|NCT03367650|environmental factor|environmental factor
968160|NCT03367637|Cancer Pain, Palliative care, Mobile Applications, Rwanda|cancer pain, palliative care, mobile applications, rwanda
968161|NCT03367624|influenza|influenza
968162|NCT03367624|Staphylococcus Aureus|staphylococcus aureus
968163|NCT03367624|Pneumonia|pneumonia
968164|NCT03367624|PV leukocidin|pv leukocidin
968165|NCT03367624|ICU|icu
968166|NCT03367611|Immunochemical faecal occult blood test|immunochemical faecal occult blood test
968167|NCT03367611|iFOBT|ifobt
968168|NCT03367611|Cancer patient pathway|cancer patient pathway
968169|NCT03367611|Colonoscopy|colonoscopy
968170|NCT03367611|Colorectal cancer|colorectal cancer
968171|NCT03367585|Supplementary Feeding|supplementary feeding
968172|NCT03367585|vitamin D|vitamin d
968173|NCT03367585|Muscle Strength|muscle strength
968174|NCT03367585|postural balance|postural balance
968175|NCT03367585|exercise|exercise
968176|NCT03367585|aged|aged
968177|NCT03367559|Rotavirus|rotavirus
968178|NCT03367559|ROTAVAC|rotavac
968179|NCT03367559|Vaccine|vaccine
968180|NCT03367559|Vietnam|vietnam
968181|NCT03367546|SCD|scd
968182|NCT03367546|cALD|cald
968183|NCT03367481|Gingival fissures|gingival fissures
968184|NCT03367481|Gingival recession|gingival recession
968185|NCT03367481|Risk factors|risk factors
968186|NCT03367481|Traumatic toothbrusing|traumatic toothbrusing
968187|NCT03367468|Plantar fascitis|plantar fascitis
968188|NCT03367468|Pain|pain
968189|NCT03367468|Exercise|exercise
968190|NCT03367468|Physiotherapy|physiotherapy
968191|NCT03367468|Quality of life|quality of life
968192|NCT03367455|Potassium|potassium
968193|NCT03367455|Genetic Variants|genetic variants
968194|NCT03367442|Thoracic trauma|thoracic trauma
968196|NCT03367442|Acute respiratory distress syndrome|acute respiratory distress syndrome
968197|NCT03367442|Esophageal pressure|esophageal pressure
968198|NCT03367442|Pleural pressure|pleural pressure
968199|NCT03367429|stroke|stroke
968200|NCT03367429|spasticity|spasticity
968201|NCT03367403|TRAILBLAZER-ALZ|trailblazer-alz
968202|NCT03367364|Venous Thromboembolism, Deep Venous Thrombosis, Clots|venous thromboembolism, deep venous thrombosis, clots
968203|NCT03367325|non-valvular atrial fibrillation|non-valvular atrial fibrillation
968204|NCT03367325|time in therapeutic range|time in therapeutic range
968205|NCT03367325|primary care|primary care
968206|NCT03367299|Acute Lymphoid Leukemia|acute lymphoid leukemia
968207|NCT03367299|Philadelphia Chromosome-Negative B-Cell Precursor|philadelphia chromosome-negative b-cell precursor
968208|NCT03367299|Adults|adults
968209|NCT03367299|Minimal residual disease|minimal residual disease
968210|NCT03367299|Blinatumomab|blinatumomab
968211|NCT03367260|patient preferences|patient preferences
968212|NCT03367247|Ovarian Cancer|ovarian cancer
968213|NCT03367247|Bowel blockage|bowel blockage
968214|NCT03367247|Ascites|ascites
968215|NCT03367247|Supportive care|supportive care
968216|NCT03367247|Nursing|nursing
968217|NCT03367247|Mobile health|mobile health
968218|NCT03367247|m-Health|m-health
968219|NCT03367247|Tele-health|tele-health
968220|NCT03367247|Palliative Care|palliative care
968222|NCT03367234|Federally Qualified Health Center|federally qualified health center
968223|NCT03367234|Contingency Management|contingency management
968224|NCT03367234|Cognitive Behavioral Therapy|cognitive behavioral therapy
968225|NCT03367234|Cognitive Behavioral / Relapse Prevention|cognitive behavioral / relapse prevention
968226|NCT03367234|Medication Assisted Treatment|medication assisted treatment
968227|NCT03367234|Behavioral Health Consultant|behavioral health consultant
968228|NCT03367234|Integrated Care|integrated care
968229|NCT03367208|metabolomic|metabolomic
968230|NCT03367195|GERD|gerd
968231|NCT03367195|DLBS2411|dlbs2411
968232|NCT03367195|omeprazole|omeprazole
968233|NCT03367169|Pilon fractures|pilon fractures
968234|NCT03367169|Osteosynthesis|osteosynthesis
968235|NCT03367169|Mini invasive plate osteosynthesis|mini invasive plate osteosynthesis
968236|NCT03367169|Locked plate|locked plate
968237|NCT03367169|Open reduction|open reduction
968238|NCT03367156|Dyspnea|dyspnea
968239|NCT03367156|Questionnaires|questionnaires
968240|NCT03367156|Surveys|surveys
968241|NCT03367156|Dexamethasone|dexamethasone
968242|NCT03367156|Decadron|decadron
968243|NCT03367156|Placebo|placebo
968244|NCT03367156|Sugar pill|sugar pill
968245|NCT03367130|Antiretroviral therapy, clinic attendance, Nepal|antiretroviral therapy, clinic attendance, nepal
968246|NCT03367091|Wearable Exoskeleton|wearable exoskeleton
968247|NCT03367091|Stroke|stroke
968248|NCT03367091|Energy Consumption|energy consumption
968249|NCT03367091|Cardiorespiratory Load|cardiorespiratory load
968250|NCT03367078|tDCS|tdcs
968251|NCT03367078|transcranial direct current stimulation|transcranial direct current stimulation
968252|NCT03367078|acquired brain injury|acquired brain injury
968253|NCT03367078|coma|coma
968254|NCT03367078|vigilance|vigilance
968255|NCT03367052|ProDisc-C vivo|prodisc-c vivo
968256|NCT03367052|Hybrid|hybrid
968257|NCT03367052|Cervical degenerative disc disease|cervical degenerative disc disease
968258|NCT03367039|ProDisc-C vivo|prodisc-c vivo
968259|NCT03367039|ACDF|acdf
968260|NCT03367039|Cervical degenerative disc disease|cervical degenerative disc disease
968261|NCT03367026|ivabradine|ivabradine
968262|NCT03367026|sepsis|sepsis
968263|NCT03367026|heart rate|heart rate
968264|NCT03366935|labor analgesia|labor analgesia
968265|NCT03366935|dural puncture epidural (DPE)|dural puncture epidural (dpe)
968266|NCT03366935|standard Epidural (EPL)|standard epidural (epl)
968267|NCT03366935|continuous epidural infusion (CEI)|continuous epidural infusion (cei)
968268|NCT03366935|programmed intermittent epidural bolus (PIEB)|programmed intermittent epidural bolus (pieb)
968269|NCT03366909|mindfulness|mindfulness
968270|NCT03366909|cannabis use|cannabis use
968271|NCT03366883|preoperative chemotherapy|preoperative chemotherapy
968272|NCT03366883|preoperative chemoradiotherapy|preoperative chemoradiotherapy
968273|NCT03366883|clinical trial|clinical trial
968274|NCT03366883|phase III|phase iii
968275|NCT03366883|Esophageal squamous cancer|esophageal squamous cancer
968276|NCT03366870|CBT-I|cbt-i
968277|NCT03366870|Insomnia|insomnia
968278|NCT03366844|invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
968279|NCT03366844|ER-positive and HER2-negative breast cancer|er-positive and her2-negative breast cancer
968280|NCT03366844|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
968281|NCT03366844|immunotherapy|immunotherapy
968282|NCT03366844|checkpoint inhibitor|checkpoint inhibitor
968283|NCT03366805|opioid|opioid
968284|NCT03366805|analgesic|analgesic
968285|NCT03366805|ambulatory|ambulatory
968286|NCT03366805|orthopedic|orthopedic
968287|NCT03366805|surgery|surgery
968288|NCT03366805|patient education|patient education
968289|NCT03366805|video|video
968290|NCT03366805|medication diary|medication diary
968295|NCT03366753|blood viscosity|blood viscosity
968296|NCT03366740|Persistent diarrhea|persistent diarrhea
968297|NCT03366740|> 6 to 36 months aged children|> 6 to 36 months aged children
968298|NCT03366740|green banana|green banana
968299|NCT03366740|rice suji|rice suji
968300|NCT03366740|milk suji|milk suji
968301|NCT03366740|comminuted chicken|comminuted chicken
968302|NCT03366727|drug eluting balloon|drug eluting balloon
1655261|NCT00168623|Vaccines|vaccines
968303|NCT03366714|Noninvasive ventilation, respiratory distress syndrome|noninvasive ventilation, respiratory distress syndrome
968304|NCT03366701|physical activity|physical activity
968305|NCT03366701|sedentary behavior|sedentary behavior
968306|NCT03366701|implicit attitudes|implicit attitudes
968307|NCT03366701|self regulation|self regulation
968308|NCT03366701|intention|intention
968309|NCT03366701|chronic diseases|chronic diseases
968310|NCT03366662|Electromyography|electromyography
968311|NCT03366649|Bypass Surgery|bypass surgery
968312|NCT03366649|Cardiology|cardiology
968313|NCT03366649|Coronary Artery Bypass Surgery|coronary artery bypass surgery
968314|NCT03366649|Mitral Valve Repair|mitral valve repair
968315|NCT03366649|Mitral Valve Surgery|mitral valve surgery
968316|NCT03366649|Coronary Revascularization|coronary revascularization
968317|NCT03366636|Pregnancy|pregnancy
968318|NCT03366636|Adolescents|adolescents
968319|NCT03366636|STIs/STDs|stis/stds
968320|NCT03366636|Self-sufficiency|self-sufficiency
968321|NCT03366623|Pain assessment|pain assessment
968322|NCT03366623|Self report|self report
968323|NCT03366623|Hospital clown intervention|hospital clown intervention
968324|NCT03366597|sevoflurane|sevoflurane
968325|NCT03366597|S100β protein|s100β protein
968326|NCT03366597|regional cerebral oxygen saturation|regional cerebral oxygen saturation
968327|NCT03366597|infant|infant
968328|NCT03366571|Liver Cirrhosis|liver cirrhosis
968329|NCT03366558|motion detectors|motion detectors
968330|NCT03366558|early stage Parkinson's disease|early stage parkinson's disease
968331|NCT03366558|advanced Parkinson's disease|advanced parkinson's disease
968332|NCT03366558|UPDRS|updrs
968333|NCT03366558|observational study with non-diseased controls|observational study with non-diseased controls
968334|NCT03366545|cardiac resynchronization therapy|cardiac resynchronization therapy
968336|NCT03366545|clinical routine|clinical routine
968337|NCT03366532|diet|diet
968338|NCT03366532|food frequency questionnaire|food frequency questionnaire
968339|NCT03366532|nutrient|nutrient
968340|NCT03366519|Embolism, Pulmonary|embolism, pulmonary
968341|NCT03366519|echocardiography|echocardiography
968342|NCT03366519|emergency|emergency
968343|NCT03366519|prognosis|prognosis
968344|NCT03366467|dental treatment|dental treatment
968345|NCT03366467|sensory adapted environment|sensory adapted environment
968346|NCT03366428|HER2|her2
968347|NCT03366428|Breast cancer|breast cancer
968348|NCT03366428|Oncology|oncology
968349|NCT03366428|Antibody drug conjugate|antibody drug conjugate
968350|NCT03366428|ADC|adc
968351|NCT03366415|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
968352|NCT03366415|concurrent chemoradiotherapy|concurrent chemoradiotherapy
968353|NCT03366415|sequential chemoradiotherapy|sequential chemoradiotherapy
968354|NCT03366376|hippocampus|hippocampus
968355|NCT03366376|radiotherapy|radiotherapy
968356|NCT03366363|Knee osteoarthritis|knee osteoarthritis
968357|NCT03366363|acupuncture|acupuncture
968358|NCT03366363|electroacupuncture|electroacupuncture
968359|NCT03366363|sham acupuncture|sham acupuncture
968360|NCT03366337|IgA Nephropathy|iga nephropathy
968361|NCT03366337|CKD associated with type 1 diabetes|ckd associated with type 1 diabetes
968362|NCT03366337|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
968363|NCT03366337|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
968364|NCT03366337|IgAN|igan
968365|NCT03366337|FSGS|fsgs
968366|NCT03366337|ADPKD|adpkd
968367|NCT03366337|Bardoxolone methyl|bardoxolone methyl
968368|NCT03366337|CDDO-ME|cddo-me
968369|NCT03366337|RTA 402|rta 402
968370|NCT03366311|intubation|intubation
968371|NCT03366311|epiglottis lift|epiglottis lift
968372|NCT03366311|hold high position|hold high position
968373|NCT03366285|Bonding|bonding
968374|NCT03366285|Gene expression|gene expression
968375|NCT03366285|Stress response|stress response
968376|NCT03366285|Neurodevelopment|neurodevelopment
968377|NCT03366246|topical anesthetic|topical anesthetic
968378|NCT03366246|nanocapsules|nanocapsules
968379|NCT03366246|nanotechnology|nanotechnology
968380|NCT03366246|lidocaine|lidocaine
968381|NCT03366246|prilocaine|prilocaine
968382|NCT03366246|fractional CO2 laser resurfacing|fractional co2 laser resurfacing
968417|NCT03365986|screening|screening
968418|NCT03365973|Pathological Fracture|pathological fracture
968419|NCT03365973|Indeterminate Instability|indeterminate instability
968420|NCT03365973|Spinal Metastases|spinal metastases
968421|NCT03365973|Breast Cancer|breast cancer
968422|NCT03365960|Watermelon|watermelon
968423|NCT03365960|Watermelon phytochemicals bioavailability|watermelon phytochemicals bioavailability
968424|NCT03365960|Flow Mediated Vasodilation|flow mediated vasodilation
968425|NCT03365960|Pharmacokinetics|pharmacokinetics
968426|NCT03365934|Microflora|microflora
968427|NCT03365934|Microbiome|microbiome
968428|NCT03365934|skin physiology|skin physiology
968429|NCT03365934|Fitzpatrick Skin Types I-III|fitzpatrick skin types i-iii
968430|NCT03365934|Tape-stripped wounds|tape-stripped wounds
968432|NCT03365895|diffusion|diffusion
968433|NCT03365895|tensor|tensor
968434|NCT03365895|imaging|imaging
1655262|NCT00168623|Mortality|mortality
968435|NCT03365895|chemotherapy|chemotherapy
968436|NCT03365895|peripheral neuropathy|peripheral neuropathy
968437|NCT03365895|breast cancer|breast cancer
968438|NCT03365895|MRI|mri
968439|NCT03365895|Magnetic Resonance Imaging|magnetic resonance imaging
968440|NCT03365895|Diffusion Tensor Imaging|diffusion tensor imaging
968441|NCT03365843|Cardiac surgery|cardiac surgery
968442|NCT03365843|Sternal closure|sternal closure
968443|NCT03365817|cognitive function|cognitive function
968444|NCT03365817|opioid dependence|opioid dependence
968445|NCT03365817|opioid withdrawal|opioid withdrawal
968446|NCT03365817|quality of life|quality of life
968447|NCT03365817|side effect|side effect
968448|NCT03365804|Ultrasound|ultrasound
968449|NCT03365804|Scoliosis|scoliosis
968450|NCT03365804|Orthoses|orthoses
968451|NCT03365804|3D Printing|3d printing
968452|NCT03365791|PDR001|pdr001
968453|NCT03365791|LAG525|lag525
968454|NCT03365791|Immune checkpoint blockade|immune checkpoint blockade
968455|NCT03365791|Solid tumor malignancy|solid tumor malignancy
968456|NCT03365791|lymphoma|lymphoma
968457|NCT03365791|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
968458|NCT03365791|Gastric/esophageal adenocarcinoma|gastric/esophageal adenocarcinoma
968459|NCT03365791|Castration resistant prostate adenocarcinoma (CRPC)|castration resistant prostate adenocarcinoma (crpc)
968460|NCT03365791|Soft tissue sarcoma|soft tissue sarcoma
968461|NCT03365791|Ovarian adenocarcinoma|ovarian adenocarcinoma
968462|NCT03365791|Advanced well-differentiated neuroendocrine tumors (NETs)|advanced well-differentiated neuroendocrine tumors (nets)
968463|NCT03365791|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
968464|NCT03365778|educational intervention|educational intervention
968465|NCT03365778|SLT|slt
968466|NCT03365778|selective laser trabeculoplasty|selective laser trabeculoplasty
968468|NCT03365739|Mango pulp phytochemicals bioavailability|mango pulp phytochemicals bioavailability
968469|NCT03365739|Pharmacokinetics|pharmacokinetics
968470|NCT03365713|COPD|copd
968471|NCT03365713|Spirometry|spirometry
968472|NCT03365713|COPD Diagnosis|copd diagnosis
968474|NCT03365713|Case Finding|case finding
968475|NCT03365713|LMIC|lmic
968476|NCT03365700|Persistent atrial fibrillation|persistent atrial fibrillation
968477|NCT03365700|Catheter ablation|catheter ablation
968478|NCT03365687|Children|children
968479|NCT03365687|Vitamin D|vitamin d
968480|NCT03365687|Respiratory viral infection|respiratory viral infection
968481|NCT03365687|Randomized controlled trial|randomized controlled trial
968482|NCT03365687|Asthma exacerbations|asthma exacerbations
968483|NCT03365674|Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration|myofascial pain syndromes, gastrocnemius, trigger points, injections, vibration
968484|NCT03365661|AML|aml
968485|NCT03365661|MDS|mds
968486|NCT03365596|Brain connectivity|brain connectivity
968487|NCT03365596|Magnetic resonance imaging|magnetic resonance imaging
968488|NCT03365596|Recovery prediction|recovery prediction
968489|NCT03365583|Vitamin B12|vitamin b12
968490|NCT03365583|Microbiome|microbiome
968491|NCT03365583|infant|infant
968492|NCT03365570|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study
968493|NCT03365531|fasting|fasting
968494|NCT03365518|Psychological Treatment|psychological treatment
968495|NCT03365518|Intimacy|intimacy
968496|NCT03365518|Cognitive Behavioural Therapy|cognitive behavioural therapy
968497|NCT03365518|Cognitive Behavioral Therapy|cognitive behavioral therapy
968498|NCT03365518|Mindfulness|mindfulness
968499|NCT03365518|Group Therapy|group therapy
968500|NCT03365518|Couples Therapy|couples therapy
968501|NCT03365479|pulmonary hypertension|pulmonary hypertension
968502|NCT03365479|iloprost|iloprost
968503|NCT03365479|inhaled|inhaled
968504|NCT03365479|breelib|breelib
968505|NCT03365479|nebulizer|nebulizer
968506|NCT03365479|pulmonary arterial hypertension|pulmonary arterial hypertension
968507|NCT03365466|recurrent implantation failure|recurrent implantation failure
968508|NCT03365466|aspirin|aspirin
968509|NCT03365466|low molecular weight heparin|low molecular weight heparin
968510|NCT03365440|ECG|ecg
968511|NCT03365440|cardiac arrhythmia|cardiac arrhythmia
968512|NCT03365440|heart rhythm|heart rhythm
968513|NCT03365440|esophageal ECG|esophageal ecg
968514|NCT03365440|non-invasive mapping|non-invasive mapping
968515|NCT03365440|supraventricular tachycardia|supraventricular tachycardia
968516|NCT03365440|atrial fibrillation|atrial fibrillation
968517|NCT03365440|atrial flutter|atrial flutter
968518|NCT03365440|extrasystole|extrasystole
968519|NCT03365427|rehabilitation|rehabilitation
968520|NCT03365427|application on smart phones|application on smart phones
968521|NCT03365414|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
968522|NCT03365414|POTS|pots
968523|NCT03365414|Syncope|syncope
968524|NCT03365414|Vasovagal|vasovagal
968525|NCT03365414|Hypotension|hypotension
968526|NCT03365414|Tachycardia|tachycardia
968527|NCT03365401|surgery|surgery
968528|NCT03365401|decompression|decompression
968529|NCT03365375|Chest Pain|chest pain
968530|NCT03365375|Anxiety|anxiety
968531|NCT03365375|Mindfulness|mindfulness
968532|NCT03365375|Emergency Service, Hospital|emergency service, hospital
968533|NCT03365362|directly observed therapy|directly observed therapy
968534|NCT03365362|varenicline|varenicline
968535|NCT03365362|long-term pharmacotherapy|long-term pharmacotherapy
968536|NCT03365323|Periprosthetic Joint Infection|periprosthetic joint infection
968537|NCT03365284|total knee arthroplasty|total knee arthroplasty
968538|NCT03365284|rehabilitation|rehabilitation
968539|NCT03365284|Smart Kneebrace|smart kneebrace
968540|NCT03365219|Surgical Site Infection|surgical site infection
968541|NCT03365219|Cesarean delivery infection|cesarean delivery infection
968542|NCT03365167|LANAP|lanap
968543|NCT03365167|Periodontitis|periodontitis
968544|NCT03365154|Peripheral Artery Disease|peripheral artery disease
968545|NCT03365154|Atherectomy|atherectomy
968546|NCT03365154|Orbital Atherectomy|orbital atherectomy
968547|NCT03365141|vitiligo|vitiligo
968548|NCT03365141|intralesional injection|intralesional injection
968549|NCT03365141|corticosteroid|corticosteroid
968550|NCT03365141|triamcinolone|triamcinolone
968551|NCT03365115|spinal anesthesia|spinal anesthesia
968552|NCT03365115|morphine|morphine
968553|NCT03365115|fentanyl|fentanyl
968554|NCT03365115|pain|pain
968555|NCT03365115|knee|knee
968556|NCT03365089|Hemodialysis fistula|hemodialysis fistula
968557|NCT03365089|Failure to mature|failure to mature
968558|NCT03365089|Collateral vein|collateral vein
968559|NCT03365063|Knowledge Translation|knowledge translation
968560|NCT03365063|Chronic Kidney Disease|chronic kidney disease
968561|NCT03365063|Matched Cluster Randomized Trial|matched cluster randomized trial
968562|NCT03365024|CBT-I|cbt-i
968563|NCT03365024|Insomnia|insomnia
968564|NCT03365011|Nitrous Oxide|nitrous oxide
968565|NCT03364972|cataract|cataract
968566|NCT03364972|cataract extraction|cataract extraction
969093|NCT03361618|Uric acid|uric acid
968567|NCT03364972|interocular lens implant|interocular lens implant
968568|NCT03364972|glistenings|glistenings
968569|NCT03364972|phacoemulsification|phacoemulsification
968570|NCT03364972|hydrophobic acrylic|hydrophobic acrylic
968571|NCT03364972|light scatter|light scatter
968572|NCT03364972|patient related outcome measures|patient related outcome measures
968573|NCT03364933|Child|child
968574|NCT03364933|Critical Illness|critical illness
968575|NCT03364933|Length of Stay|length of stay
968576|NCT03364933|Satisfaction|satisfaction
968577|NCT03364920|Maresin-1|maresin-1
968578|NCT03364920|SAP|sap
968579|NCT03364920|IPN|ipn
968580|NCT03364920|MODS|mods
968581|NCT03364920|Mortality|mortality
968582|NCT03364907|HIPEC|hipec
968583|NCT03364907|oxaliplatin|oxaliplatin
968584|NCT03364907|flushing|flushing
968585|NCT03364907|peritoneal carcinomatosis|peritoneal carcinomatosis
968586|NCT03364894|Parkinson's Disease|parkinson's disease
968587|NCT03364894|Biomarkers|biomarkers
968588|NCT03364894|Wearable sensors|wearable sensors
968590|NCT03364894|Disease progression|disease progression
968591|NCT03364868|Type 1 diabetes|type 1 diabetes
968592|NCT03364868|T1D|t1d
968593|NCT03364868|diabetes mellitus|diabetes mellitus
968594|NCT03364868|oral insulin|oral insulin
968595|NCT03364868|oral tolerance|oral tolerance
968596|NCT03364868|autoantigen|autoantigen
968597|NCT03364868|self tolerance|self tolerance
968598|NCT03364868|prevention|prevention
968599|NCT03364868|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
968600|NCT03364868|juvenile diabetes|juvenile diabetes
968601|NCT03364868|autoimmune diabetes|autoimmune diabetes
968603|NCT03364855|Patellofemoral pain syndrome|patellofemoral pain syndrome
968604|NCT03364855|Star excursion balance test|star excursion balance test
968605|NCT03364855|Kinesthetic Ability Trainer 2000|kinesthetic ability trainer 2000
968606|NCT03364816|cervical spondylosis|cervical spondylosis
968607|NCT03364816|artificial disc replacement|artificial disc replacement
968608|NCT03364816|complications|complications
968609|NCT03364816|photographic indicators|photographic indicators
968610|NCT03364816|functional efficacy|functional efficacy
968611|NCT03364803|Cushing Syndrome|cushing syndrome
968612|NCT03364803|Cushing's Disease|cushing's disease
968613|NCT03364803|Cushing Disease|cushing disease
968614|NCT03364803|17-592|17-592
968615|NCT03364803|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
968616|NCT03364790|knee - spine syndrome|knee - spine syndrome
968617|NCT03364790|PLIF|plif
968618|NCT03364790|TKA|tka
968619|NCT03364790|sagittal parameters|sagittal parameters
968620|NCT03364790|neuroelectrophysiology|neuroelectrophysiology
968621|NCT03364777|lumbar surgery, emotional state|lumbar surgery, emotional state
968622|NCT03364764|sirolimus|sirolimus
968623|NCT03364764|refractory pure red cell aplasia|refractory pure red cell aplasia
968624|NCT03364764|prospective study|prospective study
968625|NCT03364751|Oral Health|oral health
968626|NCT03364751|Smoking|smoking
968627|NCT03364751|Cigarette|cigarette
968628|NCT03364751|Reduced risk product|reduced risk product
968629|NCT03364751|Tobacco heating system|tobacco heating system
968630|NCT03364751|THS|ths
968631|NCT03364751|Modified risk tobacco product|modified risk tobacco product
968632|NCT03364751|Clinical attachment level|clinical attachment level
968633|NCT03364699|strenuous exercise|strenuous exercise
968634|NCT03364699|dietary supplementation|dietary supplementation
968635|NCT03364699|immune system|immune system
968636|NCT03364699|leucocyte function|leucocyte function
968637|NCT03364699|inflammation|inflammation
968639|NCT03364686|Biotin labeled red blood cells|biotin labeled red blood cells
968640|NCT03364673|Ovarian Cancer|ovarian cancer
968641|NCT03364673|Physical Activity|physical activity
968642|NCT03364673|Mobile Health|mobile health
968643|NCT03364673|Fitness Tracker|fitness tracker
968644|NCT03364673|Survivorship|survivorship
968645|NCT03364673|Quality of Life|quality of life
968646|NCT03364660|Epidural Stimulation|epidural stimulation
968647|NCT03364660|Spinal Cord Injury|spinal cord injury
968648|NCT03364660|Task-Specific|task-specific
968649|NCT03364634|decompressive craniectomy|decompressive craniectomy
968650|NCT03364634|intracranial pressure|intracranial pressure
968651|NCT03364634|icp|icp
968652|NCT03364634|telemetry|telemetry
968653|NCT03364634|telemetric|telemetric
968654|NCT03364621|Liver resection|liver resection
968655|NCT03364621|Metastasis|metastasis
968656|NCT03364621|Molecular profiling|molecular profiling
968657|NCT03364621|Epigenetic analysis|epigenetic analysis
968658|NCT03364621|Genomic analysis|genomic analysis
968659|NCT03364621|Sequencing|sequencing
968660|NCT03364595|radial head fracture|radial head fracture
968661|NCT03364595|replacement|replacement
968662|NCT03364595|plate|plate
968663|NCT03364582|Dietary patterns|dietary patterns
968664|NCT03364582|Metabolomics|metabolomics
968665|NCT03364582|Mortaltiy|mortaltiy
968666|NCT03364582|Colorectal cancer|colorectal cancer
968667|NCT03364569|Drainage|drainage
968668|NCT03364569|Breast augmentation|breast augmentation
968669|NCT03364569|Tranexamic acid|tranexamic acid
968670|NCT03364517|Medical regulation|medical regulation
968672|NCT03364517|Imminent delivery|imminent delivery
968673|NCT03364504|PXE|pxe
968674|NCT03364504|renal cells|renal cells
968675|NCT03364504|urine|urine
968676|NCT03364504|calcification|calcification
968677|NCT03364504|omics|omics
968678|NCT03364504|drug screening|drug screening
968679|NCT03364491|Tranexamic Acid|tranexamic acid
968680|NCT03364491|Hemorrhage|hemorrhage
968681|NCT03364491|Cesarean|cesarean
968682|NCT03364478|Surgical approach|surgical approach
968683|NCT03364478|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
968684|NCT03364452|Dietary Assessment Methodology|dietary assessment methodology
968685|NCT03364452|beverages|beverages
968686|NCT03364452|non-nutritive sweeteners|non-nutritive sweeteners
968687|NCT03364439|DLBCL|dlbcl
968688|NCT03364387|Acute Coronary Syndrome|acute coronary syndrome
968689|NCT03364387|MINOCA|minoca
968690|NCT03364387|Myocardial Infarction|myocardial infarction
968691|NCT03364387|Atrial Fibrillation|atrial fibrillation
968701|NCT03364309|immune-mediated systemic disease|immune-mediated systemic disease
968702|NCT03364309|skin lesions|skin lesions
968703|NCT03364309|scaly patches|scaly patches
968704|NCT03364309|papules|papules
968705|NCT03364296|Acute stroke, Biomarkers|acute stroke, biomarkers
968706|NCT03364283|Posterior fossa|posterior fossa
968707|NCT03364283|Pineal region|pineal region
968708|NCT03364270|atherosclerosis|atherosclerosis
968709|NCT03364257|metagenomic|metagenomic
968710|NCT03364257|infection|infection
968711|NCT03364257|diagnosis|diagnosis
968712|NCT03364244|Revatio|revatio
968713|NCT03364244|Pulmonary arterial hypertension|pulmonary arterial hypertension
968714|NCT03364244|Pediatric patients|pediatric patients
968715|NCT03364205|SFA interview technique|sfa interview technique
968716|NCT03364205|adolescence|adolescence
968717|NCT03364205|obesity|obesity
968718|NCT03364205|nutrition|nutrition
968719|NCT03364205|exercise|exercise
968720|NCT03364192|Whole Health Coaching|whole health coaching
968721|NCT03364192|Integrative Health Coaching|integrative health coaching
968722|NCT03364192|Peer Support Specialist|peer support specialist
968723|NCT03364192|Personalized Health Plan|personalized health plan
968724|NCT03364179|dementia|dementia
968725|NCT03364179|young onset dementia|young onset dementia
968726|NCT03364179|quality of death|quality of death
968727|NCT03364179|late onset dementia|late onset dementia
968728|NCT03364179|palliative care|palliative care
968729|NCT03364166|buccal squamous cell carcinoma|buccal squamous cell carcinoma
968730|NCT03364153|Zimura|zimura
968731|NCT03364153|ARC1905|arc1905
968732|NCT03364153|complement factor C5 inhibitor|complement factor c5 inhibitor
968733|NCT03364153|avacincaptad pegol|avacincaptad pegol
968734|NCT03364153|STGD1|stgd1
968735|NCT03364140|Peripartum Cardiomyopathy|peripartum cardiomyopathy
968736|NCT03364140|Heart Failure|heart failure
968737|NCT03364127|Vulvar Pain, Dyspareunia|vulvar pain, dyspareunia
968738|NCT03364088|Total knee arthroplasty|total knee arthroplasty
968739|NCT03364088|Anesthesia|anesthesia
968740|NCT03364088|Surgical tourniquet|surgical tourniquet
968741|NCT03364088|Pain|pain
968742|NCT03364088|Postoperative nausea and vomiting|postoperative nausea and vomiting
968743|NCT03364088|Quality of life|quality of life
968744|NCT03364088|Length of stay|length of stay
968745|NCT03364088|Knee function|knee function
968746|NCT03364088|Bioelectrical impedance|bioelectrical impedance
968747|NCT03364088|Knee endoprosthesis|knee endoprosthesis
968748|NCT03364062|Blood Pressure|blood pressure
968749|NCT03364062|shoulder replacement|shoulder replacement
968750|NCT03364062|proximal humeral fracture|proximal humeral fracture
968751|NCT03364036|Multiple sclerosis|multiple sclerosis
968752|NCT03364036|Mavenclad ®|mavenclad ®
968753|NCT03364036|Cladribine|cladribine
968754|NCT03364010|Motor control|motor control
968755|NCT03364010|Proprioception|proprioception
968756|NCT03363997|estriol|estriol
968757|NCT03363997|pharmacokinetic|pharmacokinetic
968758|NCT03363997|pharmacodynamic|pharmacodynamic
968759|NCT03363997|hormone replacement therapy|hormone replacement therapy
968760|NCT03363997|vaginal ring administration|vaginal ring administration
968761|NCT03363971|soft tissue, pain|soft tissue, pain
968762|NCT03363958|myocardial protection|myocardial protection
968763|NCT03363958|remote ischemic preconditioning|remote ischemic preconditioning
968764|NCT03363958|remote ischemic postconditioning|remote ischemic postconditioning
968765|NCT03363958|cardiac surgery|cardiac surgery
968775|NCT03363932|Ventricular septal defect|ventricular septal defect
968776|NCT03363932|Congenital heart disease|congenital heart disease
968777|NCT03363932|Outcome|outcome
968778|NCT03363919|adolescent|adolescent
968779|NCT03363919|biomarkers|biomarkers
968780|NCT03363880|Severe trauma|severe trauma
968781|NCT03363880|Multiple trauma|multiple trauma
968782|NCT03363880|Regional Trauma management system|regional trauma management system
968783|NCT03363880|Trauma management team|trauma management team
968784|NCT03363867|High grade serous|high grade serous
968785|NCT03363867|C1 molecular subtype|c1 molecular subtype
968786|NCT03363841|Candida auris|candida auris
968787|NCT03363815|Healthy Volunteer|healthy volunteer
968788|NCT03363815|CC-90001|cc-90001
968789|NCT03363815|Pharmacokinetics|pharmacokinetics
968793|NCT03363815|Rosuvastatin|rosuvastatin
968794|NCT03363815|Metformin|metformin
968795|NCT03363815|Digoxin|digoxin
968796|NCT03363815|Nintedanib|nintedanib
968797|NCT03363763|rash|rash
968798|NCT03363763|fibroma|fibroma
968799|NCT03363763|skin|skin
968800|NCT03363763|facial|facial
968801|NCT03363763|face|face
968802|NCT03363763|bumps|bumps
968803|NCT03363763|redness|redness
968804|NCT03363763|erythema|erythema
968805|NCT03363763|lesions|lesions
968806|NCT03363763|papules|papules
968807|NCT03363763|blood vessel|blood vessel
968808|NCT03363763|cheeks|cheeks
968809|NCT03363750|Depression|depression
968810|NCT03363750|Adolescent|adolescent
968811|NCT03363750|mind-body-skills|mind-body-skills
968812|NCT03363750|group therapy|group therapy
968813|NCT03363750|primary care|primary care
968814|NCT03363724|Parkinson Disease|parkinson disease
968815|NCT03363724|Deep Brain Stimulation|deep brain stimulation
968816|NCT03363724|Microelectrodes recording|microelectrodes recording
968817|NCT03363724|HaGuide|haguide
968818|NCT03363724|Alpha Omega Engineering Ltd.|alpha omega engineering ltd.
968819|NCT03363698|Chronic Cough|chronic cough
968820|NCT03363698|Upper-Airway Cough Syndrome|upper-airway cough syndrome
968821|NCT03363698|GERD|gerd
968822|NCT03363698|Allergic Rhinitis|allergic rhinitis
968823|NCT03363698|Methacholine Challenge Test|methacholine challenge test
968824|NCT03363698|Cough Challenge|cough challenge
968825|NCT03363698|Capsaicin|capsaicin
968826|NCT03363685|Survival Prediction|survival prediction
968827|NCT03363685|Spinal Metastases|spinal metastases
968828|NCT03363685|Non Small Cell Lung Cancer Metastatic|non small cell lung cancer metastatic
968829|NCT03363672|Chronic Postoperative Pain|chronic postoperative pain
968830|NCT03363672|Daily Life|daily life
968831|NCT03363672|Risk Factor|risk factor
968832|NCT03363659|Glioblastoma|glioblastoma
968833|NCT03363659|Glioblastoma Multiforme|glioblastoma multiforme
968834|NCT03363659|Glioma|glioma
968835|NCT03363659|Anaplastic Glioma|anaplastic glioma
968836|NCT03363659|Unmethylated|unmethylated
968837|NCT03363633|Venous Ulceration|venous ulceration
968838|NCT03363633|Refluxing Perforator Veins|refluxing perforator veins
968839|NCT03363620|maxillary expansion|maxillary expansion
968840|NCT03363620|self ligating|self ligating
968841|NCT03363620|arch form|arch form
968842|NCT03363594|Diabetes, T2D|diabetes, t2d
968843|NCT03363581|Food preferences|food preferences
968844|NCT03363581|Fat|fat
968845|NCT03363581|Weight loss|weight loss
968846|NCT03363529|Dynamic lighting, ipRGC|dynamic lighting, iprgc
968847|NCT03363503|COPD|copd
968848|NCT03363503|Salmeterol/Fluticasone|salmeterol/fluticasone
968849|NCT03363503|Discair|discair
968850|NCT03363503|Diskus|diskus
968851|NCT03363503|Spirometry|spirometry
968852|NCT03363490|Self-Management|self-management
968853|NCT03363490|Neuromuscular Exercise Therapy|neuromuscular exercise therapy
968854|NCT03363490|Knee osteoarthritis|knee osteoarthritis
968855|NCT03363477|antithrombotic|antithrombotic
968856|NCT03363477|heparin|heparin
968857|NCT03363477|anticoagulant|anticoagulant
968858|NCT03363477|low molecular weight heparin|low molecular weight heparin
968859|NCT03363477|pharmacodynamic equivalence|pharmacodynamic equivalence
968860|NCT03363425|Dexmedetomidine|dexmedetomidine
968861|NCT03363425|Lidocaine|lidocaine
968862|NCT03363425|Postoperative Pain|postoperative pain
968863|NCT03363425|Analgesic Consumption|analgesic consumption
968864|NCT03363425|Recovery|recovery
968865|NCT03363425|Abdominal Gynaecological Surgery|abdominal gynaecological surgery
968866|NCT03363399|Diagnostic accuracy study|diagnostic accuracy study
968867|NCT03363399|Flow cytometry analysis|flow cytometry analysis
968868|NCT03363399|Myeloperoxidase|myeloperoxidase
968869|NCT03363399|Peripheral blood sample|peripheral blood sample
968870|NCT03363386|aerobic exercise|aerobic exercise
968871|NCT03363386|dynamic balance|dynamic balance
968872|NCT03363386|functional capacity|functional capacity
968873|NCT03363386|HbA1c|hba1c
968874|NCT03363386|proprioceptive exercise training|proprioceptive exercise training
968875|NCT03363373|Antibody, Neuroblastoma, Pediatric, Adult|antibody, neuroblastoma, pediatric, adult
968876|NCT03363334|ITP|itp
968877|NCT03363334|Immune Thrombocytopenia|immune thrombocytopenia
968878|NCT03363321|hemophilia|hemophilia
968879|NCT03363295|endophthalmitis|endophthalmitis
968880|NCT03363282|Crosslinking|crosslinking
968881|NCT03363256|Digital therapeutics|digital therapeutics
968882|NCT03363256|Adaptation|adaptation
968883|NCT03363230|mindfulness|mindfulness
968884|NCT03363230|emotion regulation|emotion regulation
968885|NCT03363230|impulsivity|impulsivity
968886|NCT03363217|Glioma|glioma
968887|NCT03363217|Optic Pathway Glioma|optic pathway glioma
968888|NCT03363217|Low grade glioma|low grade glioma
968889|NCT03363217|MAPK/ERK|mapk/erk
968890|NCT03363217|Plexiform Neurofibroma|plexiform neurofibroma
968891|NCT03363217|Neurofibromatosis Type 1|neurofibromatosis type 1
968892|NCT03363217|Central Nervous System|central nervous system
968893|NCT03363217|CNS|cns
968894|NCT03363217|Brain Tumor|brain tumor
968895|NCT03363217|LGG|lgg
968896|NCT03363217|NF1|nf1
969088|NCT03361748|BCMA|bcma
968900|NCT03363191|fluticasone furoate/vilanterol, efficacy, asthma, Chronic obstructive pulmonary disease|fluticasone furoate/vilanterol, efficacy, asthma, chronic obstructive pulmonary disease
968901|NCT03363165|PAD|pad
968902|NCT03363087|Atrial Scar|atrial scar
968903|NCT03363087|Atrial Fibrillation Ablation|atrial fibrillation ablation
968904|NCT03363087|Mapping|mapping
968905|NCT03363087|Persistent Atrial Fibrillation|persistent atrial fibrillation
968906|NCT03363087|Catheter Ablation|catheter ablation
968907|NCT03363074|Low-Level Laser Therapy, Orthotic Insoles|low-level laser therapy, orthotic insoles
968908|NCT03363048|Food restrictions/incentives|food restrictions/incentives
968909|NCT03363048|Food Stamp program|food stamp program
968910|NCT03363048|Policy change|policy change
968911|NCT03363048|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
968912|NCT03363009|prehabilitation|prehabilitation
968913|NCT03363009|connected devices|connected devices
968914|NCT03362996|extra virgin olive oil|extra virgin olive oil
968915|NCT03362996|mild cognitive impairment|mild cognitive impairment
968916|NCT03362996|randomized double blind clinical trial|randomized double blind clinical trial
968917|NCT03362970|Bloody Diarrhea|bloody diarrhea
968918|NCT03362970|STEC|stec
968919|NCT03362970|Hematochezia|hematochezia
968920|NCT03362970|BioFire FilmArray|biofire filmarray
968921|NCT03362970|Child|child
968922|NCT03362957|embolization|embolization
968923|NCT03362957|vascular|vascular
968924|NCT03362905|Lidocaine|lidocaine
968925|NCT03362905|Dosage forms|dosage forms
968926|NCT03362905|Pain scores|pain scores
968927|NCT03362879|Advanced Parkinson's Disease|advanced parkinson's disease
968928|NCT03362879|Levodopa-Carbidopa Intestinal Gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
968929|NCT03362827|Low back pain|low back pain
968930|NCT03362827|Long-term potentiation|long-term potentiation
968931|NCT03362827|Hyperalgesia|hyperalgesia
968932|NCT03362827|Allodynia|allodynia
968936|NCT03362801|physical activity|physical activity
968937|NCT03362801|elderly|elderly
968938|NCT03362788|Antithrombotics Antiplatelets Stents Angioplasty|antithrombotics antiplatelets stents angioplasty
968939|NCT03362762|Type 2 diabetes|type 2 diabetes
968940|NCT03362762|insulin|insulin
968941|NCT03362762|Hb1Ac|hb1ac
968942|NCT03362762|glycemia|glycemia
968943|NCT03362762|Guadeloupe|guadeloupe
968944|NCT03362671|OSA|osa
968945|NCT03362671|Mandibular Advancement Splint|mandibular advancement splint
968946|NCT03362671|Oral Appliance|oral appliance
968947|NCT03362671|Treatment|treatment
968948|NCT03362671|Orthodontic Implants|orthodontic implants
968949|NCT03362658|Magnetic Resonance Imaging|magnetic resonance imaging
968950|NCT03362658|MRI|mri
968951|NCT03362658|Biomarker|biomarker
968952|NCT03362619|Cervical cancer|cervical cancer
968953|NCT03362619|Cytotoxic lymphocyte|cytotoxic lymphocyte
968954|NCT03362619|CC-CTL|cc-ctl
968955|NCT03362606|Ovarian cancer|ovarian cancer
968956|NCT03362606|Cytotoxic lymphocyte|cytotoxic lymphocyte
968957|NCT03362606|OC-CTL|oc-ctl
968958|NCT03362580|Epiretinal Membrane|epiretinal membrane
968959|NCT03362580|Diabetes|diabetes
968960|NCT03362567|Cervical Radiculopathy|cervical radiculopathy
968961|NCT03362567|Sustained Natural Apophyseal Glides|sustained natural apophyseal glides
968962|NCT03362567|Mechanical Cervical Traction|mechanical cervical traction
968963|NCT03362567|Pain Intensity|pain intensity
968964|NCT03362567|Neck Disability|neck disability
968965|NCT03362554|Insulin|insulin
968966|NCT03362554|Glucose|glucose
968967|NCT03362554|Rab3|rab3
968968|NCT03362541|multiple sclerosis|multiple sclerosis
968969|NCT03362541|fatigue|fatigue
968970|NCT03362541|self-management|self-management
968971|NCT03362541|rehabilitation|rehabilitation
968972|NCT03362502|gene therapy, mini-dystrophin, AAV|gene therapy, mini-dystrophin, aav
968973|NCT03362489|In Vitro Fertilization|in vitro fertilization
968974|NCT03362489|Intra-Uterine Insemination|intra-uterine insemination
968975|NCT03362489|Poor responders|poor responders
968976|NCT03362476|HIV|hiv
968977|NCT03362476|HCV|hcv
968978|NCT03362476|Computer Intervention|computer intervention
968979|NCT03362476|Alcoholism|alcoholism
968980|NCT03362476|Women|women
968981|NCT03362476|Russia|russia
968982|NCT03362450|Midgut volvulus|midgut volvulus
968983|NCT03362450|Fetal volvulus|fetal volvulus
968984|NCT03362450|Whirlpool sign|whirlpool sign
968985|NCT03362450|Pregnant women|pregnant women
968986|NCT03362450|Position of mesenteric vessels|position of mesenteric vessels
968987|NCT03362450|Post natal surgery|post natal surgery
968988|NCT03362450|Foetopathology if performed|foetopathology if performed
968989|NCT03362450|Hydro-meconium level in the dilated loops|hydro-meconium level in the dilated loops
968990|NCT03362411|Healthy participants|healthy participants
968991|NCT03362411|Healthy subjects|healthy subjects
968992|NCT03362385|Obstructive sleep apnea|obstructive sleep apnea
968993|NCT03362385|Acute coronary syndrome|acute coronary syndrome
968994|NCT03362385|Continuous positive airway pressure|continuous positive airway pressure
968995|NCT03362385|Outcome|outcome
968996|NCT03362359|prostatectomy|prostatectomy
968997|NCT03362359|68Ga-PSMA-11|68ga-psma-11
968998|NCT03362359|EPLND|eplnd
968999|NCT03362346|Wavelet transform|wavelet transform
969000|NCT03362346|Deep learning|deep learning
969001|NCT03362307|Low-Level Light Therapy, Osseointegration|low-level light therapy, osseointegration
969002|NCT03362281|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
969003|NCT03362281|Proton Pump Inhibitor|proton pump inhibitor
969004|NCT03362255|Optic Nerve Sheath Diameter Injection Speed|optic nerve sheath diameter injection speed
969005|NCT03362216|soft tissue, pain|soft tissue, pain
969006|NCT03362203|Conditioned pain modulation, neck pain|conditioned pain modulation, neck pain
969007|NCT03362190|Zimura|zimura
969008|NCT03362190|ARC1905|arc1905
969009|NCT03362190|Lucentis|lucentis
969010|NCT03362190|ranibizumab|ranibizumab
969011|NCT03362190|Wet AMD|wet amd
969012|NCT03362190|avacincaptad pegol|avacincaptad pegol
969013|NCT03362190|complement factor C5 inhibitor|complement factor c5 inhibitor
969014|NCT03362177|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
969015|NCT03362177|Gastrointestinal Cancer|gastrointestinal cancer
969016|NCT03362177|Colorectal Cancer|colorectal cancer
969017|NCT03362164|Fabry|fabry
969018|NCT03362164|Fibrosis|fibrosis
969019|NCT03362164|Dialysis|dialysis
969020|NCT03362164|Stroke|stroke
969021|NCT03362164|Chronic kidney disease|chronic kidney disease
969022|NCT03362151|type 1 diabetes|type 1 diabetes
969023|NCT03362151|pasta|pasta
969024|NCT03362151|rice|rice
969025|NCT03362151|protein|protein
969026|NCT03362151|carbohydrate|carbohydrate
969027|NCT03362138|melanoma|melanoma
969028|NCT03362138|dysplastic nevus|dysplastic nevus
969029|NCT03362138|artificial intelligence|artificial intelligence
969030|NCT03362138|early diagnosis|early diagnosis
969031|NCT03362112|lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
969032|NCT03362099|varenicline|varenicline
969033|NCT03362099|bupropion|bupropion
969034|NCT03362086|bone tumor osteosarcoma|bone tumor osteosarcoma
969035|NCT03362073|Ketamine|ketamine
969036|NCT03362073|Refractory cancer pain|refractory cancer pain
969037|NCT03362073|Terminally ill cancer patients|terminally ill cancer patients
969038|NCT03362073|Palliative care|palliative care
969039|NCT03362060|Triple Negative Breast Cancer|triple negative breast cancer
969040|NCT03362060|Vaccine|vaccine
969041|NCT03362060|Immunotherapy|immunotherapy
969042|NCT03362060|PD-1 Inhibitor|pd-1 inhibitor
969043|NCT03362060|Metastatic Breast Cancer|metastatic breast cancer
969044|NCT03362021|transvaginal oocyte retrieval|transvaginal oocyte retrieval
969045|NCT03362021|sedation|sedation
969046|NCT03362021|dexmedetomidine|dexmedetomidine
969047|NCT03362021|fentanyl|fentanyl
969048|NCT03362021|remifentanil|remifentanil
969049|NCT03362021|midazolam|midazolam
969050|NCT03361995|STEMI|stemi
969051|NCT03361969|quality of life|quality of life
969052|NCT03361969|hot flushes|hot flushes
969053|NCT03361969|prostate cancer|prostate cancer
969054|NCT03361969|testosterone|testosterone
969055|NCT03361930|spastic unilateral cerebral palsy, ankle-foot orthosis, AFO, muscle activity, muscular activity, electromyography, EMG,|spastic unilateral cerebral palsy, ankle-foot orthosis, afo, muscle activity, muscular activity, electromyography, emg,
969056|NCT03361917|Colonoscopy screening|colonoscopy screening
969057|NCT03361917|Colonscopy procedure|colonscopy procedure
969058|NCT03361878|Metformin|metformin
969059|NCT03361878|Intolerance|intolerance
969060|NCT03361878|Pharmacokinetics|pharmacokinetics
969061|NCT03361865|Urothelial cancer, programmed cell death 1 (PD-1) inhibitor|urothelial cancer, programmed cell death 1 (pd-1) inhibitor
969062|NCT03361865|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
969063|NCT03361852|Follicular Lymphoma|follicular lymphoma
969064|NCT03361826|Magnetic seizure therapy (MST)|magnetic seizure therapy (mst)
969065|NCT03361826|Treatment resistance|treatment resistance
969066|NCT03361826|Open-label trial|open-label trial
969067|NCT03361826|Borderline Personality Disorder|borderline personality disorder
969068|NCT03361826|Suicidal Ideation|suicidal ideation
969069|NCT03361826|Treatment-resistant depression|treatment-resistant depression
969070|NCT03361826|Dialectical behavior therapy (DBT)|dialectical behavior therapy (dbt)
969071|NCT03361826|MST + DBT|mst + dbt
969072|NCT03361826|Neuroimaging-based biomarkers|neuroimaging-based biomarkers
969073|NCT03361800|Breast Cancer|breast cancer
969074|NCT03361800|ER Negative Breast Cancer|er negative breast cancer
969075|NCT03361800|Triple Negative Breast Cancer|triple negative breast cancer
969076|NCT03361800|PR Negative Breast Cancer|pr negative breast cancer
969077|NCT03361800|ER Positive PR Positive Breast Cancer|er positive pr positive breast cancer
969078|NCT03361787|adolescents|adolescents
969079|NCT03361787|parents|parents
969080|NCT03361787|coaching|coaching
969081|NCT03361761|Chronic disease|chronic disease
969082|NCT03361761|precariousness and vulnerability|precariousness and vulnerability
969083|NCT03361761|Health education|health education
969084|NCT03361748|Multiple Myeloma|multiple myeloma
969085|NCT03361748|Efficacy and Safety|efficacy and safety
969086|NCT03361748|BB2121|bb2121
969087|NCT03361748|CAR T Cell|car t cell
969089|NCT03361748|Relapsed and Refractory|relapsed and refractory
969090|NCT03361735|PSA Level Greater than or Equal to Two|psa level greater than or equal to two
969091|NCT03361735|Stage IV Prostate Adenocarcinoma AJCC v7|stage iv prostate adenocarcinoma ajcc v7
969092|NCT03361683|High-Flow nasal oxygen|high-flow nasal oxygen
969094|NCT03361618|Adenosine deaminase|adenosine deaminase
969095|NCT03361618|Zinc Sulfate|zinc sulfate
969096|NCT03361618|5'-nucleotidase|5'-nucleotidase
969097|NCT03361618|Asthenospermia.|asthenospermia.
969098|NCT03361618|Xanthine oxidase|xanthine oxidase
969099|NCT03361592|symmetry index, functional performance tests, SMT|symmetry index, functional performance tests, smt
969100|NCT03361579|Placebo|placebo
969101|NCT03361566|physical activity|physical activity
969102|NCT03361566|energy balance|energy balance
969103|NCT03361566|caloric restriction|caloric restriction
969104|NCT03361566|overfeeding|overfeeding
969105|NCT03361566|appetite regulation|appetite regulation
969106|NCT03361540|Pharmacokinetics|pharmacokinetics
969107|NCT03361540|Safety|safety
969108|NCT03361540|ASP8302|asp8302
969109|NCT03361514|antidepressants, discontinuation, primary care, MBCT|antidepressants, discontinuation, primary care, mbct
969110|NCT03361501|Omega-3 Fatty acids|omega-3 fatty acids
969111|NCT03361501|Triglycerides|triglycerides
969112|NCT03361475|Sharing|sharing
969113|NCT03361475|Mind|mind
969114|NCT03361475|Enjoyment|enjoyment
969115|NCT03361462|Sharing|sharing
969116|NCT03361462|Mind|mind
969117|NCT03361462|Enjoyment|enjoyment
969118|NCT03361410|Mild Decline in Cognition|mild decline in cognition
969119|NCT03361410|Mild Cognitive Decline|mild cognitive decline
969120|NCT03361410|Mild Cognitive Impairment|mild cognitive impairment
969121|NCT03361410|Dementia|dementia
969122|NCT03361410|Positron Emission Tomography (PET)|positron emission tomography (pet)
969123|NCT03361410|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
969124|NCT03361410|Cerebral Metabolism|cerebral metabolism
969125|NCT03361410|Dietary Supplement|dietary supplement
969126|NCT03361410|MCI|mci
969127|NCT03361410|MDC|mdc
969128|NCT03361410|Grape|grape
969129|NCT03361410|Memory|memory
969130|NCT03361410|Randomized|randomized
969131|NCT03361410|Non-Drug|non-drug
969132|NCT03361410|Supplement|supplement
969133|NCT03361410|Non-Pharmacologic|non-pharmacologic
969134|NCT03361410|Natural|natural
969135|NCT03361410|Red Wine|red wine
969136|NCT03361410|Free|free
969137|NCT03361410|UCLA|ucla
969138|NCT03361410|Brain Scan|brain scan
969139|NCT03361410|Alzheimer's Disease|alzheimer's disease
969140|NCT03361410|Brain Diseases|brain diseases
969141|NCT03361410|Central Nervous System Diseases|central nervous system diseases
969142|NCT03361410|Cognition|cognition
969143|NCT03361410|Cognitive|cognitive
969144|NCT03361410|Neurocognitive|neurocognitive
969145|NCT03361410|Neurodegenerative|neurodegenerative
969146|NCT03361384|men who have sex with men|men who have sex with men
969147|NCT03361371|Nose suctioning|nose suctioning
969148|NCT03361371|Pediatric|pediatric
969149|NCT03361345|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
969150|NCT03361345|Acne|acne
969151|NCT03361319|NSCLC|nsclc
969152|NCT03361319|Non-Small Cell Lung Cancer|non-small cell lung cancer
969153|NCT03361319|Adenocarcinoma of lung|adenocarcinoma of lung
969154|NCT03361306|Relapsed|relapsed
969155|NCT03361280|hemodialysis|hemodialysis
969156|NCT03361280|dialytic clearance|dialytic clearance
969157|NCT03361280|pharmacokinetics|pharmacokinetics
969158|NCT03361241|Stroke|stroke
969159|NCT03361241|Postural Balance|postural balance
969160|NCT03361241|Motor Function|motor function
969161|NCT03361241|Gait|gait
969162|NCT03361241|Virtual Reality Exposure Therapy|virtual reality exposure therapy
969163|NCT03361241|Physiotherapist|physiotherapist
969164|NCT03361228|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
969165|NCT03361228|melanoma|melanoma
969166|NCT03361228|urothelial carcinoma|urothelial carcinoma
969167|NCT03361228|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
969168|NCT03361228|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
969169|NCT03361228|colorectal cancer (CRC)|colorectal cancer (crc)
969170|NCT03361228|arginase 1 inhibitor|arginase 1 inhibitor
969171|NCT03361228|indoleamine 2,3-dioxygenase 1 inhibitor|indoleamine 2,3-dioxygenase 1 inhibitor
969172|NCT03361228|programmed death-1 receptor (PD-1) inhibitor|programmed death-1 receptor (pd-1) inhibitor
969173|NCT03361215|Disease progression|disease progression
969174|NCT03361215|Disease course|disease course
969175|NCT03361215|Immunological characterization|immunological characterization
969176|NCT03361189|Congenital heart disease|congenital heart disease
969177|NCT03361189|Pacemaker|pacemaker
969178|NCT03361189|Sinus node dysfunction|sinus node dysfunction
969179|NCT03361163|Streptococcus pyogenes pharyngitis|streptococcus pyogenes pharyngitis
969180|NCT03361163|Streptococcus Pharyngitis|streptococcus pharyngitis
969181|NCT03361163|Strep Throat|strep throat
969182|NCT03361163|Streptococcus pyogenes Infection|streptococcus pyogenes infection
969183|NCT03361163|Group A Streptococcus: B Hemolytic Pharyngitis|group a streptococcus: b hemolytic pharyngitis
969277|NCT03360643|Ultrasound|ultrasound
969188|NCT03361111|severe asthma|severe asthma
969189|NCT03361111|anti-IgE|anti-ige
969190|NCT03361111|periostin|periostin
969191|NCT03361111|induced sputum,|induced sputum,
969192|NCT03361111|exhaled breath condensate|exhaled breath condensate
969193|NCT03361098|SGLT2 inhibition; dapagliflozin|sglt2 inhibition; dapagliflozin
969194|NCT03361098|GLP-1 receptor agonist; exenatide|glp-1 receptor agonist; exenatide
969195|NCT03361098|Central satiety and reward circuits|central satiety and reward circuits
969196|NCT03361098|bodyweight|bodyweight
969197|NCT03361098|brain|brain
969198|NCT03361085|non-ventilator-associated hospital acquired pneumonia|non-ventilator-associated hospital acquired pneumonia
969199|NCT03361085|Hospital-acquired Pneumonia|hospital-acquired pneumonia
969200|NCT03361085|Healthcare Associated Infection|healthcare associated infection
969201|NCT03361085|Adherence|adherence
969202|NCT03361085|infection prevention|infection prevention
969203|NCT03361085|implementation|implementation
969204|NCT03361072|oral immunotherapy|oral immunotherapy
969205|NCT03361072|milk|milk
969206|NCT03361072|peanut|peanut
969208|NCT03361072|adult|adult
969209|NCT03361059|risk factors|risk factors
969210|NCT03361059|elderly patients|elderly patients
969211|NCT03361059|risk of falling|risk of falling
969212|NCT03361046|TAVI|tavi
969213|NCT03361046|valve-in-valve|valve-in-valve
969214|NCT03361046|aortic stenosis|aortic stenosis
969215|NCT03361033|Survivorship|survivorship
969216|NCT03361033|Social Functioning|social functioning
969217|NCT03361033|Social Outcomes|social outcomes
969218|NCT03361007|TAVI|tavi
969219|NCT03361007|common carotid artery|common carotid artery
969220|NCT03360955|Extubation|extubation
969221|NCT03360955|Cardiac Surgery|cardiac surgery
969222|NCT03360929|Lung Cancer|lung cancer
969223|NCT03360916|high cholesterol|high cholesterol
969224|NCT03360916|exercise|exercise
969225|NCT03360916|statins|statins
969226|NCT03360890|thyroid cancer|thyroid cancer
969227|NCT03360890|salivary gland cancer|salivary gland cancer
969228|NCT03360890|pembrolizumab|pembrolizumab
969229|NCT03360890|docetaxel|docetaxel
969230|NCT03360864|Therapeutic education|therapeutic education
969231|NCT03360812|Medical Students|medical students
969232|NCT03360812|Education|education
969233|NCT03360812|Prognosis|prognosis
969234|NCT03360812|Online training resource|online training resource
969235|NCT03360799|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
969236|NCT03360799|Questionnaires|questionnaires
969237|NCT03360799|Surveys|surveys
969238|NCT03360786|sport concussion|sport concussion
969239|NCT03360786|cervical spine|cervical spine
969240|NCT03360786|youth|youth
969241|NCT03360760|osteosarcoma|osteosarcoma
969242|NCT03360760|pelvis|pelvis
969243|NCT03360760|sacrum|sacrum
969244|NCT03360747|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
969245|NCT03360747|Hyperlipoproteinemias|hyperlipoproteinemias
969246|NCT03360747|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
969247|NCT03360747|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
969248|NCT03360747|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
969249|NCT03360747|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
969250|NCT03360747|Hyperlipidemias|hyperlipidemias
969251|NCT03360747|Dyslipidemias|dyslipidemias
969252|NCT03360747|Lipid Metabolism Disorders|lipid metabolism disorders
969253|NCT03360747|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
969254|NCT03360747|Metabolic Diseases|metabolic diseases
969255|NCT03360747|Metabolism, Inborn Errors|metabolism, inborn errors
969256|NCT03360747|Genetic Diseases, Inborn|genetic diseases, inborn
969261|NCT03360695|Cancer Care|cancer care
969262|NCT03360695|Major Depression and Cancer|major depression and cancer
969263|NCT03360695|Schizophrenia and Cancer|schizophrenia and cancer
969264|NCT03360695|Bipolar Disorder and Cancer|bipolar disorder and cancer
969265|NCT03360695|Lung Cancer|lung cancer
969266|NCT03360695|Breast Cancer|breast cancer
969267|NCT03360695|Head and Neck Cancer|head and neck cancer
969268|NCT03360695|Gastrointestinal Cancer|gastrointestinal cancer
969269|NCT03360695|Schizophrenia|schizophrenia
969270|NCT03360695|Bipolar Disorder|bipolar disorder
969271|NCT03360695|Major Depression|major depression
969272|NCT03360669|hypertension, blood pressure, systolic, diastolic, AOBP, Omron HEM-907, research, clinical|hypertension, blood pressure, systolic, diastolic, aobp, omron hem-907, research, clinical
969273|NCT03360656|shivering, fever, normothermia|shivering, fever, normothermia
969274|NCT03360643|Point-of-care ultrasound|point-of-care ultrasound
969275|NCT03360643|Intussusception|intussusception
969276|NCT03360643|Pediatric Emergency Medicine|pediatric emergency medicine
969279|NCT03360617|Intravenous|intravenous
969280|NCT03360617|IV Push|iv push
969281|NCT03360617|Piggyback|piggyback
969282|NCT03360617|Antibiotics|antibiotics
969283|NCT03360617|Beta Lactam|beta lactam
969284|NCT03360617|Infection|infection
969285|NCT03360604|glycaemic index|glycaemic index
969286|NCT03360604|glycaemia|glycaemia
969287|NCT03360604|diabetes mellitus|diabetes mellitus
969288|NCT03360604|type 2 diabetes|type 2 diabetes
969289|NCT03360565|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
969290|NCT03360526|PICSI|picsi
969291|NCT03360526|ORP|orp
969292|NCT03360526|TESA|tesa
969293|NCT03360526|seminal oxidation reduction potential|seminal oxidation reduction potential
969294|NCT03360513|Orthodontics|orthodontics
969295|NCT03360513|Dental arch|dental arch
969394|NCT03359915|Action Plan|action plan
969296|NCT03360513|Orthodontic appliance design.|orthodontic appliance design.
969297|NCT03360500|Osteoarthritis, Knee|osteoarthritis, knee
969298|NCT03360500|Cryotherapy|cryotherapy
969299|NCT03360500|Exercise|exercise
969300|NCT03360500|Physiotherapy|physiotherapy
969301|NCT03360500|Knee|knee
969302|NCT03360448|Gene Transfer|gene transfer
969303|NCT03360422|MSM, young adult|msm, young adult
969304|NCT03360409|Cervical Disc Degeneration|cervical disc degeneration
969305|NCT03360409|cervical anterior discectomy|cervical anterior discectomy
969306|NCT03360409|Spinal alignment|spinal alignment
969307|NCT03360396|severe heterogeneous emphysema|severe heterogeneous emphysema
969308|NCT03360396|severe homogeneous emphysema|severe homogeneous emphysema
969309|NCT03360383|Spinal Fractures/surgery|spinal fractures/surgery
969310|NCT03360383|Vertebroplasty|vertebroplasty
969311|NCT03360383|Quality-Adjusted Life Years|quality-adjusted life years
969312|NCT03360370|Neurodevelopmental disorders,|neurodevelopmental disorders,
969313|NCT03360370|Congenital heart disease|congenital heart disease
969314|NCT03360370|Children|children
969315|NCT03360344|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape
969316|NCT03360318|pediatric|pediatric
969317|NCT03360318|elbow fractures|elbow fractures
969318|NCT03360318|management|management
969319|NCT03360305|emergency department|emergency department
969320|NCT03360305|prevention|prevention
969321|NCT03360305|transitions of care|transitions of care
969322|NCT03360292|Neonatology|neonatology
969323|NCT03360266|remineralization|remineralization
969324|NCT03360266|fluoride varnish|fluoride varnish
969325|NCT03360227|syncope|syncope
969326|NCT03360227|bradycardia|bradycardia
969327|NCT03360227|tachycardia|tachycardia
969328|NCT03360227|sudden cardiac death|sudden cardiac death
969329|NCT03360227|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
969330|NCT03360227|ventricular tachycardia|ventricular tachycardia
969331|NCT03360227|ventricular fibrillation|ventricular fibrillation
969332|NCT03360227|biomarker|biomarker
969333|NCT03360227|thyroid hormone|thyroid hormone
969334|NCT03360214|Mastectomy|mastectomy
969335|NCT03360214|Tissue expander|tissue expander
969336|NCT03360214|PEMF|pemf
969337|NCT03360214|PIB|pib
969338|NCT03360201|Africa|africa
969339|NCT03360201|Kenya|kenya
969340|NCT03360201|Family relations|family relations
969341|NCT03360201|Child mental health|child mental health
969342|NCT03360201|Adolescent mental health|adolescent mental health
969343|NCT03360201|Family therapy|family therapy
969344|NCT03360201|Program evaluation|program evaluation
969345|NCT03360201|Family Conflict|family conflict
969346|NCT03360201|Marital Conflict|marital conflict
969347|NCT03360201|Domestic Violence|domestic violence
969348|NCT03360201|Parenting|parenting
969349|NCT03360201|Parent-Child Relations|parent-child relations
969350|NCT03360201|child abuse|child abuse
969351|NCT03360201|low- and middle-income country|low- and middle-income country
969352|NCT03360149|Hemophilia pregnant|hemophilia pregnant
969353|NCT03360149|Hemophilia delivery|hemophilia delivery
969354|NCT03360149|Hemophilia children|hemophilia children
969355|NCT03360136|Exhaustion Disorder|exhaustion disorder
969356|NCT03360136|Burnout|burnout
969357|NCT03360136|Clinical Burnout|clinical burnout
969358|NCT03360097|In vitro Fertilization|in vitro fertilization
969359|NCT03360097|Slow Developing Blastocyst|slow developing blastocyst
969360|NCT03360097|Fresh Embryo Transfer|fresh embryo transfer
969361|NCT03360097|Frozen Embryo Transfer|frozen embryo transfer
969362|NCT03360097|Live Birth Rate|live birth rate
969363|NCT03360084|CT|ct
969364|NCT03360084|Interventional radiology|interventional radiology
969365|NCT03360084|Lung biopsy|lung biopsy
969366|NCT03360084|Transthoracic biopsy|transthoracic biopsy
969367|NCT03360084|Systemic air embolism|systemic air embolism
969368|NCT03360058|motivational techniques|motivational techniques
969369|NCT03360058|primary care|primary care
969370|NCT03360032|Incremental shuttle walk test|incremental shuttle walk test
969371|NCT03360032|Cardiopulmonary exercise test|cardiopulmonary exercise test
969372|NCT03360032|VO2 peak|vo2 peak
969373|NCT03360006|Castrate-Resistant Prostate Cancer (CRPC)|castrate-resistant prostate cancer (crpc)
969374|NCT03360006|Metastatic Castrate-Resistant Prostate Cancer (CRPC)|metastatic castrate-resistant prostate cancer (crpc)
969375|NCT03360006|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
969379|NCT03360006|Recommended phase two dose|recommended phase two dose
969380|NCT03360006|Pharmacokinetics|pharmacokinetics
969381|NCT03359993|Endotracheal intubation|endotracheal intubation
969382|NCT03359993|Neonatal premedication|neonatal premedication
969383|NCT03359993|Delivery room|delivery room
969384|NCT03359954|Malignant neoplasm of breast|malignant neoplasm of breast
969385|NCT03359954|Preoperative boost radiotherapy|preoperative boost radiotherapy
969386|NCT03359954|RT|rt
969387|NCT03359954|XRT|xrt
969388|NCT03359954|HR+/HER2-|hr+/her2-
969389|NCT03359954|Breast surgery|breast surgery
969390|NCT03359941|Integrative Treatments|integrative treatments
969391|NCT03359941|Korean Traditional medicine|korean traditional medicine
969392|NCT03359915|COPD|copd
969393|NCT03359915|Self-Management|self-management
969397|NCT03359915|COPD Diagnosis|copd diagnosis
969398|NCT03359902|Mild Cognitive Impairment|mild cognitive impairment
969399|NCT03359902|Vagal Nerve Stimulation|vagal nerve stimulation
969400|NCT03359902|tVNS|tvns
969401|NCT03359902|Alzheimer's disease|alzheimer's disease
969402|NCT03359876|Real-world study|real-world study
969403|NCT03359876|Atrial fibrillation|atrial fibrillation
969404|NCT03359876|Renal dysfunction|renal dysfunction
969405|NCT03359876|Rivaroxaban|rivaroxaban
969406|NCT03359876|Warfarin|warfarin
969407|NCT03359824|exercise, brown adipose tissue|exercise, brown adipose tissue
969408|NCT03359811|Local Anesthetic Solution|local anesthetic solution
969409|NCT03359811|Bupivacaine HCl|bupivacaine hcl
969410|NCT03359811|Liposomal Bupivacaine|liposomal bupivacaine
969411|NCT03359811|Peritoneal Cancer|peritoneal cancer
969412|NCT03359785|Drug therapy|drug therapy
969413|NCT03359772|Neuropathic Pain|neuropathic pain
969414|NCT03359772|Balance|balance
969415|NCT03359772|Kinesthetic Ability Trainer|kinesthetic ability trainer
969416|NCT03359772|Quality of Life|quality of life
969417|NCT03359759|Telemedicine|telemedicine
969418|NCT03359759|Connected watches|connected watches
969419|NCT03359759|Patient-Reported symptom monitoring|patient-reported symptom monitoring
969420|NCT03359759|Secure Platform|secure platform
969421|NCT03359733|Drug therapy|drug therapy
969422|NCT03359694|breast cancer, neoadjuvant chemotherapy,susceptible gene|breast cancer, neoadjuvant chemotherapy,susceptible gene
969423|NCT03359655|misoprostol|misoprostol
969424|NCT03359655|hyoscine butyl bromide|hyoscine butyl bromide
969425|NCT03359655|cervical dilatation|cervical dilatation
969426|NCT03359655|cervical ripening|cervical ripening
969427|NCT03359655|hysteroscopy|hysteroscopy
969428|NCT03359655|pain|pain
969433|NCT03359629|Spectrophon|spectrophon
969434|NCT03359629|Glucose|glucose
969435|NCT03359629|Biosensor|biosensor
969436|NCT03359629|Non-invasive testing|non-invasive testing
969437|NCT03359616|rectal cancer|rectal cancer
969438|NCT03359616|laparoscopic surgery|laparoscopic surgery
969439|NCT03359616|total mesorectal excision|total mesorectal excision
969440|NCT03359616|transanal surgery|transanal surgery
969441|NCT03359603|Electro-acupuncture|electro-acupuncture
969442|NCT03359603|Knee osteoarthritis|knee osteoarthritis
969443|NCT03359603|Treatment frequency|treatment frequency
969444|NCT03359577|Chronic plaque psoriasis|chronic plaque psoriasis
969445|NCT03359577|Inflammation|inflammation
969446|NCT03359577|Cardiovascular diseases|cardiovascular diseases
969447|NCT03359564|Lumbar Disc Herniation|lumbar disc herniation
969448|NCT03359564|Micro Endoscopic Discectomy|micro endoscopic discectomy
969449|NCT03359551|Choroideremia|choroideremia
969450|NCT03359551|REP1|rep1
969451|NCT03359551|Retina|retina
969452|NCT03359551|Retinal Degeneration|retinal degeneration
969453|NCT03359551|Retinal Dystrophy|retinal dystrophy
969454|NCT03359551|Natural History|natural history
969455|NCT03359538|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
969456|NCT03359538|Motor Neuron Disease|motor neuron disease
969457|NCT03359538|Rapamycin|rapamycin
969458|NCT03359512|anesthesia monitoring|anesthesia monitoring
969459|NCT03359473|GSK2881078|gsk2881078
969460|NCT03359473|COPD|copd
969461|NCT03359473|muscle weakness|muscle weakness
969462|NCT03359473|post-menopausal|post-menopausal
969463|NCT03359473|selective androgen receptor modulator|selective androgen receptor modulator
969464|NCT03359447|infant|infant
969465|NCT03359447|primary prevention|primary prevention
969466|NCT03359434|Acute Stroke|acute stroke
969467|NCT03359434|Blood Pressure|blood pressure
969468|NCT03359434|Cerebral Hemorrhage|cerebral hemorrhage
969469|NCT03359421|prehospital|prehospital
969470|NCT03359421|aeromedical|aeromedical
969471|NCT03359421|trauma|trauma
969472|NCT03359421|ems|ems
969473|NCT03359421|helicopter|helicopter
969474|NCT03359408|Health care|health care
969475|NCT03359408|Dementia care|dementia care
969476|NCT03359408|Collaborative care|collaborative care
969477|NCT03359408|Discharge management|discharge management
969478|NCT03359408|Hospital|hospital
969479|NCT03359408|Primary care|primary care
969480|NCT03359395|Anesthesia|anesthesia
969481|NCT03359356|alopecia|alopecia
969482|NCT03359356|alopecia areata|alopecia areata
969483|NCT03359356|alopecia universalis|alopecia universalis
969484|NCT03359356|alopecia totalis|alopecia totalis
969485|NCT03359356|dupixent|dupixent
969486|NCT03359356|dupilumab|dupilumab
969487|NCT03359330|Peripheral nervous system diseases|peripheral nervous system diseases
969488|NCT03359330|Wounds and injuries|wounds and injuries
969489|NCT03359330|Nerve regeneration|nerve regeneration
969490|NCT03359330|Biocompatible materials|biocompatible materials
969491|NCT03359330|Surgical procedures|surgical procedures
969492|NCT03359317|Osteoporosis|osteoporosis
969493|NCT03359317|Bone Diseases|bone diseases
969494|NCT03359304|bone tumor|bone tumor
969495|NCT03359291|macitentan|macitentan
969496|NCT03359291|rosuvastatin|rosuvastatin
969497|NCT03359291|pharmacokinetics|pharmacokinetics
969498|NCT03359278|distal radius fracture, sigmoid notch|distal radius fracture, sigmoid notch
969499|NCT03359252|coil embolization|coil embolization
969500|NCT03359252|headache|headache
969503|NCT03359239|atezolizumab|atezolizumab
969504|NCT03359239|urothelial cancer|urothelial cancer
969505|NCT03359239|personalized neoantigen vaccine|personalized neoantigen vaccine
969506|NCT03359187|Radiation- induced mucositis|radiation- induced mucositis
969507|NCT03359187|Head and Neck Cancer|head and neck cancer
969508|NCT03359187|Radiation therapy side effect|radiation therapy side effect
969509|NCT03359161|ambulatory|ambulatory
969510|NCT03359161|Subcutaneous|subcutaneous
969511|NCT03359161|furosemide|furosemide
969512|NCT03359148|Nosocomial infection|nosocomial infection
969513|NCT03359148|Ventilator system|ventilator system
969514|NCT03359148|Closed suction system|closed suction system
969515|NCT03359148|Open suction system|open suction system
969516|NCT03359148|Bacterial contamination|bacterial contamination
969517|NCT03359135|Compression garment|compression garment
969518|NCT03359096|Sleep apnea|sleep apnea
969519|NCT03359096|Tongue stimulation|tongue stimulation
969520|NCT03359096|Cardiovascular function|cardiovascular function
969521|NCT03359083|foot-ankle characteristic|foot-ankle characteristic
969522|NCT03359083|lumbopelvic control|lumbopelvic control
969523|NCT03359083|balance|balance
969524|NCT03359083|physical performance|physical performance
969525|NCT03359070|Tinea cruris|tinea cruris
969526|NCT03359070|dapaconazole|dapaconazole
969527|NCT03359070|topical antifungal|topical antifungal
969528|NCT03359070|dermatophytoses|dermatophytoses
969529|NCT03359057|Folic acid|folic acid
969530|NCT03359057|Supplementation|supplementation
969531|NCT03359057|Ethinyl estradiol|ethinyl estradiol
969532|NCT03359057|Levonorgestrel|levonorgestrel
969533|NCT03359057|Oral contraceptive|oral contraceptive
969534|NCT03359044|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
969535|NCT03359044|Neuropsychological Development|neuropsychological development
969536|NCT03359044|general anesthesia|general anesthesia
969537|NCT03359018|osteosarcoma|osteosarcoma
969538|NCT03359018|advanced|advanced
969539|NCT03359018|apatinib|apatinib
969540|NCT03359018|PD-1|pd-1
969541|NCT03359005|Ewing Sarcoma|ewing sarcoma
969542|NCT03359005|Irinotecan|irinotecan
969543|NCT03359005|Temozolomide|temozolomide
969544|NCT03358992|CESOFB|cesofb
969545|NCT03358992|clinical evaluation|clinical evaluation
969546|NCT03358992|RECIST|recist
969547|NCT03358992|histological response|histological response
969548|NCT03358992|survival|survival
969549|NCT03358992|osteosarcoma|osteosarcoma
969550|NCT03358992|Ewing sarcoma|ewing sarcoma
969551|NCT03358979|Conjunctival Diseases|conjunctival diseases
969552|NCT03358979|Dry Eye Syndromes|dry eye syndromes
969553|NCT03358979|Antigens|antigens
969554|NCT03358979|CD147|cd147
969555|NCT03358966|chronic kidney disease|chronic kidney disease
969556|NCT03358966|energy expenditure|energy expenditure
969557|NCT03358966|metabolic rate|metabolic rate
969558|NCT03358953|electronic cigarettes|electronic cigarettes
969559|NCT03358953|cardiovascular|cardiovascular
969560|NCT03358953|nicotine replacement patches|nicotine replacement patches
969561|NCT03358940|Non-medical abortion|non-medical abortion
969562|NCT03358940|Misoprostol|misoprostol
969563|NCT03358940|miscarriage complications|miscarriage complications
969564|NCT03358940|Guadeloupe|guadeloupe
969565|NCT03358927|HIV/AIDS|hiv/aids
969566|NCT03358927|Fast-track care|fast-track care
969567|NCT03358927|Behavioral economics|behavioral economics
969568|NCT03358927|Differentiated care|differentiated care
969569|NCT03358914|psoriasis, adolescents, quality of life, PRO (patient-reported outcome), validation|psoriasis, adolescents, quality of life, pro (patient-reported outcome), validation
969570|NCT03358862|myopia|myopia
969571|NCT03358862|progressive myopia|progressive myopia
969572|NCT03358862|contact lenses|contact lenses
969573|NCT03358862|extended depth of focus|extended depth of focus
969574|NCT03358862|retrospective clinical series|retrospective clinical series
969575|NCT03358862|axial length|axial length
969576|NCT03358862|refractive error|refractive error
969577|NCT03358836|Hemophilia B|hemophilia b
969578|NCT03358836|FIX|fix
969579|NCT03358836|Factor IX|factor ix
969580|NCT03358836|Factor 9|factor 9
969581|NCT03358823|AS database ; Brain Image;Neural-EEG Data|as database ; brain image;neural-eeg data
969582|NCT03358797|Community-based Intervention|community-based intervention
969583|NCT03358797|Lifestyle intervention|lifestyle intervention
969584|NCT03358797|Women in East Jerusalem|women in east jerusalem
969585|NCT03358797|Diabetes prevention|diabetes prevention
969586|NCT03358797|Leadership|leadership
969587|NCT03358784|Humeral Fractures, Proximal|humeral fractures, proximal
969588|NCT03358784|Arthroplasty, Shoulder Replacement|arthroplasty, shoulder replacement
969589|NCT03358784|Bone Plates|bone plates
969590|NCT03358771|COPD|copd
969591|NCT03358771|AECOPD|aecopd
969592|NCT03358771|Discharge care bundle|discharge care bundle
969593|NCT03358771|Patient Care Bundles|patient care bundles
969594|NCT03358758|Trauma|trauma
969595|NCT03358758|War-Related Injuries|war-related injuries
969596|NCT03358758|Firearm|firearm
969597|NCT03358758|Explosion|explosion
969598|NCT03358758|Bomb|bomb
969599|NCT03358758|Ordnance|ordnance
969600|NCT03358758|IED|ied
969601|NCT03358758|Epidemiology|epidemiology
969602|NCT03358758|Public Health|public health
969603|NCT03358745|Type 2 diabetes risk|type 2 diabetes risk
969604|NCT03358745|Cardiovascular disease risk|cardiovascular disease risk
969605|NCT03358732|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, IVF|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, ivf
969606|NCT03358667|peri-implant soft tissue augmentation|peri-implant soft tissue augmentation
969607|NCT03358654|Umbilical Cord Bleeding|umbilical cord bleeding
969608|NCT03358654|Knee Osteoarthritis|knee osteoarthritis
969609|NCT03358654|stem cells|stem cells
969610|NCT03358641|exercise|exercise
969611|NCT03358641|physical activity|physical activity
969612|NCT03358641|radiographic osteoarthritis|radiographic osteoarthritis
969613|NCT03358628|Osteosarcoma|osteosarcoma
969614|NCT03358628|Patient-derived xenograft|patient-derived xenograft
969615|NCT03358615|robson classification|robson classification
969616|NCT03358615|Egypt|egypt
969617|NCT03358602|Supraglottic cancer|supraglottic cancer
969618|NCT03358602|Laryngeal cancer|laryngeal cancer
969619|NCT03358602|Cervical lymph node|cervical lymph node
969620|NCT03358602|Neck dissection|neck dissection
969621|NCT03358563|Prostate Cancer|prostate cancer
969622|NCT03358563|Prostatectomy|prostatectomy
969623|NCT03358563|Chemohormonal therapy|chemohormonal therapy
969624|NCT03358563|Androgen deprivation therapy|androgen deprivation therapy
969625|NCT03358563|docetaxel chemotherapy|docetaxel chemotherapy
969626|NCT03358550|accommodation|accommodation
969627|NCT03358550|dark focus|dark focus
969628|NCT03358550|night myopia|night myopia
969629|NCT03358537|Dietary fiber|dietary fiber
969630|NCT03358472|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
969631|NCT03358472|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
969632|NCT03358472|indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor|indoleamine 2,3-dioxygenase 1 (ido1) inhibitor
969633|NCT03358459|phenotype; genotype|phenotype; genotype
969634|NCT03358446|central catheterization|central catheterization
969635|NCT03358446|femoral vein central catheterization|femoral vein central catheterization
969636|NCT03358446|leg angulation|leg angulation
969637|NCT03358407|Inflammatory Bowel disease|inflammatory bowel disease
969638|NCT03358407|Pro-drug|pro-drug
969639|NCT03358407|Double-blinded|double-blinded
969640|NCT03358407|Crossover|crossover
969641|NCT03358381|total knee arthroplasty|total knee arthroplasty
969642|NCT03358381|CT scan|ct scan
969643|NCT03358355|PAD|pad
969644|NCT03358355|unacylated ghrelin|unacylated ghrelin
969645|NCT03358355|Peripheral Artery Disease|peripheral artery disease
969646|NCT03358316|Rotator Cuff Tear|rotator cuff tear
969647|NCT03358316|Magnetic Resonance Imaging|magnetic resonance imaging
969648|NCT03358316|humeral migration|humeral migration
969649|NCT03358290|JTE-051|jte-051
969650|NCT03358290|Psoriasis|psoriasis
969651|NCT03358264|Vascular dysfunction, L-citrulline, arginase|vascular dysfunction, l-citrulline, arginase
969652|NCT03358225|Hybrid surgery,ACDF,C-ADR,bi-level cervical spondylosis|hybrid surgery,acdf,c-adr,bi-level cervical spondylosis
969653|NCT03358212|giant cell tumor of bone|giant cell tumor of bone
969654|NCT03358212|Denosumab|denosumab
969655|NCT03358212|post-operative|post-operative
969656|NCT03358199|LOD|lod
969657|NCT03358199|PCOS|pcos
969658|NCT03358199|AMH|amh
969659|NCT03358199|OHSS|ohss
969660|NCT03358186|Periprosthetic Fractures|periprosthetic fractures
969661|NCT03358186|Arthroplasty|arthroplasty
969662|NCT03358186|Surgical procedures|surgical procedures
969663|NCT03358173|Humeral Fractures|humeral fractures
969664|NCT03358173|plate|plate
969665|NCT03358173|Conservative Treatment|conservative treatment
969666|NCT03358134|Peripheral Spondylarthropathies|peripheral spondylarthropathies
969667|NCT03358134|Psoriatic arthritis|psoriatic arthritis
969668|NCT03358134|Reactive arthritis|reactive arthritis
969669|NCT03358056|Mindfulness|mindfulness
969671|NCT03358056|Mindfulenss-based cognitive therapy|mindfulenss-based cognitive therapy
969672|NCT03358043|respiratory failure|respiratory failure
969673|NCT03358043|mechanical ventilation|mechanical ventilation
969674|NCT03358043|prevalence|prevalence
969675|NCT03358017|Triple negative breast cancer|triple negative breast cancer
969676|NCT03358017|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
969677|NCT03358017|p53|p53
969678|NCT03358017|Zoledronate|zoledronate
969679|NCT03358017|Atorvastatin|atorvastatin
969680|NCT03358017|Mevalonate pathway inhibitors|mevalonate pathway inhibitors
969681|NCT03358017|Hippo pathway|hippo pathway
969682|NCT03358004|TNBC|tnbc
969683|NCT03358004|metronomic chemotherapy|metronomic chemotherapy
969684|NCT03358004|vinorelbine|vinorelbine
969685|NCT03358004|capecitabine|capecitabine
969686|NCT03357991|E6/E7 mRNA|e6/e7 mrna
969687|NCT03357991|anal cancer screening|anal cancer screening
969688|NCT03357991|men who have sex with men|men who have sex with men
969689|NCT03357991|cost-effectiveness analysis|cost-effectiveness analysis
969690|NCT03357991|High resolution anoscopy|high resolution anoscopy
969691|NCT03357978|immunodeficiency|immunodeficiency
969692|NCT03357978|liver disease|liver disease
969693|NCT03357978|cancer risk|cancer risk
969694|NCT03357965|maternal infant bonding|maternal infant bonding
969695|NCT03357965|depression|depression
969696|NCT03357965|anxiety|anxiety
969699|NCT03357939|pharmacokinetics|pharmacokinetics
969700|NCT03357939|biosimilar|biosimilar
969701|NCT03357900|Consciousness Monitor|consciousness monitor
969702|NCT03357900|Clinical Pharmacology|clinical pharmacology
969703|NCT03357861|cancer|cancer
969704|NCT03357861|intensive care unit|intensive care unit
969705|NCT03357861|checkpoint inhibitors|checkpoint inhibitors
969706|NCT03357861|adverse event|adverse event
969707|NCT03357835|trauma|trauma
969708|NCT03357835|triage|triage
969709|NCT03357835|software|software
969710|NCT03357835|emergency|emergency
969711|NCT03357822|Chronic hepatitis B|chronic hepatitis b
969712|NCT03357822|Nucleoside analog|nucleoside analog
969713|NCT03357822|Pegylated Interferon|pegylated interferon
969714|NCT03357822|Sequential combination therapy|sequential combination therapy
969715|NCT03357822|HBsAg loss|hbsag loss
969716|NCT03357796|Depressive Disorder, Major|depressive disorder, major
969717|NCT03357796|Depressive Disorder|depressive disorder
969718|NCT03357796|Mood Disorders|mood disorders
969719|NCT03357796|Mental Disorders|mental disorders
969720|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate
969721|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
969722|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
969723|NCT03357796|Membrane Transport Modulators|membrane transport modulators
969724|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
969725|NCT03357796|Neurotransmitter Agents|neurotransmitter agents
969726|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs
969727|NCT03357796|Antidepressive Agents|antidepressive agents
969728|NCT03357796|Psychotropic Drugs|psychotropic drugs
969729|NCT03357783|Frequency|frequency
969730|NCT03357783|Macroscopic|macroscopic
969731|NCT03357783|Deciduosis|deciduosis
969732|NCT03357783|Ovarian|ovarian
969733|NCT03357783|Neoplasm|neoplasm
969734|NCT03357783|Pregnancy|pregnancy
969735|NCT03357770|mesenchymal stem cells|mesenchymal stem cells
969736|NCT03357770|Knee Osteoarthritis|knee osteoarthritis
969737|NCT03357770|Umbilical Cord|umbilical cord
969738|NCT03357744|distress|distress
969739|NCT03357744|assessment methods|assessment methods
969740|NCT03357718|premedication|premedication
969741|NCT03357705|alveolar ridge preservation|alveolar ridge preservation
969742|NCT03357692|all on four; piezoelectric; implant; trans-sinusal|all on four; piezoelectric; implant; trans-sinusal
969743|NCT03357679|Bed up head elevated position|bed up head elevated position
969744|NCT03357679|Glidescope assisted tracheal intubation|glidescope assisted tracheal intubation
969745|NCT03357679|Laryngeal exposure|laryngeal exposure
969746|NCT03357679|Time to intubation|time to intubation
969747|NCT03357653|proteinuria|proteinuria
969748|NCT03357653|progression|progression
969749|NCT03357653|early immunoglobulin A (IgA) nephropathy|early immunoglobulin a (iga) nephropathy
969750|NCT03357627|Drug therapy|drug therapy
969751|NCT03357601|High Intensity Interval|high intensity interval
969752|NCT03357601|Moderate Endurance Exercise|moderate endurance exercise
969753|NCT03357601|Fat Loss|fat loss
969754|NCT03357601|Endurance Capacity|endurance capacity
969755|NCT03357575|Knee Osteoarthritis|knee osteoarthritis
969756|NCT03357575|adipose|adipose
969757|NCT03357575|mesenchymal stem cells|mesenchymal stem cells
969758|NCT03357562|Cystic fibrosis|cystic fibrosis
969759|NCT03357562|CT|ct
969760|NCT03357562|MRI|mri
969761|NCT03357562|radiation dose|radiation dose
969762|NCT03357562|contrast agent|contrast agent
969763|NCT03357549|Breast Feeding|breast feeding
969764|NCT03357549|Motivational Interviewing|motivational interviewing
969765|NCT03357549|Self Efficacy|self efficacy
969766|NCT03357497|colorectal surgery, early mobilization, postoperative care|colorectal surgery, early mobilization, postoperative care
969767|NCT03357484|impacted tooth|impacted tooth
969768|NCT03357484|pain|pain
969769|NCT03357484|platelet-rich fibrin|platelet-rich fibrin
969770|NCT03357484|third molar|third molar
969771|NCT03357484|tooth extraction|tooth extraction
969772|NCT03357484|wound healing|wound healing
969773|NCT03357471|Certolizumab Pegol|certolizumab pegol
969774|NCT03357471|E-Device|e-device
969775|NCT03357458|Family Integrated Care|family integrated care
969776|NCT03357458|Parenting education|parenting education
969777|NCT03357458|Nursing|nursing
969778|NCT03357458|Cost effectiveness|cost effectiveness
969779|NCT03357458|Patient engagement|patient engagement
969780|NCT03357458|Randomized controlled trial|randomized controlled trial
969781|NCT03357458|Neonatal intensive care unit|neonatal intensive care unit
969782|NCT03357445|Total hip Arthroplasty|total hip arthroplasty
969783|NCT03357445|Hip implant|hip implant
969784|NCT03357432|collagen|collagen
969785|NCT03357432|gelatin|gelatin
969786|NCT03357432|PINP|pinp
969787|NCT03357406|implant|implant
969788|NCT03357406|piezoelectric|piezoelectric
969789|NCT03357406|drills|drills
969790|NCT03357406|immediate loading|immediate loading
969791|NCT03357341|electronic health record|electronic health record
969792|NCT03357341|Pilot|pilot
969793|NCT03357341|COPD|copd
969794|NCT03357341|Sensor|sensor
969795|NCT03357341|Asthma|asthma
969796|NCT03357328|Phototherapy|phototherapy
969797|NCT03357328|Nursing home|nursing home
969798|NCT03357328|Light therapy|light therapy
969799|NCT03357250|biomarkers|biomarkers
969800|NCT03357185|Femoral bifurcation|femoral bifurcation
969801|NCT03357185|Peripheral arterial disease|peripheral arterial disease
969802|NCT03357185|Vascular surgery|vascular surgery
969803|NCT03357185|Eversion|eversion
969804|NCT03357185|Open surgery|open surgery
969805|NCT03357172|Immune recovery|immune recovery
969806|NCT03357172|Immunomodulatory cells|immunomodulatory cells
969807|NCT03357172|GVHD|gvhd
969808|NCT03357172|GVL|gvl
969809|NCT03357159|anti thymocyte globulin|anti thymocyte globulin
969810|NCT03357159|cyclophospamide|cyclophospamide
969811|NCT03357159|graft-versus-host disease|graft-versus-host disease
969812|NCT03357159|stem cell transplantation|stem cell transplantation
969813|NCT03357120|Breast Cancer|breast cancer
969814|NCT03357120|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
969815|NCT03357120|Circulating tumor DNA|circulating tumor dna
969816|NCT03357094|Pulmonary ventilation|pulmonary ventilation
969817|NCT03357094|Pulmonary perfusion|pulmonary perfusion
969818|NCT03357094|Single Photon Emission Computed Tomography|single photon emission computed tomography
969819|NCT03357055|tourniquet, pain, ketamine|tourniquet, pain, ketamine
969820|NCT03357029|Chronic pancreatitis|chronic pancreatitis
969821|NCT03357029|Vagal nerve stimulation|vagal nerve stimulation
969822|NCT03357029|Visceral Pain|visceral pain
969823|NCT03357016|interval training|interval training
969824|NCT03357016|abdominal fat mass|abdominal fat mass
969825|NCT03357016|postmenopausal women|postmenopausal women
969826|NCT03357016|lipids oxidation|lipids oxidation
969827|NCT03356964|endometrial receptivity progesterone elevation|endometrial receptivity progesterone elevation
969828|NCT03356925|Xpert®MTB/RIF|xpert®mtb/rif
969829|NCT03356925|Xpert®MTB/RIF Ultra|xpert®mtb/rif ultra
969830|NCT03356886|Chronic Low Back Pain|chronic low back pain
969831|NCT03356886|Pain Neuroscience Education|pain neuroscience education
969832|NCT03356886|Spinal Manipulative Techniques|spinal manipulative techniques
969833|NCT03356886|Psychosocial Factors|psychosocial factors
969834|NCT03356860|breast cancer|breast cancer
969835|NCT03356860|immunotherapy|immunotherapy
969836|NCT03356860|anti-PD-L1|anti-pd-l1
969837|NCT03356834|Chronic hepatitis B|chronic hepatitis b
969838|NCT03356834|Efficacy, safety, and tolerability|efficacy, safety, and tolerability
969839|NCT03356834|Tenofovir alafenamide|tenofovir alafenamide
969840|NCT03356808|Lung cancer|lung cancer
969841|NCT03356808|CAR-T|car-t
969842|NCT03356808|mesothelin|mesothelin
969843|NCT03356808|Muc1|muc1
969844|NCT03356808|GD2|gd2
969845|NCT03356808|MAGE-A4|mage-a4
969846|NCT03356795|Cervical cancer|cervical cancer
969847|NCT03356795|CAR-T|car-t
969848|NCT03356795|GD2|gd2
969849|NCT03356795|PSMA|psma
969850|NCT03356795|Muc1|muc1
969851|NCT03356795|Mesothelin|mesothelin
969852|NCT03356795|HPV|hpv
969853|NCT03356795|solid tumor|solid tumor
969854|NCT03356782|CART|cart
969855|NCT03356782|PD-1|pd-1
969856|NCT03356782|PDL-1|pdl-1
969857|NCT03356782|CTLA-4|ctla-4
969858|NCT03356782|sarcoma|sarcoma
969859|NCT03356782|solid tumor|solid tumor
969860|NCT03356769|refractory seizure|refractory seizure
969861|NCT03356769|cognitive impairment|cognitive impairment
969862|NCT03356769|electroencephalography improvement|electroencephalography improvement
969863|NCT03356769|seizure reduction|seizure reduction
969864|NCT03356769|seizure free|seizure free
969865|NCT03356769|aspirin|aspirin
969866|NCT03356743|lobectomy|lobectomy
969867|NCT03356730|Implants|implants
969868|NCT03356730|Vitamin D|vitamin d
969869|NCT03356730|Osseointegration|osseointegration
969870|NCT03356730|Histomorphometric|histomorphometric
969871|NCT03356717|simulation, high-fidelity, observer tool; learning outcomes|simulation, high-fidelity, observer tool; learning outcomes
969872|NCT03356704|adults|adults
969873|NCT03356691|Spiritist pass|spiritist pass
969874|NCT03356691|adult|adult
969875|NCT03356691|laying of hands|laying of hands
969876|NCT03356665|diagnosis|diagnosis
969877|NCT03356665|sensitivity|sensitivity
969878|NCT03356665|specificity|specificity
969879|NCT03356665|rapid diagnostic test|rapid diagnostic test
969880|NCT03356665|molecular biology|molecular biology
969881|NCT03356665|LAMP|lamp
969882|NCT03356665|RT-PCR|rt-pcr
969883|NCT03356665|serology|serology
969884|NCT03356665|ELISA|elisa
969885|NCT03356665|immune trypanolysis|immune trypanolysis
969886|NCT03356665|clinical symptom|clinical symptom
969887|NCT03356652|Cardiac resynchronizaton therapy|cardiac resynchronizaton therapy
969888|NCT03356652|Electrical activation mapping|electrical activation mapping
969889|NCT03356652|Noninvasive|noninvasive
969890|NCT03356652|Electrical dyssynchrony|electrical dyssynchrony
969891|NCT03356639|Schizophrenia|schizophrenia
969892|NCT03356639|ASP6981|asp6981
969893|NCT03356639|Safety|safety
969894|NCT03356639|Phase 1|phase 1
969895|NCT03356626|fever, inflammation|fever, inflammation
969896|NCT03356600|Brain Metastases|brain metastases
969897|NCT03356587|NGS|ngs
969898|NCT03356587|Nanostring|nanostring
969899|NCT03356587|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
969901|NCT03356535|targeted metabolomics|targeted metabolomics
969902|NCT03356535|multivariate statistics|multivariate statistics
969903|NCT03356535|metabolic signatures|metabolic signatures
969904|NCT03356535|partial least squares|partial least squares
969905|NCT03356535|healthy lifestyle index|healthy lifestyle index
969906|NCT03356535|EPIC|epic
969907|NCT03356483|Psilocybin|psilocybin
969908|NCT03356470|melanoma|melanoma
969909|NCT03356470|antimelanoma T cells|antimelanoma t cells
969910|NCT03356444|abiraterone|abiraterone
969911|NCT03356444|docetaxel|docetaxel
969912|NCT03356444|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
969913|NCT03356431|Exercise therapy|exercise therapy
969914|NCT03356431|Physical Therapy|physical therapy
969915|NCT03356418|Exercise|exercise
969916|NCT03356418|Vibration|vibration
969917|NCT03356418|Torque|torque
969918|NCT03356418|Aging|aging
969919|NCT03356392|acute stroke, thrombectomy, endovascular treatment|acute stroke, thrombectomy, endovascular treatment
969920|NCT03356379|Diagnosis|diagnosis
969921|NCT03356379|Peripheral artery disease|peripheral artery disease
969922|NCT03356379|sports|sports
969923|NCT03356314|superior mesenteric artery|superior mesenteric artery
969924|NCT03356314|superior mesenteric vein|superior mesenteric vein
969925|NCT03356314|intestinal malrotation|intestinal malrotation
969926|NCT03356314|volvulus|volvulus
969927|NCT03356314|pregnant women|pregnant women
969928|NCT03356314|mesenteric vessels position|mesenteric vessels position
1655263|NCT00168623|Morbidity|morbidity
969929|NCT03356314|postnatal diagnosis|postnatal diagnosis
969930|NCT03356314|prophylactic surgery|prophylactic surgery
969931|NCT03356301|Aortic compliance|aortic compliance
969932|NCT03356301|Aortic distensibility|aortic distensibility
969934|NCT03356301|Triathletes|triathletes
969935|NCT03356301|Ventriculo-atrial coupling|ventriculo-atrial coupling
969936|NCT03356288|Capnography, Diagnosis. Breathlessness, Exacerbations, Device|capnography, diagnosis. breathlessness, exacerbations, device
969937|NCT03356262|Cohort study|cohort study
969938|NCT03356249|Sepsis|sepsis
969939|NCT03356249|Septic shock|septic shock
969940|NCT03356249|Next-Generation Sequencing|next-generation sequencing
969941|NCT03356249|Bacteremia|bacteremia
969942|NCT03356223|Clinical Trial|clinical trial
969943|NCT03356223|Phase II|phase ii
969944|NCT03356223|Monotherapy|monotherapy
969945|NCT03356223|Abemaciclib|abemaciclib
969946|NCT03356223|Homozygous deletion of CDKN2A|homozygous deletion of cdkn2a
969947|NCT03356223|Amplification of CCND1|amplification of ccnd1
969948|NCT03356223|Amplification of CDK6|amplification of cdk6
969949|NCT03356223|Multicenter Trial|multicenter trial
969950|NCT03356158|Metastatic Colorectal Cancer,|metastatic colorectal cancer,
969951|NCT03356158|Recombinant Anti-EGFR Monoclonal Antibody|recombinant anti-egfr monoclonal antibody
969952|NCT03356145|paracervical block|paracervical block
969953|NCT03356145|abortion|abortion
969954|NCT03356145|dilation and evacuation|dilation and evacuation
969955|NCT03356145|cervical preparation|cervical preparation
969956|NCT03356132|breast implant|breast implant
969957|NCT03356132|complication|complication
969958|NCT03356132|satisfaction|satisfaction
969959|NCT03356132|quality of life|quality of life
969960|NCT03356132|augmentation|augmentation
969961|NCT03356132|textured|textured
969962|NCT03356132|polyurethane|polyurethane
969963|NCT03356119|Contraceptive Implant|contraceptive implant
969964|NCT03356106|Obstructive sleep apnea|obstructive sleep apnea
969965|NCT03356106|Pre-Eclampsia|pre-eclampsia
969966|NCT03356093|head and neck cancer, symptom cluster, change, radiotherapy|head and neck cancer, symptom cluster, change, radiotherapy
969967|NCT03356080|decitabine|decitabine
969968|NCT03356080|retinoid acid|retinoid acid
969969|NCT03356080|cytarabine C|cytarabine c
969970|NCT03356080|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
969971|NCT03356080|acute myeloid leukemia|acute myeloid leukemia
969972|NCT03356080|Myelodysplastic Syndrome|myelodysplastic syndrome
969973|NCT03356028|Trauma|trauma
969974|NCT03356028|Psychiatric Disorder|psychiatric disorder
969975|NCT03356028|mass trauma|mass trauma
969976|NCT03356015|Polyp detection rate|polyp detection rate
969977|NCT03356015|Adenoma detection rate|adenoma detection rate
969978|NCT03356015|Boston Bowel Preparation Scale|boston bowel preparation scale
969979|NCT03355989|Conditional Cash Transfer|conditional cash transfer
969980|NCT03355989|Immunization coverage|immunization coverage
969981|NCT03355989|Immunization reminder|immunization reminder
969982|NCT03355976|recurrent|recurrent
969983|NCT03355976|advanced|advanced
969984|NCT03355976|metastatitic|metastatitic
969985|NCT03355937|unexplained infertility|unexplained infertility
969986|NCT03355937|recurrent implantation failure|recurrent implantation failure
969987|NCT03355885|early onset pneumonia|early onset pneumonia
969988|NCT03355885|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
969989|NCT03355885|prognosis|prognosis
969990|NCT03355885|antibiotic|antibiotic
969991|NCT03355859|Non Hodgkin Lymphoma|non hodgkin lymphoma
969992|NCT03355859|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
969993|NCT03355859|JWCAR029|jwcar029
969994|NCT03355846|Anal Fissure|anal fissure
969995|NCT03355846|local therapy|local therapy
969996|NCT03355846|pain|pain
969997|NCT03355846|defecation|defecation
969998|NCT03355846|bleeding|bleeding
969999|NCT03355820|Immune response|immune response
970000|NCT03355820|Cervarix|cervarix
970001|NCT03355820|Persistence|persistence
970002|NCT03355820|Chinese|chinese
970003|NCT03355820|Human papillomavirus|human papillomavirus
970004|NCT03355807|sleeve gastrectomy|sleeve gastrectomy
970005|NCT03355807|magnesium sulfate|magnesium sulfate
970006|NCT03355807|postoperative pain|postoperative pain
970007|NCT03355807|bariatric surgery|bariatric surgery
970008|NCT03355794|DIPG|dipg
970009|NCT03355794|High Grade Glioma|high grade glioma
970010|NCT03355794|ribociclib|ribociclib
970011|NCT03355794|everolimus|everolimus
970012|NCT03355781|childhood trauma|childhood trauma
970013|NCT03355781|candidate gene expression|candidate gene expression
970014|NCT03355781|cerebral morphology|cerebral morphology
970015|NCT03355781|schizophrenic symptomatology|schizophrenic symptomatology
970016|NCT03355781|conceptual framework of stress vulnerability|conceptual framework of stress vulnerability
970017|NCT03355768|Romidepsin|romidepsin
970018|NCT03355768|Pralatrexate|pralatrexate
970019|NCT03355768|PTCL|ptcl
970020|NCT03355768|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
970021|NCT03355742|XIENCE|xience
970022|NCT03355742|High bleeding risk (HBR)|high bleeding risk (hbr)
970023|NCT03355742|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
970024|NCT03355742|Coronary Artery Disease|coronary artery disease
970025|NCT03355742|Drug eluting stent (DES)|drug eluting stent (des)
970026|NCT03355690|thrombectomy|thrombectomy
970027|NCT03355690|thrombolysis|thrombolysis
970028|NCT03355690|Health-economic status|health-economic status
970029|NCT03355690|Outcome after stroke|outcome after stroke
970030|NCT03355677|Case finding|case finding
970031|NCT03355677|complex case management|complex case management
970032|NCT03355664|Malaria, Falciparum|malaria, falciparum
970033|NCT03355664|Malaria|malaria
970034|NCT03355664|Protozoan Infections|protozoan infections
970035|NCT03355664|Lumefantrine|lumefantrine
970036|NCT03355664|Artemether|artemether
970037|NCT03355664|Amodiaquine|amodiaquine
970038|NCT03355664|Piperaquine|piperaquine
970039|NCT03355664|Artemether-lumefantrine combination|artemether-lumefantrine combination
970040|NCT03355664|Artemisinins|artemisinins
970041|NCT03355664|Dihydroartemisinin|dihydroartemisinin
970042|NCT03355664|Mefloquine|mefloquine
970043|NCT03355664|Artemisinin|artemisinin
970044|NCT03355664|Antimalarials|antimalarials
970045|NCT03355664|Antiparasitic Agents|antiparasitic agents
970046|NCT03355664|Anti-Infective Agents|anti-infective agents
970047|NCT03355664|ACT|act
970048|NCT03355664|TACT|tact
970049|NCT03355664|Triple ACT(s)|triple act(s)
970050|NCT03355664|Resistance|resistance
970051|NCT03355664|Antimalarial resistance|antimalarial resistance
970052|NCT03355664|Cardiotoxicity|cardiotoxicity
970053|NCT03355664|Safety|safety
970054|NCT03355664|Tolerability|tolerability
970055|NCT03355664|Efficacy|efficacy
970056|NCT03355651|Anterior Cruciate Ligament Tears|anterior cruciate ligament tears
970057|NCT03355651|Dietary Supplementations|dietary supplementations
970058|NCT03355651|Plasma Rich Proteins|plasma rich proteins
970059|NCT03355651|Collagen|collagen
970060|NCT03355651|Chondroitin Sulfate|chondroitin sulfate
970061|NCT03355651|Hyaluronic Acid|hyaluronic acid
970062|NCT03355625|Flow Cytometry|flow cytometry
970063|NCT03355625|eCPR|ecpr
970064|NCT03355625|Extracorporeal Life Support|extracorporeal life support
970065|NCT03355586|Lung diseases|lung diseases
970067|NCT03355586|Interventional pulmonology|interventional pulmonology
970068|NCT03355586|Peripheral nodule|peripheral nodule
970069|NCT03355573|Bimekizumab|bimekizumab
970070|NCT03355573|Ankylosing Spondylitis|ankylosing spondylitis
970071|NCT03355573|AS|as
970072|NCT03355534|dexmedetomidine|dexmedetomidine
970073|NCT03355534|general anesthesia|general anesthesia
970074|NCT03355534|cerebral aneurysm|cerebral aneurysm
970075|NCT03355521|functionality|functionality
970076|NCT03355521|gait|gait
970077|NCT03355521|kinematics|kinematics
970078|NCT03355521|electromyographic activity|electromyographic activity
970079|NCT03355521|depressive symptoms|depressive symptoms
970080|NCT03355521|quality of life|quality of life
970081|NCT03355495|Colonoscopy|colonoscopy
970082|NCT03355495|Cecal Intubation Rate|cecal intubation rate
970083|NCT03355456|Persistent atrial fibrillation|persistent atrial fibrillation
970084|NCT03355456|Medication refractory atrial fibrillation|medication refractory atrial fibrillation
970085|NCT03355456|Pulmonary vein isolation procedure|pulmonary vein isolation procedure
970086|NCT03355456|Low voltage directed ablation|low voltage directed ablation
970087|NCT03355443|Colonoscopy|colonoscopy
970088|NCT03355443|Lower Gastrointestinal Tract|lower gastrointestinal tract
970089|NCT03355443|Re-examination|re-examination
970090|NCT03355443|Retroflexion|retroflexion
970091|NCT03355391|SCREENING|screening
970092|NCT03355391|RISK FACTOR|risk factor
970093|NCT03355365|Mesenchymal Stem Cells|mesenchymal stem cells
970094|NCT03355365|Neural Progenitors|neural progenitors
970095|NCT03355365|Autologous|autologous
970097|NCT03355365|Multiple Sclerosis|multiple sclerosis
970098|NCT03355352|Zalviso|zalviso
970099|NCT03355352|sufentanyl|sufentanyl
970100|NCT03355352|PCA|pca
970101|NCT03355352|Dipidolor|dipidolor
970102|NCT03355339|Balance|balance
970103|NCT03355339|Dual-task|dual-task
970104|NCT03355339|King-Devick Test|king-devick test
970105|NCT03355339|Saccades|saccades
970106|NCT03355339|Binasal Occlusion|binasal occlusion
970107|NCT03355313|saliva|saliva
970108|NCT03355313|Low-level light therapy|low-level light therapy
970109|NCT03355313|salivary glands|salivary glands
970110|NCT03355274|Transcutaneous Oximetry|transcutaneous oximetry
970111|NCT03355248|postpartum|postpartum
970112|NCT03355248|postoperative cesarean pain management|postoperative cesarean pain management
970113|NCT03355248|opioid requirements|opioid requirements
970114|NCT03355222|complementary feeding|complementary feeding
970115|NCT03355222|calcium|calcium
970116|NCT03355209|LGS|lgs
970117|NCT03355196|Osteoarthritic patients|osteoarthritic patients
970118|NCT03355196|Cartilage|cartilage
970119|NCT03355196|Safety|safety
970120|NCT03355183|isokinetics|isokinetics
970121|NCT03355183|knee|knee
970122|NCT03355157|Palbociclib|palbociclib
970123|NCT03355157|Endocrine Therapy|endocrine therapy
970124|NCT03355157|Chemotherapy|chemotherapy
970125|NCT03355157|Real world setting|real world setting
970126|NCT03355157|Electronic patient-reported outcome|electronic patient-reported outcome
970127|NCT03355157|Daily Monitoring Treatment Impact|daily monitoring treatment impact
970128|NCT03355157|Health care utilization (call tracking, geofencing)|health care utilization (call tracking, geofencing)
970129|NCT03355105|Neuromuscular disease|neuromuscular disease
970130|NCT03355066|Wnt pathway|wnt pathway
970131|NCT03355066|Wnt inhibition|wnt inhibition
970132|NCT03355066|SM08502|sm08502
970133|NCT03355040|shoulder dystocia|shoulder dystocia
970134|NCT03355040|maternal and neonatal morbidity|maternal and neonatal morbidity
970135|NCT03355027|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
970136|NCT03355027|PCSK9|pcsk9
970137|NCT03355027|Alirocumab|alirocumab
970138|NCT03355027|Flow Mediated Dilatation|flow mediated dilatation
970139|NCT03355027|Arterial Stiffness|arterial stiffness
970140|NCT03355027|Carotid Intima Media Thickness|carotid intima media thickness
970141|NCT03355027|Inflammation|inflammation
970142|NCT03355027|Endothelial function|endothelial function
970143|NCT03355027|FDG PET-CT|fdg pet-ct
970144|NCT03355027|PET-MR|pet-mr
970145|NCT03355027|Ezetimibe|ezetimibe
970146|NCT03354962|Melanoma|melanoma
970147|NCT03354962|Immune checkpoint|immune checkpoint
970148|NCT03354962|Nivolumab|nivolumab
970149|NCT03354962|Ipilimumab|ipilimumab
970150|NCT03354962|Abscopal effect|abscopal effect
970151|NCT03354962|Stereotactic radiotherapy|stereotactic radiotherapy
970152|NCT03354962|PD-1|pd-1
970153|NCT03354962|CTLA-4|ctla-4
970154|NCT03354949|Wheelchair|wheelchair
970155|NCT03354949|Hemiplegia|hemiplegia
970156|NCT03354949|Stroke|stroke
970157|NCT03354949|Postural control|postural control
970158|NCT03354949|Pain|pain
970159|NCT03354910|Live Donor Kidney Transplantation|live donor kidney transplantation
970160|NCT03354910|LDKT|ldkt
970161|NCT03354910|Disparity|disparity
970162|NCT03354910|African American|african american
970163|NCT03354910|Education|education
970164|NCT03354910|Patient Support|patient support
970165|NCT03354897|stratified medicine, UMOD, torasemide|stratified medicine, umod, torasemide
970166|NCT03354858|follicle flushing|follicle flushing
970172|NCT03354754|beta-lactam antibiotics|beta-lactam antibiotics
970173|NCT03354754|creatinine clearance|creatinine clearance
970174|NCT03354754|enterobacteriaceae|enterobacteriaceae
970175|NCT03354676|adipokines, metabolic syndrome, obese children|adipokines, metabolic syndrome, obese children
970176|NCT03354663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
970178|NCT03354663|ablation|ablation
970179|NCT03354585|Mindfulness|mindfulness
970180|NCT03354585|fMRI|fmri
970181|NCT03354585|Pain|pain
970182|NCT03354585|low back|low back
970183|NCT03354585|radicular|radicular
970184|NCT03354559|coagulopathy|coagulopathy
970185|NCT03354559|trauma|trauma
970186|NCT03354559|bleeding|bleeding
970187|NCT03354559|fibrinogen|fibrinogen
970188|NCT03354559|transfusion|transfusion
970189|NCT03354507|topiramate|topiramate
970190|NCT03354507|epilepsy|epilepsy
970191|NCT03354507|sodium bicarbonate|sodium bicarbonate
970192|NCT03354507|urine alkalinization|urine alkalinization
970193|NCT03354494|Oocyte donors|oocyte donors
970194|NCT03354494|Ovarian stimulation|ovarian stimulation
970195|NCT03354494|Desogestrel|desogestrel
970196|NCT03354494|Corifolitropina alfa|corifolitropina alfa
970197|NCT03354494|Gonadotropins|gonadotropins
970198|NCT03354481|Dyscalculia|dyscalculia
970199|NCT03354468|Prevention and Control|prevention and control
970200|NCT03354468|Patient Safety|patient safety
970201|NCT03354468|Aged|aged
970202|NCT03354468|Risk Management|risk management
970203|NCT03354442|Class III treatment|class iii treatment
970204|NCT03354442|Modified Fixed Mandibular Retractor Appliance|modified fixed mandibular retractor appliance
970205|NCT03354442|RCT|rct
970206|NCT03354429|Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke|acute ischaemic stroke; transient ischaemic attack (tia); stroke
970207|NCT03354416|Imaging-Based Prognostic Markers|imaging-based prognostic markers
970208|NCT03354416|Multiparametric MRI (mpMRI)|multiparametric mri (mpmri)
970209|NCT03354416|Translation of Imaging into Treatment Decisions|translation of imaging into treatment decisions
970210|NCT03354416|Decision-Support System|decision-support system
970211|NCT03354416|Artificial Intelligence Research|artificial intelligence research
970212|NCT03354403|XLRS|xlrs
970213|NCT03354403|RS1|rs1
970214|NCT03354403|Carrier|carrier
970219|NCT03354351|Stepped-care model|stepped-care model
970220|NCT03354351|Men's health|men's health
970221|NCT03354351|Prevention|prevention
970222|NCT03354351|Early treatment|early treatment
970223|NCT03354351|Psychotherapy|psychotherapy
970224|NCT03354338|Periodontal disease|periodontal disease
970225|NCT03354338|Bacteremia|bacteremia
970226|NCT03354338|Amoxicilline|amoxicilline
970227|NCT03354338|Inflamatory markers|inflamatory markers
970228|NCT03354325|Office Visits|office visits
970229|NCT03354312|scaling and root planing|scaling and root planing
970230|NCT03354312|topical anesthesia|topical anesthesia
970231|NCT03354299|malnutrition|malnutrition
970232|NCT03354299|liver cirrhosis|liver cirrhosis
970233|NCT03354299|coconut milk|coconut milk
970235|NCT03354286|Hybrid closed-loop system|hybrid closed-loop system
970236|NCT03354286|pediatric|pediatric
970237|NCT03354234|Gz accelerations|gz accelerations
970238|NCT03354234|Head up tilt (HUT) test|head up tilt (hut) test
970239|NCT03354234|Lower body negative pressure (LBNP) method|lower body negative pressure (lbnp) method
970240|NCT03354234|Physiological parameters|physiological parameters
970241|NCT03354234|Variable gravitational stimuli|variable gravitational stimuli
970242|NCT03354221|EoE|eoe
970243|NCT03354208|biomarkers|biomarkers
970244|NCT03354182|Mandibular type II furcations|mandibular type ii furcations
970245|NCT03354182|Periodontal treatment|periodontal treatment
970246|NCT03354182|Demineralized bovine bone mineral|demineralized bovine bone mineral
970247|NCT03354182|Collagen membrane|collagen membrane
970248|NCT03354169|Metabolism|metabolism
970249|NCT03354169|Eating|eating
970250|NCT03354169|Circadian Rhythms|circadian rhythms
970251|NCT03354143|Dementia|dementia
970252|NCT03354143|Alzheimer's Disease|alzheimer's disease
970253|NCT03354143|Blood Pressure|blood pressure
970254|NCT03354143|Cognitive Function|cognitive function
970255|NCT03354143|Magnetic Resonance Imaging|magnetic resonance imaging
970256|NCT03354078|Cesarean section|cesarean section
970257|NCT03354078|Wound infection|wound infection
970258|NCT03354078|Gapping|gapping
970259|NCT03354065|pancreatitis|pancreatitis
970260|NCT03354065|mild|mild
970261|NCT03354065|biliary|biliary
970262|NCT03354065|referring|referring
970263|NCT03354052|Pain|pain
970264|NCT03354052|rTMS|rtms
970265|NCT03354052|Rehabilitation|rehabilitation
970267|NCT03354026|Blood-breaking Decotion|blood-breaking decotion
970268|NCT03354013|AOA|aoa
970269|NCT03354013|embryo developmental problems|embryo developmental problems
970270|NCT03354013|genetic screening|genetic screening
970271|NCT03354013|calcium pattern analysis|calcium pattern analysis
970272|NCT03354000|Patient Portal|patient portal
970273|NCT03354000|Healthcare disparities|healthcare disparities
970274|NCT03354000|Safety net healthcare system|safety net healthcare system
970275|NCT03353987|Post-op cognitive dysfunction|post-op cognitive dysfunction
970276|NCT03353987|Cognitive training|cognitive training
970277|NCT03353987|Logbook|logbook
970278|NCT03353987|Elderly|elderly
970279|NCT03353974|Multiple Sclerosis|multiple sclerosis
970280|NCT03353974|Video game therapy|video game therapy
970281|NCT03353974|Balance|balance
970282|NCT03353974|Cognitive functions|cognitive functions
970283|NCT03353961|NSSI|nssi
970284|NCT03353948|Polycystic Ovary Syndrome|polycystic ovary syndrome
970285|NCT03353948|Obesity|obesity
970286|NCT03353948|Infertility|infertility
970287|NCT03353948|IVF|ivf
970288|NCT03353935|surgery|surgery
970289|NCT03353935|pelvic function|pelvic function
970290|NCT03353922|cognitive function|cognitive function
970291|NCT03353909|Intrauterine adhesion|intrauterine adhesion
970292|NCT03353909|Delayed miscarriage|delayed miscarriage
970293|NCT03353909|hyaluronan gel|hyaluronan gel
970294|NCT03353831|Recurrent Ovarian Cancer|recurrent ovarian cancer
970295|NCT03353831|Atezolizumab|atezolizumab
970296|NCT03353831|Bevacizumab|bevacizumab
970297|NCT03353779|Percutaneous coronary intervention|percutaneous coronary intervention
970298|NCT03353779|antiplatelet|antiplatelet
970299|NCT03353779|platelet function|platelet function
970300|NCT03353779|prognosis|prognosis
970301|NCT03353766|Early Orthodontic treatment|early orthodontic treatment
970302|NCT03353766|Orthodontic treatment outcome|orthodontic treatment outcome
970303|NCT03353766|Crossbite treatment|crossbite treatment
970304|NCT03353727|Orthoptic rehabilitation|orthoptic rehabilitation
970305|NCT03353727|low vision|low vision
970306|NCT03353727|eye tracker|eye tracker
970307|NCT03353727|tactile device|tactile device
970308|NCT03353688|Parkinson's|parkinson's
970309|NCT03353688|Parkinson Disease|parkinson disease
970310|NCT03353675|Nivolumab|nivolumab
970311|NCT03353675|Therapeutic Vaccine|therapeutic vaccine
970312|NCT03353662|bio fortification|bio fortification
970313|NCT03353623|Immersive Virtual Environments|immersive virtual environments
970314|NCT03353623|Wearable Haptic Devices|wearable haptic devices
970315|NCT03353623|Neuromotor Impairments|neuromotor impairments
970316|NCT03353623|Rehabilitation|rehabilitation
970317|NCT03353623|Serious Game|serious game
970318|NCT03353623|Randomized Controlled Trial|randomized controlled trial
970319|NCT03353610|Tachycardia|tachycardia
970320|NCT03353610|PSVT episodes|psvt episodes
970321|NCT03353584|Virtual reality|virtual reality
970322|NCT03353584|Pain|pain
970323|NCT03353584|Nonpharmacological|nonpharmacological
970324|NCT03353493|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
970325|NCT03353493|Neural, psychological and molecular mechanisms|neural, psychological and molecular mechanisms
970326|NCT03353480|Azithromycin tablet, Bioequivalence, Phase I, Chinese, Healthy Subjects|azithromycin tablet, bioequivalence, phase i, chinese, healthy subjects
970327|NCT03353454|Cholestasis|cholestasis
970328|NCT03353454|Maralixibat|maralixibat
970329|NCT03353454|Mutation|mutation
970330|NCT03353441|Verbal Learning and Memory Test (VLMT)|verbal learning and memory test (vlmt)
970331|NCT03353441|Stroop Test|stroop test
970332|NCT03353441|Attention|attention
970333|NCT03353441|Working Memory|working memory
970334|NCT03353441|Learning and recognition|learning and recognition
970335|NCT03353441|CogTrack|cogtrack
970336|NCT03353428|Lung cancer|lung cancer
970337|NCT03353428|Cytotoxic lymphocyte|cytotoxic lymphocyte
970338|NCT03353428|LC-CTL|lc-ctl
970339|NCT03353428|NSCLC|nsclc
970340|NCT03353415|Post-bariatric Hypoglycemia;|post-bariatric hypoglycemia;
970341|NCT03353402|Melanoma|melanoma
970342|NCT03353402|Fecal Microbiota Transplantation|fecal microbiota transplantation
970343|NCT03353402|Immunotherapy|immunotherapy
970344|NCT03353389|Acute Kidney Injury|acute kidney injury
970345|NCT03353389|Hospital-acquired Acute Kidney Injury|hospital-acquired acute kidney injury
970346|NCT03353389|Community-acquired Acute Kidney Injury|community-acquired acute kidney injury
970347|NCT03353389|Acute Renal Failure|acute renal failure
970348|NCT03353363|cesarean delivery|cesarean delivery
970349|NCT03353363|liposomal bupivacaine|liposomal bupivacaine
970350|NCT03353363|Exparel|exparel
970351|NCT03353363|bupivacaine|bupivacaine
970352|NCT03353363|wound infiltration|wound infiltration
970353|NCT03353337|neurocognition|neurocognition
970354|NCT03353337|prognosis|prognosis
970355|NCT03353337|aerobic exercise|aerobic exercise
970356|NCT03353311|ERAS|eras
970357|NCT03353311|Fast-track|fast-track
970358|NCT03353311|colorectal surgery|colorectal surgery
970359|NCT03353311|immuno-nutrition|immuno-nutrition
970360|NCT03353298|Uric acid|uric acid
970361|NCT03353298|Left ventricular mass|left ventricular mass
970362|NCT03353298|Nephrectomy|nephrectomy
970363|NCT03353298|Allopurinol|allopurinol
970364|NCT03353298|Magnetic resonance imaging|magnetic resonance imaging
970365|NCT03353233|iPACK|ipack
970366|NCT03353233|Interspace between the Popliteal Artery and Capsule of the Knee|interspace between the popliteal artery and capsule of the knee
970367|NCT03353233|Posterior Capsule block|posterior capsule block
970368|NCT03353233|Nerve Block|nerve block
970369|NCT03353220|Overweight|overweight
970370|NCT03353220|Obesity|obesity
970371|NCT03353220|Weight Loss|weight loss
970372|NCT03353220|Lorcaserin|lorcaserin
970373|NCT03353220|Healthy Volunteers|healthy volunteers
970374|NCT03353207|REM Sleep Without Atonia|rem sleep without atonia
970375|NCT03353207|Dopamine transmission|dopamine transmission
970376|NCT03353207|Neurodegeneration|neurodegeneration
970377|NCT03353194|Cerebral Palsy|cerebral palsy
970378|NCT03353194|Canada|canada
970379|NCT03353194|Registry|registry
970380|NCT03353181|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
970381|NCT03353181|endoscopic drainage|endoscopic drainage
970382|NCT03353181|endoscopic nasobiliary drainage|endoscopic nasobiliary drainage
970383|NCT03353181|stent|stent
970384|NCT03353168|fear|fear
970385|NCT03353168|anxiety|anxiety
970386|NCT03353168|childbirth|childbirth
970387|NCT03353168|pregnancy|pregnancy
970388|NCT03353129|Quality Improvement|quality improvement
970389|NCT03353129|Patient Safety|patient safety
970390|NCT03353129|Outcome Improvements|outcome improvements
970391|NCT03353077|Skin SCC|skin scc
970392|NCT03353077|Skin Carcinoma, Squamous|skin carcinoma, squamous
970393|NCT03353038|assistive technology|assistive technology
970394|NCT03353038|3 Dimensional Printing|3 dimensional printing
970395|NCT03353038|Self-Management|self-management
970396|NCT03353025|non-invasive prolactinoma|non-invasive prolactinoma
970397|NCT03353012|Immediate postpartum implant|immediate postpartum implant
970398|NCT03353012|postpartum implant|postpartum implant
970399|NCT03353012|implant contraception|implant contraception
970400|NCT03353012|Etonogestrel|etonogestrel
970401|NCT03353012|Levonorgestrel|levonorgestrel
970402|NCT03352999|Refractory out-hospital cardiac arrest|refractory out-hospital cardiac arrest
970403|NCT03352999|Extracorporeal Life Support|extracorporeal life support
970404|NCT03352986|Sickle cell disease|sickle cell disease
970405|NCT03352986|anemia|anemia
970406|NCT03352986|Africa|africa
970409|NCT03352934|neuroendocrine tumor|neuroendocrine tumor
970410|NCT03352934|NET G3|net g3
970411|NCT03352934|neuroendocrine carcinoma|neuroendocrine carcinoma
970412|NCT03352934|NEC G3|nec g3
970413|NCT03352921|clinical pilates|clinical pilates
970414|NCT03352921|exercise|exercise
970415|NCT03352921|Sagital Cervical Disorientation|sagital cervical disorientation
970416|NCT03352921|Disorientation|disorientation
970417|NCT03352921|Forward Head Posture|forward head posture
970418|NCT03352908|Dysphagia|dysphagia
970419|NCT03352908|Aspiration|aspiration
970420|NCT03352908|YSP|ysp
970421|NCT03352908|FEES|fees
970422|NCT03352908|Swallow Problems|swallow problems
970423|NCT03352895|Resveratrol|resveratrol
970424|NCT03352895|chronic kidney disease|chronic kidney disease
970425|NCT03352869|Polycystic Ovary Syndrome|polycystic ovary syndrome
970426|NCT03352869|Overweight and Obesity|overweight and obesity
970427|NCT03352869|Impaired Glucose Regulation|impaired glucose regulation
970428|NCT03352869|Exenatide|exenatide
970429|NCT03352869|Metformin|metformin
970430|NCT03352856|Cereal allergy; barley starch, DBPC|cereal allergy; barley starch, dbpc
970431|NCT03352830|household air pollution|household air pollution
970432|NCT03352830|health promotion|health promotion
970433|NCT03352830|clean cookstove adoption|clean cookstove adoption
970434|NCT03352830|clean cookstove sustained use|clean cookstove sustained use
970435|NCT03352765|Rituximab|rituximab
970436|NCT03352765|Bendamustine|bendamustine
970437|NCT03352765|Melphalan|melphalan
970438|NCT03352765|Autologous Stem Cell Transplantation (ASCT)|autologous stem cell transplantation (asct)
970439|NCT03352765|17-373|17-373
970440|NCT03352752|virtual reality|virtual reality
970441|NCT03352752|fractional laser|fractional laser
970442|NCT03352752|scars|scars
970443|NCT03352752|acute pain|acute pain
970444|NCT03352752|anxiety score|anxiety score
970445|NCT03352726|EPIT|epit
970446|NCT03352726|Epicutaneous|epicutaneous
970447|NCT03352726|Immunotherapy|immunotherapy
970448|NCT03352726|Viaskin|viaskin
970449|NCT03352713|self-regulation|self-regulation
970450|NCT03352713|binge eating|binge eating
970451|NCT03352713|smoking|smoking
970452|NCT03352713|ecological momentary assessment|ecological momentary assessment
970453|NCT03352713|mobile sensing|mobile sensing
970454|NCT03352713|mHealth|mhealth
970455|NCT03352687|Shoulder surgery|shoulder surgery
970456|NCT03352687|Local regional anesthesia|local regional anesthesia
970457|NCT03352674|insulin glargine|insulin glargine
970458|NCT03352674|diabetes mellitus|diabetes mellitus
970459|NCT03352674|immunogenicity|immunogenicity
970460|NCT03352635|Ethnic Differences|ethnic differences
970461|NCT03352622|PHARMACOGENOMICS|pharmacogenomics
970462|NCT03352622|POLYMORPHISM|polymorphism
970463|NCT03352609|TMS|tms
970464|NCT03352609|rTMS|rtms
970465|NCT03352609|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
970466|NCT03352609|Smoking|smoking
970467|NCT03352609|Nicotine|nicotine
970468|NCT03352570|anastomotic leakage|anastomotic leakage
970469|NCT03352570|fistula|fistula
970470|NCT03352557|Mild cognitive impairment|mild cognitive impairment
970471|NCT03352557|Alzheimer's disease|alzheimer's disease
970472|NCT03352531|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
970473|NCT03352531|immunotherapy|immunotherapy
970474|NCT03352531|immuno-oncology|immuno-oncology
970475|NCT03352531|advanced solid tumors|advanced solid tumors
970476|NCT03352466|Anthrax|anthrax
970477|NCT03352440|Cerebral Palsy|cerebral palsy
970478|NCT03352440|Virtual Reality Exposure Therapy|virtual reality exposure therapy
970479|NCT03352440|Learning|learning
970480|NCT03352440|Motor Activity|motor activity
970481|NCT03352440|Motor Skills|motor skills
970482|NCT03352414|HIPEC|hipec
970483|NCT03352414|peritoneal carcinomatosis|peritoneal carcinomatosis
970484|NCT03352401|Pulmonary aspiration, full stomach, gastric content inhalation, Mendelson syndrom|pulmonary aspiration, full stomach, gastric content inhalation, mendelson syndrom
970485|NCT03352388|Older people|older people
970486|NCT03352388|Nutrition|nutrition
970487|NCT03352388|Snack|snack
970488|NCT03352388|Dairy|dairy
970489|NCT03352388|Protein|protein
970490|NCT03352388|Berries|berries
970491|NCT03352349|Terlipressinum|terlipressinum
970492|NCT03352349|Portal Vein Pressure|portal vein pressure
970493|NCT03352349|Liver Tumor Resection|liver tumor resection
970494|NCT03352336|Atelectasis|atelectasis
970495|NCT03352336|Oxygenation|oxygenation
970496|NCT03352336|Venous admixture|venous admixture
970497|NCT03352336|Computed Tomography|computed tomography
970498|NCT03352336|Oxygenation test|oxygenation test
970499|NCT03352310|umbilical cord blood|umbilical cord blood
970500|NCT03352297|Post burn scar face|post burn scar face
970501|NCT03352297|Unfiltered nanofat|unfiltered nanofat
970502|NCT03352297|Adipose tissue growth factors|adipose tissue growth factors
970503|NCT03352297|Adipose stem cells|adipose stem cells
970504|NCT03352297|POSAS|posas
970505|NCT03352297|Image J|image j
970506|NCT03352297|Face|face
970507|NCT03352284|Zirconia implant|zirconia implant
970508|NCT03352284|One-piece|one-piece
970509|NCT03352284|Monoblock|monoblock
970510|NCT03352284|Single tooth|single tooth
970511|NCT03352271|Incremental hemodialysis|incremental hemodialysis
970512|NCT03352271|Precision medicine|precision medicine
970513|NCT03352271|Individualized care|individualized care
970514|NCT03352258|Alzheimer's Disease|alzheimer's disease
970515|NCT03352258|Amyloid|amyloid
970516|NCT03352258|Radiotherapy|radiotherapy
970517|NCT03352219|Human immunodeficiency virus|human immunodeficiency virus
970518|NCT03352219|Sexually transmitted disease|sexually transmitted disease
970519|NCT03352219|African Americans|african americans
970520|NCT03352219|Young adults|young adults
970521|NCT03352219|Behavioral intervention|behavioral intervention
970522|NCT03352219|Entertainment-Education|entertainment-education
970523|NCT03352219|Serial drama|serial drama
970524|NCT03352219|Sexual behavior|sexual behavior
970525|NCT03352219|HIV testing|hiv testing
970526|NCT03352219|Homophobia|homophobia
970527|NCT03352219|Social cognitive theory|social cognitive theory
970528|NCT03352206|Mass drug administration|mass drug administration
970529|NCT03352206|Effectiveness|effectiveness
970530|NCT03352154|cochlear implant|cochlear implant
970531|NCT03352154|Evoked Potential P300|evoked potential p300
970532|NCT03352102|Electric Stimulation|electric stimulation
970533|NCT03352102|Intensive Care Units|intensive care units
970534|NCT03352102|Mechanical Ventilation|mechanical ventilation
970535|NCT03352102|Ventilator Weaning|ventilator weaning
970536|NCT03352089|Magnetic resonance imaging|magnetic resonance imaging
970537|NCT03352089|Positron emission tomography|positron emission tomography
970538|NCT03352076|Danazol|danazol
970539|NCT03352024|neuro degenerative diseases|neuro degenerative diseases
970540|NCT03352024|Alzheimer's disease|alzheimer's disease
970541|NCT03352024|lumbar puncture|lumbar puncture
970542|NCT03352024|CSF|csf
970543|NCT03352024|hypno analgesia|hypno analgesia
970544|NCT03352024|no drug care|no drug care
970545|NCT03352024|pain|pain
970546|NCT03352024|anxiety|anxiety
970547|NCT03352024|counseling|counseling
970548|NCT03351998|insulin sensitivity|insulin sensitivity
970549|NCT03351998|cardiorespiratory fitness|cardiorespiratory fitness
970550|NCT03351998|skeletal muscle mitochondrial function|skeletal muscle mitochondrial function
970551|NCT03351959|ypT0|ypt0
970552|NCT03351946|Atelectasis|atelectasis
970553|NCT03351946|Oxygenation|oxygenation
970554|NCT03351946|Positive end-expiratory pressure|positive end-expiratory pressure
970555|NCT03351946|Mechanical ventilation|mechanical ventilation
970556|NCT03351946|General anesthesia|general anesthesia
970557|NCT03351946|Computed tomography|computed tomography
970558|NCT03351868|Fanconi anemia|fanconi anemia
970559|NCT03351868|Lentiviral vector|lentiviral vector
970560|NCT03351868|FANCA|fanca
970561|NCT03351868|Gene|gene
970562|NCT03351855|Human papilloma virus|human papilloma virus
971052|NCT03348670|Oncology|oncology
970563|NCT03351855|Cytotoxic lymphocyte|cytotoxic lymphocyte
970564|NCT03351855|HPV-CTL|hpv-ctl
970565|NCT03351842|Adjuvant chemotherapy|adjuvant chemotherapy
970566|NCT03351842|Micropapillary Component|micropapillary component
970567|NCT03351842|Early stage lung cancer|early stage lung cancer
970568|NCT03351829|Beta Thalassemia|beta thalassemia
970569|NCT03351829|Lentiviral vector|lentiviral vector
970570|NCT03351829|Gene|gene
970571|NCT03351803|BRCA|brca
970572|NCT03351803|BFOR|bfor
970573|NCT03351803|Ashkenazi|ashkenazi
970574|NCT03351803|17-568|17-568
970575|NCT03351764|Non-Invasive Brain Stimulation|non-invasive brain stimulation
970576|NCT03351764|fMRI|fmri
970577|NCT03351764|TMS-Evoked Potential|tms-evoked potential
970578|NCT03351764|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
970579|NCT03351764|EEG|eeg
970580|NCT03351751|PF-06372865|pf-06372865
970581|NCT03351751|Safety|safety
970582|NCT03351751|Tolerability|tolerability
970583|NCT03351751|Pharmacokinetics|pharmacokinetics
970584|NCT03351751|Multiple dose|multiple dose
970585|NCT03351751|Healthy subjects|healthy subjects
970586|NCT03351738|coronary heart disease pharmacokinetic pharmacodynamics|coronary heart disease pharmacokinetic pharmacodynamics
970587|NCT03351725|peripheral venous catheter|peripheral venous catheter
970588|NCT03351725|catheter colonization|catheter colonization
970589|NCT03351712|Wearables|wearables
970590|NCT03351712|Activity Trackers|activity trackers
970591|NCT03351712|ACT|act
970592|NCT03351712|Health promotion|health promotion
970593|NCT03351712|Obesity|obesity
970594|NCT03351712|Chronic Health Condition|chronic health condition
970595|NCT03351712|Psychological well-being|psychological well-being
970596|NCT03351712|Quality of life|quality of life
970597|NCT03351712|Behavior modification|behavior modification
970598|NCT03351712|RCT|rct
970599|NCT03351686|tranexamic acid|tranexamic acid
970600|NCT03351647|Crohn Disease|crohn disease
970601|NCT03351647|Ustekinumab|ustekinumab
970602|NCT03351647|Vedolizumab|vedolizumab
970603|NCT03351647|anti-TNF|anti-tnf
970604|NCT03351647|CRP|crp
970605|NCT03351647|calprotectin|calprotectin
970606|NCT03351647|cohort|cohort
970607|NCT03351595|Growth pattern|growth pattern
970608|NCT03351595|Environmental and prenatal exposure|environmental and prenatal exposure
970609|NCT03351582|family therapy|family therapy
970610|NCT03351582|psychological health|psychological health
970611|NCT03351569|Unverricht-Lundborg disease|unverricht-lundborg disease
970612|NCT03351569|progressive myoclonus epilepsy|progressive myoclonus epilepsy
970613|NCT03351569|pharmacoresistant epilepsy|pharmacoresistant epilepsy
970614|NCT03351543|vaccine response|vaccine response
970615|NCT03351543|immune system activity|immune system activity
970616|NCT03351504|household air pollution|household air pollution
970617|NCT03351504|fine particulate matter|fine particulate matter
970618|NCT03351504|kerosene|kerosene
970619|NCT03351491|Health mobile applications|health mobile applications
970620|NCT03351491|Apps|apps
970621|NCT03351491|mhealth|mhealth
970622|NCT03351491|ehealth|ehealth
970623|NCT03351491|France|france
970624|NCT03351491|msanté|msanté
970625|NCT03351491|applications mobiles|applications mobiles
970626|NCT03351439|Hip Arthroscopy|hip arthroscopy
970627|NCT03351426|obesity|obesity
970628|NCT03351426|overweight|overweight
970629|NCT03351426|neuromodulation|neuromodulation
970630|NCT03351426|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
970631|NCT03351413|Fall Prevention|fall prevention
970632|NCT03351413|Older Adults|older adults
970633|NCT03351400|cardiac stem cells|cardiac stem cells
970634|NCT03351400|c-kit|c-kit
970635|NCT03351387|amputation|amputation
970636|NCT03351387|necrosis|necrosis
970637|NCT03351387|high risk lower extremity wound|high risk lower extremity wound
970638|NCT03351374|behavioral health|behavioral health
970639|NCT03351374|software|software
970640|NCT03351374|integration|integration
970641|NCT03351348|Bupivacaine|bupivacaine
970642|NCT03351348|Mastectomy|mastectomy
970643|NCT03351348|17-576|17-576
970644|NCT03351322|Alopecia|alopecia
970645|NCT03351322|Hair Loss|hair loss
970646|NCT03351322|Female Pattern Baldness|female pattern baldness
970647|NCT03351270|CNM|cnm
970648|NCT03351270|XLMTM|xlmtm
970649|NCT03351270|Myotubular myopathy|myotubular myopathy
970650|NCT03351205|Asherman syndrome|asherman syndrome
970651|NCT03351205|hysteroscopy|hysteroscopy
970652|NCT03351205|uterine stent|uterine stent
970653|NCT03351205|Estrogen|estrogen
970654|NCT03351205|Amnion|amnion
970655|NCT03351205|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
970656|NCT03351179|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
970657|NCT03351179|Acute MyocAcute Myocardial Infarction|acute myocacute myocardial infarction
970658|NCT03351179|Predictive factors|predictive factors
970659|NCT03351140|Multiple Myeloma|multiple myeloma
970660|NCT03351140|Patient‐Reported Outcome Measurement Information System (PROMIS)|patient‐reported outcome measurement information system (promis)
970661|NCT03351140|Non‐Small Cell Lung Cancer (NSCLC)|non‐small cell lung cancer (nsclc)
970662|NCT03351140|Breast cancer|breast cancer
970664|NCT03351140|Follicular Lymphoma|follicular lymphoma
970665|NCT03351140|Prostate Cancer|prostate cancer
970666|NCT03351140|Qualitative interview|qualitative interview
970667|NCT03351114|Morphea, Localized Scleroderma|morphea, localized scleroderma
970668|NCT03351062|premenopausal|premenopausal
970669|NCT03351062|early breast cancer|early breast cancer
970670|NCT03351062|estrogen receptor positive|estrogen receptor positive
970671|NCT03351049|Acute care, support surface|acute care, support surface
970672|NCT03351036|Hypothermia|hypothermia
970673|NCT03351010|Mindfulness, Cancer, Pain Management|mindfulness, cancer, pain management
970674|NCT03350997|Exercise|exercise
970675|NCT03350971|virtual reality|virtual reality
970676|NCT03350971|physical therapy|physical therapy
970677|NCT03350971|myocardial revascualrization|myocardial revascualrization
970678|NCT03350932|sensory imagination; foods|sensory imagination; foods
970679|NCT03350906|Exercise|exercise
970680|NCT03350906|muscle function|muscle function
970681|NCT03350880|Passive|passive
970682|NCT03350880|Stretching|stretching
970683|NCT03350880|Water|water
970684|NCT03350880|Proprioceptive Neuromuscular Facilitation (PNF)|proprioceptive neuromuscular facilitation (pnf)
970685|NCT03350867|Posture|posture
970686|NCT03350867|Orthosis|orthosis
970687|NCT03350867|Foot|foot
970688|NCT03350867|Biomechanical Phenomena|biomechanical phenomena
970689|NCT03350854|early stage breast cancer;|early stage breast cancer;
970690|NCT03350854|treatment decision making|treatment decision making
970691|NCT03350854|newly diagnosed breast cancer|newly diagnosed breast cancer
970693|NCT03350828|Cystic Fibrosis|cystic fibrosis
970694|NCT03350828|Sweat|sweat
970695|NCT03350828|Sweat chloride|sweat chloride
970696|NCT03350828|CFTR Modulator|cftr modulator
970697|NCT03350815|Ankylosing spondylitis, ASDAS inactive disease, secukinumab|ankylosing spondylitis, asdas inactive disease, secukinumab
970698|NCT03350789|acupuncture|acupuncture
970699|NCT03350789|sciatica|sciatica
970700|NCT03350789|MRI, functional|mri, functional
970701|NCT03350776|Neoplasm|neoplasm
970702|NCT03350776|Chronic disease|chronic disease
970703|NCT03350776|Complex cases|complex cases
970704|NCT03350776|Care coordination|care coordination
970705|NCT03350776|Oncologic nursing|oncologic nursing
970706|NCT03350776|Theoretical model|theoretical model
970707|NCT03350763|Pancreatic Cancer|pancreatic cancer
970708|NCT03350763|Biliary decompression|biliary decompression
970709|NCT03350737|No-option patients|no-option patients
970710|NCT03350711|Microbiota composition|microbiota composition
970711|NCT03350711|Microbiota Enrichment Program|microbiota enrichment program
970712|NCT03350711|Fecal microbiota transplant (FMT)|fecal microbiota transplant (fmt)
970713|NCT03350698|Human papilloma virus|human papilloma virus
970714|NCT03350672|HIV prevention|hiv prevention
970715|NCT03350672|PrEP|prep
970716|NCT03350672|Descovy|descovy
970717|NCT03350659|orthostatic hypotension|orthostatic hypotension
970718|NCT03350659|midodrine|midodrine
970719|NCT03350659|atomoxetine|atomoxetine
970720|NCT03350659|treatment|treatment
970721|NCT03350646|embryo transfer|embryo transfer
970722|NCT03350646|volume|volume
970723|NCT03350646|culture medium|culture medium
970724|NCT03350646|loading the catheter|loading the catheter
970725|NCT03350646|clinical pregnancy rate|clinical pregnancy rate
970727|NCT03350607|Epiretinal membrane, sweeper, forceps, microperimetry|epiretinal membrane, sweeper, forceps, microperimetry
970728|NCT03350594|Anorexia Nervosa|anorexia nervosa
970729|NCT03350594|Multiple Family Therapy|multiple family therapy
970730|NCT03350594|Systemic Family Therapy|systemic family therapy
970731|NCT03350594|Adolescence|adolescence
970732|NCT03350594|Randomised controled trial|randomised controled trial
970733|NCT03350581|Catheter ablation|catheter ablation
970734|NCT03350581|Fast anatomical mapping (FAM)|fast anatomical mapping (fam)
970735|NCT03350581|Computed tomography (CT)|computed tomography (ct)
970736|NCT03350581|Magnetic resonance image (MRI)|magnetic resonance image (mri)
970737|NCT03350581|Contact force|contact force
970738|NCT03350581|Atrial fibrillation|atrial fibrillation
970739|NCT03350568|Antioxidants|antioxidants
970740|NCT03350568|Oxidative Stress|oxidative stress
970741|NCT03350568|Atherosclerosis|atherosclerosis
970742|NCT03350568|Epidemiology|epidemiology
970743|NCT03350542|Drug-Eluting Stents|drug-eluting stents
970744|NCT03350529|prostate cancer|prostate cancer
970745|NCT03350529|benign prostatic hyperplasia|benign prostatic hyperplasia
970746|NCT03350529|benign prostatic obstruction|benign prostatic obstruction
970747|NCT03350529|high intensity focused ultrasound|high intensity focused ultrasound
970748|NCT03350529|real-time temperature feedback control|real-time temperature feedback control
970749|NCT03350529|magnetic resonance imaging|magnetic resonance imaging
970750|NCT03350503|phacoemulsification|phacoemulsification
970751|NCT03350503|intraocular lens|intraocular lens
970752|NCT03350503|vision|vision
970753|NCT03350503|toric|toric
970754|NCT03350490|Cancer ablation|cancer ablation
970755|NCT03350490|Life information rehabilitation therapy|life information rehabilitation therapy
970756|NCT03350477|Cancer ablation|cancer ablation
970757|NCT03350477|Life information rehabilitation therapy|life information rehabilitation therapy
970758|NCT03350451|Hyperoxaluria, Primary|hyperoxaluria, primary
970759|NCT03350451|Hyperoxaluria|hyperoxaluria
970760|NCT03350451|Kidney Diseases|kidney diseases
970761|NCT03350451|Urologic Diseases|urologic diseases
970762|NCT03350451|Metabolism, Inborn Errors|metabolism, inborn errors
970763|NCT03350451|Genetic Diseases, Inborn|genetic diseases, inborn
970764|NCT03350451|Metabolic Diseases|metabolic diseases
970765|NCT03350438|participation|participation
970766|NCT03350438|quality of life|quality of life
970767|NCT03350438|occupational therapy|occupational therapy
970768|NCT03350425|hemodialysis|hemodialysis
970769|NCT03350425|pneumococcal vaccination|pneumococcal vaccination
970770|NCT03350347|Renal anemia|renal anemia
970771|NCT03350334|Duloxetine|duloxetine
970772|NCT03350334|laparoscopic hysterectomy|laparoscopic hysterectomy
970773|NCT03350334|postoperative pain|postoperative pain
970774|NCT03350334|postoperative recovery|postoperative recovery
970775|NCT03350295|Relative bioavailability|relative bioavailability
970776|NCT03350295|In vitro dissolution|in vitro dissolution
970777|NCT03350269|Living kidney donation|living kidney donation
970778|NCT03350269|Kidney transplant|kidney transplant
970779|NCT03350269|Lost Wage Reimbursement|lost wage reimbursement
970780|NCT03350243|Neonatal Intensive Care Unit|neonatal intensive care unit
970781|NCT03350243|Mindfulness|mindfulness
970782|NCT03350243|Care coordination|care coordination
970783|NCT03350243|Anticipatory guidance|anticipatory guidance
970784|NCT03350243|Parental support|parental support
970785|NCT03350243|Neonatal follow-up|neonatal follow-up
970786|NCT03350152|Chemotherapy, Low-intensity therapy, elderly, prognosis,|chemotherapy, low-intensity therapy, elderly, prognosis,
970787|NCT03350126|MSI or MMR|msi or mmr
970788|NCT03350113|prognosis|prognosis
970789|NCT03350113|diagnosis|diagnosis
970790|NCT03350087|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
970791|NCT03350087|stroke|stroke
970792|NCT03350087|optimal treatment protocol|optimal treatment protocol
970793|NCT03350087|VR-based cycling training (VCT)|vr-based cycling training (vct)
970794|NCT03350087|randomized controlled trial|randomized controlled trial
970795|NCT03350087|motor control|motor control
970796|NCT03350087|clinical predictors|clinical predictors
970797|NCT03350074|Hepatitis B virus|hepatitis b virus
970798|NCT03350074|PreS/S variability|pres/s variability
970799|NCT03350074|Anti-HBV treatment|anti-hbv treatment
970800|NCT03350048|Tuberculosis|tuberculosis
970801|NCT03350048|Point-of-care test|point-of-care test
970806|NCT03349931|Aspergillosis,|aspergillosis,
970807|NCT03349931|qPCR|qpcr
970808|NCT03349931|allogenic haemopoietic stem-cell transplantation|allogenic haemopoietic stem-cell transplantation
970809|NCT03349931|leukemia|leukemia
970810|NCT03349905|Freeze all|freeze all
970812|NCT03349905|deferred embryo transfer|deferred embryo transfer
970813|NCT03349905|endometriosis|endometriosis
970814|NCT03349853|Palliative care; Acetaminophen; Subcutaneous route; Pain treatment|palliative care; acetaminophen; subcutaneous route; pain treatment
970815|NCT03349840|type 2 diabetes|type 2 diabetes
970816|NCT03349840|insulin|insulin
970817|NCT03349840|glargine u100|glargine u100
970818|NCT03349840|degludec|degludec
970819|NCT03349840|Ramadan|ramadan
970820|NCT03349814|appendicitis|appendicitis
970821|NCT03349814|appendectomy|appendectomy
970822|NCT03349814|yersinia|yersinia
970823|NCT03349801|iAMD|iamd
970824|NCT03349801|biomarker|biomarker
970825|NCT03349801|clinical endpoint|clinical endpoint
970826|NCT03349788|Left colic artery|left colic artery
970827|NCT03349788|Laparoscopic Surgery|laparoscopic surgery
970828|NCT03349788|Anterior resection of rectum|anterior resection of rectum
970829|NCT03349788|Rectum cancer|rectum cancer
970830|NCT03349775|Pulmonary Hypertension|pulmonary hypertension
970831|NCT03349775|BMI|bmi
970832|NCT03349775|Echocardiography|echocardiography
970833|NCT03349775|CPET|cpet
970834|NCT03349775|6-minute walk test|6-minute walk test
970835|NCT03349775|Cardio Metabolic disease|cardio metabolic disease
970836|NCT03349762|Huaier Granule|huaier granule
970837|NCT03349762|multisite|multisite
970838|NCT03349762|open-label|open-label
970839|NCT03349762|prospective|prospective
970840|NCT03349749|intensive care units|intensive care units
970841|NCT03349749|resuscitation|resuscitation
970842|NCT03349749|fluid therapy|fluid therapy
970843|NCT03349749|Vascular Access Devices|vascular access devices
970844|NCT03349749|cardiac output|cardiac output
970845|NCT03349749|monitoring, physiologic|monitoring, physiologic
970846|NCT03349736|Pelvic floor muscle|pelvic floor muscle
970847|NCT03349697|Liver Health|liver health
970848|NCT03349697|Hangover|hangover
970849|NCT03349697|Herbal supplement|herbal supplement
970850|NCT03349697|Liver function|liver function
970851|NCT03349658|total hip arthroplasty|total hip arthroplasty
970852|NCT03349658|cerebral oxygen saturation|cerebral oxygen saturation
970853|NCT03349658|general anesthesia|general anesthesia
970855|NCT03349593|Heart failure, diastolic dysfunction, venous return|heart failure, diastolic dysfunction, venous return
970856|NCT03349593|Left ventricular filling pressures|left ventricular filling pressures
970857|NCT03349580|rehabilitation|rehabilitation
970858|NCT03349580|randomized controlled trial|randomized controlled trial
970859|NCT03349580|strength training|strength training
970860|NCT03349580|early initiation|early initiation
970861|NCT03349580|intra-abdominal pressure|intra-abdominal pressure
970862|NCT03349554|Parkinson's disease|parkinson's disease
970864|NCT03349554|meditation|meditation
970865|NCT03349554|in-patients|in-patients
970866|NCT03349528|bipolar disorder|bipolar disorder
970867|NCT03349528|bipolar depression|bipolar depression
970868|NCT03349528|depressive episode|depressive episode
970869|NCT03349528|probiotic supplement|probiotic supplement
970870|NCT03349528|probiotics|probiotics
970871|NCT03349528|relapse prevention|relapse prevention
970872|NCT03349528|rehospitalization|rehospitalization
970873|NCT03349502|Allogeneic natural killer cell, MG4101|allogeneic natural killer cell, mg4101
970874|NCT03349489|Type 1 diabetes|type 1 diabetes
970875|NCT03349489|Exercise|exercise
970876|NCT03349489|Hypoglycemia|hypoglycemia
970877|NCT03349489|Insulin pump|insulin pump
970878|NCT03349476|Atrial Fibrillation|atrial fibrillation
970879|NCT03349476|AFIB|afib
970880|NCT03349476|Ablation|ablation
970881|NCT03349476|Paroxysmal|paroxysmal
970882|NCT03349476|Persistent|persistent
970883|NCT03349450|Lymphoma|lymphoma
970884|NCT03349450|DLBCL|dlbcl
970885|NCT03349450|Lymphoma, B-Cell|lymphoma, b-cell
970886|NCT03349450|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
970887|NCT03349450|Neoplasms by Histologic Type|neoplasms by histologic type
970888|NCT03349450|Neoplasms|neoplasms
970889|NCT03349450|Lymphoproliferative Disorders|lymphoproliferative disorders
970890|NCT03349450|Lymphatic Diseases|lymphatic diseases
970891|NCT03349450|Immunoproliferative Disorders|immunoproliferative disorders
970892|NCT03349450|Immune System Diseases|immune system diseases
970893|NCT03349450|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
970894|NCT03349450|Cyclophosphamide|cyclophosphamide
970895|NCT03349450|Pembrolizumab|pembrolizumab
970896|NCT03349450|Immunosuppressive Agents|immunosuppressive agents
970897|NCT03349450|Immunologic Factors|immunologic factors
970898|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs
970899|NCT03349450|Antirheumatic Agents|antirheumatic agents
970900|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
970901|NCT03349450|Alkylating Agents|alkylating agents
970902|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
970903|NCT03349450|Antineoplastic Agents|antineoplastic agents
970904|NCT03349450|Myeloablative Agonists|myeloablative agonists
970907|NCT03349450|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
970908|NCT03349450|refractory|refractory
970909|NCT03349450|relapsed|relapsed
970910|NCT03349450|checkpoint inhibitor|checkpoint inhibitor
970911|NCT03349450|vaccine|vaccine
970912|NCT03349450|DPX-Survivac|dpx-survivac
970913|NCT03349450|Survivin|survivin
970914|NCT03349450|Immunotherapy|immunotherapy
970915|NCT03349450|Transformed Lymphoma|transformed lymphoma
970916|NCT03349450|Double Hit|double hit
970917|NCT03349450|Large Cell Lymphoma|large cell lymphoma
970918|NCT03349450|Keytruda|keytruda
970919|NCT03349424|Somatostatin|somatostatin
970920|NCT03349424|Pancreatic Fistula|pancreatic fistula
970921|NCT03349424|Intermediate Risk|intermediate risk
970922|NCT03349424|Pancreaticoduodenectomy|pancreaticoduodenectomy
970923|NCT03349398|Uncut Roux-en-Y|uncut roux-en-y
970924|NCT03349398|Roux-en-Y|roux-en-y
970925|NCT03349385|Secondary revascularization|secondary revascularization
970926|NCT03349385|Repeat revascularization|repeat revascularization
970927|NCT03349385|Coronary revascularization|coronary revascularization
970928|NCT03349385|Coronary artery bypass graft|coronary artery bypass graft
970929|NCT03349333|FOT12-CN-301|fot12-cn-301
970930|NCT03349333|PTCL (peripheral T-cell lymphoma)|ptcl (peripheral t-cell lymphoma)
970931|NCT03349333|pralatrexate|pralatrexate
970932|NCT03349333|vitamin B12|vitamin b12
970933|NCT03349333|folic acid|folic acid
970934|NCT03349320|Alzheimer|alzheimer
970935|NCT03349320|APOE|apoe
970936|NCT03349320|CYP2D6|cyp2d6
970937|NCT03349320|Donepezil|donepezil
970938|NCT03349320|Genetics|genetics
970939|NCT03349307|lobectomy|lobectomy
970940|NCT03349294|Thyroid|thyroid
970941|NCT03349294|Thyroidectomy|thyroidectomy
970942|NCT03349294|Iodine|iodine
970943|NCT03349294|Biokinetic|biokinetic
970944|NCT03349294|Ablation|ablation
970945|NCT03349255|alpha-fetoprotein|alpha-fetoprotein
970946|NCT03349255|AFP|afp
970947|NCT03349255|HCC|hcc
970948|NCT03349255|CAR T cell therapy|car t cell therapy
970949|NCT03349229|care practices|care practices
970950|NCT03349229|geriatry|geriatry
970951|NCT03349229|oncology|oncology
970953|NCT03349138|rehabilitation|rehabilitation
970954|NCT03349138|functional electrical stimulation|functional electrical stimulation
970955|NCT03349138|electrode array|electrode array
970956|NCT03349138|upper limb|upper limb
970957|NCT03349138|chronic|chronic
970958|NCT03349138|motor relearning|motor relearning
970959|NCT03349125|Cervical Brace|cervical brace
970960|NCT03349125|Elderly|elderly
970961|NCT03349125|Dysphagia|dysphagia
970962|NCT03349125|VFSS|vfss
970963|NCT03349125|Videoflouroscopy|videoflouroscopy
970964|NCT03349125|Swallow Problems|swallow problems
970965|NCT03349112|Manometry|manometry
970966|NCT03349112|Lidocaine|lidocaine
970967|NCT03349112|Pharyngeal|pharyngeal
970968|NCT03349112|High Resolution Pharyngeal Manometry (HRPM)|high resolution pharyngeal manometry (hrpm)
970969|NCT03349112|Pressure|pressure
970970|NCT03349086|Botox Injection|botox injection
970971|NCT03349086|Spasmodic|spasmodic
970972|NCT03349086|Dysphonia|dysphonia
970973|NCT03349086|Voice Therapy|voice therapy
970974|NCT03349086|Speech Therapy|speech therapy
970975|NCT03349086|Voice Rest|voice rest
970976|NCT03349060|atopic dermatitis|atopic dermatitis
970977|NCT03349060|atopic eczema|atopic eczema
970978|NCT03349060|eczema|eczema
970979|NCT03349060|JAK|jak
970980|NCT03349060|janus kinase|janus kinase
970981|NCT03349047|Food Allergy|food allergy
970982|NCT03349047|Anxiety|anxiety
970983|NCT03349047|Casual Exposure|casual exposure
970984|NCT03349047|Peanut Hypersensitivity|peanut hypersensitivity
970985|NCT03349047|Tree nut Hypersensitivity|tree nut hypersensitivity
970986|NCT03349047|Adolescents|adolescents
970987|NCT03349034|Local anesthetics|local anesthetics
970988|NCT03349034|Randomized Control Trial|randomized control trial
970989|NCT03349034|Free tissue transfer|free tissue transfer
970990|NCT03349034|Head and neck|head and neck
970991|NCT03349034|Microvascular|microvascular
970992|NCT03349034|Postoperative Pain|postoperative pain
970993|NCT03349021|esophagus|esophagus
970994|NCT03349021|stenosis|stenosis
970995|NCT03349021|bougienage|bougienage
970996|NCT03349008|necro-inflammatory|necro-inflammatory
970997|NCT03349008|glycyrrhizin|glycyrrhizin
970998|NCT03349008|entecavir|entecavir
970999|NCT03349008|hepatic biological parameters|hepatic biological parameters
971000|NCT03349008|liver fibrosis|liver fibrosis
971001|NCT03348982|Physical activity|physical activity
971002|NCT03348982|Sleep|sleep
971003|NCT03348982|Children|children
971004|NCT03348982|Autism Spectrum Disorder|autism spectrum disorder
971005|NCT03348982|Melatonin|melatonin
971006|NCT03348969|Mitomycin C|mitomycin c
971007|NCT03348969|Neoadjuvant|neoadjuvant
971008|NCT03348904|Non-small cell lung cancer|non-small cell lung cancer
971009|NCT03348904|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
971010|NCT03348904|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
971011|NCT03348891|Melanoma|melanoma
971012|NCT03348891|TNF|tnf
971013|NCT03348891|Immune checkpoints|immune checkpoints
971014|NCT03348891|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
971015|NCT03348891|Cytokines|cytokines
1655264|NCT00168610|Vitamin A|vitamin a
971016|NCT03348891|Circulating leukocytes|circulating leukocytes
971017|NCT03348878|drug compliance|drug compliance
971018|NCT03348878|hypertension|hypertension
971019|NCT03348878|anti-hypertensive agents|anti-hypertensive agents
971020|NCT03348865|Cognitive Behavioural Therapy|cognitive behavioural therapy
971021|NCT03348839|telemedicine|telemedicine
971022|NCT03348839|telemonitoring|telemonitoring
971023|NCT03348839|educational therapy|educational therapy
971024|NCT03348813|Black|black
971025|NCT03348813|Adolescents|adolescents
971026|NCT03348813|Community-based research|community-based research
971027|NCT03348813|Randomized controlled trial|randomized controlled trial
971028|NCT03348813|Intervention|intervention
971029|NCT03348813|Behavioral science|behavioral science
971030|NCT03348800|Child|child
971031|NCT03348800|RCT|rct
971032|NCT03348800|Anesthesia|anesthesia
971033|NCT03348800|Tooth extraction|tooth extraction
971034|NCT03348787|Behavioral and Cognitive Therapies|behavioral and cognitive therapies
971035|NCT03348774|Disease Course|disease course
971036|NCT03348761|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
971037|NCT03348761|resting-state Functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
971038|NCT03348761|treatment response trajectories|treatment response trajectories
971039|NCT03348722|Active surveillance|active surveillance
971040|NCT03348722|Low risk prostate cancer|low risk prostate cancer
971041|NCT03348722|Prostatic neoplasm/therapy (MESH)|prostatic neoplasm/therapy (mesh)
971042|NCT03348722|Prostatic neoplasm/surgery (MESH)|prostatic neoplasm/surgery (mesh)
971043|NCT03348722|Prostatic neoplasm/radiotherapy (MESH)|prostatic neoplasm/radiotherapy (mesh)
971044|NCT03348722|Prostatectomy (MESH)|prostatectomy (mesh)
971045|NCT03348722|Quality of life (MESH)|quality of life (mesh)
971046|NCT03348722|Costs and Cost Analysis (MESH)|costs and cost analysis (mesh)
971047|NCT03348683|Induction|induction
971048|NCT03348683|Labor|labor
971049|NCT03348683|Propranolol|propranolol
971050|NCT03348670|SCLC|sclc
971051|NCT03348670|SNP|snp
971053|NCT03348670|Drug|drug
971054|NCT03348670|Etoposide|etoposide
971055|NCT03348670|Methotrexate|methotrexate
971056|NCT03348670|Lung|lung
971057|NCT03348670|Cancer|cancer
971058|NCT03348670|Topotecan|topotecan
971059|NCT03348670|Everolimus|everolimus
971060|NCT03348618|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
971061|NCT03348618|Anxiety|anxiety
971062|NCT03348618|PANS|pans
971063|NCT03348618|PANDAS|pandas
971064|NCT03348618|Children|children
971065|NCT03348605|Amputation|amputation
971066|NCT03348605|Phantom Pain|phantom pain
971067|NCT03348605|Gait analysis|gait analysis
971068|NCT03348592|Microbiome, p-inulin|microbiome, p-inulin
971069|NCT03348579|Intensive care unit|intensive care unit
971070|NCT03348579|Pneumonia|pneumonia
971071|NCT03348579|Ventilator associated|ventilator associated
971072|NCT03348579|Hospital acquired pneumonia|hospital acquired pneumonia
971073|NCT03348579|Guidelines|guidelines
971074|NCT03348553|Omega-fatty-acids|omega-fatty-acids
971075|NCT03348553|Absorption|absorption
971076|NCT03348553|Bioavailability|bioavailability
971077|NCT03348553|Fruit & Vegetable concentrate|fruit & vegetable concentrate
971078|NCT03348553|Lipid Metabolism|lipid metabolism
971079|NCT03348475|Guided self-help|guided self-help
971080|NCT03348475|Group-based intervention|group-based intervention
971081|NCT03348475|Binge Focused Therapy|binge focused therapy
971082|NCT03348475|Brain Over Binge|brain over binge
971083|NCT03348475|Non-expert guided|non-expert guided
971084|NCT03348475|Minimally intensive|minimally intensive
971085|NCT03348462|psoriasis|psoriasis
971086|NCT03348462|anthralin|anthralin
971087|NCT03348462|ethosome|ethosome
971088|NCT03348462|liposome|liposome
971089|NCT03348449|HIV|hiv
971090|NCT03348449|Dual therapy|dual therapy
971091|NCT03348449|Comorbidities|comorbidities
971092|NCT03348449|Nucleoside analogues sparing-regimens|nucleoside analogues sparing-regimens
971093|NCT03348436|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
971094|NCT03348436|Left Atrial Function|left atrial function
971095|NCT03348423|Peri-procedural pain|peri-procedural pain
971096|NCT03348423|Pain|pain
971097|NCT03348423|Anxiety|anxiety
971098|NCT03348423|Analgesia|analgesia
971099|NCT03348423|Anxiolysis|anxiolysis
971100|NCT03348371|Incretin effect|incretin effect
971101|NCT03348371|Ethanol|ethanol
971102|NCT03348345|eating disorders|eating disorders
971103|NCT03348345|prevention|prevention
971104|NCT03348345|yoga|yoga
971105|NCT03348345|mindfulness|mindfulness
971106|NCT03348345|embodiment|embodiment
971107|NCT03348345|self-regulation|self-regulation
971108|NCT03348345|functional action|functional action
971109|NCT03348345|interoceptive awareness|interoceptive awareness
971110|NCT03348332|exercise|exercise
971111|NCT03348332|intrapartum|intrapartum
971112|NCT03348332|aerobic exercise|aerobic exercise
971113|NCT03348332|resistance exercise|resistance exercise
971114|NCT03348332|wellbeing|wellbeing
971115|NCT03348293|biodegradable scaffold|biodegradable scaffold
971116|NCT03348293|immediate breast reconstruction|immediate breast reconstruction
971117|NCT03348293|3D printing|3d printing
971118|NCT03348241|Gum Arabic|gum arabic
971119|NCT03348241|Cancer patients|cancer patients
971120|NCT03348241|Chemotherapy|chemotherapy
971121|NCT03348241|Oral mucositis|oral mucositis
971122|NCT03348228|Hydroxycitrate Supplements|hydroxycitrate supplements
971123|NCT03348215|Gait rehabilitation|gait rehabilitation
971124|NCT03348163|Transgender women|transgender women
971125|NCT03348163|Bictegravir|bictegravir
971126|NCT03348150|HIPEC|hipec
971127|NCT03348150|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
971128|NCT03348150|gastrectomy|gastrectomy
971129|NCT03348150|cytoreductive surgery|cytoreductive surgery
971130|NCT03348150|oxaliplatin|oxaliplatin
971131|NCT03348150|docetaxel|docetaxel
971132|NCT03348124|Intellectual disability|intellectual disability
971133|NCT03348124|Parenthood|parenthood
971134|NCT03348124|Reproduction|reproduction
971135|NCT03348124|Intervention|intervention
971136|NCT03348124|Adolescents|adolescents
971137|NCT03348111|Mucositis|mucositis
971138|NCT03348111|Peri-Implantitis|peri-implantitis
971139|NCT03348111|Air-Flow Master Piezon®|air-flow master piezon®
971140|NCT03348098|Triple negative breast cancer|triple negative breast cancer
971141|NCT03348046|Infliximab|infliximab
971142|NCT03348046|Remsima|remsima
971143|NCT03348046|Biosimilar|biosimilar
971144|NCT03348046|Autoimmune Disease|autoimmune disease
971145|NCT03348046|Rheumatoid Arthritis|rheumatoid arthritis
971146|NCT03348046|Cohort Study|cohort study
971147|NCT03348046|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
971148|NCT03348046|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
971149|NCT03347994|Acute Myeloid Leukemia|acute myeloid leukemia
971151|NCT03347994|Refractory AML|refractory aml
971152|NCT03347994|Relapsed AML|relapsed aml
971153|NCT03347994|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
971154|NCT03347994|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
971155|NCT03347981|Intraocular Lens|intraocular lens
971156|NCT03347981|trifocal|trifocal
971157|NCT03347981|hydrophobic|hydrophobic
971158|NCT03347981|hydrophilic|hydrophilic
971159|NCT03347968|type 2 Diabetes Mellitus, MEDI0382|type 2 diabetes mellitus, medi0382
971160|NCT03347955|placebo effect|placebo effect
971161|NCT03347942|Overweight|overweight
971162|NCT03347942|Obesity|obesity
971163|NCT03347942|Satiety|satiety
971164|NCT03347942|Cardiovascular risk|cardiovascular risk
971165|NCT03347903|esophagus|esophagus
971166|NCT03347903|motility|motility
971167|NCT03347890|GLP-1|glp-1
971168|NCT03347890|fMRI|fmri
971169|NCT03347877|autologous osteo-periosteal cylinder graft|autologous osteo-periosteal cylinder graft
971170|NCT03347877|autologous osteochondral graft|autologous osteochondral graft
971171|NCT03347877|randomized controlled trial|randomized controlled trial
971172|NCT03347877|Hepple V osteochondral lesions of the talus|hepple v osteochondral lesions of the talus
971173|NCT03347851|mechanical heart valve|mechanical heart valve
971174|NCT03347851|On-X|on-x
971175|NCT03347838|PD-1|pd-1
971176|NCT03347838|Precancerous Conditions|precancerous conditions
971177|NCT03347838|Nivolumab|nivolumab
971178|NCT03347838|Lung Cancer Immunoprevention|lung cancer immunoprevention
971179|NCT03347812|Aortic Arch|aortic arch
971180|NCT03347812|Endovascular Treatment|endovascular treatment
971181|NCT03347812|Traditional Open Surgery|traditional open surgery
971182|NCT03347812|Chimney Technique|chimney technique
971183|NCT03347812|Fenestration Technique|fenestration technique
971184|NCT03347812|Branched Stent-grafts Technique|branched stent-grafts technique
971185|NCT03347799|very premature infants|very premature infants
971186|NCT03347799|screening|screening
971187|NCT03347799|retinopathy|retinopathy
971188|NCT03347773|Oral nutritional supplement|oral nutritional supplement
971189|NCT03347773|Sarcopenic obesity|sarcopenic obesity
971190|NCT03347773|Body composition|body composition
971191|NCT03347760|68-Ga-DOTATOC PET|68-ga-dotatoc pet
971192|NCT03347760|Myocarditis|myocarditis
971193|NCT03347734|eye exercises|eye exercises
971194|NCT03347734|convergence exercise|convergence exercise
971195|NCT03347734|hyperopia|hyperopia
971196|NCT03347734|oculomotor exercise|oculomotor exercise
971197|NCT03347734|school-age children|school-age children
971198|NCT03347708|Lumbar disc degeneration|lumbar disc degeneration
971199|NCT03347708|Low back pain|low back pain
971200|NCT03347708|Intervertebral disc degeneration|intervertebral disc degeneration
971201|NCT03347695|modified Cox-Maze|modified cox-maze
971202|NCT03347695|atrial fibrillation|atrial fibrillation
971203|NCT03347695|surgery|surgery
971204|NCT03347682|Amputation, prosthesis,psychometrics, questionnaires|amputation, prosthesis,psychometrics, questionnaires
971205|NCT03347669|Fibromyalgia|fibromyalgia
971206|NCT03347669|Small fiber neuropathy|small fiber neuropathy
971207|NCT03347669|Sudoscan®|sudoscan®
971208|NCT03347656|Mobilization Therapy|mobilization therapy
971209|NCT03347656|Clitical Illness|clitical illness
971210|NCT03347656|Stroke|stroke
971211|NCT03347656|Intensive Care|intensive care
1655265|NCT00168610|BCG|bcg
971212|NCT03347656|Functional Mobility|functional mobility
971213|NCT03347656|Quality of Life|quality of life
971214|NCT03347643|Internet game addiction|internet game addiction
971215|NCT03347643|Internet gaming disorder|internet gaming disorder
971216|NCT03347643|transcranial direct current stimulation|transcranial direct current stimulation
971217|NCT03347643|response inhibition|response inhibition
971218|NCT03347643|craving|craving
971219|NCT03347643|cue reactivity|cue reactivity
971220|NCT03347630|MRI|mri
971221|NCT03347630|oesophagus cancer|oesophagus cancer
971222|NCT03347630|Staging|staging
971223|NCT03347591|Fibrinogen|fibrinogen
971224|NCT03347591|Factor II|factor ii
971225|NCT03347591|Factor V|factor v
971226|NCT03347591|Factor V & VIII|factor v & viii
971227|NCT03347591|Factor VII|factor vii
971228|NCT03347591|Factor X|factor x
971229|NCT03347591|Factor XI|factor xi
971230|NCT03347591|Factor XIII|factor xiii
971231|NCT03347591|α2-antiplasmin|α2-antiplasmin
971232|NCT03347591|Plasminogen activator inhibitor 1|plasminogen activator inhibitor 1
971233|NCT03347591|Epidemiology|epidemiology
971234|NCT03347591|Genetics|genetics
971235|NCT03347591|Phenotype|phenotype
971236|NCT03347565|adolescents, healthy controls|adolescents, healthy controls
971237|NCT03347552|treatment engagement|treatment engagement
971238|NCT03347526|Vigabatrin|vigabatrin
971239|NCT03347526|Cosyntropin|cosyntropin
971240|NCT03347513|H-pylori|h-pylori
971241|NCT03347513|iron deficiency anemia|iron deficiency anemia
971242|NCT03347513|Pregnancy|pregnancy
971243|NCT03347513|iron therapy|iron therapy
971244|NCT03347487|Bilateral Habenula|bilateral habenula
971245|NCT03347487|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
971246|NCT03347474|Bilateral Ventral Capsule/ Ventral Striatum|bilateral ventral capsule/ ventral striatum
971247|NCT03347474|Methamphetamine Addiction|methamphetamine addiction
971248|NCT03347461|Tympanostomy tube placement|tympanostomy tube placement
971249|NCT03347461|Otiprio|otiprio
971250|NCT03347461|Ciprodex drops|ciprodex drops
971251|NCT03347461|Ear drops|ear drops
971252|NCT03347461|Middle ear|middle ear
971253|NCT03347448|Psychology|psychology
971254|NCT03347448|Skin|skin
971255|NCT03347435|clopidogrel|clopidogrel
971256|NCT03347435|pharmacogenetics|pharmacogenetics
971257|NCT03347435|antiplatelet therapy|antiplatelet therapy
971258|NCT03347435|acute coronary syndromes|acute coronary syndromes
971259|NCT03347409|ERAS, Fast-track surgery, gynecology|eras, fast-track surgery, gynecology
971260|NCT03347370|subcutaneous interferon beta therapy multiple sclerosis (MS)|subcutaneous interferon beta therapy multiple sclerosis (ms)
971261|NCT03347370|injection site reactions (ISR)|injection site reactions (isr)
971262|NCT03347370|flu-like symptoms (FLS)|flu-like symptoms (fls)
971263|NCT03347370|non-interventional study (NIS)|non-interventional study (nis)
971264|NCT03347370|SC Peginterferon beta-1a|sc peginterferon beta-1a
971265|NCT03347370|SC interferon beta-1a|sc interferon beta-1a
971266|NCT03347370|SC interferon beta-1b|sc interferon beta-1b
971267|NCT03347370|Plegridy®|plegridy®
971268|NCT03347370|Betaferon®|betaferon®
971269|NCT03347370|Extavia®|extavia®
971271|NCT03347344|Spinocerebellar ataxia-SCA2|spinocerebellar ataxia-sca2
971272|NCT03347344|SARA (Scale for the Assessment and Rating of Ataxia) score|sara (scale for the assessment and rating of ataxia) score
971273|NCT03347344|Riluzole (Rilutek)|riluzole (rilutek)
971274|NCT03347331|PET imaging- Serotonin-Radiotracer|pet imaging- serotonin-radiotracer
971275|NCT03347305|Energy expenditure|energy expenditure
971276|NCT03347305|Peritoneal dialysis|peritoneal dialysis
971277|NCT03347292|Liver cell carcinoma|liver cell carcinoma
971278|NCT03347292|Liver cancer|liver cancer
971279|NCT03347279|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
971280|NCT03347227|AF ablation|af ablation
971281|NCT03347227|Pulmonary vein isolation|pulmonary vein isolation
971282|NCT03347227|Atrial scar ablation|atrial scar ablation
971284|NCT03347201|Cardiopulmonary bypass, Heparin, Protamine|cardiopulmonary bypass, heparin, protamine
971285|NCT03347188|persistent posttraumatic headache (PPTH)|persistent posttraumatic headache (ppth)
971286|NCT03347175|Respiration, Artificial|respiration, artificial
971287|NCT03347175|Advanced Cardiac Life Support|advanced cardiac life support
971288|NCT03347175|Heart Massage|heart massage
971289|NCT03347175|Emergency Service, Hospital|emergency service, hospital
971290|NCT03347162|Cancer|cancer
971291|NCT03347162|Muscle mass|muscle mass
971292|NCT03347162|Muscle strength|muscle strength
971293|NCT03347162|Complications|complications
971294|NCT03347162|Patient reported outcomes|patient reported outcomes
971295|NCT03347162|PRO|pro
971296|NCT03347162|Physical function|physical function
971297|NCT03347149|Alarms|alarms
971298|NCT03347149|Alarm Fatigue|alarm fatigue
971299|NCT03347149|Alarm Nuisance|alarm nuisance
971300|NCT03347149|Alarm Reduction|alarm reduction
971301|NCT03347149|Patient Monitoring|patient monitoring
971302|NCT03347149|Intensive Care|intensive care
971303|NCT03347123|Epacadostat|epacadostat
971304|NCT03347123|nivolumab|nivolumab
971305|NCT03347123|ipilimumab|ipilimumab
971306|NCT03347123|lirilumab|lirilumab
971307|NCT03347123|solid tumor|solid tumor
971309|NCT03347123|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
971310|NCT03347123|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
971311|NCT03347123|IDO inhibitor|ido inhibitor
971312|NCT03347110|Bimekizumab|bimekizumab
971313|NCT03347110|Psoriatic Arthritis|psoriatic arthritis
971314|NCT03347110|PsA|psa
971315|NCT03347097|glioma|glioma
971316|NCT03347097|pd-1|pd-1
971317|NCT03347097|pd-L1|pd-l1
971318|NCT03347097|immunotherapy|immunotherapy
971319|NCT03347084|DBS|dbs
971320|NCT03347084|brain imaging|brain imaging
971321|NCT03347084|Memory|memory
971322|NCT03347084|fMRI|fmri
971323|NCT03347071|prevention|prevention
971324|NCT03347071|collegiate athletes|collegiate athletes
971325|NCT03347071|yoga|yoga
971326|NCT03347058|immunotherapy|immunotherapy
971327|NCT03347045|cystectomy|cystectomy
971328|NCT03347045|nutrition|nutrition
971329|NCT03347045|physiotherapy|physiotherapy
971330|NCT03347045|prehabilitation|prehabilitation
971331|NCT03347045|enhanced recovery after surgery|enhanced recovery after surgery
971332|NCT03347019|bankart repair|bankart repair
971333|NCT03347019|accelerated rehabilitation|accelerated rehabilitation
971334|NCT03347019|shoulder|shoulder
971335|NCT03346993|Bupivacaine|bupivacaine
971336|NCT03346993|Brachial Plexus Block|brachial plexus block
971337|NCT03346993|Ultrasound|ultrasound
971338|NCT03346980|Spigelman|spigelman
971339|NCT03346967|AD mesenchymal stem cells;sexual hormone deficiency|ad mesenchymal stem cells;sexual hormone deficiency
971340|NCT03346954|: Cushing's disease, [11C]-Methionine PET/MRI, Sensitivity|: cushing's disease, [11c]-methionine pet/mri, sensitivity
971341|NCT03346915|HPV vaccinaton|hpv vaccinaton
971342|NCT03346915|Cervical cancer screening|cervical cancer screening
971343|NCT03346915|Web-based mobile health education|web-based mobile health education
971344|NCT03346915|brief negotiated interview (BNI|brief negotiated interview (bni
971345|NCT03346889|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
971346|NCT03346889|head impulse testing|head impulse testing
971347|NCT03346889|quality of life|quality of life
971449|NCT03346213|Total haemoglobin mass|total haemoglobin mass
971348|NCT03346876|Pectus excavatum, heart rate variability|pectus excavatum, heart rate variability
971349|NCT03346863|Electrical Cardioversion|electrical cardioversion
971350|NCT03346824|Levosimendan|levosimendan
971351|NCT03346824|Veno-arterial ECMO|veno-arterial ecmo
971352|NCT03346824|Weaning|weaning
971353|NCT03346798|External eating|external eating
971354|NCT03346798|Technology|technology
971355|NCT03346798|Photography|photography
971356|NCT03346798|Social media|social media
971357|NCT03346785|External eating|external eating
971358|NCT03346785|Technology|technology
971359|NCT03346785|Photography|photography
971360|NCT03346785|Social media|social media
971361|NCT03346759|tampon|tampon
971362|NCT03346759|menstruation|menstruation
971363|NCT03346759|menstrual period|menstrual period
971364|NCT03346746|cognition|cognition
971365|NCT03346746|glycaemic|glycaemic
971366|NCT03346746|mood|mood
971367|NCT03346746|diet|diet
971368|NCT03346733|psyllium|psyllium
971369|NCT03346733|viscous fibre|viscous fibre
971370|NCT03346720|Data Sharing|data sharing
971371|NCT03346655|Treatment|treatment
971372|NCT03346642|Relapsed/Refractory|relapsed/refractory
971373|NCT03346642|primary mediastinal large B-cell lymphoma|primary mediastinal large b-cell lymphoma
971374|NCT03346642|PD-1 antibody|pd-1 antibody
971375|NCT03346642|Decitabine|decitabine
971376|NCT03346642|GVD chemotherapy|gvd chemotherapy
971377|NCT03346564|Head and neck cancer|head and neck cancer
971378|NCT03346564|Ritual training|ritual training
971379|NCT03346564|disfigurement|disfigurement
971380|NCT03346564|body image|body image
971381|NCT03346551|Postnatal depression|postnatal depression
971382|NCT03346551|Attachment|attachment
971383|NCT03346551|Self-defining memories|self-defining memories
971384|NCT03346525|echocardiography|echocardiography
971385|NCT03346525|penicillin prophylaxis|penicillin prophylaxis
971386|NCT03346525|intramuscular benzathine penicillin G|intramuscular benzathine penicillin g
971387|NCT03346525|benzathine penicillin G|benzathine penicillin g
971388|NCT03346525|low-resource setting|low-resource setting
971389|NCT03346499|HIV|hiv
971390|NCT03346486|Diet|diet
971391|NCT03346486|Metabolites|metabolites
971392|NCT03346486|Cognitive function|cognitive function
971393|NCT03346486|Physiology|physiology
971394|NCT03346486|LDL|ldl
971395|NCT03346486|Diet Habit|diet habit
971396|NCT03346486|Diet Modification|diet modification
971397|NCT03346434|Eczema|eczema
971398|NCT03346408|Analgesics|analgesics
971399|NCT03346395|Adjustment disorders|adjustment disorders
971400|NCT03346395|Anxiety disorders|anxiety disorders
971401|NCT03346395|Depression|depression
971402|NCT03346395|Mental disorders|mental disorders
971403|NCT03346395|Interventional study|interventional study
971404|NCT03346395|Primary health care|primary health care
971405|NCT03346395|Problem solving|problem solving
971406|NCT03346395|Randomized controlled trial|randomized controlled trial
971407|NCT03346395|Return to work|return to work
971408|NCT03346395|Sick leave|sick leave
971410|NCT03346382|Emergency medical services|emergency medical services
971411|NCT03346369|Nephrolithiasis|nephrolithiasis
971412|NCT03346369|Urolithiasis|urolithiasis
971413|NCT03346369|Secondary Hyperoxaluria|secondary hyperoxaluria
971414|NCT03346369|Hyperoxaluria|hyperoxaluria
971415|NCT03346369|Lanthanum Carbonate|lanthanum carbonate
971416|NCT03346369|Phosphate Binder|phosphate binder
971417|NCT03346330|Chronic pain|chronic pain
971418|NCT03346330|Neuropathic pain|neuropathic pain
971419|NCT03346317|Asherman syndrome|asherman syndrome
971420|NCT03346317|hysteroscopy|hysteroscopy
971421|NCT03346317|Uterine stent|uterine stent
971422|NCT03346317|Estrogen|estrogen
971423|NCT03346317|Amnion|amnion
971424|NCT03346317|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
971425|NCT03346304|Autofluorescence Broncoscopy (AFB)|autofluorescence broncoscopy (afb)
971426|NCT03346304|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
971427|NCT03346304|High Grade Lesions (HGLs)|high grade lesions (hgls)
971428|NCT03346304|lung cancer|lung cancer
971429|NCT03346304|photosensitiser|photosensitiser
971430|NCT03346304|Fotolon|fotolon
971431|NCT03346278|Cardiac Rehabilitation|cardiac rehabilitation
971432|NCT03346278|Text Messaging|text messaging
971433|NCT03346265|progressive modular rebalancing|progressive modular rebalancing
971434|NCT03346265|PMR|pmr
971435|NCT03346265|visual sensory cues|visual sensory cues
971436|NCT03346265|SC|sc
971437|NCT03346265|Parkinson Disease|parkinson disease
971438|NCT03346265|Movement Disorders|movement disorders
971439|NCT03346265|Parkinson rehabilitation|parkinson rehabilitation
971440|NCT03346265|neurocognitive method|neurocognitive method
971441|NCT03346265|motor performance|motor performance
971442|NCT03346265|improving gait|improving gait
971443|NCT03346265|physiotherapy|physiotherapy
971444|NCT03346265|3D motion analysis system|3d motion analysis system
971445|NCT03346265|improvements|improvements
971446|NCT03346226|Delirium Dexmedetomidine elderly|delirium dexmedetomidine elderly
971447|NCT03346213|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
971448|NCT03346213|Intravenous iron|intravenous iron
971450|NCT03346148|Food Allergy, Restaurant staff|food allergy, restaurant staff
971451|NCT03346109|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
971452|NCT03346109|medial group retropharyngeal node|medial group retropharyngeal node
971453|NCT03346096|TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )|team (thiotepa, etoposide, cytosar, melphalan )
971454|NCT03346096|autologous stem-cell transplantation (ASCT)|autologous stem-cell transplantation (asct)
971455|NCT03346096|malignant lymphoma|malignant lymphoma
971456|NCT03346057|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia
971457|NCT03346031|music therapy, pain, oxidative stress parameters|music therapy, pain, oxidative stress parameters
971458|NCT03345992|Macrolides|macrolides
971459|NCT03345979|Alkermes|alkermes
971460|NCT03345979|schizophrenia|schizophrenia
971461|NCT03345979|aripiprazole lauroxil|aripiprazole lauroxil
971462|NCT03345979|ARISTADA|aristada
971463|NCT03345940|Multiple Sclerosis|multiple sclerosis
971464|NCT03345927|S-adenosylhomocysteine|s-adenosylhomocysteine
971465|NCT03345927|Endothelial function|endothelial function
971466|NCT03345914|Eczema|eczema
971467|NCT03345901|pemafibrate|pemafibrate
971468|NCT03345875|human papillomavirus|human papillomavirus
971469|NCT03345875|cervical cancer|cervical cancer
971470|NCT03345875|self-collection|self-collection
971471|NCT03345862|Social isolation, Loneliness, Health Related Quality of Life|social isolation, loneliness, health related quality of life
971472|NCT03345849|Upadacitinib|upadacitinib
971473|NCT03345849|ABT-494|abt-494
971474|NCT03345849|Efficacy|efficacy
971475|NCT03345849|Safety|safety
971476|NCT03345849|Crohn's Disease|crohn's disease
971477|NCT03345836|Upadacitinib|upadacitinib
971478|NCT03345836|Crohn's Disease|crohn's disease
971479|NCT03345836|Efficacy|efficacy
971480|NCT03345836|Safety|safety
971481|NCT03345823|Upadacitinib|upadacitinib
971482|NCT03345823|ABT-494|abt-494
971483|NCT03345823|Extension Study|extension study
971484|NCT03345823|Efficacy|efficacy
971485|NCT03345823|Safety|safety
971486|NCT03345823|Crohn's Disease|crohn's disease
971487|NCT03345823|Maintenance Study|maintenance study
971488|NCT03345810|NSCLC|nsclc
971489|NCT03345810|Non small cell lung cancer|non small cell lung cancer
971490|NCT03345797|Paediatric|paediatric
971491|NCT03345758|respiratory failure, circulatory failure|respiratory failure, circulatory failure
971492|NCT03345745|Fetuin-A|fetuin-a
971493|NCT03345745|S100A12|s100a12
971494|NCT03345745|C-Reactive Protein|c-reactive protein
971495|NCT03345745|Chronic Periodontitis|chronic periodontitis
971496|NCT03345706|Hypothermia,ECPR|hypothermia,ecpr
971497|NCT03345693|Rehabilitation|rehabilitation
971498|NCT03345693|MoTrack Therapy|motrack therapy
971499|NCT03345693|Telemedicine|telemedicine
971500|NCT03345693|Computer Vision|computer vision
971501|NCT03345693|Compliance|compliance
971502|NCT03345680|Dental visits|dental visits
971503|NCT03345680|School-based program|school-based program
971504|NCT03345680|Dental screening|dental screening
971505|NCT03345680|Dental Caries|dental caries
971506|NCT03345641|premature birth|premature birth
971507|NCT03345641|mother's post-traumatic reaction|mother's post-traumatic reaction
971508|NCT03345641|mother-infant interactions|mother-infant interactions
971509|NCT03345628|sedation|sedation
971510|NCT03345628|critical care|critical care
971511|NCT03345628|infant|infant
971512|NCT03345628|neurodevelopment|neurodevelopment
971513|NCT03345615|atrial fibrillation|atrial fibrillation
971514|NCT03345615|myocardial infarction|myocardial infarction
971515|NCT03345615|intensive monitoring|intensive monitoring
971516|NCT03345615|oral anticoagulation|oral anticoagulation
971517|NCT03345615|hospitalization|hospitalization
971518|NCT03345589|Ursodeoxycholic Acid|ursodeoxycholic acid
971519|NCT03345576|Electric Stimulation|electric stimulation
971520|NCT03345576|Spinal Cord Injuries|spinal cord injuries
971521|NCT03345576|Muscle Denervation|muscle denervation
971522|NCT03345576|carbohydrate metabolism|carbohydrate metabolism
971523|NCT03345576|Lipids metabolism|lipids metabolism
971524|NCT03345576|Basal Metabolic Rate|basal metabolic rate
971525|NCT03345576|Muscle Proteins|muscle proteins
971526|NCT03345576|Mitochondria, Muscle|mitochondria, muscle
971527|NCT03345576|RNA|rna
971528|NCT03345576|Rehabilitation|rehabilitation
971529|NCT03345563|Prostate Cancer|prostate cancer
971530|NCT03345563|Fatigue|fatigue
971531|NCT03345563|Elderly|elderly
971532|NCT03345563|Supportive Care|supportive care
971533|NCT03345563|Light Exercise|light exercise
971534|NCT03345563|Quality of Life|quality of life
971535|NCT03345537|Inflammatory|inflammatory
971536|NCT03345537|Optic neuritis|optic neuritis
971537|NCT03345537|autoantibodies anti MOG|autoantibodies anti mog
971538|NCT03345524|Obstructive Sleep Apnea|obstructive sleep apnea
971539|NCT03345524|OSA|osa
971540|NCT03345524|Peer-Buddies|peer-buddies
971541|NCT03345524|CPAP|cpap
971542|NCT03345524|CPAP Adherence|cpap adherence
971543|NCT03345511|ultrasound guided caudal block|ultrasound guided caudal block
971544|NCT03345511|anal surgery|anal surgery
971545|NCT03345485|Phase 1 clinical trial|phase 1 clinical trial
971546|NCT03345485|Solid Tumor|solid tumor
971945|NCT03343028|depression|depression
971550|NCT03345485|Soft Tissue Sarcoma|soft tissue sarcoma
971551|NCT03345485|Relapsed/Refractory|relapsed/refractory
971552|NCT03345485|Triple Negative|triple negative
971553|NCT03345485|GIST|gist
971554|NCT03345485|Epithelial cancer|epithelial cancer
971555|NCT03345485|Peritoneal cancer|peritoneal cancer
971556|NCT03345485|Fallopian tube cancer|fallopian tube cancer
971557|NCT03345485|Metastatic|metastatic
971558|NCT03345485|Advanced|advanced
971559|NCT03345459|Internet-based treatment|internet-based treatment
971560|NCT03345407|Nemiralisib|nemiralisib
971561|NCT03345407|Dose-Finding|dose-finding
971562|NCT03345407|GSK2269557|gsk2269557
971563|NCT03345407|Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease|acute moderate or severe exacerbation of chronic obstructive pulmonary disease
971564|NCT03345394|crack cocaine|crack cocaine
971565|NCT03345394|contingency management|contingency management
971566|NCT03345394|ambulatory treatment|ambulatory treatment
971567|NCT03345394|Brazil|brazil
971568|NCT03345368|transcranial magnetic stimulation|transcranial magnetic stimulation
971569|NCT03345368|obesity|obesity
971570|NCT03345368|diet|diet
971571|NCT03345303|Bortezomib|bortezomib
971572|NCT03345290|Aging|aging
971573|NCT03345290|Central pressure|central pressure
971574|NCT03345290|FDG PET|fdg pet
971575|NCT03345290|Quantita|quantita
971576|NCT03345277|Termperature|termperature
971577|NCT03345277|Fever|fever
971578|NCT03345277|Vital Signs|vital signs
971579|NCT03345264|Sexual Dysfunction|sexual dysfunction
971580|NCT03345264|Fertility Disorders|fertility disorders
971581|NCT03345264|Cancer|cancer
971582|NCT03345251|ICSI - physical - Manipulation - scratching|icsi - physical - manipulation - scratching
971583|NCT03345238|Dry Needling|dry needling
971584|NCT03345238|Myofascial Pain Syndrome|myofascial pain syndrome
971585|NCT03345238|Neurophysiological effects|neurophysiological effects
971586|NCT03345238|Autonomic Nervous System|autonomic nervous system
971587|NCT03345225|Chemoembolization (TACE)|chemoembolization (tace)
971589|NCT03345225|Liver Cancer|liver cancer
971590|NCT03345199|Multiple Sclerosis, Inspiratory Muscle Training|multiple sclerosis, inspiratory muscle training
971591|NCT03345186|Outcome|outcome
971592|NCT03345186|Gout|gout
971593|NCT03345147|Vitamin A|vitamin a
971594|NCT03345147|Isotopic dilution|isotopic dilution
971595|NCT03345147|dietary assessment|dietary assessment
971600|NCT03345069|Premature|premature
971601|NCT03345069|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
971602|NCT03345069|Neurodevelopmental impairment|neurodevelopmental impairment
971603|NCT03345069|Cerebral Palsy|cerebral palsy
971604|NCT03345069|Cognitive Impairment|cognitive impairment
971605|NCT03345069|Diffusion MRI|diffusion mri
971606|NCT03345069|Functional MRI|functional mri
971607|NCT03345069|Infant|infant
971608|NCT03345069|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
971609|NCT03345043|VAL-339851|val-339851
971610|NCT03345043|H7N9 antigen mRNA|h7n9 antigen mrna
971611|NCT03345043|Influenza vaccine|influenza vaccine
971612|NCT03345030|comet assay|comet assay
971618|NCT03345004|Juvenile Diabetes|juvenile diabetes
971619|NCT03345004|Diabetes Type 1|diabetes type 1
971620|NCT03345004|Type 1 Diabetes|type 1 diabetes
971621|NCT03345004|Autoimmune Diabetes|autoimmune diabetes
971622|NCT03345004|Insulin Dependent Diabetes|insulin dependent diabetes
971623|NCT03345004|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
971624|NCT03345004|rhGAD65|rhgad65
971625|NCT03345004|GAD65|gad65
971626|NCT03345004|GAD-Alum|gad-alum
971627|NCT03345004|Diabetes Mellitus|diabetes mellitus
971628|NCT03345004|Diabetes Mellitus Type 1|diabetes mellitus type 1
971629|NCT03345004|Glucose Metabolism Disorders|glucose metabolism disorders
971630|NCT03345004|Metabolic Diseases|metabolic diseases
971631|NCT03345004|Vitamin D|vitamin d
971632|NCT03345004|Vitamins|vitamins
971633|NCT03345004|Micronutrients|micronutrients
971634|NCT03345004|Cholecalciferol|cholecalciferol
971635|NCT03345004|Ergocalciferols|ergocalciferols
971636|NCT03344991|Hypothermia|hypothermia
971637|NCT03344991|Newborn|newborn
971638|NCT03344978|Neonate|neonate
971639|NCT03344978|Premature|premature
971640|NCT03344978|Hypothermia|hypothermia
971641|NCT03344978|Cardboard|cardboard
971643|NCT03344965|Metastatic Breast Cancer|metastatic breast cancer
971644|NCT03344965|Invasive Breast Cancer|invasive breast cancer
971645|NCT03344965|Somatic Mutation Breast Cancer (BRCA1)|somatic mutation breast cancer (brca1)
971646|NCT03344965|Somatic Mutation Breast Cancer (BRCA2)|somatic mutation breast cancer (brca2)
971751|NCT03344315|Periodontal disease|periodontal disease
971647|NCT03344926|Acceptance and Commitment therapy|acceptance and commitment therapy
971648|NCT03344926|ACT|act
971649|NCT03344926|CBT|cbt
971650|NCT03344926|Smart phone|smart phone
971651|NCT03344926|Internet|internet
971652|NCT03344926|Intervention|intervention
971653|NCT03344900|mHealth|mhealth
971654|NCT03344900|Medication adherence|medication adherence
971655|NCT03344900|Barriers to adherence|barriers to adherence
971656|NCT03344887|anemia|anemia
971657|NCT03344887|donor sex|donor sex
971658|NCT03344887|prospective blinded pragmatic randomized|prospective blinded pragmatic randomized
971659|NCT03344874|heart sounds|heart sounds
971660|NCT03344874|Stethee|stethee
971661|NCT03344874|electronic stethoscope|electronic stethoscope
971662|NCT03344861|lung cancer|lung cancer
971663|NCT03344861|lung carcinoma|lung carcinoma
971664|NCT03344861|lung metastases|lung metastases
971665|NCT03344835|Prostate Cancer|prostate cancer
971666|NCT03344835|Disease Outcome|disease outcome
971667|NCT03344822|68Ga-PSMA PET|68ga-psma pet
971668|NCT03344809|lymphoma|lymphoma
971669|NCT03344809|unclassifiable|unclassifiable
971670|NCT03344809|next|next
971671|NCT03344809|generation|generation
971672|NCT03344809|sequencing|sequencing
971673|NCT03344796|Skin Cancer|skin cancer
971674|NCT03344796|Sunburn, erythema|sunburn, erythema
971675|NCT03344796|UV Exposure, Sunburn|uv exposure, sunburn
971676|NCT03344796|Wearable UV Device|wearable uv device
971677|NCT03344757|prostate cancer|prostate cancer
971678|NCT03344757|localized prostate cancer|localized prostate cancer
971679|NCT03344757|spanish|spanish
971680|NCT03344757|latino|latino
971681|NCT03344757|hispanic|hispanic
971682|NCT03344757|stress management|stress management
971683|NCT03344744|Subarachnoid Haemorrhage|subarachnoid haemorrhage
971684|NCT03344679|Pectoral nerve block|pectoral nerve block
971685|NCT03344679|Adenosine|adenosine
971686|NCT03344679|Magnesium sulphate|magnesium sulphate
971687|NCT03344640|Overuse tendinopathy, shoulder, rotator cuff, IL-17A-Ab|overuse tendinopathy, shoulder, rotator cuff, il-17a-ab
971688|NCT03344614|third-line treatment|third-line treatment
971689|NCT03344614|apatinib|apatinib
971690|NCT03344614|raltitrexed|raltitrexed
971691|NCT03344549|eHealth|ehealth
971692|NCT03344549|Nutrition Therapy|nutrition therapy
971693|NCT03344549|Telehealth|telehealth
971694|NCT03344549|Diabetic Kidney Disease|diabetic kidney disease
971695|NCT03344549|Chronic Kidney Disease|chronic kidney disease
971696|NCT03344536|Debio 1347|debio 1347
971697|NCT03344536|Fulvestrant|fulvestrant
971698|NCT03344536|17-379|17-379
971699|NCT03344510|lidocaine|lidocaine
971700|NCT03344510|vibration|vibration
971701|NCT03344510|anesthesia|anesthesia
971702|NCT03344510|injection|injection
971703|NCT03344510|pain|pain
971704|NCT03344510|discomfort|discomfort
971705|NCT03344510|dermatology|dermatology
971706|NCT03344510|dermatologic surgery|dermatologic surgery
971707|NCT03344510|local|local
971708|NCT03344510|device|device
971709|NCT03344471|preterm delivery|preterm delivery
971710|NCT03344471|PTSD|ptsd
971711|NCT03344471|prematurity|prematurity
971712|NCT03344471|birth|birth
971713|NCT03344471|personality|personality
971714|NCT03344458|Human Growth Hormone|human growth hormone
971715|NCT03344458|hGH|hgh
971716|NCT03344458|GHD|ghd
971717|NCT03344458|rhGH|rhgh
971718|NCT03344458|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
971719|NCT03344458|Long Acting Growth Hormone|long acting growth hormone
971720|NCT03344458|Somatropin|somatropin
971721|NCT03344458|Prodrug|prodrug
971722|NCT03344458|Growth Failure|growth failure
971723|NCT03344458|Growth Hormone Replacement Therapy|growth hormone replacement therapy
971724|NCT03344458|Sustained Release Growth Hormone|sustained release growth hormone
971725|NCT03344458|Growth Hormone Deficiency|growth hormone deficiency
971726|NCT03344458|TransCon GH|transcon gh
971727|NCT03344419|cocaine|cocaine
971728|NCT03344419|mindfulness based relapse prevention|mindfulness based relapse prevention
971729|NCT03344419|motivational enhancement therapy|motivational enhancement therapy
971730|NCT03344406|Asthma|asthma
971731|NCT03344406|Telephone interview|telephone interview
971732|NCT03344406|Cross-sectional|cross-sectional
971733|NCT03344406|Qualitative research|qualitative research
971734|NCT03344406|E-RS: COPD|e-rs: copd
971735|NCT03344380|Gene polymorphism|gene polymorphism
971736|NCT03344380|acute kidney injury|acute kidney injury
971737|NCT03344380|liver transplantation|liver transplantation
971738|NCT03344367|Non Hodgkin Lymphoma|non hodgkin lymphoma
971739|NCT03344367|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
971740|NCT03344367|JWCAR029|jwcar029
971741|NCT03344341|T2DM|t2dm
971742|NCT03344328|Chemotherapy|chemotherapy
971743|NCT03344328|Bortezomib|bortezomib
971744|NCT03344328|Multiple myeloma|multiple myeloma
971745|NCT03344315|Gingival recession|gingival recession
971746|NCT03344315|Collagen matrix|collagen matrix
971747|NCT03344315|Connective tissue graft|connective tissue graft
971748|NCT03344315|Coronally advanced flap|coronally advanced flap
971749|NCT03344315|Root coverage|root coverage
971750|NCT03344315|keratinized tissue|keratinized tissue
971752|NCT03344289|Linked-color-imaging|linked-color-imaging
971753|NCT03344289|Advanced Imaging Techniques|advanced imaging techniques
971754|NCT03344276|carotid stenosis|carotid stenosis
971755|NCT03344276|neurocognition|neurocognition
971756|NCT03344276|carotid stenting|carotid stenting
971757|NCT03344276|circle of willis|circle of willis
971758|NCT03344250|Adoptive Cell Therapy|adoptive cell therapy
971759|NCT03344250|Armed Activated T-cells|armed activated t-cells
971760|NCT03344250|Bispecific Antibodies|bispecific antibodies
971761|NCT03344250|Immunotherapy|immunotherapy
971762|NCT03344185|glycaemic index|glycaemic index
971763|NCT03344185|mood|mood
971764|NCT03344185|glucose|glucose
971765|NCT03344185|diet|diet
971766|NCT03344159|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
971767|NCT03344159|Brain natriuretic peptide (BNP)|brain natriuretic peptide (bnp)
971768|NCT03344159|Sympathetic Nervous System|sympathetic nervous system
971769|NCT03344159|Positron Emissions Tomography|positron emissions tomography
971770|NCT03344146|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy
971771|NCT03344133|Obesity|obesity
971772|NCT03344133|Exercise|exercise
971773|NCT03344133|CVD risk factors|cvd risk factors
971774|NCT03344133|Appetite Regulation|appetite regulation
971775|NCT03344133|Gut Microbiota|gut microbiota
971776|NCT03344120|Symptoms and Signs|symptoms and signs
971777|NCT03344120|Pain|pain
971778|NCT03344120|Ureteral Calculi|ureteral calculi
971779|NCT03344120|Ureteroscopy|ureteroscopy
971780|NCT03344120|Ureteral Stents|ureteral stents
971781|NCT03344107|Symptoms and Signs|symptoms and signs
971782|NCT03344107|Pain|pain
971783|NCT03344107|Renal Calculi|renal calculi
971784|NCT03344107|Ureteral Stent|ureteral stent
971785|NCT03344107|Ureteroscopy|ureteroscopy
971786|NCT03344081|attention|attention
971787|NCT03344081|interoception|interoception
971788|NCT03344081|meditation|meditation
971789|NCT03344081|mind wandering|mind wandering
971790|NCT03344068|nasopharyngeal carcinoma|nasopharyngeal carcinoma
971791|NCT03344068|nutritional support|nutritional support
971792|NCT03344068|early and whole course|early and whole course
971793|NCT03344068|efficacy and safety|efficacy and safety
971794|NCT03344055|Adenoma Detection Rate|adenoma detection rate
971795|NCT03344055|Endocuff|endocuff
971796|NCT03344055|Colonoscopy|colonoscopy
971797|NCT03344029|Influenza|influenza
971798|NCT03344029|Flu|flu
971799|NCT03343964|aEEG, cEEG|aeeg, ceeg
971800|NCT03343951|Physical Therapists|physical therapists
971801|NCT03343951|Diagnosis|diagnosis
971802|NCT03343951|Clinical Competence|clinical competence
971803|NCT03343951|Interprofessional Relations|interprofessional relations
971804|NCT03343951|Cost Analysis|cost analysis
1656277|NCT00163956|IVC filters|ivc filters
971805|NCT03343938|Group embryo culture|group embryo culture
971806|NCT03343938|Low oxygen tension|low oxygen tension
971807|NCT03343938|Closed station|closed station
971808|NCT03343938|Embryo handling|embryo handling
971809|NCT03343925|Reinfection|reinfection
971810|NCT03343912|Estriol|estriol
971811|NCT03343912|Trimegestone|trimegestone
971812|NCT03343912|Vaginal Ring|vaginal ring
971813|NCT03343886|Health Status|health status
971814|NCT03343886|Well-being|well-being
971815|NCT03343886|Mental Health|mental health
971816|NCT03343886|Risk Factors|risk factors
971817|NCT03343886|Aging|aging
971818|NCT03343873|anesthetics; fMRI; EEG; functional connectivity|anesthetics; fmri; eeg; functional connectivity
971914|NCT03343197|IDH1|idh1
971819|NCT03343834|Allogenic cell stem transplant (HSCT)|allogenic cell stem transplant (hsct)
971820|NCT03343834|EBV-induced lymphoproliferation|ebv-induced lymphoproliferation
971821|NCT03343834|Epigenetic|epigenetic
971822|NCT03343808|Cooled radiofrequency|cooled radiofrequency
971823|NCT03343808|chronic knee pain|chronic knee pain
971824|NCT03343808|knee arthroplasty|knee arthroplasty
971825|NCT03343808|genicular nerve|genicular nerve
971826|NCT03343782|Diabetes|diabetes
971827|NCT03343782|BM mesenchymal stem cell|bm mesenchymal stem cell
971828|NCT03343717|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
971829|NCT03343717|Mechanical ventilation|mechanical ventilation
971830|NCT03343717|Physical therapy|physical therapy
971831|NCT03343665|Nivolumab|nivolumab
971832|NCT03343652|Hodgkin's Lymphoma|hodgkin's lymphoma
971833|NCT03343652|Nivolumab|nivolumab
971834|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride
971835|NCT03343626|Drug therapy|drug therapy
971836|NCT03343613|IDO-1 Inhibitor|ido-1 inhibitor
971837|NCT03343613|IDO1 Inhibitor|ido1 inhibitor
971838|NCT03343613|IDO Inhibitor|ido inhibitor
971839|NCT03343574|Parkinson's Disease|parkinson's disease
971840|NCT03343574|Neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
971841|NCT03343574|Orthostatic intolerance|orthostatic intolerance
971842|NCT03343574|Exercise|exercise
971843|NCT03343574|Abdominal binder|abdominal binder
971844|NCT03343574|Autonomic dysfunction|autonomic dysfunction
971845|NCT03343574|Dizziness|dizziness
971846|NCT03343574|Physical Therapy|physical therapy
971847|NCT03343574|Blood pressure|blood pressure
971848|NCT03343574|Heart rate|heart rate
971849|NCT03343574|Autonomic function testing|autonomic function testing
971850|NCT03343574|Neurology|neurology
971851|NCT03343574|Falls risk|falls risk
971852|NCT03343574|Autonomic Nervous System|autonomic nervous system
971853|NCT03343574|Autonomic reflex screening|autonomic reflex screening
971854|NCT03343574|Cerebral blood flow|cerebral blood flow
971855|NCT03343574|Cerebral perfusion|cerebral perfusion
971856|NCT03343574|Activities of Daily Living|activities of daily living
971857|NCT03343535|portable ex-vivo lung perfusion|portable ex-vivo lung perfusion
971858|NCT03343535|breathing lung transplant|breathing lung transplant
971859|NCT03343535|portable OCS Lung System|portable ocs lung system
971860|NCT03343522|Vascular function|vascular function
971861|NCT03343522|Physical training|physical training
971862|NCT03343522|Laser Speckle Contrast Imaging|laser speckle contrast imaging
971863|NCT03343509|Hemorrhoidectomy|hemorrhoidectomy
971864|NCT03343509|Metronidazole|metronidazole
971865|NCT03343509|Postoperative analgesia|postoperative analgesia
971866|NCT03343496|awake fiberoptic intubation|awake fiberoptic intubation
971867|NCT03343483|Volunteerism|volunteerism
971868|NCT03343483|Aged|aged
971869|NCT03343483|Loneliness|loneliness
971870|NCT03343483|Quality of Life|quality of life
971871|NCT03343470|Cushing Syndrome|cushing syndrome
971872|NCT03343470|Adrenal Insufficiency|adrenal insufficiency
971873|NCT03343470|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
971874|NCT03343470|Melatonin|melatonin
971875|NCT03343470|Cortisol|cortisol
971876|NCT03343470|Immunological profile|immunological profile
971877|NCT03343470|Cushing Disease|cushing disease
971878|NCT03343457|Anxiety|anxiety
971879|NCT03343457|Chronic Pain|chronic pain
971880|NCT03343431|Hepatitis B|hepatitis b
971881|NCT03343431|Hepatitis B eAg|hepatitis b eag
971882|NCT03343431|Pregnancy|pregnancy
971883|NCT03343418|Bleeding|bleeding
971884|NCT03343418|Valve Cardiac Surgery|valve cardiac surgery
971885|NCT03343418|Desmopressin|desmopressin
971886|NCT03343405|Mind/Body|mind/body
971887|NCT03343392|Hydrogen Peroxide, Tooth Bleaching, Analgesics.|hydrogen peroxide, tooth bleaching, analgesics.
971888|NCT03343379|Abdominal muscles|abdominal muscles
971889|NCT03343379|Back muscles|back muscles
971890|NCT03343379|Core stability|core stability
971891|NCT03343379|Field test|field test
971892|NCT03343379|Muscle strength dynamometer|muscle strength dynamometer
971893|NCT03343379|Lower extremity injury|lower extremity injury
971894|NCT03343379|Risk assessment|risk assessment
971895|NCT03343379|Prospective studies|prospective studies
971896|NCT03343366|fasting plasma glucose|fasting plasma glucose
971897|NCT03343366|fasting plasma insulin|fasting plasma insulin
971898|NCT03343366|HOMA-IR insulin resistance|homa-ir insulin resistance
971899|NCT03343366|clinical attachment loss|clinical attachment loss
971900|NCT03343353|burn injury, phototherapy, wound healing|burn injury, phototherapy, wound healing
971901|NCT03343301|gastrointestinal cancer|gastrointestinal cancer
971902|NCT03343288|Silver Hydroxiapatite Coating|silver hydroxiapatite coating
971903|NCT03343288|Antimicrobial|antimicrobial
971904|NCT03343288|Medical Device|medical device
971905|NCT03343275|Stent, incrustation, pH Control|stent, incrustation, ph control
971906|NCT03343236|Head and neck cancer|head and neck cancer
971907|NCT03343236|Observational study|observational study
971908|NCT03343236|Three tertiary hospitals|three tertiary hospitals
971909|NCT03343236|Long-term follow-up|long-term follow-up
971910|NCT03343236|Survival|survival
971911|NCT03343236|Immune response|immune response
971912|NCT03343236|Metabolomics|metabolomics
971913|NCT03343197|Glioma|glioma
971917|NCT03343184|dentin bonding agents|dentin bonding agents
971918|NCT03343184|tooth sensitivity|tooth sensitivity
971919|NCT03343184|composite resin restoration|composite resin restoration
971920|NCT03343171|total hip arthroplasty|total hip arthroplasty
971921|NCT03343145|Neutropenia|neutropenia
971922|NCT03343106|Acceptance and Commitment Therapy|acceptance and commitment therapy
971923|NCT03343106|Exposure and Response Prevention|exposure and response prevention
971924|NCT03343106|Psychotherapy|psychotherapy
971925|NCT03343106|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
971926|NCT03343106|Treatment Acceptability|treatment acceptability
971927|NCT03343106|Treatment Adherence|treatment adherence
971928|NCT03343093|Erectile Dysfunction|erectile dysfunction
971929|NCT03343080|Cardiac Surgery|cardiac surgery
971930|NCT03343067|Endometriosis associated pain|endometriosis associated pain
971931|NCT03343067|Elagolix|elagolix
971932|NCT03343067|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
971933|NCT03343067|Dysmenorrhea (DYS)|dysmenorrhea (dys)
971934|NCT03343054|Phase 1|phase 1
971935|NCT03343054|talazoparib|talazoparib
971936|NCT03343054|PF-06944076|pf-06944076
971937|NCT03343054|MDV3800|mdv3800
971938|NCT03343054|BMN673|bmn673
971939|NCT03343054|PARP inhibitor|parp inhibitor
971940|NCT03343054|Japanese|japanese
971941|NCT03343054|solid tumors|solid tumors
971942|NCT03343054|C3441030|c3441030
971943|NCT03343028|veterans|veterans
971944|NCT03343028|post traumatic stress disorder|post traumatic stress disorder
971946|NCT03343015|TMD, centric relation, complete dentures|tmd, centric relation, complete dentures
971947|NCT03342989|delirium|delirium
971948|NCT03342989|speed of processing|speed of processing
971949|NCT03342989|cognitive decline|cognitive decline
971950|NCT03342976|Frailty|frailty
971951|NCT03342976|Physical impairment|physical impairment
971952|NCT03342976|Cognitive decline|cognitive decline
971953|NCT03342976|ICT|ict
971954|NCT03342937|pembrolizumab|pembrolizumab
971955|NCT03342937|XELOX|xelox
971956|NCT03342937|gastric cancer|gastric cancer
971957|NCT03342924|cognitive control|cognitive control
971958|NCT03342924|physical fitness|physical fitness
971959|NCT03342924|minority|minority
971960|NCT03342898|Drug Therapy|drug therapy
971961|NCT03342885|Low Back Pain|low back pain
971962|NCT03342885|Sleep ergonomics|sleep ergonomics
971963|NCT03342872|Adolescents|adolescents
971964|NCT03342872|Substance Use Disorders|substance use disorders
971965|NCT03342859|uterine fibroids|uterine fibroids
971966|NCT03342859|bleeding reduction|bleeding reduction
971967|NCT03342859|vilaprisan|vilaprisan
971968|NCT03342859|mode of action|mode of action
971969|NCT03342859|hysterectomy|hysterectomy
971970|NCT03342859|pharmacodynamic|pharmacodynamic
971971|NCT03342807|Hypertriglyceridemia-induced acute pancreatitis|hypertriglyceridemia-induced acute pancreatitis
971972|NCT03342807|insulin|insulin
971973|NCT03342807|triglyceride|triglyceride
971974|NCT03342807|treatment|treatment
971975|NCT03342781|bronchiolitis|bronchiolitis
971976|NCT03342781|diffuser mask|diffuser mask
971977|NCT03342781|high-flow nasal oxygen|high-flow nasal oxygen
971978|NCT03342781|pediatric intensive-care unit|pediatric intensive-care unit
971979|NCT03342716|Pancreatitis|pancreatitis
971980|NCT03342716|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
971981|NCT03342690|Selara|selara
971982|NCT03342690|Chronic Heart Failure|chronic heart failure
971983|NCT03342677|Cirrhosis|cirrhosis
971984|NCT03342677|HCC|hcc
971985|NCT03342677|Primovist|primovist
971986|NCT03342664|ICH|ich
971987|NCT03342651|Vitamin D|vitamin d
971988|NCT03342651|general anesthesia|general anesthesia
971989|NCT03342651|respiratory complications|respiratory complications
971990|NCT03342638|Autologous Stem Cell Transplantation|autologous stem cell transplantation
971991|NCT03342638|Stem Cells|stem cells
971992|NCT03342638|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
971993|NCT03342625|High intensity focused ultrasound|high intensity focused ultrasound
971994|NCT03342599|Alpha Lipoic Acid|alpha lipoic acid
971995|NCT03342586|resting state functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
971996|NCT03342586|rsfMRI|rsfmri
971997|NCT03342586|17-403|17-403
971998|NCT03342560|Liver Fibrosis|liver fibrosis
971999|NCT03342560|Ultrasound Elastography|ultrasound elastography
972000|NCT03342560|Liver Steatosis|liver steatosis
972001|NCT03342560|Shear wave speed|shear wave speed
972002|NCT03342560|Stiffness|stiffness
972003|NCT03342560|Liver Biopsy|liver biopsy
972004|NCT03342547|Norovirus|norovirus
972005|NCT03342521|myocardial infarction|myocardial infarction
972006|NCT03342521|optical coherence tomography|optical coherence tomography
972007|NCT03342521|intracoronary thrombus|intracoronary thrombus
972008|NCT03342521|VerifyNow|verifynow
972009|NCT03342508|Maternal outcomes|maternal outcomes
972010|NCT03342508|Neonatal Outcomes|neonatal outcomes
972011|NCT03342495|transition, young adults, transfer|transition, young adults, transfer
972012|NCT03342482|MSG|msg
972013|NCT03342482|Gulf War Syndrome|gulf war syndrome
972014|NCT03342482|Diet|diet
972015|NCT03342482|Glutamate|glutamate
972016|NCT03342469|ADHD|adhd
972017|NCT03342469|Food Additives|food additives
972018|NCT03342469|Artificial Food Coloring|artificial food coloring
972019|NCT03342469|Diet|diet
972020|NCT03342456|Helicobacter pylori eradication|helicobacter pylori eradication
972021|NCT03342456|Duodenal Ulcer|duodenal ulcer
972022|NCT03342456|Ilaprazole/Doxycycline-based Bismuth-containing quadruple therapy|ilaprazole/doxycycline-based bismuth-containing quadruple therapy
972023|NCT03342443|memantine|memantine
972024|NCT03342443|radiotherapy-related cognitive impairment|radiotherapy-related cognitive impairment
972025|NCT03342417|breast cancer|breast cancer
972026|NCT03342417|ovarian cancer|ovarian cancer
972027|NCT03342417|gastric cancer|gastric cancer
972028|NCT03342404|(β)-Thalassemia|(β)-thalassemia
972029|NCT03342404|Beta-Thalassemia|beta-thalassemia
972030|NCT03342404|Phase 2|phase 2
972031|NCT03342404|Luspatercept|luspatercept
972032|NCT03342404|ACE-536|ace-536
972033|NCT03342404|Safety|safety
972034|NCT03342404|Efficacy|efficacy
972035|NCT03342404|Placebo|placebo
972036|NCT03342404|Red Blood Cell Transfusions|red blood cell transfusions
972037|NCT03342404|Erythrocyte transfusion|erythrocyte transfusion
972038|NCT03342404|Hb increase|hb increase
972039|NCT03342404|NTDT|ntdt
972040|NCT03342378|HPV|hpv
972041|NCT03342378|HPV-positive|hpv-positive
972042|NCT03342378|Oropharynx Cancer|oropharynx cancer
972043|NCT03342352|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
972141|NCT03341507|retromolar|retromolar
972535|NCT03339037|PPCS|ppcs
972044|NCT03342352|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
972045|NCT03342352|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
972046|NCT03342339|influence of emotions|influence of emotions
972047|NCT03342339|positif emotional induction|positif emotional induction
972048|NCT03342339|decision making|decision making
972049|NCT03342339|Iowa Gambling Task|iowa gambling task
972050|NCT03342326|Lexical priming|lexical priming
972051|NCT03342326|Healthy Aging|healthy aging
972052|NCT03342300|soft tissue sarcoma|soft tissue sarcoma
972053|NCT03342300|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
972054|NCT03342300|pirarubicin|pirarubicin
972055|NCT03342300|toxicity for heart|toxicity for heart
972056|NCT03342300|cumulative dose|cumulative dose
972057|NCT03342287|gut microbiome|gut microbiome
972059|NCT03342287|depression|depression
972060|NCT03342287|cognition|cognition
972061|NCT03342235|Excimer Laser Surgery|excimer laser surgery
972062|NCT03342235|Photorefractive Keratectomy|photorefractive keratectomy
972063|NCT03342235|Anisometropic Amblyopia|anisometropic amblyopia
972064|NCT03342235|Visual Acuity|visual acuity
972065|NCT03342235|Refractive Surgical Procedures|refractive surgical procedures
972066|NCT03342235|PRK|prk
972067|NCT03342222|PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction|peek interference screw; fixation; anterior cruciate ligament reconstruction
972068|NCT03342209|carbon monoxide toxicity|carbon monoxide toxicity
972069|NCT03342209|high flow nasal cannula|high flow nasal cannula
972070|NCT03342209|emergency department|emergency department
972071|NCT03342196|Thiotepa|thiotepa
972072|NCT03342196|Fludarabine|fludarabine
972073|NCT03342196|Melphalan|melphalan
972074|NCT03342183|Dialysis|dialysis
972075|NCT03342183|Hemodialysis|hemodialysis
972076|NCT03342183|Remote Ischemic Preconditioning|remote ischemic preconditioning
972077|NCT03342144|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
972078|NCT03342144|Cancer|cancer
972079|NCT03342144|Leukemia|leukemia
972080|NCT03342144|venetoclax|venetoclax
972081|NCT03342131|Wnt signaling|wnt signaling
972082|NCT03342105|Rhinitis, Allergic|rhinitis, allergic
972083|NCT03342105|Moxibustion|moxibustion
972084|NCT03342053|Huntington's Disease|huntington's disease
972085|NCT03342053|HTTRx|httrx
972086|NCT03342040|TAP block|tap block
972087|NCT03342040|laparoscopic IPOM|laparoscopic ipom
972088|NCT03342040|post operative pain|post operative pain
972089|NCT03341962|Ulcerative Colitis|ulcerative colitis
972090|NCT03341962|IMU-838|imu-838
972091|NCT03341962|vidofludimus calcium|vidofludimus calcium
972092|NCT03341936|Squamous Cell Carcinoma|squamous cell carcinoma
972093|NCT03341923|contact lenses|contact lenses
972094|NCT03341923|lens centration|lens centration
972095|NCT03341923|multifocal|multifocal
972096|NCT03341897|embolization|embolization
972097|NCT03341897|coiling|coiling
972098|NCT03341897|varicocele|varicocele
972099|NCT03341871|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
972100|NCT03341871|Genotype|genotype
972101|NCT03341871|glecaprevir|glecaprevir
972102|NCT03341871|pibrentasvir|pibrentasvir
972103|NCT03341871|sustained virologic response|sustained virologic response
972104|NCT03341871|chronic hepatitis C virus genotype 1|chronic hepatitis c virus genotype 1
972105|NCT03341871|chronic hepatitis C virus genotype 2|chronic hepatitis c virus genotype 2
972106|NCT03341871|chronic hepatitis C virus genotype 3|chronic hepatitis c virus genotype 3
972107|NCT03341871|chronic hepatitis C virus genotype 4|chronic hepatitis c virus genotype 4
972108|NCT03341871|chronic hepatitis C virus genotype 5|chronic hepatitis c virus genotype 5
972109|NCT03341871|chronic hepatitis C virus genotype 6|chronic hepatitis c virus genotype 6
972110|NCT03341806|GBM|gbm
972112|NCT03341806|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
972113|NCT03341806|Bavencio|bavencio
972114|NCT03341806|immunotherapy|immunotherapy
972115|NCT03341767|HIV|hiv
972116|NCT03341767|Cryptosporidium|cryptosporidium
972117|NCT03341767|Clofazimine|clofazimine
972118|NCT03341754|Malaria Infection|malaria infection
972119|NCT03341741|chronic pulmonary infection|chronic pulmonary infection
972120|NCT03341702|jail|jail
972121|NCT03341702|violence|violence
972122|NCT03341702|predictive factors|predictive factors
972123|NCT03341702|prevention|prevention
972124|NCT03341689|Psilocybin|psilocybin
972125|NCT03341663|Stable Angina Pectoris|stable angina pectoris
972126|NCT03341663|Acupoint sensitization|acupoint sensitization
972127|NCT03341663|Correlation analysis|correlation analysis
972128|NCT03341663|Diagnostic value|diagnostic value
972129|NCT03341650|Mediterranean Diet|mediterranean diet
972130|NCT03341650|BMI|bmi
972131|NCT03341650|weight loss|weight loss
972132|NCT03341650|pasta|pasta
972133|NCT03341650|obesity|obesity
972134|NCT03341637|Drug Therapy|drug therapy
972135|NCT03341624|persistent fetal vasculature|persistent fetal vasculature
972136|NCT03341624|congenital cataract|congenital cataract
972137|NCT03341533|Analgesia|analgesia
972138|NCT03341533|Laparoscopy|laparoscopy
972139|NCT03341533|Pain|pain
972140|NCT03341507|laryngoscopy|laryngoscopy
972142|NCT03341481|galactagogues, lactogenesis, preterm labor|galactagogues, lactogenesis, preterm labor
972143|NCT03341468|Urethral catheter discomfort|urethral catheter discomfort
972144|NCT03341468|Urethral catheter pain|urethral catheter pain
972145|NCT03341468|Urethral catheter immobilization device|urethral catheter immobilization device
972146|NCT03341468|Prolonged urethral catheterization|prolonged urethral catheterization
972147|NCT03341468|Foley catheter|foley catheter
972148|NCT03341468|Urinary catheter|urinary catheter
972149|NCT03341468|Indwelling urethral catheter support|indwelling urethral catheter support
972150|NCT03341455|Sri Lanka|sri lanka
972151|NCT03341455|preschool|preschool
972152|NCT03341455|randomized control trial|randomized control trial
972153|NCT03341429|obesity|obesity
972154|NCT03341429|GLP-1|glp-1
972155|NCT03341429|liraglutide|liraglutide
972156|NCT03341429|diabetes|diabetes
972157|NCT03341429|bariatric surgery|bariatric surgery
972158|NCT03341416|cerebellar ataxia|cerebellar ataxia
972159|NCT03341416|stroke|stroke
972160|NCT03341416|Spinocerebellar ataxia|spinocerebellar ataxia
972161|NCT03341416|deep brain stimulation|deep brain stimulation
972162|NCT03341416|dentate nucleus|dentate nucleus
972163|NCT03341403|severe asthma|severe asthma
972164|NCT03341403|synbiotic|synbiotic
972165|NCT03341403|immunomodulation|immunomodulation
972166|NCT03341403|sputum|sputum
972167|NCT03341390|Healthy participants|healthy participants
972168|NCT03341390|Healthy subjects|healthy subjects
972169|NCT03341390|Strokes|strokes
972170|NCT03341351|Fourth-degree laceration|fourth-degree laceration
972171|NCT03341351|Beef tongue model|beef tongue model
972172|NCT03341325|animal-assisted therapy|animal-assisted therapy
972173|NCT03341273|Antibiotic Therapy|antibiotic therapy
972174|NCT03341273|Lower Respiratory Tract Infection|lower respiratory tract infection
972175|NCT03341273|Procalcitonin|procalcitonin
972176|NCT03341260|Pulpitis, irreversible Pulpitis,|pulpitis, irreversible pulpitis,
972177|NCT03341260|Diclofenac Potassium|diclofenac potassium
972178|NCT03341260|Premedication, Preoperative Analgesic|premedication, preoperative analgesic
972179|NCT03341260|Postoperative pain|postoperative pain
972180|NCT03341247|Obesity|obesity
972181|NCT03341247|Portion Size Effect|portion size effect
972182|NCT03341247|fMRI|fmri
972183|NCT03341247|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
972184|NCT03341247|Inhibition|inhibition
972185|NCT03341247|Decision Making|decision making
972186|NCT03341247|Satiety Responsiveness|satiety responsiveness
972187|NCT03341247|Anthropometrics|anthropometrics
972188|NCT03341247|DXA|dxa
972189|NCT03341247|Reward Processing|reward processing
972190|NCT03341234|Superficial Serratus Plane Block|superficial serratus plane block
972191|NCT03341234|Modified Radical Mastectomy|modified radical mastectomy
972192|NCT03341234|Axillary Lymph Node Disection|axillary lymph node disection
972193|NCT03341234|bupivacaine|bupivacaine
972194|NCT03341195|SMS|sms
972195|NCT03341195|Automated calls|automated calls
972196|NCT03341195|Routine immunization|routine immunization
972197|NCT03341195|mHealth|mhealth
972198|NCT03341182|epidural steroid injection|epidural steroid injection
972199|NCT03341182|radiation exposure|radiation exposure
972200|NCT03341182|mirror|mirror
972201|NCT03341156|Heart transplantation|heart transplantation
972202|NCT03341143|Unresectable|unresectable
972203|NCT03341143|Stage III|stage iii
972204|NCT03341143|Stage IV|stage iv
972205|NCT03341130|OSA|osa
972206|NCT03341130|Mandibular Advancement Splint|mandibular advancement splint
972207|NCT03341130|Oral Appliance|oral appliance
972208|NCT03341130|Treatment|treatment
972209|NCT03341130|Repositioning Splint|repositioning splint
972210|NCT03341117|acetylsalicylic acid|acetylsalicylic acid
972211|NCT03341117|antioxidant enzyme system|antioxidant enzyme system
972212|NCT03341117|stress oxidative|stress oxidative
972213|NCT03341117|type 2 diabetes mellitus.|type 2 diabetes mellitus.
972214|NCT03341091|Tai-chi|tai-chi
972215|NCT03341091|Dementia|dementia
972216|NCT03341091|Dyad approach|dyad approach
972217|NCT03341091|Fall prevention|fall prevention
972218|NCT03341091|Mobility|mobility
972219|NCT03341078|Ibudilast|ibudilast
972220|NCT03341078|Methamphetamine|methamphetamine
972221|NCT03341078|Neuroinflammation|neuroinflammation
972222|NCT03341013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
972223|NCT03341013|GLP-1 receptor agonists|glp-1 receptor agonists
972224|NCT03340987|vestibular incision subperiosteal tunnel access|vestibular incision subperiosteal tunnel access
972225|NCT03340987|coronally advanced flap|coronally advanced flap
972226|NCT03340987|subepithelial connective tissue graft|subepithelial connective tissue graft
972227|NCT03340987|multiple gingival recessions|multiple gingival recessions
972228|NCT03340974|Super Oxide Dismutase|super oxide dismutase
972229|NCT03340948|Mindfulness Based Stress Reduction|mindfulness based stress reduction
972230|NCT03340948|Depressive symptoms|depressive symptoms
972231|NCT03340948|Coronary Artery Disease|coronary artery disease
972232|NCT03340948|Mastery|mastery
972233|NCT03340935|fasting mimicking diet|fasting mimicking diet
972234|NCT03340935|malignant neoplasm|malignant neoplasm
972235|NCT03340935|metabolism|metabolism
972236|NCT03340935|metabolic effects|metabolic effects
972534|NCT03339037|PCS|pcs
972239|NCT03340922|premature ventricular complex|premature ventricular complex
972240|NCT03340922|catheter ablation|catheter ablation
972241|NCT03340922|activation mapping|activation mapping
972242|NCT03340922|wavefront|wavefront
972243|NCT03340896|Larynx, hypopharynx|larynx, hypopharynx
972244|NCT03340857|Post-cancer retraining|post-cancer retraining
972245|NCT03340857|Physical activity|physical activity
972246|NCT03340857|Intelligent electric bicycle|intelligent electric bicycle
972247|NCT03340818|Low back pain, bone marrow concentrate, disc degeneration|low back pain, bone marrow concentrate, disc degeneration
972248|NCT03340805|Sepsis|sepsis
972249|NCT03340805|Septic shock|septic shock
972250|NCT03340805|Pediatric|pediatric
972251|NCT03340805|Fluid resuscitation|fluid resuscitation
972252|NCT03340805|Saline|saline
972253|NCT03340805|Lactated Ringer's|lactated ringer's
972254|NCT03340805|Crystalloid|crystalloid
972255|NCT03340805|Mortality|mortality
972256|NCT03340805|Pragmatic trial|pragmatic trial
972257|NCT03340805|Feasibility|feasibility
972258|NCT03340792|Exoskeleton Device|exoskeleton device
972259|NCT03340792|Rehabilitation|rehabilitation
972260|NCT03340792|Body composition|body composition
972261|NCT03340792|Quality of Life|quality of life
972262|NCT03340779|Norepinephrine|norepinephrine
972263|NCT03340779|Dobutamine|dobutamine
972264|NCT03340779|Shock|shock
972265|NCT03340766|DLBCL Relapsed post-autologous hematopoietic stem cell transplantation (HSCT)|dlbcl relapsed post-autologous hematopoietic stem cell transplantation (hsct)
972266|NCT03340766|Antibodies|antibodies
972267|NCT03340766|Bispecific in combination with PD-1/PD-L1 inhibitor|bispecific in combination with pd-1/pd-l1 inhibitor
972270|NCT03340701|progesterone|progesterone
972271|NCT03340701|pharmacology|pharmacology
972272|NCT03340701|pharmacokinetics|pharmacokinetics
972273|NCT03340662|Healthy Volunteer|healthy volunteer
972274|NCT03340662|CC-122|cc-122
972275|NCT03340662|Adult|adult
972276|NCT03340662|Phase 1|phase 1
972277|NCT03340662|CYTOCHROME P450|cytochrome p450
972278|NCT03340623|DIEP|diep
972279|NCT03340623|Venous coupler|venous coupler
972280|NCT03340584|Total Knee Replacement|total knee replacement
972281|NCT03340584|Taping|taping
972282|NCT03340584|Rehabilitation|rehabilitation
972283|NCT03340584|Edema|edema
972284|NCT03340584|Pain|pain
972285|NCT03340571|Alzheimer's Disease|alzheimer's disease
972286|NCT03340571|biomarkers|biomarkers
972287|NCT03340571|blood|blood
972288|NCT03340519|Crohn|crohn
972289|NCT03340519|MRI|mri
972290|NCT03340506|Tafinlar|tafinlar
972291|NCT03340506|Mekinist|mekinist
972292|NCT03340506|Dabrafenib|dabrafenib
972293|NCT03340506|Trametinib|trametinib
972294|NCT03340506|Adult|adult
972295|NCT03340506|Pediatric|pediatric
972296|NCT03340506|Melanoma|melanoma
972297|NCT03340506|Melanoma Stage IV|melanoma stage iv
972298|NCT03340506|Metastatic Melanoma|metastatic melanoma
972299|NCT03340506|Advanced Melanoma|advanced melanoma
972300|NCT03340506|Lung Cancer|lung cancer
972301|NCT03340506|NSLC|nslc
972302|NCT03340506|Non Small Cell Lung Cancer|non small cell lung cancer
972303|NCT03340506|BRAF V600 Mutation|braf v600 mutation
972304|NCT03340506|BRAF Gene Mutation|braf gene mutation
972305|NCT03340506|Solid tumor|solid tumor
972306|NCT03340506|Rare cancers|rare cancers
972307|NCT03340506|High Grade Glioma|high grade glioma
972308|NCT03340493|Stroke|stroke
972309|NCT03340493|Ischemia|ischemia
972310|NCT03340493|Cerebral Infarction|cerebral infarction
972311|NCT03340493|Cerebrovascular Disorders|cerebrovascular disorders
972312|NCT03340493|Brain Diseases|brain diseases
972313|NCT03340493|Central Nervous System Diseases|central nervous system diseases
972314|NCT03340493|Nervous System Diseases|nervous system diseases
972513|NCT03339102|Humira®|humira®
972315|NCT03340493|Vascular Diseases|vascular diseases
972316|NCT03340493|Cardiovascular Diseases|cardiovascular diseases
972317|NCT03340493|Pathologic Processes|pathologic processes
972318|NCT03340493|Brain Infarction|brain infarction
972319|NCT03340493|Brain Ischemia|brain ischemia
972320|NCT03340493|Tenecteplase|tenecteplase
972321|NCT03340493|Fibrinolytic agents|fibrinolytic agents
972322|NCT03340493|Fibrin Modulating agents|fibrin modulating agents
972323|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
972324|NCT03340493|Plasminogen|plasminogen
972325|NCT03340493|Tissue Plasminogen Activator|tissue plasminogen activator
972326|NCT03340454|Diabetes Management|diabetes management
972327|NCT03340454|H. pylori|h. pylori
972328|NCT03340415|Hallux Valgus|hallux valgus
972329|NCT03340415|Bunion|bunion
972330|NCT03340415|Post-operative|post-operative
972331|NCT03340415|Rehabilitation|rehabilitation
972332|NCT03340415|Weight Bearing Status|weight bearing status
972333|NCT03340402|Breast Cancer|breast cancer
972334|NCT03340350|Minocycline|minocycline
972335|NCT03340350|PTSD|ptsd
972336|NCT03340337|electrical stimulation|electrical stimulation
972337|NCT03340337|Muscle Strength|muscle strength
972338|NCT03340337|Fatigue|fatigue
972340|NCT03340324|inflammation|inflammation
972341|NCT03340324|autoimmunity|autoimmunity
972342|NCT03340324|immunotherapy|immunotherapy
972343|NCT03340324|infertility|infertility
972344|NCT03340324|pelvic pain|pelvic pain
972345|NCT03340311|M-Health, GDM, Bluetooth, SMBG|m-health, gdm, bluetooth, smbg
972346|NCT03340272|prostate cancer|prostate cancer
972347|NCT03340272|pelvic irradiation|pelvic irradiation
972348|NCT03340272|hormonal treatment|hormonal treatment
972349|NCT03340259|Congenital malformations of the gastrointestinal tract|congenital malformations of the gastrointestinal tract
972350|NCT03340259|Enterostomy|enterostomy
972351|NCT03340259|Microbiota|microbiota
972352|NCT03340259|Necrotizing enterocolitis|necrotizing enterocolitis
972353|NCT03340259|Newborn Infants|newborn infants
972354|NCT03340259|Spontaneous intestinal perforation|spontaneous intestinal perforation
972355|NCT03340246|Varicose veins, phlebectomy|varicose veins, phlebectomy
972356|NCT03340233|diastolic dysfunction|diastolic dysfunction
972357|NCT03340233|mechanism|mechanism
972358|NCT03340233|MRI magnetic resonance imaging|mri magnetic resonance imaging
972359|NCT03340233|ejection fraction|ejection fraction
972361|NCT03340207|intubation|intubation
972362|NCT03340207|anesthesiology|anesthesiology
972363|NCT03340194|Systemic sclerosis|systemic sclerosis
972364|NCT03340194|Calcinosis cutis|calcinosis cutis
972365|NCT03340181|RIPC, myocardial protective effect|ripc, myocardial protective effect
972366|NCT03340168|Bisphenol S, toxicokinetics|bisphenol s, toxicokinetics
972367|NCT03340129|Immunotherapy|immunotherapy
972368|NCT03340129|Radiotherapy|radiotherapy
972369|NCT03340129|Brain metastases|brain metastases
972370|NCT03340103|Lutein/Zeaxanthin|lutein/zeaxanthin
972371|NCT03340103|Antioxidant|antioxidant
972372|NCT03340103|Oxidative stress|oxidative stress
972373|NCT03340103|Carotenoid|carotenoid
972374|NCT03340103|Preterm newborn|preterm newborn
972375|NCT03340064|Epilepsy|epilepsy
972376|NCT03340064|Partial Seizures|partial seizures
972377|NCT03340064|Levetiracetam|levetiracetam
972378|NCT03340064|Monotherapy|monotherapy
972379|NCT03340064|Adjunctive Treatment|adjunctive treatment
972380|NCT03340038|free flap reconstructive surgery, head and neck|free flap reconstructive surgery, head and neck
972381|NCT03340025|negative pressure wound therapy|negative pressure wound therapy
972382|NCT03340025|split thickness skin graft|split thickness skin graft
972383|NCT03339986|Portion Size|portion size
972384|NCT03339986|Feasibility|feasibility
972385|NCT03339986|Acceptability|acceptability
972386|NCT03339986|Snacking|snacking
972387|NCT03339986|Preschool children|preschool children
972388|NCT03339973|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
972389|NCT03339973|ABCB5|abcb5
972390|NCT03339973|allogeneic|allogeneic
972391|NCT03339973|mesenchymal stem cells|mesenchymal stem cells
972392|NCT03339973|advanced therapy medicinal product|advanced therapy medicinal product
972393|NCT03339973|somatic cell therapy|somatic cell therapy
972394|NCT03339973|phase I/IIa|phase i/iia
972395|NCT03339973|non-healing ulcers|non-healing ulcers
972396|NCT03339947|Multidrug-resistant Enterobacteriaceae acquisition|multidrug-resistant enterobacteriaceae acquisition
972397|NCT03339947|travellers' diarrhoea|travellers' diarrhoea
972398|NCT03339947|international travel|international travel
972399|NCT03339934|Hypofractionation|hypofractionation
972400|NCT03339934|Proton therapy|proton therapy
972401|NCT03339934|3D conformal radiation|3d conformal radiation
972402|NCT03339934|Randomized|randomized
972403|NCT03339934|Phase II|phase ii
972404|NCT03339895|COLORECTAL SURGERY|colorectal surgery
972405|NCT03339895|PVI GUIDED FLUID MANAGEMENT|pvi guided fluid management
972406|NCT03339895|GOAL DIRECTED THERAPY|goal directed therapy
972407|NCT03339882|remifemin|remifemin
972408|NCT03339882|preventive effect|preventive effect
972409|NCT03339882|LHRH-a|lhrh-a
972410|NCT03339882|breast cancer|breast cancer
972411|NCT03339843|cancer|cancer
972412|NCT03339830|SMA|sma
972413|NCT03339830|Spinal Muscular Atrophy|spinal muscular atrophy
972414|NCT03339830|Neuromuscular disease|neuromuscular disease
972415|NCT03339830|Spinraza|spinraza
972416|NCT03339804|Chemotherapy|chemotherapy
972417|NCT03339804|Muscle sympathetic nervous activity|muscle sympathetic nervous activity
972418|NCT03339804|Blood flow|blood flow
972419|NCT03339804|Endothelial microparticles|endothelial microparticles
972420|NCT03339765|Self-advocacy|self-advocacy
972421|NCT03339765|Advanced cancer|advanced cancer
972422|NCT03339765|Serious games|serious games
972423|NCT03339765|Self-management|self-management
972424|NCT03339739|Musculoskeletal Pain|musculoskeletal pain
972425|NCT03339739|Orofacial Pain|orofacial pain
972426|NCT03339739|Physical Therapy Modalities|physical therapy modalities
972427|NCT03339739|Oral Contraceptives|oral contraceptives
972428|NCT03339739|Mandibular Diseases|mandibular diseases
972429|NCT03339739|Muscular Diseases|muscular diseases
972430|NCT03339739|Risk factors|risk factors
972431|NCT03339739|Contraceptive Usage|contraceptive usage
972432|NCT03339739|Pain, Chronic|pain, chronic
972433|NCT03339739|Craniomandibular Disorders|craniomandibular disorders
972434|NCT03339661|CMV infection|cmv infection
972435|NCT03339661|kidney transplant|kidney transplant
972436|NCT03339661|γδ T cells monitoring|γδ t cells monitoring
972437|NCT03339648|School Resource Officer|school resource officer
972438|NCT03339648|Trauma Informed Care|trauma informed care
972439|NCT03339648|Cultural Competency|cultural competency
972440|NCT03339648|Restorative Problem Solving|restorative problem solving
972441|NCT03339648|Social Emotional Learning|social emotional learning
972442|NCT03339648|Professional Development|professional development
972443|NCT03339648|School Violence|school violence
972444|NCT03339622|uncontrollable cancer pain|uncontrollable cancer pain
972445|NCT03339622|incurable malignancy,|incurable malignancy,
972446|NCT03339596|electroconvulsive therapy|electroconvulsive therapy
972447|NCT03339596|depression|depression
972448|NCT03339596|cognition|cognition
972449|NCT03339596|cognitive side-effects|cognitive side-effects
972450|NCT03339596|erythropoietin|erythropoietin
972451|NCT03339596|functional magnetic resonance imaging|functional magnetic resonance imaging
972452|NCT03339583|chronic insomnia|chronic insomnia
972453|NCT03339583|brief behavioral treatment|brief behavioral treatment
972454|NCT03339583|behavioral treatment|behavioral treatment
972455|NCT03339583|insomnia severity index|insomnia severity index
972456|NCT03339583|predictors|predictors
972457|NCT03339583|treatment response|treatment response
972458|NCT03339531|2D|2d
972459|NCT03339531|prostate neoplasms|prostate neoplasms
972460|NCT03339531|radiotherapy|radiotherapy
972461|NCT03339531|simulation|simulation
972462|NCT03339492|rotator cuff|rotator cuff
972463|NCT03339492|PEMF|pemf
972464|NCT03339492|Pulsed Electromagnetic Field|pulsed electromagnetic field
972465|NCT03339492|Rotator Cuff Repair|rotator cuff repair
972466|NCT03339492|adjunctive therapy|adjunctive therapy
972467|NCT03339479|dielectric property|dielectric property
972468|NCT03339479|lung nodules|lung nodules
972469|NCT03339479|differential diagnosis|differential diagnosis
972470|NCT03339479|frozen pathological examination|frozen pathological examination
972471|NCT03339427|vitamin D|vitamin d
972472|NCT03339427|cardiovascular|cardiovascular
972473|NCT03339427|muscle power|muscle power
972474|NCT03339362|low back pain|low back pain
972475|NCT03339362|lumbar facet joint pain|lumbar facet joint pain
972476|NCT03339362|feasibility|feasibility
972477|NCT03339362|lumbar facet joint injection|lumbar facet joint injection
972478|NCT03339310|CCM Therapy|ccm therapy
972479|NCT03339310|2-Lead|2-lead
972480|NCT03339310|FIX-HF-5C2|fix-hf-5c2
972481|NCT03339310|Optimizer|optimizer
972482|NCT03339258|Posttraumatic Stress Disorder|posttraumatic stress disorder
972483|NCT03339258|Post-traumatic Stress Disorder|post-traumatic stress disorder
972484|NCT03339258|PTSD|ptsd
972485|NCT03339258|Doxazosin|doxazosin
972486|NCT03339258|Nightmares|nightmares
972487|NCT03339258|Sleep Disturbance|sleep disturbance
972489|NCT03339245|fructose|fructose
972490|NCT03339245|glucose|glucose
972491|NCT03339245|fecal microbiota|fecal microbiota
972492|NCT03339245|intestinal permiability|intestinal permiability
972493|NCT03339245|fecal metabolites|fecal metabolites
972494|NCT03339193|atrial fibrillation|atrial fibrillation
972495|NCT03339193|stroke|stroke
972496|NCT03339193|atrial appendage|atrial appendage
972497|NCT03339180|cardiac troponin|cardiac troponin
972498|NCT03339167|Lysine, Adult, Protein Quality|lysine, adult, protein quality
972499|NCT03339154|Healthy|healthy
972500|NCT03339154|Men|men
972501|NCT03339154|Adults|adults
972502|NCT03339154|Methionine|methionine
972503|NCT03339141|Intubation conditions|intubation conditions
972504|NCT03339141|Anaesthetic techniques|anaesthetic techniques
972505|NCT03339141|Laryngoscopy|laryngoscopy
972506|NCT03339128|Irritable Bowel Syndrome with Diarrhea|irritable bowel syndrome with diarrhea
972507|NCT03339128|IBSD|ibsd
972508|NCT03339128|IBS-D|ibs-d
972509|NCT03339128|Irritable Bowel Syndrome|irritable bowel syndrome
972510|NCT03339128|Pediatric|pediatric
972511|NCT03339102|Non-infectious intermediate, posterior and panuveitis|non-infectious intermediate, posterior and panuveitis
972512|NCT03339102|Post-Marketing Surveillance|post-marketing surveillance
972514|NCT03339089|rheumatoid arthritis|rheumatoid arthritis
972515|NCT03339089|plaque psoriasis|plaque psoriasis
972516|NCT03339089|ankylosing spondylitis|ankylosing spondylitis
972517|NCT03339089|Immune-Mediated Inflammatory Diseases|immune-mediated inflammatory diseases
972518|NCT03339089|Chinese Patients|chinese patients
972519|NCT03339063|Nontuberculous Mycobacteria|nontuberculous mycobacteria
972520|NCT03339063|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
972521|NCT03339063|NTM-PD|ntm-pd
972522|NCT03339063|NTM-LD|ntm-ld
972523|NCT03339063|MAC|mac
972524|NCT03339063|M. avium|m. avium
972525|NCT03339063|M. intracellulare|m. intracellulare
972526|NCT03339063|M. abscessus|m. abscessus
972527|NCT03339063|Atypical mycobacteria|atypical mycobacteria
972528|NCT03339063|NTM|ntm
972529|NCT03339050|church-based health promotion|church-based health promotion
972530|NCT03339050|African Americans|african americans
972531|NCT03339037|HBOT|hbot
972532|NCT03339037|TBI|tbi
972533|NCT03339037|pediatrics|pediatrics
972536|NCT03339037|concussion|concussion
972537|NCT03339037|traumatic brain injury|traumatic brain injury
972538|NCT03339037|hyperbaric oxygen|hyperbaric oxygen
972539|NCT03339024|Oxytocin|oxytocin
972540|NCT03339024|Administration, Intranasal|administration, intranasal
972541|NCT03339024|Ethanol|ethanol
972542|NCT03339024|Follow-up Studies|follow-up studies
972543|NCT03338998|stroke|stroke
972544|NCT03338998|intracerebral hemorrhage|intracerebral hemorrhage
972545|NCT03338998|ICH|ich
972546|NCT03338998|BAF312|baf312
972547|NCT03338998|siponimod|siponimod
972548|NCT03338998|sphingosine-1-phosphate receptor|sphingosine-1-phosphate receptor
972549|NCT03338946|Remote monitoring|remote monitoring
972550|NCT03338920|acute migraine|acute migraine
972551|NCT03338920|aura|aura
972552|NCT03338920|sumatriptan nasal powder|sumatriptan nasal powder
972553|NCT03338920|AVP-825|avp-825
972554|NCT03338920|adolescents|adolescents
972555|NCT03338907|cerebral hypoxia|cerebral hypoxia
972556|NCT03338907|CO2|co2
972557|NCT03338907|cerebral perfusion|cerebral perfusion
972558|NCT03338907|hypoxia|hypoxia
972559|NCT03338881|Drug therapy|drug therapy
972560|NCT03338868|physical activity|physical activity
972561|NCT03338868|pain|pain
972562|NCT03338868|uric acid|uric acid
972563|NCT03338855|T2DM, insulin resistance, skeletal muscle, mitochondrial function, Phase 4 trial, dapagliflozin|t2dm, insulin resistance, skeletal muscle, mitochondrial function, phase 4 trial, dapagliflozin
972564|NCT03338816|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
972565|NCT03338816|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
972566|NCT03338816|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
972567|NCT03338816|Variegate Porphyria (VP)|variegate porphyria (vp)
972568|NCT03338816|ALA dehydratase deficient porphyria (ADP) (ALAD)|ala dehydratase deficient porphyria (adp) (alad)
972569|NCT03338816|RNAi therapeutic|rnai therapeutic
972570|NCT03338816|Porphyria|porphyria
972571|NCT03338777|melanoma|melanoma
972572|NCT03338777|lipoplexes|lipoplexes
972573|NCT03338777|plasmid|plasmid
972574|NCT03338777|herpes simplex thymidine kinase|herpes simplex thymidine kinase
972575|NCT03338777|interleukin-2|interleukin-2
972576|NCT03338777|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
972577|NCT03338777|tumor vaccine|tumor vaccine
972578|NCT03338777|suicide gene|suicide gene
972579|NCT03338764|Transient insomnia|transient insomnia
972580|NCT03338764|Insomnia|insomnia
972581|NCT03338764|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
972582|NCT03338699|Early infant male circumcision|early infant male circumcision
972583|NCT03338699|ShangRing|shangring
972584|NCT03338699|sub-Saharan Africa|sub-saharan africa
972585|NCT03338699|HIV|hiv
972586|NCT03338699|WHO|who
972587|NCT03338686|Keratinized tissue|keratinized tissue
972588|NCT03338686|Keratinized mucosa|keratinized mucosa
972589|NCT03338686|Attached mucosa|attached mucosa
972590|NCT03338686|Dental implants|dental implants
972591|NCT03338686|Free gingival graft|free gingival graft
972592|NCT03338686|Connective tissue graft|connective tissue graft
972593|NCT03338686|Patient-centered outcomes|patient-centered outcomes
972594|NCT03338647|Stereotactic body radiation therapy|stereotactic body radiation therapy
972595|NCT03338647|transarterial chemoembolization|transarterial chemoembolization
972596|NCT03338647|SBRT|sbrt
972597|NCT03338647|TACE|tace
972598|NCT03338634|Portion Size Effect|portion size effect
972599|NCT03338634|Childhood Obesity|childhood obesity
972600|NCT03338634|fMRI|fmri
972601|NCT03338621|tuberculosis|tuberculosis
972602|NCT03338621|drug-resistant tuberculosis|drug-resistant tuberculosis
972603|NCT03338621|TB|tb
972604|NCT03338621|DR-TB|dr-tb
972605|NCT03338621|pretomanid|pretomanid
972606|NCT03338621|PA-824|pa-824
972607|NCT03338621|bedaquiline|bedaquiline
972608|NCT03338621|TMC207|tmc207
972609|NCT03338621|moxifloxacin|moxifloxacin
972610|NCT03338621|pyrazinamide|pyrazinamide
972611|NCT03338621|HRZE|hrze
972612|NCT03338621|TB Alliance|tb alliance
972613|NCT03338621|NC-008|nc-008
972614|NCT03338608|Cosmesis|cosmesis
972615|NCT03338608|Wound Healing|wound healing
972616|NCT03338608|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
972617|NCT03338608|ACDF|acdf
972618|NCT03338608|Platysma|platysma
972619|NCT03338595|arterial stiffness|arterial stiffness
972620|NCT03338595|flow-mediated dilation|flow-mediated dilation
972621|NCT03338595|endothelial function|endothelial function
972622|NCT03338595|Orkambi|orkambi
972623|NCT03338595|exercise capacity|exercise capacity
972624|NCT03338582|Pacemaker|pacemaker
972625|NCT03338582|Conduction disturbance|conduction disturbance
972626|NCT03338582|TAVI|tavi
972627|NCT03338556|Rhinovirus|rhinovirus
972628|NCT03338556|Healthy volunteer|healthy volunteer
972629|NCT03338556|Outpatient|outpatient
972630|NCT03338556|Cold virus|cold virus
972631|NCT03338556|HRV-16|hrv-16
972632|NCT03338543|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
972633|NCT03338543|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
972634|NCT03338543|pain|pain
972635|NCT03338543|liver cancer|liver cancer
972636|NCT03338543|hepatocellular carcinoma|hepatocellular carcinoma
972637|NCT03338530|Psychosocial treatment|psychosocial treatment
972638|NCT03338530|School intervention|school intervention
972639|NCT03338530|Autism Spectrum Disorder|autism spectrum disorder
972640|NCT03338504|type 2 myocardial infarction|type 2 myocardial infarction
972641|NCT03338465|Greater Trochanteric Pain Syndrome,|greater trochanteric pain syndrome,
972642|NCT03338465|Gluteal|gluteal
972643|NCT03338465|Tendinopathy|tendinopathy
972644|NCT03338465|ESWT|eswt
972645|NCT03338465|shockwave|shockwave
972646|NCT03338452|ketogenic diet|ketogenic diet
972647|NCT03338452|body composition|body composition
972648|NCT03338452|metabolism|metabolism
972649|NCT03338452|body dissatisfaction|body dissatisfaction
972650|NCT03338452|cognition|cognition
972651|NCT03338413|Rehabilitation|rehabilitation
972652|NCT03338400|Quality of Recovery, Dexamethasone, Same day surgery|quality of recovery, dexamethasone, same day surgery
972653|NCT03338387|neuropeptides|neuropeptides
972654|NCT03338387|microdialysis|microdialysis
972655|NCT03338374|Cardiac chronotropy|cardiac chronotropy
972656|NCT03338374|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
972657|NCT03338374|Rate responsive pacemaker|rate responsive pacemaker
972658|NCT03338374|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
972659|NCT03338361|approach avoidance training|approach avoidance training
972660|NCT03338361|attentional bias training|attentional bias training
972661|NCT03338361|alcohol depencence|alcohol depencence
972662|NCT03338361|relapse|relapse
972663|NCT03338348|Vosaroxin|vosaroxin
972664|NCT03338322|postoperative pain|postoperative pain
972665|NCT03338322|reciproc|reciproc
972666|NCT03338322|twisted file adaptive|twisted file adaptive
972667|NCT03338309|Fractional flow reserve|fractional flow reserve
972668|NCT03338309|Instantaneous wave-free ratio|instantaneous wave-free ratio
972669|NCT03338309|Ischemic heart disease|ischemic heart disease
972670|NCT03338296|body mass index|body mass index
972671|NCT03338296|weight loss|weight loss
972672|NCT03338296|adolescents|adolescents
972673|NCT03338296|lifestyle modification|lifestyle modification
972674|NCT03338270|MRI|mri
972675|NCT03338270|Neuroradiology|neuroradiology
972676|NCT03338270|minute-MRI|minute-mri
972677|NCT03338270|multi EPI-mix|multi epi-mix
972678|NCT03338270|Clinical Validation|clinical validation
972679|NCT03338257|Pre-school children|pre-school children
972680|NCT03338257|fruit and vegetable acceptance|fruit and vegetable acceptance
972681|NCT03338257|service-learning|service-learning
972682|NCT03338257|pre-school nutrition education|pre-school nutrition education
972683|NCT03338257|childhood obesity|childhood obesity
972684|NCT03338244|Childhood mortality|childhood mortality
972685|NCT03338244|Mass treatment|mass treatment
972686|NCT03338244|Azithromycin|azithromycin
972687|NCT03338244|Infection|infection
972688|NCT03338231|Immunity duration|immunity duration
972689|NCT03338218|Hydroxyethylstarch (HES)|hydroxyethylstarch (hes)
972690|NCT03338205|ketamine|ketamine
972691|NCT03338205|pediatric status asthmaticus|pediatric status asthmaticus
972692|NCT03338192|Low back pain|low back pain
972693|NCT03338192|Chronic pain|chronic pain
972694|NCT03338192|Health disparities in chronic low back pain|health disparities in chronic low back pain
972695|NCT03338179|Metamemory|metamemory
972696|NCT03338179|Schizophrenia|schizophrenia
972698|NCT03338114|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
972699|NCT03338114|Fasciculation|fasciculation
972700|NCT03338114|FLX-787|flx-787
972701|NCT03338062|Radiation Treatment|radiation treatment
972702|NCT03338036|Concussion|concussion
972703|NCT03338036|Post-Concussion Syndrome|post-concussion syndrome
972704|NCT03338036|Biofeedback|biofeedback
972705|NCT03338036|Heart Rate Variability|heart rate variability
972706|NCT03338036|Neurofeedback|neurofeedback
972707|NCT03338023|Insulin Glargine|insulin glargine
972708|NCT03338010|Insulin glargine|insulin glargine
972709|NCT03337997|Irreversible Electroporation|irreversible electroporation
972710|NCT03337997|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
972711|NCT03337984|Diverticulitis|diverticulitis
972712|NCT03337984|Damage Control Surgery|damage control surgery
972713|NCT03337971|Post-menopausal|post-menopausal
972714|NCT03337971|Osteoporosis|osteoporosis
972715|NCT03337971|Bone Turnover Markers|bone turnover markers
972716|NCT03337971|Dairy Products|dairy products
972717|NCT03337958|Education|education
972718|NCT03337958|Dry Powder Inhalers|dry powder inhalers
972719|NCT03337958|Metered Dose Inhalers|metered dose inhalers
972720|NCT03337958|Pulmonary Disease|pulmonary disease
972721|NCT03337958|Chronic Obstructive|chronic obstructive
972722|NCT03337945|CYP450 phenotyping in patients with liver cirrhosis|cyp450 phenotyping in patients with liver cirrhosis
972724|NCT03337867|Recurrent stroke|recurrent stroke
972725|NCT03337867|Stroke|stroke
972726|NCT03337867|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
972727|NCT03337867|Theta-Burst-Stimulation|theta-burst-stimulation
972728|NCT03337854|prognostic|prognostic
972729|NCT03337854|phenotype|phenotype
972730|NCT03337854|Computed tomography|computed tomography
972731|NCT03337854|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
972732|NCT03337841|Hepatocellular carcinoma|hepatocellular carcinoma
972733|NCT03337841|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
972734|NCT03337841|Adjuvant chemotherapy|adjuvant chemotherapy
972735|NCT03337841|Immune checkpoint inhibitor|immune checkpoint inhibitor
972736|NCT03337841|Pembrolizumab|pembrolizumab
972737|NCT03337828|Alcohol-free beer|alcohol-free beer
972738|NCT03337828|Carbohydrates|carbohydrates
972739|NCT03337828|Overweight|overweight
972740|NCT03337828|Obesity|obesity
972741|NCT03337828|Diabetes mellitus type 2|diabetes mellitus type 2
972742|NCT03337828|Microbiota|microbiota
972743|NCT03337828|Glucose metabolism|glucose metabolism
972744|NCT03337776|WhatsApp messenger|whatsapp messenger
972745|NCT03337776|crc screening|crc screening
972746|NCT03337776|screening update rate|screening update rate
972747|NCT03337763|LV-LV conduction delay|lv-lv conduction delay
972748|NCT03337750|Combat|combat
972749|NCT03337750|Psychological Treatment|psychological treatment
972750|NCT03337750|Military|military
972751|NCT03337750|Psychotherapy|psychotherapy
972752|NCT03337750|Trauma|trauma
972753|NCT03337750|Posttraumatic Stress|posttraumatic stress
972754|NCT03337750|Posttraumatic Stress Disorder|posttraumatic stress disorder
972755|NCT03337711|NSCLC;ctDNA;IIA-IIIA|nsclc;ctdna;iia-iiia
972756|NCT03337659|Family-integrated care|family-integrated care
972757|NCT03337659|neonatal intensive care unit|neonatal intensive care unit
972758|NCT03337659|premature|premature
972759|NCT03337659|infant development|infant development
972760|NCT03337646|vyvanse|vyvanse
972761|NCT03337646|executive function|executive function
972762|NCT03337646|safety|safety
972763|NCT03337633|cognitive load|cognitive load
972764|NCT03337633|galvanic skin response|galvanic skin response
972765|NCT03337633|meal size|meal size
972766|NCT03337633|kilocalories|kilocalories
972767|NCT03337633|menu design|menu design
972768|NCT03337620|chronic|chronic
972769|NCT03337607|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
972770|NCT03337607|ESWT|eswt
972771|NCT03337607|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
972772|NCT03337607|rESWT|reswt
972773|NCT03337607|Chronic non-specific low back pain|chronic non-specific low back pain
972774|NCT03337607|Non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
972775|NCT03337594|Gadolinium|gadolinium
972776|NCT03337594|MultiHance|multihance
972777|NCT03337594|Dotarem|dotarem
972778|NCT03337594|Contrast agents|contrast agents
972779|NCT03337594|Magnetic Resonance Imaging|magnetic resonance imaging
972780|NCT03337594|Gadolinium retention|gadolinium retention
972781|NCT03337594|Pediatric|pediatric
972782|NCT03337594|Bone|bone
972783|NCT03337581|Dexmedetomidine|dexmedetomidine
972784|NCT03337581|pediatrics|pediatrics
972785|NCT03337581|Pharmacodynamics|pharmacodynamics
972786|NCT03337581|Pharmacokinetics|pharmacokinetics
972787|NCT03337568|AML CR|aml cr
972788|NCT03337568|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
972789|NCT03337568|busulfan|busulfan
972790|NCT03337568|fludarabine|fludarabine
972791|NCT03337568|ATG|atg
972792|NCT03337542|AR101|ar101
972793|NCT03337542|Characterized Peanut Allergen|characterized peanut allergen
972794|NCT03337542|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
972795|NCT03337542|OIT (oral immunotherapy)|oit (oral immunotherapy)
972796|NCT03337542|Peanut Allergy|peanut allergy
972797|NCT03337542|Peanut-Allergic Children|peanut-allergic children
972798|NCT03337542|Desensitization|desensitization
972799|NCT03337542|Food Allergy|food allergy
972800|NCT03337464|exercise|exercise
972801|NCT03337464|EEG|eeg
972802|NCT03337464|EMG|emg
972803|NCT03337464|Motor function|motor function
972804|NCT03337464|Mood|mood
972805|NCT03337464|Cognition|cognition
972806|NCT03337425|Psychotherapy, group|psychotherapy, group
972807|NCT03337425|Adults|adults
972808|NCT03337412|Therapeutic Education|therapeutic education
972809|NCT03337412|physical activity|physical activity
972810|NCT03337412|overweight|overweight
972811|NCT03337412|obesity|obesity
972812|NCT03337399|Lung Cancer|lung cancer
972813|NCT03337373|Critical care|critical care
972814|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents
972815|NCT03337373|Pharmacodynamics|pharmacodynamics
972816|NCT03337373|Pharmacokinetics|pharmacokinetics
972817|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs
972818|NCT03337360|fertility|fertility
972819|NCT03337360|male subfertility|male subfertility
972820|NCT03337360|foodsupplement|foodsupplement
972821|NCT03337360|oxidative stress|oxidative stress
972822|NCT03337347|Prognostic significance|prognostic significance
972823|NCT03337321|pregnancy|pregnancy
972824|NCT03337321|emotions|emotions
972825|NCT03337321|patient experience|patient experience
972826|NCT03337321|maternal care|maternal care
972827|NCT03337308|hyperlipidemia|hyperlipidemia
972828|NCT03337308|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
972829|NCT03337308|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
972830|NCT03337308|high cholesterol|high cholesterol
972831|NCT03337308|ASCVD|ascvd
972833|NCT03337308|LDL|ldl
972834|NCT03337295|Meibomian Gland Dysfunction|meibomian gland dysfunction
972835|NCT03337295|Lipid Layer Thickness|lipid layer thickness
972836|NCT03337282|anesthesia|anesthesia
972837|NCT03337282|noncardiac surgery|noncardiac surgery
972838|NCT03337282|major surgery|major surgery
972840|NCT03337243|Stem Cell Injection|stem cell injection
972841|NCT03337243|Cytokine|cytokine
972842|NCT03337243|Wharton's Jelly|wharton's jelly
972843|NCT03337243|Stem Cells|stem cells
972844|NCT03337230|Cancer|cancer
972845|NCT03337230|Weight-Loss|weight-loss
972846|NCT03337230|Social Media|social media
972847|NCT03337217|colonoscopy|colonoscopy
972848|NCT03337191|ultrasound guided caudal injection|ultrasound guided caudal injection
972849|NCT03337191|sacral hiatus|sacral hiatus
972850|NCT03337191|sacral canal|sacral canal
972851|NCT03337165|Rheumatoid arthritis|rheumatoid arthritis
972852|NCT03337165|Auto-immune disorders|auto-immune disorders
972853|NCT03337165|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
972854|NCT03337139|Weight Loss|weight loss
972855|NCT03337139|Obesity|obesity
972856|NCT03337139|Overweight|overweight
972857|NCT03337139|Behavioral Weight Loss|behavioral weight loss
972858|NCT03337100|Opioids|opioids
972859|NCT03337100|Naloxone|naloxone
972860|NCT03337100|Co-dispensing|co-dispensing
972861|NCT03337100|Cluster randomized trial|cluster randomized trial
972862|NCT03337100|Opioid antagonist|opioid antagonist
972863|NCT03337035|Probiotics, Oxytocin|probiotics, oxytocin
972864|NCT03337022|Psoriasis|psoriasis
972865|NCT03337022|CC-90006|cc-90006
972866|NCT03337022|Mild to moderate plaque-type psoriasis|mild to moderate plaque-type psoriasis
972867|NCT03337022|Safety|safety
972868|NCT03337022|Pharmacokinetics|pharmacokinetics
972869|NCT03337022|Pharmacodynamics|pharmacodynamics
972870|NCT03337009|Opioid antagonist|opioid antagonist
972871|NCT03337009|Naloxone|naloxone
972872|NCT03337009|Opioids|opioids
972873|NCT03337009|Web-based intervention|web-based intervention
972874|NCT03336996|Motor nerve injury|motor nerve injury
972875|NCT03336996|umbilical cord interstitial stem cell|umbilical cord interstitial stem cell
972876|NCT03336996|bold-DTI|bold-dti
972877|NCT03336996|reconstruction of motor circuits|reconstruction of motor circuits
972878|NCT03336983|prostate cancer|prostate cancer
972879|NCT03336983|bone metastasis|bone metastasis
972880|NCT03336983|enzalutamide|enzalutamide
972881|NCT03336983|zoledronic acid|zoledronic acid
972882|NCT03336970|single visit root canal treatment, chlorhexidine|single visit root canal treatment, chlorhexidine
972883|NCT03336957|chromogranin A, stress, gingivitis, pregnancy|chromogranin a, stress, gingivitis, pregnancy
972884|NCT03336931|children|children
972885|NCT03336931|precision medicine|precision medicine
972886|NCT03336931|personalised medicine|personalised medicine
972887|NCT03336931|high-risk cancer|high-risk cancer
972888|NCT03336931|refractory|refractory
972889|NCT03336931|recurrent|recurrent
972890|NCT03336931|sequencing|sequencing
972891|NCT03336931|patient derived xenograft|patient derived xenograft
972892|NCT03336931|molecular profiling|molecular profiling
972893|NCT03336931|paediatric|paediatric
972894|NCT03336918|Bipolar Disorder|bipolar disorder
972895|NCT03336918|Bipolar I and II Depression|bipolar i and ii depression
972896|NCT03336918|Lithium|lithium
972897|NCT03336918|Depression|depression
972898|NCT03336905|Adolescent and young adult|adolescent and young adult
972899|NCT03336892|Care Coordination|care coordination
972900|NCT03336879|Gambling Disorder|gambling disorder
972901|NCT03336879|Mental Disorder|mental disorder
972902|NCT03336879|Behavioral Addiction|behavioral addiction
972903|NCT03336827|Emotion Regulation|emotion regulation
972904|NCT03336827|Post-Treatment Breast Cancer Care|post-treatment breast cancer care
972905|NCT03336827|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
972906|NCT03336827|CBT|cbt
972907|NCT03336827|Hypnosis|hypnosis
972908|NCT03336814|Terlipressin|terlipressin
972909|NCT03336814|norepinephrine|norepinephrine
972910|NCT03336801|sevoflurane|sevoflurane
972911|NCT03336801|propofol|propofol
972912|NCT03336775|acupuncure|acupuncure
972913|NCT03336775|dysphagia|dysphagia
972914|NCT03336775|radiation|radiation
972915|NCT03336749|Stroke, upper limb, sensory training, rehabilitation|stroke, upper limb, sensory training, rehabilitation
972916|NCT03336736|Physical Activity|physical activity
972917|NCT03336736|Diet|diet
972918|NCT03336736|Exercise|exercise
972919|NCT03336736|Sarcoidosis|sarcoidosis
972920|NCT03336736|Pulmonary sarcoidosis|pulmonary sarcoidosis
972921|NCT03336736|Lung Function|lung function
972922|NCT03336736|Fitness|fitness
972923|NCT03336736|Strength|strength
972924|NCT03336736|Endurance|endurance
972925|NCT03336710|Self-control|self-control
972926|NCT03336710|Ecological Momentary Assessment|ecological momentary assessment
972927|NCT03336710|Attentional bias|attentional bias
972928|NCT03336710|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
972929|NCT03336710|Affect|affect
972930|NCT03336710|Emotion Regulation|emotion regulation
972931|NCT03336710|Well-being|well-being
972932|NCT03336710|Decentering|decentering
972933|NCT03336710|Affective disorders|affective disorders
972934|NCT03336684|Patient education|patient education
972935|NCT03336684|Rheumatoid arthritis|rheumatoid arthritis
972936|NCT03336684|Knowledge|knowledge
972937|NCT03336684|Attitudes|attitudes
972938|NCT03336684|Practice|practice
972939|NCT03336671|Pediatric|pediatric
972940|NCT03336671|Chronic Sinusitis|chronic sinusitis
972941|NCT03336645|Seizure|seizure
972942|NCT03336645|Midazolam hydrochloride|midazolam hydrochloride
972943|NCT03336645|Convulsive|convulsive
972944|NCT03336632|PBSCT|pbsct
972945|NCT03336632|myeloablative conditioning|myeloablative conditioning
972946|NCT03336632|HDACi|hdaci
972947|NCT03336632|chidamide|chidamide
972948|NCT03336619|Influenza|influenza
972949|NCT03336606|immunotherapy|immunotherapy
972950|NCT03336606|OX40|ox40
972951|NCT03336606|antibodies|antibodies
972952|NCT03336606|HNSCC|hnscc
972953|NCT03336606|melanoma|melanoma
972954|NCT03336606|phase 1|phase 1
972955|NCT03336606|squamous cell|squamous cell
972956|NCT03336567|telephonic interview|telephonic interview
972957|NCT03336567|TCR Therapy|tcr therapy
972958|NCT03336567|cross-sectional|cross-sectional
972959|NCT03336567|CGT|cgt
972960|NCT03336567|qualitative|qualitative
972961|NCT03336554|osteosarcoma|osteosarcoma
972962|NCT03336554|epigenetic biomarker|epigenetic biomarker
972963|NCT03336554|hMe-Seal technique|hme-seal technique
972964|NCT03336541|Prenatal depression|prenatal depression
972965|NCT03336541|Ketamine|ketamine
972966|NCT03336541|Cesarean delivery|cesarean delivery
972967|NCT03336541|Postpartum depression|postpartum depression
972968|NCT03336528|Long-acting insulin analog|long-acting insulin analog
972969|NCT03336515|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
972970|NCT03336515|Postural Device|postural device
972971|NCT03336515|Treatment|treatment
972972|NCT03336476|Direct laryngoscopy|direct laryngoscopy
972973|NCT03336476|Videolaryngoscopy|videolaryngoscopy
972974|NCT03336476|Diabetes Mellitus|diabetes mellitus
972975|NCT03336476|Intubation|intubation
972976|NCT03336476|Anesthesia|anesthesia
972977|NCT03336463|Thrombophilia screening|thrombophilia screening
972978|NCT03336463|Genetic risk score|genetic risk score
972979|NCT03336437|Menopause|menopause
972980|NCT03336437|Vaginal dryness|vaginal dryness
972981|NCT03336437|Vaginal atrophy|vaginal atrophy
972982|NCT03336437|Postmenopause|postmenopause
972983|NCT03336437|Estrogen|estrogen
972984|NCT03336437|Urinary microbiome|urinary microbiome
972985|NCT03336437|Estradiol vaginal ring|estradiol vaginal ring
972986|NCT03336437|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
972987|NCT03336437|Vaginal microbiome|vaginal microbiome
972988|NCT03336424|MS|ms
972989|NCT03336424|Multiple sclerosis|multiple sclerosis
972990|NCT03336424|urinary Bladder, Neurogenic|urinary bladder, neurogenic
972991|NCT03336424|Urodynamics|urodynamics
972992|NCT03336424|Randomized controlled trial|randomized controlled trial
972993|NCT03336385|Older adults|older adults
972994|NCT03336385|Prebiotics|prebiotics
972995|NCT03336385|Intestinal permeability|intestinal permeability
972996|NCT03336385|NSAIDS|nsaids
972997|NCT03336359|colonoscopy|colonoscopy
972998|NCT03336359|image enhanced endoscopy|image enhanced endoscopy
972999|NCT03336346|DTG|dtg
973000|NCT03336346|Dolutegravir|dolutegravir
973001|NCT03336346|Efavirenz|efavirenz
973002|NCT03336346|Etonogestrel|etonogestrel
973003|NCT03336333|BGB-3111|bgb-3111
973004|NCT03336333|BTK inhibitor|btk inhibitor
973005|NCT03336333|bendamustine|bendamustine
973006|NCT03336333|rituximab|rituximab
973007|NCT03336333|Phase 3|phase 3
973008|NCT03336307|Parkinson disease|parkinson disease
973009|NCT03336307|movement Disorders|movement disorders
973010|NCT03336307|gait disturbance|gait disturbance
973011|NCT03336307|Parkinson|parkinson
973012|NCT03336307|Parkinson gait|parkinson gait
973013|NCT03336307|3D motion analysis systems|3d motion analysis systems
973014|NCT03336307|motion analysis|motion analysis
973015|NCT03336307|Parkinson rehabilitation|parkinson rehabilitation
973016|NCT03336307|rehabilitation gait improvement|rehabilitation gait improvement
973017|NCT03336307|gait improvement|gait improvement
973018|NCT03336307|SMART Capture|smart capture
973019|NCT03336307|MATLAB software|matlab software
973020|NCT03336294|Sarcopenia|sarcopenia
973021|NCT03336294|Muscle strength|muscle strength
973022|NCT03336294|SRM P31|srm p31
973023|NCT03336294|Phosphocreatine|phosphocreatine
973024|NCT03336229|cancer|cancer
973025|NCT03336229|colorectal|colorectal
973026|NCT03336229|exercise|exercise
973027|NCT03336229|physical fitness|physical fitness
973028|NCT03336203|eGFR, gout, CKD, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat|egfr, gout, ckd, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat
973029|NCT03336190|military|military
973030|NCT03336190|caregiver|caregiver
973031|NCT03336177|gynecology|gynecology
973032|NCT03336177|cancer|cancer
973033|NCT03336177|aged|aged
973034|NCT03336177|delay|delay
973035|NCT03336177|help-seeking behavior|help-seeking behavior
973036|NCT03336177|qualitative research|qualitative research
973037|NCT03336177|semiopragmatic analysis|semiopragmatic analysis
973038|NCT03336177|psychodynamic analysis|psychodynamic analysis
973039|NCT03336112|Non-cardiac chest pain|non-cardiac chest pain
973040|NCT03336112|Psychological distress|psychological distress
973041|NCT03336112|I-CBT|i-cbt
973042|NCT03336047|Exercise|exercise
973043|NCT03336047|Actigraphy|actigraphy
973044|NCT03336047|Prevention and Control|prevention and control
973045|NCT03336047|Cardiorespiratory Fitness|cardiorespiratory fitness
973046|NCT03336034|IBS-C|ibs-c
973047|NCT03336034|Experience sampling method|experience sampling method
973048|NCT03336034|Ecological momentary assessment|ecological momentary assessment
973049|NCT03336034|Abdominal pain|abdominal pain
973050|NCT03336034|Constipation|constipation
973051|NCT03335995|mechanical invasive ventilation|mechanical invasive ventilation
973052|NCT03335995|course of the care|course of the care
973053|NCT03335995|prognosis|prognosis
973054|NCT03335995|stroke|stroke
973055|NCT03335982|transendoscopic enteral tubing|transendoscopic enteral tubing
973056|NCT03335982|mid-gut|mid-gut
973057|NCT03335982|endoscopy|endoscopy
973058|NCT03335982|nasal-jejunal tube|nasal-jejunal tube
973059|NCT03335982|fecal microbiota transplantation|fecal microbiota transplantation
973060|NCT03335982|enteral nutrition|enteral nutrition
973061|NCT03335956|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
973062|NCT03335943|CDA-2, MDS|cda-2, mds
973063|NCT03335930|exercise|exercise
973064|NCT03335930|blood glucose response|blood glucose response
973065|NCT03335930|metabolic control|metabolic control
973066|NCT03335930|type 2 diabetes.|type 2 diabetes.
973067|NCT03335904|Angiotensin receptor blockade|angiotensin receptor blockade
973068|NCT03335904|control of breathing|control of breathing
973069|NCT03335904|breath-holding|breath-holding
973070|NCT03335891|asthma education program|asthma education program
973071|NCT03335891|balance|balance
973072|NCT03335891|core stabilization exercises|core stabilization exercises
973073|NCT03335839|tPA|tpa
973074|NCT03335826|Elderly|elderly
973075|NCT03335826|Cancer surgery|cancer surgery
973076|NCT03335826|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
973077|NCT03335826|Long-term survival|long-term survival
973078|NCT03335826|Quality of life|quality of life
973079|NCT03335813|brachytherapy|brachytherapy
973080|NCT03335813|multichannel balloon applicator|multichannel balloon applicator
973081|NCT03335787|Athletic Tape|athletic tape
973082|NCT03335787|Proprioception|proprioception
973083|NCT03335787|Hemiplegia|hemiplegia
973084|NCT03335787|Gait|gait
973085|NCT03335761|Urinary|urinary
973086|NCT03335761|Incontinence|incontinence
973087|NCT03335748|ADHD|adhd
973088|NCT03335748|Combined type|combined type
973089|NCT03335748|Cognitive training|cognitive training
973090|NCT03335748|Intervention|intervention
973091|NCT03335748|Youths|youths
973092|NCT03335735|alcohol|alcohol
973093|NCT03335735|driving|driving
973094|NCT03335735|breathalyzers|breathalyzers
973095|NCT03335735|smartphone|smartphone
973096|NCT03335722|stammering|stammering
973097|NCT03335722|speech motor disorder|speech motor disorder
973098|NCT03335722|electrical current stimulation|electrical current stimulation
973099|NCT03335722|metronome-timed speech|metronome-timed speech
973100|NCT03335709|Occupational therapy|occupational therapy
973101|NCT03335696|Epidemiology|epidemiology
973102|NCT03335696|Magnetic resonance imaging|magnetic resonance imaging
973103|NCT03335696|Diffusion tensor imaging|diffusion tensor imaging
973104|NCT03335696|White matter|white matter
973105|NCT03335696|Functional MRI|functional mri
973106|NCT03335696|Connectome|connectome
973107|NCT03335696|Resting state brain networks|resting state brain networks
973108|NCT03335696|Neuropsychology|neuropsychology
973109|NCT03335670|68Ga-pentixafor|68ga-pentixafor
973110|NCT03335670|(68Ga)pentixafor|(68ga)pentixafor
973111|NCT03335670|Gallium Radioisotopes|gallium radioisotopes
973112|NCT03335670|CXCR4|cxcr4
973113|NCT03335644|determinants of dietary patterns and nutritional status|determinants of dietary patterns and nutritional status
973114|NCT03335618|Activity|activity
973115|NCT03335618|Mood|mood
973116|NCT03335605|primary immunodeficiency|primary immunodeficiency
973117|NCT03335527|Aged|aged
973317|NCT03334617|AZD2281|azd2281
973118|NCT03335527|Postoperative period|postoperative period
973119|NCT03335527|Intensive Care Unit|intensive care unit
973120|NCT03335527|Mechanical ventilation|mechanical ventilation
973121|NCT03335527|Sleep quality|sleep quality
973122|NCT03335527|Dexmedetomidine|dexmedetomidine
973123|NCT03335514|GALNT4|galnt4
973124|NCT03335501|Closed-loop control|closed-loop control
973125|NCT03335501|Artificial pancreas|artificial pancreas
973126|NCT03335501|Postprandial glucose control|postprandial glucose control
973127|NCT03335501|Insulin|insulin
973128|NCT03335488|Urea|urea
973129|NCT03335488|Hyperammonemic crisis (HAC)|hyperammonemic crisis (hac)
973130|NCT03335475|congenital heart disease|congenital heart disease
973131|NCT03335475|physical activity|physical activity
973132|NCT03335436|buprenorphine maintenance|buprenorphine maintenance
973133|NCT03335397|education|education
973134|NCT03335397|health science|health science
973135|NCT03335397|app|app
973136|NCT03335397|m-learning|m-learning
973137|NCT03335358|couples|couples
973138|NCT03335358|positive psychology|positive psychology
973139|NCT03335358|behavioral intervention|behavioral intervention
973140|NCT03335358|stroke|stroke
973141|NCT03335358|depression|depression
973142|NCT03335358|wellbeing|wellbeing
973143|NCT03335358|caregiver|caregiver
973144|NCT03335345|Airway Extubation/adverse effects/ Methods|airway extubation/adverse effects/ methods
973145|NCT03335345|Nutrition|nutrition
973146|NCT03335345|Ventilator Weaning/methods|ventilator weaning/methods
973147|NCT03335345|Intensive care Unit|intensive care unit
973148|NCT03335345|Enteral Nutrition|enteral nutrition
973149|NCT03335332|High intensity exercise|high intensity exercise
973150|NCT03335332|Cardiorespiratory fitness|cardiorespiratory fitness
973151|NCT03335332|Stroke volume reserve|stroke volume reserve
973152|NCT03335332|Arrhythmia burden|arrhythmia burden
973153|NCT03335319|Cardiovascular Disease|cardiovascular disease
973154|NCT03335319|Coronary Artery Disease|coronary artery disease
973155|NCT03335319|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
973156|NCT03335319|Oxygen Uptake Kinetics|oxygen uptake kinetics
973157|NCT03335319|Skeletal Muscle Oxygenation|skeletal muscle oxygenation
973158|NCT03335319|Exercise Training|exercise training
973159|NCT03335319|Periodized Exercise|periodized exercise
973160|NCT03335306|Body constitution|body constitution
973161|NCT03335306|Chinese Medicine|chinese medicine
973162|NCT03335306|Validation|validation
973163|NCT03335293|pregnancy|pregnancy
973164|NCT03335293|repeat cesarean section|repeat cesarean section
973165|NCT03335293|spinal anesthesia|spinal anesthesia
973166|NCT03335293|bupivacaine|bupivacaine
973167|NCT03335293|epinephrine|epinephrine
973168|NCT03335293|intrathecal|intrathecal
973169|NCT03335293|analgesia|analgesia
973170|NCT03335254|Hypogonadism|hypogonadism
973171|NCT03335254|Testosterone|testosterone
973172|NCT03335254|Testosterone undecanoate|testosterone undecanoate
973173|NCT03335241|Ovarian Cancer|ovarian cancer
973174|NCT03335241|Fludarabine|fludarabine
973175|NCT03335241|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
973176|NCT03335241|Chemotherapy|chemotherapy
973177|NCT03335228|platelet rich plasma, frontal fibrosing alopecia|platelet rich plasma, frontal fibrosing alopecia
973178|NCT03335202|respiratory and intestinal microbiome|respiratory and intestinal microbiome
973179|NCT03335202|antibiotic therapy|antibiotic therapy
973180|NCT03335202|cftr modifier|cftr modifier
973181|NCT03335202|diversity|diversity
973182|NCT03335189|E-Health|e-health
973183|NCT03335189|Smartphone technology|smartphone technology
973184|NCT03335189|Real-time symptom assessment|real-time symptom assessment
973185|NCT03335189|Self-care|self-care
973186|NCT03335189|Symptom management|symptom management
973187|NCT03335150|Parkinson's disease|parkinson's disease
973188|NCT03335150|Rehabilitation|rehabilitation
973189|NCT03335150|Cognition|cognition
973190|NCT03335124|Sepsis|sepsis
973191|NCT03335124|Vitamin C|vitamin c
973192|NCT03335124|Hydrocortisone|hydrocortisone
973193|NCT03335124|Thiamine|thiamine
973194|NCT03335124|Critical Illness|critical illness
973195|NCT03335124|Fluid Responsiveness|fluid responsiveness
973196|NCT03335124|Hemodynamics|hemodynamics
973197|NCT03335111|Remote Ischemic Postconditioning|remote ischemic postconditioning
973198|NCT03335111|Peripheral Immunity|peripheral immunity
973199|NCT03335098|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
973200|NCT03335098|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
973201|NCT03335098|Bortezomib|bortezomib
973202|NCT03335098|Thalidomide|thalidomide
973203|NCT03335072|Azithromycin|azithromycin
973204|NCT03335072|Mass Drug Administration|mass drug administration
973205|NCT03335072|Antibiotic Resistance|antibiotic resistance
973206|NCT03335059|BCG|bcg
973207|NCT03335059|Bacillus Calmette-Guérin|bacillus calmette-guérin
973208|NCT03335059|CIS|cis
973209|NCT03335059|BCG-unresponsive|bcg-unresponsive
973210|NCT03335059|Synergo|synergo
973211|NCT03335059|chemohyperthermia|chemohyperthermia
973212|NCT03335059|thermochemotherapy|thermochemotherapy
973213|NCT03335059|RF|rf
973214|NCT03335059|radio frequency|radio frequency
973215|NCT03335059|RITE|rite
973216|NCT03335046|Home Visit|home visit
973217|NCT03335046|School Absenteeism|school absenteeism
973218|NCT03335033|Carotid Plaque|carotid plaque
973219|NCT03335033|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
973220|NCT03335033|Shear Wave Elastography|shear wave elastography
973221|NCT03335033|Endarterectomy|endarterectomy
973222|NCT03335033|Stenosis|stenosis
973223|NCT03335020|Ultrasound|ultrasound
973224|NCT03335020|3D ultrasonography|3d ultrasonography
973225|NCT03335020|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
973226|NCT03335020|Shear wave elastography|shear wave elastography
973227|NCT03335007|Aceclofenac|aceclofenac
973228|NCT03335007|pain|pain
973229|NCT03335007|irreversible pulpitis|irreversible pulpitis
973230|NCT03334994|Immediate dental implant, Connective tissue graft, Esthetic zone.|immediate dental implant, connective tissue graft, esthetic zone.
973231|NCT03334981|meconium concentration|meconium concentration
973232|NCT03334981|buprenorphine|buprenorphine
973233|NCT03334981|methadone|methadone
973234|NCT03334981|pregnant|pregnant
973235|NCT03334981|liquid chromatography-tandem mass spectrometry|liquid chromatography-tandem mass spectrometry
973236|NCT03334981|opioid-dependant woman|opioid-dependant woman
973238|NCT03334968|prolidase|prolidase
973239|NCT03334968|prognosis|prognosis
973240|NCT03334968|biomarker|biomarker
973241|NCT03334955|Polycystic Ovary Syndrome|polycystic ovary syndrome
973242|NCT03334955|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
973243|NCT03334955|subendometrial blood flow|subendometrial blood flow
973244|NCT03334942|youth|youth
973245|NCT03334942|parents|parents
973246|NCT03334942|posttraumatic stress|posttraumatic stress
973247|NCT03334942|violence|violence
973248|NCT03334942|violent injuries|violent injuries
973249|NCT03334929|virtual reality|virtual reality
973250|NCT03334929|trigger point injections|trigger point injections
973251|NCT03334903|Total Knee Arthroplasty|total knee arthroplasty
973252|NCT03334903|Neurontin|neurontin
973253|NCT03334903|Gabapentin|gabapentin
973254|NCT03334903|Opioid Tapering|opioid tapering
973255|NCT03334890|colorectal cancer|colorectal cancer
973256|NCT03334890|septin 9|septin 9
973257|NCT03334890|SEPT9|sept9
973258|NCT03334890|methylation|methylation
973259|NCT03334890|CEA|cea
973260|NCT03334864|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
973261|NCT03334838|Food effect|food effect
973262|NCT03334838|Dose proportionality|dose proportionality
973263|NCT03334825|HIV|hiv
973264|NCT03334825|housing|housing
973265|NCT03334825|homelessness|homelessness
973266|NCT03334812|cartilage lesion, ACI|cartilage lesion, aci
973267|NCT03334799|sacroiliac belt|sacroiliac belt
973268|NCT03334799|kinematics|kinematics
973269|NCT03334799|stability|stability
973270|NCT03334799|pelvic girdle pain|pelvic girdle pain
973271|NCT03334799|sacroiliac instability|sacroiliac instability
973272|NCT03334786|ALS|als
973273|NCT03334786|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
973274|NCT03334786|Fasciculation|fasciculation
973275|NCT03334786|FLX-787|flx-787
973276|NCT03334773|Type 2 diabetes, nutrition education programme, intervention, South Africa|type 2 diabetes, nutrition education programme, intervention, south africa
973277|NCT03334760|Cohort study|cohort study
973278|NCT03334760|Infant feeding|infant feeding
973279|NCT03334760|Overweight|overweight
973280|NCT03334760|Child BMI|child bmi
973281|NCT03334760|Breastfeeding|breastfeeding
973282|NCT03334760|Intake of protein|intake of protein
973283|NCT03334747|uncomplicated Plasmodium falciparum Malaria.|uncomplicated plasmodium falciparum malaria.
973284|NCT03334734|Tuberculosis|tuberculosis
973285|NCT03334734|PBTZ169|pbtz169
973286|NCT03334734|antimycobacterial|antimycobacterial
973287|NCT03334708|17-257|17-257
973288|NCT03334669|Childhood obesity|childhood obesity
973289|NCT03334669|Preschool|preschool
973290|NCT03334669|Head Start|head start
973291|NCT03334669|Family Interventions|family interventions
973292|NCT03334669|Community Based Participatory Research (CBPR)|community based participatory research (cbpr)
973293|NCT03334669|Empowerment Theory|empowerment theory
973294|NCT03334669|Family Ecological Theory|family ecological theory
973295|NCT03334669|Step Wedge Design|step wedge design
973296|NCT03334669|Low Income|low income
973297|NCT03334656|Split thickness skin graft donor site|split thickness skin graft donor site
973298|NCT03334656|wound healing|wound healing
973299|NCT03334656|Fetal skin bioconstruct|fetal skin bioconstruct
973300|NCT03334656|Fibroblasts|fibroblasts
973301|NCT03334656|Keratinocytes|keratinocytes
973302|NCT03334643|Type 2 Diabetes|type 2 diabetes
973303|NCT03334643|Dietary fiber|dietary fiber
973304|NCT03334643|Glycemic response|glycemic response
973305|NCT03334630|ablation|ablation
973306|NCT03334630|electrophysiology|electrophysiology
973307|NCT03334630|atrial fibrillation|atrial fibrillation
973308|NCT03334630|catheter|catheter
973309|NCT03334630|paroxysmal|paroxysmal
973310|NCT03334617|Non-small cell lung cancer|non-small cell lung cancer
973311|NCT03334617|NSCLC|nsclc
973312|NCT03334617|anti-PD-1/PD-L1|anti-pd-1/pd-l1
973313|NCT03334617|umbrella study|umbrella study
973314|NCT03334617|Durvalumab|durvalumab
973315|NCT03334617|MEDI4736|medi4736
973316|NCT03334617|Olaparib|olaparib
973322|NCT03334604|antibiotic-associated diarrhea|antibiotic-associated diarrhea
973323|NCT03334604|probiotics|probiotics
973324|NCT03334513|Bevacizumab|bevacizumab
973325|NCT03334513|Biometry|biometry
973326|NCT03334513|Ranibizumab|ranibizumab
973327|NCT03334513|Refractive error|refractive error
973328|NCT03334513|Retinopathy of prematurity|retinopathy of prematurity
973329|NCT03334487|Cancer|cancer
973330|NCT03334487|Small Cell Lung Cancer|small cell lung cancer
973331|NCT03334487|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
973332|NCT03334487|Remitting Small Cell Lung Cancer|remitting small cell lung cancer
973333|NCT03334487|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
973334|NCT03334487|DLL3 Expressing Small Cell Lung Cancer|dll3 expressing small cell lung cancer
973335|NCT03334487|Rovalpituzumab Tesirine|rovalpituzumab tesirine
973336|NCT03334461|Oral antiseptics|oral antiseptics
973337|NCT03334461|remineralisation agents|remineralisation agents
973338|NCT03334435|eczema|eczema
973339|NCT03334435|atopic eczema|atopic eczema
973340|NCT03334422|eczema|eczema
973341|NCT03334422|atopic eczema|atopic eczema
973342|NCT03334396|eczema|eczema
973343|NCT03334396|atopic eczema|atopic eczema
973344|NCT03334383|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
973345|NCT03334383|Retractor sponge|retractor sponge
973346|NCT03334383|Trendelenburg position|trendelenburg position
973347|NCT03334383|Postoperative complications|postoperative complications
973348|NCT03334370|Diabetes mellitus|diabetes mellitus
973349|NCT03334357|Physical fitness|physical fitness
973350|NCT03334357|Klotho|klotho
973351|NCT03334357|Training|training
973352|NCT03334357|HIIT|hiit
973353|NCT03334357|WB-EMS|wb-ems
973354|NCT03334292|Wilson Disease|wilson disease
973355|NCT03334266|sugar|sugar
973356|NCT03334266|sweetened|sweetened
973357|NCT03334266|beverages|beverages
973358|NCT03334266|responsive|responsive
973359|NCT03334253|Myopia|myopia
973360|NCT03334253|atropine|atropine
973362|NCT03334240|Digoxin|digoxin
973363|NCT03334240|Furosemide|furosemide
973364|NCT03334240|Vulvar HSIL|vulvar hsil
973365|NCT03334227|High-Flow Nasal Cannula|high-flow nasal cannula
973366|NCT03334227|Severe Sepsis|severe sepsis
973367|NCT03334227|qSOFA|qsofa
973368|NCT03334214|Hepatic Steatosis|hepatic steatosis
973369|NCT03334214|IONIS-DGAT2Rx|ionis-dgat2rx
973370|NCT03334214|Type 2 Diabetes|type 2 diabetes
973371|NCT03334162|Children|children
973372|NCT03334162|Adolescents|adolescents
973373|NCT03334162|Cancer|cancer
973374|NCT03334162|brain Tumor|brain tumor
973375|NCT03334162|exercise|exercise
973376|NCT03334162|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
973377|NCT03334162|CIPN|cipn
973378|NCT03334162|Sensorimotor Training|sensorimotor training
973379|NCT03334123|exercise|exercise
973380|NCT03334123|aerobic exercise|aerobic exercise
988708|NCT03235531|trauma|trauma
973381|NCT03334123|functional training|functional training
973382|NCT03334123|strength training|strength training
973383|NCT03334123|resistance training|resistance training
973384|NCT03334123|kidney failure|kidney failure
973385|NCT03334123|rehabilitation|rehabilitation
973386|NCT03334123|physical activity|physical activity
973387|NCT03334123|hemodialysis|hemodialysis
973388|NCT03334123|dialysis patients|dialysis patients
973389|NCT03334123|chronic renal failure|chronic renal failure
973390|NCT03334123|chronic kidney disease|chronic kidney disease
973391|NCT03334123|end-stage renal disease|end-stage renal disease
973392|NCT03334123|intradialytic exercise|intradialytic exercise
973393|NCT03334097|Pregnancy|pregnancy
973394|NCT03334097|fear|fear
973395|NCT03334097|Parturition|parturition
973396|NCT03334097|Prenatal Education|prenatal education
973397|NCT03334045|Neurobiology|neurobiology
973398|NCT03334045|Occupational Stress|occupational stress
973399|NCT03334045|Dopamine|dopamine
973400|NCT03334032|Body composition|body composition
973401|NCT03334032|Total body protein|total body protein
973402|NCT03334032|nutritional recovery|nutritional recovery
973403|NCT03334032|Exercise status|exercise status
973404|NCT03334032|In-vivo neutron activation analysis|in-vivo neutron activation analysis
973405|NCT03334032|Protein depletion|protein depletion
973406|NCT03334006|Pentaglobin®|pentaglobin®
973407|NCT03334006|Personalised Medicine|personalised medicine
973408|NCT03333993|Pilates exercise|pilates exercise
973409|NCT03333993|Fatigue|fatigue
973410|NCT03333993|Quality of Life|quality of life
973411|NCT03333967|apatinib|apatinib
973412|NCT03333954|atrophic macular degeneration|atrophic macular degeneration
973413|NCT03333954|geographic atrophy|geographic atrophy
973414|NCT03333954|macular degeneration|macular degeneration
973415|NCT03333954|dry macular degeneration|dry macular degeneration
973416|NCT03333954|AMD|amd
973417|NCT03333954|retina implant|retina implant
973418|NCT03333954|retinal prosthesis|retinal prosthesis
973419|NCT03333954|visual prosthesis|visual prosthesis
973420|NCT03333902|quadratus lumborum block|quadratus lumborum block
973421|NCT03333902|transversus abdominis plane block|transversus abdominis plane block
973422|NCT03333902|anesthesia|anesthesia
973423|NCT03333837|Improvisation|improvisation
973426|NCT03333837|Quality of Life|quality of life
973427|NCT03333837|Dance|dance
973428|NCT03333837|Social Group|social group
973429|NCT03333837|MRI|mri
973430|NCT03333837|mild cognitive impairment|mild cognitive impairment
973431|NCT03333837|MCI|mci
973432|NCT03333837|Social engagement|social engagement
973433|NCT03333824|Pharmacokinetics, Cardiac Conduction, Mitotic Checkpoint inhibitor, QTc interval|pharmacokinetics, cardiac conduction, mitotic checkpoint inhibitor, qtc interval
973434|NCT03333798|Intimate Partner Violence|intimate partner violence
973435|NCT03333798|Domestic Violence|domestic violence
973436|NCT03333798|Mental Health|mental health
973437|NCT03333798|Cognitive- Behavioral Therapy|cognitive- behavioral therapy
973441|NCT03333785|Continuity of care|continuity of care
973442|NCT03333785|Integration of care|integration of care
973443|NCT03333785|Communication|communication
973444|NCT03333759|laser|laser
973445|NCT03333759|Er:YAG laser|er:yag laser
973446|NCT03333759|acne|acne
973447|NCT03333759|acne vulgaris|acne vulgaris
973448|NCT03333759|optical coherence tomography|optical coherence tomography
973449|NCT03333720|Phenylketonuria|phenylketonuria
973450|NCT03333720|Inherited Metabolic Disorders|inherited metabolic disorders
973452|NCT03333681|Rheumatoid arthritis|rheumatoid arthritis
973453|NCT03333681|Stem Cells|stem cells
973454|NCT03333681|Cellular immunity|cellular immunity
973455|NCT03333668|Lisdexamfetamine|lisdexamfetamine
973456|NCT03333668|Guanfacine|guanfacine
973457|NCT03333668|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
973458|NCT03333668|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
973459|NCT03333655|Metastatic Cancer|metastatic cancer
973460|NCT03333642|diabetes|diabetes
973461|NCT03333642|metabolic surgery|metabolic surgery
973462|NCT03333642|ileal interposition|ileal interposition
973463|NCT03333629|Autistic Disorder|autistic disorder
973464|NCT03333629|Early Detection|early detection
973465|NCT03333629|Early Intervention|early intervention
973466|NCT03333616|Genitourinary Cancer|genitourinary cancer
973467|NCT03333603|Schizophrenia|schizophrenia
973468|NCT03333590|DMD|dmd
973469|NCT03333590|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
973470|NCT03333564|Vitamin D3|vitamin d3
973471|NCT03333564|Vitamin D deficiency|vitamin d deficiency
973472|NCT03333564|estradiol|estradiol
973473|NCT03333564|omega-3 fatty acids|omega-3 fatty acids
973474|NCT03333564|menopausal|menopausal
973475|NCT03333551|AL Cardiac Amyloidosis|al cardiac amyloidosis
973476|NCT03333551|18F-Florbetapir (Amyvid)|18f-florbetapir (amyvid)
973477|NCT03333538|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
973478|NCT03333538|Ebola Virus Disease|ebola virus disease
973479|NCT03333538|Ebola Virus Vaccines|ebola virus vaccines
973480|NCT03333538|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
973481|NCT03333538|GP protein, Ebola virus|gp protein, ebola virus
973482|NCT03333538|Filoviridae Infections|filoviridae infections
973483|NCT03333538|RNA Virus Infections|rna virus infections
973484|NCT03333525|Fat-protein counting|fat-protein counting
973485|NCT03333525|Type 1 diabetes|type 1 diabetes
973486|NCT03333525|Postprandial glucose level|postprandial glucose level
973487|NCT03333512|Nap|nap
973488|NCT03333512|Recovery Sleep|recovery sleep
973489|NCT03333512|Cognitive Functions|cognitive functions
973490|NCT03333512|Glucose Metabolism|glucose metabolism
973491|NCT03333512|Neurobehavioral Functions|neurobehavioral functions
973492|NCT03333512|Mood|mood
973493|NCT03333512|Subjective Sleepiness|subjective sleepiness
973494|NCT03333460|cocaine|cocaine
973495|NCT03333460|addiction|addiction
973496|NCT03333460|transcranial magnetic stimulation|transcranial magnetic stimulation
973497|NCT03333460|neuromodulation|neuromodulation
973498|NCT03333460|neuroimaging|neuroimaging
973499|NCT03333460|brain stimulation|brain stimulation
973500|NCT03333395|Mechanical ventilation|mechanical ventilation
973501|NCT03333395|Acute Exacerbation of chronic obstructive airway disease (AECOPD)|acute exacerbation of chronic obstructive airway disease (aecopd)
973502|NCT03333395|Nebulized heparin|nebulized heparin
973503|NCT03333395|C-Reactive Protein (CRP|c-reactive protein (crp
973504|NCT03333369|resting-state functional MRI|resting-state functional mri
973505|NCT03333369|Dopamine|dopamine
973506|NCT03333369|functional connectivity|functional connectivity
973507|NCT03333343|EGFR-mutant NSCLC|egfr-mutant nsclc
973508|NCT03333343|EGF816|egf816
973509|NCT03333343|LXH254|lxh254
973510|NCT03333343|INC280|inc280
973511|NCT03333343|ribociclib|ribociclib
973512|NCT03333343|trametinib|trametinib
973513|NCT03333343|gefitinib|gefitinib
973514|NCT03333343|EGFR T790M|egfr t790m
973515|NCT03333343|BRAF mutation|braf mutation
973516|NCT03333343|BRAF fusion|braf fusion
973517|NCT03333343|BRAF rearrangement|braf rearrangement
973518|NCT03333343|MET amplification|met amplification
973519|NCT03333330|Carotid atherosclerosis|carotid atherosclerosis
973520|NCT03333330|Carotid plaque|carotid plaque
973521|NCT03333330|Brain magnetic resonance imaging|brain magnetic resonance imaging
973522|NCT03333330|Contrast enhanced ultrasound|contrast enhanced ultrasound
973523|NCT03333330|Carotid CT angiography|carotid ct angiography
973524|NCT03333330|Silent brain ischemia|silent brain ischemia
974420|NCT03327597|Screening|screening
973525|NCT03333330|Vascular cognitive impairment|vascular cognitive impairment
973526|NCT03333304|Procalcitonin|procalcitonin
973527|NCT03333278|Critical Care|critical care
973528|NCT03333278|Shock, Septic|shock, septic
973529|NCT03333278|Ascorbic Acid|ascorbic acid
973530|NCT03333278|Adult|adult
973531|NCT03333252|Caregiver|caregiver
973532|NCT03333252|Psycho-social intervention|psycho-social intervention
973533|NCT03333252|Cognitive training|cognitive training
973534|NCT03333252|Quality of life|quality of life
973535|NCT03333252|Early on-set Alzheimer's Disease|early on-set alzheimer's disease
973536|NCT03333239|childhood and adolescence|childhood and adolescence
973537|NCT03333226|Breast Neoplasms|breast neoplasms
973538|NCT03333226|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
973539|NCT03333226|Lymph Node Excision|lymph node excision
973540|NCT03333226|Technetium Tc 99m|technetium tc 99m
973541|NCT03333226|Indocyanine Green|indocyanine green
973542|NCT03333226|Lymphatic System|lymphatic system
973543|NCT03333226|Secondary Prevention|secondary prevention
973544|NCT03333200|Pediatric|pediatric
973545|NCT03333200|Rare|rare
973546|NCT03333200|Neurodegenerative|neurodegenerative
973547|NCT03333200|Genetic|genetic
973548|NCT03333200|Neurodevelopment|neurodevelopment
973549|NCT03333200|Brain|brain
973550|NCT03333200|MRI|mri
973551|NCT03333200|Biorepository|biorepository
973552|NCT03333200|NDRD|ndrd
973553|NCT03333200|Longitudinal|longitudinal
973554|NCT03333200|Cognitive|cognitive
973555|NCT03333200|Motor|motor
973556|NCT03333200|Language|language
973557|NCT03333200|Adaptive behavior|adaptive behavior
973558|NCT03333187|Myelofibrosis, Myeloproliferative Disease|myelofibrosis, myeloproliferative disease
973559|NCT03333174|apnea of prematurity|apnea of prematurity
973560|NCT03333174|bradycardia|bradycardia
973561|NCT03333174|hypoxemic episode|hypoxemic episode
973562|NCT03333174|oxygen delivery|oxygen delivery
973563|NCT03333161|apnea of prematurity|apnea of prematurity
973564|NCT03333161|bradycardia|bradycardia
973565|NCT03333161|hypoxemic episode|hypoxemic episode
973566|NCT03333161|permissive hypercapnia|permissive hypercapnia
973567|NCT03333148|Colorectal Surgery|colorectal surgery
973568|NCT03333148|Immunonutrition|immunonutrition
973569|NCT03333148|Complications|complications
973570|NCT03333148|Microbiome|microbiome
973571|NCT03333148|Preoperative nutrition|preoperative nutrition
973572|NCT03333135|Ultramarathons|ultramarathons
973573|NCT03333135|Electromagnetic field therapy|electromagnetic field therapy
973574|NCT03333135|Endurance|endurance
973575|NCT03333135|Exercise|exercise
1656965|NCT00161109|Psychosis|psychosis
973576|NCT03333135|Environmental conditions|environmental conditions
973577|NCT03333109|AMG 334, erenumab, migraine, episodic, headache, CGRP|amg 334, erenumab, migraine, episodic, headache, cgrp
973578|NCT03333096|Glaucoma|glaucoma
973579|NCT03333096|Mild Cognitive Impairment|mild cognitive impairment
973580|NCT03333096|Ocusweep|ocusweep
973581|NCT03333096|Reaction Time|reaction time
973582|NCT03333096|Neuropsychology|neuropsychology
973583|NCT03333096|Dementia|dementia
973584|NCT03333096|Alzheimer's Disease|alzheimer's disease
973585|NCT03333096|Brain Diseases|brain diseases
973586|NCT03333083|Lamivudine|lamivudine
973587|NCT03333083|Raltegravir|raltegravir
973588|NCT03333031|cancer|cancer
973589|NCT03333031|imaging agent|imaging agent
973590|NCT03333031|HSP90|hsp90
973591|NCT03333018|COPD|copd
973592|NCT03332979|pre-death grief|pre-death grief
973593|NCT03332979|palliative care|palliative care
973594|NCT03332979|dementia|dementia
973595|NCT03332979|caregiver|caregiver
973596|NCT03332979|preparation for end of life|preparation for end of life
973597|NCT03332966|adolescent|adolescent
973598|NCT03332966|outpatients|outpatients
973599|NCT03332966|questionnaire|questionnaire
973600|NCT03332966|psychotic-like symptoms|psychotic-like symptoms
973601|NCT03332966|psychosis risk|psychosis risk
973602|NCT03332940|Tc99m-tilmanocept|tc99m-tilmanocept
973603|NCT03332940|Tilmanocept|tilmanocept
973604|NCT03332940|NASH|nash
973605|NCT03332940|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
973606|NCT03332914|Osteoarthritis|osteoarthritis
973607|NCT03332914|microcurrent|microcurrent
973608|NCT03332914|knee|knee
973609|NCT03332914|electrotherapy|electrotherapy
973610|NCT03332875|OurRelationship|ourrelationship
973611|NCT03332875|Couple therapy|couple therapy
973612|NCT03332875|Internet|internet
973613|NCT03332875|Marriage Counseling|marriage counseling
973614|NCT03332862|Catheter Ablation|catheter ablation
973615|NCT03332862|Atrial Fibrillation|atrial fibrillation
973616|NCT03332862|Contact Force|contact force
973617|NCT03332862|Continuous Ablation|continuous ablation
973618|NCT03332823|Mental health|mental health
973619|NCT03332823|Mental well-being|mental well-being
973620|NCT03332823|Community-based engagement|community-based engagement
973621|NCT03332823|Positive psychology|positive psychology
973622|NCT03332823|Public health approach|public health approach
973623|NCT03332810|Mental health|mental health
973624|NCT03332810|Mental well-being|mental well-being
973625|NCT03332810|Community-based engagement|community-based engagement
973626|NCT03332810|Positive psychology|positive psychology
973627|NCT03332810|Public health approach|public health approach
973628|NCT03332758|retinal detachment|retinal detachment
973629|NCT03332758|inflammasome|inflammasome
973630|NCT03332758|macular hole|macular hole
973631|NCT03332745|Troponin|troponin
973632|NCT03332732|Healthy Volunteers|healthy volunteers
973633|NCT03332732|Pharmacokinetics|pharmacokinetics
973735|NCT03332108|breastfeeding|breastfeeding
973634|NCT03332654|Urinary Incontinence, Stress|urinary incontinence, stress
973635|NCT03332654|Multiple Sclerosis|multiple sclerosis
973636|NCT03332654|Lower Urinary Tract Symptoms|lower urinary tract symptoms
973637|NCT03332628|Peer Reviewed Research|peer reviewed research
973638|NCT03332615|Palliative Care|palliative care
973639|NCT03332602|Iron deficiency|iron deficiency
973640|NCT03332602|Iron fortification|iron fortification
973641|NCT03332602|Iron encapsulation|iron encapsulation
973642|NCT03332589|Melanoma|melanoma
973643|NCT03332589|CNS metastases|cns metastases
973644|NCT03332589|BRAF mutation|braf mutation
973645|NCT03332589|MEK mutation|mek mutation
973646|NCT03332589|E6201|e6201
973647|NCT03332576|vaccine|vaccine
973648|NCT03332576|immunotherapy|immunotherapy
973649|NCT03332576|combination therapy|combination therapy
973650|NCT03332563|Adolescent|adolescent
973651|NCT03332563|Cognitive Behavioral Therapy|cognitive behavioral therapy
973652|NCT03332563|Chronic Pain|chronic pain
973653|NCT03332563|smartphone application|smartphone application
973654|NCT03332563|internet-delivered|internet-delivered
973655|NCT03332550|laparoscopic lavage|laparoscopic lavage
973656|NCT03332537|Young Adults|young adults
973658|NCT03332537|Self Management|self management
973659|NCT03332537|Pain|pain
973660|NCT03332537|Gut microbiome|gut microbiome
973661|NCT03332537|Genetics|genetics
973662|NCT03332537|Online education|online education
973663|NCT03332524|1st degree burn|1st degree burn
973664|NCT03332498|colon|colon
973665|NCT03332498|rectum|rectum
973666|NCT03332498|advanced|advanced
973667|NCT03332498|refractory|refractory
973668|NCT03332472|type 1 diabetes|type 1 diabetes
973669|NCT03332446|cold water immersion, strength training, training effect|cold water immersion, strength training, training effect
973670|NCT03332433|Hypoxia|hypoxia
973671|NCT03332433|Gastroscope|gastroscope
973672|NCT03332433|High-flow nasal cannula|high-flow nasal cannula
973673|NCT03332420|Huaiqihuang granule|huaiqihuang granule
973674|NCT03332420|primary nephrotic syndrome|primary nephrotic syndrome
973675|NCT03332420|multisite|multisite
973676|NCT03332420|prospective|prospective
973677|NCT03332420|open-label|open-label
973678|NCT03332407|Postoperative delirium|postoperative delirium
973679|NCT03332407|Sleep quality|sleep quality
973680|NCT03332407|Pediatric anesthesia|pediatric anesthesia
973681|NCT03332407|Strabismus surgery|strabismus surgery
973682|NCT03332394|Care Model|care model
973683|NCT03332394|COPD|copd
973684|NCT03332394|Exacerbations|exacerbations
973685|NCT03332394|Health Confidence Score|health confidence score
973686|NCT03332368|Triple-negative breast cancer|triple-negative breast cancer
973687|NCT03332368|Traditional Chinese Medicine|traditional chinese medicine
973688|NCT03332355|glioblastoma multiforme|glioblastoma multiforme
973689|NCT03332355|anaplastic astrocytoma|anaplastic astrocytoma
973690|NCT03332355|high grade glioma|high grade glioma
973691|NCT03332355|temozolomide|temozolomide
973692|NCT03332355|PROCASPASE ACTIVATING COMPOUND-1 (PAC-1)|procaspase activating compound-1 (pac-1)
973693|NCT03332355|advanced malignancy|advanced malignancy
973694|NCT03332355|maximal tolerated dose (MTD)|maximal tolerated dose (mtd)
973695|NCT03332342|dry eye disease|dry eye disease
973696|NCT03332342|tears|tears
973697|NCT03332342|inflammation|inflammation
973698|NCT03332342|ocular surface|ocular surface
973699|NCT03332329|HBsAg|hbsag
973700|NCT03332329|PegIFN|pegifn
973701|NCT03332329|ETV|etv
973702|NCT03332329|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
973703|NCT03332329|HBV|hbv
973704|NCT03332329|GMCSF|gmcsf
973705|NCT03332303|Vaginal Dryness|vaginal dryness
973706|NCT03332303|Vaginal and/or Vulvar Irritation/Itching|vaginal and/or vulvar irritation/itching
973707|NCT03332303|Dysuria|dysuria
973708|NCT03332303|Vaginal Pain and Bleeding|vaginal pain and bleeding
973709|NCT03332277|Active Bodysuits|active bodysuits
973710|NCT03332264|PAOD|paod
973711|NCT03332264|drug coated balloon|drug coated balloon
973712|NCT03332264|drug coated stent|drug coated stent
973713|NCT03332264|percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
973714|NCT03332251|Posture Correction Girdle|posture correction girdle
973715|NCT03332225|sepsis|sepsis
973716|NCT03332225|macrophage activation syndrome|macrophage activation syndrome
973717|NCT03332225|immunoparalysis|immunoparalysis
973718|NCT03332225|anakinra|anakinra
973719|NCT03332225|recombinant human interferon-gamma|recombinant human interferon-gamma
973720|NCT03332225|HLA-DR|hla-dr
973721|NCT03332199|symptom cluster|symptom cluster
973722|NCT03332199|oncology|oncology
973723|NCT03332199|psychoeducation|psychoeducation
973724|NCT03332199|symptom management|symptom management
973725|NCT03332199|fatigue|fatigue
973726|NCT03332199|pain|pain
973727|NCT03332199|sleep disturbance|sleep disturbance
973728|NCT03332160|Lymphedema|lymphedema
973729|NCT03332160|Cancer|cancer
973730|NCT03332160|Head Cancer|head cancer
973731|NCT03332160|Neck Cancer|neck cancer
973732|NCT03332160|Head and Neck Cancer|head and neck cancer
973733|NCT03332108|mobile health (mHealth)|mobile health (mhealth)
973734|NCT03332108|electronic health (eHealth)|electronic health (ehealth)
973736|NCT03332108|infant nutrition|infant nutrition
973737|NCT03332108|text messaging intervention|text messaging intervention
973738|NCT03332069|Hyperthermia|hyperthermia
973739|NCT03332069|cervix|cervix
973740|NCT03332069|HIV|hiv
973741|NCT03332056|Ureteral stent pain|ureteral stent pain
973742|NCT03332056|nephrolithiasis|nephrolithiasis
973743|NCT03332056|kidney stone|kidney stone
973744|NCT03332043|HIRREM|hirrem
973745|NCT03332043|Neurotechnology|neurotechnology
973746|NCT03332043|Closed-loop|closed-loop
973747|NCT03332043|Acoustic stimulation|acoustic stimulation
973748|NCT03332043|Allostatic|allostatic
973749|NCT03332043|Heart rate variability|heart rate variability
973750|NCT03332043|Baroreflex sensitivity|baroreflex sensitivity
973751|NCT03332043|Blood pressure management|blood pressure management
973752|NCT03332043|Autocalibration|autocalibration
973753|NCT03332043|Neural oscillations|neural oscillations
973754|NCT03332043|Relaxation|relaxation
973755|NCT03332043|Electroencephalic|electroencephalic
973756|NCT03332017|Relapsed/Refractory Follicular non-Hodgkin Lymphoma|relapsed/refractory follicular non-hodgkin lymphoma
973757|NCT03332004|Indocyanine Green|indocyanine green
973758|NCT03332004|Deep Infiltrating Endometriosis|deep infiltrating endometriosis
973759|NCT03332004|Near-Infrared Vision|near-infrared vision
973760|NCT03332004|Occult endometriosis|occult endometriosis
973761|NCT03332004|Invisible endometriosis|invisible endometriosis
973762|NCT03331978|Adherence|adherence
973763|NCT03331978|Antiretroviral treatment|antiretroviral treatment
973764|NCT03331978|Black/ AfricanAmerican|black/ africanamerican
973765|NCT03331965|Interventional Radiology|interventional radiology
973766|NCT03331965|Metoclopramide|metoclopramide
973767|NCT03331965|Gastrojejenostomy|gastrojejenostomy
973768|NCT03331952|Streptococcal Pneumonia|streptococcal pneumonia
973769|NCT03331952|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
973770|NCT03331887|endodontically treate teeth|endodontically treate teeth
973771|NCT03331887|Emax crowns|emax crowns
973772|NCT03331887|Fiber reinforced composite post|fiber reinforced composite post
973773|NCT03331887|Endocrowns|endocrowns
973774|NCT03331874|confocal|confocal
973775|NCT03331874|basal|basal
973776|NCT03331874|carcinoma|carcinoma
973777|NCT03331848|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
973778|NCT03331848|Foliglurax|foliglurax
973779|NCT03331848|Parkinson's Disease|parkinson's disease
973780|NCT03331848|mGlu4 PAM|mglu4 pam
973781|NCT03331822|circadian|circadian
973782|NCT03331822|light therapy|light therapy
973783|NCT03331822|ICU nurse|icu nurse
973784|NCT03331809|intubation|intubation
973785|NCT03331809|pharyngitis|pharyngitis
973786|NCT03331796|mild cognitive impairment|mild cognitive impairment
973787|NCT03331796|tms|tms
973788|NCT03331796|rtms|rtms
973789|NCT03331796|transcranial magnetic stimulation|transcranial magnetic stimulation
973790|NCT03331796|noninvasive brain stimulation|noninvasive brain stimulation
973791|NCT03331796|non-pharmacological|non-pharmacological
973792|NCT03331770|Benzalkonium Chloride|benzalkonium chloride
973793|NCT03331770|Latanoprost|latanoprost
973794|NCT03331770|BAK-free|bak-free
973795|NCT03331770|Glaucoma|glaucoma
973796|NCT03331770|Ocular hypertension|ocular hypertension
973797|NCT03331770|conjunctival hyperemia|conjunctival hyperemia
973798|NCT03331770|BUT|but
973799|NCT03331770|OSDI|osdi
973800|NCT03331770|Schirmer I|schirmer i
973801|NCT03331770|Corneal staining|corneal staining
973802|NCT03331770|Tear meniscus height|tear meniscus height
973803|NCT03331744|Infantile hemanioma|infantile hemanioma
973804|NCT03331744|Infantile hepatic hemangioma|infantile hepatic hemangioma
973805|NCT03331744|Ulcerated infantile hemangioma|ulcerated infantile hemangioma
973806|NCT03331744|Clinical characteristics|clinical characteristics
973807|NCT03331744|Demographic characteristics|demographic characteristics
973808|NCT03331718|pancreatoduodenectomy|pancreatoduodenectomy
973809|NCT03331718|pancreaticojejunostomy|pancreaticojejunostomy
973810|NCT03331718|polyethylene glycolic acid|polyethylene glycolic acid
973811|NCT03331718|Neoveil|neoveil
973812|NCT03331718|pancreatic fistula|pancreatic fistula
973813|NCT03331718|pancreas|pancreas
973814|NCT03331666|Hyperlipidemia, Hypercholesterolemia, atherothrombosis|hyperlipidemia, hypercholesterolemia, atherothrombosis
973815|NCT03331653|Cervical Pain|cervical pain
973816|NCT03331653|Motor Control|motor control
973817|NCT03331653|Sternocleidomastoid|sternocleidomastoid
973818|NCT03331653|Dry Needling|dry needling
973819|NCT03331601|Brain metastasis|brain metastasis
973820|NCT03331601|HER2|her2
973821|NCT03331588|Lung cancer|lung cancer
973822|NCT03331588|Pain|pain
973823|NCT03331588|Quality of life|quality of life
973824|NCT03331562|Pembrolizumab|pembrolizumab
973825|NCT03331562|Paricalcitol|paricalcitol
973826|NCT03331562|Pancreatic cancer|pancreatic cancer
973827|NCT03331562|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
973828|NCT03331562|Vitamin D|vitamin d
973829|NCT03331562|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
973830|NCT03331562|VDR agonist|vdr agonist
973831|NCT03331562|PD1 Inhibitor|pd1 inhibitor
973832|NCT03331510|Shoulder, Instability, Latarjet, Dislocation, Strength|shoulder, instability, latarjet, dislocation, strength
974022|NCT03330145|Cancer|cancer
973833|NCT03331484|percutaneous coronary intervention|percutaneous coronary intervention
973834|NCT03331484|bleeding|bleeding
973835|NCT03331458|physical activity|physical activity
973836|NCT03331445|inhaled nitric oxide|inhaled nitric oxide
973837|NCT03331445|non tuberculous mycobacteria|non tuberculous mycobacteria
973838|NCT03331445|drug resistant pneumonia|drug resistant pneumonia
973839|NCT03331406|Metastatic gastrointestinal cancer|metastatic gastrointestinal cancer
973840|NCT03331406|Physical Activity|physical activity
973841|NCT03331380|1.5 T CMR|1.5 t cmr
973842|NCT03331380|Low SAR CMR|low sar cmr
973843|NCT03331380|Gadolinium|gadolinium
973844|NCT03331380|Regadenoson|regadenoson
973845|NCT03331380|Adenosine|adenosine
973846|NCT03331367|Cryotherapy|cryotherapy
973847|NCT03331367|Radiation|radiation
973848|NCT03331367|Prostatectomy|prostatectomy
973849|NCT03331367|Immune Response|immune response
973850|NCT03331354|employment|employment
973851|NCT03331354|distance learning|distance learning
973852|NCT03331354|incarceration|incarceration
973853|NCT03331328|MonaLisa|monalisa
973854|NCT03331328|Genitourinary syndrome of menopause (GSM)|genitourinary syndrome of menopause (gsm)
973855|NCT03331250|Epithelioid hemangioendothelioma (EHE)|epithelioid hemangioendothelioma (ehe)
973856|NCT03331250|Angiosarcoma|angiosarcoma
973857|NCT03331211|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
973858|NCT03331198|JCAR017|jcar017
973859|NCT03331198|chimeric antigen receptor|chimeric antigen receptor
973860|NCT03331198|CLL|cll
973861|NCT03331198|SLL|sll
973862|NCT03331198|chronic lymphocytic leukemia|chronic lymphocytic leukemia
973863|NCT03331198|small lymphocytic lymphoma|small lymphocytic lymphoma
973864|NCT03331198|CAR|car
973865|NCT03331198|CAR T cells|car t cells
973866|NCT03331198|autologous T cell therapy|autologous t cell therapy
973867|NCT03331198|immunotherapy|immunotherapy
973868|NCT03331185|Extraction|extraction
973869|NCT03331185|Alveolar Ridge Augmentation|alveolar ridge augmentation
1657058|NCT00160628|Keppra|keppra
973870|NCT03331185|Freeze Dried Bone Allograft|freeze dried bone allograft
973871|NCT03331185|Leukocytic Platelet Rich Fibrin|leukocytic platelet rich fibrin
973872|NCT03331185|Volumetric Changes|volumetric changes
973873|NCT03331185|Dense Polytetrafluoroethylene Membrane|dense polytetrafluoroethylene membrane
973874|NCT03331172|HIFU|hifu
973875|NCT03331172|thyroid nodule|thyroid nodule
973876|NCT03331172|Benign|benign
973877|NCT03331172|Reapplication|reapplication
973878|NCT03331159|Lumbar Fusion|lumbar fusion
973879|NCT03331159|Hydroxyapatite|hydroxyapatite
973880|NCT03331146|Nitric Oxide|nitric oxide
973881|NCT03331146|Sodium Nitrite|sodium nitrite
973882|NCT03331146|Cardiopulmonary bypass|cardiopulmonary bypass
973883|NCT03331146|cardioplegic cardiac arrest|cardioplegic cardiac arrest
973884|NCT03331146|coronary revacularization|coronary revacularization
973885|NCT03331133|Twin|twin
973886|NCT03331133|Early Development|early development
973887|NCT03331133|Cohort|cohort
973888|NCT03331081|Overactive Bladder Syndrome|overactive bladder syndrome
973889|NCT03331055|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
973890|NCT03331055|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
973891|NCT03331055|pain|pain
973892|NCT03331055|pancreatic cancer|pancreatic cancer
973893|NCT03331042|Insomnia|insomnia
973894|NCT03331042|Transient Insomnia|transient insomnia
973895|NCT03331042|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
973896|NCT03331029|3 D Ultrasound, left atrium, Mitral inflow velocity, systolic and diastolic ventricular function|3 d ultrasound, left atrium, mitral inflow velocity, systolic and diastolic ventricular function
973897|NCT03331016|Foster caregiver|foster caregiver
973898|NCT03331016|Kinship caregiver|kinship caregiver
973899|NCT03331016|Foster youth|foster youth
973900|NCT03331016|Unintended pregnancy|unintended pregnancy
973901|NCT03331016|Curriculum|curriculum
973902|NCT03331016|Intervention|intervention
973903|NCT03331016|sexually transmitted infections|sexually transmitted infections
973904|NCT03331016|Behaviorism|behaviorism
973905|NCT03331016|Monitoring|monitoring
973906|NCT03331016|Communication|communication
973907|NCT03331016|Adolescent development|adolescent development
973908|NCT03331016|sexually transmitted diseases|sexually transmitted diseases
973909|NCT03330951|HbA1c|hba1c
973910|NCT03330951|Glycated albumin|glycated albumin
973911|NCT03330938|Hemodialysis|hemodialysis
973912|NCT03330938|Resilience|resilience
973913|NCT03330938|Cognitive Behavioral Therapy|cognitive behavioral therapy
973914|NCT03330873|Asherman syndrome|asherman syndrome
973915|NCT03330873|disposable balloon uterine stent|disposable balloon uterine stent
973916|NCT03330873|hysteroscopy|hysteroscopy
973917|NCT03330873|Foley catheter|foley catheter
973918|NCT03330847|Germline BRCA mutation|germline brca mutation
973919|NCT03330847|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
973920|NCT03330847|Olaparib|olaparib
973921|NCT03330847|Homologous Recombinant Repair (HRR)-related Genes|homologous recombinant repair (hrr)-related genes
973922|NCT03330834|CAR-T|car-t
973923|NCT03330834|advanced lung cancer|advanced lung cancer
973924|NCT03330834|single-arm|single-arm
973925|NCT03330834|phase I clinical study|phase i clinical study
974023|NCT03330145|Children|children
973926|NCT03330795|end-stage lung disease|end-stage lung disease
973927|NCT03330795|Bilateral Orthotopic Lung Transplant (BOLT) candidate|bilateral orthotopic lung transplant (bolt) candidate
973928|NCT03330795|CD3/CD19 negative allogeneic hematopoietic stem cells (HSCT)|cd3/cd19 negative allogeneic hematopoietic stem cells (hsct)
973929|NCT03330795|CD3+/CD19+ depleted Bone Marrow Transplant (BMT)|cd3+/cd19+ depleted bone marrow transplant (bmt)
973930|NCT03330795|Cadaveric (Deceased) Donor|cadaveric (deceased) donor
973931|NCT03330795|Unrelated (Deceased) Donor|unrelated (deceased) donor
973932|NCT03330782|pain|pain
973933|NCT03330782|propofol|propofol
973934|NCT03330782|remifentanil|remifentanil
973935|NCT03330769|Psoriatic Arthritis|psoriatic arthritis
973936|NCT03330769|Ultrasonography|ultrasonography
973937|NCT03330769|Minimal disease activity|minimal disease activity
973938|NCT03330756|Roux-en-Y gastric bypass|roux-en-y gastric bypass
973939|NCT03330756|Mini gastric bypass|mini gastric bypass
973940|NCT03330756|Type 2 diabetes mellitus|type 2 diabetes mellitus
973941|NCT03330756|Morbid Obesity|morbid obesity
973942|NCT03330691|CD19|cd19
973943|NCT03330691|CD22|cd22
973944|NCT03330691|CAR T-cell|car t-cell
973945|NCT03330678|Probiotic|probiotic
973946|NCT03330678|Gut microbiome|gut microbiome
973947|NCT03330678|VSL#3|vsl#3
973948|NCT03330652|Quality of life|quality of life
973949|NCT03330652|Cognitive function|cognitive function
973950|NCT03330652|Mental state|mental state
973951|NCT03330652|Functional capacity|functional capacity
973952|NCT03330652|EQ5D|eq5d
973953|NCT03330652|HADS|hads
973954|NCT03330652|Barthel Index|barthel index
973955|NCT03330652|mRS|mrs
973956|NCT03330626|Fluid management|fluid management
973957|NCT03330626|conventional method|conventional method
973958|NCT03330626|InBody S10|inbody s10
973959|NCT03330626|CRRT|crrt
973960|NCT03330574|Glaucoma|glaucoma
973961|NCT03330561|HER2-positive breast cancer|her2-positive breast cancer
973962|NCT03330561|HER2 -positive gastric cancer|her2 -positive gastric cancer
973963|NCT03330561|HER2-positive bladder cancer|her2-positive bladder cancer
973964|NCT03330561|Pieris|pieris
973965|NCT03330561|PRS-343|prs-343
973966|NCT03330561|Anticalin|anticalin
973967|NCT03330561|Bi-specific|bi-specific
973968|NCT03330561|4-1BB|4-1bb
973969|NCT03330561|CD137|cd137
973970|NCT03330561|HER2|her2
973971|NCT03330548|Plant-based diet|plant-based diet
973972|NCT03330548|Hyperlipidemia|hyperlipidemia
973973|NCT03330548|Diabetes|diabetes
973974|NCT03330548|Overweight|overweight
973975|NCT03330548|Veterans|veterans
973976|NCT03330509|Palliative care|palliative care
973977|NCT03330509|Consultation model|consultation model
973978|NCT03330496|infant-newborn|infant-newborn
973979|NCT03330496|infant-premature|infant-premature
973980|NCT03330496|pain|pain
973981|NCT03330496|acute pain|acute pain
973982|NCT03330496|repetitive pain|repetitive pain
973983|NCT03330483|pain|pain
973984|NCT03330483|discomfort|discomfort
973985|NCT03330483|hydrophylic catheter|hydrophylic catheter
973986|NCT03330483|urodynamic study|urodynamic study
973987|NCT03330444|Endometrial microbiota|endometrial microbiota
973988|NCT03330444|Bacterial pathogens|bacterial pathogens
973989|NCT03330444|Assisted reproductive techniques|assisted reproductive techniques
973990|NCT03330444|Dysbiosis|dysbiosis
973991|NCT03330444|Endometrial receptivity|endometrial receptivity
973992|NCT03330444|Endometrial diagnosis|endometrial diagnosis
973993|NCT03330405|NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial ovarian cancer, UC, and castration resistant prostate cancer (CRPC).|nsclc, tnbc, hormone receptor positive (hr+) breast cancer, recurrent epithelial ovarian cancer, uc, and castration resistant prostate cancer (crpc).
973994|NCT03330379|Endotracheal tube|endotracheal tube
973995|NCT03330379|ventilator's associated pneumonia|ventilator's associated pneumonia
973996|NCT03330379|intensive care unit|intensive care unit
973997|NCT03330379|orotracheal intubation|orotracheal intubation
973998|NCT03330340|vertebral compression fracture|vertebral compression fracture
973999|NCT03330340|osteoporosis|osteoporosis
974000|NCT03330340|glucocorticoids|glucocorticoids
974001|NCT03330340|vertebroplasty|vertebroplasty
974002|NCT03330262|Postural Instability|postural instability
974003|NCT03330262|Balance Disorder|balance disorder
974004|NCT03330262|Balance Prosthesis|balance prosthesis
974005|NCT03330262|Dizziness|dizziness
974006|NCT03330210|LAAC|laac
974007|NCT03330210|3D printing|3d printing
974008|NCT03330210|Procedure success|procedure success
974009|NCT03330210|Procedure-related complications|procedure-related complications
974010|NCT03330197|DIPG|dipg
974011|NCT03330197|Glioblastoma|glioblastoma
974012|NCT03330197|Anaplastic Astrocytoma|anaplastic astrocytoma
974727|NCT03325842|Adolescent|adolescent
974013|NCT03330197|High Grade Glioma (HGG) Not Otherwise Specified (NOS)|high grade glioma (hgg) not otherwise specified (nos)
974014|NCT03330197|Supratentorial Tumor NOS|supratentorial tumor nos
974015|NCT03330184|Bifidobacterium|bifidobacterium
974016|NCT03330184|People With Abnormal Glucose Level|people with abnormal glucose level
974017|NCT03330171|Immunogenicity|immunogenicity
974018|NCT03330171|Safety|safety
974019|NCT03330171|Vaccine|vaccine
974020|NCT03330145|Complicated Grief|complicated grief
974021|NCT03330145|Risk Factors|risk factors
974024|NCT03330119|Pregnancy|pregnancy
974025|NCT03330119|cesarean section|cesarean section
974026|NCT03330119|enhanced recovery|enhanced recovery
974027|NCT03330119|narcotic use|narcotic use
974028|NCT03330106|Drug therapy|drug therapy
974029|NCT03330093|Children|children
974030|NCT03330080|Ecological momentary assessment|ecological momentary assessment
974031|NCT03330080|Sleepiness|sleepiness
974032|NCT03330080|Fatigue|fatigue
974033|NCT03330080|Endocrinopathy|endocrinopathy
974034|NCT03330080|Family functioning|family functioning
974035|NCT03330067|laparoscope|laparoscope
974036|NCT03330041|Cutaneous Sutures|cutaneous sutures
974037|NCT03330041|Scar Cosmesis|scar cosmesis
974038|NCT03330041|Linear Wound Closure|linear wound closure
974039|NCT03330041|Wound Cosmesis|wound cosmesis
974040|NCT03330028|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
974041|NCT03330028|Gastric cancer|gastric cancer
974042|NCT03330028|Gastroesophageal cancer|gastroesophageal cancer
974043|NCT03330028|Adenocarcinoma of the stomach or gastroesophageal junction|adenocarcinoma of the stomach or gastroesophageal junction
974044|NCT03330028|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
974045|NCT03330028|HIPEC|hipec
974046|NCT03330028|Paclitaxel|paclitaxel
974047|NCT03330028|Taxol|taxol
974048|NCT03330028|Dexamethasone|dexamethasone
974049|NCT03330028|Decadron|decadron
974050|NCT03330028|Diphenhydramine|diphenhydramine
974051|NCT03330028|Benadryl|benadryl
974052|NCT03330028|Cisplatin|cisplatin
974053|NCT03330028|Platinol-AQ|platinol-aq
974054|NCT03330028|Platinol|platinol
974055|NCT03330028|CDDP|cddp
974056|NCT03330028|Mitomycin-C|mitomycin-c
974057|NCT03330028|Mitomycin|mitomycin
974058|NCT03330028|Famotidine|famotidine
974059|NCT03330028|Pepcid|pepcid
974060|NCT03330015|postmenopausal bleeding|postmenopausal bleeding
974061|NCT03330015|endometrial cancer|endometrial cancer
974062|NCT03330015|Patient's experience|patient's experience
974063|NCT03330015|Patient's choice|patient's choice
974064|NCT03330002|Arterial Closure Device|arterial closure device
974065|NCT03330002|Large Bore Closure Device|large bore closure device
974066|NCT03329950|CDX-1140|cdx-1140
974067|NCT03329950|Solid Tumors|solid tumors
974068|NCT03329950|Liver Cancer|liver cancer
974069|NCT03329950|GI Cancer|gi cancer
974070|NCT03329950|Kidney Cancer|kidney cancer
974071|NCT03329950|Celldex|celldex
974072|NCT03329898|Asherman syndrome|asherman syndrome
974073|NCT03329898|uterine stent|uterine stent
974074|NCT03329898|hysteroscopy|hysteroscopy
974075|NCT03329872|Neuro-Orthopedics|neuro-orthopedics
974076|NCT03329872|Register|register
974077|NCT03329833|Parkinson's Disease|parkinson's disease
974078|NCT03329833|Parkinson's|parkinson's
974079|NCT03329833|Motivational Interviewing|motivational interviewing
974080|NCT03329833|Exercise|exercise
974081|NCT03329833|Motivation|motivation
974082|NCT03329820|Chronic hepatitis B infection|chronic hepatitis b infection
974083|NCT03329820|Health-related quality of life|health-related quality of life
974084|NCT03329820|Cost-effectiveness|cost-effectiveness
974085|NCT03329820|Treatment|treatment
974086|NCT03329820|Chinese|chinese
974087|NCT03329781|Endotoxaemia, Curcumin.|endotoxaemia, curcumin.
974088|NCT03329755|Advanced melanoma|advanced melanoma
974089|NCT03329755|Immune checkpoint|immune checkpoint
974090|NCT03329755|E-follow-up|e-follow-up
974091|NCT03329716|brace-weaning, cost-effectiveness|brace-weaning, cost-effectiveness
974092|NCT03329703|PNES|pnes
974093|NCT03329703|UPLIFT|uplift
974094|NCT03329703|Depression|depression
974095|NCT03329703|Mindfulness|mindfulness
974096|NCT03329703|CBT|cbt
974097|NCT03329703|Managing Epilepsy Well (MEW) Network|managing epilepsy well (mew) network
974098|NCT03329703|Psychogenic Seizures|psychogenic seizures
974099|NCT03329703|Non-Epileptic Seizures|non-epileptic seizures
974100|NCT03329690|Adenocarcinoma Metastatic|adenocarcinoma metastatic
974101|NCT03329690|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
974102|NCT03329690|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
974103|NCT03329690|HER2 Overexpression|her2 overexpression
974104|NCT03329690|Adenocarcinoma, Locally Advanced|adenocarcinoma, locally advanced
974105|NCT03329625|Triple P|triple p
974106|NCT03329625|RCT|rct
974107|NCT03329625|parent management training|parent management training
974108|NCT03329625|Child welfare|child welfare
974109|NCT03329625|child behavior problems|child behavior problems
974110|NCT03329586|maximum oxygen consumption|maximum oxygen consumption
974111|NCT03329586|organ transplantation|organ transplantation
974112|NCT03329586|physical fitness|physical fitness
974728|NCT03325829|Registry|registry
974113|NCT03329586|rehabilitation|rehabilitation
974114|NCT03329573|Cross-over|cross-over
974115|NCT03329573|Chinese|chinese
974116|NCT03329573|GSKT|gskt
974117|NCT03329573|Mississauga|mississauga
974118|NCT03329573|Healthy|healthy
974119|NCT03329573|Bioequivalence|bioequivalence
974120|NCT03329573|Paroxetine|paroxetine
974121|NCT03329547|Bioequivalence|bioequivalence
974122|NCT03329547|Pharmacokinetics|pharmacokinetics
974123|NCT03329547|SKF101804|skf101804
974124|NCT03329547|Crossover|crossover
974125|NCT03329547|Cefixime|cefixime
974126|NCT03329521|Cluster Randomized Controlled Trial|cluster randomized controlled trial
974127|NCT03329521|Kidney Transplant|kidney transplant
974128|NCT03329521|Living Kidney Donation|living kidney donation
974129|NCT03329521|Kidney Disease|kidney disease
974130|NCT03329508|Parkinson disease|parkinson disease
974131|NCT03329495|right colon cancer|right colon cancer
974132|NCT03329495|superior mesenteric artery|superior mesenteric artery
974133|NCT03329495|superior mesenteric vein|superior mesenteric vein
974134|NCT03329482|Ultrasound|ultrasound
974135|NCT03329482|kneading-massage|kneading-massage
974136|NCT03329482|low back pain|low back pain
974137|NCT03329482|pain intensity|pain intensity
974138|NCT03329482|disability|disability
974139|NCT03329469|Computed Tomography Fractional Flow Reserve (CT-FFR),|computed tomography fractional flow reserve (ct-ffr),
974140|NCT03329469|Computed Coronary Tomography Angiography (CCTA)|computed coronary tomography angiography (ccta)
974141|NCT03329469|Invasive Fractional Flow Reserve (iFFR)|invasive fractional flow reserve (iffr)
974142|NCT03329469|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
974143|NCT03329469|Emergency Department (ED)|emergency department (ed)
974144|NCT03329469|Emergency Room (ER)|emergency room (er)
974145|NCT03329443|spironolactone|spironolactone
974146|NCT03329404|Thalassemia|thalassemia
974147|NCT03329404|pathogen reduction therapy|pathogen reduction therapy
974148|NCT03329391|Psychosocial model,nursing intervention|psychosocial model,nursing intervention
974149|NCT03329378|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
974150|NCT03329378|locally advanced breast cancer|locally advanced breast cancer
974151|NCT03329378|Her2neu|her2neu
974152|NCT03329365|Flow cytometry|flow cytometry
1568405|NCT00505947|diabetes mellitus|diabetes mellitus
974153|NCT03329365|Lactate dehydrogenase (LDH) release|lactate dehydrogenase (ldh) release
974154|NCT03329365|Anemia|anemia
974155|NCT03329365|Cytopenia|cytopenia
974156|NCT03329339|diet|diet
974157|NCT03329326|standardized test|standardized test
974158|NCT03329326|prosthesis|prosthesis
974159|NCT03329326|upper limb amputation|upper limb amputation
974160|NCT03329326|rehabilitation outcome|rehabilitation outcome
974161|NCT03329313|Intensive care unit|intensive care unit
974162|NCT03329313|SLEDD-f|sledd-f
974163|NCT03329313|intermittent hemodialysis/diafiltration|intermittent hemodialysis/diafiltration
974164|NCT03329300|Pediatric Obesity|pediatric obesity
974165|NCT03329300|Executive Function|executive function
974166|NCT03329300|Behavioral Intervention|behavioral intervention
974167|NCT03329287|Simplified Cognitive Behavioral Therapy (SCBT)|simplified cognitive behavioral therapy (scbt)
974168|NCT03329287|Generalized Anxiety Disorder|generalized anxiety disorder
974169|NCT03329287|Depression|depression
974170|NCT03329287|Operating manual|operating manual
974171|NCT03329287|Efficacy|efficacy
974172|NCT03329274|registry|registry
974173|NCT03329209|Drug therapy|drug therapy
974174|NCT03329183|Irinotecan|irinotecan
974175|NCT03329183|UGT1A1|ugt1a1
974176|NCT03329183|Advanced Colorectal Cancer|advanced colorectal cancer
974177|NCT03329170|Oral health|oral health
974178|NCT03329170|Dental caries|dental caries
974179|NCT03329170|Heart Defects|heart defects
974180|NCT03329170|Congenital|congenital
974181|NCT03329144|Young mother|young mother
974182|NCT03329144|Depression|depression
974183|NCT03329144|Anxiety|anxiety
974184|NCT03329144|Resilience|resilience
974185|NCT03329144|Emotion regulation|emotion regulation
974186|NCT03329144|Parenting|parenting
974187|NCT03329144|CBT|cbt
974188|NCT03329118|SHR3824,simvastatin, drug-drug interaction|shr3824,simvastatin, drug-drug interaction
974189|NCT03329105|Gingival Health|gingival health
974190|NCT03329105|Biofilm Formation|biofilm formation
974191|NCT03329092|Complicated intra-abdominal infection|complicated intra-abdominal infection
974192|NCT03329092|Hosptial acquired pneumonia|hosptial acquired pneumonia
974193|NCT03329092|Ventilator associated pneumonia|ventilator associated pneumonia
974194|NCT03329092|Gram negative infections|gram negative infections
974195|NCT03329092|Metallo-beta lactamase|metallo-beta lactamase
974196|NCT03329092|Multi drug resistant pathogens|multi drug resistant pathogens
974197|NCT03329079|rural|rural
974198|NCT03329079|men|men
974199|NCT03329079|community-based participatory research|community-based participatory research
974200|NCT03329079|weight loss|weight loss
974201|NCT03329079|mobile applications|mobile applications
974202|NCT03329079|text messaging|text messaging
974203|NCT03329066|Asthma|asthma
974204|NCT03329066|Sleep|sleep
974205|NCT03329066|Adolescents|adolescents
974206|NCT03329066|Urban|urban
974207|NCT03329066|Intervention|intervention
974208|NCT03329066|High school|high school
974209|NCT03329053|exercise prescription|exercise prescription
974210|NCT03329053|digital exercise prescription tool|digital exercise prescription tool
974211|NCT03329040|Hyperbilirubinemia|hyperbilirubinemia
974212|NCT03329040|Primiparity|primiparity
974213|NCT03329040|multiparity|multiparity
974214|NCT03329001|PARP inhibitor|parp inhibitor
974215|NCT03329001|niraparib|niraparib
974216|NCT03329001|Zejula|zejula
974217|NCT03328988|bladder cancer|bladder cancer
974218|NCT03328988|radical cystectomy|radical cystectomy
974219|NCT03328988|epidural analgesia|epidural analgesia
974220|NCT03328988|quadratus lumborum block|quadratus lumborum block
974221|NCT03328988|postoperative pain|postoperative pain
974222|NCT03328923|post-prandial cognition|post-prandial cognition
974223|NCT03328923|brown seaweed|brown seaweed
974224|NCT03328910|Emergence Delirium|emergence delirium
974225|NCT03328910|pulse oximetry|pulse oximetry
974226|NCT03328910|Children, Preschool|children, preschool
974227|NCT03328897|Chronic spontaneous urticarial|chronic spontaneous urticarial
974228|NCT03328897|ISS7|iss7
974229|NCT03328897|UAS7|uas7
974230|NCT03328897|omalizumab, China|omalizumab, china
974231|NCT03328871|Striae Gravidarum|striae gravidarum
974232|NCT03328871|Fractional Laser|fractional laser
974233|NCT03328871|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
974234|NCT03328871|Nanofat Graft|nanofat graft
974235|NCT03328871|Combination Therapy|combination therapy
974236|NCT03328858|Ketogenic Diet, brain tumors|ketogenic diet, brain tumors
974237|NCT03328845|Oxidation|oxidation
974238|NCT03328845|Insulin analogues|insulin analogues
974239|NCT03328845|Type 1 diabetes mellitus|type 1 diabetes mellitus
974240|NCT03328832|Thrombin-gelatin matrix|thrombin-gelatin matrix
974241|NCT03328832|Floseal|floseal
974242|NCT03328832|Tranexamic Acid|tranexamic acid
974243|NCT03328832|Total Knee Arthroplasty|total knee arthroplasty
974244|NCT03328819|Acupuncture|acupuncture
974245|NCT03328819|Chronic pain|chronic pain
974246|NCT03328819|Major depressive disorder|major depressive disorder
974247|NCT03328819|Biomarkers|biomarkers
974248|NCT03328819|Gene|gene
974249|NCT03328819|Comorbidity|comorbidity
974250|NCT03328806|low back pain|low back pain
974251|NCT03328806|outcome measures|outcome measures
974252|NCT03328806|cross culture adaptation|cross culture adaptation
974253|NCT03328806|Core Outcome Measure Index|core outcome measure index
974254|NCT03328793|music|music
974255|NCT03328793|gait|gait
974256|NCT03328793|emotions|emotions
974257|NCT03328793|communication|communication
974258|NCT03328780|preoperative|preoperative
974259|NCT03328780|orthopedic surgery|orthopedic surgery
974260|NCT03328754|Pitchfork|pitchfork
974261|NCT03328754|Class II malocclusion|class ii malocclusion
974262|NCT03328754|PowerScope|powerscope
974263|NCT03328741|Clinical Trials, Randomized|clinical trials, randomized
974264|NCT03328741|Telemedicine|telemedicine
974265|NCT03328702|Dysphagia|dysphagia
974266|NCT03328702|Oropharyngeal dysphagia|oropharyngeal dysphagia
974267|NCT03328702|Total Laryngectomy|total laryngectomy
974268|NCT03328702|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
974269|NCT03328689|prevention|prevention
974270|NCT03328689|exercise|exercise
974271|NCT03328689|randomized controlled trial|randomized controlled trial
974272|NCT03328689|physical activity|physical activity
974273|NCT03328663|Cancer Care|cancer care
974274|NCT03328637|Smartphone Addiction|smartphone addiction
974276|NCT03328637|Evidence based intervention|evidence based intervention
974277|NCT03328585|CBT-I|cbt-i
974278|NCT03328585|Telemedicine|telemedicine
974279|NCT03328494|Paclitaxel|paclitaxel
974280|NCT03328494|BOS172722|bos172722
974281|NCT03328494|triple-negative breast cancer|triple-negative breast cancer
974282|NCT03328468|Stroke|stroke
974283|NCT03328429|bartholin|bartholin
974284|NCT03328429|marsupialisation|marsupialisation
974285|NCT03328429|abscess|abscess
974286|NCT03328416|Image-Guided Biopsy|image-guided biopsy
974287|NCT03328416|Multidetector Computed Tomography|multidetector computed tomography
974288|NCT03328416|Diagnostic Imaging|diagnostic imaging
974289|NCT03328416|Cryosurgery|cryosurgery
974290|NCT03328416|Ablation Techniques|ablation techniques
974291|NCT03328403|Endovascular therapy|endovascular therapy
974292|NCT03328403|Mechanical thrombectomy|mechanical thrombectomy
974293|NCT03328403|Acute ischaemic stroke treatment|acute ischaemic stroke treatment
974294|NCT03328364|enzalutamide|enzalutamide
974295|NCT03328364|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
974296|NCT03328364|Xtandi|xtandi
974297|NCT03328364|registry based study|registry based study
974298|NCT03328364|MDV3100|mdv3100
974299|NCT03328364|mCRPC|mcrpc
974300|NCT03328351|Manual therapy|manual therapy
974301|NCT03328351|cervical radiculopathy|cervical radiculopathy
974302|NCT03328351|pressure pain threshold|pressure pain threshold
974303|NCT03328351|physiotherapy|physiotherapy
974304|NCT03328338|Mitochondria|mitochondria
974305|NCT03328338|Oxidative phosphorylation (mitochondrial respiration)|oxidative phosphorylation (mitochondrial respiration)
974306|NCT03328338|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
974307|NCT03328338|Heart.|heart.
974308|NCT03328325|Influenza|influenza
974309|NCT03328325|PCR|pcr
974310|NCT03328325|Seasonal Vaccination|seasonal vaccination
974311|NCT03328221|Heart rate variability|heart rate variability
974312|NCT03328221|Observational study|observational study
974313|NCT03328221|Physical activity|physical activity
974314|NCT03328221|Rehabilitation|rehabilitation
974315|NCT03328208|Nonpharmacologic analgesia|nonpharmacologic analgesia
974316|NCT03328208|Medical app|medical app
974317|NCT03328208|Relaxation|relaxation
974318|NCT03328143|Craniotomy, anxiety, malignant, cancer, brain tumor|craniotomy, anxiety, malignant, cancer, brain tumor
974325|NCT03328130|Retinal Dystrophy|retinal dystrophy
974326|NCT03328130|Eye Diseases|eye diseases
974327|NCT03328130|Vision Disorders|vision disorders
974328|NCT03328130|Eye Diseases, Hereditary|eye diseases, hereditary
974329|NCT03328130|Retinal Diseases|retinal diseases
974330|NCT03328130|Retinal Degeneration|retinal degeneration
974331|NCT03328104|T- cell acute lymphoblastic leukemia|t- cell acute lymphoblastic leukemia
974333|NCT03328104|T-cell lymphoblastic lymphoma|t-cell lymphoblastic lymphoma
974334|NCT03328104|T-LLy|t-lly
974335|NCT03328104|Everolimus|everolimus
974336|NCT03328104|Maximum tolerated dose|maximum tolerated dose
974337|NCT03328091|Prostate Cancer|prostate cancer
974338|NCT03328091|Genetics|genetics
974339|NCT03328078|DLBCL|dlbcl
974341|NCT03328078|WM|wm
974342|NCT03328078|LPL|lpl
974343|NCT03328078|MYD88|myd88
974344|NCT03328078|IRAK4|irak4
974345|NCT03327987|vaccine immunogenicity|vaccine immunogenicity
974346|NCT03327987|vaccine safety|vaccine safety
974347|NCT03327974|Aged between 18 and 65|aged between 18 and 65
974348|NCT03327974|Major depressive disorder|major depressive disorder
974349|NCT03327974|Suicide|suicide
974350|NCT03327974|Ecological momentary assessment|ecological momentary assessment
974351|NCT03327974|Smartphone application|smartphone application
974352|NCT03327948|Sacral neuromodulation (SNM)|sacral neuromodulation (snm)
974353|NCT03327948|SNM|snm
974354|NCT03327922|Subdermal|subdermal
974355|NCT03327922|Suture|suture
974356|NCT03327922|Wound Closure|wound closure
974357|NCT03327922|Wound Cosmesis|wound cosmesis
974358|NCT03327909|Intradialytic Hypotension, Hypertension, Ambulatory Blood Pressure|intradialytic hypotension, hypertension, ambulatory blood pressure
974359|NCT03327896|Quality Measures, Social Determinants of Health|quality measures, social determinants of health
974366|NCT03327844|Regenerative Endodontic Therapy|regenerative endodontic therapy
974367|NCT03327844|Infected immature permanent teeth|infected immature permanent teeth
974368|NCT03327831|aminolevulinic acid|aminolevulinic acid
974370|NCT03327831|photodynamic therapy|photodynamic therapy
974371|NCT03327831|Photochemotherapy|photochemotherapy
974372|NCT03327805|Choline|choline
974373|NCT03327805|Trimethylamine N-Oxide|trimethylamine n-oxide
974374|NCT03327805|Vascular health|vascular health
974375|NCT03327766|vitamin D and recurrent pregnancy loss|vitamin d and recurrent pregnancy loss
974376|NCT03327753|exercise|exercise
974377|NCT03327753|mobility|mobility
974378|NCT03327753|physiotherapy|physiotherapy
974379|NCT03327753|validation|validation
974380|NCT03327740|Hypersensitivity reactions (HSR)|hypersensitivity reactions (hsr)
974381|NCT03327740|HIV|hiv
974382|NCT03327740|Dolutegravir|dolutegravir
974383|NCT03327727|IA|ia
974384|NCT03327714|mindfulness|mindfulness
974385|NCT03327714|children|children
974386|NCT03327714|anxiety|anxiety
974387|NCT03327714|depression|depression
974388|NCT03327714|mental disorder|mental disorder
974389|NCT03327714|risk factor|risk factor
974390|NCT03327701|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
974391|NCT03327701|Benralizumab|benralizumab
974392|NCT03327701|Antiinterleukin 5 receptor α monoclonal antibody|antiinterleukin 5 receptor α monoclonal antibody
974393|NCT03327688|Focus assesment with sonography for trauma|focus assesment with sonography for trauma
974394|NCT03327688|POCUS|pocus
974395|NCT03327688|LOS|los
974396|NCT03327688|Point-of-care ultrasound|point-of-care ultrasound
974397|NCT03327688|length of stay|length of stay
974398|NCT03327688|cost-minimization|cost-minimization
974399|NCT03327688|primary health care|primary health care
974400|NCT03327688|Ultrasound|ultrasound
974401|NCT03327688|Emergency department|emergency department
974402|NCT03327675|prostate-specific membrane antigen|prostate-specific membrane antigen
974403|NCT03327675|Lymph Node Dissection|lymph node dissection
974404|NCT03327675|Prostatectomy|prostatectomy
974405|NCT03327675|Positron-Emission Tomography|positron-emission tomography
974406|NCT03327662|Cabazitaxel|cabazitaxel
974407|NCT03327662|Docetaxel|docetaxel
974408|NCT03327662|Circulating Tumour Cells|circulating tumour cells
974409|NCT03327649|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
974410|NCT03327649|inflammation|inflammation
974411|NCT03327636|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
974412|NCT03327636|High intensity focused ultrasound|high intensity focused ultrasound
974413|NCT03327636|Active surveillance|active surveillance
974414|NCT03327623|sleep apnea|sleep apnea
974415|NCT03327623|arrhythmia|arrhythmia
974416|NCT03327610|Respiratory Therapy|respiratory therapy
974417|NCT03327610|Positive Pressure Respiration|positive pressure respiration
974418|NCT03327610|Physical Therapy Modalities|physical therapy modalities
974419|NCT03327597|MGUS|mgus
974421|NCT03327597|Population-based|population-based
974422|NCT03327571|Drug therapy|drug therapy
974423|NCT03327545|Trigger points|trigger points
974424|NCT03327545|Trigegeminal nerve|trigegeminal nerve
974425|NCT03327545|Pain|pain
974426|NCT03327532|Acute Heart Failure|acute heart failure
974427|NCT03327532|Congestion|congestion
974428|NCT03327532|Ultrasound|ultrasound
974429|NCT03327519|Asthma|asthma
974430|NCT03327519|Insomnia|insomnia
974431|NCT03327506|Premedication/ Hypnosis/ Anxiety/Surgery|premedication/ hypnosis/ anxiety/surgery
974432|NCT03327493|Cardiogenic shock|cardiogenic shock
974433|NCT03327493|Extra-Corporeal-Life-Support (ECLS)|extra-corporeal-life-support (ecls)
974434|NCT03327493|inflammation|inflammation
974435|NCT03327493|adrenergic system|adrenergic system
974436|NCT03327480|osteoarthritis thumb|osteoarthritis thumb
974437|NCT03327480|orthosis|orthosis
974438|NCT03327480|functioning|functioning
974439|NCT03327454|Rheumatoid arthritis|rheumatoid arthritis
974440|NCT03327454|Ankylosing spondylitis|ankylosing spondylitis
974441|NCT03327454|Axial spondyloarthritis|axial spondyloarthritis
974442|NCT03327454|Benepali pen|benepali pen
974443|NCT03327454|Etanercept|etanercept
974444|NCT03327454|Patient questionnaire|patient questionnaire
974445|NCT03327454|Pre-filled pen|pre-filled pen
974446|NCT03327454|Biological DMARDs|biological dmards
974447|NCT03327454|Antirheumatic drug|antirheumatic drug
974448|NCT03327428|Anemia, Sickle Cell|anemia, sickle cell
974449|NCT03327428|Sickle Cell disease|sickle cell disease
974450|NCT03327415|Children|children
974451|NCT03327415|Food practice|food practice
974452|NCT03327415|Food consumption|food consumption
974453|NCT03327415|Nutrient intake|nutrient intake
974454|NCT03327402|SHP465|shp465
974455|NCT03327402|ADHD|adhd
974456|NCT03327402|Hyperactivity|hyperactivity
974457|NCT03327376|central venous catheters|central venous catheters
974458|NCT03327376|venous thrombosis|venous thrombosis
974459|NCT03327376|ultrasound|ultrasound
974460|NCT03327376|critical care|critical care
974461|NCT03327363|ICT based clinical trial,|ict based clinical trial,
974462|NCT03327363|eCRF|ecrf
974463|NCT03327363|electronic -institutional review board (eIRB),|electronic -institutional review board (eirb),
974464|NCT03327363|Centralized monitoring|centralized monitoring
974465|NCT03327363|contract research organization (CRO)|contract research organization (cro)
974466|NCT03327311|No condition|no condition
974467|NCT03327298|Pedicle screw. Free hand. Lumbar fixation|pedicle screw. free hand. lumbar fixation
974468|NCT03327285|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
974469|NCT03327285|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
974470|NCT03327285|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
974471|NCT03327181|short chain fatty acid metabolism|short chain fatty acid metabolism
974472|NCT03327168|Adipose Tissue, Brown|adipose tissue, brown
974473|NCT03327155|HIV prevention|hiv prevention
974474|NCT03327155|PrEP|prep
974475|NCT03327142|Adrenal Gland|adrenal gland
974476|NCT03327142|Endoscopic Ultrasound Guided FNA|endoscopic ultrasound guided fna
974477|NCT03327116|atopic dermatitis|atopic dermatitis
974478|NCT03327116|pruritus|pruritus
974479|NCT03327116|methotrexate|methotrexate
974480|NCT03327116|inflamation|inflamation
974481|NCT03327116|IL-31|il-31
974482|NCT03327103|decision making|decision making
974483|NCT03327103|advanced prostate cancer|advanced prostate cancer
974484|NCT03327103|decision aid|decision aid
974485|NCT03327103|minorities|minorities
974486|NCT03327103|mHealth|mhealth
974487|NCT03327103|community patient navigator|community patient navigator
974488|NCT03327090|Olympic Weightlifting|olympic weightlifting
974489|NCT03327090|Taping|taping
974490|NCT03327090|Muscles Facilitation|muscles facilitation
974491|NCT03327090|Jumps|jumps
974492|NCT03326999|adductor canal regional block|adductor canal regional block
974493|NCT03326999|obturator nerve regional block|obturator nerve regional block
974494|NCT03326999|total knee arthroplasty|total knee arthroplasty
974495|NCT03326999|knee replacement surgery|knee replacement surgery
974496|NCT03326999|Knee rheumatoid arthritis|knee rheumatoid arthritis
974497|NCT03326973|Quality of Life (QoL)|quality of life (qol)
974498|NCT03326973|17-518|17-518
974499|NCT03326960|general anesthesia|general anesthesia
974500|NCT03326960|postoperative delirium|postoperative delirium
974501|NCT03326960|postoperative cognitive dysfunction|postoperative cognitive dysfunction
974502|NCT03326960|biomarker|biomarker
974503|NCT03326947|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
974504|NCT03326921|HA-1|ha-1
974505|NCT03326921|TCR|tcr
974506|NCT03326921|Immunotherapy|immunotherapy
974507|NCT03326921|Leukemia|leukemia
974508|NCT03326843|low platelet count|low platelet count
974509|NCT03326843|ITP|itp
974510|NCT03326830|Respiratory Insufficiency|respiratory insufficiency
974511|NCT03326830|Oxygen Inhalation Therapy|oxygen inhalation therapy
974611|NCT03326375|SBRT|sbrt
974512|NCT03326817|Degenerative Arthritis, Rheumatic Diseases|degenerative arthritis, rheumatic diseases
974513|NCT03326804|Hip Resurfacing Arthroplasty|hip resurfacing arthroplasty
974514|NCT03326804|Ceramic|ceramic
974515|NCT03326804|H1|h1
974516|NCT03326791|Acetylsalicylic acid|acetylsalicylic acid
974517|NCT03326791|Aspirin|aspirin
974518|NCT03326791|Trombyl|trombyl
974519|NCT03326791|Secondary prevention|secondary prevention
974520|NCT03326778|Aortic Valve Stenosis|aortic valve stenosis
974521|NCT03326778|Rapid deployment Valve|rapid deployment valve
974522|NCT03326778|CABG|cabg
974523|NCT03326778|Edwards Intuity Elite|edwards intuity elite
974524|NCT03326765|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
974525|NCT03326765|Children|children
974526|NCT03326765|Adults|adults
974527|NCT03326752|Cancer|cancer
974528|NCT03326752|Lung Cancer|lung cancer
974529|NCT03326752|NSCLC|nsclc
974530|NCT03326752|Anti-PD-1 inhibitor|anti-pd-1 inhibitor
974531|NCT03326752|Immuno-oncology|immuno-oncology
974532|NCT03326752|Toll-Like Receptor (TLR) agonist|toll-like receptor (tlr) agonist
974533|NCT03326713|Genetic Testing|genetic testing
974534|NCT03326713|Prevention|prevention
974535|NCT03326687|Language|language
974536|NCT03326687|Anomia|anomia
974537|NCT03326687|Therapy|therapy
974538|NCT03326674|Tesetaxel|tesetaxel
974539|NCT03326674|Capecitabine|capecitabine
974540|NCT03326674|HER2 negative|her2 negative
974541|NCT03326674|Hormone Receptor positive|hormone receptor positive
974542|NCT03326674|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
974543|NCT03326674|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
974544|NCT03326674|Taxanes|taxanes
974545|NCT03326674|Metastatic breast cancer|metastatic breast cancer
974546|NCT03326674|Breast cancer|breast cancer
974547|NCT03326661|Tonsillectomy|tonsillectomy
974548|NCT03326661|Aspiration|aspiration
974549|NCT03326661|Quinsy|quinsy
974550|NCT03326648|Sarcopenia|sarcopenia
974551|NCT03326648|Frailty|frailty
974552|NCT03326648|Strength training|strength training
974553|NCT03326648|Autophagy|autophagy
974554|NCT03326635|Resuscitation|resuscitation
974555|NCT03326635|Frailty|frailty
974556|NCT03326635|ICU|icu
974557|NCT03326635|Ageing|ageing
974558|NCT03326635|Rehabilitation|rehabilitation
974559|NCT03326635|Elderly|elderly
974560|NCT03326622|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
974561|NCT03326622|aerobic exercise|aerobic exercise
974562|NCT03326622|functional outcome|functional outcome
974563|NCT03326622|non-invasive ventilation|non-invasive ventilation
974564|NCT03326622|oxygen uptake|oxygen uptake
974565|NCT03326596|Hemorrhage|hemorrhage
974566|NCT03326596|Tranexamic acid (TXA)|tranexamic acid (txa)
974567|NCT03326596|Estimated Blood Loss (EBL)|estimated blood loss (ebl)
974568|NCT03326583|End Stage Renal Disease|end stage renal disease
974569|NCT03326583|ESRD|esrd
974570|NCT03326583|Hyperkalemia|hyperkalemia
974571|NCT03326570|Lung cancer|lung cancer
974572|NCT03326570|Data collection post bronchoscopy|data collection post bronchoscopy
974573|NCT03326557|Induction of Labour|induction of labour
974574|NCT03326557|Previous Caesarean delivery|previous caesarean delivery
974575|NCT03326557|Foley|foley
974576|NCT03326557|Membrane sweeping|membrane sweeping
974577|NCT03326557|Vaginal delivery|vaginal delivery
974578|NCT03326505|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
974579|NCT03326505|Multiple Sclerosis|multiple sclerosis
974580|NCT03326505|Neuroimmunology|neuroimmunology
974581|NCT03326505|Autoimmune disease|autoimmune disease
974582|NCT03326505|Physical therapy|physical therapy
974583|NCT03326492|Snake bites|snake bites
974584|NCT03326492|Antivenom serum|antivenom serum
974585|NCT03326492|Snake venoms|snake venoms
974586|NCT03326479|Molecular Profiling|molecular profiling
974587|NCT03326479|Biomarker Analysis|biomarker analysis
974588|NCT03326479|Outcomes Database|outcomes database
974589|NCT03326466|Subacromial Impingement Syndrome|subacromial impingement syndrome
974590|NCT03326466|Central Nervous System Sensitization|central nervous system sensitization
974591|NCT03326466|Muscle Function|muscle function
974592|NCT03326466|EMG|emg
974593|NCT03326466|Force Steadiness|force steadiness
974594|NCT03326466|CUFF Algometry|cuff algometry
974595|NCT03326466|Manual Algometry|manual algometry
974596|NCT03326466|Pain|pain
974597|NCT03326466|Maximal Voluntary Isometric Contraction|maximal voluntary isometric contraction
974598|NCT03326453|mini dental implant|mini dental implant
974599|NCT03326453|overdenture|overdenture
974600|NCT03326453|Patient satisfaction|patient satisfaction
974601|NCT03326427|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
974602|NCT03326427|Skill Training Group|skill training group
974603|NCT03326427|Dialectical Behavior Therapy|dialectical behavior therapy
974604|NCT03326401|dietary total antioxidant activity|dietary total antioxidant activity
974605|NCT03326401|nutritional status|nutritional status
974606|NCT03326401|macular degeneration|macular degeneration
974607|NCT03326401|glycemic load|glycemic load
974608|NCT03326401|glycemic index|glycemic index
974609|NCT03326401|nutrient intake|nutrient intake
974610|NCT03326375|TACE|tace
974612|NCT03326362|chronic low back pain|chronic low back pain
974613|NCT03326362|strength training|strength training
974614|NCT03326362|biomechanics|biomechanics
974615|NCT03326362|inflammatory biomarkers|inflammatory biomarkers
974616|NCT03326349|computerized cognitive rehabilitation|computerized cognitive rehabilitation
974617|NCT03326336|Eye Diseases|eye diseases
974618|NCT03326336|Hereditary Eye Diseases|hereditary eye diseases
974619|NCT03326336|Retinal degeneration|retinal degeneration
974620|NCT03326336|Inherited retinal diseases|inherited retinal diseases
974621|NCT03326336|Rod & cone dystrophies|rod & cone dystrophies
974622|NCT03326336|Retinitis Pigmentosa|retinitis pigmentosa
974623|NCT03326336|Gene Therapy|gene therapy
974624|NCT03326336|Optogenetic|optogenetic
974625|NCT03326336|Intravitreal Injections|intravitreal injections
974626|NCT03326336|AAV Vectors|aav vectors
974627|NCT03326336|Medical device|medical device
974628|NCT03326336|Visual Interface|visual interface
974629|NCT03326323|acute normovolemic hemodilution|acute normovolemic hemodilution
974630|NCT03326310|Chronic Myeloid Leukemia|chronic myeloid leukemia
974631|NCT03326310|Myelofibrosis|myelofibrosis
974632|NCT03326310|selumetinib|selumetinib
974633|NCT03326310|azacitidine|azacitidine
974634|NCT03326297|Infant Colic|infant colic
974635|NCT03326297|Osteopathy|osteopathy
974636|NCT03326297|Stress|stress
974637|NCT03326297|Physiotherapy|physiotherapy
974638|NCT03326284|Hypocaloric diet|hypocaloric diet
974639|NCT03326284|Dietary protein|dietary protein
974640|NCT03326245|Pharmacological MRI|pharmacological mri
974641|NCT03326245|C-11 Raclopride|c-11 raclopride
974642|NCT03326245|PET Imaging|pet imaging
974643|NCT03326245|Neuropsychological Testing|neuropsychological testing
974644|NCT03326219|MOCA|moca
974645|NCT03326219|VSM|vsm
974646|NCT03326219|Clarivein|clarivein
974647|NCT03326219|Histological|histological
974648|NCT03326206|Navajo|navajo
974649|NCT03326206|Community Health Workers|community health workers
974650|NCT03326206|Community Health Representatives|community health representatives
974651|NCT03326206|Tribal health systems|tribal health systems
974652|NCT03326206|American Indian|american indian
974653|NCT03326206|Rural|rural
974654|NCT03326206|Health disparities|health disparities
974655|NCT03326193|Stage IIIb - IV|stage iiib - iv
974656|NCT03326193|gBRCAmut|gbrcamut
974657|NCT03326193|BRCA|brca
974658|NCT03326193|PARP inhibitor|parp inhibitor
974659|NCT03326193|Ovarian|ovarian
974660|NCT03326193|Primary Peritoneal|primary peritoneal
974661|NCT03326193|Fallopian Tube|fallopian tube
974662|NCT03326193|VEGF inhibitor|vegf inhibitor
974663|NCT03326193|Bevacizumab|bevacizumab
974664|NCT03326193|Niraparib|niraparib
974665|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors
974666|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents
974667|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors
974668|NCT03326154|cholecystectomy|cholecystectomy
974669|NCT03326154|quality of life|quality of life
974670|NCT03326128|Bupropion XL|bupropion xl
974671|NCT03326128|Anhedonia|anhedonia
974672|NCT03326128|Heavy Smokers|heavy smokers
974673|NCT03326128|Smoking cessation|smoking cessation
974674|NCT03326115|patient activation|patient activation
974675|NCT03326115|peer visitation|peer visitation
974676|NCT03326115|amputee|amputee
974677|NCT03326102|Breast Cancer|breast cancer
974678|NCT03326102|DHP107|dhp107
974679|NCT03326102|Paclitaxel|paclitaxel
974680|NCT03326102|Liporaxel|liporaxel
974681|NCT03326089|pulmonary rehabilitation|pulmonary rehabilitation
974682|NCT03326050|Rhinoscleroma|rhinoscleroma
974683|NCT03326050|Gemifloxacin|gemifloxacin
974684|NCT03326050|Ciprofloxacin|ciprofloxacin
974685|NCT03326037|Nephrotic Syndrome|nephrotic syndrome
974686|NCT03326037|NPHS2 gene mutation|nphs2 gene mutation
974687|NCT03326037|disease association|disease association
974688|NCT03326011|Exoskeleton Device|exoskeleton device
974689|NCT03326011|Gait rehabilitation|gait rehabilitation
974690|NCT03326011|Chronic storke|chronic storke
974691|NCT03325998|Exoskeleton Device|exoskeleton device
974692|NCT03325998|Elderly|elderly
974693|NCT03325998|Gait rehabilitation|gait rehabilitation
974694|NCT03325959|hyperbaric oxygen|hyperbaric oxygen
974695|NCT03325959|HBOT|hbot
974696|NCT03325959|fibromyalgia|fibromyalgia
974697|NCT03325959|pain|pain
974698|NCT03325933|insulin sensitivity|insulin sensitivity
974699|NCT03325933|muscle|muscle
974700|NCT03325933|strength|strength
974701|NCT03325933|resistance training|resistance training
974702|NCT03325933|strength training|strength training
974703|NCT03325933|vascular function|vascular function
974704|NCT03325933|arterial stiffness|arterial stiffness
974705|NCT03325933|glucose tolerance|glucose tolerance
974706|NCT03325920|sleep bruxism|sleep bruxism
974707|NCT03325920|diagnosis|diagnosis
974708|NCT03325920|validation study|validation study
974709|NCT03325920|assessment|assessment
974710|NCT03325907|Biopsy, Needle|biopsy, needle
974711|NCT03325907|Printing, Three-Dimensional|printing, three-dimensional
974712|NCT03325907|Image-Guided Biopsy|image-guided biopsy
974713|NCT03325894|ADHD|adhd
974714|NCT03325894|SHP465|shp465
974723|NCT03325842|Cross-cultural comparison|cross-cultural comparison
974724|NCT03325842|Disability evaluation|disability evaluation
974725|NCT03325842|Self-assessment|self-assessment
974726|NCT03325842|Child|child
974729|NCT03325829|Diverticular Disease|diverticular disease
974730|NCT03325829|Diverticulitis|diverticulitis
974731|NCT03325829|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
974732|NCT03325816|nivolumab|nivolumab
974733|NCT03325816|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
974734|NCT03325816|Lutathera|lutathera
974735|NCT03325803|actinic keratosis|actinic keratosis
974736|NCT03325803|ablative fractional laser|ablative fractional laser
974737|NCT03325803|photodynamic therapy|photodynamic therapy
974738|NCT03325803|ablative depth|ablative depth
974739|NCT03325803|protoporphyrin IX|protoporphyrin ix
974740|NCT03325790|Meniere's disease|meniere's disease
974741|NCT03325790|Hearing Loss|hearing loss
974742|NCT03325790|Vertigo|vertigo
974743|NCT03325790|Tinnitus|tinnitus
974744|NCT03325790|Ebselen|ebselen
974745|NCT03325790|Pharmacokinetics|pharmacokinetics
974746|NCT03325790|Safety|safety
974747|NCT03325790|Efficacy|efficacy
974748|NCT03325790|Speech|speech
974749|NCT03325777|Cigarettes|cigarettes
974750|NCT03325777|Tobacco Use|tobacco use
974751|NCT03325764|Obesity|obesity
974752|NCT03325764|bariatric surgery|bariatric surgery
974753|NCT03325764|sleeve gastrectomy|sleeve gastrectomy
974754|NCT03325764|physical activity|physical activity
974755|NCT03325764|movement analysis|movement analysis
974756|NCT03325725|severe aspiration|severe aspiration
974757|NCT03325699|Mild dementia|mild dementia
974758|NCT03325699|Cognitive impairment|cognitive impairment
974759|NCT03325699|Informal caregiver|informal caregiver
974760|NCT03325699|Aging|aging
974761|NCT03325699|Quality of life|quality of life
974762|NCT03325699|Health application|health application
974763|NCT03325699|Information and communication technology (ICT)|information and communication technology (ict)
974764|NCT03325686|vitamin D|vitamin d
974765|NCT03325686|atletes|atletes
974766|NCT03325686|physical performance|physical performance
974767|NCT03325660|Whole body vibration, Pelvic floor muscle|whole body vibration, pelvic floor muscle
974768|NCT03325647|body composition|body composition
974769|NCT03325647|klinefelter syndrome|klinefelter syndrome
974770|NCT03325647|XXY|xxy
974771|NCT03325647|sex chromosome variation|sex chromosome variation
974772|NCT03325647|sex chromosome aneuploidy|sex chromosome aneuploidy
974773|NCT03325647|testosterone|testosterone
974774|NCT03325621|Hepcidin|hepcidin
974775|NCT03325621|Hemoglobin|hemoglobin
974776|NCT03325621|Iron|iron
974777|NCT03325621|Anemia of chronic disease|anemia of chronic disease
974779|NCT03325556|Dementia|dementia
974780|NCT03325556|Dementia-related psychosis|dementia-related psychosis
974781|NCT03325556|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
974782|NCT03325556|Dementia with Lewy bodies|dementia with lewy bodies
974783|NCT03325556|Alzheimer's disease|alzheimer's disease
974784|NCT03325556|Behavioral variant frontotemporal dementia|behavioral variant frontotemporal dementia
974785|NCT03325556|Progressive supranuclear palsy|progressive supranuclear palsy
974786|NCT03325556|Corticobasal degeneration|corticobasal degeneration
974787|NCT03325556|Vascular dementia|vascular dementia
974788|NCT03325556|Hallucinations|hallucinations
974789|NCT03325556|Delusions|delusions
974790|NCT03325556|Psychosis|psychosis
974791|NCT03325543|Urinary Incontinence, Stress|urinary incontinence, stress
974792|NCT03325543|Pelvic Floor|pelvic floor
974793|NCT03325543|Exercise|exercise
974794|NCT03325530|Adolescent|adolescent
974795|NCT03325530|Nutrition|nutrition
974796|NCT03325530|Physical Activity|physical activity
974797|NCT03325465|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
974798|NCT03325465|head and neck cancer|head and neck cancer
974799|NCT03325465|neoadjuvant pembrolizumab|neoadjuvant pembrolizumab
974800|NCT03325465|epacadostat|epacadostat
974807|NCT03325413|Perioperative geriatric care|perioperative geriatric care
974808|NCT03325413|Geriatric assessment|geriatric assessment
974809|NCT03325413|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
974810|NCT03325413|POCD|pocd
974811|NCT03325413|Frailty|frailty
974812|NCT03325413|Depression|depression
974813|NCT03325413|Physical fitness|physical fitness
974814|NCT03325413|Geriatric anesthesia|geriatric anesthesia
974815|NCT03325413|IADL|iadl
974816|NCT03325413|Postoperative functional status|postoperative functional status
974817|NCT03325413|Quality of life|quality of life
974818|NCT03325400|Fluoride toothpaste|fluoride toothpaste
974819|NCT03325400|Cytogenetic damage|cytogenetic damage
974820|NCT03325400|Exfoliated buccal cells|exfoliated buccal cells
974821|NCT03325400|Micronucleus assay|micronucleus assay
974822|NCT03325348|Severe Pre eclampsia|severe pre eclampsia
974823|NCT03325348|Nifidepine|nifidepine
974824|NCT03325348|Labetalol|labetalol
974825|NCT03325335|midazolam premedication|midazolam premedication
974826|NCT03325322|Frailty|frailty
974827|NCT03325322|Inflammation|inflammation
974828|NCT03325322|Mesenchymal stem cell|mesenchymal stem cell
974829|NCT03325322|Mesenchymal stromal cell|mesenchymal stromal cell
974830|NCT03325309|Lumbar spinal stenosis|lumbar spinal stenosis
974831|NCT03325309|Cycling|cycling
974832|NCT03325309|Lumbar-flexion-based training|lumbar-flexion-based training
974833|NCT03325283|stroke prevention|stroke prevention
974834|NCT03325283|embolic protection|embolic protection
974835|NCT03325283|cognition|cognition
974836|NCT03325270|prebiotics|prebiotics
974837|NCT03325270|Galacto-oligosaccharides|galacto-oligosaccharides
974838|NCT03325270|Iron-deficiency|iron-deficiency
974839|NCT03325257|Unresectable melanoma|unresectable melanoma
974840|NCT03325257|metastatic melanoma|metastatic melanoma
974841|NCT03325257|Immunotherapy|immunotherapy
974842|NCT03325257|Nivolumab|nivolumab
974843|NCT03325257|Temporary Auhorization for Use (ATU)|temporary auhorization for use (atu)
974844|NCT03325205|Transcranial direct current stimulation|transcranial direct current stimulation
974845|NCT03325205|Neuromodulation|neuromodulation
974846|NCT03325205|Individualizing brain stimulation|individualizing brain stimulation
974847|NCT03325205|Neuropsychology|neuropsychology
974848|NCT03325192|Indwelling Pleural Catheter|indwelling pleural catheter
974849|NCT03325192|Pleurodesis|pleurodesis
974850|NCT03325192|Iodopovidone|iodopovidone
974851|NCT03325192|Pleural Effusion, Malignant|pleural effusion, malignant
974852|NCT03325179|Simple Obesity|simple obesity
974853|NCT03325179|Thread-embedding Therapy|thread-embedding therapy
974854|NCT03325179|Acupuncture|acupuncture
974855|NCT03325153|Obstructive Sleep Apnea|obstructive sleep apnea
974856|NCT03325153|Bronchoscopy|bronchoscopy
974857|NCT03325153|STOP-Bang questionnaire|stop-bang questionnaire
974858|NCT03325153|Cardiopulmonary events|cardiopulmonary events
1333111|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
974859|NCT03325127|Prostate Cancer, Bone metastases, Xofigo, Zytiga, Xtandi.|prostate cancer, bone metastases, xofigo, zytiga, xtandi.
974860|NCT03325114|type 1 diabetes|type 1 diabetes
974861|NCT03325114|hypercalciuria|hypercalciuria
974862|NCT03325088|Severe Asthma|severe asthma
974863|NCT03325088|airway smooth muscle cells|airway smooth muscle cells
974864|NCT03325088|Rac1 protein|rac1 protein
974865|NCT03325075|VAL-181388|val-181388
974866|NCT03325075|Chikungunya vaccine|chikungunya vaccine
974867|NCT03325049|Family Relations|family relations
974868|NCT03325049|Family Health|family health
974869|NCT03325049|Intervention study|intervention study
974870|NCT03325049|Social support|social support
974871|NCT03325049|Intensive care unit|intensive care unit
974872|NCT03325023|PCOS, microbiota, probiotic,obesity|pcos, microbiota, probiotic,obesity
974873|NCT03324984|Spinal anesthesia|spinal anesthesia
974874|NCT03324984|Pain|pain
974875|NCT03324984|Chloroprocaine|chloroprocaine
974876|NCT03324958|Endometrial cancer|endometrial cancer
974877|NCT03324958|Brachytherapy|brachytherapy
974878|NCT03324958|Virtual reality|virtual reality
974879|NCT03324958|Pain|pain
974880|NCT03324958|Anxiety|anxiety
974881|NCT03324932|bone health|bone health
974882|NCT03324932|hormone-sensitive breast cancer|hormone-sensitive breast cancer
974883|NCT03324932|postmenopausal|postmenopausal
974884|NCT03324932|aromatase inhibitor|aromatase inhibitor
974885|NCT03324932|bone mineral density|bone mineral density
974886|NCT03324919|Psoriasis|psoriasis
974887|NCT03324919|Urticaria|urticaria
974888|NCT03324919|Lupus erythematodes|lupus erythematodes
974889|NCT03324919|qualtiy of life|qualtiy of life
974890|NCT03324906|Prader-Willi Syndrome|prader-willi syndrome
974891|NCT03324906|Obesity|obesity
974892|NCT03324906|Depressive disorder|depressive disorder
974893|NCT03324906|Obsessive-compulsive disorder|obsessive-compulsive disorder
974894|NCT03324906|noninvasive brain stimulation|noninvasive brain stimulation
974895|NCT03324880|rhPTH[1-84)|rhpth[1-84)
974896|NCT03324880|Parathyroid hormone|parathyroid hormone
974897|NCT03324880|Hypocalcemia|hypocalcemia
974898|NCT03324880|Hypoparathyroidism|hypoparathyroidism
974899|NCT03324854|Mosquito net|mosquito net
974900|NCT03324854|Mesh|mesh
974901|NCT03324854|Polypropylene mesh|polypropylene mesh
974902|NCT03324854|Prolene mesh|prolene mesh
974903|NCT03324854|ventral hernia|ventral hernia
974904|NCT03324854|hernia|hernia
974905|NCT03324841|Molecular Profiling|molecular profiling
974906|NCT03324841|Biomarker Analysis|biomarker analysis
974907|NCT03324841|Next Generation Sequencing|next generation sequencing
974908|NCT03324828|anxiety|anxiety
974909|NCT03324828|surgery|surgery
974910|NCT03324828|clown|clown
974913|NCT03324815|Pain|pain
974914|NCT03324789|Single implant|single implant
974915|NCT03324789|Anterior edentulism|anterior edentulism
974916|NCT03324789|partial denture|partial denture
974917|NCT03324776|inhaled insulin|inhaled insulin
974918|NCT03324750|corticotherapy|corticotherapy
974919|NCT03324750|qualitative study|qualitative study
974920|NCT03324750|therapeutic education|therapeutic education
974921|NCT03324750|lifestyle change|lifestyle change
974922|NCT03324750|diet|diet
974923|NCT03324737|Prevention|prevention
974924|NCT03324737|Smartphone application|smartphone application
974925|NCT03324737|Randomized control trial|randomized control trial
974926|NCT03324711|Cognitive disorders|cognitive disorders
974927|NCT03324711|Alzheimer's disease|alzheimer's disease
974928|NCT03324711|Mini Mental State Examination|mini mental state examination
974929|NCT03324711|Geriatry|geriatry
974930|NCT03324685|Oral Contraceptive, Healthy Volunteers, Ethinyl Estradiol,|oral contraceptive, healthy volunteers, ethinyl estradiol,
974931|NCT03324685|Levonorgestrel|levonorgestrel
974932|NCT03324672|lumbar pain; pregnancy;|lumbar pain; pregnancy;
974933|NCT03324659|Mindfulness|mindfulness
974934|NCT03324659|Exercise|exercise
974935|NCT03324646|PET Imaging|pet imaging
974937|NCT03324633|HCV|hcv
974938|NCT03324633|cohort|cohort
974939|NCT03324633|natural history|natural history
974940|NCT03324633|cure|cure
974941|NCT03324620|physiotherapy|physiotherapy
974942|NCT03324620|nurse|nurse
974943|NCT03324620|Cost effectiveness|cost effectiveness
974944|NCT03324620|Activities of Daily Living|activities of daily living
974945|NCT03324620|exercise tolerance|exercise tolerance
974946|NCT03324620|Allogeneic|allogeneic
974947|NCT03324620|Quality of Life|quality of life
974948|NCT03324620|Rehabilitation|rehabilitation
974949|NCT03324620|Physical Activity|physical activity
974950|NCT03324594|functional performance|functional performance
974951|NCT03324594|synthetic male condom|synthetic male condom
974952|NCT03324581|ADHD|adhd
974953|NCT03324581|ADD|add
974956|NCT03324503|Pulmonary Sarcoidosis|pulmonary sarcoidosis
974957|NCT03324503|HRCT|hrct
974958|NCT03324503|Glucocorticoid|glucocorticoid
974959|NCT03324503|Prednisone|prednisone
974960|NCT03324503|FRI|fri
974961|NCT03324503|Prednisolone|prednisolone
974962|NCT03324490|Mid-thoracic spinal anesthesia|mid-thoracic spinal anesthesia
974963|NCT03324490|Mid-thoracic epidural anesthesia|mid-thoracic epidural anesthesia
974964|NCT03324490|Nephrectomy|nephrectomy
974965|NCT03324490|Lung disease|lung disease
974966|NCT03324438|pediatrics|pediatrics
974967|NCT03324425|breast cancer|breast cancer
974968|NCT03324425|metastatic breast cancer|metastatic breast cancer
974969|NCT03324399|ALS|als
974970|NCT03324399|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
974971|NCT03324386|Hypertension|hypertension
974972|NCT03324386|Tecnology|tecnology
974973|NCT03324386|Nursing|nursing
974974|NCT03324386|Education|education
974975|NCT03324347|Animal-Assisted Intervention|animal-assisted intervention
974976|NCT03324347|Dog-Assisted Intervention|dog-assisted intervention
974977|NCT03324347|Dental Care|dental care
974978|NCT03324347|Questionnaire|questionnaire
974979|NCT03324347|Pilot Project|pilot project
974980|NCT03324347|Dental Clinic|dental clinic
974981|NCT03324321|Cerebral Haemodynamics|cerebral haemodynamics
974982|NCT03324321|Carbon Dioxide|carbon dioxide
974983|NCT03324321|Cerebral Autoregulation|cerebral autoregulation
974984|NCT03324308|Coronary Artery Disease|coronary artery disease
974985|NCT03324308|Ischemia|ischemia
974986|NCT03324308|Computed Tomography|computed tomography
974987|NCT03324308|Myocardial perfusion|myocardial perfusion
974988|NCT03324308|Dynamic Imaging|dynamic imaging
974989|NCT03324282|Anti PD1|anti pd1
974990|NCT03324282|Bladder carcinoma|bladder carcinoma
974991|NCT03324282|Chemotherapy|chemotherapy
974992|NCT03324282|Immunological monitoring|immunological monitoring
974993|NCT03324256|Energy drink consumption|energy drink consumption
974994|NCT03324230|Monoclonal antibody|monoclonal antibody
974995|NCT03324230|Mepolizumab|mepolizumab
974996|NCT03324230|Eosinophil|eosinophil
974997|NCT03324217|motor imagery|motor imagery
974998|NCT03324217|action observation|action observation
974999|NCT03324191|Tea extract|tea extract
975000|NCT03324191|Triglycerides|triglycerides
975001|NCT03324191|Energy metabolism|energy metabolism
975002|NCT03324178|Neurofeedback|neurofeedback
975003|NCT03324178|Attention|attention
975004|NCT03324165|Computed Tomography|computed tomography
975005|NCT03324165|Algorithm|algorithm
975006|NCT03324165|Alvarado Score|alvarado score
975007|NCT03324152|High-intensity interval training|high-intensity interval training
975008|NCT03324152|Exercise|exercise
975009|NCT03324152|Muscle function|muscle function
975010|NCT03324152|Inflammation|inflammation
975011|NCT03324126|Preterm infants|preterm infants
975012|NCT03324126|very low birth weight|very low birth weight
975013|NCT03324126|breast milk|breast milk
975014|NCT03324126|individualized fortification|individualized fortification
975015|NCT03324126|targeted protein fortification|targeted protein fortification
975016|NCT03324126|adjustable protein fortification|adjustable protein fortification
975018|NCT03324087|HRQoL|hrqol
975019|NCT03324087|Immune Thrombocytopenia|immune thrombocytopenia
975020|NCT03324048|Preoperative anxiety|preoperative anxiety
975021|NCT03324048|Relaxation|relaxation
975022|NCT03324048|Autonomous nervous system|autonomous nervous system
975023|NCT03324048|Surgery|surgery
975024|NCT03324048|Visual Analogue Scale (VAS)|visual analogue scale (vas)
975025|NCT03324048|State-Trait Anxiety Inventory (STAI-Y)|state-trait anxiety inventory (stai-y)
975026|NCT03324022|Fibroblast growth factors|fibroblast growth factors
975027|NCT03324022|Fibroblast growth factors receptors|fibroblast growth factors receptors
975028|NCT03324022|Thyroid orbitopathy|thyroid orbitopathy
975029|NCT03323944|metastatic adenocarcinoma, pancreas|metastatic adenocarcinoma, pancreas
975030|NCT03323931|autism spectrum disorder|autism spectrum disorder
975031|NCT03323931|robot-enhanced intervention|robot-enhanced intervention
975032|NCT03323931|imitation|imitation
975033|NCT03323931|joint attention|joint attention
975034|NCT03323931|turn-taking|turn-taking
975035|NCT03323892|preimplantation development|preimplantation development
975036|NCT03323892|DNA fragmentation|dna fragmentation
975037|NCT03323892|abstinence duration|abstinence duration
975038|NCT03323879|brachytherapy|brachytherapy
975039|NCT03323879|LDR|ldr
975040|NCT03323879|HDR|hdr
975041|NCT03323879|monotherapy|monotherapy
975042|NCT03323879|focal|focal
975043|NCT03323801|Infertility|infertility
975044|NCT03323762|Pre-Eclampsia; Mild|pre-eclampsia; mild
975045|NCT03323762|Pre-Eclampsia; Moderate|pre-eclampsia; moderate
975046|NCT03323762|Gestational Hypertension|gestational hypertension
975047|NCT03323762|Remote ischemic conditioning|remote ischemic conditioning
975048|NCT03323749|Myopathy|myopathy
975049|NCT03323749|PMD|pmd
975050|NCT03323749|Primary Mitochondrial Disease|primary mitochondrial disease
975051|NCT03323749|MTP-131|mtp-131
975052|NCT03323749|elamipretide|elamipretide
975053|NCT03323710|Metastatic|metastatic
975054|NCT03323710|Renal Cell Carcinoma|renal cell carcinoma
975055|NCT03323710|Kidney Cancer|kidney cancer
975056|NCT03323710|Sunitinib|sunitinib
975057|NCT03323710|Sutent|sutent
975058|NCT03323710|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
975059|NCT03323710|Angiogenesis Inhibitor|angiogenesis inhibitor
975060|NCT03323710|Propranolol|propranolol
975061|NCT03323710|Beta-blocker|beta-blocker
975062|NCT03323710|First-line|first-line
975063|NCT03323697|Depression|depression
975064|NCT03323697|Anxiety|anxiety
975065|NCT03323697|Herbal Medicine|herbal medicine
975066|NCT03323697|Chinese Medicine|chinese medicine
975067|NCT03323697|Hamilton Scale|hamilton scale
975068|NCT03323697|SSRI|ssri
975069|NCT03323671|primary dysmenorrhea|primary dysmenorrhea
975070|NCT03323671|preemptive analgesia|preemptive analgesia
975071|NCT03323645|prostate cancer|prostate cancer
975072|NCT03323645|erectile dysfunction|erectile dysfunction
975073|NCT03323645|penile prosthesis|penile prosthesis
975074|NCT03323632|Stroke|stroke
975075|NCT03323632|Cerebrovascular accident|cerebrovascular accident
975076|NCT03323632|Upper extremity|upper extremity
975077|NCT03323632|Cerebral Infarction|cerebral infarction
975078|NCT03323632|Brain Infarction|brain infarction
975079|NCT03323632|Brain Ischemia|brain ischemia
975080|NCT03323632|Cerebrovascular Disorders|cerebrovascular disorders
975081|NCT03323632|Cardiovascular Diseases|cardiovascular diseases
975082|NCT03323632|Nervous System Diseases|nervous system diseases
975083|NCT03323632|Central Nervous System Diseases|central nervous system diseases
975084|NCT03323619|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
975085|NCT03323619|Anesthesia technique|anesthesia technique
975086|NCT03323619|Delirium|delirium
975087|NCT03323567|TMD, collagen, intramuscular injection, trigger point|tmd, collagen, intramuscular injection, trigger point
975088|NCT03323554|radical prostatectomy , Device,|radical prostatectomy , device,
975089|NCT03323541|biosimilars|biosimilars
975090|NCT03323541|filgrastim|filgrastim
975091|NCT03323541|Stem cell transplantation|stem cell transplantation
975092|NCT03323541|lymphoma|lymphoma
975093|NCT03323541|multiple myeloma|multiple myeloma
975094|NCT03323528|Dorithricin|dorithricin
975095|NCT03323528|Tyrothricin|tyrothricin
975096|NCT03323528|Benzalkonium chloride|benzalkonium chloride
975097|NCT03323528|Benzocaine|benzocaine
975098|NCT03323528|placebo-controlled|placebo-controlled
975099|NCT03323528|Pharyngitis|pharyngitis
975100|NCT03323528|sore throat|sore throat
975101|NCT03323528|throat pain|throat pain
975102|NCT03323528|difficulty swallowing|difficulty swallowing
975103|NCT03323528|complete responder|complete responder
975104|NCT03323528|lozenge|lozenge
975105|NCT03323528|Non-streptococcal Infections|non-streptococcal infections
975106|NCT03323502|Nursing Homes|nursing homes
975107|NCT03323502|Skilled Nursing Facilities|skilled nursing facilities
975108|NCT03323502|Advance Care Planning|advance care planning
975109|NCT03323502|Advance Directives|advance directives
975110|NCT03323502|Alzheimer Disease|alzheimer disease
975111|NCT03323502|Dementia|dementia
975112|NCT03323502|Do Not Resuscitate Orders|do not resuscitate orders
975113|NCT03323502|Physician Orders for Life-Sustaining Treatment|physician orders for life-sustaining treatment
975114|NCT03323502|Artificial Nutrition|artificial nutrition
975115|NCT03323502|Hospitalization|hospitalization
975116|NCT03323502|Intubation|intubation
975117|NCT03323502|Pragmatic Clinical Trials|pragmatic clinical trials
975118|NCT03323502|Randomized Controlled Trials|randomized controlled trials
975119|NCT03323502|Patient Preferences|patient preferences
975120|NCT03323502|Resuscitation Orders|resuscitation orders
975121|NCT03323489|celiac|celiac
975122|NCT03323489|radiosurgery|radiosurgery
975123|NCT03323489|sbrt|sbrt
975124|NCT03323489|radiotherapy|radiotherapy
975125|NCT03323489|pain|pain
975126|NCT03323463|squamous cell carcinoma of the neck of unknown primary|squamous cell carcinoma of the neck of unknown primary
975127|NCT03323463|HPV-Associated Oropharyngeal Squamous Cell Carcinoma|hpv-associated oropharyngeal squamous cell carcinoma
975128|NCT03323463|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
975129|NCT03323463|17-409|17-409
975130|NCT03323463|Hypoxia negative|hypoxia negative
975231|NCT03322917|ocular surface|ocular surface
975131|NCT03323463|T1-2n1-2b oropharyngeal squamous cell carcinoma|t1-2n1-2b oropharyngeal squamous cell carcinoma
975132|NCT03323450|High grade gliomas (WHO grade III or IV)|high grade gliomas (who grade iii or iv)
975133|NCT03323450|Low grade gliomas (WHO Grade II)|low grade gliomas (who grade ii)
975134|NCT03323424|Metastatic cancer|metastatic cancer
975135|NCT03323424|Abscopal effect|abscopal effect
975136|NCT03323424|Ionizing radiation|ionizing radiation
975137|NCT03323424|Antibody-Dependant Cell Cytotoxicity (ADCC)|antibody-dependant cell cytotoxicity (adcc)
975138|NCT03323424|Immuno-Radiation effect|immuno-radiation effect
975139|NCT03323424|Stereotactic Body Radio-Therapy (SBRT)|stereotactic body radio-therapy (sbrt)
975140|NCT03323424|Targeted therapies|targeted therapies
975141|NCT03323398|mRNA-2416|mrna-2416
975142|NCT03323398|OX40 ligand|ox40 ligand
975143|NCT03323398|OX40L|ox40l
975144|NCT03323385|Colorectal surgery|colorectal surgery
975145|NCT03323385|Pain|pain
975146|NCT03323385|Analgesia|analgesia
975147|NCT03323385|N1539|n1539
975148|NCT03323385|Phase 3b|phase 3b
975149|NCT03323359|Hemopatch|hemopatch
975150|NCT03323359|Hepatic resection|hepatic resection
975151|NCT03323359|Hemostasis|hemostasis
975152|NCT03323359|Surgery|surgery
975153|NCT03323346|metastatic breast cancer|metastatic breast cancer
975154|NCT03323346|disulfiram|disulfiram
975155|NCT03323346|cooper|cooper
975156|NCT03323294|Obesity|obesity
975157|NCT03323294|Pediatric Health|pediatric health
975158|NCT03323294|Type 2 Diabetes|type 2 diabetes
975159|NCT03323294|Insulin Resistance|insulin resistance
975160|NCT03323294|Metformin Therapy|metformin therapy
975161|NCT03323281|Diabetic foot|diabetic foot
975162|NCT03323281|Cognitive functions|cognitive functions
975163|NCT03323281|Psychiatric disorders|psychiatric disorders
975164|NCT03323281|Neurology|neurology
975165|NCT03323281|Psychiatry|psychiatry
975166|NCT03323268|Intensive care|intensive care
975167|NCT03323268|Cardiogenic shock|cardiogenic shock
975168|NCT03323268|Peripheral veno-arterial extracorporeal membrane oxygenation|peripheral veno-arterial extracorporeal membrane oxygenation
975169|NCT03323268|Left ventricular overload|left ventricular overload
975170|NCT03323268|Native cardiac output|native cardiac output
975171|NCT03323268|Pulmonary artery blood flow|pulmonary artery blood flow
975172|NCT03323268|End-tidal carbon dioxide|end-tidal carbon dioxide
975173|NCT03323268|Swan Ganz catheter|swan ganz catheter
975174|NCT03323268|Blood gaz|blood gaz
975175|NCT03323242|Vessel Sealing Devices|vessel sealing devices
975176|NCT03323242|Liver Transplantation|liver transplantation
975177|NCT03323229|Ultrasonography|ultrasonography
975178|NCT03323229|Ambulances|ambulances
975179|NCT03323229|Satellite Communications|satellite communications
975180|NCT03323229|Telemedicine|telemedicine
975181|NCT03323151|Relapsed Mantle-Cell Lymphoma|relapsed mantle-cell lymphoma
975182|NCT03323151|Refractory Mantle-Cell Lymphoma|refractory mantle-cell lymphoma
975183|NCT03323151|Ixazomib|ixazomib
975184|NCT03323151|Ibrutinib|ibrutinib
975185|NCT03323151|Proteasome Inhibitor|proteasome inhibitor
975186|NCT03323151|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
975187|NCT03323138|Ex-PRESS|ex-press
975188|NCT03323138|glaucoma|glaucoma
975189|NCT03323138|filtration surgery|filtration surgery
975190|NCT03323138|phacoemulsification|phacoemulsification
975191|NCT03323112|influenza|influenza
975192|NCT03323112|vaccination|vaccination
975193|NCT03323112|health care workers|health care workers
975194|NCT03323112|immune responses|immune responses
975195|NCT03323112|humoral immunity|humoral immunity
975196|NCT03323112|cellular immunity|cellular immunity
975197|NCT03323073|unipolar|unipolar
975198|NCT03323073|bipolar|bipolar
975199|NCT03323073|depression|depression
975200|NCT03323073|resting state fMRI|resting state fmri
975201|NCT03323073|neural network|neural network
975202|NCT03323073|connectivity|connectivity
975203|NCT03323047|tonsillectomy|tonsillectomy
975204|NCT03323047|acetaminophen|acetaminophen
975205|NCT03323047|dexamethasone|dexamethasone
975206|NCT03323008|Prisoners|prisoners
975207|NCT03323008|End-of-life Care|end-of-life care
975208|NCT03323008|Geriatric Care|geriatric care
975209|NCT03323008|Palliative Care|palliative care
975210|NCT03323008|Hospice Care|hospice care
975211|NCT03323008|Prison|prison
975212|NCT03323008|Corrections|corrections
975213|NCT03323008|Inmates|inmates
975214|NCT03322995|Molecular Profiling|molecular profiling
975215|NCT03322995|Neoadjuvant Therapy|neoadjuvant therapy
975216|NCT03322995|Adaptive therapeutic approach|adaptive therapeutic approach
975217|NCT03322982|diet, low-fat|diet, low-fat
975218|NCT03322956|Low back/lumbar spine|low back/lumbar spine
975219|NCT03322956|Multimodal Physical therapy|multimodal physical therapy
975220|NCT03322956|Quality of life|quality of life
975221|NCT03322956|Range of Motion|range of motion
975222|NCT03322956|Pain|pain
975223|NCT03322943|Ursodeoxycholic Acid|ursodeoxycholic acid
975224|NCT03322943|Response|response
975225|NCT03322930|microperimetry|microperimetry
975226|NCT03322930|rod visual fields|rod visual fields
975227|NCT03322917|dry eye|dry eye
975228|NCT03322917|PRP|prp
975229|NCT03322917|autologous|autologous
975230|NCT03322917|after LASIK|after lasik
975232|NCT03322904|iris collarette; autonomous nervous system|iris collarette; autonomous nervous system
975233|NCT03322891|Urology|urology
975234|NCT03322878|postoperative pain , pediatrics , magnesium sulfate|postoperative pain , pediatrics , magnesium sulfate
975235|NCT03322839|Guideline-adherence|guideline-adherence
975236|NCT03322839|Implementation|implementation
975237|NCT03322839|Implementation-strategies|implementation-strategies
975238|NCT03322839|Randomized-controlled-trial|randomized-controlled-trial
975239|NCT03322839|Organisational risk-factors|organisational risk-factors
975240|NCT03322839|Schools|schools
975241|NCT03322839|Social risk-factors|social risk-factors
975242|NCT03322813|Glioblastoma|glioblastoma
975243|NCT03322813|Blood Brain Barrier|blood brain barrier
975244|NCT03322813|BBB|bbb
975245|NCT03322813|ExAblate|exablate
975246|NCT03322813|Blood Brain Barrier Disruption|blood brain barrier disruption
975247|NCT03322774|Stepped Care|stepped care
975248|NCT03322761|Multiple sclerosis|multiple sclerosis
975249|NCT03322761|Exercise|exercise
975250|NCT03322761|Disease-modifying treatment|disease-modifying treatment
975251|NCT03322761|Early treatment|early treatment
975252|NCT03322683|Neck Pain|neck pain
975253|NCT03322683|Physical Therapy Modalities|physical therapy modalities
975254|NCT03322683|Massage|massage
975255|NCT03322683|Manual Therapy|manual therapy
991104|NCT03220412|gun|gun
975256|NCT03322670|community-acquired pneumonia|community-acquired pneumonia
975257|NCT03322670|family practice|family practice
975258|NCT03322670|streptococcus pneumoniae|streptococcus pneumoniae
975259|NCT03322657|Sugammadex|sugammadex
975260|NCT03322657|Neostigmine|neostigmine
975261|NCT03322657|Reversal of neuromuscular block|reversal of neuromuscular block
975262|NCT03322644|Pancreatitis|pancreatitis
975263|NCT03322644|Pain|pain
975264|NCT03322644|Internet Intervention|internet intervention
975265|NCT03322644|Behavioral Intervention|behavioral intervention
975266|NCT03322566|Non-small cell lung cancer|non-small cell lung cancer
975267|NCT03322566|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
975268|NCT03322566|indoleamine 2|indoleamine 2
975269|NCT03322566|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
975270|NCT03322566|chemotherapy|chemotherapy
975271|NCT03322540|non-small cell lung cancer|non-small cell lung cancer
975272|NCT03322540|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
975273|NCT03322540|indoleamine 2|indoleamine 2
975274|NCT03322540|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
975275|NCT03322514|gut hormones, obesity, appetite, propionate,fermentation|gut hormones, obesity, appetite, propionate,fermentation
975276|NCT03322449|APOA2|apoa2
975277|NCT03322449|Inflammation|inflammation
975278|NCT03322449|gene|gene
975279|NCT03322449|diet|diet
975280|NCT03322410|Fluid overload|fluid overload
975281|NCT03322410|Hydratation statud|hydratation statud
975282|NCT03322410|Peritoneal hypepermeability|peritoneal hypepermeability
975283|NCT03322410|Peritoneal dialysis|peritoneal dialysis
975284|NCT03322410|Impedancemetry|impedancemetry
975285|NCT03322397|adolescence|adolescence
975286|NCT03322397|immune function|immune function
975287|NCT03322397|gene expression|gene expression
975288|NCT03322397|psychological well-being|psychological well-being
975289|NCT03322397|social connection|social connection
975290|NCT03322397|kindness|kindness
975291|NCT03322345|lymph flow|lymph flow
975292|NCT03322345|Fontan|fontan
975293|NCT03322332|adiponectin|adiponectin
975294|NCT03322332|omentin-1|omentin-1
975295|NCT03322332|resistin|resistin
975296|NCT03322332|RBP4|rbp4
975297|NCT03322332|epicardial fat|epicardial fat
975298|NCT03322332|Coronary artery disease|coronary artery disease
975299|NCT03322319|Cardiac amyloidosis|cardiac amyloidosis
975300|NCT03322319|Caribbean|caribbean
975301|NCT03322319|Diagnosis|diagnosis
975302|NCT03322319|Transthyretin|transthyretin
975303|NCT03322306|genetic screening|genetic screening
975304|NCT03322306|neuro-degenerative disease|neuro-degenerative disease
975305|NCT03322293|Actinic Keratoses|actinic keratoses
975306|NCT03322293|photodynamic therapy|photodynamic therapy
975307|NCT03322293|aminolevulinic acid|aminolevulinic acid
975308|NCT03322293|precancerous skin lesion|precancerous skin lesion
975309|NCT03322280|Hepatocellular carcinoma|hepatocellular carcinoma
975310|NCT03322280|Portal vein tumor thrombus|portal vein tumor thrombus
975311|NCT03322280|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
975312|NCT03322280|iodine-125 seed|iodine-125 seed
975313|NCT03322267|Adjuvant pembrolizumab|adjuvant pembrolizumab
975314|NCT03322267|Chemoradiotherapy|chemoradiotherapy
975315|NCT03322228|Hospice|hospice
975316|NCT03322228|Palliative Care|palliative care
975317|NCT03322228|Integrative Medicine|integrative medicine
975318|NCT03322228|Music Therapy|music therapy
975319|NCT03322228|Inpatient|inpatient
975320|NCT03322228|Caregiver|caregiver
975321|NCT03322215|palbociclib|palbociclib
975322|NCT03322215|fulvestrant|fulvestrant
975323|NCT03322215|capecitabine|capecitabine
975324|NCT03322202|Spinal Cord Injury|spinal cord injury
975325|NCT03322202|Motivational Interviewing|motivational interviewing
975326|NCT03322150|Atropine|atropine
975327|NCT03322150|glycopyrrolate|glycopyrrolate
975329|NCT03322150|dexmedetomidine|dexmedetomidine
975330|NCT03322150|spinal anesthesia|spinal anesthesia
975331|NCT03322098|Atropine|atropine
975332|NCT03322098|glycopyrrolate|glycopyrrolate
975333|NCT03322098|bradycardia|bradycardia
975334|NCT03322098|dexmedetomidine|dexmedetomidine
975335|NCT03322098|spinal anesthesia|spinal anesthesia
975336|NCT03322085|atrial fibrillation|atrial fibrillation
975337|NCT03322085|atrial electrical remodeling|atrial electrical remodeling
975338|NCT03322046|Therapeutic Lifestyle Change|therapeutic lifestyle change
975339|NCT03322046|Cardiovascular Disease|cardiovascular disease
975340|NCT03322046|First Responders|first responders
975341|NCT03322046|Firefighters|firefighters
975343|NCT03322007|pain|pain
975344|NCT03322007|pancreas cancer|pancreas cancer
975345|NCT03322007|Scrambler Therapy|scrambler therapy
975346|NCT03321981|Bispecific Antibody IgG1, HER2 HER3|bispecific antibody igg1, her2 her3
975347|NCT03321981|MCLA-128|mcla-128
975348|NCT03321981|Antibodies, bispecific|antibodies, bispecific
975349|NCT03321981|Immunologic Factors|immunologic factors
975350|NCT03321981|Cytokines|cytokines
1568406|NCT00505947|visual loss|visual loss
975351|NCT03321981|combination Trastuzumab with and without Vinorelbine|combination trastuzumab with and without vinorelbine
975352|NCT03321968|Influenza|influenza
975353|NCT03321968|Human|human
975354|NCT03321968|RNA Virus Infections|rna virus infections
975355|NCT03321968|Lot Consistency|lot consistency
975356|NCT03321968|Immunologic|immunologic
975357|NCT03321968|Orthomyxoviridae Infections|orthomyxoviridae infections
975358|NCT03321968|Infection|infection
975359|NCT03321968|Virus Diseases|virus diseases
975360|NCT03321942|Adipose Tissue-derived Mesenchymal Stem Cells|adipose tissue-derived mesenchymal stem cells
975361|NCT03321942|Chronic Kidney Diseases|chronic kidney diseases
975362|NCT03321916|MacTel|mactel
975363|NCT03321903|Oxygen|oxygen
975364|NCT03321903|Oximetry|oximetry
975365|NCT03321903|Electron Spin Resonance Spectroscopy|electron spin resonance spectroscopy
975366|NCT03321903|Carbon|carbon
975367|NCT03321903|Charcoal|charcoal
975368|NCT03321903|Radiotherapy|radiotherapy
975369|NCT03321903|India Ink|india ink
975370|NCT03321903|EPR|epr
975371|NCT03321903|ESR|esr
975372|NCT03321903|Immunotherapy|immunotherapy
975373|NCT03321890|relapsed or refractory|relapsed or refractory
975374|NCT03321890|peripheral T-cell lymphoma|peripheral t-cell lymphoma
975375|NCT03321890|Combination therapy|combination therapy
975376|NCT03321864|Transperineal biopsy|transperineal biopsy
975377|NCT03321864|Prostate cancer|prostate cancer
975378|NCT03321864|Transrectal ultrasound|transrectal ultrasound
975379|NCT03321864|Fusion biopsy techniques|fusion biopsy techniques
975380|NCT03321812|decalcification bone scaffold|decalcification bone scaffold
975381|NCT03321812|microfracture|microfracture
975382|NCT03321812|randomized controlled trial|randomized controlled trial
975383|NCT03321812|cartilage lesions of the knee|cartilage lesions of the knee
975384|NCT03321773|Helicobacter pylori|helicobacter pylori
975385|NCT03321773|Eradication rate|eradication rate
975386|NCT03321734|Caffeine|caffeine
975387|NCT03321734|Prematurity|prematurity
975388|NCT03321721|hand|hand
975389|NCT03321721|feet lacerations|feet lacerations
975390|NCT03321721|children|children
975391|NCT03321721|conservative management|conservative management
975392|NCT03321682|Cardiopulmonary Capacity|cardiopulmonary capacity
975393|NCT03321682|Quality of Life|quality of life
975394|NCT03321682|Functional Capacity|functional capacity
975395|NCT03321682|Functional Training|functional training
975396|NCT03321630|Pebrolizumab|pebrolizumab
975397|NCT03321630|Lenvatinib|lenvatinib
975398|NCT03321604|hemodialysis|hemodialysis
975399|NCT03321604|kidney|kidney
975400|NCT03321604|dialysis|dialysis
975401|NCT03321578|nosocomial|nosocomial
975402|NCT03321578|hospital acquired|hospital acquired
975403|NCT03321578|clostridium difficile|clostridium difficile
975404|NCT03321565|obesity|obesity
975405|NCT03321552|Desert foot|desert foot
975600|NCT03320252|Juxtarenal|juxtarenal
975406|NCT03321552|No-option patients|no-option patients
975407|NCT03321552|Venous arterialization|venous arterialization
975408|NCT03321539|Nasopharyngeal carcinoma;adjuvant chemotherapy|nasopharyngeal carcinoma;adjuvant chemotherapy
975409|NCT03321513|Diabetic Macular Edema|diabetic macular edema
975410|NCT03321513|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
975411|NCT03321487|Blood-Brain Barrier disruption|blood-brain barrier disruption
975412|NCT03321487|Blood-Brain Barrier opening|blood-brain barrier opening
975413|NCT03321487|magnetic resonance-guided focused ultrasound|magnetic resonance-guided focused ultrasound
975414|NCT03321409|Somatic symptom|somatic symptom
975415|NCT03321409|SSS-Ch|sss-ch
975416|NCT03321409|PHQ-15|phq-15
975417|NCT03321409|Suspected CAD|suspected cad
975418|NCT03321409|Coronary angiography|coronary angiography
975419|NCT03321396|Sodium Alginate|sodium alginate
975420|NCT03321396|Calcium Lactate|calcium lactate
975421|NCT03321396|Gel|gel
975422|NCT03321383|dyspepsia|dyspepsia
975423|NCT03321383|health related quality of life|health related quality of life
975424|NCT03321331|Mobile Health|mobile health
975425|NCT03321331|mobile apps|mobile apps
975713|NCT03319485|ExAblate|exablate
975426|NCT03321331|weight control|weight control
975427|NCT03321331|weight management|weight management
975428|NCT03321331|self-directed intervention|self-directed intervention
975429|NCT03321331|behavioral intervention|behavioral intervention
975430|NCT03321266|Fistula plug|fistula plug
975431|NCT03321253|Posterior Capsule Opacification|posterior capsule opacification
975432|NCT03321253|Macular Pigment Optical Density|macular pigment optical density
975433|NCT03321253|Anterior Chamber Parameters|anterior chamber parameters
975434|NCT03321253|Nd: YAG Laser Posterior Capsulotomy|nd: yag laser posterior capsulotomy
975435|NCT03321253|Posterior Capsulotomy|posterior capsulotomy
975436|NCT03321253|Cystoid Macular Edema|cystoid macular edema
975437|NCT03321253|Choroidal Thickness|choroidal thickness
975438|NCT03321240|focal cortical dysplasia|focal cortical dysplasia
975439|NCT03321240|Pronostic|pronostic
975440|NCT03321240|Epilepsy surgery|epilepsy surgery
975441|NCT03321240|Epiletogenicity index|epiletogenicity index
975442|NCT03321240|SEEG|seeg
975443|NCT03321227|Children|children
975444|NCT03321227|Nutrition|nutrition
975445|NCT03321227|Eggs|eggs
975446|NCT03321227|Cognitive performance|cognitive performance
975447|NCT03321227|Glycemic response|glycemic response
975448|NCT03321227|Appetite|appetite
975449|NCT03321227|Emotion|emotion
975450|NCT03321214|Gluten Free diet|gluten free diet
975451|NCT03321188|Heated intraperitoneal chemotherapy|heated intraperitoneal chemotherapy
975452|NCT03321188|HIPEC|hipec
975453|NCT03321188|cisplatin|cisplatin
975454|NCT03321188|paclitaxel|paclitaxel
975455|NCT03321188|carboplatin|carboplatin
975456|NCT03321188|adjuvant IV chemotherapy|adjuvant iv chemotherapy
975457|NCT03321175|Wound|wound
975458|NCT03321175|infection|infection
975459|NCT03321175|cesarean section|cesarean section
975460|NCT03321162|surgical guide , double scan , triple scan protocol|surgical guide , double scan , triple scan protocol
975461|NCT03321149|Web-based intervention|web-based intervention
975462|NCT03321149|Sedentary behavior|sedentary behavior
975463|NCT03321149|Lifestyle intervention|lifestyle intervention
975464|NCT03321149|Feasibility|feasibility
975465|NCT03321123|B cell Acute Lymphoblastic Leukemia|b cell acute lymphoblastic leukemia
975466|NCT03321123|relapsed or refractory|relapsed or refractory
975467|NCT03321123|CD-19 Positive|cd-19 positive
975468|NCT03321097|stroke rehabilitation|stroke rehabilitation
975469|NCT03321097|spasticity|spasticity
975470|NCT03321097|Botulinum toxin type A injection|botulinum toxin type a injection
975471|NCT03321097|robot-assisted therapy|robot-assisted therapy
975472|NCT03321097|massed therapy|massed therapy
975473|NCT03321097|distributed therapy|distributed therapy
975474|NCT03321084|Osteoarthrosis|osteoarthrosis
975475|NCT03321084|Exercise Movement Techniques|exercise movement techniques
975476|NCT03321084|Pilates|pilates
975477|NCT03321084|Elderly|elderly
975478|NCT03321084|Physiotherapy|physiotherapy
975479|NCT03321058|Drug Substitution|drug substitution
975480|NCT03321058|Multicompartment Compliance Aid|multicompartment compliance aid
975481|NCT03321045|89Zr-Trastuzumab, HER2 Imaging|89zr-trastuzumab, her2 imaging
975482|NCT03321032|Coronary Artery Disease|coronary artery disease
975483|NCT03321032|Diabetes Mellitus|diabetes mellitus
975484|NCT03321032|Drug-eluting stents|drug-eluting stents
975485|NCT03321032|Restenosis|restenosis
975486|NCT03320993|post-prandial glucose control|post-prandial glucose control
975487|NCT03320993|alcohol|alcohol
975488|NCT03320980|ALPPS|alpps
975489|NCT03320980|RALPPS|ralpps
975490|NCT03320980|Portal Vein Embolization|portal vein embolization
975491|NCT03320980|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
975492|NCT03320980|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
975493|NCT03320954|Language|language
975494|NCT03320954|Anomia|anomia
975495|NCT03320941|Obesity disease|obesity disease
975496|NCT03320941|Over weight|over weight
975497|NCT03320941|T2DM|t2dm
975498|NCT03320941|interventional study|interventional study
975499|NCT03320941|Weight loss|weight loss
975500|NCT03320902|Family members|family members
975501|NCT03320902|sudden death|sudden death
975502|NCT03320902|sudden death counseling|sudden death counseling
975503|NCT03320902|depression|depression
975504|NCT03320837|metabolomics|metabolomics
975505|NCT03320837|microbiome|microbiome
975506|NCT03320837|infant formula|infant formula
975507|NCT03320837|synbiotics|synbiotics
975508|NCT03320837|urine samples|urine samples
975509|NCT03320837|NMR analysis|nmr analysis
975510|NCT03320811|Celiac disease|celiac disease
975511|NCT03320811|serological tests|serological tests
975512|NCT03320811|anti-deamidated gliadin peptide antibodies|anti-deamidated gliadin peptide antibodies
975513|NCT03320798|Bullous pemphigoid|bullous pemphigoid
975514|NCT03320798|neurologic disorders|neurologic disorders
975515|NCT03320785|preterm infants|preterm infants
975516|NCT03320785|sepsis|sepsis
975517|NCT03320785|chorioamnionitis|chorioamnionitis
975518|NCT03320785|circulating markers|circulating markers
975519|NCT03320746|Physical activity|physical activity
975520|NCT03320746|Sedentary time|sedentary time
975521|NCT03320746|Intervention|intervention
975522|NCT03320746|Retiree|retiree
975523|NCT03320733|dual energy CT|dual energy ct
975714|NCT03319485|TcMRgFUS|tcmrgfus
975524|NCT03320694|Gestational Diabetes Mellitus, Metformin, Insulin|gestational diabetes mellitus, metformin, insulin
975525|NCT03320681|Neurostimulator|neurostimulator
975526|NCT03320668|Falls Prevention|falls prevention
975527|NCT03320668|Otago Program|otago program
975528|NCT03320668|Community-Dwelling|community-dwelling
975529|NCT03320655|Chronic Heart Failure|chronic heart failure
975530|NCT03320655|Fragility|fragility
975531|NCT03320642|Acute leukemia|acute leukemia
975532|NCT03320642|chronic myelogenous leukemia|chronic myelogenous leukemia
975533|NCT03320642|myelodysplasia|myelodysplasia
975534|NCT03320642|chronic lymphocytic leukemia/small lymphocytic lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
975535|NCT03320642|follicular|follicular
975536|NCT03320642|marginal zone|marginal zone
975537|NCT03320642|diffuse large B-cell|diffuse large b-cell
975538|NCT03320642|Hodgkin's lymphoma|hodgkin's lymphoma
975539|NCT03320642|mantle cell lymphoma|mantle cell lymphoma
975540|NCT03320642|Janus kinase inhibitor|janus kinase inhibitor
975541|NCT03320642|graft-versus-host disease|graft-versus-host disease
975542|NCT03320590|Time lapse Primovision|time lapse primovision
975543|NCT03320590|Spermatic nuclear quality|spermatic nuclear quality
975544|NCT03320590|intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
975545|NCT03320590|Embryonic kinetics|embryonic kinetics
975546|NCT03320564|injections, intravenous|injections, intravenous
975547|NCT03320564|fluorodeoxyglucose F-18|fluorodeoxyglucose f-18
975548|NCT03320551|Education|education
975549|NCT03320538|Jiangzhong Hou Gu® Mi Xi™|jiangzhong hou gu® mi xi™
975550|NCT03320538|Shen Ling Bai Zhu San|shen ling bai zhu san
975551|NCT03320538|peptic ulcer disease|peptic ulcer disease
975552|NCT03320538|traditional Chinese medicine|traditional chinese medicine
975553|NCT03320538|randomized controlled trial|randomized controlled trial
975554|NCT03320525|YKL-40|ykl-40
975555|NCT03320525|Pharmacokinetic|pharmacokinetic
975556|NCT03320525|Solid tumors|solid tumors
975557|NCT03320525|T-ChOS|t-chos
975558|NCT03320525|Benecta|benecta
975559|NCT03320525|chitinase 3 like-1 protein (CHI3L1)|chitinase 3 like-1 protein (chi3l1)
975560|NCT03320512|PrEP|prep
975561|NCT03320512|gamification|gamification
975562|NCT03320512|mHealth|mhealth
975563|NCT03320512|HIV prevention|hiv prevention
975564|NCT03320512|truvada|truvada
975565|NCT03320512|eHealth|ehealth
975566|NCT03320512|app|app
975567|NCT03320512|adherence|adherence
975568|NCT03320512|ymsm|ymsm
975569|NCT03320512|transgender women|transgender women
975570|NCT03320486|Mycoses|mycoses
975571|NCT03320486|Dermatomycoses|dermatomycoses
975572|NCT03320486|Antifugal Agents|antifugal agents
975573|NCT03320486|Dapaconazole|dapaconazole
975574|NCT03320460|oral lichen planus; photobiomodulation; inflammation|oral lichen planus; photobiomodulation; inflammation
975575|NCT03320447|ablative fractional laser|ablative fractional laser
975576|NCT03320447|photodynamic therapy|photodynamic therapy
975577|NCT03320447|protoporphyrin IX|protoporphyrin ix
975578|NCT03320447|methy-aminolevulinate|methy-aminolevulinate
975579|NCT03320421|hypofractionated radiation|hypofractionated radiation
975580|NCT03320421|breast cancer|breast cancer
975581|NCT03320421|breast conserving surgery|breast conserving surgery
975582|NCT03320421|simultaneous boost radiation|simultaneous boost radiation
975583|NCT03320408|biobank|biobank
975584|NCT03320408|pathogenesis|pathogenesis
975585|NCT03320408|Aortic Aneurysm|aortic aneurysm
975586|NCT03320304|Difficult to Treat Depression|difficult to treat depression
975587|NCT03320304|TRD|trd
975588|NCT03320304|VNS Therapy|vns therapy
975589|NCT03320304|Vagus Nerve Stimulation|vagus nerve stimulation
975590|NCT03320304|VNS|vns
975591|NCT03320291|Rhizarthrosis|rhizarthrosis
975592|NCT03320291|Regjoint|regjoint
975593|NCT03320291|Trapeziectomy|trapeziectomy
975594|NCT03320278|endotracheal intubation|endotracheal intubation
975595|NCT03320278|airway management|airway management
975596|NCT03320265|Phosphorylcholine human monoclonal antibody|phosphorylcholine human monoclonal antibody
975597|NCT03320265|Lipoprotein a|lipoprotein a
975598|NCT03320252|CHEVAR|chevar
975599|NCT03320252|Chimney|chimney
975601|NCT03320252|Short Infrarenal /neck|short infrarenal /neck
975602|NCT03320252|Endurant|endurant
975604|NCT03320239|risk assessment|risk assessment
975605|NCT03320239|HIV testing|hiv testing
975606|NCT03320239|unprotected anal intercourse|unprotected anal intercourse
975607|NCT03320239|Social medica|social medica
975608|NCT03320213|CA125|ca125
975609|NCT03320213|Yolk sac morphology|yolk sac morphology
975610|NCT03320213|Threatened miscarriage|threatened miscarriage
975611|NCT03320174|tafenoquine|tafenoquine
975612|NCT03320174|australia|australia
975613|NCT03320161|Supportive care|supportive care
975614|NCT03320161|Cancer|cancer
975615|NCT03320161|Health-related quality of life|health-related quality of life
975616|NCT03320161|Consensus|consensus
975617|NCT03320161|Participative approach|participative approach
975618|NCT03320161|Patient involvement|patient involvement
975619|NCT03320161|DELPHI method|delphi method
975620|NCT03320135|enamel matrix derivative|enamel matrix derivative
975621|NCT03320135|proximal furcation|proximal furcation
975622|NCT03320135|randomized clinical trial|randomized clinical trial
975623|NCT03320122|Telemedicine|telemedicine
975624|NCT03320083|sleep, infants, behavioural insomnia, breastfeeding|sleep, infants, behavioural insomnia, breastfeeding
975625|NCT03320057|medication abortion|medication abortion
975626|NCT03320057|mifepristone|mifepristone
975627|NCT03320044|Circulating Tumor DNA|circulating tumor dna
975628|NCT03320044|Lung cancer Surgery|lung cancer surgery
975629|NCT03320044|early diagnosis|early diagnosis
975630|NCT03320044|immuno-sequencing|immuno-sequencing
975631|NCT03320031|Linagliptin|linagliptin
975632|NCT03320031|premixedinsulin therapy|premixedinsulin therapy
975633|NCT03320031|peritoneal dialysis|peritoneal dialysis
975634|NCT03320031|glycemic variability|glycemic variability
975635|NCT03320018|neuroprotection|neuroprotection
975636|NCT03320018|antioxidant|antioxidant
975637|NCT03320005|respiratory performance|respiratory performance
975638|NCT03320005|quality of life|quality of life
975639|NCT03320005|physical performance|physical performance
975640|NCT03319992|Robotics [H01.671.293.643]|robotics [h01.671.293.643]
975641|NCT03319992|Exoskeleton Device [E07.341]|exoskeleton device [e07.341]
975642|NCT03319992|Rehabilitation Research [H01.770.644.145.472]|rehabilitation research [h01.770.644.145.472]
975643|NCT03319992|Physical and Rehabilitation Medicine [H02.403.680]|physical and rehabilitation medicine [h02.403.680]
975644|NCT03319992|Exercise Therapy [E02.779.483]|exercise therapy [e02.779.483]
975645|NCT03319992|Patient Outcome Assessment [N05.715.360.575.575.399]|patient outcome assessment [n05.715.360.575.575.399]
975646|NCT03319979|Folate, DHFR|folate, dhfr
975647|NCT03319953|Drug therapy|drug therapy
975648|NCT03319940|Half Life Extended (HLE) Bispecific T cell engager (BiTE®)|half life extended (hle) bispecific t cell engager (bite®)
975649|NCT03319940|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
975650|NCT03319927|integrated pest management|integrated pest management
975651|NCT03319927|environmental health|environmental health
975652|NCT03319927|child care|child care
975653|NCT03319927|preschool children|preschool children
975654|NCT03319927|pesticides|pesticides
975655|NCT03319914|calciphylaxis, calcific uremic arteriolopathy,|calciphylaxis, calcific uremic arteriolopathy,
975656|NCT03319914|calcium metabolism disorders|calcium metabolism disorders
975657|NCT03319914|metabolic diseases|metabolic diseases
975658|NCT03319914|sodium thiosulfate|sodium thiosulfate
975659|NCT03319901|Leukemia|leukemia
975660|NCT03319888|CPAP, Chronic kidney disease, sleep apnea|cpap, chronic kidney disease, sleep apnea
975661|NCT03319875|Epiduroscopy|epiduroscopy
975662|NCT03319875|Discectomy|discectomy
975663|NCT03319875|Holmium Yag laser|holmium yag laser
975664|NCT03319875|Lumbar disc herniation|lumbar disc herniation
975665|NCT03319875|Minimally invasive treatment|minimally invasive treatment
975666|NCT03319849|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
975667|NCT03319849|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
975668|NCT03319810|MCI, Alzheimer Disease, AD|mci, alzheimer disease, ad
975669|NCT03319797|Autologous chondrocyte transplantation ACT|autologous chondrocyte transplantation act
975670|NCT03319771|exercise|exercise
975671|NCT03319771|neuroimaging|neuroimaging
975672|NCT03319771|walking|walking
975673|NCT03319771|multiple sclerosis|multiple sclerosis
975674|NCT03319758|bone augmentation|bone augmentation
975675|NCT03319758|esthetics|esthetics
975676|NCT03319758|immediate implant|immediate implant
975677|NCT03319758|buccal bone defects|buccal bone defects
975678|NCT03319745|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
975679|NCT03319745|Urothelial carcinoma of the bladder|urothelial carcinoma of the bladder
975680|NCT03319745|Pembrolizumab|pembrolizumab
975681|NCT03319745|Keytruda|keytruda
975682|NCT03319745|MK-3475|mk-3475
975683|NCT03319745|SCH-900475|sch-900475
975684|NCT03319654|Unexplained Infertility|unexplained infertility
975685|NCT03319654|Idiopathic Infertility|idiopathic infertility
975686|NCT03319654|DNA damage|dna damage
975687|NCT03319654|DNA fragmentation|dna fragmentation
975688|NCT03319654|Insemination|insemination
975689|NCT03319641|68Ga-PSMA|68ga-psma
975690|NCT03319641|Positron-Emission Tomography|positron-emission tomography
975691|NCT03319641|Immunohistochemistry|immunohistochemistry
975692|NCT03319615|Appetite|appetite
975693|NCT03319615|Energy Intake|energy intake
975694|NCT03319615|Body Composition|body composition
975695|NCT03319615|Energy Expenditure|energy expenditure
975696|NCT03319602|oxygen mask|oxygen mask
975697|NCT03319602|high-flow oxygen therapy|high-flow oxygen therapy
975698|NCT03319602|acute respiratory failure|acute respiratory failure
975699|NCT03319576|Gastrostomy|gastrostomy
975700|NCT03319576|Feeding|feeding
975701|NCT03319576|G-tube|g-tube
975825|NCT03318874|THERA°PEARL Eye Mask|thera°pearl eye mask
975702|NCT03319550|milk protein, endotoxemia, muscle protein synthesis, whey, casein|milk protein, endotoxemia, muscle protein synthesis, whey, casein
975703|NCT03319537|Pevonedistat|pevonedistat
975704|NCT03319537|Pemetrexed|pemetrexed
975705|NCT03319537|Cisplatin|cisplatin
975706|NCT03319537|17-361|17-361
975707|NCT03319511|thoracic spinal|thoracic spinal
975708|NCT03319511|awake mastectomy|awake mastectomy
975709|NCT03319511|paravertebral block|paravertebral block
975710|NCT03319511|analgesia|analgesia
975711|NCT03319511|ultrasound|ultrasound
975712|NCT03319511|breast cancer|breast cancer
975718|NCT03319472|simple bedside test|simple bedside test
975719|NCT03319472|rapid|rapid
975720|NCT03319472|score|score
975721|NCT03319472|widely available|widely available
975722|NCT03319472|feasible|feasible
975723|NCT03319459|Solid Tumor|solid tumor
975724|NCT03319459|HER2|her2
975725|NCT03319459|EGFR|egfr
975726|NCT03319459|Advanced Solid Tumor|advanced solid tumor
975727|NCT03319459|Breast Cancer|breast cancer
975728|NCT03319459|Head and Neck Cancer|head and neck cancer
975729|NCT03319459|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
975730|NCT03319459|Colorectal Cancer|colorectal cancer
975731|NCT03319459|Gastric Cancer|gastric cancer
1657148|NCT00160160|diabetes|diabetes
991716|NCT03216369|MRI|mri
975732|NCT03319459|HER2 Positive|her2 positive
975733|NCT03319459|EGFR Positive|egfr positive
975734|NCT03319459|EGFR+|egfr+
975735|NCT03319459|HER2+|her2+
975736|NCT03319459|Immunotherapy|immunotherapy
975737|NCT03319459|NK cell therapy|nk cell therapy
975738|NCT03319459|Natural killer cell therapy|natural killer cell therapy
975739|NCT03319459|antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
975740|NCT03319459|ADCC|adcc
975741|NCT03319433|spinal hypotension|spinal hypotension
975742|NCT03319433|perfusion index|perfusion index
975743|NCT03319433|caesarean section|caesarean section
975744|NCT03319394|Firefighters|firefighters
975745|NCT03319394|Exercise Training|exercise training
975746|NCT03319394|Resistance Training|resistance training
975747|NCT03319394|Exercise Test|exercise test
975748|NCT03319394|High-Intensity Interval Training|high-intensity interval training
975749|NCT03319381|Algorithm|algorithm
975750|NCT03319381|In-hospital mortality|in-hospital mortality
975751|NCT03319381|Multiple trauma|multiple trauma
975752|NCT03319381|Standard of care|standard of care
975753|NCT03319355|multicomponent therapy|multicomponent therapy
975754|NCT03319264|Spondylarthropathy|spondylarthropathy
975755|NCT03319264|Sarcopenia|sarcopenia
975756|NCT03319264|lean mass|lean mass
975757|NCT03319264|fat mass|fat mass
975758|NCT03319238|Chronic pain|chronic pain
975759|NCT03319238|Neuropathic pain|neuropathic pain
975760|NCT03319238|Ketamine|ketamine
975761|NCT03319238|Concomitant treatment|concomitant treatment
975762|NCT03319238|Adverse effect|adverse effect
975763|NCT03319173|Mild Cognitive Impairment|mild cognitive impairment
975764|NCT03319173|AMPK activation|ampk activation
975765|NCT03319173|DNA global hypo-methylation|dna global hypo-methylation
975766|NCT03319173|Metabolic Syndrome|metabolic syndrome
975767|NCT03319173|Ketogenic diet|ketogenic diet
975768|NCT03319147|exercise|exercise
975769|NCT03319147|recovery|recovery
975770|NCT03319147|muscle|muscle
975771|NCT03319147|protein|protein
975772|NCT03319121|Non cardiac chest pain|non cardiac chest pain
975773|NCT03319121|Empirical therapy|empirical therapy
975774|NCT03319121|Guided therapy|guided therapy
975775|NCT03319095|pelvic floor, muscle, electrical stimulation, physiotherapy|pelvic floor, muscle, electrical stimulation, physiotherapy
975776|NCT03319043|Cough Variant Asthma|cough variant asthma
975777|NCT03319043|impedance|impedance
975778|NCT03319043|inflammation|inflammation
975779|NCT03319043|Chanqin granules|chanqin granules
975780|NCT03319030|exercise|exercise
975781|NCT03319030|Aerobic Exercise|aerobic exercise
975782|NCT03319017|Hypoxia|hypoxia
975783|NCT03319017|Hyperinflammatory|hyperinflammatory
975784|NCT03319017|Hyperoxia|hyperoxia
975785|NCT03319017|Apoptosis|apoptosis
975786|NCT03319017|Oxygenation|oxygenation
975787|NCT03319017|Polymorphonuclear Cells|polymorphonuclear cells
975788|NCT03319017|Tumor necrosis factor(TNF)-α|tumor necrosis factor(tnf)-α
975789|NCT03319017|Cytokine|cytokine
975790|NCT03318991|thulium laser|thulium laser
975791|NCT03318991|GreenLight laser|greenlight laser
975792|NCT03318991|laser therapy|laser therapy
975795|NCT03318978|Benzo[a]pyrene|benzo[a]pyrene
975796|NCT03318978|Accelerator Mass Spectrometry|accelerator mass spectrometry
975797|NCT03318978|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
975798|NCT03318965|Mortality|mortality
975799|NCT03318965|Anthropometry|anthropometry
975800|NCT03318965|Nutrition Assessment|nutrition assessment
975801|NCT03318965|Caliper|caliper
975802|NCT03318952|lidocaine injection|lidocaine injection
975803|NCT03318952|articaine injections|articaine injections
975804|NCT03318952|pediatric dental anesthesia|pediatric dental anesthesia
975805|NCT03318952|post dental procedure pain|post dental procedure pain
975809|NCT03318926|tea, cup-year, renal stone disease|tea, cup-year, renal stone disease
975810|NCT03318913|Vascular function|vascular function
975811|NCT03318913|Type 2 diabetes mellitus|type 2 diabetes mellitus
975812|NCT03318913|Fish protein hydrolysates|fish protein hydrolysates
975813|NCT03318900|adoptively transferred central memory-type CTL targeting ovarian cancer antigens|adoptively transferred central memory-type ctl targeting ovarian cancer antigens
975814|NCT03318900|in vivo persistence|in vivo persistence
975815|NCT03318900|Adoptive Cellular Therapy|adoptive cellular therapy
975816|NCT03318900|IL-21-Primed CD8+ Tumor Antigen-Specific T Cells|il-21-primed cd8+ tumor antigen-specific t cells
975817|NCT03318900|epithelial ovarian cancer|epithelial ovarian cancer
975819|NCT03318887|Direct acting antiviral agents|direct acting antiviral agents
975820|NCT03318887|Hepatitis C|hepatitis c
975821|NCT03318887|Pharmacological monitoring|pharmacological monitoring
975822|NCT03318874|Dry Eye Disease|dry eye disease
975823|NCT03318874|Meibomian Gland Dysfunction|meibomian gland dysfunction
975824|NCT03318874|Blephasteam|blephasteam
975826|NCT03318848|students, nursing|students, nursing
975827|NCT03318848|simulation training|simulation training
975828|NCT03318848|Instructional Films and Videos|instructional films and videos
975829|NCT03318848|Aptitude|aptitude
975830|NCT03318835|Thalidomide|thalidomide
975831|NCT03318835|R-CHOP|r-chop
975832|NCT03318835|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
975833|NCT03318822|brain injury|brain injury
975834|NCT03318809|Cardiovascular Diseases|cardiovascular diseases
975835|NCT03318809|Renal Impairment|renal impairment
975836|NCT03318809|Heart Diseases|heart diseases
975837|NCT03318796|Bifurcation lesions|bifurcation lesions
975838|NCT03318783|Eicosanoids|eicosanoids
975839|NCT03318783|Epoxyeicosatrienoic Acids|epoxyeicosatrienoic acids
975840|NCT03318770|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
975841|NCT03318770|adult|adult
975842|NCT03318770|dasatinib|dasatinib
975843|NCT03318770|blinatumomab|blinatumomab
975844|NCT03318770|LAL2116|lal2116
975845|NCT03318757|bupivacaine liposomal injectable|bupivacaine liposomal injectable
975846|NCT03318757|post operative pain|post operative pain
975847|NCT03318757|post operative narcotic use|post operative narcotic use
975848|NCT03318757|bupivacaine hydrochloride|bupivacaine hydrochloride
975849|NCT03318744|Silent Brain Infarction|silent brain infarction
975850|NCT03318744|Antithrombotics|antithrombotics
975851|NCT03318744|Antiplatelet|antiplatelet
975852|NCT03318744|Aspirin|aspirin
975853|NCT03318744|Asymptomatic|asymptomatic
975854|NCT03318731|fenugreek extract|fenugreek extract
975855|NCT03318731|non-resistance trained|non-resistance trained
975856|NCT03318666|Adolescent|adolescent
975857|NCT03318666|Adolescent Medicine|adolescent medicine
975858|NCT03318666|Mental Health Services|mental health services
975859|NCT03318666|eHealth|ehealth
975860|NCT03318666|Online systems|online systems
975861|NCT03318666|Primary Health Care|primary health care
975862|NCT03318666|Social media|social media
975863|NCT03318666|Social support|social support
975864|NCT03318653|Blood pressure|blood pressure
975865|NCT03318653|Dialysis|dialysis
975866|NCT03318640|schizophrenia|schizophrenia
975867|NCT03318640|mindfulness|mindfulness
975868|NCT03318640|parasympathetic system|parasympathetic system
975869|NCT03318614|Gut Microbiota|gut microbiota
975870|NCT03318614|Probiotics|probiotics
975871|NCT03318614|Abdominal Pain|abdominal pain
975872|NCT03318614|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
975873|NCT03318614|Mental|mental
975874|NCT03318601|cirrhotic|cirrhotic
975875|NCT03318601|ascite|ascite
975876|NCT03318601|copeptin|copeptin
975877|NCT03318588|Retinal detachment|retinal detachment
975878|NCT03318588|Photoreceptor apoptosis|photoreceptor apoptosis
975879|NCT03318588|Cytokine|cytokine
975880|NCT03318575|remote ischemic conditioning (RIC)|remote ischemic conditioning (ric)
975881|NCT03318575|percutaneous coronary intervention|percutaneous coronary intervention
975882|NCT03318575|PCI|pci
975883|NCT03318575|cardiac troponin I|cardiac troponin i
975884|NCT03318575|cardiac catheterization|cardiac catheterization
975885|NCT03318575|myocardial injury|myocardial injury
975886|NCT03318575|myocardial necrosis|myocardial necrosis
975887|NCT03318575|autoRIC|autoric
975888|NCT03318575|Ischemia-Reperfusion Injury (IRI)|ischemia-reperfusion injury (iri)
975889|NCT03318575|Automated Remote Ischemic Conditioning|automated remote ischemic conditioning
975890|NCT03318549|virtual reality|virtual reality
975891|NCT03318549|glaucoma|glaucoma
975892|NCT03318549|age related macular degeneration|age related macular degeneration
975893|NCT03318549|quality of life|quality of life
975894|NCT03318549|visual field|visual field
975895|NCT03318549|optical coherence tomography|optical coherence tomography
975896|NCT03318536|Serotonin Antagonists|serotonin antagonists
975897|NCT03318536|Sympathomimetics|sympathomimetics
975898|NCT03318523|BIIB054|biib054
975899|NCT03318523|Parkinson's Disease|parkinson's disease
975900|NCT03318523|Alpha-synuclein|alpha-synuclein
975901|NCT03318523|Alpha synuclein|alpha synuclein
975902|NCT03318497|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
975903|NCT03318497|18F-FLT|18f-flt
975905|NCT03318497|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
975906|NCT03318497|Borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
975907|NCT03318471|MgSo4, Mayfield clamp, pressor effect|mgso4, mayfield clamp, pressor effect
975908|NCT03318445|DNA repair mutation|dna repair mutation
975909|NCT03318432|Stroke|stroke
975910|NCT03318432|Acute Stroke|acute stroke
975911|NCT03318432|Ischemic Stroke|ischemic stroke
975912|NCT03318432|Hemorrhagic Stroke|hemorrhagic stroke
975913|NCT03318432|Cerebral Ischemia|cerebral ischemia
975914|NCT03318432|Cerebral Infarction|cerebral infarction
975915|NCT03318432|Cerebral Stroke|cerebral stroke
975916|NCT03318432|Cerebral Vascular Accident|cerebral vascular accident
975917|NCT03318432|Stroke Recovery|stroke recovery
975919|NCT03318406|vapor ablation|vapor ablation
975920|NCT03318406|InterVapor|intervapor
975921|NCT03318406|BTVA|btva
975922|NCT03318315|AS03-adjuvanted Inactivated Influenza Vaccine|as03-adjuvanted inactivated influenza vaccine
975923|NCT03318315|Co-Administered|co-administered
975924|NCT03318315|Healthy Adults|healthy adults
975925|NCT03318315|Immunogenicity|immunogenicity
975926|NCT03318315|Inactivated Seasonal Influenza Vaccine|inactivated seasonal influenza vaccine
975927|NCT03318315|Phase II|phase ii
975928|NCT03318315|Safety|safety
975929|NCT03318263|Estrogen-receptor-positive breast cancer|estrogen-receptor-positive breast cancer
975930|NCT03318263|aromatase inhibitor,|aromatase inhibitor,
975931|NCT03318263|ESR1,|esr1,
975932|NCT03318263|PIK3CA|pik3ca
975933|NCT03318263|AKT|akt
975934|NCT03318263|endocrine resistance|endocrine resistance
975935|NCT03318263|circulating tumor DNA|circulating tumor dna
975936|NCT03318250|DRG Stimulation|drg stimulation
975937|NCT03318211|preeclampsia|preeclampsia
975938|NCT03318211|Magnisium sulfate|magnisium sulfate
975939|NCT03318198|Graduate Medical Education|graduate medical education
975940|NCT03318198|Attending Supervision of Residents|attending supervision of residents
975941|NCT03318198|Patient Safety|patient safety
975942|NCT03318185|gasless single-port laparoscopic surgery;rectal carcinoma|gasless single-port laparoscopic surgery;rectal carcinoma
975943|NCT03318172|Spinal Cord Stimulation|spinal cord stimulation
975944|NCT03318172|High Density Stimulation|high density stimulation
975945|NCT03318146|Plugged Tear Duct|plugged tear duct
975946|NCT03318133|general anesthesia|general anesthesia
975947|NCT03318133|sacral plexus block|sacral plexus block
975948|NCT03318133|lumbar plexus block|lumbar plexus block
975949|NCT03318133|hip fracture|hip fracture
975950|NCT03318133|elderly|elderly
975951|NCT03318094|insulin resistance|insulin resistance
975952|NCT03318094|phentolamine|phentolamine
975953|NCT03318094|microvascular recruitment|microvascular recruitment
975954|NCT03318094|autonomic nervous system|autonomic nervous system
975955|NCT03318081|Amphetamine-type stimulants|amphetamine-type stimulants
975956|NCT03318081|prefrontal-striatal circuits|prefrontal-striatal circuits
975957|NCT03318081|cognitive rehabilitation therapy|cognitive rehabilitation therapy
975958|NCT03318068|Cancer|cancer
975959|NCT03318068|Pediatric cancer|pediatric cancer
975960|NCT03318068|Yoga|yoga
975961|NCT03318068|Psychological distress|psychological distress
975962|NCT03318068|Outpatient chemotherapy|outpatient chemotherapy
975963|NCT03318029|Vitamin D|vitamin d
975964|NCT03318029|Supplementation|supplementation
975965|NCT03318029|Sunlight|sunlight
975966|NCT03318016|Arsenic Trioxide|arsenic trioxide
975967|NCT03318016|Cyclophosphamide|cyclophosphamide
975968|NCT03317990|Prostate Cancer|prostate cancer
975969|NCT03317990|Nerve sparing|nerve sparing
975970|NCT03317990|NeuroSAFE|neurosafe
975971|NCT03317990|Frozen section|frozen section
975972|NCT03317977|Asthma management, adolescents|asthma management, adolescents
975973|NCT03317925|Pediatric Renal Transplant|pediatric renal transplant
975974|NCT03317925|Renal Allograft|renal allograft
975975|NCT03317925|Angiotensin II|angiotensin ii
975976|NCT03317925|Angiotensin-(1-7)|angiotensin-(1-7)
975977|NCT03317925|ACE|ace
975978|NCT03317925|ACE2|ace2
975979|NCT03317860|perceptual disorders|perceptual disorders
975980|NCT03317860|cerebrovascular disorders|cerebrovascular disorders
975981|NCT03317860|neurobehavioral manifestations|neurobehavioral manifestations
975982|NCT03317860|neurologic manifestations|neurologic manifestations
975983|NCT03317860|neglect|neglect
975984|NCT03317860|non-invasive brain stimulation|non-invasive brain stimulation
975985|NCT03317860|rehabilitation|rehabilitation
975986|NCT03317860|tDCS|tdcs
975987|NCT03317860|paresis|paresis
975988|NCT03317795|Menorrhagia|menorrhagia
975989|NCT03317795|FIbroids|fibroids
975990|NCT03317795|Menstrual Bleeding|menstrual bleeding
975991|NCT03317795|Heavy Bleeding|heavy bleeding
975992|NCT03317795|Menses|menses
975993|NCT03317795|Uterine Fibroids|uterine fibroids
975994|NCT03317730|Xtampza ER|xtampza er
975995|NCT03317730|LAHNC|lahnc
975996|NCT03317730|Head and neck cancer|head and neck cancer
975997|NCT03317730|Pain management|pain management
975998|NCT03317691|myocardial infarction|myocardial infarction
975999|NCT03317691|artificial Intelligence|artificial intelligence
976000|NCT03317691|12 lead electrocardiogram|12 lead electrocardiogram
976001|NCT03317665|biologic|biologic
976002|NCT03317665|prosthetic|prosthetic
976003|NCT03317665|mesh|mesh
976004|NCT03317613|Neuropathic Pain|neuropathic pain
976005|NCT03317613|Qutenza|qutenza
976006|NCT03317613|Capsaicin|capsaicin
976007|NCT03317613|Cancer patient|cancer patient
976008|NCT03317561|troponin|troponin
976009|NCT03317561|major surgery|major surgery
976010|NCT03317535|Anesthesia Methods|anesthesia methods
976011|NCT03317535|Acute Ischemic Stroke|acute ischemic stroke
976012|NCT03317535|Endovascular Treatment|endovascular treatment
976013|NCT03317522|Pregnancy|pregnancy
976014|NCT03317522|teratogenesis|teratogenesis
976108|NCT03316794|Triple Negative Breast Cancer|triple negative breast cancer
976109|NCT03316794|Cancer|cancer
976110|NCT03316794|Breast Cancer|breast cancer
976015|NCT03317496|Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC), carboplatin, pemetrexed, gemcitabine, cisplatin|avelumab, immunotherapy, pd-l1 inhibitor, non-small cell lung cancer (nsclc), urothelial cancer (uc), carboplatin, pemetrexed, gemcitabine, cisplatin
976016|NCT03317444|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
976017|NCT03317431|dopamine,mechanical ventilation,lung injury|dopamine,mechanical ventilation,lung injury
976018|NCT03317366|ARQ 092|arq 092
976019|NCT03317366|ArQule|arqule
976020|NCT03317366|AKT|akt
976021|NCT03317366|PIK3CA|pik3ca
976022|NCT03317366|Overgrowth|overgrowth
976023|NCT03317366|Congenital malformations|congenital malformations
976024|NCT03317353|Vestibular Rehabilitation|vestibular rehabilitation
976025|NCT03317353|Falls in elderly|falls in elderly
976026|NCT03317353|Computerized Dynamic Posturography|computerized dynamic posturography
976027|NCT03317353|Optokinetic stimuli|optokinetic stimuli
976028|NCT03317327|HNSCC|hnscc
976029|NCT03317327|Nivolumab|nivolumab
976030|NCT03317327|immunotherapy|immunotherapy
976031|NCT03317301|Pruritus cutaneus|pruritus cutaneus
976032|NCT03317288|spinal cord injury|spinal cord injury
976033|NCT03317288|pressure ulcer|pressure ulcer
976034|NCT03317288|laser Doppler flowmetry|laser doppler flowmetry
976035|NCT03317262|quality of life, citalopram, quetiapine, pregabalin|quality of life, citalopram, quetiapine, pregabalin
976036|NCT03317249|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
976037|NCT03317249|Pregnancy Related|pregnancy related
976038|NCT03317249|IST|ist
976039|NCT03317236|Bioequivalence|bioequivalence
976040|NCT03317236|Quetiapine|quetiapine
976041|NCT03317197|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
976042|NCT03317197|Vasopressin-steroid-epinephrine (VSE)|vasopressin-steroid-epinephrine (vse)
976043|NCT03317197|Treatment Outcome|treatment outcome
976044|NCT03317197|prognosis|prognosis
976045|NCT03317197|Return of spontaneous circulation|return of spontaneous circulation
976046|NCT03317184|Physical Activity|physical activity
976047|NCT03317184|Pfannenstiel incision|pfannenstiel incision
976048|NCT03317184|Periumbilical incision|periumbilical incision
976049|NCT03317171|dietary supplementation|dietary supplementation
976050|NCT03317171|flavonoids|flavonoids
976051|NCT03317171|omega 3|omega 3
976052|NCT03317158|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
976053|NCT03317158|BCG|bcg
976054|NCT03317158|immunotherapy|immunotherapy
976055|NCT03317145|venous thromboembolism|venous thromboembolism
976056|NCT03317145|deep vein thrombosis|deep vein thrombosis
976057|NCT03317145|pulmonary embolism|pulmonary embolism
976058|NCT03317145|neuromuscular electrostimulation|neuromuscular electrostimulation
976059|NCT03317145|foot compression|foot compression
976060|NCT03317145|hip replacement|hip replacement
976061|NCT03317132|Vocational, First-episode psychosis|vocational, first-episode psychosis
976062|NCT03317080|lung cancer|lung cancer
976063|NCT03317080|circulating tumor DNA|circulating tumor dna
976064|NCT03317080|molecular classification|molecular classification
976065|NCT03317080|dynamic monitoring|dynamic monitoring
976066|NCT03317080|next generation sequencing|next generation sequencing
976067|NCT03317080|diagnosis|diagnosis
976068|NCT03317080|postoperative relapse|postoperative relapse
976069|NCT03317067|Dexmdetomidine|dexmdetomidine
976070|NCT03317067|Haloperidol|haloperidol
976071|NCT03317067|Delirium|delirium
976072|NCT03317067|Productive Delirium|productive delirium
976073|NCT03317067|Agitation|agitation
976074|NCT03317067|Intubation|intubation
976075|NCT03317067|Ventilatory free days|ventilatory free days
976076|NCT03317067|Sedation|sedation
976077|NCT03317067|ICU patients|icu patients
976078|NCT03317067|Mechanical Ventilation|mechanical ventilation
976079|NCT03317054|Gambing|gambing
976080|NCT03317054|occupational health services|occupational health services
976081|NCT03317054|psychosocial risks|psychosocial risks
976082|NCT03317041|Capacitive-resistive electric transfer therapy|capacitive-resistive electric transfer therapy
976083|NCT03317041|Radiofrequency therapy|radiofrequency therapy
976084|NCT03317041|Recovery intervention|recovery intervention
976085|NCT03317041|Fatigue|fatigue
976086|NCT03317041|Running|running
976087|NCT03316976|Drug therapy|drug therapy
976088|NCT03316963|Neostigmine|neostigmine
976089|NCT03316963|Nerve stimulant medication|nerve stimulant medication
976090|NCT03316963|Treatments for snoring|treatments for snoring
976091|NCT03316950|postmenopause|postmenopause
976092|NCT03316950|rejuvenation|rejuvenation
976093|NCT03316950|radiofrequency|radiofrequency
976094|NCT03316950|diva|diva
976095|NCT03316859|opioid-induced constipation (OIC)|opioid-induced constipation (oic)
976096|NCT03316846|Chronic Pain|chronic pain
976097|NCT03316846|Depression|depression
976098|NCT03316846|Anxiety|anxiety
976099|NCT03316846|Stress|stress
976100|NCT03316846|iCBT|icbt
976101|NCT03316846|Cognitive behavioral therapy|cognitive behavioral therapy
976102|NCT03316846|Internet delivered|internet delivered
976103|NCT03316846|Tailored treatment|tailored treatment
976104|NCT03316807|Hepatitis B, Vaccine|hepatitis b, vaccine
976105|NCT03316807|Randomized Controlled Trial|randomized controlled trial
976106|NCT03316807|HIV|hiv
976107|NCT03316807|Immunogenicity|immunogenicity
976303|NCT03315728|Diabetes|diabetes
976111|NCT03316794|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
976112|NCT03316794|Pharmacokinetics|pharmacokinetics
976113|NCT03316768|grip|grip
976114|NCT03316768|pinch|pinch
976115|NCT03316768|forces|forces
976116|NCT03316768|pressure|pressure
976117|NCT03316768|Tekscan|tekscan
976118|NCT03316768|sensor|sensor
976119|NCT03316768|ADL|adl
976120|NCT03316768|activities of daily living|activities of daily living
976121|NCT03316768|work requirements|work requirements
976122|NCT03316768|hand biomechanics|hand biomechanics
976123|NCT03316768|forceful precision grip|forceful precision grip
976124|NCT03316768|power grip|power grip
976125|NCT03316768|hominid|hominid
976126|NCT03316768|hominin|hominin
976127|NCT03316768|prehistoric|prehistoric
976128|NCT03316742|Obese|obese
976129|NCT03316742|Overweight|overweight
976130|NCT03316742|Weight loss|weight loss
976131|NCT03316742|West Africa|west africa
976132|NCT03316729|Sub-massive acute pulmonary embolism|sub-massive acute pulmonary embolism
976133|NCT03316716|caesarean section|caesarean section
976134|NCT03316716|neonatal hypothermia|neonatal hypothermia
976135|NCT03316716|maternal hypothermia|maternal hypothermia
976136|NCT03316716|active warming|active warming
976137|NCT03316716|skin-to-skin contact|skin-to-skin contact
976138|NCT03316703|Spine, Spinal injuries, Fractures, Bone|spine, spinal injuries, fractures, bone
976139|NCT03316677|anastomotic leak|anastomotic leak
976140|NCT03316677|colorectal|colorectal
976141|NCT03316677|anastomosis testing|anastomosis testing
976142|NCT03316677|Intraoperative testing|intraoperative testing
976143|NCT03316664|cognitive behavioural therapy|cognitive behavioural therapy
976144|NCT03316664|psychotic disorder|psychotic disorder
976145|NCT03316664|schizophrenia|schizophrenia
976146|NCT03316664|schizoaffective disorder|schizoaffective disorder
976147|NCT03316664|psychological intervention|psychological intervention
976148|NCT03316651|pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
976149|NCT03316651|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
976150|NCT03316651|whole lung lavage|whole lung lavage
976151|NCT03316612|Advanced Glycation End Products, Metabolites, Gut Microbiota|advanced glycation end products, metabolites, gut microbiota
976152|NCT03316599|Pancreatic Cancer|pancreatic cancer
976153|NCT03316586|Breast Cancer|breast cancer
976154|NCT03316573|Lymphoma|lymphoma
976155|NCT03316573|Histiocyte sarcoma|histiocyte sarcoma
976156|NCT03316573|Follicular Dendritic Cell Saroma|follicular dendritic cell saroma
976157|NCT03316573|Interdigitating dendritic cell sarcoma|interdigitating dendritic cell sarcoma
976158|NCT03316560|XLRP|xlrp
976159|NCT03316560|retinal degeneration|retinal degeneration
976160|NCT03316560|RPGR|rpgr
976161|NCT03316560|ORF15|orf15
976162|NCT03316560|adeno-associated virus|adeno-associated virus
976163|NCT03316560|gene therapy|gene therapy
976164|NCT03316560|AAV|aav
976165|NCT03316547|preterm|preterm
976166|NCT03316521|complement inhibition|complement inhibition
976167|NCT03316521|C3 complement inhibitor|c3 complement inhibitor
976168|NCT03316521|AMY-101|amy-101
976169|NCT03316521|Compstatin Cp40|compstatin cp40
976170|NCT03316521|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
976171|NCT03316521|C3 glomerulopathy (C3G)|c3 glomerulopathy (c3g)
976172|NCT03316521|Periodontal disease|periodontal disease
976173|NCT03316521|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
976174|NCT03316521|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
976175|NCT03316508|copeptin|copeptin
976370|NCT03315364|Taxol|taxol
976176|NCT03316508|pediatric cardiac surgery|pediatric cardiac surgery
976177|NCT03316508|heart lung machine|heart lung machine
976178|NCT03316469|Anti-mullerian hormone|anti-mullerian hormone
976179|NCT03316456|AL|al
976180|NCT03316443|Glidescope,Macintosh, Laryngscope, intubation,Hypertension.|glidescope,macintosh, laryngscope, intubation,hypertension.
976181|NCT03316404|Multiple Sclerosis|multiple sclerosis
976182|NCT03316404|MS|ms
976183|NCT03316378|Human|human
976184|NCT03316378|Pain|pain
976185|NCT03316378|Biomechanics|biomechanics
976186|NCT03316378|Anesthetics|anesthetics
976187|NCT03316313|Public Health|public health
976188|NCT03316313|Patient Education as Topic|patient education as topic
976189|NCT03316313|Hepatitis C|hepatitis c
976190|NCT03316300|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
976191|NCT03316300|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
976192|NCT03316261|infants|infants
976193|NCT03316261|type 1 diabetes|type 1 diabetes
976194|NCT03316261|Freder1k|freder1k
976195|NCT03316248|Transtibial amputation|transtibial amputation
976196|NCT03316248|visual feedback|visual feedback
976197|NCT03316248|rehabilitation|rehabilitation
976198|NCT03316196|trauma|trauma
976199|NCT03316196|PTSD|ptsd
976200|NCT03316196|cognition|cognition
976201|NCT03316183|cerebral oximetry|cerebral oximetry
976202|NCT03316183|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
976203|NCT03316183|metabolomic profiling|metabolomic profiling
976204|NCT03316183|neurocognitive outcomes|neurocognitive outcomes
976205|NCT03316183|Cerebral protection|cerebral protection
976206|NCT03316144|immunotherapy|immunotherapy
976207|NCT03316144|check point inhibitor|check point inhibitor
976208|NCT03316144|PD-1 antibody|pd-1 antibody
976209|NCT03316144|phase 1 trial|phase 1 trial
976210|NCT03316144|Malignant Lymphoma|malignant lymphoma
976211|NCT03316131|Gout|gout
976212|NCT03316131|Uric acid|uric acid
976213|NCT03316131|Hyperuricemia|hyperuricemia
976214|NCT03316131|Asymptomatic gout|asymptomatic gout
976215|NCT03316131|Febuxostat|febuxostat
976216|NCT03316131|Dapagliflozin|dapagliflozin
976217|NCT03316131|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
976218|NCT03316131|Xanthine Oxidase Inhibitor|xanthine oxidase inhibitor
976219|NCT03316131|Sodium-glucose cotransporter 2 (SGLT2) Inhibitor|sodium-glucose cotransporter 2 (sglt2) inhibitor
976220|NCT03316118|anesthesiology|anesthesiology
976221|NCT03316118|pain|pain
976222|NCT03316118|arthroplasty|arthroplasty
976223|NCT03316079|intensive care|intensive care
976224|NCT03316079|invasive mechanical ventilation|invasive mechanical ventilation
976225|NCT03316079|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
976226|NCT03316079|airway mucus clearance|airway mucus clearance
976227|NCT03316079|chest physiotherapy|chest physiotherapy
976228|NCT03316079|peak expiratory flow|peak expiratory flow
976229|NCT03316079|pulmonary mechanics|pulmonary mechanics
976230|NCT03316066|Stellate Ganglion|stellate ganglion
976231|NCT03316066|Local Anesthetic|local anesthetic
976232|NCT03316040|HIV/AIDS|hiv/aids
976233|NCT03316040|Join-in-Circuit|join-in-circuit
976234|NCT03316014|Pediatry; Adverse drug reactions; Pharmacovigilance|pediatry; adverse drug reactions; pharmacovigilance
976235|NCT03315988|type 2 diabetes|type 2 diabetes
976236|NCT03315988|vegan diet|vegan diet
976237|NCT03315988|TMAO|tmao
976238|NCT03315988|cardiovascular disease|cardiovascular disease
976239|NCT03315975|Influenza vaccine|influenza vaccine
976240|NCT03315923|Active progressive Multiple Sclerosis|active progressive multiple sclerosis
976241|NCT03315923|Glatiramer acetate|glatiramer acetate
976242|NCT03315923|Rituximab|rituximab
976243|NCT03315923|Comparative study|comparative study
976244|NCT03315923|Annualized relapse rate|annualized relapse rate
976245|NCT03315923|Disability|disability
976246|NCT03315923|Randomized clinical trial|randomized clinical trial
976247|NCT03315910|Tobacco Treatment|tobacco treatment
976248|NCT03315910|Lung CT|lung ct
976249|NCT03315910|Cancer Screening|cancer screening
976250|NCT03315910|17-500|17-500
976251|NCT03315897|bipolar disorder|bipolar disorder
976252|NCT03315897|cognition|cognition
976253|NCT03315897|cognitive dysfunction|cognitive dysfunction
976254|NCT03315897|erythropoietin|erythropoietin
976255|NCT03315897|pro-cognitive efficacy|pro-cognitive efficacy
976256|NCT03315897|prefrontal cortex|prefrontal cortex
976257|NCT03315897|functional magnetic resonance imaging|functional magnetic resonance imaging
976258|NCT03315897|biomarker|biomarker
976259|NCT03315884|TASC C, D|tasc c, d
976260|NCT03315884|CFA|cfa
976261|NCT03315884|Supera|supera
976262|NCT03315884|iliac arteries|iliac arteries
976263|NCT03315884|common femoral artery|common femoral artery
976264|NCT03315884|plasty of the common femoral artery|plasty of the common femoral artery
976265|NCT03315884|stenting Supera|stenting supera
976266|NCT03315871|Vaccine|vaccine
976267|NCT03315871|PSA|psa
976268|NCT03315871|Immunotherapy|immunotherapy
976269|NCT03315871|Immune Response|immune response
976270|NCT03315871|Checkpoint Inhibitor|checkpoint inhibitor
976271|NCT03315858|NFAT|nfat
976272|NCT03315858|gene expression|gene expression
976273|NCT03315858|tacrolimus|tacrolimus
976274|NCT03315845|BMI|bmi
976275|NCT03315845|obstetric anaesthesia|obstetric anaesthesia
976276|NCT03315845|neuraxial anaesthesia|neuraxial anaesthesia
976277|NCT03315845|neuraxial ultrasound|neuraxial ultrasound
976278|NCT03315845|difficult neuraxial anaesthesia|difficult neuraxial anaesthesia
976279|NCT03315832|Aortic Valve Stenosis|aortic valve stenosis
976280|NCT03315832|Valsartan|valsartan
976281|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
976282|NCT03315832|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
976283|NCT03315832|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
976284|NCT03315832|double-blind phase II study|double-blind phase ii study
976285|NCT03315832|left ventricular mass|left ventricular mass
976286|NCT03315819|glenohumeral dislocation|glenohumeral dislocation
976287|NCT03315819|Arthroscopic|arthroscopic
976288|NCT03315819|capsular lesions|capsular lesions
976289|NCT03315806|Dietary nitrate|dietary nitrate
976290|NCT03315806|Nitrate|nitrate
976291|NCT03315806|Flow-mediated dilation|flow-mediated dilation
976292|NCT03315806|Tissue oxygen saturation|tissue oxygen saturation
976293|NCT03315767|HVPG|hvpg
976294|NCT03315767|portal hypertension|portal hypertension
976295|NCT03315767|ARFI|arfi
976296|NCT03315767|portal vein flow|portal vein flow
976297|NCT03315767|advanced liver chronic disease (ACLD)|advanced liver chronic disease (acld)
976298|NCT03315741|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
976299|NCT03315728|Quality improvement|quality improvement
976300|NCT03315728|Indigenous|indigenous
976301|NCT03315728|First Nation|first nation
976302|NCT03315728|Participatory|participatory
976304|NCT03315728|Chronic Disease|chronic disease
976305|NCT03315702|R-spondin proteins, mechanical ventilation, lung injury|r-spondin proteins, mechanical ventilation, lung injury
976306|NCT03315663|Mobile Health|mobile health
976307|NCT03315650|Non-valvular AF|non-valvular af
976309|NCT03315650|PCI|pci
976310|NCT03315650|NOAC|noac
976311|NCT03315650|Rivaroxaban|rivaroxaban
976312|NCT03315624|Hemodialysis|hemodialysis
976313|NCT03315624|Hemodiafiltration|hemodiafiltration
976314|NCT03315624|Renal replacement therapy|renal replacement therapy
976315|NCT03315598|Neuralgia, Acupuncture Treatment|neuralgia, acupuncture treatment
976316|NCT03315585|focal therapy|focal therapy
976317|NCT03315585|IRE|ire
976318|NCT03315585|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
976319|NCT03315585|prostate cancer|prostate cancer
976320|NCT03315572|caregiver|caregiver
976321|NCT03315572|ELLIPTA|ellipta
976322|NCT03315572|Asthma|asthma
976323|NCT03315572|Dry Powder Inhaler|dry powder inhaler
976324|NCT03315572|pediatric|pediatric
976325|NCT03315559|GSK2269557|gsk2269557
976326|NCT03315559|Pharmacokinetics|pharmacokinetics
976327|NCT03315559|Radiolabel|radiolabel
976328|NCT03315559|Healthy|healthy
976329|NCT03315559|Excretion|excretion
976330|NCT03315559|Bioavailability|bioavailability
976331|NCT03315546|deep inspiration breath-hold|deep inspiration breath-hold
976332|NCT03315546|radiotherapy|radiotherapy
976333|NCT03315546|late effects|late effects
976334|NCT03315546|pediatric cancer|pediatric cancer
976335|NCT03315520|Hodgkin Lymphoma|hodgkin lymphoma
976336|NCT03315520|Non-Hodgkin lymphoma|non-hodgkin lymphoma
976337|NCT03315520|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
976338|NCT03315520|conditioning regimen|conditioning regimen
976339|NCT03315494|rheumatoid arthritis|rheumatoid arthritis
976340|NCT03315494|healthy volunteers|healthy volunteers
976341|NCT03315494|moderate to severe|moderate to severe
976342|NCT03315468|melanoma|melanoma
976343|NCT03315468|database|database
976344|NCT03315468|cohort|cohort
976345|NCT03315442|Fluid|fluid
976346|NCT03315442|Balance|balance
976347|NCT03315416|Speech Disorder|speech disorder
976348|NCT03315416|Breast Feeding|breast feeding
976349|NCT03315416|Infant Feeding|infant feeding
976350|NCT03315416|Bottle Feeding|bottle feeding
976351|NCT03315416|Speech Development|speech development
976352|NCT03315416|Speech Sound Development|speech sound development
976353|NCT03315416|Speech Sound Disorder|speech sound disorder
976354|NCT03315416|Non-nutritive Sucking|non-nutritive sucking
976355|NCT03315403|quantitative polymerase chain reaction|quantitative polymerase chain reaction
976356|NCT03315403|qPCR|qpcr
976357|NCT03315403|autolysin|autolysin
976358|NCT03315403|lytA|lyta
976359|NCT03315403|Pneumococcal pneumonia|pneumococcal pneumonia
976360|NCT03315403|Diagnostics|diagnostics
976361|NCT03315403|Community-acquired Pneumonia|community-acquired pneumonia
976362|NCT03315403|Antibiotic resistance|antibiotic resistance
976363|NCT03315390|Narrative Exposure Therapy, ICU Survival, post-traumatic stress disorders, primary health care, randomized controlled trial|narrative exposure therapy, icu survival, post-traumatic stress disorders, primary health care, randomized controlled trial
976364|NCT03315364|Recurrent breast cancer|recurrent breast cancer
976365|NCT03315364|Metastatic breast cancer|metastatic breast cancer
976366|NCT03315364|MBC|mbc
976367|NCT03315364|Firstline chemotherapy|firstline chemotherapy
976368|NCT03315364|Paclitaxel|paclitaxel
976369|NCT03315364|Liporaxel|liporaxel
976371|NCT03315351|PET-scan|pet-scan
976372|NCT03315351|Brachytherapy|brachytherapy
976373|NCT03315351|Cervical Cancer|cervical cancer
976374|NCT03315325|Aging|aging
976375|NCT03315286|ultraviolet light|ultraviolet light
976376|NCT03315286|dosimetry|dosimetry
976377|NCT03315286|actinic keratosis|actinic keratosis
976378|NCT03315286|skin cancer|skin cancer
976379|NCT03315286|sun counseling|sun counseling
976380|NCT03315286|wearable device|wearable device
976381|NCT03315273|Traumatic brain injury, motor imagery ability, validation|traumatic brain injury, motor imagery ability, validation
976382|NCT03315260|Castration resistant prostate cancer|castration resistant prostate cancer
976383|NCT03315260|Patient reported outcome|patient reported outcome
976384|NCT03315247|Obesity|obesity
976385|NCT03315247|Bariatric Surgery|bariatric surgery
976386|NCT03315247|Bariatrics|bariatrics
976387|NCT03315247|Cognitive Therapy|cognitive therapy
976388|NCT03315247|Binge Eating|binge eating
976389|NCT03315234|SYNTAX score|syntax score
976390|NCT03315234|Coronary Atherosclerosis|coronary atherosclerosis
976391|NCT03315234|Coronary Artery Disease|coronary artery disease
976392|NCT03315234|SNPs|snps
976393|NCT03315234|Genetics|genetics
976394|NCT03315234|Genetic Risk Score|genetic risk score
976395|NCT03315234|Personalized Medicine|personalized medicine
976396|NCT03315208|transdiagnostic treatment|transdiagnostic treatment
976397|NCT03315208|cognitive-behavioral therapy|cognitive-behavioral therapy
976398|NCT03315208|Unified Protocol|unified protocol
976399|NCT03315208|young adults|young adults
976400|NCT03315208|substance use disorder|substance use disorder
976401|NCT03315208|emotional disorder|emotional disorder
976402|NCT03315208|depression|depression
976404|NCT03315208|emotion dysregulation|emotion dysregulation
976405|NCT03315208|self-injurious thoughts and behaviors|self-injurious thoughts and behaviors
976406|NCT03315182|MPS IIIB|mps iiib
976407|NCT03315182|Sanfilippo Syndrome B|sanfilippo syndrome b
976408|NCT03315169|Incision and Drainage|incision and drainage
976409|NCT03315169|Packing|packing
976410|NCT03315156|Acute otitis media|acute otitis media
976411|NCT03315156|AOM|aom
976412|NCT03315156|Electrogustometer|electrogustometer
976413|NCT03315156|EGM|egm
976414|NCT03315156|Taste threshold|taste threshold
976415|NCT03315104|influenza A|influenza a
976416|NCT03315104|hospitalized|hospitalized
976417|NCT03315104|H1N1|h1n1
976418|NCT03315104|H3N2|h3n2
976419|NCT03315104|human flu|human flu
976420|NCT03315104|respiratory tract infection|respiratory tract infection
976421|NCT03315104|serious illness|serious illness
976422|NCT03315104|flu|flu
976423|NCT03315091|Pharmacokinetics, WEE1 inhibitor, food effect, safety assessments|pharmacokinetics, wee1 inhibitor, food effect, safety assessments
976424|NCT03315065|thoracic Radiation therapy|thoracic radiation therapy
976425|NCT03315065|Lung Function|lung function
976426|NCT03315052|Graft loss|graft loss
976427|NCT03315052|Renal failure|renal failure
976428|NCT03315052|Infection|infection
976429|NCT03315052|Diabetes|diabetes
976430|NCT03315052|Hypertension|hypertension
976431|NCT03315026|Siltuximab|siltuximab
976432|NCT03315026|Autologous Stem Cell Transplantation (AST)|autologous stem cell transplantation (ast)
976433|NCT03315026|17-365|17-365
976434|NCT03315013|Antiretroviral therapy initiation|antiretroviral therapy initiation
976435|NCT03315013|Sub-Sahara Africa|sub-sahara africa
976436|NCT03315013|ART|art
976437|NCT03315000|methacholine|methacholine
976438|NCT03315000|airway hyperresponsiveness|airway hyperresponsiveness
976439|NCT03314987|air pollution|air pollution
976440|NCT03314987|oxidative stress|oxidative stress
976441|NCT03314987|intervention|intervention
976442|NCT03314974|AML|aml
976443|NCT03314974|ALL|all
976444|NCT03314974|MDS|mds
976445|NCT03314974|NHL|nhl
976446|NCT03314974|CLL|cll
976447|NCT03314974|CML|cml
976448|NCT03314974|SLL|sll
976449|NCT03314961|rectal cancer|rectal cancer
976450|NCT03314935|INCB001158|incb001158
976451|NCT03314935|arginase inhibitor|arginase inhibitor
976452|NCT03314935|oxaliplatin|oxaliplatin
976453|NCT03314935|leucovorin|leucovorin
976454|NCT03314935|5 fluorouracil|5 fluorouracil
976455|NCT03314935|gemcitabine|gemcitabine
976456|NCT03314935|cisplatin|cisplatin
976457|NCT03314935|paclitaxel|paclitaxel
976458|NCT03314935|solid tumors|solid tumors
976459|NCT03314935|colorectal cancer|colorectal cancer
976460|NCT03314935|biliary tract cancer|biliary tract cancer
976461|NCT03314935|gastroesophageal cancer|gastroesophageal cancer
976462|NCT03314935|endometrial cancer|endometrial cancer
976463|NCT03314935|ovarian cancer|ovarian cancer
976464|NCT03314922|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
976465|NCT03314922|follicular lymphoma (FL)|follicular lymphoma (fl)
976466|NCT03314922|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
976467|NCT03314922|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
976468|NCT03314922|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
976469|NCT03314909|Renal Dialysis|renal dialysis
976470|NCT03314909|Hemoperfusion|hemoperfusion
976471|NCT03314909|Paraquat|paraquat
976571|NCT03314376|transplant|transplant
976472|NCT03314896|Colonic Neoplasms|colonic neoplasms
976473|NCT03314896|Laparoscopic Surgery|laparoscopic surgery
976474|NCT03314896|T4|t4
976475|NCT03314883|Ultrasound|ultrasound
976476|NCT03314883|Diaphragm|diaphragm
976477|NCT03314883|Non Invasive Ventilation|non invasive ventilation
976478|NCT03314857|TAVI|tavi
976479|NCT03314857|TAVR|tavr
976480|NCT03314857|CHINA|china
976481|NCT03314857|SAPIEN XT|sapien xt
976482|NCT03314857|High Risk|high risk
976483|NCT03314857|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
976484|NCT03314857|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
976485|NCT03314831|sepsis|sepsis
976486|NCT03314831|septic shock|septic shock
976487|NCT03314831|systemic inflammatory response syndrome|systemic inflammatory response syndrome
976488|NCT03314831|tetradecanoic acid|tetradecanoic acid
976489|NCT03314831|myristic acid|myristic acid
976490|NCT03314818|carotid atherosclerosis|carotid atherosclerosis
976491|NCT03314818|plaque progression|plaque progression
976492|NCT03314818|Framingham Risk Score|framingham risk score
976493|NCT03314805|astragalus polysaccharides|astragalus polysaccharides
976494|NCT03314805|breast cancer|breast cancer
976495|NCT03314805|adjuvant chemotherapy|adjuvant chemotherapy
976496|NCT03314792|pain|pain
976497|NCT03314792|postoperative pain|postoperative pain
976498|NCT03314792|postoperative pain management|postoperative pain management
976499|NCT03314792|opioid|opioid
976500|NCT03314792|analgesia|analgesia
976501|NCT03314792|oxycodone|oxycodone
976502|NCT03314792|tapentadol|tapentadol
976503|NCT03314792|hysterectomy|hysterectomy
976504|NCT03314792|respiratory depression|respiratory depression
1657248|NCT00159484|phase I|phase i
976505|NCT03314727|Osmolar Concentration|osmolar concentration
976506|NCT03314727|Oxidative Stress|oxidative stress
976507|NCT03314727|Salt|salt
976508|NCT03314727|Inflammation|inflammation
976509|NCT03314727|Endothelial Function|endothelial function
976510|NCT03314727|Hypertension|hypertension
976511|NCT03314701|Resting Energy Expenditure|resting energy expenditure
976512|NCT03314701|Multiple Fracture Ribs|multiple fracture ribs
976513|NCT03314701|Ventilation|ventilation
976514|NCT03314675|CRT-D, LV Latency|crt-d, lv latency
976515|NCT03314649|Peritoneal Lavage, Gene Mutation, Peritoneal Metastasis,Gastric Cancer|peritoneal lavage, gene mutation, peritoneal metastasis,gastric cancer
976516|NCT03314584|TBI|tbi
976517|NCT03314584|traumatic brain injury|traumatic brain injury
976518|NCT03314584|transcranial magnetic stimulation|transcranial magnetic stimulation
976519|NCT03314584|headache|headache
976520|NCT03314571|Epidural analgesia|epidural analgesia
976521|NCT03314571|Labor pain|labor pain
976522|NCT03314571|Satisfaction|satisfaction
976523|NCT03314571|Care assessment|care assessment
976524|NCT03314571|Psychometry|psychometry
976525|NCT03314558|COPD|copd
976526|NCT03314558|pulmonary rehabilitation|pulmonary rehabilitation
976527|NCT03314558|insomnia|insomnia
976528|NCT03314558|sleep quality|sleep quality
976529|NCT03314558|physical activity|physical activity
976530|NCT03314545|endocrown|endocrown
976531|NCT03314545|laminate veneer with coronal post|laminate veneer with coronal post
976532|NCT03314545|post and core|post and core
976533|NCT03314545|crown|crown
976534|NCT03314532|Surgical Resection|surgical resection
976535|NCT03314532|TILA-TACE|tila-tace
976536|NCT03314532|Hepatocellular carcinoma|hepatocellular carcinoma
976537|NCT03314519|Lung ultrasonography|lung ultrasonography
976538|NCT03314519|Lung collapse|lung collapse
976539|NCT03314519|fiberoptic bronchoscopy|fiberoptic bronchoscopy
976540|NCT03314519|double lumen tube|double lumen tube
976541|NCT03314506|exercise|exercise
976542|NCT03314493|Vascular calcification|vascular calcification
976543|NCT03314493|Coronary calcification|coronary calcification
976544|NCT03314493|Peritoneal Dialysis|peritoneal dialysis
976545|NCT03314493|Spironolactone|spironolactone
976546|NCT03314480|Multidetector Computed Tomography|multidetector computed tomography
976547|NCT03314480|Cone Beam Computed Tomography|cone beam computed tomography
976548|NCT03314480|Maxillofacial fractures|maxillofacial fractures
976549|NCT03314480|zygomaticomaxillary fractures|zygomaticomaxillary fractures
976550|NCT03314467|diabetic retinopathy|diabetic retinopathy
976551|NCT03314467|diabetes|diabetes
976552|NCT03314467|arterial hypertension|arterial hypertension
976553|NCT03314467|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
976554|NCT03314441|yoga|yoga
976555|NCT03314441|sleep quality|sleep quality
976556|NCT03314441|sleep quantity|sleep quantity
976557|NCT03314441|sleep efficiency|sleep efficiency
976558|NCT03314441|insomnia|insomnia
976559|NCT03314415|overweight|overweight
976560|NCT03314415|obesity|obesity
976561|NCT03314415|weight loss|weight loss
976562|NCT03314415|robot|robot
976563|NCT03314402|JAK2 inhibitor|jak2 inhibitor
976564|NCT03314402|Tolerance|tolerance
976565|NCT03314402|Pharmacokinetics|pharmacokinetics
976566|NCT03314402|Dose-escalated|dose-escalated
976567|NCT03314389|Cochet bonnet esthesiometer|cochet bonnet esthesiometer
976568|NCT03314376|prehabilitation|prehabilitation
976569|NCT03314376|surgery|surgery
976570|NCT03314376|exercise program|exercise program
976572|NCT03314376|postoperative|postoperative
976573|NCT03314363|Calorimetry, Indirect|calorimetry, indirect
976574|NCT03314363|respiratory dialysis|respiratory dialysis
976575|NCT03314350|Geriatrics|geriatrics
976576|NCT03314350|Frailty|frailty
976577|NCT03314337|Distal Pancreatectomy|distal pancreatectomy
976578|NCT03314337|Pancreatic stent|pancreatic stent
976579|NCT03314337|Post-operative pancreatic fistula|post-operative pancreatic fistula
976580|NCT03314311|Rehabilitation|rehabilitation
976581|NCT03314311|Exercise|exercise
976582|NCT03314311|Nutrition Therapy|nutrition therapy
976583|NCT03314311|Patient Education as Topic|patient education as topic
976584|NCT03314285|Cervicalgia|cervicalgia
976585|NCT03314246|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
976586|NCT03314246|Ramadan Fasting|ramadan fasting
976587|NCT03314246|Randomized controlled trial|randomized controlled trial
976588|NCT03314207|XLRP|xlrp
976589|NCT03314207|retinal degeneration|retinal degeneration
976590|NCT03314207|RPGR|rpgr
976591|NCT03314207|ORF15|orf15
976592|NCT03314181|t(11;14) positive relapsed/refractory (R/R) multiple myeloma|t(11;14) positive relapsed/refractory (r/r) multiple myeloma
976593|NCT03314181|Non-refractory Relapsed Multiple Myeloma|non-refractory relapsed multiple myeloma
976594|NCT03314181|Non-refractory Refractory Multiple Myeloma|non-refractory refractory multiple myeloma
976595|NCT03314181|Relapsed Multiple Myeloma|relapsed multiple myeloma
976596|NCT03314181|Refractory Multiple Myeloma|refractory multiple myeloma
976597|NCT03314181|Multiple Myeloma|multiple myeloma
976598|NCT03314181|Cancer|cancer
976599|NCT03314168|Breast Cancer|breast cancer
976600|NCT03314168|Combined training|combined training
976601|NCT03314168|Fatigue|fatigue
976902|NCT03311711|Dementia|dementia
976602|NCT03314155|Depressive disorder|depressive disorder
976603|NCT03314155|Treatment Resistant Depression|treatment resistant depression
976604|NCT03314155|[18 F ] DPA- 714|[18 f ] dpa- 714
976606|NCT03314155|MRI|mri
976607|NCT03314155|Inflammation|inflammation
976608|NCT03314142|blood glucose|blood glucose
976609|NCT03314142|bran particle size|bran particle size
976610|NCT03314142|glucemic index|glucemic index
976611|NCT03314116|hearing loss During basic training, otoacoustic emission|hearing loss during basic training, otoacoustic emission
976612|NCT03314090|Cleft lip|cleft lip
976613|NCT03314090|Scar|scar
976614|NCT03314090|Silicone sheet|silicone sheet
976615|NCT03314090|Silicone gel|silicone gel
976616|NCT03314064|Phase 4|phase 4
976617|NCT03314064|Russian Federation|russian federation
976618|NCT03314064|dolutegravir|dolutegravir
976619|NCT03314064|long-term safety|long-term safety
976620|NCT03314064|Human Immunodeficiency Virus|human immunodeficiency virus
976621|NCT03314051|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
976622|NCT03314051|plasma EBV DNA|plasma ebv dna
976623|NCT03314038|Chronic Atrophic Gastritis|chronic atrophic gastritis
976624|NCT03314038|Malignant Transformation|malignant transformation
976625|NCT03314038|Syndrome|syndrome
976626|NCT03314038|Traditional Chinese Medicine|traditional chinese medicine
976627|NCT03314038|Cross-sectional Study|cross-sectional study
976628|NCT03313999|Lymphedema indentometer|lymphedema indentometer
976629|NCT03313999|Durometer|durometer
976630|NCT03313986|penile curvature|penile curvature
976631|NCT03313986|Peyronie's disease|peyronie's disease
976632|NCT03313986|Nesbit|nesbit
976633|NCT03313960|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
976634|NCT03313960|Afrezza|afrezza
976635|NCT03313934|Hyaluronic Acid Filler|hyaluronic acid filler
976636|NCT03313934|Platelet Rich Fibrin (PRF)|platelet rich fibrin (prf)
976637|NCT03313934|Tear Trough Filler|tear trough filler
976638|NCT03313921|myopia|myopia
976639|NCT03313921|astigmatism|astigmatism
976640|NCT03313921|online assessment|online assessment
976641|NCT03313921|refractive error|refractive error
976642|NCT03313895|cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging|cognitive impairment, alzheimer's disease, exercise, cognitive training, imaging
976643|NCT03313882|RNA Stability|rna stability
976644|NCT03313882|HuR protein|hur protein
976645|NCT03313882|SCN5A|scn5a
976646|NCT03313869|Metabolism|metabolism
976647|NCT03313869|Lipid oxidation|lipid oxidation
976648|NCT03313869|micronutrient cocktail supplementation|micronutrient cocktail supplementation
976649|NCT03313869|physical inactivity|physical inactivity
976650|NCT03313869|glucose intolerance|glucose intolerance
976651|NCT03313869|oxidative stress|oxidative stress
976652|NCT03313843|Optical Coherence Tomography|optical coherence tomography
976653|NCT03313830|Whey|whey
976654|NCT03313830|Muscle Protein Synthesis|muscle protein synthesis
976655|NCT03313778|mRNA-4157|mrna-4157
976656|NCT03313778|Personalized cancer vaccine|personalized cancer vaccine
976657|NCT03313778|PCV|pcv
976658|NCT03313778|pembrolizumab|pembrolizumab
976659|NCT03313752|diabetes, heart, dapagliflozin,|diabetes, heart, dapagliflozin,
976660|NCT03313726|PSMA-PET|psma-pet
976661|NCT03313700|Stomach Neoplasm|stomach neoplasm
976662|NCT03313700|Robotic Surgery|robotic surgery
976663|NCT03313700|Distal Gastrectomy|distal gastrectomy
976664|NCT03313648|Recurrent HCC|recurrent hcc
976665|NCT03313648|Laparoscopic Hepatectomy|laparoscopic hepatectomy
976666|NCT03313648|RFA|rfa
976667|NCT03313648|RCT|rct
976668|NCT03313635|Prealbumin|prealbumin
976669|NCT03313622|OCD|ocd
976670|NCT03313622|Obsessive Compulsive Disorder|obsessive compulsive disorder
976671|NCT03313557|Continued access, safety assessments|continued access, safety assessments
976672|NCT03313531|Thrombin generation|thrombin generation
976673|NCT03313531|variability|variability
976674|NCT03313531|level of agreement|level of agreement
976675|NCT03313531|hemophilia|hemophilia
976676|NCT03313518|tDCS, Alzheimer Disease|tdcs, alzheimer disease
976677|NCT03313479|Nausea, vomiting|nausea, vomiting
976678|NCT03313440|Fibre|fibre
976679|NCT03313440|diet|diet
976680|NCT03313440|fecal bulk|fecal bulk
976681|NCT03313414|HCV|hcv
976682|NCT03313414|Needlestick|needlestick
976683|NCT03313375|hemodynamics|hemodynamics
976684|NCT03313375|exercise|exercise
976685|NCT03313349|ADHD, Behavioral Problems, Children and Adolescents|adhd, behavioral problems, children and adolescents
976686|NCT03313336|Dermal anesthesia.|dermal anesthesia.
976687|NCT03313336|Venipuncture and intravenous cannulation.|venipuncture and intravenous cannulation.
976688|NCT03313336|Skin blanching or erythema.|skin blanching or erythema.
976689|NCT03313336|Phase I.|phase i.
976690|NCT03313336|Therapeutic equivalence.|therapeutic equivalence.
976691|NCT03313336|Eutectic Mixture of Local anaesthetics (EMLA)|eutectic mixture of local anaesthetics (emla)
976692|NCT03313323|Immuno-PET|immuno-pet
976693|NCT03313323|Ipilimumab|ipilimumab
976694|NCT03313323|Immunotherapy|immunotherapy
976695|NCT03313310|Youth Empowerment|youth empowerment
976696|NCT03313310|Employment Intervention|employment intervention
976697|NCT03313310|Young Men Who Have Sex With Men|young men who have sex with men
976698|NCT03313310|Young Transgender Women|young transgender women
976699|NCT03313297|skin|skin
976700|NCT03313297|wound healing|wound healing
976701|NCT03313297|11 beta-hydroxysteroid dehydrogenase type 1|11 beta-hydroxysteroid dehydrogenase type 1
976702|NCT03313271|lymphoma|lymphoma
976703|NCT03313271|CLAP|clap
976704|NCT03313271|China|china
976705|NCT03313271|patient registry|patient registry
976706|NCT03313193|nausea|nausea
976707|NCT03313193|vomiting|vomiting
976708|NCT03313193|pain|pain
976709|NCT03313193|fatigue|fatigue
976710|NCT03313193|depression|depression
976711|NCT03313193|anxiety|anxiety
976712|NCT03313193|PTSD|ptsd
976713|NCT03313154|Quality of Life|quality of life
976714|NCT03313154|Psychiatric comorbidity|psychiatric comorbidity
976715|NCT03313154|Cognitive impairment|cognitive impairment
976716|NCT03313154|Chronic Hepatitis HCV-related|chronic hepatitis hcv-related
976717|NCT03313089|micronutrient powders|micronutrient powders
976718|NCT03313089|spinkles|spinkles
976719|NCT03313089|nutrition|nutrition
976720|NCT03313089|food security program|food security program
976721|NCT03313089|nutritional program|nutritional program
976722|NCT03313089|hemoglobin|hemoglobin
976723|NCT03313089|anemia|anemia
976724|NCT03313076|burn injury|burn injury
976725|NCT03313076|thermal burn injury|thermal burn injury
976726|NCT03313076|omega 3 fatty acids|omega 3 fatty acids
976727|NCT03313076|vitamin D|vitamin d
976728|NCT03313076|fish oil|fish oil
976729|NCT03313076|chronic pain|chronic pain
976730|NCT03313076|chronic pain due to trauma|chronic pain due to trauma
976731|NCT03313063|magnetic resonance imaging|magnetic resonance imaging
976732|NCT03313063|myocard|myocard
976733|NCT03313063|preeclampsia|preeclampsia
976734|NCT03313011|apraxia of speech|apraxia of speech
976735|NCT03312972|Cancer|cancer
976736|NCT03312972|HDR Brachytherapy|hdr brachytherapy
976737|NCT03312972|Prostate Cancer|prostate cancer
976738|NCT03312920|tDCS, accelerated learning, memory|tdcs, accelerated learning, memory
976739|NCT03312907|immunosuppressants|immunosuppressants
976740|NCT03312907|Systemic Lupus Erythematosus Disease Activity Index|systemic lupus erythematosus disease activity index
976741|NCT03312907|Belimumab|belimumab
976742|NCT03312907|Lupus Low Disease Activity State|lupus low disease activity state
976743|NCT03312907|Systemic Lupus Erythematosus|systemic lupus erythematosus
976744|NCT03312894|Drug therapy|drug therapy
976745|NCT03312881|pain|pain
976746|NCT03312881|neuropathic|neuropathic
976747|NCT03312881|children|children
976748|NCT03312881|QST|qst
976749|NCT03312868|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
976750|NCT03312855|coronary artery disease|coronary artery disease
976751|NCT03312855|platelet inhibition|platelet inhibition
976752|NCT03312790|augmented reality|augmented reality
976753|NCT03312790|fatigue|fatigue
976754|NCT03312790|muscle|muscle
976755|NCT03312790|heart rate|heart rate
976756|NCT03312790|mental function|mental function
976757|NCT03312777|analgesia, Cytochrome P450 2D6|analgesia, cytochrome p450 2d6
976758|NCT03312764|Prediabetes|prediabetes
976759|NCT03312764|Obesity|obesity
976760|NCT03312764|Intensive behavioral counseling|intensive behavioral counseling
976761|NCT03312764|Type 2 Diabetes|type 2 diabetes
976762|NCT03312751|Interferon-gamma|interferon-gamma
976763|NCT03312751|NI-0501|ni-0501
976764|NCT03312751|primary HLH|primary hlh
976765|NCT03312738|everolimus|everolimus
976766|NCT03312738|exemestane|exemestane
976767|NCT03312738|advanced Breast Cancer|advanced breast cancer
976866|NCT03312166|recurrence|recurrence
976768|NCT03312738|non-steroidal aromatase inhibitors|non-steroidal aromatase inhibitors
976769|NCT03312738|breast carcinoma|breast carcinoma
976770|NCT03312738|breast cancer|breast cancer
976771|NCT03312738|breast lump|breast lump
976772|NCT03312738|HER2 negative|her2 negative
976773|NCT03312738|breast cancer progression|breast cancer progression
976774|NCT03312712|FDG|fdg
976775|NCT03312712|PET|pet
976776|NCT03312712|CT|ct
976777|NCT03312712|Sarcoidosis|sarcoidosis
976778|NCT03312699|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
976779|NCT03312699|Inactivated Hepatitis A vaccine|inactivated hepatitis a vaccine
976780|NCT03312699|Inactivated, trivalent high-dose influenza vaccine|inactivated, trivalent high-dose influenza vaccine
976781|NCT03312699|Typhoid Vi Polysaccharide Vaccine|typhoid vi polysaccharide vaccine
976782|NCT03312699|Typhoid Vaccine Live Oral Ty21a|typhoid vaccine live oral ty21a
976783|NCT03312699|Influenza Vaccine, Adjuvanted|influenza vaccine, adjuvanted
976784|NCT03312686|endoflip|endoflip
976785|NCT03312660|Prebiotics|prebiotics
976786|NCT03312660|kefir|kefir
976787|NCT03312647|Adverse Drug Reaction|adverse drug reaction
976788|NCT03312647|Latent Tuberculosis Infection|latent tuberculosis infection
976789|NCT03312647|Tuberculosis|tuberculosis
976790|NCT03312634|Interventional study|interventional study
976791|NCT03312634|Clinical trial phase 3|clinical trial phase 3
1657249|NCT00159432|colorectal|colorectal
976792|NCT03312634|Efficacy and safety|efficacy and safety
976793|NCT03312634|Heterotopic ossification|heterotopic ossification
976794|NCT03312634|Flare-up|flare-up
976795|NCT03312634|Palovarotene|palovarotene
976796|NCT03312634|Retinoic acid receptor agonist|retinoic acid receptor agonist
976903|NCT03311711|Aging|aging
976797|NCT03312634|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
976798|NCT03312634|Clementia|clementia
976799|NCT03312634|Myositis Ossificans Progressiva|myositis ossificans progressiva
976800|NCT03312634|Munchmeyer's Disease|munchmeyer's disease
976801|NCT03312634|FOP|fop
976802|NCT03312621|Adolescent Health|adolescent health
976803|NCT03312608|cerebral reorganization, TMS|cerebral reorganization, tms
976804|NCT03312556|hypertension|hypertension
976805|NCT03312556|supine hypertension|supine hypertension
976806|NCT03312556|autonomic failure|autonomic failure
976807|NCT03312556|pure autonomic failure|pure autonomic failure
976808|NCT03312556|multiple system atrophy|multiple system atrophy
976809|NCT03312556|cpap|cpap
976810|NCT03312543|Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy|photoaging of skin, skin wrinkling, solar aging of skin, light therapy
976811|NCT03312517|insomnia|insomnia
976812|NCT03312517|belsomra|belsomra
976813|NCT03312517|suvorexant|suvorexant
976814|NCT03312504|sport injury|sport injury
976815|NCT03312504|injury prevention|injury prevention
976816|NCT03312504|fitness|fitness
976817|NCT03312504|neuromuscular training|neuromuscular training
976818|NCT03312504|implementation|implementation
976950|NCT03311464|Adalimumab|adalimumab
976819|NCT03312465|Total Shoulder Arthroplasty|total shoulder arthroplasty
976820|NCT03312465|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
976821|NCT03312452|Pediatric|pediatric
976822|NCT03312452|Perioperative|perioperative
976823|NCT03312452|Intravenous fluid|intravenous fluid
976824|NCT03312439|Myocardial infarction|myocardial infarction
976825|NCT03312439|Stroke|stroke
976826|NCT03312439|Diabetes|diabetes
976827|NCT03312439|Depression|depression
976828|NCT03312439|Dementia|dementia
976829|NCT03312439|Fractures|fractures
976830|NCT03312426|Cancer|cancer
976831|NCT03312426|Tumor|tumor
976832|NCT03312426|Healthy Participants|healthy participants
976833|NCT03312426|Healthy Subjects|healthy subjects
976834|NCT03312426|Neoplasm|neoplasm
976835|NCT03312413|dexmedetomidine|dexmedetomidine
976836|NCT03312413|coughing during anesthetic emergence|coughing during anesthetic emergence
976837|NCT03312413|thyroid surgery|thyroid surgery
976838|NCT03312400|Telomeres|telomeres
976839|NCT03312400|Aplastic Anemia|aplastic anemia
976840|NCT03312400|Pulmonary Fibrosis|pulmonary fibrosis
976841|NCT03312400|Androgens|androgens
976842|NCT03312400|Hepatic Fibrosis|hepatic fibrosis
976843|NCT03312335|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
976844|NCT03312335|SLE|sle
976845|NCT03312335|Interleukin-2|interleukin-2
976846|NCT03312335|IL-2|il-2
976847|NCT03312335|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
976848|NCT03312335|Treg|treg
976849|NCT03312296|Stent Thrombosis|stent thrombosis
976850|NCT03312270|aphasia|aphasia
976851|NCT03312270|comprehension|comprehension
976852|NCT03312270|text-to-speech|text-to-speech
976853|NCT03312270|social validity|social validity
976854|NCT03312231|A/H7N9|a/h7n9
976855|NCT03312231|Immunogenicity|immunogenicity
976856|NCT03312231|Influenza|influenza
976857|NCT03312231|Safety|safety
976858|NCT03312231|Sanofi Pasteur|sanofi pasteur
976859|NCT03312231|Vaccine|vaccine
976860|NCT03312192|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
976861|NCT03312192|Stand-Alone Cage|stand-alone cage
976862|NCT03312192|Anterior Plating|anterior plating
976863|NCT03312166|ear lobe|ear lobe
976864|NCT03312166|compression|compression
976865|NCT03312166|medical device|medical device
976867|NCT03312101|exercise program|exercise program
976868|NCT03312062|elbow|elbow
976869|NCT03312062|foam rolling|foam rolling
976870|NCT03312062|proprioception|proprioception
976871|NCT03312062|motor performance|motor performance
976872|NCT03312062|strength|strength
976873|NCT03312049|Aflatoxin B1|aflatoxin b1
976874|NCT03312049|Aflatoxin M1|aflatoxin m1
976875|NCT03312049|Aflatoxin|aflatoxin
976876|NCT03312049|Mycotoxin|mycotoxin
976877|NCT03312049|Stunting|stunting
976878|NCT03312049|Linear growth|linear growth
976879|NCT03312049|Pregnancy|pregnancy
976880|NCT03312049|Birth outcomes|birth outcomes
976881|NCT03312049|Nepal|nepal
976882|NCT03312036|CPFA|cpfa
976883|NCT03312036|Liver failure|liver failure
976884|NCT03312036|Resin|resin
976885|NCT03312036|detoxification|detoxification
976886|NCT03312023|Hepatitis B|hepatitis b
976887|NCT03312023|HBsAg|hbsag
976888|NCT03312023|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
976889|NCT03312023|Hepatitis B treatment|hepatitis b treatment
976890|NCT03311997|RCT|rct
976891|NCT03311997|Hamstring|hamstring
976892|NCT03311997|Suture|suture
976893|NCT03311945|Raltegravir|raltegravir
976894|NCT03311945|Lamivudine|lamivudine
976895|NCT03311776|Pancreatic cancer|pancreatic cancer
976896|NCT03311776|Biomarkers|biomarkers
976897|NCT03311776|Biobank|biobank
976898|NCT03311776|Diagnostic biomarkers|diagnostic biomarkers
976899|NCT03311776|Predictive biomarkers|predictive biomarkers
976900|NCT03311776|Prognostic biomarkers|prognostic biomarkers
976901|NCT03311763|implementation|implementation
976904|NCT03311711|Behavioral Research|behavioral research
976905|NCT03311659|Diphtheria|diphtheria
976906|NCT03311659|Pertussis|pertussis
976907|NCT03311659|Tetanus|tetanus
976908|NCT03311659|Immunogenicity|immunogenicity
976909|NCT03311633|Radius Fracture Distal|radius fracture distal
976910|NCT03311633|Radius Fracture Distal Therapy|radius fracture distal therapy
976911|NCT03311633|Fracture fixation|fracture fixation
976912|NCT03311633|Closed Fracture Reduction|closed fracture reduction
976913|NCT03311607|Post-kala-azar Dermal Leishmaniasis|post-kala-azar dermal leishmaniasis
976914|NCT03311607|Visceral Leishmaniasis|visceral leishmaniasis
976915|NCT03311607|AmBisome|ambisome
976916|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b
976917|NCT03311607|Bangladesh|bangladesh
976918|NCT03311607|Kala azar|kala azar
976919|NCT03311594|Alcohol|alcohol
976920|NCT03311594|Pain|pain
976921|NCT03311568|Ultrasonography|ultrasonography
976922|NCT03311568|Microvessels|microvessels
976923|NCT03311568|Physiopathology|physiopathology
976924|NCT03311568|Diagnostic Imaging|diagnostic imaging
976925|NCT03311568|Critical Care|critical care
976926|NCT03311555|Recurrent PSA-only prostate cancer following prostatectomy|recurrent psa-only prostate cancer following prostatectomy
976927|NCT03311542|GBM|gbm
976928|NCT03311542|Glioma|glioma
976929|NCT03311516|insulin therapy|insulin therapy
976930|NCT03311503|lentiviral|lentiviral
976931|NCT03311503|Gene therapy|gene therapy
976932|NCT03311503|busulfan|busulfan
976933|NCT03311490|Ankle Sprain|ankle sprain
976934|NCT03311490|Prophylaxis|prophylaxis
976935|NCT03311490|Indoor Sports|indoor sports
976936|NCT03311490|Ligamentous sprain|ligamentous sprain
976937|NCT03311490|Prevention|prevention
976938|NCT03311477|ABBV-399|abbv-399
976939|NCT03311477|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
976940|NCT03311477|Maximally administered dose (MAD)|maximally administered dose (mad)
976941|NCT03311477|Dose escalation|dose escalation
976942|NCT03311477|Pharmacokinetics|pharmacokinetics
976943|NCT03311477|Advanced solid tumors|advanced solid tumors
976944|NCT03311477|Cancer|cancer
976945|NCT03311477|Solid tumors|solid tumors
976946|NCT03311464|Pyoderma Gangrenosum|pyoderma gangrenosum
976947|NCT03311464|Ulcer|ulcer
976948|NCT03311464|Efficacy|efficacy
976949|NCT03311464|Safety|safety
976951|NCT03311464|Humira®|humira®
976952|NCT03311464|Japan|japan
976953|NCT03311425|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
976954|NCT03311425|prevertebral swelling|prevertebral swelling
976955|NCT03311425|swallowing|swallowing
976956|NCT03311425|methylprednisolone|methylprednisolone
976957|NCT03311425|intraoperative steroid|intraoperative steroid
976958|NCT03311412|Locally advanced/unresectable|locally advanced/unresectable
976959|NCT03311412|Metastatic solid tumor|metastatic solid tumor
976960|NCT03311412|Lymphoma|lymphoma
976961|NCT03311412|Anti-PD-1|anti-pd-1
976962|NCT03311412|PD-1|pd-1
976964|NCT03311399|Surgical Site Infection|surgical site infection
976965|NCT03311399|mHealth|mhealth
976966|NCT03311399|Cesarean Section|cesarean section
976967|NCT03311373|COPD|copd
976968|NCT03311360|vertebral artery origin stenosis|vertebral artery origin stenosis
976969|NCT03311360|drug-coated balloon|drug-coated balloon
976970|NCT03311360|stenting|stenting
976971|NCT03311360|medical treatment|medical treatment
976972|NCT03311347|pulmonary ultrasound|pulmonary ultrasound
976973|NCT03311347|hypergravity|hypergravity
976974|NCT03311347|human physiology|human physiology
976975|NCT03311347|oxygen|oxygen
976976|NCT03311347|lung ventilation|lung ventilation
976977|NCT03311347|lung perfusion|lung perfusion
976978|NCT03311347|computed tomography|computed tomography
976979|NCT03311347|electrical impedance tomography|electrical impedance tomography
976980|NCT03311347|altitude chamber|altitude chamber
976981|NCT03311334|DSP-7888|dsp-7888
976982|NCT03311334|nivolumab|nivolumab
976983|NCT03311334|atezolizumab|atezolizumab
976984|NCT03311334|immune checkpoint inhibitor|immune checkpoint inhibitor
976985|NCT03311334|cancer vaccine|cancer vaccine
976986|NCT03311334|Wilms Tumor 1|wilms tumor 1
976987|NCT03311334|ICI|ici
976988|NCT03311321|Arterial Stiffness|arterial stiffness
976989|NCT03311321|Endothelial Function|endothelial function
976990|NCT03311321|Vitamin K|vitamin k
976991|NCT03311308|Melanoma|melanoma
976992|NCT03311308|Unresectable|unresectable
976993|NCT03311308|Stage III|stage iii
976994|NCT03311308|Stage IV|stage iv
976995|NCT03311282|breastfeeding|breastfeeding
976996|NCT03311282|infants|infants
976997|NCT03311282|squeezing|squeezing
976998|NCT03311282|breathing|breathing
976999|NCT03311256|Tissue Transit Time|tissue transit time
977000|NCT03311243|cytokines|cytokines
977001|NCT03311243|scaling root planing|scaling root planing
977002|NCT03311243|oral hygiene|oral hygiene
977003|NCT03311243|systemic inflammation|systemic inflammation
977004|NCT03311204|Eyelid margin|eyelid margin
977005|NCT03311204|tear film|tear film
977006|NCT03311204|debridement|debridement
977007|NCT03311204|contact lens and ocular discomfort|contact lens and ocular discomfort
977008|NCT03311178|Shock|shock
977009|NCT03311178|Preterm infant|preterm infant
977010|NCT03311178|Dobutamine|dobutamine
977011|NCT03311165|neonate|neonate
977012|NCT03311165|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
977013|NCT03311165|prognosis|prognosis
977014|NCT03311165|risk factor|risk factor
977015|NCT03311165|clinical course|clinical course
977016|NCT03311152|Hepatocellular carcinoma|hepatocellular carcinoma
977017|NCT03311152|Cirrhosis|cirrhosis
977018|NCT03311152|Circulating epigenetic biomarker|circulating epigenetic biomarker
977019|NCT03311152|Plasma biomarker|plasma biomarker
977020|NCT03311152|SEPT9|sept9
977021|NCT03311152|Septin9|septin9
977022|NCT03311152|DNA methylation biomarker|dna methylation biomarker
977023|NCT03311152|Circulating DNA methylation biomarker|circulating dna methylation biomarker
977024|NCT03311152|Alpha-fetoprotein|alpha-fetoprotein
977025|NCT03311139|Atrial Fibrillation|atrial fibrillation
977026|NCT03311139|Acute Coronary Syndrome|acute coronary syndrome
977027|NCT03311139|Anticoagulation|anticoagulation
977028|NCT03311087|high flow nasal oxygen|high flow nasal oxygen
977029|NCT03311087|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
977030|NCT03311087|adults|adults
977031|NCT03311087|intensive care unit|intensive care unit
977032|NCT03311074|Sonication Linker Medicated Polymerase Chain Reaction|sonication linker medicated polymerase chain reaction
977033|NCT03311074|GSK2696273|gsk2696273
977034|NCT03311074|Gene therapy|gene therapy
977035|NCT03311074|Adenosine deaminase deficiency|adenosine deaminase deficiency
977036|NCT03311074|Retroviral insertion site|retroviral insertion site
977037|NCT03311074|Severe combined immunodeficiency|severe combined immunodeficiency
977038|NCT03311061|Teen Pregnancy|teen pregnancy
977039|NCT03311061|Prevention|prevention
977040|NCT03311061|Positive Youth Development|positive youth development
977041|NCT03311061|Financial Literacy|financial literacy
977042|NCT03311061|College and Career Readiness|college and career readiness
977043|NCT03311061|School Based Intervention|school based intervention
977044|NCT03311061|Age 13-19|age 13-19
977045|NCT03311061|Behavior Modification|behavior modification
977046|NCT03311048|Cleaning workers|cleaning workers
977047|NCT03311048|Work-related asthma|work-related asthma
977048|NCT03311048|Work-related rhinitis|work-related rhinitis
977049|NCT03311048|Respiratory symptoms|respiratory symptoms
977050|NCT03311048|Nasal swab|nasal swab
977051|NCT03310996|working memory|working memory
977052|NCT03310983|Fat mass|fat mass
977053|NCT03310983|Gestational weight gain|gestational weight gain
977054|NCT03310983|Fetal adipose tissue|fetal adipose tissue
977055|NCT03310970|Peer Reviewed Research|peer reviewed research
977056|NCT03310957|Breast cancer|breast cancer
977057|NCT03310957|Breast carcinoma|breast carcinoma
977058|NCT03310957|Triple negative breast cancer|triple negative breast cancer
977059|NCT03310957|Locally-advanced breast cancer|locally-advanced breast cancer
977060|NCT03310957|Metastatic breast cancer|metastatic breast cancer
977061|NCT03310957|Tumors, breast|tumors, breast
977062|NCT03310957|Breast tumors|breast tumors
977063|NCT03310957|pembrolizumab|pembrolizumab
977064|NCT03310957|LIV-1 protein, human|liv-1 protein, human
977065|NCT03310918|AML|aml
977066|NCT03310905|Research|research
977067|NCT03310905|Transplant|transplant
977068|NCT03310905|Abdominal Wall|abdominal wall
977069|NCT03310905|Hernia|hernia
977070|NCT03310892|Colorectal cancer screening|colorectal cancer screening
977071|NCT03310879|Cancer|cancer
977072|NCT03310853|probiotics|probiotics
977073|NCT03310853|infections|infections
977074|NCT03310853|bacterial vaginosis|bacterial vaginosis
977075|NCT03310827|Nutrition|nutrition
977076|NCT03310827|Nutrigenomics|nutrigenomics
977077|NCT03310801|left atrial appendage occlusion|left atrial appendage occlusion
977078|NCT03310801|antithrombotic therapy|antithrombotic therapy
977079|NCT03310801|atrial fibrillation|atrial fibrillation
977080|NCT03310801|percutaneous coronary intervention|percutaneous coronary intervention
977081|NCT03310801|drug eluting stent|drug eluting stent
977082|NCT03310788|IOP fluctuations|iop fluctuations
977083|NCT03310788|iCare Home|icare home
977084|NCT03310788|SLT|slt
977085|NCT03310788|self-tonometry|self-tonometry
977086|NCT03310775|Social skill training|social skill training
977087|NCT03310775|PEERS|peers
977088|NCT03310762|immunization coverage|immunization coverage
977089|NCT03310762|silicon bracelet|silicon bracelet
977090|NCT03310762|immunization reminders|immunization reminders
977091|NCT03310749|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
977092|NCT03310749|DPP-IV inhibitor|dpp-iv inhibitor
977093|NCT03310749|Drug-Drug Interactions|drug-drug interactions
977094|NCT03310749|Ethnicity|ethnicity
1657250|NCT00159432|cancer|cancer
977095|NCT03310736|iron deficiency|iron deficiency
977096|NCT03310736|anemia|anemia
977097|NCT03310736|hepcidin|hepcidin
977098|NCT03310697|Afebrile seizure|afebrile seizure
977099|NCT03310697|Toxicological screening|toxicological screening
977100|NCT03310697|Chromatography|chromatography
977101|NCT03310697|Mass spectrometry|mass spectrometry
977102|NCT03310697|Children|children
977103|NCT03310684|Renin-Angiotensin system|renin-angiotensin system
977104|NCT03310684|Hypertension|hypertension
977105|NCT03310684|Obesity|obesity
977106|NCT03310684|Angiotensin-(1-7)|angiotensin-(1-7)
977107|NCT03310684|Angiotensin II|angiotensin ii
977108|NCT03310684|FGF23|fgf23
977109|NCT03310684|Klotho|klotho
977110|NCT03310684|Uric acid|uric acid
977111|NCT03310684|Left ventricular hypertrophy|left ventricular hypertrophy
977112|NCT03310645|Refractory chronic cough|refractory chronic cough
977113|NCT03310645|healthy volunteers|healthy volunteers
977114|NCT03310632|Antroquinonol|antroquinonol
977115|NCT03310632|Hocena|hocena
977116|NCT03310632|metastatic pancreatic cancer|metastatic pancreatic cancer
977117|NCT03310619|JCAR017|jcar017
977118|NCT03310619|B-Cell Malignancies|b-cell malignancies
977119|NCT03310619|NHL|nhl
977120|NCT03310619|non-Hodgkin lymphoma|non-hodgkin lymphoma
977121|NCT03310619|CAR T cells|car t cells
977122|NCT03310619|chimeric antigen receptor|chimeric antigen receptor
977123|NCT03310606|Therapeutic drug monitoring|therapeutic drug monitoring
977124|NCT03310593|bipolar disorder|bipolar disorder
977125|NCT03310593|bipolar depression|bipolar depression
977126|NCT03310593|cannabidiol|cannabidiol
977127|NCT03310593|endocannabinoids|endocannabinoids
977128|NCT03310541|AZD5363|azd5363
977129|NCT03310541|AKT Mutations|akt mutations
977130|NCT03310541|17-322|17-322
977131|NCT03310528|Aspiration risk|aspiration risk
977132|NCT03310528|GI Endoscopy|gi endoscopy
977133|NCT03310528|Fasting guidelines|fasting guidelines
977134|NCT03310528|Delayed gastric emptying|delayed gastric emptying
977135|NCT03310515|PrEP|prep
977136|NCT03310515|MSM|msm
977137|NCT03310515|seroincidence|seroincidence
977138|NCT03310515|HIV-1|hiv-1
977139|NCT03310515|TGW|tgw
977140|NCT03310515|STIs|stis
977141|NCT03310502|positron emission tomography|positron emission tomography
977142|NCT03310502|skeletal muscle|skeletal muscle
977143|NCT03310502|liver|liver
977144|NCT03310502|adipose tissue|adipose tissue
977145|NCT03310502|brain|brain
977146|NCT03310502|genetics|genetics
977147|NCT03310463|infection|infection
977148|NCT03310463|gram-negative bacterium|gram-negative bacterium
977149|NCT03310463|renal impairment|renal impairment
977150|NCT03310450|troponin-I|troponin-i
977151|NCT03310450|hs-CRP|hs-crp
977152|NCT03310450|Malondialdehyde|malondialdehyde
977153|NCT03310450|predictors|predictors
977154|NCT03310385|Acute Bronchitis, Herbal Medicine|acute bronchitis, herbal medicine
977155|NCT03310333|PROM|prom
977156|NCT03310333|Dinoprostone|dinoprostone
977157|NCT03310333|cervical ripening device|cervical ripening device
977158|NCT03310333|oxytocin|oxytocin
977159|NCT03310320|Plaque psoriasis|plaque psoriasis
977160|NCT03310320|PASI|pasi
977161|NCT03310320|BSA|bsa
977162|NCT03310320|sPGA|spga
977163|NCT03310320|P-VAS|p-vas
977164|NCT03310320|IL17A-|il17a-
977165|NCT03310320|CCL20|ccl20
977166|NCT03310320|PK|pk
977167|NCT03310307|Homocysteine|homocysteine
977168|NCT03310307|Overweight|overweight
977169|NCT03310307|vitamin D3|vitamin d3
977170|NCT03310307|Reproductive women|reproductive women
977171|NCT03310307|RCT|rct
977172|NCT03310294|Lactobacillus|lactobacillus
977173|NCT03310294|Herpes Labial|herpes labial
977174|NCT03310294|Immune repsonse|immune repsonse
977175|NCT03310281|Depression|depression
977176|NCT03310229|cardiovascular complications|cardiovascular complications
977177|NCT03310216|artificial intelligent|artificial intelligent
977178|NCT03310216|visual inspection|visual inspection
977179|NCT03310190|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
977180|NCT03310190|Deletion of the short arm of chromosome 17 (Del[17p])|deletion of the short arm of chromosome 17 (del[17p])
977181|NCT03310190|Relapse Chronic Lymphocytic Leukemia|relapse chronic lymphocytic leukemia
977182|NCT03310190|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
977183|NCT03310190|Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17|chronic lymphocytic leukemia with deletion of the short arm of chromosome 17
977184|NCT03310190|Cancer|cancer
977185|NCT03310177|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
977186|NCT03310177|Metabolomics|metabolomics
977187|NCT03310138|treatment|treatment
977188|NCT03310138|brain stimulation|brain stimulation
977189|NCT03310125|Atrial Fibrillation|atrial fibrillation
977190|NCT03310125|Inflammation|inflammation
977191|NCT03310125|Thoracic Surgery|thoracic surgery
977192|NCT03310125|Randomized|randomized
977193|NCT03310125|Colchicine|colchicine
977194|NCT03310099|Obesity|obesity
977195|NCT03310099|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
977196|NCT03310099|HFpEF|hfpef
977197|NCT03310099|unsaturated fatty acids|unsaturated fatty acids
977198|NCT03310099|cardiorespiratory fitness|cardiorespiratory fitness
977199|NCT03310099|dietary intervention|dietary intervention
977200|NCT03310086|corticision|corticision
977201|NCT03310086|CBCT|cbct
977202|NCT03310086|Crowding|crowding
977203|NCT03309995|Cough|cough
977204|NCT03309995|Laryngitis|laryngitis
977205|NCT03309995|Pharyngitis|pharyngitis
977206|NCT03309995|Rhinitis|rhinitis
977207|NCT03309995|Zinc Acetate|zinc acetate
977208|NCT03309995|Zinc Lozenge|zinc lozenge
977209|NCT03309956|Ambulatory Electrocardiography|ambulatory electrocardiography
977210|NCT03309956|Holter Monitor|holter monitor
977211|NCT03309956|Zio Patch Monitor|zio patch monitor
977212|NCT03309956|Pediatrics|pediatrics
977213|NCT03309930|comprehension|comprehension
977214|NCT03309930|Strategies|strategies
977215|NCT03309930|repeated exposure|repeated exposure
977216|NCT03309865|semi-vegetarian diet|semi-vegetarian diet
977217|NCT03309865|vedolizumab|vedolizumab
977218|NCT03309865|ulcerative colitis|ulcerative colitis
977219|NCT03309839|HLA-DR expression|hla-dr expression
977220|NCT03309839|cardiopulmonary bypass|cardiopulmonary bypass
977221|NCT03309839|neonate|neonate
977222|NCT03309826|gestational hypertension|gestational hypertension
977223|NCT03309826|pre-eclampsia|pre-eclampsia
977224|NCT03309826|eclampsia|eclampsia
977225|NCT03309826|obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
977226|NCT03309826|positive airway pressure|positive airway pressure
977227|NCT03309826|polysomnography|polysomnography
977228|NCT03309826|blood pressure|blood pressure
977229|NCT03309826|arterial stiffness|arterial stiffness
977230|NCT03309813|ExAblate|exablate
977231|NCT03309813|TcMRgFUS|tcmrgfus
977232|NCT03309813|Thalamotomy|thalamotomy
977233|NCT03309800|Acute Bronchitis|acute bronchitis
977234|NCT03309774|Children|children
977235|NCT03309774|Complex Regional Pain Syndrome|complex regional pain syndrome
977236|NCT03309774|Relaxation|relaxation
977237|NCT03309774|Bergès relaxation|bergès relaxation
977238|NCT03309774|Pain|pain
977239|NCT03309748|photodynamic therapy|photodynamic therapy
977240|NCT03309748|black-stain|black-stain
977241|NCT03309748|Pigmented bacteria|pigmented bacteria
977242|NCT03309748|Tannerella forsythia|tannerella forsythia
977243|NCT03309735|threatened miscarriage|threatened miscarriage
977244|NCT03309735|miscarriage|miscarriage
977245|NCT03309735|micronized progesterone|micronized progesterone
977246|NCT03309735|dydrogesterone|dydrogesterone
977247|NCT03309670|psychiatric outcome|psychiatric outcome
977248|NCT03309670|psychosocial outcome|psychosocial outcome
977249|NCT03309670|young|young
977250|NCT03309644|Unplanned admissions|unplanned admissions
977251|NCT03309644|Visits to the ED|visits to the ed
977252|NCT03309644|Readmissions|readmissions
977253|NCT03309644|Death|death
977254|NCT03309631|Gene classifier|gene classifier
977255|NCT03309618|myocardial infarction|myocardial infarction
977256|NCT03309618|arterial stiffness|arterial stiffness
977257|NCT03309618|pulse wave velocity|pulse wave velocity
977258|NCT03309618|flow mediated dilatation|flow mediated dilatation
977259|NCT03309618|fluvastatin|fluvastatin
977260|NCT03309618|valsartan|valsartan
977261|NCT03309605|Translational read through|translational read through
977262|NCT03309579|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
977263|NCT03309579|Red Blood Cell Transfusion (RBC)|red blood cell transfusion (rbc)
977264|NCT03309579|Vasospasm|vasospasm
977265|NCT03309579|Intracranial Hemorrhages|intracranial hemorrhages
977266|NCT03309579|Cardiovascular Diseases|cardiovascular diseases
977267|NCT03309540|Low back/lumbar spine|low back/lumbar spine
977268|NCT03309540|Multimodal Physical therapy|multimodal physical therapy
977269|NCT03309540|Quality of life|quality of life
977270|NCT03309540|Range of Motion|range of motion
977271|NCT03309540|Pain|pain
977272|NCT03309527|insomia|insomia
977273|NCT03309527|Depression|depression
977274|NCT03309527|Self Harm|self harm
977275|NCT03309527|Suicide|suicide
977281|NCT03309501|Knee osteoarthritis|knee osteoarthritis
977282|NCT03309501|Randomised Double-blind Controlled trial|randomised double-blind controlled trial
977283|NCT03309501|Tong-Luo-Qu-Tong Plaster|tong-luo-qu-tong plaster
977284|NCT03309488|Food allergy|food allergy
977285|NCT03309488|Milk allergy|milk allergy
977287|NCT03309488|Nut allergy|nut allergy
977288|NCT03309488|Basophil activation test|basophil activation test
977289|NCT03309488|Diagnosis|diagnosis
977290|NCT03309488|Specific IgE|specific ige
977291|NCT03309488|Skin prick test|skin prick test
977292|NCT03309475|first episode psychosis|first episode psychosis
977293|NCT03309475|early psychosis|early psychosis
977294|NCT03309475|schizophrenia|schizophrenia
977295|NCT03309475|mindfulness|mindfulness
977296|NCT03309475|social cognition|social cognition
977297|NCT03309475|social functioning|social functioning
977298|NCT03309475|AGES-Mind|ages-mind
977299|NCT03309475|SocialMind|socialmind
977300|NCT03309462|Next generation sequencing|next generation sequencing
977301|NCT03309462|Re-biopsy|re-biopsy
977302|NCT03309462|Acquired resistance|acquired resistance
977303|NCT03309462|Tissue sample|tissue sample
977304|NCT03309462|Peripheral blood|peripheral blood
977305|NCT03309423|Blood gas analysis|blood gas analysis
977306|NCT03309423|Critical care|critical care
977307|NCT03309423|venus to arterial conversion|venus to arterial conversion
977308|NCT03309410|Blood Gas Analysis|blood gas analysis
977309|NCT03309410|Emergency Service, Hospital|emergency service, hospital
977310|NCT03309410|Venous to arterial conversion|venous to arterial conversion
977311|NCT03309410|Matched-Pair Analysis|matched-pair analysis
977312|NCT03309397|adolescent sports|adolescent sports
977313|NCT03309358|Cystic Fibrosis|cystic fibrosis
977314|NCT03309358|Pulmonary exacerbation|pulmonary exacerbation
977315|NCT03309358|Pulmonary inflammation|pulmonary inflammation
977316|NCT03309358|Respiratory tract disease|respiratory tract disease
977317|NCT03309358|Pulmonary disease|pulmonary disease
977318|NCT03309358|Biofilms|biofilms
977319|NCT03309267|pain, thoracotomy|pain, thoracotomy
977320|NCT03309228|elderly people|elderly people
977321|NCT03309228|polymedication,|polymedication,
977322|NCT03309228|ethics|ethics
977323|NCT03309228|qualitative research|qualitative research
977324|NCT03309150|Ataxia telangiectasia mutated and Rad3-related protein inhibitor (ATRi)|ataxia telangiectasia mutated and rad3-related protein inhibitor (atri)
977325|NCT03309150|M6620|m6620
977326|NCT03309150|Solid tumors|solid tumors
977327|NCT03309137|Blood stream infections|blood stream infections
977328|NCT03309137|Prospective|prospective
977329|NCT03309137|Preventative|preventative
977330|NCT03309137|Randomized|randomized
977331|NCT03309124|White potatoes|white potatoes
977332|NCT03309124|Older adults|older adults
977333|NCT03309124|Satiety|satiety
977334|NCT03309124|Glycaemia|glycaemia
977335|NCT03309072|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
977336|NCT03309072|accelerated learning|accelerated learning
977337|NCT03309072|memory|memory
977338|NCT03309059|Nursing care|nursing care
977339|NCT03309059|diaper rash|diaper rash
977340|NCT03309059|fecal incontinence|fecal incontinence
977341|NCT03309059|urinary incontinence|urinary incontinence
977342|NCT03309046|Parents|parents
977343|NCT03309046|Caregivers|caregivers
977344|NCT03309046|Veterans|veterans
977351|NCT03309007|Autophagy|autophagy
977352|NCT03308994|Multiple sclerosis|multiple sclerosis
977353|NCT03308994|Epidemiology|epidemiology
977354|NCT03308994|Oral disease modifying treatments|oral disease modifying treatments
977355|NCT03308994|Therapeutical delays|therapeutical delays
977356|NCT03308994|Socio-Economical Status|socio-economical status
977357|NCT03308981|therapeutic online game|therapeutic online game
977358|NCT03308981|resilience|resilience
977359|NCT03308981|prevention|prevention
977360|NCT03308981|emotional disorders|emotional disorders
977361|NCT03308981|child|child
977362|NCT03308981|adolescent|adolescent
977363|NCT03308942|Niraparib|niraparib
977364|NCT03308942|Zejula|zejula
977365|NCT03308942|PARP Inhibitor|parp inhibitor
977366|NCT03308942|PD-1 Inhibitor|pd-1 inhibitor
977367|NCT03308916|elastography|elastography
977368|NCT03308916|screening|screening
977369|NCT03308916|non-invasive markers|non-invasive markers
977370|NCT03308916|microbiome|microbiome
977371|NCT03308916|gut-liver-axis|gut-liver-axis
977372|NCT03308916|cost-benefit|cost-benefit
977373|NCT03308916|fibroscan|fibroscan
977374|NCT03308916|aixplorer|aixplorer
977375|NCT03308916|ultrasound elastography|ultrasound elastography
977376|NCT03308916|liver fibrosis|liver fibrosis
977377|NCT03308916|alcoholic liver disease|alcoholic liver disease
977378|NCT03308916|advanced fibrosis|advanced fibrosis
977379|NCT03308916|enhanced liver fibrosis test|enhanced liver fibrosis test
977380|NCT03308916|direct liver fibrosis markers|direct liver fibrosis markers
977381|NCT03308916|ELF|elf
977382|NCT03308916|cytokeratin-18|cytokeratin-18
977383|NCT03308916|neoepitopes|neoepitopes
977384|NCT03308916|collagen|collagen
977385|NCT03308916|NAFLD|nafld
977386|NCT03308916|ALD|ald
977387|NCT03308916|metabolomics|metabolomics
977388|NCT03308916|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
977389|NCT03308825|Influenza|influenza
977390|NCT03308825|Flu|flu
977391|NCT03308812|Cardiovascular health|cardiovascular health
977392|NCT03308812|Health coach|health coach
977393|NCT03308812|Cardiovascular risk factors|cardiovascular risk factors
977394|NCT03308812|Ethnic disparities|ethnic disparities
977395|NCT03308812|Behavioral intervention|behavioral intervention
977396|NCT03308812|E-health lifestyle intervention|e-health lifestyle intervention
977397|NCT03308812|Health360x|health360x
977398|NCT03308812|eHealthyStrides|ehealthystrides
977399|NCT03308773|Prediabetes|prediabetes
977400|NCT03308773|insulin resistance|insulin resistance
977401|NCT03308773|T2DM|t2dm
977402|NCT03308773|Carotid IMT/Plaque|carotid imt/plaque
977403|NCT03308747|Low-grade systemic inflammation|low-grade systemic inflammation
977404|NCT03308747|Muscle protein synthesis|muscle protein synthesis
977405|NCT03308747|Proteasome activation|proteasome activation
1657342|NCT00158990|sertraline|sertraline
977406|NCT03308747|Anabolic signaling|anabolic signaling
977407|NCT03308747|Aging|aging
977408|NCT03308747|Sarcopenia|sarcopenia
977409|NCT03308734|High-intensity interval training|high-intensity interval training
977410|NCT03308734|REHIT|rehit
977411|NCT03308734|Prostate cancer|prostate cancer
977412|NCT03308734|cardiorespiratory fitness|cardiorespiratory fitness
977413|NCT03308656|uterocervical angle, labor induction|uterocervical angle, labor induction
977414|NCT03308643|myomectomy|myomectomy
977415|NCT03308643|oxytocin|oxytocin
977416|NCT03308643|blood loss|blood loss
977417|NCT03308617|sonication|sonication
977418|NCT03308578|Obsructive sleep apnea|obsructive sleep apnea
977419|NCT03308578|Adipose tissue|adipose tissue
977420|NCT03308565|AIS grade A or B|ais grade a or b
977421|NCT03308513|Prolonged acute mechanical ventilation|prolonged acute mechanical ventilation
977422|NCT03308500|HIIT|hiit
977423|NCT03308500|Children|children
977424|NCT03308500|Cardiorespiratory fitness|cardiorespiratory fitness
977425|NCT03308500|Body composition|body composition
977426|NCT03308487|Vitamin D|vitamin d
977427|NCT03308487|pregnancy|pregnancy
977428|NCT03308461|difficult defecation|difficult defecation
977429|NCT03308461|fecal microbiota transplantation|fecal microbiota transplantation
977430|NCT03308461|stool pattern|stool pattern
977431|NCT03308448|Traumatic optic neuropathy|traumatic optic neuropathy
977432|NCT03308448|Erythropoietin|erythropoietin
977433|NCT03308448|EPO|epo
977434|NCT03308448|Eprex|eprex
977435|NCT03308422|screens|screens
977436|NCT03308422|preschool children|preschool children
977437|NCT03308422|parenting education|parenting education
977438|NCT03308422|social perceptions|social perceptions
977439|NCT03308396|Durvalumab|durvalumab
977440|NCT03308396|Guadecitabine|guadecitabine
977441|NCT03308357|drug monitoring|drug monitoring
977442|NCT03308331|HIV|hiv
977443|NCT03308331|nicotine|nicotine
977444|NCT03308331|brain|brain
977445|NCT03308331|smoking|smoking
977446|NCT03308318|Deep temporal fascia|deep temporal fascia
977447|NCT03308318|Deep layer of the deep temporal fascia|deep layer of the deep temporal fascia
977448|NCT03308318|Superficial layer of the deep temporal fascia|superficial layer of the deep temporal fascia
977449|NCT03308318|Temporal fascial layers|temporal fascial layers
977450|NCT03308318|Temporal anatomy|temporal anatomy
977451|NCT03308279|dry needling|dry needling
977452|NCT03308279|median nerve|median nerve
977453|NCT03308279|Pronator Teres|pronator teres
977454|NCT03308253|Vascular Surgery|vascular surgery
977455|NCT03308253|Surgical Site Infection|surgical site infection
977583|NCT03307434|Injury|injury
977456|NCT03308253|Prophylactic Antibiotics|prophylactic antibiotics
977457|NCT03308253|Implantable Beads|implantable beads
977458|NCT03308240|Magic|magic
977459|NCT03308240|Anxiety|anxiety
977460|NCT03308240|Pediatric|pediatric
977461|NCT03308227|Linezolid; PK/PD; Septic shock|linezolid; pk/pd; septic shock
977462|NCT03308214|septic shock; imipenem; VD ;pharmacokinetics|septic shock; imipenem; vd ;pharmacokinetics
977463|NCT03308188|Opioid therapy|opioid therapy
977464|NCT03308188|web-based intervention|web-based intervention
977465|NCT03308188|self-management|self-management
977466|NCT03308162|Integrated Behavioral Health Care|integrated behavioral health care
977467|NCT03308136|epidural steroid injection|epidural steroid injection
977468|NCT03308136|procedural pain|procedural pain
977469|NCT03308136|local Anesthetic Injection|local anesthetic injection
977470|NCT03308097|PrEP|prep
977471|NCT03308097|Uptake|uptake
977472|NCT03308097|MSM|msm
977473|NCT03308097|Black|black
977474|NCT03308084|transforaminal lumbar interbody fusion, methylprednisolone|transforaminal lumbar interbody fusion, methylprednisolone
977475|NCT03308071|Hypnosis|hypnosis
977476|NCT03308071|Hypnotherapy|hypnotherapy
977477|NCT03308071|Perioperative Pain Management|perioperative pain management
977478|NCT03308071|Narcotic reduction|narcotic reduction
977479|NCT03308071|Perioperative Outcomes|perioperative outcomes
977480|NCT03308071|Total knee replacement|total knee replacement
977481|NCT03308071|Total knee arthroplasty|total knee arthroplasty
977482|NCT03308058|Breastfeeding Rural Hispanic Pregnant|breastfeeding rural hispanic pregnant
977483|NCT03308045|plasmid|plasmid
977484|NCT03308045|electrotransfer|electrotransfer
977485|NCT03308045|ciliary muscle|ciliary muscle
977486|NCT03308045|uveitis|uveitis
977487|NCT03307993|Lu AE58054|lu ae58054
977488|NCT03307980|gene therapy|gene therapy
977489|NCT03307928|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
977490|NCT03307928|Aged|aged
977491|NCT03307928|Hypertension|hypertension
977492|NCT03307928|Oxygen Consumption|oxygen consumption
977493|NCT03307928|Exercise|exercise
977494|NCT03307902|Vaccination|vaccination
977495|NCT03307889|perioperative monitoring|perioperative monitoring
977496|NCT03307876|biologic,|biologic,
977497|NCT03307876|Alpha 2 Macroglobulin|alpha 2 macroglobulin
977498|NCT03307876|A2M|a2m
977499|NCT03307876|back pain|back pain
977500|NCT03307876|APIC|apic
977501|NCT03307876|FAC|fac
977502|NCT03307876|FACT|fact
977503|NCT03307863|etonogestrel implant|etonogestrel implant
993956|NCT03202264|eHealth|ehealth
977504|NCT03307863|anti-epileptic drugs|anti-epileptic drugs
977505|NCT03307863|pharmacokinetics|pharmacokinetics
977506|NCT03307850|type 1 diabetes|type 1 diabetes
977507|NCT03307850|hypoglycemia|hypoglycemia
977508|NCT03307850|exercise|exercise
977509|NCT03307850|stress|stress
977510|NCT03307850|artificial pancreas|artificial pancreas
977511|NCT03307850|cortisol|cortisol
977512|NCT03307837|nilateral Transpositional First Metatarsal Osteotomy|nilateral transpositional first metatarsal osteotomy
977513|NCT03307824|Laparoscopic Surgery|laparoscopic surgery
977514|NCT03307824|synthetic glue IFABONDTM|synthetic glue ifabondtm
977515|NCT03307824|time of surgery|time of surgery
977516|NCT03307811|liver|liver
977517|NCT03307811|biopsy|biopsy
977520|NCT03307811|fine needle biopsy|fine needle biopsy
977521|NCT03307798|dental implant,bone quality,tactile sensation|dental implant,bone quality,tactile sensation
977522|NCT03307772|lactobacillus|lactobacillus
977523|NCT03307772|Herpes Labialis|herpes labialis
977524|NCT03307772|immune response|immune response
977525|NCT03307720|agonist trigger|agonist trigger
977526|NCT03307720|Ovulation induction|ovulation induction
977527|NCT03307720|Controlled ovarian stimulation (COS)|controlled ovarian stimulation (cos)
977528|NCT03307720|Poor responder|poor responder
977529|NCT03307707|FGF23|fgf23
977530|NCT03307707|klotho|klotho
977531|NCT03307707|Mineral Bone Disorder|mineral bone disorder
977532|NCT03307694|Cancer|cancer
977533|NCT03307694|Thyroid nodule|thyroid nodule
977534|NCT03307694|Imaging|imaging
977535|NCT03307694|Radiology|radiology
977536|NCT03307681|White potatoes|white potatoes
977537|NCT03307681|Children|children
977538|NCT03307681|Satiety|satiety
977539|NCT03307681|Glycaemia|glycaemia
977540|NCT03307655|nitric oxide|nitric oxide
977541|NCT03307655|follicular fluid|follicular fluid
977542|NCT03307655|sperm|sperm
977543|NCT03307655|capacitation|capacitation
977544|NCT03307655|fertilization|fertilization
977545|NCT03307655|phosphorylation|phosphorylation
977546|NCT03307655|nitrosylation|nitrosylation
977547|NCT03307642|Influenza vaccination rates|influenza vaccination rates
977548|NCT03307642|Respiratory Tract Diseases|respiratory tract diseases
977549|NCT03307616|Systemic connective tissue disorders|systemic connective tissue disorders
977550|NCT03307616|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
977551|NCT03307616|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
977552|NCT03307616|Dedifferentiated liposarcoma of the retroperitoneum|dedifferentiated liposarcoma of the retroperitoneum
977553|NCT03307616|DDLPS|ddlps
977554|NCT03307616|Undifferentiated pleomorphic sarcoma of the trunk or extremities|undifferentiated pleomorphic sarcoma of the trunk or extremities
977555|NCT03307616|UPS|ups
977556|NCT03307616|Nivolumab|nivolumab
977557|NCT03307616|BMS-936558|bms-936558
977558|NCT03307616|Opdivo|opdivo
977559|NCT03307616|Ipilimumab|ipilimumab
977560|NCT03307616|Yervoy|yervoy
977561|NCT03307616|BMS-734016|bms-734016
977562|NCT03307616|MDX010|mdx010
977563|NCT03307616|Radiation therapy|radiation therapy
977564|NCT03307616|XRT|xrt
977565|NCT03307603|Yttrium-90 radioembolization|yttrium-90 radioembolization
977566|NCT03307603|Nivolumab|nivolumab
977567|NCT03307551|propofol, automated, manual|propofol, automated, manual
977568|NCT03307538|Perihilar cholangiocarcinoma|perihilar cholangiocarcinoma
977569|NCT03307538|Klatskin tumor|klatskin tumor
977570|NCT03307538|Stereotactic body radiation therapy|stereotactic body radiation therapy
977571|NCT03307512|inhaled insulin|inhaled insulin
977572|NCT03307512|asthma|asthma
977573|NCT03307512|COPD|copd
977574|NCT03307486|Gestational diabetes|gestational diabetes
977575|NCT03307486|Type 2 DM after GDM|type 2 dm after gdm
977580|NCT03307447|optical coherence tomography|optical coherence tomography
977582|NCT03307434|Prevention|prevention
977584|NCT03307434|Athletics|athletics
977585|NCT03307421|simulation|simulation
977586|NCT03307421|debriefing|debriefing
977587|NCT03307421|team score|team score
977588|NCT03307421|multidisciplinarity|multidisciplinarity
977589|NCT03307421|DEBRIEF sim II|debrief sim ii
977590|NCT03307395|Chronic Subdural Hematoma|chronic subdural hematoma
977591|NCT03307395|Embolization|embolization
977592|NCT03307395|Middle meningeal artery|middle meningeal artery
977593|NCT03307382|Biliary stricture, cholangioscopy|biliary stricture, cholangioscopy
977594|NCT03307369|Severe malaria|severe malaria
977595|NCT03307369|plasmodium vivax|plasmodium vivax
977596|NCT03307356|Uterine Transplant|uterine transplant
977597|NCT03307356|MRKH|mrkh
977598|NCT03307343|sedentary behavior|sedentary behavior
977599|NCT03307343|light intensity physical activity|light intensity physical activity
977600|NCT03307343|behavioral intervention|behavioral intervention
977601|NCT03307343|office workers|office workers
977602|NCT03307343|blood pressure|blood pressure
977603|NCT03307343|pulse wave velocity|pulse wave velocity
977604|NCT03307343|randomized clinical trial|randomized clinical trial
977605|NCT03307330|Obstructive Sleep Apnea|obstructive sleep apnea
977606|NCT03307330|Adipose Tissue|adipose tissue
977611|NCT03307304|Batten Disease|batten disease
977612|NCT03307304|Neurodegenerative|neurodegenerative
977613|NCT03307304|Lysosomal Storage|lysosomal storage
977614|NCT03307304|Biomarkers|biomarkers
977615|NCT03307304|Longitudinal Study|longitudinal study
977616|NCT03307265|Weighted Jacket|weighted jacket
977617|NCT03307265|Balance disorder|balance disorder
977618|NCT03307265|Equilibrium disorder|equilibrium disorder
977619|NCT03307226|Suubi|suubi
977620|NCT03307226|Adolescent Girls|adolescent girls
977621|NCT03307226|Poverty|poverty
977622|NCT03307226|Economic Empowement Interventions|economic empowement interventions
977623|NCT03307226|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
977624|NCT03307226|HIV/AIDS-impacted girls|hiv/aids-impacted girls
977625|NCT03307226|Uganda|uganda
977626|NCT03307226|Cost-effectiveness|cost-effectiveness
977627|NCT03307200|Supportive care|supportive care
977628|NCT03307200|Prospective observational study|prospective observational study
977629|NCT03307161|manual therapy|manual therapy
977630|NCT03307161|heart rate|heart rate
977631|NCT03307148|Locally Advanced or Metastatic|locally advanced or metastatic
977632|NCT03307135|Spasticity|spasticity
977633|NCT03307135|electrophysiology|electrophysiology
977634|NCT03307135|biomechanics|biomechanics
977635|NCT03307135|objective assessment|objective assessment
977636|NCT03307096|FURS|furs
977637|NCT03307096|microperc|microperc
977638|NCT03307096|renal calculus|renal calculus
977639|NCT03307096|Randomized Controlled Trial|randomized controlled trial
977640|NCT03307096|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
977641|NCT03307057|Pediatrics|pediatrics
977642|NCT03307057|Behavioral Research|behavioral research
977643|NCT03307031|training volume|training volume
977644|NCT03307031|elderly|elderly
977645|NCT03307031|lipid profile|lipid profile
977646|NCT03307031|postmenopausal|postmenopausal
977647|NCT03307018|Bronchoscopy|bronchoscopy
977648|NCT03307018|Respiratory Complications|respiratory complications
977649|NCT03307018|Anatomical Lung Resection|anatomical lung resection
977650|NCT03306992|Exercise|exercise
977651|NCT03306966|Ascending colon|ascending colon
977652|NCT03306940|botulinum toxin A|botulinum toxin a
977653|NCT03306927|blood sugar|blood sugar
977654|NCT03306927|insulin|insulin
977655|NCT03306927|appetite|appetite
977656|NCT03306927|peas|peas
977657|NCT03306875|multiple sclerosis|multiple sclerosis
977658|NCT03306875|cognitive training|cognitive training
977659|NCT03306875|telerehabilitation|telerehabilitation
977660|NCT03306875|personality|personality
977661|NCT03306875|Conscientiousness|conscientiousness
977662|NCT03306875|predict|predict
977663|NCT03306862|blood sugar|blood sugar
977664|NCT03306862|insulin|insulin
977665|NCT03306862|peas|peas
977666|NCT03306836|Hybrid operation|hybrid operation
977667|NCT03306836|Cerebral Aneurysm|cerebral aneurysm
977668|NCT03306836|Arteriovenous Malformations|arteriovenous malformations
977669|NCT03306836|Anticoagulation|anticoagulation
977670|NCT03306823|Cerebral Aneurysm|cerebral aneurysm
977671|NCT03306823|Arteriovenous Malformations|arteriovenous malformations
977672|NCT03306823|Hybrid operation|hybrid operation
977673|NCT03306823|Anticoagulation|anticoagulation
977674|NCT03306810|Perioperative complications|perioperative complications
977675|NCT03306810|Dysglycemia management team|dysglycemia management team
977676|NCT03306810|Nurse Practitioner|nurse practitioner
977677|NCT03306810|Hospital|hospital
977678|NCT03306797|Music therapy|music therapy
977679|NCT03306797|Sonification technique|sonification technique
977680|NCT03306797|Rehabilitation|rehabilitation
977682|NCT03306784|pain catastrophizing|pain catastrophizing
977683|NCT03306771|Morbid Obesity|morbid obesity
977684|NCT03306771|Carotid Stenosis|carotid stenosis
977685|NCT03306771|Metabolic Syndrome|metabolic syndrome
977686|NCT03306745|Polycystic Ovary Syndrome|polycystic ovary syndrome
977687|NCT03306745|Anti-Mullerian Hormone|anti-mullerian hormone
977688|NCT03306745|Androgens|androgens
977689|NCT03306745|Micronutrient Supplementation|micronutrient supplementation
977690|NCT03306732|Thiamine|thiamine
977691|NCT03306732|Thiamine Supplementation|thiamine supplementation
977692|NCT03306732|Vasoplegia Syndrome|vasoplegia syndrome
977693|NCT03306732|Inotropic support|inotropic support
977694|NCT03306732|Cardiac surgery|cardiac surgery
977695|NCT03306732|Renal Failure|renal failure
977696|NCT03306706|blood sugar|blood sugar
977697|NCT03306706|insulin|insulin
977698|NCT03306706|appetite|appetite
977699|NCT03306706|peas|peas
977700|NCT03306693|Emotional Intelligence|emotional intelligence
977701|NCT03306693|Quality of Life|quality of life
977702|NCT03306628|Skin Scarring|skin scarring
977703|NCT03306628|keloids|keloids
977704|NCT03306628|hypertrophic scars|hypertrophic scars
977705|NCT03306628|CO2 laser therapy|co2 laser therapy
977706|NCT03306615|Muscle Stiffness|muscle stiffness
977707|NCT03306615|Muscle Spasticity|muscle spasticity
977708|NCT03306615|Stroke|stroke
977709|NCT03306615|Cerebral Palsy|cerebral palsy
977710|NCT03306615|Hyperreflexia|hyperreflexia
977711|NCT03306602|Composite Resins|composite resins
977712|NCT03306602|Dental Restorations|dental restorations
977713|NCT03306589|Inflammation|inflammation
977714|NCT03306589|GM-CSF|gm-csf
977715|NCT03306589|LPS|lps
977716|NCT03306589|Skin blisters|skin blisters
977717|NCT03306589|Healthy subjects|healthy subjects
977718|NCT03306589|cantharidin|cantharidin
977719|NCT03306576|composite restoration|composite restoration
977720|NCT03306563|TBI|tbi
977721|NCT03306563|Mild traumatic brain injury|mild traumatic brain injury
977722|NCT03306563|Concussion|concussion
977723|NCT03306563|Diagnostics|diagnostics
977724|NCT03306563|Rapid test|rapid test
977725|NCT03306563|Traumatic Brain Injury|traumatic brain injury
977726|NCT03306563|mTBI|mtbi
977727|NCT03306550|drug-drug interaction|drug-drug interaction
977728|NCT03306550|Asprin|asprin
977729|NCT03306550|salvianolate injection|salvianolate injection
977730|NCT03306550|PK-PD model|pk-pd model
977731|NCT03306550|metabolic enzymes|metabolic enzymes
977732|NCT03306524|mechanical ventilation|mechanical ventilation
977733|NCT03306524|SIPPV|sippv
977734|NCT03306524|PSV|psv
977735|NCT03306524|Device flow|device flow
977736|NCT03306524|Circuit flow|circuit flow
977737|NCT03306524|Slope time|slope time
977738|NCT03306524|neonatal intensive care|neonatal intensive care
977739|NCT03306498|plasma free amino acids|plasma free amino acids
977740|NCT03306459|PCOS|pcos
977741|NCT03306459|Quality of life|quality of life
977742|NCT03306459|Sexuality|sexuality
977743|NCT03306459|Psychological traits|psychological traits
977744|NCT03306433|dental caries|dental caries
977745|NCT03306433|white spot lesion|white spot lesion
977746|NCT03306433|prevention|prevention
977747|NCT03306433|smooth surface sealant|smooth surface sealant
977748|NCT03306420|MS201408-0005A|ms201408-0005a
977749|NCT03306420|MS201408-0005B|ms201408-0005b
977750|NCT03306420|MS201408-0005C|ms201408-0005c
977751|NCT03306420|First-in-Human|first-in-human
977752|NCT03306420|Advanced solid tumors|advanced solid tumors
977753|NCT03306394|metastatic|metastatic
977754|NCT03306394|colorectal|colorectal
977755|NCT03306394|cancer|cancer
977756|NCT03306394|trifluridine/tipiracil|trifluridine/tipiracil
977757|NCT03306394|early access|early access
977758|NCT03306381|IBS|ibs
977759|NCT03306381|Epigenetics|epigenetics
977760|NCT03306381|Dietary intervention|dietary intervention
977761|NCT03306381|Gut Microbiota|gut microbiota
977762|NCT03306381|Inflammation|inflammation
977763|NCT03306381|Genetics|genetics
977764|NCT03306368|OUD|oud
977765|NCT03306368|XR-NTX|xr-ntx
977766|NCT03306368|assertive outreach|assertive outreach
977767|NCT03306368|youth|youth
977768|NCT03306355|Intraocular Lens|intraocular lens
977769|NCT03306355|trifocal|trifocal
977770|NCT03306355|hydrophobic|hydrophobic
977771|NCT03306355|hydrophilic|hydrophilic
977772|NCT03306342|Intraocular Lens|intraocular lens
977773|NCT03306342|trifocal|trifocal
977774|NCT03306342|hydrophobic|hydrophobic
977775|NCT03306342|hydrophilic|hydrophilic
977776|NCT03306303|melatonin|melatonin
977777|NCT03306303|STEMI|stemi
977778|NCT03306303|No-reflow|no-reflow
977779|NCT03306290|Obese|obese
977780|NCT03306290|Bariatric surgery|bariatric surgery
977781|NCT03306290|Antibiotic prophylaxis|antibiotic prophylaxis
977782|NCT03306290|Cefoxitin|cefoxitin
977783|NCT03306264|MDS|mds
977784|NCT03306264|CMML|cmml
977785|NCT03306264|decitabine|decitabine
977786|NCT03306264|Myelodysplastic Syndromes|myelodysplastic syndromes
977787|NCT03306264|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
977788|NCT03306251|HIV|hiv
977789|NCT03306251|Pregnancy|pregnancy
977790|NCT03306251|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
977791|NCT03306238|laparoscopy/ key-hole|laparoscopy/ key-hole
977792|NCT03306238|renal surgery|renal surgery
977793|NCT03306238|open/hasson|open/hasson
977794|NCT03306238|closed/veress|closed/veress
977795|NCT03306212|cerebral palsy|cerebral palsy
977796|NCT03306212|casting|casting
977797|NCT03306212|Botulinum toxin A|botulinum toxin a
977798|NCT03306186|diagnosis|diagnosis
977799|NCT03306186|prognosis|prognosis
977800|NCT03306160|central blood pressure|central blood pressure
977801|NCT03306160|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
977802|NCT03306160|blood pressure variability|blood pressure variability
977803|NCT03306147|Pain|pain
977804|NCT03306147|Opioid|opioid
977805|NCT03306147|Drug monitoring|drug monitoring
977806|NCT03306147|Pain education|pain education
977807|NCT03306121|Nasopharyngeal carcinoma;Induction chemotherapy|nasopharyngeal carcinoma;induction chemotherapy
977808|NCT03306069|Aerobic exercise|aerobic exercise
977809|NCT03306069|Interval training|interval training
977810|NCT03306069|VO2max|vo2max
977811|NCT03306069|Health Promotion|health promotion
977812|NCT03306069|Inflammation|inflammation
977813|NCT03306069|Body Composition|body composition
977814|NCT03306056|Exercise|exercise
977815|NCT03306056|Strength Training|strength training
977816|NCT03306056|Health Promotion|health promotion
977817|NCT03306056|Inflammation|inflammation
977818|NCT03306056|Body Composition|body composition
977819|NCT03306043|hypereosinophilic syndrome|hypereosinophilic syndrome
977820|NCT03306043|hypereosinophilic syndrome flare|hypereosinophilic syndrome flare
977821|NCT03306043|open-label extension study|open-label extension study
977822|NCT03306043|Mepolizumab|mepolizumab
977823|NCT03306043|SB240563|sb240563
977824|NCT03306043|Long-term safety|long-term safety
977825|NCT03306030|PEG|peg
977826|NCT03306030|Bowel preparation|bowel preparation
977827|NCT03306030|Colonoscopy|colonoscopy
977828|NCT03306030|split-does|split-does
977829|NCT03306017|left ventricular assist device|left ventricular assist device
977830|NCT03306017|platelet-leukocyte conjugates|platelet-leukocyte conjugates
977831|NCT03306017|lipo-oxygenase products|lipo-oxygenase products
977832|NCT03305991|tuberculosis|tuberculosis
977833|NCT03305991|pregnancy|pregnancy
977834|NCT03305991|ethiopia|ethiopia
977835|NCT03305978|Ultra low dose chest CT|ultra low dose chest ct
977836|NCT03305978|lung cancer screening|lung cancer screening
977837|NCT03305939|Gestational diabetes,Lifestyle,Type 2 DM|gestational diabetes,lifestyle,type 2 dm
977838|NCT03305913|mCRC|mcrc
977839|NCT03305900|formate|formate
977840|NCT03305900|one-carbon metabolism|one-carbon metabolism
977841|NCT03305887|TKA|tka
977842|NCT03305887|Barbed suture|barbed suture
977843|NCT03305887|Surgical time|surgical time
977844|NCT03305874|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
977845|NCT03305874|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
977846|NCT03305874|computer-based risk tool|computer-based risk tool
977847|NCT03305861|Thulium Laser Enucleation of the Prostate (ThuLEP)|thulium laser enucleation of the prostate (thulep)
977848|NCT03305861|Greenlight Laser Enucleation of the Prostate (Green LEP)|greenlight laser enucleation of the prostate (green lep)
977849|NCT03305861|Holmium Laser Enucleation of Prostate (HoLEP)|holmium laser enucleation of prostate (holep)
977850|NCT03305835|Primary Hyperoxaluria (PH)|primary hyperoxaluria (ph)
977851|NCT03305835|Hyperoxaluria|hyperoxaluria
977852|NCT03305835|PH|ph
977853|NCT03305835|PH 1|ph 1
977854|NCT03305835|PH 2|ph 2
977855|NCT03305835|PH 3|ph 3
977856|NCT03305835|Dent Disease|dent disease
977857|NCT03305835|Dent 1|dent 1
977858|NCT03305835|Dent 2|dent 2
977859|NCT03305835|Cystinuria|cystinuria
977860|NCT03305835|APRT Deficiency|aprt deficiency
977861|NCT03305835|24-Hydroxylase Deficiency|24-hydroxylase deficiency
977862|NCT03305835|CYP24A1|cyp24a1
977863|NCT03305809|Parkinson disease dementia|parkinson disease dementia
977864|NCT03305809|Parkinson disease|parkinson disease
977865|NCT03305809|Dopamine|dopamine
977866|NCT03305809|Cognition|cognition
977867|NCT03305744|Athlete|athlete
977868|NCT03305744|Middle-aged|middle-aged
977869|NCT03305744|Endurance training|endurance training
977870|NCT03305744|Cardiac Function|cardiac function
977871|NCT03305744|Atrial Fibrillation|atrial fibrillation
977872|NCT03305731|Rehabilitation|rehabilitation
977873|NCT03305731|Disability|disability
977874|NCT03305692|cardiac resynchronization therapy|cardiac resynchronization therapy
977875|NCT03305692|pacing|pacing
977876|NCT03305692|echocardiography|echocardiography
977877|NCT03305692|optimization|optimization
977878|NCT03305692|heart failure|heart failure
977879|NCT03305653|Pediatrics|pediatrics
977880|NCT03305588|essential tremor (ET)|essential tremor (et)
977881|NCT03305588|stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
977882|NCT03305588|radiosurgery (RS)|radiosurgery (rs)
977883|NCT03305588|deep brain stimulation (DBS)|deep brain stimulation (dbs)
977884|NCT03305588|Parkinson's Disease (PD)|parkinson's disease (pd)
977885|NCT03305588|tremor-dominant Parkinson's disease (TDPD)|tremor-dominant parkinson's disease (tdpd)
977886|NCT03305575|Cervical Cerclage|cervical cerclage
977887|NCT03305575|Bupivacaine|bupivacaine
977888|NCT03305575|Chloroprocaine|chloroprocaine
977889|NCT03305575|spinal anesthesia|spinal anesthesia
977890|NCT03305562|Hypertension|hypertension
977891|NCT03305549|Dialysis-requiring Acute Kidney Injury|dialysis-requiring acute kidney injury
977892|NCT03305549|Renal Recovery|renal recovery
977894|NCT03305523|circumcision; Thermocautery; Complication|circumcision; thermocautery; complication
977895|NCT03305497|Opioid Overdose; Naloxone|opioid overdose; naloxone
977896|NCT03305484|contact lenses|contact lenses
977897|NCT03305484|red eye|red eye
977898|NCT03305484|corneal infiltrate|corneal infiltrate
977899|NCT03305471|Chronic hemodialysis|chronic hemodialysis
977900|NCT03305471|Investigational drug|investigational drug
977901|NCT03305445|Immunotransplant|immunotransplant
977902|NCT03305445|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
977903|NCT03305445|Refractory Diffuse Large B-Cell Lymphoma|refractory diffuse large b-cell lymphoma
977904|NCT03305445|Nivolumab|nivolumab
977905|NCT03305445|Ipilimumab|ipilimumab
977906|NCT03305419|Crossover|crossover
977907|NCT03305419|Sequential|sequential
977908|NCT03305419|GSK2982772|gsk2982772
977909|NCT03305419|Safety|safety
977910|NCT03305419|Pharmacokinetics|pharmacokinetics
977911|NCT03305419|Healthy subjects|healthy subjects
977912|NCT03305393|Heart Failure|heart failure
977913|NCT03305393|CRT|crt
977914|NCT03305393|Cardiac Recynchronization Therapy|cardiac recynchronization therapy
977915|NCT03305393|left bundle branch block|left bundle branch block
977916|NCT03305393|atrio-ventricular conduction|atrio-ventricular conduction
977917|NCT03305380|anti-PD1|anti-pd1
977918|NCT03305380|anti-PD-L1|anti-pd-l1
977919|NCT03305354|mobile health|mobile health
977920|NCT03305354|physical activity|physical activity
977921|NCT03305341|SCLC|sclc
977922|NCT03305341|SNP|snp
977923|NCT03305341|Oncology|oncology
977924|NCT03305341|Drug|drug
977925|NCT03305341|Etoposide|etoposide
977926|NCT03305341|Methotrexate|methotrexate
977927|NCT03305341|Lung|lung
977928|NCT03305341|Cancer|cancer
977929|NCT03305328|Oscillations|oscillations
977930|NCT03305328|Non-invasive Brain Stimulation|non-invasive brain stimulation
977931|NCT03305328|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
977932|NCT03305276|diet;|diet;
977933|NCT03305276|exercise;|exercise;
977934|NCT03305276|hypertension;|hypertension;
977937|NCT03305237|Chrono-nutrition|chrono-nutrition
977938|NCT03305237|Diet|diet
977939|NCT03305237|energy expenditure|energy expenditure
977940|NCT03305224|castration-resistant prostate cancer|castration-resistant prostate cancer
977941|NCT03305224|bone metastasis|bone metastasis
977942|NCT03305185|AIS|ais
977943|NCT03305107|Child|child
977944|NCT03305107|Exercise|exercise
977945|NCT03305107|Chocolate milk|chocolate milk
977946|NCT03305107|Blood glucose|blood glucose
977947|NCT03305107|Cognition|cognition
977948|NCT03305107|Appetite|appetite
977949|NCT03305107|Emotions|emotions
977950|NCT03305107|Cortisol|cortisol
977951|NCT03305094|Remote ischemic preconditioning|remote ischemic preconditioning
977952|NCT03305094|Myocardial infarction|myocardial infarction
977953|NCT03305094|Cardiac surgery|cardiac surgery
977954|NCT03305055|opioid|opioid
977955|NCT03305055|ketamine|ketamine
977956|NCT03305042|aging|aging
977957|NCT03305042|alpha-retinol|alpha-retinol
977958|NCT03305042|hypervitaminosis A|hypervitaminosis a
977959|NCT03305042|vitamin A biomarkers|vitamin a biomarkers
977960|NCT03305042|serum retinol|serum retinol
977961|NCT03305029|Age related macular degeneration|age related macular degeneration
977962|NCT03305029|embryonic stem cells|embryonic stem cells
977963|NCT03305029|somatic cell nuclear transfer|somatic cell nuclear transfer
977964|NCT03305016|Human Growth Hormone|human growth hormone
977965|NCT03305016|hGH|hgh
977966|NCT03305016|GHD|ghd
977967|NCT03305016|rhGH|rhgh
977968|NCT03305016|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
977969|NCT03305016|Long Acting Growth Hormone|long acting growth hormone
977970|NCT03305016|Somatropin|somatropin
977971|NCT03305016|Prodrug|prodrug
977972|NCT03305016|Growth Failure|growth failure
977973|NCT03305016|Growth Hormone Replacement Therapy|growth hormone replacement therapy
977974|NCT03305016|Sustained Release Growth Hormone|sustained release growth hormone
977975|NCT03305016|Growth Hormone Deficiency|growth hormone deficiency
977976|NCT03305016|TransCon GH|transcon gh
977977|NCT03304964|FP-025, MMP-12 inhibitor|fp-025, mmp-12 inhibitor
977978|NCT03304912|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
977979|NCT03304912|Injection Drug Use|injection drug use
977980|NCT03304873|rectal MRSA|rectal mrsa
977981|NCT03304873|mupirocin-resistant nasal MRSA|mupirocin-resistant nasal mrsa
977991|NCT03304808|treatment|treatment
977992|NCT03304808|device|device
977993|NCT03304795|Vitamin D|vitamin d
977994|NCT03304795|Asia|asia
977995|NCT03304795|Trend|trend
977996|NCT03304795|KNHANES|knhanes
977997|NCT03304795|Temporal change|temporal change
977998|NCT03304782|Preterm Birth|preterm birth
977999|NCT03304782|FitBit|fitbit
978000|NCT03304782|Preterm Delivery|preterm delivery
978001|NCT03304769|Virtual Reality Distraction|virtual reality distraction
978002|NCT03304769|Pediatric IV placement|pediatric iv placement
978003|NCT03304756|locally advanced breast cancer|locally advanced breast cancer
978004|NCT03304756|triple negative|triple negative
978005|NCT03304756|cisplatin|cisplatin
978006|NCT03304743|dental panoramic radiographs|dental panoramic radiographs
978007|NCT03304743|osteoporosis|osteoporosis
978008|NCT03304743|feasibility study|feasibility study
978009|NCT03304730|Zygapophyseal Joint|zygapophyseal joint
978010|NCT03304730|Low Back Pain|low back pain
978011|NCT03304730|Spine Osteoarthritis|spine osteoarthritis
978012|NCT03304717|Leukodystrophy|leukodystrophy
978013|NCT03304717|Antiretroviral Drugs|antiretroviral drugs
978024|NCT03304678|mTORC1 Inhibition|mtorc1 inhibition
978025|NCT03304678|VEGF-D|vegf-d
978026|NCT03304678|MicroRNA|microrna
978031|NCT03304600|tDCS|tdcs
978032|NCT03304561|knee|knee
978033|NCT03304561|rehabilitation|rehabilitation
978034|NCT03304561|ACL|acl
978035|NCT03304561|Contralateral training|contralateral training
978036|NCT03304548|Telephone interviews|telephone interviews
978037|NCT03304548|Subcutaneous|subcutaneous
978038|NCT03304548|Low-interventional|low-interventional
978039|NCT03304548|Qualitative research|qualitative research
978040|NCT03304548|PAH|pah
978041|NCT03304535|Glaucoma|glaucoma
978042|NCT03304535|Social Worker|social worker
978043|NCT03304496|Nitroglycerin|nitroglycerin
978044|NCT03304496|Vasodilator Agents|vasodilator agents
978045|NCT03304496|Subcutaneous Injection|subcutaneous injection
978046|NCT03304496|Radial Artery|radial artery
978047|NCT03304496|Coronary Angiography|coronary angiography
978048|NCT03304496|Cardiac Catheterization|cardiac catheterization
978049|NCT03304496|Coronary Angioplasty|coronary angioplasty
978050|NCT03304496|Percutaneous Coronary Intervention|percutaneous coronary intervention
978051|NCT03304457|Lurasidone|lurasidone
978052|NCT03304457|Olanzapine|olanzapine
978053|NCT03304457|Brain derived neurotrophic factor|brain derived neurotrophic factor
978054|NCT03304457|Nerve growth factor|nerve growth factor
978055|NCT03304457|Neurotrophin 3|neurotrophin 3
978056|NCT03304431|QT dispersion|qt dispersion
978057|NCT03304431|topical lidocaine|topical lidocaine
978058|NCT03304431|P-wave values|p-wave values
978059|NCT03304405|ASD|asd
978060|NCT03304392|anxiety|anxiety
978061|NCT03304392|depression|depression
978062|NCT03304392|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
978063|NCT03304392|randomized controlled trial|randomized controlled trial
978064|NCT03304392|patient-centered|patient-centered
978065|NCT03304392|knowledge implementation|knowledge implementation
978066|NCT03304392|mental health system|mental health system
978067|NCT03304392|therapist-assistance|therapist-assistance
978068|NCT03304353|Plantar heel pain|plantar heel pain
978069|NCT03304353|Resistance training|resistance training
978070|NCT03304340|acute stroke,TENS ,posture stability, function|acute stroke,tens ,posture stability, function
978071|NCT03304327|Yoga|yoga
978072|NCT03304327|Mindfulness|mindfulness
978073|NCT03304314|PTC|ptc
978074|NCT03304314|EYES|eyes
978075|NCT03304314|Pseudotumor cerebri|pseudotumor cerebri
978076|NCT03304314|increased Intracranial pressure|increased intracranial pressure
978077|NCT03304314|ICP|icp
978078|NCT03304301|sunlight exposure|sunlight exposure
978079|NCT03304301|institutionalized elderly|institutionalized elderly
978080|NCT03304301|depression|depression
978081|NCT03304301|quality of life|quality of life
978082|NCT03304301|cognition function|cognition function
978083|NCT03304288|all-trans retinoid acid|all-trans retinoid acid
978084|NCT03304288|rituximab|rituximab
978085|NCT03304288|steroid-resistant|steroid-resistant
978086|NCT03304288|refractory|refractory
978087|NCT03304288|low-dose|low-dose
978088|NCT03304275|Pertussis|pertussis
978089|NCT03304275|Vaccination|vaccination
978090|NCT03304275|Emergency Department|emergency department
978091|NCT03304262|Metaplasticity|metaplasticity
978092|NCT03304262|Motor excitability|motor excitability
978093|NCT03304262|rTMS|rtms
978094|NCT03304262|tDCS|tdcs
978095|NCT03304236|Cervical Myelopahty|cervical myelopahty
978096|NCT03304236|sEMG|semg
978097|NCT03304236|Motion capture analysis|motion capture analysis
978098|NCT03304210|PIPAC|pipac
978099|NCT03304210|Peritoneal carcinomatosis|peritoneal carcinomatosis
978100|NCT03304210|Ovarian cancer|ovarian cancer
978101|NCT03304210|Pharmacokinetics|pharmacokinetics
978102|NCT03304210|Pharmacodynamics|pharmacodynamics
978103|NCT03304210|Safety and efficacy|safety and efficacy
978104|NCT03304210|Abraxane|abraxane
978105|NCT03304210|Breast cancer|breast cancer
978106|NCT03304210|Pancreas cancer|pancreas cancer
978107|NCT03304210|Stomach cancer|stomach cancer
978108|NCT03304158|Diabetes|diabetes
978109|NCT03304158|Non-communicable disease|non-communicable disease
978110|NCT03304158|Primary health care|primary health care
978111|NCT03304158|Nepal|nepal
978112|NCT03304145|Treatment Care Planning|treatment care planning
978113|NCT03304132|Oral Microbiome|oral microbiome
978114|NCT03304132|reflux disorders|reflux disorders
978115|NCT03304132|esophageal microbiome|esophageal microbiome
978116|NCT03304132|Alcohol Use|alcohol use
978117|NCT03304132|Tobacco Use|tobacco use
978118|NCT03304119|Tipping of tibial tuberosity|tipping of tibial tuberosity
978119|NCT03304119|Torsion of tibial tuberosity|torsion of tibial tuberosity
978120|NCT03304119|Recurrent patellar dislocation|recurrent patellar dislocation
978121|NCT03304119|MRI Measurements|mri measurements
978122|NCT03304119|Patellar instability|patellar instability
978123|NCT03304119|Patellar dislocation|patellar dislocation
978124|NCT03304119|Tibial tubercle position|tibial tubercle position
978125|NCT03304119|Tibial tubercle torsion|tibial tubercle torsion
978126|NCT03304093|IFCT|ifct
978127|NCT03304093|VIH|vih
978128|NCT03304093|Nivolumab|nivolumab
978129|NCT03304093|NSCLC|nsclc
978130|NCT03304080|Breast Neoplasms|breast neoplasms
978131|NCT03304080|Breast Diseases|breast diseases
978132|NCT03304080|Palbociclib|palbociclib
978133|NCT03304080|Trastuzumab|trastuzumab
978134|NCT03304080|Pertuzumab|pertuzumab
978135|NCT03304080|Hormone Antagonists|hormone antagonists
978136|NCT03304054|MuSK antibody positive|musk antibody positive
978137|NCT03304041|low-FODMAP|low-fodmap
978138|NCT03304041|Irritable Bowel Syndrome|irritable bowel syndrome
978139|NCT03304041|stool fermentation|stool fermentation
978140|NCT03304041|Breath test|breath test
978141|NCT03304028|Connected Devices|connected devices
978142|NCT03304028|Pulmonary Exacerbations|pulmonary exacerbations
978143|NCT03304028|Cumulative Sum (CUSUM) Chart|cumulative sum (cusum) chart
978144|NCT03304015|Intervention|intervention
978145|NCT03304015|Violence against Women|violence against women
978146|NCT03304015|Female Garment Workers|female garment workers
978147|NCT03304015|Bangladesh|bangladesh
978148|NCT03303976|pneumococcal vaccine|pneumococcal vaccine
978149|NCT03303976|bioconjugate|bioconjugate
978150|NCT03303963|culture-free|culture-free
978151|NCT03303963|tuberculosis|tuberculosis
978152|NCT03303963|multidrug resistant|multidrug resistant
978153|NCT03303963|diagnosis|diagnosis
978154|NCT03303963|follow-up|follow-up
978155|NCT03303963|africa|africa
978156|NCT03303963|molecular tools|molecular tools
978157|NCT03303937|virulence factor genes;|virulence factor genes;
978158|NCT03303937|phenotyping|phenotyping
978159|NCT03303937|genotyping|genotyping
978160|NCT03303937|antimicrobial susceptibility|antimicrobial susceptibility
978161|NCT03303924|Pharmacokinetic|pharmacokinetic
978261|NCT03303118|EEG|eeg
978162|NCT03303924|Bronchoalveolar Lavage|bronchoalveolar lavage
978163|NCT03303924|Epithelial Lining Fluid|epithelial lining fluid
978164|NCT03303924|Alveolar Macrophage|alveolar macrophage
978165|NCT03303924|Gram-negative bacterium|gram-negative bacterium
978166|NCT03303924|Acinetobacter baumannii|acinetobacter baumannii
978167|NCT03303872|atrial high rate episode|atrial high rate episode
978168|NCT03303872|pacemaker|pacemaker
978169|NCT03303872|atrial fibrillation|atrial fibrillation
978170|NCT03303872|stroke|stroke
978171|NCT03303859|Bacterial vaginosis, preterm delivery, Martinique, stress|bacterial vaginosis, preterm delivery, martinique, stress
978172|NCT03303833|Lifestyle|lifestyle
978173|NCT03303833|Nutrition|nutrition
978174|NCT03303807|Extracorporeal CO2 removal (ECCO2-R)|extracorporeal co2 removal (ecco2-r)
978175|NCT03303807|ARDS|ards
978176|NCT03303794|Total Knee arthroplasty|total knee arthroplasty
978177|NCT03303794|bupivacaine|bupivacaine
978178|NCT03303794|anesthesia|anesthesia
978179|NCT03303729|Carbohydrate|carbohydrate
978180|NCT03303729|Cluster Dextrin|cluster dextrin
978181|NCT03303729|Exercise training|exercise training
978182|NCT03303729|Protein supplement|protein supplement
978880|NCT03299101|Surgery|surgery
978183|NCT03303703|cardiac rehabilitation|cardiac rehabilitation
978184|NCT03303677|endoscopic sinus surgery|endoscopic sinus surgery
978185|NCT03303677|topical nasal therapy|topical nasal therapy
978186|NCT03303664|opioid|opioid
978187|NCT03303664|inpatient|inpatient
978188|NCT03303664|pain|pain
978189|NCT03303664|multimodal|multimodal
978190|NCT03303651|Analgesia, Monitoring, Opioid, Sufentanil, Sevoflurane|analgesia, monitoring, opioid, sufentanil, sevoflurane
978191|NCT03303638|Multi-sensory environment|multi-sensory environment
978192|NCT03303638|Snoezelen|snoezelen
978193|NCT03303638|Bathing|bathing
978194|NCT03303638|Showering|showering
978195|NCT03303638|Tub Bathing|tub bathing
978196|NCT03303599|Chronic Hepatitis C|chronic hepatitis c
978197|NCT03303599|Sustained Virological Response|sustained virological response
978198|NCT03303599|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
978199|NCT03303599|Chronic Hepatitis C genotype 2|chronic hepatitis c genotype 2
978200|NCT03303599|Chronic Hepatitis C genotype 3|chronic hepatitis c genotype 3
978201|NCT03303599|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
978202|NCT03303599|Chronic Hepatitis C genotype 5|chronic hepatitis c genotype 5
978203|NCT03303599|Chronic Hepatitis C genotype 6|chronic hepatitis c genotype 6
978204|NCT03303599|Hepatitis C|hepatitis c
978205|NCT03303586|Asthma|asthma
978206|NCT03303586|Fluid Shift|fluid shift
978207|NCT03303586|Compression stockings|compression stockings
978208|NCT03303586|intrathoracic airway narrowing|intrathoracic airway narrowing
978209|NCT03303573|Erythropoeitin|erythropoeitin
978211|NCT03303547|Tissue|tissue
978212|NCT03303547|Imaging|imaging
978213|NCT03303547|Pathology|pathology
978214|NCT03303547|Rectal|rectal
978215|NCT03303547|Cancer|cancer
978216|NCT03303534|inflammation|inflammation
978217|NCT03303534|hydrogen sulfide|hydrogen sulfide
978218|NCT03303534|caloric restriction|caloric restriction
978219|NCT03303534|vascular surgery|vascular surgery
978220|NCT03303495|FOLFIRI|folfiri
978221|NCT03303495|CPT-11|cpt-11
978222|NCT03303495|Bevacizumab|bevacizumab
978223|NCT03303495|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
978224|NCT03303456|early psychosis|early psychosis
978225|NCT03303456|clinical high risk|clinical high risk
978226|NCT03303456|mobile health|mobile health
978227|NCT03303430|cerebral microembolisation|cerebral microembolisation
978228|NCT03303430|plaque characteristics|plaque characteristics
978229|NCT03303417|Kiwifruit|kiwifruit
978230|NCT03303378|melatonin|melatonin
978231|NCT03303378|Reperfusion Injury|reperfusion injury
978232|NCT03303378|myocardial infarction|myocardial infarction
978233|NCT03303365|Brain Metastases|brain metastases
978234|NCT03303365|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
978235|NCT03303365|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
978236|NCT03303365|CYBER-Knife|cyber-knife
978237|NCT03303339|PLK1|plk1
978238|NCT03303339|PLK Inhibitor|plk inhibitor
978239|NCT03303326|sexual health|sexual health
978240|NCT03303313|RNAi therapeutic|rnai therapeutic
978241|NCT03303313|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
978242|NCT03303313|Hemolysis|hemolysis
978243|NCT03303313|Thrombocytopenia|thrombocytopenia
978244|NCT03303313|Renal insufficiency|renal insufficiency
978245|NCT03303313|Thrombotic Microangiopathy|thrombotic microangiopathy
978246|NCT03303313|aHUS|ahus
978247|NCT03303313|TMA|tma
978248|NCT03303287|health education|health education
978249|NCT03303235|methylergonovine|methylergonovine
978250|NCT03303209|opioid|opioid
978251|NCT03303209|opioids|opioids
978252|NCT03303209|taper|taper
978253|NCT03303209|chronic pain|chronic pain
978254|NCT03303196|Post-Pancreatectomy Diabetes|post-pancreatectomy diabetes
978255|NCT03303196|Insulin Therapy|insulin therapy
978256|NCT03303144|Pharmacokinetics|pharmacokinetics
978257|NCT03303144|Equivalence|equivalence
978258|NCT03303118|Hypoxia|hypoxia
978259|NCT03303118|Brain|brain
978260|NCT03303118|Cerebral vaso-reactivity|cerebral vaso-reactivity
978262|NCT03303118|Concentration performance|concentration performance
978263|NCT03303118|Cerebral oxygenation|cerebral oxygenation
978264|NCT03303118|Cerebral blood-flow|cerebral blood-flow
978265|NCT03303118|Heart rate variability|heart rate variability
978266|NCT03303066|Myelodysplastic Syndromes|myelodysplastic syndromes
978267|NCT03303066|Anemia|anemia
978268|NCT03303066|Hemoglobin (Hb)|hemoglobin (hb)
978269|NCT03303066|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
978270|NCT03303053|Hyperthyroidism,Graves disease,Cholestyramine,Prednisolone|hyperthyroidism,graves disease,cholestyramine,prednisolone
978271|NCT03303040|Mechanical ventilation|mechanical ventilation
978272|NCT03303040|Diaphragm weakness|diaphragm weakness
978273|NCT03303040|Difficulty weaning from mechanical ventilation|difficulty weaning from mechanical ventilation
978274|NCT03303040|Diaphragm stimulation|diaphragm stimulation
978275|NCT03303027|Cosmesis|cosmesis
978276|NCT03303027|Surgical Wound|surgical wound
978277|NCT03303027|Fast Absorbing Gut|fast absorbing gut
978278|NCT03303027|Linear Cutaneous Wound|linear cutaneous wound
978279|NCT03303014|Suture|suture
978280|NCT03303014|Absorbable|absorbable
978281|NCT03303014|Non-absorbable|non-absorbable
978282|NCT03303014|Split wound|split wound
978283|NCT03303014|Cutaneous Wound|cutaneous wound
978284|NCT03303001|subacromial infiltration|subacromial infiltration
978285|NCT03303001|high volumen|high volumen
978286|NCT03303001|shoulder pain|shoulder pain
978287|NCT03302988|Wound Edge Eversion|wound edge eversion
978288|NCT03302988|Dermal Sutures|dermal sutures
978289|NCT03302975|Running|running
978290|NCT03302975|Biomechanics|biomechanics
978291|NCT03302975|Kinetics|kinetics
978292|NCT03302962|asthma|asthma
978293|NCT03302962|pediatric|pediatric
978294|NCT03302962|american indian|american indian
978295|NCT03302962|children|children
978296|NCT03302949|Nutritional Supplement|nutritional supplement
978297|NCT03302949|Health-related Quality of Life|health-related quality of life
978298|NCT03302949|Dietary Intake|dietary intake
978299|NCT03302936|Midurethral sling|midurethral sling
978300|NCT03302936|Pyridium|pyridium
978301|NCT03302923|Nursing home residents|nursing home residents
978302|NCT03302923|Brisk walking|brisk walking
978303|NCT03302910|Acute Heart Failure, Chronic Heart Failure, Heart Failure, Heart conditions, nitroglycerin|acute heart failure, chronic heart failure, heart failure, heart conditions, nitroglycerin
978304|NCT03302897|Leprosy, vaccine, adjuvant, GLA, GLA-SE|leprosy, vaccine, adjuvant, gla, gla-se
978305|NCT03302871|cerebral palsy|cerebral palsy
978306|NCT03302871|botulinum toxin A|botulinum toxin a
978307|NCT03302871|constraint induced movement therapy|constraint induced movement therapy
978308|NCT03302871|transcranial direct current stimulation|transcranial direct current stimulation
978309|NCT03302832|Total Knee Arthroplasty|total knee arthroplasty
978310|NCT03302832|Total Knee Replacement|total knee replacement
978311|NCT03302806|disability|disability
978312|NCT03302806|EDSS|edss
978313|NCT03302767|Oncology|oncology
978314|NCT03302767|Work Keeping|work keeping
978315|NCT03302767|Social difficulties|social difficulties
978316|NCT03302767|Cognitive Disorders|cognitive disorders
978317|NCT03302741|stroke|stroke
978318|NCT03302728|CD 30 positive, relapsed, refractory|cd 30 positive, relapsed, refractory
978319|NCT03302702|exercise|exercise
978320|NCT03302702|duration|duration
978321|NCT03302689|TAP-block|tap-block
978322|NCT03302689|VAS of pain|vas of pain
978323|NCT03302689|Cesarean section|cesarean section
978324|NCT03302689|Postoperative analgesia|postoperative analgesia
978325|NCT03302676|Saliva substitute|saliva substitute
978326|NCT03302663|Fetal bone heart abnormality|fetal bone heart abnormality
978327|NCT03302624|acute kidney injury|acute kidney injury
978328|NCT03302624|quality of life|quality of life
1657447|NCT00158496|Genotype 4|genotype 4
978329|NCT03302624|Renal replacement therapy|renal replacement therapy
978330|NCT03302624|Intensive care unit|intensive care unit
978331|NCT03302611|major depressive disorder|major depressive disorder
978332|NCT03302611|military|military
978333|NCT03302611|surf therapy|surf therapy
978334|NCT03302611|hike therapy|hike therapy
978335|NCT03302611|randomized controlled trial|randomized controlled trial
978336|NCT03302598|enterocutaneous fistula - C-reactive protein- surgical repair|enterocutaneous fistula - c-reactive protein- surgical repair
978337|NCT03302585|Optic Neuritis|optic neuritis
978338|NCT03302585|Vitamin D|vitamin d
978339|NCT03302572|primary care|primary care
978340|NCT03302572|advance directives|advance directives
978341|NCT03302572|randomized controlled trial|randomized controlled trial
978342|NCT03302533|distal humerus fracture|distal humerus fracture
978343|NCT03302533|total elbow arthroplasty|total elbow arthroplasty
978344|NCT03302533|elbow prosthesis|elbow prosthesis
978345|NCT03302533|delayed arthroplasty|delayed arthroplasty
978346|NCT03302533|revision surgery|revision surgery
978347|NCT03302494|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
978348|NCT03302494|Left Atrial Appendage|left atrial appendage
978349|NCT03302481|Obesity surgery|obesity surgery
978351|NCT03302481|mitochondria|mitochondria
978352|NCT03302481|steatosis|steatosis
978353|NCT03302455|insomia|insomia
978354|NCT03302455|eCBTI|ecbti
978355|NCT03302455|internet|internet
978356|NCT03302455|psychotherapy|psychotherapy
978357|NCT03302455|guided self-help|guided self-help
978358|NCT03302455|psychological treatment|psychological treatment
978359|NCT03302429|Alveolar cleft -Platelet rich fibrin- calcium phosphate|alveolar cleft -platelet rich fibrin- calcium phosphate
978360|NCT03302377|Feasibility|feasibility
978361|NCT03302338|Feeding intolerance|feeding intolerance
978362|NCT03302338|Simulated amniotic fluid like solution|simulated amniotic fluid like solution
978363|NCT03302338|Necrotizing enterocolitis|necrotizing enterocolitis
978364|NCT03302325|stage IV solid tumor|stage iv solid tumor
978365|NCT03302312|Posttraumatic Stress Disorder|posttraumatic stress disorder
978366|NCT03302312|Generalized Anxiety Disorder|generalized anxiety disorder
978367|NCT03302312|Depression|depression
978368|NCT03302312|Distress|distress
978369|NCT03302312|Alcohol Use|alcohol use
978370|NCT03302312|Pain|pain
978371|NCT03302299|Adherence|adherence
978372|NCT03302299|Hepatotoxicity|hepatotoxicity
978373|NCT03302299|Phosphatidtylethanol|phosphatidtylethanol
978374|NCT03302286|Heart-Lung Machine|heart-lung machine
978375|NCT03302286|Cardiopulmonary Bypass|cardiopulmonary bypass
978376|NCT03302273|stem cell therapy|stem cell therapy
978377|NCT03302273|dry eye disease|dry eye disease
978378|NCT03302260|maternal health|maternal health
978379|NCT03302260|pregnancy|pregnancy
978380|NCT03302260|pre-eclampsia|pre-eclampsia
978381|NCT03302234|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
978382|NCT03302234|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
978383|NCT03302234|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
978384|NCT03302234|PD1|pd1
978385|NCT03302234|PD-1|pd-1
978386|NCT03302234|PDL1|pdl1
978387|NCT03302234|PD-L1|pd-l1
978388|NCT03302234|CTLA4|ctla4
978389|NCT03302208|General Anesthesia|general anesthesia
978390|NCT03302195|Heparin|heparin
978391|NCT03302195|Allogeneic blood product transfusions|allogeneic blood product transfusions
978392|NCT03302195|Bleeding|bleeding
978393|NCT03302195|Cardiac surgery|cardiac surgery
978394|NCT03302195|Obesity|obesity
978395|NCT03302169|Prostate Cancer|prostate cancer
978396|NCT03302169|Urinary incontinence|urinary incontinence
978397|NCT03302169|Radical prostatectomy|radical prostatectomy
978398|NCT03302169|Rhabdosphincter|rhabdosphincter
978399|NCT03302169|Robotic Surgery|robotic surgery
978400|NCT03302156|Uterine cancer|uterine cancer
978401|NCT03302156|Ovarian cancer|ovarian cancer
978402|NCT03302156|Hysterectomy|hysterectomy
978403|NCT03302156|Salpingo-oophorectomy|salpingo-oophorectomy
978404|NCT03302143|Dental Implant|dental implant
978405|NCT03302143|Guided Bone Regeneration|guided bone regeneration
978406|NCT03302143|Contour Augmentation|contour augmentation
978407|NCT03302117|Wood smoke|wood smoke
978408|NCT03302117|Bronchoscopy|bronchoscopy
978409|NCT03302065|inhalation|inhalation
978410|NCT03302065|anticholinergic|anticholinergic
978411|NCT03302026|nicotine treatment|nicotine treatment
978412|NCT03302026|real time fMRI|real time fmri
978413|NCT03302013|Arthroplasty|arthroplasty
978414|NCT03302013|Knee|knee
978415|NCT03302013|Bicruciate retaining|bicruciate retaining
978416|NCT03302013|Vanguard XP|vanguard xp
978417|NCT03302013|Vanguard CR|vanguard cr
978418|NCT03302013|Surgery|surgery
978419|NCT03302013|Zimmer Biomet|zimmer biomet
978420|NCT03302013|Joint Replacement|joint replacement
978421|NCT03302013|Osteoarthritis|osteoarthritis
978422|NCT03302000|prematurity|prematurity
978423|NCT03302000|sensory stimulation|sensory stimulation
978424|NCT03302000|rehabilitation|rehabilitation
978425|NCT03302000|infant|infant
1657552|NCT00158041|Mucositis|mucositis
978426|NCT03301961|Circulating Tumor DNA|circulating tumor dna
978427|NCT03301961|Early diagnosis|early diagnosis
978428|NCT03301961|Surveillance|surveillance
978429|NCT03301961|Methylation|methylation
978430|NCT03301961|Somatic mutation|somatic mutation
978431|NCT03301935|Risk assessment|risk assessment
978432|NCT03301922|Occupational Health Services|occupational health services
978433|NCT03301922|Metacognitive therapy|metacognitive therapy
978434|NCT03301922|Work focused therapy|work focused therapy
978435|NCT03301922|Sick leave|sick leave
978437|NCT03301896|LHC165|lhc165
978438|NCT03301896|PDR001|pdr001
978439|NCT03301896|intratumoral injection|intratumoral injection
978440|NCT03301896|abscopal|abscopal
978441|NCT03301896|checkpoint inhibitor|checkpoint inhibitor
978442|NCT03301896|programmed cell death|programmed cell death
978443|NCT03301896|PD-1|pd-1
978444|NCT03301896|TLR-7|tlr-7
978445|NCT03301896|toll-like receptor|toll-like receptor
978446|NCT03301896|melanoma|melanoma
978447|NCT03301896|head and neck|head and neck
978448|NCT03301831|Parents|parents
978449|NCT03301831|Technology-Dependent Child|technology-dependent child
978450|NCT03301831|Resourcefulness|resourcefulness
978451|NCT03301792|Group prenatal care|group prenatal care
978452|NCT03301792|Diabetes|diabetes
978453|NCT03301779|Red Blood Cells|red blood cells
978454|NCT03301766|lidocaine|lidocaine
978455|NCT03301740|Ultrafiltration profiling|ultrafiltration profiling
978456|NCT03301740|Hemodialysis|hemodialysis
978458|NCT03301740|Cardiovascular outcomes|cardiovascular outcomes
978459|NCT03301740|Patient-reported outcomes|patient-reported outcomes
978460|NCT03301740|Crossover study design|crossover study design
978461|NCT03301740|End Stage Renal Disease|end stage renal disease
978462|NCT03301740|Ultrafiltration|ultrafiltration
978463|NCT03301740|Echocardiogram|echocardiogram
978464|NCT03301740|Blood pressure|blood pressure
978465|NCT03301740|Hypotension|hypotension
978466|NCT03301740|Symptoms|symptoms
978467|NCT03301714|motivational interviewing|motivational interviewing
978468|NCT03301714|elderly|elderly
978469|NCT03301714|oral health|oral health
978470|NCT03301688|PD-1 antibody|pd-1 antibody
978471|NCT03301688|phase 1 trial|phase 1 trial
978472|NCT03301675|Orange juice|orange juice
978473|NCT03301675|Healthy diet|healthy diet
978474|NCT03301675|Metabolic syndrome|metabolic syndrome
978475|NCT03301675|Cardiometabolic risk factors|cardiometabolic risk factors
978476|NCT03301675|Body composition|body composition
978477|NCT03301662|atrial fibrillation|atrial fibrillation
978478|NCT03301662|cryptogenic stroke|cryptogenic stroke
978479|NCT03301662|ECG screening|ecg screening
978480|NCT03301662|health-related quality of life|health-related quality of life
978481|NCT03301662|Short Form-36|short form-36
978482|NCT03301662|stroke|stroke
978483|NCT03301662|thumb-ECG|thumb-ecg
978484|NCT03301636|Melanoma, Metastaic Melanoma|melanoma, metastaic melanoma
978485|NCT03301623|Clinical Decision Support|clinical decision support
978486|NCT03301623|Patient Education Materials|patient education materials
978487|NCT03301623|Opioid Use|opioid use
978488|NCT03301623|Chronic Pain|chronic pain
978489|NCT03301610|Pain Education|pain education
978490|NCT03301610|Information Delivery|information delivery
978491|NCT03301610|Mobile Application|mobile application
978492|NCT03301597|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
978493|NCT03301597|Bacterial Infections|bacterial infections
978494|NCT03301597|Fungal Infections|fungal infections
978495|NCT03301584|Hip fracture|hip fracture
978496|NCT03301584|ADL|adl
978497|NCT03301584|patient participation|patient participation
978498|NCT03301584|functional balance|functional balance
978499|NCT03301584|physical performance|physical performance
978500|NCT03301571|Coronary artery bypass graft|coronary artery bypass graft
978501|NCT03301571|Echocardiography|echocardiography
978502|NCT03301545|Bariatric surgery|bariatric surgery
978503|NCT03301545|Obesity|obesity
978504|NCT03301545|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
978505|NCT03301545|Indigenous Population|indigenous population
978506|NCT03301545|Randomized Control Trial|randomized control trial
978507|NCT03301545|Glycoslyated Hemoglobin A1C|glycoslyated hemoglobin a1c
978508|NCT03301545|Anthropometric measurements|anthropometric measurements
978509|NCT03301545|Medication Use|medication use
978510|NCT03301532|G1D, glucose, transporter|g1d, glucose, transporter
978511|NCT03301506|PBC|pbc
978512|NCT03301506|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
978513|NCT03301467|C3 Glomerulonephritis|c3 glomerulonephritis
978514|NCT03301467|C3 glomerulopathy|c3 glomerulopathy
978515|NCT03301467|C3G|c3g
978516|NCT03301467|DDD|ddd
978517|NCT03301467|dense deposit disease|dense deposit disease
978518|NCT03301467|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
978519|NCT03301467|MPGN|mpgn
978520|NCT03301467|C3GN|c3gn
978521|NCT03301467|idiopathic MPGN|idiopathic mpgn
978522|NCT03301441|migraine|migraine
978523|NCT03301441|migraine with aura|migraine with aura
995215|NCT03194412|Humans|humans
978524|NCT03301441|migraine without aura|migraine without aura
978525|NCT03301441|ischemic stroke|ischemic stroke
978526|NCT03301441|Mismatch|mismatch
978527|NCT03301415|Asymptomatic|asymptomatic
978528|NCT03301415|Congenital CMV Infection|congenital cmv infection
978529|NCT03301415|Valganciclovir Therapy|valganciclovir therapy
978530|NCT03301337|Amino acid uptake|amino acid uptake
978531|NCT03301337|Aging|aging
978532|NCT03301337|Meat protein|meat protein
978533|NCT03301324|intubation|intubation
978534|NCT03301272|Parkinson, Botox, Tremor|parkinson, botox, tremor
978535|NCT03301259|Necrotic pulp|necrotic pulp
978536|NCT03301259|wave-one|wave-one
978537|NCT03301259|one-shape|one-shape
978538|NCT03301259|periapical lesion|periapical lesion
978539|NCT03301194|Hypertension|hypertension
978540|NCT03301194|Effectiveness|effectiveness
978541|NCT03301194|Cost Effectiveness|cost effectiveness
978542|NCT03301194|Cost|cost
978543|NCT03301194|Multi-disciplinary|multi-disciplinary
978544|NCT03301194|Risk Stratification|risk stratification
978545|NCT03301168|ALL|all
978546|NCT03301168|AML|aml
978547|NCT03301168|hematologic neoplasms|hematologic neoplasms
978548|NCT03301168|hematologic malignancies|hematologic malignancies
978549|NCT03301168|primary immune deficiences|primary immune deficiences
978550|NCT03301142|urinary stress incontinence|urinary stress incontinence
978551|NCT03301142|urinary incontinence,stress|urinary incontinence,stress
978552|NCT03301142|laser|laser
978553|NCT03301142|physiotherapy|physiotherapy
978554|NCT03301142|kinesiotherapy|kinesiotherapy
978555|NCT03301116|Exercise|exercise
978556|NCT03301116|Frail Elderly|frail elderly
978557|NCT03301116|Homebound Persons|homebound persons
978558|NCT03301116|Activities of Daily Living|activities of daily living
978559|NCT03301116|Mobility Limitation|mobility limitation
978560|NCT03301116|Home Care Services|home care services
978561|NCT03301116|Long-Term Care|long-term care
978562|NCT03301116|Dual MEDICAID MEDICARE Eligibility|dual medicaid medicare eligibility
978563|NCT03301103|Nutrition|nutrition
978564|NCT03301103|Gastroenteritis|gastroenteritis
978565|NCT03301103|Traveler's diarrhea|traveler's diarrhea
978566|NCT03301103|E. coli|e. coli
978567|NCT03301090|Adults|adults
978568|NCT03301090|Evaluate|evaluate
978569|NCT03301090|Healthy|healthy
978570|NCT03301090|Immunogenicity|immunogenicity
978571|NCT03301090|MERS-CoV|mers-cov
978572|NCT03301090|Pharmacokinetics|pharmacokinetics
978573|NCT03301090|Phase I|phase i
978574|NCT03301090|Placebo|placebo
978575|NCT03301090|REGN MERS|regn mers
978576|NCT03301090|Safety|safety
978577|NCT03301090|Tolerability|tolerability
978578|NCT03301077|children and adolescents|children and adolescents
978579|NCT03301077|mental health|mental health
978580|NCT03301077|epidemiology|epidemiology
978582|NCT03301064|alcohol, intervention, Latino, community|alcohol, intervention, latino, community
978585|NCT03301051|RNA Virus Infections|rna virus infections
978586|NCT03301051|Efficacy|efficacy
978587|NCT03301051|Immunologic|immunologic
978588|NCT03301051|Immunogenic Factors|immunogenic factors
978589|NCT03301051|Physiological Effects of Drug|physiological effects of drug
978590|NCT03301051|Virus Diseases|virus diseases
978591|NCT03301051|Orthomyxoviridae Infections|orthomyxoviridae infections
978592|NCT03301051|Infection|infection
978593|NCT03301038|hypercalcemia|hypercalcemia
978594|NCT03301038|nephrocalcinosis|nephrocalcinosis
978595|NCT03301038|CYP24A1|cyp24a1
978596|NCT03301038|hypercalciuria|hypercalciuria
978597|NCT03301025|Pregabalin, hypotensive anesthesia, blood loss, analgesia|pregabalin, hypotensive anesthesia, blood loss, analgesia
978598|NCT03301012|Adolescent|adolescent
978599|NCT03301012|Relapse Prevention|relapse prevention
978600|NCT03301012|Smartphone|smartphone
978601|NCT03301012|Recovery Support|recovery support
978602|NCT03300999|ginger tea|ginger tea
978603|NCT03300973|urodynamic study|urodynamic study
978604|NCT03300973|stress urinary incontinence|stress urinary incontinence
978605|NCT03300882|Study co-enrollment (CTOT-20 and CTOT-22)|study co-enrollment (ctot-20 and ctot-22)
978606|NCT03300882|cytomegalovirus (CMV)|cytomegalovirus (cmv)
978607|NCT03300882|CMV seropositive positive recipient|cmv seropositive positive recipient
978608|NCT03300882|CMV infection|cmv infection
978609|NCT03300882|CMV-specific immunity|cmv-specific immunity
978610|NCT03300882|immunologic monitoring|immunologic monitoring
978611|NCT03300869|Spinal Muscular Atrophy|spinal muscular atrophy
978612|NCT03300869|Natural History|natural history
978615|NCT03300843|Cell Therapy|cell therapy
978616|NCT03300843|Immunotherapy|immunotherapy
978617|NCT03300843|Gene Therapy|gene therapy
978618|NCT03300843|Vaccines|vaccines
978619|NCT03300830|Immunodeficiency|immunodeficiency
978620|NCT03300830|Viral-Associated Cancer|viral-associated cancer
978621|NCT03300830|Kaposi Sarcoma Herpes Virus|kaposi sarcoma herpes virus
978622|NCT03300830|Idiopathic Castleman Disease|idiopathic castleman disease
978623|NCT03300830|Endogenous Retroviruses|endogenous retroviruses
978624|NCT03300804|IBS|ibs
978625|NCT03300791|heart failure|heart failure
978626|NCT03300791|readmission|readmission
978627|NCT03300791|predictive models|predictive models
978628|NCT03300778|neurocognition|neurocognition
978629|NCT03300778|high-risk|high-risk
978630|NCT03300778|prognosis|prognosis
978631|NCT03300765|Thyroid Cancer|thyroid cancer
978632|NCT03300765|Apatinib|apatinib
978633|NCT03300765|Intensity modulated radiation therapy|intensity modulated radiation therapy
978634|NCT03300726|Synaptic injury|synaptic injury
978635|NCT03300713|Mass screening|mass screening
978636|NCT03300713|Pediatrician training|pediatrician training
978637|NCT03300648|coma|coma
978638|NCT03300648|pediatrics|pediatrics
978639|NCT03300583|Interstitial lung disease|interstitial lung disease
978640|NCT03300583|Self-Management|self-management
978641|NCT03300583|Service provision|service provision
978642|NCT03300531|Pure Platelet-rich Plasma|pure platelet-rich plasma
978643|NCT03300531|Randomized Controlled Trial|randomized controlled trial
978644|NCT03300518|GnRH antagonist|gnrh antagonist
978645|NCT03300518|Estrogen pretreatment|estrogen pretreatment
978646|NCT03300518|Poor response patient|poor response patient
978647|NCT03300492|Natural Killer cells|natural killer cells
978648|NCT03300492|NK cells|nk cells
978649|NCT03300492|Immunotherapy|immunotherapy
978650|NCT03300492|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
978651|NCT03300479|nontraumatic intracerebral hemorrhage|nontraumatic intracerebral hemorrhage
978652|NCT03300479|Cleviprex®|cleviprex®
978653|NCT03300479|Ebrantil®|ebrantil®
978654|NCT03300479|Systolic blood pressure|systolic blood pressure
978655|NCT03300466|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
978656|NCT03300427|Heart failure with reduced left ventricular ejection fraction|heart failure with reduced left ventricular ejection fraction
978658|NCT03300427|Cardiac dysfunction|cardiac dysfunction
978659|NCT03300427|Heart muscle dysfunction|heart muscle dysfunction
978660|NCT03300427|Left ventricular (LV) dilation|left ventricular (lv) dilation
978661|NCT03300427|Left ventricular hypertrophy|left ventricular hypertrophy
978662|NCT03300427|HF|hf
978663|NCT03300427|AHF|ahf
978664|NCT03300427|CHF|chf
978665|NCT03300427|CCF|ccf
978666|NCT03300427|acute heart failure|acute heart failure
978667|NCT03300427|chronic heart failure|chronic heart failure
978668|NCT03300427|congestive heart failure|congestive heart failure
978669|NCT03300427|congestive cardiac failure|congestive cardiac failure
978670|NCT03300388|Insulin resistance|insulin resistance
978671|NCT03300388|Exercise|exercise
978672|NCT03300388|Omega-3 fatty acids|omega-3 fatty acids
978673|NCT03300388|Adipose tissue|adipose tissue
978674|NCT03300349|Breast cancer|breast cancer
979568|NCT03294395|Fosfomycin|fosfomycin
978675|NCT03300349|Breast cancer-related lymphedema|breast cancer-related lymphedema
978676|NCT03300349|Shoulder injury|shoulder injury
978677|NCT03300349|Prevention|prevention
978678|NCT03300349|Educational activity|educational activity
978679|NCT03300349|Physiotherapy|physiotherapy
978680|NCT03300336|Walking|walking
978681|NCT03300336|Inpatients|inpatients
978682|NCT03300336|Veterans|veterans
978683|NCT03300336|Early Ambulation|early ambulation
978684|NCT03300336|Quality of Life|quality of life
978685|NCT03300323|peri-operative|peri-operative
978686|NCT03300323|fluid|fluid
978687|NCT03300323|microcirculation|microcirculation
978688|NCT03300297|Temporomandibular joint|temporomandibular joint
978689|NCT03300297|Physical Therapy|physical therapy
978690|NCT03300297|Cervical spine thrust joint manipulation|cervical spine thrust joint manipulation
978691|NCT03300297|therapy, exercise|therapy, exercise
978692|NCT03300297|Temporomandibular Disorders|temporomandibular disorders
978693|NCT03300284|Quality of Life|quality of life
978694|NCT03300284|Decision Making|decision making
978695|NCT03300284|17-382|17-382
978696|NCT03300219|telerehabilitation|telerehabilitation
978697|NCT03300219|occupational therapy|occupational therapy
978698|NCT03300219|rct|rct
978699|NCT03300219|participation|participation
978700|NCT03300219|quality of life|quality of life
978701|NCT03300219|intervention|intervention
978702|NCT03300219|older adults|older adults
978703|NCT03300206|Breast Biopsy|breast biopsy
978704|NCT03300206|Breast Biopsy Imaging|breast biopsy imaging
978705|NCT03300206|Stereotactic Biopsy|stereotactic biopsy
978706|NCT03300193|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
978707|NCT03300193|Tremor|tremor
978708|NCT03300193|Essential Tremor|essential tremor
978709|NCT03300193|Parkinson's Disease|parkinson's disease
978710|NCT03300154|Cardiovascular risk|cardiovascular risk
978711|NCT03300154|Behavioral economics|behavioral economics
978712|NCT03300154|Text messages|text messages
978713|NCT03300154|Financial incentives|financial incentives
978714|NCT03300141|Upper Extremity|upper extremity
978715|NCT03300141|Rehabilitation|rehabilitation
978716|NCT03300141|Arm|arm
978717|NCT03300141|Robotics|robotics
978718|NCT03300141|Stroke Rehabilitation|stroke rehabilitation
978719|NCT03300141|Virtual Reality Thearpy|virtual reality thearpy
978720|NCT03300128|autism|autism
978721|NCT03300128|parenting|parenting
978722|NCT03300128|Incredible Years|incredible years
978723|NCT03300102|personalised medicine|personalised medicine
978724|NCT03300050|live attenuated influenza vaccine|live attenuated influenza vaccine
978725|NCT03300050|inactivated influenza vaccine|inactivated influenza vaccine
978726|NCT03300024|Hemodialysis|hemodialysis
978727|NCT03300024|Arteriovenous|arteriovenous
978728|NCT03300024|Graft|graft
978729|NCT03300024|polytetrafluoroethylene|polytetrafluoroethylene
978730|NCT03300024|Bovine|bovine
978731|NCT03300011|ultrasonic|ultrasonic
978732|NCT03300011|chronic total occlusion|chronic total occlusion
978733|NCT03300011|heart function|heart function
978734|NCT03299985|Gastroesophageal reflux Disease|gastroesophageal reflux disease
978735|NCT03299985|Myofascial release|myofascial release
978736|NCT03299985|Diaphragm|diaphragm
978737|NCT03299972|Sarcopenia|sarcopenia
978738|NCT03299972|Resistance exercise|resistance exercise
978739|NCT03299972|Protein|protein
978740|NCT03299946|Nivolumab|nivolumab
978741|NCT03299946|Cabozantinib|cabozantinib
978742|NCT03299946|Neoadjuvant|neoadjuvant
978743|NCT03299946|Immunotherapy|immunotherapy
978744|NCT03299946|Liver Cancer|liver cancer
978745|NCT03299946|Borderline Resectable|borderline resectable
978746|NCT03299946|Advance Resectable|advance resectable
978747|NCT03299946|Neoplasms|neoplasms
978748|NCT03299946|Hepatocellular Carcinoma|hepatocellular carcinoma
978749|NCT03299946|HCC|hcc
978750|NCT03299946|Resection|resection
978751|NCT03299894|Sepsis|sepsis
978752|NCT03299894|Shock, septic|shock, septic
978753|NCT03299894|Emergency service, hospital|emergency service, hospital
978754|NCT03299894|Anti-infective agents|anti-infective agents
978755|NCT03299894|Outcome assessment|outcome assessment
978756|NCT03299868|Peripherally inserted central catheter|peripherally inserted central catheter
978858|NCT03299270|Functional recovery|functional recovery
978757|NCT03299868|Terminally ill cancer patients|terminally ill cancer patients
978758|NCT03299868|Palliative care|palliative care
978759|NCT03299855|oncogeriatric|oncogeriatric
978760|NCT03299855|MMS|mms
978761|NCT03299855|MoCA|moca
978762|NCT03299842|seizure|seizure
978763|NCT03299842|tonic clonic|tonic clonic
978764|NCT03299842|epilepsy|epilepsy
978765|NCT03299842|myoclonic|myoclonic
978766|NCT03299842|encephalopathy|encephalopathy
978767|NCT03299829|trientine|trientine
978768|NCT03299829|Wilson's disease|wilson's disease
978769|NCT03299816|Chronic Kidney Disease|chronic kidney disease
978770|NCT03299816|Hypertension|hypertension
978771|NCT03299816|Albuminuria|albuminuria
978772|NCT03299816|African Americans|african americans
978773|NCT03299790|Type 2 diabetes|type 2 diabetes
978774|NCT03299790|Diabetic cardiomyopathy|diabetic cardiomyopathy
978775|NCT03299790|Cardiac function|cardiac function
978776|NCT03299790|Exercise echocardiography|exercise echocardiography
978777|NCT03299790|Exercise training|exercise training
978778|NCT03299751|neonatal sepsis|neonatal sepsis
978779|NCT03299751|biomarker combination|biomarker combination
978780|NCT03299751|diagnostic|diagnostic
978781|NCT03299751|antibiotic use|antibiotic use
978782|NCT03299751|newborn|newborn
978783|NCT03299751|preterm neonates|preterm neonates
978784|NCT03299751|NICU|nicu
978785|NCT03299686|Asthma, allergic, eosinophilic, non-T2 high|asthma, allergic, eosinophilic, non-t2 high
978786|NCT03299647|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
978787|NCT03299647|behavioral deficits|behavioral deficits
978788|NCT03299647|cognitive function|cognitive function
978789|NCT03299647|polyunsaturated fatty acids|polyunsaturated fatty acids
978790|NCT03299647|visual memory|visual memory
978791|NCT03299582|paclitaxel|paclitaxel
978792|NCT03299582|neuropathy|neuropathy
978793|NCT03299582|hypothermia|hypothermia
978794|NCT03299582|cryocompression|cryocompression
978795|NCT03299556|Wearable Health Technology|wearable health technology
978796|NCT03299556|iPhone|iphone
978797|NCT03299556|Apple Watch|apple watch
978798|NCT03299556|Pain Medication|pain medication
978799|NCT03299543|beta-hydroxybutyrate|beta-hydroxybutyrate
978800|NCT03299543|breath acetone|breath acetone
978801|NCT03299530|Corneal Astigmatism|corneal astigmatism
978802|NCT03299530|Scheimpflug|scheimpflug
978803|NCT03299530|pupil size|pupil size
978804|NCT03299530|Toric|toric
978805|NCT03299517|lidocaine|lidocaine
978806|NCT03299517|amiodarone|amiodarone
978807|NCT03299491|Maternity Waiting Area|maternity waiting area
978808|NCT03299491|Ethiopia|ethiopia
978809|NCT03299491|Community Leader|community leader
978810|NCT03299491|Religious Leader|religious leader
978811|NCT03299491|Skilled birth attendance|skilled birth attendance
978812|NCT03299491|Postnatal care|postnatal care
978813|NCT03299491|Information, Education, Communication|information, education, communication
978814|NCT03299491|Safe Motherhood|safe motherhood
978815|NCT03299491|Health Extension Worker|health extension worker
978816|NCT03299491|Antenatal Care|antenatal care
978817|NCT03299465|bone marrow transplantation|bone marrow transplantation
978818|NCT03299465|yoga|yoga
978819|NCT03299452|ex vivo high-throughput drug screening assay|ex vivo high-throughput drug screening assay
978820|NCT03299426|Typhoid|typhoid
1657553|NCT00158041|Nausea|nausea
978821|NCT03299426|Typhoid in Malawi|typhoid in malawi
978822|NCT03299426|Typhoid Vaccine|typhoid vaccine
978823|NCT03299413|Inflammatory Bowel Disease|inflammatory bowel disease
978824|NCT03299413|Mesenchymal stem cells|mesenchymal stem cells
978825|NCT03299413|Ulcerative colitis|ulcerative colitis
978826|NCT03299413|Neutrophils|neutrophils
978827|NCT03299400|IOP|iop
978828|NCT03299387|urinary tract|urinary tract
978829|NCT03299387|infection|infection
978830|NCT03299387|recurrent|recurrent
978831|NCT03299387|women|women
978832|NCT03299374|Pilates|pilates
978833|NCT03299374|Balance|balance
978834|NCT03299374|Falls|falls
978835|NCT03299374|Older people|older people
978836|NCT03299361|Carpal tunnel syndrome|carpal tunnel syndrome
978837|NCT03299361|Corticosteroid|corticosteroid
978838|NCT03299361|Diffusion tensor imaging|diffusion tensor imaging
978839|NCT03299361|Injection|injection
978840|NCT03299361|Magnetic resonance image|magnetic resonance image
978841|NCT03299361|Ultrasound|ultrasound
978842|NCT03299348|Psychological Mechanisms|psychological mechanisms
979097|NCT03297385|Enzalutamide|enzalutamide
978843|NCT03299348|Social-Cognitive Mechanisms|social-cognitive mechanisms
978844|NCT03299322|Bronchial Asthma，TCM，microorganism|bronchial asthma，tcm，microorganism
978845|NCT03299309|Glioma|glioma
978846|NCT03299309|Medulloblastoma|medulloblastoma
978847|NCT03299309|PRiME|prime
978848|NCT03299309|Pro00079843|pro00079843
978849|NCT03299309|Thompson|thompson
978850|NCT03299309|Pediatric|pediatric
978851|NCT03299296|Thromboprophylaxis|thromboprophylaxis
978852|NCT03299296|orthopedic|orthopedic
978853|NCT03299296|rivaroxaban|rivaroxaban
978854|NCT03299296|enoxaparin|enoxaparin
978855|NCT03299270|Surgery|surgery
978856|NCT03299270|Solid malignancy|solid malignancy
978857|NCT03299270|Elderly|elderly
978859|NCT03299257|OSA|osa
978864|NCT03299231|acute exacerbation|acute exacerbation
978865|NCT03299231|OPEP|opep
978866|NCT03299218|Specialized Nutritious Food (SNF)|specialized nutritious food (snf)
978867|NCT03299218|Behaviour change communication (BCC)|behaviour change communication (bcc)
978868|NCT03299218|Cash-based transfers|cash-based transfers
978869|NCT03299140|Bipolar disorder|bipolar disorder
978870|NCT03299140|Children|children
978871|NCT03299140|Family Focused Therapy|family focused therapy
978872|NCT03299140|CBT|cbt
978873|NCT03299114|Neuropathic Pain|neuropathic pain
978874|NCT03299114|Whirlpool|whirlpool
978875|NCT03299114|Osteoarthritis|osteoarthritis
978876|NCT03299114|Sleep|sleep
978877|NCT03299101|Frailty|frailty
978878|NCT03299101|Prehabilitation|prehabilitation
978879|NCT03299101|Exercise therapy|exercise therapy
978881|NCT03299101|Nutrition support|nutrition support
978882|NCT03299075|External eating|external eating
978883|NCT03299075|Technology|technology
978884|NCT03299075|Photography|photography
978885|NCT03299075|Social media|social media
978886|NCT03299049|Long acting Cabotegravir|long acting cabotegravir
978887|NCT03299049|Safety|safety
978888|NCT03299049|HIV-1|hiv-1
978889|NCT03299049|Efficacy|efficacy
978890|NCT03299049|Tolerability|tolerability
978891|NCT03299049|ATLAS-2M|atlas-2m
978892|NCT03299049|Long acting Rilpivirine|long acting rilpivirine
978893|NCT03299036|Hepatoma|hepatoma
978894|NCT03299036|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
978895|NCT03299036|Microsphere|microsphere
978896|NCT03299036|Doxorubicin|doxorubicin
978897|NCT03299023|Obstructive Sleep Apnea|obstructive sleep apnea
978898|NCT03299023|Orthodontics|orthodontics
978899|NCT03299023|Tooth Movement|tooth movement
978900|NCT03299023|Medibyte|medibyte
978901|NCT03299023|Apnea|apnea
978902|NCT03299023|Hypopnea|hypopnea
978903|NCT03299023|Sleep|sleep
978904|NCT03299023|Disturbed Breathing|disturbed breathing
978905|NCT03299010|Diabetes Mellitus|diabetes mellitus
978906|NCT03299010|Risk|risk
978907|NCT03299010|Complications|complications
978908|NCT03299010|Mortality|mortality
978909|NCT03299010|Cardiovascular Diseases|cardiovascular diseases
978910|NCT03299010|Chinese|chinese
978911|NCT03299010|Prediction|prediction
978912|NCT03298997|Hemorrhoids|hemorrhoids
978913|NCT03298997|Ligation|ligation
978914|NCT03298997|Ultrasound|ultrasound
978915|NCT03298997|Prospective|prospective
978916|NCT03298997|Randomized Controlled Trial|randomized controlled trial
978917|NCT03298945|colonoscopy|colonoscopy
978918|NCT03298945|colorectal cancer|colorectal cancer
978919|NCT03298945|bowel preparation regimen|bowel preparation regimen
978920|NCT03298945|pragmatic trial|pragmatic trial
978921|NCT03298932|Transesophageal echography|transesophageal echography
978922|NCT03298932|Perioperative cardiac surgery|perioperative cardiac surgery
978923|NCT03298932|Aortic valve replacement|aortic valve replacement
978924|NCT03298932|2D strain of right ventricle|2d strain of right ventricle
978925|NCT03298893|cervical cancer|cervical cancer
978926|NCT03298893|nivolumab|nivolumab
978927|NCT03298893|cisplatin|cisplatin
978928|NCT03298893|radiotherapy|radiotherapy
978929|NCT03298880|Valsalva manoeuvre|valsalva manoeuvre
978930|NCT03298880|Vagal tone|vagal tone
978931|NCT03298880|Modified Valsalva|modified valsalva
978932|NCT03298880|Valsalva Assist Device|valsalva assist device
978933|NCT03298867|Proptosis|proptosis
978934|NCT03298867|Human monoclonal antibody|human monoclonal antibody
978935|NCT03298867|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
978936|NCT03298867|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
978937|NCT03298867|Hyperthyroidism|hyperthyroidism
978938|NCT03298867|Autoimmune Thyroid Disease|autoimmune thyroid disease
978939|NCT03298802|readmission|readmission
978940|NCT03298802|triage visit for pregnancy related hypertension|triage visit for pregnancy related hypertension
978941|NCT03298802|hydrochlorothiazide|hydrochlorothiazide
978942|NCT03298789|static stretching|static stretching
978943|NCT03298789|muscle power|muscle power
978944|NCT03298789|countermovement jump|countermovement jump
978945|NCT03298789|dynamometry|dynamometry
978946|NCT03298789|warm up|warm up
978947|NCT03298789|force plate|force plate
978948|NCT03298750|Mechanical Laboratory Ovarian Stimulation Poor responders|mechanical laboratory ovarian stimulation poor responders
978949|NCT03298711|Central Nervous System Sensitization|central nervous system sensitization
978950|NCT03298711|Neuropeptides|neuropeptides
978951|NCT03298698|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
978952|NCT03298698|Minimal change disease|minimal change disease
978953|NCT03298698|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
978954|NCT03298698|Rituximab|rituximab
978955|NCT03298698|Randomized clinical trial|randomized clinical trial
978956|NCT03298685|transition|transition
978957|NCT03298685|care program|care program
978958|NCT03298685|needs|needs
978959|NCT03298672|Alzheimer's Disease|alzheimer's disease
978960|NCT03298672|Dementia|dementia
978961|NCT03298672|Brain Diseases|brain diseases
978962|NCT03298672|Central Nervous System Diseases|central nervous system diseases
978963|NCT03298672|Cognition|cognition
978964|NCT03298672|Neurodegenerative Diseases|neurodegenerative diseases
978965|NCT03298672|Neurocognitive Disorders|neurocognitive disorders
978966|NCT03298672|Mental Disorders|mental disorders
978967|NCT03298633|Male infertility|male infertility
978968|NCT03298633|In vitro fertilization|in vitro fertilization
978969|NCT03298633|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
978970|NCT03298620|nursing home|nursing home
978971|NCT03298620|gerodontology|gerodontology
978972|NCT03298620|oral hygiene|oral hygiene
978973|NCT03298568|food intolerance|food intolerance
978974|NCT03298568|histamine intolerance|histamine intolerance
978975|NCT03298568|diamine oxidase|diamine oxidase
978976|NCT03298568|DAO|dao
978977|NCT03298568|DAOsin|daosin
978978|NCT03298529|Glycemic index|glycemic index
978979|NCT03298529|Insulinemic index|insulinemic index
978980|NCT03298529|Traditional egg pasta|traditional egg pasta
978981|NCT03298503|Parkinson's disease|parkinson's disease
978982|NCT03298503|posture balance|posture balance
978983|NCT03298503|attention|attention
978984|NCT03298490|validity|validity
978985|NCT03298490|reliability|reliability
978986|NCT03298490|low back pain|low back pain
978987|NCT03298451|Hepatocellular Carcinoma Non-Resectable|hepatocellular carcinoma non-resectable
978988|NCT03298399|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
978989|NCT03298399|Haploidentical|haploidentical
978990|NCT03298399|Mesenchymal stromal cells|mesenchymal stromal cells
978991|NCT03298386|Elderly|elderly
978992|NCT03298386|Multimorbidity|multimorbidity
978993|NCT03298386|Polypharmacy|polypharmacy
978994|NCT03298373|Healthy Men|healthy men
978995|NCT03298373|Male Contraception|male contraception
978996|NCT03298373|Androgen|androgen
978997|NCT03298360|HIV cell reservoir|hiv cell reservoir
978998|NCT03298295|Diabetes Mellitus|diabetes mellitus
978999|NCT03298295|Insulin Pump Therapy|insulin pump therapy
979000|NCT03298295|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
979001|NCT03298256|AIS|ais
979002|NCT03298243|stroke|stroke
979003|NCT03298243|proprioception|proprioception
979004|NCT03298243|sensory substitution|sensory substitution
979005|NCT03298217|Inspiratory flow|inspiratory flow
979006|NCT03298217|High flow nasal cannula, spirometry|high flow nasal cannula, spirometry
979007|NCT03298217|spirometry|spirometry
979008|NCT03298217|physiologic study|physiologic study
979009|NCT03298217|Bronchiolitis patients sverity score mWCAS/ 3-5.|bronchiolitis patients sverity score mwcas/ 3-5.
979010|NCT03298178|TAVR|tavr
979011|NCT03298178|TAVI|tavi
979012|NCT03298178|SAVR|savr
979013|NCT03298152|lithium disilicate endocrowns|lithium disilicate endocrowns
979014|NCT03298152|cerasmart endocrowns|cerasmart endocrowns
979015|NCT03298126|Radial artery occlusion|radial artery occlusion
979016|NCT03298126|TR band|tr band
979017|NCT03298126|Transradial catheterization|transradial catheterization
979018|NCT03298087|oligometastatic|oligometastatic
979019|NCT03298087|SBRT|sbrt
979020|NCT03298087|abiraterone|abiraterone
979021|NCT03298087|apalutamide|apalutamide
979022|NCT03298074|platinum-resistant|platinum-resistant
979023|NCT03298074|recurrent|recurrent
979024|NCT03298061|Eosinophilic Granulomatosis|eosinophilic granulomatosis
979025|NCT03298061|MEA115921|mea115921
979026|NCT03298061|Polyangiitis|polyangiitis
979027|NCT03298061|Long-term access program|long-term access program
979028|NCT03298061|mepolizumab|mepolizumab
979029|NCT03298022|Ulcerative Colitis|ulcerative colitis
979030|NCT03297983|M7583|m7583
979031|NCT03297983|Healthy Subjects|healthy subjects
979032|NCT03297983|Cross-over|cross-over
979033|NCT03297931|Pulse|pulse
979034|NCT03297931|Snack|snack
979035|NCT03297931|Post-prandial glycemia|post-prandial glycemia
979036|NCT03297931|Appetite|appetite
979037|NCT03297931|Food intake|food intake
979038|NCT03297931|Young adults|young adults
979039|NCT03297931|Satiety|satiety
979040|NCT03297905|Chronic Pain|chronic pain
979041|NCT03297905|Military|military
979042|NCT03297853|Descriptive|descriptive
979043|NCT03297853|Support|support
979044|NCT03297853|Retrospective|retrospective
979045|NCT03297853|survey|survey
979046|NCT03297827|diagnosis|diagnosis
979047|NCT03297827|inflammatory biomarkers|inflammatory biomarkers
979048|NCT03297827|cytokines|cytokines
979049|NCT03297827|interleukin|interleukin
979050|NCT03297827|interferons|interferons
979051|NCT03297814|Peripheral arterial disease|peripheral arterial disease
979052|NCT03297814|Platelet lysate|platelet lysate
979053|NCT03297788|SCLC|sclc
979054|NCT03297788|Brain Metastases|brain metastases
979055|NCT03297788|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
979056|NCT03297788|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
979057|NCT03297775|Rheumatoid Arthritis|rheumatoid arthritis
979059|NCT03297775|Interstitial Lung Disease|interstitial lung disease
979060|NCT03297775|ILD|ild
979061|NCT03297775|lung disease|lung disease
979062|NCT03297775|connective tissue disease|connective tissue disease
979063|NCT03297775|CTD|ctd
979064|NCT03297775|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
979065|NCT03297775|IPF|ipf
979066|NCT03297775|airways disease|airways disease
979067|NCT03297593|renal cell carcinoma|renal cell carcinoma
979068|NCT03297593|Nivolumab|nivolumab
979069|NCT03297593|Ipilimumab|ipilimumab
979070|NCT03297593|metastatic renal cell carcinoma|metastatic renal cell carcinoma
979071|NCT03297593|immunotherapy|immunotherapy
979072|NCT03297593|Opdivo|opdivo
979073|NCT03297593|Yervoy|yervoy
979074|NCT03297567|Elderly|elderly
979075|NCT03297567|Hospitalization|hospitalization
979076|NCT03297567|Immobilization|immobilization
979077|NCT03297567|Exercise|exercise
979078|NCT03297567|Accelerometry|accelerometry
979079|NCT03297515|Omega-3|omega-3
979080|NCT03297515|dry AMD|dry amd
979081|NCT03297515|Stargardt|stargardt
979082|NCT03297515|visual acuity|visual acuity
979083|NCT03297424|PLX2853|plx2853
979569|NCT03294395|Ertapenem|ertapenem
979084|NCT03297424|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
979085|NCT03297424|Uveal Melanoma|uveal melanoma
979086|NCT03297424|Ovarian Clear Cell Carcinoma|ovarian clear cell carcinoma
979087|NCT03297424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
979088|NCT03297424|Advanced Malignancies|advanced malignancies
979089|NCT03297424|Solid Tumor|solid tumor
979090|NCT03297424|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
979091|NCT03297424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
979092|NCT03297424|ARID1A|arid1a
979093|NCT03297411|electroconvulsive therapy|electroconvulsive therapy
979094|NCT03297411|computer modelling|computer modelling
979095|NCT03297385|Prostate Cancer|prostate cancer
979096|NCT03297385|Androgen Receptor Genomics|androgen receptor genomics
979098|NCT03297385|Prostatectomy|prostatectomy
979099|NCT03297385|Neoadjuvant androgen ablation|neoadjuvant androgen ablation
979100|NCT03297372|Intraocular lens|intraocular lens
979101|NCT03297372|monofocal|monofocal
979102|NCT03297372|cataract|cataract
979104|NCT03297359|Dalteparin|dalteparin
979105|NCT03297359|Fragmin|fragmin
979106|NCT03297346|radiotherapy|radiotherapy
979107|NCT03297346|cardiovascular changes|cardiovascular changes
979108|NCT03297346|cardiac imaging|cardiac imaging
979109|NCT03297346|circulating biomarkers|circulating biomarkers
979110|NCT03297346|dosimetry|dosimetry
979111|NCT03297333|Obesity|obesity
979112|NCT03297333|Exercise|exercise
979113|NCT03297333|Cardiac Fat|cardiac fat
979114|NCT03297333|Cardiac Magnetic Resonance|cardiac magnetic resonance
979115|NCT03297333|Vascular Health|vascular health
979116|NCT03297320|Advance Care Planning, End of life, CPR|advance care planning, end of life, cpr
979117|NCT03297294|Painful diabetic neuropathy|painful diabetic neuropathy
979118|NCT03297294|Neuropathic pain|neuropathic pain
979119|NCT03297294|Angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
979120|NCT03297281|Photovaporization|photovaporization
979121|NCT03297281|Laser|laser
979122|NCT03297281|Benign prostatic hyperplasia|benign prostatic hyperplasia
979123|NCT03297281|Oral anticoagulation|oral anticoagulation
979124|NCT03297281|Complication|complication
979125|NCT03297268|Dementia Caregiver Empowerment|dementia caregiver empowerment
979126|NCT03297268|Caregiver Burden|caregiver burden
979127|NCT03297268|Agitation in Dementia|agitation in dementia
979128|NCT03297268|Environmental Sensors|environmental sensors
979129|NCT03297268|Wearable Technology|wearable technology
979130|NCT03297255|Primary Liver Cancer; Cohort Study|primary liver cancer; cohort study
979131|NCT03297242|Helicobacter Pylori eradication|helicobacter pylori eradication
979132|NCT03297229|Peer mentoring|peer mentoring
979133|NCT03297229|Self-monitoring|self-monitoring
979134|NCT03297229|Behavioral economics|behavioral economics
979135|NCT03297229|Hypertension|hypertension
979136|NCT03297216|PreTerm Birth|preterm birth
979137|NCT03297216|HIV-1-infection|hiv-1-infection
979138|NCT03297216|Antiretroviral Treatment|antiretroviral treatment
979139|NCT03297164|acute myocardial infarction|acute myocardial infarction
979140|NCT03297164|heart failure|heart failure
979141|NCT03297164|optimized treatment|optimized treatment
979142|NCT03297151|Resistance Training|resistance training
979143|NCT03297151|Muscle Function|muscle function
979144|NCT03297151|Protein Synthesis|protein synthesis
979145|NCT03297125|Optune Therapy|optune therapy
979146|NCT03297125|MRI|mri
979147|NCT03297125|NovoCure-TTF-200A|novocure-ttf-200a
979148|NCT03297099|robot-assisted laparosocpic|robot-assisted laparosocpic
979149|NCT03297099|hepatectomy|hepatectomy
979150|NCT03297086|multifocal intraocular lens, angle kappa, presbyopia|multifocal intraocular lens, angle kappa, presbyopia
979151|NCT03297060|Alcohol Screening|alcohol screening
979152|NCT03297047|cast, fracture, immobilization, displacement, child|cast, fracture, immobilization, displacement, child
979153|NCT03297034|Late effects|late effects
979154|NCT03297034|Childhood cancer survivors|childhood cancer survivors
979155|NCT03297034|Swiss Childhood Cancer Registry|swiss childhood cancer registry
979156|NCT03297034|Europe|europe
979157|NCT03297021|ambulatory surgery|ambulatory surgery
979158|NCT03297021|post-operative nausea and vomiting|post-operative nausea and vomiting
979159|NCT03297021|general anesthesia|general anesthesia
979160|NCT03297008|healthy|healthy
979161|NCT03297008|saliva|saliva
979162|NCT03297008|stool|stool
979163|NCT03297008|biomarkers|biomarkers
979164|NCT03297008|Respiratory Syncytial Virus|respiratory syncytial virus
979166|NCT03297008|Immunoglobulin|immunoglobulin
979167|NCT03297008|Antibody|antibody
979168|NCT03296995|glucose|glucose
979169|NCT03296995|systemic lupus erythematosus|systemic lupus erythematosus
979170|NCT03296982|Whole blood clotting time|whole blood clotting time
979171|NCT03296956|Postpartum|postpartum
979172|NCT03296956|Dietary Supplement|dietary supplement
979173|NCT03296956|Mood Symptoms|mood symptoms
979174|NCT03296930|Direct Acting Antiviral Agents (DAAs)|direct acting antiviral agents (daas)
979175|NCT03296904|Lower limb amputation|lower limb amputation
979176|NCT03296904|Wearable robotics|wearable robotics
979177|NCT03296891|Ultrasonography|ultrasonography
979178|NCT03296891|Point-of-care ultrasound|point-of-care ultrasound
979179|NCT03296891|Resuscitation|resuscitation
979180|NCT03296891|Critical Care|critical care
979181|NCT03296878|low income|low income
979183|NCT03296865|functionality|functionality
979184|NCT03296865|rehabilitation|rehabilitation
979185|NCT03296865|muscle activity|muscle activity
979186|NCT03296865|electromyography|electromyography
979187|NCT03296839|colorectal cancer|colorectal cancer
979188|NCT03296839|liver metastases|liver metastases
979189|NCT03296839|SBRT|sbrt
979190|NCT03296813|loop diuretic|loop diuretic
979191|NCT03296787|Drug therapy|drug therapy
979192|NCT03296748|asymptomatic cystocele.|asymptomatic cystocele.
979193|NCT03296748|stress urinary incontinence|stress urinary incontinence
979194|NCT03296696|Phase 1|phase 1
979195|NCT03296696|EGFRvIII-positive glioblastoma|egfrviii-positive glioblastoma
979196|NCT03296696|safety and tolerability|safety and tolerability
979197|NCT03296696|AMG 596|amg 596
979198|NCT03296670|STEMI|stemi
979199|NCT03296670|CSFP|csfp
979200|NCT03296670|Alprostadil|alprostadil
979201|NCT03296670|targeted perfusion microcatheter|targeted perfusion microcatheter
979202|NCT03296631|microbiome|microbiome
979203|NCT03296631|gut|gut
979204|NCT03296631|infant gut|infant gut
979205|NCT03296631|phages|phages
979206|NCT03296631|phages-bacteria interactions|phages-bacteria interactions
979207|NCT03296631|microbiome development|microbiome development
979208|NCT03296618|chronic stroke|chronic stroke
979209|NCT03296618|neural stem cell|neural stem cell
979210|NCT03296618|transplant|transplant
979211|NCT03296618|paralysis|paralysis
979212|NCT03296605|Obesity|obesity
979213|NCT03296592|myelopathy|myelopathy
979214|NCT03296592|diffusion MRI|diffusion mri
979215|NCT03296592|spinal cord injury|spinal cord injury
979216|NCT03296592|spinal cord compression|spinal cord compression
979217|NCT03296592|spondylosis|spondylosis
979218|NCT03296592|cervical|cervical
979219|NCT03296540|STEMI|stemi
979220|NCT03296501|ALS|als
979221|NCT03296501|ADRC|adrc
996119|NCT03188692|Hib|hib
979222|NCT03296501|adipose derived regenerative cells|adipose derived regenerative cells
979223|NCT03296501|intraspinal transplantation|intraspinal transplantation
979224|NCT03296501|mesenchymal cells|mesenchymal cells
979225|NCT03296488|post-laparotomy wound pain|post-laparotomy wound pain
979226|NCT03296488|NALDEBAIN (150 mg Nalbuphine Sebacate)|naldebain (150 mg nalbuphine sebacate)
979227|NCT03296488|PCA (patient-control-ed alagesia)|pca (patient-control-ed alagesia)
979228|NCT03296449|Hypoxia|hypoxia
979229|NCT03296449|High-Frequency Jet Ventilation|high-frequency jet ventilation
979230|NCT03296449|Continuous Positive Airway Pressure|continuous positive airway pressure
979231|NCT03296423|BCG vaccination|bcg vaccination
979232|NCT03296410|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
979233|NCT03296410|immunogenicity|immunogenicity
979234|NCT03296410|safety|safety
979235|NCT03296397|Genital warts|genital warts
979236|NCT03296397|HPV vaccine|hpv vaccine
979237|NCT03296397|Relapse|relapse
979238|NCT03296384|schizophrenia|schizophrenia
979239|NCT03296384|environmental factors|environmental factors
979240|NCT03296358|Acute urticaria|acute urticaria
979241|NCT03296358|Emergency department|emergency department
979242|NCT03296358|Acute allergic syndrome|acute allergic syndrome
979243|NCT03296358|Corticosteroid|corticosteroid
979244|NCT03296358|H1-Antihistamines|h1-antihistamines
979245|NCT03296358|Chronic urticaria|chronic urticaria
979246|NCT03296345|Ketamine|ketamine
979247|NCT03296345|Sickle Cell Disease|sickle cell disease
979248|NCT03296345|Vaso-Occlusive Crisis|vaso-occlusive crisis
979249|NCT03296332|Evaluation|evaluation
979250|NCT03296332|Population-based Intervention|population-based intervention
979251|NCT03296332|Salt intake|salt intake
979252|NCT03296332|Hypertension|hypertension
979253|NCT03296306|urothelial carcinoma|urothelial carcinoma
979254|NCT03296306|cisplatin|cisplatin
979255|NCT03296306|first-line chemotherapy|first-line chemotherapy
979256|NCT03296293|Positive end-expiratory pressure(PEEP)|positive end-expiratory pressure(peep)
979257|NCT03296293|intracranial pressure(ICP)|intracranial pressure(icp)
979258|NCT03296293|central venous pressure(CVP)|central venous pressure(cvp)
979259|NCT03296293|intracranial central venous pressure difference(IVPD)|intracranial central venous pressure difference(ivpd)
979260|NCT03296280|ultrasound|ultrasound
979261|NCT03296280|ultrasonography|ultrasonography
979262|NCT03296280|point of care|point of care
979263|NCT03296280|Doppler ultrasound|doppler ultrasound
979264|NCT03296280|ultrasound imaging|ultrasound imaging
979265|NCT03296280|diagnostic ultrasound|diagnostic ultrasound
979266|NCT03296267|bile acid|bile acid
979267|NCT03296267|bacterial uptake|bacterial uptake
979268|NCT03296254|mindfulness|mindfulness
979269|NCT03296254|meditation|meditation
979270|NCT03296254|stress|stress
979271|NCT03296254|burn-out|burn-out
979272|NCT03296254|personality|personality
979273|NCT03296254|randomized controlled trial|randomized controlled trial
979274|NCT03296241|stress urinary incontinence|stress urinary incontinence
979275|NCT03296241|sexual dysfunction|sexual dysfunction
979276|NCT03296241|laser|laser
979277|NCT03296241|Er:YAG|er:yag
979278|NCT03296241|vaginal laser|vaginal laser
979279|NCT03296241|vaginal tightening|vaginal tightening
979280|NCT03296241|non-ablative|non-ablative
979281|NCT03296241|minimally-invasive|minimally-invasive
979282|NCT03296228|AIS|ais
979283|NCT03296202|HIV|hiv
979284|NCT03296202|cohort studies|cohort studies
979285|NCT03296202|antiretroviral treatment|antiretroviral treatment
979286|NCT03296189|ureteroscopy|ureteroscopy
979287|NCT03296189|ureteric stent|ureteric stent
979288|NCT03296189|intraluminal|intraluminal
979289|NCT03296189|local anaesthetic/anesthetic|local anaesthetic/anesthetic
979290|NCT03296189|steroid/glucocorticoid|steroid/glucocorticoid
979291|NCT03296150|therapeutic educational program|therapeutic educational program
979292|NCT03296150|adherence|adherence
979293|NCT03296150|quality of life|quality of life
979294|NCT03296150|elderly|elderly
979295|NCT03296150|cancer|cancer
979296|NCT03296137|immune therapy|immune therapy
979297|NCT03296137|TILs|tils
979298|NCT03296137|Adoptive cell therapy|adoptive cell therapy
979299|NCT03296124|Prostate Cancer|prostate cancer
979300|NCT03296124|Proton Radiation|proton radiation
979301|NCT03296098|Contraception|contraception
979302|NCT03296098|Healthy Female|healthy female
979303|NCT03296098|Progestin|progestin
979304|NCT03296098|ulipristal acetate|ulipristal acetate
979305|NCT03296033|enoxaparin|enoxaparin
979306|NCT03296033|thromboembolism|thromboembolism
979307|NCT03296033|coagulation|coagulation
979308|NCT03296033|factor Xa|factor xa
979309|NCT03295994|arthroscopy|arthroscopy
979310|NCT03295994|physical therapy|physical therapy
979311|NCT03295994|rehabilitation|rehabilitation
979312|NCT03295994|surgery|surgery
979313|NCT03295994|rotator cuff tear|rotator cuff tear
979314|NCT03295929|3D model|3d model
979315|NCT03295929|Inner ear|inner ear
979316|NCT03295903|Vascular function|vascular function
979317|NCT03295903|Cannabidiol supplementation|cannabidiol supplementation
1657554|NCT00158041|Hypotension|hypotension
979318|NCT03295890|myofascial trigger point, tinnitus, dry needling|myofascial trigger point, tinnitus, dry needling
979319|NCT03295864|Arnold-Chiari Malformation, Type 1|arnold-chiari malformation, type 1
979320|NCT03295864|Multifrequency tympanometry|multifrequency tympanometry
979321|NCT03295864|Inner ear pressure|inner ear pressure
979322|NCT03295851|Anemia|anemia
979323|NCT03295851|Pre-operative|pre-operative
979324|NCT03295851|Intravenous Iron|intravenous iron
979325|NCT03295851|Ferric carboxymaltose|ferric carboxymaltose
979326|NCT03295851|abdominal surgery|abdominal surgery
979327|NCT03295838|Borderline personality disorder|borderline personality disorder
979328|NCT03295838|Psychotherapy|psychotherapy
979329|NCT03295838|Treatment outcome|treatment outcome
979330|NCT03295838|Pragmatic clinical trials as topic|pragmatic clinical trials as topic
979331|NCT03295838|Mentalization-based treatment|mentalization-based treatment
979332|NCT03295838|Alexithymia|alexithymia
979333|NCT03295825|Heparin binding protein|heparin binding protein
979334|NCT03295825|Mortality|mortality
979335|NCT03295786|Parkinson|parkinson
979336|NCT03295786|CDNF|cdnf
979337|NCT03295786|Drug Delivery System|drug delivery system
979338|NCT03295786|Intracerebral|intracerebral
979339|NCT03295773|Ischemic Stroke|ischemic stroke
979340|NCT03295773|3D-rotational angiography|3d-rotational angiography
979341|NCT03295773|Morphology|morphology
979342|NCT03295773|Atherosclerosis|atherosclerosis
979343|NCT03295721|bunion|bunion
979344|NCT03295721|bunionectomy|bunionectomy
979345|NCT03295721|bunion surgery|bunion surgery
979346|NCT03295721|postoperative pain|postoperative pain
979347|NCT03295708|Major depressive disorder,Fish Oil|major depressive disorder,fish oil
979348|NCT03295695|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
979349|NCT03295695|Tumor blood perfusion|tumor blood perfusion
979350|NCT03295630|Accelerometry|accelerometry
979351|NCT03295630|Validity|validity
979352|NCT03295617|spinal thoracic herniation|spinal thoracic herniation
979354|NCT03295617|endoscopic approach|endoscopic approach
979355|NCT03295617|thoracic spine|thoracic spine
979356|NCT03295617|minimal invasive access|minimal invasive access
979357|NCT03295604|Gingival recession|gingival recession
979358|NCT03295604|Subepithelial connective tissue grafts|subepithelial connective tissue grafts
979359|NCT03295604|CAD/CAM|cad/cam
979360|NCT03295591|Metastatic colorectal cancer|metastatic colorectal cancer
979361|NCT03295591|Liver resection|liver resection
979362|NCT03295591|Circulating tumor cells|circulating tumor cells
979363|NCT03295578|employees|employees
979364|NCT03295578|continuous glucose monitoring|continuous glucose monitoring
979365|NCT03295578|personalized feedback|personalized feedback
979366|NCT03295578|cognition|cognition
979367|NCT03295578|wellbeing|wellbeing
979368|NCT03295565|Sequencing|sequencing
979369|NCT03295565|cabazitaxel|cabazitaxel
979370|NCT03295565|abiraterone|abiraterone
979371|NCT03295565|enzalutamide|enzalutamide
979372|NCT03295565|clinical benefit rate|clinical benefit rate
979373|NCT03295565|docetaxel|docetaxel
979374|NCT03295565|second line treatment|second line treatment
979375|NCT03295552|decitabine|decitabine
979376|NCT03295552|triple negative breast cancer|triple negative breast cancer
979377|NCT03295552|carboplatin|carboplatin
979378|NCT03295552|metastatic|metastatic
979379|NCT03295526|Cervical Cancer, Lymph nodes debulking surgery|cervical cancer, lymph nodes debulking surgery
979380|NCT03295513|mutilated, root canal treated teeth, and coronal fracture|mutilated, root canal treated teeth, and coronal fracture
979381|NCT03295500|CyberKnife|cyberknife
979382|NCT03295500|hepatocellular|hepatocellular
979383|NCT03295500|dose fraction|dose fraction
979384|NCT03295500|ICG R15|icg r15
979385|NCT03295487|post menopausal stress incontinence|post menopausal stress incontinence
979386|NCT03295487|local estrogen|local estrogen
979387|NCT03295448|fatty acids|fatty acids
979388|NCT03295448|biomarker|biomarker
979389|NCT03295448|carbohydrate|carbohydrate
979390|NCT03295448|lipogenesis|lipogenesis
979391|NCT03295435|Diet|diet
979392|NCT03295435|Oral Health|oral health
979393|NCT03295435|Nutrition|nutrition
979394|NCT03295435|Dentition|dentition
979395|NCT03295422|Persistent Atrial Fibrillation|persistent atrial fibrillation
979396|NCT03295422|Radiofrequency ablation|radiofrequency ablation
979397|NCT03295422|Catheter ablation|catheter ablation
979398|NCT03295383|cyclophosphamide|cyclophosphamide
979399|NCT03295383|Rituximab|rituximab
979400|NCT03295370|Pain mechanisms|pain mechanisms
979401|NCT03295370|Cortical activation|cortical activation
979402|NCT03295370|fNIRS|fnirs
979403|NCT03295370|Accessory spinal nerve|accessory spinal nerve
979404|NCT03295370|Autonomic response|autonomic response
979405|NCT03295370|Muscular perfusion|muscular perfusion
979406|NCT03295318|Neisseria meningitidis|neisseria meningitidis
979407|NCT03295318|conjugate meningococcal vaccine|conjugate meningococcal vaccine
979408|NCT03295318|meningococcal serogroup X|meningococcal serogroup x
979409|NCT03295305|Biomarker|biomarker
979410|NCT03295305|Bipolar Disorder|bipolar disorder
979411|NCT03295305|Cognition|cognition
979412|NCT03295305|Cognitive Impairment|cognitive impairment
979413|NCT03295305|cognitive remediation|cognitive remediation
979414|NCT03295305|functional magnetic resonance imaging|functional magnetic resonance imaging
979415|NCT03295305|pro-cognitive effect|pro-cognitive effect
979416|NCT03295305|Relatives|relatives
979417|NCT03295292|Phototherapeutic Keratectomy (PTK)|phototherapeutic keratectomy (ptk)
979418|NCT03295292|photorefractive Keratectomy (PRK)|photorefractive keratectomy (prk)
979419|NCT03295292|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
979420|NCT03295292|Stem Cell Therapy|stem cell therapy
979421|NCT03295279|World Trade Center|world trade center
979422|NCT03295279|Quantitative computerized tomography|quantitative computerized tomography
979423|NCT03295279|Qualitative computerized tomography of the chest|qualitative computerized tomography of the chest
979424|NCT03295279|Chronic airway disease|chronic airway disease
979425|NCT03295279|Interstitial lung disease|interstitial lung disease
979426|NCT03295279|Occupational pulmonology|occupational pulmonology
979427|NCT03295253|urinary incontinence|urinary incontinence
979428|NCT03295253|stress urinary incontinence|stress urinary incontinence
979429|NCT03295253|stress incontinence|stress incontinence
979430|NCT03295240|Mantle Cell Lymphoma|mantle cell lymphoma
979431|NCT03295240|MCL|mcl
979432|NCT03295240|Lymphoma|lymphoma
979433|NCT03295240|Venetoclax|venetoclax
979434|NCT03295240|17-216|17-216
979435|NCT03295227|Thymoma|thymoma
979436|NCT03295227|Thymic cancer|thymic cancer
979437|NCT03295227|Pembrolizumab|pembrolizumab
979438|NCT03295227|Keytruda|keytruda
979439|NCT03295227|MK-3475|mk-3475
979440|NCT03295227|SCH-900475|sch-900475
979441|NCT03295214|Acetaminophen|acetaminophen
979442|NCT03295214|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
979443|NCT03295201|Cystic Fibrosis|cystic fibrosis
979444|NCT03295201|Postural exercise|postural exercise
979445|NCT03295201|Pulmonary rehabilitation|pulmonary rehabilitation
979446|NCT03295175|Congenital Abnormalities|congenital abnormalities
979447|NCT03295175|Hypospadias|hypospadias
979448|NCT03295175|Congenital megaprepuce|congenital megaprepuce
979449|NCT03295175|Histology|histology
979450|NCT03295110|Alzheimer's disease and Related Disorders (ADRD)|alzheimer's disease and related disorders (adrd)
979451|NCT03295110|natural caregiver|natural caregiver
979452|NCT03295110|non-medical connected device|non-medical connected device
979453|NCT03295110|caregiver's burden|caregiver's burden
979454|NCT03295110|anxiety|anxiety
979455|NCT03295110|costs|costs
979456|NCT03295110|quality of life|quality of life
979457|NCT03295110|depressive symptoms|depressive symptoms
979458|NCT03295110|independence|independence
979459|NCT03295097|pharmacogenomics|pharmacogenomics
979460|NCT03295071|Heredity Optic Atrophy|heredity optic atrophy
979461|NCT03295071|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
979462|NCT03295071|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
979463|NCT03295071|Eye Diseases|eye diseases
979464|NCT03295071|Hereditary Eye Diseases|hereditary eye diseases
979465|NCT03295071|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
979466|NCT03295071|Inborn Genetic Disease|inborn genetic disease
979467|NCT03295071|Gene Therapy|gene therapy
979468|NCT03295071|Intravitreal Injections|intravitreal injections
979469|NCT03295071|Mitochondrial Disease|mitochondrial disease
979470|NCT03295071|AAV2 Vectors|aav2 vectors
979471|NCT03295071|Nervous System Diseases|nervous system diseases
979472|NCT03295071|Neurodegenerative Disease|neurodegenerative disease
979570|NCT03294395|Gentamicin|gentamicin
979475|NCT03294980|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
979477|NCT03294967|High Myopia|high myopia
979478|NCT03294967|Caffeine|caffeine
979479|NCT03294967|Choroidal Thickness|choroidal thickness
979480|NCT03294967|Choroidal Volume|choroidal volume
979481|NCT03294967|Optical Coherence Tomography|optical coherence tomography
979482|NCT03294967|Optical Coherence Tomography Angiography|optical coherence tomography angiography
979483|NCT03294954|Neuroblastoma|neuroblastoma
979484|NCT03294954|Natural Killer T-Cells|natural killer t-cells
979485|NCT03294954|Chimerical Antigen Receptor|chimerical antigen receptor
979486|NCT03294915|prediabetes|prediabetes
979487|NCT03294915|resistant starch|resistant starch
979488|NCT03294915|insulin sensitivity|insulin sensitivity
979489|NCT03294889|Prostate cancer|prostate cancer
979490|NCT03294889|Stereotactic body radiation therapy|stereotactic body radiation therapy
979491|NCT03294889|Calypso® beacon system|calypso® beacon system
979492|NCT03294876|Glucocorticoid|glucocorticoid
979493|NCT03294876|HPA axis|hpa axis
979494|NCT03294863|Scar|scar
979495|NCT03294863|Cosmesis|cosmesis
979496|NCT03294863|Embrace Device|embrace device
979497|NCT03294863|Split Wound|split wound
979498|NCT03294863|Wound Closure|wound closure
979499|NCT03294863|Cutaneous Wound|cutaneous wound
979500|NCT03294824|NK cells|nk cells
979501|NCT03294824|Cytomegalovirus|cytomegalovirus
979502|NCT03294824|adenovirus|adenovirus
979503|NCT03294824|Allogeneic transplantation|allogeneic transplantation
979504|NCT03294772|Respiratory Tract Infections|respiratory tract infections
979505|NCT03294772|gastroenteritis|gastroenteritis
979506|NCT03294772|hand sanitizer|hand sanitizer
979507|NCT03294772|handwashing|handwashing
979508|NCT03294772|day care|day care
979510|NCT03294759|stem cell|stem cell
979512|NCT03294746|Drug induced interstitial lung disease (DIILD)|drug induced interstitial lung disease (diild)
979513|NCT03294694|Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer|metastatic hormone-receptor-positive (hr+) breast cancer
979514|NCT03294694|HER2-Negative Breast Cancer|her2-negative breast cancer
979515|NCT03294694|Metastatic Epithelial Ovarian Cancer|metastatic epithelial ovarian cancer
979516|NCT03294668|social skills group training|social skills group training
979517|NCT03294668|Adolescents|adolescents
979518|NCT03294668|Active control group|active control group
979519|NCT03294668|Australian|australian
979520|NCT03294642|exercise|exercise
979521|NCT03294642|FODMAP|fodmap
979522|NCT03294642|gastrointestinal|gastrointestinal
979523|NCT03294642|endurance|endurance
979524|NCT03294642|cycling|cycling
979525|NCT03294629|cPAP|cpap
979526|NCT03294629|SenseAwake|senseawake
979527|NCT03294616|transcutaneous electroacupuncture|transcutaneous electroacupuncture
979528|NCT03294603|Healthy Volunteer|healthy volunteer
979529|NCT03294603|CC-220|cc-220
979530|NCT03294603|Male|male
979531|NCT03294590|Child oral health behaviors|child oral health behaviors
979532|NCT03294590|Text messages|text messages
979533|NCT03294590|Motivation|motivation
979534|NCT03294590|Self efficacy|self efficacy
979535|NCT03294590|Outcome Expectations|outcome expectations
979536|NCT03294590|Bottle/sippy cup use|bottle/sippy cup use
979537|NCT03294590|Sugar sweetened beverage consumption|sugar sweetened beverage consumption
979538|NCT03294590|Fluoride varnish|fluoride varnish
979539|NCT03294590|Healthy eating|healthy eating
979540|NCT03294590|Parent oral health behaviors|parent oral health behaviors
979541|NCT03294590|Parent oral health attitudes|parent oral health attitudes
979542|NCT03294590|Fluoride|fluoride
979543|NCT03294577|Plinabulin|plinabulin
979544|NCT03294577|Pegfilgrastim|pegfilgrastim
979545|NCT03294577|bone pain|bone pain
979546|NCT03294577|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
979547|NCT03294564|Inflammation|inflammation
979548|NCT03294564|Threat sensitivity|threat sensitivity
979549|NCT03294564|Reward sensitivity|reward sensitivity
979550|NCT03294551|HPV Vaccine|hpv vaccine
979551|NCT03294551|immunization registry|immunization registry
979552|NCT03294551|Reminder recall (R/R)|reminder recall (r/r)
979553|NCT03294486|Glioblastoma|glioblastoma
979554|NCT03294486|Oncolytic viruses|oncolytic viruses
979555|NCT03294473|reminder recall (R/R), influenza vaccines|reminder recall (r/r), influenza vaccines
979560|NCT03294447|Fear of falling|fear of falling
979561|NCT03294408|fractal analysis|fractal analysis
979562|NCT03294408|trabecular bone texture|trabecular bone texture
979668|NCT03293784|Ipilimumab|ipilimumab
979563|NCT03294408|knee osteoarthritis|knee osteoarthritis
979564|NCT03294408|subchondral bone|subchondral bone
979565|NCT03294408|Medical Resonnance Imaging|medical resonnance imaging
979566|NCT03294395|Antimicrobial resistance|antimicrobial resistance
979567|NCT03294395|Antibiotics|antibiotics
979571|NCT03294395|Neisseria Gonorrhoeae|neisseria gonorrhoeae
979572|NCT03294382|epicanthoplasty|epicanthoplasty
979573|NCT03294382|Botulinum Toxins|botulinum toxins
979574|NCT03294382|scar|scar
979575|NCT03294382|intercanthal distance|intercanthal distance
979576|NCT03294382|blepharoplasty|blepharoplasty
979577|NCT03294369|Hypertension|hypertension
979578|NCT03294369|Diabetes|diabetes
979579|NCT03294369|Dyslipidemia|dyslipidemia
979580|NCT03294369|Smoking|smoking
979581|NCT03294369|Cardiovascular|cardiovascular
979582|NCT03294369|Toledo|toledo
979583|NCT03294317|His bundle pacing|his bundle pacing
979584|NCT03294317|Pacemaker|pacemaker
979585|NCT03294304|MIBC|mibc
979587|NCT03294304|Immunotherapy|immunotherapy
979588|NCT03294304|Bladder Cancer|bladder cancer
979589|NCT03294304|Neoadjuvant|neoadjuvant
979590|NCT03294304|Nivolumab|nivolumab
979591|NCT03294304|Cisplatin|cisplatin
979592|NCT03294304|Gemcitabine|gemcitabine
979593|NCT03294265|Diabetes|diabetes
979594|NCT03294265|Peer support|peer support
979595|NCT03294265|WhatsApp|whatsapp
979596|NCT03294252|PIPAC|pipac
979597|NCT03294252|oxaliplatin|oxaliplatin
979598|NCT03294252|peritoneal metastases|peritoneal metastases
979599|NCT03294187|Upper Extremity|upper extremity
979600|NCT03294187|Feedback|feedback
979601|NCT03294187|Rehabilitation|rehabilitation
979602|NCT03294187|Randomized Controlled Trial|randomized controlled trial
979603|NCT03294161|Meglumine antimoniate|meglumine antimoniate
979604|NCT03294161|L.Braziliensis|l.braziliensis
979605|NCT03294161|Immunotherapy|immunotherapy
979606|NCT03294161|Immucillin|immucillin
979607|NCT03294148|Placebo|placebo
979608|NCT03294148|Back|back
979609|NCT03294148|Pain|pain
979610|NCT03294148|Chronic|chronic
979611|NCT03294148|Mind-Body|mind-body
979612|NCT03294135|Encepur|encepur
979613|NCT03294135|Adults|adults
979614|NCT03294135|Long term immunogenicity|long term immunogenicity
979615|NCT03294135|Tick-borne Encephalitis vaccine|tick-borne encephalitis vaccine
979616|NCT03294135|Booster|booster
979617|NCT03294122|Radiotherapy|radiotherapy
979618|NCT03294122|Adverse effects|adverse effects
979619|NCT03294122|Prostate cancer|prostate cancer
979620|NCT03294122|Head and neck cancer|head and neck cancer
979621|NCT03294122|Patient risk stratification|patient risk stratification
979622|NCT03294122|Mathematical models|mathematical models
979623|NCT03294122|Microbiome|microbiome
979624|NCT03294122|Inflammatory cytokines|inflammatory cytokines
979625|NCT03294122|Magnetic Resonance Imaging|magnetic resonance imaging
979626|NCT03294109|TQL block, TAP block, donor nephrectomy, pain, patient satisfaction|tql block, tap block, donor nephrectomy, pain, patient satisfaction
979627|NCT03294083|Cancer|cancer
979628|NCT03294083|Renal cell carcinoma|renal cell carcinoma
979629|NCT03294083|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
979630|NCT03294070|hemodynamic parameters|hemodynamic parameters
979631|NCT03294070|arterial stiffness|arterial stiffness
979632|NCT03294057|Self-Management IT Program|self-management it program
979633|NCT03294044|Self-Management IT Program|self-management it program
979634|NCT03294031|Parkinson Disease|parkinson disease
979635|NCT03294031|Neurodegenerative Disorder|neurodegenerative disorder
979636|NCT03294031|Physical Activity|physical activity
979637|NCT03294031|Pilates Method|pilates method
979638|NCT03294031|Stabilometer|stabilometer
979639|NCT03293953|HCV|hcv
979640|NCT03293953|HIV|hiv
979641|NCT03293953|Liver Fibrosis|liver fibrosis
979642|NCT03293953|Liver Iron Overload|liver iron overload
979643|NCT03293940|Breast Pain|breast pain
979644|NCT03293940|Nerve Pain|nerve pain
979645|NCT03293940|Mastectomy|mastectomy
979646|NCT03293940|Lumpectomy|lumpectomy
979647|NCT03293940|Breast Reconstruction|breast reconstruction
979648|NCT03293927|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy
979649|NCT03293888|Spectral Diagnosis Probe|spectral diagnosis probe
979650|NCT03293888|Chaos Wand|chaos wand
979651|NCT03293888|Spectral Analysis|spectral analysis
979652|NCT03293888|Optical Spectroscopy|optical spectroscopy
979653|NCT03293862|laparotomy|laparotomy
979654|NCT03293862|emergency surgery|emergency surgery
979655|NCT03293862|abdominal wound dehiscence|abdominal wound dehiscence
979656|NCT03293862|prophylactic mesh|prophylactic mesh
979657|NCT03293836|Varicose ulcer|varicose ulcer
979658|NCT03293836|Venous ulcer|venous ulcer
979659|NCT03293836|Radiofrequency ablation|radiofrequency ablation
979660|NCT03293836|Perforating veins insufficiency|perforating veins insufficiency
979661|NCT03293836|Varicose veins treatment|varicose veins treatment
979662|NCT03293797|Mindfulness-based Therapy|mindfulness-based therapy
979663|NCT03293797|Wellbeing|wellbeing
979664|NCT03293797|Treatment|treatment
979665|NCT03293784|Melanoma|melanoma
979666|NCT03293784|Immune checkpoint|immune checkpoint
979667|NCT03293784|Nivolumab|nivolumab
979670|NCT03293784|Certolizumab|certolizumab
979671|NCT03293784|PD-1|pd-1
979672|NCT03293784|TNFa|tnfa
979673|NCT03293784|CTLA-4|ctla-4
979674|NCT03293771|Transgender women|transgender women
979675|NCT03293771|Male-to-female|male-to-female
979676|NCT03293771|Gender confirmation surgery|gender confirmation surgery
979677|NCT03293771|Voiding disorder|voiding disorder
979678|NCT03293771|Vaginal dysfunction|vaginal dysfunction
979679|NCT03293693|beta-glucan|beta-glucan
979680|NCT03293693|Blood glucose|blood glucose
979681|NCT03293693|Gut microbiota|gut microbiota
979682|NCT03293693|Satiety|satiety
979683|NCT03293693|Dietary intervention|dietary intervention
979684|NCT03293667|Rheumatoid Arthritis|rheumatoid arthritis
979685|NCT03293667|Regulatory T Cells|regulatory t cells
979686|NCT03293641|Children, Sickle Cell Disease, Zinc|children, sickle cell disease, zinc
979687|NCT03293628|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
979688|NCT03293628|haemostasis|haemostasis
979689|NCT03293628|vaginal pack|vaginal pack
979690|NCT03293628|Loop electrical excision procedure|loop electrical excision procedure
979691|NCT03293628|randomized clinical trials|randomized clinical trials
979692|NCT03293628|uterine cervical neoplasm|uterine cervical neoplasm
979693|NCT03293602|prostate cancer|prostate cancer
979694|NCT03293602|MRI|mri
979695|NCT03293602|BOLD|bold
979696|NCT03293602|18F-MISO|18f-miso
979697|NCT03293602|PET|pet
979698|NCT03293589|end-stage renal disease|end-stage renal disease
979699|NCT03293589|critical limb ischemia|critical limb ischemia
979700|NCT03293589|surgical revascularisation|surgical revascularisation
979701|NCT03293589|endovascular therapy|endovascular therapy
979702|NCT03293576|Behavioural Medicine|behavioural medicine
979703|NCT03293576|Health Psychology|health psychology
979704|NCT03293576|Psychosocial Intervention|psychosocial intervention
979705|NCT03293576|People Who Inject Drugs|people who inject drugs
979706|NCT03293563|Kidney cancer|kidney cancer
979707|NCT03293563|Surgical approaches|surgical approaches
979708|NCT03293563|Medical treatment|medical treatment
979709|NCT03293563|Multicentric and multidisciplinary network|multicentric and multidisciplinary network
979710|NCT03293537|Dementia|dementia
979711|NCT03293537|Aphathy|aphathy
979712|NCT03293537|Emotion|emotion
979713|NCT03293537|Images|images
979714|NCT03293537|Skin conductance|skin conductance
979715|NCT03293537|Heart rate|heart rate
979716|NCT03293524|Heredity Optic Atrophy|heredity optic atrophy
979717|NCT03293524|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
979718|NCT03293524|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
979719|NCT03293524|LHON|lhon
979720|NCT03293524|Eye Diseases|eye diseases
979721|NCT03293524|Hereditary Eye Diseases|hereditary eye diseases
979722|NCT03293524|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
979723|NCT03293524|Inborn Genetic Disease|inborn genetic disease
979724|NCT03293524|Gene Therapy|gene therapy
979725|NCT03293524|Intravitreal Injections|intravitreal injections
979726|NCT03293524|Mitochondrial Disease|mitochondrial disease
979727|NCT03293524|AAV2 Vectors|aav2 vectors
979728|NCT03293524|Nervous System Diseases|nervous system diseases
979729|NCT03293524|Neurodegenerative Disease|neurodegenerative disease
979730|NCT03293524|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
979731|NCT03293524|Atrophy|atrophy
979732|NCT03293524|Pathological Conditions, Anatomical|pathological conditions, anatomical
979733|NCT03293524|Anesthetics|anesthetics
979734|NCT03293524|Central Nervous System Depressants|central nervous system depressants
979735|NCT03293524|Physiological Effects of Drugs|physiological effects of drugs
979736|NCT03293511|Oxytocin|oxytocin
979737|NCT03293511|Eye tracking|eye tracking
979738|NCT03293511|Autistic trait|autistic trait
979739|NCT03293407|Pulmonary arterial hypertension|pulmonary arterial hypertension
979740|NCT03293407|PAH|pah
979741|NCT03293394|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
979742|NCT03293394|Motor Neuron Disease|motor neuron disease
979743|NCT03293394|Transcranial Direct Current Stimulation|transcranial direct current stimulation
979744|NCT03293368|Oral|oral
979745|NCT03293368|Lichen planus|lichen planus
979746|NCT03293368|PRP|prp
979747|NCT03293355|People Living with HIV Who Use Drugs (PLHWUD)|people living with hiv who use drugs (plhwud)
979748|NCT03293355|Community Health Workers (CHW)|community health workers (chw)
979749|NCT03293355|Multilevel Service Integration|multilevel service integration
979750|NCT03293355|HIV/AIDS|hiv/aids
979751|NCT03293355|Vietnam|vietnam
979752|NCT03293329|rotator cuff injury|rotator cuff injury
979753|NCT03293329|diaphragm|diaphragm
979754|NCT03293329|physical therapy|physical therapy
979755|NCT03293329|manual therapy|manual therapy
979756|NCT03293316|Transcranial electrical stimulation; random noise;|transcranial electrical stimulation; random noise;
979757|NCT03293316|cognitive interventions; electroencephalography;|cognitive interventions; electroencephalography;
979758|NCT03293316|inter-individual variability; stochastic resonance;|inter-individual variability; stochastic resonance;
979759|NCT03293303|Prevention|prevention
979760|NCT03293303|Physical activity|physical activity
979761|NCT03293303|Sedentary behaviour|sedentary behaviour
979762|NCT03293303|Daily activities|daily activities
979765|NCT03293303|Primary care|primary care
979766|NCT03293303|Older adults|older adults
979767|NCT03293303|Function Focused Care|function focused care
979768|NCT03293303|Reablement|reablement
979769|NCT03293303|Restorative Care|restorative care
979770|NCT03293290|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
979771|NCT03293290|criminal justice|criminal justice
979772|NCT03293290|women|women
979773|NCT03293290|risk networks|risk networks
979774|NCT03293264|metabolic syndrome|metabolic syndrome
979775|NCT03293264|exercise training|exercise training
979776|NCT03293264|employees|employees
979777|NCT03293264|workplace|workplace
979778|NCT03293264|operational health service|operational health service
979779|NCT03293238|knee|knee
979780|NCT03293238|osteoarthritis|osteoarthritis
979781|NCT03293238|ultrasound|ultrasound
979782|NCT03293238|sonography|sonography
979783|NCT03293238|injection|injection
979784|NCT03293225|cu|cu
979785|NCT03293212|Postoperative pain|postoperative pain
979786|NCT03293212|Failed back surgery syndrome|failed back surgery syndrome
979787|NCT03293212|Korean medicine|korean medicine
979788|NCT03293173|DLBCL|dlbcl
979789|NCT03293173|Chemoimmunotherapy|chemoimmunotherapy
979790|NCT03293173|High risk|high risk
979791|NCT03293173|CNS prophylaxis|cns prophylaxis
979792|NCT03293173|Biomarker-driven|biomarker-driven
979793|NCT03293147|Blood pressure|blood pressure
979794|NCT03293147|Antihypertensive treatment|antihypertensive treatment
979795|NCT03293147|Adherence|adherence
979796|NCT03293147|Biomarker|biomarker
979797|NCT03293147|Urine|urine
979798|NCT03293147|HPLC-MS/MS|hplc-ms/ms
979799|NCT03293134|Fowler syndrome|fowler syndrome
979800|NCT03293121|running related injuries|running related injuries
979801|NCT03293108|Osteoporosis|osteoporosis
979802|NCT03293108|Denosumab|denosumab
979803|NCT03293095|musculoskeletal pathology|musculoskeletal pathology
979804|NCT03293095|motion sensor|motion sensor
979805|NCT03293095|motion capture|motion capture
979806|NCT03293095|functional task|functional task
979807|NCT03293095|biomarker|biomarker
979808|NCT03293069|Conservative Iron Chelation|conservative iron chelation
979809|NCT03293069|Disease-modifying Strategy|disease-modifying strategy
979810|NCT03293056|aerobic exercises|aerobic exercises
979811|NCT03293056|training|training
979812|NCT03293056|aquatic|aquatic
979813|NCT03293030|atopic dermatitis|atopic dermatitis
979814|NCT03293030|eczema|eczema
979815|NCT03293030|dupilumab|dupilumab
979816|NCT03293004|collagen|collagen
979817|NCT03293004|tendon|tendon
979818|NCT03293004|procollagen type I N-terminal|procollagen type i n-terminal
979819|NCT03293004|athletes|athletes
979820|NCT03293004|vitamin C|vitamin c
979821|NCT03293004|hydrolyzed collagen|hydrolyzed collagen
979822|NCT03292991|Hepatocellular Carcinoma|hepatocellular carcinoma
979823|NCT03292991|SIR Spheres|sir spheres
979824|NCT03292991|SIRT|sirt
979825|NCT03292939|progestrone|progestrone
979826|NCT03292939|doppler indices|doppler indices
979827|NCT03292913|HIV|hiv
979828|NCT03292887|Mucopolysaccharidosis II|mucopolysaccharidosis ii
979829|NCT03292887|Hunter Syndrome|hunter syndrome
979830|NCT03292887|Enzyme Replacement Therapy|enzyme replacement therapy
979831|NCT03292887|Lysosomal|lysosomal
979832|NCT03292887|Glycosaminoglycans|glycosaminoglycans
979833|NCT03292874|prostate cancer|prostate cancer
979834|NCT03292874|MRI|mri
979835|NCT03292848|CNS Disorders|cns disorders
979836|NCT03292848|Brexpiprazole|brexpiprazole
979837|NCT03292835|complex|complex
979838|NCT03292835|zoonotic|zoonotic
979839|NCT03292835|medical device|medical device
979840|NCT03292796|Open Angle Glaucoma|open angle glaucoma
979841|NCT03292796|Cataract|cataract
979842|NCT03292796|Phacoemulsification,|phacoemulsification,
979843|NCT03292796|Cystoid Macular Oedema,|cystoid macular oedema,
979844|NCT03292796|Prostaglandin Analogues|prostaglandin analogues
979845|NCT03292783|VEGF|vegf
979846|NCT03292783|DLL4|dll4
979847|NCT03292783|Solid Tumors|solid tumors
979848|NCT03292783|bispecific antibody|bispecific antibody
979849|NCT03292783|anti-angiogenic|anti-angiogenic
979850|NCT03292770|Embryo Transfer|embryo transfer
979851|NCT03292770|Flushing catheter|flushing catheter
979852|NCT03292770|Pregnancy rate|pregnancy rate
979853|NCT03292770|Frozen Embryo Tranfer|frozen embryo tranfer
979854|NCT03292757|Fluorescence|fluorescence
979855|NCT03292744|immunosenescence|immunosenescence
979856|NCT03292718|PERT|pert
979857|NCT03292718|mobile application|mobile application
979858|NCT03292705|cognitive training|cognitive training
979859|NCT03292705|person-centered approach|person-centered approach
979860|NCT03292614|Multifocal Intraocular Lens|multifocal intraocular lens
979861|NCT03292614|Postoperative Measurements of refraction|postoperative measurements of refraction
979862|NCT03292601|Spinal Orthosis|spinal orthosis
979863|NCT03292601|Spinal Brace|spinal brace
979864|NCT03292588|urban setting|urban setting
979865|NCT03292588|children and adolescents|children and adolescents
979866|NCT03292588|double-masked, placebo-controlled randomized trial|double-masked, placebo-controlled randomized trial
979867|NCT03292588|asthma exacerbations (attacks)|asthma exacerbations (attacks)
979868|NCT03292588|mepolizumab adjunctive therapy|mepolizumab adjunctive therapy
979869|NCT03292588|asthma exacerbations prevention|asthma exacerbations prevention
979870|NCT03292588|difficult-to-control exacerbation-prone asthma|difficult-to-control exacerbation-prone asthma
979871|NCT03292549|Urology|urology
979872|NCT03292549|Robotic surgery|robotic surgery
979873|NCT03292549|Haemostasis|haemostasis
979874|NCT03292549|Partial Nephrectomy|partial nephrectomy
979875|NCT03292523|Hyperventilation syndrome|hyperventilation syndrome
979876|NCT03292523|Work productivity|work productivity
979877|NCT03292523|Absenteeism|absenteeism
979878|NCT03292523|Presenteeism|presenteeism
979879|NCT03292484|AR101|ar101
979880|NCT03292484|Characterized Peanut Allergen|characterized peanut allergen
979881|NCT03292484|OIT (oral immunotherapy)|oit (oral immunotherapy)
979882|NCT03292484|Peanut Allergy|peanut allergy
979883|NCT03292484|Allergy|allergy
979884|NCT03292484|Peanut-Allergic Children|peanut-allergic children
979885|NCT03292484|Peanut-Allergic Adults|peanut-allergic adults
979886|NCT03292484|Desensitization|desensitization
979887|NCT03292484|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
979888|NCT03292471|Aphasia|aphasia
979889|NCT03292471|Rehabilitation|rehabilitation
979890|NCT03292471|Stroke|stroke
979891|NCT03292458|spasmodic dysphonia|spasmodic dysphonia
979892|NCT03292458|laryngeal dystonia|laryngeal dystonia
979893|NCT03292458|functional MRI|functional mri
979894|NCT03292458|Xyrem|xyrem
979895|NCT03292432|Adherence, Medication|adherence, medication
979896|NCT03292406|T-Cell|t-cell
979897|NCT03292406|Lymphoma|lymphoma
979898|NCT03292406|Cutaneous|cutaneous
979899|NCT03292406|CTCL|ctcl
979900|NCT03292393|Hypertension|hypertension
979901|NCT03292393|Medication|medication
979902|NCT03292393|Adherence|adherence
979903|NCT03292380|Caffeine|caffeine
979904|NCT03292380|Dietary intake|dietary intake
979905|NCT03292380|Validation|validation
979906|NCT03292380|Dietary methods|dietary methods
979907|NCT03292354|Coronary Computed Tomography Angiography|coronary computed tomography angiography
979908|NCT03292354|Image Quality|image quality
979909|NCT03292354|Contrast Media Reduction|contrast media reduction
979910|NCT03292354|Personalised Injection Protocols|personalised injection protocols
979911|NCT03292328|breast cancer|breast cancer
979912|NCT03292328|neuropathy|neuropathy
979913|NCT03292328|peripheral neuropathy|peripheral neuropathy
979914|NCT03292328|yoga|yoga
979915|NCT03292328|17-449|17-449
979916|NCT03292315|Glucagon-Like Peptide-1|glucagon-like peptide-1
979917|NCT03292302|Translational read through|translational read through
979918|NCT03292289|proctectomy|proctectomy
979919|NCT03292289|coloanal continuity reconstruction|coloanal continuity reconstruction
979920|NCT03292263|Multiple Myeloma|multiple myeloma
979921|NCT03292263|Nivolumab|nivolumab
979922|NCT03292263|Melphalan|melphalan
979923|NCT03292263|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
979924|NCT03292250|NGS|ngs
979925|NCT03292250|Nanostring|nanostring
979926|NCT03292250|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
979927|NCT03292250|BYL719,poziotinib, abemaciclib, nintedanib|byl719,poziotinib, abemaciclib, nintedanib
979928|NCT03292250|Durvalumab + Tremelimumab Combination Treatment|durvalumab + tremelimumab combination treatment
979929|NCT03292237|Energy|energy
979930|NCT03292237|Nutrition|nutrition
979931|NCT03292237|Critical illness|critical illness
979932|NCT03292237|Parenteral nutrition|parenteral nutrition
979933|NCT03292237|Intensive care unit|intensive care unit
979934|NCT03292237|Ward|ward
979935|NCT03292237|Randomised Controlled Trial|randomised controlled trial
979936|NCT03292237|Intensive Nutrition|intensive nutrition
979937|NCT03292211|Early mobilization|early mobilization
979938|NCT03292211|Acute stroke|acute stroke
979939|NCT03292211|Early intervention|early intervention
979940|NCT03292211|Early mobilization therapy|early mobilization therapy
979941|NCT03292198|Subclinical lymphedema|subclinical lymphedema
979942|NCT03292198|bioimpedance|bioimpedance
979943|NCT03292198|breast cancer|breast cancer
979944|NCT03292159|stroke|stroke
979945|NCT03292159|vagus nerve stimulation|vagus nerve stimulation
979946|NCT03292159|upper extremity paresis|upper extremity paresis
979947|NCT03292133|Lung Cancer|lung cancer
979948|NCT03292081|Intracoronary Imaging|intracoronary imaging
979949|NCT03292081|Optical Frequency Domain Imaging|optical frequency domain imaging
979950|NCT03292081|Intravascular Ultrasound|intravascular ultrasound
979951|NCT03292081|Percutaneous Coronary Intervention|percutaneous coronary intervention
979952|NCT03292081|Drug Eluting Stent|drug eluting stent
979953|NCT03292055|food frequency questionnaire; psychometric properties|food frequency questionnaire; psychometric properties
979954|NCT03292042|metabolic syndrome|metabolic syndrome
979955|NCT03292042|lifestyle intervention|lifestyle intervention
979956|NCT03292042|health promotion|health promotion
979957|NCT03292042|mental health nurse|mental health nurse
979958|NCT03292042|serious mental illness|serious mental illness
979959|NCT03292029|Renal replacement therapy|renal replacement therapy
979960|NCT03292029|Haemodialsysis|haemodialsysis
979961|NCT03292029|Calcification Inhibition Test|calcification inhibition test
979962|NCT03292016|Off Episodes|off episodes
979963|NCT03292016|Parkinson Disease|parkinson disease
979964|NCT03292003|rheumatoid arthritis|rheumatoid arthritis
979965|NCT03292003|post-traumatic arthritis|post-traumatic arthritis
979966|NCT03292003|osteoarthritis|osteoarthritis
979967|NCT03292003|degenerative arthritis|degenerative arthritis
979968|NCT03292003|failed osteotomy|failed osteotomy
979969|NCT03291977|surgery - glioblastoma - fluorescein|surgery - glioblastoma - fluorescein
979970|NCT03291938|Malignant neoplasm of breast|malignant neoplasm of breast
979971|NCT03291938|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
979972|NCT03291938|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
979973|NCT03291938|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
979974|NCT03291938|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
979975|NCT03291938|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
979976|NCT03291938|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
979977|NCT03291938|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
979978|NCT03291938|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
979979|NCT03291938|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
979980|NCT03291938|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
979981|NCT03291938|IACS-010759|iacs-010759
979982|NCT03291847|maternal opioid use|maternal opioid use
979983|NCT03291847|neonatal abstinence syndrome|neonatal abstinence syndrome
979984|NCT03291847|buprenorphine-naloxone|buprenorphine-naloxone
979985|NCT03291834|type 1 diabetes mellitus|type 1 diabetes mellitus
979986|NCT03291834|sports|sports
979987|NCT03291834|child|child
979988|NCT03291834|adolescent|adolescent
979989|NCT03291821|DuoStim|duostim
979990|NCT03291821|MitoScore|mitoscore
979991|NCT03291821|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
979992|NCT03291821|MII oocyte|mii oocyte
979993|NCT03291808|Obesity; asthma; Weight loss|obesity; asthma; weight loss
979994|NCT03291743|Crohn's|crohn's
979995|NCT03291743|Capsule endoscopy|capsule endoscopy
979996|NCT03291743|IBD|ibd
979997|NCT03291730|Anxiety|anxiety
979998|NCT03291717|Mental Illness|mental illness
979999|NCT03291717|Community Participation|community participation
980000|NCT03291717|Stigma|stigma
980001|NCT03291717|Photovoice|photovoice
980002|NCT03291704|Dry Eye|dry eye
980003|NCT03291704|Thermal Therapy|thermal therapy
980004|NCT03291704|Meibomian Gland Dysfunction|meibomian gland dysfunction
980005|NCT03291691|Protective Nerve Stimulation|protective nerve stimulation
980006|NCT03291691|Regional Anesthesia|regional anesthesia
980007|NCT03291691|Sciatic nerve block|sciatic nerve block
980008|NCT03291691|femoral nerve block|femoral nerve block
980009|NCT03291691|brachial plexus block|brachial plexus block
980010|NCT03291665|Plantar Fasciitis|plantar fasciitis
980011|NCT03291665|Plantar heel pain|plantar heel pain
980012|NCT03291652|Ischemic Stroke|ischemic stroke
980013|NCT03291652|atherosclerosis|atherosclerosis
980014|NCT03291652|Plaque morphology|plaque morphology
980015|NCT03291652|DSA/3DRA|dsa/3dra
980016|NCT03291613|Sickle Cell Disease|sickle cell disease
980017|NCT03291613|Adolescence|adolescence
980018|NCT03291613|Pain Assessment|pain assessment
980019|NCT03291613|Tablet Application|tablet application
980020|NCT03291613|Pain|pain
980021|NCT03291613|mHealth|mhealth
980022|NCT03291548|Quinoa|quinoa
980023|NCT03291548|Functional food|functional food
980024|NCT03291548|Cardiovascular disease|cardiovascular disease
980025|NCT03291548|Cholesterol|cholesterol
980026|NCT03291548|Lipid profile|lipid profile
980027|NCT03291548|Randomised Control Trial|randomised control trial
980028|NCT03291522|Testicular sperm extraction|testicular sperm extraction
980029|NCT03291509|weight loss|weight loss
980030|NCT03291509|weight management|weight management
980031|NCT03291483|Whole body vibration|whole body vibration
980032|NCT03291483|mesh id D000072797|mesh id d000072797
980033|NCT03291483|Plyometric exercise|plyometric exercise
980034|NCT03291483|Muscle strength|muscle strength
980035|NCT03291483|Physical fitness|physical fitness
980036|NCT03291483|Balance|balance
980037|NCT03291470|knee|knee
980038|NCT03291431|alcohol use disorder|alcohol use disorder
980039|NCT03291431|intermittent theta burst|intermittent theta burst
980040|NCT03291431|Veterans|veterans
980041|NCT03291431|depressive disorder|depressive disorder
980042|NCT03291431|cigarette smoking|cigarette smoking
980043|NCT03291418|Healthy Volunteers, ATB-346, Naproxen sodium, GI safety|healthy volunteers, atb-346, naproxen sodium, gi safety
980044|NCT03291392|Genetics|genetics
980045|NCT03291392|Stroke|stroke
980046|NCT03291392|Biobank|biobank
980047|NCT03291392|Atherosclerosis|atherosclerosis
980048|NCT03291379|mCRC, HCC, radiopaque beads, vandetanib|mcrc, hcc, radiopaque beads, vandetanib
980049|NCT03291301|Insomnia|insomnia
980050|NCT03291301|Cognitive Behavioral Therapy|cognitive behavioral therapy
980051|NCT03291301|CBT-I|cbt-i
980052|NCT03291301|Acupressure|acupressure
980053|NCT03291301|Traditional Chinese Medicine|traditional chinese medicine
980953|NCT03285490|Neoplasms|neoplasms
980054|NCT03291288|Tenosynovial Giant Cell Tumors (TGCT)|tenosynovial giant cell tumors (tgct)
980055|NCT03291288|Kit-mutant melanoma|kit-mutant melanoma
980056|NCT03291288|Kit-mutant gastrointestinal stromal tumor (GIST)|kit-mutant gastrointestinal stromal tumor (gist)
980057|NCT03291288|Cocktail drug-drug interaction (DDI)|cocktail drug-drug interaction (ddi)
980058|NCT03291210|hyperoxemia|hyperoxemia
980059|NCT03291210|myocardial injury|myocardial injury
980060|NCT03291210|transcatheter aortic valve replacement|transcatheter aortic valve replacement
980061|NCT03291197|Suprascapular nerve block|suprascapular nerve block
980062|NCT03291197|Median nerve block|median nerve block
980063|NCT03291197|CRPS|crps
980064|NCT03291197|Shoulder hand syndrome|shoulder hand syndrome
980065|NCT03291184|neuromuscular blockade|neuromuscular blockade
980066|NCT03291184|neuromuscular monitoring|neuromuscular monitoring
980067|NCT03291171|physical activity|physical activity
980068|NCT03291171|sedentary behaviour|sedentary behaviour
980069|NCT03291171|type 2 diabetes|type 2 diabetes
980070|NCT03291171|eHealth|ehealth
980071|NCT03291171|mHealth|mhealth
980072|NCT03291171|self-regulation|self-regulation
980073|NCT03291171|behaviour change techniques|behaviour change techniques
980074|NCT03291158|Bacterial Infections|bacterial infections
980075|NCT03291145|Long QT Syndrome|long qt syndrome
980076|NCT03291132|Smoke-free|smoke-free
980077|NCT03291132|Teens|teens
980078|NCT03291119|Cervico-medullary, Extubation Failure, Risk Predictors|cervico-medullary, extubation failure, risk predictors
980079|NCT03291093|PET/MRI|pet/mri
980080|NCT03291093|Amyloid|amyloid
980081|NCT03291093|Flutemetamol|flutemetamol
1657555|NCT00158041|Rash|rash
980082|NCT03291054|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
980083|NCT03291054|GIST|gist
980084|NCT03291054|Pembrolizumab|pembrolizumab
980085|NCT03291054|Epacadostat|epacadostat
980086|NCT03291054|Columbia|columbia
980087|NCT03291015|arthroscopy|arthroscopy
980088|NCT03291015|radiographic(plain X ray)|radiographic(plain x ray)
980089|NCT03290963|depression|depression
980090|NCT03290963|bipolar I disorder|bipolar i disorder
980091|NCT03290963|bipolar II disorder|bipolar ii disorder
980092|NCT03290950|Daratumumab|daratumumab
980093|NCT03290950|Carfilzomib|carfilzomib
980094|NCT03290950|Lenalidomide|lenalidomide
980095|NCT03290950|Dexamethasone|dexamethasone
980096|NCT03290950|17-352|17-352
980097|NCT03290937|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
980098|NCT03290937|Colorectal cancer|colorectal cancer
980099|NCT03290937|Metastatic|metastatic
980100|NCT03290937|Refractory to standard therapy|refractory to standard therapy
980101|NCT03290937|Wild type RAS tumor|wild type ras tumor
980102|NCT03290937|Mutated RAS tumor|mutated ras tumor
980103|NCT03290937|Irinotecan|irinotecan
980104|NCT03290937|CPT-11|cpt-11
980105|NCT03290937|Camptosar|camptosar
980106|NCT03290937|PF-05082566|pf-05082566
980107|NCT03290937|Utomilumab|utomilumab
980108|NCT03290937|Anti-CD137|anti-cd137
980109|NCT03290937|Cetuximab|cetuximab
980110|NCT03290937|C225|c225
980111|NCT03290937|Erbitux|erbitux
980112|NCT03290937|IMC-C225|imc-c225
980113|NCT03290937|MOAB C225|moab c225
980114|NCT03290924|institutional delivery|institutional delivery
980115|NCT03290911|low responders|low responders
980116|NCT03290898|Asthma|asthma
980117|NCT03290898|Exercise|exercise
980118|NCT03290898|Asthma treatment|asthma treatment
980119|NCT03290898|Inhaled corticosteroid|inhaled corticosteroid
980120|NCT03290898|Rehabilitation|rehabilitation
980121|NCT03290859|Procedural Sedation|procedural sedation
980122|NCT03290833|Robotics|robotics
980123|NCT03290833|Stroke|stroke
980124|NCT03290833|Hand|hand
980125|NCT03290833|neurorehabilitation|neurorehabilitation
980126|NCT03290820|nasopharyngeal carcinoma|nasopharyngeal carcinoma
980127|NCT03290820|N2-3 disease|n2-3 disease
980128|NCT03290820|distant metastasis|distant metastasis
980129|NCT03290820|aspirin|aspirin
980130|NCT03290820|survival|survival
980131|NCT03290781|Ulcerative colitis|ulcerative colitis
980132|NCT03290755|Hepatitis C|hepatitis c
980133|NCT03290755|sexual network|sexual network
980134|NCT03290755|sexual transmitted|sexual transmitted
980135|NCT03290755|men who have sex with men|men who have sex with men
980136|NCT03290755|HIV positive|hiv positive
980137|NCT03290755|sexual behaviour|sexual behaviour
980138|NCT03290729|wedge implants; atrophic bone|wedge implants; atrophic bone
980139|NCT03290664|AML|aml
980140|NCT03290638|Guided Bone Regeneration|guided bone regeneration
980141|NCT03290638|Dehydrated Human Amnion Chorion Membrane|dehydrated human amnion chorion membrane
980142|NCT03290638|Type I Bovine Collagen Membrane|type i bovine collagen membrane
980143|NCT03290638|Ridge Preservation|ridge preservation
980144|NCT03290638|Ridge Healing|ridge healing
980145|NCT03290638|Teeth Extraction|teeth extraction
980146|NCT03290612|Sleep|sleep
980147|NCT03290612|Vitamin C|vitamin c
980148|NCT03290599|Cognitive dysfunction|cognitive dysfunction
980149|NCT03290599|Hip Surgery|hip surgery
980150|NCT03290599|Mini mental Test,|mini mental test,
980151|NCT03290599|Preoperative Hospitalisation|preoperative hospitalisation
980152|NCT03290599|Spinal Anesthesia|spinal anesthesia
980153|NCT03290534|wedge resection|wedge resection
980154|NCT03290534|sublobar resection|sublobar resection
980155|NCT03290534|brachytherapy|brachytherapy
980156|NCT03290534|CivaSheet|civasheet
980157|NCT03290534|Pd-103|pd-103
980158|NCT03290534|CivaTech Oncology|civatech oncology
980159|NCT03290521|pain|pain
980160|NCT03290521|laparoscopy|laparoscopy
980161|NCT03290521|washing|washing
980162|NCT03290521|intraperitoneal irrigation|intraperitoneal irrigation
980163|NCT03290508|Prolaris|prolaris
980164|NCT03290508|Prostate Cancer|prostate cancer
980165|NCT03290508|Cell Cycle Progression Test|cell cycle progression test
980166|NCT03290495|ketamine|ketamine
980167|NCT03290495|isoflurane|isoflurane
980168|NCT03290495|electroencephalography|electroencephalography
980169|NCT03290495|maintenance|maintenance
980170|NCT03290495|recovery|recovery
980171|NCT03290495|anesthesia|anesthesia
980172|NCT03290469|ICU|icu
980173|NCT03290469|Intensive Care Unit|intensive care unit
980174|NCT03290456|Vasculitis|vasculitis
980175|NCT03290456|GPA|gpa
980176|NCT03290456|Granulomatosis with Polyangitis|granulomatosis with polyangitis
980177|NCT03290456|MPA|mpa
980178|NCT03290456|Microscopic Polyangitis|microscopic polyangitis
980179|NCT03290456|Systemic anti-neutrophil cytoplasmic antibodies (ANCA)|systemic anti-neutrophil cytoplasmic antibodies (anca)
980180|NCT03290456|Prednisone|prednisone
980181|NCT03290456|glucocorticoids|glucocorticoids
980182|NCT03290456|Remission Maintenance|remission maintenance
980183|NCT03290456|Rituximab|rituximab
980184|NCT03290456|Cyclophosphamide|cyclophosphamide
980185|NCT03290443|Hepatic|hepatic
980186|NCT03290443|Pharmacokinetics|pharmacokinetics
980187|NCT03290443|Phase 1|phase 1
980188|NCT03290443|Enasidenib|enasidenib
980189|NCT03290443|CC-90007|cc-90007
980190|NCT03290430|Nicotine Dependence|nicotine dependence
980191|NCT03290430|applied behavioral research|applied behavioral research
980192|NCT03290417|Active Surveillance|active surveillance
980193|NCT03290417|Vitamin D|vitamin d
980194|NCT03290417|Omega-3 Fatty Acid|omega-3 fatty acid
980195|NCT03290417|tumeric curcumin|tumeric curcumin
980196|NCT03290404|Axillary Block|axillary block
980197|NCT03290404|LidocaÏne 1% adrenaliné|lidocaïne 1% adrenaliné
980198|NCT03290391|Russia|russia
980199|NCT03290391|Substance use|substance use
980200|NCT03290391|Peer case managers|peer case managers
980201|NCT03290391|ART|art
980202|NCT03290391|HIV|hiv
980203|NCT03290365|Platelet rich plasma|platelet rich plasma
980204|NCT03290365|Osteoarthritis of knee|osteoarthritis of knee
980205|NCT03290365|Hyaluronic acid|hyaluronic acid
980206|NCT03290339|one-day surgery|one-day surgery
980207|NCT03290339|hysterectomy|hysterectomy
980208|NCT03290339|ambulatory|ambulatory
980209|NCT03290326|Alzheimer|alzheimer
980210|NCT03290326|Memory Problems|memory problems
980211|NCT03290313|Depression|depression
980212|NCT03290313|erectile dysfunction|erectile dysfunction
980213|NCT03290313|shu gan yi yang|shu gan yi yang
980214|NCT03290300|Nasal valve|nasal valve
980215|NCT03290300|Nasal airway obstruction|nasal airway obstruction
980216|NCT03290300|Quality of Life|quality of life
980217|NCT03290287|COPD|copd
980218|NCT03290274|Deep brain stimulation|deep brain stimulation
980219|NCT03290274|Alzheimer´s Disease|alzheimer´s disease
980220|NCT03290274|Fornix|fornix
980221|NCT03290274|Basal nucleus of Meynert|basal nucleus of meynert
980222|NCT03290222|Respiratory symptoms|respiratory symptoms
980223|NCT03290222|Children|children
980224|NCT03290209|Stomach Neoplasm|stomach neoplasm
980225|NCT03290209|Elderly Patients|elderly patients
980226|NCT03290209|Laparoscopic D1 Lymphadenectomy|laparoscopic d1 lymphadenectomy
980227|NCT03290196|Shoulder|shoulder
980228|NCT03290196|Rotator cuff|rotator cuff
980229|NCT03290183|Confocal laser endomicroscopy|confocal laser endomicroscopy
980230|NCT03290157|Colonoscopy|colonoscopy
980231|NCT03290157|preparation|preparation
980232|NCT03290157|new media|new media
980233|NCT03290157|SPA|spa
980234|NCT03290157|APP|app
980235|NCT03290144|Cystic fibrosis - Pregnancy - Diabetes|cystic fibrosis - pregnancy - diabetes
980236|NCT03290105|oropharyngeal colonization|oropharyngeal colonization
980237|NCT03290079|metastatic progressive high-grade neuroendocrine|metastatic progressive high-grade neuroendocrine
980238|NCT03290079|progressive high-grade neuroendocrine|progressive high-grade neuroendocrine
980239|NCT03290079|high grade neuroendocrine|high grade neuroendocrine
980240|NCT03290079|carcinoma originating outside of the lung|carcinoma originating outside of the lung
980241|NCT03290079|poorly differentiated neuroendocrine|poorly differentiated neuroendocrine
980242|NCT03290066|Primary Dysmenorrhea|primary dysmenorrhea
980243|NCT03290066|Kinesio Taping|kinesio taping
980244|NCT03289962|Cancer vaccine|cancer vaccine
980245|NCT03289962|Neoantigen|neoantigen
980246|NCT03289962|Personalized|personalized
980247|NCT03289962|Atezolizumab|atezolizumab
980248|NCT03289962|Vaccine|vaccine
980249|NCT03289962|Immunotherapy|immunotherapy
980250|NCT03289962|Anti-PDL1|anti-pdl1
980251|NCT03289962|Checkpoint Inhibitor|checkpoint inhibitor
980252|NCT03289962|Personalized vaccine|personalized vaccine
980253|NCT03289936|preterm|preterm
980254|NCT03289936|ventilation|ventilation
980357|NCT03289338|Active Charcot's disease|active charcot's disease
980257|NCT03289936|cardio-respiratory events|cardio-respiratory events
980262|NCT03289832|Sulforaphane|sulforaphane
980263|NCT03289832|Curcumin|curcumin
980264|NCT03289832|Crucera-SGS|crucera-sgs
980265|NCT03289832|Meriva-SF|meriva-sf
980266|NCT03289832|Skin|skin
980267|NCT03289832|erythema|erythema
980268|NCT03289832|UV|uv
980269|NCT03289832|Sunburn|sunburn
980270|NCT03289832|Inflammation|inflammation
980271|NCT03289832|Redness|redness
980272|NCT03289832|ultra-violet|ultra-violet
980273|NCT03289832|sunlight|sunlight
980274|NCT03289819|TNBC|tnbc
980275|NCT03289819|neoadjuvant chemotherapy|neoadjuvant chemotherapy
980276|NCT03289819|triple negative breast cancer|triple negative breast cancer
980277|NCT03289793|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
980278|NCT03289793|ADHD|adhd
980279|NCT03289793|Children|children
980280|NCT03289793|Inattention|inattention
980281|NCT03289793|Hyperactivity|hyperactivity
980282|NCT03289793|Neurofeedback|neurofeedback
980283|NCT03289793|Neuropsychology|neuropsychology
980284|NCT03289754|knee implant|knee implant
980285|NCT03289754|osteoarthritis|osteoarthritis
980286|NCT03289754|patient-specific|patient-specific
980287|NCT03289754|knee osteoarthritis|knee osteoarthritis
980288|NCT03289741|Octreotide|octreotide
980289|NCT03289741|Lanreotide|lanreotide
980290|NCT03289741|17-422|17-422
980291|NCT03289728|elderly patients|elderly patients
980292|NCT03289728|myocardial infarction|myocardial infarction
980293|NCT03289728|myocardial revascularization strategy|myocardial revascularization strategy
980294|NCT03289728|ischemia imaging|ischemia imaging
980295|NCT03289728|coronary artery disease|coronary artery disease
980296|NCT03289663|synergistic combination|synergistic combination
980297|NCT03289663|insecticide resistance|insecticide resistance
980298|NCT03289663|vectors|vectors
980299|NCT03289650|immunosuppression|immunosuppression
980300|NCT03289624|Care Planning|care planning
980301|NCT03289624|Care Values and Preferences|care values and preferences
980302|NCT03289611|Preeclampsia|preeclampsia
980303|NCT03289611|pregnancy|pregnancy
980304|NCT03289611|biomarkers|biomarkers
980305|NCT03289611|prediction|prediction
980306|NCT03289611|safety|safety
980307|NCT03289611|cost|cost
980308|NCT03289585|Hidradenitis Suppurativa|hidradenitis suppurativa
980309|NCT03289585|Registry|registry
980310|NCT03289546|mindfulness|mindfulness
980311|NCT03289546|exercise|exercise
980312|NCT03289546|cognitive function|cognitive function
980313|NCT03289533|Cancer|cancer
980314|NCT03289533|Hepatocellular carcinoma|hepatocellular carcinoma
980315|NCT03289533|Liver disease|liver disease
980316|NCT03289533|Avelumab|avelumab
980317|NCT03289533|Axitinib|axitinib
980318|NCT03289520|Access Blood Flow Monitoring|access blood flow monitoring
980319|NCT03289520|Clinical Trial Vascular Access|clinical trial vascular access
980320|NCT03289520|Fistula Failure|fistula failure
980321|NCT03289520|Hemodialysis|hemodialysis
980322|NCT03289520|Vascular Access|vascular access
980323|NCT03289507|Longvida Curcumin|longvida curcumin
980324|NCT03289507|Pharmacokinetics|pharmacokinetics
980325|NCT03289494|Slowly Digestible Starch|slowly digestible starch
980326|NCT03289494|SDS|sds
980327|NCT03289494|Type 2 diabetes|type 2 diabetes
980328|NCT03289494|T2D|t2d
980329|NCT03289494|Glycemic response|glycemic response
980330|NCT03289494|Continuous Glucose Monitoring System|continuous glucose monitoring system
980331|NCT03289494|CGMS|cgms
980332|NCT03289481|Heart failure|heart failure
980333|NCT03289481|HFpEF|hfpef
980334|NCT03289481|Nitrate supplement|nitrate supplement
980335|NCT03289455|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
980336|NCT03289455|CD19 Positive|cd19 positive
980337|NCT03289455|CD22 Positive|cd22 positive
980338|NCT03289455|Relapsed Acute Lymphoblastic Leukaemia|relapsed acute lymphoblastic leukaemia
980339|NCT03289455|Refractory Acute Lymphoblastic Leukaemia|refractory acute lymphoblastic leukaemia
980340|NCT03289455|AUTO3|auto3
980341|NCT03289429|Atorvastatin|atorvastatin
980342|NCT03289429|Magnesium sulfate|magnesium sulfate
980343|NCT03289429|POAF|poaf
980344|NCT03289429|Cardiac|cardiac
980345|NCT03289429|Valve|valve
980346|NCT03289416|knee|knee
980347|NCT03289416|osteoarthritis|osteoarthritis
980348|NCT03289416|platelet rich plasma (PRP)|platelet rich plasma (prp)
980349|NCT03289416|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
980350|NCT03289364|Breast Cancer|breast cancer
980351|NCT03289364|Alopecia|alopecia
980352|NCT03289364|Hair Loss|hair loss
980353|NCT03289364|Scalp Cooling|scalp cooling
980354|NCT03289364|Penguin Cold Caps|penguin cold caps
980355|NCT03289338|Zoledronic acid|zoledronic acid
980356|NCT03289338|Methylprednisolone|methylprednisolone
980361|NCT03289325|Mortality|mortality
980362|NCT03289325|Quality of life|quality of life
980363|NCT03289312|sepsis, lymphocyte|sepsis, lymphocyte
980364|NCT03289299|myeloma|myeloma
980365|NCT03289299|MRD|mrd
980366|NCT03289299|smoldering|smoldering
980367|NCT03289286|Breast Cancer|breast cancer
980368|NCT03289286|Ambulatory surgery|ambulatory surgery
980369|NCT03289286|Electronic tool|electronic tool
980370|NCT03289286|e-follow-up|e-follow-up
980371|NCT03289273|Liver cancer|liver cancer
980372|NCT03289273|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
980373|NCT03289273|real-world practice conditions|real-world practice conditions
980374|NCT03289273|safety and effectiveness|safety and effectiveness
980375|NCT03289273|management and treatment of liver cancer|management and treatment of liver cancer
980376|NCT03289260|Condylomata acuminata, Fulguration, Imiquimod|condylomata acuminata, fulguration, imiquimod
980377|NCT03289195|MRI|mri
980378|NCT03289195|Biopsy|biopsy
980379|NCT03289195|17-390|17-390
980380|NCT03289143|Alzheimer Disease|alzheimer disease
980381|NCT03289143|Brain Diseases|brain diseases
980382|NCT03289143|Dementia|dementia
980383|NCT03289143|Neurodegenerative Diseases|neurodegenerative diseases
980384|NCT03289143|Neurocognitive Disorders|neurocognitive disorders
980385|NCT03289117|Urinary catheterization|urinary catheterization
980386|NCT03289117|Gel installation|gel installation
980387|NCT03289117|Novel medical device|novel medical device
980388|NCT03289117|Indwelling urinary catheter|indwelling urinary catheter
980389|NCT03289117|Long-term urinary catheter|long-term urinary catheter
980390|NCT03289117|Male patients|male patients
980391|NCT03289091|aerobic training|aerobic training
980392|NCT03289091|aquatic exercise|aquatic exercise
980394|NCT03289065|Genetic|genetic
980395|NCT03289065|Fabry Disease|fabry disease
980396|NCT03289065|Glycolipid|glycolipid
980397|NCT03289065|lysosomal|lysosomal
980398|NCT03289052|Hyaluronic acid, midface|hyaluronic acid, midface
980399|NCT03289039|Breast Cancer|breast cancer
980400|NCT03289026|Aripiprazole; Acute schizophrenia episode; positive symptoms|aripiprazole; acute schizophrenia episode; positive symptoms
980401|NCT03289000|osteoarthritis|osteoarthritis
980402|NCT03289000|knee arthroplasty|knee arthroplasty
980403|NCT03289000|knee replacement|knee replacement
980404|NCT03289000|patient specific|patient specific
980405|NCT03288974|Multiple Myeloma|multiple myeloma
980406|NCT03288974|POMALYST®|pomalyst®
980407|NCT03288974|Pomalidomide|pomalidomide
980408|NCT03288974|Observational|observational
980409|NCT03288974|Korea|korea
980410|NCT03288974|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
980411|NCT03288974|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
980412|NCT03288935|refugee|refugee
980413|NCT03288935|trauma-informed case management (TICM)|trauma-informed case management (ticm)
980414|NCT03288935|trauma-informed cultural orientation (TICO)|trauma-informed cultural orientation (tico)
980415|NCT03288935|PTSD|ptsd
980416|NCT03288935|depression|depression
980417|NCT03288935|refugee resettlement|refugee resettlement
980418|NCT03288922|Online Hemodiafiltration|online hemodiafiltration
980419|NCT03288922|Super high-flux dialyzer|super high-flux dialyzer
980420|NCT03288922|Protein-bound uremic toxin|protein-bound uremic toxin
980421|NCT03288922|P-cresol|p-cresol
980422|NCT03288896|Adolescence|adolescence
980423|NCT03288896|Alcohol Drinking|alcohol drinking
980424|NCT03288896|Binge Drinking|binge drinking
980425|NCT03288896|I-Change model|i-change model
980426|NCT03288896|Web-based interventions|web-based interventions
980427|NCT03288896|Computer-tailoring|computer-tailoring
980428|NCT03288857|Naspira|naspira
980429|NCT03288857|Suctioning|suctioning
980430|NCT03288857|Nasal suction device|nasal suction device
980431|NCT03288857|Children|children
980432|NCT03288844|LSCD, Holoclar, follow-up|lscd, holoclar, follow-up
980433|NCT03288831|Randomized, double-blinded, placebo-controlled trial|randomized, double-blinded, placebo-controlled trial
980434|NCT03288831|Oral food challenge|oral food challenge
980435|NCT03288753|Cochlear implant|cochlear implant
980439|NCT03288701|heart failure|heart failure
980440|NCT03288701|cardial decompensation|cardial decompensation
980441|NCT03288701|smart scale|smart scale
980442|NCT03288701|bioimpedance analysis|bioimpedance analysis
980443|NCT03288701|whole body water|whole body water
980444|NCT03288675|Major depressive disorder|major depressive disorder
980445|NCT03288675|Treatment resistant depression|treatment resistant depression
980446|NCT03288675|Accelerated intermittent thetaburst stimulation|accelerated intermittent thetaburst stimulation
980447|NCT03288675|Cognitive control training|cognitive control training
980448|NCT03288675|Neuroimaging|neuroimaging
980449|NCT03288662|Computed tomography|computed tomography
980450|NCT03288662|thymic epithelial tumors|thymic epithelial tumors
980451|NCT03288610|Copeptin|copeptin
980452|NCT03288610|Vasopressin|vasopressin
980458|NCT03288597|SUVmax|suvmax
980459|NCT03288597|relationship|relationship
980460|NCT03288584|Arterial stiffness|arterial stiffness
980461|NCT03288584|Endothelial function|endothelial function
980462|NCT03288584|Endothelial glycocalyx|endothelial glycocalyx
980463|NCT03288584|Left ventricular function|left ventricular function
980464|NCT03288584|Apoptosis|apoptosis
980465|NCT03288584|Oxidative stress|oxidative stress
980466|NCT03288571|Diabetes|diabetes
980467|NCT03288571|nephropathy|nephropathy
980468|NCT03288571|Kidney|kidney
980469|NCT03288571|parenchyma|parenchyma
980470|NCT03288571|Wharton Jelly|wharton jelly
980471|NCT03288571|Mesenchymal stem cells|mesenchymal stem cells
980472|NCT03288545|ASG-22ME|asg-22me
980473|NCT03288545|ASG-22CE|asg-22ce
980474|NCT03288545|Antibody-drug conjugate|antibody-drug conjugate
980475|NCT03288545|Antineoplastic agents|antineoplastic agents
980477|NCT03288545|Enfortumab vedotin|enfortumab vedotin
980478|NCT03288545|Locally advanced urothelial cancer|locally advanced urothelial cancer
980479|NCT03288545|Drug therapy|drug therapy
980480|NCT03288545|Metastatic urothelial cancer|metastatic urothelial cancer
980481|NCT03288545|Nectin-4|nectin-4
980482|NCT03288545|Atezolizumab|atezolizumab
980483|NCT03288545|Checkpoint Inhibitors|checkpoint inhibitors
980484|NCT03288545|Pembrolizumab|pembrolizumab
980485|NCT03288532|Renal Cell Carcinoma|renal cell carcinoma
980486|NCT03288532|Immunotherapy|immunotherapy
980487|NCT03288532|Multi-Arm Multi-Stage|multi-arm multi-stage
980488|NCT03288519|Cerebral aneurysm|cerebral aneurysm
980489|NCT03288519|Endovascular therapy|endovascular therapy
980490|NCT03288519|Classic laryngeal mask airway|classic laryngeal mask airway
980491|NCT03288519|Hemodynamic changes|hemodynamic changes
980492|NCT03288493|CAR-T cells|car-t cells
980493|NCT03288454|Ciraparantag|ciraparantag
980494|NCT03288454|PER977|per977
980495|NCT03288454|Apixaban|apixaban
980496|NCT03288454|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
980497|NCT03288441|Hematologic Neoplasms|hematologic neoplasms
980498|NCT03288441|Thrombocytopenia|thrombocytopenia
980499|NCT03288441|Anticoagulants|anticoagulants
980500|NCT03288441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
980501|NCT03288415|Integrated prognostic model|integrated prognostic model
980502|NCT03288389|Membrane Lipid Replacement|membrane lipid replacement
980503|NCT03288389|NTFactor Lipids|ntfactor lipids
980504|NCT03288389|Fibromyalgia|fibromyalgia
980505|NCT03288389|Pain|pain
980506|NCT03288389|Faigue|faigue
980507|NCT03288389|Gastrointestinal symptoms|gastrointestinal symptoms
980508|NCT03288376|obstructive sleep apnea|obstructive sleep apnea
980509|NCT03288376|polysomnography|polysomnography
980510|NCT03288363|tDCS|tdcs
980511|NCT03288363|cognition|cognition
980512|NCT03288350|Phase II Trial|phase ii trial
980513|NCT03288350|Esophago-Gastric Adenocarcinoma|esophago-gastric adenocarcinoma
980514|NCT03288350|Avelumab|avelumab
980515|NCT03288337|Hidradenitis Suppurativa|hidradenitis suppurativa
980516|NCT03288337|Quality of Life|quality of life
980517|NCT03288298|TSCC|tscc
980518|NCT03288298|OSCC|oscc
980519|NCT03288298|luteolin|luteolin
980520|NCT03288298|nanoluteolin|nanoluteolin
980521|NCT03288298|nanotechnology|nanotechnology
980522|NCT03288298|oral cancer|oral cancer
980523|NCT03288298|apoptosis|apoptosis
980524|NCT03288298|PCR|pcr
980525|NCT03288298|MTT|mtt
980526|NCT03288298|ELISA reader|elisa reader
980527|NCT03288285|hemodiafiltration|hemodiafiltration
980528|NCT03288285|pre-dilution|pre-dilution
980529|NCT03288285|post-dilution|post-dilution
980530|NCT03288285|uremic toxins|uremic toxins
980531|NCT03288259|Transnasal endoscopy - Obesity - endoscopy without sedation|transnasal endoscopy - obesity - endoscopy without sedation
980532|NCT03288246|adolescent|adolescent
980533|NCT03288246|HIV|hiv
980534|NCT03288246|point-of-care|point-of-care
980535|NCT03288246|viral load|viral load
980536|NCT03288233|Hemoglobin A1c|hemoglobin a1c
980537|NCT03288233|HbA1c|hba1c
980538|NCT03288233|End tidal carbon monoxide|end tidal carbon monoxide
980544|NCT03288168|Observation|observation
980545|NCT03288168|Molecular Subgroup|molecular subgroup
980546|NCT03288168|NanoString|nanostring
980547|NCT03288155|Parkinson's|parkinson's
980548|NCT03288155|Fatigue|fatigue
980549|NCT03288155|Flavonoid|flavonoid
980550|NCT03288155|Cocoa|cocoa
980551|NCT03288129|monotherapy|monotherapy
980552|NCT03288129|adjunctive therapy|adjunctive therapy
980553|NCT03288129|open-label|open-label
980554|NCT03288129|multicenter|multicenter
980555|NCT03288064|raisins|raisins
980556|NCT03288064|carbohydrates|carbohydrates
980557|NCT03288064|antioxidant capacity|antioxidant capacity
980558|NCT03288064|substrate oxidation|substrate oxidation
980559|NCT03288064|prolonged cycling|prolonged cycling
980560|NCT03288025|Insulin Resistance|insulin resistance
980561|NCT03288025|Inflammation|inflammation
980562|NCT03288025|Right Ventricular Function|right ventricular function
980563|NCT03288025|Metabolism|metabolism
980564|NCT03288025|Glucose|glucose
980565|NCT03287986|Elderly|elderly
980566|NCT03287986|MRI|mri
980567|NCT03287960|LEPR deficiency obesity|lepr deficiency obesity
980568|NCT03287960|setmelanotide|setmelanotide
980569|NCT03287960|RM-493|rm-493
980570|NCT03287960|Leptin receptor|leptin receptor
980571|NCT03287960|Obesity|obesity
980572|NCT03287960|Melanocortin 4 receptor|melanocortin 4 receptor
980573|NCT03287934|selective laser sintering, stereolithography stents|selective laser sintering, stereolithography stents
980574|NCT03287921|pulmonary care|pulmonary care
980575|NCT03287921|COPD|copd
980576|NCT03287921|small airway disease|small airway disease
980577|NCT03287921|hyperinflation|hyperinflation
980578|NCT03287908|Amgen|amgen
980579|NCT03287908|Phase 1|phase 1
980678|NCT03287427|Metastatic|metastatic
980580|NCT03287908|Clinical Trial|clinical trial
980581|NCT03287908|Oncology/Hematology|oncology/hematology
980582|NCT03287908|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
980583|NCT03287908|Immunotherapy|immunotherapy
980584|NCT03287895|Cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
980585|NCT03287895|CPR|cpr
980586|NCT03287895|Decision-making|decision-making
980587|NCT03287895|Advance Care Planning|advance care planning
980588|NCT03287895|End of life|end of life
980589|NCT03287895|Code Status|code status
980590|NCT03287895|Goals of Care|goals of care
980591|NCT03287895|Communication|communication
980592|NCT03287882|preconception supplementation|preconception supplementation
980593|NCT03287882|multiple micronutrients|multiple micronutrients
980594|NCT03287882|low birth weight|low birth weight
980595|NCT03287869|Bipolar|bipolar
980596|NCT03287869|Mania|mania
980597|NCT03287869|Brexpiprazole|brexpiprazole
980598|NCT03287856|Valve-in-valve|valve-in-valve
980599|NCT03287856|TAVI|tavi
980600|NCT03287843|Locally advanced rectal cancer|locally advanced rectal cancer
980601|NCT03287843|Neoadjuvant chemoradiation|neoadjuvant chemoradiation
980602|NCT03287830|text message|text message
980603|NCT03287830|Short message service (SMS)|short message service (sms)
980604|NCT03287830|mHealth|mhealth
980605|NCT03287817|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
980606|NCT03287817|CD19 Positive|cd19 positive
980607|NCT03287817|CD22 Positive|cd22 positive
980608|NCT03287817|Relapsed Diffuse Large B Cell Lymphoma|relapsed diffuse large b cell lymphoma
980609|NCT03287817|Refractory Diffuse Large B Cell Lymphoma|refractory diffuse large b cell lymphoma
980610|NCT03287817|AUTO3|auto3
980611|NCT03287817|PD-1|pd-1
980612|NCT03287817|Anti PD-1 antibody|anti pd-1 antibody
980613|NCT03287804|Multiple Myeloma|multiple myeloma
980614|NCT03287804|Relapsed Multiple Myeloma|relapsed multiple myeloma
980615|NCT03287804|Refractory Multiple Myeloma|refractory multiple myeloma
980616|NCT03287804|AUTO2|auto2
980617|NCT03287778|Pyridoxine|pyridoxine
980618|NCT03287778|Vitamin B6|vitamin b6
980619|NCT03287778|Neurologic Manifestations|neurologic manifestations
980620|NCT03287778|Involuntary Movements|involuntary movements
980621|NCT03287778|Movement Disorder|movement disorder
980622|NCT03287778|Dyskinesias|dyskinesias
980623|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs
980624|NCT03287778|Psychotic Disorders|psychotic disorders
980625|NCT03287778|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
980626|NCT03287778|Signs and Symptoms|signs and symptoms
980627|NCT03287765|Dementia|dementia
980628|NCT03287765|Tauopathies|tauopathies
980629|NCT03287765|cognitive impairment|cognitive impairment
980630|NCT03287765|CNS Diseases|cns diseases
980631|NCT03287765|neurodegenerative disease|neurodegenerative disease
980632|NCT03287739|Upper Extremity|upper extremity
980633|NCT03287739|Cohort Studies|cohort studies
980634|NCT03287739|Prognosis|prognosis
980635|NCT03287726|Probiotics|probiotics
980636|NCT03287726|Appetite Regulation|appetite regulation
980637|NCT03287726|Gastrointestinal microbiome|gastrointestinal microbiome
980638|NCT03287726|Caloric Restriction|caloric restriction
980639|NCT03287726|Body weight maintenance|body weight maintenance
980640|NCT03287726|Body composition|body composition
980641|NCT03287661|chronic pain|chronic pain
980642|NCT03287661|online treatment|online treatment
980643|NCT03287661|acceptance-based therapy|acceptance-based therapy
980644|NCT03287648|optical coherence tomography|optical coherence tomography
980645|NCT03287648|blue fundus autofluorescence|blue fundus autofluorescence
980646|NCT03287596|Spondylarthropathy|spondylarthropathy
980647|NCT03287596|Tendinopathy|tendinopathy
980648|NCT03287596|MRI|mri
980649|NCT03287596|Healthy Volunteer|healthy volunteer
980650|NCT03287570|Osteoarthritis, Knee|osteoarthritis, knee
980651|NCT03287570|Moxibustion|moxibustion
980652|NCT03287544|Aphasia|aphasia
980653|NCT03287544|Rehabilitation|rehabilitation
980654|NCT03287544|Communication|communication
980656|NCT03287531|conventional therapy|conventional therapy
980657|NCT03287518|Endothelial function|endothelial function
980658|NCT03287518|Blood pressure|blood pressure
980659|NCT03287518|Lipid metabolism|lipid metabolism
980660|NCT03287518|EndoPAT score RHI|endopat score rhi
980661|NCT03287492|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
980662|NCT03287492|Neoplasms of uncertain or unknown behavior|neoplasms of uncertain or unknown behavior
980663|NCT03287492|Information Materials|information materials
980664|NCT03287492|Questionnaires|questionnaires
980665|NCT03287492|Surveys|surveys
980666|NCT03287479|vitrification|vitrification
980667|NCT03287479|semi-automated|semi-automated
980668|NCT03287479|manual|manual
980669|NCT03287466|oxygen|oxygen
980670|NCT03287466|oxygen saturation|oxygen saturation
980671|NCT03287466|oxygen concentration|oxygen concentration
980672|NCT03287440|Health Disparities|health disparities
980673|NCT03287440|Lung Diseases|lung diseases
980674|NCT03287440|Self-management|self-management
980675|NCT03287440|Chronic Disease|chronic disease
980676|NCT03287440|Socio-economic status|socio-economic status
980677|NCT03287427|Advanced|advanced
980680|NCT03287401|PACU Delirium|pacu delirium
980681|NCT03287388|Laparoscopic surgery|laparoscopic surgery
980682|NCT03287388|Abdominal working space|abdominal working space
980683|NCT03287388|Moderate neuromuscular blockade|moderate neuromuscular blockade
980684|NCT03287388|Deep neuromuscular blockade|deep neuromuscular blockade
980685|NCT03287388|MRI measurement|mri measurement
980686|NCT03287362|major depressive disorder|major depressive disorder
980687|NCT03287362|cognitive behavioral therapy|cognitive behavioral therapy
980688|NCT03287362|supportive therapy|supportive therapy
980689|NCT03287362|schema therapy|schema therapy
980690|NCT03287362|biomarkers|biomarkers
980691|NCT03287362|neuropsychology|neuropsychology
980692|NCT03287362|circadian rhythm|circadian rhythm
980693|NCT03287336|tranexamic acid|tranexamic acid
980694|NCT03287336|postpartum hemorrhage|postpartum hemorrhage
980695|NCT03287323|palliative care|palliative care
980696|NCT03287323|surgical intensive care|surgical intensive care
980697|NCT03287323|family satisfaction|family satisfaction
1657755|NCT00156884|cisplatin|cisplatin
980698|NCT03287323|ICU decision-making|icu decision-making
980699|NCT03287323|end-of-life care|end-of-life care
980700|NCT03287310|eosinophils|eosinophils
980701|NCT03287310|pharmacokinetics|pharmacokinetics
980702|NCT03287310|First time in Human|first time in human
980703|NCT03287310|GSK3511294|gsk3511294
980704|NCT03287310|pharmacodynamics|pharmacodynamics
980705|NCT03287310|asthma|asthma
980706|NCT03287271|ovarian cancer|ovarian cancer
980707|NCT03287271|cancer|cancer
980708|NCT03287271|ovary|ovary
980709|NCT03287271|carboplatin|carboplatin
980710|NCT03287271|paclitaxel|paclitaxel
980711|NCT03287271|VS-6063|vs-6063
980712|NCT03287271|primary peritoneal carcinoma|primary peritoneal carcinoma
980713|NCT03287271|fallopian tube|fallopian tube
980714|NCT03287271|defactinib|defactinib
980715|NCT03287258|perineal massage|perineal massage
980716|NCT03287258|health education|health education
980717|NCT03287258|perineal tear|perineal tear
980718|NCT03287258|episiotomy|episiotomy
980719|NCT03287258|pelvic floor muscle exercise|pelvic floor muscle exercise
980720|NCT03287245|polycythemia vera|polycythemia vera
980721|NCT03287245|PV|pv
980722|NCT03287245|P vera|p vera
980723|NCT03287245|myeloproliferative diseases|myeloproliferative diseases
980724|NCT03287245|hematologic diseases|hematologic diseases
980725|NCT03287245|myeloproliferative neoplasm|myeloproliferative neoplasm
980726|NCT03287245|MPN|mpn
980727|NCT03287232|Prasterone|prasterone
980728|NCT03287232|DHEA|dhea
980729|NCT03287232|Menopause|menopause
980730|NCT03287232|Sexual Disorder|sexual disorder
980731|NCT03287180|Adolescent Community Reinforcement Approach|adolescent community reinforcement approach
980732|NCT03287180|A-CRA|a-cra
980733|NCT03287180|Opioid-Related Disorders|opioid-related disorders
980734|NCT03287180|Behavior|behavior
980735|NCT03287180|Psychosocial treatment|psychosocial treatment
980736|NCT03287180|Pharmacotherapy|pharmacotherapy
980737|NCT03287180|Randomized controlled|randomized controlled
980738|NCT03287180|Adolescent|adolescent
980739|NCT03287180|Young adult|young adult
980740|NCT03287154|Alcohol Abstinence|alcohol abstinence
980741|NCT03287154|Alcohol Addiction|alcohol addiction
980742|NCT03287154|Alcohol Consumption|alcohol consumption
980743|NCT03287154|Alcohol Dependence|alcohol dependence
980744|NCT03287141|noninvasive ventilation|noninvasive ventilation
980745|NCT03287141|continuous positive airway pressure|continuous positive airway pressure
980746|NCT03287141|intermittent positive-pressure breathing|intermittent positive-pressure breathing
980747|NCT03287141|exercise test|exercise test
980748|NCT03287141|physical endurance|physical endurance
980749|NCT03287141|physical fitness|physical fitness
980750|NCT03287089|Nitrofurantoin|nitrofurantoin
980751|NCT03287089|Prolapse|prolapse
980752|NCT03287089|Pelvic Organ Prolapse|pelvic organ prolapse
980753|NCT03287089|Anti-incontinence procedure|anti-incontinence procedure
980754|NCT03287089|Urinary retention|urinary retention
980755|NCT03287089|Urinary Tract Infection|urinary tract infection
980756|NCT03287089|Short-term catheterization|short-term catheterization
980757|NCT03287076|stroke|stroke
980758|NCT03287076|glucose|glucose
980759|NCT03287076|exenatide|exenatide
980760|NCT03287037|Unipolar depression|unipolar depression
980761|NCT03287037|bipolar depression|bipolar depression
980762|NCT03287037|Transcranial direct current stimulation|transcranial direct current stimulation
980763|NCT03287011|dental plaque|dental plaque
980764|NCT03287011|tooth pastes|tooth pastes
980765|NCT03287011|oral hygiene|oral hygiene
980766|NCT03286998|placenta previa|placenta previa
980767|NCT03286998|color doppler|color doppler
980768|NCT03286998|placenta accreta|placenta accreta
980769|NCT03286998|ultrasonography|ultrasonography
980770|NCT03286933|yoga therapy|yoga therapy
980771|NCT03286933|JIA|jia
980772|NCT03286933|quality of life|quality of life
980773|NCT03286933|pain management|pain management
980774|NCT03286920|home nutrition|home nutrition
980775|NCT03286920|BMI|bmi
980776|NCT03286920|postoperative|postoperative
980777|NCT03286920|body weight|body weight
980778|NCT03286907|Uptake of HPV vaccination|uptake of hpv vaccination
980977|NCT03285399|Nepal|nepal
980779|NCT03286881|Common Mental Disorders|common mental disorders
980780|NCT03286881|Brief Psychological Treatments|brief psychological treatments
980781|NCT03286881|Primary Care|primary care
980782|NCT03286881|Randomized Clinical Trial|randomized clinical trial
980783|NCT03286842|HER2-ve metastatic breast cancer.|her2-ve metastatic breast cancer.
980784|NCT03286842|Germline BRCA1/2 mutations.|germline brca1/2 mutations.
980785|NCT03286842|BRCA1|brca1
980786|NCT03286842|BRCA2|brca2
980787|NCT03286816|type 1 diabetes mellitus|type 1 diabetes mellitus
980788|NCT03286816|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
980789|NCT03286816|lactate|lactate
980790|NCT03286816|MR spectroscopy|mr spectroscopy
980791|NCT03286790|elderly|elderly
980792|NCT03286777|6-prenylnaringenin|6-prenylnaringenin
980793|NCT03286777|Bioavailability|bioavailability
980794|NCT03286777|Pharmacokinetics|pharmacokinetics
980795|NCT03286777|PBMC|pbmc
980796|NCT03286712|Flow mediated dilatation|flow mediated dilatation
980797|NCT03286712|Brachial artery|brachial artery
980798|NCT03286712|Anemia|anemia
980799|NCT03286712|Chronic kidney disease|chronic kidney disease
980800|NCT03286712|Renogen|renogen
980801|NCT03286712|Erythropoietin Alpha|erythropoietin alpha
980802|NCT03286686|optic ataxia|optic ataxia
980803|NCT03286686|posterior parietal cortex functions|posterior parietal cortex functions
980804|NCT03286686|multisensory integration|multisensory integration
980805|NCT03286673|calcium carbonate|calcium carbonate
980806|NCT03286673|calcium phosphate|calcium phosphate
980807|NCT03286673|metabolic effects|metabolic effects
980808|NCT03286673|human study|human study
980809|NCT03286673|calcium and phosphorus metabolism|calcium and phosphorus metabolism
980810|NCT03286660|Exercise tests|exercise tests
980811|NCT03286660|COPD|copd
980812|NCT03286660|Rehabilitation|rehabilitation
980813|NCT03286647|grief, periodontal disease|grief, periodontal disease
980814|NCT03286621|eye tracking|eye tracking
980815|NCT03286621|visual preference|visual preference
980816|NCT03286595|early psychosis|early psychosis
980817|NCT03286595|clinical high risk|clinical high risk
980818|NCT03286595|mobile health|mobile health
980819|NCT03286556|Acute Exacerbation of Idiopathic Pulmonary Fibrosis|acute exacerbation of idiopathic pulmonary fibrosis
980820|NCT03286543|electrical stimulation|electrical stimulation
980821|NCT03286543|neurostimulation|neurostimulation
980822|NCT03286543|TKA pain|tka pain
980823|NCT03286543|pain following total knee replacement|pain following total knee replacement
980824|NCT03286543|total knee arthroplasty|total knee arthroplasty
980825|NCT03286530|Acute Myeloid Leukemia|acute myeloid leukemia
980826|NCT03286530|Acute Myeloid Leukemia in Remission|acute myeloid leukemia in remission
980827|NCT03286530|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
980828|NCT03286517|Puberty, Sexuality|puberty, sexuality
980829|NCT03286491|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
980830|NCT03286478|body image|body image
980831|NCT03286478|school|school
980832|NCT03286478|adolescence|adolescence
980833|NCT03286478|intervention|intervention
980834|NCT03286478|task-shifting|task-shifting
980835|NCT03286465|blood transfusion|blood transfusion
980836|NCT03286452|Antimicrobial|antimicrobial
980837|NCT03286452|Collagen|collagen
980838|NCT03286452|Bioburden|bioburden
980839|NCT03286452|Biofilm|biofilm
980840|NCT03286452|PHMB|phmb
980841|NCT03286452|Chronic wounds|chronic wounds
980842|NCT03286452|Acute wounds|acute wounds
980843|NCT03286426|vision screening|vision screening
980844|NCT03286426|portable fundus camera|portable fundus camera
980845|NCT03286426|acne medication|acne medication
980846|NCT03286400|CTAG|ctag
980847|NCT03286400|TEVAR|tevar
980848|NCT03286387|Memory|memory
980849|NCT03286387|naturalistic|naturalistic
980850|NCT03286387|context|context
980851|NCT03286387|fMRI|fmri
980852|NCT03286387|Attention|attention
980853|NCT03286374|Obesity|obesity
980854|NCT03286374|Occupational rehabilitation|occupational rehabilitation
980855|NCT03286374|Sick leave|sick leave
980856|NCT03286374|Life style treatment|life style treatment
980857|NCT03286335|Brain Tumor|brain tumor
980858|NCT03286283|Rhytides|rhytides
980859|NCT03286283|Wrinkle Reduction|wrinkle reduction
980860|NCT03286283|J-Plasma|j-plasma
980861|NCT03286283|Dermal Resurfacing|dermal resurfacing
980863|NCT03286270|validation tool|validation tool
980864|NCT03286270|Impaired fractures|impaired fractures
980865|NCT03286257|Vascular function|vascular function
980866|NCT03286257|Vascular structure|vascular structure
980867|NCT03286257|Thermoregulation|thermoregulation
980868|NCT03286257|Hot flushes|hot flushes
980869|NCT03286257|Cerebral blood flow|cerebral blood flow
980870|NCT03286257|Exercise training|exercise training
980871|NCT03286231|gluteal venous vasculature|gluteal venous vasculature
980872|NCT03286231|prone position|prone position
980873|NCT03286231|jackknife position|jackknife position
980874|NCT03286153|Hemophilia A|hemophilia a
980875|NCT03286153|FVIII|fviii
980876|NCT03286153|Ideal body weight|ideal body weight
980877|NCT03286153|Actual body weight|actual body weight
980878|NCT03286140|endovenous ablation|endovenous ablation
980879|NCT03286075|DLPFC, tDCS, emotional processing|dlpfc, tdcs, emotional processing
980880|NCT03286036|Biomarkers, early detection|biomarkers, early detection
980881|NCT03286023|brain metastases|brain metastases
980882|NCT03286023|stereotactic radiation|stereotactic radiation
980883|NCT03286023|cyberknife|cyberknife
980884|NCT03285997|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
980885|NCT03285945|Positron-Emission Tomography|positron-emission tomography
980886|NCT03285932|Brain Metastase|brain metastase
980887|NCT03285932|Radiation of resection cavity|radiation of resection cavity
980888|NCT03285932|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
980889|NCT03285932|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
980890|NCT03285919|perturbed walking|perturbed walking
980891|NCT03285919|stepping response|stepping response
980893|NCT03285854|Dialysis|dialysis
980894|NCT03285854|calcium|calcium
980895|NCT03285854|mineral and bone disorder (MBD)|mineral and bone disorder (mbd)
980896|NCT03285854|calcification|calcification
980897|NCT03285854|DEXA|dexa
980898|NCT03285854|peripheral quantitative CT scan (pqCT)|peripheral quantitative ct scan (pqct)
980899|NCT03285841|cervical cancer|cervical cancer
980900|NCT03285841|vulvar cancer|vulvar cancer
980901|NCT03285841|optical coherence tomography|optical coherence tomography
980902|NCT03285841|autofluorescence imaging|autofluorescence imaging
980903|NCT03285828|medical education, motivational interviewing, medical empathy|medical education, motivational interviewing, medical empathy
980904|NCT03285789|Dyslexia|dyslexia
980905|NCT03285789|Visual Fields|visual fields
980906|NCT03285789|visual attention span|visual attention span
980907|NCT03285789|visual search|visual search
980908|NCT03285789|visual attention field|visual attention field
980909|NCT03285750|GRP120|grp120
980910|NCT03285750|Adipose tissue|adipose tissue
980911|NCT03285750|Type 2 diabetes|type 2 diabetes
980912|NCT03285737|Protein ingestion|protein ingestion
980913|NCT03285737|Muscle protein synthesis|muscle protein synthesis
980914|NCT03285685|Analgesia|analgesia
980915|NCT03285685|Facial pain|facial pain
980916|NCT03285685|Transcranial Direct Current Stimulation|transcranial direct current stimulation
980917|NCT03285685|Temporomandibular disorders|temporomandibular disorders
980918|NCT03285672|Hot Flashes, vasomotor symptoms, postmenopausal|hot flashes, vasomotor symptoms, postmenopausal
980919|NCT03285659|depression|depression
980920|NCT03285659|Primary Health Care|primary health care
980921|NCT03285659|Health Plan Implementation|health plan implementation
980922|NCT03285659|Collaborative care|collaborative care
980923|NCT03285659|Patient-Centered Care|patient-centered care
980924|NCT03285646|Knee|knee
980925|NCT03285646|Hip|hip
980926|NCT03285555|barbed suture|barbed suture
980927|NCT03285555|knoteless suture|knoteless suture
980928|NCT03285555|closure|closure
980929|NCT03285555|wound|wound
980930|NCT03285555|time|time
980931|NCT03285555|total hip arthroplasty|total hip arthroplasty
980932|NCT03285542|adhesive|adhesive
980933|NCT03285542|total knee arthroplasty|total knee arthroplasty
980934|NCT03285542|wound|wound
980935|NCT03285542|closure|closure
980936|NCT03285542|time|time
980937|NCT03285542|barbed suture|barbed suture
980938|NCT03285542|knoteless suture|knoteless suture
980939|NCT03285529|barbed suture|barbed suture
980940|NCT03285529|knoteless suture|knoteless suture
980941|NCT03285529|total knee arthroplasty|total knee arthroplasty
980942|NCT03285529|wound|wound
980943|NCT03285529|closure|closure
980944|NCT03285529|time|time
980945|NCT03285516|transdiagnostic treatment|transdiagnostic treatment
980946|NCT03285516|emotional disorders|emotional disorders
980947|NCT03285516|veterans|veterans
980948|NCT03285516|rural|rural
980949|NCT03285490|Actinic Keratosis|actinic keratosis
980950|NCT03285490|Keratosis|keratosis
980951|NCT03285490|Keratosis, Actinic|keratosis, actinic
980952|NCT03285490|Precancerous Conditions|precancerous conditions
980954|NCT03285490|Sun Damaged Skin|sun damaged skin
980955|NCT03285490|Actinic Keratoses|actinic keratoses
980956|NCT03285477|Actinic Keratosis|actinic keratosis
980957|NCT03285477|Keratosis|keratosis
980958|NCT03285477|Keratosis, Actinic|keratosis, actinic
980959|NCT03285477|Skin Diseases|skin diseases
980960|NCT03285477|Actinic Keratoses|actinic keratoses
980961|NCT03285477|Precancerous Conditions|precancerous conditions
980962|NCT03285477|Neoplasms|neoplasms
980963|NCT03285464|knee|knee
980965|NCT03285464|exercise|exercise
980966|NCT03285464|proximal control|proximal control
980967|NCT03285464|PFPS|pfps
980968|NCT03285451|Submental ultrasound, Obstructive sleep apnea|submental ultrasound, obstructive sleep apnea
980969|NCT03285438|Venous Thromboembolism|venous thromboembolism
980970|NCT03285438|Anticoagulant|anticoagulant
980971|NCT03285438|Direct oral anticoagulant|direct oral anticoagulant
980972|NCT03285438|risk of recurrent venous thromboembolism|risk of recurrent venous thromboembolism
980973|NCT03285438|anticoagulant-related bleeding|anticoagulant-related bleeding
980974|NCT03285425|Batten's disease|batten's disease
980975|NCT03285425|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
980976|NCT03285412|Breast Cancer|breast cancer
980978|NCT03285399|Breastfeeding|breastfeeding
980979|NCT03285399|Micronutrients|micronutrients
980980|NCT03285399|Women|women
980981|NCT03285399|Infants|infants
980982|NCT03285360|Bifluoride, sylc, hypersensitivity,|bifluoride, sylc, hypersensitivity,
980983|NCT03285347|parkinson|parkinson
980984|NCT03285347|executive dysfunction|executive dysfunction
980985|NCT03285347|attention|attention
980986|NCT03285347|computer-based cognitive training|computer-based cognitive training
980987|NCT03285321|Nivolumab|nivolumab
980988|NCT03285321|Ipilimumab|ipilimumab
980989|NCT03285321|immunotherapy|immunotherapy
980990|NCT03285269|shock|shock
980991|NCT03285269|ultrasound|ultrasound
980992|NCT03285256|Prospective memory, working memory, substance abuse|prospective memory, working memory, substance abuse
980993|NCT03285243|Delirium, anesthesia, pediatrics|delirium, anesthesia, pediatrics
980994|NCT03285217|HMB|hmb
980995|NCT03285204|optical coherence tomography|optical coherence tomography
980996|NCT03285204|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
980997|NCT03285191|NRS|nrs
980998|NCT03285191|Concept elicitation|concept elicitation
980999|NCT03285191|Real-time data capture|real-time data capture
981000|NCT03285191|Rheumatoid arthritis|rheumatoid arthritis
981001|NCT03285191|GSK3196165|gsk3196165
981002|NCT03285178|Sickle Cell Disease|sickle cell disease
981003|NCT03285178|SCD|scd
981004|NCT03285152|Ketogenic Diet|ketogenic diet
981005|NCT03285152|17-396|17-396
981006|NCT03285139|Postpartum depression|postpartum depression
981007|NCT03285139|CBT|cbt
981008|NCT03285139|Lay Peer|lay peer
981009|NCT03285074|Diagnostic discordance of obesity|diagnostic discordance of obesity
981010|NCT03285074|all-cause mortality|all-cause mortality
981011|NCT03285048|cognitive impairment|cognitive impairment
981012|NCT03285035|Cryotherapy|cryotherapy
981013|NCT03285035|Palliation|palliation
981014|NCT03285035|Dysphagia|dysphagia
981015|NCT03285022|Incomplete caries removel|incomplete caries removel
981016|NCT03285022|Partial caries removel|partial caries removel
981017|NCT03284970|Interferon beta-1a|interferon beta-1a
981018|NCT03284970|Dimethyl fumarate|dimethyl fumarate
981019|NCT03284970|Rebif|rebif
981020|NCT03284970|Tecfidera|tecfidera
981021|NCT03284970|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
981022|NCT03284892|postextubation dysphagia|postextubation dysphagia
981023|NCT03284892|endotracheal intubation|endotracheal intubation
981024|NCT03284892|randomized controlled trial|randomized controlled trial
981025|NCT03284892|dysphagia intervention;|dysphagia intervention;
981026|NCT03284892|dysphagia screening,|dysphagia screening,
981027|NCT03284879|Psoriasis vulgaris|psoriasis vulgaris
981028|NCT03284879|Psoriasis arthropathica|psoriasis arthropathica
981029|NCT03284879|Serious infections|serious infections
981030|NCT03284879|Gastrointestinal Disorders|gastrointestinal disorders
981031|NCT03284879|Serious Hypersensitivity|serious hypersensitivity
981032|NCT03284879|Weight Decrease|weight decrease
981033|NCT03284879|Vasculitis|vasculitis
981034|NCT03284879|Malignancies|malignancies
981035|NCT03284879|Depression and Suicidal Ideation|depression and suicidal ideation
981036|NCT03284840|dietary intake|dietary intake
981037|NCT03284840|nutritional status|nutritional status
981038|NCT03284840|micronutrients|micronutrients
981039|NCT03284840|thyroid health|thyroid health
981040|NCT03284827|edoxaban|edoxaban
981041|NCT03284827|dual antiplatelet therapy|dual antiplatelet therapy
981042|NCT03284827|cerebral embolization|cerebral embolization
981043|NCT03284827|leaflet thrombosis|leaflet thrombosis
981044|NCT03284814|coenzyme q10|coenzyme q10
981045|NCT03284814|single dose bioavailability|single dose bioavailability
981046|NCT03284814|multiple dose bioavailability|multiple dose bioavailability
981047|NCT03284788|acceptance-based therapy|acceptance-based therapy
981048|NCT03284788|adolescents|adolescents
981049|NCT03284788|weight|weight
981050|NCT03284788|weight loss|weight loss
981051|NCT03284788|obesity|obesity
981052|NCT03284788|overweight|overweight
981053|NCT03284749|Copper Oxide|copper oxide
981054|NCT03284749|Antibiotic Resistance|antibiotic resistance
981055|NCT03284723|HER2|her2
981056|NCT03284723|PF-06804103|pf-06804103
981058|NCT03284723|breast cancer|breast cancer
981059|NCT03284723|gastric cancer|gastric cancer
981060|NCT03284723|esophagogastric cancer|esophagogastric cancer
981061|NCT03284723|non-small cell lung cancer|non-small cell lung cancer
981062|NCT03284723|neoplasms|neoplasms
981063|NCT03284723|solid tumors|solid tumors
981064|NCT03284723|human epidermal growth receptor 2|human epidermal growth receptor 2
981065|NCT03284710|HIV|hiv
981066|NCT03284671|Transcranial Direct Current Stimulation|transcranial direct current stimulation
981067|NCT03284671|Supplementary motor area|supplementary motor area
981068|NCT03284671|Orbitofrontal cortex|orbitofrontal cortex
981069|NCT03284658|Congenital and Genetic Diseases|congenital and genetic diseases
981070|NCT03284658|Digestive Diseases|digestive diseases
981071|NCT03284658|Kidney and Urinary Diseases|kidney and urinary diseases
981072|NCT03284658|Metabolic disorders|metabolic disorders
981073|NCT03284632|Tobacco|tobacco
981074|NCT03284632|E-Cigarettes|e-cigarettes
981075|NCT03284632|Toxicants|toxicants
981076|NCT03284632|Formaldehyde DNA Adducts|formaldehyde dna adducts
981077|NCT03284632|Oxidative Damage|oxidative damage
981078|NCT03284567|Breast cancer|breast cancer
981079|NCT03284567|Football|football
981080|NCT03284567|Late effects|late effects
981081|NCT03284567|Physical exercise|physical exercise
981082|NCT03284567|Soccer training|soccer training
981083|NCT03284567|Rehabilitation|rehabilitation
981084|NCT03284567|Bone mineralization|bone mineralization
981085|NCT03284567|Body composition|body composition
981086|NCT03284567|Fitness|fitness
981087|NCT03284567|Aerobic capacity|aerobic capacity
981088|NCT03284554|Satiety|satiety
981089|NCT03284554|Nutrients|nutrients
981090|NCT03284554|Appetite|appetite
981091|NCT03284554|Encapsulation|encapsulation
981092|NCT03284554|Lipid|lipid
981093|NCT03284554|Amino acid|amino acid
981094|NCT03284554|Probiotic bacteria|probiotic bacteria
981095|NCT03284489|Pancreatitis|pancreatitis
981096|NCT03284476|Nosocomial Peritonitis|nosocomial peritonitis
981097|NCT03284476|Community-acquired Peritonitis|community-acquired peritonitis
981098|NCT03284476|Post-operative Peritonitis|post-operative peritonitis
981099|NCT03284463|acute ischemic stroke|acute ischemic stroke
981100|NCT03284463|glibenclamide|glibenclamide
981101|NCT03284463|rt-PA|rt-pa
981102|NCT03284463|blood-brain barrier|blood-brain barrier
981103|NCT03284463|brain edema|brain edema
981104|NCT03284450|Dance|dance
981105|NCT03284450|Sprint|sprint
981106|NCT03284450|Females|females
981107|NCT03284450|Recovery|recovery
981108|NCT03284424|PD1|pd1
981109|NCT03284424|PD-1|pd-1
981110|NCT03284424|PDL1|pdl1
981111|NCT03284424|PD-L1|pd-l1
981112|NCT03284398|parenteral nutrition|parenteral nutrition
981113|NCT03284398|ICU|icu
981114|NCT03284398|3-chamber bags|3-chamber bags
981115|NCT03284398|ICD-9-CM|icd-9-cm
981116|NCT03284398|BSI|bsi
981117|NCT03284398|Medical records system|medical records system
981118|NCT03284398|computerized|computerized
981119|NCT03284359|Critical Illness|critical illness
981120|NCT03284359|Mechanical Ventilation|mechanical ventilation
981121|NCT03284359|Economics, Behavioral|economics, behavioral
981122|NCT03284359|Surrogate decision maker|surrogate decision maker
981123|NCT03284307|Sedation|sedation
981124|NCT03284307|Propofol|propofol
981125|NCT03284307|Dexmedetomidine|dexmedetomidine
981126|NCT03284307|Ketamine|ketamine
981127|NCT03284307|Sevoflurane|sevoflurane
981128|NCT03284307|Electroencephalogram|electroencephalogram
981129|NCT03284268|Gene therapy|gene therapy
981130|NCT03284255|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
981131|NCT03284255|Percutaneous Coronary Intervention|percutaneous coronary intervention
981132|NCT03284255|Cardiac Catheterization|cardiac catheterization
981133|NCT03284255|Tomography, Optical Coherence|tomography, optical coherence
981134|NCT03284242|Kidney|kidney
981135|NCT03284242|Transplant|transplant
981136|NCT03284229|ELCA|elca
981137|NCT03284229|Coronary Artery Disease|coronary artery disease
981138|NCT03284229|India|india
981139|NCT03284151|prostate cancer|prostate cancer
981140|NCT03284151|good prognosis|good prognosis
981141|NCT03284151|focused treatment|focused treatment
981142|NCT03284151|Cyberknife|cyberknife
981143|NCT03284138|Schizophrenia|schizophrenia
981144|NCT03284138|rTMS|rtms
981145|NCT03284138|first rank symptoms|first rank symptoms
981146|NCT03284112|Dementia, Schools, Nutrition, Health|dementia, schools, nutrition, health
981147|NCT03284086|Oxygen consumption|oxygen consumption
981148|NCT03284086|Physical endurance|physical endurance
981149|NCT03284073|uterus|uterus
981150|NCT03284073|transplantation|transplantation
981151|NCT03284073|infertility|infertility
981152|NCT03284060|Cognitive remediation, 22q11.2 deletion syndrome|cognitive remediation, 22q11.2 deletion syndrome
981153|NCT03284008|Breast Neoplasm|breast neoplasm
981168|NCT03283904|Children|children
981169|NCT03283904|Schools|schools
981170|NCT03283891|Educational intervention|educational intervention
981171|NCT03283891|Watson's theory of human caring|watson's theory of human caring
981172|NCT03283891|Quality of working life of haemodialysis nurses|quality of working life of haemodialysis nurses
981173|NCT03283891|Quality of life of haemodialysis patients|quality of life of haemodialysis patients
981174|NCT03283839|Temporo-mandibular dysfunction|temporo-mandibular dysfunction
981175|NCT03283839|Balance control|balance control
981176|NCT03283839|Orientation function|orientation function
981177|NCT03283826|Multiple Sclerosis|multiple sclerosis
981178|NCT03283826|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
981179|NCT03283826|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
981180|NCT03283826|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
981181|NCT03283826|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
981182|NCT03283826|EBV-associated Multiple Sclerosis|ebv-associated multiple sclerosis
981183|NCT03283826|Inflammation|inflammation
981184|NCT03283826|Central Nervous System|central nervous system
981185|NCT03283826|Autoimmune Disease|autoimmune disease
981186|NCT03283826|Autoimmunity|autoimmunity
981187|NCT03283826|Demyelination|demyelination
981188|NCT03283826|Cell Therapy|cell therapy
981189|NCT03283826|T-cell|t-cell
981190|NCT03283826|Allogeneic|allogeneic
981191|NCT03283813|Paediatric Obesity|paediatric obesity
981192|NCT03283813|Insulin resistance|insulin resistance
981193|NCT03283813|Zinc|zinc
981194|NCT03283813|Myo-inositol|myo-inositol
981195|NCT03283800|Copper Oxide|copper oxide
981196|NCT03283800|Compression Therapy|compression therapy
981197|NCT03283800|Chronic Venous Disease|chronic venous disease
981198|NCT03283800|Randomised Controlled Trial|randomised controlled trial
981199|NCT03283800|Lipodermatosclerosis|lipodermatosclerosis
981200|NCT03283787|Pressure Ulcer|pressure ulcer
981201|NCT03283787|ACell|acell
981202|NCT03283787|ACell MicroMatrix®|acell micromatrix®
981203|NCT03283787|ACell Cytal™|acell cytal™
981204|NCT03283787|Extracellular Matrix|extracellular matrix
981205|NCT03283787|Urinary Bladder Matrix|urinary bladder matrix
981206|NCT03283787|Wound|wound
981207|NCT03283761|FOLFOX|folfox
981208|NCT03283761|Nab-Paclitaxel|nab-paclitaxel
981209|NCT03283735|Deprescribing|deprescribing
981210|NCT03283735|Polypharmacy|polypharmacy
981211|NCT03283735|Elderly|elderly
981212|NCT03283735|Enablement|enablement
981213|NCT03283735|Quality of Life|quality of life
981214|NCT03283683|rest-activity rhythm|rest-activity rhythm
981215|NCT03283683|survival|survival
981216|NCT03283683|actigraphy|actigraphy
981217|NCT03283670|Depression|depression
981218|NCT03283670|treatment-resistant|treatment-resistant
981219|NCT03283644|gastric bypass|gastric bypass
981220|NCT03283644|Obesity|obesity
981221|NCT03283644|Morbid obesity|morbid obesity
981222|NCT03283644|Matched Healthy Controls|matched healthy controls
981223|NCT03283631|Malignant Glioma|malignant glioma
981224|NCT03283631|INTERCEPT|intercept
981225|NCT03283631|Pro00083828|pro00083828
981226|NCT03283631|Adult|adult
981227|NCT03283631|Chimeric Antigen Receptor|chimeric antigen receptor
981228|NCT03283631|CAR T cell|car t cell
981229|NCT03283631|EGFRvIII|egfrviii
981230|NCT03283618|Weight loss|weight loss
981231|NCT03283618|Video conferencing|video conferencing
981232|NCT03283618|Health coaching|health coaching
981233|NCT03283618|Telemedicine|telemedicine
981234|NCT03283618|mHealth|mhealth
981235|NCT03283618|Obesity|obesity
981236|NCT03283566|Pancreatectomy|pancreatectomy
981237|NCT03283566|Autologous Islet Transplantation|autologous islet transplantation
981238|NCT03283566|Pancreatitis|pancreatitis
981239|NCT03283566|Diabetes|diabetes
981240|NCT03283566|Hydroxychloroquine|hydroxychloroquine
981241|NCT03283553|breast cancer|breast cancer
981242|NCT03283540|Low Anterior Resection|low anterior resection
981243|NCT03283501|TAVI|tavi
981244|NCT03283501|PCI|pci
981245|NCT03283488|anorexia|anorexia
981246|NCT03283488|cachexia|cachexia
981247|NCT03283488|mirtazapine|mirtazapine
981248|NCT03283488|megestrol|megestrol
981249|NCT03283488|palliative care|palliative care
981250|NCT03283436|Laparoscopy|laparoscopy
981251|NCT03283436|Superior hypogastric plexus block|superior hypogastric plexus block
981252|NCT03283410|propofol|propofol
981253|NCT03283410|dose-response|dose-response
981254|NCT03283410|elderly|elderly
981255|NCT03283410|young adults|young adults
981256|NCT03283384|Breast cancer|breast cancer
981257|NCT03283384|Ribociclib|ribociclib
981258|NCT03283384|Letrozole|letrozole
981259|NCT03283384|Chemotherapy|chemotherapy
981260|NCT03283384|CDK4|cdk4
981261|NCT03283384|CDK6|cdk6
981262|NCT03283384|Ki67|ki67
981263|NCT03283384|NEOLBC|neolbc
981264|NCT03283371|Drug Resistant Focal Epilepsy, Natalizumab, Seizure|drug resistant focal epilepsy, natalizumab, seizure
981265|NCT03283358|Prevention and control|prevention and control
981266|NCT03283345|breast cancer|breast cancer
981267|NCT03283345|menstrual cycle|menstrual cycle
981268|NCT03283345|breast surgery|breast surgery
981269|NCT03283345|systemic responses to trauma|systemic responses to trauma
981270|NCT03283332|Ethnicity|ethnicity
981271|NCT03283332|adolescents|adolescents
981272|NCT03283332|cohort|cohort
981273|NCT03283332|longitudinal|longitudinal
981274|NCT03283332|health inequalities|health inequalities
981275|NCT03283319|Influenza|influenza
981276|NCT03283319|human|human
981277|NCT03283319|Influenza in Birds|influenza in birds
981278|NCT03283319|Orthomyxoviridae Infections|orthomyxoviridae infections
981279|NCT03283319|RNA Virus Infections|rna virus infections
981280|NCT03283319|Virus Diseases|virus diseases
981281|NCT03283319|Respiratory Tract Infections|respiratory tract infections
981282|NCT03283319|Respiratory Tract Diseases|respiratory tract diseases
981283|NCT03283319|MF59|mf59
981284|NCT03283319|AS03|as03
981285|NCT03283319|Adjuvants|adjuvants
981286|NCT03283319|Immunologic|immunologic
981287|NCT03283293|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
981288|NCT03283293|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
981289|NCT03283293|Target Volume Delineation|target volume delineation
981290|NCT03283293|Locoregional Failure Pattern|locoregional failure pattern
981291|NCT03283293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
981292|NCT03283280|Short fiber reinforced resin composite|short fiber reinforced resin composite
981293|NCT03283280|Nanohybrid resin composite|nanohybrid resin composite
981903|NCT03279510|hearing|hearing
981294|NCT03283280|Indirect resin composite restoration|indirect resin composite restoration
981295|NCT03283267|Healthy Chinese Subjects, Pharmacodynamic Study|healthy chinese subjects, pharmacodynamic study
981296|NCT03283254|Postpartum Depression Treatment|postpartum depression treatment
981297|NCT03283202|Diffuse B-Cell Lymphoma|diffuse b-cell lymphoma
981298|NCT03283202|R-CHOP-21|r-chop-21
981299|NCT03283202|International Prognostic Index (IPI)|international prognostic index (ipi)
981300|NCT03283189|Use of cosmetics|use of cosmetics
981301|NCT03283189|Pregnant women|pregnant women
981302|NCT03283189|Risk perception|risk perception
1657855|NCT00156533|zolpidem|zolpidem
981303|NCT03283189|Preventive attitude|preventive attitude
981304|NCT03283189|Qualitative study|qualitative study
981305|NCT03283150|Deep Brain Stimulation(DBS)|deep brain stimulation(dbs)
981306|NCT03283150|Sedation|sedation
981307|NCT03283150|DBS Implantation|dbs implantation
981308|NCT03283150|Microelectrode recording(MER)|microelectrode recording(mer)
981309|NCT03283137|CLL|cll
981310|NCT03283137|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
981311|NCT03283137|pembrolizumab|pembrolizumab
981312|NCT03283137|TGR-1202|tgr-1202
981313|NCT03283098|Secondary hyperparathyroidism|secondary hyperparathyroidism
981314|NCT03283098|Chronic kidney disease CKD|chronic kidney disease ckd
981315|NCT03283098|Intact parathyroid hormone iPTH|intact parathyroid hormone ipth
981316|NCT03283098|Hemodialysis|hemodialysis
981317|NCT03283085|Immunosuppressants|immunosuppressants
981318|NCT03283085|Mesalamine|mesalamine
981319|NCT03283085|Ulcerative Colitis|ulcerative colitis
981320|NCT03283085|Crohn's disease|crohn's disease
981321|NCT03283085|Gastroenteritis|gastroenteritis
981322|NCT03283072|thermal threshold|thermal threshold
981323|NCT03283072|pressure pain threshold|pressure pain threshold
981324|NCT03283072|temporal summation|temporal summation
981325|NCT03283046|Multiple myeloma|multiple myeloma
981326|NCT03283046|Newly diagnosed|newly diagnosed
981327|NCT03283046|Nivolumab|nivolumab
981328|NCT03283046|BMS-936558|bms-936558
981329|NCT03283046|Opdivo|opdivo
981330|NCT03283046|Lenalidomide|lenalidomide
981331|NCT03283046|CC-5013|cc-5013
981332|NCT03283046|Revlimid|revlimid
981333|NCT03283046|Dexamethasone|dexamethasone
981334|NCT03283046|Decadron|decadron
981335|NCT03283046|Ipilimumab|ipilimumab
981336|NCT03283046|Yervoy|yervoy
981337|NCT03283046|BMS-734016|bms-734016
981338|NCT03283046|MDX010|mdx010
981339|NCT03283033|Children|children
981340|NCT03283033|Plate Waste|plate waste
981341|NCT03283033|Fruit and vegetable intake|fruit and vegetable intake
981342|NCT03283033|School lunch|school lunch
981343|NCT03283033|social marketing|social marketing
981344|NCT03283020|Remifentanil|remifentanil
981345|NCT03283020|Methylnaltrexone|methylnaltrexone
981346|NCT03283020|Pharyngeal dysfunction|pharyngeal dysfunction
981347|NCT03283020|Anesthetic sedation|anesthetic sedation
981348|NCT03283007|Nintedanib, lung transplantation, bronchiolitis obliterans syndrome|nintedanib, lung transplantation, bronchiolitis obliterans syndrome
981349|NCT03282968|exergaming|exergaming
981350|NCT03282968|physiotherapy|physiotherapy
981351|NCT03282968|balance|balance
981352|NCT03282942|hypertension|hypertension
981353|NCT03282942|Aerobic training|aerobic training
981354|NCT03282942|Strength training|strength training
981355|NCT03282916|Valacyclovir|valacyclovir
981356|NCT03282916|Anti-viral treatment|anti-viral treatment
981358|NCT03282890|Substance Abuse|substance abuse
981359|NCT03282890|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
981360|NCT03282890|HIV Risk Behavior|hiv risk behavior
981361|NCT03282890|Methadone Maintenance|methadone maintenance
981362|NCT03282864|asthma|asthma
981363|NCT03282864|air pollution|air pollution
981364|NCT03282864|air filtration|air filtration
981365|NCT03282864|indoor air quality|indoor air quality
981366|NCT03282864|respiratory health|respiratory health
981367|NCT03282851|MSB11456|msb11456
981368|NCT03282851|Actemra®|actemra®
981369|NCT03282851|RoActemra®|roactemra®
981370|NCT03282799|etonogestrel|etonogestrel
981371|NCT03282799|efavirenz|efavirenz
981372|NCT03282799|antiretroviral therapy|antiretroviral therapy
981373|NCT03282799|HIV|hiv
981374|NCT03282786|Inflammatory Bowel Disease|inflammatory bowel disease
981375|NCT03282786|Crohn's Disease|crohn's disease
981376|NCT03282786|Ulcerative Colitis|ulcerative colitis
981377|NCT03282786|Carbon Dioxide (CO2)|carbon dioxide (co2)
981378|NCT03282786|Colonoscopy|colonoscopy
981379|NCT03282773|acute myocardial infarction|acute myocardial infarction
981380|NCT03282773|percutaneous coronary intervention|percutaneous coronary intervention
981381|NCT03282773|deferred stent implantation|deferred stent implantation
981382|NCT03282760|Cell Transplantation|cell transplantation
981383|NCT03282760|Neural Stem Cells|neural stem cells
981384|NCT03282708|intestinal microbiome|intestinal microbiome
981385|NCT03282708|captive great apes|captive great apes
981386|NCT03282708|human beings|human beings
981387|NCT03282695|Disc Herniation|disc herniation
981388|NCT03282695|Lumbar Herniated Disc|lumbar herniated disc
981389|NCT03282695|Ozone Therapy|ozone therapy
981390|NCT03282682|hypogonadism|hypogonadism
981391|NCT03282682|aging male|aging male
982504|NCT03275415|BPD|bpd
981392|NCT03282682|strength training|strength training
981393|NCT03282682|physical activity|physical activity
981394|NCT03282682|testosterone|testosterone
981395|NCT03282669|Pregnancy|pregnancy
981396|NCT03282669|Transcutaneous Carbon Dioxide Monitoring|transcutaneous carbon dioxide monitoring
981397|NCT03282669|Pulse Oximetry|pulse oximetry
981398|NCT03282669|Cesarean Section|cesarean section
981399|NCT03282669|Postoperative pain control|postoperative pain control
981400|NCT03282669|High BMI|high bmi
981401|NCT03282669|Hypercarbia|hypercarbia
981402|NCT03282669|Hypoxemia|hypoxemia
981403|NCT03282656|Gene therapy|gene therapy
981404|NCT03282656|lentivirus vector|lentivirus vector
981405|NCT03282656|BCL11A|bcl11a
981406|NCT03282656|Fetal Hemoglobin|fetal hemoglobin
981407|NCT03282630|Acupuncture|acupuncture
981408|NCT03282630|Sphenopalatine ganglion|sphenopalatine ganglion
981409|NCT03282630|Allergic rhinitis|allergic rhinitis
981410|NCT03282630|Randomized Trial|randomized trial
981411|NCT03282604|Intubation|intubation
981412|NCT03282604|Intratracheal|intratracheal
981413|NCT03282604|Nasopharynx|nasopharynx
981414|NCT03282578|sternum|sternum
981415|NCT03282578|bone healing|bone healing
981416|NCT03282578|recovery|recovery
981417|NCT03282565|ACL|acl
981418|NCT03282565|Quadriceps|quadriceps
981419|NCT03282565|Muscle|muscle
981420|NCT03282565|Resistance Training|resistance training
981421|NCT03282539|Lumen apposing metal stents|lumen apposing metal stents
981422|NCT03282539|Double pigtail stents|double pigtail stents
981423|NCT03282539|Endoscopic ultrasonography|endoscopic ultrasonography
981424|NCT03282513|AG-120|ag-120
981425|NCT03282513|Healthy Volunteer|healthy volunteer
981426|NCT03282513|Clinical Pharmacology|clinical pharmacology
981427|NCT03282513|Hepatic Impairment|hepatic impairment
981428|NCT03282487|cortisol|cortisol
981429|NCT03282487|adrenal insufficiency|adrenal insufficiency
981430|NCT03282487|hypopituitarism|hypopituitarism
981431|NCT03282487|hydrocortisone|hydrocortisone
981432|NCT03282474|Hepatitis E|hepatitis e
981433|NCT03282422|Cerebral palsy|cerebral palsy
981434|NCT03282422|Hemiplegia|hemiplegia
981435|NCT03282422|Upper-limb splint|upper-limb splint
981436|NCT03282422|Home-based|home-based
981437|NCT03282422|Social Participation|social participation
981438|NCT03282409|Prediction|prediction
981439|NCT03282409|Chronic Renal Disease|chronic renal disease
981440|NCT03282409|Acute Kidney Injury|acute kidney injury
981441|NCT03282396|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
981442|NCT03282396|Mantle Cell Lymphoma|mantle cell lymphoma
981443|NCT03282396|MCL|mcl
981444|NCT03282396|Newly-diagnosed|newly-diagnosed
981445|NCT03282396|Ibrutinib|ibrutinib
981446|NCT03282396|PCI-32765|pci-32765
981447|NCT03282396|Imbruvica|imbruvica
981448|NCT03282383|biomarkers pneumonia severity|biomarkers pneumonia severity
981449|NCT03282370|Japanese Encephalitis|japanese encephalitis
981450|NCT03282370|JECEVAX|jecevax
981451|NCT03282370|Vietnam|vietnam
981452|NCT03282344|NKTR-214|nktr-214
981453|NCT03282344|NIVOLUMAB|nivolumab
981454|NCT03282344|17-366|17-366
981455|NCT03282331|Preoxygenation|preoxygenation
981456|NCT03282331|Intubation|intubation
981459|NCT03282331|Alveolar recruitment|alveolar recruitment
981463|NCT03282279|oocyte retrieval|oocyte retrieval
981464|NCT03282279|surgical complications|surgical complications
981466|NCT03282227|migraine|migraine
981467|NCT03282227|migraine headache|migraine headache
981468|NCT03282227|acute migraine|acute migraine
981469|NCT03282227|acute migraine headache|acute migraine headache
981470|NCT03282214|Energy conservation|energy conservation
981471|NCT03282214|Self management|self management
981473|NCT03282175|interleukin-15|interleukin-15
981474|NCT03282175|interleukin-8|interleukin-8
981475|NCT03282175|resistin|resistin
981476|NCT03282175|SPPB|sppb
981477|NCT03282162|Oxytocin|oxytocin
981478|NCT03282162|affective touch|affective touch
981479|NCT03282162|trait autism|trait autism
981480|NCT03282149|inflammation|inflammation
981481|NCT03282149|cytokine|cytokine
981482|NCT03282149|anti-inflammatory|anti-inflammatory
981483|NCT03282149|pain|pain
981484|NCT03282123|MDMA|mdma
981485|NCT03282123|methylenedioxymethamphetamine|methylenedioxymethamphetamine
981486|NCT03282123|psychotherapy|psychotherapy
981487|NCT03282071|Mental health|mental health
981488|NCT03282071|Mental well-being|mental well-being
981489|NCT03282071|Community-based engagement|community-based engagement
981490|NCT03282071|Positive psychology|positive psychology
981491|NCT03282071|Public health approach|public health approach
981492|NCT03282058|Silastic Stenting|silastic stenting
981493|NCT03282058|Trans-nasal Endoscopic Surgery|trans-nasal endoscopic surgery
981494|NCT03282058|Post-operative Intra-nasal Re-mucosalization|post-operative intra-nasal re-mucosalization
981495|NCT03282045|acute sore throat|acute sore throat
981496|NCT03282045|lysobact|lysobact
981497|NCT03282019|myAIRVO2|myairvo2
981498|NCT03282019|high-flow nasal cannula therapy|high-flow nasal cannula therapy
981499|NCT03282019|home oxygen therapy|home oxygen therapy
981500|NCT03282019|HOT|hot
981501|NCT03282019|COPD|copd
981502|NCT03282006|Pivmecillinam|pivmecillinam
981503|NCT03281993|apnea test, brain death, pupillometry|apnea test, brain death, pupillometry
981504|NCT03281980|Bangladesh|bangladesh
981505|NCT03281980|Child development|child development
981506|NCT03281980|Poor mothers|poor mothers
981507|NCT03281980|Psycho social stimulation|psycho social stimulation
981508|NCT03281980|Unconditional cash transfer|unconditional cash transfer
981509|NCT03281954|anti-PD-L1 antibody|anti-pd-l1 antibody
981510|NCT03281954|TNBC|tnbc
981511|NCT03281915|infertility|infertility
981512|NCT03281915|pain|pain
981513|NCT03281915|pregnancy|pregnancy
981514|NCT03281889|Brain Tumor|brain tumor
981515|NCT03281876|Immunogenicity|immunogenicity
981516|NCT03281876|Vaccination|vaccination
981517|NCT03281876|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
981518|NCT03281876|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
981519|NCT03281876|Acute exacerbation of COPD|acute exacerbation of copd
981520|NCT03281876|Moraxella catarrhalis|moraxella catarrhalis
981521|NCT03281876|Efficacy|efficacy
981522|NCT03281876|Safety|safety
981523|NCT03281837|osteoarthritis|osteoarthritis
981524|NCT03281837|knee osteoarthritis|knee osteoarthritis
981525|NCT03281837|patellofemoral osteoarthritis|patellofemoral osteoarthritis
981526|NCT03281837|tibiofemoral osteoarthritis|tibiofemoral osteoarthritis
981527|NCT03281837|hyaluronan|hyaluronan
981528|NCT03281837|hyaluronic acid|hyaluronic acid
981529|NCT03281837|intra-articular|intra-articular
981530|NCT03281837|arthritis|arthritis
981531|NCT03281837|joint disease|joint disease
981532|NCT03281837|active|active
981533|NCT03281837|viscosupplements|viscosupplements
981534|NCT03281837|Hymovis|hymovis
981535|NCT03281824|HER2 Positive Breast Cancer|her2 positive breast cancer
981536|NCT03281824|ALT-P7|alt-p7
981537|NCT03281824|Antibody-Drug Conjugate|antibody-drug conjugate
981538|NCT03281772|hypertension|hypertension
981539|NCT03281772|clinical decision support software|clinical decision support software
981540|NCT03281772|renin|renin
981541|NCT03281772|aldosterone|aldosterone
981542|NCT03281759|Brain Injuries, Traumatic;|brain injuries, traumatic;
981543|NCT03281759|Diffuse Axonal Injury|diffuse axonal injury
981544|NCT03281759|Low-Level Light Therapy|low-level light therapy
981545|NCT03281759|Neurologic Manifestations|neurologic manifestations
981546|NCT03281759|Quality of Life|quality of life
981547|NCT03281759|Rehabilitation|rehabilitation
981548|NCT03281733|malnutrition|malnutrition
981549|NCT03281733|adult|adult
981550|NCT03281733|hospitalized patients|hospitalized patients
981551|NCT03281733|dietitian|dietitian
981552|NCT03281733|communication|communication
981553|NCT03281733|discharge|discharge
981554|NCT03281733|nutrition|nutrition
981555|NCT03281707|NIRS|nirs
981556|NCT03281707|DO2|do2
981557|NCT03281694|nicotine|nicotine
981558|NCT03281694|positive allosteric modulator|positive allosteric modulator
981559|NCT03281694|attention|attention
981560|NCT03281694|cognition|cognition
981561|NCT03281681|adenocarcinoma of the ovary|adenocarcinoma of the ovary
981562|NCT03281681|ovarian adenocarcinoma|ovarian adenocarcinoma
981563|NCT03281681|ovarian cancer|ovarian cancer
981564|NCT03281681|cancer of the ovary|cancer of the ovary
981565|NCT03281681|ovarian neoplasm|ovarian neoplasm
981566|NCT03281681|AO|ao
981567|NCT03281681|ovarian carcinoma|ovarian carcinoma
981568|NCT03281668|Knee osteoarthritis|knee osteoarthritis
981569|NCT03281655|Visnadine|visnadine
981570|NCT03281655|Prenylflavonoids|prenylflavonoids
981571|NCT03281655|Bovine colostrum|bovine colostrum
981572|NCT03281655|Sexual wellbeing|sexual wellbeing
981573|NCT03281629|Transcranial magnetic stimulation|transcranial magnetic stimulation
981574|NCT03281629|schizophrenia|schizophrenia
981575|NCT03281629|MRI|mri
981576|NCT03281629|smoking|smoking
981577|NCT03281603|Patient satisfaction|patient satisfaction
981578|NCT03281603|Retention|retention
981579|NCT03281590|identification|identification
981580|NCT03281590|diagnosis|diagnosis
981581|NCT03281590|management|management
981582|NCT03281590|investigation|investigation
981583|NCT03281590|prevalence|prevalence
981584|NCT03281590|incidence|incidence
981585|NCT03281590|quality of care|quality of care
981586|NCT03281590|hospitalization|hospitalization
981587|NCT03281590|morbidity|morbidity
981588|NCT03281590|disability|disability
981589|NCT03281577|Drug Therapy|drug therapy
981590|NCT03281525|cardiotransplant|cardiotransplant
981591|NCT03281512|Saturated fatty acids|saturated fatty acids
981592|NCT03281512|CHNS|chns
981593|NCT03281473|ARDS; esophageal pressure; Mechanical ventilation|ards; esophageal pressure; mechanical ventilation
981594|NCT03281460|Hysterectomy, Vaginal|hysterectomy, vaginal
981595|NCT03281460|Uterine Myomatosis|uterine myomatosis
981596|NCT03281460|Morcellation|morcellation
981597|NCT03281460|Laparoscopy|laparoscopy
981598|NCT03281460|in-bag morcellation|in-bag morcellation
981599|NCT03281447|Nurse navigation|nurse navigation
981600|NCT03281447|Family|family
981601|NCT03281447|Self Efficacy|self efficacy
981602|NCT03281447|Needs assessment|needs assessment
981603|NCT03281447|Quality of Life|quality of life
981604|NCT03281447|Colorectal Neoplasms|colorectal neoplasms
981605|NCT03281447|Case Management|case management
981606|NCT03281434|Skeletal muscle|skeletal muscle
981607|NCT03281434|Protein synthesis|protein synthesis
981608|NCT03281434|Protein ingestion|protein ingestion
981609|NCT03281434|Resistance exercise|resistance exercise
981610|NCT03281356|Pilot Study|pilot study
981611|NCT03281356|Early childhood development|early childhood development
981612|NCT03281343|PrEP|prep
981613|NCT03281343|Women|women
999133|NCT03169101|HIV|hiv
981614|NCT03281343|Linkage to Care|linkage to care
981615|NCT03281317|vasoplegicsyndrome|vasoplegicsyndrome
981616|NCT03281317|cardiac surgery|cardiac surgery
981617|NCT03281317|predictive risk score|predictive risk score
981618|NCT03281304|ulcerative colitis|ulcerative colitis
981619|NCT03281304|inflammatory bowel disease|inflammatory bowel disease
981620|NCT03281291|malaria vaccine|malaria vaccine
981621|NCT03281291|infants|infants
981622|NCT03281291|Malaria|malaria
981623|NCT03281291|RTS,S/AS01|rts,s/as01
981624|NCT03281291|falciparum|falciparum
981625|NCT03281291|genomics|genomics
981626|NCT03281291|efficacy|efficacy
981627|NCT03281278|Thrombelastography,acute on chronic liver failure, platelet|thrombelastography,acute on chronic liver failure, platelet
981628|NCT03281265|pre-acute-on-chronic liver failure|pre-acute-on-chronic liver failure
981629|NCT03281265|hepatitis B|hepatitis b
981630|NCT03281252|liver failure|liver failure
981631|NCT03281239|welder, airport agent, Welding fumes|welder, airport agent, welding fumes
981632|NCT03281226|Pulmonary tuberculosis|pulmonary tuberculosis
981633|NCT03281226|HIV/AIDS|hiv/aids
981634|NCT03281226|Glutathione|glutathione
981635|NCT03281226|N-acetylcysteine|n-acetylcysteine
981636|NCT03281226|Oxidative stress|oxidative stress
981637|NCT03281187|Hormonal reposition, Testosterone nasal, Nasotestt|hormonal reposition, testosterone nasal, nasotestt
981638|NCT03281174|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
981639|NCT03281174|5-year Immune Persistence|5-year immune persistence
981640|NCT03281161|skin cancer|skin cancer
981641|NCT03281161|prevention|prevention
981642|NCT03281161|worksite|worksite
981643|NCT03281161|policy|policy
981644|NCT03281161|cost and effectiveness|cost and effectiveness
981645|NCT03281161|implementation|implementation
981646|NCT03281148|immediate implants, accuracy,extraction sockets|immediate implants, accuracy,extraction sockets
981647|NCT03281135|Cervical cancer screening|cervical cancer screening
981648|NCT03281135|Adherance|adherance
981649|NCT03281135|HPV typing|hpv typing
981650|NCT03281135|HDSS|hdss
981651|NCT03281135|Ethiopia|ethiopia
981652|NCT03281109|menstrual cycle|menstrual cycle
981653|NCT03281109|gingivitis|gingivitis
981654|NCT03281109|interleukin 1|interleukin 1
981655|NCT03281109|tumor necrosis factor alpha|tumor necrosis factor alpha
981656|NCT03281083|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
981657|NCT03281083|Diabetes Mellitus, type 2|diabetes mellitus, type 2
981759|NCT03280433|Proteome|proteome
981658|NCT03281083|Thyroid hormone|thyroid hormone
981659|NCT03281083|Levothyroxine|levothyroxine
981660|NCT03281070|Anastomotic leakage|anastomotic leakage
981661|NCT03281070|Anterior resection|anterior resection
981662|NCT03281070|Risk factors|risk factors
981663|NCT03281070|Incidence|incidence
981664|NCT03281070|Rectal Cancer|rectal cancer
981665|NCT03281031|MRI|mri
981666|NCT03281031|Acute abdominal pain|acute abdominal pain
981667|NCT03281031|Pelvic pain|pelvic pain
981668|NCT03281031|Diagnostic performance|diagnostic performance
981669|NCT03281031|Young women|young women
981670|NCT03281018|hypnosis|hypnosis
981671|NCT03281018|preoperative anxiety|preoperative anxiety
981672|NCT03281018|hysterectomy|hysterectomy
981673|NCT03281018|hospitalisation|hospitalisation
981674|NCT03281005|Retinitis pigmentosa|retinitis pigmentosa
981675|NCT03281005|Visual function evaluation|visual function evaluation
981676|NCT03280940|Inflammation|inflammation
981677|NCT03280940|Immune activation|immune activation
981678|NCT03280940|Integrase Inhibitors|integrase inhibitors
981679|NCT03280940|Naive patients|naive patients
981680|NCT03280927|Onychomycosis|onychomycosis
981681|NCT03280914|obstructive sleep apnea|obstructive sleep apnea
981682|NCT03280914|real world|real world
981683|NCT03280914|community|community
981684|NCT03280901|renal replacement therapy|renal replacement therapy
981685|NCT03280901|haemodialysis|haemodialysis
981686|NCT03280901|haemodiafiltration|haemodiafiltration
981687|NCT03280862|Heart Failure|heart failure
981688|NCT03280862|Branch Block|branch block
981689|NCT03280862|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
981690|NCT03280849|chitosan|chitosan
981691|NCT03280849|endoscopic|endoscopic
981692|NCT03280849|sellar tumor|sellar tumor
981693|NCT03280849|biomaterials|biomaterials
981694|NCT03280849|transphenoidal|transphenoidal
981695|NCT03280823|complement system|complement system
981696|NCT03280810|Schizophrenia|schizophrenia
981697|NCT03280810|Postural|postural
981698|NCT03280810|Cognitive|cognitive
981699|NCT03280810|task|task
981700|NCT03280758|Resistance training|resistance training
981701|NCT03280758|Diabetes Mellitus|diabetes mellitus
981702|NCT03280758|blood-glucose control|blood-glucose control
981703|NCT03280758|Muscle|muscle
981704|NCT03280758|Function|function
981705|NCT03280732|Lung Ultrasound|lung ultrasound
981706|NCT03280732|Chest X-Ray|chest x-ray
981707|NCT03280732|Pneumonia|pneumonia
981708|NCT03280732|Pneumothorax|pneumothorax
981709|NCT03280732|Pleural effusion|pleural effusion
981710|NCT03280719|Prone position|prone position
981711|NCT03280719|Supine position|supine position
981712|NCT03280719|Hypofractionation|hypofractionation
981713|NCT03280719|Accelerated radiotherapy|accelerated radiotherapy
981714|NCT03280719|Regional nodal irradiation|regional nodal irradiation
981715|NCT03280706|Gastric Emptying|gastric emptying
981716|NCT03280706|labor|labor
981717|NCT03280706|maltodextrin|maltodextrin
981718|NCT03280706|orange juice|orange juice
981719|NCT03280706|coffee|coffee
981720|NCT03280706|ultrasound|ultrasound
981721|NCT03280693|Body mass index,|body mass index,
981722|NCT03280693|Bone density|bone density
981723|NCT03280693|Balance|balance
981724|NCT03280693|Postmenopause|postmenopause
981725|NCT03280680|Violence against young women and girls|violence against young women and girls
981726|NCT03280680|Sexual and reproductive health and rights|sexual and reproductive health and rights
981727|NCT03280680|Consent|consent
981728|NCT03280680|Health services|health services
981729|NCT03280680|Legal services|legal services
981730|NCT03280680|Awareness raising|awareness raising
981731|NCT03280680|Community mobilization|community mobilization
981732|NCT03280654|Obesity|obesity
981733|NCT03280654|Overactive Bladder|overactive bladder
981734|NCT03280654|Urinary incontinence|urinary incontinence
981735|NCT03280654|Visceral Adiposity Index|visceral adiposity index
981736|NCT03280654|Waist Circumference|waist circumference
981737|NCT03280615|Albuminuria|albuminuria
981738|NCT03280615|Carotid Intima-Media Thickness|carotid intima-media thickness
981739|NCT03280615|Pulse Wave Velocity|pulse wave velocity
981740|NCT03280615|Inflammation|inflammation
981741|NCT03280589|Heart Rate Variability|heart rate variability
981742|NCT03280589|EEG|eeg
981743|NCT03280589|Respiration|respiration
981744|NCT03280576|Postoperative|postoperative
981745|NCT03280576|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
981746|NCT03280524|Reflexology,diabetes, quality of life|reflexology,diabetes, quality of life
981747|NCT03280485|TBI|tbi
981748|NCT03280485|management|management
981749|NCT03280485|S100B|s100b
981750|NCT03280485|biomarkers|biomarkers
981751|NCT03280485|mild head injury|mild head injury
981752|NCT03280485|intracranial complication|intracranial complication
981753|NCT03280472|Interpretation Bias|interpretation bias
981754|NCT03280472|Interpretation Modification Program|interpretation modification program
981755|NCT03280433|Epicardial adipose tissue|epicardial adipose tissue
981756|NCT03280433|Coronary artery disease|coronary artery disease
981757|NCT03280433|Atrial fibrillation|atrial fibrillation
981758|NCT03280433|Severe aortic stenosis|severe aortic stenosis
981760|NCT03280433|Mass spectrometry|mass spectrometry
981761|NCT03280433|Computed tomography|computed tomography
981762|NCT03280420|Acute urinary retention|acute urinary retention
981763|NCT03280420|BPH|bph
981764|NCT03280420|TWOC|twoc
981765|NCT03280420|Tamsulosin|tamsulosin
981766|NCT03280407|Neoadjuvant chemotherapy,|neoadjuvant chemotherapy,
981767|NCT03280407|locally advanced rectal cancer,|locally advanced rectal cancer,
981768|NCT03280407|chemotherapy|chemotherapy
981769|NCT03280407|CAPOX (oxaliplatin/capecitabine)|capox (oxaliplatin/capecitabine)
981770|NCT03280407|FOLFOX (oxaliplatin/leucovorin/5FU)|folfox (oxaliplatin/leucovorin/5fu)
981771|NCT03280394|Liquid biopsy|liquid biopsy
981772|NCT03280394|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
981773|NCT03280394|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
981774|NCT03280394|Follicular Lymphoma|follicular lymphoma
981775|NCT03280394|Mantle Cell Lymphoma|mantle cell lymphoma
981776|NCT03280394|Mutations|mutations
981777|NCT03280381|Nifty Cup|nifty cup
981778|NCT03280381|breastfeeding difficulties|breastfeeding difficulties
981779|NCT03280381|preterm infant|preterm infant
981780|NCT03280381|cup feeding|cup feeding
981781|NCT03280355|COPD|copd
981782|NCT03280355|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
981783|NCT03280355|Randomised controlled trial (RCT)|randomised controlled trial (rct)
981784|NCT03280355|Rehabilitation|rehabilitation
981785|NCT03280355|Singing Training|singing training
981786|NCT03280342|Migraine|migraine
981787|NCT03280342|Headache|headache
981788|NCT03280316|Spinal Vascular Disorder|spinal vascular disorder
981789|NCT03280316|Overactive Bladder|overactive bladder
981790|NCT03280290|Lymphocytes CD4|lymphocytes cd4
981791|NCT03280290|Lymphocytes CCR7|lymphocytes ccr7
981792|NCT03280290|ALLOGRAFT|allograft
981793|NCT03280290|Hematopoietic Stem Cells|hematopoietic stem cells
981794|NCT03280251|Cognitive disorders|cognitive disorders
981795|NCT03280251|cognitive training|cognitive training
981796|NCT03280251|symptomatic treatment|symptomatic treatment
981797|NCT03280251|Methylphenidate|methylphenidate
981798|NCT03280251|elderly|elderly
981799|NCT03280225|Suicide|suicide
981800|NCT03280225|Prevention|prevention
981801|NCT03280225|Implementation|implementation
981802|NCT03280225|Facilitation|facilitation
981803|NCT03280212|Chronic subdural hematoma|chronic subdural hematoma
981804|NCT03280212|Tranexamic acid|tranexamic acid
981805|NCT03280212|TXA|txa
981806|NCT03280186|Spinal Vascular Malformations|spinal vascular malformations
981807|NCT03280186|Bladder|bladder
981808|NCT03280186|Surgical intervention|surgical intervention
981809|NCT03280186|Urodynamics|urodynamics
981810|NCT03280147|Neonate|neonate
981811|NCT03280147|Sepsis|sepsis
981812|NCT03280147|Antibiotics|antibiotics
981813|NCT03280147|Duration|duration
981814|NCT03280134|non-sentinel lymph node|non-sentinel lymph node
981815|NCT03280134|breast cancer|breast cancer
981816|NCT03280134|prediction|prediction
981817|NCT03280134|CK19|ck19
981818|NCT03280134|contrast-enhanced ultrasound|contrast-enhanced ultrasound
981819|NCT03280121|transoral incisionless|transoral incisionless
981820|NCT03280056|MSC|msc
981821|NCT03280056|Autologous|autologous
981822|NCT03280056|Neurotrophic factors|neurotrophic factors
981823|NCT03280043|Breast reduction|breast reduction
981824|NCT03280043|Reduction mammoplasty|reduction mammoplasty
981825|NCT03280043|Hematoma|hematoma
981826|NCT03280043|Hemorrhage|hemorrhage
981827|NCT03280043|Ketorolac|ketorolac
981828|NCT03280043|Toradol|toradol
981829|NCT03280030|midostaurin|midostaurin
981830|NCT03280030|PKC412|pkc412
981831|NCT03280030|cytarabine|cytarabine
981832|NCT03280030|daunorubicin|daunorubicin
981833|NCT03280030|acute myeloid leukemia|acute myeloid leukemia
981834|NCT03280030|combination treatment|combination treatment
981835|NCT03280030|FLT3|flt3
981836|NCT03280030|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
981837|NCT03280030|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
981838|NCT03280017|anesthesia|anesthesia
981839|NCT03280017|thoracic surgery|thoracic surgery
981840|NCT03280017|thoracic paravertebral block|thoracic paravertebral block
981841|NCT03280017|ketamine|ketamine
981842|NCT03279991|biobank|biobank
981843|NCT03279991|chronic disease|chronic disease
981844|NCT03279991|omics|omics
981845|NCT03279991|big data|big data
981846|NCT03279991|4 P medicine|4 p medicine
981847|NCT03279965|Lung MRI cystic fibrosis primary ciliary dyskinesia|lung mri cystic fibrosis primary ciliary dyskinesia
981848|NCT03279913|Depression, neurofeedback, TMS|depression, neurofeedback, tms
981849|NCT03279874|decision-making|decision-making
981850|NCT03279874|repair behavior|repair behavior
981851|NCT03279874|interviews|interviews
981852|NCT03279796|Adipose-drived mesenchymal stem cells|adipose-drived mesenchymal stem cells
981853|NCT03279796|Rotator cuff injury|rotator cuff injury
981854|NCT03279796|Lateral Epicondylitis|lateral epicondylitis
981855|NCT03279796|Randomized controlled trials|randomized controlled trials
981856|NCT03279770|lnRNA|lnrna
981857|NCT03279770|CV disease|cv disease
981858|NCT03279757|Fractional laser|fractional laser
981859|NCT03279757|Topical anesthesia|topical anesthesia
981860|NCT03279757|Drug delivery|drug delivery
981861|NCT03279757|CO2 laser|co2 laser
981862|NCT03279744|Oral Verrucous Hyperplasia|oral verrucous hyperplasia
981863|NCT03279744|Oral Erythroleukoplakia|oral erythroleukoplakia
981864|NCT03279731|eating disorder, pharmacotherapy|eating disorder, pharmacotherapy
981865|NCT03279705|water exchange|water exchange
981866|NCT03279705|water jet channel colonoscopy|water jet channel colonoscopy
981867|NCT03279705|colonoscopy|colonoscopy
981868|NCT03279705|cecal insertion time|cecal insertion time
981869|NCT03279705|adenoma detection rate|adenoma detection rate
981870|NCT03279692|Meningioma|meningioma
981871|NCT03279679|costoclavicular|costoclavicular
981872|NCT03279679|paracoracoid|paracoracoid
981873|NCT03279679|brachial plexus|brachial plexus
981874|NCT03279640|Motor Network|motor network
981875|NCT03279640|Resting-state fMRI|resting-state fmri
981876|NCT03279640|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
981877|NCT03279640|Transcranial Direct Current Stimulation|transcranial direct current stimulation
981878|NCT03279627|inpatient|inpatient
981879|NCT03279627|hypoglycemia|hypoglycemia
981880|NCT03279627|hyperglycemia|hyperglycemia
981881|NCT03279627|hospital readmission|hospital readmission
981882|NCT03279627|discharge planning|discharge planning
981883|NCT03279614|ORR|orr
981884|NCT03279614|OS|os
981885|NCT03279614|PFS|pfs
981886|NCT03279614|safety|safety
981887|NCT03279601|chemotherapy|chemotherapy
981888|NCT03279601|OS|os
981889|NCT03279601|ORR|orr
981890|NCT03279601|PFS|pfs
981891|NCT03279601|safety|safety
981892|NCT03279588|Ultrasound diagnosis|ultrasound diagnosis
981893|NCT03279588|Abdominal Ultrasound|abdominal ultrasound
981894|NCT03279588|Emergency Department|emergency department
981895|NCT03279523|Dementia|dementia
981896|NCT03279523|HIV|hiv
981897|NCT03279523|Brain Disease|brain disease
981898|NCT03279523|CNS Diseases|cns diseases
981899|NCT03279523|Mild Cognitive Impairment|mild cognitive impairment
981900|NCT03279523|Neurodegenerative Disease|neurodegenerative disease
981901|NCT03279523|Tauopathies|tauopathies
981902|NCT03279510|auditory perception|auditory perception
981904|NCT03279484|safety , electrical performance|safety , electrical performance
981905|NCT03279471|autism spectrum disorder|autism spectrum disorder
981906|NCT03279471|anxiety|anxiety
981907|NCT03279471|cognitive behavior therapy|cognitive behavior therapy
981908|NCT03279471|functional neuroimaging|functional neuroimaging
981909|NCT03279458|Capnography|capnography
981910|NCT03279432|VDR, MEGALIN, haplotypes, obesity, metabolic syndrome|vdr, megalin, haplotypes, obesity, metabolic syndrome
981911|NCT03279406|Atrial fibrillation|atrial fibrillation
981912|NCT03279406|Stroke|stroke
981913|NCT03279406|Thrombus|thrombus
981914|NCT03279406|Left atrial appendage|left atrial appendage
981915|NCT03279406|Bleeding|bleeding
981916|NCT03279393|Post-Traumatic Stress Disorder|post-traumatic stress disorder
981917|NCT03279393|PTSD|ptsd
981918|NCT03279393|trauma|trauma
981919|NCT03279393|stress|stress
981920|NCT03279393|atherosclerosis|atherosclerosis
981921|NCT03279393|macrophage|macrophage
981922|NCT03279393|plaque burden|plaque burden
981923|NCT03279393|vascular inflammation|vascular inflammation
981924|NCT03279393|atherosclerotic inflammation|atherosclerotic inflammation
981925|NCT03279393|PET/MRI|pet/mri
981926|NCT03279393|18F-FDG-PET|18f-fdg-pet
981927|NCT03279380|genetic polymorphism|genetic polymorphism
981928|NCT03279380|sport performance|sport performance
981929|NCT03279380|myokines|myokines
981930|NCT03279354|Health-related quality of life|health-related quality of life
981931|NCT03279354|Physical activity|physical activity
981932|NCT03279354|Smartphone application|smartphone application
981933|NCT03279341|laxatives|laxatives
981934|NCT03279341|constipation|constipation
981935|NCT03279315|Iodine|iodine
981936|NCT03279315|Balance experiment|balance experiment
981937|NCT03279315|EAR|ear
981938|NCT03279315|Chinese women|chinese women
981939|NCT03279315|Euthyroid|euthyroid
981940|NCT03279289|FOLFIRI|folfiri
981941|NCT03279289|aflibercept|aflibercept
981942|NCT03279289|5-FU|5-fu
981943|NCT03279289|oxaliplatin|oxaliplatin
981944|NCT03279289|elderly|elderly
981945|NCT03279289|metastatic colorectal cancer|metastatic colorectal cancer
981946|NCT03279276|Hip arthroplasty|hip arthroplasty
981947|NCT03279250|Diseases of Male Genital Organs|diseases of male genital organs
981948|NCT03279250|Prostate Cancer|prostate cancer
981949|NCT03279250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
981950|NCT03279250|LHRH Agonist|lhrh agonist
981951|NCT03279250|Apalutamide|apalutamide
981952|NCT03279250|ARN-509|arn-509
981953|NCT03279250|Abiraterone Acetate|abiraterone acetate
981954|NCT03279250|Zytiga|zytiga
981955|NCT03279250|Prednisone|prednisone
981956|NCT03279237|GastroEsophageal Cancer|gastroesophageal cancer
981957|NCT03279224|Bipolar, Depression, FMT, Microbiome|bipolar, depression, fmt, microbiome
981958|NCT03279211|digestibility|digestibility
981959|NCT03279211|whey protein|whey protein
981960|NCT03279211|zein|zein
981961|NCT03279211|bioavailability|bioavailability
982353|NCT03276611|air|air
981966|NCT03279198|cost-effectiveness|cost-effectiveness
981967|NCT03279198|demographics|demographics
981968|NCT03279198|tailored intervention|tailored intervention
981969|NCT03279185|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
981970|NCT03279172|videolaryngoscope|videolaryngoscope
981971|NCT03279172|intraocular pressure|intraocular pressure
981972|NCT03279172|Direct laryngoscope|direct laryngoscope
981973|NCT03279120|HIV|hiv
981974|NCT03279120|LNG|lng
981975|NCT03279120|TFV|tfv
981976|NCT03279120|IVR|ivr
981977|NCT03279120|Contraception|contraception
981978|NCT03279120|Prevention|prevention
981979|NCT03279094|Sickle Cell Disease|sickle cell disease
981980|NCT03279094|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
981981|NCT03279094|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
981982|NCT03279094|Post-transplant Cytoxan|post-transplant cytoxan
981983|NCT03279081|Crohn's disease|crohn's disease
981984|NCT03279081|complex perianal fistula(s)|complex perianal fistula(s)
981985|NCT03279068|electronic fetal monitoring|electronic fetal monitoring
981986|NCT03279055|Insomnia|insomnia
981987|NCT03279042|En masse retraction|en masse retraction
981988|NCT03279042|Corticotomy|corticotomy
981989|NCT03279042|Acceleration of tooth movement|acceleration of tooth movement
981990|NCT03279042|Piezocision|piezocision
981991|NCT03279042|Flapless corticotomy|flapless corticotomy
981992|NCT03279042|Class II division 1 malocclusion|class ii division 1 malocclusion
981993|NCT03279042|Protrusion of upper incisors|protrusion of upper incisors
981994|NCT03279042|Sliding mechanics|sliding mechanics
981995|NCT03279042|mini-implant based anchorage|mini-implant based anchorage
981996|NCT03279042|temporary anchorage devices|temporary anchorage devices
981997|NCT03278990|PrEP|prep
981998|NCT03278990|Prevention|prevention
981999|NCT03278990|Value Affirmation|value affirmation
982000|NCT03278990|Future Selves|future selves
982001|NCT03278990|Behavioral Intervention|behavioral intervention
982002|NCT03278977|Apparent Life-Threatening Event|apparent life-threatening event
982003|NCT03278977|ALTE|alte
982004|NCT03278977|Sudden Infant Death|sudden infant death
982005|NCT03278964|Graves Disease|graves disease
982006|NCT03278964|Orbital decompression|orbital decompression
982007|NCT03278964|Graves Orbitopathy|graves orbitopathy
982008|NCT03278964|Exophthalmos|exophthalmos
982009|NCT03278964|Diplopia|diplopia
982010|NCT03278964|Restrictive Strabismus|restrictive strabismus
982011|NCT03278951|Weight loss|weight loss
982012|NCT03278951|video conferencing|video conferencing
982013|NCT03278951|mHealth|mhealth
982014|NCT03278951|Telemedicine|telemedicine
982015|NCT03278951|glycemic control|glycemic control
982016|NCT03278938|depression|depression
982017|NCT03278938|citalopram|citalopram
982018|NCT03278938|bupropion|bupropion
982019|NCT03278938|combination therapy|combination therapy
982025|NCT03278899|Adrenoleukodystropy|adrenoleukodystropy
982026|NCT03278899|X-ALD|x-ald
982028|NCT03278886|Alcohol Use|alcohol use
982029|NCT03278886|Pain|pain
982030|NCT03278886|HIV|hiv
982031|NCT03278886|Low-dose naltrexone|low-dose naltrexone
982032|NCT03278886|Nalmefene|nalmefene
982033|NCT03278860|Oxytocin|oxytocin
982034|NCT03278860|social touch|social touch
982035|NCT03278847|NNRD|nnrd
982036|NCT03278847|matching|matching
982037|NCT03278847|propensity score|propensity score
982038|NCT03278821|Informed choice|informed choice
982039|NCT03278821|Alcohol use disorder|alcohol use disorder
982040|NCT03278821|Addiction treatment|addiction treatment
982041|NCT03278795|Weaning, ventilatory support, assisted ventilation modes|weaning, ventilatory support, assisted ventilation modes
982042|NCT03278782|Refractory Peripheral T-Cell Lymphoma|refractory peripheral t-cell lymphoma
982043|NCT03278782|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
982044|NCT03278782|Pembrolizumab|pembrolizumab
982045|NCT03278782|Keytruda|keytruda
982046|NCT03278782|MK-3475|mk-3475
982047|NCT03278782|SCH-900475|sch-900475
982048|NCT03278782|Romidepsin|romidepsin
982049|NCT03278782|Istodax|istodax
982050|NCT03278782|Depsipeptide|depsipeptide
982051|NCT03278782|FK228|fk228
982052|NCT03278756|Depression|depression
982053|NCT03278756|Remission|remission
982054|NCT03278756|Relapse prevention|relapse prevention
982055|NCT03278756|Cognitive control training|cognitive control training
982056|NCT03278756|Internet intervention|internet intervention
982057|NCT03278743|tea|tea
982058|NCT03278743|cognition|cognition
982059|NCT03278743|very old|very old
982060|NCT03278743|Newcastle 85+|newcastle 85+
982061|NCT03278743|epidemiology|epidemiology
982062|NCT03278730|sepsis|sepsis
982063|NCT03278730|para-Tyrosine|para-tyrosine
982064|NCT03278730|ortho-Tyrosine|ortho-tyrosine
982065|NCT03278730|meta-Tyrosine|meta-tyrosine
982066|NCT03278704|Concurrent training|concurrent training
982067|NCT03278704|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
982068|NCT03278704|Resistance exercise|resistance exercise
982069|NCT03278704|High-Intensity Interval Training (HIIT)|high-intensity interval training (hiit)
982070|NCT03278704|Muscle hypertrophy|muscle hypertrophy
982071|NCT03278704|Interference effect|interference effect
982072|NCT03278678|Nutritional screening MNA-SF malnutrition Case Management|nutritional screening mna-sf malnutrition case management
982073|NCT03278665|Cutaneous melanoma|cutaneous melanoma
982074|NCT03278639|gait disorders|gait disorders
982075|NCT03278639|balance disorders|balance disorders
982076|NCT03278639|music|music
982077|NCT03278639|tango|tango
982078|NCT03278639|rhythmic auditory stimulation|rhythmic auditory stimulation
982079|NCT03278639|health-related quality of life|health-related quality of life
982080|NCT03278626|Locally Advanced Esophageal Squamous Cell Carcinoma|locally advanced esophageal squamous cell carcinoma
982081|NCT03278561|asthma|asthma
982082|NCT03278561|age of onset|age of onset
982083|NCT03278561|inflammation|inflammation
982084|NCT03278561|comorbidity|comorbidity
982085|NCT03278561|microbiome|microbiome
982086|NCT03278548|HES|hes
982087|NCT03278548|Hydroxyethylstarch|hydroxyethylstarch
982088|NCT03278522|ramosetron|ramosetron
982089|NCT03278496|addiction|addiction
982090|NCT03278496|substance abuse treatment|substance abuse treatment
982091|NCT03278496|aftercare|aftercare
982092|NCT03278496|outpatient counseling|outpatient counseling
982093|NCT03278496|opiates|opiates
982094|NCT03278496|cocaine|cocaine
982095|NCT03278483|Latent tuberculosis, ,|latent tuberculosis, ,
982096|NCT03278483|isoniazid, rifampin,|isoniazid, rifampin,
982097|NCT03278483|rifampin,|rifampin,
982098|NCT03278483|adverse,|adverse,
982099|NCT03278483|diabetes mellitus|diabetes mellitus
982100|NCT03278457|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
982101|NCT03278457|implantable cardioverter defibrillator|implantable cardioverter defibrillator
982102|NCT03278457|positron emission tomography|positron emission tomography
982103|NCT03278392|pregnancy|pregnancy
982104|NCT03278392|metabolism|metabolism
982105|NCT03278392|stress|stress
982106|NCT03278392|emotional state|emotional state
982107|NCT03278392|diet|diet
982108|NCT03278392|glycemic response|glycemic response
982109|NCT03278353|Expectation|expectation
982110|NCT03278353|Conservative Intervention|conservative intervention
982111|NCT03278340|Skin Cancer|skin cancer
982112|NCT03278340|Prevention|prevention
982113|NCT03278340|Policy|policy
982114|NCT03278340|Worksite|worksite
982115|NCT03278340|Scale-up|scale-up
982116|NCT03278340|Cost and Effectiveness|cost and effectiveness
982117|NCT03278275|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
982118|NCT03278275|uPAR PET/CT|upar pet/ct
982119|NCT03278275|positron emission tomography|positron emission tomography
982120|NCT03278275|neuroendocrine tumors|neuroendocrine tumors
982121|NCT03278249|brain tumor|brain tumor
982122|NCT03278223|Multipurpose Contact Lens Care System|multipurpose contact lens care system
982123|NCT03278210|EEG-fMRI|eeg-fmri
982124|NCT03278210|brain imaging|brain imaging
982125|NCT03278210|presurgical evaluation|presurgical evaluation
982126|NCT03278210|epilepsy surgery|epilepsy surgery
982127|NCT03278158|safety|safety
982128|NCT03278158|tolerability|tolerability
982129|NCT03278132|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
982130|NCT03278132|Safety|safety
982131|NCT03278132|Immunogenicity|immunogenicity
982132|NCT03278132|Infant|infant
982133|NCT03278093|Physiotherapy|physiotherapy
982134|NCT03278093|Physical therapy|physical therapy
982135|NCT03278093|Balance|balance
982136|NCT03278093|Posturography|posturography
982137|NCT03278067|England|england
982138|NCT03278067|Adverse Event of Interest|adverse event of interest
982139|NCT03278067|Seasonal influenza vaccines|seasonal influenza vaccines
982140|NCT03278067|Pilot study|pilot study
982141|NCT03278067|Prospective passive enhanced safety surveillance|prospective passive enhanced safety surveillance
982142|NCT03278054|apical periodontitis|apical periodontitis
982143|NCT03278054|hybrid|hybrid
982144|NCT03278054|ProTaper|protaper
982145|NCT03278054|rotary|rotary
982146|NCT03278015|S-1|s-1
982147|NCT03278015|nab-paclitaxel|nab-paclitaxel
982148|NCT03277976|atrial fibrillation;|atrial fibrillation;
982149|NCT03277976|catheter ablation;|catheter ablation;
982150|NCT03277976|pulmonary vein isolation|pulmonary vein isolation
982151|NCT03277976|ablation index|ablation index
982152|NCT03277963|Obesity|obesity
982153|NCT03277963|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
982154|NCT03277950|virtual reality|virtual reality
982155|NCT03277950|feedback|feedback
982156|NCT03277937|gastric varices|gastric varices
982157|NCT03277937|endoscopic ultrasound|endoscopic ultrasound
982158|NCT03277937|coils|coils
982159|NCT03277937|cyanoacrylate|cyanoacrylate
982160|NCT03277898|Breast Neoplasms|breast neoplasms
982161|NCT03277898|"Exercis* OR Aerobic Exercise"|"exercis* or aerobic exercise"
982162|NCT03277898|Cognitive Function*|cognitive function*
982163|NCT03277898|"Antineoplastic therapy OR Antineoplastic agent"|"antineoplastic therapy or antineoplastic agent"
982164|NCT03277898|Chemotherapy, Adjuvant|chemotherapy, adjuvant
982165|NCT03277885|Work related chronic pain|work related chronic pain
982166|NCT03277885|Preventive care|preventive care
982167|NCT03277859|Yoga|yoga
982168|NCT03277859|Veterans|veterans
982169|NCT03277859|Traumatic Brain Injury|traumatic brain injury
982170|NCT03277859|Post-concussive Headaches|post-concussive headaches
982171|NCT03277859|Post-concussive Symptoms|post-concussive symptoms
982172|NCT03277768|Premature infant|premature infant
982173|NCT03277768|Tissue Oxygenation|tissue oxygenation
982174|NCT03277768|Patent Ductus Arteriosus|patent ductus arteriosus
982175|NCT03277716|Huge hepatocellular carcinoma|huge hepatocellular carcinoma
982176|NCT03277716|Microwave ablation|microwave ablation
982177|NCT03277716|TACE|tace
982178|NCT03277716|Safety|safety
982179|NCT03277716|Non-resectable|non-resectable
982180|NCT03277716|Treatment|treatment
982181|NCT03277703|Influenza vaccine|influenza vaccine
982182|NCT03277703|Booster dose|booster dose
982183|NCT03277703|immunocompromised|immunocompromised
982184|NCT03277703|Biologic therapy|biologic therapy
982185|NCT03277703|Rheumatologic disease|rheumatologic disease
982186|NCT03277703|inflammatory bowel disease|inflammatory bowel disease
982187|NCT03277690|Cushing Syndrome, Adrenocortical Hyperfunction|cushing syndrome, adrenocortical hyperfunction
982188|NCT03277664|pediatric|pediatric
982189|NCT03277664|asthma adherence|asthma adherence
982190|NCT03277664|electronic device|electronic device
982191|NCT03277651|noninvasive|noninvasive
982192|NCT03277651|Hemodynamics|hemodynamics
982193|NCT03277638|recurrent glioblastoma|recurrent glioblastoma
982194|NCT03277638|brain cancer|brain cancer
982195|NCT03277625|pancreaticoduodenectomy|pancreaticoduodenectomy
982196|NCT03277573|Salsalate|salsalate
982197|NCT03277560|Major Trauma Centre|major trauma centre
982198|NCT03277560|ISS|iss
982199|NCT03277560|Outcome Measures|outcome measures
982200|NCT03277534|electrical stimulation|electrical stimulation
982201|NCT03277508|Brain-computer integration|brain-computer integration
982202|NCT03277482|Recurrent gynecological cancer|recurrent gynecological cancer
982203|NCT03277482|Metastatic Cervical Cancer|metastatic cervical cancer
982204|NCT03277482|Metastatic Ovarian Cancer|metastatic ovarian cancer
982205|NCT03277482|Metastatic Vaginal Cancer|metastatic vaginal cancer
982206|NCT03277482|Metastatic Vulvar Cancer|metastatic vulvar cancer
982207|NCT03277482|Metastatic Endometrial Cancer|metastatic endometrial cancer
982208|NCT03277482|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
1657856|NCT00156533|Ambien|ambien
982209|NCT03277482|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
982210|NCT03277482|Recurrent Vaginal Cancer|recurrent vaginal cancer
982211|NCT03277482|Recurrent Vulvar Cancer|recurrent vulvar cancer
982212|NCT03277482|Recurrent Endometrial Cancer|recurrent endometrial cancer
982213|NCT03277469|Gynecologic Cancer|gynecologic cancer
982214|NCT03277443|Skeletal open bite|skeletal open bite
982215|NCT03277430|uterus transplantation, absolute uterine factor infertility|uterus transplantation, absolute uterine factor infertility
982216|NCT03277404|EDTA|edta
982217|NCT03277404|Postoperative pain|postoperative pain
982218|NCT03277404|Pulp necrosis|pulp necrosis
982219|NCT03277404|Smear layer|smear layer
982220|NCT03277352|cervical cancer|cervical cancer
982221|NCT03277352|endometrial cancer|endometrial cancer
982222|NCT03277352|gastric cancer (including stomach and gastroesophageal junction (GEJ))|gastric cancer (including stomach and gastroesophageal junction (gej))
982223|NCT03277352|esophageal cancer|esophageal cancer
982224|NCT03277352|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
982225|NCT03277352|melanoma (mucosal or cutaneous)|melanoma (mucosal or cutaneous)
982226|NCT03277352|Merkel cell carcinoma|merkel cell carcinoma
982227|NCT03277352|mesothelioma|mesothelioma
982228|NCT03277352|microsatellite instability-high (MSI-H)|microsatellite instability-high (msi-h)
982229|NCT03277352|solid tumors|solid tumors
982230|NCT03277352|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
982231|NCT03277352|ovarian cancer|ovarian cancer
982232|NCT03277352|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
982233|NCT03277352|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
982234|NCT03277352|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
982235|NCT03277352|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
982236|NCT03277352|urothelial carcinoma|urothelial carcinoma
982237|NCT03277352|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
982238|NCT03277339|Generalized anxious disorders|generalized anxious disorders
982239|NCT03277339|Thermal cure|thermal cure
982240|NCT03277339|paroxetine|paroxetine
982241|NCT03277274|Drug therapy|drug therapy
982242|NCT03277235|fatigue|fatigue
982243|NCT03277235|colon cancer|colon cancer
982244|NCT03277235|quality of life|quality of life
982245|NCT03277222|Neurocognitive impairment|neurocognitive impairment
982246|NCT03277222|HIV-1|hiv-1
982247|NCT03277222|Intranasal insulin|intranasal insulin
982248|NCT03277222|Neurocognitive Disorder|neurocognitive disorder
982249|NCT03277222|Cognition|cognition
982250|NCT03277222|Memory|memory
982251|NCT03277183|erythropoietin|erythropoietin
982252|NCT03277170|acute asthma exacerbation|acute asthma exacerbation
982253|NCT03277170|pediatric asthma|pediatric asthma
982254|NCT03277170|leukotriene receptor antagonist|leukotriene receptor antagonist
982255|NCT03277170|montelukast|montelukast
982256|NCT03277144|linear stapler|linear stapler
982257|NCT03277092|Child, blood drawing procedure, near Infrared light|child, blood drawing procedure, near infrared light
982258|NCT03277079|coronary artery disease|coronary artery disease
982259|NCT03277079|LDL cholesterol|ldl cholesterol
982260|NCT03277079|therapeutic target|therapeutic target
982261|NCT03277053|colorectal|colorectal
982262|NCT03277053|laparoscopic|laparoscopic
982263|NCT03277053|application|application
982264|NCT03277053|ERP|erp
982265|NCT03277053|adherence|adherence
982266|NCT03277053|mobile|mobile
982267|NCT03277027|cerebral palsy|cerebral palsy
982268|NCT03277027|Health-Related Quality Of Life|health-related quality of life
982269|NCT03277027|Physical Activity|physical activity
982270|NCT03277014|Nutritional monitoring|nutritional monitoring
982271|NCT03277014|insulin-like growth factor-1|insulin-like growth factor-1
982272|NCT03277001|AECOPD|aecopd
982273|NCT03277001|VTE prevention|vte prevention
982274|NCT03277001|Rivaroxaban|rivaroxaban
982275|NCT03277001|LMWHs|lmwhs
982276|NCT03276988|Thyroid cancer|thyroid cancer
982277|NCT03276988|Thyroidectomy|thyroidectomy
982278|NCT03276988|rhTSH|rhtsh
982279|NCT03276988|GX-30|gx-30
982280|NCT03276975|CT fluoroscopy|ct fluoroscopy
982281|NCT03276975|epidural patching|epidural patching
982282|NCT03276975|spontaneous intracranial hypotension|spontaneous intracranial hypotension
982283|NCT03276962|falciparum, efficacy|falciparum, efficacy
982284|NCT03276962|RTS,S/AS01|rts,s/as01
982285|NCT03276962|malaria vaccine|malaria vaccine
982286|NCT03276962|safety|safety
982287|NCT03276962|Malaria|malaria
982288|NCT03276962|immunogenicity|immunogenicity
982289|NCT03276962|infants|infants
982290|NCT03276949|Blood glucose|blood glucose
982291|NCT03276949|non-invasive|non-invasive
982292|NCT03276949|Raman spectroscopy|raman spectroscopy
982293|NCT03276910|antidoping|antidoping
982294|NCT03276871|Balloon dissection|balloon dissection
982295|NCT03276871|Telescopic dissection|telescopic dissection
982296|NCT03276871|Inguinal hernia|inguinal hernia
982297|NCT03276871|TEP|tep
982298|NCT03276845|Ultrasound|ultrasound
982299|NCT03276845|Elastography|elastography
982300|NCT03276845|Doppler Ultrasound|doppler ultrasound
982301|NCT03276845|Contrast enhanced Ultrasound|contrast enhanced ultrasound
982302|NCT03276845|Three-dimensional Ultrasound|three-dimensional ultrasound
982303|NCT03276819|Oral potentially malignant lesions (OPML)|oral potentially malignant lesions (opml)
982304|NCT03276819|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
982305|NCT03276819|Biomarkers|biomarkers
982306|NCT03276819|Smoking cessation program|smoking cessation program
982307|NCT03276819|Loss of heterozigoty (LOH)|loss of heterozigoty (loh)
982308|NCT03276819|Medico-economics|medico-economics
982309|NCT03276819|Sociology|sociology
982310|NCT03276819|Psychology|psychology
982311|NCT03276806|CT low dose|ct low dose
982312|NCT03276806|nurse led intervention|nurse led intervention
982313|NCT03276806|safety net hospital|safety net hospital
982314|NCT03276806|lung cancer screening with CTLD|lung cancer screening with ctld
982315|NCT03276767|online intervention|online intervention
982316|NCT03276767|e-Health|e-health
982317|NCT03276767|reminder|reminder
982318|NCT03276767|SMS-textmessage|sms-textmessage
982320|NCT03276767|mobile phone|mobile phone
982321|NCT03276767|cell phone|cell phone
982322|NCT03276754|Pneumococcal infections|pneumococcal infections
982323|NCT03276754|COPD exacerbations|copd exacerbations
982324|NCT03276741|labor|labor
982325|NCT03276741|anesthesia|anesthesia
982326|NCT03276741|oral intake|oral intake
982327|NCT03276741|maternal satisfaction|maternal satisfaction
982328|NCT03276741|newborn complications|newborn complications
982329|NCT03276728|Heart Failure|heart failure
982330|NCT03276728|Cardiovascular Diseases|cardiovascular diseases
982331|NCT03276728|Heart Diseases|heart diseases
982332|NCT03276728|Ejection fraction|ejection fraction
982333|NCT03276728|Heart Failure with reduced ejection fraction|heart failure with reduced ejection fraction
982334|NCT03276728|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
982335|NCT03276715|malignant pleural effusion|malignant pleural effusion
982336|NCT03276715|lung cancer|lung cancer
982337|NCT03276637|Genome Sequencing|genome sequencing
982338|NCT03276637|Exome Sequencing|exome sequencing
982339|NCT03276637|Military|military
982340|NCT03276637|Air Force|air force
982341|NCT03276611|Assessment|assessment
982342|NCT03276611|pulmonary|pulmonary
982343|NCT03276611|artery|artery
982344|NCT03276611|right|right
982345|NCT03276611|sided|sided
982346|NCT03276611|hemodynamics|hemodynamics
982347|NCT03276611|patients|patients
982348|NCT03276611|sleep|sleep
982349|NCT03276611|apnea|apnea
982350|NCT03276611|syndrome|syndrome
982351|NCT03276611|contionous|contionous
982352|NCT03276611|positive|positive
982354|NCT03276611|way|way
982355|NCT03276611|pressure|pressure
982356|NCT03276611|treatment|treatment
982357|NCT03276585|home sleep monitor|home sleep monitor
982358|NCT03276585|Sleep Apnea Syndromes|sleep apnea syndromes
982359|NCT03276585|questionnaire|questionnaire
982360|NCT03276559|critically ill|critically ill
982361|NCT03276559|ICU|icu
982362|NCT03276559|uncommunicative|uncommunicative
982363|NCT03276559|caregivers|caregivers
982364|NCT03276533|dexmedetomidine; lidocaine; cytokine|dexmedetomidine; lidocaine; cytokine
982365|NCT03276520|ethyl glucuronide, biomarker, diagnostic randomized trial|ethyl glucuronide, biomarker, diagnostic randomized trial
982366|NCT03276481|melphalan|melphalan
982367|NCT03276481|stem cell transplantation|stem cell transplantation
982368|NCT03276481|17-404|17-404
982369|NCT03276481|hematopoietic cell transplantation|hematopoietic cell transplantation
982370|NCT03276481|HCT|hct
982371|NCT03276468|venetoclax; obinutuzumab; atezolizumab; lymphoma|venetoclax; obinutuzumab; atezolizumab; lymphoma
982372|NCT03276455|Beta thalassemia|beta thalassemia
982373|NCT03276455|Gene therapy|gene therapy
982374|NCT03276455|Beta-globin|beta-globin
982375|NCT03276455|Hematopoietic stem cells|hematopoietic stem cells
982376|NCT03276455|Lentiviral vector|lentiviral vector
982377|NCT03276429|NSCLC|nsclc
982378|NCT03276429|SCLC|sclc
982379|NCT03276429|MOLECULAR BIOMARKERS|molecular biomarkers
982380|NCT03276390|health disparities|health disparities
982381|NCT03276390|living donation|living donation
982382|NCT03276312|Lipogems|lipogems
982383|NCT03276312|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
982384|NCT03276312|Lipofilling|lipofilling
982385|NCT03276312|Diabetic foot|diabetic foot
982386|NCT03276208|Pregnancy|pregnancy
982387|NCT03276208|Tobacco|tobacco
982388|NCT03276208|Massage Therapy|massage therapy
982389|NCT03276208|Mindfulness|mindfulness
982390|NCT03276195|Neurodevelopmental Disorder|neurodevelopmental disorder
982391|NCT03276195|Genomics|genomics
982392|NCT03276195|Genetics|genetics
982393|NCT03276169|atrial fibrillation|atrial fibrillation
982394|NCT03276169|left atrial appendage closure|left atrial appendage closure
982395|NCT03276169|left atrial function|left atrial function
982396|NCT03276130|Blood coagulation disorder|blood coagulation disorder
982397|NCT03276130|Haematologic diseases|haematologic diseases
982398|NCT03276130|Coagulation protein disorder|coagulation protein disorder
982399|NCT03276130|Hemorrhagic disorder|hemorrhagic disorder
982400|NCT03276130|Genetic diseases, inborn|genetic diseases, inborn
982401|NCT03276130|Pain|pain
982402|NCT03276130|Anxiety|anxiety
982403|NCT03276130|Pain medication|pain medication
982404|NCT03276130|Anxiety medication|anxiety medication
982405|NCT03276117|pregnancy.obstructed labour|pregnancy.obstructed labour
982406|NCT03276104|IOL dislocation|iol dislocation
982407|NCT03276104|Cataract|cataract
982408|NCT03276104|Cataract surgery|cataract surgery
982409|NCT03276104|Scleral suturing|scleral suturing
982410|NCT03276104|Verisyse|verisyse
982411|NCT03276104|Iris-claw|iris-claw
982412|NCT03276104|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
982413|NCT03276091|colonoscopy|colonoscopy
982414|NCT03276091|immunochemical fecal test|immunochemical fecal test
982415|NCT03276091|screening|screening
982416|NCT03276078|COPD|copd
982417|NCT03276052|COPD, Pharmacokinetics|copd, pharmacokinetics
982418|NCT03276026|sugammadex|sugammadex
982419|NCT03276026|post anesthesia care unit recovery|post anesthesia care unit recovery
982420|NCT03276013|Oncology|oncology
982421|NCT03276013|Endometrial Cancer|endometrial cancer
982422|NCT03276013|Pembrolizumab|pembrolizumab
982423|NCT03276013|Doxorubicin|doxorubicin
982424|NCT03276013|Metastatic Endometrial Cancer|metastatic endometrial cancer
982425|NCT03276000|Misoprostol ,office hysteroscopy|misoprostol ,office hysteroscopy
982426|NCT03275987|cancer screening|cancer screening
982427|NCT03275935|ACOS|acos
982428|NCT03275935|Asthma|asthma
982429|NCT03275935|COPD|copd
982430|NCT03275935|inhalation technique|inhalation technique
982431|NCT03275922|Migraine|migraine
982432|NCT03275922|Headache|headache
982433|NCT03275922|Pain|pain
982434|NCT03275922|Efficacy|efficacy
982435|NCT03275922|Pediatric|pediatric
982436|NCT03275909|Chronic schizophrenia|chronic schizophrenia
982437|NCT03275909|Emotional Management Therapy|emotional management therapy
982438|NCT03275909|Integrated Psychological Therapy|integrated psychological therapy
982439|NCT03275844|Physical activity|physical activity
982440|NCT03275844|Physical capacity|physical capacity
982441|NCT03275844|Children|children
982442|NCT03275818|sarcoma|sarcoma
982443|NCT03275818|Desmoid tumor|desmoid tumor
982444|NCT03275818|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
982445|NCT03275818|Ewing sarcoma|ewing sarcoma
982446|NCT03275818|relapsed|relapsed
982447|NCT03275818|refractory|refractory
982448|NCT03275805|Residual dysplasia|residual dysplasia
982449|NCT03275805|Pavlik Harness|pavlik harness
982450|NCT03275792|Shiga-Toxigenic Escherichia coli|shiga-toxigenic escherichia coli
982451|NCT03275792|Child|child
982452|NCT03275753|Visual function|visual function
982653|NCT03274401|Screening|screening
982453|NCT03275753|Critical flicker fusion|critical flicker fusion
982454|NCT03275753|Dark adaptation|dark adaptation
982455|NCT03275753|Reading test|reading test
982456|NCT03275727|Breast Cancer|breast cancer
982457|NCT03275727|Survivors|survivors
982458|NCT03275727|Internet intervention|internet intervention
982459|NCT03275727|Psychosocial intervention|psychosocial intervention
982460|NCT03275727|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
982461|NCT03275727|Randomized controlled trial|randomized controlled trial
982462|NCT03275688|lung cancer|lung cancer
982463|NCT03275688|volatile organic compound|volatile organic compound
982464|NCT03275688|screening|screening
982465|NCT03275688|VOC|voc
982466|NCT03275688|clinical trial|clinical trial
982467|NCT03275675|Cancer|cancer
982468|NCT03275675|Oral chemotherapy|oral chemotherapy
982469|NCT03275675|Community Pharmacy|community pharmacy
982470|NCT03275675|Satisfaction|satisfaction
982471|NCT03275636|Haploidentical|haploidentical
982472|NCT03275636|mismatched unrelated donor|mismatched unrelated donor
982598|NCT03274817|Alzheimer's Disease|alzheimer's disease
982473|NCT03275636|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
982474|NCT03275636|donor comparison|donor comparison
982475|NCT03275584|positron emission tomography|positron emission tomography
982476|NCT03275584|NH3|nh3
982477|NCT03275571|Cognition|cognition
982478|NCT03275571|Intervention|intervention
982479|NCT03275571|Therapy|therapy
982480|NCT03275558|Nasal Spray|nasal spray
982481|NCT03275558|Gliosarcoma|gliosarcoma
982482|NCT03275558|Glioblastoma|glioblastoma
982483|NCT03275558|Gliomas|gliomas
982484|NCT03275519|distal hypospadias repair|distal hypospadias repair
982485|NCT03275519|urinary tract infection|urinary tract infection
982486|NCT03275519|prophylactic antibiotic use|prophylactic antibiotic use
982487|NCT03275506|neoadjuvant|neoadjuvant
982488|NCT03275506|debulking surgery|debulking surgery
982489|NCT03275493|CD19+ ,CAR-T, CRS|cd19+ ,car-t, crs
982490|NCT03275454|Autoimmune Diseases|autoimmune diseases
982491|NCT03275454|Hematologic Diseases|hematologic diseases
982492|NCT03275454|Immune System Diseases|immune system diseases
982493|NCT03275454|Blood Platelet Disorders|blood platelet disorders
982494|NCT03275441|electroretinogram|electroretinogram
982495|NCT03275441|ERG|erg
982496|NCT03275441|dark-adaptation|dark-adaptation
1657857|NCT00156533|Hypnotics|hypnotics
982497|NCT03275441|ophthalmology|ophthalmology
982498|NCT03275441|electrophysiology|electrophysiology
982499|NCT03275441|ISCEV|iscev
982500|NCT03275441|electroretinography|electroretinography
982501|NCT03275441|scotopic|scotopic
982502|NCT03275428|THRIVE|thrive
982503|NCT03275428|Non-intubated thoracic surgery|non-intubated thoracic surgery
982507|NCT03275415|respiratory distress syndrome|respiratory distress syndrome
982508|NCT03275402|Radioimmunotherapy|radioimmunotherapy
982509|NCT03275402|Neuroblastoma|neuroblastoma
982510|NCT03275402|CNS Metastases|cns metastases
982511|NCT03275402|Leptomeningeal Metastases|leptomeningeal metastases
982512|NCT03275402|Pediatric|pediatric
982513|NCT03275389|Safety|safety
982514|NCT03275389|Healthy adults|healthy adults
982515|NCT03275389|Immunogenicity|immunogenicity
982516|NCT03275389|Supra-seasonal universal influenza vaccines - inactivated (SUIVs)|supra-seasonal universal influenza vaccines - inactivated (suivs)
982517|NCT03275363|Subjective cognitive decline|subjective cognitive decline
982518|NCT03275363|Mild Cognitive Impairment|mild cognitive impairment
982519|NCT03275363|Dementia|dementia
982520|NCT03275363|Cerebral aging|cerebral aging
982521|NCT03275337|Social Phobia|social phobia
982522|NCT03275337|Anxiety|anxiety
982523|NCT03275337|Cerebellum|cerebellum
982524|NCT03275337|rTMS|rtms
982525|NCT03275337|Neuromodulation|neuromodulation
982526|NCT03275337|Fear Extinction|fear extinction
982527|NCT03275311|metastatic breast cancer|metastatic breast cancer
982528|NCT03275311|observational study|observational study
982529|NCT03275311|survival|survival
982530|NCT03275311|real world data|real world data
982531|NCT03275311|real life setting|real life setting
982532|NCT03275298|ovarian cancer|ovarian cancer
982533|NCT03275298|observational study|observational study
982534|NCT03275298|survival|survival
982535|NCT03275298|real world data|real world data
982536|NCT03275298|real life setting|real life setting
982537|NCT03275259|Shock wave|shock wave
982538|NCT03275259|Gynoid lipodystrophy|gynoid lipodystrophy
982539|NCT03275259|Cellulits|cellulits
982540|NCT03275246|Primary total knee replacement|primary total knee replacement
982541|NCT03275207|Chronic pain|chronic pain
982542|NCT03275207|CPSP|cpsp
982543|NCT03275207|Dexmedetomidine|dexmedetomidine
982544|NCT03275207|Surgery|surgery
982545|NCT03275155|Autonomic Dysfunction|autonomic dysfunction
982546|NCT03275155|Inflammation|inflammation
982547|NCT03275155|Cognitive impairment|cognitive impairment
982548|NCT03275155|Interoception|interoception
982549|NCT03275155|Gait impairment|gait impairment
982550|NCT03275129|ultrasound assessment|ultrasound assessment
982551|NCT03275116|Bronchodilation|bronchodilation
982552|NCT03275116|Hyperinflation|hyperinflation
982553|NCT03275116|Physical activity|physical activity
982554|NCT03275116|Sleep quality|sleep quality
982555|NCT03275090|lipid emulsions; preterm; sepsis|lipid emulsions; preterm; sepsis
982556|NCT03275077|End stage renal disease|end stage renal disease
982557|NCT03275077|ESRD|esrd
982558|NCT03275077|Thromboelastography|thromboelastography
982559|NCT03275077|Fibrinogen|fibrinogen
982560|NCT03275064|Articular cartilage, partial thickness cartilage lesion, knee, cartilage|articular cartilage, partial thickness cartilage lesion, knee, cartilage
982561|NCT03275064|regeneration|regeneration
982562|NCT03275051|Beta Thalassaemia|beta thalassaemia
982563|NCT03275051|GSK2696277|gsk2696277
982564|NCT03275051|Lentiviral vector|lentiviral vector
982565|NCT03275051|TIGET-BTHAL|tiget-bthal
982566|NCT03275051|Gene therapy|gene therapy
982567|NCT03275038|Neuroimage|neuroimage
982568|NCT03275038|Training|training
982569|NCT03275038|Aging|aging
982570|NCT03275038|Brain|brain
982571|NCT03275038|Cardiovascular risks|cardiovascular risks
982572|NCT03274960|asymptomati bacteriuria, Griess nitrite test, preterm birth|asymptomati bacteriuria, griess nitrite test, preterm birth
982573|NCT03274947|Oropharyngeal Dysphagia|oropharyngeal dysphagia
982574|NCT03274947|Stroke|stroke
982575|NCT03274934|Adolescents|adolescents
982576|NCT03274934|Web- and mobile-based intervention|web- and mobile-based intervention
982577|NCT03274934|Acceptance and Commitment therapy|acceptance and commitment therapy
982578|NCT03274934|Psychological well-being|psychological well-being
982579|NCT03274934|Career preparation|career preparation
982580|NCT03274934|Lifecontrol|lifecontrol
982581|NCT03274934|Successful educational transitions|successful educational transitions
982582|NCT03274934|Learning difficulties|learning difficulties
982583|NCT03274934|Psychological flexibility and mindfulness skills|psychological flexibility and mindfulness skills
982584|NCT03274921|cardiovascular complications|cardiovascular complications
982585|NCT03274921|biomarkers|biomarkers
982586|NCT03274882|metastatic|metastatic
982587|NCT03274882|colorectal|colorectal
982588|NCT03274882|cancer|cancer
982589|NCT03274882|Lonsurf|lonsurf
982590|NCT03274882|S95005|s95005
982591|NCT03274882|Russia|russia
982592|NCT03274869|Scrub typhus|scrub typhus
982593|NCT03274869|Cardiovascular Complication|cardiovascular complication
1657858|NCT00156455|Children|children
982594|NCT03274830|primary osteoarthritis|primary osteoarthritis
982595|NCT03274830|secondary osteoarthritis|secondary osteoarthritis
982596|NCT03274830|femoral head fracture|femoral head fracture
982597|NCT03274830|necrosis|necrosis
982599|NCT03274817|Depression|depression
982600|NCT03274817|Escitalopram|escitalopram
982601|NCT03274817|Venlafaxine|venlafaxine
982602|NCT03274791|COPD|copd
982603|NCT03274791|smoking|smoking
982604|NCT03274791|induced sputum|induced sputum
982814|NCT03273114|back pain|back pain
982605|NCT03274791|clinical features|clinical features
982606|NCT03274765|ovarian stimulation|ovarian stimulation
982607|NCT03274765|blood test|blood test
982608|NCT03274765|Medically Assisted Procreation|medically assisted procreation
982609|NCT03274752|Paroxetine|paroxetine
982610|NCT03274674|PRF|prf
982611|NCT03274674|I-PRF|i-prf
982612|NCT03274674|Microneedle|microneedle
982613|NCT03274674|Gingival Thickness|gingival thickness
982614|NCT03274674|Injectable-Platelet-Rich-Fibrin|injectable-platelet-rich-fibrin
982615|NCT03274674|Platelet Rich Fibrin|platelet rich fibrin
982616|NCT03274661|solid tumor, Pembrolizumab,|solid tumor, pembrolizumab,
982617|NCT03274609|Lung diseases|lung diseases
982618|NCT03274609|cancer|cancer
982619|NCT03274609|Interventional pulmonology|interventional pulmonology
982620|NCT03274609|peripheral nodule|peripheral nodule
982621|NCT03274596|Oxidative Damage|oxidative damage
982622|NCT03274596|Vitamin E|vitamin e
982623|NCT03274596|Total Antioxidant Capacity|total antioxidant capacity
982624|NCT03274596|Retinopathy of Prematurity|retinopathy of prematurity
982625|NCT03274583|atrial fibrillation|atrial fibrillation
982626|NCT03274583|smartphone|smartphone
982627|NCT03274583|detection|detection
982628|NCT03274557|Achilles, tendinose, tendinopathy, pain|achilles, tendinose, tendinopathy, pain
982629|NCT03274544|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
982630|NCT03274544|Chinese Medicine|chinese medicine
982631|NCT03274544|Herbal Medicine|herbal medicine
982632|NCT03274518|Hemodialysis|hemodialysis
982633|NCT03274518|Hemodiafiltration|hemodiafiltration
982634|NCT03274518|fluid status|fluid status
982635|NCT03274518|hemodynamics|hemodynamics
982636|NCT03274479|adenosine receptors|adenosine receptors
982637|NCT03274479|checkpoint inhibitors|checkpoint inhibitors
982638|NCT03274479|immune system activator|immune system activator
982639|NCT03274440|OCD|ocd
982640|NCT03274440|Marijuana|marijuana
982641|NCT03274440|THC|thc
982642|NCT03274440|Cannabis|cannabis
982643|NCT03274440|CBD|cbd
982644|NCT03274440|Cannabinoid|cannabinoid
982645|NCT03274414|squamous cell carcinoma|squamous cell carcinoma
982646|NCT03274414|esthesioneuroblastoma|esthesioneuroblastoma
982647|NCT03274414|adenoid cystic carcinoma|adenoid cystic carcinoma
982648|NCT03274414|adenocarcinoma|adenocarcinoma
982649|NCT03274414|cisplatin|cisplatin
982650|NCT03274414|17-442|17-442
982651|NCT03274401|Atrial fibrillation|atrial fibrillation
982652|NCT03274401|Pulmonary embolism|pulmonary embolism
982658|NCT03274336|preanesthesia|preanesthesia
982659|NCT03274336|movie|movie
982660|NCT03274336|brochure|brochure
982661|NCT03274336|face-to-face interview|face-to-face interview
982662|NCT03274310|Influenza|influenza
982663|NCT03274310|Text message|text message
982664|NCT03274310|Influenza-like Illness|influenza-like illness
982665|NCT03274310|Acute Respiratory Infection|acute respiratory infection
982666|NCT03274284|chemoradiation for|chemoradiation for
982667|NCT03274284|T1G3 BC|t1g3 bc
982668|NCT03274271|physical activity|physical activity
982669|NCT03274271|sedentary behaviour|sedentary behaviour
982670|NCT03274271|eHealth|ehealth
982671|NCT03274271|mHealth|mhealth
982672|NCT03274271|self-regulation|self-regulation
982673|NCT03274271|behaviour change techniques|behaviour change techniques
982674|NCT03274271|action planning|action planning
982675|NCT03274271|coping planning|coping planning
982676|NCT03274271|self-monitoring|self-monitoring
982677|NCT03274271|prevention|prevention
982678|NCT03274258|Renal Medullary Carcinoma|renal medullary carcinoma
982679|NCT03274258|RMC|rmc
982680|NCT03274258|Locally advanced or metastatic|locally advanced or metastatic
982681|NCT03274258|Nivolumab|nivolumab
982682|NCT03274258|BMS-936558|bms-936558
982683|NCT03274258|Opdivo|opdivo
982684|NCT03274258|Ipilimumab|ipilimumab
982685|NCT03274258|Yervoy|yervoy
982686|NCT03274258|BMS-734016|bms-734016
982687|NCT03274258|MDX010|mdx010
982688|NCT03274245|Public Health|public health
982689|NCT03274206|Cervical Intraepithelian Neoplasia Grade 2/3|cervical intraepithelian neoplasia grade 2/3
982690|NCT03274206|CIN 2/3|cin 2/3
982691|NCT03274206|HPV|hpv
982692|NCT03274180|Travel consultation|travel consultation
982693|NCT03274102|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
982694|NCT03274102|Concomitant vaccination|concomitant vaccination
982695|NCT03274102|Safety|safety
982696|NCT03274102|Immunogenicity|immunogenicity
982697|NCT03274102|Infant|infant
982698|NCT03274076|diffuse|diffuse
982699|NCT03274076|scleroderma|scleroderma
982700|NCT03274076|systemic sclerosis|systemic sclerosis
982701|NCT03274050|robot|robot
982702|NCT03274050|surgery|surgery
982703|NCT03274050|pediatry|pediatry
982704|NCT03273998|coagulation|coagulation
982705|NCT03273998|bleeding|bleeding
982706|NCT03273972|Healthy Volunteers|healthy volunteers
982707|NCT03273972|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
982708|NCT03273972|PCSK9|pcsk9
982709|NCT03273972|Alirocumab|alirocumab
982710|NCT03273972|Forearm Blood Flow|forearm blood flow
982711|NCT03273972|Arterial Stiffness|arterial stiffness
982712|NCT03273972|Carotid Intima Media Thickness|carotid intima media thickness
983734|NCT03267147|Anti-CCP|anti-ccp
982713|NCT03273972|Inflammation|inflammation
982714|NCT03273972|Endothelial function|endothelial function
982715|NCT03273959|Physiotherapy|physiotherapy
982716|NCT03273959|Physical Therapy|physical therapy
982717|NCT03273959|Exercise|exercise
982718|NCT03273959|Hospitalization|hospitalization
982719|NCT03273959|Pediatric|pediatric
982720|NCT03273959|Adolescents|adolescents
982721|NCT03273946|CCI18781|cci18781
982722|NCT03273946|Observational|observational
982723|NCT03273946|Post-marketing|post-marketing
982724|NCT03273946|Fluticasone propionate|fluticasone propionate
982725|NCT03273946|Asthma|asthma
982726|NCT03273920|laparoscopy-assisted gastrectomy|laparoscopy-assisted gastrectomy
982727|NCT03273920|robot-assisted gastrectomy|robot-assisted gastrectomy
982728|NCT03273920|advanced gastric cancer|advanced gastric cancer
982729|NCT03273920|D2 Lymphadenectomy|d2 lymphadenectomy
982731|NCT03273894|Hypothermia, temperature management|hypothermia, temperature management
982732|NCT03273881|Gestational diabetes mellitus|gestational diabetes mellitus
982733|NCT03273881|Pre-gestational diabetes mellitus|pre-gestational diabetes mellitus
982734|NCT03273881|Treatment|treatment
982735|NCT03273881|Neonatal hypoglycemia|neonatal hypoglycemia
982736|NCT03273803|Heart sounds, smartphone, application|heart sounds, smartphone, application
982737|NCT03273777|Cesarean section|cesarean section
982738|NCT03273777|Skin incision|skin incision
982739|NCT03273777|Skewness|skewness
982740|NCT03273777|Line drawing|line drawing
982741|NCT03273764|Preterm, RDS, Surfactant, CPAP|preterm, rds, surfactant, cpap
982745|NCT03273738|type 2 diabetes|type 2 diabetes
982746|NCT03273738|postmenopausal|postmenopausal
982747|NCT03273725|Oral Health|oral health
982748|NCT03273725|Vitamin D|vitamin d
982749|NCT03273686|Esophageal Cancer|esophageal cancer
982750|NCT03273686|Nasogastric Tube|nasogastric tube
982751|NCT03273673|Secondary ACL Injury Prevention|secondary acl injury prevention
982752|NCT03273673|Visual Biofeedback|visual biofeedback
982753|NCT03273673|Tactile Biofeedback|tactile biofeedback
982754|NCT03273634|Palpitations|palpitations
982755|NCT03273608|Hepatocellular Carcinoma|hepatocellular carcinoma
982756|NCT03273608|Advanced HCC|advanced hcc
982757|NCT03273608|Unresectable|unresectable
982758|NCT03273608|deTACE|detace
982759|NCT03273608|HepaSphere|hepasphere
982760|NCT03273517|Glycemia|glycemia
982761|NCT03273517|Preoperative fasting|preoperative fasting
982762|NCT03273517|Pediatric patients|pediatric patients
982763|NCT03273517|Anesthesia|anesthesia
982764|NCT03273517|Knowledge of the resident|knowledge of the resident
982765|NCT03273491|self-weighing|self-weighing
982766|NCT03273491|weight gain|weight gain
982767|NCT03273491|Ecological Momentary Assessment|ecological momentary assessment
982768|NCT03273491|mood|mood
982769|NCT03273491|emerging adulthood|emerging adulthood
982770|NCT03273491|obesity|obesity
982771|NCT03273491|eating disorders|eating disorders
982772|NCT03273478|Bifurcation aneurysm|bifurcation aneurysm
982773|NCT03273478|Unruptured bifurcation aneurysm|unruptured bifurcation aneurysm
982774|NCT03273478|Ruptured bifurcation aneurysm|ruptured bifurcation aneurysm
982775|NCT03273478|Stent-assisted coiling|stent-assisted coiling
982776|NCT03273478|pCONUS2 Bifurcation Aneurysm Implant|pconus2 bifurcation aneurysm implant
982778|NCT03273465|Colitis|colitis
982779|NCT03273465|fecal|fecal
982780|NCT03273465|FMT|fmt
982781|NCT03273465|microbiota|microbiota
982782|NCT03273465|transplantation|transplantation
982783|NCT03273439|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
982784|NCT03273439|Negative symptoms|negative symptoms
982785|NCT03273439|randomized controlled trial|randomized controlled trial
982786|NCT03273439|Schizophrenia|schizophrenia
982787|NCT03273439|cognition|cognition
982788|NCT03273413|Pravastatin|pravastatin
982789|NCT03273413|Statin|statin
982790|NCT03273400|Lumbar, Hamstring, Mobilisation|lumbar, hamstring, mobilisation
982791|NCT03273322|Left atrial appendage closure|left atrial appendage closure
982792|NCT03273322|Rivaroxaban|rivaroxaban
982793|NCT03273322|Dual antiplatelet therapy|dual antiplatelet therapy
982794|NCT03273322|Anticoagulation|anticoagulation
982795|NCT03273322|Stroke prevention|stroke prevention
982796|NCT03273296|microbiota|microbiota
982797|NCT03273296|metabolize|metabolize
982798|NCT03273257|Pulmonary endarterectomy|pulmonary endarterectomy
982799|NCT03273257|PEA|pea
982800|NCT03273257|Medical therapy|medical therapy
982801|NCT03273218|coronary angiography, diagnostic, transradial, catheter|coronary angiography, diagnostic, transradial, catheter
1333112|NCT01444456|Breast Cancer|breast cancer
982802|NCT03273205|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
982803|NCT03273192|healthy subjects|healthy subjects
982804|NCT03273192|adalimumab|adalimumab
982805|NCT03273192|single dose|single dose
982806|NCT03273192|Phase 1|phase 1
982807|NCT03273192|PK|pk
982808|NCT03273179|cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
982809|NCT03273179|CSF pressure|csf pressure
982810|NCT03273179|modified Rankin Scale|modified rankin scale
982811|NCT03273179|papilledema|papilledema
982812|NCT03273179|NIHSS|nihss
982813|NCT03273127|Asthma, placebo, abediterol, DPI, corticosteroids|asthma, placebo, abediterol, dpi, corticosteroids
982815|NCT03273114|physiotherapy|physiotherapy
982816|NCT03273114|exercise therapy|exercise therapy
982817|NCT03273114|cognitive functional therapy|cognitive functional therapy
982818|NCT03273114|low back pain|low back pain
982819|NCT03273114|backache|backache
982820|NCT03273114|lower back pain|lower back pain
982821|NCT03273114|lumbago|lumbago
982822|NCT03273114|multidimensional|multidimensional
982823|NCT03273114|biopsychosocial|biopsychosocial
982824|NCT03273088|healthy subjects|healthy subjects
982825|NCT03273088|Pharmacokinetics|pharmacokinetics
982826|NCT03273088|etanercept|etanercept
982827|NCT03273088|single dose|single dose
982828|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
982829|NCT03273075|P2Y12r inhibitor|p2y12r inhibitor
982830|NCT03273075|Cardiac Arrest|cardiac arrest
982831|NCT03273075|STEMI|stemi
982832|NCT03273075|HTPR|htpr
982833|NCT03273062|Brain Injury|brain injury
982834|NCT03273062|Traumatic Brain Injury|traumatic brain injury
982835|NCT03273062|Acquired Brain Injury|acquired brain injury
982836|NCT03273062|Cognition|cognition
982837|NCT03273062|Neuropsychiatric Symptopms|neuropsychiatric symptopms
982838|NCT03273062|COMT|comt
982839|NCT03272997|Positron emission thomography|positron emission thomography
982840|NCT03272997|Computed tomography|computed tomography
982841|NCT03272997|Sensitivity|sensitivity
982842|NCT03272997|Specificity|specificity
982843|NCT03272971|lung cancer|lung cancer
982844|NCT03272971|radiofrequency ablation|radiofrequency ablation
982845|NCT03272971|bronchoscopy|bronchoscopy
982846|NCT03272971|NSCLC|nsclc
982847|NCT03272958|Pruritus|pruritus
982848|NCT03272958|Bullous pemphigoid|bullous pemphigoid
982849|NCT03272919|Breast Cancer, Peripheral neuropathy, Taxol, carboplatin|breast cancer, peripheral neuropathy, taxol, carboplatin
982850|NCT03272906|aphasia|aphasia
982851|NCT03272906|stroke|stroke
982852|NCT03272906|tDCS|tdcs
982853|NCT03272906|language|language
982854|NCT03272906|stimulation|stimulation
982856|NCT03272906|speech therapy|speech therapy
982857|NCT03272893|psychoneuroimmunology|psychoneuroimmunology
982858|NCT03272880|Art Therapy|art therapy
982859|NCT03272880|Music Therapy|music therapy
982860|NCT03272815|pneumothorax|pneumothorax
982861|NCT03272815|chest tube removal|chest tube removal
982862|NCT03272815|percussion|percussion
982863|NCT03272802|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
982864|NCT03272802|Edaravone|edaravone
982865|NCT03272776|LMA Protector|lma protector
982866|NCT03272776|Second Generation Laryngeal Masks|second generation laryngeal masks
982867|NCT03272776|Airway|airway
982868|NCT03272776|Dual Gastric Acces|dual gastric acces
982869|NCT03272776|Teleflex|teleflex
982870|NCT03272776|Supraglottic Devices|supraglottic devices
982871|NCT03272776|Ambulatory Surgery|ambulatory surgery
982872|NCT03272737|KAATSU|kaatsu
982873|NCT03272737|Cardiovascular system|cardiovascular system
982874|NCT03272737|Elderly|elderly
982875|NCT03272711|Vortioxetine|vortioxetine
982876|NCT03272711|Elderly|elderly
982877|NCT03272711|Online cognitive training|online cognitive training
982878|NCT03272698|ketamine|ketamine
982879|NCT03272698|treatment-resistant depression|treatment-resistant depression
982880|NCT03272698|electroconvulsive therapy|electroconvulsive therapy
982881|NCT03272685|Reduced nicotine cigarettes|reduced nicotine cigarettes
982882|NCT03272685|Alternative nicotine products|alternative nicotine products
982883|NCT03272685|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
982884|NCT03272659|Fluorescence Sigmoidoscopy|fluorescence sigmoidoscopy
982886|NCT03272659|Photodynamic Diagnosis|photodynamic diagnosis
982887|NCT03272646|Gastric Cancer|gastric cancer
982888|NCT03272607|Adverse Drug Event|adverse drug event
982889|NCT03272607|Choosing Wisely Canada|choosing wisely canada
982890|NCT03272607|Deprescribing|deprescribing
982891|NCT03272607|Elderly|elderly
982892|NCT03272607|Frailty|frailty
982893|NCT03272607|High value healthcare|high value healthcare
982894|NCT03272607|Medication rationalization|medication rationalization
982895|NCT03272607|Medication stewardship|medication stewardship
982896|NCT03272607|Polypharmacy|polypharmacy
982897|NCT03272594|Neonatal pain|neonatal pain
982898|NCT03272594|Pediatric pain|pediatric pain
982899|NCT03272594|Pain assessment|pain assessment
982900|NCT03272594|Breastfeeding|breastfeeding
982901|NCT03272594|Sucrose|sucrose
1333113|NCT01444456|Lung Cancer|lung cancer
982902|NCT03272594|Randomized controlled trial|randomized controlled trial
982903|NCT03272594|Behavioural pain response|behavioural pain response
982904|NCT03272594|Neurophysiological pain response|neurophysiological pain response
982905|NCT03272581|Functional|functional
982906|NCT03272581|Training|training
982907|NCT03272581|Performance|performance
982908|NCT03272568|Extended Life Plasma Derived Factor Products|extended life plasma derived factor products
982909|NCT03272568|Female hemophilia A and B carriers|female hemophilia a and b carriers
982910|NCT03272568|Menorrhagia|menorrhagia
982911|NCT03272542|gastric bypass|gastric bypass
982912|NCT03272542|calcium absorption|calcium absorption
982913|NCT03272542|postmenopausal women|postmenopausal women
982914|NCT03272516|Mild to moderate Depression|mild to moderate depression
982915|NCT03272516|Mild to moderate Anxiety|mild to moderate anxiety
982916|NCT03272516|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
982917|NCT03272516|Primary care|primary care
982918|NCT03272516|PHQ-9|phq-9
982919|NCT03272516|GAD-7|gad-7
982920|NCT03272516|Antidepressants|antidepressants
982921|NCT03272516|Anxiolytica|anxiolytica
982922|NCT03272516|Subjective wellbeing|subjective wellbeing
982924|NCT03272490|locking plate|locking plate
982925|NCT03272490|anatomical preshaped|anatomical preshaped
982926|NCT03272490|polyaxial|polyaxial
982927|NCT03272490|outcome|outcome
982928|NCT03272477|hormone receptor positive|hormone receptor positive
982929|NCT03272477|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
982930|NCT03272477|Early breast cancer|early breast cancer
982931|NCT03272477|HR+/HER2+|hr+/her2+
982932|NCT03272464|Melanoma|melanoma
982933|NCT03272438|steps|steps
982934|NCT03272438|goals|goals
982935|NCT03272386|pelvic floor muscles|pelvic floor muscles
982936|NCT03272386|instruction|instruction
982937|NCT03272386|assessment|assessment
982938|NCT03272386|acceptability|acceptability
982939|NCT03272386|understanding|understanding
982940|NCT03272334|Metastatic Breast Cancer|metastatic breast cancer
982941|NCT03272334|Adoptive Cell Therapy|adoptive cell therapy
982942|NCT03272334|Armed Activated T-cells|armed activated t-cells
982943|NCT03272334|Bispecific Antibodies|bispecific antibodies
982944|NCT03272334|Immunotherapy|immunotherapy
982945|NCT03272321|biomedical intervention|biomedical intervention
982946|NCT03272321|oxytocin|oxytocin
982948|NCT03272321|skin conductance response|skin conductance response
982949|NCT03272321|heart rate|heart rate
982950|NCT03272321|gaze direction|gaze direction
982951|NCT03272321|eye contact|eye contact
982952|NCT03272282|WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour|who partograpg.obstructed labour. managment of labour
982953|NCT03272269|Diabetes Mellitus type 1|diabetes mellitus type 1
982954|NCT03272269|Autoimmune disease|autoimmune disease
982955|NCT03272269|Immunotherapy|immunotherapy
982956|NCT03272269|Diabetes treatment|diabetes treatment
982957|NCT03272269|Residual beta cell function|residual beta cell function
982958|NCT03272269|Adult patients|adult patients
982959|NCT03272243|thoracolumbar fracture|thoracolumbar fracture
982960|NCT03272243|short segment fixation|short segment fixation
982961|NCT03272243|long segment fixation|long segment fixation
982962|NCT03272243|index level|index level
982963|NCT03272230|Apathy|apathy
982964|NCT03272230|Goal-directed behavior|goal-directed behavior
982965|NCT03272230|Assessment|assessment
982966|NCT03272230|Diagnosis|diagnosis
982967|NCT03272230|Sensor|sensor
982968|NCT03272230|Ecological condition|ecological condition
982969|NCT03272230|Neurological disease|neurological disease
982970|NCT03272217|Atezolizumab|atezolizumab
982971|NCT03272217|MPDL3280A|mpdl3280a
982972|NCT03272217|Bevacizumab|bevacizumab
982973|NCT03272217|Avastin|avastin
982974|NCT03272217|Cisplatin-Ineligible|cisplatin-ineligible
982975|NCT03272217|Anti-PD-L1 Antibodies|anti-pd-l1 antibodies
982976|NCT03272204|pubic hair; grooming; urinary tract symptoms; vaginitis|pubic hair; grooming; urinary tract symptoms; vaginitis
982978|NCT03272191|Infarction|infarction
982979|NCT03272191|Infarct|infarct
982980|NCT03272191|Subacute MI|subacute mi
982981|NCT03272191|stem cell|stem cell
982982|NCT03272165|Healthy Volunteers|healthy volunteers
982983|NCT03272165|Safety|safety
982984|NCT03272165|Tolerability|tolerability
982985|NCT03272165|Pharmacokinetics|pharmacokinetics
982986|NCT03272165|Pharmacodynamics|pharmacodynamics
982987|NCT03272165|Immunogenicity|immunogenicity
982988|NCT03272126|vitamin D|vitamin d
982989|NCT03272100|lateral approach|lateral approach
982990|NCT03272100|bone augmentation|bone augmentation
982991|NCT03272100|sinus lift|sinus lift
982992|NCT03272100|flap|flap
982993|NCT03272087|Thoracoscopy|thoracoscopy
982994|NCT03272048|Firearms|firearms
982995|NCT03272035|General practice|general practice
982996|NCT03272035|death|death
982997|NCT03272035|bereavement|bereavement
982998|NCT03272022|cobalamin, folate|cobalamin, folate
982999|NCT03271996|Pilonidal sinus|pilonidal sinus
983000|NCT03271996|Bascom|bascom
983001|NCT03271996|Cleft lift|cleft lift
983002|NCT03271996|Fistulectomy|fistulectomy
983003|NCT03271996|Karydakis|karydakis
983004|NCT03271918|Pituitary Adenoma|pituitary adenoma
983005|NCT03271918|Dopaminergic Agonist|dopaminergic agonist
983006|NCT03271918|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
983007|NCT03271918|Cabergoline|cabergoline
983008|NCT03271879|Diabetes|diabetes
983009|NCT03271879|Heart|heart
983010|NCT03271879|Arrhythmia|arrhythmia
983011|NCT03271866|Schizophrenia|schizophrenia
983012|NCT03271866|Metabolic syndrome|metabolic syndrome
983013|NCT03271866|Metformin|metformin
983014|NCT03271866|Cognitive impairment|cognitive impairment
983015|NCT03271866|Clinical trial|clinical trial
983016|NCT03271827|Apnoeic oxygenation|apnoeic oxygenation
983017|NCT03271827|Airway management|airway management
983018|NCT03271827|Oxygen insufflation|oxygen insufflation
983839|NCT03266523|CT|ct
983019|NCT03271827|Paediatric general anaesthesia|paediatric general anaesthesia
983020|NCT03271775|Dizziness|dizziness
983021|NCT03271775|Instability|instability
983022|NCT03271762|MITRACLIP|mitraclip
983023|NCT03271762|primary Mitral Regurgitation|primary mitral regurgitation
983024|NCT03271762|high surgical risks|high surgical risks
983025|NCT03271749|Fast Track surgical recovery|fast track surgical recovery
983026|NCT03271749|Surgical recovery|surgical recovery
983027|NCT03271749|Thoracic surgery|thoracic surgery
983028|NCT03271736|Parkinson's disease|parkinson's disease
983029|NCT03271736|Auditory cues|auditory cues
983030|NCT03271736|step in place|step in place
983031|NCT03271736|transcranial magnetic stimulation|transcranial magnetic stimulation
983032|NCT03271736|cortical excitability|cortical excitability
983033|NCT03271723|cohort studies|cohort studies
983034|NCT03271723|infant development|infant development
983035|NCT03271723|pregnancy|pregnancy
983036|NCT03271723|Brazil|brazil
983037|NCT03271723|observational studies|observational studies
983038|NCT03271723|epidemiology|epidemiology
983039|NCT03271723|maternal health|maternal health
983040|NCT03271710|Distal embolization|distal embolization
983041|NCT03271710|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
983042|NCT03271710|Integrated embolic protection|integrated embolic protection
983043|NCT03271684|stroke, self-management, Bridges, participation, function, self-efficacy|stroke, self-management, bridges, participation, function, self-efficacy
983044|NCT03271671|neurally adjusted ventilator assist|neurally adjusted ventilator assist
983045|NCT03271671|Pressure support ventilation|pressure support ventilation
983046|NCT03271671|non invasive ventilation|non invasive ventilation
983047|NCT03271671|niv|niv
983048|NCT03271658|patient decision aid|patient decision aid
983049|NCT03271658|end-of-life care|end-of-life care
983050|NCT03271658|shared decision making|shared decision making
983051|NCT03271658|informed decision|informed decision
983052|NCT03271658|decision-making|decision-making
983053|NCT03271658|clinical decision-making|clinical decision-making
983054|NCT03271658|web-based decision aid|web-based decision aid
983055|NCT03271658|palliative|palliative
983056|NCT03271658|critical care|critical care
983057|NCT03271658|nursing|nursing
983058|NCT03271645|Depression|depression
983059|NCT03271645|Anxiety|anxiety
983060|NCT03271645|Stress|stress
983061|NCT03271645|Internet-delivered interventions|internet-delivered interventions
983062|NCT03271632|multiple myeloma|multiple myeloma
983063|NCT03271632|chimeric antigen receptor|chimeric antigen receptor
983064|NCT03271632|BCMA|bcma
983065|NCT03271632|CD38|cd38
983066|NCT03271632|CD56|cd56
983067|NCT03271632|CD138|cd138
983068|NCT03271619|Safety Issues|safety issues
983069|NCT03271580|Wound healing|wound healing
983070|NCT03271580|Diabetes|diabetes
983071|NCT03271580|Inflammatory cells|inflammatory cells
983072|NCT03271580|Macrophage|macrophage
983073|NCT03271528|Lacosamide|lacosamide
983074|NCT03271528|Alcohol craving|alcohol craving
983075|NCT03271528|Alcohol Urge Questionnaire|alcohol urge questionnaire
983076|NCT03271528|Obsessive-Compulsive Drinking Scale|obsessive-compulsive drinking scale
983077|NCT03271515|leukemia|leukemia
983078|NCT03271515|lymphoma|lymphoma
983079|NCT03271515|CAR-T|car-t
983080|NCT03271515|bispecific|bispecific
983081|NCT03271515|CD20|cd20
983082|NCT03271515|CD19|cd19
983083|NCT03271489|Elagolix Sodium|elagolix sodium
983084|NCT03271489|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
983085|NCT03271489|Heavy Uterine Bleeding|heavy uterine bleeding
983086|NCT03271489|Leiomyomata|leiomyomata
983087|NCT03271489|Menorrhagia|menorrhagia
983088|NCT03271489|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
983089|NCT03271489|Elagolix + E2/NETA|elagolix + e2/neta
983090|NCT03271489|Elagolix|elagolix
983091|NCT03271489|Safety|safety
983092|NCT03271489|Efficacy|efficacy
983093|NCT03271489|ABT-620|abt-620
983094|NCT03271476|Breast Cancer|breast cancer
983095|NCT03271476|EMDR|emdr
983096|NCT03271463|stroke|stroke
983097|NCT03271463|selective voluntary motor control|selective voluntary motor control
983098|NCT03271450|dabigatran|dabigatran
983099|NCT03271450|warfarin|warfarin
983100|NCT03271450|apixaban|apixaban
983101|NCT03271450|edoxaban|edoxaban
983102|NCT03271450|extended treatment|extended treatment
983103|NCT03271450|oral anticoagulant|oral anticoagulant
983104|NCT03271450|rivaroxaban|rivaroxaban
983105|NCT03271450|comparative safety|comparative safety
983106|NCT03271450|comparative effectiveness|comparative effectiveness
983107|NCT03271385|hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
983108|NCT03271385|hypertensive Heart Disease|hypertensive heart disease
983109|NCT03271385|cardiac magnetic resonance|cardiac magnetic resonance
983110|NCT03271307|self-test|self-test
983111|NCT03271307|testing|testing
983112|NCT03271307|cost-effectiveness|cost-effectiveness
983113|NCT03271294|pelvic organ prolapse|pelvic organ prolapse
983114|NCT03271294|Exair|exair
983115|NCT03271294|Transvaginal mesh|transvaginal mesh
983116|NCT03271281|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
983117|NCT03271281|Angiogenesis PET/CT|angiogenesis pet/ct
983118|NCT03271281|Neuroendocrine tumors|neuroendocrine tumors
983119|NCT03271268|Vascular filling|vascular filling
983120|NCT03271268|Fluid overload|fluid overload
983121|NCT03271268|Biomarkers|biomarkers
983122|NCT03271268|Lung edema|lung edema
983123|NCT03271255|apatinib|apatinib
983124|NCT03271255|bevacizumab|bevacizumab
983125|NCT03271255|FOLFIRI|folfiri
983126|NCT03271255|colorectal cancer|colorectal cancer
983127|NCT03271229|Platelet rich plasma|platelet rich plasma
983128|NCT03271229|bone marrow|bone marrow
983129|NCT03271229|stem cell|stem cell
983130|NCT03271203|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
983131|NCT03271203|Real-time data capture|real-time data capture
983132|NCT03271203|Cognitive debriefing|cognitive debriefing
983133|NCT03271203|Hand Osteoarthritis|hand osteoarthritis
983134|NCT03271203|Concept elicitation|concept elicitation
983135|NCT03271190|aging|aging
983136|NCT03271190|memory complaint|memory complaint
983137|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
983138|NCT03271138|Celiac Disease|celiac disease
983139|NCT03271138|Gluten-Free Diet|gluten-free diet
983140|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
983141|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
983142|NCT03271138|quality of life|quality of life
983143|NCT03271138|microbiota|microbiota
983144|NCT03271138|IgA TTG|iga ttg
983145|NCT03271138|IgA DGP|iga dgp
983146|NCT03271125|Intervention|intervention
983147|NCT03271125|Multiple sclerosis|multiple sclerosis
983148|NCT03271125|Treadmill|treadmill
983149|NCT03271125|Mobility|mobility
983150|NCT03271099|survivorship; navigation|survivorship; navigation
983151|NCT03271086|Relaxation training|relaxation training
983152|NCT03271086|Pediatric clinic|pediatric clinic
983153|NCT03271086|Children 6-11 years|children 6-11 years
983154|NCT03271086|Text messaging|text messaging
983155|NCT03271073|gastric cancer|gastric cancer
983156|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
983157|NCT03271073|Apatinib|apatinib
983158|NCT03271073|S1|s1
983159|NCT03271047|cancer|cancer
983160|NCT03271034|Lipedema|lipedema
983161|NCT03271034|Metabolism|metabolism
983162|NCT03271034|Body Composition|body composition
983163|NCT03271034|Fat Distribution|fat distribution
983164|NCT03271034|Immunology|immunology
983165|NCT03270995|breast cancer|breast cancer
983166|NCT03270995|gynecological cancer|gynecological cancer
983167|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
983168|NCT03270995|clinical trial|clinical trial
983169|NCT03270995|randomized controlled trial|randomized controlled trial
983170|NCT03270995|group therapy|group therapy
983171|NCT03270995|intervention|intervention
983172|NCT03270995|cognitive-existential|cognitive-existential
983173|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
983174|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
983175|NCT03270982|Revision where other devices have failed|revision where other devices have failed
983176|NCT03270982|Correction of functional deformity|correction of functional deformity
983177|NCT03270982|Oncology Applications|oncology applications
983178|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
983179|NCT03270930|Operative duration|operative duration
983180|NCT03270930|Pediatric surgery|pediatric surgery
983181|NCT03270930|Emergency laparotomy|emergency laparotomy
983182|NCT03270930|Mortality rate|mortality rate
983183|NCT03270930|Survival|survival
983184|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
983185|NCT03270930|ROC curve analysis|roc curve analysis
983186|NCT03270930|Senior resident|senior resident
983187|NCT03270917|Parenchymal preserving|parenchymal preserving
983188|NCT03270917|Postero-superior|postero-superior
983189|NCT03270917|Laparoscopy|laparoscopy
983190|NCT03270891|Pharmacogenomics|pharmacogenomics
983191|NCT03270891|Primary care physicians|primary care physicians
983192|NCT03270878|Glasdegib|glasdegib
983193|NCT03270878|PF-04449913|pf-04449913
983194|NCT03270878|Pharmacokinetics|pharmacokinetics
983195|NCT03270878|Bioavailability|bioavailability
983196|NCT03270813|Child|child
983197|NCT03270813|Adolescent|adolescent
983198|NCT03270787|Acute Mountain sickness|acute mountain sickness
983199|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
983200|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
983201|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
983202|NCT03270748|Unrelated donors|unrelated donors
983203|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
983204|NCT03270748|Myeloid Malignancies|myeloid malignancies
983205|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
983206|NCT03270748|GITMO|gitmo
983207|NCT03270709|Vitamin D3|vitamin d3
983208|NCT03270709|Pulmonary disease|pulmonary disease
983209|NCT03270709|Immunosuppression|immunosuppression
983211|NCT03270709|Smoking|smoking
983212|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
983213|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
983214|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
983215|NCT03270683|prognosis|prognosis
983216|NCT03270657|Deep Brain Stimulation|deep brain stimulation
983217|NCT03270592|Service dogs|service dogs
983218|NCT03270592|Alert dogs|alert dogs
983219|NCT03270592|Costs|costs
983220|NCT03270592|Quality of Life|quality of life
983221|NCT03270592|Cost-effectiveness|cost-effectiveness
983222|NCT03270566|Water hardness|water hardness
983223|NCT03270566|Atopic eczema prevention|atopic eczema prevention
983224|NCT03270566|Skin barrier function|skin barrier function
983225|NCT03270566|Skin microbiome|skin microbiome
983226|NCT03270527|Dietary fat modification|dietary fat modification
983227|NCT03270527|Lipids|lipids
983228|NCT03270527|LDL cholesterol|ldl cholesterol
983229|NCT03270527|Dietary fatty acids|dietary fatty acids
983230|NCT03270527|Saturated fat|saturated fat
983231|NCT03270514|cardiac surgery|cardiac surgery
983232|NCT03270514|sternotomy|sternotomy
983233|NCT03270514|post-operative pain|post-operative pain
983234|NCT03270514|sternal wound infiltration|sternal wound infiltration
983235|NCT03270488|Thumb|thumb
983236|NCT03270488|Osteoarthritis|osteoarthritis
983237|NCT03270488|Physical Therapy|physical therapy
983238|NCT03270488|Pain|pain
983239|NCT03270449|fibromyalgia|fibromyalgia
983240|NCT03270449|community-based|community-based
983241|NCT03270449|multidisciplinary|multidisciplinary
983242|NCT03270410|neonates|neonates
983243|NCT03270410|non invasive monitoring|non invasive monitoring
983244|NCT03270397|Self Esteem|self esteem
983245|NCT03270397|Body Image|body image
983246|NCT03270397|Eating disorders|eating disorders
983247|NCT03270384|early feasibility|early feasibility
983248|NCT03270384|non-randomized|non-randomized
983249|NCT03270345|Decubitus|decubitus
983250|NCT03270345|Pressure|pressure
983251|NCT03270345|Ulcer|ulcer
983252|NCT03270345|Injuries|injuries
983253|NCT03270345|Sores|sores
983254|NCT03270345|Intensive care|intensive care
983255|NCT03270319|Measurement of cardiac output|measurement of cardiac output
983256|NCT03270280|Chronic Periodontitis|chronic periodontitis
983257|NCT03270280|Phytomedicines|phytomedicines
983258|NCT03270280|Nigella sativa|nigella sativa
983259|NCT03270241|Vitiligo|vitiligo
983260|NCT03270241|Dermatology|dermatology
983261|NCT03270241|Johns Hopkins|johns hopkins
983262|NCT03270241|Compensation|compensation
983263|NCT03270241|Paid|paid
983264|NCT03270241|Phototherapy|phototherapy
983265|NCT03270241|NB-UVB|nb-uvb
983266|NCT03270241|Light treatment|light treatment
983267|NCT03270241|Skin|skin
983268|NCT03270241|Biopsies|biopsies
983269|NCT03270241|Money|money
983270|NCT03270241|Short-term|short-term
983271|NCT03270228|Incidence of cancer|incidence of cancer
983272|NCT03270228|Survival|survival
983273|NCT03270215|Computed Tomography|computed tomography
983274|NCT03270215|Specificity|specificity
983275|NCT03270215|Sensitivity|sensitivity
983276|NCT03270202|Exercise|exercise
983277|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
983278|NCT03270202|Risk factors|risk factors
983279|NCT03270202|Monitoring, physiologic|monitoring, physiologic
983280|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
983281|NCT03270202|Prognosis|prognosis
983282|NCT03270202|Norway|norway
983283|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
983284|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
983285|NCT03270137|Alzheimer Disease|alzheimer disease
983286|NCT03270137|rTMS|rtms
983287|NCT03270137|Cognition|cognition
983288|NCT03270137|Behavioral Symptoms|behavioral symptoms
983289|NCT03270137|Functionality|functionality
983290|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
983292|NCT03270124|iPAD|ipad
983293|NCT03270124|Physical Exercises|physical exercises
983294|NCT03270124|Quality of Life|quality of life
983295|NCT03270111|breast cancer survivor|breast cancer survivor
983296|NCT03270111|weight loss program|weight loss program
983297|NCT03270098|Schizophrenia|schizophrenia
983298|NCT03270098|Aerobic Exercise|aerobic exercise
983299|NCT03270098|Cognition|cognition
983300|NCT03270098|Daily Functioning|daily functioning
983301|NCT03270098|Biomarkers|biomarkers
983302|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
983303|NCT03270046|Bowel preparation|bowel preparation
983304|NCT03270046|CRC screening|crc screening
983305|NCT03270033|Shoulder Joint|shoulder joint
983306|NCT03270033|Arthroscopy|arthroscopy
983307|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
983308|NCT03270033|Pain, Postoperative|pain, postoperative
983309|NCT03270033|Brachial Plexus Block|brachial plexus block
983310|NCT03270033|Corticosteroid|corticosteroid
983311|NCT03270033|Dexamethasone|dexamethasone
983312|NCT03270033|Dexmedetomidine|dexmedetomidine
983313|NCT03270033|Bupivacaine|bupivacaine
983314|NCT03270033|Alpha 2 agonist|alpha 2 agonist
983315|NCT03270033|Postoperative analgesia|postoperative analgesia
983316|NCT03270020|treatment|treatment
983317|NCT03270020|denosumab|denosumab
983524|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
983318|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
983319|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
983320|NCT03269994|17-418|17-418
983321|NCT03269994|cefoxitin|cefoxitin
983322|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
983323|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
983324|NCT03269981|Lymphatic irradiation|lymphatic irradiation
983325|NCT03269981|Taxane|taxane
983326|NCT03269981|Anthracycline|anthracycline
983327|NCT03269981|Prospective study|prospective study
983328|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
983329|NCT03269942|Flow Diverter|flow diverter
983330|NCT03269942|Cerebral Revascularization|cerebral revascularization
983331|NCT03269851|neurological deficit|neurological deficit
983332|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
983333|NCT03269799|periodontitis|periodontitis
983334|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
983335|NCT03269799|vitamin C|vitamin c
983336|NCT03269773|Atopic Dermatitis|atopic dermatitis
983337|NCT03269773|Stem cell|stem cell
983338|NCT03269773|Cell therapy|cell therapy
983339|NCT03269773|skin disease|skin disease
983340|NCT03269773|Umbilical cord Blood|umbilical cord blood
983341|NCT03269773|UCB-MSC|ucb-msc
983342|NCT03269773|hUCB-MSC|hucb-msc
983343|NCT03269773|AD|ad
983344|NCT03269773|furestem|furestem
983345|NCT03269773|dermatitis|dermatitis
983346|NCT03269773|eczema|eczema
983347|NCT03269747|glucocorticoids|glucocorticoids
983348|NCT03269747|brown adipose tissue|brown adipose tissue
983349|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
983350|NCT03269734|Vascular Diseases|vascular diseases
983351|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
983352|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
983353|NCT03269734|Aortic aneurysm|aortic aneurysm
983354|NCT03269734|Arteriovenous malformations|arteriovenous malformations
983355|NCT03269734|Catheterization|catheterization
983356|NCT03269721|Cognition|cognition
983357|NCT03269721|Pulmonary|pulmonary
983359|NCT03269721|Lung|lung
983360|NCT03269656|Vitamin D|vitamin d
983361|NCT03269656|Cancer|cancer
983362|NCT03269656|Survival|survival
983363|NCT03269617|dysbiosis|dysbiosis
983364|NCT03269617|gut microbiota|gut microbiota
983365|NCT03269617|bacteriophage|bacteriophage
983366|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
983367|NCT03269617|gastrointestinal distress|gastrointestinal distress
983368|NCT03269617|prebiotic|prebiotic
983369|NCT03269604|Urological Surgery|urological surgery
983370|NCT03269604|Bacterial resistance|bacterial resistance
983371|NCT03269591|Dysmenorrhea|dysmenorrhea
983372|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
983373|NCT03269591|Diclofenac|diclofenac
983374|NCT03269578|Pharmacodynamics|pharmacodynamics
983375|NCT03269578|Tissue Collection|tissue collection
983376|NCT03269578|Tissue Biopsies|tissue biopsies
983377|NCT03269578|Biospecimen|biospecimen
983378|NCT03269578|Assay Development|assay development
983379|NCT03269526|Pancreatic Cancer|pancreatic cancer
983380|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
983381|NCT03269526|Adoptive cell therapy|adoptive cell therapy
983382|NCT03269526|Armed activated T-cells|armed activated t-cells
983383|NCT03269526|Bispecific antibody|bispecific antibody
983384|NCT03269526|Immunotherapy|immunotherapy
983385|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
983386|NCT03269474|genetic expression|genetic expression
983387|NCT03269474|drug repurposing|drug repurposing
983388|NCT03269474|computational approaches|computational approaches
983389|NCT03269474|drug discovery|drug discovery
983390|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
983391|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
983392|NCT03269448|carbon dioxide|carbon dioxide
983393|NCT03269448|peripheral venous blood|peripheral venous blood
983394|NCT03269448|central venous blood|central venous blood
983395|NCT03269448|venous blood gas|venous blood gas
983396|NCT03269448|blood gas analysis|blood gas analysis
983397|NCT03269422|17-407|17-407
983398|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
983399|NCT03269422|DIL|dil
983400|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
983401|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
983402|NCT03269383|stellate ganglion block|stellate ganglion block
983403|NCT03269383|cardiac surgery|cardiac surgery
983404|NCT03269383|atrial fibrillation|atrial fibrillation
983405|NCT03269370|CBT|cbt
983406|NCT03269370|Self-Help|self-help
983407|NCT03269370|Family|family
983408|NCT03269357|LARC|larc
983409|NCT03269357|contraception|contraception
983410|NCT03269357|counselling|counselling
983411|NCT03269357|unplanned pregnancy|unplanned pregnancy
983412|NCT03269331|nursing practice|nursing practice
983413|NCT03269331|evidence-based practice models|evidence-based practice models
983414|NCT03269331|military nursing|military nursing
983415|NCT03269331|clinical inquiry|clinical inquiry
983416|NCT03269266|Scrub Typhus|scrub typhus
983417|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
983418|NCT03269253|ALSPAC|alspac
983419|NCT03269253|longitudinal|longitudinal
983420|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
983421|NCT03269227|Radiotherapy|radiotherapy
983422|NCT03269227|Tomotherapy|tomotherapy
983423|NCT03269227|Hypofractionation|hypofractionation
983424|NCT03269214|osteonecrosis|osteonecrosis
983425|NCT03269214|mandible|mandible
983426|NCT03269201|parkinsonism|parkinsonism
983427|NCT03269201|ataxia|ataxia
983428|NCT03269201|tremor|tremor
983429|NCT03269201|dystonia|dystonia
983430|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
983431|NCT03269149|Alzheimer's disease|alzheimer's disease
983432|NCT03269149|African-American Women|african-american women
983433|NCT03269149|Caregivers|caregivers
983434|NCT03269149|Tango|tango
983435|NCT03269149|Dance-based intervention|dance-based intervention
983436|NCT03269136|Multiple Myeloma|multiple myeloma
983437|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
983438|NCT03269136|bispecific antibody|bispecific antibody
983439|NCT03269136|bispecific|bispecific
983440|NCT03269136|BCMA|bcma
983441|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
983442|NCT03269136|Phase 1|phase 1
983443|NCT03269136|PF-06863135|pf-06863135
983444|NCT03269123|Sensory trick|sensory trick
983445|NCT03269123|Geste Antagoniste|geste antagoniste
983446|NCT03269110|neurological|neurological
983447|NCT03269110|autism|autism
983448|NCT03269110|ASD|asd
983449|NCT03269110|behaviour|behaviour
983450|NCT03269110|folic acid|folic acid
983451|NCT03269110|pre-eclampsia|pre-eclampsia
983452|NCT03269110|asthma|asthma
983453|NCT03269110|executive function|executive function
983454|NCT03269071|Multiple Sclerosis|multiple sclerosis
983455|NCT03269071|Cell Therapy|cell therapy
983456|NCT03269071|Human Neural Stem Cells|human neural stem cells
983462|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
983464|NCT03269019|Thrombelastograghy|thrombelastograghy
983465|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
983466|NCT03269006|Vector control|vector control
983467|NCT03269006|Sand fly,|sand fly,
983468|NCT03269006|Bangladesh|bangladesh
983469|NCT03268993|prevention|prevention
983470|NCT03268993|dietary supplement|dietary supplement
983471|NCT03268993|broccoli|broccoli
983472|NCT03268967|intensive care|intensive care
983473|NCT03268967|crisis resource management|crisis resource management
983474|NCT03268967|simulation training|simulation training
983475|NCT03268967|before and after study|before and after study
983476|NCT03268954|Drug therapy|drug therapy
983477|NCT03268941|Drug therapy|drug therapy
983478|NCT03268928|Shared Book Reading|shared book reading
983479|NCT03268928|Language Development|language development
983480|NCT03268928|Syntax|syntax
983481|NCT03268928|Vocabulary|vocabulary
983482|NCT03268928|Phonological Awareness|phonological awareness
983483|NCT03268928|Young Children|young children
983484|NCT03268928|Randomised Control Trial|randomised control trial
983485|NCT03268928|Language Intervention|language intervention
983486|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
983487|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
983488|NCT03268915|Interindividual reproductibility|interindividual reproductibility
983489|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
983490|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
983491|NCT03268876|Surgery|surgery
983492|NCT03268876|Quality of life|quality of life
983493|NCT03268863|pain tolerance|pain tolerance
983494|NCT03268863|perioperative pain|perioperative pain
983495|NCT03268863|virtual reality therapy|virtual reality therapy
983496|NCT03268850|LDKT|ldkt
983497|NCT03268850|Live donor transplantation|live donor transplantation
983498|NCT03268850|Kidney transplantation|kidney transplantation
983499|NCT03268798|stroke|stroke
983500|NCT03268798|strength training|strength training
983501|NCT03268798|rehabilitation|rehabilitation
983502|NCT03268785|Parathyroid glands|parathyroid glands
983503|NCT03268785|Needle puncture|needle puncture
983504|NCT03268785|Diff-quik staining|diff-quik staining
983505|NCT03268785|PTH test assay|pth test assay
983506|NCT03268785|Thyroid cancer|thyroid cancer
983507|NCT03268759|substance abuse|substance abuse
983508|NCT03268733|Folic acid|folic acid
983509|NCT03268733|PCOS|pcos
983510|NCT03268733|Insulin resistance|insulin resistance
983511|NCT03268733|Infertility|infertility
983512|NCT03268720|gluten sensitivity|gluten sensitivity
983513|NCT03268720|gluten-free diet|gluten-free diet
983514|NCT03268720|FODMAP diet|fodmap diet
983515|NCT03268720|microbiome|microbiome
983516|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
983517|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
983518|NCT03268707|Telemetry Monitoring|telemetry monitoring
983519|NCT03268707|Cryoballoon ablation|cryoballoon ablation
983520|NCT03268655|gingerol|gingerol
983521|NCT03268655|microbiome|microbiome
983523|NCT03268655|ginger|ginger
983732|NCT03267173|CEA|cea
983525|NCT03268642|Retrospective cohort study|retrospective cohort study
983526|NCT03268629|Insomnia|insomnia
983527|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
983528|NCT03268629|Mindfulness Meditation|mindfulness meditation
983529|NCT03268629|Tai Chi|tai chi
983530|NCT03268629|Inflammation|inflammation
983531|NCT03268629|NF-κB|nf-κb
983532|NCT03268616|neural respiratory drive|neural respiratory drive
983533|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
983534|NCT03268616|electromyography|electromyography
983535|NCT03268590|Hyperoxia|hyperoxia
983536|NCT03268590|Hypoxia, Brain|hypoxia, brain
983537|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
983538|NCT03268512|ridge preservation|ridge preservation
983539|NCT03268512|growth factors|growth factors
983540|NCT03268512|platelet concentrates|platelet concentrates
983541|NCT03268486|Fetal monitoring|fetal monitoring
983542|NCT03268486|cardiotocography|cardiotocography
983543|NCT03268473|OSAS|osas
983544|NCT03268473|Obstructive Sleep Apnea|obstructive sleep apnea
983545|NCT03268473|Periodontitis|periodontitis
983546|NCT03268434|Depression|depression
983547|NCT03268434|Metacognition|metacognition
983548|NCT03268434|CBT|cbt
983549|NCT03268434|D-MCT|d-mct
983550|NCT03268434|cognitive bias|cognitive bias
983551|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
983552|NCT03268421|pain in children|pain in children
983553|NCT03268421|musculoskeletal pain|musculoskeletal pain
983554|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
983555|NCT03268421|coping skills training|coping skills training
983556|NCT03268421|neuromuscular exercise|neuromuscular exercise
983557|NCT03268421|graded aerobic exercise|graded aerobic exercise
983558|NCT03268408|community intervention|community intervention
983559|NCT03268408|newsletter|newsletter
983560|NCT03268382|Ovarian Cancer|ovarian cancer
983561|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
983562|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
983563|NCT03268382|Recurrent Cancer|recurrent cancer
983564|NCT03268382|Resistant Cancer|resistant cancer
983565|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
983566|NCT03268304|Neurorehabilitation|neurorehabilitation
983567|NCT03268304|Virtual Reality|virtual reality
983568|NCT03268304|Action Research Arm Test|action research arm test
983569|NCT03268291|Adherence to therapy|adherence to therapy
983570|NCT03268291|Myocardial Infarction|myocardial infarction
983571|NCT03268291|Coronary Artery Disease|coronary artery disease
983572|NCT03268291|Communicational program|communicational program
983573|NCT03268278|analgesia|analgesia
983574|NCT03268278|endodontic|endodontic
983575|NCT03268278|postoperative|postoperative
983576|NCT03268187|Cognitive Fatigue|cognitive fatigue
983577|NCT03268187|Multiple Sclerosis|multiple sclerosis
983578|NCT03268187|Biofeedback|biofeedback
983579|NCT03268187|Self-Alert Training|self-alert training
983580|NCT03268187|Vigilance|vigilance
983581|NCT03268187|Autonomic potentials|autonomic potentials
983582|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
983583|NCT03268161|Waldenström disease|waldenström disease
983584|NCT03268161|Mutational analysis|mutational analysis
983585|NCT03268148|neonates|neonates
983586|NCT03268148|pain|pain
983587|NCT03268148|low level laser|low level laser
983588|NCT03268135|miRNA|mirna
983589|NCT03268135|lncRNAs|lncrnas
983590|NCT03268135|transcriptome|transcriptome
983591|NCT03268135|heart failure|heart failure
983592|NCT03268135|aortic stenosis|aortic stenosis
983593|NCT03268135|biomarkers|biomarkers
983594|NCT03268122|Patient Isolation|patient isolation
983595|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
983596|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
983597|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
983598|NCT03268083|Vaccines|vaccines
983599|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
983600|NCT03268083|EV71 vaccine|ev71 vaccine
983601|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
983602|NCT03268070|Neurophysiology|neurophysiology
983603|NCT03268070|Neuroscience|neuroscience
983604|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
983605|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
983606|NCT03268057|Carcinoma|carcinoma
983607|NCT03268057|Advanced|advanced
983608|NCT03268057|VX15/2503|vx15/2503
983609|NCT03268057|Semaphorin 4D|semaphorin 4d
983610|NCT03268057|SEMA4D|sema4d
983611|NCT03268057|safety tolerability|safety tolerability
983612|NCT03268057|pharmacokinetics|pharmacokinetics
983613|NCT03268057|monoclonal antibody|monoclonal antibody
983614|NCT03268031|artificial intelligence|artificial intelligence
983615|NCT03268031|glaucoma|glaucoma
983616|NCT03268018|calcium|calcium
983617|NCT03268018|peripheral arterial disease|peripheral arterial disease
983618|NCT03267992|COPD|copd
983619|NCT03267992|Coils|coils
983620|NCT03267992|App|app
983621|NCT03267979|pain assessment|pain assessment
983622|NCT03267979|pupillary diameter|pupillary diameter
983733|NCT03267173|HER2|her2
983623|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
983624|NCT03267979|pain self assessment|pain self assessment
983625|NCT03267979|video-pupillometer|video-pupillometer
983626|NCT03267979|electrocardiogram|electrocardiogram
983627|NCT03267979|analgesic treatment|analgesic treatment
983628|NCT03267966|periampullary cancer|periampullary cancer
983629|NCT03267966|margin status|margin status
983630|NCT03267966|R1 resection|r1 resection
983631|NCT03267966|clearance margin|clearance margin
983632|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
983633|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
983634|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
983635|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
983636|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
983637|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
983638|NCT03267927|OSA|osa
983639|NCT03267927|Polysomnography|polysomnography
983640|NCT03267927|Rapid palatal expansion|rapid palatal expansion
983641|NCT03267927|Mandibular advancement|mandibular advancement
983642|NCT03267927|Sleep position|sleep position
983643|NCT03267862|biomarker|biomarker
983644|NCT03267849|biomarker|biomarker
983645|NCT03267823|Bleeding|bleeding
983646|NCT03267823|heart surgery|heart surgery
983647|NCT03267823|coagulation|coagulation
983648|NCT03267823|coagulopathy|coagulopathy
983649|NCT03267823|INR|inr
983650|NCT03267810|Neuropathic Pain|neuropathic pain
983651|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
983657|NCT03267784|allogeneic|allogeneic
983658|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
983659|NCT03267784|skin ulcer|skin ulcer
983660|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
983661|NCT03267784|somatic cell therapy|somatic cell therapy
983662|NCT03267784|phase I/IIa|phase i/iia
983663|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
983664|NCT03267745|protein|protein
983665|NCT03267745|skeletal muscle|skeletal muscle
983666|NCT03267745|immobilization|immobilization
983667|NCT03267706|Primary care|primary care
983668|NCT03267706|Palliative care|palliative care
983669|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
983670|NCT03267641|Cancer immunotherapy|cancer immunotherapy
983671|NCT03267641|Tumour microenvironment|tumour microenvironment
983672|NCT03267641|Driver mutations|driver mutations
983673|NCT03267641|Precision Medicine|precision medicine
983674|NCT03267628|intrathecal morphine|intrathecal morphine
983675|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
983676|NCT03267628|cesarean section|cesarean section
983677|NCT03267628|pain|pain
983678|NCT03267615|Liver Cirrhosis|liver cirrhosis
983679|NCT03267615|Portal Hypertension|portal hypertension
983680|NCT03267589|immunotherapy|immunotherapy
983681|NCT03267589|ovarian cancer|ovarian cancer
983682|NCT03267589|durvalumab|durvalumab
983683|NCT03267589|tremelilumab|tremelilumab
983684|NCT03267589|MEDI 9447|medi 9447
983685|NCT03267589|MEDI 0562|medi 0562
983686|NCT03267563|prevention|prevention
983687|NCT03267563|implementation|implementation
983688|NCT03267563|sustainment|sustainment
983689|NCT03267563|perinatal|perinatal
983690|NCT03267563|pregnancy|pregnancy
983691|NCT03267563|postpartum|postpartum
983692|NCT03267537|Insomnia|insomnia
983693|NCT03267537|Sleep|sleep
983694|NCT03267537|Telemedicine|telemedicine
983695|NCT03267368|Comprehensive Care Program|comprehensive care program
983696|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
983697|NCT03267316|First-in-Human|first-in-human
983698|NCT03267316|Phase 1|phase 1
983700|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
983701|NCT03267316|IL1RAP|il1rap
983702|NCT03267316|Safety|safety
983703|NCT03267316|Tolerability|tolerability
983704|NCT03267316|Cancer|cancer
983705|NCT03267316|Solid tumor|solid tumor
983706|NCT03267316|Malignant|malignant
983707|NCT03267316|Dose escalation|dose escalation
983708|NCT03267316|Dose expansion|dose expansion
983709|NCT03267316|CAN04|can04
983710|NCT03267316|Immunoglobulin|immunoglobulin
983711|NCT03267316|Clinical Trial|clinical trial
983712|NCT03267316|Infusion|infusion
983713|NCT03267316|Antineoplastic|antineoplastic
983714|NCT03267316|Anticancer|anticancer
983715|NCT03267303|Narcolepsy|narcolepsy
983721|NCT03267251|Vaccine Decision Making|vaccine decision making
983722|NCT03267251|Public Health|public health
983723|NCT03267251|Health Communication|health communication
983724|NCT03267251|Digital Interventions|digital interventions
983725|NCT03267225|drug interaction|drug interaction
983726|NCT03267225|genetic polymorphism|genetic polymorphism
983727|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
983728|NCT03267212|Ventilatory support|ventilatory support
983729|NCT03267173|Pancreatic Cancer|pancreatic cancer
983730|NCT03267173|CAR-T|car-t
983731|NCT03267173|Mesothelin|mesothelin
983735|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
983736|NCT03267121|head and neck cancer|head and neck cancer
983737|NCT03267121|Apatinib|apatinib
983738|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
983739|NCT03267121|induction chemotherapy|induction chemotherapy
983740|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
983741|NCT03267108|PF|pf
983742|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
983743|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
983744|NCT03267108|iNO|ino
983745|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
983746|NCT03267108|Oxygen|oxygen
983747|NCT03267056|drug-coated balloon|drug-coated balloon
983748|NCT03267043|preterm birth|preterm birth
983749|NCT03267043|NICU|nicu
983750|NCT03267043|neonatal|neonatal
983751|NCT03267043|skin to skin|skin to skin
983752|NCT03267043|kangaroo care|kangaroo care
983753|NCT03267043|separation stress|separation stress
983754|NCT03267043|family nurture|family nurture
983755|NCT03267043|maternal confidence|maternal confidence
983756|NCT03267043|maternal competence|maternal competence
983757|NCT03267043|calming cycle|calming cycle
983758|NCT03267043|infant neurodevelopment|infant neurodevelopment
983759|NCT03267043|infant psychological development|infant psychological development
983760|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
983761|NCT03267043|postpartum depression|postpartum depression
983762|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
983763|NCT03266965|Fatigue|fatigue
983764|NCT03266965|Histamine|histamine
983765|NCT03266952|stroke|stroke
983766|NCT03266952|race|race
983767|NCT03266952|diet|diet
983768|NCT03266952|diabetes|diabetes
983769|NCT03266952|ethnicity|ethnicity
983770|NCT03266952|myocardial infarction|myocardial infarction
983771|NCT03266874|total hip arthroplasty|total hip arthroplasty
983772|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
983773|NCT03266848|Ferumoxytol|ferumoxytol
983774|NCT03266835|Chronic Total Occlusion|chronic total occlusion
983775|NCT03266835|Peripheral|peripheral
983776|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
983777|NCT03266835|CTO|cto
983778|NCT03266835|intra-luminal|intra-luminal
983779|NCT03266835|Active wire|active wire
983780|NCT03266835|Device|device
983781|NCT03266835|Procedure|procedure
983782|NCT03266809|Cardiac function|cardiac function
983783|NCT03266809|Cardio-toxicity|cardio-toxicity
983784|NCT03266770|ureteral stent|ureteral stent
983785|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
983786|NCT03266744|Whole Body MRI|whole body mri
983787|NCT03266744|Computerised Tomography|computerised tomography
983788|NCT03266744|Bone scan|bone scan
983789|NCT03266718|cancer survivor|cancer survivor
983790|NCT03266718|breast cancer|breast cancer
983791|NCT03266718|prostate cancer|prostate cancer
983792|NCT03266718|couples|couples
983793|NCT03266692|BCMA|bcma
983794|NCT03266692|SEA-BCMA|sea-bcma
983795|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
983796|NCT03266692|ACTR|actr
983797|NCT03266692|ACTR087|actr087
983798|NCT03266692|T cell|t cell
983799|NCT03266692|T cell product|t cell product
983800|NCT03266692|relapsed|relapsed
983801|NCT03266692|refractory|refractory
983802|NCT03266692|multiple myeloma|multiple myeloma
983803|NCT03266692|adoptive T cells|adoptive t cells
983804|NCT03266692|autologous|autologous
983805|NCT03266692|gene therapy|gene therapy
983806|NCT03266692|cell therapy|cell therapy
983807|NCT03266679|bipolar disorder|bipolar disorder
983808|NCT03266679|metacognition|metacognition
983809|NCT03266679|reflective functioning|reflective functioning
983810|NCT03266679|metacognition-based intervention|metacognition-based intervention
983811|NCT03266679|sense of self|sense of self
983813|NCT03266666|grocery|grocery
983814|NCT03266666|lifestyle|lifestyle
983815|NCT03266666|lifestyle change|lifestyle change
983816|NCT03266666|behavior|behavior
983817|NCT03266666|nutrition|nutrition
983818|NCT03266640|Cytomegalovirus|cytomegalovirus
983819|NCT03266640|CMV|cmv
983820|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
983821|NCT03266627|adenovirus|adenovirus
983822|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
983823|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
983824|NCT03266614|Mental Illness|mental illness
983825|NCT03266614|Loneliness|loneliness
983826|NCT03266614|Hope|hope
983827|NCT03266614|Community|community
983828|NCT03266614|Social Media|social media
983829|NCT03266601|Aged 1-7 years old, within 72 hours of onset patients with herpangina|aged 1-7 years old, within 72 hours of onset patients with herpangina
983830|NCT03266588|migraine|migraine
983831|NCT03266588|acute|acute
983832|NCT03266575|Frailty|frailty
983833|NCT03266575|Sarcopenia|sarcopenia
983834|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
983835|NCT03266562|Positron Emission Mammography|positron emission mammography
983836|NCT03266549|botulinum toxin|botulinum toxin
983837|NCT03266549|infantile esotropia|infantile esotropia
983838|NCT03266536|Gut microbiota|gut microbiota
983841|NCT03266523|Anxiety-state|anxiety-state
983842|NCT03266523|Anxiety State-Trait|anxiety state-trait
983843|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
983844|NCT03266497|diet quality|diet quality
983845|NCT03266497|health disparities|health disparities
983846|NCT03266497|immigrants|immigrants
983847|NCT03266497|foreign-born|foreign-born
983848|NCT03266497|Blacks/African Americans|blacks/african americans
983849|NCT03266497|place of birth/nativity|place of birth/nativity
983850|NCT03266497|length of residency|length of residency
983851|NCT03266497|NHANES|nhanes
983852|NCT03266497|acculturation|acculturation
983853|NCT03266484|Microbiome|microbiome
983854|NCT03266484|Fatigue|fatigue
983855|NCT03266484|Probiotics|probiotics
983856|NCT03266471|Cytokines|cytokines
983857|NCT03266471|Pharmacogenetics|pharmacogenetics
983858|NCT03266445|relapse|relapse
983859|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
983860|NCT03266445|opioids|opioids
983861|NCT03266445|narcotics|narcotics
983862|NCT03266445|post-surgical pain|post-surgical pain
983863|NCT03266393|Envarsus XR|envarsus xr
983864|NCT03266393|Kidney transplantation|kidney transplantation
983865|NCT03266393|Grafting, Kidney|grafting, kidney
983866|NCT03266393|Tacrolimus|tacrolimus
983867|NCT03266393|Rejection|rejection
983868|NCT03266393|Adherence|adherence
983869|NCT03266393|Quality of Life|quality of life
983870|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
983871|NCT03266354|Artisan|artisan
983872|NCT03266302|vasodilatory shock|vasodilatory shock
983873|NCT03266302|hemoadsorption|hemoadsorption
983874|NCT03266302|cardiac surgery|cardiac surgery
983875|NCT03266302|cytokines|cytokines
983876|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
983877|NCT03266237|Influenza|influenza
983878|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
983879|NCT03266237|Vaxigrip|vaxigrip
983880|NCT03266237|Respiratory Tract Infections|respiratory tract infections
983881|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
983882|NCT03266237|Frailty|frailty
983883|NCT03266237|Aging|aging
983884|NCT03266237|Safety|safety
983885|NCT03266237|Immunogenicity|immunogenicity
983886|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
983887|NCT03266224|wryneck|wryneck
983888|NCT03266224|sternocleidomastoid|sternocleidomastoid
983889|NCT03266224|ultrasonography|ultrasonography
983890|NCT03266224|digital analysis|digital analysis
983891|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
983892|NCT03266172|immediate release tablet|immediate release tablet
983893|NCT03266172|GSK2982772|gsk2982772
983894|NCT03266172|Modified release|modified release
983895|NCT03266172|minitablet|minitablet
983896|NCT03266159|Dose escalation|dose escalation
983897|NCT03266159|Small cell lung cancer|small cell lung cancer
983898|NCT03266159|Trametinib|trametinib
983899|NCT03266159|GSK525762|gsk525762
983900|NCT03266159|Ras-mutations|ras-mutations
983901|NCT03266159|BET inhibitor|bet inhibitor
983902|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
983903|NCT03266146|Recurrence|recurrence
983904|NCT03266146|Methylprednisolone|methylprednisolone
983905|NCT03266146|Short-term|short-term
983906|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
983907|NCT03266133|Sleep education|sleep education
983908|NCT03266120|Gardening|gardening
983909|NCT03266120|Therapeutic Arts|therapeutic arts
983910|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
983911|NCT03266120|Anxiety|anxiety
983912|NCT03266120|Depression|depression
983913|NCT03266120|Mood States|mood states
983914|NCT03266120|Quality of Life|quality of life
983915|NCT03266120|Social Interactions|social interactions
983916|NCT03266120|Stress|stress
983917|NCT03266120|Wellness|wellness
983918|NCT03266055|Blueberry|blueberry
983919|NCT03266055|Diet|diet
983920|NCT03266003|Tuberculosis|tuberculosis
983921|NCT03266003|Directly observed therapy|directly observed therapy
983922|NCT03266003|Adherence|adherence
983923|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
983924|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
983925|NCT03266003|Mobile health|mobile health
983926|NCT03265964|Suicidal Ideation|suicidal ideation
983927|NCT03265964|Veteran|veteran
983928|NCT03265964|Uridine|uridine
983929|NCT03265964|Neuroimaging|neuroimaging
983930|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
983931|NCT03265938|Head and Neck cancer|head and neck cancer
983932|NCT03265938|Cancer of oral cavity|cancer of oral cavity
983933|NCT03265938|Ear, Nose and Throat|ear, nose and throat
983934|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
983935|NCT03265938|Awake intubation|awake intubation
983936|NCT03265938|Expected difficult intubation|expected difficult intubation
983937|NCT03265847|intimate partner violence|intimate partner violence
983938|NCT03265847|safety planning|safety planning
983939|NCT03265847|immigrant, refugee|immigrant, refugee
983940|NCT03265847|Native American|native american
983941|NCT03265847|risk for future violence|risk for future violence
983942|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
983943|NCT03265821|Smoking|smoking
983944|NCT03265821|Periodontal treatment|periodontal treatment
983945|NCT03265821|Periodontal disease|periodontal disease
983946|NCT03265821|Healing|healing
983947|NCT03265808|stem cells|stem cells
983948|NCT03265782|efficacy|efficacy
983949|NCT03265782|safety|safety
983950|NCT03265782|paracetamol|paracetamol
983951|NCT03265782|ibuprofen|ibuprofen
983952|NCT03265782|PDA|pda
983953|NCT03265782|preterms|preterms
983954|NCT03265769|Femoral approach|femoral approach
983955|NCT03265769|Radial approach|radial approach
983956|NCT03265769|Chronic total occlusion|chronic total occlusion
983957|NCT03265730|Outpatient clinics|outpatient clinics
983958|NCT03265730|oral antibiotics|oral antibiotics
983959|NCT03265730|diarrhea|diarrhea
983960|NCT03265704|Maternal PIH|maternal pih
983961|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
983962|NCT03265704|Neonatal neutropenia|neonatal neutropenia
983963|NCT03265691|Accidental Falls|accidental falls
983964|NCT03265691|Hyponatremia|hyponatremia
983965|NCT03265691|Elderly|elderly
983966|NCT03265691|Risk factors|risk factors
983967|NCT03265691|Nurse|nurse
983968|NCT03265665|walking|walking
983969|NCT03265665|African American women|african american women
983970|NCT03265665|community-based|community-based
983971|NCT03265652|Intense Pulsed Light|intense pulsed light
983972|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
983973|NCT03265652|Dry Eye Disease|dry eye disease
983974|NCT03265587|Feng Shui|feng shui
983975|NCT03265587|Inner harmony|inner harmony
983976|NCT03265587|Chi|chi
983977|NCT03265522|Mediterranean diet|mediterranean diet
983978|NCT03265522|Lifestyle|lifestyle
983979|NCT03265483|Personalized prevention trial|personalized prevention trial
983980|NCT03265483|Magnesium|magnesium
983981|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
983982|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
983983|NCT03265444|MSA|msa
983984|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
983985|NCT03265405|corticosteroids|corticosteroids
983986|NCT03265405|glucocorticoids|glucocorticoids
983987|NCT03265405|relapse|relapse
983988|NCT03265405|interstitial lung disease|interstitial lung disease
983989|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
983990|NCT03265405|immunosuppression|immunosuppression
983991|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
983992|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
983993|NCT03265353|Potassium|potassium
983994|NCT03265353|Sodium|sodium
983995|NCT03265353|Vascular function|vascular function
983996|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
983997|NCT03265288|Inflammation|inflammation
983998|NCT03265288|Essential Fatty Acids|essential fatty acids
983999|NCT03265288|Inflammation resolution|inflammation resolution
984000|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
984001|NCT03265288|Lung function|lung function
984002|NCT03265275|Fast track|fast track
984003|NCT03265223|Ropivacaine|ropivacaine
984004|NCT03265223|local anesthesia|local anesthesia
984005|NCT03265223|intraincisional infiltration|intraincisional infiltration
984006|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
984007|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
984008|NCT03265223|shoulder pain|shoulder pain
984009|NCT03265223|rescue analgesia|rescue analgesia
984010|NCT03265223|triple blinding|triple blinding
984011|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
984012|NCT03265210|Primary Care|primary care
984013|NCT03265197|Tinnitus|tinnitus
984014|NCT03265197|Intra-tympanic|intra-tympanic
984015|NCT03265197|Lidocaine|lidocaine
984016|NCT03265197|Dexamethasone|dexamethasone
984017|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
984018|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
984019|NCT03265132|Kineret|kineret
984020|NCT03265132|anakinra|anakinra
984021|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
984022|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
984023|NCT03265093|Pain Measurement|pain measurement
984024|NCT03265093|Platelet Activation|platelet activation
984025|NCT03265093|Quality of Life|quality of life
984026|NCT03265028|primary care|primary care
984027|NCT03265028|antibiotics|antibiotics
984028|NCT03265028|communication skills|communication skills
984029|NCT03265028|general practice|general practice
984030|NCT03265028|outpatient|outpatient
984031|NCT03265028|ambulatory care|ambulatory care
984032|NCT03265028|anti-bacterial agents|anti-bacterial agents
984033|NCT03265002|fibre|fibre
984034|NCT03265002|inulin|inulin
984035|NCT03265002|psyllium|psyllium
984036|NCT03265002|small bowel MRI|small bowel mri
984037|NCT03264989|Sickle cell disease|sickle cell disease
984038|NCT03264989|sickle cell anemia|sickle cell anemia
984039|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
984040|NCT03264989|P-selectin|p-selectin
984041|NCT03264989|SEG101|seg101
984042|NCT03264989|crizanlizumab|crizanlizumab
984043|NCT03264989|monoclonal antibody|monoclonal antibody
984044|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
984045|NCT03264989|HbS Disease|hbs disease
984046|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
984047|NCT03264989|Sickle Cell Disorders|sickle cell disorders
984048|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
984049|NCT03264976|diabetic retinopathy|diabetic retinopathy
984050|NCT03264976|miRNA|mirna
984051|NCT03264976|serum exosomes|serum exosomes
984052|NCT03264976|prognostic biomarker|prognostic biomarker
984053|NCT03264963|Upper airway exercises|upper airway exercises
984054|NCT03264963|Smart phone application|smart phone application
984056|NCT03264937|INR|inr
984057|NCT03264937|Warfarin|warfarin
984058|NCT03264937|social software|social software
984059|NCT03264924|physical activity|physical activity
984060|NCT03264924|motivation|motivation
984061|NCT03264924|behaviour change|behaviour change
984062|NCT03264911|pharyngitis|pharyngitis
984063|NCT03264911|amoxicillin|amoxicillin
984064|NCT03264872|Motivational Interviewing|motivational interviewing
984065|NCT03264859|NGAL|ngal
984066|NCT03264859|STEMI|stemi
984067|NCT03264859|no-reflow|no-reflow
984068|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
984069|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
984070|NCT03264807|Lymph Node 14v|lymph node 14v
984071|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
984072|NCT03264781|Cyclofem®|cyclofem®
984073|NCT03264781|Implant|implant
984074|NCT03264781|Jadelle|jadelle
984075|NCT03264781|Implanon|implanon
984076|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
984077|NCT03264781|randomized controlled trial|randomized controlled trial
984078|NCT03264768|valves|valves
984079|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
984080|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
984081|NCT03264742|ghreline, stroke|ghreline, stroke
984082|NCT03264729|plantar heel pain|plantar heel pain
984083|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
984084|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
984085|NCT03264703|Joint pain|joint pain
984086|NCT03264703|Joint stiffness|joint stiffness
984087|NCT03264703|Joint redness|joint redness
984088|NCT03264703|Loss of joint function|loss of joint function
984089|NCT03264703|Swollen joints|swollen joints
984090|NCT03264690|Crohn's disease|crohn's disease
984091|NCT03264690|Ulcerative colitis|ulcerative colitis
984092|NCT03264677|8-week HUT|8-week hut
984093|NCT03264677|Hydro Boost|hydro boost
984094|NCT03264677|Skin healthy signs|skin healthy signs
984095|NCT03264677|Environmental aggressors|environmental aggressors
984096|NCT03264677|Cosmetic|cosmetic
984097|NCT03264664|E7386|e7386
984098|NCT03264664|dose escalation|dose escalation
984099|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
984100|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
984101|NCT03264651|Aromatase inhibitor|aromatase inhibitor
984102|NCT03264638|PCOS|pcos
984103|NCT03264638|Dingkundan|dingkundan
984104|NCT03264638|Diane-35|diane-35
984105|NCT03264625|Cholecalciferol|cholecalciferol
984106|NCT03264625|Peritoneal dialysis|peritoneal dialysis
984107|NCT03264625|Peritonitis|peritonitis
984108|NCT03264573|Atrophic scar|atrophic scar
984109|NCT03264573|PRP|prp
984110|NCT03264573|ADSCs|adscs
984111|NCT03264560|Telepsychiatry|telepsychiatry
984112|NCT03264560|Synchronous|synchronous
984113|NCT03264560|Asynchronous|asynchronous
984114|NCT03264560|SNF|snf
984115|NCT03264521|Crowdsourcing|crowdsourcing
984116|NCT03264521|Patient Engagement|patient engagement
984117|NCT03264521|Chiropractic|chiropractic
984118|NCT03264508|endothelial function|endothelial function
984119|NCT03264508|arterial stiffness|arterial stiffness
984120|NCT03264508|heat|heat
984121|NCT03264508|hot water immersion|hot water immersion
984122|NCT03264443|physical activity|physical activity
984123|NCT03264443|exercise|exercise
984124|NCT03264443|aging|aging
984125|NCT03264443|older|older
984126|NCT03264430|Perianal fistula|perianal fistula
984127|NCT03264430|Hemorrhoids|hemorrhoids
984128|NCT03264404|Pancreas|pancreas
984129|NCT03264404|pembrolizumab|pembrolizumab
984130|NCT03264404|azacitidine|azacitidine
984131|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
984132|NCT03264404|first-line|first-line
984133|NCT03264391|OCT-A|oct-a
984134|NCT03264391|Retinal vasculitis|retinal vasculitis
984135|NCT03264391|Behcet's disease|behcet's disease
984136|NCT03264365|Health-related quality of life|health-related quality of life
984137|NCT03264365|Anxiety|anxiety
984138|NCT03264365|Depression|depression
984139|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
984140|NCT03264365|Recovery programme|recovery programme
984141|NCT03264365|Rehabilitation|rehabilitation
984142|NCT03264365|Follow-up programme|follow-up programme
984143|NCT03264365|Aftercare|aftercare
984335|NCT03263403|Bangladeshi|bangladeshi
984144|NCT03264365|Randomized controlled Trial|randomized controlled trial
984145|NCT03264365|Multicentre|multicentre
984146|NCT03264339|Infant|infant
984147|NCT03264339|Hand/Growth & Development|hand/growth & development
984148|NCT03264339|Motor activity|motor activity
984149|NCT03264339|Exercise|exercise
984150|NCT03264339|Communication|communication
984151|NCT03264313|tobacco|tobacco
984152|NCT03264313|Smoking Cessation|smoking cessation
984153|NCT03264313|TMS|tms
984154|NCT03264313|Neuromodulation|neuromodulation
984155|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
984156|NCT03264300|brain tumor, MRI|brain tumor, mri
984157|NCT03264287|acne vulgaris|acne vulgaris
984158|NCT03264287|acupuncture|acupuncture
984159|NCT03264287|cupping|cupping
984160|NCT03264287|ear point tapping|ear point tapping
984161|NCT03264287|randomized controlled trial|randomized controlled trial
984162|NCT03264274|Colorectal|colorectal
984163|NCT03264274|Metastatic|metastatic
984164|NCT03264274|Chemorefractory|chemorefractory
984165|NCT03264274|Ultrasound|ultrasound
984166|NCT03264274|Aflibercept|aflibercept
984167|NCT03264261|stroke, locomotion|stroke, locomotion
984168|NCT03264248|obesity|obesity
984169|NCT03264248|overweight|overweight
984170|NCT03264248|wheelchair|wheelchair
984171|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
984172|NCT03264235|Stair Training|stair training
984173|NCT03264235|Keeogo|keeogo
984174|NCT03264196|condylar hear|condylar hear
984175|NCT03264196|fracture|fracture
984176|NCT03264196|randomised controlled trial|randomised controlled trial
984177|NCT03264144|Social norms|social norms
984178|NCT03264144|Adolescent|adolescent
984179|NCT03264144|Smoking|smoking
984180|NCT03264144|Randomised controlled trial|randomised controlled trial
984181|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
984182|NCT03264131|Adcetris|adcetris
984183|NCT03264131|Lymphoma|lymphoma
984184|NCT03264131|Leukemia|leukemia
984185|NCT03264131|CD30|cd30
984186|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
984187|NCT03264118|Photochemotherapy|photochemotherapy
984188|NCT03264079|RTA 402|rta 402
984189|NCT03264079|Bardoxolone methyl|bardoxolone methyl
984190|NCT03264079|Itraconazole|itraconazole
984191|NCT03264079|Sporanox|sporanox
984192|NCT03264079|CYP3A4|cyp3a4
984193|NCT03264053|socket shield technique|socket shield technique
984194|NCT03264053|crestal bone loss|crestal bone loss
984195|NCT03264053|immediate implanation|immediate implanation
984196|NCT03264040|rounded eyebrows|rounded eyebrows
984197|NCT03264040|large head|large head
984198|NCT03264040|large ears|large ears
984199|NCT03264040|flattened bridge of the nose|flattened bridge of the nose
984200|NCT03264040|deformations of the bones in the spine (vertebrae)|deformations of the bones in the spine (vertebrae)
984201|NCT03263988|pulse contour analysis|pulse contour analysis
984202|NCT03263988|capton|capton
984203|NCT03263988|intraoperative monitoring|intraoperative monitoring
984204|NCT03263962|CHF|chf
984205|NCT03263962|Canrenone|canrenone
984206|NCT03263949|risk prediction|risk prediction
984207|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
984208|NCT03263949|myocardial infarction|myocardial infarction
984209|NCT03263936|Relapse|relapse
984210|NCT03263936|Myelogenous|myelogenous
984211|NCT03263936|Leukemia|leukemia
984212|NCT03263936|Refractory|refractory
984213|NCT03263936|Acute|acute
984214|NCT03263936|Pediatric|pediatric
984215|NCT03263923|grandmother caregivers|grandmother caregivers
984216|NCT03263923|grandfamily|grandfamily
984217|NCT03263923|grandfamilies|grandfamilies
984218|NCT03263923|custodial grandparent|custodial grandparent
984219|NCT03263923|custodial grandmother|custodial grandmother
984220|NCT03263923|multigenerational family|multigenerational family
984221|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
984222|NCT03263897|abortive effect|abortive effect
984223|NCT03263897|mobile interface|mobile interface
984224|NCT03263884|nerve growth factor|nerve growth factor
984225|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
984226|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
984227|NCT03263871|nutrition|nutrition
984228|NCT03263832|Antibiogramme|antibiogramme
984229|NCT03263832|Antibiofilmogramme|antibiofilmogramme
984230|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
984231|NCT03263806|angina|angina
984232|NCT03263806|coronary artery disease|coronary artery disease
984233|NCT03263806|coronary artery catheterization|coronary artery catheterization
984234|NCT03263806|coronary CT angiography|coronary ct angiography
984235|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
984236|NCT03263806|emergency department|emergency department
984237|NCT03263793|singing|singing
984238|NCT03263780|Diagnostic imaging|diagnostic imaging
984239|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
984240|NCT03263780|HIFU|hifu
984241|NCT03263780|18F-Fluciclovine|18f-fluciclovine
984242|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
984243|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
984244|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
984245|NCT03263767|acute GVHD|acute gvhd
984246|NCT03263767|allogenic transplantation|allogenic transplantation
984247|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
984248|NCT03263741|Paclitaxel|paclitaxel
984249|NCT03263741|S-1|s-1
984250|NCT03263741|Oxaliplatin|oxaliplatin
984251|NCT03263741|Efficiency|efficiency
984252|NCT03263741|safety|safety
984253|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
984254|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
984255|NCT03263715|Tocilizumab|tocilizumab
984256|NCT03263715|Glucocorticoid|glucocorticoid
984257|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
984258|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
984259|NCT03263702|mapping|mapping
984260|NCT03263663|colorectal cancer|colorectal cancer
984261|NCT03263663|adjuvant|adjuvant
984262|NCT03263650|prostate cancer|prostate cancer
984263|NCT03263650|genomic alterations|genomic alterations
984264|NCT03263650|DNA damage repair|dna damage repair
984265|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
984266|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
984267|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
984268|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
984269|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
984270|NCT03263637|AZD4573|azd4573
984271|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
984272|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
984273|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
984274|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
984275|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
984276|NCT03263637|Richter's syndrome|richter's syndrome
984277|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
984278|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
984279|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
984280|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
984281|NCT03263624|psoriasis|psoriasis
984282|NCT03263624|laser|laser
984283|NCT03263624|nail|nail
984284|NCT03263611|disc degeneration|disc degeneration
984285|NCT03263611|Intervertebral disc|intervertebral disc
984286|NCT03263611|discogenic pain|discogenic pain
984287|NCT03263611|chronic discogenic lumbar back pain|chronic discogenic lumbar back pain
984288|NCT03263598|liver cirrhosis|liver cirrhosis
984289|NCT03263598|ascites|ascites
984290|NCT03263585|Osteoporosis|osteoporosis
984291|NCT03263585|Vertebral Fracture|vertebral fracture
984292|NCT03263585|Back Pain|back pain
984293|NCT03263585|Spinal orthosis|spinal orthosis
984294|NCT03263585|Elderly women|elderly women
1333114|NCT01444456|Ovarian Cancer|ovarian cancer
1333115|NCT01444456|Prostate Cancer|prostate cancer
984295|NCT03263572|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
984296|NCT03263572|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
984297|NCT03263572|ALL|all
984298|NCT03263572|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
984299|NCT03263572|Ph+ ALL|ph+ all
984300|NCT03263572|BCR-ABL-positive ALL|bcr-abl-positive all
984301|NCT03263572|ALL relapsed or refractory|all relapsed or refractory
984302|NCT03263572|Methotrexate|methotrexate
984303|NCT03263572|Cytarabine|cytarabine
984304|NCT03263572|Ara-C|ara-c
984305|NCT03263572|Cytosar|cytosar
984306|NCT03263572|DepoCyt|depocyt
984307|NCT03263572|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
984308|NCT03263572|Blinatumomab|blinatumomab
984309|NCT03263572|Dexamethasone|dexamethasone
984310|NCT03263572|Decadron|decadron
984311|NCT03263572|Ponatinib|ponatinib
984312|NCT03263572|Iclusig|iclusig
984313|NCT03263572|AP24534|ap24534
984314|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
984315|NCT03263559|Haploidentical|haploidentical
984316|NCT03263559|Bone Marrow|bone marrow
984317|NCT03263559|Transplant|transplant
984318|NCT03263559|Sickle Cell Disease|sickle cell disease
984319|NCT03263533|schizophrenia|schizophrenia
984320|NCT03263533|clozapine|clozapine
984321|NCT03263533|vorinostat|vorinostat
984322|NCT03263533|HDAC|hdac
984323|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
984324|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
984325|NCT03263455|neglect,|neglect,
984326|NCT03263455|stroke,|stroke,
984327|NCT03263455|rehabilitation,|rehabilitation,
984328|NCT03263455|range of motion|range of motion
984329|NCT03263416|Metastatic solid tumor|metastatic solid tumor
984330|NCT03263416|Oral Targeted Therapy|oral targeted therapy
984331|NCT03263416|Treatment adherence|treatment adherence
984332|NCT03263403|Meningococcal Vaccine|meningococcal vaccine
984333|NCT03263403|Ingovax ACWY|ingovax acwy
984334|NCT03263403|adults|adults
984336|NCT03263403|immunogenicity|immunogenicity
984337|NCT03263390|Obesity|obesity
984338|NCT03263390|Bariatric Surgery|bariatric surgery
984339|NCT03263390|Anti Obesity Medications|anti obesity medications
984340|NCT03263390|Weight Regulation|weight regulation
984341|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
984342|NCT03263377|School feeding|school feeding
984343|NCT03263377|Fortified Biscuits|fortified biscuits
984344|NCT03263377|Bangladesh|bangladesh
984345|NCT03263312|myocardial fibrosis|myocardial fibrosis
984346|NCT03263312|exercise training|exercise training
984347|NCT03263312|Fontan|fontan
984348|NCT03263273|Minocycline|minocycline
984349|NCT03263273|Topical|topical
984350|NCT03263273|Tetracycline|tetracycline
984351|NCT03263273|Doxycycline|doxycycline
984352|NCT03263273|Rosacea|rosacea
984353|NCT03263273|Skin Disease|skin disease
984354|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
984355|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
984356|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
984357|NCT03263195|HIV|hiv
984358|NCT03263195|Zika Virus|zika virus
984359|NCT03263195|Pregnancy|pregnancy
984360|NCT03263195|MTCT|mtct
984361|NCT03263182|childbirth|childbirth
984362|NCT03263182|delivery|delivery
984363|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
984364|NCT03263156|sleep|sleep
984365|NCT03263156|ADHD|adhd
984366|NCT03263156|behavioural intervention|behavioural intervention
984367|NCT03263156|insomnia|insomnia
984368|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
984369|NCT03263117|Acute stroke|acute stroke
984370|NCT03263117|Cerebral Stroke|cerebral stroke
984371|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
984372|NCT03263091|Anemia|anemia
984373|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
984374|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
984375|NCT03263091|Low Risk MDS|low risk mds
984376|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
984377|NCT03263065|Nopal|nopal
984378|NCT03263065|Bran|bran
984379|NCT03263065|Psyllium|psyllium
984380|NCT03263052|kidney transplant|kidney transplant
984381|NCT03263052|immunosuppression|immunosuppression
984382|NCT03263052|tacrolimus XR|tacrolimus xr
984383|NCT03263052|elderly|elderly
984384|NCT03263052|quality of life|quality of life
984385|NCT03263052|neurological adverse events|neurological adverse events
984386|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
984387|NCT03263039|Pembrolizumab|pembrolizumab
984388|NCT03263039|Keytruda|keytruda
984389|NCT03263039|MK-3475|mk-3475
984390|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
984391|NCT03263026|Lymphoma|lymphoma
984392|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
984393|NCT03263026|enzastaurin|enzastaurin
984394|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
984395|NCT03263000|Belpharospasm|belpharospasm
984396|NCT03263000|Blink Reflex|blink reflex
984397|NCT03263000|Eyeblink|eyeblink
984398|NCT03262974|Imatinib|imatinib
984399|NCT03262974|Pharmacogenetics|pharmacogenetics
984400|NCT03262974|CML|cml
984401|NCT03262974|Plasma level|plasma level
984402|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
984403|NCT03262922|systemic scleroderma|systemic scleroderma
984404|NCT03262922|environmental and professional toxics|environmental and professional toxics
984405|NCT03262896|Brain Death|brain death
984406|NCT03262896|Spinal Reflex|spinal reflex
984407|NCT03262896|Electromyography|electromyography
984408|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
984409|NCT03262883|Tracheotomy|tracheotomy
984410|NCT03262857|magnesium sulfate|magnesium sulfate
984411|NCT03262857|pulpitis|pulpitis
984412|NCT03262857|anesthesia|anesthesia
984413|NCT03262805|Knee OA|knee oa
984414|NCT03262805|Joint Pain|joint pain
984415|NCT03262805|Dietary supplement|dietary supplement
984416|NCT03262805|WOMAC|womac
984417|NCT03262805|Lequesne index|lequesne index
984418|NCT03262805|hs-CRP|hs-crp
984419|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
984420|NCT03262766|Upper Extremity Training|upper extremity training
984421|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
984422|NCT03262688|INL-001|inl-001
984423|NCT03262688|Bupivacaine|bupivacaine
984424|NCT03262688|Collagen|collagen
984425|NCT03262688|Children|children
984426|NCT03262688|Pediatric|pediatric
984427|NCT03262688|Inguinal hernia|inguinal hernia
984428|NCT03262675|Heart Failure|heart failure
984429|NCT03262675|Acute Heart Failure|acute heart failure
984430|NCT03262675|Chronic Heat Failure|chronic heat failure
984431|NCT03262675|Cardiovascular diseases|cardiovascular diseases
984432|NCT03262675|Heart diseases|heart diseases
984433|NCT03262675|Registry|registry
984434|NCT03262675|Tunisia|tunisia
984435|NCT03262597|fluid balance|fluid balance
984436|NCT03262597|dehydration|dehydration
984437|NCT03262597|rehydration|rehydration
984438|NCT03262597|electrolytes|electrolytes
984440|NCT03262571|Heart failure|heart failure
984441|NCT03262571|Lung ultrasound|lung ultrasound
984442|NCT03262571|B-lines|b-lines
984443|NCT03262558|staphylococcus aureus|staphylococcus aureus
984444|NCT03262558|nosocomial infection|nosocomial infection
984445|NCT03262532|Interactive web-base simulation|interactive web-base simulation
984446|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
984447|NCT03262493|nursing|nursing
984448|NCT03262493|clinical trial|clinical trial
984449|NCT03262493|enteral nutrition|enteral nutrition
984450|NCT03262441|HIV|hiv
984451|NCT03262441|Antiretroviral treatment|antiretroviral treatment
984452|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
984453|NCT03262441|Cure|cure
984454|NCT03262441|Latency|latency
984455|NCT03262441|Reservoir|reservoir
984456|NCT03262441|CD4 T cell|cd4 t cell
984457|NCT03262441|Anti-proliferation|anti-proliferation
984458|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
984459|NCT03262402|Chronic periodontitis|chronic periodontitis
984460|NCT03262402|Candida spp|candida spp
984461|NCT03262402|Histatin-5|histatin-5
984462|NCT03262402|Lactoferrin|lactoferrin
984463|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
984464|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
984465|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
984466|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
984467|NCT03262389|C-11 acetate|c-11 acetate
984468|NCT03262376|Stress|stress
984469|NCT03262376|Anxiety|anxiety
984470|NCT03262376|Cortisol|cortisol
984471|NCT03262376|Vitamins|vitamins
984472|NCT03262376|Botanicals|botanicals
984473|NCT03262376|Minerals|minerals
984474|NCT03262363|nutrigenomics|nutrigenomics
984475|NCT03262363|Diet-gene interaction,|diet-gene interaction,
984476|NCT03262363|Curcumin,|curcumin,
984477|NCT03262363|Antioxidants,|antioxidants,
984478|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
984479|NCT03262363|Polymorphism,|polymorphism,
984480|NCT03262363|Diabetes,|diabetes,
984481|NCT03262363|Chronic kidney disease|chronic kidney disease
984482|NCT03262324|Foot and Ankle|foot and ankle
984483|NCT03262324|Disorders|disorders
984484|NCT03262324|Outcome Measure|outcome measure
984485|NCT03262298|CD22|cd22
984486|NCT03262298|CAR-T|car-t
984487|NCT03262298|Leukemia|leukemia
984488|NCT03262298|Lymphoma|lymphoma
984489|NCT03262220|Haematological malignancy|haematological malignancy
984490|NCT03262220|Total Marrow Irradiation|total marrow irradiation
984491|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
984492|NCT03262181|Exercise|exercise
984493|NCT03262181|Physical Activity|physical activity
984494|NCT03262181|Biomechanics|biomechanics
984495|NCT03262168|Exercise|exercise
984496|NCT03262168|Physical Activity|physical activity
984497|NCT03262142|COPD|copd
984498|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
984499|NCT03262116|bionic pancreas|bionic pancreas
984500|NCT03262116|insulin|insulin
984501|NCT03262116|continuous glucose monitor|continuous glucose monitor
984502|NCT03262116|type 1 diabetes|type 1 diabetes
984503|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
984504|NCT03262103|Prostate Cancer|prostate cancer
984505|NCT03262103|Gleason 8-10|gleason 8-10
984506|NCT03262103|Immunotherapy|immunotherapy
984507|NCT03262103|Neoadjuvant|neoadjuvant
984508|NCT03262090|Emergence Delirium|emergence delirium
984509|NCT03262090|desoflurane|desoflurane
984510|NCT03262090|general anesthesia|general anesthesia
984511|NCT03262077|photodynamic therapy|photodynamic therapy
984512|NCT03262077|periodontal disease|periodontal disease
984513|NCT03262077|dosimetry|dosimetry
984514|NCT03262077|methylene blue|methylene blue
984515|NCT03262051|cytochrome|cytochrome
984516|NCT03262051|chronic inflammation|chronic inflammation
984517|NCT03262051|genotyping|genotyping
984518|NCT03262051|phenotyping|phenotyping
984519|NCT03262051|acute inflammation|acute inflammation
984520|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
984521|NCT03262038|intrathecal morphine|intrathecal morphine
984522|NCT03262025|Primary cecal pathology|primary cecal pathology
984523|NCT03262025|Emergency laparotomy|emergency laparotomy
984524|NCT03262025|Ruptured liver abscess|ruptured liver abscess
984525|NCT03262025|Right hemicolectomy|right hemicolectomy
984526|NCT03262025|Conservative colonic resection|conservative colonic resection
984527|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
984528|NCT03262025|Ileocecal resection|ileocecal resection
984529|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
984530|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
984531|NCT03262025|Cecal diverticulitis|cecal diverticulitis
984532|NCT03262025|Amoebic typhilitis|amoebic typhilitis
984533|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
984534|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
984535|NCT03261986|Trident|trident
984536|NCT03261986|RSA|rsa
984537|NCT03261986|THA|tha
984538|NCT03261947|Drug therapy|drug therapy
984539|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
984540|NCT03261934|Malignant Transformation|malignant transformation
984541|NCT03261934|Risk Assessment|risk assessment
984542|NCT03261934|Syndrome Evolution|syndrome evolution
984543|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
984544|NCT03261934|Registry Study|registry study
984545|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
984546|NCT03261856|Breath test|breath test
984547|NCT03261856|SIBO|sibo
984548|NCT03261856|GI|gi
984549|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
984550|NCT03261830|Antibiotic|antibiotic
984551|NCT03261830|Pediatric|pediatric
984552|NCT03261817|web|web
984553|NCT03261817|brain imaging|brain imaging
984554|NCT03261817|heart rate variability|heart rate variability
984555|NCT03261817|circadian cycles|circadian cycles
984556|NCT03261817|cognition|cognition
984557|NCT03261817|well-being|well-being
984558|NCT03261817|hippocampus|hippocampus
984559|NCT03261817|N acetyl aspartate|n acetyl aspartate
984560|NCT03261817|white matter|white matter
984561|NCT03261817|physical activity|physical activity
984562|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
984563|NCT03261791|apatinib|apatinib
984564|NCT03261791|portal vein invasion|portal vein invasion
984565|NCT03261791|adjuvant therapy|adjuvant therapy
984566|NCT03261791|resection|resection
984567|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
984568|NCT03261726|unilateral deafness|unilateral deafness
984569|NCT03261726|acoustic neuroma|acoustic neuroma
984570|NCT03261726|cochlear implant|cochlear implant
984571|NCT03261713|rehabilitation|rehabilitation
984572|NCT03261713|telerehabilitation|telerehabilitation
984573|NCT03261713|feasibility studies|feasibility studies
984574|NCT03261713|virtual reality|virtual reality
984575|NCT03261700|women Veterans|women veterans
984576|NCT03261700|interpersonal violence|interpersonal violence
984577|NCT03261687|pregnancy|pregnancy
984578|NCT03261687|pelvic girdle pain|pelvic girdle pain
984579|NCT03261687|hydrotherapy|hydrotherapy
984580|NCT03261687|quality of life|quality of life
984581|NCT03261687|physical therapy|physical therapy
984582|NCT03261674|Insomnia|insomnia
984583|NCT03261674|Traumatic Brain Injury|traumatic brain injury
984584|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
984585|NCT03261674|Veterans|veterans
984586|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
984587|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
984588|NCT03261609|extremely preterm|extremely preterm
984589|NCT03261609|young adults|young adults
984590|NCT03261609|CVD risks factors|cvd risks factors
984591|NCT03261609|inflammation|inflammation
1658237|NCT00154596|household|household
984592|NCT03261609|chronic health conditions|chronic health conditions
984593|NCT03261609|term|term
984594|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
984595|NCT03261596|hookworm|hookworm
984596|NCT03261596|hookworm infections|hookworm infections
984597|NCT03261596|necator americanus|necator americanus
984598|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
984599|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
984600|NCT03261570|POTS|pots
984601|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
984602|NCT03261570|Digoxin|digoxin
984603|NCT03261570|Pyridostigmine|pyridostigmine
984604|NCT03261570|Mestinon|mestinon
984605|NCT03261531|Overweight|overweight
984606|NCT03261531|Class I Obesity|class i obesity
984607|NCT03261518|ileus|ileus
984608|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
984609|NCT03261518|vena cava inferior|vena cava inferior
984610|NCT03261505|fMRI|fmri
984611|NCT03261505|acupuncture|acupuncture
984612|NCT03261505|osteoarthritis|osteoarthritis
984613|NCT03261479|pneumonia|pneumonia
984614|NCT03261479|thermal imaging|thermal imaging
984615|NCT03261479|respiratory distress|respiratory distress
984616|NCT03261479|x-ray|x-ray
984617|NCT03261479|thermal|thermal
984618|NCT03261466|obesity|obesity
984619|NCT03261466|paediatric|paediatric
984620|NCT03261466|probiotic|probiotic
984621|NCT03261401|Healthy Subjects|healthy subjects
984622|NCT03261401|M5717|m5717
984623|NCT03261401|Malaria|malaria
984624|NCT03261401|Plasmodium falciparum|plasmodium falciparum
984625|NCT03261349|Follicular lymphoma|follicular lymphoma
984626|NCT03261349|MALT lymphoma|malt lymphoma
984627|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
984628|NCT03261349|Hepatitis C virus|hepatitis c virus
984629|NCT03261323|Breast Reconstruction|breast reconstruction
984630|NCT03261323|Mastectomy|mastectomy
984631|NCT03261310|acetaminophen|acetaminophen
984632|NCT03261310|pain|pain
984633|NCT03261310|laminectomy|laminectomy
984634|NCT03261310|craniotomy|craniotomy
984635|NCT03261284|D-dimer|d-dimer
984636|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
984637|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
984638|NCT03261284|INR|inr
984639|NCT03261193|quadratus lumborum block|quadratus lumborum block
984640|NCT03261193|post-operative pain|post-operative pain
984641|NCT03261193|cesarean section pain|cesarean section pain
984642|NCT03261193|analgesia|analgesia
984643|NCT03261193|nerve block|nerve block
984644|NCT03261167|Botulinum toxin A|botulinum toxin a
984645|NCT03261167|Safety|safety
984646|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
984647|NCT03261167|Efficacy|efficacy
984648|NCT03261167|GSK1358820|gsk1358820
984649|NCT03261167|double blind|double blind
984650|NCT03261154|Serum iPTH|serum ipth
984651|NCT03261154|Calcium|calcium
984652|NCT03261154|Phosphate|phosphate
984653|NCT03261128|cancer|cancer
984654|NCT03261128|chemotherapy|chemotherapy
984655|NCT03261115|Pain, Benzocaine, Clinical trial|pain, benzocaine, clinical trial
984656|NCT03261102|IBD|ibd
984657|NCT03261102|Crohn|crohn
984658|NCT03261102|adalimumab|adalimumab
984659|NCT03261102|ADAL|adal
984660|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
984661|NCT03261076|Specific Learning Disorder|specific learning disorder
984662|NCT03261076|Learning Disorders|learning disorders
984663|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
984664|NCT03261076|Mental Disorders|mental disorders
984665|NCT03261076|Developmental Reading Disability|developmental reading disability
984666|NCT03261076|Reading Disorder|reading disorder
984667|NCT03261076|Conduct Disorder|conduct disorder
984668|NCT03261050|Eating disorder|eating disorder
984669|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
984670|NCT03261050|fMRI|fmri
984671|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
984672|NCT03261011|immunotherapy|immunotherapy
984673|NCT03261011|immuno-oncology|immuno-oncology
984674|NCT03261011|advanced solid tumors|advanced solid tumors
984675|NCT03260920|oxytocin|oxytocin
984676|NCT03260920|frontotemporal dementia|frontotemporal dementia
984677|NCT03260920|apathy|apathy
984678|NCT03260920|empathy|empathy
984679|NCT03260907|Overactive bladder|overactive bladder
984680|NCT03260907|menopause|menopause
984681|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
984682|NCT03260907|Electroacupuncture|electroacupuncture
984683|NCT03260894|Renal cell carcinoma|renal cell carcinoma
984684|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
984685|NCT03260894|indoleamine 2|indoleamine 2
984686|NCT03260894|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
984687|NCT03260881|Epicardial Fat|epicardial fat
984688|NCT03260855|Lymphoma|lymphoma
984689|NCT03260855|Cancer survivorship|cancer survivorship
984690|NCT03260855|Fear|fear
984691|NCT03260842|early detection|early detection
984692|NCT03260842|biomarkers|biomarkers
984693|NCT03260842|pancreas cancer|pancreas cancer
984694|NCT03260829|vitamin C|vitamin c
984695|NCT03260829|palatally impacted canines|palatally impacted canines
984696|NCT03260829|intraepidermal injection|intraepidermal injection
984697|NCT03260816|Preschoolers|preschoolers
984698|NCT03260816|Developmental Delay|developmental delay
984699|NCT03260816|Disruptive Behavior|disruptive behavior
984700|NCT03260816|Early Intervention|early intervention
984701|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
984702|NCT03260816|Telehealth|telehealth
984703|NCT03260816|Telemental Health|telemental health
984704|NCT03260816|Telepsychiatry|telepsychiatry
984705|NCT03260803|osteopenia|osteopenia
984706|NCT03260803|oligopin|oligopin
984707|NCT03260803|postmenopause|postmenopause
984708|NCT03260803|antioxidant|antioxidant
984709|NCT03260803|bone|bone
984710|NCT03260790|Vaccine|vaccine
984711|NCT03260790|Pneumococcal|pneumococcal
984712|NCT03260790|Pneumonia|pneumonia
984713|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
984714|NCT03260764|Bifocal Spectacles|bifocal spectacles
984715|NCT03260764|Congenital Cataracts|congenital cataracts
984716|NCT03260738|Chronic Low Back Pain|chronic low back pain
984717|NCT03260738|Rehabilitation|rehabilitation
984718|NCT03260738|Robot Poppy|robot poppy
984719|NCT03260712|biliary tract cancer|biliary tract cancer
984720|NCT03260712|metastitic cancer|metastitic cancer
984721|NCT03260712|advanced cancer|advanced cancer
984722|NCT03260712|pembrolizumab|pembrolizumab
984723|NCT03260712|cisplatin|cisplatin
984724|NCT03260712|gemcitabine|gemcitabine
984725|NCT03260712|gallbladder cancer|gallbladder cancer
984726|NCT03260673|cataract|cataract
984727|NCT03260673|phacoemulsification|phacoemulsification
984728|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
984729|NCT03260673|corneal endothelial cells|corneal endothelial cells
984730|NCT03260634|voriconazole|voriconazole
984731|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
984732|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
984733|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
984734|NCT03260582|eHealth|ehealth
984735|NCT03260582|smartphone application|smartphone application
984736|NCT03260569|Mechanical ventilation|mechanical ventilation
984737|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
984738|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
984739|NCT03260543|ginseng powder|ginseng powder
984740|NCT03260543|Fatty Liver|fatty liver
984741|NCT03260543|Clinical Trial|clinical trial
984742|NCT03260491|Oncology|oncology
984743|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
984744|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
984745|NCT03260491|Metastatic|metastatic
984746|NCT03260491|Unresectable|unresectable
984747|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
984748|NCT03260491|EGFR|egfr
984749|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
984750|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
984751|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
984752|NCT03260478|Transfusion Threshold|transfusion threshold
984753|NCT03260478|Anemia|anemia
984754|NCT03260478|Oxygen Delivery|oxygen delivery
984755|NCT03260478|Neurocritical Care|neurocritical care
985140|NCT03258320|High Risk|high risk
984756|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
984757|NCT03260465|total hip replacement|total hip replacement
984758|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
984759|NCT03260452|Type 2 diabetes|type 2 diabetes
984760|NCT03260452|Adipose tissue|adipose tissue
984761|NCT03260452|Hematopoiesis|hematopoiesis
984762|NCT03260452|Inflammation|inflammation
984763|NCT03260452|Macrophages|macrophages
984764|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
984765|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
984766|NCT03260400|RPNI|rpni
984767|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
984768|NCT03260335|Challenging behaviour|challenging behaviour
984769|NCT03260335|Biofeedback|biofeedback
984770|NCT03260335|Anxiety management|anxiety management
984771|NCT03260322|Oncology|oncology
984772|NCT03260322|Tumors|tumors
984773|NCT03260322|ASP8374|asp8374
984774|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
984775|NCT03260296|smartphones addiction|smartphones addiction
984776|NCT03260283|pethidine|pethidine
984777|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
984778|NCT03260244|atrial fibrillation|atrial fibrillation
984779|NCT03260244|atrial flutter|atrial flutter
984780|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
984781|NCT03260244|ventricular tachycardia|ventricular tachycardia
1333116|NCT01444456|Colorectal Cancer|colorectal cancer
984782|NCT03260244|premature ventricular contractions|premature ventricular contractions
984783|NCT03260244|cardiac mapping system|cardiac mapping system
984784|NCT03260218|postoperative delirium|postoperative delirium
984785|NCT03260218|elderly|elderly
984786|NCT03260218|total joint replacement|total joint replacement
984787|NCT03260218|risk factors for delirium|risk factors for delirium
984788|NCT03260218|postoperative confusion|postoperative confusion
984789|NCT03260205|SPD489|spd489
984790|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
984791|NCT03260205|ADHD|adhd
984792|NCT03260205|hyperactivity|hyperactivity
984793|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
984794|NCT03260192|circulating tumor DNA|circulating tumor dna
984795|NCT03260166|nicotinamide|nicotinamide
984796|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
984797|NCT03260166|lupus erythematosus|lupus erythematosus
984798|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
984799|NCT03260153|Perihematomal edema|perihematomal edema
984800|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
984801|NCT03260140|weight loss|weight loss
984802|NCT03260140|lifestyle|lifestyle
984803|NCT03260140|diet|diet
984804|NCT03260140|exercise|exercise
984805|NCT03260140|randomized controlled trial|randomized controlled trial
984806|NCT03260127|PTSD|ptsd
984807|NCT03260127|treatment|treatment
984808|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
984809|NCT03260127|therapy|therapy
984810|NCT03260127|cognition|cognition
984811|NCT03260127|thinking|thinking
984812|NCT03260127|executive function|executive function
984813|NCT03260127|computer|computer
984814|NCT03260127|training|training
984815|NCT03260114|Physical activity|physical activity
984816|NCT03260114|Body weight|body weight
984817|NCT03260114|Obesity|obesity
984818|NCT03260062|cochlear implants|cochlear implants
984819|NCT03260062|language development|language development
984820|NCT03260062|parenting intervention|parenting intervention
984821|NCT03260062|maternal sensitivity|maternal sensitivity
984822|NCT03260062|facilitative language techniques|facilitative language techniques
984823|NCT03260036|Urea synthesis|urea synthesis
984824|NCT03260036|Ammonia|ammonia
984825|NCT03260036|Bariatric surgery|bariatric surgery
984826|NCT03260023|Avelumab|avelumab
984827|NCT03260023|Cancer|cancer
984828|NCT03260023|Anti PD-L1|anti pd-l1
984829|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
984830|NCT03259971|Rett syndrome|rett syndrome
984831|NCT03259971|Tourette syndrome|tourette syndrome
984832|NCT03259971|Probiotic|probiotic
984833|NCT03259919|Metformin|metformin
984834|NCT03259919|Pregnancy outcome|pregnancy outcome
984835|NCT03259919|Androgens|androgens
984836|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
984837|NCT03259893|Prevention|prevention
984838|NCT03259893|Safety net hospital|safety net hospital
984839|NCT03259893|Diverse inner city patients|diverse inner city patients
984840|NCT03259880|evaluation|evaluation
984841|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
984842|NCT03259867|Colorectal cancer|colorectal cancer
984843|NCT03259867|Immune checkpoint inhibitor|immune checkpoint inhibitor
984844|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
984845|NCT03259828|Internal organ motion|internal organ motion
984846|NCT03259828|Radiotherapy|radiotherapy
984847|NCT03259815|FFR Targeted PCI|ffr targeted pci
984848|NCT03259815|Post-PCI FFR|post-pci ffr
984849|NCT03259776|Intensive Care|intensive care
984850|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
984881|NCT03259633|Intermediate Access Protocol|intermediate access protocol
984883|NCT03259594|Renal functional reserve|renal functional reserve
984884|NCT03259594|Simple renal cysts|simple renal cysts
984885|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
984886|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
984887|NCT03259568|TMS|tms
984888|NCT03259555|Brexpiprazole|brexpiprazole
984889|NCT03259555|Bipolar|bipolar
984890|NCT03259555|Manic episode|manic episode
984891|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
984892|NCT03259529|Nivolumab|nivolumab
984893|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
984894|NCT03259529|Gemcitabine|gemcitabine
984895|NCT03259529|Rituximab|rituximab
984896|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
984897|NCT03259516|nivolumab|nivolumab
984898|NCT03259516|5-azacitidine|5-azacitidine
984899|NCT03259516|cytarabine|cytarabine
984900|NCT03259516|melphalan|melphalan
984901|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
984902|NCT03259516|lymphodepletion|lymphodepletion
984945|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
984946|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
984947|NCT03259477|renal cell carcinoma|renal cell carcinoma
984948|NCT03259477|renal functional reserve|renal functional reserve
984949|NCT03259438|Qigong|qigong
985141|NCT03258294|melatonin|melatonin
984950|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
984951|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
984952|NCT03259438|Cancer Related Fatigue|cancer related fatigue
984953|NCT03259438|Cancer Survivorship|cancer survivorship
984954|NCT03259438|Inflammation|inflammation
984955|NCT03259438|Flowmetry|flowmetry
984956|NCT03259438|Corticomuscular coherence|corticomuscular coherence
984957|NCT03259438|Heart Rate Variability|heart rate variability
984958|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
984959|NCT03259438|Complex Systems Analysis|complex systems analysis
984960|NCT03259438|Female|female
984961|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
984962|NCT03259373|AF|af
984963|NCT03259373|AFib|afib
984964|NCT03259373|OAC|oac
984965|NCT03259373|Atrial fibrillation|atrial fibrillation
984966|NCT03259373|Oral anticoagulant|oral anticoagulant
984967|NCT03259373|Education|education
984968|NCT03259360|Tobacco|tobacco
984969|NCT03259360|Gender Identity Minority|gender identity minority
984970|NCT03259360|Sexual Identity Minority|sexual identity minority
984971|NCT03259360|Cessation|cessation
984972|NCT03259360|Intervention|intervention
984973|NCT03259360|Young Adults|young adults
984974|NCT03259360|Social Media|social media
984975|NCT03259360|Internet|internet
984976|NCT03259360|Cigarette|cigarette
984977|NCT03259321|Fish|fish
984978|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
984979|NCT03259321|CHNS|chns
984980|NCT03259295|skin tag|skin tag
984981|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
984982|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
984983|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
984984|NCT03259230|M-HLH|m-hlh
984985|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
984986|NCT03259230|Interferon Gamma|interferon gamma
984987|NCT03259230|IFNγ|ifnγ
984988|NCT03259230|Biomarkers|biomarkers
984989|NCT03259230|Inflammatory Markers|inflammatory markers
984990|NCT03259230|Blood draws|blood draws
984991|NCT03259230|Data collection|data collection
984992|NCT03259204|Achilles tendon|achilles tendon
984993|NCT03259204|Microdialysis|microdialysis
984994|NCT03259204|Immobilization|immobilization
984995|NCT03259204|Wound healing|wound healing
985103|NCT03258684|vitamin C|vitamin c
984996|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
984997|NCT03259204|Ultrasonography|ultrasonography
984998|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
984999|NCT03259178|Binocular vision test|binocular vision test
985000|NCT03259165|Heart Failure|heart failure
985001|NCT03259165|Acute Heart Failure|acute heart failure
985002|NCT03259165|Pulmonary Edema|pulmonary edema
985003|NCT03259165|Lung Ultrasound|lung ultrasound
985004|NCT03259165|Extra vascular lung water|extra vascular lung water
985005|NCT03259165|B-lines|b-lines
985006|NCT03259165|Diuretics|diuretics
985007|NCT03259165|Nitrates|nitrates
985008|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
985009|NCT03259152|Denousmab|denousmab
985010|NCT03259152|Pathologic|pathologic
985011|NCT03259152|Clinical|clinical
985012|NCT03259152|Mechansim|mechansim
985013|NCT03259139|adolescent|adolescent
985015|NCT03259139|violence|violence
985016|NCT03259139|media|media
985017|NCT03259126|Transradial|transradial
985018|NCT03259126|Coronary|coronary
985019|NCT03259126|X-ray|x-ray
985020|NCT03259126|Radiation|radiation
985021|NCT03259126|Curtain|curtain
985022|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
985023|NCT03259113|atrial fibrillation|atrial fibrillation
985024|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
985025|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
985026|NCT03259009|colorectal cancer|colorectal cancer
985027|NCT03259009|anti-EGFR therapy|anti-egfr therapy
985028|NCT03259009|rechallenge|rechallenge
985029|NCT03259009|circulating tumor DNA|circulating tumor dna
985030|NCT03259009|biomarker|biomarker
985031|NCT03259009|RAS mutations|ras mutations
985032|NCT03258996|Gingival recession|gingival recession
985033|NCT03258996|Class III gingival recession|class iii gingival recession
985034|NCT03258996|Multiples gingival recessions|multiples gingival recessions
985035|NCT03258996|Periodontitis|periodontitis
985036|NCT03258996|Mucogingival surgery|mucogingival surgery
985037|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
985038|NCT03258996|Coronally advanced flap|coronally advanced flap
985039|NCT03258996|Connective tissue graft|connective tissue graft
985040|NCT03258996|Post-surgical pain|post-surgical pain
985041|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
985042|NCT03258983|Dietary intake|dietary intake
985043|NCT03258983|Adipose tissue|adipose tissue
985053|NCT03258866|thrombocytopenia|thrombocytopenia
985054|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
985056|NCT03258853|cystic fibrosis|cystic fibrosis
985057|NCT03258853|insulin|insulin
985058|NCT03258853|glucagon|glucagon
985059|NCT03258853|continuous glucose monitor|continuous glucose monitor
985060|NCT03258853|bionic pancreas|bionic pancreas
985061|NCT03258840|EPA|epa
985062|NCT03258840|Paraoxonase 1|paraoxonase 1
985063|NCT03258840|Paraoxonase 2|paraoxonase 2
985064|NCT03258840|Type 2 diabetes|type 2 diabetes
985065|NCT03258827|elderly|elderly
985066|NCT03258827|sarcopenia|sarcopenia
985067|NCT03258827|strengthening exercise|strengthening exercise
985068|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
985069|NCT03258814|active supervised training|active supervised training
985070|NCT03258814|physical training|physical training
985071|NCT03258814|adalimumab|adalimumab
985072|NCT03258814|spinal mobility|spinal mobility
985073|NCT03258814|physiotherapy|physiotherapy
985074|NCT03258814|physical function|physical function
985075|NCT03258814|health-related quality of life|health-related quality of life
985076|NCT03258814|pain|pain
985077|NCT03258814|disease activity|disease activity
985078|NCT03258814|psychosocial risk factors|psychosocial risk factors
985079|NCT03258814|workability|workability
985080|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
985081|NCT03258775|RMR|rmr
985082|NCT03258775|hydration|hydration
985083|NCT03258775|substrate oxidation|substrate oxidation
985084|NCT03258762|Japanese|japanese
985085|NCT03258762|Caucasian|caucasian
985086|NCT03258762|pharmacokinetics|pharmacokinetics
985087|NCT03258762|pyrimethamine|pyrimethamine
985088|NCT03258762|toxoplasmosis|toxoplasmosis
985089|NCT03258749|COPD|copd
985090|NCT03258749|GOLD|gold
985091|NCT03258749|formoterol|formoterol
985092|NCT03258749|tiotropium|tiotropium
985093|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
985094|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
985095|NCT03258710|safety|safety
985096|NCT03258710|chronic hepatitis B|chronic hepatitis b
985097|NCT03258710|virological effect|virological effect
985098|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
985099|NCT03258684|corticosteroid|corticosteroid
985100|NCT03258684|hydrocortisone|hydrocortisone
985101|NCT03258684|septic shock|septic shock
985102|NCT03258684|thiamine|thiamine
985104|NCT03258658|Urethral Stricture|urethral stricture
985105|NCT03258632|Alcohol Use Disorder|alcohol use disorder
985111|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
985112|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
985113|NCT03258593|Papillary Tumors|papillary tumors
985119|NCT03258567|Monoclonal Antibody|monoclonal antibody
985120|NCT03258541|TraceIT®|traceit®
985121|NCT03258541|Hydrogel spacer|hydrogel spacer
985122|NCT03258541|Rectal cancer|rectal cancer
985123|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
985124|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
985125|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
985126|NCT03258515|QT prolongation|qt prolongation
985127|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
985128|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
985129|NCT03258359|MDS|mds
985130|NCT03258346|Pomegranate Juice|pomegranate juice
985131|NCT03258346|Functional Tasks of Living|functional tasks of living
985132|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
985133|NCT03258320|Cabazitaxel|cabazitaxel
985134|NCT03258320|Docetaxel|docetaxel
985135|NCT03258320|Mitoxantrone|mitoxantrone
985136|NCT03258320|Satraplatin|satraplatin
985137|NCT03258320|Surgery|surgery
985138|NCT03258320|Prostate Cancer|prostate cancer
985139|NCT03258320|Localized|localized
985142|NCT03258294|sleep disturbances|sleep disturbances
985143|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
985144|NCT03258229|Glucose|glucose
985145|NCT03258229|Clinical Trial|clinical trial
985146|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
985147|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
985148|NCT03258216|Panendoscopy|panendoscopy
985149|NCT03258190|Urolithaisis|urolithaisis
985150|NCT03258190|Recurrence|recurrence
985151|NCT03258190|Citrate|citrate
985152|NCT03258190|Antioxidants|antioxidants
985153|NCT03258190|Lime Powder Regimen|lime powder regimen
985154|NCT03258177|Virtual Visits|virtual visits
985155|NCT03258177|Telehealth|telehealth
985156|NCT03258138|Pragmatic|pragmatic
985157|NCT03258138|Pilot study|pilot study
985158|NCT03258138|Mixed methods|mixed methods
1333117|NCT01444456|Aranesp|aranesp
985159|NCT03258138|Randomized controlled trial|randomized controlled trial
985160|NCT03258138|Implementation research|implementation research
985161|NCT03258138|Person-centered care|person-centered care
985162|NCT03258138|Multidisciplinary|multidisciplinary
985163|NCT03258138|Ecological approach|ecological approach
985164|NCT03258073|maternal|maternal
985165|NCT03258073|newborn|newborn
985166|NCT03258073|resuscitation|resuscitation
985167|NCT03258073|emergencies|emergencies
985168|NCT03258073|medical simulation|medical simulation
985169|NCT03258060|Heart Failure|heart failure
985170|NCT03258060|Pacing|pacing
985171|NCT03258060|Resynchronization|resynchronization
985172|NCT03258060|Electrophysiology|electrophysiology
985173|NCT03258060|Imaging|imaging
985174|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
985175|NCT03258034|Conversion therapy|conversion therapy
985176|NCT03258021|Glioblastoma|glioblastoma
985177|NCT03258021|GBM|gbm
985178|NCT03258021|Tumor-treating fields|tumor-treating fields
985179|NCT03258021|TTFields|ttfields
985180|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
985181|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
985182|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
985183|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
985184|NCT03258008|OPSCC|opscc
985185|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
985186|NCT03258008|Utomilumab|utomilumab
985187|NCT03258008|PF-05082566|pf-05082566
985188|NCT03258008|Anti-CD137|anti-cd137
985189|NCT03258008|ISA101b|isa101b
985190|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
985191|NCT03257982|Brain-computer interface|brain-computer interface
985192|NCT03257982|Functional electrical stimulation|functional electrical stimulation
985193|NCT03257969|Oral chemotherapy|oral chemotherapy
985194|NCT03257969|Health related program|health related program
985195|NCT03257969|Secured drug intake|secured drug intake
985196|NCT03257969|Pharmacist intervention|pharmacist intervention
985197|NCT03257969|Cancer outpatient|cancer outpatient
985198|NCT03257917|Financial Burden|financial burden
985199|NCT03257917|Out of Pocket expenses|out of pocket expenses
985200|NCT03257917|Time spent on Healthcare|time spent on healthcare
985201|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
985202|NCT03257904|intracranial pressure|intracranial pressure
985203|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
985204|NCT03257891|Cabazitaxel|cabazitaxel
985205|NCT03257865|Brexpiprazole|brexpiprazole
985206|NCT03257865|Bipolar|bipolar
985207|NCT03257865|Manic episode|manic episode
985208|NCT03257852|Methotrexate|methotrexate
985209|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
985210|NCT03257852|ASP5094|asp5094
985211|NCT03257839|SoftVue|softvue
985212|NCT03257839|Dense Breast Tissue|dense breast tissue
985213|NCT03257839|Breast Screening|breast screening
985214|NCT03257839|Abnormal Breast|abnormal breast
985215|NCT03257839|Normal Breast|normal breast
985216|NCT03257839|Breast Imaging|breast imaging
985217|NCT03257839|Breast Biopsy|breast biopsy
985218|NCT03257839|Mammography|mammography
985219|NCT03257839|Tomosynthesis|tomosynthesis
985220|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
985221|NCT03257839|Breast Cancer|breast cancer
985222|NCT03257839|Breast Carcinoma|breast carcinoma
985223|NCT03257839|Breast Tumors|breast tumors
985224|NCT03257839|Mammary Carcinoma|mammary carcinoma
985225|NCT03257839|Malignant Breast Tumor|malignant breast tumor
985226|NCT03257839|Mammary Neoplasm|mammary neoplasm
985227|NCT03257839|Mammary Cancer|mammary cancer
985228|NCT03257839|ABUS|abus
985229|NCT03257839|AWBUS|awbus
985230|NCT03257839|Breast Tomography|breast tomography
985231|NCT03257839|ATUS|atus
985232|NCT03257839|ABTUS|abtus
985233|NCT03257839|Mammogram|mammogram
985234|NCT03257839|3D Mammogram|3d mammogram
985235|NCT03257839|3D ABUS|3d abus
985236|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
985237|NCT03257839|DBT|dbt
985238|NCT03257839|FFDM|ffdm
985239|NCT03257839|Digital Mammography|digital mammography
985240|NCT03257839|Breast Ultrasound|breast ultrasound
985241|NCT03257839|Dense Breasts|dense breasts
985242|NCT03257839|Breast Density|breast density
985243|NCT03257839|Dense Parenchyma|dense parenchyma
985244|NCT03257839|Asymptomatic|asymptomatic
985245|NCT03257839|Delphinus|delphinus
985246|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
985247|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
985248|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
985249|NCT03257826|age of surgery|age of surgery
985250|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
985251|NCT03257813|timolol|timolol
985252|NCT03257813|dorzolamide|dorzolamide
985253|NCT03257813|brimonidine|brimonidine
985254|NCT03257813|Glaucoma|glaucoma
985255|NCT03257813|Ocular hypertension|ocular hypertension
985256|NCT03257800|ketamine|ketamine
985257|NCT03257800|Propofol|propofol
985258|NCT03257800|laryngeal masks|laryngeal masks
985259|NCT03257800|anesthesia|anesthesia
985260|NCT03257800|child|child
985261|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
985262|NCT03257722|Metastasis|metastasis
985263|NCT03257722|Recurrence|recurrence
985264|NCT03257722|Immunotherapy|immunotherapy
985265|NCT03257670|Dyspareunia|dyspareunia
985266|NCT03257670|Laser|laser
985267|NCT03257670|CO2|co2
985268|NCT03257670|Breast Cancer|breast cancer
985269|NCT03257670|Vaginal Atrophy|vaginal atrophy
985270|NCT03257670|Lidocaine|lidocaine
985271|NCT03257644|Atopic dermatitis|atopic dermatitis
985272|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
985273|NCT03257644|pediatric|pediatric
985274|NCT03257644|inflammation|inflammation
985275|NCT03257631|Pediatric|pediatric
985276|NCT03257631|Brain Tumor|brain tumor
985277|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
985278|NCT03257631|Glioma|glioma
985279|NCT03257631|High-grade glioma|high-grade glioma
985280|NCT03257631|HGG|hgg
985281|NCT03257631|Ependymoma|ependymoma
985282|NCT03257631|Medulloblastoma|medulloblastoma
985283|NCT03257631|DIPG|dipg
985284|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
985285|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
985286|NCT03257631|PomalystImnovid|pomalystimnovid
985287|NCT03257631|CC-4047|cc-4047
985288|NCT03257631|Children|children
985289|NCT03257605|Pharmacogenomics|pharmacogenomics
985290|NCT03257605|Medication Therapy Management|medication therapy management
985291|NCT03257579|Myocardial Infarction|myocardial infarction
985292|NCT03257579|Adherence|adherence
985293|NCT03257579|Medication|medication
985294|NCT03257540|bunion|bunion
985295|NCT03257540|early weight-bearing|early weight-bearing
985296|NCT03257540|Lapidus|lapidus
985297|NCT03257540|arthrodesis|arthrodesis
985298|NCT03257540|intramedullary nail|intramedullary nail
985299|NCT03257540|Hallux Valgus|hallux valgus
985300|NCT03257527|Well-being|well-being
985301|NCT03257527|Comparative Clinical Trial|comparative clinical trial
985302|NCT03257527|Positive Psychology Intervention|positive psychology intervention
985303|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
985304|NCT03257527|Group Therapy|group therapy
985305|NCT03257527|Happiness|happiness
985306|NCT03257527|Bibliotherapy|bibliotherapy
985307|NCT03257475|cervical cance|cervical cance
985308|NCT03257475|vaginal radiation injury|vaginal radiation injury
985309|NCT03257475|PIBS|pibs
985310|NCT03257475|R-V|r-v
985311|NCT03257475|VRL|vrl
985507|NCT03256188|children|children
985312|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
985313|NCT03257449|Body Weight|body weight
985314|NCT03257449|Weight loss|weight loss
985315|NCT03257449|BMI|bmi
985316|NCT03257449|Waist Circumference|waist circumference
985317|NCT03257449|Body Fat Percentage|body fat percentage
985318|NCT03257449|Viscofiber|viscofiber
985319|NCT03257449|Viscous Fibres|viscous fibres
985320|NCT03257449|supplement|supplement
985321|NCT03257436|Pacing|pacing
985322|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
985323|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
985324|NCT03257423|Antibiotic therapy|antibiotic therapy
985325|NCT03257423|Microbiological etiology|microbiological etiology
985326|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
985327|NCT03257358|RMS|rms
985328|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
985329|NCT03257358|Multiple Sclerosis|multiple sclerosis
985330|NCT03257358|MS|ms
985331|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
985332|NCT03257358|Fingolimod|fingolimod
985333|NCT03257358|FLUENT|fluent
985334|NCT03257358|Immune Phenotype|immune phenotype
985335|NCT03257345|Real world outcomes|real world outcomes
985336|NCT03257332|Rectum cancer|rectum cancer
985337|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
985338|NCT03257332|Anorectal muscle function|anorectal muscle function
985339|NCT03257306|Urinary tract stone|urinary tract stone
985340|NCT03257306|ureter double-J stent|ureter double-j stent
985341|NCT03257254|GSV|gsv
985342|NCT03257254|AASV|aasv
985343|NCT03257254|Vein|vein
985344|NCT03257254|Venous|venous
985345|NCT03257254|Ulcer|ulcer
985346|NCT03257254|Vericose Vein|vericose vein
985348|NCT03257254|venous insufficiency|venous insufficiency
985349|NCT03257254|venous disease|venous disease
985350|NCT03257254|chronic VLU|chronic vlu
985351|NCT03257241|aml|aml
985352|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
985353|NCT03257241|DAC|dac
985354|NCT03257241|DA-90|da-90
985355|NCT03257241|FLAG-IDA|flag-ida
985356|NCT03257241|CLAG-M|clag-m
985357|NCT03257241|Ara-C|ara-c
985358|NCT03257241|HiDAC|hidac
985359|NCT03257215|Vitamin D|vitamin d
1658620|NCT00152750|Aggression|aggression
985360|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
985361|NCT03257202|Surgical Site Infection|surgical site infection
985362|NCT03257202|Shoulder|shoulder
985363|NCT03257137|sleep|sleep
985364|NCT03257137|macronutrients|macronutrients
985365|NCT03257137|dietary patterns|dietary patterns
985366|NCT03257137|sleep quality|sleep quality
985367|NCT03257137|diet quality|diet quality
985368|NCT03257137|polysomnography|polysomnography
985369|NCT03257137|appetite|appetite
985370|NCT03257137|mood|mood
985371|NCT03257137|hunger|hunger
985372|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
985373|NCT03257111|activity level|activity level
985374|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
985375|NCT03257098|ABCB5|abcb5
985376|NCT03257098|Allogeneic|allogeneic
985377|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
985378|NCT03257098|varicose ulcer|varicose ulcer
985379|NCT03257098|skin ulcer|skin ulcer
985380|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
985381|NCT03257098|somatic cell therapy|somatic cell therapy
985382|NCT03257098|phase I/IIa|phase i/iia
985383|NCT03257072|hookworm|hookworm
985384|NCT03257072|controlled human infection model|controlled human infection model
985386|NCT03257020|RNFL|rnfl
985387|NCT03257020|BMO-MRW|bmo-mrw
985388|NCT03257020|Glaucoma|glaucoma
985389|NCT03256981|SBRT|sbrt
985390|NCT03256981|Oligoprogressive disease|oligoprogressive disease
985391|NCT03256981|NSCLC|nsclc
985392|NCT03256981|TKI|tki
985393|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
985394|NCT03256929|Personalized Diet|personalized diet
985395|NCT03256929|Microbiota|microbiota
985396|NCT03256929|Depression|depression
985397|NCT03256929|Elderly|elderly
985398|NCT03256929|Gut flora|gut flora
985399|NCT03256916|Cervical cancer|cervical cancer
985400|NCT03256903|Methoxyflurane|methoxyflurane
985401|NCT03256903|emergency|emergency
985402|NCT03256903|trauma pain|trauma pain
985403|NCT03256903|inhaled analgesia|inhaled analgesia
985404|NCT03256890|mindfulness|mindfulness
985405|NCT03256890|blood pressure|blood pressure
985406|NCT03256890|hypertension|hypertension
985407|NCT03256890|prehypertension|prehypertension
985408|NCT03256890|self regulation|self regulation
985409|NCT03256890|Science of Behavior Change|science of behavior change
985410|NCT03256890|attention control|attention control
985411|NCT03256890|self awareness|self awareness
985412|NCT03256890|emotion regulation|emotion regulation
985413|NCT03256838|Citric Acid|citric acid
985414|NCT03256838|Ferric Compounds|ferric compounds
985415|NCT03256838|Renal Insufficiency|renal insufficiency
985416|NCT03256838|Anticoagulants|anticoagulants
985417|NCT03256838|Calcium Chelating Agents|calcium chelating agents
985418|NCT03256838|Chelating Agents|chelating agents
985419|NCT03256838|Sequestering Agents|sequestering agents
985420|NCT03256838|Hemodialysis|hemodialysis
985421|NCT03256838|Dialysis|dialysis
985422|NCT03256838|Renal Failure|renal failure
985423|NCT03256838|Kidney Failure|kidney failure
985424|NCT03256838|Urologic Diseases|urologic diseases
985425|NCT03256838|Metabolic Disease|metabolic disease
985426|NCT03256838|Kidney Diseases|kidney diseases
985427|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
985428|NCT03256825|Diagnostic accuracy|diagnostic accuracy
985429|NCT03256825|Anti-bacterial agents|anti-bacterial agents
985430|NCT03256825|Decision support systems, clinical|decision support systems, clinical
985431|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
985432|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
985433|NCT03256786|Hypothermia and shivering|hypothermia and shivering
985434|NCT03256786|Active warming|active warming
985435|NCT03256760|Insomnia, depression|insomnia, depression
985436|NCT03256747|Diabetes Mellitus|diabetes mellitus
985437|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
985438|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
985439|NCT03256747|Metabolic Diseases|metabolic diseases
985440|NCT03256747|Endocrine System Diseases|endocrine system diseases
985441|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
985442|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
985443|NCT03256708|probiotic|probiotic
985444|NCT03256708|prebiotic|prebiotic
985445|NCT03256708|placebo|placebo
985446|NCT03256708|synbiotic|synbiotic
985447|NCT03256682|Resilience|resilience
985448|NCT03256682|Mobile video counseling|mobile video counseling
985449|NCT03256682|Emotiona labor|emotiona labor
985450|NCT03256643|traumatic brain injury|traumatic brain injury
985451|NCT03256643|brain contusion|brain contusion
985452|NCT03256643|craniocerebral trauma|craniocerebral trauma
985453|NCT03256643|exercise therapy|exercise therapy
985454|NCT03256643|chronic brain injury|chronic brain injury
985455|NCT03256643|environment impact|environment impact
985456|NCT03256643|cognitive therapy|cognitive therapy
985457|NCT03256643|health facility environment|health facility environment
985458|NCT03256630|Active Surveillance|active surveillance
985459|NCT03256630|Radical Prostatectomy|radical prostatectomy
985460|NCT03256617|low back pain|low back pain
985461|NCT03256617|cognitive reassurance|cognitive reassurance
985462|NCT03256617|physical therapist training|physical therapist training
985463|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
985464|NCT03256578|Resuscitation|resuscitation
985465|NCT03256578|Neonatal Prematurity|neonatal prematurity
985466|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
985467|NCT03256578|Respiratory Function Monitor|respiratory function monitor
985468|NCT03256461|sepsis|sepsis
985469|NCT03256461|lactate clearance|lactate clearance
985470|NCT03256461|protocolized resuscitation|protocolized resuscitation
985471|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
985472|NCT03256409|biomaterials|biomaterials
985473|NCT03256409|methacrylates|methacrylates
985474|NCT03256409|microbiology|microbiology
985475|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
985476|NCT03256409|removable prosthodontics|removable prosthodontics
985477|NCT03256409|clinical studies/trials|clinical studies/trials
985478|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
985598|NCT03255603|Dietary Fiber|dietary fiber
985479|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
985480|NCT03256396|Esophageal pressure|esophageal pressure
985481|NCT03256396|Transpulmonary pressure|transpulmonary pressure
985482|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
985483|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Breast Milk|allergic manifestation, human milk oligosaccharides, breast milk
985484|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
985485|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
985486|NCT03256344|Liver Metastases|liver metastases
985487|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
985488|NCT03256279|Orthodontic Wires|orthodontic wires
985489|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
985490|NCT03256279|Orthodontics, corrective|orthodontics, corrective
985491|NCT03256253|alcohol use disorder|alcohol use disorder
985492|NCT03256253|alcohol abuse|alcohol abuse
985493|NCT03256253|treatment|treatment
985494|NCT03256253|lyrica|lyrica
985495|NCT03256240|Crohn's recurrence|crohn's recurrence
985496|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
985497|NCT03256227|family therapy|family therapy
985498|NCT03256227|patient adherence|patient adherence
985499|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
985500|NCT03256201|Cancer|cancer
985501|NCT03256201|prehabilitation|prehabilitation
985502|NCT03256201|sarcopenia|sarcopenia
985503|NCT03256188|classroom|classroom
985504|NCT03256188|prolonged sitting|prolonged sitting
985505|NCT03256188|sedentary time|sedentary time
985506|NCT03256188|time-on-task|time-on-task
985508|NCT03256175|Myocardial Protection|myocardial protection
985509|NCT03256175|Oxygen|oxygen
985510|NCT03256175|Exercise Test|exercise test
985511|NCT03256162|ketamine|ketamine
985512|NCT03256162|glutamate|glutamate
985513|NCT03256136|Lung Cancer|lung cancer
985514|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
985515|NCT03256123|Iron Deficiency|iron deficiency
985516|NCT03256123|Parasite|parasite
985517|NCT03256123|Gut Microbiota|gut microbiota
985518|NCT03256123|Red palm oil|red palm oil
985519|NCT03256110|Advance Care Planning|advance care planning
985520|NCT03256110|Palliative Care|palliative care
985521|NCT03256110|Indians, North American|indians, north american
985522|NCT03256110|Alaska Natives|alaska natives
985523|NCT03256110|Health Communication|health communication
985524|NCT03256110|Primary Health Care|primary health care
985525|NCT03256097|Sound processing strategy|sound processing strategy
985526|NCT03256019|intubation|intubation
985527|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
985528|NCT03256006|sport exercise|sport exercise
985529|NCT03256006|ultra endurance|ultra endurance
985530|NCT03255954|Interpersonal Counseling|interpersonal counseling
985531|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
985532|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
985533|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
985628|NCT03255395|Residual Limb Pain|residual limb pain
985534|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
985535|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
985536|NCT03255941|Contraception|contraception
985537|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
985538|NCT03255941|Sayana (Sayana Press)|sayana (sayana press)
985539|NCT03255941|JHPIEGO (Johns Hopkins Program for International Education in Gynaecology and Obstetrics)|jhpiego (johns hopkins program for international education in gynaecology and obstetrics)
985540|NCT03255941|Sayana|sayana
985541|NCT03255928|Platelet activation|platelet activation
985542|NCT03255928|Ventricular Assist Device|ventricular assist device
985543|NCT03255928|Thrombosis|thrombosis
985544|NCT03255928|Bleeding|bleeding
985545|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
985546|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
985547|NCT03255915|HIV Prevention|hiv prevention
985548|NCT03255915|Intravaginal Ring|intravaginal ring
985549|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
985550|NCT03255915|Emtricitabine|emtricitabine
985551|NCT03255889|Safety|safety
985552|NCT03255889|Tolerability|tolerability
985553|NCT03255889|Pharmacokinetics|pharmacokinetics
985554|NCT03255889|Absorption|absorption
985555|NCT03255876|Polyphenols|polyphenols
985556|NCT03255876|Hyperglycemia|hyperglycemia
985557|NCT03255876|Postprandial|postprandial
985558|NCT03255876|Starch|starch
985559|NCT03255876|Alpha-amylase|alpha-amylase
985560|NCT03255863|Psychological Theory|psychological theory
985561|NCT03255850|adolescents|adolescents
985562|NCT03255850|quality of life|quality of life
985563|NCT03255850|psychological well-being|psychological well-being
985564|NCT03255837|Transcranial Stimulation|transcranial stimulation
985565|NCT03255837|Memory|memory
985566|NCT03255824|Oral Surgery|oral surgery
985567|NCT03255824|Third Molars|third molars
985568|NCT03255824|Intravenous Sedation|intravenous sedation
985569|NCT03255824|Dexmedetomidine|dexmedetomidine
985570|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
985571|NCT03255772|Magnetocardiography|magnetocardiography
985572|NCT03255772|Chest pain|chest pain
985573|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
985574|NCT03255733|Tennis Elbow|tennis elbow
985575|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
985576|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
985577|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
985578|NCT03255733|Actisound|actisound
985579|NCT03255707|Amblyopia|amblyopia
985580|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
985581|NCT03255707|Dissociative Treatment|dissociative treatment
985582|NCT03255707|Occlusion|occlusion
985583|NCT03255707|Patching|patching
985584|NCT03255681|Cosmetics|cosmetics
985585|NCT03255681|Filler|filler
985586|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
985587|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
985588|NCT03255655|Plantar Fascia Pain|plantar fascia pain
985589|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
985590|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
985591|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
985592|NCT03255655|Actisound|actisound
985593|NCT03255642|Clonazepam|clonazepam
985594|NCT03255642|Melatonin|melatonin
985595|NCT03255642|Treatment|treatment
985596|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
985597|NCT03255603|Resistant Starch|resistant starch
985599|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
985600|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
985601|NCT03255590|motor recovery|motor recovery
985602|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
985603|NCT03255590|motor learning|motor learning
985604|NCT03255590|ischemic Stroke|ischemic stroke
985605|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
985606|NCT03255577|17-384|17-384
985607|NCT03255538|patellar tendon|patellar tendon
985608|NCT03255499|cognitive training|cognitive training
985609|NCT03255499|physical exercise|physical exercise
985610|NCT03255499|brain dynamics|brain dynamics
985611|NCT03255499|cognitive abilities|cognitive abilities
985612|NCT03255499|physiological markers|physiological markers
985613|NCT03255460|Multiple Sclerosis|multiple sclerosis
985614|NCT03255460|Fatigue|fatigue
985615|NCT03255460|Physical Activity|physical activity
985616|NCT03255460|Exercise|exercise
985617|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
985618|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
985619|NCT03255447|Immunoadsorption|immunoadsorption
985620|NCT03255447|Apharesis|apharesis
985621|NCT03255421|urodynamic|urodynamic
985622|NCT03255421|backwards cystometry|backwards cystometry
985623|NCT03255421|reverse cystometry|reverse cystometry
985624|NCT03255421|follow-up|follow-up
985625|NCT03255395|MRI|mri
985626|NCT03255395|Ultrasound|ultrasound
985627|NCT03255395|Phantom Limb Pain|phantom limb pain
985629|NCT03255395|Neuroma|neuroma
985630|NCT03255382|ABBV-0066|abbv-0066
985631|NCT03255382|BI 655066|bi 655066
985632|NCT03255382|risankizumab|risankizumab
985633|NCT03255369|Zika virus|zika virus
985634|NCT03255369|Microcephaly|microcephaly
985635|NCT03255369|Child|child
985636|NCT03255369|pregnancy|pregnancy
985637|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
985638|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
985639|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
985640|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
985641|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
985642|NCT03255278|Tuberculosis|tuberculosis
985643|NCT03255278|Recombinant vaccine|recombinant vaccine
985644|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
985645|NCT03255265|organ transplantation|organ transplantation
985646|NCT03255265|cfDNA|cfdna
985647|NCT03255265|microchimerism|microchimerism
985648|NCT03255265|acute rejection|acute rejection
985649|NCT03255239|ventral hernia|ventral hernia
985650|NCT03255239|Open mesh repair|open mesh repair
985651|NCT03255239|Polyester mesh|polyester mesh
985652|NCT03255239|Preperitoneal|preperitoneal
985653|NCT03255239|Retromuscular|retromuscular
985654|NCT03255187|Biomarker|biomarker
985655|NCT03255187|Fish oil|fish oil
985656|NCT03255187|Oxidative stress|oxidative stress
985657|NCT03255187|Air pollution|air pollution
985658|NCT03255187|Cardiopulmonary system|cardiopulmonary system
985659|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
985660|NCT03255148|resting state|resting state
985662|NCT03255148|skin conductance|skin conductance
985663|NCT03255148|heart rate|heart rate
985664|NCT03255148|oxytocin|oxytocin
985665|NCT03255109|Lung|lung
985666|NCT03255109|acute|acute
985667|NCT03255109|respiratory|respiratory
985668|NCT03255109|distress|distress
985669|NCT03255109|weaning|weaning
985670|NCT03255109|mechanical ventilation|mechanical ventilation
985671|NCT03255109|respiratory infection|respiratory infection
985672|NCT03255083|Oncology|oncology
985673|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
985674|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
985675|NCT03255083|Metastatic|metastatic
985676|NCT03255083|Non-resectable|non-resectable
985677|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
985678|NCT03255083|EGFR|egfr
985679|NCT03255070|HER2|her2
985680|NCT03255070|Breast Cancer|breast cancer
985681|NCT03255070|ADC|adc
985682|NCT03255070|antibody drug conjugate|antibody drug conjugate
985683|NCT03255070|elevated HER2 expression|elevated her2 expression
985684|NCT03255070|breast neoplasm|breast neoplasm
985685|NCT03255070|stomach neoplasm|stomach neoplasm
985686|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
985687|NCT03255070|digestive system|digestive system
985688|NCT03255070|breast diseases|breast diseases
985689|NCT03255070|digestive system neoplasm|digestive system neoplasm
985690|NCT03255070|digestive system diseases|digestive system diseases
985691|NCT03255070|stomach diseases|stomach diseases
985692|NCT03255044|statin|statin
985693|NCT03255044|hydrophilic|hydrophilic
985694|NCT03255044|lipophilic|lipophilic
985695|NCT03255031|Ketogenic Diet|ketogenic diet
985696|NCT03255031|Detoxification|detoxification
985697|NCT03255031|Functional MRI|functional mri
985698|NCT03255031|MRI/MRS|mri/mrs
985699|NCT03255031|Alcoholism|alcoholism
985700|NCT03255018|Monoclonal Antibody|monoclonal antibody
985701|NCT03255018|PD-1 Receptor|pd-1 receptor
985702|NCT03255005|obesity|obesity
985703|NCT03255005|endoscopy|endoscopy
985704|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
985705|NCT03254953|digital health|digital health
985706|NCT03254953|eHealth|ehealth
985707|NCT03254953|technology|technology
985708|NCT03254953|smartphone|smartphone
985709|NCT03254953|obesity|obesity
985710|NCT03254953|overweight|overweight
985711|NCT03254953|weight loss|weight loss
985712|NCT03254953|behavioral intervention|behavioral intervention
985713|NCT03254953|self-monitoring|self-monitoring
985714|NCT03254953|tracking|tracking
985715|NCT03254953|engagement|engagement
985716|NCT03254953|adherence|adherence
985717|NCT03254953|weight change|weight change
985718|NCT03254953|e-mail|e-mail
985719|NCT03254953|mobile application|mobile application
985720|NCT03254953|goal setting|goal setting
985721|NCT03254953|action plan|action plan
985722|NCT03254953|feedback|feedback
985723|NCT03254953|electronic health|electronic health
985724|NCT03254940|text message|text message
985725|NCT03254940|digital health|digital health
985726|NCT03254940|weight loss|weight loss
985727|NCT03254940|personalized|personalized
985728|NCT03254927|Erbitux|erbitux
985729|NCT03254914|Home Blood Pressure|home blood pressure
985730|NCT03254914|Fimasartan|fimasartan
985832|NCT03254355|urinary incontinence|urinary incontinence
985731|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
985732|NCT03254862|Functional electrical stimulation|functional electrical stimulation
985733|NCT03254836|Actigraphy|actigraphy
985734|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
985735|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
985736|NCT03254797|Rehabilitation|rehabilitation
985737|NCT03254797|Neurological condition|neurological condition
985738|NCT03254797|Walking ability|walking ability
985739|NCT03254797|Feedback|feedback
985740|NCT03254797|External information|external information
985741|NCT03254771|Knee ostheoartritis|knee ostheoartritis
985742|NCT03254771|Arthroplasty|arthroplasty
985743|NCT03254771|Clinical trial|clinical trial
985744|NCT03254771|Decision aids|decision aids
985745|NCT03254745|Rheumatoid Arthritis|rheumatoid arthritis
985746|NCT03254745|Pakistan|pakistan
985747|NCT03254745|Pharmacist|pharmacist
985748|NCT03254745|Intervention|intervention
985749|NCT03254745|Treatment outcome|treatment outcome
985750|NCT03254719|Low Back Pain|low back pain
985751|NCT03254719|Chiropractic|chiropractic
985752|NCT03254719|Veterans|veterans
985754|NCT03254719|Depression|depression
985755|NCT03254719|Anxiety|anxiety
985756|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
985757|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
985758|NCT03254680|Turmeric Oil|turmeric oil
985759|NCT03254680|antiseizure medications|antiseizure medications
985760|NCT03254680|ar-turmerone|ar-turmerone
985761|NCT03254615|Plain water|plain water
985762|NCT03254615|Educative strategies|educative strategies
985763|NCT03254615|Effectiveness|effectiveness
985764|NCT03254589|Methotrexate|methotrexate
985765|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
985766|NCT03254589|Blood pressure|blood pressure
985767|NCT03254589|Arterial stiffness|arterial stiffness
985768|NCT03254589|Cardiovascular risk|cardiovascular risk
985769|NCT03254576|Overweight|overweight
985770|NCT03254576|Obesity|obesity
985771|NCT03254576|Body Mass Index|body mass index
985772|NCT03254576|Weight|weight
985773|NCT03254576|Brain imaging|brain imaging
985774|NCT03254576|Child|child
985775|NCT03254576|Learning|learning
985776|NCT03254550|PrEP|prep
985777|NCT03254524|Epidemiology Research|epidemiology research
985778|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
985779|NCT03254511|pathologic response|pathologic response
985780|NCT03254511|low molecular weight heparin|low molecular weight heparin
985781|NCT03254498|colonic adenoma|colonic adenoma
985782|NCT03254498|serrated polyps|serrated polyps
985783|NCT03254498|caecal intubation time|caecal intubation time
985784|NCT03254498|withdrawal time|withdrawal time
985785|NCT03254498|polyp miss rate|polyp miss rate
985786|NCT03254485|Heart Failure|heart failure
985787|NCT03254485|Cardiovascular|cardiovascular
985788|NCT03254485|HF|hf
985789|NCT03254485|HFpEF|hfpef
985790|NCT03254472|Biological markers|biological markers
985791|NCT03254472|Professional practice|professional practice
985792|NCT03254472|Big data analysis|big data analysis
985793|NCT03254472|Measured concentrations|measured concentrations
985794|NCT03254472|Cardiac markers|cardiac markers
985795|NCT03254472|Troponin|troponin
985796|NCT03254472|NTproBNP|ntprobnp
985797|NCT03254472|Creatinin|creatinin
985798|NCT03254472|INR|inr
985799|NCT03254472|Hemogram|hemogram
985800|NCT03254472|Lipid profile|lipid profile
985801|NCT03254446|Diabetes|diabetes
985802|NCT03254446|Hypertension|hypertension
985803|NCT03254446|Dyslipidemia|dyslipidemia
986805|NCT03247829|CardioMEMS|cardiomems
985804|NCT03254446|Cardiovascular Risk|cardiovascular risk
985805|NCT03254433|Neuroimaging|neuroimaging
985806|NCT03254433|Smoking Cessation|smoking cessation
985807|NCT03254433|Weight Loss|weight loss
985808|NCT03254407|bioequivalent|bioequivalent
985809|NCT03254407|IV/PO switch|iv/po switch
985810|NCT03254407|appropriateness|appropriateness
985811|NCT03254407|clinical pharmacy|clinical pharmacy
985812|NCT03254394|Oxaliplatin|oxaliplatin
985813|NCT03254394|Cold hypersensitivity|cold hypersensitivity
985814|NCT03254394|Neuropathy|neuropathy
985815|NCT03254394|Colorectal cancer|colorectal cancer
985816|NCT03254394|CIPN|cipn
985817|NCT03254394|Neuropathic Pain|neuropathic pain
985818|NCT03254381|cognitive assessment|cognitive assessment
985819|NCT03254381|cognitive function|cognitive function
985820|NCT03254381|community dwelling older people|community dwelling older people
985821|NCT03254381|pre-diabetes|pre-diabetes
985822|NCT03254381|randomized control trial|randomized control trial
985823|NCT03254381|exercise|exercise
985824|NCT03254381|pilot study|pilot study
985825|NCT03254381|feasibility study|feasibility study
985826|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
985827|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
985828|NCT03254368|Blood Glucose|blood glucose
985829|NCT03254368|Overweight|overweight
985830|NCT03254368|Obesity|obesity
985831|NCT03254355|avulsion injury|avulsion injury
985833|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
985834|NCT03254329|human milk|human milk
985835|NCT03254329|micronutrients|micronutrients
985836|NCT03254329|lactation|lactation
985837|NCT03254329|milk volume|milk volume
985838|NCT03254329|milk composition|milk composition
985839|NCT03254329|reference values|reference values
985840|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
985841|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
985842|NCT03254277|3BNC117-LS|3bnc117-ls
985843|NCT03254277|First in Human|first in human
985844|NCT03254277|Dose Escalation|dose escalation
985845|NCT03254225|Hypertension|hypertension
985846|NCT03254225|Elderly|elderly
985847|NCT03254225|Resistance training|resistance training
985848|NCT03254225|Heart rate variability|heart rate variability
985849|NCT03254212|Heart failure|heart failure
985850|NCT03254212|Central sleep apnea|central sleep apnea
985851|NCT03254212|oxygen therapy|oxygen therapy
985852|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
985853|NCT03254199|CMT|cmt
985854|NCT03254199|Muscle Cramps|muscle cramps
985855|NCT03254199|Muscle Cramping|muscle cramping
985856|NCT03254199|FLX-787|flx-787
985857|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
985858|NCT03254199|Neurogenetic disorder|neurogenetic disorder
985859|NCT03254199|Nervous System Malformations|nervous system malformations
985860|NCT03254199|Nervous System Diseases|nervous system diseases
985861|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
985862|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
985863|NCT03254186|Propranolol|propranolol
985864|NCT03254186|Safety|safety
985865|NCT03254186|Efficacy|efficacy
985866|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
985867|NCT03254173|Mirtazapine|mirtazapine
985868|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
985869|NCT03254173|Advanced Cancer|advanced cancer
985870|NCT03254173|Appetite|appetite
985871|NCT03254160|Stroke|stroke
985872|NCT03254160|Rehabilitation|rehabilitation
985873|NCT03254160|Ischemic|ischemic
985874|NCT03254121|Sustained virological response|sustained virological response
985875|NCT03254121|Whole genome sequencing|whole genome sequencing
985876|NCT03254095|Skin temperature|skin temperature
985877|NCT03254095|Plantar pressure|plantar pressure
985878|NCT03254095|Diabetic foot|diabetic foot
985879|NCT03254095|Tissue hardness|tissue hardness
985880|NCT03254095|Neuropathy|neuropathy
985881|NCT03254095|Peripheral artery disease|peripheral artery disease
985882|NCT03254082|sorghum health|sorghum health
985883|NCT03254056|fascial closure device|fascial closure device
985884|NCT03254056|laparoscopic surgery|laparoscopic surgery
985885|NCT03254056|postoperative pain|postoperative pain
985886|NCT03254030|Adenoma|adenoma
985887|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
985888|NCT03254017|Bilateral Habeluna|bilateral habeluna
985889|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
985890|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
985891|NCT03253900|wobble board|wobble board
985892|NCT03253900|slides|slides
985893|NCT03253900|rowing stroke|rowing stroke
985894|NCT03253900|rowing biomechanics|rowing biomechanics
985895|NCT03253900|power output|power output
985896|NCT03253887|Ethanol lock therapy|ethanol lock therapy
985897|NCT03253887|Pediatrics|pediatrics
985898|NCT03253887|Central Venous Catheter|central venous catheter
985899|NCT03253887|Bloodstream Infection|bloodstream infection
985900|NCT03253874|Pre-operative Testing|pre-operative testing
985901|NCT03253874|Cataract Surgery|cataract surgery
985902|NCT03253874|Health Service Research|health service research
985903|NCT03253874|Low-Value Care|low-value care
985904|NCT03253874|Safety-Net Hospital|safety-net hospital
985905|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
985906|NCT03253861|Acute pancreatitis|acute pancreatitis
985907|NCT03253861|Sepsis/complications|sepsis/complications
985908|NCT03253861|Infection|infection
985909|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
985910|NCT03253861|Drainage|drainage
985911|NCT03253861|Catheters|catheters
985912|NCT03253861|Antibiotics|antibiotics
985913|NCT03253861|Multiresistant organism|multiresistant organism
985914|NCT03253861|Pancreatitis/complications|pancreatitis/complications
985915|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
985916|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
985917|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
985918|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
985919|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
985920|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
985921|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
985922|NCT03253822|Decision Support Techniques|decision support techniques
985923|NCT03253822|Early Detection of Cancer|early detection of cancer
985924|NCT03253822|Educational Status|educational status
985925|NCT03253822|Decision Making|decision making
985926|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
985927|NCT03253770|Cognitive Aid|cognitive aid
985944|NCT03253692|Radiation|radiation
985945|NCT03253692|Iterative Reconstruction|iterative reconstruction
985946|NCT03253653|waterpipe|waterpipe
985947|NCT03253653|hookah|hookah
985948|NCT03253653|NNAL|nnal
985949|NCT03253653|SPMA|spma
985950|NCT03253653|1-HOP|1-hop
985951|NCT03253653|Furan-BDA-NAL|furan-bda-nal
985952|NCT03253653|Carbon monoxide|carbon monoxide
985953|NCT03253653|Pulmonary Function|pulmonary function
985954|NCT03253640|Costs and Cost Analysis|costs and cost analysis
985955|NCT03253640|Quality of Life|quality of life
985956|NCT03253640|Length of Stay|length of stay
985957|NCT03253640|Cohort study|cohort study
985958|NCT03253601|Rehabilitation|rehabilitation
985959|NCT03253601|Disability|disability
985960|NCT03253601|Mobile Health Technology|mobile health technology
985961|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
985962|NCT03253575|Breast Cancer|breast cancer
985963|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
985964|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
985965|NCT03253575|Colorectal Cancer|colorectal cancer
985966|NCT03253575|Local Recurrent Cancer|local recurrent cancer
985967|NCT03253575|Late Stage Cancer|late stage cancer
985968|NCT03253575|Clinical Utility|clinical utility
985969|NCT03253575|Outcomes Study|outcomes study
985970|NCT03253562|diabetes|diabetes
985971|NCT03253562|Metformin|metformin
985972|NCT03253562|vildagliptin|vildagliptin
985973|NCT03253562|hypertension|hypertension
985974|NCT03253562|cardiovascular risk|cardiovascular risk
985975|NCT03253549|remote automated monitoring|remote automated monitoring
985976|NCT03253549|hospital to home virtual care|hospital to home virtual care
985977|NCT03253549|cardiac surgery|cardiac surgery
985978|NCT03253549|major vascular surgery|major vascular surgery
985979|NCT03253549|self-management|self-management
985980|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
985981|NCT03253536|Quality of Life|quality of life
985982|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
985983|NCT03253536|observational|observational
985984|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
985985|NCT03253484|scar NAFL laser|scar nafl laser
985986|NCT03253458|Optical coherence tomography|optical coherence tomography
985987|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
985988|NCT03253458|Histology|histology
985989|NCT03253445|smoking cessation|smoking cessation
985990|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
985991|NCT03253445|ACT|act
985992|NCT03253445|schizophrenic patients|schizophrenic patients
985993|NCT03253445|hostel setting|hostel setting
985994|NCT03253445|randomised controlled trial|randomised controlled trial
985995|NCT03253419|Falls|falls
985996|NCT03253419|Hip Replacement|hip replacement
985997|NCT03253419|Home Safety|home safety
985998|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
985999|NCT03253341|exercise program|exercise program
986000|NCT03253341|lifestyle changes|lifestyle changes
986001|NCT03253341|fitness program|fitness program
986002|NCT03253341|lifestyle intervention|lifestyle intervention
986003|NCT03253302|transanal surgery|transanal surgery
986004|NCT03253302|total mesorectal excision|total mesorectal excision
986005|NCT03253302|rectal cancer|rectal cancer
986006|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
986007|NCT03253276|Bile Acid Transporter|bile acid transporter
986008|NCT03253237|Glycemic variability|glycemic variability
986009|NCT03253237|Hypoglycemia|hypoglycemia
986010|NCT03253211|Co-management model of care|co-management model of care
986011|NCT03253211|Primary Care|primary care
986012|NCT03253211|Specialty Care|specialty care
986013|NCT03253211|Decision support tools|decision support tools
986014|NCT03253211|Emergency Department Clinicians|emergency department clinicians
986015|NCT03253211|Co-management|co-management
986016|NCT03253185|Cancer|cancer
986017|NCT03253185|Advanced cancer|advanced cancer
986018|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
986019|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
986020|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
986021|NCT03253185|Pharmacokinetics|pharmacokinetics
986022|NCT03253146|Vimentin|vimentin
986023|NCT03253146|sepsis|sepsis
986024|NCT03253146|immune cells|immune cells
986025|NCT03253146|apoptosis|apoptosis
986026|NCT03253107|gastric cancer|gastric cancer
986027|NCT03253107|RNA sequencing|rna sequencing
986028|NCT03253107|chemotherapy response|chemotherapy response
986029|NCT03253107|miRNA sequencing|mirna sequencing
986030|NCT03253055|Physical Performance|physical performance
986031|NCT03253055|Bone|bone
986032|NCT03253055|Illness|illness
986033|NCT03253055|Injury|injury
986034|NCT03253042|Exercise|exercise
986035|NCT03253042|Vibration|vibration
986036|NCT03253042|Torque|torque
986037|NCT03253042|Aging|aging
986038|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
986039|NCT03252977|fentanyl|fentanyl
986040|NCT03252977|Pain Threshold|pain threshold
986041|NCT03252977|predicted|predicted
986042|NCT03252938|solid tumor|solid tumor
986043|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
986044|NCT03252886|intubation|intubation
986045|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
986046|NCT03252886|neck injury|neck injury
986047|NCT03252873|adherence|adherence
986048|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
986049|NCT03252873|copd|copd
986050|NCT03252847|XLRP RPGR|xlrp rpgr
986051|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
986052|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
986053|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
986054|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
986055|NCT03252808|HF10|hf10
986056|NCT03252808|Oncolytic virus|oncolytic virus
986057|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
986058|NCT03252808|Gemcitabine|gemcitabine
986059|NCT03252808|Nab-paclitaxel|nab-paclitaxel
986060|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
986061|NCT03252808|Abraxane|abraxane
986062|NCT03252808|Tegafur-gimeracil-oteracil potassium|tegafur-gimeracil-oteracil potassium
986063|NCT03252808|TS-1|ts-1
986064|NCT03252808|canerpaturev|canerpaturev
986065|NCT03252795|Infertility, female|infertility, female
986066|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
986067|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
986068|NCT03252782|Soft Tissue|soft tissue
986069|NCT03252782|Functional Appliance|functional appliance
986070|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
986071|NCT03252756|Cannabidiol|cannabidiol
986072|NCT03252756|Alcohol Use Disorder|alcohol use disorder
986073|NCT03252730|Dry scalp|dry scalp
986074|NCT03252730|Itchy scalp|itchy scalp
986075|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
986076|NCT03252678|Advanced Care Planning|advanced care planning
986077|NCT03252665|STEMI|stemi
986078|NCT03252665|myocardial perfusion|myocardial perfusion
986079|NCT03252665|TMPFC|tmpfc
986080|NCT03252665|Nicorandil|nicorandil
986081|NCT03252665|Alprostadil|alprostadil
986082|NCT03252652|Cranial vessels|cranial vessels
986083|NCT03252652|Normal parameters|normal parameters
986084|NCT03252652|Carotid Duplex|carotid duplex
986085|NCT03252652|Egyptian|egyptian
986086|NCT03252639|Renal Artery Stenosis|renal artery stenosis
986087|NCT03252639|Renal Blood Perfusion|renal blood perfusion
986088|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
986089|NCT03252613|cytokine|cytokine
986090|NCT03252613|iPSC|ipsc
986091|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
986092|NCT03252561|TAP block|tap block
986093|NCT03252561|Acute Appendicitis|acute appendicitis
986094|NCT03252561|Post-operative analgesia|post-operative analgesia
986095|NCT03252535|Huntington disease|huntington disease
986096|NCT03252535|Stem cell therapy|stem cell therapy
986097|NCT03252535|Dental pulp stem cell|dental pulp stem cell
986098|NCT03252509|percutaneous radiologic gastrostomy|percutaneous radiologic gastrostomy
986099|NCT03252509|Head and Neck Neoplasms|head and neck neoplasms
986100|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
986101|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
986102|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
986103|NCT03252457|Purpura|purpura
986104|NCT03252457|Thrombocytopenia|thrombocytopenia
986105|NCT03252457|immune throbocytopenia|immune throbocytopenia
986106|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
986107|NCT03252444|EMG biofeedback training|emg biofeedback training
986108|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
986109|NCT03252418|ascorbic acid|ascorbic acid
986110|NCT03252418|diode laser|diode laser
986111|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
986112|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
986113|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
986114|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
986115|NCT03252301|pain|pain
986116|NCT03252301|post operative|post operative
986117|NCT03252301|surgery|surgery
986118|NCT03252301|objective|objective
986119|NCT03252236|Stroke|stroke
986120|NCT03252236|Tai Chi|tai chi
986123|NCT03252236|Arterial stiffness|arterial stiffness
986124|NCT03252236|Autonomic nervous system|autonomic nervous system
986125|NCT03252236|Heart rate variability|heart rate variability
986126|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
986128|NCT03252223|hyperandrogenism|hyperandrogenism
986129|NCT03252210|Preoperative localization|preoperative localization
986130|NCT03252210|Stereoscopic Localization|stereoscopic localization
986131|NCT03252210|Wedge Resection|wedge resection
986132|NCT03252210|Ground Glass Opacity|ground glass opacity
986133|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
986134|NCT03252197|new device|new device
986135|NCT03252197|first attempt success|first attempt success
986136|NCT03252184|Phototherapy|phototherapy
986137|NCT03252184|Laser Therapy|laser therapy
986138|NCT03252184|Endothelium-Dependent|endothelium-dependent
986139|NCT03252184|Vascular Endothelium|vascular endothelium
986140|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
986141|NCT03252184|Relaxing Factors|relaxing factors
986142|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
986144|NCT03252171|glioma|glioma
986145|NCT03252080|type 2 diabetes|type 2 diabetes
986146|NCT03252080|holistic management|holistic management
986147|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
986148|NCT03252041|PCS|pcs
986149|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
986150|NCT03252002|Chronic kidney disease|chronic kidney disease
986154|NCT03251976|ovarian cancer|ovarian cancer
986155|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
986156|NCT03251976|end of life care|end of life care
986157|NCT03251976|endometrial cancer|endometrial cancer
986158|NCT03251976|cervical cancer|cervical cancer
986159|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
986160|NCT03251937|Chronic Pain|chronic pain
986161|NCT03251937|Back Pain|back pain
986162|NCT03251937|Leg Pain|leg pain
986163|NCT03251937|Pain|pain
986164|NCT03251937|Stimulation|stimulation
986165|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
986166|NCT03251937|Implantable Pulse Generator|implantable pulse generator
986167|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
986168|NCT03251872|PAH|pah
986169|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
986170|NCT03251872|PARP-1 inhibition|parp-1 inhibition
986171|NCT03251872|DNA damage|dna damage
986172|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
986173|NCT03251872|Olaparib|olaparib
986174|NCT03251872|Safety and efficacy|safety and efficacy
986175|NCT03251859|platelet reactivity|platelet reactivity
986176|NCT03251859|ticagrelor|ticagrelor
986177|NCT03251859|myocardial infarction|myocardial infarction
986178|NCT03251859|pharmacodynamics|pharmacodynamics
986179|NCT03251859|antiplatelet therapy|antiplatelet therapy
986180|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
986181|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
986182|NCT03251846|diabetes mobile application|diabetes mobile application
986183|NCT03251846|diabetes management device|diabetes management device
986184|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
986185|NCT03251820|seizure|seizure
986186|NCT03251820|cognition|cognition
986187|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
986188|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
986189|NCT03251807|Twin-block|twin-block
986190|NCT03251807|Functional treatment|functional treatment
986191|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
986192|NCT03251781|Exercise Test|exercise test
986193|NCT03251781|Rehabilitation|rehabilitation
986194|NCT03251781|Disability Evaluation|disability evaluation
986195|NCT03251768|Chemotherapy|chemotherapy
986196|NCT03251768|Neutropenia|neutropenia
986197|NCT03251768|breast cancer|breast cancer
986198|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
986199|NCT03251755|insomnia|insomnia
986200|NCT03251755|Dao-in|dao-in
986201|NCT03251742|Fontan operation|fontan operation
986202|NCT03251742|Negative pressure ventilation|negative pressure ventilation
986203|NCT03251742|MRI|mri
986204|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
986205|NCT03251716|Metabolic syndrome|metabolic syndrome
986206|NCT03251716|Schizophrenia|schizophrenia
986207|NCT03251716|Efficacy|efficacy
986208|NCT03251716|Female|female
986209|NCT03251716|Berberine|berberine
986210|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
986211|NCT03251599|peak temperature|peak temperature
986212|NCT03251599|rewarming rate|rewarming rate
986213|NCT03251599|surgical outcomes|surgical outcomes
986214|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
986215|NCT03251560|chronic pelvic pain|chronic pelvic pain
986216|NCT03251547|rFVIIa|rfviia
986217|NCT03251547|Massive Hemorrhage|massive hemorrhage
986218|NCT03251547|non-hemophilia|non-hemophilia
986219|NCT03251534|Eos imaging stereography|eos imaging stereography
986220|NCT03251534|Centromedullary nailing|centromedullary nailing
986221|NCT03251534|Quantification of malunions|quantification of malunions
986223|NCT03251521|spasticity|spasticity
986224|NCT03251521|stroke|stroke
986225|NCT03251521|injection|injection
986226|NCT03251521|botulinum toxin A|botulinum toxin a
986227|NCT03251508|Peanut|peanut
986228|NCT03251495|Vaccination|vaccination
986229|NCT03251495|Contagious Diseases|contagious diseases
986230|NCT03251495|Tropical Medicine|tropical medicine
986231|NCT03251495|Infectious Diseases|infectious diseases
986232|NCT03251469|tranexamic acid|tranexamic acid
986233|NCT03251469|blood tranfusion|blood tranfusion
986234|NCT03251469|hip fractures|hip fractures
986235|NCT03251469|elderly|elderly
986236|NCT03251469|blood loss|blood loss
986237|NCT03251456|Visual Developmental Disorders|visual developmental disorders
986238|NCT03251456|Tertiary Care|tertiary care
986239|NCT03251456|Pre-school Children|pre-school children
986240|NCT03251417|Irinotecan|irinotecan
986241|NCT03251417|Apatinib|apatinib
986242|NCT03251391|revascularization|revascularization
986243|NCT03251391|blocked arteries|blocked arteries
986244|NCT03251391|leg arteries|leg arteries
986245|NCT03251391|leg pain|leg pain
986246|NCT03251365|Pancreatic cancer|pancreatic cancer
986247|NCT03251365|Gemcitabine|gemcitabine
986248|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
986249|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
986250|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
986251|NCT03251339|Healthy Subjects|healthy subjects
986252|NCT03251339|MSB11455|msb11455
986253|NCT03251274|bath machine|bath machine
986254|NCT03251274|sleep quality|sleep quality
986255|NCT03251274|nursing home|nursing home
986256|NCT03251274|heart rate variability|heart rate variability
986257|NCT03251248|MSB11455|msb11455
986258|NCT03251248|Healthy subjects|healthy subjects
986259|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
986260|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
986261|NCT03251157|Asthma|asthma
986262|NCT03251157|Adults|adults
986263|NCT03251157|Europe|europe
986264|NCT03251157|Lung function|lung function
986265|NCT03251157|Allergy|allergy
986266|NCT03251157|Atopy|atopy
986267|NCT03251157|IgE|ige
986268|NCT03251157|Sensitisation|sensitisation
986269|NCT03251157|Diet|diet
986270|NCT03251157|Dietary patterns|dietary patterns
986271|NCT03251157|Dietary antioxidants|dietary antioxidants
986272|NCT03251157|Flavonoids|flavonoids
986273|NCT03251157|Fruits and vegetables|fruits and vegetables
986274|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
986275|NCT03251157|Fatty acids|fatty acids
986276|NCT03251144|HIV/AIDS|hiv/aids
986277|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
986278|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
986279|NCT03251144|mitochondria|mitochondria
986280|NCT03251144|toxicity|toxicity
986281|NCT03251118|Crohn's Disease|crohn's disease
986282|NCT03251118|Ulcerative colitis|ulcerative colitis
986283|NCT03251118|Indeterminate colitis|indeterminate colitis
986284|NCT03251118|Digestive System Diseases|digestive system diseases
986285|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
986286|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
986287|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
986288|NCT03251040|Fibrin sealant|fibrin sealant
986289|NCT03251040|Sealing|sealing
986290|NCT03251014|Thrombosis|thrombosis
986291|NCT03251014|Yellowstripe scad|yellowstripe scad
986292|NCT03251014|Salmon|salmon
986293|NCT03251014|Healthy overweight subjects|healthy overweight subjects
986294|NCT03251014|Randomized crossover trial|randomized crossover trial
986295|NCT03251001|gingiva|gingiva
986296|NCT03251001|keratinized mucosa|keratinized mucosa
986297|NCT03251001|gingival graft|gingival graft
986298|NCT03250975|Intubation injury|intubation injury
986299|NCT03250975|Acute laryngeal injury|acute laryngeal injury
986300|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
986301|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
986302|NCT03250936|trampoline|trampoline
986303|NCT03250923|Oral Candidiasis, Thrush, Oral Moniliasis|oral candidiasis, thrush, oral moniliasis
986304|NCT03250910|hepatitis C virus|hepatitis c virus
986305|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
986306|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
986307|NCT03250897|Alveolar macrophages|alveolar macrophages
986308|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
986309|NCT03250897|FACS analysis|facs analysis
986310|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
986506|NCT03249844|steroids|steroids
986311|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
986312|NCT03250858|Personalised nutrition|personalised nutrition
986313|NCT03250858|Mobile web application|mobile web application
986314|NCT03250845|Multigam|multigam
986315|NCT03250845|Immunoglobulin|immunoglobulin
986316|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
986317|NCT03250832|advanced solid tumors|advanced solid tumors
986318|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
986319|NCT03250832|fallopian tube cancer|fallopian tube cancer
986320|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
986321|NCT03250832|breast cancer|breast cancer
986322|NCT03250832|bladder cancer|bladder cancer
986323|NCT03250832|urothelial carcinoma|urothelial carcinoma
986324|NCT03250832|TNBC|tnbc
986325|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
986326|NCT03250832|LAG-3|lag-3
986327|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
986328|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
986329|NCT03250793|Respiration, Artificial|respiration, artificial
986330|NCT03250793|physiologic pilot study|physiologic pilot study
986331|NCT03250793|NAVA|nava
986332|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
986333|NCT03250793|esophageal transducer|esophageal transducer
986334|NCT03250793|Work of Breathing|work of breathing
986335|NCT03250754|Acupuncture|acupuncture
986336|NCT03250754|Migraine|migraine
986337|NCT03250754|Tension-type headache|tension-type headache
986338|NCT03250741|Rotigotine|rotigotine
986339|NCT03250741|Dopamine|dopamine
986340|NCT03250728|CDG|cdg
986341|NCT03250728|Stroke-like|stroke-like
986342|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
986343|NCT03250728|Protein C|protein c
986344|NCT03250728|Congenital Disorders og Glycosylation|congenital disorders og glycosylation
986345|NCT03250702|Tanzania|tanzania
986346|NCT03250702|Observational|observational
986347|NCT03250702|Sub-Saharan Africa|sub-saharan africa
986348|NCT03250702|Treatment|treatment
986349|NCT03250689|Danirixin|danirixin
986350|NCT03250689|CXCR2|cxcr2
986351|NCT03250689|NETs|nets
986352|NCT03250689|GSK1325756|gsk1325756
986353|NCT03250689|COPD|copd
986354|NCT03250689|HBr|hbr
986355|NCT03250676|HER2|her2
986356|NCT03250676|estrogen receptor alpha|estrogen receptor alpha
986357|NCT03250676|H3B-6545|h3b-6545
986358|NCT03250676|breast cancer|breast cancer
986359|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
986360|NCT03250650|Overactive Bladder|overactive bladder
986361|NCT03250650|Electric Stimulation|electric stimulation
986362|NCT03250650|Physical Therapy Modalities|physical therapy modalities
986363|NCT03250637|Gene-environment interaction|gene-environment interaction
986364|NCT03250637|Candidate gene|candidate gene
986365|NCT03250637|Western style diet|western style diet
986366|NCT03250637|Toll-like receptors|toll-like receptors
986367|NCT03250637|Prospective study|prospective study
986368|NCT03250637|Nested case-cohort|nested case-cohort
986369|NCT03250611|Occipital condyle|occipital condyle
986370|NCT03250611|Occipital condyle screw|occipital condyle screw
986371|NCT03250598|Healthy|healthy
986372|NCT03250598|Japanese|japanese
986373|NCT03250585|acute chest syndrome|acute chest syndrome
986374|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
986375|NCT03250585|exhaled breath condensate|exhaled breath condensate
986376|NCT03250585|sickle cell disease|sickle cell disease
986377|NCT03250559|Stone disease|stone disease
986378|NCT03250533|Wound healing|wound healing
986379|NCT03250533|Phototherapy|phototherapy
986380|NCT03250533|Electrotherapy|electrotherapy
986381|NCT03250507|TAP block|tap block
986382|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
986383|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
986384|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
986385|NCT03250390|Lung cancer|lung cancer
986386|NCT03250390|diagnosis|diagnosis
986387|NCT03250390|volatile organic compounds|volatile organic compounds
986388|NCT03250377|Brivaracetam|brivaracetam
986389|NCT03250377|Epilepsy|epilepsy
986390|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
986391|NCT03250377|Asian subjects|asian subjects
986392|NCT03250325|Adoptive cell transfer|adoptive cell transfer
986393|NCT03250325|Cell therapy|cell therapy
986394|NCT03250325|Immunotherapy|immunotherapy
986395|NCT03250325|NY-ESO-1|ny-eso-1
986396|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
986397|NCT03250325|Synovial sarcoma|synovial sarcoma
986398|NCT03250312|Osteopathic manipulation|osteopathic manipulation
986399|NCT03250312|low back pain|low back pain
986400|NCT03250312|immune cells|immune cells
986401|NCT03250273|Immunotherapy|immunotherapy
986402|NCT03250273|Nivolumab|nivolumab
986403|NCT03250273|Entinostat|entinostat
986404|NCT03250273|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
986405|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
986507|NCT03249844|aspirin|aspirin
986406|NCT03250273|Unresectable|unresectable
986407|NCT03250273|Metastatic|metastatic
986408|NCT03250273|PD-1|pd-1
986409|NCT03250273|Antibody|antibody
986410|NCT03250260|3-dimensional imaging|3-dimensional imaging
986411|NCT03250260|Breast Conserving Treatment|breast conserving treatment
986412|NCT03250260|Simulation|simulation
986413|NCT03250247|deep vein thrombosis|deep vein thrombosis
986414|NCT03250247|superficial venous reflux|superficial venous reflux
986415|NCT03250247|blood clot|blood clot
986416|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
986417|NCT03250247|iliac vein obstruction|iliac vein obstruction
986418|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
986419|NCT03250208|Microbiome|microbiome
986420|NCT03250208|Lactobacillus|lactobacillus
986421|NCT03250208|Probiotic|probiotic
986422|NCT03250208|Fem-Dophilus|fem-dophilus
986423|NCT03250156|Mindfulness|mindfulness
986424|NCT03250156|Attention|attention
986425|NCT03250156|Working Memory|working memory
986426|NCT03250156|Psychological Well-Being|psychological well-being
986427|NCT03250156|Proctored Practice|proctored practice
986428|NCT03250117|Parkinson Disease|parkinson disease
986429|NCT03250117|Dyskinesia|dyskinesia
986430|NCT03250117|ropinirole|ropinirole
986431|NCT03250117|implant|implant
986432|NCT03250117|ProNeura|proneura
986433|NCT03250117|movement disorders|movement disorders
986434|NCT03250117|dopamine agonist|dopamine agonist
986435|NCT03250117|extended-release|extended-release
986436|NCT03250117|Parkinsonian disorders|parkinsonian disorders
986437|NCT03250117|brain diseases|brain diseases
986438|NCT03250117|central nervous system diseases|central nervous system diseases
986439|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
986440|NCT03250117|Antiparkinson agents|antiparkinson agents
986441|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
986442|NCT03250117|dopamine agents|dopamine agents
986443|NCT03250117|neurotransmitter agents|neurotransmitter agents
986444|NCT03250117|REQUIP|requip
986445|NCT03250117|subdermal|subdermal
986446|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
986447|NCT03250104|infection control|infection control
986448|NCT03250104|nosocomial infection|nosocomial infection
986449|NCT03250104|clostridium difficile|clostridium difficile
986450|NCT03250104|MRGN bacteria|mrgn bacteria
986451|NCT03250104|health-care associated pathogens|health-care associated pathogens
986452|NCT03250104|VRE|vre
986453|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
986454|NCT03250091|gastric cancer|gastric cancer
986455|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
986456|NCT03250091|gastric atrophy|gastric atrophy
986457|NCT03250091|gastric dysplasia|gastric dysplasia
986458|NCT03250078|Pancreas|pancreas
986459|NCT03250078|Cancer|cancer
986460|NCT03250078|Diabetes Mellitus|diabetes mellitus
986461|NCT03250078|MRI|mri
986462|NCT03250078|BRCA|brca
986463|NCT03250078|Early Detection|early detection
986464|NCT03250078|Genetics|genetics
986465|NCT03250052|Fimasartan|fimasartan
986466|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
986467|NCT03250026|primary care|primary care
986468|NCT03250026|convergence dialogue|convergence dialogue
986469|NCT03250026|sick leave|sick leave
986470|NCT03250026|care manager|care manager
986471|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
986472|NCT03249974|accuracy|accuracy
986473|NCT03249974|usability|usability
986474|NCT03249974|skin reactions|skin reactions
986475|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
986476|NCT03249961|motor|motor
986477|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
986478|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
986479|NCT03249935|Azithromycin|azithromycin
986480|NCT03249935|Chlamydia|chlamydia
986481|NCT03249935|Correctional|correctional
986482|NCT03249935|Facilities|facilities
986483|NCT03249935|Symptoms|symptoms
986484|NCT03249935|Urethral|urethral
986485|NCT03249935|Urogenital|urogenital
986486|NCT03249935|Youth|youth
986487|NCT03249922|spinal cord stimulation|spinal cord stimulation
986488|NCT03249896|Gestational Diabetes|gestational diabetes
986489|NCT03249896|RCT|rct
986490|NCT03249896|Lifestyle coaching program|lifestyle coaching program
986491|NCT03249896|Smartphone app|smartphone app
986492|NCT03249896|Gestational weight gain|gestational weight gain
986493|NCT03249883|prosthetic feet|prosthetic feet
986494|NCT03249883|double blind study|double blind study
986495|NCT03249883|limited ambulators|limited ambulators
986496|NCT03249883|SACH foot|sach foot
986497|NCT03249883|prosthetic components comparison|prosthetic components comparison
986498|NCT03249857|Bipolar affective disorders|bipolar affective disorders
986499|NCT03249857|Cognition|cognition
986500|NCT03249857|Emotion|emotion
986501|NCT03249857|Embodiment|embodiment
986502|NCT03249857|Sensorimotor|sensorimotor
986503|NCT03249857|Simulation|simulation
986504|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
986505|NCT03249844|children|children
986508|NCT03249844|Methylprednisolone|methylprednisolone
986509|NCT03249844|Prednisolone|prednisolone
986510|NCT03249831|Sickle Cell Disease|sickle cell disease
986511|NCT03249831|Sickle Cell Disorders|sickle cell disorders
986512|NCT03249831|Hemoglobinopathies|hemoglobinopathies
986513|NCT03249831|Thalassemia|thalassemia
986514|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
986515|NCT03249831|Haploidentical Transplant|haploidentical transplant
986516|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
986517|NCT03249831|CD4+ T cell|cd4+ t cell
986518|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
986519|NCT03249831|Mixed Chimerism|mixed chimerism
986520|NCT03249805|LMIC|lmic
986521|NCT03249805|Medical device efficacy|medical device efficacy
986522|NCT03249740|Age-related macular degeneration|age-related macular degeneration
986523|NCT03249740|Choroidal neovascularization|choroidal neovascularization
986524|NCT03249727|natural killer cells|natural killer cells
986525|NCT03249727|natural killer cell activity|natural killer cell activity
986526|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
986527|NCT03249701|Acupoint Stimulation|acupoint stimulation
986528|NCT03249701|postoperative recovery|postoperative recovery
986529|NCT03249701|Postoperative Complications|postoperative complications
986530|NCT03249701|Peri-operation|peri-operation
986531|NCT03249688|Lifestyle intervention|lifestyle intervention
986532|NCT03249688|Medical food|medical food
986533|NCT03249688|Randomized controlled trial|randomized controlled trial
986534|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
986535|NCT03249688|Prevention|prevention
986536|NCT03249688|Intervention|intervention
986537|NCT03249688|Multidomain|multidomain
986538|NCT03249688|Multimodal|multimodal
986539|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
986540|NCT03249675|Concussion|concussion
986541|NCT03249662|periarticular infiltration|periarticular infiltration
986542|NCT03249662|postoperative pain management|postoperative pain management
986543|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
986544|NCT03249649|defibulation|defibulation
986545|NCT03249649|healthcare needs assessment|healthcare needs assessment
986546|NCT03249649|CBPR|cbpr
986547|NCT03249623|Weaning|weaning
986548|NCT03249623|Intensive Care|intensive care
986549|NCT03249623|Individualised Care|individualised care
986550|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
986551|NCT03249623|Respiratory Failure|respiratory failure
986552|NCT03249623|Mechanical Ventilation|mechanical ventilation
986553|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
986554|NCT03249623|Extubation|extubation
986555|NCT03249597|Sepsis|sepsis
986556|NCT03249597|Emergency Medical Services|emergency medical services
986557|NCT03249597|Prehospital|prehospital
986558|NCT03249597|Emergency Care|emergency care
986559|NCT03249597|Emergency Medicine|emergency medicine
986560|NCT03249571|exercise|exercise
986561|NCT03249571|flavonoids|flavonoids
986562|NCT03249571|gut permeability|gut permeability
986563|NCT03249571|gut-derived phenolics|gut-derived phenolics
986564|NCT03249558|Pain|pain
986565|NCT03249558|Pain Management|pain management
986566|NCT03249519|Radiation therapy|radiation therapy
986567|NCT03249519|Chemoradiation|chemoradiation
986568|NCT03249519|Brachytherapy|brachytherapy
986569|NCT03249519|Hyperthermia|hyperthermia
986570|NCT03249519|Cervical cancer|cervical cancer
986571|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
986572|NCT03249493|Decentralised Area|decentralised area
986573|NCT03249467|HAQ-II|haq-ii
986574|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
986575|NCT03249454|Incomplete SCI|incomplete sci
986576|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
986577|NCT03249415|Cell therapy|cell therapy
986578|NCT03249415|Regenerative factors|regenerative factors
986579|NCT03249415|Autologous treatment|autologous treatment
986580|NCT03249415|Paracrine factors|paracrine factors
986581|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
986582|NCT03249350|Substance Use Disorders|substance use disorders
986583|NCT03249350|Adolescents|adolescents
986584|NCT03249350|Treatment|treatment
986585|NCT03249350|Mediation|mediation
986586|NCT03249324|Pregnancy|pregnancy
986587|NCT03249324|Overweight|overweight
986588|NCT03249324|Obesity|obesity
986589|NCT03249324|Prevention|prevention
986590|NCT03249324|Positive-gain counseling|positive-gain counseling
986591|NCT03249311|Levomilnacipran|levomilnacipran
986592|NCT03249311|Antidepressant|antidepressant
986593|NCT03249311|Ottawa|ottawa
986594|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
986595|NCT03249311|Healthy males|healthy males
986596|NCT03249311|Tyramine response|tyramine response
986597|NCT03249311|Serotonin|serotonin
986598|NCT03249311|Norepinephrine|norepinephrine
986599|NCT03249285|hypertension|hypertension
986600|NCT03249285|pharmacogenomics|pharmacogenomics
986601|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
986607|NCT03249181|Antiretroviral|antiretroviral
986608|NCT03249181|Pregnancy|pregnancy
986609|NCT03249181|Africa|africa
986610|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
986611|NCT03249142|Ovarian Cancer|ovarian cancer
986612|NCT03249142|Anti-PD-L1|anti-pd-l1
986613|NCT03249142|Anti-CLA-4|anti-cla-4
986614|NCT03249142|Neo-adjuvant|neo-adjuvant
986615|NCT03249129|Trauma|trauma
986616|NCT03249129|spinal cord|spinal cord
986617|NCT03249129|autoimmunity|autoimmunity
986618|NCT03249129|antibody|antibody
986619|NCT03249116|human-animal interaction|human-animal interaction
1658894|NCT00151021|Pedometer|pedometer
986620|NCT03249116|animal-assisted intervention|animal-assisted intervention
986621|NCT03249103|Fibromyalgia|fibromyalgia
986622|NCT03249077|Prevention|prevention
986623|NCT03249077|Medicare|medicare
986624|NCT03249064|TREGS|tregs
986625|NCT03249064|CD91|cd91
986626|NCT03249064|LRP1|lrp1
986627|NCT03249025|lidocaine|lidocaine
986628|NCT03249025|ketamine|ketamine
986629|NCT03249025|infusion|infusion
986630|NCT03248999|multidrug resistance|multidrug resistance
986631|NCT03248999|nursing home|nursing home
986632|NCT03248999|ESBL|esbl
986633|NCT03248999|CRE|cre
986634|NCT03248947|opioid use disorder|opioid use disorder
986635|NCT03248947|Medication-assisted treatment|medication-assisted treatment
986636|NCT03248947|Buprenorphine treatment|buprenorphine treatment
986637|NCT03248947|Collaborative care model|collaborative care model
986638|NCT03248908|pupillary reflex|pupillary reflex
986639|NCT03248908|nociception|nociception
986640|NCT03248908|heart rate|heart rate
986641|NCT03248908|intraoperative monitoring|intraoperative monitoring
986642|NCT03248895|Inhaler assessment|inhaler assessment
986643|NCT03248895|Direct observation of therapy|direct observation of therapy
986644|NCT03248882|PF-05221304|pf-05221304
986645|NCT03248882|NAFLD|nafld
986646|NCT03248882|NASH|nash
986647|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
986648|NCT03248882|Dose-Ranging Study|dose-ranging study
986649|NCT03248869|asthma|asthma
986650|NCT03248869|mobile application|mobile application
986651|NCT03248869|mobile app|mobile app
986652|NCT03248869|mobile health applications|mobile health applications
986653|NCT03248869|asthma mobile health application|asthma mobile health application
986654|NCT03248843|KN035|kn035
986655|NCT03248843|Solid tumors|solid tumors
986656|NCT03248843|Phase 1|phase 1
986657|NCT03248804|Overweight|overweight
986658|NCT03248804|Obesity|obesity
986659|NCT03248804|Weight Loss|weight loss
986660|NCT03248778|disclosure|disclosure
986661|NCT03248752|Behavioural|behavioural
986662|NCT03248739|Catheter|catheter
986663|NCT03248739|Ventricular|ventricular
986664|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
986665|NCT03248739|EVD Catheter|evd catheter
986666|NCT03248739|Occlusion|occlusion
986667|NCT03248739|Ventriculostomy|ventriculostomy
986668|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
986669|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
986670|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
986671|NCT03248739|Neurosurgery|neurosurgery
986672|NCT03248726|Polyethylene Glycol|polyethylene glycol
986673|NCT03248726|Bisacodyl|bisacodyl
986674|NCT03248726|Colonoscopy|colonoscopy
986675|NCT03248726|Bowel preparation|bowel preparation
986676|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
986682|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
986683|NCT03248596|Primary hemostasis|primary hemostasis
986684|NCT03248583|Proof-of-principle|proof-of-principle
986685|NCT03248583|Feasibility|feasibility
986686|NCT03248557|resuscitation|resuscitation
986687|NCT03248557|wavelet analysis|wavelet analysis
986688|NCT03248557|spectral analysis|spectral analysis
986689|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
986690|NCT03248544|vitamin D|vitamin d
986691|NCT03248544|Brain Neoplasms|brain neoplasms
986692|NCT03248544|perioperative complications|perioperative complications
986693|NCT03248544|clinical outcomes|clinical outcomes
986694|NCT03248544|craniotomy|craniotomy
986695|NCT03248544|Immune System|immune system
986696|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
986697|NCT03248531|Bimekizumab|bimekizumab
986698|NCT03248531|HS|hs
986699|NCT03248531|Moderate to Severe HS|moderate to severe hs
986700|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
986701|NCT03248518|Fatigue|fatigue
986702|NCT03248518|Exercise|exercise
986703|NCT03248518|Behavioural Intervention|behavioural intervention
986704|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
986705|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
986706|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
986707|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
986708|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
986709|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
986710|NCT03248479|Hu5F9-G4|hu5f9-g4
986712|NCT03248479|azacitidine|azacitidine
986713|NCT03248466|platelet rich gel|platelet rich gel
986714|NCT03248466|BMMSCs|bmmscs
986715|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
986716|NCT03248453|Simulated colonoscopy|simulated colonoscopy
986717|NCT03248453|Self-regulated learning|self-regulated learning
986718|NCT03248427|Breast Cancer|breast cancer
986719|NCT03248427|Neoadjuvant|neoadjuvant
986720|NCT03248427|Luminal B tumors|luminal b tumors
986721|NCT03248427|Ribociclib|ribociclib
986722|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
986723|NCT03248375|Radioembolization|radioembolization
986724|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
986725|NCT03248349|Critically ill children|critically ill children
986726|NCT03248349|Pharmacokinetics|pharmacokinetics
986727|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
986728|NCT03248310|Quality of Life (QoL)|quality of life (qol)
986729|NCT03248310|17-377|17-377
986730|NCT03248271|Diabetes|diabetes
986731|NCT03248271|Sarcopenia|sarcopenia
986732|NCT03248271|Hypotension|hypotension
986733|NCT03248271|Tilt Table Test|tilt table test
986734|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
986735|NCT03248258|Treatment Decision Making|treatment decision making
986736|NCT03248258|Shared Decision Making|shared decision making
986737|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
986738|NCT03248245|primary school|primary school
986739|NCT03248245|learning environment|learning environment
986740|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
986741|NCT03248245|teachers working ours|teachers working ours
986742|NCT03248245|pupils learning outcome|pupils learning outcome
986743|NCT03248245|cluster-randomized|cluster-randomized
986744|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
986745|NCT03248193|paclitaxel|paclitaxel
986746|NCT03248193|neuropathy|neuropathy
986747|NCT03248193|hypothermia|hypothermia
986748|NCT03248193|cryocompression|cryocompression
986749|NCT03248193|alopecia|alopecia
986750|NCT03248180|antipsychotic|antipsychotic
986751|NCT03248180|guided dose reduction|guided dose reduction
986752|NCT03248180|maintenance treatment|maintenance treatment
986753|NCT03248180|remitted psychosis|remitted psychosis
986754|NCT03248180|relapse|relapse
986755|NCT03248167|Cannabidiol|cannabidiol
986756|NCT03248154|Biofilm|biofilm
986757|NCT03248154|Procellera|procellera
986758|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
986759|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
986760|NCT03248141|Cross-sectional|cross-sectional
986761|NCT03248141|Epidemiological|epidemiological
986762|NCT03248141|Clinical practice|clinical practice
986763|NCT03248141|United States|united states
986764|NCT03248128|Fluticasone furoate|fluticasone furoate
986765|NCT03248128|Efficacy|efficacy
986766|NCT03248128|Vilanterol|vilanterol
986767|NCT03248128|Asthma|asthma
986768|NCT03248128|Safety|safety
986769|NCT03248128|GW642444|gw642444
986770|NCT03248128|GW685698|gw685698
986771|NCT03248115|polyphenols|polyphenols
986772|NCT03248115|green tea catechins|green tea catechins
986773|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
986774|NCT03248115|metabolism|metabolism
986775|NCT03248115|inter-individual variability|inter-individual variability
986776|NCT03248115|colonic microbiota|colonic microbiota
986777|NCT03248102|paediatric|paediatric
986778|NCT03248063|Staphylococcus aureus|staphylococcus aureus
986779|NCT03248063|bacteremia|bacteremia
986780|NCT03248063|cloxacillin|cloxacillin
986781|NCT03248063|cefazolin|cefazolin
986782|NCT03248024|Chronic Disease|chronic disease
986783|NCT03248024|Ulcerative Colitis|ulcerative colitis
986784|NCT03248011|hamstring|hamstring
986785|NCT03248011|ultrasound|ultrasound
986786|NCT03248011|intervention|intervention
986787|NCT03247998|Stroke|stroke
986788|NCT03247998|endovascular repair|endovascular repair
986789|NCT03247998|general anesthesia|general anesthesia
986790|NCT03247998|conscious sedation|conscious sedation
986791|NCT03247985|Mesh|mesh
986792|NCT03247985|Repair|repair
986793|NCT03247985|Peritoneal|peritoneal
986794|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
986795|NCT03247946|infant|infant
986796|NCT03247946|feeding position|feeding position
986797|NCT03247946|respiratory|respiratory
986799|NCT03247933|COPD|copd
986800|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
986801|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
986802|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
986803|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
986804|NCT03247842|post mastectomy pain|post mastectomy pain
986806|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
986807|NCT03247829|Hemodynamic Management|hemodynamic management
986808|NCT03247803|Air-Q® SP|air-q® sp
986809|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
986810|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
986811|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
986812|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
986813|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
986814|NCT03247777|golf|golf
986815|NCT03247777|strength training|strength training
986816|NCT03247777|physical performance tests|physical performance tests
986817|NCT03247777|body composition|body composition
986818|NCT03247738|ticagrelor|ticagrelor
986819|NCT03247738|cangrelor|cangrelor
986820|NCT03247712|HNSCC|hnscc
986821|NCT03247712|radiation|radiation
986822|NCT03247712|surgery|surgery
986823|NCT03247712|phase 1|phase 1
1658895|NCT00151021|Behavioral|behavioral
986824|NCT03247712|immunotherapy|immunotherapy
986825|NCT03247712|nivolumab|nivolumab
986826|NCT03247712|antibodies|antibodies
986827|NCT03247673|safety|safety
986828|NCT03247673|Pharmacokinetics|pharmacokinetics
986829|NCT03247673|Immunogenicity|immunogenicity
986830|NCT03247647|Alcohol Intervention|alcohol intervention
986831|NCT03247647|College Students|college students
986832|NCT03247634|getting ahead|getting ahead
986833|NCT03247634|vulnerable population|vulnerable population
986834|NCT03247634|safety net practice network|safety net practice network
986835|NCT03247621|external eating, technology|external eating, technology
986836|NCT03247608|Ambio Health|ambio health
986837|NCT03247595|Colonoscopy preparation|colonoscopy preparation
986838|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
986839|NCT03247582|Real World Evidence|real world evidence
986840|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
986841|NCT03247582|Observational Safety|observational safety
986842|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
986843|NCT03247569|Real World Evidence|real world evidence
986844|NCT03247569|Observational Safety|observational safety
986845|NCT03247491|Mindfulness|mindfulness
986846|NCT03247491|Compassion|compassion
986847|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
986848|NCT03247491|Prevention|prevention
986849|NCT03247491|Stress|stress
986850|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
986851|NCT03247478|axillary lymph node status|axillary lymph node status
986852|NCT03247452|Low fiber diet|low fiber diet
986853|NCT03247452|Colonoscopy|colonoscopy
986854|NCT03247452|Bowel Cleansing|bowel cleansing
986855|NCT03247439|CMC Joint|cmc joint
986856|NCT03247439|Osteoarthritis|osteoarthritis
986857|NCT03247439|Cartilage Replacement|cartilage replacement
986858|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
986859|NCT03247439|Damaged Articular Surface|damaged articular surface
986860|NCT03247439|LRTI|lrti
986861|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
986862|NCT03247387|Wearable device|wearable device
986863|NCT03247387|Patient monitor|patient monitor
986864|NCT03247374|rehabilitation|rehabilitation
986865|NCT03247374|treatment|treatment
986866|NCT03247374|biofeedback|biofeedback
986867|NCT03247374|bio-feedback|bio-feedback
986868|NCT03247374|dysphagia|dysphagia
986869|NCT03247374|swallowing disorders|swallowing disorders
986870|NCT03247374|post-stroke|post-stroke
986871|NCT03247374|deglutition disorders|deglutition disorders
986872|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
986873|NCT03247322|Medication Safety|medication safety
986874|NCT03247322|Mobile Health Technology|mobile health technology
986875|NCT03247309|T-cell therapy|t-cell therapy
986876|NCT03247309|immunotherapy|immunotherapy
986877|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
986878|NCT03247309|T-Cell Receptor|t-cell receptor
986879|NCT03247309|IMA201|ima201
986880|NCT03247309|Cytotherapy|cytotherapy
986881|NCT03247309|Cell Therapy|cell therapy
986882|NCT03247309|Gene Therapy|gene therapy
986883|NCT03247296|Daclatasvir|daclatasvir
986884|NCT03247296|HCC|hcc
986885|NCT03247296|HCV|hcv
986886|NCT03247296|Sofosbuvir|sofosbuvir
986887|NCT03247244|Cannabis|cannabis
986888|NCT03247244|Tics|tics
986889|NCT03247244|Tourette Syndrome|tourette syndrome
986890|NCT03247231|SUBEPITHELIAL TUMORS|subepithelial tumors
986891|NCT03247231|SUBMUCOSAL TUMORS|submucosal tumors
986892|NCT03247231|ENDOSCOPIC BAND LIGATION|endoscopic band ligation
986893|NCT03247205|hip fracture|hip fracture
986894|NCT03247205|cognitive impairment|cognitive impairment
986895|NCT03247205|physical therapy|physical therapy
986896|NCT03247192|resistance training|resistance training
986897|NCT03247192|protein supplementation|protein supplementation
986898|NCT03247192|aging|aging
986899|NCT03247192|Randomized Controlled Trial|randomized controlled trial
986900|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
986901|NCT03247127|brain metastases|brain metastases
986902|NCT03247127|memory preservation|memory preservation
987302|NCT03244449|clamp|clamp
986903|NCT03247127|neurocognitive function|neurocognitive function
986904|NCT03247088|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
986905|NCT03247088|Acute Myeloid Leukemia|acute myeloid leukemia
986906|NCT03247088|AML|aml
986907|NCT03247088|flt3 positive and negative|flt3 positive and negative
986908|NCT03247088|Stem cell transplant|stem cell transplant
986909|NCT03247088|Sorafenib|sorafenib
986910|NCT03247088|Nexavar|nexavar
986911|NCT03247088|BAY 43-9006|bay 43-9006
986912|NCT03247088|Busulfan|busulfan
986913|NCT03247088|Busulfex|busulfex
986914|NCT03247088|Myleran|myleran
986915|NCT03247088|Fludarabine|fludarabine
986916|NCT03247088|Fludarabine Phosphate|fludarabine phosphate
986917|NCT03247088|Fludara|fludara
986918|NCT03247088|Tacrolimus|tacrolimus
986919|NCT03247088|Prograf|prograf
986920|NCT03247088|Filgrastim|filgrastim
986921|NCT03247088|G-CSF|g-csf
986922|NCT03247088|Neupogen|neupogen
986923|NCT03247088|Mycophenolate mofetil|mycophenolate mofetil
986924|NCT03247088|MMF|mmf
986925|NCT03247088|CellCept|cellcept
986926|NCT03247075|Social anxiety disorder|social anxiety disorder
986927|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
986928|NCT03247075|Internet-delivered treatments|internet-delivered treatments
986929|NCT03247075|Children and adolescents|children and adolescents
986930|NCT03247075|Randomized controlled trial|randomized controlled trial
986931|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
986932|NCT03246997|Food Insecure|food insecure
986933|NCT03246958|Thyroid Cancer|thyroid cancer
986934|NCT03246932|peer expert or specialist|peer expert or specialist
986935|NCT03246932|psycho-education|psycho-education
986936|NCT03246932|schizophrenia|schizophrenia
986937|NCT03246932|outpatients|outpatients
986938|NCT03246893|Sepsis|sepsis
986939|NCT03246893|Septic shock|septic shock
986940|NCT03246893|Severe sepsis|severe sepsis
986941|NCT03246893|Extubation|extubation
986942|NCT03246893|Reintubation|reintubation
986943|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
986944|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
986945|NCT03246867|isolytic stretching|isolytic stretching
986946|NCT03246867|static stretching|static stretching
986947|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
986948|NCT03246854|DBPR112|dbpr112
986949|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
986950|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
986951|NCT03246854|maximum tolerated dose|maximum tolerated dose
986952|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
986953|NCT03246841|Oncogeneticists|oncogeneticists
986954|NCT03246841|Mutations|mutations
986955|NCT03246841|Breast Cancer|breast cancer
986956|NCT03246841|Ovarian cancer|ovarian cancer
986957|NCT03246828|gliclazide|gliclazide
986958|NCT03246828|glucagon|glucagon
986959|NCT03246828|diabetes|diabetes
986960|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
986961|NCT03246802|mpMRI|mpmri
986962|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
986963|NCT03246763|childhood obesity|childhood obesity
986964|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
986965|NCT03246724|Ocular surgery|ocular surgery
986966|NCT03246724|Intravenous sedation|intravenous sedation
986967|NCT03246724|Oral sedation|oral sedation
986968|NCT03246698|Stretching|stretching
986969|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
986970|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
986971|NCT03246672|obesity, morbid|obesity, morbid
986972|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
986973|NCT03246659|MTC|mtc
986974|NCT03246659|new gastrin analog|new gastrin analog
986975|NCT03246659|111In-CP04|111in-cp04
986976|NCT03246659|CP04 indium|cp04 indium
986977|NCT03246659|personalised diagnostics|personalised diagnostics
986978|NCT03246659|personalised therapy|personalised therapy
986979|NCT03246659|theranostics|theranostics
986980|NCT03246659|advanced MTC|advanced mtc
986981|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
986982|NCT03246646|Substance Abuse|substance abuse
986983|NCT03246646|Alcohol Abuse|alcohol abuse
986984|NCT03246620|emergency|emergency
986985|NCT03246620|emergency medicine|emergency medicine
986986|NCT03246620|sedation|sedation
986987|NCT03246620|acute agitation|acute agitation
986988|NCT03246594|atrial fibrillation|atrial fibrillation
986989|NCT03246594|esophageal probe|esophageal probe
986990|NCT03246594|thermolesion|thermolesion
986991|NCT03246581|inhalation|inhalation
986992|NCT03246581|anticholinergic|anticholinergic
986993|NCT03246568|Ablation|ablation
986994|NCT03246568|Renal Denervation|renal denervation
986995|NCT03246568|Cryoballoon|cryoballoon
986996|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
986997|NCT03246477|long-term results|long-term results
986998|NCT03246477|quality of life|quality of life
986999|NCT03246477|polysomnographic measurements|polysomnographic measurements
987000|NCT03246477|skeletal stability|skeletal stability
987097|NCT03245892|Paclitaxel|paclitaxel
987001|NCT03246464|Contact lenses|contact lenses
987002|NCT03246464|Children|children
987003|NCT03246464|Myopia|myopia
987004|NCT03246451|GLP-1|glp-1
987005|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
987006|NCT03246451|Metformin|metformin
987007|NCT03246451|Exendin(9-39)|exendin(9-39)
987008|NCT03246399|SM04690|sm04690
987009|NCT03246399|Wnt pathway|wnt pathway
987010|NCT03246399|Samumed|samumed
987011|NCT03246373|cognitive impairment|cognitive impairment
987012|NCT03246334|Cohort study|cohort study
987013|NCT03246334|Critical Care|critical care
987014|NCT03246334|Follow-up study|follow-up study
987015|NCT03246334|Intensive care units|intensive care units
987016|NCT03246334|Long-term outcome|long-term outcome
987017|NCT03246334|Outcome assessment|outcome assessment
987018|NCT03246334|Quality of life|quality of life
987019|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
987020|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
987021|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
987022|NCT03246321|Laparoscopy|laparoscopy
987023|NCT03246321|Aerosols|aerosols
987024|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
987025|NCT03246321|Antineoplastic Agents|antineoplastic agents
987026|NCT03246321|Leucovorin|leucovorin
987027|NCT03246321|Fluorouracil|fluorouracil
987028|NCT03246321|Platinum|platinum
987029|NCT03246321|Intraoperative Complications|intraoperative complications
987030|NCT03246321|Postoperative Complications|postoperative complications
987031|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
987032|NCT03246321|Metabolic Side Effects of Drugs and Substances|metabolic side effects of drugs and substances
987033|NCT03246321|Disease-free survival|disease-free survival
987034|NCT03246321|Survival|survival
987035|NCT03246321|Mortality|mortality
987036|NCT03246321|Quality of Life|quality of life
987037|NCT03246321|Costs and Cost Analysis|costs and cost analysis
987038|NCT03246321|Translational Medical Research|translational medical research
987039|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
987040|NCT03246321|PIPAC|pipac
987041|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
987042|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
987043|NCT03246321|Peritoneum|peritoneum
987044|NCT03246321|Cecal Neoplasms|cecal neoplasms
987045|NCT03246321|Clinical Trials, Phase I as topic|clinical trials, phase i as topic
987046|NCT03246295|Proteomics|proteomics
987047|NCT03246295|Metabolomics|metabolomics
987048|NCT03246256|acute|acute
987049|NCT03246256|informed consent|informed consent
987050|NCT03246256|thrombolysis|thrombolysis
987051|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
987052|NCT03246243|Bottle Feeding|bottle feeding
987053|NCT03246230|newborn vaccine responses|newborn vaccine responses
987054|NCT03246178|Haploidentical|haploidentical
987055|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
987056|NCT03246178|Severe aplastic anemia|severe aplastic anemia
987057|NCT03246152|Anti-VEGF safety|anti-vegf safety
987058|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
987059|NCT03246152|Diabetic Macular Edema|diabetic macular edema
987060|NCT03246152|OCTA|octa
987061|NCT03246139|stroke|stroke
987062|NCT03246139|neurorehabilitation|neurorehabilitation
987063|NCT03246139|mirror neuron system|mirror neuron system
987064|NCT03246139|action observation|action observation
987065|NCT03246139|motor imagery|motor imagery
987066|NCT03246139|MEG|meg
987067|NCT03246113|GBM WHO Grade IV|gbm who grade iv
987068|NCT03246100|centralized reminder/recall|centralized reminder/recall
987069|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
987070|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
987071|NCT03246087|acupuncture|acupuncture
987072|NCT03246087|plantar fasiosis|plantar fasiosis
987073|NCT03246074|Phase I|phase i
987074|NCT03246074|Ovarian Cancer|ovarian cancer
987075|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
987076|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
987077|NCT03246035|Heart Failure|heart failure
987078|NCT03246035|Frailty|frailty
987079|NCT03246035|Geriatrics|geriatrics
987080|NCT03246035|Self-care|self-care
987081|NCT03246035|Emergency Medicine|emergency medicine
987082|NCT03246035|Cardiology|cardiology
987083|NCT03246035|Patient Oriented Research|patient oriented research
987084|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
987085|NCT03246022|hypertension|hypertension
987086|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
987087|NCT03246009|Neutropenia|neutropenia
987088|NCT03246009|Chemotherapy|chemotherapy
987089|NCT03246009|rHSA/GCSF|rhsa/gcsf
987090|NCT03245996|sick sinus syndrome|sick sinus syndrome
987091|NCT03245996|heart rate|heart rate
987092|NCT03245996|aortic blood pressure|aortic blood pressure
987093|NCT03245996|artificial pacemaker|artificial pacemaker
987094|NCT03245944|immature AVF|immature avf
987095|NCT03245944|percutaneous intervention|percutaneous intervention
987096|NCT03245892|Nivolumab|nivolumab
987102|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
987104|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
987105|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
987106|NCT03245866|Switzerland|switzerland
987107|NCT03245853|Keratoconus|keratoconus
987108|NCT03245853|Corneal Crosslinking|corneal crosslinking
987109|NCT03245853|CXL|cxl
987110|NCT03245814|service dogs|service dogs
987111|NCT03245814|human-animal interaction|human-animal interaction
987112|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
987113|NCT03245801|Canada|canada
987114|NCT03245801|Registry|registry
987115|NCT03245801|Clinical outcomes|clinical outcomes
987116|NCT03245801|Adverse events|adverse events
987117|NCT03245801|CAPRI|capri
987118|NCT03245788|Lay Navigator|lay navigator
987119|NCT03245788|Quality of Care|quality of care
987120|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
987121|NCT03245775|health disparities|health disparities
987122|NCT03245775|community-based participatory research|community-based participatory research
987123|NCT03245749|omega-3 status|omega-3 status
987124|NCT03245749|blood lipids|blood lipids
987125|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
987126|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
987127|NCT03245723|premature adults|premature adults
987128|NCT03245723|premature|premature
987129|NCT03245723|premature lung function|premature lung function
987130|NCT03245723|premature cardiac function|premature cardiac function
987131|NCT03245723|MRI|mri
987132|NCT03245723|PET|pet
987133|NCT03245697|breast milk|breast milk
987134|NCT03245697|composition|composition
987135|NCT03245697|Galicia|galicia
987136|NCT03245697|diet|diet
987137|NCT03245697|lactation|lactation
987138|NCT03245684|ARDS|ards
987139|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
987140|NCT03245684|cytokines|cytokines
987141|NCT03245684|mechanical ventilation|mechanical ventilation
987142|NCT03245645|FODMAP|fodmap
987143|NCT03245645|IBS|ibs
987144|NCT03245645|Diet|diet
987145|NCT03245645|Re-introduction|re-introduction
987146|NCT03245645|Fructose|fructose
987152|NCT03245606|NAFLD|nafld
987153|NCT03245606|steatosis|steatosis
987154|NCT03245606|fibrosis|fibrosis
987155|NCT03245606|transient elastography|transient elastography
987156|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
987157|NCT03245554|Propranolol|propranolol
987158|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
987159|NCT03245502|tissue oxygenation|tissue oxygenation
987160|NCT03245450|eribulin mesilate|eribulin mesilate
987161|NCT03245450|irinotecan|irinotecan
987162|NCT03245450|combination therapy|combination therapy
987163|NCT03245450|children|children
987164|NCT03245437|Social Cognition|social cognition
987165|NCT03245437|Oxytocin|oxytocin
987166|NCT03245372|cardiac output|cardiac output
987167|NCT03245372|perioperative care|perioperative care
987168|NCT03245372|postoperative complications|postoperative complications
987169|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
987170|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
987171|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
987172|NCT03245294|cervical epidural space|cervical epidural space
987173|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
987174|NCT03245281|Heart Failure|heart failure
987175|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
987176|NCT03245268|BPA|bpa
987177|NCT03245255|pressure measurements|pressure measurements
987178|NCT03245255|blood pressure|blood pressure
987179|NCT03245255|contrast echocardiography|contrast echocardiography
987180|NCT03245255|ventricular pressures|ventricular pressures
987181|NCT03245255|catheterization|catheterization
987182|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
987183|NCT03245242|urologic reconstruction|urologic reconstruction
987184|NCT03245242|pediatric urology|pediatric urology
987185|NCT03245242|bladder augmentation|bladder augmentation
987186|NCT03245242|Mitrofanoff|mitrofanoff
987187|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
987188|NCT03245242|appendicovesicostomy|appendicovesicostomy
987189|NCT03245242|ileovesicostomy|ileovesicostomy
987190|NCT03245242|appendicocecostomy|appendicocecostomy
987191|NCT03245216|Parkinson's Disease|parkinson's disease
987192|NCT03245216|motor learning|motor learning
987193|NCT03245216|aerobic exercise|aerobic exercise
987194|NCT03245216|cardiovascular exercise|cardiovascular exercise
987195|NCT03245216|balance|balance
987196|NCT03245216|postural instability|postural instability
987197|NCT03245216|motor skill|motor skill
987198|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
987199|NCT03245164|obese children|obese children
987200|NCT03245164|motor skills|motor skills
987201|NCT03245164|physiotherapy|physiotherapy
987202|NCT03245164|basketball|basketball
987203|NCT03245151|pediatrics|pediatrics
987204|NCT03245151|central nervous system tumors|central nervous system tumors
987205|NCT03245151|lenvatinib|lenvatinib
987207|NCT03245151|everolimus|everolimus
987208|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
987209|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
987210|NCT03245151|high grade glioma|high grade glioma
987211|NCT03245151|solid tumors|solid tumors
987212|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
987213|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
987214|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
987215|NCT03245060|psychosocial well-being|psychosocial well-being
987216|NCT03245060|solution focused brief therapy|solution focused brief therapy
987217|NCT03245034|Medical Residents|medical residents
987218|NCT03245034|Well-Being|well-being
987219|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
987220|NCT03244995|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
987221|NCT03244995|High grade glioma|high grade glioma
987222|NCT03244995|HGG|hgg
987223|NCT03244995|Couple-based mind-body program|couple-based mind-body program
987224|NCT03244995|CBMB|cbmb
987225|NCT03244995|Waitlist Control Group|waitlist control group
987226|NCT03244995|Questionnaires|questionnaires
987227|NCT03244995|Surveys|surveys
987228|NCT03244995|Mind-Body Intervention|mind-body intervention
987229|NCT03244995|Compact Discs (CD's)|compact discs (cd's)
987230|NCT03244995|Printed Materials|printed materials
987231|NCT03244995|Phone calls|phone calls
987232|NCT03244982|fluorescein|fluorescein
987233|NCT03244982|angiography|angiography
987234|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
987235|NCT03244917|Nursing home|nursing home
987236|NCT03244917|Palliative Care|palliative care
987237|NCT03244917|Dementia|dementia
987238|NCT03244917|Infection|infection
987239|NCT03244917|Antimicrobials|antimicrobials
987240|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
987241|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
987242|NCT03244852|OCD|ocd
987243|NCT03244852|deep brain stimulation|deep brain stimulation
987244|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
987245|NCT03244826|Cancer|cancer
987246|NCT03244800|0382, T2DM|0382, t2dm
987247|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
987248|NCT03244761|modified interface|modified interface
987249|NCT03244735|Ketogenic Diet|ketogenic diet
987250|NCT03244709|Giant cell arteritis,|giant cell arteritis,
987251|NCT03244709|Tocilizumab|tocilizumab
987252|NCT03244709|Aortitis|aortitis
987253|NCT03244709|Remission|remission
987254|NCT03244696|Multiple Sclerosis|multiple sclerosis
987255|NCT03244696|Sclerosis|sclerosis
987256|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
987257|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
987258|NCT03244696|Nervous System Diseases|nervous system diseases
987259|NCT03244696|Demyelinating Diseases|demyelinating diseases
987260|NCT03244696|Immune System Diseases|immune system diseases
987261|NCT03244696|Physical Activity|physical activity
987262|NCT03244696|Walking|walking
987263|NCT03244696|Hydration|hydration
987264|NCT03244696|Lifestyle Intervention|lifestyle intervention
987265|NCT03244696|Health Behavior Tracking|health behavior tracking
987266|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
987267|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
987268|NCT03244670|Myopia|myopia
987269|NCT03244644|C Difficile Colitis|c difficile colitis
987270|NCT03244644|Clostridium Difficile|clostridium difficile
987271|NCT03244644|CDI|cdi
987272|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
987273|NCT03244644|Fecal Transplant|fecal transplant
987274|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
987275|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
987276|NCT03244644|Diarrhea|diarrhea
987277|NCT03244644|FMT|fmt
987278|NCT03244644|Microbial Suspension|microbial suspension
987279|NCT03244592|Minocycline|minocycline
987280|NCT03244566|positron emission tomography|positron emission tomography
987281|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
987282|NCT03244540|postoperative pain|postoperative pain
987283|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
987284|NCT03244540|quadratus lumborum block|quadratus lumborum block
987285|NCT03244540|neuropathic pain|neuropathic pain
987286|NCT03244527|BCAA|bcaa
987287|NCT03244527|stroke|stroke
987288|NCT03244527|mobility|mobility
987289|NCT03244514|cardiac surgery|cardiac surgery
987290|NCT03244514|KDIGO-Guideline|kdigo-guideline
987291|NCT03244501|tSMS|tsms
987292|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
987293|NCT03244501|healthy control|healthy control
987294|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
987295|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
987296|NCT03244475|neurofeedback|neurofeedback
987297|NCT03244475|magnetoencephalography|magnetoencephalography
987298|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
987299|NCT03244449|biomarker|biomarker
987300|NCT03244449|insulin resistance|insulin resistance
987304|NCT03244423|Cyanotic heart disease|cyanotic heart disease
987305|NCT03244423|Tranexamic acid|tranexamic acid
987306|NCT03244423|Postoperative blood loss|postoperative blood loss
987307|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
987308|NCT03244358|Epalrestat|epalrestat
987309|NCT03244306|leukemia|leukemia
987310|NCT03244306|CD 22|cd 22
987311|NCT03244306|CAR T cell|car t cell
987312|NCT03244306|pediatric|pediatric
987313|NCT03244306|young adult|young adult
987314|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
987315|NCT03244267|Orthopedics|orthopedics
987316|NCT03244254|Celiac Disease|celiac disease
987317|NCT03244254|Children|children
987318|NCT03244254|I-FABP|i-fabp
987319|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
987320|NCT03244228|First in human|first in human
987321|NCT03244228|Multiple ascending dose|multiple ascending dose
987322|NCT03244228|Single ascending dose|single ascending dose
987323|NCT03244215|Recurrence of stroke|recurrence of stroke
987324|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
987325|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
987326|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
987327|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
987328|NCT03244202|Incidental Findings|incidental findings
987329|NCT03244202|Decision Aids|decision aids
987330|NCT03244202|Genomic Sequencing|genomic sequencing
987331|NCT03244202|Randomized Controlled Trail|randomized controlled trail
987332|NCT03244202|Genetic Counselling|genetic counselling
987333|NCT03244189|Urinary Stone Disease|urinary stone disease
987334|NCT03244189|Kidney Stone|kidney stone
987335|NCT03244189|Urinary Calculi|urinary calculi
987336|NCT03244176|DLBCL|dlbcl
987337|NCT03244163|Spyglass DS|spyglass ds
987338|NCT03244163|Laser lithotripsy|laser lithotripsy
987339|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
987340|NCT03244150|Physical activity|physical activity
987341|NCT03244150|Obesity|obesity
987342|NCT03244150|Overweight|overweight
987343|NCT03244150|Lifestyle|lifestyle
987344|NCT03244150|Diet|diet
987345|NCT03244124|dentin bonding agents|dentin bonding agents
987346|NCT03244124|tooth sensitivity|tooth sensitivity
987347|NCT03244124|composite resin restoration|composite resin restoration
987348|NCT03244059|COPD|copd
987349|NCT03244059|belimumab|belimumab
987350|NCT03244059|biologic agent|biologic agent
987351|NCT03244059|GRP78|grp78
987352|NCT03244046|Low Back pain|low back pain
987353|NCT03244046|Pain|pain
987354|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
987355|NCT03244046|PTSD|ptsd
987356|NCT03244046|Somatic Experiencing|somatic experiencing
987357|NCT03244046|SE|se
987358|NCT03244033|context|context
987359|NCT03244033|contextual error|contextual error
987360|NCT03244033|contextual care|contextual care
987361|NCT03244033|electronic medical record|electronic medical record
987362|NCT03244033|clinical decision support|clinical decision support
987363|NCT03244007|macular hole|macular hole
987364|NCT03244007|lamellar macular hole|lamellar macular hole
987365|NCT03243994|Cor pulmonale|cor pulmonale
987366|NCT03243994|COPD|copd
987367|NCT03243994|Malabsorption|malabsorption
987368|NCT03243994|D-xylose|d-xylose
987369|NCT03243994|Zinc|zinc
987370|NCT03243955|acupuncture|acupuncture
987371|NCT03243955|TENS|tens
987372|NCT03243955|TEAS|teas
987373|NCT03243955|constipation|constipation
987374|NCT03243955|transcutaneous|transcutaneous
987375|NCT03243942|pressure measurements|pressure measurements
987376|NCT03243942|blood pressure|blood pressure
987377|NCT03243942|contrast echocardiography|contrast echocardiography
987378|NCT03243942|ventricular pressures|ventricular pressures
987379|NCT03243942|catheterization|catheterization
987380|NCT03243916|interventional therapy|interventional therapy
987381|NCT03243916|TACE|tace
987382|NCT03243916|Cyberknife|cyberknife
987383|NCT03243903|T2DM|t2dm
987384|NCT03243903|QS-M needle free injector|qs-m needle free injector
987385|NCT03243903|insulin pen|insulin pen
987386|NCT03243903|effective|effective
987387|NCT03243903|safety|safety
987388|NCT03243877|Screening|screening
987389|NCT03243877|Mammography|mammography
987390|NCT03243851|Glioblastoma|glioblastoma
987391|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
987392|NCT03243838|apatinib|apatinib
987393|NCT03243838|pCR|pcr
987394|NCT03243838|OS|os
987395|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
987396|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
987397|NCT03243825|brachytherapy|brachytherapy
987398|NCT03243825|radiotherapy|radiotherapy
987399|NCT03243812|Sickle Cell Disease|sickle cell disease
987400|NCT03243812|Muscle function|muscle function
987401|NCT03243812|Hemorheological disorders|hemorheological disorders
987402|NCT03243760|CCI15106|cci15106
987403|NCT03243760|pharmacokinetics|pharmacokinetics
987404|NCT03243760|BAL|bal
987405|NCT03243760|COPD|copd
987406|NCT03243734|spray cryotherapy|spray cryotherapy
987407|NCT03243734|quality of life|quality of life
987408|NCT03243734|symptom reduction|symptom reduction
987409|NCT03243734|esophageal malignancies|esophageal malignancies
987410|NCT03243734|liquid nitrogen|liquid nitrogen
987411|NCT03243734|ablation|ablation
987412|NCT03243721|multiple sclerosis|multiple sclerosis
987413|NCT03243721|thalamus|thalamus
987414|NCT03243721|high field MRI|high field mri
987415|NCT03243721|cognition|cognition
987416|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
987417|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
987418|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
987419|NCT03243682|Bidirectional|bidirectional
987421|NCT03243669|Colonoscopy|colonoscopy
987422|NCT03243669|High-definition endoscopy|high-definition endoscopy
987423|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
987424|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
987425|NCT03243604|Cardiotoxicity|cardiotoxicity
987426|NCT03243604|abiraterone acetate|abiraterone acetate
987427|NCT03243604|androgen antagonist|androgen antagonist
987428|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
987429|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
987430|NCT03243565|children|children
987431|NCT03243565|respiratory tract infection|respiratory tract infection
987432|NCT03243565|adenotonsillectomy|adenotonsillectomy
987433|NCT03243565|OM-85|om-85
987434|NCT03243539|lung protective ventilation|lung protective ventilation
987435|NCT03243500|atracurium|atracurium
987436|NCT03243500|high myopes|high myopes
987437|NCT03243500|percaruncular|percaruncular
987438|NCT03243500|phacoemulsification|phacoemulsification
987439|NCT03243500|medial canthal|medial canthal
987440|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
987441|NCT03243461|Glioblastoma|glioblastoma
987442|NCT03243461|high grade glioma|high grade glioma
987443|NCT03243461|brain tumor|brain tumor
987444|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
987445|NCT03243461|DIPG|dipg
987446|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
987447|NCT03243461|Diffuse midline glioma|diffuse midline glioma
987448|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
987449|NCT03243409|clinical complications|clinical complications
987450|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
987451|NCT03243396|Mental health|mental health
987452|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
987453|NCT03243396|Task-shifting|task-shifting
987454|NCT03243396|Global health|global health
987455|NCT03243396|Teacher|teacher
987456|NCT03243396|Community health volunteer|community health volunteer
987457|NCT03243396|Children|children
987458|NCT03243396|Orphans|orphans
987459|NCT03243396|Abandoned children|abandoned children
987460|NCT03243396|TF-CBT|tf-cbt
987461|NCT03243396|Mental health policy|mental health policy
987462|NCT03243396|Ministry of Education|ministry of education
987463|NCT03243396|Ministry of Health|ministry of health
987464|NCT03243396|Delivery|delivery
987465|NCT03243396|Implementation science|implementation science
987466|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
987467|NCT03243396|Implementation practices and policies|implementation practices and policies
987468|NCT03243396|Youth|youth
987469|NCT03243396|Adoption|adoption
987470|NCT03243396|Fidelity|fidelity
987471|NCT03243396|Kenya|kenya
987472|NCT03243396|Bungoma|bungoma
987473|NCT03243396|Kanduyi|kanduyi
987474|NCT03243396|East Africa|east africa
987475|NCT03243396|Posttraumatic stress|posttraumatic stress
987476|NCT03243396|Childhood traumatic grief|childhood traumatic grief
987477|NCT03243396|Grief|grief
987478|NCT03243396|Trauma|trauma
987479|NCT03243383|readmission|readmission
987480|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
987481|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
987482|NCT03243331|Breast Cancer|breast cancer
987483|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
987484|NCT03243292|Alair|alair
987485|NCT03243292|Registry|registry
987486|NCT03243227|carpal tunnel syndrome|carpal tunnel syndrome
987487|NCT03243227|neurodynamics|neurodynamics
987488|NCT03243227|median nerve gliding exercise|median nerve gliding exercise
987489|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
988178|NCT03238794|bile acid|bile acid
987490|NCT03243188|Palliative Care|palliative care
987491|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
987492|NCT03243175|atrial fibrillation|atrial fibrillation
987493|NCT03243175|microhemorrhage|microhemorrhage
987494|NCT03243175|oral anticoagulation|oral anticoagulation
987495|NCT03243175|left atrial appendage closure|left atrial appendage closure
987497|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
987498|NCT03243084|low back pain|low back pain
987499|NCT03243084|chronic pain|chronic pain
987500|NCT03243084|alpha oscillations|alpha oscillations
987501|NCT03243084|heart rate variability|heart rate variability
987502|NCT03243071|Medical Care|medical care
987503|NCT03243071|Racial Discrimination|racial discrimination
987504|NCT03243071|Poor Health Literacy|poor health literacy
987505|NCT03243071|Medical Care Disparities|medical care disparities
987506|NCT03243045|Arterial hypertension|arterial hypertension
987507|NCT03243045|Microcirculation|microcirculation
987508|NCT03243045|Sympathetic nervous system|sympathetic nervous system
987509|NCT03243019|cervico-facial|cervico-facial
987510|NCT03243019|rapamycin|rapamycin
987511|NCT03243006|acute pain|acute pain
987512|NCT03243006|emergency department|emergency department
987513|NCT03243006|opioid consumption|opioid consumption
987514|NCT03242980|HIV|hiv
987515|NCT03242980|Adherence|adherence
987516|NCT03242980|Viral re-suppression|viral re-suppression
987517|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
987518|NCT03242967|Anemia|anemia
987519|NCT03242967|hemoglobin|hemoglobin
987520|NCT03242967|darbepoetin alfa|darbepoetin alfa
987521|NCT03242967|TIW|tiw
987522|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
987523|NCT03242967|HIF-PHI|hif-phi
987524|NCT03242967|AKB-6548|akb-6548
987525|NCT03242967|vadadustat|vadadustat
987526|NCT03242967|renal|renal
987527|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
987528|NCT03242967|HIF|hif
987529|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
987530|NCT03242967|CKD|ckd
987531|NCT03242967|DD-CKD|dd-ckd
987532|NCT03242967|kidney|kidney
987533|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
987534|NCT03242967|ESA|esa
987535|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
987536|NCT03242902|light therapy|light therapy
987537|NCT03242902|cancer related fatigue|cancer related fatigue
987538|NCT03242902|sleep quality|sleep quality
987539|NCT03242902|biological rhythms|biological rhythms
987540|NCT03242850|Reading|reading
987541|NCT03242850|Text Messages|text messages
987542|NCT03242850|Video|video
987543|NCT03242850|Cognitive Development|cognitive development
987544|NCT03242850|Child Development|child development
987545|NCT03242850|Infants|infants
987546|NCT03242811|Medical age assessment|medical age assessment
987547|NCT03242798|liver cirrhosis|liver cirrhosis
987548|NCT03242798|malnutrition|malnutrition
987549|NCT03242798|nutritional status|nutritional status
987550|NCT03242798|nutritional assessment|nutritional assessment
987551|NCT03242785|Self-monitoring|self-monitoring
987552|NCT03242785|Education|education
987553|NCT03242785|Self-titration|self-titration
987554|NCT03242785|antihypertensives|antihypertensives
987555|NCT03242746|LEEP|leep
987556|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
987557|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
987558|NCT03242746|pregnancy outcome|pregnancy outcome
987559|NCT03242733|Gastroparesis|gastroparesis
987560|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
987561|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
987562|NCT03242694|catheter ablation|catheter ablation
987563|NCT03242694|left atrial function|left atrial function
987564|NCT03242694|left atrial pressure|left atrial pressure
987565|NCT03242694|voltage map|voltage map
987566|NCT03242694|strain|strain
987567|NCT03242694|scar|scar
987568|NCT03242694|success|success
987569|NCT03242694|biomarker|biomarker
987570|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
987571|NCT03242642|Heart disease|heart disease
987572|NCT03242642|valve disease|valve disease
987573|NCT03242642|heart valve disease|heart valve disease
987574|NCT03242642|mitral regurgitation|mitral regurgitation
987575|NCT03242642|cardiovascular disease|cardiovascular disease
987576|NCT03242642|mitral insufficiency|mitral insufficiency
987577|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
987578|NCT03242629|chloral hydrate|chloral hydrate
987579|NCT03242629|Effects Comparison|effects comparison
987580|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
987581|NCT03242603|Anti-GD2|anti-gd2
987582|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
987583|NCT03242603|Immunotherapy|immunotherapy
987584|NCT03242538|Exercise|exercise
987585|NCT03242512|RANKL|rankl
987586|NCT03242512|osteoporosis|osteoporosis
987587|NCT03242512|bone resorption|bone resorption
987588|NCT03242512|post-menopausal women|post-menopausal women
987589|NCT03242512|TK006|tk006
987590|NCT03242434|Mannitol|mannitol
987591|NCT03242434|Intestinal permeability|intestinal permeability
987592|NCT03242434|Thermal injury|thermal injury
987593|NCT03242434|HESTIA|hestia
987594|NCT03242434|Sucralose|sucralose
987595|NCT03242434|Lactulose|lactulose
987596|NCT03242421|test-retest reliability|test-retest reliability
987597|NCT03242421|Binocular vision tests|binocular vision tests
987598|NCT03242395|Neuroinflammation|neuroinflammation
987599|NCT03242395|fMRI|fmri
987600|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
987601|NCT03242395|Systemic inflammation|systemic inflammation
987602|NCT03242395|Severe burns|severe burns
987606|NCT03242369|colorectal neoplasia|colorectal neoplasia
987607|NCT03242369|colonoscopy|colonoscopy
987608|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
987609|NCT03242369|bowel preparation|bowel preparation
987610|NCT03242330|Implant survival|implant survival
987611|NCT03242330|Patient satisfaction|patient satisfaction
987612|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
987613|NCT03242278|Prevention|prevention
987614|NCT03242278|Stroke|stroke
987615|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
987616|NCT03242239|Trastuzumab|trastuzumab
987617|NCT03242239|Biosimilar|biosimilar
987618|NCT03242226|+3.00ADD|+3.00add
987619|NCT03242226|single vision spectacle|single vision spectacle
987620|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
987621|NCT03242200|young adult female|young adult female
987622|NCT03242200|mobile app|mobile app
987623|NCT03242200|questionnaire|questionnaire
987624|NCT03242200|health tracking|health tracking
987625|NCT03242187|Minimally invasive surgery|minimally invasive surgery
987626|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
987627|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
987628|NCT03242070|Patient Portals|patient portals
987629|NCT03242070|Chronic Disease|chronic disease
987630|NCT03242070|Older Adults|older adults
987631|NCT03242057|NAVA|nava
987632|NCT03242057|Extubation|extubation
987633|NCT03242057|NIPPV|nippv
987634|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
987635|NCT03241992|IBD|ibd
987636|NCT03241992|Electronic Health Record|electronic health record
987637|NCT03241992|Patient Portal|patient portal
987638|NCT03241992|Quality of Life|quality of life
987639|NCT03241966|Parkinson's Disease|parkinson's disease
987640|NCT03241966|Online Study|online study
987641|NCT03241966|Quality of Life|quality of life
987642|NCT03241966|Activities of Daily Living|activities of daily living
987643|NCT03241966|Perception|perception
987644|NCT03241966|Cognition|cognition
987645|NCT03241966|Gait|gait
987646|NCT03241927|Pembrolizumab|pembrolizumab
987647|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
987648|NCT03241927|PD-1|pd-1
987649|NCT03241927|Unresectable|unresectable
987650|NCT03241927|Stage III|stage iii
987651|NCT03241927|Stage IV|stage iv
987652|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
987653|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
987654|NCT03241888|megestrol acetate|megestrol acetate
987655|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
987656|NCT03241875|pregabalin|pregabalin
987657|NCT03241875|gabapentin|gabapentin
987658|NCT03241875|post operative pain|post operative pain
987659|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
987660|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
987661|NCT03241797|AIP|aip
987662|NCT03241797|EUS-FNA|eus-fna
987663|NCT03241784|ALS|als
987664|NCT03241784|T-Regulatory Cells|t-regulatory cells
987665|NCT03241745|Nivolumab|nivolumab
987666|NCT03241745|17-180|17-180
987667|NCT03241732|Traumatic Brain Injury|traumatic brain injury
987668|NCT03241732|TBI|tbi
987669|NCT03241732|Brain Trauma|brain trauma
987670|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
987671|NCT03241732|Concussion|concussion
987672|NCT03241732|NAC|nac
987673|NCT03241732|Integrative Medicine|integrative medicine
987674|NCT03241732|EEG|eeg
987675|NCT03241732|electroencephalogram|electroencephalogram
987676|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
987677|NCT03241732|fMRI|fmri
987678|NCT03241732|PET|pet
987679|NCT03241732|Positron emission tomography|positron emission tomography
987680|NCT03241732|MRI|mri
987681|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
987682|NCT03241706|hypoglycemia|hypoglycemia
987683|NCT03241706|type 1 diabetes|type 1 diabetes
987684|NCT03241706|liver glucose metabolism|liver glucose metabolism
987685|NCT03241628|Skin blisters|skin blisters
987686|NCT03241628|Finger webbing|finger webbing
987687|NCT03241628|Finger contracture|finger contracture
987688|NCT03241628|Hand contracture|hand contracture
987689|NCT03241589|Teledermatology|teledermatology
987690|NCT03241589|Telehealth|telehealth
987691|NCT03241589|Dermatology|dermatology
987692|NCT03241589|Telemedicine|telemedicine
987693|NCT03241589|Mobile Application|mobile application
987694|NCT03241550|invasive fungal disease|invasive fungal disease
987695|NCT03241550|Cresemba®|cresemba®
987696|NCT03241550|Hematological malignancy|hematological malignancy
987697|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
987698|NCT03241550|ASP9766|asp9766
987699|NCT03241550|isavuconazole|isavuconazole
987700|NCT03241550|pediatric population|pediatric population
987701|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
987702|NCT03241524|Physical Therapy|physical therapy
987703|NCT03241524|Sexual function evaluation|sexual function evaluation
987799|NCT03240926|COPD Exacerbation|copd exacerbation
987704|NCT03241511|Periodontitis, End Stage Renal Disease, Periodontal treatment|periodontitis, end stage renal disease, periodontal treatment
987705|NCT03241498|Medicines optimisation|medicines optimisation
987706|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
987707|NCT03241498|HRQOL|hrqol
987708|NCT03241498|Pharmacist-led|pharmacist-led
987709|NCT03241498|GP based|gp based
987710|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
987712|NCT03241459|Peripheral Artery Disease|peripheral artery disease
987713|NCT03241459|PAD|pad
987714|NCT03241459|Paclitaxel|paclitaxel
987715|NCT03241433|Exercise|exercise
987716|NCT03241394|Monocyte subsets|monocyte subsets
987717|NCT03241394|Obesity|obesity
987718|NCT03241394|Metabolic Syndrome|metabolic syndrome
987719|NCT03241381|observational sample|observational sample
987720|NCT03241368|Irritable Bowel Disease|irritable bowel disease
987721|NCT03241368|IBD|ibd
987722|NCT03241368|Mucosal Disease|mucosal disease
987723|NCT03241329|Endometriosis|endometriosis
987724|NCT03241329|Metabolomics|metabolomics
987725|NCT03241329|Transcriptomics|transcriptomics
987726|NCT03241329|Follicular fluid|follicular fluid
987727|NCT03241329|Cumulus cells|cumulus cells
987728|NCT03241329|Oocyte quality|oocyte quality
987729|NCT03241316|qualitative and survey research|qualitative and survey research
987730|NCT03241303|Glp-1|glp-1
987731|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
987732|NCT03241303|acarbose|acarbose
987733|NCT03241290|C-arm|c-arm
987734|NCT03241290|Medical Imaging Device|medical imaging device
987735|NCT03241290|Radiological|radiological
987736|NCT03241277|social phobia|social phobia
987737|NCT03241277|anxiety disorders|anxiety disorders
987738|NCT03241277|DSM-IV TR|dsm-iv tr
987739|NCT03241277|periodontal disease|periodontal disease
987740|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
987741|NCT03241251|psychosocial risk|psychosocial risk
987742|NCT03241225|Elder abuse|elder abuse
987743|NCT03241225|Depression|depression
987744|NCT03241225|Mental health|mental health
987745|NCT03241212|adolescent|adolescent
987746|NCT03241212|young adult|young adult
987747|NCT03241212|knowledge|knowledge
987748|NCT03241212|self-care|self-care
987749|NCT03241186|Ipilimumab|ipilimumab
987750|NCT03241186|Nivolumab|nivolumab
987751|NCT03241186|OPDIVO|opdivo
987752|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
987753|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
987754|NCT03241173|endometrial cancer|endometrial cancer
987755|NCT03241173|esophageal cancer|esophageal cancer
987756|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
987757|NCT03241173|melanoma|melanoma
987758|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
987759|NCT03241173|mesothelioma|mesothelioma
987760|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
987761|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
987762|NCT03241173|ovarian cancer|ovarian cancer
987763|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
987764|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
987765|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
987766|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
987767|NCT03241173|TNBC|tnbc
987768|NCT03241173|urothelial carcinoma|urothelial carcinoma
987769|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
987770|NCT03241173|SCCHN|scchn
987771|NCT03241173|MSI-H CRC|msi-h crc
987772|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
987773|NCT03241134|Dry needling|dry needling
987774|NCT03241134|Sham needling|sham needling
987775|NCT03241134|Office workers|office workers
987776|NCT03241134|Myofascial pain|myofascial pain
987777|NCT03241134|Surface electromyography|surface electromyography
987778|NCT03241121|Time Restricted Feeding|time restricted feeding
987779|NCT03241121|Eating patterns|eating patterns
987780|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
987781|NCT03241095|Golf|golf
987782|NCT03241069|bio-impedance|bio-impedance
987783|NCT03241069|BIOPAC system|biopac system
987784|NCT03241069|dyspnea|dyspnea
987785|NCT03241069|acute heart failure|acute heart failure
987786|NCT03241043|Pharmacokinetic study|pharmacokinetic study
987787|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
987788|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
987789|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
987790|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
987791|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
987792|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
987793|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
987794|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
987795|NCT03240991|quality of life|quality of life
987796|NCT03240939|Dutasteride|dutasteride
987797|NCT03240939|Tadalafil|tadalafil
987798|NCT03240926|COPD|copd
987800|NCT03240926|COPD Asthma|copd asthma
987801|NCT03240926|COPD Bronchitis|copd bronchitis
987802|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
987803|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
987804|NCT03240874|Gestational Diabetes|gestational diabetes
987805|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
987806|NCT03240861|T cells|t cells
987807|NCT03240861|stem cells|stem cells
987808|NCT03240861|gene therapy|gene therapy
987809|NCT03240861|NYESO|nyeso
987810|NCT03240848|congenital cataract|congenital cataract
987811|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
987812|NCT03240835|pre-Albumin|pre-albumin
987813|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
987814|NCT03240835|Transferrin|transferrin
987815|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
987816|NCT03240835|nutrition|nutrition
987817|NCT03240822|Penile Trauma|penile trauma
987818|NCT03240822|Allotransplantation|allotransplantation
987819|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
987820|NCT03240822|VCA|vca
987821|NCT03240822|Genital Trauma|genital trauma
987822|NCT03240822|Penile Transplantation|penile transplantation
987823|NCT03240822|Amputation|amputation
987824|NCT03240822|Penile Injury|penile injury
987825|NCT03240796|dense cataract|dense cataract
987826|NCT03240796|intraocular lens implantation|intraocular lens implantation
987827|NCT03240796|traditional cataract surgery|traditional cataract surgery
987828|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
987829|NCT03240783|Oral Dexamethasone|oral dexamethasone
987830|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
987831|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
987832|NCT03240783|Betamethasone injectable|betamethasone injectable
987833|NCT03240783|Dexamethasone injectable|dexamethasone injectable
987834|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
987835|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
987836|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
987837|NCT03240770|HFV|hfv
987838|NCT03240770|HFA|hfa
987839|NCT03240770|High Frequency Vibration|high frequency vibration
987840|NCT03240757|meal absorption|meal absorption
987841|NCT03240757|exercise|exercise
987842|NCT03240757|energy balance|energy balance
987843|NCT03240757|lipolysis|lipolysis
987844|NCT03240744|immunogenicity|immunogenicity
987845|NCT03240744|safety|safety
987846|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
987847|NCT03240731|sickle cell disease|sickle cell disease
987848|NCT03240731|haploidentical|haploidentical
987849|NCT03240731|graft|graft
987850|NCT03240731|marrow|marrow
987851|NCT03240705|Stress|stress
987852|NCT03240705|Medical education|medical education
987853|NCT03240692|Major Depressive Disorder|major depressive disorder
987854|NCT03240692|Treatment Resistant Depression|treatment resistant depression
987855|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
987856|NCT03240692|Theta Burst|theta burst
987857|NCT03240679|Barrett's esophagus|barrett's esophagus
987858|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
987859|NCT03240640|Inspiratory muscle training|inspiratory muscle training
987860|NCT03240640|COPD|copd
987861|NCT03240640|Dyspnea|dyspnea
987862|NCT03240640|Balance|balance
987863|NCT03240562|serratus anterior plane block|serratus anterior plane block
987864|NCT03240562|ultrasound-guided|ultrasound-guided
987865|NCT03240562|regional anesthesia|regional anesthesia
987866|NCT03240562|thoracic surgery|thoracic surgery
987867|NCT03240562|postoperative pain|postoperative pain
987868|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
987869|NCT03240549|Bevacizumab|bevacizumab
987870|NCT03240549|First line chemotherapy|first line chemotherapy
987871|NCT03240549|Stable disease|stable disease
987872|NCT03240536|Rheumatology Referral|rheumatology referral
987873|NCT03240536|Choosing Wisely|choosing wisely
987874|NCT03240510|Breast cancer|breast cancer
987875|NCT03240510|Male|male
987876|NCT03240471|Distal radius fracture|distal radius fracture
987877|NCT03240471|Conservative treatment|conservative treatment
988179|NCT03238794|weight loss|weight loss
987878|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
987879|NCT03240419|Obesity|obesity
987880|NCT03240419|Inflammation|inflammation
987881|NCT03240419|Pregnancy|pregnancy
987882|NCT03240419|Programming|programming
987883|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
987884|NCT03240393|NSCLC|nsclc
987885|NCT03240393|INC280|inc280
987886|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
987887|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
987888|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
987889|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
987890|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
987891|NCT03240393|lung cancer|lung cancer
987892|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
987893|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
987894|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
987895|NCT03240393|MET exon 14 deletion|met exon 14 deletion
987896|NCT03240393|MET exon 14 skipping|met exon 14 skipping
987897|NCT03240393|MET exon 14 mutation|met exon 14 mutation
987898|NCT03240393|MET mutation|met mutation
987899|NCT03240393|MET amplification|met amplification
987900|NCT03240393|MET inhibitor|met inhibitor
987901|NCT03240393|MET dysregulation|met dysregulation
987902|NCT03240393|MET activation|met activation
987903|NCT03240393|MET signaling|met signaling
987904|NCT03240393|MET pathway|met pathway
987905|NCT03240393|MET|met
987906|NCT03240393|cMET|cmet
987907|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
987908|NCT03240250|VATS|vats
987909|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
987910|NCT03240250|Uniportal|uniportal
987911|NCT03240250|Postoperative pain|postoperative pain
987912|NCT03240250|Thoracic surgery|thoracic surgery
987913|NCT03240237|HFpEF|hfpef
987914|NCT03240224|Cancer ablation|cancer ablation
987915|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
987916|NCT03240211|Pembrolizumab|pembrolizumab
987917|NCT03240211|Decitabine|decitabine
987918|NCT03240211|Pralatrexate|pralatrexate
987919|NCT03240211|T-cell lymphoma|t-cell lymphoma
987920|NCT03240198|occupational|occupational
987921|NCT03240198|cohort|cohort
987922|NCT03240198|biomarkers|biomarkers
987923|NCT03240185|hemorrhoid|hemorrhoid
987924|NCT03240185|pain|pain
987925|NCT03240185|deep breathing|deep breathing
987926|NCT03240185|multimodal pain control|multimodal pain control
987927|NCT03240133|HAE|hae
987928|NCT03240133|hereditary angioedema|hereditary angioedema
987929|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
987930|NCT03240133|plasma kallikrein|plasma kallikrein
987931|NCT03240107|levator resection|levator resection
987932|NCT03240107|levator tucking|levator tucking
987933|NCT03240107|Fair levator function|fair levator function
987934|NCT03240107|Eyelid contour|eyelid contour
987935|NCT03240094|Ehealth|ehealth
987936|NCT03240094|Older adults|older adults
987937|NCT03240094|Undernutrition|undernutrition
987938|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
987939|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
987940|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
987941|NCT03240081|Sexual pain|sexual pain
987942|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
987943|NCT03240068|Inflammation|inflammation
987944|NCT03240068|Cardiovascular|cardiovascular
987945|NCT03240068|Atherosclerosis|atherosclerosis
987946|NCT03240055|spinal anesthesia|spinal anesthesia
987947|NCT03240055|etomidate|etomidate
987948|NCT03240055|median effective dose|median effective dose
987949|NCT03240055|BIS50|bis50
987950|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
987951|NCT03240042|cuff pressure|cuff pressure
987952|NCT03240042|nasotracheal|nasotracheal
987953|NCT03240042|orotracheal|orotracheal
987954|NCT03240029|children|children
987955|NCT03240029|life quality|life quality
987956|NCT03240029|school reintegration|school reintegration
987957|NCT03240003|Social Anxiety|social anxiety
987958|NCT03240003|Social Anxiety Disorder|social anxiety disorder
987959|NCT03240003|SAD|sad
987960|NCT03239990|Children's mental health|children's mental health
987961|NCT03239990|Conduct disorders|conduct disorders
987962|NCT03239990|Conduct problems|conduct problems
987963|NCT03239990|Externalizing problems|externalizing problems
987964|NCT03239990|Parental Intervention|parental intervention
987965|NCT03239990|Groups based intervention|groups based intervention
987966|NCT03239990|Finland|finland
987967|NCT03239990|Social learning theory|social learning theory
987968|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
987969|NCT03239977|social intelligence|social intelligence
987970|NCT03239977|quality of life|quality of life
987971|NCT03239977|social competence|social competence
987972|NCT03239964|recurrent keloid|recurrent keloid
987973|NCT03239964|surgical excision|surgical excision
987974|NCT03239964|steroids injection|steroids injection
987975|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
987976|NCT03239938|central sensitization|central sensitization
987977|NCT03239938|electroencephalography|electroencephalography
987978|NCT03239938|physiotherapy|physiotherapy
987979|NCT03239938|chronic pain|chronic pain
987980|NCT03239938|functionality|functionality
987981|NCT03239938|quality of life|quality of life
987982|NCT03239938|stress management|stress management
987983|NCT03239938|randomized controlled trial|randomized controlled trial
987984|NCT03239938|modern neuroscience approach|modern neuroscience approach
987985|NCT03239938|pain neuroscience education|pain neuroscience education
987986|NCT03239938|neck school|neck school
987987|NCT03239938|exercise therapy|exercise therapy
987988|NCT03239938|pain cognitions|pain cognitions
987989|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
987990|NCT03239912|Low-level laser|low-level laser
987991|NCT03239912|functional treatment|functional treatment
987992|NCT03239912|twin-block|twin-block
987994|NCT03239899|HIV|hiv
987996|NCT03239899|Immunotherapy|immunotherapy
987997|NCT03239860|Multiple Sclerosis|multiple sclerosis
987998|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
987999|NCT03239860|GNbAC1|gnbac1
988000|NCT03239860|MRI|mri
988001|NCT03239860|Monoclonal antibody|monoclonal antibody
988002|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
988003|NCT03239860|MS|ms
988004|NCT03239860|RRMS|rrms
988005|NCT03239860|HERV-W|herv-w
988006|NCT03239808|once-weekly haemodialysis|once-weekly haemodialysis
988007|NCT03239808|incremental haemodialysis|incremental haemodialysis
988008|NCT03239808|randomized clinical trial|randomized clinical trial
988009|NCT03239795|Posters|posters
988010|NCT03239795|Pamphlets|pamphlets
988011|NCT03239795|Primary Health Care|primary health care
988012|NCT03239795|Health Facilities|health facilities
988013|NCT03239769|Thyroid surgery|thyroid surgery
988014|NCT03239769|Thyroidectomy|thyroidectomy
988015|NCT03239769|Minimally invasive access|minimally invasive access
988016|NCT03239769|Aesthetic principle|aesthetic principle
988017|NCT03239769|POSAS|posas
988018|NCT03239743|virtual reality|virtual reality
988019|NCT03239743|adenoidectomy|adenoidectomy
988020|NCT03239743|induction of anesthesia|induction of anesthesia
988021|NCT03239743|pre-operative anxiety|pre-operative anxiety
988022|NCT03239730|dyspnea|dyspnea
988023|NCT03239730|pH|ph
988024|NCT03239730|blood gas analysis|blood gas analysis
988025|NCT03239730|emergency department|emergency department
988026|NCT03239730|Intensive care unit|intensive care unit
988027|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
988028|NCT03239704|Ulcerative Colitis|ulcerative colitis
988029|NCT03239704|Crohn Disease|crohn disease
988030|NCT03239704|Quality Improvement|quality improvement
988031|NCT03239704|Telemedicine|telemedicine
988032|NCT03239678|Preoxygenation|preoxygenation
988033|NCT03239678|Oxygen Concentration|oxygen concentration
988034|NCT03239665|Vaccine|vaccine
988035|NCT03239665|Educational intervention|educational intervention
988036|NCT03239665|Senior Center Model of Care|senior center model of care
988037|NCT03239665|Older adults|older adults
988038|NCT03239652|Microsphere|microsphere
988039|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
988040|NCT03239639|Substitute decision makers of patient|substitute decision makers of patient
988041|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
988042|NCT03239600|Safety|safety
988043|NCT03239600|GSK2618960|gsk2618960
988044|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
988045|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
988046|NCT03239587|Abdominal cancer patients|abdominal cancer patients
988047|NCT03239587|Musical preop intervention|musical preop intervention
988048|NCT03239587|Surveys|surveys
988049|NCT03239587|Questionnaires|questionnaires
988050|NCT03239587|Blood draws|blood draws
988051|NCT03239548|Opinion,|opinion,
988052|NCT03239548|Doctors,|doctors,
988053|NCT03239548|Nurses,|nurses,
988054|NCT03239548|Key informants,|key informants,
988055|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
988056|NCT03239522|GSK1278863|gsk1278863
988057|NCT03239522|pharmacokinetics|pharmacokinetics
988058|NCT03239522|mass balance|mass balance
988059|NCT03239522|daprodustat|daprodustat
988060|NCT03239509|long-term survival|long-term survival
988061|NCT03239509|bioprosthesis|bioprosthesis
988062|NCT03239509|complications|complications
988063|NCT03239509|anticoagulation|anticoagulation
988064|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
988065|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
988066|NCT03239470|PolyTregs|polytregs
988067|NCT03239470|open-label|open-label
988068|NCT03239470|Phase 1 (safety)|phase 1 (safety)
988069|NCT03239444|ICE|ice
988070|NCT03239444|Ablation|ablation
988071|NCT03239444|Trans-septal|trans-septal
988072|NCT03239444|Septum|septum
988073|NCT03239444|Echocardiography|echocardiography
988074|NCT03239431|asthma|asthma
988075|NCT03239431|lung function|lung function
988076|NCT03239431|forced oscillometry technique|forced oscillometry technique
988077|NCT03239431|exacerbation|exacerbation
988078|NCT03239418|NMES|nmes
988079|NCT03239405|laparoscopic|laparoscopic
988080|NCT03239405|sleeve|sleeve
988081|NCT03239405|gastrectomy|gastrectomy
988082|NCT03239392|BNZ-1|bnz-1
988083|NCT03239392|Cytokine|cytokine
988084|NCT03239392|IL-2|il-2
988085|NCT03239392|IL-15|il-15
988086|NCT03239379|cytokine inhibitor|cytokine inhibitor
988087|NCT03239379|IL-2|il-2
988088|NCT03239379|IL-9|il-9
988089|NCT03239379|IL-15|il-15
988090|NCT03239366|T2D|t2d
988091|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
988092|NCT03239327|Misoprostol|misoprostol
988093|NCT03239327|neonatal|neonatal
988094|NCT03239327|respiratory distress|respiratory distress
988095|NCT03239327|cesarean section|cesarean section
988097|NCT03239288|Postprandial glucose|postprandial glucose
988098|NCT03239288|Insulin|insulin
988099|NCT03239288|Resistant Starch Type 4|resistant starch type 4
988100|NCT03239275|en masse retraction|en masse retraction
988101|NCT03239275|biocreative therapy|biocreative therapy
988102|NCT03239275|class II|class ii
988103|NCT03239275|skeletal anchorage|skeletal anchorage
988104|NCT03239262|Atrial Fibrillation|atrial fibrillation
988105|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
988106|NCT03239262|Ganglionated Plexi|ganglionated plexi
988107|NCT03239262|Open-Heart Surgery|open-heart surgery
988108|NCT03239249|school dropout prevention|school dropout prevention
988109|NCT03239249|intervention study|intervention study
988110|NCT03239249|cluster-randomized|cluster-randomized
988111|NCT03239210|Brain Function|brain function
988112|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
988113|NCT03239210|Sensory processing|sensory processing
988114|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
988115|NCT03239210|OCD|ocd
988116|NCT03239184|Cancer ablation|cancer ablation
988117|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
988118|NCT03239171|Cancer ablation|cancer ablation
988119|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
988120|NCT03239158|Cancer ablation|cancer ablation
988121|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
988122|NCT03239145|Advanced Solid Tumor|advanced solid tumor
988123|NCT03239145|Melanoma|melanoma
988124|NCT03239145|Ovarian Cancer|ovarian cancer
988125|NCT03239145|Renal Cancer|renal cancer
988126|NCT03239145|Colorectal Cancer|colorectal cancer
988127|NCT03239119|rE-4|re-4
988128|NCT03239119|Exenatide|exenatide
988129|NCT03239119|Metformin|metformin
988130|NCT03239119|Sulfonylurea|sulfonylurea
988131|NCT03239106|itch|itch
988132|NCT03239106|pruritus|pruritus
988133|NCT03239106|CIP|cip
988134|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
988135|NCT03239080|HR-pQCT|hr-pqct
988136|NCT03239080|erosion|erosion
988137|NCT03239080|denosumab|denosumab
988138|NCT03239067|Ticagrelor|ticagrelor
988139|NCT03239067|Clopidogrel|clopidogrel
988140|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
988141|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
988142|NCT03239028|diet quality|diet quality
988143|NCT03239028|pregnancy|pregnancy
988144|NCT03239028|adolescence|adolescence
988145|NCT03239028|longitudinal study|longitudinal study
988146|NCT03239028|food frequency questionnaire|food frequency questionnaire
988147|NCT03238989|Interstitial lung disease|interstitial lung disease
988148|NCT03238976|breast core biopsy|breast core biopsy
988149|NCT03238976|core needle biopsies|core needle biopsies
988150|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
988151|NCT03238924|oxytocin|oxytocin
988152|NCT03238924|Prolonged Exposure|prolonged exposure
988153|NCT03238898|muscle cramps|muscle cramps
988154|NCT03238898|diabetic neuropathy|diabetic neuropathy
988155|NCT03238898|botulinum toxin|botulinum toxin
988156|NCT03238872|Anxiety|anxiety
988157|NCT03238872|Depression|depression
988158|NCT03238872|CBT|cbt
988159|NCT03238872|Outcome monitoring|outcome monitoring
988160|NCT03238872|Dissemination|dissemination
988161|NCT03238872|Routine services|routine services
988162|NCT03238833|In vitro fertilization|in vitro fertilization
988163|NCT03238833|Poor ovarian responder|poor ovarian responder
988164|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
988165|NCT03238833|Antagonist protocol|antagonist protocol
988166|NCT03238833|Cumulus cells|cumulus cells
988167|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
988168|NCT03238820|Robot|robot
988169|NCT03238820|manual suture|manual suture
988170|NCT03238807|hCG|hcg
988171|NCT03238807|Intrauterine hCG|intrauterine hcg
988172|NCT03238807|IVF|ivf
988173|NCT03238807|ICSI|icsi
988174|NCT03238794|Body Mass Index|body mass index
988175|NCT03238794|gastric|gastric
988176|NCT03238794|bypass|bypass
988177|NCT03238794|bariatric surgery|bariatric surgery
988180|NCT03238794|diet|diet
988181|NCT03238794|low calorie|low calorie
988182|NCT03238781|Migraine|migraine
988183|NCT03238781|Headache|headache
988184|NCT03238781|Prevention|prevention
988185|NCT03238781|Prophylaxis|prophylaxis
988186|NCT03238768|Nutrition|nutrition
988187|NCT03238768|Body Composition|body composition
988188|NCT03238768|Preterm|preterm
988189|NCT03238768|Neonate|neonate
988190|NCT03238755|HIV|hiv
988191|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
988192|NCT03238755|Myocardial fibrosis|myocardial fibrosis
988193|NCT03238755|Statin|statin
988194|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
988195|NCT03238690|LVAD|lvad
988196|NCT03238690|Cardiac Recovery|cardiac recovery
988197|NCT03238677|speech sound disorder|speech sound disorder
988198|NCT03238651|Drug therapy|drug therapy
988199|NCT03238638|Epacadostat|epacadostat
988200|NCT03238638|Pembrolizumab|pembrolizumab
988201|NCT03238638|PD-1|pd-1
988205|NCT03238612|clarithromycin|clarithromycin
988206|NCT03238612|mortality|mortality
988207|NCT03238612|hospitalisation|hospitalisation
988208|NCT03238586|hiv|hiv
988209|NCT03238586|aids|aids
988210|NCT03238586|alcohol|alcohol
988211|NCT03238586|health|health
988212|NCT03238586|knowledge|knowledge
988213|NCT03238586|motivation|motivation
988214|NCT03238586|skills|skills
988215|NCT03238586|behavior|behavior
988216|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
988217|NCT03238508|Deferred stenting|deferred stenting
988218|NCT03238508|Microvascular dysfunction|microvascular dysfunction
988219|NCT03238495|Operable breast cancer|operable breast cancer
988220|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
988221|NCT03238469|Microwave Ablation|microwave ablation
988222|NCT03238469|Hair Follicle|hair follicle
988223|NCT03238469|Sweat gland|sweat gland
988224|NCT03238456|Pacific Islander|pacific islander
988225|NCT03238456|Native Hawaiian|native hawaiian
988226|NCT03238456|NHPI|nhpi
988227|NCT03238456|Tobacco Health|tobacco health
988228|NCT03238456|Tobacco Use|tobacco use
988229|NCT03238456|Tobacco Smoking|tobacco smoking
988230|NCT03238456|Tobacco Use Cessation|tobacco use cessation
988231|NCT03238456|Smoking Cessation|smoking cessation
988232|NCT03238456|Smoking|smoking
988233|NCT03238456|Cigarette Use|cigarette use
988234|NCT03238456|Young Adult|young adult
988235|NCT03238443|DSA|dsa
988236|NCT03238430|Intrathecal morphine, continuous wound infiltration|intrathecal morphine, continuous wound infiltration
988237|NCT03238417|women's health|women's health
988238|NCT03238417|primary health care|primary health care
988239|NCT03238417|mental health|mental health
988240|NCT03238417|Veterans|veterans
988241|NCT03238417|quality improvement|quality improvement
988242|NCT03238404|gastric cancer|gastric cancer
988243|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
988244|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
988245|NCT03238404|gastrectomy|gastrectomy
988246|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
988247|NCT03238391|Ischemic preconditioning|ischemic preconditioning
988248|NCT03238378|head and neck cancer|head and neck cancer
988249|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
988250|NCT03238378|Brachytherapy|brachytherapy
988251|NCT03238378|Hyperthermia|hyperthermia
988252|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
988253|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
988254|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
988255|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
988256|NCT03238326|Brexpiprazole|brexpiprazole
988257|NCT03238326|Schizophrenia|schizophrenia
988258|NCT03238300|adolescent|adolescent
988259|NCT03238287|Emergency|emergency
988260|NCT03238287|Mechanical chest compression|mechanical chest compression
988261|NCT03238287|Cerebral oximetry|cerebral oximetry
988262|NCT03238222|Walking|walking
988263|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
988264|NCT03238222|Illness Perceptions|illness perceptions
988265|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
988266|NCT03238209|neural respiratory drive|neural respiratory drive
988267|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
988268|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
988269|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
988270|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
988271|NCT03238196|FGFR inhibitor|fgfr inhibitor
988272|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
988273|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
988274|NCT03238196|Endocrine therapy|endocrine therapy
988275|NCT03238183|knee osteoarthritis|knee osteoarthritis
988276|NCT03238183|hyaluronic acid|hyaluronic acid
988277|NCT03238183|dextrose|dextrose
988278|NCT03238183|therapeutic effects|therapeutic effects
988279|NCT03238118|irritability|irritability
988280|NCT03238118|severe mood dysregulation|severe mood dysregulation
988281|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
988282|NCT03238105|Dark circles|dark circles
988283|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
988284|NCT03238105|Facial aesthetics|facial aesthetics
988285|NCT03238092|in vitro fertilization|in vitro fertilization
988286|NCT03238092|estradiol|estradiol
988287|NCT03238092|gnrh antagonist|gnrh antagonist
988288|NCT03238092|testosterone|testosterone
988289|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms|laser treatment, randomized trial, menopause, vaginal symptoms
988290|NCT03238040|Critical illness|critical illness
988291|NCT03238040|PICU|picu
988292|NCT03238040|biomarkers|biomarkers
988293|NCT03238027|SNDX-6352|sndx-6352
988294|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
988295|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
988296|NCT03238027|Solid Tumor|solid tumor
988297|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
988298|NCT03238027|unresectable solid tumor|unresectable solid tumor
988299|NCT03238027|Metastatic tumor|metastatic tumor
988300|NCT03238027|durvalumab|durvalumab
988301|NCT03238001|Cognitive assessment|cognitive assessment
988302|NCT03238001|Cognition|cognition
988303|NCT03238001|Clock Test|clock test
988304|NCT03237975|type 2 diabetes|type 2 diabetes
988305|NCT03237975|sense of coherence|sense of coherence
988306|NCT03237975|self-care|self-care
988307|NCT03237975|strengths-based intervention|strengths-based intervention
988308|NCT03237962|High flow nasal cannula|high flow nasal cannula
988309|NCT03237962|Pulmonary rehab|pulmonary rehab
988310|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
988311|NCT03237962|Nasal cannula|nasal cannula
988312|NCT03237962|Exercise endurance|exercise endurance
988313|NCT03237962|Oxygen Therapy|oxygen therapy
988314|NCT03237962|COPD|copd
988315|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
988316|NCT03237949|Tobacco Use Disorder|tobacco use disorder
988317|NCT03237949|Hospitalized patients|hospitalized patients
988318|NCT03237949|Text message|text message
988319|NCT03237949|Motivational Interview|motivational interview
988320|NCT03237949|Substance-Related Disorders|substance-related disorders
988321|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
988322|NCT03237923|fluid|fluid
988323|NCT03237910|amplitude spectrum area|amplitude spectrum area
988324|NCT03237910|defibrillation|defibrillation
988325|NCT03237910|waveform analysis|waveform analysis
988326|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
988327|NCT03237910|cardiac arrest|cardiac arrest
988328|NCT03237897|ERAS|eras
988329|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
988330|NCT03237884|Palliative Care|palliative care
988331|NCT03237884|Oncology|oncology
988332|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
988333|NCT03237884|integration|integration
988334|NCT03237884|development|development
988335|NCT03237884|palliative care interventions|palliative care interventions
988336|NCT03237884|process indicators|process indicators
988337|NCT03237884|Romania|romania
988338|NCT03237858|heart failure|heart failure
988339|NCT03237858|diagnostics|diagnostics
988340|NCT03237858|heart sounds|heart sounds
988341|NCT03237858|CRT-D|crt-d
988342|NCT03237858|ICD|icd
988343|NCT03237858|remote monitoring|remote monitoring
988344|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
988345|NCT03237819|Intensive care|intensive care
988346|NCT03237806|ARDS,|ards,
988347|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
988348|NCT03237806|Sedation|sedation
988349|NCT03237754|migraine|migraine
988350|NCT03237754|neurostimulation|neurostimulation
988351|NCT03237754|neuroimaging|neuroimaging
988352|NCT03237754|tDCS|tdcs
988353|NCT03237754|MRI|mri
988354|NCT03237702|prostate cancer|prostate cancer
988355|NCT03237702|prostate biopsy|prostate biopsy
988356|NCT03237702|biomarkers|biomarkers
988357|NCT03237702|metabolomics|metabolomics
988358|NCT03237702|overtreatment|overtreatment
988359|NCT03237702|cancer screening|cancer screening
988360|NCT03237702|urine|urine
988361|NCT03237702|lycopene|lycopene
988362|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
988363|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
988364|NCT03237676|neuropsychology|neuropsychology
988365|NCT03237676|functional outcome|functional outcome
988366|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
988367|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
988368|NCT03237624|gingivitis|gingivitis
988369|NCT03237611|emesis|emesis
988370|NCT03237611|aprepitant|aprepitant
988371|NCT03237611|carboplatin|carboplatin
988372|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
988373|NCT03237585|gender based violence|gender based violence
988374|NCT03237585|violence against women|violence against women
988375|NCT03237585|intimate partner violence|intimate partner violence
988376|NCT03237585|impact assessment|impact assessment
988377|NCT03237585|rural response system|rural response system
1658896|NCT00151008|psoriasis|psoriasis
988378|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
988379|NCT03237572|breast cancer|breast cancer
988380|NCT03237572|pembrolizumab|pembrolizumab
988381|NCT03237572|focused ultrasound|focused ultrasound
988382|NCT03237572|immunotherapy|immunotherapy
988383|NCT03237559|Eugenics|eugenics
988384|NCT03237559|Eligible Couples|eligible couples
988385|NCT03237559|Knowledge|knowledge
988386|NCT03237559|Attitude|attitude
988387|NCT03237559|Practice|practice
988388|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
988389|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
988390|NCT03237494|Nervous System Diseases|nervous system diseases
988391|NCT03237494|Metabolism, Inborn Errors|metabolism, inborn errors
988392|NCT03237494|Genetic Diseases, Inborn|genetic diseases, inborn
988393|NCT03237481|inguinal hernia|inguinal hernia
988394|NCT03237481|hernia|hernia
988395|NCT03237481|hernia surgery|hernia surgery
988396|NCT03237481|postoperative pain|postoperative pain
988397|NCT03237481|herniorrhaphy|herniorrhaphy
988398|NCT03237468|concussion|concussion
988399|NCT03237468|football|football
988400|NCT03237468|student|student
988401|NCT03237468|athlete|athlete
988402|NCT03237468|sports|sports
988403|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
988404|NCT03237429|arterial stiffness|arterial stiffness
988405|NCT03237416|Drug-drug interaction|drug-drug interaction
988406|NCT03237403|Sepsis|sepsis
988407|NCT03237403|Adults|adults
988408|NCT03237403|Pre hospital settings|pre hospital settings
988409|NCT03237403|Triage|triage
988410|NCT03237403|Hospital orientation|hospital orientation
988411|NCT03237403|Outcome|outcome
988412|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
988413|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
988414|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
988415|NCT03237351|acute lung injury|acute lung injury
988416|NCT03237325|OM|om
988417|NCT03237325|Head and Neck Cancer|head and neck cancer
988418|NCT03237325|SGX942|sgx942
988419|NCT03237325|Dusquetide|dusquetide
988420|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
988421|NCT03237299|Pharyngitis|pharyngitis
988422|NCT03237299|case-control study|case-control study
988423|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
988424|NCT03237286|depression|depression
988425|NCT03237286|ketamine|ketamine
988426|NCT03237286|neurocognitive|neurocognitive
988427|NCT03237286|fMRI|fmri
988428|NCT03237286|cognitive training|cognitive training
988429|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
988430|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
988431|NCT03237208|emergency medicine|emergency medicine
988432|NCT03237182|whole genome sequencing;|whole genome sequencing;
988433|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
988434|NCT03237104|Adolescent|adolescent
988435|NCT03237104|Athlete|athlete
988436|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
988437|NCT03237078|probiotics|probiotics
988438|NCT03237078|major depressive disorder|major depressive disorder
988439|NCT03237078|gut-brain axis|gut-brain axis
988440|NCT03237078|inflammation|inflammation
988441|NCT03237039|Roussouly type|roussouly type
988442|NCT03237039|spine alignment|spine alignment
988443|NCT03237039|fall-risk|fall-risk
988444|NCT03237039|gait cycle analysis|gait cycle analysis
988445|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
988446|NCT03237013|Sunbathing|sunbathing
988447|NCT03237013|Indoor Tanning|indoor tanning
988448|NCT03237013|Facial Morphing|facial morphing
988449|NCT03237013|Skin Cancer Risk|skin cancer risk
988450|NCT03237000|Preeclampsia|preeclampsia
988451|NCT03237000|MgSO4|mgso4
988452|NCT03236987|MAC|mac
988453|NCT03236987|Clarithromycin|clarithromycin
988454|NCT03236987|Azithromycin|azithromycin
988455|NCT03236987|Efficacy|efficacy
988456|NCT03236987|Safety|safety
988457|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
988582|NCT03236142|duodenal switch|duodenal switch
988458|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
988459|NCT03236961|antibiotic therapy|antibiotic therapy
988460|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
988461|NCT03236896|Menopause|menopause
988462|NCT03236896|Hot Flash|hot flash
988463|NCT03236896|MENQOL|menqol
988464|NCT03236896|Mobile exercise device|mobile exercise device
988465|NCT03236870|psoriasis|psoriasis
988466|NCT03236870|effectiveness|effectiveness
988467|NCT03236870|safety|safety
988468|NCT03236870|adalimumab|adalimumab
988469|NCT03236857|cancer|cancer
988470|NCT03236857|Venetoclax|venetoclax
988471|NCT03236857|pediatric|pediatric
988472|NCT03236857|relapsed or refractory|relapsed or refractory
988473|NCT03236831|Ventricular Assist Device|ventricular assist device
988474|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
988475|NCT03236818|right ventricle|right ventricle
988476|NCT03236818|MRI|mri
988477|NCT03236818|medical combination therapy|medical combination therapy
988478|NCT03236805|Morphine|morphine
988479|NCT03236805|Ketamine|ketamine
988480|NCT03236805|Acute pain|acute pain
988481|NCT03236805|prehospital|prehospital
988482|NCT03236792|Newly Diagnosed|newly diagnosed
988483|NCT03236792|AL Amyloidosis|al amyloidosis
988484|NCT03236792|Amyloid|amyloid
988485|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
988486|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
988487|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
988488|NCT03236753|Low Back Pain|low back pain
988489|NCT03236753|Radiculopathy|radiculopathy
988490|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
988491|NCT03236701|hyperphosphatemia|hyperphosphatemia
988492|NCT03236701|hemodialysis|hemodialysis
988493|NCT03236701|dietary treatment|dietary treatment
988495|NCT03236701|protein energy wasting|protein energy wasting
988496|NCT03236662|BMD|bmd
988497|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
988498|NCT03236662|epicatechin|epicatechin
988499|NCT03236662|clinical trial|clinical trial
988500|NCT03236662|neuromuscular disease|neuromuscular disease
988501|NCT03236623|Surgical Patient|surgical patient
988502|NCT03236623|Menthol|menthol
988503|NCT03236623|Clinical Study|clinical study
988504|NCT03236571|Marfan syndrome|marfan syndrome
988505|NCT03236571|Personal Training Program|personal training program
988506|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
988507|NCT03236571|Muscular rehabilitation|muscular rehabilitation
988508|NCT03236558|Type 1 diabetes|type 1 diabetes
988509|NCT03236558|Juvenile diabetes|juvenile diabetes
988510|NCT03236558|Immune-tolerance|immune-tolerance
988511|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
988512|NCT03236558|Treg|treg
988513|NCT03236558|TCR|tcr
988514|NCT03236558|Repertoire|repertoire
988515|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
988516|NCT03236506|Illicit drug|illicit drug
988517|NCT03236506|Injecting drug|injecting drug
988518|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
988519|NCT03236454|brain stimulation|brain stimulation
988520|NCT03236454|cognitive training|cognitive training
988521|NCT03236454|cognition|cognition
988522|NCT03236454|treatment|treatment
988523|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
988524|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
988525|NCT03236441|cardiac catheterization|cardiac catheterization
988526|NCT03236441|coronary artery disease|coronary artery disease
988527|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
988528|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
988529|NCT03236402|Knowledge|knowledge
988530|NCT03236402|Opinion|opinion
988531|NCT03236402|Adoption|adoption
988532|NCT03236402|Adults|adults
988533|NCT03236402|Cross-Sectional|cross-sectional
988534|NCT03236363|Physical activity|physical activity
988535|NCT03236363|Obesity|obesity
988536|NCT03236363|Children|children
988537|NCT03236363|Cognitive function|cognitive function
988538|NCT03236363|Academic achievement|academic achievement
988539|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
988540|NCT03236363|Adiposity|adiposity
988541|NCT03236363|Cardiovascular fitness|cardiovascular fitness
988542|NCT03236363|Aerobic capacity|aerobic capacity
988543|NCT03236350|Chronic Kidney Disease|chronic kidney disease
988544|NCT03236350|Hypertension|hypertension
988545|NCT03236350|Cardiovascular Disease|cardiovascular disease
988546|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
988547|NCT03236350|Proteinuria|proteinuria
988548|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
988549|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
988550|NCT03236337|Physical activity|physical activity
988551|NCT03236337|Obesity|obesity
988552|NCT03236337|Children|children
988553|NCT03236337|Cognitive function|cognitive function
988554|NCT03236337|Academic achievement|academic achievement
988555|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
988556|NCT03236337|Adiposity|adiposity
988557|NCT03236337|Cardiovascular fitness|cardiovascular fitness
988558|NCT03236337|Atherosclerosis|atherosclerosis
988559|NCT03236337|Aerobic capacity|aerobic capacity
988560|NCT03236298|Epidural|epidural
988561|NCT03236298|Labor analgesia|labor analgesia
988562|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
988563|NCT03236285|Obesity|obesity
988564|NCT03236285|Microcirculation|microcirculation
988565|NCT03236285|Endothelial function|endothelial function
988566|NCT03236285|Laser speckle imaging|laser speckle imaging
988567|NCT03236285|Capillary density|capillary density
988568|NCT03236272|Biomarkers|biomarkers
988569|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
988570|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
988571|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
988572|NCT03236220|poor graft function|poor graft function
988573|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
988574|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
988575|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
988576|NCT03236220|Acute leukemia|acute leukemia
988577|NCT03236181|Energy Expenditure|energy expenditure
988578|NCT03236181|Appetite|appetite
988580|NCT03236155|Opioids|opioids
988581|NCT03236142|bariatric|bariatric
988583|NCT03236142|DS|ds
988584|NCT03236142|weight loss surgery|weight loss surgery
988585|NCT03236142|SIPS|sips
988586|NCT03236142|Single Anastomosis|single anastomosis
988587|NCT03236129|DLI|dli
988588|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
988589|NCT03236129|Hematological malignancies|hematological malignancies
988590|NCT03236129|Relapse|relapse
988591|NCT03236103|Ventricular assist device|ventricular assist device
988592|NCT03236090|Cirrhosis|cirrhosis
988593|NCT03236090|Probiotics|probiotics
988594|NCT03236090|Systemic inflammation|systemic inflammation
988595|NCT03236090|neuroinflammation|neuroinflammation
988596|NCT03236090|Cognitive function|cognitive function
988597|NCT03236090|Bacterial translocation|bacterial translocation
988598|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
988599|NCT03236051|gastric cancer|gastric cancer
988600|NCT03236051|gastrectomy|gastrectomy
988601|NCT03236051|multimodal analgesia|multimodal analgesia
988602|NCT03236051|parecoxib|parecoxib
988603|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
988604|NCT03236038|liver cirrhosis|liver cirrhosis
988605|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
988606|NCT03236038|malnutrition|malnutrition
988607|NCT03236038|prevalence|prevalence
988608|NCT03236025|smoking cessation|smoking cessation
988609|NCT03236025|video|video
988610|NCT03236025|male smoker|male smoker
988611|NCT03235986|RDS|rds
988612|NCT03235973|refractory acute leukemia|refractory acute leukemia
988613|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
988614|NCT03235973|cladribine dose escalation|cladribine dose escalation
988615|NCT03235947|Renal transplant|renal transplant
988616|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
988617|NCT03235947|Fosfomycin|fosfomycin
988618|NCT03235947|Urinary tract infection|urinary tract infection
988619|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
988620|NCT03235934|glucose monitoring|glucose monitoring
988621|NCT03235921|hemorrhagic shock|hemorrhagic shock
988622|NCT03235921|perfusion index|perfusion index
988623|NCT03235921|lactate|lactate
988624|NCT03235921|nitroglycerin|nitroglycerin
988625|NCT03235908|Copeptin|copeptin
988626|NCT03235908|Outcome prediction|outcome prediction
988627|NCT03235882|Lung surfactant|lung surfactant
988628|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
988629|NCT03235882|Prematurity|prematurity
988630|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
988631|NCT03235882|gastric aspirate|gastric aspirate
988632|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
988633|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
988634|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
988635|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
988636|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
988637|NCT03235843|Heart Failure|heart failure
988638|NCT03235843|Exercise Intolerance|exercise intolerance
988639|NCT03235830|Healthcare utilization|healthcare utilization
988640|NCT03235830|Health literacy|health literacy
988641|NCT03235817|Proseal™ LMA|proseal™ lma
988642|NCT03235817|infants|infants
988643|NCT03235817|ventilation|ventilation
988644|NCT03235817|general anesthesia|general anesthesia
988645|NCT03235817|outpatient surgery|outpatient surgery
988646|NCT03235804|High-protein diet|high-protein diet
988647|NCT03235804|Inflammation|inflammation
988648|NCT03235804|Gut microbiota|gut microbiota
988649|NCT03235804|Energy metabolism|energy metabolism
988650|NCT03235804|Body composition|body composition
988651|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
988652|NCT03235765|NSCLC|nsclc
988653|NCT03235765|Cancer panel|cancer panel
988654|NCT03235765|NGS|ngs
988655|NCT03235765|Actionable mutation|actionable mutation
988656|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
988657|NCT03235752|Randomized|randomized
988658|NCT03235752|Double-blind|double-blind
988659|NCT03235752|Placebo-controlled|placebo-controlled
988660|NCT03235752|Safety|safety
988661|NCT03235752|Efficacy|efficacy
988662|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
988663|NCT03235726|bystander|bystander
988664|NCT03235726|inhalation powder|inhalation powder
988665|NCT03235726|monodose device|monodose device
988666|NCT03235726|COPD|copd
988667|NCT03235726|pharmacokinetics|pharmacokinetics
988668|NCT03235726|safety|safety
988669|NCT03235726|Healthy|healthy
988670|NCT03235726|CCI15106|cci15106
988671|NCT03235726|tolerability|tolerability
988672|NCT03235713|Ecological momentary assessments|ecological momentary assessments
988673|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
988674|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
988675|NCT03235700|adenosine|adenosine
988676|NCT03235700|hyperemia|hyperemia
988677|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
988678|NCT03235674|interval exercise|interval exercise
988679|NCT03235635|microbiome|microbiome
988680|NCT03235635|preterm|preterm
988681|NCT03235635|newborn|newborn
988682|NCT03235635|gut microbiome|gut microbiome
988683|NCT03235635|allergic predisposition|allergic predisposition
988684|NCT03235596|executive functions|executive functions
988685|NCT03235596|tDCS|tdcs
988686|NCT03235583|Energy expenditure|energy expenditure
988687|NCT03235583|physical activity|physical activity
988688|NCT03235583|accelerometer|accelerometer
988689|NCT03235583|magnetometer|magnetometer
988690|NCT03235583|monitoring|monitoring
988691|NCT03235583|free-living conditions|free-living conditions
988692|NCT03235583|doubly labelled water|doubly labelled water
988693|NCT03235570|Solid tumor|solid tumor
988694|NCT03235570|malignancy|malignancy
988695|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
988696|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
988697|NCT03235557|prostate|prostate
988698|NCT03235557|cancer|cancer
988699|NCT03235557|radiation|radiation
988700|NCT03235557|stereotactic|stereotactic
988701|NCT03235557|CyberKnife|cyberknife
988702|NCT03235557|elderly|elderly
988703|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
988704|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
988705|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
988706|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
988707|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
988709|NCT03235531|alcohol use disorder|alcohol use disorder
988710|NCT03235531|alcohol|alcohol
988711|NCT03235531|lorazepam|lorazepam
988712|NCT03235531|benzodiazepine|benzodiazepine
988713|NCT03235531|valproate|valproate
988714|NCT03235518|HIV Prevention|hiv prevention
988715|NCT03235518|Female sex workers|female sex workers
988716|NCT03235505|Smoking Cessation|smoking cessation
988717|NCT03235505|Electronic cigarette|electronic cigarette
988718|NCT03235505|Adults|adults
988719|NCT03235492|diabetes|diabetes
988720|NCT03235492|salivary glycated albumin|salivary glycated albumin
988721|NCT03235492|HbA1c|hba1c
988722|NCT03235453|Parkinson|parkinson
988723|NCT03235453|Quality of Life|quality of life
988724|NCT03235453|Sleep Disorder|sleep disorder
988725|NCT03235453|Gait Disorders|gait disorders
988726|NCT03235453|Mobility|mobility
988727|NCT03235427|Coronary|coronary
988728|NCT03235427|Coronary Disease|coronary disease
988729|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
988730|NCT03235427|Heart Disease|heart disease
988731|NCT03235427|Cardiotoxicity|cardiotoxicity
988732|NCT03235427|Breast Cancer|breast cancer
988733|NCT03235427|Carcinoma|carcinoma
988734|NCT03235427|Coronary Vessels|coronary vessels
988735|NCT03235427|Radiation|radiation
988736|NCT03235427|Radiation Therapy|radiation therapy
988737|NCT03235427|Coronary Artery Disease|coronary artery disease
988738|NCT03235427|CAD|cad
988739|NCT03235427|RT|rt
988740|NCT03235427|CT|ct
988741|NCT03235427|Cardiac toxicity|cardiac toxicity
988742|NCT03235427|Cardiac calcium score|cardiac calcium score
988743|NCT03235427|Chest RT|chest rt
988744|NCT03235427|Lung Cancer|lung cancer
988745|NCT03235427|Lymphoma|lymphoma
988746|NCT03235427|Cardiac CT Scan|cardiac ct scan
988747|NCT03235427|Coronary Artery|coronary artery
988748|NCT03235427|Coronary arteries|coronary arteries
988749|NCT03235427|Cardiac Side Effect|cardiac side effect
988750|NCT03235427|Cardiac tissue|cardiac tissue
988751|NCT03235427|Cardiac|cardiac
988752|NCT03235401|Questionnaire|questionnaire
988753|NCT03235401|Disability assessment|disability assessment
988754|NCT03235401|Bothersomeness|bothersomeness
988755|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
988756|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
988757|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
988758|NCT03235388|Trauma|trauma
988759|NCT03235388|Injury|injury
988760|NCT03235388|Audit filter|audit filter
988761|NCT03235388|Quality improvement|quality improvement
988762|NCT03235388|India|india
988763|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
988764|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
988765|NCT03235349|Genotype 1 to 6|genotype 1 to 6
1008157|NCT03110354|AML|aml
988766|NCT03235349|Cirrhosis|cirrhosis
988767|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
988768|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
988769|NCT03235349|co-infection|co-infection
988775|NCT03235323|External Counterpulsation|external counterpulsation
988776|NCT03235310|HIV|hiv
988777|NCT03235310|Pregnancy|pregnancy
988778|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
988779|NCT03235297|Altitude|altitude
988780|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
988781|NCT03235297|COPD|copd
988782|NCT03235297|Pulmonary function testing|pulmonary function testing
988783|NCT03235258|HIV Infection|hiv infection
988784|NCT03235258|Adolescent|adolescent
988785|NCT03235245|cutaneous melanoma|cutaneous melanoma
988786|NCT03235245|mucosal melanoma|mucosal melanoma
988787|NCT03235245|BRAF mutation|braf mutation
988788|NCT03235206|Police Officers|police officers
988789|NCT03235154|HCV|hcv
988790|NCT03235154|suboxone|suboxone
988791|NCT03235154|epclusa|epclusa
988792|NCT03235154|psychiatrist|psychiatrist
988793|NCT03235141|Azithromycin eye drops|azithromycin eye drops
988794|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
988795|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
988796|NCT03235063|registry|registry
988797|NCT03235063|heart failure|heart failure
988798|NCT03235063|pregnancy|pregnancy
988799|NCT03234959|Early Intervention|early intervention
988800|NCT03234959|Cerebral Palsy|cerebral palsy
988801|NCT03234959|CareToy Intervention|caretoy intervention
988802|NCT03234959|Infant Massage|infant massage
988803|NCT03234959|Information Communication Technology|information communication technology
988804|NCT03234946|Diabetes|diabetes
988805|NCT03234946|Family|family
988806|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
988807|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
988808|NCT03234933|Cancer|cancer
988809|NCT03234920|cirrhosis|cirrhosis
988810|NCT03234920|liver transplantation|liver transplantation
988811|NCT03234920|HMB|hmb
988812|NCT03234907|Drug therapy|drug therapy
988813|NCT03234881|Recurrent Binge Eating|recurrent binge eating
988814|NCT03234881|Cognitive Behavioral Therapist|cognitive behavioral therapist
988815|NCT03234881|Weight reduction|weight reduction
988816|NCT03234842|Esophagus|esophagus
988817|NCT03234842|Proton|proton
988818|NCT03234842|Radiation|radiation
988819|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
988825|NCT03234764|IgE|ige
988826|NCT03234764|Allergy|allergy
988827|NCT03234764|Tolerance|tolerance
988828|NCT03234764|Immunotherapy|immunotherapy
988829|NCT03234764|Desensitization|desensitization
988830|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
988831|NCT03234725|Blue light imaging|blue light imaging
988832|NCT03234725|Linked color imaging|linked color imaging
988833|NCT03234725|Optical histology|optical histology
988834|NCT03234725|Adenoma detection rate|adenoma detection rate
988835|NCT03234725|Variable stiffness|variable stiffness
988836|NCT03234725|Deep learning|deep learning
988837|NCT03234712|Advanced Solid Tumors|advanced solid tumors
988838|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
988839|NCT03234712|EGFR ligands|egfr ligands
988840|NCT03234712|Colorectal carcinoma (CRC)|colorectal carcinoma (crc)
988841|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
988842|NCT03234712|Squamous non-small cell lung cancer (sqNSCLC)|squamous non-small cell lung cancer (sqnsclc)
988843|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
988844|NCT03234712|Cancer|cancer
988845|NCT03234712|Overexpression of Epidermal Growth Factor Receptor (EGFR) or EGFR Ligands|overexpression of epidermal growth factor receptor (egfr) or egfr ligands
988846|NCT03234686|Dementia|dementia
988847|NCT03234686|Alzheimer's Disease|alzheimer's disease
988848|NCT03234621|protective ventilation strategy|protective ventilation strategy
988849|NCT03234608|Healthcare services|healthcare services
988850|NCT03234608|Adults|adults
988851|NCT03234595|Cerebraca wafer|cerebraca wafer
988852|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
988853|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
988854|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
988855|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
988856|NCT03234569|hysterosalpingogagraphy|hysterosalpingogagraphy
988857|NCT03234543|Abdominal Surgery|abdominal surgery
988858|NCT03234543|Pre-conditioning|pre-conditioning
988859|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
988860|NCT03234543|Post-Operative Complications|post-operative complications
988861|NCT03234543|Acute Phase Response|acute phase response
988862|NCT03234530|albuminuria|albuminuria
988863|NCT03234530|sleep apnea|sleep apnea
988864|NCT03234530|particulate matter|particulate matter
988865|NCT03234530|renal injury|renal injury
988866|NCT03234491|Diabetes|diabetes
988868|NCT03234478|deep brain stimulation|deep brain stimulation
988869|NCT03234478|cognition|cognition
988870|NCT03234478|young onset Parkinson disease|young onset parkinson disease
988871|NCT03234452|Lactoflorene plus|lactoflorene plus
988872|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
988873|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
988874|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
988875|NCT03234452|Inflammation|inflammation
988876|NCT03234452|gut permeability|gut permeability
988877|NCT03234452|disbiosis|disbiosis
988878|NCT03234452|probiotic|probiotic
988879|NCT03234452|IgA|iga
988880|NCT03234452|IL10|il10
988881|NCT03234439|digital behavioral health|digital behavioral health
988882|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
988883|NCT03234374|Pharmacokinetics|pharmacokinetics
988884|NCT03234374|Bioavailability|bioavailability
988885|NCT03234374|Safety|safety
988886|NCT03234374|Bupivacaine|bupivacaine
988887|NCT03234374|Collagen|collagen
988888|NCT03234374|Implant|implant
988889|NCT03234374|Marcaine|marcaine
988890|NCT03234374|Hernioplasty|hernioplasty
988891|NCT03234361|Hypertension|hypertension
988892|NCT03234361|High phosphorus diet|high phosphorus diet
988893|NCT03234361|FGF 23|fgf 23
988894|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
988895|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
988896|NCT03234348|biodegradable stent|biodegradable stent
988898|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
988899|NCT03234348|Vasomotion|vasomotion
988900|NCT03234335|Multiple Myeloma|multiple myeloma
988901|NCT03234335|Renal Failure|renal failure
988902|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
988903|NCT03234335|Melphalan|melphalan
988904|NCT03234322|prevention|prevention
988905|NCT03234322|risk score|risk score
988906|NCT03234322|behaviour|behaviour
988907|NCT03234322|physical activity|physical activity
988908|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
988909|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
988910|NCT03234296|antibiotic therapy|antibiotic therapy
988911|NCT03234296|spontaneous resolution|spontaneous resolution
988912|NCT03234283|Intubation|intubation
988913|NCT03234270|Heat stress, pilots|heat stress, pilots
988914|NCT03234257|Carotid stenosis|carotid stenosis
988915|NCT03234257|stiffness|stiffness
988916|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
988917|NCT03234257|Plaque stability|plaque stability
988918|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
988919|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
988920|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
988921|NCT03234192|Astym Treatment Technique|astym treatment technique
988922|NCT03234192|Graston Treatment Technique|graston treatment technique
988923|NCT03234179|Non small cell lung cancer|non small cell lung cancer
988924|NCT03234179|Genetic study|genetic study
988925|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
988926|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
988927|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
988928|NCT03234153|Durvalumab|durvalumab
988929|NCT03234153|Tremelimumab|tremelimumab
988930|NCT03234114|new generation drug eluting stent (DES)|new generation drug eluting stent (des)
988931|NCT03234114|triple antithrombotic therapy (TT)|triple antithrombotic therapy (tt)
988932|NCT03234114|pragmatic clinical trial (PCT)|pragmatic clinical trial (pct)
988933|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
988934|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
988935|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
988936|NCT03234101|Clinical practice guidelines|clinical practice guidelines
988937|NCT03234101|Prospective cohort studies|prospective cohort studies
988938|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
988939|NCT03234101|Healthy Diet|healthy diet
988940|NCT03234101|Exercise|exercise
988941|NCT03234101|Physical activity|physical activity
988942|NCT03234101|Body weight|body weight
988943|NCT03234101|Sleep|sleep
988944|NCT03234101|alcohol|alcohol
988945|NCT03234101|Smoking|smoking
988946|NCT03234101|Cardiovascular disease|cardiovascular disease
988947|NCT03234101|Coronary heart disease|coronary heart disease
988948|NCT03234101|Stroke|stroke
988949|NCT03234101|Diabetes|diabetes
988950|NCT03234101|Cancer|cancer
988951|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
988952|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
988953|NCT03234101|Stroke mortality|stroke mortality
988954|NCT03234101|All-cause mortality|all-cause mortality
988955|NCT03234088|Congestive Heart Failure|congestive heart failure
988956|NCT03234088|Heart Failure|heart failure
988957|NCT03234088|Home telemonitoring|home telemonitoring
988958|NCT03234088|Telehealth|telehealth
988959|NCT03234088|HF Disease Management|hf disease management
988960|NCT03234088|Heart failure remote self management|heart failure remote self management
988961|NCT03234049|pediatric|pediatric
988962|NCT03234049|checklist|checklist
988963|NCT03234049|cognitive aid|cognitive aid
988964|NCT03234036|GSK2838232|gsk2838232
988965|NCT03234036|safety|safety
988966|NCT03234036|food effect|food effect
988967|NCT03234036|capsule|capsule
988968|NCT03234036|healthy|healthy
988970|NCT03234036|tablet|tablet
988971|NCT03233984|bisphenol-A|bisphenol-a
988972|NCT03233984|prevention|prevention
988973|NCT03233984|endocrine disruptors|endocrine disruptors
988974|NCT03233932|CKD-841|ckd-841
988975|NCT03233932|Leuplin|leuplin
988976|NCT03233932|Postmenopausal|postmenopausal
988977|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
988978|NCT03233893|based dentin substitute|based dentin substitute
988979|NCT03233893|dentin bridge|dentin bridge
988980|NCT03233893|tertiary dentin|tertiary dentin
988981|NCT03233893|indirect pulp treatment|indirect pulp treatment
988982|NCT03233880|chlamydia|chlamydia
988983|NCT03233880|prevention|prevention
988984|NCT03233841|Natural History Study|natural history study
988985|NCT03233841|Observational Study|observational study
988986|NCT03233841|Prospective Study|prospective study
988987|NCT03233841|Retrospective Study|retrospective study
988988|NCT03233841|Farber Disease|farber disease
988989|NCT03233841|Farber's Disease|farber's disease
988990|NCT03233841|ASAH1|asah1
989277|NCT03231995|prognosis|prognosis
988991|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
988992|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
988993|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
988994|NCT03233841|Metabolic Diseases|metabolic diseases
988995|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
988996|NCT03233841|Lipidoses|lipidoses
988997|NCT03233841|Sphingolipidoses|sphingolipidoses
988998|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
988999|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
989000|NCT03233841|Connective Tissue Diseases|connective tissue diseases
989001|NCT03233841|Central Nervous System Diseases|central nervous system diseases
989002|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
989003|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
989004|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
989005|NCT03233841|Brain Diseases|brain diseases
989006|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
989007|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
989008|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
989009|NCT03233828|Intralesional Injection|intralesional injection
989010|NCT03233828|Immunotherapy|immunotherapy
989011|NCT03233828|Immune Response|immune response
989012|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
989013|NCT03233828|Tumor Infiltration|tumor infiltration
989014|NCT03233828|Metastasis Prevention|metastasis prevention
989015|NCT03233815|Inhaled anesthesia|inhaled anesthesia
989016|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
989017|NCT03233802|Alcohol Use Disorder|alcohol use disorder
989018|NCT03233802|Treatment|treatment
989019|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
989020|NCT03233802|Individualized Treatment|individualized treatment
989021|NCT03233776|Anakinra|anakinra
989022|NCT03233776|Mucositis|mucositis
989023|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
989024|NCT03233776|Febrile neutropenia|febrile neutropenia
989025|NCT03233737|local anesthesia|local anesthesia
989026|NCT03233737|pain tolerance|pain tolerance
989027|NCT03233737|experimental pain|experimental pain
989028|NCT03233724|PD-L1|pd-l1
989029|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
989030|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
989031|NCT03233724|Cytidine Deaminase|cytidine deaminase
989032|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
989033|NCT03233685|Tennis|tennis
989034|NCT03233685|Reaction Time|reaction time
989035|NCT03233685|Visual training|visual training
989036|NCT03233672|adjuvant|adjuvant
989037|NCT03233672|hypofractionation|hypofractionation
989038|NCT03233672|IMRT|imrt
989039|NCT03233672|phase I-II|phase i-ii
989040|NCT03233672|prostate neoplasms|prostate neoplasms
989041|NCT03233672|radiotherapy|radiotherapy
989042|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
989043|NCT03233646|OCT angiography|oct angiography
989044|NCT03233646|Optical Coherence Tomography|optical coherence tomography
989045|NCT03233646|Vessel Density|vessel density
989046|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
989047|NCT03233646|retinal microvasculature|retinal microvasculature
989048|NCT03233646|OCTA|octa
989049|NCT03233633|pain management|pain management
989050|NCT03233633|terminally ill|terminally ill
989051|NCT03233620|knee arthroplasty|knee arthroplasty
989052|NCT03233620|working-age|working-age
989053|NCT03233620|patient related outcome measures|patient related outcome measures
989054|NCT03233607|Postpartum|postpartum
989055|NCT03233607|Hemoglobin|hemoglobin
989056|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
989057|NCT03233594|Chronic Pain|chronic pain
989058|NCT03233594|Chiropractic|chiropractic
989059|NCT03233594|PET|pet
989060|NCT03233594|MRI|mri
989061|NCT03233594|Positron emission tomography|positron emission tomography
989062|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
989063|NCT03233542|Cognitive biases|cognitive biases
989064|NCT03233542|Associations|associations
989065|NCT03233542|Interpretations|interpretations
989066|NCT03233542|Physiological and biological markers|physiological and biological markers
989067|NCT03233529|atopic dermatitis|atopic dermatitis
989068|NCT03233529|atopic eczema|atopic eczema
989069|NCT03233529|eczema|eczema
989070|NCT03233529|topical treatment|topical treatment
989071|NCT03233529|skin diseases|skin diseases
989072|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
989073|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
989074|NCT03233529|crisaborole|crisaborole
989075|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
989076|NCT03233516|Pediatrics|pediatrics
989077|NCT03233516|Etiology|etiology
989078|NCT03233516|Point-of-care test|point-of-care test
989079|NCT03233516|MxA|mxa
989080|NCT03233516|CRP|crp
989081|NCT03233516|Procalcitonin|procalcitonin
989082|NCT03233516|Infectious diseases|infectious diseases
989083|NCT03233516|Respiratory viruses|respiratory viruses
989084|NCT03233516|Pediatric asthma|pediatric asthma
989085|NCT03233490|CPR training|cpr training
989086|NCT03233490|students|students
989087|NCT03233490|willingness|willingness
989088|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
989089|NCT03233477|cytokine expression|cytokine expression
989090|NCT03233477|cytomegalovirus|cytomegalovirus
989091|NCT03233438|Critical Pathways|critical pathways
989092|NCT03233438|Health Facilities|health facilities
989093|NCT03233438|Clinical Protocols|clinical protocols
989094|NCT03233438|Patient Satisfaction|patient satisfaction
989095|NCT03233438|Absenteeism|absenteeism
989096|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
989097|NCT03233438|Quality of Life|quality of life
989098|NCT03233438|Economics, Medical|economics, medical
989099|NCT03233438|Health Resources|health resources
989100|NCT03233438|Health resource utilization|health resource utilization
989101|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
989102|NCT03233425|Child|child
989103|NCT03233425|adolescent|adolescent
989104|NCT03233425|co-morbidity|co-morbidity
989105|NCT03233425|psychology|psychology
989106|NCT03233425|motivation|motivation
989107|NCT03233425|physical activity|physical activity
989108|NCT03233425|eating disorders|eating disorders
989109|NCT03233425|quality of life|quality of life
989110|NCT03233425|therapy|therapy
989111|NCT03233425|predictors|predictors
989112|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
989113|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
989114|NCT03233399|Electroencephalography|electroencephalography
989115|NCT03233399|Magnetoencephalography|magnetoencephalography
989116|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
989117|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
989118|NCT03233373|Devices|devices
989119|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
989120|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
989121|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
989122|NCT03233321|Dry cold application|dry cold application
989123|NCT03233321|Pain|pain
989124|NCT03233321|Bruise|bruise
989125|NCT03233321|Subcutaneous injection|subcutaneous injection
989126|NCT03233243|Rosuvastatin|rosuvastatin
989127|NCT03233243|Sodium fluoride|sodium fluoride
989128|NCT03233243|Positron-emission tomography|positron-emission tomography
989129|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
989130|NCT03233230|American College of Rheumatology|american college of rheumatology
989131|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
989132|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
989133|NCT03233217|Influenza|influenza
989134|NCT03233191|Digital Mammography|digital mammography
989135|NCT03233191|Breast Tomography|breast tomography
989136|NCT03233191|Screening Mammography|screening mammography
989137|NCT03233191|TMIST|tmist
989138|NCT03233165|laser therapy|laser therapy
989139|NCT03233165|recurrence|recurrence
989140|NCT03233165|leukoplakia|leukoplakia
989141|NCT03233165|precancerous lesion|precancerous lesion
989142|NCT03233152|recurrence|recurrence
989143|NCT03233139|Japanese patients|japanese patients
989144|NCT03233113|Exposure therapy|exposure therapy
989145|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
989146|NCT03233113|Anxiety disorders|anxiety disorders
989148|NCT03233100|gut microbiota|gut microbiota
989149|NCT03233100|gut-brain disorder|gut-brain disorder
989150|NCT03233100|constipation|constipation
989151|NCT03233100|depression|depression
989152|NCT03233100|anxiety|anxiety
989153|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
989154|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
989155|NCT03233074|Bone Marrow|bone marrow
989156|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
989157|NCT03233074|Healthy donor|healthy donor
989158|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
989159|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
989160|NCT03232996|Balance|balance
989161|NCT03232996|Gait|gait
989162|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
989163|NCT03232931|auditory|auditory
989164|NCT03232931|tactile|tactile
989165|NCT03232931|mother's voice|mother's voice
989166|NCT03232931|multisensory|multisensory
989167|NCT03232892|NSCLC|nsclc
989168|NCT03232892|NF-1 mutant|nf-1 mutant
989169|NCT03232879|Motor Imagery|motor imagery
989170|NCT03232879|Action Observation|action observation
989171|NCT03232879|Heart Rate|heart rate
989172|NCT03232879|Respiration Rate|respiration rate
989173|NCT03232879|Electrodermal Activity|electrodermal activity
989174|NCT03232866|Exercise Movement Techniques|exercise movement techniques
989175|NCT03232866|Exercise|exercise
989176|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
989177|NCT03232866|Heart Rate|heart rate
989178|NCT03232866|Autonomic Nervous System|autonomic nervous system
989179|NCT03232866|Heart rate variability|heart rate variability
989180|NCT03232853|medical error in anesthesia|medical error in anesthesia
989181|NCT03232853|drug error in anesthesia|drug error in anesthesia
989182|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
989183|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
989184|NCT03232801|female sexual dysfunction|female sexual dysfunction
989185|NCT03232801|low libido|low libido
989186|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
989187|NCT03232801|low desire|low desire
989188|NCT03232801|sexual dysfunction|sexual dysfunction
989189|NCT03232788|Periodontal disease|periodontal disease
989190|NCT03232788|Recession|recession
989191|NCT03232788|Black space|black space
989192|NCT03232775|visual pedagogy|visual pedagogy
989193|NCT03232723|Magnetoencephalography|magnetoencephalography
989194|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
989195|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
989196|NCT03232554|Buxue Yimu Pills|buxue yimu pills
989197|NCT03232554|Ferrous Sulfate|ferrous sulfate
989198|NCT03232554|clinical observations|clinical observations
989199|NCT03232554|adult women|adult women
989200|NCT03232554|Metabonomics|metabonomics
989201|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
989202|NCT03232515|Chronic Renal Failure|chronic renal failure
989203|NCT03232515|Dialysis|dialysis
989204|NCT03232515|Dry weight|dry weight
989205|NCT03232515|Blood Pressure|blood pressure
989206|NCT03232437|HbA1c|hba1c
989207|NCT03232411|prostate disease|prostate disease
989208|NCT03232411|prostatic neoplasm|prostatic neoplasm
989209|NCT03232411|biobank|biobank
989210|NCT03232411|prostate cancer in black males|prostate cancer in black males
989211|NCT03232411|biospecimen|biospecimen
989212|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
989213|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
989214|NCT03232346|buprenorphine|buprenorphine
989215|NCT03232346|naltrexone|naltrexone
989216|NCT03232346|Vivitrol|vivitrol
989217|NCT03232346|opioid dependence|opioid dependence
989218|NCT03232307|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
989219|NCT03232307|Mantle Cell Lymphoma|mantle cell lymphoma
989220|NCT03232307|MCL|mcl
989221|NCT03232307|Newly-diagnosed|newly-diagnosed
989222|NCT03232307|Ibrutinib|ibrutinib
989223|NCT03232307|PCI-32765|pci-32765
989224|NCT03232307|Imbruvica|imbruvica
989225|NCT03232307|Rituximab|rituximab
989226|NCT03232307|Rituxan|rituxan
989227|NCT03232307|Lenalidomide|lenalidomide
989228|NCT03232307|CC-5013|cc-5013
989229|NCT03232307|Revlimid|revlimid
989230|NCT03232307|Dexamethasone|dexamethasone
989231|NCT03232307|Decadron|decadron
989232|NCT03232294|fetal macrosomia|fetal macrosomia
989233|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
989234|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
989235|NCT03232268|Microtransplantation|microtransplantation
989236|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
989237|NCT03232203|Human leukocyte antigen|human leukocyte antigen
989238|NCT03232203|Key Risk Message|key risk message
989239|NCT03232203|ADA-SCID|ada-scid
989240|NCT03232203|Health care providers|health care providers
989241|NCT03232190|prematurity|prematurity
989242|NCT03232190|psychomotor development|psychomotor development
989541|NCT03230149|Stroke|stroke
989243|NCT03232190|parent empowerment|parent empowerment
989244|NCT03232190|e-health|e-health
989245|NCT03232190|parental support|parental support
989246|NCT03232190|post discharge follow-up|post discharge follow-up
989247|NCT03232164|Prostate Cancer|prostate cancer
989248|NCT03232164|Prostate neoplasm|prostate neoplasm
989249|NCT03232151|Stroke|stroke
989250|NCT03232138|Sulforaphane|sulforaphane
989251|NCT03232138|Chemoprevention|chemoprevention
989252|NCT03232138|Former Smokers|former smokers
989253|NCT03232112|Alcohol|alcohol
989254|NCT03232112|Addiction|addiction
989255|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
989256|NCT03232112|GLP-1|glp-1
989257|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
989258|NCT03232099|TMAO|tmao
989259|NCT03232099|Gut Microbiota|gut microbiota
989260|NCT03232099|Gut Flora|gut flora
989261|NCT03232099|Atherosclerosis|atherosclerosis
989262|NCT03232099|Wine|wine
989263|NCT03232099|Red Wine|red wine
989264|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
989265|NCT03232086|Cardiovascular|cardiovascular
989266|NCT03232047|Computerized Working Memory Training|computerized working memory training
989267|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
989268|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
989269|NCT03232021|urinary bladder|urinary bladder
989270|NCT03232021|urinary catheters|urinary catheters
989271|NCT03232021|pregabalin|pregabalin
989272|NCT03232008|Blood glucose|blood glucose
989273|NCT03232008|Appetite|appetite
989274|NCT03231995|Severe influenza|severe influenza
989275|NCT03231995|biomarkers|biomarkers
989276|NCT03231995|respiratory microbiome|respiratory microbiome
989280|NCT03231943|Tolerability|tolerability
989281|NCT03231943|Dose-escalation|dose-escalation
989282|NCT03231943|HIV-1|hiv-1
989283|NCT03231943|Safety|safety
989284|NCT03231943|PK|pk
989285|NCT03231943|GSK3640254|gsk3640254
989286|NCT03231943|Maturation inhibitor|maturation inhibitor
989287|NCT03231930|Diagnosis|diagnosis
989288|NCT03231930|Point of Care Diagnostics|point of care diagnostics
989289|NCT03231930|Hepatitis|hepatitis
989290|NCT03231826|Home monitoring|home monitoring
989291|NCT03231826|ECG|ecg
989292|NCT03231826|Myocardial Infarction|myocardial infarction
989293|NCT03231826|Arrythmia|arrythmia
989294|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
989295|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
989296|NCT03231813|emollients|emollients
989297|NCT03231813|transepidermal water loss|transepidermal water loss
989298|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
989299|NCT03231774|Echocardiography|echocardiography
989300|NCT03231774|Right heart catheterization|right heart catheterization
989301|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
989302|NCT03231722|RAS and BRAF wt|ras and braf wt
989303|NCT03231696|nerve block|nerve block
989304|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
989305|NCT03231657|preeclampsia|preeclampsia
989306|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
989307|NCT03231657|angiogenic factors|angiogenic factors
989308|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
989309|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
989310|NCT03231644|Mazabrauds|mazabrauds
989311|NCT03231644|FD/MAS|fd/mas
989312|NCT03231631|Exercise|exercise
989313|NCT03231631|Education|education
989314|NCT03231631|Stents|stents
989315|NCT03231631|Angioplasty|angioplasty
989316|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
989317|NCT03231631|Cholesterol, HDL|cholesterol, hdl
989318|NCT03231631|Metabolic Equivalent|metabolic equivalent
989319|NCT03231618|dietary intake|dietary intake
989320|NCT03231618|cross-over intervention|cross-over intervention
989321|NCT03231618|energy expenditure|energy expenditure
989322|NCT03231540|Critical care|critical care
989323|NCT03231540|nutrition|nutrition
989324|NCT03231540|whey protein|whey protein
989325|NCT03231540|mechanical ventilation|mechanical ventilation
989326|NCT03231540|muscle function|muscle function
989327|NCT03231514|body composition|body composition
989328|NCT03231514|exercise performance|exercise performance
989329|NCT03231514|keto-adaptation|keto-adaptation
989330|NCT03231475|NSCLC|nsclc
989331|NCT03231475|EGFR-TKI|egfr-tki
989332|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
989333|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
989334|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
989335|NCT03231436|failed spinal|failed spinal
989336|NCT03231423|Obesity|obesity
989337|NCT03231423|VAS|vas
989338|NCT03231423|Pain|pain
989339|NCT03231423|Laparoscopy|laparoscopy
989340|NCT03231423|Bypass|bypass
989341|NCT03231410|arteriovenous fistula|arteriovenous fistula
989342|NCT03231410|maturation|maturation
989343|NCT03231410|monocyte adhesion|monocyte adhesion
989344|NCT03231410|vascular access|vascular access
989345|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
989346|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
989347|NCT03231345|Peripheral IV|peripheral iv
989348|NCT03231345|Internal jugular vein|internal jugular vein
989349|NCT03231345|IJ|ij
989350|NCT03231345|Peripheral IJ|peripheral ij
989351|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
989352|NCT03231332|Helicobacter pylori|helicobacter pylori
989353|NCT03231332|Eradication|eradication
989354|NCT03231332|Microbiome|microbiome
989355|NCT03231332|ESBL|esbl
989356|NCT03231332|GIT|git
989357|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
989358|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
989359|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
989360|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
989361|NCT03231306|Neurofibromas|neurofibromas
989362|NCT03231280|knee|knee
989363|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
989364|NCT03231267|digestive colonization|digestive colonization
989365|NCT03231267|bacteriophages|bacteriophages
989366|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
989367|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
989368|NCT03231241|Headaches|headaches
989369|NCT03231241|Tension-Type Headache|tension-type headache
989370|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
989371|NCT03231241|Migraine|migraine
989372|NCT03231202|Non-operative management|non-operative management
989373|NCT03231202|Splenic Injury|splenic injury
989374|NCT03231202|Blunt|blunt
989375|NCT03231202|Splenic artery embolization|splenic artery embolization
989376|NCT03231202|Trauma|trauma
989377|NCT03231189|Coronary artery disease|coronary artery disease
989378|NCT03231189|cardiac MRI|cardiac mri
989379|NCT03231189|heart failure|heart failure
989380|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
989381|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
989382|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
989383|NCT03231085|Craniosynostosis|craniosynostosis
989384|NCT03231085|hemoglobin|hemoglobin
989385|NCT03231085|iron peros|iron peros
989386|NCT03231085|iron intravenous|iron intravenous
989387|NCT03231072|mechanical ventilation|mechanical ventilation
989388|NCT03231072|pleural effusion|pleural effusion
989389|NCT03231072|EIT|eit
989390|NCT03231059|Coronary artery disease|coronary artery disease
989391|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
989392|NCT03231059|Drug-eluting stent|drug-eluting stent
989393|NCT03231059|Antiplatelet drugs|antiplatelet drugs
989394|NCT03231059|Clinical event committee|clinical event committee
989395|NCT03231020|single ventricle|single ventricle
989396|NCT03231020|pediatric cardiology|pediatric cardiology
989397|NCT03231020|interstage|interstage
989398|NCT03231020|home monitoring|home monitoring
989399|NCT03231020|mHealth|mhealth
989400|NCT03230994|adenomyosis|adenomyosis
989401|NCT03230994|diagnosis|diagnosis
989402|NCT03230994|treatment|treatment
989403|NCT03230994|epidemiology|epidemiology
989404|NCT03230994|Complications|complications
989405|NCT03230981|biomechanics|biomechanics
989406|NCT03230981|cornea|cornea
989407|NCT03230981|optical coherence tomography|optical coherence tomography
989408|NCT03230981|vibrography|vibrography
989409|NCT03230981|brillouin microscopy|brillouin microscopy
989410|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
989411|NCT03230968|Respiratory diseases|respiratory diseases
989412|NCT03230968|Mexico|mexico
989413|NCT03230955|Randomized clinical trial|randomized clinical trial
989414|NCT03230955|Hotlines|hotlines
989415|NCT03230942|patient education|patient education
989416|NCT03230942|arthritis|arthritis
989417|NCT03230942|knee|knee
989418|NCT03230942|arthroplasty|arthroplasty
989419|NCT03230942|gait|gait
989420|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
989421|NCT03230903|Multiple Sclerosis|multiple sclerosis
989422|NCT03230903|Telerehabilitation|telerehabilitation
989423|NCT03230903|Physical rehabilitation|physical rehabilitation
989424|NCT03230890|PTSD|ptsd
989425|NCT03230890|military|military
989426|NCT03230890|neurotechnology|neurotechnology
989427|NCT03230890|HIRREM|hirrem
989428|NCT03230890|allostasis|allostasis
989429|NCT03230890|heart rate variability|heart rate variability
989430|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
989431|NCT03230890|closed loop|closed loop
989432|NCT03230890|acoustic stimulation|acoustic stimulation
989433|NCT03230890|neural oscillations|neural oscillations
989434|NCT03230890|autonomic|autonomic
989435|NCT03230890|hyperarousal|hyperarousal
989436|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
989437|NCT03230864|Lu AF35700|lu af35700
989438|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
989439|NCT03230851|Indobufen|indobufen
989440|NCT03230851|Aspirin|aspirin
989441|NCT03230851|Plasma Thromboxane|plasma thromboxane
989442|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
989443|NCT03230825|incomplete abortion|incomplete abortion
989444|NCT03230825|retained products of conception|retained products of conception
989445|NCT03230825|combined oral contraceptives|combined oral contraceptives
989446|NCT03230825|ultrasound|ultrasound
989447|NCT03230812|Insulin sensitivity|insulin sensitivity
989448|NCT03230812|Metabolic flexibility|metabolic flexibility
989449|NCT03230799|dense cataract|dense cataract
989450|NCT03230799|lens-shell technique|lens-shell technique
989451|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
989452|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
989453|NCT03230786|KBP-042|kbp-042
989454|NCT03230760|acupuncture|acupuncture
989455|NCT03230760|breast engorgement|breast engorgement
989456|NCT03230760|lactation|lactation
989457|NCT03230734|prostate cancer|prostate cancer
989458|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
989459|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
989460|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
989461|NCT03230734|radium-223|radium-223
989462|NCT03230734|Docetaxel|docetaxel
989463|NCT03230721|laser|laser
989464|NCT03230721|HoLEP|holep
989465|NCT03230721|ThuLEP|thulep
989466|NCT03230721|Thulium|thulium
989467|NCT03230721|Thulium-fiber|thulium-fiber
989468|NCT03230721|BPH|bph
989469|NCT03230721|EEP|eep
989470|NCT03230721|monopolar enucleation|monopolar enucleation
989471|NCT03230708|Microparticles|microparticles
989472|NCT03230708|Erythrocytes|erythrocytes
989473|NCT03230708|Methotrexate|methotrexate
989474|NCT03230695|stroke|stroke
989475|NCT03230695|robotic therapy|robotic therapy
989476|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
989477|NCT03230682|early improvement|early improvement
989478|NCT03230682|antidepressants|antidepressants
989479|NCT03230682|major depression diorder|major depression diorder
989480|NCT03230682|resting-state fMRI|resting-state fmri
989481|NCT03230669|substance abuse|substance abuse
989482|NCT03230669|addiction|addiction
989483|NCT03230669|etherapy|etherapy
989484|NCT03230591|Fabry's disease|fabry's disease
989485|NCT03230591|Agalsidase Alfa|agalsidase alfa
989486|NCT03230591|Cardiomyopathy|cardiomyopathy
989487|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
989488|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
989489|NCT03230591|LV vortex flow|lv vortex flow
989490|NCT03230591|Cardiac MRI|cardiac mri
989491|NCT03230578|Pharmacists|pharmacists
989492|NCT03230578|Prescriptions|prescriptions
989493|NCT03230513|vertigo|vertigo
989494|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
989495|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
989496|NCT03230500|computer guided|computer guided
989497|NCT03230500|immediate implant|immediate implant
989498|NCT03230500|patient satisfaction|patient satisfaction
989499|NCT03230461|CPR|cpr
989500|NCT03230461|Basic life support|basic life support
989501|NCT03230448|Acute alcoholism|acute alcoholism
989502|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
989503|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
989504|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
989505|NCT03230396|vitamins|vitamins
989506|NCT03230396|dietary supplements|dietary supplements
989507|NCT03230396|chewing gum|chewing gum
989508|NCT03230396|pharmacokinetics|pharmacokinetics
989509|NCT03230396|healthy human subjects|healthy human subjects
989510|NCT03230370|intensity|intensity
989511|NCT03230370|rehabilitation|rehabilitation
989512|NCT03230318|iCCA|icca
989513|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
989514|NCT03230318|FGFR2 gene fusion|fgfr2 gene fusion
989515|NCT03230318|ARQ 087|arq 087
989516|NCT03230318|biliary cancer|biliary cancer
989517|NCT03230318|bile duct cancer|bile duct cancer
989518|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
989519|NCT03230318|liver cancer|liver cancer
989520|NCT03230318|targeted therapy|targeted therapy
989521|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
989522|NCT03230318|cHCC-CCA|chcc-cca
989523|NCT03230305|Elderly|elderly
989524|NCT03230305|Cancer|cancer
989525|NCT03230305|Ethnographic interview|ethnographic interview
989526|NCT03230305|Social representation|social representation
989527|NCT03230305|Clinical trials|clinical trials
989528|NCT03230305|Reasons of non-participation|reasons of non-participation
989529|NCT03230305|Qualitative method|qualitative method
989530|NCT03230292|Psoriasis|psoriasis
1658897|NCT00151008|bexarotene|bexarotene
989531|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
989532|NCT03230292|Bimekizumab|bimekizumab
989533|NCT03230279|Sacroiliac pain|sacroiliac pain
989534|NCT03230279|Low back pain|low back pain
989535|NCT03230188|asthma|asthma
989536|NCT03230188|neurocircuitry|neurocircuitry
989537|NCT03230188|severe asthma|severe asthma
989538|NCT03230188|mild to moderate asthma|mild to moderate asthma
989539|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
989540|NCT03230149|Fabry|fabry
989542|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
989543|NCT03230149|small fiber neuropathy|small fiber neuropathy
989544|NCT03230136|Myocardial injury|myocardial injury
989545|NCT03230136|Ischemia reperfusion|ischemia reperfusion
989546|NCT03230136|cardiac surgery|cardiac surgery
989547|NCT03230136|cardioprotection|cardioprotection
989548|NCT03230123|Diabetes Mellitus|diabetes mellitus
989549|NCT03230123|green banana|green banana
989550|NCT03230123|resistant starch|resistant starch
989551|NCT03230123|glucose|glucose
989552|NCT03230123|prebiotics|prebiotics
989553|NCT03230123|insulin|insulin
989554|NCT03230123|incretins|incretins
989555|NCT03230110|Sleep disordered breathing|sleep disordered breathing
989556|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
989557|NCT03230110|Hypertension|hypertension
989558|NCT03230110|Pregnancy|pregnancy
989559|NCT03230084|Infertility|infertility
989560|NCT03230084|Ovulation|ovulation
989561|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
989562|NCT03230084|Progesterone|progesterone
989563|NCT03230084|Urine dipstick test|urine dipstick test
989564|NCT03230084|Feasibility study|feasibility study
989565|NCT03230084|Fertile period|fertile period
989566|NCT03230084|Menstrual cycle|menstrual cycle
989567|NCT03230084|Natural family planning|natural family planning
989568|NCT03230084|Fertility awareness methods|fertility awareness methods
989569|NCT03230071|Herbal therapy|herbal therapy
989570|NCT03230071|Randomized controlled trial|randomized controlled trial
989571|NCT03230071|Vascular Dementia|vascular dementia
989572|NCT03230045|acupoint stimulation|acupoint stimulation
989573|NCT03230045|elderly patients|elderly patients
989574|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
989575|NCT03230019|wedge resection|wedge resection
989576|NCT03230019|tubeless|tubeless
989577|NCT03229980|myocardial protection|myocardial protection
989578|NCT03229980|potassium cardioplegia|potassium cardioplegia
989579|NCT03229980|tropinin|tropinin
989580|NCT03229980|Custodiol|custodiol
989581|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
989582|NCT03229967|Microbiome|microbiome
989583|NCT03229967|Microbiota|microbiota
989584|NCT03229967|Premature infant|premature infant
989585|NCT03229967|Observational cohort study|observational cohort study
989586|NCT03229928|Behavior|behavior
989587|NCT03229928|Outcome Measures|outcome measures
989588|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
989589|NCT03229902|stroke|stroke
989590|NCT03229889|Access Sheath|access sheath
989591|NCT03229889|PCNL|pcnl
989592|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
989593|NCT03229889|Ureteroscopy|ureteroscopy
989594|NCT03229889|Alpha Blocker|alpha blocker
989595|NCT03229889|Flomax|flomax
989596|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
989597|NCT03229889|Cialis|cialis
989598|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
989599|NCT03229863|Breastfeeding|breastfeeding
989600|NCT03229863|First foods|first foods
989601|NCT03229850|Diabetes|diabetes
989602|NCT03229850|Insulin|insulin
989603|NCT03229850|Lipohypertrophy|lipohypertrophy
989604|NCT03229850|Euglycemic Clamp|euglycemic clamp
989605|NCT03229837|Construct validity|construct validity
989606|NCT03229837|Minimally important differences|minimally important differences
989607|NCT03229837|Patient-reported outcomes|patient-reported outcomes
989608|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
989609|NCT03229837|PROMIS pediatric measures|promis pediatric measures
989610|NCT03229824|Drain antisepsis|drain antisepsis
989611|NCT03229824|Bacterial colonization|bacterial colonization
989612|NCT03229824|Surgical site infection|surgical site infection
989613|NCT03229733|Stroke|stroke
989614|NCT03229733|Kinect|kinect
989615|NCT03229733|Rehabilitation|rehabilitation
989616|NCT03229733|Upper limbs|upper limbs
989617|NCT03229720|Audio Visual Distraction|audio visual distraction
989618|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
989619|NCT03229668|urinary bladder|urinary bladder
989620|NCT03229668|urinary catheters|urinary catheters
989621|NCT03229668|pregabalin|pregabalin
989622|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
989623|NCT03229642|opioid use disorder|opioid use disorder
989624|NCT03229642|craving|craving
989625|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
989626|NCT03229642|neuropsychological tests|neuropsychological tests
989627|NCT03229629|Behavior change communication|behavior change communication
989628|NCT03229629|Ethiopia|ethiopia
989629|NCT03229629|Food voucher|food voucher
989630|NCT03229629|complementary feeding practice|complementary feeding practice
989631|NCT03229629|affordability|affordability
989632|NCT03229629|accessibility|accessibility
989634|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
989635|NCT03229564|Burns|burns
989636|NCT03229564|Scar|scar
989637|NCT03229564|Skin|skin
989638|NCT03229564|Wound healing|wound healing
989639|NCT03229564|Tissue Engineering|tissue engineering
989640|NCT03229564|Dermis|dermis
989641|NCT03229564|Epidermis|epidermis
989642|NCT03229564|Thermal Injuries|thermal injuries
989643|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
989644|NCT03229512|Sildenafil|sildenafil
989645|NCT03229499|Randomized Controlled Trial|randomized controlled trial
989646|NCT03229499|clinical trial|clinical trial
989647|NCT03229499|anastrozole|anastrozole
989648|NCT03229499|pulmonary hypertension|pulmonary hypertension
989649|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
989650|NCT03229499|PAH|pah
989651|NCT03229486|emergence delirium|emergence delirium
989652|NCT03229486|tonsillectomy|tonsillectomy
989653|NCT03229473|Balance|balance
989654|NCT03229473|Falls|falls
989655|NCT03229473|Screening|screening
989656|NCT03229473|COPD|copd
989657|NCT03229434|affective responses|affective responses
989658|NCT03229434|stress-related parameters|stress-related parameters
989659|NCT03229434|green exercise|green exercise
989660|NCT03229421|Zika Virus|zika virus
989661|NCT03229408|Inflammation|inflammation
989662|NCT03229408|Hyperandrogenism|hyperandrogenism
989663|NCT03229408|Anovulation|anovulation
989664|NCT03229408|Insulin Resistance|insulin resistance
989665|NCT03229395|skeletal muscle|skeletal muscle
989666|NCT03229395|muscle mass|muscle mass
989667|NCT03229395|glucocorticoids|glucocorticoids
989668|NCT03229395|biomarkers|biomarkers
989669|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
989670|NCT03229369|ACL|acl
989671|NCT03229369|ALL|all
989672|NCT03229369|Ligament injury|ligament injury
989673|NCT03229369|Reconstruction|reconstruction
989674|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
989675|NCT03229330|Wound Healing|wound healing
989676|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
989677|NCT03229317|Lung function|lung function
989678|NCT03229317|Children|children
989684|NCT03229291|Wnt inhibitor|wnt inhibitor
989685|NCT03229226|Simulation|simulation
989686|NCT03229226|Task Trainer|task trainer
989687|NCT03229213|cystic fibrosis|cystic fibrosis
989688|NCT03229213|video games|video games
989689|NCT03229213|exercise|exercise
989690|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
989691|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
989692|NCT03229148|Thrombectomy|thrombectomy
989693|NCT03229148|Anesthesia|anesthesia
989694|NCT03229148|Conscious sedation|conscious sedation
989695|NCT03229148|Stroke|stroke
989696|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
989697|NCT03229109|dehydration|dehydration
989698|NCT03229109|spectrophon|spectrophon
989699|NCT03229109|device|device
989700|NCT03229109|perspiration|perspiration
989701|NCT03229096|gastric cancer|gastric cancer
989702|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
989703|NCT03229096|apatinib|apatinib
989704|NCT03229070|Thoracic Surgery|thoracic surgery
989705|NCT03229070|Postoperative Period|postoperative period
989706|NCT03229070|Rehabilitation|rehabilitation
989707|NCT03229070|Early mobilization|early mobilization
989708|NCT03229070|Cycle-ergometer|cycle-ergometer
989709|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
989710|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
989711|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
989712|NCT03228966|Pediatric|pediatric
989713|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
989714|NCT03228953|Depression|depression
989715|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
989716|NCT03228901|Oxytocin|oxytocin
989717|NCT03228901|Affiliation|affiliation
989718|NCT03228888|Rhythm|rhythm
989719|NCT03228888|Ecological sounds|ecological sounds
989720|NCT03228888|Auditory stimuli|auditory stimuli
989721|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
989722|NCT03228888|Parkinson's Disease|parkinson's disease
989723|NCT03228888|Gait|gait
989724|NCT03228888|Gait analysis|gait analysis
989725|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
989726|NCT03228875|pregnancy outcomes, birth outcomes|pregnancy outcomes, birth outcomes
989727|NCT03228849|Bony mallet injury|bony mallet injury
989728|NCT03228849|Anchor suture|anchor suture
989729|NCT03228849|Conservative treatment|conservative treatment
989730|NCT03228849|DIP joint|dip joint
989731|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
989732|NCT03228823|Cardiomyopathy|cardiomyopathy
989733|NCT03228797|pain|pain
989734|NCT03228771|PRGF|prgf
989735|NCT03228771|Statins|statins
989736|NCT03228771|socket augmentation|socket augmentation
989737|NCT03228758|POEM|poem
989738|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
989739|NCT03228745|total knee arthroplasty|total knee arthroplasty
989740|NCT03228745|pre-operative|pre-operative
989741|NCT03228719|Total Knee Replacement|total knee replacement
989742|NCT03228719|Physical Therapy|physical therapy
989743|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
989744|NCT03228706|Medication Adherence|medication adherence
989745|NCT03228706|Malay patients|malay patients
989746|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
989747|NCT03228706|Randomised controlled trial|randomised controlled trial
989748|NCT03228693|Keloid|keloid
989749|NCT03228667|Pembrolizumab|pembrolizumab
989750|NCT03228667|Nivolumab|nivolumab
989751|NCT03228667|Non-Small Cell Lung Cancer|non-small cell lung cancer
989752|NCT03228667|Immunotherapy|immunotherapy
989753|NCT03228667|Interleukin-15|interleukin-15
989754|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
989755|NCT03228667|ALT-803|alt-803
989756|NCT03228641|skin rejuvenation|skin rejuvenation
989757|NCT03228641|wrinkle removal|wrinkle removal
989758|NCT03228641|skin laxity reduction|skin laxity reduction
989759|NCT03228628|Spinal puncture|spinal puncture
989760|NCT03228628|Pain|pain
989761|NCT03228628|Anxiety|anxiety
989762|NCT03228628|Nitrous oxyde|nitrous oxyde
989763|NCT03228615|shared decision making|shared decision making
989764|NCT03228576|Tacrolimus|tacrolimus
989765|NCT03228576|Envarsus|envarsus
989766|NCT03228576|Everolimus|everolimus
989767|NCT03228576|kidney|kidney
989768|NCT03228576|Transplant|transplant
989769|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
989770|NCT03228550|B vitamins|b vitamins
989771|NCT03228550|vitamin E|vitamin e
989772|NCT03228550|Phosphatidylserine|phosphatidylserine
989773|NCT03228550|Gingko biloba|gingko biloba
989774|NCT03228550|Gait|gait
989775|NCT03228550|Aerobic Exercise|aerobic exercise
989776|NCT03228550|Memory|memory
989777|NCT03228550|Cognitive function|cognitive function
989778|NCT03228485|Smartphone|smartphone
989779|NCT03228485|Application|application
989780|NCT03228485|Pilot|pilot
989781|NCT03228485|mhealth|mhealth
989782|NCT03228459|Kidney Diseases|kidney diseases
989783|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
989784|NCT03228459|Atherosclerosis|atherosclerosis
989785|NCT03228459|Biomarkers|biomarkers
989786|NCT03228459|Prevention|prevention
989787|NCT03228459|Lung capacity|lung capacity
989788|NCT03228459|Early diagnosis|early diagnosis
989789|NCT03228459|Advanced glycation end products|advanced glycation end products
989790|NCT03228459|Atrial fibrillation|atrial fibrillation
989791|NCT03228459|Diabetes|diabetes
989792|NCT03228459|Arterial ultrasound|arterial ultrasound
989793|NCT03228446|training intervention|training intervention
989794|NCT03228446|filter training|filter training
989795|NCT03228446|distractor inhibition|distractor inhibition
989796|NCT03228433|Drug Therapy|drug therapy
989797|NCT03228394|Postpartum Care|postpartum care
989798|NCT03228394|Postpartum Depression|postpartum depression
989799|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
989800|NCT03228381|Heart Failure|heart failure
989801|NCT03228355|Levcromakalim|levcromakalim
989802|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
989803|NCT03228342|Ultrasound|ultrasound
989804|NCT03228342|Impact|impact
989805|NCT03228329|cardiometry|cardiometry
989806|NCT03228329|stroke volume|stroke volume
989807|NCT03228329|liver transplantation|liver transplantation
989808|NCT03228290|Cirrhosis|cirrhosis
989809|NCT03228290|Liver|liver
989810|NCT03228290|Liver Transplant|liver transplant
989811|NCT03228290|Frailty|frailty
989812|NCT03228290|end stage|end stage
989813|NCT03228277|Extracellular vesicles|extracellular vesicles
989814|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
989815|NCT03228277|Liquid biopsy|liquid biopsy
989816|NCT03228277|T790M|t790m
989817|NCT03228277|NSCLC|nsclc
989818|NCT03228277|Exosomes|exosomes
989819|NCT03228277|EGFR mutation testing|egfr mutation testing
989820|NCT03228199|Randomised Control Trial|randomised control trial
989821|NCT03228199|Productivity|productivity
989822|NCT03228199|Agricultural workers|agricultural workers
989823|NCT03228199|India|india
989824|NCT03228199|Vision correction|vision correction
989825|NCT03228173|Cognition|cognition
989826|NCT03228173|Executive functioning|executive functioning
989827|NCT03228173|Depression|depression
989828|NCT03228173|Affect|affect
989829|NCT03228173|adult females|adult females
989830|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
1658898|NCT00151008|narrow band|narrow band
989831|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
989832|NCT03228160|Stellate Ganglion|stellate ganglion
989833|NCT03228160|Heart Rate Variability|heart rate variability
989834|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
989835|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
989836|NCT03228108|Culture-guided|culture-guided
989837|NCT03228108|Targeted prophylaxis|targeted prophylaxis
989838|NCT03228108|Prostate biopsy|prostate biopsy
989839|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
989840|NCT03228095|Volatile Organic Compounds|volatile organic compounds
989841|NCT03228095|Tuberculosis|tuberculosis
989842|NCT03228095|Nano-sensors|nano-sensors
989843|NCT03228095|Electronic nose|electronic nose
989844|NCT03228095|Digestive cancers|digestive cancers
989845|NCT03228082|Patient empowerment|patient empowerment
989846|NCT03228082|Women's Health|women's health
989847|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
989848|NCT03228069|rabies vaccination|rabies vaccination
989849|NCT03228056|postoperative pain|postoperative pain
989850|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
989851|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
989852|NCT03228056|lung lobectomy|lung lobectomy
989853|NCT03228043|Apatinib|apatinib
989854|NCT03228043|Outcome, Fatal|outcome, fatal
989855|NCT03228043|Colorectal Cancer|colorectal cancer
989856|NCT03228043|surgery|surgery
989857|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
989858|NCT03228030|thiamine|thiamine
989859|NCT03228030|heart failure|heart failure
989860|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
989861|NCT03228030|geriatric|geriatric
989862|NCT03228030|thiamin|thiamin
989863|NCT03228030|vitamin b1|vitamin b1
989864|NCT03228030|congestive heart failure|congestive heart failure
989865|NCT03228017|cardiovascular disease|cardiovascular disease
989866|NCT03228017|CVD|cvd
989867|NCT03227991|Suicide|suicide
989868|NCT03227978|pleurodesis|pleurodesis
989869|NCT03227978|PCL|pcl
989870|NCT03227965|cancer|cancer
989871|NCT03227926|RAS|ras
989872|NCT03227926|Panitumumab|panitumumab
989873|NCT03227926|EGFR|egfr
989874|NCT03227926|Clonal evolution|clonal evolution
989875|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
989876|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
989877|NCT03227835|prophylaxis|prophylaxis
989878|NCT03227835|intravenous hydration|intravenous hydration
989879|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
989880|NCT03227809|Substance use|substance use
989881|NCT03227809|Alcohol|alcohol
989882|NCT03227809|Marijuana|marijuana
990091|NCT03226626|Sepsis|sepsis
989883|NCT03227809|Illicit drugs|illicit drugs
989884|NCT03227809|Prescription drug misuse|prescription drug misuse
989885|NCT03227809|Risky sexual behaviors|risky sexual behaviors
989886|NCT03227796|osteoarthritis|osteoarthritis
989887|NCT03227796|knee|knee
989888|NCT03227796|healthy|healthy
989889|NCT03227796|volunteer|volunteer
989890|NCT03227796|LEVI-04|levi-04
989891|NCT03227770|Hemoperfusion|hemoperfusion
989892|NCT03227770|Hemodialysis|hemodialysis
989893|NCT03227770|Mortality|mortality
989894|NCT03227757|TRILUMINATE|triluminate
989895|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
989896|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
989897|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
989898|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
989899|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
989900|NCT03227731|safety|safety
989901|NCT03227731|HIV prevention|hiv prevention
989902|NCT03227731|pregnant women|pregnant women
989903|NCT03227731|lactating women|lactating women
989904|NCT03227718|VOR|vor
989905|NCT03227705|Preterm birth|preterm birth
989906|NCT03227705|Short cervix|short cervix
989907|NCT03227705|Pessary|pessary
989908|NCT03227705|Progesterone|progesterone
989909|NCT03227679|Personalized Medicine|personalized medicine
989910|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
989911|NCT03227679|Varenicline|varenicline
989912|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
989913|NCT03227679|Smoking Cessation|smoking cessation
989914|NCT03227679|Pharmacotherapy|pharmacotherapy
989915|NCT03227666|Postural sway|postural sway
989916|NCT03227666|Progressive balance exercise|progressive balance exercise
989917|NCT03227666|RCT|rct
989918|NCT03227666|Functional balance|functional balance
989919|NCT03227653|Efavirenz|efavirenz
989920|NCT03227653|Child Behavior|child behavior
989921|NCT03227653|Cognition|cognition
989922|NCT03227653|Medication Adherence|medication adherence
989923|NCT03227653|Drug-Related Side Effects|drug-related side effects
989924|NCT03227614|abortion|abortion
989925|NCT03227614|social support|social support
989926|NCT03227614|Anxiety|anxiety
989927|NCT03227614|Pain|pain
989928|NCT03227588|Fractional Flow Reserve|fractional flow reserve
1658899|NCT00151008|UVB|uvb
989929|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
989930|NCT03227562|risperidone|risperidone
989931|NCT03227562|anxiety|anxiety
989932|NCT03227562|cognition|cognition
989933|NCT03227562|stress|stress
989934|NCT03227536|Neonatal asphyxia|neonatal asphyxia
989935|NCT03227536|neonatal acidosis|neonatal acidosis
989936|NCT03227536|fetal ECG|fetal ecg
989937|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
989938|NCT03227523|low back pain|low back pain
989939|NCT03227523|respiratory disorders|respiratory disorders
989940|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
989941|NCT03227523|postural balance|postural balance
989942|NCT03227523|functional laterality|functional laterality
989943|NCT03227523|diaphragm|diaphragm
990044|NCT03226873|PrEP|prep
990045|NCT03226873|peer navigation|peer navigation
989944|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
989945|NCT03227497|Blood Pressure|blood pressure
989946|NCT03227497|Cholesterol|cholesterol
989947|NCT03227497|Triglycerides|triglycerides
989948|NCT03227497|Walnuts|walnuts
989949|NCT03227458|areal bone mineral density|areal bone mineral density
989950|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
989951|NCT03227458|postmenopause|postmenopause
989952|NCT03227458|exercise|exercise
989953|NCT03227458|sex hormones|sex hormones
989954|NCT03227445|DISKUS|diskus
989955|NCT03227445|HandiHaler|handihaler
989956|NCT03227445|COPD|copd
989957|NCT03227445|Placebo|placebo
989958|NCT03227445|Cross-over|cross-over
989959|NCT03227445|Dry powder inhaler|dry powder inhaler
989960|NCT03227445|ELLIPTA|ellipta
989961|NCT03227432|Multiple Myeloma|multiple myeloma
989962|NCT03227406|sleep|sleep
989963|NCT03227406|memory|memory
989964|NCT03227406|REM sleep|rem sleep
989965|NCT03227406|slow wave sleep|slow wave sleep
989966|NCT03227406|cognition|cognition
989967|NCT03227406|sleep spindles|sleep spindles
989968|NCT03227393|Heart Failure, Systolic|heart failure, systolic
989969|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
989970|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
989971|NCT03227367|biomaterials|biomaterials
989972|NCT03227367|apoptosis|apoptosis
989973|NCT03227367|bone regeneration|bone regeneration
989974|NCT03227354|Medical Device|medical device
989975|NCT03227341|asthma control|asthma control
989976|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
989977|NCT03227328|luminal B breast cancer|luminal b breast cancer
989978|NCT03227328|metastatic breast cancer|metastatic breast cancer
989979|NCT03227328|First line treatment|first line treatment
989980|NCT03227328|endocrine therapy|endocrine therapy
989981|NCT03227328|chemotherapy|chemotherapy
990092|NCT03226626|Prevention|prevention
989982|NCT03227328|randomized phase III trial|randomized phase iii trial
989983|NCT03227328|aromatase inhibitor|aromatase inhibitor
989984|NCT03227276|Litramine|litramine
989985|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
989986|NCT03227276|weight loss|weight loss
989987|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
989988|NCT03227263|VEGF therapy|vegf therapy
989989|NCT03227263|Bevacizumab|bevacizumab
989990|NCT03227250|freezing of gait|freezing of gait
989991|NCT03227250|Parkinson disease|parkinson disease
989992|NCT03227250|GPi|gpi
989993|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
989994|NCT03227211|COPD exacerbated|copd exacerbated
989995|NCT03227211|Readmission|readmission
989996|NCT03227211|Prospective cohort study|prospective cohort study
989997|NCT03227211|Nested case control study|nested case control study
989998|NCT03227211|Clinical prediction rules|clinical prediction rules
989999|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
990000|NCT03227159|Troponin|troponin
990001|NCT03227159|Emergency department|emergency department
990002|NCT03227146|Burns|burns
990003|NCT03227146|Scar|scar
990004|NCT03227146|Skin|skin
990005|NCT03227146|Wound healing|wound healing
990006|NCT03227146|Tissue Engineering|tissue engineering
990007|NCT03227146|Dermis|dermis
990008|NCT03227146|Epidermis|epidermis
990009|NCT03227146|Thermal Injuries|thermal injuries
990010|NCT03227120|Exercise Therapy|exercise therapy
990011|NCT03227094|Diabetes|diabetes
990012|NCT03227094|Screening test|screening test
990013|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
990014|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
990015|NCT03227068|pediatric oncology|pediatric oncology
990016|NCT03227068|parent|parent
990017|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
990018|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
990019|NCT03227042|MPS IIIB|mps iiib
990020|NCT03227042|MPS 3 B|mps 3 b
990021|NCT03226990|pressure area|pressure area
990022|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
990023|NCT03226990|wax spacer|wax spacer
990024|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
990025|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
990026|NCT03226938|dietary patterns|dietary patterns
990027|NCT03226938|dietary adherence|dietary adherence
990028|NCT03226938|popular diets|popular diets
990029|NCT03226938|Paleo|paleo
990030|NCT03226938|vegan|vegan
990031|NCT03226938|behavior change|behavior change
990032|NCT03226938|adherence|adherence
990033|NCT03226938|compliance|compliance
990034|NCT03226938|vegetarian|vegetarian
990035|NCT03226938|low carb|low carb
990036|NCT03226938|low-carb|low-carb
990037|NCT03226938|whole food plant-based|whole food plant-based
990038|NCT03226938|social ecological model|social ecological model
990039|NCT03226925|thoracic tumors|thoracic tumors
990040|NCT03226925|motion management|motion management
990041|NCT03226925|radiotherapy|radiotherapy
990042|NCT03226925|ventilator|ventilator
990043|NCT03226873|HIV prevention|hiv prevention
990049|NCT03226821|Tesamorelin|tesamorelin
990050|NCT03226821|Body Composition|body composition
990051|NCT03226821|Visceral Adiposity|visceral adiposity
990052|NCT03226795|Cystic fibrosis|cystic fibrosis
990053|NCT03226795|Therapeutic adherence|therapeutic adherence
990054|NCT03226795|Co-constructed intervention|co-constructed intervention
990055|NCT03226795|Patient involvement|patient involvement
990056|NCT03226743|stepped and collaborative care|stepped and collaborative care
990057|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
990058|NCT03226743|health services research|health services research
990059|NCT03226743|evidence-based medicine|evidence-based medicine
990060|NCT03226743|complex intervention|complex intervention
990061|NCT03226743|guideline implementation|guideline implementation
990062|NCT03226743|collaborative network|collaborative network
990063|NCT03226730|Female Adolescent|female adolescent
990064|NCT03226730|Married|married
990065|NCT03226730|West Africa|west africa
990066|NCT03226730|Family Planning|family planning
990067|NCT03226730|Contraceptive Use|contraceptive use
990068|NCT03226730|Birth Spacing|birth spacing
990074|NCT03226691|Plerixafor|plerixafor
990075|NCT03226691|Leukapheresis|leukapheresis
990076|NCT03226691|Mobilization|mobilization
990077|NCT03226691|Stem Cells|stem cells
990078|NCT03226691|Sickle Cell Disease|sickle cell disease
990079|NCT03226665|obstruction|obstruction
990080|NCT03226665|small bowel|small bowel
990081|NCT03226665|ultrasound|ultrasound
990082|NCT03226639|Atrial Fibrillation|atrial fibrillation
990083|NCT03226639|First Ablation|first ablation
990084|NCT03226626|Tumescent|tumescent
990085|NCT03226626|Lidocaine|lidocaine
990086|NCT03226626|Epinephrine|epinephrine
990087|NCT03226626|Cefazolin|cefazolin
990088|NCT03226626|Metronidazole|metronidazole
990089|NCT03226626|Surgical Site Infection|surgical site infection
990090|NCT03226626|Thrombosis|thrombosis
990094|NCT03226613|Human Papillomavirus|human papillomavirus
990095|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
990096|NCT03226613|Base of Tongue Cancer|base of tongue cancer
990097|NCT03226613|Tonsil Cancer|tonsil cancer
990098|NCT03226600|Gingival Recession|gingival recession
990099|NCT03226600|Connective Tissue Graft|connective tissue graft
990100|NCT03226600|OrACELL|oracell
990101|NCT03226600|Decellularized Dermis|decellularized dermis
990102|NCT03226600|Periodontics|periodontics
990103|NCT03226587|blue light|blue light
990104|NCT03226587|blood pressure|blood pressure
990105|NCT03226587|vascular function|vascular function
990106|NCT03226587|endothelial function|endothelial function
990107|NCT03226587|health volunteers|health volunteers
990108|NCT03226574|Resiniferatoxin|resiniferatoxin
990110|NCT03226574|Cancer pain|cancer pain
990111|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
990112|NCT03226548|Tax Credit|tax credit
990113|NCT03226548|Paycheck Plus|paycheck plus
990114|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
990115|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
990116|NCT03226535|Image Fusion|image fusion
990117|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
990118|NCT03226535|Needle path|needle path
990119|NCT03226535|Needle Guidance|needle guidance
990120|NCT03226535|CT|ct
990121|NCT03226535|Ultrasound|ultrasound
990122|NCT03226509|cascade of care|cascade of care
990123|NCT03226483|Brain Metastases|brain metastases
990124|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
990125|NCT03226483|Neurosurgery|neurosurgery
990126|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
990127|NCT03226470|Human papillomavirus|human papillomavirus
990128|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
990129|NCT03226457|Heart Failure|heart failure
990130|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
990131|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
990132|NCT03226457|Natriuresis|natriuresis
990133|NCT03226457|Diuresis|diuresis
990134|NCT03226444|Dry Eye|dry eye
990135|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
990136|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
990137|NCT03226405|Cancer|cancer
990138|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
990139|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
990140|NCT03226366|emergency department care|emergency department care
990141|NCT03226366|antimicrobial|antimicrobial
990142|NCT03226366|care reorganization|care reorganization
990143|NCT03226366|severe sepsis|severe sepsis
990144|NCT03226366|swarming|swarming
990145|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
990146|NCT03226288|Plantar Fascitis|plantar fascitis
990147|NCT03226288|orthopedic|orthopedic
990148|NCT03226288|3D surface scanning|3d surface scanning
990149|NCT03226275|Concor AM®|concor am®
990150|NCT03226275|Concor®|concor®
990151|NCT03226275|Norvasc®|norvasc®
990152|NCT03226275|Bisoprolol|bisoprolol
990153|NCT03226275|Amlodipine|amlodipine
990154|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
990155|NCT03226275|Chinese Subjects|chinese subjects
990156|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
990157|NCT03226236|vaccination|vaccination
990158|NCT03226236|dendritic cells|dendritic cells
990159|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
990160|NCT03226236|High Dose -IL2|high dose -il2
990161|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
990162|NCT03226236|secondary|secondary
990163|NCT03226210|Diabetes Mellitus|diabetes mellitus
990164|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
990165|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
990166|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
990167|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
990168|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
990169|NCT03226158|Pediatric|pediatric
990171|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
990172|NCT03226119|HTLV|htlv
990173|NCT03226119|Confirmatory|confirmatory
990174|NCT03226119|Supplemental|supplemental
990175|NCT03226119|Blot|blot
990176|NCT03226119|HTLV-I|htlv-i
990177|NCT03226119|HTLV-II|htlv-ii
990178|NCT03226106|Rehabilitation|rehabilitation
990179|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
990180|NCT03226106|Telemedicine|telemedicine
990181|NCT03226106|Physical Activity|physical activity
990182|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
990183|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
990184|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
990185|NCT03226041|urologic surgery|urologic surgery
990186|NCT03226041|anesthesia|anesthesia
990187|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
990188|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
990292|NCT03225534|Environment|environment
990189|NCT03226015|Amniotic membrane|amniotic membrane
990190|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
990191|NCT03226002|Airtraq NT|airtraq nt
990192|NCT03226002|nasotracheal intubation|nasotracheal intubation
990193|NCT03226002|right|right
990194|NCT03226002|left|left
990195|NCT03225976|Phototherapy|phototherapy
990196|NCT03225976|Athletic Performance|athletic performance
990197|NCT03225976|Muscle Strength|muscle strength
990198|NCT03225976|Fatigue|fatigue
990199|NCT03225963|Glioblastoma|glioblastoma
990200|NCT03225963|Bevacizumab|bevacizumab
990201|NCT03225950|Periodontal disease|periodontal disease
990202|NCT03225950|Periodontitis|periodontitis
990203|NCT03225950|Aggressive periodontitis|aggressive periodontitis
990204|NCT03225950|Dysbiosis|dysbiosis
990205|NCT03225950|Inflammation|inflammation
990206|NCT03225950|Regulation|regulation
990207|NCT03225950|Cytokines|cytokines
990208|NCT03225950|Bacteria|bacteria
990209|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
990210|NCT03225950|Saliva|saliva
990211|NCT03225950|Anti-CCP|anti-ccp
990212|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
990213|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
990214|NCT03225898|blood flow restriction|blood flow restriction
990215|NCT03225898|resistance exercise|resistance exercise
990216|NCT03225885|gestational age|gestational age
990217|NCT03225885|multi-media|multi-media
990218|NCT03225885|mobile application|mobile application
990219|NCT03225885|anxiety|anxiety
990220|NCT03225885|clinical trial|clinical trial
990221|NCT03225885|random allocation|random allocation
990222|NCT03225872|Osteosarcoma|osteosarcoma
990223|NCT03225872|Bone cancer|bone cancer
990224|NCT03225872|Family-based study|family-based study
990225|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
990226|NCT03225859|Self-Management|self-management
990227|NCT03225820|pharmacogenomic information|pharmacogenomic information
990228|NCT03225807|Intubated|intubated
990229|NCT03225807|Intubation|intubation
990230|NCT03225807|Ventilator|ventilator
990231|NCT03225807|Ventilator-free days|ventilator-free days
990232|NCT03225807|Ventilator free days|ventilator free days
990233|NCT03225807|Mechanical Ventilation|mechanical ventilation
990234|NCT03225807|Meta-Analysis|meta-analysis
990235|NCT03225807|Tidal Volume|tidal volume
990236|NCT03225807|Tidal Volumes|tidal volumes
990237|NCT03225807|inflammation|inflammation
990238|NCT03225807|cytokines|cytokines
990239|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
990240|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
990241|NCT03225807|Low Tidal Volumes|low tidal volumes
990242|NCT03225807|Protective Ventilation|protective ventilation
990243|NCT03225794|Retrovirus|retrovirus
990244|NCT03225794|Viral emergence|viral emergence
990245|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
990246|NCT03225755|Adipose Tissue|adipose tissue
990247|NCT03225755|Inflammation|inflammation
990248|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
990249|NCT03225703|Exercise|exercise
990250|NCT03225703|Osteoporosis|osteoporosis
990251|NCT03225703|Osteoarthritis|osteoarthritis
990252|NCT03225703|MRI|mri
990253|NCT03225703|DXA|dxa
990254|NCT03225703|High Impact|high impact
990255|NCT03225703|Cartilage|cartilage
990256|NCT03225703|Bone|bone
990257|NCT03225664|Non-Small Cell Lung Cancer|non-small cell lung cancer
990258|NCT03225664|NSCLC|nsclc
990259|NCT03225664|Trametinib|trametinib
990260|NCT03225664|GSK1120212|gsk1120212
990261|NCT03225664|Pembrolizumab|pembrolizumab
990262|NCT03225664|Keytruda|keytruda
990263|NCT03225664|MK-3475|mk-3475
990264|NCT03225664|SCH-900475|sch-900475
990265|NCT03225664|Metastatic|metastatic
990266|NCT03225664|Unresectable|unresectable
990267|NCT03225664|Locally advanced|locally advanced
990268|NCT03225664|Recurrent|recurrent
990269|NCT03225651|Stem cell|stem cell
990270|NCT03225651|Autism|autism
990271|NCT03225651|Psychological|psychological
990272|NCT03225651|Rehabilitation|rehabilitation
990273|NCT03225625|spinal cord injury|spinal cord injury
990274|NCT03225625|spinal cord compression|spinal cord compression
990275|NCT03225625|spinal cord ischemia|spinal cord ischemia
990276|NCT03225625|spinal cord diseases|spinal cord diseases
990277|NCT03225625|spinal paralysis|spinal paralysis
990278|NCT03225625|paraplegia|paraplegia
990279|NCT03225625|paraparesis|paraparesis
990280|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
990281|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
990282|NCT03225560|Smart Phone Application|smart phone application
990283|NCT03225560|Bowel Preparation|bowel preparation
990284|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
990285|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
990286|NCT03225547|breast cancer|breast cancer
990287|NCT03225547|pembrolizumab|pembrolizumab
990288|NCT03225547|mifepristone|mifepristone
990289|NCT03225534|Asthma|asthma
990290|NCT03225534|Allergy|allergy
990291|NCT03225534|Epidemiology|epidemiology
990294|NCT03225521|Physical Activity|physical activity
990295|NCT03225521|Mobile Health|mobile health
990296|NCT03225521|Self Monitoring|self monitoring
990297|NCT03225521|Wearable Sensors|wearable sensors
990298|NCT03225521|Tailored Health Communication|tailored health communication
990299|NCT03225521|Implementation Intentions|implementation intentions
990300|NCT03225521|Mobile Apps|mobile apps
990301|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
990302|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
990303|NCT03225521|Health Belief Model|health belief model
990304|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
990305|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
990306|NCT03225482|Cognitive training|cognitive training
990307|NCT03225482|Cognitive remediation|cognitive remediation
990308|NCT03225469|Bowel Preparation|bowel preparation
990309|NCT03225469|Colonoscopy|colonoscopy
990310|NCT03225469|Quality|quality
990311|NCT03225469|Family Support|family support
990312|NCT03225469|Education|education
990313|NCT03225456|appetite regulation|appetite regulation
990314|NCT03225456|obesity|obesity
990315|NCT03225456|oxytocin|oxytocin
990316|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
990317|NCT03225443|Particle radiotherapy|particle radiotherapy
990318|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
990319|NCT03225417|Ixazomib|ixazomib
990320|NCT03225404|Tendinopathy|tendinopathy
990321|NCT03225404|Electrolysis|electrolysis
990322|NCT03225404|Exercise|exercise
990323|NCT03225404|Dry needing|dry needing
990324|NCT03225391|Residents|residents
990325|NCT03225391|Naps|naps
990326|NCT03225391|decision making|decision making
990327|NCT03225378|Fluid responsiveness|fluid responsiveness
990328|NCT03225378|Passive leg raising|passive leg raising
1658900|NCT00150982|psoriasis|psoriasis
990329|NCT03225378|Pulse pressure variation|pulse pressure variation
990330|NCT03225365|Melanoma|melanoma
990331|NCT03225365|Nivolumab|nivolumab
990332|NCT03225365|Ipilimumab|ipilimumab
990333|NCT03225365|Immune modulation|immune modulation
990334|NCT03225326|articaine|articaine
990335|NCT03225326|local anesthesia|local anesthesia
990336|NCT03225326|AMSA|amsa
990337|NCT03225300|Glioblastoma|glioblastoma
990338|NCT03225300|Chemoradiation|chemoradiation
990339|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
990340|NCT03225274|Breathing exercises|breathing exercises
990341|NCT03225274|Respiratory status|respiratory status
990342|NCT03225274|Nebulization therapy|nebulization therapy
990343|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
990372|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
990373|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
990374|NCT03225131|Dark Adaptation|dark adaptation
990375|NCT03225118|Rebound|rebound
990376|NCT03225118|Reinitiation|reinitiation
990377|NCT03225118|ART|art
990378|NCT03225118|Reservoirs|reservoirs
990379|NCT03225118|Immune Exhaustion|immune exhaustion
990380|NCT03225105|Solid Tumors|solid tumors
990381|NCT03225105|M3541|m3541
990382|NCT03225105|Palliative radiotherapy|palliative radiotherapy
990383|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
990384|NCT03225092|Chronic Knee Pain|chronic knee pain
990385|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
990386|NCT03225092|Platelet Rich Plasma|platelet rich plasma
990387|NCT03225079|Pentaglobin® use|pentaglobin® use
990388|NCT03225079|severe bacterial infection|severe bacterial infection
990389|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
990390|NCT03225053|Physiotherapy|physiotherapy
990391|NCT03225040|Acromegaly|acromegaly
990392|NCT03225040|Pegvisomant|pegvisomant
990393|NCT03225040|Osteoporosis|osteoporosis
990394|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
990395|NCT03225001|Sapien XT|sapien xt
990396|NCT03225001|Partner II|partner ii
990397|NCT03225001|cardiovascular disease|cardiovascular disease
990398|NCT03225001|heart disease|heart disease
990399|NCT03225001|aortic disease|aortic disease
990400|NCT03225001|SAVR|savr
990401|NCT03225001|TAVR|tavr
990402|NCT03225001|failing surgical valve|failing surgical valve
990403|NCT03225001|failing valve|failing valve
990404|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
990405|NCT03224988|Alzheimer's Disease|alzheimer's disease
990406|NCT03224988|AD|ad
990407|NCT03224988|MCI-AD|mci-ad
990408|NCT03224988|MCI|mci
990409|NCT03224988|Memory|memory
990410|NCT03224988|TMS|tms
990411|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
990412|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
990413|NCT03224988|MRI|mri
990414|NCT03224988|DTI|dti
990415|NCT03224988|EEG|eeg
990416|NCT03224975|Pain|pain
990417|NCT03224975|Brain responses|brain responses
990418|NCT03224975|Neuroimaging|neuroimaging
990419|NCT03224975|fMRI|fmri
990420|NCT03224975|Burn|burn
990421|NCT03224975|Memory|memory
990422|NCT03224962|pit and fissure caries|pit and fissure caries
990426|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
990427|NCT03224897|Reappraisal|reappraisal
990428|NCT03224897|Emotion Regulation|emotion regulation
990429|NCT03224897|tDCS|tdcs
990430|NCT03224897|Reinterpretation|reinterpretation
990431|NCT03224858|Patient-Centered Care|patient-centered care
990432|NCT03224858|Comorbidity|comorbidity
990433|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
990434|NCT03224741|Behavioral Economics|behavioral economics
990435|NCT03224702|M6495|m6495
990436|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
990437|NCT03224702|Osteoarthritis|osteoarthritis
990438|NCT03224676|Quality of sleep|quality of sleep
990439|NCT03224676|Perceived sleep distractors|perceived sleep distractors
990440|NCT03224676|Adult patients|adult patients
990441|NCT03224663|Effectiveness|effectiveness
990442|NCT03224663|Module based learning|module based learning
990443|NCT03224663|Mobile application based learning|mobile application based learning
990444|NCT03224663|Facility based newborn care|facility based newborn care
990445|NCT03224663|Knowledge|knowledge
990446|NCT03224663|Practices|practices
990447|NCT03224663|Nursing students|nursing students
990448|NCT03224585|anakinra|anakinra
990449|NCT03224585|Kineret|kineret
990450|NCT03224585|pericarditis|pericarditis
990451|NCT03224572|vitamin C|vitamin c
990452|NCT03224572|quality of life|quality of life
990453|NCT03224572|terminal cancer|terminal cancer
990454|NCT03224533|nut consumption|nut consumption
990455|NCT03224533|NHANES|nhanes
990456|NCT03224533|epidemiology|epidemiology
990457|NCT03224533|plasma glucose|plasma glucose
990458|NCT03224533|hemoglobin A1c|hemoglobin a1c
990459|NCT03224507|multiple myeloma|multiple myeloma
990460|NCT03224507|induction therapy|induction therapy
990461|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
990462|NCT03224507|KRdD|krdd
990463|NCT03224507|Daratumumab|daratumumab
990464|NCT03224507|Carfilzomib|carfilzomib
990465|NCT03224507|Lenalidomide|lenalidomide
990466|NCT03224468|medical marijuana|medical marijuana
990467|NCT03224468|cannabis|cannabis
990468|NCT03224468|pain|pain
990469|NCT03224468|insomnia|insomnia
990470|NCT03224468|depression|depression
990471|NCT03224468|anxiety|anxiety
990472|NCT03224468|addiction|addiction
990473|NCT03224468|dependence|dependence
990474|NCT03224468|neurocognition|neurocognition
990475|NCT03224468|MRI|mri
990476|NCT03224455|sleep|sleep
990477|NCT03224455|sleep in children|sleep in children
990478|NCT03224455|children and sleep|children and sleep
990479|NCT03224455|environment|environment
990480|NCT03224455|environment and sleep|environment and sleep
990481|NCT03224455|environment and children|environment and children
990482|NCT03224416|Alcohol|alcohol
990483|NCT03224416|Delay Discounting|delay discounting
990484|NCT03224416|Risky Sexual Behavior|risky sexual behavior
990485|NCT03224416|Decision Making|decision making
990486|NCT03224416|MSM|msm
990487|NCT03224390|Contraception|contraception
990488|NCT03224390|Family Planning|family planning
990489|NCT03224390|Digital Health|digital health
990490|NCT03224390|Kenya|kenya
990491|NCT03224390|Unmet Need|unmet need
990492|NCT03224364|Solo surgery|solo surgery
990493|NCT03224364|Camera holder|camera holder
990494|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
990495|NCT03224325|Drug therapy|drug therapy
990496|NCT03224312|Primary aldosteronism|primary aldosteronism
990497|NCT03224312|cardiovascular events|cardiovascular events
990498|NCT03224312|cerebrovascular events|cerebrovascular events
990499|NCT03224286|Pressure sensitive mat|pressure sensitive mat
990500|NCT03224273|proximal box design preparation|proximal box design preparation
990501|NCT03224247|vertical splitting|vertical splitting
990502|NCT03224247|Cesarean Section Complications|cesarean section complications
990503|NCT03224247|uterine vessels|uterine vessels
990504|NCT03224247|injury|injury
990505|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
990506|NCT03224234|Insulclock|insulclock
990507|NCT03224234|Electronic device|electronic device
990508|NCT03224234|Alarm system|alarm system
990509|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
990510|NCT03224221|apatinib|apatinib
990511|NCT03224208|melanoma|melanoma
990512|NCT03224208|advanced|advanced
990513|NCT03224208|vemurafenib|vemurafenib
990514|NCT03224208|cobimetinib|cobimetinib
990515|NCT03224195|rehabilitation|rehabilitation
990516|NCT03224195|patient perspective|patient perspective
990517|NCT03224195|semi-structured interview|semi-structured interview
990518|NCT03224143|dementia|dementia
990519|NCT03224143|doll therapy|doll therapy
990520|NCT03224143|attachment|attachment
990521|NCT03224130|transitions of care|transitions of care
990522|NCT03224130|reutilization|reutilization
990523|NCT03224130|nurse phone call|nurse phone call
990524|NCT03224104|elderly|elderly
990525|NCT03224104|TG02|tg02
990526|NCT03224104|newly diagnosed|newly diagnosed
990527|NCT03224104|first relapse|first relapse
990528|NCT03224091|Eating disorders|eating disorders
990529|NCT03224091|psychopathology|psychopathology
990530|NCT03224091|pathophysiology|pathophysiology
990531|NCT03224091|prospective|prospective
990532|NCT03224091|longitudinal|longitudinal
990533|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
990534|NCT03224052|Falciparum|falciparum
990535|NCT03224052|Vivax|vivax
990536|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
990537|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
990538|NCT03224000|Human papilloma virus positive|human papilloma virus positive
990539|NCT03224000|HPV+|hpv+
990540|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
990541|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
990542|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
990543|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
990544|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
990545|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
990555|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
990557|NCT03223987|16S rRNA|16s rrna
990558|NCT03223987|Microbiome|microbiome
990559|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
990560|NCT03223974|Angioplasty|angioplasty
990561|NCT03223974|drug-coated balloon|drug-coated balloon
990562|NCT03223974|bifurcation|bifurcation
990563|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
990564|NCT03223961|erythropoetin|erythropoetin
990565|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
990566|NCT03223922|genu of corpus callosum|genu of corpus callosum
990567|NCT03223922|cognitive function|cognitive function
990568|NCT03223909|dry eye|dry eye
990569|NCT03223909|Chondroitin sulfate|chondroitin sulfate
990570|NCT03223909|Ocular lubricants|ocular lubricants
990571|NCT03223896|antagonist|antagonist
990572|NCT03223896|nasal|nasal
990573|NCT03223857|visual outcomes|visual outcomes
990574|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
990575|NCT03223857|patient satisfaction|patient satisfaction
990576|NCT03223857|spectacle independence|spectacle independence
990577|NCT03223844|Dopamine|dopamine
990578|NCT03223844|Amphetamine|amphetamine
990579|NCT03223844|Positron Emission Tomography|positron emission tomography
990580|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
990581|NCT03223844|Schizophrenia|schizophrenia
990582|NCT03223844|Psychosis|psychosis
990583|NCT03223844|[18F]FDOPA|[18f]fdopa
990584|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
990585|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
990586|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
990587|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
990588|NCT03223818|Liver|liver
990589|NCT03223818|Digestive system|digestive system
990590|NCT03223779|Colorectal Cancer|colorectal cancer
990591|NCT03223766|Proton therapy|proton therapy
990592|NCT03223766|Long-term effects|long-term effects
990593|NCT03223727|Radium-223|radium-223
990594|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
990595|NCT03223714|ME|me
990596|NCT03223714|CRVO|crvo
990600|NCT03223649|Metabolism|metabolism
990601|NCT03223649|Children|children
990602|NCT03223649|Walking Bouts|walking bouts
990603|NCT03223649|Glucose|glucose
990604|NCT03223649|Insulin|insulin
990610|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
990611|NCT03223623|CRPS|crps
990612|NCT03223623|Dystonia|dystonia
990615|NCT03223597|Radium-223|radium-223
990616|NCT03223597|quality of life|quality of life
990617|NCT03223597|Pain|pain
990618|NCT03223571|stroke|stroke
990619|NCT03223571|Upper arm|upper arm
990620|NCT03223571|Cerebral plasticity|cerebral plasticity
990621|NCT03223571|Functional connectivity|functional connectivity
990622|NCT03223571|Rehabilitation|rehabilitation
990623|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
990624|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
990625|NCT03223545|Meditation|meditation
990626|NCT03223519|DOMS|doms
990627|NCT03223519|Exercise|exercise
990628|NCT03223519|Ibuprofen|ibuprofen
990629|NCT03223519|Magnesium|magnesium
990630|NCT03223519|Vitamin C|vitamin c
990631|NCT03223519|Muscle pain|muscle pain
990632|NCT03223467|Obesity|obesity
990633|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
990634|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
990635|NCT03223467|Metabolic syndrome|metabolic syndrome
990636|NCT03223441|Pulse wave velocity|pulse wave velocity
990637|NCT03223441|anesthesia|anesthesia
990638|NCT03223415|Clostridium difficile infection|clostridium difficile infection
990639|NCT03223415|Infection Control|infection control
990640|NCT03223415|Prevention|prevention
991233|NCT03219398|Occludin|occludin
990642|NCT03223415|Colonization|colonization
990643|NCT03223415|Pilot Study|pilot study
990644|NCT03223415|Contact Precaution|contact precaution
990645|NCT03223415|Detection|detection
990646|NCT03223363|Birth weight Prediction|birth weight prediction
990647|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
990648|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
990649|NCT03223337|GSK1278863|gsk1278863
990650|NCT03223337|Daprodustat|daprodustat
990651|NCT03223337|Healthy control|healthy control
990652|NCT03223337|Single dose|single dose
990653|NCT03223337|Hepatic Impairment|hepatic impairment
990654|NCT03223324|Threatened Premature Labor|threatened premature labor
990655|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
990656|NCT03223298|Myofascial Pain|myofascial pain
990657|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
990658|NCT03223298|Maxillofacial Pain|maxillofacial pain
990659|NCT03223298|Masseter Muscle|masseter muscle
990660|NCT03223298|Temporalis Muscle|temporalis muscle
990661|NCT03223298|Botulinum Toxin|botulinum toxin
990662|NCT03223285|Cervical spine;|cervical spine;
990663|NCT03223285|Diaphragm;|diaphragm;
990664|NCT03223285|Manual Therapy|manual therapy
990665|NCT03223285|Pain|pain
990666|NCT03223285|Range of Motion|range of motion
990667|NCT03223272|hypertension|hypertension
990668|NCT03223272|sympathetic tone|sympathetic tone
990669|NCT03223272|resperpine|resperpine
990670|NCT03223259|Dance Injuries|dance injuries
990671|NCT03223259|Injury Prevention Workshops|injury prevention workshops
990672|NCT03223259|Motor Skill Theory|motor skill theory
990673|NCT03223259|Gross Motor Skills|gross motor skills
990674|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
990675|NCT03223194|Crigler-Najjar|crigler-najjar
990676|NCT03223194|CN|cn
990677|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
990678|NCT03223194|Adeno Associated Virus|adeno associated virus
990679|NCT03223181|Comiss|comiss
990680|NCT03223155|Small cell lung cancer|small cell lung cancer
990681|NCT03223155|ipilimumab|ipilimumab
990682|NCT03223155|nivolumab|nivolumab
990683|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
990684|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
990685|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
990686|NCT03223129|Metabolomics|metabolomics
990687|NCT03223116|heartburn|heartburn
990688|NCT03223116|regurgitation|regurgitation
990689|NCT03223103|Brain cancer|brain cancer
990690|NCT03223103|Glioblastoma|glioblastoma
990691|NCT03223103|Personalized vaccine|personalized vaccine
990692|NCT03223103|Poly-ICLC|poly-iclc
990693|NCT03223103|Immunotherapy|immunotherapy
990694|NCT03223103|Cancer|cancer
990695|NCT03223103|NovoTTF-200A|novottf-200a
990696|NCT03223103|Optune|optune
990697|NCT03223103|GBM|gbm
990698|NCT03223103|immunogenicity|immunogenicity
990699|NCT03223090|Language|language
990700|NCT03223090|learning|learning
990701|NCT03223090|plasticity|plasticity
990702|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
990703|NCT03223051|Children|children
990704|NCT03223051|Motor assessment|motor assessment
990705|NCT03223051|Space exploration|space exploration
990706|NCT03223051|Upper limbs|upper limbs
990708|NCT03223025|IGHD|ighd
990709|NCT03223025|somatropin|somatropin
990710|NCT03223012|Adalimumab|adalimumab
990711|NCT03223012|Humira®|humira®
990712|NCT03223012|AbbVie patient care support program|abbvie patient care support program
990713|NCT03223012|Psoriasis and ankylosing spondylitis|psoriasis and ankylosing spondylitis
990714|NCT03223012|Rheumatoid Arthritis|rheumatoid arthritis
990715|NCT03223012|Ulcerative Colitis|ulcerative colitis
990716|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
990717|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
990718|NCT03222973|Remyelination|remyelination
990719|NCT03222973|Re-myelination|re-myelination
990720|NCT03222973|DMT|dmt
990721|NCT03222973|LINGO-1|lingo-1
990722|NCT03222973|Anti-LINGO-1|anti-lingo-1
990723|NCT03222973|Opicinumab|opicinumab
990724|NCT03222921|high tibial osteotomy|high tibial osteotomy
990725|NCT03222908|Behavior|behavior
990726|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
990727|NCT03222908|contract agreement|contract agreement
990728|NCT03222908|implementation intentions|implementation intentions
990729|NCT03222908|precommitment|precommitment
990730|NCT03222908|smoking cessation|smoking cessation
990731|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
990732|NCT03222895|Lymph node metastases|lymph node metastases
990733|NCT03222895|Esophagectomy|esophagectomy
990734|NCT03222843|ITP|itp
990735|NCT03222804|Infants|infants
990736|NCT03222804|Probiotic|probiotic
990737|NCT03222804|B. Infantis|b. infantis
990738|NCT03222791|Diabetes|diabetes
990739|NCT03222778|fluid responsiveness|fluid responsiveness
990740|NCT03222778|tissue doppler|tissue doppler
990741|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
990742|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
990743|NCT03222752|Alpha-Stim|alpha-stim
990744|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
990746|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
990747|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
990748|NCT03222674|AML|aml
990749|NCT03222674|CAR T|car t
990750|NCT03222674|Muc1, CD33, CD38, CD56, and/or CD123|muc1, cd33, cd38, cd56, and/or cd123
990751|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
990752|NCT03222648|Exercise training|exercise training
990753|NCT03222648|Health related quality of life|health related quality of life
990754|NCT03222648|Biomarkers|biomarkers
990755|NCT03222635|Barrett's esophagus|barrett's esophagus
990756|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
990757|NCT03222635|Endoscopic treatment|endoscopic treatment
990758|NCT03222635|Endoscopic follow-up|endoscopic follow-up
990759|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
990760|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
990761|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
990762|NCT03222609|ruxolitinib|ruxolitinib
990763|NCT03222609|navitoclax|navitoclax
990764|NCT03222609|splenic volume|splenic volume
990765|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
990766|NCT03222609|Jakafi|jakafi
990767|NCT03222609|enlarged spleen|enlarged spleen
990768|NCT03222609|splenomegaly|splenomegaly
990769|NCT03222609|ABT 263|abt 263
990770|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
990771|NCT03222596|Quality of Life|quality of life
990772|NCT03222596|Fatigue|fatigue
990773|NCT03222596|Physical Disability|physical disability
990774|NCT03222596|Disabilities Psychological|disabilities psychological
990775|NCT03222596|Pain|pain
990776|NCT03222596|Motivation|motivation
990777|NCT03222596|Multiple sclerosis|multiple sclerosis
990778|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
990779|NCT03222583|Genotype 1 to 6|genotype 1 to 6
990780|NCT03222583|Asian|asian
990781|NCT03222583|non-cirrhotic|non-cirrhotic
990782|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
990783|NCT03222583|co-infection|co-infection
990784|NCT03222583|Treatment-naïve|treatment-naïve
990785|NCT03222583|Treatment-experienced|treatment-experienced
990786|NCT03222583|interferon|interferon
990787|NCT03222544|Indocyanine Green|indocyanine green
990788|NCT03222544|Photodynamics Therapy|photodynamics therapy
990789|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
990790|NCT03222505|Stroke|stroke
990791|NCT03222505|Gait Stride Management Assist|gait stride management assist
990792|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
990793|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
990794|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
990795|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
990796|NCT03222492|Brentuximab vedotin|brentuximab vedotin
990797|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
990798|NCT03222453|thalassemia|thalassemia
990799|NCT03222453|stem cell|stem cell
990800|NCT03222388|IIEF|iief
990801|NCT03222388|electronic validation|electronic validation
990802|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
990803|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
990804|NCT03222375|Center of Synergetics|center of synergetics
990805|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
990806|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
990807|NCT03222375|Autowave Reverberator|autowave reverberator
990808|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
990809|NCT03222375|Spiral Autowaves|spiral autowaves
990810|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
990811|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
990812|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
990813|NCT03222375|Autowaves/SQUED|autowaves/squed
990814|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
990815|NCT03222362|retinal detachment|retinal detachment
990816|NCT03222362|trauma|trauma
990817|NCT03222362|age related macular degeneration|age related macular degeneration
990818|NCT03222349|interictal state|interictal state
990819|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
990820|NCT03222323|volunteers|volunteers
990821|NCT03222284|diabetes|diabetes
990822|NCT03222284|type 2 diabetes|type 2 diabetes
990823|NCT03222284|type ii diabetes|type ii diabetes
990824|NCT03222284|insulin|insulin
990825|NCT03222284|mobile applications|mobile applications
990826|NCT03222284|Diabetes Mellitus|diabetes mellitus
990827|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
991234|NCT03219398|KIM-1|kim-1
990828|NCT03222284|smartphone application|smartphone application
990829|NCT03222284|health application|health application
990830|NCT03222271|NIV weaning strategy|niv weaning strategy
990831|NCT03222258|Palliative Care|palliative care
990832|NCT03222258|Quality of Life|quality of life
990833|NCT03222258|Prospective Cohort Study|prospective cohort study
990834|NCT03222258|Treatment decision|treatment decision
990835|NCT03222258|Utilization of health care|utilization of health care
990836|NCT03222232|intestinal failure|intestinal failure
990837|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
990838|NCT03222232|catheter salvage|catheter salvage
990839|NCT03222232|recurrent infections|recurrent infections
990840|NCT03222232|home parenteral support|home parenteral support
990841|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
990842|NCT03222206|Hepatokine|hepatokine
990843|NCT03222206|Adipokine|adipokine
990844|NCT03222206|Saccharometabolism|saccharometabolism
990845|NCT03222206|Lipid metabolism|lipid metabolism
990846|NCT03222193|Medical device|medical device
990847|NCT03222193|Retraining|retraining
990848|NCT03222193|Snoring|snoring
990849|NCT03222193|TRP|trp
990850|NCT03222193|Tongue|tongue
990851|NCT03222167|Elbasvir|elbasvir
990852|NCT03222167|Grazoprevir|grazoprevir
990853|NCT03222167|SVR12|svr12
990854|NCT03222167|hepatitis C|hepatitis c
990855|NCT03222167|metabolic syndrome|metabolic syndrome
1658901|NCT00150982|alefacept|alefacept
990856|NCT03222154|High Energy Shock Waves|high energy shock waves
990857|NCT03222154|physiotherapy|physiotherapy
990858|NCT03222141|Sapien 3|sapien 3
990859|NCT03222141|Transfemoral|transfemoral
990860|NCT03222141|Transapical|transapical
990861|NCT03222141|Transaortic|transaortic
990862|NCT03222141|TAVI|tavi
990863|NCT03222141|Aortic Stenosis|aortic stenosis
990864|NCT03222141|THV|thv
990865|NCT03222141|Aortic Valve|aortic valve
990866|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
990867|NCT03222141|TAVR|tavr
990868|NCT03222128|SAPIEN 3|sapien 3
990869|NCT03222128|Transfemoral|transfemoral
990870|NCT03222128|Transapical|transapical
990871|NCT03222128|Transaortic|transaortic
990872|NCT03222128|NovaFlex|novaflex
990873|NCT03222128|TAVI|tavi
990874|NCT03222128|Aortic Stenosis|aortic stenosis
990875|NCT03222128|THV|thv
990876|NCT03222128|Aortic Valve|aortic valve
990877|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
990878|NCT03222128|TAVR|tavr
990879|NCT03222076|Hepatocellular carcinoma|hepatocellular carcinoma
990880|NCT03222076|Resectable|resectable
990881|NCT03222076|Potentially resectable|potentially resectable
990882|NCT03222076|Nivolumab|nivolumab
990883|NCT03222076|BMS-936558|bms-936558
990884|NCT03222076|Opdivo|opdivo
990885|NCT03222076|Ipilimumab|ipilimumab
990886|NCT03222076|Yervoy|yervoy
990887|NCT03222076|BMS-734016|bms-734016
990888|NCT03222076|MDX010|mdx010
990889|NCT03222063|Play interventions, anxiety|play interventions, anxiety
990890|NCT03222024|ischaemic stroke|ischaemic stroke
990891|NCT03222024|severe|severe
990892|NCT03222024|malignant|malignant
990893|NCT03222024|courses|courses
990894|NCT03222024|risk factors|risk factors
990895|NCT03222024|clinical course|clinical course
990896|NCT03222024|management|management
990897|NCT03222024|prognosis|prognosis
990898|NCT03222011|Crohn Disease|crohn disease
990899|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
990900|NCT03222011|Intestinal stricture|intestinal stricture
990901|NCT03221998|morbidly obese|morbidly obese
990902|NCT03221998|,elective sleeve|,elective sleeve
990903|NCT03221998|gastrectomy|gastrectomy
990904|NCT03221998|paracetamol|paracetamol
990905|NCT03221998|IV Perfelgan|iv perfelgan
990906|NCT03221985|experience sampling method|experience sampling method
990907|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
990908|NCT03221972|6-17 years old|6-17 years old
990909|NCT03221972|vitamin D deficiency|vitamin d deficiency
990910|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
990911|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
990912|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
990913|NCT03221894|Complementary therapies|complementary therapies
990914|NCT03221868|motor activity|motor activity
990915|NCT03221868|women|women
990916|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
990917|NCT03221842|Renal|renal
990918|NCT03221829|spinal anaesthesia|spinal anaesthesia
990919|NCT03221829|elderly patients|elderly patients
990920|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
990921|NCT03221816|Menopause|menopause
990922|NCT03221816|homocysteine|homocysteine
990923|NCT03221816|lipid profile|lipid profile
990924|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
990925|NCT03221790|Low FODMAP diet|low fodmap diet
990926|NCT03221790|Mucosal Inflammation|mucosal inflammation
990927|NCT03221751|randomized controlled trial|randomized controlled trial
990928|NCT03221738|BDD|bdd
990929|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
991724|NCT03216317|Hypotension|hypotension
990930|NCT03221725|stress urinary incontinence|stress urinary incontinence
990931|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
990932|NCT03221712|chronic total occlusion|chronic total occlusion
990933|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
990934|NCT03221673|Exercise|exercise
990935|NCT03221673|Children|children
990936|NCT03221673|Arkansas|arkansas
990937|NCT03221673|Physical activity|physical activity
990938|NCT03221673|Sedentary|sedentary
990939|NCT03221660|filling material, polymerization|filling material, polymerization
990940|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
990941|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
990942|NCT03221634|PD-1|pd-1
990943|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
990944|NCT03221634|PD-L1|pd-l1
990945|NCT03221621|Acne inversa|acne inversa
990946|NCT03221621|Adalimumab|adalimumab
990947|NCT03221621|Cost-effectiveness|cost-effectiveness
990948|NCT03221608|Colorectal Cancer|colorectal cancer
990949|NCT03221608|HIPEC|hipec
990950|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
990951|NCT03221608|Lobaplatin|lobaplatin
990952|NCT03221556|Comparative effectiveness research|comparative effectiveness research
990953|NCT03221556|Patient-centered medical home|patient-centered medical home
990954|NCT03221556|Shared decision-making|shared decision-making
990955|NCT03221530|suicidal ideation|suicidal ideation
990956|NCT03221530|mental health|mental health
990957|NCT03221530|adolescent|adolescent
990958|NCT03221530|Latino|latino
990959|NCT03221530|immigrant|immigrant
990960|NCT03221504|urinary tract infections|urinary tract infections
990961|NCT03221504|pyelonephritis|pyelonephritis
990962|NCT03221504|cefuroxime|cefuroxime
990963|NCT03221504|children|children
990964|NCT03221491|Analgesia|analgesia
990965|NCT03221491|Colorectal Surgery|colorectal surgery
990966|NCT03221491|Background Infusion|background infusion
990967|NCT03221439|back pain|back pain
990968|NCT03221439|physiotherapy|physiotherapy
990969|NCT03221439|exercise therapy|exercise therapy
990970|NCT03221439|cognitive functional therapy|cognitive functional therapy
990971|NCT03221439|low back pain|low back pain
990972|NCT03221439|backache|backache
990973|NCT03221439|lower back pain|lower back pain
990974|NCT03221439|lumbago|lumbago
990975|NCT03221439|multidimensional|multidimensional
990976|NCT03221439|biopsychosocial|biopsychosocial
990977|NCT03221426|PD1|pd1
990978|NCT03221426|PD-1|pd-1
990979|NCT03221426|PDL1|pdl1
990980|NCT03221426|PD-L1|pd-l1
990981|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
990982|NCT03221413|Neuroimaging|neuroimaging
990983|NCT03221413|EEG|eeg
990984|NCT03221387|Therapy|therapy
990985|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
990986|NCT03221335|EUS-guided RFA|eus-guided rfa
990987|NCT03221335|liver|liver
990988|NCT03221335|stomach|stomach
990989|NCT03221335|adrenal|adrenal
990990|NCT03221335|kidney tumour|kidney tumour
990991|NCT03221283|Music therapy|music therapy
990992|NCT03221283|Depression|depression
990993|NCT03221283|Emotion|emotion
990994|NCT03221283|Motivation|motivation
990995|NCT03221270|tACS|tacs
990996|NCT03221270|Sham|sham
990997|NCT03221270|Auditory Hallucinations|auditory hallucinations
990998|NCT03221270|Schizophrenia|schizophrenia
990999|NCT03221270|Schizo Affective Disorder|schizo affective disorder
991000|NCT03221270|EEG|eeg
991001|NCT03221244|Distractibility|distractibility
991002|NCT03221244|Virtual Reality|virtual reality
991003|NCT03221244|Attention|attention
991004|NCT03221244|Child|child
991005|NCT03221244|Pediatric|pediatric
991006|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
991007|NCT03221205|obesity|obesity
991008|NCT03221205|DM2|dm2
991009|NCT03221205|TEI index|tei index
991010|NCT03221205|CPAP|cpap
991011|NCT03221192|Real-time data capture|real-time data capture
991012|NCT03221192|Concept elicitation|concept elicitation
991013|NCT03221192|Nasal polyps|nasal polyps
991014|NCT03221192|Cognitive debriefing|cognitive debriefing
991015|NCT03221192|Patient-reported outcomes|patient-reported outcomes
991016|NCT03221192|HRQoL|hrqol
991017|NCT03221166|Children|children
991018|NCT03221166|Crohn disease|crohn disease
991019|NCT03221166|Thalidomide|thalidomide
991020|NCT03221166|Mucosal healing|mucosal healing
991021|NCT03221153|Patient Safety|patient safety
991022|NCT03221153|Quality|quality
991023|NCT03221153|Simulation|simulation
991024|NCT03221153|Undergraduate|undergraduate
991025|NCT03221153|Medical Student|medical student
991026|NCT03221114|Hispanics/Latinos|hispanics/latinos
991027|NCT03221114|Underserved Population|underserved population
991028|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
991029|NCT03221075|Azole resistance|azole resistance
991030|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
991031|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
991032|NCT03221075|Patient registry|patient registry
991831|NCT03215602|strength|strength
991033|NCT03221049|diagnosis performance|diagnosis performance
991034|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
991035|NCT03221049|liver fibrosis|liver fibrosis
991037|NCT03221036|Drug therapy|drug therapy
991038|NCT03221023|Vancomycin|vancomycin
991039|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
991040|NCT03221023|Deep Brain Stimulation|deep brain stimulation
991041|NCT03221023|Surgical Site Infection|surgical site infection
991042|NCT03221010|Smoking|smoking
991043|NCT03221010|Smoking cessation|smoking cessation
991044|NCT03221010|Motivational Interviewing|motivational interviewing
991045|NCT03221010|Primary health care|primary health care
991046|NCT03221010|Randomized clinical trial|randomized clinical trial
991047|NCT03220997|Sequela|sequela
991048|NCT03220997|Ketosis|ketosis
991049|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
991050|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
991051|NCT03220919|Insulin|insulin
991052|NCT03220919|Type 2 diabetes|type 2 diabetes
991053|NCT03220880|Dexmedetomidine|dexmedetomidine
991054|NCT03220880|Sedation|sedation
991055|NCT03220880|Pediatric|pediatric
991056|NCT03220841|Crohn Disease|crohn disease
991057|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
991058|NCT03220841|Intestinal stricture|intestinal stricture
991059|NCT03220698|endotracheal intubation|endotracheal intubation
991060|NCT03220698|confirmation|confirmation
991061|NCT03220698|ultrasonography|ultrasonography
991062|NCT03220685|Microbiota|microbiota
991063|NCT03220672|Pelvic floor muscles|pelvic floor muscles
991064|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
991065|NCT03220672|motor control|motor control
991066|NCT03220672|Educational intervention|educational intervention
991067|NCT03220672|menopause|menopause
991068|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
991069|NCT03220646|17-261|17-261
991070|NCT03220620|fluid therapy|fluid therapy
991071|NCT03220620|perioperative|perioperative
991072|NCT03220620|hemodilution|hemodilution
991073|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
991074|NCT03220594|hypogastric artery|hypogastric artery
991075|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
991076|NCT03220594|ovarian reserve|ovarian reserve
991077|NCT03220594|postpartum|postpartum
991078|NCT03220555|Buzzy|buzzy
991079|NCT03220555|anesthetic cream|anesthetic cream
991080|NCT03220555|pediatric|pediatric
991081|NCT03220555|pain|pain
991082|NCT03220555|venipuncture|venipuncture
991083|NCT03220555|vaccination|vaccination
991084|NCT03220555|vibration|vibration
991085|NCT03220555|cold|cold
991086|NCT03220555|distraction|distraction
991087|NCT03220555|vaccination center|vaccination center
991088|NCT03220542|Helicobacter Pylori|helicobacter pylori
991089|NCT03220542|Probiotics|probiotics
991090|NCT03220542|Sulforaphane|sulforaphane
991091|NCT03220477|Pembrolizumab|pembrolizumab
991092|NCT03220477|guadecitabine|guadecitabine
991093|NCT03220477|mocetinostat|mocetinostat
991094|NCT03220477|17-241|17-241
991095|NCT03220451|pressure ulcer|pressure ulcer
991096|NCT03220451|pressure sore|pressure sore
991097|NCT03220451|decubitus ulcer|decubitus ulcer
991098|NCT03220451|spinal cord injury|spinal cord injury
991099|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
991100|NCT03220451|taping|taping
991101|NCT03220451|kinesio taping|kinesio taping
991102|NCT03220451|neuro taping|neuro taping
991103|NCT03220412|adolescent|adolescent
991105|NCT03220412|violence|violence
991106|NCT03220412|media|media
991107|NCT03220386|staphylococcus aureus|staphylococcus aureus
991108|NCT03220386|nosocomial infection|nosocomial infection
991109|NCT03220386|decolonization|decolonization
991110|NCT03220386|emergency department|emergency department
991111|NCT03220373|Neuropsychology|neuropsychology
991112|NCT03220373|Cognition|cognition
991113|NCT03220373|Drop-out|drop-out
991114|NCT03220373|Follow-up|follow-up
991115|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
991116|NCT03220347|Safety|safety
991117|NCT03220347|Efficacy|efficacy
991118|NCT03220347|CC-90010|cc-90010
991119|NCT03220347|Solid Tumors|solid tumors
991120|NCT03220347|Relapsed/Refractory|relapsed/refractory
991121|NCT03220308|Self-control|self-control
991122|NCT03220308|Well-being|well-being
991123|NCT03220269|Utstein|utstein
991124|NCT03220269|Resuscitation|resuscitation
991125|NCT03220269|Epidemiology|epidemiology
991126|NCT03220269|Emergency medicine|emergency medicine
991127|NCT03220269|Resuscitation Registry|resuscitation registry
991128|NCT03220230|Next generation sequencing|next generation sequencing
991129|NCT03220230|Lung cancer|lung cancer
991130|NCT03220230|target therapies|target therapies
991131|NCT03220204|Heart Failure|heart failure
991132|NCT03220204|Positive Psychology|positive psychology
991133|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
991134|NCT03220178|breast cancer|breast cancer
991135|NCT03220178|HER2 negative|her2 negative
991136|NCT03220178|hormone receptor positive|hormone receptor positive
991137|NCT03220178|advanced|advanced
991138|NCT03220178|metastatic|metastatic
991140|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
991141|NCT03220100|Lung Cancer|lung cancer
991142|NCT03219983|interscalene block|interscalene block
991143|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
991144|NCT03219957|HCV|hcv
991145|NCT03219957|Hepatitis C Virus|hepatitis c virus
991146|NCT03219957|RNA Viruses|rna viruses
991147|NCT03219957|Flavivirus|flavivirus
991148|NCT03219957|Liver Diseases|liver diseases
991149|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
991150|NCT03219957|Flaviviridae Infections|flaviviridae infections
991151|NCT03219931|infant colics|infant colics
991152|NCT03219931|probiotic|probiotic
991153|NCT03219931|gut microbiome|gut microbiome
991154|NCT03219931|bifidobacterium breve|bifidobacterium breve
991155|NCT03219931|crying time|crying time
991156|NCT03219918|Colorectal adenoma|colorectal adenoma
991157|NCT03219918|Colonoscopy|colonoscopy
991158|NCT03219918|Caps|caps
991159|NCT03219918|Adenoma detection rate|adenoma detection rate
991160|NCT03219892|freezing of gait|freezing of gait
991161|NCT03219892|rTMS|rtms
991162|NCT03219892|fMRI|fmri
991163|NCT03219879|Relapse prevention|relapse prevention
991164|NCT03219879|Persistent depressive disorder|persistent depressive disorder
991165|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
991166|NCT03219879|Telephone-based intervention|telephone-based intervention
991167|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
991168|NCT03219866|Nebulizer|nebulizer
991169|NCT03219866|Inhaler|inhaler
991170|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
991171|NCT03219840|Chewing Gum|chewing gum
991172|NCT03219814|body-image|body-image
991173|NCT03219814|attention|attention
991174|NCT03219814|cognitive dissonance|cognitive dissonance
991175|NCT03219814|eating disorder prevention|eating disorder prevention
991176|NCT03219788|emergence|emergence
991177|NCT03219788|remifentanil|remifentanil
991178|NCT03219788|recovery|recovery
991179|NCT03219788|desflurene|desflurene
991180|NCT03219775|tailored immuno therapy|tailored immuno therapy
991181|NCT03219775|Nivolumab|nivolumab
991182|NCT03219775|Ipilimumab|ipilimumab
991183|NCT03219775|boost|boost
991184|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
991185|NCT03219749|exercise training|exercise training
991186|NCT03219749|vascular function|vascular function
991187|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
991188|NCT03219710|olanzapine|olanzapine
991189|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
991190|NCT03219658|Parenting|parenting
991191|NCT03219658|Home visiting|home visiting
991192|NCT03219658|Childhood obesity treatment|childhood obesity treatment
991193|NCT03219606|Systemic sclerosis|systemic sclerosis
991194|NCT03219606|Education|education
991195|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
991196|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
991197|NCT03219528|Diarrhea|diarrhea
991198|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
991199|NCT03219528|Gut Microbiota|gut microbiota
991200|NCT03219502|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
991201|NCT03219502|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
991202|NCT03219502|rTMS|rtms
991203|NCT03219502|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
991204|NCT03219502|CIPN|cipn
991205|NCT03219502|Electroencephalogram|electroencephalogram
991206|NCT03219502|EEG|eeg
991207|NCT03219502|Assessment Questionnaires|assessment questionnaires
991208|NCT03219502|Pain Questionnaires|pain questionnaires
991209|NCT03219502|Surveys|surveys
991210|NCT03219489|Electronic Medical Record|electronic medical record
991211|NCT03219489|Progesterone|progesterone
991212|NCT03219476|aromatase inhibitor|aromatase inhibitor
991213|NCT03219476|breast cancer|breast cancer
991214|NCT03219476|estrogen receptor|estrogen receptor
991215|NCT03219476|progesterone receptor|progesterone receptor
991216|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
991217|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
991218|NCT03219476|HR+|hr+
991219|NCT03219476|HER2-negative|her2-negative
991220|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
991221|NCT03219450|Leukemia|leukemia
991222|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
991223|NCT03219437|ABBV-066|abbv-066
991224|NCT03219437|BI 655066|bi 655066
991225|NCT03219424|Return to work status|return to work status
991226|NCT03219424|Functional outcome|functional outcome
991227|NCT03219424|Quality of life|quality of life
991228|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
991229|NCT03219398|Pneumoperitoneum|pneumoperitoneum
991230|NCT03219398|Renal resistive index|renal resistive index
991231|NCT03219398|Syndecan-1|syndecan-1
991232|NCT03219398|soluble VEGF-R2|soluble vegf-r2
991235|NCT03219398|Interleukin-6|interleukin-6
991236|NCT03219385|uterine leiomyoma|uterine leiomyoma
991237|NCT03219385|uterine fibroid|uterine fibroid
991238|NCT03219385|uterine myoma|uterine myoma
991730|NCT03216148|FET PET|fet pet
991239|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
991240|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
991241|NCT03219385|menorrhagia|menorrhagia
991242|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
991243|NCT03219385|ultrasound imaging|ultrasound imaging
991244|NCT03219359|IBD|ibd
991245|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
991246|NCT03219359|Gastroenteritis|gastroenteritis
991247|NCT03219359|Crohn's disease|crohn's disease
991248|NCT03219359|Colitis|colitis
991249|NCT03219359|Vedolizumab|vedolizumab
991250|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
991251|NCT03219333|Enfortumab vedotin|enfortumab vedotin
991252|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
991253|NCT03219333|ASG-22CE|asg-22ce
991254|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
1658902|NCT00150969|vitamin K|vitamin k
991255|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
991256|NCT03219333|Nectin-4|nectin-4
991257|NCT03219333|Platinum-naïve|platinum-naïve
991258|NCT03219333|Cisplatin-ineligible|cisplatin-ineligible
991259|NCT03219333|Antineoplastic Agents|antineoplastic agents
991260|NCT03219333|Drug Therapy|drug therapy
991261|NCT03219333|ASG-22ME|asg-22me
991262|NCT03219320|Type 2 Diabetes|type 2 diabetes
991263|NCT03219320|Neuropathic Pain|neuropathic pain
991264|NCT03219320|Peripheral Nervous System|peripheral nervous system
991265|NCT03219307|cartilage repair|cartilage repair
991266|NCT03219307|cartilage regeneration|cartilage regeneration
991267|NCT03219307|cartilage reconstruction|cartilage reconstruction
991268|NCT03219307|cartilage restoration|cartilage restoration
991269|NCT03219307|autologous chondrocyte implantation|autologous chondrocyte implantation
991270|NCT03219307|matrix associated chondrocyte implantation|matrix associated chondrocyte implantation
991271|NCT03219294|neuromuscular blockade|neuromuscular blockade
991272|NCT03219294|sugammadex|sugammadex
991273|NCT03219255|Post-marketing|post-marketing
991274|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
991275|NCT03219255|Drug use investigation|drug use investigation
991276|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
991277|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
991278|NCT03219229|Fat-free mass|fat-free mass
991279|NCT03219229|Tanner stage 1|tanner stage 1
991280|NCT03219229|Pre-pubertal|pre-pubertal
991281|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
991282|NCT03219216|Genotype 1 - 6|genotype 1 - 6
991283|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
991284|NCT03219216|Glecaprevir|glecaprevir
991285|NCT03219216|Pibrentasvir|pibrentasvir
991286|NCT03219216|Treatment naïve|treatment naïve
991287|NCT03219216|Cirrhosis|cirrhosis
991288|NCT03219216|Compensated cirrhosis|compensated cirrhosis
991289|NCT03219203|HBV vaccination|hbv vaccination
991290|NCT03219203|immunity|immunity
991291|NCT03219138|muscle function tests|muscle function tests
991292|NCT03219125|marrow adipose tissue|marrow adipose tissue
991293|NCT03219125|bone marrow adiposity|bone marrow adiposity
991294|NCT03219112|balance|balance
991295|NCT03219112|rehabilitation|rehabilitation
991296|NCT03219112|exergaming|exergaming
991297|NCT03219112|virtual reality|virtual reality
991298|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
991299|NCT03219086|caesarian section|caesarian section
991300|NCT03219086|prilocaine|prilocaine
991301|NCT03219086|bupivacaine|bupivacaine
991302|NCT03219073|multiple sclerosis|multiple sclerosis
991303|NCT03219073|neuropathic pain|neuropathic pain
991304|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
991305|NCT03219073|tDCS|tdcs
991306|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
991307|NCT03219060|Cognitive dissonance|cognitive dissonance
991308|NCT03219060|Motivational interviewing|motivational interviewing
991309|NCT03219060|Health Professional role|health professional role
991310|NCT03219060|Nurses|nurses
991311|NCT03219060|Health Promotion|health promotion
991312|NCT03219060|Lifestyle|lifestyle
991313|NCT03219060|Smoking cessation|smoking cessation
991314|NCT03219047|Mantle Cell Lymphoma|mantle cell lymphoma
991315|NCT03219047|MCL|mcl
991316|NCT03219047|Relapsed/refractory|relapsed/refractory
991317|NCT03219047|Xenograft|xenograft
991318|NCT03219047|PDX|pdx
991319|NCT03219047|Ibrutinib|ibrutinib
991320|NCT03219047|PCI-32765|pci-32765
991321|NCT03219047|Imbruvica|imbruvica
991322|NCT03219034|oral appliance|oral appliance
991323|NCT03219034|sleep quality|sleep quality
991324|NCT03219034|sleep apnea|sleep apnea
991325|NCT03219021|Cleft lip and Palate|cleft lip and palate
991326|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
991327|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
991328|NCT03219021|arch dimensions|arch dimensions
991329|NCT03219021|arch discrepancies|arch discrepancies
991330|NCT03219021|dental arch dimensions|dental arch dimensions
991331|NCT03219021|arch parameter|arch parameter
991332|NCT03219021|arch circumference|arch circumference
991333|NCT03219021|intercanine width|intercanine width
991334|NCT03219021|first deciduous molar width|first deciduous molar width
991335|NCT03219021|second deciduous molar width|second deciduous molar width
991336|NCT03219021|permanent first molar width|permanent first molar width
991337|NCT03219008|depressive disorder|depressive disorder
991338|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
991339|NCT03219008|individualized therapy|individualized therapy
991340|NCT03219008|management technique|management technique
991341|NCT03219008|e-MBC|e-mbc
991342|NCT03219008|MBC|mbc
991343|NCT03218995|DMD|dmd
991344|NCT03218995|Duchenne|duchenne
991345|NCT03218995|Eteplirsen|eteplirsen
991346|NCT03218995|dystrophy|dystrophy
991347|NCT03218995|dystrophin|dystrophin
991348|NCT03218995|exon 51|exon 51
991349|NCT03218982|Caregiver|caregiver
991350|NCT03218982|Vietnamese|vietnamese
991351|NCT03218982|Alzheimer's Disease|alzheimer's disease
991352|NCT03218956|Protein requirement|protein requirement
991353|NCT03218943|BiPAP|bipap
991354|NCT03218943|APRV|aprv
991355|NCT03218943|Physiological dead space|physiological dead space
991356|NCT03218943|volumetric capnography|volumetric capnography
991357|NCT03218943|ARDS|ards
991358|NCT03218943|impaired oxygenation|impaired oxygenation
991360|NCT03218943|Mechanical ventilation|mechanical ventilation
991361|NCT03218930|General Practice|general practice
991362|NCT03218930|Social Marketing|social marketing
991363|NCT03218930|Behavior Change|behavior change
991364|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
991365|NCT03218917|P aeruginosa|p aeruginosa
991366|NCT03218917|bronchiectasis|bronchiectasis
991367|NCT03218917|active neutrophil elastase|active neutrophil elastase
991368|NCT03218904|Glucose Breath Test|glucose breath test
991369|NCT03218891|Refractory Angina|refractory angina
991370|NCT03218891|Rehabilitation|rehabilitation
991371|NCT03218839|PrePex|prepex
991372|NCT03218839|HIV Seropositivity|hiv seropositivity
991373|NCT03218800|subcutaneous|subcutaneous
991374|NCT03218800|ertapenem|ertapenem
991375|NCT03218800|urinary tract infection|urinary tract infection
991376|NCT03218800|advanced cancer|advanced cancer
991377|NCT03218800|palliative care|palliative care
991378|NCT03218787|Coronary Artery Lesions|coronary artery lesions
991379|NCT03218787|XIENCE|xience
991380|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
991381|NCT03218787|Reduced DAPT|reduced dapt
991382|NCT03218787|Risk of bleeding|risk of bleeding
991383|NCT03218787|Drug-eluting stents|drug-eluting stents
991384|NCT03218761|norepinephrine|norepinephrine
991385|NCT03218761|norepinephrine transporter|norepinephrine transporter
991386|NCT03218748|Mental illness|mental illness
991387|NCT03218748|Disclosure|disclosure
991388|NCT03218748|stigma|stigma
991389|NCT03218748|soldiers|soldiers
991390|NCT03218748|secrecy|secrecy
991391|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
991392|NCT03218722|Acute traumatic coagulopathy|acute traumatic coagulopathy
991393|NCT03218722|Hemostasis|hemostasis
991394|NCT03218722|Severe hemorrhage|severe hemorrhage
991395|NCT03218696|cough|cough
991396|NCT03218696|children|children
991397|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
991398|NCT03218683|relapsed|relapsed
991399|NCT03218683|refractory|refractory
991400|NCT03218683|AZD5991|azd5991
991401|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
991402|NCT03218683|Richter syndrome|richter syndrome
991403|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
991404|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
991405|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
991406|NCT03218657|Aplastic Anemia|aplastic anemia
991407|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
991408|NCT03218657|clinical study|clinical study
991409|NCT03218644|Proprioception|proprioception
991410|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
991411|NCT03218605|Achilles tendon|achilles tendon
991412|NCT03218605|Warming-up|warming-up
991413|NCT03218605|Vascularisation|vascularisation
991414|NCT03218605|Physical activity|physical activity
991415|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
991416|NCT03218592|Adherence|adherence
991417|NCT03218592|Hair|hair
991418|NCT03218579|microbiome|microbiome
991419|NCT03218579|intestinal bacteria|intestinal bacteria
991420|NCT03218566|pulmonary embolism|pulmonary embolism
991421|NCT03218566|clot|clot
991422|NCT03218540|stroke volume variation|stroke volume variation
991423|NCT03218540|central venous pressure|central venous pressure
991424|NCT03218540|serum lactate|serum lactate
991425|NCT03218540|serum creatinine|serum creatinine
991426|NCT03218514|Obesity|obesity
991427|NCT03218514|Venous thromboembolism|venous thromboembolism
991428|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
991429|NCT03218514|Body Composition|body composition
991430|NCT03218514|Glomerular filtration rate|glomerular filtration rate
992225|NCT03213327|assessment|assessment
991431|NCT03218514|Bariatric Surgery|bariatric surgery
991432|NCT03218501|Uremic Pruritus|uremic pruritus
991433|NCT03218462|sensory adapted environment|sensory adapted environment
991434|NCT03218462|pediatric dentistry|pediatric dentistry
991435|NCT03218462|oral health|oral health
991436|NCT03218462|Developmental Disability|developmental disability
991437|NCT03218462|Intellectual Disability|intellectual disability
991438|NCT03218462|dental anxiety|dental anxiety
991439|NCT03218462|autism spectrum|autism spectrum
991440|NCT03218423|screening|screening
991442|NCT03218423|DNA methylation|dna methylation
991443|NCT03218410|surgical embolectomy|surgical embolectomy
991444|NCT03218410|catheter-directed therapy|catheter-directed therapy
991445|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
991446|NCT03218397|ICU|icu
991447|NCT03218397|Critically ill|critically ill
991448|NCT03218397|Intensive Care Unit|intensive care unit
991449|NCT03218397|Rapid identification|rapid identification
991450|NCT03218397|Rapid susceptibility|rapid susceptibility
991451|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
991452|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
991579|NCT03217669|sirolimus|sirolimus
991453|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
991454|NCT03218397|Antimicrobial use|antimicrobial use
991455|NCT03218384|Injectafer|injectafer
991456|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
991457|NCT03218384|Supplemental Iron|supplemental iron
991458|NCT03218371|scleral indentation|scleral indentation
991459|NCT03218371|chandelier light|chandelier light
991460|NCT03218371|air vitrectomy|air vitrectomy
991461|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
991462|NCT03218345|EUS-guided RFA|eus-guided rfa
991463|NCT03218345|pancreatic ca|pancreatic ca
991464|NCT03218345|interventional EUS|interventional eus
991465|NCT03218306|SPI|spi
991466|NCT03218306|Remifentanil|remifentanil
991467|NCT03218306|Target controlled infusion|target controlled infusion
991468|NCT03218280|trauma|trauma
991469|NCT03218280|antioxidant|antioxidant
991470|NCT03218280|oxidative stress|oxidative stress
991471|NCT03218280|Vitamin C|vitamin c
991472|NCT03218280|Ascorbic Acid|ascorbic acid
991473|NCT03218267|total hip replacement|total hip replacement
991474|NCT03218267|static disbalance|static disbalance
991475|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
991476|NCT03218241|Healthy Volunteers|healthy volunteers
991477|NCT03218228|aggressive periodontitis|aggressive periodontitis
991478|NCT03218215|cough assits|cough assits
991479|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
991480|NCT03218202|Crohn Disease|crohn disease
991481|NCT03218202|Ulcerative Colitis|ulcerative colitis
991482|NCT03218202|Intestinal stricture|intestinal stricture
991483|NCT03218189|Essential medicines lists|essential medicines lists
991484|NCT03218163|bone marrow|bone marrow
991485|NCT03218163|bone marrow transplant|bone marrow transplant
991486|NCT03218163|allogeneic|allogeneic
991487|NCT03218163|Medi-551|medi-551
991488|NCT03218137|Subjects|subjects
991489|NCT03218137|diagnosed|diagnosed
991490|NCT03218124|Thyroidectomy|thyroidectomy
991491|NCT03218124|Remifentanil|remifentanil
991492|NCT03218124|Extubation|extubation
991493|NCT03218124|Cough|cough
991494|NCT03218124|Target controlled infusion|target controlled infusion
991495|NCT03218111|Glymphatic network|glymphatic network
991496|NCT03218111|healthy|healthy
991497|NCT03218111|central nervous system|central nervous system
991498|NCT03218085|tenofovir|tenofovir
991499|NCT03218085|prevention|prevention
991500|NCT03218085|microbiome|microbiome
991501|NCT03218085|cervicovaginal|cervicovaginal
991502|NCT03218085|biopsy|biopsy
991503|NCT03218085|swab|swab
991504|NCT03218085|cytokines|cytokines
991505|NCT03218085|inflammation|inflammation
991506|NCT03218085|pharmacology|pharmacology
991507|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
991508|NCT03218033|systemic lupus|systemic lupus
991509|NCT03218033|self-management|self-management
991510|NCT03218033|social media|social media
991511|NCT03217942|Muscle soreness|muscle soreness
991512|NCT03217942|NGF-induced pain|ngf-induced pain
991513|NCT03217942|Pain model|pain model
991514|NCT03217942|Long-lasting sensitization|long-lasting sensitization
991515|NCT03217929|vagus nerve|vagus nerve
991516|NCT03217929|obesity|obesity
991517|NCT03217929|craving|craving
991518|NCT03217929|food|food
991519|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
991520|NCT03217916|kidney injury|kidney injury
991521|NCT03217916|preeclampsia|preeclampsia
991522|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
991523|NCT03217877|noninvasive stress testing|noninvasive stress testing
991524|NCT03217877|high risk|high risk
991525|NCT03217877|unstable angina|unstable angina
991526|NCT03217877|PCI|pci
991527|NCT03217864|Cancer|cancer
991528|NCT03217864|palliative care|palliative care
991529|NCT03217864|hospitalization at home|hospitalization at home
991530|NCT03217864|home health care provider|home health care provider
991531|NCT03217851|Plasmodium falciparum|plasmodium falciparum
991532|NCT03217851|Prevalence Survey|prevalence survey
991533|NCT03217851|Antimalarial Drug|antimalarial drug
991534|NCT03217838|AML|aml
991731|NCT03216135|Microbiome|microbiome
991535|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
991536|NCT03217838|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
991537|NCT03217838|AZD2811|azd2811
991538|NCT03217838|AZD1152|azd1152
991539|NCT03217838|AZD1152 hQPA|azd1152 hqpa
991540|NCT03217838|barasertib|barasertib
991541|NCT03217786|Macrovascular Disease|macrovascular disease
991542|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
991543|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
991544|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
991545|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
991546|NCT03217786|Optical Coherence Tomography|optical coherence tomography
1659000|NCT00150631|Prevention|prevention
991547|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
991548|NCT03217786|Fractional Flow Reserve|fractional flow reserve
991549|NCT03217786|Coronary Flow Reserve|coronary flow reserve
991550|NCT03217786|Positron Emission Tomography|positron emission tomography
991551|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
991552|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
991553|NCT03217747|Metastatic solid tumors|metastatic solid tumors
991554|NCT03217747|Advanced solid tumors|advanced solid tumors
991555|NCT03217747|Avelumab|avelumab
991556|NCT03217747|MSBOO10718C|msboo10718c
991557|NCT03217747|Utomilumab|utomilumab
991558|NCT03217747|PF-05082566|pf-05082566
991559|NCT03217747|Anti-CD137|anti-cd137
991560|NCT03217747|PF-04518600|pf-04518600
991561|NCT03217747|Cisplatin|cisplatin
991562|NCT03217747|Platinol-AQ|platinol-aq
991563|NCT03217747|Platinol|platinol
991564|NCT03217747|CDDP|cddp
991565|NCT03217747|Radiation Therapy|radiation therapy
991566|NCT03217747|XRT|xrt
991567|NCT03217695|Heart rate variability|heart rate variability
991568|NCT03217695|Self-efficacy|self-efficacy
991569|NCT03217695|Pediatrics|pediatrics
991570|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
991571|NCT03217695|Symptoms|symptoms
991572|NCT03217682|Hospice|hospice
991573|NCT03217682|Palliative Care|palliative care
991574|NCT03217682|Integrative Medicine|integrative medicine
991575|NCT03217682|Massage Therapy|massage therapy
991576|NCT03217682|Music Therapy|music therapy
991577|NCT03217682|Caregivers|caregivers
991578|NCT03217669|epacadostat|epacadostat
991580|NCT03217617|SCID-X1|scid-x1
991581|NCT03217617|lentiviral vector|lentiviral vector
991582|NCT03217604|PF-06852231|pf-06852231
991583|NCT03217604|Safety|safety
991584|NCT03217604|Tolerability|tolerability
991585|NCT03217604|Pharmacokinetics|pharmacokinetics
991586|NCT03217604|First-in-human|first-in-human
991587|NCT03217604|Healthy subjects|healthy subjects
991588|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
991589|NCT03217578|Newborn Screening|newborn screening
991590|NCT03217526|Burn injury|burn injury
991591|NCT03217526|Gait|gait
991592|NCT03217526|Physical Function|physical function
991593|NCT03217513|osteoporosis|osteoporosis
991594|NCT03217513|osteoarthritis|osteoarthritis
991595|NCT03217513|knee|knee
991596|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
991597|NCT03217396|synaptic plasticity|synaptic plasticity
991598|NCT03217396|neuroinflammation|neuroinflammation
991599|NCT03217396|neurodegeneration|neurodegeneration
991600|NCT03217383|Oral appliance therapy|oral appliance therapy
991601|NCT03217383|mandibular protrusion|mandibular protrusion
991602|NCT03217370|patient blood management|patient blood management
991603|NCT03217370|restrictive transfusion|restrictive transfusion
991604|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
991605|NCT03217318|ureteral stent|ureteral stent
991606|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
991607|NCT03217279|stroke-participation|stroke-participation
991608|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
991609|NCT03217201|Breast Cancer|breast cancer
991610|NCT03217201|Oncology|oncology
991611|NCT03217201|Circadian Rhythm|circadian rhythm
991612|NCT03217201|Light Therapy|light therapy
991613|NCT03217201|Chemotherapy side effects|chemotherapy side effects
991614|NCT03217188|Proton Re-Irradiation|proton re-irradiation
991615|NCT03217188|17-300|17-300
991616|NCT03217175|bionic pancreas|bionic pancreas
991617|NCT03217175|type 1 diabetes|type 1 diabetes
991618|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
991619|NCT03217110|Cerebellum|cerebellum
991620|NCT03217097|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
991621|NCT03217097|Broncho-pulmonary neuroendocrine tumors|broncho-pulmonary neuroendocrine tumors
991622|NCT03217097|O6-Methylguanine-DNA methyltransferase (MGMT) methylation|o6-methylguanine-dna methyltransferase (mgmt) methylation
991623|NCT03217097|Alkylating agents|alkylating agents
991624|NCT03217097|Oxaliplatin|oxaliplatin
992426|NCT03212118|Sick Leave|sick leave
991625|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
991626|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
991627|NCT03217058|digital health|digital health
991628|NCT03217058|implementation|implementation
991629|NCT03217058|primary care|primary care
991630|NCT03217032|Hemophilia A|hemophilia a
991631|NCT03217032|Hemophilia B|hemophilia b
991632|NCT03217032|factor VIII|factor viii
991633|NCT03217032|factor IX|factor ix
991634|NCT03217032|Gene therapy|gene therapy
991635|NCT03217032|lentiviral vector|lentiviral vector
991636|NCT03217019|Radial Artery|radial artery
991637|NCT03217019|Vascular Catheters|vascular catheters
991638|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
991639|NCT03217006|multiple arterial graft|multiple arterial graft
991640|NCT03217006|radial artery graft|radial artery graft
991641|NCT03216993|feeding protocol|feeding protocol
991642|NCT03216980|cardiovascular disease|cardiovascular disease
991643|NCT03216980|vascular function|vascular function
991645|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
991646|NCT03216928|Reverse Signaling|reverse signaling
991647|NCT03216928|Anti-TNF|anti-tnf
991648|NCT03216915|Heart Rhythm|heart rhythm
991649|NCT03216915|Fingolimod|fingolimod
991650|NCT03216915|autonomic nervous system|autonomic nervous system
991651|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
991652|NCT03216902|Glaucoma|glaucoma
991653|NCT03216889|Multiple Sclerosis|multiple sclerosis
991654|NCT03216837|Perinatal stroke|perinatal stroke
991655|NCT03216837|hemiplegia|hemiplegia
991656|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
991657|NCT03216772|Gynecologic Surgery|gynecologic surgery
991658|NCT03216772|larscopy|larscopy
991659|NCT03216772|morcellation|morcellation
991660|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
991661|NCT03216759|Intestinal complications|intestinal complications
991662|NCT03216759|laparotomy|laparotomy
991663|NCT03216746|oral health|oral health
991664|NCT03216746|knowledge|knowledge
991665|NCT03216746|adolescent|adolescent
991666|NCT03216733|DES|des
991667|NCT03216733|Angina pectoris|angina pectoris
991668|NCT03216733|Stent|stent
991669|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
991670|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
991671|NCT03216720|Thrombin generation|thrombin generation
991672|NCT03216655|congenital cataract|congenital cataract
991673|NCT03216655|anxiety|anxiety
991674|NCT03216655|guardian|guardian
991675|NCT03216642|Dacryocystitis|dacryocystitis
991676|NCT03216642|Bacteriology|bacteriology
991677|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
991678|NCT03216629|Pain|pain
991679|NCT03216629|Empathy|empathy
991680|NCT03216629|Dressing change|dressing change
991681|NCT03216616|fatigue|fatigue
991682|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
991683|NCT03216616|Coping|coping
991684|NCT03216616|self-efficacy|self-efficacy
991685|NCT03216603|Health literacy|health literacy
991686|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
991687|NCT03216590|Soft Tissue Swelling|soft tissue swelling
991688|NCT03216590|Rotator Cuff Repair|rotator cuff repair
991689|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
991690|NCT03216577|health-related quality of life|health-related quality of life
991691|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
991692|NCT03216551|minimally invasive surgery|minimally invasive surgery
991693|NCT03216460|T1D, Omnipod|t1d, omnipod
991694|NCT03216447|adherence|adherence
991695|NCT03216447|conversion|conversion
991696|NCT03216447|advagraf|advagraf
991697|NCT03216447|prograf|prograf
991698|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
991699|NCT03216434|dopamine|dopamine
991700|NCT03216434|biomarker|biomarker
991701|NCT03216421|DCIS|dcis
991702|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
991703|NCT03216421|Lumpectomy|lumpectomy
991704|NCT03216421|Breast Conserving Surgery|breast conserving surgery
991705|NCT03216382|High worry|high worry
991706|NCT03216382|Anxiety|anxiety
991707|NCT03216382|Attention Training Technique|attention training technique
991708|NCT03216382|Attention Control|attention control
991709|NCT03216382|Attention|attention
991710|NCT03216382|Mindfulness|mindfulness
991711|NCT03216382|Attention Bias|attention bias
991712|NCT03216382|Worry|worry
991713|NCT03216382|Pathological Worry|pathological worry
991714|NCT03216382|Anxiety Disorder|anxiety disorder
991715|NCT03216369|Arterial Spin Labeling|arterial spin labeling
991717|NCT03216369|Perfusion|perfusion
991718|NCT03216369|Carotid artery stenting|carotid artery stenting
991719|NCT03216369|Carotid endarterectomy|carotid endarterectomy
991720|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
991721|NCT03216330|Deep dyspareunia|deep dyspareunia
991722|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
991723|NCT03216317|Hypertension|hypertension
991725|NCT03216317|Cardiovascular system|cardiovascular system
991726|NCT03216278|healthy,|healthy,
991727|NCT03216278|fasted,|fasted,
991728|NCT03216278|fed|fed
991729|NCT03216226|Glucagon|glucagon
991732|NCT03216109|Supportive Care|supportive care
991733|NCT03216109|Quality of Life|quality of life
991734|NCT03216083|colpocleisis|colpocleisis
991735|NCT03216083|vaginectomy|vaginectomy
991736|NCT03216083|tranexamic acid|tranexamic acid
991737|NCT03216070|Dasatinib|dasatinib
991738|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
991739|NCT03216057|pediatric obesity|pediatric obesity
991740|NCT03216057|omega 3|omega 3
991741|NCT03216044|childbirth|childbirth
991742|NCT03216044|caesarean delivery|caesarean delivery
991743|NCT03216044|vaginal delivery|vaginal delivery
991744|NCT03216044|chronic pain|chronic pain
991745|NCT03216044|painful sexual intercourse|painful sexual intercourse
991746|NCT03216031|Falls prevention|falls prevention
991747|NCT03216031|Gardening|gardening
991748|NCT03216018|resilience|resilience
991749|NCT03216018|prevention program|prevention program
991750|NCT03216018|body-image|body-image
991751|NCT03216018|self-esteem|self-esteem
991752|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
991753|NCT03215966|bioequivalence|bioequivalence
991754|NCT03215953|offloading|offloading
991755|NCT03215953|plantar pressure|plantar pressure
991756|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
991757|NCT03215953|cast shoe|cast shoe
991758|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
991759|NCT03215927|ILD|ild
991760|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
991761|NCT03215914|Insulin Pump|insulin pump
991762|NCT03215914|Glycemic control|glycemic control
991763|NCT03215914|Glucose Counterregulation|glucose counterregulation
991764|NCT03215901|Population-based survey|population-based survey
991765|NCT03215901|HIV treatment|hiv treatment
991766|NCT03215901|HIV testing|hiv testing
991767|NCT03215901|Survival expectations|survival expectations
991768|NCT03215901|Condom use|condom use
991769|NCT03215901|Life plans|life plans
991770|NCT03215901|South African young adults|south african young adults
991771|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
991772|NCT03215862|Normal Saline|normal saline
991773|NCT03215862|Lactated Ringer's|lactated ringer's
991774|NCT03215823|Intubation|intubation
991775|NCT03215823|videolaryngoscope|videolaryngoscope
991776|NCT03215810|Stage IV|stage iv
991777|NCT03215810|NSCLC|nsclc
991778|NCT03215810|Recurrent|recurrent
991779|NCT03215810|TIL|til
991780|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
991781|NCT03215797|svv|svv
991782|NCT03215797|norepinephrine|norepinephrine
991783|NCT03215797|phenylephrine|phenylephrine
991784|NCT03215797|elderly|elderly
991785|NCT03215784|obesity|obesity
991786|NCT03215784|placenta|placenta
991787|NCT03215784|inflammation|inflammation
991788|NCT03215784|fish oil|fish oil
991789|NCT03215784|probiotics|probiotics
991790|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
991791|NCT03215745|Delirium|delirium
991792|NCT03215745|Critical Care|critical care
991793|NCT03215745|Prevention & control|prevention & control
991794|NCT03215745|Clinical Trial|clinical trial
991795|NCT03215732|prevalence|prevalence
991796|NCT03215732|vaccine coverage|vaccine coverage
991797|NCT03215732|risk factors|risk factors
991798|NCT03215732|morbidity|morbidity
991799|NCT03215732|mortality|mortality
991800|NCT03215732|quality of life|quality of life
991801|NCT03215732|economic vulnerability|economic vulnerability
991802|NCT03215732|food security|food security
991803|NCT03215732|treatment needs|treatment needs
991804|NCT03215732|decentralized care|decentralized care
991805|NCT03215732|health costs|health costs
991806|NCT03215732|caregivers training|caregivers training
991807|NCT03215719|Radiation Therapy|radiation therapy
991808|NCT03215680|Urinary iodine concentration|urinary iodine concentration
991809|NCT03215654|mental health|mental health
991810|NCT03215654|promotion|promotion
991811|NCT03215654|prevention|prevention
991812|NCT03215654|adolescence|adolescence
991813|NCT03215654|school programs|school programs
991814|NCT03215654|intervention|intervention
991815|NCT03215641|obesity|obesity
991816|NCT03215641|pediatrics|pediatrics
991817|NCT03215641|weight management program|weight management program
991818|NCT03215641|Fitbit|fitbit
991819|NCT03215641|personal activity tracker|personal activity tracker
991820|NCT03215628|CEUS|ceus
991821|NCT03215628|TCEUS|tceus
991822|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
991823|NCT03215628|perfusion|perfusion
991824|NCT03215628|cerebral perfusion|cerebral perfusion
991825|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
991826|NCT03215628|SonoVue|sonovue
991827|NCT03215602|knee|knee
991828|NCT03215602|osteoarthritis|osteoarthritis
991829|NCT03215602|exercise|exercise
991830|NCT03215602|quadriceps|quadriceps
991832|NCT03215602|activities of daily living|activities of daily living
991833|NCT03215602|treatment outcome|treatment outcome
991834|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
991835|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
991937|NCT03215160|Exercise|exercise
991836|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
991837|NCT03215537|physical activity|physical activity
991838|NCT03215537|cardiopulmonary function|cardiopulmonary function
991839|NCT03215537|quality of life|quality of life
991840|NCT03215537|Perioperative management|perioperative management
991841|NCT03215537|comprehensive intervention|comprehensive intervention
991842|NCT03215537|health behavior model|health behavior model
991843|NCT03215511|NTRK Fusion Positive|ntrk fusion positive
991844|NCT03215511|LOXO-195|loxo-195
1012075|NCT03086616|CED|ced
991845|NCT03215511|Loxo|loxo
991846|NCT03215511|TRK|trk
991847|NCT03215511|TRK Fusion|trk fusion
991848|NCT03215511|NTRK1|ntrk1
991849|NCT03215511|NTRK2|ntrk2
991850|NCT03215511|NTRK3|ntrk3
991851|NCT03215511|TRKA|trka
991852|NCT03215511|TRKB|trkb
991853|NCT03215511|TRKC|trkc
991854|NCT03215511|NTRK|ntrk
991855|NCT03215511|ETV6|etv6
991856|NCT03215511|fusion|fusion
991857|NCT03215511|tumors|tumors
991858|NCT03215511|CNS tumors|cns tumors
991859|NCT03215511|solid tumors|solid tumors
991860|NCT03215511|central nervous system tumors|central nervous system tumors
991861|NCT03215511|advanced cancer|advanced cancer
991862|NCT03215511|primary CNS tumor|primary cns tumor
991863|NCT03215511|Advanced CNS tumor|advanced cns tumor
991864|NCT03215511|Metastatic CNS tumor|metastatic cns tumor
991865|NCT03215511|NTRK1 fusion|ntrk1 fusion
991866|NCT03215511|NTRK2 fusion|ntrk2 fusion
991867|NCT03215511|NTRK3 fusion|ntrk3 fusion
991868|NCT03215511|ETV6-NTRK3|etv6-ntrk3
991869|NCT03215511|ETV6 fusion|etv6 fusion
991870|NCT03215511|Metastatic cancer|metastatic cancer
991871|NCT03215511|Cancer of Unknown Primary Site|cancer of unknown primary site
991872|NCT03215511|Pediatric|pediatric
991873|NCT03215511|NTRK1 gene rearrangement|ntrk1 gene rearrangement
991874|NCT03215511|NTRK2 gene rearrangement|ntrk2 gene rearrangement
991875|NCT03215511|NTRK3 gene rearrangement|ntrk3 gene rearrangement
991876|NCT03215511|ETV6 gene rearrangement|etv6 gene rearrangement
991877|NCT03215511|NTRK gene rearragements|ntrk gene rearragements
991878|NCT03215511|Congenital Nephroma|congenital nephroma
991879|NCT03215511|Metastatic Infantile Fibrosarcoma|metastatic infantile fibrosarcoma
991880|NCT03215511|Advanced Infantile Fibrosarcoma|advanced infantile fibrosarcoma
991881|NCT03215485|adolescent|adolescent
991882|NCT03215485|sports|sports
991883|NCT03215485|nutrition|nutrition
991884|NCT03215485|physical activity|physical activity
991885|NCT03215485|body mass index|body mass index
991886|NCT03215485|virtual world|virtual world
991887|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
991888|NCT03215394|Social ABCs|social abcs
991889|NCT03215394|autism|autism
991890|NCT03215394|autism spectrum disorder|autism spectrum disorder
991891|NCT03215394|Early Intervention|early intervention
991892|NCT03215394|Toddler|toddler
991893|NCT03215394|Early Identification|early identification
991894|NCT03215394|Pivotal Response Treatment|pivotal response treatment
991895|NCT03215394|ASD|asd
991896|NCT03215394|PRT|prt
991897|NCT03215394|Control Group|control group
991898|NCT03215394|treatment Group|treatment group
991899|NCT03215394|At Risk|at risk
991900|NCT03215394|Social Communication|social communication
991901|NCT03215394|Positive Affect|positive affect
991902|NCT03215394|Smiling|smiling
991903|NCT03215394|Social Orienting|social orienting
991904|NCT03215394|Attentional Control|attentional control
991905|NCT03215394|Attentional Disengagement|attentional disengagement
991906|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
991907|NCT03215394|NDBI|ndbi
991908|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
991909|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
991910|NCT03215355|Contrast media|contrast media
991911|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
991912|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
991913|NCT03215342|Child|child
991914|NCT03215342|Rehabilitation|rehabilitation
991915|NCT03215342|Psychotherapy, groups|psychotherapy, groups
991916|NCT03215303|Asthma|asthma
991917|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
991918|NCT03215303|Oxygen consumption|oxygen consumption
991919|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
991920|NCT03215277|Bimekizumab|bimekizumab
991921|NCT03215277|AS|as
991922|NCT03215277|Certolizumab Pegol|certolizumab pegol
991923|NCT03215277|Cimzia|cimzia
991924|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
991925|NCT03215225|Endodontology|endodontology
991926|NCT03215225|Endodontics|endodontics
991927|NCT03215212|ear plug|ear plug
991928|NCT03215212|eye mask|eye mask
991929|NCT03215212|ocean sound|ocean sound
991930|NCT03215212|sleep quality|sleep quality
991931|NCT03215212|intensive care unit|intensive care unit
991932|NCT03215186|congenital cataract|congenital cataract
991933|NCT03215186|risk factor|risk factor
991934|NCT03215186|mathematic model|mathematic model
991935|NCT03215160|Mobilization|mobilization
991936|NCT03215160|Manual Therapies|manual therapies
991938|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
991939|NCT03215147|Airway Disease|airway disease
991940|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
991941|NCT03215134|Primary mental health service|primary mental health service
991942|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
991943|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
991944|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
991945|NCT03215095|RAI-avid|rai-avid
991946|NCT03215095|17-218|17-218
991947|NCT03215043|Eriocitrin|eriocitrin
991948|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
991949|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
991950|NCT03215030|Drug therapy|drug therapy
991951|NCT03215004|Volunteer|volunteer
991953|NCT03215004|Leukapheresis|leukapheresis
991954|NCT03214978|thyroid|thyroid
991955|NCT03214965|Kidney transplantation|kidney transplantation
991956|NCT03214965|Facebook|facebook
991957|NCT03214965|Education|education
991958|NCT03214965|Adolescent|adolescent
991959|NCT03214965|Social Networking|social networking
991960|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
991961|NCT03214926|Parkinson's disease|parkinson's disease
991962|NCT03214926|Dance|dance
991963|NCT03214926|Google Glass|google glass
991964|NCT03214926|Mobility|mobility
991965|NCT03214926|Balance|balance
991966|NCT03214913|resuscitation|resuscitation
991967|NCT03214913|fluid therapy|fluid therapy
991968|NCT03214887|Hyaluronan|hyaluronan
991969|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
991970|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
991971|NCT03214848|Post Abortion|post abortion
991972|NCT03214848|Iintrauterine device|iintrauterine device
991973|NCT03214848|Contraceptive implant|contraceptive implant
991974|NCT03214848|LARC|larc
991975|NCT03214848|IUD|iud
991976|NCT03214835|Larynx|larynx
991977|NCT03214835|reflux|reflux
991978|NCT03214835|LPR|lpr
991979|NCT03214835|tumor|tumor
991980|NCT03214835|lesion|lesion
991981|NCT03214822|Microbiome|microbiome
991982|NCT03214809|ultrasound|ultrasound
991983|NCT03214809|MET team|met team
991984|NCT03214809|Concordance|concordance
991985|NCT03214783|artificial intelligence|artificial intelligence
991986|NCT03214783|facial recognition|facial recognition
991987|NCT03214783|facial characteristic|facial characteristic
991988|NCT03214731|artesunate|artesunate
991989|NCT03214705|CT perfusion|ct perfusion
991990|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
991991|NCT03214705|Vasospasm|vasospasm
991992|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
991993|NCT03214692|Gum Arabic|gum arabic
991994|NCT03214692|Renal failure|renal failure
991995|NCT03214692|Hemodialysis|hemodialysis
991996|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
991997|NCT03214679|Hepatitis C|hepatitis c
991998|NCT03214679|HCV|hcv
991999|NCT03214679|PWID|pwid
992000|NCT03214679|People who inject drugs|people who inject drugs
992001|NCT03214666|MDS|mds
992002|NCT03214666|AML|aml
992003|NCT03214640|neuraxial analgesia|neuraxial analgesia
992004|NCT03214640|spinal block|spinal block
992005|NCT03214640|epidural block|epidural block
992006|NCT03214588|Drug Therapy|drug therapy
992007|NCT03214575|Central Venous Vascular Access|central venous vascular access
992008|NCT03214575|Intensive Care Unit|intensive care unit
992009|NCT03214575|Needle Navigation Technology|needle navigation technology
992010|NCT03214562|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
992011|NCT03214562|Acute Myeloid Leukemia|acute myeloid leukemia
992012|NCT03214562|AML|aml
992013|NCT03214562|Newly diagnosed|newly diagnosed
992014|NCT03214562|Relapsed/refractory|relapsed/refractory
992015|NCT03214562|Fludarabine|fludarabine
992016|NCT03214562|Fludarabine phosphate|fludarabine phosphate
992017|NCT03214562|Fludara|fludara
992018|NCT03214562|Cytarabine|cytarabine
992019|NCT03214562|Ara-C|ara-c
992020|NCT03214562|Cytosar|cytosar
992021|NCT03214562|DepoCyt|depocyt
992022|NCT03214562|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
992023|NCT03214562|Idarubicin|idarubicin
992024|NCT03214562|Idamycin|idamycin
992025|NCT03214562|Filgrastim|filgrastim
992026|NCT03214562|G-CSF|g-csf
992027|NCT03214562|Neupogen|neupogen
992028|NCT03214562|Pegylated filgrastim|pegylated filgrastim
992029|NCT03214562|Neulasta|neulasta
992030|NCT03214562|Venetoclax|venetoclax
992031|NCT03214562|ABT-199|abt-199
992032|NCT03214562|GDC-0199|gdc-0199
992033|NCT03214536|spine surgery|spine surgery
992034|NCT03214536|regional anaesthesia|regional anaesthesia
992035|NCT03214536|opioid consumption|opioid consumption
992036|NCT03214536|acute postoperative pain|acute postoperative pain
992037|NCT03214523|sleep|sleep
992038|NCT03214523|actigraphy|actigraphy
992039|NCT03214510|Diseases of liver|diseases of liver
992040|NCT03214510|Thoracic epidural analgesia|thoracic epidural analgesia
992041|NCT03214510|TEA|tea
992431|NCT03212092|Aggression|aggression
992042|NCT03214510|Transversus abdominus plane|transversus abdominus plane
992043|NCT03214510|TAP|tap
992044|NCT03214510|Liver resection|liver resection
992045|NCT03214510|Bupivacaine|bupivacaine
992046|NCT03214510|Liposomal Bupivacaine|liposomal bupivacaine
992047|NCT03214510|Hydromorphone|hydromorphone
1012256|NCT03085589|obesity|obesity
992048|NCT03214510|Questionnaires|questionnaires
992049|NCT03214510|Surveys|surveys
992050|NCT03214497|laryngeal mask|laryngeal mask
992051|NCT03214497|Supreme|supreme
992052|NCT03214497|Protector|protector
992053|NCT03214471|bariatric surgery|bariatric surgery
992054|NCT03214471|healthy lifestyle|healthy lifestyle
992055|NCT03214458|Therapy|therapy
992056|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
992057|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
992058|NCT03214432|Concussion|concussion
992059|NCT03214432|Labour market affiliation|labour market affiliation
992060|NCT03214432|Return to work|return to work
992061|NCT03214432|Sickness absence|sickness absence
992062|NCT03214432|Long-term sickness absence|long-term sickness absence
992063|NCT03214432|Disability pension|disability pension
992064|NCT03214419|Breast cancer|breast cancer
992065|NCT03214419|3D Optical scanning|3d optical scanning
992066|NCT03214419|Preoperative MRI|preoperative mri
992067|NCT03214419|Tumor localization|tumor localization
992068|NCT03214354|sickle cell disease|sickle cell disease
992069|NCT03214354|stem cell transplant|stem cell transplant
992070|NCT03214354|red blood cell engraftment|red blood cell engraftment
992071|NCT03214354|nonmyeloablative|nonmyeloablative
992072|NCT03214354|pure red cell aplasia|pure red cell aplasia
992073|NCT03214341|mediastinal masses|mediastinal masses
992074|NCT03214341|MRI diffusion|mri diffusion
992075|NCT03214315|Prostatectomy|prostatectomy
992076|NCT03214302|antiviral treatment|antiviral treatment
992077|NCT03214302|hepatitis B virus|hepatitis b virus
992078|NCT03214302|pregnant woman|pregnant woman
992079|NCT03214302|Postpartum hepatitis|postpartum hepatitis
992080|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
992081|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
992082|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
992083|NCT03214276|polyphenols|polyphenols
992084|NCT03214276|cycling|cycling
992085|NCT03214276|endurance|endurance
992086|NCT03214276|aerobic|aerobic
992087|NCT03214276|pain|pain
992088|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
992089|NCT03214263|Biomarkers|biomarkers
992090|NCT03214263|Tailored treatment|tailored treatment
992091|NCT03214263|Personalised medicine|personalised medicine
992092|NCT03214263|DANBIO|danbio
992093|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
992094|NCT03214263|clinical data|clinical data
992095|NCT03214250|Nivolumab|nivolumab
992096|NCT03214250|APX005M|apx005m
992097|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
992098|NCT03214250|Gemcitabine|gemcitabine
992099|NCT03214250|nab-Paclitaxel|nab-paclitaxel
992100|NCT03214224|Telemedicine|telemedicine
992101|NCT03214224|Pulmonary Function Testing|pulmonary function testing
992102|NCT03214224|Telehealth|telehealth
992103|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
992104|NCT03214185|infertility, female|infertility, female
992105|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
992106|NCT03214185|in vitro fertilization|in vitro fertilization
992107|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
992108|NCT03214146|ALS|als
992109|NCT03214146|Motor Neuron Disease|motor neuron disease
992110|NCT03214146|Neuromuscular Disease|neuromuscular disease
992111|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
992112|NCT03214146|Central Nervous System Disease|central nervous system disease
992113|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
992114|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
992115|NCT03214107|Exercise|exercise
992116|NCT03214107|Hypoglycemia|hypoglycemia
992117|NCT03214107|Carbohydrates|carbohydrates
992118|NCT03214029|troponin|troponin
992119|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
992120|NCT03214029|acute myocardial infarction|acute myocardial infarction
992121|NCT03214016|Pilates Training|pilates training
992122|NCT03214016|Aerobic Exercises|aerobic exercises
992123|NCT03214016|Hypertension|hypertension
992124|NCT03214016|Clinical trial|clinical trial
992125|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
992126|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
992127|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
992128|NCT03213990|Sepsis|sepsis
992129|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
992130|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
992131|NCT03213964|Recurrent|recurrent
992132|NCT03213964|Platinum Resistant|platinum resistant
992133|NCT03213964|Platinum Sensitive|platinum sensitive
992134|NCT03213951|Surgical resection|surgical resection
992135|NCT03213951|Margins of resection|margins of resection
992136|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
992137|NCT03213951|Beta probe device|beta probe device
992138|NCT03213951|Ex-vivo|ex-vivo
992139|NCT03213938|Chronic prostatitis|chronic prostatitis
992140|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
992141|NCT03213938|acupuncture|acupuncture
992142|NCT03213938|randomized controlled trial|randomized controlled trial
992143|NCT03213912|effective concentration|effective concentration
992144|NCT03213899|Subjective Global Assessment|subjective global assessment
992145|NCT03213899|Nutritional Status|nutritional status
992146|NCT03213899|Hospital Mortality|hospital mortality
992147|NCT03213899|Length of Stay|length of stay
992148|NCT03213899|Malnutrition|malnutrition
992149|NCT03213886|hip fracture|hip fracture
992150|NCT03213886|elderly|elderly
992151|NCT03213886|vitamin D|vitamin d
992152|NCT03213886|rehabilitation|rehabilitation
992153|NCT03213873|Balance control|balance control
992154|NCT03213873|Exercise|exercise
992155|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
992156|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
992157|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
992158|NCT03213847|Superb microvascular imaging|superb microvascular imaging
992159|NCT03213847|Doppler ultrasound|doppler ultrasound
992160|NCT03213847|Ultrasound|ultrasound
992161|NCT03213847|Median Nerve Entrapment|median nerve entrapment
992162|NCT03213847|Diagnoses Disease|diagnoses disease
992163|NCT03213808|Allergic diseases|allergic diseases
992164|NCT03213808|hypersensitivity|hypersensitivity
992165|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
992166|NCT03213808|World Health Organization (WHO)|world health organization (who)
992167|NCT03213782|Nature Based Sounds|nature based sounds
992168|NCT03213782|Agitation|agitation
992169|NCT03213782|Anxiety|anxiety
992170|NCT03213782|Patients|patients
992171|NCT03213782|Intensive Care Units|intensive care units
992172|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
992173|NCT03213769|topical Q10 gel|topical q10 gel
992174|NCT03213769|topical antioxidant|topical antioxidant
992175|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
992176|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
992177|NCT03213756|doppler ultrasound|doppler ultrasound
992178|NCT03213756|physical exercise|physical exercise
992179|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
992180|NCT03213717|Obesity|obesity
992181|NCT03213717|Loading|loading
992182|NCT03213717|Edema|edema
992183|NCT03213717|Urine|urine
992184|NCT03213613|Teen health|teen health
992185|NCT03213613|Teen development|teen development
992186|NCT03213613|Adolescent development|adolescent development
992187|NCT03213613|Memory|memory
992188|NCT03213613|Attention|attention
992189|NCT03213613|Reward processing|reward processing
992190|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
992191|NCT03213548|alar base reduction|alar base reduction
992192|NCT03213548|alar facial groove|alar facial groove
992193|NCT03213548|alectomy|alectomy
992194|NCT03213548|Flare|flare
992195|NCT03213548|Nose|nose
992196|NCT03213535|PROM|prom
992197|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
992198|NCT03213483|gingival recession|gingival recession
992199|NCT03213483|connective tissue graft|connective tissue graft
992200|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
992201|NCT03213483|free gingival graft|free gingival graft
992202|NCT03213457|Elagolix|elagolix
992203|NCT03213457|Endometriosis associated pain|endometriosis associated pain
992204|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
992205|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
992206|NCT03213444|Colon cancer|colon cancer
992207|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
992208|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
992209|NCT03213444|peripheral vascular function|peripheral vascular function
992210|NCT03213431|Cancer survivors|cancer survivors
992211|NCT03213431|Instrument development|instrument development
992212|NCT03213431|Neurocognitive functioning|neurocognitive functioning
992213|NCT03213431|Patient-reported outcomes|patient-reported outcomes
992214|NCT03213431|Qualitative interview|qualitative interview
992215|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
992216|NCT03213405|Phase I|phase i
992217|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
992218|NCT03213379|actimeter|actimeter
992219|NCT03213379|apomorphin pump|apomorphin pump
992220|NCT03213366|PrEP|prep
992221|NCT03213366|HIV prevention|hiv prevention
992222|NCT03213366|Public Health Social Media Campaign|public health social media campaign
992223|NCT03213366|Peer Intervention|peer intervention
992224|NCT03213327|mental health|mental health
992226|NCT03213327|health promotion|health promotion
992227|NCT03213327|case management|case management
992228|NCT03213327|health insurance|health insurance
992229|NCT03213314|LiverMultiScan|livermultiscan
992230|NCT03213314|multiparameter MRI|multiparameter mri
992231|NCT03213314|functional liver remnant|functional liver remnant
992232|NCT03213314|liver resection|liver resection
992233|NCT03213314|hepatic resection|hepatic resection
992234|NCT03213314|portal vein embolisation|portal vein embolisation
992235|NCT03213314|preoperative liver function|preoperative liver function
992236|NCT03213314|postoperative liver failure|postoperative liver failure
992237|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
992238|NCT03213301|Lurbinectedin|lurbinectedin
992239|NCT03213301|Mesothelioma|mesothelioma
992240|NCT03213301|Phase II Trial|phase ii trial
992241|NCT03213275|Extremely premature infants|extremely premature infants
992242|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
992243|NCT03213275|neonatal brain injury|neonatal brain injury
992244|NCT03213275|gut microbiome|gut microbiome
992245|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
992246|NCT03213275|neonatal immunity|neonatal immunity
992247|NCT03213223|retention|retention
992248|NCT03213223|attrition|attrition
992249|NCT03213223|PMTCT|pmtct
992250|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
992251|NCT03213184|Birth cohort|birth cohort
992252|NCT03213184|asthma|asthma
992253|NCT03213184|allergies|allergies
992254|NCT03213171|organ donation|organ donation
992255|NCT03213171|family physician|family physician
992256|NCT03213171|primary care|primary care
992257|NCT03213171|clinical trial|clinical trial
992258|NCT03213171|registry trial|registry trial
992259|NCT03213171|cluster trial|cluster trial
992260|NCT03213171|stepped-wedge|stepped-wedge
992261|NCT03213145|drug-drug interaction|drug-drug interaction
992262|NCT03213132|sleep|sleep
992263|NCT03213132|insomnia|insomnia
992264|NCT03213132|CBT|cbt
992265|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
992266|NCT03213119|Brain Stimulation|brain stimulation
992267|NCT03213119|Reward|reward
992268|NCT03213119|Vestibular System|vestibular system
992269|NCT03213119|Cingulate Cortex|cingulate cortex
992270|NCT03213119|Cancellation Tasks|cancellation tasks
992271|NCT03213106|TMS|tms
992272|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
992273|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
992274|NCT03213093|Diabetes|diabetes
992275|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
992276|NCT03213093|Plantar pressure|plantar pressure
992277|NCT03213080|Targeted Lung Denervation|targeted lung denervation
992278|NCT03213080|TLD|tld
992279|NCT03213054|esophageal cancer|esophageal cancer
992280|NCT03213054|OBP-301|obp-301
992281|NCT03213054|radiation|radiation
992282|NCT03213054|Telomelysin|telomelysin
992283|NCT03213054|radiotherapy|radiotherapy
992284|NCT03213054|oncolytic|oncolytic
992285|NCT03213054|virotherapy|virotherapy
992286|NCT03213054|loco regional|loco regional
992287|NCT03213015|confiability|confiability
992288|NCT03213015|ankle|ankle
992289|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
992290|NCT03212989|HIV|hiv
992291|NCT03212989|HXTC|hxtc
992292|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
992293|NCT03212989|HIV-Infected|hiv-infected
992294|NCT03212989|Vorinostat|vorinostat
992295|NCT03212989|AIDS|aids
992296|NCT03212976|Non-Invasive|non-invasive
992297|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
992298|NCT03212976|Ventricular catheters|ventricular catheters
992299|NCT03212924|cochlear implant|cochlear implant
992300|NCT03212924|Listening effort|listening effort
992301|NCT03212924|pupillometry|pupillometry
992302|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
992303|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
992304|NCT03212885|Deep Brain Stimulation|deep brain stimulation
992305|NCT03212872|Ammonia|ammonia
992306|NCT03212872|bleeding risk factors|bleeding risk factors
992307|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
992308|NCT03212872|esophageal varices|esophageal varices
992309|NCT03212859|older adults|older adults
992310|NCT03212859|physiotherapy|physiotherapy
992311|NCT03212859|physical activity|physical activity
992312|NCT03212846|hippotherapy|hippotherapy
992313|NCT03212846|cerebral palsy|cerebral palsy
992314|NCT03212846|spasticity|spasticity
992315|NCT03212807|Checkpoint inhibition|checkpoint inhibition
992316|NCT03212807|PDL1|pdl1
992317|NCT03212807|EBV DLBCL|ebv dlbcl
992318|NCT03212807|PCNSL|pcnsl
992319|NCT03212716|Infectiology|infectiology
992320|NCT03212716|Biology of infectious agents|biology of infectious agents
992321|NCT03212716|Flu|flu
992322|NCT03212716|Intensive care|intensive care
992323|NCT03212703|Mindfulness training|mindfulness training
992324|NCT03212703|Parents and families|parents and families
992325|NCT03212703|Pediatric OCD|pediatric ocd
992326|NCT03212690|mechanical ventilation|mechanical ventilation
992327|NCT03212690|echocardiography|echocardiography
992328|NCT03212690|right ventricular function|right ventricular function
992329|NCT03212690|Ang (1-7)|ang (1-7)
992330|NCT03212690|Ang II|ang ii
992331|NCT03212690|Renin-angiotensin system|renin-angiotensin system
992332|NCT03212625|Urea Cream|urea cream
992333|NCT03212625|Sorafenib|sorafenib
992334|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
992335|NCT03212599|APP-processing|app-processing
992336|NCT03212599|Disulfiram|disulfiram
992337|NCT03212599|ADAM10|adam10
992338|NCT03212599|Alzheimer's disease|alzheimer's disease
992339|NCT03212599|blood|blood
992340|NCT03212560|Exercise capacity|exercise capacity
992341|NCT03212560|Physical activity|physical activity
992342|NCT03212560|Quality of life|quality of life
992343|NCT03212560|Pulmonary functions|pulmonary functions
992344|NCT03212560|Muscle strength|muscle strength
992345|NCT03212560|Respiratory muscle strength|respiratory muscle strength
992346|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
992347|NCT03212560|Dyspnea|dyspnea
992348|NCT03212560|Anxiety|anxiety
992349|NCT03212560|Fatigue|fatigue
992350|NCT03212547|Social withdrawal|social withdrawal
992351|NCT03212547|Preterm Infant|preterm infant
992352|NCT03212547|Parent's mental health|parent's mental health
992353|NCT03212534|Dascena|dascena
992354|NCT03212534|patient mortality|patient mortality
992355|NCT03212534|machine learning|machine learning
992356|NCT03212534|algorithm|algorithm
992357|NCT03212534|diagnostic|diagnostic
992358|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
992359|NCT03212521|Hepatitis|hepatitis
992360|NCT03212521|HCV genotype|hcv genotype
992361|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
992362|NCT03212521|platelet|platelet
992363|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
992364|NCT03212521|glecaprevir|glecaprevir
992365|NCT03212521|pibrentasvir|pibrentasvir
992366|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
992367|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
992368|NCT03212495|knee arthroscopy|knee arthroscopy
992369|NCT03212495|dexmedetomidine|dexmedetomidine
992370|NCT03212495|neostigmine|neostigmine
992371|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
992372|NCT03212456|general anesthesia|general anesthesia
992373|NCT03212456|cancer recurrence|cancer recurrence
992374|NCT03212456|opioids analgesics|opioids analgesics
992375|NCT03212456|neoplasm|neoplasm
992376|NCT03212430|L-kynurenine|l-kynurenine
992377|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
992378|NCT03212430|Headache|headache
992379|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
992380|NCT03212404|Cancer|cancer
992381|NCT03212404|PD-L1|pd-l1
992382|NCT03212404|PDL1|pdl1
992383|NCT03212404|PD-1|pd-1
992384|NCT03212404|PD1|pd1
992385|NCT03212404|Solid tumors|solid tumors
992386|NCT03212404|Anti PD-L1|anti pd-l1
992387|NCT03212352|miscarriage|miscarriage
992388|NCT03212352|mifepristone|mifepristone
992389|NCT03212352|misoprostol|misoprostol
992390|NCT03212352|medical treatment|medical treatment
992391|NCT03212352|patient satisfaction|patient satisfaction
992392|NCT03212352|abortifacient agents|abortifacient agents
992393|NCT03212339|parent-child interactions|parent-child interactions
992394|NCT03212339|mental health care|mental health care
992395|NCT03212339|child health services|child health services
992396|NCT03212339|parenting confidence|parenting confidence
992397|NCT03212339|adverse childhood events|adverse childhood events
992398|NCT03212339|dyadic care model|dyadic care model
992399|NCT03212313|Adults|adults
992400|NCT03212313|Liver Disease|liver disease
992401|NCT03212300|aerobic exercise training|aerobic exercise training
992402|NCT03212300|delirium|delirium
992403|NCT03212261|Lymphoma|lymphoma
992404|NCT03212222|screening|screening
992405|NCT03212222|cell phone application|cell phone application
992406|NCT03212209|Sleep Apnea|sleep apnea
992407|NCT03212209|CPAP|cpap
992408|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
992409|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
992410|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
992411|NCT03212196|Stent|stent
992412|NCT03212196|Transanastomotic drain|transanastomotic drain
992413|NCT03212183|web-based intervention|web-based intervention
992414|NCT03212183|self-management|self-management
992415|NCT03212183|nursing|nursing
992416|NCT03212183|epilepsy|epilepsy
992417|NCT03212183|seizures|seizures
992418|NCT03212170|Invasive Breast Cancer|invasive breast cancer
992419|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
992420|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
992421|NCT03212144|nuts|nuts
992422|NCT03212144|exercise|exercise
992423|NCT03212144|vagal activity|vagal activity
992424|NCT03212144|peanuts|peanuts
992425|NCT03212144|heart rate variability|heart rate variability
992427|NCT03212118|Return to work|return to work
992428|NCT03212118|Motivational interviewing|motivational interviewing
992429|NCT03212118|Absenteeism|absenteeism
1659001|NCT00150631|Offspring|offspring
992430|NCT03212118|Occupational Health|occupational health
992432|NCT03212092|aggressive behavior|aggressive behavior
992433|NCT03212092|nutritional supplements|nutritional supplements
992434|NCT03212092|dietary supplements|dietary supplements
992435|NCT03212092|vitamin, mineral|vitamin, mineral
992436|NCT03212092|omega-3|omega-3
992437|NCT03212092|n-3 fatty acids|n-3 fatty acids
992438|NCT03212092|intellectual disability|intellectual disability
992439|NCT03212079|Cancer Survivors|cancer survivors
992440|NCT03212079|Physical Activities|physical activities
992441|NCT03212079|Baltimore|baltimore
992442|NCT03212079|State of Maryland|state of maryland
992443|NCT03212053|Essential thrombocythemia|essential thrombocythemia
992444|NCT03212053|Multiplate|multiplate
992445|NCT03212053|ROTEM|rotem
992446|NCT03212053|haemorrhage|haemorrhage
992447|NCT03212053|thrombosis|thrombosis
992448|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
992449|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
992450|NCT03212027|aquaporins|aquaporins
992451|NCT03212014|Parkinson Disease|parkinson disease
992452|NCT03212014|intelligent|intelligent
992453|NCT03212014|Rehabilitaion|rehabilitaion
992454|NCT03211988|abdominal|abdominal
992455|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
992456|NCT03211988|columbia|columbia
992457|NCT03211988|relapsed|relapsed
992458|NCT03211988|refractory|refractory
992459|NCT03211949|axillary nerve block|axillary nerve block
992460|NCT03211923|muscle relaxation|muscle relaxation
992461|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
992462|NCT03211923|myopathy|myopathy
992463|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
992464|NCT03211884|Problem solving therapy|problem solving therapy
992465|NCT03211884|Military family caregivers|military family caregivers
992466|NCT03211884|Cognitive impariment|cognitive impariment
992467|NCT03211884|Traumatic brain injury|traumatic brain injury
992468|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
992469|NCT03211845|Ehealth|ehealth
992470|NCT03211845|Older adults|older adults
992471|NCT03211845|Undernutrition|undernutrition
992472|NCT03211845|Feasibility study|feasibility study
992473|NCT03211832|Dissemination research|dissemination research
992474|NCT03211832|Public health workforce|public health workforce
992475|NCT03211832|Diabetes prevention|diabetes prevention
992476|NCT03211832|Diabetes control|diabetes control
992477|NCT03211832|Chronic disease prevention|chronic disease prevention
992478|NCT03211832|Evidence-based public health|evidence-based public health
992479|NCT03211832|Public health accreditation|public health accreditation
992480|NCT03211819|immediate|immediate
992481|NCT03211819|esthetics|esthetics
992482|NCT03211793|systemic sclerosis|systemic sclerosis
992483|NCT03211793|scleroderma|scleroderma
992484|NCT03211793|digital ulcer|digital ulcer
992485|NCT03211793|vasculopathy|vasculopathy
992486|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
992487|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
992488|NCT03211754|Walnuts|walnuts
992489|NCT03211754|almonds|almonds
992490|NCT03211754|adiponectin|adiponectin
992491|NCT03211754|lipocalin-2|lipocalin-2
992492|NCT03211754|obesity|obesity
992493|NCT03211741|Bevacizumab|bevacizumab
992494|NCT03211702|geriatric assessments|geriatric assessments
992495|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
992496|NCT03211702|activity of daily living|activity of daily living
992497|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
992498|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
992499|NCT03211689|Exercise|exercise
992500|NCT03211689|Stress|stress
992501|NCT03211689|Fatigue|fatigue
992502|NCT03211689|Quality of Life|quality of life
992503|NCT03211676|dialyzer|dialyzer
992504|NCT03211676|beta2-microglobilin|beta2-microglobilin
992505|NCT03211676|myoglobin|myoglobin
992506|NCT03211637|nursing care|nursing care
992507|NCT03211637|skin lesions|skin lesions
992508|NCT03211637|wound healing|wound healing
992509|NCT03211637|varicose ulcers|varicose ulcers
992510|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
992511|NCT03211611|Breast cancer|breast cancer
992512|NCT03211611|General practitionner|general practitionner
992513|NCT03211572|breast|breast
992514|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
992515|NCT03211559|clinical pilates exercise|clinical pilates exercise
992516|NCT03211559|aerobic exercise|aerobic exercise
992517|NCT03211559|functional exercise capacity|functional exercise capacity
992518|NCT03211559|pulmonary function|pulmonary function
992519|NCT03211546|Pediatric femur fracture|pediatric femur fracture
992520|NCT03211546|Spica casting|spica casting
992521|NCT03211546|Traction|traction
992522|NCT03211546|Intramedullary nailing|intramedullary nailing
992523|NCT03211546|Children|children
992524|NCT03211546|Internal fixation|internal fixation
993010|NCT03208049|Insomnia|insomnia
992525|NCT03211546|External fixation|external fixation
992526|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
992527|NCT03211533|MRI|mri
992528|NCT03211533|general movements|general movements
992529|NCT03211520|Cancer treatment|cancer treatment
992530|NCT03211520|Anthracyclines|anthracyclines
992531|NCT03211520|Cardiac MRI|cardiac mri
992532|NCT03211494|Mechanical ventilation|mechanical ventilation
992533|NCT03211494|Driving pressure|driving pressure
992534|NCT03211494|Closed-loop ventilation|closed-loop ventilation
992535|NCT03211494|Esophageal catheter|esophageal catheter
992536|NCT03211455|bariatric surgery|bariatric surgery
992537|NCT03211455|rehabilitation|rehabilitation
992538|NCT03211455|lidocaine|lidocaine
992539|NCT03211442|Breast cancer|breast cancer
992540|NCT03211442|Radiotherapy|radiotherapy
992541|NCT03211442|Cardiac complications|cardiac complications
992542|NCT03211442|Acute coronary events|acute coronary events
992543|NCT03211442|NTCP model|ntcp model
992544|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
992545|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
992546|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
992547|NCT03211286|Hip fracture|hip fracture
992548|NCT03211286|Tranexamic acid|tranexamic acid
992549|NCT03211286|Perioperative blood loss|perioperative blood loss
992550|NCT03211286|Blood Transfusion|blood transfusion
992551|NCT03211260|Parkinson Disease|parkinson disease
992552|NCT03211260|Freezing of gait|freezing of gait
992553|NCT03211260|Equistasi|equistasi
992554|NCT03211247|EPIT|epit
992555|NCT03211247|Epicutaneous|epicutaneous
992556|NCT03211247|Immunotherapy|immunotherapy
992557|NCT03211247|Viaskin|viaskin
992558|NCT03211221|OCD|ocd
992559|NCT03211221|TMS|tms
992560|NCT03211182|lifestyle intervention|lifestyle intervention
992561|NCT03211182|prediabetes|prediabetes
992562|NCT03211156|Amoxicillin|amoxicillin
992563|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
992564|NCT03211156|Vaginal Colonization|vaginal colonization
992565|NCT03211143|GERD|gerd
992566|NCT03211143|CKD-381|ckd-381
992567|NCT03211143|Nexium|nexium
992568|NCT03211143|Bioequivalence|bioequivalence
992569|NCT03211130|medication adherence|medication adherence
992570|NCT03211130|self-management|self-management
992571|NCT03211130|antithrombotic|antithrombotic
992572|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
992573|NCT03211104|curcumin|curcumin
992574|NCT03211078|Early lung cancer|early lung cancer
992575|NCT03211078|Photodynamic therapy|photodynamic therapy
992576|NCT03211078|ENB|enb
992577|NCT03211065|Rituximab|rituximab
992578|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
992579|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
992580|NCT03211039|Rady Children's|rady children's
992581|NCT03211039|Pediatric|pediatric
992582|NCT03211039|Genomic|genomic
992583|NCT03211039|Precision Medicine|precision medicine
992584|NCT03211039|Neonate|neonate
992585|NCT03211026|Urinary tract infection|urinary tract infection
992586|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
992587|NCT03211026|Candiduria|candiduria
992588|NCT03211026|Epidemiology|epidemiology
992589|NCT03211026|Graft rejection|graft rejection
992590|NCT03211026|Solid organ transplantation|solid organ transplantation
992591|NCT03211013|oxytocin|oxytocin
992592|NCT03211013|PTSD|ptsd
992593|NCT03211013|attention bias|attention bias
992594|NCT03211013|startle|startle
992595|NCT03211000|aortic aneurysm|aortic aneurysm
992596|NCT03211000|autophagy|autophagy
992597|NCT03211000|oxidative stress|oxidative stress
992598|NCT03211000|Hippo pathway|hippo pathway
992599|NCT03210987|ward round|ward round
992600|NCT03210987|patient case presentation|patient case presentation
992601|NCT03210987|communication|communication
992602|NCT03210987|patient-centered care|patient-centered care
992603|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
992604|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
992605|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
992606|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
992607|NCT03210870|Maternal health|maternal health
992608|NCT03210870|maternal nutrition|maternal nutrition
992609|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
992610|NCT03210857|apnea|apnea
992611|NCT03210857|neck extension|neck extension
992612|NCT03210857|syncope|syncope
992613|NCT03210857|diving blackout|diving blackout
992614|NCT03210857|right internal carotid arteria|right internal carotid arteria
992615|NCT03210857|pulsatility index|pulsatility index
992616|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
992617|NCT03210857|doppler ultrasonography|doppler ultrasonography
992618|NCT03210844|total hip arthroplasty|total hip arthroplasty
992619|NCT03210844|direct anterior|direct anterior
992620|NCT03210844|posterior approach|posterior approach
992621|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
993011|NCT03208049|CBT|cbt
992622|NCT03210779|oral wound healing|oral wound healing
992623|NCT03210779|probiotics|probiotics
992624|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
992625|NCT03210753|Multiple Myeloma|multiple myeloma
992626|NCT03210753|Peripheral neuropathy|peripheral neuropathy
992627|NCT03210753|Subcutaneous injection|subcutaneous injection
992628|NCT03210753|Bortezomib|bortezomib
992629|NCT03210753|Risk factors|risk factors
992630|NCT03210701|pharmacy|pharmacy
992631|NCT03210701|pharmacist|pharmacist
992632|NCT03210701|POCT|poct
992633|NCT03210701|Implementation science|implementation science
992634|NCT03210688|Prednisolone|prednisolone
992635|NCT03210688|alfacalcidol|alfacalcidol
992636|NCT03210688|Minimal change nephropathy|minimal change nephropathy
992637|NCT03210662|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
992638|NCT03210662|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
992639|NCT03210662|NHL|nhl
992640|NCT03210662|Relapsed|relapsed
992641|NCT03210662|Refractory|refractory
992642|NCT03210662|Pembrolizumab|pembrolizumab
992643|NCT03210662|Keytruda|keytruda
992644|NCT03210662|MK-3475|mk-3475
992645|NCT03210662|SCH-900475|sch-900475
992646|NCT03210662|External Beam Radiotherapy|external beam radiotherapy
992647|NCT03210662|EBRT|ebrt
992648|NCT03210662|Radiation therapy|radiation therapy
992649|NCT03210649|Dyslipidemia|dyslipidemia
992650|NCT03210597|water-base exercise|water-base exercise
992651|NCT03210584|Knee joint|knee joint
992652|NCT03210584|Cartilage degeneration|cartilage degeneration
992653|NCT03210584|Ultrasound imaging|ultrasound imaging
992654|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
992655|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
992656|NCT03210584|Multimodal evaluation|multimodal evaluation
992657|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
992658|NCT03210545|Biomarker|biomarker
992659|NCT03210545|Glucocorticoids|glucocorticoids
992660|NCT03210545|Metabolism|metabolism
992661|NCT03210506|chronic hepatitis B|chronic hepatitis b
992662|NCT03210506|hepatitis B virus|hepatitis b virus
992663|NCT03210506|Cytokines|cytokines
992664|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
992665|NCT03210506|Nucleoside Analogues|nucleoside analogues
992666|NCT03210493|chronic hepatitis B|chronic hepatitis b
992667|NCT03210493|hepatitis B virus|hepatitis b virus
992668|NCT03210493|Treg Cells|treg cells
992669|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
992670|NCT03210493|Nucleoside Analogues|nucleoside analogues
992671|NCT03210480|Lithium Sulphate|lithium sulphate
992672|NCT03210480|Prolonged release formulation|prolonged release formulation
992673|NCT03210480|Lithium carbonate|lithium carbonate
992674|NCT03210480|Immediate release formulation|immediate release formulation
992675|NCT03210480|Bipolar Disorder|bipolar disorder
992676|NCT03210480|Tremor|tremor
992677|NCT03210467|chronic hepatitis B|chronic hepatitis b
992678|NCT03210467|hepatitis B virus|hepatitis b virus
992679|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
992680|NCT03210467|entecavir|entecavir
992681|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
992682|NCT03210415|Preterm Labor|preterm labor
992683|NCT03210415|China|china
992684|NCT03210415|Pregnant Women|pregnant women
992685|NCT03210415|≥35 Years Old|≥35 years old
992686|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
992687|NCT03210389|lobaptin|lobaptin
992688|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
992689|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
992690|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
992691|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
992692|NCT03210376|Neuromuscular blockade|neuromuscular blockade
992693|NCT03210376|NMB|nmb
992694|NCT03210376|Sugammadex|sugammadex
992695|NCT03210376|Neostigmine|neostigmine
992696|NCT03210376|Pain Assessment|pain assessment
992697|NCT03210376|Survey|survey
992698|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
992699|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
992700|NCT03210298|PIPAC|pipac
992701|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
992703|NCT03210298|Cisplatin|cisplatin
992704|NCT03210298|Oxaliplatin|oxaliplatin
992705|NCT03210298|Gemcitabine|gemcitabine
992706|NCT03210298|Paclitaxel|paclitaxel
992707|NCT03210298|nab-Paclitaxel|nab-paclitaxel
992708|NCT03210298|Doxorubicine|doxorubicine
992709|NCT03210298|Mitomycin|mitomycin
992710|NCT03210285|Whole exome sequencing|whole exome sequencing
992711|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
992712|NCT03210285|Acoustic Neuroma|acoustic neuroma
992713|NCT03210285|Vestibular schwannoma|vestibular schwannoma
992714|NCT03210194|Inservice Training|inservice training
992715|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
992716|NCT03210194|Randomized Cluster Trial|randomized cluster trial
992717|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
992719|NCT03210155|Post Partum|post partum
992720|NCT03210155|Anxiety|anxiety
992721|NCT03210155|Depression|depression
992723|NCT03210155|Sleep Quality|sleep quality
992724|NCT03210155|Maternal Functioning|maternal functioning
992725|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
992726|NCT03210129|Motivation|motivation
992727|NCT03210129|Behavior|behavior
992728|NCT03210129|Exercise|exercise
992729|NCT03210129|Motivational interview|motivational interview
992730|NCT03210129|Cancer|cancer
992731|NCT03210129|economic evaluation|economic evaluation
992732|NCT03210103|Transoral Surgery|transoral surgery
992733|NCT03210103|Head and Neck Cancer|head and neck cancer
992734|NCT03210090|Stem cells transplantation|stem cells transplantation
992735|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
992736|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
992737|NCT03210090|Immune reconstitution|immune reconstitution
992738|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
992739|NCT03210090|Interferon-gamma|interferon-gamma
992740|NCT03210077|general anesthesia|general anesthesia
992741|NCT03210077|Entropy|entropy
992742|NCT03210077|Hypnosis|hypnosis
992743|NCT03210064|Apatinib|apatinib
992744|NCT03210051|Acute ischemic stroke|acute ischemic stroke
992745|NCT03210051|Endovascular treatment|endovascular treatment
992746|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
992747|NCT03210051|Reperfusion therapy|reperfusion therapy
992748|NCT03210051|Neuroprotection|neuroprotection
992749|NCT03210038|Cystoscopy|cystoscopy
992750|NCT03209986|Liver Cirrhosis|liver cirrhosis
992751|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
992752|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
992753|NCT03209947|Ultrasound|ultrasound
992754|NCT03209934|Bone and Joint Infection|bone and joint infection
992755|NCT03209934|Daptomycin|daptomycin
992756|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
992757|NCT03209921|Bone and Joint Infection|bone and joint infection
992758|NCT03209921|Daptomycin|daptomycin
992759|NCT03209908|antiviral treatment|antiviral treatment
992760|NCT03209908|hepatitis B virus|hepatitis b virus
992761|NCT03209908|mother-to-child transmission|mother-to-child transmission
992762|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
992763|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
992764|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
992765|NCT03209830|mental fatigue|mental fatigue
992766|NCT03209830|drug therapy|drug therapy
992767|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
992768|NCT03209830|stroke|stroke
992769|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
992770|NCT03209752|3D analysis|3d analysis
992771|NCT03209752|Brace|brace
992772|NCT03209752|EOS imagind system|eos imagind system
992773|NCT03209752|Anatomical transfer|anatomical transfer
992774|NCT03209713|Mexican|mexican
992775|NCT03209713|Mexican-American|mexican-american
992776|NCT03209713|17-336|17-336
992777|NCT03209674|Cardiac surgery|cardiac surgery
992778|NCT03209674|Thoracic surgery|thoracic surgery
992779|NCT03209661|vascular function|vascular function
992780|NCT03209622|Smoking Cessation|smoking cessation
992781|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
992782|NCT03209622|Cardiology|cardiology
992784|NCT03209596|Athletes|athletes
992785|NCT03209596|Food intake|food intake
992786|NCT03209596|Supplementation|supplementation
992787|NCT03209596|Biochemical biomarkers|biochemical biomarkers
992788|NCT03209596|Soccer Players|soccer players
992789|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
992790|NCT03209557|Mobile Technology|mobile technology
992791|NCT03209557|Sociobehavioral|sociobehavioral
992792|NCT03209544|Suicidal ideation|suicidal ideation
992793|NCT03209544|Suicide|suicide
992794|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
992795|NCT03209544|Online intervention|online intervention
992796|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
992797|NCT03209531|ACL|acl
992798|NCT03209531|Surgery|surgery
992799|NCT03209531|Quadrcieps weakness|quadrcieps weakness
992800|NCT03209531|Operant conditioning|operant conditioning
992801|NCT03209531|Cortical excitability|cortical excitability
992802|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
992803|NCT03209505|Coefficient of Friction|coefficient of friction
992804|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
992805|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
992806|NCT03209466|Wound healing|wound healing
992807|NCT03209453|family work shop|family work shop
992808|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
992809|NCT03209414|Frailty syndrome|frailty syndrome
992810|NCT03209414|Coronary heart disease|coronary heart disease
992811|NCT03209414|Coronary revascularization|coronary revascularization
992908|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
992812|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
992813|NCT03209414|Arterial stiffness|arterial stiffness
992814|NCT03209414|Applanation tonometry|applanation tonometry
992815|NCT03209414|Lean body mass|lean body mass
992816|NCT03209414|ST2 biomarker|st2 biomarker
992817|NCT03209401|Niraparib|niraparib
992820|NCT03209375|early warning system|early warning system
992821|NCT03209362|Knee|knee
992822|NCT03209362|Osteoarthritis|osteoarthritis
992823|NCT03209362|Intra-articular injection|intra-articular injection
992824|NCT03209349|Sigmoidoscopy|sigmoidoscopy
992825|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
992826|NCT03209336|Intersphincteric resection|intersphincteric resection
992827|NCT03209336|IORT|iort
992828|NCT03209323|Epileptiform patterns|epileptiform patterns
992829|NCT03209323|sevoflurane|sevoflurane
992830|NCT03209323|propofol|propofol
992831|NCT03209323|bispectral index|bispectral index
992832|NCT03209323|state entropy|state entropy
992833|NCT03209323|response entropy|response entropy
992834|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
992835|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
992836|NCT03209284|maxillary atrophy|maxillary atrophy
992837|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
992838|NCT03209271|Fluid therapy|fluid therapy
992839|NCT03209258|Stroke|stroke
992840|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
992841|NCT03209258|Care Bundle|care bundle
992842|NCT03209258|Clinical Trial|clinical trial
992843|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
992844|NCT03209258|Management|management
992845|NCT03209258|Blood Pressure|blood pressure
992846|NCT03209219|effectiveness, safety|effectiveness, safety
992847|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
992848|NCT03209206|Docetaxel|docetaxel
992849|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
992850|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
992851|NCT03209193|sevoflurane|sevoflurane
992852|NCT03209193|desflurane|desflurane
992853|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
992854|NCT03209180|HFrEF|hfref
992855|NCT03209180|Carvedilol|carvedilol
992856|NCT03209180|Slow Release|slow release
992857|NCT03209180|NT-proBNP|nt-probnp
992858|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
992859|NCT03209154|Adherence|adherence
992860|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
992861|NCT03209154|Patient perspective|patient perspective
992862|NCT03209141|hypertension|hypertension
992863|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
992864|NCT03209141|impedance cardiography|impedance cardiography
992865|NCT03209141|echocardiography|echocardiography
992866|NCT03209076|rectal neoplasms|rectal neoplasms
992867|NCT03209076|sexual dysfunctions|sexual dysfunctions
992868|NCT03209076|Urinary incontinence|urinary incontinence
992869|NCT03209076|Quality of life|quality of life
992870|NCT03209076|robotic surgical procedures|robotic surgical procedures
992871|NCT03209076|laparoscopy|laparoscopy
992872|NCT03209037|chronic hepatitis B|chronic hepatitis b
992873|NCT03209037|hepatitis B virus|hepatitis b virus
992874|NCT03209037|CD8+T Cells|cd8+t cells
992875|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
992876|NCT03209037|Nucleoside Analogues|nucleoside analogues
992877|NCT03209024|hypertension|hypertension
992878|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
992879|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
992880|NCT03209024|telemedicine|telemedicine
992881|NCT03209024|health apps|health apps
992882|NCT03209024|informatics|informatics
992883|NCT03209024|data collection|data collection
992884|NCT03209024|personal health records|personal health records
992885|NCT03209024|smartphone|smartphone
992886|NCT03209024|self care|self care
992887|NCT03209024|blood pressure monitors|blood pressure monitors
992888|NCT03209011|chronic hepatitis B|chronic hepatitis b
992889|NCT03209011|hepatitis B virus|hepatitis b virus
992890|NCT03209011|CD4+T Cells|cd4+t cells
992891|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
992892|NCT03209011|Nucleoside Analogues|nucleoside analogues
992893|NCT03208998|hepatitis B virus|hepatitis b virus
992894|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
992895|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
992896|NCT03208998|Nucleoside Analogues|nucleoside analogues
992897|NCT03208998|Natural Killer Cells|natural killer cells
992898|NCT03208985|Emergency contraception|emergency contraception
992899|NCT03208972|IVF|ivf
992900|NCT03208972|ovarian stimulation|ovarian stimulation
992901|NCT03208972|low dose hCG|low dose hcg
992902|NCT03208972|hp-FSH|hp-fsh
992903|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
992904|NCT03208972|costs of IVF|costs of ivf
992905|NCT03208946|Advanced glycation end products|advanced glycation end products
992906|NCT03208946|Absorption|absorption
992907|NCT03208946|Excretion|excretion
993009|NCT03208062|Orthopaedic|orthopaedic
992909|NCT03208907|Vivax malaria|vivax malaria
992910|NCT03208907|Radical cure|radical cure
992911|NCT03208907|Elimination|elimination
992912|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
992913|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
992914|NCT03208816|pain|pain
992915|NCT03208816|constipation|constipation
992916|NCT03208803|Myelofibrosis|myelofibrosis
992917|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
992918|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
992919|NCT03208803|Ruxolitinib|ruxolitinib
992920|NCT03208725|Malnutrition|malnutrition
992921|NCT03208725|Hospitalization|hospitalization
992922|NCT03208725|Acute Illness|acute illness
992923|NCT03208725|Pediatric|pediatric
992924|NCT03208725|Post-discharge mortality|post-discharge mortality
992925|NCT03208725|Mortality|mortality
992926|NCT03208725|Cohort|cohort
992927|NCT03208725|Nested case control|nested case control
992928|NCT03208725|Antimicrobial resistance|antimicrobial resistance
992929|NCT03208725|Antibiotic|antibiotic
992930|NCT03208725|Feeding|feeding
992931|NCT03208725|Undernutrition|undernutrition
992932|NCT03208699|anorexia|anorexia
992933|NCT03208699|bulimia|bulimia
992934|NCT03208686|Gender|gender
992936|NCT03208686|Black/African American|black/african american
992937|NCT03208686|Self-management|self-management
992938|NCT03208660|seizure|seizure
992939|NCT03208660|Fycompa|fycompa
992940|NCT03208647|case-control study|case-control study
992941|NCT03208647|Multiple risk factors|multiple risk factors
992942|NCT03208634|robotics|robotics
992943|NCT03208634|motor performance|motor performance
992944|NCT03208634|stroke patient|stroke patient
992945|NCT03208634|upper limb|upper limb
992946|NCT03208634|rehabilitation|rehabilitation
992947|NCT03208608|RBANS-H|rbans-h
992948|NCT03208608|Older adults|older adults
992949|NCT03208608|Normal hearing|normal hearing
992950|NCT03208608|Cognition|cognition
992951|NCT03208608|Age-related hearing loss|age-related hearing loss
992952|NCT03208569|anticholinergic|anticholinergic
992953|NCT03208569|alzheimer|alzheimer
992954|NCT03208569|cognition|cognition
992955|NCT03208569|MMSE|mmse
992956|NCT03208569|anticholinergic cognitive burden scale|anticholinergic cognitive burden scale
992957|NCT03208543|thermotherapy|thermotherapy
992958|NCT03208543|Pakistan|pakistan
992959|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
992960|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
992961|NCT03208465|Empagliflozin|empagliflozin
992962|NCT03208465|Sitagliptin|sitagliptin
992963|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
992964|NCT03208426|Efficacy, Self|efficacy, self
992965|NCT03208413|thalidomide|thalidomide
992966|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
992967|NCT03208387|17-338|17-338
992968|NCT03208387|Cognitive function|cognitive function
992969|NCT03208387|Behavioral function|behavioral function
992970|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
992971|NCT03208374|IMPACT testing|impact testing
992972|NCT03208374|17-327|17-327
992973|NCT03208335|rh-endostatin|rh-endostatin
992974|NCT03208335|radiotherapy|radiotherapy
992975|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
992976|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
992977|NCT03208257|esmolol|esmolol
992978|NCT03208257|adrenergic storm|adrenergic storm
992979|NCT03208257|septic shock|septic shock
992980|NCT03208244|Heart Disease|heart disease
992981|NCT03208244|Heart Transplant|heart transplant
992982|NCT03208244|HCV|hcv
992983|NCT03208244|Hepatitis C|hepatitis c
992984|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
992985|NCT03208218|Healthy volunteers|healthy volunteers
992986|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
992987|NCT03208218|Healthy male volunteers|healthy male volunteers
992988|NCT03208192|colorectal liver metastases|colorectal liver metastases
992989|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
992990|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
992991|NCT03208192|tumor of liver|tumor of liver
992992|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
992993|NCT03208192|hemangioma liver|hemangioma liver
992994|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
992995|NCT03208140|intubation device|intubation device
992996|NCT03208140|laryngeal vision|laryngeal vision
992997|NCT03208140|success intubation|success intubation
992998|NCT03208140|videolaryngoscope|videolaryngoscope
992999|NCT03208140|direct intubation|direct intubation
993000|NCT03208127|HCV|hcv
993001|NCT03208127|Epclusa|epclusa
993002|NCT03208127|ESLD|esld
993003|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
993004|NCT03208075|phosphorus,diet|phosphorus,diet
993005|NCT03208075|phosphorus|phosphorus
993006|NCT03208075|healthy subject|healthy subject
993007|NCT03208062|Biobank|biobank
993008|NCT03208062|Waste material|waste material
993012|NCT03208049|Gulf War Veterans|gulf war veterans
993013|NCT03208036|schizophrenia|schizophrenia
993014|NCT03208036|tdcs|tdcs
993015|NCT03208036|working memory|working memory
993016|NCT03208036|cognitive remediation|cognitive remediation
993017|NCT03208036|cognition|cognition
993018|NCT03207997|Scleroderma|scleroderma
993019|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
993020|NCT03207997|MRI|mri
993021|NCT03207997|quantification|quantification
993022|NCT03207984|Gingival Recession|gingival recession
993023|NCT03207984|Collagen Matrix|collagen matrix
993024|NCT03207984|Periodontics|periodontics
993025|NCT03207971|Gingival recession|gingival recession
993026|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
993027|NCT03207971|Periodontics|periodontics
993028|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
993029|NCT03207919|maternal health|maternal health
993030|NCT03207919|maternal stress|maternal stress
993031|NCT03207919|Lullaby Project|lullaby project
993032|NCT03207880|pregnancy test|pregnancy test
993033|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
993034|NCT03207841|SCI|sci
993035|NCT03207841|High Protein|high protein
993036|NCT03207841|Low Carbohydrate|low carbohydrate
993037|NCT03207841|Metabolic Health|metabolic health
993038|NCT03207841|Microbiome|microbiome
993039|NCT03207828|Behavioral activation|behavioral activation
993040|NCT03207763|Safety|safety
993041|NCT03207763|Reactogenicity|reactogenicity
993042|NCT03207763|Acceptability|acceptability
993043|NCT03207763|Microneedle patch|microneedle patch
993044|NCT03207750|Immunogenicity|immunogenicity
993045|NCT03207750|lyophilized formulation|lyophilized formulation
993046|NCT03207750|United States|united states
993047|NCT03207750|Reactogenicity|reactogenicity
993048|NCT03207750|Safety|safety
993049|NCT03207750|Porcine circovirus -free|porcine circovirus -free
993050|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
993051|NCT03207750|liquid formulation|liquid formulation
993052|NCT03207750|Healthy infants|healthy infants
993053|NCT03207737|Spinal Cord Injuries|spinal cord injuries
993054|NCT03207737|SCI|sci
993055|NCT03207737|Telehealth|telehealth
993056|NCT03207737|Mindfulness|mindfulness
993057|NCT03207737|Nutrition|nutrition
993058|NCT03207737|Exercise|exercise
993059|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
993060|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
993061|NCT03207724|recurrent diagnosis|recurrent diagnosis
993062|NCT03207724|new diagnosis|new diagnosis
993063|NCT03207724|adenocarcinoma|adenocarcinoma
993064|NCT03207685|Epilepsy|epilepsy
993065|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
993066|NCT03207685|EMU|emu
993067|NCT03207685|Seizure|seizure
993068|NCT03207685|Seizure Detection|seizure detection
993069|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
993070|NCT03207672|dose escalation|dose escalation
993071|NCT03207672|maximum tolerated dose|maximum tolerated dose
993072|NCT03207672|pharmacokinetics|pharmacokinetics
993073|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
993074|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
993199|NCT03206892|SILS|sils
993075|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
993076|NCT03207646|Digital Health Solution|digital health solution
993077|NCT03207646|Medication Adherence|medication adherence
993078|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
993079|NCT03207607|Adults|adults
993080|NCT03207607|Snacks|snacks
993081|NCT03207607|Appetite|appetite
993082|NCT03207607|Blood glucose|blood glucose
993083|NCT03207607|Insulin|insulin
993084|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
993085|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
993086|NCT03207555|CLL|cll
993087|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
993088|NCT03207555|SLL|sll
993089|NCT03207555|Ibrutinib|ibrutinib
993090|NCT03207555|PCI-32765|pci-32765
993091|NCT03207555|Imbruvica|imbruvica
993092|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
993093|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
993094|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
993095|NCT03207542|ALL|all
993096|NCT03207542|Daratumumab|daratumumab
993097|NCT03207529|Malignant neoplasm of breast|malignant neoplasm of breast
993098|NCT03207529|Metastatic breast cancer|metastatic breast cancer
993099|NCT03207529|Androgen receptor (AR)-positive and PTEN positive|androgen receptor (ar)-positive and pten positive
993100|NCT03207529|Alpelisib|alpelisib
993101|NCT03207529|BY719|by719
993102|NCT03207529|Enzalutamide|enzalutamide
993103|NCT03207529|MDV3100|mdv3100
993104|NCT03207529|XTANDI|xtandi
993105|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
993106|NCT03207490|Hand|hand
993107|NCT03207490|Rehabilitation|rehabilitation
993108|NCT03207490|sEMG|semg
993109|NCT03207477|Infant|infant
993110|NCT03207477|Prematurely born|prematurely born
993111|NCT03207477|maturation|maturation
993112|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
993113|NCT03207425|Hepatic Impairment|hepatic impairment
993114|NCT03207386|Sexual Violence|sexual violence
993115|NCT03207386|Prevention|prevention
993116|NCT03207386|Mixed-Methods|mixed-methods
993117|NCT03207386|Outcome Evaluation|outcome evaluation
993118|NCT03207386|Process Evaluation|process evaluation
993119|NCT03207386|Adolescence|adolescence
993120|NCT03207347|BAP1|bap1
993121|NCT03207347|niraparib|niraparib
993122|NCT03207347|DNA repair|dna repair
993123|NCT03207347|PARP inhibitor|parp inhibitor
993124|NCT03207347|homologous repair deficiency|homologous repair deficiency
993125|NCT03207347|renal cell carcinoma|renal cell carcinoma
993126|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
993127|NCT03207347|mesothelioma|mesothelioma
993128|NCT03207347|uveal melanoma|uveal melanoma
993129|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
993130|NCT03207334|genomic signatures|genomic signatures
993131|NCT03207334|midostaurin|midostaurin
993132|NCT03207334|relapsed|relapsed
993133|NCT03207334|refractory|refractory
993134|NCT03207334|PKC412|pkc412
993135|NCT03207308|Vitamin A Status|vitamin a status
993136|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
993137|NCT03207308|Total body vitamin A stores|total body vitamin a stores
993138|NCT03207308|Children|children
993139|NCT03207308|Senegal|senegal
993140|NCT03207295|Nesiritide|nesiritide
993141|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
993142|NCT03207295|Congenital Heart Disease|congenital heart disease
993143|NCT03207243|Severe asthma|severe asthma
993144|NCT03207243|Safety|safety
993145|NCT03207243|GSK3772847|gsk3772847
993146|NCT03207243|Efficacy|efficacy
993147|NCT03207217|Safety Planning|safety planning
993148|NCT03207217|Access to Lethal Means|access to lethal means
993149|NCT03207217|Zero Suicide|zero suicide
993150|NCT03207204|Dental bleaching|dental bleaching
993151|NCT03207204|Color|color
993152|NCT03207204|Sensitivity|sensitivity
993153|NCT03207204|violet LED|violet led
993154|NCT03207204|Quality of life|quality of life
993155|NCT03207165|Cardiogenic shock|cardiogenic shock
993156|NCT03207165|Inotropes|inotropes
993157|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
993158|NCT03207139|cancer prostate|cancer prostate
993159|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
993160|NCT03207139|staging|staging
993161|NCT03207139|biochemical failure|biochemical failure
993162|NCT03207126|Ultrasound|ultrasound
993163|NCT03207126|Biopsy|biopsy
993164|NCT03207126|Endometrial cancer|endometrial cancer
993165|NCT03207113|prostate-specific antigen|prostate-specific antigen
993166|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
993167|NCT03207113|mobile health|mobile health
993168|NCT03207113|realist evaluation|realist evaluation
993169|NCT03207113|case study|case study
993170|NCT03207100|Intracerebral hemorrhage|intracerebral hemorrhage
993171|NCT03207100|Early antihypertensive treatment|early antihypertensive treatment
993172|NCT03207100|Analgesia-first|analgesia-first
993173|NCT03207100|Sedation|sedation
993174|NCT03207074|iKnife|iknife
993175|NCT03207074|Mass Spectrometry|mass spectrometry
993176|NCT03207074|Point-of-care|point-of-care
993177|NCT03207074|Diagnosis|diagnosis
993178|NCT03207074|Endometrial Cancer|endometrial cancer
993179|NCT03207061|endometrial cancer|endometrial cancer
993180|NCT03207061|staging|staging
993181|NCT03207061|3 Dimensional|3 dimensional
993182|NCT03207061|Ultrasound|ultrasound
993183|NCT03207061|Myometrial invasion|myometrial invasion
993184|NCT03206996|autism|autism
993185|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
993186|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
993187|NCT03206996|auditory processing|auditory processing
993188|NCT03206996|exposure therapy|exposure therapy
993189|NCT03206996|exposure and response prevention|exposure and response prevention
993190|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
993191|NCT03206996|occupational therapy|occupational therapy
993192|NCT03206983|Small pupil|small pupil
993193|NCT03206944|standardized tomato extract|standardized tomato extract
993194|NCT03206944|anti-aggregation|anti-aggregation
993195|NCT03206944|high cardiovascular risk|high cardiovascular risk
993196|NCT03206944|diet supplement|diet supplement
993197|NCT03206892|LESS surgery|less surgery
993198|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
993200|NCT03206892|Single-site surgery|single-site surgery
993201|NCT03206892|Covidien|covidien
993202|NCT03206892|laparoscopy|laparoscopy
993203|NCT03206892|minimally invasive surgery|minimally invasive surgery
993204|NCT03206892|ovarian drilling|ovarian drilling
993205|NCT03206892|PCOS|pcos
993206|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
993207|NCT03206879|ESBL|esbl
993208|NCT03206879|Enterobacteriaceae|enterobacteriaceae
993209|NCT03206879|multidrug-resistance|multidrug-resistance
993210|NCT03206840|mindfulness meditation|mindfulness meditation
993211|NCT03206840|hypnosis|hypnosis
993212|NCT03206840|meta-awareness|meta-awareness
993213|NCT03206840|absorption|absorption
993214|NCT03206840|consciousness|consciousness
993215|NCT03206840|self|self
993216|NCT03206827|colorectal cancer|colorectal cancer
993217|NCT03206827|type 2 diabetes|type 2 diabetes
993218|NCT03206827|diet|diet
993219|NCT03206827|plant protein|plant protein
993220|NCT03206827|animal protein|animal protein
993221|NCT03206814|Hypertension|hypertension
993222|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
993223|NCT03206814|Home Blood Pressure|home blood pressure
993224|NCT03206814|ESH-CARE APP|esh-care app
993225|NCT03206801|Urine biomarker|urine biomarker
993226|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
993227|NCT03206801|Post-transplant monitoring|post-transplant monitoring
993228|NCT03206801|Protocol biopsy|protocol biopsy
993229|NCT03206723|corneal abrasion|corneal abrasion
993230|NCT03206723|contact lens|contact lens
993231|NCT03206723|eye trauma|eye trauma
993232|NCT03206710|vitamin C|vitamin c
993233|NCT03206710|ascorbic acid|ascorbic acid
993234|NCT03206710|wheeze|wheeze
993235|NCT03206710|nicotine|nicotine
993236|NCT03206710|smoke exposure|smoke exposure
993237|NCT03206710|long term follow up|long term follow up
993238|NCT03206710|pulmonary function testing|pulmonary function testing
993239|NCT03206710|forced expiratory flows|forced expiratory flows
993240|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
993241|NCT03206658|acute kidney injury|acute kidney injury
993242|NCT03206658|prevention|prevention
993243|NCT03206658|severity|severity
993244|NCT03206658|biomarker|biomarker
993245|NCT03206619|smoking|smoking
993246|NCT03206619|habit|habit
993247|NCT03206619|preference|preference
993248|NCT03206619|behavior|behavior
993249|NCT03206619|tailoring|tailoring
993250|NCT03206619|cessation|cessation
993251|NCT03206619|engagement|engagement
993252|NCT03206619|digital|digital
993253|NCT03206619|mobile app|mobile app
993254|NCT03206619|recommender system|recommender system
993255|NCT03206606|COPD|copd
993256|NCT03206606|Spirometry|spirometry
993257|NCT03206606|Mobile application|mobile application
993258|NCT03206580|aging|aging
993259|NCT03206580|strength training|strength training
993260|NCT03206580|functionality|functionality
993261|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
993262|NCT03206541|Neurological syndromes|neurological syndromes
993263|NCT03206541|Arbovirus infection|arbovirus infection
993264|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
993265|NCT03206476|Food Habits|food habits
993266|NCT03206476|Adolescents|adolescents
993267|NCT03206476|Educative Intervention|educative intervention
993268|NCT03206476|Nutrition Assessment|nutrition assessment
993269|NCT03206476|Behavior Modifications|behavior modifications
993270|NCT03206437|mindfulness|mindfulness
993271|NCT03206437|meditation|meditation
993272|NCT03206359|Unfolded Protein Response|unfolded protein response
993273|NCT03206359|GADD34|gadd34
993274|NCT03206359|Type I IFN|type i ifn
993275|NCT03206359|IFN response genes|ifn response genes
993276|NCT03206359|Type II IFN|type ii ifn
993277|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
993278|NCT03206333|Breast cancer|breast cancer
993279|NCT03206333|Cardiovascular diseases|cardiovascular diseases
993280|NCT03206333|Coronary artery calcium|coronary artery calcium
993281|NCT03206333|Prediction|prediction
993282|NCT03206333|Risk stratification|risk stratification
993283|NCT03206333|Deep learning technique|deep learning technique
993284|NCT03206333|Software development|software development
993285|NCT03206333|Computed tomography scan|computed tomography scan
993286|NCT03206307|Return to work|return to work
993287|NCT03206307|medical rehabilitation|medical rehabilitation
993288|NCT03206281|clinical weight estimation|clinical weight estimation
993289|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
993290|NCT03206268|uveitis|uveitis
993291|NCT03206268|SD-OCT|sd-oct
993292|NCT03206268|GDx VCC|gdx vcc
993293|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
993294|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
993295|NCT03206255|adolescent girl|adolescent girl
993296|NCT03206255|non-inferiority|non-inferiority
993297|NCT03206255|immuno-persistence|immuno-persistence
993298|NCT03206242|Rehabilitation|rehabilitation
993299|NCT03206242|Physiotherapy|physiotherapy
993300|NCT03206242|Trismus|trismus
993301|NCT03206242|Pain|pain
993302|NCT03206242|Return to work|return to work
993303|NCT03206242|Quality of life|quality of life
993304|NCT03206190|SPG4|spg4
993305|NCT03206190|presymptomatic|presymptomatic
993306|NCT03206190|at risk|at risk
993307|NCT03206190|mutation carriers|mutation carriers
993308|NCT03206190|biomarkers|biomarkers
993309|NCT03206190|longitudinal progression|longitudinal progression
993310|NCT03206164|Health Services Research|health services research
993311|NCT03206138|Investigator trial|investigator trial
993312|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
993313|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
993318|NCT03206112|Healthy Volunteers|healthy volunteers
993319|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
993320|NCT03206099|Genetic Disorders and Defects|genetic disorders and defects
993321|NCT03206099|Novel Clinical Phenotypes|novel clinical phenotypes
993322|NCT03206099|Immune Diseases|immune diseases
993324|NCT03206099|Mendelian Disorders|mendelian disorders
993330|NCT03206073|Oncolytic Vaccinia Virus|oncolytic vaccinia virus
993331|NCT03206073|Tumor Cell Death|tumor cell death
993332|NCT03206073|Viral Therapy|viral therapy
993333|NCT03206073|Anti-Tumor Immunity|anti-tumor immunity
993334|NCT03206060|Hypertension|hypertension
993335|NCT03206060|Catecholamine|catecholamine
993336|NCT03206060|Familial Syndromes|familial syndromes
993337|NCT03206060|Somatostatin Receptors|somatostatin receptors
993338|NCT03206060|Ionizing Radiation|ionizing radiation
993339|NCT03206034|Memory|memory
993340|NCT03206034|Cognition|cognition
993341|NCT03205995|TMA|tma
993342|NCT03205995|aHUS|ahus
993343|NCT03205982|Wisepill|wisepill
993344|NCT03205982|ART|art
993345|NCT03205982|PLWH|plwh
993346|NCT03205969|Breast Cancer|breast cancer
993347|NCT03205969|chemotherapy side effect|chemotherapy side effect
993348|NCT03205969|mobile game|mobile game
993349|NCT03205956|Parkinson's disease|parkinson's disease
993350|NCT03205956|PD|pd
993351|NCT03205956|levodopa|levodopa
993352|NCT03205943|ICON|icon
993353|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
993354|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
993355|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
993356|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
993357|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
993358|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
993359|NCT03205891|SGN-35|sgn-35
993360|NCT03205891|Adcetris|adcetris
993361|NCT03205891|TAK228|tak228
993362|NCT03205891|TAK-228|tak-228
993363|NCT03205891|MLN0128|mln0128
993364|NCT03205891|Glucose Monitor|glucose monitor
993365|NCT03205891|Glucometer|glucometer
993366|NCT03205826|Emphysema|emphysema
993367|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
993368|NCT03205826|CHARTIS measurement|chartis measurement
993369|NCT03205813|Pain, Postoperative|pain, postoperative
993370|NCT03205813|Cesarean delivery|cesarean delivery
993371|NCT03205813|Intrathecal morphine|intrathecal morphine
993372|NCT03205761|Advanced Breast Cancer|advanced breast cancer
993373|NCT03205761|Triple Negative|triple negative
993374|NCT03205761|olaparib|olaparib
993375|NCT03205761|lynparza|lynparza
993376|NCT03205761|BRCA|brca
993377|NCT03205761|Methylation|methylation
993378|NCT03205709|memory|memory
993379|NCT03205709|computerized training|computerized training
993380|NCT03205709|cognition|cognition
993381|NCT03205709|MRI|mri
993382|NCT03205709|mci|mci
993383|NCT03205709|memory problems|memory problems
993384|NCT03205709|memory complaints|memory complaints
993385|NCT03205670|Autologous Cells|autologous cells
993386|NCT03205670|Buccal Mucosa|buccal mucosa
993387|NCT03205670|Urethroplasty|urethroplasty
993388|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
993389|NCT03205670|Hybrid matrix|hybrid matrix
993390|NCT03205670|Collagen|collagen
993391|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
993392|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
993393|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
993394|NCT03205527|Fall risk|fall risk
993395|NCT03205527|Stroke survivors|stroke survivors
993396|NCT03205527|Perturbation training|perturbation training
993397|NCT03205501|BE|be
993398|NCT03205501|EAC|eac
993399|NCT03205501|HGD|hgd
993400|NCT03205501|Esophagus|esophagus
993401|NCT03205488|Northwestern|northwestern
993402|NCT03205488|Nilotinib|nilotinib
993403|NCT03205488|USA|usa
993404|NCT03205488|NILO-PD|nilo-pd
993405|NCT03205488|Parkinson Disease|parkinson disease
993406|NCT03205475|Training|training
993407|NCT03205475|Intervention|intervention
993408|NCT03205475|Social Communication|social communication
993409|NCT03205475|Play|play
993410|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
993411|NCT03205462|antibiotic resistance|antibiotic resistance
993412|NCT03205462|nosocomial infection|nosocomial infection
993413|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
993414|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
993415|NCT03205462|chronic infection|chronic infection
993416|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
993417|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
993418|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
993419|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
993420|NCT03205358|Meningitis|meningitis
993421|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
993422|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
993423|NCT03205358|NIMENRIX®|nimenrix®
993424|NCT03205345|Cirrhosis|cirrhosis
993425|NCT03205345|NASH Cirrhosis|nash cirrhosis
993426|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
993427|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
993428|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
993429|NCT03205332|Worry|worry
993431|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
993432|NCT03205319|E-learning|e-learning
993433|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
993434|NCT03205319|Deimplementation|deimplementation
993435|NCT03205306|Myasthenia Gravis|myasthenia gravis
993436|NCT03205306|Psyche|psyche
993437|NCT03205306|Depression|depression
993438|NCT03205306|Anxiety Disorder|anxiety disorder
993439|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
993440|NCT03205306|Disease Processing|disease processing
993441|NCT03205293|School-Based Intervention|school-based intervention
993442|NCT03205293|Ecological Model|ecological model
993443|NCT03205293|Participatory Approach|participatory approach
993444|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
993445|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
993446|NCT03205254|Mediterranean diet|mediterranean diet
993447|NCT03205254|HDL|hdl
993448|NCT03205254|Fast food|fast food
993449|NCT03205254|Gut microbiota|gut microbiota
993450|NCT03205254|Inflammation|inflammation
993451|NCT03205241|Exercise|exercise
993452|NCT03205241|Fish Oil|fish oil
993453|NCT03205241|Cycling|cycling
993454|NCT03205241|Inflammation|inflammation
993455|NCT03205241|Oxidative stress|oxidative stress
993456|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
993457|NCT03205215|Pressurized oxygen|pressurized oxygen
993458|NCT03205215|Concussion|concussion
993459|NCT03205215|Post concussive syndrome|post concussive syndrome
993460|NCT03205215|Oxygen therapy|oxygen therapy
993461|NCT03205189|postoperative pain|postoperative pain
993462|NCT03205189|ambulatory surgery|ambulatory surgery
993463|NCT03205189|general anesthesia|general anesthesia
993464|NCT03205189|anesthesia consultation|anesthesia consultation
993465|NCT03205189|post-op prescription|post-op prescription
993466|NCT03205176|AZD5153|azd5153
993467|NCT03205176|Malignant solid tumors|malignant solid tumors
993468|NCT03205176|Lymphoma|lymphoma
993469|NCT03205176|Ovarian Cancer|ovarian cancer
993470|NCT03205176|BRD4|brd4
993471|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
993472|NCT03205150|NASH|nash
993473|NCT03205150|Obese|obese
993474|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
993475|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
993476|NCT03205098|biological markers|biological markers
993477|NCT03205098|mesenteric ischemia|mesenteric ischemia
993478|NCT03205098|ultratrail|ultratrail
993479|NCT03205072|ERCP|ercp
993480|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
993481|NCT03205072|Liver Transplantation|liver transplantation
993482|NCT03205072|Spy Glass|spy glass
993483|NCT03205033|Melatonin|melatonin
993484|NCT03205033|Breast cancer|breast cancer
993485|NCT03205033|Chemotherapy|chemotherapy
993486|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
993487|NCT03205033|Circadian rhythms|circadian rhythms
993488|NCT03205007|Health Promotion|health promotion
993489|NCT03205007|Nutrition|nutrition
993490|NCT03205007|Older Adults|older adults
993491|NCT03204994|Colorectal surgery|colorectal surgery
993492|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
993493|NCT03204981|intramural needle ablation|intramural needle ablation
993494|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
993495|NCT03204968|vagus nerve|vagus nerve
993496|NCT03204968|Lung lobectomy|lung lobectomy
993497|NCT03204955|Osmolar therapy|osmolar therapy
993498|NCT03204955|Acetate|acetate
993499|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
993500|NCT03204903|Dry eye|dry eye
993501|NCT03204903|Laser acupuncture|laser acupuncture
993502|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
993503|NCT03204877|Melatonin|melatonin
993504|NCT03204877|Insulin sensitivity|insulin sensitivity
993505|NCT03204877|Insulin secretion|insulin secretion
993506|NCT03204877|Incretin response|incretin response
993507|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
1659595|NCT00147836|metformin|metformin
993508|NCT03204825|Patient education|patient education
993509|NCT03204825|Pain management|pain management
993608|NCT03204227|Japanese Encephalitis|japanese encephalitis
993510|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
993511|NCT03204825|Physical activity|physical activity
993512|NCT03204825|Feasibility|feasibility
993513|NCT03204812|prostate cancer|prostate cancer
993514|NCT03204812|metastatic disease|metastatic disease
993515|NCT03204812|Immune responses|immune responses
993516|NCT03204812|Immunotherapies|immunotherapies
993517|NCT03204812|PD-L1-dependent immunosuppressive effects|pd-l1-dependent immunosuppressive effects
993518|NCT03204812|cytotoxic activity|cytotoxic activity
993519|NCT03204812|anti-tumor T-cells|anti-tumor t-cells
993520|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
993521|NCT03204786|Autism|autism
993522|NCT03204747|Gait speed|gait speed
993523|NCT03204747|multiple sclerosis|multiple sclerosis
993524|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
993525|NCT03204747|overactive bladder|overactive bladder
993526|NCT03204734|therapy|therapy
993527|NCT03204734|Capecitabine|capecitabine
993528|NCT03204734|breast cancer|breast cancer
993529|NCT03204708|postoperative analgsia|postoperative analgsia
993530|NCT03204708|peripheral block catheter|peripheral block catheter
993531|NCT03204708|modified radical mastectomy|modified radical mastectomy
993532|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
993533|NCT03204695|Atrial Fibrillation|atrial fibrillation
993534|NCT03204695|Stroke|stroke
993535|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
993536|NCT03204695|LAA Closure|laa closure
993537|NCT03204695|LAA Occlusion|laa occlusion
993538|NCT03204695|WaveCrest|wavecrest
993539|NCT03204682|Endometriosis|endometriosis
993540|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
993541|NCT03204682|Chronic pain|chronic pain
993542|NCT03204682|Analgesic|analgesic
993543|NCT03204669|Copper|copper
993544|NCT03204669|Selenium|selenium
993545|NCT03204669|Zinc|zinc
993546|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
993547|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
993548|NCT03204656|selective lung intubation|selective lung intubation
993549|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
993550|NCT03204630|infant nutrition|infant nutrition
993551|NCT03204630|probiotic|probiotic
993552|NCT03204617|HIV infection|hiv infection
993553|NCT03204617|First in Human|first in human
993554|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
993556|NCT03204617|HIV reservoir|hiv reservoir
993557|NCT03204604|Memory|memory
993558|NCT03204604|Dietary Treatment|dietary treatment
993559|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
993560|NCT03204539|inhibitor|inhibitor
993561|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
993562|NCT03204513|Prosthesis|prosthesis
993563|NCT03204513|Powered Prosthesis|powered prosthesis
993564|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
993565|NCT03204500|Dual therapy|dual therapy
993566|NCT03204500|Randomized controlled trial|randomized controlled trial
993567|NCT03204500|ALSFRS-R|alsfrs-r
993568|NCT03204487|tear film thickness|tear film thickness
993569|NCT03204487|ocular surface disease|ocular surface disease
993570|NCT03204487|OCT|oct
993571|NCT03204474|Lacosamide|lacosamide
993572|NCT03204474|Bioequivalence|bioequivalence
993573|NCT03204474|Intravenous solution|intravenous solution
993574|NCT03204474|Tablet|tablet
993575|NCT03204422|urinary sodium excretion|urinary sodium excretion
993576|NCT03204422|24-hout urine|24-hout urine
993577|NCT03204422|salt intakes|salt intakes
993578|NCT03204422|hypertension|hypertension
993579|NCT03204409|CHIKV|chikv
993580|NCT03204409|DENGUE|dengue
993581|NCT03204409|Chikungunya|chikungunya
993582|NCT03204409|DENV|denv
993583|NCT03204357|Cardiac surgery|cardiac surgery
993584|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
993585|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
993586|NCT03204344|Diabetic patients|diabetic patients
993587|NCT03204344|Postoperative recovery|postoperative recovery
993588|NCT03204331|Endometriosis|endometriosis
993589|NCT03204331|Pain|pain
993590|NCT03204331|Dysmenorrhea|dysmenorrhea
993591|NCT03204318|Endometriosis|endometriosis
993592|NCT03204318|Pain|pain
993593|NCT03204318|Dysmenorrhea|dysmenorrhea
993594|NCT03204305|Marijuana|marijuana
993595|NCT03204305|cannabis|cannabis
993596|NCT03204305|cannabinoid receptor|cannabinoid receptor
993597|NCT03204292|Inferior vena cava|inferior vena cava
993598|NCT03204292|Fluid responsiveness|fluid responsiveness
993599|NCT03204292|Central venous pressure|central venous pressure
993600|NCT03204266|urinary tract|urinary tract
993601|NCT03204266|Bladder cancer|bladder cancer
993602|NCT03204266|Radical cystectomy|radical cystectomy
993603|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
993604|NCT03204240|Spinal Cord Injury|spinal cord injury
993605|NCT03204240|Skeletal Muscle|skeletal muscle
993606|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
993607|NCT03204240|Diabetes|diabetes
993609|NCT03204227|JECEVAX|jecevax
993610|NCT03204227|Vietnam|vietnam
993611|NCT03204214|binge drinking|binge drinking
993612|NCT03204201|Fluorescence|fluorescence
993613|NCT03204188|BTK Inhibitor|btk inhibitor
993614|NCT03204188|Checkpoint Inhibitor|checkpoint inhibitor
993615|NCT03204123|prostate cancer|prostate cancer
993616|NCT03204123|prostatectomy|prostatectomy
993617|NCT03204123|biochemical recurrence|biochemical recurrence
993618|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
993619|NCT03204123|16-306|16-306
993620|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
993621|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
993622|NCT03204110|Retinal vessel analyser|retinal vessel analyser
993623|NCT03204110|retinography|retinography
993624|NCT03204110|Prospective analysis|prospective analysis
994037|NCT03201679|Sepsis|sepsis
993625|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
993626|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
993627|NCT03204032|Tegafur|tegafur
993628|NCT03204032|Temozolomide|temozolomide
993629|NCT03204032|Thalidomide|thalidomide
993630|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
993631|NCT03204019|Tegafur|tegafur
993632|NCT03204019|Temozolomide|temozolomide
993633|NCT03204019|Thalidomide|thalidomide
993634|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
993635|NCT03203993|BRCA mutation|brca mutation
993636|NCT03203967|Adults|adults
993637|NCT03203967|Unilateral TKA|unilateral tka
993638|NCT03203967|Single femoral nerve block|single femoral nerve block
993639|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
993640|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
993641|NCT03203967|Quality of life|quality of life
993642|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
993643|NCT03203928|ADHD|adhd
993644|NCT03203928|Occupational Therapy|occupational therapy
993645|NCT03203915|cholesterol|cholesterol
993646|NCT03203915|triglyceride|triglyceride
993647|NCT03203915|grape seed extract|grape seed extract
993648|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
993649|NCT03203915|polyphenol|polyphenol
993650|NCT03203915|gut microbiome|gut microbiome
993651|NCT03203902|Therapeutic touch|therapeutic touch
993652|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
993653|NCT03203902|Homeless|homeless
993654|NCT03203889|American Indians|american indians
993655|NCT03203889|Native Americans|native americans
993656|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
993657|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
993658|NCT03203889|Treatment Entry|treatment entry
993659|NCT03203889|Cultural adaptations|cultural adaptations
993660|NCT03203889|Spirituality|spirituality
993661|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
993662|NCT03203850|ICL670|icl670
993663|NCT03203850|deferasirox FCT|deferasirox fct
993664|NCT03203850|iron overload|iron overload
993665|NCT03203837|Radioembolization|radioembolization
993666|NCT03203837|Y90|y90
993667|NCT03203837|TheraSphere|therasphere
993668|NCT03203837|HCC|hcc
993669|NCT03203837|Biomarker|biomarker
993670|NCT03203837|Prognostic factor|prognostic factor
993671|NCT03203837|Angiogenesis|angiogenesis
993672|NCT03203837|Inflammatory|inflammatory
993673|NCT03203837|Liver|liver
993674|NCT03203811|Healthy Subjects|healthy subjects
993675|NCT03203746|Lycopene|lycopene
993676|NCT03203746|Chronic periodontitis|chronic periodontitis
993677|NCT03203746|Protein carbonyl|protein carbonyl
993678|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
993679|NCT03203720|adherence|adherence
993680|NCT03203720|adolescent|adolescent
993681|NCT03203720|Motivational Intervention|motivational intervention
993682|NCT03203707|IPSRT|ipsrt
993683|NCT03203707|early intervention|early intervention
993684|NCT03203707|bipolar disorder|bipolar disorder
993685|NCT03203668|Hyperparathyroidism|hyperparathyroidism
993686|NCT03203668|Imaging|imaging
993687|NCT03203668|Scintigraphy|scintigraphy
993688|NCT03203668|18F-choline|18f-choline
993689|NCT03203668|18F-fluorocholine|18f-fluorocholine
993690|NCT03203668|PET|pet
993691|NCT03203668|PET/CT|pet/ct
993692|NCT03203655|Mobile text|mobile text
993693|NCT03203655|Obesity|obesity
993694|NCT03203655|Hispanic|hispanic
993695|NCT03203655|Women|women
993696|NCT03203642|ADPKD|adpkd
993697|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
993698|NCT03203642|Polycystic Kidney|polycystic kidney
993699|NCT03203642|Tesevatinib|tesevatinib
993700|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
993701|NCT03203642|PKD|pkd
993702|NCT03203603|asthma|asthma
993703|NCT03203603|pulmonary function testing|pulmonary function testing
993704|NCT03203603|wheeze|wheeze
993705|NCT03203603|vitamin C|vitamin c
993706|NCT03203603|antioxidants|antioxidants
993707|NCT03203603|forced expiratory flows|forced expiratory flows
993708|NCT03203551|Dentures|dentures
993709|NCT03203551|Biofilms|biofilms
993710|NCT03203551|Disinfection|disinfection
993711|NCT03203551|Candidiasis|candidiasis
993712|NCT03203551|Candida|candida
993713|NCT03203538|night work|night work
993714|NCT03203538|shift work|shift work
993715|NCT03203538|light|light
993716|NCT03203538|bright light|bright light
993717|NCT03203538|sleep|sleep
993718|NCT03203538|cognitive performance|cognitive performance
993719|NCT03203538|circadian rhythm|circadian rhythm
993720|NCT03203525|Liver Cancer|liver cancer
993721|NCT03203525|Hepatic metastases|hepatic metastases
993722|NCT03203525|Advanced liver cancer|advanced liver cancer
993723|NCT03203525|Eloxatin|eloxatin
993724|NCT03203525|Oxaliplatin|oxaliplatin
993725|NCT03203525|Leucovorin|leucovorin
993726|NCT03203525|Citrovorum|citrovorum
993727|NCT03203525|Wellcovorin|wellcovorin
993728|NCT03203525|5-fluorouracil|5-fluorouracil
993729|NCT03203525|Fluorouracil|fluorouracil
993730|NCT03203525|5-FU|5-fu
993731|NCT03203525|Adrucil|adrucil
993732|NCT03203525|Efudex|efudex
993733|NCT03203525|Bevacizumab|bevacizumab
993734|NCT03203525|Avastin|avastin
993735|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
993736|NCT03203525|rhuMab-VEGF|rhumab-vegf
993737|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
993738|NCT03203525|Doxil|doxil
993739|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
993740|NCT03203525|Temsirolimus|temsirolimus
993741|NCT03203525|CCI-779|cci-779
993742|NCT03203525|Torisel|torisel
993743|NCT03203525|NovoTTF-100L System|novottf-100l system
993744|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
993745|NCT03203499|Substance abuse disorder|substance abuse disorder
993746|NCT03203486|NAFLD|nafld
993747|NCT03203486|no fibrosis|no fibrosis
993748|NCT03203486|Mediterranean diet|mediterranean diet
993749|NCT03203486|STAT3|stat3
993750|NCT03203486|GCKR|gckr
993751|NCT03203486|visfatin|visfatin
993752|NCT03203486|oxidized LDL|oxidized ldl
993753|NCT03203486|fasting glucose|fasting glucose
993754|NCT03203486|inflammation|inflammation
993755|NCT03203473|Renal Cancer|renal cancer
993756|NCT03203460|Prostate Cancer|prostate cancer
993757|NCT03203460|Active Surveillance|active surveillance
993758|NCT03203460|Exercise|exercise
993759|NCT03203460|High-Intensity Interval Training|high-intensity interval training
993760|NCT03203460|Randomized Controlled Trial|randomized controlled trial
993761|NCT03203447|RVO|rvo
993762|NCT03203447|ME|me
993763|NCT03203447|Microneedle|microneedle
993764|NCT03203447|Microinjection|microinjection
993765|NCT03203447|Triamcinolone|triamcinolone
993766|NCT03203447|Choroid|choroid
993767|NCT03203447|Choroid injection|choroid injection
993768|NCT03203447|Suprachoroidal|suprachoroidal
993769|NCT03203447|Anti-VEGF|anti-vegf
993770|NCT03203447|Subretinal Fluid|subretinal fluid
993771|NCT03203447|Cystoid Macular Edema|cystoid macular edema
993772|NCT03203447|Optical Coherence Tomography|optical coherence tomography
993773|NCT03203447|OCT|oct
993774|NCT03203447|Central Subfield Thickness|central subfield thickness
993775|NCT03203447|Lucentis|lucentis
993776|NCT03203447|Avastin|avastin
993777|NCT03203447|Ranibizumab|ranibizumab
993778|NCT03203447|Bevacizumab|bevacizumab
993779|NCT03203434|Pancreatic cancer|pancreatic cancer
993780|NCT03203434|Esophageal cancer|esophageal cancer
993781|NCT03203434|volatile organic compounds|volatile organic compounds
993782|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
993783|NCT03203395|Depression|depression
993784|NCT03203395|Anxiety|anxiety
993785|NCT03203395|Panic Attacks|panic attacks
993786|NCT03203395|Collaborative Care|collaborative care
993787|NCT03203395|Heart disease and depression|heart disease and depression
993788|NCT03203395|Heart disease and anxiety|heart disease and anxiety
993789|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
993790|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
993791|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
993792|NCT03203369|Hematologic malignancies|hematologic malignancies
993793|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
993794|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
993795|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
993796|NCT03203369|Allogeneic|allogeneic
993797|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
993798|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
993799|NCT03203356|growth hormone|growth hormone
993800|NCT03203356|children|children
1659596|NCT00147836|insulin|insulin
993801|NCT03203356|adrenal function|adrenal function
993802|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
993803|NCT03203343|Children, Only|children, only
993804|NCT03203343|Inflammatory Response|inflammatory response
993805|NCT03203343|Surgery|surgery
993806|NCT03203343|Interleukin-6|interleukin-6
993807|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
993808|NCT03203343|C reactive protein|c reactive protein
993809|NCT03203343|Leukocytes|leukocytes
993810|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
993811|NCT03203304|nivolumab|nivolumab
993812|NCT03203304|ipilimumab|ipilimumab
993813|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
993814|NCT03203304|SBRT|sbrt
993815|NCT03203291|stroke|stroke
993816|NCT03203291|robotic training|robotic training
993817|NCT03203291|gait|gait
993818|NCT03203278|South Asian|south asian
993819|NCT03203265|HIV home testing|hiv home testing
993820|NCT03203239|red light|red light
993821|NCT03203239|vasodilation|vasodilation
993822|NCT03203239|nitric oxide|nitric oxide
993823|NCT03203226|Intellectual Disability|intellectual disability
993824|NCT03203226|Feldenkrais Method|feldenkrais method
993825|NCT03203226|Short Physical Performance Battery|short physical performance battery
993826|NCT03203226|Stabilometry|stabilometry
993827|NCT03203226|Supported employment|supported employment
993828|NCT03203213|Poisoning|poisoning
993829|NCT03203213|Psychoactive substances|psychoactive substances
993830|NCT03203174|microneedle|microneedle
993831|NCT03203174|botulinum toxin|botulinum toxin
993832|NCT03203174|botox|botox
993833|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
993834|NCT03203174|sweating|sweating
993835|NCT03203174|hyperhidrosis|hyperhidrosis
993836|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
993837|NCT03203148|Blood Coagulation Testing|blood coagulation testing
993838|NCT03203148|Point-of-Care Testing|point-of-care testing
993839|NCT03203109|lateropulsion|lateropulsion
993840|NCT03203109|pusher syndrome|pusher syndrome
993841|NCT03203109|posture|posture
993842|NCT03203109|balance|balance
993843|NCT03203109|PASS|pass
993844|NCT03203109|verticality perception|verticality perception
993845|NCT03203109|gait|gait
993846|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
993847|NCT03203083|Reproducibility of Results|reproducibility of results
993848|NCT03203083|Clinical Assessment|clinical assessment
993849|NCT03203044|Dietary Intervention|dietary intervention
993850|NCT03203031|pain|pain
993851|NCT03203031|neonate|neonate
993852|NCT03203031|regional anesthesia|regional anesthesia
993853|NCT03203031|postoperative|postoperative
993854|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
993855|NCT03203018|Community-based intervention|community-based intervention
993856|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
993857|NCT03203018|Health literacy (HL)|health literacy (hl)
993858|NCT03202979|Trazodone|trazodone
993859|NCT03202979|Placebo|placebo
993860|NCT03202979|Gabapentin|gabapentin
993861|NCT03202979|Neuropathic pain|neuropathic pain
993862|NCT03202940|Lung Cancer|lung cancer
993863|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
993864|NCT03202862|fulvestrant|fulvestrant
993865|NCT03202862|ESR1|esr1
993866|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
993867|NCT03202849|vitamin a|vitamin a
993868|NCT03202849|vitamin d|vitamin d
993869|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
993870|NCT03202758|Durvalumab|durvalumab
993871|NCT03202758|Tremelimumab|tremelimumab
993872|NCT03202758|FOLFOX|folfox
993873|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
993874|NCT03202732|Self-management|self-management
993875|NCT03202732|Patient Activeted measure|patient activeted measure
993876|NCT03202732|Patient-reported outcome|patient-reported outcome
993877|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
993878|NCT03202732|Non-inferiority study|non-inferiority study
993879|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
993880|NCT03202719|Polio|polio
993881|NCT03202719|oral polio vaccine|oral polio vaccine
993882|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
993883|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
993884|NCT03202667|Treatment|treatment
993885|NCT03202641|ARDS|ards
993886|NCT03202641|PEEP titration|peep titration
993887|NCT03202641|Open Lung Strategy|open lung strategy
993888|NCT03202641|Right heart function|right heart function
993889|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
993890|NCT03202641|Esophageal Pressure|esophageal pressure
993891|NCT03202641|Respiratory system compliance|respiratory system compliance
993892|NCT03202615|lactoferrin|lactoferrin
993893|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
993894|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
993895|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
993896|NCT03202602|Telemoedicine|telemoedicine
993897|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
993898|NCT03202589|FOCUS Echocardiography|focus echocardiography
993899|NCT03202589|Orthopedic|orthopedic
993900|NCT03202589|Surgery|surgery
993901|NCT03202589|Geriatric|geriatric
993902|NCT03202576|nasogastric tube|nasogastric tube
993903|NCT03202576|microbridle|microbridle
993904|NCT03202550|Oral Sedation|oral sedation
993905|NCT03202550|Lorazepam|lorazepam
993915|NCT03202485|high myopia|high myopia
993916|NCT03202485|phakic intraocular lens|phakic intraocular lens
993917|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
993918|NCT03202485|toric|toric
993919|NCT03202459|Anesthesia|anesthesia
993920|NCT03202459|Complications|complications
993921|NCT03202459|Nausea|nausea
993922|NCT03202459|Vomiting|vomiting
993923|NCT03202433|Virtual Reality|virtual reality
993924|NCT03202433|Stress Reduction|stress reduction
993925|NCT03202433|Needle Aspiration|needle aspiration
993926|NCT03202433|Blood Donors|blood donors
993927|NCT03202433|Intervention|intervention
993928|NCT03202394|intubation|intubation
993929|NCT03202394|aerosol|aerosol
993930|NCT03202394|sepsis|sepsis
993931|NCT03202394|edema|edema
993932|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
993933|NCT03202381|GnRH antagonist|gnrh antagonist
993934|NCT03202355|Alignment phase|alignment phase
993935|NCT03202355|Photobiomodulation|photobiomodulation
993936|NCT03202355|Orthodontic treatment|orthodontic treatment
993937|NCT03202355|Malocclusion|malocclusion
993938|NCT03202355|OrthoPulse™|orthopulse™
993939|NCT03202316|Malignant neoplasm of breast|malignant neoplasm of breast
993940|NCT03202316|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
993941|NCT03202316|mIBC|mibc
993942|NCT03202316|Cobimetinib|cobimetinib
993943|NCT03202316|Atezolizumab|atezolizumab
993944|NCT03202316|MPDL3280A|mpdl3280a
993945|NCT03202316|Eribulin|eribulin
993946|NCT03202316|E7389|e7389
993947|NCT03202303|Autism|autism
993948|NCT03202303|Irritability|irritability
993949|NCT03202303|cannabinoids|cannabinoids
993950|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
993951|NCT03202264|Polypharmacy|polypharmacy
993952|NCT03202264|Mobility|mobility
993953|NCT03202264|Multimorbidity|multimorbidity
993954|NCT03202264|Drug Discontinuation|drug discontinuation
993955|NCT03202264|Patient Preference|patient preference
993957|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
993958|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
993959|NCT03202173|Optical biopsy|optical biopsy
993960|NCT03202160|Goiter|goiter
993961|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
993962|NCT03202108|Ketogenic|ketogenic
993963|NCT03202108|Diet|diet
993964|NCT03202108|Epilepsy|epilepsy
993965|NCT03202108|Glut-1 DS|glut-1 ds
993966|NCT03202108|Krio|krio
993967|NCT03202095|Depression|depression
993968|NCT03202095|Type 2 Diabetes|type 2 diabetes
993969|NCT03202095|Creatine|creatine
993970|NCT03202095|Diabetes|diabetes
993971|NCT03202069|Protein|protein
993972|NCT03202069|Weight Loss|weight loss
993973|NCT03202056|hip osteoarthritis|hip osteoarthritis
993974|NCT03202056|physiotherapy|physiotherapy
993975|NCT03202056|manual therapy|manual therapy
993976|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
993977|NCT03202030|bio-oss|bio-oss
993978|NCT03202030|immediate dental implant|immediate dental implant
993979|NCT03202030|bovine bone|bovine bone
993980|NCT03202004|PGA|pga
993981|NCT03202004|efficacy|efficacy
993982|NCT03202004|PASI|pasi
993983|NCT03202004|GSK2894512|gsk2894512
993984|NCT03202004|NRS|nrs
993985|NCT03202004|Topical|topical
993986|NCT03202004|psoriasis|psoriasis
993987|NCT03201991|ALS|als
993988|NCT03201978|Healthy adults|healthy adults
993989|NCT03201978|GSK2894512|gsk2894512
993990|NCT03201978|Topical|topical
993991|NCT03201978|Psoriasis|psoriasis
993992|NCT03201978|Pharmacokinetics|pharmacokinetics
993993|NCT03201952|Glucose|glucose
993994|NCT03201952|Ileostomy|ileostomy
993995|NCT03201939|HIV/AIDS|hiv/aids
993996|NCT03201939|sub-Saharan Africa|sub-saharan africa
993997|NCT03201939|Kidney disease|kidney disease
993998|NCT03201939|Albuminuria|albuminuria
993999|NCT03201939|Genetic risk|genetic risk
994000|NCT03201900|perampanel|perampanel
994001|NCT03201848|Huaiqihuang granule|huaiqihuang granule
994002|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
994003|NCT03201848|randomized|randomized
994004|NCT03201848|double-blind|double-blind
994005|NCT03201848|placebo-controlled,|placebo-controlled,
994006|NCT03201822|flavanol|flavanol
994007|NCT03201822|ADME|adme
994008|NCT03201822|cocoa flavanols|cocoa flavanols
994009|NCT03201822|polyphenols|polyphenols
994010|NCT03201796|Bacterial prostatitis|bacterial prostatitis
994011|NCT03201796|CBP|cbp
994012|NCT03201796|Levofloxacin|levofloxacin
994013|NCT03201796|Prulifloxacin|prulifloxacin
994014|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
994015|NCT03201783|time interval|time interval
994016|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
994017|NCT03201770|Pyramax|pyramax
994018|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
994019|NCT03201757|Alkermes|alkermes
994020|NCT03201757|ALKS 3831|alks 3831
994021|NCT03201757|Olanzapine|olanzapine
994022|NCT03201757|Samidorphan|samidorphan
994023|NCT03201757|Schizophrenia|schizophrenia
994024|NCT03201757|Schizophreniform|schizophreniform
994025|NCT03201757|Bipolar I|bipolar i
994026|NCT03201718|Hepatitis C|hepatitis c
994027|NCT03201718|Paritaprevir|paritaprevir
994028|NCT03201718|Ritonavir|ritonavir
994029|NCT03201718|Ombitasvir|ombitasvir
994030|NCT03201718|Dasabuvir|dasabuvir
994031|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
994032|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
994033|NCT03201705|Pain Management|pain management
994034|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
994035|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
994036|NCT03201679|Hip Fracture Surgery|hip fracture surgery
994039|NCT03201666|prenatal diagnosis|prenatal diagnosis
994040|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
994041|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
994042|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
994043|NCT03201653|Pancreatic Fistula|pancreatic fistula
994044|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
994045|NCT03201653|Pancreatectomy|pancreatectomy
994046|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
994047|NCT03201601|D-chiro-inositol|d-chiro-inositol
994048|NCT03201601|Fertility|fertility
994049|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
994050|NCT03201575|Intensive care|intensive care
994051|NCT03201575|septic shock|septic shock
994052|NCT03201575|multiple organ failure|multiple organ failure
994053|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
994054|NCT03201575|ischemic conditioning|ischemic conditioning
994055|NCT03201575|remote conditioning|remote conditioning
994056|NCT03201575|SOFA score|sofa score
994057|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
994058|NCT03201523|Community-based Intervention|community-based intervention
994059|NCT03201523|Socio-ecological Model|socio-ecological model
994060|NCT03201523|Participatory Approach|participatory approach
994061|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
994062|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
994063|NCT03201432|Ischemic Stroke|ischemic stroke
994064|NCT03201432|Stent|stent
994065|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
994066|NCT03201393|Back pain|back pain
994067|NCT03201393|Neuropathic Pain|neuropathic pain
994068|NCT03201393|Radiculopathy|radiculopathy
994069|NCT03201393|Allodynia|allodynia
994070|NCT03201367|Portal vein|portal vein
994071|NCT03201367|thrombosis|thrombosis
994072|NCT03201367|acute|acute
994073|NCT03201367|rivaroxaban|rivaroxaban
994074|NCT03201354|Glaucoma|glaucoma
994075|NCT03201354|Ocular hypertension|ocular hypertension
994076|NCT03201354|Filtration surgery|filtration surgery
994077|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
994078|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
994079|NCT03201354|Phacoemulsification|phacoemulsification
994080|NCT03201354|Combined surgery|combined surgery
994081|NCT03201341|Stroke|stroke
994082|NCT03201341|Multisensory|multisensory
994083|NCT03201341|Plasticity|plasticity
994084|NCT03201341|Body|body
994085|NCT03201341|Space|space
994086|NCT03201341|MRI|mri
994087|NCT03201315|Fentanyl, opioids|fentanyl, opioids
994088|NCT03201302|bone|bone
994089|NCT03201302|childhood|childhood
994090|NCT03201302|pre-adolescence|pre-adolescence
994091|NCT03201302|bone turnover markers|bone turnover markers
994092|NCT03201302|sclerostin|sclerostin
994093|NCT03201302|sports|sports
994094|NCT03201302|physical activity|physical activity
994095|NCT03201302|nutrition|nutrition
994096|NCT03201276|glucosamine sulfate|glucosamine sulfate
994097|NCT03201276|individual differences|individual differences
994098|NCT03201276|gene polymorphism|gene polymorphism
994099|NCT03201250|carfilzomib|carfilzomib
994100|NCT03201250|cabozantinib|cabozantinib
994101|NCT03201250|proteasome inhibitor|proteasome inhibitor
994102|NCT03201250|resistance|resistance
994103|NCT03201237|Cerebral palsy|cerebral palsy
994104|NCT03201211|Safety|safety
994105|NCT03201211|Immunogenicity|immunogenicity
994106|NCT03201198|physical activity|physical activity
994107|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1660696|NCT00142285|treatment|treatment
994108|NCT03201185|Cardiovascular events|cardiovascular events
994109|NCT03201185|Ventricular remodeling|ventricular remodeling
994111|NCT03201081|elderly|elderly
994112|NCT03201081|motivation|motivation
994113|NCT03201081|adherence|adherence
994114|NCT03201081|resistance-training|resistance-training
994115|NCT03201081|health|health
994116|NCT03201029|center for ethnic skin|center for ethnic skin
994117|NCT03201029|skin of color clinic|skin of color clinic
994118|NCT03201029|ethnic skin center|ethnic skin center
994119|NCT03201016|cirrhosis|cirrhosis
994120|NCT03201003|AR101|ar101
994121|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
994122|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
994123|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
994124|NCT03201003|Peanut Allergy|peanut allergy
994125|NCT03201003|Peanut-Allergic Children|peanut-allergic children
994126|NCT03201003|Desensitization|desensitization
994127|NCT03201003|ARTEMIS|artemis
994128|NCT03201003|Allergy|allergy
994129|NCT03200990|pressure-volume loops|pressure-volume loops
994130|NCT03200990|cardiac mechanics|cardiac mechanics
994131|NCT03200990|high-risk PCI|high-risk pci
994132|NCT03200938|pulpotomy|pulpotomy
994133|NCT03200938|Biological cement|biological cement
994134|NCT03200938|Deciduous tooth|deciduous tooth
994135|NCT03200925|video|video
994136|NCT03200925|skin-to-skin|skin-to-skin
994137|NCT03200925|kangaroo care|kangaroo care
994138|NCT03200925|prenatal education|prenatal education
994139|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
994140|NCT03200886|hyaluronic acid|hyaluronic acid
994141|NCT03200886|intra-articular injections|intra-articular injections
994142|NCT03200886|triamcinolone|triamcinolone
994143|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
994144|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
994145|NCT03200873|theta burst stimulation|theta burst stimulation
994146|NCT03200873|impulsivity|impulsivity
994147|NCT03200860|heart failure|heart failure
994148|NCT03200860|diuretic response|diuretic response
994149|NCT03200860|empagliflozin|empagliflozin
994150|NCT03200847|Pembrolizumab|pembrolizumab
994151|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
994152|NCT03200834|Right colon cancer|right colon cancer
994153|NCT03200834|D3 dissection|d3 dissection
994154|NCT03200834|complete mesocolic excision|complete mesocolic excision
994155|NCT03200834|Hemicolectomy|hemicolectomy
994156|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
994157|NCT03200808|methylene blue|methylene blue
994158|NCT03200808|treatment|treatment
994159|NCT03200795|Diabetes|diabetes
994160|NCT03200795|Musculoskelatal pain|musculoskelatal pain
994161|NCT03200795|Rebound exercises|rebound exercises
994162|NCT03200795|Depression|depression
994163|NCT03200795|Glucose|glucose
994164|NCT03200795|Quality of life|quality of life
994165|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
994166|NCT03200782|bariatric surgery|bariatric surgery
994167|NCT03200782|late dumping syndrome|late dumping syndrome
994168|NCT03200782|anakinra|anakinra
994169|NCT03200782|empagliflozin|empagliflozin
994170|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
994171|NCT03200782|IL-1Beta|il-1beta
994172|NCT03200782|IL1|il1
994173|NCT03200769|CPAP|cpap
994174|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
994175|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
994176|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
994177|NCT03200756|sedentary behavior|sedentary behavior
994178|NCT03200743|Hypertension|hypertension
994179|NCT03200743|Pregnancy|pregnancy
994180|NCT03200743|Catestatin|catestatin
994181|NCT03200730|Family Dignity Intervention|family dignity intervention
994182|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
994183|NCT03200730|Palliative Care|palliative care
994184|NCT03200730|End-of-Life Care|end-of-life care
994185|NCT03200717|renal cell carcinoma|renal cell carcinoma
994186|NCT03200717|metastatic renal cell|metastatic renal cell
994187|NCT03200717|pazopanib|pazopanib
994188|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
994189|NCT03200717|RCC|rcc
994190|NCT03200717|hypernephroma|hypernephroma
994191|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
994192|NCT03200717|kidney cancer|kidney cancer
994193|NCT03200717|renal cancer|renal cancer
994194|NCT03200717|adult|adult
994195|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
994196|NCT03200691|PD-1|pd-1
994197|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
994198|NCT03200678|knee muscle|knee muscle
994199|NCT03200678|strength|strength
994200|NCT03200678|fatigue|fatigue
994201|NCT03200678|MRI|mri
994202|NCT03200678|ACL|acl
994203|NCT03200652|Lysine|lysine
994204|NCT03200652|Adult|adult
994205|NCT03200652|Protein Quality|protein quality
994206|NCT03200639|Breast Cancer Female|breast cancer female
994207|NCT03200639|Gynecologic Cancer|gynecologic cancer
994208|NCT03200639|Menopause|menopause
994209|NCT03200639|Physical Activity|physical activity
994210|NCT03200613|Spinal cord injury|spinal cord injury
994211|NCT03200613|Venous thromboembolism|venous thromboembolism
994212|NCT03200613|Hemorrhage|hemorrhage
994213|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
994214|NCT03200600|Surgery|surgery
994215|NCT03200600|Dexamethasone|dexamethasone
994216|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
994217|NCT03200600|Delirium|delirium
994218|NCT03200587|Metastatic|metastatic
994219|NCT03200574|Perceval|perceval
994220|NCT03200574|Mitroflow|mitroflow
994221|NCT03200574|CROWN PRT|crown prt
994222|NCT03200574|Freedom Solo|freedom solo
994223|NCT03200574|Solo Smart|solo smart
994224|NCT03200522|Asthma, Diet|asthma, diet
994225|NCT03200509|nonspecific low back pain|nonspecific low back pain
994226|NCT03200509|chronic pain|chronic pain
994227|NCT03200483|Autonomic Nervous System|autonomic nervous system
994228|NCT03200483|Aerobic exercise|aerobic exercise
994229|NCT03200483|Recuperation|recuperation
994230|NCT03200483|Music|music
994231|NCT03200457|Liver iron|liver iron
994232|NCT03200457|Liver steatosis|liver steatosis
994234|NCT03200405|umbilical hernia|umbilical hernia
994235|NCT03200405|mesh repair|mesh repair
994236|NCT03200405|MRI-visibility|mri-visibility
994237|NCT03200405|underlay|underlay
994238|NCT03200405|NANEP|nanep
994239|NCT03200405|DynaMeshCICAT|dynameshcicat
994240|NCT03200405|DynaMeshVisible|dynameshvisible
994241|NCT03200405|preperitoneal|preperitoneal
994242|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
994243|NCT03200392|connective tissue graft|connective tissue graft
994244|NCT03200392|root coverage|root coverage
994245|NCT03200392|mucogingival surgery|mucogingival surgery
994246|NCT03200392|gingival recession|gingival recession
994247|NCT03200366|Cancer Screening Tests|cancer screening tests
994248|NCT03200366|Colonoscopy|colonoscopy
994249|NCT03200275|Legionella urine antigen test|legionella urine antigen test
994250|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
994251|NCT03200236|Lung Cancer Screening|lung cancer screening
994252|NCT03200236|Smoking Cessation|smoking cessation
994253|NCT03200236|Tobacco Use|tobacco use
994254|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
994255|NCT03200210|Hyperuricemia|hyperuricemia
994256|NCT03200210|Cardiovascular events|cardiovascular events
994257|NCT03200210|Treatment|treatment
994258|NCT03200197|Chewing gum|chewing gum
994259|NCT03200197|Artificial saliva|artificial saliva
994260|NCT03200197|Saliva|saliva
994261|NCT03200197|Mastication|mastication
994262|NCT03200197|Salivary glands|salivary glands
994263|NCT03200197|Xerostomia|xerostomia
994264|NCT03200184|Hepatitis C|hepatitis c
994265|NCT03200184|sofosbuvir|sofosbuvir
994266|NCT03200184|daclatasvir|daclatasvir
994267|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
994268|NCT03200171|Hepatitis C|hepatitis c
994269|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
994270|NCT03200158|APACHEII score|apacheii score
994271|NCT03200158|C-reactive protein|c-reactive protein
994272|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
994273|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
994274|NCT03200158|interleukin (IL)|interleukin (il)
994275|NCT03200093|Clostridium difficile|clostridium difficile
994276|NCT03200093|C diff|c diff
994277|NCT03200093|Oral Vancomycin|oral vancomycin
994278|NCT03200093|Prophylaxis|prophylaxis
994279|NCT03200054|therapy|therapy
994280|NCT03200054|postnatal|postnatal
994281|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
994282|NCT03199989|colon cancer|colon cancer
994283|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
994284|NCT03199989|high risk|high risk
994285|NCT03199976|wheeze|wheeze
994286|NCT03199976|shortness of breath|shortness of breath
994287|NCT03199963|Mammographic|mammographic
994288|NCT03199963|Breast|breast
994289|NCT03199963|Density|density
994290|NCT03199963|BIRADS C or D|birads c or d
994291|NCT03199950|Delirium|delirium
994292|NCT03199950|Haloperidol|haloperidol
994293|NCT03199950|Prophylactic|prophylactic
994294|NCT03199950|High-risk|high-risk
994295|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
994296|NCT03199937|Executive Functioning|executive functioning
994297|NCT03199937|Intervention|intervention
994298|NCT03199937|Flexible|flexible
994299|NCT03199937|Unstuck|unstuck
994300|NCT03199937|Transition|transition
994301|NCT03199937|Behavior|behavior
994302|NCT03199937|High school|high school
994303|NCT03199937|Problem Solving|problem solving
994304|NCT03199937|Self-Control|self-control
994305|NCT03199937|Coping|coping
994306|NCT03199924|acute pain|acute pain
994307|NCT03199924|Renal colic|renal colic
994308|NCT03199924|Diclofenac|diclofenac
994309|NCT03199924|Lidocain|lidocain
994310|NCT03199924|Magnesium sulfate|magnesium sulfate
994311|NCT03199898|Lung/Growth & Development|lung/growth & development
994312|NCT03199898|Respiration, artificial|respiration, artificial
994313|NCT03199898|Reproducibility of Results|reproducibility of results
994314|NCT03199898|Observer Variation|observer variation
994315|NCT03199859|gastric cancer|gastric cancer
994316|NCT03199859|postoperative|postoperative
994317|NCT03199859|subsyndromal delirium|subsyndromal delirium
994318|NCT03199859|quality of life|quality of life
994319|NCT03199833|rehabilitation|rehabilitation
994320|NCT03199833|orthosis|orthosis
994321|NCT03199833|functional electrical stimulation|functional electrical stimulation
994322|NCT03199833|electrode array|electrode array
994323|NCT03199833|upper limb|upper limb
994324|NCT03199833|sub-acute|sub-acute
994325|NCT03199833|motor relearning|motor relearning
994326|NCT03199807|HCC|hcc
994327|NCT03199807|NRT|nrt
994328|NCT03199807|TOMO radiotherapy|tomo radiotherapy
994329|NCT03199781|cellulits of leg|cellulits of leg
994330|NCT03199781|Motorized power massage|motorized power massage
994331|NCT03199781|massage|massage
994332|NCT03199768|architecture|architecture
994333|NCT03199768|delirium|delirium
994334|NCT03199768|environment|environment
994335|NCT03199768|hospital design and construction|hospital design and construction
994336|NCT03199755|therapeutic|therapeutic
994337|NCT03199755|ACT|act
994338|NCT03199755|gametocyte|gametocyte
994339|NCT03199729|Overground training|overground training
994340|NCT03199729|Dynamic Stability|dynamic stability
994341|NCT03199729|Fall risk|fall risk
994342|NCT03199703|PVI Ablation|pvi ablation
994343|NCT03199703|Cryoballoon|cryoballoon
994344|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
994345|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
994346|NCT03199638|Children|children
994347|NCT03199638|Exercise|exercise
994348|NCT03199638|Glycated hemoglobin|glycated hemoglobin
994349|NCT03199638|Adolescents|adolescents
994350|NCT03199638|Insulin sensitivity|insulin sensitivity
994351|NCT03199638|Glutamine|glutamine
994352|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
994353|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
994354|NCT03199625|Panic Disorder|panic disorder
994355|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
994356|NCT03199599|PET/CT|pet/ct
994357|NCT03199599|image processing|image processing
994358|NCT03199599|outcome|outcome
994359|NCT03199573|sunscreen|sunscreen
994360|NCT03199534|Pelvic Pain|pelvic pain
994361|NCT03199534|Dyspareunia|dyspareunia
994362|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
994363|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
994364|NCT03199534|Chemodenervation|chemodenervation
994365|NCT03199534|Botulinum Toxin A|botulinum toxin a
994366|NCT03199534|Vaginismus|vaginismus
994367|NCT03199521|apixaban|apixaban
994368|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
994369|NCT03199521|warfarin|warfarin
994370|NCT03199521|aspirin|aspirin
994371|NCT03199521|thrombotic status|thrombotic status
994372|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
994373|NCT03199508|Voiding Diary|voiding diary
994374|NCT03199495|traditional Chinese medicine|traditional chinese medicine
994375|NCT03199495|electroacupuncture|electroacupuncture
994376|NCT03199495|abdominal pain|abdominal pain
994377|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
994378|NCT03199469|XLMTM|xlmtm
994379|NCT03199469|Adeno Associated Virus|adeno associated virus
994380|NCT03199443|Sacral neuromodulation|sacral neuromodulation
994381|NCT03199443|Electromyography|electromyography
994382|NCT03199443|Pelvic floor|pelvic floor
994383|NCT03199430|catecholamines|catecholamines
994384|NCT03199430|Exercise|exercise
994385|NCT03199430|lipid metabolism|lipid metabolism
994386|NCT03199365|Cancer Prevention|cancer prevention
994387|NCT03199365|Latino Families|latino families
994388|NCT03199365|Healthy eating|healthy eating
994389|NCT03199365|Physical activity|physical activity
994390|NCT03199365|PA|pa
994391|NCT03199365|Food inventory|food inventory
994392|NCT03199365|Questionnaires|questionnaires
994393|NCT03199365|Surveys|surveys
994394|NCT03199365|Interviews|interviews
994395|NCT03199365|Accelerometer|accelerometer
994396|NCT03199339|tuberculosis|tuberculosis
994397|NCT03199339|TBA7371|tba7371
994398|NCT03199339|TBA-7371|tba-7371
994399|NCT03199339|TB Alliance|tb alliance
994400|NCT03199339|TB|tb
994401|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
994402|NCT03199313|tuberculosis|tuberculosis
994403|NCT03199313|TB|tb
994404|NCT03199313|Sutezolid|sutezolid
994405|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
994406|NCT03199300|bleomycin|bleomycin
994407|NCT03199300|cisplatin|cisplatin
994408|NCT03199300|trastuzumab|trastuzumab
994409|NCT03199300|anthracyclines|anthracyclines
994410|NCT03199300|toxicity|toxicity
994411|NCT03199287|metagenomics|metagenomics
1660697|NCT00142285|efficacy|efficacy
994412|NCT03199287|next-generation sequencing|next-generation sequencing
994413|NCT03199287|bioinformatics|bioinformatics
994414|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
994415|NCT03199248|Digital Mucous Cyst|digital mucous cyst
994416|NCT03199248|capsulotomy|capsulotomy
994417|NCT03199235|iron intake|iron intake
994418|NCT03199235|iron bioavailability|iron bioavailability
994419|NCT03199222|amputation|amputation
994420|NCT03199222|transtibial|transtibial
994423|NCT03199209|Physical Activity and Nutrition|physical activity and nutrition
994424|NCT03199209|Latino adults|latino adults
994425|NCT03199209|Questionnaires|questionnaires
994426|NCT03199209|Surveys|surveys
994427|NCT03199209|Community Health Worker|community health worker
994428|NCT03199209|CHW|chw
994429|NCT03199209|Accelerometer|accelerometer
994430|NCT03199196|Cancer Prevention|cancer prevention
994431|NCT03199196|African-American woman|african-american woman
994432|NCT03199196|Hispanic woman|hispanic woman
994433|NCT03199196|Sedentary|sedentary
994434|NCT03199196|Activity Tracker|activity tracker
994435|NCT03199196|Smartphone Application|smartphone application
994436|NCT03199196|Questionnaires|questionnaires
994437|NCT03199196|Surveys|surveys
994438|NCT03199196|Focus Group|focus group
994439|NCT03199196|Electronic Newsletters|electronic newsletters
994440|NCT03199196|Telephone Counseling|telephone counseling
994441|NCT03199183|Takayasu Arteritis|takayasu arteritis
994442|NCT03199183|registry|registry
994443|NCT03199170|Caesarean Section|caesarean section
994444|NCT03199170|Spinal anesthesia|spinal anesthesia
994445|NCT03199170|Quadratus lumborum block|quadratus lumborum block
994446|NCT03199170|Postoperative pain|postoperative pain
994447|NCT03199170|Intrathecal morphine|intrathecal morphine
994448|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
994449|NCT03199144|Borderline resectable|borderline resectable
994450|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
994451|NCT03199144|Chemotherapy|chemotherapy
994452|NCT03199144|Stereotactic radiation|stereotactic radiation
994453|NCT03199118|root coverage|root coverage
994454|NCT03199092|Reading|reading
994455|NCT03199092|Developmental Dyslexia|developmental dyslexia
994456|NCT03199092|Music|music
994457|NCT03199092|Rhythm|rhythm
994458|NCT03199092|Intervention|intervention
994459|NCT03199066|survival|survival
994460|NCT03199066|therapy|therapy
994461|NCT03199066|epidemiology|epidemiology
994463|NCT03199027|Adherence|adherence
994464|NCT03199001|Fabry Disease|fabry disease
994465|NCT03199001|T1 Mapping|t1 mapping
994466|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
994467|NCT03198975|magnetic resonance image features|magnetic resonance image features
994468|NCT03198975|pathological differentiation|pathological differentiation
994469|NCT03198975|machine learning-based model|machine learning-based model
994470|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
994471|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
994472|NCT03198897|high cholesterol levels|high cholesterol levels
994473|NCT03198897|low-density lipoprotein|low-density lipoprotein
994474|NCT03198897|xanthelasma palpebrarum|xanthelasma palpebrarum
994475|NCT03198897|atherosclerosis|atherosclerosis
994476|NCT03198897|arcus senilis corneae|arcus senilis corneae
994477|NCT03198897|Primary hyperlipoproteinemia|primary hyperlipoproteinemia
994478|NCT03198871|Post-operative pain|post-operative pain
994479|NCT03198871|Major abdominal surgery|major abdominal surgery
994480|NCT03198871|Colorectal surgery|colorectal surgery
994481|NCT03198871|Gastric surgery|gastric surgery
994482|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
994483|NCT03198845|knee osteoarthritis|knee osteoarthritis
994484|NCT03198845|video game|video game
994485|NCT03198845|therapeutic effects|therapeutic effects
994486|NCT03198832|Periodontal Disease|periodontal disease
994487|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
994488|NCT03198832|Z-scan|z-scan
994489|NCT03198832|Atherosclerosis|atherosclerosis
994490|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
994491|NCT03198806|Autonomic Nervous System|autonomic nervous system
994492|NCT03198806|Fluid Therapy|fluid therapy
994493|NCT03198806|Heart Rate|heart rate
994494|NCT03198806|Exercise|exercise
994495|NCT03198767|obesity|obesity
994496|NCT03198767|overweight|overweight
994497|NCT03198767|body mass index|body mass index
994498|NCT03198767|BMI|bmi
994499|NCT03198767|diarrhea|diarrhea
994500|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
994501|NCT03198754|Multiple Myeloma|multiple myeloma
994502|NCT03198754|oncology|oncology
994503|NCT03198754|circadian rhythms|circadian rhythms
994504|NCT03198754|light therapy|light therapy
994505|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
994506|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
994507|NCT03198715|TAFIa inhibitor|tafia inhibitor
994508|NCT03198715|Developmental Phase I|developmental phase i
994509|NCT03198702|physiotherapy|physiotherapy
994510|NCT03198702|children|children
994511|NCT03198702|shoulder deformation|shoulder deformation
994512|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
994513|NCT03198689|systemic sclerosis|systemic sclerosis
994514|NCT03198689|scleroderma|scleroderma
994515|NCT03198689|brentuximab vedotin|brentuximab vedotin
994516|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
994517|NCT03198689|antirheumatic agents|antirheumatic agents
994518|NCT03198689|antineoplastic agents|antineoplastic agents
994519|NCT03198689|connective tissue diseases|connective tissue diseases
994520|NCT03198689|skin diseases|skin diseases
994521|NCT03198689|immunologic factors|immunologic factors
994522|NCT03198637|efficient|efficient
994523|NCT03198637|neuromuscular|neuromuscular
994524|NCT03198637|blockade|blockade
994525|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
994526|NCT03198559|HIV latency|hiv latency
994527|NCT03198559|Disulfiram|disulfiram
994528|NCT03198559|Vorinostat|vorinostat
994529|NCT03198559|Latency Reversing Agents|latency reversing agents
994530|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
994531|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
994532|NCT03198546|immunotherapy|immunotherapy
994533|NCT03198546|CAR-T cell therapy|car-t cell therapy
994534|NCT03198546|GPC3 targeting|gpc3 targeting
994535|NCT03198546|Phase I clinical study|phase i clinical study
994536|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
994537|NCT03198546|interventional radiology|interventional radiology
994538|NCT03198533|Knee|knee
994539|NCT03198533|Arthrosis|arthrosis
994540|NCT03198533|Implant|implant
994541|NCT03198481|midurethral sling|midurethral sling
994542|NCT03198481|movie|movie
994543|NCT03198481|preparedness|preparedness
994544|NCT03198481|Video Counseling|video counseling
994545|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
994546|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
994547|NCT03198468|Lung Cancer|lung cancer
994548|NCT03198468|Vapor Ablation|vapor ablation
994549|NCT03198468|BTVA|btva
994550|NCT03198429|domestic violence|domestic violence
994551|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
994552|NCT03198429|fathers|fathers
994553|NCT03198429|parenting|parenting
994554|NCT03198429|young children|young children
994555|NCT03198377|Pain Threshold|pain threshold
994556|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
994557|NCT03198377|Habituation|habituation
994558|NCT03198325|HIV-1|hiv-1
994559|NCT03198299|therapeutic effects|therapeutic effects
994560|NCT03198299|insoles|insoles
994561|NCT03198299|children|children
994562|NCT03198273|clinical pilates|clinical pilates
994563|NCT03198273|exercise|exercise
994564|NCT03198273|lumbar disc herniation|lumbar disc herniation
994565|NCT03198273|chronic low back pain|chronic low back pain
994566|NCT03198234|Pediatric|pediatric
994567|NCT03198234|GvHD|gvhd
994568|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
994569|NCT03198234|Stem Cells|stem cells
994570|NCT03198234|Transplant|transplant
994571|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
994572|NCT03198221|Golytely, Clenpiq, bowel prep|golytely, clenpiq, bowel prep
994573|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
994574|NCT03198156|Without Cataplexy|without cataplexy
994575|NCT03198143|Decision-making|decision-making
994576|NCT03198143|Ghrelin|ghrelin
994577|NCT03198143|Healthy Volunteers|healthy volunteers
994578|NCT03198143|Obese|obese
994579|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
994580|NCT03198104|Paediatric|paediatric
994581|NCT03198091|stable angina pectoris|stable angina pectoris
994582|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
994583|NCT03198078|Brexpiprazole|brexpiprazole
994584|NCT03198078|Schizophrenia|schizophrenia
994585|NCT03198078|Adolescent|adolescent
994586|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
994587|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
994588|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
994589|NCT03198065|Simple appendicitis|simple appendicitis
994590|NCT03198065|Complicated appendicitis|complicated appendicitis
994591|NCT03198052|Lung Cancer|lung cancer
994592|NCT03198052|Immunotherapy|immunotherapy
994593|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
994594|NCT03198052|PSCA|psca
994595|NCT03198052|MUC1|muc1
994596|NCT03198052|PD-L1|pd-l1
994597|NCT03198052|CD80/86|cd80/86
994598|NCT03198052|Cancer expressing PSCA,MUC1,PD-L1,or/and CD80/86|cancer expressing psca,muc1,pd-l1,or/and cd80/86
994599|NCT03198039|Meditation|meditation
994600|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
994601|NCT03198039|Postoperative Period|postoperative period
994602|NCT03198039|Cardiac Surgery|cardiac surgery
994603|NCT03198000|Eye Redness|eye redness
994604|NCT03198000|Eye Comfort|eye comfort
994605|NCT03198000|Red Eyes|red eyes
994606|NCT03197987|adenoma detection rate|adenoma detection rate
994607|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
994608|NCT03197987|endocuff|endocuff
994609|NCT03197974|stage|stage
994610|NCT03197974|online|online
994611|NCT03197974|self-help|self-help
994612|NCT03197974|coaching support|coaching support
994613|NCT03197974|quality of life|quality of life
994614|NCT03197974|mindfulness|mindfulness
994615|NCT03197974|psychoeducation|psychoeducation
994616|NCT03197974|persuasive systems design|persuasive systems design
994617|NCT03197974|psychosocial|psychosocial
994618|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
994619|NCT03197922|Constipation|constipation
994620|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
994621|NCT03197909|Atrophy|atrophy
994622|NCT03197909|cell cultur|cell cultur
994623|NCT03197909|systemic inflammation|systemic inflammation
994624|NCT03197909|Catabolism|catabolism
994625|NCT03197857|Bariatric surgery|bariatric surgery
994626|NCT03197857|Morbid obesity|morbid obesity
994627|NCT03197857|Physical condition|physical condition
994628|NCT03197857|Muscle|muscle
994629|NCT03197857|6-minute walking test|6-minute walking test
994630|NCT03197857|Protein supplementation|protein supplementation
994631|NCT03197857|Physical activity program|physical activity program
994632|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
994633|NCT03197818|COPD|copd
994634|NCT03197818|Anticholinergics|anticholinergics
994635|NCT03197818|Triple Combination|triple combination
994636|NCT03197805|Equivocal Her 2|equivocal her 2
994637|NCT03197805|Genomic test|genomic test
994638|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
994639|NCT03197792|TEE|tee
994640|NCT03197792|Portal vein pulsatility|portal vein pulsatility
994641|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
994642|NCT03197792|Venous congestion|venous congestion
994643|NCT03197792|Strain|strain
994644|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
994645|NCT03197792|Pulmonary hypertension|pulmonary hypertension
994646|NCT03197792|Venous hypertension|venous hypertension
994647|NCT03197766|Achondroplasia|achondroplasia
994648|NCT03197766|Dwarfism|dwarfism
994649|NCT03197766|Bone Diseases|bone diseases
994650|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
994651|NCT03197766|ACH|ach
994652|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
994653|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
994654|NCT03197766|Natriuretic Agents|natriuretic agents
994655|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
994656|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
994657|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
994658|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
994659|NCT03197753|laryngeal mask airway|laryngeal mask airway
994660|NCT03197753|nasotracheal intubation|nasotracheal intubation
994661|NCT03197753|dental treatment|dental treatment
994662|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
994663|NCT03197714|Myeloid Leukemia|myeloid leukemia
994664|NCT03197701|Lung function|lung function
994665|NCT03197701|Inspiratory flow rates|inspiratory flow rates
994666|NCT03197675|Chronic pain|chronic pain
994667|NCT03197675|Acupuncture|acupuncture
994668|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
994669|NCT03197662|Hyperphagia|hyperphagia
994670|NCT03197636|Vitamin D|vitamin d
994671|NCT03197636|Soluble PD-1|soluble pd-1
994672|NCT03197623|Glucocorticoids|glucocorticoids
994673|NCT03197610|gingival recession|gingival recession
994674|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
994675|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
994676|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
994677|NCT03197597|B. pertussis|b. pertussis
994678|NCT03197597|Acellular vaccination|acellular vaccination
994679|NCT03197597|Strain variation|strain variation
994680|NCT03197532|fertility|fertility
994681|NCT03197532|hormones|hormones
994682|NCT03197532|healthy|healthy
994683|NCT03197532|chemotherapy|chemotherapy
994684|NCT03197532|oncofertility|oncofertility
994685|NCT03197532|alkylating agent|alkylating agent
994686|NCT03197532|fertility after cancer|fertility after cancer
994687|NCT03197532|late effects|late effects
994688|NCT03197532|survivorship|survivorship
994689|NCT03197532|healthy volunteers|healthy volunteers
994690|NCT03197532|perimenopause|perimenopause
994691|NCT03197532|middle age|middle age
994692|NCT03197519|mHealth|mhealth
994693|NCT03197519|Eating Disorders|eating disorders
994694|NCT03197519|Randomised Controlled Trial|randomised controlled trial
994695|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
994696|NCT03197519|cost effectiveness|cost effectiveness
994697|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
994698|NCT03197480|Aflibercept|aflibercept
1660698|NCT00142285|children|children
1015658|NCT03065699|ACLF|aclf
994699|NCT03197480|Intravitreal injection|intravitreal injection
994700|NCT03197480|Diabetic Macular Edema|diabetic macular edema
994701|NCT03197441|Platelet-rich plasma|platelet-rich plasma
994702|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
994703|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
994704|NCT03197428|Ankle Injuries|ankle injuries
994705|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
994706|NCT03197415|Platelet-rich plasma|platelet-rich plasma
994707|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
994708|NCT03197415|Low Back Pain|low back pain
994709|NCT03197402|Leucine|leucine
994710|NCT03197402|Protein|protein
994711|NCT03197402|Supplementation|supplementation
994712|NCT03197389|Biomarker|biomarker
994713|NCT03197363|Civilization diseases|civilization diseases
994714|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
994715|NCT03197363|Population study|population study
994716|NCT03197363|Intestinal microbiome|intestinal microbiome
994717|NCT03197363|Oral microbiome|oral microbiome
994718|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
994719|NCT03197350|Imaging|imaging
994720|NCT03197350|Prognosis|prognosis
994721|NCT03197337|Vulvodynia|vulvodynia
994722|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
994723|NCT03197337|Referred pain|referred pain
994724|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
994725|NCT03197311|Oral surgery|oral surgery
994726|NCT03197311|Medication adherence|medication adherence
994727|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
994728|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
994729|NCT03197298|Drug-Eluting Stents|drug-eluting stents
994730|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
994731|NCT03197298|Ticagrelor|ticagrelor
994732|NCT03197298|clopidogrel|clopidogrel
994733|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
994734|NCT03197285|neck pain|neck pain
994736|NCT03197285|propioception|propioception
994737|NCT03197285|range of motion|range of motion
994738|NCT03197285|pain|pain
994739|NCT03197272|Myopia|myopia
994740|NCT03197272|corneal Crosslinking|corneal crosslinking
994741|NCT03197259|CLL, del(17p)|cll, del(17p)
994742|NCT03197246|PICC line|picc line
994743|NCT03197246|ECG|ecg
994744|NCT03197246|chest x-ray|chest x-ray
994745|NCT03197246|IVECG|ivecg
994746|NCT03197246|ICECG|icecg
994747|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
994748|NCT03197194|visual acuity|visual acuity
994749|NCT03197194|visual field|visual field
994750|NCT03197194|mRs|mrs
994751|NCT03197194|NEI-VFQ-25|nei-vfq-25
994752|NCT03197168|stigma|stigma
994753|NCT03197168|psychosocial intervention|psychosocial intervention
994754|NCT03197168|low-and-middle income countries|low-and-middle income countries
994755|NCT03197142|cardiac arrest|cardiac arrest
994756|NCT03197142|resuscitation|resuscitation
994757|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
994758|NCT03197142|CPR|cpr
994759|NCT03197103|Autologous fat grafting|autologous fat grafting
994760|NCT03197103|Breast|breast
994761|NCT03197103|Deformity|deformity
994762|NCT03197103|Asymmetry|asymmetry
994763|NCT03197103|Tuberous breast|tuberous breast
994764|NCT03197103|Acetylcysteine|acetylcysteine
994765|NCT03197090|Screening|screening
994766|NCT03197090|Zenicor|zenicor
994767|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
994768|NCT03197051|Acute kidney injury|acute kidney injury
994769|NCT03197051|Valvular heart disease|valvular heart disease
994770|NCT03197038|Cognitive function|cognitive function
994771|NCT03197038|Kidney Disease|kidney disease
994772|NCT03197038|Exercise|exercise
994773|NCT03197038|Older adults|older adults
994774|NCT03197025|HPV-16|hpv-16
994775|NCT03197025|premalignancy|premalignancy
994776|NCT03197025|T Cell Therapy|t cell therapy
994777|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
994778|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
994779|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
994780|NCT03196999|PTSD|ptsd
994781|NCT03196999|Attention bias modification|attention bias modification
994782|NCT03196999|Remote app-based study|remote app-based study
994783|NCT03196999|Digital Health|digital health
994784|NCT03196960|Mobilization Therapy|mobilization therapy
994785|NCT03196960|Critical Illness|critical illness
994786|NCT03196960|Muscle Strength|muscle strength
994787|NCT03196960|Functional Mobility|functional mobility
994788|NCT03196960|Outcome|outcome
994789|NCT03196960|Intensive Care Unit|intensive care unit
994790|NCT03196960|Quality of Life|quality of life
994791|NCT03196947|multiple myeloma|multiple myeloma
994792|NCT03196947|APO010|apo010
994793|NCT03196947|Drug Response Predictor|drug response predictor
994794|NCT03196947|DRP|drp
994795|NCT03196921|amphotericin B|amphotericin b
994796|NCT03196921|cryptococcal|cryptococcal
994798|NCT03196908|Blood Pressure|blood pressure
994799|NCT03196908|Energy Drinks|energy drinks
994800|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
994801|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
994802|NCT03196895|Lifestyle Modification|lifestyle modification
994803|NCT03196882|pregnancy|pregnancy
994804|NCT03196882|iron|iron
994805|NCT03196882|hemoglobin|hemoglobin
994806|NCT03196882|supplementation|supplementation
994807|NCT03196882|neurodevelopment|neurodevelopment
994808|NCT03196882|newborn|newborn
994809|NCT03196882|anemia|anemia
994810|NCT03196882|clinical trial|clinical trial
994811|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
994812|NCT03196856|Greek Yogurt|greek yogurt
994813|NCT03196856|Muscle Size|muscle size
994814|NCT03196856|Bone Health|bone health
994815|NCT03196856|Body Composition|body composition
994816|NCT03196856|Exercise|exercise
994817|NCT03196843|raltitrexed|raltitrexed
994818|NCT03196843|radiotherapy|radiotherapy
994819|NCT03196843|older patient|older patient
994820|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
994821|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
994822|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
994823|NCT03196817|Random Allocation|random allocation
994824|NCT03196817|Injections|injections
994825|NCT03196817|Orthotic Devices|orthotic devices
994826|NCT03196765|X-ALD|x-ald
994827|NCT03196752|cricothyroid membrane|cricothyroid membrane
994828|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
994829|NCT03196713|Allegiance|allegiance
994830|NCT03196713|Knowledge|knowledge
994831|NCT03196713|Supervision|supervision
994832|NCT03196713|Early intervention|early intervention
994833|NCT03196713|Autism|autism
994834|NCT03196700|palliative care|palliative care
994835|NCT03196700|head and neck cancer|head and neck cancer
994836|NCT03196700|radiotherapy|radiotherapy
994837|NCT03196700|pain|pain
994838|NCT03196700|quality of life|quality of life
994839|NCT03196687|diastolic dysfunction|diastolic dysfunction
994840|NCT03196661|safety investigation|safety investigation
994841|NCT03196648|Gingivitis|gingivitis
994842|NCT03196648|Periodontal disease|periodontal disease
994843|NCT03196648|Inflammation|inflammation
994844|NCT03196648|Teeth whitening|teeth whitening
994845|NCT03196648|Breath freshening|breath freshening
994846|NCT03196648|Periodontal pathogens|periodontal pathogens
994847|NCT03196648|Bleeding on probing|bleeding on probing
994848|NCT03196622|Sarcopenia|sarcopenia
994849|NCT03196622|Elderly people|elderly people
994850|NCT03196622|Hospitalization|hospitalization
994851|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
994852|NCT03196596|TAVI|tavi
994853|NCT03196596|Computer simulation|computer simulation
994854|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
994855|NCT03196583|video-polysomnography|video-polysomnography
994856|NCT03196583|mandibular advancement device|mandibular advancement device
994857|NCT03196583|oral device|oral device
994858|NCT03196583|cephalometry|cephalometry
994859|NCT03196518|PET Imaging|pet imaging
994860|NCT03196518|18F-TFB|18f-tfb
994861|NCT03196518|17-315|17-315
994862|NCT03196505|Anesthetics, Local|anesthetics, local
994863|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
994864|NCT03196505|Bupivacaine|bupivacaine
994865|NCT03196505|Postoperative Complications|postoperative complications
994866|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
994867|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
994868|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
994869|NCT03196466|antiepileptics|antiepileptics
994870|NCT03196466|pharmacokinetics|pharmacokinetics
994871|NCT03196466|children|children
994872|NCT03196453|overweight|overweight
994873|NCT03196453|probiotic|probiotic
994874|NCT03196453|weight management|weight management
994875|NCT03196440|elderly|elderly
994876|NCT03196440|taste|taste
994877|NCT03196440|thresholds|thresholds
994878|NCT03196427|Drug Therapy|drug therapy
994879|NCT03196401|Durvalumb|durvalumb
994880|NCT03196401|Radiation Therapy|radiation therapy
994881|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
994882|NCT03196401|MEDI4736|medi4736
994883|NCT03196401|17-269|17-269
994884|NCT03196388|ENZALUTAMIDE|enzalutamide
994885|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
994886|NCT03196375|Motor Neuron Disease|motor neuron disease
994887|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
994888|NCT03196375|Nervous System Diseases|nervous system diseases
994889|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
994890|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
994891|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
994892|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
994893|NCT03196375|Muscle cramps|muscle cramps
994894|NCT03196375|Muscle cramping|muscle cramping
994895|NCT03196375|ALS|als
994896|NCT03196375|MND|mnd
994897|NCT03196375|PMA|pma
994898|NCT03196375|PLS|pls
994899|NCT03196375|FLX-787|flx-787
994900|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
994901|NCT03196362|pioglitazone|pioglitazone
994902|NCT03196362|metformin|metformin
994903|NCT03196362|remission|remission
994904|NCT03196362|sequential therapy|sequential therapy
994905|NCT03196258|fracture|fracture
994906|NCT03196258|persistent pain|persistent pain
994907|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
994908|NCT03196258|post surgical pain|post surgical pain
994909|NCT03196258|health-related quality of life|health-related quality of life
994910|NCT03196167|sugammadex|sugammadex
994911|NCT03196167|extubation|extubation
994913|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
994914|NCT03196154|Insulin Resistance|insulin resistance
994915|NCT03196154|Beta Cell Function|beta cell function
994916|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
994917|NCT03196115|Autosomal Recessive Disorder|autosomal recessive disorder
994918|NCT03196115|Gingival Hypertrophy|gingival hypertrophy
994919|NCT03196115|Skin and Connective Tissue Diseases|skin and connective tissue diseases
994920|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
994921|NCT03196063|Exercise Therapy|exercise therapy
994922|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
994923|NCT03196063|Rehabilitation|rehabilitation
994924|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
994925|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
994926|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
994927|NCT03196024|Risk Reduction Behavior|risk reduction behavior
994928|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
994929|NCT03196024|Community Health Workers|community health workers
994930|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
994931|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
994932|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
994936|NCT03195933|Childhood Adversity|childhood adversity
994937|NCT03195933|Childhood Abuse|childhood abuse
994938|NCT03195933|Cortisol|cortisol
994939|NCT03195933|Emotional Memory|emotional memory
994940|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
994941|NCT03195907|Stroke|stroke
994942|NCT03195907|Mortality|mortality
994943|NCT03195907|Intensive care unit|intensive care unit
994944|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
994945|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
994946|NCT03195868|chemotherapy|chemotherapy
994947|NCT03195868|chemo-induced|chemo-induced
994948|NCT03195868|CIPN|cipn
994949|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
994950|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
994951|NCT03195829|Cognition|cognition
994952|NCT03195829|Psychosocial factors|psychosocial factors
994953|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
994954|NCT03195816|white matter hyperintensities|white matter hyperintensities
994955|NCT03195816|computerized cognitive training|computerized cognitive training
994956|NCT03195816|brain plasticity|brain plasticity
994957|NCT03195751|telemonitoring|telemonitoring
994958|NCT03195738|pediatrics|pediatrics
994959|NCT03195738|case series|case series
994960|NCT03195738|feasibility|feasibility
994961|NCT03195712|BMI|bmi
994962|NCT03195712|Obesity|obesity
994963|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
994964|NCT03195673|Carotid artery stenting|carotid artery stenting
994965|NCT03195673|Silent embolism|silent embolism
994966|NCT03195673|Terazosin|terazosin
994967|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
994968|NCT03195660|ASV|asv
994969|NCT03195660|HFpEF|hfpef
994970|NCT03195647|cardiovascular|cardiovascular
994971|NCT03195647|potassium supplementation|potassium supplementation
994972|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
994973|NCT03195634|Cirrhosis|cirrhosis
994974|NCT03195634|Portal Hypertension|portal hypertension
994975|NCT03195621|Coronary Artery Disease|coronary artery disease
994976|NCT03195621|Critical lesion|critical lesion
994977|NCT03195608|In-vehicle technologies|in-vehicle technologies
994978|NCT03195608|Parkinson's disease|parkinson's disease
994979|NCT03195608|Driving performance|driving performance
994980|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
994981|NCT03195543|Blood coagulation disorders|blood coagulation disorders
994982|NCT03195543|Platelets|platelets
994983|NCT03195543|Thrombin|thrombin
994984|NCT03195543|Treatment|treatment
994985|NCT03195517|Osteopenia|osteopenia
994986|NCT03195517|Physical activity|physical activity
994987|NCT03195517|Bone turnover markers|bone turnover markers
994988|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
994989|NCT03195517|Quality of life|quality of life
994991|NCT03195452|Antiretrovirals|antiretrovirals
994992|NCT03195452|Raltegravir|raltegravir
994993|NCT03195413|Hand blast injury|hand blast injury
994994|NCT03195413|Nerve block|nerve block
994995|NCT03195413|Hand injury|hand injury
994996|NCT03195413|Forearm nerve block|forearm nerve block
994997|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
994998|NCT03195413|Ultrasound nerve block|ultrasound nerve block
994999|NCT03195413|Emergency department|emergency department
995000|NCT03195413|Emergency physician|emergency physician
995001|NCT03195413|Emergency room|emergency room
995002|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
995008|NCT03195335|Participation|participation
995009|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
995011|NCT03195335|Reliability|reliability
995016|NCT03195309|Cesarean Delivery|cesarean delivery
995017|NCT03195309|Ropivacaine|ropivacaine
995018|NCT03195309|Fentanyl|fentanyl
995019|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
995020|NCT03195283|meal service|meal service
995021|NCT03195283|protein intake|protein intake
995022|NCT03195283|satisfaction|satisfaction
995023|NCT03195283|hospitalized patients|hospitalized patients
995024|NCT03195270|Positron emission tomography|positron emission tomography
995025|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
995026|NCT03195270|PET/MRI|pet/mri
995027|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
995028|NCT03195270|FDG|fdg
995029|NCT03195270|Pain|pain
995030|NCT03195270|Chronic Pain|chronic pain
995031|NCT03195270|Neuropathic Pain|neuropathic pain
995032|NCT03195270|Inflammatory Pain|inflammatory pain
995033|NCT03195270|Nociceptive Pain|nociceptive pain
995034|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
995035|NCT03195231|Parkinson`s disease|parkinson`s disease
995036|NCT03195231|Depression|depression
995037|NCT03195231|Wuling Powder|wuling powder
995038|NCT03195218|Cancer prevention|cancer prevention
995039|NCT03195218|Diagnosis|diagnosis
995040|NCT03195218|Microendoscope|microendoscope
995041|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
995042|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
995043|NCT03195179|urethra|urethra
995046|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
995047|NCT03195140|Diabetes Mellitus|diabetes mellitus
995048|NCT03195140|Diabetes|diabetes
995049|NCT03195140|Sensor Augmented Pump|sensor augmented pump
995050|NCT03195140|Hypoglycemia|hypoglycemia
995051|NCT03195127|Physical Therapy Modalities|physical therapy modalities
995052|NCT03195127|Rehabilitation|rehabilitation
995053|NCT03195127|Exercise Therapy|exercise therapy
995054|NCT03195127|Critical Illness|critical illness
995055|NCT03195127|Respiration, Artificial|respiration, artificial
995056|NCT03195127|Chronic Disease|chronic disease
995057|NCT03195114|post TAVR quantification|post tavr quantification
995058|NCT03195114|cardiac MRI|cardiac mri
995059|NCT03195114|echocardiography|echocardiography
995060|NCT03195114|biomarkers|biomarkers
995061|NCT03195101|orbital tumors|orbital tumors
995062|NCT03195101|transconjunctival approach|transconjunctival approach
995063|NCT03195062|Fructose|fructose
995064|NCT03195062|Obesity|obesity
995065|NCT03195062|Metabolism|metabolism
995066|NCT03195062|Post-prandial kinetics|post-prandial kinetics
995067|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
995068|NCT03195049|kernicterus|kernicterus
995069|NCT03195036|HIV-exposed|hiv-exposed
995070|NCT03195036|Early Childhood Development|early childhood development
995071|NCT03195036|Cameroon|cameroon
995072|NCT03195023|Renal Insufficiency, Chronic|renal insufficiency, chronic
995073|NCT03194997|Breast Cancer|breast cancer
995074|NCT03194997|Quality of life|quality of life
995075|NCT03194997|Lymphedema|lymphedema
995076|NCT03194997|Fatigue|fatigue
995077|NCT03194997|Depressive symptoms|depressive symptoms
995078|NCT03194997|Body image|body image
995079|NCT03194997|Self Esteem|self esteem
995080|NCT03194997|Optimism|optimism
995081|NCT03194997|Sexual function|sexual function
995082|NCT03194997|Stress|stress
995083|NCT03194997|Sleep quality|sleep quality
995084|NCT03194997|Pain|pain
995085|NCT03194997|Muscular strength|muscular strength
995086|NCT03194997|Postural|postural
995087|NCT03194997|Balance|balance
995088|NCT03194997|Range of motion|range of motion
995089|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
995090|NCT03194984|dental whitening|dental whitening
995091|NCT03194984|Dental office whitening|dental office whitening
995092|NCT03194971|glioblastoma|glioblastoma
995093|NCT03194971|brain tumor autopsy|brain tumor autopsy
995094|NCT03194971|autopsy|autopsy
995095|NCT03194971|Optune therapy|optune therapy
995096|NCT03194971|tumor treatment fields|tumor treatment fields
995097|NCT03194971|TTFields|ttfields
995098|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
995099|NCT03194971|grade IV|grade iv
995100|NCT03194971|brain tumor|brain tumor
995101|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
995102|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
995103|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
995109|NCT03194906|Pediatric oncology|pediatric oncology
995111|NCT03194906|Low grade glioma|low grade glioma
995112|NCT03194906|Cognitive late effects|cognitive late effects
995113|NCT03194906|Radiation therapy|radiation therapy
995114|NCT03194906|Neuroprotection|neuroprotection
995115|NCT03194906|Memantine|memantine
995116|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
995117|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
995118|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
995119|NCT03194893|Alectinib|alectinib
995120|NCT03194893|Crizotinib|crizotinib
995126|NCT03194828|Adherence|adherence
995127|NCT03194828|Mobile health|mobile health
995128|NCT03194828|Real-time data|real-time data
995129|NCT03194815|Psychosis|psychosis
995130|NCT03194815|Immunotherapy|immunotherapy
995131|NCT03194815|Autoantibodies|autoantibodies
995132|NCT03194789|FGBMM|fgbmm
995133|NCT03194789|LPSE|lpse
995134|NCT03194789|UDI - 6|udi - 6
995135|NCT03194789|UIQ - 7|uiq - 7
995136|NCT03194776|PAD|pad
995137|NCT03194776|peripheral artery/arterial disease|peripheral artery/arterial disease
995138|NCT03194776|peripheral vascular disease|peripheral vascular disease
995139|NCT03194776|leg pain|leg pain
995140|NCT03194776|claudication|claudication
995141|NCT03194776|leg pain with exercise|leg pain with exercise
995142|NCT03194776|exercise test|exercise test
995143|NCT03194776|walk test|walk test
995144|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
995145|NCT03194737|BPH|bph
995146|NCT03194737|Urinary retention|urinary retention
995147|NCT03194737|prostate|prostate
995148|NCT03194737|hypertrophy|hypertrophy
995149|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
995150|NCT03194711|Optical Coherence Tomography|optical coherence tomography
995151|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
995152|NCT03194698|Intense Pulsed Light|intense pulsed light
995153|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
995154|NCT03194659|Nutrition|nutrition
995155|NCT03194659|choline|choline
995156|NCT03194659|pregnancy|pregnancy
995157|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
995160|NCT03194646|Uterine Fibroid|uterine fibroid
995161|NCT03194620|Flavanols|flavanols
995162|NCT03194620|Cocoa Flavanols|cocoa flavanols
995163|NCT03194620|Epicatechins|epicatechins
995164|NCT03194620|Polyphenols|polyphenols
995165|NCT03194620|Procyanidins|procyanidins
995166|NCT03194620|EGCG|egcg
995167|NCT03194620|EGC|egc
995168|NCT03194620|ECG|ecg
995169|NCT03194620|Theaflavins|theaflavins
995170|NCT03194620|Thearubigins|thearubigins
995171|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
995172|NCT03194568|Scoliosis|scoliosis
995173|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
995174|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
995175|NCT03194555|Innate Immune System|innate immune system
995176|NCT03194555|Cytokines|cytokines
995177|NCT03194555|Cox-2|cox-2
995178|NCT03194555|Headache|headache
995179|NCT03194555|Migraine|migraine
995180|NCT03194555|Migraine Prevention|migraine prevention
995181|NCT03194542|Luspatercept|luspatercept
995182|NCT03194542|ACE-536|ace-536
995183|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
995184|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
995185|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
995186|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
995187|NCT03194542|Anemia|anemia
995188|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
995189|NCT03194542|Ruxolitinib|ruxolitinib
995190|NCT03194529|Crohn's Disease|crohn's disease
995191|NCT03194529|PCDAI|pcdai
995192|NCT03194529|16s rRNA|16s rrna
995193|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
995194|NCT03194529|Gut Microbiome|gut microbiome
995195|NCT03194529|FMT|fmt
995196|NCT03194516|prostate cancer|prostate cancer
995197|NCT03194516|ketogenic diet|ketogenic diet
995198|NCT03194516|overweight, obese|overweight, obese
995199|NCT03194503|Intubation|intubation
995200|NCT03194503|Video Laryngoscope|video laryngoscope
995201|NCT03194503|Coaching/training|coaching/training
995202|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
995203|NCT03194464|hemiparesis|hemiparesis
995406|NCT03193047|LDL-C|ldl-c
1661546|NCT00137800|Erlotinib|erlotinib
995204|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
995205|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
995206|NCT03194438|Symptom Management|symptom management
995207|NCT03194438|Behavioral Intervention|behavioral intervention
995208|NCT03194438|Integrative Therapy|integrative therapy
995209|NCT03194438|Quality of Life|quality of life
995210|NCT03194425|Sacral neuromodulation|sacral neuromodulation
995211|NCT03194425|Electromyography|electromyography
995212|NCT03194425|Pelvic floor|pelvic floor
995213|NCT03194412|Frail Elderly|frail elderly
995214|NCT03194412|Geriatric Assessment|geriatric assessment
995216|NCT03194412|Aged|aged
995217|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
995218|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
995219|NCT03194334|vegetarianism|vegetarianism
995220|NCT03194334|creatine|creatine
995221|NCT03194334|carnosine|carnosine
995222|NCT03194334|carnitine|carnitine
995223|NCT03194308|HIV risk reduction|hiv risk reduction
995224|NCT03194308|Safer Conception|safer conception
995225|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
995226|NCT03194308|South Africa|south africa
995227|NCT03194308|Women|women
995228|NCT03194308|Reproductive Health|reproductive health
995229|NCT03194295|Drug-free community support|drug-free community support
995230|NCT03194295|Methadone maintenance|methadone maintenance
995231|NCT03194295|Social networks|social networks
995232|NCT03194256|Smoking|smoking
995233|NCT03194256|Cigarettes|cigarettes
995234|NCT03194256|E-Cigarettes|e-cigarettes
995235|NCT03194243|acute dyspnea|acute dyspnea
995236|NCT03194243|acute heart failure|acute heart failure
995237|NCT03194243|emergency|emergency
995238|NCT03194230|Cervical dilators|cervical dilators
995239|NCT03194230|induction of labor|induction of labor
995240|NCT03194230|cervical ripening|cervical ripening
995241|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
995242|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
995243|NCT03194191|Insomnia|insomnia
995244|NCT03194191|Pregnancy|pregnancy
995245|NCT03194191|Acupuncture|acupuncture
995246|NCT03194191|Insomnia severity index|insomnia severity index
995247|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
995248|NCT03194191|Anxiety|anxiety
995249|NCT03194191|Depression|depression
995250|NCT03194165|antiretroviral|antiretroviral
995251|NCT03194165|children|children
995252|NCT03194165|pharmacokinetics|pharmacokinetics
995253|NCT03194139|Healthy Adult|healthy adult
995254|NCT03194139|Superoxide Dismutase|superoxide dismutase
995255|NCT03194139|First in Human|first in human
995256|NCT03194139|Free Radical Dismutase|free radical dismutase
995257|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
995258|NCT03194087|Low parathyroid hormone|low parathyroid hormone
995259|NCT03194087|Hemodialysis|hemodialysis
995260|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
995261|NCT03194074|Desflurane|desflurane
995262|NCT03194074|Propofol|propofol
995263|NCT03194061|chemotherapy|chemotherapy
995264|NCT03194061|complication|complication
995265|NCT03194048|drooling|drooling
995266|NCT03194048|tongue thrust|tongue thrust
995267|NCT03194035|inflammation|inflammation
995268|NCT03194035|exercise|exercise
995269|NCT03194035|ultra endurance|ultra endurance
995270|NCT03194009|diabetes|diabetes
995271|NCT03194009|prevention|prevention
995272|NCT03194009|metformin|metformin
995273|NCT03194009|Mexico City|mexico city
995274|NCT03193983|occlusive dressing|occlusive dressing
995275|NCT03193970|Bladder Cancer|bladder cancer
995276|NCT03193970|Registry|registry
995277|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
995278|NCT03193970|Radical cystectomy|radical cystectomy
995279|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
995280|NCT03193970|MDASI|mdasi
995281|NCT03193892|registry|registry
995282|NCT03193892|China|china
995283|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
995284|NCT03193879|Pulmonary function|pulmonary function
995285|NCT03193879|Particulate matter|particulate matter
995286|NCT03193879|COPD|copd
995287|NCT03193879|Asthma|asthma
995288|NCT03193866|Immunomodulating treatment|immunomodulating treatment
995289|NCT03193866|Cohort study|cohort study
995290|NCT03193866|Dimethyl fumarate|dimethyl fumarate
995291|NCT03193866|Fingolimod|fingolimod
995292|NCT03193866|Interferon-beta|interferon-beta
995293|NCT03193866|Natalizumab|natalizumab
995294|NCT03193866|Rituximab|rituximab
995295|NCT03193866|Glatiramer acetate|glatiramer acetate
995296|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
995297|NCT03193827|vip score|vip score
995298|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
995299|NCT03193827|particles|particles
995300|NCT03193801|SAPIEN 3|sapien 3
995301|NCT03193801|PARTNER 3|partner 3
995302|NCT03193801|cardiovascular disease|cardiovascular disease
995303|NCT03193801|TMVR|tmvr
995304|NCT03193801|failing valve|failing valve
995305|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
995306|NCT03193775|HBV vaccine|hbv vaccine
995307|NCT03193775|persistent|persistent
995308|NCT03193775|HBsAg|hbsag
995309|NCT03193775|IP-10|ip-10
995310|NCT03193762|pain|pain
995311|NCT03193762|pain management|pain management
995312|NCT03193762|anxiety|anxiety
995313|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
995314|NCT03193723|Hernia|hernia
995315|NCT03193723|Local anesthesia|local anesthesia
995316|NCT03193723|ultrasound|ultrasound
995317|NCT03193710|Intravenous anesthesia|intravenous anesthesia
995318|NCT03193710|Inhalational anesthesia|inhalational anesthesia
995319|NCT03193710|Colorectal cancer resection|colorectal cancer resection
995320|NCT03193710|Lymphocytes|lymphocytes
995321|NCT03193710|Metastasis|metastasis
995322|NCT03193710|Survival|survival
995323|NCT03193710|Molecular mechanism|molecular mechanism
995325|NCT03193671|CA125|ca125
995326|NCT03193671|RMI|rmi
995327|NCT03193671|ROMA|roma
995328|NCT03193658|spine surgery|spine surgery
995329|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
995330|NCT03193658|regional anesthesia|regional anesthesia
995331|NCT03193658|postoperative analgesia|postoperative analgesia
995332|NCT03193658|opioid consumption|opioid consumption
995333|NCT03193632|lean body mass|lean body mass
995334|NCT03193632|resting energy expenditure|resting energy expenditure
995335|NCT03193632|oxygen consumption|oxygen consumption
995336|NCT03193632|Indirect calorimetry|indirect calorimetry
995337|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
995338|NCT03193632|respiratory quotient|respiratory quotient
995339|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
995340|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
995341|NCT03193580|tDCS|tdcs
995342|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
995343|NCT03193580|Pediatrics|pediatrics
995344|NCT03193489|Balance|balance
995345|NCT03193489|Posturograpy|posturograpy
995346|NCT03193489|quality of life|quality of life
995347|NCT03193463|Topotecan|topotecan
995348|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
995349|NCT03193450|helicobactor pylori|helicobactor pylori
995350|NCT03193437|Thymus|thymus
995351|NCT03193437|Selinexor|selinexor
995352|NCT03193437|KPT-330|kpt-330
995353|NCT03193398|Major Depressive Disorder|major depressive disorder
995354|NCT03193398|Anhedonia|anhedonia
995355|NCT03193398|antidepressant|antidepressant
995356|NCT03193398|Nociceptin|nociceptin
995357|NCT03193398|NOPR|nopr
995358|NCT03193333|glaucoma|glaucoma
995359|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
995464|NCT03192722|Low vision|low vision
995360|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
995361|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
995362|NCT03193333|timolol|timolol
995363|NCT03193333|brimonidine|brimonidine
995364|NCT03193333|dorzolamide|dorzolamide
995365|NCT03193320|plethysmographic variability index|plethysmographic variability index
995366|NCT03193320|PVI|pvi
995367|NCT03193281|Dasatinib|dasatinib
995368|NCT03193281|Imatinib|imatinib
995369|NCT03193268|sensorimotor training|sensorimotor training
995370|NCT03193268|quality of life|quality of life
995371|NCT03193268|posture|posture
995372|NCT03193242|Asthma|asthma
995373|NCT03193242|Asthma Action Plan|asthma action plan
995374|NCT03193216|Barrett's|barrett's
995375|NCT03193216|GERD|gerd
995376|NCT03193216|reflux|reflux
995377|NCT03193216|alginate solution|alginate solution
995378|NCT03193216|proton pump inhibitor|proton pump inhibitor
995379|NCT03193177|fasting-like diet|fasting-like diet
995380|NCT03193177|chronic diseases|chronic diseases
995381|NCT03193177|autoimmune diseases|autoimmune diseases
995382|NCT03193177|metabolic disorder|metabolic disorder
995383|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
995384|NCT03193151|Liver transplant|liver transplant
995385|NCT03193151|global gene expression|global gene expression
995386|NCT03193151|molecular diagnostics|molecular diagnostics
995387|NCT03193138|Cardiotoxicity|cardiotoxicity
995388|NCT03193138|Androgens|androgens
995389|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
995390|NCT03193138|Testosterone|testosterone
995391|NCT03193138|Androgen Antagonists|androgen antagonists
995392|NCT03193112|Agomelatine|agomelatine
995393|NCT03193112|Depression|depression
995394|NCT03193112|Intraocular pressure|intraocular pressure
995395|NCT03193086|Multiple Sclerosis|multiple sclerosis
995396|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
995397|NCT03193086|Treatment response|treatment response
995398|NCT03193086|Metabolism|metabolism
995399|NCT03193086|Alemtuzumab|alemtuzumab
995400|NCT03193086|Perfusion|perfusion
995401|NCT03193086|Oxygen consumption|oxygen consumption
995402|NCT03193047|Cholesterol|cholesterol
995403|NCT03193047|PCSK9|pcsk9
995404|NCT03193047|Repatha|repatha
995405|NCT03193047|evolocumab|evolocumab
995407|NCT03193034|Arthroplasty|arthroplasty
995408|NCT03193034|replacement|replacement
995409|NCT03193034|Knee|knee
995410|NCT03193034|function|function
995411|NCT03193034|radiographic|radiographic
995412|NCT03193034|survivorship|survivorship
995413|NCT03193021|vessel closure|vessel closure
995414|NCT03193021|venous access site|venous access site
995415|NCT03193021|femoral venotomy|femoral venotomy
995416|NCT03193021|medium bore|medium bore
995417|NCT03193021|multiple access sites|multiple access sites
995418|NCT03193008|Breast Cancer|breast cancer
995419|NCT03193008|Axillary ultrasound|axillary ultrasound
995420|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
995421|NCT03193008|Axillary management|axillary management
995422|NCT03192995|HIV|hiv
995423|NCT03192995|sexual behavior|sexual behavior
995424|NCT03192956|Hyperbaric|hyperbaric
995425|NCT03192956|Decompression sickness|decompression sickness
995426|NCT03192956|Decompression injury|decompression injury
995427|NCT03192956|Inflammation|inflammation
995428|NCT03192956|Central nervous injury|central nervous injury
995429|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
995430|NCT03192930|Hyperbaric|hyperbaric
995431|NCT03192930|Saturation|saturation
995432|NCT03192930|Decompression injury|decompression injury
995433|NCT03192930|Decompression sickness|decompression sickness
995434|NCT03192930|Inflammation|inflammation
995435|NCT03192930|Central nervous system injury|central nervous system injury
995436|NCT03192930|Diving medicine|diving medicine
995437|NCT03192917|Shock wave therapy|shock wave therapy
995438|NCT03192917|erectile dysfunction|erectile dysfunction
995439|NCT03192904|Lung cancer|lung cancer
995440|NCT03192904|Segmentectomy|segmentectomy
995441|NCT03192904|Postoperative Complication|postoperative complication
995442|NCT03192904|Stapling Device|stapling device
995443|NCT03192904|Energy Device|energy device
995444|NCT03192878|infliximab|infliximab
995445|NCT03192878|biosimilars|biosimilars
995446|NCT03192878|treatment|treatment
995447|NCT03192852|Tooth bleaching color|tooth bleaching color
995448|NCT03192852|dental esthetic|dental esthetic
995449|NCT03192852|Clinical Trial|clinical trial
995450|NCT03192852|Violet LED light|violet led light
995451|NCT03192852|Violet LED|violet led
995452|NCT03192852|color|color
995453|NCT03192852|sensibility|sensibility
995454|NCT03192852|dental aesthetic|dental aesthetic
995455|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
995456|NCT03192826|ocular hypertension|ocular hypertension
995457|NCT03192826|brimonidine|brimonidine
995458|NCT03192826|brinzolamide|brinzolamide
995459|NCT03192800|clinical outcome|clinical outcome
995460|NCT03192800|prognositic factor|prognositic factor
995461|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
995462|NCT03192722|Filters|filters
995463|NCT03192722|Illumination|illumination
995466|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
995467|NCT03192631|financial incentive|financial incentive
995468|NCT03192579|neoatherosclerosis|neoatherosclerosis
995469|NCT03192566|Acetaminophen|acetaminophen
995470|NCT03192566|Anesthesia|anesthesia
995471|NCT03192566|Adolescent|adolescent
995472|NCT03192566|Obesity|obesity
995473|NCT03192553|donning|donning
995474|NCT03192553|doffing|doffing
995475|NCT03192553|self-contamination|self-contamination
995476|NCT03192553|healthcare workers|healthcare workers
995477|NCT03192540|Exercise|exercise
995478|NCT03192527|KN015|kn015
995479|NCT03192527|Long-acting FSH|long-acting fsh
995480|NCT03192514|Polypharmacy|polypharmacy
995481|NCT03192514|Benzodiazepine use|benzodiazepine use
995482|NCT03192501|lung cancer|lung cancer
995483|NCT03192501|iCAGES|icages
995484|NCT03192501|gene mutation|gene mutation
995485|NCT03192501|precision medicine|precision medicine
995486|NCT03192501|advanced cancers|advanced cancers
995487|NCT03192462|Pancreatic Cancer|pancreatic cancer
995488|NCT03192462|Immune-based therapies|immune-based therapies
995489|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
995490|NCT03192423|Stress|stress
995491|NCT03192423|Performance of procedures|performance of procedures
995492|NCT03192423|Lumbar Puncture|lumbar puncture
995493|NCT03192410|myocardial infarction|myocardial infarction
995494|NCT03192410|cardiovascular diseases|cardiovascular diseases
995495|NCT03192410|mortality|mortality
995496|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
995497|NCT03192410|risk prediction|risk prediction
995498|NCT03192410|kidney function|kidney function
995499|NCT03192410|mental well-being|mental well-being
995500|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
995501|NCT03192384|Hospital falls|hospital falls
995502|NCT03192371|Zagreb regimen|zagreb regimen
995503|NCT03192371|Encephalitis|encephalitis
995504|NCT03192371|Antibody persistence|antibody persistence
995505|NCT03192371|Essen regimen|essen regimen
995506|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
995507|NCT03192371|Rabies|rabies
995508|NCT03192358|Thickened Liquids|thickened liquids
995509|NCT03192358|Dysphagia Management|dysphagia management
995510|NCT03192358|Videofluoroscopy|videofluoroscopy
995511|NCT03192358|Swallowing Physiology|swallowing physiology
995512|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
995513|NCT03192332|Endovascular treatment|endovascular treatment
995514|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
995515|NCT03192332|Bridging thrombolysis|bridging thrombolysis
995516|NCT03192332|Acute ischemic stroke|acute ischemic stroke
995517|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
995518|NCT03192319|Cell-mediated immunity|cell-mediated immunity
995519|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
995520|NCT03192306|Herpes Labialis|herpes labialis
995521|NCT03192306|Cold Sore|cold sore
995522|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
995523|NCT03192267|lung disease|lung disease
995525|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
995526|NCT03192228|Patient Education|patient education
995527|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
995528|NCT03192215|Cryptogenic stroke|cryptogenic stroke
995529|NCT03192215|Ischemic stroke|ischemic stroke
995530|NCT03192215|Apixaban|apixaban
995531|NCT03192215|Aspirin|aspirin
995532|NCT03192202|Lymphoma|lymphoma
995533|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
995534|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
995535|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
995536|NCT03192176|Menopause|menopause
995537|NCT03192176|Hot flashes|hot flashes
995538|NCT03192176|Perimenopause|perimenopause
995539|NCT03192176|Vasomotor symptoms|vasomotor symptoms
995540|NCT03192124|primary total knee|primary total knee
995541|NCT03192124|infection|infection
995542|NCT03192111|Healthy Volunteers|healthy volunteers
995543|NCT03192111|Mild Renal Impairment|mild renal impairment
995544|NCT03192111|Moderate Renal Impairment|moderate renal impairment
995545|NCT03192111|Severe Renal Impairment|severe renal impairment
995546|NCT03192111|Entinostat|entinostat
995547|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
995548|NCT03192111|HDAC|hdac
995549|NCT03192059|Immunotherapy|immunotherapy
995550|NCT03192059|Radiotherapy|radiotherapy
995551|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
995552|NCT03192020|Hand dysfunction|hand dysfunction
995553|NCT03192020|Xiapex|xiapex
995554|NCT03192020|Xiaflex|xiaflex
995555|NCT03192020|Aponeurectomy|aponeurectomy
995556|NCT03192020|Aponeurotomy|aponeurotomy
995557|NCT03192020|Dupuytren disease|dupuytren disease
995558|NCT03192020|Joint contracture|joint contracture
995559|NCT03192020|Surgery|surgery
995560|NCT03191968|Behavior change|behavior change
995561|NCT03191968|Prostate cancer|prostate cancer
995562|NCT03191968|Behavioral counseling|behavioral counseling
995563|NCT03191968|Physical Activity|physical activity
995564|NCT03191968|Randomized controlled trial|randomized controlled trial
995565|NCT03191942|Myopia control|myopia control
995566|NCT03191942|Orthokeratology|orthokeratology
995567|NCT03191942|Children|children
995568|NCT03191942|Treatment zone|treatment zone
995569|NCT03191929|Depression|depression
995570|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
995571|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
995572|NCT03191929|Primary Care Provider|primary care provider
995573|NCT03191929|Mental Health Screening|mental health screening
995574|NCT03191916|Parkinson's Disease|parkinson's disease
995575|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
995576|NCT03191916|tDCS|tdcs
995577|NCT03191916|Cognitive function|cognitive function
995578|NCT03191890|in vivo culture|in vivo culture
995579|NCT03191877|coffee consumption|coffee consumption
995580|NCT03191877|Cesarean section|cesarean section
995581|NCT03191877|intestinal motility|intestinal motility
995582|NCT03191864|Esophagitis|esophagitis
995583|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
995584|NCT03191864|Fluticasone|fluticasone
995585|NCT03191864|Dysphagia|dysphagia
995586|NCT03191864|Safety|safety
995587|NCT03191864|Efficacy|efficacy
995588|NCT03191864|Pharmacokinetics|pharmacokinetics
995589|NCT03191864|Esophageal Diseases|esophageal diseases
995590|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
995591|NCT03191864|Digestive System Diseases|digestive system diseases
995592|NCT03191864|Glucocorticoids|glucocorticoids
995593|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
995594|NCT03191825|online intervention|online intervention
995595|NCT03191825|mHealth m-Health|mhealth m-health
995596|NCT03191825|eHealth e-Health|ehealth e-health
995597|NCT03191825|smoking cessation|smoking cessation
995598|NCT03191825|lapse management|lapse management
995599|NCT03191825|relapse prevention|relapse prevention
995600|NCT03191812|Falls|falls
995601|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
995602|NCT03191812|Mobility|mobility
995603|NCT03191812|Dual Task|dual task
995604|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
995605|NCT03191760|Social Support|social support
995606|NCT03191760|Primary Care|primary care
995607|NCT03191747|Masculine Norms|masculine norms
995608|NCT03191747|Skin Care|skin care
995609|NCT03191747|Gender|gender
995610|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
995611|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
995612|NCT03191734|AQUABEAM|aquabeam
995613|NCT03191734|Aquablation|aquablation
995614|NCT03191721|Peri-implantitis|peri-implantitis
995615|NCT03191721|Triclosan|triclosan
995616|NCT03191721|Toothpastes|toothpastes
995617|NCT03191721|Therapeutics|therapeutics
995618|NCT03191721|Periodontal Diseases|periodontal diseases
995619|NCT03191721|Periodontitis|periodontitis
995620|NCT03191721|Dentifrices|dentifrices
995621|NCT03191708|Fractional Flow Reserve|fractional flow reserve
995622|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
995623|NCT03191708|Coronary artery disease|coronary artery disease
995624|NCT03191708|Angina pectoris|angina pectoris
995625|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
995626|NCT03191695|Participation|participation
995627|NCT03191695|Activity|activity
995628|NCT03191695|Cerebral Palsy|cerebral palsy
995629|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
995630|NCT03191695|Gross Motor Function|gross motor function
995631|NCT03191695|Health-related Quality of Life|health-related quality of life
995632|NCT03191695|Family|family
995633|NCT03191630|Kidney transplant|kidney transplant
995634|NCT03191630|SystemCHANGE|systemchange
995635|NCT03191630|physical activity|physical activity
995636|NCT03191630|smart phone|smart phone
995637|NCT03191630|Fitbit|fitbit
995638|NCT03191630|activity monitor|activity monitor
995639|NCT03191630|step count|step count
995640|NCT03191630|post-surgery|post-surgery
995641|NCT03191630|quality of life|quality of life
995642|NCT03191630|cardiovascular|cardiovascular
995643|NCT03191604|Endoscopy|endoscopy
995644|NCT03191604|Narrow band imaging|narrow band imaging
995645|NCT03191604|Dysplasia|dysplasia
995646|NCT03191591|Overweight|overweight
995647|NCT03191591|Obesity|obesity
995648|NCT03191591|Maternal-child|maternal-child
995649|NCT03191591|Social Determinants of Health|social determinants of health
995650|NCT03191578|NMIBC|nmibc
995651|NCT03191578|Immunotherapy|immunotherapy
995652|NCT03191578|RUTI|ruti
995653|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
995654|NCT03191565|mhealth|mhealth
995655|NCT03191565|self-monitoring|self-monitoring
995656|NCT03191565|Outcome monitoring|outcome monitoring
995657|NCT03191552|Cerebral palsy|cerebral palsy
995658|NCT03191552|lycra garments|lycra garments
995659|NCT03191552|orthosis|orthosis
995660|NCT03191552|suit therapy|suit therapy
995661|NCT03191552|trunk control|trunk control
995662|NCT03191513|Interesterified|interesterified
995663|NCT03191513|Postprandial|postprandial
995664|NCT03191513|Lipid|lipid
995665|NCT03191474|PrEP|prep
995666|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
995668|NCT03191474|Client-centered case management|client-centered case management
995669|NCT03191474|Transgender|transgender
995670|NCT03191474|Gender non-conforming|gender non-conforming
995671|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
995672|NCT03191461|Anth-bC|anth-bc
995673|NCT03191461|Chemotherapy|chemotherapy
995674|NCT03191461|Myocardial Perfusion|myocardial perfusion
995675|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
995676|NCT03191435|Inspiratory muscle training|inspiratory muscle training
995677|NCT03191435|Glycemic control|glycemic control
995678|NCT03191435|Glucose|glucose
995679|NCT03191435|Exercise|exercise
995680|NCT03191435|Diaphragm exercise|diaphragm exercise
995681|NCT03191435|Inspiratory loading|inspiratory loading
995682|NCT03191422|Rehabilitation|rehabilitation
995683|NCT03191422|Occupational Performance|occupational performance
995684|NCT03191409|cognitive impairment|cognitive impairment
995685|NCT03191409|ESRD|esrd
995686|NCT03191409|functional MRI|functional mri
995687|NCT03191383|Maternal immunization|maternal immunization
995688|NCT03191383|Immunogenicity|immunogenicity
995689|NCT03191383|Vaccines|vaccines
995690|NCT03191383|Safety|safety
995691|NCT03191383|Reactogenicity|reactogenicity
995692|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
995693|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
995694|NCT03191357|traumatic brain injury,posttraumatic stress,service member|traumatic brain injury,posttraumatic stress,service member
995695|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
995696|NCT03191344|total thyroidectomy|total thyroidectomy
995697|NCT03191344|thyroid cancer|thyroid cancer
995698|NCT03191344|hypoparathyroidism|hypoparathyroidism
995699|NCT03191344|prediction|prediction
995700|NCT03191331|dietary intervention|dietary intervention
995701|NCT03191331|gestational weight gain|gestational weight gain
995702|NCT03191331|gestational diabetes|gestational diabetes
995703|NCT03191331|overweight|overweight
995704|NCT03191331|obesity|obesity
995705|NCT03191318|ERAS|eras
995807|NCT03190863|Reach-to-grasp|reach-to-grasp
995706|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
995707|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
995708|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
995709|NCT03191292|prosthetic joint infection|prosthetic joint infection
995710|NCT03191292|treatment failure|treatment failure
995711|NCT03191279|Wounds and injury|wounds and injury
995712|NCT03191279|Trauma|trauma
995713|NCT03191279|First aid|first aid
995714|NCT03191279|Bystander|bystander
995715|NCT03191279|Laypersons|laypersons
995716|NCT03191266|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
995717|NCT03191266|alcohol use disorder|alcohol use disorder
995718|NCT03191266|neuroimaging|neuroimaging
995719|NCT03191266|relapse|relapse
995720|NCT03191266|Veterans|veterans
995721|NCT03191253|food insecurity|food insecurity
995722|NCT03191253|community-based|community-based
995723|NCT03191253|food assistance|food assistance
995724|NCT03191253|food support|food support
995725|NCT03191253|intervention|intervention
995726|NCT03191253|medically tailored|medically tailored
995727|NCT03191253|nutrition|nutrition
995728|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
995729|NCT03191240|Vasopressin|vasopressin
995730|NCT03191214|Infra-red thermography|infra-red thermography
995731|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
995732|NCT03191175|HIV|hiv
995733|NCT03191175|Inflammasome|inflammasome
995734|NCT03191162|Benznidazole|benznidazole
995735|NCT03191162|PCR|pcr
995736|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
995737|NCT03191123|Hepatic Resection|hepatic resection
995738|NCT03191123|TACE|tace
995739|NCT03191123|Solitary Huge Tumor|solitary huge tumor
995740|NCT03191123|Overall Survival|overall survival
995741|NCT03191110|COLON|colon
995742|NCT03191110|colorectal cancer|colorectal cancer
995743|NCT03191110|nutrition|nutrition
995744|NCT03191110|lifestyle|lifestyle
995745|NCT03191110|survival|survival
995746|NCT03191110|recurrence|recurrence
995747|NCT03191110|quality of life|quality of life
995748|NCT03191084|marijuana|marijuana
995749|NCT03191084|THC|thc
995750|NCT03191084|cannabis|cannabis
995751|NCT03191084|driving|driving
995752|NCT03191084|impairment|impairment
995753|NCT03191084|intoxication|intoxication
995754|NCT03191071|pneumonia|pneumonia
995755|NCT03191071|procalcitonin|procalcitonin
995756|NCT03191071|lung ultrassound|lung ultrassound
995757|NCT03191071|point of care testing|point of care testing
995758|NCT03191071|antibiotic prescription|antibiotic prescription
995759|NCT03191071|respiratory pathogens|respiratory pathogens
995760|NCT03191071|host biomarkers|host biomarkers
995761|NCT03191058|Depression|depression
995762|NCT03191058|Unipolar Depression|unipolar depression
995763|NCT03191058|Treatment Resistant Depression|treatment resistant depression
995764|NCT03191058|Magnetic Seizure Therapy|magnetic seizure therapy
995967|NCT03189719|PDL1|pdl1
995765|NCT03191058|Suicidal Ideation|suicidal ideation
995766|NCT03191058|Electroconvulsive Therapy|electroconvulsive therapy
995767|NCT03191045|MRI|mri
995768|NCT03191045|motility|motility
995769|NCT03191045|perfused manometry|perfused manometry
995770|NCT03191045|stomach|stomach
995771|NCT03191045|bowel|bowel
995772|NCT03191045|water|water
995773|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
995774|NCT03191019|Cell phones|cell phones
995775|NCT03191019|Women|women
995776|NCT03191006|effect|effect
995777|NCT03191006|insoles|insoles
995778|NCT03191006|children|children
995779|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
995780|NCT03190967|Systemic Control of Disease|systemic control of disease
995781|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
995782|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
995783|NCT03190954|C-11 Raclopride|c-11 raclopride
995784|NCT03190954|[11C] NNC-112|[11c] nnc-112
995785|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
995786|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
995787|NCT03190954|D2 Receptors|d2 receptors
995788|NCT03190941|KRAS|kras
995789|NCT03190941|HRAS|hras
995790|NCT03190941|NRAS|nras
995791|NCT03190941|Cell Therapy|cell therapy
995792|NCT03190941|Immunotherapy|immunotherapy
995793|NCT03190928|Disease Monitoring|disease monitoring
995794|NCT03190928|Molecular Monitoring|molecular monitoring
995795|NCT03190928|Novel Biomarker Identification|novel biomarker identification
995796|NCT03190928|Gene Expression Analyses|gene expression analyses
995797|NCT03190928|Watchful-Waiting|watchful-waiting
995798|NCT03190889|ACL Reconstruction|acl reconstruction
995799|NCT03190889|Rehabilitation|rehabilitation
995800|NCT03190889|Sports Injury|sports injury
995801|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
995802|NCT03190889|Knee Injury|knee injury
995803|NCT03190876|Drain usage|drain usage
995804|NCT03190863|Tenodesis grasp|tenodesis grasp
995805|NCT03190863|Neurofeedback|neurofeedback
995806|NCT03190863|Motor imagery|motor imagery
995808|NCT03190863|Rehabilitation|rehabilitation
995809|NCT03190863|Physical therapy|physical therapy
995810|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
995811|NCT03190863|Tetraplegia|tetraplegia
995812|NCT03190863|AIS A|ais a
995813|NCT03190863|AIS B|ais b
995814|NCT03190850|Sleep Apnea|sleep apnea
995815|NCT03190850|Elderly|elderly
995816|NCT03190850|Inspiratory training|inspiratory training
995817|NCT03190837|gaucher|gaucher
995818|NCT03190837|gaucher disease|gaucher disease
995819|NCT03190824|melanoma|melanoma
995820|NCT03190824|immunotherapy|immunotherapy
995821|NCT03190824|immune oncology|immune oncology
995822|NCT03190824|loco regional therapy|loco regional therapy
995823|NCT03190824|adenovirus|adenovirus
995824|NCT03190824|oncolytic virus|oncolytic virus
995825|NCT03190824|unresectable|unresectable
995826|NCT03190824|telomerase|telomerase
995827|NCT03190811|advanced solid tumor|advanced solid tumor
995828|NCT03190811|DC-CIK|dc-cik
995829|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
995830|NCT03190811|immunotherapy|immunotherapy
995831|NCT03190785|benzoic acid|benzoic acid
995832|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
995833|NCT03190785|leptin|leptin
995834|NCT03190785|metabolic rate|metabolic rate
995835|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
995836|NCT03190733|ATG|atg
995837|NCT03190733|chronic GVHD|chronic gvhd
995838|NCT03190733|leukemia relapse|leukemia relapse
995839|NCT03190694|chronic kidney disease|chronic kidney disease
995840|NCT03190694|non diabetic|non diabetic
995841|NCT03190668|tissue microdialysis|tissue microdialysis
995842|NCT03190668|spinal fusion|spinal fusion
995843|NCT03190668|surgical site infection|surgical site infection
995844|NCT03190642|Orthognathic Surgery|orthognathic surgery
995845|NCT03190642|Swelling|swelling
995846|NCT03190629|body composition|body composition
995847|NCT03190629|bioimpedance|bioimpedance
995848|NCT03190629|hemodialysis|hemodialysis
995849|NCT03190629|hemodiafiltration|hemodiafiltration
995850|NCT03190629|nutritional status|nutritional status
995851|NCT03190629|protein energy wasting|protein energy wasting
995852|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
995853|NCT03190577|Transthyretin mutation|transthyretin mutation
995854|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
995855|NCT03190551|retroclavicular approach|retroclavicular approach
995856|NCT03190551|costoclavicular approach|costoclavicular approach
995857|NCT03190551|upper limb surgery|upper limb surgery
995858|NCT03190551|needle shaft visibility|needle shaft visibility
995859|NCT03190512|Periodontal disease|periodontal disease
995860|NCT03190512|depression|depression
995861|NCT03190512|body image|body image
995862|NCT03190512|self-esteem|self-esteem
995863|NCT03190499|Cancer|cancer
995864|NCT03190499|Leukemia|leukemia
995865|NCT03190486|Baby cries|baby cries
995866|NCT03190486|pain|pain
995867|NCT03190486|brain responses|brain responses
995868|NCT03190486|neuroimaging|neuroimaging
995869|NCT03190486|fMRI|fmri
995870|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
995871|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
995872|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
995873|NCT03190395|Longterm success rate|longterm success rate
995874|NCT03190317|electronic medical record|electronic medical record
995875|NCT03190317|personal health record|personal health record
995876|NCT03190317|Veteran|veteran
995877|NCT03190317|self-management|self-management
995878|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
995879|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
995880|NCT03190278|Newly diagnosed AML|newly diagnosed aml
995881|NCT03190278|ELN adverse genetic risk group|eln adverse genetic risk group
995882|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
995883|NCT03190278|Allogeneic|allogeneic
995884|NCT03190265|cy|cy
995885|NCT03190265|Cyclophosphamide|cyclophosphamide
995886|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
995887|NCT03190265|GVAX|gvax
995888|NCT03190265|Nivolumab|nivolumab
995889|NCT03190265|Vaccine|vaccine
995890|NCT03190265|Ipilimumab|ipilimumab
995891|NCT03190265|CRS-207|crs-207
995892|NCT03190265|Immunotherapy|immunotherapy
995893|NCT03190265|PD-1|pd-1
995894|NCT03190265|Adenocarcinoma|adenocarcinoma
995895|NCT03190265|Carcinoma|carcinoma
995896|NCT03190265|Neoplasms|neoplasms
995897|NCT03190252|Diving medicine|diving medicine
995898|NCT03190252|Inflammation|inflammation
995899|NCT03190252|Central nervous system injury|central nervous system injury
995900|NCT03190252|Trimix|trimix
1661547|NCT00137800|OSI-774|osi-774
995901|NCT03190252|Decompression sickness|decompression sickness
995902|NCT03190252|Venous gas emboli|venous gas emboli
995903|NCT03190226|L-PRF|l-prf
995904|NCT03190226|keratinised tissues|keratinised tissues
995905|NCT03190226|implant|implant
995906|NCT03190226|free gingival graft|free gingival graft
995907|NCT03190213|high grade|high grade
995908|NCT03190161|Schizophrenia|schizophrenia
995909|NCT03190148|GLP-1|glp-1
995910|NCT03190148|Ectopic Lipids|ectopic lipids
995911|NCT03190135|Overweight|overweight
995912|NCT03190135|Obesity|obesity
995913|NCT03190135|School|school
995914|NCT03190135|Physical Activity|physical activity
995915|NCT03190109|bone age measurement|bone age measurement
995916|NCT03190109|skeletal age measurement|skeletal age measurement
995917|NCT03190109|ultrasound|ultrasound
995918|NCT03190109|x-Ray|x-ray
995919|NCT03190083|mastectomy|mastectomy
995920|NCT03190083|lumpectomy|lumpectomy
995921|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
995922|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
995923|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
995924|NCT03190057|BioFreedom|biofreedom
995925|NCT03190057|Drug Eluting Stent|drug eluting stent
995926|NCT03190057|Coronary Artery Disease|coronary artery disease
995927|NCT03190031|training|training
995928|NCT03190031|exercise|exercise
995929|NCT03190031|quality of life|quality of life
995930|NCT03190005|PRU|pru
995931|NCT03190005|P2Y12 receptor|p2y12 receptor
995932|NCT03189979|community based participatory research|community based participatory research
995933|NCT03189979|Childhood obesity|childhood obesity
995934|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
995935|NCT03189966|quadratus lumborum block|quadratus lumborum block
995936|NCT03189966|ultrasound-guided|ultrasound-guided
995937|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
995938|NCT03189966|postoperative analgesia|postoperative analgesia
995939|NCT03189914|pancreatic cancer|pancreatic cancer
995940|NCT03189914|Abraxane|abraxane
995941|NCT03189914|first line|first line
995942|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
995943|NCT03189849|Farming environment|farming environment
995944|NCT03189836|CD20+|cd20+
995945|NCT03189836|B cell|b cell
995946|NCT03189836|ACTR|actr
995947|NCT03189836|ACTR707|actr707
995948|NCT03189836|relapsed|relapsed
995949|NCT03189836|refractory|refractory
995950|NCT03189836|T cell|t cell
995951|NCT03189836|T cell product|t cell product
995952|NCT03189836|adoptive T cells|adoptive t cells
995953|NCT03189836|gene therapy|gene therapy
995954|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
995955|NCT03189810|Schizophrenia|schizophrenia
995956|NCT03189810|Cannabis Use Disorder|cannabis use disorder
995957|NCT03189810|Cognitive Function|cognitive function
995958|NCT03189758|chronic kidney disease|chronic kidney disease
995959|NCT03189758|hemodialysis|hemodialysis
995960|NCT03189758|sodium restriction|sodium restriction
995961|NCT03189758|MRI|mri
995962|NCT03189732|lipolysis|lipolysis
995963|NCT03189732|adipose tissue|adipose tissue
995964|NCT03189732|exercise|exercise
995965|NCT03189719|PD1|pd1
995966|NCT03189719|PD-1|pd-1
995971|NCT03189706|Temozolomide|temozolomide
995972|NCT03189706|Sargramostim|sargramostim
995973|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
995974|NCT03189706|17-251|17-251
995975|NCT03189680|sensorimotor training|sensorimotor training
995976|NCT03189680|exergaming|exergaming
995977|NCT03189680|posture|posture
995978|NCT03189680|quality of life|quality of life
995979|NCT03189641|Drug eluting stents|drug eluting stents
995980|NCT03189641|Coronary artery disease|coronary artery disease
995981|NCT03189641|Coronary artery stenosis|coronary artery stenosis
995982|NCT03189641|Myocardial ischemia|myocardial ischemia
995983|NCT03189641|Angioplasty|angioplasty
995984|NCT03189628|stromal vascular fraction|stromal vascular fraction
995985|NCT03189628|skin regeneration|skin regeneration
995986|NCT03189628|skin texture|skin texture
995987|NCT03189628|anti-aging|anti-aging
995988|NCT03189602|Takayasu Arteritis|takayasu arteritis
995989|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
995990|NCT03189589|Pharmacokinetics|pharmacokinetics
995991|NCT03189589|Healthy|healthy
995992|NCT03189589|ELLIPTA|ellipta
995993|NCT03189589|Safety|safety
995994|NCT03189589|GSK2269557|gsk2269557
995995|NCT03189589|Inhalation|inhalation
995996|NCT03189589|Tolerability|tolerability
995997|NCT03189537|Profilaxis|profilaxis
995998|NCT03189537|Ingavirin|ingavirin
995999|NCT03189511|Brown Adipose Tissue|brown adipose tissue
996000|NCT03189511|Brown Fat|brown fat
996001|NCT03189511|Fluvastatin|fluvastatin
996002|NCT03189511|Prospective Clinical Trial|prospective clinical trial
1661747|NCT00136890|Lung Cancer|lung cancer
1017293|NCT03054701|PFP|pfp
996003|NCT03189446|Endometrial Cancer|endometrial cancer
996004|NCT03189446|Gynecologic Cancer|gynecologic cancer
996005|NCT03189420|glioma|glioma
996006|NCT03189420|glioblastoma|glioblastoma
996007|NCT03189420|low grade tumor|low grade tumor
996008|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
996009|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
996010|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
996404|NCT03187067|ultrasound|ultrasound
996019|NCT03189368|Multi-site Pacing|multi-site pacing
996020|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
996021|NCT03189368|Energy Efficiency|energy efficiency
996022|NCT03189342|Balance|balance
996023|NCT03189342|Dual-task interference|dual-task interference
996024|NCT03189342|Falls|falls
996025|NCT03189342|Gait|gait
996026|NCT03189342|Older Adults|older adults
996027|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
996028|NCT03189316|Peritoneal fluid|peritoneal fluid
996029|NCT03189316|B cells|b cells
996030|NCT03189316|Regulatory B cells|regulatory b cells
996031|NCT03189316|Human|human
996032|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
996033|NCT03189264|Postoperative Complications|postoperative complications
996034|NCT03189264|Renal Stone|renal stone
996035|NCT03189264|Surgical Success|surgical success
996036|NCT03189264|Surgical Complications|surgical complications
996037|NCT03189264|Pneumatic Dilation|pneumatic dilation
996038|NCT03189212|Telemedicine|telemedicine
996039|NCT03189186|Kidney Cancer|kidney cancer
996040|NCT03189186|Immunotherapy|immunotherapy
996041|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
996042|NCT03189186|Cryoablation|cryoablation
996043|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
996044|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
996045|NCT03189173|Ventilatory Control Instability|ventilatory control instability
996046|NCT03189173|Complex Sleep Apnea|complex sleep apnea
996047|NCT03189121|Metabolism|metabolism
996048|NCT03189121|Macronutrients|macronutrients
996049|NCT03189121|Obesity|obesity
996050|NCT03189121|Energy Expenditure|energy expenditure
996051|NCT03189121|Glucose|glucose
996052|NCT03189108|Paracentesis|paracentesis
996053|NCT03189108|Thoracentesis|thoracentesis
996054|NCT03189095|exercise|exercise
996055|NCT03189095|physical activity|physical activity
996056|NCT03189095|SCI|sci
996057|NCT03189095|spinal cord injury|spinal cord injury
996058|NCT03189095|online|online
996059|NCT03189056|chronic Chagas disease|chronic chagas disease
996060|NCT03189056|bladder|bladder
996061|NCT03189056|lower urinary tract|lower urinary tract
996062|NCT03189056|urodynamic|urodynamic
996063|NCT03189030|metastatic|metastatic
996064|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
996065|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
996073|NCT03188965|First in human|first in human
996074|NCT03188965|Solid tumors|solid tumors
996075|NCT03188965|Lymphomas|lymphomas
996076|NCT03188965|Dose escalation|dose escalation
996077|NCT03188965|Dose expansion|dose expansion
996078|NCT03188913|Burns|burns
996079|NCT03188913|Coagulation|coagulation
996080|NCT03188913|Factor XIII|factor xiii
996081|NCT03188913|Glycocalix|glycocalix
996082|NCT03188913|Cicatrization|cicatrization
996083|NCT03188900|Preeclampsia|preeclampsia
996084|NCT03188900|apheresis|apheresis
996085|NCT03188900|sflt-1|sflt-1
996087|NCT03188887|Kidney biopsy|kidney biopsy
996088|NCT03188887|GFR|gfr
996089|NCT03188887|Corticotherapy|corticotherapy
996090|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
996091|NCT03188861|multimorbidity|multimorbidity
996092|NCT03188861|health care utilization|health care utilization
996093|NCT03188809|Postoperative Pain|postoperative pain
996094|NCT03188809|Functional Outcomes|functional outcomes
996095|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
996096|NCT03188809|Adductor Canal Block|adductor canal block
996097|NCT03188809|Femoral Nerve Block|femoral nerve block
996098|NCT03188796|vitamin D|vitamin d
996099|NCT03188796|critical care|critical care
996100|NCT03188770|Middle-income countries|middle-income countries
996101|NCT03188744|Cervical cancer|cervical cancer
996102|NCT03188744|Pelvic floor muscles|pelvic floor muscles
996103|NCT03188744|Physiotherapy|physiotherapy
996104|NCT03188744|Quality of life|quality of life
996105|NCT03188731|ZIKA|zika
996106|NCT03188731|Dengue|dengue
996107|NCT03188731|Chikungunya|chikungunya
996108|NCT03188731|Pregnant Women|pregnant women
996109|NCT03188731|Pregnant Woman|pregnant woman
996110|NCT03188731|ZIKV|zikv
996111|NCT03188718|Polysomnogram|polysomnogram
996117|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
996118|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
996120|NCT03188692|DPT-IPV|dpt-ipv
996121|NCT03188692|Intramuscular|intramuscular
996123|NCT03188679|neurological impairment|neurological impairment
996124|NCT03188679|outcome prediction|outcome prediction
996125|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
996126|NCT03188640|Bariatric surgery|bariatric surgery
996127|NCT03188640|Sex hormones|sex hormones
996128|NCT03188640|Women|women
996129|NCT03188640|Quality of life|quality of life
996130|NCT03188614|shock|shock
996131|NCT03188614|crystalloid|crystalloid
996132|NCT03188614|acute kidney injury|acute kidney injury
996133|NCT03188601|Graft vs Host Disease|graft vs host disease
996134|NCT03188601|Immune System Diseases|immune system diseases
996135|NCT03188601|Protease Inhibitors|protease inhibitors
996136|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
996137|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
996138|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
996139|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
996140|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
996141|NCT03188484|Atrial Fibrillation|atrial fibrillation
996142|NCT03188484|Electrocardiography|electrocardiography
996143|NCT03188484|Biological Markers|biological markers
996144|NCT03188484|Risk Assessment|risk assessment
996145|NCT03188458|Infants|infants
996146|NCT03188458|Cord blood sample|cord blood sample
996147|NCT03188458|Acellular pertussis|acellular pertussis
996148|NCT03188458|Boostrix|boostrix
996149|NCT03188458|Colombia|colombia
996150|NCT03188458|Pregnant women|pregnant women
996157|NCT03188380|nec|nec
996158|NCT03188380|abdominal ultrasound|abdominal ultrasound
996159|NCT03188380|abdominal radiograph|abdominal radiograph
996160|NCT03188380|preterm|preterm
996161|NCT03188367|dose-finding|dose-finding
996162|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
996163|NCT03188367|gluten|gluten
996164|NCT03188367|intestinal symptoms|intestinal symptoms
996165|NCT03188367|placebo|placebo
996166|NCT03188354|Positron-Emission Tomography|positron-emission tomography
996167|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
996168|NCT03188341|vascular surgery|vascular surgery
996169|NCT03188341|repolarization disturbances|repolarization disturbances
996170|NCT03188341|cardiac complications|cardiac complications
996171|NCT03188341|high risk patient|high risk patient
996172|NCT03188341|high risk procedure|high risk procedure
996173|NCT03188302|Stool consistency|stool consistency
996174|NCT03188302|Texture Analyser|texture analyser
996175|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
996176|NCT03188289|chitosan|chitosan
996177|NCT03188289|clorhexidine|clorhexidine
996178|NCT03188289|suture|suture
996179|NCT03188289|bacteria|bacteria
996180|NCT03188289|wisdom|wisdom
996181|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
996182|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
996183|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
996184|NCT03188276|NK cells|nk cells
996185|NCT03188263|diabetes|diabetes
996186|NCT03188263|sleep|sleep
996187|NCT03188263|circadian rhythm|circadian rhythm
996188|NCT03188263|light treatment|light treatment
996189|NCT03188224|Transition|transition
996190|NCT03188224|Improved patient outcomes|improved patient outcomes
996191|NCT03188224|RCT|rct
996192|NCT03188224|Child health|child health
996193|NCT03188224|Empower youth|empower youth
996194|NCT03188185|Alkermes|alkermes
996195|NCT03188185|Major Depressive Disorder|major depressive disorder
996196|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
996197|NCT03188185|ALKS 5461|alks 5461
996198|NCT03188133|Schizophrenia|schizophrenia
996199|NCT03188133|Visual Hallucination|visual hallucination
996200|NCT03188133|False Perception|false perception
996201|NCT03188133|emotional priming|emotional priming
996202|NCT03188107|Risky Infant|risky infant
996203|NCT03188107|Cerebral Palsy|cerebral palsy
996204|NCT03188107|Down Syndrome|down syndrome
996205|NCT03188107|Spina Bifida|spina bifida
996206|NCT03188107|Infant Motor Profile|infant motor profile
996207|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
996208|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
996209|NCT03188068|Sirolimus|sirolimus
996210|NCT03188068|Prednisolone|prednisolone
996211|NCT03188055|patient decision making|patient decision making
996212|NCT03188055|surgical decision making|surgical decision making
996213|NCT03188055|shared decision making|shared decision making
996214|NCT03188055|decision support techniques|decision support techniques
996215|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
996216|NCT03188042|Glaucoma|glaucoma
996217|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
996218|NCT03188016|"music therapy"|"music therapy"
996219|NCT03188016|"Intensive Interaction"|"intensive interaction"
996220|NCT03188016|"non-verbal communication"|"non-verbal communication"
996221|NCT03188016|"musical improvisation"|"musical improvisation"
996222|NCT03188016|"feasibility study"|"feasibility study"
996223|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
996224|NCT03188003|Exercise Movement Techniques|exercise movement techniques
996225|NCT03188003|Low Back Pain|low back pain
996226|NCT03188003|Exercise|exercise
996227|NCT03187990|PSMA PET/MRI|psma pet/mri
996228|NCT03187990|Guided Biopsy|guided biopsy
996229|NCT03187990|Prostate Cancer|prostate cancer
996230|NCT03187977|Cognitive intervention|cognitive intervention
996231|NCT03187977|Survivors|survivors
996232|NCT03187977|Childhood ALL|childhood all
996233|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
996234|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
996235|NCT03187964|Xpert Ultra|xpert ultra
996236|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
996237|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
996238|NCT03187951|Pancreatic cancer|pancreatic cancer
996239|NCT03187951|Questionnaires|questionnaires
996240|NCT03187951|Surveys|surveys
996241|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
996242|NCT03187951|Nutritional Counseling|nutritional counseling
996243|NCT03187951|Booklet|booklet
996244|NCT03187951|Pamphlet|pamphlet
996245|NCT03187951|Educational materials|educational materials
996246|NCT03187951|Aerobic Exercise|aerobic exercise
996247|NCT03187951|Strength Training Exercises|strength training exercises
996248|NCT03187951|Physical Assessments|physical assessments
996249|NCT03187951|Walk Test|walk test
996250|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
996251|NCT03187938|Pregnancy|pregnancy
996252|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
996253|NCT03187938|Placental insufficiency|placental insufficiency
996254|NCT03187938|Low birth weight|low birth weight
996255|NCT03187938|IUGR|iugr
996256|NCT03187899|cervical plexus block|cervical plexus block
996257|NCT03187899|clavicle fracture|clavicle fracture
996258|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
996259|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
996260|NCT03187886|CAA-RI|caa-ri
996262|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
996263|NCT03187873|community participation|community participation
996264|NCT03187873|Maternal and child health|maternal and child health
996265|NCT03187873|Kenya|kenya
996266|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
996267|NCT03187860|mucus|mucus
996268|NCT03187860|Air Liquid Interface|air liquid interface
996269|NCT03187847|Physical Activity|physical activity
996270|NCT03187847|Fatigue|fatigue
996271|NCT03187847|Rehabilitation|rehabilitation
996272|NCT03187834|infection|infection
996273|NCT03187834|azithromycin|azithromycin
996274|NCT03187834|amoxicillin|amoxicillin
996275|NCT03187834|co-trimoxazole|co-trimoxazole
996276|NCT03187834|trachoma|trachoma
996277|NCT03187834|mass treatment|mass treatment
996278|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
996279|NCT03187795|Spinal Cord Injuries|spinal cord injuries
996280|NCT03187795|Randomized Controlled Trial|randomized controlled trial
996281|NCT03187795|Neurogenic Bladder|neurogenic bladder
996282|NCT03187795|Rehabilitation|rehabilitation
996283|NCT03187769|Alkermes|alkermes
996284|NCT03187769|ALKS 3831|alks 3831
996285|NCT03187769|Olanzapine|olanzapine
996286|NCT03187769|Samidorphan|samidorphan
996287|NCT03187769|Schizophrenia|schizophrenia
996288|NCT03187769|Schizophreniform|schizophreniform
996289|NCT03187769|Bipolar I|bipolar i
996290|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
996291|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
996292|NCT03187756|Posttransplantation|posttransplantation
996293|NCT03187743|Lupus erythematosus|lupus erythematosus
996294|NCT03187743|Systemic|systemic
996295|NCT03187743|Corticosteroid|corticosteroid
996296|NCT03187743|Prednisone|prednisone
996297|NCT03187743|Pharmacokinetics|pharmacokinetics
996298|NCT03187730|Smoking Cassation|smoking cassation
996299|NCT03187730|Immigrants|immigrants
996300|NCT03187730|Economic Disparity|economic disparity
996301|NCT03187717|Postoperative pain|postoperative pain
996302|NCT03187717|Recovery period|recovery period
996303|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
996304|NCT03187717|Inhalation anesthesia|inhalation anesthesia
996305|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
996306|NCT03187678|switch|switch
996307|NCT03187678|intravenous|intravenous
996308|NCT03187678|selexipag|selexipag
996309|NCT03187665|Pediatric|pediatric
996310|NCT03187665|Pulse Oximeter|pulse oximeter
996311|NCT03187665|Wireless|wireless
996312|NCT03187665|Motion|motion
996313|NCT03187665|False Alarm|false alarm
996314|NCT03187639|Coronary artery disease|coronary artery disease
996315|NCT03187639|CT coronary angiography|ct coronary angiography
996316|NCT03187639|FFRct|ffrct
996317|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
996318|NCT03187639|Stable chest pain|stable chest pain
996319|NCT03187639|Resource utilisation|resource utilisation
996320|NCT03187639|Quality of life|quality of life
996321|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
996322|NCT03187626|Botulinum toxin A|botulinum toxin a
996323|NCT03187626|Intra-articular therapy|intra-articular therapy
996324|NCT03187626|Randomized trial|randomized trial
996325|NCT03187613|Retinal shift|retinal shift
996326|NCT03187613|Aniseikonia|aniseikonia
996327|NCT03187613|Metamorphopsia|metamorphopsia
996328|NCT03187613|Autofluorescence|autofluorescence
996329|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
996330|NCT03187587|Laser Coagulation|laser coagulation
996331|NCT03187587|Laser Therapy|laser therapy
996332|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
996333|NCT03187561|Sleep|sleep
996334|NCT03187561|Parenting|parenting
996335|NCT03187561|Marital relationship|marital relationship
996336|NCT03187561|Parent-child relations|parent-child relations
996337|NCT03187548|WSL|wsl
996338|NCT03187548|CPP-ACP|cpp-acp
996339|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
996340|NCT03187522|AAA|aaa
996341|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
996342|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
996343|NCT03187496|drug-drug interaction|drug-drug interaction
996344|NCT03187444|Cardiovascular risk|cardiovascular risk
996345|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
996346|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
996347|NCT03187444|Spondyloarthritis|spondyloarthritis
996348|NCT03187444|Inflammation|inflammation
996349|NCT03187431|Stem cell|stem cell
996350|NCT03187431|Therapy|therapy
996351|NCT03187431|IPF|ipf
996352|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
996353|NCT03187418|Micropulse TSCPC|micropulse tscpc
996354|NCT03187418|Laser ablation|laser ablation
996355|NCT03187418|Laser therapy|laser therapy
996356|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
996357|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
996358|NCT03187405|Cerebral Ischemia|cerebral ischemia
996359|NCT03187405|Ventriculostomy|ventriculostomy
996360|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
996361|NCT03187353|Cognitive complaints|cognitive complaints
996362|NCT03187353|RRSO|rrso
996363|NCT03187353|Oophorectomy|oophorectomy
996364|NCT03187353|Memory|memory
996365|NCT03187353|Cognition|cognition
996366|NCT03187353|Early menopause|early menopause
996367|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
996368|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
996369|NCT03187327|p53 expression|p53 expression
996370|NCT03187327|ovarian cancers|ovarian cancers
996371|NCT03187314|Esophageal cancer|esophageal cancer
996372|NCT03187314|Radiation|radiation
996373|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
996374|NCT03187301|Parkinson's Disease|parkinson's disease
996375|NCT03187301|Off episodes|off episodes
996376|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
996377|NCT03187275|Prostate Cancer|prostate cancer
996378|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
996379|NCT03187275|Cancer|cancer
996380|NCT03187275|Quality of Life (QOL)|quality of life (qol)
996381|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
996382|NCT03187223|Multiple Myeloma|multiple myeloma
996383|NCT03187223|Bendamustine|bendamustine
996384|NCT03187223|Melphalan|melphalan
996385|NCT03187223|ASCT|asct
996386|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
996387|NCT03187210|ASCT|asct
996388|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
996389|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
996390|NCT03187132|virtual reality|virtual reality
996391|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
996392|NCT03187132|analgesia|analgesia
996395|NCT03187119|Technology-supported intervention|technology-supported intervention
996396|NCT03187119|Asthma Action Plan|asthma action plan
996397|NCT03187119|Health literacy|health literacy
996398|NCT03187093|MDD|mdd
996399|NCT03187093|Vortioxetine|vortioxetine
996400|NCT03187093|IGF-1|igf-1
996401|NCT03187093|Cognitive dysfunction|cognitive dysfunction
996402|NCT03187067|pneumonia|pneumonia
996403|NCT03187067|diagnostic|diagnostic
996405|NCT03187067|Pakistan|pakistan
996406|NCT03187067|Mozambique|mozambique
996407|NCT03187041|blood draw tourniquets|blood draw tourniquets
996408|NCT03187041|skin surface pressure|skin surface pressure
996409|NCT03187041|blood draw band|blood draw band
996410|NCT03187041|elastic tourniquet|elastic tourniquet
996411|NCT03187041|phlebotomy|phlebotomy
996412|NCT03187041|tourniquet pressure|tourniquet pressure
996413|NCT03187028|Cancer of Pancreas|cancer of pancreas
996414|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
996415|NCT03187028|Pancreas Cancer|pancreas cancer
996416|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
996417|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
996418|NCT03187028|Pancreatic Cancer|pancreatic cancer
996419|NCT03187015|Healthy Volunteers|healthy volunteers
996420|NCT03187015|Entinostat|entinostat
996421|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
996422|NCT03187015|HDAC|hdac
996423|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
996424|NCT03186989|ISIS 814907|isis 814907
996425|NCT03186976|Risk Factor Modification|risk factor modification
996426|NCT03186976|Catheter ablation|catheter ablation
996427|NCT03186963|distal radius fracture|distal radius fracture
996428|NCT03186963|volar plate|volar plate
996429|NCT03186963|immobilization|immobilization
996430|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
996431|NCT03186898|HCC|hcc
996432|NCT03186898|Proton Therapy|proton therapy
996433|NCT03186898|Photon Therapy|photon therapy
996434|NCT03186898|Liver cancer|liver cancer
996435|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
996436|NCT03186859|bariatric surgery|bariatric surgery
996437|NCT03186846|cognitive decline|cognitive decline
996438|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
996439|NCT03186846|LIDCO|lidco
996440|NCT03186846|INVOS|invos
996441|NCT03186846|BIS|bis
996442|NCT03186846|brain injury biomarkers|brain injury biomarkers
996443|NCT03186820|Endometriosis|endometriosis
996444|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
996445|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
996446|NCT03186807|normogram|normogram
996447|NCT03186807|brain lumination|brain lumination
996448|NCT03186807|fetal cortex|fetal cortex
996449|NCT03186807|ultrasound|ultrasound
996450|NCT03186794|Fatigue|fatigue
996451|NCT03186781|Flu Virus|flu virus
996452|NCT03186781|Flu Shot|flu shot
996453|NCT03186781|H2N2|h2n2
996454|NCT03186781|Protein|protein
996455|NCT03186781|Immune Response|immune response
996456|NCT03186742|Eplerenone|eplerenone
996457|NCT03186742|Concentric hypertrophy|concentric hypertrophy
996458|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
996459|NCT03186716|Colostrum|colostrum
996460|NCT03186716|Enteral Nutrition|enteral nutrition
996461|NCT03186716|Intestinal Permeability|intestinal permeability
996462|NCT03186716|Intensive Care Unit|intensive care unit
996463|NCT03186703|Cancer prevention|cancer prevention
996464|NCT03186703|Knowledge translation|knowledge translation
996465|NCT03186703|Physical activity|physical activity
996466|NCT03186703|Diet|diet
996467|NCT03186703|Alcohol|alcohol
996468|NCT03186703|Smoking|smoking
996469|NCT03186690|vital pulp therapy|vital pulp therapy
996470|NCT03186690|Biodentine|biodentine
996471|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
996472|NCT03186677|ISU304|isu304
996473|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
996474|NCT03186677|FIX|fix
996475|NCT03186677|Factor IX|factor ix
996476|NCT03186677|CB2679d|cb2679d
996477|NCT03186651|Vaginal|vaginal
996478|NCT03186651|Medical Device|medical device
996479|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
996480|NCT03186625|acute coronary syndrome|acute coronary syndrome
996481|NCT03186625|gut microbiota|gut microbiota
996482|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
996483|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
996484|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
996485|NCT03186599|Medication Event Monitoring System|medication event monitoring system
996486|NCT03186599|adherence|adherence
996487|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
996488|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
996489|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
996490|NCT03186508|obesity prevention|obesity prevention
996491|NCT03186508|sleep|sleep
996492|NCT03186508|behavioral intervention|behavioral intervention
996493|NCT03186456|acute cerebral infarction|acute cerebral infarction
996494|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
996495|NCT03186443|herpetic neuralgia|herpetic neuralgia
996496|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
996497|NCT03186443|pregabalin|pregabalin
996498|NCT03186430|Vaccine|vaccine
996499|NCT03186430|Vaccination|vaccination
996500|NCT03186430|Behavioral Research|behavioral research
996501|NCT03186430|Adolescent|adolescent
997003|NCT03183193|miRNAs|mirnas
996502|NCT03186430|Health Promotion|health promotion
996503|NCT03186430|Public Health|public health
996504|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
996505|NCT03186352|photodynamic therapy|photodynamic therapy
996506|NCT03186352|photoactivated disinfection|photoactivated disinfection
996507|NCT03186352|primary root caries lesion|primary root caries lesion
996508|NCT03186352|cavity disinfection|cavity disinfection
996509|NCT03186352|lasers|lasers
996510|NCT03186352|root caries|root caries
996511|NCT03186339|QoL|qol
996512|NCT03186339|TAVI|tavi
996513|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
996514|NCT03186339|Aortic stenosis|aortic stenosis
996515|NCT03186326|immunotherapy|immunotherapy
996516|NCT03186326|second line|second line
996518|NCT03186313|Sofosbuvir|sofosbuvir
996519|NCT03186313|Ribavirin|ribavirin
996520|NCT03186300|bolus advisor|bolus advisor
996521|NCT03186248|Achalasia cardia|achalasia cardia
996522|NCT03186248|myotomy|myotomy
996523|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
996524|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
996525|NCT03186209|Asthma,|asthma,
996526|NCT03186209|Bronchial Diseases,|bronchial diseases,
996527|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
996528|NCT03186209|Lung Diseases,|lung diseases,
996529|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
996530|NCT03186196|Folate|folate
996531|NCT03186196|Polymorphism|polymorphism
996532|NCT03186196|Overweight and Obesity|overweight and obesity
996533|NCT03186196|Inflammatory markers|inflammatory markers
996534|NCT03186183|HIV prevention|hiv prevention
996535|NCT03186183|Sexual health|sexual health
996536|NCT03186183|Motivational interviewing|motivational interviewing
996537|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
996538|NCT03186183|Health promotion|health promotion
996539|NCT03186157|trephined syndrome|trephined syndrome
996540|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
996541|NCT03186157|craniectomy|craniectomy
996542|NCT03186157|decompressive craniectomy|decompressive craniectomy
996543|NCT03186157|neurosurgical complications|neurosurgical complications
996544|NCT03186118|pediatric|pediatric
996545|NCT03186118|young adult|young adult
996546|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
996547|NCT03186118|CD 19|cd 19
996548|NCT03186118|leukemia|leukemia
996549|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
996550|NCT03186118|T cell|t cell
996551|NCT03186105|Appendicitis Acute|appendicitis acute
996552|NCT03186105|AMBULATORY|ambulatory
996553|NCT03186092|Respiratory muscle strength|respiratory muscle strength
996554|NCT03186092|Pulmonary hypertension|pulmonary hypertension
996555|NCT03186092|Respiratory muscle training|respiratory muscle training
996556|NCT03186027|chronic fatigue|chronic fatigue
996557|NCT03186027|Sleep problems|sleep problems
996558|NCT03186027|Autonomic dysfunction|autonomic dysfunction
996559|NCT03186027|Health-Related Quality of Life|health-related quality of life
996560|NCT03186027|Coenzyme Q10|coenzyme q10
996561|NCT03186027|NADH|nadh
996562|NCT03186014|Malignant dysphagia|malignant dysphagia
996563|NCT03186014|Stent|stent
996564|NCT03186014|Esophageal neoplasms|esophageal neoplasms
996565|NCT03186014|Brachytherapy|brachytherapy
996566|NCT03186001|frontalis|frontalis
996567|NCT03186001|frontal line|frontal line
996568|NCT03186001|glabellar line|glabellar line
996569|NCT03186001|botulinum toxin|botulinum toxin
996570|NCT03186001|abobotulinum|abobotulinum
996571|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
996572|NCT03185988|Biliary tract cancer|biliary tract cancer
996573|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
996574|NCT03185988|Targeted therapy|targeted therapy
996575|NCT03185975|HIV|hiv
996576|NCT03185975|transgender|transgender
996577|NCT03185975|trans|trans
996578|NCT03185975|youth|youth
996579|NCT03185975|home testing|home testing
996580|NCT03185936|optic disc pit|optic disc pit
996581|NCT03185936|retinal detachment|retinal detachment
996582|NCT03185936|maculopathy|maculopathy
996583|NCT03185923|Community-Acquired Infections|community-acquired infections
996584|NCT03185923|Humans|humans
996585|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
996586|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
996587|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
996588|NCT03185858|secondary prevention|secondary prevention
996589|NCT03185858|primary healthcare|primary healthcare
996590|NCT03185858|village doctors|village doctors
996591|NCT03185858|rural China|rural china
996592|NCT03185858|medication adherence|medication adherence
996593|NCT03185858|physical activity|physical activity
996594|NCT03185832|Hear failure|hear failure
996595|NCT03185832|Sudden Cardiac Death|sudden cardiac death
996596|NCT03185832|Arrhythmia|arrhythmia
996597|NCT03185832|Implanted device|implanted device
996598|NCT03185832|ICD|icd
996599|NCT03185832|CRT|crt
997004|NCT03183193|Lipidomics|lipidomics
996600|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
996601|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
996602|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
996603|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
996604|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
996605|NCT03185780|glioblastoma|glioblastoma
996606|NCT03185780|quality of life|quality of life
996607|NCT03185780|adherence|adherence
996608|NCT03185754|lung cancer|lung cancer
996610|NCT03185754|lobectomy|lobectomy
996611|NCT03185754|sublobar resection|sublobar resection
996612|NCT03185728|Child Abuse|child abuse
996613|NCT03185728|Mandated Reporting|mandated reporting
996614|NCT03185728|Online Learning|online learning
996615|NCT03185728|Child Protection|child protection
996616|NCT03185728|GAMIFICATION|gamification
996617|NCT03185728|Early Childhood Education|early childhood education
996618|NCT03185715|oocyte donation|oocyte donation
996619|NCT03185715|recipient counselling|recipient counselling
996620|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
996621|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
996622|NCT03185715|decision-making|decision-making
996623|NCT03185689|Glycemic control|glycemic control
996624|NCT03185689|Diabetes self-management education|diabetes self-management education
996625|NCT03185650|Healthy Volunteers|healthy volunteers
996626|NCT03185637|Outcomes|outcomes
996627|NCT03185637|Mortality|mortality
996628|NCT03185637|Complications|complications
996629|NCT03185637|Neonatal surgery|neonatal surgery
996630|NCT03185637|Paediatric surgery|paediatric surgery
996631|NCT03185637|Childrens surgery|childrens surgery
996632|NCT03185637|Sub-Saharan Africa|sub-saharan africa
996633|NCT03185637|Research Collaboration|research collaboration
996634|NCT03185637|Gastroschisis|gastroschisis
996635|NCT03185637|Anorectal malformation|anorectal malformation
996636|NCT03185637|Appendicitis|appendicitis
996637|NCT03185637|Intussuception|intussuception
996638|NCT03185637|Inguinal hernia|inguinal hernia
996639|NCT03185585|Nutritional screenings|nutritional screenings
996640|NCT03185520|Stroke|stroke
996641|NCT03185520|Ischemic Stroke|ischemic stroke
996642|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
996643|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
996644|NCT03185520|ESUS|esus
996645|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
996646|NCT03185481|Parkinson's Disease|parkinson's disease
996647|NCT03185481|Motor Fluctuations|motor fluctuations
996648|NCT03185481|D1 partial agonist|d1 partial agonist
996649|NCT03185468|CAR T|car t
996650|NCT03185468|Bladder|bladder
996651|NCT03185455|Hypertension|hypertension
996652|NCT03185455|Pregnancy|pregnancy
996653|NCT03185455|Text|text
996654|NCT03185442|fMRI|fmri
996655|NCT03185442|PRF|prf
996656|NCT03185416|Quality of Life|quality of life
996657|NCT03185416|Caregiver|caregiver
996658|NCT03185416|Quality Improvement|quality improvement
996659|NCT03185403|hemodynamic effect|hemodynamic effect
996660|NCT03185403|para vertebral block|para vertebral block
996661|NCT03185390|periampullary lesions|periampullary lesions
996662|NCT03185351|midazolam|midazolam
996663|NCT03185351|brachial plexus block|brachial plexus block
996664|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
996665|NCT03185299|Polyp detection rate|polyp detection rate
996666|NCT03185299|Adenoma detection rate|adenoma detection rate
996667|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
996668|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
996669|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
996670|NCT03185260|Cardiac Arrest|cardiac arrest
996671|NCT03185260|Training|training
996672|NCT03185247|Transdiagnostic|transdiagnostic
996673|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
996674|NCT03185247|Therapy|therapy
996675|NCT03185234|tDCS|tdcs
996676|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
996677|NCT03185208|Lithium|lithium
996678|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
996679|NCT03185208|MCI|mci
996680|NCT03185208|Dementia|dementia
996681|NCT03185208|Alzheimer|alzheimer
996682|NCT03185208|Alzheimer's Disease|alzheimer's disease
996683|NCT03185208|Cognition|cognition
996684|NCT03185208|Memory|memory
996685|NCT03185208|Thinking|thinking
996686|NCT03185208|Prevention|prevention
996687|NCT03185208|amyloid|amyloid
996688|NCT03185208|imaging|imaging
996689|NCT03185208|MRI|mri
996690|NCT03185208|PET|pet
996691|NCT03185208|tau|tau
996696|NCT03185169|breast cancer survivor|breast cancer survivor
996697|NCT03185169|postmenopausal|postmenopausal
996698|NCT03185169|dysuria|dysuria
996699|NCT03185169|dyspareunia|dyspareunia
996700|NCT03185169|vaginal dryness|vaginal dryness
996701|NCT03185169|urinary tract infections|urinary tract infections
996702|NCT03185169|urinary frequency|urinary frequency
996703|NCT03185169|urinary urgency|urinary urgency
996704|NCT03185169|genital burning|genital burning
996705|NCT03185169|genital itching|genital itching
996706|NCT03185169|genital dryness|genital dryness
996707|NCT03185156|nausea and vomiting|nausea and vomiting
996708|NCT03185156|hemabate|hemabate
996709|NCT03185156|propofol|propofol
996710|NCT03185130|Headache|headache
996711|NCT03185130|Benign Headache|benign headache
996712|NCT03185117|opioid consumption|opioid consumption
996713|NCT03185117|postdischarge|postdischarge
996714|NCT03185117|major orthopedic surgery|major orthopedic surgery
996715|NCT03185104|removable partial denture|removable partial denture
996716|NCT03185104|silver diamine fluoride|silver diamine fluoride
996717|NCT03185078|physical therapy|physical therapy
996719|NCT03185026|Psychiatry|psychiatry
996720|NCT03185026|Suicide|suicide
996721|NCT03185026|Psychoeducation|psychoeducation
996722|NCT03185026|Randomized controlled trial|randomized controlled trial
996723|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
996724|NCT03185026|DSM-5|dsm-5
996725|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
996726|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
996727|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
996728|NCT03185013|CIN 2|cin 2
996729|NCT03185013|CIN 3|cin 3
996730|NCT03185013|papillomavirus|papillomavirus
996731|NCT03184987|fluticasone furoate|fluticasone furoate
996732|NCT03184987|fixed dose combination|fixed dose combination
996733|NCT03184987|Japanese subjects|japanese subjects
996734|NCT03184987|vilanterol|vilanterol
996735|NCT03184987|asthma|asthma
996736|NCT03184987|umeclidinium bromide|umeclidinium bromide
996737|NCT03184987|closed triple therapy|closed triple therapy
996738|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
996739|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
996740|NCT03184922|femoral suspensory loops|femoral suspensory loops
996741|NCT03184857|maxillary sinus|maxillary sinus
996742|NCT03184857|augmentation|augmentation
996743|NCT03184857|bovine bone|bovine bone
996744|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
996745|NCT03184844|Thalidomide TI|thalidomide ti
996746|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
996747|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
996749|NCT03184779|Snowboard|snowboard
996750|NCT03184779|Snow Sport|snow sport
996751|NCT03184779|Injury|injury
996752|NCT03184779|Injury Prevention|injury prevention
996753|NCT03184779|Safety|safety
996754|NCT03184779|Safety Video|safety video
996755|NCT03184779|Video Intervention|video intervention
996756|NCT03184779|Youth|youth
996757|NCT03184779|Children|children
996758|NCT03184779|Adolescent|adolescent
996759|NCT03184779|Education|education
996760|NCT03184779|Knowledge|knowledge
996761|NCT03184753|Autologous|autologous
996762|NCT03184753|IgT|igt
996763|NCT03184753|Ovarian Cancer|ovarian cancer
996764|NCT03184753|CART|cart
996765|NCT03184701|Telehealth|telehealth
996766|NCT03184701|Quality of Life|quality of life
996767|NCT03184688|platelet rich plasma|platelet rich plasma
996768|NCT03184688|Perineural injection therapy|perineural injection therapy
996769|NCT03184688|hydrodissection|hydrodissection
996770|NCT03184662|High-intensity physical activity|high-intensity physical activity
996771|NCT03184662|Diabetes|diabetes
996772|NCT03184662|Renal function decline|renal function decline
996773|NCT03184636|ACLF|aclf
996774|NCT03184636|SOFA|sofa
996775|NCT03184636|Zagazig university|zagazig university
996776|NCT03184610|Keratoconus|keratoconus
996777|NCT03184610|Optical Coherence Tomography|optical coherence tomography
996778|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
996779|NCT03184597|HLA screening|hla screening
996780|NCT03184597|SJS/TEN|sjs/ten
996781|NCT03184597|MPE|mpe
996782|NCT03184597|AEDs|aeds
996783|NCT03184571|bemcentinib|bemcentinib
996784|NCT03184571|NSCLC|nsclc
996785|NCT03184571|pembrolizumab|pembrolizumab
996786|NCT03184571|Keytruda|keytruda
996787|NCT03184571|BGB324|bgb324
996788|NCT03184558|bemcentinib|bemcentinib
996789|NCT03184558|TNBC|tnbc
996790|NCT03184558|pembrolizumab|pembrolizumab
996791|NCT03184558|Keytruda|keytruda
996792|NCT03184558|BGB324|bgb324
996793|NCT03184545|anterior knee pain|anterior knee pain
996794|NCT03184480|Drug Use Investigation|drug use investigation
996795|NCT03184480|GW685698|gw685698
996796|NCT03184480|asthma|asthma
996797|NCT03184480|Post-marketing surveillance|post-marketing surveillance
996798|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
996799|NCT03184467|GV1001|gv1001
997403|NCT03181100|PLX4032|plx4032
996800|NCT03184467|Alzheimer Disease|alzheimer disease
996801|NCT03184454|OCD|ocd
996802|NCT03184454|deep brain stimulation|deep brain stimulation
996803|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
996804|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
996805|NCT03184389|Behavioral Counseling|behavioral counseling
996806|NCT03184389|Cigarette Smoking|cigarette smoking
996807|NCT03184389|Mobile Health|mobile health
996808|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
996809|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
996810|NCT03184389|Mobile Apps|mobile apps
996811|NCT03184389|Physiological Monitoring|physiological monitoring
996812|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
996813|NCT03184389|Stress-Management Interventions|stress-management interventions
996814|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
996815|NCT03184389|Smartphone Apps|smartphone apps
996816|NCT03184389|Smoking Cessation|smoking cessation
996817|NCT03184389|Wearable Sensors|wearable sensors
996818|NCT03184389|Eating Behavior|eating behavior
996819|NCT03184389|Stress-Related Eating|stress-related eating
996820|NCT03184376|Gut microbiota|gut microbiota
996821|NCT03184376|Prebiotic|prebiotic
996822|NCT03184376|Liver biopsy|liver biopsy
996823|NCT03184376|Oligofructose|oligofructose
996824|NCT03184350|cervical cancer|cervical cancer
996825|NCT03184350|endometrial cancer|endometrial cancer
996826|NCT03184350|proton therapy|proton therapy
996827|NCT03184337|Weight loss|weight loss
996828|NCT03184337|Women|women
996829|NCT03184337|Sleep|sleep
996830|NCT03184337|Intervention|intervention
996831|NCT03184337|Diet|diet
996832|NCT03184337|Physical activity|physical activity
996833|NCT03184337|Fitbit|fitbit
996834|NCT03184311|Iron deficiency|iron deficiency
996835|NCT03184311|Therapy response prediction|therapy response prediction
996836|NCT03184311|Exercise tolerance|exercise tolerance
996837|NCT03184298|Military Personnel|military personnel
996838|NCT03184298|Sexual Assault|sexual assault
996839|NCT03184298|Military Sexual Trauma|military sexual trauma
996840|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
996841|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
996842|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
996843|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
996844|NCT03184246|Direct laryngoscopy|direct laryngoscopy
996845|NCT03184220|Neck Pain|neck pain
996846|NCT03184220|Physical Therapy Modalities|physical therapy modalities
996847|NCT03184220|Fascia|fascia
996848|NCT03184220|Manual Therapy|manual therapy
996849|NCT03184220|Massage|massage
996850|NCT03184194|daratumumab|daratumumab
996851|NCT03184194|nivolumab|nivolumab
996852|NCT03184194|cyclophosphamide|cyclophosphamide
996853|NCT03184181|tendinopathy|tendinopathy
996854|NCT03184181|electrolysis|electrolysis
996855|NCT03184181|exercise|exercise
996856|NCT03184181|dry needling|dry needling
996857|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
996858|NCT03184155|Nicardipine|nicardipine
996859|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
996860|NCT03184155|Coronary Artery Disease|coronary artery disease
996861|NCT03184142|Intimidation|intimidation
996862|NCT03184142|Simulation|simulation
996863|NCT03184142|Medical education|medical education
996864|NCT03184142|Surgical education|surgical education
996865|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
996866|NCT03184077|Obestric laceration|obestric laceration
996867|NCT03184064|Blackcurrant|blackcurrant
996868|NCT03184064|Citrus|citrus
996869|NCT03184064|Polyphenols|polyphenols
996870|NCT03184064|Glucose|glucose
996871|NCT03184064|Postprandial|postprandial
996872|NCT03184064|Metabolism|metabolism
996873|NCT03184051|Knee|knee
996874|NCT03184051|Osteoarthritis|osteoarthritis
996875|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
996876|NCT03184051|Articular cartilage|articular cartilage
996877|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
996878|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
996879|NCT03184012|caries|caries
996880|NCT03184012|full coverage|full coverage
996881|NCT03184012|strip crown|strip crown
996882|NCT03184012|Zirconia crown|zirconia crown
996883|NCT03184012|primary anterior teeth|primary anterior teeth
996884|NCT03184012|crown|crown
996885|NCT03183960|Self-management|self-management
996886|NCT03183960|Quality of Life|quality of life
996887|NCT03183960|Self-efficacy|self-efficacy
996888|NCT03183960|Support|support
996889|NCT03183960|Stroke|stroke
996890|NCT03183960|Older adults|older adults
996891|NCT03183947|fMRI|fmri
996892|NCT03183947|neurofeedback|neurofeedback
996893|NCT03183947|emotion regulation|emotion regulation
996894|NCT03183947|schizophrenia|schizophrenia
996895|NCT03183947|cognitive reappraisal|cognitive reappraisal
996896|NCT03183947|depression|depression
996897|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
996898|NCT03183934|Stem cell|stem cell
996899|NCT03183908|influenza vaccine|influenza vaccine
996900|NCT03183908|fever following vaccination|fever following vaccination
996901|NCT03183908|pain following vaccination|pain following vaccination
996902|NCT03183908|quality of life|quality of life
996903|NCT03183869|microbiome|microbiome
996904|NCT03183869|multiple sclerosis|multiple sclerosis
996905|NCT03183869|microbiota|microbiota
996907|NCT03183843|Atrial Fibrillation|atrial fibrillation
996908|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
1662626|NCT00133744|prenatal|prenatal
996909|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
996910|NCT03183843|Dabigatran|dabigatran
996911|NCT03183843|Biological Prosthesis|biological prosthesis
996912|NCT03183843|Mitral Valve Replacement|mitral valve replacement
996913|NCT03183843|Cox-Maze Procedure|cox-maze procedure
996914|NCT03183830|Cardiovascular Disease|cardiovascular disease
996915|NCT03183830|Inorganic nitrate|inorganic nitrate
996916|NCT03183830|Nitric Oxide|nitric oxide
996917|NCT03183830|Inflammation|inflammation
996918|NCT03183817|Person-centred care|person-centred care
996919|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
996920|NCT03183752|thyroid|thyroid
996921|NCT03183752|insulin|insulin
996922|NCT03183752|thyroid nodule|thyroid nodule
996923|NCT03183752|insulin resistance|insulin resistance
996924|NCT03183752|thyroid volume|thyroid volume
996925|NCT03183752|metformin|metformin
996926|NCT03183739|ASP8062|asp8062
996927|NCT03183739|Pharmacokinetics|pharmacokinetics
996928|NCT03183739|Safety|safety
996929|NCT03183700|Screening HPV|screening hpv
996930|NCT03183700|Self sampling|self sampling
996931|NCT03183700|DNA Methylation|dna methylation
996932|NCT03183687|neurosurgery|neurosurgery
996933|NCT03183687|resident wellness|resident wellness
996934|NCT03183687|health|health
996935|NCT03183687|mental health|mental health
996936|NCT03183687|physical activity|physical activity
996937|NCT03183687|physician health|physician health
996938|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
996939|NCT03183596|Deep Serratus Block|deep serratus block
996940|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
996941|NCT03183596|Superficial Serratus block|superficial serratus block
996942|NCT03183583|Tissue Adhesive|tissue adhesive
996943|NCT03183492|Israel|israel
996944|NCT03183492|Universal Mass Vaccination|universal mass vaccination
996945|NCT03183492|Havrix®|havrix®
996946|NCT03183492|Hepatitis A|hepatitis a
996947|NCT03183492|Healthy adults|healthy adults
996948|NCT03183492|Long term persistence|long term persistence
996949|NCT03183492|Toddlers|toddlers
996950|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
996951|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
996952|NCT03183479|perioperative blood loss|perioperative blood loss
996953|NCT03183479|transfusion|transfusion
996954|NCT03183453|Confabulations|confabulations
996955|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
996956|NCT03183453|Memory|memory
996957|NCT03183440|Atopic dermatitis|atopic dermatitis
996958|NCT03183440|Prevention|prevention
996959|NCT03183440|Prebiotics|prebiotics
996960|NCT03183440|Pregnancy|pregnancy
996961|NCT03183414|cardiac surgery|cardiac surgery
996962|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
996963|NCT03183401|childhood cancer survivor|childhood cancer survivor
996964|NCT03183388|psychotherapy|psychotherapy
996965|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
996966|NCT03183323|hfpef|hfpef
996967|NCT03183323|hfref|hfref
996968|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
996969|NCT03183323|exercise|exercise
996970|NCT03183323|telerehabilitation|telerehabilitation
996971|NCT03183323|rehabilitation|rehabilitation
996972|NCT03183284|dexamethazone|dexamethazone
996973|NCT03183284|prednislone|prednislone
996974|NCT03183284|severe ITP|severe itp
996975|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
996976|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
996977|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
996978|NCT03183193|NAFLD|nafld
996979|NCT03183193|NASH|nash
996980|NCT03183193|Obesity|obesity
996981|NCT03183193|AASLD|aasld
996983|NCT03183193|Energy-restricted diet|energy-restricted diet
996984|NCT03183193|Lifestyle intervention|lifestyle intervention
996985|NCT03183193|Mediterranean diet|mediterranean diet
996986|NCT03183193|Weight loss|weight loss
996987|NCT03183193|Liver damage|liver damage
996988|NCT03183193|Inflammation|inflammation
996989|NCT03183193|Oxidative stress|oxidative stress
996990|NCT03183193|Microbiota composition|microbiota composition
996991|NCT03183193|Eating behaviour|eating behaviour
996992|NCT03183193|Satiety|satiety
996993|NCT03183193|Physical activity|physical activity
996994|NCT03183193|Sedentary behaviours|sedentary behaviours
996995|NCT03183193|Sleep quality|sleep quality
996996|NCT03183193|Sleep duration|sleep duration
996997|NCT03183193|Psychological factors|psychological factors
996998|NCT03183193|Nutrigenomics|nutrigenomics
996999|NCT03183193|Nutrigenetics|nutrigenetics
997000|NCT03183193|Transcriptomics|transcriptomics
997001|NCT03183193|Epigenetics|epigenetics
997002|NCT03183193|Metabolomics|metabolomics
997005|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
997006|NCT03183115|Radiofrequency ablation|radiofrequency ablation
997007|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
997008|NCT03183115|Esophageal cancer|esophageal cancer
997009|NCT03183115|Recurrence|recurrence
997010|NCT03183115|Field cancerization|field cancerization
997011|NCT03183076|epilepsy|epilepsy
997012|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
997013|NCT03183076|Drug Resistance|drug resistance
997014|NCT03183037|Acupuncture|acupuncture
997015|NCT03183037|17-298|17-298
997016|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
997017|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
997018|NCT03183011|heart failure|heart failure
997019|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
997020|NCT03182972|medication reconciliation|medication reconciliation
997021|NCT03182972|implementation|implementation
997022|NCT03182972|pharmacists|pharmacists
997023|NCT03182972|southwestern Nigeria|southwestern nigeria
997024|NCT03182959|Nrf2 pathway|nrf2 pathway
997025|NCT03182959|Oral mucosa|oral mucosa
997026|NCT03182959|HNSCC|hnscc
997027|NCT03182959|Head and Neck Cancer|head and neck cancer
997028|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
997029|NCT03182959|Avmacol|avmacol
997030|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
997031|NCT03182959|broccoli sprout powder|broccoli sprout powder
997032|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
997033|NCT03182933|10 meter walk test|10 meter walk test
997034|NCT03182933|Opioid consumption|opioid consumption
997035|NCT03182894|chemo-refractory|chemo-refractory
997036|NCT03182894|pembrolizumab|pembrolizumab
997037|NCT03182894|epacadostat|epacadostat
997038|NCT03182894|azacitidine|azacitidine
997039|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
997040|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
997041|NCT03182881|Myofascial-reléase|myofascial-reléase
997042|NCT03182881|Fibromyalgia|fibromyalgia
997043|NCT03182881|Lymphatic drainage|lymphatic drainage
997044|NCT03182881|Breast cancer|breast cancer
997045|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
997046|NCT03182855|STEMI|stemi
997047|NCT03182855|Platelet reactivity|platelet reactivity
997048|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
997049|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
997050|NCT03182829|apixaban|apixaban
997051|NCT03182829|dabigatran|dabigatran
997052|NCT03182829|edoxaban|edoxaban
997053|NCT03182829|rivaroxaban|rivaroxaban
997054|NCT03182829|urine|urine
997055|NCT03182829|LC-MS/MS|lc-ms/ms
997056|NCT03182829|evaluation study|evaluation study
997057|NCT03182829|point of care test|point of care test
997058|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
997059|NCT03182816|CTLA-4|ctla-4
997060|NCT03182816|PD-1|pd-1
997061|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
997062|NCT03182816|solid tumor|solid tumor
997063|NCT03182803|mesothelin|mesothelin
997064|NCT03182803|CTLA-4|ctla-4
997065|NCT03182803|PD-1|pd-1
997066|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
997067|NCT03182803|solid tumor|solid tumor
997068|NCT03182790|Smoking Cessation|smoking cessation
997069|NCT03182790|Quit to Win|quit to win
997070|NCT03182790|Brief intervention|brief intervention
997071|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
997072|NCT03182790|Incentives|incentives
997073|NCT03182790|AWARD model|award model
997074|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
997075|NCT03182790|Regular messages|regular messages
997076|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
997077|NCT03182777|channelopathies|channelopathies
997078|NCT03182777|death, sudden|death, sudden
997079|NCT03182777|genetic testing|genetic testing
997080|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
997081|NCT03182777|anesthesia, local|anesthesia, local
997082|NCT03182777|dentistry|dentistry
997083|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
997084|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
997085|NCT03182725|POTS|pots
997086|NCT03182725|tachycardia|tachycardia
997087|NCT03182725|ivabradine|ivabradine
997088|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
997089|NCT03182699|Hemodialysis|hemodialysis
997090|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
997091|NCT03182699|FGF 23|fgf 23
997092|NCT03182699|Etelcalcetide|etelcalcetide
997093|NCT03182699|Alfacalcidol|alfacalcidol
997094|NCT03182686|osteoarthritis|osteoarthritis
997344|NCT03181360|computed tomography|computed tomography
997095|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
997096|NCT03182686|OA|oa
997097|NCT03182686|OAK|oak
997098|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
997099|NCT03182673|advanced solid tumor|advanced solid tumor
997100|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
997101|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
997102|NCT03182673|Safety|safety
997103|NCT03182673|Pharmacokinetics|pharmacokinetics
997104|NCT03182621|Physical Fitness|physical fitness
997105|NCT03182621|Body Composition|body composition
997106|NCT03182621|Executive Cognitive Function|executive cognitive function
997107|NCT03182582|Laser Debridement|laser debridement
997108|NCT03182582|Debridement|debridement
997109|NCT03182556|Dance Therapy|dance therapy
997110|NCT03182556|Exercise|exercise
997111|NCT03182556|Myofeedback|myofeedback
997112|NCT03182556|Fibromyalgia|fibromyalgia
997113|NCT03182543|Exercise|exercise
997114|NCT03182543|Oxidative stress|oxidative stress
997115|NCT03182543|Antioxidant|antioxidant
997116|NCT03182491|Platelet activating factor|platelet activating factor
997117|NCT03182491|Basophil activation test|basophil activation test
997118|NCT03182491|Anaphylatoxins|anaphylatoxins
997119|NCT03182478|skin picking|skin picking
997120|NCT03182478|SPD|spd
997121|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
997122|NCT03182478|CBT|cbt
997123|NCT03182478|Group treatment|group treatment
997124|NCT03182478|Rothbaum protocol|rothbaum protocol
997125|NCT03182452|Alarms|alarms
997126|NCT03182452|Alarm Fatigue|alarm fatigue
997127|NCT03182452|Alarm Nuisance|alarm nuisance
997128|NCT03182452|Alarm Reduction|alarm reduction
997129|NCT03182452|Patient Monitoring|patient monitoring
997130|NCT03182452|Intensive Care|intensive care
997131|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
997132|NCT03182413|modafinil|modafinil
997133|NCT03182413|connexin|connexin
997134|NCT03182413|sleep deprivation|sleep deprivation
997135|NCT03182413|cognitive performance|cognitive performance
997136|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
997137|NCT03182387|amylase assay|amylase assay
997138|NCT03182387|aspiration pneumonia|aspiration pneumonia
997139|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
997140|NCT03182374|Intra-articular Injection|intra-articular injection
997141|NCT03182374|Osteoarthritis|osteoarthritis
997142|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
997143|NCT03182348|Microvessels|microvessels
997144|NCT03182348|Cardiovascular disease|cardiovascular disease
997145|NCT03182348|OCT|oct
997146|NCT03182322|Type 1 diabetes|type 1 diabetes
997147|NCT03182322|T1D|t1d
997148|NCT03182322|diabetes mellitus|diabetes mellitus
997149|NCT03182322|intranasal insulin|intranasal insulin
997150|NCT03182322|mucosal tolerance|mucosal tolerance
997151|NCT03182322|autoantigen|autoantigen
997152|NCT03182322|self tolerance|self tolerance
997153|NCT03182322|prevention|prevention
997154|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
997155|NCT03182322|juvenile diabetes|juvenile diabetes
997156|NCT03182296|beta cell mass|beta cell mass
997157|NCT03182296|exendin|exendin
997158|NCT03182296|GLP-1 PET|glp-1 pet
997159|NCT03182283|Person-centered care|person-centered care
997160|NCT03182283|Psychosis care|psychosis care
997161|NCT03182283|Integrated care|integrated care
997162|NCT03182257|TRK|trk
997163|NCT03182257|TRKA|trka
997164|NCT03182257|TRKB|trkb
997165|NCT03182257|TRKC|trkc
997166|NCT03182257|NTRK1|ntrk1
997167|NCT03182257|NTRK2|ntrk2
997168|NCT03182257|NTRK3|ntrk3
997169|NCT03182257|NTRK fusion positive|ntrk fusion positive
997170|NCT03182257|NTRK1 fusion|ntrk1 fusion
997171|NCT03182257|NTRK2 fusion|ntrk2 fusion
997172|NCT03182257|NTRK3 fusion|ntrk3 fusion
997173|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
997174|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
997175|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
997176|NCT03182257|ETV6-NTRK3|etv6-ntrk3
997177|NCT03182257|fusion|fusion
997178|NCT03182257|tumors|tumors
997179|NCT03182257|solid tumors|solid tumors
997180|NCT03182257|CNS tumors|cns tumors
997181|NCT03182257|central nervous system tumors|central nervous system tumors
997182|NCT03182257|TRK fusion|trk fusion
997183|NCT03182257|ETV6|etv6
997184|NCT03182257|ETV6 fusion|etv6 fusion
997185|NCT03182257|solid CNS tumor|solid cns tumor
997186|NCT03182257|advanced CNS tumor|advanced cns tumor
997187|NCT03182257|primary CNS tumor|primary cns tumor
997188|NCT03182244|gilteritinib|gilteritinib
997189|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
997190|NCT03182244|ASP2215|asp2215
997191|NCT03182231|exendin|exendin
997192|NCT03182231|GLP1|glp1
997193|NCT03182231|beta cell mass|beta cell mass
997194|NCT03182218|Periprocedural|periprocedural
997195|NCT03182218|Anticoagulation|anticoagulation
997196|NCT03182218|Dabigatran|dabigatran
997197|NCT03182218|Rivaroxaban|rivaroxaban
997198|NCT03182218|Apixaban|apixaban
997199|NCT03182218|Edoxaban|edoxaban
997200|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
997201|NCT03182218|Surgery|surgery
997202|NCT03182218|Anaesthesia|anaesthesia
997203|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
997204|NCT03182218|Perioperative medicine|perioperative medicine
997205|NCT03182205|Breathing Exercises|breathing exercises
1662627|NCT00133744|perinatal|perinatal
997206|NCT03182205|Autonomic Nervous System|autonomic nervous system
997207|NCT03182205|Hemodynamics|hemodynamics
997208|NCT03182192|Betal cells|betal cells
997209|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
997210|NCT03182192|exendin|exendin
997211|NCT03182192|GLP1|glp1
997212|NCT03182166|golimumab|golimumab
997213|NCT03182166|clinical response|clinical response
997214|NCT03182166|mayo score|mayo score
997215|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
997216|NCT03182166|ulcerative colitis|ulcerative colitis
997217|NCT03182140|long-acting contraception,|long-acting contraception,
997218|NCT03182140|unintended pregnancy|unintended pregnancy
997219|NCT03182140|satisfaction|satisfaction
997220|NCT03182140|bleeding profile|bleeding profile
997221|NCT03182140|amenorrhea|amenorrhea
997345|NCT03181347|Bariatrics|bariatrics
997222|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
997223|NCT03182075|OCD|ocd
997224|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
997225|NCT03182075|Compulsive Behavior|compulsive behavior
997226|NCT03182075|Personality Disorders|personality disorders
997227|NCT03182075|Mental Disorders|mental disorders
997228|NCT03182075|Anxiety Disorders|anxiety disorders
997229|NCT03182075|Impulsive Behavior|impulsive behavior
997230|NCT03182075|Cognition|cognition
997231|NCT03182075|Emotion|emotion
997232|NCT03182075|Emotional Regulation|emotional regulation
997233|NCT03182062|one lung ventilation|one lung ventilation
997234|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
997235|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
997236|NCT03182049|GPA|gpa
997237|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
997238|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
997239|NCT03182049|Subglottic Stenosis|subglottic stenosis
997240|NCT03182049|Bronchial Stenosis|bronchial stenosis
997241|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
997242|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
997243|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
997244|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
997245|NCT03181997|Cancer|cancer
997246|NCT03181997|Malignancy|malignancy
997247|NCT03181971|water|water
997248|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
997249|NCT03181971|schools|schools
997250|NCT03181958|nasal high frequency oscillation ventilation(NHFOV)|nasal high frequency oscillation ventilation(nhfov)
997251|NCT03181958|nasal continuous positive airway pressure(NCPAP)|nasal continuous positive airway pressure(ncpap)
997252|NCT03181958|nasal intermittent positive pressure ventilation（NIPPV）|nasal intermittent positive pressure ventilation（nippv）
997253|NCT03181958|neonatal respiratory distress syndrome(NRDS)|neonatal respiratory distress syndrome(nrds)
997254|NCT03181958|preterm infants|preterm infants
997255|NCT03181906|medication discrepancy|medication discrepancy
997256|NCT03181906|primary care|primary care
997257|NCT03181906|transition of care|transition of care
997258|NCT03181880|ASTUTE|astute
997259|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
997260|NCT03181880|Randomised|randomised
997261|NCT03181880|Pragmatic|pragmatic
997262|NCT03181880|Standard of Care|standard of care
997263|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
997264|NCT03181880|Duaklir|duaklir
997265|NCT03181880|Genuair|genuair
997266|NCT03181867|PET/ CT|pet/ ct
997267|NCT03181867|Endorectal MRI|endorectal mri
997268|NCT03181867|Imaging|imaging
997269|NCT03181867|PSMA|psma
997270|NCT03181867|Prostate Cancer Relapse|prostate cancer relapse
997271|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
997272|NCT03181828|CPSI deficiency|cpsi deficiency
997273|NCT03181828|OTC Deficiency|otc deficiency
997274|NCT03181828|AS Deficiency|as deficiency
997275|NCT03181828|AL Deficiency|al deficiency
997276|NCT03181815|CLADRIBINE|cladribine
997277|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
997278|NCT03181789|HIV vaccine|hiv vaccine
997279|NCT03181789|DNA vaccine|dna vaccine
997280|NCT03181789|IL-12|il-12
997281|NCT03181789|Electroporation|electroporation
997282|NCT03181789|p24|p24
997283|NCT03181789|Gag|gag
997284|NCT03181789|Adjuvant|adjuvant
997285|NCT03181789|Healthy|healthy
997286|NCT03181763|MDMA|mdma
997287|NCT03181763|Startle response|startle response
997288|NCT03181763|sleep|sleep
997289|NCT03181750|Palliative Care|palliative care
997290|NCT03181750|Latino|latino
997291|NCT03181750|Patient Navigation|patient navigation
997404|NCT03181100|R05185426|r05185426
997405|NCT03181100|Cobimetinib|cobimetinib
997292|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
997293|NCT03181711|Dental caries|dental caries
997294|NCT03181711|Tooth, deciduous|tooth, deciduous
997295|NCT03181711|Children|children
997296|NCT03181711|Radiography/bitewing|radiography/bitewing
1662628|NCT00133744|anemia|anemia
997301|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
997302|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
997304|NCT03181659|Patient Education|patient education
997305|NCT03181659|Low back pain|low back pain
997307|NCT03181633|Paroxysmal|paroxysmal
997308|NCT03181633|Hemoglobinuria|hemoglobinuria
997309|NCT03181633|ACH-0144471|ach-0144471
997310|NCT03181581|ultrasonography|ultrasonography
997311|NCT03181581|ultrasonics|ultrasonics
997312|NCT03181581|brain|brain
997313|NCT03181581|surgery|surgery
997314|NCT03181555|Pregnant|pregnant
997315|NCT03181555|Obese|obese
997316|NCT03181555|Omic|omic
997317|NCT03181490|Pulmonary Nodule|pulmonary nodule
997318|NCT03181490|Solitary|solitary
997319|NCT03181477|Phase II|phase ii
997320|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
997321|NCT03181477|Tomozolomide|tomozolomide
997322|NCT03181438|Renal Transplantation|renal transplantation
997323|NCT03181438|Acute pain|acute pain
997324|NCT03181438|Regional Anesthesia|regional anesthesia
997325|NCT03181438|TAP Block|tap block
997326|NCT03181425|Knee cartilage|knee cartilage
997327|NCT03181425|Early Osteoarthritis|early osteoarthritis
997328|NCT03181425|MRI tractography|mri tractography
997329|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
997330|NCT03181386|Dabigatran|dabigatran
997331|NCT03181386|Rivaroxaban|rivaroxaban
997332|NCT03181386|Apixaban|apixaban
997333|NCT03181386|Warfarin|warfarin
997334|NCT03181386|Tooth Extraction|tooth extraction
997335|NCT03181373|Craniocerebral injury|craniocerebral injury
997336|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
997337|NCT03181373|Neuropsychological abilities|neuropsychological abilities
997338|NCT03181373|Clinical assessment|clinical assessment
997339|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
997340|NCT03181360|ischemic stroke|ischemic stroke
997341|NCT03181360|wake-up|wake-up
997342|NCT03181360|thrombolysis|thrombolysis
997343|NCT03181360|tenecteplase|tenecteplase
997346|NCT03181347|Microbiology|microbiology
997347|NCT03181334|colorectal|colorectal
997348|NCT03181334|cancer|cancer
997349|NCT03181334|neoplasm|neoplasm
997350|NCT03181334|CRC screening|crc screening
997351|NCT03181334|FIT|fit
997352|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
997359|NCT03181295|Family Medicine|family medicine
997360|NCT03181295|Primary Care|primary care
997361|NCT03181295|Exercise prescriptions|exercise prescriptions
997362|NCT03181295|Technology|technology
997363|NCT03181282|Deep brain stimulation|deep brain stimulation
997364|NCT03181282|Balance|balance
997365|NCT03181282|Gait|gait
997366|NCT03181282|Physical Therapy|physical therapy
997367|NCT03181282|Parkinson disease|parkinson disease
997368|NCT03181230|Turner syndrome|turner syndrome
997369|NCT03181230|45,XO|45,xo
997370|NCT03181230|body composition|body composition
997371|NCT03181230|cardiometabolism|cardiometabolism
997372|NCT03181230|quality of life|quality of life
997373|NCT03181230|fitness|fitness
997374|NCT03181178|Complementary food supplement|complementary food supplement
997375|NCT03181178|Protein quality and linear growth|protein quality and linear growth
997376|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
997377|NCT03181165|Low-carbohydrate|low-carbohydrate
997378|NCT03181165|Low calorie|low calorie
997379|NCT03181165|Energy restricted|energy restricted
997380|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
997381|NCT03181139|Fast-track surgery|fast-track surgery
997382|NCT03181139|Pec Blocks|pec blocks
997383|NCT03181139|Mastectomy|mastectomy
997384|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
997385|NCT03181126|Cancer|cancer
997386|NCT03181126|Venetoclax|venetoclax
997387|NCT03181126|Navitoclax|navitoclax
997388|NCT03181113|peginterferon alpha|peginterferon alpha
997389|NCT03181113|HBeAg seroconversion|hbeag seroconversion
997390|NCT03181113|immune control|immune control
997391|NCT03181100|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
997392|NCT03181100|Anaplastic thyroid carcinoma|anaplastic thyroid carcinoma
997393|NCT03181100|ATC|atc
997394|NCT03181100|Poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
997395|NCT03181100|PDTC|pdtc
997396|NCT03181100|Nab-paclitaxel|nab-paclitaxel
997397|NCT03181100|Paclitaxel (protein bound)|paclitaxel (protein bound)
997398|NCT03181100|Abraxane|abraxane
997399|NCT03181100|ABI-007|abi-007
997400|NCT03181100|Paclitaxel|paclitaxel
997401|NCT03181100|Taxol|taxol
997402|NCT03181100|Vemurafenib|vemurafenib
997406|NCT03181100|Atezolizumab|atezolizumab
997407|NCT03181100|MPDL3280A|mpdl3280a
997408|NCT03181100|Bevacizumab|bevacizumab
997409|NCT03181100|Avastin|avastin
997410|NCT03181100|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
997411|NCT03181100|rhuMAb-VEGF|rhumab-vegf
997412|NCT03181100|BRAF|braf
997413|NCT03181100|BRAF inhibitor|braf inhibitor
997414|NCT03181100|MEK|mek
997415|NCT03181100|MEK inhibitor|mek inhibitor
997416|NCT03181100|Immunotherapy|immunotherapy
997417|NCT03181100|Targeted therapy|targeted therapy
997418|NCT03181087|Mesenchymal Stem Cells|mesenchymal stem cells
997419|NCT03181087|Cesarean Section|cesarean section
997420|NCT03181087|Uterine Scar|uterine scar
997421|NCT03181035|Oral Tongue Cancer|oral tongue cancer
997422|NCT03181035|Tumor Hypoxia|tumor hypoxia
997423|NCT03181022|Patient-Provider Communication|patient-provider communication
997424|NCT03181022|Motivational Interviewing|motivational interviewing
997425|NCT03181022|Medication Adherence|medication adherence
997426|NCT03181009|Oral Immunotherapy|oral immunotherapy
997427|NCT03181009|Omalizumab|omalizumab
997428|NCT03181009|OIT|oit
997429|NCT03181009|Xolair|xolair
997430|NCT03180996|FEVAR|fevar
997431|NCT03180996|Fenestrated|fenestrated
997432|NCT03180996|Endovascular|endovascular
997433|NCT03180996|AAA|aaa
997434|NCT03180996|Custom device|custom device
997435|NCT03180957|Dupuytren|dupuytren
997436|NCT03180957|adalimumab|adalimumab
997437|NCT03180957|anti TNF|anti tnf
997438|NCT03180957|phase II clinical trial|phase ii clinical trial
997439|NCT03180957|randomized controlled trial|randomized controlled trial
997440|NCT03180957|double-blind method|double-blind method
997441|NCT03180957|Dupuytren's|dupuytren's
997442|NCT03180957|Dupuytren's contracture|dupuytren's contracture
997443|NCT03180892|Iodine|iodine
997444|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
997445|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
997446|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
997447|NCT03180840|Fabry Disease|fabry disease
997448|NCT03180801|broad|broad
997449|NCT03180801|universal|universal
997450|NCT03180801|vaccine|vaccine
997451|NCT03180801|influenza|influenza
997452|NCT03180801|peptide|peptide
997453|NCT03180801|T cell|t cell
997454|NCT03180801|H1N1|h1n1
997455|NCT03180801|human challenge|human challenge
997456|NCT03180788|ESD|esd
997457|NCT03180788|Traction assisted ESD|traction assisted esd
997458|NCT03180788|Polypectomy|polypectomy
997459|NCT03180788|Clip and thread ESD|clip and thread esd
997460|NCT03180775|Amino acids|amino acids
997461|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
997462|NCT03180775|Triglycerides|triglycerides
997463|NCT03180775|Cholesterol|cholesterol
997464|NCT03180775|Lipoproteins|lipoproteins
997465|NCT03180697|Amide Proton Transfer|amide proton transfer
997466|NCT03180697|bevacizumab|bevacizumab
997467|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
997468|NCT03180697|efficacy|efficacy
997469|NCT03180684|HPV-16|hpv-16
997470|NCT03180684|HPV-18|hpv-18
997471|NCT03180671|anterior deprogrammer|anterior deprogrammer
997472|NCT03180671|muscle pain|muscle pain
997473|NCT03180671|centric relation|centric relation
997474|NCT03180606|Elderly|elderly
997475|NCT03180606|Frail|frail
997476|NCT03180606|Primary care|primary care
997477|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
997478|NCT03180554|Vagal nerve stimulation|vagal nerve stimulation
997479|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
997480|NCT03180554|chronic widespread pain|chronic widespread pain
997481|NCT03180554|parasympathetic nervous system|parasympathetic nervous system
997482|NCT03180554|heart rate variability|heart rate variability
997483|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
997484|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
997485|NCT03180450|Heart Failure|heart failure
997486|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
997487|NCT03180437|Immunotherapy|immunotherapy
997488|NCT03180437|γδ T Cell|γδ t cell
997489|NCT03180437|Pancreatic Cancer|pancreatic cancer
997490|NCT03180424|carnitine|carnitine
997491|NCT03180424|elderly|elderly
997492|NCT03180424|functional status|functional status
997493|NCT03180411|Colorectal Cancer|colorectal cancer
997494|NCT03180411|CRC|crc
997495|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
997496|NCT03180411|Decision support tool|decision support tool
997497|NCT03180411|Interviews|interviews
997498|NCT03180411|Questionnaire|questionnaire
997499|NCT03180411|Survey|survey
997500|NCT03180385|NAVA|nava
997501|NCT03180385|BiPAP|bipap
997502|NCT03180385|Pediatrics|pediatrics
997503|NCT03180385|Cardiac Surgery|cardiac surgery
997504|NCT03180359|solid transplant|solid transplant
997509|NCT03180359|solid transplant candidate children|solid transplant candidate children
997510|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
997511|NCT03180320|chronic heart failure|chronic heart failure
997512|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
997513|NCT03180320|Baduanjin|baduanjin
997514|NCT03180203|INTELLiVENT-ASV|intellivent-asv
1662629|NCT00133744|birthweight|birthweight
997515|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
997516|NCT03180203|Wean|wean
997517|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
997518|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
997519|NCT03180177|Interval Debulking Surgery|interval debulking surgery
997520|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
997521|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
997522|NCT03180151|corticotomy|corticotomy
997523|NCT03180151|enmass retraction|enmass retraction
997524|NCT03180151|mini implant|mini implant
997525|NCT03180138|mobile phone|mobile phone
997526|NCT03180138|Children's Health|children's health
997527|NCT03180125|hydrodissection|hydrodissection
997528|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
997529|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
997530|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
997531|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
997532|NCT03180086|Breast cancer risk|breast cancer risk
997533|NCT03180086|Primary Care|primary care
997534|NCT03180086|Women|women
997535|NCT03180060|Likelihood Ratio|likelihood ratio
997536|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
997538|NCT03180060|Myocardial Perfusion|myocardial perfusion
997539|NCT03180060|Predictive Values|predictive values
997540|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
997541|NCT03180060|CTP|ctp
997542|NCT03180060|SPECT|spect
997543|NCT03180060|PET|pet
997544|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
997545|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
997546|NCT03180060|Area Under the Curve|area under the curve
997547|NCT03180060|ROC Curve|roc curve
997553|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
997554|NCT03179943|bladder cancer|bladder cancer
997555|NCT03179943|Ureteral Cancer|ureteral cancer
997556|NCT03179943|Urothelial cancer|urothelial cancer
997557|NCT03179943|Urethral cancer|urethral cancer
997558|NCT03179930|Entinostat|entinostat
997559|NCT03179930|Pembrolizumab|pembrolizumab
997560|NCT03179930|17-073|17-073
997561|NCT03179917|Pembrolizumab|pembrolizumab
997562|NCT03179917|Radiation Therapy|radiation therapy
997563|NCT03179917|17-054|17-054
997564|NCT03179891|Interictal Period A|interictal period a
997565|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
997566|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
997567|NCT03179813|hydrocortisone|hydrocortisone
997568|NCT03179813|third molar|third molar
997569|NCT03179813|oral surgery|oral surgery
997570|NCT03179813|postoperative pain|postoperative pain
997571|NCT03179813|edema|edema
997572|NCT03179800|Hypertension|hypertension
997573|NCT03179800|Resistant Hypertension|resistant hypertension
997574|NCT03179800|Baroreceptor|baroreceptor
997575|NCT03179800|BAT|bat
997576|NCT03179722|Aging|aging
997577|NCT03179722|Drug-related problems|drug-related problems
997578|NCT03179722|Medication review|medication review
997579|NCT03179722|Community pharmacist|community pharmacist
997580|NCT03179722|Medication use|medication use
997581|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
997582|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
997583|NCT03179709|Interviews|interviews
997584|NCT03179709|Implementation Science|implementation science
997585|NCT03179696|Schizophrenia|schizophrenia
997586|NCT03179696|CBSST|cbsst
997587|NCT03179696|mobile CBT|mobile cbt
997588|NCT03179696|negative symptoms|negative symptoms
997589|NCT03179683|aluminum step-wedge|aluminum step-wedge
997590|NCT03179683|demineralized bone matrix|demineralized bone matrix
997591|NCT03179683|dental implant|dental implant
997592|NCT03179683|digital densitometry|digital densitometry
997593|NCT03179683|low level laser therapy|low level laser therapy
997594|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
997595|NCT03179657|Prospective Cohort study|prospective cohort study
997596|NCT03179657|Nutrition|nutrition
997597|NCT03179657|Diet|diet
997598|NCT03179657|Guangzhou|guangzhou
997599|NCT03179657|Chinese|chinese
997600|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
997601|NCT03179631|Dystrophinopathy|dystrophinopathy
997602|NCT03179631|Nonsense Mutation|nonsense mutation
997603|NCT03179631|Premature Stop Codon|premature stop codon
997604|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
997605|NCT03179631|DMD/BMD|dmd/bmd
997606|NCT03179631|PTC124|ptc124
997607|NCT03179631|Ataluren|ataluren
997608|NCT03179618|Unstable Angina|unstable angina
997609|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
997610|NCT03179592|Computed Tomography|computed tomography
997611|NCT03179579|Gastric Cancer|gastric cancer
997612|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
997613|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
997614|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
997615|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
997616|NCT03179566|drug disposal|drug disposal
997617|NCT03179540|Low Rectal Cancer|low rectal cancer
997618|NCT03179540|Complete Clinical Response|complete clinical response
997619|NCT03179540|Non-operative Management|non-operative management
997620|NCT03179527|Unstable Angina|unstable angina
997621|NCT03179527|Shuanghe Decoction|shuanghe decoction
997622|NCT03179514|Unstable Angina|unstable angina
997623|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
997624|NCT03179514|Danshen Decoction|danshen decoction
997625|NCT03179475|Spinal Cord Injury|spinal cord injury
997626|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
997627|NCT03179475|Targin®|targin®
997629|NCT03179475|Naloxone|naloxone
997630|NCT03179475|Opioid Induced Constipation|opioid induced constipation
997631|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
997632|NCT03179436|PD1|pd1
997633|NCT03179436|PD-1|pd-1
997634|NCT03179436|PDL1|pdl1
997635|NCT03179436|PD-L1|pd-l1
997636|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
997637|NCT03179423|T1D|t1d
997638|NCT03179423|Monoclonal antibody|monoclonal antibody
997639|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
997640|NCT03179423|Human Endogenous Retrovirus Type W (HERV-W)|human endogenous retrovirus type w (herv-w)
997641|NCT03179423|GNbAC1|gnbac1
997642|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
997643|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
997644|NCT03179345|Volunteer|volunteer
997645|NCT03179345|Pharmacodynamics|pharmacodynamics
997646|NCT03179345|Pharmacokinetics|pharmacokinetics
997647|NCT03179319|PrEP|prep
997648|NCT03179319|HIV testing|hiv testing
997649|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
997650|NCT03179319|Mobile app|mobile app
997651|NCT03179319|Young men who have sex with men|young men who have sex with men
997652|NCT03179319|Technology|technology
997653|NCT03179306|Cervix|cervix
997654|NCT03179306|HPV|hpv
997655|NCT03179306|Imaging|imaging
997656|NCT03179306|Costa Rica|costa rica
997657|NCT03179280|Type 1 diabetes|type 1 diabetes
997658|NCT03179280|Dual-wave bolus|dual-wave bolus
997659|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
997660|NCT03179267|vital signs|vital signs
997661|NCT03179267|monitoring|monitoring
997662|NCT03179267|early warning score|early warning score
997663|NCT03179202|Electrical Stimulation|electrical stimulation
997664|NCT03179202|Neurostimulation|neurostimulation
997665|NCT03179202|Neuromodulation|neuromodulation
997666|NCT03179202|Back Pain|back pain
997667|NCT03179202|Low Back Pain|low back pain
997668|NCT03179163|Hypertension|hypertension
997669|NCT03179163|Blood Pressure|blood pressure
997670|NCT03179163|Cardiovascular Disease|cardiovascular disease
997671|NCT03179163|ACE Inhibitor|ace inhibitor
997672|NCT03179163|Diuretic|diuretic
997673|NCT03179163|Nitric Oxide|nitric oxide
997674|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
997675|NCT03179163|Captopril|captopril
997676|NCT03179163|Enalapril|enalapril
997677|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
997678|NCT03179163|Microcirculation|microcirculation
997679|NCT03179163|Skin|skin
997680|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
997681|NCT03179150|Web|web
997682|NCT03179150|Cloud computing|cloud computing
997683|NCT03179150|lung cancer|lung cancer
997684|NCT03179124|cerebral palsy|cerebral palsy
997685|NCT03179124|trunk control|trunk control
997686|NCT03179124|upper extremity|upper extremity
997687|NCT03179098|Elbow|elbow
997688|NCT03179098|Stretching|stretching
997689|NCT03179098|Joint amplitude|joint amplitude
997690|NCT03179098|Electromyography|electromyography
997691|NCT03179098|Surface heat|surface heat
997692|NCT03179098|Orthosis|orthosis
997693|NCT03179098|Posttraumatic|posttraumatic
997694|NCT03179085|Diabetes|diabetes
997695|NCT03179085|American Indians|american indians
997696|NCT03179085|Disparity|disparity
997697|NCT03179085|microalbuminuria|microalbuminuria
997698|NCT03179085|Telemedicine|telemedicine
997699|NCT03179085|Community health representative (CHR)|community health representative (chr)
997700|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
997701|NCT03179085|Home base kidney care|home base kidney care
997702|NCT03179059|Reproductive Health|reproductive health
997703|NCT03179059|Family Planning|family planning
997704|NCT03179059|Randomization Trial|randomization trial
997705|NCT03179059|Uganda|uganda
997706|NCT03179033|LVAD|lvad
997707|NCT03179033|Passive leg raising|passive leg raising
997708|NCT03179020|Intensive Care Units|intensive care units
997709|NCT03179020|Brain Death|brain death
997710|NCT03179020|Organ Donation|organ donation
997711|NCT03179020|Family interview|family interview
997712|NCT03179007|MUC1|muc1
997713|NCT03179007|CTLA-4|ctla-4
997714|NCT03179007|PD-1|pd-1
997715|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
997716|NCT03179007|solid tumor|solid tumor
997717|NCT03178994|Post - adolescence acne|post - adolescence acne
997718|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
997719|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
997720|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
997721|NCT03178864|anticoagulation|anticoagulation
997722|NCT03178799|Fractures|fractures
997723|NCT03178799|Osteoporosis|osteoporosis
997724|NCT03178799|Care management|care management
997725|NCT03178799|cost-effeciveness|cost-effeciveness
997726|NCT03178799|Randomized controlled trial|randomized controlled trial
997727|NCT03178786|Art Therapy|art therapy
997728|NCT03178773|mobile health|mobile health
997729|NCT03178773|social support|social support
997730|NCT03178773|health disparity|health disparity
997731|NCT03178773|Latino|latino
997732|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
997733|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
997734|NCT03178747|Methylene blue|methylene blue
997735|NCT03178747|Giemsa|giemsa
997736|NCT03178747|Tzanck smear|tzanck smear
997737|NCT03178695|Infertility|infertility
997738|NCT03178695|Pregnancy|pregnancy
997739|NCT03178695|Menopause|menopause
997740|NCT03178695|Perimenopause|perimenopause
997741|NCT03178695|Premature Ovarian Failure|premature ovarian failure
997742|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
997743|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
997744|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
997745|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
997746|NCT03178669|Glucocorticoids|glucocorticoids
997747|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
997748|NCT03178669|Therapeutic uses|therapeutic uses
997749|NCT03178669|Kappaproct|kappaproct
997750|NCT03178669|IDX0150|idx0150
997751|NCT03178669|DIMS0150|dims0150
997752|NCT03178656|sorafenib, operation|sorafenib, operation
997753|NCT03178578|Fluid therapy|fluid therapy
997754|NCT03178565|Respiratory Failure|respiratory failure
997755|NCT03178565|Mechanical Ventilation|mechanical ventilation
997756|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
997757|NCT03178565|Airway mucus clearance|airway mucus clearance
997758|NCT03178539|tonsillectomy|tonsillectomy
997759|NCT03178539|post operative analgesia|post operative analgesia
997760|NCT03178539|diklofanic|diklofanic
997761|NCT03178539|ketorolac|ketorolac
997762|NCT03178500|clomiphene citrate|clomiphene citrate
997763|NCT03178500|stair- step|stair- step
997764|NCT03178500|poly cystic ovary|poly cystic ovary
997765|NCT03178487|Upadacitinib|upadacitinib
997766|NCT03178487|ABT-494|abt-494
997767|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
997768|NCT03178487|Safety|safety
997769|NCT03178487|Efficacy|efficacy
997770|NCT03178474|infant formula|infant formula
997771|NCT03178474|Clinical trial|clinical trial
997772|NCT03178474|Chinese infant|chinese infant
997773|NCT03178474|body growth|body growth
997774|NCT03178474|gut microbiota|gut microbiota
997775|NCT03178474|Stool characteristics|stool characteristics
997776|NCT03178461|Caesarean Section|caesarean section
997777|NCT03178461|Delivery|delivery
997778|NCT03178435|risk score|risk score
997779|NCT03178435|Acute kidney injury|acute kidney injury
997780|NCT03178435|critical care|critical care
997781|NCT03178422|tobacco use cessation|tobacco use cessation
997782|NCT03178422|smoking prevention|smoking prevention
997783|NCT03178422|NRT|nrt
997784|NCT03178370|Gastroparesis|gastroparesis
997785|NCT03178370|Nausea and Vomiting|nausea and vomiting
997786|NCT03178370|Abdominal Pain|abdominal pain
997787|NCT03178370|Gastric Emptying|gastric emptying
997788|NCT03178370|Electrophysiology|electrophysiology
997789|NCT03178370|Hormones|hormones
997790|NCT03178370|Inflammation|inflammation
997791|NCT03178370|Enteric Nervous System|enteric nervous system
997792|NCT03178370|Autonomic Nervous System|autonomic nervous system
997793|NCT03178331|Children|children
997794|NCT03178331|Student|student
997795|NCT03178331|Questionnaires|questionnaires
997796|NCT03178331|Screening|screening
997797|NCT03178331|Health check|health check
997798|NCT03178331|School health services|school health services
997799|NCT03178279|physical health|physical health
997800|NCT03178201|Relapsed follicular lymphoma|relapsed follicular lymphoma
997801|NCT03178201|Refractory follicular lymphoma|refractory follicular lymphoma
997997|NCT03176992|surgicel|surgicel
997802|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
997803|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
997804|NCT03178175|Scalp acupuncture|scalp acupuncture
997805|NCT03178175|Parkinson's disease|parkinson's disease
997807|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
997808|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
997809|NCT03178149|ASP7317|asp7317
997810|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
997811|NCT03178136|virus load|virus load
997812|NCT03178136|multi-site|multi-site
997813|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
997814|NCT03178123|Mucosal Melanoma|mucosal melanoma
997815|NCT03178123|Interferons|interferons
998118|NCT03176264|CRC|crc
997816|NCT03178110|physical therapy|physical therapy
997817|NCT03178110|cancer rehabilitation|cancer rehabilitation
997818|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
997819|NCT03178084|HIV|hiv
997820|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
997821|NCT03178084|immune recovery|immune recovery
997822|NCT03178084|maraviroc|maraviroc
997823|NCT03178084|efavirenz|efavirenz
997824|NCT03178071|NSCLC|nsclc
997825|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
997826|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
997827|NCT03177980|Term infants|term infants
997828|NCT03177980|Analgesia|analgesia
997829|NCT03177980|fentanyl|fentanyl
997830|NCT03177980|clonidine|clonidine
997831|NCT03177980|pharmacokinetics|pharmacokinetics
997832|NCT03177980|sedation|sedation
997833|NCT03177980|pharmacodynamics|pharmacodynamics
997834|NCT03177980|neurophysiology|neurophysiology
997835|NCT03177980|pharmacogenetics|pharmacogenetics
997836|NCT03177980|asphyxia|asphyxia
997837|NCT03177980|hypothermia|hypothermia
997838|NCT03177967|Insomnia|insomnia
997839|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
997840|NCT03177941|Melanoma|melanoma
997841|NCT03177941|Skin Self-Examination|skin self-examination
997842|NCT03177941|First-degree Relative|first-degree relative
997843|NCT03177941|Mobile Application|mobile application
997844|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
997845|NCT03177863|neoplasm|neoplasm
997846|NCT03177863|uterine cervix|uterine cervix
997847|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
997848|NCT03177850|respiratory polygraphy|respiratory polygraphy
997849|NCT03177850|airway disease|airway disease
997850|NCT03177850|emphysema|emphysema
997851|NCT03177850|acetazolamide|acetazolamide
997852|NCT03177850|altitude|altitude
997853|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
997854|NCT03177837|exercise performance|exercise performance
997855|NCT03177837|maximal spiroergometry|maximal spiroergometry
997856|NCT03177837|airway disease|airway disease
997857|NCT03177837|emphysema|emphysema
997858|NCT03177837|prevention|prevention
997859|NCT03177837|acetazolamide|acetazolamide
997860|NCT03177837|altitude|altitude
997861|NCT03177811|postural control|postural control
997862|NCT03177811|balance performance|balance performance
997863|NCT03177811|airway disease|airway disease
997864|NCT03177811|altitude|altitude
997865|NCT03177811|prevention|prevention
997866|NCT03177811|acetazolamide|acetazolamide
997867|NCT03177772|caregivers|caregivers
997868|NCT03177772|grief|grief
997869|NCT03177772|dementia|dementia
997870|NCT03177772|long-term care|long-term care
997871|NCT03177772|psychotherapy group|psychotherapy group
997872|NCT03177733|breast surgery|breast surgery
997873|NCT03177733|acute pain|acute pain
997874|NCT03177733|regional anesthesia|regional anesthesia
997875|NCT03177694|cough|cough
997876|NCT03177694|exacerbation|exacerbation
997877|NCT03177694|connected device|connected device
997878|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
997879|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
997880|NCT03177681|Probiotics|probiotics
997881|NCT03177681|Yogurt|yogurt
997882|NCT03177681|Stool sample|stool sample
997883|NCT03177681|Questionnaires|questionnaires
997884|NCT03177681|Surveys|surveys
997885|NCT03177681|Holter monitor|holter monitor
997886|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
997887|NCT03177629|Helicobacter pylori|helicobacter pylori
997888|NCT03177616|Migraine|migraine
997889|NCT03177616|Women|women
997890|NCT03177616|Adult|adult
997891|NCT03177616|Feasibility|feasibility
997892|NCT03177616|Safety|safety
997893|NCT03177616|Pilot Randomized Trial|pilot randomized trial
997894|NCT03177616|Randomized Control Trial|randomized control trial
997895|NCT03177616|Chiropractic|chiropractic
997896|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
997897|NCT03177603|Dose-escalation|dose-escalation
997898|NCT03177603|Safety|safety
997899|NCT03177603|Tolerability|tolerability
997900|NCT03177603|GSK2586881|gsk2586881
997901|NCT03177590|autism|autism
997905|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
997906|NCT03177551|Nomograms|nomograms
997907|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
997908|NCT03177538|suboptimal response|suboptimal response
997909|NCT03177538|Corifollitropin alfa|corifollitropin alfa
997911|NCT03177538|Ovarian stimulation|ovarian stimulation
997912|NCT03177525|parent training|parent training
997913|NCT03177525|social skills|social skills
997914|NCT03177512|PrEP|prep
997915|NCT03177512|HIV Testing|hiv testing
997916|NCT03177512|STI Testing|sti testing
997917|NCT03177512|Mobile app|mobile app
997918|NCT03177512|Technology|technology
997919|NCT03177512|Young men who have sex with men|young men who have sex with men
997920|NCT03177499|Portal pressure gradient|portal pressure gradient
998119|NCT03176264|MMS|mms
997921|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
997922|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
997923|NCT03177486|Syntax score|syntax score
997924|NCT03177486|Frank sign|frank sign
997925|NCT03177486|Coronary angiography|coronary angiography
997926|NCT03177473|degenerative disc disease|degenerative disc disease
997927|NCT03177473|CervicalStim devic|cervicalstim devic
997928|NCT03177473|cervical|cervical
997929|NCT03177473|cervical fusion|cervical fusion
997930|NCT03177460|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
997931|NCT03177460|Prostate Cancer|prostate cancer
997932|NCT03177460|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
997933|NCT03177460|High-risk|high-risk
997934|NCT03177460|Localized|localized
997935|NCT03177460|Daratumumab|daratumumab
997936|NCT03177460|Prostatectomy|prostatectomy
997937|NCT03177447|Cardiac Failure|cardiac failure
997938|NCT03177447|Congestive Heart Failure|congestive heart failure
997939|NCT03177447|Heart Decompensation|heart decompensation
997940|NCT03177447|Heart Failure, Congestive|heart failure, congestive
997941|NCT03177434|constipation|constipation
997942|NCT03177434|children|children
997943|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
997944|NCT03177434|lactulose|lactulose
997945|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
997946|NCT03177408|Hypertension|hypertension
997947|NCT03177408|HMGB1|hmgb1
997948|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
997949|NCT03177382|Rectal Cancer|rectal cancer
997950|NCT03177382|High Risk Factors|high risk factors
997951|NCT03177382|Chemoradiotherapy|chemoradiotherapy
997952|NCT03177369|Bone and joint infection|bone and joint infection
997953|NCT03177369|Staphylococcus aureus|staphylococcus aureus
997954|NCT03177369|Teicoplanin|teicoplanin
997955|NCT03177369|Subcutaneous administration|subcutaneous administration
997956|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
997957|NCT03177343|Pristinamycin|pristinamycin
997958|NCT03177343|Staphylococcus aureus|staphylococcus aureus
997959|NCT03177343|Bone and joint infection|bone and joint infection
997960|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
997961|NCT03177304|Internet|internet
997962|NCT03177304|Training|training
997963|NCT03177304|Depression|depression
997964|NCT03177304|Dissemination|dissemination
997965|NCT03177291|NSCLC|nsclc
997966|NCT03177291|SCLC|sclc
997967|NCT03177265|nicotine dependence|nicotine dependence
997968|NCT03177265|tobacco cessation|tobacco cessation
997969|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
997970|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
997971|NCT03177174|Toxic reaction|toxic reaction
997972|NCT03177161|PROM|prom
997973|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
997974|NCT03177161|PROMIS|promis
997975|NCT03177161|PROMIS-10|promis-10
997976|NCT03177161|PROMIS Global Health|promis global health
997977|NCT03177161|RiksStroke|riksstroke
997978|NCT03177161|ICHOM|ichom
997979|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
997980|NCT03177161|Wales|wales
997981|NCT03177161|Administration|administration
997982|NCT03177161|Method|method
997983|NCT03177161|Delivery|delivery
997984|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
997985|NCT03177122|Myo-Inositol|myo-inositol
997986|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
997987|NCT03177122|oocyte performance|oocyte performance
997988|NCT03177122|pregnancy|pregnancy
997992|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
997993|NCT03177070|Ureteric injury|ureteric injury
997994|NCT03177070|Colorectal Surgery|colorectal surgery
997995|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
997996|NCT03176992|ablation|ablation
997998|NCT03176953|PTSD|ptsd
997999|NCT03176953|alcohol use disorder|alcohol use disorder
998000|NCT03176953|Veterans|veterans
998001|NCT03176940|Escalating Dosage|escalating dosage
998002|NCT03176927|magnetogastrogram|magnetogastrogram
998003|NCT03176927|gastroparesis|gastroparesis
998004|NCT03176927|electrogastrogram|electrogastrogram
998005|NCT03176927|gastric slow wave|gastric slow wave
998006|NCT03176914|Community mobilisation|community mobilisation
998007|NCT03176901|urinary urge incontinence|urinary urge incontinence
998008|NCT03176901|urinary incontinence|urinary incontinence
998009|NCT03176901|older adult women|older adult women
998010|NCT03176901|older adults|older adults
998011|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
998012|NCT03176901|health enhancement program|health enhancement program
998013|NCT03176901|feasibility|feasibility
998014|NCT03176901|randomized controlled trial|randomized controlled trial
1019805|NCT03038776|vaccine|vaccine
998015|NCT03176901|complementary|complementary
998016|NCT03176901|integrative|integrative
998017|NCT03176901|therapies|therapies
998018|NCT03176888|Exercise|exercise
998019|NCT03176888|Aerobic capacity|aerobic capacity
998020|NCT03176888|Rehabilitation|rehabilitation
998021|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
998022|NCT03176810|optical coherence tomography|optical coherence tomography
998023|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
998024|NCT03176784|Varenicline|varenicline
998025|NCT03176784|Nicotine Patch|nicotine patch
998026|NCT03176784|Quit Smoking|quit smoking
998027|NCT03176784|Tobacco|tobacco
998028|NCT03176784|Cigarettes|cigarettes
998029|NCT03176732|Sleep Apnea|sleep apnea
998030|NCT03176732|Hypertension|hypertension
998031|NCT03176732|Positive Airway Pressure|positive airway pressure
998032|NCT03176732|Blood Pressure|blood pressure
998033|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
998034|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
998035|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
998036|NCT03176641|Meniscus|meniscus
998037|NCT03176641|Knee Injuries|knee injuries
998038|NCT03176628|Pharmacokinetics|pharmacokinetics
998039|NCT03176628|Pharmacodynamics|pharmacodynamics
998040|NCT03176615|Gastric Bypass|gastric bypass
998041|NCT03176602|Subjective Global Assessment|subjective global assessment
998042|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
998043|NCT03176602|Critical Illness|critical illness
998044|NCT03176589|positive expiratory pressure|positive expiratory pressure
998045|NCT03176589|oxygen saturation|oxygen saturation
998046|NCT03176589|abdominal surgery|abdominal surgery
998047|NCT03176589|carbon dioxide|carbon dioxide
998048|NCT03176576|cancer among adolescents|cancer among adolescents
998049|NCT03176576|cancer among young adults|cancer among young adults
998050|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
998051|NCT03176576|quality of life|quality of life
998052|NCT03176576|reduce stress|reduce stress
998053|NCT03176576|patient navigation|patient navigation
998054|NCT03176576|questionnaire|questionnaire
998055|NCT03176576|supportive care|supportive care
998056|NCT03176576|distress levels|distress levels
998057|NCT03176576|support resources|support resources
998058|NCT03176576|satisfaction survey|satisfaction survey
998059|NCT03176576|teen cancer|teen cancer
998060|NCT03176563|herbal treatment|herbal treatment
998061|NCT03176563|antibiotics|antibiotics
998062|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
998063|NCT03176511|older adults|older adults
998064|NCT03176511|dual task|dual task
998065|NCT03176511|A Matter of Balance|a matter of balance
998066|NCT03176498|cerebral Infarction|cerebral infarction
998067|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
998068|NCT03176485|metastatic|metastatic
998069|NCT03176485|melanoma|melanoma
998070|NCT03176485|cancer|cancer
998071|NCT03176485|colon|colon
998072|NCT03176485|thyroid|thyroid
998073|NCT03176485|Differentiated|differentiated
998074|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
998075|NCT03176485|HCC|hcc
998076|NCT03176485|RCC|rcc
998077|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
998078|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
998079|NCT03176472|Neuropathic Pain|neuropathic pain
998080|NCT03176472|HDAC6|hdac6
998081|NCT03176472|ricolinostat|ricolinostat
998082|NCT03176459|bupvacaine|bupvacaine
998083|NCT03176459|exparel|exparel
998084|NCT03176459|analgesic|analgesic
998085|NCT03176459|TAP Block|tap block
998086|NCT03176407|sensor capsule|sensor capsule
998087|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
998088|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
998089|NCT03176381|Abiraterone Acetate|abiraterone acetate
998090|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
998091|NCT03176381|Neurotensin|neurotensin
998092|NCT03176381|yes-associated protein 1|yes-associated protein 1
998093|NCT03176381|AKR1C3 protein|akr1c3 protein
998094|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
998095|NCT03176368|dry mouth|dry mouth
998096|NCT03176368|coconut oil|coconut oil
998097|NCT03176368|radiation|radiation
998098|NCT03176342|Drug patch tests|drug patch tests
998099|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
998100|NCT03176329|Critical care|critical care
998101|NCT03176316|ileus|ileus
998102|NCT03176316|fusion of spine|fusion of spine
998103|NCT03176277|Leukemia|leukemia
998104|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
998105|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
998106|NCT03176277|MER|mer
998107|NCT03176277|MERTK|mertk
998108|NCT03176277|TYRO3|tyro3
998109|NCT03176277|AXL|axl
998110|NCT03176277|AML|aml
998111|NCT03176277|de novo AML|de novo aml
998112|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
998113|NCT03176277|TAM|tam
998114|NCT03176264|PDR001|pdr001
998115|NCT03176264|immunotherapy|immunotherapy
998116|NCT03176264|bevacizumab|bevacizumab
998117|NCT03176264|mFOLFOX6|mfolfox6
998121|NCT03176264|ElevatION;CRC-101|elevation;crc-101
998122|NCT03176238|post menopausal|post menopausal
998123|NCT03176238|advanced breast cancer|advanced breast cancer
998124|NCT03176238|metastatic breast cancer|metastatic breast cancer
998125|NCT03176238|everolimus|everolimus
998126|NCT03176238|exemestane|exemestane
998127|NCT03176238|mTor inhibitor|mtor inhibitor
998128|NCT03176238|endocrine therapy|endocrine therapy
998129|NCT03176212|Gut permeability|gut permeability
998130|NCT03176212|Cytokine|cytokine
998131|NCT03176212|Endotoxin|endotoxin
998132|NCT03176199|control-released oxycodone|control-released oxycodone
998133|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
998134|NCT03176199|cancer pain|cancer pain
998135|NCT03176199|opioid-naive|opioid-naive
998136|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
998137|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
998138|NCT03176160|LITT|litt
998139|NCT03176160|Fecci|fecci
998140|NCT03176160|Pro00079623|pro00079623
998141|NCT03176160|Glioblastoma|glioblastoma
998142|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
998143|NCT03176160|Palliative|palliative
998144|NCT03176147|Anemia|anemia
998145|NCT03176147|Pregnancy|pregnancy
998146|NCT03176147|Hepcidine|hepcidine
998147|NCT03176147|Iron|iron
998148|NCT03176121|Oxycodone|oxycodone
998149|NCT03176121|Cancer Pain|cancer pain
998150|NCT03176121|Long-term use|long-term use
998151|NCT03176082|colorectal cancer screening|colorectal cancer screening
998152|NCT03176082|colorectal cancer|colorectal cancer
998153|NCT03176069|Vaginismus|vaginismus
998154|NCT03176069|Muscle Tone|muscle tone
998155|NCT03176069|Sexual dysfunctions|sexual dysfunctions
998156|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
998157|NCT03176056|Low carbohydrate diet|low carbohydrate diet
998158|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
998159|NCT03176017|Prostate|prostate
998160|NCT03176017|Holmium Laser|holmium laser
998161|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
998162|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
998163|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
998164|NCT03175939|NPC|npc
998165|NCT03175926|Asthma|asthma
998166|NCT03175926|inhaler device|inhaler device
998167|NCT03175926|handling|handling
998168|NCT03175900|Migraine|migraine
998169|NCT03175900|Naoan dripping pills|naoan dripping pills
998170|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
998171|NCT03175900|fMRI|fmri
998172|NCT03175900|Randomized Controlled trial|randomized controlled trial
998173|NCT03175887|depression|depression
998174|NCT03175887|trd|trd
998175|NCT03175887|treatment-resistant depression|treatment-resistant depression
998176|NCT03175887|TMS|tms
998177|NCT03175874|Osteoporosis|osteoporosis
998178|NCT03175874|Alzheimer Disease|alzheimer disease
998179|NCT03175848|Cervical Cancer|cervical cancer
998180|NCT03175848|Radiotherapy|radiotherapy
998181|NCT03175848|Chemotherapy|chemotherapy
998182|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
998183|NCT03175835|Dyslipidemia|dyslipidemia
998184|NCT03175835|CKD-519|ckd-519
998185|NCT03175835|Rosuvastatin|rosuvastatin
998186|NCT03175835|Drug-Drug Interaction|drug-drug interaction
998187|NCT03175809|Chronic pelvic pain|chronic pelvic pain
998188|NCT03175809|Pain|pain
998189|NCT03175809|Dry needling|dry needling
998190|NCT03175809|Biofeedback|biofeedback
998191|NCT03175809|Pelvic pain|pelvic pain
998192|NCT03175731|Esophageal and gastric varices|esophageal and gastric varices
998193|NCT03175731|Hemorrhage|hemorrhage
998194|NCT03175718|Sarcoma|sarcoma
998195|NCT03175718|Wound|wound
998196|NCT03175718|Therapy|therapy
998197|NCT03175627|Dental caries|dental caries
998198|NCT03175627|Proximal surfaces|proximal surfaces
998199|NCT03175627|Posterior teeth|posterior teeth
998200|NCT03175627|Carious lesions|carious lesions
998201|NCT03175627|Tooth diseases|tooth diseases
998202|NCT03175627|Dental restorations|dental restorations
998203|NCT03175627|Composite resin|composite resin
998204|NCT03175614|Physical activity|physical activity
998205|NCT03175614|Food Habits|food habits
998206|NCT03175614|Information and communiation Technology|information and communiation technology
998207|NCT03175614|Health education|health education
998208|NCT03175601|Sleep disturbances|sleep disturbances
998209|NCT03175601|Biomarkers|biomarkers
998210|NCT03175601|Prefrailty|prefrailty
998211|NCT03175601|Insulin resistance|insulin resistance
998212|NCT03175601|Olfactory impairment|olfactory impairment
998213|NCT03175601|Multiplex array|multiplex array
998214|NCT03175601|Gait speed|gait speed
998215|NCT03175536|high-deductible health plan|high-deductible health plan
998216|NCT03175536|medication adherence|medication adherence
998217|NCT03175536|out-of-pocket costs|out-of-pocket costs
998218|NCT03175536|preventive drug list|preventive drug list
998219|NCT03175536|value-based insurance design|value-based insurance design
998220|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
998221|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
998222|NCT03175523|Intravascular Imaging|intravascular imaging
998223|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
998224|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
998225|NCT03175484|High Fidelity Simulation|high fidelity simulation
998226|NCT03175484|Cognitive Load|cognitive load
998227|NCT03175484|Simulation Training/methods*|simulation training/methods*
998228|NCT03175484|Task Performance and Analysis*|task performance and analysis*
998229|NCT03175484|Students, Medical|students, medical
998230|NCT03175484|Prospective Studies|prospective studies
998231|NCT03175458|tenting|tenting
998232|NCT03175458|grafting|grafting
998233|NCT03175458|implant placement|implant placement
998234|NCT03175432|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
998235|NCT03175432|Untreated Melanoma Brain Metastases|untreated melanoma brain metastases
998236|NCT03175432|Bevacizumab|bevacizumab
998237|NCT03175432|rhuMA-VEGF|rhuma-vegf
998238|NCT03175432|Avastin|avastin
998239|NCT03175432|ANTI-VEGF monoclonal antibody|anti-vegf monoclonal antibody
998240|NCT03175432|Atezolizumab|atezolizumab
998241|NCT03175432|MPDL3280A|mpdl3280a
998242|NCT03175432|Questionnaires|questionnaires
998243|NCT03175432|Surveys|surveys
998244|NCT03175432|Neurocognitive Exam|neurocognitive exam
998245|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
998246|NCT03175341|breast cancer|breast cancer
998247|NCT03175341|ascorbic acid|ascorbic acid
998248|NCT03175341|vitamin C|vitamin c
998249|NCT03175341|vitamin supplementation|vitamin supplementation
998250|NCT03175341|quality of life|quality of life
998251|NCT03175315|psychoeducation|psychoeducation
998252|NCT03175315|treatment and education programme|treatment and education programme
998253|NCT03175315|self-management|self-management
998254|NCT03175315|diabetes education|diabetes education
998255|NCT03175315|flash glucose monitoring|flash glucose monitoring
998256|NCT03175302|cognitive processes|cognitive processes
998257|NCT03175302|perioperative cognition|perioperative cognition
998258|NCT03175302|neurocognitive impairment|neurocognitive impairment
998259|NCT03175276|Delirium|delirium
998260|NCT03175276|Cognitive decline|cognitive decline
998261|NCT03175276|IQCODE|iqcode
998262|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
998263|NCT03175224|Advanced Solid Tumor|advanced solid tumor
998264|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
998265|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
998266|NCT03175159|Risk Reduction|risk reduction
998267|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
998268|NCT03175159|Cocaine|cocaine
998269|NCT03175159|Stimulant Abuse|stimulant abuse
998270|NCT03175159|HIV|hiv
998271|NCT03175159|Behavioral Activation|behavioral activation
998272|NCT03175133|rehabilitation|rehabilitation
998273|NCT03175133|physical therapy|physical therapy
998274|NCT03175107|exergaming|exergaming
998275|NCT03175107|physiotherapy|physiotherapy
998276|NCT03175107|upper extremities|upper extremities
998277|NCT03175107|telerehabilitation|telerehabilitation
998278|NCT03175094|women|women
998279|NCT03175094|HIV prevention|hiv prevention
998280|NCT03175094|criminal justice|criminal justice
998281|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
998282|NCT03175081|Ropivacaine|ropivacaine
998283|NCT03175081|Postoperative pain|postoperative pain
998284|NCT03175081|Bariatric surgery|bariatric surgery
998285|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
998286|NCT03175068|Electroencephalography|electroencephalography
998287|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
998288|NCT03175068|Supportive Therapy|supportive therapy
998289|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
998290|NCT03174990|aspirin|aspirin
998291|NCT03174990|clopidogrel|clopidogrel
998292|NCT03174990|peripheral arterial disease|peripheral arterial disease
998293|NCT03174990|genetics|genetics
998386|NCT03174392|Multimodal|multimodal
998294|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
998296|NCT03174964|Pregnancy Rate|pregnancy rate
998297|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
998298|NCT03174951|IVIg|ivig
998299|NCT03174951|Pregnancy Rate|pregnancy rate
998300|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
998301|NCT03174912|EORTC|eortc
998302|NCT03174912|CUETO|cueto
998303|NCT03174912|bladder neoplasm|bladder neoplasm
998304|NCT03174912|disease progression|disease progression
998305|NCT03174912|recurrence|recurrence
998306|NCT03174886|tau|tau
998307|NCT03174886|neurofibrillary|neurofibrillary
998308|NCT03174886|degeneration|degeneration
998309|NCT03174886|primary progressive aphasia|primary progressive aphasia
998310|NCT03174886|agrammatic|agrammatic
998311|NCT03174886|tauopathy|tauopathy
998312|NCT03174886|immunotherapy|immunotherapy
998313|NCT03174886|immunization|immunization
998314|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
998315|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
998316|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
998317|NCT03174847|Primary aldosteronism|primary aldosteronism
998318|NCT03174847|Blood pressure|blood pressure
998319|NCT03174847|Adrenalectomy|adrenalectomy
998320|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
998321|NCT03174847|Cardiovascular|cardiovascular
998322|NCT03174847|Endothelial|endothelial
998323|NCT03174847|Renal|renal
998324|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
998325|NCT03174834|Clean Catch Urine|clean catch urine
998326|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
998327|NCT03174821|Diabetic nephropathy|diabetic nephropathy
998328|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
998329|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
998330|NCT03174756|Hypochlorous Acid|hypochlorous acid
998331|NCT03174756|Chlorhexidine|chlorhexidine
998332|NCT03174756|Antiplaque agents|antiplaque agents
998333|NCT03174756|Substantivity|substantivity
998334|NCT03174730|smoking|smoking
998335|NCT03174730|smartphone|smartphone
998336|NCT03174730|technology|technology
998337|NCT03174730|addiction|addiction
998338|NCT03174678|Dexmedetomidine|dexmedetomidine
998339|NCT03174678|child|child
998340|NCT03174678|premedication|premedication
998341|NCT03174678|emergence delirium|emergence delirium
998342|NCT03174678|dental treatment|dental treatment
998343|NCT03174626|caregiver|caregiver
998344|NCT03174626|stress management|stress management
998345|NCT03174600|Stroke|stroke
998346|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
998347|NCT03174600|Functional status|functional status
998348|NCT03174600|Mini mental test|mini mental test
998349|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
998350|NCT03174587|HLA-haplo-matching|hla-haplo-matching
998351|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
998352|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
998353|NCT03174535|Ischemic Stroke|ischemic stroke
998354|NCT03174535|Secondary Prevention|secondary prevention
998355|NCT03174535|Endpoint Events|endpoint events
998356|NCT03174535|Risk Assessment|risk assessment
998357|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
998358|NCT03174535|Registry Study|registry study
998359|NCT03174522|Autologous|autologous
998360|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
998361|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
998362|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
998363|NCT03174522|Revascularization|revascularization
998364|NCT03174522|Angiogenesis|angiogenesis
998365|NCT03174522|Vasculogenesis|vasculogenesis
998366|NCT03174522|Arteriogenesis|arteriogenesis
998367|NCT03174509|airway extubation|airway extubation
998368|NCT03174509|positive-pressure respiration|positive-pressure respiration
998369|NCT03174509|suction|suction
998370|NCT03174509|ventilator weaning|ventilator weaning
998371|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
998372|NCT03174457|Paediatric|paediatric
998373|NCT03174457|Invasive Candidiasis|invasive candidiasis
998374|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
998375|NCT03174457|Candidemia|candidemia
998376|NCT03174457|Aspergillosis|aspergillosis
998377|NCT03174457|Micafungin|micafungin
998378|NCT03174444|Chinese American|chinese american
998379|NCT03174444|Asian American|asian american
998380|NCT03174444|Colorectal cancer screening|colorectal cancer screening
998381|NCT03174444|Print materials|print materials
998382|NCT03174418|Optical coherence tomography|optical coherence tomography
998383|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
998384|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
998385|NCT03174392|Exercise|exercise
998393|NCT03174275|neoadjuvant induction|neoadjuvant induction
998394|NCT03174275|post-operative treatment|post-operative treatment
998395|NCT03174262|Ergonomics|ergonomics
998396|NCT03174262|Computer Workstation|computer workstation
998397|NCT03174262|Habit|habit
998398|NCT03174262|Self-efficacy|self-efficacy
998399|NCT03174262|Knowledge|knowledge
998400|NCT03174249|Behavioural therapy|behavioural therapy
998401|NCT03174249|Exposure in vivo|exposure in vivo
998402|NCT03174249|Cortical reorganisation|cortical reorganisation
998403|NCT03174249|Mirror therapy|mirror therapy
998404|NCT03174210|COPD|copd
998405|NCT03174210|supplemental oxygen|supplemental oxygen
998406|NCT03174210|oxygen concentrator|oxygen concentrator
998407|NCT03174197|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
998408|NCT03174197|Glioblastoma (GBM)|glioblastoma (gbm)
998410|NCT03174197|Gliosarcoma|gliosarcoma
998411|NCT03174197|Temozolomide|temozolomide
998412|NCT03174197|Temodar|temodar
998413|NCT03174197|TMZ|tmz
998414|NCT03174197|Atezolizumab|atezolizumab
998415|NCT03174197|MPDL3280A|mpdl3280a
998416|NCT03174197|Radiation therapy|radiation therapy
998417|NCT03174197|External beam|external beam
998419|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
998420|NCT03174158|text messaging|text messaging
998421|NCT03174093|Mobile Health|mobile health
998422|NCT03174080|Positron-Emission|positron-emission
998423|NCT03174080|PET Scan Tomography|pet scan tomography
998424|NCT03174067|buprenorphine|buprenorphine
998425|NCT03174067|emergency department|emergency department
998426|NCT03174054|Men aged 40 and over|men aged 40 and over
998427|NCT03174054|multi parametric MRI|multi parametric mri
998428|NCT03174015|Sanitation|sanitation
998429|NCT03174015|Demand|demand
998430|NCT03174015|Peri-urban|peri-urban
998431|NCT03174015|Behavior Change|behavior change
998432|NCT03174015|Lusaka|lusaka
998433|NCT03174015|Zambia|zambia
998434|NCT03174002|Oxygenation|oxygenation
998435|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
998436|NCT03174002|Mechanical ventilation|mechanical ventilation
998437|NCT03174002|Critical illness|critical illness
998438|NCT03174002|Critical care|critical care
998439|NCT03173989|osteoarthritis|osteoarthritis
998440|NCT03173989|hand deformities|hand deformities
998441|NCT03173989|hand strength|hand strength
998442|NCT03173989|assistive technology|assistive technology
998443|NCT03173989|exercise|exercise
998444|NCT03173989|health education|health education
998450|NCT03173950|Immunotherapy|immunotherapy
998451|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
998452|NCT03173950|Brain Tumors|brain tumors
998453|NCT03173950|MDASI-BT|mdasi-bt
998454|NCT03173950|Spinal Cord Tumors|spinal cord tumors
998455|NCT03173937|Haploidentical|haploidentical
998456|NCT03173937|Nonmyeloablative|nonmyeloablative
998457|NCT03173924|Small Molecule|small molecule
998458|NCT03173924|Radiolabeled|radiolabeled
998459|NCT03173924|PSA|psa
998460|NCT03173924|Diagnostic|diagnostic
998461|NCT03173924|PMSA|pmsa
998462|NCT03173911|Balance|balance
998463|NCT03173911|Postural control|postural control
998464|NCT03173911|Elastic Bandages|elastic bandages
998465|NCT03173911|Force plate|force plate
998466|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
998467|NCT03173872|Reiki|reiki
998468|NCT03173872|Chronic Pain|chronic pain
998469|NCT03173872|Military|military
998470|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
998471|NCT03173846|neurofeedback|neurofeedback
998472|NCT03173846|episodic memory|episodic memory
998473|NCT03173846|real-time functional MRI|real-time functional mri
998474|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
998475|NCT03173820|tacrolimus|tacrolimus
998476|NCT03173820|transplantation|transplantation
998477|NCT03173820|CYP3A5|cyp3a5
998478|NCT03173820|genotype|genotype
998479|NCT03173768|intravenous antibiotics|intravenous antibiotics
998480|NCT03173768|appropriateness|appropriateness
998481|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
998482|NCT03173716|DEFINITY contrast|definity contrast
998483|NCT03173677|Mononuclear cells|mononuclear cells
998484|NCT03173677|Whey proteins|whey proteins
998485|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
998486|NCT03173677|Macrophage Polarization|macrophage polarization
998488|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
998489|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
998490|NCT03173638|intravitreal injection|intravitreal injection
998491|NCT03173638|safety|safety
998492|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
998493|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
998495|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
998496|NCT03173560|lenvatinib|lenvatinib
998497|NCT03173560|everolimus|everolimus
998498|NCT03173560|E7080|e7080
998499|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
998500|NCT03173508|right ventricular function|right ventricular function
998501|NCT03173508|echocardiography|echocardiography
998502|NCT03173508|obstructive airway disease|obstructive airway disease
998503|NCT03173508|emphysema|emphysema
998504|NCT03173508|acetazolamide|acetazolamide
998505|NCT03173508|altitude|altitude
998506|NCT03173495|fat metabolism|fat metabolism
998507|NCT03173495|fructose|fructose
998508|NCT03173495|exercise|exercise
998509|NCT03173456|acute pain|acute pain
998510|NCT03173456|musculoskeletal pain|musculoskeletal pain
998511|NCT03173456|emergency medicine|emergency medicine
998512|NCT03173456|Emergency Service, Hospital|emergency service, hospital
998513|NCT03173456|analgesics|analgesics
998514|NCT03173456|Acetaminophen|acetaminophen
998515|NCT03173456|Ibuprofen|ibuprofen
998516|NCT03173456|oxycodone|oxycodone
998517|NCT03173456|hydrocodone|hydrocodone
998518|NCT03173456|codeine|codeine
998519|NCT03173456|adult|adult
998520|NCT03173443|Fiberoptic intubation|fiberoptic intubation
998521|NCT03173443|double lumen tube|double lumen tube
998522|NCT03173391|GKA|gka
998523|NCT03173391|T2DM|t2dm
998524|NCT03173391|HMS5552|hms5552
998525|NCT03173391|mono therapy|mono therapy
998526|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
998529|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
998530|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
998531|NCT03173352|Hemangioma|hemangioma
998532|NCT03173339|intubation|intubation
998533|NCT03173339|pharyngitis|pharyngitis
998534|NCT03173339|remifentanil|remifentanil
998535|NCT03173313|Hypothermia|hypothermia
998536|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
998537|NCT03173313|AMI|ami
998538|NCT03173313|PCI|pci
998539|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
998540|NCT03173300|PMM2-CDG|pmm2-cdg
998541|NCT03173300|CDG-Ia|cdg-ia
998542|NCT03173287|Hepatic fibrosis|hepatic fibrosis
998543|NCT03173287|IVIM|ivim
998544|NCT03173287|1.5T MRI|1.5t mri
998545|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
998546|NCT03173248|Leukemia|leukemia
998547|NCT03173248|Azacitidine|azacitidine
998548|NCT03173248|AG-120|ag-120
998549|NCT03173248|ivosidenib|ivosidenib
998550|NCT03173209|school|school
998551|NCT03173196|severe sepsis|severe sepsis
998552|NCT03173196|encephalopathy|encephalopathy
998553|NCT03173170|Drug Therapy|drug therapy
998554|NCT03173144|Life Style|life style
998555|NCT03173144|Diet|diet
998556|NCT03173144|Food|food
998557|NCT03173144|Exercise|exercise
998558|NCT03173144|Treatment Outcome|treatment outcome
998559|NCT03173144|Biomarkers|biomarkers
998560|NCT03173144|Smoking|smoking
998561|NCT03173105|Visually Impaired Persons|visually impaired persons
998562|NCT03173105|Postural Balance|postural balance
998563|NCT03173105|Rehabilitation|rehabilitation
998564|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
998565|NCT03173092|Drug therapy|drug therapy
998566|NCT03173053|S. aureus|s. aureus
998567|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
998568|NCT03173053|Intestinal failure|intestinal failure
998569|NCT03173053|Eradication|eradication
998570|NCT03173053|Decolonization|decolonization
998571|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
998572|NCT03173040|Niu Bang Zi pill|niu bang zi pill
998573|NCT03173040|methotrexate|methotrexate
998574|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
998575|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
998576|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
998577|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
998578|NCT03172988|Surgery|surgery
998579|NCT03172988|Dexamethasone|dexamethasone
998580|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
998581|NCT03172988|Long-term survival|long-term survival
998582|NCT03172975|Controlled infection|controlled infection
998583|NCT03172975|Na-GST-1|na-gst-1
998584|NCT03172975|Hookworm vaccine|hookworm vaccine
998585|NCT03172936|injected lesion|injected lesion
998586|NCT03172936|distal lesion|distal lesion
998587|NCT03172936|abscopal activity|abscopal activity
998588|NCT03172936|intratumoral|intratumoral
998786|NCT03171532|ACL|acl
998589|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
998590|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
998591|NCT03172936|programmed cell death|programmed cell death
998592|NCT03172910|PER977|per977
998593|NCT03172910|Ciraparantag|ciraparantag
998594|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
998595|NCT03172910|Rivaroxaban|rivaroxaban
998596|NCT03172897|Adult|adult
998597|NCT03172897|Intensive care unit|intensive care unit
998598|NCT03172897|Mechanical ventilation|mechanical ventilation
998599|NCT03172897|Delirium|delirium
998600|NCT03172897|Dexmedetomidine|dexmedetomidine
998601|NCT03172884|Renal Impairment|renal impairment
998602|NCT03172884|Pharmacokinetics|pharmacokinetics
998603|NCT03172884|Hepatic impairment|hepatic impairment
998604|NCT03172871|Schizophrenia|schizophrenia
998605|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
998606|NCT03172871|Acute treatment|acute treatment
998607|NCT03172858|cervical ripening|cervical ripening
998608|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
998609|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
998610|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
998611|NCT03172845|optical coherence tomography|optical coherence tomography
998612|NCT03172845|vulnerable plaque|vulnerable plaque
998613|NCT03172793|telavancin|telavancin
998614|NCT03172793|lipoglycopeptide|lipoglycopeptide
998615|NCT03172793|MRSA|mrsa
998616|NCT03172793|pharmacokinetics|pharmacokinetics
998617|NCT03172767|Preterm|preterm
998618|NCT03172767|Sensory processing|sensory processing
998619|NCT03172767|School Readiness|school readiness
998620|NCT03172741|Cannabis|cannabis
998621|NCT03172715|Open reduction internal fixation|open reduction internal fixation
998622|NCT03172715|Arthroplasty|arthroplasty
998623|NCT03172715|Surgery|surgery
998624|NCT03172715|Randomized controlled trial|randomized controlled trial
998625|NCT03172663|obesity|obesity
998626|NCT03172624|Nivolumab|nivolumab
998627|NCT03172624|Ipilimumab|ipilimumab
998628|NCT03172624|17-219|17-219
998629|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
998630|NCT03172572|pancreas surgery|pancreas surgery
998631|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
998632|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
998633|NCT03172559|SBRT|sbrt
998634|NCT03172559|Radiotherapy|radiotherapy
998635|NCT03172559|Bridging therapy|bridging therapy
998636|NCT03172559|Transplant|transplant
998637|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
998638|NCT03172546|hemorrhagic complication|hemorrhagic complication
998639|NCT03172546|thrombotic complication|thrombotic complication
998640|NCT03172546|genetic polymorphisms|genetic polymorphisms
998641|NCT03172533|anorexia nervosa|anorexia nervosa
998642|NCT03172533|estrogen|estrogen
998643|NCT03172533|psychotherapy|psychotherapy
998644|NCT03172533|cortisol|cortisol
998645|NCT03172533|appetite regulation|appetite regulation
998646|NCT03172533|neurocognitive performance|neurocognitive performance
998647|NCT03172533|eating disorder|eating disorder
998648|NCT03172533|sexual hormone|sexual hormone
998649|NCT03172520|Parotidectomy|parotidectomy
998650|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
998651|NCT03172442|Class III treatment|class iii treatment
998652|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
998653|NCT03172442|RCT|rct
998654|NCT03172429|pulmonary hypertension|pulmonary hypertension
998655|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
998656|NCT03172429|disease progression|disease progression
998657|NCT03172429|hypoxia|hypoxia
998658|NCT03172416|Gastric Cancer|gastric cancer
998659|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
998660|NCT03172416|Oxaliplatin|oxaliplatin
998661|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
998662|NCT03172403|Cachexia|cachexia
998663|NCT03172403|Colon cancer|colon cancer
998664|NCT03172403|Myostatin|myostatin
998665|NCT03172403|Skeletal muscle|skeletal muscle
998666|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
998667|NCT03172390|Aortic wall shear stress|aortic wall shear stress
998668|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
998669|NCT03172390|Aortic dissection|aortic dissection
998670|NCT03172377|adalimumab|adalimumab
998671|NCT03172377|anti-TNF|anti-tnf
998672|NCT03172377|Humira|humira
998673|NCT03172377|interval lengthening|interval lengthening
998674|NCT03172377|dosing interval|dosing interval
998675|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
998676|NCT03172377|antidrug antibodies|antidrug antibodies
998677|NCT03172377|trough levels|trough levels
998678|NCT03172377|pharmacokinetics|pharmacokinetics
998679|NCT03172377|immunogenicity|immunogenicity
998680|NCT03172377|cost-effectiveness|cost-effectiveness
998681|NCT03172377|dose reduction|dose reduction
998682|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
998683|NCT03172312|total thyroidectomy|total thyroidectomy
998684|NCT03172312|thyroid cancer|thyroid cancer
998685|NCT03172312|hypoparathyroidism|hypoparathyroidism
998686|NCT03172312|prediction|prediction
998687|NCT03172273|Liver Cirrhosis|liver cirrhosis
998688|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
998689|NCT03172273|Refractory ascites|refractory ascites
998690|NCT03172247|cardiology diabetes|cardiology diabetes
998691|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
998692|NCT03172221|malaria|malaria
998693|NCT03172221|pregnancy|pregnancy
998694|NCT03172221|diagnosis|diagnosis
998695|NCT03172221|low-transmission|low-transmission
998696|NCT03172221|Plasmodium falciparum|plasmodium falciparum
998697|NCT03172221|rapid diagnostic test|rapid diagnostic test
998698|NCT03172195|ulcerative colitis|ulcerative colitis
998699|NCT03172195|inflammation|inflammation
998700|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
998701|NCT03172195|herpesvirus|herpesvirus
998702|NCT03172195|qPCR|qpcr
998703|NCT03172195|colonic mucosa|colonic mucosa
998704|NCT03172156|NSCLC|nsclc
998705|NCT03172156|stage I|stage i
1662630|NCT00133744|preterm|preterm
998706|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
998707|NCT03172156|ctDNA|ctdna
998708|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
998709|NCT03172130|CPAP|cpap
998710|NCT03172091|Lung transplant|lung transplant
998711|NCT03172091|Acute resection|acute resection
998712|NCT03172091|Volatile Organic Compounds|volatile organic compounds
998713|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
998714|NCT03172078|ERCP|ercp
998715|NCT03172078|EUS|eus
998716|NCT03172078|target-controlled infusion|target-controlled infusion
998717|NCT03172078|sedation|sedation
998718|NCT03172078|propofol|propofol
998719|NCT03172039|hemodialysis|hemodialysis
998720|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
998721|NCT03172039|antimicrobial agents|antimicrobial agents
998722|NCT03172039|bacterial infections|bacterial infections
999216|NCT03168685|actigraph|actigraph
998723|NCT03172039|ambulatory care|ambulatory care
998724|NCT03172026|Telerehabilitation|telerehabilitation
998725|NCT03172026|Maraviroc|maraviroc
998726|NCT03171987|lidocaine patch|lidocaine patch
998727|NCT03171987|flurbiprofen patch|flurbiprofen patch
998728|NCT03171987|acute back pain|acute back pain
998729|NCT03171974|breast capsular contructure|breast capsular contructure
998730|NCT03171961|weight loss|weight loss
998731|NCT03171961|Diet|diet
998732|NCT03171961|online visit|online visit
998733|NCT03171961|clinic visit|clinic visit
998734|NCT03171948|almond|almond
998735|NCT03171948|weight loss|weight loss
998736|NCT03171948|Weight maintenance|weight maintenance
998737|NCT03171948|hypoenergetic diet|hypoenergetic diet
998738|NCT03171922|weight loss|weight loss
998739|NCT03171922|internet-based diet|internet-based diet
998740|NCT03171922|online dietary coach|online dietary coach
998741|NCT03171922|clinic visit approach|clinic visit approach
998742|NCT03171922|Diet|diet
998743|NCT03171792|Musculoskeletal pain|musculoskeletal pain
998744|NCT03171792|Adolescent|adolescent
998745|NCT03171792|Qualitative research|qualitative research
998746|NCT03171792|Attitude|attitude
998747|NCT03171792|Health professionals|health professionals
998748|NCT03171740|Emergence Delirium|emergence delirium
998749|NCT03171740|Emergence Agitation|emergence agitation
998750|NCT03171740|premedication|premedication
998751|NCT03171740|dexmedetomidine|dexmedetomidine
998752|NCT03171740|midazolam|midazolam
998753|NCT03171714|Drainage Catheter|drainage catheter
998754|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
998755|NCT03171688|cesarean|cesarean
998756|NCT03171688|risk factors|risk factors
998757|NCT03171675|Chronic Periodontitis|chronic periodontitis
998758|NCT03171675|Preterm Labor|preterm labor
998759|NCT03171675|Preterm Birth|preterm birth
998760|NCT03171675|Interleukin-17|interleukin-17
998761|NCT03171675|IL-17|il-17
998762|NCT03171675|Periodontal Disease|periodontal disease
998763|NCT03171675|Periodontitis|periodontitis
998764|NCT03171675|Periodontal risk factors|periodontal risk factors
998765|NCT03171675|Medical risk factors|medical risk factors
998766|NCT03171649|rehabilitation|rehabilitation
998767|NCT03171649|exoskeleton|exoskeleton
998768|NCT03171649|functional electrical stimulation|functional electrical stimulation
998769|NCT03171649|upper limb|upper limb
998770|NCT03171649|sub-acute|sub-acute
998771|NCT03171649|motor re-learning|motor re-learning
998772|NCT03171623|T2DM|t2dm
998773|NCT03171623|Diabetes|diabetes
998774|NCT03171623|GKA|gka
998775|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
998776|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
998777|NCT03171610|sufentanil|sufentanil
998778|NCT03171610|fentanyl|fentanyl
998779|NCT03171597|Unstable Angina|unstable angina
998780|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
998781|NCT03171571|eating Behavior|eating behavior
998782|NCT03171571|Volunteers|volunteers
998783|NCT03171545|Peer Mentoring|peer mentoring
998784|NCT03171545|Team Training|team training
998785|NCT03171545|Checklist|checklist
998787|NCT03171519|Physical activity|physical activity
998788|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
998789|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
998790|NCT03171519|Acupuncture|acupuncture
998791|NCT03171506|ketogenic diet|ketogenic diet
998792|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
998793|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
998794|NCT03171480|Preeclampsia|preeclampsia
998795|NCT03171480|Induction|induction
998796|NCT03171454|hysteroscopic operation|hysteroscopic operation
998797|NCT03171454|intrauterine balloon|intrauterine balloon
998798|NCT03171454|adhesions|adhesions
998799|NCT03171415|Obesity|obesity
998800|NCT03171415|Overweight|overweight
998801|NCT03171415|Thermogenesis|thermogenesis
998802|NCT03171415|Fat reduction|fat reduction
998803|NCT03171389|GIST|gist
998804|NCT03171389|KIT secondary mutation|kit secondary mutation
998805|NCT03171389|ponatinib|ponatinib
998806|NCT03171376|Root canal treatment|root canal treatment
998807|NCT03171376|Coronal leakage|coronal leakage
998808|NCT03171376|Intraorifice barrier|intraorifice barrier
998809|NCT03171363|Attention bias modification treatment|attention bias modification treatment
998810|NCT03171363|Anxiety disorders|anxiety disorders
998811|NCT03171363|Attention training|attention training
998812|NCT03171337|Chronic tension-type headache|chronic tension-type headache
998813|NCT03171337|Acupuncture|acupuncture
998814|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
998815|NCT03171337|fMRI|fmri
998816|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
998817|NCT03171246|dietary intervention|dietary intervention
998818|NCT03171220|Neoantigen|neoantigen
998819|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
998820|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
998821|NCT03171220|Advanced Solid Tumor|advanced solid tumor
998822|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
999217|NCT03168685|tracking|tracking
998823|NCT03171220|PD-1 antibody|pd-1 antibody
998824|NCT03171220|SHR1210|shr1210
998825|NCT03171207|Gait Therapy|gait therapy
998826|NCT03171194|Lupus|lupus
998827|NCT03171194|Stem Cell|stem cell
998828|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
998829|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
998830|NCT03171168|Gait Analysis|gait analysis
998831|NCT03171168|WOMAC|womac
998832|NCT03171168|SF-36|sf-36
998833|NCT03171142|Heliox|heliox
998834|NCT03171129|Respiratory Distress|respiratory distress
998835|NCT03171129|Nasal CPAP|nasal cpap
998836|NCT03171129|high flow nasal canula|high flow nasal canula
998837|NCT03171116|ghrelin|ghrelin
998838|NCT03171116|obestatin|obestatin
998839|NCT03171116|children|children
998840|NCT03171064|Exercise|exercise
998841|NCT03171064|Cancer|cancer
998842|NCT03171064|Melanoma|melanoma
998843|NCT03171064|Feasibility|feasibility
998844|NCT03171064|PD-1 antibodies|pd-1 antibodies
998845|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
998846|NCT03171064|Immune system|immune system
998847|NCT03171038|Telemonitoring|telemonitoring
998848|NCT03171038|Chronic Heart Failure|chronic heart failure
998849|NCT03171038|eHealth|ehealth
998850|NCT03171038|Mortality|mortality
998851|NCT03171025|Muscle Invasive|muscle invasive
998852|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
998853|NCT03170999|China|china
998854|NCT03170999|Cognitive testing|cognitive testing
998855|NCT03170999|COPD exacerbation|copd exacerbation
998856|NCT03170999|CERT|cert
998857|NCT03170973|Obesity|obesity
998858|NCT03170973|Motor Activity|motor activity
998859|NCT03170973|Fatty acids|fatty acids
998860|NCT03170973|Lipid|lipid
998861|NCT03170960|Kidney|kidney
998862|NCT03170960|Bladder|bladder
998863|NCT03170960|Renal pelvis|renal pelvis
998864|NCT03170960|Ureter|ureter
998865|NCT03170960|Urethra|urethra
998866|NCT03170960|Cancer|cancer
998867|NCT03170960|Prostate|prostate
998868|NCT03170960|Castration-resistant|castration-resistant
998869|NCT03170960|Lung|lung
998870|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
998871|NCT03170947|Foot|foot
998872|NCT03170947|Insoles|insoles
998873|NCT03170947|Quality of life|quality of life
998874|NCT03170947|Physical Activity|physical activity
998875|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
998876|NCT03170882|Drug therapy|drug therapy
998877|NCT03170778|Congenital Heart Disease|congenital heart disease
998879|NCT03170778|Fontan|fontan
998880|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
998881|NCT03170739|dexmedetomidine|dexmedetomidine
998882|NCT03170739|dopamine|dopamine
998883|NCT03170739|surgery|surgery
998884|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
998885|NCT03170726|Intraoperative analgesia|intraoperative analgesia
998886|NCT03170726|Third molar tooth surgery|third molar tooth surgery
998887|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
998888|NCT03170713|trismus|trismus
998889|NCT03170713|edema|edema
998890|NCT03170713|Third molar tooth extraction|third molar tooth extraction
998891|NCT03170713|Antiinflammatory effect|antiinflammatory effect
998892|NCT03170700|preschool|preschool
998893|NCT03170700|eating behaviors|eating behaviors
998894|NCT03170700|family|family
998895|NCT03170648|Acupuncture|acupuncture
998896|NCT03170648|Breast Cancer|breast cancer
998897|NCT03170635|recess, occupational therapy|recess, occupational therapy
998898|NCT03170622|children|children
998899|NCT03170622|paediatrics|paediatrics
998900|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
998901|NCT03170622|diagnosis|diagnosis
998902|NCT03170622|pathogenesis|pathogenesis
998903|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
998904|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
998905|NCT03170570|re-irradiation|re-irradiation
998906|NCT03170570|intensity-modulated raditherapy|intensity-modulated raditherapy
1020925|NCT03032016|VOD|vod
998907|NCT03170557|Persistent pain|persistent pain
998908|NCT03170557|Spinal cord injury|spinal cord injury
998909|NCT03170557|Acupuncture|acupuncture
998910|NCT03170557|Randomized Controlled Trial|randomized controlled trial
998911|NCT03170557|RCT|rct
998912|NCT03170531|MRI|mri
998913|NCT03170531|MR imaging|mr imaging
998914|NCT03170531|17-267|17-267
998915|NCT03170505|cleft palate|cleft palate
998916|NCT03170466|Palliative care|palliative care
998917|NCT03170453|Autism|autism
998918|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
998919|NCT03170453|Asperger's Syndrome|asperger's syndrome
998920|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
998921|NCT03170453|Cognition|cognition
998922|NCT03170453|Social Cognition|social cognition
998923|NCT03170453|Psychosocial Treatment|psychosocial treatment
998924|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
998925|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
998926|NCT03170453|Therapy|therapy
998927|NCT03170453|Psychotherapy|psychotherapy
998928|NCT03170440|Sleep|sleep
998929|NCT03170440|Vagal nerve stimulation|vagal nerve stimulation
998930|NCT03170414|HIV|hiv
998931|NCT03170414|Kidney Transplant|kidney transplant
998932|NCT03170414|Liver Transplant|liver transplant
998933|NCT03170414|Transplant|transplant
998934|NCT03170414|HOPE Act|hope act
998935|NCT03170375|obesity|obesity
998936|NCT03170375|sodium|sodium
998937|NCT03170375|DASH diet|dash diet
998938|NCT03170375|hypertension|hypertension
998939|NCT03170375|vascular stiffness|vascular stiffness
998940|NCT03170375|diastolic function|diastolic function
998941|NCT03170362|Treatment|treatment
998942|NCT03170362|Pharmacogenetics|pharmacogenetics
998943|NCT03170362|Depression|depression
998944|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
998945|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
998946|NCT03170271|Asthma|asthma
998947|NCT03170271|Inflammation|inflammation
998948|NCT03170271|Bronchial Diseases|bronchial diseases
998949|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
998950|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
998951|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
998952|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
998953|NCT03170271|Hypersensitivity|hypersensitivity
998954|NCT03170271|Immune System Diseases|immune system diseases
998955|NCT03170271|Pathologic Processes|pathologic processes
998956|NCT03170258|real-time fMRI|real-time fmri
998957|NCT03170258|reward|reward
998958|NCT03170258|motivation|motivation
998959|NCT03170258|dopamine|dopamine
998960|NCT03170258|EEG|eeg
998961|NCT03170232|HRQoL|hrqol
998962|NCT03170232|Disease Progression|disease progression
998963|NCT03170232|Danirixin|danirixin
998964|NCT03170232|COPD|copd
998965|NCT03170206|Lung Cancer|lung cancer
998966|NCT03170141|CAR T|car t
998967|NCT03170141|EGFRviii|egfrviii
998968|NCT03170141|GBM|gbm
998969|NCT03170141|PDL1|pdl1
998970|NCT03170141|PD1|pd1
998971|NCT03170141|brain tumor|brain tumor
998972|NCT03170115|Rectal Cancer|rectal cancer
998973|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
998974|NCT03170115|Induction chemotherapy|induction chemotherapy
998975|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
998976|NCT03170102|occupational therapy|occupational therapy
998977|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
998978|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
998979|NCT03170063|Parkinson's Disease|parkinson's disease
998980|NCT03170063|Alpha-Synuclein|alpha-synuclein
998981|NCT03170063|Biomarker|biomarker
998982|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
998983|NCT03170011|Sit to Stand|sit to stand
998984|NCT03170011|Function|function
998985|NCT03169985|Rosuvastatin|rosuvastatin
998986|NCT03169985|Ezetimibe|ezetimibe
998987|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
999868|NCT03163719|Lactate|lactate
998988|NCT03169985|Intravascular ultrasound|intravascular ultrasound
998989|NCT03169959|Anti-diabetic|anti-diabetic
998990|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
998991|NCT03169959|Bioequivalence|bioequivalence
998992|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
998993|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
998994|NCT03169959|XIGDUO® XR|xigduo® xr
998995|NCT03169959|ONGLYZA®|onglyza®
998996|NCT03169933|adjuvant|adjuvant
998997|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
998998|NCT03169933|literature review|literature review
998999|NCT03169933|phase II|phase ii
999000|NCT03169933|prostate neoplasms|prostate neoplasms
999001|NCT03169933|radiotherapy|radiotherapy
999002|NCT03169907|Cardiac functions|cardiac functions
999003|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
999004|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
999005|NCT03169907|Myocardial performance index|myocardial performance index
999006|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
999007|NCT03169868|clinical decision support|clinical decision support
999008|NCT03169868|drug levels in blood|drug levels in blood
999009|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
999010|NCT03169868|medication adherence|medication adherence
999011|NCT03169868|medication therapy management|medication therapy management
999012|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
999013|NCT03169855|Glare|glare
999014|NCT03169855|Cataract|cataract
999015|NCT03169855|Nighttime driving|nighttime driving
999016|NCT03169855|contrast sensitivity|contrast sensitivity
999017|NCT03169855|mesopic vision|mesopic vision
999018|NCT03169829|Hemodialysis|hemodialysis
999019|NCT03169829|Renal Disease|renal disease
999020|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
999021|NCT03169803|Electrodes|electrodes
999022|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
999023|NCT03169803|Sympathetic Fibers|sympathetic fibers
999024|NCT03169803|Post Ganglionic|post ganglionic
999025|NCT03169803|Congestive Heart Failure|congestive heart failure
999026|NCT03169803|Heart Failure|heart failure
999027|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
999028|NCT03169673|Pulmonary Function|pulmonary function
999029|NCT03169634|Failed knee replacement|failed knee replacement
999030|NCT03169634|loosening|loosening
999031|NCT03169634|wear|wear
999032|NCT03169634|reoperation|reoperation
999033|NCT03169621|Chronic Endometritis|chronic endometritis
999034|NCT03169621|Endometrial pathogens|endometrial pathogens
999035|NCT03169621|Microbiological diagnosis|microbiological diagnosis
999036|NCT03169621|Next Generation Sequencing|next generation sequencing
999037|NCT03169621|Metagenomics|metagenomics
999038|NCT03169621|Endometrial receptivity|endometrial receptivity
999039|NCT03169608|autonomic nervous system|autonomic nervous system
999040|NCT03169608|atrial fibrillation|atrial fibrillation
999041|NCT03169608|acute kidney injury|acute kidney injury
999042|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
999043|NCT03169608|microcirculation|microcirculation
999044|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
999045|NCT03169569|hemostatic powder|hemostatic powder
999046|NCT03169569|post-ESD bleeding|post-esd bleeding
999047|NCT03169569|antithrombotic therapy|antithrombotic therapy
999048|NCT03169569|high risk of bleeding|high risk of bleeding
999049|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
999050|NCT03169569|adverse event|adverse event
999051|NCT03169556|Intubation|intubation
999052|NCT03169556|light wand|light wand
999053|NCT03169556|video laryngoscopy|video laryngoscopy
999054|NCT03169556|cervical spine immobilization|cervical spine immobilization
999055|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
999056|NCT03169517|Peripheral nerve block|peripheral nerve block
999057|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
999058|NCT03169517|blood flow index|blood flow index
999059|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
999060|NCT03169504|Acupuncture Therapy|acupuncture therapy
999061|NCT03169504|Humans|humans
999062|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
999063|NCT03169491|Child|child
999064|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
999065|NCT03169491|Perioperative management|perioperative management
999066|NCT03169491|Adenotonsillectomy|adenotonsillectomy
999067|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
999068|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
999069|NCT03169478|balloon dilatation|balloon dilatation
999070|NCT03169478|adhesions|adhesions
999071|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
999072|NCT03169426|beta-blocker|beta-blocker
999073|NCT03169400|vascular calcification|vascular calcification
999074|NCT03169400|haemodialysis|haemodialysis
999075|NCT03169400|dialysis membrane|dialysis membrane
999076|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
999077|NCT03169374|Virtual Reality|virtual reality
999078|NCT03169374|Mechanical Ventilation|mechanical ventilation
999079|NCT03169374|Anxiety|anxiety
999080|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
999081|NCT03169309|military|military
999082|NCT03169309|binaural beat technology|binaural beat technology
999083|NCT03169309|brain entrainment technology|brain entrainment technology
999084|NCT03169309|sleep|sleep
999085|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
999086|NCT03169296|Mutations|mutations
999087|NCT03169296|Next-generation sequencing|next-generation sequencing
999088|NCT03169270|Exercise training|exercise training
999089|NCT03169270|Muscle dysfunction|muscle dysfunction
999090|NCT03169270|COPD|copd
999091|NCT03169257|paediatric obesity|paediatric obesity
999092|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
999093|NCT03169257|metabolic syndrome|metabolic syndrome
999094|NCT03169257|adipokines|adipokines
999095|NCT03169257|inflammation|inflammation
999096|NCT03169257|oxidative stress|oxidative stress
999097|NCT03169218|Adult|adult
999098|NCT03169218|Chronic pain|chronic pain
999099|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
999100|NCT03169218|Exercise therapy|exercise therapy
999101|NCT03169218|Humans|humans
999102|NCT03169218|Neuronal plasticity|neuronal plasticity
999103|NCT03169218|Mirror neurons|mirror neurons
999104|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
999105|NCT03169218|Physiotherapy|physiotherapy
999106|NCT03169218|Somatosensory cortex|somatosensory cortex
999107|NCT03169179|Physical activity|physical activity
999108|NCT03169179|Mobile health|mobile health
999109|NCT03169179|Wearable fitness technology|wearable fitness technology
999110|NCT03169179|Organisational wellness|organisational wellness
999111|NCT03169179|Occupational health|occupational health
999112|NCT03169179|Police force|police force
999113|NCT03169166|GnRH agonist|gnrh agonist
999114|NCT03169166|In Vitro fertilization|in vitro fertilization
999218|NCT03168685|hemophilia|hemophilia
999115|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
999116|NCT03169166|Follicule Maturation|follicule maturation
999117|NCT03169166|Pregnancy|pregnancy
999118|NCT03169153|contact lenses|contact lenses
999119|NCT03169153|lipids|lipids
999120|NCT03169153|deposits|deposits
999121|NCT03169140|pain management|pain management
999122|NCT03169140|topical analgesic|topical analgesic
999123|NCT03169140|acute low back pain|acute low back pain
999124|NCT03169140|kinesiology tape|kinesiology tape
999125|NCT03169127|Ibuprofen|ibuprofen
999126|NCT03169127|Lower third molar|lower third molar
999127|NCT03169127|Oral Surgery|oral surgery
999128|NCT03169114|Appendicitis|appendicitis
999129|NCT03169114|Surgery|surgery
999130|NCT03169114|Antibiotic therapy|antibiotic therapy
999131|NCT03169114|RIPASA Score|ripasa score
999132|NCT03169101|Smoking Cessation|smoking cessation
999134|NCT03169101|Cognition|cognition
999135|NCT03169088|eating Behavior|eating behavior
999136|NCT03169088|Volunteers|volunteers
999137|NCT03169075|Adapted physical ctivity|adapted physical ctivity
999138|NCT03169075|Oral targeted thérapy|oral targeted thérapy
999139|NCT03169075|Advanced cancer|advanced cancer
999140|NCT03169075|Fatigue|fatigue
999141|NCT03169075|Quality of life|quality of life
999142|NCT03169075|Randomized Study|randomized study
999143|NCT03169049|nerve conduction block|nerve conduction block
999144|NCT03169049|high frequency stimulation|high frequency stimulation
999145|NCT03169049|handgrip|handgrip
999146|NCT03169010|registry|registry
999147|NCT03169010|pulmonary hypertension|pulmonary hypertension
999148|NCT03169010|survival|survival
999149|NCT03169010|biomarker|biomarker
999150|NCT03169010|whole genome sequencing|whole genome sequencing
999151|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
999152|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
999153|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
999154|NCT03168984|UCB0942|ucb0942
999155|NCT03168971|Cancer|cancer
999156|NCT03168971|Anxiety|anxiety
999157|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
999158|NCT03168971|Elderly|elderly
999159|NCT03168971|Caregivers|caregivers
999160|NCT03168945|Active Case Finding|active case finding
999161|NCT03168906|Amyloidosis|amyloidosis
999162|NCT03168906|NEOD001|neod001
999163|NCT03168906|RAIN|rain
999164|NCT03168893|deep brain stimulation|deep brain stimulation
999165|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
999166|NCT03168867|adolescents/young adults|adolescents/young adults
999167|NCT03168867|e-health intervention|e-health intervention
999168|NCT03168867|parental monitoring|parental monitoring
999169|NCT03168854|Anopheles stephensi|anopheles stephensi
999170|NCT03168854|GAP3KO|gap3ko
999171|NCT03168854|Malaria|malaria
999172|NCT03168854|Mosquitoes|mosquitoes
999173|NCT03168854|Plasmodium falciparum|plasmodium falciparum
999174|NCT03168815|HFNC|hfnc
999175|NCT03168815|Bronchoscopy|bronchoscopy
999176|NCT03168815|Hypoxia|hypoxia
999177|NCT03168815|Immunocompromised|immunocompromised
999178|NCT03168815|Hematological malignancy|hematological malignancy
1000559|NCT03159442|Safety|safety
999179|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
999180|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
999181|NCT03168802|Facet joint syndrome|facet joint syndrome
999182|NCT03168802|Chronic low back pain|chronic low back pain
999183|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
999184|NCT03168776|Drug-eluting stent|drug-eluting stent
999185|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
999186|NCT03168763|Advanced Cancer|advanced cancer
999187|NCT03168763|Videos|videos
999188|NCT03168763|Questionnaires|questionnaires
999189|NCT03168763|Surveys|surveys
1568407|NCT00505947|diabetic retinopathy|diabetic retinopathy
1021326|NCT03029429|AHO|aho
999190|NCT03168737|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
999191|NCT03168737|Solid tumors|solid tumors
999192|NCT03168737|PET-CT|pet-ct
999193|NCT03168737|18F-fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
999194|NCT03168737|18F-FAZA|18f-faza
999195|NCT03168724|Cognition|cognition
999196|NCT03168724|Intervention|intervention
999197|NCT03168724|Self-management|self-management
999198|NCT03168724|Rehabilitation|rehabilitation
999199|NCT03168711|ALS|als
999200|NCT03168711|Inosine|inosine
999201|NCT03168711|Uric acid|uric acid
999202|NCT03168711|Urate|urate
999203|NCT03168711|Glutathione|glutathione
999204|NCT03168711|Biomarker|biomarker
999205|NCT03168711|Oxidative stress|oxidative stress
999206|NCT03168711|Oxidative damage|oxidative damage
999207|NCT03168698|pregnancy|pregnancy
999208|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
999209|NCT03168698|cesarean delivery|cesarean delivery
999210|NCT03168698|carbetocin|carbetocin
999211|NCT03168698|duratocin|duratocin
999212|NCT03168698|oxytocin|oxytocin
999213|NCT03168685|smartphones|smartphones
999214|NCT03168685|clinical trials|clinical trials
999215|NCT03168685|weight|weight
999219|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
999220|NCT03168633|Web-based intervention|web-based intervention
999221|NCT03168633|medication adherence|medication adherence
999222|NCT03168633|lifestyle changes|lifestyle changes
999223|NCT03168607|ORR|orr
999224|NCT03168607|OS|os
999225|NCT03168607|PFS|pfs
999226|NCT03168607|safety|safety
999227|NCT03168594|chemotherapy|chemotherapy
999228|NCT03168594|OS|os
999229|NCT03168594|ORR|orr
999230|NCT03168594|PFS|pfs
999231|NCT03168594|safety|safety
999232|NCT03168529|Acute Heart Failure|acute heart failure
999233|NCT03168529|Observation|observation
999234|NCT03168529|Ivabradine|ivabradine
999235|NCT03168516|Oxygen|oxygen
999236|NCT03168516|closed-loop automatic control|closed-loop automatic control
999237|NCT03168516|Oxygen saturation|oxygen saturation
999238|NCT03168516|preterm infants|preterm infants
999239|NCT03168451|text messaging|text messaging
999240|NCT03168438|Cell Therapy|cell therapy
999241|NCT03168438|Multiple Myeloma|multiple myeloma
999242|NCT03168438|Immuno-oncology|immuno-oncology
999243|NCT03168438|T Cell Therapy|t cell therapy
999244|NCT03168438|Metastatic|metastatic
999245|NCT03168438|SPEAR T Cell|spear t cell
999246|NCT03168438|T Cell Receptor|t cell receptor
999247|NCT03168438|Previously Treated|previously treated
999248|NCT03168438|NY-ESO-1|ny-eso-1
999249|NCT03168425|safe opioid prescribing|safe opioid prescribing
999250|NCT03168412|Hepatitis E|hepatitis e
999251|NCT03168399|Phenylketonuria|phenylketonuria
999252|NCT03168399|PKU|pku
999253|NCT03168399|Metabolism|metabolism
999254|NCT03168399|Metabolic|metabolic
999255|NCT03168399|Control|control
999256|NCT03168399|Acceptability|acceptability
999257|NCT03168347|Decision making|decision making
999258|NCT03168269|CCTA interpretation|ccta interpretation
999259|NCT03168269|technicians|technicians
999260|NCT03168269|experts|experts
999261|NCT03168269|comparison|comparison
999262|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
999263|NCT03168217|Periodontitis|periodontitis
999264|NCT03168217|classification|classification
999265|NCT03168217|Cluster analysis|cluster analysis
999266|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
999267|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
999268|NCT03168139|NOX-A12|nox-a12
999269|NCT03168139|Olaptesed pegol|olaptesed pegol
999270|NCT03168139|Spiegelmer|spiegelmer
999271|NCT03168139|Pembrolizumab|pembrolizumab
999272|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
999273|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
999274|NCT03168139|CXCL12|cxcl12
999275|NCT03168139|Tumor microenvironment|tumor microenvironment
999276|NCT03168139|Immunotherapy|immunotherapy
999277|NCT03168139|Checkpoint inhibition|checkpoint inhibition
999278|NCT03168113|skin barrier function|skin barrier function
999279|NCT03168113|microbiome|microbiome
999280|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
999281|NCT03168113|epidermal transcriptome|epidermal transcriptome
999282|NCT03168113|epidermal lipid composition|epidermal lipid composition
999287|NCT03168048|patient-care|patient-care
999288|NCT03168048|mhealth|mhealth
999289|NCT03168048|follow-up|follow-up
999290|NCT03168048|patient satisfaction|patient satisfaction
999291|NCT03168048|quality of life|quality of life
999292|NCT03168009|BAT|bat
999293|NCT03168009|Bariatric Surgery|bariatric surgery
999294|NCT03168009|Energy Metabolism|energy metabolism
999295|NCT03167996|South Asian|south asian
999296|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
999297|NCT03167996|Metabolic Disorders|metabolic disorders
999298|NCT03167996|Lifestyle modifications|lifestyle modifications
999299|NCT03167957|fluconazole|fluconazole
999300|NCT03167957|fluconazole-resistant|fluconazole-resistant
999301|NCT03167944|Mastectomy|mastectomy
999302|NCT03167944|Seroma|seroma
999303|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
999304|NCT03167931|neuromodulation|neuromodulation
999305|NCT03167931|semantic tasks|semantic tasks
999306|NCT03167918|calcium dobesilate|calcium dobesilate
999307|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
999308|NCT03167918|pulmonary function|pulmonary function
999309|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
999310|NCT03167905|Epidural anesthesia|epidural anesthesia
999311|NCT03167905|Postnatal depression|postnatal depression
999312|NCT03167905|Persistent pain|persistent pain
999313|NCT03167879|family planning|family planning
999314|NCT03167879|safer conception|safer conception
999315|NCT03167879|HIV|hiv
999316|NCT03167879|serodiscordant couples|serodiscordant couples
999317|NCT03167879|Uganda|uganda
999318|NCT03167879|contraception|contraception
999319|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
999320|NCT03167827|pelvic floor|pelvic floor
999321|NCT03167827|climateric|climateric
999322|NCT03167827|exercise|exercise
999323|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
999324|NCT03167801|tetraplegia|tetraplegia
999325|NCT03167801|spinal cord injury|spinal cord injury
999327|NCT03167801|sleep quality|sleep quality
999328|NCT03167801|sleepiness|sleepiness
999329|NCT03167723|Chest tube size|chest tube size
999330|NCT03167723|Hemothorax|hemothorax
999331|NCT03167723|Empyema|empyema
999332|NCT03167697|Phenylketonuria|phenylketonuria
999333|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
999334|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
999335|NCT03167671|Oswestry|oswestry
999336|NCT03167671|SF 36|sf 36
999337|NCT03167671|Promis Pain and Function|promis pain and function
999338|NCT03167671|Berg Balance|berg balance
999339|NCT03167658|Wellness|wellness
999340|NCT03167658|Prevention|prevention
999341|NCT03167619|Mestastic|mestastic
999342|NCT03167619|Platinum Sensitive|platinum sensitive
999343|NCT03167619|Advanced|advanced
999344|NCT03167619|PARP inhibitor|parp inhibitor
999345|NCT03167606|myPEEPS|mypeeps
999346|NCT03167606|Mobile Intervention|mobile intervention
999347|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
999348|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
999349|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
999351|NCT03167593|Vaccine|vaccine
999352|NCT03167528|Pain|pain
999353|NCT03167528|Quality of life|quality of life
999354|NCT03167476|miRNA|mirna
999355|NCT03167476|biomarker|biomarker
999361|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
999362|NCT03167437|HDAC Inhibitors|hdac inhibitors
999363|NCT03167424|In-stent restenosis|in-stent restenosis
999364|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
999365|NCT03167424|Coronary angiography|coronary angiography
999366|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
999367|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
999368|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
999369|NCT03167398|carrier|carrier
999370|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
999371|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
999372|NCT03167372|Light Therapy|light therapy
999373|NCT03167372|N-of-1|n-of-1
999374|NCT03167359|Psychiatry|psychiatry
999375|NCT03167359|Radiation Therapy|radiation therapy
999376|NCT03167346|stroke|stroke
999377|NCT03167346|core symptoms|core symptoms
999378|NCT03167346|public awareness|public awareness
999379|NCT03167346|FAST|fast
999380|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
999381|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
999382|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
999384|NCT03167307|suicidality|suicidality
999385|NCT03167307|cognition|cognition
999386|NCT03167307|childhood depression|childhood depression
999387|NCT03167307|pediatric depression|pediatric depression
999388|NCT03167294|Aquablation|aquablation
999389|NCT03167294|AQUABEAM|aquabeam
999390|NCT03167294|BPH|bph
999391|NCT03167294|LUTS|luts
999392|NCT03167281|Chest tube|chest tube
999393|NCT03167281|Thoracostomy|thoracostomy
999394|NCT03167281|Pleural Diseases|pleural diseases
999395|NCT03167281|Lung Neoplasms|lung neoplasms
999396|NCT03167281|Pulmonary Embolism|pulmonary embolism
999397|NCT03167281|Pneumothorax|pneumothorax
999398|NCT03167281|Thoracic Surgery|thoracic surgery
999399|NCT03167281|Deoxyribonucleases|deoxyribonucleases
999400|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
999401|NCT03167281|Drainage|drainage
999402|NCT03167281|Pleural Effusion|pleural effusion
999403|NCT03167268|Lycopene|lycopene
999404|NCT03167268|Anti EGFR therapy|anti egfr therapy
999405|NCT03167216|chronic pain|chronic pain
999406|NCT03167216|prostatitis|prostatitis
999407|NCT03167216|pelvic pain|pelvic pain
999408|NCT03167203|hESC-RPE|hesc-rpe
999409|NCT03167203|Macular Degenerative Disease|macular degenerative disease
999410|NCT03167190|Point of Care Ultrasound|point of care ultrasound
999411|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
999412|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
999413|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
999414|NCT03167151|Phase I/II|phase i/ii
999415|NCT03167151|Marker-lesion|marker-lesion
999416|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
999417|NCT03167138|Shoulder pain|shoulder pain
999418|NCT03167138|Rotator cuff disease|rotator cuff disease
999419|NCT03167138|Spinal cord injuries|spinal cord injuries
999420|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
999421|NCT03167138|Regenerative medicine|regenerative medicine
999422|NCT03167138|Rehabilitation|rehabilitation
999423|NCT03167125|colorectal cancer screening|colorectal cancer screening
999424|NCT03167125|cancer screening|cancer screening
999425|NCT03167125|pragmatic trial|pragmatic trial
999426|NCT03167125|boot camp translation|boot camp translation
999427|NCT03167112|Potentially Curable|potentially curable
999428|NCT03167112|Preoperative|preoperative
999429|NCT03167112|FOLFIRINOX|folfirinox
999430|NCT03167073|smartphone application|smartphone application
999431|NCT03167073|low-income women|low-income women
999432|NCT03167073|breastfeeding|breastfeeding
999433|NCT03167073|health education|health education
999434|NCT03167073|health disparities|health disparities
999435|NCT03167073|postpartum weight loss|postpartum weight loss
999436|NCT03167034|exercise|exercise
999437|NCT03167034|echocardiography|echocardiography
999438|NCT03167034|right ventricular function|right ventricular function
999439|NCT03167034|obstructive airway disease|obstructive airway disease
999440|NCT03167034|emphysema|emphysema
999441|NCT03167034|acetazolamide|acetazolamide
999442|NCT03167034|altitude|altitude
999443|NCT03167021|Cannabis|cannabis
999444|NCT03167021|Community pharmacy|community pharmacy
999445|NCT03167021|Prevention|prevention
999446|NCT03167021|Students|students
999447|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
999448|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
999449|NCT03166982|Transvaginal drainage|transvaginal drainage
999450|NCT03166982|Laparoscopic treatment|laparoscopic treatment
999451|NCT03166956|Vitamin C|vitamin c
999452|NCT03166956|Glutamine|glutamine
999453|NCT03166956|Interleukin-6|interleukin-6
999454|NCT03166956|Clinical outcomes|clinical outcomes
999455|NCT03166930|Muscle Spasticity|muscle spasticity
999456|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
999457|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
999458|NCT03166878|CAR-T|car-t
999459|NCT03166878|Cancer treatment|cancer treatment
999460|NCT03166878|Immunotherapy|immunotherapy
999461|NCT03166878|Adoptive cell therapy|adoptive cell therapy
999462|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
999463|NCT03166878|Universal CAR-T|universal car-t
999464|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
999465|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
999466|NCT03166839|maternal health|maternal health
999467|NCT03166839|statistical analysis plan|statistical analysis plan
999468|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
999469|NCT03166813|childhood cancer|childhood cancer
999470|NCT03166813|cardio-oncology|cardio-oncology
999471|NCT03166813|anthracycline|anthracycline
999472|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
999473|NCT03166800|mitoquinone|mitoquinone
999474|NCT03166800|Fatigue|fatigue
999475|NCT03166800|Multiple Sclerosis|multiple sclerosis
999476|NCT03166748|Incomplete lower first molar|incomplete lower first molar
999477|NCT03166748|Immature permanent molar|immature permanent molar
999478|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
999479|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
999480|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
999481|NCT03166644|Postoperative Analgesia|postoperative analgesia
999482|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
999483|NCT03166566|glaucoma|glaucoma
999484|NCT03166566|glaucoma surgery|glaucoma surgery
999485|NCT03166566|glaucoma drainage device|glaucoma drainage device
999486|NCT03166566|glaucoma implant|glaucoma implant
999487|NCT03166566|blindness|blindness
999488|NCT03166540|coffee|coffee
999489|NCT03166540|cocoa|cocoa
999490|NCT03166540|bioavailability|bioavailability
999491|NCT03166540|pharmacokinetics|pharmacokinetics
999492|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
999493|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
999494|NCT03166540|flavan-3-ol|flavan-3-ol
999495|NCT03166540|caffeine|caffeine
999496|NCT03166540|trigonelline|trigonelline
1021734|NCT03027193|MAP|map
999497|NCT03166540|diterpene|diterpene
999498|NCT03166449|Traumatic Brain injury|traumatic brain injury
999499|NCT03166449|Immunonutrition|immunonutrition
999500|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
999501|NCT03166371|Endocrinology|endocrinology
999502|NCT03166371|Nutrition|nutrition
999503|NCT03166371|Aging|aging
999504|NCT03166332|Mindfulness|mindfulness
999505|NCT03166332|Mediterranean diet|mediterranean diet
999506|NCT03166332|Neurodevelopment|neurodevelopment
999507|NCT03166332|Epigenetics|epigenetics
999508|NCT03166332|Fetal growth restriction|fetal growth restriction
999509|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
999510|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
999511|NCT03166293|Cerebral Palsy|cerebral palsy
999512|NCT03166293|Physical Therapy|physical therapy
999513|NCT03166293|Rehabilitation|rehabilitation
999514|NCT03166280|hepatitis C|hepatitis c
999515|NCT03166280|vitamin D|vitamin d
999516|NCT03166280|iron|iron
999517|NCT03166280|hepcidin|hepcidin
999518|NCT03166215|Drug therapy|drug therapy
999519|NCT03166202|age-related macular degeneration|age-related macular degeneration
999520|NCT03166189|Repeated IVF failure|repeated ivf failure
999521|NCT03166189|Stem cell|stem cell
999522|NCT03166163|bleeding on brushing|bleeding on brushing
999523|NCT03166150|Urinary Incontinence, pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
999524|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
999525|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
999526|NCT03166085|HER2-Negative|her2-negative
999527|NCT03166085|PU-H71|pu-h71
999528|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
999529|NCT03166085|17-093|17-093
999530|NCT03166072|Low-vision|low-vision
999531|NCT03166072|health related quality of life|health related quality of life
999532|NCT03166072|visual aids|visual aids
999533|NCT03166072|randomized controlled trial|randomized controlled trial
999534|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
999535|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
999536|NCT03166033|etiology|etiology
999537|NCT03166033|risk factor|risk factor
999538|NCT03166020|Serious Game|serious game
999539|NCT03166020|Stroke|stroke
999540|NCT03166020|Rehabilitation|rehabilitation
999541|NCT03166020|Connected objects|connected objects
999542|NCT03166007|Multiple Sclerosis|multiple sclerosis
999543|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
999544|NCT03166007|Abdominal massage|abdominal massage
999545|NCT03165994|esophagus|esophagus
999546|NCT03165994|gastroesoophageal (GE) junction|gastroesoophageal (ge) junction
999547|NCT03165994|T1-3N0-1|t1-3n0-1
999548|NCT03165981|Influenza vaccine|influenza vaccine
999549|NCT03165981|fever following vaccination|fever following vaccination
999550|NCT03165981|PCV13 vaccine|pcv13 vaccine
999551|NCT03165981|DTaP vaccine|dtap vaccine
999552|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
999553|NCT03165955|breast cancer|breast cancer
999554|NCT03165955|paclitaxel|paclitaxel
999555|NCT03165929|free gingival grafts|free gingival grafts
999556|NCT03165929|connective tissue grafts|connective tissue grafts
999557|NCT03165929|flurbiprofen|flurbiprofen
999558|NCT03165890|cognition|cognition
999559|NCT03165890|visuomotor learning|visuomotor learning
999560|NCT03165890|airway disease|airway disease
999561|NCT03165890|altitude|altitude
999562|NCT03165890|prevention|prevention
999563|NCT03165890|acetazolamide|acetazolamide
999564|NCT03165877|GLYCEMIC INDEX|glycemic index
999565|NCT03165877|NAFLD|nafld
999566|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
999567|NCT03165877|SATIETY|satiety
999568|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
999569|NCT03165838|postpartum|postpartum
999570|NCT03165838|pregnancy|pregnancy
999571|NCT03165838|contraception|contraception
999572|NCT03165838|RROP|rrop
999573|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
999574|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
999575|NCT03165812|Single Anastomosis|single anastomosis
999576|NCT03165812|Intensive Medical Therapy|intensive medical therapy
999601|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
999602|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
999604|NCT03165695|Delirium|delirium
999605|NCT03165695|Insomnia|insomnia
999606|NCT03165695|Ramelteon|ramelteon
999607|NCT03165682|fatigue|fatigue
999608|NCT03165682|depression|depression
999609|NCT03165682|cortical excitability|cortical excitability
999610|NCT03165669|education|education
999611|NCT03165669|sleep|sleep
999612|NCT03165669|pillow|pillow
999613|NCT03165669|neck|neck
999614|NCT03165656|Echocardiography|echocardiography
999615|NCT03165656|right ventricular function|right ventricular function
999616|NCT03165656|pulmonary hypertension|pulmonary hypertension
999617|NCT03165656|disease progression|disease progression
999618|NCT03165656|hypoxia|hypoxia
999619|NCT03165617|Influenza vaccine|influenza vaccine
999620|NCT03165604|Physical fitness|physical fitness
999621|NCT03165604|Exercise|exercise
999622|NCT03165604|Childhood Obesity|childhood obesity
999623|NCT03165604|Information|information
999624|NCT03165539|Postoperative|postoperative
999625|NCT03165539|One-lung ventilation|one-lung ventilation
999626|NCT03165539|Cerebral oximetry|cerebral oximetry
999627|NCT03165539|Cerebral desaturation|cerebral desaturation
999628|NCT03165513|Traditional healer|traditional healer
999629|NCT03165513|faith healer|faith healer
999630|NCT03165513|depression|depression
999631|NCT03165513|mhGAP|mhgap
999632|NCT03165513|Kenya|kenya
999633|NCT03165500|Exodontia|exodontia
999634|NCT03165500|Sedation|sedation
999635|NCT03165500|Nitrous Oxide|nitrous oxide
999636|NCT03165500|Benzodiazepines|benzodiazepines
999637|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
999638|NCT03165487|microenvironment|microenvironment
999639|NCT03165487|IORT|iort
999640|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
999641|NCT03165474|childhood obesity|childhood obesity
999642|NCT03165474|mhealth|mhealth
999643|NCT03165474|digital health|digital health
999644|NCT03165474|nutrition|nutrition
999645|NCT03165474|intervention|intervention
999646|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
999647|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
999648|NCT03165448|oral surgery|oral surgery
999649|NCT03165448|psychology|psychology
999650|NCT03165448|fear|fear
999651|NCT03165448|pain|pain
999652|NCT03165448|dentistry|dentistry
999653|NCT03165396|mild cognitive impairment|mild cognitive impairment
999654|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
999655|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
999656|NCT03165357|Crossfit|crossfit
999657|NCT03165357|Sodium bicarbonate|sodium bicarbonate
999658|NCT03165357|Physical capacity|physical capacity
999659|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
999660|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
999661|NCT03165318|Muscle|muscle
999662|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
999663|NCT03165253|Children|children
999664|NCT03165253|Synbiotic|synbiotic
999665|NCT03165253|Standard Triple Therapy|standard triple therapy
999666|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
999667|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
999668|NCT03165175|prescription drug abuse|prescription drug abuse
999669|NCT03165175|prescription drug misuse|prescription drug misuse
999670|NCT03165175|risk reduction|risk reduction
999671|NCT03165175|education|education
999672|NCT03165175|military|military
999673|NCT03165175|mobile application|mobile application
999674|NCT03165175|substance misuse|substance misuse
999675|NCT03165175|substance abuse|substance abuse
999676|NCT03165162|natural|natural
999677|NCT03165162|Food Label Choices|food label choices
999678|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
999679|NCT03165136|First trimester abortion|first trimester abortion
999680|NCT03165136|Hydroxychloroquine|hydroxychloroquine
999681|NCT03165136|Antiphospholipid antibody|antiphospholipid antibody
999682|NCT03165097|tolerability|tolerability
999683|NCT03165097|safety|safety
999684|NCT03165084|Self-management|self-management
999685|NCT03165084|Primary Health Care|primary health care
999686|NCT03165084|eHealth|ehealth
999687|NCT03165032|exercise|exercise
999688|NCT03165032|echocardiography|echocardiography
999689|NCT03165032|right ventricular function|right ventricular function
999690|NCT03165032|pulmonary hypertension|pulmonary hypertension
999691|NCT03165032|hypoxia|hypoxia
999692|NCT03165019|high altitude illness|high altitude illness
999693|NCT03165019|pulmonary hypertension|pulmonary hypertension
999694|NCT03165019|sleep apnea|sleep apnea
999695|NCT03165019|disease progression|disease progression
999696|NCT03165019|hypoxia|hypoxia
999697|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
999698|NCT03164993|Neoplasms|neoplasms
999699|NCT03164980|Quality of life|quality of life
999700|NCT03164980|ovarian cancer|ovarian cancer
999701|NCT03164980|platinum sensitive|platinum sensitive
999702|NCT03164980|recurrent|recurrent
999703|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
999704|NCT03164941|practice|practice
999705|NCT03164941|treatment|treatment
999706|NCT03164941|intraocular pressure|intraocular pressure
999707|NCT03164928|Denosumab|denosumab
999708|NCT03164928|Pediatric GIOP|pediatric giop
999709|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
999710|NCT03164928|Osteoporosis|osteoporosis
999711|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
999712|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
999713|NCT03164824|Questionnaire|questionnaire
1021946|NCT03025789|HAT|hat
999714|NCT03164824|Functional Rating Index|functional rating index
999715|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
999716|NCT03164824|Psychometric properties testing|psychometric properties testing
999717|NCT03164772|mRNA Vaccine|mrna vaccine
999718|NCT03164772|Durvalumab|durvalumab
999719|NCT03164772|MEDI4736|medi4736
999720|NCT03164772|anti-PD-L1|anti-pd-l1
999721|NCT03164772|tremelimumab|tremelimumab
999722|NCT03164772|anti-CTLA-4|anti-ctla-4
999723|NCT03164772|BI 1361849|bi 1361849
999724|NCT03164746|Autism|autism
999725|NCT03164746|Therapeutic body wraps|therapeutic body wraps
999726|NCT03164681|sheerly|sheerly
999727|NCT03164642|Depressive Symptoms|depressive symptoms
999728|NCT03164642|Developmental Disabilities|developmental disabilities
999729|NCT03164642|Early Intervention|early intervention
999730|NCT03164642|Language Development|language development
999731|NCT03164642|Communication|communication
999732|NCT03164642|Maternal Empowerment|maternal empowerment
999733|NCT03164629|BPH|bph
999734|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
999735|NCT03164629|Urine Retention|urine retention
999736|NCT03164616|NSCLC|nsclc
999737|NCT03164616|PD-L1|pd-l1
999738|NCT03164616|Durvalumab|durvalumab
999739|NCT03164616|Tremelimumab|tremelimumab
999740|NCT03164616|PFS|pfs
999741|NCT03164551|GERI+|geri+
999742|NCT03164551|TICON|ticon
999743|NCT03164551|EEVA|eeva
999744|NCT03164551|Embryo culture|embryo culture
999745|NCT03164551|In Vitro Fertilization|in vitro fertilization
999746|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
999747|NCT03164525|Thai version|thai version
999748|NCT03164525|validated|validated
999749|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
999750|NCT03164525|Behavioral Pain Scale|behavioral pain scale
999751|NCT03164525|adult ICU patients|adult icu patients
999752|NCT03164499|Health education|health education
999753|NCT03164499|Life style|life style
999754|NCT03164499|Risk factors|risk factors
999755|NCT03164499|Cardiovascular diseases|cardiovascular diseases
999756|NCT03164499|Cognitive performance|cognitive performance
999757|NCT03164499|Quality of life|quality of life
999758|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
999759|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
999760|NCT03164473|maintenance therapy|maintenance therapy
999761|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
999762|NCT03164473|vasculitis remission|vasculitis remission
999763|NCT03164473|asthma control|asthma control
999764|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
999765|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
999766|NCT03164473|steroid sparing effect|steroid sparing effect
999767|NCT03164473|damage|damage
999768|NCT03164460|Head and Neck Cancer|head and neck cancer
999769|NCT03164460|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
999770|NCT03164460|SBRT|sbrt
999771|NCT03164460|Intensity modulated radiation therapy|intensity modulated radiation therapy
999772|NCT03164460|IMRT|imrt
999773|NCT03164460|Intensity modulated proton therapy|intensity modulated proton therapy
999774|NCT03164460|IMPT|impt
999775|NCT03164460|Questionnaires|questionnaires
999776|NCT03164460|Surveys|surveys
999777|NCT03164434|intracranial pressure|intracranial pressure
999778|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
999779|NCT03164434|waveform analysis|waveform analysis
999780|NCT03164395|atrial fibrillation|atrial fibrillation
999781|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
999782|NCT03164395|cardioversion|cardioversion
999783|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
999784|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
999785|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
999786|NCT03164343|Pain Neuroscience Education|pain neuroscience education
999787|NCT03164330|Health Care|health care
999788|NCT03164330|Workplace Wellness|workplace wellness
999789|NCT03164330|Preventative Health Care|preventative health care
999790|NCT03164330|Health Costs|health costs
999791|NCT03164317|Hypertension|hypertension
999792|NCT03164317|High blood pressure|high blood pressure
999793|NCT03164317|Task shifting|task shifting
999794|NCT03164317|Decision support system|decision support system
999795|NCT03164291|MAC and NTM|mac and ntm
999796|NCT03164278|Wheelchair|wheelchair
999797|NCT03164278|Biomechanics|biomechanics
999798|NCT03164278|Transfer|transfer
999799|NCT03164278|Participation|participation
999800|NCT03164278|Training|training
999801|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
999802|NCT03164252|Third molar;|third molar;
999803|NCT03164252|Third molar surgery;|third molar surgery;
999804|NCT03164252|Laser;|laser;
999805|NCT03164252|Tissue Repair.|tissue repair.
999806|NCT03164226|endothelial function|endothelial function
1568408|NCT00505947|macula|macula
999807|NCT03164226|acute coronary syndrome|acute coronary syndrome
999808|NCT03164213|tDCS|tdcs
999809|NCT03164213|aphasia|aphasia
999810|NCT03164161|Pain Sensitivity|pain sensitivity
999811|NCT03164161|Measurement|measurement
999812|NCT03164161|Cold Pressor|cold pressor
999813|NCT03164161|β-endorphins|β-endorphins
999814|NCT03164161|saliva|saliva
999815|NCT03164161|oral surgery|oral surgery
999816|NCT03164109|Healthy Adult|healthy adult
999817|NCT03164109|Superoxide Dismutase|superoxide dismutase
999818|NCT03164109|Free Radical Dismutase|free radical dismutase
999819|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
999820|NCT03164083|Joint Diseases|joint diseases
999821|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
999822|NCT03164083|Arthritis|arthritis
999823|NCT03164070|Osteoarthritis|osteoarthritis
999824|NCT03164070|Flow cytometry|flow cytometry
999825|NCT03164070|Synovial fluid|synovial fluid
999826|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
999827|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
999828|NCT03164044|Allergy|allergy
999829|NCT03164044|Drug allergy|drug allergy
999830|NCT03164044|Basophil activation test|basophil activation test
999831|NCT03164044|Flow cytometry|flow cytometry
999832|NCT03164005|VEGF-B|vegf-b
999833|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
999834|NCT03163953|Physical Activity|physical activity
999835|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
999836|NCT03163953|Office Workers|office workers
999837|NCT03163940|Laughter Yoga|laughter yoga
999838|NCT03163940|Major Depressive Disorder|major depressive disorder
999839|NCT03163940|Anxiety|anxiety
999840|NCT03163940|Stress|stress
999841|NCT03163940|Depression|depression
999842|NCT03163940|Quality of Life|quality of life
999843|NCT03163940|Mood Disorder|mood disorder
999844|NCT03163914|vasopressor|vasopressor
999845|NCT03163914|spinal anaesthesia|spinal anaesthesia
999846|NCT03163901|traumatic brain injury|traumatic brain injury
999847|NCT03163875|erythema|erythema
999848|NCT03163875|wheal formation|wheal formation
999849|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
999851|NCT03163836|Double Valve Replacement|double valve replacement
999852|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
999853|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
999854|NCT03163797|integrated PET/MR|integrated pet/mr
999855|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
999856|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
999857|NCT03163758|Ischemic stroke|ischemic stroke
999858|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
999859|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
999860|NCT03163758|Brain Reorganization|brain reorganization
999861|NCT03163732|Solid tumor|solid tumor
999862|NCT03163732|Advanced tumor|advanced tumor
999863|NCT03163732|Profiling panel|profiling panel
999864|NCT03163719|Seizure|seizure
999865|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
999866|NCT03163719|Convulsions|convulsions
999867|NCT03163719|Creatine Kinase|creatine kinase
999869|NCT03163719|Lactacidaemia|lactacidaemia
999870|NCT03163719|Diagnostic|diagnostic
999871|NCT03163719|Losing consciousness|losing consciousness
999872|NCT03163719|Epilepsy|epilepsy
999873|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
999874|NCT03163706|Schizophrenia|schizophrenia
999875|NCT03163706|Stroop effect|stroop effect
999876|NCT03163706|Semantic conflict|semantic conflict
999877|NCT03163706|Response conflict|response conflict
999878|NCT03163693|Dexmedetomidine|dexmedetomidine
999879|NCT03163693|Cardiac Troponin I|cardiac troponin i
999880|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
999881|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
999882|NCT03163680|Marginal Ulcer|marginal ulcer
999883|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
999884|NCT03163680|Peptic Ulcer|peptic ulcer
999885|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
999886|NCT03163667|RCC|rcc
999887|NCT03163667|CB-839|cb-839
999888|NCT03163667|Everolimus|everolimus
999889|NCT03163667|CBE|cbe
999890|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
999891|NCT03163667|Glutaminase|glutaminase
999892|NCT03163667|Tumor Metabolism|tumor metabolism
999893|NCT03163667|Glutamine|glutamine
999894|NCT03163654|multiple gingival recessions|multiple gingival recessions
999895|NCT03163654|collagen matrix|collagen matrix
999896|NCT03163654|connective tissue graft|connective tissue graft
999897|NCT03163654|tunnel technique|tunnel technique
999898|NCT03163628|severe bacterial infection|severe bacterial infection
999899|NCT03163628|acute infection|acute infection
999900|NCT03163628|infection viral|infection viral
999901|NCT03163628|biomarker combination|biomarker combination
999902|NCT03163628|diagnostic|diagnostic
999903|NCT03163628|child|child
999904|NCT03163602|Peri-Implantitis|peri-implantitis
999905|NCT03163602|Infection|infection
999906|NCT03163602|Bone substitutes|bone substitutes
999907|NCT03163524|family planning|family planning
999908|NCT03163524|reproductive health|reproductive health
999909|NCT03163524|m-health|m-health
999910|NCT03163498|Hypertension|hypertension
999911|NCT03163498|Exercise|exercise
999912|NCT03163498|Sleep|sleep
999913|NCT03163485|epilepsy|epilepsy
999914|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
999915|NCT03163485|depth EEG|depth eeg
999916|NCT03163485|microdialysis|microdialysis
999917|NCT03163485|brain injury|brain injury
999918|NCT03163485|brain tissue at risk|brain tissue at risk
999919|NCT03163485|NCSE|ncse
999920|NCT03163485|short time monitoring|short time monitoring
999921|NCT03163485|neurologic ICU|neurologic icu
999922|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
999923|NCT03163459|selective brain cooling|selective brain cooling
999924|NCT03163446|Staphylococcus aureus|staphylococcus aureus
999925|NCT03163446|bacteremia|bacteremia
999926|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
999927|NCT03163433|Patient activation measure|patient activation measure
999928|NCT03163433|Self-efficacy|self-efficacy
999929|NCT03163433|Patient participation in research|patient participation in research
999930|NCT03163433|Patient reported outcome measures|patient reported outcome measures
999931|NCT03163420|Anesthetic efficacy|anesthetic efficacy
999932|NCT03163420|Diclofenac|diclofenac
999933|NCT03163420|Irreversible pulpitis|irreversible pulpitis
999934|NCT03163381|first-line treatment failure|first-line treatment failure
999935|NCT03163381|one measurable lesion|one measurable lesion
999936|NCT03163368|metastatic tumor|metastatic tumor
999937|NCT03163368|brain lesion|brain lesion
999938|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
999939|NCT03163368|neoadjuvant|neoadjuvant
999940|NCT03163368|maximum tolerated dose|maximum tolerated dose
999941|NCT03163368|dose escalation|dose escalation
999942|NCT03163368|neurosurgical resection|neurosurgical resection
999950|NCT03163303|Intervention|intervention
999951|NCT03163303|Young adults|young adults
999952|NCT03163303|Internet|internet
999953|NCT03163303|Social media|social media
999954|NCT03163264|obesity|obesity
999955|NCT03163264|weight loss|weight loss
999956|NCT03163264|weight gain|weight gain
999957|NCT03163264|weight management|weight management
999958|NCT03163264|primary care|primary care
999959|NCT03163264|health coach|health coach
999960|NCT03163251|READ-SG|read-sg
999961|NCT03163251|Burnout|burnout
999962|NCT03163251|Professional identity|professional identity
999963|NCT03163251|Empathy|empathy
999964|NCT03163251|Emotional intelligence|emotional intelligence
999965|NCT03163238|Dexmedetomidine|dexmedetomidine
999966|NCT03163238|Congenital Heart Disease|congenital heart disease
999967|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
999968|NCT03163238|Interleukin|interleukin
999969|NCT03163225|outpatient care|outpatient care
999970|NCT03163225|emergency department visits|emergency department visits
999971|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
999972|NCT03163173|Healthy Adult|healthy adult
999973|NCT03163173|Superoxide Dismutase|superoxide dismutase
999974|NCT03163173|Absorption|absorption
999975|NCT03163173|Metabolism|metabolism
999976|NCT03163173|Elimination|elimination
999977|NCT03163173|Mass Balance|mass balance
999978|NCT03163173|Male Subjects|male subjects
999979|NCT03163160|pelvic floor muscles|pelvic floor muscles
999980|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
999981|NCT03163160|manual therapy|manual therapy
999982|NCT03163160|electrolysis|electrolysis
999983|NCT03163160|galvanic|galvanic
999984|NCT03163147|frequency|frequency
999985|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
999986|NCT03163121|Plasmodium falciparum|plasmodium falciparum
999987|NCT03163121|PfSPZ Vaccine|pfspz vaccine
999988|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
999989|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
999990|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
999991|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
999992|NCT03163108|controller|controller
999993|NCT03163108|hyperoxia|hyperoxia
999994|NCT03163108|hypoxia|hypoxia
999995|NCT03163108|ventilation|ventilation
999996|NCT03163108|cerebral oxygenation|cerebral oxygenation
999997|NCT03163095|sepsis|sepsis
999998|NCT03163095|abdominal infection|abdominal infection
999999|NCT03163095|open abdomen management|open abdomen management
1000000|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
1000001|NCT03163082|Coercion theory|coercion theory
1000002|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
1000003|NCT03163069|tooth bleaching|tooth bleaching
1000004|NCT03163069|dentifrice|dentifrice
1000005|NCT03163056|Smoking cessation|smoking cessation
1000006|NCT03163056|Depression|depression
1000007|NCT03163056|Clinical trial|clinical trial
1000008|NCT03163030|Heart Failure|heart failure
1000009|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
1000010|NCT03163030|VNS|vns
1000011|NCT03163030|Vagus Nerve|vagus nerve
1000012|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
1000013|NCT03163017|3D Fluoroscopy|3d fluoroscopy
1000014|NCT03163004|Sedentary behavior|sedentary behavior
1000015|NCT03162978|Exercise|exercise
1000016|NCT03162978|behavior economics|behavior economics
1000017|NCT03162952|Chronic pain|chronic pain
1000018|NCT03162913|Strawberry|strawberry
1000019|NCT03162913|Cognition|cognition
1000020|NCT03162913|Gait|gait
1000021|NCT03162913|Posture|posture
1000022|NCT03162900|Glasdegib|glasdegib
1000023|NCT03162900|PF-04449913|pf-04449913
1000024|NCT03162900|Pharmacokinetics|pharmacokinetics
1000025|NCT03162900|QTc|qtc
1000026|NCT03162900|TQT|tqt
1000027|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
1000028|NCT03162874|Wearing-off|wearing-off
1000029|NCT03162874|Foliglurax|foliglurax
1000030|NCT03162874|Parkinson's Disease|parkinson's disease
1000031|NCT03162874|mGluR4 PAM|mglur4 pam
1000032|NCT03162835|Pain Neuroscience Education|pain neuroscience education
1000033|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
1000034|NCT03162822|Early Childhood Caries|early childhood caries
1000035|NCT03162809|infertility|infertility
1000036|NCT03162809|in vitro fertilization|in vitro fertilization
1000037|NCT03162809|Estradiol|estradiol
1000038|NCT03162809|Progesterone|progesterone
1000039|NCT03162783|Aldeyra|aldeyra
1000040|NCT03162770|mindfulness meditation|mindfulness meditation
1000041|NCT03162770|hemodialysis|hemodialysis
1000042|NCT03162770|quality of life|quality of life
1000043|NCT03162770|stress|stress
1000044|NCT03162718|lung cancer|lung cancer
1000045|NCT03162718|exercise|exercise
1000046|NCT03162718|pre-operative exercise program|pre-operative exercise program
1000047|NCT03162679|trauma treatment|trauma treatment
1000048|NCT03162679|Refugees|refugees
1000049|NCT03162679|Emotion regulation|emotion regulation
1000050|NCT03162679|Group therapy|group therapy
1000051|NCT03162679|randomized controlled|randomized controlled
1000052|NCT03162679|PTSD|ptsd
1000054|NCT03162653|hypothermia therapy|hypothermia therapy
1000055|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1000056|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
1000057|NCT03162653|childbirth outcome|childbirth outcome
1000058|NCT03162653|perinatal asphyxia|perinatal asphyxia
1000059|NCT03162640|Early onset of cannabis use|early onset of cannabis use
1000060|NCT03162640|Addiction|addiction
1000061|NCT03162640|Time perception|time perception
1000062|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
1000063|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1000064|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1000065|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
1000066|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
1000067|NCT03162627|Solid tumors|solid tumors
1000068|NCT03162627|Ras Pathway Alterations|ras pathway alterations
1000069|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
1000070|NCT03162627|Selumetinib|selumetinib
1000071|NCT03162627|AZD6244|azd6244
1000072|NCT03162627|Olaparib|olaparib
1000073|NCT03162627|Lynparza|lynparza
1000074|NCT03162614|healthy volunteers|healthy volunteers
1000075|NCT03162614|Malaria|malaria
1000076|NCT03162614|malaria vaccine|malaria vaccine
1000077|NCT03162614|controlled human challenge|controlled human challenge
1000078|NCT03162614|RTS,S/AS01|rts,s/as01
1000079|NCT03162536|ARQ 531|arq 531
1000080|NCT03162536|Hematologic Malignancies|hematologic malignancies
1000081|NCT03162536|SLL|sll
1000082|NCT03162536|CLL|cll
1000083|NCT03162536|B-cell NHL|b-cell nhl
1000084|NCT03162536|WM|wm
1000085|NCT03162536|BTK|btk
1000086|NCT03162536|cancer|cancer
1000087|NCT03162536|refractory|refractory
1000088|NCT03162536|relapsed|relapsed
1000089|NCT03162510|SOLAR regimen|solar regimen
1000090|NCT03162471|Corneal astigmatism|corneal astigmatism
1000091|NCT03162471|Cataract surgery|cataract surgery
1000092|NCT03162471|Corneal hysteresis|corneal hysteresis
1000093|NCT03162471|Corneal resistance factor|corneal resistance factor
1000094|NCT03162471|Intraocular pressure|intraocular pressure
1000095|NCT03162445|bone mineral density|bone mineral density
1000096|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
1000097|NCT03162445|Autism|autism
1000098|NCT03162432|IBD|ibd
1000099|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
1000100|NCT03162380|Bipolar Disorder|bipolar disorder
1000101|NCT03162380|occupational stress|occupational stress
1000102|NCT03162367|Burn|burn
1000103|NCT03162367|Epidermal cell suspension|epidermal cell suspension
1000104|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
1000105|NCT03162341|UltraSonography|ultrasonography
1000107|NCT03162341|Urate deposition|urate deposition
1000108|NCT03162302|MRI|mri
1000109|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
1000110|NCT03162302|fat quantification|fat quantification
1000111|NCT03162302|iron quantification|iron quantification
1000112|NCT03162289|Fasting|fasting
1000113|NCT03162289|Vegan|vegan
1000114|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
1000115|NCT03162276|The Work|the work
1000116|NCT03162276|RCT|rct
1000117|NCT03162276|IBSR|ibsr
1000118|NCT03162263|Ekso|ekso
1000119|NCT03162263|neuroplasticity|neuroplasticity
1000120|NCT03162263|functional recovery|functional recovery
1000121|NCT03162237|Type1 diabetes|type1 diabetes
1000122|NCT03162237|porcine islets|porcine islets
1000123|NCT03162237|treg cells|treg cells
1000124|NCT03162237|immunosuppress|immunosuppress
1000125|NCT03162237|xenotransplantation|xenotransplantation
1000126|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1000127|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
1000128|NCT03162224|HPV|hpv
1000129|NCT03162224|Human Papilloma Virus|human papilloma virus
1000130|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
1000131|NCT03162224|Check point inhibitors|check point inhibitors
1000132|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
1000133|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
1000134|NCT03162224|Durvalumab|durvalumab
1000135|NCT03162224|MEDI0457|medi0457
1000136|NCT03162224|Antineoplastic agents|antineoplastic agents
1000137|NCT03162224|Neoplasms|neoplasms
1000138|NCT03162185|Neuroplasticity|neuroplasticity
1000139|NCT03162185|SSRI|ssri
1000140|NCT03162185|Motor Learning|motor learning
1000141|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
1000142|NCT03162172|short stature|short stature
1000143|NCT03162172|growth hormone treatment|growth hormone treatment
1000144|NCT03162133|Breast Cancer|breast cancer
1000145|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
1000146|NCT03162133|Baduanjin Exercise|baduanjin exercise
1000147|NCT03162107|adherence|adherence
1000148|NCT03162107|HIV|hiv
1000149|NCT03162107|MDR/XDR TB|mdr/xdr tb
1000150|NCT03162107|Health Care Worker|health care worker
1000151|NCT03162081|addiction|addiction
1000152|NCT03162081|cognition|cognition
1000153|NCT03162081|impulsivity|impulsivity
1000154|NCT03162081|neuropsychology|neuropsychology
1000155|NCT03162081|prescription drug misuse|prescription drug misuse
1000156|NCT03162081|dependence|dependence
1000157|NCT03162068|Cushing's syndrome|cushing's syndrome
1000158|NCT03162068|Osteoporosis|osteoporosis
1000159|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
1000160|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
1000161|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
1000162|NCT03162068|Bone Strength|bone strength
1000163|NCT03162055|COPD|copd
1000164|NCT03162042|Activin A|activin a
1000165|NCT03162042|Myostatin|myostatin
1000166|NCT03162042|Follistatin|follistatin
1000167|NCT03162042|Cachexia|cachexia
1000168|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
1000169|NCT03162029|CBCT|cbct
1000170|NCT03162029|Bone quality|bone quality
1000171|NCT03162029|Renal failure|renal failure
1000172|NCT03161990|DAIR|dair
1000173|NCT03161990|Transgluteal approach|transgluteal approach
1000174|NCT03161990|Posterior approach|posterior approach
1000175|NCT03161964|Hypoglycemia|hypoglycemia
1000176|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
1000177|NCT03161964|Propranolol|propranolol
1000178|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
1000179|NCT03161912|Diabetes|diabetes
1000180|NCT03161912|Retinal Diseases|retinal diseases
1000181|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
1000182|NCT03161912|Diabetic macular edema|diabetic macular edema
1000183|NCT03161912|Retinal vein occlusion|retinal vein occlusion
1000184|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
1000185|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
1000186|NCT03161912|VEGF inhibitor|vegf inhibitor
1000187|NCT03161912|aflibercept|aflibercept
1000188|NCT03161912|real world data|real world data
1000189|NCT03161912|treatment pattern|treatment pattern
1000190|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
1000191|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
1000192|NCT03161860|Program evaluation|program evaluation
1000193|NCT03161860|Cost-effectiveness|cost-effectiveness
1000194|NCT03161860|Community participation|community participation
1000195|NCT03161860|empowerment|empowerment
1000196|NCT03161847|OPMD|opmd
1000197|NCT03161834|DNA|dna
1000198|NCT03161834|Circulating tumor cells|circulating tumor cells
1000199|NCT03161795|Chemical coping|chemical coping
1000200|NCT03161795|Long-term opioid therapy|long-term opioid therapy
1000201|NCT03161795|Risk factors|risk factors
1000202|NCT03161795|Predictive tools|predictive tools
1000203|NCT03161795|Frequency|frequency
1000204|NCT03161782|pain|pain
1000205|NCT03161782|exercise|exercise
1000206|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
1000207|NCT03161782|static stretching|static stretching
1000208|NCT03161743|platelet-rich plasma|platelet-rich plasma
1000209|NCT03161743|platelet|platelet
1000210|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
1000211|NCT03161717|electrical stimulation|electrical stimulation
1000212|NCT03161717|vaginal delivery|vaginal delivery
1000213|NCT03161678|Pharmacogenetics|pharmacogenetics
1000214|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
1000215|NCT03161678|Antiplatelet therapy|antiplatelet therapy
1000216|NCT03161652|diabetic retinopathy|diabetic retinopathy
1000217|NCT03161652|blindness|blindness
1000218|NCT03161652|eye|eye
1000219|NCT03161652|macular edema|macular edema
1000220|NCT03161652|prolactin|prolactin
1000221|NCT03161652|dopamine antagonists|dopamine antagonists
1000222|NCT03161652|peptide hormones|peptide hormones
1000223|NCT03161639|Pulpectomy|pulpectomy
1000224|NCT03161639|Primary teeth|primary teeth
1000225|NCT03161639|Working length|working length
1000226|NCT03161639|Apex locator|apex locator
1000227|NCT03161587|FEV1|fev1
1000228|NCT03161587|COPD|copd
1000229|NCT03161587|CAT|cat
1000230|NCT03161587|treatment modality|treatment modality
1000231|NCT03161587|FVC|fvc
1000232|NCT03161587|GOLD 2016|gold 2016
1000233|NCT03161587|mMRC|mmrc
1000234|NCT03161574|neochemotherapy|neochemotherapy
1000235|NCT03161574|CRM|crm
1000236|NCT03161522|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1000237|NCT03161522|Esophageal Cancer|esophageal cancer
1000238|NCT03161522|Gastric Cancer|gastric cancer
1000239|NCT03161522|Oligometastatic|oligometastatic
1000240|NCT03161522|Chemotherapy|chemotherapy
1000241|NCT03161522|Radiation therapy|radiation therapy
1000242|NCT03161522|Surgery|surgery
1000243|NCT03161522|Questionnaires|questionnaires
1000244|NCT03161522|Surveys|surveys
1000245|NCT03161483|CC-220|cc-220
1000246|NCT03161483|Safety|safety
1000247|NCT03161483|Efficacy|efficacy
1000248|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
1000249|NCT03161457|RA|ra
1000250|NCT03161457|Moderate RA|moderate ra
1000251|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1000252|NCT03161457|Severe RA|severe ra
1000253|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
1000640|NCT03158948|TREM1|trem1
1000254|NCT03161457|Moderate to Severe RA|moderate to severe ra
1000255|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
1000256|NCT03161431|Immunotherapy|immunotherapy
1000257|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
1000258|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
1000259|NCT03161405|Drug Therapy|drug therapy
1000260|NCT03161392|mammography|mammography
1000261|NCT03161392|ductal ectasia|ductal ectasia
1000262|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
1000263|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
1000264|NCT03161392|female|female
1000265|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
1000266|NCT03161379|immunotherapy|immunotherapy
1000267|NCT03161379|Cytoxan|cytoxan
1000268|NCT03161379|Cyclophosphamide|cyclophosphamide
1000269|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
1000270|NCT03161379|SBRT|sbrt
1000271|NCT03161379|GVAX|gvax
1000272|NCT03161379|Nivolumab|nivolumab
1000273|NCT03161379|borderline resectable|borderline resectable
1000274|NCT03161379|Radioimmunotherapy|radioimmunotherapy
1000275|NCT03161379|Vaccine|vaccine
1000276|NCT03161379|Antibody|antibody
1000277|NCT03161379|Anti-PD-1|anti-pd-1
1000278|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
1000279|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
1000280|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
1000281|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
1000282|NCT03161340|Rapamycin|rapamycin
1000283|NCT03161340|Pregnancy Rate|pregnancy rate
1000284|NCT03161327|ankle brachial index|ankle brachial index
1000285|NCT03161327|peripheral arterial disease|peripheral arterial disease
1000286|NCT03161314|Plantar Fasciitis|plantar fasciitis
1000287|NCT03161314|Plantar Heel Pain|plantar heel pain
1000288|NCT03161314|Multisegment Foot Motion|multisegment foot motion
1000289|NCT03161314|EMG|emg
1000290|NCT03161314|Gait|gait
1000291|NCT03161275|cerebral saturation|cerebral saturation
1000292|NCT03161275|epidural anaesthesia|epidural anaesthesia
1000293|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
1000294|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
1000295|NCT03161262|Text-message reminder|text-message reminder
1000296|NCT03161262|Post-operative medication|post-operative medication
1000297|NCT03161262|Behavioral Research|behavioral research
1000298|NCT03161262|Social Research|social research
1000299|NCT03161262|Short Message Service (SMS)|short message service (sms)
1000300|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
1000301|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
1000302|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
1000303|NCT03161184|maternal health|maternal health
1000304|NCT03161184|community health|community health
1000305|NCT03161184|health services|health services
1000306|NCT03161184|Tanzania|tanzania
1000307|NCT03161184|evaluation|evaluation
1000308|NCT03161184|cluster randomized trial|cluster randomized trial
1000309|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
1000310|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
1000311|NCT03161158|Ultrafiltration|ultrafiltration
1000312|NCT03161067|Tetraplegia|tetraplegia
1000313|NCT03161067|Rehabilitation|rehabilitation
1000314|NCT03161067|Brain Computer Interface|brain computer interface
1000315|NCT03161067|Intracortical Microstimulation|intracortical microstimulation
1000316|NCT03161067|Upper extremity prosthetics|upper extremity prosthetics
1000317|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
1000318|NCT03161054|Elderly non-fit patients|elderly non-fit patients
1000319|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
1000320|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
1000321|NCT03161028|multiple sclerosis|multiple sclerosis
1000322|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
1000323|NCT03161028|gait|gait
1000324|NCT03161028|neuroprotective agents|neuroprotective agents
1000325|NCT03161028|thioctic acid|thioctic acid
1000326|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
1000327|NCT03161028|mobility|mobility
1000328|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
1000329|NCT03160989|Blood pressure variability|blood pressure variability
1000330|NCT03160989|Combined physical exercise|combined physical exercise
1000331|NCT03160989|Hypertension|hypertension
1000332|NCT03160963|elderly|elderly
1000333|NCT03160937|pain|pain
1000334|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
1000335|NCT03160924|ERAS|eras
1000336|NCT03160924|Fast track recovery|fast track recovery
1000337|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
1000338|NCT03160924|Gastric Cancer|gastric cancer
1000339|NCT03160911|Over-the-scope clip|over-the-scope clip
1000340|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
1000341|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1000342|NCT03160898|ALS|als
1000343|NCT03160898|CK-2127107|ck-2127107
1000641|NCT03158948|TREM-1|trem-1
1000344|NCT03160872|Donor sperm insemination|donor sperm insemination
1000345|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
1000346|NCT03160872|Ovarian reserve|ovarian reserve
1000347|NCT03160872|Antral follicle count|antral follicle count
1000348|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
1000349|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
1000350|NCT03160859|cap|cap
1000351|NCT03160859|colonoscopy pain|colonoscopy pain
1000352|NCT03160846|Inotrope|inotrope
1000353|NCT03160846|Milrinone|milrinone
1000354|NCT03160846|Dopamine|dopamine
1000355|NCT03160846|Dobutamine|dobutamine
1000356|NCT03160833|HMPL453|hmpl453
1000357|NCT03160833|solid tumor|solid tumor
1000358|NCT03160833|dose escalation|dose escalation
1000359|NCT03160794|Prostate cancer|prostate cancer
1000360|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
1000361|NCT03160794|PET/MR|pet/mr
1000362|NCT03160768|p16|p16
1000363|NCT03160768|T cell isolation|t cell isolation
1000364|NCT03160768|physiologic age|physiologic age
1000365|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
1000366|NCT03160690|Choroidal thickness|choroidal thickness
1000367|NCT03160690|Open Angle Glaucoma|open angle glaucoma
1000368|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
1000369|NCT03160677|Acute Stroke|acute stroke
1000370|NCT03160677|Blood Pressure|blood pressure
1000371|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
1000372|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
1000373|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
1000374|NCT03160664|bipolar mania|bipolar mania
1000375|NCT03160664|cognition|cognition
1000376|NCT03160664|randomized controlled trial|randomized controlled trial
1000377|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
1000378|NCT03160651|spontaneous improvement|spontaneous improvement
1000379|NCT03160651|corticosteroids|corticosteroids
1000380|NCT03160638|Azithromycin|azithromycin
1000381|NCT03160638|Immunomodulation|immunomodulation
1000382|NCT03160638|Pharmacokinetics|pharmacokinetics
1000383|NCT03160638|Tissue degradation|tissue degradation
1000384|NCT03160638|Tissue remodelling|tissue remodelling
1000385|NCT03160612|Wheelchair|wheelchair
1000386|NCT03160612|Biomechanics|biomechanics
1000387|NCT03160612|Transfer|transfer
1000388|NCT03160612|Training|training
1000389|NCT03160586|Stuttering|stuttering
1000390|NCT03160586|Anxiety|anxiety
1000391|NCT03160495|PET/MR|pet/mr
1568409|NCT00505947|maculopathy|maculopathy
1022798|NCT03020433|CVA|cva
1000392|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
1000393|NCT03160495|Heterogeneity|heterogeneity
1000394|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
1000395|NCT03160482|Papillary Carcinoma|papillary carcinoma
1000396|NCT03160482|Follicular Carcinoma|follicular carcinoma
1000397|NCT03160482|Colloid Nodule|colloid nodule
1000398|NCT03160482|Hyperplastic Nodule|hyperplastic nodule
1000399|NCT03160482|Adenomatoid Nodule|adenomatoid nodule
1000400|NCT03160482|Follicular Adenoma|follicular adenoma
1000401|NCT03160482|Thyroid Cancer|thyroid cancer
1000402|NCT03160482|Bethesda Classification|bethesda classification
1000403|NCT03160482|Biomarkers|biomarkers
1000404|NCT03160482|Protein convertase|protein convertase
1000405|NCT03160469|obesity|obesity
1000406|NCT03160456|upper airway|upper airway
1000407|NCT03160456|genioglossus|genioglossus
1000408|NCT03160456|CPAP|cpap
1000409|NCT03160456|electrical stimulation|electrical stimulation
1000410|NCT03160456|sleep|sleep
1000411|NCT03160456|sleep disordered breathing|sleep disordered breathing
1000412|NCT03160443|Anorexia nervosa|anorexia nervosa
1000413|NCT03160443|Bulimia|bulimia
1000414|NCT03160443|Binge eating disorders|binge eating disorders
1000415|NCT03160443|Neuropsychology|neuropsychology
1000416|NCT03160443|Neurocognition|neurocognition
1000417|NCT03160443|Daily functioning|daily functioning
1000418|NCT03160430|Chronic Kidney Failure|chronic kidney failure
1000419|NCT03160430|ESRD|esrd
1000420|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
1000421|NCT03160430|End-Stage Renal Disease|end-stage renal disease
1000422|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
1000423|NCT03160430|Renal Failure, Chronic|renal failure, chronic
1000424|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
1000425|NCT03160404|Exercise|exercise
1000426|NCT03160404|Zolpidem|zolpidem
1000427|NCT03160404|Sleep|sleep
1000428|NCT03160326|chronic kidney disease|chronic kidney disease
1000429|NCT03160326|ultrasound|ultrasound
1000430|NCT03160326|muscle loss|muscle loss
1000431|NCT03160313|Social engagement|social engagement
1000432|NCT03160313|Physical Activity|physical activity
1000433|NCT03160313|Sleep Quality|sleep quality
1000434|NCT03160313|Traumatic Brain Injury|traumatic brain injury
1000435|NCT03160313|Veteran|veteran
1000436|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
1000437|NCT03160274|tumor suppressor gene|tumor suppressor gene
1000438|NCT03160274|oncogene|oncogene
1000439|NCT03160274|mutation|mutation
1000440|NCT03160274|susceptibility gene|susceptibility gene
1000441|NCT03160222|reliability|reliability
1000442|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
1000443|NCT03160222|computed tomography|computed tomography
1000444|NCT03160222|strength|strength
1000445|NCT03160222|mobility|mobility
1000446|NCT03160209|risk factors|risk factors
1000447|NCT03160209|case-control study|case-control study
1000448|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1000449|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1000450|NCT03160183|initiating chemotherapy|initiating chemotherapy
1000451|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
1000452|NCT03160183|non randomized, non interventional|non randomized, non interventional
1000453|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
1000454|NCT03160170|operative time and efficiency|operative time and efficiency
1000455|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
1000456|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
1000457|NCT03160144|open lung approach|open lung approach
1000458|NCT03160131|Stroke|stroke
1000459|NCT03160131|Visual impairment|visual impairment
1000460|NCT03160131|Hemianopia|hemianopia
1000461|NCT03160131|Neuro Vision Technology|neuro vision technology
1000462|NCT03160131|Rehabilitation|rehabilitation
1000463|NCT03160079|blinatumomab|blinatumomab
1000464|NCT03160079|pembrolizumab|pembrolizumab
1000465|NCT03160079|MK-3475|mk-3475
1000466|NCT03160079|relapsed|relapsed
1000467|NCT03160079|refractory|refractory
1000468|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
1000469|NCT03160079|ALL|all
1000470|NCT03160066|Psychobiotic|psychobiotic
1000471|NCT03160066|Brain-gut axis|brain-gut axis
1000472|NCT03160066|Stress|stress
1000473|NCT03160066|Cognition|cognition
1000474|NCT03160066|EEG|eeg
1000475|NCT03160001|Niclosamide|niclosamide
1000476|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
1000477|NCT03160001|diseases activity|diseases activity
1000478|NCT03160001|Efficacy|efficacy
1000479|NCT03160001|Safety|safety
1000480|NCT03159975|Tuberculosis|tuberculosis
1000481|NCT03159975|DNA vaccine|dna vaccine
1000482|NCT03159975|Electroporation|electroporation
1000483|NCT03159975|GX-70|gx-70
1000484|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
1000485|NCT03159962|Mandibular response|mandibular response
1000486|NCT03159962|Class II malocclusion|class ii malocclusion
1000487|NCT03159962|Growing subjects|growing subjects
1000488|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
1000489|NCT03159910|Shoulder Pain|shoulder pain
1000490|NCT03159910|Occupational Exposure|occupational exposure
1000491|NCT03159910|Clinical Trial|clinical trial
1000492|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
1000493|NCT03159897|ABVD DD-DI|abvd dd-di
1000494|NCT03159897|PET|pet
1000495|NCT03159871|Cesarean section|cesarean section
1000496|NCT03159871|C- section|c- section
1000497|NCT03159871|Suture|suture
1000498|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
1000499|NCT03159845|zinc|zinc
1000500|NCT03159832|Efficacy|efficacy
1000501|NCT03159832|PK/PD study|pk/pd study
1000502|NCT03159832|Renal Insufficiency|renal insufficiency
1000503|NCT03159832|Type 2 Diabetes|type 2 diabetes
1000504|NCT03159728|Ability Care|ability care
1000505|NCT03159728|Caregiver overload|caregiver overload
1000506|NCT03159728|Family caregiver|family caregiver
1000507|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
1000508|NCT03159702|hematological malignancy|hematological malignancy
1000509|NCT03159702|EVOMELA|evomela
1000510|NCT03159702|Melphalan HCl|melphalan hcl
1000511|NCT03159702|Total Body Irradiation|total body irradiation
1000512|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
1000513|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
1000514|NCT03159702|Fludarabine|fludarabine
1000515|NCT03159702|Hematologic Diseases|hematologic diseases
1000516|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
1000517|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
1000518|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
1000519|NCT03159676|Prostate cancer|prostate cancer
1000520|NCT03159676|Radiation therapy|radiation therapy
1000521|NCT03159676|Radiotherapy|radiotherapy
1000522|NCT03159676|Proton|proton
1000523|NCT03159676|Proton beam|proton beam
1000524|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
1000525|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
1000526|NCT03159676|SABR|sabr
1000527|NCT03159676|SBRT|sbrt
1000528|NCT03159676|Localized|localized
1000529|NCT03159676|Low risk|low risk
1000530|NCT03159676|Intermediate risk|intermediate risk
1000531|NCT03159637|Pneumoperitoneum|pneumoperitoneum
1000532|NCT03159637|Trendelenburg position|trendelenburg position
1000533|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
1000534|NCT03159624|nasoseptal flap|nasoseptal flap
1000535|NCT03159624|tissue repair|tissue repair
1000536|NCT03159624|wound healing|wound healing
1000537|NCT03159624|remucosalization|remucosalization
1000538|NCT03159624|upper airway|upper airway
1000539|NCT03159624|granulation tissue|granulation tissue
1000741|NCT03158259|MSU|msu
1000540|NCT03159624|tissue graft|tissue graft
1000541|NCT03159598|A-BR|a-br
1000542|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
1000543|NCT03159598|Seroma|seroma
1000544|NCT03159572|Ovarian cancer|ovarian cancer
1000545|NCT03159572|Fallopian tube cancer|fallopian tube cancer
1000546|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
1000547|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
1000548|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
1000549|NCT03159520|Pain|pain
1000550|NCT03159507|Omega-3 Index|omega-3 index
1000551|NCT03159507|Cellular metabolism|cellular metabolism
1000552|NCT03159507|EPA Monoglyceride|epa monoglyceride
1000553|NCT03159507|Quality of life|quality of life
1000554|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1000555|NCT03159442|Asthma|asthma
1000556|NCT03159442|AZD8871|azd8871
1000557|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
1000558|NCT03159442|Phase I|phase i
1000560|NCT03159442|Tolerability|tolerability
1000561|NCT03159442|Pharmacokinetics|pharmacokinetics
1000562|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
1000563|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
1000564|NCT03159442|Japanese|japanese
1000565|NCT03159390|dietary supplements|dietary supplements
1000566|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
1000567|NCT03159364|Virus-CTL|virus-ctl
1000569|NCT03159364|CMV|cmv
1000570|NCT03159364|ADV|adv
1000571|NCT03159364|BKV|bkv
1000572|NCT03159325|internet|internet
1000573|NCT03159325|chronic disease management|chronic disease management
1000574|NCT03159325|technology|technology
1000575|NCT03159325|telehealth|telehealth
1000576|NCT03159325|application|application
1000577|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
1000578|NCT03159299|mHealth|mhealth
1000579|NCT03159299|Hispanic/Latinos|hispanic/latinos
1000580|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
1000581|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
1000582|NCT03159273|Cold symptoms|cold symptoms
1000583|NCT03159273|Stress|stress
1000584|NCT03159273|Immunity|immunity
1000585|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
1000586|NCT03159273|Lung function|lung function
1000587|NCT03159273|Cardiovascular activity|cardiovascular activity
1000588|NCT03159260|night-time leg cramps|night-time leg cramps
1000589|NCT03159260|topical|topical
1000590|NCT03159260|spasm|spasm
1000591|NCT03159247|education|education
1000592|NCT03159247|counseling|counseling
1000593|NCT03159247|motivational interviewing|motivational interviewing
1000594|NCT03159247|tailoring|tailoring
1000595|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
1000596|NCT03159221|obesity in adolescents|obesity in adolescents
1000597|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
1000598|NCT03159208|Prognosis|prognosis
1000599|NCT03159208|Critical Illness|critical illness
1000600|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
1000601|NCT03159208|Disease Attributes|disease attributes
1000602|NCT03159208|Socioeconomic Factors|socioeconomic factors
1000603|NCT03159208|Activities of Daily LIving|activities of daily living
1000604|NCT03159208|Cognition|cognition
1000605|NCT03159195|metastatic breast cancer|metastatic breast cancer
1000606|NCT03159195|advanced breast cancer|advanced breast cancer
1000607|NCT03159195|HR+/ HER2-|hr+/ her2-
1000608|NCT03159182|Hypertrophic scarring|hypertrophic scarring
1000609|NCT03159182|Silicone Material|silicone material
1000610|NCT03159182|Pressure garments|pressure garments
1000611|NCT03159169|Neck Pain|neck pain
1000612|NCT03159169|Upper Limb Pain|upper limb pain
1000613|NCT03159130|Pain pump catheters|pain pump catheters
1000614|NCT03159130|bariatric surgery|bariatric surgery
1000615|NCT03159130|OnQ pump|onq pump
1000616|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
1000617|NCT03159130|continuous infusion catheter|continuous infusion catheter
1000618|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
1000619|NCT03159117|Stage III Melanoma|stage iii melanoma
1000620|NCT03159117|Stage IV Melanoma|stage iv melanoma
1000621|NCT03159117|17-165|17-165
1000622|NCT03159078|Acinetobacter|acinetobacter
1000623|NCT03159078|Polymyxins|polymyxins
1000624|NCT03159078|Imipenem|imipenem
1000625|NCT03159078|Pseudomona|pseudomona
1000626|NCT03159078|Klebsiella|klebsiella
1000627|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
1000628|NCT03159013|Pyrethroids|pyrethroids
1000629|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
1000630|NCT03159013|Biomarkers|biomarkers
1000631|NCT03159013|Toxicokinetics|toxicokinetics
1000632|NCT03158974|External Genital Warts|external genital warts
1000633|NCT03158961|Thyroid|thyroid
1000634|NCT03158961|Thyroidectomy|thyroidectomy
1000635|NCT03158961|Transoral|transoral
1000636|NCT03158961|Endoscopic|endoscopic
1000637|NCT03158961|Surgery|surgery
1000638|NCT03158948|Sepsis|sepsis
1000639|NCT03158948|LR12|lr12
1000642|NCT03158935|adoptive cell therapy|adoptive cell therapy
1000643|NCT03158935|melanoma|melanoma
1000644|NCT03158935|ovarian|ovarian
1000645|NCT03158935|cyclophosphamide|cyclophosphamide
1000646|NCT03158935|fludarabine|fludarabine
1000647|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
1000648|NCT03158935|pembrolizumab|pembrolizumab
1000649|NCT03158935|interleukin-2|interleukin-2
1000650|NCT03158935|anti-PD-1|anti-pd-1
1000651|NCT03158935|immune checkpoint|immune checkpoint
1000652|NCT03158909|Eyemask|eyemask
1000653|NCT03158909|Earplugs|earplugs
1000654|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
1000655|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1000656|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
1000657|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
1000658|NCT03158896|Wharton's jelly|wharton's jelly
1000659|NCT03158896|umbilical cord blood|umbilical cord blood
1000660|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
1000661|NCT03158883|Avelumab|avelumab
1000662|NCT03158883|NSCLC|nsclc
1000663|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
1000664|NCT03158857|Myanmar|myanmar
1000665|NCT03158857|HIV|hiv
1000666|NCT03158831|Drug Allergy|drug allergy
1000667|NCT03158831|Penicillin Allergy|penicillin allergy
1000668|NCT03158831|Antibiotic Allergy|antibiotic allergy
1000669|NCT03158831|Graded Drug Challenge|graded drug challenge
1000670|NCT03158792|Anticoagulation|anticoagulation
1000671|NCT03158792|Thromboprophylaxis|thromboprophylaxis
1000672|NCT03158792|Anti-Xa levels|anti-xa levels
1000673|NCT03158792|Elderly|elderly
1000674|NCT03158792|Prevention|prevention
1000675|NCT03158792|Enoxaparin|enoxaparin
1000676|NCT03158792|Low molecular weight heparin|low molecular weight heparin
1000677|NCT03158766|infection|infection
1000678|NCT03158766|intervertebral disc|intervertebral disc
1000679|NCT03158766|Propionibacterium acnes|propionibacterium acnes
1000680|NCT03158766|spine|spine
1000681|NCT03158727|intensive care|intensive care
1000682|NCT03158701|evaluation|evaluation
1568410|NCT00505947|infliximab|infliximab
1000683|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
1000684|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
1000685|NCT03158662|Recessive Dystrophic|recessive dystrophic
1000686|NCT03158662|Simplex|simplex
1000687|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
1000688|NCT03158649|Pregnancy|pregnancy
1000689|NCT03158649|Prenatal well-being|prenatal well-being
1000690|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
1000691|NCT03158649|Positive Psychology|positive psychology
1000692|NCT03158649|Positive Psychology Intervention|positive psychology intervention
1000693|NCT03158649|Web-based intervention|web-based intervention
1000694|NCT03158623|total joint arthroplasty|total joint arthroplasty
1000695|NCT03158623|platelet-rich plasma|platelet-rich plasma
1000696|NCT03158623|activated collagen|activated collagen
1000697|NCT03158571|Gastric Cancer|gastric cancer
1000698|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
1000699|NCT03158571|cancer subtypes|cancer subtypes
1000700|NCT03158571|prognosis|prognosis
1000701|NCT03158571|survival|survival
1000702|NCT03158571|molecular classification|molecular classification
1000703|NCT03158571|chemotherapy|chemotherapy
1000704|NCT03158571|immunotherapy|immunotherapy
1000705|NCT03158519|Physical activity|physical activity
1000706|NCT03158480|DC-CIK|dc-cik
1000707|NCT03158480|interferon|interferon
1000708|NCT03158441|MRI|mri
1000709|NCT03158441|Diffusion|diffusion
1000710|NCT03158441|DTI|dti
1000711|NCT03158415|mHealth|mhealth
1000712|NCT03158402|Inspiratory muscle training|inspiratory muscle training
1000844|NCT03157765|endometrial injury|endometrial injury
1000713|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1000714|NCT03158389|MGMT methylation|mgmt methylation
1000715|NCT03158389|targeted therapy|targeted therapy
1000716|NCT03158389|umbrella protocol|umbrella protocol
1000717|NCT03158376|gabapentin|gabapentin
1000718|NCT03158376|thoracotomy|thoracotomy
1000719|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
1000720|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
1000721|NCT03158376|quality of life|quality of life
1000722|NCT03158376|neuropathic pain|neuropathic pain
1000723|NCT03158363|immobilization|immobilization
1000724|NCT03158363|fasting|fasting
1000725|NCT03158363|endotoxemia|endotoxemia
1000726|NCT03158363|LPS|lps
1000727|NCT03158363|metabolism|metabolism
1000728|NCT03158363|model of disease|model of disease
1000729|NCT03158337|Exercise|exercise
1000730|NCT03158337|Physical Activity|physical activity
1000731|NCT03158337|Brain blood flow|brain blood flow
1000732|NCT03158337|Cognition|cognition
1000733|NCT03158337|Fitness|fitness
1000734|NCT03158311|QVM149|qvm149
1000735|NCT03158311|asthma|asthma
1000736|NCT03158311|adult|adult
1000737|NCT03158259|IS|is
1000738|NCT03158259|ICH|ich
1000739|NCT03158259|rtPa|rtpa
1000740|NCT03158259|Prehospital|prehospital
1000742|NCT03158246|zoledronic acid|zoledronic acid
1000743|NCT03158246|Yigu|yigu
1000744|NCT03158246|Aclasta|aclasta
1000745|NCT03158246|Osteoporosis|osteoporosis
1000746|NCT03158246|Postmenopausal|postmenopausal
1000747|NCT03158246|BMD|bmd
1000748|NCT03158246|fracture|fracture
1000749|NCT03158246|Biochemical markers|biochemical markers
1000750|NCT03158233|Zika virus disease|zika virus disease
1000751|NCT03158194|Anxiety|anxiety
1000752|NCT03158194|Stress|stress
1000753|NCT03158194|Asthma|asthma
1000754|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
1000755|NCT03158129|Non-Small Cell Lung Cancer|non-small cell lung cancer
1000756|NCT03158129|NSCLC|nsclc
1000757|NCT03158129|Nivolumab|nivolumab
1000758|NCT03158129|BMS-936558|bms-936558
1000759|NCT03158129|Opdivo|opdivo
1000760|NCT03158129|Ipilimumab|ipilimumab
1000761|NCT03158129|Yervoy|yervoy
1000762|NCT03158129|BMS-734016|bms-734016
1000763|NCT03158129|MDX010|mdx010
1000764|NCT03158129|Amenable For Surgical Resection|amenable for surgical resection
1000765|NCT03158116|tracheostomy tube|tracheostomy tube
1000766|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
1000767|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
1000768|NCT03158103|Pexidartinib|pexidartinib
1000770|NCT03158090|Acromegaly|acromegaly
1000771|NCT03158064|17-160|17-160
1000772|NCT03158064|durvalumab|durvalumab
1000773|NCT03158064|tremelimumab|tremelimumab
1000774|NCT03158064|MEDI4736|medi4736
1000775|NCT03158051|Hypertension|hypertension
1000776|NCT03158051|Young Adult|young adult
1000777|NCT03158051|Self-Management|self-management
1000778|NCT03158051|Health coach|health coach
1000779|NCT03158038|Trivalent|trivalent
1000780|NCT03158038|Influenza|influenza
1000781|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
1000782|NCT03158038|Vaccine|vaccine
1000783|NCT03158038|Prevention|prevention
1000784|NCT03158038|Healthy|healthy
1000785|NCT03158038|Monovalent|monovalent
1000786|NCT03158025|Recreational sedatives|recreational sedatives
1568411|NCT00505934|Epilepsy|epilepsy
1000787|NCT03158025|Healthy participants|healthy participants
1000788|NCT03158025|Lemborexant|lemborexant
1000789|NCT03158025|E2006|e2006
1000790|NCT03158025|Zolpidem|zolpidem
1000791|NCT03158025|Suvorexant|suvorexant
1000792|NCT03157999|Older Adults|older adults
1000793|NCT03157999|Transitional Care|transitional care
1000794|NCT03157999|Caregiver|caregiver
1000795|NCT03157999|Intervention|intervention
1000796|NCT03157986|COPD|copd
1000797|NCT03157986|Balance|balance
1000798|NCT03157986|Whole Body Vibration Training|whole body vibration training
1000799|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
1000800|NCT03157986|exercise|exercise
1000801|NCT03157973|Information Literacy|information literacy
1000802|NCT03157973|Nursing Care|nursing care
1000803|NCT03157973|Social Support|social support
1000804|NCT03157960|Fructose|fructose
1000805|NCT03157960|Uric acid|uric acid
1000806|NCT03157960|Oxidised LDL|oxidised ldl
1000807|NCT03157960|Interleukin 6|interleukin 6
1000808|NCT03157947|decision aid|decision aid
1000809|NCT03157947|focus group|focus group
1000810|NCT03157934|stroke network|stroke network
1000811|NCT03157934|acute stroke care|acute stroke care
1000812|NCT03157934|emergency medical services|emergency medical services
1000813|NCT03157934|integrated care|integrated care
1000814|NCT03157908|South Africa|south africa
1000815|NCT03157908|Retention in care|retention in care
1000816|NCT03157908|Pregnancy|pregnancy
1000817|NCT03157908|Mobile health|mobile health
1000818|NCT03157895|Foster Families|foster families
1000819|NCT03157882|pediatric|pediatric
1000820|NCT03157882|children|children
1000821|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
1000822|NCT03157882|Wong Baker FACES|wong baker faces
1000823|NCT03157882|pain scales|pain scales
1000824|NCT03157882|BRIGANCE|brigance
1000825|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
1000826|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
1000827|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
1000828|NCT03157856|Medical device|medical device
1000829|NCT03157830|Multiple Sclerosis|multiple sclerosis
1000830|NCT03157830|MS|ms
1000831|NCT03157830|ocrelizumab|ocrelizumab
1000832|NCT03157830|OCREVUS|ocrevus
1000833|NCT03157830|Natalizumab|natalizumab
1000834|NCT03157830|Tysabri|tysabri
1000835|NCT03157791|simethicone|simethicone
1000836|NCT03157778|pregnenolone|pregnenolone
1000837|NCT03157778|endocannabinoid|endocannabinoid
1000838|NCT03157778|food intake|food intake
1000839|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
1000840|NCT03157765|recurrent implantation failure|recurrent implantation failure
1000841|NCT03157765|frozen embryo transfer|frozen embryo transfer
1000842|NCT03157765|IVF|ivf
1000843|NCT03157765|endometrial scratch|endometrial scratch
1000845|NCT03157739|Migraine|migraine
1000846|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
1000847|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
1000848|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
1000849|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
1000850|NCT03157713|Obesity|obesity
1000851|NCT03157713|Weight-loss|weight-loss
1000852|NCT03157713|Financial Incentives|financial incentives
1000853|NCT03157713|Behavioral Economics|behavioral economics
1000854|NCT03157648|Shivering temperature|shivering temperature
1000855|NCT03157622|Chronic Low Back Pain|chronic low back pain
1000856|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
1000857|NCT03157622|Exposure|exposure
1000858|NCT03157622|Therapeutic processes|therapeutic processes
1000859|NCT03157622|Single-case study|single-case study
1000860|NCT03157609|Thermometry|thermometry
1000861|NCT03157609|SpotOn|spoton
1000862|NCT03157596|disability|disability
1000863|NCT03157596|developmental disability|developmental disability
1000864|NCT03157596|special healthcare needs|special healthcare needs
1000865|NCT03157557|Treatment|treatment
1000902|NCT03157336|Isoprostanes|isoprostanes
1000903|NCT03157336|Oxidative Damage|oxidative damage
1000904|NCT03157323|Glycemic Index|glycemic index
1000905|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1000906|NCT03157323|Dietary Change|dietary change
1000907|NCT03157323|Pediatric Oncology|pediatric oncology
1000908|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
1000909|NCT03157219|Heart failure|heart failure
1000910|NCT03157219|Institutional level registry|institutional level registry
1000911|NCT03157219|Systolic heart failure|systolic heart failure
1000912|NCT03157219|Acute heart failure|acute heart failure
1000913|NCT03157219|Heart failure India|heart failure india
1000914|NCT03157193|Peri-Implantitis|peri-implantitis
1000915|NCT03157193|Dental Implants|dental implants
1000916|NCT03157193|Hyaluronic Acid|hyaluronic acid
1000917|NCT03157193|Clinical Trial|clinical trial
1000918|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
1000919|NCT03157154|Haemophilia|haemophilia
1000920|NCT03157154|Atherosclerosis|atherosclerosis
1000921|NCT03157154|Atrial fibrillation|atrial fibrillation
1000922|NCT03157154|Antiplatelets|antiplatelets
1000923|NCT03157154|Anticoagulant|anticoagulant
1000924|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
1000925|NCT03157141|total ankle replacement|total ankle replacement
1000926|NCT03157141|ankle arthrodesis|ankle arthrodesis
1000927|NCT03157141|kinematics|kinematics
1000928|NCT03157141|kinetics|kinetics
1000929|NCT03157141|plantar pressure measurements|plantar pressure measurements
1000930|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
1001080|NCT03156946|mother-to-mother support|mother-to-mother support
1001081|NCT03156946|lactation consultant|lactation consultant
1001082|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
1001083|NCT03156946|peer counseling|peer counseling
1001084|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
1001085|NCT03156907|Chronic pain|chronic pain
1001086|NCT03156907|Analgesics opioids|analgesics opioids
1001087|NCT03156907|Withdrawal symptoms|withdrawal symptoms
1001088|NCT03156894|Graft Dysfunction|graft dysfunction
1001089|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
1001090|NCT03156894|heart transplant|heart transplant
1001091|NCT03156894|heart failure|heart failure
1001092|NCT03156894|Hemodynamic parameters|hemodynamic parameters
1001093|NCT03156894|Incidence of PDG|incidence of pdg
1001094|NCT03156855|efficacy|efficacy
1001095|NCT03156855|safety|safety
1001096|NCT03156855|H. pylori eradication|h. pylori eradication
1001097|NCT03156842|Hypertension|hypertension
1001098|NCT03156842|Dyslipidemia|dyslipidemia
1001099|NCT03156842|Fimasartan|fimasartan
1001100|NCT03156842|Rosuvastatin|rosuvastatin
1001101|NCT03156829|splinting|splinting
1001102|NCT03156829|steroid|steroid
1001103|NCT03156829|cortisone|cortisone
1001104|NCT03156829|trigger digit|trigger digit
1001105|NCT03156816|Myocardial Infarction|myocardial infarction
1001106|NCT03156816|STEMI|stemi
1001107|NCT03156816|Inflammation|inflammation
1001108|NCT03156816|Left ventricular remodeling|left ventricular remodeling
1001109|NCT03156816|Colchicine|colchicine
1001110|NCT03156816|CMR|cmr
1001111|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
1001112|NCT03156790|Spectrila®|spectrila®
1001113|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
1001114|NCT03156790|BRALL 2014|brall 2014
1001115|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
1001116|NCT03156764|Qp/Qs ratio|qp/qs ratio
1001117|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
1001118|NCT03156751|Syphilis screening|syphilis screening
1001119|NCT03156751|antenatal care|antenatal care
1001120|NCT03156751|prenatal diagnosis|prenatal diagnosis
1001121|NCT03156751|rapid diagnosis test|rapid diagnosis test
1001122|NCT03156751|Burkina Faso|burkina faso
1001123|NCT03156751|feasibility|feasibility
1001124|NCT03156725|Iron Bioavailability|iron bioavailability
1001125|NCT03156725|hepcidin|hepcidin
1001126|NCT03156725|ferritin|ferritin
1001127|NCT03156725|iron absorption|iron absorption
1001128|NCT03156725|iron status|iron status
1001129|NCT03156712|Anemia|anemia
1001130|NCT03156712|Iron deficiency anemia|iron deficiency anemia
1001131|NCT03156712|Iron fortification|iron fortification
1001132|NCT03156712|ferrous sulfate|ferrous sulfate
1001133|NCT03156712|aspergillus oryzae|aspergillus oryzae
1001134|NCT03156712|iron supplementation|iron supplementation
1001135|NCT03156712|AUC|auc
1001136|NCT03156686|Acute Heart Failure|acute heart failure
1001137|NCT03156686|Chronic Heart Failure|chronic heart failure
1001138|NCT03156686|Home care services|home care services
1001139|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
1001140|NCT03156686|Quality of life|quality of life
1001141|NCT03156634|Patient education|patient education
1001142|NCT03156634|Internet|internet
1001143|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
1001144|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
1001145|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
1001146|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
1001147|NCT03156530|Acupunture|acupunture
1001148|NCT03156530|Acupunture Therapy|acupunture therapy
1001149|NCT03156530|Acupunture Points|acupunture points
1001150|NCT03156530|Acupunture Ear|acupunture ear
1001151|NCT03156530|Postural Balance|postural balance
1001152|NCT03156517|Treatment|treatment
1001153|NCT03156517|Deep Brain Stimulation|deep brain stimulation
1001154|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
1001155|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
1001156|NCT03156517|Zona Incerta|zona incerta
1001157|NCT03156517|Efficacy|efficacy
1001158|NCT03156517|Safety|safety
1001159|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
1001160|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
1001161|NCT03156491|fetal-maternal interface|fetal-maternal interface
1001162|NCT03156491|decidualization|decidualization
1001163|NCT03156491|co-culture|co-culture
1001164|NCT03156491|implantation|implantation
1001165|NCT03156491|immune regulation|immune regulation
1001166|NCT03156478|Prevention|prevention
1001167|NCT03156478|Digital solutions|digital solutions
1001168|NCT03156478|Type 2 diabetes|type 2 diabetes
1001169|NCT03156478|Life style modification|life style modification
1001170|NCT03156478|Physical activity|physical activity
1001171|NCT03156478|Healthy diet|healthy diet
1001172|NCT03156478|Health economics|health economics
1001173|NCT03156478|Environmental choice architecture|environmental choice architecture
1001174|NCT03156478|Socio-economic facilitators|socio-economic facilitators
1001175|NCT03156478|Socio-economic barriers|socio-economic barriers
1001176|NCT03156478|Wellbeing|wellbeing
1001178|NCT03156387|scalpel surgery|scalpel surgery
1001179|NCT03156387|frenectomy|frenectomy
1001180|NCT03156387|postoperative complications|postoperative complications
1001181|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
1001182|NCT03156348|Older adult|older adult
1001183|NCT03156348|Internal medicine|internal medicine
1001184|NCT03156348|Adverse drug event|adverse drug event
1001185|NCT03156322|cesarean section|cesarean section
1001186|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
1001187|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
1001188|NCT03156322|postoperative pain|postoperative pain
1001189|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
1001190|NCT03156283|smartphone|smartphone
1001191|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
1001192|NCT03156283|adherence|adherence
1001193|NCT03156270|nasal valve|nasal valve
1001194|NCT03156270|nasal airway obstruction|nasal airway obstruction
1001195|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
1001197|NCT03156231|airway disease|airway disease
1001198|NCT03156231|bronchitis|bronchitis
1001199|NCT03156231|emphysema|emphysema
1001200|NCT03156231|altitude|altitude
1001201|NCT03156231|prevention|prevention
1001202|NCT03156231|acetazolamide|acetazolamide
1001203|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
1001204|NCT03156205|critically ill patients|critically ill patients
1001205|NCT03156205|music therapy|music therapy
1001206|NCT03156205|sleep|sleep
1001207|NCT03156205|delirium|delirium
1001208|NCT03156205|melatonin|melatonin
1001209|NCT03156205|elderly|elderly
1001210|NCT03156192|Caregivers|caregivers
1001211|NCT03156192|Family-centered care|family-centered care
1001212|NCT03156192|Music use|music use
1001213|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
1001214|NCT03156088|Predictors|predictors
1001215|NCT03156088|Sacral neuromodulation|sacral neuromodulation
1001216|NCT03156088|Outcomes|outcomes
1001217|NCT03156088|Overactive bladder|overactive bladder
1001218|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
1001219|NCT03156036|Temozolomide|temozolomide
1001220|NCT03156036|Capecitabine|capecitabine
1001221|NCT03156036|MGMT|mgmt
1001222|NCT03156010|oculomotor testing|oculomotor testing
1001223|NCT03155997|early stage breast cancer|early stage breast cancer
1001224|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
1001225|NCT03155971|Drug-Coated Balloon|drug-coated balloon
1001226|NCT03155971|Main Coronary Artery|main coronary artery
1001227|NCT03155971|De Novo Lesion|de novo lesion
1001228|NCT03155919|taurine|taurine
1001229|NCT03155919|triathletes|triathletes
1001230|NCT03155919|oxidative stress|oxidative stress
1001231|NCT03155919|chocolate milk|chocolate milk
1001232|NCT03155906|Chronic hepatitis C|chronic hepatitis c
1001233|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
1001234|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
1001235|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
1001236|NCT03155841|Prevention|prevention
1001237|NCT03155841|Internet|internet
1001238|NCT03155841|Adolescence|adolescence
1001239|NCT03155841|LGBT|lgbt
1001240|NCT03155841|Sexuality|sexuality
1001241|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
1001242|NCT03155763|kidney transplantation|kidney transplantation
1001243|NCT03155763|implantation biopsy|implantation biopsy
1001244|NCT03155763|histology|histology
1001245|NCT03155763|allograft function|allograft function
1001246|NCT03155763|allograft survival|allograft survival
1001247|NCT03155750|insomnia|insomnia
1001248|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
1001249|NCT03155685|antipsychotic|antipsychotic
1001250|NCT03155685|palliative care|palliative care
1001251|NCT03155659|Fish|fish
1001252|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
1001253|NCT03155659|Mortality|mortality
1001254|NCT03155659|CHNS|chns
1001255|NCT03155659|NHANES|nhanes
1001256|NCT03155646|TAP block|tap block
1001257|NCT03155646|Dexmedetomidine|dexmedetomidine
1001258|NCT03155646|Clonidine|clonidine
1001259|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
1001260|NCT03155594|Diabetes|diabetes
1001261|NCT03155594|Diabetes Mellitus|diabetes mellitus
1001262|NCT03155594|Diabetes Type 1|diabetes type 1
1001263|NCT03155594|Diabetes Type 2|diabetes type 2
1001264|NCT03155594|CGM|cgm
1001265|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
1001266|NCT03155594|Inpatient|inpatient
1001267|NCT03155594|Outpatient|outpatient
1001268|NCT03155594|Transition of care|transition of care
1001269|NCT03155594|DM-1|dm-1
1001270|NCT03155594|DM-2|dm-2
1001271|NCT03155594|Freestyle Libre|freestyle libre
1001272|NCT03155555|Fluid Responsiveness|fluid responsiveness
1001273|NCT03155555|Pediatric surgery|pediatric surgery
1001274|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
1001275|NCT03155542|alcohol|alcohol
1001276|NCT03155542|gene polymorphisms|gene polymorphisms
1001277|NCT03155542|Colorectal cancer|colorectal cancer
1001278|NCT03155529|cervical cancer|cervical cancer
1001279|NCT03155529|radical hysterectomy|radical hysterectomy
1001280|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
1001281|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
1001282|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
1001283|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
1001284|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
1001285|NCT03155516|Cancer pain|cancer pain
1001286|NCT03155516|GPM|gpm
1001287|NCT03155516|pain assessment|pain assessment
1001288|NCT03155503|SUVN-911|suvn-911
1001289|NCT03155503|Depression|depression
1001290|NCT03155503|single dose|single dose
1001291|NCT03155503|multiple dose|multiple dose
1001292|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
1001293|NCT03155503|first in human|first in human
1001294|NCT03155503|safety|safety
1001295|NCT03155503|pharmacokinetics|pharmacokinetics
1001296|NCT03155503|tolerability|tolerability
1001297|NCT03155490|Hospital medical emergency team|hospital medical emergency team
1001298|NCT03155490|Leadership|leadership
1001299|NCT03155490|Simulation training|simulation training
1001300|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
1001301|NCT03155464|indocyanine-green|indocyanine-green
1001302|NCT03155464|systemic scerlosis|systemic scerlosis
1001303|NCT03155438|Oxidative stress|oxidative stress
1001304|NCT03155438|Cumulus cell|cumulus cell
1001305|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1001306|NCT03155438|In vitro fertilization|in vitro fertilization
1001307|NCT03155438|Low responder|low responder
1001308|NCT03155412|Type 2 Diabetes|type 2 diabetes
1001309|NCT03155412|adipose tissue|adipose tissue
1001310|NCT03155412|preadipocytes|preadipocytes
1001311|NCT03155412|expandability|expandability
1001312|NCT03155412|hypertrophy|hypertrophy
1001313|NCT03155412|hyperplasia|hyperplasia
1001314|NCT03155412|lipogenesis|lipogenesis
1001315|NCT03155412|adipogenesis|adipogenesis
1001316|NCT03155412|insulin sensitivity|insulin sensitivity
1001317|NCT03155399|Stroke|stroke
1001318|NCT03155399|Neurorehabilitation|neurorehabilitation
1001319|NCT03155399|Proprioceptive Training|proprioceptive training
1001320|NCT03155399|Bilateral Arm Training|bilateral arm training
1001321|NCT03155399|Intracortical Inhibition|intracortical inhibition
1001322|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1001323|NCT03155360|Colics|colics
1001324|NCT03155360|infant colics|infant colics
1001325|NCT03155360|Migraine equivalent|migraine equivalent
1001327|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
1001328|NCT03155360|Colic|colic
1001329|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
1001330|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
1001331|NCT03155243|Humira®|humira®
1001332|NCT03155243|Adalimumab|adalimumab
1001333|NCT03155243|Ocular inflammation|ocular inflammation
1001334|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
1001335|NCT03155230|Inguinal hernia|inguinal hernia
1001336|NCT03155217|melanoma|melanoma
1001337|NCT03155217|elderly|elderly
1001338|NCT03155217|tolerance|tolerance
1001339|NCT03155217|adverse effects|adverse effects
1001340|NCT03155217|targeted therapies|targeted therapies
1001341|NCT03155204|inhalation|inhalation
1001342|NCT03155204|LABA|laba
1001343|NCT03155204|corticosteroid|corticosteroid
1001344|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1001345|NCT03155191|Leukemia|leukemia
1001346|NCT03155191|Lymphoblastic|lymphoblastic
1001347|NCT03155191|TBI-1501|tbi-1501
1001348|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
1001349|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
1001350|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
1001351|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
1001352|NCT03155191|Retroviral Vector|retroviral vector
1001353|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
1001354|NCT03155191|Neoplasms|neoplasms
1001355|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
1001356|NCT03155191|Immune System Diseases|immune system diseases
1001357|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
1001358|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
1001359|NCT03155139|prevalence|prevalence
1001360|NCT03155139|primary aldosteronism|primary aldosteronism
1001361|NCT03155139|hypertension|hypertension
1001362|NCT03155139|nationwide|nationwide
1001363|NCT03155126|shock|shock
1001364|NCT03155126|acute kidney injury|acute kidney injury
1001365|NCT03155126|crystalloid|crystalloid
1001366|NCT03155113|Chronic infection|chronic infection
1001367|NCT03155113|HCV|hcv
1001368|NCT03155113|DAA therapy|daa therapy
1001369|NCT03155113|immune response|immune response
1001370|NCT03155087|T2DM|t2dm
1001371|NCT03155087|genetic polymorphism|genetic polymorphism
1001372|NCT03155087|diabetic nephropathy|diabetic nephropathy
1001373|NCT03155035|deworming|deworming
1001374|NCT03155035|STH|sth
1001375|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
1001376|NCT03154996|Gliomas|gliomas
1001377|NCT03154996|Recurrent|recurrent
1001378|NCT03154996|Chronic Convection|chronic convection
1001379|NCT03154996|High Grade Gliomas|high grade gliomas
1001380|NCT03154983|Mesylate Apatinib|mesylate apatinib
1001381|NCT03154983|The First-line Treatment|the first-line treatment
1001382|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
1001383|NCT03154970|Physical Therapy Specialty|physical therapy specialty
1001384|NCT03154931|PTSD|ptsd
1001385|NCT03154931|CBT|cbt
1001386|NCT03154931|CFT|cft
1001387|NCT03154931|compassion|compassion
1001388|NCT03154931|shame|shame
1001389|NCT03154931|guilty|guilty
1001390|NCT03154931|self-criticism|self-criticism
1001391|NCT03154879|Heart arrest|heart arrest
1001392|NCT03154879|Hypothermia|hypothermia
1001393|NCT03154879|EEG|eeg
1001394|NCT03154879|Prognosis|prognosis
1001395|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
1001396|NCT03154866|Microbial Colonization|microbial colonization
1001397|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
1001398|NCT03154814|ulinastatin|ulinastatin
1001399|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
1001400|NCT03154814|cardiac surgery|cardiac surgery
1001401|NCT03154788|Falls prevention|falls prevention
1001402|NCT03154788|Community-Based Participatory Research|community-based participatory research
1001403|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1001404|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
1001405|NCT03154736|CVD|cvd
1001406|NCT03154736|FDRCV|fdrcv
1001407|NCT03154736|Developing countries|developing countries
1001408|NCT03154736|Rcih countries|rcih countries
1001409|NCT03154710|Web-mediated follow up|web-mediated follow up
1001410|NCT03154710|Lymphoma|lymphoma
1001411|NCT03154710|Personalized medicine|personalized medicine
1001412|NCT03154684|Autonomy|autonomy
1001413|NCT03154684|Rehabilitation|rehabilitation
1001414|NCT03154684|Falls|falls
1001415|NCT03154684|Quality of life|quality of life
1001416|NCT03154684|Senior|senior
1001417|NCT03154671|older adult;|older adult;
1001418|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
1001419|NCT03154671|chemotherapy|chemotherapy
1001420|NCT03154671|integrated care|integrated care
1001421|NCT03154671|randomized controlled trial|randomized controlled trial
1001422|NCT03154632|Myofascial trigger point|myofascial trigger point
1001423|NCT03154632|Trapezius Muscle|trapezius muscle
1001424|NCT03154632|Diathermy|diathermy
1001425|NCT03154632|Ultrasound|ultrasound
1001426|NCT03154593|Prevalence|prevalence
1001427|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
1001428|NCT03154515|Respiratory Tract Infections|respiratory tract infections
1001429|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
1001430|NCT03154502|Sodium intake|sodium intake
1001431|NCT03154502|Urinary sodium excretion|urinary sodium excretion
1001432|NCT03154411|ABY-029|aby-029
1001433|NCT03154411|Affibody|affibody
1001434|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
1001435|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1001436|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
1001437|NCT03154385|ITP|itp
1001438|NCT03154346|Baseline|baseline
1001439|NCT03154346|Project Baseline|project baseline
1001440|NCT03154346|Baseline Study|baseline study
1001441|NCT03154346|Project Baseline Study|project baseline study
1001442|NCT03154333|Epidermolysis|epidermolysis
1001443|NCT03154333|bullosa|bullosa
1001444|NCT03154333|simplex|simplex
1001445|NCT03154333|blister|blister
1001446|NCT03154333|EBS|ebs
1001447|NCT03154333|topical|topical
1001448|NCT03154333|ointment|ointment
1001449|NCT03154333|lesion|lesion
1001450|NCT03154281|Breast|breast
1001451|NCT03154281|Ovarian|ovarian
1001452|NCT03154268|Gestational weight gain|gestational weight gain
1001453|NCT03154268|Chinese pregnant women|chinese pregnant women
1001454|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
1001455|NCT03154268|China|china
1001456|NCT03154268|IOM guideline|iom guideline
1001457|NCT03154268|Adverse outcome|adverse outcome
1001458|NCT03154268|Model|model
1001459|NCT03154255|Obesity|obesity
1001460|NCT03154255|Paediatric|paediatric
1001461|NCT03154255|Mediterranean diet|mediterranean diet
1001462|NCT03154255|Gamification|gamification
1001463|NCT03154255|Insulin-resistance|insulin-resistance
1001464|NCT03154242|non small cell lung cancer|non small cell lung cancer
1001465|NCT03154242|NSCLC|nsclc
1001466|NCT03154242|Platinum|platinum
1001467|NCT03154151|PTSD|ptsd
1001468|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1001469|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
1001470|NCT03154151|World Trade Center|world trade center
1001471|NCT03154151|9/11|9/11
1001472|NCT03154151|first responder|first responder
1001473|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
1001475|NCT03154138|hemiplegia|hemiplegia
1001476|NCT03154138|rehabilitation|rehabilitation
1001477|NCT03154138|prismatic adaptation|prismatic adaptation
1001478|NCT03154138|postural imbalance|postural imbalance
1001479|NCT03154138|posture|posture
1001480|NCT03154138|spatial cognition|spatial cognition
1001481|NCT03154099|CIRCI|circi
1001482|NCT03154086|REarranged during Transfection|rearranged during transfection
1001483|NCT03154073|Exercise|exercise
1001484|NCT03154073|Physical activity|physical activity
1001485|NCT03154073|Blood glucose|blood glucose
1001486|NCT03154073|Sleep|sleep
1001487|NCT03154060|Flash glucose monitoring|flash glucose monitoring
1001488|NCT03154060|Accuracy|accuracy
1001489|NCT03154060|Precision|precision
1001490|NCT03154034|Stress echocardiography|stress echocardiography
1001491|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1001492|NCT03154034|ergospirometry|ergospirometry
1001493|NCT03154021|Gingival Index|gingival index
1001494|NCT03154021|Plaque Index|plaque index
1001495|NCT03154021|Bleeding|bleeding
1001496|NCT03154021|Pocket Depth|pocket depth
1001497|NCT03154008|reward|reward
1001498|NCT03154008|emotion regulation|emotion regulation
1001499|NCT03154008|electroencephalogram|electroencephalogram
1001500|NCT03154008|event-related potentials|event-related potentials
1001501|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
1001502|NCT03153995|expander|expander
1001503|NCT03153982|HNSCC|hnscc
1001504|NCT03153956|AposTherapy® System|apostherapy® system
1001505|NCT03153956|Osteoarthritis|osteoarthritis
1001506|NCT03153956|Total knee arthroplasties|total knee arthroplasties
1001507|NCT03153956|Degenerative joint disease|degenerative joint disease
1001508|NCT03153930|sedentary behavior|sedentary behavior
1001509|NCT03153930|youth|youth
1001510|NCT03153930|moderating factors|moderating factors
1001511|NCT03153930|metabolic outcomes|metabolic outcomes
1001512|NCT03153917|shift work|shift work
1001513|NCT03153917|melatonin|melatonin
1001514|NCT03153917|sleep|sleep
1001515|NCT03153904|anxiety|anxiety
1001516|NCT03153904|depression|depression
1001517|NCT03153904|trauma|trauma
1001518|NCT03153904|behavior problems|behavior problems
1001519|NCT03153904|evidence-based treatments|evidence-based treatments
1001520|NCT03153904|manualized treatments|manualized treatments
1001521|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
1001522|NCT03153904|youth|youth
1001523|NCT03153904|mental health|mental health
1001524|NCT03153891|environment|environment
1001525|NCT03153891|nature|nature
1001526|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
1001527|NCT03153878|Benefit-risk|benefit-risk
1001528|NCT03153878|Ischemic heart disease|ischemic heart disease
1001529|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
1001530|NCT03153878|Antithrombotic|antithrombotic
1001531|NCT03153878|Anticoagulant|anticoagulant
1001532|NCT03153878|People's Republic of China|people's republic of china
1001533|NCT03153878|Multicenter Studies|multicenter studies
1001534|NCT03153839|Children|children
1001535|NCT03153839|Babies|babies
1001536|NCT03153839|Infant|infant
1001537|NCT03153839|Swimming pool|swimming pool
1001538|NCT03153839|Aquatic physical activity|aquatic physical activity
1001539|NCT03153839|Motor development|motor development
1001540|NCT03153839|Neurodevelopment|neurodevelopment
1001541|NCT03153826|COPD Exacerbation|copd exacerbation
1001542|NCT03153826|Muscle atrophy|muscle atrophy
1001543|NCT03153826|Inflammation|inflammation
1001544|NCT03153826|Oxidative stress|oxidative stress
1001545|NCT03153813|pain|pain
1001546|NCT03153813|knee osteoarthritis|knee osteoarthritis
1001547|NCT03153813|obesity|obesity
1001548|NCT03153813|capsaicin|capsaicin
1001549|NCT03153787|implantation failure|implantation failure
1001550|NCT03153787|fertility|fertility
1001551|NCT03153787|microbiome|microbiome
1001552|NCT03153787|Assisted reproduction|assisted reproduction
1001553|NCT03153774|Sarcopenia|sarcopenia
1001554|NCT03153774|Heart failure (HF)|heart failure (hf)
1001555|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
1001556|NCT03153748|Treatment strategy|treatment strategy
1001557|NCT03153735|Hyaluronic acid|hyaluronic acid
1001558|NCT03153735|Small Penis|small penis
1001559|NCT03153735|Penile Enhancement|penile enhancement
1001560|NCT03153722|pediatric|pediatric
1001561|NCT03153722|hospital discharge|hospital discharge
1001562|NCT03153722|quality improvement|quality improvement
1001563|NCT03153722|transition of care|transition of care
1001564|NCT03153709|Pregnancy rates|pregnancy rates
1001565|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
1001566|NCT03153709|Women on efavirenz|women on efavirenz
1001567|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
1001568|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
1001569|NCT03153683|Acute|acute
1001570|NCT03153683|Ischemic|ischemic
1001571|NCT03153683|Stroke|stroke
1001572|NCT03153683|Biomarkers|biomarkers
1001573|NCT03153683|Proteins|proteins
1001574|NCT03153683|Leukocyte|leukocyte
1001575|NCT03153683|Inflammatory Cells|inflammatory cells
1001576|NCT03153683|Acid/Base Balance|acid/base balance
1001577|NCT03153657|Tooth Bleaching|tooth bleaching
1001578|NCT03153644|Qualitative Research|qualitative research
1001579|NCT03153644|Medical conditions|medical conditions
1001580|NCT03153644|Birth control methods|birth control methods
1001581|NCT03153644|Intrauterine Devices|intrauterine devices
1001582|NCT03153644|Physicians, Primary Care|physicians, primary care
1001583|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
1001584|NCT03153540|Aphasia|aphasia
1001585|NCT03153540|Agrammatism|agrammatism
1001586|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
1001587|NCT03153540|Tauopathies|tauopathies
1001588|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
1001589|NCT03153540|Language Disorders|language disorders
1001590|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
1001592|NCT03153488|ADHD|adhd
1001593|NCT03153488|Methylphenidate|methylphenidate
1001594|NCT03153488|Amphetamine|amphetamine
1001595|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1001596|NCT03153488|Treatment|treatment
1001597|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
1001598|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
1001599|NCT03153410|Pancreas vaccine|pancreas vaccine
1001600|NCT03153410|immunotherapy|immunotherapy
1001601|NCT03153410|antibody|antibody
1001602|NCT03153410|PD-1|pd-1
1001603|NCT03153410|IMC-CS4|imc-cs4
1001604|NCT03153410|Pembrolizumab|pembrolizumab
1001605|NCT03153410|GVAX|gvax
1001606|NCT03153410|Borderline Resectable|borderline resectable
1001607|NCT03153397|trauma|trauma
1001608|NCT03153397|brain|brain
1001609|NCT03153397|neurological|neurological
1001610|NCT03153397|injury|injury
1001611|NCT03153397|enteral|enteral
1001612|NCT03153397|tube|tube
1001613|NCT03153397|feeding|feeding
1001614|NCT03153397|nutrition|nutrition
1001615|NCT03153384|Diagnosis|diagnosis
1001616|NCT03153384|Blood Culture|blood culture
1001617|NCT03153371|Alzheimer's disease|alzheimer's disease
1001618|NCT03153371|Young-onset|young-onset
1001619|NCT03153371|variant|variant
1001620|NCT03153371|visuospatial|visuospatial
1001621|NCT03153371|language|language
1001622|NCT03153371|apraxia|apraxia
1001623|NCT03153371|control|control
1001624|NCT03153371|dementia|dementia
1001625|NCT03153371|memory|memory
1001626|NCT03153371|MRI|mri
1001627|NCT03153371|neurology|neurology
1001628|NCT03153371|neuropsychology|neuropsychology
1001629|NCT03153371|brain|brain
1001630|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
1001631|NCT03153306|Albumin|albumin
1001632|NCT03153293|LHON,G11778A mutation, rAAV2-ND4，gene therapy|lhon,g11778a mutation, raav2-nd4，gene therapy
1001633|NCT03153254|Upper extremity|upper extremity
1001634|NCT03153254|Rehabilitation|rehabilitation
1001635|NCT03153254|Robot assisted therapy|robot assisted therapy
1001636|NCT03153254|Robotics|robotics
1001637|NCT03153254|Devices|devices
1001638|NCT03153254|Orthosis|orthosis
1001639|NCT03153228|E-cigarettes|e-cigarettes
1001640|NCT03153202|Ibrutinib|ibrutinib
1001641|NCT03153202|Pembrolizumab|pembrolizumab
1001642|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1001643|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
1001644|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
1001645|NCT03153176|physical activity|physical activity
1001646|NCT03153176|physical fitness|physical fitness
1001647|NCT03153176|eating habits|eating habits
1001648|NCT03153176|sedentary behavior|sedentary behavior
1001649|NCT03153176|sleep quality|sleep quality
1001650|NCT03153176|satisfaction personal|satisfaction personal
1001651|NCT03153176|school health|school health
1001652|NCT03153176|adolescent|adolescent
1001653|NCT03153150|Oral anticoagulant|oral anticoagulant
1001654|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
1001655|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
1001656|NCT03153150|Vitamin K antagonist|vitamin k antagonist
1001657|NCT03153150|Antiplatelet drug|antiplatelet drug
1001658|NCT03153124|Respiratory muscle strength|respiratory muscle strength
1001659|NCT03153124|Renal insufficiency|renal insufficiency
1001660|NCT03153124|Respiratory muscle training|respiratory muscle training
1001661|NCT03153098|physical activity|physical activity
1001662|NCT03153098|intervention|intervention
1001663|NCT03153098|behaviour change|behaviour change
1001664|NCT03153098|inactive adults|inactive adults
1001665|NCT03153098|behaviour change techniques|behaviour change techniques
1001666|NCT03153098|well-being|well-being
1001667|NCT03153085|Unresectable melanoma|unresectable melanoma
1001668|NCT03153085|Metastatic melanoma|metastatic melanoma
1001669|NCT03153085|Recurrent Melanoma|recurrent melanoma
1001670|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
1001672|NCT03153085|HSV-1|hsv-1
1001673|NCT03153085|Oncolytic virus|oncolytic virus
1001674|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
1001677|NCT03153085|canerpaturev|canerpaturev
1001678|NCT03153059|gut microbiota|gut microbiota
1001679|NCT03153059|stool frequency|stool frequency
1001680|NCT03153046|prebiotics|prebiotics
1001681|NCT03153046|cognitive impairment|cognitive impairment
1001682|NCT03153046|weight gain|weight gain
1001683|NCT03153033|Wheelchair propulsion|wheelchair propulsion
1001684|NCT03153033|Shoulder|shoulder
1001685|NCT03153033|Biomechanics|biomechanics
1001686|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1001687|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1001688|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
1001689|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
1001690|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
1001691|NCT03152968|FMS|fms
1001692|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
1001693|NCT03152955|nerve block|nerve block
1001694|NCT03152929|Surgery|surgery
1001695|NCT03152929|Breast|breast
1001696|NCT03152929|Pectoral Never Block|pectoral never block
1001697|NCT03152929|Paravertebral Block|paravertebral block
1001698|NCT03152929|Analgesia|analgesia
1001699|NCT03152929|Mastectomy|mastectomy
1001700|NCT03152916|subtalar joint|subtalar joint
1001701|NCT03152916|arthrodesis|arthrodesis
1001702|NCT03152916|3d printing|3d printing
1001703|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
1001704|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
1001705|NCT03152903|Recurrence|recurrence
1001706|NCT03152903|Efficacy|efficacy
1001707|NCT03152890|Insulin|insulin
1001708|NCT03152890|Liver transplantation|liver transplantation
1001709|NCT03152890|Hyperglycemia|hyperglycemia
1001710|NCT03152825|myocardial ischaemia|myocardial ischaemia
1001711|NCT03152825|myocardial viability|myocardial viability
1001712|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
1001713|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
1001714|NCT03152825|stress CMR|stress cmr
1001715|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
1001716|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
1001717|NCT03152799|cerebral infarction|cerebral infarction
1001718|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
1001719|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
1001720|NCT03152799|anterior circulation stroke|anterior circulation stroke
1001721|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
1001722|NCT03152773|MRI Catheterization|mri catheterization
1001723|NCT03152773|Real-time MRI|real-time mri
1001728|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
1001729|NCT03152721|accelerometry|accelerometry
1001730|NCT03152721|home based|home based
1001731|NCT03152721|motor complications|motor complications
1001732|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
1001733|NCT03152721|Registry|registry
1001734|NCT03152682|glucose|glucose
1001735|NCT03152682|glucose homeostasis|glucose homeostasis
1001736|NCT03152669|asthma|asthma
1001737|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1001738|NCT03152669|Salford Lung Study|salford lung study
1001739|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
1001740|NCT03152656|total cholesterol|total cholesterol
1001741|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
1001742|NCT03152656|tendon xanthomas|tendon xanthomas
1001743|NCT03152656|premature atherosclerosis|premature atherosclerosis
1001744|NCT03152643|Cumulative live birth rates|cumulative live birth rates
1001745|NCT03152643|cleavage-stage embryo transfer|cleavage-stage embryo transfer
1001746|NCT03152643|blastocyst transfer|blastocyst transfer
1001747|NCT03152630|lncRNAs|lncrnas
1001748|NCT03152630|Alzheimer's disease|alzheimer's disease
1001749|NCT03152630|vascular dementia|vascular dementia
1001750|NCT03152617|bariatric surgery|bariatric surgery
1001751|NCT03152617|gastric bypass|gastric bypass
1001752|NCT03152617|malnutrition|malnutrition
1001753|NCT03152617|bone disease|bone disease
1001754|NCT03152617|oral health|oral health
1001755|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
1001756|NCT03152591|PCOS|pcos
1001757|NCT03152591|hyperandrogenism|hyperandrogenism
1001758|NCT03152591|insulin resistance|insulin resistance
1001759|NCT03152591|overweight|overweight
1001760|NCT03152591|obesity|obesity
1001761|NCT03152552|diabetes type 2|diabetes type 2
1001762|NCT03152552|heart failure|heart failure
1001763|NCT03152500|IOL|iol
1001764|NCT03152500|Stability|stability
1001765|NCT03152500|FEMTIS IOL|femtis iol
1001766|NCT03152500|Acrysof IOL|acrysof iol
1001767|NCT03152500|FLACS|flacs
1001768|NCT03152500|Capsulotomy|capsulotomy
1001769|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
1001770|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
1001771|NCT03152487|radiofrequency ablation|radiofrequency ablation
1001772|NCT03152487|pancreatic cancer|pancreatic cancer
1001773|NCT03152461|Viscoelastic testing|viscoelastic testing
1001774|NCT03152461|Coagulation|coagulation
1001775|NCT03152461|Quantra|quantra
1001776|NCT03152461|Hemostasis|hemostasis
1001777|NCT03152448|Prolaris|prolaris
1001778|NCT03152448|Prostate Cancer|prostate cancer
1001779|NCT03152409|Aspirin|aspirin
1001780|NCT03152409|Treatment|treatment
1001781|NCT03152409|Salicylic acid|salicylic acid
1001782|NCT03152409|anti-inflammatory|anti-inflammatory
1001783|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
1001784|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
1001785|NCT03152396|blood pressure|blood pressure
1001786|NCT03152396|LDL-cholesterol|ldl-cholesterol
1001787|NCT03152396|total-cholesterol|total-cholesterol
1001788|NCT03152396|HDL-cholesterol|hdl-cholesterol
1001789|NCT03152396|hemoglobin A1C|hemoglobin a1c
1001790|NCT03152396|tobacco cessation|tobacco cessation
1001791|NCT03152396|patient satisfaction|patient satisfaction
1001792|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
1001793|NCT03152383|Behavioral Research|behavioral research
1001794|NCT03152383|Psychology|psychology
1001795|NCT03152383|Cognitive Disorders|cognitive disorders
1001796|NCT03152370|E7046|e7046
1001797|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
1001798|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
1001799|NCT03152370|Rectal cancer|rectal cancer
1001800|NCT03152357|osteoarthritis|osteoarthritis
1001801|NCT03152357|total knee arthroplasty|total knee arthroplasty
1001802|NCT03152357|TKA|tka
1001803|NCT03152357|TKR|tkr
1001804|NCT03152357|patient specific|patient specific
1001805|NCT03152357|Conformis|conformis
1001806|NCT03152344|Fall|fall
1001807|NCT03152344|Balance control|balance control
1001808|NCT03152344|Screening test|screening test
1001809|NCT03152344|Oxygen|oxygen
1001810|NCT03152344|Skeletal muscle mass|skeletal muscle mass
1001811|NCT03152331|Neurofeedback|neurofeedback
1001812|NCT03152318|Malignant Glioma|malignant glioma
1001813|NCT03152318|Brain Tumor|brain tumor
1001814|NCT03152318|Glioblastoma|glioblastoma
1001815|NCT03152305|Migraine|migraine
1001816|NCT03152305|Intracranial pressure|intracranial pressure
1001817|NCT03152305|Headache|headache
1001818|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
1001819|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
1001820|NCT03152240|Primary Angioplasty|primary angioplasty
1001821|NCT03152240|Gender|gender
1001822|NCT03152214|Transition out of military|transition out of military
1001823|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
1001824|NCT03152188|Cirrhosis|cirrhosis
1001825|NCT03152188|Liver|liver
1001826|NCT03152188|Openbiome|openbiome
1001827|NCT03152188|FMT Capsule|fmt capsule
1001828|NCT03152188|Placebo|placebo
1001829|NCT03152175|Memory Reconsolidation|memory reconsolidation
1001830|NCT03152175|Propranolol|propranolol
1001831|NCT03152175|Police officers|police officers
1001832|NCT03152175|911 operators|911 operators
1001833|NCT03152175|Efficacy|efficacy
1001834|NCT03152175|Cost-effectiveness|cost-effectiveness
1001835|NCT03152162|osteoarthritis|osteoarthritis
1001836|NCT03152162|patient-specific|patient-specific
1001837|NCT03152162|knee replacement|knee replacement
1001838|NCT03152162|TKA|tka
1001839|NCT03152162|knee arthroplasty|knee arthroplasty
1001840|NCT03152162|total knee replacement|total knee replacement
1001841|NCT03152162|posterior stabilized|posterior stabilized
1001842|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1001843|NCT03152110|High Intensity Interval Training|high intensity interval training
1001844|NCT03152110|HIIT|hiit
1001845|NCT03152110|Physical Activity|physical activity
1001846|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
1001847|NCT03152071|RATS|rats
1001848|NCT03152071|VATS|vats
1001849|NCT03152071|Robot|robot
1001850|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
1001851|NCT03152032|employment service|employment service
1001852|NCT03152032|vocational counseling|vocational counseling
1001853|NCT03152032|employment outcome|employment outcome
1001854|NCT03152032|schizophrenia|schizophrenia
1001855|NCT03152032|bipolar|bipolar
1001856|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
1001857|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
1001858|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
1001859|NCT03152019|Tacrolimus|tacrolimus
1001860|NCT03152006|Healthcare transition|healthcare transition
1001861|NCT03152006|Adolescents|adolescents
1001862|NCT03152006|Nigeria|nigeria
1001863|NCT03151993|Ischemic Stroke|ischemic stroke
1001864|NCT03151993|Fibrinolysis|fibrinolysis
1001865|NCT03151993|Fortelyzin|fortelyzin
1001866|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
1001867|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
1001868|NCT03151954|proliferation|proliferation
1001869|NCT03151954|differentiation|differentiation
1001870|NCT03151863|Dexmedetomidine|dexmedetomidine
1001871|NCT03151863|Opioids|opioids
1001872|NCT03151863|Palliative Care|palliative care
1001873|NCT03151863|Elderly people|elderly people
1001874|NCT03151863|Nursing care|nursing care
1001875|NCT03151863|Analgesia|analgesia
1001876|NCT03151863|Sedation|sedation
1001877|NCT03151863|Anxiolysis|anxiolysis
1001878|NCT03151863|Intranasal|intranasal
1001879|NCT03151850|fungal|fungal
1001880|NCT03151850|mucosa|mucosa
1001881|NCT03151850|diversity|diversity
1001882|NCT03151850|Basidiomycete|basidiomycete
1001883|NCT03151837|Diabetes|diabetes
1001884|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
1001885|NCT03151837|Insulin sensitivity|insulin sensitivity
1001886|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
1001887|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
1001888|NCT03151811|Melflufen|melflufen
1001889|NCT03151811|Pomalidomide|pomalidomide
1001890|NCT03151811|Dexamethasone|dexamethasone
1001891|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
1001892|NCT03151798|Exercise|exercise
1001893|NCT03151798|Weight loss diet|weight loss diet
1001894|NCT03151785|CPR|cpr
1001895|NCT03151785|Schools|schools
1001896|NCT03151785|Education|education
1001897|NCT03151785|Lifesaver|lifesaver
1001898|NCT03151733|SILS|sils
1001899|NCT03151733|colorectal cancer|colorectal cancer
1001900|NCT03151694|childhood obesity|childhood obesity
1001901|NCT03151694|body weight|body weight
1001902|NCT03151694|nutritional risk|nutritional risk
1001903|NCT03151681|Reconsolidation|reconsolidation
1001904|NCT03151681|Propranolol|propranolol
1001905|NCT03151681|Infidelity|infidelity
1001906|NCT03151681|Attachment injury|attachment injury
1001907|NCT03151681|Romantic relationships|romantic relationships
1001908|NCT03151603|Uva Ursi|uva ursi
1001909|NCT03151603|fosfomycin|fosfomycin
1001910|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
1001911|NCT03151564|Diseases of liver|diseases of liver
1001912|NCT03151564|Colon carcinoma|colon carcinoma
1001913|NCT03151564|Colorectal carcinoma|colorectal carcinoma
1001914|NCT03151564|Liver metastases|liver metastases
1001915|NCT03151564|Computed tomography|computed tomography
1001916|NCT03151564|CT|ct
1001917|NCT03151564|Reduced radiation doses|reduced radiation doses
1001918|NCT03151538|Pedography|pedography
1001919|NCT03151538|Exercise|exercise
1001920|NCT03151538|Play Training|play training
1001921|NCT03151538|Pes Planus|pes planus
1001922|NCT03151538|Femoral Anteversion|femoral anteversion
1001923|NCT03151512|MRI|mri
1001924|NCT03151512|distortion correction|distortion correction
1001925|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
1001926|NCT03151512|prostheses|prostheses
1001927|NCT03151447|Breast Cancer|breast cancer
1001928|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
1001929|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1001930|NCT03151434|VATS|vats
1001931|NCT03151434|pain|pain
1001932|NCT03151421|air quality feedback|air quality feedback
1001933|NCT03151421|second-hand smoke|second-hand smoke
1001934|NCT03151421|passive smoking|passive smoking
1002977|NCT03144453|Curare|curare
1001935|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
1001936|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
1001937|NCT03151408|AML|aml
1001938|NCT03151395|COPD|copd
1001939|NCT03151395|AECOPD|aecopd
1001940|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
1001941|NCT03151395|Asia Pacific|asia pacific
1001942|NCT03151382|Alzheimer Disease|alzheimer disease
1001943|NCT03151382|Cognitive Function|cognitive function
1001944|NCT03151382|tandospirone|tandospirone
1001945|NCT03151304|MDS|mds
1001946|NCT03151291|cancer cachexia|cancer cachexia
1001947|NCT03151291|WB-EMS|wb-ems
1001948|NCT03151291|skeletal muscle mass|skeletal muscle mass
1001949|NCT03151291|exercise|exercise
1001950|NCT03151291|nutrition|nutrition
1001951|NCT03151291|dietary supplements|dietary supplements
1001952|NCT03151278|Fluoroscopy|fluoroscopy
1001953|NCT03151278|Ablation|ablation
1001954|NCT03151278|Three dimensional|three dimensional
1001955|NCT03151278|Atrial arrhythmia|atrial arrhythmia
1001956|NCT03151278|Radiation|radiation
1001957|NCT03151265|Functional Outcome Measures|functional outcome measures
1001958|NCT03151265|Wearable Sensors|wearable sensors
1001959|NCT03151265|ViMove|vimove
1001960|NCT03151265|Low Back Pain|low back pain
1001961|NCT03151265|Range of Movement|range of movement
1001962|NCT03151265|Muscle Activity|muscle activity
1001963|NCT03151265|ThermaCare|thermacare
1001964|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
1001965|NCT03151226|respiratory depression|respiratory depression
1001966|NCT03151226|cesarean section|cesarean section
1001967|NCT03151200|Amblyopia treatment|amblyopia treatment
1001968|NCT03151161|chemotherapy|chemotherapy
1001969|NCT03151161|maintenance therapy|maintenance therapy
1001970|NCT03151161|icotinib|icotinib
1001971|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
1001972|NCT03151148|dysbiosis in AD|dysbiosis in ad
1001973|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
1001974|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
1001975|NCT03151148|randomized trial|randomized trial
1001976|NCT03151135|Energy metabolism|energy metabolism
1002010|NCT03150992|Feasibility|feasibility
1002011|NCT03150992|Elemental Diet|elemental diet
1002012|NCT03150992|Quality of life|quality of life
1002013|NCT03150992|Palliative|palliative
1002014|NCT03150992|Nutrition|nutrition
1002015|NCT03150992|Ovarian|ovarian
1002016|NCT03150992|Peritoneal|peritoneal
1002017|NCT03150992|Advanced|advanced
1002018|NCT03150992|Metastatic|metastatic
1002019|NCT03150992|Bowel obstruction|bowel obstruction
1002020|NCT03150992|Inoperable|inoperable
1002021|NCT03150979|Stroke|stroke
1002022|NCT03150979|Assistive devices|assistive devices
1002023|NCT03150979|Gait|gait
1002024|NCT03150979|Rehabilitation|rehabilitation
1002025|NCT03150979|Clinical trial|clinical trial
1002026|NCT03150966|Multiple sclerosis|multiple sclerosis
1002027|NCT03150966|Nanocurcumin|nanocurcumin
1002028|NCT03150966|MicroRNAs|micrornas
1002029|NCT03150966|Th17 cells|th17 cells
1002030|NCT03150953|anesthesia|anesthesia
1002032|NCT03150953|thermoregulation|thermoregulation
1002049|NCT03150836|bladder cancer|bladder cancer
1002050|NCT03150836|urothelial|urothelial
1002051|NCT03150823|Direct current|direct current
1002052|NCT03150823|Galvanic current|galvanic current
1002053|NCT03150823|Handgrip Force|handgrip force
1002054|NCT03150823|Palmar Grip|palmar grip
1002055|NCT03150823|Dynamometry|dynamometry
1002056|NCT03150823|Miofeedback|miofeedback
1002069|NCT03150797|UCSF|ucsf
1002070|NCT03150797|UCLA|ucla
1002071|NCT03150797|melatonin|melatonin
1002072|NCT03150797|migraine|migraine
1002073|NCT03150797|headache|headache
1002074|NCT03150784|Motor Learning|motor learning
1002075|NCT03150784|Coordination|coordination
1002076|NCT03150784|Children|children
1002077|NCT03150784|Motor Skills Disorders|motor skills disorders
1002078|NCT03150784|Movement|movement
1002079|NCT03150758|Erectile Disfunction|erectile disfunction
1002080|NCT03150758|Urinary Function|urinary function
1002081|NCT03150706|POLE mutation|pole mutation
1002082|NCT03150706|mismatch repair deficient|mismatch repair deficient
1002083|NCT03150706|Avelumab|avelumab
1002084|NCT03150680|SYNTAX score|syntax score
1002085|NCT03150680|SNPs|snps
1002086|NCT03150680|Genetics|genetics
1002087|NCT03150680|Pharmacogenetics|pharmacogenetics
1002088|NCT03150680|Genetic Risk Score|genetic risk score
1002089|NCT03150680|Precision Medicine|precision medicine
1002090|NCT03150654|macular pigment|macular pigment
1002091|NCT03150654|macular pigment optical density|macular pigment optical density
1002092|NCT03150654|diabetic retinopathy|diabetic retinopathy
1002093|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
1002094|NCT03150641|Maternal blood loss|maternal blood loss
1002095|NCT03150641|Cesarean delivery|cesarean delivery
1002096|NCT03150641|Delayed cord clamping|delayed cord clamping
1002097|NCT03150641|Neonatal health|neonatal health
1002098|NCT03150576|Triple negative breast cancer|triple negative breast cancer
1002099|NCT03150576|germline BRCA|germline brca
1002100|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
1002101|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1002102|NCT03150576|olaparib|olaparib
1002103|NCT03150563|Stretching|stretching
1002104|NCT03150563|Stretching sensation|stretching sensation
1002105|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
1002106|NCT03150563|Stretching load.|stretching load.
1002107|NCT03150550|Mindfulness|mindfulness
1002108|NCT03150550|Alcohol|alcohol
1002109|NCT03150550|Alcohol Use Disorder|alcohol use disorder
1002110|NCT03150550|Relapse|relapse
1002111|NCT03150550|Relapse Prevention|relapse prevention
1002112|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
1002113|NCT03150537|jet injector|jet injector
1002114|NCT03150537|influenza vaccine|influenza vaccine
1002115|NCT03150537|immune response|immune response
1002116|NCT03150524|stroke|stroke
1002117|NCT03150524|RCVS|rcvs
1002118|NCT03150498|Food Effect|food effect
1002119|NCT03150498|Pharmacokinetics|pharmacokinetics
1002120|NCT03150472|Dental Instruments|dental instruments
1002121|NCT03150472|Dental Technology|dental technology
1002122|NCT03150446|laparoscopy|laparoscopy
1002123|NCT03150446|ureteral catheterization|ureteral catheterization
1002124|NCT03150420|calciphylaxis|calciphylaxis
1002125|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
1002126|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
1002127|NCT03150420|metabolic diseases|metabolic diseases
1002128|NCT03150420|sodium thiosulfate|sodium thiosulfate
1002129|NCT03150342|CZT scanner|czt scanner
1002130|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
1002131|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1002132|NCT03150303|Periprocedural period|periprocedural period
1002133|NCT03150303|Anticoagulant treatment|anticoagulant treatment
1002134|NCT03150303|Thromboembolic events|thromboembolic events
1002135|NCT03150303|Bleeding events|bleeding events
1002136|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
1002137|NCT03150264|obesity|obesity
1002138|NCT03150225|andropause|andropause
1002139|NCT03150225|depressive symptoms|depressive symptoms
1002140|NCT03150225|stress|stress
1002141|NCT03150225|abdominal Obesity|abdominal obesity
1002142|NCT03150225|testosterone|testosterone
1002143|NCT03150225|erectile dysfunction|erectile dysfunction
1002144|NCT03150186|second hand smoke|second hand smoke
1002145|NCT03150186|passive smoking|passive smoking
1002146|NCT03150186|airborne nicotine|airborne nicotine
1002147|NCT03150186|private settings|private settings
1002148|NCT03150186|outdoors|outdoors
1002149|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
1002150|NCT03150160|travoprost|travoprost
1002151|NCT03150160|brinzolamide 1% / brimonidine 0.2%|brinzolamide 1% / brimonidine 0.2%
1002152|NCT03150160|normal tension glaucoma|normal tension glaucoma
1002153|NCT03150160|intraocular pressure|intraocular pressure
1002154|NCT03150160|efficacy|efficacy
1002155|NCT03150160|safety|safety
1002156|NCT03150147|Organ preservation|organ preservation
1002157|NCT03150147|Survival|survival
1002158|NCT03150147|Graft function|graft function
1002159|NCT03150147|Reperfusion injury|reperfusion injury
1002160|NCT03150147|Heart transplantation|heart transplantation
1002161|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
1002162|NCT03150134|transplantation|transplantation
1002163|NCT03150134|allogeneic transplantation|allogeneic transplantation
1002164|NCT03150134|immunosuppressive agents|immunosuppressive agents
1002165|NCT03150082|GR37547|gr37547
1002166|NCT03150082|Cross-over|cross-over
1002167|NCT03150082|Bioequivalence|bioequivalence
1002168|NCT03150082|Ciprofloxacin|ciprofloxacin
1002169|NCT03150069|Pregnancy|pregnancy
1002170|NCT03150056|abiraterone|abiraterone
1002559|NCT03147352|sTM|stm
1002171|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1002172|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
1002173|NCT03150056|RP2D|rp2d
1002174|NCT03150056|enzalutamide|enzalutamide
1002175|NCT03150056|GSK525762|gsk525762
1002176|NCT03150043|Hemoglobin|hemoglobin
1002177|NCT03150043|Cesarean delivery|cesarean delivery
1002178|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
1002179|NCT03150004|AML|aml
1002180|NCT03150004|salvage chemotherapy|salvage chemotherapy
1002181|NCT03150004|CLAG-M|clag-m
1002182|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
1002183|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1002184|NCT03150004|phase II|phase ii
1002185|NCT03150004|pharmacogenomics|pharmacogenomics
1002186|NCT03149991|treatment resistant|treatment resistant
1002187|NCT03149991|inadequate response|inadequate response
1002188|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
1002189|NCT03149978|treatment effect prediction|treatment effect prediction
1002190|NCT03149978|metabonomics|metabonomics
1002191|NCT03149913|below the knee artery|below the knee artery
1002192|NCT03149913|endovascular|endovascular
1002193|NCT03149913|drug coated balloon|drug coated balloon
1002194|NCT03149913|critical limb ischemia|critical limb ischemia
1003494|NCT03140722|AKB-6548|akb-6548
1002195|NCT03149848|Tuberculosis|tuberculosis
1002196|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
1002197|NCT03149848|Rifabutin|rifabutin
1002198|NCT03149848|Drug-drug interaction|drug-drug interaction
1002199|NCT03149848|Cabotegravir|cabotegravir
1002200|NCT03149809|Urinary incontinence|urinary incontinence
1002201|NCT03149809|Parkinson disease|parkinson disease
1002202|NCT03149809|Overactive urinary bladder|overactive urinary bladder
1002203|NCT03149809|Nocturia|nocturia
1002204|NCT03149757|Treatment Adherence|treatment adherence
1002205|NCT03149757|Alcohol or Drugs|alcohol or drugs
1002206|NCT03149757|Behavioral|behavioral
1002207|NCT03149757|Internet|internet
1002208|NCT03149757|Adolescents|adolescents
1002209|NCT03149757|Young Adults|young adults
1002210|NCT03149757|Social Support|social support
1002211|NCT03149718|Pharmacy|pharmacy
1002212|NCT03149718|Intervention|intervention
1002213|NCT03149718|Medication Adherence|medication adherence
1002214|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
1002215|NCT03149679|Cyclophosphamide|cyclophosphamide
1002216|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
1568412|NCT00505934|Child|child
1002217|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
1002218|NCT03149653|lipid emulsion|lipid emulsion
1002219|NCT03149653|olive oil|olive oil
1002220|NCT03149653|fish oil|fish oil
1002221|NCT03149653|intestinal failure|intestinal failure
1002222|NCT03149653|home parenteral nutrition|home parenteral nutrition
1002223|NCT03149640|Prevention|prevention
1002224|NCT03149640|inhaled amikacin|inhaled amikacin
1002225|NCT03149640|placebo|placebo
1002226|NCT03149614|mobilization|mobilization
1002227|NCT03149614|resonant oscillation|resonant oscillation
1002228|NCT03149575|Glioma|glioma
1002229|NCT03149575|Glioblastoma|glioblastoma
1002230|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
1002231|NCT03149575|GBM|gbm
1002232|NCT03149575|brain tumor|brain tumor
1002233|NCT03149575|brain cancer|brain cancer
1002234|NCT03149575|recurrent brain tumor|recurrent brain tumor
1002235|NCT03149575|recurrent brain cancer|recurrent brain cancer
1002236|NCT03149575|refractory brain tumor|refractory brain tumor
1002237|NCT03149575|refractory brain cancer|refractory brain cancer
1002238|NCT03149575|recurrent GBM|recurrent gbm
1002239|NCT03149575|refractory GBM|refractory gbm
1002240|NCT03149575|recurrent glioma|recurrent glioma
1002241|NCT03149575|refractory glioma|refractory glioma
1002242|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
1002243|NCT03149575|refractory glioblastoma|refractory glioblastoma
1002244|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1002245|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
1002246|NCT03149575|failed temodar|failed temodar
1002247|NCT03149575|failed temozolomide|failed temozolomide
1002248|NCT03149575|temodar refractory|temodar refractory
1002249|NCT03149575|temozolomide refractory|temozolomide refractory
1002250|NCT03149575|failed avastin|failed avastin
1002251|NCT03149575|avastin refractory|avastin refractory
1002252|NCT03149575|failed bevacizumab|failed bevacizumab
1002253|NCT03149575|bevacizumab refractory|bevacizumab refractory
1002254|NCT03149575|avastin failure|avastin failure
1002255|NCT03149575|bevacizumab failure|bevacizumab failure
1002256|NCT03149575|STAR-3|star-3
1002257|NCT03149549|cancer|cancer
1002258|NCT03149549|solid tumor|solid tumor
1002259|NCT03149549|PROCLAIM|proclaim
1002260|NCT03149549|CX-2009|cx-2009
1002261|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
1002262|NCT03149549|Drug Conjugate|drug conjugate
1002263|NCT03149549|Antibody drug conjugate|antibody drug conjugate
1002264|NCT03149549|CD166|cd166
1002265|NCT03149536|pharmacogenetic|pharmacogenetic
1002266|NCT03149536|pharmacogenomic|pharmacogenomic
1002267|NCT03149536|polymorphism|polymorphism
1002365|NCT03148886|Physical activity|physical activity
1002268|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
1002269|NCT03149536|algorithm|algorithm
1002270|NCT03149536|assisted reproduction|assisted reproduction
1002271|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
1002272|NCT03149523|targeted therapies|targeted therapies
1002273|NCT03149523|colon cancer|colon cancer
1002274|NCT03149523|kidney cancer|kidney cancer
1002275|NCT03149523|liver cancer|liver cancer
1002276|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
1002277|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
1002278|NCT03149510|mobile application|mobile application
1002279|NCT03149510|mHealth|mhealth
1002280|NCT03149458|stroke|stroke
1002281|NCT03149458|balance|balance
1002282|NCT03149458|dance|dance
1002283|NCT03149432|mirror therapy|mirror therapy
1002284|NCT03149432|amputation|amputation
1002285|NCT03149432|phantom pain|phantom pain
1002286|NCT03149419|postmenopause|postmenopause
1002287|NCT03149419|paroxetine|paroxetine
1002288|NCT03149419|endothelial dysfunction|endothelial dysfunction
1002289|NCT03149419|blood pressure|blood pressure
1002290|NCT03149419|heart rate variability|heart rate variability
1002291|NCT03149419|sleep quality|sleep quality
1002292|NCT03149419|perceived stress|perceived stress
1002293|NCT03149419|sleepiness|sleepiness
1002294|NCT03149393|Functional Dyspepsia|functional dyspepsia
1002295|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
1002296|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
1002297|NCT03149328|Home Dialysis|home dialysis
1002298|NCT03149328|Person-Centred Care|person-centred care
1002299|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
1002300|NCT03149328|Process Evaluation|process evaluation
1002301|NCT03149328|Educational Support|educational support
1002302|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
1002303|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
1002304|NCT03149302|Manual therapy|manual therapy
1002305|NCT03149302|Sensorimotor exercises|sensorimotor exercises
1002306|NCT03149302|Balance exercises|balance exercises
1002307|NCT03149302|Cervical mobilization|cervical mobilization
1002308|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
1002309|NCT03149263|botulinum toxin|botulinum toxin
1662631|NCT00133744|iron|iron
1002310|NCT03149263|anxiety reduction|anxiety reduction
1002311|NCT03149263|pain reduction|pain reduction
1002312|NCT03149263|medical clowns|medical clowns
1002313|NCT03149263|distraction|distraction
1002314|NCT03149250|Aggregometry|aggregometry
1002315|NCT03149237|Mozambique|mozambique
1002316|NCT03149237|Couples-based services|couples-based services
1002317|NCT03149237|HIV/AIDS|hiv/aids
1002318|NCT03149237|Ante-natal Care|ante-natal care
1002319|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
1002320|NCT03149185|prostate cancer|prostate cancer
1002321|NCT03149185|advanced prostate cancer|advanced prostate cancer
1002322|NCT03149185|technology based|technology based
1002323|NCT03149146|Clinical Decision Making|clinical decision making
1002324|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
1002325|NCT03149146|Educational workshop|educational workshop
1002326|NCT03149133|Biomechanics|biomechanics
1002327|NCT03149133|Strength training|strength training
1002328|NCT03149133|Elastography|elastography
1002329|NCT03149133|Ultrasound|ultrasound
1002330|NCT03149120|Metastatic|metastatic
1002331|NCT03149120|Unresectable|unresectable
1002332|NCT03149120|anthracycline|anthracycline
1002333|NCT03149120|chemotherapy|chemotherapy
1002334|NCT03149120|systemic therapy|systemic therapy
1002335|NCT03149107|Prodrome, CHR, Schizophrenia, prevention, N-acetylcysteine|prodrome, chr, schizophrenia, prevention, n-acetylcysteine
1002336|NCT03149094|Self-Management|self-management
1002337|NCT03149094|mHealth|mhealth
1002338|NCT03149042|FFR|ffr
1002339|NCT03149042|Fractional Flow Reserve|fractional flow reserve
1002340|NCT03149042|Atherosclerosis|atherosclerosis
1002341|NCT03149042|Coronary|coronary
1002342|NCT03149042|stenosis|stenosis
1002343|NCT03149029|Metastatic Melanoma|metastatic melanoma
1002344|NCT03149003|Glioblastoma|glioblastoma
1002345|NCT03149003|Wilms Tumor 1|wilms tumor 1
1002346|NCT03149003|Cancer Vaccines|cancer vaccines
1002347|NCT03149003|Neoplasms|neoplasms
1002348|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
1002349|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
1002350|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
1002351|NCT03148951|MPV|mpv
1002352|NCT03148951|NLR|nlr
1002353|NCT03148951|Postoperative pain|postoperative pain
1002354|NCT03148938|DAM|dam
1002355|NCT03148938|multiple sclerosis|multiple sclerosis
1002356|NCT03148938|MSFC|msfc
1002357|NCT03148938|application|application
1002358|NCT03148938|mobile|mobile
1002359|NCT03148925|nicotine vaccine|nicotine vaccine
1002360|NCT03148925|smoking vaccine|smoking vaccine
1002361|NCT03148925|smoking cessation|smoking cessation
1002362|NCT03148925|SELA-070|sela-070
1002363|NCT03148899|Sleep Apnea|sleep apnea
1002364|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
1002558|NCT03147352|suPAR|supar
1002366|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
1002367|NCT03148860|Ustekinumab|ustekinumab
1002368|NCT03148860|Methotrexate|methotrexate
1002369|NCT03148860|DAS28|das28
1002370|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
1002371|NCT03148821|pressure ulcer|pressure ulcer
1002372|NCT03148821|pressure sore|pressure sore
1002373|NCT03148821|patient positioning|patient positioning
1002374|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
1002375|NCT03148678|Emotional reactivity|emotional reactivity
1002376|NCT03148678|Cognitive flexibility|cognitive flexibility
1002377|NCT03148665|Oral Cancer|oral cancer
1002378|NCT03148665|Head and Neck Cancer|head and neck cancer
1002379|NCT03148639|auditory hallucination|auditory hallucination
1002380|NCT03148639|schizophrenia|schizophrenia
1002381|NCT03148639|treatment-resistant|treatment-resistant
1002382|NCT03148639|psychotherapy|psychotherapy
1002383|NCT03148639|virtual reality|virtual reality
1002384|NCT03148639|avatar|avatar
1002385|NCT03148626|mindfulness curriculum|mindfulness curriculum
1002386|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
1002387|NCT03148587|abortion|abortion
1002388|NCT03148587|medical abortion|medical abortion
1002389|NCT03148587|mifepristone|mifepristone
1002390|NCT03148587|pregnancy test|pregnancy test
1002391|NCT03148548|VTE|vte
1002392|NCT03148548|thrombophilia screening|thrombophilia screening
1002393|NCT03148548|patients|patients
1002394|NCT03148548|risk factors|risk factors
1002395|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
1002396|NCT03148496|abdominal surgery|abdominal surgery
1002397|NCT03148496|wound complication|wound complication
1002398|NCT03148483|Pregnancy outcome|pregnancy outcome
1002399|NCT03148483|Feasibility|feasibility
1002400|NCT03148483|Milk Fortification|milk fortification
1002401|NCT03148483|Periodontitis|periodontitis
1002402|NCT03148483|Pregnant women|pregnant women
1002403|NCT03148483|Periodontal Therapy|periodontal therapy
1002404|NCT03148470|theta burst stimulation|theta burst stimulation
1002405|NCT03148470|Language switching|language switching
1002406|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1002407|NCT03148457|Stroke|stroke
1002408|NCT03148457|Direct oral anticoagulation|direct oral anticoagulation
1025083|NCT03005873|DSP|dsp
1002409|NCT03148457|Apixaban|apixaban
1002410|NCT03148457|Dabigatran|dabigatran
1002411|NCT03148457|Rivaroxaban|rivaroxaban
1002412|NCT03148457|Edoxaban|edoxaban
1002413|NCT03148457|Therapy initiation|therapy initiation
1002414|NCT03148457|Major bleeding|major bleeding
1002415|NCT03148457|Atrial fibrillation|atrial fibrillation
1002416|NCT03148379|Total Knee Replacement|total knee replacement
1002417|NCT03148366|Self Efficacy|self efficacy
1002418|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
1002419|NCT03148249|Randomized control trial|randomized control trial
1002420|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
1002421|NCT03148249|visual hallucinations|visual hallucinations
1002422|NCT03148249|age related macular degeneration|age related macular degeneration
1002423|NCT03148249|patient education|patient education
1002424|NCT03148223|Dysmenorrhea|dysmenorrhea
1002425|NCT03148223|acupuncture|acupuncture
1002426|NCT03148223|auriculotherapy|auriculotherapy
1002427|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1002428|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
1002429|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
1002430|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
1002431|NCT03148184|60 years old or younger|60 years old or younger
1002432|NCT03148184|outcomes|outcomes
1002433|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
1002434|NCT03148158|Bladder Cancer|bladder cancer
1002435|NCT03148158|Flexible cystoscopy|flexible cystoscopy
1002436|NCT03148158|Diagnosis|diagnosis
1002437|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
1002438|NCT03148132|VEGF|vegf
1002439|NCT03148132|Bevacizumab|bevacizumab
1002440|NCT03148132|Ranibizumab|ranibizumab
1002441|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
1002442|NCT03148093|Registry|registry
1002443|NCT03148093|Patient Reported Outcomes|patient reported outcomes
1002444|NCT03148093|Treatment Patterns|treatment patterns
1002445|NCT03148093|Prescription Use|prescription use
1002446|NCT03148067|Risk Factors|risk factors
1002447|NCT03148067|Incidence|incidence
1002448|NCT03148067|Epidemiology|epidemiology
1002449|NCT03148054|Anastomosis|anastomosis
1002450|NCT03148054|Colon|colon
1002451|NCT03148054|CT|ct
1002452|NCT03148054|Endoscopy|endoscopy
1002453|NCT03148054|Enema|enema
1002454|NCT03148054|Detection leak|detection leak
1002455|NCT03148054|Anastomotic leak|anastomotic leak
1002456|NCT03147989|MultiHance|multihance
1002457|NCT03147989|MRI|mri
1002458|NCT03147989|CNS|cns
1002459|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
1002460|NCT03147963|therapy|therapy
1002461|NCT03147963|breast cancer|breast cancer
1002462|NCT03147963|docetaxel|docetaxel
1002463|NCT03147963|metastasis|metastasis
1002464|NCT03147950|Prone-Flexed Position|prone-flexed position
1002465|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
1002466|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
1002467|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
1002468|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
1002469|NCT03147898|Whooping cough|whooping cough
1002470|NCT03147898|Pertussis|pertussis
1002471|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
1002472|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
1002473|NCT03147781|auriculotherapy, human milk, breastfeeding, lactogenesis|auriculotherapy, human milk, breastfeeding, lactogenesis
1002474|NCT03147768|Laser Tissue Welding|laser tissue welding
1002475|NCT03147768|Pancreatic Sealing|pancreatic sealing
1002476|NCT03147768|Hemostasis|hemostasis
1002477|NCT03147768|Pancreatic Tumors|pancreatic tumors
1002478|NCT03147768|Pancreatic Resection|pancreatic resection
1002479|NCT03147768|Pancreatic leakage|pancreatic leakage
1002480|NCT03147768|LTW|ltw
1002481|NCT03147755|stroke|stroke
1002482|NCT03147742|ruxolitinib|ruxolitinib
1002483|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
1002484|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
1002485|NCT03147729|Radiofrequency|radiofrequency
1002486|NCT03147729|Anal incontinence|anal incontinence
1002487|NCT03147729|Fecal incontinence|fecal incontinence
1002488|NCT03147729|Women sexual function|women sexual function
1002489|NCT03147729|Sexuality|sexuality
1002490|NCT03147703|Microbiota|microbiota
1002491|NCT03147703|Food timing|food timing
1002492|NCT03147703|Obesity|obesity
1002493|NCT03147690|Solid Organ Injury|solid organ injury
1002494|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
1002495|NCT03147677|Alfacalcidol|alfacalcidol
1002496|NCT03147664|pompe disease|pompe disease
1002497|NCT03147664|exercise capacity|exercise capacity
1002498|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1002499|NCT03147651|Cystic fibrosis|cystic fibrosis
1002500|NCT03147651|exercise capacity|exercise capacity
1002501|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
1002502|NCT03147651|bronchiectasis|bronchiectasis
1002503|NCT03147625|Aged|aged
1002504|NCT03147625|Independent living|independent living
1002505|NCT03147625|Health Promotion|health promotion
1002506|NCT03147625|Residence Characteristics|residence characteristics
1002507|NCT03147625|Elderly-only household|elderly-only household
1002508|NCT03147599|Mebeverine|mebeverine
1002509|NCT03147599|Incontinence|incontinence
1002510|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
1002511|NCT03147586|Immune Nutrition|immune nutrition
1002512|NCT03147586|Morbidity|morbidity
1002513|NCT03147573|Hypertension|hypertension
1002514|NCT03147573|Blood pressure monitoring|blood pressure monitoring
1002515|NCT03147560|Immunogenicity|immunogenicity
1002516|NCT03147560|Safety|safety
1002517|NCT03147560|Sabin IPV|sabin ipv
1002518|NCT03147560|bOPV|bopv
1002519|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
1002520|NCT03147456|bariatric|bariatric
1002521|NCT03147456|obesity|obesity
1002522|NCT03147456|protein supplements|protein supplements
1002523|NCT03147443|traditional Chinese medicine|traditional chinese medicine
1002524|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
1002525|NCT03147443|N-of-1 trials|n-of-1 trials
1002526|NCT03147443|sputum|sputum
1002527|NCT03147443|symptoms|symptoms
1002528|NCT03147443|individualized treatment|individualized treatment
1002529|NCT03147443|stable bronchiectasis|stable bronchiectasis
1002530|NCT03147391|Atrial Fibrillation|atrial fibrillation
1002531|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
1002532|NCT03147391|LAmbre device|lambre device
1002533|NCT03147391|Stroke|stroke
1002534|NCT03147352|Fasciitis|fasciitis
1002535|NCT03147352|Gangrene|gangrene
1002536|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
1002537|NCT03147352|Soft Tissue Infections|soft tissue infections
1002538|NCT03147352|Fournier's Gangrene|fournier's gangrene
1002539|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
1002540|NCT03147352|Flesh eating bacteria|flesh eating bacteria
1002541|NCT03147352|Meleneys ulcer|meleneys ulcer
1002542|NCT03147352|Wounds and Injuries|wounds and injuries
1002543|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
1002544|NCT03147352|Staphylococcus aureus|staphylococcus aureus
1002545|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
1002546|NCT03147352|Necrosis/blood|necrosis/blood
1002547|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
1002548|NCT03147352|Necrosis/mortality|necrosis/mortality
1002549|NCT03147352|Necrosis/surgery|necrosis/surgery
1002550|NCT03147352|Prognosis|prognosis
1002551|NCT03147352|Risk Factors|risk factors
1002552|NCT03147352|Bacterial Infections|bacterial infections
1002553|NCT03147352|Infection|infection
1002554|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
1002555|NCT03147352|Observational study|observational study
1002556|NCT03147352|Biological markers|biological markers
1002557|NCT03147352|Endothelium|endothelium
1002560|NCT03147352|syndecan-1|syndecan-1
1002561|NCT03147352|sE-selectin|se-selectin
1002562|NCT03147352|VE-cadherin|ve-cadherin
1002563|NCT03147352|protein C|protein c
1002564|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1002565|NCT03147352|HBOT|hbot
1002566|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
1002567|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
1002568|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
1002569|NCT03147313|nerve regeneration|nerve regeneration
1002570|NCT03147300|Low back pain|low back pain
1002571|NCT03147300|Model of care|model of care
1002572|NCT03147300|Primary health care|primary health care
1002573|NCT03147300|Implementation|implementation
1002574|NCT03147300|Patient-rated outcome|patient-rated outcome
1002575|NCT03147300|Clinician-rated outcome|clinician-rated outcome
1002576|NCT03147300|Cost-effectiveness|cost-effectiveness
1002577|NCT03147287|Breast Cancer|breast cancer
1002578|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1002579|NCT03147274|Adolescence|adolescence
1002580|NCT03147222|hip fracture|hip fracture
1002581|NCT03147222|dementia|dementia
1002582|NCT03147222|intervention|intervention
1002583|NCT03147157|tacrolimus|tacrolimus
1002584|NCT03147157|histocompatibility antigens|histocompatibility antigens
1002585|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
1002586|NCT03147131|Short Stem|short stem
1002587|NCT03147131|DEXA|dexa
1002588|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
1002589|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
1002590|NCT03147079|obesity|obesity
1002591|NCT03147079|pregnancy|pregnancy
1002592|NCT03147079|lifestyle|lifestyle
1002593|NCT03147079|gestational weight gain|gestational weight gain
1002594|NCT03147079|weight of offspring|weight of offspring
1002595|NCT03147079|antenatal care|antenatal care
1002596|NCT03147079|health behavior|health behavior
1002597|NCT03147079|physical activity|physical activity
1002598|NCT03147079|diet|diet
1002599|NCT03147079|programme evaluation|programme evaluation
1002600|NCT03147079|costs and costs analysis|costs and costs analysis
1002601|NCT03147066|Dezocine|dezocine
1002602|NCT03147066|CRBD|crbd
1002603|NCT03147066|General anesthesia|general anesthesia
1002604|NCT03147066|Urinary catheter|urinary catheter
1002605|NCT03147040|Lobular|lobular
1002606|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
1002607|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
1002608|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
1002609|NCT03147027|prophylactic ablation|prophylactic ablation
1002610|NCT03147014|Echocardiography|echocardiography
1002611|NCT03147014|Congenital Heart Disease|congenital heart disease
1002612|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
1002613|NCT03147001|Endurance exercise|endurance exercise
1002614|NCT03147001|Dietary protein|dietary protein
1002615|NCT03146975|Beta-defensins|beta-defensins
1002616|NCT03146975|Chronic periodontitis|chronic periodontitis
1002617|NCT03146975|Diabetes mellitus|diabetes mellitus
1002618|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
1002619|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
1002620|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
1002621|NCT03146845|Pressure Ulcer|pressure ulcer
1002622|NCT03146845|Leg Ulcer|leg ulcer
1002623|NCT03146819|osteoarthritis|osteoarthritis
1002624|NCT03146819|osteoarthritis knee|osteoarthritis knee
1002625|NCT03146819|total knee replacement|total knee replacement
1002626|NCT03146819|patient specific|patient specific
1002627|NCT03146819|total knee arthroplasty|total knee arthroplasty
1002628|NCT03146819|orthopedics|orthopedics
1002629|NCT03146806|Cancer pain|cancer pain
1002630|NCT03146806|Anesthesiology|anesthesiology
1002631|NCT03146806|Opiates|opiates
1002632|NCT03146806|Intranasal ketamine|intranasal ketamine
1002633|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
1002634|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
1002635|NCT03146793|Renal Dialysis|renal dialysis
1002636|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
1002637|NCT03146793|Time Factors|time factors
1002638|NCT03146741|Heart Failure|heart failure
1002639|NCT03146702|Quality of Life|quality of life
1002640|NCT03146689|osteoarthritis|osteoarthritis
1002641|NCT03146689|n-of-1|n-of-1
1002642|NCT03146689|ibuprofen|ibuprofen
1002643|NCT03146689|capsaicin|capsaicin
1002644|NCT03146689|NSAID|nsaid
1002645|NCT03146689|topical|topical
1002646|NCT03146663|Platinum-resistant|platinum-resistant
1002647|NCT03146663|ovarian neoplasm|ovarian neoplasm
1002648|NCT03146663|antineoplastic agents|antineoplastic agents
1002649|NCT03146663|ovarian diseases|ovarian diseases
1002650|NCT03146663|cancer of the ovary|cancer of the ovary
1002651|NCT03146637|PD-1 activated CIK|pd-1 activated cik
1002652|NCT03146637|MUC1|muc1
1002653|NCT03146637|Bispecfic antibody|bispecfic antibody
1002654|NCT03146637|liver cancer|liver cancer
1002655|NCT03146598|Foot deformity|foot deformity
1002656|NCT03146598|Orthopaedic management|orthopaedic management
1002657|NCT03146598|prevention|prevention
1002658|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
1002659|NCT03146585|Glycocalyx|glycocalyx
1002660|NCT03146559|Cross education|cross education
1002661|NCT03146559|EMG|emg
1002662|NCT03146520|Syndecan 2|syndecan 2
1002663|NCT03146520|Methylation biomarker|methylation biomarker
1002664|NCT03146520|Colorectal cancer|colorectal cancer
1002665|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
1002666|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
1002667|NCT03146455|Thrombelastograghy|thrombelastograghy
1002668|NCT03146455|reference ranges|reference ranges
1002669|NCT03146455|racial|racial
1002670|NCT03146455|geographic|geographic
1002671|NCT03146455|Blood Transfusion|blood transfusion
1002672|NCT03146442|increased dietary protein|increased dietary protein
1002673|NCT03146442|breakfast|breakfast
1002674|NCT03146442|weight management|weight management
1002675|NCT03146442|satiety|satiety
1002676|NCT03146442|glucose control|glucose control
1002677|NCT03146442|fMRI|fmri
1002678|NCT03146442|cognitive performance|cognitive performance
1002679|NCT03146442|memory|memory
1002680|NCT03146442|attention|attention
1002681|NCT03146442|executive function|executive function
1002682|NCT03146442|structural MRI|structural mri
1002683|NCT03146442|sleep quality|sleep quality
1002684|NCT03146403|HSV|hsv
1002685|NCT03146403|Herpes|herpes
1002686|NCT03146403|Genital Herpes|genital herpes
1002687|NCT03146403|Vaccine|vaccine
1002688|NCT03146390|biofilms|biofilms
1002689|NCT03146390|essential oils|essential oils
1002690|NCT03146390|microscopy, confocal|microscopy, confocal
1002691|NCT03146390|mouthwashes|mouthwashes
1002692|NCT03146364|Virtual Reality|virtual reality
1002693|NCT03146351|preterm|preterm
1002694|NCT03146351|infant|infant
1002695|NCT03146351|physiotherapy|physiotherapy
1002696|NCT03146338|Anti-EGFR|anti-egfr
1002697|NCT03146338|Hypomagnesemia|hypomagnesemia
1002698|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
1002699|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
1002700|NCT03146325|H. pylori infection|h. pylori infection
1002701|NCT03146312|gene expression|gene expression
1002702|NCT03146312|gene array|gene array
1002703|NCT03146312|epigenetics|epigenetics
1002704|NCT03146312|DNA methylation|dna methylation
1002705|NCT03146260|TESE|tese
1002706|NCT03146260|Sperm retreival|sperm retreival
1002707|NCT03146260|Azoospermia|azoospermia
1002708|NCT03146260|FSH|fsh
1002709|NCT03146260|LH|lh
1002710|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
1002711|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
1002712|NCT03146208|Coronroy artery diseases|coronroy artery diseases
1002713|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
1002714|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
1002715|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
1002716|NCT03146195|space coordinates|space coordinates
1002717|NCT03146182|C-reactive protein|c-reactive protein
1002718|NCT03146182|Procalcitonin|procalcitonin
1002719|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
1002720|NCT03146182|Antibiotic stewardship|antibiotic stewardship
1002721|NCT03146156|obesity|obesity
1002722|NCT03146156|overweight|overweight
1002723|NCT03146156|lifestyle intervention|lifestyle intervention
1002724|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
1002725|NCT03146156|Mediterranean diet|mediterranean diet
1002726|NCT03146117|PET CT|pet ct
1002727|NCT03146091|Antibiotics|antibiotics
1002728|NCT03146052|Colon cleansing|colon cleansing
1002729|NCT03146013|HTLV|htlv
1002730|NCT03146013|Confirmatory|confirmatory
1002731|NCT03146013|Supplemental|supplemental
1002732|NCT03146013|Blot|blot
1002733|NCT03146013|HTLV-I|htlv-i
1002734|NCT03146013|HTLV-II|htlv-ii
1002735|NCT03145987|Cognitive functioning|cognitive functioning
1002736|NCT03145987|Neuropsychological status|neuropsychological status
1002737|NCT03145987|Vitis vinifera|vitis vinifera
1002738|NCT03145974|respiratory failure|respiratory failure
1002739|NCT03145974|mechanical ventilation|mechanical ventilation
1002740|NCT03145961|Breast cancer early stage|breast cancer early stage
1002741|NCT03145961|circulating tumour DNA|circulating tumour dna
1002742|NCT03145961|pembrolizumab|pembrolizumab
1002743|NCT03145961|targeted therapy|targeted therapy
1002744|NCT03145961|randomised clinical trial|randomised clinical trial
1002745|NCT03145961|phase II|phase ii
1002746|NCT03145961|mutation screening|mutation screening
1002747|NCT03145961|intermediate endpoint|intermediate endpoint
1002748|NCT03145948|Tolerability|tolerability
1002749|NCT03145948|Psoriasis|psoriasis
1002750|NCT03145948|Pharmacokinetics|pharmacokinetics
1002751|NCT03145948|Safety|safety
1002752|NCT03145948|Healthy Volunteers|healthy volunteers
1002753|NCT03145909|Cancer|cancer
1002754|NCT03145909|Metastatic|metastatic
1002755|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
1002756|NCT03145909|Breast cancer|breast cancer
1002757|NCT03145909|Colorectal cancer|colorectal cancer
1002758|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
1002759|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
1002760|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
1002761|NCT03145896|vitamin D|vitamin d
1002762|NCT03145896|Anemia|anemia
1002764|NCT03145857|Gallium-68|gallium-68
1002765|NCT03145857|Positron Emission Tomography|positron emission tomography
1002766|NCT03145844|DAA|daa
1002767|NCT03145844|Hepatitis|hepatitis
1002768|NCT03145831|Pediatrics|pediatrics
1002769|NCT03145818|dissemination|dissemination
1002770|NCT03145805|blood chemical analysis|blood chemical analysis
1002771|NCT03145805|bupivacaine|bupivacaine
1002772|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
1002773|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
1002774|NCT03145766|Rabies virus|rabies virus
1002775|NCT03145753|HIV testing program|hiv testing program
1002776|NCT03145753|HCV testing program|hcv testing program
1002777|NCT03145753|education|education
1002778|NCT03145727|Chemotherapy|chemotherapy
1002779|NCT03145727|nausea|nausea
1002780|NCT03145727|vomiting|vomiting
1002781|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1002782|NCT03145714|POCD|pocd
1002783|NCT03145714|Elderly|elderly
1002784|NCT03145688|Behavioural|behavioural
1002785|NCT03145688|Family physical activity habit|family physical activity habit
1002786|NCT03145675|Anticoagulation|anticoagulation
1002787|NCT03145675|Enoxaparin|enoxaparin
1002788|NCT03145675|Dose|dose
1002789|NCT03145649|Breast milk|breast milk
1002790|NCT03145649|Hormone|hormone
1002791|NCT03145649|Infant growth|infant growth
1002792|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
1002793|NCT03145636|Obesity|obesity
1002794|NCT03145636|Bariatric surgery|bariatric surgery
1663302|NCT00130923|Treatment|treatment
1002795|NCT03145636|Vagal blocking|vagal blocking
1002796|NCT03145636|vBloc therapy|vbloc therapy
1002797|NCT03145636|Vagus Nerve|vagus nerve
1002798|NCT03145636|Percent excess weight loss|percent excess weight loss
1002799|NCT03145636|Percent total body weight loss|percent total body weight loss
1002800|NCT03145597|facings|facings
1002801|NCT03145597|veneers|veneers
1002802|NCT03145597|laminates|laminates
1002803|NCT03145597|existing|existing
1002804|NCT03145597|restorations|restorations
1002805|NCT03145597|esthetics|esthetics
1002806|NCT03145597|dental|dental
1002807|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
1002808|NCT03145584|Physiotherapy|physiotherapy
1002809|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
1002810|NCT03145493|Drainage, Suction|drainage, suction
1002811|NCT03145493|tranexamic acid|tranexamic acid
1002812|NCT03145480|leukemia|leukemia
1002813|NCT03145480|richter|richter
1002814|NCT03145467|Migraine|migraine
1002815|NCT03145467|Paracetamol|paracetamol
1002816|NCT03145467|Zolmitriptan|zolmitriptan
1002817|NCT03145467|Emergency services|emergency services
1002818|NCT03145454|Pain|pain
1002819|NCT03145454|children|children
1002820|NCT03145454|emergency|emergency
1002821|NCT03145454|electroencephalography|electroencephalography
1002822|NCT03145454|heart rate|heart rate
1002823|NCT03145454|skin conductance|skin conductance
1002824|NCT03145454|pupillary diameter|pupillary diameter
1002825|NCT03145415|pudendal nerve block|pudendal nerve block
1002826|NCT03145415|hypospadias|hypospadias
1002827|NCT03145415|caudal block|caudal block
1002828|NCT03145376|TAVI|tavi
1002829|NCT03145376|MitraClip|mitraclip
1002830|NCT03145376|geriatric assessment|geriatric assessment
1002831|NCT03145376|heart rate variability|heart rate variability
1002832|NCT03145376|elderly|elderly
1002833|NCT03145350|NAFLD|nafld
1002834|NCT03145350|Fat intake|fat intake
1002835|NCT03145350|Sugar intake|sugar intake
1002836|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
1002837|NCT03145298|HPAH (heritable)|hpah (heritable)
1002838|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
1002839|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
1002840|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
1002841|NCT03145285|Abiraterone Acetate|abiraterone acetate
1002842|NCT03145285|Cushing Syndrome|cushing syndrome
1002843|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
1002844|NCT03145272|Pharmacogenomics|pharmacogenomics
1002845|NCT03145272|Pharmacokinetics|pharmacokinetics
1002846|NCT03145272|Oxycodone|oxycodone
1002847|NCT03145246|intrabony defect|intrabony defect
1002848|NCT03145246|periodontal regeneration|periodontal regeneration
1002849|NCT03145233|physiotherapy|physiotherapy
1002850|NCT03145220|EA-230|ea-230
1002851|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1002852|NCT03145220|Acute Kidney Injury|acute kidney injury
1002853|NCT03145220|Interleukin-6|interleukin-6
1002854|NCT03145220|Safety|safety
1002855|NCT03145220|Tolerability|tolerability
1002856|NCT03145220|Phase II|phase ii
1002857|NCT03145220|Randomized clinical trial|randomized clinical trial
1002858|NCT03145155|continuum of care|continuum of care
1002859|NCT03145155|maternal|maternal
1002860|NCT03145155|newborn|newborn
1002861|NCT03145155|child health|child health
1002862|NCT03145155|noncommunicable diseases|noncommunicable diseases
1002863|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
1002864|NCT03145129|Intraocular pressure|intraocular pressure
1002866|NCT03145129|CPAP|cpap
1002867|NCT03145090|bone scintigraphy|bone scintigraphy
1002868|NCT03145090|knee arthroplasty|knee arthroplasty
1002869|NCT03145090|spect-ct|spect-ct
1002870|NCT03145090|quantification|quantification
1002871|NCT03145077|Head and Neck Cancer|head and neck cancer
1002872|NCT03145077|Osteoradionecrosis|osteoradionecrosis
1002873|NCT03145077|ORN|orn
1002874|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
1002875|NCT03145077|DCE-MRI|dce-mri
1002876|NCT03145077|Questionnaires|questionnaires
1002877|NCT03145077|Surveys|surveys
1002878|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
1002879|NCT03145051|saline solution|saline solution
1002880|NCT03145051|minerals|minerals
1002881|NCT03145051|cystic fibrosis|cystic fibrosis
1002882|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
1002883|NCT03145051|nasal irrigation|nasal irrigation
1002884|NCT03145012|Cancer|cancer
1002885|NCT03145012|Immunity|immunity
1002886|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1002887|NCT03145012|Ranitidine|ranitidine
1002888|NCT03144999|Dry AMD|dry amd
1002889|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
1002890|NCT03144999|Gene Therapy|gene therapy
1002891|NCT03144999|Complement|complement
1002892|NCT03144999|Intravitreal Injection|intravitreal injection
1002893|NCT03144999|Geographic Atrophy|geographic atrophy
1002894|NCT03144999|Drusen|drusen
1002895|NCT03144999|Membrane Attack Complex|membrane attack complex
1002896|NCT03144999|CD59|cd59
1002898|NCT03144921|Early-stage Dementia|early-stage dementia
1002899|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
1002900|NCT03144921|Care partner|care partner
1002901|NCT03144921|Caregivers|caregivers
1002902|NCT03144921|Caregiving|caregiving
1002903|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
1002904|NCT03144869|physical activity|physical activity
1002905|NCT03144869|children|children
1002906|NCT03144869|constant glucose monitoring|constant glucose monitoring
1002907|NCT03144856|Biliary Tract Cancer|biliary tract cancer
1002908|NCT03144856|Second line thrapy|second line thrapy
1002909|NCT03144856|Apatinib|apatinib
1002910|NCT03144843|Gastric cancer|gastric cancer
1002911|NCT03144843|Peritoneal metastasis|peritoneal metastasis
1002912|NCT03144843|Paclitaxol|paclitaxol
1002913|NCT03144843|Apatinib|apatinib
1002914|NCT03144843|Second-line chemotherapy|second-line chemotherapy
1002915|NCT03144817|hemodialysis|hemodialysis
1002916|NCT03144817|fluid overload|fluid overload
1002917|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
1002918|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
1002919|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
1002920|NCT03144804|Colorectal Cancer|colorectal cancer
1002921|NCT03144778|Malignant Neoplasms of Oropharynx|malignant neoplasms of oropharynx
1002922|NCT03144778|CD8+ tumor infiltrating lymphocytes|cd8+ tumor infiltrating lymphocytes
1002923|NCT03144778|Biomarkers|biomarkers
1002924|NCT03144778|Durvalumab|durvalumab
1002925|NCT03144778|MEDI4736|medi4736
1002926|NCT03144778|Tremelimumab|tremelimumab
1002927|NCT03144778|Ticilimumab|ticilimumab
1002928|NCT03144778|CP-675,206|cp-675,206
1002929|NCT03144765|taTME|tatme
1002930|NCT03144765|Transanal|transanal
1002931|NCT03144765|Rectal cancer|rectal cancer
1002932|NCT03144765|Colorectal|colorectal
1002933|NCT03144765|Total mesorectal excision|total mesorectal excision
1002934|NCT03144765|TME|tme
1002935|NCT03144687|Myelofibrosis|myelofibrosis
1002936|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
1002937|NCT03144687|itacitinib|itacitinib
1002938|NCT03144687|ruxolitinib|ruxolitinib
1002939|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
1002940|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
1002941|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
1002942|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
1002943|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
1002944|NCT03144661|esophageal|esophageal
1002945|NCT03144661|nasopharyngeal|nasopharyngeal
1002946|NCT03144661|serous ovarian|serous ovarian
1002947|NCT03144661|solid tumors|solid tumors
1002948|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
1002949|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
1002950|NCT03144635|Direct Acting Antivirals|direct acting antivirals
1002951|NCT03144635|Grazoprevir|grazoprevir
1002952|NCT03144635|Elbasvir|elbasvir
1002953|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
1002954|NCT03144622|18F-FSPG|18f-fspg
1002955|NCT03144622|PET/CT|pet/ct
1003262|NCT03142412|SLE|sle
1002956|NCT03144622|system xC-transporter|system xc-transporter
1002957|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
1002958|NCT03144583|CART19|cart19
1002959|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
1002960|NCT03144557|Education|education
1002961|NCT03144557|COPD|copd
1002962|NCT03144557|Inhalation Devices|inhalation devices
1002963|NCT03144544|Similarity|similarity
1002964|NCT03144544|Diversity|diversity
1002965|NCT03144531|School-age child|school-age child
1002966|NCT03144518|Positive Affect|positive affect
1002967|NCT03144518|Positive Mood|positive mood
1002968|NCT03144518|Influenza Vaccination|influenza vaccination
1002969|NCT03144518|Vaccination|vaccination
1002970|NCT03144518|Randomised Controlled Trial|randomised controlled trial
1002971|NCT03144505|Type 2 Diabetes|type 2 diabetes
1002972|NCT03144505|Exercise|exercise
1002973|NCT03144505|High Intensity Interval Training|high intensity interval training
1002974|NCT03144505|Glycemic Control|glycemic control
1002975|NCT03144492|Cell Culture|cell culture
1002976|NCT03144492|Microgravity co-culture|microgravity co-culture
1002978|NCT03144453|Robotic surgery|robotic surgery
1002979|NCT03144440|ZEPATIER|zepatier
1002980|NCT03144427|albumin|albumin
1002981|NCT03144427|resuscitation|resuscitation
1002982|NCT03144427|burns|burns
1002983|NCT03144427|shock|shock
1002984|NCT03144427|fluid creep|fluid creep
1002985|NCT03144401|cesarean section|cesarean section
1002986|NCT03144401|Misoprostol|misoprostol
1002987|NCT03144401|sublingual|sublingual
1002988|NCT03144401|uterotonics|uterotonics
1002989|NCT03144323|Intraoral elastics|intraoral elastics
1002990|NCT03144258|congenital heart defects|congenital heart defects
1002991|NCT03144258|systemic microcirculation|systemic microcirculation
1002992|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
1002993|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
1002994|NCT03144245|AML|aml
1002995|NCT03144245|treatment|treatment
1002996|NCT03144245|relapsed|relapsed
1002997|NCT03144245|refractory|refractory
1002998|NCT03144245|phase 1|phase 1
1002999|NCT03144219|intracranial pressure|intracranial pressure
1003000|NCT03144219|transcranial Doppler|transcranial doppler
1003001|NCT03144219|jugular compression|jugular compression
1003002|NCT03144219|cerebral compliance|cerebral compliance
1003003|NCT03144193|topical treatment|topical treatment
1003004|NCT03144193|wrinkles|wrinkles
1003005|NCT03144193|extracellular matrix|extracellular matrix
1003006|NCT03144180|pregnant|pregnant
1003007|NCT03144180|third trimester|third trimester
1003008|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
1003009|NCT03144154|Cancer|cancer
1003010|NCT03144154|Fatigue|fatigue
1003011|NCT03144154|Hypnosis|hypnosis
1003012|NCT03144154|Self-hypnosis|self-hypnosis
1003013|NCT03144154|Self-care|self-care
1003014|NCT03144154|Emotional distress|emotional distress
1003015|NCT03144154|Cancer survivors|cancer survivors
1003016|NCT03144128|vitamin D|vitamin d
1003017|NCT03144128|muscle|muscle
1003018|NCT03144128|metabolism|metabolism
1003019|NCT03144128|cancer cachexia|cancer cachexia
1003020|NCT03144115|oxytocin|oxytocin
1003021|NCT03144115|sex hormone|sex hormone
1003022|NCT03144115|verbal reward|verbal reward
1003023|NCT03144115|mate selection|mate selection
1003024|NCT03144115|metaphorical language|metaphorical language
1003025|NCT03144089|Morbid obesity|morbid obesity
1003026|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
1003027|NCT03144089|Mask ventilation|mask ventilation
1003028|NCT03144089|Upper airway obstruction|upper airway obstruction
1003029|NCT03144076|healthcare|healthcare
1003030|NCT03144076|India|india
1003031|NCT03144076|health insurance|health insurance
1003032|NCT03144076|RSBY|rsby
1003033|NCT03144076|free health insurance|free health insurance
1003034|NCT03144076|inpatient insurance|inpatient insurance
1003035|NCT03144076|wealth transfer|wealth transfer
1003036|NCT03144063|Disease Activity|disease activity
1003037|NCT03144063|SLEDAI-2K|sledai-2k
1003038|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
1003039|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
1003040|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
1003041|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
1003042|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
1003043|NCT03143985|TEW-7197|tew-7197
1003044|NCT03143985|Pomalidomide|pomalidomide
1003045|NCT03143972|Dexmedetomidine|dexmedetomidine
1003046|NCT03143972|Remifentanil|remifentanil
1003047|NCT03143972|Pharmacodynamics|pharmacodynamics
1003048|NCT03143972|Interaction|interaction
1003049|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
1003050|NCT03143946|vitamin|vitamin
1003051|NCT03143946|diet|diet
1003052|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
1003053|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
1003054|NCT03143920|inflammation|inflammation
1003055|NCT03143920|chronic disease|chronic disease
1003056|NCT03143920|urinary bladder|urinary bladder
1003057|NCT03143920|urinary tract infection|urinary tract infection
1003058|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
1003059|NCT03143920|painful bladder syndrome|painful bladder syndrome
1003060|NCT03143920|chronic pain|chronic pain
1003061|NCT03143920|hypoxia|hypoxia
1003062|NCT03143920|bacterial infection|bacterial infection
1003063|NCT03143907|Mindfulness|mindfulness
1003064|NCT03143907|Group Therapy|group therapy
1003065|NCT03143894|Breast Cancer|breast cancer
1003066|NCT03143894|Cognition|cognition
1003067|NCT03143894|Fatigue|fatigue
1003068|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
1003069|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1003070|NCT03143868|acute exercise|acute exercise
1003071|NCT03143868|resistance exercise|resistance exercise
1003072|NCT03143868|aerobic exercise|aerobic exercise
1003073|NCT03143868|appetite|appetite
1003074|NCT03143868|energy intake|energy intake
1003075|NCT03143855|oxycodone|oxycodone
1003076|NCT03143855|lorcaserin|lorcaserin
1003077|NCT03143855|Belviq|belviq
1003078|NCT03143842|VNS|vns
1003079|NCT03143842|accelerate learning|accelerate learning
1003080|NCT03143842|memory|memory
1003081|NCT03143829|gerontology|gerontology
1003082|NCT03143829|symptom self-management|symptom self-management
1003083|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1003084|NCT03143816|diabetes|diabetes
1003085|NCT03143816|time in range|time in range
1003086|NCT03143816|inhaled insulin|inhaled insulin
1003087|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
1003088|NCT03143816|type 1 diabetes|type 1 diabetes
1003089|NCT03143816|hypoglycemia|hypoglycemia
1003090|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
1003091|NCT03143790|Erectile Function|erectile function
1003092|NCT03143790|Prostatectomy|prostatectomy
1003093|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
1003094|NCT03143790|IIEF-5|iief-5
1003095|NCT03143777|physiotherapy|physiotherapy
1003096|NCT03143777|rehabilitation|rehabilitation
1003097|NCT03143777|critical care|critical care
1003098|NCT03143777|seating|seating
1003099|NCT03143738|regional anesthesia|regional anesthesia
1003100|NCT03143738|knee replacement|knee replacement
1003101|NCT03143738|pain treatment|pain treatment
1003102|NCT03143738|rehabilitation|rehabilitation
1003103|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
1003104|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
1003105|NCT03143660|obesity|obesity
1003106|NCT03143608|GERD|gerd
1003107|NCT03143608|Hiatal hernia repair|hiatal hernia repair
1003108|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
1003109|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
1003110|NCT03143595|Elderly|elderly
1003111|NCT03143595|Outcomes|outcomes
1003112|NCT03143556|renal transplant|renal transplant
1003113|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
1003114|NCT03143556|Black-Star®|black-star®
1003115|NCT03143543|cocaine disorder|cocaine disorder
1003116|NCT03143543|opioid disorder|opioid disorder
1003117|NCT03143543|lorcaserin|lorcaserin
1003118|NCT03143543|MRI|mri
1003119|NCT03143543|fMRI|fmri
1003120|NCT03143530|Ropivacaine|ropivacaine
1003121|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
1003122|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
1003123|NCT03143517|Ulcerative Colitis|ulcerative colitis
1003124|NCT03143517|Crohn Disease|crohn disease
1003125|NCT03143517|Indeterminate Colitis|indeterminate colitis
1003126|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
1003127|NCT03143426|Junior surgeons|junior surgeons
1003128|NCT03143426|Complication|complication
1003129|NCT03143426|Conversion|conversion
1003130|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
1003131|NCT03143413|Systemic sclerosis|systemic sclerosis
1003132|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
1003133|NCT03143413|Sicca syndrome|sicca syndrome
1003134|NCT03143400|Probiotics|probiotics
1003135|NCT03143400|Galenic form|galenic form
1003136|NCT03143400|Digestive tract|digestive tract
1003137|NCT03143400|Intestinal microbiota|intestinal microbiota
1003138|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
1003139|NCT03143361|aortic valve stenosis|aortic valve stenosis
1003140|NCT03143361|heart valves|heart valves
1003141|NCT03143361|heart surgery|heart surgery
1003142|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
1003143|NCT03143322|Bone-only metastases|bone-only metastases
1003144|NCT03143322|solid tumors|solid tumors
1003145|NCT03143322|SBRT|sbrt
1003146|NCT03143283|suicide|suicide
1003147|NCT03143283|lethal means|lethal means
1003148|NCT03143283|counseling|counseling
1003149|NCT03143283|youth|youth
1003150|NCT03143283|parents|parents
1003151|NCT03143283|firearms|firearms
1003152|NCT03143283|medication|medication
1003153|NCT03143283|suicidal|suicidal
1003154|NCT03143283|emergency department|emergency department
1003155|NCT03143270|nivolumab|nivolumab
1003156|NCT03143270|deb-TACE|deb-tace
1003157|NCT03143270|17-087|17-087
1003158|NCT03143218|Malaria|malaria
1003159|NCT03143218|Seasonal vaccination|seasonal vaccination
1003160|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
1003161|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
1003162|NCT03143140|Ablation Techniques|ablation techniques
1003163|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
1003164|NCT03143101|Trivalent|trivalent
1003165|NCT03143101|Influenza|influenza
1003166|NCT03143101|Vaccine|vaccine
1003167|NCT03143101|Prevention|prevention
1003168|NCT03143088|Blood pressure|blood pressure
1003169|NCT03143088|Medical clown|medical clown
1003170|NCT03143088|Pediatric|pediatric
1003171|NCT03143062|National Early Warning Score|national early warning score
1003172|NCT03143062|Rapid response system|rapid response system
1003173|NCT03143049|Pomalidomide|pomalidomide
1003174|NCT03143036|daratumumab|daratumumab
1003175|NCT03142971|Shock waves|shock waves
1003176|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
1003177|NCT03142932|smoking|smoking
1003178|NCT03142919|Mood Disorder|mood disorder
1003179|NCT03142919|MDD|mdd
1003180|NCT03142919|Endotoxin|endotoxin
1003181|NCT03142919|MRI|mri
1003182|NCT03142919|CRP|crp
1003183|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
1003184|NCT03142893|testosterone|testosterone
1003185|NCT03142893|cortisol|cortisol
1003186|NCT03142880|marginally hyperbaric|marginally hyperbaric
1003187|NCT03142880|ropivacaine|ropivacaine
1003188|NCT03142880|cesarean|cesarean
1568413|NCT00505934|Levetiracetam|levetiracetam
1003189|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1003190|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
1003191|NCT03142867|Prevalence|prevalence
1003192|NCT03142867|Coronary Artery Disease|coronary artery disease
1003193|NCT03142867|PDFF|pdff
1003194|NCT03142854|bowel preparation|bowel preparation
1003195|NCT03142854|colonoscopy|colonoscopy
1003196|NCT03142854|predictive model|predictive model
1003197|NCT03142841|Depression|depression
1003198|NCT03142841|Burden|burden
1003199|NCT03142841|Problem Solving Ability|problem solving ability
1003200|NCT03142841|Caregivers|caregivers
1003201|NCT03142841|Stroke|stroke
1003202|NCT03142841|Veterans|veterans
1003203|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
1003204|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
1003205|NCT03142802|Testicular cancer|testicular cancer
1003206|NCT03142802|low-dose CT|low-dose ct
1003207|NCT03142802|CT scan|ct scan
1003208|NCT03142789|Pain|pain
1003209|NCT03142789|Total knee arthroplasty|total knee arthroplasty
1003210|NCT03142789|Regional anesthesia|regional anesthesia
1003211|NCT03142776|clarithromycin|clarithromycin
1003212|NCT03142776|photodynamic therapy|photodynamic therapy
1003213|NCT03142776|Antimicrobial therapy|antimicrobial therapy
1003214|NCT03142776|Periodontal pocket|periodontal pocket
1003215|NCT03142724|HV|hv
1003216|NCT03142698|hepatic steatosis|hepatic steatosis
1003217|NCT03142698|MRImaging|mrimaging
1003218|NCT03142685|NEC|nec
1003219|NCT03142685|Bowel Ultrasound|bowel ultrasound
1003220|NCT03142685|CHD|chd
1003221|NCT03142672|Postoperative pain|postoperative pain
1003222|NCT03142672|child|child
1003223|NCT03142672|pulpotomy|pulpotomy
1003224|NCT03142672|general anesthesia|general anesthesia
1003352|NCT03141788|Aligners|aligners
1003225|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
1003226|NCT03142620|vitamin D|vitamin d
1003227|NCT03142620|gastritis|gastritis
1003228|NCT03142529|Non dialysis|non dialysis
1003229|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
1003230|NCT03142516|Elderly|elderly
1003231|NCT03142516|Aged|aged
1003232|NCT03142516|Disease-Free Survival|disease-free survival
1003233|NCT03142516|Safety|safety
1003234|NCT03142516|Tolerability|tolerability
1003235|NCT03142516|Chemotherapy regimen|chemotherapy regimen
1003236|NCT03142516|Monoclonal antibody|monoclonal antibody
1003237|NCT03142516|FOLFIRI|folfiri
1003238|NCT03142516|Panitumumab|panitumumab
1003239|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
1003240|NCT03142503|psoriatic arthritis|psoriatic arthritis
1003241|NCT03142503|psoriasis|psoriasis
1003242|NCT03142503|body composition|body composition
1003243|NCT03142503|DXA measurements|dxa measurements
1003244|NCT03142503|spondyloarthritis|spondyloarthritis
1003245|NCT03142503|diet therapy|diet therapy
1003246|NCT03142503|adipose tissue|adipose tissue
1003247|NCT03142490|Acupuncture|acupuncture
1003248|NCT03142490|Infertility|infertility
1003249|NCT03142490|In vitro fertilization|in vitro fertilization
1003250|NCT03142490|Quality of life|quality of life
1003251|NCT03142490|Stress|stress
1003252|NCT03142490|Anxiety|anxiety
1003253|NCT03142477|Therapeutic touch|therapeutic touch
1003254|NCT03142477|Reiki|reiki
1003255|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
1003256|NCT03142477|Spiritual Therapies|spiritual therapies
1003257|NCT03142464|saline solution|saline solution
1003258|NCT03142464|laparoscopy|laparoscopy
1003259|NCT03142464|cholecystectomy|cholecystectomy
1003260|NCT03142464|outcomes|outcomes
1003261|NCT03142412|Lupus|lupus
1003263|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
1003264|NCT03142399|heart failure|heart failure
1003265|NCT03142399|cardiac reabilitation|cardiac reabilitation
1003266|NCT03142399|nutritional status|nutritional status
1003267|NCT03142399|quality of life|quality of life
1003268|NCT03142399|milk protein|milk protein
1003269|NCT03142386|geriatric oncology|geriatric oncology
1003270|NCT03142386|pain|pain
1003271|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
1003272|NCT03142386|quality of life|quality of life
1003273|NCT03142373|heart rate variability|heart rate variability
1003274|NCT03142373|autonomic nervous system|autonomic nervous system
1003275|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
1003276|NCT03142373|skin conductance|skin conductance
1003277|NCT03142347|remote endarterectomy|remote endarterectomy
1003278|NCT03142347|DCB balloon|dcb balloon
1003279|NCT03142334|PD1|pd1
1003280|NCT03142334|PD-1|pd-1
1003281|NCT03142334|PDL1|pdl1
1003282|NCT03142334|PD-L1|pd-l1
1003283|NCT03142334|Adjuvant|adjuvant
1003284|NCT03142308|Satisfaction|satisfaction
1003285|NCT03142308|Training program|training program
1003286|NCT03142308|Egypt|egypt
1003287|NCT03142308|Cross-sectional|cross-sectional
1003288|NCT03142308|Multi-center|multi-center
1003289|NCT03142295|Urine transfusion|urine transfusion
1003290|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
1026227|NCT02999282|TMS|tms
1003291|NCT03142295|Urinary microbiota|urinary microbiota
1003292|NCT03142282|maintenance treatment|maintenance treatment
1003293|NCT03142243|Tennis|tennis
1003294|NCT03142243|Asymmetry|asymmetry
1003295|NCT03142243|Morphological|morphological
1003296|NCT03142230|feeding tube|feeding tube
1003297|NCT03142230|gastric|gastric
1003298|NCT03142230|newborn infant|newborn infant
1003299|NCT03142230|nursing|nursing
1003300|NCT03142230|pain|pain
1003301|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
1003302|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
1003303|NCT03142191|CC-90001|cc-90001
1003304|NCT03142191|Safety|safety
1003305|NCT03142191|Efficacy|efficacy
1003306|NCT03142191|IPF|ipf
1003307|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1003308|NCT03142178|osteoarthritis|osteoarthritis
1003309|NCT03142178|pain|pain
1003310|NCT03142178|knee|knee
1003311|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
1003312|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
1003313|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
1003314|NCT03142152|Coronary sinus Annuloplasty|coronary sinus annuloplasty
1003315|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
1003316|NCT03142152|Functional MR|functional mr
1003317|NCT03142152|FMR|fmr
1003318|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
1003319|NCT03142113|optimization|optimization
1003320|NCT03142113|adalimumab|adalimumab
1003321|NCT03142087|balance|balance
1003322|NCT03142087|brain tumor|brain tumor
1003323|NCT03142087|virtual reality|virtual reality
1003324|NCT03142074|Improve diagnosis|improve diagnosis
1003325|NCT03142009|Community-Based Participatory Research|community-based participatory research
1003326|NCT03141996|vibration|vibration
1003327|NCT03141996|stroke|stroke
1003328|NCT03141996|activities of daily living|activities of daily living
1003329|NCT03141983|ESRD|esrd
1003330|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
1003331|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
1003332|NCT03141957|Aging|aging
1003333|NCT03141957|Hypermetabolism|hypermetabolism
1003334|NCT03141944|non motor symptoms|non motor symptoms
1003335|NCT03141931|Nutraceutical supplement|nutraceutical supplement
1003336|NCT03141905|patient safety|patient safety
1003337|NCT03141905|self-management|self-management
1003338|NCT03141905|remote monitoring|remote monitoring
1003339|NCT03141879|Frailty|frailty
1003340|NCT03141879|Physical Activity|physical activity
1003341|NCT03141879|Resistance training|resistance training
1003342|NCT03141853|Randomized Controlled Trial|randomized controlled trial
1003343|NCT03141853|Intervention Study|intervention study
1003344|NCT03141827|Lipoprotein|lipoprotein
1003345|NCT03141827|Apolipoprotein|apolipoprotein
1003346|NCT03141827|Pancreatic clamp|pancreatic clamp
1003347|NCT03141827|Insulin|insulin
1003348|NCT03141827|Nasal|nasal
1003349|NCT03141801|ACL|acl
1003350|NCT03141801|Knee|knee
1003351|NCT03141801|Muscle|muscle
1003353|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
1003354|NCT03141762|Falls|falls
1003355|NCT03141762|Intensive care|intensive care
1003356|NCT03141736|Infant|infant
1003357|NCT03141736|Newborn|newborn
1003358|NCT03141736|Preterm|preterm
1003359|NCT03141736|Hypothermia|hypothermia
1003360|NCT03141736|Kangaroo|kangaroo
1003361|NCT03141736|Plastic|plastic
1003362|NCT03141736|Bag|bag
1003363|NCT03141723|Infant|infant
1003366|NCT03141723|Hypothermia|hypothermia
1003367|NCT03141723|Kangaroo|kangaroo
1003368|NCT03141723|Plastic|plastic
1003369|NCT03141723|Bag|bag
1003370|NCT03141697|Carbon Dioxide|carbon dioxide
1003371|NCT03141697|Coloboscopy|coloboscopy
1003373|NCT03141658|TS-134|ts-134
1003374|NCT03141658|ketamine|ketamine
1003375|NCT03141658|fMRI|fmri
1003376|NCT03141619|cerebral oximetry|cerebral oximetry
1003377|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
1003378|NCT03141619|neurocognitive|neurocognitive
1003379|NCT03141619|post-ICU syndrome|post-icu syndrome
1003380|NCT03141593|adherence to medication|adherence to medication
1003381|NCT03141593|electronic monitoring|electronic monitoring
1003382|NCT03141567|Lymphangiogenesis|lymphangiogenesis
1003383|NCT03141567|Heart Failure|heart failure
1003384|NCT03141541|low back pain|low back pain
1003385|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
1003386|NCT03141541|randomised controlled trial|randomised controlled trial
1003387|NCT03141528|Self-learning|self-learning
1003388|NCT03141528|Instructor-led learning|instructor-led learning
1003389|NCT03141528|Long-term retention|long-term retention
1003390|NCT03141515|lung ultrasound|lung ultrasound
1003391|NCT03141515|recruitment maneuver|recruitment maneuver
1003392|NCT03141515|atelectasis|atelectasis
1003393|NCT03141515|children|children
1003394|NCT03141502|tension wound|tension wound
1003395|NCT03141502|skin stretching device|skin stretching device
1003396|NCT03141502|skin grafting|skin grafting
1003397|NCT03141476|Surgery|surgery
1003398|NCT03141476|Obesity|obesity
1003399|NCT03141476|Drug|drug
1003400|NCT03141476|Antibiotics|antibiotics
1003401|NCT03141476|Cefuroxime|cefuroxime
1003402|NCT03141463|Therapeutic vaccination|therapeutic vaccination
1003403|NCT03141437|Malignant Neoplasm of Breast|malignant neoplasm of breast
1003404|NCT03141437|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
1003405|NCT03141437|Lymphoma|lymphoma
1003406|NCT03141437|Myeloma|myeloma
1003407|NCT03141437|Decision Aid Website|decision aid website
1003408|NCT03141437|DA|da
1003409|NCT03141437|Fertility preservation support|fertility preservation support
1003410|NCT03141437|Questionnaires|questionnaires
1003411|NCT03141437|Surveys|surveys
1003412|NCT03141437|Educational materials|educational materials
1003413|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
1003414|NCT03141372|Urinary Retention|urinary retention
1003415|NCT03141372|Backfill Void Trial|backfill void trial
1003416|NCT03141372|Autofill Void Trial|autofill void trial
1003417|NCT03141307|Neonatal screening|neonatal screening
1003418|NCT03141307|Biobank|biobank
1003419|NCT03141307|Broad Consent|broad consent
1003420|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
1003421|NCT03141281|aging|aging
1003422|NCT03141281|cognitive ability|cognitive ability
1003423|NCT03141281|IADL|iadl
1003424|NCT03141281|driving|driving
1003425|NCT03141281|financial fraud|financial fraud
1003426|NCT03141281|perception|perception
1003427|NCT03141281|attention|attention
1003428|NCT03141281|memory|memory
1003429|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
1003430|NCT03141242|Advance Care Planning|advance care planning
1003431|NCT03141242|Group Medial Visit|group medial visit
1003432|NCT03141242|Shared Medical Appointment|shared medical appointment
1003433|NCT03141229|MBSR|mbsr
1003434|NCT03141229|Children|children
1003435|NCT03141229|Teacher|teacher
1003436|NCT03141229|School|school
1003437|NCT03141229|Burnout|burnout
1003438|NCT03141229|Classroom behavior|classroom behavior
1003439|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
1003440|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
1003441|NCT03141125|B-cell Activating Factor|b-cell activating factor
1003442|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
1003443|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
1003444|NCT03141125|Scleroderma|scleroderma
1003445|NCT03141099|OHCA|ohca
1003446|NCT03141099|Hemodynamic|hemodynamic
1003447|NCT03141099|TTM|ttm
1003448|NCT03141099|post-rescusitation care|post-rescusitation care
1003449|NCT03141099|Blood pressure targets|blood pressure targets
1003450|NCT03141099|Oxygenation targets|oxygenation targets
1003451|NCT03141086|shift work disorder|shift work disorder
1003452|NCT03141073|GKA|gka
1003453|NCT03141073|T2DM|t2dm
1003454|NCT03141073|HMS5552|hms5552
1003455|NCT03141073|Add on therapy|add on therapy
1003456|NCT03141073|Metformin|metformin
1003457|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
1003458|NCT03141008|Ketosis|ketosis
1003459|NCT03141008|NAFLD|nafld
1003460|NCT03141008|Obesity|obesity
1003461|NCT03140995|Exercise|exercise
1003462|NCT03140995|Sleep|sleep
1003463|NCT03140982|propofol|propofol
1003464|NCT03140982|pharmacology|pharmacology
1003465|NCT03140982|anesthesic induction|anesthesic induction
1003466|NCT03140982|drug titration|drug titration
1003467|NCT03140969|CEP290|cep290
1003468|NCT03140969|p.Cys998X|p.cys998x
1003469|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
1003470|NCT03140969|RNA therapy|rna therapy
1003471|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
1003472|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
1003473|NCT03140943|carfilzomib|carfilzomib
1003474|NCT03140917|Liver function|liver function
1003475|NCT03140917|Future liver remnant|future liver remnant
1003476|NCT03140917|Chemotherapy|chemotherapy
1003477|NCT03140891|preterm infant|preterm infant
1003478|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
1003479|NCT03140891|nasal high frequence oscillation ventilation|nasal high frequence oscillation ventilation
1003480|NCT03140865|Alzheimer's|alzheimer's
1003481|NCT03140865|observational|observational
1003482|NCT03140865|prediabetes|prediabetes
1003483|NCT03140865|mild cognitive impairment|mild cognitive impairment
1003484|NCT03140774|Ebola vaccine|ebola vaccine
1003485|NCT03140774|immunogenicity|immunogenicity
1003486|NCT03140774|persistence|persistence
1003487|NCT03140722|anemia|anemia
1003488|NCT03140722|kidney|kidney
1003489|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
1003491|NCT03140722|DD-CKD|dd-ckd
1003492|NCT03140722|renal|renal
1003493|NCT03140722|vadadustat|vadadustat
1003495|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
1003496|NCT03140722|HIF|hif
1003497|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1003498|NCT03140722|HIF-PHI|hif-phi
1003499|NCT03140722|hyporesponder|hyporesponder
1003500|NCT03140722|hyporesponsive|hyporesponsive
1003501|NCT03140722|epoetin alfa|epoetin alfa
1003502|NCT03140722|hemoglobin|hemoglobin
1003503|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1003504|NCT03140722|ESA|esa
1003505|NCT03140709|Salivary|salivary
1003506|NCT03140709|Oxytocin|oxytocin
1003507|NCT03140709|Induction|induction
1003508|NCT03140709|Labor|labor
1003509|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
1003510|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
1003511|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
1003512|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
1003513|NCT03140631|atrial fibrillation|atrial fibrillation
1003514|NCT03140631|catheter ablation|catheter ablation
1003515|NCT03140631|protamine sulfate|protamine sulfate
1003516|NCT03140631|anticoagulation reversal|anticoagulation reversal
1003517|NCT03140618|single-system-design|single-system-design
1003518|NCT03140618|mixed methods|mixed methods
1003519|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
1003520|NCT03140618|work environment|work environment
1003521|NCT03140618|rebuilding|rebuilding
1003522|NCT03140579|recruitment|recruitment
1003523|NCT03140579|lung homogeneity|lung homogeneity
1003524|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
1003525|NCT03140566|heart failure|heart failure
1003526|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
1003527|NCT03140566|congestion|congestion
1003528|NCT03140566|inferior vena cava|inferior vena cava
1003529|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
1003530|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
1003531|NCT03140540|Fluid management|fluid management
1003532|NCT03140540|goal-directed therapy|goal-directed therapy
1003533|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
1003534|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
1003535|NCT03140488|Induction of labor|induction of labor
1003536|NCT03140488|Pitocin|pitocin
1003537|NCT03140488|BMI|bmi
1003538|NCT03140475|Metacognition|metacognition
1003539|NCT03140475|Mousetracking|mousetracking
1003540|NCT03140475|EEG|eeg
1003541|NCT03140475|Event related potentials|event related potentials
1003542|NCT03140475|Frequency analysis|frequency analysis
1003543|NCT03140475|Depression|depression
1003544|NCT03140462|Tacrolimus|tacrolimus
1003545|NCT03140462|Pharmacokinetics|pharmacokinetics
1003546|NCT03140462|Genetic polymorphisms|genetic polymorphisms
1003547|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
1003548|NCT03140449|facial angiofibroma|facial angiofibroma
1003549|NCT03140449|rapamycin|rapamycin
1003550|NCT03140449|calcitriol|calcitriol
1003551|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
1003552|NCT03140423|MRSA|mrsa
1003553|NCT03140423|healthcare-associated infections|healthcare-associated infections
1003554|NCT03140423|mupirocin|mupirocin
1003555|NCT03140423|iodophor|iodophor
1003556|NCT03140423|resistance|resistance
1003557|NCT03140410|Staphylococci|staphylococci
1003558|NCT03140410|Blood-stream infections|blood-stream infections
1003559|NCT03140410|Linezolid|linezolid
1003560|NCT03140397|Bioavailability|bioavailability
1003561|NCT03140397|Pharmacokinetics|pharmacokinetics
1003562|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
1003563|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
1003564|NCT03140397|Prenylflavonoids|prenylflavonoids
1003565|NCT03140397|PBMC|pbmc
1003566|NCT03140371|Enteral feeding|enteral feeding
1003567|NCT03140371|Oral nutritional supplements|oral nutritional supplements
1003568|NCT03140371|Peptide-based feed|peptide-based feed
1003569|NCT03140371|Hydrolysed feed|hydrolysed feed
1003570|NCT03140371|Semi-elemental feed|semi-elemental feed
1003571|NCT03140345|Hemodialysis|hemodialysis
1003572|NCT03140345|Microcirculation|microcirculation
1003573|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
1003574|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
1003575|NCT03140319|Fibroblast|fibroblast
1003576|NCT03140319|Cell transplantation|cell transplantation
1003577|NCT03140306|Computed tomography|computed tomography
1003578|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
1003579|NCT03140306|Low dose CT|low dose ct
1003580|NCT03140293|Chorionic villus sampling|chorionic villus sampling
1003582|NCT03140293|Anxiety|anxiety
1003583|NCT03140280|Black raspberries|black raspberries
1003584|NCT03140280|MDS|mds
1003585|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
1003586|NCT03140280|hypomethylating effects|hypomethylating effects
1003587|NCT03140280|chemopreventive agent|chemopreventive agent
1003588|NCT03140280|BRB|brb
1003589|NCT03140280|pharmokinetics|pharmokinetics
1003590|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
1003592|NCT03140267|Inspiratory muscle training|inspiratory muscle training
1003593|NCT03140215|Baska|baska
1003594|NCT03140215|seal pressure|seal pressure
1003595|NCT03140215|I-Gel|i-gel
1003596|NCT03140215|Supraglottic airway device|supraglottic airway device
1003597|NCT03140189|Esophageal cancer|esophageal cancer
1003598|NCT03140189|Robotic|robotic
1003599|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
1003600|NCT03140176|Sunitinib|sunitinib
1003601|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1003602|NCT03140176|Africa Middle East|africa middle east
1003603|NCT03140098|Collagen membrane|collagen membrane
1003604|NCT03140098|Cardiac surgery|cardiac surgery
1003605|NCT03140098|Postoperative complication|postoperative complication
1003606|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
1003607|NCT03140059|surgical procedure|surgical procedure
1003608|NCT03140059|residual pockets|residual pockets
1003609|NCT03140059|agressive periodontitis|agressive periodontitis
1003610|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
1003611|NCT03140020|aneurysm|aneurysm
1003612|NCT03140020|cognition|cognition
1003613|NCT03140020|functional connectivity|functional connectivity
1003614|NCT03140020|frontal lobe function|frontal lobe function
1003615|NCT03140020|neuropsychological testing|neuropsychological testing
1003616|NCT03140020|coiling|coiling
1003617|NCT03140020|clipping|clipping
1003618|NCT03140007|ERCP|ercp
1003619|NCT03140007|cholangioscopy|cholangioscopy
1003620|NCT03139994|occlusion|occlusion
1003621|NCT03139994|pain|pain
1003622|NCT03139981|eczema|eczema
1003623|NCT03139955|Feasibility Study|feasibility study
1003624|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
1003625|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
1003626|NCT03139955|Patient Deterioration Identification|patient deterioration identification
1003627|NCT03139955|Bodytrak|bodytrak
1003628|NCT03139955|National Early Warning System|national early warning system
1003629|NCT03139955|Patient Safety|patient safety
1003630|NCT03139942|Endoscopy|endoscopy
1003631|NCT03139942|Colonoscopy|colonoscopy
1003632|NCT03139942|Hyperspectral imaging|hyperspectral imaging
1003633|NCT03139942|Tissue classification|tissue classification
1003634|NCT03139942|Tissue autofluorescence|tissue autofluorescence
1003635|NCT03139942|Advanced imaging techniques|advanced imaging techniques
1003636|NCT03139916|Glioblastoma|glioblastoma
1003637|NCT03139903|Seckel Syndrome|seckel syndrome
1003638|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
1003639|NCT03139864|Type 1 diabetes|type 1 diabetes
1003640|NCT03139864|Control|control
1003641|NCT03139864|Physical activity|physical activity
1003642|NCT03139864|Substrate utilization|substrate utilization
1003643|NCT03139864|Hormonal regulation|hormonal regulation
1003644|NCT03139851|Solid tumor|solid tumor
1003645|NCT03139851|Breast cancer|breast cancer
1003646|NCT03139851|Metastatic cancer|metastatic cancer
1003647|NCT03139851|Pembrolizumab|pembrolizumab
1003648|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
1003649|NCT03139838|Palliative Care|palliative care
1003650|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
1003651|NCT03139838|Electronic Health Records|electronic health records
1003652|NCT03139838|Economics, Behavioral|economics, behavioral
1003653|NCT03139812|continuous contact lens wear|continuous contact lens wear
1003654|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
1003655|NCT03139812|irrigation|irrigation
1003656|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
1003657|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
1003658|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
1003659|NCT03139708|Mydriasis|mydriasis
1003660|NCT03139708|Cycloplegics|cycloplegics
1003661|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
1003662|NCT03139630|Dyslipidemia|dyslipidemia
1003663|NCT03139630|Protease Inhibitor|protease inhibitor
1003664|NCT03139630|Ritonavir|ritonavir
1003666|NCT03139630|Observational|observational
1003667|NCT03139617|Fascia Iliaca Block|fascia iliaca block
1003668|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
1003669|NCT03139617|Fracture femur|fracture femur
1003670|NCT03139617|Spinal anesthesia|spinal anesthesia
1003671|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
1003672|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
1003673|NCT03139604|itacitinib|itacitinib
1003674|NCT03139604|corticosteroids|corticosteroids
1003675|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
1003676|NCT03139565|Influenza|influenza
1003677|NCT03139565|Solid Organ Transplant|solid organ transplant
1003678|NCT03139565|Infection|infection
1003679|NCT03139565|Vaccine|vaccine
1003680|NCT03139565|Immunogenicity|immunogenicity
1003681|NCT03139552|Taste Test|taste test
1003682|NCT03139552|Spices|spices
1003683|NCT03139552|Reduced sugar|reduced sugar
1003684|NCT03139552|Food liking|food liking
1003685|NCT03139526|Craniopharyngioma|craniopharyngioma
1003686|NCT03139526|Children|children
1003973|NCT03137290|Rocuronium|rocuronium
1003687|NCT03139526|Social participation|social participation
1003688|NCT03139526|Life-H questionnaire|life-h questionnaire
1003689|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
1003690|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
1003691|NCT03139487|Low molecular weight heparin|low molecular weight heparin
1003692|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
1003693|NCT03139461|Physical Therapy|physical therapy
1003694|NCT03139461|Capacity Building|capacity building
1003695|NCT03139461|Clinical-Community Linkages|clinical-community linkages
1003696|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
1003697|NCT03139383|postoperative nausea|postoperative nausea
1003698|NCT03139383|postoperative vomiting|postoperative vomiting
1003699|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
1003700|NCT03139344|metabolism|metabolism
1003701|NCT03139344|exercise|exercise
1003702|NCT03139344|glucose|glucose
1003703|NCT03139344|secondary health conditions|secondary health conditions
1003704|NCT03139344|quality of life|quality of life
1003705|NCT03139305|glucagon|glucagon
1003706|NCT03139266|cystic fibrosis|cystic fibrosis
1003707|NCT03139266|mindfulness|mindfulness
1003708|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
1003709|NCT03139266|UPLIFT|uplift
1003710|NCT03139266|anxiety|anxiety
1003711|NCT03139266|depression|depression
1003712|NCT03139266|web based intervention|web based intervention
1003713|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
1003714|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
1003715|NCT03139253|Triple Therapy|triple therapy
1003716|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
1003717|NCT03139188|Cancer|cancer
1003718|NCT03139188|incurable pathologies|incurable pathologies
1003719|NCT03139188|palliative care|palliative care
1003720|NCT03139162|Home Care Services|home care services
1003721|NCT03139162|Aging|aging
1003722|NCT03139162|Frailty|frailty
1003723|NCT03139162|Complexity|complexity
1003724|NCT03139162|Nursing|nursing
1003725|NCT03139149|conservative treatment|conservative treatment
1003726|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
1003727|NCT03139149|strangulation|strangulation
1003728|NCT03139071|coffee consumption|coffee consumption
1003729|NCT03139071|cardiovascular diseases|cardiovascular diseases
1003730|NCT03139071|coronary artery calcium|coronary artery calcium
1003731|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
1003732|NCT03139019|Diabetes prevention|diabetes prevention
1003733|NCT03139019|Weight loss|weight loss
1003734|NCT03139019|Lifestyle change|lifestyle change
1003735|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
1003736|NCT03138967|Bladder cancer|bladder cancer
1003737|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
1003738|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
1003739|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
1003740|NCT03138967|TURB|turb
1003741|NCT03138967|Rocuronium|rocuronium
1003742|NCT03138967|Rocuronium Bromide|rocuronium bromide
1003743|NCT03138967|Zemuron|zemuron
1003744|NCT03138967|Sugammadex|sugammadex
1003745|NCT03138967|Neostigmine|neostigmine
1003746|NCT03138967|Glycopyrrolate|glycopyrrolate
1003747|NCT03138928|glaucoma|glaucoma
1003748|NCT03138928|trabeculectomy|trabeculectomy
1003749|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
1003750|NCT03138928|XEN45 gel stent|xen45 gel stent
1003751|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
1003752|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
1003753|NCT03138915|radiomics|radiomics
1003754|NCT03138889|NKTR-214|nktr-214
1003755|NCT03138889|Atezolizumab|atezolizumab
1003756|NCT03138889|Tecentriq®|tecentriq®
1003757|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
1003758|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
1003759|NCT03138889|Pembrolizumab|pembrolizumab
1003760|NCT03138889|Keytruda®|keytruda®
1003761|NCT03138889|Melanoma|melanoma
1003762|NCT03138889|Bladder|bladder
1003763|NCT03138889|NSCLC|nsclc
1003764|NCT03138850|intravenous sedation|intravenous sedation
1003765|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
1003766|NCT03138850|upper airway|upper airway
1003767|NCT03138850|mandibular advancement device|mandibular advancement device
1003768|NCT03138850|high flow nasal cannula|high flow nasal cannula
1003769|NCT03138837|Bladder cancer|bladder cancer
1003770|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
1003771|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
1003772|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
1003773|NCT03138824|TURBT|turbt
1003774|NCT03138824|Recurrence|recurrence
1003775|NCT03138824|Progression|progression
1003776|NCT03138811|asthma|asthma
1003777|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
1003778|NCT03138811|pharmacodynamics|pharmacodynamics
1003779|NCT03138811|pharmacokinetics|pharmacokinetics
1003780|NCT03138811|safety|safety
1003781|NCT03138811|tolerability|tolerability
1003782|NCT03138798|Labor|labor
1003783|NCT03138798|Second stage|second stage
1003784|NCT03138798|Dental device|dental device
1003785|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
1003786|NCT03138746|insulin sensitivity|insulin sensitivity
1003787|NCT03138746|human|human
1003788|NCT03138746|inflammation|inflammation
1003789|NCT03138655|Drug therapy|drug therapy
1003790|NCT03138642|mucosal melanoma|mucosal melanoma
1003791|NCT03138642|radiotherapy|radiotherapy
1003792|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
1003793|NCT03138616|vitamin D|vitamin d
1003794|NCT03138616|postpartum|postpartum
1003795|NCT03138603|surgery|surgery
1003796|NCT03138603|heart disease|heart disease
1003797|NCT03138603|metoprolol|metoprolol
1003798|NCT03138603|myocardial injury|myocardial injury
1003799|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1003800|NCT03138590|accelerate learning|accelerate learning
1003801|NCT03138590|memory|memory
1003802|NCT03138564|Nursing|nursing
1003803|NCT03138564|Nephrology|nephrology
1003804|NCT03138564|Behavioral Research|behavioral research
1003805|NCT03138564|Social Research|social research
1003806|NCT03138551|Sensory Food Aversions|sensory food aversions
1003807|NCT03138538|Advanced Solid Tumors|advanced solid tumors
1003808|NCT03138538|M8891|m8891
1003809|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
1003810|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
1003811|NCT03138473|SYNTAX Score|syntax score
1003812|NCT03138473|residual SYNTAX score|residual syntax score
1003813|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
1003814|NCT03138447|insulin|insulin
1003815|NCT03138447|basal|basal
1003816|NCT03138447|titration|titration
1003817|NCT03138447|digital health|digital health
1003818|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1003819|NCT03138434|4D flow MRI|4d flow mri
1003820|NCT03138434|DCE-MRI|dce-mri
1003821|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
1003822|NCT03138408|Ovarian cancer|ovarian cancer
1003823|NCT03138408|Endometrial cancer|endometrial cancer
1003824|NCT03138408|SC-004|sc-004
1003825|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
1003826|NCT03138408|ABBV-181|abbv-181
1003827|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
1003828|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
1003829|NCT03138395|relapse|relapse
1003830|NCT03138395|PCR|pcr
1003831|NCT03138395|droplet digital|droplet digital
1003832|NCT03138395|polymerase chain reaction|polymerase chain reaction
1003833|NCT03138382|obesity|obesity
1003834|NCT03138382|metabolic syndrome|metabolic syndrome
1003835|NCT03138369|Obesity|obesity
1003836|NCT03138369|Metabolic Syndrome|metabolic syndrome
1003837|NCT03138369|Prediabetes|prediabetes
1003838|NCT03138369|Glycemic control|glycemic control
1003839|NCT03138369|Hypercholesterolemia|hypercholesterolemia
1003840|NCT03138369|Abdominal obesity|abdominal obesity
1003841|NCT03138369|Weight Loss|weight loss
1003842|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
1003843|NCT03138304|decision making|decision making
1003844|NCT03138304|heuristics|heuristics
1003845|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
1003846|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
1003847|NCT03138213|surgical outcome|surgical outcome
1003848|NCT03138200|Transfusion|transfusion
1003849|NCT03138200|ScvO2|scvo2
1003850|NCT03138200|Hemoglobin|hemoglobin
1003851|NCT03138187|spontaneous physical activity|spontaneous physical activity
1003852|NCT03138187|caloric intake|caloric intake
1003853|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
1003854|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
1003855|NCT03138148|intensive care|intensive care
1003856|NCT03138135|PrEP|prep
1003857|NCT03138135|HIV prevention|hiv prevention
1003858|NCT03138135|Risk reduction|risk reduction
1003859|NCT03138135|STI prevention|sti prevention
1003860|NCT03138135|Home HIV testing|home hiv testing
1003861|NCT03138135|HIV testing|hiv testing
1003862|NCT03138135|STI testing|sti testing
1003863|NCT03138109|non-cardiac surgery|non-cardiac surgery
1003864|NCT03138109|major adverse cardiac event|major adverse cardiac event
1003865|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
1003866|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
1003867|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
1003868|NCT03138044|Alcohol Treatment|alcohol treatment
1003869|NCT03138044|CILDAT|cildat
1003870|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
1003871|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
1003872|NCT03138005|Resuscitation|resuscitation
1003873|NCT03138005|Oxygen|oxygen
1003874|NCT03138005|Cardiac Arrest|cardiac arrest
1003875|NCT03138005|Heart Arrest|heart arrest
1003876|NCT03137992|COPD|copd
1003877|NCT03137979|Periodontitis|periodontitis
1003974|NCT03137290|Neostigmine|neostigmine
1003878|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
1003879|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
1003880|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
1003881|NCT03137940|tDCS|tdcs
1003882|NCT03137940|Safety|safety
1003883|NCT03137940|Upper Limb functions|upper limb functions
1003884|NCT03137927|bordetella pertussis|bordetella pertussis
1003885|NCT03137927|vaccine|vaccine
1003886|NCT03137927|Immunologic Factors|immunologic factors
1003887|NCT03137927|whooping cough|whooping cough
1003888|NCT03137914|orthognathic surgery|orthognathic surgery
1003889|NCT03137914|TMJ|tmj
1003890|NCT03137914|osteoarthritis|osteoarthritis
1003891|NCT03137875|Tuberculosis|tuberculosis
1003892|NCT03137875|TB|tb
1003893|NCT03137875|MDR-TB|mdr-tb
1003894|NCT03137875|LIPA|lipa
1003895|NCT03137875|filter paper|filter paper
1003896|NCT03137875|slides|slides
1003897|NCT03137875|MTBDR Plus|mtbdr plus
1003898|NCT03137849|Yoga|yoga
1003899|NCT03137849|Hypertension|hypertension
1003900|NCT03137849|Post-Menopausal Women|post-menopausal women
1003901|NCT03137849|Heart Rate Variability|heart rate variability
1003902|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
1003903|NCT03137784|asthma,|asthma,
1003904|NCT03137784|NVA237,|nva237,
1003905|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
1003906|NCT03137784|allergic asthma,|allergic asthma,
1003907|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
1003908|NCT03137784|reactive asthma,|reactive asthma,
1003909|NCT03137784|asthma attack,|asthma attack,
1003910|NCT03137784|difficulty breathing|difficulty breathing
1003911|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
1003912|NCT03137693|histologically proven|histologically proven
1003913|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
1003914|NCT03137693|node negative (N0)|node negative (n0)
1003915|NCT03137693|breast-conserving surgery|breast-conserving surgery
1003916|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
1003917|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
1003918|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
1003919|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
1003920|NCT03137680|Pre-operative Exercise|pre-operative exercise
1003921|NCT03137680|Fistula Maturation|fistula maturation
1003922|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
1003923|NCT03137654|Cognitive Training|cognitive training
1003924|NCT03137654|Emotion Processing|emotion processing
1003925|NCT03137641|occupational exposure|occupational exposure
1003926|NCT03137641|antineoplastic drugs|antineoplastic drugs
1003927|NCT03137641|biomonitoring|biomonitoring
1003928|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
1003929|NCT03137589|Telemedicine|telemedicine
1003930|NCT03137576|Awake Thoracic Surgery, Erector Spinae Plane Block|awake thoracic surgery, erector spinae plane block
1003931|NCT03137563|Women|women
1003932|NCT03137563|25-65 years|25-65 years
1003933|NCT03137537|Lymphoma|lymphoma
1003934|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
1003935|NCT03137537|Autonomic imbalance|autonomic imbalance
1003936|NCT03137537|Cancer survivorship|cancer survivorship
1003937|NCT03137524|Fan or Air Therapy|fan or air therapy
1003938|NCT03137511|Public Health|public health
1003939|NCT03137511|General Medicine|general medicine
1003940|NCT03137511|Dermatology|dermatology
1003941|NCT03137498|renal colic|renal colic
1003942|NCT03137498|lidocaine|lidocaine
1003943|NCT03137498|ketorolac|ketorolac
1003944|NCT03137498|acute pain|acute pain
1003945|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
1003946|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
1003947|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
1003948|NCT03137446|Septic shock|septic shock
1003949|NCT03137446|Severe sepsis|severe sepsis
1003950|NCT03137446|Fluid restriction|fluid restriction
1003951|NCT03137433|Weight loss|weight loss
1003952|NCT03137433|Cardiometabolic|cardiometabolic
1003953|NCT03137433|Meal-replacement therapy|meal-replacement therapy
1003954|NCT03137407|heel pain|heel pain
1003955|NCT03137394|spinal cord injury|spinal cord injury
1003956|NCT03137394|shoulder pain|shoulder pain
1003957|NCT03137394|psychosocial|psychosocial
1003958|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
1003959|NCT03137368|breast cancer|breast cancer
1003960|NCT03137368|Exemestane|exemestane
1003961|NCT03137368|Tamoxifen|tamoxifen
1003962|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
1003963|NCT03137355|Leigh Syndrome|leigh syndrome
1003964|NCT03137355|Leigh Disease|leigh disease
1003965|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
1003966|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
1003967|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
1003968|NCT03137342|PrEP|prep
1003969|NCT03137342|Adherence|adherence
1003970|NCT03137342|Risk Reduction|risk reduction
1003971|NCT03137342|Stimulant Use|stimulant use
1003972|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
1003978|NCT03137277|Adenoma detection rate|adenoma detection rate
1003979|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
1003980|NCT03137277|Olympus colonoscopes|olympus colonoscopes
1003981|NCT03137264|T790M mutation|t790m mutation
1003982|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
1003983|NCT03137264|non-invasive testing|non-invasive testing
1003984|NCT03137264|lung cancer|lung cancer
1003985|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1003986|NCT03137251|TENS|tens
1003987|NCT03137251|Analgesia|analgesia
1003988|NCT03137251|Labour pain|labour pain
1003989|NCT03137251|Physical therapy modality|physical therapy modality
1003990|NCT03137238|Self-motion perception|self-motion perception
1003991|NCT03137238|Optic flow|optic flow
1003992|NCT03137238|Vestibular system|vestibular system
1003993|NCT03137238|Multisensory integration|multisensory integration
1003994|NCT03137238|Parkinson's disease|parkinson's disease
1003995|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
1003996|NCT03137212|STEMI|stemi
1003997|NCT03137212|Thrombosis|thrombosis
1003998|NCT03137199|stem cell|stem cell
1003999|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
1004000|NCT03137199|lung|lung
1004001|NCT03137199|asthma|asthma
1004002|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
1004003|NCT03137147|pediatric|pediatric
1004004|NCT03137147|children|children
1004005|NCT03137147|adolescent|adolescent
1004006|NCT03137147|sleep|sleep
1004007|NCT03137147|pain|pain
1004008|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
1004009|NCT03137121|nausea|nausea
1004010|NCT03137121|vomiting|vomiting
1004011|NCT03137121|olanzapine|olanzapine
1004012|NCT03137082|Alcohol Use Disorder|alcohol use disorder
1004013|NCT03137082|Guanfacine|guanfacine
1004014|NCT03137082|Stress|stress
1004015|NCT03137082|Craving|craving
1004016|NCT03137082|Gender|gender
1004017|NCT03137082|Relapse|relapse
1004018|NCT03137056|Hemodialysis|hemodialysis
1004019|NCT03137056|Membrane|membrane
1004020|NCT03137056|Albumin|albumin
1004021|NCT03137056|Proteomics|proteomics
1004022|NCT03137043|GINA guidelines|gina guidelines
1004023|NCT03137043|Prevalence|prevalence
1004024|NCT03137043|Mepolizumab|mepolizumab
1004025|NCT03137043|severe asthma|severe asthma
1004026|NCT03137043|Spain|spain
1004027|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
1004028|NCT03137030|Hydrocodone|hydrocodone
1004029|NCT03137030|Analgesics, Opioid|analgesics, opioid
1004030|NCT03137030|Narcotics|narcotics
1004031|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
1004032|NCT03137017|Hydrocodone|hydrocodone
1004033|NCT03137017|Analgesics, Opioid|analgesics, opioid
1004034|NCT03137017|Narcotics|narcotics
1004035|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
1004036|NCT03136978|Macrophages|macrophages
1004037|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
1004038|NCT03136978|Endometriosis|endometriosis
1004039|NCT03136952|NIRS|nirs
1004040|NCT03136952|Monitoring|monitoring
1004041|NCT03136952|Pediatric|pediatric
1004042|NCT03136874|donors|donors
1004043|NCT03136874|gametes|gametes
1004044|NCT03136874|motivation|motivation
1004045|NCT03136874|psychological|psychological
1004046|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
1004047|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
1004048|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
1004049|NCT03136861|inflammatory back pain|inflammatory back pain
1004050|NCT03136861|spinal pain|spinal pain
1004051|NCT03136861|secukinumab|secukinumab
1004052|NCT03136861|AIN457|ain457
1004053|NCT03136848|perfusion|perfusion
1004054|NCT03136822|Diabetic Foot|diabetic foot
1004055|NCT03136744|Sedentary behaviour|sedentary behaviour
1004056|NCT03136744|Co-morbidity|co-morbidity
1004057|NCT03136744|Intervention|intervention
1004058|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
1004059|NCT03136718|mHealth|mhealth
1004060|NCT03136718|Hearing aids|hearing aids
1004061|NCT03136718|Auditory rehabilitation|auditory rehabilitation
1004062|NCT03136718|Adult|adult
1004063|NCT03136718|Reusable Learning Object|reusable learning object
1004064|NCT03136718|Education|education
1004065|NCT03136718|Personalised|personalised
1004066|NCT03136718|Telehealth|telehealth
1004067|NCT03136718|Teleaudiology|teleaudiology
1004068|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
1004069|NCT03136705|FGF23|fgf23
1004070|NCT03136705|Vitamin D|vitamin d
1004071|NCT03136692|app|app
1004072|NCT03136692|weight loss|weight loss
1004074|NCT03136692|behavior|behavior
1004075|NCT03136653|DARPin|darpin
1004076|NCT03136653|MP0250|mp0250
1004077|NCT03136653|VEGF|vegf
1004078|NCT03136653|HGF|hgf
1004079|NCT03136653|RRMM|rrmm
1004080|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
1004081|NCT03136588|Information and Communication Technology|information and communication technology
1004082|NCT03136588|Adherence|adherence
1004190|NCT03136094|SBIRT|sbirt
1004083|NCT03136588|Kidney transplantation|kidney transplantation
1004084|NCT03136523|NSCLC|nsclc
1004085|NCT03136523|SCLC|sclc
1004086|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
1004087|NCT03136523|EGFR|egfr
1004088|NCT03136523|PD-L1|pd-l1
1004089|NCT03136523|ALK|alk
1004090|NCT03136523|KRAS|kras
1004091|NCT03136458|contrast media|contrast media
1004092|NCT03136458|nephropathy|nephropathy
1004093|NCT03136458|ischemic preconditioning|ischemic preconditioning
1004094|NCT03136445|Tranexamic acid|tranexamic acid
1004095|NCT03136445|Platelet transfusion|platelet transfusion
1004096|NCT03136432|Cerebral Palsy|cerebral palsy
1004097|NCT03136432|Functional Exercise Capacity|functional exercise capacity
1004098|NCT03136432|Quality of Life|quality of life
1004099|NCT03136419|microbiota|microbiota
1004100|NCT03136419|innate immunity|innate immunity
1004101|NCT03136393|nutrition|nutrition
1004102|NCT03136393|pregnancy|pregnancy
1004103|NCT03136393|birth weight|birth weight
1004235|NCT03135795|DNA methylation|dna methylation
1004104|NCT03136380|healthy Japanese subjects|healthy japanese subjects
1004105|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
1004106|NCT03136380|Danirixin|danirixin
1004107|NCT03136367|encounter decision aids|encounter decision aids
1004108|NCT03136367|shared decision making|shared decision making
1004109|NCT03136367|socioeconomic status|socioeconomic status
1004110|NCT03136367|disparities|disparities
1004111|NCT03136367|decision quality|decision quality
1004112|NCT03136341|Upper Limb|upper limb
1004113|NCT03136341|Tremor|tremor
1004114|NCT03136341|task-dependent|task-dependent
1004115|NCT03136315|Renal failure|renal failure
1004116|NCT03136315|athlete|athlete
1004117|NCT03136315|ultra endurance|ultra endurance
1004118|NCT03136263|Attention|attention
1004119|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
1004120|NCT03136263|Cognitive control|cognitive control
1004121|NCT03136263|Executive control|executive control
1004122|NCT03136263|Executive functions|executive functions
1004123|NCT03136263|Impulse control|impulse control
1004124|NCT03136263|Impulsivity|impulsivity
1004125|NCT03136263|Oxytocin|oxytocin
1004126|NCT03136250|Muscle Energy Techniques|muscle energy techniques
1004127|NCT03136250|Autogenic Inhibition|autogenic inhibition
1004128|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
1004129|NCT03136250|Stretching|stretching
1004130|NCT03136250|Range of Motion|range of motion
1004131|NCT03136250|Muscle Strength|muscle strength
1004132|NCT03136250|VAS|vas
1004133|NCT03136250|Neck Disability Index|neck disability index
1004134|NCT03136250|NDI|ndi
1004135|NCT03136224|circumcision|circumcision
1004136|NCT03136224|Thermocautery|thermocautery
1004137|NCT03136224|Clamp|clamp
1004138|NCT03136224|Surgical Circumcision|surgical circumcision
1004139|NCT03136198|Heart Failure|heart failure
1004140|NCT03136198|Acute Heart Failure|acute heart failure
1004141|NCT03136198|Pulmonary Edema|pulmonary edema
1004142|NCT03136198|Lung ultrasound|lung ultrasound
1004143|NCT03136198|Extra vascular lung water|extra vascular lung water
1004144|NCT03136198|B-lines|b-lines
1004145|NCT03136185|LSD1|lsd1
1004146|NCT03136159|pregnancy|pregnancy
1004147|NCT03136159|delivery|delivery
1004148|NCT03136159|cesarean section|cesarean section
1004149|NCT03136159|wound healing|wound healing
1004150|NCT03136159|silver-containing dressing|silver-containing dressing
1004151|NCT03136146|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1004152|NCT03136146|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1004153|NCT03136146|ALL|all
1004154|NCT03136146|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1004155|NCT03136146|LL|ll
1004156|NCT03136146|Relapsed/Refractory|relapsed/refractory
1004157|NCT03136146|Clofarabine|clofarabine
1004158|NCT03136146|Clofarex|clofarex
1004159|NCT03136146|Clolar|clolar
1004160|NCT03136146|Etoposide|etoposide
1004161|NCT03136146|VePesid|vepesid
1004162|NCT03136146|Cyclophosphamide|cyclophosphamide
1004163|NCT03136146|Cytoxan|cytoxan
1004164|NCT03136146|Neosar|neosar
1004165|NCT03136146|Liposomal Vincristine|liposomal vincristine
1004166|NCT03136146|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
1004167|NCT03136146|VSLI|vsli
1004168|NCT03136146|Marqibo|marqibo
1004169|NCT03136146|Bortezomib|bortezomib
1004170|NCT03136146|Velcade|velcade
1004171|NCT03136146|LDP-341|ldp-341
1004172|NCT03136146|MLN341|mln341
1004173|NCT03136146|PS-341|ps-341
1004174|NCT03136146|Ofatumumab|ofatumumab
1004175|NCT03136146|Arzerra|arzerra
1004176|NCT03136146|Rituximab|rituximab
1004177|NCT03136146|Rituxan|rituxan
1004178|NCT03136146|Pegfilgrastim|pegfilgrastim
1004179|NCT03136146|Neulasta|neulasta
1004180|NCT03136146|PEG-G-CSF|peg-g-csf
1004181|NCT03136120|Ipratropium bromide|ipratropium bromide
1004182|NCT03136120|Cryobiopsy|cryobiopsy
1004183|NCT03136120|TBCB|tbcb
1004184|NCT03136120|IPF|ipf
1004185|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
1004186|NCT03136120|Interstitial lung disease|interstitial lung disease
1004187|NCT03136094|American Indian|american indian
1004188|NCT03136094|Alaska Native|alaska native
1004189|NCT03136094|Youth and Young Adult|youth and young adult
1004191|NCT03136081|Septic shock|septic shock
1004192|NCT03136081|Candidiasis|candidiasis
1004193|NCT03136081|Candidemia|candidemia
1004194|NCT03136081|Bacteremia|bacteremia
1004195|NCT03136081|Immunoparalysis|immunoparalysis
1004196|NCT03136055|NEC|nec
1004197|NCT03136029|HFrEF|hfref
1004198|NCT03136029|Exercise Intolerance|exercise intolerance
1004199|NCT03136029|Nitric Oxide|nitric oxide
1004200|NCT03135990|Virtual Reality|virtual reality
1004201|NCT03135990|Exposure Therapy|exposure therapy
1004202|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
1004203|NCT03135990|Extinction Learning|extinction learning
1004204|NCT03135964|NPWT|npwt
1004205|NCT03135964|foam|foam
1004206|NCT03135964|gauze|gauze
1004207|NCT03135951|Breast Cancer|breast cancer
1004208|NCT03135951|Pharmacokinetics|pharmacokinetics
1004209|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
1004210|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
1004211|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
1004212|NCT03135912|Tinea Pedis|tinea pedis
1004213|NCT03135912|Athlete's Foot|athlete's foot
1004214|NCT03135886|HIV|hiv
1004215|NCT03135886|HIV Testing|hiv testing
1004216|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
1004217|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
1004218|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
1004219|NCT03135886|Hepatitis C Virus|hepatitis c virus
1004220|NCT03135886|Practice Coaching|practice coaching
1004221|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
1004222|NCT03135860|COPD|copd
1004223|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1004224|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
1004225|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
1004226|NCT03135808|MRI|mri
1004227|NCT03135808|Imaging,|imaging,
1004228|NCT03135808|Anatomy|anatomy
1004229|NCT03135808|Tissue|tissue
1004230|NCT03135808|Colorectal|colorectal
1004231|NCT03135808|Sigmoid|sigmoid
1004232|NCT03135808|Colon|colon
1004233|NCT03135808|Pathology|pathology
1004234|NCT03135795|sufentanil|sufentanil
1004236|NCT03135769|avelumab|avelumab
1004237|NCT03135769|PDL1|pdl1
1004238|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
1004239|NCT03135769|GTN|gtn
1004240|NCT03135769|Hydatiform mole|hydatiform mole
1004241|NCT03135769|hCG|hcg
1004242|NCT03135717|Chronic kidney disease|chronic kidney disease
1004243|NCT03135717|Enteral nutrition|enteral nutrition
1004244|NCT03135717|Oral nutritional supplements|oral nutritional supplements
1004245|NCT03135717|Parenteral nutrition|parenteral nutrition
1004246|NCT03135717|Refeeding|refeeding
1004247|NCT03135717|Wasting|wasting
1004248|NCT03135652|Radiotherapy|radiotherapy
1004249|NCT03135652|Colorectal Cancer|colorectal cancer
1004250|NCT03135652|Liver Metastases|liver metastases
1004251|NCT03135639|tACS|tacs
1004252|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
1004253|NCT03135639|stimulation|stimulation
1004254|NCT03135639|healthy control|healthy control
1004255|NCT03135639|alpha oscillations|alpha oscillations
1004256|NCT03135639|heart rate variability|heart rate variability
1004257|NCT03135626|Pulpotomy|pulpotomy
1004258|NCT03135626|Primary molars|primary molars
1004259|NCT03135613|Knee tumor|knee tumor
1004260|NCT03135613|Microwave|microwave
1004261|NCT03135613|Gait|gait
1004262|NCT03135600|Knee|knee
1004263|NCT03135600|ACL Injury|acl injury
1004264|NCT03135600|Kinematics|kinematics
1004265|NCT03135587|Knee|knee
1004266|NCT03135587|Loading|loading
1004267|NCT03135587|Kinematics|kinematics
1004268|NCT03135522|Chronic cough|chronic cough
1004269|NCT03135522|Refractory cough|refractory cough
1004270|NCT03135522|Chronic refractory cough|chronic refractory cough
1004271|NCT03135522|Zinc|zinc
1004272|NCT03135522|Zinc acetate|zinc acetate
1004273|NCT03135509|Healthy Subjects|healthy subjects
1004274|NCT03135509|CC-220 Capsules|cc-220 capsules
1004275|NCT03135509|Relative Bioavailability|relative bioavailability
1004276|NCT03135509|Phase 1|phase 1
1004277|NCT03135470|pain|pain
1004278|NCT03135470|ambulatory surgery|ambulatory surgery
1004279|NCT03135470|oxycodone|oxycodone
1004280|NCT03135470|adverse effect|adverse effect
1004281|NCT03135444|Screening|screening
1004282|NCT03135444|Shared Decision Making|shared decision making
1027490|NCT02990793|TBI|tbi
1004283|NCT03135418|Virtual Reality|virtual reality
1004284|NCT03135392|Breast Cancer|breast cancer
1004285|NCT03135392|sensation recovery|sensation recovery
1004286|NCT03135392|Neurotization|neurotization
1004287|NCT03135366|Tuberculosis|tuberculosis
1004288|NCT03135366|TB|tb
1004289|NCT03135366|Adherence|adherence
1004290|NCT03135366|Mobile Health|mobile health
1004291|NCT03135366|mHealth|mhealth
1004292|NCT03135366|Behavior change|behavior change
1004293|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
1004294|NCT03135366|Drug-Resistance|drug-resistance
1004295|NCT03135366|Keheala|keheala
1004296|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
1004297|NCT03135275|Multivessel coronary disease|multivessel coronary disease
1004298|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
1004299|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
1004300|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
1004301|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
1004302|NCT03135236|Parent training|parent training
1004303|NCT03135236|Family education|family education
1004304|NCT03135236|Young adults|young adults
1004305|NCT03135236|Down syndrome|down syndrome
1004306|NCT03135236|sexuality|sexuality
1004307|NCT03135223|Physical activity|physical activity
1004308|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
1004309|NCT03135145|Physical Therapy|physical therapy
1004310|NCT03135145|Gait Training|gait training
1004311|NCT03135145|Functional Walking|functional walking
1004312|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
1004313|NCT03135132|High visceral fat|high visceral fat
1004314|NCT03135132|Low calorie diet|low calorie diet
1004315|NCT03135132|Mild weight loss|mild weight loss
1004316|NCT03135132|Metabolomics|metabolomics
1004317|NCT03135132|Metabolites|metabolites
1004318|NCT03135132|Acylcarnitines|acylcarnitines
1004319|NCT03135093|synergies|synergies
1004320|NCT03135093|upper limb|upper limb
1004321|NCT03135093|vision|vision
1004322|NCT03135067|HIV self-testing|hiv self-testing
1004323|NCT03135067|female sex workers|female sex workers
1004324|NCT03135067|partner testing|partner testing
1004325|NCT03135067|couples testing|couples testing
1004326|NCT03135067|transactional sex|transactional sex
1004327|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
1004328|NCT03135041|Prebiotics|prebiotics
1004329|NCT03135041|Microbiome|microbiome
1004330|NCT03135041|Glucose metabolism|glucose metabolism
1004331|NCT03134976|Salvage surgery|salvage surgery
1004332|NCT03134976|Head and neck cancer|head and neck cancer
1004333|NCT03134976|Wound healing|wound healing
1004334|NCT03134976|Hypothyroidism|hypothyroidism
1004335|NCT03134976|Levothyroxine|levothyroxine
1004336|NCT03134937|Gastric Ultrasound|gastric ultrasound
1004337|NCT03134937|Gastric Distension|gastric distension
1004338|NCT03134937|Gastric Volume|gastric volume
1004339|NCT03134937|Gastric Fluid Volume|gastric fluid volume
1004340|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
1004341|NCT03134937|HFHHNO|hfhhno
1004342|NCT03134937|Healthy volunteer|healthy volunteer
1004343|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
1004344|NCT03134885|suicide|suicide
1004345|NCT03134885|suicidal conducts|suicidal conducts
1004346|NCT03134885|post discharge monitoring system|post discharge monitoring system
1004347|NCT03134872|PD-1|pd-1
1004348|NCT03134872|PD-L1|pd-l1
1004349|NCT03134872|SHR-1210|shr-1210
1004350|NCT03134872|Carboplatin|carboplatin
1004351|NCT03134872|Pemetrexed|pemetrexed
1004352|NCT03134859|motor development|motor development
1004353|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
1004354|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
1004355|NCT03134846|Molecular imaging|molecular imaging
1004356|NCT03134833|HIV|hiv
1004357|NCT03134833|STI|sti
1004358|NCT03134833|Mental Health|mental health
1004359|NCT03134833|Substance Use|substance use
1004360|NCT03134833|Peer Support|peer support
1004361|NCT03134820|Low molecular weight heparins|low molecular weight heparins
1004362|NCT03134820|Procoagulants|procoagulants
1004363|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
1004364|NCT03134794|neuroeconomics|neuroeconomics
1004365|NCT03134794|multiple sclerosis|multiple sclerosis
1004366|NCT03134794|educational intervention|educational intervention
1004367|NCT03134794|traffic light system|traffic light system
1004368|NCT03134794|aversion to ambiguity|aversion to ambiguity
1004370|NCT03134794|outcomes|outcomes
1004371|NCT03134794|knowledge|knowledge
1004372|NCT03134794|action|action
1004373|NCT03134794|gaps|gaps
1004374|NCT03134794|disease modifying agents|disease modifying agents
1004375|NCT03134755|Asthma|asthma
1004376|NCT03134755|Children|children
1004377|NCT03134755|Stress|stress
1004378|NCT03134755|Puerto Rican|puerto rican
1004379|NCT03134755|Health disparities|health disparities
1004380|NCT03134755|Treatment response|treatment response
1004381|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
1004382|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
1004383|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
1004384|NCT03134677|Spinal anesthesia|spinal anesthesia
1004385|NCT03134677|General anesthesia|general anesthesia
1004386|NCT03134677|P wave dispersion|p wave dispersion
1004387|NCT03134651|Anxiety|anxiety
1004388|NCT03134651|Oocyte retrieval|oocyte retrieval
1004389|NCT03134651|Monitoring of brain function|monitoring of brain function
1004390|NCT03134625|metabolomics|metabolomics
1004391|NCT03134625|biomarker|biomarker
1004392|NCT03134625|acute rejection|acute rejection
1004393|NCT03134612|lidocain|lidocain
1004394|NCT03134612|ondansetron|ondansetron
1004395|NCT03134612|pain|pain
1004396|NCT03134612|propofol|propofol
1004397|NCT03134586|Capsule endoscopy|capsule endoscopy
1004398|NCT03134586|Crohn's disease|crohn's disease
1004399|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
1004400|NCT03134586|Ileocolonoscopy|ileocolonoscopy
1004401|NCT03134586|Bowel Ultrasound|bowel ultrasound
1004402|NCT03134586|diagnostic imaging|diagnostic imaging
1004403|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
1004404|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
1004405|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
1004406|NCT03134560|vein display instrument|vein display instrument
1004407|NCT03134560|pediatric|pediatric
1004408|NCT03134560|vein access|vein access
1004409|NCT03134560|vein cannulation|vein cannulation
1004410|NCT03134547|emergence agitation|emergence agitation
1004411|NCT03134547|sevoflurane|sevoflurane
1004412|NCT03134547|children|children
1004413|NCT03134534|lobectomy|lobectomy
1004414|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
1004415|NCT03134534|lung cancer|lung cancer
1004416|NCT03134521|bone and joint infection|bone and joint infection
1004417|NCT03134521|daptomycin|daptomycin
1004418|NCT03134521|population pharmacokinetics|population pharmacokinetics
1004419|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
1004420|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
1004421|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
1004422|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
1004423|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
1004424|NCT03134430|Regional nerve block|regional nerve block
1004425|NCT03134430|cancer recurrence|cancer recurrence
1004426|NCT03134404|RAMP|ramp
1004427|NCT03134404|Rapid Access|rapid access
1004428|NCT03134404|Metastasis to Bone|metastasis to bone
1004429|NCT03134404|Cancer|cancer
1004430|NCT03134378|Helicobacter pylori|helicobacter pylori
1004431|NCT03134378|triple therapy|triple therapy
1004432|NCT03134378|eradication|eradication
1004433|NCT03134365|meal ingestion|meal ingestion
1004434|NCT03134365|palatability|palatability
1004435|NCT03134365|postprandial responses|postprandial responses
1004436|NCT03134365|hedonic response|hedonic response
1004437|NCT03134352|subacute|subacute
1004438|NCT03134339|nicotine, smoking|nicotine, smoking
1004439|NCT03134209|Monocryl|monocryl
1004440|NCT03134209|Dermabond|dermabond
1004441|NCT03134209|Polyester mesh|polyester mesh
1004442|NCT03134209|Joint Disease|joint disease
1004443|NCT03134209|Arthropathy|arthropathy
1004444|NCT03134209|Joint Replacement|joint replacement
1004445|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
1004446|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
1004447|NCT03134196|Varicella Zoster Virus|varicella zoster virus
1004448|NCT03134196|Zoster|zoster
1004449|NCT03134196|Shingles|shingles
1004451|NCT03134183|dilation and evacuation|dilation and evacuation
1004452|NCT03134183|abortion|abortion
1004453|NCT03134183|second trimester|second trimester
1004454|NCT03134183|mifepristone|mifepristone
1004455|NCT03134183|misoprostol|misoprostol
1004456|NCT03134170|pharmacist|pharmacist
1004457|NCT03134170|diabetes|diabetes
1004458|NCT03134170|Preventative Care|preventative care
1004459|NCT03134170|Quality of Life|quality of life
1004460|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
1004461|NCT03134144|Exoskeleton|exoskeleton
1004462|NCT03134144|Manual materials handling|manual materials handling
1004463|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
1004464|NCT03134144|Posture|posture
1004465|NCT03134144|Standing work|standing work
1004466|NCT03134144|Muscle activity|muscle activity
1004467|NCT03134118|Thymoma|thymoma
1004468|NCT03134118|Phase II|phase ii
1004469|NCT03134118|nivolumab|nivolumab
1004470|NCT03134118|Thymic carcinoma|thymic carcinoma
1004471|NCT03134079|Taste Testing|taste testing
1004472|NCT03134079|Spices|spices
1004473|NCT03134079|Reduced sugar|reduced sugar
1004474|NCT03134079|Food liking|food liking
1004475|NCT03134053|hypertrophy scar|hypertrophy scar
1004476|NCT03134053|burn|burn
1004477|NCT03134040|Incentives|incentives
1004478|NCT03134040|Motivation|motivation
1004479|NCT03133975|high dose vitamin D|high dose vitamin d
1004480|NCT03133975|dyslipidemia|dyslipidemia
1004481|NCT03133975|premenopausal women|premenopausal women
1004482|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
1004483|NCT03133910|Pharmacokinetics|pharmacokinetics
1004484|NCT03133910|Ceftazidime|ceftazidime
1004485|NCT03133897|dexamethasone|dexamethasone
1004486|NCT03133897|prednisone|prednisone
1004487|NCT03133897|inpatient|inpatient
1004488|NCT03133897|paediatrics|paediatrics
1004489|NCT03133884|chronic tension-type headache|chronic tension-type headache
1004490|NCT03133884|acupuncture|acupuncture
1004491|NCT03133884|Deqi|deqi
1004496|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
1004497|NCT03133832|Praziquantel|praziquantel
1004498|NCT03133832|A randomized controlled trial|a randomized controlled trial
1004499|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
1004500|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1004501|NCT03133767|Normal saline|normal saline
1004502|NCT03133767|Lactated ringers|lactated ringers
1004503|NCT03133767|Emergency department|emergency department
1004505|NCT03133741|GIP receptor antagonist|gip receptor antagonist
1004506|NCT03133728|EID HIV|eid hiv
1004507|NCT03133728|Early Infant Diagnosis|early infant diagnosis
1004508|NCT03133728|Point of Care|point of care
1004509|NCT03133728|Infant|infant
1004510|NCT03133728|HIV|hiv
1004511|NCT03133715|robot-assisted|robot-assisted
1004512|NCT03133689|Alcohol|alcohol
1004513|NCT03133689|Coronary heart disease|coronary heart disease
1004514|NCT03133689|Ischemic heart disease|ischemic heart disease
1004515|NCT03133689|Cardiovascular health|cardiovascular health
1004516|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
1004517|NCT03133689|Longitudinal|longitudinal
1004518|NCT03133676|Osteoarthritis|osteoarthritis
1004519|NCT03133676|Arthritis|arthritis
1004520|NCT03133676|Joint Disease|joint disease
1004521|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
1004522|NCT03133663|electrocardiogram|electrocardiogram
1004523|NCT03133663|premature|premature
1004524|NCT03133663|resuscitation|resuscitation
1004525|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
1004526|NCT03133650|15-319|15-319
1004527|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
1004528|NCT03133624|rupture risk|rupture risk
1004529|NCT03133624|computational fluid dynamic|computational fluid dynamic
1004530|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
1004531|NCT03133624|gene|gene
1004532|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
1004533|NCT03133624|clinical features|clinical features
1004534|NCT03133624|risk factors|risk factors
1004535|NCT03133624|registry study|registry study
1004536|NCT03133624|china|china
1004537|NCT03133624|biomarkers|biomarkers
1004538|NCT03133611|Speech disorder|speech disorder
1004539|NCT03133611|Acoustic analysis|acoustic analysis
1004540|NCT03133611|Dysarthria|dysarthria
1004541|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
1004542|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
1004543|NCT03133598|Prospective cohort study|prospective cohort study
1004544|NCT03133598|China|china
1004545|NCT03133546|NSCLC|nsclc
1004546|NCT03133546|EGFR|egfr
1004547|NCT03133546|TKI|tki
1004548|NCT03133546|EGFRm|egfrm
1004549|NCT03133546|T790M|t790m
1004550|NCT03133533|robot-assisted|robot-assisted
1004551|NCT03133520|Respiratory failure|respiratory failure
1004552|NCT03133520|immuncompromise patients|immuncompromise patients
1004553|NCT03133520|high flow oxygen|high flow oxygen
1004554|NCT03133507|cancer|cancer
1004555|NCT03133507|salivary alpha amylase|salivary alpha amylase
1004556|NCT03133507|pain|pain
1004557|NCT03133507|positive affect|positive affect
1004558|NCT03133507|emotion regulation strategies|emotion regulation strategies
1004559|NCT03133481|Adductor Canal Block|adductor canal block
1004560|NCT03133481|Femoral Canal Block|femoral canal block
1004561|NCT03133468|AJM347|ajm347
1004562|NCT03133468|pharmacokinetics|pharmacokinetics
1004563|NCT03133468|food effect study|food effect study
1004564|NCT03133468|pharmacodynamics|pharmacodynamics
1004565|NCT03133455|Rumination|rumination
1004566|NCT03133429|carotid artery|carotid artery
1004567|NCT03133429|stroke|stroke
1004568|NCT03133429|stent|stent
1004569|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
1004570|NCT03133416|rotator cuff tear|rotator cuff tear
1004571|NCT03133416|platelet-rich plasma|platelet-rich plasma
1004572|NCT03133416|physiotherapy|physiotherapy
1004573|NCT03133416|exercise|exercise
1004574|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
1004575|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
1004576|NCT03133286|Anal Cancer|anal cancer
1004577|NCT03133286|Bladder|bladder
1004578|NCT03133286|Cervical|cervical
1004579|NCT03133286|Colorectal|colorectal
1004580|NCT03133286|Esophageal|esophageal
1004581|NCT03133286|Gallbladder|gallbladder
1004582|NCT03133286|Liver|liver
1004583|NCT03133286|Ovarian|ovarian
1004584|NCT03133286|Pancreas|pancreas
1004585|NCT03133286|Pancreatic|pancreatic
1004586|NCT03133286|Prostate|prostate
1004587|NCT03133286|Rectal|rectal
1004588|NCT03133286|Renal|renal
1004589|NCT03133286|Kidney|kidney
1004590|NCT03133286|Stomach|stomach
1004591|NCT03133286|Testicular|testicular
1004592|NCT03133286|Uterine|uterine
1004593|NCT03133286|Cancer|cancer
1004594|NCT03133286|Radiation Therapy|radiation therapy
1004595|NCT03133286|Radiation Treatment|radiation treatment
1004596|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
1004597|NCT03133273|Chemosensitivity|chemosensitivity
1004599|NCT03133221|indolent NHL|indolent nhl
1004600|NCT03133221|Zydelig|zydelig
1004601|NCT03133221|Idelalisib|idelalisib
1004602|NCT03133221|B-cell NHL|b-cell nhl
1004603|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1004604|NCT03133221|Maintenance|maintenance
1004605|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
1004606|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1004607|NCT03133208|sepsis|sepsis
1004608|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
1004609|NCT03133208|sepsis associated delirium|sepsis associated delirium
1004610|NCT03133208|altered mental status|altered mental status
1004611|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
1004612|NCT03133169|Thalassemia|thalassemia
1004613|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
1004614|NCT03133169|Pulmonary hypertension|pulmonary hypertension
1004615|NCT03133156|Exercise|exercise
1004616|NCT03133156|Training|training
1004617|NCT03133156|Type 2 Diabetes|type 2 diabetes
1004618|NCT03133156|Mellitus|mellitus
1004619|NCT03133143|Cognitive Function|cognitive function
1004620|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1004621|NCT03133143|Computers, Digital|computers, digital
1004622|NCT03133130|Scar|scar
1004623|NCT03133130|Scar prevention|scar prevention
1004624|NCT03133130|siRNA|sirna
1004625|NCT03133091|PIEB|pieb
1004626|NCT03133091|PCEA|pcea
1004627|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
1004628|NCT03133078|Side Hop|side hop
1004629|NCT03133078|Forward Hop|forward hop
1004630|NCT03133078|Step test|step test
1004631|NCT03133078|Vertical Jump|vertical jump
1004632|NCT03133052|cognitive control training|cognitive control training
1004633|NCT03133052|aMCI|amci
1004634|NCT03133052|MRI|mri
1004635|NCT03133052|RCT|rct
1004636|NCT03133026|obstructive Jaundice|obstructive jaundice
1004637|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
1004638|NCT03133026|Cholangitis|cholangitis
1004639|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
1004640|NCT03133000|Incisional hernia|incisional hernia
1004641|NCT03132987|quadriceps strength|quadriceps strength
1004642|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
1004643|NCT03132987|progressive strength program|progressive strength program
1004644|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
1004645|NCT03132961|Electrocochleography|electrocochleography
1004646|NCT03132961|Infrasound|infrasound
1004647|NCT03132948|ALL Cancer Patients|all cancer patients
1004648|NCT03132948|Quality of Life|quality of life
1004649|NCT03132948|Fitness|fitness
1004650|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
1004651|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1004652|NCT03132935|Telemedicine|telemedicine
1004653|NCT03132922|Cell Therapy|cell therapy
1004654|NCT03132922|T Cell Therapy|t cell therapy
1004655|NCT03132922|SPEAR T Cell|spear t cell
1004656|NCT03132922|MAGE-A4|mage-a4
1004657|NCT03132922|Immuno-oncology|immuno-oncology
1004658|NCT03132922|Metastatic|metastatic
1004659|NCT03132922|Urothelial Cancer|urothelial cancer
1004859|NCT03131700|RPH-101|rph-101
1004660|NCT03132922|Previously Treated|previously treated
1004661|NCT03132922|T Cell Receptor|t cell receptor
1004662|NCT03132922|Squamous, adenosquamous, or large cell NSCLC|squamous, adenosquamous, or large cell nsclc
1004663|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
1004664|NCT03132922|Sarcoma|sarcoma
1004665|NCT03132922|Melanoma|melanoma
1004666|NCT03132922|Bladder|bladder
1004667|NCT03132922|Ovarian|ovarian
1004668|NCT03132818|Procreation with donation|procreation with donation
1004669|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
1004670|NCT03132792|Cell Therapy|cell therapy
1004671|NCT03132792|T Cell Therapy|t cell therapy
1004672|NCT03132792|SPEAR T Cell|spear t cell
1004673|NCT03132792|Immuno-oncology|immuno-oncology
1004674|NCT03132792|Metastatic|metastatic
1004675|NCT03132792|Previously treated|previously treated
1004676|NCT03132792|T Cell Receptor|t cell receptor
1004677|NCT03132779|Intralipid|intralipid
1004678|NCT03132779|NK cells|nk cells
1004679|NCT03132779|Recurrent miscarriage|recurrent miscarriage
1004680|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
1004681|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
1004682|NCT03132714|Clarithromycin|clarithromycin
1004683|NCT03132714|Amoxicillin|amoxicillin
1004684|NCT03132714|Metronidazole|metronidazole
1004685|NCT03132714|Antimicrobial therapy|antimicrobial therapy
1004686|NCT03132714|Photodynamic therapy|photodynamic therapy
1004687|NCT03132714|Low-level laser therapy|low-level laser therapy
1004688|NCT03132675|Melanoma|melanoma
1004689|NCT03132675|pIL-12|pil-12
1004690|NCT03132675|pembrolizumab|pembrolizumab
1004691|NCT03132675|tavokinogene telseplasmid|tavokinogene telseplasmid
1004692|NCT03132649|Three dimensional visualization|three dimensional visualization
1004693|NCT03132649|Operation strategy|operation strategy
1004694|NCT03132597|stress|stress
1004695|NCT03132597|anxiety|anxiety
1004697|NCT03132597|quality of life|quality of life
1004698|NCT03132597|Mindfulness|mindfulness
1004699|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
1004700|NCT03132571|Schizophrenia|schizophrenia
1004701|NCT03132571|Diabetes|diabetes
1004702|NCT03132571|Obesity|obesity
1004703|NCT03132519|Cough|cough
1004704|NCT03132519|Hypertension|hypertension
1004705|NCT03132519|Remifentanil|remifentanil
1004706|NCT03132519|Sevoflurane|sevoflurane
1004707|NCT03132519|Desflurane|desflurane
1004708|NCT03132467|Breast Cancer|breast cancer
1004709|NCT03132467|Hormone Receptor Positive, HER2 Negative Breast Cancer|hormone receptor positive, her2 negative breast cancer
1004710|NCT03132467|Tremelimumab|tremelimumab
1004711|NCT03132467|Ticilimumab|ticilimumab
1004712|NCT03132467|CP-675,206|cp-675,206
1004713|NCT03132467|Durvalumab|durvalumab
1004714|NCT03132467|MEDI4736|medi4736
1004715|NCT03132454|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1004716|NCT03132454|Acute myeloid leukemia|acute myeloid leukemia
1004718|NCT03132454|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1004719|NCT03132454|ALL|all
1004720|NCT03132454|Relapsed or refractory|relapsed or refractory
1004721|NCT03132454|R/R|r/r
1004722|NCT03132454|Palbociclib|palbociclib
1004723|NCT03132454|PD-0332991|pd-0332991
1004724|NCT03132454|Ibrance|ibrance
1004725|NCT03132454|Sorafenib|sorafenib
1004726|NCT03132454|Nexavar|nexavar
1004727|NCT03132454|BAY 43-9006|bay 43-9006
1004728|NCT03132454|Decitabine|decitabine
1004729|NCT03132454|Dacogen|dacogen
1004730|NCT03132454|Dexamethasone|dexamethasone
1004731|NCT03132454|Decadron|decadron
1004732|NCT03132441|advanced heart failure|advanced heart failure
1004733|NCT03132441|NYHA Class III-IV|nyha class iii-iv
1004734|NCT03132441|frailty|frailty
1004735|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
1004736|NCT03132415|Prevention & Control|prevention & control
1004737|NCT03132415|Internet|internet
1004738|NCT03132415|Adolescents|adolescents
1004739|NCT03132415|Young adults|young adults
1004740|NCT03132402|Elisa|elisa
1004741|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
1004742|NCT03132389|Sexual assault|sexual assault
1004743|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
1004744|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
1004745|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
1004746|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
1004747|NCT03132389|Hepatitis B and C|hepatitis b and c
1004748|NCT03132389|HIV|hiv
1004749|NCT03132389|Syphilis|syphilis
1004750|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
1004751|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
1004752|NCT03132324|sickle cell SS|sickle cell ss
1004753|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
1004754|NCT03132311|yellow fever vaccine|yellow fever vaccine
1004755|NCT03132311|hiv|hiv
1004756|NCT03132272|ADAsorb apheresis|adasorb apheresis
1004757|NCT03132272|Globaffin adsorber|globaffin adsorber
1004758|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
1004759|NCT03132272|Immunoadsorption|immunoadsorption
1004760|NCT03132272|Alzheimer Dementia|alzheimer dementia
1004761|NCT03132259|Dexmedethomidine|dexmedethomidine
1004762|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1004763|NCT03132246|Infection|infection
1004764|NCT03132246|Biofilm Assay|biofilm assay
1004765|NCT03132233|Migraine|migraine
1004766|NCT03132233|Prevention|prevention
1004767|NCT03132233|Prophylaxis|prophylaxis
1004768|NCT03132233|Ketone bodies|ketone bodies
1004769|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
1004770|NCT03132233|Double-blind|double-blind
1004771|NCT03132233|Randomised|randomised
1004772|NCT03132233|Placebo controlled|placebo controlled
1004773|NCT03132233|Mitochondrial functioning|mitochondrial functioning
1004774|NCT03132233|Energy metabolism|energy metabolism
1004775|NCT03132233|Intervention|intervention
1004776|NCT03132233|Dietary Supplement|dietary supplement
1004777|NCT03132220|critical care nurses|critical care nurses
1004778|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1004779|NCT03132220|Burn-out Syndrome|burn-out syndrome
1004780|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
1004781|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
1004782|NCT03132207|Oral Health|oral health
1004783|NCT03132207|Pregnancy|pregnancy
1004784|NCT03132207|Prevention|prevention
1004785|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
1004786|NCT03132181|Empagliflozin|empagliflozin
1004787|NCT03132181|Diabetes|diabetes
1004788|NCT03132181|Systemic vascular resistance|systemic vascular resistance
1004789|NCT03132181|Cardiac output|cardiac output
1004790|NCT03132181|Blood pressure|blood pressure
1004791|NCT03132168|cystectomy|cystectomy
1004792|NCT03132168|urology|urology
1004793|NCT03132168|surgery|surgery
1004794|NCT03132129|Type 2 diabetes|type 2 diabetes
1004795|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
1004796|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
1004797|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
1004798|NCT03132116|Infectious Diseases|infectious diseases
1004799|NCT03132103|Vitamin D deficiency|vitamin d deficiency
1004800|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
1004801|NCT03132103|Oral vitamin D3|oral vitamin d3
1004802|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
1004803|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
1004804|NCT03132025|Apatinib|apatinib
1004805|NCT03132025|Capecitabine|capecitabine
1004806|NCT03131999|VEGF-D|vegf-d
1004807|NCT03131999|Imatinib mesylate|imatinib mesylate
1004808|NCT03131999|Sirolimus|sirolimus
1004809|NCT03131921|Energy expenditure|energy expenditure
1004810|NCT03131921|Nutrition|nutrition
1004811|NCT03131921|Colorectal cancer|colorectal cancer
1004812|NCT03131921|Dietary needs|dietary needs
1004813|NCT03131921|Breast cancer|breast cancer
1004814|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
1004815|NCT03131908|Metastatic Melanoma|metastatic melanoma
1004816|NCT03131908|GSK2633771|gsk2633771
1004817|NCT03131908|Pembrolizumab|pembrolizumab
1004818|NCT03131908|Keytruda|keytruda
1004819|NCT03131908|MK-3475|mk-3475
1004820|NCT03131908|SCH-900475|sch-900475
1004821|NCT03131895|Drug therapy|drug therapy
1004822|NCT03131882|trigger finger|trigger finger
1004823|NCT03131882|trigger thumb|trigger thumb
1004824|NCT03131882|ultrasound guided|ultrasound guided
1004825|NCT03131882|hyaluronic acid|hyaluronic acid
1004826|NCT03131856|Geriatrics|geriatrics
1004827|NCT03131856|Nutritional risk|nutritional risk
1004828|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
1004829|NCT03131856|Randomized Controlled Trial|randomized controlled trial
1004830|NCT03131843|skin infection|skin infection
1004831|NCT03131843|vaccination|vaccination
1004832|NCT03131843|children|children
1004833|NCT03131843|alcohol swab|alcohol swab
1004834|NCT03131843|skin preparation|skin preparation
1004835|NCT03131804|Aerobic|aerobic
1004836|NCT03131804|Intradialytic|intradialytic
1004837|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
1004838|NCT03131804|Dialysis Adequacy|dialysis adequacy
1004839|NCT03131804|Quality of Life|quality of life
1004840|NCT03131804|Cost Effectiveness|cost effectiveness
1004841|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
1004842|NCT03131791|Spasticity in stokes|spasticity in stokes
1004843|NCT03131791|Botulinum toxin|botulinum toxin
1004844|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1004845|NCT03131752|muscle strength|muscle strength
1004846|NCT03131752|physical activity|physical activity
1004847|NCT03131739|Resilience|resilience
1004848|NCT03131739|Alaska Native|alaska native
1004849|NCT03131739|Community Based Participatory Research|community based participatory research
1004850|NCT03131739|Culture and Community Factors|culture and community factors
1004851|NCT03131739|Protective Factors|protective factors
1004852|NCT03131739|Risk Factors|risk factors
1004853|NCT03131726|simvastatin|simvastatin
1004854|NCT03131726|diclofenac|diclofenac
1004855|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
1004856|NCT03131713|pain|pain
1004857|NCT03131713|functional status|functional status
1004858|NCT03131700|RPH101|rph101
1004867|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
1004869|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
1004870|NCT03131570|Secukinumab|secukinumab
1004878|NCT03131479|renal function|renal function
1004879|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
1004880|NCT03131479|pharmacokinetics|pharmacokinetics
1004881|NCT03131479|decreased renal function|decreased renal function
1004882|NCT03131479|decreased kidney function|decreased kidney function
1004883|NCT03131479|kidney disease|kidney disease
1004884|NCT03131479|urinary glucose excretion|urinary glucose excretion
1004885|NCT03131479|UGE|uge
1004886|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
1004887|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
1004888|NCT03131466|Gasserian Ganglion|gasserian ganglion
1004889|NCT03131453|Placebo controlled,|placebo controlled,
1004890|NCT03131453|APOE4 carriers,|apoe4 carriers,
1004891|NCT03131453|Homozygotes,|homozygotes,
1004892|NCT03131453|Heterozygotes,|heterozygotes,
1004893|NCT03131453|Brain Amyloid,|brain amyloid,
1004894|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
1004895|NCT03131453|Aβ lowering,|aβ lowering,
1004896|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
1004897|NCT03131427|Wilson's Disease|wilson's disease
1004898|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
1004899|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
1004900|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
1004901|NCT03131427|Genetic Testing|genetic testing
1004902|NCT03131375|dexmedetomidine|dexmedetomidine
1004903|NCT03131375|emergence delirium|emergence delirium
1004904|NCT03131375|anesthesia|anesthesia
1004905|NCT03131375|propofol|propofol
1004906|NCT03131375|children|children
1004908|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
1004909|NCT03131297|anal fistulas|anal fistulas
1004910|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
1004911|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
1004912|NCT03131271|Femoral arterial catheter|femoral arterial catheter
1004913|NCT03131271|Pain|pain
1004914|NCT03131271|Cold application|cold application
1004915|NCT03131271|Nursing|nursing
1004916|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
1004917|NCT03131206|NSCLC|nsclc
1004918|NCT03131206|ALK|alk
1004919|NCT03131206|RET|ret
1004920|NCT03131206|alectinib|alectinib
1004921|NCT03131206|Thyroid cancer|thyroid cancer
1004922|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
1004923|NCT03131128|Weight loss|weight loss
1004924|NCT03131128|Workplace health promotion|workplace health promotion
1004925|NCT03131128|Obesity|obesity
1004926|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1004927|NCT03131063|Sepsis|sepsis
1004928|NCT03131063|Antibiotics|antibiotics
1004929|NCT03131063|Pharmacokinetic|pharmacokinetic
1004930|NCT03131063|Intensive Care Unit|intensive care unit
1004931|NCT03131050|Scopolamine|scopolamine
1004932|NCT03131037|immunotherapy|immunotherapy
1004933|NCT03131037|immuno-oncology|immuno-oncology
1004934|NCT03131037|tumor vaccine|tumor vaccine
1004935|NCT03131024|anthracyclines|anthracyclines
1004936|NCT03130998|smoking cessation|smoking cessation
1004937|NCT03130998|depression|depression
1004938|NCT03130998|mental health|mental health
1004939|NCT03130998|mood management|mood management
1004940|NCT03130998|primary care|primary care
1004941|NCT03130998|screening|screening
1004942|NCT03130998|brief intervention|brief intervention
1004943|NCT03130998|referral to treatment|referral to treatment
1004944|NCT03130985|microRNA|microrna
1004945|NCT03130985|biomarker|biomarker
1004946|NCT03130946|breast neoplasms|breast neoplasms
1004947|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
1004948|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
1004949|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
1004950|NCT03130933|third molar|third molar
1004951|NCT03130933|oral surgical procedures|oral surgical procedures
1004952|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
1004953|NCT03130933|placebo effect|placebo effect
1004954|NCT03130920|preconditioning, resection|preconditioning, resection
1004955|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
1004956|NCT03130894|type2 Diabetes|type2 diabetes
1005055|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
1004957|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
1004958|NCT03130855|pediatric patients|pediatric patients
1004959|NCT03130855|articaine local anesthesia|articaine local anesthesia
1004960|NCT03130829|NSCLC|nsclc
1004961|NCT03130829|QoL|qol
1004962|NCT03130829|Fucoidan|fucoidan
1004963|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
1004964|NCT03130816|Cytokine changes|cytokine changes
1004965|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
1004966|NCT03130712|immunotherapy|immunotherapy
1004967|NCT03130712|GPC3-CART|gpc3-cart
1004968|NCT03130712|HCC|hcc
1004969|NCT03130699|Diabetes|diabetes
1004970|NCT03130699|mHealth|mhealth
1004971|NCT03130699|Medical Assistant|medical assistant
1004972|NCT03130699|Automated|automated
1004973|NCT03130699|Adaptive Feedback|adaptive feedback
1004974|NCT03130699|Self-Management Support|self-management support
1004975|NCT03130699|Hispanics|hispanics
1004976|NCT03130699|HbA1c|hba1c
1004977|NCT03130699|Cyberinfrastructure|cyberinfrastructure
1004978|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
1004979|NCT03130699|Cost-Effectiveness|cost-effectiveness
1004980|NCT03130699|T2DM|t2dm
1004981|NCT03130699|Pay-for-Performance|pay-for-performance
1004982|NCT03130699|Medication Adherence|medication adherence
1004983|NCT03130699|LDL-C|ldl-c
1004984|NCT03130699|Systolic Blood Pressure|systolic blood pressure
1004985|NCT03130699|Text Messaging|text messaging
1004986|NCT03130673|hip fracture|hip fracture
1004987|NCT03130673|trochanteric fracure|trochanteric fracure
1004988|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
1004989|NCT03130673|femoral head fracture|femoral head fracture
1004990|NCT03130673|epidemiology|epidemiology
1004991|NCT03130660|central line|central line
1004992|NCT03130660|Central Line Complication|central line complication
1004993|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
1004994|NCT03130634|silymarin|silymarin
1004995|NCT03130634|GI toxicity|gi toxicity
1004996|NCT03130608|liver disease|liver disease
1004997|NCT03130608|transplant|transplant
1004998|NCT03130608|muscle wasting|muscle wasting
1004999|NCT03130608|breathing exercise|breathing exercise
1005000|NCT03130595|accelerometry|accelerometry
1005001|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
1005002|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
1005003|NCT03130569|Risk Assessment|risk assessment
1005004|NCT03130569|Personal Genomic Testing|personal genomic testing
1005005|NCT03130569|Skin Cancer|skin cancer
1005006|NCT03130569|Primary Care|primary care
1005007|NCT03130556|Glasdegib|glasdegib
1005008|NCT03130556|PF-04449913|pf-04449913
1005009|NCT03130556|Pharmacokinetics|pharmacokinetics
1005010|NCT03130556|Bioavailability|bioavailability
1005011|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
1005012|NCT03130530|robotic|robotic
1005013|NCT03130530|colorectal|colorectal
1005014|NCT03130530|surgery|surgery
1005015|NCT03130517|hemolysis,newborn|hemolysis,newborn
1005016|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
1005017|NCT03130478|persistence|persistence
1005018|NCT03130465|adherence|adherence
1005019|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
1005020|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
1005021|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
1005022|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
1005023|NCT03130439|Breast Cancer|breast cancer
1005024|NCT03130426|Diabetes|diabetes
1005025|NCT03130426|iGlarLixi|iglarlixi
1005026|NCT03130426|Metformin|metformin
1005027|NCT03130426|Insulin|insulin
1005028|NCT03130426|Diet|diet
1005029|NCT03130426|Exercise|exercise
1005030|NCT03130426|Lifestyle|lifestyle
1005031|NCT03130413|Ambu Aura Gain|ambu aura gain
1005032|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
1005033|NCT03130413|Paediatric surgery|paediatric surgery
1005034|NCT03130400|Knee|knee
1005035|NCT03130400|Gait|gait
1005036|NCT03130400|Injuries|injuries
1005037|NCT03130400|Arthritis|arthritis
1005038|NCT03130387|Hytsteroscopy|hytsteroscopy
1005039|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
1005040|NCT03130374|Tracheal Stenosis|tracheal stenosis
1005041|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
1005042|NCT03130374|cell therapy|cell therapy
1005043|NCT03130309|Knee|knee
1005044|NCT03130309|Replacement|replacement
1005045|NCT03130309|Mobile-bearing|mobile-bearing
1005046|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
1005047|NCT03130296|HIV infection|hiv infection
1005048|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
1005049|NCT03130283|Acute patients|acute patients
1005050|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
1005051|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1005052|NCT03130270|disease-free survival|disease-free survival
1005053|NCT03130270|adverse reaction|adverse reaction
1005054|NCT03130257|blood pressure measurement|blood pressure measurement
1005652|NCT03126123|acetic acid|acetic acid
1005056|NCT03130179|Bioequivalence|bioequivalence
1005057|NCT03130166|Postoperative pain|postoperative pain
1005058|NCT03130166|Postoperative recovery|postoperative recovery
1005059|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
1005060|NCT03130166|Robotic right colectomy|robotic right colectomy
1005061|NCT03130114|Mortality|mortality
1005063|NCT03130114|Antibiotics|antibiotics
1005064|NCT03130114|Linear Growth|linear growth
1005065|NCT03130101|Type 1 Diabetes|type 1 diabetes
1005066|NCT03130101|Exercise|exercise
1005067|NCT03130101|Basal insulin|basal insulin
1005068|NCT03130101|CSII|csii
1005069|NCT03130101|OmniPod|omnipod
1005070|NCT03130101|CGM|cgm
1005071|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
1005072|NCT03130088|Resuscitation Registry|resuscitation registry
1005073|NCT03130088|EuReCa TWO|eureca two
1005074|NCT03130062|Resistance Exercise|resistance exercise
1005075|NCT03130062|Functional Fitness|functional fitness
1005076|NCT03130062|Actigraphy|actigraphy
1005077|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
1005078|NCT03130049|Peripheral nerve block|peripheral nerve block
1005079|NCT03130049|Ultrasound|ultrasound
1005080|NCT03130036|Memory|memory
1005081|NCT03130036|Cognitive|cognitive
1005082|NCT03129984|mandibular movements|mandibular movements
1005083|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
1005084|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
1005085|NCT03129945|Tocolytic Agents|tocolytic agents
1005086|NCT03129932|gluten|gluten
1005087|NCT03129932|adipokine|adipokine
1005088|NCT03129932|obesity|obesity
1005089|NCT03129932|diet|diet
1005090|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
1005091|NCT03129880|Voice disorder|voice disorder
1005092|NCT03129880|Hoarseness|hoarseness
1005093|NCT03129880|Phonation Disorders|phonation disorders
1005094|NCT03129880|Speech Disorders|speech disorders
1005095|NCT03129854|prostate cancer|prostate cancer
1005096|NCT03129854|metastatic|metastatic
1005097|NCT03129854|cryotherapy|cryotherapy
1005098|NCT03129854|ADT|adt
1005099|NCT03129841|weight loss|weight loss
1005100|NCT03129841|dietary pattern|dietary pattern
1005101|NCT03129841|late dinner|late dinner
1005102|NCT03129841|early dinner|early dinner
1005103|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1005104|NCT03129828|Ibrutinib|ibrutinib
1005105|NCT03129828|Bortezomib|bortezomib
1005106|NCT03129815|extubation|extubation
1005107|NCT03129815|pediatric resuscitation|pediatric resuscitation
1005108|NCT03129815|reintubation|reintubation
1005109|NCT03129815|failures of extubation.|failures of extubation.
1005110|NCT03129802|extubation|extubation
1005111|NCT03129802|pediatric resuscitation|pediatric resuscitation
1005112|NCT03129802|reintubation|reintubation
1005113|NCT03129802|failures of extubation.|failures of extubation.
1005114|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
1005115|NCT03129763|SPY-ICG Angiography|spy-icg angiography
1005116|NCT03129763|Tissue Expander|tissue expander
1005117|NCT03129763|Capsule Pressure|capsule pressure
1005118|NCT03129763|Blood Supply|blood supply
1005119|NCT03129724|Kidney Neoplasms|kidney neoplasms
1005120|NCT03129724|Kidney|kidney
1005121|NCT03129724|Neoplasms|neoplasms
1005122|NCT03129724|TKI|tki
1005123|NCT03129724|Axitinib|axitinib
1005124|NCT03129724|VEGF|vegf
1005125|NCT03129724|mTORi|mtori
1005126|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
1005127|NCT03129685|Devascularization|devascularization
1005128|NCT03129672|allograft|allograft
1005129|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
1005130|NCT03129659|Coronary CT Angiography|coronary ct angiography
1005131|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
1005132|NCT03129659|Diagnosis|diagnosis
1005133|NCT03129620|Ampicillin|ampicillin
1005134|NCT03129607|POPF|popf
1005135|NCT03129607|Classification system|classification system
1005136|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
1005137|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
1005138|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
1005139|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
1005140|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
1005141|NCT03129516|imaginary|imaginary
1005142|NCT03129516|Turkish version|turkish version
1005143|NCT03129516|motor imagery|motor imagery
1005144|NCT03129516|reliability|reliability
1005145|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1005146|NCT03129490|Atrial Fibrillation|atrial fibrillation
1005147|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
1005148|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
1005149|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
1005150|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
1005151|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
1005152|NCT03129477|Noninvasive ventilation|noninvasive ventilation
1005153|NCT03129477|Tele-monitoring|tele-monitoring
1005154|NCT03129438|continuous EEG|continuous eeg
1005155|NCT03129438|routine EEG|routine eeg
1005156|NCT03129438|prognosis|prognosis
1005157|NCT03129425|Patient|patient
1005158|NCT03129425|Caregiver|caregiver
1005159|NCT03129425|Coping|coping
1005160|NCT03129425|Psychosocial adaptation|psychosocial adaptation
1005161|NCT03129399|anesthesia|anesthesia
1005162|NCT03129399|King Vision|king vision
1005163|NCT03129399|videolaryngoscope|videolaryngoscope
1005164|NCT03129399|nasotracheal|nasotracheal
1005165|NCT03129360|Early Psychosis|early psychosis
1005166|NCT03129360|Levetiracetam|levetiracetam
1005167|NCT03129308|HIV|hiv
1005168|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
1005169|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
1005170|NCT03129269|Cognitive decline|cognitive decline
1005171|NCT03129269|frailty|frailty
1005172|NCT03129269|mild cognitive impairment|mild cognitive impairment
1005173|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
1005174|NCT03129269|Alzheimer disease|alzheimer disease
1005175|NCT03129269|amyloid load|amyloid load
1568414|NCT00505934|Keppra®|keppra®
1005176|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
1005177|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
1005178|NCT03129256|Apatinib|apatinib
1005179|NCT03129256|S1|s1
1005180|NCT03129217|Diaphragm function|diaphragm function
1005181|NCT03129217|Acute respiratory failure|acute respiratory failure
1005182|NCT03129217|Weaning|weaning
1005183|NCT03129204|intensive care unit|intensive care unit
1005184|NCT03129204|critical care|critical care
1005185|NCT03129204|family|family
1005186|NCT03129204|caregiver|caregiver
1005187|NCT03129204|actigraphy|actigraphy
1005188|NCT03129178|Nitrate|nitrate
1005189|NCT03129178|Nitric oxide|nitric oxide
1005190|NCT03129178|Microvascular|microvascular
1005191|NCT03129165|Cardiovascular diseases|cardiovascular diseases
1005192|NCT03129165|Public Health|public health
1005193|NCT03129165|Hypertension|hypertension
1005194|NCT03129165|Smoking|smoking
1005195|NCT03129165|Hypercholesterolemia|hypercholesterolemia
1005196|NCT03129165|Food Habits|food habits
1005197|NCT03129165|Exercise|exercise
1005198|NCT03129165|Anxiety|anxiety
1005199|NCT03129165|Depression|depression
1005200|NCT03129165|Obesity|obesity
1005201|NCT03129165|Diabetes|diabetes
1005202|NCT03129139|Metastatic|metastatic
1005203|NCT03128996|Bone marrow transplant|bone marrow transplant
1005204|NCT03128996|Transplant|transplant
1005205|NCT03128996|Transplantation|transplantation
1005206|NCT03128996|Reduced Intensity|reduced intensity
1005207|NCT03128996|Familial HLA mismatched|familial hla mismatched
1005208|NCT03128905|Colchicine|colchicine
1005209|NCT03128905|Corticoids|corticoids
1005210|NCT03128905|Prednisone|prednisone
1005211|NCT03128905|CPPD|cppd
1005212|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
1005213|NCT03128879|Primary lymphoid haematopoietic neoplasms|primary lymphoid haematopoietic neoplasms
1005214|NCT03128879|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1005215|NCT03128879|CLL|cll
1005216|NCT03128879|Small lymphocytic lymphoma|small lymphocytic lymphoma
1005217|NCT03128879|SLL|sll
1005218|NCT03128879|High risk|high risk
1005219|NCT03128879|Venetoclax|venetoclax
1005220|NCT03128879|ABT-199|abt-199
1005221|NCT03128879|GDC-0199|gdc-0199
1005222|NCT03128879|Ibrutinib|ibrutinib
1005223|NCT03128879|PCI-32765|pci-32765
1005224|NCT03128879|Imbruvica|imbruvica
1005225|NCT03128879|Allopurinol|allopurinol
1005226|NCT03128879|Lopurin|lopurin
1005227|NCT03128879|Zurinol|zurinol
1005228|NCT03128879|Zyloprim|zyloprim
1005229|NCT03128866|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
1005230|NCT03128866|Pelvic Tumor|pelvic tumor
1005231|NCT03128866|Tranexamic acid|tranexamic acid
1005232|NCT03128814|Tennis|tennis
1005233|NCT03128814|Asymmetry|asymmetry
1005234|NCT03128814|Structural|structural
1005235|NCT03128814|Functional|functional
1005236|NCT03128801|Low Back Pain|low back pain
1005237|NCT03128801|Back Pain|back pain
1005238|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
1005239|NCT03128801|Stabilization Exercise|stabilization exercise
1005240|NCT03128801|Exercise Therapy|exercise therapy
1005241|NCT03128801|Exercise Movement|exercise movement
1005242|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
1005243|NCT03128801|Pain|pain
1005244|NCT03128801|Disability|disability
1005245|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
1005246|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1005247|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
1005248|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1005249|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1005250|NCT03128749|Neuropsychology|neuropsychology
1005251|NCT03128749|Childhood Maltreatment|childhood maltreatment
1005252|NCT03128723|Acne|acne
1005253|NCT03128710|Survey|survey
1005254|NCT03128710|Focus Group|focus group
1005255|NCT03128710|Treatment Preferences|treatment preferences
1005256|NCT03128697|Obesity|obesity
1005257|NCT03128697|Satiety quotient|satiety quotient
1005258|NCT03128697|Appetite control|appetite control
1005259|NCT03128697|Weight loss|weight loss
1005260|NCT03128697|Satiety phenotype|satiety phenotype
1005261|NCT03128697|Functional food|functional food
1005262|NCT03128684|lentils|lentils
1005263|NCT03128684|satiety|satiety
1005264|NCT03128684|appetite|appetite
1005265|NCT03128684|food intake|food intake
1005266|NCT03128684|24-hour energy intake|24-hour energy intake
1005267|NCT03128671|intensive care unit|intensive care unit
1005268|NCT03128671|critical care|critical care
1005269|NCT03128671|mechanical ventilation|mechanical ventilation
1005270|NCT03128671|confusion|confusion
1005271|NCT03128671|polysomnography|polysomnography
1005272|NCT03128671|delirium|delirium
1005273|NCT03128671|adult|adult
1005274|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
1005275|NCT03128554|Not Ready to Quit|not ready to quit
1005276|NCT03128554|Primary Care|primary care
1005277|NCT03128554|Tobacco|tobacco
1005278|NCT03128554|Reduce to Quit|reduce to quit
1005279|NCT03128554|Smoking Reduction|smoking reduction
1005280|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
1005281|NCT03128515|Hydroxyurea|hydroxyurea
1005282|NCT03128502|saliva|saliva
1005283|NCT03128502|GCF|gcf
1005284|NCT03128502|pentraxin-3|pentraxin-3
1005285|NCT03128489|Safety|safety
1005286|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
1005287|NCT03128489|Immunogenicity|immunogenicity
1005288|NCT03128489|Indian infants|indian infants
1005289|NCT03128489|Combined vaccine|combined vaccine
1005290|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
1005291|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1005292|NCT03128463|Pathological Myopia|pathological myopia
1005293|NCT03128463|Conbercept|conbercept
1005294|NCT03128450|Parkinson Disease|parkinson disease
1005295|NCT03128450|Neural stem cell|neural stem cell
1005296|NCT03128450|Nasal delivery|nasal delivery
1005297|NCT03128437|Anxiety|anxiety
1005298|NCT03128437|Young Adults|young adults
1005299|NCT03128437|Health Behaviors|health behaviors
1005300|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
1005301|NCT03128398|Gastroparesis|gastroparesis
1005302|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
1005303|NCT03128385|Neurological rehabilitation|neurological rehabilitation
1005304|NCT03128385|Upper extremity|upper extremity
1005305|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
1005306|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1005307|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
1005308|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
1005309|NCT03128281|AIS|ais
1005409|NCT03127800|Analgesia|analgesia
1005310|NCT03128281|Conventional Insufflation System|conventional insufflation system
1005311|NCT03128281|CIS|cis
1005312|NCT03128281|Questionnaires|questionnaires
1005313|NCT03128281|Surveys|surveys
1005314|NCT03128255|Fusion|fusion
1005315|NCT03128255|Hybrid Imaging|hybrid imaging
1005316|NCT03128255|Mapping|mapping
1005317|NCT03128255|Iodine|iodine
1005318|NCT03128255|Ultrasound|ultrasound
1005319|NCT03128242|oxytocin|oxytocin
1005320|NCT03128242|attention bias|attention bias
1005321|NCT03128242|attention training|attention training
1005322|NCT03128242|eye-tracking|eye-tracking
1005323|NCT03128203|Oxytocin|oxytocin
1005324|NCT03128203|Resting-state|resting-state
1005325|NCT03128203|Functional connectivity|functional connectivity
1005326|NCT03128203|BOLD|bold
1005327|NCT03128190|high-risk surgery|high-risk surgery
1005328|NCT03128190|pulse-pressure variation|pulse-pressure variation
1005329|NCT03128190|monitoring|monitoring
1005330|NCT03128190|Postoperative Complications|postoperative complications
1005331|NCT03128177|nocturnal hypertension|nocturnal hypertension
1005332|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
1005333|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
1005334|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
1005335|NCT03128151|Anesthesia|anesthesia
1005336|NCT03128151|Curarization|curarization
1005337|NCT03128151|TOFr (train of four)|tofr (train of four)
1005338|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
1005339|NCT03128151|Monitorization|monitorization
1005340|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
1005341|NCT03128099|Social Skills|social skills
1005342|NCT03128099|Social attention|social attention
1005343|NCT03128099|Virtual reality|virtual reality
1005344|NCT03128099|Eye tracking|eye tracking
1005345|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
1005346|NCT03128047|pediatric cancer|pediatric cancer
1005347|NCT03128047|brain tumor|brain tumor
1005348|NCT03128047|glioblastoma|glioblastoma
1005349|NCT03128047|high grade brain tumor|high grade brain tumor
1005350|NCT03128047|malignant brain tumor|malignant brain tumor
1005351|NCT03128021|Depression|depression
1005352|NCT03128021|fMRI|fmri
1005353|NCT03128021|Escitalopram|escitalopram
1005354|NCT03128021|Lexapro|lexapro
1005355|NCT03128021|Randomized Clinical Trial|randomized clinical trial
1005356|NCT03128021|Levomilnacipran|levomilnacipran
1005357|NCT03128021|Fetzima|fetzima
1005358|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
1005359|NCT03127995|Lymph Node Irradiation|lymph node irradiation
1005360|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
1005361|NCT03127969|Rheumatoid hand|rheumatoid hand
1005362|NCT03127969|Fluidotherapy|fluidotherapy
1005363|NCT03127969|Rehabilitation|rehabilitation
1005364|NCT03127943|lidocaine, mandible|lidocaine, mandible
1005365|NCT03127930|Cognitive Impairment|cognitive impairment
1005366|NCT03127930|Memory loss|memory loss
1005367|NCT03127930|Caregivers|caregivers
1005368|NCT03127930|Medication adherence|medication adherence
1005369|NCT03127930|Medication compliance|medication compliance
1005370|NCT03127930|Medication management|medication management
1005371|NCT03127930|Problem solving|problem solving
1005372|NCT03127930|Quality of Life|quality of life
1005373|NCT03127930|Health resource utilization|health resource utilization
1028841|NCT02982538|PTSD|ptsd
1005374|NCT03127930|Community dwelling|community dwelling
1005375|NCT03127917|Gait Speed|gait speed
1005376|NCT03127917|Cognitive Function|cognitive function
1005377|NCT03127904|Varicose ulcer|varicose ulcer
1005378|NCT03127904|Compressive therapy|compressive therapy
1005379|NCT03127904|Venous ulcer|venous ulcer
1005380|NCT03127904|Chronic venous disease|chronic venous disease
1005381|NCT03127891|pranayama yoga|pranayama yoga
1005382|NCT03127878|Exercise|exercise
1005383|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1005384|NCT03127878|Activities of Daily Living|activities of daily living
1005385|NCT03127878|Upper Extremity|upper extremity
1005386|NCT03127878|Motor Activity|motor activity
1005387|NCT03127839|Exercise|exercise
1005388|NCT03127839|Pain Neuroscience Education|pain neuroscience education
1005389|NCT03127839|Physical Therapy|physical therapy
1005390|NCT03127839|Subacromial Pain|subacromial pain
1005391|NCT03127839|Rotator Cuff|rotator cuff
1005392|NCT03127826|Low Back Pain|low back pain
1005393|NCT03127826|Risk-Stratified Care|risk-stratified care
1005394|NCT03127813|glaucoma|glaucoma
1005395|NCT03127813|OSA|osa
1005396|NCT03127813|apnoea|apnoea
1005397|NCT03127813|intraocular|intraocular
1005398|NCT03127813|CPAP|cpap
1005399|NCT03127813|airway|airway
1005400|NCT03127813|pressure|pressure
1005401|NCT03127813|blindness|blindness
1005402|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
1005403|NCT03127800|Morphine sulphate|morphine sulphate
1005404|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
1005405|NCT03127800|Central Sleep Apnoea|central sleep apnoea
1005406|NCT03127800|Hypoxaemia|hypoxaemia
1005407|NCT03127800|Hypercapnia|hypercapnia
1005408|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
1005411|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
1005412|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
1005413|NCT03127800|Oximetry|oximetry
1005414|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
1005415|NCT03127800|Polysomnography|polysomnography
1005416|NCT03127774|Cisplatin|cisplatin
1005417|NCT03127774|Heated Cisplatin|heated cisplatin
1005418|NCT03127761|Multiple Myeloma|multiple myeloma
1005419|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
1005420|NCT03127735|Phase 1|phase 1
1005421|NCT03127735|mIDH1|midh1
1005422|NCT03127735|IDH1 mutation|idh1 mutation
1005423|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
1005424|NCT03127709|17-199|17-199
1005425|NCT03127709|histiocytosis|histiocytosis
1005426|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
1005427|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
1005428|NCT03127553|salt intake|salt intake
1005429|NCT03127553|functional food|functional food
1005430|NCT03127553|low-salt bread|low-salt bread
1005431|NCT03127553|blood pressure|blood pressure
1005432|NCT03127514|Randomized|randomized
1005433|NCT03127514|Double-blind|double-blind
1005434|NCT03127514|Placebo-controlled|placebo-controlled
1005435|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1005436|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
1005437|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
1005438|NCT03127475|Parkinson's disease|parkinson's disease
1005439|NCT03127475|freezing of gait|freezing of gait
1005440|NCT03127475|electrophysiology|electrophysiology
1005441|NCT03127475|magnetic resonance image|magnetic resonance image
1005442|NCT03127475|direct current stimulation|direct current stimulation
1005443|NCT03127423|Hybrid ablation|hybrid ablation
1005444|NCT03127423|Thoracoscope|thoracoscope
1005445|NCT03127397|antiretroviral therapy|antiretroviral therapy
1005446|NCT03127397|HIV/AIDS|hiv/aids
1005447|NCT03127397|ART adherence|art adherence
1005448|NCT03127371|Nitrous Oxide|nitrous oxide
1005449|NCT03127371|Abscess|abscess
1005450|NCT03127371|Incision and drainage|incision and drainage
1005451|NCT03127358|Addiction|addiction
1005452|NCT03127358|Sustained Viral Response|sustained viral response
1005453|NCT03127358|Adherence|adherence
1005454|NCT03127358|Adverse Effects|adverse effects
1005455|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
1005456|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
1005457|NCT03127358|Resistance Development|resistance development
1005458|NCT03127358|Methadone Clinic|methadone clinic
1005459|NCT03127358|Primary Care|primary care
1005460|NCT03127358|Directly Observed Therapy|directly observed therapy
1005461|NCT03127358|Randomized Controlled Trial|randomized controlled trial
1005462|NCT03127358|Resistance|resistance
1005463|NCT03127358|Reinfection|reinfection
1005464|NCT03127358|Treatment Outcome|treatment outcome
1005465|NCT03127358|Patient Navigation|patient navigation
1005466|NCT03127358|Multi-Site|multi-site
1005467|NCT03127358|Liver Disease|liver disease
1005468|NCT03127358|Intervention|intervention
1005469|NCT03127332|Treatment care planning|treatment care planning
1005470|NCT03127306|Pain|pain
1568415|NCT00505934|Infusion|infusion
1005471|NCT03127306|Behavioural Pain Scale|behavioural pain scale
1005472|NCT03127306|BPS|bps
1005473|NCT03127306|NRS|nrs
1005474|NCT03127306|Delirium|delirium
1005475|NCT03127306|CAM-ICU|cam-icu
1005476|NCT03127280|urinary tract infections|urinary tract infections
1005477|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
1005478|NCT03127280|foley removal|foley removal
1005479|NCT03127280|patient satisfaction|patient satisfaction
1005480|NCT03127254|Video Narrative|video narrative
1005481|NCT03127241|Assistive devices|assistive devices
1005482|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
1005483|NCT03127241|Upper limbs|upper limbs
1005484|NCT03127241|Robotic devices|robotic devices
1005485|NCT03127228|Laser|laser
1005486|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1005487|NCT03127150|Chylous leakage|chylous leakage
1005488|NCT03127150|Diagnostic criteria|diagnostic criteria
1005489|NCT03127150|Pancreas surgery|pancreas surgery
1005490|NCT03127150|Therapy|therapy
1005491|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
1005492|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
1005493|NCT03127098|CEA|cea
1005494|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
1005495|NCT03127072|colorectal cancer|colorectal cancer
1005496|NCT03127072|liver metastasis|liver metastasis
1005497|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
1005498|NCT03127072|chemotherapy|chemotherapy
1005499|NCT03127072|target therapy|target therapy
1005500|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
1005501|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
1005502|NCT03127059|Breathing Exercises|breathing exercises
1005503|NCT03127059|Adults|adults
1005504|NCT03127007|immunotherapy|immunotherapy
1005505|NCT03127007|anti-PD-L1|anti-pd-l1
1005506|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
1005507|NCT03126942|Aged patients|aged patients
1005508|NCT03126942|Cost Estimates|cost estimates
1005509|NCT03126942|Complete Denture|complete denture
1005510|NCT03126942|Dental Economics|dental economics
1005511|NCT03126942|Dental Implants|dental implants
1005512|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
1005513|NCT03126942|Denture Retention|denture retention
1005514|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1005515|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
1005516|NCT03126942|Overdenture|overdenture
1005517|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
1005518|NCT03126942|Quality of Healthcare|quality of healthcare
1005519|NCT03126942|Quality of Life|quality of life
1005520|NCT03126942|Patient Satisfaction|patient satisfaction
1005521|NCT03126942|Single implant overdenture|single implant overdenture
1005522|NCT03126929|disorders of consciousness|disorders of consciousness
1005523|NCT03126929|Vegetative state|vegetative state
1005524|NCT03126929|Minimally conscious state|minimally conscious state
1005525|NCT03126929|Emergence from MCS|emergence from mcs
1005526|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
1005527|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
1005528|NCT03126890|Linezolid|linezolid
1005529|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
1005530|NCT03126890|Myelosuppression|myelosuppression
1005531|NCT03126890|Lactic acidosis|lactic acidosis
1005532|NCT03126890|Peripheral neuropathy|peripheral neuropathy
1005533|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1005534|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
1005535|NCT03126864|AML|aml
1005536|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
1005537|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
1005538|NCT03126864|Fludarabine|fludarabine
1005539|NCT03126864|Fludarabine phosphate|fludarabine phosphate
1005540|NCT03126864|Fludara|fludara
1005541|NCT03126864|Cyclophosphamide|cyclophosphamide
1005542|NCT03126864|Cytoxan|cytoxan
1005543|NCT03126864|Neosar|neosar
1005544|NCT03126838|diaphragm|diaphragm
1005545|NCT03126838|ultrasound|ultrasound
1005546|NCT03126838|dysfunction|dysfunction
1005547|NCT03126838|cardiac surgery|cardiac surgery
1005548|NCT03126838|weaning|weaning
1005549|NCT03126812|Primary stage 4|primary stage 4
1005550|NCT03126812|Neo adjuvant|neo adjuvant
1005551|NCT03126786|Diabetes Mellitus|diabetes mellitus
1005552|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
1005553|NCT03126786|Microneedle|microneedle
1005554|NCT03126786|Mircoinjection|mircoinjection
1005555|NCT03126786|Triamcinolone|triamcinolone
1005557|NCT03126786|Choroid Injection|choroid injection
1005558|NCT03126786|Aflibercept|aflibercept
1005559|NCT03126786|Suprachoroidal|suprachoroidal
1005560|NCT03126773|non-interventional|non-interventional
1005561|NCT03126773|cohort|cohort
1005562|NCT03126773|Angeliq Micro|angeliq micro
1005563|NCT03126773|menopause|menopause
1005564|NCT03126773|Russia|russia
1005565|NCT03126734|Down Syndrome|down syndrome
1005566|NCT03126734|Acceptance|acceptance
1005567|NCT03126734|Commitment|commitment
1005568|NCT03126734|Concience of influence|concience of influence
1005569|NCT03126721|drug interaction|drug interaction
1005570|NCT03126721|PF-06751979|pf-06751979
1005571|NCT03126721|oral midazolam|oral midazolam
1005572|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
1005573|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
1005574|NCT03126695|Acute coronary syndrome|acute coronary syndrome
1005575|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
1005576|NCT03126695|Brilinta|brilinta
1005577|NCT03126682|Wellbutrin|wellbutrin
1005578|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
1005579|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
1005580|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
1005581|NCT03126669|multitasking performance|multitasking performance
1005582|NCT03126669|cognitive funcitons|cognitive funcitons
1005583|NCT03126656|testosterone|testosterone
1005584|NCT03126656|chronic heart failure|chronic heart failure
1005585|NCT03126552|hookworm|hookworm
1005586|NCT03126552|controlled human infection model|controlled human infection model
1005588|NCT03126539|ultraviolet exposure|ultraviolet exposure
1005589|NCT03126539|skin fragility|skin fragility
1005590|NCT03126539|sulforaphane|sulforaphane
1005591|NCT03126513|G-POEM|g-poem
1005592|NCT03126513|Safety|safety
1005593|NCT03126513|Efficacy|efficacy
1005594|NCT03126500|Malnutrition|malnutrition
1005595|NCT03126500|Disease-related malnutrition|disease-related malnutrition
1005596|NCT03126500|Frailty|frailty
1005597|NCT03126500|Sarcopenia|sarcopenia
1005598|NCT03126500|Hospital discharge|hospital discharge
1005599|NCT03126500|Geriatrics|geriatrics
1005600|NCT03126461|metastatic melanoma|metastatic melanoma
1005601|NCT03126448|Infection|infection
1005602|NCT03126448|Nonunion|nonunion
1005603|NCT03126448|Fracture healing|fracture healing
1005604|NCT03126435|FOLFIRINOX|folfirinox
1005605|NCT03126435|5-Fluorouracil|5-fluorouracil
1005606|NCT03126435|folinic acid|folinic acid
1005607|NCT03126435|irinotecan|irinotecan
1005608|NCT03126435|oxaliplatin|oxaliplatin
1005610|NCT03126409|coronary artery disease|coronary artery disease
1005611|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
1005612|NCT03126344|King Vision|king vision
1005613|NCT03126331|Kidney Cancer|kidney cancer
1005614|NCT03126331|Metastatic|metastatic
1005615|NCT03126331|Nivolumab|nivolumab
1005616|NCT03126305|exposure|exposure
1005617|NCT03126305|response prevention|response prevention
1005618|NCT03126305|web-based application|web-based application
1005619|NCT03126292|Medical home|medical home
1005620|NCT03126292|Primary care|primary care
1005621|NCT03126292|Children|children
1005622|NCT03126292|Development|development
1005623|NCT03126279|Osteoarthritis|osteoarthritis
1005625|NCT03126279|Postoperative Pain|postoperative pain
1005626|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
1005627|NCT03126227|AR101|ar101
1005628|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
1005629|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
1005630|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
1005631|NCT03126227|Peanut Allergy|peanut allergy
1005632|NCT03126227|Peanut-Allergic Children|peanut-allergic children
1005633|NCT03126227|Desensitization|desensitization
1005634|NCT03126227|ARC007|arc007
1005635|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
1005636|NCT03126214|atrial fibrillation|atrial fibrillation
1005637|NCT03126214|stroke|stroke
1005638|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
1005639|NCT03126214|pharmacist case management|pharmacist case management
1005640|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1005641|NCT03126201|disease progression|disease progression
1005642|NCT03126175|conservative treatment, treatment outcome|conservative treatment, treatment outcome
1005643|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
1005644|NCT03126162|same-day discharge|same-day discharge
1005645|NCT03126162|bladder testing|bladder testing
1005646|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
1005647|NCT03126136|Pregnancy|pregnancy
1005648|NCT03126136|Epidural analgesia|epidural analgesia
1005649|NCT03126136|Pulse pressure|pulse pressure
1005650|NCT03126123|Anal condylomatosis|anal condylomatosis
1005651|NCT03126123|surgery|surgery
1005653|NCT03126123|dysplastic areas|dysplastic areas
1005654|NCT03126110|cervical cancer|cervical cancer
1005655|NCT03126110|endometrial cancer|endometrial cancer
1005656|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
1005657|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1005658|NCT03126110|melanoma|melanoma
1005659|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
1005660|NCT03126110|mesothelioma|mesothelioma
1005661|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
1005662|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1005663|NCT03126110|ovarian cancer|ovarian cancer
1005664|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
1005665|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1005666|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
1005667|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
1005668|NCT03126110|urothelial carcinoma|urothelial carcinoma
1005669|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
1005670|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
1005671|NCT03126058|colorectal cancer|colorectal cancer
1005672|NCT03126045|Lumbar puncture|lumbar puncture
1005673|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
1005674|NCT03126045|Atraumatic needle|atraumatic needle
1005675|NCT03126045|Haematology|haematology
1005676|NCT03126032|Sepsis|sepsis
1005677|NCT03126032|SIRS|sirs
1005678|NCT03126032|Glycocalyx|glycocalyx
1005679|NCT03126032|Glycocheck™-System|glycocheck™-system
1005680|NCT03126032|Infection|infection
1005681|NCT03126019|Follicular lymphoma|follicular lymphoma
1005682|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1005683|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
1005684|NCT03125993|obesity; brisk walking|obesity; brisk walking
1005685|NCT03125928|Atezolizumab|atezolizumab
1005686|NCT03125928|PD-L1|pd-l1
1005687|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
1005688|NCT03125889|Image-guided|image-guided
1005689|NCT03125889|BPH|bph
1005690|NCT03125889|Aquablation|aquablation
1005691|NCT03125889|AQUABEAM|aquabeam
1005692|NCT03125889|LUTS|luts
1005693|NCT03125889|Tissue resection|tissue resection
1005694|NCT03125889|Robotics|robotics
1005695|NCT03125863|Image-guided|image-guided
1005696|NCT03125863|BPH|bph
1005697|NCT03125863|Aquablation|aquablation
1005698|NCT03125863|AQUABEAM|aquabeam
1005699|NCT03125863|LUTS|luts
1005700|NCT03125863|Tissue resection|tissue resection
1005701|NCT03125863|Robotics|robotics
1005702|NCT03125850|day-ward|day-ward
1005704|NCT03125811|Isopropyl alcohol|isopropyl alcohol
1005705|NCT03125811|Zofran|zofran
1005706|NCT03125811|antiemetics|antiemetics
1005707|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
1005708|NCT03125798|LigaSure|ligasure
1005709|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
1005710|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
1005711|NCT03125772|coronary artery disease|coronary artery disease
1005712|NCT03125772|diabetes mellitus|diabetes mellitus
1005713|NCT03125772|everolimus|everolimus
1005714|NCT03125772|paclitaxel stents|paclitaxel stents
1005715|NCT03125759|Ischemic Stroke|ischemic stroke
1005716|NCT03125759|Omentin|omentin
1005717|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
1005718|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
1005719|NCT03125733|Therapeutic|therapeutic
1005720|NCT03125733|Complications|complications
1005721|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
1005722|NCT03125720|chronic heart failure|chronic heart failure
1005723|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
1005724|NCT03125720|SPECT|spect
1005725|NCT03125720|venogram|venogram
1005726|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
1005727|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
1005728|NCT03125655|cytokines|cytokines
1005729|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1005730|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
1005731|NCT03125642|Follicular Lymphoma|follicular lymphoma
1005732|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1005733|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
1005734|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
1005735|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
1005736|NCT03125616|Prematurity|prematurity
1005737|NCT03125616|Vaccination|vaccination
1005738|NCT03125603|Immunotherapy|immunotherapy
1005739|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
1005740|NCT03125603|Anti-CTLA-4|anti-ctla-4
1005741|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
1005742|NCT03125577|4S CAR-T|4s car-t
1005743|NCT03125577|CD19|cd19
1005744|NCT03125577|CD20|cd20
1005745|NCT03125577|CD22|cd22
1005746|NCT03125577|CD38|cd38
1005747|NCT03125577|CD123|cd123
1005748|NCT03125577|B cell leukemia|b cell leukemia
1005749|NCT03125577|B-ALL|b-all
1005750|NCT03125577|CD70|cd70
1005751|NCT03125551|Dietary supplements|dietary supplements
1005752|NCT03125551|Bleeding tendency|bleeding tendency
1005753|NCT03125538|Motor Imagery|motor imagery
1005754|NCT03125538|Amputation|amputation
1005755|NCT03125538|Functional rehabilitation|functional rehabilitation
1005756|NCT03125538|Locomotion|locomotion
1005757|NCT03125538|Phantom-limb pain|phantom-limb pain
1005758|NCT03125525|migraine|migraine
1005759|NCT03125525|transcutaneous|transcutaneous
1005760|NCT03125525|supraorbital|supraorbital
1005761|NCT03125525|nerve|nerve
1005762|NCT03125525|stimulation|stimulation
1005763|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
1005764|NCT03125512|Positional sleep apnea|positional sleep apnea
1005765|NCT03125512|CPAP|cpap
1005766|NCT03125512|Night Shift|night shift
1005767|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
1005768|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
1005770|NCT03125486|GSK1550188|gsk1550188
1005771|NCT03125447|Prematurely born children|prematurely born children
1005772|NCT03125447|Attention function|attention function
1005773|NCT03125447|Posture|posture
1005774|NCT03125447|Mobility|mobility
1005775|NCT03125356|diet soda|diet soda
1005776|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
1005777|NCT03125356|obesity|obesity
1005778|NCT03125343|radiotherapy|radiotherapy
1005779|NCT03125343|chemotherapy|chemotherapy
1005780|NCT03125343|complete response|complete response
1005781|NCT03125330|Coaching|coaching
1005782|NCT03125330|Professional coaching|professional coaching
1005783|NCT03125330|Emergency physicians|emergency physicians
1005784|NCT03125330|Emergency medicine|emergency medicine
1005785|NCT03125330|Goal attainment|goal attainment
1005786|NCT03125330|Leadership strengths|leadership strengths
1005787|NCT03125330|Well-being|well-being
1005788|NCT03125330|Burnout|burnout
1005789|NCT03125330|Adult level of development|adult level of development
1005790|NCT03125330|Group coaching|group coaching
1005791|NCT03125330|Instructor|instructor
1005792|NCT03125330|Assistant professor|assistant professor
1005793|NCT03125330|Academic faculty|academic faculty
1005794|NCT03125330|Subject-Object Interview|subject-object interview
1005795|NCT03125304|Endometriosis|endometriosis
1005796|NCT03125304|acupuncture|acupuncture
1005797|NCT03125304|pain|pain
1005798|NCT03125304|dysmenorrhea|dysmenorrhea
1005799|NCT03125291|Substance Use and Abuse|substance use and abuse
1005800|NCT03125291|Risky Sexual Behavior|risky sexual behavior
1005801|NCT03125291|Behavior Problems|behavior problems
1005802|NCT03125291|Academic Achievement|academic achievement
1005804|NCT03125265|hemodialysis|hemodialysis
1005805|NCT03125265|mortality|mortality
1005806|NCT03125265|omega 3|omega 3
1005807|NCT03125252|Delirium|delirium
1005808|NCT03125252|Reanimation|reanimation
1005809|NCT03125252|Conversational hypnosis|conversational hypnosis
1005810|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
1005811|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
1005812|NCT03125187|Sodium Heparin|sodium heparin
1005813|NCT03125187|Intravenous administration|intravenous administration
1005814|NCT03125187|Pharmacokinetics|pharmacokinetics
1005815|NCT03125187|Coagulation factor|coagulation factor
1005816|NCT03125174|sputum|sputum
1005817|NCT03125174|bronchiectasis|bronchiectasis
1005818|NCT03125174|lung disease|lung disease
1005819|NCT03125161|colorectal cancer|colorectal cancer
1005820|NCT03125161|liver metastasis|liver metastasis
1005821|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
1005822|NCT03125161|chemotherapy|chemotherapy
1005823|NCT03125161|target therapy|target therapy
1005824|NCT03125161|conversional resection rates|conversional resection rates
1005825|NCT03125083|Skin restricted lupus|skin restricted lupus
1005826|NCT03125083|Psychiatric disorders|psychiatric disorders
1005827|NCT03125083|Inflammation|inflammation
1005828|NCT03125083|Kynurenine pathway|kynurenine pathway
1005829|NCT03124667|adherence|adherence
1005830|NCT03124667|cognition|cognition
1005831|NCT03124667|exercise|exercise
1005832|NCT03124667|aging|aging
1005833|NCT03124667|brain training|brain training
1005834|NCT03124667|cognitive training|cognitive training
1005835|NCT03124667|executive function|executive function
1005836|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
1005837|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
1005838|NCT03124641|Extended criteria donation|extended criteria donation
1005839|NCT03124641|Donation after brain death|donation after brain death
1005840|NCT03124641|HOPE|hope
1005841|NCT03124563|Exercise|exercise
1005842|NCT03124563|Health Behavior|health behavior
1005843|NCT03124563|Aging|aging
1005844|NCT03124550|Caregivers|caregivers
1005845|NCT03124550|Exercise|exercise
1005846|NCT03124550|Behavior Change|behavior change
1005847|NCT03124537|Physical Exercise|physical exercise
1005848|NCT03124537|Behavior Change|behavior change
1005849|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
1005850|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
1005851|NCT03124524|pelvic pain|pelvic pain
1005852|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
1005853|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
1568416|NCT00505934|Intravenous|intravenous
1005854|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
1005855|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
1005856|NCT03124446|mindfulness|mindfulness
1005857|NCT03124433|prostate cancer|prostate cancer
1005858|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
1005859|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
1005860|NCT03124420|Helicobacter Infection|helicobacter infection
1005861|NCT03124420|Eradication therapy|eradication therapy
1005862|NCT03124420|Antibiotics|antibiotics
1005863|NCT03124355|vagal stimulation|vagal stimulation
1005864|NCT03124355|POTS|pots
1005865|NCT03124355|galantamine|galantamine
1005866|NCT03124355|pyridostigmine|pyridostigmine
1005867|NCT03124238|massage|massage
1005868|NCT03124212|mutation carrier|mutation carrier
1005869|NCT03124212|blood relative|blood relative
1005870|NCT03124212|genetic testing|genetic testing
1005871|NCT03124212|family-based cohort|family-based cohort
1005872|NCT03124199|Eradication|eradication
1005873|NCT03124199|Helicobacter pylori|helicobacter pylori
1005874|NCT03124199|rifaximin|rifaximin
1005875|NCT03124199|therapy|therapy
1005876|NCT03124199|standard triple therapy|standard triple therapy
1005877|NCT03124186|motor recovery|motor recovery
1005878|NCT03124186|neuroplasticity|neuroplasticity
1005879|NCT03124186|subacute|subacute
1005880|NCT03124186|human|human
1005881|NCT03124186|sensory|sensory
1005882|NCT03124186|nerve stimulation|nerve stimulation
1005883|NCT03124173|fMRI|fmri
1005884|NCT03124173|cingulate cortex|cingulate cortex
1005885|NCT03124173|adaptation|adaptation
1005886|NCT03124173|frontal cortex|frontal cortex
1005887|NCT03124160|Healthy Women|healthy women
1005888|NCT03124160|Female Contraception|female contraception
1005889|NCT03124160|IUD|iud
1005890|NCT03124147|motor recovery|motor recovery
1005891|NCT03124147|neuroplasticity|neuroplasticity
1005892|NCT03124147|chronic|chronic
1005893|NCT03124147|human|human
1005894|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
1005895|NCT03124147|neuromodulation|neuromodulation
1005896|NCT03124108|Elafibranor|elafibranor
1005897|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
1005898|NCT03124108|Alkaline phosphatase|alkaline phosphatase
1005899|NCT03124095|physical exercise|physical exercise
1005900|NCT03124095|combined training|combined training
1005901|NCT03124095|physical activity|physical activity
1005902|NCT03124095|physical fitness|physical fitness
1005903|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
1005904|NCT03124056|Biomarker of response|biomarker of response
1005905|NCT03124056|Steroid resistant|steroid resistant
1005906|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
1005907|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
1005908|NCT03124030|dental extraction|dental extraction
1005909|NCT03124030|bleeding complication|bleeding complication
1005910|NCT03124030|atrial fibrillation|atrial fibrillation
1005911|NCT03124030|deep venous thrombosis|deep venous thrombosis
1005912|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
1005913|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
1005914|NCT03124004|periodontal disease|periodontal disease
1005915|NCT03124004|periodontal debridement|periodontal debridement
1005916|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
1005917|NCT03124004|ultrasonic scaling|ultrasonic scaling
1005918|NCT03124004|periodontal scaling|periodontal scaling
1005919|NCT03124004|subgingival scaling|subgingival scaling
1005920|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
1005921|NCT03123965|Special Access Scheme|special access scheme
1005922|NCT03123965|Expanded Access|expanded access
1005923|NCT03123965|Pre-approval Access|pre-approval access
1005924|NCT03123965|Compassionate Use|compassionate use
1005925|NCT03123965|Special Access Program|special access program
1005926|NCT03123965|Named Patient Basis|named patient basis
1005927|NCT03123952|Expanded Access|expanded access
1005928|NCT03123952|Pre-approval Access|pre-approval access
1005929|NCT03123952|Compassionate Use|compassionate use
1005930|NCT03123952|Special Access Program|special access program
1005931|NCT03123952|Named Patient Basis|named patient basis
1005932|NCT03123952|Special Access Scheme|special access scheme
1005933|NCT03123939|ALL|all
1005934|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
1005935|NCT03123926|lipids|lipids
1005936|NCT03123926|biomarkers|biomarkers
1005937|NCT03123874|human milk|human milk
1005938|NCT03123874|breast milk|breast milk
1005939|NCT03123874|expressed human milk|expressed human milk
1005940|NCT03123874|bacterial communities|bacterial communities
1005941|NCT03123874|microbiome|microbiome
1005942|NCT03123874|breast pump|breast pump
1005943|NCT03123874|bacterial growth|bacterial growth
1005944|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
1005945|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
1005946|NCT03123861|opioid use|opioid use
1005947|NCT03123835|Achalasia|achalasia
1005948|NCT03123835|Fistula|fistula
1005949|NCT03123835|Obesity|obesity
1005950|NCT03123835|POEM|poem
1005951|NCT03123835|GERD|gerd
1005952|NCT03123835|endoscopic|endoscopic
1029562|NCT02978053|Sleep|sleep
1005953|NCT03123835|treatments|treatments
1005954|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
1005955|NCT03123835|endoluminal|endoluminal
1005956|NCT03123835|Bariatric Surgery|bariatric surgery
1005957|NCT03123835|Barretts|barretts
1005958|NCT03123809|Diabetes Mellitus|diabetes mellitus
1005959|NCT03123809|gastroparesis|gastroparesis
1005960|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
1005961|NCT03123809|pyloroplasty|pyloroplasty
1005962|NCT03123809|Idiopathic -unknown etiology|idiopathic -unknown etiology
1005963|NCT03123796|chronic rejection|chronic rejection
1005964|NCT03123796|transplant outcome|transplant outcome
1005965|NCT03123783|CD40|cd40
1005966|NCT03123783|Immunotherapy|immunotherapy
1005967|NCT03123783|Nivolumab|nivolumab
1005968|NCT03123783|APX005M|apx005m
1005969|NCT03123783|PD-1|pd-1
1005970|NCT03123770|Breast cancer|breast cancer
1005971|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1005972|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1005973|NCT03123770|PLD|pld
1005974|NCT03123744|Palbociclib|palbociclib
1005975|NCT03123744|Cyclin Pathway|cyclin pathway
1005976|NCT03123744|kinase inhibitor|kinase inhibitor
1005977|NCT03123731|physical activity|physical activity
1005978|NCT03123731|diet|diet
1005979|NCT03123731|mHealth|mhealth
1005980|NCT03123731|Fitbit|fitbit
1005981|NCT03123731|neurocognition|neurocognition
1005982|NCT03123731|text messaging|text messaging
1005983|NCT03123718|methotrexate|methotrexate
1005984|NCT03123640|Medication reconciliation|medication reconciliation
1005985|NCT03123640|Medication review|medication review
1005986|NCT03123640|Drug related admission|drug related admission
1005987|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
1005988|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
1005989|NCT03123601|Nursing home|nursing home
1005990|NCT03123601|Falls|falls
1005991|NCT03123601|Dysphasia|dysphasia
1005992|NCT03123601|Choking|choking
1005993|NCT03123601|Dehydration|dehydration
1005994|NCT03123588|Essential thrombocythemia|essential thrombocythemia
1005995|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
1005996|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
1005997|NCT03123588|ruxolitinib|ruxolitinib
1005998|NCT03123588|anagrelide|anagrelide
1005999|NCT03123562|Cerebral palsy|cerebral palsy
1006000|NCT03123562|Stem cells|stem cells
1006001|NCT03123562|Neonatal icterus|neonatal icterus
1006003|NCT03123536|complication|complication
1006004|NCT03123536|Ultrasonography|ultrasonography
1006005|NCT03123510|probiotics|probiotics
1006006|NCT03123510|prebiotics|prebiotics
1006007|NCT03123510|synbiotics|synbiotics
1006008|NCT03123510|obesity|obesity
1006009|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1006010|NCT03123484|beta-elemene|beta-elemene
1006011|NCT03123471|Plaque Psoriasis|plaque psoriasis
1006012|NCT03123471|Scalp|scalp
1006013|NCT03123471|Double-Blind|double-blind
1006014|NCT03123471|Efficacy|efficacy
1006015|NCT03123471|Safety|safety
1006016|NCT03123471|CC-10004|cc-10004
1006017|NCT03123471|Apremilast|apremilast
1006018|NCT03123471|Otezla|otezla
1006019|NCT03123471|Itch|itch
1006020|NCT03123471|Head|head
1006021|NCT03123458|MSC|msc
1006022|NCT03123458|GVHDs|gvhds
1006023|NCT03123458|transplantation|transplantation
1006024|NCT03123445|endostar|endostar
1006025|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
1006026|NCT03123406|cinacalcet|cinacalcet
1006027|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
1006028|NCT03123406|calcimimetics|calcimimetics
1006029|NCT03123406|CKD-MBD|ckd-mbd
1006030|NCT03123393|Drug therapy|drug therapy
1006031|NCT03123315|hysterectomy|hysterectomy
1006032|NCT03123315|ureter|ureter
1006033|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
1006034|NCT03123289|PET/CT|pet/ct
1006035|NCT03123289|68Gallium Citrate|68gallium citrate
1006036|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
1006037|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1006038|NCT03123250|AQUABEAM|aquabeam
1006039|NCT03123250|Aquablation|aquablation
1006040|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1006041|NCT03123224|Caregiver|caregiver
1006042|NCT03123224|Caregiving|caregiving
1006043|NCT03123224|TBI|tbi
1006044|NCT03123224|dementia|dementia
1006045|NCT03123224|Alzheimer's disease|alzheimer's disease
1006046|NCT03123224|physical exercise|physical exercise
1006047|NCT03123224|physical activity|physical activity
1006048|NCT03123224|psychosocial|psychosocial
1006049|NCT03123224|caregiver skills training|caregiver skills training
1006050|NCT03123211|Expanded Access|expanded access
1006051|NCT03123211|Pre-approval Access|pre-approval access
1006052|NCT03123211|Compassionate Use|compassionate use
1006053|NCT03123211|Special Access Program|special access program
1006054|NCT03123211|Named Patient Basis|named patient basis
1006055|NCT03123211|Special Access Scheme|special access scheme
1006056|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
1006058|NCT03123172|PPV|ppv
1006059|NCT03123172|resuscitation|resuscitation
1006060|NCT03123172|liver transplantation|liver transplantation
1006061|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
1006062|NCT03123107|Vitamin C|vitamin c
1006063|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
1006064|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
1006065|NCT03123107|ascorbic acid|ascorbic acid
1006066|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
1006067|NCT03123055|UCC|ucc
1006068|NCT03123055|bladder cancer|bladder cancer
1006069|NCT03123055|B-701|b-701
1006070|NCT03123055|FGFR3|fgfr3
1006071|NCT03123055|invasive bladder cancer|invasive bladder cancer
1006072|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
1006073|NCT03123055|TCC|tcc
1006074|NCT03123055|second line therapy|second line therapy
1006075|NCT03123055|monoclonal antibody|monoclonal antibody
1006076|NCT03123055|combination therapy|combination therapy
1006077|NCT03123055|Phase 1b|phase 1b
1006078|NCT03123055|pembrolizumab|pembrolizumab
1006079|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
1006080|NCT03123055|Phase 2|phase 2
1006081|NCT03123055|Urothelial Carcinoma|urothelial carcinoma
1006082|NCT03123042|Sentinel lymph node|sentinel lymph node
1006083|NCT03123042|Early gastric cancer|early gastric cancer
1006084|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
1006085|NCT03123029|Expanded Access|expanded access
1006086|NCT03123029|Pre-approval Access|pre-approval access
1006087|NCT03123029|Compassionate Use|compassionate use
1006088|NCT03123029|Special Access Program|special access program
1006089|NCT03123029|Named Patient Basis|named patient basis
1006090|NCT03123029|Special Access Scheme|special access scheme
1006091|NCT03123016|Vitiligo|vitiligo
1006092|NCT03123003|Bone age,|bone age,
1006093|NCT03123003|Height prediction|height prediction
1006094|NCT03123003|Growth|growth
1006095|NCT03122938|lactoferrin|lactoferrin
1006096|NCT03122938|Iron Metabolism|iron metabolism
1006097|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
1006098|NCT03122938|pregnant women|pregnant women
1006099|NCT03122938|fetal development|fetal development
1006100|NCT03122912|fish oil|fish oil
1006101|NCT03122899|SI-BONE|si-bone
1006102|NCT03122899|sacroiliac joint|sacroiliac joint
1006103|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
1006104|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
1006105|NCT03122899|iFuse|ifuse
1006107|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
1006108|NCT03122860|osteoarthritis|osteoarthritis
1006109|NCT03122860|Samumed|samumed
1006110|NCT03122834|Heart Failure|heart failure
1006111|NCT03122834|Genetic Polymorphism|genetic polymorphism
1006112|NCT03122834|RAAS|raas
1006113|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
1006114|NCT03122834|Remodeling|remodeling
1006115|NCT03122808|Tachysystole|tachysystole
1006116|NCT03122808|Excessive Uterine Activity|excessive uterine activity
1006117|NCT03122769|Metformin|metformin
1006118|NCT03122769|Heart Failure|heart failure
1006119|NCT03122769|Organic cation transporter|organic cation transporter
1006120|NCT03122769|Pharmacogenetics|pharmacogenetics
1006121|NCT03122769|Pharmacokinetics|pharmacokinetics
1006122|NCT03122769|Positron Emission Tomography|positron emission tomography
1006123|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
1006124|NCT03122756|Spinal Anesthesia|spinal anesthesia
1006125|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
1006126|NCT03122730|Cardiac surgery|cardiac surgery
1006127|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
1006128|NCT03122730|Epoprostenol|epoprostenol
1006129|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
1006130|NCT03122665|Nefopam|nefopam
1006131|NCT03122665|Pharmacokinetics|pharmacokinetics
1006132|NCT03122665|Shivering,|shivering,
1006133|NCT03122665|Thermoregulation|thermoregulation
1006134|NCT03122665|Anesthesia|anesthesia
1006135|NCT03122626|stroke|stroke
1006136|NCT03122626|community-based exercise program|community-based exercise program
1006137|NCT03122626|task-oriented exercise|task-oriented exercise
1006138|NCT03122626|group exercise program|group exercise program
1006139|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
1006140|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
1006141|NCT03122626|mixed methods|mixed methods
1006142|NCT03122587|tACS|tacs
1006143|NCT03122587|Brain Stimulation|brain stimulation
1006144|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
1006145|NCT03122587|Substance Use|substance use
1006146|NCT03122574|aromatherapy|aromatherapy
1006147|NCT03122574|pediatric|pediatric
1006148|NCT03122574|venipuncture|venipuncture
1006149|NCT03122574|lavender|lavender
1006150|NCT03122574|pain management|pain management
1029818|NCT02976922|RAS|ras
1006151|NCT03122548|stomach cancer|stomach cancer
1006152|NCT03122548|gastric cancer|gastric cancer
1006153|NCT03122548|esophageal cancer|esophageal cancer
1006154|NCT03122548|digestive system diseases|digestive system diseases
1006155|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
1006156|NCT03122548|stomach diseases|stomach diseases
1006157|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
1006158|NCT03122535|Visual acuity|visual acuity
1006159|NCT03122535|Refractive errors|refractive errors
1006160|NCT03122535|Side-cut angles|side-cut angles
1006161|NCT03122522|unresectable|unresectable
1006162|NCT03122522|III or stage IV|iii or stage iv
1006163|NCT03122522|Ipilimumab|ipilimumab
1006164|NCT03122522|Nivolumab|nivolumab
1006165|NCT03122522|17-162|17-162
1006166|NCT03122509|Durvalumab|durvalumab
1006167|NCT03122509|Tremelimumab|tremelimumab
1006168|NCT03122509|Radiation Therapy|radiation therapy
1006169|NCT03122509|Ablation|ablation
1006170|NCT03122509|17-139|17-139
1006171|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
1006172|NCT03122496|Tremelimumab|tremelimumab
1006173|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
1006174|NCT03122496|17-108|17-108
1006175|NCT03122470|TRUS biopsy|trus biopsy
1006176|NCT03122470|Pelvic MRI|pelvic mri
1006177|NCT03122457|Actinic Keratosis|actinic keratosis
1006178|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
1006179|NCT03122366|Toll-like receptor-4|toll-like receptor-4
1006180|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
1006181|NCT03122340|Polyprenols|polyprenols
1006182|NCT03122340|Cholesterol|cholesterol
1006183|NCT03122314|paracetamol|paracetamol
1006184|NCT03122314|dexketoprofen|dexketoprofen
1006185|NCT03122314|emergency department|emergency department
1006186|NCT03122314|musculoskeletal pain|musculoskeletal pain
1006187|NCT03122275|Adherence|adherence
1006188|NCT03122275|Directive Counseling|directive counseling
1006189|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
1006190|NCT03122262|dolutegravir|dolutegravir
1006191|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
1006192|NCT03122249|Palliative care|palliative care
1006193|NCT03122249|Symptom management|symptom management
1006194|NCT03122249|Self-management|self-management
1006195|NCT03122249|Rural area|rural area
1006196|NCT03122249|eHealth|ehealth
1006197|NCT03122249|telehealth|telehealth
1006198|NCT03122223|HIV|hiv
1006199|NCT03122158|major depressive disorder|major depressive disorder
1006200|NCT03122158|anxiety disorders|anxiety disorders
1006201|NCT03122158|adolescent|adolescent
1006202|NCT03122158|child|child
1006203|NCT03122145|healthy|healthy
1006204|NCT03122145|volunteer|volunteer
1006205|NCT03122132|Hepatitis C Infection|hepatitis c infection
1006206|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
1006207|NCT03122119|Sacroiliac|sacroiliac
1006208|NCT03122119|Joint Injection|joint injection
1006209|NCT03122119|Platelet Rich Plasma|platelet rich plasma
1006210|NCT03122119|Ultrasound|ultrasound
1006211|NCT03122119|Low Back Pain|low back pain
1006212|NCT03122119|Corticosteroid|corticosteroid
1006213|NCT03122093|pediatric|pediatric
1006214|NCT03122093|dietary treatment|dietary treatment
1006215|NCT03122093|celiac disease|celiac disease
1006216|NCT03122093|T1D|t1d
1006217|NCT03122080|acupuncture|acupuncture
1006218|NCT03122080|insomnia|insomnia
1006219|NCT03122080|depression|depression
1006220|NCT03122080|antidepressants|antidepressants
1006221|NCT03122067|oxytocin|oxytocin
1006222|NCT03122067|social cognition|social cognition
1006223|NCT03122067|fMRI|fmri
1006224|NCT03122067|empathy|empathy
1006225|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
1006226|NCT03122041|metformin intolerance|metformin intolerance
1006227|NCT03122041|PCOS|pcos
1006228|NCT03122041|Sitagliptin|sitagliptin
1006229|NCT03122041|beta cell function|beta cell function
1006230|NCT03122028|LAmbre|lambre
1006231|NCT03122002|Ischemic Stroke|ischemic stroke
1006232|NCT03122002|Cerebral Infarction|cerebral infarction
1006233|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
1006234|NCT03121950|dementia|dementia
1006235|NCT03121924|oocyte denudation|oocyte denudation
1006236|NCT03121924|preincubation|preincubation
1006237|NCT03121924|icsi|icsi
1006238|NCT03121924|oocyte donation|oocyte donation
1006239|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
1006240|NCT03121911|Interval Physical Training|interval physical training
1006241|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
1006242|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
1006243|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
1006244|NCT03121911|Inflammatory Markers|inflammatory markers
1006245|NCT03121911|Heart Rate Variability|heart rate variability
1006247|NCT03121859|interferential current therapy|interferential current therapy
1006248|NCT03121859|Chronic neck pain|chronic neck pain
1006249|NCT03121846|Apatinib|apatinib
1006250|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
1006251|NCT03121833|Endostar|endostar
1006252|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
1006253|NCT03121833|Chemotherapy|chemotherapy
1006254|NCT03121807|home parenteral nutrition|home parenteral nutrition
1006255|NCT03121794|ultrasonography|ultrasonography
1006256|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
1006258|NCT03121794|anatomic landmark|anatomic landmark
1006259|NCT03121768|Prognostic Model|prognostic model
1006260|NCT03121768|Bladder Cancer|bladder cancer
1006261|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
1006262|NCT03121768|Recurrence|recurrence
1006263|NCT03121768|Progression|progression
1006264|NCT03121768|BCG|bcg
1006265|NCT03121742|Suicide|suicide
1006266|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
1006267|NCT03121729|gastric cancer|gastric cancer
1006268|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
1006269|NCT03121651|Mobile technology|mobile technology
1006270|NCT03121651|Reinforcement-learning|reinforcement-learning
1006271|NCT03121651|Medication management|medication management
1006272|NCT03121638|Varicella Vaccine|varicella vaccine
1006273|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
1006274|NCT03121612|RDS|rds
1006275|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
1006276|NCT03121560|Hysteroscopy|hysteroscopy
1006277|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
1006278|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1006279|NCT03121534|Richter's transformation|richter's transformation
1006280|NCT03121534|RT|rt
1006281|NCT03121534|Blinatumomab|blinatumomab
1006282|NCT03121534|Dexamethasone|dexamethasone
1006283|NCT03121534|Decadron|decadron
1006284|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
1006285|NCT03121430|peripheral arterial disease|peripheral arterial disease
1006286|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
1006287|NCT03121430|primary patency|primary patency
1006288|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
1006289|NCT03121378|Bone Cements|bone cements
1006290|NCT03121378|Impedance Aggregometry|impedance aggregometry
1006291|NCT03121378|Platelet Activation|platelet activation
1006292|NCT03121365|Digital literacy|digital literacy
1006293|NCT03121365|Reading|reading
1006294|NCT03121352|Carboplatin|carboplatin
1006295|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
1006296|NCT03121352|Pembrolizumab|pembrolizumab
1006297|NCT03121326|Sarcopenia|sarcopenia
1006298|NCT03121326|Aging|aging
1006299|NCT03121326|Biomarkers|biomarkers
1006300|NCT03121326|Metabolomics|metabolomics
1006301|NCT03121313|Tegafur-uracil|tegafur-uracil
1006302|NCT03121313|distant metastasis|distant metastasis
1006303|NCT03121313|oral cavity cancer|oral cavity cancer
1006304|NCT03121261|levobupivacaine|levobupivacaine
1006305|NCT03121261|nerve fibers|nerve fibers
1006307|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
1006308|NCT03121248|Older women|older women
1006309|NCT03121248|Hypo-fractonation|hypo-fractonation
1006310|NCT03121235|aspergillosis|aspergillosis
1006311|NCT03121235|mycosis|mycosis
1006312|NCT03121235|neutropenia|neutropenia
1006313|NCT03121235|hematologic diseases|hematologic diseases
1006314|NCT03121235|AsperGenius PCR|aspergenius pcr
1006315|NCT03121235|Ambisome|ambisome
1006316|NCT03121235|Voriconazole|voriconazole
1006317|NCT03121196|Social deprivation|social deprivation
1006318|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
1006319|NCT03121183|Cardiology|cardiology
1006320|NCT03121183|Device Removal|device removal
1006321|NCT03121183|Pacemaker|pacemaker
1006322|NCT03121183|Defibrillators|defibrillators
1006323|NCT03121183|Catheterization|catheterization
1006324|NCT03121183|Laser Therapy|laser therapy
1006325|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
1006326|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
1006327|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
1006328|NCT03121170|traditional Chinese medicine|traditional chinese medicine
1006329|NCT03121157|African Americans|african americans
1006330|NCT03121157|Emerging adults|emerging adults
1006331|NCT03121157|Medication adherence|medication adherence
1006332|NCT03121157|eHealth|ehealth
1006333|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
1006334|NCT03121118|Amyvid|amyvid
1006335|NCT03121118|Amyloid Imaging|amyloid imaging
1006336|NCT03121118|PET Brain Scan|pet brain scan
1006337|NCT03121118|Amyloid Plaque|amyloid plaque
1006338|NCT03121118|Ethics|ethics
1006339|NCT03121118|Results disclosure|results disclosure
1006340|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
1006341|NCT03121105|Multiple Sclerosis|multiple sclerosis
1006342|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
1006343|NCT03121105|MRI|mri
1006344|NCT03121105|pahtological|pahtological
1006345|NCT03121079|Interferon-alpha|interferon-alpha
1006346|NCT03121079|Relapse|relapse
1006347|NCT03121079|prevention|prevention
1006348|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
1006349|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
1006350|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1006351|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
1006352|NCT03121066|Theta Burst Protocol|theta burst protocol
1006353|NCT03121066|Brain connectivity|brain connectivity
1006354|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1006355|NCT03121066|Parietal cortex|parietal cortex
1006356|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1006357|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1006358|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
1006359|NCT03121040|Young athletes|young athletes
1006360|NCT03121040|Nutrition|nutrition
1006361|NCT03121040|lactic acid accumulation|lactic acid accumulation
1006362|NCT03121040|Anaerobic metabolism|anaerobic metabolism
1006364|NCT03121040|Sports damage|sports damage
1006365|NCT03121027|Anemia|anemia
1006366|NCT03121027|Ever married women|ever married women
1006367|NCT03121027|Economic inequality|economic inequality
1006368|NCT03121027|Diabetes|diabetes
1006369|NCT03121027|Maternity|maternity
1006370|NCT03121027|BMI|bmi
1006371|NCT03120988|Knee OA|knee oa
1006372|NCT03120988|lavage|lavage
1006373|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
1006374|NCT03120975|Anti-Infective Agents|anti-infective agents
1006375|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
1006376|NCT03120975|Quality Improvement|quality improvement
1006377|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
1006378|NCT03120949|moderate|moderate
1006379|NCT03120949|severe|severe
1006380|NCT03120949|subcutaneous|subcutaneous
1006381|NCT03120949|Olokizumab|olokizumab
1006382|NCT03120949|open-label|open-label
1006383|NCT03120936|Adherence|adherence
1006384|NCT03120936|Transgender|transgender
1006385|NCT03120936|PrEP|prep
1006386|NCT03120936|HIV Prevention|hiv prevention
1006387|NCT03120936|Truvada|truvada
1006388|NCT03120936|HIV Risk Reduction|hiv risk reduction
1006389|NCT03120923|subacromial injection|subacromial injection
1006390|NCT03120871|Beta cell failure|beta cell failure
1006391|NCT03120871|Puberty|puberty
1006392|NCT03120871|Microbiome|microbiome
1006393|NCT03120871|Insulin Sensitivity|insulin sensitivity
1006394|NCT03120858|motor imagery|motor imagery
1006395|NCT03120858|kinesthetic imagery|kinesthetic imagery
1006396|NCT03120858|reliability|reliability
1006397|NCT03120858|Turkish version|turkish version
1006398|NCT03120845|Pain,|pain,
1006399|NCT03120845|one-visit|one-visit
1006400|NCT03120845|two visits|two visits
1006401|NCT03120819|exercise|exercise
1006402|NCT03120819|fatigue|fatigue
1006403|NCT03120819|physical activity|physical activity
1006404|NCT03120754|ERAS|eras
1006405|NCT03120754|Peritoneal drainage|peritoneal drainage
1006406|NCT03120754|Primary Closure|primary closure
1006407|NCT03120741|Healthcare Quality|healthcare quality
1006408|NCT03120728|Emergency contraception|emergency contraception
1006409|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
1006410|NCT03120728|NuvaRing|nuvaring
1006411|NCT03120728|Contraception|contraception
1006412|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
1006413|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
1006414|NCT03120715|pregnancy|pregnancy
1006415|NCT03120689|VITOM|vitom
1006416|NCT03120689|Adult learners|adult learners
1006417|NCT03120689|Medical students|medical students
1006418|NCT03120689|Residents|residents
1006419|NCT03120689|Vaginal surgery|vaginal surgery
1006420|NCT03120689|Medical education|medical education
1006421|NCT03120676|Relapsed|relapsed
1006422|NCT03120676|Refractory|refractory
1006423|NCT03120676|Atezolizumab|atezolizumab
1006424|NCT03120676|17-191|17-191
1006425|NCT03120663|antimicrobials|antimicrobials
1006426|NCT03120663|pharmacokinetics|pharmacokinetics
1006427|NCT03120663|augmented renal clearance|augmented renal clearance
1006428|NCT03120663|non critically ill|non critically ill
1006429|NCT03120637|Methylene Blue|methylene blue
1006430|NCT03120637|Septic Shock|septic shock
1006431|NCT03120637|Vasoplegia|vasoplegia
1006432|NCT03120637|Cirrhosis|cirrhosis
1006433|NCT03120611|Exercise|exercise
1006434|NCT03120611|Hemodialysis|hemodialysis
1006435|NCT03120611|Virtual Reality|virtual reality
1006436|NCT03120598|preparation strategies|preparation strategies
1006437|NCT03120598|implementation strategies|implementation strategies
1006438|NCT03120598|sustainment strategies|sustainment strategies
1006439|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
1006440|NCT03120585|fluid restriction|fluid restriction
1006441|NCT03120572|Respiratory muscle strength|respiratory muscle strength
1006442|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
1006443|NCT03120572|Functional capacity|functional capacity
1006444|NCT03120559|Gingivitis|gingivitis
1006445|NCT03120559|SMS|sms
1006446|NCT03120559|Dental floss|dental floss
1006447|NCT03120559|behavior change|behavior change
1006448|NCT03120559|HAPA|hapa
1006449|NCT03120546|cervical spine motion|cervical spine motion
1006450|NCT03120546|video laryngoscope|video laryngoscope
1006451|NCT03120546|rigid video stylet|rigid video stylet
1006452|NCT03120533|iontophoresis|iontophoresis
1006453|NCT03120533|treprostinil|treprostinil
1006454|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
1006455|NCT03120507|IHCA|ihca
1006456|NCT03120507|quality of life|quality of life
1006457|NCT03120507|QoL|qol
1006458|NCT03120507|patient-reported outcomes|patient-reported outcomes
1006459|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
1006460|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
1006461|NCT03120455|weight loss|weight loss
1006462|NCT03120455|Almond|almond
1006463|NCT03120455|Pistachio|pistachio
1006464|NCT03120455|hypoenergetic diet|hypoenergetic diet
1006465|NCT03120455|Nut|nut
1006466|NCT03120442|postoperative delirium|postoperative delirium
1006467|NCT03120442|total knee arthroplasty|total knee arthroplasty
1006468|NCT03120442|propofol|propofol
1006469|NCT03120442|dexmedetomidine|dexmedetomidine
1006470|NCT03120442|fentanyl|fentanyl
1006471|NCT03120442|inflammatory response|inflammatory response
1006472|NCT03120442|interleukins|interleukins
1006473|NCT03120442|CAM-ICU|cam-icu
1006474|NCT03120429|lean fish|lean fish
1006475|NCT03120429|weight loss|weight loss
1006476|NCT03120429|Diet|diet
1006477|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
1006478|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
1006479|NCT03120338|Child and Adolescent|child and adolescent
1006480|NCT03120338|Randomised Controlled Trial|randomised controlled trial
1006481|NCT03120338|Paediatrics|paediatrics
1006482|NCT03120338|DAWBA|dawba
1006483|NCT03120338|eHealth Services|ehealth services
1006484|NCT03120312|outcome|outcome
1006485|NCT03120286|OBESITY|obesity
1006486|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
1006487|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
1006488|NCT03120260|Caloric Restriction|caloric restriction
1006489|NCT03120260|weight loss|weight loss
1006490|NCT03120260|sleep|sleep
1006491|NCT03120221|Pregnancy|pregnancy
1006492|NCT03120221|Iodine deficiency|iodine deficiency
1006493|NCT03120221|Thyroid|thyroid
1006494|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
1006495|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
1006496|NCT03120182|aspirin|aspirin
1006497|NCT03120182|bleeding risk|bleeding risk
1006498|NCT03120182|intracranial bleeding|intracranial bleeding
1006499|NCT03120182|burr-hole drainage|burr-hole drainage
1006500|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
1006501|NCT03120182|anticoagulation|anticoagulation
1006502|NCT03120169|COPD|copd
1006503|NCT03120169|exercise|exercise
1006504|NCT03120169|training|training
1006505|NCT03120169|cycling|cycling
1006506|NCT03120169|treadmill|treadmill
1006507|NCT03120169|walking|walking
1006806|NCT03118414|Exercise|exercise
1006508|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
1006509|NCT03120156|sensomotoric insoles|sensomotoric insoles
1006510|NCT03120156|postural control|postural control
1006511|NCT03120156|proprioceptive insoles|proprioceptive insoles
1006512|NCT03120156|insoles|insoles
1006513|NCT03120143|Small-sided ball games|small-sided ball games
1006514|NCT03120143|Aging|aging
1006515|NCT03120143|Muscle mass|muscle mass
1006516|NCT03120143|Health|health
1006517|NCT03120143|Training|training
1006518|NCT03120143|Protein intake|protein intake
1006519|NCT03120143|Physical function|physical function
1006520|NCT03120143|Physiological adaptations|physiological adaptations
1006521|NCT03120130|Phase I,|phase i,
1006522|NCT03120117|Midurethral Slings|midurethral slings
1006523|NCT03120078|Ultrasound|ultrasound
1006524|NCT03120065|adherence|adherence
1006525|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
1006526|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
1006527|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
1006528|NCT03120013|Cerebellar ataxia|cerebellar ataxia
1006529|NCT03120000|DLBCL|dlbcl
1006530|NCT03119987|Red cell Distribution Width|red cell distribution width
1006531|NCT03119987|Risk|risk
1006532|NCT03119987|Mortality|mortality
1006533|NCT03119987|Hemorrhage|hemorrhage
1006534|NCT03119974|ITP|itp
1006535|NCT03119974|TPO-RAS|tpo-ras
1006536|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
1006537|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
1006538|NCT03119961|Tau Protein|tau protein
1006539|NCT03119961|Sonication|sonication
1006540|NCT03119948|Muscle spasticity|muscle spasticity
1006541|NCT03119948|Botulinum toxin|botulinum toxin
1006542|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
1006543|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
1006544|NCT03119922|children|children
1006545|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
1006546|NCT03119909|fMRI|fmri
1006547|NCT03119909|cingulate cortex|cingulate cortex
1006548|NCT03119909|adaptation|adaptation
1006549|NCT03119909|frontal cortex|frontal cortex
1006550|NCT03119896|chronic pain|chronic pain
1006551|NCT03119896|self-management|self-management
1006552|NCT03119896|pain management|pain management
1006553|NCT03119896|doctor patient communication|doctor patient communication
1006554|NCT03119896|primary care|primary care
1006555|NCT03119883|Myeloma|myeloma
1006556|NCT03119883|Metabolism|metabolism
1006557|NCT03119883|Glutamine|glutamine
1006558|NCT03119870|fMRI|fmri
1006559|NCT03119870|EEG|eeg
1006560|NCT03119870|behavior|behavior
1006561|NCT03119870|cingulate cortex|cingulate cortex
1006562|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
1006563|NCT03119831|chlorhexidine|chlorhexidine
1006564|NCT03119831|alcohol|alcohol
1006565|NCT03119831|C31G|c31g
1006566|NCT03119831|Mouthrinses|mouthrinses
1006567|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
1006568|NCT03119818|ESRD|esrd
1006569|NCT03119818|hemodialysis|hemodialysis
1006570|NCT03119818|phosphate|phosphate
1006571|NCT03119818|ATP|atp
1006572|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1006573|NCT03119805|composite scores|composite scores
1006574|NCT03119805|patient reported outcomes|patient reported outcomes
1006575|NCT03119805|patient perpective|patient perpective
1006576|NCT03119805|physician perspective|physician perspective
1006577|NCT03119805|cut-off values|cut-off values
1006578|NCT03119805|flare|flare
1006579|NCT03119805|remission|remission
1006580|NCT03119805|minimal disease activity|minimal disease activity
1006581|NCT03119805|low disease activity|low disease activity
1006582|NCT03119792|Behavioral Modification|behavioral modification
1006583|NCT03119792|Health Community|health community
1006584|NCT03119792|Community Intervention|community intervention
1006585|NCT03119792|Prevention|prevention
1006586|NCT03119792|Cardiovascular Health|cardiovascular health
1006587|NCT03119792|Education Intervention|education intervention
1006588|NCT03119792|Colombia|colombia
1006589|NCT03119779|pulpotomy|pulpotomy
1006590|NCT03119779|deep caries|deep caries
1006591|NCT03119779|permanent molars|permanent molars
1006592|NCT03119779|MTA|mta
1006593|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
1006594|NCT03119753|complete denture|complete denture
1006595|NCT03119714|bronchoprovocation|bronchoprovocation
1006596|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
1006597|NCT03119714|mast cell stabilizer|mast cell stabilizer
1006598|NCT03119714|mast cell mediators|mast cell mediators
1006599|NCT03119714|sputum eosinophils|sputum eosinophils
1006600|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
1006601|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
1006602|NCT03119675|Myopia|myopia
1006603|NCT03119675|Hyperopia|hyperopia
1006604|NCT03119675|Anisometropia|anisometropia
1006605|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
1006606|NCT03119675|Risk Factors|risk factors
1006607|NCT03119675|Smartphone Application (App)|smartphone application (app)
1006608|NCT03119675|Photoscreening|photoscreening
1006609|NCT03119675|Vision Screening|vision screening
1006610|NCT03119675|Mobile Vision Screening|mobile vision screening
1006611|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
1006612|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
1006613|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
1006614|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
1006739|NCT03118726|Contraception|contraception
1006615|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
1006616|NCT03119662|Iodixanol|iodixanol
1006617|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
1006618|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
1006619|NCT03119623|Heart Failure|heart failure
1006620|NCT03119623|Endothelial function|endothelial function
1006621|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
1006622|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
1006623|NCT03119623|Enalapril|enalapril
1006624|NCT03119623|HFREF|hfref
1006625|NCT03119597|low mood, depression|low mood, depression
1006626|NCT03119584|chronic constipation|chronic constipation
1006627|NCT03119584|diabetes|diabetes
1006628|NCT03119571|Cardiac arrest|cardiac arrest
1006629|NCT03119571|Ventricular fibrillation|ventricular fibrillation
1006630|NCT03119571|coronary artery disease|coronary artery disease
1006631|NCT03119545|intervention|intervention
1006632|NCT03119545|support program|support program
1006633|NCT03119545|family centered|family centered
1006634|NCT03119545|parental death|parental death
1006635|NCT03119519|NSCLC|nsclc
1006636|NCT03119519|Oligometastases|oligometastases
1006637|NCT03119519|radiotherapy|radiotherapy
1006638|NCT03119493|Metabolic syndrome X|metabolic syndrome x
1006639|NCT03119493|Autonomic nervous system|autonomic nervous system
1006640|NCT03119493|Aerobic exercise|aerobic exercise
1006641|NCT03119493|Exercise|exercise
1006642|NCT03119493|Heart rate|heart rate
1006643|NCT03119480|Acute Kidney Injury|acute kidney injury
1006644|NCT03119480|Electronic alerts|electronic alerts
1006646|NCT03119402|Developmental Dyslexia|developmental dyslexia
1006647|NCT03119402|Music|music
1006648|NCT03119402|Rhythm|rhythm
1006649|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
1006650|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
1006651|NCT03119389|Hand Hygiene|hand hygiene
1006652|NCT03119389|Non-sterile glove use|non-sterile glove use
1006653|NCT03119376|peer review|peer review
1006654|NCT03119376|online tool|online tool
1006655|NCT03119376|Randomized Controlled Trial|randomized controlled trial
1006656|NCT03119363|cancer-related fatigue|cancer-related fatigue
1006657|NCT03119363|circadian rhythms|circadian rhythms
1006658|NCT03119363|light therapy|light therapy
1006659|NCT03119363|systematic light exposure|systematic light exposure
1006660|NCT03119363|cancer survivors|cancer survivors
1006661|NCT03119363|oncology|oncology
1006662|NCT03119363|Multiple Myeloma|multiple myeloma
1006663|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1006664|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
1006665|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
1006666|NCT03119324|Biomodulation|biomodulation
1006667|NCT03119324|LLLT|lllt
1006668|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
1006669|NCT03119324|Pain management|pain management
1006670|NCT03119285|ovarian cancer|ovarian cancer
1006671|NCT03119285|BRCA1|brca1
1006672|NCT03119285|BRCA2|brca2
1006673|NCT03119285|BROCA|broca
1006674|NCT03119246|beta testing|beta testing
1006675|NCT03119246|assessment battery|assessment battery
1006677|NCT03119207|ICU|icu
1006678|NCT03119168|screening|screening
1006679|NCT03119168|adenoma detection rate|adenoma detection rate
1006680|NCT03119168|simethicone|simethicone
1006681|NCT03119155|Congenital Heart Disease|congenital heart disease
1006682|NCT03119155|Echocardiography|echocardiography
1006683|NCT03119155|Diagnosis|diagnosis
1006684|NCT03119129|prevention|prevention
1006685|NCT03119129|health disparities|health disparities
1006686|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
1006687|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
1006688|NCT03119103|respiratory pattern|respiratory pattern
1006689|NCT03119103|sensor data|sensor data
1006690|NCT03119103|bed sheet|bed sheet
1006691|NCT03119103|pressure|pressure
1006692|NCT03119103|respiration rate|respiration rate
1006693|NCT03119090|biomarkers|biomarkers
1006694|NCT03119090|Fontan operation|fontan operation
1006695|NCT03119090|Single ventricle|single ventricle
1006696|NCT03119090|congenital heart disease|congenital heart disease
1006697|NCT03119077|PCOS|pcos
1006698|NCT03119051|mild cognitive impairment|mild cognitive impairment
1006699|NCT03119038|total hip|total hip
1006700|NCT03119038|degenerative joint disease|degenerative joint disease
1006701|NCT03119038|osteoarthritis|osteoarthritis
1006702|NCT03119025|Dendritic Cells|dendritic cells
1006703|NCT03119025|DC-based Vaccines|dc-based vaccines
1006704|NCT03119025|Chronic HCV Infection|chronic hcv infection
1006705|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
1006706|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
1006707|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
1006708|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
1006709|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
1006710|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
1006711|NCT03119012|Coronary artery disease|coronary artery disease
1006712|NCT03118986|olanzapine|olanzapine
1006713|NCT03118986|vomiting|vomiting
1006714|NCT03118986|children|children
1006715|NCT03118986|adolescents|adolescents
1006716|NCT03118986|bone marrow transplant|bone marrow transplant
1006717|NCT03118986|supportive care|supportive care
1006718|NCT03118934|contact lenses|contact lenses
1006719|NCT03118934|presbyopia|presbyopia
1006720|NCT03118934|multifocal|multifocal
1006721|NCT03118908|Succinate|succinate
1006722|NCT03118908|B complex vitamins|b complex vitamins
1006723|NCT03118908|menopause|menopause
1006724|NCT03118882|Breast cancer screening|breast cancer screening
1006725|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
1006726|NCT03118882|Primary prevention|primary prevention
1006727|NCT03118882|Lifestyles|lifestyles
1006728|NCT03118882|Teachable moment|teachable moment
1006729|NCT03118869|Asthma|asthma
1006730|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
1006731|NCT03118869|Polymorphism|polymorphism
1006732|NCT03118804|Weaning|weaning
1006733|NCT03118804|Mechanical ventilation|mechanical ventilation
1006734|NCT03118804|Electrical impedance tomography|electrical impedance tomography
1006735|NCT03118804|Tidal distribution|tidal distribution
1006736|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
1006737|NCT03118726|LARC|larc
1006738|NCT03118726|New Mexico|new mexico
1006740|NCT03118713|Glimepride|glimepride
1006741|NCT03118713|Metformin|metformin
1006742|NCT03118713|Ipragliflozin|ipragliflozin
1006743|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1006744|NCT03118713|ASP1941|asp1941
1006745|NCT03118687|Immune system|immune system
1006746|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
1006747|NCT03118648|upper limb|upper limb
1006748|NCT03118648|functional recovery|functional recovery
1006749|NCT03118648|activities of daily living|activities of daily living
1006750|NCT03118635|Summer|summer
1006751|NCT03118635|Diet|diet
1006752|NCT03118635|Physical Activity|physical activity
1006753|NCT03118635|Sedentary behavior|sedentary behavior
1006754|NCT03118635|Low-income|low-income
1006755|NCT03118609|Caregivers|caregivers
1006756|NCT03118609|Chronic Pain|chronic pain
1006757|NCT03118596|intubation|intubation
1006758|NCT03118596|tracheal|tracheal
1006759|NCT03118596|airway device|airway device
1006760|NCT03118596|supra-glottic airway device|supra-glottic airway device
1006761|NCT03118596|fibreoptic scope|fibreoptic scope
1006762|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
1006763|NCT03118570|Brittle Bone Disease|brittle bone disease
1006764|NCT03118557|pelvic floor|pelvic floor
1006765|NCT03118557|strengthening|strengthening
1006766|NCT03118557|Stress|stress
1006767|NCT03118557|urinary|urinary
1006768|NCT03118557|incontinence|incontinence
1006769|NCT03118544|Chronic Total Occlusion|chronic total occlusion
1006770|NCT03118544|Coronary Artery Disease|coronary artery disease
1006771|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
1006772|NCT03118544|CTO|cto
1006773|NCT03118544|PCI|pci
1006774|NCT03118531|Long Lesion|long lesion
1006775|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
1006776|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
1006777|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1006778|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1006779|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1006780|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
1006781|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
1006782|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
1006783|NCT03118479|IHH|ihh
1006784|NCT03118479|KS|ks
1006785|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
1006786|NCT03118479|GnRH deficiency|gnrh deficiency
1006787|NCT03118466|AML|aml
1006788|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
1006789|NCT03118453|Behavioral medicine|behavioral medicine
1006790|NCT03118453|Physical therapy|physical therapy
1006791|NCT03118453|Cost-benefit analyses|cost-benefit analyses
1006792|NCT03118453|Treatment outcome|treatment outcome
1006793|NCT03118453|Adults|adults
1006794|NCT03118440|Fluoroscopy|fluoroscopy
1006795|NCT03118440|Pacemaker|pacemaker
1006796|NCT03118440|Three dimensional|three dimensional
1006797|NCT03118440|Radiation|radiation
1006798|NCT03118440|Imaging|imaging
1006799|NCT03118427|Fluoroscopy|fluoroscopy
1006800|NCT03118427|Pacemaker|pacemaker
1006801|NCT03118427|Three dimensional|three dimensional
1006802|NCT03118427|Radiation|radiation
1006803|NCT03118427|Imaging|imaging
1006804|NCT03118414|Balance|balance
1006805|NCT03118414|Cognition|cognition
1006808|NCT03118362|Critically ill|critically ill
1006809|NCT03118362|Acid-Base status|acid-base status
1006810|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
1006811|NCT03118323|willingness topay|willingness topay
1006812|NCT03118323|WTP|wtp
1006813|NCT03118323|health economic|health economic
1006814|NCT03118323|preference-based measures|preference-based measures
1006815|NCT03118310|Reduction of liver fat|reduction of liver fat
1006816|NCT03118297|Etonogestrel Implant|etonogestrel implant
1006817|NCT03118284|Foley catheter|foley catheter
1006818|NCT03118271|lumbar disc herniation|lumbar disc herniation
1006819|NCT03118271|lumbar traction|lumbar traction
1006820|NCT03118271|spinal manipulation|spinal manipulation
1006821|NCT03118271|lumbar surgery|lumbar surgery
1006822|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
1006823|NCT03118258|Pap test smear|pap test smear
1006824|NCT03118258|cervical cancer screening|cervical cancer screening
1006825|NCT03118258|deprivation|deprivation
1006826|NCT03118258|sexual and reproductive health|sexual and reproductive health
1006827|NCT03118258|Precariousness|precariousness
1006828|NCT03118232|Nursing Homes|nursing homes
1006829|NCT03118232|Health Facilities|health facilities
1006830|NCT03118232|Infections|infections
1006831|NCT03118232|Readmissions|readmissions
1006832|NCT03118232|Multi-Drug resistance|multi-drug resistance
1006833|NCT03118232|Antibiotic Use|antibiotic use
1006834|NCT03118219|assisted reproductive technology|assisted reproductive technology
1006835|NCT03118219|embryo transfer|embryo transfer
1006836|NCT03118219|online intervention|online intervention
1006837|NCT03118219|rct|rct
1006838|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
1006839|NCT03118206|spinal manipulation|spinal manipulation
1006840|NCT03118206|physical therapy|physical therapy
1006841|NCT03118206|surgery|surgery
1006842|NCT03118193|depression|depression
1006843|NCT03118193|antidepressant|antidepressant
1006844|NCT03118193|resistance|resistance
1006845|NCT03118167|Acrylamide|acrylamide
1006846|NCT03118167|Tea polyphenols|tea polyphenols
1006847|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
1006848|NCT03118154|endometriosis|endometriosis
1006849|NCT03118154|pelvic pain|pelvic pain
1006850|NCT03118154|dysmenorrhea|dysmenorrhea
1006851|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
1006852|NCT03118141|single embryo transfer|single embryo transfer
1006853|NCT03118141|frozen embryo transfer|frozen embryo transfer
1006854|NCT03118141|cumulative live birth rate|cumulative live birth rate
1006855|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
1006856|NCT03118115|bioimpedance|bioimpedance
1006857|NCT03118115|thrombosis|thrombosis
1006858|NCT03118115|free flap|free flap
1006859|NCT03118115|microsurgerie|microsurgerie
1006860|NCT03118115|breast reconstruction|breast reconstruction
1006861|NCT03118089|Oral nutritional supplements|oral nutritional supplements
1006862|NCT03118050|exercise|exercise
1006863|NCT03118050|bed rest|bed rest
1006865|NCT03118050|nutrition|nutrition
1006866|NCT03118050|amino acids|amino acids
1006867|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
1006868|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
1006869|NCT03118024|fluid restriction|fluid restriction
1006870|NCT03118024|catecholamine restriction|catecholamine restriction
1006871|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
1006872|NCT03117985|HIV reservoirs|hiv reservoirs
1006873|NCT03117985|HIV persistence|hiv persistence
1006874|NCT03117985|Viral rebound|viral rebound
1006875|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
1006876|NCT03117972|Biomarker|biomarker
1006877|NCT03117972|Chemotherapy intensification|chemotherapy intensification
1006878|NCT03117972|Syndecan1|syndecan1
1006879|NCT03117972|LDH|ldh
1006880|NCT03117972|CD138|cd138
1006881|NCT03117946|immunomonitoring|immunomonitoring
1006882|NCT03117946|immune checkpoint|immune checkpoint
1006883|NCT03117946|chemoradiation|chemoradiation
1006884|NCT03117946|T cells|t cells
1006885|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
1006886|NCT03117933|Platinum resistance|platinum resistance
1006887|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
1006888|NCT03117920|Minnelide|minnelide
1006889|NCT03117920|Minnelide002|minnelide002
1006890|NCT03117920|2017-000126-36|2017-000126-36
1006891|NCT03117881|Multiple Sclerosis|multiple sclerosis
1006892|NCT03117881|Yoga|yoga
1006893|NCT03117881|Pilates|pilates
1006894|NCT03117881|Telerehabilitation|telerehabilitation
1006895|NCT03117881|Physical activity|physical activity
1006896|NCT03117842|Female entertainment workers|female entertainment workers
1006897|NCT03117842|mHealth|mhealth
1006898|NCT03117842|HIV testing|hiv testing
1006899|NCT03117842|Cambodia|cambodia
1006900|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
1006901|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
1006902|NCT03117803|Registries|registries
1006903|NCT03117803|Multicenter Studies|multicenter studies
1006904|NCT03117803|People's Republic of China|people's republic of china
1006905|NCT03117790|elderly|elderly
1006906|NCT03117790|surgery|surgery
1006908|NCT03117790|dexmedetomidine|dexmedetomidine
1006909|NCT03117790|sleep quality|sleep quality
1006910|NCT03117751|Leukemia|leukemia
1006911|NCT03117751|Lymphoma|lymphoma
1006912|NCT03117751|Pediatric|pediatric
1006913|NCT03117751|B-Cell|b-cell
1006914|NCT03117751|T-Cell|t-cell
1006915|NCT03117725|oxidative stress|oxidative stress
1006916|NCT03117725|antioxidants|antioxidants
1006917|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
1006918|NCT03117712|cerebral blood supply|cerebral blood supply
1006919|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
1006920|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
1006921|NCT03117699|Hemiplegia|hemiplegia
1006922|NCT03117699|transport device|transport device
1006923|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
1006924|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
1006925|NCT03117634|anti vegf|anti vegf
1006926|NCT03117634|aflibercept|aflibercept
1006927|NCT03117634|treat and extend|treat and extend
1006928|NCT03117621|Blincyto|blincyto
1006929|NCT03117608|OA|oa
1006930|NCT03117608|aMAT|amat
1006931|NCT03117608|PRP|prp
1006932|NCT03117595|Single Shot Spinal|single shot spinal
1006933|NCT03117595|Intrathecal narcotics|intrathecal narcotics
1006934|NCT03117595|Morphine|morphine
1006935|NCT03117595|Fentanyl|fentanyl
1006936|NCT03117595|Labour Analgesia|labour analgesia
1006937|NCT03117582|C. diff|c. diff
1006938|NCT03117582|CDI|cdi
1663401|NCT00130442|PI-88|pi-88
1006939|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
1006940|NCT03117582|Diarrhea|diarrhea
1006941|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
1006942|NCT03117582|FMT|fmt
1006943|NCT03117543|Screening|screening
1006944|NCT03117530|minocycline|minocycline
1006945|NCT03117530|brain inflammation|brain inflammation
1006949|NCT03117504|Stress urinary incontinence|stress urinary incontinence
1006951|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
1006952|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
1006953|NCT03117491|local anesthesia|local anesthesia
1006954|NCT03117491|molar|molar
1006955|NCT03117491|pulpitis|pulpitis
1006956|NCT03117452|schizophrenia|schizophrenia
1006957|NCT03117452|visual processing|visual processing
1006958|NCT03117452|cognitive training|cognitive training
1006959|NCT03117452|visual training|visual training
1006960|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
1006961|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
1006962|NCT03117426|Trifocal IOL|trifocal iol
1006963|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
1006964|NCT03117413|Cochlear implantation|cochlear implantation
1006965|NCT03117413|Deafness|deafness
1006966|NCT03117413|Auditory cortex|auditory cortex
1006967|NCT03117413|Auditory plasticity|auditory plasticity
1006968|NCT03117413|Tinnitus|tinnitus
1006969|NCT03117361|multiple myeloma|multiple myeloma
1006970|NCT03117361|plitidepsin|plitidepsin
1006971|NCT03117361|Aplidin|aplidin
1006972|NCT03117348|Enteral Nutrition|enteral nutrition
1006973|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
1006974|NCT03117348|Randomized Controlled Trial|randomized controlled trial
1006975|NCT03117348|Clinical Outcomes|clinical outcomes
1006976|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
1006977|NCT03117335|Sulijia|sulijia
1006978|NCT03117335|Recombinant endostatin|recombinant endostatin
1006979|NCT03117335|Vinorelbine|vinorelbine
1006980|NCT03117335|Cisplatin|cisplatin
1006981|NCT03117322|cerebral palsy|cerebral palsy
1006982|NCT03117322|children|children
1006983|NCT03117322|chronic constipation|chronic constipation
1006984|NCT03117322|synbiotic|synbiotic
1006985|NCT03117322|prebiotics|prebiotics
1006986|NCT03117322|probiotics|probiotics
1006987|NCT03117322|agave inulin|agave inulin
1006988|NCT03117322|microbiota|microbiota
1006993|NCT03117296|physical therapy|physical therapy
1006994|NCT03117296|occupational therapy|occupational therapy
1006995|NCT03117296|tAVR|tavr
1006996|NCT03117283|Laparoscopic surgery|laparoscopic surgery
1006997|NCT03117283|Radical total gastrectomy|radical total gastrectomy
1006998|NCT03117283|Bursectomy|bursectomy
1006999|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
1007000|NCT03117257|Lobaplatin|lobaplatin
1007001|NCT03117257|head and neck cancer|head and neck cancer
1007002|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
1007003|NCT03117231|osteoarthritis|osteoarthritis
1007004|NCT03117231|elderly|elderly
1007005|NCT03117231|musculoskeletal pain|musculoskeletal pain
1007006|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
1007007|NCT03117192|zinc supplementation|zinc supplementation
1007008|NCT03117192|immunity|immunity
1007009|NCT03117192|thalassemia|thalassemia
1007010|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
1007011|NCT03117140|Brachial Plexus Block|brachial plexus block
1007012|NCT03117140|Clonidine|clonidine
1007013|NCT03117140|Dexamethasone|dexamethasone
1007014|NCT03117140|Buprenorphine|buprenorphine
1007015|NCT03117114|colonoscopy|colonoscopy
1007016|NCT03117114|polyp|polyp
1007018|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
1007019|NCT03117088|Standardized handover|standardized handover
1007020|NCT03117088|Online-based|online-based
1007021|NCT03117088|SOFA-Score|sofa-score
1007022|NCT03117088|ICU|icu
1007023|NCT03117088|ISBAR3|isbar3
1007024|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
1007025|NCT03117036|lymphoma|lymphoma
1007026|NCT03117036|cohort|cohort
1007027|NCT03117036|serum|serum
1007028|NCT03117036|cell-free DNA|cell-free dna
1007029|NCT03117023|dexmedetomidine|dexmedetomidine
1007030|NCT03117023|sleep deprivation|sleep deprivation
1007031|NCT03117023|gastric cancer|gastric cancer
1007032|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
1007033|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1007034|NCT03116997|neuromuscular blockade|neuromuscular blockade
1007035|NCT03116997|sugammadex|sugammadex
1007036|NCT03116997|SUG|sug
1007037|NCT03116997|neostigmine|neostigmine
1007038|NCT03116997|NEO/GLYCO|neo/glyco
1007039|NCT03116997|17-207|17-207
1007040|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
1007041|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
1007042|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
1333118|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
1333119|NCT01444456|Chemotherapy|chemotherapy
1007043|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
1007044|NCT03116958|CPAP compliance|cpap compliance
1007045|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
1007046|NCT03116958|Standard management|standard management
1007047|NCT03116958|Cost-effectiveness|cost-effectiveness
1007048|NCT03116945|PET/CT|pet/ct
1007049|NCT03116945|68Gallium Citrate|68gallium citrate
1007050|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
1007051|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
1007052|NCT03116919|nutrition|nutrition
1007053|NCT03116919|Potatoes|potatoes
1007054|NCT03116919|endothelial function|endothelial function
1007055|NCT03116919|feeding trial|feeding trial
1007056|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
1007057|NCT03116880|Endovascular Procedures|endovascular procedures
1007058|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
1007059|NCT03116854|Beta Blockers|beta blockers
1007060|NCT03116854|Prognosis|prognosis
1007061|NCT03116828|epilepsy|epilepsy
1007062|NCT03116828|seizures|seizures
1007063|NCT03116828|partial on-set seizures|partial on-set seizures
1007064|NCT03116815|blood pressure|blood pressure
1007065|NCT03116815|monitoring|monitoring
1007066|NCT03116815|hypertension|hypertension
1007067|NCT03116815|patient reported outcomes|patient reported outcomes
1007068|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
1007069|NCT03116776|dry eye|dry eye
1007070|NCT03116776|randomized controlled trial|randomized controlled trial
1007071|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
1007072|NCT03116737|AOM|aom
1007073|NCT03116724|catheterization, central venous|catheterization, central venous
1007074|NCT03116724|jugular veins|jugular veins
1007075|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
1007076|NCT03116672|pain|pain
1007077|NCT03116672|Diclofenac|diclofenac
1007078|NCT03116672|NSAID|nsaid
1007079|NCT03116672|Ketorolac|ketorolac
1007080|NCT03116646|mastication|mastication
1007081|NCT03116646|cerebral palsy|cerebral palsy
1007082|NCT03116646|family|family
1007083|NCT03116633|lung cancer|lung cancer
1007084|NCT03116633|biopsy|biopsy
1007085|NCT03116620|mastication|mastication
1007086|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
1007087|NCT03116607|User satisfaction|user satisfaction
1007088|NCT03116607|Readmission|readmission
1007089|NCT03116607|Emergency department|emergency department
1007090|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
1007091|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
1007092|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
1007093|NCT03116581|Perceptual Decision|perceptual decision
1007094|NCT03116581|Social Cognition|social cognition
1007095|NCT03116581|Motivation|motivation
1007096|NCT03116568|IBD|ibd
1007097|NCT03116568|Meconium|meconium
1007098|NCT03116568|Pregnancy|pregnancy
1007099|NCT03116568|Microbiota|microbiota
1007100|NCT03116568|Newborn|newborn
1007101|NCT03116555|Apatinib|apatinib
1007102|NCT03116555|Irinotecan|irinotecan
1007103|NCT03116555|Second-line|second-line
1007104|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
1007105|NCT03116529|Neoadjuvant|neoadjuvant
1007106|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
1007107|NCT03116529|Immunotherapy|immunotherapy
1007108|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
1007109|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
1007110|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
1007111|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
1007112|NCT03116529|Radiotherapy|radiotherapy
1007113|NCT03116529|Durvalumab|durvalumab
1007114|NCT03116529|Tremelimumab|tremelimumab
1007115|NCT03116529|Surgery|surgery
1007116|NCT03116529|Radiation|radiation
1007117|NCT03116529|Combined|combined
1007118|NCT03116529|Preoperative|preoperative
1007119|NCT03116503|Suicide|suicide
1007120|NCT03116490|morbidity|morbidity
1007121|NCT03116490|mortality|mortality
1007122|NCT03116490|hip fracture|hip fracture
1007123|NCT03116490|anesthesia type|anesthesia type
1007124|NCT03116490|POSSUM|possum
1007125|NCT03116451|foot health|foot health
1007126|NCT03116451|nurses|nurses
1007127|NCT03116451|work well-being|work well-being
1007128|NCT03116438|Coronary Artery Disease|coronary artery disease
1007129|NCT03116438|Nuclear Stress Test|nuclear stress test
1007130|NCT03116438|CT Angiography|ct angiography
1007131|NCT03116438|Angiography|angiography
1007132|NCT03116425|Precision Medicine|precision medicine
1007133|NCT03116425|Functional Neuroimaging|functional neuroimaging
1007134|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1007135|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1007136|NCT03116425|Monocentric|monocentric
1007137|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
1333120|NCT01444456|Bladder Cancer|bladder cancer
1007138|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
1007139|NCT03116412|Malignant melanoma|malignant melanoma
1007140|NCT03116412|Follow up|follow up
1007141|NCT03116412|Radiology|radiology
1007142|NCT03116412|Survival|survival
1007143|NCT03116399|Older adults|older adults
1007144|NCT03116399|Social Support|social support
1007145|NCT03116399|Technology uptake|technology uptake
1007147|NCT03116373|Physiology|physiology
1007148|NCT03116373|Head|head
1007149|NCT03116373|Intubation|intubation
1007150|NCT03116373|Intratracheal methods|intratracheal methods
1007151|NCT03116334|Obesity|obesity
1007152|NCT03116334|BMI|bmi
1007153|NCT03116334|executive functioning|executive functioning
1007154|NCT03116334|general cognitive ability|general cognitive ability
1007155|NCT03116334|twin study|twin study
1007156|NCT03116334|heritability|heritability
1007157|NCT03116334|cognition|cognition
1007158|NCT03116334|GCTA|gcta
1007159|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
1007160|NCT03116243|early childhood education|early childhood education
1007161|NCT03116243|head start|head start
1007162|NCT03116230|Knee pathology|knee pathology
1007163|NCT03116217|renal function|renal function
1007164|NCT03116217|post natal|post natal
1007165|NCT03116217|peptidome|peptidome
1007166|NCT03116204|Dependency|dependency
1007167|NCT03116204|FRC department|frc department
1007168|NCT03116204|scale validation|scale validation
1007169|NCT03116204|validity|validity
1007170|NCT03116204|reliability|reliability
1007171|NCT03116178|Fluid therapy|fluid therapy
1007172|NCT03116178|oximetry|oximetry
1007173|NCT03116178|thromboelastography|thromboelastography
1007174|NCT03116178|intraoperative/method|intraoperative/method
1007175|NCT03116178|monitoring|monitoring
1007176|NCT03116139|Computed tomography scan|computed tomography scan
1007177|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
1007178|NCT03116139|Acute kidney injury|acute kidney injury
1007179|NCT03116139|Pulmonary embolism|pulmonary embolism
1007180|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
1007181|NCT03116087|Postmenopausal women|postmenopausal women
1007182|NCT03116061|Multimorbidity|multimorbidity
1007183|NCT03116061|Family Medicine|family medicine
1007184|NCT03116061|decompensation|decompensation
1007185|NCT03116061|predictive value|predictive value
1007186|NCT03116022|menopause|menopause
1007187|NCT03116022|sexual dysfunction|sexual dysfunction
1007188|NCT03116022|coital pain|coital pain
1007189|NCT03116022|vagina|vagina
1007190|NCT03116009|Obesity|obesity
1007191|NCT03116009|Pregnancy|pregnancy
1007192|NCT03116009|Diabetes Mellitus|diabetes mellitus
1007193|NCT03116009|Perinatal Outcomes|perinatal outcomes
1007194|NCT03115957|Parenteral Nutrition|parenteral nutrition
1007195|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
1007196|NCT03115957|Randomized Controlled Trials|randomized controlled trials
1007197|NCT03115957|Clinical Outcomes|clinical outcomes
1007198|NCT03115957|Postoperative Period|postoperative period
1007199|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
1007200|NCT03115905|Emergency Medical Services|emergency medical services
1007201|NCT03115905|Registry Study|registry study
1007202|NCT03115905|China|china
1007203|NCT03115866|Healthy Diet|healthy diet
1007204|NCT03115866|Fruits and Vegetables|fruits and vegetables
1007205|NCT03115866|Metabolome|metabolome
1007206|NCT03115866|Microbiome|microbiome
1007207|NCT03115866|Young Adults|young adults
1007208|NCT03115788|Thermal|thermal
1007209|NCT03115762|ASKB1202|askb1202
1007210|NCT03115749|Crohn's disease|crohn's disease
1007211|NCT03115749|ulcerative colitis|ulcerative colitis
1007212|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
1007213|NCT03115749|intestinal inflammation|intestinal inflammation
1007214|NCT03115736|HIV|hiv
1007216|NCT03115736|Renal dysfunction|renal dysfunction
1007217|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
1007218|NCT03115723|Hospitalization|hospitalization
1007219|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
1007220|NCT03115710|Keratoconus|keratoconus
1007221|NCT03115710|Prevalence|prevalence
1007222|NCT03115671|Phosphatidylserine|phosphatidylserine
1007223|NCT03115671|Omega-3|omega-3
1007224|NCT03115606|videolaryngoscope|videolaryngoscope
1007225|NCT03115606|Fastrach LMA|fastrach lma
1007226|NCT03115606|cervical motion|cervical motion
1007227|NCT03115593|hysteroscopy|hysteroscopy
1007228|NCT03115593|pipette|pipette
1007229|NCT03115593|biopsy|biopsy
1007230|NCT03115593|endometrial cancer|endometrial cancer
1007231|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1007232|NCT03115541|deep vein thrombosis|deep vein thrombosis
1007233|NCT03115541|pulmonary embolus|pulmonary embolus
1007234|NCT03115541|esophageal resection|esophageal resection
1007235|NCT03115541|incidence|incidence
1007236|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1007237|NCT03115528|Medical oncologists|medical oncologists
1007238|NCT03115528|Palliative care physicians|palliative care physicians
1007239|NCT03115528|Questionnaire|questionnaire
1007240|NCT03115528|Survey|survey
1007241|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
1007242|NCT03115489|seizure|seizure
1007243|NCT03115489|glutamate activation|glutamate activation
1007244|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
1007245|NCT03115489|gamma-aminobutyric acid receptor|gamma-aminobutyric acid receptor
1007246|NCT03115489|Ketamine|ketamine
1007247|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
1007248|NCT03115463|Prematurity|prematurity
1007249|NCT03115463|Oxygen|oxygen
1007250|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
1007251|NCT03115450|Placement of Bolt|placement of bolt
1007252|NCT03115437|Body mass|body mass
1007253|NCT03115437|Running-related injury|running-related injury
1007254|NCT03115437|Sports injury prevention|sports injury prevention
1007255|NCT03115437|Impact forces|impact forces
1007256|NCT03115437|Epidemiology|epidemiology
1007257|NCT03115437|Running biomechanics|running biomechanics
1007258|NCT03115437|Sports footwear|sports footwear
1007259|NCT03115437|Shoe cushioning|shoe cushioning
1007260|NCT03115424|Weight Loss|weight loss
1007261|NCT03115424|Bariatric Surgery|bariatric surgery
1007262|NCT03115398|Fitness Tracker|fitness tracker
1007263|NCT03115398|Activity Monitoring|activity monitoring
1007264|NCT03115398|Chemotherapy|chemotherapy
1007265|NCT03115398|Radiation Therapy|radiation therapy
1007266|NCT03115398|Chemoradiotherapy|chemoradiotherapy
1007267|NCT03115359|Chronic Low Back Pain|chronic low back pain
1007268|NCT03115359|Opioid Therapy|opioid therapy
1007269|NCT03115359|Chronic Pain|chronic pain
1007270|NCT03115359|Mindfulness Meditation|mindfulness meditation
1007271|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
1007272|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
1007273|NCT03115359|CLBP|clbp
1007274|NCT03115307|Insemination|insemination
1007275|NCT03115307|Luteal phase support|luteal phase support
1007276|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
1007277|NCT03115307|Triptoreline|triptoreline
1007278|NCT03115268|social support|social support
1007279|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
1007280|NCT03115255|ranibizumab|ranibizumab
1007281|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
1007282|NCT03115229|Obesity|obesity
1007283|NCT03115229|Overweight|overweight
1007284|NCT03115229|Physical Activity|physical activity
1007285|NCT03115229|Nutrition|nutrition
1007286|NCT03115229|Nursing|nursing
1007287|NCT03115203|muscle skin|muscle skin
1007288|NCT03115203|IRM 3 tesla|irm 3 tesla
1007289|NCT03115138|Biopsy|biopsy
1007290|NCT03115125|B lymphocyte|b lymphocyte
1007291|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
1007292|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
1007293|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
1007294|NCT03115086|Cholic Acid|cholic acid
1007295|NCT03115086|Cholbam|cholbam
1007296|NCT03115086|Kolbam|kolbam
1007297|NCT03115086|The Replace Registry|the replace registry
1007298|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
1007299|NCT03115073|Candiplus|candiplus
1007300|NCT03115073|Clotrimazole|clotrimazole
1007301|NCT03115073|Safety|safety
1007302|NCT03115073|Tolerability|tolerability
1007303|NCT03115073|Clinical efficacy|clinical efficacy
1007304|NCT03115034|carotid stenosis|carotid stenosis
1007305|NCT03115034|melatonin|melatonin
1007306|NCT03115034|vascular injury|vascular injury
1007307|NCT03115034|ischemia reperfusion|ischemia reperfusion
1007308|NCT03114995|Tirofiban|tirofiban
1007309|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
1007310|NCT03114982|Prevention of varicella|prevention of varicella
1007311|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
1007312|NCT03114969|Overall error|overall error
1007313|NCT03114969|Error rate|error rate
1007314|NCT03114969|Critical error|critical error
1007315|NCT03114969|COPD|copd
1007316|NCT03114969|ELLIPTA|ellipta
1007317|NCT03114969|Dry powder inhaler|dry powder inhaler
1007318|NCT03114943|prevention of varicella|prevention of varicella
1007319|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
1007320|NCT03114917|Suicide|suicide
1007321|NCT03114917|Self-harm|self-harm
1007322|NCT03114917|Psychosis|psychosis
1007323|NCT03114917|Community|community
1007324|NCT03114917|Suicide Prevention|suicide prevention
1007326|NCT03114917|CARMS|carms
1007327|NCT03114917|Randomised controlled trial|randomised controlled trial
1007328|NCT03114891|post-traumatic stress|post-traumatic stress
1007329|NCT03114891|depression|depression
1007330|NCT03114865|bone marrow|bone marrow
1007331|NCT03114865|bone marrow transplant|bone marrow transplant
1007332|NCT03114865|allogeneic|allogeneic
1007333|NCT03114865|tacrolimus|tacrolimus
1007334|NCT03114865|cyclophosphamide|cyclophosphamide
1007335|NCT03114865|Blinatumomab|blinatumomab
1007336|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
1007337|NCT03114839|Yakult|yakult
1007338|NCT03114839|IntelliCap|intellicap
1007339|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1007340|NCT03114761|Internal Herniation|internal herniation
1007341|NCT03114761|Computed Tomography|computed tomography
1007342|NCT03114748|deep brain stimulation|deep brain stimulation
1007343|NCT03114748|EEG|eeg
1007344|NCT03114709|Mindfulness|mindfulness
1007345|NCT03114709|Exercise|exercise
1007346|NCT03114709|Physical activity|physical activity
1007347|NCT03114709|Behavior change|behavior change
1007348|NCT03114709|Aging|aging
1007349|NCT03114709|Randomized controlled trial|randomized controlled trial
1007350|NCT03114709|Pilot|pilot
1007351|NCT03114670|Leukemia|leukemia
1007352|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
1007353|NCT03114670|Recurrence|recurrence
1007354|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
1007355|NCT03114670|Disease Attributes|disease attributes
1007356|NCT03114670|Cyclophosphamide|cyclophosphamide
1007357|NCT03114670|Fludarabine|fludarabine
1007358|NCT03114670|CD123|cd123
1007359|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
1007360|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
1007361|NCT03114566|transplant donor|transplant donor
1007362|NCT03114566|HLA typed|hla typed
1007363|NCT03114566|17-211|17-211
1007364|NCT03114553|family health history|family health history
1007365|NCT03114553|prevention|prevention
1007366|NCT03114553|genetic risk|genetic risk
1007367|NCT03114553|clinical decision support|clinical decision support
1007368|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
1007369|NCT03114527|DDL|ddl
1007370|NCT03114527|Leiomyosarcoma|leiomyosarcoma
1007372|NCT03114527|Ribociclib|ribociclib
1007373|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
1007374|NCT03114501|Head and Neck Cancer|head and neck cancer
1007375|NCT03114501|Yoga|yoga
1007376|NCT03114501|Questionnaires|questionnaires
1007377|NCT03114501|Surveys|surveys
1007378|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
1007379|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
1007380|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
1007381|NCT03114462|HYDRA|hydra
1007382|NCT03114462|Questionnaires|questionnaires
1007383|NCT03114462|Surveys|surveys
1007384|NCT03114423|EMDR|emdr
1007385|NCT03114423|Psychotherapy|psychotherapy
1007386|NCT03114423|Substance Use Disorders|substance use disorders
1007387|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
1007388|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
1007389|NCT03114371|Oxytocin|oxytocin
1007390|NCT03114371|Behavioural troubles|behavioural troubles
1007391|NCT03114358|De-escalation|de-escalation
1007392|NCT03114358|Carbapenems|carbapenems
1007393|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
1007394|NCT03114345|Pressure ulcer|pressure ulcer
1007395|NCT03114345|Interface pressure|interface pressure
1007396|NCT03114345|Pressure mapping device|pressure mapping device
1007397|NCT03114345|Monitoring|monitoring
1007398|NCT03114345|Microvascularization|microvascularization
1007399|NCT03114319|TNO155|tno155
1007400|NCT03114319|SHP2|shp2
1007401|NCT03114319|advanced solid tumor|advanced solid tumor
1007402|NCT03114319|NSCLC|nsclc
1007403|NCT03114319|HNSCC|hnscc
1007404|NCT03114319|Esophageal SCC|esophageal scc
1007405|NCT03114319|EGFR|egfr
1007406|NCT03114319|GIST|gist
1007407|NCT03114319|PTPN11|ptpn11
1007408|NCT03114319|cancers with a mass|cancers with a mass
1007409|NCT03114319|bulky tumor|bulky tumor
1007410|NCT03114319|nodule|nodule
1007411|NCT03114319|lump|lump
1007412|NCT03114319|advanced solid malignancies|advanced solid malignancies
1007413|NCT03114306|ERAS|eras
1007414|NCT03114306|pain|pain
1007415|NCT03114306|knee arthroplasty|knee arthroplasty
1007416|NCT03114306|joint pain|joint pain
1007816|NCT03112200|AccuFill|accufill
1007417|NCT03114306|regional anaesthesia|regional anaesthesia
1007418|NCT03114293|Physical activity|physical activity
1007419|NCT03114293|Mobility|mobility
1007420|NCT03114254|Recurrent|recurrent
1007421|NCT03114254|Locally advanced|locally advanced
1007422|NCT03114254|Metastatic|metastatic
1007423|NCT03114241|COPD|copd
1007424|NCT03114241|Physical activity|physical activity
1007425|NCT03114241|Endothelial function|endothelial function
1007426|NCT03114228|myeloid|myeloid
1007427|NCT03114228|leukemia|leukemia
1007428|NCT03114228|FLT3-mutated|flt3-mutated
1007429|NCT03114228|PKC412|pkc412
1007430|NCT03114228|midostaurin|midostaurin
1007431|NCT03114228|adult|adult
1007432|NCT03114228|AML|aml
1007433|NCT03114228|ETP|etp
1007434|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
1007435|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
1007436|NCT03114215|Biotin|biotin
1007437|NCT03114215|MD1003|md1003
1007438|NCT03114215|ALSFRS-R|alsfrs-r
1007439|NCT03114189|Sleep disturbance|sleep disturbance
1007440|NCT03114189|footbath|footbath
1007442|NCT03114189|care of sleep|care of sleep
1007443|NCT03114189|sleep|sleep
1007444|NCT03114150|physical activity|physical activity
1007445|NCT03114150|aging|aging
1007446|NCT03114150|learning and memory|learning and memory
1007447|NCT03114150|exercise|exercise
1007448|NCT03114150|brain|brain
1007449|NCT03114137|Sub-Saharan Africa|sub-saharan africa
1007450|NCT03114137|Sickle Cell Disease|sickle cell disease
1007451|NCT03114137|Vasculopathy|vasculopathy
1007452|NCT03114137|Nephropathy|nephropathy
1007453|NCT03114137|Pulmonary hypertension|pulmonary hypertension
1007454|NCT03114137|cardiac disease|cardiac disease
1007455|NCT03114137|hemolysis|hemolysis
1007456|NCT03114137|pulse wave velocity|pulse wave velocity
1007457|NCT03114137|blood viscosity|blood viscosity
1007458|NCT03114124|ablation|ablation
1007459|NCT03114124|atrioventricular node|atrioventricular node
1007460|NCT03114124|microfidelity|microfidelity
1007461|NCT03114098|Drug Resistance|drug resistance
1007462|NCT03114098|CYP2D6|cyp2d6
1007463|NCT03114098|cytochrom P450|cytochrom p450
1007464|NCT03114072|Pregnancy|pregnancy
1007465|NCT03114072|Blue-blockers|blue-blockers
1007466|NCT03114072|Sleep quality|sleep quality
1007467|NCT03114072|Melatonin|melatonin
1007468|NCT03114059|Late Effects of Surgery|late effects of surgery
1007469|NCT03114033|Cardiac Arrest|cardiac arrest
1007470|NCT03114033|Intensive Care Unit|intensive care unit
1007471|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
1007472|NCT03114033|Normocapnia|normocapnia
1007473|NCT03114033|Mortality|mortality
1007474|NCT03114033|Neurological function|neurological function
1007475|NCT03114020|Emphysema|emphysema
1007476|NCT03114020|COPD|copd
1007477|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1007478|NCT03114007|Mental health problems|mental health problems
1007479|NCT03114007|Substance misuse|substance misuse
1007480|NCT03114007|Psychosocial difficulties|psychosocial difficulties
1007481|NCT03114007|Youth|youth
1007482|NCT03113994|Spinal Cord Injury|spinal cord injury
1007483|NCT03113994|Osteoporosis|osteoporosis
1007484|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
1007485|NCT03113916|Culturally-tailored|culturally-tailored
1007486|NCT03113916|Weight Loss|weight loss
1007487|NCT03113916|Diabetes|diabetes
1007488|NCT03113916|Women|women
1007489|NCT03113916|Hispanic|hispanic
1007490|NCT03113916|Obesity|obesity
1007491|NCT03113903|Pain|pain
1007492|NCT03113903|psychophysics|psychophysics
1007493|NCT03113903|Nociception|nociception
1007494|NCT03113903|Sensitivity|sensitivity
1007495|NCT03113903|Senses|senses
1007496|NCT03113903|Phenotyping|phenotyping
1007497|NCT03113903|Questionnaire|questionnaire
1007498|NCT03113903|Anxiety|anxiety
1007499|NCT03113903|Depression|depression
1007500|NCT03113903|Catastrophizing|catastrophizing
1007501|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
1007503|NCT03113890|assay|assay
1007504|NCT03113890|PTSD|ptsd
1007505|NCT03113890|pharmacodynamic|pharmacodynamic
1007506|NCT03113890|pharmacokinetic|pharmacokinetic
1007507|NCT03113890|psychiatric disorders|psychiatric disorders
1007508|NCT03113864|Vision|vision
1007509|NCT03113864|Eye Health|eye health
1007510|NCT03113864|Lutein|lutein
1007511|NCT03113864|Carotenoids|carotenoids
1007512|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
1007513|NCT03113825|breast carcinoma|breast carcinoma
1007514|NCT03113825|DCIS|dcis
1007515|NCT03113786|Discectomy|discectomy
1007516|NCT03113786|Lumbar discectomy|lumbar discectomy
1007517|NCT03113786|Protruding disc|protruding disc
1007518|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
1007519|NCT03113747|burn wounds|burn wounds
1007520|NCT03113747|wound healing|wound healing
1007521|NCT03113747|regeneration|regeneration
1007522|NCT03113747|repair|repair
1007523|NCT03113747|skin tissue engineering|skin tissue engineering
1007524|NCT03113708|heparin|heparin
1007525|NCT03113708|heparin antagonists|heparin antagonists
1007526|NCT03113708|cardiac surgery|cardiac surgery
1009067|NCT03104543|adherence|adherence
1007527|NCT03113708|active clotting time|active clotting time
1007528|NCT03113695|Richter's Syndrome|richter's syndrome
1007530|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
1007531|NCT03113695|obinutuzumab|obinutuzumab
1007532|NCT03113695|HDMP|hdmp
1007533|NCT03113695|lenalidomide|lenalidomide
1007534|NCT03113695|cancer|cancer
1007535|NCT03113695|methylprednisolone|methylprednisolone
1007536|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
1007537|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
1007538|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1007539|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1007540|NCT03113630|User-Computer Interface|user-computer interface
1007541|NCT03113630|Rehabilitation|rehabilitation
1007542|NCT03113630|Motor Activity|motor activity
1007543|NCT03113591|total hip arthroplasty|total hip arthroplasty
1007544|NCT03113591|minimal invasive|minimal invasive
1007545|NCT03113578|Balloon enteroscopy|balloon enteroscopy
1031565|NCT02966093|E7080|e7080
1007546|NCT03113578|colonoscopy|colonoscopy
1007547|NCT03113578|polyps|polyps
1007548|NCT03113461|cognitive impairment|cognitive impairment
1007549|NCT03113461|sleep apnea|sleep apnea
1007550|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
1007551|NCT03113448|capsaicin|capsaicin
1007552|NCT03113448|neuropathic pain|neuropathic pain
1007553|NCT03113448|diabetic neuropathy|diabetic neuropathy
1007554|NCT03113448|topical lotion|topical lotion
1007555|NCT03113435|CO2 gap|co2 gap
1007556|NCT03113435|oxygen consumption|oxygen consumption
1007557|NCT03113435|Stroke volume optimization|stroke volume optimization
1007558|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
1007559|NCT03113422|Venetoclax|venetoclax
1007560|NCT03113422|Obinutuzumab|obinutuzumab
1007561|NCT03113422|Bendamustine|bendamustine
1007562|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
1007563|NCT03113422|Monoclonal Antibody|monoclonal antibody
1007564|NCT03113409|Outpatient detoxification|outpatient detoxification
1007565|NCT03113409|Opioid dependence|opioid dependence
1007566|NCT03113409|Naltrexone|naltrexone
1007567|NCT03113409|Vivitrol|vivitrol
1007568|NCT03113409|Buprenorphine|buprenorphine
1007569|NCT03113383|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
1007570|NCT03113383|Endovascular Aneurysm Repair|endovascular aneurysm repair
1007571|NCT03113383|Stent-Graft|stent-graft
1007572|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1007573|NCT03113370|tobacco use|tobacco use
1007574|NCT03113370|postpartum|postpartum
1007575|NCT03113357|myofascial release|myofascial release
1007576|NCT03113357|cervicogenic headache|cervicogenic headache
1007577|NCT03113357|pain intensity|pain intensity
1007578|NCT03113357|exercise therapy|exercise therapy
1007579|NCT03113357|pressure pain threshold|pressure pain threshold
1007580|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
1007581|NCT03113331|Preterm birth|preterm birth
1007582|NCT03113331|Birth defect|birth defect
1007583|NCT03113331|Infant growth|infant growth
1007584|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
1007585|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
1007586|NCT03113318|Metastasis|metastasis
1007587|NCT03113318|colorectal neoplasm|colorectal neoplasm
1007588|NCT03113305|Gastric bypass|gastric bypass
1007589|NCT03113305|Morbid obesity|morbid obesity
1007590|NCT03113305|Food choice|food choice
1007591|NCT03113305|Ingestive behaviour|ingestive behaviour
1007592|NCT03113292|physical therapy|physical therapy
1007593|NCT03113292|therapeutic exercises|therapeutic exercises
1007594|NCT03113292|low back pain|low back pain
1007595|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1007596|NCT03113266|Metastatic|metastatic
1007597|NCT03113266|Advanced|advanced
1007598|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
1007599|NCT03113253|Tranexamic Acid|tranexamic acid
1007600|NCT03113253|Burn|burn
1007601|NCT03113253|Surgery|surgery
1007602|NCT03113253|Excision|excision
1007603|NCT03113240|Glutamin|glutamin
1007604|NCT03113240|Enteral Nutrition|enteral nutrition
1007605|NCT03113240|Intensive Care Unit|intensive care unit
1007606|NCT03113240|Intestinal Permeability|intestinal permeability
1007607|NCT03113227|induction of labor|induction of labor
1007608|NCT03113227|Bishop score|bishop score
1007609|NCT03113227|posterior cervical angle|posterior cervical angle
1007610|NCT03113227|cervical length|cervical length
1007611|NCT03113201|Depression|depression
1007612|NCT03113201|Collaborative care|collaborative care
1007613|NCT03113201|Care manager|care manager
1007614|NCT03113201|Anxiety|anxiety
1007615|NCT03113201|Psychiatry|psychiatry
1007616|NCT03113201|Consultation-liaison|consultation-liaison
1007617|NCT03113201|General practitioner|general practitioner
1007618|NCT03113175|Anxiety|anxiety
1007619|NCT03113175|Collaborative care|collaborative care
1007620|NCT03113175|Consultation-liaison|consultation-liaison
1007621|NCT03113175|General practitioner|general practitioner
1007622|NCT03113175|Psychiatry|psychiatry
1007623|NCT03113162|multiple sclerosis|multiple sclerosis
1007624|NCT03113162|HSCT|hsct
1007625|NCT03113149|Physical Therapy Modalities|physical therapy modalities
1007626|NCT03113149|Recovery of Function|recovery of function
1007627|NCT03113149|Predictive Value of Tests|predictive value of tests
1007628|NCT03113149|Cohort Studies|cohort studies
1007629|NCT03113123|Adherence|adherence
1007630|NCT03113123|Prevention|prevention
1007631|NCT03113123|Tenofovir|tenofovir
1007632|NCT03113123|Emtricitabine|emtricitabine
1007633|NCT03113123|Antiretroviral|antiretroviral
1007634|NCT03113123|Prophylaxis|prophylaxis
1007635|NCT03113123|Men who have sex with men|men who have sex with men
1007636|NCT03113110|Empagliflozin|empagliflozin
1007637|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
1007638|NCT03113110|Glucose Metabolism|glucose metabolism
1007639|NCT03113084|Sodium Heparin|sodium heparin
1007640|NCT03113084|Pharmacokinetics|pharmacokinetics
1007641|NCT03113084|Coagulation factor|coagulation factor
1333121|NCT01444456|Endometrial Cancer|endometrial cancer
1031746|NCT02964884|NF1|nf1
1007642|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
1007643|NCT03113032|total knee replacement|total knee replacement
1007644|NCT03113032|sensorimotor training|sensorimotor training
1007645|NCT03113032|pre-surgery exercise|pre-surgery exercise
1007646|NCT03113032|sensorimotor function|sensorimotor function
1007647|NCT03113032|neuromuscular|neuromuscular
1007648|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
1007649|NCT03112993|spine surgery|spine surgery
1007650|NCT03112993|neuromuscular blockade|neuromuscular blockade
1007651|NCT03112993|sugammadex|sugammadex
1007652|NCT03112993|elderly|elderly
1007653|NCT03112993|reversal|reversal
1007654|NCT03112993|neostigmine|neostigmine
1007655|NCT03112993|recovery|recovery
1008446|NCT03108482|Acute Pain|acute pain
1007656|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
1007657|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1007658|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
1007659|NCT03112980|Intermediate operative risk|intermediate operative risk
1007660|NCT03112915|postoperative pain|postoperative pain
1007661|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1007662|NCT03112915|Quadratus lumborum block|quadratus lumborum block
1007663|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
1007664|NCT03112889|McArdle Disease|mcardle disease
1007665|NCT03112889|McArdle's Disease|mcardle's disease
1007666|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
1007667|NCT03112889|GSDV|gsdv
1007668|NCT03112889|Sodium Valproate|sodium valproate
1007669|NCT03112889|Valproic Acid|valproic acid
1007670|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
1007671|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
1007672|NCT03112889|Glycogenosis|glycogenosis
1007673|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
1007674|NCT03112876|younger age|younger age
1007675|NCT03112876|older age|older age
1007676|NCT03112876|atopic dermatitis|atopic dermatitis
1007677|NCT03112876|acne|acne
1007678|NCT03112876|smoker|smoker
1007679|NCT03112850|Crossover design|crossover design
1007680|NCT03112850|Randomized controlled trial|randomized controlled trial
1007681|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
1007682|NCT03112798|tracheal intubation|tracheal intubation
1007683|NCT03112798|Macintosh blade|macintosh blade
1007684|NCT03112798|Miller blade|miller blade
1007686|NCT03112785|Arthroplasty|arthroplasty
1007687|NCT03112785|Stem|stem
1007688|NCT03112785|Outcome|outcome
1007689|NCT03112746|child|child
1007690|NCT03112746|goal|goal
1007691|NCT03112746|intervention|intervention
1007692|NCT03112746|motor skills disorder|motor skills disorder
1007693|NCT03112746|occupational therapy|occupational therapy
1007694|NCT03112655|diagnosis|diagnosis
1007695|NCT03112655|sensitivity|sensitivity
1007696|NCT03112655|specificity|specificity
1007697|NCT03112655|therapeutic outcome|therapeutic outcome
1007698|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
1007699|NCT03112629|Quality of Care|quality of care
1007700|NCT03112629|aortic stenosis|aortic stenosis
1007701|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1007702|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
1007703|NCT03112629|facilitated data relay|facilitated data relay
1007704|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
1007705|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
1007706|NCT03112603|steroid-refractory|steroid-refractory
1007707|NCT03112603|ruxolitinib|ruxolitinib
1007708|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
1007709|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
1007710|NCT03112590|Unresectable breast cancer|unresectable breast cancer
1007711|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
1007712|NCT03112590|Metastatic breast cancer|metastatic breast cancer
1007713|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
1007714|NCT03112564|Endotracheal intubation|endotracheal intubation
1007715|NCT03112564|muscle relaxants|muscle relaxants
1007716|NCT03112564|inhalational anesthesia|inhalational anesthesia
1007717|NCT03112538|insulin pump|insulin pump
1007718|NCT03112538|basal bolus insulin|basal bolus insulin
1007719|NCT03112525|rivaroxaban|rivaroxaban
1007720|NCT03112525|apixaban|apixaban
1007721|NCT03112525|cytochrome|cytochrome
1007722|NCT03112525|anticoagulant|anticoagulant
1007723|NCT03112525|transporter|transporter
1007724|NCT03112525|polymorphism|polymorphism
1007725|NCT03112525|genotyping|genotyping
1007726|NCT03112525|phenotyping|phenotyping
1007727|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
1007728|NCT03112512|Electrical impedance tomography|electrical impedance tomography
1007729|NCT03112499|Acute Kidney Injury|acute kidney injury
1007730|NCT03112499|PCNL|pcnl
1007731|NCT03112499|mini-PCNL|mini-pcnl
1007732|NCT03112499|RIRS|rirs
1007733|NCT03112499|urine biomarkers|urine biomarkers
1007734|NCT03112486|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1007735|NCT03112486|neurological outcome|neurological outcome
1007736|NCT03112486|prognostication|prognostication
1007737|NCT03112486|cerebral performance category|cerebral performance category
1007738|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
1007739|NCT03112486|biomarkers|biomarkers
1007740|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1007741|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
1007742|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
1007743|NCT03112421|IVD|ivd
1007744|NCT03112408|cerebellar lesion|cerebellar lesion
1007745|NCT03112408|saccadic adaptation|saccadic adaptation
1007746|NCT03112408|spatial localization|spatial localization
1007747|NCT03112408|visuo spatial perception|visuo spatial perception
1007748|NCT03112408|eye movements|eye movements
1007749|NCT03112369|American Indian / Alaska Native|american indian / alaska native
1007750|NCT03112369|HIV Prevention|hiv prevention
1007751|NCT03112369|Sexual Risk Behavior|sexual risk behavior
1007752|NCT03112369|Trauma|trauma
1007753|NCT03112369|Substance Use|substance use
1007754|NCT03112356|infectious endocarditis|infectious endocarditis
1007755|NCT03112356|prosthetic valve infection|prosthetic valve infection
1007756|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
1007757|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
1007758|NCT03112343|ICT based clinical trial|ict based clinical trial
1007759|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
1007760|NCT03112343|eCRF|ecrf
1007761|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
1007762|NCT03112343|Centralized monitoring|centralized monitoring
1007763|NCT03112330|atrophic rhinitis|atrophic rhinitis
1007764|NCT03112317|Surgery|surgery
1007765|NCT03112317|Hypothermia|hypothermia
1007766|NCT03112317|Prevention|prevention
1007767|NCT03112317|Surgical Site Infection|surgical site infection
1007768|NCT03112317|Bleeding|bleeding
1007769|NCT03112304|children|children
1007770|NCT03112304|youth|youth
1007771|NCT03112304|adolescents|adolescents
1007772|NCT03112304|anxiety|anxiety
1007773|NCT03112304|depression|depression
1007774|NCT03112304|trauma|trauma
1007775|NCT03112304|behavior problems|behavior problems
1007776|NCT03112304|evidence-based treatments|evidence-based treatments
1007777|NCT03112304|manualized|manualized
1007778|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
1007779|NCT03112304|mental health|mental health
1007780|NCT03112291|anti-microbial agents|anti-microbial agents
1007781|NCT03112291|apexification|apexification
1007782|NCT03112291|dental pulp|dental pulp
1007783|NCT03112291|endodontics|endodontics
1007784|NCT03112291|root canal therapy|root canal therapy
1007785|NCT03112291|dental trauma|dental trauma
1007786|NCT03112278|tooth erosion|tooth erosion
1007787|NCT03112278|Computer-Aided Design|computer-aided design
1007788|NCT03112278|occlusal veneers|occlusal veneers
1007789|NCT03112278|dental veneers|dental veneers
1007790|NCT03112265|anxiety|anxiety
1007791|NCT03112265|depression|depression
1007792|NCT03112265|trauma|trauma
1007793|NCT03112265|behavior problems|behavior problems
1007794|NCT03112265|evidence-based treatments|evidence-based treatments
1007795|NCT03112265|manualized treatments|manualized treatments
1007796|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
1007797|NCT03112265|youth|youth
1007798|NCT03112265|mental health|mental health
1007799|NCT03112265|self-regulation|self-regulation
1007800|NCT03112265|neuroimaging|neuroimaging
1007801|NCT03112252|Immunotherapy|immunotherapy
1007802|NCT03112239|Asthma|asthma
1007803|NCT03112239|Photobiomodulation|photobiomodulation
1007804|NCT03112239|Resistance Training|resistance training
1007805|NCT03112226|cognitive impairment|cognitive impairment
1007806|NCT03112226|menopause|menopause
1007807|NCT03112226|estrogen|estrogen
1007808|NCT03112226|functional MRI|functional mri
1007809|NCT03112226|executive function|executive function
1007810|NCT03112226|endothelial function|endothelial function
1007811|NCT03112226|arterial stiffness|arterial stiffness
1007812|NCT03112200|Subchondroplasty|subchondroplasty
1007813|NCT03112200|Arthroscopy|arthroscopy
1007814|NCT03112200|Bone Substitute Material|bone substitute material
1007815|NCT03112200|Subchondral Bone Defect|subchondral bone defect
1007817|NCT03112200|Bone Marrow Lesion|bone marrow lesion
1007818|NCT03112187|IDA|ida
1007819|NCT03112187|iron deficiency anemia|iron deficiency anemia
1007820|NCT03112187|iron supplements|iron supplements
1007821|NCT03112187|Pakistan|pakistan
1007822|NCT03112187|Liposomal iron|liposomal iron
1007823|NCT03112174|PCYC|pcyc
1007824|NCT03112174|MCL|mcl
1007825|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1007826|NCT03112174|NHL|nhl
1007827|NCT03112174|ibrutinib|ibrutinib
1007828|NCT03112174|venetoclax|venetoclax
1007829|NCT03112174|Pharmacyclics|pharmacyclics
1007830|NCT03112122|Bone Marrow Edema|bone marrow edema
1007831|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
1007832|NCT03112096|Tau|tau
1007833|NCT03112096|neurodegeneration|neurodegeneration
1007834|NCT03112096|positron emission tomography|positron emission tomography
1007835|NCT03112083|krill powder|krill powder
1007836|NCT03112083|krill oil|krill oil
1007837|NCT03112083|safety|safety
1007838|NCT03112083|tolerability|tolerability
1007839|NCT03112083|adverse event|adverse event
1007840|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
1007841|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
1007842|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
1007843|NCT03112044|Lung|lung
1007844|NCT03112044|Transplant|transplant
1007845|NCT03112044|Hepatitis C|hepatitis c
1007846|NCT03112044|DAAs|daas
1007847|NCT03112044|Epclusa|epclusa
1007848|NCT03112031|Tamoxifen|tamoxifen
1007849|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
1007850|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
1007851|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
1007852|NCT03112018|premature birth|premature birth
1007857|NCT03111992|Multiple Myeloma,|multiple myeloma,
1007858|NCT03111992|Hematologic Diseases,|hematologic diseases,
1007859|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
1007860|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
1007861|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
1007862|NCT03111979|beta-alanine|beta-alanine
1007863|NCT03111979|Carnosine|carnosine
1007864|NCT03111979|Neuromuscular|neuromuscular
1007865|NCT03111979|Stimulation|stimulation
1007866|NCT03111979|Skeletal muscle|skeletal muscle
1007867|NCT03111966|Hepatitis C|hepatitis c
1007868|NCT03111953|Bariatric Surgery|bariatric surgery
1007869|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1007870|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
1007871|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
1007872|NCT03111901|pembrolizumab|pembrolizumab
1007873|NCT03111901|IL-2|il-2
1007874|NCT03111901|interleukin-2|interleukin-2
1007875|NCT03111901|MK-3475|mk-3475
1007876|NCT03111875|Hypothermia|hypothermia
1007877|NCT03111875|Intraoperative warming|intraoperative warming
1007878|NCT03111875|non-cardiac surgery|non-cardiac surgery
1007879|NCT03111875|myocardial injury|myocardial injury
1007880|NCT03111849|COPD|copd
1007881|NCT03111849|Sarcopenia|sarcopenia
1007882|NCT03111849|Prevalence|prevalence
1007883|NCT03111849|Mortality|mortality
1007884|NCT03111849|Malnutrition|malnutrition
1007885|NCT03111849|Nutritional assessment|nutritional assessment
1007886|NCT03111849|Body composition|body composition
1007887|NCT03111849|Pulmonary cachexia|pulmonary cachexia
1007888|NCT03111810|Corticosteroids|corticosteroids
1007889|NCT03111810|Prednisolone|prednisolone
1007890|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
1007891|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
1007892|NCT03111810|AZD4017|azd4017
1007893|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
1007894|NCT03111771|Cancer|cancer
1007895|NCT03111771|Cachexia|cachexia
1007896|NCT03111771|Myosteatosis|myosteatosis
1007897|NCT03111771|Mitochondrial activity|mitochondrial activity
1007898|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
1007899|NCT03111771|Lipotoxicity|lipotoxicity
1007903|NCT03111732|Immune-Based Strategies|immune-based strategies
1007904|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
1007905|NCT03111732|Chronic Inflammation|chronic inflammation
1007906|NCT03111732|Combination Chemotherapy|combination chemotherapy
1007907|NCT03111693|Epicardial fat|epicardial fat
1007908|NCT03111693|Obesity|obesity
1007909|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
1007910|NCT03111693|Metabolic syndrome|metabolic syndrome
1007911|NCT03111693|Low dose computed tomography|low dose computed tomography
1007912|NCT03111667|Marijuana|marijuana
1007913|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
1007914|NCT03111667|Adolescents|adolescents
1007915|NCT03111615|Aromatase inhibitors|aromatase inhibitors
1007916|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
1007917|NCT03111602|polyphenols|polyphenols
1007918|NCT03111602|pregnant|pregnant
1007919|NCT03111602|fetal ductal constriction|fetal ductal constriction
1007920|NCT03111602|prostaglandin E2|prostaglandin e2
1007921|NCT03111589|Sickle Cell Disease|sickle cell disease
1007922|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
1007923|NCT03111537|cigarette|cigarette
1007924|NCT03111537|smoking|smoking
1007925|NCT03111537|e-cigarette|e-cigarette
1007926|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
1007927|NCT03111537|nrt|nrt
1007928|NCT03111537|tobacco|tobacco
1007929|NCT03111524|stuttering|stuttering
1007930|NCT03111524|children who stutter|children who stutter
1007931|NCT03111524|peer attitudes|peer attitudes
1007932|NCT03111524|classroom-based intervention|classroom-based intervention
1007933|NCT03111524|teasing|teasing
1007934|NCT03111524|bullying|bullying
1007935|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
1007936|NCT03111498|technical skills|technical skills
1007937|NCT03111498|training|training
1007938|NCT03111459|endograft repair,|endograft repair,
1007939|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
1007940|NCT03111433|Coenzyme Q10|coenzyme q10
1007941|NCT03111433|endothelial dysfunction|endothelial dysfunction
1007942|NCT03111433|pediatric patients|pediatric patients
1007943|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
1007944|NCT03111394|MS|ms
1007945|NCT03111394|23andMe|23andme
1007946|NCT03111394|MRI|mri
1007947|NCT03111394|Genome-wide association studies|genome-wide association studies
1007948|NCT03111368|eus-fna|eus-fna
1007949|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
1007950|NCT03111368|slow-pull|slow-pull
1007951|NCT03111368|negative pressure|negative pressure
1007952|NCT03111355|nuts|nuts
1007953|NCT03111355|micronutrients|micronutrients
1007954|NCT03111355|nutrigenomics|nutrigenomics
1007955|NCT03111355|nutrigenetics|nutrigenetics
1007956|NCT03111342|Intrauterine contraception|intrauterine contraception
1007957|NCT03111342|Pain|pain
1007958|NCT03111342|Anesthesia|anesthesia
1007959|NCT03111342|LNG-IUD|lng-iud
1007960|NCT03111342|nulligravida|nulligravida
1007961|NCT03111329|Gastric residuals assessment|gastric residuals assessment
1007962|NCT03111329|Prematurity|prematurity
1007963|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
1007964|NCT03111329|Sepsis Newborn|sepsis newborn
1007965|NCT03111329|Nutrition of newborn|nutrition of newborn
1007966|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
1007967|NCT03111316|Cervical Ripening|cervical ripening
1007968|NCT03111316|Induction of Labor|induction of labor
1007969|NCT03111290|Facial recognition|facial recognition
1007970|NCT03111277|neuropathic pain|neuropathic pain
1007971|NCT03111264|Overweight|overweight
1007972|NCT03111264|Obesity|obesity
1007973|NCT03111264|Prevention|prevention
1007974|NCT03111264|Children|children
1007975|NCT03111264|Childcare|childcare
1007976|NCT03111264|Physical Activity|physical activity
1007977|NCT03111264|Nutrition|nutrition
1007978|NCT03111264|Wellness|wellness
1007979|NCT03111264|Environment|environment
1007980|NCT03111264|Intervention|intervention
1007981|NCT03111264|Feeding|feeding
1007982|NCT03111238|Autologous|autologous
1007983|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
1007984|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
1007985|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
1007986|NCT03111238|Revascularization|revascularization
1007987|NCT03111238|Angiogenesis|angiogenesis
1007988|NCT03111238|Vasculogenesis|vasculogenesis
1007989|NCT03111238|Arteriogenesis|arteriogenesis
1007990|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
1007991|NCT03111199|Low back pain|low back pain
1007992|NCT03111199|Analgesia|analgesia
1007993|NCT03111199|Physical therapy|physical therapy
1007994|NCT03111186|oxycodone|oxycodone
1007995|NCT03111186|ibuprofen|ibuprofen
1007996|NCT03111186|acetaminophen|acetaminophen
1007997|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
1007998|NCT03111186|carpal tunnel release|carpal tunnel release
1007999|NCT03111186|Dupuytren contracture release|dupuytren contracture release
1008000|NCT03111186|Trigger digit release|trigger digit release
1008001|NCT03111186|Ganglion cyst removal|ganglion cyst removal
1008002|NCT03111186|De Quervain's release|de quervain's release
1008003|NCT03111173|ECG|ecg
1008004|NCT03111173|Fetus|fetus
1008005|NCT03111173|R peak extraction|r peak extraction
1008006|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
1008007|NCT03111160|femtosecond laser|femtosecond laser
1008008|NCT03111160|lower laser energy level|lower laser energy level
1008009|NCT03111160|early visual recovery|early visual recovery
1008010|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
1008011|NCT03111134|layered closure|layered closure
1008012|NCT03111134|component separation technique|component separation technique
1008013|NCT03111121|deeply anesthetized|deeply anesthetized
1008014|NCT03111121|ideal surgical exposure|ideal surgical exposure
1008015|NCT03111121|muscle relaxation|muscle relaxation
1008016|NCT03111121|Adults|adults
1008017|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
1008018|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
1008019|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
1008020|NCT03111069|Unresectable or Refractory|unresectable or refractory
1008021|NCT03111069|Abdominal tumors|abdominal tumors
1008022|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
1008023|NCT03111069|HIPEC|hipec
1008024|NCT03111069|Abdominal surgery|abdominal surgery
1008025|NCT03111069|Doxorubicin|doxorubicin
1008026|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1008027|NCT03111069|Adriamycin PFS|adriamycin pfs
1008028|NCT03111069|Adriamycin RDF|adriamycin rdf
1008029|NCT03111069|Adriamycin|adriamycin
1008030|NCT03111069|Rubex|rubex
1008031|NCT03111069|Intra-operative radiation|intra-operative radiation
1008032|NCT03111069|IORT|iort
1008033|NCT03111069|Brachytherapy|brachytherapy
1008034|NCT03111043|computed tomography|computed tomography
1008035|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
1008036|NCT03111043|Cardiac computed tomography|cardiac computed tomography
1008037|NCT03111043|Diagnostic accuracy|diagnostic accuracy
1008038|NCT03111043|Clinical outcome|clinical outcome
1008039|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
1008040|NCT03111017|exercise tolerance|exercise tolerance
1008041|NCT03111017|exercise training|exercise training
1008042|NCT03111017|peak oxygen uptake|peak oxygen uptake
1008043|NCT03111004|information technology|information technology
1008044|NCT03111004|telemedicine|telemedicine
1008073|NCT03110822|Ruxolitinib|ruxolitinib
1008074|NCT03110822|Steroids|steroids
1008075|NCT03110822|Lenalidomide|lenalidomide
1008076|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1008077|NCT03110809|obesity|obesity
1008078|NCT03110809|brown|brown
1008079|NCT03110809|fat|fat
1008080|NCT03110809|weight|weight
1008081|NCT03110809|loss|loss
1008082|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
1008083|NCT03110783|elective posterior fossa|elective posterior fossa
1008084|NCT03110783|supratentorial procedure|supratentorial procedure
1008085|NCT03110770|Flavivirus|flavivirus
1008086|NCT03110770|Zika|zika
1008087|NCT03110770|Vaccine|vaccine
1008088|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
1008089|NCT03110770|Immunologic Factors|immunologic factors
1008090|NCT03110770|Virus-like Particles|virus-like particles
1008091|NCT03110770|Zika vaccine|zika vaccine
1008092|NCT03110757|AP 10-701|ap 10-701
1008093|NCT03110757|healthy adults|healthy adults
1008094|NCT03110757|Immunogenicity|immunogenicity
1008095|NCT03110757|Phase Ib|phase ib
1008096|NCT03110757|Reactogenicity|reactogenicity
1008097|NCT03110757|Safety|safety
1008098|NCT03110757|Schistosomiasis|schistosomiasis
1008099|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
1008100|NCT03110718|robotic rehabilitation|robotic rehabilitation
1008101|NCT03110718|muscle vibration|muscle vibration
1008102|NCT03110718|combined approach|combined approach
1008103|NCT03110679|osteoarthritis|osteoarthritis
1008104|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
1008105|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
1008106|NCT03110666|bone marrow aspirate|bone marrow aspirate
1008107|NCT03110666|injections|injections
1008108|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
1008109|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
1008110|NCT03110627|Atrial fibrillation|atrial fibrillation
1008111|NCT03110627|Atrial flutter|atrial flutter
1008112|NCT03110627|Stroke|stroke
1008113|NCT03110614|COPD|copd
1008114|NCT03110614|acute|acute
1008115|NCT03110614|exacerbation|exacerbation
1008116|NCT03110614|lung ultrasound|lung ultrasound
1008117|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
1008118|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
1008119|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
1008120|NCT03110575|TNX-102 SL|tnx-102 sl
1008121|NCT03110575|Bedtime|bedtime
1008122|NCT03110575|Sublingual|sublingual
1008123|NCT03110575|3-month|3-month
1008124|NCT03110575|Safety|safety
1008125|NCT03110575|Efficacy|efficacy
1008126|NCT03110575|PTSD|ptsd
1008127|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1008128|NCT03110562|RRMM|rrmm
1008129|NCT03110562|Bortezomib|bortezomib
1008130|NCT03110562|Dexamethasone|dexamethasone
1008131|NCT03110536|Burnout syndrome|burnout syndrome
1008132|NCT03110536|Triage|triage
1008133|NCT03110536|Nurse|nurse
1008134|NCT03110536|Emergency Department|emergency department
1008135|NCT03110536|Romania|romania
1008136|NCT03110497|Cervical cancer|cervical cancer
1008137|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
1008138|NCT03110497|single application|single application
1008139|NCT03110471|Cognitive impairment|cognitive impairment
1008140|NCT03110471|antipsychotics|antipsychotics
1008141|NCT03110471|antidepressants|antidepressants
1008142|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
1008143|NCT03110419|Elderly|elderly
1008144|NCT03110419|Frailty|frailty
1008646|NCT03107208|children|children
1008145|NCT03110419|Multicomponent training|multicomponent training
1008146|NCT03110419|Physical exercise|physical exercise
1008147|NCT03110419|Functional capacity|functional capacity
1008148|NCT03110419|Complexity|complexity
1008149|NCT03110419|Physical Therapy|physical therapy
1008150|NCT03110406|renal transplant recipients|renal transplant recipients
1008151|NCT03110406|exercise|exercise
1008152|NCT03110406|heart rate variability|heart rate variability
1008153|NCT03110406|Cardiovascular mortality|cardiovascular mortality
1008154|NCT03110393|Obese|obese
1008155|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
1008156|NCT03110393|Anaesthesia|anaesthesia
1008159|NCT03110354|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
1008160|NCT03110354|DS-3201b|ds-3201b
1008161|NCT03110315|Multiple Sclerosis|multiple sclerosis
1008162|NCT03110315|Fatigue|fatigue
1008163|NCT03110315|Insomnia|insomnia
1008164|NCT03110315|Suvorexant|suvorexant
1008165|NCT03110315|Belsomra|belsomra
1008166|NCT03110315|Sleep disorder|sleep disorder
1008167|NCT03110315|Sleep|sleep
1008168|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
1008169|NCT03110302|Telehealth|telehealth
1008170|NCT03110302|Video teleconferencing|video teleconferencing
1008171|NCT03110302|In home therapy|in home therapy
1008172|NCT03110302|Prolonged Exposure|prolonged exposure
1008173|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
1008174|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
1008175|NCT03110250|registry|registry
1008176|NCT03110250|Turkey|turkey
1008177|NCT03110250|Lipid lowering therapy|lipid lowering therapy
1008178|NCT03110224|Subchondroplasty|subchondroplasty
1008179|NCT03110224|Bone Marrow Lesion|bone marrow lesion
1008180|NCT03110224|Arthroscopy|arthroscopy
1008181|NCT03110224|Bone Substitute Material|bone substitute material
1008182|NCT03110224|AccuFill|accufill
1008183|NCT03110224|Subchondral Bone Defect|subchondral bone defect
1008184|NCT03110198|Mesalazine|mesalazine
1008185|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
1008186|NCT03110198|Enema|enema
1008187|NCT03110172|Osteoarthritis|osteoarthritis
1008188|NCT03110172|Depression|depression
1008189|NCT03110172|Pain|pain
1008190|NCT03110159|Photodynamic therapy|photodynamic therapy
1008191|NCT03110159|Prevention|prevention
1008192|NCT03110159|Actinic Keratosis|actinic keratosis
1008193|NCT03110159|Skin Cancer|skin cancer
1008194|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
1008195|NCT03110159|Sun Damaged Skin|sun damaged skin
1008196|NCT03110159|Solid Organ Transplant|solid organ transplant
1008197|NCT03110159|PDT|pdt
1008198|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
1008199|NCT03110133|CP101|cp101
1008200|NCT03110133|Crestovo|crestovo
1008201|NCT03110133|FMT|fmt
1008202|NCT03110133|CDI|cdi
1008203|NCT03110133|C. difficile|c. difficile
1008204|NCT03110133|C. diff|c. diff
1008205|NCT03110133|Recurrenct Clostridium Difficile Infection|recurrenct clostridium difficile infection
1008206|NCT03110133|Recurrent C. diff|recurrent c. diff
1008207|NCT03110133|Recurrent CDI|recurrent cdi
1008208|NCT03110133|Finch|finch
1008209|NCT03110068|microvascular invasion|microvascular invasion
1008210|NCT03110068|serum biomarker|serum biomarker
1008211|NCT03110068|radiological feature|radiological feature
1008212|NCT03110068|pathological differentiation|pathological differentiation
1008213|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
1008214|NCT03110003|Combined spinal epidural|combined spinal epidural
1008215|NCT03110003|Epidural volume extension|epidural volume extension
1008216|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
1008217|NCT03109977|17-059|17-059
1008218|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
1008219|NCT03109951|Type 2 diabetes|type 2 diabetes
1008220|NCT03109951|colonoscopy|colonoscopy
1008221|NCT03109951|hypoglycemia|hypoglycemia
1008222|NCT03109951|hyperglycemia|hyperglycemia
1008223|NCT03109951|polyethylene glycol|polyethylene glycol
1008224|NCT03109925|PAE|pae
1008225|NCT03109925|embolization|embolization
1008226|NCT03109925|non-surgical|non-surgical
1008227|NCT03109925|prostate artery embolization|prostate artery embolization
1008228|NCT03109925|radio-opaque embolic|radio-opaque embolic
1008229|NCT03109899|mHealth|mhealth
1008230|NCT03109899|HIV Prevention|hiv prevention
1008231|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
1008232|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
1008233|NCT03109886|Child-Pugh Class A|child-pugh class a
1008234|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
1008235|NCT03109834|Weight Management Programs|weight management programs
1008236|NCT03109834|Weight loss stabilization|weight loss stabilization
1008237|NCT03109834|Cardiometabolic risk|cardiometabolic risk
1008238|NCT03109821|Exercise Therapy|exercise therapy
1008239|NCT03109821|Rehabilitation|rehabilitation
1008240|NCT03109782|Spinal Cord Injury|spinal cord injury
1008241|NCT03109782|Spine Surgery|spine surgery
1008242|NCT03109782|Patient Registry|patient registry
1008243|NCT03109782|Trauma|trauma
1008244|NCT03109743|HIV treatment|hiv treatment
1009251|NCT03103490|PET/MR|pet/mr
1008251|NCT03109652|total knee arthroplasty|total knee arthroplasty
1008252|NCT03109652|tranexamic acid|tranexamic acid
1008253|NCT03109652|oral tranexamic acid|oral tranexamic acid
1008254|NCT03109652|transfusion|transfusion
1008255|NCT03109652|blood loss|blood loss
1008256|NCT03109639|EUS|eus
1008257|NCT03109639|FNA|fna
1008258|NCT03109639|FNB|fnb
1008259|NCT03109639|Core Histology|core histology
1008260|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
1008261|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
1008262|NCT03109613|PEEP|peep
1008263|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1008264|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
1008265|NCT03109613|V/Q mismatch|v/q mismatch
1008266|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
1008267|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
1008268|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
1008269|NCT03109522|lymphedema|lymphedema
1008270|NCT03109522|breast cancer|breast cancer
1008271|NCT03109522|surgery|surgery
1008273|NCT03109496|Otitis Media with Effusion|otitis media with effusion
1008274|NCT03109496|Microbiota|microbiota
1008275|NCT03109496|Microbiome|microbiome
1008276|NCT03109496|URT|urt
1008277|NCT03109496|Upper Respiratory Tract|upper respiratory tract
1008278|NCT03109496|Healthy URT microbiota|healthy urt microbiota
1008279|NCT03109483|geriatric patients|geriatric patients
1008280|NCT03109483|elderly|elderly
1008281|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
1008282|NCT03109470|Tocilizumab|tocilizumab
1008283|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
1008284|NCT03109470|Observational|observational
1008285|NCT03109470|Canadian|canadian
1008286|NCT03109457|Hepatitis C Virus|hepatitis c virus
1008287|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
1008288|NCT03109444|Hip Growth Chart|hip growth chart
1008289|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
1008290|NCT03109431|HIV Disease Progression|hiv disease progression
1008291|NCT03109431|Mental Health|mental health
1008292|NCT03109431|Substance Use|substance use
1008293|NCT03109431|ARV Adherence|arv adherence
1008294|NCT03109431|Retention in Care|retention in care
1008295|NCT03109431|STI|sti
1008296|NCT03109418|Ketamine|ketamine
1008297|NCT03109418|Postoperative morbidity|postoperative morbidity
1008298|NCT03109353|Photopheresis|photopheresis
1008299|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
1008300|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
1008301|NCT03109340|abdominal obesity|abdominal obesity
1008302|NCT03109340|walking|walking
1008303|NCT03109340|aerobic exercise|aerobic exercise
1008304|NCT03109314|amblyopia|amblyopia
1008305|NCT03109314|donepezil|donepezil
1008306|NCT03109314|perceptual learning|perceptual learning
1008307|NCT03109314|crowding|crowding
1008308|NCT03109314|contrast sensitivity|contrast sensitivity
1008309|NCT03109314|visual acuity|visual acuity
1008317|NCT03109184|Dating violence prevention|dating violence prevention
1008318|NCT03109184|Adolescent boys|adolescent boys
1008319|NCT03109184|Middle school|middle school
1008320|NCT03109184|Web-based prevention|web-based prevention
1008321|NCT03109171|Endoscopy|endoscopy
1008322|NCT03109171|Lasers|lasers
1008323|NCT03109171|Fiber Optic Technology|fiber optic technology
1008324|NCT03109171|Bronchoscopy|bronchoscopy
1008325|NCT03109171|Esthesiometer|esthesiometer
1008326|NCT03109171|Mechanoreceptors|mechanoreceptors
1008327|NCT03109171|Diagnosis|diagnosis
1008328|NCT03109171|Reflex|reflex
1008329|NCT03109171|Reproducibility of Results|reproducibility of results
1008330|NCT03109171|Reliability of Results|reliability of results
1008331|NCT03109171|Validity of Results|validity of results
1008332|NCT03109171|Sensory Thresholds|sensory thresholds
1008333|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
1008334|NCT03109158|head|head
1008335|NCT03109158|neck|neck
1008336|NCT03109145|Shared decision making|shared decision making
1008337|NCT03109145|Knowledge|knowledge
1008338|NCT03109145|Patient portal|patient portal
1008339|NCT03109145|Secure messaging|secure messaging
1008340|NCT03109119|genomic instability|genomic instability
1008341|NCT03109119|Sevoflurane|sevoflurane
1008342|NCT03109119|General anaesthesia|general anaesthesia
1008343|NCT03109106|MICU|micu
1008344|NCT03109106|CICU|cicu
1008345|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
1008346|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
1008347|NCT03109106|Antibiotic initiation|antibiotic initiation
1008348|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
1008349|NCT03109093|ALL|all
1008350|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1008351|NCT03109093|MRD positive|mrd positive
1008352|NCT03109093|minimal residual disease|minimal residual disease
1008353|NCT03109093|blinatumomab|blinatumomab
1008354|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
1008355|NCT03109054|Melatonin|melatonin
1008356|NCT03109054|Anxiety|anxiety
1008357|NCT03109041|Whipple|whipple
1008358|NCT03109041|brachytherapy|brachytherapy
1008359|NCT03109041|CivaSheet|civasheet
1008360|NCT03109041|CivaTech Oncology|civatech oncology
1008361|NCT03109041|radiation|radiation
1008362|NCT03109041|intraoperative radiation|intraoperative radiation
1008363|NCT03109041|IORT|iort
1008364|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
1008365|NCT03109041|Pd-103|pd-103
1008366|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1008367|NCT03109015|sunitinib|sunitinib
1008368|NCT03109015|Sutent|sutent
1008369|NCT03109015|cardiopulmonary function|cardiopulmonary function
1008370|NCT03108976|Autism|autism
1008371|NCT03108976|Sensori-motor learning|sensori-motor learning
1008372|NCT03108976|Development|development
1008373|NCT03108976|Neuroimaging|neuroimaging
1008374|NCT03108872|Anticoagulants|anticoagulants
1008375|NCT03108872|Atrial Appendage|atrial appendage
1008376|NCT03108872|Stroke|stroke
1008377|NCT03108846|Alzheimer's Disease|alzheimer's disease
1008378|NCT03108846|Agitation|agitation
1008379|NCT03108807|Emergency Department|emergency department
1008380|NCT03108807|Medical patients|medical patients
1008381|NCT03108807|D-dimer|d-dimer
1008382|NCT03108807|National Early Warning Score|national early warning score
1008383|NCT03108807|NEWS|news
1008384|NCT03108807|30-days mortality|30-days mortality
1008385|NCT03108807|Mortality|mortality
1008386|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
1008387|NCT03108781|Dementia|dementia
1008388|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
1008389|NCT03108781|Treatment|treatment
1008390|NCT03108755|ASP7713|asp7713
1008391|NCT03108729|epilepsy|epilepsy
1008392|NCT03108729|Partial-onset seizures|partial-onset seizures
1008393|NCT03108729|Focal epilepsy|focal epilepsy
1008394|NCT03108729|Focal seizures|focal seizures
1008395|NCT03108729|Partial onset seizures|partial onset seizures
1008396|NCT03108729|Pediatric|pediatric
1008397|NCT03108729|Partial seizures|partial seizures
1008399|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1008400|NCT03108703|SBRT|sbrt
1008401|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
1008402|NCT03108703|SABR|sabr
1008403|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
1008404|NCT03108690|Continuous infusion|continuous infusion
1008405|NCT03108690|Beta-lactam|beta-lactam
1008406|NCT03108690|Antibiotics|antibiotics
1008407|NCT03108690|Bacteraemia|bacteraemia
1008408|NCT03108677|RNA profiling|rna profiling
1008409|NCT03108677|Exosome|exosome
1008410|NCT03108677|Lung Metastases|lung metastases
1008411|NCT03108677|Osteosarcoma|osteosarcoma
1008412|NCT03108664|SYL1001|syl1001
1008413|NCT03108664|siRNA|sirna
1008414|NCT03108625|children|children
1008415|NCT03108625|adolescent|adolescent
1008416|NCT03108612|diagnostic accuracy|diagnostic accuracy
1008417|NCT03108612|upper limb|upper limb
1008418|NCT03108599|Health Promotion|health promotion
1008419|NCT03108599|Injury Prevention|injury prevention
1008420|NCT03108599|Safety|safety
1008421|NCT03108599|Wellbeing|wellbeing
1008422|NCT03108599|Physical Activity|physical activity
1008423|NCT03108599|Sleep|sleep
1008424|NCT03108599|Whole Body Vibration|whole body vibration
1008425|NCT03108599|Self-Monitoring|self-monitoring
1008426|NCT03108586|restorations|restorations
1008427|NCT03108586|diagnosis|diagnosis
1008428|NCT03108586|secondary caries|secondary caries
1008429|NCT03108586|treatment decision|treatment decision
1008430|NCT03108560|sublobar resection|sublobar resection
1008431|NCT03108560|lobectomy|lobectomy
1008432|NCT03108547|Sarcoidosis|sarcoidosis
1008433|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
1008434|NCT03108547|Fatigue|fatigue
1008435|NCT03108547|Biomarker|biomarker
1008436|NCT03108547|Psychological distress|psychological distress
1008437|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
1008438|NCT03108495|LN-145|ln-145
1008439|NCT03108495|Cell Therapy|cell therapy
1008440|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
1008441|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
1008442|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
1008443|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1008444|NCT03108495|TIL|til
1008445|NCT03108495|IL-2|il-2
1008447|NCT03108482|Post-surgical Pain|post-surgical pain
1008448|NCT03108482|Bunionectomy|bunionectomy
1008449|NCT03108482|Co-crystal|co-crystal
1008450|NCT03108482|Tramadol|tramadol
1008451|NCT03108482|Celecoxib|celecoxib
1008452|NCT03108469|migraine|migraine
1008453|NCT03108456|atherectomy|atherectomy
1008454|NCT03108456|CAD|cad
1008455|NCT03108456|severe calcium|severe calcium
1008456|NCT03108456|orbital atherectomy|orbital atherectomy
1008457|NCT03108456|minimum stent area|minimum stent area
1008458|NCT03108404|predictive score|predictive score
1008459|NCT03108378|Gadolinium|gadolinium
1008460|NCT03108378|Bone|bone
1008461|NCT03108378|Skin|skin
1008462|NCT03108300|efficacy|efficacy
1008463|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
1008464|NCT03108300|sts|sts
1008465|NCT03108274|Midazolam|midazolam
1008466|NCT03108274|Fexofenadine|fexofenadine
1008467|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
1008468|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
1008470|NCT03108248|irradiation|irradiation
1008471|NCT03108248|survival|survival
1008472|NCT03108248|decompensation|decompensation
1008473|NCT03108248|tumor response|tumor response
1008474|NCT03108222|chronic kidney disease|chronic kidney disease
1008475|NCT03108222|CKD|ckd
1008476|NCT03108222|renal failure|renal failure
1008477|NCT03108222|phosphorus|phosphorus
1008478|NCT03108222|phosphate|phosphate
1008479|NCT03108222|intestinal absorption|intestinal absorption
1008480|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
1008481|NCT03108157|IVF|ivf
1008482|NCT03108157|DONOR EGGS|donor eggs
1008483|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
1008484|NCT03108157|PIPELLE|pipelle
1008485|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
1008486|NCT03108144|smoking cessation|smoking cessation
1008487|NCT03108144|alcohol|alcohol
1008488|NCT03108144|primary care|primary care
1008489|NCT03108144|screening|screening
1008490|NCT03108144|brief intervention|brief intervention
1008491|NCT03108144|referral to treatment|referral to treatment
1008492|NCT03108144|cancer risk|cancer risk
1008493|NCT03108131|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
1008494|NCT03108131|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
1008495|NCT03108131|Appendiceal Adenocarcinoma|appendiceal adenocarcinoma
1008496|NCT03108131|Cutaneous Squamous Cell Carcinoma|cutaneous squamous cell carcinoma
1008497|NCT03108131|Small Bowel Adenocarcinoma|small bowel adenocarcinoma
1008498|NCT03108131|Advanced rare tumors|advanced rare tumors
1008499|NCT03108131|Cobimetinib|cobimetinib
1008500|NCT03108131|Atezolizumab|atezolizumab
1008501|NCT03108131|MPDL3280A|mpdl3280a
1008502|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
1008503|NCT03108118|Acute respiratory failure|acute respiratory failure
1008505|NCT03108092|Drug Utilization Review|drug utilization review
1008506|NCT03108092|Older people|older people
1008507|NCT03108092|Health economics|health economics
1008508|NCT03108079|Urologic Injuries|urologic injuries
1008509|NCT03108079|Urologic Diseases|urologic diseases
1008510|NCT03108079|Bladder Infection|bladder infection
1008511|NCT03108079|Urinary Tract Infections|urinary tract infections
1008512|NCT03108079|Mucosal Inflammation|mucosal inflammation
1008513|NCT03108079|Mucosal Infection|mucosal infection
1008514|NCT03108079|Bladder Injury|bladder injury
1008515|NCT03108079|Catheter Related Infections|catheter related infections
1008516|NCT03108079|Catheter Complications|catheter complications
1008517|NCT03108079|Catheter Infection|catheter infection
1008518|NCT03108079|Indwelling Catheter|indwelling catheter
1008519|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
1008520|NCT03108079|Urinary Incontinence|urinary incontinence
1008521|NCT03108053|urinary stones|urinary stones
1008522|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
1008523|NCT03108053|guidewire|guidewire
1008524|NCT03108027|QVM149,|qvm149,
1008525|NCT03108027|asthma,|asthma,
1008526|NCT03108027|allergic asthma,|allergic asthma,
1008527|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
1008528|NCT03108027|reactive asthma,|reactive asthma,
1008529|NCT03108027|asthma attack,|asthma attack,
1008530|NCT03108027|difficulty breathing|difficulty breathing
1008531|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
1008532|NCT03107962|immunotherapy|immunotherapy
1008533|NCT03107962|clinical trial|clinical trial
1008534|NCT03107962|RR|rr
1008535|NCT03107962|PFS|pfs
1008536|NCT03107962|OS|os
1008537|NCT03107949|Diaphragm atrophy|diaphragm atrophy
1008538|NCT03107949|VIDD|vidd
1008539|NCT03107949|weaning failure|weaning failure
1008540|NCT03107949|SBT|sbt
1008541|NCT03107923|Myocardial fibrosis|myocardial fibrosis
1008542|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
1008543|NCT03107923|TAVI|tavi
1008544|NCT03107923|Outcome|outcome
1008545|NCT03107897|TAVR|tavr
1008546|NCT03107897|elevated frailty score|elevated frailty score
1008547|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
1008548|NCT03107871|valganciclovir|valganciclovir
1008549|NCT03107845|CBT|cbt
1009355|NCT03102684|smoking|smoking
1008550|NCT03107845|Psychometric Feedback|psychometric feedback
1008551|NCT03107845|Clinical Support Tools|clinical support tools
1008552|NCT03107845|Personalized Mental Health|personalized mental health
1008553|NCT03107819|Plasma metabolomics|plasma metabolomics
1008554|NCT03107819|Urinary metabolomics|urinary metabolomics
1008555|NCT03107819|Metabonomics|metabonomics
1008556|NCT03107819|Biomarker discovery|biomarker discovery
1008557|NCT03107806|acute coronary syndromes|acute coronary syndromes
1008558|NCT03107806|hyperglycemia|hyperglycemia
1008559|NCT03107806|hypoglycemia|hypoglycemia
1008560|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
1008561|NCT03107741|Metabolic Syndrome|metabolic syndrome
1008562|NCT03107741|Waist circumference|waist circumference
1008563|NCT03107741|Blood pressure|blood pressure
1008564|NCT03107741|Triglyceride|triglyceride
1008565|NCT03107741|HDL cholesterol|hdl cholesterol
1008566|NCT03107728|orthotics|orthotics
1008567|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
1008568|NCT03107728|physical therapy|physical therapy
1008570|NCT03107728|functional performance|functional performance
1008571|NCT03107728|performance assessment|performance assessment
1008572|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
1008573|NCT03107715|health disparity|health disparity
1008574|NCT03107715|prenatal intervention|prenatal intervention
1008575|NCT03107689|ILE|ile
1008576|NCT03107689|lipid|lipid
1008577|NCT03107689|overdose|overdose
1008578|NCT03107689|resuscitation|resuscitation
1008579|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
1008580|NCT03107663|PET/CT|pet/ct
1008581|NCT03107663|Imaging|imaging
1008582|NCT03107663|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
1008583|NCT03107663|CD8 + T Cells|cd8 + t cells
1008584|NCT03107663|Standard of Care|standard of care
1008585|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
1008586|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
1008587|NCT03107637|cardiac source of embolism|cardiac source of embolism
1008588|NCT03107637|ischemic stroke|ischemic stroke
1008589|NCT03107598|spinal anesthesia|spinal anesthesia
1008590|NCT03107598|neonatal outcome|neonatal outcome
1008591|NCT03107598|Caesarean Section|caesarean section
1008592|NCT03107585|cervical plexus block|cervical plexus block
1008593|NCT03107585|thyroidectomy|thyroidectomy
1008594|NCT03107585|opioid consumption|opioid consumption
1008595|NCT03107559|perfüsion index|perfüsion index
1008596|NCT03107559|epidural analgesia|epidural analgesia
1008597|NCT03107559|labor|labor
1008598|NCT03107546|Syndactyly|syndactyly
1008599|NCT03107546|Syndactyly release surgery|syndactyly release surgery
1008600|NCT03107546|Full thickness skin graft|full thickness skin graft
1008601|NCT03107546|Hyalomatrix|hyalomatrix
1008602|NCT03107546|Scar formation|scar formation
1008603|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1008604|NCT03107520|Lumason|lumason
1008605|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
1008606|NCT03107520|avascular necrosis|avascular necrosis
1008607|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
1008608|NCT03107507|Levetiracetam|levetiracetam
1008609|NCT03107507|Phenobarbitone|phenobarbitone
1008610|NCT03107507|neonatal seizures|neonatal seizures
1008611|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
1008612|NCT03107481|Acetaminophen|acetaminophen
1008613|NCT03107481|Hydromorphone|hydromorphone
1008614|NCT03107481|Emergency Department|emergency department
1008615|NCT03107481|Narcotics|narcotics
1008616|NCT03107481|Analgesics, Opioid|analgesics, opioid
1008617|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
1008618|NCT03107468|Non-surgical treatment|non-surgical treatment
1008619|NCT03107468|Acupuncture|acupuncture
1008620|NCT03107468|Chuna|chuna
1008621|NCT03107468|Physiotherapy|physiotherapy
1008622|NCT03107468|Epidural steroid injection|epidural steroid injection
1008623|NCT03107455|MitraClip|mitraclip
1008624|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
1008625|NCT03107455|Acute myocardial infarction|acute myocardial infarction
1008626|NCT03107442|Arterial stiffness|arterial stiffness
1008627|NCT03107442|Markers of Inflammation|markers of inflammation
1008628|NCT03107442|Exercise|exercise
1008629|NCT03107442|Physical fitness|physical fitness
1008630|NCT03107442|Cardiovascular risk|cardiovascular risk
1008631|NCT03107442|Autoimmune diseases|autoimmune diseases
1008632|NCT03107429|Trendelenburg|trendelenburg
1008633|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
1008634|NCT03107429|POVL|povl
1008635|NCT03107416|Bumetanide|bumetanide
1008636|NCT03107416|Diuretic|diuretic
1008637|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
1008638|NCT03107416|17-141|17-141
1008639|NCT03107403|dreams bereavement|dreams bereavement
1008640|NCT03107403|emotional|emotional
1008641|NCT03107403|regulation|regulation
1008642|NCT03107403|bereavement|bereavement
1008643|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
1008644|NCT03107208|DKA|dka
1008645|NCT03107208|type 1 diabetes|type 1 diabetes
1008648|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
1008649|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1008650|NCT03107156|Treatment care planning|treatment care planning
1008651|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
1008652|NCT03107143|Pressure injury|pressure injury
1008653|NCT03107091|Terlipressin|terlipressin
1008654|NCT03107091|Terlipressin acetate|terlipressin acetate
1008658|NCT03107013|Mass Balance|mass balance
1008659|NCT03107013|Phase 1|phase 1
1008660|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
1008661|NCT03106987|PARPi re-treatment|parpi re-treatment
1008662|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
1008663|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
1008664|NCT03106987|Olaparib|olaparib
1008665|NCT03106987|ovarian cancer|ovarian cancer
1663402|NCT00130429|dementia|dementia
1033070|NCT02956993|PAD|pad
1008666|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
1008667|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
1008668|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
1008669|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
1008670|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
1008671|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
1008672|NCT03106935|Levothyroxine|levothyroxine
1008673|NCT03106922|Polyethylene glycol|polyethylene glycol
1008674|NCT03106922|Bowel cleansing|bowel cleansing
1008675|NCT03106922|Colonoscopy|colonoscopy
1008676|NCT03106909|stroke|stroke
1008677|NCT03106909|pneumonia|pneumonia
1008678|NCT03106909|biomarkers|biomarkers
1008679|NCT03106909|pulmonary CT|pulmonary ct
1008680|NCT03106883|Attention bias modification|attention bias modification
1008681|NCT03106883|Cognitive bias modification|cognitive bias modification
1008682|NCT03106883|Eye-tracking|eye-tracking
1008683|NCT03106883|Treatment|treatment
1008684|NCT03106844|FMT|fmt
1008685|NCT03106844|IBD|ibd
1008686|NCT03106805|intrauterine device|intrauterine device
1008687|NCT03106779|Phase 3|phase 3
1008688|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1008689|NCT03106779|CML|cml
1008690|NCT03106779|bosutinib|bosutinib
1008691|NCT03106779|ABL001|abl001
1008692|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1008693|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
1008694|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
1008695|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
1008696|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
1008697|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
1008698|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
1008699|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
1008700|NCT03106753|External Cephalic Version|external cephalic version
1008701|NCT03106753|neuraxial analgesia|neuraxial analgesia
1008702|NCT03106740|Microglia|microglia
1008703|NCT03106740|Minocycline|minocycline
1008704|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
1008705|NCT03106740|Positron Emission Tomography|positron emission tomography
1008706|NCT03106740|Pain|pain
1008707|NCT03106740|Astrocytes|astrocytes
1008708|NCT03106740|Glia|glia
1008709|NCT03106740|Human|human
1008710|NCT03106740|Back Pain|back pain
1008711|NCT03106727|Community Health Workers|community health workers
1008712|NCT03106727|Maternal and Child Health|maternal and child health
1008713|NCT03106727|Integrated Care|integrated care
1008714|NCT03106727|Malawi|malawi
1008715|NCT03106727|NCD|ncd
1008716|NCT03106714|persistence|persistence
1008717|NCT03106714|body fluids|body fluids
1008718|NCT03106688|PET imaging|pet imaging
1008719|NCT03106688|Cannabinoid receptor|cannabinoid receptor
1008720|NCT03106688|Opioid receptor|opioid receptor
1008721|NCT03106688|Addiction|addiction
1008722|NCT03106688|fMRI imaging|fmri imaging
1008723|NCT03106675|HIFU|hifu
1008724|NCT03106675|MR-HIFU|mr-hifu
1008725|NCT03106675|MRgFUs|mrgfus
1008726|NCT03106675|MRI-intervention|mri-intervention
1008727|NCT03106675|Palliation|palliation
1008728|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
1008729|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1008730|NCT03106662|graft-versus-host disease|graft-versus-host disease
1008731|NCT03106662|engraftment|engraftment
1008732|NCT03106636|Preschool-aged|preschool-aged
1008733|NCT03106636|Foster children|foster children
1008734|NCT03106636|child welfare|child welfare
1008735|NCT03106636|Fostercare|fostercare
1008736|NCT03106636|Parent training|parent training
1008737|NCT03106636|early adversity|early adversity
1008738|NCT03106636|curriculum based|curriculum based
1008739|NCT03106636|early intervention|early intervention
1008740|NCT03106636|preschool|preschool
1008741|NCT03106636|foster placement disruptions|foster placement disruptions
1008742|NCT03106636|manualized intervention|manualized intervention
1008743|NCT03106636|group based intervention|group based intervention
1008744|NCT03106636|high-risk children|high-risk children
1008745|NCT03106610|Bladder cancer|bladder cancer
1008746|NCT03106610|Cancer of urothelium|cancer of urothelium
1008747|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
1008748|NCT03106610|Carcinoma in situ|carcinoma in situ
1008749|NCT03106610|Nivolumab|nivolumab
1008750|NCT03106610|BMS-936558|bms-936558
1008751|NCT03106610|Opdivo|opdivo
1008752|NCT03106610|Questionnaires|questionnaires
1008753|NCT03106610|Surveys|surveys
1008754|NCT03106597|Peripheral Edema|peripheral edema
1008755|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
1008756|NCT03106584|Knee pain|knee pain
1008757|NCT03106584|Glucosamine|glucosamine
1008758|NCT03106584|WOMAC|womac
1008759|NCT03106584|Osteoarthritis|osteoarthritis
1008760|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
1008761|NCT03106506|Implants|implants
1008762|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
1008763|NCT03106506|Prospective study|prospective study
1008764|NCT03106480|Pre-diabetes|pre-diabetes
1008765|NCT03106480|Diabetes Mellitus|diabetes mellitus
1008766|NCT03106480|HIV|hiv
1008767|NCT03106480|ART|art
1008768|NCT03106480|Body composition|body composition
1008769|NCT03106480|Inflammation|inflammation
1008770|NCT03106480|Insulin resistance|insulin resistance
1008771|NCT03106480|Beta-cell function|beta-cell function
1008772|NCT03106480|Pre-Hypertension|pre-hypertension
1008773|NCT03106480|Hypertension|hypertension
1008774|NCT03106467|appendectomy|appendectomy
1008775|NCT03106467|laparoscopic|laparoscopic
1008776|NCT03106467|single port|single port
1008777|NCT03106467|randomized|randomized
1008778|NCT03106389|misoprostol|misoprostol
1008779|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
1008780|NCT03106389|second trimester|second trimester
1008781|NCT03106389|induced abortion|induced abortion
1008782|NCT03106337|Thyroid|thyroid
1008783|NCT03106337|Follicular Neoplasms|follicular neoplasms
1008784|NCT03106337|Bethesda System|bethesda system
1008785|NCT03106337|Elastography|elastography
1008786|NCT03106337|Doppler ultrasound|doppler ultrasound
1008787|NCT03106337|Thyroidectomy|thyroidectomy
1008788|NCT03106324|Multiple Myeloma|multiple myeloma
1008789|NCT03106324|Non transplant eligible|non transplant eligible
1008790|NCT03106324|Revlimid|revlimid
1008791|NCT03106324|PASS|pass
1008792|NCT03106324|Non-interventional|non-interventional
1008793|NCT03106324|Lenalidomide|lenalidomide
1008794|NCT03106298|Iron Deficiency|iron deficiency
1008795|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
1008796|NCT03106298|Phosphate|phosphate
1008797|NCT03106259|FURESTEM-RA|furestem-ra
1008798|NCT03106246|Extracellular vesicles|extracellular vesicles
1008799|NCT03106246|Autoimmunity|autoimmunity
1008800|NCT03106246|Beta-cell injury|beta-cell injury
1008801|NCT03106233|Breast reconstruction|breast reconstruction
1008802|NCT03106233|Perforator flap|perforator flap
1008803|NCT03106233|Microsurgery|microsurgery
1008804|NCT03106168|Extraction|extraction
1008805|NCT03106168|Local Anesthetic|local anesthetic
1008806|NCT03106168|Mepivacaine|mepivacaine
1008807|NCT03106168|Mandibular Molar|mandibular molar
1008808|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
1008809|NCT03106116|Coronary Heart Disease|coronary heart disease
1008810|NCT03106116|Ventricular Function|ventricular function
1008811|NCT03106116|Vascular Endothelium|vascular endothelium
1008812|NCT03106116|Counterpulsation, External|counterpulsation, external
1008813|NCT03106103|urodynamics|urodynamics
1008814|NCT03106103|cystitis|cystitis
1008815|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
1008816|NCT03106103|bacteriuria|bacteriuria
1008817|NCT03106090|survivorship care plan|survivorship care plan
1008818|NCT03106090|head and neck cancer|head and neck cancer
1008819|NCT03106090|survivorship|survivorship
1008820|NCT03106077|Malignant neoplasm of breast|malignant neoplasm of breast
1008821|NCT03106077|Triple-Negative Breast Cancer|triple-negative breast cancer
1008822|NCT03106077|TNBC|tnbc
1008823|NCT03106077|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
1008824|NCT03106077|Newly Diagnosed Triple-Negative Breast Cancer|newly diagnosed triple-negative breast cancer
1008825|NCT03106077|Mirvetuximab Soravtansine|mirvetuximab soravtansine
1008826|NCT03106077|IMGN853|imgn853
1008827|NCT03106051|Arthritis|arthritis
1008828|NCT03106051|Psoriatic|psoriatic
1008829|NCT03106051|Observational|observational
1008830|NCT03106051|Apremilast|apremilast
1008831|NCT03106038|contrast agent|contrast agent
1008832|NCT03106038|ureter imaging|ureter imaging
1008833|NCT03106038|intraoperative monitoring|intraoperative monitoring
1008834|NCT03106038|intraoperative procedures|intraoperative procedures
1008835|NCT03106038|near infrared fluorescence|near infrared fluorescence
1008836|NCT03106038|minimally invasive|minimally invasive
1008837|NCT03105973|jail|jail
1008838|NCT03105973|prison|prison
1008839|NCT03105973|technology|technology
1008840|NCT03105973|depression|depression
1008841|NCT03105973|CBT|cbt
1008842|NCT03105947|lipids|lipids
1008843|NCT03105947|dietary fats|dietary fats
1008844|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
1008845|NCT03105921|Irreversible electroporation|irreversible electroporation
1008846|NCT03105921|Interventional radiology|interventional radiology
1008847|NCT03105895|Incisional hernia|incisional hernia
1008848|NCT03105895|Mesh prevention|mesh prevention
1008849|NCT03105895|Mesh augmentation|mesh augmentation
1008850|NCT03105882|Spinal Cord Injury|spinal cord injury
1008851|NCT03105882|SCI|sci
1008852|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
1008853|NCT03105869|repeatability|repeatability
1008854|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
1008855|NCT03105869|fluorocholine|fluorocholine
1008856|NCT03105856|Mass screening|mass screening
1008857|NCT03105856|Vaccination|vaccination
1008858|NCT03105856|Mexico|mexico
1008859|NCT03105843|Asthma|asthma
1008860|NCT03105843|Cough|cough
1663403|NCT00130429|memory|memory
1008861|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
1008862|NCT03105843|Hypertonic Saline|hypertonic saline
1008863|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
1008864|NCT03105817|Biocompatibility|biocompatibility
1009271|NCT03103269|Overweight|overweight
1008865|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
1008866|NCT03105817|Convective volume|convective volume
1008867|NCT03105817|Adequacy|adequacy
1008868|NCT03105778|BNP|bnp
1008869|NCT03105778|IVD|ivd
1008870|NCT03105765|Neuropathic Pain|neuropathic pain
1008871|NCT03105765|Chronic Pain|chronic pain
1008872|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
1008873|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
1008874|NCT03105752|Volunteers|volunteers
1008875|NCT03105752|Informed consent|informed consent
1008876|NCT03105752|Comprehension|comprehension
1008877|NCT03105752|Language tests|language tests
1008878|NCT03105726|End Stage Heart Failure|end stage heart failure
1008879|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
1008880|NCT03105726|Heart transplantation|heart transplantation
1008881|NCT03105726|Ventricular assisted devices|ventricular assisted devices
1008882|NCT03105726|Cardiogenic shock|cardiogenic shock
1008883|NCT03105713|Checklist|checklist
1008884|NCT03105713|Patient Checklist|patient checklist
1008885|NCT03105713|Surgery|surgery
1008886|NCT03105713|Safety|safety
1008887|NCT03105713|Patient Involvement|patient involvement
1008888|NCT03105700|epilepsy|epilepsy
1008889|NCT03105700|depression|depression
1008890|NCT03105700|refractory|refractory
1008891|NCT03105700|temporal lobe|temporal lobe
1008892|NCT03105700|TMS|tms
1008893|NCT03105700|biomarker|biomarker
1008894|NCT03105687|mHealth|mhealth
1008895|NCT03105687|SMS reminders|sms reminders
1008896|NCT03105687|adherence|adherence
1008897|NCT03105687|antihypertensive drugs|antihypertensive drugs
1008898|NCT03105687|pharmacists|pharmacists
1008899|NCT03105687|cost-effectiveness|cost-effectiveness
1008900|NCT03105674|analgesia|analgesia
1008901|NCT03105674|peri-anal procedure|peri-anal procedure
1008902|NCT03105674|peri-anal block|peri-anal block
1008903|NCT03105674|anal surgery|anal surgery
1008904|NCT03105635|Community Resources|community resources
1008905|NCT03105635|Health Navigator|health navigator
1008906|NCT03105622|Exercise|exercise
1008907|NCT03105622|Screen|screen
1008908|NCT03105622|Music|music
1008909|NCT03105622|Energy compensation|energy compensation
1008910|NCT03105622|Adolescents|adolescents
1008911|NCT03105622|Running+screen|running+screen
1008912|NCT03105622|Running+music|running+music
1008913|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
1008914|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
1008915|NCT03105583|Medication beliefs|medication beliefs
1008916|NCT03105583|Information desire|information desire
1008917|NCT03105583|Vitamin deficiencies|vitamin deficiencies
1008918|NCT03105570|breast neoplasms|breast neoplasms
1008919|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
1008920|NCT03105570|Areola|areola
1008921|NCT03105557|Prematurely born newborns|prematurely born newborns
1008922|NCT03105557|Urine|urine
1008923|NCT03105557|Collecting device|collecting device
1008924|NCT03105544|simulation-based training|simulation-based training
1008925|NCT03105544|obstetric ultrasound|obstetric ultrasound
1008926|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
1008927|NCT03105544|ultrasound simulation|ultrasound simulation
1008928|NCT03105531|primary aldosteronism|primary aldosteronism
1008929|NCT03105531|hypertension|hypertension
1008930|NCT03105531|screening|screening
1008931|NCT03105531|secondary hypertension|secondary hypertension
1008932|NCT03105518|assisted reproduction|assisted reproduction
1008933|NCT03105518|postoperative pain|postoperative pain
1008934|NCT03105518|opioid|opioid
1008935|NCT03105492|Prenatal Testing|prenatal testing
1008936|NCT03105492|Whole Genome Sequencing|whole genome sequencing
1008937|NCT03105479|vancomycin|vancomycin
1008938|NCT03105479|children|children
1008939|NCT03105479|cadazolid|cadazolid
1008940|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
1008941|NCT03105466|Corneal Transplantation|corneal transplantation
1008942|NCT03105466|Xenotransplantation|xenotransplantation
1008943|NCT03105466|Bioegineered cornea|bioegineered cornea
1009550|NCT03101514|mucositis|mucositis
1008944|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
1008945|NCT03105453|Microbiome|microbiome
1008946|NCT03105440|breast cancer|breast cancer
1008947|NCT03105440|lymphedema|lymphedema
1008948|NCT03105440|pain|pain
1008949|NCT03105440|range of motion|range of motion
1008950|NCT03105440|technologic innovation|technologic innovation
1008951|NCT03105440|rehabilitation|rehabilitation
1008952|NCT03105414|Mechanical ventilation|mechanical ventilation
1008953|NCT03105414|Pediatrics|pediatrics
1008954|NCT03105414|Cross infection|cross infection
1008955|NCT03105414|Intensive care|intensive care
1008956|NCT03105414|Diagnosis|diagnosis
1333122|NCT01444456|Renal Cancer|renal cancer
1008957|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
1008958|NCT03105375|X842|x842
1008959|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
1008960|NCT03105375|Esophagitis|esophagitis
1008961|NCT03105375|Intragastric pH|intragastric ph
1008962|NCT03105375|Acid inhibition|acid inhibition
1008963|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
1008964|NCT03105310|Hepatitis D|hepatitis d
1008965|NCT03105310|Ezetimibe|ezetimibe
1008966|NCT03105310|Pegylated interferon|pegylated interferon
1008967|NCT03105297|Nasal dilator strip|nasal dilator strip
1008968|NCT03105297|Sleep disordered breathing|sleep disordered breathing
1008969|NCT03105284|stem cell|stem cell
1008970|NCT03105284|liposuction|liposuction
1008971|NCT03105284|regenerative medicine|regenerative medicine
1008972|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
1008973|NCT03105245|anaesthesia|anaesthesia
1008974|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
1008975|NCT03105206|anatomical parameters|anatomical parameters
1008976|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
1008977|NCT03105193|Colon surgery|colon surgery
1008978|NCT03105193|Lignocaine|lignocaine
1008979|NCT03105193|Lidocaine|lidocaine
1008980|NCT03105193|Analgesia|analgesia
1008981|NCT03105193|Local anaesthetic|local anaesthetic
1008982|NCT03105167|CBT|cbt
1008983|NCT03105167|RCT|rct
1008984|NCT03105167|TLIF|tlif
1008985|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
1008986|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
1008987|NCT03105141|Stroke|stroke
1008988|NCT03105115|fentanyl|fentanyl
1008989|NCT03105115|dexmedetomidine|dexmedetomidine
1008990|NCT03105102|risankizumab|risankizumab
1008991|NCT03105102|ABBV-066|abbv-066
1008992|NCT03105102|BI 655066|bi 655066
1008993|NCT03105050|access|access
1008994|NCT03105050|policy|policy
1008995|NCT03105024|specific phobia|specific phobia
1008996|NCT03105024|height phobia|height phobia
1008997|NCT03105024|exposure|exposure
1008998|NCT03105024|virtual reality|virtual reality
1008999|NCT03105024|extinction|extinction
1009000|NCT03105024|self-efficacy|self-efficacy
1009001|NCT03105011|Type 2 diabetes|type 2 diabetes
1009002|NCT03104998|Idiopathic|idiopathic
1009003|NCT03104998|Infertility|infertility
1009004|NCT03104998|coenzyme q10|coenzyme q10
1009005|NCT03104998|Pakistan|pakistan
1009006|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
1009007|NCT03104972|ADHD|adhd
1009008|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
1009009|NCT03104959|hangovers|hangovers
1009010|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
1009011|NCT03104959|alcohol|alcohol
1009012|NCT03104933|Proadrenomedullin|proadrenomedullin
1009013|NCT03104933|Copeptin|copeptin
1009014|NCT03104933|Vasopressors|vasopressors
1009015|NCT03104933|Septic Shock|septic shock
1009016|NCT03104920|ERAS|eras
1009017|NCT03104920|Time to ready for discharge|time to ready for discharge
1009018|NCT03104907|IPSS|ipss
1009019|NCT03104907|Quality of Life|quality of life
1009020|NCT03104907|DAN-PSS|dan-pss
1009021|NCT03104907|Complications|complications
1009022|NCT03104907|Prostate cancer|prostate cancer
1009023|NCT03104881|stroke|stroke
1009024|NCT03104855|cystic fibrosis|cystic fibrosis
1009025|NCT03104855|vitamin d catabolism|vitamin d catabolism
1009026|NCT03104816|Acetaminophen po|acetaminophen po
1009027|NCT03104816|Acetaminophen IV|acetaminophen iv
1009028|NCT03104816|Pain management|pain management
1009029|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
1009030|NCT03104816|Ofirmev|ofirmev
1009031|NCT03104816|Analgesics|analgesics
1009032|NCT03104816|Opioid|opioid
1009033|NCT03104816|Pain|pain
1009034|NCT03104816|Postoperative|postoperative
1009035|NCT03104816|Spinal|spinal
1009036|NCT03104764|labial frenulum|labial frenulum
1009037|NCT03104764|surgery|surgery
1009038|NCT03104764|scalpel technique|scalpel technique
1009039|NCT03104764|Er:YAG laser|er:yag laser
1009040|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
1009041|NCT03104751|Infants|infants
1009042|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
1009043|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
1009044|NCT03104725|PARKINSONS DISEASE|parkinsons disease
1009045|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
1009046|NCT03104712|glycemic index|glycemic index
1009047|NCT03104699|Antibodies|antibodies
1009048|NCT03104699|Immunologic effects|immunologic effects
1009049|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
1009050|NCT03104673|Molecular signature|molecular signature
1009051|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
1009052|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
1009053|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
1009054|NCT03104582|ERCP|ercp
1009055|NCT03104582|PTBD|ptbd
1009056|NCT03104582|EBD|ebd
1009057|NCT03104582|Cholangitis|cholangitis
1009058|NCT03104582|Complication|complication
1009059|NCT03104582|Klatskin tumor|klatskin tumor
1009060|NCT03104569|ERCP|ercp
1009061|NCT03104569|Contrast agent|contrast agent
1009062|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
1009063|NCT03104569|Cholangitis|cholangitis
1009064|NCT03104569|Nonionic|nonionic
1009065|NCT03104543|survivor|survivor
1009066|NCT03104543|undertreatment|undertreatment
1009068|NCT03104543|self-efficacy|self-efficacy
1009069|NCT03104530|Crab|crab
1009070|NCT03104530|Brown meat|brown meat
1009071|NCT03104530|Cadmium body burden|cadmium body burden
1009072|NCT03104530|Ferritin|ferritin
1009073|NCT03104530|Zinc|zinc
1009074|NCT03104530|Selenium|selenium
1009075|NCT03104530|Creatinine|creatinine
1009076|NCT03104530|B2-Microglobulin|b2-microglobulin
1009077|NCT03104517|Urinary Incontinence|urinary incontinence
1009078|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
1009079|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1009080|NCT03104517|Urinary Bladder|urinary bladder
1009081|NCT03104517|Urinary Tract Diseases|urinary tract diseases
1009082|NCT03104517|Bladder|bladder
1009083|NCT03104517|Urinary Leak|urinary leak
1009084|NCT03104517|Urine Leak|urine leak
1009085|NCT03104517|Bladder Leak|bladder leak
1009086|NCT03104517|Urethra|urethra
1009087|NCT03104517|Urethral Sphincter|urethral sphincter
1009088|NCT03104504|Suicide Screening|suicide screening
1009089|NCT03104504|Safety Planning|safety planning
1009090|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1009091|NCT03104491|donor chimerism|donor chimerism
1009092|NCT03104478|DLBCL|dlbcl
1009093|NCT03104478|Real time molecular characterization|real time molecular characterization
1009094|NCT03104465|Chronic Pain|chronic pain
1009095|NCT03104465|Mindfulness|mindfulness
1009096|NCT03104465|Behavioral Health|behavioral health
1009097|NCT03104465|Quality of Life|quality of life
1009098|NCT03104439|Pancreatic Cancer|pancreatic cancer
1009099|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
1009100|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
1009101|NCT03104426|HDFN|hdfn
1009102|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
1009103|NCT03104413|ABBV-066|abbv-066
1009104|NCT03104413|BI 655066|bi 655066
1009105|NCT03104400|Arthritis|arthritis
1009106|NCT03104400|Psoriasis|psoriasis
1009107|NCT03104400|Anti-inflammatory|anti-inflammatory
1009108|NCT03104400|Joint disease|joint disease
1009109|NCT03104400|Musculoskeletal disease|musculoskeletal disease
1009110|NCT03104400|Anti-Rheumatic|anti-rheumatic
1009111|NCT03104387|Air pollution|air pollution
1009112|NCT03104387|Diesel exhaust|diesel exhaust
1009113|NCT03104387|Ultrafine particles|ultrafine particles
1009114|NCT03104387|Vascular function|vascular function
1009115|NCT03104387|Endothelium function|endothelium function
1009116|NCT03104387|Heart rate variability|heart rate variability
1009117|NCT03104387|DNA damage|dna damage
1009118|NCT03104374|Arthritis|arthritis
1009119|NCT03104374|Psoriasis|psoriasis
1009120|NCT03104374|Anti-Rheumatic|anti-rheumatic
1009121|NCT03104374|Anti-inflammatory|anti-inflammatory
1009122|NCT03104374|Joint disease|joint disease
1009123|NCT03104374|Musculoskeletal disease|musculoskeletal disease
1009124|NCT03104361|intersitial cystitis|intersitial cystitis
1009125|NCT03104361|Bladder pain syndrome|bladder pain syndrome
1009126|NCT03104361|Intravesical treatment|intravesical treatment
1009127|NCT03104348|COPD|copd
1009128|NCT03104348|Primary care|primary care
1009129|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
1009130|NCT03104335|advanced|advanced
1009131|NCT03104335|apatinib|apatinib
1009132|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
1009133|NCT03104322|digital health|digital health
1009134|NCT03104322|home spirometry|home spirometry
1009135|NCT03104322|patient reported outcome measure|patient reported outcome measure
1009136|NCT03104322|e-health|e-health
1009137|NCT03104322|pirfenidone|pirfenidone
1009138|NCT03104322|nintedanib|nintedanib
1009139|NCT03104322|FVC|fvc
1009140|NCT03104322|antifibrotic|antifibrotic
1009141|NCT03104296|NIRS|nirs
1009142|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
1009143|NCT03104296|prematurity|prematurity
1009144|NCT03104283|apatinib|apatinib
1009145|NCT03104283|gastric cancer|gastric cancer
1009146|NCT03104283|elderly patients|elderly patients
1009147|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
1009551|NCT03101514|toxicity|toxicity
1009148|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
1009149|NCT03104244|concussion|concussion
1009150|NCT03104244|subconcussive impacts|subconcussive impacts
1009151|NCT03104244|brain function|brain function
1009152|NCT03104244|football|football
1009153|NCT03104231|atrial fibrillation|atrial fibrillation
1009154|NCT03104231|oral anticoagulantion|oral anticoagulantion
1009155|NCT03104231|stroke prevention|stroke prevention
1009156|NCT03104231|education|education
1009157|NCT03104231|e-medicine|e-medicine
1009158|NCT03104205|frail elderly|frail elderly
1009159|NCT03104205|telemedicine|telemedicine
1009160|NCT03104205|obesity|obesity
1009161|NCT03104205|rural health|rural health
1009162|NCT03104205|health promotion|health promotion
1009163|NCT03104205|weight loss|weight loss
1009164|NCT03104192|frail elderly|frail elderly
1009165|NCT03104192|telemedicine|telemedicine
1009166|NCT03104192|obesity|obesity
1009167|NCT03104192|rural health|rural health
1009272|NCT03103269|Obesity|obesity
1009168|NCT03104192|health promotion|health promotion
1009169|NCT03104192|weight loss|weight loss
1009170|NCT03104127|Lower-limb robotic device|lower-limb robotic device
1009171|NCT03104127|Gait|gait
1009172|NCT03104127|Balance|balance
1009173|NCT03104127|Pressure|pressure
1009174|NCT03104127|Chronic stroke|chronic stroke
1009175|NCT03104127|Blood pressure|blood pressure
1009176|NCT03104127|Blood velocity|blood velocity
1009177|NCT03104127|Aerobic fitness|aerobic fitness
1009178|NCT03104127|Strength|strength
1009179|NCT03104101|PTNS|ptns
1009180|NCT03104101|Neuromodulation|neuromodulation
1009181|NCT03104101|TPTNS|tptns
1009182|NCT03104101|Trospium chloride|trospium chloride
1009183|NCT03104075|Genomics|genomics
1009184|NCT03104075|Epigenomics|epigenomics
1009185|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
1009186|NCT03104075|Elderly|elderly
1009187|NCT03104049|Parkinson's Disease|parkinson's disease
1009188|NCT03104049|Neuromuscular taping|neuromuscular taping
1009189|NCT03104049|Trunk|trunk
1009190|NCT03104049|Posture|posture
1009191|NCT03104049|Kinematic|kinematic
1009192|NCT03104049|rehabilitation|rehabilitation
1009193|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
1009194|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
1009195|NCT03103997|Liver|liver
1009196|NCT03103997|EUS|eus
1009197|NCT03103997|Biopsy|biopsy
1009198|NCT03103997|Heparin|heparin
1009199|NCT03103984|Obesity|obesity
1009200|NCT03103984|Liver transplantation|liver transplantation
1009201|NCT03103984|weight loss diet|weight loss diet
1009202|NCT03103984|immunosuppression|immunosuppression
1009203|NCT03103958|probiotic|probiotic
1009204|NCT03103958|metagenomic|metagenomic
1009205|NCT03103958|constipation|constipation
1009206|NCT03103945|Atrial Fibrillation|atrial fibrillation
1009207|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
1009208|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
1009209|NCT03103945|Cardiac Diseases|cardiac diseases
1009210|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
1009211|NCT03103945|Electrophysiology|electrophysiology
1009212|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
1009213|NCT03103945|Contact Detection System|contact detection system
1009214|NCT03103932|biomarkers|biomarkers
1009215|NCT03103932|heart failure|heart failure
1009216|NCT03103932|hospital admission|hospital admission
1009217|NCT03103919|Parkinson´s Disease|parkinson´s disease
1009218|NCT03103919|Kinesia-360™|kinesia-360™
1009219|NCT03103919|Kinesia-ONE™|kinesia-one™
1009220|NCT03103919|Biosensor|biosensor
1009221|NCT03103880|Patient Adherence|patient adherence
1009222|NCT03103880|Mobile Applications|mobile applications
1009223|NCT03103880|Mobile Health|mobile health
1009224|NCT03103854|Exercise|exercise
1009225|NCT03103854|Secondary Prevention|secondary prevention
1009226|NCT03103854|Diabetes|diabetes
1009227|NCT03103854|Rehabilitation|rehabilitation
1009228|NCT03103841|Children|children
1009229|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
1009230|NCT03103763|Elderly|elderly
1009231|NCT03103763|Anticoagulation|anticoagulation
1009232|NCT03103763|Risk Assessment|risk assessment
1009233|NCT03103750|Vitamin D|vitamin d
1009234|NCT03103737|Well-being|well-being
1009235|NCT03103737|Information and communication technologies|information and communication technologies
1009236|NCT03103737|Hospital|hospital
1009237|NCT03103711|Virtual reality|virtual reality
1009238|NCT03103711|Well-being|well-being
1009239|NCT03103711|Hospital|hospital
1009240|NCT03103698|analgesia per-operative|analgesia per-operative
1009241|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
1009242|NCT03103685|Dental procedure|dental procedure
1009243|NCT03103672|quality of anesthesia|quality of anesthesia
1009244|NCT03103672|reduce recovery time|reduce recovery time
1009245|NCT03103633|oxygen dynamics|oxygen dynamics
1009246|NCT03103633|Prognosis|prognosis
1009247|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
1009248|NCT03103542|ITI|iti
1009249|NCT03103542|rFVIIIFc|rfviiifc
1009250|NCT03103542|Immune Tolerance Induction|immune tolerance induction
1009252|NCT03103425|New onset seizures|new onset seizures
1009253|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
1009254|NCT03103386|fermented rye bran|fermented rye bran
1009255|NCT03103386|H. pylori infections|h. pylori infections
1009256|NCT03103386|non-communicable diseases|non-communicable diseases
1009257|NCT03103373|Echocardiography|echocardiography
1009258|NCT03103373|anesthesia|anesthesia
1009259|NCT03103373|general surgery|general surgery
1009261|NCT03103347|Parkinson Disease|parkinson disease
1009262|NCT03103347|Beta Oscillations|beta oscillations
1009263|NCT03103308|Cancer|cancer
1009264|NCT03103308|Exercise|exercise
1009265|NCT03103308|Physical Function|physical function
1009266|NCT03103295|tissue engineering,|tissue engineering,
1009267|NCT03103295|regeneration,|regeneration,
1009268|NCT03103295|repair,|repair,
1009269|NCT03103295|traumatic bone defects,|traumatic bone defects,
1009270|NCT03103295|regenerative therapy|regenerative therapy
1009275|NCT03103269|Physical activity|physical activity
1009276|NCT03103269|Depression|depression
1009277|NCT03103269|Anxiety|anxiety
1009278|NCT03103269|Stages of change|stages of change
1009279|NCT03103269|Barriers|barriers
1009280|NCT03103269|Perceptions|perceptions
1009281|NCT03103269|Environment|environment
1009282|NCT03103269|Eating Disorder|eating disorder
1009283|NCT03103269|Self efficacy|self efficacy
1009284|NCT03103243|Lupus|lupus
1009285|NCT03103243|SLE|sle
1009286|NCT03103243|Erythematosus|erythematosus
1009287|NCT03103230|Motor evoked potentials|motor evoked potentials
1009288|NCT03103230|aphasia|aphasia
1009289|NCT03103230|prognosis|prognosis
1009290|NCT03103230|stroke|stroke
1009291|NCT03103204|Obesity|obesity
1009292|NCT03103204|Periodontitis|periodontitis
1009293|NCT03103204|Therapeutics|therapeutics
1009294|NCT03103204|Chlorhexidine|chlorhexidine
1009295|NCT03103152|Prostate Cancer|prostate cancer
1009296|NCT03103152|Active Surveillance|active surveillance
1009297|NCT03103152|Chemo-prevention|chemo-prevention
1009298|NCT03103126|pedometer-determined walking|pedometer-determined walking
1009299|NCT03103126|resistance exercise|resistance exercise
1009300|NCT03103100|Local anesthetic|local anesthetic
1009301|NCT03103100|Labor epidural|labor epidural
1009302|NCT03103074|botulinum toxin|botulinum toxin
1009303|NCT03103061|Computed Tomography|computed tomography
1009304|NCT03102996|Alkali|alkali
1009305|NCT03102996|Graft|graft
1009306|NCT03102996|Acid base|acid base
1009307|NCT03102996|Metabolic acidosis|metabolic acidosis
1009308|NCT03102996|Chronic kidney disease|chronic kidney disease
1009309|NCT03102983|MRI, Functional|mri, functional
1009310|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
1009311|NCT03102918|Cannabidiol|cannabidiol
1009312|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
1009313|NCT03102879|regenerative procedures|regenerative procedures
1009314|NCT03102879|tissue engineering|tissue engineering
1009315|NCT03102879|regenerative endodontic|regenerative endodontic
1009316|NCT03102879|scaffold|scaffold
1009317|NCT03102879|cell encapsulation|cell encapsulation
1009318|NCT03102879|dental pulp|dental pulp
1009319|NCT03102879|pulp regeneration|pulp regeneration
1009320|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
1009321|NCT03102879|allogenic stem cells|allogenic stem cells
1009322|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
1009323|NCT03102879|adult stem cells|adult stem cells
1009324|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
1009325|NCT03102840|Carriage|carriage
1009326|NCT03102840|Immunogenicity|immunogenicity
1009327|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
1009328|NCT03102840|Children|children
1009329|NCT03102840|Pneumococcus|pneumococcus
1009330|NCT03102775|poverty|poverty
1009331|NCT03102775|unemployment|unemployment
1009332|NCT03102775|cluster-randomized|cluster-randomized
1009333|NCT03102775|family-project|family-project
1009334|NCT03102762|Erectile dysfunction|erectile dysfunction
1009335|NCT03102762|Botulinum toxin A|botulinum toxin a
1009336|NCT03102762|Botox|botox
1009337|NCT03102749|Airways|airways
1009338|NCT03102749|asthma|asthma
1009339|NCT03102749|overweight|overweight
1009340|NCT03102736|depression|depression
1009341|NCT03102736|ketamine|ketamine
1009342|NCT03102736|nitroprusside|nitroprusside
1009343|NCT03102723|STEMI|stemi
1009344|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
1009345|NCT03102723|cangrelor|cangrelor
1009346|NCT03102723|reperfusion|reperfusion
1009347|NCT03102697|Intragastric balloon|intragastric balloon
1009348|NCT03102697|obesity|obesity
1009349|NCT03102697|metabolic syndrome|metabolic syndrome
1009350|NCT03102697|bariatric surgery|bariatric surgery
1009351|NCT03102684|e-cigarette|e-cigarette
1009352|NCT03102684|electronic cigarette|electronic cigarette
1009353|NCT03102684|passive exposure|passive exposure
1009354|NCT03102684|secondhand exposure|secondhand exposure
1009356|NCT03102684|respiratory system|respiratory system
1009357|NCT03102619|Wireless monitoring|wireless monitoring
1009358|NCT03102619|Postoperative complications|postoperative complications
1009359|NCT03102619|Vital parameters|vital parameters
1009360|NCT03102619|Continuous monitoring|continuous monitoring
1009361|NCT03102606|Plinabulin|plinabulin
1009362|NCT03102606|Pegfilgrastim|pegfilgrastim
1009363|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
1009364|NCT03102606|Bone Pain|bone pain
1009365|NCT03102580|Shared Decision Making|shared decision making
1009366|NCT03102554|Exome Sequencing|exome sequencing
1009367|NCT03102502|Coronary Heart Disease|coronary heart disease
1009368|NCT03102502|Atherosclerosis|atherosclerosis
1009369|NCT03102502|Vascular Endothelium|vascular endothelium
1009370|NCT03102502|Counterpulsation, External|counterpulsation, external
1009371|NCT03102463|Insulin sensitivity|insulin sensitivity
1009372|NCT03102463|Obesity|obesity
1009373|NCT03102463|Insulin resistance|insulin resistance
1009374|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
1009375|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
1009376|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
1009377|NCT03102437|CCM|ccm
1009379|NCT03102437|Continued Access|continued access
1009380|NCT03102398|Erectile Dysfunction|erectile dysfunction
1009381|NCT03102398|PDE5 inhibitor|pde5 inhibitor
1009382|NCT03102398|Sexual Dysfunction|sexual dysfunction
1009383|NCT03102385|blood donation|blood donation
1009384|NCT03102385|motivation|motivation
1009385|NCT03102385|donor retention|donor retention
1009386|NCT03102372|FFM|ffm
1009387|NCT03102372|VLCD|vlcd
1009388|NCT03102372|exercise|exercise
1009389|NCT03102372|Protein|protein
1009390|NCT03102372|Obesity|obesity
1009391|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
1009392|NCT03102346|coronary artery disease|coronary artery disease
1009393|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
1009394|NCT03102346|remote control|remote control
1009395|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
1009396|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
1009397|NCT03102320|pancreatic cancer|pancreatic cancer
1009398|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
1009399|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
1009400|NCT03102320|thymic carcinoma|thymic carcinoma
1009401|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
1009402|NCT03102307|Targeted axillary dissection|targeted axillary dissection
1009403|NCT03102307|Sentinel node biopsy|sentinel node biopsy
1009404|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1009405|NCT03102255|Nasotracheal intubation|nasotracheal intubation
1009406|NCT03102229|Activity Monitoring|activity monitoring
1009407|NCT03102229|Chemotherapy|chemotherapy
1009408|NCT03102229|Radiotherapy|radiotherapy
1009409|NCT03102164|heart failure|heart failure
1009410|NCT03102164|decompensation|decompensation
1009411|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
1009412|NCT03102112|Glioma APT MRI|glioma apt mri
1009413|NCT03102073|Reading speed|reading speed
1009414|NCT03102047|microsatellite stable|microsatellite stable
1009415|NCT03102047|MSS|mss
1009416|NCT03102047|durvalumab|durvalumab
1009417|NCT03102047|NSABP|nsabp
1009418|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
1009419|NCT03102008|Emotional Disorders|emotional disorders
1009420|NCT03102008|Adolescence|adolescence
1009421|NCT03102008|Psychotherapy|psychotherapy
1009422|NCT03101995|Treatment|treatment
1009423|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
1009424|NCT03101995|Renal failure|renal failure
1009425|NCT03101995|Gemcitabine|gemcitabine
1009426|NCT03101969|language|language
1009427|NCT03101969|scheduled|scheduled
1009428|NCT03101969|appointment|appointment
1009429|NCT03101956|Spine Manipulation|spine manipulation
1009430|NCT03101943|Sugar|sugar
1009431|NCT03101943|Sweetened|sweetened
1009432|NCT03101943|Beverages|beverages
1009433|NCT03101891|Amnioinfusion|amnioinfusion
1009434|NCT03101891|Fetal therapy|fetal therapy
1009435|NCT03101878|Healthy Volunteers, IONIS AGT-Lrx|healthy volunteers, ionis agt-lrx
1009436|NCT03101865|Type 1 diabetes|type 1 diabetes
1009437|NCT03101865|Artificial Pancreas|artificial pancreas
1009438|NCT03101865|Closed-loop glucose control|closed-loop glucose control
1009439|NCT03101865|Very young children|very young children
1009440|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1009441|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
1009442|NCT03101852|severe acute malnutrition|severe acute malnutrition
1009443|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
1009444|NCT03101852|HIV-infection|hiv-infection
1009445|NCT03101852|adolescents|adolescents
1009446|NCT03101852|antiretroviral|antiretroviral
1009447|NCT03101852|Africa|africa
1009448|NCT03101852|ready-to-use food|ready-to-use food
1009449|NCT03101852|outpatient care|outpatient care
1009450|NCT03101839|AZD4785|azd4785
1009451|NCT03101839|KRAS|kras
1009452|NCT03101839|KRAS mutations|kras mutations
1009453|NCT03101839|Non-small cell lung cancer|non-small cell lung cancer
1009454|NCT03101839|Advanced solid tumours|advanced solid tumours
1009455|NCT03101826|Polyvagal Theory|polyvagal theory
1009456|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
1009457|NCT03101826|Heart rate|heart rate
1009458|NCT03101826|Social Behavior|social behavior
1009459|NCT03101826|Arginine Vasopressin|arginine vasopressin
1009460|NCT03101826|Dichotic Listening Tests|dichotic listening tests
1009461|NCT03101826|Oxytocin|oxytocin
1009462|NCT03101826|Hyperacusis|hyperacusis
1009463|NCT03101826|Affect|affect
1009464|NCT03101826|Auditory perception|auditory perception
1009465|NCT03101826|Sound spectrography|sound spectrography
1009466|NCT03101800|Azathioprine|azathioprine
1009467|NCT03101800|Allopurinol|allopurinol
1009468|NCT03101800|Antimetabolites|antimetabolites
1009469|NCT03101800|Ulcerative Colitis|ulcerative colitis
1009470|NCT03101787|ECPR|ecpr
1009471|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
1009472|NCT03101787|OHCA|ohca
1009473|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
1009474|NCT03101787|CPR|cpr
1009475|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
1009476|NCT03101787|ECMO|ecmo
1009477|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1009478|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
1009479|NCT03101774|inspiratory muscle training|inspiratory muscle training
1009480|NCT03101748|Malignant neoplasm of breast|malignant neoplasm of breast
1009481|NCT03101748|Metastatic breast cancer|metastatic breast cancer
1009482|NCT03101748|Locally advanced breast cancer|locally advanced breast cancer
1009483|NCT03101748|HER2-positive|her2-positive
1009484|NCT03101748|HER2+|her2+
1009485|NCT03101748|HER2-negative/ER-positive|her2-negative/er-positive
1009486|NCT03101748|HER2-/ER+|her2-/er+
1009487|NCT03101748|Locally advanced inflammatory breast cancer|locally advanced inflammatory breast cancer
1009488|NCT03101748|IBC|ibc
1009489|NCT03101748|Neratinib|neratinib
1009490|NCT03101748|Paclitaxel|paclitaxel
1009491|NCT03101748|Taxol|taxol
1009492|NCT03101748|Doxorubicin|doxorubicin
1009493|NCT03101748|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1009494|NCT03101748|Adriamycin PFS|adriamycin pfs
1009495|NCT03101748|Adriamycin RDF|adriamycin rdf
1009496|NCT03101748|Adriamycin|adriamycin
1009497|NCT03101748|Rubex|rubex
1009498|NCT03101748|Pertuzumab|pertuzumab
1009499|NCT03101748|Perjeta|perjeta
1009500|NCT03101748|Trastuzumab|trastuzumab
1009501|NCT03101748|Herceptin|herceptin
1009502|NCT03101748|Cyclophosphamide|cyclophosphamide
1009503|NCT03101748|Cytoxan|cytoxan
1009504|NCT03101748|Neosar|neosar
1009505|NCT03101722|presbycusis|presbycusis
1009506|NCT03101722|tinnitus|tinnitus
1009507|NCT03101722|cognitive impairment|cognitive impairment
1009508|NCT03101722|Huperzine A|huperzine a
1009509|NCT03101722|hearing aid|hearing aid
1009760|NCT03100188|end stage renal disease|end stage renal disease
1009510|NCT03101722|age-related hearing impairment|age-related hearing impairment
1009511|NCT03101696|coronary angiography|coronary angiography
1009512|NCT03101696|coronary conductance|coronary conductance
1009513|NCT03101696|hyperemia|hyperemia
1009514|NCT03101696|regadenoson|regadenoson
1009515|NCT03101696|fractional flow reserve|fractional flow reserve
1009516|NCT03101696|coronary flow reserve|coronary flow reserve
1009517|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
1009518|NCT03101631|Elderly population with cancer|elderly population with cancer
1009519|NCT03101631|Toxicity risk|toxicity risk
1009520|NCT03101631|Mortality risk|mortality risk
1009521|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
1009522|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
1009523|NCT03101618|allergen|allergen
1009524|NCT03101618|allergy|allergy
1009525|NCT03101618|pet|pet
1009526|NCT03101592|antiretroviral therapy|antiretroviral therapy
1009527|NCT03101592|retention|retention
1009528|NCT03101592|ART|art
1009529|NCT03101592|cost-effectiveness|cost-effectiveness
1009530|NCT03101592|virologic suppression|virologic suppression
1009531|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
1009532|NCT03101579|Recurrence|recurrence
1009533|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
1009534|NCT03101579|Pemetrexed|pemetrexed
1009535|NCT03101540|Major Depressive Disorder,|major depressive disorder,
1009536|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
1009537|NCT03101540|PUFA|pufa
1009538|NCT03101540|Pregnancy|pregnancy
1009539|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
1009540|NCT03101540|cytokine|cytokine
1009541|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1009542|NCT03101527|Major Depressive Disorder|major depressive disorder
1009543|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
1009544|NCT03101527|PUFA|pufa
1009545|NCT03101527|Pregnancy|pregnancy
1009546|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
1009547|NCT03101514|head and neck|head and neck
1009548|NCT03101514|tumor|tumor
1009549|NCT03101514|radiotherapy|radiotherapy
1009552|NCT03101514|Kanglaite injection|kanglaite injection
1009553|NCT03101488|KN035|kn035
1009554|NCT03101488|phase 1|phase 1
1009555|NCT03101475|Colorectal Cancer|colorectal cancer
1009556|NCT03101475|Liver Metastases|liver metastases
1009557|NCT03101475|Durvalumab|durvalumab
1009558|NCT03101475|Tremelimumab|tremelimumab
1009559|NCT03101436|Insulin Resistance|insulin resistance
1009560|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
1009561|NCT03101436|Red Wine|red wine
1009562|NCT03101436|Diet|diet
1009563|NCT03101436|Microbiota|microbiota
1009564|NCT03101423|thalassemia|thalassemia
1009565|NCT03101423|transplantation|transplantation
1009566|NCT03101423|chimerism|chimerism
1009567|NCT03101423|donor ymphocytes|donor ymphocytes
1009568|NCT03101410|Gluten|gluten
1009569|NCT03101410|sport performance|sport performance
1009570|NCT03101397|serum KL-6|serum kl-6
1009571|NCT03101397|pulmonary function test|pulmonary function test
1009572|NCT03101397|CT score|ct score
1009573|NCT03101397|evaluation|evaluation
1009574|NCT03101358|cutaneous metastases|cutaneous metastases
1009575|NCT03101358|cutaneous metastasis|cutaneous metastasis
1009576|NCT03101358|skin metastases|skin metastases
1009577|NCT03101358|skin metastasis|skin metastasis
1009578|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
1009579|NCT03101293|Drug therapy|drug therapy
1009580|NCT03101267|Cedar pollinosis|cedar pollinosis
1009581|NCT03101267|ASP4070|asp4070
1009582|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
1009583|NCT03101254|Melanoma|melanoma
1009584|NCT03101241|Essential Tremor|essential tremor
1009585|NCT03101241|Movement Disorders|movement disorders
1009586|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
1009587|NCT03101228|Physical Activity|physical activity
1009588|NCT03101228|Metabolic Syndrome|metabolic syndrome
1009589|NCT03101228|Insulin Sensitivity|insulin sensitivity
1009590|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
1009591|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
1009592|NCT03101228|Accelerometry|accelerometry
1009593|NCT03101189|safety|safety
1009594|NCT03101189|Japanese|japanese
1009595|NCT03101189|pharmacokinetics|pharmacokinetics
1009596|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
1009597|NCT03101176|prostate cancer|prostate cancer
1009598|NCT03101176|contrast ultrasound|contrast ultrasound
1009599|NCT03101176|CEUS|ceus
1009600|NCT03101176|radical prostatectomy|radical prostatectomy
1009601|NCT03101150|Maternal vitamin D|maternal vitamin d
1009602|NCT03101150|Deficiency|deficiency
1009603|NCT03101150|Insufficiency|insufficiency
1009604|NCT03101150|Pregnancy|pregnancy
1009605|NCT03101150|Pre-eclampsia|pre-eclampsia
1009606|NCT03101150|IUGR|iugr
1009607|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
1009608|NCT03101124|Tranexamic Acid|tranexamic acid
1009609|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
1009610|NCT03101124|Administration, Cutaneous|administration, cutaneous
1009611|NCT03101124|Administration, Intravenous|administration, intravenous
1009612|NCT03101124|Administration, Topical|administration, topical
1009613|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
1009614|NCT03101072|antibiotic durations|antibiotic durations
1009615|NCT03101072|point-of-care randomization|point-of-care randomization
1009616|NCT03101059|Tracheal|tracheal
1009617|NCT03101059|Bronchial|bronchial
1009618|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
1009619|NCT03101059|Collapse|collapse
1009620|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1009621|NCT03101059|Computer Tomography|computer tomography
1009622|NCT03101059|Impedance Tomography|impedance tomography
1009623|NCT03101046|Docetaxel|docetaxel
1009624|NCT03101046|Cabazitaxel|cabazitaxel
1009625|NCT03101033|Herniated lumbar disc|herniated lumbar disc
1009626|NCT03101033|Epidural neuroplasty|epidural neuroplasty
1009627|NCT03101033|Epidural injection|epidural injection
1009628|NCT03101020|Visceral Manipulation|visceral manipulation
1009629|NCT03101007|Comparative study|comparative study
1009630|NCT03101007|Knee Prosthesis|knee prosthesis
1009631|NCT03101007|Prosthesis Design|prosthesis design
1009632|NCT03101007|Treatment Outcome|treatment outcome
1009633|NCT03101007|Follow-up studies|follow-up studies
1009634|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
1009635|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1009636|NCT03100981|Internet-delivered|internet-delivered
1009637|NCT03100981|Breast cancer|breast cancer
1009638|NCT03100981|Prostate cancer|prostate cancer
1009639|NCT03100981|Survivors|survivors
1009640|NCT03100981|Depression|depression
1009641|NCT03100981|Anxiety|anxiety
1009642|NCT03100981|Stress|stress
1009643|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
1009644|NCT03100838|Bioequivalence|bioequivalence
1009645|NCT03100838|Drug-Drug Interaction|drug-drug interaction
1009646|NCT03100838|Modified Release|modified release
1009647|NCT03100838|Nifedipine|nifedipine
1009648|NCT03100825|QVM149,|qvm149,
1009649|NCT03100825|Asthma,|asthma,
1009650|NCT03100825|Japanese,|japanese,
1009651|NCT03100825|Allergic asthma,|allergic asthma,
1009854|NCT03099564|KEYTRUDA®|keytruda®
1009652|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
1009653|NCT03100825|Reactive asthma,|reactive asthma,
1009654|NCT03100825|Asthma attack,|asthma attack,
1009655|NCT03100825|Difficulty breathing|difficulty breathing
1009656|NCT03100812|Hypertensive|hypertensive
1009657|NCT03100812|Hypertension|hypertension
1009658|NCT03100812|Filipino|filipino
1009659|NCT03100799|Osteoarthritis|osteoarthritis
1009660|NCT03100799|Senescence|senescence
1009661|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
1009662|NCT03100799|Arthroscopy|arthroscopy
1009663|NCT03100799|Arthrocentesis|arthrocentesis
1009664|NCT03100799|Biomarker|biomarker
1009665|NCT03100786|Tuberculosis|tuberculosis
1009666|NCT03100786|tuberculous meningitis|tuberculous meningitis
1009667|NCT03100786|drug induced liver injury|drug induced liver injury
1009668|NCT03100786|dexamethasone|dexamethasone
1009669|NCT03100786|LTA4H|lta4h
1009670|NCT03100786|host genotype|host genotype
1009671|NCT03100786|personalized medicine|personalized medicine
1009672|NCT03100773|alpha-amylases|alpha-amylases
1009673|NCT03100773|child|child
1009674|NCT03100773|cortisol|cortisol
1009675|NCT03100773|dental anxiety|dental anxiety
1009776|NCT03100084|Reduced Fetal Movements|reduced fetal movements
1009676|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
1009677|NCT03100773|health education|health education
1009678|NCT03100773|microbiota|microbiota
1009679|NCT03100773|oral hygiene|oral hygiene
1009680|NCT03100773|quality of life|quality of life
1009681|NCT03100773|saliva|saliva
1009682|NCT03100734|Rheumatoid arthritis|rheumatoid arthritis
1009683|NCT03100734|Axial spondyloarthritis|axial spondyloarthritis
1009684|NCT03100734|Observational|observational
1009685|NCT03100734|Biosimilar|biosimilar
1009686|NCT03100734|Etanercept|etanercept
1009687|NCT03100734|Benepali|benepali
1009688|NCT03100734|Enbrel|enbrel
1009689|NCT03100721|Chronic pain|chronic pain
1009690|NCT03100721|Musculoskeletal diseases|musculoskeletal diseases
1009691|NCT03100721|Pain Neuroscience Education|pain neuroscience education
1009692|NCT03100721|Physiotherapy|physiotherapy
1009693|NCT03100656|psychopathology|psychopathology
1009694|NCT03100656|treatment|treatment
1009695|NCT03100656|epoxide hydrolases|epoxide hydrolases
1009696|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
1009697|NCT03100656|eicosanoids|eicosanoids
1009698|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
1009699|NCT03100617|Family caregiver|family caregiver
1009700|NCT03100604|middle ear pressure|middle ear pressure
1009701|NCT03100604|sevoflurane|sevoflurane
1009702|NCT03100604|desflurane|desflurane
1009703|NCT03100578|PANCREAS|pancreas
1009704|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
1009705|NCT03100578|PLASTIC STENT|plastic stent
1009706|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
1009707|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
1009708|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
1009709|NCT03100565|colposcopy|colposcopy
1009710|NCT03100565|pain|pain
1009711|NCT03100565|coughing|coughing
1009712|NCT03100565|anesthetic spray|anesthetic spray
1009713|NCT03100552|Colonoscopy|colonoscopy
1009714|NCT03100552|Endoscopic resection|endoscopic resection
1009715|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
1009716|NCT03100539|Massage|massage
1009717|NCT03100539|Caregiver|caregiver
1009718|NCT03100539|Fascia|fascia
1009719|NCT03100526|High-Risk Patients|high-risk patients
1009720|NCT03100500|QVM149,|qvm149,
1009721|NCT03100500|Asthma,|asthma,
1009722|NCT03100500|Japanese,|japanese,
1009723|NCT03100500|Allergic asthma,|allergic asthma,
1009724|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
1009725|NCT03100500|Reactive asthma,|reactive asthma,
1009726|NCT03100500|Asthma attack,|asthma attack,
1009727|NCT03100500|Difficulty breathing|difficulty breathing
1009728|NCT03100474|tremor|tremor
1009729|NCT03100474|Parkinson's|parkinson's
1009730|NCT03100474|movement|movement
1009731|NCT03100474|neuropathic|neuropathic
1009732|NCT03100474|pain|pain
1009733|NCT03100461|Cancer Screening|cancer screening
1009734|NCT03100461|Colon Cancer|colon cancer
1009735|NCT03100461|Colon Cancer Screening|colon cancer screening
1009736|NCT03100409|Cervical cancer|cervical cancer
1009737|NCT03100383|gestational diabetes|gestational diabetes
1009738|NCT03100383|Type2 Diabetes|type2 diabetes
1009739|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
1009740|NCT03100331|HIV/AIDS|hiv/aids
1009741|NCT03100331|international adoption|international adoption
1009742|NCT03100331|perinatal infection|perinatal infection
1009743|NCT03100292|primary bariatric surgery|primary bariatric surgery
1009744|NCT03100292|morbid obesity|morbid obesity
1009745|NCT03100292|South Korea|south korea
1009746|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
1009747|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
1009748|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
1009749|NCT03100279|treatment mediators|treatment mediators
1009750|NCT03100279|trajectories of change|trajectories of change
1009751|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
1009752|NCT03100253|Tocilizumab|tocilizumab
1009753|NCT03100253|anti-TNF treatment|anti-tnf treatment
1663508|NCT00130091|hernia|hernia
1009754|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
1009755|NCT03100201|humeral fracture|humeral fracture
1009756|NCT03100201|randomised controlled study|randomised controlled study
1009757|NCT03100188|peritoneal dialysis|peritoneal dialysis
1009758|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
1009759|NCT03100188|quality of life|quality of life
1009761|NCT03100188|adequacy|adequacy
1009762|NCT03100162|probiotics|probiotics
1009763|NCT03100162|metabolic syndrome|metabolic syndrome
1009764|NCT03100162|obesity|obesity
1009765|NCT03100162|microbiome|microbiome
1009767|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
1009768|NCT03100136|Reliability|reliability
1009769|NCT03100136|Scan, Safety|scan, safety
1009770|NCT03100110|Brain-Computer Interface|brain-computer interface
1009771|NCT03100110|Brain-Machine Interface|brain-machine interface
1009772|NCT03100110|Prefrontal Cortex|prefrontal cortex
1009773|NCT03100084|Preeclampsia|preeclampsia
1009774|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
1009775|NCT03100084|Fetal Growth Restriction|fetal growth restriction
1009777|NCT03100058|Obesity|obesity
1009783|NCT03100045|anal dysplasia|anal dysplasia
1009784|NCT03100045|treatment|treatment
1009785|NCT03100045|alternative treatment|alternative treatment
1009786|NCT03100045|anal precancer|anal precancer
1009787|NCT03100045|Johns Hopkins|johns hopkins
1009788|NCT03100045|Sandy Fang|sandy fang
1009789|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
1009790|NCT03100032|Spinal Fusion|spinal fusion
1009791|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
1009792|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
1009793|NCT03100032|Bone Graft|bone graft
1009794|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
1009795|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
1009796|NCT03100019|Resveratrol|resveratrol
1009797|NCT03100019|Cerebral blood flow|cerebral blood flow
1009798|NCT03100019|Cognition|cognition
1009799|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
1009800|NCT03099993|kinematics|kinematics
1009801|NCT03099993|electromyography|electromyography
1009802|NCT03099993|constraint-induced therapy|constraint-induced therapy
1009803|NCT03099993|muscle activation|muscle activation
1009804|NCT03099993|upper limb|upper limb
1009805|NCT03099993|child|child
1009806|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
1009807|NCT03099902|Asthma|asthma
1009808|NCT03099902|Wheezing|wheezing
1009809|NCT03099902|GSTP1|gstp1
1009810|NCT03099902|TNFa|tnfa
1009811|NCT03099902|Secondhand smoking|secondhand smoking
1009812|NCT03099902|Passive smoking|passive smoking
1009813|NCT03099902|Intrauterine smoking|intrauterine smoking
1009814|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
1009815|NCT03099850|Data management|data management
1009816|NCT03099850|Regulatory compliance|regulatory compliance
1009817|NCT03099850|Protocol monitoring|protocol monitoring
1009818|NCT03099824|Healthy Adult|healthy adult
1009819|NCT03099824|Oral Capsule|oral capsule
1009820|NCT03099824|Superoxide Dismutase|superoxide dismutase
1009821|NCT03099824|Free Radical Oxygen|free radical oxygen
1009822|NCT03099824|Single Ascending Dose|single ascending dose
1009823|NCT03099824|GC4702 Oral Form Capsule|gc4702 oral form capsule
1009824|NCT03099824|Food Effect Cohort|food effect cohort
1009825|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1009826|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
1009827|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
1009828|NCT03099746|chronically critically ill|chronically critically ill
1009829|NCT03099746|surrogate decision maker|surrogate decision maker
1009830|NCT03099707|Treatment|treatment
1009831|NCT03099707|ART|art
1009832|NCT03099707|South Africa|south africa
1009833|NCT03099694|NRDS|nrds
1009834|NCT03099694|nHFOV|nhfov
1009835|NCT03099694|nCPAP|ncpap
1009836|NCT03099694|preterm infants|preterm infants
1009837|NCT03099655|Heart Failure|heart failure
1009838|NCT03099655|Cardiac Pacing|cardiac pacing
1009839|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1009840|NCT03099655|Left Ventricular Lead|left ventricular lead
1009841|NCT03099642|lumbar puncture|lumbar puncture
1009842|NCT03099642|Point of care ultrasound|point of care ultrasound
1009843|NCT03099642|children|children
1009844|NCT03099629|Inspiratory muscle training|inspiratory muscle training
1009845|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
1009846|NCT03099629|Respiratory muscle strength|respiratory muscle strength
1009847|NCT03099629|Functional capacity|functional capacity
1009848|NCT03099616|propofol|propofol
1009849|NCT03099616|CLADS|clads
1009850|NCT03099616|Desflurane|desflurane
1009851|NCT03099616|Obesity|obesity
1009852|NCT03099564|Pembrolizumab|pembrolizumab
1663509|NCT00130091|hydrocele|hydrocele
1034463|NCT02948452|anxiety|anxiety
1009853|NCT03099564|Y90 Radioembolization|y90 radioembolization
1009860|NCT03099551|gingivitis|gingivitis
1009861|NCT03099551|sonic toothbrush|sonic toothbrush
1009862|NCT03099551|manual toothbrush|manual toothbrush
1009863|NCT03099538|Ixekizumab|ixekizumab
1009864|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
1009865|NCT03099538|Pemphigoid|pemphigoid
1009866|NCT03099538|IL17|il17
1009867|NCT03099538|IL-17|il-17
1009868|NCT03099538|Interleukin 17|interleukin 17
1009869|NCT03099512|Patellofemoral pain|patellofemoral pain
1009870|NCT03099512|foot deformity|foot deformity
1009871|NCT03099512|foot pronation|foot pronation
1009872|NCT03099512|short foot exercise|short foot exercise
1009873|NCT03099473|electroacupuncture|electroacupuncture
1009874|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
1009875|NCT03099473|eyeball movement|eyeball movement
1009876|NCT03099473|diplopia|diplopia
1009877|NCT03099473|ocular motility disorder|ocular motility disorder
1009878|NCT03099460|electroacupuncture|electroacupuncture
1009879|NCT03099460|abducens nerve palsy|abducens nerve palsy
1009880|NCT03099460|eyeball movement|eyeball movement
1009881|NCT03099460|diplopia|diplopia
1009882|NCT03099460|ocular motility disorder|ocular motility disorder
1009883|NCT03099447|electroacupuncture|electroacupuncture
1009884|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
1009885|NCT03099447|rehabilitation|rehabilitation
1009887|NCT03099447|ocular motility disorder|ocular motility disorder
1009888|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
1009889|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
1009890|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
1009891|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
1009892|NCT03099421|prostatic artery embolization|prostatic artery embolization
1009893|NCT03099421|Quality of Life|quality of life
1009894|NCT03099421|IPSS|ipss
1009895|NCT03099421|DAN-PSS|dan-pss
1009896|NCT03099421|Complications|complications
1009897|NCT03099408|Recurrence|recurrence
1009898|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
1009899|NCT03099395|myocardial infarction|myocardial infarction
1009900|NCT03099369|Peripheral Artery Disease|peripheral artery disease
1009901|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
1009902|NCT03099369|Exercise|exercise
1009903|NCT03099369|Step Count|step count
1009904|NCT03099369|Fitness Monitor|fitness monitor
1009905|NCT03099369|Mobile Health|mobile health
1009906|NCT03099369|Walking Ability|walking ability
1009907|NCT03099369|Quality of Life|quality of life
1009908|NCT03099343|sodium|sodium
1009909|NCT03099343|salt|salt
1009910|NCT03099343|diet|diet
1009911|NCT03099343|tailored messaging|tailored messaging
1009912|NCT03099343|mobile application|mobile application
1009913|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
1009914|NCT03099317|Sinew Acupuncture|sinew acupuncture
1009915|NCT03099317|Pain|pain
1009916|NCT03099304|Vitiligo|vitiligo
1009917|NCT03099304|depigmenting disorder|depigmenting disorder
1009918|NCT03099304|topical JAK inhibitor|topical jak inhibitor
1009919|NCT03099278|hepatitis D|hepatitis d
1009920|NCT03099278|Ezetimibe|ezetimibe
1009921|NCT03099278|HDV RNA|hdv rna
1009922|NCT03099161|Advanced Solid Tumor|advanced solid tumor
1009923|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
1009924|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
1009926|NCT03099161|PD-1|pd-1
1009927|NCT03099161|PDL1|pdl1
1009928|NCT03099161|PD-L1|pd-l1
1009929|NCT03099109|TIM-3|tim-3
1009930|NCT03099109|PD-L1|pd-l1
1009936|NCT03099083|Psoriasis|psoriasis
1009937|NCT03099083|Adalimumab|adalimumab
1009938|NCT03099083|Humira|humira
1009939|NCT03099083|Korea|korea
1009940|NCT03099070|Stress|stress
1009941|NCT03099070|Fasting|fasting
1009942|NCT03099070|Migraine|migraine
1009943|NCT03099031|Ottawa score|ottawa score
1009944|NCT03099031|tinzaparin|tinzaparin
1009945|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
1009946|NCT03099031|anticoagulants|anticoagulants
1009947|NCT03099031|venous thrombosis|venous thrombosis
1009948|NCT03099031|thromboembolism|thromboembolism
1009949|NCT03099031|hemostatic disorders|hemostatic disorders
1009950|NCT03099031|vascular disease|vascular disease
1009951|NCT03099031|neoplasms|neoplasms
1009952|NCT03099031|breast neoplasms|breast neoplasms
1009953|NCT03099031|lung neoplasms|lung neoplasms
1009954|NCT03099031|prostatic neoplasms|prostatic neoplasms
1009955|NCT03099031|colorectal neoplasms|colorectal neoplasms
1009956|NCT03099031|genital neoplasms|genital neoplasms
1009961|NCT03099031|leukemia|leukemia
1009962|NCT03099031|multiple myeloma|multiple myeloma
1009963|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
1009964|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
1009965|NCT03099031|lymphatic disease|lymphatic disease
1009966|NCT03099018|GAS|gas
1009967|NCT03099018|pharyngitis|pharyngitis
1009968|NCT03099018|children|children
1009969|NCT03099018|RADT|radt
1009970|NCT03099005|neuropathic pain|neuropathic pain
1009971|NCT03099005|human immunovirus|human immunovirus
1009972|NCT03099005|vaporized cannabis|vaporized cannabis
1009973|NCT03098979|Chronic Heart Failure|chronic heart failure
1009974|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1009975|NCT03098953|Ocular Installation|ocular installation
1009976|NCT03098927|Motor Imagery|motor imagery
1009977|NCT03098927|Spinal Cord Injury|spinal cord injury
1009978|NCT03098927|Motor Function Improvement|motor function improvement
1009979|NCT03098914|Pathogen|pathogen
1009980|NCT03098914|Mortality|mortality
1009981|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
1009982|NCT03098914|Risk factors|risk factors
1009983|NCT03098901|TTR Amyloidosis|ttr amyloidosis
1009984|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1009985|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
1009986|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
1009987|NCT03098888|side effects|side effects
1009988|NCT03098888|decision making|decision making
1009989|NCT03098888|indications|indications
1009990|NCT03098888|risk factors|risk factors
1009996|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
1009997|NCT03098836|metastatic|metastatic
1009998|NCT03098836|castrate resistant|castrate resistant
1009999|NCT03098797|Barth Syndrome|barth syndrome
1010000|NCT03098797|elamipretide|elamipretide
1010001|NCT03098797|MTP-131|mtp-131
1010002|NCT03098797|Stealth|stealth
1010003|NCT03098797|Stealth BT|stealth bt
1010004|NCT03098797|BTHS|bths
1010005|NCT03098784|airport environment|airport environment
1010006|NCT03098784|Air France|air france
1010007|NCT03098784|flightline employees|flightline employees
1010008|NCT03098784|administrative employees|administrative employees
1010009|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
1010010|NCT03098758|gastric cancer|gastric cancer
1010011|NCT03098758|citology|citology
1010012|NCT03098758|peritoneal washing|peritoneal washing
1010013|NCT03098758|CK20|ck20
1010014|NCT03098758|CEA|cea
1010015|NCT03098758|BER-EP4|ber-ep4
1010016|NCT03098732|Stroke|stroke
1010017|NCT03098732|Ischemic|ischemic
1010018|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
1010019|NCT03098732|Thrombolysis|thrombolysis
1010020|NCT03098732|Vascular Diseases|vascular diseases
1010021|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
1010022|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
1010023|NCT03098732|Plasminogen|plasminogen
1010024|NCT03098693|Serodiscordant|serodiscordant
1010025|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1010026|NCT03098693|Self-testing|self-testing
1010027|NCT03098693|Tanzania|tanzania
1010028|NCT03098680|Adverse reactions|adverse reactions
1010029|NCT03098680|Cardiovascular|cardiovascular
1010030|NCT03098680|Translation|translation
1010031|NCT03098680|Modelling|modelling
1010032|NCT03098680|Pharmacokinetics|pharmacokinetics
1010033|NCT03098680|Pharmacodynamics|pharmacodynamics
1010034|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
1010035|NCT03098654|Community Health Services|community health services
1010036|NCT03098654|Chronic Disease|chronic disease
1010037|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
1010038|NCT03098654|Tanzania|tanzania
1010039|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
1010040|NCT03098589|Teratogenicity|teratogenicity
1010041|NCT03098589|Myelosuppression|myelosuppression
1010042|NCT03098589|Haemorrhage|haemorrhage
1010043|NCT03098589|Infection|infection
1010044|NCT03098589|Thromboembolism|thromboembolism
1010045|NCT03098589|Hypersensitivity|hypersensitivity
1010046|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
1010047|NCT03098589|Peripheral neuropathy|peripheral neuropathy
1010048|NCT03098589|Ischaemic heart disease|ischaemic heart disease
1010049|NCT03098589|Cardiac failure|cardiac failure
1010050|NCT03098589|Arrhythmia|arrhythmia
1010051|NCT03098589|Renal failure|renal failure
1010052|NCT03098589|Interstitial lung disease|interstitial lung disease
1010053|NCT03098589|Hepatic disorder|hepatic disorder
1010054|NCT03098589|Hypothyroidism|hypothyroidism
1010055|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
1010056|NCT03098589|Orthostatic hypotension|orthostatic hypotension
1010057|NCT03098589|Convulsion|convulsion
1010058|NCT03098589|Somnolence|somnolence
1010059|NCT03098589|Confusion|confusion
1010060|NCT03098589|Fatigue|fatigue
1010061|NCT03098589|Dizziness|dizziness
1010062|NCT03098589|Blurred vision|blurred vision
1010063|NCT03098589|Second primary cancer|second primary cancer
1010064|NCT03098589|Cataract|cataract
1010065|NCT03098589|Revlimid capsules|revlimid capsules
1010066|NCT03098576|advanced|advanced
1010067|NCT03098576|metastatic solid tumors|metastatic solid tumors
1010068|NCT03098563|Clinical Trial|clinical trial
1010069|NCT03098563|Phase II|phase ii
1663510|NCT00130091|pediatric|pediatric
1010070|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1010071|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
1010072|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
1010073|NCT03098524|Cardiac surgery|cardiac surgery
1010074|NCT03098524|Mechanical ventilation|mechanical ventilation
1010075|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
1010076|NCT03098524|Pneumonia|pneumonia
1010077|NCT03098524|Atelectasis|atelectasis
1010078|NCT03098511|Neurological Determination of Death|neurological determination of death
1010079|NCT03098511|Determination of Death|determination of death
1010080|NCT03098511|CT-Perfusion scan|ct-perfusion scan
1010081|NCT03098511|Ancillary Test|ancillary test
1010082|NCT03098511|Organ Donation|organ donation
1010083|NCT03098498|periodontitis|periodontitis
1010084|NCT03098498|scaling|scaling
1010085|NCT03098498|attachment gain|attachment gain
1010086|NCT03098498|air polishing|air polishing
1010087|NCT03098498|periodontal lesion|periodontal lesion
1010088|NCT03098459|Delirium|delirium
1010089|NCT03098459|Cognitive Impairment|cognitive impairment
1010090|NCT03098459|Alzheimer's Disease|alzheimer's disease
1010091|NCT03098459|Encephalopathy|encephalopathy
1010092|NCT03098459|Trauma|trauma
1010093|NCT03098459|Polytrauma|polytrauma
1010094|NCT03098459|ICU|icu
1010095|NCT03098459|Critical Illness|critical illness
1010096|NCT03098459|Traumatic Brain Injury|traumatic brain injury
1010097|NCT03098459|INSIGHT-ICU|insight-icu
1010098|NCT03098459|INSIGHT|insight
1010099|NCT03098459|Intracerebral hemorrhage|intracerebral hemorrhage
1010100|NCT03098459|Subarachnoid hemorrhage|subarachnoid hemorrhage
1010102|NCT03098459|Neuropsychology|neuropsychology
1010103|NCT03098459|Dementia|dementia
1010104|NCT03098459|Critical Care|critical care
1010105|NCT03098459|Subdural hemorrhage|subdural hemorrhage
1010106|NCT03098459|Cognition|cognition
1010107|NCT03098459|Neuropsychological Outcomes|neuropsychological outcomes
1010108|NCT03098459|Neuropsychology Dysfunction|neuropsychology dysfunction
1010109|NCT03098459|Inflammation|inflammation
1010110|NCT03098459|Neuroinflammation|neuroinflammation
1010111|NCT03098459|Inflammatory Mechanisms|inflammatory mechanisms
1010112|NCT03098459|Burn|burn
1010113|NCT03098459|Critically Injured|critically injured
1010114|NCT03098459|Injury|injury
1010115|NCT03098459|Head Injury|head injury
1010116|NCT03098459|Long-term Cognitive Impairment|long-term cognitive impairment
1010117|NCT03098459|ICU-related Dementia|icu-related dementia
1010118|NCT03098459|Employment|employment
1010119|NCT03098459|Return to Work|return to work
1010120|NCT03098394|Rapid turnaround test|rapid turnaround test
1010121|NCT03098394|RTAT|rtat
1010122|NCT03098394|Gonorrhea|gonorrhea
1010123|NCT03098394|Chlamydia|chlamydia
1010124|NCT03098394|STI|sti
1010125|NCT03098368|Parkinson's disease|parkinson's disease
1010126|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
1010127|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
1010128|NCT03098355|CART|cart
1010129|NCT03098355|CD19|cd19
1010130|NCT03098355|CD22|cd22
1010131|NCT03098355|Interleukin-2|interleukin-2
1010132|NCT03098342|Onychomycosis|onychomycosis
1010133|NCT03098342|photodynamic therapy|photodynamic therapy
1010134|NCT03098342|methylene blue|methylene blue
1010135|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
1010136|NCT03098342|Asians|asians
1010137|NCT03098329|Screening|screening
1010138|NCT03098329|men|men
1010139|NCT03098329|expedited treatment|expedited treatment
1010140|NCT03098316|Cross sectional studies|cross sectional studies
1010141|NCT03098316|Metabolomics|metabolomics
1010142|NCT03098316|Glaucoma|glaucoma
1010143|NCT03098316|Low tension glaucoma|low tension glaucoma
1010144|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
1010145|NCT03098290|GermanVasc|germanvasc
1010146|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
1010147|NCT03098290|IDOMENEO|idomeneo
1010148|NCT03098290|Routine Data|routine data
1010149|NCT03098290|Registry Data|registry data
1010150|NCT03098290|Data Validity|data validity
1010151|NCT03098199|Antimullerian Hormone|antimullerian hormone
1010152|NCT03098199|In vitro fertilization|in vitro fertilization
1010153|NCT03098199|Medications|medications
1010154|NCT03098199|Dosing|dosing
1010155|NCT03098186|Medication adherence|medication adherence
1010156|NCT03098186|mHealth|mhealth
1010157|NCT03098173|Early colonoscopy|early colonoscopy
1010158|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
1010159|NCT03098173|Rebleeding|rebleeding
1010160|NCT03098160|Immunotherapy|immunotherapy
1010161|NCT03098160|Hypoxia|hypoxia
1010162|NCT03098160|Evofosfamide|evofosfamide
1010163|NCT03098160|Ipilimumab|ipilimumab
1010164|NCT03098160|TH-302|th-302
1010165|NCT03098069|Kangaroo Mother Care|kangaroo mother care
1010166|NCT03098069|Low Birth Weight|low birth weight
1010167|NCT03098069|Implementation research|implementation research
1010168|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
1663511|NCT00130091|clonidine|clonidine
1034867|NCT02945774|PET|pet
1010169|NCT03098043|Donation after circulatory death|donation after circulatory death
1010170|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
1010171|NCT03098030|Dinutuximab|dinutuximab
1010172|NCT03098030|Irinotecan|irinotecan
1010173|NCT03098030|Topotecan|topotecan
1010174|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
1010175|NCT03097913|nasotracheal intubation|nasotracheal intubation
1010176|NCT03097913|video-stylet|video-stylet
1010177|NCT03097913|nasal cavity injury|nasal cavity injury
1010178|NCT03097900|Postoperative Ileus|postoperative ileus
1010179|NCT03097900|Caffeine Citrate|caffeine citrate
1010180|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
1010181|NCT03097887|Reflux|reflux
1010182|NCT03097887|Mini Gastric Bypass|mini gastric bypass
1010183|NCT03097874|anorexia|anorexia
1010184|NCT03097874|anorexia nervosa|anorexia nervosa
1010185|NCT03097874|eating disorder|eating disorder
1010186|NCT03097874|weight|weight
1010187|NCT03097874|eating|eating
1010188|NCT03097874|weight loss|weight loss
1010189|NCT03097874|family based treatment|family based treatment
1010190|NCT03097874|FBT|fbt
1010191|NCT03097874|family treatment|family treatment
1010192|NCT03097874|therapy|therapy
1010193|NCT03097874|Maudsley method|maudsley method
1010194|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
1010195|NCT03097757|Ultrasound|ultrasound
1010196|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
1010197|NCT03097757|Pediatric Emergency Department|pediatric emergency department
1010198|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
1010199|NCT03097744|Medial Meniscus Tear|medial meniscus tear
1010200|NCT03097731|interleukin-10|interleukin-10
1010201|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
1010202|NCT03097692|cardiac preconditioning|cardiac preconditioning
1010203|NCT03097692|open heart surgery|open heart surgery
1010204|NCT03097692|createnine|createnine
1010205|NCT03097692|inflammation|inflammation
1010206|NCT03097653|breast cancer screening|breast cancer screening
1010207|NCT03097653|mammography|mammography
1010208|NCT03097653|decision-aid|decision-aid
1010209|NCT03097653|informed choice|informed choice
1010210|NCT03097653|National Cancer Screening Program|national cancer screening program
1010211|NCT03097627|Indocyanine Green|indocyanine green
1010212|NCT03097627|Near-infrared imaging|near-infrared imaging
1010213|NCT03097575|Lung lesions|lung lesions
1010214|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
1010215|NCT03097575|Near infrared imaging|near infrared imaging
1010216|NCT03097575|Lymphadenectomy|lymphadenectomy
1010217|NCT03097562|Cataract|cataract
1010218|NCT03097562|Femtosecond laser|femtosecond laser
1010219|NCT03097562|Cornea|cornea
1010220|NCT03097562|Anatomy|anatomy
1010221|NCT03097562|FSL|fsl
1010222|NCT03097562|surgery|surgery
1010223|NCT03097549|urinary incontinence|urinary incontinence
1010224|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
1010225|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
1010226|NCT03097549|smartphone application|smartphone application
1010227|NCT03097549|ehealth|ehealth
1010228|NCT03097549|mhealth|mhealth
1010229|NCT03097549|randomized controlled trial|randomized controlled trial
1010230|NCT03097549|self management|self management
1010231|NCT03097549|treatment|treatment
1010232|NCT03097536|Blood Sugar|blood sugar
1010233|NCT03097523|NSBRI|nsbri
1010234|NCT03097510|Perceived stress|perceived stress
1010235|NCT03097510|Leadership|leadership
1010236|NCT03097510|Transcendental Meditation|transcendental meditation
1010237|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
1010238|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
1010239|NCT03097497|Physiotherapy|physiotherapy
1010240|NCT03097497|Therapeutic Exercise|therapeutic exercise
1010241|NCT03097497|Primary Care|primary care
1010242|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
1010243|NCT03097458|Counselling for Families|counselling for families
1010244|NCT03097458|Parental cancer|parental cancer
1010245|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
1010246|NCT03097445|Smoking|smoking
1010247|NCT03097445|Nicotine|nicotine
1010248|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
1010249|NCT03097445|Nicotine Patch|nicotine patch
1010250|NCT03097445|Mass Distribution|mass distribution
1010251|NCT03097445|Tobacco Control|tobacco control
1010252|NCT03097445|Cancer Prevention|cancer prevention
1010253|NCT03097445|Randomized Controlled Trial|randomized controlled trial
1010254|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
1010255|NCT03097419|myocardial infarction|myocardial infarction
1010256|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
1010257|NCT03097419|ischemic conditioning|ischemic conditioning
1010258|NCT03097419|sphygmomanometer|sphygmomanometer
1010259|NCT03097419|metabolomics|metabolomics
1010260|NCT03097380|Healthy volunteer study|healthy volunteer study
1010261|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
1663512|NCT00130091|nerve block|nerve block
1010262|NCT03097367|urinary incontinence|urinary incontinence
1010263|NCT03097367|prostate cancer|prostate cancer
1010264|NCT03097367|bladder neck level|bladder neck level
1010265|NCT03097367|urodynamics|urodynamics
1010266|NCT03097354|alcohol use|alcohol use
1010267|NCT03097354|consumption measure|consumption measure
1010268|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
1010269|NCT03097354|internet survey|internet survey
1010270|NCT03097354|standardized assessment|standardized assessment
1010271|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
1010272|NCT03097315|Uveitis|uveitis
1010273|NCT03097315|UME|ume
1010274|NCT03097315|Posterior Uveitis|posterior uveitis
1010275|NCT03097315|Anterior Uveitis|anterior uveitis
1010276|NCT03097315|Intermediate Uveitis|intermediate uveitis
1010277|NCT03097315|Panuveitis|panuveitis
1010278|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
1010279|NCT03097315|Triamcinolone|triamcinolone
1010280|NCT03097315|Choroid|choroid
1010281|NCT03097315|Choroidal Injection|choroidal injection
1010282|NCT03097315|Suprachoroidal|suprachoroidal
1010283|NCT03097315|Microneedle|microneedle
1010284|NCT03097315|Microinjection|microinjection
1010285|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
1010286|NCT03097302|anterior astigmatism|anterior astigmatism
1010287|NCT03097302|posterior astigmatism|posterior astigmatism
1010288|NCT03097302|total corneal refractive power|total corneal refractive power
1010289|NCT03097302|nomogram|nomogram
1010290|NCT03097289|Healthy Adults|healthy adults
1010291|NCT03097250|PKU|pku
1010292|NCT03097250|Neuropsychology|neuropsychology
1010293|NCT03097250|MRI|mri
1010294|NCT03097198|Juvenile|juvenile
1010295|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
1010296|NCT03097198|Plum-blossom needle|plum-blossom needle
1010297|NCT03097185|pancreatitis|pancreatitis
1010298|NCT03097185|islet cell|islet cell
1010299|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1010300|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1010301|NCT03097172|Cardiac MRI|cardiac mri
1010302|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1010303|NCT03097172|Doppler Flow Velocity|doppler flow velocity
1010304|NCT03097172|Cardiovascular Disease|cardiovascular disease
1010305|NCT03097172|Atherosclerosis|atherosclerosis
1010306|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
1010307|NCT03097159|costoclavicular block|costoclavicular block
1010308|NCT03097146|Stroke|stroke
1010309|NCT03097146|Aftercare|aftercare
1010310|NCT03097146|Comprehensive Care|comprehensive care
1010311|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
1010312|NCT03097107|dyslipidemia|dyslipidemia
1010313|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
1010314|NCT03097107|lipid disorder|lipid disorder
1010315|NCT03097094|Dog allergy|dog allergy
1010316|NCT03097094|Can f 5|can f 5
1010317|NCT03097094|Male dog|male dog
1010318|NCT03097094|Female dog|female dog
1010319|NCT03097094|Allergen components|allergen components
1010320|NCT03097055|Stroke|stroke
1010321|NCT03097055|Acupuncture|acupuncture
1010322|NCT03097055|antiinflammatory|antiinflammatory
1010323|NCT03097055|NIHSS|nihss
1010324|NCT03097029|pancreatic enzymes|pancreatic enzymes
1010325|NCT03097016|Renal Impairment|renal impairment
1010326|NCT03097016|Pharmacokinetics|pharmacokinetics
1010327|NCT03097016|CC-122|cc-122
1010328|NCT03097016|Mild|mild
1010329|NCT03097016|Moderate|moderate
1010330|NCT03097016|Severe|severe
1010331|NCT03097003|Proriasis|proriasis
1010332|NCT03097003|Real-life management|real-life management
1010333|NCT03097003|Observational|observational
1010334|NCT03097003|Otezla|otezla
1010335|NCT03097003|CC-10004|cc-10004
1010336|NCT03097003|Apremilast|apremilast
1010337|NCT03097003|Belgium|belgium
1010338|NCT03097003|OTELO|otelo
1010339|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
1010340|NCT03096990|Observational|observational
1010341|NCT03096990|Otezla|otezla
1010342|NCT03096990|Apremilast|apremilast
1010343|NCT03096990|Real-Life management|real-life management
1010344|NCT03096990|Belgium|belgium
1010345|NCT03096990|APOLO|apolo
1010346|NCT03096990|CC-10004|cc-10004
1010347|NCT03096977|Hand dexterity|hand dexterity
1010348|NCT03096977|Multiple sclerosis|multiple sclerosis
1010349|NCT03096977|Nine Holes Peg|nine holes peg
1010350|NCT03096964|Elderly training|elderly training
1010351|NCT03096964|Pole walking|pole walking
1010352|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
1010353|NCT03096964|Self-selected speed of walking|self-selected speed of walking
1010354|NCT03096964|Recovery|recovery
1010355|NCT03096938|cell-free DNA|cell-free dna
1010356|NCT03096938|methylation|methylation
1010357|NCT03096938|markers|markers
1010358|NCT03096938|cancer|cancer
1010359|NCT03096938|screening|screening
1010665|NCT03095638|Healthy|healthy
1010360|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
1010361|NCT03096925|anxiety|anxiety
1010362|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
1010363|NCT03096912|LEE011|lee011
1010364|NCT03096912|ribociclib|ribociclib
1010365|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
1010366|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
1010367|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
1010368|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
1010369|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
1010370|NCT03096886|CBT|cbt
1010371|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
1010372|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
1010373|NCT03096847|ribociclib|ribociclib
1010374|NCT03096847|LEE011|lee011
1010375|NCT03096847|RIBECCA|ribecca
1010376|NCT03096847|breast cancer|breast cancer
1010377|NCT03096847|breast carcinoma|breast carcinoma
1010378|NCT03096847|HR-positive|hr-positive
1010379|NCT03096847|HER2-negative|her2-negative
1010380|NCT03096847|advanced breast cancer|advanced breast cancer
1010381|NCT03096847|Letrozole|letrozole
1010382|NCT03096847|CDK4/6|cdk4/6
1010383|NCT03096834|Migraine|migraine
1010384|NCT03096834|attack|attack
1010385|NCT03096834|headache|headache
1010386|NCT03096834|episodic|episodic
1010387|NCT03096834|aura|aura
1010388|NCT03096834|AMG 334|amg 334
1010389|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
1010390|NCT03096834|erenumab|erenumab
1010391|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
1010392|NCT03096808|ART|art
1010393|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
1010394|NCT03096808|IMRT|imrt
1010395|NCT03096795|MEDI3506|medi3506
1010396|NCT03096795|Safety|safety
1010397|NCT03096795|Tolerability|tolerability
1010398|NCT03096795|Pharmacokinetics|pharmacokinetics
1010399|NCT03096795|Immunogenicity|immunogenicity
1010400|NCT03096782|Acute Myelogenous Leukemia|acute myelogenous leukemia
1010402|NCT03096782|Myelodysplastic Syndrome|myelodysplastic syndrome
1010403|NCT03096782|MDS|mds
1010404|NCT03096782|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1010405|NCT03096782|ALL|all
1010406|NCT03096782|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1010407|NCT03096782|NHL|nhl
1010408|NCT03096782|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1010409|NCT03096782|SLL|sll
1010410|NCT03096782|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1010411|NCT03096782|CLL|cll
1010412|NCT03096782|Hodgkin's Disease|hodgkin's disease
1010413|NCT03096782|HD|hd
1010414|NCT03096782|Busulfan|busulfan
1010415|NCT03096782|Busulfex|busulfex
1010416|NCT03096782|Myleran|myleran
1010417|NCT03096782|Rituximab|rituximab
1010418|NCT03096782|Rituxan|rituxan
1010419|NCT03096782|ATG|atg
1010420|NCT03096782|ATG(rabbit)|atg(rabbit)
1010421|NCT03096782|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
1010422|NCT03096782|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
1010423|NCT03096782|Rabbit ATG|rabbit atg
1010424|NCT03096782|rATg|ratg
1010425|NCT03096782|Thymoglobulin|thymoglobulin
1010426|NCT03096782|Fludarabine|fludarabine
1010427|NCT03096782|Fludarabine Phosphate|fludarabine phosphate
1010428|NCT03096782|Fludara|fludara
1010429|NCT03096782|Clofarabine|clofarabine
1010430|NCT03096782|Clofarex|clofarex
1010431|NCT03096782|Clolar|clolar
1010432|NCT03096782|Total Body Irradiation|total body irradiation
1010433|NCT03096782|TBI|tbi
1010434|NCT03096782|XRT|xrt
1010435|NCT03096782|External Beam Radiotherapy|external beam radiotherapy
1010436|NCT03096782|Mycophenolate Mofetil|mycophenolate mofetil
1010437|NCT03096782|MMF|mmf
1010438|NCT03096782|CellCept|cellcept
1010439|NCT03096782|Tacrolimus|tacrolimus
1010440|NCT03096782|Prograf|prograf
1010441|NCT03096782|G-CSF|g-csf
1010442|NCT03096782|Filgrastim|filgrastim
1010443|NCT03096782|Neupogen|neupogen
1010444|NCT03096782|Melphalan|melphalan
1010445|NCT03096782|Alkeran|alkeran
1010446|NCT03096782|Cyclophosphamide|cyclophosphamide
1010447|NCT03096782|Cytoxan|cytoxan
1010448|NCT03096782|Neosar|neosar
1010449|NCT03096782|Mesna|mesna
1010450|NCT03096782|Mesnex|mesnex
1010451|NCT03096782|Cord Blood Transplantation|cord blood transplantation
1010452|NCT03096782|Stem Cell Transplant|stem cell transplant
1010453|NCT03096756|Oral Formulation|oral formulation
1010454|NCT03096756|Food Effect|food effect
1010455|NCT03096756|Superoxide Dismutase|superoxide dismutase
1010456|NCT03096756|Single Ascending Dose|single ascending dose
1010457|NCT03096756|GC4702|gc4702
1010458|NCT03096756|Bioavailability|bioavailability
1010459|NCT03096756|Pharmacokinetics|pharmacokinetics
1010460|NCT03096756|Active Comparator|active comparator
1010461|NCT03096730|Remifentanil|remifentanil
1010462|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
1010463|NCT03096730|Postoperative pain|postoperative pain
1010464|NCT03096730|pain intensity|pain intensity
1010465|NCT03096691|cervical pessary|cervical pessary
1010466|NCT03096691|preterm labor|preterm labor
1010467|NCT03096691|Cervical insufficiency|cervical insufficiency
1010468|NCT03096678|Left Bundle Branch Block|left bundle branch block
1010469|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
1010470|NCT03096678|Mechanical asynchrony|mechanical asynchrony
1010471|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
1010472|NCT03096678|Outcome|outcome
1010473|NCT03096678|Cardiovascular events|cardiovascular events
1010474|NCT03096665|venous blood|venous blood
1010475|NCT03096665|arterial blood|arterial blood
1010476|NCT03096665|capillary blood|capillary blood
1010477|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
1010478|NCT03096639|Diaphragm atrophy|diaphragm atrophy
1010479|NCT03096639|VIDD|vidd
1010480|NCT03096639|Weaning failure|weaning failure
1010481|NCT03096626|Depression|depression
1010482|NCT03096613|heart failure|heart failure
1010483|NCT03096613|Subclinical Hypothyroidism|subclinical hypothyroidism
1010484|NCT03096613|levothyroxine|levothyroxine
1010485|NCT03096613|6-minute walk test|6-minute walk test
1010486|NCT03096600|spine|spine
1010487|NCT03096587|XP Endo Finisher|xp endo finisher
1010488|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
1010489|NCT03096587|postoperative pain|postoperative pain
1010490|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1010491|NCT03096574|Maternal vaccination|maternal vaccination
1010492|NCT03096574|Attitudes|attitudes
1010493|NCT03096574|Pregnancy|pregnancy
1010494|NCT03096548|Skin Cancer|skin cancer
1010495|NCT03096548|Tattoo|tattoo
1010496|NCT03096496|Quality of life|quality of life
1010497|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
1010498|NCT03096496|ATO|ato
1010499|NCT03096457|leishmaniasis|leishmaniasis
1010500|NCT03096457|L.braziliensis|l.braziliensis
1010501|NCT03096457|paromomycin cream|paromomycin cream
1010502|NCT03096457|intralesional pentamidine|intralesional pentamidine
1010503|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
1010504|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
1010505|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
1010506|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
1010507|NCT03096431|physical activity|physical activity
1010512|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1010513|NCT03096353|NALOXONE|naloxone
1010514|NCT03096353|fMRI|fmri
1010515|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1010516|NCT03096340|SN-38|sn-38
1010517|NCT03096340|irinotecan|irinotecan
1010518|NCT03096327|Quality of Life|quality of life
1010519|NCT03096327|Asthma control test|asthma control test
1010520|NCT03096327|Montelukast|montelukast
1010521|NCT03096327|Asthma|asthma
1010522|NCT03096314|ARDS|ards
1010523|NCT03096314|Vitamin D|vitamin d
1010524|NCT03096301|temporomandibular disorder|temporomandibular disorder
1010525|NCT03096301|photobiomodulation|photobiomodulation
1010527|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
1010528|NCT03096275|Methotrexate|methotrexate
1010529|NCT03096275|cyclophosphamide|cyclophosphamide
1010530|NCT03096262|cognitive skills|cognitive skills
1010531|NCT03096262|technical|technical
1010532|NCT03096262|internet platform|internet platform
1010533|NCT03096262|Stroke|stroke
1010534|NCT03096262|Hemiparesis|hemiparesis
1010535|NCT03096249|oxytocin|oxytocin
1010536|NCT03096249|emotion recognition|emotion recognition
1010537|NCT03096249|emotion processing|emotion processing
1010538|NCT03096249|social salience|social salience
1010539|NCT03096249|face processing|face processing
1010540|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
1010541|NCT03096210|Maxillar sinus|maxillar sinus
1010542|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
1010543|NCT03096210|Allograft|allograft
1010544|NCT03096210|implant|implant
1010545|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
1010546|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
1010547|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
1010548|NCT03096184|head and neck cancer|head and neck cancer
1010549|NCT03096184|Apatinib|apatinib
1010550|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
1010551|NCT03096171|Stress|stress
1010552|NCT03096171|Well-being|well-being
1010553|NCT03096171|Positive Psychology|positive psychology
1010554|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
1010555|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
1010556|NCT03096158|Functional electrical stimulation|functional electrical stimulation
1010557|NCT03096158|Inspiratory muscle training|inspiratory muscle training
1010558|NCT03096158|Aerobic training|aerobic training
1010559|NCT03096158|Isometric handgrip training|isometric handgrip training
1010560|NCT03096158|Functional capacity|functional capacity
1010561|NCT03096158|Endothelial function|endothelial function
1010562|NCT03096158|Cardiac function|cardiac function
1010563|NCT03096145|tobacco|tobacco
1010564|NCT03096145|quitlines|quitlines
1010565|NCT03096145|social support|social support
1010566|NCT03096145|mobile support|mobile support
1010567|NCT03096132|Obesity|obesity
1010568|NCT03096132|Overweight|overweight
1035370|NCT02942641|UTI|uti
1010569|NCT03096132|Overeating|overeating
1010570|NCT03096132|Body Mass Index|body mass index
1010571|NCT03096132|Treatment|treatment
1010572|NCT03096132|Intervention|intervention
1010573|NCT03096132|Family Based Therapy|family based therapy
1010574|NCT03096132|Weight|weight
1010575|NCT03096132|Children|children
1010576|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
1010577|NCT03096119|Asia|asia
1010578|NCT03096093|Pancreatic|pancreatic
1010579|NCT03096093|Late stage cancer|late stage cancer
1010580|NCT03096093|Immunotherapy|immunotherapy
1010581|NCT03096093|Phase I|phase i
1010582|NCT03096093|Vaccination|vaccination
1010583|NCT03096080|ARPKD|arpkd
1010584|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
1010585|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
1010586|NCT03096080|Tesevatinib|tesevatinib
1010587|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
1010588|NCT03096041|auriculotherapy|auriculotherapy
1010589|NCT03096041|aromatase inhibitors|aromatase inhibitors
1010590|NCT03096041|adjuvant treatment|adjuvant treatment
1010591|NCT03096028|maternal nutrition|maternal nutrition
1010592|NCT03096028|neurocognitive development|neurocognitive development
1010593|NCT03096028|brain volume|brain volume
1010594|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
1010595|NCT03095989|mindfulness|mindfulness
1010596|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
1010597|NCT03095976|Amnion-Chorion,|amnion-chorion,
1010598|NCT03095976|Intrabony defects,|intrabony defects,
1010599|NCT03095976|furcation|furcation
1010600|NCT03095950|Spin|spin
1010601|NCT03095950|Misleading reporting|misleading reporting
1010602|NCT03095950|Misleading interpretation|misleading interpretation
1010603|NCT03095950|Misleading extrapolation|misleading extrapolation
1010604|NCT03095950|Randomized controlled trials|randomized controlled trials
1010605|NCT03095950|Patients|patients
1010606|NCT03095924|Spin|spin
1010607|NCT03095924|Misleading reporting|misleading reporting
1010608|NCT03095924|Misleading interpretation|misleading interpretation
1010609|NCT03095924|Misleading extrapolation|misleading extrapolation
1010610|NCT03095924|Randomized controlled trials|randomized controlled trials
1010611|NCT03095924|Patients|patients
1010612|NCT03095911|Spin|spin
1010613|NCT03095911|Misleading reporting|misleading reporting
1010614|NCT03095911|Misleading interpretation|misleading interpretation
1010615|NCT03095911|Misleading extrapolation|misleading extrapolation
1010616|NCT03095911|Randomized controlled trials|randomized controlled trials
1010617|NCT03095911|Patients|patients
1010618|NCT03095898|Colonoscopy|colonoscopy
1010619|NCT03095898|Acupuncture|acupuncture
1010620|NCT03095885|Urine Oxalate|urine oxalate
1010621|NCT03095885|Nephrolithiasis|nephrolithiasis
1010622|NCT03095885|Kidney Stones|kidney stones
1010623|NCT03095885|Hyperoxaluria|hyperoxaluria
1010624|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
1010625|NCT03095885|urological Diseases|urological diseases
1010626|NCT03095885|Kidney Diseases|kidney diseases
1010627|NCT03095885|Dietary Oxalate|dietary oxalate
1010628|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
1010629|NCT03095885|Oxalate Absorption|oxalate absorption
1010630|NCT03095872|photodamaged skin|photodamaged skin
1010631|NCT03095872|wound healing|wound healing
1010632|NCT03095872|CO2 laser|co2 laser
1010633|NCT03095820|Community|community
1010634|NCT03095820|Depressive Symptoms|depressive symptoms
1010635|NCT03095820|Mental Health Program|mental health program
1010636|NCT03095820|Older adults|older adults
1010637|NCT03095768|Lifestyle|lifestyle
1010638|NCT03095768|Nutrition|nutrition
1010639|NCT03095768|Cooking|cooking
1010640|NCT03095742|Microdialysis|microdialysis
1010641|NCT03095742|Cerebral metabolism|cerebral metabolism
1010642|NCT03095742|Cardiac arrest|cardiac arrest
1010643|NCT03095742|Intravenous|intravenous
1010644|NCT03095742|Neurological prognosis|neurological prognosis
1010645|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
1010646|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
1010647|NCT03095716|Post-operative recovery|post-operative recovery
1010648|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
1010649|NCT03095703|Sirolimus|sirolimus
1010650|NCT03095703|Intestinal adenomas|intestinal adenomas
1010651|NCT03095690|Osteoporosis|osteoporosis
1010652|NCT03095690|Parkinson|parkinson
1010653|NCT03095690|HR-pQCT|hr-pqct
1010654|NCT03095690|bone microstructure|bone microstructure
1010655|NCT03095690|fracture risk|fracture risk
1010656|NCT03095677|dynamic apnea|dynamic apnea
1010657|NCT03095677|muscle oxygenation|muscle oxygenation
1010658|NCT03095677|physical performance|physical performance
1010659|NCT03095664|lifestyle intervention|lifestyle intervention
1010660|NCT03095664|endometrial cancer|endometrial cancer
1010661|NCT03095664|survival|survival
1010662|NCT03095638|Dispersible tablets|dispersible tablets
1010663|NCT03095638|Bioavailability|bioavailability
1010664|NCT03095638|Dolutegravir|dolutegravir
1010666|NCT03095638|Conventional tablets|conventional tablets
1010667|NCT03095625|Sepsis|sepsis
1010668|NCT03095625|Bleeding disorder|bleeding disorder
1010669|NCT03095625|Viscoelastic tests|viscoelastic tests
1010670|NCT03095599|Influenza|influenza
1010671|NCT03095599|Vaccine|vaccine
1010672|NCT03095586|Spin|spin
1010673|NCT03095586|Misleading reporting|misleading reporting
1010674|NCT03095586|Misleading interpretation|misleading interpretation
1010675|NCT03095586|Misleading extrapolation|misleading extrapolation
1010676|NCT03095586|Randomized controlled trials|randomized controlled trials
1010677|NCT03095586|Patients|patients
1010678|NCT03095573|Celiac disease|celiac disease
1010679|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
1010680|NCT03095573|Refractory celiac disease|refractory celiac disease
1010681|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
1010682|NCT03095534|Occupational Therapy|occupational therapy
1010683|NCT03095534|Aging in place|aging in place
1010684|NCT03095534|Activities of daily living|activities of daily living
1010685|NCT03095534|Community program|community program
1010686|NCT03095521|Angal|angal
1010687|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
1010688|NCT03095521|sore throat|sore throat
1010689|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
1010690|NCT03095508|Angal S|angal s
1010691|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
1010692|NCT03095508|Sore Throat|sore throat
1010693|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
1010694|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
1010695|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
1010696|NCT03095495|Bronchiolitis|bronchiolitis
1010697|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1010698|NCT03095495|Respiratory Failure|respiratory failure
1010699|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
1010700|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
1010701|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
1010702|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
1010703|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
1010798|NCT03094676|Massage|massage
1011098|NCT03093090|furosemide|furosemide
1010704|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
1010705|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate|chronic obstructive pulmonary disease, copd, low peak inspiratory flow rate
1010706|NCT03095443|Delirium|delirium
1010707|NCT03095443|Critical Illness|critical illness
1010708|NCT03095443|Music Therapy|music therapy
1010709|NCT03095430|Trauma|trauma
1010710|NCT03095430|General Anesthesia|general anesthesia
1010711|NCT03095430|Surgical Pleth Index|surgical pleth index
1010712|NCT03095430|Entropy|entropy
1010713|NCT03095417|Delirium|delirium
1010714|NCT03095417|Alzheimer's Disease|alzheimer's disease
1010715|NCT03095417|Aging|aging
1010716|NCT03095417|Exercise Therapy|exercise therapy
1010717|NCT03095417|Cognitive Training|cognitive training
1010718|NCT03095378|gingival recession|gingival recession
1010719|NCT03095339|Burkina Faso|burkina faso
1010720|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
1010721|NCT03095339|Cysticercosis|cysticercosis
1010722|NCT03095339|Implementation Research|implementation research
1010723|NCT03095339|Effectiveness|effectiveness
1010724|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
1010725|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
1010726|NCT03095300|Prone Position|prone position
1010727|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
1010728|NCT03095287|Factor VIII|factor viii
1010729|NCT03095287|von Willebrand Factor|von willebrand factor
1010730|NCT03095287|Plasma-derived|plasma-derived
1010731|NCT03095287|Inhibitors|inhibitors
1010732|NCT03095287|Immune tolerance induction|immune tolerance induction
1010733|NCT03095287|ITI|iti
1010734|NCT03095287|Antibodies|antibodies
1010735|NCT03095287|Hemophilia A|hemophilia a
1010736|NCT03095261|Cardiovascular Disease|cardiovascular disease
1010737|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
1010738|NCT03095261|Financial Incentives|financial incentives
1010739|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
1010740|NCT03095235|keratoconus|keratoconus
1010741|NCT03095235|cornea ectasia|cornea ectasia
1010742|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
1010743|NCT03095183|Pediatric|pediatric
1010744|NCT03095183|Tongue Depressor|tongue depressor
1010745|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
1010746|NCT03095144|pyloromyotomy|pyloromyotomy
1010747|NCT03095144|spinal anaesthesia|spinal anaesthesia
1010748|NCT03095144|surgical outcomes|surgical outcomes
1010749|NCT03095144|general anaesthesia|general anaesthesia
1010750|NCT03095144|infants|infants
1010751|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
1010752|NCT03095079|endostar|endostar
1010753|NCT03095079|dacarbazine|dacarbazine
1010754|NCT03095079|cisplatin|cisplatin
1010755|NCT03095066|aggression|aggression
1010756|NCT03095066|agitation|agitation
1010757|NCT03095066|irritability|irritability
1010758|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
1010759|NCT03095066|traumatic brain injury|traumatic brain injury
1010760|NCT03095066|TBI|tbi
1010761|NCT03095066|AVP-786|avp-786
1010762|NCT03095053|blastocyst|blastocyst
1010763|NCT03095053|comprehensive chromosome screening|comprehensive chromosome screening
1010764|NCT03095053|euploidy|euploidy
1010765|NCT03095053|frozen embryo transfer|frozen embryo transfer
1010766|NCT03095001|bevacizumab|bevacizumab
1010767|NCT03095001|Intraperitoneal administration|intraperitoneal administration
1010768|NCT03095001|Ovarian Cancer|ovarian cancer
1010769|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
1010770|NCT03094962|Kinematics|kinematics
1010771|NCT03094962|MRI Scans|mri scans
1010772|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
1010773|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
1010774|NCT03094949|microwave ablation|microwave ablation
1010775|NCT03094949|partial nephrectomy|partial nephrectomy
1010776|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
1010777|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
1010778|NCT03094910|Autonomic Imbalance|autonomic imbalance
1010779|NCT03094910|Thermography|thermography
1010780|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
1010781|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
1010782|NCT03094832|ARQ 092|arq 092
1010783|NCT03094832|ArQule|arqule
1010784|NCT03094832|AKT|akt
1010785|NCT03094832|PIK3CA|pik3ca
1010786|NCT03094832|Overgrowth|overgrowth
1010787|NCT03094832|Congenital malformations|congenital malformations
1010788|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
1010789|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1010790|NCT03094767|Heart Rate Variability|heart rate variability
1010791|NCT03094767|Rehabilitation|rehabilitation
1010792|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
1010793|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
1010794|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
1010795|NCT03094689|Physical activity|physical activity
1010796|NCT03094689|Muscle pain|muscle pain
1010797|NCT03094689|Cryotherapy|cryotherapy
1010799|NCT03094676|Autonomic nervous system|autonomic nervous system
1010800|NCT03094676|Recovery of Physiological Function|recovery of physiological function
1010801|NCT03094676|Heart Rate|heart rate
1010802|NCT03094663|IPACK|ipack
1010803|NCT03094663|PAI|pai
1010804|NCT03094650|stroke|stroke
1010805|NCT03094650|neurorehabilitation|neurorehabilitation
1010806|NCT03094650|virtual reality|virtual reality
1010807|NCT03094650|rehabilitation dose|rehabilitation dose
1010808|NCT03094650|motor rehabilitation|motor rehabilitation
1010809|NCT03094637|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1010810|NCT03094637|Myelodysplastic Syndrome|myelodysplastic syndrome
1010811|NCT03094637|MDS|mds
1010812|NCT03094637|Higher risk|higher risk
1010813|NCT03094637|Azacitidine|azacitidine
1010814|NCT03094637|5-azacytidine|5-azacytidine
1010815|NCT03094637|5-aza|5-aza
1010816|NCT03094637|Vidaza|vidaza
1010817|NCT03094637|5-AZC|5-azc
1010818|NCT03094637|AZA-CR|aza-cr
1010819|NCT03094637|Ladakamycin|ladakamycin
1010820|NCT03094637|NSC-102816|nsc-102816
1010821|NCT03094637|Azacytidine|azacytidine
1010822|NCT03094637|Pembrolizumab|pembrolizumab
1010823|NCT03094637|Keytruda|keytruda
1010824|NCT03094637|MK-3475|mk-3475
1010825|NCT03094637|SCH-900475|sch-900475
1010826|NCT03094624|Amusia|amusia
1010827|NCT03094624|Audition|audition
1010828|NCT03094624|Short-term memory|short-term memory
1010829|NCT03094624|Emotions|emotions
1010830|NCT03094624|EEG|eeg
1010831|NCT03094624|MEG|meg
1010832|NCT03094624|MRI|mri
1010833|NCT03094611|Acute lymphocytic leukemia|acute lymphocytic leukemia
1010834|NCT03094611|ALL|all
1010835|NCT03094611|CD22-positive|cd22-positive
1010836|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin
1010837|NCT03094611|CMC-544|cmc-544
1010838|NCT03094585|Healthy nurses|healthy nurses
1010839|NCT03094572|spinal cord circuitry|spinal cord circuitry
1010840|NCT03094572|hemiplegia|hemiplegia
1010841|NCT03094572|rhythmic task|rhythmic task
1010842|NCT03094559|peripheral arterial disease|peripheral arterial disease
1010843|NCT03094546|subjective cognitive decline|subjective cognitive decline
1010844|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
1010845|NCT03094546|dietary supplement|dietary supplement
1010846|NCT03094546|polyamine|polyamine
1010847|NCT03094546|prevention|prevention
1010848|NCT03094546|treatment|treatment
1010849|NCT03094546|lifestyle|lifestyle
1010850|NCT03094546|memory|memory
1010851|NCT03094546|autophagy|autophagy
1010852|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
1010853|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
1010854|NCT03094533|propofol|propofol
1010855|NCT03094533|sevoflurane|sevoflurane
1010856|NCT03094533|glucose|glucose
1010857|NCT03094468|terbinafine nail solution|terbinafine nail solution
1010858|NCT03094468|nail fungal infection|nail fungal infection
1010859|NCT03094468|topical antifungal drug|topical antifungal drug
1010956|NCT03094052|crofelemer|crofelemer
1010860|NCT03094455|Tele-rehabilitation|tele-rehabilitation
1010861|NCT03094455|Action Observation|action observation
1010862|NCT03094455|Mirror neurons|mirror neurons
1010864|NCT03094442|Quality of Recovery|quality of recovery
1010865|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
1010866|NCT03094442|Dexamethasone|dexamethasone
1010867|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
1010868|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
1010869|NCT03094364|video game|video game
1010870|NCT03094364|virtual reality|virtual reality
1010871|NCT03094364|upper extremity|upper extremity
1010872|NCT03094364|CI therapy|ci therapy
1010873|NCT03094364|rehabilitation|rehabilitation
1010874|NCT03094364|hemiparesis|hemiparesis
1010875|NCT03094364|MS|ms
1010876|NCT03094364|multiple sclerosis|multiple sclerosis
1010877|NCT03094364|progressive multiple sclerosis|progressive multiple sclerosis
1010878|NCT03094364|primary progressive multiple sclerosis|primary progressive multiple sclerosis
1010879|NCT03094364|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
1010880|NCT03094364|motor|motor
1010881|NCT03094364|physical therapy|physical therapy
1010882|NCT03094364|physiotherapy|physiotherapy
1010883|NCT03094364|occupational therapy|occupational therapy
1010884|NCT03094364|arm|arm
1010885|NCT03094364|hand|hand
1010886|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
1010887|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
1010888|NCT03094351|esophageal cancer|esophageal cancer
1010889|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
1010890|NCT03094325|Septal Myectomy|septal myectomy
1010891|NCT03094312|SEEG|seeg
1010892|NCT03094312|ISD|isd
1010893|NCT03094312|cognitive disorder|cognitive disorder
1010894|NCT03094312|epilepsy surgery|epilepsy surgery
1010895|NCT03094286|HIV|hiv
1010896|NCT03094286|HIV with cancer patient|hiv with cancer patient
1010897|NCT03094286|D006678|d006678
1010898|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
1010899|NCT03094273|Biopsy|biopsy
1010900|NCT03094273|Saucerization biopsy|saucerization biopsy
1010901|NCT03094273|Skin lesion|skin lesion
1010902|NCT03094247|Malnutrition|malnutrition
1010903|NCT03094247|Micronutrients|micronutrients
1010904|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
1010905|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
1010906|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
1010907|NCT03094247|Peanuts|peanuts
1010908|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
1010909|NCT03094195|neuropathic pain|neuropathic pain
1010910|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
1010911|NCT03094195|dose ranging|dose ranging
1010912|NCT03094130|Spin|spin
1010913|NCT03094130|Misleading reporting|misleading reporting
1010914|NCT03094130|Misleading interpretation|misleading interpretation
1010915|NCT03094130|Misleading extrapolation|misleading extrapolation
1010916|NCT03094130|phase I/II trials|phase i/ii trials
1010917|NCT03094130|non-randomized trials|non-randomized trials
1010918|NCT03094130|Patients|patients
1010919|NCT03094117|Spin|spin
1010920|NCT03094117|Misleading reporting|misleading reporting
1010921|NCT03094117|Misleading interpretation|misleading interpretation
1010922|NCT03094117|Misleading extrapolation|misleading extrapolation
1010923|NCT03094117|phase I/II trials|phase i/ii trials
1010924|NCT03094117|non-randomized trials|non-randomized trials
1010925|NCT03094117|Patients|patients
1010926|NCT03094104|Spin|spin
1010927|NCT03094104|Misleading reporting|misleading reporting
1010928|NCT03094104|Misleading interpretation|misleading interpretation
1010929|NCT03094104|Misleading extrapolation|misleading extrapolation
1010930|NCT03094104|phase I/II trials|phase i/ii trials
1010931|NCT03094104|non-randomized trials|non-randomized trials
1010932|NCT03094104|Patients|patients
1010933|NCT03094091|Spin|spin
1010934|NCT03094091|Misleading reporting|misleading reporting
1010935|NCT03094091|Misleading interpretation|misleading interpretation
1010936|NCT03094091|Misleading extrapolation|misleading extrapolation
1010937|NCT03094091|phase I/II trials|phase i/ii trials
1010938|NCT03094091|non-randomized trials|non-randomized trials
1010939|NCT03094091|Patients|patients
1010940|NCT03094078|Spin|spin
1010941|NCT03094078|Misleading reporting|misleading reporting
1010942|NCT03094078|Misleading interpretation|misleading interpretation
1010943|NCT03094078|Misleading extrapolation|misleading extrapolation
1010944|NCT03094078|Animal studies|animal studies
1010945|NCT03094078|Cell culture studies|cell culture studies
1010946|NCT03094078|Pre-clinical studies|pre-clinical studies
1010947|NCT03094065|Spin|spin
1010948|NCT03094065|Misleading reporting|misleading reporting
1010949|NCT03094065|Misleading interpretation|misleading interpretation
1010950|NCT03094065|Misleading extrapolation|misleading extrapolation
1010951|NCT03094065|Animal studies|animal studies
1010952|NCT03094065|Cell culture studies|cell culture studies
1010953|NCT03094065|Pre-clinical studies|pre-clinical studies
1010954|NCT03094052|neratinib|neratinib
1010955|NCT03094052|trastuzumab|trastuzumab
1010957|NCT03094026|Hematologic cancers|hematologic cancers
1010958|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
1010959|NCT03094026|cognitive training|cognitive training
1010960|NCT03094026|genetic knowledge|genetic knowledge
1010961|NCT03094026|genetic attitude|genetic attitude
1010962|NCT03094026|adult cancer survivors|adult cancer survivors
1010963|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
1010964|NCT03094000|Bulimia Nervosa|bulimia nervosa
1010965|NCT03094000|Binge-Eating|binge-eating
1010966|NCT03094000|Self monitoring|self monitoring
1010967|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1010968|NCT03094000|Mindfulness|mindfulness
1010970|NCT03093987|Critical Care Ultrasound|critical care ultrasound
1010971|NCT03093987|Lactate|lactate
1010972|NCT03093987|Mortality|mortality
1010973|NCT03093987|Prognosis|prognosis
1010974|NCT03093935|Post-Stroke|post-stroke
1010975|NCT03093935|Neuromodulation|neuromodulation
1010976|NCT03093935|Axillary nerve|axillary nerve
1010977|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
1010978|NCT03093922|Gemcitabine|gemcitabine
1010979|NCT03093922|Atezolizumab|atezolizumab
1010980|NCT03093922|Cisplatin|cisplatin
1010981|NCT03093922|16-1621|16-1621
1010982|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
1010983|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
1010984|NCT03093909|aerosol GCB|aerosol gcb
1010985|NCT03093909|Lung metastases|lung metastases
1010986|NCT03093909|osteosarcoma|osteosarcoma
1010987|NCT03093896|almonds|almonds
1010988|NCT03093896|cereal snack|cereal snack
1010989|NCT03093870|Neoplasms|neoplasms
1010990|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
1010991|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
1010992|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
1010993|NCT03093844|Stem Cell Transplant|stem cell transplant
1010994|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
1010995|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
1010996|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1010997|NCT03093805|Graft Versus Host Disease|graft versus host disease
1010998|NCT03093779|Hearing Loss|hearing loss
1010999|NCT03093779|Deaf|deaf
1011000|NCT03093779|Health Literacy|health literacy
1011001|NCT03093779|Health Information|health information
1011002|NCT03093779|Visual Learning|visual learning
1011003|NCT03093766|Aetiology|aetiology
1011004|NCT03093740|hemodialysis|hemodialysis
1011005|NCT03093740|renal failure|renal failure
1011006|NCT03093740|kidney transplant|kidney transplant
1011007|NCT03093714|Cystic Fibrosis|cystic fibrosis
1011008|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1011009|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1011010|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
1011011|NCT03093636|Insulin Pen|insulin pen
1011012|NCT03093636|inControl Advice|incontrol advice
1011013|NCT03093636|Decision Support System (DSS)|decision support system (dss)
1011014|NCT03093623|physical activity|physical activity
1011015|NCT03093623|abstain from smoking|abstain from smoking
1011016|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
1011017|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1011018|NCT03093558|adherence|adherence
1011019|NCT03093558|quality of life|quality of life
1011020|NCT03093558|health literacy|health literacy
1011021|NCT03093545|rabies|rabies
1011022|NCT03093545|obese|obese
1011023|NCT03093545|immunoglobulin|immunoglobulin
1011024|NCT03093545|rabies vaccine|rabies vaccine
1011025|NCT03093545|post-exposure|post-exposure
1011026|NCT03093545|immunogenicity|immunogenicity
1011027|NCT03093532|emergency department|emergency department
1011028|NCT03093532|stage 2 hypertension|stage 2 hypertension
1011029|NCT03093532|minorities|minorities
1011030|NCT03093506|Erythropoietin|erythropoietin
1011031|NCT03093506|Randomized controlled trial|randomized controlled trial
1011032|NCT03093506|Human volunteers|human volunteers
1011033|NCT03093506|Mitochondrial function|mitochondrial function
1011034|NCT03093506|Cognitive performance|cognitive performance
1011035|NCT03093467|Internet|internet
1011036|NCT03093467|Mental Health|mental health
1011037|NCT03093441|High-intensity interval training|high-intensity interval training
1011038|NCT03093441|cardiometabolic|cardiometabolic
1011039|NCT03093441|physical performance|physical performance
1011040|NCT03093441|psychosocial adaptation|psychosocial adaptation
1011041|NCT03093428|Prostate Cancer|prostate cancer
1011042|NCT03093415|Hepatitis C|hepatitis c
1011043|NCT03093415|HCV|hcv
1011044|NCT03093415|People Who Inject Drugs|people who inject drugs
1011045|NCT03093415|PWID|pwid
1011046|NCT03093415|Medication Assisted Therapy|medication assisted therapy
1011047|NCT03093415|MAT|mat
1011048|NCT03093415|Needle Exchange Program|needle exchange program
1333123|NCT01444456|Pancreatic Cancer|pancreatic cancer
1035975|NCT02938741|ATG|atg
1011049|NCT03093402|JBT-101 (also known as lenabasum)|jbt-101 (also known as lenabasum)
1011050|NCT03093402|efficacy|efficacy
1011051|NCT03093402|musculoskeletal disease|musculoskeletal disease
1011052|NCT03093402|randomized trial|randomized trial
1011053|NCT03093376|Anxiety|anxiety
1011057|NCT03093350|Breast Cancer|breast cancer
1011058|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
1011059|NCT03093337|Neuromotor sequelae|neuromotor sequelae
1011060|NCT03093337|Cognitive disorders|cognitive disorders
1011061|NCT03093337|Cerebral development|cerebral development
1011062|NCT03093337|Psychomotoricity|psychomotoricity
1011063|NCT03093337|Postural management|postural management
1011064|NCT03093337|Motor coordination|motor coordination
1011065|NCT03093337|Parenthood|parenthood
1011066|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1011067|NCT03093324|RRMS|rrms
1011068|NCT03093324|Multiple Sclerosis|multiple sclerosis
1011069|NCT03093324|MS|ms
1011070|NCT03093324|Alkermes|alkermes
1011071|NCT03093324|ALKS 8700|alks 8700
1011072|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
1011073|NCT03093324|DMF|dmf
1011074|NCT03093324|Tecfidera|tecfidera
1011075|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
1011076|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
1011077|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
1011078|NCT03093272|Prostate Cancer|prostate cancer
1011079|NCT03093259|ABX464|abx464
1011080|NCT03093259|Ulcerative Colitis|ulcerative colitis
1011081|NCT03093259|Refractory|refractory
1011082|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
1011083|NCT03093246|Aspirin|aspirin
1011084|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
1011085|NCT03093246|Non-surgical therapy|non-surgical therapy
1011086|NCT03093207|Aggressive periodontitis|aggressive periodontitis
1011087|NCT03093207|Aspirin|aspirin
1011088|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
1011089|NCT03093207|Surgical therapy|surgical therapy
1011090|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
1011091|NCT03093142|neurofeedback|neurofeedback
1011092|NCT03093116|ALK Gene Rearrangement|alk gene rearrangement
1011093|NCT03093116|ROS1 Gene Rearrangement|ros1 gene rearrangement
1011094|NCT03093116|NTRK 1/2/3 Gene Rearrangement|ntrk 1/2/3 gene rearrangement
1011095|NCT03093103|empagliflozin|empagliflozin
1011096|NCT03093103|kidney|kidney
1011097|NCT03093103|BOLD-MRI|bold-mri
1011102|NCT03093025|Major Depressive Disorder|major depressive disorder
1011103|NCT03093025|Adjunctive Treatment|adjunctive treatment
1011104|NCT03092999|Pharmacokinetics|pharmacokinetics
1011105|NCT03092960|Latino|latino
1011106|NCT03092960|Male|male
1011107|NCT03092934|Small Cell Lung Carcinoma|small cell lung carcinoma
1011108|NCT03092908|calcium oxalate|calcium oxalate
1011109|NCT03092908|nephrolithiasis|nephrolithiasis
1011110|NCT03092908|Mature vinegar|mature vinegar
1011111|NCT03092908|prophylaxis|prophylaxis
1011112|NCT03092869|Feet|feet
1011113|NCT03092869|Ankle|ankle
1011114|NCT03092869|Balance|balance
1011115|NCT03092869|Manual Therapy|manual therapy
1011116|NCT03092869|Older Adult|older adult
1011117|NCT03092830|SCC|scc
1011118|NCT03092830|BCC|bcc
1011119|NCT03092830|DNA|dna
1011120|NCT03092830|RNA|rna
1011121|NCT03092830|HEDGE HOG|hedge hog
1011122|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
1011123|NCT03092817|Tuberculosis|tuberculosis
1011124|NCT03092817|tuberculous meningitis|tuberculous meningitis
1011125|NCT03092817|drug induced liver injury|drug induced liver injury
1011126|NCT03092817|HIV|hiv
1011127|NCT03092817|IRIS|iris
1011128|NCT03092817|randomized controlled trial|randomized controlled trial
1011129|NCT03092817|dexamethasone|dexamethasone
1011130|NCT03092804|Shunting|shunting
1011131|NCT03092804|Brain constructure|brain constructure
1011132|NCT03092804|Neural network|neural network
1011133|NCT03092791|Drug Therapy|drug therapy
1011134|NCT03092778|Cryoablation|cryoablation
1011135|NCT03092778|Radiology|radiology
1011136|NCT03092765|E6011|e6011
1011137|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
1011138|NCT03092765|Japan|japan
1011139|NCT03092726|ASP8062|asp8062
1011140|NCT03092726|Fibromyalgia|fibromyalgia
1011141|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
1011142|NCT03092713|Supported employment|supported employment
1011143|NCT03092713|Mild and moderate TBI|mild and moderate tbi
1011144|NCT03092713|Return to work|return to work
1011145|NCT03092713|Randomized Controlled Trial|randomized controlled trial
1011149|NCT03092661|Oxygen saturation|oxygen saturation
1011150|NCT03092661|Pulse oximetry|pulse oximetry
1011151|NCT03092661|Neonate|neonate
1011152|NCT03092661|Infant|infant
1011153|NCT03092622|Exercise Therapy|exercise therapy
1011154|NCT03092609|Attentional Bias to Threat|attentional bias to threat
1011155|NCT03092596|HIV infection|hiv infection
1011156|NCT03092596|drug abuse|drug abuse
1011845|NCT03088202|referral|referral
1011157|NCT03092596|substance use|substance use
1011158|NCT03092596|alcohol abuse|alcohol abuse
1011159|NCT03092596|screening|screening
1011160|NCT03092596|treatment|treatment
1011161|NCT03092596|primary care|primary care
1011162|NCT03092596|motivational interviewing|motivational interviewing
1011163|NCT03092570|Motor learning|motor learning
1011164|NCT03092570|stroke|stroke
1011165|NCT03092570|tDCS|tdcs
1011166|NCT03092570|upper limb|upper limb
1011168|NCT03092531|ART Adherence|art adherence
1011169|NCT03092531|Adolescents|adolescents
1011170|NCT03092518|Surgical Resection|surgical resection
1011171|NCT03092518|Progression Free Survival|progression free survival
1011172|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
1011173|NCT03092505|Herpes|herpes
1011174|NCT03092505|Uganda|uganda
1011175|NCT03092505|HSV|hsv
1011176|NCT03092505|Sample|sample
1011177|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
1011178|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
1011179|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
1011180|NCT03092466|femoral nerve block|femoral nerve block
1011181|NCT03092466|elderly patient|elderly patient
1011182|NCT03092466|cognitive impairment|cognitive impairment
1011183|NCT03092466|hip fracture|hip fracture
1011184|NCT03092466|regional anesthesia|regional anesthesia
1011185|NCT03092440|Medical Education|medical education
1011186|NCT03092440|simulation|simulation
1011187|NCT03092440|serious game|serious game
1011188|NCT03092440|validity|validity
1011189|NCT03092401|Liver transplantation|liver transplantation
1011190|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
1011191|NCT03092401|Liver Cirrhosis|liver cirrhosis
1011192|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
1011193|NCT03092388|Heart Failure|heart failure
1011194|NCT03092388|Leg Fluid Shift|leg fluid shift
1011195|NCT03092375|HCV|hcv
1011196|NCT03092375|Previously treated|previously treated
1011197|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
1011198|NCT03092362|Heart rate variability|heart rate variability
1011199|NCT03092362|quality of life|quality of life
1011200|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
1011201|NCT03092310|Artificial Pancreas|artificial pancreas
1011202|NCT03092271|suicide|suicide
1011203|NCT03092271|suicide attempt|suicide attempt
1011204|NCT03092271|self harm|self harm
1011205|NCT03092271|depression|depression
1011206|NCT03092193|Naproxen|naproxen
1011207|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
1011697|NCT03089177|Obesity|obesity
1011208|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
1011209|NCT03092193|Cytochrome P450|cytochrome p450
1011210|NCT03092180|Dermatomyositis|dermatomyositis
1011211|NCT03092180|Immunomodulation|immunomodulation
1011212|NCT03092180|Immunosuppressive agents|immunosuppressive agents
1011213|NCT03092180|Myositis|myositis
1011214|NCT03092180|Polymyositis|polymyositis
1011215|NCT03092180|Necrotizing myopathies|necrotizing myopathies
1011216|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
1011217|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
1011218|NCT03092128|Imatinib|imatinib
1011219|NCT03092128|Pharmacogenetics|pharmacogenetics
1011220|NCT03092128|Pharmacokinetics|pharmacokinetics
1011221|NCT03092128|Precision medicine|precision medicine
1011222|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
1011223|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
1011224|NCT03092115|mHealth|mhealth
1011225|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
1011226|NCT03092115|native android app|native android app
1011227|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
1011228|NCT03092076|pharmacokinetics|pharmacokinetics
1011229|NCT03092076|antiplatelet effects|antiplatelet effects
1011230|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
1011231|NCT03092024|Systemic Sclerosis|systemic sclerosis
1011232|NCT03092024|Scleroderma|scleroderma
1011233|NCT03092024|Hand|hand
1011234|NCT03092024|Intervention|intervention
1011235|NCT03092024|Exercise|exercise
1011236|NCT03091985|Breastshield|breastshield
1011237|NCT03091985|Breastpump|breastpump
1011238|NCT03091985|Breastfeeding|breastfeeding
1011239|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
1011240|NCT03091972|Linear ablation|linear ablation
1011241|NCT03091972|Catheter ablation|catheter ablation
1011242|NCT03091972|Contact force|contact force
1011243|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
1011244|NCT03091933|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1011245|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
1011246|NCT03091933|HLA matched donor|hla matched donor
1036235|NCT02936713|gas|gas
1011247|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
1011248|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
1011249|NCT03091907|Followup|followup
1011250|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
1011251|NCT03091907|Growth impairments|growth impairments
1011252|NCT03091907|Gut function|gut function
1011253|NCT03091907|Behavioural impairments|behavioural impairments
1011254|NCT03091894|Dexmedetomidine|dexmedetomidine
1011255|NCT03091894|Sleep|sleep
1011256|NCT03091894|Endoscopy|endoscopy
1011257|NCT03091894|Propofol|propofol
1011258|NCT03091881|Granisetron|granisetron
1011259|NCT03091881|Spinal induced hypotension|spinal induced hypotension
1011260|NCT03091790|ventral hernia|ventral hernia
1011261|NCT03091790|mesh|mesh
1011262|NCT03091777|bacterial vaginosis|bacterial vaginosis
1011263|NCT03091777|vaginal infection|vaginal infection
1011264|NCT03091777|BV|bv
1011265|NCT03091764|NMIBC|nmibc
1011266|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1011267|NCT03091764|Patient reported outcome|patient reported outcome
1011268|NCT03091764|Symptom burden|symptom burden
1011269|NCT03091764|Questionnaire|questionnaire
1011270|NCT03091751|Factor IX (FIX)|factor ix (fix)
1011271|NCT03091738|sleep|sleep
1011272|NCT03091725|Obesity|obesity
1011273|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
1011274|NCT03091725|Very low calorie diet|very low calorie diet
1011275|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
1011276|NCT03091712|Degludec|degludec
1011277|NCT03091712|MIDS|mids
1011278|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
1011279|NCT03091712|Glooko|glooko
1011280|NCT03091712|Tresiba|tresiba
1011281|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
1011282|NCT03091699|Smoking|smoking
1011283|NCT03091699|Nicotine|nicotine
1011284|NCT03091699|Exercise|exercise
1011285|NCT03091699|Cognition|cognition
1011286|NCT03091686|Sedentary Behaviour|sedentary behaviour
1011287|NCT03091686|Health Behaviour Change|health behaviour change
1011288|NCT03091686|Health Action Process Approach|health action process approach
1011289|NCT03091686|Intervention|intervention
1011290|NCT03091686|Prolonged Sitting|prolonged sitting
1011291|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
1011292|NCT03091686|Motivational Factors|motivational factors
1011293|NCT03091686|Intentions|intentions
1011294|NCT03091686|Diabetes|diabetes
1011295|NCT03091686|Self-Efficacy|self-efficacy
1011296|NCT03091686|Risk Perception|risk perception
1011297|NCT03091686|Outcome Expectancies|outcome expectancies
1011298|NCT03091647|Chinese women|chinese women
1011299|NCT03091647|Cancer-related fatigue|cancer-related fatigue
1011300|NCT03091647|Acupressure|acupressure
1011301|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
1011302|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
1011303|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
1011304|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
1011305|NCT03091621|pulmonary embolism|pulmonary embolism
1011306|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
1011307|NCT03091582|Psychological Therapy|psychological therapy
1011308|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
1011309|NCT03091530|Throwing|throwing
1011310|NCT03091530|Sleeper Stretch|sleeper stretch
1011311|NCT03091530|Balloon Blow|balloon blow
1011312|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
1011313|NCT03091517|Online lifestyle modification|online lifestyle modification
1011314|NCT03091517|Self-management|self-management
1011315|NCT03091517|HbA1c|hba1c
1011316|NCT03091439|Osteomyelitis|osteomyelitis
1011317|NCT03091439|dalbavancin|dalbavancin
1011318|NCT03091439|antibiotic|antibiotic
1011319|NCT03091400|Memory Disorders|memory disorders
1011320|NCT03091400|Multiple Sclerosis|multiple sclerosis
1011321|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
1011322|NCT03091387|neonates, extubation|neonates, extubation
1011323|NCT03091361|Bacterial imaging|bacterial imaging
1011324|NCT03091361|PPV|ppv
1011325|NCT03091361|Chronic wounds|chronic wounds
1011326|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
1011327|NCT03091309|Medication Adherence|medication adherence
1011328|NCT03091309|Crohn Disease|crohn disease
1011329|NCT03091309|Ulcerative Colitis|ulcerative colitis
1011330|NCT03091309|Pregnancy|pregnancy
1011331|NCT03091309|Counselling|counselling
1011332|NCT03091309|Patient Education|patient education
1011333|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
1011334|NCT03091270|gliomas|gliomas
1011335|NCT03091270|motor functional cortex|motor functional cortex
1011336|NCT03091270|ZOOMit-fMRI|zoomit-fmri
1011337|NCT03091270|BOLD-fMRI|bold-fmri
1011338|NCT03091257|Multiple Myeloma|multiple myeloma
1011339|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
1011340|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
1011341|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
1011343|NCT03091192|Savolitinib|savolitinib
1011344|NCT03091179|airway management|airway management
1011345|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
1011346|NCT03091179|high flow nasal cannula|high flow nasal cannula
1011347|NCT03091179|THRIVE|thrive
1011348|NCT03091140|Parathyroidectomy|parathyroidectomy
1011349|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
1011350|NCT03091140|Parathyroid Glands|parathyroid glands
1011351|NCT03091114|fractures, risk prediction|fractures, risk prediction
1011352|NCT03091101|keratoconus|keratoconus
1011353|NCT03091101|corneal innervation|corneal innervation
1011354|NCT03091101|scleral contact lenses|scleral contact lenses
1011355|NCT03091075|Rotator Cuff Tear|rotator cuff tear
1011356|NCT03091075|Rotator Cuff|rotator cuff
1011357|NCT03091075|Anabolic Steroid|anabolic steroid
1011358|NCT03091075|Testosterone|testosterone
1011359|NCT03091075|Oxandrolone|oxandrolone
1011360|NCT03091049|coronary|coronary
1011361|NCT03091049|catheterization|catheterization
1011362|NCT03091049|transradial|transradial
1011363|NCT03091049|anesthesia|anesthesia
1011364|NCT03091036|Chronic|chronic
1011365|NCT03091036|Complex|complex
1011366|NCT03091023|Endometrial receptivity|endometrial receptivity
1011367|NCT03091023|Transcriptomic|transcriptomic
1011368|NCT03091023|Single cell|single cell
1011369|NCT03091023|Endometrial fluid|endometrial fluid
1011370|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
1011371|NCT03090984|Hemodialysis|hemodialysis
1011372|NCT03090984|Coagulation activation|coagulation activation
1011373|NCT03090958|technology|technology
1011374|NCT03090958|app|app
1011375|NCT03090958|YMSM|ymsm
1011376|NCT03090958|HIV|hiv
1011377|NCT03090945|Endoscopy|endoscopy
1011378|NCT03090945|GI Bleeding|gi bleeding
1011379|NCT03090945|Pediatrics|pediatrics
1011380|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
1011381|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
1011382|NCT03090906|volume gain|volume gain
1011383|NCT03090906|soft tissue augmentation|soft tissue augmentation
1011384|NCT03090906|dental implants|dental implants
1011385|NCT03090906|histology|histology
1011386|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
1011387|NCT03090880|Tinzaparin|tinzaparin
1011388|NCT03090867|Clinical Practice Guideline|clinical practice guideline
1011389|NCT03090867|Critical care|critical care
1011390|NCT03090867|Family-centered care|family-centered care
1011391|NCT03090867|Professional-family relations|professional-family relations
1011392|NCT03090867|Family nursing|family nursing
1011393|NCT03090867|Anxiety|anxiety
1011394|NCT03090867|Depression|depression
1011395|NCT03090867|Participation in care|participation in care
1011396|NCT03090854|Alzheimer's Disease|alzheimer's disease
1011397|NCT03090854|Cognition|cognition
1011398|NCT03090854|Cholinergic target|cholinergic target
1011399|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
1011400|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
1011401|NCT03090841|Omics|omics
1011402|NCT03090841|Biomarkers|biomarkers
1011403|NCT03090828|economic evaluation|economic evaluation
1011404|NCT03090828|e health|e health
1011405|NCT03090815|Circulating Tumor DNA|circulating tumor dna
1011406|NCT03090815|Prognostic|prognostic
1011407|NCT03090815|Molecular tests|molecular tests
1011408|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
1011409|NCT03090802|resilience|resilience
1011410|NCT03090802|adolescent mothers|adolescent mothers
1011411|NCT03090802|Sub-Saharan Africa|sub-saharan africa
1011412|NCT03090802|intimate partner violence|intimate partner violence
1011413|NCT03090802|postpartum period|postpartum period
1011414|NCT03090789|Friedreich Ataxia|friedreich ataxia
1011415|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
1011416|NCT03090698|osteoarthritis|osteoarthritis
1011417|NCT03090698|knee|knee
1011418|NCT03090698|treatment|treatment
1011419|NCT03090685|Chikungunya Fever|chikungunya fever
1011420|NCT03090685|Pain|pain
1011421|NCT03090685|Mobility Limitation|mobility limitation
1011422|NCT03090685|Auriculotherapy|auriculotherapy
1011423|NCT03090685|Complementary Therapies|complementary therapies
1011424|NCT03090685|Physical Therapy|physical therapy
1011425|NCT03090672|Arthritis|arthritis
1011426|NCT03090672|Degenerative|degenerative
1011427|NCT03090672|Tendinosis|tendinosis
1011428|NCT03090672|Jont disease|jont disease
1011429|NCT03090672|Low back pain|low back pain
1011430|NCT03090659|multiple myeloma|multiple myeloma
1011431|NCT03090659|BCMA|bcma
1011432|NCT03090659|CAR-T|car-t
1011433|NCT03090646|social behavioral|social behavioral
1011434|NCT03090646|living donor kidney transplant|living donor kidney transplant
1011435|NCT03090646|follow-up|follow-up
1011436|NCT03090646|health utilization|health utilization
1011437|NCT03090646|incentives|incentives
1011438|NCT03090633|Fetoscopy|fetoscopy
1011439|NCT03090633|Fetal surgery|fetal surgery
1011440|NCT03090633|Fetal spina bifida|fetal spina bifida
1011441|NCT03090594|Cryoprobe|cryoprobe
1011442|NCT03090594|Bronchoscopy|bronchoscopy
1011443|NCT03090594|Acute cellular rejection|acute cellular rejection
1011444|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
1011445|NCT03090581|Lung Transplantation|lung transplantation
1011446|NCT03090581|Cryoprobe|cryoprobe
1011447|NCT03090555|adhesive capsulitis|adhesive capsulitis
1011448|NCT03090555|clinical trial|clinical trial
1011449|NCT03090555|manipulation|manipulation
1011940|NCT03087500|Adolescents|adolescents
1011450|NCT03090529|Exercise training|exercise training
1011451|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
1011452|NCT03090529|Resistant Hypertension|resistant hypertension
1011453|NCT03090529|Nitric Oxide|nitric oxide
1011454|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
1011455|NCT03090516|Alzheimer's|alzheimer's
1011456|NCT03090503|Antipsychotic agents|antipsychotic agents
1011457|NCT03090503|Treatment|treatment
1011458|NCT03090503|Effectiveness|effectiveness
1011459|NCT03090503|Aripiprazole|aripiprazole
1011460|NCT03090503|Risperidone|risperidone
1011461|NCT03090490|Treatment|treatment
1011462|NCT03090490|Maintenance|maintenance
1011463|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
1011464|NCT03090464|Digital disease management|digital disease management
1011465|NCT03090464|T2DM|t2dm
1011466|NCT03090464|Hyperglycemia|hyperglycemia
1011467|NCT03090464|Diabetes mellitus|diabetes mellitus
1011468|NCT03090451|Insulin|insulin
1011469|NCT03090451|Glucose Clamp|glucose clamp
1011470|NCT03090451|Glucose Tracer|glucose tracer
1011471|NCT03090451|Artificial Pancreas|artificial pancreas
1011472|NCT03090451|Exercise|exercise
1011473|NCT03090451|Aerobic|aerobic
1011474|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
1011475|NCT03090373|Catheter|catheter
1011476|NCT03090373|UTI's|uti's
1011477|NCT03090360|Healthy babies|healthy babies
1011478|NCT03090360|Infant formula|infant formula
1011479|NCT03090360|Growth|growth
1011480|NCT03090334|beta-d-glucan|beta-d-glucan
1011481|NCT03090334|abdominal candidiasis|abdominal candidiasis
1011482|NCT03090321|fitness|fitness
1011483|NCT03090321|health|health
1011484|NCT03090321|activity|activity
1011485|NCT03090321|heart risk|heart risk
1011486|NCT03090321|wellness|wellness
1011487|NCT03090282|mechanical treatment|mechanical treatment
1011488|NCT03090282|implant|implant
1011489|NCT03090269|cocaine|cocaine
1011490|NCT03090269|methylphenidate|methylphenidate
1011491|NCT03090269|psychostimulant|psychostimulant
1011492|NCT03090269|ADHD|adhd
1011493|NCT03090269|effective dose|effective dose
1011494|NCT03090269|pharmacokinetics|pharmacokinetics
1011495|NCT03090269|crack|crack
1011496|NCT03090243|Glaucoma|glaucoma
1011497|NCT03090243|Intraocular pressure|intraocular pressure
1011498|NCT03090243|Colonoscopy|colonoscopy
1011499|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
1011500|NCT03090243|Valsalva|valsalva
1011501|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
1011503|NCT03090230|Transection|transection
1011698|NCT03089177|Cancer Prevention|cancer prevention
1011504|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
1011505|NCT03090217|Radiotherapy|radiotherapy
1011506|NCT03090217|Brachytherapy|brachytherapy
1011507|NCT03090217|Physiotherapy|physiotherapy
1011508|NCT03090217|Vaginal dilators|vaginal dilators
1011509|NCT03090217|Pelvic floor exercises|pelvic floor exercises
1011510|NCT03090217|Vaginal Stenosis|vaginal stenosis
1011511|NCT03090204|strain|strain
1011512|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
1011513|NCT03090204|right ventricle (RV)|right ventricle (rv)
1011514|NCT03090204|systolic RV function|systolic rv function
1011515|NCT03090204|preload dependence|preload dependence
1011516|NCT03090204|contractility|contractility
1011517|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
1011518|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
1011519|NCT03090165|ribociclib|ribociclib
1011520|NCT03090165|LEE011|lee011
1011521|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
1011522|NCT03090165|bicalutamide|bicalutamide
1011523|NCT03090152|Total Hip Replacement|total hip replacement
1011524|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
1011525|NCT03090139|Drug therapy|drug therapy
1011526|NCT03090113|Stroke|stroke
1011527|NCT03090113|Embolic Stroke|embolic stroke
1011528|NCT03090113|Shuxuetong|shuxuetong
1011529|NCT03090113|Recurrence|recurrence
1011530|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
1011531|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
1011532|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
1011533|NCT03090087|Adenosine|adenosine
1011534|NCT03090087|Hypoxia|hypoxia
1011535|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
1011536|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
1011537|NCT03090009|NSAID|nsaid
1011538|NCT03090009|Microbiome|microbiome
1011539|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
1011540|NCT03089996|piezocision|piezocision
1011541|NCT03089996|corticotomy|corticotomy
1011542|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
1011543|NCT03089983|prison|prison
1011544|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1011545|NCT03089957|Critical Illness|critical illness
1011546|NCT03089957|Randomized Controlled Trial|randomized controlled trial
1011547|NCT03089957|Ulinastatin|ulinastatin
1011548|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1011549|NCT03089944|Glecaprevir|glecaprevir
1011550|NCT03089944|Pibrentasvir|pibrentasvir
1011551|NCT03089944|Treatment Naïve|treatment naïve
1011552|NCT03089944|Cirrhosis|cirrhosis
1011553|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
1011554|NCT03089944|Genotype (GT) 1-6|genotype (gt) 1-6
1011555|NCT03089944|Pangenotypic|pangenotypic
1011556|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
1011557|NCT03089879|Immunologic Memory|immunologic memory
1011558|NCT03089879|GMMA|gmma
1011559|NCT03089879|Shigella Vaccines|shigella vaccines
1011560|NCT03089879|Shigellosis|shigellosis
1011561|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
1011562|NCT03089879|Healthy Volunteers|healthy volunteers
1011563|NCT03089879|Safety|safety
1011564|NCT03089879|Bacteria|bacteria
1011565|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
1011566|NCT03089879|Shigella sonnei|shigella sonnei
1011567|NCT03089866|Central nervous System|central nervous system
1011568|NCT03089866|Memory functions|memory functions
1011569|NCT03089866|Executive functions|executive functions
1011570|NCT03089866|Cognitive impairment|cognitive impairment
1011571|NCT03089853|COPD|copd
1011572|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
1011573|NCT03089853|telehealth|telehealth
1011574|NCT03089853|smart|smart
1011575|NCT03089853|technology|technology
1011576|NCT03089853|NEMS|nems
1011577|NCT03089853|acute exacerbation|acute exacerbation
1011578|NCT03089840|normothermic perfusion|normothermic perfusion
1011579|NCT03089840|liver transplantation|liver transplantation
1011580|NCT03089827|Memory|memory
1011581|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
1011582|NCT03089801|health care access|health care access
1011583|NCT03089801|eHealth|ehealth
1011584|NCT03089801|telehealth|telehealth
1011585|NCT03089775|Contact|contact
1011586|NCT03089775|Treatment|treatment
1011587|NCT03089775|Prevention|prevention
1011588|NCT03089775|BBI-2000|bbi-2000
1011589|NCT03089775|Dermatitis|dermatitis
1011590|NCT03089775|Allergic|allergic
1011591|NCT03089736|Pain|pain
1011592|NCT03089736|Head and neck cancer|head and neck cancer
1011593|NCT03089736|depression|depression
1011594|NCT03089736|anxiety|anxiety
1011595|NCT03089736|health|health
1011596|NCT03089736|catastrophizing|catastrophizing
1011597|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
1011598|NCT03089723|hyaluronic acid|hyaluronic acid
1011599|NCT03089723|Rhizarthrosis|rhizarthrosis
1011600|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
1011601|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
1011699|NCT03089177|Neighborhood|neighborhood
1011602|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
1011603|NCT03089684|NHANES|nhanes
1011604|NCT03089684|Folate|folate
1011605|NCT03089684|Folic Acid|folic acid
1011606|NCT03089671|Vitamin B|vitamin b
1011607|NCT03089671|5% Dextrose in Water|5% dextrose in water
1011608|NCT03089671|Cystoscopy|cystoscopy
1011609|NCT03089671|Ureter|ureter
1011610|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
1011611|NCT03089658|Expanded Access Program|expanded access program
1011612|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
1011613|NCT03089658|Avelumab|avelumab
1011614|NCT03089632|gluten-free diet|gluten-free diet
1011615|NCT03089632|gluten sensitivity|gluten sensitivity
1011616|NCT03089632|dyspepsia|dyspepsia
1011617|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
1011618|NCT03089632|gastroparesis|gastroparesis
1011619|NCT03089632|motility|motility
1011620|NCT03089619|Alveolar bone|alveolar bone
1011621|NCT03089619|Bone resorption|bone resorption
1011622|NCT03089619|dental implants|dental implants
1011623|NCT03089593|Thermic Effect of Food|thermic effect of food
1011624|NCT03089593|Energy Expenditure|energy expenditure
1011625|NCT03089593|Ginger|ginger
1011626|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
1011627|NCT03089567|Streptococcus mutans|streptococcus mutans
1011628|NCT03089567|Caries prevention|caries prevention
1011629|NCT03089567|Fluoride|fluoride
1011630|NCT03089528|Direct laryngoscopy|direct laryngoscopy
1011631|NCT03089528|Videolaryngoscopy|videolaryngoscopy
1011632|NCT03089528|Diabetes Mellitus|diabetes mellitus
1011633|NCT03089528|Intubation|intubation
1011634|NCT03089528|Anesthesia|anesthesia
1011635|NCT03089515|World Trade Center|world trade center
1011636|NCT03089515|World Trade Center Survivors|world trade center survivors
1011637|NCT03089502|Exercise|exercise
1011638|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
1011639|NCT03089502|Breast Caner|breast caner
1011640|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
1011641|NCT03089502|Trastuzumab|trastuzumab
1011642|NCT03089502|Anthracyclines|anthracyclines
1011643|NCT03089489|Primary graft dysfunction|primary graft dysfunction
1011644|NCT03089489|Lung transplantation|lung transplantation
1011645|NCT03089489|Surfactant Protein|surfactant protein
1011646|NCT03089489|inflammation|inflammation
1011647|NCT03089476|Prevention|prevention
1011648|NCT03089476|Predictors|predictors
1011649|NCT03089463|Diabetes|diabetes
1011650|NCT03089463|Diabetic Foot|diabetic foot
1011651|NCT03089463|Biomechanics|biomechanics
1011652|NCT03089463|Stratification|stratification
1011653|NCT03089463|Diabetes Complications|diabetes complications
1011654|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
1011655|NCT03089463|Risk Factors|risk factors
1011656|NCT03089463|Prospective Studies|prospective studies
1011657|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
1011658|NCT03089411|myeloma multiple|myeloma multiple
1011659|NCT03089411|newly diagnosed|newly diagnosed
1011660|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
1011661|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1011662|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
1011663|NCT03089372|Erectile Dysfunction|erectile dysfunction
1011664|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
1011665|NCT03089359|Unspecific symptoms|unspecific symptoms
1011666|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
1011667|NCT03089359|Lactate|lactate
1011668|NCT03089359|Emergency Medical Services|emergency medical services
1011669|NCT03089346|Imaging|imaging
1011670|NCT03089346|Bronchial Remodeling|bronchial remodeling
1011671|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
1011672|NCT03089307|Erectile Dysfunction|erectile dysfunction
1011673|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
1011674|NCT03089294|Erectile Dysfunction|erectile dysfunction
1011675|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
1011676|NCT03089268|sessile serrated polyp|sessile serrated polyp
1011677|NCT03089268|prevalence|prevalence
1011678|NCT03089268|colorectal cancer|colorectal cancer
1011679|NCT03089268|molecular biology|molecular biology
1011680|NCT03089255|Thrombophylaxis|thrombophylaxis
1011681|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
1011682|NCT03089255|Pulmonary Embolism|pulmonary embolism
1011683|NCT03089255|Lower Leg Trauma|lower leg trauma
1011684|NCT03089229|Topical Cream|topical cream
1011685|NCT03089229|Novel|novel
1011686|NCT03089190|Appetite|appetite
1011687|NCT03089190|Satiety|satiety
1011688|NCT03089190|Energy intake|energy intake
1011689|NCT03089190|Hunger|hunger
1011690|NCT03089190|Peptide|peptide
1011691|NCT03089190|Encapsulation|encapsulation
1011692|NCT03089177|Randomized Controlled Trial|randomized controlled trial
1011693|NCT03089177|Community Gardening|community gardening
1011694|NCT03089177|Health Behavior Change|health behavior change
1011695|NCT03089177|Physical Activity|physical activity
1011696|NCT03089177|Diet|diet
1011700|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
1011701|NCT03089151|Community Garden|community garden
1011702|NCT03089151|Health Behavior Change|health behavior change
1011703|NCT03089151|Physical Activity|physical activity
1011704|NCT03089151|Diet|diet
1011705|NCT03089151|Obesity|obesity
1011706|NCT03089151|Neighborhood|neighborhood
1011707|NCT03089151|Microbiome|microbiome
1011708|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
1011709|NCT03089125|Lung Cancer|lung cancer
1011710|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1011711|NCT03089099|circulating tumor cells|circulating tumor cells
1011712|NCT03089099|Prognosis|prognosis
1011713|NCT03089099|Liquid biopsy|liquid biopsy
1011714|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
1011715|NCT03089086|herd immunity|herd immunity
1011716|NCT03089086|adolescents|adolescents
1011717|NCT03089086|young adults|young adults
1011718|NCT03089086|south australia|south australia
1011719|NCT03089060|Fingertip Amputation|fingertip amputation
1011720|NCT03089060|Fingertip Regeneration|fingertip regeneration
1011721|NCT03089060|Infection|infection
1011722|NCT03089060|Occlusive Dressings|occlusive dressings
1011723|NCT03089060|Pediatric Surgery|pediatric surgery
1011724|NCT03089060|Silicone Finger Cap|silicone finger cap
1011725|NCT03089021|neck pain,|neck pain,
1011726|NCT03088982|Family Medicine|family medicine
1011727|NCT03088982|multimorbidity|multimorbidity
1011728|NCT03088982|prevention|prevention
1011729|NCT03088969|Chronic Low Back Pain|chronic low back pain
1011730|NCT03088969|Function|function
1011731|NCT03088969|Self-efficacy|self-efficacy
1011732|NCT03088969|Return to work|return to work
1011733|NCT03088969|Questionnaire|questionnaire
1011734|NCT03088956|Longitudinal|longitudinal
1011735|NCT03088956|Caregiver|caregiver
1011736|NCT03088956|Cognitive assessments|cognitive assessments
1011737|NCT03088956|Behavioral assessments|behavioral assessments
1011738|NCT03088956|Functional assessments|functional assessments
1011739|NCT03088904|Inactivated influenza vaccine quadrivalent|inactivated influenza vaccine quadrivalent
1011740|NCT03088904|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
1011741|NCT03088904|Monozygotic twins|monozygotic twins
1011742|NCT03088904|Dizygotic twins|dizygotic twins
1011743|NCT03088904|Adults|adults
1011744|NCT03088904|Adolescents|adolescents
1011745|NCT03088891|altitude training|altitude training
1011746|NCT03088891|antioxidants|antioxidants
1011747|NCT03088891|oxidative stress|oxidative stress
1011748|NCT03088891|elite athletes|elite athletes
1011749|NCT03088891|inflammation|inflammation
1011750|NCT03088891|diet|diet
1011751|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1011752|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
1011753|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
1011754|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
1011755|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
1011756|NCT03088774|Low back pain|low back pain
1011757|NCT03088761|tracheal tube|tracheal tube
1011758|NCT03088761|cuff pressure|cuff pressure
1011759|NCT03088748|total knee arthroplasty|total knee arthroplasty
1011760|NCT03088722|Contraceptive implant|contraceptive implant
1011761|NCT03088722|Task sharing|task sharing
1011762|NCT03088722|Nigeria|nigeria
1011763|NCT03088709|NHL|nhl
1011764|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1011765|NCT03088709|Haploidentical|haploidentical
1011766|NCT03088709|Bone Marrow Transplant|bone marrow transplant
1011767|NCT03088709|Stem Cell Transplant|stem cell transplant
1011768|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
1011769|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1011770|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
1011771|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1011772|NCT03088709|GVHD|gvhd
1011773|NCT03088696|laparoscopic|laparoscopic
1011774|NCT03088696|acupuncture|acupuncture
1011775|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
1011776|NCT03088683|liver retractor|liver retractor
1011777|NCT03088683|nathanson|nathanson
1011778|NCT03088683|reveel|reveel
1011779|NCT03088683|liver trauma|liver trauma
1011780|NCT03088657|Cohort study|cohort study
1011781|NCT03088657|early-onset mood disorders|early-onset mood disorders
1011782|NCT03088618|Nasal obstruction|nasal obstruction
1011783|NCT03088618|Septal deformity|septal deformity
1011784|NCT03088618|Septoplasty|septoplasty
1011785|NCT03088618|TnR Mesh|tnr mesh
1011786|NCT03088618|polycaprolactone|polycaprolactone
1011787|NCT03088592|Deep Brain Stimulation|deep brain stimulation
1011788|NCT03088579|radiation shielding|radiation shielding
1011789|NCT03088553|Ganciclovir|ganciclovir
1011790|NCT03088553|trough concentrations|trough concentrations
1011791|NCT03088553|CMV viral load|cmv viral load
1011792|NCT03088553|safety|safety
1011793|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
1011794|NCT03088514|Hypertension|hypertension
1011795|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
1011796|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
1011798|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
1011799|NCT03088488|25-OH vitamin D|25-oh vitamin d
1011800|NCT03088488|RANKL|rankl
1011801|NCT03088488|Osteoprotogerin|osteoprotogerin
1011802|NCT03088488|TNF-α|tnf-α
1011803|NCT03088462|Bipolar Disorder|bipolar disorder
1011804|NCT03088462|Smartphone|smartphone
1011805|NCT03088462|Behavior Therapy|behavior therapy
1011806|NCT03088449|Crohns disease|crohns disease
1011807|NCT03088449|primary non response|primary non response
1011808|NCT03088449|lose of response|lose of response
1011809|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
1011810|NCT03088449|Anti-TNF|anti-tnf
1011811|NCT03088449|PANTS|pants
1011812|NCT03088449|Biosimilars|biosimilars
1011813|NCT03088436|MRI|mri
1011814|NCT03088436|Breast|breast
1011815|NCT03088423|MRI|mri
1011816|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
1011817|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
1011818|NCT03088384|PTSD|ptsd
1011819|NCT03088384|Combat Trauma|combat trauma
1011820|NCT03088371|Total knee replacement|total knee replacement
1011821|NCT03088371|Psoas Sciatic block|psoas sciatic block
1011822|NCT03088371|Epidural anaesthesia|epidural anaesthesia
1011823|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
1011824|NCT03088345|Post-Operative Care|post-operative care
1011825|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
1011826|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
1011827|NCT03088293|infliximab|infliximab
1011828|NCT03088293|cyclophosphamide|cyclophosphamide
1011829|NCT03088241|randomized clinical trial|randomized clinical trial
1011830|NCT03088241|low level viremia|low level viremia
1011831|NCT03088241|lesotho|lesotho
1011832|NCT03088241|resource-limited setting|resource-limited setting
1011833|NCT03088241|ART first-line failure|art first-line failure
1011834|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
1011835|NCT03088215|shock-waves|shock-waves
1011836|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
1011837|NCT03088215|pain|pain
1011838|NCT03088215|trigger point|trigger point
1011839|NCT03088215|referred pain|referred pain
1011840|NCT03088202|cancer|cancer
1011841|NCT03088202|palliative care|palliative care
1011842|NCT03088202|PROMs|proms
1011843|NCT03088202|survival|survival
1011844|NCT03088202|QoL|qol
1011846|NCT03088189|maternal nutrition|maternal nutrition
1011847|NCT03088189|periconceptional|periconceptional
1011848|NCT03088189|neurocognitive development|neurocognitive development
1011849|NCT03088176|Melanoma|melanoma
1011850|NCT03088176|BRAF inhibitor|braf inhibitor
1011851|NCT03088176|Intratumoral injection|intratumoral injection
1011852|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
1011853|NCT03088176|MEK inhibitor|mek inhibitor
1011854|NCT03088176|dabrafenib|dabrafenib
1011855|NCT03088176|trametinib|trametinib
1011856|NCT03088150|Hepatic resection|hepatic resection
1011857|NCT03088150|Liver surgery|liver surgery
1011858|NCT03088150|Thermal ablation|thermal ablation
1011859|NCT03088150|Radiofrequency ablation|radiofrequency ablation
1011860|NCT03088150|Microwave ablation|microwave ablation
1011861|NCT03088150|RFA|rfa
1011862|NCT03088150|MWA|mwa
1011863|NCT03088137|in vitro fertilization|in vitro fertilization
1011864|NCT03088111|Anthim®|anthim®
1011865|NCT03088111|Obiltoxaximab|obiltoxaximab
1011866|NCT03088111|anthrax|anthrax
1011867|NCT03088111|anti-toxin|anti-toxin
1011868|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
1011869|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1011870|NCT03088098|atrial fibrillation|atrial fibrillation
1011871|NCT03088072|Edoxaban|edoxaban
1011872|NCT03088072|WATCHMAN device|watchman device
1011873|NCT03088020|CCHS|cchs
1011874|NCT03088020|PHOX2B|phox2b
1011875|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
1011876|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
1011877|NCT03088020|control of breathing|control of breathing
1011878|NCT03088020|Hirschsprung disease|hirschsprung disease
1011879|NCT03088020|neural crest tumors|neural crest tumors
1011880|NCT03088020|neuroblastoma|neuroblastoma
1011881|NCT03088020|ganglioneuroma|ganglioneuroma
1011882|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
1011883|NCT03088020|artificial ventilation|artificial ventilation
1011884|NCT03088020|diaphragm pacing|diaphragm pacing
1011885|NCT03088007|Intellectual Deficiency|intellectual deficiency
1011886|NCT03088007|cognitive, adaptive|cognitive, adaptive
1011887|NCT03088007|behavioral and academic profile|behavioral and academic profile
1011888|NCT03088007|regular and special schools|regular and special schools
1011889|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
1011890|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
1011891|NCT03087942|renal impairment|renal impairment
1011892|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
1011893|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
1011894|NCT03087890|Microbial drug resistance|microbial drug resistance
1011895|NCT03087890|Beta-lactamase|beta-lactamase
1011896|NCT03087890|Cotrimoxazole|cotrimoxazole
1011897|NCT03087890|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1011898|NCT03087890|Tanzania|tanzania
1011899|NCT03087864|esophageal cancer|esophageal cancer
1011900|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
1011901|NCT03087864|chemoradiation|chemoradiation
1011902|NCT03087851|Denosumab|denosumab
1011903|NCT03087851|Bone Turnover markers|bone turnover markers
1011904|NCT03087851|Drug Holiday|drug holiday
1011905|NCT03087812|Microbiological burden|microbiological burden
1011906|NCT03087812|kidney|kidney
1011907|NCT03087812|stone|stone
1011908|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
1011909|NCT03087734|Prostheses and Implants|prostheses and implants
1011910|NCT03087721|Metabolic Syndrome|metabolic syndrome
1011911|NCT03087721|Exercise Training|exercise training
1011912|NCT03087721|Interval Training|interval training
1011913|NCT03087721|Skeletal Muscle|skeletal muscle
1011914|NCT03087721|Risk Factors|risk factors
1011915|NCT03087721|Insulin Resistance|insulin resistance
1011916|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1011917|NCT03087695|EBV DNA|ebv dna
1011918|NCT03087695|Chemoradiotherapy|chemoradiotherapy
1011919|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
1011920|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
1011921|NCT03087656|levofloxacin|levofloxacin
1011922|NCT03087656|Ceftriaxone|ceftriaxone
1011923|NCT03087656|Cholangitis|cholangitis
1011924|NCT03087656|ERCP|ercp
1011925|NCT03087643|Flow-mediated dilation|flow-mediated dilation
1011926|NCT03087643|Passive limb movement|passive limb movement
1011927|NCT03087604|epidural catheter placement|epidural catheter placement
1011928|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
1011929|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
1011930|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
1011931|NCT03087526|Huntington's Disease|huntington's disease
1011932|NCT03087526|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
1011933|NCT03087526|Fragile X syndrome|fragile x syndrome
1011934|NCT03087526|Spinocerebellar Ataxia type 1|spinocerebellar ataxia type 1
1011935|NCT03087526|Spinocerebellar Ataxia type 2|spinocerebellar ataxia type 2
1011936|NCT03087526|Spinocerebellar Ataxia type 3|spinocerebellar ataxia type 3
1011937|NCT03087500|Down Syndrome|down syndrome
1011938|NCT03087500|Typically Developing Participants|typically developing participants
1011939|NCT03087500|Children|children
1011942|NCT03087448|ALK rearranged|alk rearranged
1011943|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
1011944|NCT03087448|Stage IV NSCLC|stage iv nsclc
1011945|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
1011946|NCT03087396|bone marrow defect|bone marrow defect
1011947|NCT03087396|bone marrow lesion|bone marrow lesion
1011948|NCT03087396|stress fracture|stress fracture
1011949|NCT03087396|calcium phosphate|calcium phosphate
1011950|NCT03087396|bone substitute material|bone substitute material
1011951|NCT03087370|CXCR4 Mutation|cxcr4 mutation
1011952|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
1011953|NCT03087370|Warts|warts
1011954|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
1011955|NCT03087370|Infections|infections
1011956|NCT03087370|Myelokathexis|myelokathexis
1011957|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
1011958|NCT03087370|Neutropenia|neutropenia
1011959|NCT03087370|Herpes|herpes
1011960|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
1011961|NCT03087344|Transient elastography|transient elastography
1011962|NCT03087344|Cirrhosis|cirrhosis
1011963|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
1011964|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
1011965|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
1011966|NCT03087318|Sport prescription|sport prescription
1011967|NCT03087318|Physical activity|physical activity
1011968|NCT03087305|Interventional Pulmonary|interventional pulmonary
1011969|NCT03087305|EBUS-TBNA|ebus-tbna
1011970|NCT03087305|Lung cancer staging|lung cancer staging
1011971|NCT03087292|blood flow restriction|blood flow restriction
1011972|NCT03087292|resistance training|resistance training
1011973|NCT03087292|coronary heart disease|coronary heart disease
1011974|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
1011975|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
1011976|NCT03087240|Dental Scaling|dental scaling
1011977|NCT03087240|Dental Polishing|dental polishing
1011978|NCT03087240|Oral Health|oral health
1011979|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
1011980|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
1011981|NCT03087240|Biofilm|biofilm
1011982|NCT03087240|Oral Microbiome|oral microbiome
1011983|NCT03087240|Intestinal Microbiome|intestinal microbiome
1011984|NCT03087227|mHealth|mhealth
1011985|NCT03087227|febrile neutropenia|febrile neutropenia
1011986|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
1011987|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
1011988|NCT03087227|Patient readmission|patient readmission
1011989|NCT03087227|disease management|disease management
1011990|NCT03087201|Chronic tic disorders|chronic tic disorders
1011991|NCT03087201|Tourette syndrome|tourette syndrome
1011992|NCT03087149|vitamin D|vitamin d
1011993|NCT03087149|supplementation|supplementation
1011994|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
1011995|NCT03087149|pretrem infants|pretrem infants
1011996|NCT03087149|osteopenia|osteopenia
1011997|NCT03087136|multiple sclerosis|multiple sclerosis
1011998|NCT03087136|pediatric|pediatric
1011999|NCT03087123|single-case design|single-case design
1012000|NCT03087123|children|children
1012001|NCT03087123|health equity|health equity
1012002|NCT03087123|mobile health|mobile health
1012003|NCT03087071|Colorectal cancer|colorectal cancer
1012004|NCT03087071|Colorectal adenocarcinoma|colorectal adenocarcinoma
1012005|NCT03087071|EGFR S492R or other ectodomain mutations in circulating free tumor DNA|egfr s492r or other ectodomain mutations in circulating free tumor dna
1012006|NCT03087071|Detectable KRAS or NRAS mutations in exons 2, 3, or 4; or BRAF codon 600 mutations in circulating free tumor DNA|detectable kras or nras mutations in exons 2, 3, or 4; or braf codon 600 mutations in circulating free tumor dna
1012007|NCT03087071|No detectable mutations in circulating free tumor DNA|no detectable mutations in circulating free tumor dna
1012008|NCT03087071|Panitumumab|panitumumab
1012009|NCT03087071|Vectibix|vectibix
1012010|NCT03087071|Trametinib|trametinib
1012011|NCT03087071|GSK1120212|gsk1120212
1012012|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
1012013|NCT03087058|Hyperkalemia|hyperkalemia
1012014|NCT03087058|Potassium|potassium
1012015|NCT03087058|Chronic Kidney Disease|chronic kidney disease
1012016|NCT03087032|Liraglutide|liraglutide
1012017|NCT03087032|Insulin Glargine|insulin glargine
1012018|NCT03087032|Prandial Insulin|prandial insulin
1012019|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
1012020|NCT03086980|health related quality of life|health related quality of life
1012021|NCT03086980|utility|utility
1012022|NCT03086980|regression|regression
1012023|NCT03086967|cervical ripening|cervical ripening
1012024|NCT03086967|double lumen catheter|double lumen catheter
1012025|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
1012026|NCT03086915|neuromuscular blockade|neuromuscular blockade
1012027|NCT03086915|muscle relaxation|muscle relaxation
1012028|NCT03086915|muscle relaxant|muscle relaxant
1012029|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
1012030|NCT03086863|electroacupuncture|electroacupuncture
1012424|NCT03084419|Abatacept|abatacept
1012031|NCT03086863|randomized controlled trial|randomized controlled trial
1012032|NCT03086824|Bone Metastasis|bone metastasis
1012033|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
1012034|NCT03086798|Magill forceps|magill forceps
1012035|NCT03086798|cuff inflation|cuff inflation
1012036|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
1012037|NCT03086746|Remodeling|remodeling
1012038|NCT03086733|Lung Cancer|lung cancer
1012039|NCT03086733|Non small cell lung cancer|non small cell lung cancer
1012040|NCT03086733|Metformin|metformin
1012041|NCT03086733|Pre-operative treatment|pre-operative treatment
1012042|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
1012044|NCT03086733|Phase II|phase ii
1012045|NCT03086720|Adhesive system|adhesive system
1012046|NCT03086720|Controlled clinical trial|controlled clinical trial
1012047|NCT03086720|Dental restoration|dental restoration
1012048|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
1012049|NCT03086720|Dental restoration failure|dental restoration failure
1012050|NCT03086720|Sodium hypochlorite|sodium hypochlorite
1012051|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
1012052|NCT03086707|saccharine transit time|saccharine transit time
1012053|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
1012054|NCT03086694|nasotracheal intubation|nasotracheal intubation
1012055|NCT03086694|stroke volume variation|stroke volume variation
1012056|NCT03086681|Cervical carcinoma|cervical carcinoma
1012057|NCT03086681|endostar|endostar
1012058|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1012059|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
1012060|NCT03086668|jaw thrust|jaw thrust
1012061|NCT03086668|hook-finger|hook-finger
1012062|NCT03086655|biological markers|biological markers
1012063|NCT03086655|monitoring device|monitoring device
1012064|NCT03086655|wireless technology|wireless technology
1012065|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
1012066|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
1012067|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
1012068|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
1012069|NCT03086642|refractory|refractory
1012070|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
1012071|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
1012072|NCT03086642|T-Vec|t-vec
1012073|NCT03086642|T Vec|t vec
1012074|NCT03086616|DIPG|dipg
1012076|NCT03086616|glioma|glioma
1012077|NCT03086590|Body composition|body composition
1012078|NCT03086590|Ultrasound|ultrasound
1012079|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
1012080|NCT03086590|Respiratory muscles|respiratory muscles
1012082|NCT03086564|ADCC|adcc
1012084|NCT03086564|immuno therapy|immuno therapy
1012085|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1012086|NCT03086551|Motor Impairment|motor impairment
1012087|NCT03086551|Rehabilitation|rehabilitation
1012088|NCT03086551|Motor Learning|motor learning
1012089|NCT03086525|Chronic pain|chronic pain
1012090|NCT03086525|Psychological factors|psychological factors
1012091|NCT03086525|Musculoskeletal pain|musculoskeletal pain
1012092|NCT03086525|Prognosis|prognosis
1012093|NCT03086499|pectus excavatum|pectus excavatum
1012094|NCT03086486|Tuberculosis|tuberculosis
1012095|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
1012096|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
1012097|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
1012098|NCT03086486|Pretomanid|pretomanid
1012099|NCT03086486|PA-824|pa-824
1012100|NCT03086486|Bedaquiline|bedaquiline
1012101|NCT03086486|Linezolid|linezolid
1012102|NCT03086486|NC-007|nc-007
1012103|NCT03086486|TB Alliance|tb alliance
1012104|NCT03086486|pre-XDR-TB|pre-xdr-tb
1012105|NCT03086473|caffeine|caffeine
1012106|NCT03086473|intubation|intubation
1012107|NCT03086473|hemodynamics|hemodynamics
1037360|NCT02929927|PDT|pdt
1012108|NCT03086473|mechanical ventilation|mechanical ventilation
1012109|NCT03086473|cardiac output|cardiac output
1012110|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
1012111|NCT03086473|functional echocardiography|functional echocardiography
1012112|NCT03086434|Culturally tailored intervention|culturally tailored intervention
1012113|NCT03086434|American Indian early adolescents|american indian early adolescents
1012114|NCT03086434|Prevention of substance use|prevention of substance use
1012115|NCT03086421|Childhood cancer|childhood cancer
1012116|NCT03086421|Social functioning|social functioning
1012117|NCT03086421|Social development|social development
1012118|NCT03086408|airway management|airway management
1012119|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
1012120|NCT03086408|high flow nasal cannula|high flow nasal cannula
1012121|NCT03086408|THRIVE|thrive
1012122|NCT03086395|relapsed|relapsed
1012123|NCT03086395|refractory|refractory
1012124|NCT03086382|Lacosamide|lacosamide
1012125|NCT03086382|Syrup|syrup
1012126|NCT03086382|Bioequivalence|bioequivalence
1012127|NCT03086382|Tablet|tablet
1012128|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
1012129|NCT03086343|Arthritis|arthritis
1012130|NCT03086343|Joint Disease|joint disease
1012131|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
1012132|NCT03086343|Antirheumatic agents|antirheumatic agents
1012133|NCT03086317|Pulmonary Medicine|pulmonary medicine
1012134|NCT03086317|Therapy Evaluation|therapy evaluation
1012135|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
1012136|NCT03086265|airway management|airway management
1012137|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
1012138|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
1012139|NCT03086265|THRIVE|thrive
1012140|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
1012141|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
1012142|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
1012143|NCT03086239|Cancer|cancer
1012144|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
1012145|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
1012146|NCT03086213|paravertebral nerve block|paravertebral nerve block
1012147|NCT03086213|intercostal nerve block|intercostal nerve block
1012148|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
1012149|NCT03086200|PrEP|prep
1012150|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1012151|NCT03086200|Text messaging|text messaging
1012152|NCT03086200|Truvada|truvada
1012153|NCT03086200|Motivational interviewing|motivational interviewing
1012154|NCT03086200|Transgender|transgender
1012155|NCT03086200|Gender Non-conforming|gender non-conforming
1012156|NCT03086187|weight bearing|weight bearing
1012157|NCT03086187|muscle unloading|muscle unloading
1012158|NCT03086187|bone loss|bone loss
1012159|NCT03086187|arterial adaptation|arterial adaptation
1012160|NCT03086187|muscular adaptation|muscular adaptation
1012161|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1012162|NCT03086174|advanced|advanced
1012163|NCT03086174|melanoma|melanoma
1012164|NCT03086174|kidney cancer|kidney cancer
1012165|NCT03086122|OSA|osa
1012166|NCT03086122|Erectile Dysfunction|erectile dysfunction
1012167|NCT03086122|CPAP treatment|cpap treatment
1012168|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
1012169|NCT03086122|Cardiovascular risk|cardiovascular risk
1012170|NCT03086109|prevalence|prevalence
1012171|NCT03086109|Bone Degenerative Disease|bone degenerative disease
1012172|NCT03086083|Traumatic memories|traumatic memories
1012173|NCT03086083|comparative study|comparative study
1012174|NCT03086083|single session|single session
1012175|NCT03086083|EMDR|emdr
1012176|NCT03086083|Beck inventory|beck inventory
1012177|NCT03086070|omeprazole|omeprazole
1012178|NCT03086070|placebo|placebo
1012183|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
1012184|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
1012185|NCT03086005|Metformin|metformin
1012186|NCT03085992|rectal cancer|rectal cancer
1012187|NCT03085992|FOLFOXIRI|folfoxiri
1012188|NCT03085992|bevacizumab|bevacizumab
1012189|NCT03085992|trust|trust
1012190|NCT03085966|central memory T cell|central memory t cell
1012191|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1012192|NCT03085953|Psychological health|psychological health
1012193|NCT03085953|Well-being|well-being
1012194|NCT03085953|Employee|employee
1012195|NCT03085927|music therapy|music therapy
1012196|NCT03085927|neoplasms|neoplasms
1012197|NCT03085927|play|play
1012198|NCT03085927|children|children
1012199|NCT03085927|parents|parents
1012200|NCT03085914|solid tumors|solid tumors
1012201|NCT03085914|colorectal cancer|colorectal cancer
1012202|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1012203|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
1012204|NCT03085914|PD-1|pd-1
1012205|NCT03085914|PD-L1|pd-l1
1012206|NCT03085914|epacadostat|epacadostat
1012207|NCT03085914|IDO inhibitor|ido inhibitor
1012208|NCT03085888|Cancer Screening|cancer screening
1012209|NCT03085888|Next Generation Sequencing|next generation sequencing
1012210|NCT03085888|Circulating cell-free nucleic acid|circulating cell-free nucleic acid
1012211|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
1012212|NCT03085888|Deep sequencing|deep sequencing
1012213|NCT03085875|Weight Change|weight change
1012214|NCT03085875|Healthy Pregnancy|healthy pregnancy
1012215|NCT03085875|Physiologic Sensors|physiologic sensors
1012216|NCT03085862|Ultrasonography|ultrasonography
1012217|NCT03085862|Extravascular lung water|extravascular lung water
1012218|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
1012219|NCT03085836|Drug Therapy|drug therapy
1012220|NCT03085797|SB240563|sb240563
1012221|NCT03085797|Nasal Polyps|nasal polyps
1012222|NCT03085797|Mepolizumab|mepolizumab
1012223|NCT03085797|Phase 3|phase 3
1012527|NCT03083769|tacrolimus|tacrolimus
1012224|NCT03085797|Parallel group|parallel group
1012225|NCT03085797|Efficacy|efficacy
1012226|NCT03085758|Early Septic Shock|early septic shock
1012227|NCT03085745|Writer's cramp|writer's cramp
1012228|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
1012229|NCT03085745|TMS|tms
1012230|NCT03085745|Afferent inhibition|afferent inhibition
1012231|NCT03085745|Motor mapping|motor mapping
1012232|NCT03085745|Sensory mapping|sensory mapping
1012233|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
1012234|NCT03085745|fine motor control|fine motor control
1012235|NCT03085732|saline irrigation|saline irrigation
1012236|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
1012237|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
1012238|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
1012239|NCT03085719|Head and Neck Cancer|head and neck cancer
1012240|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
1012241|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
1012242|NCT03085667|Watchman device|watchman device
1012243|NCT03085667|Atrial fibrillation|atrial fibrillation
1012244|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
1012245|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
1012246|NCT03085654|multiple doses|multiple doses
1012247|NCT03085654|oxytocin|oxytocin
1012248|NCT03085654|trait anxiety|trait anxiety
1012249|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
1012250|NCT03085628|social sharing|social sharing
1012251|NCT03085628|social reward|social reward
1012252|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
1012253|NCT03085628|reward circuit|reward circuit
1012254|NCT03085589|elderly|elderly
1012255|NCT03085589|telemedicine|telemedicine
1012257|NCT03085589|rural health|rural health
1012258|NCT03085589|health promotion|health promotion
1012259|NCT03085576|Atrial Fibrillation|atrial fibrillation
1012260|NCT03085576|Anticoagulation|anticoagulation
1012261|NCT03085576|Stroke|stroke
1012262|NCT03085576|Vitamin K antagonist|vitamin k antagonist
1012263|NCT03085576|Cardioversion|cardioversion
1012264|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
1012265|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
1012266|NCT03085550|diabetes mellitus|diabetes mellitus
1012267|NCT03085550|fat grafting|fat grafting
1012268|NCT03085550|platelet rich plasma|platelet rich plasma
1012269|NCT03085550|wound healing|wound healing
1012270|NCT03085537|home monitoring|home monitoring
1012271|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
1012272|NCT03085511|Egg breakfast|egg breakfast
1012273|NCT03085511|Weight loss|weight loss
1012274|NCT03085511|Satiety|satiety
1012275|NCT03085511|Insulin|insulin
1012276|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
1012277|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
1012278|NCT03085511|Ghrelin|ghrelin
1012279|NCT03085511|Glucose|glucose
1012280|NCT03085511|Protein quality|protein quality
1012281|NCT03085498|retinal vessels|retinal vessels
1012282|NCT03085498|physical activity|physical activity
1012283|NCT03085498|children|children
1012284|NCT03085498|psychosocial health|psychosocial health
1012285|NCT03085485|COPD|copd
1012286|NCT03085485|CFTR|cftr
1012287|NCT03085485|ivacaftor|ivacaftor
1012288|NCT03085485|topic trial|topic trial
1012289|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
1012290|NCT03085472|stroke|stroke
1012291|NCT03085472|China|china
1012292|NCT03085472|hematoma|hematoma
1012293|NCT03085472|CT|ct
1012294|NCT03085472|predictor|predictor
1012295|NCT03085472|prognosis|prognosis
1012296|NCT03085472|outcome|outcome
1012297|NCT03085420|Burns|burns
1012298|NCT03085420|Pediatrics|pediatrics
1012299|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
1012300|NCT03085394|Morbid Obesity|morbid obesity
1037621|NCT02928237|VAS|vas
1012301|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
1012302|NCT03085368|breast cancer|breast cancer
1012303|NCT03085368|her-2 positive|her-2 positive
1012304|NCT03085368|lapatinib|lapatinib
1012305|NCT03085368|herceptin|herceptin
1012306|NCT03085355|neck pain|neck pain
1012307|NCT03085342|liver|liver
1012308|NCT03085342|fibrosis|fibrosis
1012309|NCT03085342|MRI|mri
1012310|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
1012311|NCT03085329|respiratory support|respiratory support
1012312|NCT03085290|dry eye syndrome|dry eye syndrome
1012313|NCT03085290|serum eye drops|serum eye drops
1012314|NCT03085277|Bovine colostrum|bovine colostrum
1012315|NCT03085277|Preterm formula|preterm formula
1012316|NCT03085277|Very preterm infants|very preterm infants
1012317|NCT03085277|Enteral feeding|enteral feeding
1012318|NCT03085225|Advanced tumor|advanced tumor
1012319|NCT03085225|Pretreated tumor|pretreated tumor
1012320|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
1012321|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
1012322|NCT03085225|Phase Ib|phase ib
1012323|NCT03085225|Circulating DNA|circulating dna
1012324|NCT03085199|gastric cancer|gastric cancer
1012325|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
1012727|NCT03082456|sonography|sonography
1012326|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
1012327|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
1012328|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
1012329|NCT03085173|16-1570|16-1570
1012330|NCT03085147|Tongue|tongue
1012331|NCT03085147|Mouth|mouth
1012332|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
1012333|NCT03085147|PARPi-FL|parpi-fl
1012334|NCT03085147|15-336|15-336
1012335|NCT03085121|extramedullary|extramedullary
1012336|NCT03085121|intramedullary|intramedullary
1012337|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
1012338|NCT03085069|PD-1|pd-1
1012339|NCT03085069|PD-L1|pd-l1
1012340|NCT03085069|shr-1210|shr-1210
1012341|NCT03085056|Trametinib|trametinib
1012342|NCT03085056|Paclitaxel|paclitaxel
1012343|NCT03085056|15-055|15-055
1012344|NCT03085043|Prostate Cancer|prostate cancer
1012345|NCT03085043|Whole body MRI|whole body mri
1012346|NCT03085043|MRI of the pelvis|mri of the pelvis
1012347|NCT03085043|Magnetic resonance imaging|magnetic resonance imaging
1012348|NCT03085043|Bone scan|bone scan
1012349|NCT03085043|Computed tomography scan of abdomen and pelvis|computed tomography scan of abdomen and pelvis
1012350|NCT03085043|CT|ct
1012351|NCT03085030|infertility|infertility
1012352|NCT03085030|IVF|ivf
1012353|NCT03085030|ICSI|icsi
1012354|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
1012355|NCT03085030|antioxidant|antioxidant
1012356|NCT03085004|Pancreatic cyst|pancreatic cyst
1012357|NCT03085004|Cyst Ablation|cyst ablation
1012358|NCT03085004|Eus-FNA (fine-needle aspiration )|eus-fna (fine-needle aspiration )
1012359|NCT03085004|Chemotherapy|chemotherapy
1012360|NCT03084952|safety|safety
1012361|NCT03084952|pharmacokynetics|pharmacokynetics
1012362|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
1012363|NCT03084913|dietary treatment|dietary treatment
1012364|NCT03084887|Tissue Expansion Devices|tissue expansion devices
1012365|NCT03084887|Tissue Expansion|tissue expansion
1012366|NCT03084887|common complications|common complications
1012367|NCT03084887|intervention study|intervention study
1012368|NCT03084874|COPD|copd
1012369|NCT03084874|Physical Activity|physical activity
1012370|NCT03084874|Sedentary behaviour|sedentary behaviour
1012371|NCT03084874|Hospitalization|hospitalization
1012372|NCT03084848|brain/cognitive measures|brain/cognitive measures
1012373|NCT03084848|condition|condition
1012374|NCT03084848|inhibitor control|inhibitor control
1012375|NCT03084848|training at adolescence|training at adolescence
1012376|NCT03084835|tobacco|tobacco
1012377|NCT03084835|smoking|smoking
1012378|NCT03084835|low dose computed tomography|low dose computed tomography
1012379|NCT03084835|lung screening|lung screening
1012380|NCT03084835|text messaging|text messaging
1012381|NCT03084783|dexamethasone|dexamethasone
1012382|NCT03084783|HSV encephalitis|hsv encephalitis
1012383|NCT03084770|NF-PNEN|nf-pnen
1012385|NCT03084731|Complementary Food|complementary food
1012386|NCT03084692|caregiver|caregiver
1012387|NCT03084692|lung cancer|lung cancer
1012388|NCT03084692|yoga|yoga
1012389|NCT03084692|resistance exercise|resistance exercise
1012390|NCT03084679|Heart Failure|heart failure
1012391|NCT03084679|Hypertrophy|hypertrophy
1012392|NCT03084679|Fibrosis|fibrosis
1012393|NCT03084679|Magnetic Resonance|magnetic resonance
1012394|NCT03084653|Trocar entery|trocar entery
1012395|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
1012396|NCT03084627|tailored dietary advice|tailored dietary advice
1012397|NCT03084627|nutrient adequacy|nutrient adequacy
1012398|NCT03084627|dietary modifications|dietary modifications
1012399|NCT03084614|Infectious Diseases|infectious diseases
1012400|NCT03084614|Dendritic Cells|dendritic cells
1012401|NCT03084614|Pathogens|pathogens
1012402|NCT03084614|Passive Cellular Immunity|passive cellular immunity
1012403|NCT03084614|Immune-Modulating|immune-modulating
1012404|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
1012405|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
1012406|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1012407|NCT03084497|Massage|massage
1012408|NCT03084497|Development|development
1012409|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
1012410|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
1012411|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
1012412|NCT03084458|Increasing daily physical activity|increasing daily physical activity
1012413|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
1012414|NCT03084445|Phthalates|phthalates
1012415|NCT03084445|pregnant women|pregnant women
1012416|NCT03084445|newborn|newborn
1012417|NCT03084445|Heavy Metals|heavy metals
1012418|NCT03084445|Volatile Organic Compounds|volatile organic compounds
1012419|NCT03084432|caffeine|caffeine
1012420|NCT03084432|bone mineral content|bone mineral content
1012421|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
1012422|NCT03084419|Interstitial Lung Disease|interstitial lung disease
1012423|NCT03084419|RA-ILD|ra-ild
1012432|NCT03084354|bladder care|bladder care
1012433|NCT03084354|pregnancy|pregnancy
1012434|NCT03084354|labour|labour
1012435|NCT03084354|postpartum|postpartum
1012436|NCT03084341|Elasticity|elasticity
1012437|NCT03084341|Electric Stimulation|electric stimulation
1012438|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
1012439|NCT03084315|smoking|smoking
1012440|NCT03084315|electronic cigarettes|electronic cigarettes
1012441|NCT03084315|nicotine|nicotine
1012442|NCT03084302|sedentary behavior|sedentary behavior
1012443|NCT03084302|physical activity|physical activity
1012444|NCT03084276|meal ingestion|meal ingestion
1012445|NCT03084276|meal composition|meal composition
1012446|NCT03084276|postprandial responses|postprandial responses
1012447|NCT03084276|hedonic sensations|hedonic sensations
1012448|NCT03084276|homeostatic sensations|homeostatic sensations
1012449|NCT03084276|new composition|new composition
1012450|NCT03084211|emergency department|emergency department
1012451|NCT03084211|concussion|concussion
1012452|NCT03084211|head injury|head injury
1012453|NCT03084198|Bioartificial Liver|bioartificial liver
1012454|NCT03084198|Acute Liver Failure|acute liver failure
1012455|NCT03084185|decompensation|decompensation
1012456|NCT03084185|deficit|deficit
1012457|NCT03084185|metabolomics|metabolomics
1012458|NCT03084185|portal hypertension|portal hypertension
1012459|NCT03084133|Therapeutic education strategy|therapeutic education strategy
1012460|NCT03084107|Elder care|elder care
1012461|NCT03084107|Active aging|active aging
1012462|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
1012463|NCT03084094|Fibromyalgia|fibromyalgia
1012464|NCT03084094|tDCS|tdcs
1012465|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1012466|NCT03084081|Cryotherapy|cryotherapy
1012467|NCT03084081|Thermoablation|thermoablation
1012468|NCT03084081|Thermocoagulation|thermocoagulation
1012469|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
1012470|NCT03084042|emotional impairments|emotional impairments
1012471|NCT03084042|cognitive impairments|cognitive impairments
1012472|NCT03084029|oxytocin|oxytocin
1012473|NCT03084029|fMRI|fmri
1012474|NCT03084029|empathy|empathy
1012475|NCT03083964|Middle aged women|middle aged women
1012476|NCT03083964|35-64yrs|35-64yrs
1012477|NCT03083964|BMI= >30|bmi= >30
1012478|NCT03083951|Complete mesocolon excision|complete mesocolon excision
1012479|NCT03083951|Sigmoid cancer|sigmoid cancer
1012480|NCT03083951|Colorectal cancer|colorectal cancer
1012481|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
1012482|NCT03083938|Omentum|omentum
1012483|NCT03083938|Wrapping|wrapping
1012484|NCT03083938|Roll-up|roll-up
1012485|NCT03083938|Whipple|whipple
1012486|NCT03083912|Malnutrition|malnutrition
1012487|NCT03083912|Disability|disability
1012488|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
1012489|NCT03083899|Diabetes|diabetes
1012490|NCT03083899|Organization|organization
1012491|NCT03083899|Out-patient control|out-patient control
1012500|NCT03083847|Malaria|malaria
1012501|NCT03083847|Parasitemia|parasitemia
1012502|NCT03083847|Immune|immune
1012503|NCT03083847|Responses|responses
1012504|NCT03083847|Sporozoites|sporozoites
1012505|NCT03083834|cosyntropin|cosyntropin
1012506|NCT03083834|salivary free cortisol|salivary free cortisol
1012507|NCT03083834|mitotane|mitotane
1012508|NCT03083808|PD-1|pd-1
1012509|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
1012510|NCT03083808|Pembrolizumab|pembrolizumab
1012511|NCT03083808|Docetaxel|docetaxel
1012512|NCT03083808|Pemetrexed|pemetrexed
1037866|NCT02926703|seizure|seizure
1012513|NCT03083808|Gemcitabine|gemcitabine
1012514|NCT03083795|Social relationships|social relationships
1012515|NCT03083795|Vulnerable connections|vulnerable connections
1012516|NCT03083795|Diabetes Distress|diabetes distress
1012517|NCT03083795|Support group|support group
1012518|NCT03083782|Apixaban|apixaban
1012519|NCT03083782|Cyclosporine|cyclosporine
1012520|NCT03083782|Tacrolimus|tacrolimus
1012521|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
1012522|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
1012523|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
1012524|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
1012525|NCT03083782|Anticoagulants|anticoagulants
1012526|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
1012528|NCT03083769|genetic variants|genetic variants
1012529|NCT03083769|side effects|side effects
1012530|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1012531|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1012532|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
1012533|NCT03083743|Lung Neoplasms|lung neoplasms
1012534|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
1012535|NCT03083743|Neoplasms|neoplasms
1012536|NCT03083743|Lung Diseases|lung diseases
1012537|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
1012538|NCT03083743|Antineoplastic Agents|antineoplastic agents
1012539|NCT03083743|Biological activity factor|biological activity factor
1012540|NCT03083743|Genetic Engineering|genetic engineering
1012541|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1012542|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
1012543|NCT03083730|Atopic Dermatitis|atopic dermatitis
1012544|NCT03083730|Eczema|eczema
1012545|NCT03083730|Systemic Inflammation|systemic inflammation
1012546|NCT03083730|UVB Phototherapy|uvb phototherapy
1012547|NCT03083691|Nivolumab|nivolumab
1012548|NCT03083691|Ipilimumab|ipilimumab
1012549|NCT03083678|EGFR|egfr
1012550|NCT03083678|Afatinib|afatinib
1012551|NCT03083665|Epilepsy|epilepsy
1012552|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
1012553|NCT03083665|Brivaracetam|brivaracetam
1012554|NCT03083665|Asian subjects|asian subjects
1012555|NCT03083652|physiotherapy|physiotherapy
1012556|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1012557|NCT03083652|exercise capacity|exercise capacity
1012558|NCT03083639|Drug Therapy|drug therapy
1012559|NCT03083626|Chronic pain|chronic pain
1012560|NCT03083626|Narcotic abuse|narcotic abuse
1012561|NCT03083626|Opioid related disorders|opioid related disorders
1012562|NCT03083626|Opiate substitution treatment|opiate substitution treatment
1012563|NCT03083626|Buprenorphine|buprenorphine
1012564|NCT03083626|Pregabalin|pregabalin
1012565|NCT03083626|Methadone|methadone
1012566|NCT03083613|Raltitrexed|raltitrexed
1012567|NCT03083613|Paclitaxel|paclitaxel
1012568|NCT03083613|chemotherapy|chemotherapy
1012569|NCT03083613|Gastric cancer|gastric cancer
1012570|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1012571|NCT03083600|protein hydrolysates|protein hydrolysates
1012572|NCT03083600|HbA1c|hba1c
1012573|NCT03083600|prediabetes|prediabetes
1012574|NCT03083574|Hematology|hematology
1012575|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
1012576|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
1012577|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1012578|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
1012579|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
1012580|NCT03083522|Korean medicine|korean medicine
1012581|NCT03083522|Ojeok-san|ojeok-san
1012582|NCT03083522|Cold intolerance|cold intolerance
1012583|NCT03083418|AECOPD|aecopd
1012584|NCT03083418|EDP|edp
1012585|NCT03083418|Neural Respiratory Drive|neural respiratory drive
1012586|NCT03083418|Surface EMGdi|surface emgdi
1012587|NCT03083392|DIVA|diva
1012588|NCT03083392|sinusitis|sinusitis
1012589|NCT03083392|maxillary|maxillary
1012590|NCT03083379|Incentive spirometry|incentive spirometry
1012591|NCT03083379|EzPAP|ezpap
1012592|NCT03083379|Electrical impedance tomography|electrical impedance tomography
1012593|NCT03083366|spinal cord injury|spinal cord injury
1012594|NCT03083366|Neurogenic|neurogenic
1012595|NCT03083366|bladder|bladder
1012596|NCT03083366|electrical stimulation|electrical stimulation
1012597|NCT03083366|neuromodulation|neuromodulation
1012598|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
1012599|NCT03083223|patient positioning|patient positioning
1012600|NCT03083223|lung diseases|lung diseases
1012601|NCT03083223|oxygenation|oxygenation
1012602|NCT03083223|hemodynamic parameters|hemodynamic parameters
1012603|NCT03083223|vital signs|vital signs
1012604|NCT03083197|Scrub Typhus|scrub typhus
1012605|NCT03083197|Antibiotic Resistance|antibiotic resistance
1012606|NCT03083184|Hemodialysis|hemodialysis
1663613|NCT00129597|NMDA|nmda
1012607|NCT03083184|hemodiafiltration|hemodiafiltration
1012608|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
1012609|NCT03083184|interdialytic lock solution|interdialytic lock solution
1012610|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
1012611|NCT03083171|Adrecizumab|adrecizumab
1012612|NCT03083171|Adrenomedullin|adrenomedullin
1012613|NCT03083171|Healthy volunteers|healthy volunteers
1012614|NCT03083171|LPS|lps
1012615|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
1012616|NCT03083132|freezing of gait|freezing of gait
1012617|NCT03083067|AECOPD|aecopd
1012618|NCT03083067|air pollution|air pollution
1012619|NCT03083067|COPD|copd
1012620|NCT03083067|salvational Intervention|salvational intervention
1012621|NCT03083041|SHR-1210|shr-1210
1012622|NCT03083041|Apatinib|apatinib
1012623|NCT03083041|NSCLC|nsclc
1012624|NCT03083028|Ankle Fracture|ankle fracture
1012728|NCT03082456|recall rate|recall rate
1012625|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
1012626|NCT03083015|revascularization|revascularization
1012627|NCT03082963|atrial fibrillation|atrial fibrillation
1012628|NCT03082963|ablation|ablation
1012629|NCT03082950|hpv prevalence|hpv prevalence
1012630|NCT03082950|recurrence rate|recurrence rate
1012631|NCT03082950|survival|survival
1012632|NCT03082924|surface EMGdi|surface emgdi
1012633|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
1012634|NCT03082924|inspiratory muscle training|inspiratory muscle training
1012635|NCT03082924|exercise training|exercise training
1012636|NCT03082911|screening|screening
1012637|NCT03082911|early detection|early detection
1012638|NCT03082911|participation|participation
1012639|NCT03082872|Reduction, Fracture|reduction, fracture
1012640|NCT03082859|Exercise|exercise
1012641|NCT03082859|Interval Training|interval training
1012642|NCT03082859|Glycaemic Control|glycaemic control
1012643|NCT03082859|Type 2 Diabetes|type 2 diabetes
1012644|NCT03082846|malignant glioma|malignant glioma
1012645|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
1012646|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
1012647|NCT03082846|hypofractionation|hypofractionation
1012648|NCT03082846|temozolomide|temozolomide
1012649|NCT03082846|maximum tolerated dose|maximum tolerated dose
1012650|NCT03082807|Caloric Restriction|caloric restriction
1012651|NCT03082807|Diet|diet
1012652|NCT03082807|Exercise|exercise
1012653|NCT03082807|Obesity|obesity
1012654|NCT03082807|Overweight|overweight
1012655|NCT03082807|Sedentary lifestyle|sedentary lifestyle
1012656|NCT03082807|weight loss|weight loss
1012657|NCT03082807|Men|men
1012658|NCT03082794|Dietary Formulations|dietary formulations
1012659|NCT03082794|Lifestyle|lifestyle
1012660|NCT03082794|Obesity|obesity
1012661|NCT03082794|Overweight|overweight
1012662|NCT03082794|weight loss|weight loss
1012663|NCT03082781|Diet|diet
1012664|NCT03082781|Exercise|exercise
1012665|NCT03082781|Obesity|obesity
1012666|NCT03082781|Overweight|overweight
1012667|NCT03082781|Weight loss|weight loss
1012668|NCT03082768|HV|hv
1012669|NCT03082742|diuretics|diuretics
1012670|NCT03082742|furosemide|furosemide
1012671|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
1012672|NCT03082742|CKD-MBD|ckd-mbd
1012673|NCT03082742|HRpQCT|hrpqct
1012674|NCT03082742|parathyroid hormone|parathyroid hormone
1012675|NCT03082716|cardioplegia|cardioplegia
1012676|NCT03082716|myocardial protection|myocardial protection
1012677|NCT03082716|custodiol|custodiol
1012678|NCT03082716|htk|htk
1012679|NCT03082677|Ixazomib|ixazomib
1012680|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
1012681|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1012682|NCT03082677|16-076|16-076
1012683|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
1012684|NCT03082612|Behavioral research|behavioral research
1012685|NCT03082612|Social research|social research
1012686|NCT03082612|Spirituality|spirituality
1012687|NCT03082612|Late stage cancer|late stage cancer
1012688|NCT03082547|Headache|headache
1012689|NCT03082547|Neuropsychological tests|neuropsychological tests
1012690|NCT03082547|Myofascial trigger points|myofascial trigger points
1012691|NCT03082547|electrophysiology|electrophysiology
1012692|NCT03082534|Head and Neck Cancer|head and neck cancer
1012693|NCT03082534|Pembrolizumab|pembrolizumab
1012694|NCT03082534|Keytruda®|keytruda®
1012695|NCT03082534|Cetuximab|cetuximab
1012696|NCT03082534|Erbitux®|erbitux®
1012697|NCT03082534|Recurrent|recurrent
1012698|NCT03082534|Metastatic|metastatic
1012701|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
1012702|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
1012703|NCT03082508|Algisyl|algisyl
1012704|NCT03082508|Heart Failure|heart failure
1012705|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
1012706|NCT03082508|Alginate Hydrogel|alginate hydrogel
1012707|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
1012708|NCT03082508|Congestive Heart Failure|congestive heart failure
1012709|NCT03082495|Exercise|exercise
1012710|NCT03082495|Cancer|cancer
1012711|NCT03082495|Symptom management|symptom management
1012712|NCT03082495|Quality of life|quality of life
1012713|NCT03082495|presurgical|presurgical
1012714|NCT03082495|chemoradiotherapy|chemoradiotherapy
1012715|NCT03082495|Physical Fitness|physical fitness
1012716|NCT03082482|Smoking Cessation|smoking cessation
1012717|NCT03082482|HIV|hiv
1012718|NCT03082482|AIDS|aids
1012719|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
1012720|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
1012721|NCT03082469|Cytokine removal|cytokine removal
1012722|NCT03082469|Vasopressor dependency index|vasopressor dependency index
1012723|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
1012724|NCT03082456|MBI|mbi
1012725|NCT03082456|breast cancer|breast cancer
1012726|NCT03082456|mammography|mammography
1012729|NCT03082456|diagnostic accuracy|diagnostic accuracy
1012730|NCT03082456|breast echo|breast echo
1012731|NCT03082456|female population|female population
1012732|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
1012733|NCT03082443|psychology|psychology
1012734|NCT03082443|nutrition|nutrition
1012735|NCT03082443|stress|stress
1012736|NCT03082443|quality of life|quality of life
1012737|NCT03082417|Bone Fracture|bone fracture
1012738|NCT03082417|75 years old|75 years old
1012739|NCT03082417|Elderly|elderly
1012740|NCT03082417|Older adults|older adults
1012741|NCT03082417|Pain scale|pain scale
1012742|NCT03082417|Pain documentation|pain documentation
1012743|NCT03082417|Analgesics|analgesics
1012744|NCT03082417|Acetaminophen|acetaminophen
1012745|NCT03082417|Opioid|opioid
1012746|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
1012747|NCT03082417|Emergency Department|emergency department
1012748|NCT03082404|Chronic kidney disease|chronic kidney disease
1012749|NCT03082404|Inspiratory muscle training|inspiratory muscle training
1012750|NCT03082391|Ventral Hernia Repair|ventral hernia repair
1012751|NCT03082391|Heavyweight Mesh|heavyweight mesh
1012752|NCT03082391|Mediumweight Mesh|mediumweight mesh
1012753|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
1012754|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
1012755|NCT03082326|shock|shock
1012756|NCT03082326|critical care ultrasound|critical care ultrasound
1012757|NCT03082326|hemodynamics|hemodynamics
1012758|NCT03082326|lung pathology|lung pathology
1012759|NCT03082326|epidemic|epidemic
1012760|NCT03082326|prognosis|prognosis
1012761|NCT03082313|infant|infant
1012762|NCT03082313|leg movement|leg movement
1012763|NCT03082313|wearable sensors|wearable sensors
1012764|NCT03082313|early intervention|early intervention
1012765|NCT03082300|ASP8273|asp8273
1012766|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
1012767|NCT03082300|naquotinib|naquotinib
1012768|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1012769|NCT03082300|Bioequivalence|bioequivalence
1012770|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
1012771|NCT03082261|Radiculopathy|radiculopathy
1012772|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
1012773|NCT03082248|Low Back Pain|low back pain
1012774|NCT03082248|Surgery|surgery
1012775|NCT03082248|Lumbar Spine|lumbar spine
1012776|NCT03082248|Physical Therapy Modalities|physical therapy modalities
1012777|NCT03082248|Rehabilitation|rehabilitation
1012778|NCT03082235|Healthy participants|healthy participants
1012779|NCT03082235|E6742|e6742
1012780|NCT03082235|pharmacokinetics|pharmacokinetics
1012781|NCT03082222|partial onset seizures with or without secondary generalization|partial onset seizures with or without secondary generalization
1012782|NCT03082209|Solid Tumors|solid tumors
1012783|NCT03082209|Hematologic Malignancies|hematologic malignancies
1012784|NCT03082209|Cancer|cancer
1012785|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
1012786|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1012787|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
1012788|NCT03082209|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1012789|NCT03082196|sodium fluoride|sodium fluoride
1012790|NCT03082196|povidone iodine|povidone iodine
1012791|NCT03082196|varnish|varnish
1012792|NCT03082170|sleep apnea|sleep apnea
1012793|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
1012794|NCT03082170|soft palate surgery|soft palate surgery
1012795|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
1012796|NCT03082170|dysphagia|dysphagia
1012797|NCT03082131|Gut Microbiota|gut microbiota
1012798|NCT03082131|Glycemic Response|glycemic response
1012799|NCT03082131|Resistant Starch|resistant starch
1012800|NCT03082131|Fiber|fiber
1012801|NCT03082092|Knee|knee
1012802|NCT03082092|Pain|pain
1012803|NCT03082092|Recovery|recovery
1012804|NCT03082092|Steroid|steroid
1012805|NCT03082092|Replacement|replacement
1012806|NCT03082092|Arthroplasty|arthroplasty
1012807|NCT03082079|GIST|gist
1012808|NCT03082079|ESD|esd
1012809|NCT03082066|bone access|bone access
1012810|NCT03082066|intraosseus needle|intraosseus needle
1012811|NCT03082066|resuscitation|resuscitation
1012812|NCT03082066|infusion|infusion
1012813|NCT03082066|volume therapy|volume therapy
1012814|NCT03082066|emergency|emergency
1012815|NCT03082027|ultrasonography|ultrasonography
1012816|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
1012817|NCT03082014|Hypertension|hypertension
1012818|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
1012819|NCT03082014|Blood Pressure Variability|blood pressure variability
1012820|NCT03082001|Neonate|neonate
1012821|NCT03082001|Pain|pain
1012822|NCT03082001|ELBW|elbw
1012823|NCT03081988|Esophageal Cancer|esophageal cancer
1012824|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
1012825|NCT03081988|molecular factors|molecular factors
1012826|NCT03081975|adenoma detection rate|adenoma detection rate
1012827|NCT03081975|narrow band imaging|narrow band imaging
1013025|NCT03080584|IVF|ivf
1012828|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
1012829|NCT03081949|Ventricular remodelling|ventricular remodelling
1012830|NCT03081949|Survival|survival
1012831|NCT03081949|Selenium|selenium
1012832|NCT03081949|Oxidative stress|oxidative stress
1012833|NCT03081949|Nigeria|nigeria
1012834|NCT03081923|Immunotherapy|immunotherapy
1012835|NCT03081923|Durvalumab|durvalumab
1012836|NCT03081923|Tremelimumab|tremelimumab
1012837|NCT03081923|Combination therapy|combination therapy
1012838|NCT03081923|Testicular cancer|testicular cancer
1012839|NCT03081910|Autologous CAR T cells|autologous car t cells
1012840|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
1012841|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
1012842|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
1012843|NCT03081884|Prostate cancer|prostate cancer
1012844|NCT03081884|Metastatic cancer|metastatic cancer
1012845|NCT03081884|Urogenital disorders|urogenital disorders
1012846|NCT03081884|Oncology|oncology
1012847|NCT03081884|Radiology|radiology
1012848|NCT03081858|NMIBC|nmibc
1012849|NCT03081858|Paclitaxel|paclitaxel
1012850|NCT03081858|Antineoplastic Agents|antineoplastic agents
1012851|NCT03081832|Prader-Willi|prader-willi
1012852|NCT03081832|Oxytocin|oxytocin
1012853|NCT03081832|Communication skills|communication skills
1012854|NCT03081832|Oral skills|oral skills
1012855|NCT03081832|Brain activity|brain activity
1012856|NCT03081832|Hormonal disease|hormonal disease
1012857|NCT03081806|Phase 3|phase 3
1012858|NCT03081806|Efficacy|efficacy
1012859|NCT03081806|Safety|safety
1012860|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
1012861|NCT03081793|postoperative monitoring|postoperative monitoring
1012862|NCT03081793|plethysmography|plethysmography
1012863|NCT03081793|monitoring|monitoring
1012865|NCT03081767|PET/CT|pet/ct
1012866|NCT03081767|digital PET/CT|digital pet/ct
1012867|NCT03081715|esophageal cancer|esophageal cancer
1012868|NCT03081715|immune checkpoint|immune checkpoint
1012869|NCT03081715|PD-1|pd-1
1012870|NCT03081715|CRISPER|crisper
1012871|NCT03081715|autologous cell infusion|autologous cell infusion
1012872|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
1012873|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
1012874|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
1012875|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
1012876|NCT03081676|Glimepiride|glimepiride
1012877|NCT03081676|Sulphonylurea|sulphonylurea
1012878|NCT03081676|Glucose clamp|glucose clamp
1012879|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
1012880|NCT03081663|total knee arthroplasty|total knee arthroplasty
1012881|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
1012882|NCT03081663|medial para-patellar|medial para-patellar
1012883|NCT03081624|preterm|preterm
1012884|NCT03081624|neurological status|neurological status
1012885|NCT03081624|School Readiness|school readiness
1012886|NCT03081585|fmri|fmri
1012887|NCT03081585|neuronal reward processing|neuronal reward processing
1012888|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
1012889|NCT03081585|fasting|fasting
1012890|NCT03081559|transgender|transgender
1012891|NCT03081559|women|women
1012892|NCT03081533|Circular dance|circular dance
1012893|NCT03081533|Older caregiver|older caregiver
1012894|NCT03081533|Dance Therapy|dance therapy
1012895|NCT03081507|Muslim Americans|muslim americans
1012896|NCT03081507|Patient Navigation|patient navigation
1012897|NCT03081507|Breast Cancer|breast cancer
1012898|NCT03081507|Cervical Cancer|cervical cancer
1012899|NCT03081494|PDR001|pdr001
1012900|NCT03081494|immunotherapy|immunotherapy
1012901|NCT03081494|regorafenib|regorafenib
1012902|NCT03081494|CRC|crc
1012905|NCT03081494|ElevatION:CRC-102|elevation:crc-102
1012906|NCT03081481|Intraprostatic|intraprostatic
1012907|NCT03081481|MRI lesion|mri lesion
1012908|NCT03081481|Prostate biopsies|prostate biopsies
1012909|NCT03081468|Optical coherence tomography|optical coherence tomography
1012910|NCT03081468|Pupillometry|pupillometry
1012911|NCT03081468|Automated|automated
1012912|NCT03081468|Binocular|binocular
1012913|NCT03081455|Screening|screening
1012914|NCT03081455|Hereditary Cancer|hereditary cancer
1012915|NCT03081403|Sensitive skin|sensitive skin
1012916|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
1012917|NCT03081364|Cardiac Implanted Device|cardiac implanted device
1012918|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
1012919|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
1012920|NCT03081325|uRM|urm
1012921|NCT03081325|RIF|rif
1012922|NCT03081325|Th1|th1
1012923|NCT03081325|Th2|th2
1012924|NCT03081325|Treg|treg
1012925|NCT03081325|lymphocyte immunotherapy|lymphocyte immunotherapy
1012926|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
1012927|NCT03081312|Needs|needs
1012928|NCT03081312|Burden of Care|burden of care
1012931|NCT03081273|Biofilm formation|biofilm formation
1012932|NCT03081273|Bone and joint infection|bone and joint infection
1012933|NCT03081273|Corynebacterium spp|corynebacterium spp
1012935|NCT03081273|Outcome|outcome
1012936|NCT03081273|Prosthetic joint infection|prosthetic joint infection
1012937|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
1012938|NCT03081260|Patella|patella
1012939|NCT03081260|Resurfacing|resurfacing
1012940|NCT03081260|IKS score|iks score
1012941|NCT03081234|Hormone receptor-positive|hormone receptor-positive
1012942|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
1012943|NCT03081234|HER2-negative|her2-negative
1012944|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
1012945|NCT03081234|Adjuvant|adjuvant
1012946|NCT03081234|Ribociclib|ribociclib
1012947|NCT03081234|LEE011|lee011
1012948|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
1012949|NCT03081234|Endocrine therapy|endocrine therapy
1012950|NCT03081234|Phase III|phase iii
1012951|NCT03081234|breast carcinoma|breast carcinoma
1012952|NCT03081234|breast cancer|breast cancer
1012953|NCT03081208|IVF|ivf
1012954|NCT03081208|ICSI|icsi
1012955|NCT03081195|child behavior|child behavior
1012956|NCT03081195|intervention|intervention
1012957|NCT03081195|multiple family group|multiple family group
1012958|NCT03081195|Sub Saharan Africa|sub saharan africa
1012959|NCT03081195|caregivers|caregivers
1012960|NCT03081182|Pediatric Chronic Pancreatitis|pediatric chronic pancreatitis
1012961|NCT03081182|Data management|data management
1012962|NCT03081182|Regulatory compliance|regulatory compliance
1012963|NCT03081182|Protocol monitoring|protocol monitoring
1012964|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1012965|NCT03081156|exercise intolerance|exercise intolerance
1012966|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
1012967|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
1012968|NCT03081117|Intranasal|intranasal
1012969|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
1012970|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
1012971|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
1012972|NCT03081039|gemcitabine|gemcitabine
1012973|NCT03081039|carboplatin|carboplatin
1012974|NCT03081039|cisplatin|cisplatin
1012975|NCT03081026|surgery|surgery
1012976|NCT03081026|ages 6-16|ages 6-16
1012977|NCT03081013|adolescents|adolescents
1012978|NCT03081013|social norms|social norms
1012979|NCT03080974|irreversible electroporation|irreversible electroporation
1012980|NCT03080974|Nivolumab|nivolumab
1012981|NCT03080961|Barrier cream|barrier cream
1012982|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
1012983|NCT03080922|Relapsed|relapsed
1012984|NCT03080922|Refractory|refractory
1012985|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
1012986|NCT03080909|Satiety|satiety
1012987|NCT03080909|Nutrient|nutrient
1012988|NCT03080909|Appetite|appetite
1012989|NCT03080909|Encapsulation|encapsulation
1012990|NCT03080909|Lipid|lipid
1012991|NCT03080909|Amino acid|amino acid
1012992|NCT03080909|Probiotic bacteria|probiotic bacteria
1012993|NCT03080870|Art intervention|art intervention
1012994|NCT03080870|Quality of Life|quality of life
1012995|NCT03080870|Well-being|well-being
1012996|NCT03080870|Physical performance|physical performance
1012997|NCT03080870|Family caregivers|family caregivers
1012998|NCT03080870|Older adults|older adults
1012999|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
1013000|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
1013001|NCT03080792|stem cell transplantation|stem cell transplantation
1013002|NCT03080792|exercise|exercise
1013003|NCT03080792|high intensity interval training|high intensity interval training
1013004|NCT03080792|resistance training|resistance training
1013005|NCT03080792|physical fitness|physical fitness
1013008|NCT03080753|Intersphincteric implants|intersphincteric implants
1013009|NCT03080753|Gatekeeper|gatekeeper
1013013|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
1013014|NCT03080675|Aging population|aging population
1013015|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
1013016|NCT03080636|Post-exercise hypotension|post-exercise hypotension
1013017|NCT03080636|Aerobic Exercise|aerobic exercise
1013018|NCT03080636|Resistance Exercise|resistance exercise
1013019|NCT03080636|Autonomic Stress|autonomic stress
1013020|NCT03080636|Heart Rate Variability|heart rate variability
1013021|NCT03080636|Sex difference|sex difference
1013022|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
1013023|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
1013024|NCT03080584|acupuncture|acupuncture
1013029|NCT03080558|Rectal vascularisation|rectal vascularisation
1013030|NCT03080558|Vaginal vascularisation|vaginal vascularisation
1013031|NCT03080558|Laparoscopic surgery|laparoscopic surgery
1013032|NCT03080558|Rectal shaving|rectal shaving
1013033|NCT03080558|Recto vaginal node|recto vaginal node
1013034|NCT03080558|Deep Endometriosis|deep endometriosis
1013035|NCT03080532|Microbiome|microbiome
1013036|NCT03080532|Mediterranean diet|mediterranean diet
1013037|NCT03080519|renal artery stenosis|renal artery stenosis
1013038|NCT03080519|balloon angioplasty|balloon angioplasty
1013039|NCT03080519|stents|stents
1013044|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
1013045|NCT03080480|Severe Infection|severe infection
1013046|NCT03080480|PPARγ|pparγ
1013047|NCT03080480|Pioglitazone|pioglitazone
1013048|NCT03080480|phagocytes|phagocytes
1013049|NCT03080467|Trauma|trauma
1013050|NCT03080467|Laceration|laceration
1013051|NCT03080467|Suture|suture
1013052|NCT03080467|Cosmesis|cosmesis
1013053|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
1013054|NCT03080467|Tissue adhesive|tissue adhesive
1013055|NCT03080467|Lip lacerations|lip lacerations
1013056|NCT03080467|Skalp lacerations|skalp lacerations
1013057|NCT03080467|Facial injuries|facial injuries
1013058|NCT03080454|stroke|stroke
1013060|NCT03080454|Spasticity|spasticity
1013061|NCT03080454|hemiparesis|hemiparesis
1013062|NCT03080454|rehabilitation|rehabilitation
1013063|NCT03080454|tsDCS|tsdcs
1013064|NCT03080454|non-invasive stimulation|non-invasive stimulation
1013065|NCT03080428|Breast cancer|breast cancer
1013066|NCT03080428|ER-positive|er-positive
1013067|NCT03080428|Her-2 negative|her-2 negative
1013068|NCT03080428|genomic test|genomic test
1013069|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
1013070|NCT03080402|ACL injury|acl injury
1013071|NCT03080402|Injury prevention|injury prevention
1013072|NCT03080402|Perturbation training|perturbation training
1013073|NCT03080402|Risk factors|risk factors
1013074|NCT03080389|overactive bladder|overactive bladder
1013075|NCT03080389|overactive detrusor|overactive detrusor
1013076|NCT03080389|urgency-frequency|urgency-frequency
1013077|NCT03080389|urinary tract infection|urinary tract infection
1013078|NCT03080376|Exercise|exercise
1013079|NCT03080376|Web-based intervention|web-based intervention
1013080|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
1013081|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
1013082|NCT03080363|bupivacaine|bupivacaine
1013083|NCT03080363|lidocaine|lidocaine
1013084|NCT03080350|Fentanyl|fentanyl
1013085|NCT03080350|Transmucosal administration|transmucosal administration
1013086|NCT03080350|Endovenous administration|endovenous administration
1013087|NCT03080350|Pain therapy|pain therapy
1013088|NCT03080350|Mountain emergency medicine|mountain emergency medicine
1013089|NCT03080324|Fentanyl|fentanyl
1013090|NCT03080324|Transmucosal administration|transmucosal administration
1013091|NCT03080324|Endovenous administration|endovenous administration
1013092|NCT03080324|Pain therapy|pain therapy
1013093|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
1013094|NCT03080272|individual patient|individual patient
1013095|NCT03080259|ADHD|adhd
1013096|NCT03080259|Stimulant Misuse|stimulant misuse
1013097|NCT03080259|Stimulant Diversion|stimulant diversion
1013098|NCT03080233|stroke|stroke
1013099|NCT03080233|Validation|validation
1013100|NCT03080233|Clinical decision support tool|clinical decision support tool
1013101|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
1013102|NCT03080207|Physiotherapy|physiotherapy
1013103|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
1013104|NCT03080207|Low Level Laser|low level laser
1013105|NCT03080207|Platelet rich plasma|platelet rich plasma
1013106|NCT03080194|schizophrenia|schizophrenia
1013107|NCT03080194|violence risk|violence risk
1013108|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
1013109|NCT03080194|community-based|community-based
1013110|NCT03080168|suicidal ideation|suicidal ideation
1013111|NCT03080168|suicidal behavior|suicidal behavior
1013112|NCT03080168|Veterans|veterans
1038688|NCT02922153|VAS|vas
1013113|NCT03080168|inpatients|inpatients
1013114|NCT03080168|Actigraphy|actigraphy
1013115|NCT03080168|implicit associations|implicit associations
1013116|NCT03080168|risk factors|risk factors
1013117|NCT03080129|Liver cirrhosis|liver cirrhosis
1013118|NCT03080129|Sarcopenia|sarcopenia
1013119|NCT03080129|Microbiome|microbiome
1013120|NCT03080116|Randomized|randomized
1013121|NCT03080116|Placebo-controlled|placebo-controlled
1013122|NCT03080116|Neoadjuvant|neoadjuvant
1013123|NCT03080116|Androgen deprivation|androgen deprivation
1013124|NCT03080116|Antiandrogen|antiandrogen
1013125|NCT03080116|Radical Prostatectomy|radical prostatectomy
1013126|NCT03080103|Acute Appendicitis|acute appendicitis
1013530|NCT03077945|women|women
1013127|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
1013128|NCT03080103|Appendectomy|appendectomy
1013129|NCT03080103|Conservative Treatment|conservative treatment
1013130|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
1013131|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
1013132|NCT03080103|Prospective Study|prospective study
1013133|NCT03080051|PSP|psp
1013134|NCT03080051|AD|ad
1013135|NCT03080051|HV|hv
1013136|NCT03080038|Sepsis|sepsis
1013137|NCT03080038|Shock|shock
1013138|NCT03080038|Septic Shock|septic shock
1013139|NCT03080038|Fluid Therapy|fluid therapy
1013140|NCT03080038|Resuscitation|resuscitation
1013141|NCT03080038|Pediatrics|pediatrics
1013142|NCT03080038|Emergency Medicine|emergency medicine
1013143|NCT03080038|Critical Care|critical care
1013144|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
1013145|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
1013146|NCT03080025|Real Time Social Interaction|real time social interaction
1013147|NCT03080025|Eye-Tracking|eye-tracking
1013148|NCT03080025|Heart Rate Variability|heart rate variability
1013149|NCT03080025|IL-6|il-6
1013150|NCT03080025|IL-1b|il-1b
1013151|NCT03080025|Cortisol|cortisol
1013152|NCT03080025|Alpha-Amylase|alpha-amylase
1013153|NCT03080025|Randomised Controlled Trial|randomised controlled trial
1013154|NCT03080025|Compassion|compassion
1013155|NCT03080025|Empathy|empathy
1013156|NCT03080025|Relationship Quality|relationship quality
1013157|NCT03080025|Interpersonal Relations|interpersonal relations
1013158|NCT03080025|Stress|stress
1013159|NCT03079986|Pancreatic surgery|pancreatic surgery
1013160|NCT03079986|Chylous ascites|chylous ascites
1013161|NCT03079973|Calcipotriene|calcipotriene
1013162|NCT03079960|Parkinson|parkinson
1013163|NCT03079960|DBS|dbs
1013164|NCT03079960|Deep Brain Stimulation|deep brain stimulation
1013165|NCT03079960|LFP|lfp
1013166|NCT03079960|Local Field Potentials|local field potentials
1013167|NCT03079960|EEG|eeg
1013168|NCT03079960|Electroencephalogram|electroencephalogram
1013169|NCT03079947|Circulating DNA|circulating dna
1013170|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1013171|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1013172|NCT03079947|prognosis|prognosis
1013173|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
1013174|NCT03079934|Optical coherence tomography|optical coherence tomography
1013175|NCT03079934|strut coverage|strut coverage
1013176|NCT03079934|acute coronary syndrome|acute coronary syndrome
1013177|NCT03079921|Islet Graft Function|islet graft function
1013178|NCT03079921|Islet Cell transplantation|islet cell transplantation
1013179|NCT03079921|Auto-islet transplantation|auto-islet transplantation
1013180|NCT03079921|Intra-hepatic islets|intra-hepatic islets
1013181|NCT03079921|Extra-hepatic islets|extra-hepatic islets
1013182|NCT03079908|Laparoscopy|laparoscopy
1013183|NCT03079908|Surgery|surgery
1013184|NCT03079908|Training|training
1013185|NCT03079908|Virtual reality|virtual reality
1013186|NCT03079908|Simulation|simulation
1013187|NCT03079908|Robotic Surgery|robotic surgery
1013188|NCT03079908|Da Vinci|da vinci
1013189|NCT03079895|Depression|depression
1013190|NCT03079895|internet|internet
1013191|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
1013192|NCT03079895|CBT|cbt
1013193|NCT03079895|computer|computer
1013194|NCT03079895|Primary Care|primary care
1013195|NCT03079895|Psychiatry|psychiatry
1013196|NCT03079895|treatment|treatment
1013197|NCT03079895|self-help|self-help
1013198|NCT03079895|managed care|managed care
1013199|NCT03079882|Ultrasound|ultrasound
1013200|NCT03079882|Viscoelasticity|viscoelasticity
1013201|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
1013202|NCT03079856|Emerging adults|emerging adults
1013203|NCT03079856|Drugs|drugs
1013204|NCT03079856|HIV|hiv
1013205|NCT03079856|Risky Sex Behaviors|risky sex behaviors
1013206|NCT03079830|aortic valve surgery|aortic valve surgery
1013207|NCT03079830|postoperative pain|postoperative pain
1013208|NCT03079791|OCT|oct
1013209|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
1013210|NCT03079791|CAV|cav
1013211|NCT03079791|intravascular imaging|intravascular imaging
1013212|NCT03079765|Telehealth|telehealth
1013213|NCT03079765|Functional behavior assessment|functional behavior assessment
1013214|NCT03079713|pain|pain
1013215|NCT03079713|anesthesia|anesthesia
1013216|NCT03079713|vibrator|vibrator
1013217|NCT03079713|intravitreal|intravitreal
1013218|NCT03079713|injection|injection
1013219|NCT03079687|Ovarian cancer|ovarian cancer
1013220|NCT03079687|gynaecological cancer|gynaecological cancer
1013221|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
1013222|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
1013223|NCT03079687|Olaparib|olaparib
1013224|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
1013225|NCT03079687|Neoplasms|neoplasms
1013226|NCT03079687|Ovarian Disease|ovarian disease
1013227|NCT03079687|fallopean tube cancer|fallopean tube cancer
1013228|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
1013531|NCT03077945|female|female
1013229|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
1013230|NCT03079687|PARP inhibitors|parp inhibitors
1013231|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
1013232|NCT03079674|transient Ischemic Attack|transient ischemic attack
1013233|NCT03079674|minor Stroke|minor stroke
1013234|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
1013235|NCT03079674|biomarker|biomarker
1013236|NCT03079674|epidemiology|epidemiology
1013237|NCT03079674|prognosis|prognosis
1013238|NCT03079661|pollution|pollution
1013239|NCT03079661|ozone|ozone
1013240|NCT03079661|Copd|copd
1013241|NCT03079661|particles|particles
1013242|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
1013243|NCT03079648|Hyperlipidemia|hyperlipidemia
1013244|NCT03079648|Clinical Trial|clinical trial
1013245|NCT03079596|gastric cancer|gastric cancer
1013246|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
1013247|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
1013248|NCT03079557|Adolescent|adolescent
1013249|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
1013250|NCT03079557|Endoscopy|endoscopy
1013251|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
1013252|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
1013253|NCT03079518|iron deficiency|iron deficiency
1013254|NCT03079518|HFREF|hfref
1013255|NCT03079518|FGF23|fgf23
1013256|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
1013257|NCT03079479|Arthoplasty|arthoplasty
1013258|NCT03079479|Gait|gait
1013259|NCT03079479|muscle strenght|muscle strenght
1013260|NCT03079479|Quality of life|quality of life
1013261|NCT03079466|Sleep apnea|sleep apnea
1013262|NCT03079466|Elderly|elderly
1013263|NCT03079466|CPAP|cpap
1013264|NCT03079453|Dexamethasone|dexamethasone
1013265|NCT03079453|Tonsillectomy|tonsillectomy
1013266|NCT03079453|Uvula|uvula
1013267|NCT03079453|Edema|edema
1013268|NCT03079453|Uvula edema|uvula edema
1013269|NCT03079453|Post-tonsillectomy|post-tonsillectomy
1013270|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
1013271|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
1013272|NCT03079440|Capecitabine|capecitabine
1013273|NCT03079440|Temozolomide|temozolomide
1013274|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
1013275|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
1013276|NCT03079414|Sudden Cardiac Death|sudden cardiac death
1013277|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
1013278|NCT03079414|Electrophysiology Study|electrophysiology study
1013279|NCT03079414|Genetics|genetics
1013280|NCT03079401|biventricular conversion|biventricular conversion
1013281|NCT03079375|cross sectional|cross sectional
1013282|NCT03079375|medication review|medication review
1013283|NCT03079375|readmissions|readmissions
1013284|NCT03079375|follow-up|follow-up
1013285|NCT03079336|Randomized controlled design development|randomized controlled design development
1013286|NCT03079336|Translational Research|translational research
1013287|NCT03079336|Psychological Interventions|psychological interventions
1013288|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
1013289|NCT03079323|External beam radiotherapy|external beam radiotherapy
1013290|NCT03079323|Prostate cancer|prostate cancer
1013291|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
1013292|NCT03079323|PART|part
1013293|NCT03079310|spinal cord stimulation|spinal cord stimulation
1013294|NCT03079310|gait analysis|gait analysis
1013295|NCT03079310|whole-body kinematics|whole-body kinematics
1013296|NCT03079310|Parkinson's disease|parkinson's disease
1013297|NCT03079310|Neuromodulation|neuromodulation
1013298|NCT03079310|Feature extraction|feature extraction
1013299|NCT03079297|Antidepressant|antidepressant
1013300|NCT03079297|Inflammation|inflammation
1013301|NCT03079297|Biomarker|biomarker
1013302|NCT03079297|Depression|depression
1013303|NCT03079297|Treatment Resistant Depression|treatment resistant depression
1013304|NCT03079297|Leucine|leucine
1013305|NCT03079258|vascular structure|vascular structure
1013306|NCT03079258|vascular function|vascular function
1013307|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
1013308|NCT03079258|physical activity|physical activity
1663614|NCT00129597|mastectomy|mastectomy
1013309|NCT03079258|sedentary behaviour|sedentary behaviour
1013310|NCT03079258|offspring health|offspring health
1013311|NCT03079258|maternal health|maternal health
1013312|NCT03079245|Neonatal ICU|neonatal icu
1013313|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
1013314|NCT03079232|Optical biopsy|optical biopsy
1013315|NCT03079232|Skin cancer|skin cancer
1013643|NCT03077464|Fruit|fruit
1013316|NCT03079232|Diagnostic performance|diagnostic performance
1013317|NCT03079206|hazelnut|hazelnut
1013318|NCT03079206|allergens|allergens
1013319|NCT03079206|basophile-activation-test|basophile-activation-test
1013320|NCT03079206|food|food
1013321|NCT03079206|allergy|allergy
1013322|NCT03079193|post thyroidectomy|post thyroidectomy
1013323|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
1013324|NCT03079180|Tendon|tendon
1013325|NCT03079180|Ageing|ageing
1013326|NCT03079180|Training|training
1013327|NCT03079180|Achilles tendon|achilles tendon
1013328|NCT03079180|Patella tendon|patella tendon
1013329|NCT03079180|Skeletal muscle|skeletal muscle
1013330|NCT03079180|Adaptation|adaptation
1013331|NCT03079180|Triceps Surae|triceps surae
1013332|NCT03079180|Quadriceps|quadriceps
1013333|NCT03079115|Atorvastatin|atorvastatin
1013334|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
1013335|NCT03079089|Sequential chemotherapy|sequential chemotherapy
1013336|NCT03079089|Haploidentical transplant|haploidentical transplant
1013337|NCT03079076|Postoperative Analgesia|postoperative analgesia
1013338|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
1013339|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
1013340|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1013341|NCT03078998|Cerebral Palsy|cerebral palsy
1013342|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
1013343|NCT03078998|Human Computer Interaction|human computer interaction
1013344|NCT03078998|Leap Motion|leap motion
1013345|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
1013346|NCT03078985|real-time MRI|real-time mri
1013347|NCT03078985|electrophysiology study|electrophysiology study
1013348|NCT03078985|atrial flutter ablation|atrial flutter ablation
1013349|NCT03078985|active tracking|active tracking
1013350|NCT03078946|Cardiac surgery|cardiac surgery
1013351|NCT03078946|delirium|delirium
1013352|NCT03078946|dexmedetomidine|dexmedetomidine
1013353|NCT03078946|morphine|morphine
1013354|NCT03078946|midazolam|midazolam
1013355|NCT03078933|DFU|dfu
1013356|NCT03078907|daily life|daily life
1013357|NCT03078907|physical activity|physical activity
1013358|NCT03078907|actigraphy|actigraphy
1013359|NCT03078907|PAH-SYMPACT|pah-sympact
1013360|NCT03078894|Zika|zika
1013361|NCT03078894|Dengue|dengue
1013362|NCT03078894|Chikagunya|chikagunya
1013363|NCT03078894|Peru|peru
1013364|NCT03078829|gender identity|gender identity
1013365|NCT03078829|trans female|trans female
1013366|NCT03078829|GnRH agonists|gnrh agonists
1013367|NCT03078829|QTc interval|qtc interval
1013368|NCT03078803|fecal transplant|fecal transplant
1013369|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
1013370|NCT03078777|Pharmacokinetics|pharmacokinetics
1013371|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
1013372|NCT03078751|Hormone receptor-positive|hormone receptor-positive
1013373|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
1013374|NCT03078751|HER2-negative|her2-negative
1013375|NCT03078751|High risk early breast cancer|high risk early breast cancer
1013376|NCT03078751|Adjuvant|adjuvant
1013377|NCT03078751|Ribociclib|ribociclib
1013378|NCT03078751|LEE011|lee011
1013379|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
1013380|NCT03078751|Endocrine therapy|endocrine therapy
1013381|NCT03078751|Phase III|phase iii
1013382|NCT03078751|Breast carcinoma|breast carcinoma
1013383|NCT03078751|Breast cancer|breast cancer
1013384|NCT03078738|OMT-28|omt-28
1013385|NCT03078738|Atrial Fibrillation|atrial fibrillation
1013386|NCT03078738|SAD|sad
1013387|NCT03078738|MAD|mad
1013388|NCT03078738|First-in-Man|first-in-man
1013389|NCT03078738|Cardiovascular|cardiovascular
1013390|NCT03078725|gestational diabetes|gestational diabetes
1013391|NCT03078725|glyburide|glyburide
1013392|NCT03078725|metformin|metformin
1013393|NCT03078725|failure rate|failure rate
1013394|NCT03078712|Septic Shock|septic shock
1013395|NCT03078712|Lactate|lactate
1013396|NCT03078712|Capillary Refill Time|capillary refill time
1013397|NCT03078712|Fluid Responsiveness|fluid responsiveness
1013398|NCT03078712|Mortality|mortality
1013399|NCT03078699|Thymoma|thymoma
1013400|NCT03078699|Thymic tumor|thymic tumor
1013401|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
1013402|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
1013403|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
1013404|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
1013405|NCT03078634|Constipation|constipation
1013406|NCT03078634|Functional dyspepsia|functional dyspepsia
1013407|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
1013408|NCT03078621|stem cells|stem cells
1013409|NCT03078608|anxiety|anxiety
1013410|NCT03078608|quality of life|quality of life
1013411|NCT03078608|mindfulness|mindfulness
1013412|NCT03078608|meditation|meditation
1013413|NCT03078608|depression|depression
1013414|NCT03078595|periodontal disease|periodontal disease
1013415|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
1013416|NCT03078595|bleeding on probing|bleeding on probing
1013417|NCT03078595|von willebrand disease|von willebrand disease
1013418|NCT03078595|gingival bleeding|gingival bleeding
1013419|NCT03078582|PNH|pnh
1013420|NCT03078569|Poor responders|poor responders
1013421|NCT03078556|FDC|fdc
1013422|NCT03078556|Lamivudine|lamivudine
1013423|NCT03078556|Bio-equivalence|bio-equivalence
1013424|NCT03078556|Dolutegravir|dolutegravir
1013425|NCT03078556|HIV|hiv
1013426|NCT03078530|GWI|gwi
1013427|NCT03078530|IBS|ibs
1013428|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
1013532|NCT03077945|smoker|smoker
1013429|NCT03078530|Gulf War Illness|gulf war illness
1013430|NCT03078530|Probiotics|probiotics
1013431|NCT03078517|I-gel|i-gel
1013432|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
1013433|NCT03078491|type 1 diabetes|type 1 diabetes
1013434|NCT03078491|geriatrics|geriatrics
1013435|NCT03078491|older adults|older adults
1013436|NCT03078491|technology|technology
1013437|NCT03078491|CGM|cgm
1013438|NCT03078491|clinical decision support|clinical decision support
1013439|NCT03078491|hypoglycemia|hypoglycemia
1013440|NCT03078439|very preterm birth|very preterm birth
1013441|NCT03078439|developmental disorders|developmental disorders
1013442|NCT03078439|health problems|health problems
1013443|NCT03078439|prospective population-based cohort|prospective population-based cohort
1013444|NCT03078426|Lung|lung
1013445|NCT03078426|MRI|mri
1013446|NCT03078426|CT|ct
1013447|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
1013448|NCT03078426|Ultra-short echo time|ultra-short echo time
1013449|NCT03078413|Mustard Procedure|mustard procedure
1013450|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
1013451|NCT03078361|cancer screening|cancer screening
1013452|NCT03078361|colon|colon
1013453|NCT03078348|cancer screening|cancer screening
1013454|NCT03078335|Late onset sepsis|late onset sepsis
1013455|NCT03078335|glove based care|glove based care
1013456|NCT03078335|NICU|nicu
1013457|NCT03078335|Non sterile gloves|non sterile gloves
1013458|NCT03078335|infection control|infection control
1013459|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
1013460|NCT03078309|retinal degeneration|retinal degeneration
1013461|NCT03078309|cannabis|cannabis
1013462|NCT03078309|THC|thc
1013463|NCT03078309|CBD|cbd
1013464|NCT03078309|electrophysiology|electrophysiology
1013465|NCT03078309|visual functions|visual functions
1013466|NCT03078309|eye|eye
1013467|NCT03078309|retina|retina
1013468|NCT03078270|social anxiety|social anxiety
1013469|NCT03078270|botulinum toxin|botulinum toxin
1013470|NCT03078270|botox|botox
1013471|NCT03078257|Platelet Activities|platelet activities
1013472|NCT03078257|light aggregometry|light aggregometry
1013473|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
1013474|NCT03078257|peripheral vein|peripheral vein
1013475|NCT03078257|peripheral artery|peripheral artery
1013476|NCT03078257|intracoronary artery|intracoronary artery
1013477|NCT03078257|tirofiban|tirofiban
1013478|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
1013479|NCT03078218|Pulse oximetry|pulse oximetry
1013480|NCT03078218|Asymptomatic newborns|asymptomatic newborns
1013481|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
1013482|NCT03078205|ART failure|art failure
1013483|NCT03078179|Probiotic|probiotic
1013484|NCT03078179|Child|child
1013485|NCT03078179|Care, dental|care, dental
1013486|NCT03078166|Cardiac Failure|cardiac failure
1013487|NCT03078166|Congestive Heart Failure|congestive heart failure
1013488|NCT03078166|Heart Decompensation|heart decompensation
1013489|NCT03078166|Heart Failure, Congestive|heart failure, congestive
1013490|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
1013491|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
1013492|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
1013493|NCT03078166|Myocardial Failure|myocardial failure
1013494|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
1013495|NCT03078166|Outcomes|outcomes
1013496|NCT03078166|Co-morbidities|co-morbidities
1013497|NCT03078166|Biomarkers|biomarkers
1013498|NCT03078101|Empagliflozin|empagliflozin
1013499|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
1013500|NCT03078075|Methamphetamine|methamphetamine
1013501|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
1013502|NCT03078075|Naltrexone|naltrexone
1013503|NCT03078075|Bupropion|bupropion
1013504|NCT03078075|Vivitrol®|vivitrol®
1013505|NCT03078062|Spinal anesthesia|spinal anesthesia
1013506|NCT03078062|Motor block|motor block
1013507|NCT03078062|Sensory block|sensory block
1013508|NCT03078062|Dexamethasone|dexamethasone
1013509|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
1013510|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
1013511|NCT03078023|EoE|eoe
1013512|NCT03078010|Antibiotic|antibiotic
1013513|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
1013514|NCT03078010|cefepime|cefepime
1013515|NCT03078010|aztreonam|aztreonam
1013516|NCT03078010|17-097|17-097
1013517|NCT03077997|Diabetes|diabetes
1013518|NCT03077997|Diabetes distress|diabetes distress
1013519|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
1013520|NCT03077971|Carer Strain|carer strain
1013521|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
1013522|NCT03077945|biofeedback|biofeedback
1013523|NCT03077945|heart rate variability|heart rate variability
1013524|NCT03077945|HRV|hrv
1013525|NCT03077945|psychophysiology|psychophysiology
1013526|NCT03077945|reappraisal|reappraisal
1013527|NCT03077945|cognitive reappraisal|cognitive reappraisal
1013528|NCT03077945|arousal reappraisal|arousal reappraisal
1013529|NCT03077945|woman|woman
1013543|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
1013544|NCT03077919|Depression|depression
1013545|NCT03077919|Distress|distress
1013546|NCT03077919|Alcohol Use|alcohol use
1013547|NCT03077919|Pain|pain
1013548|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
1013549|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
1013550|NCT03077880|implant insertion|implant insertion
1013551|NCT03077880|bone resorption|bone resorption
1013552|NCT03077880|soft tissue|soft tissue
1013553|NCT03077867|sinus lift|sinus lift
1013554|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
1013555|NCT03077867|bone graft|bone graft
1013556|NCT03077854|Lung Cancer|lung cancer
1013557|NCT03077854|Radiotherapy|radiotherapy
1013558|NCT03077854|Biomarkers|biomarkers
1013559|NCT03077854|Radiation Lung Injury|radiation lung injury
1013560|NCT03077854|Quality of Life|quality of life
1013561|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
1013562|NCT03077841|Breast cancer|breast cancer
1013563|NCT03077841|Radiation therapy|radiation therapy
1013564|NCT03077841|XRT|xrt
1013565|NCT03077841|External beam radiation therapy|external beam radiation therapy
1013566|NCT03077841|Shorter course|shorter course
1013567|NCT03077841|Questionnaires|questionnaires
1013568|NCT03077841|Surveys|surveys
1013569|NCT03077802|Seldinger technique|seldinger technique
1013570|NCT03077802|Modified Seldinger technique|modified seldinger technique
1013571|NCT03077802|Complication|complication
1013572|NCT03077802|Success rate|success rate
1013573|NCT03077789|visual acuity|visual acuity
1013574|NCT03077789|prognosis epidemiology|prognosis epidemiology
1013575|NCT03077763|nitrite|nitrite
1013576|NCT03077763|haemoglobin|haemoglobin
1013577|NCT03077763|normoxia|normoxia
1013578|NCT03077763|hypoxia|hypoxia
1013579|NCT03077763|vasodilatation|vasodilatation
1013580|NCT03077763|blood|blood
1013581|NCT03077750|viral skin disease|viral skin disease
1013582|NCT03077737|Treatment access|treatment access
1013583|NCT03077737|Treatment utilization|treatment utilization
1013584|NCT03077737|Smoking cessation|smoking cessation
1013585|NCT03077737|Low income|low income
1013586|NCT03077737|Electronic health record system|electronic health record system
1013587|NCT03077737|Electronic referral|electronic referral
1013588|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1013589|NCT03077724|tobacco use|tobacco use
1013590|NCT03077724|pregnancy|pregnancy
1013591|NCT03077698|Endometrial cancer|endometrial cancer
1013592|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
1013593|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
1013594|NCT03077698|Sodium Cridanimod|sodium cridanimod
1013601|NCT03077672|Mitochondrial DNA|mitochondrial dna
1013602|NCT03077672|Lactate|lactate
1013603|NCT03077672|Mortality|mortality
1013604|NCT03077672|Emergency Department|emergency department
1013605|NCT03077672|Intensive Care Unit|intensive care unit
1013606|NCT03077672|Triage|triage
1013607|NCT03077672|Organ Dysfunction|organ dysfunction
1013608|NCT03077672|Biomarker|biomarker
1013609|NCT03077672|Prognosis|prognosis
1013610|NCT03077659|prostate cancer|prostate cancer
1013611|NCT03077659|prostatic neoplasms|prostatic neoplasms
1013612|NCT03077659|genital neoplasms, male|genital neoplasms, male
1013613|NCT03077659|urogenital neoplasms|urogenital neoplasms
1013614|NCT03077659|prostatic diseases|prostatic diseases
1013615|NCT03077646|firearm|firearm
1013616|NCT03077646|gun|gun
1013617|NCT03077646|safety|safety
1013618|NCT03077646|pediatric|pediatric
1013619|NCT03077646|inpatient|inpatient
1013620|NCT03077633|Cerclage|cerclage
1013621|NCT03077633|Cervical shortening|cervical shortening
1013622|NCT03077633|Twins|twins
1013623|NCT03077633|Progesterone|progesterone
1013624|NCT03077568|internet|internet
1013625|NCT03077568|web-based|web-based
1013626|NCT03077568|behavior change|behavior change
1013627|NCT03077568|stress-management|stress-management
1333124|NCT01444456|Esophageal Cancer|esophageal cancer
1013628|NCT03077555|quick starting contraception|quick starting contraception
1013732|NCT03076879|Nursing|nursing
1013634|NCT03077503|Hemodynamic response|hemodynamic response
1013635|NCT03077503|Skull pins application|skull pins application
1013637|NCT03077503|Fentanyl|fentanyl
1013638|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
1013639|NCT03077490|transvaginal mesh|transvaginal mesh
1013640|NCT03077490|complications|complications
1013641|NCT03077464|nutrition education|nutrition education
1013642|NCT03077464|Vegetables|vegetables
1013645|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
1013646|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
1013647|NCT03077438|MENVEO®|menveo®
1013648|NCT03077399|lateropulsion|lateropulsion
1013649|NCT03077399|stroke|stroke
1013650|NCT03077399|Pusher syndrome|pusher syndrome
1013651|NCT03077386|patient navigator|patient navigator
1013652|NCT03077386|community health worker|community health worker
1013653|NCT03077386|multi-morbidity|multi-morbidity
1013654|NCT03077386|primary care|primary care
1013655|NCT03077386|social determinants of health|social determinants of health
1013656|NCT03077373|systolic blood pressure|systolic blood pressure
1013657|NCT03077373|physical activity|physical activity
1013658|NCT03077373|sedentary time|sedentary time
1013659|NCT03077373|smoking|smoking
1013660|NCT03077347|Schizophrenia|schizophrenia
1013661|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1013662|NCT03077347|tDCS|tdcs
1013663|NCT03077347|Cognitive Control|cognitive control
1013664|NCT03077347|fMRI|fmri
1013665|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1013666|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
1013667|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
1013668|NCT03077269|burn|burn
1013669|NCT03077269|coagulation|coagulation
1013670|NCT03077269|inflammation|inflammation
1013671|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
1013672|NCT03077256|Cellular Allograft|cellular allograft
1013673|NCT03077243|Human Papillomavirus|human papillomavirus
1013674|NCT03077243|Oropharynx|oropharynx
1013675|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
1013676|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
1013677|NCT03077243|Radiation Therapy|radiation therapy
1013678|NCT03077243|Chemotherapy|chemotherapy
1013679|NCT03077243|p16|p16
1013680|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
1013681|NCT03077217|low-dose rifaximin|low-dose rifaximin
1013682|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
1013683|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
1013684|NCT03077204|Failed previous fusion|failed previous fusion
1013685|NCT03077204|Spinal stenosis|spinal stenosis
1013686|NCT03077204|Tumor|tumor
1013687|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
1013688|NCT03077204|Pseudoarthrosis|pseudoarthrosis
1013689|NCT03077204|Curvatures|curvatures
1013690|NCT03077204|Deformities|deformities
1013691|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
1013692|NCT03077191|breast cancer|breast cancer
1013693|NCT03077191|conservative treatment|conservative treatment
1013694|NCT03077191|quality of life|quality of life
1013695|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
1013696|NCT03077178|Surgery|surgery
1013697|NCT03077178|Functional Impact|functional impact
1013698|NCT03077178|Elderly Patient|elderly patient
1013699|NCT03077178|Geriatrics|geriatrics
1013700|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
1013701|NCT03077126|elastography|elastography
1013702|NCT03077126|ultrasound|ultrasound
1013703|NCT03077126|prostate|prostate
1013704|NCT03077126|cancer screening|cancer screening
1013705|NCT03077113|lung cancer|lung cancer
1013706|NCT03077113|radiation therapy|radiation therapy
1013707|NCT03077048|CKD|ckd
1013708|NCT03077048|Ketosteril|ketosteril
1013709|NCT03077048|keto-acids|keto-acids
1013710|NCT03077048|ketoanalogues|ketoanalogues
1013711|NCT03077048|Chronic kidney disease|chronic kidney disease
1013712|NCT03077035|ICDAS|icdas
1013713|NCT03077035|DIAGNOdent|diagnodent
1013714|NCT03077035|glass ionomer sealant|glass ionomer sealant
1013715|NCT03077035|resin-based sealant|resin-based sealant
1013716|NCT03077035|pit and fissure sealants|pit and fissure sealants
1013717|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
1013718|NCT03076983|Ventilation Monitoring|ventilation monitoring
1013719|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
1013720|NCT03076931|Voice|voice
1013721|NCT03076931|Biomarker|biomarker
1013722|NCT03076931|Airway Reconstruction|airway reconstruction
1013723|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
1013724|NCT03076892|PDT|pdt
1013725|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
1013726|NCT03076892|light emitting textile|light emitting textile
1013727|NCT03076879|Cervical Cancer|cervical cancer
1013728|NCT03076879|Pap smear|pap smear
1013729|NCT03076879|Screening|screening
1013730|NCT03076879|Beliefs|beliefs
1013731|NCT03076879|Attitude|attitude
1013737|NCT03076801|Psychosocial Stress|psychosocial stress
1013738|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
1013739|NCT03076788|echocardiography|echocardiography
1013740|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
1013741|NCT03076788|cardiac remodeling|cardiac remodeling
1013742|NCT03076788|athletes|athletes
1013743|NCT03076775|Betamethasone|betamethasone
1013744|NCT03076775|Late preterm|late preterm
1013745|NCT03076775|Steroids|steroids
1013746|NCT03076762|interstitial cystitis|interstitial cystitis
1013747|NCT03076762|pain|pain
1013748|NCT03076762|intravesical injection|intravesical injection
1013749|NCT03076762|therapy|therapy
1013750|NCT03076762|bladder|bladder
1013751|NCT03076749|Betalactam|betalactam
1013752|NCT03076749|Decision tree|decision tree
1013753|NCT03076749|Drug hypersensitivity|drug hypersensitivity
1013754|NCT03076749|Logistic regression|logistic regression
1013755|NCT03076749|Predictive modelling|predictive modelling
1013756|NCT03076710|spine surgery|spine surgery
1013757|NCT03076710|post-operative pain|post-operative pain
1013758|NCT03076710|patient controlled analgesia|patient controlled analgesia
1013759|NCT03076710|Exparel®|exparel®
1013760|NCT03076710|bupivacaine|bupivacaine
1013761|NCT03076697|fundus photography|fundus photography
1013762|NCT03076697|smartphone-based photography|smartphone-based photography
1013763|NCT03076671|Palliative Care|palliative care
1013764|NCT03076671|Supportive Care|supportive care
1013765|NCT03076671|Movement Disorders|movement disorders
1013766|NCT03076671|Brain Disease|brain disease
1013767|NCT03076671|Neurodegeneration|neurodegeneration
1013768|NCT03076671|Parkinson's Disease|parkinson's disease
1013769|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
1013770|NCT03076632|neurostimulation|neurostimulation
1013771|NCT03076632|non-invasive stimulation|non-invasive stimulation
1013772|NCT03076632|closed-loop stimulation|closed-loop stimulation
1013773|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
1013774|NCT03076619|ophthalmoscopy|ophthalmoscopy
1013775|NCT03076593|geriatric|geriatric
1013781|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
1013782|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
1013783|NCT03076541|Restless legs syndrome|restless legs syndrome
1013784|NCT03076541|Periodic leg movements|periodic leg movements
1013785|NCT03076541|Heart rate|heart rate
1013786|NCT03076541|Heart rate variability|heart rate variability
1013787|NCT03076541|Microarousals|microarousals
1013788|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
1013789|NCT03076528|exercise|exercise
1013790|NCT03076528|exergame|exergame
1013791|NCT03076528|hemodialysis|hemodialysis
1013792|NCT03076528|balance|balance
1013793|NCT03076502|ctDNA|ctdna
1013794|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
1013795|NCT03076502|ROS|ros
1013796|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
1013797|NCT03076476|Coronary Stent|coronary stent
1013798|NCT03076476|PCI|pci
1013799|NCT03076476|BVS|bvs
1013800|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
1013801|NCT03076463|Polyphenols|polyphenols
1013802|NCT03076463|Metabolic syndrome|metabolic syndrome
1013803|NCT03076463|Cardiometabolic risk|cardiometabolic risk
1013804|NCT03076463|Grape pomace|grape pomace
1013805|NCT03076463|Postprandial glucose|postprandial glucose
1013806|NCT03076463|Insulin resistance|insulin resistance
1013807|NCT03076463|Obesity|obesity
1013808|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
1013809|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
1013810|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
1013811|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
1013812|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
1013813|NCT03076411|Dyspepsia|dyspepsia
1013814|NCT03076411|Observational trial|observational trial
1013815|NCT03076411|Enzyme therapy|enzyme therapy
1013816|NCT03076411|Pepsin|pepsin
1013817|NCT03076385|VAL-506440|val-506440
1013818|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
1013819|NCT03076385|Influenza vaccine|influenza vaccine
1013820|NCT03076372|Cancer|cancer
1013821|NCT03076372|Oncology|oncology
1013822|NCT03076372|Phase I|phase i
1013823|NCT03076372|Gemcitabine|gemcitabine
1013824|NCT03076372|Carboplatin|carboplatin
1013825|NCT03076372|MM-310|mm-310
1013826|NCT03076372|EphA2|epha2
1013827|NCT03076372|Ephrin A2|ephrin a2
1013828|NCT03076372|Solid tumors|solid tumors
1013829|NCT03076372|urothelial carcinoma|urothelial carcinoma
1013830|NCT03076372|gastric carcinoma|gastric carcinoma
1013831|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1013832|NCT03076372|ovarian cancer|ovarian cancer
1013833|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1013834|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
1013835|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
1663903|NCT00128791|angioplasty|angioplasty
1013836|NCT03076372|small cell lung cancer|small cell lung cancer
1013837|NCT03076372|triple negative breast cancer|triple negative breast cancer
1013838|NCT03076372|endometrial carcinoma|endometrial carcinoma
1013839|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
1013840|NCT03076372|Merrimack|merrimack
1013841|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
1013842|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
1013843|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
1013844|NCT03076294|knee ostearthritis|knee ostearthritis
1013845|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
1013846|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1013847|NCT03076294|chronic pain|chronic pain
1013848|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
1013849|NCT03076216|Pancreatic Cancer|pancreatic cancer
1013850|NCT03076216|Pancreas|pancreas
1013851|NCT03076216|metastases|metastases
1013852|NCT03076216|pancreatic tumour|pancreatic tumour
1013853|NCT03076216|unresectable|unresectable
1013854|NCT03076216|locally advanced|locally advanced
1013855|NCT03076216|implantable|implantable
1013856|NCT03076216|radiographic|radiographic
1013857|NCT03076216|device|device
1013858|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
1013859|NCT03076216|OncoSil™|oncosil™
1013860|NCT03076216|brachytherapy|brachytherapy
1013861|NCT03076216|gemcitabine|gemcitabine
1013862|NCT03076216|nab-paclitaxel|nab-paclitaxel
1013863|NCT03076216|Abraxane|abraxane
1013864|NCT03076190|psychology|psychology
1013865|NCT03076190|pain|pain
1013866|NCT03076190|surgery|surgery
1013867|NCT03076190|treatment|treatment
1013868|NCT03076190|catastrophizing|catastrophizing
1013869|NCT03076190|cancer|cancer
1013870|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
1013871|NCT03076164|erlotinib|erlotinib
1013872|NCT03076164|trametinib|trametinib
1013873|NCT03076164|15-098|15-098
1013874|NCT03076151|Transplantation|transplantation
1013875|NCT03076151|Kidney|kidney
1013876|NCT03076151|pharmacokinetic|pharmacokinetic
1013877|NCT03076151|bayesian estimators|bayesian estimators
1013878|NCT03076138|Gene-activated matrix|gene-activated matrix
1013879|NCT03076138|Bone substitute|bone substitute
1013880|NCT03076138|Bone grafting|bone grafting
1013881|NCT03076138|Dental implantation|dental implantation
1013882|NCT03076138|gene therapy|gene therapy
1013883|NCT03076138|plasmid DNA|plasmid dna
1013884|NCT03076138|VEGF gene|vegf gene
1013885|NCT03076138|octacalcium phosphate|octacalcium phosphate
1013886|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
1013887|NCT03076112|Ipragliflozin|ipragliflozin
1013888|NCT03076112|Sitagliptin|sitagliptin
1013889|NCT03076099|Dexmedetomidine|dexmedetomidine
1013890|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
1013891|NCT03076099|embolization|embolization
1013892|NCT03076099|post-operative hypertension|post-operative hypertension
1013893|NCT03076073|Ultrasound|ultrasound
1013894|NCT03076073|Achilles tendon|achilles tendon
1013895|NCT03076073|Patellar tendon|patellar tendon
1013896|NCT03076073|obesity|obesity
1013897|NCT03076060|Ketogenic Diet|ketogenic diet
1013898|NCT03076060|Very low calories diet|very low calories diet
1013899|NCT03076060|ketone bodies|ketone bodies
1013900|NCT03075995|lapatinib|lapatinib
1013901|NCT03075995|steady state plasma concentration|steady state plasma concentration
1013902|NCT03075995|high-fat breakfast|high-fat breakfast
1013903|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
1013904|NCT03075930|Atrial fibrillation|atrial fibrillation
1013905|NCT03075930|ECG|ecg
1013906|NCT03075930|Body surface potential map|body surface potential map
1013907|NCT03075930|Recurrence of AF|recurrence of af
1013908|NCT03075917|Allergic rhinitis|allergic rhinitis
1013909|NCT03075865|intermaxillary fixation|intermaxillary fixation
1013910|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
1013911|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
1013912|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
1013913|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
1013914|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
1013915|NCT03075787|Heart rate|heart rate
1013916|NCT03075787|Heart rate variability|heart rate variability
1013917|NCT03075787|Microarousals|microarousals
1013918|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
1013919|NCT03075761|Venous thromboembolism|venous thromboembolism
1013920|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
1013921|NCT03075761|Lower Extremity|lower extremity
1013922|NCT03075761|Blood clot|blood clot
1013923|NCT03075761|Anticoagulation|anticoagulation
1013924|NCT03075761|Physical Activity|physical activity
1013925|NCT03075761|Fitbit|fitbit
1013926|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
1013930|NCT03075748|Stent|stent
1013931|NCT03075748|Graft|graft
1664287|NCT00127322|survival|survival
1039635|NCT02916810|MRI|mri
1013932|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1013933|NCT03075735|DNA-repair|dna-repair
1013934|NCT03075735|BRCA1|brca1
1013935|NCT03075735|BRCA2|brca2
1013936|NCT03075735|ATM|atm
1013937|NCT03075735|PALB2|palb2
1013938|NCT03075709|Clinical Pathway|clinical pathway
1013939|NCT03075709|CPW|cpw
1013940|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1013941|NCT03075709|COPD|copd
1013942|NCT03075709|Protocol|protocol
1013943|NCT03075709|Adherence|adherence
1013944|NCT03075709|Readmission|readmission
1013945|NCT03075709|Length of Stay|length of stay
1013946|NCT03075709|Cost|cost
1013947|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
1013948|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
1013949|NCT03075683|Internet mediated|internet mediated
1013950|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
1013951|NCT03075566|coronary artery disease|coronary artery disease
1013952|NCT03075566|risk factors|risk factors
1013953|NCT03075566|inflammation|inflammation
1013954|NCT03075566|biomarkers|biomarkers
1013955|NCT03075566|atherosclerosis|atherosclerosis
1013956|NCT03075540|Latinas|latinas
1013957|NCT03075527|Mesothelioma|mesothelioma
1013958|NCT03075514|ketogenic|ketogenic
1013959|NCT03075501|drug cues|drug cues
1013960|NCT03075475|Child|child
1013961|NCT03075475|Adolescent|adolescent
1013962|NCT03075475|Mental Health|mental health
1013963|NCT03075475|Randomized Controlled Trial|randomized controlled trial
1013964|NCT03075462|PARP inhibitor|parp inhibitor
1013965|NCT03075462|VEGFR inhibitor|vegfr inhibitor
1013966|NCT03075462|Combination therapy|combination therapy
1013967|NCT03075462|Ovarian Cancer|ovarian cancer
1013968|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
1013969|NCT03075436|Sanitation|sanitation
1013970|NCT03075436|Hygiene|hygiene
1013971|NCT03075436|Public Health|public health
1013972|NCT03075436|Behavior change|behavior change
1013973|NCT03075436|Neglected tropical diseases|neglected tropical diseases
1013974|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
1013975|NCT03075436|Mental well-being|mental well-being
1013976|NCT03075436|Water insecurity|water insecurity
1013977|NCT03075436|Sanitation insecurity|sanitation insecurity
1013978|NCT03075436|Collective efficacy|collective efficacy
1013979|NCT03075410|ascending dose|ascending dose
1013980|NCT03075410|Pharmacokinetics|pharmacokinetics
1013981|NCT03075410|GSK3036656|gsk3036656
1013982|NCT03075410|FTIH|ftih
1013983|NCT03075410|Safety|safety
1013984|NCT03075397|HIV-1|hiv-1
1013985|NCT03075397|Colo-rectal transmission|colo-rectal transmission
1013986|NCT03075397|seminal plasma|seminal plasma
1013987|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
1013988|NCT03075332|Detraining|detraining
1013989|NCT03075332|Physical aptitude|physical aptitude
1013990|NCT03075332|HIV|hiv
1013991|NCT03075280|ERCP|ercp
1013992|NCT03075280|ERAS|eras
1013993|NCT03075280|complication|complication
1013994|NCT03075280|fatigue|fatigue
1013995|NCT03075280|high carbohydrate diet|high carbohydrate diet
1013996|NCT03075254|Pain|pain
1013997|NCT03075254|Fatigue|fatigue
1013998|NCT03075241|Sleep Disturbances|sleep disturbances
1013999|NCT03075241|Alzheimer Disease|alzheimer disease
1014000|NCT03075241|Insomnia|insomnia
1014001|NCT03075241|Z-Drugs|z-drugs
1014002|NCT03075241|Treatment|treatment
1014003|NCT03075228|microbiota|microbiota
1014004|NCT03075228|small intestine|small intestine
1014005|NCT03075228|metabolic disease|metabolic disease
1014006|NCT03075202|Schizophrenia|schizophrenia
1014007|NCT03075202|Smoking|smoking
1014008|NCT03075202|E-cigarette|e-cigarette
1014009|NCT03075189|Frailty|frailty
1014010|NCT03075189|geriatric|geriatric
1014011|NCT03075189|hospitalized|hospitalized
1014012|NCT03075189|enrichment|enrichment
1014013|NCT03075189|whey protein|whey protein
1014014|NCT03075189|protein intake|protein intake
1014015|NCT03075189|sarcopenia|sarcopenia
1014016|NCT03075189|dietary counseling|dietary counseling
1014017|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
1014018|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
1014019|NCT03075163|PONV|ponv
1014020|NCT03075163|Nausea|nausea
1014021|NCT03075163|Vomiting|vomiting
1014022|NCT03075163|Acupressure|acupressure
1014027|NCT03075137|ischemic stroke|ischemic stroke
1014028|NCT03075137|external counter pulsation|external counter pulsation
1014029|NCT03075137|mRS|mrs
1014030|NCT03075124|Coronary Artery Disease|coronary artery disease
1014031|NCT03075124|external counter pulsation|external counter pulsation
1014032|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
1014033|NCT03075098|Colposcopy|colposcopy
1014034|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
1014035|NCT03075098|diagnostic accuracy|diagnostic accuracy
1014036|NCT03075072|Brain metastases|brain metastases
1014037|NCT03075072|Brain metastasis|brain metastasis
1014038|NCT03075072|Lung cancer|lung cancer
1014039|NCT03075072|Melanoma|melanoma
1014040|NCT03075072|Breast cancer|breast cancer
1014041|NCT03075072|Kidney cancer|kidney cancer
1014042|NCT03075072|Renal cell carcinoma|renal cell carcinoma
1014043|NCT03075072|Stereotactic radiation|stereotactic radiation
1014044|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
1014045|NCT03075072|SRS|srs
1014046|NCT03075072|Stereotactic|stereotactic
1014047|NCT03075072|Whole brain radiation|whole brain radiation
1014048|NCT03075072|WBRT|wbrt
1014049|NCT03075072|Hippocampal avoidance|hippocampal avoidance
1014050|NCT03075072|Hippocampal sparing|hippocampal sparing
1014051|NCT03075072|Hippocampal|hippocampal
1014052|NCT03075072|Hippocampus|hippocampus
1014053|NCT03075072|Radiation|radiation
1014054|NCT03075072|Quality of Life|quality of life
1014055|NCT03075072|Neurocognitive|neurocognitive
1014056|NCT03075072|Neurocognition|neurocognition
1014057|NCT03075072|Survival|survival
1014058|NCT03075072|Salvage|salvage
1014059|NCT03075072|MDASI|mdasi
1014060|NCT03075072|Chemotherapy|chemotherapy
1014061|NCT03075072|Recurrence|recurrence
1014062|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
1014063|NCT03075046|Women|women
1014064|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
1014065|NCT03075007|Alzheimer Disease|alzheimer disease
1014066|NCT03075007|Aging|aging
1014067|NCT03075007|Dementia|dementia
1014068|NCT03075007|PET|pet
1014069|NCT03074994|Tranexamic acid|tranexamic acid
1014070|NCT03074994|Peri-articular injection|peri-articular injection
1014071|NCT03074994|Intraarticular injection|intraarticular injection
1014072|NCT03074994|Total knee arthroplasty|total knee arthroplasty
1014073|NCT03074994|Blood loss|blood loss
1014074|NCT03074955|Hypotension|hypotension
1014075|NCT03074955|Propofol|propofol
1014076|NCT03074955|Trendelenburg|trendelenburg
1014077|NCT03074955|leg wrapping|leg wrapping
1014078|NCT03074929|risk communication|risk communication
1014079|NCT03074903|intrauterine device|intrauterine device
1014080|NCT03074903|bleeding|bleeding
1014081|NCT03074877|Substance Use|substance use
1014082|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
1014083|NCT03074851|low sodium salt|low sodium salt
1014084|NCT03074851|blood pressure|blood pressure
1014085|NCT03074851|reporter|reporter
1014086|NCT03074838|Cardiac surgery|cardiac surgery
1014087|NCT03074838|TAVI|tavi
1014088|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1014089|NCT03074825|Relapsed/Refractory|relapsed/refractory
1014090|NCT03074825|Aurora kinase B|aurora kinase b
1014091|NCT03074734|secondhand smoke|secondhand smoke
1014092|NCT03074734|passive smoking|passive smoking
1014093|NCT03074734|respiratory diseases|respiratory diseases
1014094|NCT03074734|COPD|copd
1014095|NCT03074734|asthma|asthma
1014096|NCT03074734|SHS health effect|shs health effect
1014097|NCT03074708|Three-Dimensional Image|three-dimensional image
1014098|NCT03074708|Three Dimensional Printing|three dimensional printing
1014099|NCT03074682|Resuscitation|resuscitation
1014100|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
1014101|NCT03074656|infliximab|infliximab
1014102|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
1014103|NCT03074656|anti drug antibodies|anti drug antibodies
1014104|NCT03074604|Brain Injuries|brain injuries
1014105|NCT03074604|Neurological Injury|neurological injury
1014106|NCT03074604|Stroke|stroke
1014107|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1014108|NCT03074604|Postoperative Delirium|postoperative delirium
1014109|NCT03074604|Coronary Artery Disease|coronary artery disease
1014110|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1014111|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1014112|NCT03074604|Bypass surgery|bypass surgery
1014113|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
1014114|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
1014115|NCT03074591|Iron deficiency|iron deficiency
1014116|NCT03074591|Heart failure|heart failure
1014117|NCT03074578|sleep|sleep
1014118|NCT03074578|verbal abuse|verbal abuse
1014119|NCT03074578|polysomnography|polysomnography
1014120|NCT03074578|perception|perception
1014121|NCT03074578|neuropsychological tests|neuropsychological tests
1014122|NCT03074565|Sanative Therapy|sanative therapy
1014123|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
1014124|NCT03074565|Deep Scaling|deep scaling
1014125|NCT03074565|Hand Scaling|hand scaling
1014126|NCT03074552|probiotics|probiotics
1014127|NCT03074552|VAP|vap
1014128|NCT03074552|microbiome|microbiome
1014129|NCT03074552|trauma|trauma
1014130|NCT03074552|infections|infections
1014131|NCT03074513|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1015327|NCT03067376|Excretion|excretion
1014132|NCT03074513|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
1333125|NCT01444456|Gastric Cancer|gastric cancer
1014133|NCT03074513|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
1014134|NCT03074513|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
1014135|NCT03074513|Rare Solid Tumors|rare solid tumors
1014136|NCT03074513|Atezolizumab|atezolizumab
1014137|NCT03074513|MPDL3280A|mpdl3280a
1014138|NCT03074513|Bevacizumab|bevacizumab
1014139|NCT03074513|Avastin|avastin
1014140|NCT03074513|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1014141|NCT03074513|rhuMAb-VEGF|rhumab-vegf
1014142|NCT03074513|Phone call|phone call
1014143|NCT03074500|Kinesio taping|kinesio taping
1014144|NCT03074500|lateral epicondylitis|lateral epicondylitis
1014145|NCT03074500|tennis elbow|tennis elbow
1014146|NCT03074500|treatment|treatment
1014147|NCT03074487|Spinal cord ischemia|spinal cord ischemia
1014148|NCT03074487|Postoperative|postoperative
1014149|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
1014152|NCT03074461|Rectal Cancer|rectal cancer
1014153|NCT03074461|Low Anterior Resection|low anterior resection
1014154|NCT03074461|Coloplasty Pouch|coloplasty pouch
1014155|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
1014156|NCT03074461|Continence|continence
1014157|NCT03074461|Quality of Life|quality of life
1014158|NCT03074448|Colonoscopy|colonoscopy
1014159|NCT03074448|Intestinal Cleaning|intestinal cleaning
1014160|NCT03074448|Picoprep|picoprep
1014161|NCT03074448|Aquanet|aquanet
1014162|NCT03074422|Functional neurosurgery|functional neurosurgery
1014163|NCT03074422|Pain management|pain management
1014164|NCT03074422|Hypnosis|hypnosis
1014165|NCT03074422|Stereotaxy|stereotaxy
1014166|NCT03074422|Parkinson disease|parkinson disease
1014167|NCT03074422|Essential tremor|essential tremor
1014168|NCT03074422|Dystonia|dystonia
1014169|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
1014170|NCT03074409|Oxytocin|oxytocin
1014171|NCT03074344|Dry Eye Syndrome|dry eye syndrome
1014172|NCT03074344|artificial tear|artificial tear
1014173|NCT03074344|CoQ10|coq10
1014174|NCT03074344|Hyaluronic acid|hyaluronic acid
1014175|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
1014176|NCT03074305|drug-eluting stent|drug-eluting stent
1014177|NCT03074305|drug-eluting balloon|drug-eluting balloon
1014178|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
1014179|NCT03074279|Epilepsy|epilepsy
1014180|NCT03074279|SUDEP|sudep
1014181|NCT03074279|case-control study|case-control study
1014182|NCT03074279|risks factors|risks factors
1014183|NCT03074240|Truncal block|truncal block
1014184|NCT03074240|Surgical anesthesia|surgical anesthesia
1014185|NCT03074240|Postoperative pain control|postoperative pain control
1014186|NCT03074214|copeptin|copeptin
1014187|NCT03074214|myocardial infarct size|myocardial infarct size
1014188|NCT03074214|prognosis|prognosis
1014189|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
1014190|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
1014191|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
1014192|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
1014193|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
1014194|NCT03074136|photodynamic therapy|photodynamic therapy
1014195|NCT03074136|diode laser|diode laser
1014196|NCT03074136|immature permanent teeth|immature permanent teeth
1014197|NCT03074136|endodontic therapy|endodontic therapy
1014198|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
1014199|NCT03074123|low-dose|low-dose
1014200|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
1014201|NCT03074110|Carbon Dioxide|carbon dioxide
1014202|NCT03074110|Hyperventilation|hyperventilation
1014203|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
1014204|NCT03074110|Ventilators|ventilators
1014205|NCT03074097|Rectus sheath block, Postoperative pain,TNF alpha and IL-6|rectus sheath block, postoperative pain,tnf alpha and il-6
1014206|NCT03074084|abdominal pain|abdominal pain
1014207|NCT03074084|adult|adult
1014208|NCT03074084|emergency department|emergency department
1014209|NCT03074084|electronic nose|electronic nose
1014210|NCT03074084|celiac disease|celiac disease
1014211|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
1014212|NCT03074045|Intrauterine|intrauterine
1014213|NCT03074045|Birth control|birth control
1014214|NCT03073993|nasogastric|nasogastric
1014215|NCT03073993|orogastric|orogastric
1014216|NCT03073993|nutrition|nutrition
1014217|NCT03073993|preterm|preterm
1014218|NCT03073993|feeding tube|feeding tube
1014219|NCT03073993|insertion|insertion
1014220|NCT03073993|episodes|episodes
1014221|NCT03073993|bradycardia|bradycardia
1014222|NCT03073993|desaturation|desaturation
1014223|NCT03073980|in vitro fertilization|in vitro fertilization
1014224|NCT03073980|oocyte retrieval|oocyte retrieval
1014225|NCT03073980|acetaminophen|acetaminophen
1014226|NCT03073980|postoperative pain control|postoperative pain control
1014227|NCT03073954|Health Behavior|health behavior
1014228|NCT03073954|Executive function|executive function
1014229|NCT03073954|Working-memory training|working-memory training
1014230|NCT03073954|Feasibility|feasibility
1014231|NCT03073954|Impulsivity|impulsivity
1014232|NCT03073941|Knee arthroplasty|knee arthroplasty
1014233|NCT03073941|Knee function|knee function
1014234|NCT03073941|Total knee replacement|total knee replacement
1014235|NCT03073941|Persona total knee system|persona total knee system
1014236|NCT03073941|NexGen total knee system|nexgen total knee system
1014237|NCT03073928|Nerve block|nerve block
1014238|NCT03073928|Diaphragm function|diaphragm function
1014239|NCT03073889|Aneurysm Clipping|aneurysm clipping
1014240|NCT03073889|Scalp nerve block|scalp nerve block
1014241|NCT03073889|Scalp infiltration|scalp infiltration
1014242|NCT03073889|Ropivacaine|ropivacaine
1014243|NCT03073876|Alzheimer Disease|alzheimer disease
1014244|NCT03073876|Attention|attention
1014245|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
1014246|NCT03073863|LDL Cholesterol|ldl cholesterol
1014247|NCT03073863|Statin intensity|statin intensity
1014248|NCT03073863|post hoc analysis|post hoc analysis
1014249|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
1014250|NCT03073811|protein supplementation|protein supplementation
1014251|NCT03073811|older adults|older adults
1014252|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
1014253|NCT03073811|perioperative optimization|perioperative optimization
1014254|NCT03073811|Veterans|veterans
1014255|NCT03073798|Lung Disease|lung disease
1014256|NCT03073798|Breathing Difficulty|breathing difficulty
1014257|NCT03073798|Smoking|smoking
1014258|NCT03073798|Mucociliary|mucociliary
1014259|NCT03073746|Google|google
1014260|NCT03073746|Knowledge Panels|knowledge panels
1014261|NCT03073746|Health Search|health search
1014262|NCT03073746|Online|online
1014263|NCT03073746|Internet|internet
1014264|NCT03073746|Smartphone|smartphone
1014265|NCT03073746|Tablet|tablet
1014266|NCT03073746|Digital|digital
1014267|NCT03073746|Mobile|mobile
1014268|NCT03073746|Symptoms|symptoms
1014269|NCT03073746|Differential diagnosis|differential diagnosis
1014270|NCT03073746|Diagnosis|diagnosis
1014271|NCT03073746|Anxiety|anxiety
1014272|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
1014273|NCT03073707|Invasive blood stream infections|invasive blood stream infections
1014274|NCT03073707|Reservoir|reservoir
1014275|NCT03073707|Household environment|household environment
1014276|NCT03073707|Children|children
1014277|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
1014278|NCT03073694|mitomycin-c|mitomycin-c
1014279|NCT03073694|melphalan|melphalan
1014280|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
1014281|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1014282|NCT03073681|cataract|cataract
1014283|NCT03073655|shoulder pain|shoulder pain
1014284|NCT03073655|shoulder function|shoulder function
1014285|NCT03073642|Hydrotherapy|hydrotherapy
1014286|NCT03073642|Pain education|pain education
1014287|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1014288|NCT03073577|Islet Transplantation|islet transplantation
1014289|NCT03073577|Diabetes|diabetes
1014290|NCT03073577|Diabetes Treatment|diabetes treatment
1014291|NCT03073564|Dyspnea|dyspnea
1014292|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
1014293|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
1014294|NCT03073525|Stage IIIb|stage iiib
1014295|NCT03073525|Stage IV|stage iv
1014296|NCT03073525|Ovarian Cancer|ovarian cancer
1014297|NCT03073525|Cervical Cancer|cervical cancer
1014298|NCT03073525|Uterine Cancer|uterine cancer
1014299|NCT03073525|Immunotherapy|immunotherapy
1014300|NCT03073447|Myocardial infarction|myocardial infarction
1014301|NCT03073447|Women|women
1014302|NCT03073447|Young|young
1014303|NCT03073447|Primary PCI|primary pci
1014304|NCT03073447|Hormone|hormone
1014305|NCT03073408|Propofol|propofol
1014306|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
1014307|NCT03073408|Closed loop|closed loop
1014308|NCT03073356|Myocardial metabolism|myocardial metabolism
1014309|NCT03073356|Positron emission tomography|positron emission tomography
1014310|NCT03073356|Echocardiography|echocardiography
1014311|NCT03073356|Right sided heart catheterization|right sided heart catheterization
1014312|NCT03073317|Preterm Infants|preterm infants
1014313|NCT03073317|Premature Birth|premature birth
1014314|NCT03073317|Placenta growth factor|placenta growth factor
1014315|NCT03073317|Prenatal Care|prenatal care
1014316|NCT03073317|PERINATAL MORTALITY|perinatal mortality
1014317|NCT03073317|Pre-Eclampsia|pre-eclampsia
1014318|NCT03073304|isolated limb perfusion|isolated limb perfusion
1014319|NCT03073291|cannabis|cannabis
1014320|NCT03073291|commerce|commerce
1014321|NCT03073265|DOAC|doac
1014322|NCT03073265|apixaban|apixaban
1014324|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1014325|NCT03073239|Bulbar disfunction|bulbar disfunction
1014326|NCT03073239|Rik factors ALS|rik factors als
1014327|NCT03073200|children|children
1014332|NCT03073187|Adolescents|adolescents
1014333|NCT03073187|Urban|urban
1014334|NCT03073187|Intervention|intervention
1014335|NCT03073187|High school|high school
1014336|NCT03073174|dietary intake|dietary intake
1014337|NCT03073174|nutritional supplements|nutritional supplements
1014338|NCT03073174|sanative therapy|sanative therapy
1014339|NCT03073174|healing|healing
1014340|NCT03073174|flavonoids|flavonoids
1014341|NCT03073174|tea|tea
1014342|NCT03073161|flavonoids|flavonoids
1014343|NCT03073161|tea|tea
1014344|NCT03073161|dietary intake|dietary intake
1014345|NCT03073161|nutritional supplements|nutritional supplements
1014346|NCT03073161|periodontal disease|periodontal disease
1014347|NCT03073161|healing|healing
1014348|NCT03073161|sanative therapy|sanative therapy
1014349|NCT03073096|axillary nodal dissection|axillary nodal dissection
1014350|NCT03073096|groin nodal dissection|groin nodal dissection
1014351|NCT03073083|autograft|autograft
1014352|NCT03073070|diabetic children|diabetic children
1014353|NCT03073070|RBC lifespan|rbc lifespan
1014354|NCT03073044|Quality of life|quality of life
1014355|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
1014356|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
1014357|NCT03073005|heart failure|heart failure
1014358|NCT03073005|simulation|simulation
1014363|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
1014364|NCT03072927|Interspinous process decompression|interspinous process decompression
1014365|NCT03072927|MILD|mild
1014366|NCT03072927|Medicare|medicare
1014367|NCT03072888|acute pain|acute pain
1014368|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1014369|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
1014370|NCT03072875|Suicidality|suicidality
1014371|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
1014372|NCT03072875|Technology|technology
1014373|NCT03072875|Suicide Prevention|suicide prevention
1014374|NCT03072875|Suicide Intervention|suicide intervention
1014375|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
1014376|NCT03072849|Pediatrics|pediatrics
1014377|NCT03072849|Airflow obstruction|airflow obstruction
1014378|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
1014379|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1014380|NCT03072823|CVDs|cvds
1014381|NCT03072823|cardiovascular diseases|cardiovascular diseases
1014382|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1014383|NCT03072823|depression|depression
1014384|NCT03072810|Positive psychology|positive psychology
1014385|NCT03072810|Wellbeing|wellbeing
1014386|NCT03072810|Chronic pain|chronic pain
1014387|NCT03072810|Mindfulness|mindfulness
1014388|NCT03072797|Atherosclerosis|atherosclerosis
1014389|NCT03072797|Longitudinal|longitudinal
1014390|NCT03072797|Biomarker|biomarker
1014391|NCT03072797|Coronary angiography|coronary angiography
1014392|NCT03072797|Follow-up|follow-up
1014393|NCT03072797|Metabolomics|metabolomics
1014394|NCT03072797|Risk factor|risk factor
1014395|NCT03072758|Male partner involvement|male partner involvement
1014396|NCT03072745|Cognitive Impairment|cognitive impairment
1014397|NCT03072732|Heart Failure|heart failure
1014398|NCT03072732|Hemodialysis|hemodialysis
1014399|NCT03072706|hip replacement|hip replacement
1014400|NCT03072706|acetabulum|acetabulum
1014401|NCT03072706|anteversion|anteversion
1014402|NCT03072706|position|position
1014403|NCT03072706|guide|guide
1014404|NCT03072667|prematurity|prematurity
1014405|NCT03072667|bowel atresia|bowel atresia
1014406|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
1014407|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
1014408|NCT03072667|intestinal failure|intestinal failure
1014409|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
1014410|NCT03072667|fish oil|fish oil
1014411|NCT03072641|Probiotics|probiotics
1014412|NCT03072641|Epigenetics|epigenetics
1014413|NCT03072641|Microbiota|microbiota
1014414|NCT03072628|nicotine|nicotine
1014415|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
1014416|NCT03072628|oxidative stress|oxidative stress
1014417|NCT03072602|Racial differences|racial differences
1014418|NCT03072576|Diagnosis|diagnosis
1014419|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
1014420|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
1014421|NCT03072550|fungal nail|fungal nail
1014422|NCT03072550|toenail fungus|toenail fungus
1014423|NCT03072537|growth, BMI, obesity, overweight, weight, height, childhood, adolescence, development|growth, bmi, obesity, overweight, weight, height, childhood, adolescence, development
1014424|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
1014425|NCT03072524|severe hemiparesis|severe hemiparesis
1015524|NCT03066388|SIRS|sirs
1014426|NCT03072524|large vessel occlusion|large vessel occlusion
1014427|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
1014429|NCT03072472|Colorectal Cancer|colorectal cancer
1014430|NCT03072472|Endoscopy|endoscopy
1014431|NCT03072472|Screening|screening
1014432|NCT03072472|Colonic Adenoma|colonic adenoma
1014433|NCT03072472|Adenoma Detection Rate|adenoma detection rate
1014434|NCT03072472|Endocuff|endocuff
1014435|NCT03072472|Endocuff Vision|endocuff vision
1014436|NCT03072446|Uterine Fibroid|uterine fibroid
1014437|NCT03072446|Embolization|embolization
1014438|NCT03072446|symptoms|symptoms
1014439|NCT03072446|Gel-Beads|gel-beads
1014440|NCT03072433|child malnutrition|child malnutrition
1014441|NCT03072433|child development|child development
1014442|NCT03072433|counseling|counseling
1014443|NCT03072420|MRI, fingers compression|mri, fingers compression
1014444|NCT03072381|CLE|cle
1014445|NCT03072381|epicondylosis|epicondylosis
1014446|NCT03072381|platelet rich plasma|platelet rich plasma
1014447|NCT03072381|PRP|prp
1014448|NCT03072381|ultrasound|ultrasound
1014449|NCT03072381|shear wave ultrasound|shear wave ultrasound
1014450|NCT03072381|tendinopathy|tendinopathy
1014451|NCT03072381|elbow|elbow
1014452|NCT03072381|tenis elbow|tenis elbow
1014453|NCT03072381|plasma|plasma
1014454|NCT03072381|plasma injection|plasma injection
1014455|NCT03072381|tendinosis|tendinosis
1014456|NCT03072381|tendinitis|tendinitis
1014457|NCT03072355|fatigue|fatigue
1014458|NCT03072355|resistance test|resistance test
1014459|NCT03072316|breast cancer|breast cancer
1014460|NCT03072316|mastectomy|mastectomy
1014461|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
1014462|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
1014463|NCT03072303|Brittle Bone|brittle bone
1014464|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
1014465|NCT03072303|BBD|bbd
1014466|NCT03072303|OI|oi
1014467|NCT03072303|Congenital Abnormalities|congenital abnormalities
1014468|NCT03072303|Congenital Bone Disorder|congenital bone disorder
1014469|NCT03072303|Lobstein Syndrome|lobstein syndrome
1014470|NCT03072277|DHA|dha
1014471|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
1014472|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
1014473|NCT03072277|Newborn Outcome|newborn outcome
1014474|NCT03072277|Birth Size|birth size
1014475|NCT03072277|Gestational Age|gestational age
1014476|NCT03072277|DASII|dasii
1014477|NCT03072277|Prenatal Supplementation|prenatal supplementation
1014478|NCT03072277|Randomized Controlled Trial|randomized controlled trial
1014479|NCT03072277|Neurodevelopment|neurodevelopment
1014480|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
1014481|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
1014482|NCT03072225|herbal medicine|herbal medicine
1014483|NCT03072225|stroke|stroke
1014484|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
1014485|NCT03072212|HIV|hiv
1014486|NCT03072212|Stroke|stroke
1014487|NCT03072212|Cerebral vascular accident|cerebral vascular accident
1014488|NCT03072212|Uganda|uganda
1014489|NCT03072199|Rituximab|rituximab
1014490|NCT03072199|B cells|b cells
1014491|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
1014492|NCT03072160|Vaccine Therapy|vaccine therapy
1014493|NCT03072160|TKI-Naive|tki-naive
1014494|NCT03072134|Glioma|glioma
1014495|NCT03072134|Glioblastoma|glioblastoma
1014496|NCT03072134|Astrocytoma|astrocytoma
1014497|NCT03072134|Brain Cancer|brain cancer
1014498|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
1014499|NCT03072134|Temozolomide|temozolomide
1014500|NCT03072134|Radiation|radiation
1014501|NCT03072134|Neural Stem Cells|neural stem cells
1014502|NCT03072134|Virotherapy|virotherapy
1014503|NCT03072134|Adenovirus|adenovirus
1014504|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
1014505|NCT03072121|coronary artery disease|coronary artery disease
1014506|NCT03072121|revascularization|revascularization
1014507|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
1014508|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
1014509|NCT03072095|Colonic Neoplasms|colonic neoplasms
1014510|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1014511|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
1014512|NCT03072095|Neoplasms|neoplasms
1014513|NCT03072095|Digestive System Diseases|digestive system diseases
1014514|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
1014515|NCT03072095|Colonic Diseases|colonic diseases
1014516|NCT03072095|Rectal Diseases|rectal diseases
1014517|NCT03072082|coronary artery disease|coronary artery disease
1014518|NCT03072082|revascularization|revascularization
1014519|NCT03072082|Danlou Tablet|danlou tablet
1014520|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1014521|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
1014522|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
1014523|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
1014524|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1014525|NCT03072030|Ebola Virus Disease|ebola virus disease
1014526|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
1014527|NCT03072030|Vaccines|vaccines
1664755|NCT00125515|Heroin|heroin
1014528|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
1014529|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
1014531|NCT03072004|Neuropathy|neuropathy
1014532|NCT03072004|LLLT|lllt
1014533|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
1014534|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
1014535|NCT03071991|postoperative pain|postoperative pain
1014536|NCT03071978|Heart Failure|heart failure
1014537|NCT03071978|LV-fusion pacing|lv-fusion pacing
1014538|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1014539|NCT03071952|Heart Failure|heart failure
1014540|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
1014541|NCT03071952|Rate Response|rate response
1014542|NCT03071952|Exercise Test|exercise test
1014543|NCT03071874|Meningioma|meningioma
1014544|NCT03071861|darbepoetin|darbepoetin
1014545|NCT03071861|Brain Diseases|brain diseases
1014546|NCT03071835|Stem Cells|stem cells
1014547|NCT03071835|Cardiovascular|cardiovascular
1014548|NCT03071835|Quality of Life|quality of life
1014549|NCT03071835|Cardiomyopathy|cardiomyopathy
1014550|NCT03071822|PTCLs|ptcls
1014551|NCT03071809|Solid tumor|solid tumor
1014552|NCT03071809|carcinoma|carcinoma
1014553|NCT03071809|sarcoma|sarcoma
1014554|NCT03071809|stage I|stage i
1014555|NCT03071809|stage II|stage ii
1014556|NCT03071809|stage III|stage iii
1014557|NCT03071770|Healthy Volunteers|healthy volunteers
1014558|NCT03071770|Japanese|japanese
1014559|NCT03071770|Caucasian|caucasian
1014560|NCT03071757|Solid Tumors|solid tumors
1014561|NCT03071757|Cancer|cancer
1014562|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
1014563|NCT03071757|Advanced Solid Tumors|advanced solid tumors
1014564|NCT03071757|Triple negative breast cancer|triple negative breast cancer
1014565|NCT03071757|Ovarian cancer|ovarian cancer
1014566|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1014567|NCT03071757|Gastric cancer|gastric cancer
1014568|NCT03071757|Mesothelioma|mesothelioma
1014569|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1014570|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
1014571|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
1014572|NCT03071757|Melanoma|melanoma
1014573|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1014574|NCT03071731|Glittre|glittre
1014575|NCT03071731|COPD|copd
1014576|NCT03071731|sit-to-stand|sit-to-stand
1014577|NCT03071731|responsiveness|responsiveness
1014578|NCT03071731|bronchodilation|bronchodilation
1014579|NCT03071718|cardiovascular diseases|cardiovascular diseases
1014580|NCT03071718|gut microbiota|gut microbiota
1014581|NCT03071718|Mediterranean diet|mediterranean diet
1014582|NCT03071705|NSCLC|nsclc
1014583|NCT03071705|metformin|metformin
1014584|NCT03071705|metformin plus TKI|metformin plus tki
1014585|NCT03071705|EGFR positive status|egfr positive status
1014586|NCT03071666|Nepal|nepal
1014587|NCT03071666|South Asia|south asia
1014588|NCT03071666|Nutrition|nutrition
1014589|NCT03071666|Pregnancy|pregnancy
1014590|NCT03071666|Neurodevelopment|neurodevelopment
1014591|NCT03071666|Growth|growth
1014592|NCT03071653|Cardiomyopathy|cardiomyopathy
1014593|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
1014594|NCT03071640|old|old
1014595|NCT03071640|elderly|elderly
1014596|NCT03071640|radiotherapy|radiotherapy
1014597|NCT03071640|geriatric assessment|geriatric assessment
1014598|NCT03071627|Spin|spin
1014599|NCT03071627|Misleading reporting|misleading reporting
1014600|NCT03071627|Misleading interpretation|misleading interpretation
1014601|NCT03071627|Misleading extrapolation|misleading extrapolation
1014602|NCT03071627|Animal studies|animal studies
1014603|NCT03071627|Cell culture studies|cell culture studies
1014604|NCT03071627|Pre-clinical studies|pre-clinical studies
1014605|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
1014606|NCT03071614|Misleading reporting|misleading reporting
1014607|NCT03071614|Misleading interpretation|misleading interpretation
1014608|NCT03071614|Misleading extrapolation|misleading extrapolation
1014609|NCT03071614|Animal studies|animal studies
1014610|NCT03071614|Cell culture studies|cell culture studies
1014611|NCT03071614|Pre-clinical studies|pre-clinical studies
1014612|NCT03071601|Laceration|laceration
1014613|NCT03071601|Suture|suture
1014614|NCT03071601|Topical anesthesia|topical anesthesia
1014615|NCT03071601|Lidocaine|lidocaine
1014616|NCT03071575|measles|measles
1014617|NCT03071575|rubella|rubella
1014618|NCT03071575|immunogenicity|immunogenicity
1014619|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
1014620|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
1014621|NCT03071562|HIV|hiv
1014622|NCT03071562|Cognitive impairment|cognitive impairment
1014623|NCT03071562|Aging|aging
1015731|NCT03065348|hydration|hydration
1014624|NCT03071562|Physical Activity|physical activity
1040478|NCT02910960|EUS|eus
1014625|NCT03071562|Exercise|exercise
1014626|NCT03071562|Yoga|yoga
1014627|NCT03071562|Neuroplasticity|neuroplasticity
1014628|NCT03071549|Acne vulgaris|acne vulgaris
1014629|NCT03071549|Chemical peeling|chemical peeling
1014630|NCT03071549|Dermoscopy|dermoscopy
1014631|NCT03071536|furosemide stress test|furosemide stress test
1014632|NCT03071536|kidney transplantation|kidney transplantation
1014633|NCT03071536|urine output|urine output
1014634|NCT03071536|perioperation|perioperation
1014635|NCT03071536|delayed graft function|delayed graft function
1014636|NCT03071497|Iron-deficiency|iron-deficiency
1014637|NCT03071497|Anemia|anemia
1014638|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
1014639|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
1014640|NCT03071484|Early Stages of Psychosis|early stages of psychosis
1014641|NCT03071484|Schizophrenia|schizophrenia
1014642|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1014643|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
1014644|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
1014645|NCT03071419|fathers|fathers
1014646|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
1014647|NCT03071406|Metastatic|metastatic
1014648|NCT03071406|Metastasis|metastasis
1014649|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1014650|NCT03071406|Immunology|immunology
1014651|NCT03071406|Antibody|antibody
1014652|NCT03071406|Nivolumab|nivolumab
1014654|NCT03071406|Metastatic skin cancer|metastatic skin cancer
1014655|NCT03071406|Cutaneous|cutaneous
1014656|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
1014657|NCT03071393|walking|walking
1014658|NCT03071393|breathing|breathing
1014659|NCT03071393|standing|standing
1014660|NCT03071393|sitting|sitting
1014661|NCT03071393|spinal cord injury|spinal cord injury
1014662|NCT03071367|Airway Management|airway management
1014663|NCT03071367|Medical students|medical students
1014664|NCT03071367|Intratracheal intubation|intratracheal intubation
1014665|NCT03071367|Educational Technology|educational technology
1014666|NCT03071354|ICU-acquired weakness|icu-acquired weakness
1014667|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
1014668|NCT03071315|Economic evaluation|economic evaluation
1014669|NCT03071315|Heroin dependence|heroin dependence
1014670|NCT03071315|Compulsory treatment|compulsory treatment
1014671|NCT03071315|Methadone treatment|methadone treatment
1014672|NCT03071315|Vietnam|vietnam
1014673|NCT03071315|East and Southeast Asia|east and southeast asia
1014674|NCT03071315|Cost-effectiveness|cost-effectiveness
1014675|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
1014676|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
1014677|NCT03071263|Hyperkalemia|hyperkalemia
1014678|NCT03071263|Potassium|potassium
1014679|NCT03071263|Chronic Kidney Disease|chronic kidney disease
1014680|NCT03071263|Hypertension|hypertension
1014681|NCT03071263|Resistant Hypertension|resistant hypertension
1014682|NCT03071263|Spironolactone|spironolactone
1014683|NCT03071237|infrapyloric artery|infrapyloric artery
1014684|NCT03071237|gastric cancer|gastric cancer
1014685|NCT03071224|AD|ad
1014686|NCT03071224|HV|hv
1014687|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
1014688|NCT03071211|urinary catheters|urinary catheters
1014689|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1014690|NCT03071185|free flap|free flap
1014691|NCT03071185|nerve block|nerve block
1014692|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
1014693|NCT03071185|free fibular|free fibular
1014694|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
1014695|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
1014696|NCT03071159|Usability|usability
1014697|NCT03071159|Metabolic control|metabolic control
1014698|NCT03071055|Macular Degeneration|macular degeneration
1014699|NCT03071055|AMD|amd
1014700|NCT03071055|Wet AMD|wet amd
1014701|NCT03071055|Lucentis|lucentis
1014702|NCT03071029|family planning|family planning
1014703|NCT03071029|reproductive health|reproductive health
1014704|NCT03071029|abortion|abortion
1014705|NCT03071029|health providers|health providers
1014706|NCT03071016|T2D,|t2d,
1014707|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
1014708|NCT03071016|T2DM|t2dm
1014709|NCT03071003|Pharmacokinetics|pharmacokinetics
1014710|NCT03071003|Healthy Volunteer Study|healthy volunteer study
1014711|NCT03070990|Enfortumab vedotin|enfortumab vedotin
1014712|NCT03070990|ASG-22CE|asg-22ce
1014713|NCT03070990|ASG-22ME|asg-22me
1014714|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
1014715|NCT03070977|Interprofessional education|interprofessional education
1014716|NCT03070977|study unit|study unit
1014717|NCT03070977|Psychiatry|psychiatry
1014718|NCT03070951|Uterine Fibroid|uterine fibroid
1014719|NCT03070951|Leiomyomata|leiomyomata
1014720|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
1014721|NCT03070951|HMB|hmb
1014722|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
1014723|NCT03070951|Menorrhagia|menorrhagia
1014724|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
1014725|NCT03070938|Chronic wounds|chronic wounds
1014726|NCT03070938|Acute Wounds|acute wounds
1014728|NCT03070938|Wound Management|wound management
1014729|NCT03070938|Bioburden|bioburden
1014730|NCT03070938|Collagen|collagen
1014731|NCT03070925|Antimicrobial|antimicrobial
1014732|NCT03070925|Collagen|collagen
1014733|NCT03070925|Bioburden|bioburden
1014734|NCT03070925|Biofilm|biofilm
1014735|NCT03070925|PHMB|phmb
1014736|NCT03070925|Chronic wounds|chronic wounds
1014737|NCT03070925|Acute wounds|acute wounds
1014738|NCT03070912|mechanical circulatory support|mechanical circulatory support
1014739|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
1014740|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
1014741|NCT03070899|Uterine Fibroid|uterine fibroid
1014742|NCT03070899|Leiomyomata|leiomyomata
1014743|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
1014744|NCT03070899|HMB|hmb
1014745|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
1014746|NCT03070899|Menorrhagia|menorrhagia
1014747|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
1014748|NCT03070873|Quality of life|quality of life
1014749|NCT03070873|Vaginal mesh|vaginal mesh
1014750|NCT03070873|Mesh complications|mesh complications
1014751|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
1014752|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
1014753|NCT03070860|Calcium Score|calcium score
1014754|NCT03070847|tranexamic acid|tranexamic acid
1014756|NCT03070847|bleeding reduction|bleeding reduction
1014757|NCT03070821|neurofeedback|neurofeedback
1014758|NCT03070821|real-time functional MRI|real-time functional mri
1014759|NCT03070821|parahippocampus|parahippocampus
1014760|NCT03070808|obesity|obesity
1014761|NCT03070808|voice|voice
1014762|NCT03070795|post-operative ileus|post-operative ileus
1014763|NCT03070795|early feeding|early feeding
1014764|NCT03070795|delayed feeding|delayed feeding
1014765|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
1014766|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
1014767|NCT03070782|Dyslipidemia|dyslipidemia
1014768|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
1014769|NCT03070782|Hyperlipidemia|hyperlipidemia
1014770|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
1014771|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
1014772|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
1014773|NCT03070782|Lipoprotein|lipoprotein
1014774|NCT03070782|Lipoprotein(a)|lipoprotein(a)
1014775|NCT03070782|Lipoprotein a|lipoprotein a
1014776|NCT03070782|Lp(a)|lp(a)
1014777|NCT03070782|Lp a|lp a
1014778|NCT03070756|auto-CPAP|auto-cpap
1014779|NCT03070756|forced oscillation technique|forced oscillation technique
1014780|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
1014781|NCT03070743|basilar invagination|basilar invagination
1014782|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
1014783|NCT03070743|surgery|surgery
1014784|NCT03070743|restoration technique|restoration technique
1014785|NCT03070730|Tachycardia|tachycardia
1014786|NCT03070730|orthostatic symptoms|orthostatic symptoms
1014787|NCT03070730|autonomic reflex|autonomic reflex
1014788|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
1014789|NCT03070691|Basal cell carcinoma|basal cell carcinoma
1014790|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
1014791|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
1014792|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
1014793|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
1014794|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
1014795|NCT03070691|topical|topical
1014796|NCT03070691|Smoothened|smoothened
1014797|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
1014798|NCT03070665|postoperation bleeding|postoperation bleeding
1014799|NCT03070652|attachment|attachment
1014800|NCT03070652|bonding psychological|bonding psychological
1014801|NCT03070626|General Surgery|general surgery
1014802|NCT03070626|Carbohydrates|carbohydrates
1014803|NCT03070626|Perioperative|perioperative
1014804|NCT03070613|Colonoscopy|colonoscopy
1014805|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
1014806|NCT03070600|PrEP|prep
1014807|NCT03070574|Lynch Syndrome|lynch syndrome
1014808|NCT03070574|Chemoprevention|chemoprevention
1014809|NCT03070574|Mesalazine|mesalazine
1014810|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
1014811|NCT03070496|Myocardial infarction|myocardial infarction
1014812|NCT03070496|bio-collection|bio-collection
1014813|NCT03070496|Imaging markers|imaging markers
1014814|NCT03070496|biomarkers|biomarkers
1014815|NCT03070496|STEMI|stemi
1014816|NCT03070496|clinical outcomes|clinical outcomes
1014817|NCT03070457|bariatric surgery|bariatric surgery
1014818|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
1014819|NCT03070457|eras|eras
1014820|NCT03070444|Essix retainer|essix retainer
1014821|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
1014822|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
1014824|NCT03070418|DCS|dcs
1014825|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
1014826|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1014827|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
1014828|NCT03070405|Tuberculosis|tuberculosis
1014829|NCT03070405|HIV|hiv
1014830|NCT03070392|Melanoma|melanoma
1014831|NCT03070392|Uveal Cancer|uveal cancer
1014832|NCT03070392|IMCgp100|imcgp100
1014833|NCT03070392|Immunotherapy|immunotherapy
1014834|NCT03070366|Oligometastasis|oligometastasis
1014835|NCT03070366|stereotactic irradiation|stereotactic irradiation
1014836|NCT03070353|Cirrhosis|cirrhosis
1014837|NCT03070353|AKI|aki
1014838|NCT03070353|Albumin|albumin
1014839|NCT03070353|Dextran|dextran
1014840|NCT03070340|mastectomy|mastectomy
1014841|NCT03070340|breast MRI|breast mri
1014842|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
1014843|NCT03070340|CEDM|cedm
1014844|NCT03070340|17-045|17-045
1014845|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
1014846|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
1014847|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
1014848|NCT03070327|Lenalidomide|lenalidomide
1014849|NCT03070327|17-025|17-025
1014850|NCT03070314|Echinacea|echinacea
1014851|NCT03070314|bioavailability|bioavailability
1014852|NCT03070314|children|children
1014853|NCT03070301|LEE011|lee011
1014854|NCT03070301|Everolimus|everolimus
1014855|NCT03070301|16-1535|16-1535
1014856|NCT03070288|RGB|rgb
1014857|NCT03070288|red-green-blue|red-green-blue
1014858|NCT03070288|rhinitis|rhinitis
1014859|NCT03070288|allergic rhinitis|allergic rhinitis
1014860|NCT03070288|nasal mucosa|nasal mucosa
1014861|NCT03070275|surgical implant placement|surgical implant placement
1014862|NCT03070275|crestal bone|crestal bone
1014863|NCT03070275|mucosa thickness|mucosa thickness
1014864|NCT03070275|stem cells|stem cells
1014865|NCT03070275|fibrin glue|fibrin glue
1014866|NCT03070275|collagen fleece|collagen fleece
1014867|NCT03070262|esophageal cancer|esophageal cancer
1014868|NCT03070262|caffeic acid|caffeic acid
1014869|NCT03070249|Emergency Department|emergency department
1014870|NCT03070236|Breast Cancer|breast cancer
1014871|NCT03070184|Racial differences|racial differences
1014872|NCT03070158|Premature Infant|premature infant
1014873|NCT03070158|Mother-Infant Interaction|mother-infant interaction
1014874|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
1014875|NCT03070158|Touch|touch
1014876|NCT03070158|Visual Stimulation|visual stimulation
1014877|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
1014879|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1014880|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
1014881|NCT03070093|gilteritinib|gilteritinib
1014882|NCT03070093|Expanded access|expanded access
1014883|NCT03070093|ASP2215|asp2215
1014884|NCT03070015|Weight Loss|weight loss
1014885|NCT03070015|Obesity|obesity
1014886|NCT03070015|Overweight|overweight
1014887|NCT03069989|Tolerability|tolerability
1014888|NCT03069989|IPF|ipf
1014889|NCT03069989|PET imaging|pet imaging
1014890|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1014891|NCT03069989|Safety|safety
1014892|NCT03069989|Pharmacokinetics|pharmacokinetics
1014893|NCT03069989|Double-blind|double-blind
1014894|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
1014895|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
1014896|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
1014897|NCT03069950|FLUOROURACIL|fluorouracil
1014898|NCT03069950|PANITUMUMAB|panitumumab
1014899|NCT03069950|16-1341|16-1341
1014900|NCT03069911|Parkinson Disease|parkinson disease
1014901|NCT03069911|Parkinsonism|parkinsonism
1014902|NCT03069911|Depression|depression
1014903|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
1014904|NCT03069911|BOTOX|botox
1014905|NCT03069898|Marital relationship|marital relationship
1014906|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
1014907|NCT03069872|General practice|general practice
1014908|NCT03069872|Early diagnosis|early diagnosis
1014909|NCT03069872|Symptoms|symptoms
1014910|NCT03069859|Post partum hemorrhage|post partum hemorrhage
1014911|NCT03069859|Tranexamic acid|tranexamic acid
1014912|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
1014913|NCT03069859|C-section|c-section
1014914|NCT03069846|skin cancer|skin cancer
1014915|NCT03069846|laser spectroscopy|laser spectroscopy
1014916|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
1014917|NCT03069781|estrogen|estrogen
1014918|NCT03069768|Nicotine addiction|nicotine addiction
1014919|NCT03069768|Cigarette smoking|cigarette smoking
1014920|NCT03069768|Smoking cessation|smoking cessation
1014921|NCT03069768|Quit smoking|quit smoking
1014922|NCT03069755|India|india
1014923|NCT03069755|Perioperative mortality|perioperative mortality
1014924|NCT03069755|Trauma|trauma
1014925|NCT03069755|Surgery|surgery
1014926|NCT03069742|Breast Cancer Prevention|breast cancer prevention
1014927|NCT03069742|Risk Assessment|risk assessment
1014928|NCT03069742|Chemoprevention|chemoprevention
1014929|NCT03069742|Decision Making|decision making
1014930|NCT03069729|screen|screen
1014931|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1014932|NCT03069703|Vaccine|vaccine
1014933|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
1014934|NCT03069703|pneumovax|pneumovax
1014935|NCT03069703|prevenar|prevenar
1014936|NCT03069703|pneumovas|pneumovas
1014937|NCT03069677|midazolam|midazolam
1014938|NCT03069664|Pancreatic Cancer|pancreatic cancer
1014939|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
1014940|NCT03069664|Endoscopic treatment|endoscopic treatment
1014941|NCT03069638|sedation|sedation
1014942|NCT03069638|pediatrics|pediatrics
1014943|NCT03069638|intranasal sedation|intranasal sedation
1014944|NCT03069638|dexmedetomidine|dexmedetomidine
1014945|NCT03069638|dinitrous oxide|dinitrous oxide
1014946|NCT03069638|intra-articular joint injection|intra-articular joint injection
1014947|NCT03069625|Cystic Fibrosis|cystic fibrosis
1014948|NCT03069625|Exercise Testing|exercise testing
1014949|NCT03069625|Muscular strength|muscular strength
1014950|NCT03069625|Pediatrics|pediatrics
1014951|NCT03069625|Quality of life|quality of life
1014952|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1014953|NCT03069612|working memory|working memory
1014954|NCT03069612|gamma oscillations|gamma oscillations
1014955|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1014956|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
1014957|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
1014960|NCT03069560|suicide attempt|suicide attempt
1014961|NCT03069560|SMS monitoring|sms monitoring
1014962|NCT03069560|Phone|phone
1014963|NCT03069560|Prevention control|prevention control
1014964|NCT03069560|tertiary healthcare|tertiary healthcare
1014965|NCT03069534|MDR-TB|mdr-tb
1014966|NCT03069534|rhIL-2|rhil-2
1014967|NCT03069534|immunotherapy|immunotherapy
1014968|NCT03069495|Allergy|allergy
1014969|NCT03069495|Asthma|asthma
1014970|NCT03069495|Urticaria|urticaria
1014971|NCT03069482|Smoking|smoking
1014972|NCT03069482|mHealth|mhealth
1014973|NCT03069482|Serious Mental Illness|serious mental illness
1014974|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
1014975|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
1014976|NCT03069469|CSF1R|csf1r
1014978|NCT03069469|CML|cml
1014979|NCT03069469|AML|aml
1014980|NCT03069469|MDS|mds
1014981|NCT03069456|sevoflurane|sevoflurane
1014982|NCT03069456|Bistpectral index|bistpectral index
1014983|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
1014984|NCT03069456|population pharmacodynamics|population pharmacodynamics
1014985|NCT03069443|Isometric handgrip training|isometric handgrip training
1014986|NCT03069443|home training|home training
1014987|NCT03069443|older adults|older adults
1014988|NCT03069443|Hypertension|hypertension
1014989|NCT03069417|HIV|hiv
1014990|NCT03069417|Medication adherence|medication adherence
1014991|NCT03069417|PMTCT|pmtct
1014992|NCT03069417|Depression|depression
1014993|NCT03069391|exercise|exercise
1014994|NCT03069391|exergame|exergame
1014995|NCT03069378|Metastatic|metastatic
1014996|NCT03069378|Locally Advanced|locally advanced
1014997|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
1014998|NCT03069378|Pembrolizumab|pembrolizumab
1014999|NCT03069378|16-1534|16-1534
1015000|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
1015001|NCT03069365|Chronic Kidney Disease|chronic kidney disease
1015002|NCT03069365|Glecaprevir|glecaprevir
1015003|NCT03069365|Pibrentasvir|pibrentasvir
1015004|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
1015005|NCT03069365|compensated cirrhosis|compensated cirrhosis
1015006|NCT03069365|non-cirrhotic|non-cirrhotic
1015007|NCT03069365|interferon (IFN)|interferon (ifn)
1015008|NCT03069365|treatment naïve|treatment naïve
1015009|NCT03069365|sofosbuvir (SOF)|sofosbuvir (sof)
1015010|NCT03069365|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
1015011|NCT03069365|ribavirin (RBV)|ribavirin (rbv)
1015012|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
1015013|NCT03069352|Leukemia|leukemia
1015014|NCT03069352|Treatment naïve|treatment naïve
1015015|NCT03069352|Venetoclax|venetoclax
1015016|NCT03069352|Cytarabine|cytarabine
1015017|NCT03069326|Ruxolitinib|ruxolitinib
1015018|NCT03069326|Thalidomide|thalidomide
1015019|NCT03069326|16-1498|16-1498
1015020|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
1015021|NCT03069313|Breast Cancer|breast cancer
1015022|NCT03069313|Arthralgia|arthralgia
1015023|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
1015024|NCT03069313|Joint pain|joint pain
1015025|NCT03069261|Breast reconstruction|breast reconstruction
1015026|NCT03069261|Autologous tissue flaps|autologous tissue flaps
1015027|NCT03069261|Indocyanine green angiography|indocyanine green angiography
1015028|NCT03069261|Breast cancer|breast cancer
1015030|NCT03069235|Breast Feeding|breast feeding
1015031|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
1015032|NCT03069196|Prevalence|prevalence
1015033|NCT03069196|Incidence|incidence
1015034|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
1015035|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
1015036|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
1015037|NCT03069183|Fascia Iliaca Block|fascia iliaca block
1015038|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
1015039|NCT03069183|Total Hip Replacement|total hip replacement
1015040|NCT03069183|Ultrasound|ultrasound
1015041|NCT03069144|Psoriasis|psoriasis
1015042|NCT03069144|Topical|topical
1015043|NCT03069131|primary prophylaxis|primary prophylaxis
1015044|NCT03069131|rifaximin|rifaximin
1015045|NCT03069118|Telemedicine|telemedicine
1015046|NCT03069118|Online Treatment|online treatment
1015047|NCT03069118|Digital Intervention|digital intervention
1015048|NCT03069079|primary immunodeficiency|primary immunodeficiency
1015049|NCT03069079|dental health|dental health
1015050|NCT03069079|neutrophil defect|neutrophil defect
1015051|NCT03069079|periodontitis|periodontitis
1015052|NCT03069066|In-stent restenosis|in-stent restenosis
1015053|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
1015054|NCT03069066|Stent|stent
1015055|NCT03069066|Drug-eluting stent|drug-eluting stent
1015056|NCT03069066|Coronary angiography|coronary angiography
1015057|NCT03069066|Scoring balloon|scoring balloon
1015058|NCT03069040|cervical cancer|cervical cancer
1015059|NCT03069040|NSRH|nsrh
1015060|NCT03069040|RH|rh
1015061|NCT03069040|urine flow mechanics|urine flow mechanics
1015062|NCT03069040|anorectal dynamics|anorectal dynamics
1015063|NCT03069027|Nasal surgery|nasal surgery
1015064|NCT03069027|external nasal nerve block|external nasal nerve block
1015065|NCT03069027|postoperative agitation|postoperative agitation
1015066|NCT03069001|HCV treatment|hcv treatment
1015067|NCT03068988|bone marrow stem cells|bone marrow stem cells
1015068|NCT03068988|rotator cuff lesion|rotator cuff lesion
1015069|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1015070|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
1015071|NCT03068936|Cisplatin|cisplatin
1015072|NCT03068923|Blood clot|blood clot
1015073|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
1015074|NCT03068923|Pulmonary Embolism|pulmonary embolism
1015075|NCT03068923|Lower Extremity|lower extremity
1015076|NCT03068923|Upper Extremity|upper extremity
1015077|NCT03068923|Cerebral sinus|cerebral sinus
1015078|NCT03068923|Renal vein|renal vein
1015079|NCT03068923|Portal vein|portal vein
1015080|NCT03068923|thrombin|thrombin
1015081|NCT03068923|fibrinolysis|fibrinolysis
1015082|NCT03068923|coagulation|coagulation
1015083|NCT03068923|anticoagulation|anticoagulation
1015084|NCT03068923|Post trombotic syndrome|post trombotic syndrome
1015085|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
1015086|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1015087|NCT03068910|PCOS|pcos
1015088|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
1015089|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
1015090|NCT03068845|drug-eluting balloon|drug-eluting balloon
1015091|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
1015092|NCT03068754|ALS|als
1015093|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
1015094|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
1015095|NCT03068715|theta burst|theta burst
1015096|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
1015097|NCT03068676|Depression|depression
1015098|NCT03068676|Anxiety|anxiety
1015099|NCT03068676|Internet-delivered|internet-delivered
1015100|NCT03068676|CBT|cbt
1015101|NCT03068676|Primary Care|primary care
1015102|NCT03068663|lung cancer|lung cancer
1015103|NCT03068663|intestinal microbiota|intestinal microbiota
1015104|NCT03068663|lung microbiota|lung microbiota
1015105|NCT03068663|surgery|surgery
1015106|NCT03068663|chemotherapy|chemotherapy
1015107|NCT03068624|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
1015108|NCT03068624|Metastatic uveal melanoma|metastatic uveal melanoma
1015109|NCT03068624|Autologous CD8+ T cells|autologous cd8+ t cells
1015110|NCT03068624|Cyclophosphamide|cyclophosphamide
1015111|NCT03068624|Cytoxan|cytoxan
1015112|NCT03068624|Neosar|neosar
1015113|NCT03068624|Interleukin-2|interleukin-2
1015114|NCT03068624|IL-2|il-2
1015115|NCT03068624|Aldesleukin|aldesleukin
1015116|NCT03068624|Proleukin|proleukin
1015117|NCT03068624|Ipilimumab|ipilimumab
1015118|NCT03068624|Yervoy|yervoy
1015119|NCT03068624|BMS-734016|bms-734016
1015120|NCT03068624|MDX010|mdx010
1015121|NCT03068585|PAD|pad
1015123|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
1015124|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
1015125|NCT03068572|Linked Color imaging|linked color imaging
1015126|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
1015127|NCT03068546|Oral Microbiota|oral microbiota
1015128|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
1015129|NCT03068520|PET|pet
1015130|NCT03068520|MRI|mri
1015131|NCT03068520|BRAIN METASTASIS|brain metastasis
1015132|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
1015133|NCT03068520|RESPONSE TO TREATMENT|response to treatment
1015134|NCT03068507|Perioperative|perioperative
1015135|NCT03068507|functional capability|functional capability
1015136|NCT03068507|Prehabilitation|prehabilitation
1015137|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
1015138|NCT03068507|Lung Cancer|lung cancer
1015139|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
1015140|NCT03068494|2nd generation drug-eluting stent|2nd generation drug-eluting stent
1015141|NCT03068442|Carotid artery|carotid artery
1015142|NCT03068442|MRI|mri
1015143|NCT03068442|PET|pet
1015144|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
1015145|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
1015146|NCT03068429|fear conditioning|fear conditioning
1015147|NCT03068429|functional neuroimaging|functional neuroimaging
1015148|NCT03068429|sertraline|sertraline
1015149|NCT03068403|CEUS Perfusion|ceus perfusion
1015150|NCT03068403|Rectal Cancer|rectal cancer
1015151|NCT03068403|Tumor Perfusion|tumor perfusion
1015152|NCT03068403|Radiochemotherapy|radiochemotherapy
1015153|NCT03068377|lycopene|lycopene
1015154|NCT03068377|eye|eye
1015155|NCT03068377|vessel function|vessel function
1015156|NCT03068364|Mortality|mortality
1015157|NCT03068364|Hypertension|hypertension
1015158|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
1015159|NCT03068364|NT-proBNP|nt-probnp
1015160|NCT03068364|ECG|ecg
1015161|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
1015166|NCT03068299|Frail elderly|frail elderly
1015167|NCT03068299|Dancing therapy|dancing therapy
1015168|NCT03068299|Rural population|rural population
1015169|NCT03068273|Hospitalization|hospitalization
1015170|NCT03068260|caesarean section|caesarean section
1015171|NCT03068260|postoperative pain|postoperative pain
1015172|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
1015173|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
1015174|NCT03068208|Methylene blue|methylene blue
1015175|NCT03068208|photodynamic therapy|photodynamic therapy
1015176|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
1015177|NCT03068208|lichen amyloidosis|lichen amyloidosis
1015178|NCT03068195|laparoscopy|laparoscopy
1015179|NCT03068195|microwave|microwave
1015180|NCT03068195|ablation technique|ablation technique
1015181|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
1015182|NCT03068169|remote ECG|remote ecg
1015183|NCT03068169|atrial fibrillation|atrial fibrillation
1015184|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
1015185|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
1015186|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
1015187|NCT03068156|308-nm excimer laser|308-nm excimer laser
1015188|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
1015189|NCT03068156|lichen amyloidosis|lichen amyloidosis
1015190|NCT03068156|Asians|asians
1015191|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1015192|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
1015193|NCT03068130|PH|ph
1015194|NCT03068130|PAH|pah
1015195|NCT03068130|Bardoxolone methyl|bardoxolone methyl
1015196|NCT03068130|6-minute walk distance|6-minute walk distance
1015197|NCT03068130|CDDO-ME|cddo-me
1015198|NCT03068130|RTA 402|rta 402
1015199|NCT03068130|LARIAT|lariat
1015200|NCT03068130|CATALYST|catalyst
1015201|NCT03068130|RANGER|ranger
1015202|NCT03068117|Specialist Palliative Care|specialist palliative care
1015203|NCT03068117|Symptom Control|symptom control
1015204|NCT03068117|Early Referral|early referral
1015205|NCT03068117|Quality of Life|quality of life
1015206|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1015207|NCT03068117|Mesothelioma|mesothelioma
1015208|NCT03068104|Trauma|trauma
1015209|NCT03068104|Haemorrhage|haemorrhage
1015210|NCT03068104|Massive transfusion|massive transfusion
1015211|NCT03068104|India|india
1015212|NCT03068091|Interstitial Lung Disease|interstitial lung disease
1015213|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1015214|NCT03068065|Liraglutide|liraglutide
1015215|NCT03068065|Metformin|metformin
1015216|NCT03068065|Gliclazide|gliclazide
1015217|NCT03068039|MRI|mri
1015218|NCT03068039|blood glucose|blood glucose
1015219|NCT03068039|porridge|porridge
1015220|NCT03068039|breakfast|breakfast
1015221|NCT03068039|satiety|satiety
1015222|NCT03068039|plasma peptides|plasma peptides
1015223|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1015837|NCT03064724|Asian|asian
1015225|NCT03068013|CALM|calm
1015226|NCT03068013|Depression|depression
1015227|NCT03068013|Demoralization|demoralization
1015228|NCT03068013|Cancer|cancer
1015229|NCT03068013|Spirituality|spirituality
1015230|NCT03068013|Psychotherapy|psychotherapy
1015231|NCT03068013|Quality of Life|quality of life
1015232|NCT03068013|Anxiety|anxiety
1015233|NCT03068013|Post-Traumatic Growth|post-traumatic growth
1015234|NCT03068000|Martial arts|martial arts
1015235|NCT03068000|Judo|judo
1015236|NCT03068000|Motor skills|motor skills
1015237|NCT03068000|Physical fitness|physical fitness
1015238|NCT03068000|Cardiovascular parameters|cardiovascular parameters
1015239|NCT03068000|Quality of life|quality of life
1015240|NCT03068000|Physical Activity|physical activity
1015241|NCT03067974|ketamine|ketamine
1015242|NCT03067974|pediatric|pediatric
1015243|NCT03067974|procedural sedation|procedural sedation
1015244|NCT03067961|Enteric fever|enteric fever
1015245|NCT03067961|Typhoid|typhoid
1015246|NCT03067961|Salmonella Typhi|salmonella typhi
1015247|NCT03067961|Challenge study|challenge study
1015248|NCT03067961|Human model of infection|human model of infection
1015249|NCT03067961|Typhoid toxin|typhoid toxin
1015250|NCT03067922|Mastectomy|mastectomy
1015251|NCT03067922|Pain|pain
1015252|NCT03067922|Severity|severity
1015253|NCT03067922|Life quality|life quality
1015254|NCT03067896|spinal block|spinal block
1015255|NCT03067896|stress response|stress response
1015256|NCT03067896|dexmedetomidine|dexmedetomidine
1015257|NCT03067896|intrathecally|intrathecally
1015258|NCT03067870|Stem cells|stem cells
1015259|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
1015260|NCT03067831|stem cells|stem cells
1015261|NCT03067818|arm|arm
1015262|NCT03067818|rehabilitation|rehabilitation
1015263|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
1015264|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
1015265|NCT03067818|upper extremity|upper extremity
1015266|NCT03067805|Oxytocin effect|oxytocin effect
1015267|NCT03067805|romantic jealousy|romantic jealousy
1015268|NCT03067805|Arousal Rating|arousal rating
1015269|NCT03067805|Jealousy Rating|jealousy rating
1015270|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
1015271|NCT03067792|palliative chemotherapy|palliative chemotherapy
1015272|NCT03067740|appendicectomy|appendicectomy
1015273|NCT03067740|children|children
1015274|NCT03067740|local anesthetics|local anesthetics
1015275|NCT03067740|laparoscopy|laparoscopy
1015276|NCT03067740|peritoneum|peritoneum
1015278|NCT03067623|Thin endometrium|thin endometrium
1015279|NCT03067623|Endometrial thickness|endometrial thickness
1015280|NCT03067584|Familial cancer|familial cancer
1015281|NCT03067584|Genetic predisposition|genetic predisposition
1015282|NCT03067584|Heritable disease|heritable disease
1015283|NCT03067584|Cancer risk|cancer risk
1015284|NCT03067584|Genome analysis|genome analysis
1015285|NCT03067584|Genetic modifiers|genetic modifiers
1015286|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
1015287|NCT03067584|Genetic counseling|genetic counseling
1015288|NCT03067584|DNA|dna
1015289|NCT03067571|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
1015290|NCT03067571|Acute Myelogenous Leukemia|acute myelogenous leukemia
1015291|NCT03067571|AML|aml
1015292|NCT03067571|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1015293|NCT03067571|MDA|mda
1015294|NCT03067571|Daratumumab|daratumumab
1015295|NCT03067558|Pneumonia|pneumonia
1015296|NCT03067558|Diagnostics|diagnostics
1015297|NCT03067558|Childhood|childhood
1015298|NCT03067558|Respiratory rate|respiratory rate
1015299|NCT03067558|Ethiopia|ethiopia
1015300|NCT03067506|Drug Therapy|drug therapy
1015301|NCT03067454|early mobilisation|early mobilisation
1015302|NCT03067454|metacarpal fracture|metacarpal fracture
1015303|NCT03067454|operation|operation
1015304|NCT03067441|hyperlipidemia|hyperlipidemia
1015305|NCT03067441|cholesterol|cholesterol
1015306|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
1015307|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1015308|NCT03067441|ASCVD|ascvd
1015309|NCT03067441|HeFH|hefh
1015310|NCT03067441|LDL|ldl
1015311|NCT03067428|Fructose|fructose
1015312|NCT03067428|Diet|diet
1015313|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
1015314|NCT03067415|Ocular hypertension|ocular hypertension
1015315|NCT03067415|CKD-351|ckd-351
1015316|NCT03067402|Myocardial Infarction|myocardial infarction
1015317|NCT03067402|Physiological Stress Test|physiological stress test
1015318|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
1015319|NCT03067402|Angioplasty|angioplasty
1015320|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
1015321|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
1015323|NCT03067402|Ischemia|ischemia
1015324|NCT03067376|ADME|adme
1015325|NCT03067376|Metabolism|metabolism
1015326|NCT03067376|Metabolite Profiling|metabolite profiling
1015328|NCT03067350|voriconazole|voriconazole
1015329|NCT03067350|pharmacogenetics|pharmacogenetics
1015330|NCT03067350|pharmacokinetics|pharmacokinetics
1015331|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
1015332|NCT03067337|Stainless Steel Crowns|stainless steel crowns
1015333|NCT03067337|Zirconia Crowns|zirconia crowns
1015334|NCT03067337|Aesthetic restorations|aesthetic restorations
1015335|NCT03067324|Islet Transplantation|islet transplantation
1015336|NCT03067298|pregnancy|pregnancy
1015337|NCT03067298|screening|screening
1015338|NCT03067298|doppler|doppler
1015339|NCT03067298|markers|markers
1015340|NCT03067298|PlGF|plgf
1015341|NCT03067298|sFlt-1|sflt-1
1015342|NCT03067298|placenta|placenta
1015343|NCT03067272|Permanent contraception|permanent contraception
1015344|NCT03067272|Birth control|birth control
1015345|NCT03067259|eldery patients|eldery patients
1015346|NCT03067259|cognitive impairment|cognitive impairment
1015347|NCT03067246|Supraglottic device|supraglottic device
1015348|NCT03067246|Fibre optic scope|fibre optic scope
1015349|NCT03067246|Endotracheal intubation|endotracheal intubation
1015350|NCT03067220|outpatients|outpatients
1015351|NCT03067220|general surgery|general surgery
1015352|NCT03067220|virtual clinic|virtual clinic
1015353|NCT03067220|patient satisfaction|patient satisfaction
1015354|NCT03067207|mindfulness meditation|mindfulness meditation
1015355|NCT03067207|Adolescent|adolescent
1015356|NCT03067207|eHealth|ehealth
1015357|NCT03067207|randomized trial|randomized trial
1015358|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
1015359|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1015360|NCT03067155|CMV reactivation|cmv reactivation
1015361|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
1015362|NCT03067129|Glecaprevir|glecaprevir
1015363|NCT03067129|Pibrentasvir|pibrentasvir
1015364|NCT03067129|Pharmacokinetic|pharmacokinetic
1015365|NCT03067129|Treatment naïve|treatment naïve
1015366|NCT03067129|Treatment experienced|treatment experienced
1015367|NCT03067129|Interferon (IFN)|interferon (ifn)
1015368|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
1015369|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
1015370|NCT03067129|sofosbuvir|sofosbuvir
1015371|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
1015372|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
1015373|NCT03067116|balance, postural|balance, postural
1015374|NCT03067116|fall risk|fall risk
1015375|NCT03067116|anthropometrics|anthropometrics
1015376|NCT03067116|blood pressure|blood pressure
1015377|NCT03067116|SpO2|spo2
1015378|NCT03067116|heart rate|heart rate
1015379|NCT03067116|heart rate variability|heart rate variability
1015380|NCT03067116|stance width|stance width
1015381|NCT03067103|Adenotonsillectomy|adenotonsillectomy
1015382|NCT03067103|pain|pain
1015383|NCT03067103|topic analgesia|topic analgesia
1015384|NCT03067103|child|child
1015385|NCT03067077|SMILE|smile
1015386|NCT03067077|LASIK|lasik
1015387|NCT03067077|Myopia|myopia
1015388|NCT03067077|Wavefront-guided|wavefront-guided
1015389|NCT03067012|Oncometabolic surgery|oncometabolic surgery
1015390|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
1015391|NCT03067012|Obesity|obesity
1015392|NCT03067012|Diabetes|diabetes
1015393|NCT03067012|Early gastric cancer|early gastric cancer
1015394|NCT03066986|Venom anaphylaxis|venom anaphylaxis
1015395|NCT03066986|Myrmecia piluosa|myrmecia piluosa
1015396|NCT03066986|Immunological adjuvant|immunological adjuvant
1015397|NCT03066986|Immunotherapy|immunotherapy
1015398|NCT03066986|Jack jumper ant|jack jumper ant
1015399|NCT03066973|breath exercises|breath exercises
1015400|NCT03066973|labor pain|labor pain
1015401|NCT03066973|labor duration|labor duration
1015402|NCT03066973|VAS|vas
1015403|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
1015404|NCT03066934|Nasal high flow|nasal high flow
1015405|NCT03066934|Respiratory Failure|respiratory failure
1015406|NCT03066934|Childhood|childhood
1015407|NCT03066921|Lactic acid bacteria|lactic acid bacteria
1015408|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
1015409|NCT03066921|Hemodialysis|hemodialysis
1015410|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
1015411|NCT03066882|Caloric Restriction|caloric restriction
1015412|NCT03066882|Diet|diet
1015413|NCT03066882|Obesity|obesity
1015414|NCT03066882|Overweight|overweight
1015415|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
1015416|NCT03066882|Weight loss|weight loss
1015417|NCT03066882|Women|women
1015418|NCT03066856|BRCA genes|brca genes
1015419|NCT03066856|Mutation carriers|mutation carriers
1015420|NCT03066856|IGF-I|igf-i
1015421|NCT03066856|Diet|diet
1015422|NCT03066817|Vitamin D|vitamin d
1015423|NCT03066817|Deficiency|deficiency
1015424|NCT03066817|Insufficiency|insufficiency
1015425|NCT03066817|Bone turnover|bone turnover
1015426|NCT03066817|Bone healing|bone healing
1015427|NCT03066817|Polytrauma|polytrauma
1015428|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
1015429|NCT03066804|Heart Failure|heart failure
1015523|NCT03066388|volume expansion|volume expansion
1015430|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1015431|NCT03066804|NT-proBNP|nt-probnp
1015432|NCT03066804|KCCQ|kccq
1015433|NCT03066804|6 MWT|6 mwt
1015434|NCT03066804|SF-36|sf-36
1015435|NCT03066804|NYHA Class|nyha class
1015436|NCT03066804|LCZ696|lcz696
1015437|NCT03066804|Enalapril|enalapril
1015438|NCT03066804|Valsartan|valsartan
1015439|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
1015440|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
1015441|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
1015442|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
1015443|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
1015444|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
1015445|NCT03066778|PD1|pd1
1015446|NCT03066778|PDL1|pdl1
1015447|NCT03066726|Biophysical profile|biophysical profile
1015448|NCT03066726|Cesarean section|cesarean section
1015449|NCT03066726|Estimated fetal weight|estimated fetal weight
1015450|NCT03066726|Middle cerebral artery|middle cerebral artery
1015451|NCT03066726|Umbilical artery|umbilical artery
1015452|NCT03066726|Fetal growth restriction|fetal growth restriction
1015453|NCT03066726|Pulsatility index|pulsatility index
1015454|NCT03066726|Estimated gestational age|estimated gestational age
1015455|NCT03066726|Doppler|doppler
1015456|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
1015457|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
1015458|NCT03066635|Nerve block|nerve block
1015459|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
1015460|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
1015461|NCT03066635|Injection|injection
1015462|NCT03066609|Plaque psoriasis, Secukinumab, Skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules|plaque psoriasis, secukinumab, skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules
1015463|NCT03066583|meniscus repair|meniscus repair
1015464|NCT03066583|platelet rich plasma|platelet rich plasma
1015465|NCT03066570|Graded Exposure|graded exposure
1015466|NCT03066570|Quality of Life|quality of life
1015467|NCT03066570|Physical Activity|physical activity
1015468|NCT03066570|Anxiety|anxiety
1015469|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
1015470|NCT03066557|Apatinib|apatinib
1015471|NCT03066544|migraine|migraine
1015472|NCT03066544|responder|responder
1015473|NCT03066544|non-responder|non-responder
1015474|NCT03066544|treatment|treatment
1015475|NCT03066531|ACT|act
1015476|NCT03066531|CBT obesity|cbt obesity
1015477|NCT03066531|Eating disorders|eating disorders
1015478|NCT03066531|Health psychology|health psychology
1015479|NCT03066518|melatonin|melatonin
1015480|NCT03066518|sleep|sleep
1015481|NCT03066518|dementia|dementia
1015482|NCT03066518|cognition|cognition
1015483|NCT03066492|Tertiary Care Center|tertiary care center
1015484|NCT03066492|Patient Readmission|patient readmission
1015485|NCT03066492|Health Services Research|health services research
1015486|NCT03066492|Hospital Readmissions|hospital readmissions
1015487|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
1015488|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1015489|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
1015490|NCT03066466|BMT|bmt
1015491|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
1015492|NCT03066466|Graft versus Host Disease|graft versus host disease
1015493|NCT03066466|GVHD|gvhd
1015494|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
1015495|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
1015496|NCT03066440|fluid management|fluid management
1015497|NCT03066440|hyperchloremia|hyperchloremia
1015498|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
1015499|NCT03066427|Sunitinib|sunitinib
1015500|NCT03066414|hemochromatosis|hemochromatosis
1015501|NCT03066414|blood withdrawal|blood withdrawal
1015502|NCT03066414|respiratory variations|respiratory variations
1015503|NCT03066414|inferior vena cava|inferior vena cava
1015504|NCT03066414|internal jugular vein|internal jugular vein
1015505|NCT03066414|ultrasound|ultrasound
1015506|NCT03066414|ultrasonography|ultrasonography
1015507|NCT03066414|echography|echography
1015508|NCT03066401|hyperferritinemia|hyperferritinemia
1015509|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
1015510|NCT03066401|obese|obese
1015511|NCT03066401|blood withdrawal|blood withdrawal
1015512|NCT03066401|respiratory variations|respiratory variations
1015513|NCT03066401|inferior vena cava|inferior vena cava
1015514|NCT03066401|internal jugular vein|internal jugular vein
1015515|NCT03066401|ultrasound|ultrasound
1015516|NCT03066401|ultrasonography|ultrasonography
1015517|NCT03066401|echography|echography
1015519|NCT03066388|fluid responsiveness|fluid responsiveness
1015520|NCT03066388|pulse pressure|pulse pressure
1015521|NCT03066388|noninvasive monitoring|noninvasive monitoring
1015522|NCT03066388|pulse pressure variations|pulse pressure variations
1015525|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1015526|NCT03066375|vena cava|vena cava
1015527|NCT03066375|fluid|fluid
1015528|NCT03066375|sepsis|sepsis
1015529|NCT03066375|echocardiography|echocardiography
1015530|NCT03066375|ultrasound|ultrasound
1015531|NCT03066375|ultrasonography|ultrasonography
1015532|NCT03066375|collapsibility index|collapsibility index
1015533|NCT03066375|circulatory failure|circulatory failure
1015534|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
1015535|NCT03066375|fluid responsiveness|fluid responsiveness
1015536|NCT03066375|Spontaneous breathing|spontaneous breathing
1015537|NCT03066362|Spontaneous ventilation|spontaneous ventilation
1015538|NCT03066323|Blood glucose|blood glucose
1015539|NCT03066310|Bladder cancer|bladder cancer
1015540|NCT03066310|Urine|urine
1015541|NCT03066310|DNA biomarker|dna biomarker
1015542|NCT03066310|Diagnosis|diagnosis
1015543|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
1015544|NCT03066297|Lobectomy|lobectomy
1015545|NCT03066297|Segmentectomy|segmentectomy
1015546|NCT03066297|Wedge resection|wedge resection
1015547|NCT03066297|Sublobar resection|sublobar resection
1015548|NCT03066297|Limited resection|limited resection
1015549|NCT03066284|Children|children
1015550|NCT03066284|Adolescents|adolescents
1015551|NCT03066284|Parents|parents
1015552|NCT03066284|Insulin Pump Therapy|insulin pump therapy
1015553|NCT03066271|Aerobic exercise|aerobic exercise
1015554|NCT03066271|Lung Cancer|lung cancer
1015555|NCT03066258|nAMD|namd
1015556|NCT03066258|wet AMD|wet amd
1015557|NCT03066258|gene therapy|gene therapy
1015558|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
1015559|NCT03066245|PLGA|plga
1015560|NCT03066245|Platelet Lysate|platelet lysate
1015561|NCT03066245|Bone marrow|bone marrow
1015562|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
1015563|NCT03066232|Delirium|delirium
1015564|NCT03066232|Dementia|dementia
1015565|NCT03066232|Physical function|physical function
1015566|NCT03066206|Malignant Neoplasm of Respiratory and Intrathoracic Organ|malignant neoplasm of respiratory and intrathoracic organ
1015567|NCT03066206|Non-Small Cell Lung Cancer|non-small cell lung cancer
1015568|NCT03066206|NSCLC|nsclc
1015569|NCT03066206|Advanced|advanced
1015570|NCT03066206|EGFR exon 20 mutation|egfr exon 20 mutation
1015571|NCT03066206|EGFR-positive|egfr-positive
1015572|NCT03066206|Poziotinib|poziotinib
1015573|NCT03066193|Motor tics|motor tics
1015574|NCT03066193|Vocal tics|vocal tics
1015575|NCT03066193|Cannabinoids|cannabinoids
1015576|NCT03066193|Dronabinol|dronabinol
1015577|NCT03066193|PEA|pea
1015578|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
1015579|NCT03066193|Tourettes|tourettes
1015580|NCT03066193|TS|ts
1015581|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
1015582|NCT03066167|Watson score|watson score
1015583|NCT03066167|Ogilvie score|ogilvie score
1015584|NCT03066167|Goldschmid score|goldschmid score
1015585|NCT03066167|Validation|validation
1015586|NCT03066167|Quality of Life|quality of life
1015587|NCT03066154|High risk prostate cancer|high risk prostate cancer
1015588|NCT03066154|>T2cN+M0|>t2cn+m0
1015589|NCT03066128|Task shifting|task shifting
1015590|NCT03066128|HIV care|hiv care
1015591|NCT03066115|Cerebral blood flow|cerebral blood flow
1015592|NCT03066115|Cyclooxygenase|cyclooxygenase
1015593|NCT03066115|Nitric oxide synthase|nitric oxide synthase
1015594|NCT03066115|Reactive Oxygen Species|reactive oxygen species
1015595|NCT03066102|sensorimotor system|sensorimotor system
1015596|NCT03066102|scapular joint position sense|scapular joint position sense
1015597|NCT03066102|fatigue|fatigue
1015598|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
1015599|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1015600|NCT03066050|Mitral Valve Disease|mitral valve disease
1015601|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
1015602|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
1015603|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
1015604|NCT03066037|block series|block series
1015605|NCT03066037|invasive pain treatment|invasive pain treatment
1015606|NCT03066011|mold-active triazoles|mold-active triazoles
1015607|NCT03065972|kidney disease|kidney disease
1015608|NCT03065972|vascular access|vascular access
1015609|NCT03065972|graft|graft
1015610|NCT03065972|fistula|fistula
1015611|NCT03065972|hemodialysis|hemodialysis
1015612|NCT03065972|dialysis|dialysis
1015613|NCT03065959|CK-2127107|ck-2127107
1015614|NCT03065959|Mobility Limitation|mobility limitation
1015615|NCT03065959|Phase 1b|phase 1b
1015616|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
1015617|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
1015618|NCT03065946|Electroencephalogram|electroencephalogram
1015619|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
1015620|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
1015621|NCT03065946|S-100B|s-100b
1015622|NCT03065933|mania|mania
1015623|NCT03065933|clonidine|clonidine
1015624|NCT03065933|bipolar disorder|bipolar disorder
1015625|NCT03065894|stratified care|stratified care
1015626|NCT03065894|psychologically informed practice|psychologically informed practice
1015627|NCT03065894|matched care|matched care
1015628|NCT03065868|gastric polyp|gastric polyp
1015629|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
1015630|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
1015631|NCT03065855|rectal cancer|rectal cancer
1015632|NCT03065855|urinary distention|urinary distention
1015633|NCT03065842|Stigma|stigma
1015634|NCT03065842|Pregnancy|pregnancy
1015635|NCT03065842|Abortion|abortion
1015636|NCT03065842|Contraception|contraception
1015637|NCT03065842|Adolescence|adolescence
1015638|NCT03065829|caregiver|caregiver
1015639|NCT03065829|chronically critically ill|chronically critically ill
1015640|NCT03065777|single file.|single file.
1015641|NCT03065777|ONE ENDO.|one endo.
1015642|NCT03065777|F6 SkyTaper.|f6 skytaper.
1015643|NCT03065777|ProTaper Universal.|protaper universal.
1015644|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
1015645|NCT03065777|postoperative pain.|postoperative pain.
1015646|NCT03065764|Pembrolizumab|pembrolizumab
1015647|NCT03065764|89Zirconium|89zirconium
1015648|NCT03065738|reduction osteotomy|reduction osteotomy
1015649|NCT03065738|knee arthroplasty|knee arthroplasty
1015650|NCT03065712|Breast Cancer|breast cancer
1015651|NCT03065712|PET/CT|pet/ct
1015652|NCT03065712|FES|fes
1015653|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
1015654|NCT03065712|Breast|breast
1015655|NCT03065699|Medical device|medical device
1015656|NCT03065699|Liver dialysis|liver dialysis
1015657|NCT03065699|Haemofilter|haemofilter
1015659|NCT03065686|Cleft Lip and Palate|cleft lip and palate
1015660|NCT03065686|CL/P|cl/p
1015661|NCT03065686|WES|wes
1015662|NCT03065673|Tooth bleaching|tooth bleaching
1015663|NCT03065673|Tooth sensitivity|tooth sensitivity
1015664|NCT03065660|Missed miscarriage|missed miscarriage
1015665|NCT03065660|Mifepristone|mifepristone
1015666|NCT03065660|Misoprostol|misoprostol
1015667|NCT03065660|Medical management|medical management
1015668|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1015669|NCT03065647|Cardiac Arrest|cardiac arrest
1015670|NCT03065647|Heart Arrest|heart arrest
1015671|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
1015991|NCT03063658|Morphine|morphine
1015672|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1015673|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
1015674|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1015675|NCT03065647|CPR|cpr
1015676|NCT03065647|ECPR|ecpr
1015677|NCT03065647|ECMO|ecmo
1015678|NCT03065647|Emergency Medical Services|emergency medical services
1015679|NCT03065647|EMS|ems
1015680|NCT03065647|OHCA|ohca
1015681|NCT03065621|Breast|breast
1015682|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
1015683|NCT03065595|IGF-1|igf-1
1015684|NCT03065595|hypoalbuminemia|hypoalbuminemia
1015685|NCT03065595|MNA score|mna score
1015686|NCT03065595|elderly|elderly
1015687|NCT03065543|Hyperlipidemias|hyperlipidemias
1015688|NCT03065543|Secondary prevention|secondary prevention
1015689|NCT03065543|high risk patients|high risk patients
1015690|NCT03065543|very high risk patients|very high risk patients
1015691|NCT03065530|Dexmedetomidine|dexmedetomidine
1015692|NCT03065530|Butorphanol tartrate|butorphanol tartrate
1015693|NCT03065530|Analgesia|analgesia
1015694|NCT03065530|Breastfeeding|breastfeeding
1015695|NCT03065530|Relative infant dose|relative infant dose
1015696|NCT03065517|Criminal Justice|criminal justice
1015697|NCT03065517|Juvenile Delinquency|juvenile delinquency
1015698|NCT03065491|Red yeast rice|red yeast rice
1015699|NCT03065491|Phytosterols|phytosterols
1015700|NCT03065491|L-Tyrosol|l-tyrosol
1015701|NCT03065491|Lipids|lipids
1015702|NCT03065491|LDL-cholesterol|ldl-cholesterol
1015703|NCT03065491|Endothelial function|endothelial function
1015704|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
1015705|NCT03065478|Chemotherapy induced|chemotherapy induced
1015706|NCT03065478|CIPN|cipn
1015707|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
1015708|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
1015709|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
1015710|NCT03065465|Ulcers|ulcers
1015711|NCT03065400|Myelofibrosis|myelofibrosis
1015712|NCT03065400|Acute Leukemia|acute leukemia
1015713|NCT03065387|Metastatic solid tumors|metastatic solid tumors
1015714|NCT03065387|Genetic mutation|genetic mutation
1015715|NCT03065387|Biomarkers|biomarkers
1015716|NCT03065387|Neratinib|neratinib
1015717|NCT03065387|Everolimus|everolimus
1015718|NCT03065387|Afinitor|afinitor
1015719|NCT03065387|Zortress|zortress
1015720|NCT03065387|RAD001|rad001
1015721|NCT03065387|Palbociclib|palbociclib
1015722|NCT03065387|PD-0332991|pd-0332991
1015723|NCT03065387|Ibrance|ibrance
1015724|NCT03065387|Trametinib|trametinib
1015725|NCT03065361|Chronic Kidney Disease|chronic kidney disease
1015726|NCT03065361|Handgrip Strength|handgrip strength
1015727|NCT03065361|Fine Motor Skills|fine motor skills
1015728|NCT03065361|Sensitivity|sensitivity
1015729|NCT03065348|prehabilitation|prehabilitation
1015730|NCT03065348|nutrition|nutrition
1015732|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
1015733|NCT03065348|regional anesthesia|regional anesthesia
1015734|NCT03065348|cognition|cognition
1015735|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
1015736|NCT03065335|Magnetoencephalography|magnetoencephalography
1015737|NCT03065335|Major Depressive Disorder|major depressive disorder
1015738|NCT03065335|Ketamine|ketamine
1015739|NCT03065335|NEUROPHARMACOLOGY|neuropharmacology
1015740|NCT03065322|PCOS|pcos
1015741|NCT03065322|OSA|osa
1015742|NCT03065296|Behavior|behavior
1015743|NCT03065296|education|education
1015744|NCT03065296|medical residents|medical residents
1015745|NCT03065296|knowledge|knowledge
1015746|NCT03065296|confidence|confidence
1015747|NCT03065296|skills assessment|skills assessment
1015748|NCT03065257|EMR|emr
1015749|NCT03065257|ESD|esd
1015750|NCT03065257|Resection|resection
1015751|NCT03065257|STER|ster
1015752|NCT03065257|EFTR|eftr
1015753|NCT03065257|Submucosal dissection|submucosal dissection
1015754|NCT03065257|Endoscopic resection|endoscopic resection
1015755|NCT03065244|Kawasaki disease|kawasaki disease
1015756|NCT03065218|Thyroid|thyroid
1015757|NCT03065218|sestamibi|sestamibi
1015758|NCT03065192|Gene Therapy|gene therapy
1015759|NCT03065192|PD|pd
1015760|NCT03065192|Parkinson's Disease|parkinson's disease
1015761|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
1015762|NCT03065192|AADC|aadc
1015763|NCT03065192|AAV2-AADC|aav2-aadc
1015764|NCT03065192|AAV2|aav2
1015765|NCT03065192|Viral Vector|viral vector
1015766|NCT03065192|Gene Transfer|gene transfer
1015767|NCT03065192|MRI|mri
1015768|NCT03065192|PET|pet
1015769|NCT03065192|VY-AADC01|vy-aadc01
1015770|NCT03065153|Torso|torso
1015771|NCT03065153|Trunk|trunk
1015772|NCT03065088|Exercise|exercise
1015773|NCT03065088|Feasibility Studies|feasibility studies
1015774|NCT03065088|Healthy Lifestyle|healthy lifestyle
1015775|NCT03065088|Health Promotion|health promotion
1015776|NCT03065088|Health Behavior|health behavior
1015777|NCT03065088|Aging|aging
1015778|NCT03065088|Activities of Daily Living|activities of daily living
1015779|NCT03065088|Mobile Applications|mobile applications
1015780|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
1015781|NCT03065062|Head & Neck Cancer|head & neck cancer
1015782|NCT03065062|Neoplasms|neoplasms
1015783|NCT03065062|Endometrial Cancer|endometrial cancer
1015784|NCT03065049|Physical Activity|physical activity
1015785|NCT03065049|Peer-facilitation|peer-facilitation
1015786|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
1015787|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
1015788|NCT03065036|POAG|poag
1015789|NCT03065023|advanced tumor|advanced tumor
1015790|NCT03065023|intratumoral injection|intratumoral injection
1015791|NCT03065023|intralesional injection|intralesional injection
1015792|NCT03064997|prebiotic|prebiotic
1015793|NCT03064997|pediatric patients|pediatric patients
1015794|NCT03064997|health status|health status
1015795|NCT03064997|intestine permeability|intestine permeability
1015796|NCT03064971|Quitline|quitline
1015797|NCT03064971|culturally specific|culturally specific
1015798|NCT03064958|glucose regulation|glucose regulation
1015799|NCT03064958|lipids|lipids
1015800|NCT03064958|Immune markers|immune markers
1015801|NCT03064958|Endothelium, Vascular|endothelium, vascular
1015802|NCT03064945|Livia TENS|livia tens
1015803|NCT03064945|safety and efficacy|safety and efficacy
1015804|NCT03064945|menstruating women|menstruating women
1015805|NCT03064919|hunger and fullness|hunger and fullness
1015806|NCT03064919|regulation of energy intake|regulation of energy intake
1015807|NCT03064919|energy compensation|energy compensation
1015808|NCT03064919|nutrition knowledge|nutrition knowledge
1015809|NCT03064906|T1D, Omnipod|t1d, omnipod
1015810|NCT03064880|Thoracic surgery|thoracic surgery
1015811|NCT03064880|Fluid responsiveness|fluid responsiveness
1015812|NCT03064880|Hemodynamics|hemodynamics
1015813|NCT03064880|Oxidative stress|oxidative stress
1015814|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
1015815|NCT03064867|venetoclax|venetoclax
1015816|NCT03064867|rituximab|rituximab
1015817|NCT03064867|ifosfamide|ifosfamide
1015818|NCT03064867|carboplatin|carboplatin
1015819|NCT03064867|etoposide|etoposide
1015820|NCT03064854|PDR001|pdr001
1015821|NCT03064854|immunotherapy|immunotherapy
1015822|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
1015823|NCT03064854|lung|lung
1015824|NCT03064854|NSCLC|nsclc
1015825|NCT03064802|BioBurst|bioburst
1015826|NCT03064802|Spinal Fusion|spinal fusion
1015827|NCT03064802|Cellular Allograft|cellular allograft
1015828|NCT03064789|Candidiases|candidiases
1015829|NCT03064789|Vaginal Infections|vaginal infections
1015830|NCT03064776|telemedicine|telemedicine
1015831|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
1015832|NCT03064750|Exercise Therapy|exercise therapy
1015833|NCT03064750|Pelvic Floor|pelvic floor
1015834|NCT03064750|Preoperative Care|preoperative care
1015835|NCT03064724|smoking|smoking
1015836|NCT03064724|tobacco use|tobacco use
1015838|NCT03064724|patients|patients
1015839|NCT03064724|provider advice|provider advice
1015840|NCT03064724|digital health intervention|digital health intervention
1015841|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
1015842|NCT03064685|Liver transplantation|liver transplantation
1015843|NCT03064685|Biliary disease|biliary disease
1015844|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
1015845|NCT03064659|Driving Pressure|driving pressure
1015846|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
1015847|NCT03064659|Cardiac Surgery|cardiac surgery
1015848|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
1015849|NCT03064646|ORGAN PRESERVATION|organ preservation
1015850|NCT03064646|WATCH AND WAIT|watch and wait
1015851|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
1015852|NCT03064633|Dexamethasone|dexamethasone
1015853|NCT03064633|Dexmedetomidine|dexmedetomidine
1015854|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
1015855|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
1015856|NCT03064633|postoperative pain|postoperative pain
1015857|NCT03064620|PCV effects|pcv effects
1015858|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
1015859|NCT03064620|S. aureus carriage|s. aureus carriage
1015860|NCT03064620|Indirect vaccination effects|indirect vaccination effects
1015861|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
1015862|NCT03064607|Neonates|neonates
1015863|NCT03064607|biomarkers|biomarkers
1015864|NCT03064607|EXIT procedure|exit procedure
1015865|NCT03064607|Cesarean Section|cesarean section
1015866|NCT03064581|Cervical Cancer|cervical cancer
1015867|NCT03064581|Screening|screening
1015868|NCT03064581|Pap Test|pap test
1015869|NCT03064581|Pacific Islander Americans|pacific islander americans
1015870|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
1015871|NCT03064555|Renal|renal
1015872|NCT03064555|Acute|acute
1015873|NCT03064555|Exercise|exercise
1015874|NCT03064555|Dialysis|dialysis
1015875|NCT03064555|Hemodialysis|hemodialysis
1015876|NCT03064555|End stage renal disease|end stage renal disease
1015877|NCT03064555|Aerobic|aerobic
1015878|NCT03064503|myocardial fibrosis|myocardial fibrosis
1015879|NCT03064503|cardiac function|cardiac function
1015880|NCT03064503|ageing|ageing
1015881|NCT03064477|Unified Protocol|unified protocol
1015882|NCT03064477|Transdiagnostic approach|transdiagnostic approach
1015883|NCT03064477|Public health|public health
1015884|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1015885|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
1015886|NCT03064373|S. aureus|s. aureus
1015887|NCT03064373|carriage|carriage
1015888|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
1015889|NCT03064373|microbiome|microbiome
1015890|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1015891|NCT03064347|Obesity|obesity
1015892|NCT03064347|Nutrient|nutrient
1015893|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
1015894|NCT03064308|Frailty|frailty
1015895|NCT03064308|Surgery|surgery
1015896|NCT03064308|Physical function|physical function
1015897|NCT03064308|Cognitive function|cognitive function
1015898|NCT03064308|Quality of life|quality of life
1015899|NCT03064308|Exercise|exercise
1015900|NCT03064308|Rehabilitation|rehabilitation
1015901|NCT03064308|Delirium|delirium
1015902|NCT03064308|Morbidity|morbidity
1015903|NCT03064308|Mortality|mortality
1015904|NCT03064308|Length of stay|length of stay
1015905|NCT03064308|Well-being|well-being
1015906|NCT03064308|Elderly|elderly
1015907|NCT03064308|Older surgical patient|older surgical patient
1015908|NCT03064308|Radical prostatectomy|radical prostatectomy
1015909|NCT03064308|Radical cystectomy|radical cystectomy
1016288|NCT03061825|Vascular Diseases|vascular diseases
1015910|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
1015911|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
1015912|NCT03064308|Major Cavity Surgery|major cavity surgery
1015913|NCT03064308|Abdominal Surgery|abdominal surgery
1015914|NCT03064308|Recovery|recovery
1015915|NCT03064308|Nephrectomy|nephrectomy
1015916|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
1015917|NCT03064256|Exercisy therapy|exercisy therapy
1015918|NCT03064256|Hypertension|hypertension
1015919|NCT03064256|Physiopathology|physiopathology
1015920|NCT03064256|Heart rate|heart rate
1015921|NCT03064256|Nonlinear dynamics|nonlinear dynamics
1015922|NCT03064217|Clinical crown lengthening|clinical crown lengthening
1015923|NCT03064217|intraoral imaging|intraoral imaging
1015924|NCT03064217|Emax crown|emax crown
1015925|NCT03064191|intra-canal medications|intra-canal medications
1015926|NCT03064178|periodontal therapy|periodontal therapy
1015927|NCT03064178|anticipated pain|anticipated pain
1015928|NCT03064178|experienced pain|experienced pain
1015929|NCT03064178|pain medication use|pain medication use
1015930|NCT03064139|physical activity|physical activity
1015931|NCT03064139|gait|gait
1015932|NCT03064139|biomechanics|biomechanics
1015933|NCT03064126|Artery|artery
1015946|NCT03064087|Cervical Cancer Screening|cervical cancer screening
1015947|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
1015948|NCT03064048|Urea Cycle Disorder|urea cycle disorder
1015950|NCT03064022|head circumference|head circumference
1015951|NCT03064022|length|length
1015952|NCT03064022|neurodevelopment|neurodevelopment
1015953|NCT03063983|osteosarcoma|osteosarcoma
1015954|NCT03063983|metastatic|metastatic
1015955|NCT03063983|metronomic therapy|metronomic therapy
1015956|NCT03063970|Upper extremity|upper extremity
1015957|NCT03063970|Rehabilitation|rehabilitation
1015958|NCT03063931|Breast cancer|breast cancer
1015959|NCT03063931|Mastectomy|mastectomy
1015960|NCT03063931|Pain|pain
1015961|NCT03063931|Anxiety and Depression|anxiety and depression
1015962|NCT03063931|Cognition|cognition
1015963|NCT03063931|Quality of life|quality of life
1015964|NCT03063905|Opioid related disorders|opioid related disorders
1015965|NCT03063905|Narcotic abuse|narcotic abuse
1015966|NCT03063879|hepatitis C|hepatitis c
1015967|NCT03063879|renal failure|renal failure
1015968|NCT03063879|sofosbuvir|sofosbuvir
1015969|NCT03063879|daclatasvir|daclatasvir
1015970|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
1015971|NCT03063840|microwave ablation|microwave ablation
1015972|NCT03063840|liver cancer|liver cancer
1015973|NCT03063801|Congenital Heart Disease|congenital heart disease
1015974|NCT03063801|Blood products transfusion|blood products transfusion
1015975|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
1015976|NCT03063762|RO6874281|ro6874281
1015977|NCT03063762|Atezolizumab|atezolizumab
1015978|NCT03063762|Bevacizumab|bevacizumab
1015979|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
1015980|NCT03063723|Monocytes|monocytes
1015981|NCT03063723|Nk cells|nk cells
1015982|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
1015983|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
1015984|NCT03063697|Essential hypertension|essential hypertension
1015985|NCT03063697|Chronic stable angina|chronic stable angina
1015986|NCT03063697|Congestive heart failure|congestive heart failure
1015987|NCT03063671|postmastectomy pain|postmastectomy pain
1015988|NCT03063658|Ibuprofen|ibuprofen
1015989|NCT03063658|Paracetamol|paracetamol
1015990|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1015992|NCT03063658|Visual analog scale|visual analog scale
1015993|NCT03063645|Healthy volunteer|healthy volunteer
1015994|NCT03063645|AC-1202|ac-1202
1015995|NCT03063645|AC-SD-01|ac-sd-01
1015996|NCT03063645|Pharacokinetic|pharacokinetic
1015997|NCT03063645|ketone body|ketone body
1015998|NCT03063554|Endoscopy|endoscopy
1015999|NCT03063554|Pancreatic Cancer|pancreatic cancer
1016000|NCT03063554|Bile duct|bile duct
1016001|NCT03063554|Periampullary|periampullary
1016002|NCT03063554|ERCP|ercp
1016003|NCT03063554|Biliary drainage|biliary drainage
1016004|NCT03063554|Biliary obstruction|biliary obstruction
1016005|NCT03063554|EUSBD|eusbd
1016006|NCT03063554|TEUS|teus
1016007|NCT03063554|EUS|eus
1016008|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
1016009|NCT03063528|Pregnancy|pregnancy
1016010|NCT03063528|Weight|weight
1016011|NCT03063528|Gestational weight gain|gestational weight gain
1016012|NCT03063528|Stress reduction|stress reduction
1016013|NCT03063528|Exercise|exercise
1016014|NCT03063515|Insulin secretion|insulin secretion
1016015|NCT03063450|anti PD-L1|anti pd-l1
1016016|NCT03063450|nivolumab|nivolumab
1016017|NCT03063450|immunotherapy|immunotherapy
1016018|NCT03063450|RECIST|recist
1016019|NCT03063450|quality of life|quality of life
1016020|NCT03063450|survival|survival
1016021|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
1016035|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
1016289|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
1016036|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
1016037|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
1016038|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
1016039|NCT03063411|Maths reasoning|maths reasoning
1016040|NCT03063411|Working memory|working memory
1016041|NCT03063411|Executive Functions|executive functions
1016042|NCT03063411|Cognitive Control|cognitive control
1016043|NCT03063411|Academic Skills|academic skills
1042291|NCT02899533|PAH|pah
1016044|NCT03063411|Randomised Control Trial|randomised control trial
1016045|NCT03063385|Adolescents|adolescents
1016046|NCT03063385|Parents|parents
1016047|NCT03063385|Web-based|web-based
1016048|NCT03063385|Puerto Rico|puerto rico
1016049|NCT03063385|Latino|latino
1016050|NCT03063385|Sexual communication|sexual communication
1016051|NCT03063385|Stigma|stigma
1016052|NCT03063385|Randomized controlled trial|randomized controlled trial
1016053|NCT03063385|STD|std
1016054|NCT03063385|Intercourse|intercourse
1016055|NCT03063385|Sexual behavior|sexual behavior
1016056|NCT03063385|HIV/AIDS|hiv/aids
1016057|NCT03063372|Pomegranate|pomegranate
1016058|NCT03063372|Burnout|burnout
1016059|NCT03063372|Psychological Distress|psychological distress
1016060|NCT03063372|Antioxidant|antioxidant
1016061|NCT03063359|traumatic pain|traumatic pain
1016062|NCT03063359|children|children
1016063|NCT03063359|fentanyl|fentanyl
1016064|NCT03063359|intranasal use|intranasal use
1016065|NCT03063333|spinal cord injury|spinal cord injury
1016066|NCT03063333|hypnosis|hypnosis
1016067|NCT03063333|pain|pain
1016068|NCT03063333|pain catastrophizing|pain catastrophizing
1016069|NCT03063333|coping|coping
1016070|NCT03063307|Tooth, Deciduous|tooth, deciduous
1016071|NCT03063307|Dental Caries|dental caries
1016072|NCT03063307|Glass Ionomer Cements|glass ionomer cements
1016073|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1016074|NCT03063307|Cariostatic Agents|cariostatic agents
1016075|NCT03063307|Fluorides|fluorides
1016076|NCT03063294|Coordination, Administrative|coordination, administrative
1016077|NCT03063294|Coaching|coaching
1016078|NCT03063294|Primary Care|primary care
1016079|NCT03063294|Quality Improvement|quality improvement
1016080|NCT03063281|ficolin-2|ficolin-2
1016081|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
1016082|NCT03063281|lupus nephritis|lupus nephritis
1016083|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1016084|NCT03063281|biomarker|biomarker
1016085|NCT03063281|ficolin-3|ficolin-3
1016086|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
1016087|NCT03063268|Electronic Consent|electronic consent
1016088|NCT03063268|Human Behavior|human behavior
1016089|NCT03063268|Bioethics|bioethics
1016090|NCT03063268|Research Ethics|research ethics
1016091|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
1016092|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
1016093|NCT03063268|Informed Consent Form|informed consent form
1016094|NCT03063268|Interactive Consent|interactive consent
1016095|NCT03063268|Health Record Data|health record data
1016096|NCT03063242|Sargramostim|sargramostim
1016097|NCT03063229|Insulin Pump Therapy|insulin pump therapy
1016098|NCT03063229|Islet Cell Transplant|islet cell transplant
1016099|NCT03063229|Energy Expenditure|energy expenditure
1016100|NCT03063177|chronic thoracic pain|chronic thoracic pain
1016101|NCT03063177|spine stiffness|spine stiffness
1016102|NCT03063177|spinal manipulation|spinal manipulation
1016103|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
1016104|NCT03063164|Femtosecond laser|femtosecond laser
1016106|NCT03063164|Intralase IFS150|intralase ifs150
1016107|NCT03063164|LASIK|lasik
1016108|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
1016109|NCT03063138|Measurement|measurement
1016110|NCT03063138|Wound healing|wound healing
1016111|NCT03063138|Measurement device|measurement device
1016112|NCT03063138|Three-dimensional measurements|three-dimensional measurements
1016113|NCT03063125|radical cystectomy|radical cystectomy
1016114|NCT03063125|hypogonadism|hypogonadism
1016115|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
1016116|NCT03062930|stroke|stroke
1016117|NCT03062930|hemiparesis|hemiparesis
1016118|NCT03062930|lesion hemisphere|lesion hemisphere
1016119|NCT03062930|ipsilesional deficits|ipsilesional deficits
1016120|NCT03062930|contralesional deficits|contralesional deficits
1016121|NCT03062930|rehabilitation|rehabilitation
1016122|NCT03062930|remediation|remediation
1016123|NCT03062930|paretic arm|paretic arm
1016124|NCT03062904|healthy|healthy
1016125|NCT03062904|respiratory system|respiratory system
1016126|NCT03062904|ventilation|ventilation
1016127|NCT03062904|paradoxical effect|paradoxical effect
1016128|NCT03062904|methacholine|methacholine
1016129|NCT03062904|bronchodilator|bronchodilator
1016130|NCT03062904|NEP|nep
1016131|NCT03062904|EFL|efl
1016132|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1016133|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
1016134|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
1016232|NCT03062228|supine|supine
1016335|NCT03061474|Niacinamide|niacinamide
1016135|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
1016136|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
1016137|NCT03062852|Safety Management|safety management
1016138|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
1016139|NCT03062826|OCT|oct
1016140|NCT03062826|STEMI|stemi
1016141|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
1016142|NCT03062800|thalidomide|thalidomide
1016143|NCT03062800|pemetrexed|pemetrexed
1016144|NCT03062800|nsclc|nsclc
1016145|NCT03062800|maintenance treatment|maintenance treatment
1016146|NCT03062722|microsurgical treatment|microsurgical treatment
1016147|NCT03062722|pain|pain
1016148|NCT03062722|dexterity|dexterity
1016149|NCT03062722|Phalen sign|phalen sign
1016150|NCT03062722|functional status|functional status
1016151|NCT03062709|tobacco cessation|tobacco cessation
1016152|NCT03062709|bronchiolitis|bronchiolitis
1016153|NCT03062709|pneumonia|pneumonia
1016154|NCT03062709|pediatric|pediatric
1016155|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
1016156|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
1016157|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
1016158|NCT03062709|tobacco smoke|tobacco smoke
1016159|NCT03062709|asthma|asthma
1016160|NCT03062709|reactive airway disease|reactive airway disease
1016161|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1016162|NCT03062683|lactate|lactate
1016163|NCT03062683|syncope|syncope
1016164|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
1016165|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
1016166|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
1016167|NCT03062631|3,4 DAP|3,4 dap
1016168|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
1016169|NCT03062592|incretin|incretin
1016170|NCT03062592|insulin|insulin
1016171|NCT03062592|glucose|glucose
1016172|NCT03062566|biomarkers|biomarkers
1016173|NCT03062566|point-of-care analysis|point-of-care analysis
1016174|NCT03062540|PTSD|ptsd
1016175|NCT03062540|Military-related PTSD|military-related ptsd
1016176|NCT03062527|Nutrition|nutrition
1016177|NCT03062527|Training support|training support
1016178|NCT03062527|Low Glycemic Index|low glycemic index
1016179|NCT03062527|Moderate Glycemic Index|moderate glycemic index
1016180|NCT03062527|Endurance|endurance
1016181|NCT03062527|Running|running
1016182|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
1016183|NCT03062436|CML, treatment free remission|cml, treatment free remission
1016184|NCT03062410|Health Related Quality of Life|health related quality of life
1016185|NCT03062410|Routine clinical practice|routine clinical practice
1016186|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
1016187|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
1016188|NCT03062410|Pazopanib|pazopanib
1016189|NCT03062410|Sunitinib|sunitinib
1016190|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
1016191|NCT03062410|Patient Reported Outcome|patient reported outcome
1016192|NCT03062410|Supportive Care|supportive care
1016193|NCT03062410|Quality of Life|quality of life
1016194|NCT03062384|brain|brain
1016195|NCT03062384|health|health
1016196|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
1016197|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
1016198|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
1016199|NCT03062358|PD1|pd1
1016200|NCT03062358|PD-1|pd-1
1016205|NCT03062345|Virtual Reality Therapy|virtual reality therapy
1016206|NCT03062345|Rehabilitation|rehabilitation
1016207|NCT03062345|Upper Extremity|upper extremity
1016208|NCT03062345|Arm|arm
1016209|NCT03062345|Telerehabilitation|telerehabilitation
1016210|NCT03062319|anticoagulant|anticoagulant
1016211|NCT03062319|antiplatelet|antiplatelet
1016212|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
1016213|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1016214|NCT03062306|Chest Compression|chest compression
1016215|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
1016216|NCT03062293|Rehabilitation|rehabilitation
1016217|NCT03062293|Exercise|exercise
1016218|NCT03062293|Low back pain|low back pain
1016219|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
1016220|NCT03062280|Extension study|extension study
1016221|NCT03062267|mhealth|mhealth
1016222|NCT03062267|texting intervention|texting intervention
1016223|NCT03062267|mobile health|mobile health
1016224|NCT03062267|mobile mental health|mobile mental health
1016225|NCT03062254|PSMA|psma
1016226|NCT03062241|cryoablation|cryoablation
1016227|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
1016228|NCT03062228|stillbirth|stillbirth
1016229|NCT03062228|sleep|sleep
1016230|NCT03062228|low birth weight|low birth weight
1016231|NCT03062228|pregnancy|pregnancy
1016233|NCT03062228|small for gestational age|small for gestational age
1016234|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
1016235|NCT03062215|Internet-delivered treatment|internet-delivered treatment
1016236|NCT03062215|Depression|depression
1016237|NCT03062215|Latin America|latin america
1016238|NCT03062202|Depression|depression
1016240|NCT03062202|Online interventions|online interventions
1016241|NCT03062202|CBT|cbt
1016242|NCT03062202|IAPT|iapt
1016243|NCT03062176|Heart failure|heart failure
1016244|NCT03062176|End-stage renal disease|end-stage renal disease
1016245|NCT03062176|Interleukin-1|interleukin-1
1016246|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
1016247|NCT03062176|Metabolomics|metabolomics
1016248|NCT03062176|Lipidomics|lipidomics
1016249|NCT03062176|Chronic kidney disease|chronic kidney disease
1016250|NCT03062137|bronchoscopy|bronchoscopy
1016251|NCT03062137|saturation|saturation
1016252|NCT03062124|SpyGlass|spyglass
1016253|NCT03062124|Pancreatoscopy|pancreatoscopy
1016254|NCT03062072|normoglycemia|normoglycemia
1016255|NCT03062072|cancer|cancer
1016256|NCT03062072|chemotherapy|chemotherapy
1016257|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
1016258|NCT03062046|Atrial Fibrillation|atrial fibrillation
1016259|NCT03062020|Preterm Birth|preterm birth
1016260|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
1016261|NCT03062020|QUIPP|quipp
1016262|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
1016263|NCT03062020|Cervical length|cervical length
1016264|NCT03061968|acupressure|acupressure
1016265|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
1016266|NCT03061968|body weight|body weight
1016267|NCT03061968|behavioral state|behavioral state
1016268|NCT03061968|developmental status|developmental status
1016269|NCT03061903|total hip arthroplasty|total hip arthroplasty
1016270|NCT03061903|direct anterior approach|direct anterior approach
1016271|NCT03061903|wound complication|wound complication
1016272|NCT03061890|children's environmental health|children's environmental health
1016273|NCT03061890|prematurity|prematurity
1016274|NCT03061890|preterm birth|preterm birth
1016275|NCT03061890|phthalates|phthalates
1016276|NCT03061890|NICU|nicu
1016277|NCT03061890|stress|stress
1016278|NCT03061890|lung health|lung health
1016279|NCT03061890|neurodevelopment|neurodevelopment
1016280|NCT03061890|growth|growth
1016281|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
1016282|NCT03061877|Anxiety|anxiety
1016283|NCT03061877|Depression|depression
1016284|NCT03061825|Aneurysm|aneurysm
1016285|NCT03061825|Aortic Aneurysm|aortic aneurysm
1016286|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1016287|NCT03061825|Iliac Aneurysm|iliac aneurysm
1016290|NCT03061825|Aortic Diseases|aortic diseases
1016291|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1016292|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
1016293|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
1016294|NCT03061812|topotecan|topotecan
1016295|NCT03061812|metastatic|metastatic
1016296|NCT03061760|Prostate cancer|prostate cancer
1016297|NCT03061760|Incontinence|incontinence
1016298|NCT03061760|Radical prostatectomy|radical prostatectomy
1016299|NCT03061760|Urge urinary incontinence|urge urinary incontinence
1016300|NCT03061734|Migraine Disorders|migraine disorders
1016301|NCT03061734|Headache Disorders|headache disorders
1016302|NCT03061734|Migraine with Aura|migraine with aura
1016303|NCT03061734|Migraine without Aura|migraine without aura
1016304|NCT03061721|NASH|nash
1016305|NCT03061721|NAFLD|nafld
1016306|NCT03061721|Saroglitazar|saroglitazar
1016307|NCT03061669|heart failure|heart failure
1016308|NCT03061669|pulmonary hypertension|pulmonary hypertension
1016703|NCT03058848|Metabolic|metabolic
1016309|NCT03061669|right heart catheterization|right heart catheterization
1016310|NCT03061591|Turmeric|turmeric
1016311|NCT03061591|Curcumin|curcumin
1016312|NCT03061591|colorectal polyps|colorectal polyps
1016313|NCT03061591|colorectal neoplasia|colorectal neoplasia
1016314|NCT03061591|mutyh mutation|mutyh mutation
1016315|NCT03061591|apc mutation|apc mutation
1016316|NCT03061578|Tear Film|tear film
1016317|NCT03061578|Hyperspectral imaging|hyperspectral imaging
1016318|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
1016319|NCT03061565|erythropoietin|erythropoietin
1016320|NCT03061565|traumatic brain injury|traumatic brain injury
1016321|NCT03061539|Immunogenic signature|immunogenic signature
1016322|NCT03061513|Parkinson Disease|parkinson disease
1016323|NCT03061513|ubiquinol|ubiquinol
1016324|NCT03061513|CoQ10|coq10
1016325|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1016326|NCT03061513|lactate|lactate
1016327|NCT03061513|glutathione|glutathione
1016328|NCT03061500|Proadrenomedullin|proadrenomedullin
1016329|NCT03061500|Sepsis|sepsis
1016330|NCT03061500|Intraabdominal Infections|intraabdominal infections
1016331|NCT03061500|prognosis|prognosis
1016332|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
1016333|NCT03061474|Alzheimer's Disease|alzheimer's disease
1016334|NCT03061474|Nicotinamide|nicotinamide
1016337|NCT03061474|Nicotinic Acids|nicotinic acids
1016338|NCT03061474|Vitamin|vitamin
1016339|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
1016340|NCT03061474|Tauopathies|tauopathies
1016341|NCT03061474|Dementia|dementia
1016342|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
1016343|NCT03061461|ESWT|eswt
1016344|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
1016345|NCT03061461|rESWT|reswt
1016346|NCT03061461|Diabetes|diabetes
1016347|NCT03061435|Vulvar Cancer|vulvar cancer
1016348|NCT03061435|Cervical Cancer|cervical cancer
1016349|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
1016350|NCT03061435|Cervical Dysplasia|cervical dysplasia
1016351|NCT03061435|Anal Cancer|anal cancer
1016352|NCT03061435|Anal Dysplasia|anal dysplasia
1016353|NCT03061435|HPV|hpv
1016354|NCT03061357|activity tracker|activity tracker
1016355|NCT03061357|behavior change|behavior change
1016356|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
1016357|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
1016358|NCT03061279|headless screws|headless screws
1016359|NCT03061279|headed screws|headed screws
1016360|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
1016361|NCT03061253|Electronic Cigarettes|electronic cigarettes
1016362|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
1016363|NCT03061253|Ultrasound|ultrasound
1016364|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
1016365|NCT03061240|Internet of Things|internet of things
1016366|NCT03061136|Cognition|cognition
1016367|NCT03061136|Gamma oscillations|gamma oscillations
1016368|NCT03061136|EEG|eeg
1016369|NCT03061136|Executive function|executive function
1016370|NCT03061136|Benzodiazepine|benzodiazepine
1016371|NCT03061136|GABA|gaba
1016372|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
1016373|NCT03061084|Spina Bifida,Neurogenic bladder, Myelomeningocele, Meningocele|spina bifida,neurogenic bladder, myelomeningocele, meningocele
1016374|NCT03061071|Positional Sleep Apnea|positional sleep apnea
1016375|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
1016376|NCT03061071|POSA|posa
1016377|NCT03061071|OSA|osa
1016378|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
1016379|NCT03061071|Sleep Apnea|sleep apnea
1016380|NCT03061019|child|child
1016381|NCT03061019|myofunctional therapy|myofunctional therapy
1016382|NCT03061019|adenotonsillectomy|adenotonsillectomy
1016383|NCT03061019|randomized controlled trial|randomized controlled trial
1016384|NCT03060993|Cannabis|cannabis
1016385|NCT03060993|Marijuana|marijuana
1016386|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
1016387|NCT03060954|Visual Disorder|visual disorder
1016388|NCT03060928|Rotator Cuff Tear|rotator cuff tear
1016389|NCT03060928|Artelon®|artelon®
1016390|NCT03060915|Actigraphy|actigraphy
1016391|NCT03060915|Polysomnography|polysomnography
1016392|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
1016393|NCT03060889|Cesarean section|cesarean section
1016394|NCT03060889|placenta previa|placenta previa
1016395|NCT03060889|Tranexamic acid|tranexamic acid
1016396|NCT03060876|shoulder fractures|shoulder fractures
1016397|NCT03060876|humeral fractures|humeral fractures
1016398|NCT03060876|operative therapy|operative therapy
1016399|NCT03060876|conservative therapy|conservative therapy
1016400|NCT03060876|range of motion, articular|range of motion, articular
1016401|NCT03060876|quality of life|quality of life
1016402|NCT03060876|proximal|proximal
1016403|NCT03060863|children|children
1016404|NCT03060837|RIRS|rirs
1016405|NCT03060837|Kidney Stone|kidney stone
1016406|NCT03060837|Single lung ventilation|single lung ventilation
1016407|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
1016408|NCT03060824|Osmolality|osmolality
1016409|NCT03060824|Sodium|sodium
1016410|NCT03060824|CABG|cabg
1016411|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
1016412|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
1016413|NCT03060772|Pulmonary Medicine|pulmonary medicine
1016414|NCT03060772|Oxidative Stress|oxidative stress
1016415|NCT03060772|Pioglitazone|pioglitazone
1016416|NCT03060772|Immunology|immunology
1016417|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
1016418|NCT03060759|Multiple Sclerosis|multiple sclerosis
1016419|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1016420|NCT03060759|Fatigue|fatigue
1016421|NCT03060759|Light Therapy|light therapy
1016422|NCT03060720|Pancreatic Cancer|pancreatic cancer
1016423|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1016424|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1016425|NCT03060668|Critical Illness|critical illness
1016426|NCT03060668|Indirect Calorimetry|indirect calorimetry
1016427|NCT03060668|Dietary Proteins|dietary proteins
1016428|NCT03060655|PLGA-Mg|plga-mg
1016429|NCT03060655|fracture|fracture
1016430|NCT03060655|fixation|fixation
1016431|NCT03060655|union|union
1016432|NCT03060642|Microenvironment|microenvironment
1016433|NCT03060642|Microbiome|microbiome
1016434|NCT03060642|Screening|screening
1016435|NCT03060642|Barrett Esophagus|barrett esophagus
1016436|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
1016437|NCT03060603|Erythropoietin|erythropoietin
1016438|NCT03060603|Endometrium|endometrium
1016439|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
1016440|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
1016441|NCT03060564|shoulder|shoulder
1016442|NCT03060564|orthopaedics|orthopaedics
1016443|NCT03060525|Deaf|deaf
1016444|NCT03060525|American Sign Language|american sign language
1016445|NCT03060525|Overweight|overweight
1016446|NCT03060525|Obese|obese
1016447|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
1016448|NCT03060512|constipation,|constipation,
1016449|NCT03060512|laxative,|laxative,
1016450|NCT03060512|bowel movement,|bowel movement,
1016451|NCT03060512|Movantik,|movantik,
1016452|NCT03060512|Naloxegol|naloxegol
1016453|NCT03060499|Thyroidectomy|thyroidectomy
1016454|NCT03060499|Myocardial Function|myocardial function
1016455|NCT03060499|Thyroid gland|thyroid gland
1016456|NCT03060499|Heart|heart
1016457|NCT03060473|PPROM|pprom
1016458|NCT03060473|Azithromycin|azithromycin
1016459|NCT03060473|Erythromycin|erythromycin
1016460|NCT03060434|pentoxifylline|pentoxifylline
1016461|NCT03060434|Disc hernia|disc hernia
1016462|NCT03060434|sciatica|sciatica
1016463|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
1016464|NCT03060408|Fluid Therapy|fluid therapy
1016465|NCT03060408|Laparoscopy|laparoscopy
1016466|NCT03060369|Tissue Perfusion|tissue perfusion
1016467|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
1016468|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
1016469|NCT03060369|CareGuide|careguide
1016470|NCT03060317|Disorders of consciousness|disorders of consciousness
1016471|NCT03060317|validation studies|validation studies
1016472|NCT03060317|coma|coma
1016473|NCT03060317|vegetative state|vegetative state
1016474|NCT03060304|tamoxifen|tamoxifen
1016475|NCT03060304|thin endometrium|thin endometrium
1016476|NCT03060304|frozen embryo transfer|frozen embryo transfer
1016477|NCT03060304|pregnancy rate|pregnancy rate
1016478|NCT03060291|Family Check-up|family check-up
1016479|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
1016480|NCT03060265|multimodal analgesia|multimodal analgesia
1016481|NCT03060265|paracetamol|paracetamol
1016482|NCT03060265|cesarean section|cesarean section
1016483|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
1016484|NCT03060239|Parkinson Disease|parkinson disease
1016485|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
1016486|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
1016487|NCT03060239|Supplementary motor area|supplementary motor area
1016488|NCT03060213|Well-Being|well-being
1016489|NCT03060213|e-Health|e-health
1016490|NCT03060213|Randomized Controlled Trial|randomized controlled trial
1016491|NCT03060213|Self-Efficacy|self-efficacy
1016492|NCT03060213|Interpersonal well-being|interpersonal well-being
1016493|NCT03060213|Community well-being|community well-being
1016494|NCT03060213|Occupational well-being|occupational well-being
1016495|NCT03060213|Physical well-being|physical well-being
1016496|NCT03060213|Psychological well-being|psychological well-being
1016497|NCT03060213|Economic well-being|economic well-being
1016498|NCT03060200|depression|depression
1016499|NCT03060200|treatment|treatment
1016500|NCT03060200|CBT|cbt
1016501|NCT03060200|online|online
1016502|NCT03060200|app|app
1016503|NCT03060161|Health promotion|health promotion
1016504|NCT03060161|Healthy Diet|healthy diet
1016505|NCT03060161|Exercise|exercise
1016506|NCT03060148|Heart failure|heart failure
1016507|NCT03060148|Spinal cord stimulation|spinal cord stimulation
1016508|NCT03060109|Traumatic brain injury|traumatic brain injury
1016509|NCT03060109|Head injury|head injury
1016510|NCT03060031|Oxytocin|oxytocin
1016511|NCT03060005|Sjögren's syndrome|sjögren's syndrome
1016512|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
1016513|NCT03060005|dry eye disease|dry eye disease
1016514|NCT03059940|Smoking Cessation|smoking cessation
1016515|NCT03059940|Low Dose computed tomography|low dose computed tomography
1016516|NCT03059940|LDCT|ldct
1016517|NCT03059940|Quitline|quitline
1016518|NCT03059940|Questionnaires|questionnaires
1016519|NCT03059940|Surveys|surveys
1016520|NCT03059940|Counseling|counseling
1016521|NCT03059940|Smoking cessation drugs|smoking cessation drugs
1016522|NCT03059940|Anti-Smoking Drug|anti-smoking drug
1016523|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
1016524|NCT03059940|NRT|nrt
1016525|NCT03059940|Nicotine Patch|nicotine patch
1016526|NCT03059927|Cruciate retaining|cruciate retaining
1016527|NCT03059927|Anterior stabilized|anterior stabilized
1016528|NCT03059927|Posterior stabilized|posterior stabilized
1016529|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
1016530|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
1016531|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
1017221|NCT03055208|Gamma Knife|gamma knife
1016532|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
1016533|NCT03059901|Physical Activity|physical activity
1016534|NCT03059901|Latina Women|latina women
1016535|NCT03059901|Minority Health|minority health
1016536|NCT03059901|Mobile Technology|mobile technology
1016537|NCT03059901|Social Support|social support
1016538|NCT03059875|Breastcancer|breastcancer
1016662|NCT03059030|Thrombocytopenia|thrombocytopenia
1016539|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
1016540|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
1016541|NCT03059862|immunity|immunity
1016542|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
1016543|NCT03059862|immune homeostasis|immune homeostasis
1016544|NCT03059862|microbiota|microbiota
1016545|NCT03059862|tryptophan|tryptophan
1016546|NCT03059836|n3 PUFA|n3 pufa
1016547|NCT03059823|Solid tumors|solid tumors
1016548|NCT03059823|Metastatic cancer|metastatic cancer
1016549|NCT03059745|Cholecystitis|cholecystitis
1016550|NCT03059745|Cholelithiasis|cholelithiasis
1016551|NCT03059732|Gastric cancer|gastric cancer
1016552|NCT03059732|Thailand|thailand
1016553|NCT03059732|Japan|japan
1016554|NCT03059719|safety|safety
1016555|NCT03059719|pharmacokinetics|pharmacokinetics
1016556|NCT03059719|pharmacodynamics|pharmacodynamics
1016557|NCT03059693|Eczema|eczema
1016558|NCT03059693|Topical|topical
1016559|NCT03059680|Potassium|potassium
1016560|NCT03059680|Nutrition|nutrition
1016561|NCT03059667|Small Cell Lun cancer|small cell lun cancer
1016562|NCT03059667|IFCT|ifct
1016563|NCT03059667|immune therapy|immune therapy
1016564|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
1016565|NCT03059654|surgical tracheostomy|surgical tracheostomy
1016566|NCT03059654|airway ultrasound|airway ultrasound
1016567|NCT03059654|intensive care|intensive care
1016568|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
1016569|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
1016570|NCT03059641|liquid biopsy|liquid biopsy
1016571|NCT03059641|EGFR Gene mutation|egfr gene mutation
1016572|NCT03059589|food anaphylaxis|food anaphylaxis
1016573|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
1016574|NCT03059589|food oral immunotherapy|food oral immunotherapy
1016575|NCT03059589|food allergy|food allergy
1016576|NCT03059589|food allergy treatment|food allergy treatment
1016577|NCT03059576|Chronobiology|chronobiology
1016578|NCT03059576|Circadian rhythms|circadian rhythms
1016579|NCT03059576|Heritability|heritability
1016580|NCT03059576|Twins|twins
1016581|NCT03059563|Varenicline|varenicline
1016582|NCT03059563|Positron Emission Tomography|positron emission tomography
1016583|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1016584|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
1016585|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
1016586|NCT03059550|prediabetes|prediabetes
1016587|NCT03059524|microRNA|microrna
1016588|NCT03059498|PECS I and II|pecs i and ii
1016589|NCT03059498|PECS blocks|pecs blocks
1016590|NCT03059485|Leukemia|leukemia
1016591|NCT03059472|physical activity|physical activity
1016592|NCT03059472|nutrition|nutrition
1016593|NCT03059472|social network|social network
1016594|NCT03059472|civic engagement|civic engagement
1016595|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
1016596|NCT03059459|Air Pollution|air pollution
1016597|NCT03059459|Particulate Matter|particulate matter
1016598|NCT03059433|Substance use|substance use
1016599|NCT03059433|adolescent|adolescent
1016600|NCT03059433|health|health
1016601|NCT03059433|social network|social network
1016602|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
1016603|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
1016704|NCT03058848|Control|control
1016604|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
1016605|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
1016606|NCT03059420|Strabismus|strabismus
1016607|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
1016608|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
1016609|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
1016610|NCT03059420|Moebius|moebius
1016611|NCT03059394|reliability|reliability
1016612|NCT03059394|validity|validity
1016613|NCT03059394|measurement error|measurement error
1016614|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
1016615|NCT03059381|partial seizures|partial seizures
1016616|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
1016617|NCT03059342|spastic diplegic CP|spastic diplegic cp
1016618|NCT03059342|self-care|self-care
1016619|NCT03059342|functional mobility|functional mobility
1016620|NCT03059342|multilevel surgery|multilevel surgery
1016621|NCT03059329|adult epilepsy participants|adult epilepsy participants
1016622|NCT03059329|partial seizures|partial seizures
1016623|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
1016624|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
1016625|NCT03059290|post operative pain|post operative pain
1016626|NCT03059290|Post operative flare ups|post operative flare ups
1016627|NCT03059290|Post endodontic pain|post endodontic pain
1016628|NCT03059290|Post endodontic flare ups|post endodontic flare ups
1016629|NCT03059290|Necrotic teeth|necrotic teeth
1016630|NCT03059290|Non vital teeth|non vital teeth
1016631|NCT03059290|Neolix file|neolix file
1016632|NCT03059290|Single rotating file|single rotating file
1016633|NCT03059290|Protaper next file|protaper next file
1016634|NCT03059290|Multiple rotating file|multiple rotating file
1016635|NCT03059290|Single visit|single visit
1016636|NCT03059277|Diabetic Macular Edema|diabetic macular edema
1016637|NCT03059277|Diabetes|diabetes
1016638|NCT03059277|reduced treatment frequency|reduced treatment frequency
1016639|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
1016640|NCT03059238|Pain control|pain control
1016641|NCT03059238|TACE|tace
1016642|NCT03059238|Opioids|opioids
1016643|NCT03059238|NSAIDs|nsaids
1016644|NCT03059225|Stroke|stroke
1016645|NCT03059225|Aphasia|aphasia
1016646|NCT03059225|rTMS|rtms
1016647|NCT03059225|Functional MRI|functional mri
1016648|NCT03059225|Speech training|speech training
1016649|NCT03059212|working memory|working memory
1016650|NCT03059212|parkinson's disease|parkinson's disease
1016651|NCT03059199|Prospective/Retrospective|prospective/retrospective
1016652|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
1016653|NCT03059173|Reproductive medicine|reproductive medicine
1016654|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
1016655|NCT03059134|Overactive bladder|overactive bladder
1016656|NCT03059134|Pharmacotherapy|pharmacotherapy
1016657|NCT03059134|Adverse event|adverse event
1016658|NCT03059121|HIV|hiv
1016659|NCT03059121|Lipodystrophy|lipodystrophy
1016660|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
1016661|NCT03059043|viscoelastic|viscoelastic
1016663|NCT03059030|cirrhosis|cirrhosis
1016664|NCT03059030|Therasphere®|therasphere®
1016665|NCT03059030|Y90|y90
1016666|NCT03059030|Radioembolization|radioembolization
1016667|NCT03059004|physical therapy|physical therapy
1016668|NCT03058965|AD|ad
1016669|NCT03058965|HV|hv
1016670|NCT03058965|PSP|psp
1016671|NCT03058952|pain management|pain management
1016672|NCT03058952|fatigue|fatigue
1016673|NCT03058952|mindfulness|mindfulness
1016674|NCT03058952|Gulf War|gulf war
1016675|NCT03058939|Breast Cancer|breast cancer
1016676|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
1016677|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
1016678|NCT03058939|Paclitaxel|paclitaxel
1016679|NCT03058939|Taxol|taxol
1016680|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
1016681|NCT03058926|Diabetes|diabetes
1016682|NCT03058926|Pancreatic Cancer|pancreatic cancer
1016683|NCT03058926|Data Management|data management
1016684|NCT03058926|Protocol compliance|protocol compliance
1016685|NCT03058926|Regulatory compliance|regulatory compliance
1016686|NCT03058926|Consortium studies|consortium studies
1016687|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
1016688|NCT03058900|FMT|fmt
1016689|NCT03058900|Randomized Controlled Trial|randomized controlled trial
1016690|NCT03058900|Intestinal microbiome|intestinal microbiome
1016691|NCT03058900|RCT|rct
1016692|NCT03058887|High Intensity Interval Training|high intensity interval training
1016693|NCT03058887|Exercise|exercise
1016694|NCT03058887|Microcirculation|microcirculation
1016695|NCT03058874|Chronic Kidney Disease|chronic kidney disease
1016696|NCT03058874|Hemodialysis|hemodialysis
1016697|NCT03058874|Hypertension|hypertension
1016698|NCT03058874|Arterial Stifness|arterial stifness
1016699|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1016700|NCT03058848|Phenylketonuria|phenylketonuria
1016701|NCT03058848|PKU|pku
1016702|NCT03058848|Metabolism|metabolism
1016705|NCT03058848|Acceptability|acceptability
1016706|NCT03058835|HIV|hiv
1016707|NCT03058835|Truvada|truvada
1016708|NCT03058796|stroke|stroke
1016709|NCT03058796|rehabilitation|rehabilitation
1016710|NCT03058796|Hemipelegia|hemipelegia
1016711|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
1016712|NCT03058692|Immunogenicity|immunogenicity
1016713|NCT03058692|Influenza Vaccine|influenza vaccine
1016714|NCT03058692|M-001 vaccine|m-001 vaccine
1016715|NCT03058692|Reactogenicity|reactogenicity
1016716|NCT03058692|Safety|safety
1016717|NCT03058679|diet|diet
1016718|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
1016719|NCT03058679|Mediterranean style diet|mediterranean style diet
1016720|NCT03058679|randomized controlled trial|randomized controlled trial
1016721|NCT03058666|Aerosol|aerosol
1016722|NCT03058666|surfactant|surfactant
1016723|NCT03058666|calfactant|calfactant
1016724|NCT03058666|Infasurf|infasurf
1016725|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
1016726|NCT03058666|RDS|rds
1016727|NCT03058666|Premature|premature
1016728|NCT03058666|Neonates|neonates
1016729|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1017321|NCT03054363|Letrozole|letrozole
1016730|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
1016731|NCT03058575|Microbiome|microbiome
1016732|NCT03058575|Gut|gut
1016733|NCT03058575|Skin|skin
1016734|NCT03058575|Fiber|fiber
1016735|NCT03058575|Starch|starch
1016736|NCT03058549|Expectant parents|expectant parents
1016737|NCT03058549|Relationship education|relationship education
1016738|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
1016739|NCT03058523|Flavour|flavour
1016740|NCT03058523|Infants|infants
1016741|NCT03058523|Taste|taste
1016742|NCT03058523|Pregnancy|pregnancy
1016743|NCT03058523|Programming|programming
1016744|NCT03058523|Fruit|fruit
1016745|NCT03058523|Vegetables|vegetables
1016746|NCT03058523|Bitter profile|bitter profile
1016747|NCT03058523|Food preferences|food preferences
1016748|NCT03058510|bifurcation lesion|bifurcation lesion
1016749|NCT03058510|atherectomy|atherectomy
1016750|NCT03058510|calcification|calcification
1016751|NCT03058510|stent|stent
1016752|NCT03058445|Central venous catheter|central venous catheter
1016753|NCT03058445|MMode echocardiography|mmode echocardiography
1016754|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
1016755|NCT03058406|Halaven Injection|halaven injection
1016756|NCT03058406|E7389|e7389
1016757|NCT03058341|postoperative pain|postoperative pain
1016758|NCT03058341|propofol|propofol
1016759|NCT03058341|TIVA|tiva
1016760|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
1016761|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
1016762|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
1016763|NCT03058315|Physical activity|physical activity
1016764|NCT03058315|Disease perception|disease perception
1016765|NCT03058315|Pain beliefs|pain beliefs
1016766|NCT03058315|Disability|disability
1016767|NCT03058315|Advice|advice
1016768|NCT03058289|Neoplasm|neoplasm
1016769|NCT03058289|Malignancy|malignancy
1016770|NCT03058289|Intratumoral|intratumoral
1016771|NCT03058289|Intralesional|intralesional
1016772|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
1016773|NCT03058289|Immuno therapy|immuno therapy
1016774|NCT03058289|Dose escalation|dose escalation
1016775|NCT03058289|Platinum|platinum
1016776|NCT03058289|Intensity Therapeutics|intensity therapeutics
1016777|NCT03058289|INT230-6|int230-6
1016778|NCT03058289|cisplatin|cisplatin
1016779|NCT03058289|vinblastine|vinblastine
1016780|NCT03058289|PD-1|pd-1
1016781|NCT03058276|rTMS|rtms
1016782|NCT03058276|AAT|aat
1016783|NCT03058276|Alcohol-Dependence|alcohol-dependence
1016784|NCT03058276|Relapses|relapses
1016785|NCT03058224|Pain, Symptom Severity|pain, symptom severity
1016786|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
1016787|NCT03058224|Fibromyalgia|fibromyalgia
1016788|NCT03058224|Widespread Pain Index|widespread pain index
1016789|NCT03058224|Eggyolk|eggyolk
1016790|NCT03058224|FIQ-R|fiq-r
1016791|NCT03058224|SF-36v2TM|sf-36v2tm
1016792|NCT03058224|MOS-SS|mos-ss
1016793|NCT03058224|FSS|fss
1016794|NCT03058224|PGIC|pgic
1016795|NCT03058224|Quality of life|quality of life
1016796|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
1016797|NCT03058211|Acute cardiovascular events|acute cardiovascular events
1016798|NCT03058198|Glioma|glioma
1016799|NCT03058198|PET|pet
1016800|NCT03058198|EGFR vIII|egfr viii
1016801|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
1016802|NCT03058198|Molecular pathology|molecular pathology
1016803|NCT03058198|PET-CT|pet-ct
1016804|NCT03058198|Neuronavigation|neuronavigation
1016805|NCT03058185|Lamin A/C|lamin a/c
1016806|NCT03058185|Emerin|emerin
1016807|NCT03058146|Exercise|exercise
1016808|NCT03058146|Fitness|fitness
1016809|NCT03058146|Physical Activity|physical activity
1017101|NCT03056144|children|children
1016810|NCT03058146|Cognitive Aging|cognitive aging
1016811|NCT03058146|Cerebral Blood Flow|cerebral blood flow
1016812|NCT03058146|Brain Imaging|brain imaging
1016813|NCT03058146|Unsupervised Intervention|unsupervised intervention
1016814|NCT03058146|Mobile Health|mobile health
1016815|NCT03058146|Free-living exercise intervention|free-living exercise intervention
1016816|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
1016817|NCT03058107|Nutrition Therapy|nutrition therapy
1016818|NCT03058081|COPD|copd
1016819|NCT03058081|Exercise|exercise
1016820|NCT03058081|High Flow Nasal|high flow nasal
1016821|NCT03058081|Muscle Oxygenation|muscle oxygenation
1016822|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
1016823|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
1016824|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
1016825|NCT03058042|Physical Therapy Modalities|physical therapy modalities
1016826|NCT03058003|balance, postural|balance, postural
1016827|NCT03058003|postural equilibrium|postural equilibrium
1016828|NCT03058003|chronic pain|chronic pain
1016829|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
1016830|NCT03058003|Fibromyalgia|fibromyalgia
1016831|NCT03058003|Cervicogenic headache|cervicogenic headache
1017322|NCT03054363|HR-positive|hr-positive
1016832|NCT03058003|Chronic tension type headache|chronic tension type headache
1016833|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
1016834|NCT03058003|Whiplash associated disorder|whiplash associated disorder
1016835|NCT03058003|Temporomandibular disorder|temporomandibular disorder
1016836|NCT03057990|Pyrimethamine|pyrimethamine
1016837|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
1016838|NCT03057990|Refractory|refractory
1016839|NCT03057990|Relapsed|relapsed
1016840|NCT03057938|Alzheimer|alzheimer
1016841|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
1016842|NCT03057938|Florbetaben|florbetaben
1016843|NCT03057925|thyroid nodule|thyroid nodule
1016844|NCT03057925|microwave ablation|microwave ablation
1016845|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
1016846|NCT03057912|TALEN|talen
1016847|NCT03057912|CRISPR/Cas9|crispr/cas9
1016848|NCT03057899|Herbal medicine|herbal medicine
1016849|NCT03057899|phytotherapy|phytotherapy
1016850|NCT03057899|testosterone|testosterone
1016851|NCT03057873|protein|protein
1016852|NCT03057873|fiber|fiber
1016853|NCT03057873|weight loss|weight loss
1016854|NCT03057873|fat loss|fat loss
1016855|NCT03057821|hydrogen peroxide|hydrogen peroxide
1016856|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
1016857|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
1016858|NCT03057808|Pregnancy|pregnancy
1016859|NCT03057808|Postpartum|postpartum
1016860|NCT03057782|Pain|pain
1016861|NCT03057782|Sedation|sedation
1016862|NCT03057782|Surgery|surgery
1016863|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
1016864|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
1016865|NCT03057756|short course regimen protocol|short course regimen protocol
1016866|NCT03057730|acellular dermal matrix|acellular dermal matrix
1016867|NCT03057704|Propofol|propofol
1016868|NCT03057704|lidocaine|lidocaine
1016869|NCT03057704|pain|pain
1016870|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
1016871|NCT03057691|Major Depressive Disorder|major depressive disorder
1016872|NCT03057691|Generalized Anxiety Disorder|generalized anxiety disorder
1016873|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
1016874|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
1016875|NCT03057613|radiation|radiation
1016876|NCT03057613|resected|resected
1016877|NCT03057600|African ancestry|african ancestry
1016878|NCT03057600|African American|african american
1016879|NCT03057600|CB-839|cb-839
1016880|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
1016881|NCT03057600|Glutaminase|glutaminase
1016882|NCT03057600|TNBC|tnbc
1016883|NCT03057600|Tumor Metabolism|tumor metabolism
1016884|NCT03057600|Glutamine|glutamine
1016885|NCT03057561|CAD|cad
1016886|NCT03057548|Atrial Fibrillation|atrial fibrillation
1016887|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
1016888|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
1016889|NCT03057535|Exercise|exercise
1016890|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
1016891|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
1016892|NCT03057522|Run|run
1016893|NCT03057522|Cadence|cadence
1016894|NCT03057522|Home exercise|home exercise
1016895|NCT03057509|Carcinoid Tumors|carcinoid tumors
1016896|NCT03057470|Diabetes|diabetes
1016897|NCT03057470|Exercise|exercise
1016898|NCT03057470|Insulin|insulin
1016899|NCT03057444|resistant starch type III|resistant starch type iii
1016900|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
1016901|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
1016902|NCT03057444|prediabetes|prediabetes
1016903|NCT03057431|kidney stones|kidney stones
1016904|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
1017102|NCT03056118|OPTIMA-C|optima-c
1016905|NCT03057405|intra-operative navigation|intra-operative navigation
1016906|NCT03057405|3D virtual planning|3d virtual planning
1016907|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
1016908|NCT03057392|immersion|immersion
1016909|NCT03057392|ultrafiltration|ultrafiltration
1016910|NCT03057392|dialysis|dialysis
1016911|NCT03057379|HPV vaccine|hpv vaccine
1016912|NCT03057379|Immunization registry|immunization registry
1016913|NCT03057379|Reminder recall|reminder recall
1016914|NCT03057366|Drug therapy|drug therapy
1016915|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1016916|NCT03057340|Dribbles|dribbles
1016917|NCT03057275|Threatened Premature Labor|threatened premature labor
1016918|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
1016919|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
1016920|NCT03057262|disc displacement with reduction|disc displacement with reduction
1016921|NCT03057262|anterior repositioning splint|anterior repositioning splint
1016922|NCT03057249|Surgery|surgery
1016923|NCT03057249|Thermography|thermography
1016924|NCT03057249|Perfusion|perfusion
1016925|NCT03057249|Imaging|imaging
1333126|NCT01444443|Type 1 diabetes|type 1 diabetes
1016926|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
1016927|NCT03057223|3D printing|3d printing
1016928|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
1016929|NCT03057223|mandibular malignancy|mandibular malignancy
1016930|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
1016931|NCT03057223|orthognathic surgery|orthognathic surgery
1016932|NCT03057223|mandibular reconstruction|mandibular reconstruction
1016933|NCT03057210|Exercise|exercise
1016934|NCT03057210|Massage|massage
1016935|NCT03057210|Post-exercise recovery|post-exercise recovery
1016936|NCT03057210|Athletic performance|athletic performance
1016937|NCT03057184|Adult Day Care Center|adult day care center
1016938|NCT03057184|behavioral problems|behavioral problems
1016939|NCT03057184|caregivers|caregivers
1016940|NCT03057171|Helicobacter pylori|helicobacter pylori
1016941|NCT03057171|long non-coding RNA|long non-coding rna
1016942|NCT03057171|THRIL|thril
1016943|NCT03057171|PACER|pacer
1016944|NCT03057171|cagA|caga
1016945|NCT03057158|OAB|oab
1016946|NCT03057158|Insulin resistance|insulin resistance
1016947|NCT03057158|diabetes|diabetes
1016948|NCT03057158|pre-diabetes|pre-diabetes
1016949|NCT03057145|Solid Tumor|solid tumor
1016950|NCT03057093|NSTEMI, ECG|nstemi, ecg
1016951|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
1016952|NCT03057067|Pelvis|pelvis
1016953|NCT03056976|Overdenture|overdenture
1016954|NCT03056976|Dental implant|dental implant
1016955|NCT03056976|Complete denture|complete denture
1016956|NCT03056976|Cost analysis|cost analysis
1016957|NCT03056963|Guided Imagery|guided imagery
1016958|NCT03056950|Blood Flow Restriciton|blood flow restriciton
1016959|NCT03056950|Occlusion training|occlusion training
1016960|NCT03056950|Distal radius fracture|distal radius fracture
1016961|NCT03056911|ozone therapy|ozone therapy
1016962|NCT03056911|percutaneous treatment|percutaneous treatment
1016963|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
1016964|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
1016965|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
1016966|NCT03056911|cervical|cervical
1016967|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
1016968|NCT03056898|EPA|epa
1016969|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
1016970|NCT03056898|DHA|dha
1016971|NCT03056898|omega-3 index|omega-3 index
1016972|NCT03056885|one-lung ventilation|one-lung ventilation
1016973|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
1016974|NCT03056885|protective ventilation|protective ventilation
1016975|NCT03056885|cytokines|cytokines
1016976|NCT03056885|thoracic surgery|thoracic surgery
1016977|NCT03056859|Operator satisfaction with device|operator satisfaction with device
1016978|NCT03056846|probiotic|probiotic
1016979|NCT03056846|gastrointestinal|gastrointestinal
1016980|NCT03056846|stress|stress
1016981|NCT03056846|student|student
1016982|NCT03056820|tracheal intubation|tracheal intubation
1016983|NCT03056807|tolerable apneic time|tolerable apneic time
1016984|NCT03056807|bariatric surgery|bariatric surgery
1016985|NCT03056807|gastric band surgery|gastric band surgery
1016986|NCT03056807|intubation|intubation
1016987|NCT03056794|pyruvate|pyruvate
1016988|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
1016989|NCT03056794|PDC|pdc
1016990|NCT03056794|PDCD|pdcd
1016991|NCT03056755|advanced breast cancer|advanced breast cancer
1016992|NCT03056755|PIK3CA|pik3ca
1016993|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
1016994|NCT03056755|fulvestrant|fulvestrant
1016995|NCT03056755|letrozole|letrozole
1016996|NCT03056755|HR+|hr+
1016997|NCT03056755|HER-negative|her-negative
1016998|NCT03056755|post menopausal|post menopausal
1016999|NCT03056755|pre-menopausal|pre-menopausal
1017000|NCT03056716|thoracic surgery|thoracic surgery
1017001|NCT03056716|silastic drains|silastic drains
1017002|NCT03056716|conventional drains|conventional drains
1017003|NCT03056690|ASP0819|asp0819
1017004|NCT03056690|Fibromyalgia|fibromyalgia
1017005|NCT03056677|Whey protein|whey protein
1017006|NCT03056677|Dietary supplementation|dietary supplementation
1017007|NCT03056677|Glucose|glucose
1017008|NCT03056677|GLP-1|glp-1
1017009|NCT03056677|Satiety|satiety
1017010|NCT03056651|heart failure|heart failure
1017011|NCT03056651|day care|day care
1017012|NCT03056651|prognosis|prognosis
1017013|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
1017014|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
1017015|NCT03056638|16-1686|16-1686
1017016|NCT03056625|fortified rice|fortified rice
1017017|NCT03056625|lactating women|lactating women
1017018|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
1017019|NCT03056625|vitamin A liver store|vitamin a liver store
1017020|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
1017021|NCT03056599|personalized medicine|personalized medicine
1017022|NCT03056599|precision oncology|precision oncology
1017023|NCT03056599|in vivo oncology|in vivo oncology
1017024|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
1017025|NCT03056599|chemotherapy|chemotherapy
1017026|NCT03056599|microinjection|microinjection
1017027|NCT03056599|microdosing|microdosing
1017028|NCT03056573|TAVI|tavi
1017029|NCT03056573|Valvular heart disease|valvular heart disease
1017617|NCT03052751|UCB7665|ucb7665
1017030|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1017031|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
1017032|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
1017033|NCT03056534|Degenerative Joint Disease|degenerative joint disease
1017034|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
1017035|NCT03056508|diet|diet
1017036|NCT03056508|nutrition|nutrition
1017037|NCT03056508|aerobic exercise|aerobic exercise
1017038|NCT03056508|cognition|cognition
1017039|NCT03056508|grey matter|grey matter
1017040|NCT03056508|cerebral blood flow|cerebral blood flow
1017041|NCT03056508|neural activity|neural activity
1017042|NCT03056508|resting state connectivity|resting state connectivity
1017043|NCT03056482|cannabis|cannabis
1017044|NCT03056482|haloperidol|haloperidol
1017045|NCT03056482|ondansetron|ondansetron
1017046|NCT03056482|hyperemesis|hyperemesis
1017047|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
1017048|NCT03056469|patient-reported outcomes|patient-reported outcomes
1017049|NCT03056469|supportive care|supportive care
1017050|NCT03056469|clinical practice|clinical practice
1017051|NCT03056469|hematological cancer|hematological cancer
1017052|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
1017053|NCT03056417|chronic pain|chronic pain
1017054|NCT03056417|telomere|telomere
1017055|NCT03056417|telomerase|telomerase
1017056|NCT03056417|life style|life style
1017057|NCT03056391|knowlesi malaria|knowlesi malaria
1017058|NCT03056391|paracetamol|paracetamol
1017059|NCT03056391|renal function|renal function
1017060|NCT03056391|haemolysis|haemolysis
1017061|NCT03056391|oxidative stress|oxidative stress
1017062|NCT03056365|Detoxification|detoxification
1017063|NCT03056365|Outpatient|outpatient
1017064|NCT03056365|Advanced Nursing|advanced nursing
1017065|NCT03056365|Health Services|health services
1017066|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
1017067|NCT03056339|Relapsed/Refractory|relapsed/refractory
1017068|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
1017069|NCT03056339|ALL|all
1017070|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1017071|NCT03056339|CLL|cll
1017072|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1017073|NCT03056339|NHL|nhl
1017074|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
1017075|NCT03056339|CB-NK cells|cb-nk cells
1017076|NCT03056339|Fludarabine|fludarabine
1017077|NCT03056339|Fludarabine phosphate|fludarabine phosphate
1017078|NCT03056339|Fludara|fludara
1017079|NCT03056339|Cyclophosphamide|cyclophosphamide
1017080|NCT03056339|Cytoxan|cytoxan
1017081|NCT03056339|Neosar|neosar
1017082|NCT03056339|AP1903|ap1903
1017083|NCT03056339|Mesna|mesna
1017084|NCT03056339|Mesnex|mesnex
1017085|NCT03056313|Delivery, Obstetric|delivery, obstetric
1017086|NCT03056313|Uterine Contraction|uterine contraction
1017087|NCT03056313|Cervix Uteri|cervix uteri
1017088|NCT03056274|Metformin|metformin
1017089|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
1017090|NCT03056274|Outcomes|outcomes
1017091|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
1017092|NCT03056235|Atrophic acne scar|atrophic acne scar
1017093|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
1017094|NCT03056157|Moral Injury|moral injury
1017095|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
1017096|NCT03056157|Traumatic Loss|traumatic loss
1017097|NCT03056157|Adaptive Disclosure|adaptive disclosure
1017098|NCT03056157|Veterans|veterans
1017099|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
1017100|NCT03056144|total body vibration|total body vibration
1017103|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
1017104|NCT03056092|ranibizumab|ranibizumab
1017105|NCT03056092|aqueous cytokine|aqueous cytokine
1017106|NCT03056092|age related macular degeneration|age related macular degeneration
1017107|NCT03056092|diabetic macular edema|diabetic macular edema
1017108|NCT03056092|retinal vein occlusion|retinal vein occlusion
1017109|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
1017110|NCT03056079|diabetic macular edema|diabetic macular edema
1017111|NCT03056079|retinal vein occlusion|retinal vein occlusion
1017112|NCT03056079|aflibercept|aflibercept
1017113|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
1017114|NCT03056053|insomnia|insomnia
1017115|NCT03055975|Bacteria|bacteria
1017116|NCT03055975|Root canal treatment|root canal treatment
1017117|NCT03055975|Endodontics|endodontics
1017118|NCT03055962|Healthy Participants|healthy participants
1017119|NCT03055962|E2609|e2609
1017120|NCT03055962|Pharmacokinetics|pharmacokinetics
1017121|NCT03055962|Japan|japan
1017122|NCT03055949|early rehabilitation|early rehabilitation
1017123|NCT03055949|early mobilization|early mobilization
1017124|NCT03055949|surgical intensive care unit|surgical intensive care unit
1017816|NCT03051256|REL-1017|rel-1017
1017125|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1017126|NCT03055884|accelerated learning|accelerated learning
1017127|NCT03055884|memory|memory
1017128|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
1017129|NCT03055858|PDA, ADO II AS|pda, ado ii as
1017130|NCT03055819|Brow Lift|brow lift
1017131|NCT03055819|Brow Ptosis|brow ptosis
1017132|NCT03055806|Sex|sex
1017133|NCT03055806|Sexual Dysfunction|sexual dysfunction
1017134|NCT03055806|IX-01|ix-01
1017135|NCT03055741|Alzheimer's disease|alzheimer's disease
1017136|NCT03055728|streptococcal infections|streptococcal infections
1017137|NCT03055728|rapid strep testing|rapid strep testing
1017138|NCT03055728|rapid antigen detection test|rapid antigen detection test
1017139|NCT03055715|NSCLC|nsclc
1017140|NCT03055715|Radiotherapy|radiotherapy
1017141|NCT03055715|young DEGRO|young degro
1017142|NCT03055715|tumor volume|tumor volume
1017143|NCT03055715|lung cancer|lung cancer
1017144|NCT03055715|radiochemotherapy|radiochemotherapy
1017145|NCT03055715|prognostic factors|prognostic factors
1017146|NCT03055702|Short Message Service|short message service
1017147|NCT03055702|appointment reminder|appointment reminder
1017148|NCT03055702|Attendance rate|attendance rate
1017149|NCT03055689|Colonoscopy|colonoscopy
1017150|NCT03055689|Educational intervention|educational intervention
1017151|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
1017152|NCT03055676|Time of drain removal|time of drain removal
1017153|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
1017154|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1017155|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1017156|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
1017157|NCT03055611|Hematologic Diseases|hematologic diseases
1017158|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
1017159|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
1017160|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
1017161|NCT03055585|Wolbachia; Ae. aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; ae. aegypti; indonesia; dengue; cluster-randomised trial
1017162|NCT03055572|Rhinitis|rhinitis
1017163|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
1017164|NCT03055572|Olfactory Training|olfactory training
1017165|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
1017166|NCT03055546|oxytocin|oxytocin
1017167|NCT03055546|emotion regulation|emotion regulation
1017168|NCT03055533|Behavioral|behavioral
1017169|NCT03055533|Social|social
1017170|NCT03055533|Headsprout reading program|headsprout reading program
1017171|NCT03055520|schizophrenia|schizophrenia
1017172|NCT03055520|cognition|cognition
1017173|NCT03055520|arithmetic training|arithmetic training
1017174|NCT03055520|Kumon method|kumon method
1017175|NCT03055481|neonatal jaundice|neonatal jaundice
1017176|NCT03055481|phototherapy|phototherapy
1017177|NCT03055481|neonate|neonate
1017178|NCT03055429|Prisoners|prisoners
1017179|NCT03055429|End-of-life care|end-of-life care
1017180|NCT03055429|Geriatric care|geriatric care
1017181|NCT03055429|Palliative care|palliative care
1017182|NCT03055429|Hospice care|hospice care
1017183|NCT03055416|Overweight|overweight
1017184|NCT03055416|Obesity|obesity
1017185|NCT03055416|Physical Activity|physical activity
1017186|NCT03055416|African-American Men|african-american men
1017187|NCT03055416|mHealth|mhealth
1017188|NCT03055416|Mobile Health|mobile health
1017189|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
1017190|NCT03055390|progress of labor|progress of labor
1017191|NCT03055390|duration of labor|duration of labor
1017192|NCT03055377|cannabis|cannabis
1017193|NCT03055377|marijuana|marijuana
1017194|NCT03055377|youth|youth
1017195|NCT03055377|adolescent|adolescent
1017196|NCT03055377|pharmacotherapy|pharmacotherapy
1017197|NCT03055377|medication|medication
1017198|NCT03055377|n-acetylcysteine|n-acetylcysteine
1017199|NCT03055377|trial|trial
1017200|NCT03055351|Exercise motivation|exercise motivation
1017201|NCT03055351|Psychological well-being|psychological well-being
1017202|NCT03055351|Healthy living|healthy living
1017203|NCT03055351|Physical activity|physical activity
1017204|NCT03055351|Autonomy support|autonomy support
1017205|NCT03055351|Self-determination theory|self-determination theory
1017206|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
1017207|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
1017208|NCT03055338|Mental Disorders|mental disorders
1017209|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
1017210|NCT03055247|Ibuprofen|ibuprofen
1017211|NCT03055247|Mobilization regimen|mobilization regimen
1017212|NCT03055247|Gene Therapy|gene therapy
1017213|NCT03055234|Oral treprostinil|oral treprostinil
1017214|NCT03055234|6-Minute Walk Distance|6-minute walk distance
1017215|NCT03055234|PH|ph
1017216|NCT03055234|sickle cell|sickle cell
1017217|NCT03055221|Remodulin|remodulin
1017218|NCT03055221|6-Minute Walk Test|6-minute walk test
1017219|NCT03055208|Glioblastoma|glioblastoma
1017220|NCT03055208|Radiosurgery|radiosurgery
1017222|NCT03055195|subcutaneous|subcutaneous
1017223|NCT03055195|safety|safety
1017224|NCT03055195|mepolizumab|mepolizumab
1017225|NCT03055195|efficacy|efficacy
1017226|NCT03055195|atopic dermatitis|atopic dermatitis
1017227|NCT03055182|Isokinetic|isokinetic
1017228|NCT03055182|oxygenation|oxygenation
1017229|NCT03055182|deoxygenation|deoxygenation
1017230|NCT03055182|aerobic metabolism|aerobic metabolism
1017231|NCT03055169|hyperglycemia|hyperglycemia
1017232|NCT03055169|Multiple Organ Failure|multiple organ failure
1017233|NCT03055169|biobank|biobank
1017234|NCT03055169|diabetes|diabetes
1017235|NCT03055156|Sleep Apnea|sleep apnea
1017236|NCT03055156|Insomnia|insomnia
1017237|NCT03055156|sleep disorders|sleep disorders
1017238|NCT03055156|sleep environment|sleep environment
1017239|NCT03055156|core body temperature|core body temperature
1017240|NCT03055117|Shoulder pain|shoulder pain
1017241|NCT03055117|Physiotherapy|physiotherapy
1017242|NCT03055117|Rehabilitation|rehabilitation
1017243|NCT03055117|Exercise|exercise
1017244|NCT03055104|severe malnutrition|severe malnutrition
1017245|NCT03055104|Critically Ill|critically ill
1017246|NCT03055104|refeeding syndrome|refeeding syndrome
1017247|NCT03055104|guideline|guideline
1017248|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
1017249|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
1017250|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
1017251|NCT03055000|Mosquito Transmission|mosquito transmission
1017252|NCT03055000|Vector Borne Viruses|vector borne viruses
1017253|NCT03055000|Vaccine|vaccine
1017254|NCT03054974|Stroke|stroke
1017255|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
1017256|NCT03054974|Rehabilitation|rehabilitation
1017257|NCT03054961|epilepsy|epilepsy
1017258|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
1017259|NCT03054961|childhood epilepsy|childhood epilepsy
1017260|NCT03054961|partial epilepsy|partial epilepsy
1017261|NCT03054961|NIRS|nirs
1017262|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
1017263|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
1017264|NCT03054935|Energy Expenditure|energy expenditure
1017265|NCT03054935|Body Composition|body composition
1017266|NCT03054935|Food Intake|food intake
1017267|NCT03054896|Richter Syndrome|richter syndrome
1017268|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
1017269|NCT03054883|minimal residual disease|minimal residual disease
1017270|NCT03054883|cytosine arabinoside|cytosine arabinoside
1017271|NCT03054870|pulmonary ventilation|pulmonary ventilation
1017272|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
1017273|NCT03054844|Intranasal|intranasal
1017274|NCT03054844|Pain|pain
1017275|NCT03054844|Lidocaine|lidocaine
1017276|NCT03054844|Midazolam|midazolam
1017277|NCT03054844|Emergency department|emergency department
1017278|NCT03054766|Laser Photocoagulation|laser photocoagulation
1017279|NCT03054766|Ranibizumab|ranibizumab
1017280|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
1017281|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
1017282|NCT03054753|Abduction brace|abduction brace
1017283|NCT03054753|Compliance|compliance
1017284|NCT03054753|Rotator cuff tear|rotator cuff tear
1017285|NCT03054753|Rotator cuff repair|rotator cuff repair
1017286|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
1017287|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
1017288|NCT03054727|Venous Thromboembolism|venous thromboembolism
1017289|NCT03054727|Incidence|incidence
1017290|NCT03054727|Risk factors|risk factors
1017291|NCT03054727|Venous ulcer|venous ulcer
1017292|NCT03054701|Patellofemoral pain|patellofemoral pain
1017294|NCT03054701|PFPS|pfps
1017295|NCT03054675|lung resection|lung resection
1017296|NCT03054675|lung function|lung function
1017297|NCT03054675|VATS|vats
1017300|NCT03054610|plantar fascitis|plantar fascitis
1017301|NCT03054610|Botulinum toxin A|botulinum toxin a
1017302|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
1017303|NCT03054610|infiltration|infiltration
1017304|NCT03054610|plantar fascia|plantar fascia
1017305|NCT03054558|Junctional zone|junctional zone
1017306|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
1017307|NCT03054558|3D power Doppler|3d power doppler
1017308|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
1017309|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
1017310|NCT03054441|Upper limb|upper limb
1017311|NCT03054441|Inertial sensors|inertial sensors
1664756|NCT00125515|Opiates|opiates
1017312|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
1017313|NCT03054376|Immobilization|immobilization
1017314|NCT03054376|Angiogenesis|angiogenesis
1017315|NCT03054376|Skeletal muscle|skeletal muscle
1017316|NCT03054376|Exercise training|exercise training
1017317|NCT03054376|Vascular function|vascular function
1017318|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
1017319|NCT03054363|Tucatinib|tucatinib
1017320|NCT03054363|Palbociclib|palbociclib
1017323|NCT03054363|HER2-positive|her2-positive
1017324|NCT03054363|ER-positive|er-positive
1017325|NCT03054363|PR-positive|pr-positive
1017326|NCT03054363|HER2-targeted therapy|her2-targeted therapy
1017327|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
1017328|NCT03054363|ONT-380|ont-380
1017329|NCT03054363|Ibrance|ibrance
1017330|NCT03054350|Anemia|anemia
1017331|NCT03054350|kidney|kidney
1017332|NCT03054350|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
1017334|NCT03054350|DD-CKD|dd-ckd
1017335|NCT03054350|renal|renal
1017336|NCT03054350|vadadustat|vadadustat
1017337|NCT03054350|AKB-6548|akb-6548
1017338|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
1017339|NCT03054350|HIF|hif
1017340|NCT03054350|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1017341|NCT03054350|HIF-PHI|hif-phi
1017342|NCT03054350|Japan|japan
1017343|NCT03054350|Japanese|japanese
1017344|NCT03054337|Anemia|anemia
1017345|NCT03054337|kidney|kidney
1017346|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
1017347|NCT03054337|CKD|ckd
1017348|NCT03054337|NDD-CKD|ndd-ckd
1017349|NCT03054337|renal|renal
1017350|NCT03054337|vadadustat|vadadustat
1017351|NCT03054337|AKB-6548|akb-6548
1017352|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
1017353|NCT03054337|HIF|hif
1017354|NCT03054337|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1017355|NCT03054337|HIF-PHI|hif-phi
1017356|NCT03054337|Japan|japan
1017357|NCT03054337|Japanese|japanese
1017358|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
1017359|NCT03054324|Fractional Flow Reserve|fractional flow reserve
1017360|NCT03054324|Ischemic Heart Disease|ischemic heart disease
1017361|NCT03054324|CT Angiogram|ct angiogram
1017362|NCT03054285|Seizures|seizures
1017363|NCT03054285|Traumatic Brain Injury|traumatic brain injury
1017364|NCT03054285|Prophylaxis|prophylaxis
1017365|NCT03054285|Levetiracetam|levetiracetam
1017366|NCT03054272|High-fidelity simulation|high-fidelity simulation
1017367|NCT03054272|Eye-tracking|eye-tracking
1017368|NCT03054272|Difficult intubation|difficult intubation
1017369|NCT03054233|spinal anesthesia|spinal anesthesia
1017370|NCT03054233|spinal-bone contact|spinal-bone contact
1017371|NCT03054233|caesarian section|caesarian section
1017372|NCT03054233|crossed leg sitting position|crossed leg sitting position
1017373|NCT03054194|Healthy participants|healthy participants
1017374|NCT03054194|E2730|e2730
1017375|NCT03054194|Pharmacokinetics|pharmacokinetics
1017376|NCT03054181|Observational|observational
1017377|NCT03054181|Infection|infection
1017378|NCT03054181|Utilisation|utilisation
1017379|NCT03054181|Safety|safety
1017380|NCT03054181|Tolerability|tolerability
1017381|NCT03054181|Infusion|infusion
1017382|NCT03054181|chronic|chronic
1017383|NCT03054168|Protein Synthesis|protein synthesis
1017384|NCT03054168|Hypertrophy|hypertrophy
1017385|NCT03054168|Testosterone|testosterone
1017386|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
1017387|NCT03054155|hidradenitis|hidradenitis
1017388|NCT03054155|laser|laser
1017389|NCT03054103|ketamine|ketamine
1017390|NCT03054103|midazolam|midazolam
1017391|NCT03054103|sedation|sedation
1017392|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
1017393|NCT03054090|Primary Care|primary care
1017394|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
1017395|NCT03054077|children|children
1017396|NCT03054077|pediatric sedation|pediatric sedation
1017397|NCT03054051|HIV prevention|hiv prevention
1017398|NCT03054051|Preadolescence|preadolescence
1017399|NCT03054051|Mobile phone game|mobile phone game
1017400|NCT03054051|Feasibility|feasibility
1017401|NCT03054012|CAD-CAM software|cad-cam software
1017402|NCT03054012|accuracy|accuracy
1017403|NCT03054012|head and neck region|head and neck region
1017404|NCT03054012|mandibular reconstruction|mandibular reconstruction
1017405|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
1017406|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
1017407|NCT03053999|Hyperparathyroidism|hyperparathyroidism
1017408|NCT03053999|HPTH|hpth
1017409|NCT03053999|PNET|pnet
1017410|NCT03053999|Biomarkers|biomarkers
1017411|NCT03053999|Parathyroidectomy|parathyroidectomy
1017412|NCT03053999|Genome sequencing|genome sequencing
1017413|NCT03053999|Data review|data review
1017414|NCT03053973|COPD|copd
1017415|NCT03053973|airway inflammation|airway inflammation
1017416|NCT03053973|airway remodeling|airway remodeling
1017417|NCT03053973|health-related auality of life|health-related auality of life
1017418|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
1017419|NCT03053947|Intranasal Ketamine|intranasal ketamine
1017420|NCT03053947|Pain Management|pain management
1017421|NCT03053934|Online counselling|online counselling
1017422|NCT03053921|gingival recession|gingival recession
1017423|NCT03053921|Zuchellis technique,|zuchellis technique,
1017424|NCT03053921|placental membrane|placental membrane
1017817|NCT03051256|d-Methadone|d-methadone
1017426|NCT03053908|Core Body Temperature|core body temperature
1017427|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
1017428|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1017429|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
1017430|NCT03053843|Atrial fibrillation|atrial fibrillation
1017431|NCT03053843|Mediterranean Diet|mediterranean diet
1017432|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
1017433|NCT03053843|Ablation|ablation
1017434|NCT03053830|Ketamine|ketamine
1017435|NCT03053830|Major Depressive Disorder|major depressive disorder
1017436|NCT03053804|MR/PET|mr/pet
1017437|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1017438|NCT03053791|Deep brain stimulation|deep brain stimulation
1017439|NCT03053791|DBS|dbs
1017440|NCT03053791|Spinal cord injury|spinal cord injury
1017441|NCT03053791|SCI|sci
1017442|NCT03053791|Paraplegia|paraplegia
1017443|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
1017444|NCT03053791|MLR|mlr
1017445|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
1017446|NCT03053791|PPN|ppn
1017447|NCT03053778|Readmission|readmission
1017448|NCT03053778|Early follow-up|early follow-up
1017449|NCT03053778|Heart valves|heart valves
1017450|NCT03053778|Heart valve surgery|heart valve surgery
1017451|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
1017452|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
1017453|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
1017454|NCT03053713|nutrition|nutrition
1017455|NCT03053713|diet intervention|diet intervention
1017456|NCT03053713|disease activity|disease activity
1017457|NCT03053713|intestinal microbiome|intestinal microbiome
1017458|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
1017459|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
1017460|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1017461|NCT03053661|cancer-specific immunity|cancer-specific immunity
1017462|NCT03053661|cancer immunology|cancer immunology
1017463|NCT03053661|cancer-testis antigens|cancer-testis antigens
1017464|NCT03053661|human papilloma virus|human papilloma virus
1017465|NCT03053661|immune modulatory cells|immune modulatory cells
1017466|NCT03053648|Insomnia|insomnia
1017467|NCT03053648|Randomized controlled trial|randomized controlled trial
1017468|NCT03053648|Acupressure|acupressure
1017469|NCT03053648|Self-help|self-help
1017470|NCT03053635|Photodynamic Therapy|photodynamic therapy
1017471|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
1017472|NCT03053635|Urothelial carcinoma|urothelial carcinoma
1017473|NCT03053635|Ta bladder cancer|ta bladder cancer
1017474|NCT03053635|T1 bladder cancer|t1 bladder cancer
1017475|NCT03053635|Refractory to BCG|refractory to bcg
1017476|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
1017477|NCT03053609|apnea|apnea
1017478|NCT03053609|bradycardia|bradycardia
1017479|NCT03053609|desaturation|desaturation
1017480|NCT03053609|impedance|impedance
1017481|NCT03053596|HCC|hcc
1017482|NCT03053596|LifePearl|lifepearl
1017483|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
1017484|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
1017485|NCT03053583|airway|airway
1017486|NCT03053583|pediatric|pediatric
1017487|NCT03053570|Cryoballoon|cryoballoon
1017488|NCT03053570|Contact Force|contact force
1017489|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
1017490|NCT03053557|mental health consumers|mental health consumers
1017491|NCT03053544|rectal cancer|rectal cancer
1017492|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1017493|NCT03053544|node positive rectal tumors|node positive rectal tumors
1017494|NCT03053544|metformin|metformin
1017495|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
1017496|NCT03053518|Type 2 Diabetes|type 2 diabetes
1017497|NCT03053518|Hyperglycemia|hyperglycemia
1044997|NCT02881957|stroke|stroke
1017498|NCT03053518|Personal Nutrition Project|personal nutrition project
1017499|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
1017500|NCT03053505|Clostridium difficile infection|clostridium difficile infection
1017501|NCT03053505|gut flora|gut flora
1017502|NCT03053505|human microbiome|human microbiome
1017503|NCT03053505|colitis|colitis
1017504|NCT03053492|Video Games|video games
1017505|NCT03053479|surgery|surgery
1017506|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
1017507|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
1017508|NCT03053479|vaginal mesh|vaginal mesh
1017509|NCT03053466|Advanced Solid Tumor|advanced solid tumor
1017510|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
1017511|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
1017512|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
1017513|NCT03053427|Restless Legs Syndrome|restless legs syndrome
1017514|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
1017515|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
1017516|NCT03053401|Anterior cruciate ligament repair|anterior cruciate ligament repair
1017517|NCT03053401|Femoral nerve block|femoral nerve block
1017518|NCT03053401|Adductor Canal block|adductor canal block
1017519|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
1017520|NCT03053401|Pediatrics|pediatrics
1017521|NCT03053401|Postoperative analgesia|postoperative analgesia
1017522|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
1017523|NCT03053323|Preconception|preconception
1017524|NCT03053323|Pregnancy|pregnancy
1017525|NCT03053323|Lifestyle|lifestyle
1017526|NCT03053310|surgery|surgery
1017527|NCT03053310|curative intent|curative intent
1017528|NCT03053310|geriatric assessment|geriatric assessment
1017529|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
1017530|NCT03053297|EGFR|egfr
1017531|NCT03053297|EGFR mutation|egfr mutation
1017532|NCT03053297|EGFRm|egfrm
1017533|NCT03053297|EGFR-TKI|egfr-tki
1017534|NCT03053297|Health care resource utilization|health care resource utilization
1017535|NCT03053297|Health-Related Quality of Life|health-related quality of life
1017536|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
1017537|NCT03053297|NSCLC|nsclc
1017538|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
1017539|NCT03053297|Observational study|observational study
1017540|NCT03053297|Osimertinib|osimertinib
1017541|NCT03053297|Personalized medicine|personalized medicine
1017542|NCT03053297|PRO|pro
1017543|NCT03053297|Patient Reported Outcome|patient reported outcome
1017544|NCT03053297|Resistance|resistance
1017545|NCT03053297|T790M|t790m
1017546|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1017547|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1017548|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
1017549|NCT03053297|Lung Neoplasms|lung neoplasms
1017550|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
1017551|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
1017552|NCT03053297|Lung diseases|lung diseases
1017553|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
1017554|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
1017555|NCT03053297|Combination Chemotherapy|combination chemotherapy
1017556|NCT03053297|Immunotherapy|immunotherapy
1017557|NCT03053297|Radiation|radiation
1017558|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
1017559|NCT03053271|ATR-101|atr-101
1017560|NCT03053271|CS|cs
1017561|NCT03053245|Collaborative Care Model|collaborative care model
1017562|NCT03053245|Intensive Care Unit|intensive care unit
1017563|NCT03053193|breast cancer|breast cancer
1017564|NCT03053193|stage I|stage i
1017565|NCT03053193|stage II|stage ii
1017566|NCT03053193|stage III|stage iii
1017567|NCT03053180|Paritaprevir|paritaprevir
1017568|NCT03053180|Dasabuvir|dasabuvir
1017569|NCT03053180|Ombitasvir|ombitasvir
1017570|NCT03053180|Ritonavir|ritonavir
1017571|NCT03053180|Ribavirin free|ribavirin free
1017572|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
1017573|NCT03053180|Cirrhosis|cirrhosis
1017574|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
1017575|NCT03053180|Hepatitis|hepatitis
1017576|NCT03053167|Raltitrexed|raltitrexed
1017577|NCT03053167|Irinotecan|irinotecan
1017578|NCT03053167|Second-line Treatment|second-line treatment
1017579|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
1017580|NCT03053154|Pelvic Inclination|pelvic inclination
1017581|NCT03053154|Sit to Stand|sit to stand
1017582|NCT03053154|Stroke|stroke
1017583|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
1017584|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
1017585|NCT03053128|cardiac ischemia|cardiac ischemia
1017586|NCT03053102|PNH|pnh
1017587|NCT03053102|Paroxysmal|paroxysmal
1017588|NCT03053102|Hemoglobinuria|hemoglobinuria
1017589|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
1017590|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
1017591|NCT03053076|safety|safety
1017592|NCT03053076|effect|effect
1017593|NCT03053076|neonates|neonates
1017594|NCT03053037|apical size|apical size
1017595|NCT03053037|root canal treatment success|root canal treatment success
1017596|NCT03053037|micro biome analysis|micro biome analysis
1017597|NCT03053037|pulp necrosis|pulp necrosis
1017598|NCT03052985|medical devices (meshes)|medical devices (meshes)
1017599|NCT03052985|surgery|surgery
1017600|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
1017601|NCT03052933|copanlisib|copanlisib
1017602|NCT03052933|gemcitabine|gemcitabine
1017603|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1017604|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
1017605|NCT03052920|cochlear implant|cochlear implant
1017606|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
1017607|NCT03052894|anesthesiology|anesthesiology
1017608|NCT03052894|neuromuscular blockade|neuromuscular blockade
1017609|NCT03052894|monitoring device|monitoring device
1017610|NCT03052855|Psychiatry|psychiatry
1017611|NCT03052855|Suicidal behaviour|suicidal behaviour
1017612|NCT03052855|Cerebral metabolites|cerebral metabolites
1017613|NCT03052855|MRI|mri
1017614|NCT03052855|Inflammatory markers|inflammatory markers
1017615|NCT03052803|coronary stenosis|coronary stenosis
1017616|NCT03052803|fractional flow reserve|fractional flow reserve
1017619|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
1017620|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
1017621|NCT03052712|Alzheimer|alzheimer
1017622|NCT03052712|frontal temporal dementia|frontal temporal dementia
1017623|NCT03052712|Parkinson|parkinson
1017624|NCT03052712|Huntington|huntington
1017625|NCT03052712|traumatic brain injury|traumatic brain injury
1017626|NCT03052712|stroke|stroke
1017627|NCT03052712|focal lesions|focal lesions
1017628|NCT03052699|Complications; Cesarean Section|complications; cesarean section
1017629|NCT03052686|Uterine rupture|uterine rupture
1017630|NCT03052673|ketamine|ketamine
1017631|NCT03052673|fentanyl|fentanyl
1017632|NCT03052673|postoperative pain|postoperative pain
1017633|NCT03052660|Midazolam|midazolam
1017634|NCT03052660|Anxiety|anxiety
1017635|NCT03052660|Clinical trial|clinical trial
1017636|NCT03052660|Patient Satisfaction|patient satisfaction
1017637|NCT03052647|dermaclip|dermaclip
1017638|NCT03052647|subcuticular|subcuticular
1017639|NCT03052647|cesarean section|cesarean section
1017640|NCT03052647|staples|staples
1017641|NCT03052647|adhesive latch|adhesive latch
1017642|NCT03052647|rousseau|rousseau
1017643|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
1017644|NCT03052556|cystic Fibrosis|cystic fibrosis
1017645|NCT03052556|cervical cancer|cervical cancer
1017646|NCT03052556|screening|screening
1017647|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
1017648|NCT03052556|pap smear test|pap smear test
1017650|NCT03052465|Motility|motility
1017651|NCT03052413|thinning hair|thinning hair
1017652|NCT03052413|female pattern hair loss|female pattern hair loss
1017653|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
1017654|NCT03052400|insulin resistance|insulin resistance
1017655|NCT03052400|mifepristone|mifepristone
1017656|NCT03052400|glucocorticoids|glucocorticoids
1017657|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
1017658|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
1017659|NCT03052361|Children|children
1017660|NCT03052361|emergency department|emergency department
1017661|NCT03052361|ondansetron|ondansetron
1017662|NCT03052348|Topical Antibiotics|topical antibiotics
1017663|NCT03052348|Fusidic Acid|fusidic acid
1017664|NCT03052348|Atopic Dermatitis|atopic dermatitis
1017665|NCT03052348|Eczema|eczema
1017666|NCT03052335|colorectal cancer|colorectal cancer
1017667|NCT03052335|screening|screening
1017668|NCT03052335|colon capsule|colon capsule
1017669|NCT03052335|colonoscopy|colonoscopy
1017670|NCT03052283|Cystic fibrosis|cystic fibrosis
1017671|NCT03052283|Abdomen|abdomen
1017672|NCT03052283|Pancreas|pancreas
1017673|NCT03052283|Liver|liver
1017675|NCT03052283|Symptom Score|symptom score
1017676|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
1017677|NCT03052257|Glaucoma|glaucoma
1017678|NCT03052257|Disease management|disease management
1017679|NCT03052257|Smart bottle|smart bottle
1017680|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
1017681|NCT03052244|Visual illusion|visual illusion
1017682|NCT03052244|Neuropathic pain|neuropathic pain
1017683|NCT03052244|Spinal cord Injury|spinal cord injury
1017684|NCT03052231|adherence|adherence
1017685|NCT03052231|cystic fibrosis|cystic fibrosis
1017686|NCT03052218|children|children
1017687|NCT03052218|pain|pain
1017688|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
1017689|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
1017690|NCT03052218|Pupillometry|pupillometry
1017691|NCT03052205|ILLUMINATE-101|illuminate-101
1017692|NCT03052205|melanoma|melanoma
1017693|NCT03052127|Uveal melanoma|uveal melanoma
1017694|NCT03052127|Eye cancer|eye cancer
1017695|NCT03052127|Ocular melanoma|ocular melanoma
1017696|NCT03052127|Choroidal melanoma|choroidal melanoma
1017697|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
1017698|NCT03052114|EIT|eit
1017699|NCT03052114|Stroke|stroke
1017700|NCT03052114|Craniocerebral Injury|craniocerebral injury
1017701|NCT03052114|Head Injury|head injury
1017702|NCT03052101|PLCH|plch
1017703|NCT03052101|Air travel|air travel
1017704|NCT03052101|pneumothorax|pneumothorax
1017705|NCT03052101|pleurodesis|pleurodesis
1017706|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
1017707|NCT03052075|Parathyroidectomy|parathyroidectomy
1017708|NCT03052075|Bone mineral density|bone mineral density
1017709|NCT03052075|BMD|bmd
1017710|NCT03052075|Data Review|data review
1017711|NCT03052049|Prostate Artery Embolization|prostate artery embolization
1017712|NCT03052036|Acute Coronory Syndrome|acute coronory syndrome
1017713|NCT03052023|dual approach|dual approach
1017714|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
1017715|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
1017716|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
1017717|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
1017718|NCT03051919|reinforcement|reinforcement
1017719|NCT03051919|leak|leak
1017720|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
1017721|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
1017722|NCT03051906|Radiotherapy|radiotherapy
1017723|NCT03051906|Immunotherapy|immunotherapy
1017724|NCT03051880|Epidermal Growth Factor|epidermal growth factor
1017725|NCT03051854|Violence|violence
1017726|NCT03051854|Children|children
1017727|NCT03051854|Prevalence|prevalence
1017728|NCT03051854|Abuse|abuse
1017729|NCT03051854|Prevention|prevention
1017730|NCT03051828|fencing, cancer|fencing, cancer
1017731|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
1017732|NCT03051802|Endoscopy|endoscopy
1017733|NCT03051802|HDR Brachytherapy|hdr brachytherapy
1017734|NCT03051802|navigation|navigation
1017735|NCT03051789|Menstrual hygiene management|menstrual hygiene management
1017736|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
1017737|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
1017738|NCT03051789|School dropoout|school dropoout
1017739|NCT03051789|sub-Saharan Africa|sub-saharan africa
1017740|NCT03051789|Kenya|kenya
1017741|NCT03051776|Compression garments|compression garments
1017742|NCT03051776|Kinesio Taping|kinesio taping
1017743|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
1017744|NCT03051763|pulmonary hypertension|pulmonary hypertension
1017745|NCT03051763|commercial air travel|commercial air travel
1017746|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
1017747|NCT03051750|Complex Physical Therapy|complex physical therapy
1017748|NCT03051750|Pressotherapy|pressotherapy
1017749|NCT03051750|Kinesio Taping|kinesio taping
1017750|NCT03051750|Physiotherapy|physiotherapy
1017751|NCT03051750|Manual Lymph Drainage|manual lymph drainage
1017752|NCT03051750|Multilayer Bandage|multilayer bandage
1017753|NCT03051750|TTDL questionnaire|ttdl questionnaire
1017754|NCT03051737|Multi-scale|multi-scale
1017755|NCT03051737|Prediction|prediction
1017756|NCT03051737|Patient Flow|patient flow
1017757|NCT03051737|Emergency Department|emergency department
1017758|NCT03051737|Hospitalization|hospitalization
1017759|NCT03051737|Ile-de-France|ile-de-france
1017760|NCT03051724|OSA|osa
1017761|NCT03051724|CPAP management|cpap management
1017762|NCT03051724|Telemedicine|telemedicine
1017763|NCT03051698|C1-inhibitor|c1-inhibitor
1017764|NCT03051698|house dust mite|house dust mite
1017765|NCT03051698|complement system|complement system
1017766|NCT03051672|Breast Cancer|breast cancer
1017767|NCT03051659|Breast Cancer|breast cancer
1017768|NCT03051646|Exercise|exercise
1017769|NCT03051646|Time to Exhaustion|time to exhaustion
1017770|NCT03051620|Bone turnover markers|bone turnover markers
1017771|NCT03051620|Alendronate|alendronate
1017772|NCT03051620|Drug Holiday|drug holiday
1017773|NCT03051607|Motor Fluctuations|motor fluctuations
1017774|NCT03051607|Off time|off time
1017775|NCT03051607|On time|on time
1017776|NCT03051607|Dyskinesia|dyskinesia
1017777|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
1017778|NCT03051581|Positron-Emission Tomography|positron-emission tomography
1017779|NCT03051581|Prognosis|prognosis
1017780|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
1017781|NCT03051568|Positron-Emission Tomography|positron-emission tomography
1017782|NCT03051568|Prognosis|prognosis
1017783|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
1017784|NCT03051555|Positron-Emission Tomography|positron-emission tomography
1017785|NCT03051555|Prognosis|prognosis
1017786|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
1017787|NCT03051542|Positron-Emission Tomography|positron-emission tomography
1017788|NCT03051542|Prognosis|prognosis
1017789|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
1017790|NCT03051451|Placebo|placebo
1017791|NCT03051451|Obesity|obesity
1017792|NCT03051425|Probiotics|probiotics
1017793|NCT03051425|Immune function|immune function
1017794|NCT03051425|Natural killer cell activity|natural killer cell activity
1017795|NCT03051425|Interleukin-12|interleukin-12
1017796|NCT03051425|Interferon-gamma|interferon-gamma
1017797|NCT03051425|Immunoglobulin|immunoglobulin
1017798|NCT03051399|Constipation|constipation
1664757|NCT00125515|naltrexone|naltrexone
1017799|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
1017800|NCT03051399|Quality of life|quality of life
1017801|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
1017802|NCT03051399|Gut microbiome|gut microbiome
1017803|NCT03051360|aortic valve stenosis|aortic valve stenosis
1017804|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
1017805|NCT03051308|Parathyroid cell viability|parathyroid cell viability
1017806|NCT03051308|Ischemia|ischemia
1017807|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
1017808|NCT03051308|Vitamin D Receptor|vitamin d receptor
1017809|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
1017810|NCT03051295|Communication Barriers|communication barriers
1017811|NCT03051295|Persuasive Communication|persuasive communication
1017812|NCT03051295|Risk|risk
1017813|NCT03051269|Electroporation|electroporation
1017814|NCT03051269|Calcium|calcium
1017815|NCT03051269|Head and Neck cancer|head and neck cancer
1017818|NCT03051256|Methadone|methadone
1017819|NCT03051256|Depression|depression
1017820|NCT03051256|Refractory Depression|refractory depression
1017821|NCT03051256|Antidepressant|antidepressant
1017822|NCT03051256|Adjunctive Treatment|adjunctive treatment
1017823|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
1017824|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
1017825|NCT03051256|Glutamate Antagonist|glutamate antagonist
1017826|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
1017827|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
1017828|NCT03051230|Superovulation|superovulation
1017829|NCT03051230|Fertilization in Vitro|fertilization in vitro
1017830|NCT03051230|Biomarkers|biomarkers
1017831|NCT03051217|Psoriasis|psoriasis
1017832|NCT03051217|PSO|pso
1017833|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
1017834|NCT03051217|Certolizumb Pegol|certolizumb pegol
1017835|NCT03051217|Cimzia|cimzia
1017836|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
1017837|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
1017838|NCT03051191|nonischemic heart failure|nonischemic heart failure
1017839|NCT03051191|cancer|cancer
1017840|NCT03051165|Cardiovascular Disease|cardiovascular disease
1017841|NCT03051165|Pulmonary Medicine|pulmonary medicine
1017842|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
1017843|NCT03051139|Implementation Science|implementation science
1017844|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
1017845|NCT03051126|Parathyroid disease|parathyroid disease
1017846|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
1017847|NCT03051126|Database|database
1017848|NCT03051126|Blood samples|blood samples
1017849|NCT03051100|hyperlididemia|hyperlididemia
1017850|NCT03051100|LDL|ldl
1017851|NCT03051100|cholesterol|cholesterol
1017852|NCT03051074|Anxiety|anxiety
1017853|NCT03051074|Floating|floating
1017854|NCT03051061|Atrial Fibrillation|atrial fibrillation
1017855|NCT03051061|Coronary Heart Disease|coronary heart disease
1017856|NCT03051061|antithrombotic treatment|antithrombotic treatment
1017857|NCT03051061|clinical prognosis|clinical prognosis
1017858|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
1017859|NCT03051035|non-hematological malignancies|non-hematological malignancies
1017860|NCT03051035|non-squamous|non-squamous
1017861|NCT03051035|squamous|squamous
1017862|NCT03051035|BRAF|braf
1017863|NCT03051035|KRAS|kras
1017864|NCT03051035|NRAS|nras
1017865|NCT03051022|Bupivacaine|bupivacaine
1017866|NCT03051022|adjuvant|adjuvant
1017867|NCT03051022|regional anesthesia|regional anesthesia
1017868|NCT03051022|dexamethasone|dexamethasone
1017869|NCT03051022|morphine|morphine
1017870|NCT03050983|Respiratory Compromise|respiratory compromise
1017871|NCT03050970|minor head trauma|minor head trauma
1017872|NCT03050970|child|child
1017873|NCT03050970|age less than 2 years|age less than 2 years
1017874|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
1017875|NCT03050970|Computed tomography scan|computed tomography scan
1017876|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
1017877|NCT03050944|Fertility|fertility
1017878|NCT03050944|Infertility|infertility
1017879|NCT03050944|Dietary Patterns|dietary patterns
1017880|NCT03050944|Mediterranean diet|mediterranean diet
1017881|NCT03050944|Adiponectin|adiponectin
1017882|NCT03050944|Follistatin|follistatin
1017883|NCT03050944|Assisted Reproduction|assisted reproduction
1017884|NCT03050944|In Vitro Fertilization|in vitro fertilization
1017885|NCT03050944|Semen quality|semen quality
1017886|NCT03050944|Diet|diet
1017887|NCT03050944|IVF|ivf
1017888|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
1017889|NCT03050931|EIT|eit
1017890|NCT03050931|Epilepsy|epilepsy
1017891|NCT03050879|Stomach Neoplasms|stomach neoplasms
1017892|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
1017893|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
1017894|NCT03050879|Lymph Node Dissection|lymph node dissection
1017895|NCT03050866|Androgen Receptor|androgen receptor
1017896|NCT03050866|AR-V7|ar-v7
1017897|NCT03050866|Predictive Factor|predictive factor
1017898|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
1017899|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
1017900|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
1017901|NCT03050814|Progression Free Survival|progression free survival
1017902|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
1017903|NCT03050801|Explicit Memory|explicit memory
1017904|NCT03050801|Implicit Memory|implicit memory
1017905|NCT03050801|Memory Disorder|memory disorder
1017906|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
1017907|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
1017908|NCT03050788|Point of care diagnosis|point of care diagnosis
1017909|NCT03050762|Endocrine Disease|endocrine disease
1017910|NCT03050762|Thyroid disease|thyroid disease
1017911|NCT03050762|Parathyroid disease|parathyroid disease
1017912|NCT03050762|Adrenal disease|adrenal disease
1017913|NCT03050762|Data Review|data review
1017914|NCT03050762|Database|database
1017917|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
1017918|NCT03050736|GBM|gbm
1017919|NCT03050736|brain tumor|brain tumor
1017920|NCT03050736|brain cancer|brain cancer
1017921|NCT03050632|working memory|working memory
1017922|NCT03050632|adherence|adherence
1017923|NCT03050606|Exercise Therapy|exercise therapy
1017924|NCT03050606|Exercise Movement Techniques|exercise movement techniques
1017925|NCT03050606|Pilates-Based Exercises|pilates-based exercises
1017926|NCT03050606|Cost-effectiveness|cost-effectiveness
1017927|NCT03050593|HFpEF|hfpef
1017928|NCT03050593|HFrEF|hfref
1017929|NCT03050580|Abused women|abused women
1017930|NCT03050580|treatment group|treatment group
1017931|NCT03050580|family violence|family violence
1017932|NCT03050567|Microemboli|microemboli
1017933|NCT03050554|cancer|cancer
1017934|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
1017935|NCT03050554|SBRT|sbrt
1017936|NCT03050554|Avelumab|avelumab
1017937|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1017938|NCT03050554|radiation|radiation
1017939|NCT03050554|NSCLC|nsclc
1017940|NCT03050554|PD-1|pd-1
1017941|NCT03050554|PD-L1|pd-l1
1017942|NCT03050554|Immunotherapy|immunotherapy
1017943|NCT03050554|Lung|lung
1017946|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
1017947|NCT03050528|Exercise|exercise
1017948|NCT03050528|Psychology|psychology
1017949|NCT03050528|Psychological therapy|psychological therapy
1017950|NCT03050528|Physiotherapy|physiotherapy
1017951|NCT03050528|Physical therapy|physical therapy
1017952|NCT03050502|Hemothorax|hemothorax
1017953|NCT03050502|Management|management
1017954|NCT03050489|CABG|cabg
1017955|NCT03050489|Off-Pump CABG|off-pump cabg
1017956|NCT03050489|On-Pump CABG|on-pump cabg
1017957|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
1017958|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
1017959|NCT03050489|Ischemic Heart Disease|ischemic heart disease
1017960|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
1017961|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
1017962|NCT03050476|side-effects|side-effects
1017963|NCT03050476|heart-lung machine|heart-lung machine
1017964|NCT03050476|alkaline phosphatase|alkaline phosphatase
1017965|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
1017966|NCT03050437|EGFR Activating Mutation|egfr activating mutation
1017967|NCT03050437|Pemetrexed|pemetrexed
1017968|NCT03050424|COPD|copd
1017969|NCT03050424|Iron|iron
1017970|NCT03050424|Exercise Capacity|exercise capacity
1017971|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
1017972|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
1017973|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
1017974|NCT03050411|Apatinib|apatinib
1017975|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
1017976|NCT03050398|HR-positive|hr-positive
1017977|NCT03050398|HER2-negative|her2-negative
1017978|NCT03050398|Advanced breast cancer|advanced breast cancer
1017979|NCT03050398|LEE011|lee011
1017980|NCT03050398|ribociclib|ribociclib
1017981|NCT03050398|letrozole|letrozole
1017982|NCT03050398|femara|femara
1017983|NCT03050398|CDK|cdk
1017984|NCT03050398|CDK4|cdk4
1017985|NCT03050398|CDK6|cdk6
1017986|NCT03050398|CDK4/6|cdk4/6
1017987|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
1017988|NCT03050398|Phase III|phase iii
1017989|NCT03050398|Phase IIIb|phase iiib
1017990|NCT03050398|ER-positive|er-positive
1017991|NCT03050398|PR-positive|pr-positive
1017992|NCT03050398|Postmenopausal|postmenopausal
1017993|NCT03050398|Premenopausal|premenopausal
1017994|NCT03050398|Men|men
1017995|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
1017996|NCT03050359|Drug therapy|drug therapy
1017997|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
1017998|NCT03050359|Digestive System Diseases|digestive system diseases
1019387|NCT03041766|GLA-SE|gla-se
1017999|NCT03050359|Lansoprazole|lansoprazole
1664758|NCT00125515|memantine|memantine
1018000|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
1018001|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
1018002|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
1018003|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
1018004|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1018005|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
1018006|NCT03050346|Coronary Artery Disease|coronary artery disease
1018007|NCT03050346|Apnea|apnea
1018008|NCT03050346|Hyperventilation|hyperventilation
1018009|NCT03050346|BOLD|bold
1018010|NCT03050346|Breathing Maneuvers|breathing maneuvers
1018011|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
1018012|NCT03050320|Resilience|resilience
1018013|NCT03050320|Exercise in the workplace|exercise in the workplace
1018014|NCT03050307|Drug therapy|drug therapy
1018015|NCT03050268|Familial cancer|familial cancer
1018016|NCT03050268|Genetic predisposition|genetic predisposition
1018017|NCT03050268|Heritable disease|heritable disease
1018018|NCT03050268|Cancer risk|cancer risk
1018019|NCT03050268|Genome analysis|genome analysis
1018020|NCT03050268|Genetic modifiers|genetic modifiers
1018021|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
1018022|NCT03050268|Genetic counseling|genetic counseling
1018024|NCT03050255|supplemental oxygen|supplemental oxygen
1018025|NCT03050255|walking capacity|walking capacity
1018026|NCT03050255|exercise capacity|exercise capacity
1018027|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
1018028|NCT03050190|CART therapy|cart therapy
1018029|NCT03050190|4SCAR19|4scar19
1018030|NCT03050190|CD19|cd19
1018031|NCT03050190|B cell leukemia|b cell leukemia
1018032|NCT03050190|B-ALL|b-all
1018033|NCT03050177|Bioequivalence Study|bioequivalence study
1018034|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
1018035|NCT03050138|Venous Thrombosis|venous thrombosis
1018036|NCT03050138|Quality of Life|quality of life
1018037|NCT03050138|Hemorrhage|hemorrhage
1018038|NCT03050138|Recurrence|recurrence
1018039|NCT03050112|MacNew questionnaire|macnew questionnaire
1018040|NCT03050112|Quality of life|quality of life
1018041|NCT03050034|Wireless monitoring system|wireless monitoring system
1018042|NCT03050034|Acute Medicine|acute medicine
1018043|NCT03050034|Poly-pathological patients|poly-pathological patients
1018044|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
1018045|NCT03050034|Acute Complex Care Model|acute complex care model
1018046|NCT03050021|Delirium|delirium
1018047|NCT03050021|Intensive care unit|intensive care unit
1018048|NCT03050008|Cataract Surgery|cataract surgery
1018049|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
1018050|NCT03049982|Oral appliance therapy|oral appliance therapy
1018051|NCT03049969|Working Memory|working memory
1018052|NCT03049969|Cognitive Training|cognitive training
1018053|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1018054|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
1018055|NCT03049943|low level laser therapy|low level laser therapy
1018056|NCT03049943|hyposalivation|hyposalivation
1018057|NCT03049930|Burns|burns
1018058|NCT03049930|Ketamine|ketamine
1018059|NCT03049930|Anesthesia|anesthesia
1018060|NCT03049917|financial incentive|financial incentive
1018061|NCT03049917|pediatric HIV testing|pediatric hiv testing
1018062|NCT03049904|Indian, North America|indian, north america
1018063|NCT03049904|Male, Two-Spirit|male, two-spirit
1018064|NCT03049904|HIV Prevention|hiv prevention
1018065|NCT03049904|MSM|msm
1018066|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
1018067|NCT03049891|Retention|retention
1018068|NCT03049891|Loss to Follow Up|loss to follow up
1018069|NCT03049878|postoperative pain|postoperative pain
1018070|NCT03049878|paracetamol|paracetamol
1018071|NCT03049878|codeine|codeine
1018072|NCT03049878|tooth extractions|tooth extractions
1018073|NCT03049878|analgesia|analgesia
1018074|NCT03049878|premedication|premedication
1018075|NCT03049826|nutrient|nutrient
1018076|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
1018077|NCT03049800|Healthy controls|healthy controls
1018078|NCT03049800|Cognitive training|cognitive training
1018079|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
1018080|NCT03049787|physical therapy|physical therapy
1018081|NCT03049787|home exercise|home exercise
1018082|NCT03049787|adhesive capsulitis|adhesive capsulitis
1018083|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
1018084|NCT03049709|central blood pressure|central blood pressure
1018085|NCT03049709|measurement|measurement
1018086|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
1018087|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
1018088|NCT03049696|Bariatric Surgery|bariatric surgery
1018089|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
1018090|NCT03049696|Obesity|obesity
1018091|NCT03049696|Exercise|exercise
1018092|NCT03049696|Behaviour Modification|behaviour modification
1019589|NCT03040557|insoles|insoles
1018093|NCT03049696|Surgical Outcomes|surgical outcomes
1018094|NCT03049696|Quality of Life|quality of life
1018095|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
1018096|NCT03049670|Safety Issue|safety issue
1018097|NCT03049644|chronic lower back pain|chronic lower back pain
1018098|NCT03049644|Manual Therapy|manual therapy
1018099|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
1018100|NCT03049631|Pre-diabetes|pre-diabetes
1018101|NCT03049631|red raspberry|red raspberry
1018102|NCT03049631|fructooligosaccharide|fructooligosaccharide
1018103|NCT03049631|metagenomics|metagenomics
1018104|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
1018105|NCT03049631|glycemic response|glycemic response
1018106|NCT03049631|insulin response|insulin response
1018107|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
1018108|NCT03049592|Diabetes|diabetes
1018109|NCT03049592|Contraception|contraception
1018110|NCT03049592|Prenatal Counseling|prenatal counseling
1018111|NCT03049566|Bleeding|bleeding
1018112|NCT03049566|Adverse Cardiac Events|adverse cardiac events
1018113|NCT03049566|Adherence, Medication|adherence, medication
1018114|NCT03049566|Aspirin|aspirin
1018115|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
1018116|NCT03049553|Cervical screening|cervical screening
1018117|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
1018118|NCT03049553|Cytology|cytology
1018119|NCT03049553|HPV-test|hpv-test
1018120|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1018121|NCT03049527|Chronic Kidney Disease|chronic kidney disease
1018122|NCT03049527|Unknown Origin|unknown origin
1018123|NCT03049514|Thrombolysis|thrombolysis
1018124|NCT03049514|Recanalization|recanalization
1018125|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
1018126|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
1018127|NCT03049501|Technology-based intervention|technology-based intervention
1018128|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
1018129|NCT03049488|Immune Response|immune response
1018130|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
1018131|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
1018132|NCT03049488|Neutralizing Antibody|neutralizing antibody
1018133|NCT03049488|Antibody Response|antibody response
1018134|NCT03049475|Pain|pain
1018135|NCT03049475|Cell Free DNA|cell free dna
1018136|NCT03049475|Inflammatory Markers|inflammatory markers
1018137|NCT03049475|Microparticles|microparticles
1018138|NCT03049475|NETosis|netosis
1018139|NCT03049462|Brown Adipose Tissue|brown adipose tissue
1018140|NCT03049462|Energy Expenditure|energy expenditure
1018141|NCT03049462|Energy Metabolism|energy metabolism
1018142|NCT03049462|Obesity|obesity
1018143|NCT03049449|Gene Therapy|gene therapy
1018144|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
1018145|NCT03049449|T-cell infusion|t-cell infusion
1018146|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1018147|NCT03049449|Immunohistochemistry|immunohistochemistry
1018148|NCT03049436|Physical activity|physical activity
1018149|NCT03049436|cancer|cancer
1018150|NCT03049436|chemotherapy|chemotherapy
1018151|NCT03049436|daily care unit|daily care unit
1018152|NCT03049410|Cystectomy|cystectomy
1018153|NCT03049332|Quality of Life|quality of life
1018154|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
1018155|NCT03049306|CPAP|cpap
1018156|NCT03049306|Propranolol|propranolol
1018157|NCT03049306|Metabolism|metabolism
1018158|NCT03049293|COPD,IVF|copd,ivf
1018159|NCT03049267|acne inversa|acne inversa
1018160|NCT03049241|Children|children
1018161|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
1018162|NCT03049241|Muscle group|muscle group
1018163|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
1018164|NCT03049241|Muscle length|muscle length
1018165|NCT03049241|Stiffness|stiffness
1018166|NCT03049241|prepubertal children|prepubertal children
1018167|NCT03049241|adults|adults
1018168|NCT03049228|Spectrum Analysis|spectrum analysis
1018169|NCT03049228|Mitochondria|mitochondria
1018170|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
1018171|NCT03049228|Respirometry|respirometry
1018172|NCT03049228|Human|human
1018173|NCT03049228|Heart|heart
1018174|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
1018175|NCT03049189|non-functional GE-NET|non-functional ge-net
1018176|NCT03049176|HIV-discordant couple|hiv-discordant couple
1018177|NCT03049176|ART|art
1018178|NCT03049176|PrEP|prep
1018179|NCT03049176|semen washing|semen washing
1018180|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
1018181|NCT03049176|safer conception|safer conception
1018182|NCT03049176|pregnancy|pregnancy
1018183|NCT03049150|Urine|urine
1018184|NCT03049150|Mass Spectometry|mass spectometry
1018185|NCT03049150|Observational|observational
1018186|NCT03049124|Exercise|exercise
1018187|NCT03049124|Feasibility trial|feasibility trial
1018188|NCT03049124|Cancer|cancer
1018189|NCT03049124|Chemoradiation|chemoradiation
1018190|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
1018191|NCT03049098|Eye-tracking|eye-tracking
1018192|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
1018193|NCT03049098|Visual Perception|visual perception
1018194|NCT03049085|OPCAB|opcab
1018195|NCT03049085|ASA|asa
1018196|NCT03049085|Aspirin|aspirin
1018197|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
1018198|NCT03049020|sacrocolpopexy|sacrocolpopexy
1018199|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
1018200|NCT03049007|bereavement|bereavement
1018201|NCT03049007|natural grief|natural grief
1018202|NCT03049007|prolonged grief|prolonged grief
1018203|NCT03049007|complicated grief|complicated grief
1018204|NCT03048994|Glutamine|glutamine
1018205|NCT03048994|Severe sepsis|severe sepsis
1018206|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
1018207|NCT03048981|Fish oil|fish oil
1018208|NCT03048981|Alternative medicine|alternative medicine
1018209|NCT03048981|Point of care testing|point of care testing
1018210|NCT03048981|Coagulation monitoring|coagulation monitoring
1018211|NCT03048968|Exoskeleton Device|exoskeleton device
1018212|NCT03048968|elderly|elderly
1018213|NCT03048968|stroke|stroke
1018214|NCT03048942|Breast cancer|breast cancer
1018215|NCT03048942|HER2 negative|her2 negative
1018216|NCT03048942|Cabazitaxel|cabazitaxel
1018217|NCT03048942|Paclitaxel|paclitaxel
1018218|NCT03048942|Chemotherapy|chemotherapy
1018219|NCT03048916|dysphagia|dysphagia
1018220|NCT03048916|stroke|stroke
1018221|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
1018222|NCT03048916|videofluoroscopy|videofluoroscopy
1018223|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
1018224|NCT03048903|sepsis|sepsis
1018225|NCT03048903|trauma|trauma
1018226|NCT03048890|PAD|pad
1018227|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
1018228|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
1018229|NCT03048877|Apatinib|apatinib
1018230|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
1018231|NCT03048864|Metabolic Screening|metabolic screening
1018232|NCT03048864|24 hour urine|24 hour urine
1018233|NCT03048851|Cerebral palsy|cerebral palsy
1018234|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
1018235|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
1018236|NCT03048812|Dental implant|dental implant
1018237|NCT03048812|Mandibular overdenture|mandibular overdenture
1018238|NCT03048812|Cross-over study|cross-over study
1018239|NCT03048786|Peer mentoring|peer mentoring
1018240|NCT03048786|social support|social support
1018241|NCT03048786|text messaging|text messaging
1018242|NCT03048786|smoking cessation|smoking cessation
1018243|NCT03048773|shockwave therapy|shockwave therapy
1018244|NCT03048773|knee osteoarthritis|knee osteoarthritis
1018245|NCT03048760|MRI scan|mri scan
1018246|NCT03048760|Organs at Risk|organs at risk
1018247|NCT03048708|Bariatric surgery|bariatric surgery
1018248|NCT03048708|Leptin|leptin
1018249|NCT03048708|Thyroid function tests|thyroid function tests
1018250|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
1018251|NCT03048617|Stealth|stealth
1018252|NCT03048617|Myopathy|myopathy
1018253|NCT03048617|exercise intolerance|exercise intolerance
1018254|NCT03048617|muscle pain|muscle pain
1018255|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
1018256|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
1018257|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
1018258|NCT03048565|mindfulness|mindfulness
1018259|NCT03048565|caregivers|caregivers
1018260|NCT03048552|drug use|drug use
1018261|NCT03048552|drug addiction|drug addiction
1018262|NCT03048552|drug habituation|drug habituation
1018263|NCT03048552|drug use disorders|drug use disorders
1018264|NCT03048552|organic mental disorders|organic mental disorders
1018265|NCT03048552|substance-induced|substance-induced
1018266|NCT03048552|substance abuse|substance abuse
1018267|NCT03048552|substance addiction|substance addiction
1018268|NCT03048552|substance dependence|substance dependence
1018269|NCT03048552|substance use disorders|substance use disorders
1018270|NCT03048539|Endoscopic surgery|endoscopic surgery
1018271|NCT03048539|Thyroidectomy|thyroidectomy
1018272|NCT03048539|Quality of life|quality of life
1018273|NCT03048513|Melioidosis|melioidosis
1018274|NCT03048513|Head and Neck|head and neck
1018275|NCT03048513|Clinical|clinical
1018276|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
1018277|NCT03048448|Hepatic impairment,|hepatic impairment,
1018278|NCT03048448|Fevipiprant,|fevipiprant,
1018279|NCT03048448|adults,|adults,
1018280|NCT03048448|pharmacokinetics|pharmacokinetics
1018281|NCT03048435|Cervical Cancer|cervical cancer
1018282|NCT03048435|Patient Reported Outcomes|patient reported outcomes
1018283|NCT03048435|Radiation Therapy|radiation therapy
1018284|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
1018285|NCT03048435|Quality of Life|quality of life
1018286|NCT03048383|Facial paralysis|facial paralysis
1018287|NCT03048383|Facial synkinesis|facial synkinesis
1018288|NCT03048383|Botulinum toxin|botulinum toxin
1018289|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
1018290|NCT03048344|APL|apl
1018291|NCT03048344|arsenic trioxide|arsenic trioxide
1018292|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
1018293|NCT03048331|Tetraplegia|tetraplegia
1018294|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
1018295|NCT03048292|Embolectomy|embolectomy
1018296|NCT03048292|Embolus|embolus
1018297|NCT03048292|Thrombectomy|thrombectomy
1018298|NCT03048292|Thrombolysis|thrombolysis
1018299|NCT03048292|Thrombus|thrombus
1018300|NCT03048292|Mobile|mobile
1018301|NCT03048292|Interventional|interventional
1018302|NCT03048292|Neurointervention|neurointervention
1018303|NCT03048292|Stroke|stroke
1018304|NCT03048292|Ischemic|ischemic
1018305|NCT03048292|Acute|acute
1018306|NCT03048292|Endovascular|endovascular
1018307|NCT03048292|Cerebrovascular|cerebrovascular
1018308|NCT03048292|Clot|clot
1018309|NCT03048292|Stent Retriever|stent retriever
1018310|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
1018311|NCT03048292|Drip and Ship|drip and ship
1018315|NCT03048279|MEN1|men1
1018316|NCT03048279|MEN2|men2
1018317|NCT03048279|Relatives|relatives
1018318|NCT03048279|Database|database
1018319|NCT03048279|Questionnaires|questionnaires
1018320|NCT03048279|Surveys|surveys
1018321|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
1018322|NCT03048266|MEN1|men1
1018323|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
1018324|NCT03048266|PNET|pnet
1018325|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
1018326|NCT03048266|Metabolomics|metabolomics
1018327|NCT03048266|Genetics|genetics
1018328|NCT03048266|Biomarkers|biomarkers
1018329|NCT03048240|Glioblastoma|glioblastoma
1018330|NCT03048227|TIDM|tidm
1018331|NCT03048227|Type1diabetes|type1diabetes
1018332|NCT03048227|Implantable Pump|implantable pump
1018333|NCT03048227|CGM|cgm
1018334|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
1018335|NCT03048201|Physica KR|physica kr
1018336|NCT03048201|Physica CR|physica cr
1018337|NCT03048201|Physica PS|physica ps
1018338|NCT03048201|Kinematic Retaining|kinematic retaining
1018339|NCT03048201|Cruciate Retaining|cruciate retaining
1018340|NCT03048201|Posterior Stabilized|posterior stabilized
1018341|NCT03048201|Physica System|physica system
1018342|NCT03048175|C-reactive protein|c-reactive protein
1018343|NCT03048175|Systemic inflammation|systemic inflammation
1018344|NCT03048175|Third molar|third molar
1018345|NCT03048175|Wisdom tooth|wisdom tooth
1018346|NCT03048149|hazelnut allergy|hazelnut allergy
1018347|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1018348|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
1018349|NCT03048123|Large and unresectable HCC|large and unresectable hcc
1018350|NCT03048071|Contegra|contegra
1018351|NCT03048071|Homograft|homograft
1018352|NCT03048045|chronic periodontitis|chronic periodontitis
1018353|NCT03048045|aggressive periodontitis|aggressive periodontitis
1018354|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
1018355|NCT03048032|acute heart failure|acute heart failure
1018356|NCT03048032|right ventricular failure|right ventricular failure
1018357|NCT03048032|cardiac biomarkers|cardiac biomarkers
1018358|NCT03048032|echocardiography|echocardiography
1018359|NCT03048032|diagnosis|diagnosis
1018360|NCT03048032|prognosis|prognosis
1018361|NCT03047993|Myelodysplastic syndrome|myelodysplastic syndrome
1018362|NCT03047993|MDS|mds
1018363|NCT03047993|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
1018364|NCT03047993|CB-839|cb-839
1018365|NCT03047993|Azacitidine|azacitidine
1018366|NCT03047993|5-azacytidine|5-azacytidine
1018367|NCT03047993|5-aza|5-aza
1018368|NCT03047993|Vidaza|vidaza
1018369|NCT03047993|5-AZC|5-azc
1018370|NCT03047993|AZA-CR|aza-cr
1018371|NCT03047993|Ladakamycin|ladakamycin
1018372|NCT03047993|NSC-102816|nsc-102816
1018373|NCT03047993|Azacytidine|azacytidine
1018374|NCT03047993|Pharmacokinetic testing|pharmacokinetic testing
1018375|NCT03047993|Pharmacodynamic testing|pharmacodynamic testing
1018376|NCT03047980|SWS|sws
1018377|NCT03047980|Cognitive impairment|cognitive impairment
1018378|NCT03047980|sirolimus|sirolimus
1018379|NCT03047915|Anxiety|anxiety
1018380|NCT03047915|Music intervention|music intervention
1018381|NCT03047915|Emergency department (ED)|emergency department (ed)
1018382|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
1018383|NCT03047876|cardiac|cardiac
1018384|NCT03047876|aortic arch surgery|aortic arch surgery
1018385|NCT03047876|Brain vascular reactivity|brain vascular reactivity
1018386|NCT03047876|neonates|neonates
1018387|NCT03047876|infants|infants
1018388|NCT03047863|Epidermal Growth Factor|epidermal growth factor
1018389|NCT03047850|Sternotomy|sternotomy
1018390|NCT03047837|Colorectal cancer|colorectal cancer
1018391|NCT03047837|aspirin|aspirin
1045252|NCT02880202|Hospice|hospice
1018392|NCT03047837|metformin|metformin
1018393|NCT03047837|chemoprevention|chemoprevention
1018394|NCT03047798|centella asiatica|centella asiatica
1018395|NCT03047798|bamboo salt|bamboo salt
1018396|NCT03047798|magnolia bark|magnolia bark
1018397|NCT03047798|gingivitis|gingivitis
1018398|NCT03047798|dental plaque|dental plaque
1018399|NCT03047798|mouthrinse|mouthrinse
1018400|NCT03047785|Myocardial Infarction|myocardial infarction
1018401|NCT03047785|Highly sensitive troponin|highly sensitive troponin
1018402|NCT03047785|Hospital population|hospital population
1018403|NCT03047785|99th percentile|99th percentile
1018404|NCT03047785|Upper limit of normal|upper limit of normal
1018405|NCT03047733|Vitiligo|vitiligo
1018406|NCT03047733|308 nm excimer laser|308 nm excimer laser
1018407|NCT03047720|bedwetting|bedwetting
1018412|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
1018413|NCT03047694|tactile tablet|tactile tablet
1018414|NCT03047681|TAVR|tavr
1018415|NCT03047681|tryptse|tryptse
1018416|NCT03047681|mast|mast
1018417|NCT03047642|biomarker|biomarker
1018418|NCT03047642|low and middle income countries|low and middle income countries
1018419|NCT03047642|fever|fever
1018420|NCT03047642|antimicrobial resistance|antimicrobial resistance
1018421|NCT03047642|diagnostic|diagnostic
1018422|NCT03047629|non-motor symptoms|non-motor symptoms
1018423|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
1018424|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
1018425|NCT03047603|Differential diagnosis|differential diagnosis
1018426|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
1018427|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
1018428|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
1018429|NCT03047590|exercise behavior|exercise behavior
1018430|NCT03047590|exercise prescription|exercise prescription
1018431|NCT03047590|affect-based exercise|affect-based exercise
1018432|NCT03047590|affect-guided exercise|affect-guided exercise
1018433|NCT03047590|self-paced exercise|self-paced exercise
1018434|NCT03047590|self-selected exercise|self-selected exercise
1018435|NCT03047577|Brief intervention|brief intervention
1018436|NCT03047577|Alcohol|alcohol
1018437|NCT03047577|Alcohol use disorder|alcohol use disorder
1018438|NCT03047577|Intensive care unit|intensive care unit
1018439|NCT03047577|Critically ill|critically ill
1018440|NCT03047577|Audit|audit
1018441|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
1018442|NCT03047564|Total Knee Replacement|total knee replacement
1018443|NCT03047564|Outcome|outcome
1018444|NCT03047564|Metal ion concentration|metal ion concentration
1018445|NCT03047564|Results|results
1018446|NCT03047551|Abortion, induced|abortion, induced
1018447|NCT03047551|Ultrasonography|ultrasonography
1018448|NCT03047551|Health Services accessibility|health services accessibility
1018449|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
1018450|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
1018451|NCT03047538|Arterial hypertension|arterial hypertension
1018452|NCT03047538|Dyslipidemia|dyslipidemia
1018453|NCT03047538|Blood pressure control|blood pressure control
1018454|NCT03047538|Fixed combination|fixed combination
1018455|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
1018456|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
1018457|NCT03047512|Depression in adolescents|depression in adolescents
1018458|NCT03047512|Mental Health|mental health
1018459|NCT03047512|E-mental health|e-mental health
1018460|NCT03047512|Prevention and Early intervention|prevention and early intervention
1018461|NCT03047486|insulin pump|insulin pump
1018462|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
1018463|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
1018464|NCT03047473|newly diagnosed|newly diagnosed
1018465|NCT03047460|motor evoked potential|motor evoked potential
1018466|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
1018467|NCT03047460|biomarker|biomarker
1018468|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
1018469|NCT03047408|Parkinson's Disease|parkinson's disease
1018470|NCT03047408|REM sleep without Atonia|rem sleep without atonia
1018471|NCT03047395|ABBV-066|abbv-066
1018472|NCT03047395|BI 655066|bi 655066
1018473|NCT03047369|leukodystrophy|leukodystrophy
1018474|NCT03047369|white matter disease|white matter disease
1018475|NCT03047369|leukoencephalopathy|leukoencephalopathy
1018476|NCT03047369|myelin|myelin
1018477|NCT03047369|demyelinating|demyelinating
1018478|NCT03047369|mdbp|mdbp
1018479|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
1018480|NCT03047330|menopause|menopause
1018481|NCT03047330|sleep fragmentation|sleep fragmentation
1018482|NCT03047330|leuprolide|leuprolide
1018483|NCT03047330|adipokine|adipokine
1018484|NCT03047330|weight gain|weight gain
1018485|NCT03047330|leptin|leptin
1018486|NCT03047317|pharmacokinetics|pharmacokinetics
1018487|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
1018488|NCT03047226|Lynch Syndrome|lynch syndrome
1018489|NCT03047226|mismatch repair|mismatch repair
1018490|NCT03047226|microsatellite instability|microsatellite instability
1018491|NCT03047226|next-generation sequencing|next-generation sequencing
1018492|NCT03047226|immunohistochemistry|immunohistochemistry
1018493|NCT03047200|Diabetes Mellitus|diabetes mellitus
1018494|NCT03047200|Hypoglycemia|hypoglycemia
1018495|NCT03047200|Hyperglycemia|hyperglycemia
1018496|NCT03047200|Type 1 Diabetes|type 1 diabetes
1018497|NCT03047200|Islet Cell Transplantation|islet cell transplantation
1018498|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
1018499|NCT03047161|magnetocardiography|magnetocardiography
1018500|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
1018501|NCT03047122|Breast|breast
1018502|NCT03047122|ultrasonography|ultrasonography
1018503|NCT03047109|Ephedrine|ephedrine
1018504|NCT03047109|Phenylephrine|phenylephrine
1018505|NCT03047109|Spinal Hypotension|spinal hypotension
1018506|NCT03047109|Cesarean Section|cesarean section
1018507|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
1018508|NCT03047083|Retrospective|retrospective
1018509|NCT03047083|Non-interventional Study|non-interventional study
1018510|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
1018511|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
1018512|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
1018513|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
1018514|NCT03047018|Nutrition|nutrition
1018515|NCT03046992|EGFR|egfr
1018516|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
1018517|NCT03046992|T790M|t790m
1018518|NCT03046992|Brain Metastasis|brain metastasis
1018519|NCT03046979|apatinib|apatinib
1018520|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1018521|NCT03046953|Lymphoma|lymphoma
1018522|NCT03046927|Type 1 diabetes|type 1 diabetes
1018523|NCT03046927|vitamin D|vitamin d
1018524|NCT03046927|honeymoon phase|honeymoon phase
1018525|NCT03046901|Vancomycin|vancomycin
1018526|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
1018527|NCT03046901|Post-liver transplantation|post-liver transplantation
1018528|NCT03046849|Lynch Syndrome|lynch syndrome
1018529|NCT03046849|next-generation sequencing|next-generation sequencing
1018530|NCT03046849|germline mutation|germline mutation
1018531|NCT03046836|Couples|couples
1018532|NCT03046836|Oxytocin|oxytocin
1018533|NCT03046836|Aggression|aggression
1018534|NCT03046836|Alcohol|alcohol
1018535|NCT03046771|falls|falls
1018536|NCT03046771|readmissions|readmissions
1018537|NCT03046771|emergency department visits|emergency department visits
1018538|NCT03046771|transitions of care|transitions of care
1018539|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
1018540|NCT03046732|Kidney Transplant Education|kidney transplant education
1018541|NCT03046732|Transplant Readiness|transplant readiness
1018542|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
1018543|NCT03046732|Chronic Kidney Disease|chronic kidney disease
1018544|NCT03046732|End Stage Kidney Disease|end stage kidney disease
1018545|NCT03046732|Renal Replacement Therapy|renal replacement therapy
1018546|NCT03046719|bupivacaine|bupivacaine
1018547|NCT03046719|intravitreal|intravitreal
1018548|NCT03046719|analgesia|analgesia
1018549|NCT03046719|silicone oil removal|silicone oil removal
1018550|NCT03046719|retinal detachment|retinal detachment
1018551|NCT03046719|subconjunctival|subconjunctival
1018552|NCT03046706|voice rest|voice rest
1018553|NCT03046706|laryngeal surgery|laryngeal surgery
1018554|NCT03046706|glottic polyp|glottic polyp
1018555|NCT03046706|glottic cyst|glottic cyst
1018556|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
1018557|NCT03046693|pattern electroretinography|pattern electroretinography
1018558|NCT03046693|citicoline|citicoline
1018559|NCT03046693|retinal ganglion cell|retinal ganglion cell
1018560|NCT03046693|visual field|visual field
1018561|NCT03046667|Beta glucans|beta glucans
1018562|NCT03046667|Barley|barley
1018563|NCT03046667|SCFA|scfa
1018564|NCT03046667|Calprotectin|calprotectin
1018565|NCT03046667|Microbiota|microbiota
1018566|NCT03046667|Hydrogene|hydrogene
1018567|NCT03046667|Methane|methane
1018568|NCT03046667|Metabolomics|metabolomics
1018569|NCT03046667|Stool volume|stool volume
1018570|NCT03046667|Stool frequency|stool frequency
1018571|NCT03046641|Caloric Restriction|caloric restriction
1018572|NCT03046641|Dietary Formulations|dietary formulations
1018573|NCT03046641|Exercise|exercise
1018574|NCT03046641|Men|men
1018575|NCT03046615|EEG electrodes|eeg electrodes
1018576|NCT03046563|acupressure|acupressure
1018577|NCT03046563|abdominal massage|abdominal massage
1018578|NCT03046563|constipation|constipation
1018579|NCT03046563|stroke patients|stroke patients
1018580|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
1018581|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
1018582|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
1018583|NCT03046524|Chart Review|chart review
1018584|NCT03046485|AMD|amd
1018585|NCT03046485|vision loss|vision loss
1018586|NCT03046485|self-management strategies|self-management strategies
1018587|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
1018588|NCT03046485|IVI|ivi
1018589|NCT03046472|thorax curve angle|thorax curve angle
1018590|NCT03046459|cytokines|cytokines
1018591|NCT03046459|interleukin-2|interleukin-2
1018592|NCT03046459|Safety Issues|safety issues
1018593|NCT03046446|Osteoarthritis|osteoarthritis
1018594|NCT03046446|Knee|knee
1018595|NCT03046446|Pain|pain
1018596|NCT03046446|Steroid|steroid
1018597|NCT03046446|Intra-articular|intra-articular
1018598|NCT03046446|Injection|injection
1018599|NCT03046433|children|children
1018600|NCT03046433|asthma|asthma
1018601|NCT03046433|China|china
1018602|NCT03046394|prosthetic feet|prosthetic feet
1018603|NCT03046394|gait pattern|gait pattern
1018604|NCT03046394|one leg standing|one leg standing
1018605|NCT03046394|walking speed|walking speed
1018902|NCT03044353|Amyloidosis|amyloidosis
1018606|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
1018607|NCT03046329|patient care planning|patient care planning
1018608|NCT03046316|Therapeutics|therapeutics
1018609|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
1018610|NCT03046264|central blood pressure|central blood pressure
1018611|NCT03046264|measurement|measurement
1018612|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
1018613|NCT03046186|Gastric sleeve|gastric sleeve
1018614|NCT03046186|Gastric bypass|gastric bypass
1018615|NCT03046160|PPT|ppt
1018616|NCT03046160|Scapula|scapula
1018617|NCT03046160|Intervention|intervention
1018618|NCT03046160|Manual therapy|manual therapy
1018619|NCT03046160|mobilization|mobilization
1018620|NCT03046121|dementia|dementia
1018621|NCT03046121|acute care|acute care
1018622|NCT03046121|post-acute recovery|post-acute recovery
1018623|NCT03046121|family caregivers|family caregivers
1018624|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
1018625|NCT03046095|Muscle Atrophy|muscle atrophy
1018626|NCT03046095|Resistance Training|resistance training
1018627|NCT03046095|Immobilization|immobilization
1018628|NCT03046069|Triple therapy|triple therapy
1018629|NCT03046069|COPD|copd
1018630|NCT03046069|DCE|dce
1018631|NCT03046069|Qualitative|qualitative
1018632|NCT03046004|breast cancer|breast cancer
1018633|NCT03046004|screening|screening
1018634|NCT03046004|decision aid|decision aid
1018635|NCT03046004|informed choice|informed choice
1018636|NCT03046004|decisional conflict|decisional conflict
1018637|NCT03045965|Salpingectomy|salpingectomy
1018638|NCT03045965|Hysterectomy|hysterectomy
1018639|NCT03045965|Ovarian cancer|ovarian cancer
1018640|NCT03045952|Multicenter study|multicenter study
1018641|NCT03045952|microwave|microwave
1018642|NCT03045939|cervical ripening|cervical ripening
1018643|NCT03045939|labor induction|labor induction
1018644|NCT03045939|double balloon device|double balloon device
1018645|NCT03045939|cervical ripening device|cervical ripening device
1018646|NCT03045939|unfavorable cervix|unfavorable cervix
1018647|NCT03045913|Observational registry|observational registry
1018648|NCT03045913|All-comers open label registry|all-comers open label registry
1018649|NCT03045913|Genoss DES|genoss des
1018650|NCT03045913|Multicenter|multicenter
1018651|NCT03045913|Stenting|stenting
1018652|NCT03045913|Coronary Artery Disease|coronary artery disease
1018653|NCT03045913|Coronary revascularization|coronary revascularization
1018654|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
1018655|NCT03045887|repeat dose|repeat dose
1018656|NCT03045887|GSK2292767|gsk2292767
1018657|NCT03045887|smoke|smoke
1018658|NCT03045887|tolerability|tolerability
1018659|NCT03045887|safety|safety
1018660|NCT03045887|dry powder inhalation|dry powder inhalation
1018661|NCT03045887|pharmacokinetics|pharmacokinetics
1018662|NCT03045887|single dose|single dose
1018663|NCT03045848|Observational registry|observational registry
1018664|NCT03045848|All-comers open label registry|all-comers open label registry
1018665|NCT03045848|Drug coated stent|drug coated stent
1018666|NCT03045848|Multicenter|multicenter
1018667|NCT03045848|Stenting|stenting
1018668|NCT03045848|Coronary Artery Disease|coronary artery disease
1018669|NCT03045848|Coronary revascularization|coronary revascularization
1018670|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
1018671|NCT03045835|laparoscopic cholecystectomy BASKA mask Endotracheal tube|laparoscopic cholecystectomy baska mask endotracheal tube
1018672|NCT03045822|Bioimpedance analysis|bioimpedance analysis
1018673|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
1018674|NCT03045822|pacemakers|pacemakers
1018675|NCT03045809|Syndromic management|syndromic management
1018676|NCT03045809|Point of care testing|point of care testing
1018677|NCT03045783|gastric varices|gastric varices
1018678|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
1018679|NCT03045731|kidney transplantation|kidney transplantation
1018680|NCT03045731|ultrasound|ultrasound
1018681|NCT03045731|mathematical model|mathematical model
1667262|NCT00116129|MK-0677|mk-0677
1018682|NCT03045718|Horticultural Therapy|horticultural therapy
1018683|NCT03045718|Dementia|dementia
1018684|NCT03045718|Randomized Controlled Trial|randomized controlled trial
1018685|NCT03045718|Elderly|elderly
1018686|NCT03045718|Prevention|prevention
1018687|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
1018688|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
1018689|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
1018690|NCT03045679|Mini-gastric bypass|mini-gastric bypass
1018691|NCT03045679|metabolic surgery|metabolic surgery
1018692|NCT03045653|Breast Cancer|breast cancer
1018693|NCT03045653|high dose Tamoxifen|high dose tamoxifen
1018694|NCT03045653|endocrine therapy|endocrine therapy
1018695|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
1018696|NCT03045653|Tamoxifen|tamoxifen
1018697|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
1018698|NCT03045640|ECD|ecd
1018699|NCT03045640|parenting program|parenting program
1018700|NCT03045640|home visiting|home visiting
1018701|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
1018702|NCT03045627|PEG-G-CSF|peg-g-csf
1018703|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
1018704|NCT03045601|Coronary Angiography|coronary angiography
1018705|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1018706|NCT03045601|Echocardiography, Stress|echocardiography, stress
1018707|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
1018708|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1018709|NCT03045484|Oral Mucositis Pain|oral mucositis pain
1018710|NCT03045484|Oxycodone|oxycodone
1018711|NCT03045458|one stage dental implant|one stage dental implant
1018712|NCT03045458|two stage dental implant|two stage dental implant
1018713|NCT03045458|Interleukin-1β|interleukin-1β
1018714|NCT03045445|CT|ct
1018715|NCT03045445|dual energy|dual energy
1018716|NCT03045445|low dose|low dose
1018717|NCT03045432|Stroke|stroke
1018718|NCT03045432|Hemiplegia|hemiplegia
1018719|NCT03045432|Rotator Cuff Injury|rotator cuff injury
1018720|NCT03045419|MRI|mri
1018721|NCT03045419|gadoxetic acid|gadoxetic acid
1018722|NCT03045419|CT|ct
1018723|NCT03045393|Neoadjuvant|neoadjuvant
1018724|NCT03045393|Breast Cancer|breast cancer
1018725|NCT03045393|Folate Receptor Alpha|folate receptor alpha
1018726|NCT03045393|FRa|fra
1018727|NCT03045393|TNBC|tnbc
1018728|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
1018729|NCT03045393|Preoperative|preoperative
1018730|NCT03045393|Presurgery|presurgery
1018731|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
1018732|NCT03045393|IMGN853|imgn853
1018733|NCT03045367|Metamorphopsia|metamorphopsia
1018734|NCT03045367|Epiretinal membrane|epiretinal membrane
1018735|NCT03045367|Vitrectomy|vitrectomy
1018736|NCT03045354|children|children
1018737|NCT03045354|dietary carbohydrates|dietary carbohydrates
1018738|NCT03045354|satiety|satiety
1018739|NCT03045354|appetite|appetite
1018740|NCT03045354|blood glucose|blood glucose
1018741|NCT03045354|solanum tuberosum|solanum tuberosum
1018742|NCT03045354|obesity|obesity
1018743|NCT03045354|breakfast|breakfast
1018744|NCT03045276|Spina Bifida|spina bifida
1018745|NCT03045276|Kidney Transplant|kidney transplant
1018746|NCT03045263|ASD|asd
1018747|NCT03045237|Pregnancy|pregnancy
1018748|NCT03045237|Physical activity|physical activity
1018749|NCT03045237|Newborn|newborn
1018750|NCT03045237|Depressive Symptoms|depressive symptoms
1018751|NCT03045237|Dietary habits|dietary habits
1018752|NCT03045237|Healthy lifestyles|healthy lifestyles
1018753|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
1018754|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
1018755|NCT03045198|cystic fibrosis|cystic fibrosis
1018756|NCT03045185|Non Vital teeth|non vital teeth
1018757|NCT03045185|Traumatised teeth|traumatised teeth
1018758|NCT03045185|Immature teeth|immature teeth
1018759|NCT03045185|Regenerative Endodontics|regenerative endodontics
1018760|NCT03045172|Lichen Sclerosus|lichen sclerosus
1018761|NCT03045172|Platelet Rich Plasma|platelet rich plasma
1018762|NCT03045172|Vulvar|vulvar
1018763|NCT03045172|Vulva|vulva
1018764|NCT03045159|deployment cycle|deployment cycle
1018765|NCT03045159|military family|military family
1018766|NCT03045159|prevention|prevention
1018767|NCT03045159|stress|stress
1018768|NCT03045159|military child|military child
1018769|NCT03045159|parenting|parenting
1018770|NCT03045159|coparenting|coparenting
1018771|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
1018772|NCT03045133|Postoperative pain|postoperative pain
1018773|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
1018774|NCT03045133|Quality of recovery|quality of recovery
1018775|NCT03045133|QoR-40|qor-40
1018776|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
1018777|NCT03045107|right colon|right colon
1018778|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
1018779|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
1018780|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
1018781|NCT03045107|hospital stay|hospital stay
1018782|NCT03045107|quality of life|quality of life
1018783|NCT03045107|costs|costs
1018784|NCT03045094|pediatric|pediatric
1018785|NCT03045094|intubation|intubation
1018786|NCT03045094|neck movement|neck movement
1018787|NCT03045055|Acute ischemic stroke|acute ischemic stroke
1018788|NCT03045055|Endovascular treatment|endovascular treatment
1018789|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
1018790|NCT03045042|Pompe|pompe
1018791|NCT03045042|microRNA|microrna
1018792|NCT03045042|biomarker|biomarker
1018793|NCT03045042|muscle MRI|muscle mri
1018794|NCT03045042|glycogenosis|glycogenosis
1018795|NCT03045029|PAH|pah
1018796|NCT03045029|Oral Treprostiinil|oral treprostiinil
1018797|NCT03045029|Orenitram|orenitram
1018798|NCT03045016|Acute stress Disorder|acute stress disorder
1018799|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
1018800|NCT03045016|Prevention|prevention
1018801|NCT03045016|trauma|trauma
1018802|NCT03045016|prazosin|prazosin
1019204|NCT03042793|PD-L1|pd-l1
1018803|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
1018804|NCT03044990|Acute coronary syndrome|acute coronary syndrome
1018805|NCT03044990|renal insufficiency|renal insufficiency
1018806|NCT03044990|mortality|mortality
1018807|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
1018808|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
1018809|NCT03044977|theranostic|theranostic
1018810|NCT03044977|radionuclide|radionuclide
1018811|NCT03044977|MIBG|mibg
1018812|NCT03044977|DOTA|dota
1018813|NCT03044964|Angina, Chest Pain|angina, chest pain
1018814|NCT03044951|atrial fibrillation|atrial fibrillation
1018815|NCT03044951|cryoablation|cryoablation
1018816|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
1018817|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
1018818|NCT03044938|Asthma|asthma
1018819|NCT03044938|Salbutamol|salbutamol
1018820|NCT03044938|Exercise|exercise
1018821|NCT03044938|Heart Rate|heart rate
1018822|NCT03044938|Blood pressure|blood pressure
1018823|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
1018824|NCT03044925|remote magnetic navigation|remote magnetic navigation
1018825|NCT03044925|cryoablation|cryoablation
1018826|NCT03044899|Surgery|surgery
1018827|NCT03044899|Complications|complications
1018828|NCT03044899|Mortality|mortality
1018829|NCT03044886|Vitamin D|vitamin d
1018830|NCT03044821|Neural Tube Defect|neural tube defect
1018831|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
1018832|NCT03044795|veliparib|veliparib
1018833|NCT03044795|PARP inhibitor|parp inhibitor
1018834|NCT03044795|biomarker|biomarker
1018835|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
1018836|NCT03044756|GnRH antagonist|gnrh antagonist
1018837|NCT03044756|Pituitary downregulation|pituitary downregulation
1018838|NCT03044756|IVF|ivf
1018839|NCT03044756|ICSI|icsi
1018840|NCT03044743|PD-1|pd-1
1018841|NCT03044743|CRISPR Cas9|crispr cas9
1018842|NCT03044743|EBV|ebv
1018843|NCT03044743|advanced stage malignancies|advanced stage malignancies
1018844|NCT03044717|Nutrition Education|nutrition education
1018845|NCT03044717|Cardiology Fellows|cardiology fellows
1018846|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
1018847|NCT03044626|Nivolumab|nivolumab
1018848|NCT03044626|Radiotherapy|radiotherapy
1018849|NCT03044600|Parathyroid disease|parathyroid disease
1018850|NCT03044600|Hyperparathyroidism|hyperparathyroidism
1018851|NCT03044600|Chart review|chart review
1018852|NCT03044600|MEN1-negative|men1-negative
1018853|NCT03044600|HRPT2 mutations|hrpt2 mutations
1018854|NCT03044587|Biliary Tract Cancer|biliary tract cancer
1018855|NCT03044587|NaI-IRI|nai-iri
1018856|NCT03044574|venous thromboembolism|venous thromboembolism
1018857|NCT03044574|deep vein thrombosis|deep vein thrombosis
1018858|NCT03044574|pulmonary embolism|pulmonary embolism
1018859|NCT03044574|prevention|prevention
1018860|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
1018861|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
1018862|NCT03044574|surgery|surgery
1018863|NCT03044574|elastic compression|elastic compression
1018864|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
1018865|NCT03044574|prophylaxis|prophylaxis
1018866|NCT03044535|quality of life|quality of life
1018867|NCT03044535|mechanical circulatory support|mechanical circulatory support
1018868|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
1018869|NCT03044509|TB exposure|tb exposure
1018870|NCT03044509|Latent TB|latent tb
1018871|NCT03044509|TB disease|tb disease
1018872|NCT03044509|Biomarkers|biomarkers
1018873|NCT03044496|NIR Spectroscopy|nir spectroscopy
1018874|NCT03044496|Nerve Blockade|nerve blockade
1018875|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
1018876|NCT03044483|Sepsis|sepsis
1018877|NCT03044483|Microcirculatory function|microcirculatory function
1018878|NCT03044444|performance|performance
1018879|NCT03044444|polyphenols|polyphenols
1018880|NCT03044444|nutrition|nutrition
1018881|NCT03044444|sports|sports
1018882|NCT03044431|Shortness of breath|shortness of breath
1018883|NCT03044431|Breathlessness|breathlessness
1018884|NCT03044431|Stem cells|stem cells
1018885|NCT03044431|Platelet rich plasma|platelet rich plasma
1018886|NCT03044431|Quality of life|quality of life
1018887|NCT03044431|Pulmonary Function|pulmonary function
1018888|NCT03044418|laser|laser
1018889|NCT03044418|endotracheal tube|endotracheal tube
1018890|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
1018891|NCT03044418|side effect|side effect
1018892|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
1018893|NCT03044405|fluid responsiveness|fluid responsiveness
1018894|NCT03044405|focused echocardiography|focused echocardiography
1018895|NCT03044405|major surgery|major surgery
1018896|NCT03044392|Programmed Intermittent Epidural Bolus|programmed intermittent epidural bolus
1018897|NCT03044392|Labour Analgesia|labour analgesia
1018898|NCT03044392|Pain|pain
1018899|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
1018900|NCT03044353|skin biopsy|skin biopsy
1018901|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
1018903|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
1018904|NCT03044353|biomarkers|biomarkers
1018905|NCT03044353|cardiac functional measures|cardiac functional measures
1018906|NCT03044353|left ventricular mass|left ventricular mass
1018907|NCT03044314|pulmonary hypertension|pulmonary hypertension
1018908|NCT03044314|vasodilator challenge|vasodilator challenge
1018909|NCT03044314|echocardiography|echocardiography
1018910|NCT03044314|outcomes|outcomes
1018911|NCT03044314|iloprost|iloprost
1018912|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
1018913|NCT03044249|Psychotic Disorders|psychotic disorders
1018914|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
1018915|NCT03044223|critically ill patient|critically ill patient
1018916|NCT03044223|sepsis|sepsis
1018917|NCT03044223|monocyte|monocyte
1018918|NCT03044223|macrophage|macrophage
1018919|NCT03044223|cytokine|cytokine
1018920|NCT03044223|severity of disease|severity of disease
1018921|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
1018922|NCT03044210|Hormonal axis|hormonal axis
1018923|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
1018924|NCT03044210|Basal metabolism|basal metabolism
1018925|NCT03044197|prostate cancer|prostate cancer
1018926|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
1018927|NCT03044197|transperineal biopsy|transperineal biopsy
1018928|NCT03044197|target lesion|target lesion
1018929|NCT03044197|fusion biopsy|fusion biopsy
1018930|NCT03044184|Tranexamic Acid|tranexamic acid
1018931|NCT03044184|Antifibrinolytic|antifibrinolytic
1018932|NCT03044158|tuberculosis|tuberculosis
1018933|NCT03044158|implementation science|implementation science
1018934|NCT03044158|point-of-care|point-of-care
1018935|NCT03044158|diagnostics|diagnostics
1018936|NCT03044158|GeneXpert|genexpert
1018937|NCT03044158|Uganda|uganda
1018938|NCT03044145|Cultural Competence|cultural competence
1018939|NCT03044145|Patient-Clinician communication|patient-clinician communication
1018940|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
1018941|NCT03044132|DFU|dfu
1018942|NCT03044132|Lower Extremity Wound|lower extremity wound
1018943|NCT03044132|Skin Substitute|skin substitute
1018944|NCT03044106|hamstrings|hamstrings
1018945|NCT03044106|flexibility|flexibility
1018946|NCT03044106|strength|strength
1018947|NCT03044106|pain pressure threshold|pain pressure threshold
1018948|NCT03044106|lllt|lllt
1018949|NCT03044106|photobiomodulation|photobiomodulation
1018950|NCT03044106|cranial reflex|cranial reflex
1018951|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
1018952|NCT03044106|CLRT|clrt
1018953|NCT03044080|Walking Disorder|walking disorder
1018954|NCT03044080|Stroke|stroke
1018955|NCT03044080|Botulinum Toxin|botulinum toxin
1018956|NCT03044080|Spasticity|spasticity
1018957|NCT03044067|Chronic pain|chronic pain
1018958|NCT03044067|Fibromyalgia|fibromyalgia
1018959|NCT03044067|Pain neuroscience education|pain neuroscience education
1018960|NCT03044067|Exercise|exercise
1018961|NCT03044054|HIFU|hifu
1018962|NCT03044041|Blood loss|blood loss
1018963|NCT03044041|Tranexamic acid|tranexamic acid
1018964|NCT03044041|Total knee arthroplasty|total knee arthroplasty
1018965|NCT03044041|Topical administration|topical administration
1018966|NCT03043989|docetaxel|docetaxel
1018967|NCT03043989|cabazitaxel|cabazitaxel
1018968|NCT03043989|phase 1b|phase 1b
1018969|NCT03043989|castration-resistant|castration-resistant
1018970|NCT03043989|bone metastasis|bone metastasis
1018971|NCT03043976|Physical activity|physical activity
1018972|NCT03043976|Steps count|steps count
1018973|NCT03043950|mCRC|mcrc
1018974|NCT03043950|First line|first line
1018975|NCT03043950|Panitumumab|panitumumab
1018976|NCT03043950|mCCS Prognostic Score|mccs prognostic score
1018977|NCT03043950|Prognosis|prognosis
1018978|NCT03043950|Ras wild type|ras wild type
1018979|NCT03043924|hypothalamus|hypothalamus
1018980|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1018981|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1018982|NCT03043911|early detection|early detection
1018983|NCT03043911|respiratory events|respiratory events
1018984|NCT03043911|sepsis|sepsis
1018985|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
1018986|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
1018987|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
1018988|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
1018989|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
1018990|NCT03043846|Treat to Target approach|treat to target approach
1018991|NCT03043820|raloxifene|raloxifene
1018992|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
1018993|NCT03043820|schizophrenia|schizophrenia
1018994|NCT03043820|psychosis|psychosis
1018995|NCT03043820|cognition|cognition
1018996|NCT03043820|negative symptoms|negative symptoms
1018997|NCT03043807|prostatectomy|prostatectomy
1018998|NCT03043807|androgen deprivation|androgen deprivation
1018999|NCT03043807|chemotherapy|chemotherapy
1019000|NCT03043807|radiation|radiation
1019001|NCT03043794|early stage|early stage
1019002|NCT03043794|low risk|low risk
1019003|NCT03043768|Parkinson's disease|parkinson's disease
1019004|NCT03043768|Autonomic|autonomic
1019005|NCT03043768|Diagnosis|diagnosis
1019006|NCT03043768|Pilomotor|pilomotor
1019007|NCT03043768|Alpha-synuclein|alpha-synuclein
1019008|NCT03043768|Axon-reflex|axon-reflex
1019009|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
1019010|NCT03043729|neoadjuvant|neoadjuvant
1019011|NCT03043729|MRI-defined T3|mri-defined t3
1019012|NCT03043729|mFOLFOX6|mfolfox6
1019013|NCT03043729|Aflibercept|aflibercept
1019014|NCT03043690|menopause|menopause
1019015|NCT03043690|ammonium succinate|ammonium succinate
1019016|NCT03043664|GEP-NET|gep-net
1019017|NCT03043664|Pembrolizumab|pembrolizumab
1019018|NCT03043664|Lanreotide depot|lanreotide depot
1019019|NCT03043664|PD-1|pd-1
1019020|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
1019021|NCT03043651|HFpEF|hfpef
1019022|NCT03043651|6-Minute Walk Test|6-minute walk test
1019023|NCT03043651|Oral Treprostinil|oral treprostinil
1019024|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
1019025|NCT03043638|platelet rich plasma|platelet rich plasma
1019026|NCT03043638|acellular dermal matrix|acellular dermal matrix
1019027|NCT03043638|coronally advanced flap|coronally advanced flap
1019028|NCT03043638|gingival recession|gingival recession
1019029|NCT03043638|root coverage|root coverage
1019030|NCT03043638|clinical attachment level|clinical attachment level
1019031|NCT03043625|Neck pain|neck pain
1019032|NCT03043625|visceral manipulation|visceral manipulation
1019033|NCT03043625|functional dyspepsia|functional dyspepsia
1019034|NCT03043625|electromyography|electromyography
1019035|NCT03043625|pain|pain
1019036|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
1019037|NCT03043599|Thoracic|thoracic
1019038|NCT03043599|Radiotherapy|radiotherapy
1019039|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
1019040|NCT03043599|Immunotherapy|immunotherapy
1019041|NCT03043599|Ipilimumab|ipilimumab
1019042|NCT03043599|Nivolumab|nivolumab
1019043|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
1019044|NCT03043586|Acromegaly|acromegaly
1019045|NCT03043560|depression|depression
1019046|NCT03043560|anhedonia|anhedonia
1019047|NCT03043560|reward|reward
1019048|NCT03043547|nal-IRI|nal-iri
1019049|NCT03043547|5-Fluorouracil|5-fluorouracil
1019050|NCT03043508|Genetic mutation|genetic mutation
1019051|NCT03043508|MEN1|men1
1019052|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
1019053|NCT03043508|PNET|pnet
1019054|NCT03043508|Chart review|chart review
1019055|NCT03043508|Questionnaire|questionnaire
1019056|NCT03043508|Survey|survey
1019057|NCT03043495|dexamethasone|dexamethasone
1019058|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
1019059|NCT03043495|ultrasound|ultrasound
1019060|NCT03043482|VS-105|vs-105
1019061|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
1019062|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
1019063|NCT03043469|dysfunctional breathing|dysfunctional breathing
1019064|NCT03043443|sleep|sleep
1019065|NCT03043443|Alcohol dependence|alcohol dependence
1019066|NCT03043443|Melatonin|melatonin
1019067|NCT03043417|Stigma|stigma
1019068|NCT03043417|Primary Health Care|primary health care
1019069|NCT03043417|Recovery|recovery
1019070|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
1019071|NCT03043391|PVSRIPO|pvsripo
1019072|NCT03043391|Pro00071228|pro00071228
1019073|NCT03043391|Eric Thompson|eric thompson
1019074|NCT03043391|Darell Bigner|darell bigner
1019075|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
1019076|NCT03043391|David Ashley|david ashley
1019077|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
1019078|NCT03043378|Non-malignant pain|non-malignant pain
1019079|NCT03043378|Supportive care|supportive care
1019080|NCT03043378|Questionnaires|questionnaires
1019082|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
1019083|NCT03043365|Fish Oils|fish oils
1019084|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
1019085|NCT03043365|Lipoproteins|lipoproteins
1019086|NCT03043365|Cardiovascular Disease|cardiovascular disease
1019087|NCT03043352|SAM|sam
1019088|NCT03043352|Malnutrition|malnutrition
1019089|NCT03043352|LHW|lhw
1019090|NCT03043352|CMAM|cmam
1019091|NCT03043339|Microbiota composition|microbiota composition
1019092|NCT03043339|Kidney transplant recipient|kidney transplant recipient
1019093|NCT03043339|Kidney transplant donor|kidney transplant donor
1019094|NCT03043339|Antibiotics|antibiotics
1019095|NCT03043339|Drug resistance|drug resistance
1019096|NCT03043339|Transplantation surgery|transplantation surgery
1019097|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1019098|NCT03043326|MSM and transgender women|msm and transgender women
1019099|NCT03043313|Tucatinib|tucatinib
1019100|NCT03043313|Trastuzumab|trastuzumab
1019101|NCT03043313|HER2|her2
1019102|NCT03043313|ERBB2|erbb2
1019103|NCT03043313|Colorectal cancer|colorectal cancer
1019300|NCT03042234|Adolescent|adolescent
1019104|NCT03043300|Travelers' diarrhea|travelers' diarrhea
1019105|NCT03043300|Intestinal microbiota|intestinal microbiota
1019106|NCT03043300|Antibiotic resistance|antibiotic resistance
1019107|NCT03043300|Antibiotics|antibiotics
1019108|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
1019109|NCT03043300|Infectious diseases|infectious diseases
1019110|NCT03043300|International Travel|international travel
1019111|NCT03043300|Travel Medicine|travel medicine
1019112|NCT03043300|Resistome|resistome
1019113|NCT03043300|Microbiome|microbiome
1019114|NCT03043261|CHF|chf
1019115|NCT03043248|TRK-700|trk-700
1019116|NCT03043248|PK|pk
1019117|NCT03043248|Digoxin|digoxin
1019118|NCT03043248|Midazolam|midazolam
1019119|NCT03043248|Drug-Drug interaction|drug-drug interaction
1019120|NCT03043248|P-glycoprotein|p-glycoprotein
1019121|NCT03043248|CYP3A4|cyp3a4
1019122|NCT03043248|MDR1|mdr1
1019123|NCT03043248|pharmacokinetics|pharmacokinetics
1019124|NCT03043248|multidrug resistance 1|multidrug resistance 1
1019125|NCT03043222|prostate artery embolization|prostate artery embolization
1019126|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
1019127|NCT03043222|Minimally invasive|minimally invasive
1019128|NCT03043222|non-surgical|non-surgical
1019129|NCT03043222|maintenance of sexual function|maintenance of sexual function
1019130|NCT03043222|complications of TURP , surgery|complications of turp , surgery
1019131|NCT03043183|gastric cancer|gastric cancer
1019132|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
1019133|NCT03043170|Adults|adults
1019134|NCT03043170|Emergency Department|emergency department
1019135|NCT03043170|Haemodynamics|haemodynamics
1019136|NCT03043170|Resuscitation|resuscitation
1019137|NCT03043170|Shock|shock
1019138|NCT03043170|Uscom|uscom
1019139|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
1019140|NCT03043131|Plasma Lyte - A|plasma lyte - a
1019141|NCT03043131|Ringer;s lactate|ringer;s lactate
1019142|NCT03043131|Acidosis|acidosis
1019143|NCT03043118|Eating Behaviors|eating behaviors
1019144|NCT03043118|Preschool|preschool
1019145|NCT03043118|Vegetable Intake|vegetable intake
1019146|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
1019147|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
1019148|NCT03043105|Efficacy|efficacy
1019149|NCT03043105|Safety|safety
1019150|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
1019151|NCT03043066|Chronic Periodontitis|chronic periodontitis
1019152|NCT03043066|TRAP-5b|trap-5b
1019153|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
1019154|NCT03043066|Systemic antibiotics|systemic antibiotics
1019155|NCT03043053|weight loss|weight loss
1019156|NCT03043053|body mass index|body mass index
1019157|NCT03043053|oxytocin|oxytocin
1019158|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
1019159|NCT03043040|suicide, attempted|suicide, attempted
1019160|NCT03043040|prevention|prevention
1019161|NCT03043040|telemedicine|telemedicine
1019162|NCT03042988|supine hypertension|supine hypertension
1019163|NCT03042988|autonomic failure|autonomic failure
1019164|NCT03042988|heat stress|heat stress
1019165|NCT03042988|orthostatic hypotension|orthostatic hypotension
1019166|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
1019167|NCT03042975|dystonia|dystonia
1019168|NCT03042975|laryngeal dystonia|laryngeal dystonia
1019169|NCT03042975|imaging|imaging
1019170|NCT03042975|genetics|genetics
1019171|NCT03042962|dystonia|dystonia
1019172|NCT03042962|imaging|imaging
1019173|NCT03042962|genetics|genetics
1019174|NCT03042962|neuropathology|neuropathology
1019175|NCT03042936|Children|children
1019176|NCT03042936|Teens|teens
1019177|NCT03042936|Adolescents|adolescents
1019178|NCT03042936|Type 2 diabetes|type 2 diabetes
1019179|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
1019180|NCT03042936|Exercise|exercise
1019181|NCT03042936|Nutrition|nutrition
1019182|NCT03042936|Education|education
1019183|NCT03042923|Intestinal permeability|intestinal permeability
1019184|NCT03042884|Benign Neoplasms|benign neoplasms
1019185|NCT03042884|In Situ Neoplasms|in situ neoplasms
1019186|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
1019187|NCT03042884|Wearable exercise trackers|wearable exercise trackers
1019188|NCT03042884|Questionnaires|questionnaires
1019189|NCT03042884|Surveys|surveys
1019190|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
1019191|NCT03042858|PPV|ppv
1019192|NCT03042858|patent processus vaginalis|patent processus vaginalis
1019193|NCT03042858|inguinal hernia|inguinal hernia
1019194|NCT03042832|Leadership|leadership
1019195|NCT03042832|Organizational Climate|organizational climate
1019196|NCT03042832|Implementation|implementation
1019197|NCT03042832|Implementation Climate|implementation climate
1019198|NCT03042832|Motivational Interviewing|motivational interviewing
1019199|NCT03042832|Fidelity|fidelity
1019200|NCT03042806|Physical Activity|physical activity
1019201|NCT03042806|Questionnaire|questionnaire
1019202|NCT03042793|myeloma|myeloma
1019203|NCT03042793|vaccination|vaccination
1019205|NCT03042793|peptide vaccine|peptide vaccine
1019206|NCT03042793|cancer vaccine|cancer vaccine
1019207|NCT03042793|immunotherapy|immunotherapy
1019208|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
1019209|NCT03042780|Metastatic|metastatic
1019210|NCT03042780|High grade|high grade
1019211|NCT03042780|Pancreas|pancreas
1019212|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
1019213|NCT03042754|LAM|lam
1019214|NCT03042754|XpertMTB/RIF|xpertmtb/rif
1019215|NCT03042754|treatment outcome|treatment outcome
1019216|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
1019217|NCT03042715|Supportive Care|supportive care
1019218|NCT03042689|AML|aml
1019219|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
1019220|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
1019221|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
1019222|NCT03042663|stellate ganglion block|stellate ganglion block
1019223|NCT03042663|arterial cannula|arterial cannula
1019224|NCT03042663|ischemia|ischemia
1019225|NCT03042663|septic shock|septic shock
1019226|NCT03042611|Gastric Cancer|gastric cancer
1019227|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
1019228|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
1019229|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
1019230|NCT03042611|Stomach Cancer|stomach cancer
1019231|NCT03042611|Tumor|tumor
1019232|NCT03042611|Oncology|oncology
1019233|NCT03042611|Antiangiogenesis|antiangiogenesis
1019234|NCT03042611|Metastatic|metastatic
1019235|NCT03042598|Safe Apneic Period|safe apneic period
1019236|NCT03042598|Emergency Intubation|emergency intubation
1019237|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
1019238|NCT03042598|Non-invasive ventilation|non-invasive ventilation
1019239|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
1019240|NCT03042598|desaturation|desaturation
1019241|NCT03042598|waveform capnography|waveform capnography
1019242|NCT03042598|Patient safety|patient safety
1019243|NCT03042585|BMT|bmt
1019244|NCT03042585|NHL|nhl
1019245|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1019246|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
1019247|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
1019248|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
1019249|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
1019250|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
1019251|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
1019252|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
1019253|NCT03042572|Cardiovascular disease|cardiovascular disease
1019254|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
1019255|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
1019256|NCT03042494|Prebiotic|prebiotic
1019257|NCT03042494|Gut microbiota|gut microbiota
1019258|NCT03042494|Dietary fiber|dietary fiber
1019259|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
1019260|NCT03042481|chronic hepatitis B|chronic hepatitis b
1019261|NCT03042481|entecavir|entecavir
1019262|NCT03042481|tenofovir|tenofovir
1019263|NCT03042481|off-therapy|off-therapy
1019264|NCT03042481|relapse|relapse
1019265|NCT03042442|pancreatic cancer|pancreatic cancer
1019266|NCT03042442|cachexia|cachexia
1019267|NCT03042442|perineural invasion|perineural invasion
1019268|NCT03042442|pain|pain
1019269|NCT03042442|diabetes|diabetes
1019270|NCT03042429|neuroblastoma|neuroblastoma
1019271|NCT03042429|chemotherapy|chemotherapy
1019272|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
1019273|NCT03042429|radiotherapy|radiotherapy
1019274|NCT03042429|mIBG|mibg
1019275|NCT03042429|tumor resection|tumor resection
1019276|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
1019277|NCT03042403|hemodynamics|hemodynamics
1019278|NCT03042403|physiotherapy|physiotherapy
1019279|NCT03042403|breath stacking|breath stacking
1019280|NCT03042377|Endodontics|endodontics
1019281|NCT03042377|Retreatment|retreatment
1019282|NCT03042377|Postoperative Pain|postoperative pain
1019283|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
1019284|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
1019590|NCT03040557|pain|pain
1019285|NCT03042351|Urinary Incontinence|urinary incontinence
1019286|NCT03042351|Pelvic Floor|pelvic floor
1019287|NCT03042325|Drug therapy|drug therapy
1019288|NCT03042286|statin|statin
1019289|NCT03042286|myalgia|myalgia
1019290|NCT03042286|myopathy|myopathy
1019291|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
1019292|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
1019293|NCT03042273|recurrent|recurrent
1019294|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
1019295|NCT03042260|Infection|infection
1019296|NCT03042260|Prophylaxis|prophylaxis
1019297|NCT03042234|Obesity|obesity
1019298|NCT03042234|Exercise|exercise
1019299|NCT03042234|Fat oxidation|fat oxidation
1019301|NCT03042234|Insulin resistance|insulin resistance
1019302|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
1019303|NCT03042195|Postoperative Nutrition|postoperative nutrition
1019304|NCT03042195|Postoperative complications|postoperative complications
1019305|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
1019306|NCT03042169|palliative surgery|palliative surgery
1019307|NCT03042169|chemotherapy|chemotherapy
1019308|NCT03042169|survival|survival
1019309|NCT03042169|quality of life|quality of life
1019310|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
1019311|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
1019312|NCT03042104|Stenosis|stenosis
1019313|NCT03042104|Heart Disease|heart disease
1019314|NCT03042104|Valve|valve
1019315|NCT03042104|Tricuspid|tricuspid
1019316|NCT03042104|Aortic Valve|aortic valve
1019317|NCT03042104|Asymptomatic|asymptomatic
1019318|NCT03042078|Fluoroscopy|fluoroscopy
1019319|NCT03042078|Ablation|ablation
1019320|NCT03042078|Three dimensional|three dimensional
1019321|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
1019322|NCT03042078|Radiation|radiation
1019323|NCT03042065|pediatrics|pediatrics
1019324|NCT03042065|asthma|asthma
1019325|NCT03042065|nebulization|nebulization
1019326|NCT03042065|vibrating mesh|vibrating mesh
1019327|NCT03042065|salbutamol|salbutamol
1019328|NCT03042065|Efficiency|efficiency
1019329|NCT03042013|ASP8273|asp8273
1019330|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1019331|NCT03042013|EGFR mutations|egfr mutations
1019332|NCT03042013|Oncology|oncology
1019333|NCT03042000|rectal cancer|rectal cancer
1019334|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
1019335|NCT03042000|circulating tumor DNA|circulating tumor dna
1019336|NCT03042000|local recurrence|local recurrence
1019337|NCT03042000|long-term survival|long-term survival
1019338|NCT03041987|Cohort studies|cohort studies
1019339|NCT03041987|Prognosis|prognosis
1019340|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
1019341|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
1019342|NCT03041961|Vascular function|vascular function
1019343|NCT03041961|Endothelial function|endothelial function
1019344|NCT03041961|(Poly)phenols|(poly)phenols
1019345|NCT03041948|Inguinal hernia|inguinal hernia
1019346|NCT03041948|Caudal nerve block|caudal nerve block
1019347|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
1019348|NCT03041948|Pain|pain
1019349|NCT03041935|Testicle|testicle
1019350|NCT03041935|Pain|pain
1019351|NCT03041935|Orchiopexy|orchiopexy
1019352|NCT03041935|Caudal nerve block|caudal nerve block
1019353|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
1019354|NCT03041922|Elastography|elastography
1019355|NCT03041922|Buttocks|buttocks
1019356|NCT03041922|Ultrasound|ultrasound
1019357|NCT03041922|Soft tissue|soft tissue
1019358|NCT03041870|PET-fMRI|pet-fmri
1019359|NCT03041870|dominance|dominance
1019360|NCT03041870|5HT transporter|5ht transporter
1019361|NCT03041857|Videofluoroscopy|videofluoroscopy
1019362|NCT03041857|GMK Sphere|gmk sphere
1019363|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
1019364|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
1019365|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
1019366|NCT03041844|quality of life|quality of life
1019367|NCT03041831|frail elderly|frail elderly
1019368|NCT03041831|telemedicine|telemedicine
1019369|NCT03041831|obesity|obesity
1019370|NCT03041831|rural health|rural health
1019371|NCT03041831|health promotion|health promotion
1019372|NCT03041818|cerebral palsy|cerebral palsy
1019373|NCT03041818|horseback riding|horseback riding
1019374|NCT03041805|venous thromboembolism|venous thromboembolism
1019375|NCT03041805|deep vein thrombosis|deep vein thrombosis
1019376|NCT03041805|pulmonary embolism|pulmonary embolism
1019377|NCT03041805|varicose veins|varicose veins
1019378|NCT03041805|surgery|surgery
1019379|NCT03041805|endovenous laser treatment|endovenous laser treatment
1019380|NCT03041805|radiofrequency ablation|radiofrequency ablation
1019381|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
1019382|NCT03041805|register|register
1019383|NCT03041805|anticoagulation|anticoagulation
1019384|NCT03041766|Schistosomiasis|schistosomiasis
1019385|NCT03041766|Recombinant vaccine|recombinant vaccine
1019386|NCT03041766|rSm14|rsm14
1019388|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
1019389|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
1019390|NCT03041766|Senegal|senegal
1019391|NCT03041753|stroke|stroke
1019392|NCT03041753|thrombolysis|thrombolysis
1019393|NCT03041753|metalloproteinases|metalloproteinases
1019394|NCT03041753|blood brain barrier|blood brain barrier
1019395|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1019396|NCT03041740|Neonates|neonates
1019397|NCT03041714|Essential Tremor|essential tremor
1019398|NCT03041714|Cervical Dystonia|cervical dystonia
1019399|NCT03041714|Hand Dystonia|hand dystonia
1019400|NCT03041714|Neurophysiology|neurophysiology
1019401|NCT03041714|Dystonic Tremor|dystonic tremor
1019402|NCT03041701|ERMS|erms
1019403|NCT03041701|ARMS|arms
1019404|NCT03041701|Monoclonal Antibody|monoclonal antibody
1019405|NCT03041701|YES|yes
1019406|NCT03041701|RMS|rms
1019407|NCT03041675|Lacer Acupuncture|lacer acupuncture
1019408|NCT03041675|Paralytic ileus|paralytic ileus
1019409|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
1019410|NCT03041649|Feeding Disorder|feeding disorder
1019411|NCT03041649|Gastrostomy tube|gastrostomy tube
1019412|NCT03041649|Family Satisfaction|family satisfaction
1019413|NCT03041649|GT button|gt button
1019414|NCT03041649|Enteral nutrition|enteral nutrition
1019415|NCT03041649|Gastrostomy button|gastrostomy button
1019416|NCT03041636|Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
1019417|NCT03041636|Other Diseases of Blood and Blood-Forming Organs|other diseases of blood and blood-forming organs
1019418|NCT03041636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1019419|NCT03041636|CLL|cll
1019420|NCT03041636|Ruxolitinib|ruxolitinib
1019421|NCT03041636|Jakafi|jakafi
1019422|NCT03041636|INCB018424|incb018424
1019423|NCT03041636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1019424|NCT03041636|SLL|sll
1019425|NCT03041623|IIPs|iips
1019426|NCT03041558|healthy relationships|healthy relationships
1019427|NCT03041558|interpersonal relations|interpersonal relations
1019428|NCT03041558|domestic violence|domestic violence
1019429|NCT03041532|retroflexion proximal|retroflexion proximal
1019430|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
1019431|NCT03041532|adenoma detection rate|adenoma detection rate
1019432|NCT03041532|right colon|right colon
1019433|NCT03041519|Fluoroscopy|fluoroscopy
1019434|NCT03041519|Ablation|ablation
1019435|NCT03041519|Three dimensional|three dimensional
1019436|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
1019437|NCT03041519|Radiation|radiation
1019438|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
1019439|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
1019440|NCT03041506|Sedation|sedation
1019441|NCT03041493|Electronic Cigarettes|electronic cigarettes
1019442|NCT03041493|17-071|17-071
1019443|NCT03041480|chronic periodontitis|chronic periodontitis
1019444|NCT03041480|lipids|lipids
1019445|NCT03041480|Lp-PLA2|lp-pla2
1019446|NCT03041402|non-invasive ventilation|non-invasive ventilation
1019447|NCT03041402|Pressure Support Ventilation|pressure support ventilation
1019448|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1019449|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
1019450|NCT03041402|ventilator performance|ventilator performance
1019451|NCT03041402|asynchrony|asynchrony
1019452|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
1019453|NCT03041350|Emergency Medical Services|emergency medical services
1019454|NCT03041350|Smartphone|smartphone
1019455|NCT03041350|Survival|survival
1019456|NCT03041324|MPS ll|mps ll
1019457|NCT03041324|Mucopolysaccharidosis|mucopolysaccharidosis
1019458|NCT03041324|Hunter syndrome|hunter syndrome
1019459|NCT03041324|gene editing|gene editing
1019460|NCT03041324|gene therapy|gene therapy
1019461|NCT03041324|zinc finger|zinc finger
1019462|NCT03041324|ZFN|zfn
1019463|NCT03041324|SB-913|sb-913
1019464|NCT03041324|rare|rare
1019465|NCT03041324|genetic|genetic
1019466|NCT03041324|DNA|dna
1019467|NCT03041324|Sangamo|sangamo
1019468|NCT03041324|Genomic editing|genomic editing
1019469|NCT03041324|Champions|champions
1019470|NCT03041324|Hunter|hunter
1019471|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
1019472|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
1019473|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
1019474|NCT03041246|pelvic floor|pelvic floor
1019475|NCT03041207|ventilator associated infection|ventilator associated infection
1019476|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
1019477|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
1019478|NCT03041207|Lower respiratory infection|lower respiratory infection
1019479|NCT03041181|Nivolumab|nivolumab
1019480|NCT03041181|BMS-936558-01|bms-936558-01
1019481|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
1019482|NCT03041181|Docetaxel|docetaxel
1019483|NCT03041181|Pemetrexed|pemetrexed
1019484|NCT03041181|Gemcitabine|gemcitabine
1019485|NCT03041142|Obesity|obesity
1019486|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
1019487|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
1019488|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
1019489|NCT03041116|PKAN|pkan
1019490|NCT03041090|infiltration|infiltration
1019491|NCT03041090|extravasation|extravasation
1019492|NCT03041090|PET/CT|pet/ct
1019493|NCT03041090|PET|pet
1019494|NCT03041090|PET-CT|pet-ct
1019495|NCT03041025|Systemic Sclerosis|systemic sclerosis
1019496|NCT03041025|Repeat-dose|repeat-dose
1019497|NCT03041025|Phase IIA|phase iia
1019498|NCT03041025|GSK2330811|gsk2330811
1019499|NCT03041025|Pharmacodynamics|pharmacodynamics
1019500|NCT03041025|Pharmacokinetics|pharmacokinetics
1019501|NCT03041025|Proof of mechanism study|proof of mechanism study
1019502|NCT03041012|HIV-1|hiv-1
1019503|NCT03041012|Latency Reversal Agent|latency reversal agent
1019504|NCT03041012|Immunotherapy|immunotherapy
1019505|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1019506|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
1019507|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
1019508|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
1019509|NCT03040999|PD1|pd1
1019510|NCT03040999|PD-1|pd-1
1019511|NCT03040999|PDL1|pdl1
1019512|NCT03040999|PD-L1|pd-l1
1019513|NCT03040999|PDL2|pdl2
1019514|NCT03040973|capmatinib|capmatinib
1019515|NCT03040973|cMET|cmet
1019516|NCT03040973|advanced solid tumor|advanced solid tumor
1019517|NCT03040973|cancer|cancer
1019518|NCT03040960|infection|infection
1019519|NCT03040960|wound infection|wound infection
1019520|NCT03040960|surgical wound infection|surgical wound infection
1019521|NCT03040960|Staphylococcal infections|staphylococcal infections
1019522|NCT03040960|wound and injuries|wound and injuries
1019523|NCT03040960|postoperative complications|postoperative complications
1019524|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
1019525|NCT03040960|bacterial infections|bacterial infections
1019526|NCT03040895|Parenting practices|parenting practices
1019527|NCT03040856|Omega 3|omega 3
1019528|NCT03040856|Supplements|supplements
1019529|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
1019530|NCT03040843|documentation|documentation
1019531|NCT03040843|altered mental status|altered mental status
1019532|NCT03040843|definition|definition
1019533|NCT03040843|clinically|clinically
1019534|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
1019535|NCT03040804|HS|hs
1019536|NCT03040804|radiotherapy|radiotherapy
1019537|NCT03040791|prostate cancer|prostate cancer
1019538|NCT03040778|MRONJ|mronj
1019539|NCT03040778|BRONJ|bronj
1019540|NCT03040765|Osteoporosis|osteoporosis
1019541|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
1019542|NCT03040765|Denosumab|denosumab
1019543|NCT03040765|Zoledronic Acid|zoledronic acid
1019544|NCT03040739|O'ARM|o'arm
1019545|NCT03040726|In situ neoplasm|in situ neoplasm
1019546|NCT03040726|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1019547|NCT03040726|Symptoms and signs involving the digestive system and abdomen|symptoms and signs involving the digestive system and abdomen
1019548|NCT03040726|Chronic nausea and vomiting|chronic nausea and vomiting
1019549|NCT03040726|Netupitant/Palonosetron|netupitant/palonosetron
1019550|NCT03040726|NEPA|nepa
1019551|NCT03040726|Placebo|placebo
1019552|NCT03040726|Sugar pill|sugar pill
1019553|NCT03040726|Symptom questionnaires|symptom questionnaires
1019554|NCT03040726|Surveys|surveys
1019555|NCT03040726|Pill diary|pill diary
1019556|NCT03040726|Akynzeo|akynzeo
1019557|NCT03040700|coronary artery disease|coronary artery disease
1019558|NCT03040700|surgery|surgery
1019559|NCT03040700|angina|angina
1019560|NCT03040700|myocardial ischemia|myocardial ischemia
1019561|NCT03040700|non-invasive testing|non-invasive testing
1019562|NCT03040687|ETEC|etec
1019563|NCT03040687|Escherichia coli|escherichia coli
1019564|NCT03040687|enteritis|enteritis
1019565|NCT03040687|challenge|challenge
1019567|NCT03040687|B7A|b7a
1019568|NCT03040674|Shortness of breath|shortness of breath
1019569|NCT03040674|Breathlessness|breathlessness
1019570|NCT03040674|Stem cells|stem cells
1019571|NCT03040674|Platelet rich plasma|platelet rich plasma
1019572|NCT03040674|Quality of life|quality of life
1019573|NCT03040674|Pulmonary function|pulmonary function
1019574|NCT03040622|WATCHMAN|watchman
1019575|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
1019576|NCT03040622|Thrombosis|thrombosis
1019577|NCT03040622|Platelet Function|platelet function
1019578|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
1019579|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
1019580|NCT03040596|vocal fold nodules|vocal fold nodules
1019581|NCT03040596|inhaled steroid|inhaled steroid
1019582|NCT03040596|steroid|steroid
1019583|NCT03040596|children|children
1019584|NCT03040596|nodules|nodules
1019585|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
1019586|NCT03040583|auto-immune diseases|auto-immune diseases
1019587|NCT03040557|plantar fasciitis|plantar fasciitis
1019588|NCT03040557|shoes|shoes
1019592|NCT03040544|minimally invasive surgery|minimally invasive surgery
1019593|NCT03040544|video-based trainer|video-based trainer
1019594|NCT03040531|glucocorticoid|glucocorticoid
1019595|NCT03040531|genistein|genistein
1019596|NCT03040531|alendronate|alendronate
1019597|NCT03040518|Behaviour change|behaviour change
1019598|NCT03040518|Male obesity|male obesity
1019599|NCT03040518|SMS|sms
1019600|NCT03040518|Financial Incentive|financial incentive
1019601|NCT03040518|Endowment incentive|endowment incentive
1019602|NCT03040466|ureteroscopy|ureteroscopy
1019995|NCT03037541|Cryosurgery|cryosurgery
1019603|NCT03040466|flexible ureteroscope|flexible ureteroscope
1019604|NCT03040466|randomized controlled trial|randomized controlled trial
1019605|NCT03040453|Irreversible electroporation|irreversible electroporation
1019606|NCT03040453|Microwave ablation|microwave ablation
1019607|NCT03040427|F-18 florbetapir|f-18 florbetapir
1019608|NCT03040427|Amyvid|amyvid
1019609|NCT03040427|PET scan|pet scan
1019610|NCT03040427|Early detection|early detection
1019611|NCT03040414|Hybrid closed loop|hybrid closed loop
1019612|NCT03040414|Closed loop|closed loop
1019613|NCT03040414|Artificial pancreas|artificial pancreas
1019614|NCT03040401|CMML|cmml
1019615|NCT03040401|Ceplene|ceplene
1019616|NCT03040401|Interleukin-2|interleukin-2
1019617|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
1019618|NCT03040388|Depressive Disorder|depressive disorder
1019619|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
1019620|NCT03040388|Hippocampus|hippocampus
1019621|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1019622|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1019623|NCT03040388|Blood-Brain Barrier|blood-brain barrier
1019624|NCT03040349|primary care|primary care
1019625|NCT03040349|greece|greece
1019626|NCT03040349|cyprus|cyprus
1019627|NCT03040349|tobacco use treatment|tobacco use treatment
1019628|NCT03040349|evidence-based guidelines|evidence-based guidelines
1019629|NCT03040336|surgery|surgery
1019630|NCT03040336|prehabilitation|prehabilitation
1019631|NCT03040336|exercise therapy|exercise therapy
1019632|NCT03040336|nutrition support|nutrition support
1019633|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
1019634|NCT03040297|tracheostomized patients|tracheostomized patients
1019635|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
1019636|NCT03040284|noninvasive monitoring|noninvasive monitoring
1019637|NCT03040284|intracranial pressure|intracranial pressure
1019638|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
1019639|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
1019640|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
1019641|NCT03040284|brain diseases|brain diseases
1019642|NCT03040271|School-based intervention|school-based intervention
1019643|NCT03040258|School-based intervention|school-based intervention
1019644|NCT03040245|Emergency physician|emergency physician
1019645|NCT03040245|Whiplash Book|whiplash book
1019646|NCT03040245|Whiplash trauma|whiplash trauma
1019647|NCT03040245|Fears|fears
1019648|NCT03040245|Beliefs|beliefs
1019649|NCT03040193|Lignocaine|lignocaine
1019650|NCT03040180|Neoplasms|neoplasms
1019651|NCT03040180|Neoplasms, primary|neoplasms, primary
1019652|NCT03040180|Cancer|cancer
1019653|NCT03040180|Colorectal cancer|colorectal cancer
1019654|NCT03040180|rectal cancer|rectal cancer
1019655|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
1019656|NCT03040180|Electrochemotherapy|electrochemotherapy
1019657|NCT03040180|Electroporation|electroporation
1019658|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
1019659|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
1019660|NCT03040180|Bleomycin|bleomycin
1019661|NCT03040180|Pathologic processes|pathologic processes
1019662|NCT03040180|Neoplastic processes|neoplastic processes
1019663|NCT03040154|Filipino|filipino
1019664|NCT03040102|Advanced Cancer|advanced cancer
1019665|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
1019666|NCT03040024|Anesthesiology|anesthesiology
1019667|NCT03040011|Vaginal Surgery|vaginal surgery
1019668|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
1019669|NCT03040011|Postoperative Pain|postoperative pain
1019670|NCT03039959|Chronic Kidney Disease|chronic kidney disease
1019671|NCT03039946|Fluid therapy|fluid therapy
1019672|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
1019673|NCT03039946|Closed-loop system|closed-loop system
1019674|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
1019675|NCT03039946|Anesthesiology|anesthesiology
1019677|NCT03039907|Replacement|replacement
1019678|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
1019679|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
1019680|NCT03039855|Mitral|mitral
1019681|NCT03039855|Regurgitation|regurgitation
1019682|NCT03039855|Heart valve|heart valve
1019683|NCT03039855|Transcatheter|transcatheter
1019684|NCT03039855|Transapical|transapical
1019685|NCT03039855|Functional|functional
1019686|NCT03039855|Degenerative|degenerative
1019687|NCT03039855|TMVR|tmvr
1019688|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
1019689|NCT03039790|Immunogenicity, Norovirus vaccination|immunogenicity, norovirus vaccination
1019690|NCT03039686|muscular dystrophy|muscular dystrophy
1019691|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
1019692|NCT03039686|DMD|dmd
1019693|NCT03039673|interleukin-2|interleukin-2
1019694|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
1019695|NCT03039608|esophageal stricture|esophageal stricture
1019696|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
1019697|NCT03039608|prevention|prevention
1019996|NCT03037541|Cream|cream
1019698|NCT03039595|Early rectal cancer|early rectal cancer
1019699|NCT03039595|Ploidy|ploidy
1019700|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
1019701|NCT03039582|perineal tear|perineal tear
1019702|NCT03039582|bidigital palpation|bidigital palpation
1019703|NCT03039582|perineal ultrasound|perineal ultrasound
1019704|NCT03039582|post partum diagnostics|post partum diagnostics
1019705|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
1019706|NCT03039569|Diabetes self-management|diabetes self-management
1019707|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
1019708|NCT03039569|Home food environment|home food environment
1019709|NCT03039569|Text message|text message
1019710|NCT03039530|Postpartum Depression|postpartum depression
1019711|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
1019712|NCT03039530|Public Health|public health
1019713|NCT03039530|Mother|mother
1019714|NCT03039530|Infant|infant
1019715|NCT03039530|Emotion|emotion
1019716|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
1019717|NCT03039504|Succinates|succinates
1019718|NCT03039504|Dietary supplement|dietary supplement
1019719|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
1019720|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
1019721|NCT03039465|Voice Rehabilitation|voice rehabilitation
1019722|NCT03039465|Total Laryngectomy|total laryngectomy
1019723|NCT03039439|Immunohistochemical profiling of tumors|immunohistochemical profiling of tumors
1019724|NCT03039439|Biomarkers|biomarkers
1019725|NCT03039374|OASI|oasi
1019726|NCT03039374|Faecal incontinence|faecal incontinence
1019727|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
1019728|NCT03039374|MRI|mri
1019729|NCT03039348|Breast Cancer Female|breast cancer female
1019730|NCT03039348|Mastectomy|mastectomy
1019731|NCT03039348|Breast Reconstruction|breast reconstruction
1019732|NCT03039348|questionnaire|questionnaire
1019733|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
1019734|NCT03039296|Low back pain|low back pain
1019735|NCT03039296|Facet joints|facet joints
1019736|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
1019737|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
1019738|NCT03039270|Tooth Sensitivity|tooth sensitivity
1019739|NCT03039270|Tooth Bleaching|tooth bleaching
1019740|NCT03039270|Desensitizing agent|desensitizing agent
1019741|NCT03039270|Sonic vibration|sonic vibration
1019742|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1019743|NCT03039257|vitamin a|vitamin a
1019744|NCT03039244|Photochemotherapy|photochemotherapy
1019745|NCT03039244|Photosensitizing agents|photosensitizing agents
1019746|NCT03039244|Smokers|smokers
1019747|NCT03039231|PTSD|ptsd
1019748|NCT03039218|erectile dysfunction|erectile dysfunction
1019749|NCT03039218|shockwave|shockwave
1019750|NCT03039218|Dornier|dornier
1019751|NCT03039205|Platelet aggregation|platelet aggregation
1019752|NCT03039205|Adenosine|adenosine
1019753|NCT03039205|Coronary artery disease|coronary artery disease
1019754|NCT03039205|Kidney dysfunction|kidney dysfunction
1019755|NCT03039205|Ticagrelor|ticagrelor
1019756|NCT03039205|Clopidogrel|clopidogrel
1019757|NCT03039127|Hyperthermia|hyperthermia
1019758|NCT03039127|Laser Coagulation|laser coagulation
1019759|NCT03039127|Laser Therapy|laser therapy
1019760|NCT03039127|Induced|induced
1019761|NCT03039114|Follicular lymphoma|follicular lymphoma
1019762|NCT03039114|relapsed|relapsed
1019763|NCT03039114|refractory|refractory
1019764|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
1019765|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
1019766|NCT03039101|allergen|allergen
1019767|NCT03039101|neutrophils|neutrophils
1019768|NCT03039101|allergy|allergy
1019769|NCT03039062|Serum miR-122|serum mir-122
1019770|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
1019771|NCT03039062|malignant tumor patients|malignant tumor patients
1019772|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
1019773|NCT03039049|IVF|ivf
1019774|NCT03039049|Luteal phase support|luteal phase support
1019775|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
1019776|NCT03039036|Labor Induction|labor induction
1019777|NCT03039036|Early Amniotomy|early amniotomy
1019778|NCT03039036|Foley catheter|foley catheter
1019779|NCT03039023|TMAO|tmao
1019780|NCT03039023|choline|choline
1019781|NCT03039023|eggs|eggs
1019782|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
1019783|NCT03039023|healthy volunteers|healthy volunteers
1019784|NCT03038984|IBD|ibd
1019984|NCT03037593|Pregnancy|pregnancy
1019785|NCT03038984|Telemedicine|telemedicine
1019786|NCT03038984|At-home monitoring|at-home monitoring
1019787|NCT03038984|Disease activity|disease activity
1019788|NCT03038984|fecal calprotectin|fecal calprotectin
1019789|NCT03038984|Total inflammation burden|total inflammation burden
1019790|NCT03038984|11 years follow up|11 years follow up
1019791|NCT03038958|Local Anaesthetic|local anaesthetic
1019792|NCT03038958|spinal anesthesia|spinal anesthesia
1019793|NCT03038958|Knee arthroscopy|knee arthroscopy
1019794|NCT03038945|Laparoscopy|laparoscopy
1019795|NCT03038945|Hysterectomy|hysterectomy
1019796|NCT03038945|Suture Techniques|suture techniques
1019797|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
1019798|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
1019799|NCT03038919|critically ill patients|critically ill patients
1019800|NCT03038919|anabolic steroid|anabolic steroid
1019801|NCT03038893|Ultrasonography|ultrasonography
1019802|NCT03038893|Point-of-care systems|point-of-care systems
1019803|NCT03038893|Deep venous thrombosis|deep venous thrombosis
1019804|NCT03038893|Hospitalization|hospitalization
1019806|NCT03038750|Healthy Volunteers|healthy volunteers
1019807|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
1019808|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1019809|NCT03038750|Coronary Disease|coronary disease
1019810|NCT03038750|Hypertension|hypertension
1019811|NCT03038750|Venous Thromboses|venous thromboses
1019812|NCT03038750|Venous Thromboembolism|venous thromboembolism
1019813|NCT03038750|Coronary Heart Disease|coronary heart disease
1019814|NCT03038750|Coronary Artery Disease|coronary artery disease
1019815|NCT03038737|nylon|nylon
1019816|NCT03038737|polyamide|polyamide
1019817|NCT03038737|PEEK|peek
1019818|NCT03038737|partial denture|partial denture
1019819|NCT03038724|HIV testing|hiv testing
1019820|NCT03038698|spirometry|spirometry
1019821|NCT03038698|normative values|normative values
1019822|NCT03038698|health|health
1019823|NCT03038698|south africa|south africa
1019824|NCT03038698|children|children
1019825|NCT03038685|Secondary prevention|secondary prevention
1019826|NCT03038685|Web-based intervention|web-based intervention
1019827|NCT03038685|Strokecoach|strokecoach
1019828|NCT03038646|Pharmacokinetics|pharmacokinetics
1019829|NCT03038646|Food Effect|food effect
1019830|NCT03038620|Obesity|obesity
1019831|NCT03038620|Visceral|visceral
1019832|NCT03038620|Cardiovascular Disease|cardiovascular disease
1019833|NCT03038620|Fat|fat
1019834|NCT03038594|Burns|burns
1019835|NCT03038594|Growth Hormone|growth hormone
1019836|NCT03038594|Lean Body Mass|lean body mass
1019837|NCT03038594|Strength|strength
1019838|NCT03038594|Exercise Endurance|exercise endurance
1019839|NCT03038581|Deep wrist injury|deep wrist injury
1019840|NCT03038581|Self inflicted|self inflicted
1019841|NCT03038581|Traumatic wrist injury|traumatic wrist injury
1019842|NCT03038568|colorectal liver metastases|colorectal liver metastases
1019843|NCT03038568|CT scan|ct scan
1019844|NCT03038568|17-010|17-010
1019845|NCT03038555|Medical staff|medical staff
1019846|NCT03038555|preeclampsia|preeclampsia
1019847|NCT03038555|cohort study|cohort study
1019848|NCT03038555|further effect|further effect
1019849|NCT03038529|low back pain , Ozone|low back pain , ozone
1019850|NCT03038503|refractory septic shock|refractory septic shock
1019851|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
1019852|NCT03038503|terlipressin|terlipressin
1019853|NCT03038503|methylene blue|methylene blue
1019854|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
1019855|NCT03038477|Durvalumab|durvalumab
1019856|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
1019857|NCT03038399|vamorolone|vamorolone
1019858|NCT03038347|cross-cultural competencies|cross-cultural competencies
1019859|NCT03038347|internet-based training|internet-based training
1019860|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
1019861|NCT03038347|psychotherapy training|psychotherapy training
1019862|NCT03038347|competence training|competence training
1019863|NCT03038321|BCG Cystitis|bcg cystitis
1019864|NCT03038321|Bladder Cancer|bladder cancer
1019865|NCT03038321|Levofloxacin|levofloxacin
1019866|NCT03038321|Solifenacin|solifenacin
1019867|NCT03038321|Lornoxicam|lornoxicam
1019868|NCT03038308|ropinirole|ropinirole
1019869|NCT03038308|hyperprolactinemia|hyperprolactinemia
1019870|NCT03038308|prolactin|prolactin
1019871|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
1019872|NCT03038295|propranolol|propranolol
1019873|NCT03038295|ROP|rop
1019874|NCT03038269|Robotics|robotics
1019875|NCT03038269|Upper Extremity|upper extremity
1019876|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
1019877|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
1019878|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
1019879|NCT03038243|Shigella|shigella
1019880|NCT03038243|vaccine|vaccine
1019881|NCT03038243|shigellosis|shigellosis
1019882|NCT03038243|dysentery|dysentery
1019883|NCT03038243|whole cell|whole cell
1021293|NCT03029650|Research|research
1019884|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
1019885|NCT03038230|MCLA-117|mcla-117
1019886|NCT03038230|First in Human|first in human
1019887|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
1019888|NCT03038230|Immunologic Factors|immunologic factors
1019889|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
1019890|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
1019891|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
1019892|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
1019893|NCT03038230|CD34+CD38|cd34+cd38
1019894|NCT03038230|T-cell recruiting|t-cell recruiting
1019895|NCT03038217|rectal cancer|rectal cancer
1019896|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
1019897|NCT03038217|circulating tumor DNA|circulating tumor dna
1019898|NCT03038204|Papillary muscles approximation|papillary muscles approximation
1019899|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
1019900|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
1019901|NCT03038178|Amikacin|amikacin
1019902|NCT03038178|Inhalation|inhalation
1019903|NCT03038165|Hemodialysis|hemodialysis
1019904|NCT03038165|Intradialytic hypertension|intradialytic hypertension
1019905|NCT03038165|Hemodynamics changes|hemodynamics changes
1019906|NCT03038152|Disorder of breast|disorder of breast
1019907|NCT03038152|Breast Cancer|breast cancer
1019908|NCT03038152|Lymph node metastasis|lymph node metastasis
1019909|NCT03038152|Magseed marker|magseed marker
1019910|NCT03038152|Lymph node removal|lymph node removal
1019911|NCT03038139|forward head posture|forward head posture
1019912|NCT03038139|postural correction|postural correction
1019913|NCT03038139|spinal muscles|spinal muscles
1019914|NCT03038126|chronic kidney disease|chronic kidney disease
1019915|NCT03038126|patient safety|patient safety
1019916|NCT03038126|home telehealth|home telehealth
1019917|NCT03038061|Diaphragm|diaphragm
1019919|NCT03038061|Laparoscopy|laparoscopy
1019920|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
1019921|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
1019922|NCT03038009|Gastrointestinal|gastrointestinal
1019923|NCT03038009|Mucosal Injury|mucosal injury
1019924|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
1019925|NCT03037996|anesthesia|anesthesia
1019926|NCT03037996|satisfaction|satisfaction
1019927|NCT03037983|Schizophrenia|schizophrenia
1019928|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
1019929|NCT03037983|Electroencephalography|electroencephalography
1019930|NCT03037944|Adenomyosis|adenomyosis
1019931|NCT03037944|Contraceptive pills|contraceptive pills
1019932|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
1019933|NCT03037918|Gut Microbiota|gut microbiota
1019934|NCT03037918|High Fat Diets|high fat diets
1019935|NCT03037918|Probiotics|probiotics
1019936|NCT03037918|Glycaemic Control|glycaemic control
1019937|NCT03037853|Atlas|atlas
1019938|NCT03037853|Full human Body|full human body
1019939|NCT03037853|MRI|mri
1019940|NCT03037840|RF EMF|rf emf
1019941|NCT03037840|In Vivo|in vivo
1019942|NCT03037840|tumor specific frequencies|tumor specific frequencies
1019943|NCT03037827|endovenous laser ablation|endovenous laser ablation
1019944|NCT03037827|radial fiber|radial fiber
1019945|NCT03037827|linear endovenous energy density|linear endovenous energy density
1019946|NCT03037827|1470 nm|1470 nm
1019947|NCT03037827|occlusion rate|occlusion rate
1019948|NCT03037814|restorative materials|restorative materials
1019949|NCT03037814|primary teeth|primary teeth
1019950|NCT03037814|children|children
1019951|NCT03037788|Excessive sweating|excessive sweating
1019952|NCT03037775|tobacco|tobacco
1019953|NCT03037775|cardiovascular system|cardiovascular system
1019954|NCT03037775|sympathetic nervous system|sympathetic nervous system
1019955|NCT03037684|neuropathic pain|neuropathic pain
1019956|NCT03037684|chronic postoperative pain|chronic postoperative pain
1019957|NCT03037671|Malglycemia|malglycemia
1019958|NCT03037658|physical activity|physical activity
1019959|NCT03037658|walking|walking
1019960|NCT03037658|incentive|incentive
1019961|NCT03037658|step count|step count
1019962|NCT03037645|CLL|cll
1019963|NCT03037645|hematological diseases|hematological diseases
1019964|NCT03037645|relapsed|relapsed
1019965|NCT03037645|cancer|cancer
1019966|NCT03037645|malignancy|malignancy
1019967|NCT03037645|SNS-062|sns-062
1019968|NCT03037645|B-lymphoid|b-lymphoid
1019969|NCT03037645|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1019970|NCT03037645|small lymphocytic lymphoma|small lymphocytic lymphoma
1019971|NCT03037645|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
1019972|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
1019973|NCT03037645|mantle cell lymphoma|mantle cell lymphoma
1019974|NCT03037645|SLL|sll
1019975|NCT03037645|LPL|lpl
1019976|NCT03037645|WM|wm
1019977|NCT03037645|MCL|mcl
1019978|NCT03037645|refractory|refractory
1019979|NCT03037645|DLBCL-ABC|dlbcl-abc
1019980|NCT03037645|DLBCL|dlbcl
1019981|NCT03037645|follicular lymphoma|follicular lymphoma
1019982|NCT03037645|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1019983|NCT03037645|CLL/SLL|cll/sll
1019985|NCT03037593|Gestational Diabetes|gestational diabetes
1019986|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
1019987|NCT03037580|6-Minute Walk Test|6-minute walk test
1019988|NCT03037580|HFpEF|hfpef
1019989|NCT03037580|Oral Treprostinil|oral treprostinil
1019990|NCT03037554|Skin Temperature|skin temperature
1019991|NCT03037554|Hot Flashes|hot flashes
1019992|NCT03037554|Sleep Disturbance|sleep disturbance
1019993|NCT03037541|Wake Forest|wake forest
1019994|NCT03037541|Actinic Keratosis|actinic keratosis
1019997|NCT03037502|Men's Health|men's health
1019998|NCT03037502|weight loss|weight loss
1019999|NCT03037502|African American men|african american men
1020000|NCT03037502|Latino men|latino men
1020001|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
1020002|NCT03037437|Sorafenib|sorafenib
1020003|NCT03037437|Hydroxychloroquine|hydroxychloroquine
1020004|NCT03037424|Cyroprecipitate|cyroprecipitate
1020005|NCT03037424|Fibrinogen|fibrinogen
1020006|NCT03037424|Cardiac Surgery|cardiac surgery
1020007|NCT03037411|Atherosclerosis|atherosclerosis
1020008|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
1020009|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
1020010|NCT03037411|Stenting|stenting
1020011|NCT03037411|Paclitaxel|paclitaxel
1020012|NCT03037411|Health Economics|health economics
1020013|NCT03037385|RET Lung|ret lung
1020014|NCT03037385|RET Thyroid|ret thyroid
1020015|NCT03037385|RET fusion|ret fusion
1020016|NCT03037385|RET alteration|ret alteration
1020017|NCT03037385|RET mutation|ret mutation
1020018|NCT03037385|RET positive|ret positive
1020019|NCT03037385|RET inhibitor|ret inhibitor
1020020|NCT03037385|RET altered|ret altered
1020021|NCT03037385|RET rearrangement|ret rearrangement
1020022|NCT03037385|RET NSCLC|ret nsclc
1020023|NCT03037385|RET medullary thyroid cancer|ret medullary thyroid cancer
1020024|NCT03037385|RET-rearranged NSCLC|ret-rearranged nsclc
1020025|NCT03037385|RET-rearranged thyroid|ret-rearranged thyroid
1020027|NCT03037385|TRIM33-RET|trim33-ret
1020028|NCT03037385|RET fusion lung cancer|ret fusion lung cancer
1020029|NCT03037385|RET fusion thyroid cancer|ret fusion thyroid cancer
1020030|NCT03037385|lung cancer mutation|lung cancer mutation
1020031|NCT03037385|BLUE 667|blue 667
1020032|NCT03037385|RET tyrosine kinase|ret tyrosine kinase
1020033|NCT03037385|RET gene mutation|ret gene mutation
1020034|NCT03037385|RET kinase|ret kinase
1020035|NCT03037385|RET MTC|ret mtc
1020036|NCT03037385|advanced lung cancer|advanced lung cancer
1020037|NCT03037385|advanced non small cell lung cancer|advanced non small cell lung cancer
1020038|NCT03037385|metastatic lung cancer|metastatic lung cancer
1020039|NCT03037385|KIF5B-RET|kif5b-ret
1020040|NCT03037385|CCDC6-RET|ccdc6-ret
1020041|NCT03037385|NCOA4-RET|ncoa4-ret
1020042|NCT03037385|advance solid tumor|advance solid tumor
1020043|NCT03037385|V804L|v804l
1020044|NCT03037385|V804M|v804m
1020045|NCT03037385|thyroid cancer RET inhibitor|thyroid cancer ret inhibitor
1020046|NCT03037385|lung cancer RET inhibitor|lung cancer ret inhibitor
1020047|NCT03037385|RET PTC|ret ptc
1020048|NCT03037385|rearranged during transfection|rearranged during transfection
1020049|NCT03037372|adults|adults
1020050|NCT03037372|antiretroviral therapy|antiretroviral therapy
1020051|NCT03037359|PID|pid
1020052|NCT03037346|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1020053|NCT03037346|Invasive gynecologic malignancy|invasive gynecologic malignancy
1020054|NCT03037346|Medical Power of Attorney Documents|medical power of attorney documents
1020055|NCT03037346|MPOAD|mpoad
1020056|NCT03037346|Questionnaires|questionnaires
1020057|NCT03037346|Surveys|surveys
1020058|NCT03037333|echocardiogram|echocardiogram
1020059|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
1020060|NCT03037333|fluoroscopy|fluoroscopy
1020061|NCT03037229|Myocardial Infarction|myocardial infarction
1020062|NCT03037229|Ischemia|ischemia
1020063|NCT03037229|Myocardial Ischemia|myocardial ischemia
1020064|NCT03037229|Heart Diseases|heart diseases
1020065|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
1020066|NCT03037229|Vascular Diseases|vascular diseases
1020067|NCT03037216|Exercise|exercise
1020068|NCT03037164|INTERCEPT|intercept
1020069|NCT03037164|Red Blood Cells|red blood cells
1020070|NCT03037164|RBC|rbc
1020071|NCT03037164|Pathogen Inactivation|pathogen inactivation
1020072|NCT03037164|Zika|zika
1020073|NCT03037164|Cerus|cerus
1020074|NCT03037164|Pathogen Reduction|pathogen reduction
1020075|NCT03037151|Safety|safety
1020076|NCT03037151|Efficacy|efficacy
1020077|NCT03037151|grazoprevir|grazoprevir
1020078|NCT03037151|elbasvir|elbasvir
1020079|NCT03037151|compensated cirrhosis|compensated cirrhosis
1020080|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
1020081|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
1020082|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
1020083|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1020084|NCT03037138|postdialysis washed-out|postdialysis washed-out
1020085|NCT03037099|Glycemic index|glycemic index
1020086|NCT03037099|dietary intakes|dietary intakes
1020087|NCT03037086|NSCLC|nsclc
1020088|NCT03037073|Duloxetine|duloxetine
1021800|NCT03026790|Back pain|back pain
1020089|NCT03037073|Succinylcholine|succinylcholine
1020090|NCT03037073|Postoperative Myalgia|postoperative myalgia
1020091|NCT03037073|Microlaryngoscopy|microlaryngoscopy
1020092|NCT03037060|Alcohol use, problem|alcohol use, problem
1020093|NCT03037021|Sickle Cell Disease|sickle cell disease
1020094|NCT03037021|Needs Assessment|needs assessment
1020095|NCT03037021|Barriers to care|barriers to care
1020096|NCT03037021|Access to care|access to care
1020097|NCT03037021|Primary care|primary care
1020098|NCT03037008|perineal sonography|perineal sonography
1020099|NCT03037008|male sling|male sling
1020100|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
1020101|NCT03037008|ultrasonography|ultrasonography
1020102|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
1020103|NCT03036904|venetoclax|venetoclax
1020104|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
1020105|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
1020106|NCT03036904|Lymphoma|lymphoma
1020107|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1020108|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1020109|NCT03036904|Double hit lymphoma|double hit lymphoma
1020110|NCT03036891|Gastroparesis|gastroparesis
1020111|NCT03036891|Opioid-Induced|opioid-induced
1020112|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
1020113|NCT03036878|Osteochondral|osteochondral
1020114|NCT03036878|Marrow Stimulation|marrow stimulation
1020115|NCT03036878|ReNu|renu
1020116|NCT03036865|Healthy participants|healthy participants
1020117|NCT03036865|BOS161721|bos161721
1020118|NCT03036865|Pharmacokinetics|pharmacokinetics
1020119|NCT03036865|Pharmacodynamics|pharmacodynamics
1020120|NCT03036826|renal replacement therapy|renal replacement therapy
1020121|NCT03036787|Premature Baby|premature baby
1020122|NCT03036787|motor development|motor development
1020123|NCT03036787|cognitive development|cognitive development
1020124|NCT03036774|Gastric contents|gastric contents
1020125|NCT03036774|Ultrasound|ultrasound
1020126|NCT03036774|Diabetes|diabetes
1020127|NCT03036761|Auriculotherapy|auriculotherapy
1020128|NCT03036696|Retention|retention
1020129|NCT03036696|Lactation|lactation
1020130|NCT03036696|Human milk|human milk
1020131|NCT03036696|Pregnancy|pregnancy
1020132|NCT03036696|Clinical Research Studies|clinical research studies
1020133|NCT03036696|BEACH|beach
1020134|NCT03036657|Acupuncture|acupuncture
1020135|NCT03036657|Electroacupuncture|electroacupuncture
1020136|NCT03036657|Nerve Conduction Studies|nerve conduction studies
1020137|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
1020138|NCT03036644|electronic cigarette|electronic cigarette
1020139|NCT03036644|e-cigarette|e-cigarette
1020140|NCT03036644|oxidative stress|oxidative stress
1020141|NCT03036644|tobacco smoking|tobacco smoking
1020142|NCT03036618|BMI|bmi
1020143|NCT03036618|Blood Cholesterol|blood cholesterol
1020144|NCT03036618|Glucose|glucose
1020145|NCT03036618|Insulin|insulin
1020146|NCT03036618|Gut health|gut health
1020147|NCT03036605|dexamethasone|dexamethasone
1020148|NCT03036605|bupivacaine|bupivacaine
1020149|NCT03036605|nasal surgery|nasal surgery
1020150|NCT03036605|nasal packing|nasal packing
1020151|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
1020152|NCT03036579|CAD/CAM|cad/cam
1020153|NCT03036579|Ceramic|ceramic
1020154|NCT03036579|Crown|crown
1020155|NCT03036553|Chronic pain|chronic pain
1020156|NCT03036553|Psychological factors|psychological factors
1020157|NCT03036553|Musculoskeletal pain|musculoskeletal pain
1020158|NCT03036553|Prognosis|prognosis
1020159|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
1020160|NCT03036527|Bladder|bladder
1020161|NCT03036527|Sexual Function|sexual function
1020162|NCT03036514|numeric rating scale|numeric rating scale
1020163|NCT03036514|opioid side effects|opioid side effects
1020164|NCT03036488|PD1|pd1
1020165|NCT03036488|PD-1|pd-1
1020166|NCT03036488|PDL1|pdl1
1020167|NCT03036488|PD-L1|pd-l1
1020168|NCT03036462|intravenous iron|intravenous iron
1020169|NCT03036462|systolic heart failure|systolic heart failure
1020170|NCT03036462|iron deficiency|iron deficiency
1020171|NCT03036462|morbidity|morbidity
1020172|NCT03036462|mortality|mortality
1020173|NCT03036449|Medication errors|medication errors
1020174|NCT03036449|Patient safety|patient safety
1020175|NCT03036436|Cancer|cancer
1020176|NCT03036436|EHealth|ehealth
1020177|NCT03036436|Cancer Survivor|cancer survivor
1020178|NCT03036436|Rehabilitation|rehabilitation
1020179|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
1020180|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
1020181|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
1020182|NCT03036397|Anxiety|anxiety
1020183|NCT03036397|Vasopressin|vasopressin
1020184|NCT03036397|Fear-Potentiated Startle|fear-potentiated startle
1020185|NCT03036397|Shock Threat|shock threat
1020186|NCT03036397|Emotion Recognition|emotion recognition
1020187|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
1020188|NCT03036384|spinal anesthesia|spinal anesthesia
1020189|NCT03036384|local anesthesia|local anesthesia
1020190|NCT03036371|Neurogenesis|neurogenesis
1020191|NCT03036371|Memory|memory
1020192|NCT03036371|Spatial Processing|spatial processing
1020193|NCT03036371|Hippocampus|hippocampus
1020194|NCT03036371|Cognition|cognition
1020195|NCT03036371|Aerobic Exercise|aerobic exercise
1020196|NCT03036332|aerobic interval training|aerobic interval training
1020197|NCT03036332|biomarkers|biomarkers
1020198|NCT03036306|scar|scar
1020199|NCT03036306|nefopam|nefopam
1020200|NCT03036306|cicatrix|cicatrix
1020201|NCT03036280|E2609|e2609
1020202|NCT03036280|elenbecestat|elenbecestat
1020203|NCT03036280|Alzheimer's Disease|alzheimer's disease
1020204|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
1020205|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
1020206|NCT03036280|Dementia|dementia
1020207|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
1020208|NCT03036280|mild cognitive impairment|mild cognitive impairment
1020209|NCT03036280|MissionAD2|missionad2
1020210|NCT03036267|health disparity|health disparity
1020211|NCT03036267|motivational interviewing|motivational interviewing
1020212|NCT03036267|African American adults|african american adults
1020213|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
1020214|NCT03036267|adherence|adherence
1020215|NCT03036267|health beliefs|health beliefs
1020216|NCT03036267|self-management|self-management
1020217|NCT03036267|asthma control|asthma control
1020218|NCT03036254|Diabetes Mellitus|diabetes mellitus
1020219|NCT03036254|Cognition|cognition
1020220|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
1020221|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
1020222|NCT03036241|restenosis|restenosis
1020223|NCT03036228|Solid tumours|solid tumours
1020224|NCT03036202|epinephrine|epinephrine
1020225|NCT03036163|Tuberculosis|tuberculosis
1020226|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1020227|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
1020228|NCT03036150|Phase III outcome trial|phase iii outcome trial
1020229|NCT03036137|Tinnitus|tinnitus
1020230|NCT03036137|Electroencephalogram|electroencephalogram
1020231|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1020232|NCT03036124|HFrEF|hfref
1020233|NCT03036124|Heart Failure (HF)|heart failure (hf)
1020234|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
1020235|NCT03036124|Phase III outcome trial|phase iii outcome trial
1020236|NCT03036085|postoperative pain|postoperative pain
1020237|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
1020238|NCT03036085|opioids|opioids
1020239|NCT03036085|bupivacaine|bupivacaine
1020240|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
1020241|NCT03036085|analgesia|analgesia
1020242|NCT03036085|local anesthetics|local anesthetics
1020243|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
1020244|NCT03036059|Twice a year treatment|twice a year treatment
1020245|NCT03036059|Biannual treatment|biannual treatment
1020246|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
1020247|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
1020248|NCT03035968|Vojta therapy|vojta therapy
1020249|NCT03035968|reflex locomotion|reflex locomotion
1020250|NCT03035968|stroke rehabilitation|stroke rehabilitation
1020251|NCT03035968|stroke|stroke
1020252|NCT03035968|physiotherapy|physiotherapy
1020253|NCT03035955|Rosacea|rosacea
1020254|NCT03035955|Wake Forest|wake forest
1020255|NCT03035955|Demodex|demodex
1020256|NCT03035955|Finacea Gel|finacea gel
1020257|NCT03035942|Intrathecal morphine|intrathecal morphine
1020258|NCT03035942|Nausea and vomiting|nausea and vomiting
1020259|NCT03035942|Quality of recovery|quality of recovery
1020260|NCT03035942|Patient satisfaction|patient satisfaction
1020261|NCT03035942|Pruritus|pruritus
1020262|NCT03035942|Postoperative pain|postoperative pain
1020263|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
1020264|NCT03035916|epidural anesthesia|epidural anesthesia
1020265|NCT03035916|stress response|stress response
1020266|NCT03035916|anesthetic recovery|anesthetic recovery
1020267|NCT03035890|NSCLC|nsclc
1020268|NCT03035890|Lung Cancer|lung cancer
1020269|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
1020270|NCT03035877|Antisocial Behavior|antisocial behavior
1020271|NCT03035877|Alcohol Abuse|alcohol abuse
1020272|NCT03035877|Drug Abuse|drug abuse
1020273|NCT03035877|Young Adults|young adults
1020274|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
1020275|NCT03035864|cataract surgery|cataract surgery
1020276|NCT03035864|refractive surgery|refractive surgery
1020277|NCT03035851|Alzheimer Disease|alzheimer disease
1020278|NCT03035851|Dementia|dementia
1020279|NCT03035851|Exercise|exercise
1020280|NCT03035851|Physical Activity|physical activity
1020281|NCT03035851|Brain blood flow|brain blood flow
1020282|NCT03035851|Cognition|cognition
1020283|NCT03035851|Fitness|fitness
1020284|NCT03035812|Bicarbonate|bicarbonate
1020285|NCT03035773|Cancer|cancer
1020286|NCT03035773|Oncology|oncology
1020287|NCT03035773|Survivorship|survivorship
1020288|NCT03035760|Helminths|helminths
1020289|NCT03035760|Oxfendazole|oxfendazole
1020290|NCT03035760|Pharmacokinetics|pharmacokinetics
1020291|NCT03035760|Safety|safety
1020292|NCT03035747|registry|registry
1020293|NCT03035747|varicose veins|varicose veins
1020294|NCT03035747|conventional surgery|conventional surgery
1020295|NCT03035747|thermal ablation|thermal ablation
1020296|NCT03035747|radiofrequency|radiofrequency
1020297|NCT03035747|laser|laser
1020298|NCT03035747|sclerotherapy|sclerotherapy
1020299|NCT03035721|Full term healthy infants|full term healthy infants
1020300|NCT03035721|Low protein content formula|low protein content formula
1020301|NCT03035721|Safety|safety
1020302|NCT03035721|Growth|growth
1020303|NCT03035721|Body composition|body composition
1020304|NCT03035695|Trauma|trauma
1020305|NCT03035695|Scalp injuries|scalp injuries
1020306|NCT03035695|Profused Bleeding|profused bleeding
1020307|NCT03035695|Accident|accident
1020308|NCT03035656|Pain|pain
1020309|NCT03035656|analgesic|analgesic
1020310|NCT03035656|spinal fusion|spinal fusion
1020311|NCT03035630|Avelumab|avelumab
1020312|NCT03035630|Sunitinib|sunitinib
1020313|NCT03035630|MSB0010718C|msb0010718c
1020314|NCT03035630|Sutent|sutent
1020315|NCT03035630|IgG1 antibody|igg1 antibody
1020316|NCT03035630|Anti-PD-L1|anti-pd-l1
1020317|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1020318|NCT03035617|Bupivacaine|bupivacaine
1020319|NCT03035604|Malnutrition|malnutrition
1020320|NCT03035604|Nutritional status|nutritional status
1020321|NCT03035604|Mini Nutritional Assessment|mini nutritional assessment
1020322|NCT03035604|MNA|mna
1020323|NCT03035604|Weight loss|weight loss
1020324|NCT03035604|Body Mass Index|body mass index
1020325|NCT03035604|BMI|bmi
1020326|NCT03035604|Lean muscle mas|lean muscle mas
1020327|NCT03035604|American Society for Parenteral and Enteral Nutrition|american society for parenteral and enteral nutrition
1020328|NCT03035604|ASPEN|aspen
1020329|NCT03035578|Pharmacokinetics|pharmacokinetics
1020330|NCT03035578|Pharmacodynamics|pharmacodynamics
1020331|NCT03035578|Morphine|morphine
1020332|NCT03035578|Neonatal|neonatal
1020333|NCT03035565|Heart Failure|heart failure
1020334|NCT03035565|Cognition in Heart Failure|cognition in heart failure
1020335|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
1020336|NCT03035552|Non-Nutritive Suck|non-nutritive suck
1020337|NCT03035539|Rehabilitation|rehabilitation
1020338|NCT03035513|Continuous spikes|continuous spikes
1020339|NCT03035513|Epilepsy|epilepsy
1020340|NCT03035513|Nervous system disease|nervous system disease
1020341|NCT03035513|Neuronal plasticity|neuronal plasticity
1020342|NCT03035513|Diffusion MRI|diffusion mri
1020343|NCT03035513|Functional MRI|functional mri
1020344|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
1020345|NCT03035474|Heart Failure|heart failure
1020346|NCT03035474|Quality Improvement|quality improvement
1020347|NCT03035461|diagnosis annoucement|diagnosis annoucement
1020348|NCT03035461|patient's feelings|patient's feelings
1020349|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1020350|NCT03035448|Advanced cancer|advanced cancer
1020351|NCT03035448|Recurrent cancer|recurrent cancer
1020352|NCT03035448|Metastatic disease|metastatic disease
1020353|NCT03035448|Palliative care|palliative care
1020354|NCT03035448|Videos|videos
1020355|NCT03035448|Questionnaires|questionnaires
1020356|NCT03035448|Surveys|surveys
1020357|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
1020358|NCT03035435|fast-track surgery|fast-track surgery
1020359|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
1020360|NCT03035409|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1020361|NCT03035409|Advanced Cancer|advanced cancer
1020362|NCT03035409|Metastatic or recurrent incurable solid tumors|metastatic or recurrent incurable solid tumors
1020363|NCT03035409|Anamorelin|anamorelin
1020364|NCT03035409|Physical activity|physical activity
1020365|NCT03035409|Questionnaires|questionnaires
1020366|NCT03035409|Surveys|surveys
1020367|NCT03035409|Dietary Counseling|dietary counseling
1020368|NCT03035409|Exercise Counseling|exercise counseling
1020369|NCT03035383|Large thyroid|large thyroid
1020370|NCT03035383|purse string suture|purse string suture
1020371|NCT03035383|thyroidectomy|thyroidectomy
1020372|NCT03035370|Pertussis|pertussis
1020373|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
1020374|NCT03035370|Vaccine|vaccine
1020375|NCT03035370|Viaskin PT|viaskin pt
1020376|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
1020377|NCT03035357|Prostate cancer|prostate cancer
1020378|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1020379|NCT03035357|Daratumumab|daratumumab
1020380|NCT03035357|Biomarker response|biomarker response
1020381|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
1020382|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
1020383|NCT03035305|Children|children
1020384|NCT03035305|Mali|mali
1020385|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
1020386|NCT03035279|Cancer|cancer
1020387|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
1020388|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
1020389|NCT03035279|Maximum tolerated dose|maximum tolerated dose
1020390|NCT03035279|Pharmacokinetics|pharmacokinetics
1020391|NCT03035266|blood flow restriction|blood flow restriction
1020392|NCT03035266|strength|strength
1020393|NCT03035266|muscle atrophy|muscle atrophy
1020394|NCT03035266|post-operative therapy|post-operative therapy
1020395|NCT03035266|knee|knee
1020396|NCT03035201|Memory|memory
1020397|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
1020398|NCT03035201|Alzheimer's Disease|alzheimer's disease
1020399|NCT03035201|Cognition|cognition
1020400|NCT03035188|resectable|resectable
1020401|NCT03035175|Residences|residences
1020402|NCT03035175|Video Laryngoscopy|video laryngoscopy
1020403|NCT03035175|Intubations|intubations
1020404|NCT03035175|Neonatal|neonatal
1020405|NCT03035175|NICU|nicu
1020406|NCT03035175|neonates|neonates
1020407|NCT03035175|Medical Education|medical education
1020408|NCT03035162|dual tDCS|dual tdcs
1020409|NCT03035162|physical rehabilitation|physical rehabilitation
1020410|NCT03035162|lower limb functions|lower limb functions
1020411|NCT03035149|Obesity|obesity
1020412|NCT03035149|Metabolic Syndrome|metabolic syndrome
1020413|NCT03035149|Dyspnea|dyspnea
1020414|NCT03035149|Pulmonary Function|pulmonary function
1020415|NCT03035149|Exercise Capacity|exercise capacity
1020416|NCT03035136|polyps|polyps
1020417|NCT03035123|Heart Failure|heart failure
1020418|NCT03035123|Therapeutic education|therapeutic education
1020419|NCT03035123|Quality of life|quality of life
1020420|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
1020421|NCT03035071|Esophageal resection|esophageal resection
1020422|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
1020423|NCT03035058|Drug therapy|drug therapy
1020424|NCT03035032|Leuprolide acetate|leuprolide acetate
1020425|NCT03035032|Prostate cancer|prostate cancer
1020426|NCT03035019|anxiety|anxiety
1020427|NCT03035019|behavioral app|behavioral app
1020428|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
1020429|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
1020430|NCT03035006|TLC388|tlc388
1020431|NCT03035006|Chemoradiotherapy|chemoradiotherapy
1020432|NCT03035006|Lipotecan|lipotecan
1020433|NCT03034967|HCRU exacerbations|hcru exacerbations
1020434|NCT03034967|SGRQ|sgrq
1020435|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
1020436|NCT03034967|GSK1325756|gsk1325756
1020437|NCT03034967|Danirixin|danirixin
1020438|NCT03034967|COPD|copd
1020439|NCT03034941|Obesity|obesity
1020440|NCT03034941|PCOS|pcos
1020441|NCT03034941|Infertility|infertility
1020442|NCT03034941|Liraglutide|liraglutide
1020443|NCT03034941|Metformin|metformin
1020444|NCT03034941|IVF|ivf
1020445|NCT03034915|Vilanterol|vilanterol
1020446|NCT03034915|COPD|copd
1020447|NCT03034915|HRQoL|hrqol
1020448|NCT03034915|Salmeterol|salmeterol
1020449|NCT03034915|Umeclidinium|umeclidinium
1020450|NCT03034889|Anesthesia|anesthesia
1020451|NCT03034889|Children|children
1020452|NCT03034889|General Anesthesia|general anesthesia
1020453|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
1020454|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
1020455|NCT03034863|Family Caregivers|family caregivers
1020456|NCT03034863|Spouse Caregivers|spouse caregivers
1020457|NCT03034863|Veterans|veterans
1020458|NCT03034863|Suicide|suicide
1020459|NCT03034863|Clinical Trial|clinical trial
1020460|NCT03034863|Military Families|military families
1020461|NCT03034863|Military Psychology|military psychology
1020462|NCT03034850|cytoreductive surgery|cytoreductive surgery
1020463|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
1020464|NCT03034850|platelet function|platelet function
1020465|NCT03034850|thrombin generation|thrombin generation
1020466|NCT03034850|thromboelastometry|thromboelastometry
1020467|NCT03034824|diode laser|diode laser
1020468|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
1020469|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
1020470|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
1020471|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
1020472|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
1020473|NCT03034811|Osteoarthritis|osteoarthritis
1020474|NCT03034811|Avascular necrosis|avascular necrosis
1020475|NCT03034811|Traumatic arthritis|traumatic arthritis
1020476|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
1020477|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
1020478|NCT03034772|neovascular|neovascular
1020479|NCT03034772|wet|wet
1020480|NCT03034772|age-related|age-related
1020481|NCT03034772|macular degeneration|macular degeneration
1020482|NCT03034772|dorzolamide|dorzolamide
1020483|NCT03034772|timolol|timolol
1020484|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
1020583|NCT03034148|Thrombin generation|thrombin generation
1020485|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
1020486|NCT03034733|Arthroplasty|arthroplasty
1020487|NCT03034733|Knee Replacement|knee replacement
1020488|NCT03034733|Pain, Postoperative|pain, postoperative
1020489|NCT03034733|Glucocorticoids|glucocorticoids
1020490|NCT03034733|Dexamethasone|dexamethasone
1020491|NCT03034720|Concussion|concussion
1020492|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
1020493|NCT03034720|CBT|cbt
1020494|NCT03034720|collaborative care|collaborative care
1020495|NCT03034720|Depression|depression
1020496|NCT03034720|Anxiety|anxiety
1020497|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
1020498|NCT03034707|biotinylated assay|biotinylated assay
1020499|NCT03034707|hormone measurement|hormone measurement
1020500|NCT03034707|thyroid|thyroid
1020501|NCT03034707|parathyroid|parathyroid
1020502|NCT03034707|prolactin|prolactin
1020503|NCT03034668|Botanical Supplement|botanical supplement
1020504|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
1020505|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
1020506|NCT03034655|Falls in elderly|falls in elderly
1020507|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
1020508|NCT03034655|Mobile posturography|mobile posturography
1020509|NCT03034642|Apoptosis|apoptosis
1020510|NCT03034642|Bronchoscopy|bronchoscopy
1020511|NCT03034642|Human|human
1020512|NCT03034642|Mice, inbred strains|mice, inbred strains
1020513|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
1020514|NCT03034642|MicroRNAs|micrornas
1020515|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
1020516|NCT03034642|Fluticasone|fluticasone
1020517|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
1020518|NCT03034616|In-vivo activation|in-vivo activation
1020519|NCT03034551|Adherence|adherence
1020520|NCT03034551|Financial Incentives|financial incentives
1020521|NCT03034551|Remote Monitoring|remote monitoring
1020522|NCT03034551|Self-Weighing|self-weighing
1020523|NCT03034551|Behavioral Economics|behavioral economics
1020524|NCT03034551|Telehealth|telehealth
1020525|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
1020526|NCT03034551|Smartphone App|smartphone app
1020527|NCT03034551|Wellth App|wellth app
1020528|NCT03034486|Glaucoma|glaucoma
1020529|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
1020530|NCT03034473|translational research|translational research
1020531|NCT03034473|Biomarker|biomarker
1020532|NCT03034447|Asthma|asthma
1020533|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
1020534|NCT03034447|Children|children
1020535|NCT03034447|Teenagers|teenagers
1020536|NCT03034408|Impulsivity|impulsivity
1020537|NCT03034408|Nalmefene|nalmefene
1020538|NCT03034408|Baclofen|baclofen
1020539|NCT03034395|Melanoma|melanoma
1020540|NCT03034395|cT2N0M0|ct2n0m0
1020541|NCT03034382|morphine|morphine
1020542|NCT03034382|nalbuphine|nalbuphine
1020543|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1020544|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
1020545|NCT03034369|Integration|integration
1020546|NCT03034369|Primary Care|primary care
1020547|NCT03034369|Behavioral Health|behavioral health
1020548|NCT03034369|Health Care Reform|health care reform
1020549|NCT03034369|Medical Home|medical home
1020550|NCT03034369|Accountable Care Organization|accountable care organization
1020551|NCT03034356|Schizophrenia|schizophrenia
1020552|NCT03034343|Mindfulness|mindfulness
1020553|NCT03034343|Internet program|internet program
1020554|NCT03034343|Depression|depression
1020555|NCT03034343|Cost-effectiveness|cost-effectiveness
1020556|NCT03034330|informal care|informal care
1020557|NCT03034330|empowerment|empowerment
1020558|NCT03034330|family-focused intervention|family-focused intervention
1020559|NCT03034330|stroke rehabilitation|stroke rehabilitation
1020560|NCT03034317|Diaphragm Pacing|diaphragm pacing
1020561|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
1020562|NCT03034304|Advanced solid tumors|advanced solid tumors
1020563|NCT03034304|Bladder Cancer|bladder cancer
1020564|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
1020565|NCT03034291|Cocoa|cocoa
1020566|NCT03034291|obesity|obesity
1020567|NCT03034291|HOMA-IR|homa-ir
1020568|NCT03034291|BMI|bmi
1020569|NCT03034291|Quality of life|quality of life
1020570|NCT03034278|opioid use|opioid use
1020571|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
1020572|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
1020573|NCT03034213|mesh|mesh
1020574|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
1020575|NCT03034200|ONC201|onc201
1020576|NCT03034187|Acute toxicity|acute toxicity
1020577|NCT03034187|Late toxicity|late toxicity
1020578|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
1020579|NCT03034174|tigecycline|tigecycline
1020580|NCT03034174|pharmacokinetics|pharmacokinetics
1020581|NCT03034148|Coronary artery disease|coronary artery disease
1020582|NCT03034148|Atherothrombosis|atherothrombosis
1020584|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
1020585|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1020586|NCT03034109|Stroke|stroke
1020587|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
1020588|NCT03034109|Prefrontal Cortex|prefrontal cortex
1020589|NCT03034109|Electroencephalography|electroencephalography
1020590|NCT03034109|Cognition|cognition
1020591|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
1020592|NCT03034109|Memory|memory
1020593|NCT03034109|Working Memory|working memory
1020594|NCT03034109|Attention|attention
1020595|NCT03034109|Concentration|concentration
1020596|NCT03034109|Short-Term Memory|short-term memory
1020597|NCT03034109|Planning|planning
1020598|NCT03034109|Executive Function|executive function
1020599|NCT03034109|Cerebrovascular disease|cerebrovascular disease
1020600|NCT03034083|healthy marriage|healthy marriage
1020601|NCT03034083|healthy relationships|healthy relationships
1020602|NCT03034083|parenting|parenting
1020603|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
1020604|NCT03034070|MRI|mri
1020605|NCT03034070|MRI sequences|mri sequences
1020606|NCT03034070|prostate cancer|prostate cancer
1020607|NCT03034070|cancer|cancer
1020608|NCT03034070|staging|staging
1020609|NCT03034070|bone metastasis|bone metastasis
1020610|NCT03034070|node metastasis|node metastasis
1020611|NCT03034031|Traumatic Brain Injury|traumatic brain injury
1020612|NCT03034031|Children|children
1020613|NCT03034031|Pediatric|pediatric
1020614|NCT03034031|MRI|mri
1020615|NCT03034031|fMRI|fmri
1020616|NCT03034031|Cognition|cognition
1020617|NCT03034031|DTI|dti
1020618|NCT03034031|Longitudinal|longitudinal
1020619|NCT03034031|Connectivity|connectivity
1020620|NCT03034031|DAI|dai
1020621|NCT03034031|Neuropsychology|neuropsychology
1020622|NCT03034031|Rehabilitation|rehabilitation
1020623|NCT03034018|insomnia|insomnia
1020624|NCT03034018|hot flashes|hot flashes
1020625|NCT03034018|menopause|menopause
1020626|NCT03034018|suvorexant|suvorexant
1020627|NCT03034018|belsomra|belsomra
1020628|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
1020629|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
1020630|NCT03034005|Airway smooth muscle|airway smooth muscle
1020631|NCT03034005|sodium-potassium pump|sodium-potassium pump
1020632|NCT03033966|Cerebral Oximetry|cerebral oximetry
1020633|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
1020634|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
1020635|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
1020636|NCT03033927|FOLFIRINOX|folfirinox
1020637|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
1020638|NCT03033927|17-042|17-042
1020639|NCT03033914|Nivolumab|nivolumab
1020640|NCT03033914|adriamycin|adriamycin
1020641|NCT03033914|bleomycin|bleomycin
1020642|NCT03033914|vinblastine|vinblastine
1020643|NCT03033914|dacarbazine|dacarbazine
1020644|NCT03033914|16-1536|16-1536
1020645|NCT03033901|Veterans|veterans
1020646|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
1020647|NCT03033901|Diagnosis|diagnosis
1020648|NCT03033836|transgender women|transgender women
1020649|NCT03033823|Alcoholism|alcoholism
1020650|NCT03033823|Delirium|delirium
1020651|NCT03033823|Magnesium Deficiency|magnesium deficiency
1020652|NCT03033797|assitive technology|assitive technology
1020653|NCT03033797|virtual reality games|virtual reality games
1020654|NCT03033797|intellectual disability|intellectual disability
1020655|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
1020656|NCT03033784|Neuroscience|neuroscience
1020657|NCT03033758|comorbidities|comorbidities
1020658|NCT03033732|opioid agonist treatment|opioid agonist treatment
1020659|NCT03033732|pragmatic|pragmatic
1020660|NCT03033732|prescription opioid use|prescription opioid use
1020661|NCT03033732|patient engagement|patient engagement
1020662|NCT03033719|Colorectal Surgery|colorectal surgery
1020663|NCT03033719|Geriatrics|geriatrics
1020664|NCT03033719|Digestive Oncology|digestive oncology
1020665|NCT03033719|Colon cancer|colon cancer
1020666|NCT03033719|Elderly patients|elderly patients
1020667|NCT03033719|Laparoscopy|laparoscopy
1020668|NCT03033719|Laparotomy|laparotomy
1020669|NCT03033719|Morbidity|morbidity
1020670|NCT03033667|perioperative fasting|perioperative fasting
1020671|NCT03033667|free fatty acids|free fatty acids
1020672|NCT03033667|coronary bypass grfting|coronary bypass grfting
1020673|NCT03033589|Pain control|pain control
1020674|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
1020675|NCT03033589|Regional Anesthesia|regional anesthesia
1020676|NCT03033550|HPV vaccination|hpv vaccination
1020677|NCT03033550|Cervical cancer screening|cervical cancer screening
1020678|NCT03033550|Primary care setting|primary care setting
1020679|NCT03033550|Primary prevention of cervical cancer|primary prevention of cervical cancer
1020680|NCT03033550|Secondary prevention of cervical cancer|secondary prevention of cervical cancer
1020681|NCT03033550|Mobile health information|mobile health information
1020884|NCT03032354|remission|remission
1020682|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
1020683|NCT03033511|Cancer|cancer
1020684|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
1020685|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
1020686|NCT03033511|first-line chemotherapy|first-line chemotherapy
1020687|NCT03033511|(SCLC)|(sclc)
1020688|NCT03033485|Picolinamide|picolinamide
1020689|NCT03033485|PET/CT|pet/ct
1020690|NCT03033485|Diagnosis|diagnosis
1020691|NCT03033485|Melanoma|melanoma
1020692|NCT03033459|breast feeding|breast feeding
1020693|NCT03033459|motivational interviewing|motivational interviewing
1020694|NCT03033420|Unipolar disorder|unipolar disorder
1020695|NCT03033420|Bipolar disorder|bipolar disorder
1020696|NCT03033420|Randomized controlled trial|randomized controlled trial
1020697|NCT03033420|Smartphone|smartphone
1020698|NCT03033420|Re-admission|re-admission
1020700|NCT03033381|Children|children
1020701|NCT03033381|Inguinal hernia|inguinal hernia
1020702|NCT03033381|Testis|testis
1020703|NCT03033381|Doppler ultrasonography|doppler ultrasonography
1020704|NCT03033368|immunological outcome|immunological outcome
1020705|NCT03033368|virologic outcomes|virologic outcomes
1020706|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
1020707|NCT03033368|EFV switch to RPV|efv switch to rpv
1020708|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
1020709|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
1020710|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
1020711|NCT03033342|Phase 1|phase 1
1020712|NCT03033316|Multiple Myeloma|multiple myeloma
1020713|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
1020714|NCT03033316|Targeted Drug Delivery|targeted drug delivery
1020715|NCT03033303|Hu3F8|hu3f8
1020716|NCT03033303|GM-CSF|gm-csf
1020717|NCT03033303|Isotretinoin|isotretinoin
1020718|NCT03033303|16-1643|16-1643
1020719|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
1020720|NCT03033290|immune-modulation|immune-modulation
1020721|NCT03033290|gut microbiota|gut microbiota
1020722|NCT03033251|COPD exacerbation|copd exacerbation
1020723|NCT03033251|Work of breathing|work of breathing
1020724|NCT03033251|Non invasive ventilation|non invasive ventilation
1020725|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
1020726|NCT03033225|Pancrease|pancrease
1020727|NCT03033225|Cancer|cancer
1020728|NCT03033225|Photodynamic Therapy|photodynamic therapy
1020729|NCT03033225|Pancreatic|pancreatic
1020730|NCT03033225|Tumor|tumor
1020731|NCT03033225|unresectable|unresectable
1020732|NCT03033199|Gut microbiota|gut microbiota
1020733|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
1020734|NCT03033186|Everolimus|everolimus
1020735|NCT03033186|Long term site effects|long term site effects
1020736|NCT03033186|Dried Blood Spot|dried blood spot
1020737|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
1020738|NCT03033160|Estrogen|estrogen
1020739|NCT03033160|Hematuria|hematuria
1020740|NCT03033121|growth hormone|growth hormone
1020741|NCT03033121|children|children
1020742|NCT03033121|metabolism|metabolism
1020743|NCT03033095|TNF inhibitor|tnf inhibitor
1020744|NCT03033095|Etanercept|etanercept
1020745|NCT03033095|Spondyloarthritis|spondyloarthritis
1020746|NCT03033095|Biomarkers analysis|biomarkers analysis
1020747|NCT03033095|Personnalized medicine|personnalized medicine
1020748|NCT03033056|fear-conditioning|fear-conditioning
1020749|NCT03033056|behavioral avoidance|behavioral avoidance
1020750|NCT03033056|anxiety disorders|anxiety disorders
1020752|NCT03033043|aortic|aortic
1020753|NCT03033043|dissection|dissection
1020754|NCT03033043|type B|type b
1020755|NCT03033043|thoracic|thoracic
1020756|NCT03033030|Ultrasound|ultrasound
1020757|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
1020758|NCT03033030|Cancer Detection rate|cancer detection rate
1020759|NCT03033030|Sensitivity|sensitivity
1020760|NCT03033030|Specificity|specificity
1020761|NCT03033030|Breast density|breast density
1020762|NCT03033017|HIV|hiv
1020763|NCT03032991|Gestational diabetes|gestational diabetes
1020764|NCT03032991|Neurodevelopment|neurodevelopment
1020765|NCT03032991|Placenta|placenta
1020766|NCT03032991|Gut microbiota|gut microbiota
1020767|NCT03032991|Protectins|protectins
1020768|NCT03032991|MFSD2a|mfsd2a
1020769|NCT03032991|AdipoRon|adiporon
1020770|NCT03032965|atrial fibrillation|atrial fibrillation
1020771|NCT03032965|ablation|ablation
1020772|NCT03032965|adenosine|adenosine
1020773|NCT03032952|RCT|rct
1020774|NCT03032952|Computerised interventions|computerised interventions
1020775|NCT03032952|Mobile applications|mobile applications
1020776|NCT03032952|Stress, Psychological|stress, psychological
1020777|NCT03032952|Depressive symptoms|depressive symptoms
1020778|NCT03032952|Anxious symptoms|anxious symptoms
1020779|NCT03032952|Students|students
1020780|NCT03032952|Mental health|mental health
1020781|NCT03032926|Anxiety|anxiety
1020782|NCT03032913|Pancreas|pancreas
1020783|NCT03032913|Pancreatic|pancreatic
1020784|NCT03032913|Cancer|cancer
1020987|NCT03031496|FTIH|ftih
1020785|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
1020786|NCT03032913|Adenocarcinoma|adenocarcinoma
1020787|NCT03032913|Ductal|ductal
1020788|NCT03032913|Exosome|exosome
1020789|NCT03032900|Major lung resection|major lung resection
1020790|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
1020791|NCT03032900|2D Strain|2d strain
1020792|NCT03032887|hygiene|hygiene
1020793|NCT03032887|prenatal care|prenatal care
1020794|NCT03032887|postnatal care|postnatal care
1020795|NCT03032874|Colorectal cancer|colorectal cancer
1020796|NCT03032874|Polyps|polyps
1020797|NCT03032874|Colonoscopy|colonoscopy
1020798|NCT03032874|Rectal bleeding|rectal bleeding
1020799|NCT03032874|Nigeria|nigeria
1020800|NCT03032861|Orange juice|orange juice
1020801|NCT03032861|Microbiota|microbiota
1020802|NCT03032861|Prebiotic|prebiotic
1020803|NCT03032861|Flavanones|flavanones
1020804|NCT03032861|Bioavailability|bioavailability
1020805|NCT03032835|Calciphylaxis|calciphylaxis
1020806|NCT03032835|Warfarin|warfarin
1020807|NCT03032835|Dialysis|dialysis
1020808|NCT03032822|Opioid consumption|opioid consumption
1020809|NCT03032822|postdischarge|postdischarge
1020810|NCT03032822|cystectomy|cystectomy
1020811|NCT03032744|Pediatric|pediatric
1020812|NCT03032744|School Based Health Center|school based health center
1020813|NCT03032731|Physical activity|physical activity
1020814|NCT03032731|Diet|diet
1020815|NCT03032731|Health Behavior|health behavior
1020816|NCT03032705|Restorations|restorations
1020817|NCT03032705|Composite|composite
1020818|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
1020819|NCT03032666|Thalassemia|thalassemia
1020820|NCT03032666|HCV|hcv
1020821|NCT03032666|Sofosbuvir|sofosbuvir
1020822|NCT03032666|Ledipasvir|ledipasvir
1020823|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
1020824|NCT03032640|Glucose|glucose
1020825|NCT03032640|Sweet taste receptors|sweet taste receptors
1020826|NCT03032640|Artificial sweeteners|artificial sweeteners
1020827|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
1020828|NCT03032601|Acute Fulminating|acute fulminating
1020829|NCT03032601|Sclerosis|sclerosis
1020830|NCT03032601|FDG|fdg
1020831|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
1020832|NCT03032601|18F-FDG|18f-fdg
1020833|NCT03032601|18FDG|18fdg
1020834|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
1020835|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
1020836|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
1020837|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
1020838|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
1020839|NCT03032601|PET Scan|pet scan
1020840|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
1020841|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1020842|NCT03032601|fMRI|fmri
1020843|NCT03032601|PET-MRI|pet-mri
1020844|NCT03032601|Acetylcysteine|acetylcysteine
1048399|NCT02860273|COPD|copd
1020845|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
1020846|NCT03032601|NAC|nac
1020847|NCT03032601|Oral supplements|oral supplements
1020848|NCT03032575|HIV|hiv
1020849|NCT03032562|respiratory muscle strength|respiratory muscle strength
1020850|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
1020851|NCT03032562|neuromuscular disease|neuromuscular disease
1020852|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
1020853|NCT03032497|Brain Computer Interface|brain computer interface
1020854|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
1020855|NCT03032497|Chronic Pain|chronic pain
1020856|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1020857|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
1020858|NCT03032471|Cognitive Impairment|cognitive impairment
1020859|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
1020860|NCT03032471|MoCA|moca
1020861|NCT03032471|Cognitive Deterioration|cognitive deterioration
1020862|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
1020863|NCT03032458|Ketorolac|ketorolac
1020864|NCT03032458|Xylocaine Gel|xylocaine gel
1020865|NCT03032458|Pethidine|pethidine
1020866|NCT03032445|Body Water/physiology|body water/physiology
1020867|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
1020868|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
1020869|NCT03032445|Running/physiology|running/physiology
1020870|NCT03032445|Sodium/blood|sodium/blood
1020871|NCT03032445|Ethanol|ethanol
1020872|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
1020873|NCT03032380|S-649266|s-649266
1020874|NCT03032380|linezolid|linezolid
1020875|NCT03032380|meropenem|meropenem
1020876|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
1020877|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
1020878|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
1020879|NCT03032380|Gram-negative pathogens|gram-negative pathogens
1020880|NCT03032380|pneumonia|pneumonia
1020881|NCT03032380|cefiderocol|cefiderocol
1020882|NCT03032354|probiotics|probiotics
1020883|NCT03032354|children|children
1020885|NCT03032341|mobility assessment tool|mobility assessment tool
1020886|NCT03032302|TBI|tbi
1020887|NCT03032289|active transport|active transport
1020888|NCT03032289|cycling|cycling
1020889|NCT03032289|walking|walking
1020890|NCT03032276|Safe motherhood|safe motherhood
1020891|NCT03032276|Newborn survival|newborn survival
1020892|NCT03032276|Community|community
1020893|NCT03032276|Cluster Randomized Trial|cluster randomized trial
1020894|NCT03032237|Protein intake|protein intake
1020895|NCT03032237|Older adults|older adults
1020896|NCT03032237|Protein-rich|protein-rich
1020897|NCT03032237|Acceptance|acceptance
1020898|NCT03032237|Liking|liking
1020899|NCT03032237|Readymade meals|readymade meals
1020900|NCT03032224|Body composition|body composition
1020901|NCT03032224|sarcopenia|sarcopenia
1020902|NCT03032224|Dysphagia|dysphagia
1020903|NCT03032224|Surgery|surgery
1020904|NCT03032224|Quality of Life|quality of life
1020905|NCT03032224|Morbidity|morbidity
1020906|NCT03032185|menopause|menopause
1020907|NCT03032185|post-menopause|post-menopause
1020908|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1020909|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
1020910|NCT03032185|women's health|women's health
1020911|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
1020912|NCT03032133|Total Knee Replacement|total knee replacement
1020913|NCT03032133|Outcome|outcome
1020914|NCT03032133|Results|results
1020915|NCT03032133|Pain|pain
1020916|NCT03032107|Breast Cancer|breast cancer
1020917|NCT03032094|Gingival Recession|gingival recession
1020918|NCT03032055|sickle cell desease|sickle cell desease
1020919|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
1020920|NCT03032055|acute chest syndrome|acute chest syndrome
1020921|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
1020922|NCT03032042|intestinal microbiome|intestinal microbiome
1020923|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
1020924|NCT03032042|mass drug administration|mass drug administration
1020926|NCT03032016|Defibrotide|defibrotide
1020927|NCT03032016|Defitelio|defitelio
1020928|NCT03032016|Registry|registry
1020929|NCT03032016|SOS|sos
1020930|NCT03031990|Yoga|yoga
1020931|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
1020932|NCT03031990|In-vitro fertilization|in-vitro fertilization
1020933|NCT03031951|Former athletes|former athletes
1020934|NCT03031951|Body composition|body composition
1020935|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
1020936|NCT03031951|Physical activity|physical activity
1020937|NCT03031951|Energy expenditure|energy expenditure
1020938|NCT03031951|Sedentary behavior|sedentary behavior
1020939|NCT03031951|Fat mass|fat mass
1020940|NCT03031951|Abdominal fat mass|abdominal fat mass
1020941|NCT03031951|Nutrition|nutrition
1667461|NCT00115414|TAC|tac
1020942|NCT03031951|Behavior modification|behavior modification
1020943|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
1020944|NCT03031925|Annexin A2|annexin a2
1020945|NCT03031925|biomarker|biomarker
1020946|NCT03031821|Prostate Cancer|prostate cancer
1020947|NCT03031821|ADT|adt
1020948|NCT03031821|iADT|iadt
1020949|NCT03031821|Metabolic Syndrome|metabolic syndrome
1020950|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
1020951|NCT03031821|Phase III|phase iii
1020952|NCT03031821|Phase 3|phase 3
1020953|NCT03031821|Randomized|randomized
1020954|NCT03031821|Intermittent Androgen Deprivation Therapy|intermittent androgen deprivation therapy
1020955|NCT03031795|intrauterine device|intrauterine device
1020956|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
1020957|NCT03031756|Air polishing|air polishing
1020958|NCT03031743|rotavirus vaccine|rotavirus vaccine
1020959|NCT03031743|human microbiome|human microbiome
1020960|NCT03031743|fecal microbiome|fecal microbiome
1020961|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
1020962|NCT03031743|Rotarix|rotarix
1020963|NCT03031743|immune response, mucosal|immune response, mucosal
1020964|NCT03031665|GABA|gaba
1020965|NCT03031665|Depression|depression
1020966|NCT03031665|Stress|stress
1020967|NCT03031665|Androgens|androgens
1020968|NCT03031652|pain|pain
1020969|NCT03031652|axial length|axial length
1020970|NCT03031652|anterior chamber depth|anterior chamber depth
1020971|NCT03031652|intraocular pressure|intraocular pressure
1020972|NCT03031639|endoscopic|endoscopic
1020973|NCT03031639|thyroidectomy|thyroidectomy
1020974|NCT03031613|intraocular pressure|intraocular pressure
1020975|NCT03031613|intracerebral pressure|intracerebral pressure
1020976|NCT03031587|Thermometric MRI|thermometric mri
1020977|NCT03031587|Myocardium|myocardium
1020978|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
1020979|NCT03031574|Phase 1|phase 1
1020980|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
1020981|NCT03031496|Cross-over|cross-over
1020982|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
1020983|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
1020984|NCT03031496|Phase I|phase i
1020985|NCT03031496|GSK3542503|gsk3542503
1020986|NCT03031496|Bioequivalence|bioequivalence
1020988|NCT03031470|Liver Transplant|liver transplant
1020989|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
1020990|NCT03031470|Early allograft dysfunction|early allograft dysfunction
1020991|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
1020992|NCT03031444|preoperative|preoperative
1020993|NCT03031444|chemotherapy|chemotherapy
1020994|NCT03031444|targeted therapy|targeted therapy
1020995|NCT03031431|Hypothermia|hypothermia
1020996|NCT03031431|Infant Warmer|infant warmer
1020997|NCT03031340|Spinal fusion|spinal fusion
1020998|NCT03031340|pregabalin|pregabalin
1020999|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
1021000|NCT03031340|two or more vertebrae|two or more vertebrae
1021001|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
1021002|NCT03031327|Refractive Surgery|refractive surgery
1021003|NCT03031314|Joint Replacement|joint replacement
1021004|NCT03031314|Knee Replacement|knee replacement
1021005|NCT03031314|Wound Healing|wound healing
1021006|NCT03031314|Hip Replacement|hip replacement
1021007|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
1021008|NCT03031288|swallow|swallow
1021009|NCT03031288|feeding bottle|feeding bottle
1021010|NCT03031288|cardiorespiratory|cardiorespiratory
1021011|NCT03031288|apnoea|apnoea
1021012|NCT03031288|preterm|preterm
1021013|NCT03031288|impedance-pH-metry|impedance-ph-metry
1021014|NCT03031275|extracorporeal circulation|extracorporeal circulation
1021015|NCT03031275|critical care outcomes|critical care outcomes
1021016|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
1021017|NCT03031236|Psychosocial stimulation|psychosocial stimulation
1021018|NCT03031236|Cognition|cognition
1021019|NCT03031236|Parenting|parenting
1021020|NCT03031236|Malnutrition|malnutrition
1021021|NCT03031236|Bangladesh|bangladesh
1021022|NCT03031236|Childhood Maltreatment|childhood maltreatment
1021023|NCT03031223|Spinal cord injuries|spinal cord injuries
1021024|NCT03031223|low-level laser therapy|low-level laser therapy
1021025|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
1021026|NCT03031210|Amoxicillin treatment|amoxicillin treatment
1021027|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
1021028|NCT03031197|adherence|adherence
1021029|NCT03031197|adolescent|adolescent
1021030|NCT03031197|HIV/AIDS|hiv/aids
1021031|NCT03031197|Vietnam|vietnam
1021032|NCT03031184|Agitation|agitation
1021033|NCT03031184|Agitated behaviours|agitated behaviours
1021034|NCT03031184|Alzheimer's Disease|alzheimer's disease
1021035|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
1021036|NCT03031132|Protein-rich breakfast|protein-rich breakfast
1021037|NCT03031132|Breakfast Skipping|breakfast skipping
1021038|NCT03031132|Young Adults|young adults
1048630|NCT02858804|EDOCH|edoch
1021039|NCT03031132|Breakfast|breakfast
1021040|NCT03031132|Food form|food form
1021041|NCT03031132|fMRI|fmri
1021042|NCT03031132|Ghrelin|ghrelin
1021043|NCT03031132|PYY|pyy
1021044|NCT03031132|Sleep|sleep
1021045|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1021046|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
1021047|NCT03031093|aerosol therapy|aerosol therapy
1021048|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
1021049|NCT03031093|upper airways anatomy|upper airways anatomy
1021050|NCT03031093|High Flow Nasal Cannula|high flow nasal cannula
1021051|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
1021052|NCT03031067|Donors and donation|donors and donation
1021053|NCT03031067|Extended criteria donor|extended criteria donor
1021054|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
1021055|NCT03031067|Liver transplantation|liver transplantation
1021056|NCT03031067|Kidney transplantation|kidney transplantation
1021057|NCT03031067|Preservation injury|preservation injury
1021058|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
1021059|NCT03031054|Hydrodissection|hydrodissection
1021060|NCT03031054|hyaluronic acid|hyaluronic acid
1021061|NCT03031041|Hydrodissection|hydrodissection
1021062|NCT03031041|short-axis|short-axis
1021063|NCT03031041|long-axis|long-axis
1021064|NCT03031028|refractory epilepsy,|refractory epilepsy,
1021065|NCT03031028|ketogenic diet|ketogenic diet
1021066|NCT03031028|classic ketogenic diet|classic ketogenic diet
1021067|NCT03031028|seizure rate|seizure rate
1021068|NCT03031028|efficacy|efficacy
1021069|NCT03031028|epilepsy|epilepsy
1021070|NCT03031015|Reduction, Fracture|reduction, fracture
1021071|NCT03031002|exposure|exposure
1021072|NCT03031002|spider phobia|spider phobia
1021073|NCT03031002|generalization|generalization
1021074|NCT03031002|extinction|extinction
1021075|NCT03030976|CD19|cd19
1021076|NCT03030976|CAR-T|car-t
1021077|NCT03030976|SLE|sle
1021078|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
1021079|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
1021080|NCT03030963|Blood loss|blood loss
1021081|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
1021082|NCT03030963|Prone position|prone position
1021083|NCT03030924|suicide|suicide
1021084|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
1021085|NCT03030885|16-1110|16-1110
1021086|NCT03030846|pregnancy|pregnancy
1021087|NCT03030846|pelvic floor muscles|pelvic floor muscles
1021088|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
1021089|NCT03030846|Stabilization exercises|stabilization exercises
1021090|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
1021091|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
1021092|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
1021093|NCT03030820|cirrhosis|cirrhosis
1021097|NCT03030820|inflammation|inflammation
1021098|NCT03030794|Gulf War Illness|gulf war illness
1021099|NCT03030794|Headache|headache
1021100|NCT03030794|Muscle Pain|muscle pain
1021101|NCT03030794|Joint Pain|joint pain
1021102|NCT03030794|TMS|tms
1021103|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1021104|NCT03030768|Fertility|fertility
1021105|NCT03030768|mHealth|mhealth
1021106|NCT03030768|Pregnancy|pregnancy
1021107|NCT03030716|antinutrients|antinutrients
1021108|NCT03030716|tannins|tannins
1021109|NCT03030716|proanthocyanidins|proanthocyanidins
1021110|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
1021111|NCT03030703|Phytic acid|phytic acid
1021112|NCT03030703|Cystatin|cystatin
1021113|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
1021114|NCT03030703|antinutrient|antinutrient
1021115|NCT03030690|Proximal Dental Caries|proximal dental caries
1021116|NCT03030690|Glass Carbomer|glass carbomer
1021117|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
1021118|NCT03030690|Primary Teeth|primary teeth
1021119|NCT03030677|pecs block|pecs block
1021120|NCT03030677|breast surgery|breast surgery
1021121|NCT03030677|ultrasound guidence|ultrasound guidence
1021122|NCT03030664|constipation|constipation
1021123|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
1021124|NCT03030664|probiotics|probiotics
1021125|NCT03030651|Breastfeeding|breastfeeding
1021126|NCT03030651|Education and support|education and support
1021127|NCT03030651|Ethiopia|ethiopia
1021128|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
1021129|NCT03030625|Prostate Cancer|prostate cancer
1021130|NCT03030625|VMAT|vmat
1021131|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
1021132|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
1021133|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
1021134|NCT03030573|Bile duct injury|bile duct injury
1021135|NCT03030573|Bile duct defect|bile duct defect
1021136|NCT03030573|Round ligament|round ligament
1021137|NCT03030573|Reconstruction|reconstruction
1021138|NCT03030508|biomarks|biomarks
1021139|NCT03030508|colorectal cancer|colorectal cancer
1021140|NCT03030508|capecitabine|capecitabine
1021141|NCT03030508|gene polymorphism|gene polymorphism
1021142|NCT03030495|Ischemic Heart Disease|ischemic heart disease
1021143|NCT03030495|Stable angina|stable angina
1021144|NCT03030495|Fractional flow reserve|fractional flow reserve
1021145|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
1021146|NCT03030495|Coronary Flow Reserve|coronary flow reserve
1021147|NCT03030495|Intravascular Imaging|intravascular imaging
1021148|NCT03030482|Anxiety|anxiety
1021149|NCT03030482|intensive care|intensive care
1021150|NCT03030482|mechanical ventilation|mechanical ventilation
1021151|NCT03030482|touch massage|touch massage
1021152|NCT03030456|whole body vibration|whole body vibration
1021153|NCT03030456|Oxidative Stress|oxidative stress
1021154|NCT03030456|Aged|aged
1021155|NCT03030456|Biochemical profile|biochemical profile
1021156|NCT03030456|muscle strength|muscle strength
1021157|NCT03030456|flexibility|flexibility
1021158|NCT03030443|Pain management|pain management
1021159|NCT03030443|Nitrous|nitrous
1021160|NCT03030417|Topoisomerase 1 Inhibitor|topoisomerase 1 inhibitor
1021161|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
1021162|NCT03030417|Pharmacodynamics|pharmacodynamics
1021163|NCT03030417|DNA Damage|dna damage
1021164|NCT03030417|Pharmacokinetics|pharmacokinetics
1021165|NCT03030404|Genetics|genetics
1021166|NCT03030404|Familial Background|familial background
1021167|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
1021168|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
1021169|NCT03030404|Genetic Testing|genetic testing
1021173|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
1021174|NCT03030352|Child Mental Health|child mental health
1021175|NCT03030352|Parenting|parenting
1021176|NCT03030352|Autonomy Support|autonomy support
1021177|NCT03030352|How-to Parenting Program|how-to parenting program
1021178|NCT03030352|Randomized Controlled Trial|randomized controlled trial
1021179|NCT03030352|Primary Prevention|primary prevention
1021180|NCT03030352|Parental Mental Health|parental mental health
1021181|NCT03030352|Child Well-Being|child well-being
1021182|NCT03030339|Vitamin A status|vitamin a status
1021183|NCT03030339|infant|infant
1021184|NCT03030339|dietary assessment|dietary assessment
1021185|NCT03030339|retinol isotope dilution|retinol isotope dilution
1021186|NCT03030339|breast milk intake|breast milk intake
1021187|NCT03030300|type 2 diabetes|type 2 diabetes
1021188|NCT03030300|remission|remission
1021189|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
1021190|NCT03030235|diabetes|diabetes
1021191|NCT03030235|heart failure|heart failure
1021195|NCT03030222|heart failure|heart failure
1021196|NCT03030222|empagliflozin|empagliflozin
1021197|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
1021198|NCT03030209|pancreatectomy|pancreatectomy
1021199|NCT03030209|diabetes mellitus|diabetes mellitus
1021200|NCT03030183|PNH|pnh
1021201|NCT03030157|urothelial cancer|urothelial cancer
1021202|NCT03030157|bladder cancer|bladder cancer
1021203|NCT03030157|nephroureterectomy|nephroureterectomy
1021204|NCT03030131|IFCT|ifct
1021205|NCT03030131|neodjuvant|neodjuvant
1021206|NCT03030131|immune therapy|immune therapy
1021207|NCT03030131|Non small cell lung cancer|non small cell lung cancer
1021208|NCT03030118|hydroxychloroquine|hydroxychloroquine
1021209|NCT03030105|Cognition|cognition
1021210|NCT03030105|Dementia|dementia
1021211|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
1021212|NCT03030105|PDE4D|pde4d
1021213|NCT03030105|Scopolamine|scopolamine
1021214|NCT03030105|Donepezil|donepezil
1021215|NCT03030066|DS-1001b|ds-1001b
1021216|NCT03030066|IDH1 mutation|idh1 mutation
1021217|NCT03030066|Developmental Phase I|developmental phase i
1021218|NCT03030066|Glioma|glioma
1021219|NCT03030053|Flavanols|flavanols
1021220|NCT03030053|Flavonoids|flavonoids
1021221|NCT03030053|Polyphenols|polyphenols
1021222|NCT03030053|Cognition|cognition
1021223|NCT03030053|Aging|aging
1021224|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1021225|NCT03030040|self-help|self-help
1021226|NCT03030040|healthcare staff|healthcare staff
1021230|NCT03030001|mesothelin|mesothelin
1021231|NCT03030001|PD-1|pd-1
1021232|NCT03030001|CAR T|car t
1021233|NCT03030001|solid tumor|solid tumor
1021234|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
1021235|NCT03029975|beef|beef
1021236|NCT03029975|protein|protein
1021237|NCT03029975|resistance training|resistance training
1021238|NCT03029975|strength|strength
1021239|NCT03029975|performance|performance
1021240|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
1021241|NCT03029962|LGB Girls|lgb girls
1021242|NCT03029962|Text-Messaging|text-messaging
1021243|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
1021244|NCT03029949|chronic dizziness|chronic dizziness
1021245|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
1021246|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
1021247|NCT03029949|behavior therapy|behavior therapy
1021248|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
1021249|NCT03029936|obesity|obesity
1021250|NCT03029936|asthma|asthma
1021251|NCT03029936|diaphragm excursion|diaphragm excursion
1021252|NCT03029936|pulmonary function test|pulmonary function test
1021253|NCT03029923|smoking|smoking
1021254|NCT03029923|depression|depression
1021255|NCT03029923|Behavioral Activation|behavioral activation
1021256|NCT03029910|Eccentric exercise|eccentric exercise
1021257|NCT03029910|Whole body vibration|whole body vibration
1021258|NCT03029910|Cryotherapy|cryotherapy
1021259|NCT03029884|thalamic pain|thalamic pain
1021260|NCT03029884|chronic pain|chronic pain
1021261|NCT03029884|spinal cord injury|spinal cord injury
1021262|NCT03029884|phantom limb|phantom limb
1021263|NCT03029871|lung cancer|lung cancer
1021264|NCT03029871|adenovirus|adenovirus
1021265|NCT03029871|gene therapy|gene therapy
1021266|NCT03029871|SBRT|sbrt
1021267|NCT03029793|Esophageal Cancer|esophageal cancer
1021268|NCT03029793|Prediction|prediction
1021269|NCT03029793|Biomarker|biomarker
1021270|NCT03029793|MRI-DWI|mri-dwi
1021271|NCT03029793|PET-CT|pet-ct
1021272|NCT03029767|Hypertension|hypertension
1021273|NCT03029767|Anthropometry|anthropometry
1021274|NCT03029767|Aerobic exercise|aerobic exercise
1021275|NCT03029767|Resistance exercise|resistance exercise
1021276|NCT03029728|Hereditary and acquired C1-inhibitor deficiency|hereditary and acquired c1-inhibitor deficiency
1021277|NCT03029728|C1 esterase inhibitor, hereditary angioedema,|c1 esterase inhibitor, hereditary angioedema,
1021278|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
1021279|NCT03029715|TIVA|tiva
1021280|NCT03029702|Gestational diabetes|gestational diabetes
1021281|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
1021282|NCT03029702|Insulin resistance|insulin resistance
1021283|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
1021284|NCT03029689|HIV infection|hiv infection
1021285|NCT03029689|Gut microbiome|gut microbiome
1021286|NCT03029689|Raltegravir|raltegravir
1021287|NCT03029689|Raltegravir intensification|raltegravir intensification
1021288|NCT03029689|Bacterial richness|bacterial richness
1021289|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
1021290|NCT03029663|bladder cancer|bladder cancer
1021291|NCT03029663|postoperative complications|postoperative complications
1021292|NCT03029650|Peer Review|peer review
1021294|NCT03029637|Resin bonded bridges|resin bonded bridges
1021295|NCT03029637|Randomized controlled trial|randomized controlled trial
1021296|NCT03029585|ovarian carcinoma|ovarian carcinoma
1021297|NCT03029585|ovarian cancer|ovarian cancer
1021298|NCT03029585|ovarian neoplasms|ovarian neoplasms
1021299|NCT03029585|ovarian diseases|ovarian diseases
1021300|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
1021301|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
1021302|NCT03029520|iRoot SP Sealer|iroot sp sealer
1021303|NCT03029520|Randomized Clinical Trial|randomized clinical trial
1021304|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
1021305|NCT03029507|Obesity|obesity
1021306|NCT03029507|Military|military
1021307|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
1021308|NCT03029507|Overweight|overweight
1021309|NCT03029507|Weight-management|weight-management
1021310|NCT03029507|Navy Personnel|navy personnel
1021311|NCT03029507|Fitness|fitness
1021312|NCT03029494|oxidative stress|oxidative stress
1021313|NCT03029494|saliva|saliva
1021314|NCT03029468|Cognitive behavioral therapy|cognitive behavioral therapy
1021315|NCT03029468|Chronic pain|chronic pain
1021316|NCT03029468|Sickle cell disease|sickle cell disease
1021317|NCT03029468|Mobile phone app|mobile phone app
1021318|NCT03029468|Mental health|mental health
1021319|NCT03029468|Behavioral intervention|behavioral intervention
1021320|NCT03029468|Behavioral health|behavioral health
1021321|NCT03029442|Spinal Cord Injury|spinal cord injury
1021322|NCT03029442|Denosumab|denosumab
1021323|NCT03029442|Osteoporosis|osteoporosis
1021324|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
1021325|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
1021327|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
1021328|NCT03029390|Prediabetes|prediabetes
1021329|NCT03029390|hyperglycemia|hyperglycemia
1021330|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
1021331|NCT03029390|Metformin|metformin
1021332|NCT03029390|Berberine|berberine
1021333|NCT03029390|glucose intolerance|glucose intolerance
1021334|NCT03029377|CFS|cfs
1021335|NCT03029377|Stress|stress
1021336|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
1021337|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
1021338|NCT03029377|Healthy Controls|healthy controls
1021339|NCT03029377|Fatigue|fatigue
1667462|NCT00115414|Amgen|amgen
1021340|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
1021341|NCT03029364|Exercise|exercise
1021342|NCT03029364|Intra-individual variability|intra-individual variability
1021343|NCT03029364|Determinants|determinants
1021344|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
1021345|NCT03029364|Body composition|body composition
1021346|NCT03029351|albuminuria|albuminuria
1021347|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
1021348|NCT03029351|Type 2 Diabetes|type 2 diabetes
1021349|NCT03029338|lymphoma|lymphoma
1021350|NCT03029338|non-hodgkin|non-hodgkin
1021351|NCT03029338|B-cell|b-cell
1021352|NCT03029338|CD19 CAR T cells|cd19 car t cells
1021353|NCT03029338|refractory|refractory
1021354|NCT03029338|relapse|relapse
1021355|NCT03029312|whole body vibration|whole body vibration
1021356|NCT03029312|Muscle function|muscle function
1021357|NCT03029312|Physical activity|physical activity
1021358|NCT03029312|bone density|bone density
1021359|NCT03029286|Breast Cancer|breast cancer
1021360|NCT03029286|Breast Density|breast density
1021361|NCT03029247|Anemia|anemia
1021362|NCT03029247|Daprodustat|daprodustat
1021363|NCT03029247|Blood pressure|blood pressure
1021364|NCT03029247|ESA|esa
1021365|NCT03029247|CKD|ckd
1021366|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
1021367|NCT03029195|cleft lip and palate|cleft lip and palate
1021368|NCT03029195|nasoalveolar molding|nasoalveolar molding
1021369|NCT03029195|Egyptian infants|egyptian infants
1021370|NCT03029195|quantitative analysis|quantitative analysis
1021371|NCT03029182|Exercise|exercise
1021372|NCT03029182|Cancer|cancer
1021373|NCT03029182|Obesity|obesity
1021374|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
1021375|NCT03029169|Septic shock|septic shock
1021376|NCT03029169|Propafenone|propafenone
1021377|NCT03029169|Amiodarone|amiodarone
1021378|NCT03029169|Intensive Care|intensive care
1021379|NCT03029156|Asthma|asthma
1021380|NCT03029156|Aeroneb|aeroneb
1021381|NCT03029156|Aerogen|aerogen
1021382|NCT03029156|Bronchodilator|bronchodilator
1021383|NCT03029143|Drug Therapy|drug therapy
1021384|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
1021385|NCT03029130|urinary catheter|urinary catheter
1021386|NCT03029130|catheter extension|catheter extension
1021387|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
1021388|NCT03029104|Keratoconus|keratoconus
1021389|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
1021390|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
1021391|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
1021493|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
1021392|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
1021393|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
1021394|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
1021395|NCT03029078|XDR|xdr
1021396|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
1021397|NCT03029078|eradicate|eradicate
1021398|NCT03029078|colonization|colonization
1021399|NCT03029078|CRE|cre
1021400|NCT03029078|GRE|gre
1021401|NCT03029078|bacteria|bacteria
1021402|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
1021403|NCT03029039|Platelet|platelet
1021404|NCT03029039|severe sepsis|severe sepsis
1021405|NCT03029039|inflammation|inflammation
1021406|NCT03029039|S. aureus|s. aureus
1021407|NCT03029039|biomarkers|biomarkers
1021408|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
1021409|NCT03029026|Aortic stenosis|aortic stenosis
1021410|NCT03029026|DPD scintigraphy|dpd scintigraphy
1021411|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
1021412|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
1021413|NCT03028987|Identical twin adults|identical twin adults
1021414|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
1021415|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1021416|NCT03028974|Young children|young children
1021417|NCT03028974|Adults|adults
1021418|NCT03028922|creos xenogain|creos xenogain
1021419|NCT03028909|Influenza A|influenza a
1021420|NCT03028909|MEDI8852|medi8852
1021421|NCT03028896|LMA Flexible|lma flexible
1021422|NCT03028870|Osteoarthritis|osteoarthritis
1021423|NCT03028870|Pain|pain
1021424|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
1021425|NCT03028844|Neonate|neonate
1021426|NCT03028844|preterm|preterm
1021427|NCT03028844|pain|pain
1021428|NCT03028844|music|music
1021429|NCT03028844|EEG|eeg
1021430|NCT03028844|venepuncture|venepuncture
1021431|NCT03028805|Informatics|informatics
1021432|NCT03028805|COPD|copd
1021433|NCT03028805|quality improvement|quality improvement
1021434|NCT03028792|attention training, youth, latino|attention training, youth, latino
1333127|NCT01444443|Glucose control|glucose control
1333128|NCT01444443|Closed-loop|closed-loop
1333129|NCT01444443|Insulin pump|insulin pump
1021435|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
1021436|NCT03028714|University|university
1021437|NCT03028714|College|college
1021438|NCT03028714|University students|university students
1021439|NCT03028714|Health education|health education
1021440|NCT03028714|Educational techonology|educational techonology
1021441|NCT03028714|Internet|internet
1021442|NCT03028714|Nutrition knowledge|nutrition knowledge
1021443|NCT03028714|Eating behaviour|eating behaviour
1021444|NCT03028714|Diet|diet
1021445|NCT03028714|Physical Activity|physical activity
1021446|NCT03028714|Weight gain prevention|weight gain prevention
1021447|NCT03028701|Formoterol|formoterol
1021448|NCT03028701|Budesonide|budesonide
1021449|NCT03028701|Dry powder inhalation|dry powder inhalation
1021450|NCT03028701|Discair|discair
1021451|NCT03028701|COPD|copd
1021452|NCT03028662|Alcohol Dependence|alcohol dependence
1021453|NCT03028662|Brain Connectivity|brain connectivity
1021454|NCT03028662|Inhibition|inhibition
1021455|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
1021456|NCT03028649|Sport supplements|sport supplements
1021457|NCT03028649|Training support|training support
1021458|NCT03028649|Adaptation|adaptation
1021459|NCT03028636|fecal incontinence|fecal incontinence
1021460|NCT03028636|bowel control|bowel control
1021461|NCT03028636|accidental bowel leakage|accidental bowel leakage
1021462|NCT03028636|medical device|medical device
1021463|NCT03028636|women's health|women's health
1021464|NCT03028636|vaginal insert|vaginal insert
1021465|NCT03028636|pessary|pessary
1021466|NCT03028636|incontinence|incontinence
1021467|NCT03028636|bowel continence|bowel continence
1021468|NCT03028636|pump|pump
1021469|NCT03028597|Hypertension|hypertension
1021470|NCT03028597|Medication Adherence|medication adherence
1021471|NCT03028597|Values Affirmation|values affirmation
1021472|NCT03028597|African Americans|african americans
1021473|NCT03028584|BrCa|brca
1021474|NCT03028584|PrCa|prca
1021475|NCT03028584|CRCa|crca
1021476|NCT03028558|Electronic Cigarettes|electronic cigarettes
1021477|NCT03028558|Healthy Volunteers|healthy volunteers
1021478|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
1021479|NCT03028558|E-Cigarettes|e-cigarettes
1021480|NCT03028545|schizophrenia|schizophrenia
1021481|NCT03028545|anorexia|anorexia
1021482|NCT03028545|bipolar disorders|bipolar disorders
1021483|NCT03028545|personality disorders|personality disorders
1021484|NCT03028532|Healthy Volunteers|healthy volunteers
1021485|NCT03028532|Sports Medicine|sports medicine
1021486|NCT03028532|Anti-doping|anti-doping
1021487|NCT03028532|Athletes|athletes
1021488|NCT03028532|Men's Health|men's health
1021489|NCT03028480|Exacerbation|exacerbation
1021490|NCT03028480|Mepolizumab|mepolizumab
1021491|NCT03028480|NUCALA|nucala
1021492|NCT03028467|GSK3196165|gsk3196165
1021500|NCT03028467|Japanese Subjects|japanese subjects
1021502|NCT03028441|Immunogenicity|immunogenicity
1021503|NCT03028441|Measles|measles
1021504|NCT03028441|Vaccine|vaccine
1021505|NCT03028428|Osteoarthritis|osteoarthritis
1021506|NCT03028428|Stem Cell|stem cell
1021507|NCT03028428|Knee|knee
1021508|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
1021509|NCT03028389|elderly patients|elderly patients
1021510|NCT03028389|non-cardiac surgery|non-cardiac surgery
1021511|NCT03028389|ischemic preconditioning|ischemic preconditioning
1021512|NCT03028389|delirium|delirium
1021513|NCT03028376|biomarker|biomarker
1021514|NCT03028376|point-of-care analysis|point-of-care analysis
1021515|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
1021516|NCT03028337|Solid tumor malignancy|solid tumor malignancy
1021517|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
1021518|NCT03028337|Spine radiosurgery|spine radiosurgery
1021519|NCT03028337|Radiation therapy|radiation therapy
1021520|NCT03028337|Radiotherapy|radiotherapy
1021521|NCT03028337|Questionnaires|questionnaires
1021522|NCT03028337|Surveys|surveys
1021523|NCT03028337|XRT|xrt
1021524|NCT03028311|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1021525|NCT03028311|Metastatic liver tumors|metastatic liver tumors
1021526|NCT03028311|SIR-Spheres treatment|sir-spheres treatment
1021527|NCT03028311|90Y-radioembolization|90y-radioembolization
1021528|NCT03028285|succinate|succinate
1021529|NCT03028285|arginine|arginine
1021530|NCT03028285|vasodilation|vasodilation
1021531|NCT03028285|peripheral vascular disease|peripheral vascular disease
1021532|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
1021540|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
1021541|NCT03028207|COPD|copd
1021542|NCT03028207|Epidemiology|epidemiology
1021543|NCT03028207|Spain|spain
1021544|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1021545|NCT03028207|Prevalence|prevalence
1021546|NCT03028207|Cross-sectional|cross-sectional
1021547|NCT03028194|Pre-eclampsia|pre-eclampsia
1021548|NCT03028194|Eclampsia|eclampsia
1021549|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
1021551|NCT03028181|acute pancreatitis|acute pancreatitis
1021552|NCT03028181|pro/antioxidant status|pro/antioxidant status
1021553|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
1021554|NCT03028181|lipid profile|lipid profile
1021555|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
1021556|NCT03028168|Yôga|yôga
1021557|NCT03028168|Breathing Techniques|breathing techniques
1021558|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
1021559|NCT03028129|Tuberculosis|tuberculosis
1021560|NCT03028129|Primary prevention|primary prevention
1021561|NCT03028129|Prisoners|prisoners
1021562|NCT03028129|Controlled Clinical Trial|controlled clinical trial
1021563|NCT03028129|Isoniazid|isoniazid
1021564|NCT03028116|vaccine|vaccine
1021565|NCT03028116|1 phase|1 phase
1021566|NCT03028116|safety|safety
1021567|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
1021568|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
1021569|NCT03028077|acute respiratory illness|acute respiratory illness
1021570|NCT03028077|clinical trial|clinical trial
1021571|NCT03028038|Platelet-rich plasma|platelet-rich plasma
1021572|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
1021573|NCT03028038|Buccal bone thickness|buccal bone thickness
1021574|NCT03028038|Alveolar bone loss|alveolar bone loss
1021575|NCT03028038|Alveolar bone resorption|alveolar bone resorption
1021576|NCT03028025|radial artery occlusion|radial artery occlusion
1021577|NCT03028025|time to hemostasis|time to hemostasis
1021578|NCT03028025|radial artery|radial artery
1021579|NCT03028025|transradial catheterization|transradial catheterization
1021580|NCT03028025|TR band|tr band
1021581|NCT03028025|Statseal|statseal
1021582|NCT03028025|hemostasis band|hemostasis band
1021583|NCT03028025|potassium ferrate|potassium ferrate
1021584|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
1021585|NCT03028012|Trigger Point Injections|trigger point injections
1021586|NCT03028012|steroid|steroid
1021587|NCT03028012|nsaid|nsaid
1021588|NCT03027999|Rituximab|rituximab
1021589|NCT03027999|tight monitoring|tight monitoring
1021590|NCT03027960|cardio-renal|cardio-renal
1021591|NCT03027947|Phantom Limb Pain|phantom limb pain
1021592|NCT03027947|Lower-Limb Amputation|lower-limb amputation
1021593|NCT03027947|Electrodes|electrodes
1021594|NCT03027947|Stimulation|stimulation
1021595|NCT03027947|Pain|pain
1021596|NCT03027947|Sensation|sensation
1021597|NCT03027882|Reliability|reliability
1021598|NCT03027882|Validity|validity
1021599|NCT03027882|Functional Testing|functional testing
1021600|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
1021601|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1021602|NCT03027856|Bifurcation lesion|bifurcation lesion
1021603|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
1021604|NCT03027843|low ovarian reserve|low ovarian reserve
1021605|NCT03027843|growth hormone|growth hormone
1021606|NCT03027843|embryo quality|embryo quality
1021607|NCT03027843|live birth|live birth
1021608|NCT03027843|clinical pregnancy|clinical pregnancy
1021609|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
1021610|NCT03027830|iFR|ifr
1021611|NCT03027830|Pilot study|pilot study
1021612|NCT03027817|Prone positioning|prone positioning
1021613|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
1021614|NCT03027791|Biosensors|biosensors
1021615|NCT03027791|Virtual Reality|virtual reality
1021616|NCT03027791|Dietary Sodium|dietary sodium
1021617|NCT03027778|arterial stiffness|arterial stiffness
1021618|NCT03027778|hemodialysis|hemodialysis
1021619|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
1021620|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
1021621|NCT03027778|chronic kidney disease|chronic kidney disease
1021622|NCT03027778|hemodynamics|hemodynamics
1021623|NCT03027778|augmentation index|augmentation index
1021624|NCT03027752|carotid endaretectomy|carotid endaretectomy
1021625|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
1021626|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
1021627|NCT03027713|Weaning|weaning
1021628|NCT03027687|Smoking|smoking
1021629|NCT03027687|EMA|ema
1021630|NCT03027687|ERPs|erps
1021631|NCT03027687|tDCS|tdcs
1021632|NCT03027687|Cigarette consumption|cigarette consumption
1021633|NCT03027687|Inhibitory control|inhibitory control
1021634|NCT03027687|Reward processing|reward processing
1021635|NCT03027674|Raynaud Phenomena|raynaud phenomena
1021636|NCT03027674|System; Sclerosis|system; sclerosis
1021637|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1021638|NCT03027674|Ultrasound|ultrasound
1021639|NCT03027674|sildenafil|sildenafil
1021640|NCT03027674|Nifedipine|nifedipine
1021641|NCT03027661|para-cervical block|para-cervical block
1021642|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
1333130|NCT01444443|Glucose sensor|glucose sensor
1021643|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
1021644|NCT03027648|adenomyosis|adenomyosis
1021645|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
1021646|NCT03027635|Paracentesis|paracentesis
1021647|NCT03027635|PleurX|pleurx
1021648|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
1021649|NCT03027622|quality of life|quality of life
1021650|NCT03027622|pericoronitis|pericoronitis
1021651|NCT03027622|third molar|third molar
1021652|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
1021653|NCT03027609|pneumonia|pneumonia
1021654|NCT03027570|Exergame|exergame
1021655|NCT03027570|Cellular apps|cellular apps
1021656|NCT03027570|Smartphone|smartphone
1021657|NCT03027570|Overweight|overweight
1021658|NCT03027570|Obesity|obesity
1021659|NCT03027570|Children|children
1021660|NCT03027570|Physical activity|physical activity
1021661|NCT03027570|Fitness|fitness
1021662|NCT03027570|Motivation|motivation
1021663|NCT03027570|BMI|bmi
1021664|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
1021665|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
1021666|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
1021667|NCT03027557|Cinacalcet|cinacalcet
1021668|NCT03027557|Denosumab|denosumab
1021669|NCT03027557|Drug Therapy|drug therapy
1021670|NCT03027557|Bone Mineral Density|bone mineral density
1021671|NCT03027557|Calcium|calcium
1021672|NCT03027544|multiple brain metastases|multiple brain metastases
1021673|NCT03027544|large brain metastases|large brain metastases
1021674|NCT03027544|meningeal metastases|meningeal metastases
1021675|NCT03027544|tomotherapy|tomotherapy
1021676|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
1021677|NCT03027505|MUAC|muac
1021678|NCT03027505|Acute malnutrition|acute malnutrition
1021679|NCT03027505|RUTF|rutf
1021680|NCT03027505|Children|children
1021681|NCT03027505|Burkina Faso|burkina faso
1021682|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
1021683|NCT03027492|gynaecological disorders|gynaecological disorders
1021684|NCT03027492|gluten-free diet|gluten-free diet
1021685|NCT03027479|weight loss|weight loss
1021686|NCT03027479|ovarian cancer|ovarian cancer
1021687|NCT03027479|endometrial cancer|endometrial cancer
1021688|NCT03027479|energy metabolism|energy metabolism
1021689|NCT03027479|Body mass index|body mass index
1021690|NCT03027479|obesity|obesity
1021691|NCT03027479|muscle energy|muscle energy
1021692|NCT03027466|Quitting Smoking|quitting smoking
1021693|NCT03027466|Phone Application|phone application
1021694|NCT03027440|Stress Response|stress response
1021695|NCT03027440|Neurodevelopment|neurodevelopment
1021696|NCT03027440|Biomarkers|biomarkers
1021697|NCT03027440|Cohort Study|cohort study
1021698|NCT03027427|Screening|screening
1021699|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
1021700|NCT03027427|Molecular Profiling|molecular profiling
1021701|NCT03027427|Molecular Alterations|molecular alterations
1021702|NCT03027414|Anxiety|anxiety
1021703|NCT03027414|Startle|startle
1021704|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1021705|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1021706|NCT03027414|Working Memory|working memory
1021707|NCT03027401|Genetic Testing|genetic testing
1021708|NCT03027401|Tumor Profiling|tumor profiling
1021709|NCT03027401|Biorepository|biorepository
1021710|NCT03027388|Brain Tumor|brain tumor
1021711|NCT03027388|Blood Brain Barrier|blood brain barrier
1021712|NCT03027388|Pharmacokinetics|pharmacokinetics
1021713|NCT03027388|Pharmacodynamics|pharmacodynamics
1021714|NCT03027375|chronic heart failure|chronic heart failure
1021715|NCT03027375|traditional Chinese medicine|traditional chinese medicine
1021716|NCT03027375|Qishen granules|qishen granules
1021717|NCT03027336|dyslipidemia|dyslipidemia
1021718|NCT03027336|dietary supplement|dietary supplement
1021719|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
1021720|NCT03027323|central venous cannulation|central venous cannulation
1021721|NCT03027310|Dystonic Tremor|dystonic tremor
1021722|NCT03027310|Essential Tremor|essential tremor
1021723|NCT03027310|Tremor|tremor
1021724|NCT03027310|Voice Tremor|voice tremor
1021725|NCT03027310|Parkinson's Disease|parkinson's disease
1021726|NCT03027284|Neoplasm|neoplasm
1021727|NCT03027258|Mobile health technology|mobile health technology
1021728|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
1021729|NCT03027245|peripheral neuropathy|peripheral neuropathy
1021730|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1021731|NCT03027245|eribulin|eribulin
1021732|NCT03027232|infection|infection
1021733|NCT03027193|Vaccine|vaccine
1021735|NCT03027154|diagnostic test|diagnostic test
1021736|NCT03027154|children|children
1021737|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
1021738|NCT03027141|Face Transplant|face transplant
1021739|NCT03027128|Phase 1|phase 1
1021740|NCT03027128|Metastatic|metastatic
1668033|NCT00113659|Probiotics|probiotics
1021741|NCT03027128|Locally Advanced|locally advanced
1021742|NCT03027128|Cancer|cancer
1021743|NCT03027128|Cell Therapy|cell therapy
1021744|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
1021745|NCT03027102|DNT cells|dnt cells
1021746|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
1021747|NCT03027076|prostatitis|prostatitis
1021748|NCT03027076|chronic prostatitis|chronic prostatitis
1021749|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
1021750|NCT03027076|interstitial cystitis|interstitial cystitis
1021751|NCT03027076|painful bladder syndrome|painful bladder syndrome
1021752|NCT03027076|bladder pain syndrome|bladder pain syndrome
1021753|NCT03027076|biomarkers|biomarkers
1021754|NCT03027076|biological markers|biological markers
1021755|NCT03027076|bacteria|bacteria
1021756|NCT03027076|microbiome|microbiome
1021757|NCT03027076|inflammation|inflammation
1021758|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
1021759|NCT03027050|periodontitis|periodontitis
1021760|NCT03027050|Growth factors|growth factors
1021761|NCT03027050|Periodontal healing|periodontal healing
1021762|NCT03027024|Intraocular Lens|intraocular lens
1021763|NCT03027024|trifocal|trifocal
1021764|NCT03027024|cataract|cataract
1021765|NCT03027024|PhysIOL|physiol
1021766|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
1021767|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
1021768|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1021769|NCT03026985|Ultrasonography|ultrasonography
1021770|NCT03026985|Intensive Care Units|intensive care units
1021771|NCT03026972|Safety|safety
1021772|NCT03026972|Tolerance|tolerance
1021773|NCT03026946|Alitretinoin|alitretinoin
1021774|NCT03026946|Cyclosporine A|cyclosporine a
1021775|NCT03026946|Hand eczema|hand eczema
1021776|NCT03026920|Fracture|fracture
1021777|NCT03026920|outcome|outcome
1021778|NCT03026920|pelvic|pelvic
1021779|NCT03026920|acetabular|acetabular
1021780|NCT03026907|Alitretinoin|alitretinoin
1021781|NCT03026907|Azathioprine|azathioprine
1021782|NCT03026907|Hand eczema|hand eczema
1021783|NCT03026881|PARP inhibitor|parp inhibitor
1021784|NCT03026881|VEGFR inhibitor|vegfr inhibitor
1021785|NCT03026881|Combination therapy|combination therapy
1021786|NCT03026881|Gastric cancer|gastric cancer
1021787|NCT03026868|acetabular|acetabular
1021788|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
1021789|NCT03026855|Autologous PRP|autologous prp
1021790|NCT03026855|Non-healing ulcer|non-healing ulcer
1021791|NCT03026855|Point-of-care|point-of-care
1021792|NCT03026829|Sound therapy|sound therapy
1021793|NCT03026829|Tinnitus relief|tinnitus relief
1021794|NCT03026816|epidural stimulation|epidural stimulation
1021795|NCT03026816|spinal cord stimulation|spinal cord stimulation
1021796|NCT03026816|autonomic dysfunction|autonomic dysfunction
1021797|NCT03026790|Opioid analgesics|opioid analgesics
1021798|NCT03026790|Opioid partial agonists|opioid partial agonists
1021799|NCT03026790|Health care delivery|health care delivery
1021801|NCT03026790|Osteoarthritis|osteoarthritis
1021802|NCT03026790|Veterans health|veterans health
1021804|NCT03026764|total hip replacement|total hip replacement
1021805|NCT03026764|outpatient Surgery|outpatient surgery
1021806|NCT03026764|satisfaction|satisfaction
1021807|NCT03026764|arthroplasty|arthroplasty
1021808|NCT03026725|tooth sensitivity|tooth sensitivity
1021809|NCT03026725|tri calcium phosphate|tri calcium phosphate
1021810|NCT03026725|at-home whitening|at-home whitening
1021811|NCT03026712|Robotic therapy|robotic therapy
1021812|NCT03026712|tDCS|tdcs
1021813|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
1021814|NCT03026712|ArmeoPower|armeopower
1021815|NCT03026712|interhemispheric balance|interhemispheric balance
1021816|NCT03026699|Brain|brain
1021817|NCT03026699|Nervous system|nervous system
1021818|NCT03026699|Neuro-oncology|neuro-oncology
1021819|NCT03026699|Caregivers|caregivers
1021820|NCT03026699|Cancer patient|cancer patient
1021821|NCT03026699|Family caregivers|family caregivers
1021822|NCT03026699|Brain tumors|brain tumors
1021823|NCT03026699|Quality of life|quality of life
1021824|NCT03026699|Stress|stress
1021825|NCT03026699|Social support|social support
1021826|NCT03026699|Feasibility|feasibility
1021827|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
1021828|NCT03026660|Moringa Oleifera|moringa oleifera
1021829|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
1021830|NCT03026634|Heart Failure|heart failure
1021831|NCT03026634|Heart Transplantation|heart transplantation
1021832|NCT03026569|orange juice|orange juice
1021833|NCT03026569|chronic hepatitis C|chronic hepatitis c
1021834|NCT03026569|biochemical markers|biochemical markers
1021835|NCT03026569|oxidative stress|oxidative stress
1021836|NCT03026569|nutritional status|nutritional status
1021837|NCT03026569|antioxidants|antioxidants
1021838|NCT03026517|Phenformin|phenformin
1021839|NCT03026517|Dabrafenib|dabrafenib
1021840|NCT03026517|Trametinib|trametinib
1049649|NCT02852304|liver|liver
1021841|NCT03026517|BRAF|braf
1021842|NCT03026517|15-318|15-318
1021843|NCT03026478|oral lichen planus|oral lichen planus
1021844|NCT03026478|betamethasone|betamethasone
1021845|NCT03026478|clobetasol|clobetasol
1021846|NCT03026478|orabase|orabase
1021847|NCT03026439|mild COPD|mild copd
1021848|NCT03026439|early COPD|early copd
1021849|NCT03026439|six-min walk test|six-min walk test
1021850|NCT03026439|computed tomography|computed tomography
1021851|NCT03026439|emphysema|emphysema
1021852|NCT03026439|airway disease|airway disease
1021853|NCT03026439|peripheral muscle mass|peripheral muscle mass
1021854|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
1021855|NCT03026426|Depression|depression
1021856|NCT03026426|Chronic diseases|chronic diseases
1021857|NCT03026426|Mobile technology|mobile technology
1021858|NCT03026426|Clinical trial|clinical trial
1021859|NCT03026413|atrial fibrillation|atrial fibrillation
1021860|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
1021861|NCT03026413|Contact Force|contact force
1021862|NCT03026413|antrum|antrum
1021863|NCT03026387|Suicidal behavior|suicidal behavior
1021864|NCT03026387|Suicide attempt|suicide attempt
1021865|NCT03026387|Emergency department|emergency department
1021866|NCT03026387|Psychometrics|psychometrics
1021867|NCT03026387|Neuropsychological tests|neuropsychological tests
1021868|NCT03026387|Suicidal ideation|suicidal ideation
1021869|NCT03026374|psychosocial support|psychosocial support
1021870|NCT03026374|resilience|resilience
1021871|NCT03026374|metastatic breast cancer|metastatic breast cancer
1021872|NCT03026374|survival|survival
1021873|NCT03026374|Quality of Life|quality of life
1021874|NCT03026348|RSV|rsv
1021875|NCT03026335|Positive Youth Development|positive youth development
1021876|NCT03026296|Physical Fitness|physical fitness
1021877|NCT03026296|Health Status|health status
1021878|NCT03026296|Exercise|exercise
1021879|NCT03026296|Tobacco Use Cessation|tobacco use cessation
1021880|NCT03026296|Quality of Life|quality of life
1021881|NCT03026296|Healthy Diet|healthy diet
1021882|NCT03026296|Health Promotion|health promotion
1021883|NCT03026296|Patient Education as Topic|patient education as topic
1021884|NCT03026296|Counseling|counseling
1021885|NCT03026270|Physiotherapy|physiotherapy
1021886|NCT03026270|Paraffin|paraffin
1021887|NCT03026270|Burn|burn
1021888|NCT03026270|Contracture|contracture
1021889|NCT03026244|Immunity|immunity
1021890|NCT03026244|Elderly|elderly
1021891|NCT03026244|Inflammation|inflammation
1021892|NCT03026244|Milk protein|milk protein
1021893|NCT03026244|Prebiotics|prebiotics
1021894|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
1021895|NCT03026166|Cancer|cancer
1021896|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
1021897|NCT03026166|Nivolumab|nivolumab
1021898|NCT03026166|Ipilimumab|ipilimumab
1021899|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
1021900|NCT03026140|MSI tumors|msi tumors
1021901|NCT03026140|MSS tumors|mss tumors
1021902|NCT03026140|short-term immunotherapy|short-term immunotherapy
1021903|NCT03026140|surgical resection|surgical resection
1021904|NCT03026140|nivolumab|nivolumab
1021905|NCT03026140|ipilimumab|ipilimumab
1021906|NCT03026127|Suicide|suicide
1021907|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
1021908|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
1021909|NCT03026127|Emotion Regulation|emotion regulation
1021910|NCT03026088|Chronic Heart Failure|chronic heart failure
1021911|NCT03026088|Bisoprolol|bisoprolol
1021912|NCT03026088|Heart rate control|heart rate control
1021913|NCT03026062|Recurrent Platinum-Resistant Epithelial Ovarian Cancer|recurrent platinum-resistant epithelial ovarian cancer
1021914|NCT03026062|Ovarian Cancer|ovarian cancer
1021915|NCT03026062|epithelial ovarian cancer|epithelial ovarian cancer
1021916|NCT03026036|Depression|depression
1021917|NCT03026036|MRI|mri
1021918|NCT03026036|PET|pet
1021919|NCT03026036|Reward|reward
1021920|NCT03026023|Heart Transplant|heart transplant
1021921|NCT03026023|Cardiac Transplant|cardiac transplant
1021922|NCT03026023|Hepatitis C|hepatitis c
1021923|NCT03026023|Zepatier|zepatier
1021924|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
1021925|NCT03025919|Advanced glycation end-product|advanced glycation end-product
1021926|NCT03025919|Glycosuria|glycosuria
1021927|NCT03025893|Sunitinib|sunitinib
1021928|NCT03025893|Lomustine|lomustine
1021929|NCT03025893|High-dose|high-dose
1021930|NCT03025893|Intermittent|intermittent
1021931|NCT03025880|Advanced Breast Cancer|advanced breast cancer
1021932|NCT03025880|Pembrolizumab|pembrolizumab
1021933|NCT03025880|HER2-negative|her2-negative
1021934|NCT03025828|Membranous nephropathy|membranous nephropathy
1021935|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
1021936|NCT03025828|ACTH|acth
1021937|NCT03025828|proteinuria|proteinuria
1021938|NCT03025828|glomerulonephritis|glomerulonephritis
1021939|NCT03025815|Infant, Premature|infant, premature
1021940|NCT03025802|Molecular diagnosis|molecular diagnosis
1021941|NCT03025802|Pathogen identification|pathogen identification
1021942|NCT03025802|Sepsis|sepsis
1021943|NCT03025802|Bacteremia|bacteremia
1021944|NCT03025802|Rapid diagnostics|rapid diagnostics
1021945|NCT03025789|T.b gambiense|t.b gambiense
1021947|NCT03025789|outpatients|outpatients
1021948|NCT03025763|Craniosynostosis|craniosynostosis
1021949|NCT03025763|Bone|bone
1021950|NCT03025763|Birth Defect|birth defect
1021951|NCT03025763|Congenital Anomaly|congenital anomaly
1021952|NCT03025763|Malformation|malformation
1021953|NCT03025763|Genetics|genetics
1021954|NCT03025763|Genomics|genomics
1021955|NCT03025763|Skull|skull
1021956|NCT03025763|Human|human
1021957|NCT03025763|Mouse|mouse
1021958|NCT03025763|Imaging|imaging
1021959|NCT03025763|Cell Biology|cell biology
1021960|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
1021961|NCT03025763|System Biology|system biology
1021962|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
1021963|NCT03025737|Ventricular Remodeling|ventricular remodeling
1021964|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
1021965|NCT03025711|Pertuzumab|pertuzumab
1021966|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
1021967|NCT03025711|Compassionate use|compassionate use
1021968|NCT03025711|Early access program|early access program
1021969|NCT03025711|Effectiveness|effectiveness
1021970|NCT03025711|Safety|safety
1021971|NCT03025698|Eltrombopag|eltrombopag
1021972|NCT03025698|hATG|hatg
1021973|NCT03025698|CsA|csa
1021974|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
1021975|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
1021976|NCT03025698|Severe aplastic anemia|severe aplastic anemia
1021977|NCT03025698|Pharmacokinetics|pharmacokinetics
1021978|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
1021979|NCT03025698|ETB115|etb115
1021980|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
1021981|NCT03025685|Coronary Artery Disease|coronary artery disease
1021982|NCT03025685|Wire|wire
1021983|NCT03025685|Coronary stenting|coronary stenting
1021984|NCT03025659|pediatric|pediatric
1021985|NCT03025659|congenital heart disease|congenital heart disease
1021986|NCT03025646|Maternal depression|maternal depression
1021987|NCT03025646|ASD|asd
1021988|NCT03025646|Home based training program|home based training program
1021989|NCT03025633|PEARL|pearl
1021990|NCT03025620|Alphalinolenic acid|alphalinolenic acid
1021991|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
1021992|NCT03025620|Inflammation|inflammation
1021993|NCT03025607|Prevention|prevention
1021994|NCT03025607|Mobile health|mobile health
1022000|NCT03025568|nylon|nylon
1022001|NCT03025568|polyamide|polyamide
1022002|NCT03025568|denture base|denture base
1022003|NCT03025555|nylon|nylon
1022004|NCT03025555|polyamide|polyamide
1022005|NCT03025555|PEEK|peek
1022006|NCT03025555|partial denture|partial denture
1022007|NCT03025542|Psoriasis|psoriasis
1022008|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
1022009|NCT03025542|Bimekizumab|bimekizumab
1022010|NCT03025490|Capnography|capnography
1022011|NCT03025490|Electrophysiology|electrophysiology
1022012|NCT03025477|Intraperitoneal|intraperitoneal
1022013|NCT03025477|Intravenous|intravenous
1022014|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
1022015|NCT03025477|Carboplatin|carboplatin
1022016|NCT03025477|Epirubicin|epirubicin
1022017|NCT03025477|Paclitaxel|paclitaxel
1022018|NCT03025477|Cisplatin|cisplatin
1022019|NCT03025451|nutrition|nutrition
1022020|NCT03025451|exercise|exercise
1022021|NCT03025451|stress|stress
1022022|NCT03025451|gender|gender
1022023|NCT03025451|age|age
1022024|NCT03025451|community support|community support
1022025|NCT03025451|cardiovascular disease|cardiovascular disease
1022026|NCT03025451|diabetes|diabetes
1022027|NCT03025451|hypertension|hypertension
1022028|NCT03025451|dyslipidemia|dyslipidemia
1022029|NCT03025451|cholesterol|cholesterol
1022030|NCT03025451|overweight|overweight
1022031|NCT03025451|obesity|obesity
1022032|NCT03025451|lifestyle|lifestyle
1022033|NCT03025438|angiosarcoma|angiosarcoma
1022034|NCT03025438|Cytology|cytology
1022035|NCT03025438|liver|liver
1022036|NCT03025438|cancer|cancer
1022037|NCT03025412|Achilles Tendon|achilles tendon
1022038|NCT03025412|Endoscopy|endoscopy
1022039|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1022040|NCT03025412|Exercise therapy|exercise therapy
1022041|NCT03025399|tang wang prescription|tang wang prescription
1022042|NCT03025321|Cocaine|cocaine
1022043|NCT03025321|tDCS|tdcs
1022044|NCT03025321|EMA|ema
1022045|NCT03025321|Inhibitory control|inhibitory control
1022046|NCT03025321|Reward processing|reward processing
1022047|NCT03025321|Addiction|addiction
1022048|NCT03025321|dlPFC|dlpfc
1022049|NCT03025321|craving|craving
1022050|NCT03025321|cognitive control|cognitive control
1668034|NCT00113659|Prevention|prevention
1022057|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
1022058|NCT03025204|Regeneration Procedures|regeneration procedures
1022059|NCT03025204|Intrabony Defects|intrabony defects
1022060|NCT03025204|Cronic Periodontitis|cronic periodontitis
1022061|NCT03025191|incarceration|incarceration
1022062|NCT03025191|HIV|hiv
1022063|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
1022064|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
1022065|NCT03025152|radical gastrectomy|radical gastrectomy
1022066|NCT03025152|gastric cancer|gastric cancer
1022067|NCT03025152|traditional Chinese medicine|traditional chinese medicine
1022068|NCT03025152|randomized controlled trial|randomized controlled trial
1022069|NCT03025139|breast cancer|breast cancer
1022070|NCT03025139|younger women|younger women
1022071|NCT03025139|education|education
1022072|NCT03025139|mindfulness meditation|mindfulness meditation
1022073|NCT03025139|depression|depression
1022074|NCT03025139|cancer survivor|cancer survivor
1022075|NCT03025074|Liver Disease|liver disease
1022076|NCT03025074|Obesity|obesity
1022077|NCT03025074|Hepatitis|hepatitis
1022078|NCT03025074|HIV|hiv
1022079|NCT03025074|Hepatology|hepatology
1022080|NCT03025061|Breath pattern|breath pattern
1022081|NCT03025061|Children|children
1022082|NCT03025061|Repeatability|repeatability
1022083|NCT03025035|BRCA-mutation|brca-mutation
1022084|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
1022085|NCT03025035|Immunotherapy|immunotherapy
1022086|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
1022087|NCT03024957|morphine|morphine
1022088|NCT03024957|dexmedetomidine|dexmedetomidine
1022089|NCT03024957|immune system|immune system
1022090|NCT03024944|Diabetes Mellitus|diabetes mellitus
1022091|NCT03024944|Alzheimer's Disease|alzheimer's disease
1022092|NCT03024944|Dementia|dementia
1022093|NCT03024944|THK|thk
1022094|NCT03024918|monochorionic|monochorionic
1022095|NCT03024918|placental sharing|placental sharing
1022096|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
1022097|NCT03024892|indocyanide green|indocyanide green
1022098|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1022099|NCT03024892|common bile duct injury|common bile duct injury
1022100|NCT03024879|Motilin|motilin
1022101|NCT03024879|Erythromycin|erythromycin
1022102|NCT03024879|Food intake|food intake
1022103|NCT03024853|Best Possible Self|best possible self
1022104|NCT03024853|Positive Intervention|positive intervention
1022105|NCT03024853|Optimism|optimism
1022106|NCT03024840|Propofol|propofol
1022107|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
1022108|NCT03024840|Liver transplantation|liver transplantation
1022109|NCT03024840|Pediatrics|pediatrics
1022110|NCT03024840|Brain Injuries|brain injuries
1022111|NCT03024827|Infantile Spasms|infantile spasms
1022112|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
1022113|NCT03024827|Doose Syndrome|doose syndrome
1022114|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
1022115|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
1022116|NCT03024827|Dravet Syndrome|dravet syndrome
1022117|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
1022118|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
1022119|NCT03024788|advanced glycation end products|advanced glycation end products
1022120|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
1022121|NCT03024775|ancient wheats|ancient wheats
1022122|NCT03024775|modern wheats|modern wheats
1022123|NCT03024775|ATIs|atis
1022124|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
1022125|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
1022126|NCT03024723|Obese patient|obese patient
1022127|NCT03024723|nasal CPAP|nasal cpap
1022128|NCT03024710|Stunting|stunting
1022129|NCT03024710|complementary feeding Index|complementary feeding index
1022130|NCT03024710|Bangladesh|bangladesh
1022131|NCT03024697|Breast surgery|breast surgery
1022132|NCT03024697|Pectoral plane block|pectoral plane block
1022133|NCT03024697|PECs|pecs
1022134|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
1022135|NCT03024697|Analgesia|analgesia
1022136|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
1022137|NCT03024684|statin|statin
1022138|NCT03024684|curative ablation|curative ablation
1022139|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
1022140|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
1022141|NCT03024658|morbidly obese|morbidly obese
1022142|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
1022143|NCT03024645|Postpartum Depression|postpartum depression
1022144|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1022145|NCT03024645|Prevention|prevention
1022146|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
1022147|NCT03024593|Cyberchondria|cyberchondria
1022148|NCT03024593|health-related internet use|health-related internet use
1022149|NCT03024593|pathological health anxiety|pathological health anxiety
1022150|NCT03024580|Megestrol Acetate|megestrol acetate
1022151|NCT03024580|Steroid, Receptors|steroid, receptors
1022152|NCT03024567|Calorimetry|calorimetry
1022153|NCT03024567|Blood pressure|blood pressure
1022154|NCT03024567|Immunophenotyping|immunophenotyping
1022155|NCT03024567|Gut microbial composition|gut microbial composition
1022156|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
1022157|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
1022158|NCT03024554|MFM|mfm
1022159|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
1022160|NCT03024554|Multilayer Stent|multilayer stent
1022161|NCT03024528|Pain|pain
1022162|NCT03024528|CPOT|cpot
1022163|NCT03024528|ICU Delirium|icu delirium
1022164|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
1022165|NCT03024528|NRS|nrs
1022166|NCT03024528|Behaviour|behaviour
1022167|NCT03024528|Critical care|critical care
1022168|NCT03024528|Intensive Care|intensive care
1022169|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
1022170|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
1022171|NCT03024502|clotrimazol|clotrimazol
1022172|NCT03024489|Phase I/II|phase i/ii
1022173|NCT03024476|behavioral intervention|behavioral intervention
1022174|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
1022175|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
1022176|NCT03024463|Breast Neoplasm; Internal Lymph Node; Sentinel Lymph Node Biospy|breast neoplasm; internal lymph node; sentinel lymph node biospy
1022177|NCT03024450|Gastric cancer|gastric cancer
1022178|NCT03024450|HER2|her2
1022179|NCT03024450|trastuzumab|trastuzumab
1022180|NCT03024450|prognosis|prognosis
1022181|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
1022182|NCT03024359|Obesity|obesity
1022183|NCT03024359|Brown adipose tissue|brown adipose tissue
1022184|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
1022185|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
1022186|NCT03024333|Dysphagia|dysphagia
1022187|NCT03024333|Swallowing Sound|swallowing sound
1022188|NCT03024333|Acoustic Analysis|acoustic analysis
1022189|NCT03024307|Pharmaceutical Care|pharmaceutical care
1022190|NCT03024307|Medication Adherence|medication adherence
1022191|NCT03024307|Direct Costs|direct costs
1022192|NCT03024281|Aspergillus|aspergillus
1022193|NCT03024281|Antifungal susceptibility|antifungal susceptibility
1022194|NCT03024281|Azole resistance|azole resistance
1022195|NCT03024255|sweat gland disease|sweat gland disease
1022196|NCT03024255|sweating|sweating
1022197|NCT03024255|underarm|underarm
1022198|NCT03024229|Transplantation;perfusion machine|transplantation;perfusion machine
1022199|NCT03024190|stroke|stroke
1022200|NCT03024190|spasticity|spasticity
1022201|NCT03024190|Kinesiotaping|kinesiotaping
1022202|NCT03024190|sonography|sonography
1022203|NCT03024190|exercise|exercise
1022204|NCT03024177|Human rhinovirus|human rhinovirus
1022205|NCT03024177|HRV|hrv
1022206|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1022207|NCT03024177|HSCT|hsct
1022208|NCT03024177|Antiviral|antiviral
1022209|NCT03024177|vapendavir|vapendavir
1022210|NCT03024177|Allogeneic|allogeneic
1022211|NCT03024177|Autologous|autologous
1022212|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
1022213|NCT03024125|lean mass|lean mass
1022214|NCT03024125|postmenopausal|postmenopausal
1022216|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
1022217|NCT03024060|Actinic Keratosis|actinic keratosis
1022218|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
1022219|NCT03024021|targeted temperature management|targeted temperature management
1022220|NCT03024021|neurological outcome|neurological outcome
1022221|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
1022222|NCT03024008|Critical Gap|critical gap
1022223|NCT03024008|Comminuted Fracture|comminuted fracture
1022224|NCT03024008|Extra-Articular|extra-articular
1022225|NCT03023930|Opioid Use Disorder|opioid use disorder
1022226|NCT03023917|jaundice,complication|jaundice,complication
1022227|NCT03023891|glucocorticoids|glucocorticoids
1022228|NCT03023891|efficacy|efficacy
1022229|NCT03023891|metabolic toxicity|metabolic toxicity
1022230|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
1022231|NCT03023839|Delirium|delirium
1022232|NCT03023839|Trauma|trauma
1022233|NCT03023839|Injury|injury
1022234|NCT03023839|restraints|restraints
1022235|NCT03023761|Endodontic retreatments|endodontic retreatments
1022236|NCT03023761|Low level laser|low level laser
1022237|NCT03023761|Pain|pain
1022238|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
1022239|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
1022240|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
1022241|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
1022242|NCT03023696|C5 Palsy|c5 palsy
1022243|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1022244|NCT03023683|Children and young adults|children and young adults
1050193|NCT02848586|HIV|hiv
1022245|NCT03023670|Lung|lung
1022246|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
1022247|NCT03023670|Pediatric|pediatric
1022248|NCT03023670|Cardiac surgery|cardiac surgery
1022249|NCT03023657|arousal|arousal
1022250|NCT03023657|Consciousness Disorders|consciousness disorders
1022251|NCT03023657|vegetative state|vegetative state
1022252|NCT03023657|minimally conscious state|minimally conscious state
1022253|NCT03023644|Congenital Heart Disease|congenital heart disease
1022254|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
1022255|NCT03023644|Children|children
1022256|NCT03023644|Executive Function|executive function
1022257|NCT03023644|Working Memory|working memory
1022258|NCT03023644|Cognitive interventions|cognitive interventions
1022259|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
1022260|NCT03023631|GARDASIL 9|gardasil 9
1022261|NCT03023631|Post allogeneic stem cell transplantation|post allogeneic stem cell transplantation
1022262|NCT03023631|HPV infection prevention|hpv infection prevention
1022263|NCT03023618|[G09.330.380]|[g09.330.380]
1022264|NCT03023605|Pulmonary embolism|pulmonary embolism
1022265|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
1022266|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
1022267|NCT03023605|Clinical prediction rules|clinical prediction rules
1022268|NCT03023605|Elderly patients|elderly patients
1022269|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
1022270|NCT03023592|Iguratimod|iguratimod
1022271|NCT03023566|Dotarem|dotarem
1022272|NCT03023566|MRI|mri
1022273|NCT03023566|pediatric|pediatric
1022274|NCT03023566|safety|safety
1022275|NCT03023566|efficacy|efficacy
1022276|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
1022277|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1022278|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
1022279|NCT03023553|Young adults|young adults
1022280|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
1022281|NCT03023540|Peripheral neuropathy|peripheral neuropathy
1022282|NCT03023540|PXT3003|pxt3003
1022283|NCT03023527|Refractory|refractory
1022284|NCT03023527|Relapsed|relapsed
1022285|NCT03023527|Nivolumab|nivolumab
1022286|NCT03023514|Oocyte donation|oocyte donation
1022287|NCT03023514|IVF|ivf
1022288|NCT03023514|Lipoic acid|lipoic acid
1022289|NCT03023514|Implantation rate|implantation rate
1022290|NCT03023514|Endometrial receptivity|endometrial receptivity
1022291|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
1022292|NCT03023488|blood flow|blood flow
1022293|NCT03023436|Stomach Neoplasms|stomach neoplasms
1022294|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
1022295|NCT03023410|Revision TKA|revision tka
1022296|NCT03023410|Instability|instability
1022297|NCT03023410|Stiffness|stiffness
1022298|NCT03023410|Aseptic Loosening|aseptic loosening
1022299|NCT03023410|Polyethylene Wear|polyethylene wear
1022300|NCT03023410|Malrotation|malrotation
1022301|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
1022302|NCT03023397|E-cig smokers|e-cig smokers
1022303|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
1022304|NCT03023384|Chemotherapy|chemotherapy
1022305|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1022306|NCT03023384|Developing country|developing country
1022307|NCT03023384|Clinical network|clinical network
1022308|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
1022507|NCT03022266|Wellth App|wellth app
1022309|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
1022310|NCT03023345|cancer|cancer
1022311|NCT03023345|prostate|prostate
1022312|NCT03023345|PSA|psa
1022313|NCT03023345|biopsies|biopsies
1022314|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
1022315|NCT03023332|Caregiver|caregiver
1022316|NCT03023332|Biofeedback|biofeedback
1022317|NCT03023332|Resourcefulness|resourcefulness
1022318|NCT03023332|Self-Management|self-management
1022319|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1022320|NCT03023293|irisin|irisin
1022321|NCT03023241|BPS/IC|bps/ic
1022322|NCT03023241|OAB|oab
1022323|NCT03023228|Diabetes mellitus|diabetes mellitus
1022324|NCT03023228|Hyperglycemia|hyperglycemia
1022325|NCT03023228|Inpatient|inpatient
1022326|NCT03023228|self-management education|self-management education
1022327|NCT03023215|Meditation|meditation
1022328|NCT03023215|Breast Biopsy|breast biopsy
1022329|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
1022330|NCT03023215|SBB|sbb
1022331|NCT03023215|Guided meditation|guided meditation
1022332|NCT03023215|Focused breathing|focused breathing
1022333|NCT03023215|Electroencephalogram|electroencephalogram
1022334|NCT03023215|EEG|eeg
1022335|NCT03023215|Heart rate|heart rate
1022336|NCT03023215|HR|hr
1022337|NCT03023215|Questionnaires|questionnaires
1022338|NCT03023215|Surveys|surveys
1022339|NCT03023189|Upper digestive bleeding|upper digestive bleeding
1022340|NCT03023189|Haemorrhage|haemorrhage
1022341|NCT03023189|Cirrhosis|cirrhosis
1022342|NCT03023189|Antifibrinolytic|antifibrinolytic
1022343|NCT03023189|Tranexamic acid|tranexamic acid
1022344|NCT03023189|Emergency|emergency
1022345|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
1022346|NCT03023176|Child identical twins|child identical twins
1022347|NCT03023176|Child fraternal twins|child fraternal twins
1022348|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
1022349|NCT03023163|baroreceptor integrity|baroreceptor integrity
1022350|NCT03023163|sympathetic integrity|sympathetic integrity
1022351|NCT03023163|vagal integrity|vagal integrity
1022352|NCT03023163|autonomic integrity|autonomic integrity
1022353|NCT03023163|arterial stiffness|arterial stiffness
1022354|NCT03023163|cognitive function|cognitive function
1022355|NCT03023163|traumatic brain injury|traumatic brain injury
1022356|NCT03023163|cerebral blood flow|cerebral blood flow
1022357|NCT03023163|white matter hyperintensities|white matter hyperintensities
1022358|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
1022359|NCT03023137|prevention|prevention
1022360|NCT03023137|carbohydrate|carbohydrate
1022361|NCT03023137|exercise|exercise
1022362|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
1022363|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
1022364|NCT03023111|miltefosine|miltefosine
1022365|NCT03023111|cytokines|cytokines
1022366|NCT03023111|treatment|treatment
1022367|NCT03023098|Restenosis|restenosis
1022368|NCT03023098|Drug-eluting balloon|drug-eluting balloon
1022369|NCT03023098|Vein graft|vein graft
1022370|NCT03023059|L-DOPA|l-dopa
1022371|NCT03023059|GPR143|gpr143
1022372|NCT03023059|PEDF|pedf
1022373|NCT03023059|VEGF|vegf
1022374|NCT03023033|PMTCT|pmtct
1022375|NCT03023033|MNCH|mnch
1022376|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
1022377|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
1022378|NCT03022994|eosinophils|eosinophils
1022379|NCT03022994|lymphocytes|lymphocytes
1022380|NCT03022994|duodenal biopsies|duodenal biopsies
1022381|NCT03022994|rectal biopsies|rectal biopsies
1022382|NCT03022825|BCG|bcg
1022383|NCT03022825|bladder cancer|bladder cancer
1022384|NCT03022825|immunotherapy|immunotherapy
1022385|NCT03022825|interleukin-15|interleukin-15
1022386|NCT03022825|intravesical|intravesical
1022387|NCT03022825|non-muscle invasive|non-muscle invasive
1022388|NCT03022825|NMIBC|nmibc
1022389|NCT03022812|Neck pain|neck pain
1022390|NCT03022812|Rehabilitation|rehabilitation
1022391|NCT03022812|Exercise Therapy|exercise therapy
1022392|NCT03022812|Internet|internet
1022393|NCT03022799|FAF1|faf1
1022394|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
1022395|NCT03022799|FAF1 inhibitor|faf1 inhibitor
1022396|NCT03022799|KM-819|km-819
1022397|NCT03022786|Dermatitis|dermatitis
1022398|NCT03022760|Exhaustion Disorder|exhaustion disorder
1022399|NCT03022682|ethnicity|ethnicity
1022400|NCT03022682|inflammation|inflammation
1022401|NCT03022669|mobile health|mobile health
1022402|NCT03022669|veterans|veterans
1022403|NCT03022669|cardiovascular disease|cardiovascular disease
1022404|NCT03022669|medication adherence|medication adherence
1022405|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
1022406|NCT03022630|palliative care|palliative care
1022407|NCT03022630|cirrhosis|cirrhosis
1022408|NCT03022630|liver disease|liver disease
1022409|NCT03022630|hepatology|hepatology
1022410|NCT03022630|end of life care|end of life care
1022411|NCT03022630|supportive care|supportive care
1022505|NCT03022266|Behavioral Economics|behavioral economics
1022506|NCT03022266|Aspirin|aspirin
1022412|NCT03022578|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|malignant neoplasms of eye brain and other parts of central nervous system
1022413|NCT03022578|Glioblastoma|glioblastoma
1022414|NCT03022578|Anaplastic Astrocytoma|anaplastic astrocytoma
1022415|NCT03022578|AA|aa
1022416|NCT03022578|Laser interstitial thermal therapy|laser interstitial thermal therapy
1022417|NCT03022578|LITT|litt
1022418|NCT03022578|Lomustine|lomustine
1022419|NCT03022578|CeeNU|ceenu
1022420|NCT03022578|CCNU|ccnu
1022421|NCT03022565|Uveal Melanoma|uveal melanoma
1022422|NCT03022552|Myocardial Infarction|myocardial infarction
1022423|NCT03022552|Women|women
1022424|NCT03022552|Platelets|platelets
1022425|NCT03022552|Blood Collection|blood collection
1022426|NCT03022552|Genomics|genomics
1022427|NCT03022526|Pregnant|pregnant
1022428|NCT03022526|Analgesia|analgesia
1022429|NCT03022526|Labor analgesia|labor analgesia
1022430|NCT03022526|Epidural|epidural
1022431|NCT03022526|Combined spinal epidural|combined spinal epidural
1022432|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
1022433|NCT03022513|fibromyalgia|fibromyalgia
1022434|NCT03022513|synovitis|synovitis
1022435|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
1022436|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1022437|NCT03022487|electrophysiological|electrophysiological
1022438|NCT03022487|EP|ep
1022439|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
1022440|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
1022441|NCT03022487|ICD|icd
1022442|NCT03022474|Childhood obesity|childhood obesity
1050401|NCT02847676|MSC|msc
1022443|NCT03022461|Heart Failure|heart failure
1022444|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
1022445|NCT03022461|Cardiomyopathies|cardiomyopathies
1022446|NCT03022461|Heart Disease|heart disease
1022447|NCT03022461|Cardiovascular Disease|cardiovascular disease
1022448|NCT03022461|Heart-assist Devices|heart-assist devices
1022449|NCT03022461|Thoratec Corporation|thoratec corporation
1022450|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
1022451|NCT03022448|trabectedin|trabectedin
1022452|NCT03022448|metastatic STS patients|metastatic sts patients
1022453|NCT03022448|overall survival|overall survival
1022454|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
1022455|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1022456|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
1022457|NCT03022435|Adult fraternal twins|adult fraternal twins
1022458|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
1022459|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
1022460|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
1022461|NCT03022422|Adult fraternal twins|adult fraternal twins
1022462|NCT03022409|Treatment naïve|treatment naïve
1022463|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
1022464|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
1022465|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
1022466|NCT03022396|Identical twins|identical twins
1022467|NCT03022396|Fraternal twins|fraternal twins
1022468|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
1022469|NCT03022396|Elderly twins|elderly twins
1022470|NCT03022396|Child twins|child twins
1022471|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
1022472|NCT03022383|no known ocular pathology|no known ocular pathology
1022473|NCT03022370|informal settlements|informal settlements
1022474|NCT03022370|poverty|poverty
1022475|NCT03022344|DD2 plaque study|dd2 plaque study
1022476|NCT03022344|Coronary plaque|coronary plaque
1022477|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
1022478|NCT03022331|Idiopathic aortitis|idiopathic aortitis
1022479|NCT03022331|Isolated aortitis|isolated aortitis
1022480|NCT03022331|Vasculitis|vasculitis
1022481|NCT03022318|GPR143|gpr143
1022482|NCT03022318|PEDF|pedf
1022483|NCT03022318|VEGF|vegf
1022484|NCT03022318|LDOPA|ldopa
1022485|NCT03022305|Hip alignment|hip alignment
1022486|NCT03022305|Hip misalignment|hip misalignment
1022487|NCT03022305|Shoulder function|shoulder function
1022488|NCT03022305|Shoulder rotation|shoulder rotation
1022489|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
1022490|NCT03022305|Athletic hip alignment|athletic hip alignment
1022491|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
1022492|NCT03022305|Hip joint|hip joint
1022493|NCT03022305|Hip joint alignment|hip joint alignment
1022494|NCT03022305|Hip joint misalignment|hip joint misalignment
1022495|NCT03022279|Pediatric|pediatric
1022496|NCT03022279|post-operative pain prevention|post-operative pain prevention
1022497|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
1022498|NCT03022279|Nerve Blockade|nerve blockade
1022499|NCT03022266|Adherence|adherence
1022500|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
1022501|NCT03022266|Smartphone App|smartphone app
1022502|NCT03022266|Telehealth|telehealth
1022503|NCT03022266|Digital Health|digital health
1022504|NCT03022266|Mobile Phone App|mobile phone app
1022510|NCT03022227|cochlear implant ;|cochlear implant ;
1022511|NCT03022214|Dietary supplementation|dietary supplementation
1022512|NCT03022214|Exercise|exercise
1022513|NCT03022214|Increase Resilience|increase resilience
1022514|NCT03022214|Oxidative Stress|oxidative stress
1022515|NCT03022214|Efficacy|efficacy
1022516|NCT03022201|Motilitone|motilitone
1022517|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
1022518|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
1022519|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
1022520|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
1022521|NCT03022175|Safety|safety
1022522|NCT03022175|Tolerability|tolerability
1022523|NCT03022175|Pharmacokinetics|pharmacokinetics
1022524|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
1022525|NCT03022136|epidural block|epidural block
1022526|NCT03022136|dermatome|dermatome
1022527|NCT03022136|human|human
1022528|NCT03022136|spinal nerve|spinal nerve
1022529|NCT03022136|thoracic|thoracic
1022530|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
1022531|NCT03022071|Psychodynamic therapy|psychodynamic therapy
1022532|NCT03022071|Mediators|mediators
1022533|NCT03022071|Moderators|moderators
1668035|NCT00113659|Eczema|eczema
1022534|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
1022535|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
1022536|NCT03022045|risankizumab|risankizumab
1022537|NCT03022045|Japanese|japanese
1022538|NCT03022032|Gynecologic cancer|gynecologic cancer
1022539|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
1022540|NCT03022019|vitiligo|vitiligo
1022541|NCT03022019|non-segmental|non-segmental
1022542|NCT03022019|ReNovaCell|renovacell
1022543|NCT03021967|incurable pathologies|incurable pathologies
1022544|NCT03021967|palliative care|palliative care
1022545|NCT03021954|platelet rich plasma|platelet rich plasma
1022546|NCT03021954|pelvic floor disorders|pelvic floor disorders
1022547|NCT03021954|primipara|primipara
1022548|NCT03021941|Gaucher Disease|gaucher disease
1022549|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
1022550|NCT03021928|Stroke|stroke
1022551|NCT03021928|Atrial Fibrillation|atrial fibrillation
1022552|NCT03021928|Anticoagulation|anticoagulation
1022553|NCT03021928|NOAC|noac
1022554|NCT03021889|HIV / AIDS|hiv / aids
1022555|NCT03021889|Dyslipidemia|dyslipidemia
1022556|NCT03021889|Adolescents|adolescents
1022557|NCT03021889|Nutritional Therapy|nutritional therapy
1022558|NCT03021863|Dissemination|dissemination
1022559|NCT03021863|Tone|tone
1022560|NCT03021863|Survey reminders|survey reminders
1022561|NCT03021863|Questionnaires|questionnaires
1022562|NCT03021850|Pliability|pliability
1022563|NCT03021850|Cryotherapy|cryotherapy
1022564|NCT03021850|Hot temperature|hot temperature
1022565|NCT03021850|Hyperthermia, induced|hyperthermia, induced
1022566|NCT03021850|Randomized Controlled Trial|randomized controlled trial
1022567|NCT03021850|Hamstring muscles|hamstring muscles
1022568|NCT03021850|Muscle stretching exercises|muscle stretching exercises
1022569|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1022570|NCT03021824|ARDS|ards
1022571|NCT03021824|Acute Lung Injury|acute lung injury
1022572|NCT03021824|ALI|ali
1022573|NCT03021824|Mechanical Ventilation|mechanical ventilation
1022574|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1022575|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
1022576|NCT03021824|Vasodilator Agents|vasodilator agents
1022577|NCT03021824|Prone Position|prone position
1022578|NCT03021824|ECMO|ecmo
1022579|NCT03021824|Acute Respiratory Failure|acute respiratory failure
1022580|NCT03021798|Sarcopenia|sarcopenia
1022581|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
1022582|NCT03021798|observational study|observational study
1022583|NCT03021798|6-minute walking distance|6-minute walking distance
1022584|NCT03021798|400 meters walking test|400 meters walking test
1022585|NCT03021798|Patient Reported Outcomes|patient reported outcomes
1022586|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1022587|NCT03021785|Anti-VEGF|anti-vegf
1022588|NCT03021785|CNV|cnv
1022589|NCT03021785|TK001|tk001
1022590|NCT03021772|Neostigmine|neostigmine
1022591|NCT03021772|Dexamethasone|dexamethasone
1022592|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
1022593|NCT03021746|African-American|african-american
1022594|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
1022595|NCT03021720|Uterine artery embolization|uterine artery embolization
1022596|NCT03021720|Arterial access|arterial access
1022597|NCT03021720|Radial access|radial access
1022598|NCT03021720|Interventional radiology|interventional radiology
1022599|NCT03021720|Quality of life|quality of life
1022600|NCT03021720|Patient Satisfaction|patient satisfaction
1022601|NCT03021720|Patient centered care|patient centered care
1022602|NCT03021720|Uterine fibroid|uterine fibroid
1022603|NCT03021655|Youth|youth
1022604|NCT03021655|Randomized controlled trial|randomized controlled trial
1022605|NCT03021655|Adventure-based training|adventure-based training
1022606|NCT03021655|WhatsApp|whatsapp
1022607|NCT03021642|healthy volunteer|healthy volunteer
1022608|NCT03021642|Tepotinib|tepotinib
1022609|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
1022610|NCT03021642|Translocated promoter region|translocated promoter region
1022611|NCT03021616|energy drink|energy drink
1022612|NCT03021616|qtc interval|qtc interval
1022613|NCT03021616|clotting time|clotting time
1022614|NCT03021616|thorough qt study|thorough qt study
1022615|NCT03021603|Hope|hope
1022616|NCT03021603|psychotherapy|psychotherapy
1022617|NCT03021603|palliative|palliative
1022618|NCT03021603|low-intensity intervention|low-intensity intervention
1022619|NCT03021590|Helicobacter pylori|helicobacter pylori
1022620|NCT03021590|Helicobacter Infections|helicobacter infections
1022621|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
1022622|NCT03021590|sequential therapy|sequential therapy
1022623|NCT03021590|Clarithromycin|clarithromycin
1022624|NCT03021590|Tinidazole|tinidazole
1022625|NCT03021577|orbital atherectomy system|orbital atherectomy system
1022626|NCT03021577|rotational atherectomy|rotational atherectomy
1022627|NCT03021577|Fractional flow reserve|fractional flow reserve
1022628|NCT03021577|coronary flow reserve|coronary flow reserve
1022629|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
1022630|NCT03021551|oxygen|oxygen
1022631|NCT03021551|desaturation|desaturation
1022632|NCT03021551|obesity|obesity
1022633|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
1022634|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1022635|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
1022636|NCT03021538|Hemorrhage|hemorrhage
1022637|NCT03021538|Mechanical Ventilator|mechanical ventilator
1022638|NCT03021525|Goal-directed therapy|goal-directed therapy
1022639|NCT03021525|postoperative morbidity|postoperative morbidity
1022640|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
1022641|NCT03021525|individualised medicine|individualised medicine
1022642|NCT03021525|Pulse pressure variation|pulse pressure variation
1022643|NCT03021525|Cardiac output|cardiac output
1022644|NCT03021499|lupus nephritis|lupus nephritis
1022645|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
1022646|NCT03021499|voclosporin|voclosporin
1022647|NCT03021486|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1022648|NCT03021486|Haloperidol|haloperidol
1022649|NCT03021486|Chlorpromazine|chlorpromazine
1022650|NCT03021486|Chlorpromazine hydrochloride|chlorpromazine hydrochloride
1022651|NCT03021486|Thorazine|thorazine
1022652|NCT03021486|Symptom questionnaire|symptom questionnaire
1022653|NCT03021486|Survey|survey
1022654|NCT03021486|Delirium|delirium
1022655|NCT03021486|Acute palliative care unit|acute palliative care unit
1022656|NCT03021486|APCU|apcu
1022657|NCT03021473|oxygen reserve index|oxygen reserve index
1022658|NCT03021473|desaturation|desaturation
1022659|NCT03021473|safety|safety
1022660|NCT03021434|Water Supply/standards|water supply/standards
1022661|NCT03021434|Water microbiology|water microbiology
1022662|NCT03021434|India|india
1022663|NCT03021434|Hand disinfection|hand disinfection
1022664|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
1022665|NCT03021434|Hygiene|hygiene
1022666|NCT03021434|Health behavior|health behavior
1022667|NCT03021434|Drinking water|drinking water
1022668|NCT03021434|Informational intervention|informational intervention
1022669|NCT03021421|Total knee arthroplasty|total knee arthroplasty
1022670|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
1022671|NCT03021421|psoas compartment block|psoas compartment block
1022672|NCT03021421|sciatic nerve block|sciatic nerve block
1022673|NCT03021421|haemodynamic effects|haemodynamic effects
1022674|NCT03021343|Atrial fibrillation|atrial fibrillation
1022675|NCT03021343|Colchicine|colchicine
1022676|NCT03021343|Cardiac surgery|cardiac surgery
1022677|NCT03021304|SB240563|sb240563
1022678|NCT03021304|self-administration|self-administration
1022679|NCT03021304|Mepolizumab|mepolizumab
1022680|NCT03021304|safety syringe|safety syringe
1022681|NCT03021304|Eosinophilic asthma|eosinophilic asthma
1022682|NCT03021278|Tactile acuity|tactile acuity
1022683|NCT03021278|Chronic pain|chronic pain
1022684|NCT03021278|Two-point discrimination|two-point discrimination
1022685|NCT03021278|Point-to-point test|point-to-point test
1022686|NCT03021278|Two-point estimation|two-point estimation
1022687|NCT03021278|Body image|body image
1022688|NCT03021239|Ramp Test|ramp test
1022689|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
1022690|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
1022691|NCT03021226|Health Behavior|health behavior
1022692|NCT03021174|CIPN|cipn
1022693|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1022694|NCT03021161|probiotic|probiotic
1022695|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
1022696|NCT03021148|self-reported|self-reported
1022697|NCT03021122|Medication errors|medication errors
1022698|NCT03021122|Resuscitation|resuscitation
1022699|NCT03021122|Drugs|drugs
1022700|NCT03021122|Pediatrics|pediatrics
1022701|NCT03021122|Biomedical technology|biomedical technology
1022788|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
1022789|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1022790|NCT03020472|Children|children
1022791|NCT03020459|macular holes|macular holes
1022793|NCT03020433|rehab|rehab
1022794|NCT03020433|rehabilitation|rehabilitation
1022795|NCT03020433|paresis|paresis
1022796|NCT03020433|paralysis|paralysis
1022797|NCT03020433|stroke therapy|stroke therapy
1022799|NCT03020433|cerebrovascular accident|cerebrovascular accident
1022800|NCT03020433|brain diseases|brain diseases
1022801|NCT03020433|TMS|tms
1022802|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
1022803|NCT03020433|CIMT|cimt
1022804|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
1022805|NCT03020433|MRI|mri
1022806|NCT03020407|Septic Shock|septic shock
1022807|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
1022808|NCT03020407|Resuscitation|resuscitation
1022809|NCT03020407|Mortality|mortality
1022810|NCT03020394|COPD Exacerbation|copd exacerbation
1022811|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
1022812|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
1022813|NCT03020394|severe|severe
1022814|NCT03020342|HCC|hcc
1022815|NCT03020342|chimera DNA|chimera dna
1022816|NCT03020342|circulating DNA|circulating dna
1022817|NCT03020342|biomarker|biomarker
1022818|NCT03020329|Induction Chemotherapy|induction chemotherapy
1022819|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1022820|NCT03020329|Chemoradiotherapy|chemoradiotherapy
1022821|NCT03020290|femoropopliteal artery|femoropopliteal artery
1022822|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
1022823|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
1022824|NCT03020290|TASC C and TASC D|tasc c and tasc d
1022825|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
1022826|NCT03020264|Type 2 Diabetes|type 2 diabetes
1022827|NCT03020264|Hypoglycemia|hypoglycemia
1022828|NCT03020264|Elderly|elderly
1022829|NCT03020264|Insulinotherapy|insulinotherapy
1022830|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
1022831|NCT03020251|chest physiotherapy|chest physiotherapy
1022832|NCT03020251|lung cancer resection|lung cancer resection
1022833|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1022834|NCT03020212|High altitude|high altitude
1022835|NCT03020212|Oxygen|oxygen
1022836|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
1022837|NCT03020212|pulmonary hypertension|pulmonary hypertension
1022838|NCT03020212|chronic hypoxemia|chronic hypoxemia
1022839|NCT03020199|Psoriasis|psoriasis
1022843|NCT03020095|Ravidasvir|ravidasvir
1022844|NCT03020095|HCV GT1|hcv gt1
1022845|NCT03020095|SVR12|svr12
1022846|NCT03020095|Danoprevir/r|danoprevir/r
1022847|NCT03020082|Danoprevir|danoprevir
1022848|NCT03020082|non-cirrhotic|non-cirrhotic
1022849|NCT03020082|Chinese HCV G1|chinese hcv g1
1022850|NCT03020082|SVR12|svr12
1022851|NCT03020069|Type 1 Diabetes|type 1 diabetes
1022852|NCT03020069|Adolescents|adolescents
1022853|NCT03020069|Glucose Monitoring|glucose monitoring
1022854|NCT03020056|cataract surgery|cataract surgery
1022855|NCT03020056|socioeconomic status|socioeconomic status
1022856|NCT03020056|quality of life|quality of life
1022857|NCT03020056|rural area|rural area
1022858|NCT03020056|China|china
1022859|NCT03020056|randomized controlled trial|randomized controlled trial
1022860|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1022861|NCT03020004|Danoprevir|danoprevir
1022862|NCT03020004|SVR12|svr12
1022863|NCT03020004|Chinese HCV G1|chinese hcv g1
1022864|NCT03020004|non-cirrhotic|non-cirrhotic
1022865|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
1022866|NCT03019939|Acute Myeloid Leukemia|acute myeloid leukemia
1022867|NCT03019939|AML|aml
1022868|NCT03019939|Myelodysplastic Syndrome|myelodysplastic syndrome
1022869|NCT03019939|MDS|mds
1022870|NCT03019939|Neutropenia|neutropenia
1022871|NCT03019939|Invasive fungal infection|invasive fungal infection
1022872|NCT03019939|IFI|ifi
1022873|NCT03019939|Isavuconazole|isavuconazole
1022874|NCT03019939|BAL8557|bal8557
1022875|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
1022876|NCT03019926|observance|observance
1022877|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
1022878|NCT03019926|risk factors of non-observance|risk factors of non-observance
1022879|NCT03019926|SLICC score|slicc score
1022880|NCT03019926|SLEDAI score|sledai score
1022881|NCT03019913|Skeletal muscle|skeletal muscle
1022882|NCT03019861|Ayurveda|ayurveda
1022883|NCT03019861|IBS|ibs
1022885|NCT03019861|nutritional counseling|nutritional counseling
1022886|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
1022888|NCT03019835|neostigmine|neostigmine
1022889|NCT03019835|antagonism|antagonism
1022890|NCT03019783|Endothelial function|endothelial function
1022891|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1022892|NCT03019770|HIV|hiv
1022893|NCT03019770|Decision Aid|decision aid
1022894|NCT03019770|Shared Decision Making|shared decision making
1022895|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
1022896|NCT03019744|Cerebrovascular accident|cerebrovascular accident
1022897|NCT03019744|Stroke|stroke
1022898|NCT03019744|Electromyography|electromyography
1022899|NCT03019731|Tics|tics
1022900|NCT03019731|Behavioral therapy|behavioral therapy
1022901|NCT03019731|Neurologic Examination|neurologic examination
1022902|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
1022903|NCT03019718|Internet-based intervention|internet-based intervention
1022904|NCT03019718|Aftercare|aftercare
1022905|NCT03019718|Return to work|return to work
1022906|NCT03019718|Psychodynamic|psychodynamic
1022907|NCT03019705|Cyberchondria|cyberchondria
1022908|NCT03019705|health-related internet use|health-related internet use
1022909|NCT03019705|pathological health anxiety|pathological health anxiety
1022910|NCT03019705|ambulatory assessment|ambulatory assessment
1022911|NCT03019666|MM|mm
1022912|NCT03019666|NHL|nhl
1022913|NCT03019640|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
1022914|NCT03019640|Relapsed follicular lymphoma|relapsed follicular lymphoma
1022915|NCT03019640|Indolent B-cell histology|indolent b-cell histology
1022916|NCT03019640|Natural killer cells|natural killer cells
1022917|NCT03019640|NK|nk
1022918|NCT03019640|Stem cell transplant|stem cell transplant
1022919|NCT03019640|Rituximab|rituximab
1022920|NCT03019640|Rituxan|rituxan
1022921|NCT03019640|Carmustine|carmustine
1022922|NCT03019640|BCNU|bcnu
1022923|NCT03019640|BiCNU|bicnu
1022924|NCT03019640|Etoposide|etoposide
1022925|NCT03019640|VePesid|vepesid
1022926|NCT03019640|Cytarabine|cytarabine
1022927|NCT03019640|Ara-C|ara-c
1022928|NCT03019640|Cytosar|cytosar
1022929|NCT03019640|DepoCyt|depocyt
1022930|NCT03019640|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1022931|NCT03019640|Melphalan|melphalan
1022932|NCT03019640|Alkeran|alkeran
1022933|NCT03019640|Lenalidomide|lenalidomide
1022934|NCT03019640|CC-5013|cc-5013
1022935|NCT03019640|Revlimid|revlimid
1022936|NCT03019640|G-CSF|g-csf
1022937|NCT03019640|Filgrastim|filgrastim
1022938|NCT03019640|Neupogen|neupogen
1022939|NCT03019601|HIV|hiv
1022940|NCT03019601|PMTCT|pmtct
1022941|NCT03019588|PD1|pd1
1022942|NCT03019588|PD-1|pd-1
1022943|NCT03019588|PDL1|pdl1
1022944|NCT03019588|PD-L1|pd-l1
1022945|NCT03019562|postoperative pain|postoperative pain
1022946|NCT03019523|caffeine|caffeine
1022947|NCT03019523|mental performance|mental performance
1022948|NCT03019523|reaction time|reaction time
1022949|NCT03019523|focus|focus
1022950|NCT03019497|PTSD|ptsd
1022951|NCT03019497|Related Problems|related problems
1022952|NCT03019497|Therapy|therapy
1022953|NCT03019497|Traumatic Event|traumatic event
1022954|NCT03019497|Quality of Life|quality of life
1022955|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1022956|NCT03019497|Major depression|major depression
1022957|NCT03019497|Sleep disorders|sleep disorders
1022958|NCT03019497|Pain|pain
1022959|NCT03019497|Stressors|stressors
1022960|NCT03019497|Social support|social support
1022961|NCT03019497|Substance use disorder|substance use disorder
1022962|NCT03019497|Anxiety disorder|anxiety disorder
1022963|NCT03019484|Self-efficacy|self-efficacy
1022964|NCT03019484|Self Efficacy|self efficacy
1022965|NCT03019484|Nurses's Role|nurses's role
1022966|NCT03019484|Professional Role|professional role
1022967|NCT03019484|Clinical Trial|clinical trial
1022968|NCT03019484|Breast Feeding|breast feeding
1022969|NCT03019458|prospective randomized trial|prospective randomized trial
1022972|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
1022973|NCT03019393|Red meat|red meat
1022974|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
1022975|NCT03019367|Premature infants|premature infants
1022976|NCT03019367|Umbilical cord milking|umbilical cord milking
1022977|NCT03019367|Delayed cord clamping|delayed cord clamping
1022978|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
1022979|NCT03019367|Death|death
1022980|NCT03019354|high flow oxygen|high flow oxygen
1022981|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
1022982|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
1022983|NCT03019341|Nausea|nausea
1022984|NCT03019341|Vomiting|vomiting
1022985|NCT03019341|Non-ionic contrast media|non-ionic contrast media
1022986|NCT03019341|Side effect|side effect
1022987|NCT03019328|peanut allergy|peanut allergy
1022988|NCT03019328|food allergens|food allergens
1022989|NCT03019328|atopic dermatitis|atopic dermatitis
1022990|NCT03019328|eczema|eczema
1022991|NCT03019328|infant food allergy testing|infant food allergy testing
1022992|NCT03019328|skin prick testing|skin prick testing
1022993|NCT03019328|peanut IgE|peanut ige
1022994|NCT03019328|early peanut introduction|early peanut introduction
1022995|NCT03019328|food allergy prevention|food allergy prevention
1022996|NCT03019315|Ovarian Cancer|ovarian cancer
1022997|NCT03019315|Chemotherapy|chemotherapy
1022998|NCT03019315|Response Rate|response rate
1022999|NCT03019315|Survival|survival
1023000|NCT03019250|Colostrum|colostrum
1023001|NCT03019250|Critical Care Outcomes|critical care outcomes
1023002|NCT03019250|Intensive Care Unit|intensive care unit
1023003|NCT03019250|Inflammation|inflammation
1023004|NCT03019250|Infection|infection
1023005|NCT03019250|mortality|mortality
1023006|NCT03019224|Tooth whitening|tooth whitening
1023007|NCT03019224|Dentifrice|dentifrice
1023008|NCT03019224|Sensitivity|sensitivity
1023009|NCT03019211|Physical Therapy Modalities|physical therapy modalities
1023010|NCT03019211|Accidental Fall|accidental fall
1023011|NCT03019211|Elderly|elderly
1023012|NCT03019211|Hydrotherapy|hydrotherapy
1023013|NCT03019211|Nursing Home|nursing home
1023014|NCT03019198|Tranexamic Acid|tranexamic acid
1023015|NCT03019198|Blood loss|blood loss
1023016|NCT03019198|Tranfusion|tranfusion
1023017|NCT03019185|Alport Syndrome|alport syndrome
1023018|NCT03019185|Bardoxolone methyl|bardoxolone methyl
1023019|NCT03019185|CDDO-ME|cddo-me
1023020|NCT03019185|RTA 402|rta 402
1023021|NCT03019146|Prehabilitation|prehabilitation
1023022|NCT03019133|Heart rate|heart rate
1023023|NCT03019133|Blood pressure variability|blood pressure variability
1023024|NCT03019094|overactive bladder|overactive bladder
1023025|NCT03019094|urge urinary incontinence|urge urinary incontinence
1023026|NCT03019094|urgency frequency|urgency frequency
1023027|NCT03019068|recruitment potential|recruitment potential
1023028|NCT03019068|prediction|prediction
1023029|NCT03019068|databases|databases
1023030|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
1023031|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
1023032|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
1023033|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
1023034|NCT03019042|traditional Chinese medicine|traditional chinese medicine
1023035|NCT03019042|randomized controlled trial|randomized controlled trial
1668660|NCT00111397|Microarray|microarray
1023036|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
1023037|NCT03019003|Head and Neck Cancer|head and neck cancer
1023038|NCT03018964|Single incision|single incision
1023039|NCT03018964|Solo surgery|solo surgery
1023040|NCT03018951|frailty, assessement|frailty, assessement
1023041|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
1023042|NCT03018938|basal insulin analog|basal insulin analog
1023043|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
1023044|NCT03018912|Primary Care|primary care
1023045|NCT03018912|Sleep Medicine|sleep medicine
1023046|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1023047|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
1023048|NCT03018912|Insomnia|insomnia
1023049|NCT03018912|Complex Sleep Disorders|complex sleep disorders
1023050|NCT03018912|Predictive Analytics|predictive analytics
1023051|NCT03018912|Screening|screening
1023052|NCT03018912|Therapy Outcomes|therapy outcomes
1023053|NCT03018899|paravertebral block|paravertebral block
1023054|NCT03018899|ultrasound|ultrasound
1023055|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1023056|NCT03018899|postoperative pain|postoperative pain
1023057|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
1023058|NCT03018873|acute myocardial infarction|acute myocardial infarction
1023059|NCT03018860|Active second stage|active second stage
1023060|NCT03018860|Neonatal morbidity|neonatal morbidity
1023061|NCT03018860|Operative delivery|operative delivery
1023062|NCT03018860|Labor|labor
1023063|NCT03018834|Acute Myocarditis|acute myocarditis
1023064|NCT03018834|ANAKINRA|anakinra
1023065|NCT03018808|Eosinophilia|eosinophilia
1023066|NCT03018808|COPD prevalence|copd prevalence
1023067|NCT03018808|Primary care subjects|primary care subjects
1023068|NCT03018795|peri-implantitis|peri-implantitis
1023069|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
1023070|NCT03018795|ozone therapy|ozone therapy
1023071|NCT03018730|Fabry disease|fabry disease
1023072|NCT03018730|Enzyme-Replacement Therapy|enzyme-replacement therapy
1023073|NCT03018730|pegunigalsidase alfa|pegunigalsidase alfa
1023074|NCT03018730|PRX-102|prx-102
1023075|NCT03018730|alpha galactosidase-A|alpha galactosidase-a
1023076|NCT03018704|alcoholism|alcoholism
1023077|NCT03018704|treatment|treatment
1023078|NCT03018652|COPD|copd
1023079|NCT03018652|Ig|ig
1023080|NCT03018652|IPRAC|iprac
1023081|NCT03018652|outpatient|outpatient
1023082|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
1023083|NCT03018626|R-ACVBP|r-acvbp
1023084|NCT03018626|DA-EPOCH-R|da-epoch-r
1023085|NCT03018613|Chronic Functional Constipation|chronic functional constipation
1023683|NCT03014947|Humira®|humira®
1023086|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
1023087|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
1023088|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
1023089|NCT03018509|JTE-451|jte-451
1023090|NCT03018509|psoriasis|psoriasis
1023091|NCT03018470|COPD|copd
1023092|NCT03018470|Non invasive ventilation|non invasive ventilation
1023093|NCT03018470|NIV|niv
1023094|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
1023095|NCT03018470|AECOPD|aecopd
1023096|NCT03018470|Telemonitoring|telemonitoring
1023097|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
1023098|NCT03018457|alveolar bone|alveolar bone
1023099|NCT03018457|osseointegration|osseointegration
1023100|NCT03018457|dental implant|dental implant
1023101|NCT03018431|Lung ultrasonography|lung ultrasonography
1023102|NCT03018431|Chest CT scan|chest ct scan
1023103|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
1023104|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
1023105|NCT03018431|antibiotic stewardship|antibiotic stewardship
1023106|NCT03018418|Anal Cancer|anal cancer
1023107|NCT03018379|Obesity|obesity
1023108|NCT03018379|Body composition|body composition
1023109|NCT03018379|energy expenditure|energy expenditure
1023110|NCT03018379|sedentarity|sedentarity
1023111|NCT03018379|dietary behaviors|dietary behaviors
1023112|NCT03018366|estrogen|estrogen
1023113|NCT03018366|premenopause|premenopause
1023114|NCT03018366|menopause|menopause
1023115|NCT03018366|amenorrhea|amenorrhea
1023116|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
1023117|NCT03018353|Jail|jail
1023118|NCT03018353|Patient Navigation|patient navigation
1023119|NCT03018353|Incarcerated Population|incarcerated population
1023120|NCT03018353|HCV|hcv
1023121|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
1023122|NCT03018353|Hepatitis C|hepatitis c
1023123|NCT03018288|Malignant Gliomas|malignant gliomas
1023124|NCT03018288|Immunotherapy|immunotherapy
1023125|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
1023126|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
1023127|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
1023128|NCT03018275|Transepidermal Water Loss|transepidermal water loss
1023129|NCT03018275|Allergic Diseases|allergic diseases
1668661|NCT00111397|Proteomics|proteomics
1023130|NCT03018262|Surround Inhibition|surround inhibition
1023131|NCT03018262|Motor Control|motor control
1023132|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1023133|NCT03018262|TMS-Evoked Potential|tms-evoked potential
1023134|NCT03018236|cocaine|cocaine
1023135|NCT03018236|alcohol|alcohol
1023136|NCT03018236|substance use disorders|substance use disorders
1023137|NCT03018236|addiction|addiction
1023138|NCT03018236|N-acetylcysteine|n-acetylcysteine
1023139|NCT03018236|randomized controlled trial|randomized controlled trial
1023140|NCT03018223|Acute leukemia in CR|acute leukemia in cr
1023141|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
1023142|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
1023143|NCT03018223|Graft vs. Host Disease|graft vs. host disease
1023144|NCT03018223|GVHD|gvhd
1023145|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
1023146|NCT03018197|Personal Health Record|personal health record
1023147|NCT03018197|Medication Knowledge|medication knowledge
1023148|NCT03018197|Anticoagulants|anticoagulants
1023149|NCT03018197|Patient Engagement|patient engagement
1023150|NCT03018184|MRI|mri
1023151|NCT03018184|CCSA|ccsa
1023152|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
1023153|NCT03018184|Strength|strength
1023154|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
1023155|NCT03018132|perinatal mental health|perinatal mental health
1023156|NCT03018106|Female sexual disorder|female sexual disorder
1023157|NCT03018106|Aging|aging
1023158|NCT03018106|Menopause|menopause
1023159|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
1023160|NCT03018106|Female urogenital disorder|female urogenital disorder
1023161|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
1023162|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
1023163|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
1023164|NCT03018054|Japanese|japanese
1023165|NCT03018041|Kidney transplantation|kidney transplantation
1023166|NCT03018041|Renal transplantation|renal transplantation
1023167|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
1023168|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
1023169|NCT03018041|Fatty acids|fatty acids
1023170|NCT03018041|Inflammation|inflammation
1023171|NCT03018041|Interstitial fibrosis|interstitial fibrosis
1023172|NCT03018041|Glomerular filtration rate|glomerular filtration rate
1023173|NCT03018041|Renal function|renal function
1023174|NCT03018041|Allograft function|allograft function
1023175|NCT03018041|Proteinuria|proteinuria
1023176|NCT03018041|Blood pressure|blood pressure
1023177|NCT03018041|Heart rate variability|heart rate variability
1023178|NCT03018041|Lipids|lipids
1023179|NCT03018041|Blood glucose|blood glucose
1023180|NCT03018041|Body mass index|body mass index
1023181|NCT03018041|Fatty acid composition|fatty acid composition
1023182|NCT03018041|Gas chromatography|gas chromatography
1023183|NCT03018041|Interventional study|interventional study
1023184|NCT03018041|Allograft biopsy|allograft biopsy
1023185|NCT03018041|Kidney biopsy|kidney biopsy
1023186|NCT03018015|Bioequivalence|bioequivalence
1023187|NCT03018015|Healthy|healthy
1023188|NCT03018015|Bioavailability|bioavailability
1023189|NCT03018015|Ibuprofen|ibuprofen
1023190|NCT03018002|HIV, PMTCT|hiv, pmtct
1023191|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
1023192|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
1023193|NCT03017963|acute coronary syndrome|acute coronary syndrome
1023194|NCT03017963|sodium thiosulfate|sodium thiosulfate
1023195|NCT03017963|maximum tolerable dose|maximum tolerable dose
1023196|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
1023197|NCT03017911|PICC Line|picc line
1023198|NCT03017911|Complications|complications
1023199|NCT03017911|Thrombosis|thrombosis
1023200|NCT03017911|Infection|infection
1023201|NCT03017898|FiLaC|filac
1023202|NCT03017898|Fistula Laser Closure|fistula laser closure
1023203|NCT03017898|Laser Coagulation|laser coagulation
1023204|NCT03017872|HIV, second-line|hiv, second-line
1023205|NCT03017833|Solid Tumors|solid tumors
1023206|NCT03017833|Advanced Cancer|advanced cancer
1023207|NCT03017833|Metformin|metformin
1023208|NCT03017833|Metformin ER|metformin er
1023209|NCT03017833|TAK-228|tak-228
1023210|NCT03017833|MLN0128|mln0128
1023211|NCT03017833|TAK228|tak228
1023212|NCT03017794|Radiotherapy|radiotherapy
1023213|NCT03017794|Chromogranin A|chromogranin a
1023214|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
1023215|NCT03017781|Bipolar|bipolar
1023216|NCT03017781|High-Risk Off-Spring|high-risk off-spring
1023217|NCT03017781|Psychosocial Functioning|psychosocial functioning
1023218|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
1023219|NCT03017716|Inflammatory back pain|inflammatory back pain
1023220|NCT03017716|gluten-free diet|gluten-free diet
1023221|NCT03017716|celiac disease|celiac disease
1023222|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
1023223|NCT03017703|Endothelial dysfunction|endothelial dysfunction
1669672|NCT00108810|Pain|pain
1023224|NCT03017703|Insulin resistance|insulin resistance
1023225|NCT03017703|Type 2 diabetes|type 2 diabetes
1023226|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
1023227|NCT03017625|COPD|copd
1023228|NCT03017625|Cardiovascular Disease|cardiovascular disease
1023229|NCT03017625|Platelets|platelets
1023230|NCT03017625|Inflammation|inflammation
1023231|NCT03017612|Presbyopia|presbyopia
1023232|NCT03017573|Immunological biomarkers|immunological biomarkers
1023233|NCT03017573|molecular profil|molecular profil
1023234|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
1023235|NCT03017560|Breast Cancer|breast cancer
1023236|NCT03017560|Chemotherapy|chemotherapy
1023237|NCT03017560|Verbal Memory|verbal memory
1023238|NCT03017560|Processing Speed|processing speed
1023239|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
1023240|NCT03017534|Non-Specific Effects|non-specific effects
1023241|NCT03017534|Manual Therapy|manual therapy
1023242|NCT03017534|Neurodynamics|neurodynamics
1023243|NCT03017534|Sham|sham
1023244|NCT03017521|Refractory solid tumors|refractory solid tumors
1023245|NCT03017521|AKT inhibitor|akt inhibitor
1023246|NCT03017508|Cross-over study|cross-over study
1023247|NCT03017508|Riluzole|riluzole
1023248|NCT03017508|Double-blind study|double-blind study
1023249|NCT03017508|Speech task|speech task
1023250|NCT03017508|Social Anxiety Disorder|social anxiety disorder
1023251|NCT03017495|food-drug interaction|food-drug interaction
1023252|NCT03017495|drug-drug interaction|drug-drug interaction
1023253|NCT03017495|pharmacokinetics|pharmacokinetics
1023254|NCT03017469|Resilience|resilience
1023255|NCT03017469|Workplace Stress|workplace stress
1023256|NCT03017469|Occupational Fatigue|occupational fatigue
1023257|NCT03017469|Compassion Fatigue|compassion fatigue
1023258|NCT03017469|Peer Support|peer support
1023259|NCT03017469|Self-Care|self-care
1023260|NCT03017469|Employee Assistance|employee assistance
1023261|NCT03017456|Survivorship|survivorship
1023262|NCT03017456|Prostate Cancer|prostate cancer
1023263|NCT03017456|Survivorship Care Plan|survivorship care plan
1023264|NCT03017443|Weight Loss|weight loss
1023265|NCT03017443|Obesity|obesity
1023266|NCT03017443|Overweight|overweight
1023267|NCT03017391|palliative care|palliative care
1023268|NCT03017391|palliative medicine|palliative medicine
1023269|NCT03017391|palliative|palliative
1023270|NCT03017378|influenza vector|influenza vector
1023271|NCT03017378|tuberculosis|tuberculosis
1023272|NCT03017378|vaccine|vaccine
1023273|NCT03017365|Motor Control|motor control
1023274|NCT03017365|Balance|balance
1023275|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1023276|NCT03017352|Exenatide|exenatide
1023277|NCT03017352|Incretins|incretins
1023278|NCT03017352|GLP-1|glp-1
1023279|NCT03017352|Insulin|insulin
1023280|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
1023281|NCT03017339|Exercise Therapy|exercise therapy
1023287|NCT03017261|Osteoarthritis|osteoarthritis
1023288|NCT03017261|Arthroplasty|arthroplasty
1023289|NCT03017261|Robotic Surgery|robotic surgery
1023290|NCT03017261|Knee|knee
1023291|NCT03017248|pain|pain
1023292|NCT03017248|ketamine|ketamine
1023293|NCT03017248|morphine|morphine
1023294|NCT03017248|analgesia|analgesia
1023295|NCT03017248|emergency|emergency
1023296|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
1023297|NCT03017144|human factors|human factors
1023298|NCT03017144|team work|team work
1023413|NCT03016442|Labor induction|labor induction
1023299|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
1023300|NCT03017144|technical skills (TS)|technical skills (ts)
1023301|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1023302|NCT03017144|Advanced cardiac life support|advanced cardiac life support
1023303|NCT03017079|Semi-solidification|semi-solidification
1023304|NCT03017079|caloric debt|caloric debt
1023305|NCT03017079|enteral nutrition|enteral nutrition
1023306|NCT03017079|critical illness|critical illness
1023307|NCT03017066|Ultrasonography|ultrasonography
1023308|NCT03017066|Child|child
1023309|NCT03017066|Preoperative period|preoperative period
1023310|NCT03017053|Neck dissection|neck dissection
1023311|NCT03017053|Survival|survival
1023312|NCT03017053|Early oral cancer|early oral cancer
1023313|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
1023314|NCT03017027|human-animal interaction|human-animal interaction
1023315|NCT03017014|Crohn's Disease|crohn's disease
1023316|NCT03017014|Adalimumab|adalimumab
1023317|NCT03017014|Humira®|humira®
1023318|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
1023319|NCT03016988|Bortezomib|bortezomib
1023320|NCT03016988|Fludarabine|fludarabine
1023321|NCT03016988|Cytarabine|cytarabine
1023329|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
1023330|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
1023331|NCT03016936|Noncardiac surgery|noncardiac surgery
1023332|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
1023333|NCT03016923|cerebral palsy|cerebral palsy
1023334|NCT03016923|hemiplegia|hemiplegia
1023336|NCT03016923|grasping|grasping
1023337|NCT03016897|ALS|als
1023338|NCT03016897|neurodegenerative|neurodegenerative
1023339|NCT03016884|Herpes Zoster|herpes zoster
1023340|NCT03016884|anti TNF alpha|anti tnf alpha
1023341|NCT03016884|tofacitinib|tofacitinib
1023342|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
1023343|NCT03016845|ciprofloxacin|ciprofloxacin
1023344|NCT03016845|pharmacokinetics|pharmacokinetics
1023345|NCT03016845|Intensive Care Unit|intensive care unit
1023346|NCT03016845|Cystatin C|cystatin c
1023347|NCT03016845|CKD-EPI|ckd-epi
1023348|NCT03016845|renal function|renal function
1023349|NCT03016780|Ulcerative Colitis|ulcerative colitis
1023350|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
1023351|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
1023352|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
1023353|NCT03016767|oral feeding|oral feeding
1023354|NCT03016767|oral stimulation|oral stimulation
1023355|NCT03016767|physiotherapy intervention|physiotherapy intervention
1023356|NCT03016754|sudden cardiac death|sudden cardiac death
1023357|NCT03016754|SCD|scd
1023358|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
1023359|NCT03016754|SCA|sca
1023360|NCT03016754|heart failure|heart failure
1023361|NCT03016754|HF|hf
1023362|NCT03016741|cognitive function|cognitive function
1023363|NCT03016741|hormonal therapy|hormonal therapy
1023364|NCT03016741|cancer survivorship|cancer survivorship
1023365|NCT03016741|dementia|dementia
1023366|NCT03016741|cognitive dysfunction|cognitive dysfunction
1023367|NCT03016741|mild cognitive impairment|mild cognitive impairment
1023368|NCT03016728|exercise|exercise
1023369|NCT03016728|physical activity|physical activity
1023370|NCT03016728|pilot study|pilot study
1023371|NCT03016728|randomized controlled trial|randomized controlled trial
1023372|NCT03016728|cancer|cancer
1023373|NCT03016728|adolescent and young adult|adolescent and young adult
1023374|NCT03016728|AYA|aya
1023375|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
1023376|NCT03016676|Spinal Manipulation|spinal manipulation
1023377|NCT03016676|Postural Instability|postural instability
1023378|NCT03016676|Quality of Life|quality of life
1023989|NCT03013244|prevention|prevention
1023383|NCT03016598|oxytocin|oxytocin
1023384|NCT03016598|substance-related disorders|substance-related disorders
1023385|NCT03016598|Opioid Replacement Therapy|opioid replacement therapy
1023386|NCT03016598|Psychophysiology|psychophysiology
1023387|NCT03016598|Stress Biomarkers|stress biomarkers
1023393|NCT03016559|releasing muscle|releasing muscle
1023394|NCT03016559|quadratus lumborum|quadratus lumborum
1023395|NCT03016559|hip angle|hip angle
1023396|NCT03016546|Pregnancy|pregnancy
1023397|NCT03016533|Dolutegravir|dolutegravir
1023398|NCT03016533|Continued access study|continued access study
1023399|NCT03016533|HIV-1|hiv-1
1023400|NCT03016533|GSK1349572|gsk1349572
1023401|NCT03016533|Pediatric|pediatric
1023402|NCT03016507|intraocular pressure|intraocular pressure
1023403|NCT03016507|phacoemulsification|phacoemulsification
1023404|NCT03016507|cataract|cataract
1023405|NCT03016468|Oral Treprostinil|oral treprostinil
1023406|NCT03016468|Remodulin|remodulin
1023407|NCT03016468|Selexipag|selexipag
1023408|NCT03016468|6 Minute Walk Test|6 minute walk test
1023409|NCT03016455|Kidney Transplant|kidney transplant
1023410|NCT03016455|Immunology|immunology
1023411|NCT03016442|Double balloon catheter|double balloon catheter
1023412|NCT03016442|Dinoprostone|dinoprostone
1023414|NCT03016429|pacemaker|pacemaker
1023415|NCT03016429|defibrillator|defibrillator
1023416|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
1023417|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
1023418|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
1023419|NCT03016390|Pacemaker|pacemaker
1023420|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
1023547|NCT03015597|Tobacco Smoking|tobacco smoking
1023421|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
1023422|NCT03016390|Keyless access system|keyless access system
1023423|NCT03016390|Keyless entry system|keyless entry system
1023424|NCT03016377|CAR T cells|car t cells
1023425|NCT03016377|CD19|cd19
1023426|NCT03016377|Leukemia|leukemia
1023427|NCT03016377|T Lymphocytes|t lymphocytes
1023428|NCT03016377|AP1903|ap1903
1023429|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
1023430|NCT03016351|Hypertension|hypertension
1023431|NCT03016351|Exercise|exercise
1023432|NCT03016351|African Americans|african americans
1023433|NCT03016351|Arterial Function|arterial function
1023434|NCT03016351|Arterial Stiffness|arterial stiffness
1023435|NCT03016286|Whole body vibration|whole body vibration
1023436|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
1023437|NCT03016286|H-reflex|h-reflex
1023438|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
1023439|NCT03016260|Anti TNF|anti tnf
1023440|NCT03016260|Infliximab|infliximab
1023441|NCT03016260|Adalimumab|adalimumab
1023442|NCT03016260|Etanercept|etanercept
1023443|NCT03016260|Golimumab|golimumab
1023444|NCT03016260|Certolizumab Pegol|certolizumab pegol
1023445|NCT03016260|Infliximab biosimilar|infliximab biosimilar
1023446|NCT03016260|Etanercept biosimilar|etanercept biosimilar
1023447|NCT03016260|Methotrexate|methotrexate
1023448|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
1023449|NCT03016234|intraocular pressure|intraocular pressure
1023450|NCT03016234|trendelenburg position|trendelenburg position
1023451|NCT03016234|pneumoperitoneum|pneumoperitoneum
1023452|NCT03016221|local skin responses|local skin responses
1023453|NCT03016221|hyperemia|hyperemia
1023454|NCT03016221|thermal sensation|thermal sensation
1023455|NCT03016221|topical warming ointments|topical warming ointments
1023456|NCT03016221|topical cooling ointments|topical cooling ointments
1023457|NCT03016221|skin perfusion|skin perfusion
1023458|NCT03016221|subjective thermal sensation|subjective thermal sensation
1023459|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
1023460|NCT03016221|skin temperature|skin temperature
1023461|NCT03016221|skin redness|skin redness
1023462|NCT03016221|erythema|erythema
1023463|NCT03016143|phase II|phase ii
1023464|NCT03016143|split|split
1023465|NCT03016143|vaccine|vaccine
1023466|NCT03016130|leukemia|leukemia
1023467|NCT03016130|myelodysplastic|myelodysplastic
1023468|NCT03016130|myeloid|myeloid
1023469|NCT03016130|lymphoblastic|lymphoblastic
1023470|NCT03016130|diet|diet
1023471|NCT03016130|infection|infection
1023472|NCT03016130|hematopoietic|hematopoietic
1023473|NCT03016130|stem cell|stem cell
1023474|NCT03016130|transplant|transplant
1023475|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
1023476|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
1023477|NCT03016104|bipolar mania|bipolar mania
1023478|NCT03016104|cognition|cognition
1023479|NCT03016104|controlled trial|controlled trial
1023480|NCT03016052|ABMT|abmt
1023481|NCT03016052|social anxiety|social anxiety
1023482|NCT03016052|generalized anxiety|generalized anxiety
1023483|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
1023484|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1023485|NCT03016000|Thalidomide|thalidomide
1023486|NCT03016000|Maintenance|maintenance
1023487|NCT03015987|Diode laser|diode laser
1023488|NCT03015987|asymptomatic pulp|asymptomatic pulp
1023489|NCT03015987|Laser activated irrigation|laser activated irrigation
1023490|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
1023491|NCT03015987|post obturation pain|post obturation pain
1023492|NCT03015935|Obesity, Morbid|obesity, morbid
1023493|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
1023494|NCT03015883|Alpha emitting radiation|alpha emitting radiation
1023495|NCT03015870|vocal dysfunction|vocal dysfunction
1023496|NCT03015870|voice|voice
1023497|NCT03015870|vocal folds|vocal folds
1023498|NCT03015870|vocal aging|vocal aging
1023499|NCT03015844|MIBG|mibg
1023500|NCT03015844|131I-MIBG|131i-mibg
1023501|NCT03015844|relapsed|relapsed
1023502|NCT03015844|neuroblastoma|neuroblastoma
1023503|NCT03015844|pheochromocytoma|pheochromocytoma
1023504|NCT03015831|Atrial fibrillation|atrial fibrillation
1023505|NCT03015831|Cardiac surgery|cardiac surgery
1023506|NCT03015831|Colchicine|colchicine
1023507|NCT03015766|insomnia|insomnia
1023508|NCT03015766|hemodialysis|hemodialysis
1023509|NCT03015766|auricular acupressure|auricular acupressure
1023510|NCT03015766|randomized controlled trial|randomized controlled trial
1023511|NCT03015753|Migraine|migraine
1023512|NCT03015753|Tai Chi|tai chi
1023515|NCT03015740|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
1023516|NCT03015740|Other disorders of kidney and ureter|other disorders of kidney and ureter
1023517|NCT03015740|Renal cell carcinoma|renal cell carcinoma
1023518|NCT03015740|RCC|rcc
1023519|NCT03015740|Metastatic|metastatic
1023520|NCT03015740|MGCD516|mgcd516
1023521|NCT03015740|Nivolumab|nivolumab
1023522|NCT03015740|BMS-936558|bms-936558
1023523|NCT03015740|Opdivo|opdivo
1023524|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1023525|NCT03015727|Induction chemotherapy|induction chemotherapy
1023526|NCT03015727|radiotherapy|radiotherapy
1023527|NCT03015727|chemoradiotherapy|chemoradiotherapy
1023528|NCT03015701|Unresectable|unresectable
1023529|NCT03015688|Biomarkers|biomarkers
1023530|NCT03015662|Quality of Life|quality of life
1023531|NCT03015662|Fatigue|fatigue
1023532|NCT03015662|Anxiety|anxiety
1023533|NCT03015662|Physical Therapy Modalities|physical therapy modalities
1023534|NCT03015662|Pain|pain
1023535|NCT03015649|breast cancer, surgical guidance system|breast cancer, surgical guidance system
1023536|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
1023537|NCT03015636|Psychological Intervention|psychological intervention
1669776|NCT00108394|Dialysis|dialysis
1023538|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
1023539|NCT03015623|MSC|msc
1023540|NCT03015623|Stem cells|stem cells
1023541|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
1023542|NCT03015610|Personalized Medicine|personalized medicine
1023543|NCT03015610|CYP2C19|cyp2c19
1023544|NCT03015610|Lansoprazole|lansoprazole
1023545|NCT03015610|Pharmacokinetics|pharmacokinetics
1023546|NCT03015597|Smoking|smoking
1023548|NCT03015597|Smoking, Tobacco|smoking, tobacco
1023549|NCT03015597|Smoking Cessation|smoking cessation
1023550|NCT03015597|Opiate Addiction|opiate addiction
1023551|NCT03015597|Opiate Dependence|opiate dependence
1023552|NCT03015597|Contingency Management|contingency management
1023553|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
1023554|NCT03015571|cervical inlet patch|cervical inlet patch
1023555|NCT03015571|narrow band imaging|narrow band imaging
1023556|NCT03015571|endoscopy|endoscopy
1023557|NCT03015558|Drug Resistance|drug resistance
1023558|NCT03015558|Neuropathic Pain|neuropathic pain
1023559|NCT03015558|opercular-insular cortex|opercular-insular cortex
1023560|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1023561|NCT03015545|Muscle Stiffness|muscle stiffness
1023562|NCT03015545|Ultrasound elastography|ultrasound elastography
1023563|NCT03015545|H-reflex|h-reflex
1023564|NCT03015545|Whole body vibration|whole body vibration
1023565|NCT03015532|knee|knee
1023566|NCT03015532|knee replacement|knee replacement
1023567|NCT03015532|arthroplasty|arthroplasty
1023568|NCT03015532|joint replacement|joint replacement
1023569|NCT03015532|knee pain|knee pain
1023570|NCT03015519|GSK716155|gsk716155
1023571|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
1023572|NCT03015519|albiglutide|albiglutide
1023573|NCT03015519|safety|safety
1023574|NCT03015519|pediatric|pediatric
1023575|NCT03015519|efficacy|efficacy
1023576|NCT03015493|Neck pain|neck pain
1023577|NCT03015493|Neurodynamics|neurodynamics
1023578|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
1023579|NCT03015480|Mobile Application|mobile application
1023580|NCT03015480|Chronic Kidney Disease|chronic kidney disease
1023581|NCT03015480|Diabetes Mellitus|diabetes mellitus
1023582|NCT03015480|Albuminuria|albuminuria
1023583|NCT03015480|Diet|diet
1023584|NCT03015467|acute pancreatitis|acute pancreatitis
1023585|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
1023586|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
1023587|NCT03015454|InSight|insight
1023588|NCT03015454|Dascena|dascena
1023589|NCT03015441|Healthy subjects|healthy subjects
1023590|NCT03015441|Probiotics|probiotics
1023591|NCT03015441|Breath test|breath test
1023592|NCT03015441|Dihydrogen|dihydrogen
1023593|NCT03015441|Methane|methane
1023594|NCT03015441|Intestinal gas production|intestinal gas production
1023595|NCT03015441|Gut microbiota|gut microbiota
1023596|NCT03015428|Family caregivers|family caregivers
1023597|NCT03015428|training programme|training programme
1023598|NCT03015428|dementia|dementia
1023599|NCT03015415|elbow|elbow
1023600|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
1023601|NCT03015415|elbow contractures|elbow contractures
1023602|NCT03015415|stiff elbow|stiff elbow
1023603|NCT03015415|dynamic orthoses|dynamic orthoses
1023604|NCT03015415|Dynamic splint|dynamic splint
1023605|NCT03015415|Rehabilitation|rehabilitation
1023606|NCT03015415|Splint|splint
1023607|NCT03015415|Effectiveness of bracing|effectiveness of bracing
1023608|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
1023609|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
1023610|NCT03015376|next-generation sequencing|next-generation sequencing
1023611|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1023612|NCT03015363|Hypertension|hypertension
1023613|NCT03015363|Telemonitoring|telemonitoring
1023614|NCT03015363|Vital signs|vital signs
1023615|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
1023616|NCT03015350|blood desflurane concentration|blood desflurane concentration
1023617|NCT03015350|one lung ventilation|one lung ventilation
1023618|NCT03015311|Blood pressure control|blood pressure control
1023619|NCT03015298|gastric cancer|gastric cancer
1023620|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
1023621|NCT03015298|PET/CT|pet/ct
1023622|NCT03015272|minimally-verbal|minimally-verbal
1023623|NCT03015272|children|children
1023624|NCT03015272|intervention|intervention
1023625|NCT03015272|singing|singing
1023626|NCT03015272|music|music
1023627|NCT03015233|Lactate|lactate
1023628|NCT03015233|Acute Abdominal Pain|acute abdominal pain
1023629|NCT03015233|Acute Abdomen|acute abdomen
1023630|NCT03015233|Strong Ion Gap|strong ion gap
1023631|NCT03015233|Renal Colic|renal colic
1023632|NCT03015233|Emergency Department|emergency department
1023633|NCT03015233|Emergency|emergency
1023634|NCT03015233|Surgery|surgery
1023635|NCT03015233|Stewart|stewart
1023636|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
1333131|NCT01444430|Symbicort pMDI|symbicort pmdi
1023637|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
1023638|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
1023639|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
1023640|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
1023641|NCT03015181|Broadly Neutralizing|broadly neutralizing
1023642|NCT03015181|HIV Prevention|hiv prevention
1023643|NCT03015181|Anti-Drug Antibody|anti-drug antibody
1023644|NCT03015181|HIV-1|hiv-1
1023645|NCT03015181|Immune Response|immune response
1023646|NCT03015129|Durvalumab|durvalumab
1023647|NCT03015129|MEDI4736|medi4736
1023648|NCT03015129|Tremelimumab|tremelimumab
1023649|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
1023650|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
1023651|NCT03015129|16-1491|16-1491
1023652|NCT03015116|photobiomodulation|photobiomodulation
1023653|NCT03015116|plantar fasciitis|plantar fasciitis
1023654|NCT03015090|COPD|copd
1023655|NCT03015090|CYP1A2|cyp1a2
1023656|NCT03015090|Theophylline|theophylline
1023657|NCT03015077|Glutamine|glutamine
1023658|NCT03015051|Bronchiolitis|bronchiolitis
1023659|NCT03015051|High flow nasal cannula|high flow nasal cannula
1023660|NCT03015051|Oxygen therapy|oxygen therapy
1023661|NCT03015025|Acenocoumarol|acenocoumarol
1023662|NCT03015025|Cytochrome P450|cytochrome p450
1023663|NCT03015025|Pharmacogenetics|pharmacogenetics
1023664|NCT03015025|Algorithm|algorithm
1023665|NCT03015025|CYP2C9|cyp2c9
1023666|NCT03015025|VKORC1|vkorc1
1023667|NCT03015025|CYP4F2|cyp4f2
1023668|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
1023669|NCT03015012|Nutrigenomics|nutrigenomics
1023670|NCT03015012|Genetics|genetics
1023671|NCT03015012|Overweight|overweight
1023672|NCT03015012|Obesity|obesity
1023673|NCT03015012|Transplantation|transplantation
1023674|NCT03015012|Nutrition|nutrition
1023675|NCT03015012|Dietetics|dietetics
1023676|NCT03015012|BMI|bmi
1023677|NCT03015012|Body Composition|body composition
1023678|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1023679|NCT03014999|Spinal Cord Injury|spinal cord injury
1023680|NCT03014999|Humans|humans
1023681|NCT03014986|HCV|hcv
1023682|NCT03014947|MSB11022|msb11022
1023684|NCT03014934|Aspergillosis|aspergillosis
1023685|NCT03014934|IA|ia
1023686|NCT03014908|Type 1 diabetes|type 1 diabetes
1023687|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
1023688|NCT03014908|Metabolomics|metabolomics
1023689|NCT03014908|Pediatrics|pediatrics
1023690|NCT03014895|E3112|e3112
1023691|NCT03014895|Pharmacokinetics|pharmacokinetics
1023692|NCT03014895|Japanese|japanese
1023693|NCT03014869|COPD Exacerbation|copd exacerbation
1023694|NCT03014869|High Flow Oxygen|high flow oxygen
1023695|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
1023696|NCT03014869|moderate|moderate
1023697|NCT03014856|Metabolic syndrome|metabolic syndrome
1023698|NCT03014856|Metabolomics|metabolomics
1023699|NCT03014856|NMR spectroscopy|nmr spectroscopy
1023700|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
1023701|NCT03014791|Epidemiology|epidemiology
1023702|NCT03014791|Ethnicity|ethnicity
1023703|NCT03014791|Age|age
1023704|NCT03014791|Weight|weight
1023705|NCT03014791|Hypertensive|hypertensive
1023706|NCT03014791|Cardiac Output|cardiac output
1023707|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
1023708|NCT03014791|Arterial Stiffness|arterial stiffness
1023709|NCT03014791|Healthy Volunteers|healthy volunteers
1023710|NCT03014791|Endothelial function|endothelial function
1023711|NCT03014791|Arterial Structure|arterial structure
1023712|NCT03014791|Left ventricular mass/function|left ventricular mass/function
1023713|NCT03014765|endothelial dysfunction|endothelial dysfunction
1023714|NCT03014765|perioperative stress|perioperative stress
1023715|NCT03014765|cardiovascular complications|cardiovascular complications
1023716|NCT03014765|inflammatory markers|inflammatory markers
1023818|NCT03014232|cytokines|cytokines
1023717|NCT03014739|Elastography|elastography
1023718|NCT03014739|Musculoskeletal System|musculoskeletal system
1023719|NCT03014726|reduced urine flow rate|reduced urine flow rate
1023720|NCT03014726|low peak flow rate|low peak flow rate
1023721|NCT03014726|urinary tract infections|urinary tract infections
1023722|NCT03014713|Dexmedetomidine|dexmedetomidine
1023723|NCT03014713|Dezocine|dezocine
1023724|NCT03014713|Flubiprofen|flubiprofen
1023725|NCT03014713|Analgesia|analgesia
1023726|NCT03014713|Colorectal Surgery|colorectal surgery
1023727|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
1023728|NCT03014674|SB-240563|sb-240563
1023729|NCT03014674|subcutaneous|subcutaneous
1023730|NCT03014674|lyophilized drug product|lyophilized drug product
1023731|NCT03014674|Mepolizumab|mepolizumab
1023732|NCT03014674|liquid drug product|liquid drug product
1023733|NCT03014674|safety syringe|safety syringe
1023734|NCT03014674|auto injector|auto injector
1023735|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
1023736|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
1023737|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
1023738|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1023739|NCT03014609|cardiovascular risk|cardiovascular risk
1023740|NCT03014609|inflammation|inflammation
1023741|NCT03014609|oxidative stress|oxidative stress
1023742|NCT03014609|peripheral muscle function|peripheral muscle function
1023743|NCT03014570|behavior,|behavior,
1023744|NCT03014570|apathy|apathy
1023745|NCT03014570|mood|mood
1023746|NCT03014570|function|function
1023747|NCT03014570|cognition|cognition
1023748|NCT03014557|atrial fibrillation|atrial fibrillation
1023749|NCT03014557|left atrial appendage closure|left atrial appendage closure
1023750|NCT03014557|WATCHMAN|watchman
1023751|NCT03014518|Adolescent|adolescent
1023752|NCT03014518|Biological Markers|biological markers
1023753|NCT03014518|Biomarkers|biomarkers
1023754|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
1023755|NCT03014518|Blood brain barrier|blood brain barrier
1023756|NCT03014518|Clinical predictors|clinical predictors
1023757|NCT03014518|Cytokine|cytokine
1023758|NCT03014518|Feeling suicidal|feeling suicidal
1023759|NCT03014518|Inflammation|inflammation
1023760|NCT03014518|Inflammatory marker|inflammatory marker
1023761|NCT03014518|Inpatient discharge|inpatient discharge
1023762|NCT03014518|Interleukin-1 beta|interleukin-1 beta
1023763|NCT03014518|IL-1ß|il-1ß
1023764|NCT03014518|Interleukin-6|interleukin-6
1023765|NCT03014518|IL-6|il-6
1023766|NCT03014518|Kynurenic acid|kynurenic acid
1023767|NCT03014518|Kynurenine pathway|kynurenine pathway
1023768|NCT03014518|Neuroinflammation|neuroinflammation
1023769|NCT03014518|Novel marker|novel marker
1023770|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
1023771|NCT03014518|Picolinic acid|picolinic acid
1023772|NCT03014518|Plasma biomarker|plasma biomarker
1023773|NCT03014518|Psychiatric inpatient|psychiatric inpatient
1023774|NCT03014518|S100B|s100b
1023775|NCT03014518|Serum biomarker|serum biomarker
1023776|NCT03014518|Stress|stress
1023777|NCT03014518|Suicide|suicide
1023778|NCT03014518|Suicidal behavior|suicidal behavior
1023779|NCT03014518|Suicidal risk|suicidal risk
1023780|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
1023781|NCT03014518|TNF-α|tnf-α
1023782|NCT03014505|Cirrhosis|cirrhosis
1024092|NCT03012516|Exercise|exercise
1023783|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
1023784|NCT03014505|Intestinal flora|intestinal flora
1023785|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
1023786|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
1023787|NCT03014401|stem cell|stem cell
1023788|NCT03014401|knee pain|knee pain
1023789|NCT03014401|osteoarthritis|osteoarthritis
1023790|NCT03014401|arthritis|arthritis
1023791|NCT03014401|ADSC|adsc
1023792|NCT03014401|fat stem cell|fat stem cell
1023793|NCT03014349|Glaucoma|glaucoma
1023794|NCT03014349|Ocular hypertension|ocular hypertension
1023795|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
1023796|NCT03014323|insulin sensitivity|insulin sensitivity
1023797|NCT03014323|African American|african american
1023798|NCT03014323|obese|obese
1023799|NCT03014310|A/H5N8|a/h5n8
1023800|NCT03014310|Adjuvants|adjuvants
1023801|NCT03014310|AS03|as03
1023802|NCT03014310|Inactivated|inactivated
1023803|NCT03014310|Influenza|influenza
1023804|NCT03014310|MF59|mf59
1023805|NCT03014310|Monovalent|monovalent
1023806|NCT03014284|Tissue collection|tissue collection
1023807|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
1023808|NCT03014258|Biology|biology
1023809|NCT03014258|falciparum|falciparum
1023810|NCT03014258|Immunity|immunity
1023811|NCT03014258|Infections|infections
1023812|NCT03014258|Malaria|malaria
1023813|NCT03014258|Pf|pf
1023814|NCT03014258|Plasmodium|plasmodium
1023815|NCT03014258|Systems|systems
1023816|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
1023817|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
1023819|NCT03014180|Heart failure, CRT|heart failure, crt
1023820|NCT03014167|transmission interruption|transmission interruption
1023821|NCT03014167|intestinal nematodes|intestinal nematodes
1023822|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
1023823|NCT03014167|mass drug administration|mass drug administration
1023824|NCT03014167|Benin|benin
1023825|NCT03014167|India|india
1023826|NCT03014167|Malawi|malawi
1023827|NCT03014154|video games|video games
1023828|NCT03014154|asthma|asthma
1023829|NCT03014154|physical exercise|physical exercise
1023830|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
1023831|NCT03014128|upper extremity|upper extremity
1023832|NCT03014128|work|work
1023833|NCT03014128|surgical instruments|surgical instruments
1023834|NCT03014115|arachidonic|arachidonic
1023835|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
1023836|NCT03014115|infant formula|infant formula
1023837|NCT03014089|mRNA-1325|mrna-1325
1023838|NCT03014089|Zika vaccine|zika vaccine
1023839|NCT03014063|sepsis|sepsis
1023840|NCT03014063|septic shock|septic shock
1023841|NCT03014063|vasopressin|vasopressin
1023842|NCT03014063|AVP|avp
1023843|NCT03014050|physical activity|physical activity
1023844|NCT03014050|fitness|fitness
1023845|NCT03014050|cognition|cognition
1023846|NCT03014050|mood|mood
1023847|NCT03014050|depression|depression
1023848|NCT03014050|anxiety|anxiety
1023849|NCT03014050|sleep quality|sleep quality
1023850|NCT03014050|tremor|tremor
1023851|NCT03014050|gait|gait
1023852|NCT03014037|Orthopedics|orthopedics
1023853|NCT03014024|Distal Radius Fracture|distal radius fracture
1023854|NCT03014024|Low Level Laser Therapy|low level laser therapy
1023855|NCT03013985|Blood glucose|blood glucose
1023856|NCT03013972|ColoRectal Cancer|colorectal cancer
1023857|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
1023858|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
1023859|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
1023860|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
1023861|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
1023862|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
1023863|NCT03013920|urothelial carcinoma|urothelial carcinoma
1023864|NCT03013907|Hypertension|hypertension
1023865|NCT03013907|Coping|coping
1023866|NCT03013907|Relaxing|relaxing
1023867|NCT03013894|bladder neoplasm|bladder neoplasm
1023868|NCT03013894|urothelium carcinoma|urothelium carcinoma
1023869|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
1023870|NCT03013881|UB-921|ub-921
1023871|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
1023872|NCT03013881|breast neoplasm|breast neoplasm
1023873|NCT03013881|breast cancer|breast cancer
1023874|NCT03013881|Herceptin|herceptin
1023875|NCT03013881|Trastuzumab|trastuzumab
1023876|NCT03013881|HER2|her2
1023877|NCT03013855|Digital rectal exam|digital rectal exam
1023878|NCT03013855|Colon cancer screening|colon cancer screening
1023879|NCT03013842|pregnancy|pregnancy
1023880|NCT03013842|fetal monitoring|fetal monitoring
1023881|NCT03013842|fetal oximetry|fetal oximetry
1023882|NCT03013842|fetal heart rate|fetal heart rate
1023883|NCT03013842|pulse oximetry|pulse oximetry
1023884|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
1023885|NCT03013829|Kidney Paired Donation|kidney paired donation
1023886|NCT03013777|Familial dysautonomia|familial dysautonomia
1023887|NCT03013699|diet|diet
1023888|NCT03013699|nutrition|nutrition
1023889|NCT03013699|survival|survival
1023890|NCT03013699|recurrence|recurrence
1023891|NCT03013699|cruciferous|cruciferous
1023892|NCT03013699|dark leafy greens|dark leafy greens
1023893|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
1023894|NCT03013647|actinic keratosis|actinic keratosis
1023895|NCT03013647|field cancerization|field cancerization
1023896|NCT03013647|photodynamic therapy|photodynamic therapy
1023897|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
1023898|NCT03013634|dexmedetomidine|dexmedetomidine
1023899|NCT03013621|Renal Failure|renal failure
1023900|NCT03013621|Renal Insufficiency|renal insufficiency
1023901|NCT03013621|Acute Renal Failure|acute renal failure
1023902|NCT03013621|Acute Renal Injury|acute renal injury
1023903|NCT03013621|Kidney Failure|kidney failure
1023904|NCT03013621|Kidney Insufficiency|kidney insufficiency
1023905|NCT03013621|Acute Kidney Failure|acute kidney failure
1023906|NCT03013621|Acute Kidney Injury|acute kidney injury
1023907|NCT03013621|Ventricular dysfunction|ventricular dysfunction
1023908|NCT03013621|Venous congestion|venous congestion
1023909|NCT03013621|Renal function|renal function
1023910|NCT03013621|Kidney function|kidney function
1023911|NCT03013621|Venous heart failure|venous heart failure
1023912|NCT03013608|Nail bed injury|nail bed injury
1023913|NCT03013608|Nail bed injuries|nail bed injuries
1023914|NCT03013608|Nail|nail
1023915|NCT03013608|Children|children
1023916|NCT03013608|Fingertip injury|fingertip injury
1023917|NCT03013595|Mental health|mental health
1023918|NCT03013595|Youth mental health|youth mental health
1023923|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
1023924|NCT03013595|Young adult|young adult
1023925|NCT03013556|HBeAg positive|hbeag positive
1023926|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
1023927|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
1023928|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
1023929|NCT03013543|Alström Syndrome|alström syndrome
1023930|NCT03013530|Intensive care unit|intensive care unit
1023931|NCT03013530|Triage and Therapy.|triage and therapy.
1023932|NCT03013530|Advance Directives (AD).|advance directives (ad).
1023933|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
1023934|NCT03013530|Intensivist physician.|intensivist physician.
1023935|NCT03013517|Allergy|allergy
1023936|NCT03013517|food allergy|food allergy
1023937|NCT03013517|viaskin|viaskin
1023938|NCT03013517|peanut|peanut
1023939|NCT03013517|epicutaneous|epicutaneous
1023940|NCT03013504|randomized|randomized
1023941|NCT03013504|double-blind|double-blind
1023942|NCT03013504|parallel group|parallel group
1023943|NCT03013504|equivalence|equivalence
1023944|NCT03013504|multicentre|multicentre
1023945|NCT03013504|phase III|phase iii
1023946|NCT03013504|efficacy|efficacy
1023947|NCT03013504|safety|safety
1023948|NCT03013504|pharmacokinetics|pharmacokinetics
1023949|NCT03013504|HD201|hd201
1023950|NCT03013504|docetaxel|docetaxel
1023951|NCT03013504|Herceptin|herceptin
1023952|NCT03013504|HER2 positive|her2 positive
1023953|NCT03013504|breast cancer|breast cancer
1023954|NCT03013504|early breast cancer|early breast cancer
1023955|NCT03013491|cancer|cancer
1023956|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
1023957|NCT03013491|monotherapy|monotherapy
1023958|NCT03013491|combination|combination
1023959|NCT03013491|PD-L1|pd-l1
1023960|NCT03013491|CTLA-4|ctla-4
1023961|NCT03013491|solid tumor|solid tumor
1023962|NCT03013491|lymphoma|lymphoma
1023963|NCT03013491|BRAF|braf
1023964|NCT03013491|PROCLAIM|proclaim
1023965|NCT03013491|CX-072|cx-072
1023966|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
1023967|NCT03013374|protein accretion|protein accretion
1023968|NCT03013374|body composition|body composition
1023969|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
1023970|NCT03013335|Clear-cell|clear-cell
1023971|NCT03013335|Nivolumab|nivolumab
1023972|NCT03013335|Renal cell carcinoma|renal cell carcinoma
1023973|NCT03013335|Immunotherapy|immunotherapy
1023974|NCT03013309|Hybrid|hybrid
1023975|NCT03013309|Implementation|implementation
1023976|NCT03013309|Effectiveness|effectiveness
1023977|NCT03013309|Parent training|parent training
1023978|NCT03013309|Fidelity|fidelity
1023979|NCT03013309|Cost-Effectiveness|cost-effectiveness
1023980|NCT03013309|Primary Care|primary care
1023981|NCT03013296|GIP|gip
1023982|NCT03013296|GIP receptor antagonist|gip receptor antagonist
1023983|NCT03013270|Rehabilitation|rehabilitation
1023984|NCT03013270|Exercise|exercise
1023985|NCT03013270|Training|training
1023986|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
1023987|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
1023988|NCT03013257|RAI|rai
1023990|NCT03013244|eating disorder|eating disorder
1023991|NCT03013244|men|men
1023992|NCT03013244|intervention|intervention
1023993|NCT03013244|muscle dysmorphia|muscle dysmorphia
1023994|NCT03013244|peer-led|peer-led
1023995|NCT03013231|ACL Reconstruction|acl reconstruction
1023996|NCT03013231|Return to Sport|return to sport
1023997|NCT03013231|Resilience|resilience
1023998|NCT03013218|Neoplasms|neoplasms
1023999|NCT03013218|CD47|cd47
1024000|NCT03013218|SIRPα|sirpα
1024001|NCT03013218|ALX148|alx148
1024002|NCT03013205|adhesive capsulitis|adhesive capsulitis
1024003|NCT03013153|Rectal Cancer|rectal cancer
1024004|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
1024005|NCT03013153|Ligation|ligation
1024006|NCT03013153|Apical Lymph Nodes|apical lymph nodes
1024007|NCT03013153|Laparoscopy|laparoscopy
1024008|NCT03013153|IMA Types|ima types
1024009|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
1024010|NCT03013140|fluid therapy|fluid therapy
1024011|NCT03013140|cesarean section|cesarean section
1024012|NCT03013140|spinal anesthesia|spinal anesthesia
1024013|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
1024014|NCT03013127|Osteosarcoma|osteosarcoma
1024015|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
1024016|NCT03013127|Pembrolizumab|pembrolizumab
1024017|NCT03013127|Immunotherapy|immunotherapy
1024018|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
1024019|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1024020|NCT03013101|advanced|advanced
1024021|NCT03013101|metastatic|metastatic
1024022|NCT03013101|melanoma|melanoma
1024023|NCT03013088|Chronic|chronic
1024024|NCT03013088|Occlusion|occlusion
1024025|NCT03013088|CTO|cto
1024026|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
1024027|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
1024028|NCT03013023|Preterm Infants|preterm infants
1024046|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
1024047|NCT03012945|Long-term survival|long-term survival
1024048|NCT03012945|Quality of life|quality of life
1024049|NCT03012919|active decision support system|active decision support system
1024050|NCT03012919|goal directed therapy|goal directed therapy
1024051|NCT03012919|Lidco|lidco
1024052|NCT03012919|vascular surgery|vascular surgery
1024053|NCT03012919|hemodynamic optimization|hemodynamic optimization
1024054|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
1024055|NCT03012867|criticall illness|criticall illness
1024056|NCT03012867|enteral nutrition|enteral nutrition
1024057|NCT03012854|Esophageal achalasia|esophageal achalasia
1024058|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
1024059|NCT03012854|POEM|poem
1024060|NCT03012815|gabapentin|gabapentin
1024061|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
1024062|NCT03012815|benzodiazepine|benzodiazepine
1024063|NCT03012815|symptom-triggered|symptom-triggered
1024064|NCT03012724|TMS|tms
1024065|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
1024066|NCT03012724|MDD|mdd
1024067|NCT03012724|Major Depressive Disorder|major depressive disorder
1024068|NCT03012659|contraceptive counseling|contraceptive counseling
1024069|NCT03012659|cluster randomized trial|cluster randomized trial
1024070|NCT03012659|provider counseling training|provider counseling training
1024071|NCT03012646|Treprostinil|treprostinil
1024072|NCT03012646|PH|ph
1024073|NCT03012646|COPD|copd
1024074|NCT03012646|6 Minute Walk Test|6 minute walk test
1024075|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
1024076|NCT03012607|PrEP|prep
1024077|NCT03012594|Small bowel motility disorder|small bowel motility disorder
1024078|NCT03012594|Slow intestinal motility|slow intestinal motility
1024079|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
1024080|NCT03012555|Sickle Cell Disease|sickle cell disease
1024081|NCT03012555|Vitamin D|vitamin d
1024082|NCT03012529|Rifampin|rifampin
1024083|NCT03012529|Double-blind|double-blind
1024084|NCT03012529|Clinical Trial|clinical trial
1024085|NCT03012529|Veterans|veterans
1024086|NCT03012529|Diabetes|diabetes
1024087|NCT03012516|Physical Therapy Specialty|physical therapy specialty
1024088|NCT03012516|Exercise Test|exercise test
1024089|NCT03012516|Prescriptions|prescriptions
1024090|NCT03012516|Counseling|counseling
1024091|NCT03012516|Primary Health Care|primary health care
1024093|NCT03012490|Remote monitoring|remote monitoring
1024094|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
1024095|NCT03012451|Stress|stress
1024096|NCT03012451|Insecurity|insecurity
1024097|NCT03012451|Mental Health|mental health
1024098|NCT03012438|Near infrared fluorescence|near infrared fluorescence
1024100|NCT03012438|Parathyroid gland|parathyroid gland
1024101|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
1024102|NCT03012425|Acupuncture|acupuncture
1024103|NCT03012425|17-001|17-001
1024104|NCT03012399|Malignant Neoplasm of Breast|malignant neoplasm of breast
1024105|NCT03012399|Breast Cancer|breast cancer
1024106|NCT03012399|Hypnosedation|hypnosedation
1024107|NCT03012399|Hypnotherapist|hypnotherapist
1024108|NCT03012399|Questionnaires|questionnaires
1024109|NCT03012399|Surveys|surveys
1024110|NCT03012386|CD36|cd36
1024111|NCT03012386|Endothelial dysfunction|endothelial dysfunction
1024112|NCT03012386|African Americans|african americans
1024113|NCT03012373|methadone|methadone
1024114|NCT03012373|heroin|heroin
1024115|NCT03012373|acupuncture|acupuncture
1024116|NCT03012360|Infectiology|infectiology
1024117|NCT03012360|Biology of infectious agents|biology of infectious agents
1024118|NCT03012360|Hygiene|hygiene
1024119|NCT03012360|Pneumology|pneumology
1024120|NCT03012360|Critical Care|critical care
1024121|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
1024122|NCT03012308|left ventricular|left ventricular
1024123|NCT03012308|mitral valve doppler|mitral valve doppler
1024124|NCT03012308|mitral ring doppler|mitral ring doppler
1024125|NCT03012308|ultrasound signs|ultrasound signs
1024126|NCT03012308|lung edema|lung edema
1024127|NCT03012295|Genetic Testing|genetic testing
1024128|NCT03012295|Chinese Population|chinese population
1024129|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
1024130|NCT03012256|Chronic Disease Management|chronic disease management
1024131|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
1024132|NCT03012256|Multi-component Intervention|multi-component intervention
1024133|NCT03012256|DIVERT Scale|divert scale
1024134|NCT03012256|Frail Elderly|frail elderly
1024135|NCT03012256|Interprofessional Care|interprofessional care
1024136|NCT03012256|Pragmatic Trial|pragmatic trial
1024137|NCT03012256|Targeted Intervention|targeted intervention
1024138|NCT03012256|Home Care|home care
1024139|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
1024140|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1024141|NCT03012178|Mitral Regurgitation|mitral regurgitation
1024142|NCT03012178|Mitral valve Surgery|mitral valve surgery
1024143|NCT03012178|MRI|mri
1024144|NCT03012165|ADX-102|adx-102
1024145|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
1024146|NCT03012152|Oncoplastic surgery|oncoplastic surgery
1024147|NCT03012152|Standard conservative surgery|standard conservative surgery
1024148|NCT03012152|Patient satisfaction|patient satisfaction
1024149|NCT03012152|Margin Status|margin status
1024150|NCT03012113|Adipose tissue|adipose tissue
1024151|NCT03012113|Type 2 Diabetes|type 2 diabetes
1024152|NCT03012061|Respiratory|respiratory
1024153|NCT03012061|Efficacy|efficacy
1024154|NCT03012061|Umeclidinium bromide|umeclidinium bromide
1024155|NCT03012061|Parallel|parallel
1024156|NCT03012061|Asthma|asthma
1024157|NCT03012061|Dry powder inhaler|dry powder inhaler
1024158|NCT03012048|water treatment|water treatment
1024159|NCT03012035|psychotherapy|psychotherapy
1024160|NCT03012035|exposition|exposition
1024161|NCT03012035|spider fear|spider fear
1024162|NCT03012035|expectation|expectation
1024163|NCT03012022|Healthy Volunteers|healthy volunteers
1024164|NCT03012022|Congestive Heart Failure|congestive heart failure
1024165|NCT03012022|Cardiomyopathies|cardiomyopathies
1024166|NCT03012022|Heart Failure|heart failure
1024167|NCT03012022|Risk Factors|risk factors
1024168|NCT03012009|Bowen's Disease|bowen's disease
1024169|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
1024170|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
1024171|NCT03012009|Photodynamic therapy|photodynamic therapy
1024172|NCT03012009|PDT|pdt
1024173|NCT03012009|CO2 laser|co2 laser
1024174|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
1024175|NCT03012009|Carbon dioxide laser|carbon dioxide laser
1024176|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
1024177|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
1024178|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1024179|NCT03011892|Atopic dermatitis|atopic dermatitis
1024180|NCT03011892|eczema|eczema
1024181|NCT03011892|pruritus|pruritus
1024182|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
1024183|NCT03011840|Patient education handout|patient education handout
1024184|NCT03011840|Patient satisfaction|patient satisfaction
1024185|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
1024186|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
1024187|NCT03011749|Radium-223 therapy|radium-223 therapy
1024188|NCT03011710|e-cigarette|e-cigarette
1024189|NCT03011710|blood flow|blood flow
1024190|NCT03011710|oral effects|oral effects
1024191|NCT03011710|oral pH|oral ph
1024192|NCT03011684|Fertility Preservation|fertility preservation
1024193|NCT03011684|Breast Cancer|breast cancer
1024194|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
1024195|NCT03011671|Acetazolamide|acetazolamide
1024196|NCT03011671|Temozolomide|temozolomide
1024197|NCT03011619|Depression|depression
1024198|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1024199|NCT03011606|prostate|prostate
1024200|NCT03011606|ablation|ablation
1024201|NCT03011606|focal|focal
1024202|NCT03011606|cancer|cancer
1024203|NCT03011580|Vitamin D|vitamin d
1024204|NCT03011567|Postpartum|postpartum
1024205|NCT03011541|Stem Cells|stem cells
1024206|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
1024207|NCT03011541|BMSC|bmsc
1024208|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
1024209|NCT03011541|MSC|msc
1024210|NCT03011541|Eye Disease|eye disease
1024211|NCT03011541|Ophthalmology|ophthalmology
1024212|NCT03011541|Ophthalmic Disease|ophthalmic disease
1024213|NCT03011541|Retina|retina
1024214|NCT03011541|Retinal Disease|retinal disease
1024215|NCT03011541|Macular Degeneration|macular degeneration
1024216|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
1024217|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
1024218|NCT03011541|Geographic Atrophy|geographic atrophy
1024219|NCT03011541|Dry Macular Degeneration|dry macular degeneration
1024220|NCT03011541|Wet Macular Degeneration|wet macular degeneration
1024221|NCT03011541|Retinal Atrophy|retinal atrophy
1024222|NCT03011541|Retinal Dystrophy|retinal dystrophy
1024223|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
1024224|NCT03011541|Malattia Leventinese|malattia leventinese
1024225|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
1024226|NCT03011541|Stargardt Disease|stargardt disease
1024227|NCT03011541|Cone Dystrophy|cone dystrophy
1024228|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
1024229|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
1024230|NCT03011541|Maculopathy|maculopathy
1024231|NCT03011541|Optic Nerve Disease|optic nerve disease
1024232|NCT03011541|Optic Atrophy|optic atrophy
1024233|NCT03011541|Optic Neuropathy|optic neuropathy
1024234|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
1024235|NCT03011541|Optic Nerve Damage|optic nerve damage
1024236|NCT03011541|Optic Nerve Compression|optic nerve compression
1024237|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
1024238|NCT03011541|Devics Syndrome|devics syndrome
1024239|NCT03011541|Ushers Syndrome|ushers syndrome
1024240|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
1024241|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
1024242|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
1024243|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
1024244|NCT03011541|Blindness|blindness
1024245|NCT03011541|Vision Loss|vision loss
1024246|NCT03011541|Retina Atrophy|retina atrophy
1024247|NCT03011437|linked color imaging|linked color imaging
1024248|NCT03011437|Helicobacter Pylori|helicobacter pylori
1024249|NCT03011424|Liver resection|liver resection
1024250|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
1024251|NCT03011424|liver dialysis|liver dialysis
1024252|NCT03011424|encephalopathy|encephalopathy
1024253|NCT03011424|mortality|mortality
1024254|NCT03011411|methods, qualitative research|methods, qualitative research
1024255|NCT03011372|Myeloid neoplasm|myeloid neoplasm
1024256|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
1024257|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
1024258|NCT03011372|8p11|8p11
1024259|NCT03011372|eosinophilia|eosinophilia
1024260|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
1024261|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
1024262|NCT03011359|Colon resection|colon resection
1024263|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
1024264|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
1024265|NCT03011346|Aortic valve stenosis|aortic valve stenosis
1024266|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1024267|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1024268|NCT03011346|Randomized controlled trial|randomized controlled trial
1024269|NCT03011320|ovarian cancer|ovarian cancer
1024270|NCT03011320|specimen collection|specimen collection
1024271|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
1024272|NCT03011268|Infliximab|infliximab
1024273|NCT03011268|Adalimumab|adalimumab
1024274|NCT03011268|Golimumab|golimumab
1024275|NCT03011268|Recurrence|recurrence
1024276|NCT03011255|Esophageal cancer|esophageal cancer
1024277|NCT03011255|Peptide specific CTL|peptide specific ctl
1024278|NCT03011255|Radiation|radiation
1024279|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
1024280|NCT03011242|PDUS|pdus
1024281|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
1024282|NCT03011203|exercise|exercise
1024283|NCT03011203|ketone esters|ketone esters
1024284|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1024285|NCT03011190|Terapia Iconica|terapia iconica
1024286|NCT03011190|BPD|bpd
1024287|NCT03011190|adolescence|adolescence
1024288|NCT03011190|suicide|suicide
1024289|NCT03011164|Running|running
1024290|NCT03011164|Gait velocity|gait velocity
1024291|NCT03011164|Kinematics|kinematics
1024292|NCT03011151|pediatric|pediatric
1024293|NCT03011151|critical illness|critical illness
1024294|NCT03011151|surgery|surgery
1024295|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
1024296|NCT03011151|gastric emptying|gastric emptying
1024297|NCT03011151|epithelial barrier|epithelial barrier
1024298|NCT03011151|nutrition|nutrition
1024299|NCT03011138|knee|knee
1024300|NCT03011138|gait velocity|gait velocity
1024301|NCT03011138|kinematic parameters|kinematic parameters
1024302|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
1024303|NCT03011112|WOMAC|womac
1024304|NCT03011112|gait|gait
1024305|NCT03011112|kinematics|kinematics
1024306|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
1024307|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1024308|NCT03011060|pathological complete response|pathological complete response
1024309|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
1024310|NCT03011060|Capecitabine|capecitabine
1024311|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1024312|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
1024313|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
1024314|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
1024315|NCT03011021|Liraglutide|liraglutide
1024316|NCT03010995|electronic cigarette|electronic cigarette
1024317|NCT03010995|endothelial function|endothelial function
1024318|NCT03010969|Endothelial dysfunction|endothelial dysfunction
1024319|NCT03010969|Surgery|surgery
1024320|NCT03010969|Pulmonary function|pulmonary function
1024321|NCT03010969|Blood glucose level|blood glucose level
1024322|NCT03010969|Patient-related outcomes|patient-related outcomes
1024323|NCT03010956|Arterial stiffness|arterial stiffness
1024324|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
1024325|NCT03010956|Coronary flow reserve|coronary flow reserve
1024326|NCT03010943|virtual reality|virtual reality
1024327|NCT03010943|glioma surgery|glioma surgery
1024328|NCT03010943|awake craniotomy|awake craniotomy
1024329|NCT03010943|brain tumor|brain tumor
1024330|NCT03010943|glioma|glioma
1024331|NCT03010943|neurosurgery|neurosurgery
1024332|NCT03010917|Alcohol Dependence|alcohol dependence
1024333|NCT03010917|Fish Oil|fish oil
1024334|NCT03010891|Preterm infant|preterm infant
1024335|NCT03010891|Stress|stress
1024336|NCT03010891|Salivary DHEA|salivary dhea
1024337|NCT03010891|Salivary cortisol|salivary cortisol
1024338|NCT03010891|Actigraphy|actigraphy
1024360|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
1024361|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
1024362|NCT03010709|Induced Hypertension|induced hypertension
1024363|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
1024364|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
1024365|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
1024366|NCT03010696|Uremic toxins|uremic toxins
1024367|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
1024368|NCT03010696|Metabolomics|metabolomics
1024369|NCT03010683|Arterial stiffness|arterial stiffness
1024370|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
1024371|NCT03010683|Coronary flow reserve|coronary flow reserve
1024372|NCT03010670|Oxytocin|oxytocin
1024373|NCT03010670|Gaze processing|gaze processing
1024374|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
1024375|NCT03010618|hall technique|hall technique
1024376|NCT03010618|stainless steel crowns|stainless steel crowns
1024377|NCT03010618|temporomandibular joint|temporomandibular joint
1024378|NCT03010618|dental caries|dental caries
1024379|NCT03010618|occlusion|occlusion
1024380|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
1024381|NCT03010605|range of motion|range of motion
1024382|NCT03010605|goniometry|goniometry
1024383|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
1024384|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
1024385|NCT03010592|Microvesicles|microvesicles
1024386|NCT03010579|Anemia|anemia
1024387|NCT03010579|Lymphoma|lymphoma
1024388|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1024389|NCT03010579|Erythropoietin|erythropoietin
1024390|NCT03010566|Lung volume reduction coil|lung volume reduction coil
1024391|NCT03010566|Lung Microbiome|lung microbiome
1024392|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
1024393|NCT03010527|Psoriasis|psoriasis
1024394|NCT03010527|Bimekizumab|bimekizumab
1024395|NCT03010488|Chronotherapy|chronotherapy
1024396|NCT03010488|Light Therapy|light therapy
1024397|NCT03010462|Stroke|stroke
1024398|NCT03010462|rTMS|rtms
1024399|NCT03010462|Motor rehabilitation|motor rehabilitation
1024400|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
1024401|NCT03010449|Autologous blood instillation|autologous blood instillation
1024402|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
1024403|NCT03010449|Endobronchial valve|endobronchial valve
1024404|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
1024405|NCT03010423|Nicorandil|nicorandil
1024406|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
1024407|NCT03010332|Cytomegalovirus|cytomegalovirus
1024408|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
1024409|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
1024410|NCT03010332|CMV Infection|cmv infection
1024411|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
1024412|NCT03010332|Solid Organ Transplant|solid organ transplant
1024413|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
1024414|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
1024415|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1024416|NCT03010332|CMV|cmv
1024417|NCT03010332|CMV syndrome|cmv syndrome
1024418|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
1024419|NCT03010332|CMV disease|cmv disease
1024420|NCT03010332|CMV viremia|cmv viremia
1024421|NCT03010332|allogeneic|allogeneic
1024422|NCT03010332|third-party|third-party
1024423|NCT03010293|Antimicrobial therapy|antimicrobial therapy
1024424|NCT03010293|Debridement|debridement
1024425|NCT03010293|Osteomyelitis|osteomyelitis
1024426|NCT03010293|Muscular flap|muscular flap
1024427|NCT03010293|Pressure ulcer|pressure ulcer
1333133|NCT01444430|safety|safety
1024428|NCT03010293|Treatment failure|treatment failure
1024429|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
1024431|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
1024432|NCT03010241|Chinese medicine|chinese medicine
1024433|NCT03010228|VLA15|vla15
1024434|NCT03010228|Lyme Borreliosis|lyme borreliosis
1024435|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
1024436|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
1024437|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
1024438|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
1024439|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
1024440|NCT03010215|Forefoot|forefoot
1024441|NCT03010215|Metatarsal bones|metatarsal bones
1024442|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
1024443|NCT03010202|rituximab|rituximab
1024444|NCT03010202|thrombocytopenia|thrombocytopenia
1024445|NCT03010189|Cluster headache|cluster headache
1024446|NCT03010189|Actigraphy|actigraphy
1024447|NCT03010189|Pupillometry|pupillometry
1024448|NCT03010163|pedometer|pedometer
1024449|NCT03010163|walking|walking
1024450|NCT03010163|taxi driver|taxi driver
1024451|NCT03010163|16-1659|16-1659
1024552|NCT03009565|human gut microbiota|human gut microbiota
1024452|NCT03010150|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
1024453|NCT03010150|Head and Neck Cancer|head and neck cancer
1024454|NCT03010150|Nasopharyngeal cancer|nasopharyngeal cancer
1024455|NCT03010150|Oropharyngeal cancer|oropharyngeal cancer
1024456|NCT03010150|Hypopharyngeal cancer|hypopharyngeal cancer
1024457|NCT03010150|Laryngeal cancer|laryngeal cancer
1024458|NCT03010150|Unknown primary cancer with cervical metastases|unknown primary cancer with cervical metastases
1024459|NCT03010150|Questionnaire|questionnaire
1024460|NCT03010150|Survey|survey
1024461|NCT03010150|Blood draw|blood draw
1024462|NCT03010150|Cytokines|cytokines
1024463|NCT03010111|Latent Tuberculosis|latent tuberculosis
1024464|NCT03010111|Interferons|interferons
1024465|NCT03010111|Tuberculosis|tuberculosis
1024466|NCT03010111|Healthcare|healthcare
1024467|NCT03010098|POCD|pocd
1024468|NCT03010098|narcotrend|narcotrend
1024469|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
1024470|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
1024471|NCT03010033|lobectomy|lobectomy
1024472|NCT03010033|smoker|smoker
1024473|NCT03010020|HIV Prevention|hiv prevention
1024474|NCT03010020|MSM|msm
1024475|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
1024476|NCT03010020|Rectal Chlamydia|rectal chlamydia
1024477|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
1024478|NCT03010007|Influenza|influenza
1024479|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1024480|NCT03010007|Viral Transmission|viral transmission
1024482|NCT03009981|Degarelix|degarelix
1024483|NCT03009981|Apalutamide|apalutamide
1024484|NCT03009981|Abiraterone Acetate|abiraterone acetate
1024485|NCT03009981|Radical Prostatectomy|radical prostatectomy
1024486|NCT03009942|nitric oxide|nitric oxide
1024487|NCT03009942|arginase|arginase
1024488|NCT03009942|loading|loading
1024489|NCT03009890|elderly|elderly
1024490|NCT03009890|intra articular|intra articular
1024491|NCT03009890|RCT|rct
1024492|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
1024493|NCT03009864|TCM|tcm
1024494|NCT03009864|RCT|rct
1024495|NCT03009825|Trauma exposure|trauma exposure
1024496|NCT03009825|Psychological distress|psychological distress
1024497|NCT03009825|Emotion regulation|emotion regulation
1024498|NCT03009825|Mindfulness|mindfulness
1024499|NCT03009825|Eating pathology|eating pathology
1024500|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
1024501|NCT03009799|iota-carrageenan|iota-carrageenan
1024502|NCT03009773|subacute stroke|subacute stroke
1024503|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
1024504|NCT03009773|walking|walking
1024505|NCT03009747|rectal cancer|rectal cancer
1024506|NCT03009747|anterior resection syndrome|anterior resection syndrome
1024507|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
1024508|NCT03009708|Allograft|allograft
1024509|NCT03009708|Cytomegalovirus|cytomegalovirus
1024510|NCT03009708|Platelets|platelets
1024511|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
1024512|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
1024513|NCT03009708|Hemostasis|hemostasis
1024514|NCT03009708|Adaptive immunity|adaptive immunity
1024515|NCT03009708|Innate immunity|innate immunity
1024516|NCT03009708|Post graft follow up|post graft follow up
1024517|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1024518|NCT03009695|Obesity|obesity
1024519|NCT03009695|Food Craving|food craving
1024520|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
1024521|NCT03009695|fMRI|fmri
1024522|NCT03009695|Intestinal microbiota|intestinal microbiota
1024523|NCT03009695|Physical activity|physical activity
1024524|NCT03009669|pleth variability index|pleth variability index
1024525|NCT03009669|stroke volume variation|stroke volume variation
1024526|NCT03009669|perfusion Index|perfusion index
1024527|NCT03009669|intraoperative|intraoperative
1024528|NCT03009669|intestinal tumor|intestinal tumor
1024529|NCT03009656|Stroke|stroke
1024530|NCT03009656|Emergency|emergency
1024531|NCT03009656|Focal Neurological Deficits|focal neurological deficits
1024532|NCT03009656|Diagnostic|diagnostic
1024533|NCT03009643|Nitric Oxide|nitric oxide
1024534|NCT03009643|hypoxemia|hypoxemia
1024535|NCT03009643|aortic surgery|aortic surgery
1024536|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
1024537|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
1024538|NCT03009630|Peripheral lung cancer|peripheral lung cancer
1024539|NCT03009617|adolescents|adolescents
1024540|NCT03009617|web-based health education|web-based health education
1024541|NCT03009617|eHealth literacy|ehealth literacy
1024542|NCT03009591|Hemophilia|hemophilia
1024543|NCT03009591|Elbow|elbow
1024544|NCT03009591|Arthropathy|arthropathy
1024545|NCT03009591|Joint pain|joint pain
1024546|NCT03009591|Range of motion|range of motion
1024547|NCT03009591|Myofascial techniques|myofascial techniques
1024548|NCT03009591|Safety patients|safety patients
1024549|NCT03009591|Quality of life|quality of life
1024550|NCT03009591|Functionality|functionality
1024551|NCT03009565|coronary artery disease|coronary artery disease
1024553|NCT03009565|microbiome|microbiome
1024554|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
1024555|NCT03009552|strain|strain
1024556|NCT03009552|strain rate|strain rate
1024557|NCT03009552|torsion|torsion
1024558|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
1024559|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
1024560|NCT03009539|Hispanic adolescent|hispanic adolescent
1024561|NCT03009539|Familias Unidas|familias unidas
1024562|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
1024563|NCT03009539|effectiveness trial|effectiveness trial
1024564|NCT03009539|sexually transmitted disease|sexually transmitted disease
1024565|NCT03009539|parent-centered|parent-centered
1024566|NCT03009539|Hispanic|hispanic
1024567|NCT03009539|sexual risk behavior|sexual risk behavior
1024568|NCT03009526|Malaria|malaria
1024569|NCT03009526|Pregnancy|pregnancy
1024570|NCT03009526|Malawi|malawi
1024571|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
1024572|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1024573|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1024574|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
1024575|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
1024576|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1024577|NCT03009461|Sorafenib|sorafenib
1024578|NCT03009396|Crohn's Disease,|crohn's disease,
1024579|NCT03009396|moderate to severe|moderate to severe
1024580|NCT03009396|remission|remission
1024581|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
1024582|NCT03009396|antibiotic|antibiotic
1024583|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
1024584|NCT03009357|wearable activity tracker|wearable activity tracker
1024585|NCT03009357|thyrotoxicosis|thyrotoxicosis
1024586|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
1024587|NCT03009344|tazemetostat|tazemetostat
1024588|NCT03009344|Japan|japan
1024589|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
1024590|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
1024591|NCT03009331|Recruitment manouver|recruitment manouver
1024592|NCT03009331|Prone position|prone position
1024593|NCT03009318|Glioma|glioma
1024594|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1024595|NCT03009318|Methionine|methionine
1024596|NCT03009318|PET/CT|pet/ct
1024597|NCT03009292|solid tumor|solid tumor
1024598|NCT03009292|Lenvatinib|lenvatinib
1024599|NCT03009292|pharmacokinetics|pharmacokinetics
1024600|NCT03009279|blood pressure|blood pressure
1024601|NCT03009279|fasting plasma glucose|fasting plasma glucose
1024602|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
1024603|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
1024604|NCT03009253|Pancreatic Cancer|pancreatic cancer
1024605|NCT03009227|colon cancer|colon cancer
1024606|NCT03009227|lymph node dissection|lymph node dissection
1024607|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
1024608|NCT03009214|solid epithelial cancer|solid epithelial cancer
1024609|NCT03009214|CD44v6|cd44v6
1024610|NCT03009214|c-Met|c-met
1024611|NCT03009214|VEGFR-2|vegfr-2
1024612|NCT03009214|RON|ron
1024613|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
1024614|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
1024615|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
1024616|NCT03009136|Herbal Medicine|herbal medicine
1024617|NCT03009136|Korean Medicine|korean medicine
1024618|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
1024619|NCT03009123|cohort study|cohort study
1024620|NCT03009123|prostate cancer|prostate cancer
1024621|NCT03009123|population-based study|population-based study
1024622|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
1024623|NCT03009097|Chronic periodontitis|chronic periodontitis
1024624|NCT03009097|atorvastatin|atorvastatin
1024625|NCT03009097|intrabony defect|intrabony defect
1024626|NCT03009071|Neck Pain|neck pain
1024627|NCT03009071|Disability Evaluation|disability evaluation
1024628|NCT03009071|Costs and Cost Analysis|costs and cost analysis
1024629|NCT03009071|Doin Exercise Therapy|doin exercise therapy
1024630|NCT03009071|Acupuncture|acupuncture
1024631|NCT03009058|Unresectable cancer|unresectable cancer
1024632|NCT03009058|pancreatic|pancreatic
1024633|NCT03009058|melanoma|melanoma
1024634|NCT03009058|breast|breast
1024635|NCT03009058|lung|lung
1024636|NCT03009058|colorectal|colorectal
1024637|NCT03009058|cholangio|cholangio
1024638|NCT03009058|sarcoma|sarcoma
1024639|NCT03009045|bone and joint infection|bone and joint infection
1024640|NCT03009045|osteomyelitis|osteomyelitis
1024641|NCT03009045|tedizolid|tedizolid
1024642|NCT03009032|HIV|hiv
1024643|NCT03009032|immunologic recovery|immunologic recovery
1024644|NCT03009032|microbiota|microbiota
1024645|NCT03009032|prebiotics|prebiotics
1024646|NCT03009032|probiotics|probiotics
1024647|NCT03009032|synbiotics|synbiotics
1024648|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
1024649|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
1024650|NCT03009006|Chlorhexidene gel|chlorhexidene gel
1024651|NCT03009006|CHX gel|chx gel
1024652|NCT03009006|Root canal treatment|root canal treatment
1024653|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
1024654|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
1024655|NCT03008967|Rehabilitation|rehabilitation
1024656|NCT03008954|weight loss|weight loss
1024657|NCT03008954|body composition|body composition
1024658|NCT03008954|glycemic control|glycemic control
1024659|NCT03008954|satiety|satiety
1024660|NCT03008941|HIV|hiv
1024661|NCT03008941|microbiota|microbiota
1024662|NCT03008941|inflammation|inflammation
1024663|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
1024664|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1024665|NCT03008915|Emphysema|emphysema
1024666|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1024667|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
1024668|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
1024669|NCT03008876|neonate|neonate
1024670|NCT03008876|acetaminophen|acetaminophen
1024671|NCT03008850|Shivering|shivering
1024672|NCT03008850|Intrathecal|intrathecal
1024673|NCT03008850|Magnesium Sulfate|magnesium sulfate
1024674|NCT03008811|Atrial Fibrillation|atrial fibrillation
1024772|NCT03008057|YKL40|ykl40
1024675|NCT03008811|Catheter Ablation|catheter ablation
1024676|NCT03008798|Intracranial Artery|intracranial artery
1024677|NCT03008798|in-stent restenosis|in-stent restenosis
1024678|NCT03008798|Herbal Medicine|herbal medicine
1024679|NCT03008785|isoflavone|isoflavone
1024680|NCT03008785|blood pressure|blood pressure
1024681|NCT03008785|climateric symptoms|climateric symptoms
1024682|NCT03008785|exercise|exercise
1024683|NCT03008759|Fluoride|fluoride
1024684|NCT03008759|Dental caries|dental caries
1024685|NCT03008759|Dentifrice|dentifrice
1024686|NCT03008720|functional electrical simulation|functional electrical simulation
1024687|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
1024688|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
1024689|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
1024690|NCT03008707|D004238|d004238
1024691|NCT03008694|PET/CT|pet/ct
1024692|NCT03008642|Polycythemia|polycythemia
1024693|NCT03008642|CO-Rebreathing|co-rebreathing
1024694|NCT03008642|red cell mass determination|red cell mass determination
1024695|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
1024696|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
1024697|NCT03008603|Robot|robot
1024698|NCT03008590|Pain management|pain management
1024699|NCT03008590|Naltrexone|naltrexone
1024700|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
1024701|NCT03008512|Liver Neoplasms|liver neoplasms
1024702|NCT03008512|Antineoplastic Agents|antineoplastic agents
1024703|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1024704|NCT03008512|Genexol-PM|genexol-pm
1024705|NCT03008512|Neoplasms by Site|neoplasms by site
1024706|NCT03008512|Sorafenib|sorafenib
1024707|NCT03008512|Liver Diseases|liver diseases
1024708|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
1024709|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
1024710|NCT03008499|High-activity natural killer|high-activity natural killer
1024711|NCT03008447|E2006|e2006
1024712|NCT03008447|postural stability|postural stability
1024713|NCT03008447|auditory awakening threshold|auditory awakening threshold
1024714|NCT03008447|cognitive performance|cognitive performance
1333134|NCT01444430|budesonide|budesonide
1024715|NCT03008447|healthy participants|healthy participants
1024716|NCT03008434|yoga|yoga
1024717|NCT03008434|Traumatic Brain Injury|traumatic brain injury
1024718|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1024719|NCT03008408|Endometrial carcinoma|endometrial carcinoma
1024720|NCT03008408|Advanced or Recurrent|advanced or recurrent
1024721|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
1024722|NCT03008408|Ribociclib|ribociclib
1024723|NCT03008408|LEE011|lee011
1024724|NCT03008408|Everolimus|everolimus
1024725|NCT03008408|Afinitor|afinitor
1024726|NCT03008408|Zortress|zortress
1024727|NCT03008408|RAD001|rad001
1024728|NCT03008408|Letrozole|letrozole
1024729|NCT03008408|Femara|femara
1024730|NCT03008382|Interstitial Cystitis|interstitial cystitis
1024731|NCT03008382|Pelvic Pain|pelvic pain
1024732|NCT03008343|Irreversible Electroporation|irreversible electroporation
1024733|NCT03008343|NK Immunotherapy|nk immunotherapy
1024734|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
1024735|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
1024736|NCT03008330|High-activity natural killer|high-activity natural killer
1024737|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
1024738|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
1024739|NCT03008265|Fascial dehiscence|fascial dehiscence
1024740|NCT03008265|Mortality|mortality
1024741|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
1024742|NCT03008252|lactose intolerance|lactose intolerance
1024743|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
1024749|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
1024750|NCT03008161|GAIM|gaim
1024751|NCT03008161|amyloid|amyloid
1024752|NCT03008161|anti-aBeta|anti-abeta
1024753|NCT03008161|anti-tau|anti-tau
1024754|NCT03008122|Flavivirus|flavivirus
1024755|NCT03008122|Inactivated|inactivated
1024756|NCT03008122|Phase I|phase i
1024757|NCT03008122|Vaccine|vaccine
1024758|NCT03008122|ZIKA|zika
1024759|NCT03008122|ZPIV|zpiv
1024760|NCT03008109|EGFR-TKI|egfr-tki
1024761|NCT03008109|Recombinant human endostatin|recombinant human endostatin
1024762|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1024763|NCT03008070|NASH|nash
1024764|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
1024765|NCT03008070|Liver Diseases|liver diseases
1024766|NCT03008070|Fibrosis|fibrosis
1024767|NCT03008070|Fatty Liver|fatty liver
1024768|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1024769|NCT03008070|Digestive System Diseases|digestive system diseases
1024770|NCT03008070|IVA337|iva337
1024771|NCT03008057|vitamin D|vitamin d
1024773|NCT03008057|PAI-1|pai-1
1024774|NCT03008057|RAGE|rage
1024775|NCT03008057|AGEs|ages
1024776|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
1024777|NCT03008057|TNF-alpha|tnf-alpha
1024778|NCT03008057|IL-6|il-6
1024779|NCT03008057|Diabetes|diabetes
1024780|NCT03007992|Breast cancer|breast cancer
1024781|NCT03007992|Vinorelbine|vinorelbine
1024782|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
1024783|NCT03007953|Palliative Care|palliative care
1024784|NCT03007953|Supportive Care|supportive care
1024785|NCT03007940|Implementation Strategies|implementation strategies
1024786|NCT03007940|Sustainability|sustainability
1024787|NCT03007940|Integrated Services|integrated services
1024788|NCT03007927|pain|pain
1024789|NCT03007927|hernia repair|hernia repair
1024790|NCT03007927|Dexamethasone|dexamethasone
1024791|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1024792|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
1024793|NCT03007914|Humans|humans
1024794|NCT03007914|Treatment Outcome|treatment outcome
1024795|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
1024796|NCT03007875|Metastatic lung cancer|metastatic lung cancer
1024797|NCT03007875|High-activity natural killer|high-activity natural killer
1024798|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
1024799|NCT03007836|High-activity natural killer|high-activity natural killer
1024800|NCT03007823|Metastatic Melanoma|metastatic melanoma
1024801|NCT03007823|High-activity natural killer|high-activity natural killer
1024802|NCT03007784|Consciousness|consciousness
1024803|NCT03007784|Disorder of consciousness|disorder of consciousness
1024804|NCT03007784|Minimally conscious state|minimally conscious state
1024805|NCT03007784|Vegetative state|vegetative state
1024806|NCT03007784|Exit-MCS|exit-mcs
1024807|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1024808|NCT03007784|CRS-R|crs-r
1024810|NCT03007784|Cognitive ERPs|cognitive erps
1024811|NCT03007758|Hernia repair|hernia repair
1024812|NCT03007758|Robotic hernia repair|robotic hernia repair
1053483|NCT02828761|ccs|ccs
1024813|NCT03007758|Open hernia repair|open hernia repair
1024814|NCT03007758|Incisional hernia|incisional hernia
1024815|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
1024816|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
1024817|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
1024818|NCT03007628|controlled trial|controlled trial
1024819|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1024820|NCT03007602|Aerobic exercise|aerobic exercise
1024821|NCT03007602|Quality of Life|quality of life
1024822|NCT03007602|Muscle Strength|muscle strength
1024823|NCT03007602|Depression|depression
1024824|NCT03007602|exercise capacity|exercise capacity
1024825|NCT03007602|dyspnea|dyspnea
1024826|NCT03007602|anxiety|anxiety
1024827|NCT03007602|fatigue|fatigue
1024828|NCT03007602|pulmonary functions|pulmonary functions
1024829|NCT03007589|erythema|erythema
1024830|NCT03007589|persistent pigment darkening|persistent pigment darkening
1024831|NCT03007589|sunburn|sunburn
1024832|NCT03007589|suntan|suntan
1024833|NCT03007563|Diagnosis|diagnosis
1024834|NCT03007563|Cell Phones|cell phones
1024835|NCT03007563|Infant, Newborn|infant, newborn
1024836|NCT03007550|Gastric cancer|gastric cancer
1024837|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
1024838|NCT03007550|Open total gastrectomy|open total gastrectomy
1024839|NCT03007537|Erythropoietin|erythropoietin
1024840|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
1024841|NCT03007524|rosuvastatin|rosuvastatin
1024842|NCT03007524|optical coherence tomography|optical coherence tomography
1024843|NCT03007524|acute coronary syndrome|acute coronary syndrome
1024844|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
1024845|NCT03007511|Feeding tube|feeding tube
1024846|NCT03007511|Enteral nutrition|enteral nutrition
1024847|NCT03007511|Endoscopy|endoscopy
1024848|NCT03007511|Gastrointestinal|gastrointestinal
1024849|NCT03007472|cochlear implant, sound processor|cochlear implant, sound processor
1024850|NCT03007459|Body composition|body composition
1024851|NCT03007459|Bone mineral density|bone mineral density
1024852|NCT03007459|Binge Eating|binge eating
1024853|NCT03007459|Eating Disorder|eating disorder
1024854|NCT03007459|Exercise Dependency|exercise dependency
1024855|NCT03007459|Depression|depression
1024856|NCT03007459|Perfectionism|perfectionism
1024857|NCT03007459|Body building|body building
1024858|NCT03007459|Drive for Muscularity|drive for muscularity
1024859|NCT03007459|Drive for leanness|drive for leanness
1024860|NCT03007446|Apatinib|apatinib
1024861|NCT03007446|SOX|sox
1024862|NCT03007446|Conversion Surgery|conversion surgery
1024863|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
1024864|NCT03007433|gastric emptying|gastric emptying
1024865|NCT03007433|functional dyspepsia|functional dyspepsia
1024866|NCT03007433|non invasive imaging|non invasive imaging
1024867|NCT03007433|MRI|mri
1024868|NCT03007433|gamma scintigraphy|gamma scintigraphy
1024869|NCT03007433|gastroparesis|gastroparesis
1025164|NCT03005379|intestine|intestine
1024870|NCT03007407|microsatellite stable|microsatellite stable
1024871|NCT03007407|MSS|mss
1024872|NCT03007407|durvalumab|durvalumab
1024873|NCT03007407|tremelimumab|tremelimumab
1024874|NCT03007407|mCRC|mcrc
1024875|NCT03007407|NSABP|nsabp
1024876|NCT03007394|Cocaine Use Disorder|cocaine use disorder
1024877|NCT03007342|Amoxicillin|amoxicillin
1024878|NCT03007342|clavulanic acid|clavulanic acid
1024879|NCT03007342|Periapical periodontitis|periapical periodontitis
1024880|NCT03007342|Post-operative pain|post-operative pain
1024881|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
1024882|NCT03007329|GLP1 agonist|glp1 agonist
1024883|NCT03007329|type 2 Diabetes|type 2 diabetes
1024884|NCT03007329|steatosis of the liver|steatosis of the liver
1024885|NCT03007329|ectopic lipids|ectopic lipids
1024886|NCT03007329|combined therapy|combined therapy
1024887|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
1024888|NCT03007264|pain|pain
1024889|NCT03007264|bacteria|bacteria
1024890|NCT03007264|skin parameters|skin parameters
1024891|NCT03007186|Blood glucose monitoring|blood glucose monitoring
1024892|NCT03007186|Glucose tolerance|glucose tolerance
1024893|NCT03007186|HbA1C|hba1c
1024894|NCT03007186|Insulin|insulin
1024895|NCT03007186|Betamethasone|betamethasone
1024896|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
1024897|NCT03007082|endovascular treatment|endovascular treatment
1024898|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
1024899|NCT03007082|stent retriever|stent retriever
1024900|NCT03007082|human|human
1024901|NCT03007056|high flow nasal cannula|high flow nasal cannula
1024902|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
1024903|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
1024904|NCT03007056|newborn developmental care|newborn developmental care
1024905|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1024906|NCT03007056|weaning|weaning
1024907|NCT03007056|pain|pain
1024908|NCT03007056|length of stay|length of stay
1024909|NCT03007030|Lung Diseases Due to External Agents|lung diseases due to external agents
1024910|NCT03007030|Mesothelioma|mesothelioma
1024911|NCT03007030|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
1024912|NCT03007030|MPM|mpm
1024913|NCT03007030|CD30+|cd30+
1024914|NCT03007030|Brentuximab vedotin|brentuximab vedotin
1024915|NCT03007030|SGN-35|sgn-35
1024916|NCT03007030|Adcetris|adcetris
1024917|NCT03007004|Systemic aclerosis|systemic aclerosis
1024918|NCT03007004|digital ulcer|digital ulcer
1024919|NCT03007004|botulinum toxin|botulinum toxin
1024920|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
1024921|NCT03006965|hemophilia|hemophilia
1024922|NCT03006965|Hemophilia A|hemophilia a
1024923|NCT03006965|Factor VIII|factor viii
1024924|NCT03006965|Advate|advate
1024925|NCT03006965|Antithrombotic factor|antithrombotic factor
1024926|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
1024927|NCT03006965|hemarthrosis|hemarthrosis
1024928|NCT03006965|myPKFiT|mypkfit
1024929|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
1024930|NCT03006926|E7080|e7080
1024931|NCT03006926|lenvatinib|lenvatinib
1024932|NCT03006926|pembrolizumab|pembrolizumab
1024933|NCT03006926|Japan|japan
1024934|NCT03006913|Genetic counseling modes|genetic counseling modes
1024935|NCT03006887|solid tumors|solid tumors
1024936|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
1024937|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
1024938|NCT03006887|endometrial carcinoma|endometrial carcinoma
1024939|NCT03006887|urothelial carcinoma|urothelial carcinoma
1024940|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1024941|NCT03006887|non-uveal melanoma|non-uveal melanoma
1024942|NCT03006887|E7080|e7080
1024943|NCT03006887|lenvatinib|lenvatinib
1024944|NCT03006887|pembrolizumab|pembrolizumab
1024945|NCT03006887|Japan|japan
1024946|NCT03006848|Osteosarcoma|osteosarcoma
1024949|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
1024950|NCT03006822|Myofascial Trigger Points|myofascial trigger points
1024951|NCT03006822|Liberation for Pression|liberation for pression
1024952|NCT03006822|Therapy Soft Tissue|therapy soft tissue
1024953|NCT03006809|Ulcerative colitis|ulcerative colitis
1024954|NCT03006809|FMT|fmt
1024955|NCT03006809|fecal transplant|fecal transplant
1024956|NCT03006796|Obesity|obesity
1024957|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
1024958|NCT03006614|Breast Cancer Model|breast cancer model
1024959|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
1024960|NCT03006614|breast cancer|breast cancer
1024961|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
1024962|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
1024963|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
1024964|NCT03006575|Locoregional recurrence|locoregional recurrence
1024965|NCT03006575|Postoperative recurrence|postoperative recurrence
1024966|NCT03006575|Consolidation chemotherapy|consolidation chemotherapy
1024967|NCT03006549|Emergency Manual|emergency manual
1024968|NCT03006549|Crisis Checklist|crisis checklist
1024969|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
1024970|NCT03006523|insemination volume|insemination volume
1024971|NCT03006523|Live Birth Rates|live birth rates
1024972|NCT03006523|donor sperm|donor sperm
1024973|NCT03006510|inpatient diabetes|inpatient diabetes
1024974|NCT03006510|hypoglycemia|hypoglycemia
1024975|NCT03006497|neck|neck
1024976|NCT03006497|motor control|motor control
1024977|NCT03006497|motor learning|motor learning
1024978|NCT03006484|Cardiac arrest|cardiac arrest
1024979|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
1024980|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1024981|NCT03006471|Prediabetes|prediabetes
1024982|NCT03006471|Prehypertension|prehypertension
1024983|NCT03006471|Variability of blood pressure|variability of blood pressure
1024984|NCT03006471|ABPM|abpm
1024985|NCT03006471|Dapagliflozin|dapagliflozin
1024986|NCT03006471|SGLT2|sglt2
1024987|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
1024988|NCT03006419|kidney transplantation|kidney transplantation
1024989|NCT03006419|induction|induction
1024990|NCT03006419|thymoglobulin|thymoglobulin
1024991|NCT03006419|basiliximab|basiliximab
1024992|NCT03006419|acute rejection|acute rejection
1024993|NCT03006419|graft loss|graft loss
1024994|NCT03006406|endometriosis|endometriosis
1024995|NCT03006406|long term GnRH-a|long term gnrh-a
1024996|NCT03006393|Neuroscience|neuroscience
1024997|NCT03006393|Behavioral|behavioral
1024998|NCT03006393|Social|social
1024999|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
1025000|NCT03006354|newborn|newborn
1025001|NCT03006354|noninvasive ventilation|noninvasive ventilation
1025002|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
1025003|NCT03006328|weight gain|weight gain
1025004|NCT03006328|weight loss|weight loss
1025005|NCT03006315|multiple myeloma|multiple myeloma
1025006|NCT03006315|garmin vivofit|garmin vivofit
1025007|NCT03006302|pancreatic cancer|pancreatic cancer
1025008|NCT03006302|vaccine|vaccine
1025009|NCT03006302|immunotherapy|immunotherapy
1025010|NCT03006302|MK-3475|mk-3475
1025011|NCT03006302|PD-1|pd-1
1025013|NCT03006289|Metabolic Syndrome|metabolic syndrome
1025014|NCT03006289|fasting plasma glucose|fasting plasma glucose
1025015|NCT03006263|Stomach Neoplasms|stomach neoplasms
1025016|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
1025017|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
1025018|NCT03006250|Desflurane|desflurane
1025019|NCT03006250|Sevoflurane|sevoflurane
1025020|NCT03006250|Respiratory Complications|respiratory complications
1025021|NCT03006224|secondary smoking|secondary smoking
1025022|NCT03006224|one lung ventilation|one lung ventilation
1025023|NCT03006224|arterial oxygen tension|arterial oxygen tension
1025024|NCT03006224|lobectomy|lobectomy
1025025|NCT03006211|nitrogen protoxide|nitrogen protoxide
1025026|NCT03006211|oxygen|oxygen
1025027|NCT03006211|corneal endothelial|corneal endothelial
1025028|NCT03006211|pediatric|pediatric
1025029|NCT03006107|Irreversible pulpitis|irreversible pulpitis
1025030|NCT03006107|Post endodontic pain|post endodontic pain
1025031|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
1025032|NCT03006107|Single visit RCT pain|single visit rct pain
1025033|NCT03006107|Root canal treatment flare up|root canal treatment flare up
1025034|NCT03006107|Single dose piroxicam|single dose piroxicam
1025035|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
1025036|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
1025037|NCT03006094|questionnaire|questionnaire
1025038|NCT03006094|hip|hip
1025039|NCT03006094|pain|pain
1025040|NCT03006081|Retinal nonperfusion|retinal nonperfusion
1025041|NCT03006081|Aflibercept|aflibercept
1025042|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
1025043|NCT03006068|ABT-494|abt-494
1025044|NCT03006068|Open-Label Extension (OLE)|open-label extension (ole)
1025045|NCT03006068|Safety|safety
1025050|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
1025051|NCT03006042|toxicity|toxicity
1025052|NCT03006042|ultrasound guidance|ultrasound guidance
1025053|NCT03006042|QTc interval|qtc interval
1025054|NCT03006003|Osteoporosis|osteoporosis
1025055|NCT03006003|Raloxifene|raloxifene
1025056|NCT03006003|Central nervous disorders|central nervous disorders
1025057|NCT03005990|Sleep disturbance|sleep disturbance
1025058|NCT03005990|Body composition|body composition
1025059|NCT03005990|Energy metabolism|energy metabolism
1025060|NCT03005990|Exercise training|exercise training
1025061|NCT03005990|Community-dwelling elderly|community-dwelling elderly
1025062|NCT03005977|Urodynamics|urodynamics
1025063|NCT03005977|Pyridium pad test|pyridium pad test
1025064|NCT03005977|Cough stress test|cough stress test
1025065|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
1025066|NCT03005938|Cerebral Palsy|cerebral palsy
1025067|NCT03005938|Spinal Manipulation|spinal manipulation
1025068|NCT03005938|Muscle Spasticity|muscle spasticity
1025069|NCT03005938|Manual Dexterity|manual dexterity
1025070|NCT03005912|Speech Comprehension|speech comprehension
1025071|NCT03005912|Telephony|telephony
1025072|NCT03005912|VoIP|voip
1025073|NCT03005886|Periodontitis|periodontitis
1025074|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
1025075|NCT03005886|Cardiovascular diseases|cardiovascular diseases
1025076|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
1025077|NCT03005886|Acute myocardial infarction|acute myocardial infarction
1025078|NCT03005886|Neopterin|neopterin
1025079|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
1025080|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
1025081|NCT03005873|TLC599|tlc599
1025082|NCT03005873|Dexamethasone|dexamethasone
1025084|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
1025085|NCT03005821|pediatric massage|pediatric massage
1025086|NCT03005821|Tuina therapy|tuina therapy
1025087|NCT03005821|acute diarrhea|acute diarrhea
1025088|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
1025089|NCT03005795|cervical dysplasia|cervical dysplasia
1025090|NCT03005795|colposcopy|colposcopy
1025091|NCT03005795|anxiety|anxiety
1025092|NCT03005795|music|music
1025093|NCT03005795|mozart|mozart
1025094|NCT03005795|randomized controlled trial|randomized controlled trial
1025095|NCT03005769|persistence|persistence
1025096|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
1025097|NCT03005769|adherence|adherence
1025098|NCT03005743|Cervical cancer|cervical cancer
1025099|NCT03005743|Brachytherapy|brachytherapy
1025100|NCT03005743|Conventional planning|conventional planning
1025101|NCT03005743|MR based Brachytherapy|mr based brachytherapy
1025102|NCT03005717|submental|submental
1025103|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
1025104|NCT03005717|LIPO-202|lipo-202
1025105|NCT03005717|bulge|bulge
1025106|NCT03005704|Ticagrelor|ticagrelor
1025107|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
1025108|NCT03005704|Platelet transfusion|platelet transfusion
1025109|NCT03005704|Reversal|reversal
1025110|NCT03005691|metabolite|metabolite
1025111|NCT03005691|central sensitization|central sensitization
1025112|NCT03005691|whiplash|whiplash
1025113|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
1025114|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
1025115|NCT03005665|acetazolamide|acetazolamide
1025116|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
1025117|NCT03005652|Mental Health|mental health
1025118|NCT03005652|Meditation|meditation
1025119|NCT03005652|Health Education|health education
1025120|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
1025121|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
1025122|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
1025123|NCT03005613|Clinical outcome|clinical outcome
1025124|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
1025125|NCT03005574|Severe Mental Illness|severe mental illness
1025126|NCT03005574|Cognitive Remediation|cognitive remediation
1025127|NCT03005574|Employment|employment
1025128|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1025129|NCT03005548|Pain Postoperative|pain postoperative
1025130|NCT03005548|Thoracotomy|thoracotomy
1025131|NCT03005509|Quality improvement|quality improvement
1025132|NCT03005509|Injury|injury
1025133|NCT03005509|Injuries|injuries
1025134|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
1025135|NCT03005470|Prehypertension|prehypertension
1025136|NCT03005470|Hypertension|hypertension
1025137|NCT03005470|Blood pressure|blood pressure
1025138|NCT03005470|Intervention|intervention
1025139|NCT03005470|Lifestyle|lifestyle
1025140|NCT03005470|Blood pressure monitoring|blood pressure monitoring
1025141|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1025142|NCT03005470|Text Messages|text messages
1025143|NCT03005470|High blood pressure|high blood pressure
1025144|NCT03005444|liver cirrhosis|liver cirrhosis
1025446|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
1025145|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
1025146|NCT03005444|Anticoagulation|anticoagulation
1025147|NCT03005444|Survival|survival
1025148|NCT03005444|Additional decompensation|additional decompensation
1025149|NCT03005431|Parenting|parenting
1025150|NCT03005431|Training|training
1025151|NCT03005431|Support|support
1025152|NCT03005431|On-line|on-line
1025153|NCT03005431|Stress|stress
1025154|NCT03005405|Dental Caries|dental caries
1025155|NCT03005405|Primary tooth|primary tooth
1025156|NCT03005405|Ionomer Sealants|ionomer sealants
1025157|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
1025158|NCT03005392|Cancer|cancer
1025159|NCT03005392|Physical therapy|physical therapy
1025160|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
1025161|NCT03005379|FMT|fmt
1025162|NCT03005379|recurrent c. difficile|recurrent c. difficile
1025163|NCT03005379|infectious disease|infectious disease
1025165|NCT03005379|clinical trial|clinical trial
1025166|NCT03005379|gastrointestinal|gastrointestinal
1025167|NCT03005379|prevention|prevention
1025168|NCT03005379|randomized|randomized
1025169|NCT03005379|diarrhea|diarrhea
1025170|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
1025171|NCT03005366|Atrial fibrillation|atrial fibrillation
1025172|NCT03005366|vernakalant|vernakalant
1025173|NCT03005366|flecainide|flecainide
1025174|NCT03005366|cardioversion|cardioversion
1025175|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
1025176|NCT03005288|type 2 diabetes|type 2 diabetes
1025177|NCT03005288|obesity|obesity
1025178|NCT03005288|DXA|dxa
1025179|NCT03005288|MRI|mri
1025180|NCT03005236|Kidney transplant|kidney transplant
1025181|NCT03005236|Tacrolimus|tacrolimus
1025182|NCT03005236|Envarsus|envarsus
1025183|NCT03005236|Older adult|older adult
1025184|NCT03005236|Elderly|elderly
1025185|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
1025186|NCT03005158|Myocardial infarction|myocardial infarction
1025187|NCT03005158|Acute coronary syndrome|acute coronary syndrome
1025188|NCT03005158|Cluster-randomized trial|cluster-randomized trial
1025189|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
1025190|NCT03004989|Qualitative study|qualitative study
1025191|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
1025192|NCT03004989|Return to Work Programme|return to work programme
1025193|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
1025194|NCT03004976|umbilical cord blood|umbilical cord blood
1025195|NCT03004976|stroke|stroke
1025196|NCT03004976|ischemic stroke|ischemic stroke
1670250|NCT00106782|Dystonia|dystonia
1025197|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
1025198|NCT03004963|Volume Status|volume status
1025199|NCT03004963|Body Composition Monitor|body composition monitor
1025200|NCT03004911|fibromyalgia|fibromyalgia
1025201|NCT03004911|mobile application|mobile application
1025202|NCT03004911|self-care|self-care
1025203|NCT03004911|quality of life|quality of life
1025204|NCT03004872|birth experience|birth experience
1025205|NCT03004872|postpartum depression|postpartum depression
1025206|NCT03004872|PTSD|ptsd
1025207|NCT03004872|pain during labor|pain during labor
1025208|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
1025209|NCT03004872|non-elective induction of labor|non-elective induction of labor
1025210|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
1025211|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
1025212|NCT03004859|atrial fibrillation|atrial fibrillation
1025213|NCT03004859|screening|screening
1025214|NCT03004859|electrocardiogram|electrocardiogram
1025215|NCT03004859|community pharmacy|community pharmacy
1025216|NCT03004859|Germany|germany
1025217|NCT03004846|Vehicle- controlled|vehicle- controlled
1025218|NCT03004846|GSK2981278|gsk2981278
1025219|NCT03004846|Plaque psoriasis|plaque psoriasis
1025220|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
1025221|NCT03004820|Transient Ischemic Attack|transient ischemic attack
1025222|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
1025223|NCT03004807|Nutrition|nutrition
1025224|NCT03004807|Aging|aging
1025225|NCT03004807|Multivitamin|multivitamin
1025226|NCT03004781|parenting intervention|parenting intervention
1025227|NCT03004781|externalizing behavior|externalizing behavior
1025228|NCT03004781|emotion coaching practices|emotion coaching practices
1025229|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
1025230|NCT03004742|polyphenols|polyphenols
1025231|NCT03004742|metabolomics|metabolomics
1025232|NCT03004742|oxidative stress|oxidative stress
1025233|NCT03004729|Allergy|allergy
1025234|NCT03004729|Atopic Dermatitis|atopic dermatitis
1025235|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
1025236|NCT03004729|CMPA|cmpa
1025237|NCT03004703|Interleukin 6|interleukin 6
1025238|NCT03004703|Tocilizumab|tocilizumab
1025239|NCT03004703|Acute coronary syndrome|acute coronary syndrome
1025240|NCT03004703|STEMI|stemi
1025241|NCT03004703|Inflammation|inflammation
1025242|NCT03004690|biosafety|biosafety
1025243|NCT03004690|outbreaks|outbreaks
1025244|NCT03004690|clinic|clinic
1025554|NCT03003117|Pregnancy|pregnancy
1025245|NCT03004690|personal protective equipment|personal protective equipment
1025246|NCT03004690|ergonomics|ergonomics
1025247|NCT03004690|error rates|error rates
1025248|NCT03004664|Latinos|latinos
1025249|NCT03004664|Low Income|low income
1025250|NCT03004664|Self Management|self management
1025251|NCT03004664|Education|education
1025252|NCT03004664|Cultural Competence|cultural competence
1025253|NCT03004638|Atherosclerosis|atherosclerosis
1025254|NCT03004638|Cardiovascular Disease|cardiovascular disease
1025255|NCT03004638|CAD|cad
1025256|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
1025257|NCT03004612|prediabetes|prediabetes
1025258|NCT03004599|Valvular Heart Disease|valvular heart disease
1025259|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
1025260|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
1025261|NCT03004599|High Risk|high risk
1025262|NCT03004599|Aortic Valve Replacement|aortic valve replacement
1025263|NCT03004599|Cardiovascular Disease|cardiovascular disease
1025264|NCT03004599|Aortic Stenosis|aortic stenosis
1025265|NCT03004599|Heart Valve Therapy|heart valve therapy
1025266|NCT03004599|Transcatheter|transcatheter
1025267|NCT03004599|Transfemoral|transfemoral
1025268|NCT03004599|TAVI|tavi
1025269|NCT03004599|TAVR|tavr
1025270|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
1025271|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
1025272|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
1025273|NCT03004586|Lung cancer|lung cancer
1025274|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
1025275|NCT03004586|EBUS-TBNA|ebus-tbna
1025276|NCT03004586|25-gauge needle|25-gauge needle
1025277|NCT03004586|22-gauge needle|22-gauge needle
1025278|NCT03004573|Parkinson Disease|parkinson disease
1025279|NCT03004573|emotional recognition|emotional recognition
1025280|NCT03004573|Deep Brain Stimulation|deep brain stimulation
1025281|NCT03004560|Bariatric|bariatric
1025282|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
1025283|NCT03004560|minimally invasive|minimally invasive
1025284|NCT03004560|scars|scars
1025285|NCT03004560|psychology|psychology
1025286|NCT03004534|Breast Cancer|breast cancer
1025287|NCT03004534|Breast Carcinoma|breast carcinoma
1025288|NCT03004534|Breast Tumours|breast tumours
1025289|NCT03004534|Early Breast Cancer|early breast cancer
1025290|NCT03004521|Lithium|lithium
1025291|NCT03004521|Quetiapine|quetiapine
1025292|NCT03004521|Augmentation|augmentation
1025293|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
1025294|NCT03004508|Safety|safety
1025295|NCT03004508|Genomic Stability|genomic stability
1025296|NCT03004508|DNA cell maintenance|dna cell maintenance
1025297|NCT03004482|NICU|nicu
1025298|NCT03004482|Recorded video images|recorded video images
1025299|NCT03004482|physiological disorders|physiological disorders
1025300|NCT03004456|Phlebotomy|phlebotomy
1025301|NCT03004456|Pain|pain
1025302|NCT03004456|Distress|distress
1025303|NCT03004443|Psychiatry|psychiatry
1025304|NCT03004430|Mantra|mantra
1025305|NCT03004430|Meditation|meditation
1025306|NCT03004391|Shared decision making|shared decision making
1025307|NCT03004391|Follow-up|follow-up
1025308|NCT03004378|obesity|obesity
1025309|NCT03004378|adolescent|adolescent
1025310|NCT03004378|tracking device|tracking device
1025311|NCT03004378|fitbit|fitbit
1025313|NCT03004326|CSS|css
1025314|NCT03004326|EGPA|egpa
1025315|NCT03004326|HSP|hsp
1025316|NCT03004326|GPA|gpa
1025317|NCT03004326|MPA|mpa
1025318|NCT03004326|PAN|pan
1025319|NCT03004326|Wegeners|wegeners
1025320|NCT03004313|migraine|migraine
1025321|NCT03004300|maxillary expansion|maxillary expansion
1025322|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
1025323|NCT03004300|airway volume|airway volume
1025324|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
1025325|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
1025326|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1025327|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
1025328|NCT03004209|Erythropoietin|erythropoietin
1025329|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
1025330|NCT03004196|White Spot Lesion|white spot lesion
1025331|NCT03004196|Probiotics|probiotics
1025332|NCT03004196|Chlorhexidine|chlorhexidine
1025333|NCT03004196|Streptococcus Mutans|streptococcus mutans
1025334|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
1025335|NCT03004170|HIV|hiv
1025336|NCT03004170|Motivational Interviewing|motivational interviewing
1025337|NCT03004170|Telephone|telephone
1025338|NCT03004170|Telehealth|telehealth
1025339|NCT03004170|Risky Sex|risky sex
1025340|NCT03004170|Unprotected Sex|unprotected sex
1025341|NCT03004170|Condoms|condoms
1025342|NCT03004170|Older Adults|older adults
1025343|NCT03004157|infant|infant
1025344|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1025345|NCT03004157|hemodynamics|hemodynamics
1025346|NCT03004157|chest compressions|chest compressions
1025447|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
1025347|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
1025348|NCT03004105|Advanced Lung Cancer|advanced lung cancer
1025349|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
1025350|NCT03004105|Selumetinib|selumetinib
1025351|NCT03004105|AZD6244|azd6244
1025352|NCT03004105|Durvalumab|durvalumab
1025353|NCT03004105|MEDI4736|medi4736
1025354|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
1025355|NCT03004092|lateral flow device|lateral flow device
1025356|NCT03004092|JF5|jf5
1025357|NCT03004092|Galactomannan|galactomannan
1025358|NCT03004092|Invasive aspergillosis|invasive aspergillosis
1025359|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
1025360|NCT03004053|Normal Oral Tissue|normal oral tissue
1025361|NCT03004053|16-1652|16-1652
1025362|NCT03004027|health behaviour change|health behaviour change
1025363|NCT03004027|implementation intention|implementation intention
1025364|NCT03004027|if then plan|if then plan
1025365|NCT03004027|skin condition|skin condition
1025366|NCT03004027|visible difference|visible difference
1025367|NCT03004027|self help|self help
1025368|NCT03004014|sleep endoscopy|sleep endoscopy
1025369|NCT03004014|sedation|sedation
1025370|NCT03004001|Severe proteinuria|severe proteinuria
1025371|NCT03004001|Dyslipidemia|dyslipidemia
1025372|NCT03003975|Ablation|ablation
1025373|NCT03003975|Cryoballoon|cryoballoon
1025374|NCT03003975|Achieve|achieve
1025375|NCT03003962|NSCLC|nsclc
1025376|NCT03003962|PD-L1|pd-l1
1025377|NCT03003962|Durvalumab (MEDI4736)|durvalumab (medi4736)
1025378|NCT03003962|OS|os
1025379|NCT03003949|perimenopause|perimenopause
1025380|NCT03003949|menopause transition|menopause transition
1025381|NCT03003949|estrogen|estrogen
1025382|NCT03003949|stress|stress
1025383|NCT03003949|mood|mood
1025384|NCT03003936|Glucose tolerance|glucose tolerance
1025385|NCT03003936|MTNR1B|mtnr1b
1025386|NCT03003936|nutrigenomics|nutrigenomics
1025387|NCT03003936|Food timing|food timing
1025388|NCT03003923|Vegetable intake|vegetable intake
1025389|NCT03003923|Taste exposures|taste exposures
1025390|NCT03003923|Educational intervention|educational intervention
1025391|NCT03003923|Preschool children|preschool children
1025392|NCT03003923|Healthy eating intervention|healthy eating intervention
1025393|NCT03003910|Best Possible Self|best possible self
1025394|NCT03003897|Dietary Fiber|dietary fiber
1025395|NCT03003897|Soluble Fiber|soluble fiber
1025396|NCT03003897|Body Mass Index|body mass index
1025397|NCT03003897|Body Weight|body weight
1025398|NCT03003897|Blood Glucose|blood glucose
1025399|NCT03003897|Insulin|insulin
1025400|NCT03003871|stroke|stroke
1025401|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
1025402|NCT03003871|oral health promotion|oral health promotion
1025403|NCT03003858|gingivitis|gingivitis
1025404|NCT03003858|hyaluronic acid|hyaluronic acid
1025405|NCT03003858|pediatrics|pediatrics
1025406|NCT03003858|medical devices|medical devices
1025407|NCT03003806|Insulin pump treatment|insulin pump treatment
1025408|NCT03003806|Type 1 diabetes|type 1 diabetes
1025409|NCT03003806|Pump setting advisor|pump setting advisor
1025410|NCT03003689|Scaling and Root Planing|scaling and root planing
1025411|NCT03003689|Er:YAG|er:yag
1025412|NCT03003663|Fall Prevention|fall prevention
1025413|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
1025414|NCT03003663|Patient Safety|patient safety
1025415|NCT03003663|Patient-Centered Care|patient-centered care
1025416|NCT03003663|Patient Monitoring|patient monitoring
1025417|NCT03003663|Health Care Technology|health care technology
1025418|NCT03003663|Mobile Applications|mobile applications
1025419|NCT03003663|Bedside Monitor|bedside monitor
1025420|NCT03003663|Mechanical Fall|mechanical fall
1025421|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
1025422|NCT03003624|Incisions|incisions
1025423|NCT03003624|microdissection needle|microdissection needle
1025424|NCT03003598|Intraocular pressure|intraocular pressure
1025425|NCT03003598|videolaryngoscope|videolaryngoscope
1025426|NCT03003598|direct laryngoscope|direct laryngoscope
1025427|NCT03003585|intraocular pressure|intraocular pressure
1025428|NCT03003585|direct laryngoscopy|direct laryngoscopy
1025429|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
1025430|NCT03003572|Sjögren's syndrome|sjögren's syndrome
1025431|NCT03003572|Immunoglobulin E|immunoglobulin e
1025432|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
1025433|NCT03003572|Autoimmune disease|autoimmune disease
1025434|NCT03003572|Biomarker|biomarker
1025435|NCT03003559|COPD Exacerbation|copd exacerbation
1025436|NCT03003559|High Flow Oxygen|high flow oxygen
1025437|NCT03003559|Nasal Cannula|nasal cannula
1025438|NCT03003559|mild|mild
1025439|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
1025440|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
1025441|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
1025442|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
1025443|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
1025444|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
1025445|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
1025448|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
1025449|NCT03003533|Gene Therapy|gene therapy
1025450|NCT03003533|Gene Transfer|gene transfer
1025451|NCT03003533|Hematologic Diseases|hematologic diseases
1025452|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
1025453|NCT03003533|Recombinant|recombinant
1025454|NCT03003533|Vector|vector
1025455|NCT03003520|Lymphoma|lymphoma
1025456|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
1025457|NCT03003520|Durvalumab|durvalumab
1025458|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
1025459|NCT03003520|MEDI4736|medi4736
1025460|NCT03003520|Immune Checkpoint|immune checkpoint
1025461|NCT03003520|Rituximab|rituximab
1025462|NCT03003520|Cyclophosphamide|cyclophosphamide
1025463|NCT03003520|Doxorubicin|doxorubicin
1025464|NCT03003520|Vincristine|vincristine
1025465|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
1025466|NCT03003520|Lenalidomide|lenalidomide
1025467|NCT03003507|Hyperglycemia|hyperglycemia
1025468|NCT03003507|Fructose|fructose
1025469|NCT03003507|Diabetes mellitus|diabetes mellitus
1025470|NCT03003507|Enteral Nutrition|enteral nutrition
1025471|NCT03003507|Glycemic Variability|glycemic variability
1025472|NCT03003468|Anti-PD-1|anti-pd-1
1025473|NCT03003468|Pembrolizumab|pembrolizumab
1025474|NCT03003468|Imprime PGG|imprime pgg
1025475|NCT03003468|MK-3475|mk-3475
1025476|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
1025477|NCT03003442|Multivitamin/mineral|multivitamin/mineral
1025478|NCT03003442|Exercise|exercise
1025479|NCT03003442|Fatigue|fatigue
1025480|NCT03003442|Stress|stress
1025481|NCT03003442|Arousal|arousal
1025482|NCT03003442|Energy expenditure|energy expenditure
1025483|NCT03003442|Recovery biomarkers|recovery biomarkers
1025484|NCT03003442|Cognition|cognition
1025485|NCT03003429|Heart rate variability|heart rate variability
1025486|NCT03003429|anxiety|anxiety
1025487|NCT03003429|Autonomic dysfunction|autonomic dysfunction
1025488|NCT03003403|mHealth|mhealth
1025489|NCT03003403|Digital Health|digital health
1025490|NCT03003403|Primary Care|primary care
1025491|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
1025492|NCT03003403|Behavior Change|behavior change
1025493|NCT03003403|Weight Management|weight management
1025494|NCT03003390|child|child
1025495|NCT03003390|critical illness|critical illness
1025496|NCT03003390|venous thromboembolism|venous thromboembolism
1025497|NCT03003390|enoxaparin|enoxaparin
1025498|NCT03003390|thrombin generation|thrombin generation
1025499|NCT03003377|Sevoflurane|sevoflurane
1025500|NCT03003377|Remifentanil|remifentanil
1025501|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
1025502|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
1025503|NCT03003351|Fistula|fistula
1025504|NCT03003351|Cohort Study|cohort study
1025505|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
1025506|NCT03003338|HCV RNA|hcv rna
1025507|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
1025508|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
1025509|NCT03003325|low risk of thrombosis|low risk of thrombosis
1025510|NCT03003325|Interferon|interferon
1025511|NCT03003312|Urolithiasis|urolithiasis
1025512|NCT03003312|Uyghur|uyghur
1025513|NCT03003312|Prevalence|prevalence
1025514|NCT03003312|Associated factors|associated factors
1025515|NCT03003312|Children|children
1025516|NCT03003299|Sapien 3|sapien 3
1025517|NCT03003299|Partner 3|partner 3
1025518|NCT03003299|cardiovascular disease|cardiovascular disease
1025519|NCT03003299|heart disease|heart disease
1025520|NCT03003299|aortic stenosis|aortic stenosis
1025521|NCT03003299|SAVR|savr
1025522|NCT03003299|TAVR|tavr
1025523|NCT03003299|failing surgical valve|failing surgical valve
1025524|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
1025525|NCT03003299|failing valve|failing valve
1025526|NCT03003286|Contingency Behavior Management|contingency behavior management
1025527|NCT03003286|Flexible|flexible
1025528|NCT03003286|Unstuck|unstuck
1025529|NCT03003286|Low Income|low income
1025530|NCT03003286|Behavior|behavior
1025531|NCT03003286|Coping|coping
1025532|NCT03003286|Disparity|disparity
1025533|NCT03003286|Problem Solving|problem solving
1025534|NCT03003286|Self-Control|self-control
1025535|NCT03003286|impulsive|impulsive
1025536|NCT03003286|intervention|intervention
1025537|NCT03003221|Parent training|parent training
1025538|NCT03003221|Dental care|dental care
1025539|NCT03003169|surgery|surgery
1025540|NCT03003169|breast cancer|breast cancer
1025541|NCT03003169|quality of life|quality of life
1025542|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
1025543|NCT03003156|schizophrenia|schizophrenia
1025544|NCT03003156|controlled trial|controlled trial
1025545|NCT03003156|cognition|cognition
1025546|NCT03003130|Hyaluronic acid|hyaluronic acid
1025547|NCT03003130|Comparative study|comparative study
1025548|NCT03003130|NLF|nlf
1025549|NCT03003117|Infant|infant
1025550|NCT03003117|Diet|diet
1025551|NCT03003117|Growth|growth
1025552|NCT03003117|Breastfeeding|breastfeeding
1025553|NCT03003117|Complementary feeding|complementary feeding
1025555|NCT03003117|Body mass index|body mass index
1025556|NCT03003117|Social disadvantage|social disadvantage
1025557|NCT03003117|Randomized controlled trial|randomized controlled trial
1025558|NCT03003117|Education|education
1025559|NCT03003117|Food vouchers|food vouchers
1025560|NCT03003104|Skin diseases|skin diseases
1025561|NCT03003104|rosacea|rosacea
1025562|NCT03003078|Pancreatic cancer|pancreatic cancer
1025563|NCT03003078|Pancreas|pancreas
1025564|NCT03003078|metastases|metastases
1025565|NCT03003078|pancreatic tumour|pancreatic tumour
1025566|NCT03003078|unresectable|unresectable
1025567|NCT03003078|locally advanced|locally advanced
1025568|NCT03003078|implantable|implantable
1025569|NCT03003078|radiographic|radiographic
1025570|NCT03003078|device|device
1025571|NCT03003078|Phosphorous-32|phosphorous-32
1025572|NCT03003078|OncoSil™|oncosil™
1025584|NCT03003052|evidence-based dentistry|evidence-based dentistry
1025585|NCT03003039|GB241|gb241
1025586|NCT03003039|Rituximab|rituximab
1025587|NCT03003039|B-cell Lymphoma|b-cell lymphoma
1025588|NCT03003026|motor learning|motor learning
1025589|NCT03003026|participation|participation
1025590|NCT03003013|Odontogenic cysts|odontogenic cysts
1025591|NCT03003013|Bone substitutes materials|bone substitutes materials
1025592|NCT03003013|SYMBIOS®|symbios®
1025593|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
1025594|NCT03003013|Bone regeneration|bone regeneration
1025598|NCT03002896|Cancer|cancer
1025599|NCT03002896|Caregivers|caregivers
1025600|NCT03002896|Pep-pal|pep-pal
1025601|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
1025602|NCT03002896|Treatment as Usual|treatment as usual
1025603|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
1025604|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
1025605|NCT03002831|CIK|cik
1025606|NCT03002831|Chemotherapy|chemotherapy
1025607|NCT03002831|Pancreatic Cancer|pancreatic cancer
1025608|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
1025609|NCT03002818|Genotype 1|genotype 1
1025610|NCT03002818|Paritaprevir|paritaprevir
1025611|NCT03002818|Ritonavir|ritonavir
1025612|NCT03002818|ombitasvir|ombitasvir
1025613|NCT03002818|Dasabuvir|dasabuvir
1568417|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
1025614|NCT03002818|Sustained Virological Response|sustained virological response
1025615|NCT03002805|Phase I|phase i
1025616|NCT03002805|CBT-1®|cbt-1®
1025617|NCT03002805|Doxorubicin|doxorubicin
1025618|NCT03002805|Sarcoma|sarcoma
1025619|NCT03002792|anesthesia|anesthesia
1025620|NCT03002792|neurodevelopment|neurodevelopment
1025621|NCT03002792|dental caries|dental caries
1025622|NCT03002753|OCD|ocd
1025623|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
1025624|NCT03002753|cognitive therapy|cognitive therapy
1025625|NCT03002753|metacognitive therapy|metacognitive therapy
1025626|NCT03002753|cognitive restructuring|cognitive restructuring
1025627|NCT03002753|detached mindfulness|detached mindfulness
1025628|NCT03002753|comparison|comparison
1025629|NCT03002753|Germany|germany
1025630|NCT03002753|Muenster|muenster
1025631|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
1025632|NCT03002753|metacognition|metacognition
1025633|NCT03002727|Colorectal cancer|colorectal cancer
1025634|NCT03002727|Microsatellite|microsatellite
1025635|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
1025636|NCT03002714|Resistance Training|resistance training
1025637|NCT03002714|Psychological Stress|psychological stress
1025638|NCT03002714|Aging|aging
1025639|NCT03002714|Hypertension|hypertension
1025640|NCT03002714|Autonomic Nervous System|autonomic nervous system
1025641|NCT03002701|Prevention|prevention
1025642|NCT03002701|Critical care|critical care
1025643|NCT03002701|Delirium|delirium
1025644|NCT03002701|Nurse|nurse
1025645|NCT03002701|RCT|rct
1025646|NCT03002675|Adipose tissue|adipose tissue
1025647|NCT03002675|Type 2 diabetes|type 2 diabetes
1025648|NCT03002649|Dermatomyositis|dermatomyositis
1025649|NCT03002649|Tofacitinib|tofacitinib
1025650|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
1025651|NCT03002636|Obesity|obesity
1025652|NCT03002636|Anesthesia Complications|anesthesia complications
1025653|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
1025654|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
1025655|NCT03002623|HDAC2|hdac2
1025656|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
1025657|NCT03002584|IBS, population|ibs, population
1025658|NCT03002558|Hypertension|hypertension
1025659|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
1025660|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
1025661|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
1025662|NCT03002545|Magnesium|magnesium
1025663|NCT03002545|Type II diabetes|type ii diabetes
1025664|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
1025665|NCT03002532|Breast cancer|breast cancer
1025666|NCT03002532|Brain metastasis|brain metastasis
1025667|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
1025668|NCT03002532|Hippocampal avoidance|hippocampal avoidance
1025669|NCT03002532|Neurocognitive function|neurocognitive function
1025670|NCT03002532|intracranial failure|intracranial failure
1025671|NCT03002506|ceftolozane|ceftolozane
1025672|NCT03002506|tazobactam|tazobactam
1025673|NCT03002493|Rifampicin|rifampicin
1025674|NCT03002493|Pharmacokinetics|pharmacokinetics
1025675|NCT03002493|Eribulin Mesylate|eribulin mesylate
1025676|NCT03002493|E7389|e7389
1025677|NCT03002493|Advanced Solid Tumors|advanced solid tumors
1025678|NCT03002493|Tumors|tumors
1025679|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
1025680|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
1025681|NCT03002454|Technetium|technetium
1025682|NCT03002454|Molybdenum|molybdenum
1025683|NCT03002454|MDP|mdp
1025684|NCT03002454|neutron activation|neutron activation
1025685|NCT03002402|asthma|asthma
1025686|NCT03002402|insomnia|insomnia
1025687|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
1025688|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1025689|NCT03002389|COPD|copd
1025690|NCT03002389|emphysema|emphysema
1025691|NCT03002389|MRI|mri
1025692|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
1025693|NCT03002363|autism|autism
1025694|NCT03002363|audiology|audiology
1025695|NCT03002363|video modeling|video modeling
1025696|NCT03002363|testing compliance|testing compliance
1025697|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
1025698|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
1025699|NCT03002350|Cell sorting|cell sorting
1025700|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
1025701|NCT03002350|disruptive mutation|disruptive mutation
1025702|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
1025703|NCT03002324|Vaccines|vaccines
1025704|NCT03002324|Childhood Vaccination|childhood vaccination
1025705|NCT03002324|Decision Making|decision making
1025706|NCT03002324|Health Belief Model|health belief model
1025707|NCT03002311|Bioinformatics|bioinformatics
1025708|NCT03002311|Electronic pharmacology|electronic pharmacology
1025709|NCT03002311|Mobile health|mobile health
1025710|NCT03002311|Electronic health|electronic health
1025711|NCT03002311|Adherence|adherence
1025712|NCT03002311|Digital health|digital health
1054553|NCT02821494|HPV|hpv
1025713|NCT03002311|Health information technology|health information technology
1025714|NCT03002311|mHealth|mhealth
1025715|NCT03002311|eHealth|ehealth
1025716|NCT03002259|cardiac surgery|cardiac surgery
1025717|NCT03002233|TRK-820|trk-820
1025718|NCT03002233|Hemodialysis|hemodialysis
1025719|NCT03002233|Uremic Pruritus|uremic pruritus
1025720|NCT03002194|rhytides|rhytides
1025721|NCT03002194|wrinkle|wrinkle
1025722|NCT03002142|Alzheimer|alzheimer
1025723|NCT03002142|Hearing loss|hearing loss
1025724|NCT03002142|Cognition|cognition
1025725|NCT03002142|Quality of life|quality of life
1025726|NCT03002142|Hearing aids|hearing aids
1025727|NCT03002090|iron deficiency|iron deficiency
1025728|NCT03002090|anemia|anemia
1025729|NCT03002090|exercise training|exercise training
1025730|NCT03002090|aerobic|aerobic
1025731|NCT03002090|performance|performance
1025732|NCT03002090|Chinese medicine|chinese medicine
1025733|NCT03002090|BaZhen KeLi|bazhen keli
1025734|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
1025735|NCT03002064|First-line chemotherapy|first-line chemotherapy
1025736|NCT03002064|Docetaxel|docetaxel
1025737|NCT03002064|Cisplatin|cisplatin
1025738|NCT03002064|5-fluorouracil|5-fluorouracil
1025739|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
1025740|NCT03002038|azathioprine|azathioprine
1025741|NCT03002038|rituximab|rituximab
1025742|NCT03002038|clinical trial|clinical trial
1025743|NCT03002038|annual relapse rate|annual relapse rate
1025744|NCT03002038|expanded disability status scale|expanded disability status scale
1025745|NCT03002012|cryptococcal antigen|cryptococcal antigen
1025746|NCT03002012|preemptive treatment|preemptive treatment
1025747|NCT03002012|CRAG+|crag+
1025748|NCT03002012|sertraline|sertraline
1025749|NCT03002012|fluconazole|fluconazole
1025750|NCT03002012|randomized clinical trial|randomized clinical trial
1025751|NCT03002012|HIV|hiv
1025752|NCT03001999|Diabetes|diabetes
1025753|NCT03001999|Positive Psychology|positive psychology
1025754|NCT03001999|Physical Activity|physical activity
1025755|NCT03001986|safety|safety
1025756|NCT03001986|efficacy|efficacy
1025757|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
1025758|NCT03001973|Lupus nephritis|lupus nephritis
1025759|NCT03001973|Patient survival|patient survival
1025760|NCT03001973|Renal survival|renal survival
1025761|NCT03001947|IgA nephropathy|iga nephropathy
1025762|NCT03001947|All-cause mortality|all-cause mortality
1025763|NCT03001947|Cardiovascular mortality|cardiovascular mortality
1025764|NCT03001947|A composite renal outcome|a composite renal outcome
1025765|NCT03001934|Nephrotic syndrome|nephrotic syndrome
1025766|NCT03001934|Treatment response|treatment response
1025767|NCT03001934|Renal function|renal function
1025768|NCT03001921|Hemodialysis|hemodialysis
1025769|NCT03001921|Patient survival|patient survival
1025770|NCT03001921|Quality of life|quality of life
1025771|NCT03001921|Hemodialysis access|hemodialysis access
1025785|NCT03001778|Independent Living Facilities|independent living facilities
1025786|NCT03001778|Multimedia technology|multimedia technology
1025787|NCT03001752|post-extraction dental implant|post-extraction dental implant
1025788|NCT03001752|immediate dental implant|immediate dental implant
1025789|NCT03001752|open flap|open flap
1025790|NCT03001752|flapless|flapless
1025791|NCT03001752|bone grafting|bone grafting
1025792|NCT03001752|CT Cone Beam|ct cone beam
1025793|NCT03001687|hepcidin|hepcidin
1025794|NCT03001687|sepsis|sepsis
1025795|NCT03001687|surgery|surgery
1025796|NCT03001687|vitamin D|vitamin d
1025797|NCT03001661|Propess|propess
1025798|NCT03001661|Dilapan-S|dilapan-s
1025799|NCT03001661|Dinoprostone|dinoprostone
1025800|NCT03001661|Labour|labour
1025801|NCT03001661|Induction|induction
1025802|NCT03001661|Child birth|child birth
1025803|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
1025804|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1025805|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
1025806|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
1025807|NCT03001583|Mediterranean diet|mediterranean diet
1025808|NCT03001583|weight loss|weight loss
1025809|NCT03001583|type 2 diabetes|type 2 diabetes
1025810|NCT03001583|education program|education program
1025811|NCT03001583|cooking|cooking
1025812|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
1025814|NCT03001557|circadian rhythms|circadian rhythms
1025815|NCT03001531|Complete paraplegia|complete paraplegia
1025816|NCT03001466|Cataract|cataract
1025817|NCT03001466|Urea-loaded NPs|urea-loaded nps
1025818|NCT03001466|TEM examination|tem examination
1025819|NCT03001453|Exparel|exparel
1025820|NCT03001453|total hip replacement|total hip replacement
1025821|NCT03001453|bupivacaine|bupivacaine
1025822|NCT03001440|REMS|rems
1025823|NCT03001440|Smoking cessation|smoking cessation
1025824|NCT03001440|WELLBUTRIN|wellbutrin
1025825|NCT03001440|ZYBAN|zyban
1025826|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
1025827|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
1025828|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
1025829|NCT03001388|Cystic Fibrosis|cystic fibrosis
1025830|NCT03001388|Transient Elastography|transient elastography
1025831|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
1025832|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
1025833|NCT03001375|Anastomotic leakage.|anastomotic leakage.
1025834|NCT03001349|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1025835|NCT03001349|Neuroendocrine Tumors|neuroendocrine tumors
1025836|NCT03001349|NET|net
1025837|NCT03001349|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
1025838|NCT03001349|PET/CT scan|pet/ct scan
1025839|NCT03001349|68Ga-DOTATOC|68ga-dotatoc
1025840|NCT03001336|Thyroid|thyroid
1025841|NCT03001336|Diabetes Mellitus|diabetes mellitus
1025842|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
1025843|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
1025844|NCT03001271|Renin-angiotensin System|renin-angiotensin system
1025845|NCT03001271|Autonomic Nervous System|autonomic nervous system
1025846|NCT03001245|adolescents|adolescents
1025847|NCT03001245|depression|depression
1025848|NCT03001245|psychotherapy|psychotherapy
1025849|NCT03001245|interpersonal therapy|interpersonal therapy
1025850|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
1025851|NCT03001232|QoL|qol
1025852|NCT03001232|ADL|adl
1025853|NCT03001232|Nursing Home|nursing home
1025854|NCT03001193|Primary slow progress|primary slow progress
1025855|NCT03001193|Prolonged latent phase|prolonged latent phase
1025856|NCT03001193|Labor arrest|labor arrest
1025857|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
1025858|NCT03001180|Vascular Anomaly|vascular anomaly
1025859|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
1025860|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
1025861|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1025862|NCT03001180|Biomarkers|biomarkers
1025863|NCT03001180|GLA|gla
1025864|NCT03001180|KLA|kla
1025865|NCT03001180|KHE|khe
1025866|NCT03001180|GSD|gsd
1025867|NCT03001167|Microbiome|microbiome
1025868|NCT03001167|Antibiotics|antibiotics
1025869|NCT03001167|Growth|growth
1025870|NCT03001141|MultiPoint Pacing|multipoint pacing
1025871|NCT03001141|Heart Failure|heart failure
1025872|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1025873|NCT03001141|Quadripolar pacing|quadripolar pacing
1025874|NCT03001115|Adalimumab|adalimumab
1025875|NCT03001115|Safety|safety
1025876|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
1025877|NCT03001115|Korean participants|korean participants
1025878|NCT03001102|Preoperative Care|preoperative care
1025879|NCT03001102|Baths|baths
1025880|NCT03001102|Chlorhexidine|chlorhexidine
1025881|NCT03001102|Soaps|soaps
1025882|NCT03001102|Povidone-Iodine|povidone-iodine
1025883|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1025884|NCT03001102|Surgical Wound Infection|surgical wound infection
1025885|NCT03001089|Neonatology|neonatology
1025886|NCT03001089|Endocrinology|endocrinology
1025887|NCT03001076|hyperlididemia|hyperlididemia
1025888|NCT03001076|LDL|ldl
1025889|NCT03001076|cholesterol|cholesterol
1025890|NCT03001076|statin intolerance|statin intolerance
1025891|NCT03001037|Functional Outcome Measures|functional outcome measures
1025892|NCT03001037|Wearable Sensors|wearable sensors
1025893|NCT03001037|ViMove|vimove
1025894|NCT03001037|Low Back Pain|low back pain
1025895|NCT03001037|Range of Movement|range of movement
1025896|NCT03001037|Muscle Activity|muscle activity
1025897|NCT03000998|HPV|hpv
1025898|NCT03000998|Cancer|cancer
1025899|NCT03000985|schizophrenia|schizophrenia
1025900|NCT03000985|psychoeducation program|psychoeducation program
1025901|NCT03000985|family caregiver|family caregiver
1025902|NCT03000985|relapse|relapse
1025903|NCT03000985|medication adherence|medication adherence
1025904|NCT03000985|burden|burden
1025905|NCT03000972|Augmentation|augmentation
1025906|NCT03000972|PET-CT|pet-ct
1025907|NCT03000972|Positron Emission Tomography|positron emission tomography
1025908|NCT03000972|Fluorine-18|fluorine-18
1025909|NCT03000946|Pancreatectomy|pancreatectomy
1025910|NCT03000946|Somatostatin analogue|somatostatin analogue
1025911|NCT03000946|Octreotide|octreotide
1025912|NCT03000946|Pancreatic fistula|pancreatic fistula
1025913|NCT03000920|short message service (SMS)|short message service (sms)
1025914|NCT03000920|screening|screening
1025915|NCT03000920|cost-effectiveness|cost-effectiveness
1025916|NCT03000907|prevention|prevention
1025917|NCT03000907|frailty|frailty
1025918|NCT03000907|obese|obese
1025919|NCT03000907|elderly|elderly
1025920|NCT03000907|physical exercise|physical exercise
1025921|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
1025922|NCT03000894|insomnia|insomnia
1025923|NCT03000894|mood disorder|mood disorder
1025924|NCT03000868|Colonic Polyps|colonic polyps
1025925|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
1025926|NCT03000868|Colonoscopy|colonoscopy
1025927|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
1025928|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
1025929|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
1025930|NCT03000842|autonomic control|autonomic control
1025931|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
1025932|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
1025933|NCT03000829|Code blue|code blue
1025934|NCT03000829|Code team|code team
1025935|NCT03000829|Crisis team leadership|crisis team leadership
1025936|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1025937|NCT03000829|Telemedicine|telemedicine
1025938|NCT03000829|Simulation|simulation
1025939|NCT03000829|Mock code|mock code
1025940|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
1025941|NCT03000790|Anterior disc displacement|anterior disc displacement
1025942|NCT03000790|TMD therapy|tmd therapy
1025943|NCT03000790|internal derangement|internal derangement
1025944|NCT03000790|Lingual Ring|lingual ring
1025945|NCT03000777|melatonin|melatonin
1025946|NCT03000777|zinc|zinc
1025947|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
1025948|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
1025949|NCT03000777|sleep|sleep
1025950|NCT03000777|pain|pain
1025951|NCT03000764|Skin biopsy|skin biopsy
1025952|NCT03000764|Radiotherapy|radiotherapy
1025953|NCT03000764|RNA biomarker|rna biomarker
1025954|NCT03000764|HSP biomarker|hsp biomarker
1025955|NCT03000764|Exon junction array|exon junction array
1025956|NCT03000764|Gene expression|gene expression
1025957|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
1025958|NCT03000751|CT scan|ct scan
1025959|NCT03000751|CT exam|ct exam
1025960|NCT03000751|ionizing radiation|ionizing radiation
1025961|NCT03000751|medical imaging|medical imaging
1025962|NCT03000751|cat scan|cat scan
1025963|NCT03000751|radiation|radiation
1025964|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
1025965|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
1025966|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1025967|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1025968|NCT03000738|prognosis|prognosis
1025969|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
1025970|NCT03000712|osteoarthritis|osteoarthritis
1025971|NCT03000712|degenerative arthritis|degenerative arthritis
1026673|NCT02996630|LVOTO|lvoto
1025972|NCT03000712|kyung hee university hospital|kyung hee university hospital
1025974|NCT03000712|Rbio|rbio
1025975|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
1025976|NCT03000712|High tibial osteotomy|high tibial osteotomy
1025977|NCT03000712|Joint Diseases|joint diseases
1025978|NCT03000699|cognitive bias modification|cognitive bias modification
1025979|NCT03000699|interpretation bias|interpretation bias
1025980|NCT03000699|suicidal ideation|suicidal ideation
1025981|NCT03000699|depression|depression
1025982|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
1025985|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
1025986|NCT03000660|ABT-199|abt-199
1025987|NCT03000660|Venetoclax|venetoclax
1025988|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
1025989|NCT03000647|Supervision|supervision
1025990|NCT03000647|Physiotherapy|physiotherapy
1025991|NCT03000621|MicroRNA|microrna
1025992|NCT03000621|miR-122|mir-122
1025993|NCT03000621|Diagnosis|diagnosis
1025994|NCT03000621|Prognosis|prognosis
1025995|NCT03000595|eczema|eczema
1025996|NCT03000569|Parkinson|parkinson
1025997|NCT03000543|vitamin A|vitamin a
1025998|NCT03000543|vitamin A isotope|vitamin a isotope
1025999|NCT03000543|Inflammation|inflammation
1026000|NCT03000530|Depression|depression
1026001|NCT03000517|levofloxacin|levofloxacin
1026002|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
1026003|NCT03000517|pharmacokinetics|pharmacokinetics
1026004|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
1026005|NCT03000465|laparoscopic pressure|laparoscopic pressure
1568418|NCT00505921|Lymphoma|lymphoma
1026006|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
1026007|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
1026008|NCT03000465|abdominal compliance|abdominal compliance
1026009|NCT03000452|Multiple Myeloma|multiple myeloma
1026010|NCT03000452|Daratumumab|daratumumab
1026011|NCT03000452|Durvalumab|durvalumab
1026012|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1026013|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
1026014|NCT03000439|Xeljanz|xeljanz
1026015|NCT03000439|Tofacitinib|tofacitinib
1026016|NCT03000439|sJIA|sjia
1026017|NCT03000439|CP-690 550|cp-690 550
1026018|NCT03000426|Low level laser therapy|low level laser therapy
1026019|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
1026020|NCT03000387|Smoking Cessation|smoking cessation
1026021|NCT03000387|Randomized Clinical Trial|randomized clinical trial
1026022|NCT03000387|Nicotine Patch|nicotine patch
1026023|NCT03000387|Abstinence|abstinence
1026024|NCT03000387|Placebo|placebo
1026025|NCT03000387|Double blind|double blind
1026026|NCT03000361|Colonoscopy|colonoscopy
1026027|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
1026028|NCT03000361|adenoma detection rate|adenoma detection rate
1026029|NCT03000348|Exacerbation|exacerbation
1026031|NCT03000348|Lung disease|lung disease
1026032|NCT03000348|Lung infection|lung infection
1026033|NCT03000348|Gram negative|gram negative
1026034|NCT03000348|Bacterial Infection|bacterial infection
1026035|NCT03000348|pneumonia|pneumonia
1026036|NCT03000348|bronchitis|bronchitis
1026037|NCT03000335|microRNA|microrna
1026038|NCT03000335|relapse|relapse
1026039|NCT03000335|blood|blood
1026040|NCT03000335|in vitro diagnostics|in vitro diagnostics
1026041|NCT03000335|prediction|prediction
1026042|NCT03000335|lab test|lab test
1026043|NCT03000296|autologous|autologous
1026044|NCT03000296|lymphoablation|lymphoablation
1026045|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
1026046|NCT03000296|immune system|immune system
1026047|NCT03000296|Bone marrow transplant|bone marrow transplant
1026048|NCT03000283|Conivaptan|conivaptan
1026049|NCT03000270|Infarct Size|infarct size
1026050|NCT03000270|Impella|impella
1026051|NCT03000270|Unloading|unloading
1026052|NCT03000270|Left Ventricle|left ventricle
1026053|NCT03000270|PPCI|ppci
1026054|NCT03000270|STEMI|stemi
1026055|NCT03000257|Cancer|cancer
1026056|NCT03000257|Advanced Solid Tumors|advanced solid tumors
1026057|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1026058|NCT03000257|Triple negative breast cancer|triple negative breast cancer
1026059|NCT03000257|Ovarian cancer|ovarian cancer
1026060|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
1026061|NCT03000257|Gastric cancer|gastric cancer
1026062|NCT03000257|Small cell lung cancer|small cell lung cancer
1026063|NCT03000257|Mesothelioma|mesothelioma
1026064|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
1026065|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
1026066|NCT03000257|Head and neck cancer|head and neck cancer
1026067|NCT03000244|Natural History|natural history
1026068|NCT03000244|HCT|hct
1026069|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
1026070|NCT03000205|patients|patients
1026071|NCT03000192|Survivorship|survivorship
1026072|NCT03000192|Cancer|cancer
1026073|NCT03000192|Recovery|recovery
1026074|NCT03000192|Self-management|self-management
1026075|NCT03000192|Cohort|cohort
1026076|NCT03000179|small bowel cancer, small bowel carcinoma|small bowel cancer, small bowel carcinoma
1026077|NCT03000127|testosterone|testosterone
1026078|NCT03000127|multiple sclerosis|multiple sclerosis
1026079|NCT03000127|fatigue|fatigue
1026080|NCT03000114|Collagenase injection|collagenase injection
1026081|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
1026082|NCT03000101|Biomarkers|biomarkers
1026083|NCT03000101|Colitis|colitis
1026084|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
1026085|NCT03000101|Colonic Diseases|colonic diseases
1026086|NCT03000101|Crohn Disease|crohn disease
1026087|NCT03000101|Digestive System Diseases|digestive system diseases
1026088|NCT03000101|Fruit|fruit
1026089|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
1026090|NCT03000101|Gastroenteritis|gastroenteritis
1026091|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
1026092|NCT03000101|Humans|humans
1026093|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
1026094|NCT03000101|Inflammation|inflammation
1026095|NCT03000101|Inflammatory Bowel Diseases|inflammatory bowel diseases
1026096|NCT03000101|Intestinal Diseases|intestinal diseases
1026097|NCT03000101|Punicaceae|punicaceae
1026098|NCT03000075|BI 655066|bi 655066
1026099|NCT03000075|ABBV-066|abbv-066
1026100|NCT03000075|risankizumab|risankizumab
1026101|NCT03000062|overweight, general practice|overweight, general practice
1026102|NCT03000049|sepsis|sepsis
1026103|NCT03000049|septic shock|septic shock
1026104|NCT03000049|blood cultures|blood cultures
1026105|NCT03000049|anti-infective therapy|anti-infective therapy
1026106|NCT03000036|Breast cancer|breast cancer
1026107|NCT03000036|Doxorubicin|doxorubicin
1026108|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
1026109|NCT03000036|T1 mapping|t1 mapping
1026110|NCT03000023|Hepatitis C|hepatitis c
1026111|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
1026112|NCT03000023|DAA Treatment|daa treatment
1026113|NCT03000023|Qualitative|qualitative
1026114|NCT03000023|Mixed methods|mixed methods
1026115|NCT03000010|Wound Vac|wound vac
1026116|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
1026117|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
1026118|NCT02999997|Physical therapy modalities|physical therapy modalities
1026119|NCT02999997|Dual-task performance|dual-task performance
1026120|NCT02999997|Parkinson's disease|parkinson's disease
1026121|NCT02999997|Active music therapy|active music therapy
1026122|NCT02999997|Physical activity|physical activity
1026123|NCT02999971|circuit class therapy|circuit class therapy
1026124|NCT02999971|ICF model|icf model
1026125|NCT02999971|aquatic therapy|aquatic therapy
1026126|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
1026127|NCT02999945|preterm infants|preterm infants
1026128|NCT02999945|SGA infants|sga infants
1026129|NCT02999945|IUGR infants|iugr infants
1026131|NCT02999945|body composition|body composition
1026132|NCT02999945|metabolomics|metabolomics
1026133|NCT02999945|microbiome|microbiome
1026134|NCT02999945|adiposity markers|adiposity markers
1026135|NCT02999945|metabolic programming|metabolic programming
1026136|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
1026137|NCT02999906|PAH|pah
1026138|NCT02999906|Oral Treprostinil|oral treprostinil
1026139|NCT02999906|dual therapy|dual therapy
1026140|NCT02999906|6 Minute Walk Test|6 minute walk test
1026141|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1026142|NCT02999854|Graft-versus-host disease|graft-versus-host disease
1026143|NCT02999854|Immune reconstitution|immune reconstitution
1026144|NCT02999854|Alloreactive T-cells|alloreactive t-cells
1026145|NCT02999854|Photodynamic treatment|photodynamic treatment
1026146|NCT02999854|Hematologic malignancy|hematologic malignancy
1026147|NCT02999854|Transplant-related mortality|transplant-related mortality
1026148|NCT02999854|Overall survival|overall survival
1026149|NCT02999854|GRFS|grfs
1026150|NCT02999854|GVHD|gvhd
1026151|NCT02999841|Visceral fat|visceral fat
1026152|NCT02999828|safety|safety
1026153|NCT02999828|immune persistence|immune persistence
1026154|NCT02999815|Tetanus|tetanus
1026155|NCT02999802|Nutrient Sensing|nutrient sensing
1026156|NCT02999802|Exercise|exercise
1026157|NCT02999802|Elderly|elderly
1026158|NCT02999789|Asthma/drug therapy|asthma/drug therapy
1026159|NCT02999789|Medication Adherence/statistics & numerical data|medication adherence/statistics & numerical data
1026160|NCT02999789|Reminder Systems|reminder systems
1026161|NCT02999789|Communication Barriers|communication barriers
1026162|NCT02999776|Plaques Psoriasis|plaques psoriasis
1026163|NCT02999776|Topical|topical
1026164|NCT02999776|Laser microporation|laser microporation
1026165|NCT02999763|lipolysis|lipolysis
1026166|NCT02999763|fat reduction|fat reduction
1026167|NCT02999763|circumference reduction|circumference reduction
1026168|NCT02999737|Platelet Rich Plasma|platelet rich plasma
1026169|NCT02999737|PRP|prp
1026170|NCT02999737|Hair loss|hair loss
1026171|NCT02999737|Alopecia|alopecia
1026172|NCT02999737|Hypotrichosis|hypotrichosis
1026173|NCT02999737|Hair diseases|hair diseases
1026175|NCT02999698|Hidradenitis|hidradenitis
1026176|NCT02999698|Psychological impact|psychological impact
1026177|NCT02999698|Quality of life|quality of life
1026178|NCT02999659|pupillometry|pupillometry
1026179|NCT02999659|autonomous nerve system|autonomous nerve system
1026180|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1026181|NCT02999646|cancer|cancer
1026182|NCT02999646|HNSCC|hnscc
1026183|NCT02999646|immunotherapy|immunotherapy
1026184|NCT02999646|MVX-ONCO-1|mvx-onco-1
1026185|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
1026186|NCT02999607|Positron emission tomography|positron emission tomography
1026187|NCT02999529|Chemotherapy|chemotherapy
1026199|NCT02999412|Integrated Healthcare System|integrated healthcare system
1026200|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
1026201|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
1026202|NCT02999412|Crossover Design|crossover design
1026203|NCT02999412|Randomised Controlled Trial|randomised controlled trial
1026204|NCT02999399|Smoker|smoker
1026205|NCT02999399|Former smoker|former smoker
1026206|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
1026207|NCT02999386|interleukin-6|interleukin-6
1026208|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
1026209|NCT02999360|Aphasia|aphasia
1026210|NCT02999360|Speech Therapy|speech therapy
1026211|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
1026212|NCT02999347|Treatment Outcome|treatment outcome
1026213|NCT02999347|Mid-urethral slings|mid-urethral slings
1026214|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
1026215|NCT02999334|Group healthcare models|group healthcare models
1026216|NCT02999334|Antenatal care|antenatal care
1026217|NCT02999334|Prenatal care|prenatal care
1026218|NCT02999334|Perinatal health|perinatal health
1026219|NCT02999334|CenteringPregnancy|centeringpregnancy
1026220|NCT02999334|sub-Saharan Africa|sub-saharan africa
1026221|NCT02999334|Malawi|malawi
1026222|NCT02999334|Tanzania|tanzania
1026223|NCT02999334|Pregnancy|pregnancy
1026224|NCT02999308|haemophilia|haemophilia
1026225|NCT02999308|prophylaxis|prophylaxis
1026226|NCT02999308|children|children
1026228|NCT02999282|tDCS|tdcs
1026229|NCT02999282|Rehabilitation|rehabilitation
1026230|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
1026231|NCT02999269|MRI|mri
1026232|NCT02999269|major depressive disorder|major depressive disorder
1026233|NCT02999256|Tart Cherry Juice|tart cherry juice
1026234|NCT02999256|Fat Oxidation|fat oxidation
1026235|NCT02999256|Lipid Profile|lipid profile
1026236|NCT02999256|Anthocyanins|anthocyanins
1026237|NCT02999256|Exercise|exercise
1026238|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
1026239|NCT02999230|Cavities|cavities
1026240|NCT02999217|iron isomaltoside|iron isomaltoside
1026241|NCT02999217|plasma ferritin|plasma ferritin
1026242|NCT02999217|haemoglobin|haemoglobin
1026243|NCT02999217|colorectal cancer|colorectal cancer
1026244|NCT02999165|Breastfeeding|breastfeeding
1026245|NCT02999165|CPAP|cpap
1026246|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
1026247|NCT02999165|preterm neonate|preterm neonate
1026248|NCT02999152|Bio-markers|bio-markers
1026249|NCT02999152|Radiation|radiation
1026250|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
1026251|NCT02999152|Total Body Irradiation|total body irradiation
1026252|NCT02999152|Partial Body Irradiation|partial body irradiation
1026253|NCT02999139|Injury|injury
1026254|NCT02999139|Prevention|prevention
1026255|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
1026256|NCT02999126|Titration|titration
1026257|NCT02999126|Target Controlled Infusion|target controlled infusion
1026258|NCT02999126|Propofol|propofol
1026259|NCT02999126|Bispectral index|bispectral index
1026260|NCT02999113|non-technical skills|non-technical skills
1026261|NCT02999113|patient safety|patient safety
1026262|NCT02999113|medical education|medical education
1026263|NCT02999100|oxytocin|oxytocin
1026264|NCT02999100|non-pregnant|non-pregnant
1026265|NCT02999100|pregnant|pregnant
1026266|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
1026267|NCT02999087|Head and Neck cancer|head and neck cancer
1026268|NCT02999087|Immunotherapy|immunotherapy
1026269|NCT02999074|exercise|exercise
1026270|NCT02999074|resistance training|resistance training
1026271|NCT02999074|aerobic training|aerobic training
1026272|NCT02999074|breast cancer|breast cancer
1026273|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1026274|NCT02999074|fatigue|fatigue
1026275|NCT02999074|quality of life|quality of life
1026276|NCT02999074|tumor response|tumor response
1026277|NCT02999061|pre-term children|pre-term children
1026278|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
1026279|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
1026280|NCT02999048|hematoma|hematoma
1026281|NCT02999048|neurological function|neurological function
1026282|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
1026283|NCT02999022|bone fractures|bone fractures
1026284|NCT02999022|bony callus|bony callus
1026285|NCT02999022|fractures, bone|fractures, bone
1026286|NCT02999022|lithium|lithium
1026287|NCT02999022|lithium carbonate|lithium carbonate
1026288|NCT02999022|osteogenesis|osteogenesis
1026289|NCT02999022|bone development|bone development
1026290|NCT02999022|fracture healing|fracture healing
1026291|NCT02999022|fracture repair|fracture repair
1026292|NCT02998970|Cardiovascular Disease|cardiovascular disease
1026293|NCT02998970|Type 2 Diabetes|type 2 diabetes
1026294|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1026295|NCT02998957|Acupuncture|acupuncture
1026296|NCT02998957|TENS|tens
1026297|NCT02998957|Physiotherapy|physiotherapy
1026307|NCT02998918|Supplementation|supplementation
1026308|NCT02998918|Curcumin|curcumin
1026309|NCT02998918|polyphenol|polyphenol
1026310|NCT02998918|V-cam|v-cam
1026311|NCT02998918|I-cam|i-cam
1026312|NCT02998918|atherosclerosis|atherosclerosis
1026313|NCT02998918|cardiovascular disease|cardiovascular disease
1026314|NCT02998918|atherogenesis|atherogenesis
1026315|NCT02998918|antioxidant|antioxidant
1026316|NCT02998918|resveratrol|resveratrol
1026317|NCT02998918|quercetin|quercetin
1026318|NCT02998892|Sedentary Behavior|sedentary behavior
1026319|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
1026320|NCT02998866|Esophageal Effects|esophageal effects
1026321|NCT02998853|Non culprit|non culprit
1026322|NCT02998853|STEMI PCI|stemi pci
1026323|NCT02998853|angio QFR|angio qfr
1026324|NCT02998853|FFR|ffr
1026325|NCT02998853|Staged procedure|staged procedure
1026326|NCT02998840|elevated blood pressure|elevated blood pressure
1026327|NCT02998814|fissure sealant|fissure sealant
1026328|NCT02998814|etch and rinse|etch and rinse
1026329|NCT02998814|self etch|self etch
1026330|NCT02998788|heart failure|heart failure
1026331|NCT02998788|risk factor|risk factor
1026332|NCT02998788|cardiovascular disease|cardiovascular disease
1026333|NCT02998788|lifestyle behavior|lifestyle behavior
1026334|NCT02998775|in vitro protein binding|in vitro protein binding
1026335|NCT02998775|hepatic impairment|hepatic impairment
1026336|NCT02998775|renal impairment|renal impairment
1026337|NCT02998762|major depression|major depression
1026338|NCT02998762|major depressive disorder|major depressive disorder
1026339|NCT02998762|biomarkers|biomarkers
1026340|NCT02998762|MDD|mdd
1026341|NCT02998762|long term follow up|long term follow up
1026342|NCT02998736|Colon|colon
1026343|NCT02998723|Basic Life Support|basic life support
1026344|NCT02998723|Education, Medical|education, medical
1026345|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1026346|NCT02998723|Learning|learning
1026347|NCT02998697|Systolic Heart Failure|systolic heart failure
1026348|NCT02998697|Anemia|anemia
1026349|NCT02998697|Iron Deficiency|iron deficiency
1026350|NCT02998684|Autism|autism
1026351|NCT02998684|Adolescent|adolescent
1026352|NCT02998684|Social skills|social skills
1026353|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
1026354|NCT02998658|Laparoscopy|laparoscopy
1026355|NCT02998658|Barbed sutures|barbed sutures
1026356|NCT02998658|Hysterectomy|hysterectomy
1026357|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
1026358|NCT02998645|SAA|saa
1026359|NCT02998645|first line|first line
1026360|NCT02998645|eltrombopag|eltrombopag
1026361|NCT02998645|cyclosporine|cyclosporine
1026362|NCT02998645|h-ATG|h-atg
1026363|NCT02998645|severe aplastic anemia|severe aplastic anemia
1026364|NCT02998645|aplastic anemia|aplastic anemia
1026365|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
1026366|NCT02998580|late-life depression|late-life depression
1026367|NCT02998580|treatment resistance|treatment resistance
1026368|NCT02998515|supplemental oxygen|supplemental oxygen
1026369|NCT02998515|concentrator|concentrator
1026370|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
1026371|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
1026372|NCT02998502|Anxiety|anxiety
1026373|NCT02998502|Pediatrics|pediatrics
1026374|NCT02998489|enteral nutrition|enteral nutrition
1026375|NCT02998489|infant,premature|infant,premature
1026376|NCT02998489|feeding method|feeding method
1026377|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1026378|NCT02998476|relapsed|relapsed
1026379|NCT02998476|refractory|refractory
1026380|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
1026381|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
1026382|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
1026383|NCT02998463|Skin-to-skin|skin-to-skin
1026384|NCT02998463|Kangaroo Care|kangaroo care
1026385|NCT02998463|Kangaroo Mother Care|kangaroo mother care
1026386|NCT02998450|Sickle Cell Disease|sickle cell disease
1026387|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
1026388|NCT02998424|propofol|propofol
1026389|NCT02998424|pupillary diameter|pupillary diameter
1026390|NCT02998411|anti-infectives|anti-infectives
1026391|NCT02998411|adults|adults
1026392|NCT02998411|pharmacokinetic|pharmacokinetic
1026393|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
1026394|NCT02998411|clinical cure|clinical cure
1026395|NCT02998398|Biosimilar|biosimilar
1026396|NCT02998385|salivary glands|salivary glands
1026397|NCT02998385|sinus carcinoma|sinus carcinoma
1026398|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
1026399|NCT02998385|cisplatin|cisplatin
1026400|NCT02998385|protontherapy|protontherapy
1026401|NCT02998346|Nutrition|nutrition
1026402|NCT02998346|CRRT|crrt
1026403|NCT02998346|CVVH|cvvh
1026404|NCT02998346|citrate|citrate
1026405|NCT02998346|anticoagulation|anticoagulation
1026406|NCT02998346|caloric uptake|caloric uptake
1026407|NCT02998333|Instability|instability
1026408|NCT02998333|Ankle|ankle
1026409|NCT02998333|Surgical stabilization|surgical stabilization
1026410|NCT02998281|cerebral palsy|cerebral palsy
1026411|NCT02998281|inspiratory muscle training|inspiratory muscle training
1026412|NCT02998255|PEG|peg
1026413|NCT02998255|Bowel preparation|bowel preparation
1026414|NCT02998255|Colonoscopy|colonoscopy
1026415|NCT02998203|organic diet|organic diet
1026416|NCT02998203|health|health
1026417|NCT02998203|pesticides|pesticides
1026418|NCT02998203|inflammation biomarkers|inflammation biomarkers
1026419|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
1026420|NCT02998177|Postoperative pain|postoperative pain
1026421|NCT02998177|Rebound pain|rebound pain
1026422|NCT02998177|Gut microbiome|gut microbiome
1026423|NCT02998177|Gut microbiota|gut microbiota
1026424|NCT02998177|Peripheral nerve block|peripheral nerve block
1026425|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
1026426|NCT02998138|Chronic Pain|chronic pain
1026427|NCT02998138|Pain, Postoperative|pain, postoperative
1026428|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
1026429|NCT02998112|Ulcerative colitis|ulcerative colitis
1026430|NCT02998099|Healthy Volunteers|healthy volunteers
1026431|NCT02998099|Rivipansel|rivipansel
1026432|NCT02998060|Robot|robot
1026433|NCT02998060|Spinal Fusion|spinal fusion
1026434|NCT02998060|Spine|spine
1026435|NCT02998060|Navigation|navigation
1026436|NCT02998060|Freehand|freehand
1026437|NCT02998008|Exercise Therapy|exercise therapy
1026438|NCT02998008|Heart Function Tests|heart function tests
1026439|NCT02998008|Heart/physiology|heart/physiology
1026440|NCT02998008|Echocardiography|echocardiography
1026441|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
1026442|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
1026443|NCT02997995|PD-1|pd-1
1026444|NCT02997995|Neoadjuvant|neoadjuvant
1026445|NCT02997995|Immune-attractants|immune-attractants
1026446|NCT02997995|lymphocytes activation|lymphocytes activation
1026447|NCT02997982|Alzheimer's Disease|alzheimer's disease
1026448|NCT02997982|Herpes Simplex Virus|herpes simplex virus
1026449|NCT02997982|HSV|hsv
1026450|NCT02997982|Antiviral Drugs|antiviral drugs
1026451|NCT02997969|HIV|hiv
1026452|NCT02997943|Obesity|obesity
1026453|NCT02997943|Weight Loss|weight loss
1026454|NCT02997943|Diet|diet
1026455|NCT02997943|Physical Activity|physical activity
1026456|NCT02997943|Mobile Health|mobile health
1026457|NCT02997904|lice comb|lice comb
1026458|NCT02997904|human head lice infestations|human head lice infestations
1026459|NCT02997904|combing solution|combing solution
1026460|NCT02997891|cognition|cognition
1026461|NCT02997891|hip replacement|hip replacement
1026462|NCT02997891|physical activity|physical activity
1026463|NCT02997891|quality of life|quality of life
1026464|NCT02997891|psychological distress|psychological distress
1026465|NCT02997878|autoimmune|autoimmune
1026466|NCT02997878|AiH|aih
1026467|NCT02997878|PSC|psc
1026468|NCT02997878|liver disease|liver disease
1026469|NCT02997878|cholangitis|cholangitis
1026470|NCT02997865|heart failure|heart failure
1026471|NCT02997865|depressive disorder, major|depressive disorder, major
1026472|NCT02997865|cognitive therapy|cognitive therapy
1026473|NCT02997865|antidepressive agents|antidepressive agents
1026474|NCT02997865|self-care|self-care
1026475|NCT02997852|human-animal interaction|human-animal interaction
1026476|NCT02997787|adenomyosis|adenomyosis
1026477|NCT02997787|leiomyoma|leiomyoma
1026478|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
1026479|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
1026480|NCT02997748|acute kidney injury|acute kidney injury
1026481|NCT02997748|cardiac surgery|cardiac surgery
1026482|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
1026483|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
1026484|NCT02997735|Secondhand Smoke|secondhand smoke
1026485|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
1026486|NCT02997735|Clinical Decision Support|clinical decision support
1026487|NCT02997735|Tobacco quitline|tobacco quitline
1026488|NCT02997722|ketamine|ketamine
1026490|NCT02997709|Prostate Cancer|prostate cancer
1026491|NCT02997709|Circulating Tumor Cells|circulating tumor cells
1026492|NCT02997709|CTCs|ctcs
1026493|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
1026494|NCT02997709|ADT|adt
1026495|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
1026496|NCT02997644|patient education|patient education
1026497|NCT02997644|orthopaedic surgery|orthopaedic surgery
1026498|NCT02997644|post-surgical pain|post-surgical pain
1026499|NCT02997644|chronic opioid use|chronic opioid use
1026500|NCT02997631|Pain Management|pain management
1026501|NCT02997631|Distraction Therapy|distraction therapy
1026502|NCT02997631|Robot Based Distraction|robot based distraction
1026503|NCT02997631|MEDi|medi
1026504|NCT02997605|low disease activity|low disease activity
1026505|NCT02997605|remission|remission
1026506|NCT02997566|Autonomic Nervous System|autonomic nervous system
1026507|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
1026508|NCT02997566|Heart Rate|heart rate
1026509|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
1026510|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
1026511|NCT02997553|Technetium99|technetium99
1026512|NCT02997553|Tumors|tumors
1026513|NCT02997553|Optonuclear probe|optonuclear probe
1026514|NCT02997553|Surgery|surgery
1026515|NCT02997540|female breast lesion|female breast lesion
1026516|NCT02997540|ultrasound examination|ultrasound examination
1026517|NCT02997514|Solution focused coaching|solution focused coaching
1026518|NCT02997514|Self determination|self determination
1026519|NCT02997488|videolaryngoscope|videolaryngoscope
1026520|NCT02997475|Bulimia Nervosa|bulimia nervosa
1026521|NCT02997475|Bulimia|bulimia
1026522|NCT02997475|fMRI|fmri
1026523|NCT02997475|Emotion Regulation|emotion regulation
1026524|NCT02997475|Response Inhibition|response inhibition
1026525|NCT02997462|Monocyte|monocyte
1026526|NCT02997462|Oxidative Stress|oxidative stress
1026527|NCT02997462|Endothelial Function|endothelial function
1026528|NCT02997462|Congestive Heart Failure|congestive heart failure
1026529|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1026530|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
1026531|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
1026532|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
1026533|NCT02997423|Biomarker|biomarker
1026534|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
1026535|NCT02997423|Newly diagnosed|newly diagnosed
1026536|NCT02997410|Ozone|ozone
1026537|NCT02997371|Traumatic brain injury|traumatic brain injury
1026538|NCT02997371|Microdialysis|microdialysis
1026539|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
1026540|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
1026541|NCT02997371|Positron Emission Tomography|positron emission tomography
1026542|NCT02997345|PPROM|pprom
1026543|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1026544|NCT02997319|Insulin Resistance|insulin resistance
1026545|NCT02997319|Shift Work|shift work
1026546|NCT02997319|Circadian Rhythms|circadian rhythms
1026547|NCT02997319|MTNR1B|mtnr1b
1026548|NCT02997306|Moh's Surgery|moh's surgery
1026549|NCT02997306|Erythema|erythema
1026550|NCT02997306|Face|face
1026551|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
1026552|NCT02997306|Running Sutures|running sutures
1026553|NCT02997306|Image Processing|image processing
1026554|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
1026555|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
1026556|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
1026557|NCT02997280|ruxolitinib|ruxolitinib
1026558|NCT02997280|JAK inhibitors|jak inhibitors
1026559|NCT02997254|atrial fibrillation|atrial fibrillation
1026560|NCT02997254|ablation|ablation
1026561|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
1026562|NCT02997241|Colonic Neoplasms|colonic neoplasms
1026563|NCT02997241|recurrence|recurrence
1026564|NCT02997215|intravenous lidocaine|intravenous lidocaine
1026565|NCT02997215|postoperative pain management|postoperative pain management
1026566|NCT02997202|Gilteritinib|gilteritinib
1026567|NCT02997202|ASP2215|asp2215
1026568|NCT02997202|Safety and Efficacy|safety and efficacy
1026569|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
1026570|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
1026571|NCT02997150|Safety|safety
1026572|NCT02997150|Efficacy|efficacy
1026573|NCT02997137|Chronic psychological distress|chronic psychological distress
1026588|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
1026589|NCT02997072|drive pressure|drive pressure
1026590|NCT02997059|Crohn disease|crohn disease
1026591|NCT02997059|Candida|candida
1026592|NCT02997059|ASCA|asca
1026593|NCT02997046|Ferumoxytol|ferumoxytol
1026594|NCT02997046|MRI|mri
1026595|NCT02997046|fistula|fistula
1026596|NCT02997046|graft|graft
1026597|NCT02997046|kidney transplant|kidney transplant
1026598|NCT02997046|angiography|angiography
1026599|NCT02997046|arteriovenous|arteriovenous
1026600|NCT02997033|Bone|bone
1026601|NCT02997033|Sex steroids|sex steroids
1026602|NCT02997033|Body composition|body composition
1026603|NCT02997033|Men|men
1026604|NCT02997007|tDCS|tdcs
1026605|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
1026606|NCT02997007|fMRI|fmri
1026607|NCT02997007|Healthy ageing|healthy ageing
1026608|NCT02996955|Low Back Pain|low back pain
1026609|NCT02996955|Social Support|social support
1026610|NCT02996955|Illness Perceptions|illness perceptions
1026611|NCT02996955|Activity Advice|activity advice
1026612|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
1026613|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
1026614|NCT02996903|coronary artery disease|coronary artery disease
1026615|NCT02996903|malignancy induction|malignancy induction
1026616|NCT02996903|radiation dose|radiation dose
1026617|NCT02996903|dose saving techniques|dose saving techniques
1026618|NCT02996903|effective dose|effective dose
1026619|NCT02996864|college students|college students
1026620|NCT02996864|physical activity|physical activity
1026621|NCT02996864|sleep behaviors|sleep behaviors
1026623|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
1026624|NCT02996851|Adverse effects|adverse effects
1026625|NCT02996851|Norway|norway
1026626|NCT02996851|Registries|registries
1026627|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
1026628|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
1026629|NCT02996812|Late dumping syndrome|late dumping syndrome
1026639|NCT02996747|bone tumors|bone tumors
1026640|NCT02996747|chondroma|chondroma
1026641|NCT02996747|chondrosarcoma|chondrosarcoma
1026642|NCT02996734|bone tumors|bone tumors
1026643|NCT02996734|giant cell tumor|giant cell tumor
1026644|NCT02996734|treatment|treatment
1026645|NCT02996708|Telemedicine|telemedicine
1026646|NCT02996708|Health economics|health economics
1026653|NCT02996682|Communicable Diseases|communicable diseases
1026654|NCT02996682|Hepatitis|hepatitis
1026655|NCT02996682|Hepatitis C|hepatitis c
1026656|NCT02996682|Virus Diseases|virus diseases
1026657|NCT02996682|Liver Diseases|liver diseases
1026658|NCT02996682|Digestive System Diseases|digestive system diseases
1026659|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
1026660|NCT02996682|Velpatasvir|velpatasvir
1026661|NCT02996682|Flaviviridae Infections|flaviviridae infections
1026662|NCT02996682|RNA Virus Infections|rna virus infections
1026663|NCT02996682|Ribavirin|ribavirin
1026664|NCT02996682|Sofosbuvir|sofosbuvir
1026665|NCT02996682|Antiviral Agents|antiviral agents
1026666|NCT02996682|Antimetabolites|antimetabolites
1026667|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1026668|NCT02996682|Anti-Infective Agents|anti-infective agents
1026669|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
1026670|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1026671|NCT02996643|Brace Treatment|brace treatment
1026672|NCT02996643|Ultrasound Imaging|ultrasound imaging
1026674|NCT02996630|Fallot|fallot
1026675|NCT02996630|Great Arteries Transposition|great arteries transposition
1026676|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
1026677|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
1026678|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
1026679|NCT02996617|Neutropenia|neutropenia
1026680|NCT02996604|acupuncture|acupuncture
1026681|NCT02996604|functional dyspepsia|functional dyspepsia
1026682|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1026683|NCT02996591|Nerve Block|nerve block
1026684|NCT02996591|General Anesthesia|general anesthesia
1026685|NCT02996591|Spinal Anesthesia|spinal anesthesia
1026686|NCT02996591|Pain|pain
1026687|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1026688|NCT02996578|Cognition|cognition
1026689|NCT02996578|Cacao|cacao
1026690|NCT02996578|Flavan-3-ols|flavan-3-ols
1026691|NCT02996578|Blood Pressure|blood pressure
1026692|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
1026693|NCT02996578|Memory|memory
1026694|NCT02996565|Clinic care|clinic care
1026695|NCT02996565|Team-based care|team-based care
1026696|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
1026697|NCT02996565|Telehealth|telehealth
1026698|NCT02996565|Cluster-randomized|cluster-randomized
1026699|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
1026700|NCT02996565|Pharmacist|pharmacist
1026701|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
1026702|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
1026703|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
1026704|NCT02996513|Vitamin A status|vitamin a status
1026705|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
1026706|NCT02996513|Nigeria|nigeria
1026707|NCT02996513|Preschool children|preschool children
1026708|NCT02996513|Malaria|malaria
1026709|NCT02996513|Inflammation|inflammation
1026710|NCT02996474|Pembrolizumab|pembrolizumab
1026711|NCT02996474|Decitabine|decitabine
1026712|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
1026713|NCT02996461|Zika Infection|zika infection
1026714|NCT02996461|Immune Response|immune response
1026715|NCT02996461|Flavivirus|flavivirus
1026716|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
1026717|NCT02996448|AD-HIES|ad-hies
1026718|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
1026719|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
1026720|NCT02996448|Candida Albicans|candida albicans
1026721|NCT02996448|RNA Transcriptome|rna transcriptome
1026722|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
1026723|NCT02996383|arthroplasty|arthroplasty
1026724|NCT02996370|esthetic|esthetic
1026725|NCT02996370|inter-implant papilla|inter-implant papilla
1026726|NCT02996370|soft tissue tickness|soft tissue tickness
1568419|NCT00505921|Campath-1H|campath-1h
1055872|NCT02813694|CAP|cap
1026727|NCT02996370|crestal bone loss|crestal bone loss
1026728|NCT02996370|second stage surgery|second stage surgery
1026729|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
1026730|NCT02996357|Risk factor|risk factor
1026731|NCT02996357|Intensive care unit|intensive care unit
1026732|NCT02996357|Prevention|prevention
1026733|NCT02996331|Ulcer|ulcer
1026734|NCT02996331|Pressure Ulcer|pressure ulcer
1026735|NCT02996331|Pathologic Processes|pathologic processes
1026736|NCT02996331|Skin Ulcer|skin ulcer
1026737|NCT02996331|Skin Diseases|skin diseases
1026738|NCT02996292|Crowding|crowding
1026739|NCT02996292|Self ligating|self ligating
1026740|NCT02996292|CBCT|cbct
1026741|NCT02996292|RCT|rct
1026742|NCT02996279|Neonate|neonate
1026743|NCT02996279|Chorioamnionitis|chorioamnionitis
1026744|NCT02996279|S100A12|s100a12
1026745|NCT02996266|Targeted Temperature Management|targeted temperature management
1026746|NCT02996175|Behavior|behavior
1026747|NCT02996175|Sleep|sleep
1026748|NCT02996175|Problems|problems
1026749|NCT02996175|Intervention|intervention
1026750|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1026751|NCT02996162|Chronic Lung Disease|chronic lung disease
1026752|NCT02996162|Prematurity|prematurity
1026753|NCT02996084|Imaging research|imaging research
1026754|NCT02995980|breast cancer screening|breast cancer screening
1026755|NCT02995980|dense breasts|dense breasts
1026756|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
1026757|NCT02995954|Combination therapy|combination therapy
1026758|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
1026759|NCT02995941|reliability|reliability
1026760|NCT02995941|validity|validity
1026761|NCT02995941|classification|classification
1026762|NCT02995941|irritability|irritability
1026763|NCT02995941|symptom|symptom
1026764|NCT02995941|intensity|intensity
1026765|NCT02995941|intervention|intervention
1026766|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1026767|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
1026768|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
1026769|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1026770|NCT02995837|Cerebral Blood Flow|cerebral blood flow
1026771|NCT02995837|Neurocognition|neurocognition
1026772|NCT02995824|Liver transplantation|liver transplantation
1026773|NCT02995824|HIV infection|hiv infection
1026774|NCT02995824|Antiretroviral therapy|antiretroviral therapy
1026775|NCT02995824|Raltegravir|raltegravir
1026776|NCT02995785|Simulation|simulation
1026777|NCT02995733|asthma|asthma
1026778|NCT02995733|African Americans|african americans
1026779|NCT02995733|Hispanics|hispanics
1026780|NCT02995707|Thalidomide NTDT|thalidomide ntdt
1026781|NCT02995681|COPD|copd
1026782|NCT02995681|Falls|falls
1026783|NCT02995681|Balance training|balance training
1026784|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1026785|NCT02995642|Carotid Stenosis|carotid stenosis
1026786|NCT02995642|Atherosclerosis|atherosclerosis
1026787|NCT02995642|Angiogenesis|angiogenesis
1026788|NCT02995642|Inflammation|inflammation
1026789|NCT02995642|Macrophages|macrophages
1026790|NCT02995642|Positron-Emission Tomography|positron-emission tomography
1026791|NCT02995642|Computerized tomography|computerized tomography
1026792|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
1026793|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
1026794|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
1026795|NCT02995616|Guidance force|guidance force
1026796|NCT02995616|Stroke|stroke
1026797|NCT02995616|Energy Consumption|energy consumption
1026798|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
1026799|NCT02995564|Social Skills|social skills
1026800|NCT02995564|Asperger's|asperger's
1026801|NCT02995564|High-functioning autism|high-functioning autism
1026802|NCT02995564|Young adults|young adults
1026803|NCT02995551|Menisci, Tibial|menisci, tibial
1026804|NCT02995551|Knee Injuries|knee injuries
1026805|NCT02995551|Arthroscopy|arthroscopy
1026806|NCT02995551|Exercise|exercise
1026807|NCT02995551|Young adults|young adults
1026808|NCT02995551|Treatment Outcome|treatment outcome
1026809|NCT02995551|Humans|humans
1026810|NCT02995512|myocardial infarction|myocardial infarction
1026811|NCT02995512|colchicine|colchicine
1026812|NCT02995512|anti-inflammatory|anti-inflammatory
1026813|NCT02995499|ASA-PS classification|asa-ps classification
1026814|NCT02995499|inter-rater reliability|inter-rater reliability
1026815|NCT02995499|general surgery|general surgery
1026816|NCT02995473|Psoriasis|psoriasis
1026817|NCT02995460|Exercise Therapy|exercise therapy
1026818|NCT02995447|propofol|propofol
1026819|NCT02995447|electroencephalogram|electroencephalogram
1026820|NCT02995434|Virtual Reality|virtual reality
1026821|NCT02995434|Cancer Survivorship|cancer survivorship
1026822|NCT02995434|Pain Management|pain management
1026823|NCT02995434|Cancer Pain Management|cancer pain management
1026824|NCT02995434|Chronic Pain Management|chronic pain management
1670251|NCT00106782|Brain|brain
1026825|NCT02995434|Adjunctive Pain Management|adjunctive pain management
1026826|NCT02995408|resiliency training|resiliency training
1026827|NCT02995408|parenting|parenting
1026828|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
1026829|NCT02995369|Sealants|sealants
1026830|NCT02995369|Dryshield|dryshield
1026831|NCT02995369|Cotton roll|cotton roll
1026832|NCT02995369|Isolation|isolation
1026833|NCT02995369|Efficiency|efficiency
1026834|NCT02995369|Preference|preference
1026835|NCT02995356|Ectopic pregnancy|ectopic pregnancy
1026836|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
1026837|NCT02995356|Creatine Kinase|creatine kinase
1026838|NCT02995356|Cervical fluid|cervical fluid
1026839|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1026840|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
1026841|NCT02995317|Aged|aged
1026842|NCT02995317|Gait|gait
1026843|NCT02995317|Postural Balance|postural balance
1026844|NCT02995317|Accelerometry|accelerometry
1026845|NCT02995317|Physical Activity|physical activity
1026846|NCT02995265|Exoskeleton|exoskeleton
1026847|NCT02995265|Stroke|stroke
1026848|NCT02995265|Walking|walking
1026849|NCT02995265|Rehabilitation|rehabilitation
1026850|NCT02995187|Apatinib|apatinib
1026851|NCT02995187|Third-line and Later Therapy|third-line and later therapy
1026852|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
1026853|NCT02995174|amblyopia|amblyopia
1026854|NCT02995174|fixation stability|fixation stability
1026855|NCT02995174|perceptual learning|perceptual learning
1026856|NCT02995083|osteoarthritis|osteoarthritis
1026857|NCT02995057|Microneedles|microneedles
1026858|NCT02995057|Biocompatibility|biocompatibility
1026859|NCT02995057|Allergy|allergy
1026860|NCT02995057|Metal|metal
1026861|NCT02995057|Nickel|nickel
1026862|NCT02995057|Contact dermatitis|contact dermatitis
1026863|NCT02995005|mother to child transmission|mother to child transmission
1026864|NCT02995005|hepatitis B|hepatitis b
1026865|NCT02995005|tenofovir|tenofovir
1026866|NCT02994953|Avelumab|avelumab
1026867|NCT02994953|M9241|m9241
1026868|NCT02994953|NHS-IL12|nhs-il12
1026869|NCT02994953|Advanced Solid Tumors|advanced solid tumors
1026870|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
1026871|NCT02994927|complement|complement
1026872|NCT02994927|vasculitis|vasculitis
1026873|NCT02994927|C5aR|c5ar
1026874|NCT02994927|avacopan|avacopan
1026875|NCT02994927|CCX168|ccx168
1026876|NCT02994927|MPA|mpa
1026877|NCT02994927|GPA|gpa
1026878|NCT02994914|Breast Cancer|breast cancer
1026879|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
1026880|NCT02994914|Radiotherapy|radiotherapy
1026881|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
1026882|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
1026883|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
1026884|NCT02994901|Sarcopenia|sarcopenia
1026885|NCT02994901|Geriatrics|geriatrics
1026886|NCT02994901|Biomarker|biomarker
1026887|NCT02994836|Crohn's Disease|crohn's disease
1026888|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
1026889|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
1026890|NCT02994836|Ulcerative colitis|ulcerative colitis
1026891|NCT02994810|Breastfeeding|breastfeeding
1026892|NCT02994810|Orientation|orientation
1026893|NCT02994797|salivary glands|salivary glands
1026894|NCT02994797|ultrasonography|ultrasonography
1026895|NCT02994797|elastometry|elastometry
1026896|NCT02994797|elastography|elastography
1026897|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
1026898|NCT02994758|Prostate|prostate
1026899|NCT02994758|bladder|bladder
1026900|NCT02994758|renal|renal
1026901|NCT02994758|NGS|ngs
1026902|NCT02994758|DSRT|dsrt
1026903|NCT02994758|drug screening|drug screening
1026904|NCT02994758|sequencing|sequencing
1026905|NCT02994758|personalised medicine|personalised medicine
1026906|NCT02994680|Air Pollution|air pollution
1026907|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
1026908|NCT02994680|Cookstove|cookstove
1026909|NCT02994680|Behavioral Intervention|behavioral intervention
1026910|NCT02994680|Propane Stove|propane stove
1026911|NCT02994667|Electrophysiology|electrophysiology
1026912|NCT02994641|critical care|critical care
1026913|NCT02994641|patient discharge|patient discharge
1026914|NCT02994641|costs and cost analysis|costs and cost analysis
1026915|NCT02994641|length of stay|length of stay
1026916|NCT02994641|hospital mortality|hospital mortality
1026917|NCT02994628|oxidative stress|oxidative stress
1026918|NCT02994628|immune function|immune function
1026919|NCT02994628|muscle damage|muscle damage
1026920|NCT02994628|carbohydrate|carbohydrate
1026921|NCT02994628|polyphenols|polyphenols
1026922|NCT02994628|cycling|cycling
1026923|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
1026924|NCT02994615|Microvascular dysfunction|microvascular dysfunction
1026925|NCT02994602|Healthy Men|healthy men
1026926|NCT02994602|Male Contraception|male contraception
1026927|NCT02994602|Healthy Women|healthy women
1026928|NCT02994602|Transfer|transfer
1026929|NCT02994602|Transference|transference
1026930|NCT02994602|Gel|gel
1026931|NCT02994602|Nestorone|nestorone
1026932|NCT02994602|Testosterone|testosterone
1026933|NCT02994550|FSH|fsh
1026934|NCT02994550|LH|lh
1026935|NCT02994550|IVF|ivf
1026936|NCT02994511|Circulating tumour DNA|circulating tumour dna
1026937|NCT02994511|ctDNA|ctdna
1026938|NCT02994420|Obesity|obesity
1026939|NCT02994420|Menstrual Cycle|menstrual cycle
1027427|NCT02991131|Erysipelas|erysipelas
1026940|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
1026941|NCT02994420|Satiety Response|satiety response
1026942|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
1026943|NCT02994420|Cholecystokinin|cholecystokinin
1026944|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
1026945|NCT02994381|Healthy Male Adults|healthy male adults
1026946|NCT02994381|14C|14c
1026947|NCT02994381|RPC1063|rpc1063
1026948|NCT02994368|retinal degeneration|retinal degeneration
1026949|NCT02994368|eye|eye
1026950|NCT02994368|REP-1 gene|rep-1 gene
1026951|NCT02994355|Family planning clinics|family planning clinics
1026952|NCT02994355|Implementation Science|implementation science
1026953|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
1026954|NCT02994342|vaginal dryness|vaginal dryness
1026955|NCT02994342|vaginal gel|vaginal gel
1026956|NCT02994342|colostrum|colostrum
1026957|NCT02994342|vaginal atrophy|vaginal atrophy
1026958|NCT02994329|HIV testing|hiv testing
1026959|NCT02994329|Linkage to care|linkage to care
1026960|NCT02994303|Fabry disease|fabry disease
1026961|NCT02994303|Fabry nephropathy|fabry nephropathy
1026962|NCT02994303|end-stage renal disease|end-stage renal disease
1026963|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
1026964|NCT02994303|Fabry's disease|fabry's disease
1026965|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
1026966|NCT02994277|"control System"|"control system"
1026967|NCT02994277|"Closed loop"|"closed loop"
1026968|NCT02994277|diabetes|diabetes
1026969|NCT02994277|"T1DM"|"t1dm"
1026970|NCT02994277|"pump"|"pump"
1026971|NCT02994277|algorithm|algorithm
1026972|NCT02994277|CGM|cgm
1026973|NCT02994199|Active video gaming|active video gaming
1026974|NCT02994199|Energy expenditure|energy expenditure
1026975|NCT02994186|cognitive function|cognitive function
1026976|NCT02994186|obesity|obesity
1026977|NCT02994186|bariatric surgery|bariatric surgery
1026978|NCT02994186|metabolic surgery|metabolic surgery
1026979|NCT02994160|peripheral nerve|peripheral nerve
1026980|NCT02994160|intraneural electrode|intraneural electrode
1026981|NCT02994160|hand amputation|hand amputation
1026982|NCT02994108|Human Papillomavirus|human papillomavirus
1026983|NCT02994108|Men Who Have Sex with Men|men who have sex with men
1026984|NCT02994082|Rural health|rural health
1026985|NCT02994082|Veterans|veterans
1026986|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
1026987|NCT02994069|Cisplatin|cisplatin
1026988|NCT02994069|Squamous Cell|squamous cell
1026989|NCT02994069|Carcinoma|carcinoma
1026990|NCT02994030|neuromuscular disorder|neuromuscular disorder
1026991|NCT02994017|cystic fibrosis|cystic fibrosis
1026992|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1026993|NCT02994017|prognostic|prognostic
1026994|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
1026995|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
1026996|NCT02993926|Drug Therapy|drug therapy
1026997|NCT02993887|Caregiver|caregiver
1026998|NCT02993887|Technology Dependent Children|technology dependent children
1026999|NCT02993887|Resourcefulness|resourcefulness
1027000|NCT02993887|Mindfulness|mindfulness
1027001|NCT02993874|Ergonemic resources|ergonemic resources
1027002|NCT02993874|Walking capacity|walking capacity
1027003|NCT02993874|Peripheral artery disease|peripheral artery disease
1027004|NCT02993861|Epilepsy|epilepsy
1027005|NCT02993861|Obese|obese
1027006|NCT02993848|Scapula|scapula
1027007|NCT02993848|Fracture|fracture
1027008|NCT02993796|Krabbe disease|krabbe disease
1027009|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
1027010|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
1027011|NCT02993796|sphingolipidosis|sphingolipidosis
1027012|NCT02993783|Drug Therapy|drug therapy
1027013|NCT02993757|Dengue Fever|dengue fever
1027014|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1027015|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
1027016|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
1027017|NCT02993757|Dengvaxia®|dengvaxia®
1027018|NCT02993757|Gardasil®|gardasil®
1027019|NCT02993744|preterm birth|preterm birth
1027020|NCT02993744|corticosteroids|corticosteroids
1027021|NCT02993744|inflammatory parameters|inflammatory parameters
1027022|NCT02993744|betamethasone|betamethasone
1027023|NCT02993744|leukocytes|leukocytes
1027024|NCT02993731|Neoplasms|neoplasms
1027025|NCT02993731|Neoplasms by Site|neoplasms by site
1027026|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
1027027|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
1670552|NCT00105482|Tobacco|tobacco
1027028|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
1027029|NCT02993731|Adenocarcinoma|adenocarcinoma
1027030|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1027031|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
1027032|NCT02993731|Digestive System Diseases|digestive system diseases
1027033|NCT02993731|Pancreatic Diseases|pancreatic diseases
1027034|NCT02993731|Endocrine System Diseases|endocrine system diseases
1027035|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
1027036|NCT02993731|Gemcitabine|gemcitabine
1028216|NCT02986334|MRI|mri
1027037|NCT02993692|direct laryngoscopy|direct laryngoscopy
1027038|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
1027039|NCT02993692|nasotracheal intubation|nasotracheal intubation
1027040|NCT02993640|vasopressin|vasopressin
1027041|NCT02993640|nitroglycerine|nitroglycerine
1027042|NCT02993640|portal pressure|portal pressure
1027043|NCT02993640|portal flow|portal flow
1027044|NCT02993627|obesity|obesity
1027045|NCT02993627|BMI|bmi
1027046|NCT02993627|body weight|body weight
1027047|NCT02993601|Heart Failure|heart failure
1027048|NCT02993601|Edema|edema
1027049|NCT02993601|Oedema|oedema
1027050|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
1027051|NCT02993588|Melatonin|melatonin
1027052|NCT02993588|IVF/ICSI|ivf/icsi
1027053|NCT02993588|Poor ovarian response|poor ovarian response
1027054|NCT02993575|Pharmacokinetics|pharmacokinetics
1027055|NCT02993575|Flucloxacillin|flucloxacillin
1027056|NCT02993575|Continuous infusion|continuous infusion
1027057|NCT02993575|Intensive Care Unit|intensive care unit
1027058|NCT02993562|Food intake|food intake
1027059|NCT02993562|Resting Energy Expenditure|resting energy expenditure
1027060|NCT02993562|Gall Bladder emptying|gall bladder emptying
1027061|NCT02993562|Insulin response|insulin response
1027062|NCT02993562|Body Composition|body composition
1027063|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
1027064|NCT02993523|Venetoclax|venetoclax
1027065|NCT02993523|Treatment Naïve|treatment naïve
1027066|NCT02993523|Azacitidine|azacitidine
1027067|NCT02993510|microfracture|microfracture
1027068|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
1027069|NCT02993510|articular cartilage|articular cartilage
1027070|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
1027071|NCT02993510|Chondro-Gide®|chondro-gide®
1027072|NCT02993510|knee surgery|knee surgery
1027073|NCT02993510|AMIC|amic
1027074|NCT02993458|dietary patterns|dietary patterns
1027075|NCT02993458|blood pressure|blood pressure
1027076|NCT02993458|adolescents|adolescents
1027077|NCT02993458|dietary sodium|dietary sodium
1027078|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
1027079|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
1027080|NCT02993380|Olive oil|olive oil
1027081|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
1027082|NCT02993380|Oleic acid|oleic acid
1027083|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
1027085|NCT02993367|fMRI|fmri
1027086|NCT02993302|vitamin D|vitamin d
1027087|NCT02993302|graves' disease|graves' disease
1027088|NCT02993302|dendritic cells|dendritic cells
1027089|NCT02993224|thalassemia|thalassemia
1027090|NCT02993224|TDT|tdt
1027091|NCT02993224|transfusion-dependent|transfusion-dependent
1027092|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
1027093|NCT02993224|NTDT|ntdt
1027094|NCT02993211|Bladder cancer|bladder cancer
1027095|NCT02993211|Transurethral resection|transurethral resection
1027096|NCT02993211|En bloc resection|en bloc resection
1027097|NCT02993211|TURBT|turbt
1027098|NCT02993185|pregnancy|pregnancy
1027099|NCT02993185|adolescents|adolescents
1027100|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
1027101|NCT02993185|decision making|decision making
1027102|NCT02993185|prevention education|prevention education
1027103|NCT02993107|AR101|ar101
1027104|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
1027105|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
1027106|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
1027107|NCT02993107|Peanut Allergy|peanut allergy
1027108|NCT02993107|Allergy|allergy
1027109|NCT02993107|Peanut-Allergic Children|peanut-allergic children
1027110|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
1027111|NCT02993107|Desensitization|desensitization
1027112|NCT02993107|PALISADE|palisade
1027113|NCT02993094|breast cancer|breast cancer
1027114|NCT02993094|advanced triple negative|advanced triple negative
1027115|NCT02993094|ixazomib|ixazomib
1027116|NCT02993094|carboplatin|carboplatin
1027117|NCT02993094|CARIXA|carixa
1027118|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
1027119|NCT02993081|YAG laser|yag laser
1027120|NCT02993068|Genetic testing|genetic testing
1027121|NCT02993068|Genetic educational video|genetic educational video
1027122|NCT02993068|Genetic counseling|genetic counseling
1027123|NCT02993068|Online genetic test results|online genetic test results
1027124|NCT02993068|Telephone genetic counseling|telephone genetic counseling
1027125|NCT02993068|Saliva test|saliva test
1027126|NCT02993068|Questionnaires|questionnaires
1027127|NCT02993068|Surveys|surveys
1027128|NCT02993042|Rehabilitation|rehabilitation
1027129|NCT02993042|Robot-assisted gait training|robot-assisted gait training
1027130|NCT02993029|99Tc-MDP|99tc-mdp
1027131|NCT02993029|osteoarthritis|osteoarthritis
1027132|NCT02993029|celecoxib|celecoxib
1027133|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
1027134|NCT02992951|Infection|infection
1027135|NCT02992951|Surgical Site Infection|surgical site infection
1027136|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
1027137|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
1027138|NCT02992938|Acetazolamide|acetazolamide
1027139|NCT02992938|Remifentanil|remifentanil
1027140|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
1027141|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
1027142|NCT02992925|Hib|hib
1027143|NCT02992925|DPT-IPV|dpt-ipv
1027144|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
1027145|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
1027146|NCT02992899|PTSD|ptsd
1027147|NCT02992899|vagal nerve|vagal nerve
1027148|NCT02992886|elderly patients|elderly patients
1027149|NCT02992886|rectal cancer|rectal cancer
1027150|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
1027151|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
1027152|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1027153|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1027154|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
1027155|NCT02992860|leukemic stem cell|leukemic stem cell
1027156|NCT02992860|CD123|cd123
1027157|NCT02992860|immunotherapy|immunotherapy
1027158|NCT02992847|Multiple sclerosis|multiple sclerosis
1027159|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
1027160|NCT02992847|MRI|mri
1027161|NCT02992847|Dentate nucleus|dentate nucleus
1027162|NCT02992821|Hand-held|hand-held
1027163|NCT02992821|Ultrasound|ultrasound
1027164|NCT02992821|Diagnosis|diagnosis
1027165|NCT02992821|Carotid artery stenosis|carotid artery stenosis
1027166|NCT02992808|IVF|ivf
1027167|NCT02992808|Ovarian stimulation|ovarian stimulation
1027168|NCT02992808|Androgenic profile|androgenic profile
1027169|NCT02992808|Follicular fluid|follicular fluid
1027170|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
1027171|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
1027172|NCT02992769|Breast Cancer|breast cancer
1027173|NCT02992769|Nomogram|nomogram
1027174|NCT02992769|Ultrasound|ultrasound
1027175|NCT02992769|Axillary Metastases|axillary metastases
1027176|NCT02992743|Sarcoma|sarcoma
1027177|NCT02992743|Cell Therapy|cell therapy
1027178|NCT02992743|T Cell Therapy|t cell therapy
1027179|NCT02992743|NY-ESO-1|ny-eso-1
1027180|NCT02992743|Immuno-oncology|immuno-oncology
1027181|NCT02992743|Metastatic|metastatic
1027182|NCT02992743|Previously treated|previously treated
1027183|NCT02992743|T Cell Receptor|t cell receptor
1027184|NCT02992730|Medication Adherence|medication adherence
1027185|NCT02992665|Calcium ionophore|calcium ionophore
1027186|NCT02992665|Fertilization|fertilization
1027187|NCT02992665|Sperm|sperm
1027188|NCT02992665|Oocyte|oocyte
1027189|NCT02992665|ICSI|icsi
1027190|NCT02992639|High visceral fat|high visceral fat
1027191|NCT02992639|Liver enzymes|liver enzymes
1027192|NCT02992639|Aminotransferase|aminotransferase
1027193|NCT02992639|Mild calorie restriction|mild calorie restriction
1027194|NCT02992600|non-cardiac surgery|non-cardiac surgery
1027321|NCT02991742|catheterization|catheterization
1027195|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1027196|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
1027197|NCT02992574|Node Negative|node negative
1027198|NCT02992574|Early breast Cancer|early breast cancer
1027199|NCT02992561|Aggression|aggression
1027200|NCT02992561|Violence|violence
1027201|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
1027202|NCT02992561|Demobilization|demobilization
1027203|NCT02992561|Traumatized offenders|traumatized offenders
1027204|NCT02992548|chronic kidney disease|chronic kidney disease
1027205|NCT02992548|pravastatin|pravastatin
1027206|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
1027207|NCT02992483|multiple myeloma|multiple myeloma
1027208|NCT02992483|lymphoma|lymphoma
1027209|NCT02992483|dlbcl|dlbcl
1027210|NCT02992431|patient care planning|patient care planning
1027211|NCT02992431|primary health care|primary health care
1027212|NCT02992431|comorbidity|comorbidity
1027213|NCT02992418|Dengue Fever|dengue fever
1027214|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1027215|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
1027216|NCT02992418|Degavaxia®|degavaxia®
1027217|NCT02992392|Tear film|tear film
1027218|NCT02992392|Lipid layer|lipid layer
1027219|NCT02992392|Liposic|liposic
1027220|NCT02992392|Tears Naturale Forte|tears naturale forte
1027221|NCT02992379|Anterior disc displacement|anterior disc displacement
1056457|NCT02810327|MZ|mz
1027222|NCT02992379|Stabilizing splint|stabilizing splint
1027223|NCT02992366|socket shield|socket shield
1027224|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
1027225|NCT02992366|immediate implant|immediate implant
1027226|NCT02992353|VATS|vats
1027227|NCT02992353|NSCLC|nsclc
1027228|NCT02992353|recurrence rate|recurrence rate
1027229|NCT02992288|Chronic Heart Failure|chronic heart failure
1027230|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
1027231|NCT02992275|Hip|hip
1027232|NCT02992275|Muscle|muscle
1027233|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
1027234|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
1027235|NCT02992223|Relapsed|relapsed
1027236|NCT02992223|Refractory|refractory
1027237|NCT02992223|Zevalin|zevalin
1027238|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
1027239|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
1027240|NCT02992223|BEAM|beam
1027241|NCT02992223|Recurrent|recurrent
1027242|NCT02992210|CAR|car
1027243|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
1027244|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
1027245|NCT02992197|Rotavirus|rotavirus
1027246|NCT02992197|Oral vaccines|oral vaccines
1027247|NCT02992197|Vaccine underperformance|vaccine underperformance
1027248|NCT02992197|Vaccine shedding|vaccine shedding
1027249|NCT02992184|HCV|hcv
1027250|NCT02992184|Genedrive|genedrive
1027251|NCT02992184|Point of Care|point of care
1027252|NCT02992119|safety|safety
1027253|NCT02992119|immunogenicity|immunogenicity
1027254|NCT02992106|Maternal Obesity|maternal obesity
1027255|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
1027256|NCT02992106|Childhood Obesity|childhood obesity
1027257|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
1027258|NCT02992093|Metabonomics|metabonomics
1027259|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
1027260|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
1027261|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
1027262|NCT02992067|lymph node metastasis|lymph node metastasis
1027263|NCT02992067|breast cancer|breast cancer
1027264|NCT02992067|CK19|ck19
1027265|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
1027266|NCT02992028|Rotator cuff repair|rotator cuff repair
1027267|NCT02992028|Vitamin C|vitamin c
1027268|NCT02992028|postoperative pain|postoperative pain
1027269|NCT02991989|Home-based exercise|home-based exercise
1027270|NCT02991989|Exercise snacking|exercise snacking
1027271|NCT02991989|Protein|protein
1027272|NCT02991989|Yogurt|yogurt
1027273|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
1027274|NCT02991976|Cerebral oxygenation|cerebral oxygenation
1027275|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
1027276|NCT02991976|Carotid endarterectomy|carotid endarterectomy
1027277|NCT02991976|TIVA|tiva
1027278|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
1027279|NCT02991924|EBUS-TBNA|ebus-tbna
1027280|NCT02991924|lung cancer|lung cancer
1027281|NCT02991924|staging|staging
1027282|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
1027283|NCT02991898|CML|cml
1027284|NCT02991898|MDS|mds
1027285|NCT02991898|CLL|cll
1027286|NCT02991898|ALL|all
1027287|NCT02991898|AML|aml
1027288|NCT02991872|Persistence|persistence
1027289|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
1027290|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
1027291|NCT02991872|Immunogenicity|immunogenicity
1027292|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
1027293|NCT02991872|Rabipur|rabipur
1027294|NCT02991859|Dose-response|dose-response
1027295|NCT02991859|AMP challenge|amp challenge
1027296|NCT02991859|cortisol suppression|cortisol suppression
1027297|NCT02991859|dose escalation|dose escalation
1027298|NCT02991859|therapeutic index|therapeutic index
1027299|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
1027300|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
1027301|NCT02991846|NIH consensus criteria|nih consensus criteria
1027302|NCT02991846|GITMO|gitmo
1027303|NCT02991833|fecal incontinence|fecal incontinence
1027304|NCT02991833|care product|care product
1027305|NCT02991833|bowel incontinence|bowel incontinence
1027306|NCT02991807|PTEN|pten
1027307|NCT02991807|PTEN Gene Mutation|pten gene mutation
1027308|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
1027309|NCT02991807|Autism|autism
1027310|NCT02991807|Intellectual Disability|intellectual disability
1027311|NCT02991807|Neurocognition|neurocognition
1027312|NCT02991807|Afinitor|afinitor
1027313|NCT02991807|Everolimus|everolimus
1027314|NCT02991807|RAD001|rad001
1027315|NCT02991794|prostatectomy|prostatectomy
1027316|NCT02991794|laparoscopy|laparoscopy
1027317|NCT02991794|3D visualization|3d visualization
1027318|NCT02991794|learning curve|learning curve
1027319|NCT02991794|anastomosis|anastomosis
1027320|NCT02991742|nephropathy|nephropathy
1027322|NCT02991742|contrast media|contrast media
1027323|NCT02991742|ioxaglate|ioxaglate
1027324|NCT02991742|iodixanol|iodixanol
1027325|NCT02991742|high risk|high risk
1027326|NCT02991742|prevention|prevention
1027327|NCT02991729|Decision aid|decision aid
1027328|NCT02991703|Arterial stiffness|arterial stiffness
1027329|NCT02991703|pulse wave velocity|pulse wave velocity
1027330|NCT02991703|Sphygmocor|sphygmocor
1027331|NCT02991703|applanation tonometry|applanation tonometry
1027332|NCT02991703|pOpmètre|popmètre
1027333|NCT02991703|children|children
1027334|NCT02991703|EPIPAGE cohort|epipage cohort
1027335|NCT02991690|Hypothermia|hypothermia
1028507|NCT02984462|Akin ;|akin ;
1027336|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
1027337|NCT02991690|Trauma|trauma
1027338|NCT02991677|exercise|exercise
1027339|NCT02991677|neuropathy|neuropathy
1027340|NCT02991664|glass ionomer cement|glass ionomer cement
1027341|NCT02991664|composite resin|composite resin
1027342|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
1027343|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
1027344|NCT02991599|Immunogenicity|immunogenicity
1027345|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
1027346|NCT02991599|Randomized Controlled Trial|randomized controlled trial
1027347|NCT02991586|Emotional Instability|emotional instability
1027348|NCT02991586|Family Therapy|family therapy
1027349|NCT02991586|BPD|bpd
1027350|NCT02991586|DBT|dbt
1027351|NCT02991560|physiotherapy|physiotherapy
1027352|NCT02991560|taping|taping
1027353|NCT02991560|conservative treatment|conservative treatment
1027354|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
1027355|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
1027356|NCT02991534|Women [M01.975]|women [m01.975]
1027357|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
1027358|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
1027359|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
1027360|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
1027361|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
1027362|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
1027363|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
1027364|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
1027365|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
1027366|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
1027367|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
1027368|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
1027369|NCT02991508|Adrecizumab|adrecizumab
1027370|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
1027763|NCT02988947|Hypnosis|hypnosis
1027371|NCT02991508|Adrenomedullin|adrenomedullin
1027372|NCT02991508|Healthy volunteers|healthy volunteers
1027373|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
1027374|NCT02991495|epidemic response|epidemic response
1027375|NCT02991482|MPM|mpm
1027376|NCT02991456|malignant glioma|malignant glioma
1027377|NCT02991456|temozolomide|temozolomide
1027378|NCT02991456|temodar|temodar
1027379|NCT02991456|radiation|radiation
1027380|NCT02991456|emesis|emesis
1027381|NCT02991456|nausea|nausea
1027382|NCT02991456|vomiting|vomiting
1027383|NCT02991456|chemotherapy|chemotherapy
1027384|NCT02991456|Affronti|affronti
1027385|NCT02991456|Peters|peters
1027386|NCT02991456|00076418|00076418
1027387|NCT02991430|migraine headache, episodic|migraine headache, episodic
1027388|NCT02991378|preschool children|preschool children
1027389|NCT02991378|emotional disorders/problems|emotional disorders/problems
1027390|NCT02991378|stress related disorders/problems|stress related disorders/problems
1027391|NCT02991378|early intervention|early intervention
1027392|NCT02991352|Vascular Malformations|vascular malformations
1027393|NCT02991352|Image Guidance|image guidance
1027394|NCT02991339|Dexamethasone|dexamethasone
1027395|NCT02991339|Liver Dysfunction|liver dysfunction
1027396|NCT02991339|Hepatectomy|hepatectomy
1027397|NCT02991339|Bilirubinaemia|bilirubinaemia
1027398|NCT02991339|Jaundice|jaundice
1027399|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1027400|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
1027401|NCT02991300|focal defect|focal defect
1027402|NCT02991300|focal lesion|focal lesion
1027403|NCT02991300|chondral lesion|chondral lesion
1027404|NCT02991300|osteochondral lesion|osteochondral lesion
1027405|NCT02991274|T790M|t790m
1027406|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
1027407|NCT02991274|NSCLC|nsclc
1027408|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
1027409|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
1027410|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
1027411|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
1027412|NCT02991183|Caregivers|caregivers
1027413|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
1027414|NCT02991170|myocardial infarction|myocardial infarction
1027415|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
1027416|NCT02991170|radiofrequency ablation|radiofrequency ablation
1027417|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
1027418|NCT02991157|cerebral vasospasm|cerebral vasospasm
1027419|NCT02991157|nimodipine|nimodipine
1027420|NCT02991144|Gene Transfer|gene transfer
1027421|NCT02991144|OTC Deficiency|otc deficiency
1027422|NCT02991144|Urea Cycle Disorder|urea cycle disorder
1027423|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
1027424|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
1027425|NCT02991131|Abscess|abscess
1027426|NCT02991131|Cellulitis|cellulitis
1027428|NCT02991131|Wound infection|wound infection
1027429|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
1027430|NCT02991118|hyperlipidemia|hyperlipidemia
1027431|NCT02991118|cholesterol|cholesterol
1027432|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
1027433|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1027434|NCT02991118|ASCVD|ascvd
1027435|NCT02991118|HeFH|hefh
1027436|NCT02991118|LDL|ldl
1027437|NCT02991105|Malignancy|malignancy
1027438|NCT02991105|Cancer|cancer
1027439|NCT02991105|Organ Transplantation|organ transplantation
1027440|NCT02991092|colon carcinoma|colon carcinoma
1027441|NCT02991092|liquid treatment|liquid treatment
1027442|NCT02991092|fast-track surgery|fast-track surgery
1027443|NCT02991079|Food Habits|food habits
1027444|NCT02991079|Health education|health education
1027445|NCT02991079|Physical activity|physical activity
1027446|NCT02991079|Information and Communication Technologies|information and communication technologies
1027447|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
1027448|NCT02991066|Coagulopathy|coagulopathy
1027449|NCT02991066|Microparticles|microparticles
1027450|NCT02991066|Mechanism|mechanism
1027451|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
1027452|NCT02991053|Pediatric patient|pediatric patient
1027453|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
1027454|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
1027455|NCT02991027|no known ocular pathology|no known ocular pathology
1027456|NCT02991014|music intervention|music intervention
1027457|NCT02991014|heart rate variability|heart rate variability
1027458|NCT02991014|frequency modulation|frequency modulation
1027459|NCT02991014|pain perception|pain perception
1027460|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
1027461|NCT02991001|Hydrodissection|hydrodissection
1027462|NCT02990988|Blood donation|blood donation
1027463|NCT02990988|Iron repletion|iron repletion
1027464|NCT02990988|Transfusion|transfusion
1027465|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
1028152|NCT02986672|children|children
1027466|NCT02990975|Pediatric patient|pediatric patient
1027467|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
1027468|NCT02990962|perineural injection|perineural injection
1027469|NCT02990962|ultrasound-guided|ultrasound-guided
1027470|NCT02990962|dextrose|dextrose
1027471|NCT02990962|steroid|steroid
1027472|NCT02990936|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
1027473|NCT02990936|tumor growth|tumor growth
1027474|NCT02990936|predictive markers|predictive markers
1027475|NCT02990936|tumoral kinetics|tumoral kinetics
1027476|NCT02990910|respiratory adverse events|respiratory adverse events
1027477|NCT02990910|adenotonsillectomy|adenotonsillectomy
1027478|NCT02990910|opioid analgesia|opioid analgesia
1027479|NCT02990910|children|children
1027480|NCT02990897|Medical informatics|medical informatics
1027481|NCT02990897|Quality of care|quality of care
1027482|NCT02990897|Referral|referral
1027483|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
1027484|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
1027485|NCT02990884|Pediatric patient|pediatric patient
1027486|NCT02990819|Immunodeficiencies|immunodeficiencies
1027487|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
1027488|NCT02990793|PTSD|ptsd
1027489|NCT02990793|Concussion|concussion
1027491|NCT02990793|TMS|tms
1027492|NCT02990741|atrial fibrillation|atrial fibrillation
1027493|NCT02990741|automated ECG system|automated ecg system
1027494|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
1027495|NCT02990715|average risk CRC screening|average risk crc screening
1027496|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
1027497|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
1027498|NCT02990702|Infraclavicular block|infraclavicular block
1027499|NCT02990702|Retroclavicular block|retroclavicular block
1027500|NCT02990702|Ultrasound|ultrasound
1027501|NCT02990676|Cognition|cognition
1027502|NCT02990676|Computerised cognitive training|computerised cognitive training
1027503|NCT02990676|Feasibility study|feasibility study
1027504|NCT02990676|Huntington's disease|huntington's disease
1027505|NCT02990676|Translational|translational
1027506|NCT02990663|Pragmatic|pragmatic
1027507|NCT02990663|Primary Care|primary care
1027508|NCT02990663|Chronotherapy|chronotherapy
1027509|NCT02990663|Administrative Data|administrative data
1027511|NCT02990663|Myocardial Infarction|myocardial infarction
1027512|NCT02990663|Congestive Heart Failure|congestive heart failure
1027513|NCT02990663|Glaucoma|glaucoma
1027514|NCT02990663|Dementia|dementia
1027515|NCT02990663|Hip Fracture|hip fracture
1027516|NCT02990637|Olive leaf extract|olive leaf extract
1027517|NCT02990637|Cardiovascular health|cardiovascular health
1027518|NCT02990637|Cholesterol|cholesterol
1027519|NCT02990624|psoriasis|psoriasis
1027520|NCT02990624|photochemotherapy|photochemotherapy
1027521|NCT02990624|atherosclerosis|atherosclerosis
1027522|NCT02990624|metabolic syndrome|metabolic syndrome
1028508|NCT02984462|osteotomy|osteotomy
1027523|NCT02990624|cardiovascular risk|cardiovascular risk
1027524|NCT02990598|Hydroxyurea|hydroxyurea
1027525|NCT02990572|Amish|amish
1027526|NCT02990572|Mennonite|mennonite
1027527|NCT02990559|Iron repletion|iron repletion
1027528|NCT02990559|Blood donation|blood donation
1027529|NCT02990559|Transfusion|transfusion
1027530|NCT02990507|mobility impairment|mobility impairment
1027531|NCT02990507|virtual environment|virtual environment
1027532|NCT02990507|exercise|exercise
1027533|NCT02990507|physical activity|physical activity
1027534|NCT02990468|Mucositis|mucositis
1027535|NCT02990468|Xerostomia|xerostomia
1027536|NCT02990455|alcohol|alcohol
1027537|NCT02990455|drinking|drinking
1027538|NCT02990455|smoking|smoking
1027539|NCT02990455|cigarette|cigarette
1027540|NCT02990455|nicotine|nicotine
1027541|NCT02990442|rTMS|rtms
1027542|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1027543|NCT02990442|Brain Stimulation|brain stimulation
1027544|NCT02990429|hypothermia|hypothermia
1027545|NCT02990429|Shivering|shivering
1027546|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
1027547|NCT02990429|Warming|warming
1027548|NCT02990429|General anesthesia|general anesthesia
1027549|NCT02990377|Opioid Analgesics|opioid analgesics
1027550|NCT02990377|Opioid Safety|opioid safety
1027551|NCT02990377|Emergency Department|emergency department
1027552|NCT02990377|Motivational Enhancement|motivational enhancement
1027553|NCT02990377|Interactive Voice Response|interactive voice response
1027554|NCT02990377|Reinforcement Learning|reinforcement learning
1027555|NCT02990377|mHealth|mhealth
1027556|NCT02990364|Circumcision|circumcision
1027557|NCT02990364|Analgesia|analgesia
1027558|NCT02990364|Controlled Clinical Trial|controlled clinical trial
1027559|NCT02990325|ABX464, HIV infection|abx464, hiv infection
1027560|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1027561|NCT02990299|Medication Adherence|medication adherence
1027562|NCT02990299|Telemedicine|telemedicine
1027563|NCT02990299|Community Health Workers|community health workers
1027564|NCT02990299|Pharmacists|pharmacists
1027565|NCT02990299|Mobile Health|mobile health
1027566|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
1027567|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
1027568|NCT02990286|connective tissue disease|connective tissue disease
1027569|NCT02990286|rituximab|rituximab
1027570|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
1027571|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
1027572|NCT02990247|Asthma|asthma
1027573|NCT02990247|Exacerbations|exacerbations
1027574|NCT02990247|Telemonitoring|telemonitoring
1027575|NCT02990247|Biomarkers|biomarkers
1027576|NCT02990234|Capsular Repair|capsular repair
1027577|NCT02990234|FAI|fai
1027578|NCT02990234|Hip|hip
1027579|NCT02990221|Field Cancerization|field cancerization
1027580|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
1027581|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1027582|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
1027583|NCT02990182|Immunity, Humoral|immunity, humoral
1027584|NCT02990182|Immunity, Cellular|immunity, cellular
1027585|NCT02990182|children|children
1027586|NCT02990156|Coils|coils
1027587|NCT02990091|TBI|tbi
1027588|NCT02990091|DHA|dha
1027589|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
1027590|NCT02990091|synaptamide|synaptamide
1027591|NCT02990078|TBI|tbi
1027592|NCT02990078|CVR|cvr
1027593|NCT02990078|Hypercapnia|hypercapnia
1027594|NCT02990078|fNIRS|fnirs
1027595|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
1027596|NCT02990065|NUTRITIONAL STATUS|nutritional status
1027597|NCT02990039|physical activity|physical activity
1027598|NCT02990039|sedentary time|sedentary time
1027599|NCT02990039|feasibility study|feasibility study
1027600|NCT02990039|accelerometer|accelerometer
1027601|NCT02989987|PTSD|ptsd
1027602|NCT02989987|Shame|shame
1027603|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
1027604|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
1027605|NCT02989987|DR Congo|dr congo
1027606|NCT02989974|Survivorship Care|survivorship care
1027607|NCT02989974|Caregiving|caregiving
1027608|NCT02989948|Endovascular|endovascular
1027609|NCT02989935|respiratory muscle|respiratory muscle
1027610|NCT02989935|bronchodilator|bronchodilator
1027611|NCT02989896|Perfusion index|perfusion index
1027612|NCT02989896|Peripheral nerve block success|peripheral nerve block success
1027613|NCT02989896|older age|older age
1027614|NCT02989883|achalasia|achalasia
1027615|NCT02989883|POEM|poem
1027616|NCT02989883|outcome|outcome
1027617|NCT02989870|Liver Disease|liver disease
1027618|NCT02989870|Child-Pugh Class A|child-pugh class a
1027619|NCT02989870|Child-Pugh Class B7|child-pugh class b7
1027620|NCT02989857|IDH1|idh1
1027621|NCT02989831|diabetic neuropathy|diabetic neuropathy
1027622|NCT02989831|foot ulcers|foot ulcers
1027623|NCT02989831|random vibration|random vibration
1027624|NCT02989831|vibration perception threshold|vibration perception threshold
1027625|NCT02989831|mechanical noise|mechanical noise
1027626|NCT02989805|Emergency Medicine|emergency medicine
1027627|NCT02989805|Psychiatry|psychiatry
1027628|NCT02989805|Health Promotion|health promotion
1027629|NCT02989805|Public Health|public health
1027630|NCT02989792|pain|pain
1027631|NCT02989753|Prevention|prevention
1027632|NCT02989740|Diabetes Mellitus|diabetes mellitus
1027633|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
1027634|NCT02989740|Optical Coherence Tomography|optical coherence tomography
1027635|NCT02989740|Fractional Flow Reserve|fractional flow reserve
1027636|NCT02989701|Plerixafor|plerixafor
1027637|NCT02989675|pediatric|pediatric
1027638|NCT02989675|critical illness|critical illness
1027639|NCT02989675|Malawi|malawi
1027640|NCT02989649|Drug Therapy|drug therapy
1027641|NCT02989584|bladder cancer|bladder cancer
1027642|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
1027643|NCT02989584|atezolizumab|atezolizumab
1027644|NCT02989584|urothelial carcinoma|urothelial carcinoma
1027645|NCT02989519|preterm labor|preterm labor
1027646|NCT02989519|progesterone efficacy|progesterone efficacy
1027647|NCT02989519|threatened preterm labor|threatened preterm labor
1027648|NCT02989493|Alcoholism|alcoholism
1027649|NCT02989493|Stress|stress
1027650|NCT02989493|Norepinephrine|norepinephrine
1027651|NCT02989493|Doxazosin|doxazosin
1027652|NCT02989493|Anxiety|anxiety
1027653|NCT02989493|Startle Potentiation|startle potentiation
1027654|NCT02989493|Relapse|relapse
1027655|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
1027656|NCT02989493|Surrogate Endpoint|surrogate endpoint
1027657|NCT02989480|Cardiomyopathy|cardiomyopathy
1027658|NCT02989441|Perfusion Index|perfusion index
1027659|NCT02989441|Hemodynamics|hemodynamics
1027660|NCT02989441|Anesthesia|anesthesia
1027661|NCT02989441|Stroke Volume|stroke volume
1027662|NCT02989415|Anesthesia|anesthesia
1027663|NCT02989415|Mechanical Ventilation|mechanical ventilation
1027664|NCT02989415|Robotic Surgery|robotic surgery
1027665|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
1027666|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
1028153|NCT02986672|nutrition|nutrition
1027667|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
1027668|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
1027669|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
1027670|NCT02989337|Dehydration|dehydration
1027671|NCT02989311|Iron absorption|iron absorption
1027672|NCT02989311|Iron deficiency|iron deficiency
1027673|NCT02989311|Hepcidin|hepcidin
1027674|NCT02989311|Stable isotopes|stable isotopes
1027675|NCT02989311|Anemia|anemia
1027676|NCT02989311|Infants|infants
1027677|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
1027678|NCT02989298|Residual renal function|residual renal function
1027679|NCT02989298|Peritoneum function|peritoneum function
1027680|NCT02989298|Peritonitis rate|peritonitis rate
1027681|NCT02989298|Technical survival|technical survival
1027682|NCT02989298|Patient survival|patient survival
1027683|NCT02989285|HIV|hiv
1027684|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
1027685|NCT02989285|Neurology|neurology
1027686|NCT02989285|Latent HIV|latent hiv
1027687|NCT02989285|HIV Reservoirs|hiv reservoirs
1027688|NCT02989259|apatinib|apatinib
1027689|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
1027690|NCT02989259|non-squamous|non-squamous
1027691|NCT02989246|pediatrics|pediatrics
1027692|NCT02989246|ventilator weaning|ventilator weaning
1027693|NCT02989220|Miscarriage|miscarriage
1027694|NCT02989207|Glaucoma|glaucoma
1027695|NCT02989207|Trabeculectomy|trabeculectomy
1027696|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
1027697|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
1027698|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1027699|NCT02989168|hypoxemia|hypoxemia
1027700|NCT02989168|oxygen|oxygen
1027701|NCT02989142|interpregnancy|interpregnancy
1027702|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
1568420|NCT00505921|Allogenic Transplantation|allogenic transplantation
1027703|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
1027704|NCT02989142|caesarean section|caesarean section
1027705|NCT02989142|large-for-gestational-age|large-for-gestational-age
1027706|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
1027707|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
1027708|NCT02989129|CINP|cinp
1027709|NCT02989129|Quercetin|quercetin
1027710|NCT02989129|Questionnaires|questionnaires
1027711|NCT02989129|Surveys|surveys
1027712|NCT02989116|Learning|learning
1027713|NCT02989116|Executive functions|executive functions
1027714|NCT02989116|Cognitive control|cognitive control
1027715|NCT02989116|Prefrontal Cortex|prefrontal cortex
1027716|NCT02989116|Typically developing children|typically developing children
1027717|NCT02989116|Genotype|genotype
1027718|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1027719|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
1027720|NCT02989116|Inhibition|inhibition
1029011|NCT02981368|Diagnostic|diagnostic
1027721|NCT02989116|Working Memory|working memory
1027722|NCT02989116|Metacognition|metacognition
1027723|NCT02989116|Mindfulness|mindfulness
1027724|NCT02989116|Preterm children|preterm children
1027725|NCT02989116|Developmental Psychology|developmental psychology
1027726|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
1027727|NCT02989116|Touch screen tablet|touch screen tablet
1027728|NCT02989116|Adaptive training|adaptive training
1027729|NCT02989103|Hyperthyroidism|hyperthyroidism
1027730|NCT02989103|Radiation|radiation
1027731|NCT02989103|Mortality|mortality
1027732|NCT02989090|Patient Engagement|patient engagement
1027733|NCT02989090|Defibrillators|defibrillators
1027734|NCT02989090|Health Records, Personal|health records, personal
1027735|NCT02989090|Patient Portal|patient portal
1027736|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
1027737|NCT02989064|Cell Therapy|cell therapy
1027738|NCT02989064|T Cell Therapy|t cell therapy
1027739|NCT02989064|SPEAR T Cell|spear t cell
1027740|NCT02989064|MAGE-A10|mage-a10
1027741|NCT02989064|Immuno-oncology|immuno-oncology
1027742|NCT02989064|Metastatic|metastatic
1027743|NCT02989064|Urothelial Cancer|urothelial cancer
1027744|NCT02989064|Previously Treated|previously treated
1027745|NCT02989064|T Cell Receptor|t cell receptor
1027746|NCT02989038|smoker|smoker
1027747|NCT02989038|young adult|young adult
1027748|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
1027749|NCT02988986|mTOR|mtor
1027750|NCT02988986|Tamoxifen|tamoxifen
1027751|NCT02988986|Breast Cancer|breast cancer
1027752|NCT02988973|Roxadustat|roxadustat
1027753|NCT02988973|Anemia|anemia
1027754|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
1027755|NCT02988973|ASP1517|asp1517
1027756|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1027757|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
1027758|NCT02988960|Advanced solid tumor|advanced solid tumor
1027759|NCT02988960|Cancer|cancer
1027760|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1027761|NCT02988960|Cutaneous melanoma|cutaneous melanoma
1027762|NCT02988947|Knee Arthroplasty|knee arthroplasty
1027764|NCT02988947|Pain Neuroscience Education|pain neuroscience education
1027766|NCT02988947|Catastrophizing|catastrophizing
1027767|NCT02988947|Optimism|optimism
1027768|NCT02988947|Distress|distress
1027769|NCT02988947|Hope|hope
1027770|NCT02988947|Self-Efficacy|self-efficacy
1027771|NCT02988895|Brachytherapy|brachytherapy
1027772|NCT02988895|Wet AMD|wet amd
1027773|NCT02988869|COPD|copd
1027774|NCT02988869|Tiotropium|tiotropium
1027775|NCT02988869|Formoterol|formoterol
1027776|NCT02988843|GCT|gct
1027777|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
1027778|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
1027779|NCT02988804|laryngeal mask|laryngeal mask
1027780|NCT02988765|vulvar cancer|vulvar cancer
1027781|NCT02988765|inguinal lymph node|inguinal lymph node
1027782|NCT02988765|lymph node status|lymph node status
1027783|NCT02988765|cytology|cytology
1027784|NCT02988765|core biopsy|core biopsy
1027785|NCT02988726|Neurofibroma|neurofibroma
1027786|NCT02988726|Schwannoma|schwannoma
1027787|NCT02988713|stimulation|stimulation
1027788|NCT02988713|chronic pain|chronic pain
1027789|NCT02988713|back pain|back pain
1027790|NCT02988713|leg pain|leg pain
1027791|NCT02988687|fatigue|fatigue
1027792|NCT02988687|quality of life|quality of life
1027793|NCT02988687|depression|depression
1027794|NCT02988687|cognitive function|cognitive function
1027795|NCT02988687|growth hormone|growth hormone
1027796|NCT02988687|traumatic brain injury|traumatic brain injury
1027797|NCT02988674|Adalimumab|adalimumab
1027798|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
1027799|NCT02988674|Psoriatic arthritis|psoriatic arthritis
1027800|NCT02988674|Spondylarthritis|spondylarthritis
1027801|NCT02988674|Humira®|humira®
1027802|NCT02988661|Autoimmunity|autoimmunity
1027803|NCT02988661|Immune System Disorders|immune system disorders
1027804|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
1027805|NCT02988635|Early Palliative Care|early palliative care
1027806|NCT02988635|Simultaneous Care|simultaneous care
1027807|NCT02988635|Chemotherapy|chemotherapy
1027808|NCT02988635|Quality of Life|quality of life
1027809|NCT02988596|Concussion|concussion
1027810|NCT02988596|Rehabilitation|rehabilitation
1027811|NCT02988583|silicone oil|silicone oil
1027812|NCT02988583|emulsification|emulsification
1027813|NCT02988583|retinal detachment surgery|retinal detachment surgery
1027814|NCT02988557|cerebral palsy|cerebral palsy
1027815|NCT02988557|gait|gait
1027816|NCT02988557|slope|slope
1027817|NCT02988557|electromyography|electromyography
1027818|NCT02988531|PET|pet
1027819|NCT02988531|MRI|mri
1027820|NCT02988531|Attenuation|attenuation
1027821|NCT02988531|Correction|correction
1027822|NCT02988531|Cardiovascular|cardiovascular
1027823|NCT02988531|coronary|coronary
1027824|NCT02988531|disease|disease
1027825|NCT02988518|Psychiatry|psychiatry
1027826|NCT02988518|Bipolar disorder|bipolar disorder
1027827|NCT02988518|Memory complaints|memory complaints
1027828|NCT02988518|Global functioning|global functioning
1027829|NCT02988518|Cognitive remediation|cognitive remediation
1027830|NCT02988518|Working memory|working memory
1027831|NCT02988466|Acute Leukemias|acute leukemias
1027832|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1027833|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
1027834|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
1027835|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
1027836|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
1027837|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
1027838|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
1027839|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
1027840|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
1027841|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
1027842|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
1027843|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
1027844|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
1027845|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1027846|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
1027847|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
1027848|NCT02988453|mentalization-based treatment|mentalization-based treatment
1027849|NCT02988453|conduct disorder|conduct disorder
1027850|NCT02988453|adolescents|adolescents
1027851|NCT02988440|HCC|hcc
1027852|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
1027853|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1027854|NCT02988440|PDR001|pdr001
1027855|NCT02988440|liver cancer|liver cancer
1027856|NCT02988440|immunotherapy liver|immunotherapy liver
1027857|NCT02988440|malignant hepatoma|malignant hepatoma
1027858|NCT02988440|Hepatocellular cancer|hepatocellular cancer
1027859|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
1027860|NCT02988440|advanced liver cancer|advanced liver cancer
1027861|NCT02988440|liver cancer progression|liver cancer progression
1027862|NCT02988440|sorafenib|sorafenib
1027863|NCT02988440|anti-PD1|anti-pd1
1027864|NCT02988440|first line|first line
1027865|NCT02988414|Sepsis|sepsis
1027866|NCT02988414|Infection|infection
1027867|NCT02988414|Culture|culture
1027868|NCT02988414|Sequencing|sequencing
1027869|NCT02988414|Non-invasive|non-invasive
1027870|NCT02988414|NGS|ngs
1027871|NCT02988375|insomnia|insomnia
1027872|NCT02988375|depression|depression
1027873|NCT02988375|digital CBTI|digital cbti
1027874|NCT02988375|online CBTI|online cbti
1027875|NCT02988336|difficult intubation|difficult intubation
1027876|NCT02988336|thyromental height|thyromental height
1027877|NCT02988323|sport concussion|sport concussion
1027878|NCT02988323|cervical spine|cervical spine
1027879|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
1027880|NCT02988323|exercise|exercise
1027881|NCT02988323|rehabilitation|rehabilitation
1027882|NCT02988323|children|children
1027883|NCT02988323|youth|youth
1027884|NCT02988310|Limb Loss|limb loss
1027885|NCT02988310|Gait Characteristics|gait characteristics
1027886|NCT02988284|Gait variability|gait variability
1027887|NCT02988271|Meditation|meditation
1027888|NCT02988271|Anxiety|anxiety
1027889|NCT02988271|Psychosocial distress|psychosocial distress
1027890|NCT02988271|Depression|depression
1027891|NCT02988271|Questionnaires|questionnaires
1027892|NCT02988271|Surveys|surveys
1027893|NCT02988271|Meditation Video|meditation video
1027894|NCT02988271|Meditation app|meditation app
1670553|NCT00105482|Smoking|smoking
1027895|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
1027896|NCT02988258|T cell receptor transduction|t cell receptor transduction
1027897|NCT02988258|Immunotherapy|immunotherapy
1027898|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
1027899|NCT02988258|CMV|cmv
1027900|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
1027901|NCT02988232|Korean Medicine|korean medicine
1027902|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
1027903|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
1027904|NCT02988219|epidural anesthesia|epidural anesthesia
1027905|NCT02988219|combined anesthesia|combined anesthesia
1027906|NCT02988219|general anesthesia|general anesthesia
1027907|NCT02988219|NSS|nss
1027908|NCT02988219|radical nephrectomy|radical nephrectomy
1027909|NCT02988219|extraperitoneal|extraperitoneal
1027910|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
1027911|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
1027912|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
1027913|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
1027914|NCT02988167|Extubation|extubation
1029012|NCT02981368|Imaging|imaging
1027915|NCT02988167|Extubation Readiness|extubation readiness
1027916|NCT02988154|Medical education|medical education
1027917|NCT02988154|simulation|simulation
1027918|NCT02988154|neurosurgical education|neurosurgical education
1027919|NCT02988154|Simulation laboratory|simulation laboratory
1027920|NCT02988154|Ventricular drain|ventricular drain
1027921|NCT02988128|Embolization Device|embolization device
1027922|NCT02988128|Flow Diverter|flow diverter
1027923|NCT02988128|Intra saccular device|intra saccular device
1027924|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
1027925|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
1027926|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
1027927|NCT02988115|hyperlipidemia|hyperlipidemia
1027928|NCT02988115|cholesterol|cholesterol
1027929|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
1027930|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1027931|NCT02988115|ASCVD|ascvd
1027932|NCT02988115|HeFH|hefh
1027933|NCT02988115|LDL|ldl
1027934|NCT02988115|statin intolerence|statin intolerence
1027935|NCT02988102|S100B, NSE|s100b, nse
1027936|NCT02988102|moderate brain trauma|moderate brain trauma
1027937|NCT02988102|mild brain trauma|mild brain trauma
1027938|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
1027939|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
1027940|NCT02988076|database|database
1027941|NCT02988076|probability|probability
1027942|NCT02988076|response|response
1027943|NCT02988076|depression|depression
1027944|NCT02988076|medication|medication
1027945|NCT02988076|quantitative|quantitative
1027946|NCT02988076|electroencephalogram|electroencephalogram
1027947|NCT02988063|Varithena|varithena
1027948|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
1027949|NCT02988050|Epilepsy Surgery|epilepsy surgery
1027950|NCT02988050|Conscious sedation|conscious sedation
1027951|NCT02988011|type 2 diabetes|type 2 diabetes
1027952|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
1027953|NCT02988011|low calorie diet|low calorie diet
1027954|NCT02988011|glucose metabolism|glucose metabolism
1027955|NCT02987998|Pembrolizumab|pembrolizumab
1027956|NCT02987998|Chemoradiation|chemoradiation
1027957|NCT02987985|Opioid-sparing|opioid-sparing
1027958|NCT02987985|Opioid-free|opioid-free
1027961|NCT02987959|mTOR|mtor
1027962|NCT02987933|Chronic Pain|chronic pain
1027963|NCT02987933|fMRI|fmri
1027964|NCT02987933|DTI|dti
1027965|NCT02987894|TAVI|tavi
1027966|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1027967|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
1027968|NCT02987894|Transfemoral access|transfemoral access
1027969|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
1027970|NCT02987868|Somatostatin|somatostatin
1027971|NCT02987868|Thyroid Hormone|thyroid hormone
1027972|NCT02987868|Growth Hormone|growth hormone
1027973|NCT02987842|Mild cognitive impairment|mild cognitive impairment
1027974|NCT02987842|Alzhiemer's disease|alzhiemer's disease
1027975|NCT02987842|Neurofeedback|neurofeedback
1027976|NCT02987842|EEG|eeg
1027977|NCT02987803|Patient Engagement|patient engagement
1027978|NCT02987803|Public Reporting|public reporting
1027979|NCT02987803|Quality Measurement|quality measurement
1027980|NCT02987790|Intensive care|intensive care
1027981|NCT02987790|Sepsis|sepsis
1027982|NCT02987790|Biomarkers|biomarkers
1027983|NCT02987790|C-reactive Protein|c-reactive protein
1027984|NCT02987790|Antimicrobial|antimicrobial
1027985|NCT02987790|Systemic infection|systemic infection
1027986|NCT02987764|Premature|premature
1027987|NCT02987764|Birth weight|birth weight
1027988|NCT02987725|Adolescence|adolescence
1027989|NCT02987725|Autonomic Nervous System|autonomic nervous system
1027990|NCT02987725|Hypnosis|hypnosis
1027991|NCT02987725|Pain|pain
1027992|NCT02987725|Sickle Cell Disease|sickle cell disease
1027993|NCT02987712|Thromboelastography|thromboelastography
1027994|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
1027995|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1027996|NCT02987699|optimal dose|optimal dose
1027997|NCT02987686|Topical Infliximab|topical infliximab
1027998|NCT02987686|Cornea|cornea
1027999|NCT02987686|Keratolysis|keratolysis
1028000|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
1028001|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
1028002|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
1028003|NCT02987634|gingivitis|gingivitis
1028004|NCT02987634|dental implant|dental implant
1028005|NCT02987634|mouthwash|mouthwash
1028006|NCT02987595|intervention|intervention
1028007|NCT02987595|lignans|lignans
1028008|NCT02987595|whole-grain|whole-grain
1028009|NCT02987582|mental health|mental health
1028010|NCT02987582|mindfulness|mindfulness
1028011|NCT02987582|shame|shame
1028012|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
1028013|NCT02987569|HPN|hpn
1028014|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
1028015|NCT02987569|TPN|tpn
1028016|NCT02987569|mConnect|mconnect
1028017|NCT02987569|SBS|sbs
1028018|NCT02987569|short bowel disorder|short bowel disorder
1028019|NCT02987569|telehealth|telehealth
1028020|NCT02987569|telemedicine|telemedicine
1028021|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
1028022|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
1028023|NCT02987530|primary infection|primary infection
1028024|NCT02987517|running|running
1028025|NCT02987517|vertical load rates|vertical load rates
1028026|NCT02987517|cadence|cadence
1028027|NCT02987517|footstrike|footstrike
1028028|NCT02987504|Cancer|cancer
1028029|NCT02987504|Solid tumor|solid tumor
1028030|NCT02987504|Phase 1|phase 1
1028031|NCT02987491|exercise|exercise
1028032|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
1028033|NCT02987452|exercise|exercise
1028034|NCT02987452|resistant hypertension|resistant hypertension
1028035|NCT02987452|blood pressure|blood pressure
1028036|NCT02987439|COPD|copd
1028037|NCT02987439|Exacerbation|exacerbation
1028038|NCT02987439|Rehabilitation|rehabilitation
1028039|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1028040|NCT02987400|DLBCL|dlbcl
1028041|NCT02987400|GA-101|ga-101
1028042|NCT02987400|ABT-199|abt-199
1028043|NCT02987400|relapsed DLBCL|relapsed dlbcl
1028044|NCT02987400|refractory DLBCL|refractory dlbcl
1028045|NCT02987400|AGMT|agmt
1028046|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1028047|NCT02987400|window of opportunity|window of opportunity
1028048|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
1028049|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
1028050|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
1028051|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
1028052|NCT02987387|Pulmonary Atresia|pulmonary atresia
1028053|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
1028054|NCT02987374|Influenza Vaccine|influenza vaccine
1028055|NCT02987348|type 2 diabetes|type 2 diabetes
1028056|NCT02987309|indirect calorimetry|indirect calorimetry
1028057|NCT02987309|method comparison|method comparison
1028058|NCT02987296|Colorectal Cancer|colorectal cancer
1028059|NCT02987296|Surgery|surgery
1028060|NCT02987296|Arginine depletion|arginine depletion
1028061|NCT02987296|Immune system dysfunction|immune system dysfunction
1028062|NCT02987296|Arginine Supplementation|arginine supplementation
1028063|NCT02987270|mass screen and treat|mass screen and treat
1028064|NCT02987270|malaria|malaria
1028065|NCT02987270|asymptomatic infections|asymptomatic infections
1028066|NCT02987270|transmission reduction|transmission reduction
1028067|NCT02987270|infectious reservoir|infectious reservoir
1028068|NCT02987270|kenya|kenya
1028069|NCT02987257|Therapeutics|therapeutics
1028070|NCT02987257|Management|management
1028071|NCT02987257|Cyclosporine|cyclosporine
1028072|NCT02987257|Etanercept|etanercept
1028073|NCT02987257|Supportive Care|supportive care
1028074|NCT02987257|Immunopathogenesis|immunopathogenesis
1028075|NCT02987257|Genetics|genetics
1028076|NCT02987257|Adverse Drug Reaction|adverse drug reaction
1028077|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
1028078|NCT02987218|POCD|pocd
1028079|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
1028080|NCT02987218|Propofol|propofol
1028081|NCT02987218|Desflurane|desflurane
1028082|NCT02987192|spinal anesthesia|spinal anesthesia
1028083|NCT02987192|anticoagulation|anticoagulation
1028084|NCT02987192|minimally invasive|minimally invasive
1028085|NCT02987192|Cesarean Section|cesarean section
1028086|NCT02987192|Maternal|maternal
1028087|NCT02987166|immunotherapy|immunotherapy
1028088|NCT02987166|pembrolizumab|pembrolizumab
1028089|NCT02987166|MK-3475|mk-3475
1568421|NCT00505921|Stem Cell Transplant|stem cell transplant
1028090|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
1028091|NCT02987166|HDCRT|hdcrt
1028092|NCT02987166|advanced solid tumor|advanced solid tumor
1028093|NCT02987153|Kyphoplasty|kyphoplasty
1028094|NCT02987153|Spinal metastases|spinal metastases
1028095|NCT02987153|IORT|iort
1028096|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
1028097|NCT02987153|Pain management|pain management
1028098|NCT02987140|Parkinson's disease|parkinson's disease
1028099|NCT02987140|freezing of gait|freezing of gait
1028100|NCT02987140|context-dependency|context-dependency
1028101|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
1028102|NCT02987140|visual cues|visual cues
1028103|NCT02987062|Atrial Fibrillation|atrial fibrillation
1028104|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
1028105|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
1028106|NCT02987062|ROCKET-AF|rocket-af
1028107|NCT02987062|RE-LY|re-ly
1028108|NCT02987062|ARISTOTLE|aristotle
1028109|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
1028110|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
1028111|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
1028112|NCT02986997|epidural anesthesia|epidural anesthesia
1028113|NCT02986997|prone position|prone position
1028114|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1028115|NCT02986984|Diabetes|diabetes
1028116|NCT02986984|Chronic kidney disease|chronic kidney disease
1028117|NCT02986984|Progression|progression
1028118|NCT02986984|Genomics|genomics
1028119|NCT02986984|Transcriptomics|transcriptomics
1028120|NCT02986971|Contraceptive implant|contraceptive implant
1028121|NCT02986945|Depressive symptoms|depressive symptoms
1028122|NCT02986945|resiliency|resiliency
1028123|NCT02986945|Health Promotion|health promotion
1028124|NCT02986945|minority health|minority health
1028125|NCT02986945|text-messaging app|text-messaging app
1028126|NCT02986945|participatory technology development|participatory technology development
1028127|NCT02986932|Blood-Brain Barrier|blood-brain barrier
1028128|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
1028129|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
1028130|NCT02986906|Dextrose|dextrose
1028131|NCT02986906|perineural injection|perineural injection
1028132|NCT02986893|Multiple Sclerosis|multiple sclerosis
1028133|NCT02986893|Diet|diet
1028134|NCT02986893|Clinical Trial|clinical trial
1028135|NCT02986854|Meningococcal disease|meningococcal disease
1028136|NCT02986854|Booster vaccination|booster vaccination
1028137|NCT02986854|Meningitis|meningitis
1028138|NCT02986854|Antibody persistence|antibody persistence
1028139|NCT02986828|platelet rich plasma|platelet rich plasma
1028140|NCT02986828|Hydrodissection|hydrodissection
1028141|NCT02986737|TAVI|tavi
1028142|NCT02986737|Aortic Stenosis|aortic stenosis
1028143|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
1028144|NCT02986724|Drug therapy|drug therapy
1028145|NCT02986698|intrauterine transfusion|intrauterine transfusion
1028146|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
1028147|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
1028148|NCT02986685|Rabeprazole|rabeprazole
1028149|NCT02986685|trimebutine maleate|trimebutine maleate
1028150|NCT02986672|ADHD|adhd
1028151|NCT02986672|omega 3|omega 3
1028154|NCT02986672|MUFA|mufa
1028155|NCT02986672|ADD|add
1028156|NCT02986672|PUFA|pufa
1028157|NCT02986672|Calanus|calanus
1028158|NCT02986672|learning difficulties|learning difficulties
1028159|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1028160|NCT02986633|Echocardiography|echocardiography
1028161|NCT02986633|Biventricular Pacing|biventricular pacing
1028162|NCT02986568|Ontogenetic surgery|ontogenetic surgery
1028163|NCT02986568|TMMR|tmmr
1028164|NCT02986568|PMMR|pmmr
1028165|NCT02986568|LEER|leer
1028166|NCT02986555|Stress|stress
1028167|NCT02986555|Virtual Reality|virtual reality
1028168|NCT02986555|Motion sickness|motion sickness
1028169|NCT02986555|Visual Fatigue|visual fatigue
1028170|NCT02986555|Biofeedback|biofeedback
1028171|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
1028172|NCT02986490|Mental disorders|mental disorders
1028173|NCT02986490|Antipsychotic agents|antipsychotic agents
1028174|NCT02986490|Magnesium|magnesium
1028175|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
1028176|NCT02986490|Metabolic syndrome|metabolic syndrome
1028177|NCT02986464|Virtual reality|virtual reality
1028178|NCT02986464|Immersive distraction|immersive distraction
1028179|NCT02986464|Virtual world|virtual world
1028180|NCT02986464|Virtual environment|virtual environment
1028181|NCT02986464|Procedural pain|procedural pain
1028182|NCT02986464|Acute pain|acute pain
1028183|NCT02986464|Pain Management|pain management
1028184|NCT02986464|Children, Child|children, child
1028185|NCT02986464|Kid, Kids|kid, kids
1568422|NCT00505921|Alemtuzumab|alemtuzumab
1028186|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
1028187|NCT02986464|Young children|young children
1028189|NCT02986464|Burn injuries|burn injuries
1028190|NCT02986464|Burn unit|burn unit
1028191|NCT02986464|Hydrotherapy|hydrotherapy
1028192|NCT02986464|Burn dressing|burn dressing
1028193|NCT02986464|Non-pharmacological|non-pharmacological
1028194|NCT02986464|Clinical Research|clinical research
1028195|NCT02986464|Nursing Practice|nursing practice
1028196|NCT02986438|Cocaine|cocaine
1028197|NCT02986438|Addiction|addiction
1028198|NCT02986438|rTMS|rtms
1028199|NCT02986438|fMRI|fmri
1028200|NCT02986425|Drug Utilization Review|drug utilization review
1028201|NCT02986425|Older people|older people
1028202|NCT02986399|fast track|fast track
1028203|NCT02986386|Dental Occlusion|dental occlusion
1028204|NCT02986386|Oral Health|oral health
1028205|NCT02986386|Mastication|mastication
1028206|NCT02986386|Dementia|dementia
1028207|NCT02986386|Psychological health|psychological health
1028208|NCT02986373|risankizumab|risankizumab
1028209|NCT02986373|ABBV-066|abbv-066
1028210|NCT02986373|BI655066|bi655066
1028211|NCT02986334|chronic|chronic
1028212|NCT02986334|low back|low back
1028213|NCT02986334|back|back
1028214|NCT02986334|pain|pain
1028215|NCT02986334|brain|brain
1028217|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
1028218|NCT02986321|PDE4 inhibitor|pde4 inhibitor
1028219|NCT02986308|Metabolomics|metabolomics
1028220|NCT02986308|Intestinal Polyps|intestinal polyps
1028221|NCT02986308|TCM Syndromes|tcm syndromes
1028222|NCT02986308|TCM Constitution Types|tcm constitution types
1028223|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
1028224|NCT02986282|ankle - brachial index|ankle - brachial index
1028225|NCT02986269|Respiratory Function|respiratory function
1028226|NCT02986269|Patient Positioning|patient positioning
1028227|NCT02986269|anesthesia|anesthesia
1028228|NCT02986256|telemedicine|telemedicine
1028229|NCT02986230|Cancer prevention|cancer prevention
1028230|NCT02986230|Clinical Decision Support|clinical decision support
1028231|NCT02986230|Rural Health|rural health
1028232|NCT02986230|Shared Decision Making|shared decision making
1028233|NCT02986204|implant removal|implant removal
1028234|NCT02986204|Nexplanon|nexplanon
1028235|NCT02986204|Implanon|implanon
1028236|NCT02986204|contraception|contraception
1028237|NCT02986204|ENG|eng
1028238|NCT02986191|gingival graft|gingival graft
1028239|NCT02986191|free gingival graft|free gingival graft
1028240|NCT02986191|coronally advanced flap|coronally advanced flap
1028241|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
1028242|NCT02986178|Glioblastoma|glioblastoma
1028243|NCT02986178|Glioma|glioma
1028244|NCT02986178|PVSRIPO|pvsripo
1028245|NCT02986178|Duke|duke
1028246|NCT02986178|Pro00077024|pro00077024
1028247|NCT02986178|Ashley|ashley
1028248|NCT02986178|Brain tumor|brain tumor
1028249|NCT02986178|Bigner|bigner
1028250|NCT02986165|Platelet Aggregation|platelet aggregation
1028251|NCT02986152|PTSD|ptsd
1028252|NCT02986152|anxiety|anxiety
1028253|NCT02986152|depression|depression
1028254|NCT02986152|distress|distress
1028255|NCT02986152|fear|fear
1028256|NCT02986152|coping|coping
1028257|NCT02986152|support|support
1028258|NCT02986152|caregiver|caregiver
1028259|NCT02986152|oncology|oncology
1028260|NCT02986152|app|app
1028261|NCT02986152|mobile app|mobile app
1028262|NCT02986126|Depression|depression
1028263|NCT02986126|Resilience|resilience
1028264|NCT02986126|Minority health|minority health
1028265|NCT02986126|Community-based participatory research|community-based participatory research
1028266|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
1028267|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
1028268|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
1028269|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
1028270|NCT02986100|rucaparib|rucaparib
1028271|NCT02986100|CO-338|co-338
1028272|NCT02986100|Clovis|clovis
1028273|NCT02986100|Clovis Oncology|clovis oncology
1028274|NCT02986100|PARP inhibitor|parp inhibitor
1028275|NCT02986100|Absorption|absorption
1028276|NCT02986100|Metabolism|metabolism
1028277|NCT02986100|Excretion|excretion
1028278|NCT02986048|proton beam|proton beam
1028279|NCT02986048|registry|registry
1028280|NCT02986048|radiation|radiation
1028281|NCT02986048|cancer|cancer
1028282|NCT02986022|Self-efficacy|self-efficacy
1028283|NCT02986022|optimism|optimism
1028284|NCT02986022|altruism|altruism
1028285|NCT02986022|goal setting|goal setting
1028286|NCT02986009|emotion management|emotion management
1028287|NCT02986009|positive and negative affect|positive and negative affect
1028288|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
1028289|NCT02986009|subjective happiness|subjective happiness
1028290|NCT02986009|family harmony|family harmony
1028291|NCT02985996|Preventative Medicine|preventative medicine
1028292|NCT02985996|Infectious Diseases|infectious diseases
1028293|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
1028294|NCT02985983|Brodalumab|brodalumab
1028295|NCT02985983|KHK4827|khk4827
1028296|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
1028297|NCT02985970|crush induction, RSI|crush induction, rsi
1028298|NCT02985944|colorectal cancer|colorectal cancer
1028299|NCT02985944|Colon polyp|colon polyp
1028300|NCT02985944|Colonoscopy|colonoscopy
1028301|NCT02985944|Adenoma detection rate|adenoma detection rate
1028302|NCT02985905|Zinc supplementation|zinc supplementation
1028303|NCT02985905|Thiol|thiol
1028304|NCT02985905|Glutathione peroxidase|glutathione peroxidase
1028305|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
1028306|NCT02985892|Physical therapy|physical therapy
1028307|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
1028308|NCT02985892|Low Back pain|low back pain
1028309|NCT02985879|PSP|psp
1028310|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
1028311|NCT02985879|tauopathy|tauopathy
1028312|NCT02985866|Artificial Pancreas|artificial pancreas
1028313|NCT02985866|Closed Loop Control|closed loop control
1028314|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1028315|NCT02985866|inControl Diabetes Management Platform|incontrol diabetes management platform
1028316|NCT02985840|ondansetron|ondansetron
1028317|NCT02985840|dexamethasone|dexamethasone
1028318|NCT02985814|COPD Asthma Overlap|copd asthma overlap
1028319|NCT02985775|CMV-specific T cell|cmv-specific t cell
1028320|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
1028321|NCT02985775|immunologic response|immunologic response
1028322|NCT02985775|acute GVHD|acute gvhd
1028323|NCT02985762|bupivacaine|bupivacaine
1028324|NCT02985762|exparel|exparel
1028325|NCT02985762|analgesic|analgesic
1028326|NCT02985762|lumbar spine|lumbar spine
1028327|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
1028328|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
1028329|NCT02985749|ASD|asd
1028330|NCT02985749|PDD|pdd
1028331|NCT02985749|Oxytocin|oxytocin
1028332|NCT02985749|Syntocinon|syntocinon
1028333|NCT02985749|Social Impairment|social impairment
1028334|NCT02985749|Treatment|treatment
1028335|NCT02985671|Postural Low Back Pain|postural low back pain
1028336|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
1028337|NCT02985671|Low Back Pain|low back pain
1028338|NCT02985671|acetaminophen|acetaminophen
1028339|NCT02985671|caffeine|caffeine
1028340|NCT02985671|orphenadrine|orphenadrine
1028341|NCT02985671|diclofenac sodium|diclofenac sodium
1028342|NCT02985645|CGF|cgf
1028343|NCT02985645|sinus augmentation|sinus augmentation
1028344|NCT02985645|DIVA|diva
1028345|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
1028346|NCT02985554|hematologic malignancies|hematologic malignancies
1028347|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
1028348|NCT02985541|Birth Control|birth control
1028349|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
1028350|NCT02985515|Anosmia|anosmia
1028351|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
1028352|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
1028353|NCT02985502|Quality of Life|quality of life
1028354|NCT02985502|Diabetes Mellitus|diabetes mellitus
1028355|NCT02985502|Pancreatectomy|pancreatectomy
1028356|NCT02985476|Electronic health records|electronic health records
1028357|NCT02985476|Health records personal|health records personal
1028358|NCT02985437|wound healing|wound healing
1028359|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
1028360|NCT02985437|SATOSU|satosu
1028361|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
1028362|NCT02985359|Program impact evaluation|program impact evaluation
1028363|NCT02985359|Malawi|malawi
1028364|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
1028365|NCT02985359|Social behavior change communication|social behavior change communication
1028366|NCT02985359|Childhood stunting|childhood stunting
1028367|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
1028368|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
1028369|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
1028370|NCT02985320|Sabin strain|sabin strain
1028371|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
1028372|NCT02985320|poliomyelitis|poliomyelitis
1028373|NCT02985320|safety|safety
1028374|NCT02985320|immunogenicity|immunogenicity
1028375|NCT02985320|infant|infant
1028376|NCT02985294|Neuropathic pain|neuropathic pain
1028377|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
1028378|NCT02985294|Multiple Excitability Measures|multiple excitability measures
1028379|NCT02985294|Threshold Tracking|threshold tracking
1028380|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
1028381|NCT02985268|MitraClip|mitraclip
1028382|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
1028383|NCT02985268|Six minute walk test|six minute walk test
1028384|NCT02985268|Mitral regurgitation|mitral regurgitation
1028385|NCT02985268|CRT-D|crt-d
1028386|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1028387|NCT02985255|Tongue Malignancy|tongue malignancy
1028388|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
1028389|NCT02985203|lung cancer|lung cancer
1028390|NCT02985203|vinorelbine|vinorelbine
1028391|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
1028392|NCT02985190|Azacitidine|azacitidine
1028393|NCT02985190|MDS|mds
1028394|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
1028395|NCT02985177|Children|children
1028396|NCT02985177|Musculoskeletal injury|musculoskeletal injury
1028397|NCT02985177|Emergency department|emergency department
1028398|NCT02985177|Analgesia|analgesia
1028399|NCT02985177|Opioids|opioids
1028400|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
1028401|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
1028402|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
1028403|NCT02985151|Scar|scar
1028404|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
1028405|NCT02985151|Laser Ablation|laser ablation
1028406|NCT02985125|Pancreas|pancreas
1028407|NCT02985125|5-FU|5-fu
1028408|NCT02985125|Gemcitabine|gemcitabine
1028409|NCT02985125|LEE011|lee011
1028410|NCT02985125|Everolimus|everolimus
1028411|NCT02985125|Refractory|refractory
1028412|NCT02985125|Chemotherapy|chemotherapy
1028413|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
1028414|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
1028415|NCT02985047|Brief admission|brief admission
1028416|NCT02985047|admission|admission
1028417|NCT02985047|deliberate self-harm|deliberate self-harm
1028418|NCT02985047|self-harm|self-harm
1028419|NCT02985034|HCC|hcc
1028420|NCT02985034|RFA|rfa
1028421|NCT02985034|Liver tumor|liver tumor
1028422|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
1028423|NCT02984995|FLT3-ITD|flt3-itd
1028424|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
1028425|NCT02984995|Hematology malignancy|hematology malignancy
1028426|NCT02984995|Developmental Phase II|developmental phase ii
1028427|NCT02984956|Hypotension|hypotension
1028428|NCT02984956|Pleth variability index|pleth variability index
1028429|NCT02984956|Hip Fracture|hip fracture
1028430|NCT02984956|Spinal anesthesia|spinal anesthesia
1028431|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
1028432|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
1028433|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
1028434|NCT02984904|Fusarium Infection|fusarium infection
1028435|NCT02984904|Corneal ulcer|corneal ulcer
1028436|NCT02984904|Spain|spain
1028437|NCT02984904|Epidemiology|epidemiology
1028438|NCT02984891|Intravascular ultrasound|intravascular ultrasound
1028439|NCT02984891|Optical coherence tomography|optical coherence tomography
1028440|NCT02984865|transversus plane block|transversus plane block
1028441|NCT02984865|opioid|opioid
1028442|NCT02984865|nalbuphine|nalbuphine
1028443|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
1028444|NCT02984865|elderly patient|elderly patient
1028445|NCT02984865|rectus sheath block|rectus sheath block
1028446|NCT02984865|Peritoneal dialysis|peritoneal dialysis
1028447|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
1028448|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
1028449|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
1028450|NCT02984787|Gastric Cancer|gastric cancer
1028452|NCT02984787|2D|2d
1028453|NCT02984774|Endometriosis|endometriosis
1028454|NCT02984774|Infertility|infertility
1028455|NCT02984774|Telomerase activity|telomerase activity
1028456|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
1028457|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
1028458|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
1028459|NCT02984761|Neoplasms by Site|neoplasms by site
1028460|NCT02984761|Neoplasms|neoplasms
1028461|NCT02984761|Lung Diseases|lung diseases
1028462|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
1028463|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1028464|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
1028465|NCT02984761|Radiosurgery|radiosurgery
1028466|NCT02984761|Radiotherapy|radiotherapy
1028467|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
1028468|NCT02984761|Lung Neoplasms|lung neoplasms
1028469|NCT02984748|cochlear implants|cochlear implants
1028470|NCT02984748|hearing loss|hearing loss
1028471|NCT02984735|chewing|chewing
1028472|NCT02984735|cerebral palsy|cerebral palsy
1028473|NCT02984735|chewing disorders|chewing disorders
1028474|NCT02984735|gross motor function|gross motor function
1028475|NCT02984722|PCOS|pcos
1028476|NCT02984722|metformin|metformin
1028477|NCT02984670|Cognitive therapy|cognitive therapy
1028478|NCT02984670|Behavior therapy|behavior therapy
1028479|NCT02984670|Moderation|moderation
1028480|NCT02984670|Mediation|mediation
1028481|NCT02984657|Hypoxemia|hypoxemia
1028482|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
1028483|NCT02984592|premature ejaculation|premature ejaculation
1028484|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
1028485|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
1028486|NCT02984566|Primary liver cancer|primary liver cancer
1028487|NCT02984566|Secondary liver cancer|secondary liver cancer
1028488|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
1028489|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
1028490|NCT02984553|accelerometry|accelerometry
1028491|NCT02984553|aerobic fitness|aerobic fitness
1028492|NCT02984553|metabolic thresholds|metabolic thresholds
1028493|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
1028494|NCT02984501|radiochemotherapy|radiochemotherapy
1028495|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
1028496|NCT02984488|necrotic teeth|necrotic teeth
1028497|NCT02984488|single visit|single visit
1028498|NCT02984488|multiple visits|multiple visits
1028499|NCT02984488|protaper next|protaper next
1028500|NCT02984475|Beta Thalassemia|beta thalassemia
1028501|NCT02984475|Metformin|metformin
1028502|NCT02984475|Oxidative stress|oxidative stress
1028503|NCT02984475|Iron overload|iron overload
1028504|NCT02984475|Liver function|liver function
1028505|NCT02984462|percutaneous|percutaneous
1028506|NCT02984462|non-fixed|non-fixed
1028509|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
1028510|NCT02984449|surgical complications|surgical complications
1028511|NCT02984449|quality of life|quality of life
1028512|NCT02984449|preoperative|preoperative
1028513|NCT02984449|cardiac surgery|cardiac surgery
1028514|NCT02984423|Ovarian Cancer|ovarian cancer
1028515|NCT02984423|BRCA mutations|brca mutations
1028516|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
1028517|NCT02984397|pain|pain
1028518|NCT02984397|ketotifen|ketotifen
1028519|NCT02984397|pediatric|pediatric
1028520|NCT02984397|mast cell|mast cell
1028521|NCT02984384|Trauma|trauma
1028522|NCT02984384|Blood clot|blood clot
1028523|NCT02984384|Venous Thromboembolism|venous thromboembolism
1028524|NCT02984384|Pulmonary Embolism|pulmonary embolism
1028525|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
1028526|NCT02984384|Thromboprophylaxis|thromboprophylaxis
1028527|NCT02984384|Blood clot prevention|blood clot prevention
1028528|NCT02984384|trauma patients|trauma patients
1028529|NCT02984371|atrial fibrillation|atrial fibrillation
1028530|NCT02984371|ganglionated plexi|ganglionated plexi
1028531|NCT02984371|ischemic heart disease|ischemic heart disease
1028532|NCT02984293|Atorvastatin|atorvastatin
1028533|NCT02984293|LILRB5|lilrb5
1028534|NCT02984293|Statin intolerance|statin intolerance
1028535|NCT02984254|knee|knee
1028536|NCT02984254|knee osteoarthritis|knee osteoarthritis
1028537|NCT02984254|Bracing|bracing
1028538|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
1028539|NCT02984189|Physical Exercise|physical exercise
1028540|NCT02984189|Physical Therapy|physical therapy
1028541|NCT02984189|Physical Performance|physical performance
1028542|NCT02984189|Critical Power|critical power
1028543|NCT02984189|Respiratory Muscle|respiratory muscle
1028544|NCT02984176|Simethicone|simethicone
1028545|NCT02984176|Laparoscopies|laparoscopies
1028546|NCT02984176|Pain|pain
1028547|NCT02984163|cancer|cancer
1028548|NCT02984163|exercise|exercise
1028549|NCT02984137|Lewy body disease|lewy body disease
1028550|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
1028551|NCT02984137|Parkinson disease|parkinson disease
1028552|NCT02984137|Imaging|imaging
1028553|NCT02984137|Bio-markers|bio-markers
1028554|NCT02984137|Prospective cohort|prospective cohort
1028555|NCT02984111|Coronary artery bypass|coronary artery bypass
1028556|NCT02984111|Erythropoietin|erythropoietin
1028557|NCT02984111|Inflammation|inflammation
1028558|NCT02984111|IL-6|il-6
1028559|NCT02984111|Reperfusion injury|reperfusion injury
1028560|NCT02984111|YKL- 40|ykl- 40
1028561|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
1028562|NCT02984085|RDEB|rdeb
1028563|NCT02984085|Stem cells|stem cells
1028564|NCT02984085|Gene therapy|gene therapy
1028565|NCT02984046|Acute bronchiolitis|acute bronchiolitis
1028566|NCT02984046|RSV|rsv
1028567|NCT02984046|CC16|cc16
1028568|NCT02984046|SP-D|sp-d
1028569|NCT02984046|sRAGE|srage
1028570|NCT02984046|Severity|severity
1028571|NCT02984046|Biomarkers|biomarkers
1028572|NCT02983994|asthma, devices|asthma, devices
1028573|NCT02983968|Oncology|oncology
1028574|NCT02983968|Hepatology|hepatology
1028575|NCT02983968|Public Health|public health
1028576|NCT02983968|Liver|liver
1028577|NCT02983942|ketogenic diet|ketogenic diet
1028578|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
1028579|NCT02983942|chemotherapy|chemotherapy
1028580|NCT02983916|Adhesions|adhesions
1028581|NCT02983916|Adhesiolysis|adhesiolysis
1028582|NCT02983916|chronic pain|chronic pain
1028583|NCT02983916|post-operative complications|post-operative complications
1028584|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
1028585|NCT02983916|cine-MRI|cine-mri
1028586|NCT02983916|shared decision making|shared decision making
1028587|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
1028588|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
1028590|NCT02983838|BDNF|bdnf
1028591|NCT02983838|major depressive disorder|major depressive disorder
1028592|NCT02983838|cognitive decline|cognitive decline
1028593|NCT02983825|CPAP|cpap
1028594|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1028595|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
1028596|NCT02983825|V/Q mismatch|v/q mismatch
1028597|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
1028598|NCT02983760|Pulmonary embolism|pulmonary embolism
1028599|NCT02983747|Platelet Rich Plasma|platelet rich plasma
1028600|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
1028601|NCT02983747|Low Back Pain|low back pain
1028602|NCT02983747|Ultrasound Guided|ultrasound guided
1028603|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
1028604|NCT02983734|Gulf War|gulf war
1028605|NCT02983734|D-cycloserine|d-cycloserine
1028606|NCT02983734|Neuroinflammation|neuroinflammation
1028607|NCT02983734|Cognition|cognition
1028608|NCT02983734|Memory|memory
1028609|NCT02983708|Neuroregeneration|neuroregeneration
1028610|NCT02983708|G-CSF|g-csf
1028611|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
1028612|NCT02983708|Cerebral palsy|cerebral palsy
1028613|NCT02983682|Anesthetics, Local|anesthetics, local
1028614|NCT02983682|Lidocaine|lidocaine
1028615|NCT02983682|Pediatrics|pediatrics
1028616|NCT02983682|Children|children
1028617|NCT02983682|Adolescents|adolescents
1028618|NCT02983669|Thymus Plant|thymus plant
1028619|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
1028620|NCT02983669|Zataria multiflora|zataria multiflora
1028621|NCT02983669|Complementary Therapies|complementary therapies
1028622|NCT02983669|Herbal Medicine|herbal medicine
1028623|NCT02983669|Medicine, traditional|medicine, traditional
1028624|NCT02983656|Vaccine Safety|vaccine safety
1028625|NCT02983643|Skeletal Muscle Index|skeletal muscle index
1028626|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
1028627|NCT02983643|Metabolic Syndrome|metabolic syndrome
1028628|NCT02983604|Exemestane|exemestane
1028629|NCT02983604|Aromasin|aromasin
1028630|NCT02983604|Fulvestrant|fulvestrant
1028631|NCT02983604|Faslodex|faslodex
1028632|NCT02983604|Breast Cancer,|breast cancer,
1028633|NCT02983604|HER 2-|her 2-
1028634|NCT02983604|Estrogen receptor positive|estrogen receptor positive
1028635|NCT02983578|Pancreatic cancer|pancreatic cancer
1028636|NCT02983578|Mismatch deficient colorectal cancer|mismatch deficient colorectal cancer
1028637|NCT02983578|Non-small cell lung cancer|non-small cell lung cancer
1028638|NCT02983578|NSCLC|nsclc
1028639|NCT02983578|AZD9150|azd9150
1028640|NCT02983578|MEDI4736|medi4736
1028641|NCT02983578|Durvalumab|durvalumab
1028642|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
1028643|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
1028644|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
1028645|NCT02983552|Amblyopia|amblyopia
1028646|NCT02983539|sarcomas|sarcomas
1028647|NCT02983539|immunocytochemistry|immunocytochemistry
1028648|NCT02983539|circulating tumor cells|circulating tumor cells
1028649|NCT02983526|short stem|short stem
1028650|NCT02983513|Early intervention|early intervention
1028651|NCT02983513|Brain Development|brain development
1028652|NCT02983513|Neurodevelopment|neurodevelopment
1028653|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
1028654|NCT02983487|Bordetella Pertussis|bordetella pertussis
1028655|NCT02983487|Whooping Cough|whooping cough
1028656|NCT02983487|vaccine|vaccine
1028657|NCT02983461|urinary incontinence|urinary incontinence
1028658|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
1028659|NCT02983435|Osteopathic Treatment|osteopathic treatment
1028660|NCT02983435|Postural control|postural control
1028661|NCT02983435|Neuromuscular activation|neuromuscular activation
1028662|NCT02983435|Physiotherapy|physiotherapy
1028663|NCT02983409|computerized tomography|computerized tomography
1028664|NCT02983409|Urinary Calculi|urinary calculi
1028665|NCT02983409|Patient admission|patient admission
1028666|NCT02983409|Pain|pain
1028667|NCT02983396|RELF method|relf method
1028668|NCT02983396|Medical device|medical device
1028669|NCT02983396|Admission delay|admission delay
1028670|NCT02983383|Varicocele|varicocele
1028671|NCT02983383|TAP block|tap block
1028672|NCT02983383|spinal anesthesia|spinal anesthesia
1028673|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
1028674|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
1028675|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
1028676|NCT02983344|fentanyl|fentanyl
1028677|NCT02983266|Hyperadrenergia|hyperadrenergia
1028678|NCT02983266|Inflammatory stress|inflammatory stress
1028679|NCT02983214|Cilostazol|cilostazol
1028680|NCT02983214|Clopidogrel|clopidogrel
1028681|NCT02983214|Peripheral Artery Disease|peripheral artery disease
1028682|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
1028683|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
1028684|NCT02983201|Filiform needle|filiform needle
1028685|NCT02983201|Acupuncture|acupuncture
1028686|NCT02983188|Schizophrenia|schizophrenia
1028687|NCT02983188|Berberine|berberine
1028688|NCT02983188|Metabolic Syndrome|metabolic syndrome
1028689|NCT02983188|Chinese medicine|chinese medicine
1028690|NCT02983188|Herbal medicine|herbal medicine
1028691|NCT02983175|ultrasonogaphy|ultrasonogaphy
1028692|NCT02983175|full stomach|full stomach
1028693|NCT02983175|pulmonary aspiration|pulmonary aspiration
1028694|NCT02983175|anaesthesia|anaesthesia
1028695|NCT02983136|Hand Hygiene|hand hygiene
1028696|NCT02983136|Implementation|implementation
1028697|NCT02983136|Partnership|partnership
1028698|NCT02983136|Surgery|surgery
1028699|NCT02983123|Acute MI|acute mi
1028700|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
1028701|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
1028702|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
1028703|NCT02983123|Outpatient clinic|outpatient clinic
1028704|NCT02983123|Cardiac troponin|cardiac troponin
1028705|NCT02983123|Chest pain|chest pain
1028706|NCT02983110|Hormones, Transgender|hormones, transgender
1028707|NCT02983097|lymphoma|lymphoma
1028708|NCT02983097|relapse|relapse
1028709|NCT02983097|recurrence|recurrence
1028710|NCT02983097|progress|progress
1028711|NCT02983097|progressive|progressive
1028712|NCT02983097|b-cell lymphoma|b-cell lymphoma
1028713|NCT02983097|chemotherapy|chemotherapy
1028714|NCT02983097|immunotherapy|immunotherapy
1028715|NCT02983097|IMiD|imid
1028716|NCT02983097|Salvage chemotherapy|salvage chemotherapy
1028717|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
1028718|NCT02983097|lenalidomide|lenalidomide
1028719|NCT02983097|Rituximab|rituximab
1028720|NCT02983097|CD20|cd20
1028721|NCT02983097|Cytarabine|cytarabine
1028722|NCT02983097|Ara-C|ara-c
1028723|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
1028724|NCT02983097|Cisplatin|cisplatin
1028725|NCT02983097|Carboplatin|carboplatin
1028726|NCT02983097|Cisplatinum|cisplatinum
1028727|NCT02983097|Carboplatinum|carboplatinum
1028728|NCT02983097|Dexamethasone|dexamethasone
1028729|NCT02983084|Orthodontic wires|orthodontic wires
1028730|NCT02983084|Root resorption|root resorption
1028731|NCT02983071|Breast Cancer|breast cancer
1028732|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
1028733|NCT02983071|HER2-Negative|her2-negative
1028734|NCT02983071|HR-Positive|hr-positive
1028735|NCT02983071|HR+|hr+
1028736|NCT02983071|HER2-|her2-
1028737|NCT02983071|HER2 -ve|her2 -ve
1028738|NCT02983071|HER2 +ve|her2 +ve
1028739|NCT02983032|Caregivers|caregivers
1028740|NCT02983032|Insomnia|insomnia
1028741|NCT02983019|influenza|influenza
1028742|NCT02983019|flu|flu
1028743|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
1028744|NCT02983019|ARVI|arvi
1028745|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
1028746|NCT02983019|AURI|auri
1028747|NCT02983006|TRAIL-DR5|trail-dr5
1028748|NCT02983006|DS-8273a|ds-8273a
1028749|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
1028750|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
1028852|NCT02982499|glaucoma|glaucoma
1028751|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
1028753|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
1028754|NCT02983006|Monoclonal antibody|monoclonal antibody
1028755|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
1028756|NCT02982993|hepatitis C virus|hepatitis c virus
1028757|NCT02982993|linkage-to-care|linkage-to-care
1028758|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
1028759|NCT02982993|Baby Boomer|baby boomer
1028760|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
1028761|NCT02982967|child|child
1028762|NCT02982967|physical activity|physical activity
1028763|NCT02982967|irisin|irisin
1028764|NCT02982967|EPCs|epcs
1028765|NCT02982941|Neuroblastoma|neuroblastoma
1028766|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
1028767|NCT02982941|Osteosarcoma|osteosarcoma
1028768|NCT02982941|Ewing Sarcoma|ewing sarcoma
1028769|NCT02982941|Wilms Tumor|wilms tumor
1028770|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
1028771|NCT02982941|pediatric|pediatric
1028772|NCT02982928|Obesity|obesity
1028773|NCT02982928|Bariatrics|bariatrics
1058442|NCT02798445|vein|vein
1028774|NCT02982928|Acetaminophen|acetaminophen
1028775|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
1028776|NCT02982928|Pharmacokinetics|pharmacokinetics
1028777|NCT02982902|Immunotherapy|immunotherapy
1028778|NCT02982902|T-Cell Therapy|t-cell therapy
1028779|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
1028780|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
1028781|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
1028782|NCT02982876|Silicone Airway stent|silicone airway stent
1028783|NCT02982876|Metallic Airway stent|metallic airway stent
1028784|NCT02982850|Atrial Fibrillation|atrial fibrillation
1028785|NCT02982850|Valvular Insufficiency|valvular insufficiency
1028786|NCT02982850|Valvular Stenosis|valvular stenosis
1028787|NCT02982824|Children|children
1028788|NCT02982824|IQ|iq
1028789|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
1028790|NCT02982824|Magnesium supplementation|magnesium supplementation
1028791|NCT02982824|Seizure control|seizure control
1028792|NCT02982824|Chalfont score|chalfont score
1028793|NCT02982811|Activity-based|activity-based
1028794|NCT02982811|Client-centred|client-centred
1028795|NCT02982811|Rehabilitation|rehabilitation
1028796|NCT02982811|Quality of life|quality of life
1028797|NCT02982772|Nicotine Replacement|nicotine replacement
1028798|NCT02982772|Smoking|smoking
1028799|NCT02982772|HIV|hiv
1028800|NCT02982746|Head and neck cancer|head and neck cancer
1028801|NCT02982746|Person Centred Care|person centred care
1028802|NCT02982746|Health related quality of life|health related quality of life
1028803|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
1028804|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
1028805|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
1028806|NCT02982720|Pembrolizumab|pembrolizumab
1028807|NCT02982720|MK-3475|mk-3475
1028808|NCT02982720|Sylatron|sylatron
1028809|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
1028810|NCT02982694|MSI|msi
1028811|NCT02982694|colorectal|colorectal
1028812|NCT02982694|chemotherapy|chemotherapy
1028813|NCT02982694|Bevacizumab|bevacizumab
1028814|NCT02982694|Atezolizumab|atezolizumab
1028815|NCT02982681|Periodontal disease|periodontal disease
1028816|NCT02982681|Platelet rich fibrin|platelet rich fibrin
1028817|NCT02982668|severe stroke|severe stroke
1028818|NCT02982668|Acute Stroke|acute stroke
1028819|NCT02982668|Enteral Feeding|enteral feeding
1028820|NCT02982668|Mortality|mortality
1028821|NCT02982668|Disability|disability
1028822|NCT02982668|Clinical trial|clinical trial
1028823|NCT02982655|Severe Stroke|severe stroke
1028824|NCT02982655|Acute Stroke|acute stroke
1028825|NCT02982655|Antihypertension|antihypertension
1028826|NCT02982655|mortality|mortality
1028827|NCT02982655|disability|disability
1028828|NCT02982655|clinical trial|clinical trial
1028829|NCT02982629|Glaucoma|glaucoma
1028830|NCT02982629|Eye Care|eye care
1028831|NCT02982629|Community Outreach|community outreach
1028832|NCT02982577|Xerostomia|xerostomia
1028833|NCT02982577|Pilocarpine|pilocarpine
1028834|NCT02982577|Quality of life|quality of life
1028835|NCT02982564|Exercise|exercise
1028836|NCT02982564|Physical Functioning|physical functioning
1028837|NCT02982564|Hispanic|hispanic
1028838|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
1028839|NCT02982538|implementation|implementation
1028840|NCT02982538|dissemination|dissemination
1028842|NCT02982525|Mussels|mussels
1028843|NCT02982525|Dietary Intervention|dietary intervention
1028844|NCT02982525|Long-term intervention|long-term intervention
1028845|NCT02982525|Vitamin D status|vitamin d status
1028846|NCT02982525|Selenium|selenium
1028847|NCT02982525|Iodine|iodine
1028848|NCT02982525|Vitamin B12|vitamin b12
1028849|NCT02982525|Omega-3 index|omega-3 index
1028850|NCT02982512|Potential local fields|potential local fields
1028851|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
1028853|NCT02982499|Leber optic neuropathy|leber optic neuropathy
1028854|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
1028855|NCT02982486|nivolumab|nivolumab
1028856|NCT02982486|ipilimumab|ipilimumab
1028857|NCT02982486|immunotherapy|immunotherapy
1028858|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
1028859|NCT02982486|sarcoma|sarcoma
1028860|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
1028861|NCT02982460|Eccentric exercise|eccentric exercise
1028862|NCT02982460|Isoinertial training|isoinertial training
1028863|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
1028864|NCT02982434|atrial fibrillation|atrial fibrillation
1028865|NCT02982434|botulinum toxin|botulinum toxin
1028866|NCT02982434|ischemic heart disease|ischemic heart disease
1028867|NCT02982395|Nanoxel M|nanoxel m
1028868|NCT02982395|Docetaxel PM|docetaxel pm
1028869|NCT02982395|Docetaxel|docetaxel
1028870|NCT02982395|Mitomycin C|mitomycin c
1028871|NCT02982395|BCG|bcg
1028872|NCT02982395|BCG refractory|bcg refractory
1028873|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
1028874|NCT02982395|intravesical|intravesical
1028875|NCT02982395|superficial bladder cancer|superficial bladder cancer
1028876|NCT02982395|Urothelial carcinoma|urothelial carcinoma
1028877|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
1028878|NCT02982382|Low Back Pain|low back pain
1028879|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
1028880|NCT02982382|Neurophysiology|neurophysiology
1028881|NCT02982382|Education|education
1028882|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
1028883|NCT02982317|Obstetrics|obstetrics
1028884|NCT02982317|Ultrasound|ultrasound
1028885|NCT02982252|Power mobility|power mobility
1028886|NCT02982252|Wheelchair skills training|wheelchair skills training
1028887|NCT02982252|Older adults|older adults
1028888|NCT02982226|Plantar Fasciitis|plantar fasciitis
1028889|NCT02982226|Jogger's Heel|jogger's heel
1028891|NCT02982213|Newest Vital Sign|newest vital sign
1028892|NCT02982213|Anxiety|anxiety
1028893|NCT02982213|Health literacy|health literacy
1028894|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
1028895|NCT02982213|Epidural catheter placement|epidural catheter placement
1028896|NCT02982213|Pregnancy|pregnancy
1028897|NCT02982213|Parturients|parturients
1028898|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
1028899|NCT02982213|STAI questionnaire|stai questionnaire
1028900|NCT02982213|Companion|companion
1028901|NCT02982200|Embolization Device|embolization device
1028902|NCT02982200|Medina|medina
1028903|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
1028904|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
1028905|NCT02982187|HANDIHALER|handihaler
1028906|NCT02982187|ELLIPTA|ellipta
1028907|NCT02982187|TURBUHALER|turbuhaler
1028908|NCT02982187|DISKUS|diskus
1028909|NCT02982187|COPD|copd
1028910|NCT02982187|critical error|critical error
1028911|NCT02982187|inhaler preference|inhaler preference
1028912|NCT02982174|no known ocular pathology|no known ocular pathology
1028913|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
1028914|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
1028915|NCT02982148|methylene blue|methylene blue
1029013|NCT02981368|2301|2301
1028916|NCT02982148|intradermal injection|intradermal injection
1028917|NCT02982148|subcutaneous injection|subcutaneous injection
1028918|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
1028919|NCT02982135|bypass|bypass
1028920|NCT02982135|indirect bypass|indirect bypass
1028921|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
1028922|NCT02982083|Raloxifene|raloxifene
1028923|NCT02982083|Disease activity|disease activity
1028924|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
1028925|NCT02982044|blood flow|blood flow
1028926|NCT02982044|endothelial function|endothelial function
1028927|NCT02982044|shear stress|shear stress
1028928|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
1028929|NCT02982031|Shamrock technique|shamrock technique
1028930|NCT02982031|Paramedian transverse scan|paramedian transverse scan
1028931|NCT02982031|USG LPB|usg lpb
1028932|NCT02982031|USGRA|usgra
1028933|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
1028934|NCT02981979|Takayasu Arteritis|takayasu arteritis
1028935|NCT02981979|Leflunomide|leflunomide
1028936|NCT02981953|Valtech Cardio|valtech cardio
1028937|NCT02981953|Cardioband|cardioband
1028938|NCT02981953|Tricuspid|tricuspid
1028939|NCT02981940|Brain Tumor|brain tumor
1028940|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
1028941|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
1028942|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
1028943|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
1028944|NCT02981914|pembrolizumab|pembrolizumab
1028945|NCT02981875|reading eye movement|reading eye movement
1028946|NCT02981862|HPV infection|hpv infection
1028947|NCT02981862|Blood sample|blood sample
1028948|NCT02981862|Biopsy|biopsy
1028949|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
1028950|NCT02981836|protective effect|protective effect
1028951|NCT02981836|safety|safety
1028952|NCT02981836|immunogenicity|immunogenicity
1028953|NCT02981836|child|child
1028954|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
1028955|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
1028956|NCT02981797|metastatic|metastatic
1028957|NCT02981797|castration resistant|castration resistant
1028958|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
1028959|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
1028960|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1028961|NCT02981732|Osteoporosis|osteoporosis
1028962|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
1028963|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
1028964|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
1028965|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
1028966|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
1028967|NCT02981641|Pancreatic cancer|pancreatic cancer
1028968|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
1028969|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
1028970|NCT02981602|Hepatitis|hepatitis
1028972|NCT02981602|HBV|hbv
1028973|NCT02981576|Spinal Cord Injury|spinal cord injury
1028974|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
1028975|NCT02981563|engagement|engagement
1028976|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
1028977|NCT02981563|mental health nursing|mental health nursing
1028978|NCT02981563|quality interactions|quality interactions
1028979|NCT02981550|Infection|infection
1028980|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
1028981|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1028982|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
1028983|NCT02981524|Neoplasms by Site|neoplasms by site
1028984|NCT02981524|Neoplasms|neoplasms
1028985|NCT02981524|Digestive System Diseases|digestive system diseases
1028986|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
1028987|NCT02981524|Intestinal Diseases|intestinal diseases
1028988|NCT02981524|Rectal Diseases|rectal diseases
1028989|NCT02981524|Colonic Diseases|colonic diseases
1028990|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1028991|NCT02981498|Sorafenib|sorafenib
1028992|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
1028993|NCT02981459|bladder pain|bladder pain
1028994|NCT02981459|urinary frequency|urinary frequency
1028995|NCT02981459|urinary urgency|urinary urgency
1028996|NCT02981459|mirabegron|mirabegron
1028997|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
1028998|NCT02981407|Anemia|anemia
1028999|NCT02981407|Heart Disease|heart disease
1029000|NCT02981407|Cardiovascular Disease|cardiovascular disease
1029001|NCT02981381|sTMS|stms
1029002|NCT02981381|NeoSync|neosync
1029003|NCT02981381|NEST|nest
1029004|NCT02981381|synchronous|synchronous
1029005|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
1029006|NCT02981381|TMS|tms
1029007|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1029008|NCT02981381|PTSD|ptsd
1029009|NCT02981381|EEG|eeg
1029010|NCT02981381|Depression|depression
1029017|NCT02981368|radical prostatectomy|radical prostatectomy
1029018|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
1029019|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
1029020|NCT02981355|BST-CarGel|bst-cargel
1029021|NCT02981355|Microfracture|microfracture
1029022|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
1029023|NCT02981355|Femoral condyle|femoral condyle
1029024|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
1029025|NCT02981355|Cartilage Repair|cartilage repair
1029026|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
1029027|NCT02981342|pancreatic cancer|pancreatic cancer
1029028|NCT02981329|Metformin|metformin
1029029|NCT02981329|Sickle Cell Anemia|sickle cell anemia
1029030|NCT02981329|Sickle Cell Disease|sickle cell disease
1029031|NCT02981329|Hemoglobinopathies|hemoglobinopathies
1029032|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
1029033|NCT02981329|Blood Disease|blood disease
1029034|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
1029035|NCT02981329|Hemoglobin Disease|hemoglobin disease
1029036|NCT02981277|Bronchoscopy|bronchoscopy
1029037|NCT02981277|Lignocaine|lignocaine
1029038|NCT02981264|Bronchoscopy|bronchoscopy
1029039|NCT02981264|Lignocaine|lignocaine
1029040|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
1029041|NCT02981251|Hypertension|hypertension
1029042|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
1029043|NCT02981251|Health education|health education
1029044|NCT02981251|Community based|community based
1029045|NCT02981199|microtransplantation|microtransplantation
1029046|NCT02981199|multiple myeloma|multiple myeloma
1029047|NCT02981186|Intraocular Lens|intraocular lens
1029048|NCT02981186|trifocal|trifocal
1029049|NCT02981186|cataract|cataract
1029050|NCT02981186|PhysIOL|physiol
1029051|NCT02981147|cough|cough
1029052|NCT02981147|thyme|thyme
1029053|NCT02981147|Cisti|cisti
1029054|NCT02981147|Ivy Leaves|ivy leaves
1029055|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
1029056|NCT02981134|computed tomography|computed tomography
1029057|NCT02981121|Diabetes Prevention|diabetes prevention
1029058|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
1029059|NCT02981056|Skincare regimens|skincare regimens
1029060|NCT02981056|Skin moisturization|skin moisturization
1029061|NCT02981056|Skin barrier|skin barrier
1029062|NCT02981056|Skin development|skin development
1029063|NCT02981017|Chronic sinusitis|chronic sinusitis
1029064|NCT02981017|Frontal sinusitis|frontal sinusitis
1029065|NCT02981017|Skull base neoplasm|skull base neoplasm
1029066|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
1029067|NCT02980965|breast cancer|breast cancer
1029068|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1029069|NCT02980965|endocrine therapy|endocrine therapy
1029070|NCT02980965|concurrent|concurrent
1029071|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
1029072|NCT02980874|RVO|rvo
1029073|NCT02980874|ME|me
1029074|NCT02980874|Central Subfield Thickness|central subfield thickness
1029075|NCT02980874|OCT|oct
1029076|NCT02980874|Optical Coherence Tomography|optical coherence tomography
1029077|NCT02980874|Cystoid Macular Edema|cystoid macular edema
1029078|NCT02980874|Subretinal Fluid|subretinal fluid
1029079|NCT02980874|Eylea|eylea
1029080|NCT02980874|Aflibercept|aflibercept
1029081|NCT02980874|Anti-VEGF|anti-vegf
1029082|NCT02980874|Suprachoroidal|suprachoroidal
1029083|NCT02980861|Gastric Cancer|gastric cancer
1029084|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
1029085|NCT02980861|Gastrectomy|gastrectomy
1029086|NCT02980848|digital mammography|digital mammography
1029087|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
1029088|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
1029089|NCT02980848|screening|screening
1029090|NCT02980848|breast density|breast density
1029091|NCT02980848|breast imaging|breast imaging
1029092|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
1029093|NCT02980796|Brain|brain
1029094|NCT02980796|MRI|mri
1029095|NCT02980796|Exercise|exercise
1029096|NCT02980796|Rehabilitation|rehabilitation
1029097|NCT02980796|TMS|tms
1029098|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
1029099|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
1029100|NCT02980770|Hypercapnia|hypercapnia
1029101|NCT02980770|Post-Op Complication|post-op complication
1029102|NCT02980770|Acid-Base Imbalance|acid-base imbalance
1029103|NCT02980744|Stroke|stroke
1029104|NCT02980744|Sedentary behaviour|sedentary behaviour
1029105|NCT02980744|Intervention|intervention
1029106|NCT02980731|Relapsed CLL|relapsed cll
1029107|NCT02980731|Refractory CLL|refractory cll
1029108|NCT02980731|17p deletion|17p deletion
1029109|NCT02980731|TP53 gene|tp53 gene
1029110|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
1029111|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
1029112|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
1029113|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
1029114|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
1029115|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
1029116|NCT02980731|Overall survival (OS)|overall survival (os)
1029117|NCT02980718|Olfaction training|olfaction training
1029118|NCT02980718|Smell|smell
1029119|NCT02980653|Phase II study|phase ii study
1029120|NCT02980653|Critical body weight loss|critical body weight loss
1029121|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1029122|NCT02980653|Megestrol acetate|megestrol acetate
1029123|NCT02980653|Head and neck cancer|head and neck cancer
1029124|NCT02980640|Multiple Sclerosis|multiple sclerosis
1029125|NCT02980640|Treatment|treatment
1029126|NCT02980640|Quality of Life|quality of life
1029127|NCT02980640|Symptoms|symptoms
1029128|NCT02980627|Eating Disorders|eating disorders
1029129|NCT02980627|Diabulimia|diabulimia
1029130|NCT02980627|ED-T1DM|ed-t1dm
1029131|NCT02980627|Type 1 Diabetes|type 1 diabetes
1029132|NCT02980627|Mobile Technology|mobile technology
1029133|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
1029134|NCT02980614|phase-contrast MRI|phase-contrast mri
1029135|NCT02980614|blood flow|blood flow
1029136|NCT02980614|velocity mapping|velocity mapping
1029137|NCT02980614|Quantitative MRI|quantitative mri
1029138|NCT02980614|Cardiac imaging|cardiac imaging
1029139|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
1029140|NCT02980601|Traumatic Defect|traumatic defect
1029141|NCT02980601|Chronic Wounds|chronic wounds
1029142|NCT02980575|COPD|copd
1029143|NCT02980575|Music|music
1029144|NCT02980575|Exercise|exercise
1029145|NCT02980562|Bowel preparation|bowel preparation
1029146|NCT02980562|Ascorbic acid|ascorbic acid
1029147|NCT02980562|Bisacodyl|bisacodyl
1029148|NCT02980562|Polyethylene glycol|polyethylene glycol
1029149|NCT02980536|NSCLC|nsclc
1029151|NCT02980536|Mutation|mutation
1029152|NCT02980536|Liquid Biopsy|liquid biopsy
1029153|NCT02980497|mouthrinse|mouthrinse
1029154|NCT02980497|plaque|plaque
1029155|NCT02980497|gingivitis|gingivitis
1029156|NCT02980497|gum bleeding|gum bleeding
1029157|NCT02980484|rTMS|rtms
1029158|NCT02980458|Healthy|healthy
1029159|NCT02980458|Bioequivalence|bioequivalence
1029160|NCT02980458|Deferiprone|deferiprone
1029161|NCT02980445|Myopia|myopia
1029162|NCT02980445|Outdoor time|outdoor time
1029163|NCT02980445|Children|children
1029164|NCT02980445|Intervention|intervention
1029165|NCT02980445|Prevention|prevention
1029166|NCT02980432|vestibular|vestibular
1029167|NCT02980432|spatial orientation|spatial orientation
1029168|NCT02980432|vision|vision
1029169|NCT02980432|optokinetic|optokinetic
1029170|NCT02980406|FODMAP|fodmap
1029171|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
1029172|NCT02980406|Gastric accommodation|gastric accommodation
1029173|NCT02980406|Gastric motility|gastric motility
1029174|NCT02980406|brain-gut axis|brain-gut axis
1029175|NCT02980393|congenital heart disease|congenital heart disease
1029176|NCT02980393|smart mobile technology|smart mobile technology
1029177|NCT02980393|children|children
1029178|NCT02980393|adolescents|adolescents
1029179|NCT02980393|lifestyle counselling|lifestyle counselling
1029180|NCT02980393|nutrition|nutrition
1029181|NCT02980393|physical activity|physical activity
1029182|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
1029183|NCT02980380|communication|communication
1029184|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1029185|NCT02980380|complete locked-in state|complete locked-in state
1029186|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
1029187|NCT02980367|ACL|acl
1029188|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
1029189|NCT02980367|ACL deficiency|acl deficiency
1029190|NCT02980367|ACLD|acld
1029191|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
1029192|NCT02980367|ACL reconstruction|acl reconstruction
1029193|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
1029194|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
1029195|NCT02980367|ACL physiotherapy|acl physiotherapy
1029196|NCT02980367|ACL rehabilitation|acl rehabilitation
1029197|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
1029198|NCT02980367|ACL management|acl management
1029199|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
1029200|NCT02980341|Oncology|oncology
1029201|NCT02980341|HER3|her3
1029202|NCT02980341|Antibody drug conjugate|antibody drug conjugate
1029203|NCT02980341|Developmental Phase I/II|developmental phase i/ii
1029204|NCT02980328|Overactive bladder|overactive bladder
1029205|NCT02980328|Urinary incontinence|urinary incontinence
1029206|NCT02980328|Low-level light therapy|low-level light therapy
1029207|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1029208|NCT02980315|EBV related cancers|ebv related cancers
1029209|NCT02980302|Mental retardation MR|mental retardation mr
1029210|NCT02980302|IQ|iq
1029213|NCT02980276|Gestational Diabetes|gestational diabetes
1029214|NCT02980276|Diabetes|diabetes
1029215|NCT02980276|Pregnancy|pregnancy
1029216|NCT02980263|Kawasaki disease|kawasaki disease
1029217|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
1029218|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
1029219|NCT02980263|lymph node syndrome|lymph node syndrome
1029220|NCT02980263|canakinumab|canakinumab
1029221|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
1029222|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
1029223|NCT02980263|pediatric|pediatric
1029224|NCT02980250|feeding intolerance|feeding intolerance
1029225|NCT02980250|premature infant|premature infant
1029226|NCT02980250|domperidone|domperidone
1029227|NCT02980237|Office workers|office workers
1029228|NCT02980237|Quality of life|quality of life
1029229|NCT02980237|e-Learning|e-learning
1029230|NCT02980237|Occupational health|occupational health
1029231|NCT02980211|Alveolar Bone|alveolar bone
1029232|NCT02980211|Alveolar Ridge|alveolar ridge
1029233|NCT02980211|Bone Resorption|bone resorption
1029234|NCT02980211|Bone Grafting|bone grafting
1029235|NCT02980211|Barrier Membrane|barrier membrane
1029236|NCT02980172|triage|triage
1029237|NCT02980120|Eating Disorders|eating disorders
1029238|NCT02980120|Anorexia Nervosa|anorexia nervosa
1029239|NCT02980120|Bulimia Nervosa|bulimia nervosa
1029240|NCT02980094|aging|aging
1029241|NCT02980094|nutrients|nutrients
1029242|NCT02980094|milk|milk
1029243|NCT02980094|dietary supplementation|dietary supplementation
1029244|NCT02980055|connective tissue graft|connective tissue graft
1029245|NCT02980055|transplantation|transplantation
1029246|NCT02980055|collagen|collagen
1029247|NCT02980055|autologous|autologous
1029248|NCT02980055|gingiva|gingiva
1029249|NCT02980029|Resectable Tumors|resectable tumors
1029250|NCT02980003|contrast media|contrast media
1029251|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
1029252|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
1029253|NCT02979990|infertility|infertility
1029254|NCT02979990|education|education
1029255|NCT02979951|Observational Study|observational study
1670554|NCT00105482|Weight|weight
1029256|NCT02979951|Non-Interventional Study|non-interventional study
1029257|NCT02979951|Registries|registries
1029258|NCT02979951|Prospective|prospective
1029259|NCT02979951|Monitored|monitored
1029260|NCT02979951|Multicentric|multicentric
1029261|NCT02979951|International|international
1029262|NCT02979951|Fosfomycin|fosfomycin
1029263|NCT02979951|Infectofos|infectofos
1029264|NCT02979951|Fomicyt|fomicyt
1029265|NCT02979951|Bacterial Infections|bacterial infections
1029266|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
1029267|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
1029268|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
1029269|NCT02979951|Osteomyelitis|osteomyelitis
1029270|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
1029271|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
1029272|NCT02979951|Encephalitis|encephalitis
1029273|NCT02979951|Brain Abscess|brain abscess
1029274|NCT02979951|Urinary Tract Infections|urinary tract infections
1029275|NCT02979951|Respiratory Tract Infections|respiratory tract infections
1029276|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
1029277|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
1029278|NCT02979951|Soft Tissue Infections|soft tissue infections
1029279|NCT02979951|Intraabdominal Infections|intraabdominal infections
1029280|NCT02979951|Sepsis|sepsis
1029281|NCT02979951|Bacteremia|bacteremia
1029282|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
1029283|NCT02979951|Treatment Outcome|treatment outcome
1029284|NCT02979951|Clinical Efficacy|clinical efficacy
1029285|NCT02979951|Microbiological Efficacy|microbiological efficacy
1029286|NCT02979951|Safety|safety
1029287|NCT02979925|neuropathic pain|neuropathic pain
1029288|NCT02979925|TMS|tms
1029289|NCT02979925|nerve injury|nerve injury
1029290|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
1029291|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
1029292|NCT02979912|Platelet Lysate|platelet lysate
1029293|NCT02979899|angiosarcoma|angiosarcoma
1029294|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
1029295|NCT02979873|Rapamycin|rapamycin
1029296|NCT02979873|Relapse Prevention|relapse prevention
1029297|NCT02979873|Immune Tolerance|immune tolerance
1029298|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
1029299|NCT02979847|catheter ablation|catheter ablation
1029300|NCT02979847|hybrid|hybrid
1029301|NCT02979834|fetal movement|fetal movement
1029302|NCT02979834|placenta site|placenta site
1029303|NCT02979834|body mass index|body mass index
1029304|NCT02979834|maternal education|maternal education
1029305|NCT02979821|pan-HER inhibitor|pan-her inhibitor
1029306|NCT02979782|cardiac surgery|cardiac surgery
1029307|NCT02979782|neurological outcome|neurological outcome
1029431|NCT02978859|Sarcoma|sarcoma
1029308|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
1029309|NCT02979769|Open-label extension study|open-label extension study
1029310|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
1029311|NCT02979769|Efficacy and safety|efficacy and safety
1029312|NCT02979769|Heterotopic ossification|heterotopic ossification
1029313|NCT02979769|Flare-up|flare-up
1029314|NCT02979769|Palovarotene|palovarotene
1029315|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
1029316|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
1029317|NCT02979769|Clementia|clementia
1029318|NCT02979769|Myositis Ossificans|myositis ossificans
1029319|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
1029320|NCT02979769|FOP|fop
1029321|NCT02979717|satiety|satiety
1029322|NCT02979717|protein|protein
1029323|NCT02979717|fiber|fiber
1029324|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
1029325|NCT02979639|Herpes Zoster|herpes zoster
1029326|NCT02979639|Reactogenicity|reactogenicity
1029327|NCT02979639|Quality of life|quality of life
1029328|NCT02979639|Shingles|shingles
1029329|NCT02979626|hospitalization|hospitalization
1029330|NCT02979626|intensive care unit|intensive care unit
1029331|NCT02979626|school absenteeism|school absenteeism
1029332|NCT02979626|work absenteeism|work absenteeism
1029333|NCT02979600|Oral immunotherapy|oral immunotherapy
1029334|NCT02979600|Oral tolerance induction|oral tolerance induction
1029335|NCT02979574|acupuncture|acupuncture
1029336|NCT02979574|pain|pain
1029337|NCT02979574|chronic pain|chronic pain
1029338|NCT02979574|pain management|pain management
1029339|NCT02979574|16-1579|16-1579
1029340|NCT02979561|Dabigatran etexilate|dabigatran etexilate
1029341|NCT02979561|Recurrence of DVT|recurrence of dvt
1029342|NCT02979561|Pulmonary Embolism|pulmonary embolism
1029343|NCT02979561|Warfarin|warfarin
1029344|NCT02979548|Aprepitant|aprepitant
1029345|NCT02979535|Dengue Fever|dengue fever
1029346|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1029347|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
1029348|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
1029349|NCT02979535|Dengvaxia®|dengvaxia®
1059197|NCT02794610|Topical|topical
1029350|NCT02979535|Cervarix®|cervarix®
1029351|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
1029352|NCT02979496|immune|immune
1029353|NCT02979496|citrus|citrus
1029354|NCT02979470|advanced colon cancer|advanced colon cancer
1029355|NCT02979470|advanced rectum cancer|advanced rectum cancer
1029356|NCT02979470|circulating tumor cells|circulating tumor cells
1029357|NCT02979470|immune response|immune response
1029358|NCT02979470|mutations|mutations
1029359|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
1029360|NCT02979418|Water insecurity|water insecurity
1029361|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
1029362|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
1029363|NCT02979275|acute kidney injury|acute kidney injury
1029364|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
1029365|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
1029366|NCT02979275|tissue hypoxia|tissue hypoxia
1029367|NCT02979249|Interventional|interventional
1029368|NCT02979249|open-label|open-label
1029369|NCT02979249|EPP|epp
1029370|NCT02979249|XLP|xlp
1029371|NCT02979249|porphyria|porphyria
1029372|NCT02979197|High blood pressure|high blood pressure
1029373|NCT02979197|Systolic blood pressure|systolic blood pressure
1029374|NCT02979197|Diastolic blood pressure|diastolic blood pressure
1029375|NCT02979197|Antihypertensive|antihypertensive
1029376|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
1029377|NCT02979119|Hemophilia|hemophilia
1029378|NCT02979119|Children, ,|children, ,
1029379|NCT02979119|Inhibitors,|inhibitors,
1029380|NCT02979119|Prophylaxis|prophylaxis
1029381|NCT02979119|Long-term outcome|long-term outcome
1029382|NCT02979119|Congenital|congenital
1029383|NCT02979093|maternal drug addiction|maternal drug addiction
1029384|NCT02979093|mother-infant attachment|mother-infant attachment
1029385|NCT02979093|intranasal oxytocin|intranasal oxytocin
1029386|NCT02979093|unresolved trauma|unresolved trauma
1029387|NCT02979093|maternal brain responses|maternal brain responses
1029388|NCT02979093|mother-infant synchrony|mother-infant synchrony
1029389|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
1029390|NCT02979041|neck pain|neck pain
1029391|NCT02979041|Virtual reality|virtual reality
1029392|NCT02979041|Range of motion|range of motion
1029393|NCT02979041|physiotherapy|physiotherapy
1029394|NCT02979041|Air force|air force
1029395|NCT02979041|kinematics|kinematics
1029396|NCT02979028|TEAS|teas
1029397|NCT02979028|complication|complication
1029398|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1029399|NCT02978989|Solo surgery|solo surgery
1029400|NCT02978989|Camera holder|camera holder
1029401|NCT02978989|Cholecystitis|cholecystitis
1029403|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
1029404|NCT02978963|Excessive worry|excessive worry
1029405|NCT02978963|Worry|worry
1029406|NCT02978963|Adolescents|adolescents
1029407|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
1029408|NCT02978950|duplex ultrasound|duplex ultrasound
1029409|NCT02978950|trauma|trauma
1029410|NCT02978950|venous thromboembolism|venous thromboembolism
1029411|NCT02978950|prevention|prevention
1029412|NCT02978924|spinal cord|spinal cord
1029413|NCT02978924|tsDCS|tsdcs
1029414|NCT02978924|3D motion capture|3d motion capture
1029415|NCT02978924|EMG|emg
1029416|NCT02978911|RMI|rmi
1029417|NCT02978898|Follicular Lymphoma|follicular lymphoma
1029418|NCT02978898|flow cytometry|flow cytometry
1029419|NCT02978898|CD180|cd180
1029420|NCT02978898|Toll-like receptor|toll-like receptor
1029421|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
1029422|NCT02978885|Acute lung injury|acute lung injury
1029423|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1029424|NCT02978885|Whipple procedures|whipple procedures
1029425|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
1029426|NCT02978872|Cardiac surgery|cardiac surgery
1029427|NCT02978872|Quantra|quantra
1029428|NCT02978872|Viscoelastic testing|viscoelastic testing
1029429|NCT02978872|Coagulation|coagulation
1029430|NCT02978859|MGCD516|mgcd516
1029432|NCT02978859|liposarcoma|liposarcoma
1029433|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
1029434|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
1029435|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
1029436|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
1029437|NCT02978820|core stabilization training|core stabilization training
1029438|NCT02978820|bracing|bracing
1029439|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1029440|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
1029441|NCT02978781|Tremor|tremor
1029442|NCT02978768|dementia|dementia
1059316|NCT02793830|mHealth|mhealth
1029443|NCT02978768|Tai Chi|tai chi
1029444|NCT02978768|mental training|mental training
1029445|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
1029446|NCT02978742|Eating Disorders|eating disorders
1029447|NCT02978742|Bulimia Nervosa|bulimia nervosa
1029448|NCT02978742|Binge Eating Disorder|binge eating disorder
1029449|NCT02978742|App|app
1029450|NCT02978742|Smartphone|smartphone
1029451|NCT02978742|Self-Help|self-help
1029452|NCT02978742|Coaching|coaching
1029453|NCT02978742|Recovery Record|recovery record
1029454|NCT02978742|Mobile Phone|mobile phone
1029455|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
1029456|NCT02978729|Telemedicine|telemedicine
1029457|NCT02978729|Counseling, Genetic|counseling, genetic
1029458|NCT02978716|Breast Cancer|breast cancer
1029459|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
1029460|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
1029461|NCT02978716|Metastatic|metastatic
1029462|NCT02978677|brain tumors|brain tumors
1029463|NCT02978677|proton radiotherapy|proton radiotherapy
1029464|NCT02978677|photon radiotherapy|photon radiotherapy
1029465|NCT02978664|colonoscopy|colonoscopy
1029466|NCT02978664|water exchange|water exchange
1029467|NCT02978664|adenoma detection rate|adenoma detection rate
1029468|NCT02978664|distraction|distraction
1029469|NCT02978651|EDS|eds
1029470|NCT02978651|OSA|osa
1029471|NCT02978638|Spinal cord injury|spinal cord injury
1029472|NCT02978638|Bladder capacity|bladder capacity
1029473|NCT02978638|Electrical stimulation|electrical stimulation
1029474|NCT02978638|Continence|continence
1029475|NCT02978638|Urodynamics|urodynamics
1029476|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
1029477|NCT02978586|PSMA|psma
1029478|NCT02978586|PET/MRI|pet/mri
1029479|NCT02978573|First MTP Joint|first mtp joint
1029480|NCT02978573|Hallux Rigidus|hallux rigidus
1029481|NCT02978573|Hallux Limitus|hallux limitus
1029482|NCT02978573|Cartilage Replacement|cartilage replacement
1029483|NCT02978573|Osteoarthritis|osteoarthritis
1029484|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
1029485|NCT02978573|Big Toe Pain|big toe pain
1029486|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
1029487|NCT02978547|PDAC|pdac
1029488|NCT02978547|Metformin|metformin
1029489|NCT02978534|pregnant|pregnant
1029490|NCT02978534|quetiapine|quetiapine
1029491|NCT02978534|bipolar|bipolar
1029492|NCT02978534|women|women
1029493|NCT02978534|female|female
1029494|NCT02978534|postpartum|postpartum
1029495|NCT02978534|seroquel|seroquel
1029496|NCT02978534|perinatal|perinatal
1029497|NCT02978534|manic-depressive|manic-depressive
1029498|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
1029499|NCT02978456|IVUS guided PCI|ivus guided pci
1029500|NCT02978456|QCA guided PCI|qca guided pci
1029501|NCT02978443|Melanoma|melanoma
1029502|NCT02978443|Mucosal|mucosal
1029503|NCT02978443|Acral Lentiginous|acral lentiginous
1029504|NCT02978443|Ipilimumab|ipilimumab
1029505|NCT02978443|Nivolumab|nivolumab
1029507|NCT02978443|Potential Predictors|potential predictors
1029508|NCT02978443|Opdivo|opdivo
1029509|NCT02978443|Yervoy|yervoy
1029510|NCT02978430|Fluid therapy|fluid therapy
1029511|NCT02978430|Anesthesiology|anesthesiology
1029512|NCT02978430|Major surgery|major surgery
1029513|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
1029514|NCT02978430|Fluid responsiveness|fluid responsiveness
1029515|NCT02978430|Closed-loop system|closed-loop system
1029516|NCT02978417|Medication-assisted treatment|medication-assisted treatment
1029517|NCT02978417|Drug Court|drug court
1029518|NCT02978417|Pilot study|pilot study
1029519|NCT02978417|Opioid dependence|opioid dependence
1029520|NCT02978417|Criminal justice|criminal justice
1029521|NCT02978404|radiosurgery|radiosurgery
1029522|NCT02978404|PD-1|pd-1
1029523|NCT02978404|Nivolumab|nivolumab
1029524|NCT02978326|Postpartum Care|postpartum care
1029525|NCT02978287|Calcium sensing receptor|calcium sensing receptor
1029526|NCT02978287|Parathyroid cell viability|parathyroid cell viability
1029527|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
1029528|NCT02978287|Transporting solution|transporting solution
1029529|NCT02978235|Multiple Myeloma|multiple myeloma
1029530|NCT02978235|Relapsed/Refractory|relapsed/refractory
1029531|NCT02978235|Lymphoma|lymphoma
1029532|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1029533|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1029534|NCT02978235|DLBCL|dlbcl
1029535|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
1029536|NCT02978235|MCL|mcl
1029537|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1029538|NCT02978235|PTCL|ptcl
1029539|NCT02978235|TAS4464|tas4464
1029540|NCT02978235|NEDD8|nedd8
1029541|NCT02978235|NAE inhibitor|nae inhibitor
1029542|NCT02978235|Neoplasms|neoplasms
1029543|NCT02978235|Hematologic Diseases|hematologic diseases
1029544|NCT02978235|Myeloma|myeloma
1029545|NCT02978170|Bronchoscopy|bronchoscopy
1029546|NCT02978170|Lung lesions|lung lesions
1029547|NCT02978170|Cone Beam Computed Tomography|cone beam computed tomography
1029548|NCT02978170|CBCT|cbct
1029549|NCT02978170|Cone Beam CT|cone beam ct
1029550|NCT02978157|Helicobacter pylori|helicobacter pylori
1029551|NCT02978157|Eradication rate|eradication rate
1029552|NCT02978157|Rescue treatment|rescue treatment
1029553|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1029554|NCT02978131|TUBERCULOSIS|tuberculosis
1029555|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
1029556|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
1029557|NCT02978131|Immunohistochemistry|immunohistochemistry
1029558|NCT02978131|Histochemistry|histochemistry
1029559|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
1029560|NCT02978053|Bright light|bright light
1029561|NCT02978053|Sleepiness|sleepiness
1029563|NCT02978053|Psychomotor vigilance|psychomotor vigilance
1029564|NCT02978040|Antiplatelet therapy|antiplatelet therapy
1029565|NCT02978040|Cangrelor|cangrelor
1029566|NCT02978040|Tirofiban|tirofiban
1029567|NCT02978040|Prasugrel|prasugrel
1029568|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
1029569|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
1029570|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
1029571|NCT02978027|motivational interviewing|motivational interviewing
1029572|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
1029573|NCT02978014|Prostate|prostate
1029574|NCT02978014|Radiotherapy|radiotherapy
1029575|NCT02978014|Obturator|obturator
1029576|NCT02978014|Toxicity|toxicity
1029577|NCT02978014|Bowel|bowel
1029578|NCT02978014|Urinary|urinary
1029579|NCT02978014|Sexual|sexual
1029580|NCT02978014|PROM|prom
1029581|NCT02978014|EPIC|epic
1029582|NCT02977988|Mindfulness|mindfulness
1029583|NCT02977988|Women|women
1029584|NCT02977988|Relapse prevention|relapse prevention
1029585|NCT02977988|Clinical trial|clinical trial
1029586|NCT02977988|Substance use disorder|substance use disorder
1029587|NCT02977988|Ethnically diverse|ethnically diverse
1029588|NCT02977988|Underserved|underserved
1029589|NCT02977988|Health disparities|health disparities
1029590|NCT02977988|Stress|stress
1029591|NCT02977988|Addiction|addiction
1029592|NCT02977988|Latina/Hispanic|latina/hispanic
1029593|NCT02977988|African American|african american
1029594|NCT02977988|Treatment retention|treatment retention
1029595|NCT02977988|Residential treatment|residential treatment
1029596|NCT02977988|Brain Imaging|brain imaging
1029597|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
1029598|NCT02977975|The human microbiome|the human microbiome
1029599|NCT02977975|Microbiota|microbiota
1029600|NCT02977975|Gut microbiota|gut microbiota
1029601|NCT02977975|Probiotics|probiotics
1029602|NCT02977975|Sauerkraut|sauerkraut
1029603|NCT02977949|SERM|serm
1029604|NCT02977949|Season|season
1029605|NCT02977949|Variation|variation
1029606|NCT02977949|Vitamin D|vitamin d
1029607|NCT02977923|Virtual reality|virtual reality
1029608|NCT02977923|Immersive distraction|immersive distraction
1029610|NCT02977923|Virtual world|virtual world
1029611|NCT02977923|Virtual environment|virtual environment
1029612|NCT02977923|Procedural pain|procedural pain
1029613|NCT02977923|Procedural anxiety|procedural anxiety
1029614|NCT02977923|Acute pain|acute pain
1029615|NCT02977923|Pain management|pain management
1029616|NCT02977923|Anxiety|anxiety
1029617|NCT02977923|Children, Child|children, child
1029618|NCT02977923|Kid, Kids|kid, kids
1029619|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
1029620|NCT02977923|Young children|young children
1029621|NCT02977923|Burns|burns
1029622|NCT02977923|Burn injuries|burn injuries
1029623|NCT02977923|Burn unit|burn unit
1029624|NCT02977923|Physiotherapy|physiotherapy
1029625|NCT02977923|Physical therapy|physical therapy
1029626|NCT02977923|Burn dressing|burn dressing
1029627|NCT02977923|Dressing change|dressing change
1029628|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
1029629|NCT02977923|Clinical Research|clinical research
1029630|NCT02977923|Nursing Practice|nursing practice
1029631|NCT02977923|Trauma|trauma
1029632|NCT02977897|Diarrhea|diarrhea
1029633|NCT02977897|Immunosuppression|immunosuppression
1029634|NCT02977897|Post-transplantation|post-transplantation
1029635|NCT02977897|Octreotide|octreotide
1029636|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
1029637|NCT02977897|Fecal Calprotectin|fecal calprotectin
1029638|NCT02977884|nutrition|nutrition
1029639|NCT02977884|exercise|exercise
1029640|NCT02977884|stress|stress
1029641|NCT02977884|cardiovascular disease|cardiovascular disease
1029642|NCT02977884|diabetes|diabetes
1029643|NCT02977884|hypertension|hypertension
1029644|NCT02977884|dyslipidemia|dyslipidemia
1029645|NCT02977884|cholesterol|cholesterol
1029646|NCT02977884|overweight|overweight
1029647|NCT02977884|obesity|obesity
1029648|NCT02977884|lifestyle|lifestyle
1029649|NCT02977871|Cesarean section|cesarean section
1029650|NCT02977871|operating time|operating time
1029651|NCT02977871|bladder|bladder
1029652|NCT02977871|urinary retention|urinary retention
1029653|NCT02977845|dypsnea|dypsnea
1029654|NCT02977845|fatigue|fatigue
1029655|NCT02977845|anxiety|anxiety
1029656|NCT02977845|Qigong|qigong
1029657|NCT02977845|Lung cancer|lung cancer
1029658|NCT02977832|LUTS|luts
1029659|NCT02977832|Iresine celosia|iresine celosia
1029660|NCT02977832|Odyliresin|odyliresin
1029661|NCT02977832|medical therapy|medical therapy
1029662|NCT02977780|Glioblastoma|glioblastoma
1029663|NCT02977728|MTBI|mtbi
1029664|NCT02977728|olfaction|olfaction
1029665|NCT02977728|acute|acute
1029666|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
1029667|NCT02977715|IMVAMUNE|imvamune
1029668|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
1029669|NCT02977715|Monkeypox|monkeypox
1029670|NCT02977715|Orthopoxvirus|orthopoxvirus
1029671|NCT02977715|Vaccine|vaccine
1029672|NCT02977715|Vaccinia virus|vaccinia virus
1029673|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
1029674|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
1029675|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
1029676|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
1029677|NCT02977689|IDH305|idh305
1029678|NCT02977689|IDHR132 mutations|idhr132 mutations
1029679|NCT02977689|Astrocytoma|astrocytoma
1029680|NCT02977689|Oligodendroglioma|oligodendroglioma
1029681|NCT02977689|Oligoastrocytoma|oligoastrocytoma
1029682|NCT02977689|IDH1 R132H|idh1 r132h
1029683|NCT02977689|IDH1|idh1
1029684|NCT02977637|hht|hht
1029685|NCT02977637|hereditary|hereditary
1029686|NCT02977637|hemorrhagic|hemorrhagic
1029687|NCT02977637|telangiectasia|telangiectasia
1029688|NCT02977637|feraheme|feraheme
1029689|NCT02977585|continous positive airway pressure|continous positive airway pressure
1029690|NCT02977585|helmet|helmet
1029691|NCT02977585|non invasive|non invasive
1029692|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
1029693|NCT02977585|severe bronchiolitis|severe bronchiolitis
1029694|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
1029695|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
1029696|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
1029697|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
1029698|NCT02977572|acute respiratory failure|acute respiratory failure
1029699|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
1029700|NCT02977546|Hemodynamics|hemodynamics
1029701|NCT02977546|Noninvasive|noninvasive
1029702|NCT02977546|Pulse contour analysis|pulse contour analysis
1029703|NCT02977546|Heart failure|heart failure
1029704|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
1029705|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
1029706|NCT02977468|triple negative breast cancer|triple negative breast cancer
1029707|NCT02977468|Pembrolizumab|pembrolizumab
1029708|NCT02977468|IORT|iort
1029709|NCT02977468|tumor microenvironment|tumor microenvironment
1029710|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
1029711|NCT02977442|Insulin Resistance|insulin resistance
1029712|NCT02977442|Exercise and Diabetes|exercise and diabetes
1029713|NCT02977429|Tumor|tumor
1029714|NCT02977429|Abdominal infection|abdominal infection
1029715|NCT02977429|Hemodynamics|hemodynamics
1029716|NCT02977429|Pcv-aCO2|pcv-aco2
1029717|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
1029718|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
1029719|NCT02977416|fat oxidation|fat oxidation
1029720|NCT02977416|exercise|exercise
1029721|NCT02977403|Binge Eating|binge eating
1029722|NCT02977403|Eating Behavior|eating behavior
1029723|NCT02977403|Children|children
1029724|NCT02977403|Magnetoencephalography|magnetoencephalography
1029725|NCT02977403|Loss of Control|loss of control
1029726|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
1029727|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
1029728|NCT02977325|Physical activity level|physical activity level
1029729|NCT02977325|Personal efficacy|personal efficacy
1029730|NCT02977325|Knee osteoarthritis|knee osteoarthritis
1029731|NCT02977325|Self-management|self-management
1029732|NCT02977325|Self-care|self-care
1029733|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
1029734|NCT02977273|Meal size|meal size
1029735|NCT02977260|Meal size|meal size
1029736|NCT02977247|SoftVue|softvue
1029737|NCT02977247|Dense Breast Tissue|dense breast tissue
1029738|NCT02977247|Breast Screening|breast screening
1029739|NCT02977247|Abnormal Breast|abnormal breast
1029740|NCT02977247|Normal Breast|normal breast
1029741|NCT02977247|Breast Imaging|breast imaging
1029742|NCT02977247|Breast Biopsy|breast biopsy
1029743|NCT02977247|Mammography|mammography
1029744|NCT02977247|Tomosynthesis|tomosynthesis
1029745|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
1029746|NCT02977247|Breast Cancer|breast cancer
1029747|NCT02977247|Breast Carcinoma|breast carcinoma
1029748|NCT02977247|Breast Tumors|breast tumors
1029749|NCT02977247|Mammary Carcinoma|mammary carcinoma
1029750|NCT02977247|Malignant Breast Tumor|malignant breast tumor
1029751|NCT02977247|Mammary Neoplasm|mammary neoplasm
1029752|NCT02977247|Mammary Cancer|mammary cancer
1029753|NCT02977247|ABUS|abus
1029754|NCT02977247|AWBUS|awbus
1029755|NCT02977247|Breast Tomography|breast tomography
1029756|NCT02977247|ATUS|atus
1029757|NCT02977247|ABTUS|abtus
1029758|NCT02977247|Mammogram|mammogram
1029759|NCT02977247|3D Mammogram|3d mammogram
1029760|NCT02977247|3D ABUS|3d abus
1029761|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
1029762|NCT02977247|DBT|dbt
1029763|NCT02977247|FFDM|ffdm
1029764|NCT02977247|Digital Mammography|digital mammography
1029765|NCT02977247|Breast Ultrasound|breast ultrasound
1029766|NCT02977247|Dense Breasts|dense breasts
1029767|NCT02977247|Breast Density|breast density
1029768|NCT02977247|Dense Parenchyma|dense parenchyma
1029769|NCT02977247|Asymptomatic|asymptomatic
1029770|NCT02977247|Delphinus|delphinus
1029771|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
1029772|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
1029773|NCT02977221|corticotomy|corticotomy
1029774|NCT02977221|piezocision|piezocision
1029775|NCT02977221|piezosurgery|piezosurgery
1029776|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
1029777|NCT02977221|crowded anterior teeth|crowded anterior teeth
1029778|NCT02977208|Gabapentin|gabapentin
1029779|NCT02977208|OCT2|oct2
1029780|NCT02977208|OCTN1|octn1
1029781|NCT02977208|Pharmacogenetics|pharmacogenetics
1029782|NCT02977208|Pharmacokinetics|pharmacokinetics
1029783|NCT02977208|Polymorphisms|polymorphisms
1029784|NCT02977195|First in Human|first in human
1029785|NCT02977195|monoclonal antibody|monoclonal antibody
1029786|NCT02977195|Netrin-1|netrin-1
1029787|NCT02977156|Injectable lesion|injectable lesion
1029788|NCT02977156|Intra-tumoral injection|intra-tumoral injection
1029789|NCT02977143|fluid responsiveness|fluid responsiveness
1029790|NCT02977143|central venous pressure|central venous pressure
1029791|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
1029792|NCT02977143|robot surgery|robot surgery
1029793|NCT02977117|magnesium|magnesium
1029794|NCT02977117|ectopic calcification|ectopic calcification
1029795|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
1029796|NCT02977117|serum calcification propensity|serum calcification propensity
1029797|NCT02977091|short stature|short stature
1029798|NCT02977091|fitness|fitness
1029799|NCT02977091|children|children
1029800|NCT02977078|Inhaler|inhaler
1029801|NCT02977065|Dyslipidemia|dyslipidemia
1029802|NCT02977065|CETP Inhibitors|cetp inhibitors
1029803|NCT02977065|Hyperlipidemia|hyperlipidemia
1029804|NCT02977052|Melanoma|melanoma
1029805|NCT02977052|Ipilimumab|ipilimumab
1029806|NCT02977052|Nivolumab|nivolumab
1029807|NCT02977052|Neo-adjuvant|neo-adjuvant
1029808|NCT02976987|Colvir|colvir
1029809|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
1029810|NCT02976987|cervix|cervix
1029811|NCT02976974|chronic pain|chronic pain
1029812|NCT02976974|central sensitization|central sensitization
1029815|NCT02976974|ultrasonography|ultrasonography
1029816|NCT02976961|Information|information
1029817|NCT02976961|Empowerment|empowerment
1029819|NCT02976922|microbiome|microbiome
1029820|NCT02976922|probiotics|probiotics
1029821|NCT02976883|Hypoxia|hypoxia
1029822|NCT02976883|HX4|hx4
1029823|NCT02976883|PET CT|pet ct
1029824|NCT02976883|Radiotherapy|radiotherapy
1029825|NCT02976870|Hydronephrosis|hydronephrosis
1029826|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
1029827|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
1029828|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
1029829|NCT02976844|optimal balloon volume|optimal balloon volume
1029830|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
1029831|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
1029832|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1029833|NCT02976792|Acute Kidney Injury|acute kidney injury
1029834|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
1029835|NCT02976792|Nephrocheck™|nephrocheck™
1029836|NCT02976792|Renal Resistive Index|renal resistive index
1029837|NCT02976766|Neuroprotection|neuroprotection
1029838|NCT02976766|Clinical trial|clinical trial
1029839|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
1029840|NCT02976766|Axonal loss|axonal loss
1029841|NCT02976766|Jiaogulan|jiaogulan
1029852|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
1029854|NCT02976727|Calcipotriol|calcipotriol
1029855|NCT02976727|Ablative fractional laser|ablative fractional laser
1029856|NCT02976727|Actinic keratosis|actinic keratosis
1029857|NCT02976727|Photodynamic therapy|photodynamic therapy
1029858|NCT02976714|Cystic Fibrosis|cystic fibrosis
1029859|NCT02976714|Lung disease|lung disease
1029860|NCT02976714|DNA methylation|dna methylation
1029861|NCT02976714|Predictive biomarkers|predictive biomarkers
1029862|NCT02976701|STEMI|stemi
1029863|NCT02976701|acute coronary syndrome|acute coronary syndrome
1029864|NCT02976701|DLBS1033|dlbs1033
1029865|NCT02976701|microvascular resistance index|microvascular resistance index
1029866|NCT02976701|Left ventricular function|left ventricular function
1029867|NCT02976688|Endstage renal Disease|endstage renal disease
1029868|NCT02976688|Hemodialysis|hemodialysis
1029869|NCT02976649|Morbid obesity|morbid obesity
1029870|NCT02976649|Bariatric surgery|bariatric surgery
1029871|NCT02976649|Multi-dimensional score|multi-dimensional score
1029872|NCT02976636|Obesity treatment|obesity treatment
1029873|NCT02976636|Parenting training|parenting training
1029874|NCT02976636|Parenting style|parenting style
1029875|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
1029876|NCT02976623|metrics|metrics
1029877|NCT02976623|feedback|feedback
1029878|NCT02976623|ultrasound-guided|ultrasound-guided
1029879|NCT02976623|procedural skills|procedural skills
1029880|NCT02976610|hemolysis|hemolysis
1029881|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
1029882|NCT02976584|EEG|eeg
1029883|NCT02976584|Cardiac Surgery|cardiac surgery
1029884|NCT02976584|Seizure|seizure
1029885|NCT02976584|Tranexamic acid|tranexamic acid
1029886|NCT02976558|CAM|cam
1029887|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
1029888|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
1029889|NCT02976558|Depression|depression
1029890|NCT02976558|Quality of Life|quality of life
1029891|NCT02976558|Acupuncture|acupuncture
1029892|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
1029893|NCT02976558|Integrative medicine|integrative medicine
1029894|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
1029895|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
1029896|NCT02976558|Clown theatrical performance|clown theatrical performance
1029897|NCT02976558|Humour|humour
1029898|NCT02976558|Chemotherapy side effects|chemotherapy side effects
1029899|NCT02976558|Psycho neuro immune system|psycho neuro immune system
1029900|NCT02976558|GvHD|gvhd
1029901|NCT02976558|PNEIS|pneis
1029902|NCT02976558|CMV|cmv
1029903|NCT02976558|EBV|ebv
1029904|NCT02976558|holistic medicine|holistic medicine
1029905|NCT02976532|Electromagnetic tracking|electromagnetic tracking
1029906|NCT02976532|Internal rotation gait|internal rotation gait
1029907|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
1029908|NCT02976480|Irrigation|irrigation
1029909|NCT02976454|Obesity treatment|obesity treatment
1029910|NCT02976454|Primary care|primary care
1029911|NCT02976454|Guided Self-Help|guided self-help
1029912|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
1029913|NCT02976428|sensor-guided|sensor-guided
1029914|NCT02976428|range of motion|range of motion
1029915|NCT02976415|Cardiac Surgery|cardiac surgery
1029916|NCT02976415|Physiotherapy|physiotherapy
1029917|NCT02976415|In-Bed Cycling|in-bed cycling
1029918|NCT02976415|Mechanical Ventilation|mechanical ventilation
1029919|NCT02976415|Cycle Ergometry|cycle ergometry
1029920|NCT02976415|Early Mobilization|early mobilization
1029921|NCT02976415|Rehabilitation|rehabilitation
1029922|NCT02976415|Critical Care|critical care
1029923|NCT02976415|Intensive Care Unit|intensive care unit
1029924|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
1029925|NCT02976389|Food insecurity|food insecurity
1029926|NCT02976389|fruit and vegetable|fruit and vegetable
1029927|NCT02976389|healthy diet|healthy diet
1029928|NCT02976376|Myocardial infarction|myocardial infarction
1029929|NCT02976376|e-Health|e-health
1029930|NCT02976376|mHealth|mhealth
1029931|NCT02976376|mobile phones|mobile phones
1029932|NCT02976376|smartphone|smartphone
1029933|NCT02976376|follow-up|follow-up
1029934|NCT02976363|Radiotherapy|radiotherapy
1029935|NCT02976363|Respiratory muscles|respiratory muscles
1029936|NCT02976363|Neoplasms|neoplasms
1029937|NCT02976363|Breast|breast
1029938|NCT02976350|Heart failure|heart failure
1029939|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1029940|NCT02976350|GH deficiency|gh deficiency
1029941|NCT02976350|Testosterone deficiency|testosterone deficiency
1029942|NCT02976350|Low- T3 syndrome|low- t3 syndrome
1029943|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
1029944|NCT02976337|Central sensitization|central sensitization
1029945|NCT02976337|Endogenous opioids|endogenous opioids
1029946|NCT02976337|Humans|humans
1029947|NCT02976337|Latent sensitization|latent sensitization
1029948|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
1029949|NCT02976337|Naloxone|naloxone
1029950|NCT02976337|Pain|pain
1029951|NCT02976337|Pressure algometry|pressure algometry
1672101|NCT00100009|Steroid|steroid
1029952|NCT02976337|Randomized controlled trial|randomized controlled trial
1029953|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
1029954|NCT02976337|Target controlled infusion|target controlled infusion
1029955|NCT02976311|inflammatory reaction|inflammatory reaction
1029956|NCT02976311|IL-6|il-6
1029958|NCT02976311|Misgav Ladach technique|misgav ladach technique
1029959|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
1029960|NCT02976311|cesarean delivery|cesarean delivery
1029961|NCT02976311|cesarean technique|cesarean technique
1029962|NCT02976298|cerebellum|cerebellum
1029963|NCT02976298|supplementary motor area|supplementary motor area
1029964|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1029965|NCT02976285|patch augmentation|patch augmentation
1029966|NCT02976272|Bortezomib regimen|bortezomib regimen
1029967|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
1029968|NCT02976233|Acute Respiratory Failure|acute respiratory failure
1029969|NCT02976233|Non Invasive Ventilation|non invasive ventilation
1029970|NCT02976233|Ultrasound|ultrasound
1029971|NCT02976233|Diaphragm Thickening|diaphragm thickening
1029972|NCT02976168|Cognitive functioning|cognitive functioning
1029973|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
1029974|NCT02976168|cerebral perfusion|cerebral perfusion
1029975|NCT02976168|head down tilt|head down tilt
1029976|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
1029977|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
1029978|NCT02976142|positive wash cytology|positive wash cytology
1029979|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
1029980|NCT02976116|Fruquintinib|fruquintinib
1029981|NCT02976116|NSCLC|nsclc
1029982|NCT02976116|1st line|1st line
1029983|NCT02976103|recovery|recovery
1029984|NCT02976103|pain|pain
1029985|NCT02976103|surgical drains|surgical drains
1029986|NCT02976077|social cognition|social cognition
1029987|NCT02976077|cognitive remediation|cognitive remediation
1029988|NCT02976077|emotions|emotions
1029989|NCT02976077|theory of mind|theory of mind
1029990|NCT02976077|attributions|attributions
1029991|NCT02976077|social perception|social perception
1029992|NCT02976064|physical activity|physical activity
1029993|NCT02976064|lifestyle|lifestyle
1029994|NCT02976064|adaptive case management|adaptive case management
1029995|NCT02976064|telemedicine|telemedicine
1029996|NCT02976064|integrated care|integrated care
1029997|NCT02976064|collaborative self-management|collaborative self-management
1029998|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
1029999|NCT02976038|Stealth|stealth
1030000|NCT02976038|elamipretide|elamipretide
1030001|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1030002|NCT02976012|Aflibercept|aflibercept
1030003|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
1030004|NCT02975986|Nephrolithiasis, Uric Acid|nephrolithiasis, uric acid
1030005|NCT02975986|Fatty Acid|fatty acid
1030006|NCT02975973|tDCS|tdcs
1030007|NCT02975973|cognitive control|cognitive control
1030008|NCT02975973|EEG|eeg
1030009|NCT02975973|gamma oscillations|gamma oscillations
1030010|NCT02975960|systemic sclerosis|systemic sclerosis
1030011|NCT02975960|adipose derived stem cell|adipose derived stem cell
1030012|NCT02975960|stromal vascular fraction|stromal vascular fraction
1030013|NCT02975960|digital ulcer|digital ulcer
1030014|NCT02975960|gangrene|gangrene
1030015|NCT02975934|CRPC|crpc
1030016|NCT02975934|PARP inhibitor|parp inhibitor
1030017|NCT02975934|PARPi|parpi
1030018|NCT02975934|BRCA|brca
1030019|NCT02975934|ATM|atm
1030020|NCT02975934|HRD|hrd
1030021|NCT02975934|TRITON|triton
1030022|NCT02975934|homologous recombination|homologous recombination
1030023|NCT02975934|DNA repair|dna repair
1030024|NCT02975934|DNA defect|dna defect
1030025|NCT02975934|DNA anomaly|dna anomaly
1030026|NCT02975934|germline|germline
1030027|NCT02975934|somatic|somatic
1030028|NCT02975921|Pleural Effusion|pleural effusion
1030029|NCT02975921|Thoracentesis|thoracentesis
1030030|NCT02975921|Pleural Cavity|pleural cavity
1030031|NCT02975921|Pleurodesis|pleurodesis
1030032|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
1030033|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1030034|NCT02975908|epidemiology|epidemiology
1030035|NCT02975908|clinical features|clinical features
1030036|NCT02975908|management|management
1030037|NCT02975908|prognosis|prognosis
1030038|NCT02975869|Leukemia|leukemia
1030039|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
1030040|NCT02975856|Anthocyanins|anthocyanins
1030041|NCT02975856|Bioavailability|bioavailability
1030042|NCT02975856|Flavonoids|flavonoids
1030043|NCT02975856|Port wine|port wine
1030044|NCT02975856|Red wine|red wine
1030045|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
1030046|NCT02975804|cerebral palsy|cerebral palsy
1030047|NCT02975804|video games|video games
1030048|NCT02975804|postural control|postural control
1030049|NCT02975804|balance|balance
1030050|NCT02975804|children|children
1030051|NCT02975791|Airway Obstruction|airway obstruction
1030052|NCT02975778|80 years old|80 years old
1030053|NCT02975765|corticotomy|corticotomy
1030054|NCT02975765|minimally invasive|minimally invasive
1030055|NCT02975765|piezosurgery|piezosurgery
1030056|NCT02975765|piezocision|piezocision
1030057|NCT02975765|pain|pain
1030058|NCT02975765|discomfort|discomfort
1030059|NCT02975739|Intratumoral|intratumoral
1030060|NCT02975739|Tongue|tongue
1030061|NCT02975739|Microspheres|microspheres
1030062|NCT02975726|Liver Cirrhosis|liver cirrhosis
1030063|NCT02975726|Refractory ascites|refractory ascites
1030064|NCT02975726|PD catheter|pd catheter
1030065|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
1030066|NCT02975700|PLX3397|plx3397
1030067|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
1030068|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
1030069|NCT02975700|Developmental Phase I/II|developmental phase i/ii
1030070|NCT02975687|Acute|acute
1030071|NCT02975687|Leukemia|leukemia
1030072|NCT02975687|Lymphoid|lymphoid
1030073|NCT02975687|CD19|cd19
1030074|NCT02975687|Refractory|refractory
1030075|NCT02975635|Patients' Preferences|patients' preferences
1030076|NCT02975596|educational intervention|educational intervention
1030077|NCT02975583|Atherosclerosis|atherosclerosis
1030078|NCT02975557|Brimonidine|brimonidine
1030079|NCT02975557|Dry Eye|dry eye
1030080|NCT02975557|oGVHD|ogvhd
1030081|NCT02975557|MGD|mgd
1030082|NCT02975544|social and emotional competence|social and emotional competence
1030083|NCT02975544|healthy lifestyles|healthy lifestyles
1030084|NCT02975544|children|children
1030085|NCT02975544|educational programme|educational programme
1030086|NCT02975531|Pompage|pompage
1030087|NCT02975479|Hay fever|hay fever
1030088|NCT02975479|Pollen allergy|pollen allergy
1030089|NCT02975479|Allergic rhinitis|allergic rhinitis
1030090|NCT02975440|Vilaprisan|vilaprisan
1030091|NCT02975440|PK|pk
1030092|NCT02975440|rifampicin|rifampicin
1030093|NCT02975440|midazolam,|midazolam,
1030094|NCT02975440|CYP3A4 induction|cyp3a4 induction
1030095|NCT02975440|drug-drug interaction|drug-drug interaction
1030096|NCT02975427|Diet|diet
1030097|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
1030098|NCT02975427|Anthropometry|anthropometry
1030099|NCT02975427|Insulin resistance|insulin resistance
1030100|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
1030101|NCT02975349|M2951|m2951
1030102|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1030103|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
1030104|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
1030105|NCT02975336|M2951|m2951
1030106|NCT02975336|Placebo|placebo
1030107|NCT02975336|Dose response|dose response
1030108|NCT02975336|Oral Corticosteroids|oral corticosteroids
1030109|NCT02975336|Safety|safety
1030110|NCT02975336|Efficacy|efficacy
1030111|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
1030112|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
1030113|NCT02975323|liver disease|liver disease
1030114|NCT02975323|US Doppler waveform|us doppler waveform
1030115|NCT02975323|Cirrhosis|cirrhosis
1030116|NCT02975297|smoking|smoking
1030117|NCT02975297|pre-diabetes|pre-diabetes
1030118|NCT02975297|overweight|overweight
1030119|NCT02975297|exenatide|exenatide
1030120|NCT02975297|GLP-1 agonists|glp-1 agonists
1030121|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
1030122|NCT02975284|long term|long term
1030123|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
1030124|NCT02975258|HIV|hiv
1030127|NCT02975258|Lung disease|lung disease
1030128|NCT02975258|Weight|weight
1030129|NCT02975258|Fat|fat
1030130|NCT02975258|Obese|obese
1030131|NCT02975245|Male infertility|male infertility
1030132|NCT02975245|Germ cells|germ cells
1030133|NCT02975245|Chemotherapy|chemotherapy
1030134|NCT02975245|Sperm|sperm
1030135|NCT02975232|nutrition disparities|nutrition disparities
1030136|NCT02975232|SNAP population|snap population
1030137|NCT02975232|behavioral economics|behavioral economics
1030138|NCT02975232|retail setting|retail setting
1030139|NCT02975232|point of purchase education|point of purchase education
1030140|NCT02975232|pediatric obesity|pediatric obesity
1030141|NCT02975232|rural population|rural population
1030639|NCT02972008|stroke|stroke
1030142|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
1030143|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
1030144|NCT02975193|Parkinsons Disease|parkinsons disease
1030145|NCT02975193|Cognition|cognition
1030146|NCT02975167|Induction of labor|induction of labor
1030147|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
1030148|NCT02975167|patient satisfaction|patient satisfaction
1030149|NCT02975167|outpatient|outpatient
1030150|NCT02975167|cost savings|cost savings
1030151|NCT02975154|osteoarthritis|osteoarthritis
1030152|NCT02975154|microcurrent|microcurrent
1030153|NCT02975154|knee|knee
1030154|NCT02975154|electrotherapy|electrotherapy
1030155|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
1030156|NCT02975141|Afatinib|afatinib
1030157|NCT02975141|Gemcitabine|gemcitabine
1030158|NCT02975141|nab-paclitaxel|nab-paclitaxel
1030159|NCT02975141|pancreatic cancer|pancreatic cancer
1030160|NCT02975128|Minimal invasive|minimal invasive
1030161|NCT02975128|Biopsy|biopsy
1030162|NCT02975089|Frailty|frailty
1030163|NCT02975089|nutrition education|nutrition education
1030164|NCT02975089|designed dishware|designed dishware
1030165|NCT02975089|balanced diet|balanced diet
1030166|NCT02975089|multiple dietary components|multiple dietary components
1030167|NCT02975076|Sanchitongshu|sanchitongshu
1030168|NCT02975076|Acute Minor Stroke|acute minor stroke
1030169|NCT02975076|Transient Ischemic Attack|transient ischemic attack
1030170|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
1030171|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
1030172|NCT02975024|wound healing|wound healing
1030173|NCT02975024|microcirculation|microcirculation
1030174|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
1030175|NCT02975024|Mucograft|mucograft
1030176|NCT02975024|strip gingival graft|strip gingival graft
1030177|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
1030178|NCT02975011|Patient Satisfaction|patient satisfaction
1030179|NCT02975011|Numeric Rating Scale|numeric rating scale
1030180|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1030181|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
1030182|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
1030183|NCT02974998|Substance Abuse|substance abuse
1030184|NCT02974998|Gender Based Violence|gender based violence
1030185|NCT02974998|Gang Violence|gang violence
1030186|NCT02974998|Victimization|victimization
1030187|NCT02974998|Linkage to Care|linkage to care
1030188|NCT02974998|Sexual Risk|sexual risk
1030189|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
1030190|NCT02974998|Young Women|young women
1030191|NCT02974985|Facelift|facelift
1030192|NCT02974985|HA Filler|ha filler
1030193|NCT02974985|Hyaluronic acid|hyaluronic acid
1030194|NCT02974985|Facial Rejuvenation|facial rejuvenation
1030195|NCT02974985|Aging Face|aging face
1030196|NCT02974985|WIZDOM|wizdom
1030197|NCT02974985|Midface lift|midface lift
1030198|NCT02974985|Midface augmentation|midface augmentation
1030199|NCT02974933|apatinib|apatinib
1030200|NCT02974933|pemetrexed|pemetrexed
1030201|NCT02974933|NSCLC|nsclc
1030202|NCT02974907|Dry Eye Syndrome|dry eye syndrome
1030203|NCT02974907|Dry Eye|dry eye
1030204|NCT02974907|DES|des
1030205|NCT02974868|Phase 2|phase 2
1030206|NCT02974868|randomized|randomized
1030207|NCT02974868|double-blind|double-blind
1030208|NCT02974868|placebo|placebo
1030209|NCT02974868|alopecia areata|alopecia areata
1030210|NCT02974868|safety|safety
1030211|NCT02974868|efficacy|efficacy
1030212|NCT02974868|JAK|jak
1030213|NCT02974868|janus kinase|janus kinase
1030214|NCT02974868|moderate|moderate
1030215|NCT02974868|severe|severe
1030216|NCT02974855|hemophilia|hemophilia
1030217|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
1030218|NCT02974816|Glooko|glooko
1030219|NCT02974816|Mobile health application|mobile health application
1030220|NCT02974816|Insulin treated|insulin treated
1030221|NCT02974816|Type 2 Diabetes|type 2 diabetes
1030222|NCT02974816|Remote patient monitoring|remote patient monitoring
1030223|NCT02974816|Certified diabetes educator|certified diabetes educator
1030224|NCT02974816|mHealth Advantage|mhealth advantage
1030225|NCT02974816|Population health|population health
1030226|NCT02974790|echocardiography|echocardiography
1030227|NCT02974790|training|training
1030228|NCT02974790|emergency department|emergency department
1030229|NCT02974790|circulatory failure|circulatory failure
1030230|NCT02974751|Aquablation|aquablation
1030231|NCT02974751|AQUABEAM|aquabeam
1030232|NCT02974751|BPH|bph
1030233|NCT02974751|LUTS|luts
1030234|NCT02974725|NSCLC|nsclc
1030235|NCT02974725|KRAS|kras
1030236|NCT02974725|BRAF|braf
1030237|NCT02974725|LXH254|lxh254
1030238|NCT02974725|LTT462|ltt462
1030239|NCT02974725|Trametinib|trametinib
1030240|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1030241|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
1030242|NCT02974725|lung cancer|lung cancer
1030243|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
1030640|NCT02972008|Epigenetic|epigenetic
1030244|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
1030245|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
1030246|NCT02974725|Non small cell lung cancer|non small cell lung cancer
1030247|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
1030248|NCT02974725|Large cell lung cancer|large cell lung cancer
1030249|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
1030250|NCT02974712|Arterial blood gases|arterial blood gases
1030252|NCT02974712|HR|hr
1030253|NCT02974673|Spinal Cord Injury|spinal cord injury
1030254|NCT02974673|Genito sexuals disorders|genito sexuals disorders
1030255|NCT02974673|Ejaculatory test|ejaculatory test
1030256|NCT02974647|Ruxolitinib|ruxolitinib
1030257|NCT02974647|T or NK Cell|t or nk cell
1030258|NCT02974647|Relapsed|relapsed
1030259|NCT02974647|Refractory|refractory
1030260|NCT02974634|Ileostomy|ileostomy
1030261|NCT02974608|Placental|placental
1030262|NCT02974608|Fetal Loss|fetal loss
1030263|NCT02974608|Observational|observational
1030264|NCT02974608|Antenatal|antenatal
1030265|NCT02974608|Infection|infection
1030266|NCT02974608|Malaria|malaria
1030267|NCT02974595|Autoinflammation|autoinflammation
1030268|NCT02974595|Pediatric Syndromes|pediatric syndromes
1030269|NCT02974595|Immune Dysregulation|immune dysregulation
1030270|NCT02974595|IL-1 Mediated Diseases|il-1 mediated diseases
1030271|NCT02974595|Interferonopathies|interferonopathies
1030272|NCT02974582|Marketing|marketing
1030273|NCT02974582|Smoking|smoking
1030274|NCT02974582|Cigarette|cigarette
1030275|NCT02974582|Young Adult|young adult
1030276|NCT02974582|Socioeconomic Status|socioeconomic status
1030277|NCT02974569|adolescents|adolescents
1030278|NCT02974569|young adults|young adults
1030279|NCT02974543|tinnitus|tinnitus
1030280|NCT02974517|time-lapes|time-lapes
1030281|NCT02974517|IVF/ICSI|ivf/icsi
1030282|NCT02974517|pregnancy outcome|pregnancy outcome
1030283|NCT02974491|hemodialysis|hemodialysis
1030284|NCT02974491|diabetes mellitus|diabetes mellitus
1030285|NCT02974491|apple juice|apple juice
1030286|NCT02974491|potassium|potassium
1030287|NCT02974478|orange juice consumption|orange juice consumption
1030288|NCT02974478|glucose homeostasis|glucose homeostasis
1030289|NCT02974478|antioxidative status|antioxidative status
1030290|NCT02974465|Brain injuries|brain injuries
1030291|NCT02974465|upper extremity|upper extremity
1030292|NCT02974465|biofeedback|biofeedback
1030293|NCT02974465|electromyography|electromyography
1030294|NCT02974465|recovery of function|recovery of function
1030295|NCT02974400|internet-based intervention|internet-based intervention
1030296|NCT02974400|e-mental health|e-mental health
1030297|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
1030298|NCT02974322|Crohn's Disease|crohn's disease
1030299|NCT02974322|GED-0301|ged-0301
1030300|NCT02974322|Mongersen|mongersen
1030301|NCT02974322|Adolescent|adolescent
1030302|NCT02974322|Pediatric|pediatric
1030303|NCT02974322|Children|children
1030304|NCT02974309|Youth|youth
1030305|NCT02974309|Diabetes Management|diabetes management
1030306|NCT02974309|Sleep|sleep
1030307|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
1030308|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
1030309|NCT02974257|cardiac arrest|cardiac arrest
1030310|NCT02974257|thiamine|thiamine
1030311|NCT02974257|oxygen consumption|oxygen consumption
1030312|NCT02974257|lactate|lactate
1030313|NCT02974257|shock|shock
1030314|NCT02974244|Type 2 diabetes|type 2 diabetes
1030315|NCT02974192|Ischemic stroke|ischemic stroke
1030316|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
1030317|NCT02974192|Neopetrin|neopetrin
1030318|NCT02974192|stroke risk factors|stroke risk factors
1030319|NCT02974192|functional outcome|functional outcome
1030320|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
1030321|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1030322|NCT02974166|Rigid Splint|rigid splint
1030323|NCT02974166|Speech Therapy|speech therapy
1030324|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
1030325|NCT02974127|radiosurgery|radiosurgery
1030326|NCT02974127|large meningioma|large meningioma
1030327|NCT02974127|critical site|critical site
1030328|NCT02974127|multisession radiosurgery|multisession radiosurgery
1030329|NCT02974101|Spinal cord stimulation|spinal cord stimulation
1030330|NCT02974101|AdaptiveStim|adaptivestim
1030331|NCT02974062|Position sense|position sense
1030332|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
1030333|NCT02974049|Ivermectin|ivermectin
1030334|NCT02974049|Albendazole|albendazole
1030335|NCT02974049|Diethylcarbamazine|diethylcarbamazine
1030336|NCT02974036|Patient education|patient education
1030337|NCT02974036|Osteoarthritis|osteoarthritis
1030338|NCT02974036|Primary health care|primary health care
1030339|NCT02974010|d-cycloserine|d-cycloserine
1030340|NCT02974010|lurasidone|lurasidone
1030341|NCT02974010|ketamine|ketamine
1030342|NCT02974010|randomized controlled trial|randomized controlled trial
1030343|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
1030344|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
1030348|NCT02973984|Atrial Fibrillation|atrial fibrillation
1030349|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
1030354|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
1030355|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
1030356|NCT02973945|The Venturi Mask|the venturi mask
1030357|NCT02973945|Exercise capacity|exercise capacity
1030358|NCT02973945|Aerobic capacity|aerobic capacity
1030360|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
1030361|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
1030362|NCT02973932|internet-based|internet-based
1030363|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
1030364|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
1030365|NCT02973880|Phaco-emulsification|phaco-emulsification
1030366|NCT02973880|Cataract extraction|cataract extraction
1030367|NCT02973867|Bone mineral density|bone mineral density
1030368|NCT02973867|Myokines|myokines
1030369|NCT02973867|Adipokines|adipokines
1030370|NCT02973815|family meals|family meals
1030371|NCT02973815|home food availability|home food availability
1030372|NCT02973802|Graves Disease|graves disease
1030373|NCT02973802|Phase 1|phase 1
1030374|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
1030375|NCT02973789|NSCLC|nsclc
1030376|NCT02973789|Treatment|treatment
1030377|NCT02973789|Minimal Toxicity|minimal toxicity
1030378|NCT02973789|TTFields|ttfields
1030379|NCT02973789|TTF|ttf
1030380|NCT02973789|Tumor Treating Fields|tumor treating fields
1030381|NCT02973789|Novocure|novocure
1030382|NCT02973789|Docetaxel|docetaxel
1030383|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
1030384|NCT02973789|PD-L1 inhibitor|pd-l1 inhibitor
1030385|NCT02973789|Immune checkpoint inhibitor|immune checkpoint inhibitor
1030386|NCT02973750|high-grade serous cancer|high-grade serous cancer
1030387|NCT02973750|stage III cancer|stage iii cancer
1030388|NCT02973750|stage IV cancer|stage iv cancer
1030389|NCT02973724|Extubation|extubation
1030390|NCT02973724|Remifentanil|remifentanil
1030391|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
1030392|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1030393|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
1030394|NCT02973685|BCLC A/B|bclc a/b
1030395|NCT02973672|Fluorescence|fluorescence
1030396|NCT02973672|Surgery|surgery
1030397|NCT02973672|Cancer|cancer
1030398|NCT02973672|SGM-101|sgm-101
1030399|NCT02973672|Near Infrared|near infrared
1030400|NCT02973672|Immunophotodetection|immunophotodetection
1030401|NCT02973646|chronic hepatitis b|chronic hepatitis b
1030402|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
1030403|NCT02973646|interferon gene mutation|interferon gene mutation
1030404|NCT02973646|interferon receptor|interferon receptor
1030405|NCT02973633|Heart Failure|heart failure
1030406|NCT02973633|Remodeling|remodeling
1030407|NCT02973633|Myocardial Infarction|myocardial infarction
1030408|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
1030409|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
1030410|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
1030411|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
1030412|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
1030413|NCT02973594|HCN4 inhibition|hcn4 inhibition
1030414|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
1030415|NCT02973594|gene expression|gene expression
1030416|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
1030417|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
1030418|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
1030419|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
1030420|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
1030421|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
1030422|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
1030423|NCT02973581|Postoperative nausea nad vomiting (PONV)|postoperative nausea nad vomiting (ponv)
1030424|NCT02973581|paracetamol|paracetamol
1030425|NCT02973581|metamizol|metamizol
1030426|NCT02973542|IBS|ibs
1030427|NCT02973542|Ethosuximide|ethosuximide
1030428|NCT02973542|Pain|pain
1030429|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
1030430|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1030431|NCT02973529|Bifurcation lesion|bifurcation lesion
1030432|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
1030435|NCT02973503|Non Severe Fibrosis|non severe fibrosis
1030436|NCT02973503|Treatment Naïve|treatment naïve
1030437|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
1030438|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
1030441|NCT02973438|Obesity|obesity
1030442|NCT02973438|Insulin Resistance|insulin resistance
1030443|NCT02973438|Intermittent hypoxia|intermittent hypoxia
1030444|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
1030446|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
1030447|NCT02973399|Hsp90|hsp90
1030448|NCT02973399|Ibrutinib|ibrutinib
1030449|NCT02973386|Local advanced|local advanced
1030450|NCT02973386|High Risk|high risk
1030451|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1030452|NCT02973373|MRI|mri
1030453|NCT02973373|Chest|chest
1030454|NCT02973373|Apnea|apnea
1030455|NCT02973347|Enteral Feeding|enteral feeding
1030456|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1030457|NCT02973347|Mechanical Ventilation|mechanical ventilation
1030458|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
1030459|NCT02973347|Critical Illness|critical illness
1030460|NCT02973334|sweeteners|sweeteners
1030461|NCT02973334|sugar|sugar
1030462|NCT02973334|stress response|stress response
1030463|NCT02973295|NAFLD;|nafld;
1030464|NCT02973295|Fibroscan|fibroscan
1030465|NCT02973295|Silymarin|silymarin
1030466|NCT02973256|Meningioma grade II|meningioma grade ii
1030467|NCT02973256|Meningioma grade III|meningioma grade iii
1030468|NCT02973243|early warning scoring|early warning scoring
1030469|NCT02973243|respiration rate|respiration rate
1030470|NCT02973243|acute care teams|acute care teams
1030471|NCT02973243|NEWS|news
1030472|NCT02973243|CREWS|crews
1030473|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
1030474|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1030475|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
1030476|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
1030477|NCT02973217|Laser Coagulation|laser coagulation
1030478|NCT02973217|Laser Therapy|laser therapy
1030479|NCT02973204|tumor DNA|tumor dna
1030480|NCT02973204|circulating tumor cells|circulating tumor cells
1030481|NCT02973204|biopsy|biopsy
1030482|NCT02973191|Leukemia|leukemia
1030483|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
1030484|NCT02973191|JCAR015|jcar015
1030485|NCT02973152|Type I Thyroplasty|type i thyroplasty
1030486|NCT02973152|Reinnervation|reinnervation
1030487|NCT02973113|Nivolumab|nivolumab
1030488|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
1030489|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1030490|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
1030491|NCT02973113|EBV-specific T Cells|ebv-specific t cells
1030492|NCT02973074|iron deficiency|iron deficiency
1030493|NCT02973074|patient blood management|patient blood management
1030494|NCT02973074|anemia|anemia
1030498|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
1030499|NCT02973009|bariatric surgery|bariatric surgery
1030500|NCT02973009|laparoscopy|laparoscopy
1030501|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
1030502|NCT02972983|Staphylococcus aureus|staphylococcus aureus
1030503|NCT02972983|Bacteremia|bacteremia
1030504|NCT02972983|Daptomycin|daptomycin
1030505|NCT02972957|intranasal|intranasal
1030506|NCT02972957|flu vaccine|flu vaccine
1030507|NCT02972957|Gambian children|gambian children
1030508|NCT02972931|HIV infection|hiv infection
1030509|NCT02972931|low HIV reservoir|low hiv reservoir
1030510|NCT02972931|functional cure|functional cure
1030511|NCT02972905|pharmacokinetics|pharmacokinetics
1030512|NCT02972905|GSK2269557|gsk2269557
1030513|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
1030514|NCT02972905|tolerability|tolerability
1030515|NCT02972905|safety|safety
1030516|NCT02972905|ELLIPTA|ellipta
1030517|NCT02972879|trigger finger|trigger finger
1030518|NCT02972879|Therapeutic Modalities|therapeutic modalities
1030519|NCT02972879|Corticosteroid Injection|corticosteroid injection
1030520|NCT02972879|non-surgical treatment|non-surgical treatment
1030521|NCT02972879|physical therapy|physical therapy
1030522|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1030524|NCT02972840|ACP-196|acp-196
1030525|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
1030526|NCT02972840|acalabrutinib|acalabrutinib
1030527|NCT02972840|ACE-LY-308|ace-ly-308
1030528|NCT02972840|Treatment naive|treatment naive
1030529|NCT02972840|Lymphoma|lymphoma
1030530|NCT02972840|non-Hodgkins|non-hodgkins
1030531|NCT02972814|Troponin|troponin
1030532|NCT02972814|Point of care test|point of care test
1030533|NCT02972814|myocardial infarction|myocardial infarction
1030534|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
1030535|NCT02972801|Testis|testis
1030536|NCT02972801|Fertility|fertility
1030537|NCT02972801|Infertility|infertility
1030538|NCT02972801|Oncofertility|oncofertility
1030641|NCT02971969|gene therapy|gene therapy
1030539|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
1030540|NCT02972736|Radiation dose|radiation dose
1030541|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
1030542|NCT02972736|Coronary|coronary
1030543|NCT02972736|Interventional radiology|interventional radiology
1030544|NCT02972736|Electrophysiology|electrophysiology
1030545|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
1030546|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
1030547|NCT02972684|Hemorrhage|hemorrhage
1030548|NCT02972684|blood transfusion|blood transfusion
1030549|NCT02972684|Point-of-care test|point-of-care test
1030550|NCT02972684|health economics|health economics
1030551|NCT02972671|MiStent|mistent
1030552|NCT02972658|Alzheimer's Disease|alzheimer's disease
1030553|NCT02972658|Dementia|dementia
1030554|NCT02972658|Brain Diseases|brain diseases
1030555|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
1030556|NCT02972658|Central Nervous System Diseases|central nervous system diseases
1030557|NCT02972658|Nervous System Diseases|nervous system diseases
1030558|NCT02972658|Mental Disorders|mental disorders
1030559|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1030560|NCT02972658|Tauopathies|tauopathies
1030561|NCT02972658|Memory|memory
1030562|NCT02972658|Amyloid|amyloid
1030563|NCT02972632|Drug Therapy|drug therapy
1030564|NCT02972619|Blood Pressure|blood pressure
1030565|NCT02972619|Lipids|lipids
1030566|NCT02972619|Cardiovascular|cardiovascular
1030567|NCT02972619|Health Services|health services
1030568|NCT02972619|Hypertension|hypertension
1030569|NCT02972606|HIV|hiv
1030570|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
1030571|NCT02972606|Chronic Pain|chronic pain
1030572|NCT02972606|Qualitative Research|qualitative research
1030573|NCT02972567|probiotics|probiotics
1030574|NCT02972567|metabolic syndrome|metabolic syndrome
1030575|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1030576|NCT02972528|DFU|dfu
1030577|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
1030578|NCT02972528|Diabetes|diabetes
1030579|NCT02972528|Platelet Rich Plasma|platelet rich plasma
1030580|NCT02972515|Smoking|smoking
1030581|NCT02972515|Smoking cessation|smoking cessation
1030582|NCT02972515|Multiple behaviors|multiple behaviors
1030583|NCT02972515|mHealth|mhealth
1030584|NCT02972515|Mobile Application|mobile application
1030585|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
1030586|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
1030587|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1030588|NCT02972463|Gastrointestinal|gastrointestinal
1030589|NCT02972463|Microbiome|microbiome
1030590|NCT02972463|Inflammation|inflammation
1030591|NCT02972437|GAS in oral cavity|gas in oral cavity
1030592|NCT02972424|pelvic fracture|pelvic fracture
1030593|NCT02972424|healing|healing
1030594|NCT02972424|teriparatide|teriparatide
1030595|NCT02972398|treatment resistant depression|treatment resistant depression
1030596|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
1030597|NCT02972398|inflammation mediators|inflammation mediators
1030598|NCT02972398|oxidative stress|oxidative stress
1030599|NCT02972398|brain imaging|brain imaging
1030600|NCT02972385|warfarin|warfarin
1030601|NCT02972385|blood clotting|blood clotting
1030602|NCT02972372|esophageal cancer|esophageal cancer
1030603|NCT02972372|chemoradiation|chemoradiation
1030604|NCT02972372|esophagectomy|esophagectomy
1030605|NCT02972359|Neridronic Acid|neridronic acid
1030606|NCT02972359|Neridronate|neridronate
1030607|NCT02972359|CRPS|crps
1030608|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
1030609|NCT02972294|iron isomaltoside|iron isomaltoside
1030610|NCT02972294|tranexamic acid|tranexamic acid
1030611|NCT02972203|Mindfulness|mindfulness
1030612|NCT02972203|primary care|primary care
1030613|NCT02972203|self-control|self-control
1030614|NCT02972203|self-regulation|self-regulation
1030615|NCT02972203|adherence|adherence
1030616|NCT02972177|Lung cancer|lung cancer
1030617|NCT02972177|Transbronchial ablation|transbronchial ablation
1030618|NCT02972177|Radiofrequency ablation|radiofrequency ablation
1030619|NCT02972177|Microwave ablation|microwave ablation
1030620|NCT02972164|Childhood obesity|childhood obesity
1030621|NCT02972164|Lifestyle|lifestyle
1030622|NCT02972164|Prevention|prevention
1030623|NCT02972164|Intervention|intervention
1030624|NCT02972164|Behavioural psychology|behavioural psychology
1030625|NCT02972138|Sickle-cells Disease|sickle-cells disease
1030626|NCT02972138|bisphosphonates|bisphosphonates
1030627|NCT02972138|Vitamine D|vitamine d
1030628|NCT02972125|Lacosamide|lacosamide
1030629|NCT02972125|Bioequivalence|bioequivalence
1030630|NCT02972125|Dry Syrup|dry syrup
1030631|NCT02972073|Low back pain|low back pain
1030632|NCT02972073|Neuromuscular control|neuromuscular control
1030633|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
1030634|NCT02972047|Reflux|reflux
1030635|NCT02972021|respiratory insufficiency|respiratory insufficiency
1030636|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
1030637|NCT02972008|Aortic stenosis|aortic stenosis
1030638|NCT02972008|Transaortic valve replacement|transaortic valve replacement
1030645|NCT02971917|Image improvements|image improvements
1030646|NCT02971917|Image Reconstruction|image reconstruction
1030653|NCT02971904|human milk analyzer|human milk analyzer
1030654|NCT02971904|neonatology|neonatology
1030655|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
1030656|NCT02971904|low birth weight|low birth weight
1030657|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
1030658|NCT02971865|Chiropractic|chiropractic
1030659|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1030660|NCT02971865|Primary care shared visit|primary care shared visit
1030661|NCT02971852|Hypnosis|hypnosis
1030662|NCT02971852|Anesthesia|anesthesia
1030663|NCT02971852|Suggestion|suggestion
1030664|NCT02971852|Thermography|thermography
1030665|NCT02971826|Stroke|stroke
1030666|NCT02971826|thrombectomy|thrombectomy
1030667|NCT02971826|REVIVETM SE|revivetm se
1030668|NCT02971826|MRI|mri
1030669|NCT02971826|Computed Tomography|computed tomography
1030670|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
1030671|NCT02971813|social media|social media
1030672|NCT02971813|adherence|adherence
1030673|NCT02971813|motivation|motivation
1030674|NCT02971800|sodium fluorescein|sodium fluorescein
1030675|NCT02971800|ureteral efflux|ureteral efflux
1030676|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
1030677|NCT02971774|stroke|stroke
1030678|NCT02971774|botulinum toxin injection|botulinum toxin injection
1030679|NCT02971774|daily life|daily life
1030680|NCT02971748|hormone receptor-positive localized inflammatory breast cancer|hormone receptor-positive localized inflammatory breast cancer
1030681|NCT02971748|Hormonal therapy|hormonal therapy
1030682|NCT02971748|IBC|ibc
1030683|NCT02971748|standard adjuvant hormonal therapy|standard adjuvant hormonal therapy
1030684|NCT02971748|maintenance therapy|maintenance therapy
1030685|NCT02971748|immune related biomarkers|immune related biomarkers
1030686|NCT02971748|PD-L1 expression|pd-l1 expression
1030687|NCT02971748|HR positive|hr positive
1030688|NCT02971748|HR-positive localized IBC|hr-positive localized ibc
1030689|NCT02971735|cognitive style|cognitive style
1030690|NCT02971735|e-learning|e-learning
1030691|NCT02971735|mobile technology|mobile technology
1030692|NCT02971735|randomized controlled trial|randomized controlled trial
1030693|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
1030694|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
1030695|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
1030696|NCT02971657|Antibiotic resistance|antibiotic resistance
1030697|NCT02971657|Orthopedic device related infections|orthopedic device related infections
1030698|NCT02971657|Phenotypic characterization|phenotypic characterization
1030699|NCT02971631|Dumping syndrome|dumping syndrome
1030700|NCT02971631|Gastrectomy|gastrectomy
1030701|NCT02971631|GLP-1|glp-1
1030702|NCT02971631|Insulin|insulin
1030707|NCT02971579|ERCP|ercp
1030708|NCT02971579|biliary diseases|biliary diseases
1030709|NCT02971579|Pancreatic diseases|pancreatic diseases
1030710|NCT02971579|outcome|outcome
1030711|NCT02971579|Quality|quality
1030712|NCT02971579|Training|training
1030713|NCT02971566|feeding intolerance|feeding intolerance
1030714|NCT02971566|preterm infants|preterm infants
1030715|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
1030716|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
1030717|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
1030718|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
1030719|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
1030720|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
1030721|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
1030722|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
1030723|NCT02971488|Hepatitis C|hepatitis c
1030724|NCT02971488|PWID|pwid
1030725|NCT02971488|Linkage-to-care|linkage-to-care
1030726|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
1030727|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
1030728|NCT02971475|chronic pancreatitis|chronic pancreatitis
1030729|NCT02971475|pain relief|pain relief
1030730|NCT02971462|stroke|stroke
1030731|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
1030732|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
1030733|NCT02971449|Village Healthcare Team|village healthcare team
1030734|NCT02971449|mHealth|mhealth
1030735|NCT02971449|Telemedicine|telemedicine
1030736|NCT02971423|infection|infection
1030737|NCT02971423|gram-negative bacterium|gram-negative bacterium
1030844|NCT02971072|time|time
1030738|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
1030739|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
1030740|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
1030741|NCT02971345|stent|stent
1030742|NCT02971345|chemoembolization|chemoembolization
1030743|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
1030744|NCT02971306|alcoholic liver disease|alcoholic liver disease
1030745|NCT02971306|jaundice|jaundice
1030746|NCT02971306|ascites|ascites
1030747|NCT02971306|regeneration|regeneration
1030748|NCT02971293|AZD8871|azd8871
1030749|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
1030750|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
1030751|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
1030752|NCT02971293|pharmacokinetics|pharmacokinetics
1030753|NCT02971293|safety|safety
1030754|NCT02971293|tolerability|tolerability
1030755|NCT02971293|efficacy|efficacy
1030756|NCT02971293|Phase IIa|phase iia
1030757|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
1030758|NCT02971267|heart failure|heart failure
1030759|NCT02971267|cardiomyopathy|cardiomyopathy
1030760|NCT02971267|myocarditis|myocarditis
1030761|NCT02971254|cognitive functions|cognitive functions
1030762|NCT02971254|anaesthesia recovery|anaesthesia recovery
1030763|NCT02971254|sevoflurane|sevoflurane
1030764|NCT02971254|desflurane|desflurane
1030765|NCT02971241|Integeneration|integeneration
1030766|NCT02971241|Mobile technology|mobile technology
1030767|NCT02971241|Chronic disease management|chronic disease management
1030768|NCT02971241|Diabetes self-management|diabetes self-management
1030769|NCT02971228|glucagon|glucagon
1030770|NCT02971228|T1DM|t1dm
1030771|NCT02971228|Bionic Pancreas|bionic pancreas
1030772|NCT02971228|diabetes|diabetes
1030773|NCT02971228|iLet|ilet
1030774|NCT02971228|iPhone|iphone
1030775|NCT02971228|Beta Bionics|beta bionics
1030776|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
1030777|NCT02971228|Glucagon Analog|glucagon analog
1030778|NCT02971202|o-glcnacylation|o-glcnacylation
1030779|NCT02971202|hexosamine|hexosamine
1030780|NCT02971163|Syncope|syncope
1030781|NCT02971163|Shared Decision-Making|shared decision-making
1030782|NCT02971163|Emergency Medicine|emergency medicine
1030783|NCT02971163|Decision Aid|decision aid
1030784|NCT02971137|Smoking|smoking
1030785|NCT02971137|Cigarette Smoking|cigarette smoking
1030786|NCT02971137|Veterans|veterans
1030787|NCT02971137|Tobacco Use|tobacco use
1030788|NCT02971137|Pain|pain
1030789|NCT02971124|Cognitive Performance|cognitive performance
1030790|NCT02971124|Meaningful Play|meaningful play
1030791|NCT02971124|Screening test|screening test
1030792|NCT02971124|Dementia|dementia
1030793|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
1030794|NCT02971085|active surveillance|active surveillance
1030795|NCT02971085|pathologic reclassification|pathologic reclassification
1030796|NCT02971072|address|address
1030797|NCT02971072|atrophic|atrophic
1030798|NCT02971072|base|base
1030799|NCT02971072|clinical|clinical
1030800|NCT02971072|cost|cost
1030801|NCT02971072|data|data
1030802|NCT02971072|disability|disability
1030803|NCT02971072|effectiveness|effectiveness
1030804|NCT02971072|attention|attention
1030805|NCT02971072|biofeedback|biofeedback
1030806|NCT02971072|electrical stimulation|electrical stimulation
1030807|NCT02971072|electromyography|electromyography
1030808|NCT02971072|exercise|exercise
1030809|NCT02971072|exertion|exertion
1030810|NCT02971072|health care service utilization|health care service utilization
1030811|NCT02971072|improved|improved
1030812|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
1030813|NCT02971072|innovation|innovation
1030814|NCT02971072|intervention|intervention
1030815|NCT02971072|knowledge|knowledge
1030816|NCT02971072|local anesthetics|local anesthetics
1030817|NCT02971072|measures|measures
1030818|NCT02971072|modeling|modeling
1030819|NCT02971072|motor|motor
1030820|NCT02971072|motor control|motor control
1030821|NCT02971072|muscle|muscle
1030822|NCT02971072|neuroadaptation|neuroadaptation
1030823|NCT02971072|neurophysiology|neurophysiology
1030824|NCT02971072|novel|novel
1030825|NCT02971072|outcome|outcome
1030826|NCT02971072|outcome measure|outcome measure
1030827|NCT02971072|pain inhibition|pain inhibition
1030828|NCT02971072|patients|patients
1030829|NCT02971072|pattern|pattern
1030830|NCT02971072|programs|programs
1030831|NCT02971072|public health relevance|public health relevance
1030832|NCT02971072|rehabilitation strategy|rehabilitation strategy
1030833|NCT02971072|relating to nervous system|relating to nervous system
1030834|NCT02971072|reporting|reporting
1030835|NCT02971072|research|research
1030836|NCT02971072|rotator cuff|rotator cuff
1030837|NCT02971072|shoulder|shoulder
1030838|NCT02971072|staging|staging
1030839|NCT02971072|strength training|strength training
1030840|NCT02971072|success|success
1030841|NCT02971072|systematic review|systematic review
1030842|NCT02971072|techniques|techniques
1030843|NCT02971072|testing|testing
1030845|NCT02971072|training|training
1030846|NCT02971072|treatment strategy|treatment strategy
1030847|NCT02971072|United States|united states
1030848|NCT02971072|work|work
1030849|NCT02971059|Elderly|elderly
1030850|NCT02971059|Phenylalanine|phenylalanine
1030851|NCT02971059|Healthy|healthy
1030852|NCT02971046|healthy children|healthy children
1030853|NCT02971046|protein|protein
1030854|NCT02971046|glutathione|glutathione
1030855|NCT02971046|protein requirement|protein requirement
1030856|NCT02971033|hepatitis C virus|hepatitis c virus
1030857|NCT02971033|antiviral treatment|antiviral treatment
1030858|NCT02971033|viral entry inhibitor|viral entry inhibitor
1030859|NCT02971033|mathematical modeling|mathematical modeling
1030860|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
1030861|NCT02970994|< 34 weeks|< 34 weeks
1030862|NCT02970981|Monoclonal antibody|monoclonal antibody
1030863|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
1030864|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
1333214|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1030865|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
1030866|NCT02970981|Antigen|antigen
1030867|NCT02970929|Schizophrenia|schizophrenia
1030868|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
1030869|NCT02970916|FOLFIRI|folfiri
1030870|NCT02970916|aflibercept|aflibercept
1030871|NCT02970916|oxaliplatin|oxaliplatin
1030872|NCT02970916|ACE polymorphisms|ace polymorphisms
1030873|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
1030874|NCT02970890|Phototherapy|phototherapy
1030875|NCT02970890|Low-level laser therapy|low-level laser therapy
1030876|NCT02970890|Light-emitting diodes|light-emitting diodes
1030877|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
1030878|NCT02970877|Intestinal microbiome|intestinal microbiome
1030879|NCT02970877|Oral microbiome|oral microbiome
1030880|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
1030881|NCT02970877|Appetite|appetite
1030882|NCT02970877|Metabolome|metabolome
1030883|NCT02970877|Depression|depression
1030884|NCT02970877|Anxiety|anxiety
1030885|NCT02970864|Nerve regeneration|nerve regeneration
1030886|NCT02970864|Peripheral nerve injury|peripheral nerve injury
1030887|NCT02970864|Nerve conduits|nerve conduits
1030888|NCT02970864|Sensory nerve transection|sensory nerve transection
1030889|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
1030890|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
1030891|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
1030892|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
1030893|NCT02970838|Formula diet|formula diet
1030894|NCT02970825|exercise medicine|exercise medicine
1030895|NCT02970825|youth|youth
1030896|NCT02970825|adolescents|adolescents
1030897|NCT02970825|students|students
1030898|NCT02970721|bipolar disorder|bipolar disorder
1030899|NCT02970721|adverse outcomes|adverse outcomes
1030900|NCT02970721|readmission|readmission
1030901|NCT02970721|polytherapy|polytherapy
1030902|NCT02970695|insomnia|insomnia
1030903|NCT02970695|older people|older people
1030904|NCT02970695|auriculotherapy|auriculotherapy
1030905|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
1030906|NCT02970669|Cardiac dysfunction|cardiac dysfunction
1030907|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
1030908|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
1030909|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
1030910|NCT02970669|HF|hf
1030911|NCT02970669|AHF|ahf
1030912|NCT02970669|CHF|chf
1030913|NCT02970669|acute heart failure|acute heart failure
1030914|NCT02970669|chronic heart failure|chronic heart failure
1030915|NCT02970669|congestive heart failure|congestive heart failure
1030916|NCT02970669|congestive cardiac failure|congestive cardiac failure
1030917|NCT02970669|Heart failure|heart failure
1030918|NCT02970669|HReEF|hreef
1030919|NCT02970669|Physical Activity|physical activity
1030920|NCT02970669|Actigraphy|actigraphy
1030921|NCT02970669|Home sleep test|home sleep test
1030922|NCT02970669|wake|wake
1030923|NCT02970643|Olanzapine|olanzapine
1030924|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1030925|NCT02970643|Moderate risk|moderate risk
1030926|NCT02970630|prophylaxis|prophylaxis
1030927|NCT02970591|FODMAPS|fodmaps
1030928|NCT02970591|carbohydrates|carbohydrates
1030929|NCT02970591|metabolomics|metabolomics
1030930|NCT02970591|microbiota|microbiota
1030931|NCT02970565|Family Nurture Intervention|family nurture intervention
1030932|NCT02970565|Martha G. Welch MD|martha g. welch md
1030933|NCT02970565|Randomized Control Trial|randomized control trial
1030934|NCT02970565|Pre-school Intervention|pre-school intervention
1030935|NCT02970565|Preschool Intervention|preschool intervention
1030936|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
1030937|NCT02970565|Emotional Connection|emotional connection
1030938|NCT02970565|Co-regulation|co-regulation
1030939|NCT02970552|PreTerm Birth|preterm birth
1030941|NCT02970552|Vaginal Progesterone|vaginal progesterone
1030942|NCT02970552|ART|art
1030943|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
1030944|NCT02970513|Escherichia coli|escherichia coli
1030945|NCT02970513|Microbiota|microbiota
1030946|NCT02970513|Colorectal cancer|colorectal cancer
1030947|NCT02970513|Psychiatric disorders|psychiatric disorders
1030948|NCT02970513|Personality traits|personality traits
1030949|NCT02970500|Cognitive impairment|cognitive impairment
1030950|NCT02970500|Methylphenidate|methylphenidate
1030951|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
1030952|NCT02970500|Mixed method|mixed method
1030953|NCT02970500|Phase II study|phase ii study
1030954|NCT02970500|Breast cancer|breast cancer
1030955|NCT02970487|cataract|cataract
1030956|NCT02970461|personal health record|personal health record
1030957|NCT02970461|gamification|gamification
1030958|NCT02970461|chronic patient care|chronic patient care
1030959|NCT02970448|LITT|litt
1030960|NCT02970448|Brain Tumor|brain tumor
1030961|NCT02970448|Temozolomide|temozolomide
1030962|NCT02970435|surgery|surgery
1030963|NCT02970435|video discharge instructions|video discharge instructions
1030964|NCT02970422|Survey|survey
1030965|NCT02970422|Priorities|priorities
1030966|NCT02970422|Activities|activities
1030967|NCT02970422|Participation|participation
1030968|NCT02970357|Evaluation|evaluation
1030969|NCT02970357|Therapeutic education|therapeutic education
1030970|NCT02970357|Type 1 Diabetes|type 1 diabetes
1030971|NCT02970357|Children|children
1030972|NCT02970344|Coping Skills Training|coping skills training
1030973|NCT02970344|Diabetes Education|diabetes education
1030974|NCT02970318|CLL|cll
1030975|NCT02970318|BTK|btk
1030976|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
1030977|NCT02970318|acalabrutinib|acalabrutinib
1030978|NCT02970318|ACP-196|acp-196
1030979|NCT02970279|Behavioural activation|behavioural activation
1030980|NCT02970279|Psychotherapy, group|psychotherapy, group
1030981|NCT02970279|Depression|depression
1030982|NCT02970279|Depressive disorder|depressive disorder
1030983|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
1030984|NCT02970266|Genetic Decryption|genetic decryption
1030985|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
1030986|NCT02970266|Ethnicity families|ethnicity families
1030987|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1030988|NCT02970240|inflammation|inflammation
1030989|NCT02970240|oxidative status|oxidative status
1030990|NCT02970227|heart failure|heart failure
1030991|NCT02970227|cardiomyopathies|cardiomyopathies
1030992|NCT02970227|myocarditis|myocarditis
1030993|NCT02970214|heart failure|heart failure
1030994|NCT02970214|heart disease|heart disease
1030995|NCT02970214|cardiovascular disease|cardiovascular disease
1030996|NCT02970214|metabolic risk|metabolic risk
1030997|NCT02970214|comorbidities|comorbidities
1030998|NCT02970201|eHealth|ehealth
1030999|NCT02970201|mHealth|mhealth
1031000|NCT02970201|Hemodialysis|hemodialysis
1031001|NCT02970201|Adherence|adherence
1031002|NCT02970201|Electronic intervention|electronic intervention
1031003|NCT02970201|ESRD|esrd
1031004|NCT02970201|Nephrology|nephrology
1031005|NCT02970188|time restricted feeding|time restricted feeding
1031006|NCT02970188|endothelial function|endothelial function
1031007|NCT02970188|arterial stiffness|arterial stiffness
1031008|NCT02970188|intermittent fasting|intermittent fasting
1031009|NCT02970175|Terlipressin|terlipressin
1031010|NCT02970162|LEMS|lems
1031011|NCT02970136|Increased Screening Uptake|increased screening uptake
1031012|NCT02970136|Community Health Worker|community health worker
1031013|NCT02970136|Medically Underserved|medically underserved
1031014|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
1031015|NCT02970097|wrist arthroscopy|wrist arthroscopy
1031016|NCT02970097|quality of recovery score|quality of recovery score
1031017|NCT02970097|pain score|pain score
1031018|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
1031019|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
1031020|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
1031021|NCT02970071|Echocardiography|echocardiography
1031022|NCT02970006|spinal cord stimulation|spinal cord stimulation
1031023|NCT02970006|virtual reality|virtual reality
1031024|NCT02970006|full body illusion|full body illusion
1031025|NCT02969980|MDS|mds
1031026|NCT02969980|AML progressed from MDS|aml progressed from mds
1031027|NCT02969980|CMML|cmml
1031028|NCT02969967|rehabilitation|rehabilitation
1031029|NCT02969967|upper extremity|upper extremity
1031030|NCT02969967|orthosis|orthosis
1031031|NCT02969967|SaeboFlex|saeboflex
1031032|NCT02969941|Parkinson Disease|parkinson disease
1031033|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1031034|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1031035|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
1031036|NCT02969928|Clarithromycin|clarithromycin
1031037|NCT02969928|Amoxicillin|amoxicillin
1031038|NCT02969928|Metronidazole|metronidazole
1031039|NCT02969915|people who inject drugs|people who inject drugs
1031040|NCT02969915|men who have sex with men|men who have sex with men
1031041|NCT02969915|HIV|hiv
1031042|NCT02969915|India|india
1031043|NCT02969902|Procedural pain|procedural pain
1031044|NCT02969902|Phlebotomy|phlebotomy
1031045|NCT02969902|Distraction|distraction
1031046|NCT02969902|Hand-held computer|hand-held computer
1031047|NCT02969902|Children|children
1031048|NCT02969889|Airtraq|airtraq
1031049|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
1031050|NCT02969889|BMI>35|bmi>35
1031051|NCT02969863|bionic pancreas|bionic pancreas
1031052|NCT02969850|vitamin D supplementation|vitamin d supplementation
1031053|NCT02969850|calcium supplementation|calcium supplementation
1031054|NCT02969837|Multiple Myeloma|multiple myeloma
1031055|NCT02969837|Elotuzumab|elotuzumab
1031056|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
1333215|NCT01443962|PEEP|peep
1031057|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
1031058|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
1031059|NCT02969824|Sport Injury|sport injury
1031060|NCT02969824|Concussion|concussion
1031061|NCT02969824|Active Recovery|active recovery
1031062|NCT02969785|Postural control|postural control
1031063|NCT02969785|Physiotherapy|physiotherapy
1031064|NCT02969785|Sports injuries|sports injuries
1031065|NCT02969785|Low back pain|low back pain
1031066|NCT02969785|training|training
1031067|NCT02969759|Bioenergetics|bioenergetics
1031068|NCT02969759|Protein Metabolism|protein metabolism
1031069|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
1031070|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
1031071|NCT02969733|postoperative analgesia|postoperative analgesia
1031072|NCT02969733|PainMatcher|painmatcher
1031073|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1031074|NCT02969707|functional MRI|functional mri
1031075|NCT02969707|Fibromyalgia|fibromyalgia
1031076|NCT02969707|Hypnosis|hypnosis
1031077|NCT02969707|Pain Assessment|pain assessment
1031078|NCT02969694|addiction|addiction
1031079|NCT02969694|hypersexuality|hypersexuality
1031080|NCT02969694|psychostimulants|psychostimulants
1031081|NCT02969668|opioid substitution treatment|opioid substitution treatment
1031082|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
1031083|NCT02969668|hepatitis c therapy|hepatitis c therapy
1031084|NCT02969655|Safety|safety
1031085|NCT02969655|Efficacy|efficacy
1031086|NCT02969655|Daprodustat|daprodustat
1031087|NCT02969655|Chronic kidney disease|chronic kidney disease
1031088|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
1031089|NCT02969603|PET/MRI|pet/mri
1031090|NCT02969603|muscular activity|muscular activity
1031091|NCT02969603|11C-acetate|11c-acetate
1031092|NCT02969590|Contraception|contraception
1031093|NCT02969590|Mucus|mucus
1031094|NCT02969590|Cervix|cervix
1031095|NCT02969590|progestin|progestin
1031096|NCT02969590|hormones|hormones
1031097|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
1031098|NCT02969577|ADT|adt
1031099|NCT02969564|prostate cancer|prostate cancer
1031100|NCT02969564|bone metastases|bone metastases
1031101|NCT02969564|PET/MRI|pet/mri
1031102|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
1031103|NCT02969525|PsA|psa
1031104|NCT02969525|Bimekizumab|bimekizumab
1031105|NCT02969512|Patient education|patient education
1031106|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
1031107|NCT02969512|Online education|online education
1031108|NCT02969512|Computer-assisted instruction|computer-assisted instruction
1031109|NCT02969512|e-learning|e-learning
1031110|NCT02969512|Older adult|older adult
1031111|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
1031112|NCT02969499|Dementia|dementia
1031113|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1031114|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1031115|NCT02969473|docetaxel|docetaxel
1031116|NCT02969473|cisplatin|cisplatin
1031117|NCT02969473|5-fluorouracil|5-fluorouracil
1031118|NCT02969447|Retained Placenta|retained placenta
1031119|NCT02969447|Second trimester medical termination|second trimester medical termination
1031120|NCT02969447|Third stage labor|third stage labor
1031121|NCT02969447|Oxytocin|oxytocin
1031122|NCT02969395|3T|3t
1031123|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1031124|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1031125|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
1031126|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
1031127|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
1031128|NCT02969382|Schizophrenia|schizophrenia
1031129|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
1031130|NCT02969304|Tecfidera|tecfidera
1031131|NCT02969304|Off-label|off-label
1031132|NCT02969304|Utilization|utilization
1031133|NCT02969278|vulvar cancer|vulvar cancer
1031134|NCT02969278|sentinel node biopsy|sentinel node biopsy
1031135|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
1031136|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
1031137|NCT02969278|guidelines|guidelines
1031138|NCT02969278|preoperative imaging|preoperative imaging
1031139|NCT02969265|Drug therapy|drug therapy
1031140|NCT02969226|mechanical ventilation|mechanical ventilation
1031141|NCT02969226|weaning|weaning
1031142|NCT02969226|critically ill|critically ill
1031143|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
1031144|NCT02969226|screening|screening
1031145|NCT02969226|invasive ventilation|invasive ventilation
1031146|NCT02969226|SBT technique|sbt technique
1031147|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
1032639|NCT02959710|ketone body|ketone body
1031148|NCT02969213|biological etiology|biological etiology
1031149|NCT02969213|Chinese children|chinese children
1031150|NCT02969200|Fabry Disease|fabry disease
1031151|NCT02969200|Nephropathy|nephropathy
1031152|NCT02969200|Measured GFR|measured gfr
1031153|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
1031154|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
1031155|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
1031156|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
1031157|NCT02969161|Option B+ (B+)|option b+ (b+)
1031158|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
1031159|NCT02969148|Laparoscopic|laparoscopic
1031160|NCT02969148|Bursectomy|bursectomy
1031161|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
1031162|NCT02969148|Gastric Cancer|gastric cancer
1031163|NCT02969122|gastric cancer|gastric cancer
1031164|NCT02969122|peritoneal cytology|peritoneal cytology
1031165|NCT02969083|UTUC|utuc
1031166|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
1031167|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1031168|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
1031169|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
1031170|NCT02969057|Lipidemic Response|lipidemic response
1031171|NCT02969031|communication|communication
1031172|NCT02969018|plaque psoriasis|plaque psoriasis
1031173|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
1031174|NCT02969005|methylene blue|methylene blue
1031175|NCT02969005|reduce radiation exposure|reduce radiation exposure
1031176|NCT02968979|cachexia|cachexia
1031177|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
1031178|NCT02968979|anorexia|anorexia
1031179|NCT02968979|malnutrition|malnutrition
1031180|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
1031181|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
1031182|NCT02968940|Immunotherapy|immunotherapy
1031183|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
1031184|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
1031185|NCT02968940|Glioma|glioma
1031186|NCT02968914|Asthma|asthma
1031187|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
1031188|NCT02968914|Pharmacokinetics|pharmacokinetics
1031189|NCT02968914|Healthy volunteers|healthy volunteers
1031190|NCT02968875|endurance training|endurance training
1031191|NCT02968875|BDNF analysis|bdnf analysis
1031192|NCT02968875|cognitive function|cognitive function
1031193|NCT02968875|physiological abilities|physiological abilities
1031194|NCT02968849|HIV|hiv
1031195|NCT02968823|Postoperative Pain|postoperative pain
1031196|NCT02968823|Anesthesia|anesthesia
1031197|NCT02968823|Oral Surgery|oral surgery
1031198|NCT02968784|Prostate Cancer|prostate cancer
1031199|NCT02968784|MRgFUS|mrgfus
1031200|NCT02968784|ExAblate|exablate
1031201|NCT02968784|Focused Ultrasound|focused ultrasound
1031202|NCT02968771|Coronary artery disease|coronary artery disease
1031203|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
1031204|NCT02968771|Metabolomics|metabolomics
1031205|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
1031206|NCT02968745|human activity|human activity
1031207|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
1031208|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
1031209|NCT02968706|Colonoscopy|colonoscopy
1031210|NCT02968706|Obesity|obesity
1031211|NCT02968654|Blood Transfusion|blood transfusion
1031212|NCT02968654|Brain Injury|brain injury
1031213|NCT02968654|Outcome|outcome
1031214|NCT02968654|Hemoglobin|hemoglobin
1031215|NCT02968615|fiber|fiber
1031216|NCT02968615|lean protein|lean protein
1031217|NCT02968615|loss weight|loss weight
1031218|NCT02968589|Tele-rehabilitation|tele-rehabilitation
1031219|NCT02968589|Function|function
1031220|NCT02968589|Quality of life|quality of life
1031221|NCT02968589|Exercise|exercise
1031222|NCT02968589|Occupational Therapy|occupational therapy
1031223|NCT02968589|Physiotherapy|physiotherapy
1031224|NCT02968589|Caregiver burden|caregiver burden
1031225|NCT02968576|healthy volunteers|healthy volunteers
1031226|NCT02968576|pharmacokinetics|pharmacokinetics
1031227|NCT02968537|Alcohol use disorders|alcohol use disorders
1031228|NCT02968537|inhibition|inhibition
1031229|NCT02968537|EEG|eeg
1031230|NCT02968537|cortisol|cortisol
1031231|NCT02968537|Training|training
1031232|NCT02968537|clinical outcome measures|clinical outcome measures
1031233|NCT02968498|Blood glucose level|blood glucose level
1031234|NCT02968498|Oral intake|oral intake
1031235|NCT02968498|Lactulose|lactulose
1031236|NCT02968498|Healthy volunteers|healthy volunteers
1031237|NCT02968485|advanced solid tumor|advanced solid tumor
1031238|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
1031239|NCT02968485|Safety|safety
1031240|NCT02968485|Pharmacokinetics|pharmacokinetics
1031241|NCT02968472|4s CAR-T19|4s car-t19
1031242|NCT02968472|B cell leukemia|b cell leukemia
1031243|NCT02968472|B-ALL|b-all
1031244|NCT02968459|Mesenchymal Stem Cells|mesenchymal stem cells
1031245|NCT02968459|Cesarean Section|cesarean section
1031246|NCT02968459|Uterine Scar|uterine scar
1031247|NCT02968446|Valchlor|valchlor
1031248|NCT02968446|Vitamin D|vitamin d
1031249|NCT02968446|Healthy Volunteer|healthy volunteer
1031250|NCT02968433|Young Male Plasma|young male plasma
1031251|NCT02968381|tobacco|tobacco
1031252|NCT02968381|smoking|smoking
1031253|NCT02968381|imagery|imagery
1031254|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
1031255|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
1031256|NCT02968212|Clofazimine|clofazimine
1031257|NCT02968186|Mass Screening|mass screening
1031258|NCT02968186|Counseling|counseling
1031259|NCT02968186|Primary Health Care|primary health care
1031260|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
1031261|NCT02968173|RSV hospitalization|rsv hospitalization
1031262|NCT02968173|Palivizumab|palivizumab
1031263|NCT02968173|Immunoprophylaxis|immunoprophylaxis
1031264|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
1031265|NCT02968147|atrial fibrillation|atrial fibrillation
1031266|NCT02968147|catheter ablation|catheter ablation
1031267|NCT02968147|general anaesthesia|general anaesthesia
1031269|NCT02968082|Scopolamine|scopolamine
1031270|NCT02968082|Microvascular Decompression|microvascular decompression
1031271|NCT02968056|atrial fibrillation|atrial fibrillation
1031272|NCT02968056|radiofrequency ablation|radiofrequency ablation
1031273|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
1031274|NCT02968030|Aged|aged
1031275|NCT02968030|Postural balance|postural balance
1031276|NCT02968030|Muscle strength|muscle strength
1031277|NCT02967991|EUS|eus
1031278|NCT02967991|Biopsy|biopsy
1031279|NCT02967991|Liver|liver
1031280|NCT02967991|FNA|fna
1031281|NCT02967991|FNB|fnb
1031282|NCT02967978|risk factors|risk factors
1031283|NCT02967978|Calcium isotopes|calcium isotopes
1031284|NCT02967978|calcium turnover|calcium turnover
1031285|NCT02967978|DXA|dxa
1031286|NCT02967965|clinical confounders|clinical confounders
1031287|NCT02967965|myocardial infarction size|myocardial infarction size
1031288|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
1031289|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
1031290|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
1031291|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
1031292|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
1031293|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
1031294|NCT02967926|common bile duct stone|common bile duct stone
1031295|NCT02967926|cholangioscopy|cholangioscopy
1031296|NCT02967926|SpyGlass|spyglass
1031297|NCT02967926|non-fluoroscopic|non-fluoroscopic
1031298|NCT02967913|Cesarean delivery|cesarean delivery
1031299|NCT02967913|Obstetrical delivery|obstetrical delivery
1031300|NCT02967913|PFDI-20|pfdi-20
1031301|NCT02967913|UDI-6|udi-6
1031302|NCT02967913|Bladder flap|bladder flap
1031303|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
1031304|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
1031305|NCT02967874|Intra-articular Administration|intra-articular administration
1031306|NCT02967874|Liposuction|liposuction
1031307|NCT02967861|chronic periodontitis|chronic periodontitis
1031308|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
1031309|NCT02967861|Pranayama|pranayama
1031310|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
1031311|NCT02967861|Red complex microorganisms|red complex microorganisms
1031312|NCT02967848|Radiotherapy|radiotherapy
1031313|NCT02967848|Mebrofenin|mebrofenin
1031314|NCT02967848|Liver|liver
1031315|NCT02967848|Cancer|cancer
1031316|NCT02967848|SPECT|spect
1031317|NCT02967770|Metastatic|metastatic
1031318|NCT02967770|Pancreas|pancreas
1031319|NCT02967770|Cancer|cancer
1031320|NCT02967692|PDR001|pdr001
1031321|NCT02967692|dabrafenib|dabrafenib
1031322|NCT02967692|trametinib|trametinib
1031323|NCT02967692|melanoma|melanoma
1031324|NCT02967692|immunotherapy|immunotherapy
1031325|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
1031326|NCT02967692|anti PD1|anti pd1
1031327|NCT02967692|PD-1|pd-1
1031328|NCT02967692|anti-PD-1|anti-pd-1
1031329|NCT02967692|combination treatment|combination treatment
1031330|NCT02967692|malignant skin cancer|malignant skin cancer
1031331|NCT02967692|skin cancer|skin cancer
1031332|NCT02967692|BRAF V600|braf v600
1031432|NCT02966834|itch|itch
1031333|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
1031334|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
1031335|NCT02967679|Neuropathy|neuropathy
1031336|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
1031337|NCT02967640|Ketamine|ketamine
1031338|NCT02967640|Analgesics|analgesics
1031339|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
1031340|NCT02967640|Receptors, Glutamate|receptors, glutamate
1031341|NCT02967640|Shoulder|shoulder
1031342|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
1032743|NCT02958904|Sexuality|sexuality
1031343|NCT02967588|Medication adherence|medication adherence
1333216|NCT01443962|rSO2|rso2
1061760|NCT02780297|PH|ph
1031344|NCT02967588|Behavioural intervention|behavioural intervention
1031345|NCT02967588|Acute coronary syndrome|acute coronary syndrome
1031346|NCT02967588|Medication beliefs|medication beliefs
1031347|NCT02967588|Implementation intentions|implementation intentions
1031348|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
1031349|NCT02967536|cognitive function|cognitive function
1031350|NCT02967536|microglia|microglia
1031351|NCT02967536|neuroinflammation|neuroinflammation
1031352|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
1031353|NCT02967523|DEB-TACE|deb-tace
1031354|NCT02967497|Chemotherapy|chemotherapy
1031355|NCT02967497|Herbal medicine|herbal medicine
1031356|NCT02967497|Lung cancer|lung cancer
1031357|NCT02967484|Acupuncture|acupuncture
1031358|NCT02967484|Hypertension|hypertension
1031359|NCT02967484|Second prevention of Stroke|second prevention of stroke
1031360|NCT02967484|Efficacy|efficacy
1031361|NCT02967484|RCT|rct
1031362|NCT02967484|Study protocol|study protocol
1031363|NCT02967471|ARDS|ards
1031364|NCT02967458|prostate cancer|prostate cancer
1031365|NCT02967458|prostate ultrasound|prostate ultrasound
1031366|NCT02967458|subharmonic imaging|subharmonic imaging
1031367|NCT02967458|prostate biopsy|prostate biopsy
1031368|NCT02967432|Staphylococcus aureus|staphylococcus aureus
1031369|NCT02967432|Staphylococcal colonization|staphylococcal colonization
1031370|NCT02967432|Staphylococcal infection|staphylococcal infection
1031371|NCT02967432|Mupirocin|mupirocin
1031372|NCT02967432|Mupirocin-resistance|mupirocin-resistance
1031373|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
1031374|NCT02967406|Lifestyle modification|lifestyle modification
1031375|NCT02967406|Primary prevention|primary prevention
1031376|NCT02967406|Community-based intervention|community-based intervention
1031377|NCT02967406|Randomized control trial|randomized control trial
1031378|NCT02967328|Reticulated Platelets|reticulated platelets
1031379|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
1031380|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
1031381|NCT02967289|colon|colon
1031382|NCT02967289|cancer|cancer
1031383|NCT02967289|stage 3|stage 3
1031384|NCT02967289|high-risk|high-risk
1031385|NCT02967289|mFolfirinox|mfolfirinox
1031386|NCT02967289|mFolfox6|mfolfox6
1031387|NCT02967289|adjuvant|adjuvant
1031388|NCT02967276|Metformin|metformin
1031389|NCT02967276|Dexamethasone|dexamethasone
1031390|NCT02967276|Multiple Myeloma|multiple myeloma
1031391|NCT02967263|Acute Kidney Injury|acute kidney injury
1031392|NCT02967263|Proteinosis|proteinosis
1031393|NCT02967263|Epidemiology|epidemiology
1031394|NCT02967263|Risk factors|risk factors
1031395|NCT02967198|Fusion|fusion
1031396|NCT02967198|Ablation|ablation
1031397|NCT02967198|Percutaneous biopsy|percutaneous biopsy
1031398|NCT02967198|Shear wave elastography|shear wave elastography
1031399|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1031400|NCT02967159|asthma|asthma
1031401|NCT02967107|adenoma|adenoma
1031402|NCT02967107|colorectal cancer|colorectal cancer
1031403|NCT02967107|polypectomy|polypectomy
1031404|NCT02967107|colonoscopy|colonoscopy
1031405|NCT02967081|Pulpitis|pulpitis
1031406|NCT02967081|Biomarker|biomarker
1031407|NCT02967081|Diagnostic|diagnostic
1031408|NCT02967081|Dentinal fluid|dentinal fluid
1031409|NCT02967068|CSS|css
1031410|NCT02967068|EGPA|egpa
1031411|NCT02967068|GCA|gca
1031412|NCT02967068|GPA|gpa
1031413|NCT02967068|MPA|mpa
1031414|NCT02967068|PAN|pan
1031415|NCT02967068|TAK|tak
1031416|NCT02967068|HSP|hsp
1031417|NCT02966951|osteoarthrosis|osteoarthrosis
1031418|NCT02966951|knee|knee
1031419|NCT02966951|adipose tissue|adipose tissue
1031420|NCT02966951|stem cells|stem cells
1031421|NCT02966951|cell therapy|cell therapy
1031422|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
1031423|NCT02966886|Surgical Management|surgical management
1031424|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
1031425|NCT02966873|Addiction|addiction
1031426|NCT02966873|Alcohol Use Disorder|alcohol use disorder
1031427|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
1031428|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
1031429|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
1031430|NCT02966847|Cone beam computed tomography|cone beam computed tomography
1031431|NCT02966834|PBC|pbc
1031433|NCT02966834|GSK2330672|gsk2330672
1031434|NCT02966834|GLIMMER|glimmer
1031435|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
1031436|NCT02966834|pruritus|pruritus
1031437|NCT02966821|Sulfatinib|sulfatinib
1031438|NCT02966821|Biliary Tract Cancer|biliary tract cancer
1031439|NCT02966821|Second-line|second-line
1031440|NCT02966795|glecaprevir|glecaprevir
1031441|NCT02966795|pibrentasvir|pibrentasvir
1031442|NCT02966795|compensated cirrhosis|compensated cirrhosis
1031443|NCT02966795|non-cirrhotic|non-cirrhotic
1032846|NCT02958241|MRI|mri
1031444|NCT02966795|interferon (IFN)|interferon (ifn)
1031445|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
1031446|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
1031447|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
1031448|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
1031449|NCT02966782|Relapsed/refractory|relapsed/refractory
1031450|NCT02966782|Venetoclax|venetoclax
1031451|NCT02966782|Azacitidine|azacitidine
1031452|NCT02966782|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
1031453|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
1031454|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
1031455|NCT02966756|17p deletion|17p deletion
1031456|NCT02966756|venetoclax|venetoclax
1031457|NCT02966756|Leukemia|leukemia
1031458|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
1031459|NCT02966730|follicular lymphoma|follicular lymphoma
1031460|NCT02966730|Ibrutinib|ibrutinib
1031461|NCT02966730|FLIPP|flipp
1031462|NCT02966730|16-396|16-396
1031463|NCT02966717|Rituximab|rituximab
1031464|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
1031465|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
1031466|NCT02966717|chronic kidney disease|chronic kidney disease
1031467|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
1031468|NCT02966652|Male|male
1031469|NCT02966652|Hypogonadism|hypogonadism
1031470|NCT02966652|Primary|primary
1031471|NCT02966652|Secondary|secondary
1031472|NCT02966652|Androgen deficiency|androgen deficiency
1031473|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
1031474|NCT02966574|Whole body MRI|whole body mri
1031475|NCT02966574|Breastcancer|breastcancer
1031476|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
1031477|NCT02966561|Physical Activity|physical activity
1031478|NCT02966561|Behaviour Change|behaviour change
1031479|NCT02966561|Pedometer|pedometer
1031480|NCT02966522|Thalidoide|thalidoide
1031481|NCT02966483|Rectal cancer|rectal cancer
1031482|NCT02966483|Laparoscopic surgery|laparoscopic surgery
1031483|NCT02966483|Total mesorectal excision|total mesorectal excision
1031484|NCT02966483|Transanal|transanal
1031485|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
1031486|NCT02966470|surgical outcomes|surgical outcomes
1031487|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
1031488|NCT02966418|Hypoxic preconditioning|hypoxic preconditioning
1031489|NCT02966418|Carotid artery stenosis|carotid artery stenosis
1031490|NCT02966418|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
1031491|NCT02966392|Cuff pressure|cuff pressure
1031492|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
1031493|NCT02966392|Respiratory tract infections|respiratory tract infections
1031494|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
1031495|NCT02966353|Ruxolitinib|ruxolitinib
1031496|NCT02966353|anemia|anemia
1031497|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
1031498|NCT02966353|PMF|pmf
1031499|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
1031500|NCT02966353|PPV-MF|ppv-mf
1031501|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1031502|NCT02966353|PET-MF|pet-mf
1031503|NCT02966340|Alcoholism|alcoholism
1031504|NCT02966340|Prazosin|prazosin
1031505|NCT02966340|Startle Potentiation|startle potentiation
1031506|NCT02966340|Norepinephrine|norepinephrine
1031507|NCT02966340|Anxiety|anxiety
1031508|NCT02966340|Fear|fear
1031509|NCT02966340|Stress|stress
1031510|NCT02966314|Angioedema|angioedema
1031511|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
1031512|NCT02966314|IAE|iae
1031513|NCT02966301|c GvHD|c gvhd
1031514|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
1031515|NCT02966301|Hematology|hematology
1031516|NCT02966275|glucagon|glucagon
1031517|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
1031518|NCT02966275|artificial pancreas|artificial pancreas
1031519|NCT02966275|hypoglycemia|hypoglycemia
1031520|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
1031521|NCT02966275|bionic pancreas|bionic pancreas
1031522|NCT02966275|bariatric surgery|bariatric surgery
1031523|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
1031524|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1031525|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
1031526|NCT02966158|Aerobic Interval Training|aerobic interval training
1031527|NCT02966158|Fitness|fitness
1031528|NCT02966158|Endothelial Function|endothelial function
1031529|NCT02966158|Cognition|cognition
1031530|NCT02966145|CBD|cbd
1031531|NCT02966145|CBS|cbs
1031532|NCT02966145|CBGD|cbgd
1031533|NCT02966145|PSP|psp
1031534|NCT02966145|nfvPPA|nfvppa
1031535|NCT02966145|oPSP|opsp
1031536|NCT02966145|vPSP|vpsp
1031537|NCT02966145|o/vPSP|o/vpsp
1031538|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
1031539|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
1031540|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
1031541|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
1031542|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
1031543|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
1031544|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
1031545|NCT02966145|Biomarker|biomarker
1031546|NCT02966145|Neuroimaging|neuroimaging
1031547|NCT02966145|MRI|mri
1031548|NCT02966145|PET|pet
1031549|NCT02966145|Tau|tau
1031550|NCT02966145|Oculomotor|oculomotor
1031551|NCT02966145|Retinal Imaging|retinal imaging
1031552|NCT02966132|Asian American|asian american
1031553|NCT02966132|Immigrant Health|immigrant health
1031554|NCT02966132|Digital Health Intervention|digital health intervention
1031555|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
1031556|NCT02966119|stroke|stroke
1031557|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
1031558|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
1031559|NCT02966119|antithrombotic drugs|antithrombotic drugs
1031560|NCT02966119|brain microbleeds|brain microbleeds
1031561|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
1031562|NCT02966093|Chinese participants|chinese participants
1031563|NCT02966093|Phase 3|phase 3
1031564|NCT02966093|Lenvatinib|lenvatinib
1031566|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1031567|NCT02966080|intravenous heparin|intravenous heparin
1031568|NCT02966067|Microneedles|microneedles
1031569|NCT02966067|Dental Anaesthesia|dental anaesthesia
1031570|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1031571|NCT02966041|PONV|ponv
1031572|NCT02966041|CSICU|csicu
1031573|NCT02966041|post-cardiac surgery|post-cardiac surgery
1031574|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
1031575|NCT02966028|CAC|cac
1031576|NCT02966028|calcium|calcium
1031577|NCT02966028|ESRD|esrd
1031578|NCT02966028|calcification|calcification
1031579|NCT02966028|cardiovascular|cardiovascular
1031580|NCT02966028|heart|heart
1031581|NCT02966028|kidney|kidney
1031582|NCT02966028|hemodialysis|hemodialysis
1031583|NCT02966028|Agatston|agatston
1031584|NCT02965989|nursery care|nursery care
1031585|NCT02965989|nursery infection|nursery infection
1031586|NCT02965989|online learning|online learning
1031587|NCT02965950|breast cancer|breast cancer
1031588|NCT02965950|TP53|tp53
1031589|NCT02965950|cyclophosphamide|cyclophosphamide
1031590|NCT02965937|Attentively embracing story|attentively embracing story
1031591|NCT02965937|story-centred care|story-centred care
1031592|NCT02965937|heart rate variability|heart rate variability
1031593|NCT02965937|cognitive function|cognitive function
1031594|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
1031595|NCT02965898|chronic pancreatitis|chronic pancreatitis
1031596|NCT02965898|vitamin d|vitamin d
1031597|NCT02965898|pancreatitis|pancreatitis
1031598|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
1031599|NCT02965898|rct|rct
1031600|NCT02965885|Phase I|phase i
1031601|NCT02965885|Solid Tumors|solid tumors
1031602|NCT02965885|Pharmacokinetics|pharmacokinetics
1031603|NCT02965885|Pharmacodynamics|pharmacodynamics
1031604|NCT02965885|MTD|mtd
1031605|NCT02965885|TAS116|tas116
1031606|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
1031607|NCT02965885|Neoplasms|neoplasms
1031608|NCT02965885|HER2 positive MBC|her2 positive mbc
1031609|NCT02965885|NSCLC EGFR|nsclc egfr
1031610|NCT02965885|NSCLC ALK positive|nsclc alk positive
1031611|NCT02965872|Postural Balance|postural balance
1031612|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
1031613|NCT02965846|EDE|ede
1031614|NCT02965846|evaporative dry eye|evaporative dry eye
1031615|NCT02965833|Contact lens induced dryness|contact lens induced dryness
1031616|NCT02965820|Contact lens induced dryness|contact lens induced dryness
1031617|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
1031618|NCT02965807|moderate asthma|moderate asthma
1031619|NCT02965807|China|china
1031620|NCT02965794|surgery|surgery
1031621|NCT02965794|bowel|bowel
1031622|NCT02965794|rectum|rectum
1031623|NCT02965794|cancer|cancer
1031624|NCT02965794|nutrition|nutrition
1031625|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
1031626|NCT02965755|Breast Cancer|breast cancer
1031627|NCT02965755|Molecular profiling|molecular profiling
1031628|NCT02965755|Personalized medicine|personalized medicine
1031629|NCT02965742|DXA|dxa
1031630|NCT02965742|DMS|dms
1031631|NCT02965742|STRATOS|stratos
1031632|NCT02965729|behavior goals|behavior goals
1031633|NCT02965729|self-monitoring|self-monitoring
1031634|NCT02965729|pedometer|pedometer
1031635|NCT02965729|physical activity|physical activity
1031636|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1031637|NCT02965690|TKR|tkr
1031638|NCT02965690|Knee kinematics|knee kinematics
1031639|NCT02965690|Dynamic RSA|dynamic rsa
1031640|NCT02965690|Fluoroscopy|fluoroscopy
1031641|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
1031642|NCT02965677|drug eluting balloon|drug eluting balloon
1031643|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
1031644|NCT02965651|embodied conversational agent|embodied conversational agent
1031645|NCT02965651|virtual patient agent|virtual patient agent
1031646|NCT02965651|meditation|meditation
1031647|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
1031648|NCT02965651|nutrition|nutrition
1031649|NCT02965638|LHH|lhh
1031650|NCT02965612|Grass Allergy|grass allergy
1031651|NCT02965612|Allergic Rhinitis|allergic rhinitis
1031652|NCT02965612|Allergic Asthma|allergic asthma
1031653|NCT02965612|Paediatric|paediatric
1031654|NCT02965599|pharmacodynamics|pharmacodynamics
1031655|NCT02965599|tolerability|tolerability
1031656|NCT02965599|GSK3117391|gsk3117391
1031657|NCT02965599|safety|safety
1031658|NCT02965599|efficacy|efficacy
1031659|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
1031660|NCT02965599|pharmacokinetics|pharmacokinetics
1031661|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
1031662|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
1031663|NCT02965534|night vision|night vision
1031664|NCT02965534|mesopic visual acuity|mesopic visual acuity
1031665|NCT02965534|aberrometry|aberrometry
1031666|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
1031667|NCT02965534|night myopia|night myopia
1031668|NCT02965508|Home-bound|home-bound
1031669|NCT02965508|home-based primary care|home-based primary care
1031670|NCT02965495|Osteoarthritis|osteoarthritis
1031671|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
1031672|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
1031673|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
1031674|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
1031675|NCT02965404|safety|safety
1031676|NCT02965404|adult|adult
1031677|NCT02965404|adolescent|adolescent
1031678|NCT02965404|child|child
1031679|NCT02965391|Circulating Tumor DNA|circulating tumor dna
1031680|NCT02965391|Half time|half time
1031681|NCT02965391|Lung cancer|lung cancer
1031682|NCT02965391|Surgery|surgery
1031683|NCT02965391|Surveillance|surveillance
1031684|NCT02965339|Vasoplegia|vasoplegia
1031685|NCT02965339|endothelial dysfunction|endothelial dysfunction
1031686|NCT02965339|extracorporeal circulation|extracorporeal circulation
1031687|NCT02965339|cardiac surgery|cardiac surgery
1031688|NCT02965300|Pulmonary lesion|pulmonary lesion
1031689|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
1031690|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
1031691|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1031692|NCT02965222|blastocyst|blastocyst
1031693|NCT02965222|pregnancy rate|pregnancy rate
1031694|NCT02965209|endoscopy|endoscopy
1031695|NCT02965209|small bowel endoscopy|small bowel endoscopy
1031696|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
1031697|NCT02965209|spiral endoscopy|spiral endoscopy
1031698|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
1031699|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
1031700|NCT02965079|registry|registry
1031701|NCT02965079|COPD and ARDS|copd and ards
1031702|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
1031703|NCT02965040|ASP1517|asp1517
1031704|NCT02965040|Normal renal function|normal renal function
1031705|NCT02965040|Dialysis|dialysis
1031706|NCT02965040|Roxadustat|roxadustat
1031707|NCT02965040|Metabolites|metabolites
1031708|NCT02965040|Pharmacokinetics|pharmacokinetics
1031709|NCT02965040|Impaired renal function|impaired renal function
1031710|NCT02965027|Chronic Headache|chronic headache
1031711|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1031712|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
1031713|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1031714|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
1031715|NCT02965014|mHealth|mhealth
1031716|NCT02965014|Substance abuse|substance abuse
1031717|NCT02965014|Violence|violence
1031718|NCT02965014|Victimization|victimization
1031719|NCT02965014|Sexual Risk|sexual risk
1031720|NCT02965001|Molecular Imaging|molecular imaging
1031721|NCT02965001|uPAR-PET/CT|upar-pet/ct
1031722|NCT02965001|Head and neck cancer|head and neck cancer
1031723|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
1031724|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
1031725|NCT02964949|High Creatinine Clearance|high creatinine clearance
1031726|NCT02964949|Developmental Phase III|developmental phase iii
1031727|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
1031728|NCT02964936|Anemia|anemia
1031729|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
1031730|NCT02964936|Roxadustat|roxadustat
1031731|NCT02964936|ASP1517|asp1517
1031732|NCT02964923|Genetic polymorphism|genetic polymorphism
1031733|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
1031734|NCT02964923|schizophrenia|schizophrenia
1031735|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
1031736|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
1031737|NCT02964910|Hepatitis E|hepatitis e
1031738|NCT02964897|justice involvement|justice involvement
1031739|NCT02964897|Homeless|homeless
1031740|NCT02964897|Vulnerable Populations|vulnerable populations
1031741|NCT02964897|Linkage to care|linkage to care
1031742|NCT02964897|Veterans|veterans
1031743|NCT02964884|Neurofibromatosis Type 1|neurofibromatosis type 1
1031744|NCT02964884|Learning Disability|learning disability
1031745|NCT02964884|Reading Disability|reading disability
1031747|NCT02964871|Long-term care facility|long-term care facility
1031748|NCT02964871|Elderly|elderly
1031749|NCT02964858|Radiation Dose|radiation dose
1031750|NCT02964858|Optimization|optimization
1031751|NCT02964858|NHL|nhl
1031752|NCT02964858|DLBCL|dlbcl
1031753|NCT02964858|R-CHOP|r-chop
1031754|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
1031755|NCT02964793|Fetal Growth Restriction|fetal growth restriction
1031756|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
1031757|NCT02964793|Estimated fetal Weight|estimated fetal weight
1031758|NCT02964793|Symphysis Fundal Height|symphysis fundal height
1031759|NCT02964767|HIV|hiv
1031760|NCT02964767|HIV-Tb co infection|hiv-tb co infection
1031761|NCT02964767|CD4 Cell|cd4 cell
1031762|NCT02964741|Episodic Migraine|episodic migraine
1031763|NCT02964741|Headache|headache
1031764|NCT02964741|Opioid|opioid
1031765|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1031766|NCT02964689|KRAS mutations|kras mutations
1031767|NCT02964689|Binimetinib|binimetinib
1031768|NCT02964689|Pemetrexed|pemetrexed
1031769|NCT02964689|Cisplatin|cisplatin
1031770|NCT02964689|Phase IB trial|phase ib trial
1031771|NCT02964624|Osteoarthritis|osteoarthritis
1031772|NCT02964624|biomarkers|biomarkers
1031773|NCT02964624|HMGB1|hmgb1
1031774|NCT02964624|knee|knee
1031775|NCT02964598|Adolescent|adolescent
1031776|NCT02964598|Population-based|population-based
1031777|NCT02964598|Social jetlag|social jetlag
1031778|NCT02964598|Intervention|intervention
1031779|NCT02964598|Bright light|bright light
1031780|NCT02964598|Motivation|motivation
1031781|NCT02964598|Circadian regulation|circadian regulation
1031782|NCT02964598|Behavioral change|behavioral change
1031783|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1031784|NCT02964585|Endothelial Cells|endothelial cells
1031785|NCT02964585|Cellular Biomarker|cellular biomarker
1031786|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
1031787|NCT02964585|CD34+|cd34+
1031788|NCT02964585|Impaired renal function|impaired renal function
1031789|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
1031790|NCT02964546|atrial fibrillation|atrial fibrillation
1031791|NCT02964546|renal function|renal function
1031792|NCT02964546|ckd-epi|ckd-epi
1031793|NCT02964546|plasmatic concentration|plasmatic concentration
1031794|NCT02964520|trait anxiety|trait anxiety
1031795|NCT02964520|A/T neurofeedback|a/t neurofeedback
1031796|NCT02964520|EEG biofeedback|eeg biofeedback
1031797|NCT02964520|randomized|randomized
1031798|NCT02964507|GSK525762|gsk525762
1031799|NCT02964507|ER+ breast cancer|er+ breast cancer
1031800|NCT02964507|mTPI|mtpi
1031801|NCT02964481|malignant|malignant
1031802|NCT02964481|genetics|genetics
1031803|NCT02964481|RYR1|ryr1
1031804|NCT02964481|CAC-NA1S|cac-na1s
1031805|NCT02964481|hyperthermia|hyperthermia
1031806|NCT02964468|Rectal Cancer|rectal cancer
1031807|NCT02964468|IMRT|imrt
1031808|NCT02964468|Radiation Dose Escalation|radiation dose escalation
1031809|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1031810|NCT02964455|Chemoradiotherapy|chemoradiotherapy
1031811|NCT02964455|Docetaxel|docetaxel
1031812|NCT02964455|Nedaplatin|nedaplatin
1031813|NCT02964455|Twice weekly|twice weekly
1031814|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
1031815|NCT02964416|extubation response|extubation response
1031816|NCT02964416|emergence|emergence
1031817|NCT02964416|tramadol|tramadol
1031818|NCT02964403|COX-2|cox-2
1031819|NCT02964403|ERCP|ercp
1031820|NCT02964403|Pancreatitis|pancreatitis
1031821|NCT02964390|CTEPH|cteph
1031822|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
1031823|NCT02964377|Pediatric|pediatric
1031824|NCT02964377|muscle disease|muscle disease
1031825|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
1031826|NCT02964377|cardiomyopathy|cardiomyopathy
1031827|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
1031828|NCT02964351|MicroRNA|microrna
1031829|NCT02964351|Prostate Carcinoma|prostate carcinoma
1031830|NCT02964351|PET-MR|pet-mr
1031831|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
1031832|NCT02964325|hematologic malignancies|hematologic malignancies
1031833|NCT02964325|thrombocytopenia|thrombocytopenia
1031834|NCT02964325|platelet therapy|platelet therapy
1031835|NCT02964325|apheresis|apheresis
1031836|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
1031837|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
1031838|NCT02964299|Moderate sedation|moderate sedation
1031839|NCT02964299|Airway management|airway management
1031840|NCT02964286|Cancer|cancer
1031841|NCT02964286|Acupressure|acupressure
1031842|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
1031843|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1031844|NCT02964273|ADPKD|adpkd
1031845|NCT02964273|Tolvaptan|tolvaptan
1031846|NCT02964273|Renal cysts|renal cysts
1031847|NCT02964273|Chronic Kidney Disease|chronic kidney disease
1031848|NCT02964273|Genetic Kidney Disease|genetic kidney disease
1031849|NCT02964260|Hepatocellular Carcinoma; Embolization; Ablation; simultaneously; sequentially|hepatocellular carcinoma; embolization; ablation; simultaneously; sequentially
1031850|NCT02964234|Mammography Screening|mammography screening
1031851|NCT02964234|Latinas|latinas
1031852|NCT02964234|Breast cancer disparities|breast cancer disparities
1031853|NCT02964208|Atrial Fibrillation|atrial fibrillation
1031854|NCT02964208|Thromboembolism|thromboembolism
1031855|NCT02964208|Stroke|stroke
1031856|NCT02964208|ACP|acp
1031857|NCT02964208|Left Atrial Appendage|left atrial appendage
1031858|NCT02964208|Cardiac Plug|cardiac plug
1031859|NCT02964182|Mental and Behavioral Disorders Due to Use of Tobacco|mental and behavioral disorders due to use of tobacco
1031860|NCT02964182|Carbon monoxide Testing|carbon monoxide testing
1031861|NCT02964182|CO|co
1031862|NCT02964182|Questionnaires|questionnaires
1031863|NCT02964182|Surveys|surveys
1031864|NCT02964182|Smartphone assessments|smartphone assessments
1031865|NCT02964182|Electronic assessments|electronic assessments
1031866|NCT02964182|Usual brand cigarettes|usual brand cigarettes
1031867|NCT02964182|UB|ub
1031868|NCT02964182|Very Low Nicotine Content Cigarettes|very low nicotine content cigarettes
1031869|NCT02964182|VLNCC|vlncc
1031870|NCT02964182|E-cigarettes|e-cigarettes
1031871|NCT02964182|ECIG|ecig
1031872|NCT02964156|RA|ra
1031873|NCT02964156|Insole|insole
1031874|NCT02964156|Forefoot|forefoot
1031875|NCT02964156|Walking Ability|walking ability
1031876|NCT02964156|Pain|pain
1031877|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1031878|NCT02964091|Hepatitis C Virus|hepatitis c virus
1031879|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
1031880|NCT02964091|Efficacy|efficacy
1031881|NCT02964078|Kidney Disease|kidney disease
1031882|NCT02964078|Metastatic|metastatic
1031883|NCT02964078|Antibody|antibody
1031884|NCT02964065|Influenza Vaccines|influenza vaccines
1031885|NCT02964065|LAIV|laiv
1031886|NCT02964039|stroke|stroke
1031887|NCT02964039|rehabilitation|rehabilitation
1031888|NCT02964039|gait|gait
1031889|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
1031890|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
1031891|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
1031892|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
1031893|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
1031894|NCT02964013|PD-1|pd-1
1031895|NCT02964013|PDL1|pdl1
1031896|NCT02964013|PD-L1|pd-l1
1031897|NCT02964013|PD-L2|pd-l2
1031898|NCT02964000|Pain|pain
1031899|NCT02964000|Low level laser therapy|low level laser therapy
1031900|NCT02964000|Sham|sham
1031901|NCT02964000|Chronic Pain|chronic pain
1031902|NCT02964000|Opioid|opioid
1031903|NCT02964000|Physical activity|physical activity
1031904|NCT02964000|Quality of sleep|quality of sleep
1031905|NCT02963974|cochlear implant|cochlear implant
1031906|NCT02963961|Delirium|delirium
1031907|NCT02963961|Cognition|cognition
1031908|NCT02963961|Prehabilitation|prehabilitation
1031909|NCT02963961|Neuroplasticity|neuroplasticity
1031910|NCT02963909|Adjuvant|adjuvant
1031911|NCT02963909|Alum|alum
1031912|NCT02963909|Inactivated|inactivated
1031913|NCT02963909|Purified|purified
1031914|NCT02963909|Vaccine|vaccine
1031915|NCT02963909|Virus|virus
1031916|NCT02963909|Zika|zika
1031917|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
1031918|NCT02963883|ScVO2|scvo2
1031919|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
1031920|NCT02963870|Cognitive behavioral|cognitive behavioral
1031921|NCT02963870|security plan|security plan
1031922|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
1031923|NCT02963857|breast surgery|breast surgery
1031924|NCT02963857|acute pain|acute pain
1031925|NCT02963857|regional anesthesia|regional anesthesia
1031926|NCT02963831|Oncos-102|oncos-102
1031927|NCT02963831|Durvalumab|durvalumab
1031928|NCT02963831|Peritoneal|peritoneal
1031929|NCT02963831|Cyclophosphamide|cyclophosphamide
1031930|NCT02963818|Brief intervention|brief intervention
1031931|NCT02963818|Harm reduction|harm reduction
1031932|NCT02963818|Young adult|young adult
1031933|NCT02963818|College Student|college student
1031934|NCT02963805|Children|children
1031935|NCT02963805|Physical activity|physical activity
1031936|NCT02963805|Physical competence|physical competence
1031937|NCT02963805|Obesity|obesity
1031938|NCT02963805|School|school
1031939|NCT02963805|Health|health
1031940|NCT02963805|Fundamental movement skills|fundamental movement skills
1031941|NCT02963792|Professionalism|professionalism
1031942|NCT02963792|Burnout prevention|burnout prevention
1031943|NCT02963792|Resiliency|resiliency
1031944|NCT02963792|Student education|student education
1031945|NCT02963766|Pediatrics|pediatrics
1031946|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
1031947|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
1031948|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
1031949|NCT02963740|breast cancer survivor|breast cancer survivor
1031950|NCT02963740|weight loss program|weight loss program
1031951|NCT02963727|osteoarthrosis|osteoarthrosis
1031952|NCT02963727|Knee|knee
1031953|NCT02963727|Wharton Jelly|wharton jelly
1031954|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
1031955|NCT02963714|Randomized Controlled Trial|randomized controlled trial
1031956|NCT02963714|Hemodialysis|hemodialysis
1031957|NCT02963714|Immunogenicity|immunogenicity
1031958|NCT02963662|obesity|obesity
1031959|NCT02963662|bariatric surgery|bariatric surgery
1031960|NCT02963662|gut hormones|gut hormones
1031961|NCT02963662|inflammatory adipokine|inflammatory adipokine
1031962|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
1031963|NCT02963636|family medicine group|family medicine group
1031964|NCT02963636|pharmacists|pharmacists
1031965|NCT02963636|primary health care|primary health care
1031966|NCT02963636|pharmaceutical services|pharmaceutical services
1031967|NCT02963636|interprofessional relations|interprofessional relations
1031968|NCT02963623|fibtem|fibtem
1031969|NCT02963623|total knee replacement|total knee replacement
1031970|NCT02963584|chronic total occlusion|chronic total occlusion
1031971|NCT02963584|decision aid|decision aid
1031972|NCT02963506|AS|as
1031973|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
1031974|NCT02963506|Bimekizumab|bimekizumab
1031975|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
1031976|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
1031977|NCT02963467|smoking|smoking
1031978|NCT02963467|pulmonary disorder|pulmonary disorder
1031979|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
1031980|NCT02963441|Macular Edema|macular edema
1031981|NCT02963415|Subjective memory complaint|subjective memory complaint
1031982|NCT02963363|Breast cancer|breast cancer
1031983|NCT02963363|HER2+|her2+
1031984|NCT02963363|Adapted physical activity|adapted physical activity
1031985|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1031986|NCT02963337|remifentanil|remifentanil
1031987|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
1031988|NCT02963337|multiparous|multiparous
1031989|NCT02963272|Heart failure|heart failure
1031990|NCT02963272|ST2|st2
1031991|NCT02963272|fibrosis|fibrosis
1031992|NCT02963246|mindfulness|mindfulness
1031993|NCT02963246|quality of life|quality of life
1031994|NCT02963246|Bowel Disease|bowel disease
1031995|NCT02963207|colorectal polyp|colorectal polyp
1031996|NCT02963207|colorectal lesion|colorectal lesion
1031997|NCT02963207|Modified Sano's Classification|modified sano's classification
1031998|NCT02963207|NICE classification|nice classification
1031999|NCT02963207|NBI|nbi
1032000|NCT02963207|PIVI guidelines|pivi guidelines
1032001|NCT02963207|SSA/P|ssa/p
1032002|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
1032003|NCT02963207|sessile serrated polyp|sessile serrated polyp
1032004|NCT02963194|self-processing|self-processing
1032005|NCT02963194|endowment effect|endowment effect
1032006|NCT02963194|neuroimage|neuroimage
1032007|NCT02963181|Melatonin|melatonin
1032008|NCT02963181|Yohimbine|yohimbine
1032009|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
1032010|NCT02963155|prostate, metastatic|prostate, metastatic
1032011|NCT02963142|Intensive care|intensive care
1032012|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
1032013|NCT02963142|Severe Respiratory Infections|severe respiratory infections
1032014|NCT02963142|Sequencing|sequencing
1032015|NCT02963142|Metagenome|metagenome
1032016|NCT02963142|Diagnosis|diagnosis
1032017|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1032018|NCT02963129|Epistaxis|epistaxis
1032019|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
1032020|NCT02963116|Bioavailability (BA)|bioavailability (ba)
1032021|NCT02963116|Safety|safety
1032022|NCT02963116|Tolerability|tolerability
1032023|NCT02963116|Healthy Volunteers|healthy volunteers
1032024|NCT02963103|Tacrolimus|tacrolimus
1032025|NCT02963103|Kidney transplantation|kidney transplantation
1032026|NCT02963090|SCLC|sclc
1032027|NCT02963090|small cell lung cancer|small cell lung cancer
1032028|NCT02963090|lung cancer|lung cancer
1032029|NCT02963090|topotecan|topotecan
1032030|NCT02963090|pembrolizumab|pembrolizumab
1032031|NCT02963064|Immunodeficiency|immunodeficiency
1032032|NCT02963064|Pediatric|pediatric
1032033|NCT02963064|SCID|scid
1032034|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
1032035|NCT02963064|GVHD|gvhd
1032036|NCT02963064|Stem Cells|stem cells
1032037|NCT02963064|Chimerism|chimerism
1032038|NCT02963064|Transplant|transplant
1032039|NCT02963064|BMT|bmt
1032040|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
1032041|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
1032042|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
1032043|NCT02963051|Copper|copper
1032044|NCT02963051|Disulfiram|disulfiram
1032045|NCT02962999|Ketamine|ketamine
1032046|NCT02962999|One lung ventilation|one lung ventilation
1032047|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1032048|NCT02962986|vasopressor|vasopressor
1032049|NCT02962986|blood pressure|blood pressure
1032050|NCT02962986|cesarean section|cesarean section
1032051|NCT02962986|spinal anesthesia|spinal anesthesia
1032052|NCT02962973|Advanced heart failure|advanced heart failure
1032053|NCT02962973|Total artificial heart|total artificial heart
1032054|NCT02962947|Melanoma|melanoma
1032055|NCT02962947|Propanolol|propanolol
1032056|NCT02962947|Betablockers|betablockers
1032057|NCT02962908|broad|broad
1032058|NCT02962908|universal|universal
1032059|NCT02962908|vaccine|vaccine
1032060|NCT02962908|influenza|influenza
1032061|NCT02962908|peptide|peptide
1032062|NCT02962908|Tcell|tcell
1032063|NCT02962908|UNISEC|unisec
1032064|NCT02962895|Sjogren, VAY736, ianalumab|sjogren, vay736, ianalumab
1032065|NCT02962843|Behavior Problem|behavior problem
1032066|NCT02962843|Social Competence|social competence
1032067|NCT02962843|Student|student
1032068|NCT02962843|Children|children
1032069|NCT02962830|fetal pain|fetal pain
1032070|NCT02962830|fetal analgesia|fetal analgesia
1032071|NCT02962804|kidney|kidney
1032072|NCT02962804|renal cell|renal cell
1032073|NCT02962804|cancer|cancer
1032074|NCT02962804|metastatic|metastatic
1032075|NCT02962804|recurrent|recurrent
1032076|NCT02962791|symptomatic heart failure|symptomatic heart failure
1032077|NCT02962778|treatment-resistant|treatment-resistant
1032078|NCT02962739|healthy volunteers|healthy volunteers
1032079|NCT02962726|Anorexia|anorexia
1032080|NCT02962726|Depression|depression
1032081|NCT02962726|Microbiome|microbiome
1032082|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
1032083|NCT02962713|glass ionomer cement|glass ionomer cement
1032084|NCT02962713|primary teeth|primary teeth
1032085|NCT02962713|dental caries.|dental caries.
1032086|NCT02962700|continuous haemofiltration|continuous haemofiltration
1032087|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
1032088|NCT02962687|Veterans|veterans
1032089|NCT02962687|Cognitive impairments|cognitive impairments
1032090|NCT02962687|Nursing care management|nursing care management
1032091|NCT02962687|Videoconferencing|videoconferencing
1032092|NCT02962674|BPH|bph
1032093|NCT02962661|Other forms of heart disease|other forms of heart disease
1032094|NCT02962661|Left ventricular dysfunction|left ventricular dysfunction
1032095|NCT02962661|LV|lv
1032096|NCT02962661|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
1032097|NCT02962661|Human mesenchymal stem cells|human mesenchymal stem cells
1032098|NCT02962661|hMSCs|hmscs
1032099|NCT02962661|Mesenchymal Stromal Cells|mesenchymal stromal cells
1032100|NCT02962661|MSCs|mscs
1032101|NCT02962661|Intravenous infusion|intravenous infusion
1032102|NCT02962661|Transendocardial injection|transendocardial injection
1032103|NCT02962661|Standard of care drugs for heart failure|standard of care drugs for heart failure
1032104|NCT02962648|IDA|ida
1032105|NCT02962622|Neurocognition|neurocognition
1032106|NCT02962622|Exercise|exercise
1032107|NCT02962622|Metabolism|metabolism
1032108|NCT02962622|Hispanic women|hispanic women
1032109|NCT02962609|Feeding|feeding
1032110|NCT02962609|preterm infant|preterm infant
1032111|NCT02962609|physiological characteristics|physiological characteristics
1032112|NCT02962609|position|position
1032113|NCT02962609|ESL|esl
1032114|NCT02962609|ESU|esu
1032115|NCT02962557|ventilatory depression|ventilatory depression
1032116|NCT02962544|Femtosecond|femtosecond
1032117|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
1032118|NCT02962544|Lenticule extraction|lenticule extraction
1032119|NCT02962544|LASIK|lasik
1032120|NCT02962544|Myopia|myopia
1032121|NCT02962518|Pressure Device|pressure device
1032122|NCT02962518|Clip|clip
1032123|NCT02962518|Triamcinolone|triamcinolone
1032124|NCT02962518|Fillet Technique|fillet technique
1032125|NCT02962492|Dapagliflozin|dapagliflozin
1032126|NCT02962492|Ketogenesis|ketogenesis
1032127|NCT02962492|Type 1 Diabetes|type 1 diabetes
1032128|NCT02962492|DKA|dka
1032129|NCT02962492|ketones|ketones
1032130|NCT02962492|exenatide/Bydureon|exenatide/bydureon
1032131|NCT02962414|Everolimus|everolimus
1032234|NCT02961816|Sympt-X|sympt-x
1032132|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
1032133|NCT02962414|TSC|tsc
1032134|NCT02962414|Refractory seizure|refractory seizure
1032135|NCT02962414|Roll over study|roll over study
1032136|NCT02962414|Long term safety|long term safety
1032137|NCT02962414|PASS|pass
1032138|NCT02962388|efficacy|efficacy
1032139|NCT02962388|safety|safety
1032140|NCT02962375|orange pomace fiber|orange pomace fiber
1032141|NCT02962375|glycemic response|glycemic response
1032142|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
1032143|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
1032144|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
1032145|NCT02962271|Enthesopathy|enthesopathy
1032146|NCT02962245|Ulcerative Colitis|ulcerative colitis
1032147|NCT02962245|Berberine|berberine
1032148|NCT02962232|drug eluting balloon|drug eluting balloon
1032149|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
1032150|NCT02962219|oesophagectomy|oesophagectomy
1032151|NCT02962193|ADL|adl
1032152|NCT02962193|Bariatric surgery|bariatric surgery
1032153|NCT02962193|Daily participation|daily participation
1032154|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
1032155|NCT02962167|measles virus|measles virus
1032156|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
1032157|NCT02962167|recurrent ATRT|recurrent atrt
1032158|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
1032159|NCT02962154|Myocardial Infarction|myocardial infarction
1032160|NCT02962154|Major Depressive Disorder|major depressive disorder
1032161|NCT02962154|Bipolar I Disorder|bipolar i disorder
1032162|NCT02962154|Bipolar II Disorder|bipolar ii disorder
1032163|NCT02962154|Mental Stress|mental stress
1032164|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
1032165|NCT02962089|Protein-energy wasting|protein-energy wasting
1032166|NCT02962089|Hemodialysis patients|hemodialysis patients
1032167|NCT02962089|Microbiota|microbiota
1032168|NCT02962089|Branched chain amino acids|branched chain amino acids
1032169|NCT02962089|Undernutrition|undernutrition
1032170|NCT02962089|Malnutrition|malnutrition
1032171|NCT02962089|Renal failure|renal failure
1032172|NCT02962089|Dialysis|dialysis
1032173|NCT02962089|Protein|protein
1032174|NCT02962089|Appetite|appetite
1032175|NCT02962089|Body composition|body composition
1032176|NCT02962089|Energy expenditure|energy expenditure
1032177|NCT02962063|Durvalumab|durvalumab
1032178|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
1032179|NCT02962063|16-1405|16-1405
1032180|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
1032181|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
1032182|NCT02961998|sorafenib|sorafenib
1032183|NCT02961998|celecoxib|celecoxib
1032184|NCT02961972|vegetarianism|vegetarianism
1032185|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
1032186|NCT02961972|vegan vegetarian|vegan vegetarian
1032187|NCT02961933|hypoxemia|hypoxemia
1032188|NCT02961933|intubation|intubation
1032189|NCT02961933|apneic oxygenation|apneic oxygenation
1032190|NCT02961907|periconceptional habits|periconceptional habits
1032191|NCT02961907|Pregnancy|pregnancy
1032192|NCT02961907|Infertility|infertility
1032193|NCT02961894|Atherectomy|atherectomy
1032194|NCT02961894|Atherosclerosis|atherosclerosis
1032195|NCT02961868|Renal Artery Obstruction|renal artery obstruction
1032196|NCT02961868|Carotid Artery Diseases|carotid artery diseases
1032197|NCT02961868|Genetic Association Studies|genetic association studies
1032198|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
1032199|NCT02961829|antiretroviral intensification|antiretroviral intensification
1032200|NCT02961829|Auranofin|auranofin
1032201|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1032202|NCT02961829|residual viral replication|residual viral replication
1032203|NCT02961829|HIV sanctuaries|hiv sanctuaries
1032204|NCT02961829|HIV latency|hiv latency
1032205|NCT02961816|Lymphoma|lymphoma
1032206|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
1032207|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1032208|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
1032209|NCT02961816|T-cell Lymphoma|t-cell lymphoma
1032210|NCT02961816|Palifermin|palifermin
1032211|NCT02961816|Kepivance|kepivance
1032212|NCT02961816|Panobinostat|panobinostat
1032213|NCT02961816|LBH589B|lbh589b
1032214|NCT02961816|Gemcitabine|gemcitabine
1032215|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1032216|NCT02961816|Gemzar|gemzar
1032217|NCT02961816|Busulfan|busulfan
1032218|NCT02961816|Busulfex|busulfex
1032219|NCT02961816|Myleran|myleran
1032220|NCT02961816|Melphalan|melphalan
1032221|NCT02961816|Alkeran|alkeran
1032222|NCT02961816|Rituximab|rituximab
1032223|NCT02961816|Rituxan|rituxan
1032224|NCT02961816|Dexamethasone|dexamethasone
1032225|NCT02961816|Decadron|decadron
1032226|NCT02961816|Caphosol|caphosol
1032227|NCT02961816|Glutamine|glutamine
1032228|NCT02961816|Enterex|enterex
1032229|NCT02961816|Glutapak-10|glutapak-10
1032230|NCT02961816|NutreStore|nutrestore
1032231|NCT02961816|Resource|resource
1032232|NCT02961816|GlutaSolve|glutasolve
1032233|NCT02961816|Sympt-X G.I.|sympt-x g.i.
1032235|NCT02961816|Pyridoxine|pyridoxine
1032237|NCT02961816|Filgrastim|filgrastim
1032238|NCT02961816|Neupogen|neupogen
1032239|NCT02961816|Stem cell transplant|stem cell transplant
1032240|NCT02961803|AMN|amn
1032241|NCT02961803|MD1003|md1003
1032242|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
1032243|NCT02961803|ALD|ald
1032244|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
1032245|NCT02961803|Biotin|biotin
1032246|NCT02961803|2MWT|2mwt
1033143|NCT02956590|obesity|obesity
1032247|NCT02961803|Two-minute walk test|two-minute walk test
1032248|NCT02961803|TW25|tw25
1032249|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
1032250|NCT02961764|Critical Pathways|critical pathways
1032251|NCT02961764|Health Facilities|health facilities
1032252|NCT02961764|Clinical Protocols|clinical protocols
1032253|NCT02961764|Patient Satisfaction|patient satisfaction
1032254|NCT02961764|Absenteeism|absenteeism
1032255|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
1032256|NCT02961764|Quality of Life|quality of life
1032257|NCT02961764|Economics, Medical|economics, medical
1032258|NCT02961764|Health Resources|health resources
1032259|NCT02961764|Health resource utilization|health resource utilization
1032260|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
1032261|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
1032262|NCT02961751|Gyrase A Assay|gyrase a assay
1032263|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
1032264|NCT02961647|Hemodynamic stress test|hemodynamic stress test
1032265|NCT02961647|Surgical intervention|surgical intervention
1032266|NCT02961634|onychomycosis|onychomycosis
1032267|NCT02961634|nail|nail
1032268|NCT02961595|Oral polio vaccine|oral polio vaccine
1032269|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
1032270|NCT02961595|Enterovirus|enterovirus
1032271|NCT02961595|Type 1 diabetes|type 1 diabetes
1032272|NCT02961595|Autoantibody|autoantibody
1032273|NCT02961582|Sacral neuromodulation|sacral neuromodulation
1032274|NCT02961582|Constipation|constipation
1032275|NCT02961582|Slow-transit constipation|slow-transit constipation
1032276|NCT02961582|Surgery|surgery
1032277|NCT02961582|Colorectal surgery|colorectal surgery
1032278|NCT02961582|Cost-effectiveness|cost-effectiveness
1032279|NCT02961582|Quality of life|quality of life
1032280|NCT02961556|AJG555|ajg555
1032281|NCT02961556|Constipation|constipation
1032282|NCT02961556|Phase 3|phase 3
1032283|NCT02961556|Pediatric participants|pediatric participants
1032284|NCT02961491|MIBG|mibg
1032285|NCT02961491|Azedra|azedra
1032286|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
1032287|NCT02961491|Iobenguane I 131|iobenguane i 131
1032288|NCT02961491|Progenics|progenics
1032289|NCT02961465|Sacral neuromodulation|sacral neuromodulation
1032290|NCT02961465|Constipation|constipation
1032291|NCT02961465|Slow-transit constipation|slow-transit constipation
1032292|NCT02961465|Surgery|surgery
1032293|NCT02961465|Colorectal surgery|colorectal surgery
1032294|NCT02961465|Cost-effectiveness|cost-effectiveness
1032295|NCT02961465|Quality of life|quality of life
1032296|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
1032297|NCT02961361|dexmedetomidine|dexmedetomidine
1032298|NCT02961361|coracoid|coracoid
1032299|NCT02961361|brachial plexus block|brachial plexus block
1032300|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
1032301|NCT02961309|THC|thc
1032302|NCT02961309|marijuana|marijuana
1032303|NCT02961309|tobacco cigarette|tobacco cigarette
1032304|NCT02961309|smoking|smoking
1032305|NCT02961296|Helicobacter Pylori|helicobacter pylori
1032306|NCT02961283|BRAF Kinases|braf kinases
1032307|NCT02961283|PIK3CA protein, human|pik3ca protein, human
1032308|NCT02961244|Surgical Site Infection|surgical site infection
1032309|NCT02961244|normothermia|normothermia
1032310|NCT02961244|hypothermia|hypothermia
1032311|NCT02961244|prewarming|prewarming
1032312|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1032313|NCT02961231|Herd immunity|herd immunity
1032314|NCT02961231|Reduced dosing schedule|reduced dosing schedule
1032315|NCT02961218|Sickle cell disease|sickle cell disease
1032316|NCT02961218|hemoglobinopathy|hemoglobinopathy
1032317|NCT02961218|pediatric|pediatric
1032318|NCT02961166|IVIG|ivig
1032319|NCT02961166|ARDS|ards
1032320|NCT02961166|ECMO|ecmo
1032321|NCT02961140|Outcome|outcome
1032322|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
1032323|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
1032324|NCT02961114|Nocturia|nocturia
1032325|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
1032326|NCT02961101|relapsed or refractory|relapsed or refractory
1032327|NCT02961101|malignancies|malignancies
1032328|NCT02961101|decitabine|decitabine
1032329|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
1032330|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
1032331|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1032332|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1032333|NCT02961088|Clinical practice guidelines|clinical practice guidelines
1032434|NCT02960646|Filgrastim|filgrastim
1032334|NCT02961088|Glycemic index|glycemic index
1032335|NCT02961088|Pasta|pasta
1032336|NCT02961088|Glycemic load|glycemic load
1032337|NCT02961088|Body weight|body weight
1032338|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
1032339|NCT02961088|Cardiovascular disease|cardiovascular disease
1032340|NCT02961062|ocular pain|ocular pain
1032341|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
1032342|NCT02961062|SAF312|saf312
1032343|NCT02961062|corneal epithelial defect|corneal epithelial defect
1032344|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
1032345|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
1032346|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
1032347|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
1032348|NCT02960958|Metabolomics|metabolomics
1032349|NCT02960958|urine|urine
1032350|NCT02960932|Hemiplegic|hemiplegic
1032351|NCT02960932|Child|child
1032352|NCT02960932|Elastography|elastography
1032353|NCT02960932|paralysis|paralysis
1032354|NCT02960893|Ataxia|ataxia
1032356|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
1032357|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
1032358|NCT02960867|paediatric|paediatric
1032359|NCT02960867|kidney|kidney
1032360|NCT02960815|influenza vaccine|influenza vaccine
1032361|NCT02960815|Transplantation|transplantation
1032362|NCT02960815|imiquimod|imiquimod
1032363|NCT02960815|HIV infection|hiv infection
1032364|NCT02960815|immunogenicity|immunogenicity
1032365|NCT02960802|kidney transplant|kidney transplant
1032366|NCT02960802|renal blood flow|renal blood flow
1032367|NCT02960789|Dehydration|dehydration
1032368|NCT02960789|Children|children
1032369|NCT02960789|Measurement|measurement
1032370|NCT02960776|Body Weight|body weight
1032371|NCT02960776|Habitual sleep|habitual sleep
1032372|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
1032373|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
1032374|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
1032375|NCT02960750|workplace|workplace
1032376|NCT02960750|sedentary behavior|sedentary behavior
1032377|NCT02960750|physical activity|physical activity
1032378|NCT02960750|physical risk factors|physical risk factors
1032379|NCT02960750|mental well-being|mental well-being
1032380|NCT02960750|presenteeism|presenteeism
1032381|NCT02960750|work productivity|work productivity
1032382|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
1032383|NCT02960737|Dysphagia|dysphagia
1032384|NCT02960737|Stroke|stroke
1032385|NCT02960737|Intervention|intervention
1032386|NCT02960737|Oral screen|oral screen
1032387|NCT02960737|Incidence|incidence
1032388|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
1032389|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
1032390|NCT02960724|oral cancer|oral cancer
1032391|NCT02960724|Positron Emission Tomography|positron emission tomography
1032392|NCT02960698|cognitive impulsivity|cognitive impulsivity
1032393|NCT02960698|IRM|irm
1032394|NCT02960698|Tourette Syndrome|tourette syndrome
1032395|NCT02960672|KL-6|kl-6
1032396|NCT02960672|disease progression|disease progression
1032397|NCT02960672|predict|predict
1032398|NCT02960672|biomarkers|biomarkers
1032399|NCT02960672|MMP-7|mmp-7
1032400|NCT02960659|Metformin|metformin
1032401|NCT02960659|Glucose|glucose
1032402|NCT02960646|Leukemia|leukemia
1032403|NCT02960646|Blood And Marrow Transplantation|blood and marrow transplantation
1032404|NCT02960646|Acute lymphocytic leukemia|acute lymphocytic leukemia
1032405|NCT02960646|ALL|all
1032406|NCT02960646|Acute myeloid leukemia|acute myeloid leukemia
1032407|NCT02960646|AML|aml
1032408|NCT02960646|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1032409|NCT02960646|CLL|cll
1032410|NCT02960646|Chronic myeloid leukemia|chronic myeloid leukemia
1032411|NCT02960646|CML|cml
1032412|NCT02960646|Hodgkin's disease|hodgkin's disease
1032413|NCT02960646|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1032414|NCT02960646|NHL|nhl
1032415|NCT02960646|Small lymphocytic lymphoma|small lymphocytic lymphoma
1032416|NCT02960646|SLL|sll
1032417|NCT02960646|Myelodysplastic syndrome (MDS|myelodysplastic syndrome (mds
1032418|NCT02960646|MDS|mds
1032419|NCT02960646|Aplastic anemia|aplastic anemia
1032420|NCT02960646|Modified (CD45RA depleted) peripheral blood (PB) stem cell infusion|modified (cd45ra depleted) peripheral blood (pb) stem cell infusion
1032421|NCT02960646|T cells|t cells
1032422|NCT02960646|Haploidentical transplantation|haploidentical transplantation
1032423|NCT02960646|Rituximab|rituximab
1032424|NCT02960646|Rituxan|rituxan
1032425|NCT02960646|Melphalan|melphalan
1032426|NCT02960646|Alkeran|alkeran
1032427|NCT02960646|Fludarabine|fludarabine
1032428|NCT02960646|Fludarabine Phosphate|fludarabine phosphate
1032430|NCT02960646|Cyclophosphamide|cyclophosphamide
1032431|NCT02960646|Cytoxan|cytoxan
1032432|NCT02960646|Neosar|neosar
1032433|NCT02960646|G-CSF|g-csf
1032435|NCT02960646|Neupogen|neupogen
1032436|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
1032437|NCT02960620|Liver Disease|liver disease
1032438|NCT02960620|HDE #980006|hde #980006
1032439|NCT02960594|Immunotherapy|immunotherapy
1032440|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
1032441|NCT02960594|Breast Neoplasms|breast neoplasms
1032442|NCT02960594|Lung Neoplasms|lung neoplasms
1032443|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
1032444|NCT02960594|High Risk of Relapse|high risk of relapse
1032445|NCT02960594|Post Definitive Surgery|post definitive surgery
1032446|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
1032447|NCT02960594|No Evidence of Disease|no evidence of disease
1032448|NCT02960568|primaquine|primaquine
1032449|NCT02960568|metabolism|metabolism
1032450|NCT02960568|malaria|malaria
1032451|NCT02960568|hypnozoite|hypnozoite
1032452|NCT02960568|vivax|vivax
1032453|NCT02960568|CYP2D6|cyp2d6
1032454|NCT02960568|active duty personnel|active duty personnel
1032455|NCT02960555|Myeloma|myeloma
1032456|NCT02960555|Smoldering Multiple Myeloma|smoldering multiple myeloma
1032458|NCT02960555|Intermediate or high risk|intermediate or high risk
1032459|NCT02960555|SAR650984|sar650984
1032460|NCT02960555|Diphenhydramine|diphenhydramine
1032461|NCT02960555|Benadryl|benadryl
1032462|NCT02960555|Ranitidine|ranitidine
1032463|NCT02960555|Ranitidine Hydrochloride|ranitidine hydrochloride
1032464|NCT02960555|Zantac|zantac
1032465|NCT02960555|Methylprednisolone|methylprednisolone
1032466|NCT02960555|Depo-Medrol|depo-medrol
1032467|NCT02960555|Medrol|medrol
1032468|NCT02960555|Solu-Medrol|solu-medrol
1032469|NCT02960542|lifestyle intervention|lifestyle intervention
1032470|NCT02960542|weight-loss|weight-loss
1032471|NCT02960503|sickle cell disease|sickle cell disease
1032472|NCT02960503|pulmonary complications|pulmonary complications
1032473|NCT02960503|reduced FEV1|reduced fev1
1032474|NCT02960503|azithromycin|azithromycin
1032475|NCT02960503|lung function|lung function
1032476|NCT02960490|E6011|e6011
1032477|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
1032478|NCT02960477|Shoulder pain|shoulder pain
1032479|NCT02960477|Shoulder surgery|shoulder surgery
1032480|NCT02960477|Pain neuroscience education|pain neuroscience education
1032481|NCT02960477|Chronic pain|chronic pain
1032482|NCT02960464|Parkinson Disease|parkinson disease
1032483|NCT02960464|Depression|depression
1032484|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1032485|NCT02960464|Neuromodulation|neuromodulation
1032486|NCT02960451|prodrome|prodrome
1032487|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
1032488|NCT02960451|family focused therapy|family focused therapy
1032489|NCT02960438|E6011|e6011
1032490|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
1032491|NCT02960373|Dried fruit|dried fruit
1032492|NCT02960373|Glycemic Index|glycemic index
1032493|NCT02960373|Catalytic dose|catalytic dose
1032494|NCT02960373|Glycemic response|glycemic response
1032495|NCT02960373|Fructose|fructose
1032496|NCT02960373|Postprandial|postprandial
1032497|NCT02960373|Randomized clinical trial|randomized clinical trial
1032498|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
1032499|NCT02960334|Screening|screening
1032500|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
1032501|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
1032502|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
1032503|NCT02960334|MyDiagnostick|mydiagnostick
1032504|NCT02960334|Opportunistic Screening|opportunistic screening
1032505|NCT02960334|Preoperative Consultation|preoperative consultation
1032506|NCT02960334|OAC|oac
1032507|NCT02960334|VKA|vka
1032508|NCT02960334|NOAC|noac
1032509|NCT02960321|myocardial injury|myocardial injury
1032510|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
1032511|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
1032512|NCT02960269|rural health|rural health
1032513|NCT02960269|telehealth|telehealth
1032514|NCT02960269|physiotherapy|physiotherapy
1032515|NCT02960269|interprofessional|interprofessional
1032516|NCT02960243|Deep Brain Stimulation|deep brain stimulation
1032517|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
1032518|NCT02960243|Essential Voice Tremor|essential voice tremor
1032519|NCT02960243|Essential Tremor|essential tremor
1032520|NCT02960230|peptide vaccine|peptide vaccine
1032521|NCT02960230|immunotherapy|immunotherapy
1032522|NCT02960230|DIPG|dipg
1032523|NCT02960230|vaccine|vaccine
1032524|NCT02960204|cirrhosis|cirrhosis
1032525|NCT02960204|Portal Hypertension|portal hypertension
1032526|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1032527|NCT02960204|Liver cirrhosis|liver cirrhosis
1032528|NCT02960152|periodontitis|periodontitis
1032529|NCT02960113|cesarean section|cesarean section
1032530|NCT02960113|acupressure point p6|acupressure point p6
1032531|NCT02960113|scopolamine patch|scopolamine patch
1032532|NCT02960100|Cancer prevention|cancer prevention
1032533|NCT02960100|HPV|hpv
1032534|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
1032535|NCT02960074|Allergy, Peanut|allergy, peanut
1032536|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
1032537|NCT02960074|Peanut Allergy|peanut allergy
1032538|NCT02960074|Donor Feces Infusion|donor feces infusion
1032539|NCT02960074|Fecal Transplant|fecal transplant
1032540|NCT02960074|Fecal Transplantation|fecal transplantation
1032541|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
1032542|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
1032543|NCT02960074|Food allergy|food allergy
1032544|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1032545|NCT02960061|gastric cancer|gastric cancer
1033653|NCT02953678|ruxolitinib|ruxolitinib
1032546|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1032547|NCT02960048|Anterior disc displacement|anterior disc displacement
1032548|NCT02960048|TMD therapy|tmd therapy
1032549|NCT02960048|internal derangement|internal derangement
1032550|NCT02960048|occlusal splint|occlusal splint
1032551|NCT02960048|anterior repositioning splint|anterior repositioning splint
1032552|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
1032553|NCT02960035|Spondyloarthropathy|spondyloarthropathy
1032554|NCT02960035|Ultrasonics|ultrasonics
1032555|NCT02960035|Etanercept|etanercept
1032556|NCT02960022|prostate cancer|prostate cancer
1032557|NCT02960022|prednisone|prednisone
1032558|NCT02960022|MDV3100|mdv3100
1032559|NCT02960022|enzalutamide|enzalutamide
1032560|NCT02960022|Xtandi|xtandi
1032561|NCT02960022|abiraterone acetate|abiraterone acetate
1032562|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
1032563|NCT02959944|PCYC1140|pcyc1140
1032564|NCT02959944|PCYC1140IM|pcyc1140im
1032565|NCT02959944|1140|1140
1032566|NCT02959944|Ibrutinib|ibrutinib
1032567|NCT02959944|GVHD|gvhd
1032568|NCT02959944|Steroid dependent|steroid dependent
1032569|NCT02959944|refractory|refractory
1032570|NCT02959944|chronic|chronic
1032571|NCT02959944|PCI32765|pci32765
1032572|NCT02959944|IMBRUVICA|imbruvica
1032573|NCT02959944|Pharmacyclics|pharmacyclics
1032574|NCT02959944|PCYC|pcyc
1032575|NCT02959944|graft versus host disease|graft versus host disease
1032576|NCT02959944|immunology|immunology
1032577|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
1032578|NCT02959944|INTEGRATE|integrate
1032579|NCT02959944|Corticosteroids|corticosteroids
1032580|NCT02959944|prednisone|prednisone
1032581|NCT02959931|Dietary Potassium|dietary potassium
1032582|NCT02959892|Drug therapy|drug therapy
1032583|NCT02959879|FOLFOX|folfox
1032584|NCT02959879|FOLFIRINOX|folfirinox
1032585|NCT02959853|Hypogonadism|hypogonadism
1032586|NCT02959853|Severe obesity|severe obesity
1032587|NCT02959827|Hypothyroidism,|hypothyroidism,
1032588|NCT02959827|children,|children,
1032589|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
1032590|NCT02959827|retrospective cohort,|retrospective cohort,
1032591|NCT02959827|database|database
1032592|NCT02959814|Fractional Flow Reserve|fractional flow reserve
1032593|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
1032594|NCT02959814|Stable coronary artery disease|stable coronary artery disease
1032595|NCT02959814|Angina pectoris|angina pectoris
1032596|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
1032597|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
1032598|NCT02959788|Heart rate variability|heart rate variability
1032599|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
1032600|NCT02959775|Immunogenicity|immunogenicity
1032601|NCT02959775|Randomized controlled trial|randomized controlled trial
1032602|NCT02959775|Drug abuse|drug abuse
1032603|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
1032604|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
1032605|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
1032606|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
1032607|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
1032608|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
1032609|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
1032610|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
1032611|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
1032612|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
1032613|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
1032614|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
1032615|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
1032616|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
1032617|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
1032618|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
1032619|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
1032620|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
1032621|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
1032622|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
1032623|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
1032624|NCT02959749|Osimertinib|osimertinib
1032625|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
1032626|NCT02959749|Docetaxel|docetaxel
1032627|NCT02959749|Bevacizumab|bevacizumab
1032628|NCT02959749|Non Small Cell Lung|non small cell lung
1032629|NCT02959736|Vegetative State (VS)|vegetative state (vs)
1032630|NCT02959736|Minimally Conscious State (MCS)|minimally conscious state (mcs)
1032631|NCT02959736|Brain Injuries|brain injuries
1032632|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1032633|NCT02959723|BMPR2|bmpr2
1032634|NCT02959723|Inflammation|inflammation
1032635|NCT02959710|Healthy volunteers|healthy volunteers
1032636|NCT02959710|AC-1202|ac-1202
1032637|NCT02959710|AC-1204|ac-1204
1032638|NCT02959710|Pharmacokinetic|pharmacokinetic
1032640|NCT02959697|Blepharoptosis|blepharoptosis
1032641|NCT02959697|Ptosis|ptosis
1032642|NCT02959697|Surgery|surgery
1032643|NCT02959697|Pain Reduction|pain reduction
1032644|NCT02959697|Anesthetic|anesthetic
1032645|NCT02959697|Local Anesthetic|local anesthetic
1032646|NCT02959697|Subconjunctival|subconjunctival
1032647|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
1032648|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
1032649|NCT02959593|visual stimulation|visual stimulation
1032650|NCT02959580|Granulomatous|granulomatous
1032651|NCT02959580|Mastitis|mastitis
1032652|NCT02959580|topical steroids|topical steroids
1032653|NCT02959567|cervix|cervix
1032654|NCT02959567|cervical dilation|cervical dilation
1032655|NCT02959567|balloon catheter|balloon catheter
1032656|NCT02959554|Advanced|advanced
1032657|NCT02959554|Metastatic|metastatic
1032659|NCT02959541|Leukovorin|leukovorin
1032660|NCT02959476|Postoperative pain|postoperative pain
1032661|NCT02959476|Postsurgical pain|postsurgical pain
1032662|NCT02959463|Malignant pleural mesothelioma|malignant pleural mesothelioma
1032663|NCT02959463|MPM|mpm
1032664|NCT02959463|Non-metastatic|non-metastatic
1032665|NCT02959463|Pembrolizumab|pembrolizumab
1032666|NCT02959463|Keytruda|keytruda
1032667|NCT02959463|MK-3475|mk-3475
1032668|NCT02959463|SCH-900475|sch-900475
1032669|NCT02959463|Radiation therapy|radiation therapy
1032670|NCT02959463|Radiation treatment|radiation treatment
1032671|NCT02959463|XRT|xrt
1032672|NCT02959463|Intensity modulated radiation therapy|intensity modulated radiation therapy
1032673|NCT02959463|IMRT|imrt
1032674|NCT02959463|Proton beam therapy|proton beam therapy
1032675|NCT02959463|PBT|pbt
1032676|NCT02959463|3D conformal therapy|3d conformal therapy
1032677|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
1032678|NCT02959437|Solid tumors|solid tumors
1032679|NCT02959437|NSCLC|nsclc
1032680|NCT02959437|CRC|crc
1032681|NCT02959359|Chronic hepatitis C|chronic hepatitis c
1032682|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
1032683|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
1032684|NCT02959359|Recurrence|recurrence
1032685|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
1032686|NCT02959346|Pain control|pain control
1032687|NCT02959346|Acupuncture|acupuncture
1032688|NCT02959346|Randomized controlled trial|randomized controlled trial
1032689|NCT02959307|Depression|depression
1032690|NCT02959307|Major Depressive Disorder|major depressive disorder
1032691|NCT02959307|Major Depressive Episode|major depressive episode
1032692|NCT02959294|TBI|tbi
1032693|NCT02959294|mTBI|mtbi
1032694|NCT02959294|Concussion, Brain|concussion, brain
1032695|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
1032696|NCT02959294|Headaches|headaches
1032697|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
1032698|NCT02959229|Late onset sepsis|late onset sepsis
1032699|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
1032700|NCT02959216|Aerobic Exercise|aerobic exercise
1032701|NCT02959203|Central Venous Catheter|central venous catheter
1032702|NCT02959203|Ultrasound|ultrasound
1032703|NCT02959203|Chest X-ray|chest x-ray
1032704|NCT02959203|Pneumothorax|pneumothorax
1032705|NCT02959190|prevention|prevention
1032706|NCT02959190|prophylaxis|prophylaxis
1032707|NCT02959190|headache|headache
1032708|NCT02959177|prevention|prevention
1032709|NCT02959177|prophylaxis|prophylaxis
1032710|NCT02959177|headache|headache
1032711|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
1032712|NCT02959112|epinephrine|epinephrine
1032713|NCT02959112|papilla|papilla
1032714|NCT02959112|rectal indomethacin|rectal indomethacin
1032715|NCT02959099|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
1032716|NCT02959099|Atherosclerotic plaque morphology|atherosclerotic plaque morphology
1032717|NCT02959099|Coronary Computed Tomographic Angiography (CCTA)|coronary computed tomographic angiography (ccta)
1032718|NCT02959099|Gender disparities|gender disparities
1063507|NCT02769923|IPV|ipv
1032719|NCT02959086|Epidemiology|epidemiology
1032720|NCT02959086|Shanghai|shanghai
1032721|NCT02959086|Cancer|cancer
1032722|NCT02959086|Adolescents|adolescents
1032723|NCT02959086|Children|children
1032724|NCT02959073|Symptom recording|symptom recording
1032725|NCT02959047|MRI|mri
1032726|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
1032727|NCT02959047|LDL cholesterol|ldl cholesterol
1032728|NCT02959021|weight loss|weight loss
1032729|NCT02959021|behavioral|behavioral
1032730|NCT02959021|primary care|primary care
1032731|NCT02959021|lifestyle|lifestyle
1032732|NCT02958995|Drug Therapy|drug therapy
1032733|NCT02958982|RP3128|rp3128
1032734|NCT02958982|Phase 1|phase 1
1032735|NCT02958982|Healthy volunteers|healthy volunteers
1032736|NCT02958969|venous thromboembolism|venous thromboembolism
1032737|NCT02958969|multiple myeloma|multiple myeloma
1032738|NCT02958969|anticoagulation|anticoagulation
1032739|NCT02958956|Drug Therapy|drug therapy
1032740|NCT02958943|atrial fibrillation|atrial fibrillation
1032741|NCT02958943|stroke|stroke
1032742|NCT02958943|computerized decision support|computerized decision support
1032744|NCT02958904|Spinal cord injuries|spinal cord injuries
1032745|NCT02958904|Erectile dysfunction|erectile dysfunction
1032746|NCT02958904|depression|depression
1032747|NCT02958865|Mayo score|mayo score
1032748|NCT02958852|Breast Cancer|breast cancer
1032749|NCT02958852|Endocrine Treatment|endocrine treatment
1032750|NCT02958852|Atorvastatin|atorvastatin
1032751|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
1032752|NCT02958852|Statins|statins
1032753|NCT02958852|Fulvestrant|fulvestrant
1032754|NCT02958852|Circulating Tumor Cells|circulating tumor cells
1032755|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
1032756|NCT02958852|Tumor Marker Expression|tumor marker expression
1032757|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
1032758|NCT02958852|Circulating Tumor DNA|circulating tumor dna
1032759|NCT02958852|Cholesterol|cholesterol
1032760|NCT02958839|Atrial fibrillation|atrial fibrillation
1032761|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
1032762|NCT02958800|Deprescribing|deprescribing
1032763|NCT02958800|Single patient open label trial|single patient open label trial
1032764|NCT02958800|Long-term care|long-term care
1032765|NCT02958761|knee arthrosis|knee arthrosis
1032766|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
1032767|NCT02958735|exercise|exercise
1032768|NCT02958735|cognition|cognition
1032769|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
1032770|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
1032771|NCT02958735|cortisol|cortisol
1032772|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
1032773|NCT02958683|Structure light plethysmography|structure light plethysmography
1032774|NCT02958683|Respiratory Function Tests|respiratory function tests
1032775|NCT02958657|Platelet function|platelet function
1032776|NCT02958657|Autonomic Nervous System|autonomic nervous system
1032777|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
1032778|NCT02958657|VerifyNow®|verifynow®
1032779|NCT02958644|synbiotic|synbiotic
1032780|NCT02958644|obesity|obesity
1032781|NCT02958644|body mass index|body mass index
1032782|NCT02958644|microbiota|microbiota
1032783|NCT02958605|Children|children
1032784|NCT02958605|resuscitation|resuscitation
1032785|NCT02958605|smartphone|smartphone
1032786|NCT02958592|shear-wave elastography|shear-wave elastography
1032787|NCT02958592|hepatic fibrosis|hepatic fibrosis
1032788|NCT02958592|liver tumor|liver tumor
1032789|NCT02958566|Pain control|pain control
1032790|NCT02958566|Post-operative pain|post-operative pain
1032791|NCT02958566|Narcotic|narcotic
1032792|NCT02958566|Non-narcotic|non-narcotic
1032793|NCT02958566|Side effect|side effect
1032794|NCT02958566|Toxicity|toxicity
1032795|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
1032796|NCT02958553|Prosthesis Use|prosthesis use
1032797|NCT02958540|Prophylaxis|prophylaxis
1032798|NCT02958527|Effexor|effexor
1032799|NCT02958527|Depression|depression
1032800|NCT02958527|Depressed state|depressed state
1032801|NCT02958514|IPL|ipl
1032802|NCT02958514|MGD|mgd
1032803|NCT02958501|Vitamin D|vitamin d
1032804|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
1032805|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
1032806|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
1032807|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
1032808|NCT02958436|Safety|safety
1032809|NCT02958436|Tolerability|tolerability
1032810|NCT02958436|Pharmacokinetics|pharmacokinetics
1032811|NCT02958436|REGN3500|regn3500
1032812|NCT02958410|CD30|cd30
1032813|NCT02958410|CAR-T|car-t
1032814|NCT02958397|Myeloid Malignancies|myeloid malignancies
1032815|NCT02958397|CAR-T|car-t
1032816|NCT02958397|CD33|cd33
1032817|NCT02958384|Myeloid Malignancies|myeloid malignancies
1032818|NCT02958384|CAR-T|car-t
1032819|NCT02958384|LeY|ley
1032820|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
1032821|NCT02958371|Taste|taste
1032822|NCT02958371|Feeding behavior|feeding behavior
1032823|NCT02958371|Choice behavior|choice behavior
1032824|NCT02958358|pulmonary hypertension|pulmonary hypertension
1032825|NCT02958358|ambrisentan|ambrisentan
1032826|NCT02958358|PET imaging|pet imaging
1032827|NCT02958358|CT/PET|ct/pet
1032828|NCT02958332|video games|video games
1032829|NCT02958306|cleft lip repair|cleft lip repair
1032830|NCT02958306|cheiloplasty|cheiloplasty
1032832|NCT02958306|platelet rich plasma|platelet rich plasma
1032833|NCT02958280|Exercise|exercise
1032834|NCT02958280|Smartphone|smartphone
1032835|NCT02958267|knee osteoarthritis|knee osteoarthritis
1032836|NCT02958267|regenerative medicine|regenerative medicine
1032837|NCT02958267|orthobiologics|orthobiologics
1032838|NCT02958267|cellular therapy|cellular therapy
1032839|NCT02958254|hamstring|hamstring
1032840|NCT02958254|ultrasonography|ultrasonography
1032841|NCT02958254|validation|validation
1032842|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
1032843|NCT02958254|muscle thickness|muscle thickness
1032844|NCT02958241|spondylolisthesis|spondylolisthesis
1032845|NCT02958241|Lumbar spine|lumbar spine
1032847|NCT02958228|Positive Affect|positive affect
1032848|NCT02958228|Mental Imagery|mental imagery
1032849|NCT02958228|Cognitive Bias Modification|cognitive bias modification
1032850|NCT02958228|Cognitive Control Training|cognitive control training
1032851|NCT02958215|Orthostatic|orthostatic
1032852|NCT02958215|Cesarean section|cesarean section
1032853|NCT02958215|Pregnant|pregnant
1032854|NCT02958215|Phenyephrine|phenyephrine
1032855|NCT02958215|Hypotension|hypotension
1032856|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1032857|NCT02958202|DMD|dmd
1032858|NCT02958202|Dystrophin|dystrophin
1032859|NCT02958202|BMN 044|bmn 044
1032860|NCT02958202|PRO044|pro044
1032861|NCT02958202|BioMarin|biomarin
1032862|NCT02958189|Twitter|twitter
1032863|NCT02958189|social support|social support
1032864|NCT02958189|internet intervention|internet intervention
1032865|NCT02958189|sedentary lifestyle|sedentary lifestyle
1032866|NCT02958189|walking|walking
1032867|NCT02958189|behavior change|behavior change
1032868|NCT02958163|Hepatocellular cancer|hepatocellular cancer
1032869|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1032870|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1032871|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1032872|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
1032873|NCT02958111|Capecitabine|capecitabine
1032874|NCT02958098|myocardial infarction|myocardial infarction
1032875|NCT02958098|stroke|stroke
1032876|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
1032877|NCT02958098|systolic heart failure|systolic heart failure
1032878|NCT02958098|atrial fibrillation|atrial fibrillation
1032879|NCT02958098|aortic dissection|aortic dissection
1032880|NCT02958098|wearable devices|wearable devices
1032881|NCT02958098|genomic sequencing|genomic sequencing
1032882|NCT02958072|Malleoli ulcers|malleoli ulcers
1032883|NCT02958072|Diabetes|diabetes
1032884|NCT02958072|Healing|healing
1032885|NCT02958072|Dressing|dressing
1032886|NCT02958072|LeucoPatch|leucopatch
1032887|NCT02958059|ERCP|ercp
1032888|NCT02958059|prophylaxis|prophylaxis
1032889|NCT02958059|antibiotics|antibiotics
1032890|NCT02958059|infection|infection
1032891|NCT02958059|cholangitis|cholangitis
1032892|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
1032893|NCT02957981|BRCA1|brca1
1032894|NCT02957981|BRCA2|brca2
1032895|NCT02957981|Men|men
1032896|NCT02957981|Hereditary Cancer|hereditary cancer
1032897|NCT02957981|Prostate Cancer|prostate cancer
1032898|NCT02957981|Male Breast Cancer|male breast cancer
1032899|NCT02957968|Breast Cancer|breast cancer
1032900|NCT02957955|Heart failure|heart failure
1032901|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1032902|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
1032903|NCT02957942|Dystonia|dystonia
1032904|NCT02957877|Anticoagulation|anticoagulation
1032905|NCT02957877|Anti-Xa activity|anti-xa activity
1032906|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
1032907|NCT02957877|Unfractionated heparin|unfractionated heparin
1032908|NCT02957838|Transferrin Receptor|transferrin receptor
1032909|NCT02957838|Type 2 Diabetes|type 2 diabetes
1032910|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
1032911|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
1032912|NCT02957838|Crossover Study|crossover study
1032913|NCT02957812|Gait|gait
1032914|NCT02957812|Balance Control|balance control
1032915|NCT02957812|Orthotics|orthotics
1032916|NCT02957799|Pregnancy|pregnancy
1032917|NCT02957799|Home Healthcare Visits|home healthcare visits
1032918|NCT02957799|Community Health Workers|community health workers
1032919|NCT02957799|Infants|infants
1032920|NCT02957786|cytisine|cytisine
1032921|NCT02957786|varenicline|varenicline
1063752|NCT02768324|sepsis|sepsis
1032922|NCT02957786|smoking cessation|smoking cessation
1032923|NCT02957786|indigenous|indigenous
1032924|NCT02957747|Women Veterans|women veterans
1032925|NCT02957747|Sexual Trauma|sexual trauma
1032926|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
1032927|NCT02957734|Direct composite restorations|direct composite restorations
1032928|NCT02957734|Indirect composite restorations|indirect composite restorations
1032929|NCT02957734|Tooth wear|tooth wear
1032930|NCT02957734|Failure|failure
1032931|NCT02957734|Quality of Life|quality of life
1032932|NCT02957695|frontal brain lesions|frontal brain lesions
1032933|NCT02957695|neurofeedback|neurofeedback
1032934|NCT02957695|cognitive functions|cognitive functions
1032935|NCT02957682|Hyperlipidemias|hyperlipidemias
1032936|NCT02957682|Dyslipidemias|dyslipidemias
1032937|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
1032938|NCT02957630|Estetrol (E4)|estetrol (e4)
1032939|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
1032940|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
1032941|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
1032942|NCT02957630|Oral contraceptive|oral contraceptive
1032943|NCT02957630|Prevention of pregnancy|prevention of pregnancy
1032944|NCT02957630|Hemostasis|hemostasis
1032945|NCT02957630|Metabolism|metabolism
1032946|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy|neuropathic pain from lumbosacral radiculopathy
1032947|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol|pregnancy; cardiovascular diseases; high serum cholesterol
1032948|NCT02957591|Depression|depression
1032949|NCT02957591|probiotic supplementation|probiotic supplementation
1032950|NCT02957591|Adjuvant Therapy|adjuvant therapy
1032951|NCT02957591|Gut microbiome|gut microbiome
1032952|NCT02957591|Psychological functioning|psychological functioning
1032953|NCT02957591|Brain imaging|brain imaging
1032954|NCT02957591|Brain-Gut interactions|brain-gut interactions
1032955|NCT02957591|Sleep|sleep
1032956|NCT02957578|Tympanostomy Tube|tympanostomy tube
1032957|NCT02957578|Ventilation Tube|ventilation tube
1032958|NCT02957578|Grommet|grommet
1032959|NCT02957578|Otitis Media|otitis media
1032960|NCT02957578|Middle Ear Effusion|middle ear effusion
1032961|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1032962|NCT02957565|Questionnaires|questionnaires
1032963|NCT02957565|Surveys|surveys
1032964|NCT02957565|Videos|videos
1032965|NCT02957565|Advanced Cancer|advanced cancer
1032966|NCT02957539|motivation|motivation
1032967|NCT02957539|patient incentives|patient incentives
1032968|NCT02957513|Diabetes|diabetes
1032969|NCT02957513|Uncontrolled|uncontrolled
1032970|NCT02957513|Chronic Disease|chronic disease
1032971|NCT02957513|Chronic Conditions|chronic conditions
1032972|NCT02957513|Medically Underserved Areas|medically underserved areas
1032973|NCT02957513|African Americans|african americans
1032974|NCT02957513|Health Coaching|health coaching
1032975|NCT02957513|Health Education|health education
1032976|NCT02957513|Text Messaging|text messaging
1032977|NCT02957513|Text Messages|text messages
1032978|NCT02957513|Mobile Health|mobile health
1032979|NCT02957474|Healthy Volunteers|healthy volunteers
1032980|NCT02957474|Pharmacokinetics|pharmacokinetics
1032981|NCT02957474|Food Effect|food effect
1032982|NCT02957474|Proton Pump|proton pump
1032983|NCT02957474|GED-0301|ged-0301
1032984|NCT02957474|Mongersen|mongersen
1032985|NCT02957422|milk|milk
1032986|NCT02957422|brain aging|brain aging
1032987|NCT02957422|antioxidant|antioxidant
1032988|NCT02957422|glutathione|glutathione
1032989|NCT02957422|dietary intervention|dietary intervention
1032990|NCT02957422|brain imaging|brain imaging
1032991|NCT02957409|Heart failure|heart failure
1032992|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
1032993|NCT02957409|HFrEF|hfref
1032994|NCT02957383|Sleep, Melatonin|sleep, melatonin
1032995|NCT02957383|Circadian Rhythm|circadian rhythm
1032996|NCT02957383|Temperature|temperature
1032997|NCT02957383|screen illumination|screen illumination
1032998|NCT02957344|health communication|health communication
1032999|NCT02957344|Zika virus|zika virus
1033000|NCT02957344|legislation|legislation
1033001|NCT02957344|vaccination|vaccination
1033002|NCT02957344|Child Care|child care
1033003|NCT02957305|misoprostol|misoprostol
1033004|NCT02957305|miscarriage|miscarriage
1033005|NCT02957279|sepsis|sepsis
1033006|NCT02957279|exosomes|exosomes
1033007|NCT02957279|dendritic cell|dendritic cell
1033008|NCT02957266|cervical cancer|cervical cancer
1033009|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
1033010|NCT02957266|gemcitabine|gemcitabine
1033011|NCT02957266|volumetric arc therapy|volumetric arc therapy
1033012|NCT02957253|Quality of care|quality of care
1033013|NCT02957253|Health related quality of life|health related quality of life
1033014|NCT02957253|Nurse-led clinic|nurse-led clinic
1033015|NCT02957253|Health economics|health economics
1033016|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
1033017|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
1333217|NCT01443949|fMRI|fmri
1033018|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
1033019|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
1033020|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
1033021|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
1033022|NCT02957240|motor representation techniques|motor representation techniques
1033023|NCT02957240|mirror therapy|mirror therapy
1033024|NCT02957240|Women [M01.975]|women [m01.975]
1033025|NCT02957227|Alzheimer's disease|alzheimer's disease
1033026|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
1033027|NCT02957227|Lewy Body Dementia|lewy body dementia
1033028|NCT02957227|Diagnosis|diagnosis
1033029|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
1033030|NCT02957188|Arachidonic acid|arachidonic acid
1033031|NCT02957188|Metabolism|metabolism
1033032|NCT02957188|Healthy aging|healthy aging
1033033|NCT02957175|Immunophenotyping|immunophenotyping
1033034|NCT02957175|Perioperative Care|perioperative care
1033035|NCT02957175|Innate Immunity|innate immunity
1033036|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
1033037|NCT02957136|Respiratory Tract Infections|respiratory tract infections
1033038|NCT02957136|Influenza, Human|influenza, human
1033039|NCT02957136|Common Cold|common cold
1033040|NCT02957136|Viral Infection|viral infection
1033041|NCT02957136|Pathology, Molecular|pathology, molecular
1033042|NCT02957136|Molecular Diagnostics|molecular diagnostics
1033043|NCT02957136|Diagnostic Testing|diagnostic testing
1033044|NCT02957136|Clinical Microbiology|clinical microbiology
1033045|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
1033046|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
1033047|NCT02957136|Antimicrobial Use|antimicrobial use
1033048|NCT02957136|Emergency Department|emergency department
1033049|NCT02957136|Emergency Room|emergency room
1033050|NCT02957123|macrophages M2 type|macrophages m2 type
1033051|NCT02957123|cytokines|cytokines
1033052|NCT02957123|intranasal administration|intranasal administration
1033053|NCT02957123|neuroprotection|neuroprotection
1033054|NCT02957123|neuroregeneration|neuroregeneration
1033055|NCT02957123|organic brain syndrome|organic brain syndrome
1033056|NCT02957123|neurocognitive disorders|neurocognitive disorders
1033057|NCT02957097|Gabapentin|gabapentin
1033058|NCT02957097|acute pain|acute pain
1033059|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
1033060|NCT02957084|neck circumference|neck circumference
1033061|NCT02957084|sternomental distance|sternomental distance
1033062|NCT02957084|thyromental distance|thyromental distance
1033063|NCT02957084|hyomental distance|hyomental distance
1033064|NCT02957084|thyrosternal distance|thyrosternal distance
1033065|NCT02957058|Colonoscopy|colonoscopy
1033066|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
1033067|NCT02957058|Adenoma Recurrence|adenoma recurrence
1033068|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
1033069|NCT02956993|peripheral artery disease|peripheral artery disease
1033071|NCT02956993|vonapanitase|vonapanitase
1033072|NCT02956993|critical limb ischemia|critical limb ischemia
1033073|NCT02956993|CLI|cli
1033074|NCT02956993|tibial artery|tibial artery
1033075|NCT02956993|stenosis|stenosis
1033076|NCT02956993|distal popliteal artery|distal popliteal artery
1033077|NCT02956993|peroneal artery|peroneal artery
1033078|NCT02956993|below the knee|below the knee
1033079|NCT02956993|BTK|btk
1033080|NCT02956993|elastase|elastase
1033081|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
1033082|NCT02956993|CELA1|cela1
1033083|NCT02956993|PRT-201|prt-201
1033084|NCT02956980|type 1 interferons|type 1 interferons
1033085|NCT02956980|children|children
1033086|NCT02956980|gender|gender
1033087|NCT02956980|pubertal status|pubertal status
1033088|NCT02956980|sex difference|sex difference
1033089|NCT02956967|Non-Interventional Study|non-interventional study
1033090|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
1033091|NCT02956941|Academic performance|academic performance
1033092|NCT02956941|Behaviour change communication|behaviour change communication
1033093|NCT02956941|Nutritional status|nutritional status
1033094|NCT02956941|School children|school children
1033095|NCT02956941|Ethiopia|ethiopia
1033096|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1033097|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
1033098|NCT02956915|Length of stay|length of stay
1033099|NCT02956915|Aortic stenosis|aortic stenosis
1033100|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
1033101|NCT02956889|Vismodegib|vismodegib
1033102|NCT02956889|Radiotherapy|radiotherapy
1033103|NCT02956837|Vaccines|vaccines
1033104|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
1033105|NCT02956837|Safety|safety
1033106|NCT02956837|Reactogenicity|reactogenicity
1033107|NCT02956837|Ranking of Formulations|ranking of formulations
1033108|NCT02956837|Immunogenicity|immunogenicity
1033109|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1033110|NCT02956824|Sacro-iliac joints|sacro-iliac joints
1033111|NCT02956824|Pelvis|pelvis
1033112|NCT02956824|Erosion|erosion
1033113|NCT02956824|Fat deposit|fat deposit
1033114|NCT02956824|Subchondral sclerosis|subchondral sclerosis
1033115|NCT02956824|Bone marrow edema|bone marrow edema
1033116|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
1033117|NCT02956811|Type 2 Diabetes|type 2 diabetes
1033118|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
1033119|NCT02956811|Dapagliflozin|dapagliflozin
1033120|NCT02956785|Propess|propess
1033121|NCT02956759|diabetic retinopathy|diabetic retinopathy
1033122|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
1033123|NCT02956759|proliferative|proliferative
1033124|NCT02956759|non-proliferative|non-proliferative
1033125|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
1033126|NCT02956707|neonates|neonates
1033127|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
1033128|NCT02956707|adrenal insufficiency|adrenal insufficiency
1033129|NCT02956707|congenital heart disease|congenital heart disease
1033130|NCT02956694|Aged|aged
1033131|NCT02956694|Cognitive impairment|cognitive impairment
1033132|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
1033133|NCT02956694|Shared decision making|shared decision making
1033134|NCT02956694|Distance learning|distance learning
1033135|NCT02956694|Primary care|primary care
1033136|NCT02956694|Decision support tool|decision support tool
1033137|NCT02956694|Patient decision aid|patient decision aid
1033138|NCT02956668|tDCS|tdcs
1033139|NCT02956668|Visual field|visual field
1033140|NCT02956668|Stroke|stroke
1033141|NCT02956616|Enhanced Recovery|enhanced recovery
1033142|NCT02956590|dyslipidemia|dyslipidemia
1033144|NCT02956590|pitavastatin|pitavastatin
1033145|NCT02956590|lipids|lipids
1033146|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
1033147|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
1033148|NCT02956577|Cardiac dysfunction|cardiac dysfunction
1033149|NCT02956577|Microcirculation|microcirculation
1033150|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
1033151|NCT02956577|Type 1 Diabetes|type 1 diabetes
1033152|NCT02956577|Type 2 Diabetes|type 2 diabetes
1033153|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1033154|NCT02956551|cell based therapy|cell based therapy
1033155|NCT02956551|safety|safety
1033156|NCT02956551|clinical efficacy|clinical efficacy
1033157|NCT02956486|elenbecestat|elenbecestat
1033158|NCT02956486|E2609|e2609
1033159|NCT02956486|Alzheimer's Disease|alzheimer's disease
1033160|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
1033161|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
1033162|NCT02956486|Dementia|dementia
1033163|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
1033164|NCT02956486|mild cognitive impairment|mild cognitive impairment
1033165|NCT02956486|MissionAD1|missionad1
1033166|NCT02956473|Breast Cancer|breast cancer
1033167|NCT02956447|Kisspeptin|kisspeptin
1033168|NCT02956447|Hyperprolactinemia|hyperprolactinemia
1033169|NCT02956408|Obesity|obesity
1033170|NCT02956408|Pediatrics|pediatrics
1033171|NCT02956408|Vitamin D deficiency|vitamin d deficiency
1033172|NCT02956395|adaptive case management approach|adaptive case management approach
1033173|NCT02956395|Transitional Care|transitional care
1033174|NCT02956395|multimorbidity|multimorbidity
1033175|NCT02956382|Ibrutinib|ibrutinib
1033176|NCT02956382|Venetoclax|venetoclax
1033177|NCT02956382|Follicular|follicular
1033178|NCT02956382|Refractory|refractory
1033179|NCT02956382|Relapsed|relapsed
1033180|NCT02956382|Lymphoma|lymphoma
1033181|NCT02956343|Atrial fibrillation|atrial fibrillation
1033182|NCT02956343|cardiovascular App|cardiovascular app
1033183|NCT02956343|Rhythm monitoring|rhythm monitoring
1033184|NCT02956343|Stroke prevention|stroke prevention
1033186|NCT02956330|ME|me
1033187|NCT02956330|Central Subfield Thickness|central subfield thickness
1033188|NCT02956330|OCT|oct
1033189|NCT02956330|Optical Coherence Tomography|optical coherence tomography
1033190|NCT02956330|Cystoid Macular Edema|cystoid macular edema
1033191|NCT02956330|Subretinal Fluid|subretinal fluid
1033192|NCT02956330|Eylea|eylea
1033193|NCT02956330|Aflibercept|aflibercept
1033194|NCT02956330|Anti-VEGF|anti-vegf
1033195|NCT02956291|glioma|glioma
1033196|NCT02956291|brain tumor|brain tumor
1033197|NCT02956291|brain metastasis|brain metastasis
1033198|NCT02956278|allopurinol|allopurinol
1033199|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
1033200|NCT02956252|spinal anesthesia|spinal anesthesia
1033201|NCT02956252|general anesthesia|general anesthesia
1033202|NCT02956252|cholecystectomy|cholecystectomy
1033203|NCT02956239|cervical precancer|cervical precancer
1033204|NCT02956239|screening|screening
1033205|NCT02956239|treatment|treatment
1033206|NCT02956239|thermo-coagulation|thermo-coagulation
1033207|NCT02956239|thermal ablation|thermal ablation
1033208|NCT02956239|Reducing overtreatment|reducing overtreatment
1033209|NCT02956213|COPD|copd
1033210|NCT02956213|air filter|air filter
1033211|NCT02956213|indoor air quality|indoor air quality
1033212|NCT02956213|respiratory symptoms|respiratory symptoms
1033213|NCT02956213|emphysema|emphysema
1033214|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1033215|NCT02956213|tobacco use|tobacco use
1033216|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
1033217|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
1033218|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
1033219|NCT02956200|Acute ischemic stroke|acute ischemic stroke
1033220|NCT02956161|Sleep|sleep
1033221|NCT02956161|Auditory stimulations|auditory stimulations
1033222|NCT02956161|Slow oscillations|slow oscillations
1033223|NCT02956096|tDCS|tdcs
1033224|NCT02956096|Stroke|stroke
1033225|NCT02956096|Autonomic Modulation|autonomic modulation
1033226|NCT02956070|dental bleaching|dental bleaching
1033227|NCT02956070|antiinflammatory|antiinflammatory
1033228|NCT02956070|tooth sensitivity|tooth sensitivity
1033229|NCT02956031|cancer prevention|cancer prevention
1033230|NCT02956031|cervical screening|cervical screening
1033231|NCT02956031|cervical cancer|cervical cancer
1033232|NCT02956031|cervical disease|cervical disease
1033233|NCT02956031|cervical neoplasm|cervical neoplasm
1033234|NCT02956031|HPV testing|hpv testing
1033235|NCT02956031|immunocytochemistry|immunocytochemistry
1033236|NCT02956031|triage techniques|triage techniques
1033237|NCT02956018|children|children
1033238|NCT02955979|acute renal insufficiency|acute renal insufficiency
1033239|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
1033240|NCT02955979|pediatric|pediatric
1033241|NCT02955966|Aspergillosis|aspergillosis
1033242|NCT02955966|Haematological malignancy|haematological malignancy
1033243|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
1033244|NCT02955966|Biomarkers|biomarkers
1033245|NCT02955940|Solid tumors|solid tumors
1033246|NCT02955940|ruxolitinib|ruxolitinib
1033247|NCT02955940|regorafenib|regorafenib
1033248|NCT02955940|capecitabine|capecitabine
1033249|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
1033250|NCT02955914|Optimism|optimism
1033251|NCT02955914|Pessimism|pessimism
1033252|NCT02955914|Recovery|recovery
1033253|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
1033254|NCT02955901|Randomized controlled trial|randomized controlled trial
1033255|NCT02955901|Colonoscopy|colonoscopy
1033256|NCT02955901|Colon Disease|colon disease
1033257|NCT02955901|Low residue diet|low residue diet
1033258|NCT02955901|Colon preparation|colon preparation
1033259|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1033260|NCT02955875|Pharmaceutical Services|pharmaceutical services
1033261|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
1033262|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
1033263|NCT02955862|HIV/AIDS|hiv/aids
1033264|NCT02955849|glaucoma|glaucoma
1033265|NCT02955849|rural|rural
1033266|NCT02955849|China|china
1033267|NCT02955849|SLT|slt
1033268|NCT02955836|Patient Safety|patient safety
1033269|NCT02955836|Quality indicator|quality indicator
1033270|NCT02955836|Information system|information system
1033271|NCT02955836|Nursing|nursing
1033272|NCT02955836|Healthcare Quality|healthcare quality
1033273|NCT02955836|Quality measurement|quality measurement
1033274|NCT02955823|B cell Lymphoma|b cell lymphoma
1033275|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
1033276|NCT02955823|Elderly patients|elderly patients
1033277|NCT02955810|Newly Diagnosed|newly diagnosed
1033278|NCT02955810|Treatment Naiive|treatment naiive
1033279|NCT02955797|Meningitis|meningitis
1033280|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
1033281|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
1033282|NCT02955797|Nimenrix®|nimenrix®
1033283|NCT02955797|Menjugate®|menjugate®
1033284|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
1033285|NCT02955771|stenting|stenting
1033286|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
1033287|NCT02955771|Deuteporfin|deuteporfin
1033288|NCT02955719|Collaborative Care|collaborative care
1033289|NCT02955719|Depression|depression
1033290|NCT02955719|Anxiety|anxiety
1033291|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
1033292|NCT02955719|Integrated Care Pathway|integrated care pathway
1033293|NCT02955693|Pharmacokinetics|pharmacokinetics
1033294|NCT02955693|Healthy volunteers|healthy volunteers
1033295|NCT02955693|Monomethylfumarate|monomethylfumarate
1033296|NCT02955693|Dimethyl fumarate|dimethyl fumarate
1033297|NCT02955693|Fumaderm®|fumaderm®
1033298|NCT02955693|Ethyl fumarate|ethyl fumarate
1033299|NCT02955680|emergence delirium|emergence delirium
1033300|NCT02955680|emergence time|emergence time
1033301|NCT02955680|bispectral index|bispectral index
1033302|NCT02955667|invivo microscopy|invivo microscopy
1033303|NCT02955667|colposcopy|colposcopy
1033304|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
1033305|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
1033306|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
1033307|NCT02955602|PBC|pbc
1033308|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
1033309|NCT02955576|Psoriasis|psoriasis
1333218|NCT01443949|Reward|reward
1033310|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
1033311|NCT02955563|intensive care|intensive care
1033312|NCT02955563|surrogate decision making|surrogate decision making
1033313|NCT02955563|patient centered care|patient centered care
1033314|NCT02955563|Palliative Care|palliative care
1033315|NCT02955563|End of Life|end of life
1033316|NCT02955563|Quality of Communication|quality of communication
1033317|NCT02955563|Anxiety|anxiety
1033318|NCT02955563|Depression|depression
1033319|NCT02955550|Multiple Myeloma|multiple myeloma
1033320|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
1033321|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
1033322|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
1033323|NCT02955550|PNK-007|pnk-007
1033324|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
1033325|NCT02955550|Human IL-2|human il-2
1033326|NCT02955550|Bone Marrow Transplant|bone marrow transplant
1033327|NCT02955537|Hypertension|hypertension
1033328|NCT02955537|mHealth|mhealth
1033329|NCT02955485|Ankle|ankle
1033330|NCT02955485|Instability|instability
1033331|NCT02955485|Prediction|prediction
1033332|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
1033333|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
1033334|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
1033335|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
1033336|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
1033337|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
1033338|NCT02955472|Neuralgia|neuralgia
1033339|NCT02955472|Neuropathic Pain|neuropathic pain
1033340|NCT02955472|Pregabalin|pregabalin
1033341|NCT02955472|Pharmacokinetics|pharmacokinetics
1033342|NCT02955472|Bioequivalent|bioequivalent
1034065|NCT02950818|self-care|self-care
1033343|NCT02955459|Healthy volunteers|healthy volunteers
1033344|NCT02955459|Pharmacokinetics|pharmacokinetics
1033345|NCT02955446|Refractory Tumors|refractory tumors
1033346|NCT02955446|Advanced Solid Tumors|advanced solid tumors
1033347|NCT02955433|Rideshare|rideshare
1033348|NCT02955433|Digital transportation network|digital transportation network
1033349|NCT02955433|Missed appointment|missed appointment
1033350|NCT02955420|Autoantibodies|autoantibodies
1033351|NCT02955420|Heart Failure|heart failure
1033352|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
1033353|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
1033354|NCT02955420|Cardiomyopathies|cardiomyopathies
1033355|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
1033356|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
1033357|NCT02955394|Enzalutamide|enzalutamide
1033358|NCT02955368|DP-R212|dp-r212
1033359|NCT02955303|Cognitive training|cognitive training
1033360|NCT02955303|Tablet computers|tablet computers
1033361|NCT02955277|Cognitive training|cognitive training
1033362|NCT02955277|Tablet computers|tablet computers
1033363|NCT02955264|Glycosylation|glycosylation
1033364|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
1033365|NCT02955264|Galactose|galactose
1033366|NCT02955251|Cancer|cancer
1033367|NCT02955251|Neoplasm|neoplasm
1033368|NCT02955251|Advanced solid tumor|advanced solid tumor
1033369|NCT02955251|Nivolumab|nivolumab
1033370|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1033371|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
1033372|NCT02955251|Ovarian cancer|ovarian cancer
1033373|NCT02955238|Intervention|intervention
1033374|NCT02955238|Cardiovascular Disease|cardiovascular disease
1033375|NCT02955238|CVD|cvd
1033376|NCT02955238|Diabetes|diabetes
1033377|NCT02955238|Latinos|latinos
1033378|NCT02955238|CIMT|cimt
1033379|NCT02955238|Medication Adherence|medication adherence
1033380|NCT02955238|Risk Factors|risk factors
1033381|NCT02955238|T2D|t2d
1033382|NCT02955225|Knee loads|knee loads
1033383|NCT02955225|Knee adduction moment|knee adduction moment
1033384|NCT02955225|Biomechanical intervention|biomechanical intervention
1033385|NCT02955225|Insole|insole
1033386|NCT02955225|Shoe|shoe
1033387|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
1033388|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
1033389|NCT02955212|ABT-494|abt-494
1033390|NCT02955134|central blinded histological assessment|central blinded histological assessment
1033391|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
1033392|NCT02955134|long-term follow-up study|long-term follow-up study
1033393|NCT02955134|biological specimen banks|biological specimen banks
1033394|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
1033395|NCT02955121|Pharmacogenetics|pharmacogenetics
1033396|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1033397|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
1033398|NCT02955069|Advanced or metastatic|advanced or metastatic
1033399|NCT02955069|NET|net
1033400|NCT02955069|pNET|pnet
1033401|NCT02955069|GI NET|gi net
1033402|NCT02955069|thoracic NET|thoracic net
1033403|NCT02955069|GEP-NEC|gep-nec
1033404|NCT02955056|Weber B|weber b
1333219|NCT01443949|Adolescents|adolescents
1033405|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1033406|NCT02955043|Fatigue|fatigue
1033407|NCT02955043|Insomnia|insomnia
1033408|NCT02955043|Depression|depression
1033409|NCT02955043|Behavioral Intervention|behavioral intervention
1033410|NCT02955017|obesity|obesity
1033411|NCT02955017|children|children
1033412|NCT02955017|adolescents|adolescents
1033413|NCT02955017|new technology|new technology
1033414|NCT02955017|mobile health|mobile health
1033415|NCT02955017|chronic disease|chronic disease
1033416|NCT02955004|silent brain embolism|silent brain embolism
1033417|NCT02955004|atrial fibrillation|atrial fibrillation
1033418|NCT02955004|cardioversion|cardioversion
1033419|NCT02954965|graduate student|graduate student
1033420|NCT02954965|burnout|burnout
1033421|NCT02954965|stress|stress
1033422|NCT02954965|mood|mood
1033423|NCT02954939|lupus nephritis|lupus nephritis
1033424|NCT02954939|lymphocyte subsets|lymphocyte subsets
1033425|NCT02954939|cytokines|cytokines
1033426|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
1034027|NCT02950974|chloride|chloride
1033427|NCT02954939|cyclophosphamide|cyclophosphamide
1033428|NCT02954900|Breast Cancer Prevention|breast cancer prevention
1033429|NCT02954900|Risk Assessment|risk assessment
1033430|NCT02954900|Chemoprevention|chemoprevention
1033431|NCT02954900|Decision Making|decision making
1033432|NCT02954887|GWP42003-P|gwp42003-p
1033433|NCT02954887|Cannabidiol|cannabidiol
1033434|NCT02954809|fatigue|fatigue
1033435|NCT02954809|sleep disturbances|sleep disturbances
1033436|NCT02954809|circadian activity rhythms|circadian activity rhythms
1033437|NCT02954783|Prostate cancer|prostate cancer
1033438|NCT02954783|Localized|localized
1033439|NCT02954783|Exercise|exercise
1033440|NCT02954783|Physical activity|physical activity
1033441|NCT02954783|Natural killer cells|natural killer cells
1033442|NCT02954783|Immune cells|immune cells
1033443|NCT02954757|uterine adenomyosis|uterine adenomyosis
1033444|NCT02954744|uterine fibroid|uterine fibroid
1033445|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
1033446|NCT02954731|Negative Affect|negative affect
1033447|NCT02954731|Unified Protocol|unified protocol
1033448|NCT02954731|Session Tracking|session tracking
1033449|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
1033450|NCT02954718|activity performance|activity performance
1033451|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1033452|NCT02954718|virtual reality|virtual reality
1033453|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
1033454|NCT02954679|Substance-related Disorder|substance-related disorder
1033455|NCT02954679|Off label-use|off label-use
1033456|NCT02954679|Cognitive Enhancement|cognitive enhancement
1033457|NCT02954679|Students|students
1033458|NCT02954679|Doping|doping
1033459|NCT02954679|Stimulants|stimulants
1033460|NCT02954679|Drug abuse|drug abuse
1033461|NCT02954679|Methylphenidate|methylphenidate
1033462|NCT02954679|Addictovigilance|addictovigilance
1033463|NCT02954679|CEIP|ceip
1033464|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
1033465|NCT02954666|cardio-neuroablation|cardio-neuroablation
1033466|NCT02954666|ablation|ablation
1033467|NCT02954666|ganglionated plexi|ganglionated plexi
1033468|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
1033469|NCT02954666|syncope|syncope
1033470|NCT02954653|relapsed|relapsed
1033471|NCT02954653|refractory|refractory
1033472|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
1033473|NCT02954653|AML|aml
1033474|NCT02954627|Osteoarthritis|osteoarthritis
1033475|NCT02954627|Obesity|obesity
1033476|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
1033477|NCT02954627|Liraglutide|liraglutide
1033478|NCT02954627|Ultrasound|ultrasound
1033479|NCT02954601|Oral Insulin|oral insulin
1033480|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
1033481|NCT02954562|anxiety|anxiety
1033482|NCT02954562|fMRI|fmri
1033483|NCT02954562|emotion regulation|emotion regulation
1033484|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
1033485|NCT02954536|pembrolizumab|pembrolizumab
1033486|NCT02954536|trastuzumab|trastuzumab
1033487|NCT02954536|capecitabine|capecitabine
1033488|NCT02954536|cisplatin|cisplatin
1033489|NCT02954536|Stage IV|stage iv
1033490|NCT02954536|HER2-positive|her2-positive
1033491|NCT02954536|esophagogastric cancer|esophagogastric cancer
1033492|NCT02954536|16-937|16-937
1033493|NCT02954536|Oxaliplatin|oxaliplatin
1033494|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
1033495|NCT02954523|NSCLC|nsclc
1033496|NCT02954523|Non-small cell|non-small cell
1033497|NCT02954523|Lung Cancer|lung cancer
1033498|NCT02954523|Dasatinib|dasatinib
1033499|NCT02954523|Osimertinib|osimertinib
1033500|NCT02954523|AZD9291|azd9291
1033501|NCT02954523|EGFR Mutations|egfr mutations
1033502|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
1033503|NCT02954445|BCMA|bcma
1033504|NCT02954445|CAR-T|car-t
1333220|NCT01443949|Impulse Control|impulse control
1033505|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
1033506|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
1033507|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
1033508|NCT02954419|IgA Nephropathy|iga nephropathy
1033509|NCT02954419|Biomarker|biomarker
1033510|NCT02954406|Drug Therapy|drug therapy
1033511|NCT02954393|Periodontal disease|periodontal disease
1033512|NCT02954393|Metronidazole|metronidazole
1033513|NCT02954393|Amoxicillin|amoxicillin
1033514|NCT02954393|Scaling and root planing|scaling and root planing
1033515|NCT02954393|Healing phase|healing phase
1033516|NCT02954354|Flu|flu
1033517|NCT02954354|Baloxavir Marboxil|baloxavir marboxil
1033518|NCT02954354|Oseltamivir|oseltamivir
1033519|NCT02954354|Tamiflu®|tamiflu®
1033520|NCT02954302|Delayed gastric emptying|delayed gastric emptying
1033521|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
1033522|NCT02954289|modifiable risk factors|modifiable risk factors
1033523|NCT02954289|lifestyle|lifestyle
1033524|NCT02954289|nutrition|nutrition
1033525|NCT02954289|weight control|weight control
1033526|NCT02954289|dietary intervention|dietary intervention
1033527|NCT02954289|health promotion|health promotion
1034028|NCT02950974|fluid|fluid
1033528|NCT02954289|patient-partner outcomes|patient-partner outcomes
1033529|NCT02954289|survivorship|survivorship
1033530|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
1033531|NCT02954276|safety|safety
1033532|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
1033533|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
1033534|NCT02954237|Anticoagulant|anticoagulant
1033535|NCT02954237|Warfarin|warfarin
1033536|NCT02954237|Stroke|stroke
1033537|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
1033538|NCT02954211|rTMS|rtms
1033652|NCT02953678|steroid-refractory|steroid-refractory
1033539|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
1033540|NCT02954211|physical therapy|physical therapy
1033541|NCT02954185|Shoulder Pain|shoulder pain
1033542|NCT02954146|Veterans|veterans
1033543|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
1033544|NCT02954146|Anger|anger
1033545|NCT02954146|Behavioral Health|behavioral health
1033546|NCT02954146|Mobile Health Technology|mobile health technology
1033547|NCT02954133|Alignment phase|alignment phase
1033548|NCT02954133|Photobiomodulation|photobiomodulation
1033549|NCT02954133|Orthodontic treatment|orthodontic treatment
1033550|NCT02954133|Malocclusion|malocclusion
1033551|NCT02954133|OrthoPulse™|orthopulse™
1033552|NCT02954133|Invisalign|invisalign
1033553|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
1033554|NCT02954120|Malondialdehyde|malondialdehyde
1033555|NCT02954120|Total antioxidant status|total antioxidant status
1033556|NCT02954120|Oxidative stres|oxidative stres
1033557|NCT02954068|Oxytocin|oxytocin
1033558|NCT02954055|locally advanced|locally advanced
1033559|NCT02954055|metastatic|metastatic
1033560|NCT02954055|breast cancer|breast cancer
1033561|NCT02954055|ER-positive|er-positive
1033562|NCT02954055|HER2-negative|her2-negative
1033563|NCT02954055|Stage IV|stage iv
1033564|NCT02954042|Incontinence|incontinence
1033565|NCT02954016|Obesity|obesity
1033566|NCT02954016|Weight Loss|weight loss
1033567|NCT02954016|Hypertension|hypertension
1033568|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1033569|NCT02954016|Hyperlipidemia|hyperlipidemia
1033570|NCT02954003|Obesity|obesity
1033571|NCT02954003|Weight Loss|weight loss
1033572|NCT02953990|Pregnancy|pregnancy
1033573|NCT02953990|Self-Management|self-management
1033574|NCT02953990|Yoga|yoga
1033575|NCT02953951|blood transfusion|blood transfusion
1033576|NCT02953951|free hemoglobin|free hemoglobin
1033577|NCT02953951|nitric oxide|nitric oxide
1033578|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
1033579|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
1033580|NCT02953951|cardiac surgery.|cardiac surgery.
1033581|NCT02953938|Ranibizumab|ranibizumab
1033582|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
1033583|NCT02953938|Macular edema,|macular edema,
1033584|NCT02953938|Branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
1033585|NCT02953938|BCVA|bcva
1033586|NCT02953938|CSFT|csft
1033587|NCT02953938|pro re nata|pro re nata
1033588|NCT02953925|primary health care|primary health care
1033589|NCT02953925|village doctor|village doctor
1033590|NCT02953925|township hospital|township hospital
1033591|NCT02953925|community health center|community health center
1033592|NCT02953912|Rotation|rotation
1033593|NCT02953912|Reciprocation|reciprocation
1033594|NCT02953912|single file|single file
1033595|NCT02953912|postoperative pain|postoperative pain
1033596|NCT02953912|Reciproc|reciproc
1033597|NCT02953912|One Shape|one shape
1033598|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
1033599|NCT02953899|Internet|internet
1033600|NCT02953899|Contingency Management|contingency management
1033601|NCT02953899|Gambling Disorder|gambling disorder
1033602|NCT02953899|Rural|rural
1033603|NCT02953886|Caries|caries
1033604|NCT02953886|Cavity|cavity
1033605|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
1033606|NCT02953886|HOMINGS|homings
1033607|NCT02953860|Advanced Breast Cancer|advanced breast cancer
1033608|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
1033609|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
1033610|NCT02953834|kisspeptin|kisspeptin
1033611|NCT02953808|GSK2315698|gsk2315698
1033612|NCT02953808|Dose-ascending|dose-ascending
1033613|NCT02953808|Systemic amyloidosis|systemic amyloidosis
1033614|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
1033615|NCT02953756|Brain metastases|brain metastases
1033616|NCT02953756|Cognition|cognition
1033617|NCT02953756|Radiosurgery|radiosurgery
1033618|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
1033619|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
1033620|NCT02953756|Quality of Life|quality of life
1033621|NCT02953756|Fatigue|fatigue
1033622|NCT02953756|Anxiety|anxiety
1033623|NCT02953756|Depression|depression
1033624|NCT02953743|E7080|e7080
1033625|NCT02953743|Lenvatinib|lenvatinib
1033626|NCT02953743|Pharmacokinetic study|pharmacokinetic study
1033627|NCT02953743|Chinese participants|chinese participants
1033640|NCT02953704|essential thrombocythemia|essential thrombocythemia
1033641|NCT02953704|clinical characteristics|clinical characteristics
1033642|NCT02953704|disease burden|disease burden
1033643|NCT02953704|patient-reported outcomes|patient-reported outcomes
1033644|NCT02953691|perioperative|perioperative
1033646|NCT02953691|pain|pain
1033647|NCT02953691|anxiety|anxiety
1033648|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
1033649|NCT02953691|cognition|cognition
1033650|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
1033651|NCT02953678|acute GVHD|acute gvhd
1033654|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
1033655|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
1033656|NCT02953665|Antidiabetic agents|antidiabetic agents
1033657|NCT02953665|GLP-1 agonists|glp-1 agonists
1033658|NCT02953665|Insulin resistance|insulin resistance
1033659|NCT02953626|pilot RCT|pilot rct
1033660|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
1033661|NCT02953626|postpartum depression|postpartum depression
1033662|NCT02953613|Cardiac Catheterization|cardiac catheterization
1033663|NCT02953613|Cardiac intervention|cardiac intervention
1033664|NCT02953613|coronary angiogram|coronary angiogram
1033665|NCT02953613|coronary artery disease|coronary artery disease
1033666|NCT02953613|atherosclerosis|atherosclerosis
1033667|NCT02953587|Obesity|obesity
1033668|NCT02953587|Bariatric Surgery|bariatric surgery
1033669|NCT02953574|geriatric nursing|geriatric nursing
1033685|NCT02953548|GWP42003-P|gwp42003-p
1033686|NCT02953548|Cannabidiol|cannabidiol
1033687|NCT02953522|Polymorphism|polymorphism
1033688|NCT02953522|Folate|folate
1033689|NCT02953522|Oxidative stress|oxidative stress
1033690|NCT02953522|Overweight and Obesity|overweight and obesity
1033691|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1033692|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1033693|NCT02953509|indolent lymphoma|indolent lymphoma
1033694|NCT02953509|Hu5F9-G4|hu5f9-g4
1033695|NCT02953509|CD47|cd47
1033696|NCT02953496|peripheral artery disease|peripheral artery disease
1033697|NCT02953496|PAD|pad
1033698|NCT02953496|vonapanitase|vonapanitase
1033699|NCT02953496|claudication|claudication
1033700|NCT02953496|superficial femoral artery|superficial femoral artery
1033701|NCT02953496|SFA|sfa
1033702|NCT02953496|popliteal artery|popliteal artery
1033703|NCT02953496|stenosis|stenosis
1033704|NCT02953496|elastase|elastase
1033705|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
1033706|NCT02953496|CELA1|cela1
1033707|NCT02953496|PRT-201|prt-201
1033708|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
1033709|NCT02953470|chronic pain|chronic pain
1033710|NCT02953470|community-dwelling|community-dwelling
1033711|NCT02953470|older adults|older adults
1033712|NCT02953470|physical activity|physical activity
1033713|NCT02953470|physiotherapy|physiotherapy
1033714|NCT02953470|behavioural medicine|behavioural medicine
1033715|NCT02953470|biopsychosocial|biopsychosocial
1033716|NCT02953470|exercise|exercise
1033717|NCT02953470|independency|independency
1033718|NCT02953470|everyday activities|everyday activities
1033719|NCT02953470|self-efficacy|self-efficacy
1033720|NCT02953470|quality of life|quality of life
1033721|NCT02953470|pain-related beliefs|pain-related beliefs
1033722|NCT02953470|pain-related disability|pain-related disability
1033723|NCT02953431|Asthma|asthma
1033724|NCT02953431|Obesity|obesity
1033725|NCT02953353|Obesity|obesity
1033726|NCT02953353|Feeding behavior|feeding behavior
1033727|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
1033728|NCT02953353|Weight loss|weight loss
1033729|NCT02953340|Neutropenia|neutropenia
1033730|NCT02953340|Breast Cancer|breast cancer
1033731|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
1033732|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
1033733|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
1033734|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
1033735|NCT02953327|Middle aged|middle aged
1033736|NCT02953327|Immunity, heterologous|immunity, heterologous
1033737|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
1033738|NCT02953301|Maintenance|maintenance
1033739|NCT02953301|resminostat|resminostat
1033740|NCT02953301|4SC|4sc
1033741|NCT02953301|HDAC|hdac
1033742|NCT02953301|Mycosis Fungoides|mycosis fungoides
1033743|NCT02953301|Sézary Syndrome|sézary syndrome
1033744|NCT02953262|Diabetes Mellitus|diabetes mellitus
1033745|NCT02953262|Personal Health Records|personal health records
1033746|NCT02953262|Patient Outcome Assessment|patient outcome assessment
1033747|NCT02953262|Mental Health|mental health
1033748|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1033749|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1033750|NCT02953184|breast cancer|breast cancer
1033751|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
1033752|NCT02953171|The human microbiome|the human microbiome
1033753|NCT02953171|Microbiota|microbiota
1033754|NCT02953171|Gut microbiota|gut microbiota
1033755|NCT02953171|Probiotics|probiotics
1033756|NCT02953171|Sauerkraut|sauerkraut
1033757|NCT02953106|Asthma|asthma
1033758|NCT02953106|Rhinitis|rhinitis
1033759|NCT02953106|Dymista|dymista
1033760|NCT02953106|allergy|allergy
1033761|NCT02953093|acarbose|acarbose
1033762|NCT02953093|aging|aging
1033763|NCT02953054|Pain|pain
1033764|NCT02953054|Bunionectomy|bunionectomy
1033765|NCT02953054|Dexmedetomidine|dexmedetomidine
1033766|NCT02953054|Transdermal|transdermal
1033767|NCT02953054|Patch|patch
1033768|NCT02953054|Postoperative|postoperative
1033769|NCT02953054|DMTS|dmts
1033871|NCT02952456|Qualitative research|qualitative research
1033770|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
1033771|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
1033772|NCT02953028|Efficacy|efficacy
1033773|NCT02953028|Compliance|compliance
1033774|NCT02953028|Health related quality of life|health related quality of life
1033775|NCT02953028|Randomized Controlled Trial|randomized controlled trial
1033776|NCT02953028|Snoring|snoring
1033777|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
1033778|NCT02953028|Mandibular Advancing Device|mandibular advancing device
1033779|NCT02953028|Humans|humans
1033780|NCT02953028|Quality of Life|quality of life
1033781|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
1033782|NCT02953015|Chronic Migraine|chronic migraine
1033783|NCT02953015|Manipulative treatments|manipulative treatments
1033784|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
1033785|NCT02952989|MSI-high|msi-high
1033786|NCT02952989|dMMR|dmmr
1033787|NCT02952989|PD-L1|pd-l1
1033788|NCT02952976|open abdomen|open abdomen
1033789|NCT02952976|Damage control|damage control
1033790|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
1033791|NCT02952950|Intra Oral Vacuum|intra oral vacuum
1033792|NCT02952950|protein content breastmilk|protein content breastmilk
1033793|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
1033794|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
1033795|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
1033796|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
1033797|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
1033798|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
1033799|NCT02952937|Neuralgia|neuralgia
1033800|NCT02952937|Neuropathic Pain|neuropathic pain
1033801|NCT02952937|Pregabalin|pregabalin
1033802|NCT02952937|Pharmacokinetics|pharmacokinetics
1033803|NCT02952937|Bioequivalent|bioequivalent
1033804|NCT02952898|solar keratoses|solar keratoses
1033805|NCT02952872|Computerized Brief Intervention|computerized brief intervention
1033806|NCT02952833|Inactivated|inactivated
1033807|NCT02952833|Phase I|phase i
1033808|NCT02952833|placebo-controlled|placebo-controlled
1033809|NCT02952833|Vaccine|vaccine
1033810|NCT02952833|ZIKA|zika
1033811|NCT02952820|insomnia|insomnia
1033812|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
1033813|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
1033814|NCT02952781|ECG Monitoring|ecg monitoring
1033815|NCT02952781|Palpitations|palpitations
1033816|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
1033817|NCT02952716|delayed encephalopathy|delayed encephalopathy
1033818|NCT02952638|Lipids|lipids
1033819|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
1033820|NCT02952638|Lysophospholipids|lysophospholipids
1033821|NCT02952638|phosphatidylcholine|phosphatidylcholine
1033822|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
1033823|NCT02952638|autotaxin|autotaxin
1033824|NCT02952638|dietary|dietary
1033825|NCT02952625|PET/MRI|pet/mri
1033826|NCT02952599|Non-interventional Study|non-interventional study
1033827|NCT02952599|Real World Evidence|real world evidence
1034029|NCT02950974|SID|sid
1033828|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
1033829|NCT02952599|Efficacy/Safety|efficacy/safety
1033830|NCT02952560|Ultrasound|ultrasound
1033831|NCT02952560|Computed Tomography|computed tomography
1033832|NCT02952560|Oral cavity size|oral cavity size
1033833|NCT02952560|The Mallampati classification|the mallampati classification
1033834|NCT02952534|CRPC|crpc
1033835|NCT02952534|PARP inhibitor|parp inhibitor
1033836|NCT02952534|PARPi|parpi
1033837|NCT02952534|BRCA|brca
1033838|NCT02952534|ATM|atm
1033839|NCT02952534|HRD|hrd
1033840|NCT02952534|TRITON|triton
1033841|NCT02952534|homologous recombination|homologous recombination
1033842|NCT02952534|DNA repair|dna repair
1033843|NCT02952534|DNA defect|dna defect
1033844|NCT02952534|DNA anomaly|dna anomaly
1033845|NCT02952534|BARD1|bard1
1033846|NCT02952534|BRIP1|brip1
1033847|NCT02952534|CDK12|cdk12
1033848|NCT02952534|CHEK2|chek2
1033849|NCT02952534|FANCA|fanca
1033850|NCT02952534|NBN|nbn
1033851|NCT02952534|PALB2|palb2
1033852|NCT02952534|RAD51|rad51
1033853|NCT02952534|RAD51B|rad51b
1033854|NCT02952534|RAD51C|rad51c
1033855|NCT02952534|RAD51D|rad51d
1033856|NCT02952534|RAD54L|rad54l
1033857|NCT02952534|germline|germline
1033858|NCT02952534|somatic|somatic
1033859|NCT02952495|Alcohol Consumption|alcohol consumption
1033860|NCT02952495|Older Adults|older adults
1033861|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
1033862|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
1033863|NCT02952469|Positron-Emission Tomography|positron-emission tomography
1033864|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
1033865|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
1033866|NCT02952469|Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))|glu-nh-co-nh-lys-(ahx)-((68)ga(hbed-cc))
1033867|NCT02952469|(68)Ga-PSMA|(68)ga-psma
1033868|NCT02952469|68Ga-PSMA-11|68ga-psma-11
1033869|NCT02952456|SUDEP|sudep
1033870|NCT02952456|Epilepsy|epilepsy
1033872|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
1033873|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
1033874|NCT02952391|cognition|cognition
1033875|NCT02952391|cholinergic system|cholinergic system
1033876|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
1033877|NCT02952300|irreversible pulpitis|irreversible pulpitis
1033878|NCT02952300|reciprocation|reciprocation
1033879|NCT02952300|rotation|rotation
1033880|NCT02952300|single file|single file
1033881|NCT02952300|wave one|wave one
1033882|NCT02952300|neolix|neolix
1033883|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
1033884|NCT02952209|Xenograft bone graft|xenograft bone graft
1033885|NCT02952209|Collagen membrane|collagen membrane
1033886|NCT02952196|Amphetamine|amphetamine
1033887|NCT02952196|Cannabinoids|cannabinoids
1033888|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
1033889|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
1033890|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
1033891|NCT02952105|cardiac arrest|cardiac arrest
1033892|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
1033893|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
1033894|NCT02952105|defibrillation|defibrillation
1033895|NCT02952092|ASP1517|asp1517
1033896|NCT02952092|Renal anemia|renal anemia
1033897|NCT02952092|Hemodialysis|hemodialysis
1033898|NCT02952092|Roxadustat|roxadustat
1033899|NCT02952053|Myofascial Trigger Points|myofascial trigger points
1033900|NCT02952053|Dry needling|dry needling
1033901|NCT02952053|Myotonometry|myotonometry
1033902|NCT02952040|ASP1517|asp1517
1033903|NCT02952040|Pharmacokinetics|pharmacokinetics
1033904|NCT02952040|Drug-drug interaction|drug-drug interaction
1033905|NCT02952001|Uveitis|uveitis
1033906|NCT02952001|UME|ume
1033907|NCT02952001|Posterior Uveitis|posterior uveitis
1033908|NCT02952001|Anterior Uveitis|anterior uveitis
1033909|NCT02952001|Intermediate Uveitis|intermediate uveitis
1033910|NCT02952001|Panuveitis|panuveitis
1033911|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
1033912|NCT02952001|Triamcinolone|triamcinolone
1033913|NCT02952001|Choroid|choroid
1033914|NCT02952001|Choroidal Injection|choroidal injection
1033915|NCT02952001|Suprachoroidal|suprachoroidal
1033916|NCT02952001|Microneedle|microneedle
1033917|NCT02952001|Microinjection|microinjection
1033918|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
1033919|NCT02951897|circulating tumor cells|circulating tumor cells
1033920|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
1033921|NCT02951897|treatment|treatment
1033922|NCT02951897|early diagnosis|early diagnosis
1033923|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
1033924|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
1033925|NCT02951858|Brief Intervention|brief intervention
1033926|NCT02951858|Substance Use|substance use
1033927|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
1034030|NCT02950974|pH|ph
1033928|NCT02951793|intensive care unit|intensive care unit
1033929|NCT02951793|delirium|delirium
1033930|NCT02951793|substance withdrawal|substance withdrawal
1033931|NCT02951767|anti-PD-L1|anti-pd-l1
1033932|NCT02951767|PD-L1|pd-l1
1033933|NCT02951767|MPDL3280A|mpdl3280a
1033934|NCT02951767|PD-1|pd-1
1033935|NCT02951767|bladder cancer|bladder cancer
1033936|NCT02951767|atezolizumab|atezolizumab
1033937|NCT02951767|Tecentriq|tecentriq
1033938|NCT02951754|ADHD|adhd
1033939|NCT02951754|Adults|adults
1033940|NCT02951754|treatment|treatment
1033941|NCT02951754|Methylphenidate|methylphenidate
1033942|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
1033943|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
1033944|NCT02951624|Exercise|exercise
1033945|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
1033946|NCT02951624|physical activity|physical activity
1033947|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
1033948|NCT02951572|Physical activity|physical activity
1033949|NCT02951520|Patients|patients
1033950|NCT02951481|Clostridium difficile.|clostridium difficile.
1033951|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
1033952|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
1033953|NCT02951442|Arterial stiffness|arterial stiffness
1033954|NCT02951442|Klotho-FGF23|klotho-fgf23
1033955|NCT02951403|elbow arthroscopy|elbow arthroscopy
1033956|NCT02951403|DASH|dash
1033957|NCT02951403|elbow locking|elbow locking
1033958|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
1033959|NCT02951390|Surveillance|surveillance
1033960|NCT02951390|Colorectal cancer|colorectal cancer
1033961|NCT02951390|Colonoscopy|colonoscopy
1033962|NCT02951390|Adenoma|adenoma
1033963|NCT02951390|Chromoendoscopy|chromoendoscopy
1033964|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
1033965|NCT02951377|physical therapy|physical therapy
1033966|NCT02951377|steroid injection|steroid injection
1033967|NCT02951377|exercise|exercise
1033968|NCT02951364|observational|observational
1033969|NCT02951338|Physical activity|physical activity
1033970|NCT02951338|Exercise|exercise
1033971|NCT02951338|Behaviour change|behaviour change
1033972|NCT02951338|Rehabilitation|rehabilitation
1033973|NCT02951338|Self-management|self-management
1033974|NCT02951338|Education|education
1033975|NCT02951325|adjuvant RT|adjuvant rt
1033976|NCT02951312|Emphysema|emphysema
1033977|NCT02951312|Chronic bronchitis|chronic bronchitis
1033978|NCT02951312|COPD|copd
1033979|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1033980|NCT02951286|Skeletal openbite|skeletal openbite
1033981|NCT02951286|Molar intrusion|molar intrusion
1033982|NCT02951286|high pull headgear|high pull headgear
1033983|NCT02951273|abdominal surgery|abdominal surgery
1033984|NCT02951273|blood pressure|blood pressure
1033985|NCT02951273|cardiac output|cardiac output
1033986|NCT02951273|cerebral blood flow|cerebral blood flow
1033987|NCT02951273|cerebral oxygenation|cerebral oxygenation
1033988|NCT02951273|CO2 reactivity|co2 reactivity
1033989|NCT02951273|duplex ultrasound|duplex ultrasound
1033990|NCT02951273|general anaesthesia|general anaesthesia
1033991|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
1033992|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
1033993|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
1033994|NCT02951234|coronary artery lesions|coronary artery lesions
1033995|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
1033996|NCT02951234|Kawasaki disease|kawasaki disease
1033997|NCT02951234|randomized clinical trial|randomized clinical trial
1033998|NCT02951234|aspirin|aspirin
1033999|NCT02951130|CDH|cdh
1034000|NCT02951130|PPHN|pphn
1034001|NCT02951130|HRF|hrf
1034002|NCT02951117|lymphoid malignancies|lymphoid malignancies
1034003|NCT02951117|Next generation sequencing|next generation sequencing
1034004|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
1034005|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
1034006|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
1034007|NCT02951052|Virologic failure|virologic failure
1034008|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
1034009|NCT02951052|Antiretroviral|antiretroviral
1034010|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
1034011|NCT02951039|Non-interventional Study|non-interventional study
1034012|NCT02951039|Efficacy/Safety|efficacy/safety
1034013|NCT02951039|Real World Evidence|real world evidence
1034014|NCT02951026|knee|knee
1034015|NCT02951026|osteoarthritis|osteoarthritis
1034016|NCT02951026|intra-articular injection|intra-articular injection
1034017|NCT02951026|SM04690|sm04690
1034018|NCT02951000|thyroidectomy|thyroidectomy
1034019|NCT02951000|postoperative pain|postoperative pain
1034020|NCT02951000|wound healing|wound healing
1034021|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
1333221|NCT01443949|Cabergoline|cabergoline
1034022|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
1034023|NCT02950987|LFS|lfs
1034024|NCT02950974|sterofundin|sterofundin
1034025|NCT02950974|resuscitation|resuscitation
1034026|NCT02950974|normal saline|normal saline
1034031|NCT02950974|osmolality|osmolality
1034032|NCT02950974|urine|urine
1034033|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
1034034|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
1034035|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
1034036|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
1034037|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
1034038|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
1034039|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
1034040|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
1034041|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
1034042|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
1034043|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
1034044|NCT02950909|Therapeutic exercise|therapeutic exercise
1034045|NCT02950909|Chronic pain|chronic pain
1034046|NCT02950909|Neck extensors|neck extensors
1034047|NCT02950883|Cystic Fibrosis|cystic fibrosis
1034048|NCT02950883|Hypertonic Saline|hypertonic saline
1034049|NCT02950883|Inhaled Saline|inhaled saline
1034050|NCT02950883|Digestive System Diseases|digestive system diseases
1034051|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
1034052|NCT02950883|Lung Diseases|lung diseases
1034053|NCT02950883|Pancreatic Diseases|pancreatic diseases
1034054|NCT02950883|Pathologic Processes|pathologic processes
1034055|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
1034056|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
1034057|NCT02950844|Atrial fibrillation|atrial fibrillation
1034058|NCT02950844|Electrogram|electrogram
1034059|NCT02950844|Ablation|ablation
1034060|NCT02950844|Drivers|drivers
1034061|NCT02950831|Chronic Pain|chronic pain
1034062|NCT02950831|BurstDR|burstdr
1034063|NCT02950831|spinal cord stimulation|spinal cord stimulation
1034064|NCT02950831|Accelerometry|accelerometry
1034066|NCT02950818|health education|health education
1034067|NCT02950818|chronic disease|chronic disease
1034068|NCT02950818|heart diseases|heart diseases
1034069|NCT02950818|risk factors for heart disease|risk factors for heart disease
1034070|NCT02950805|AZD5634|azd5634
1034071|NCT02950805|Mucociliary Clearance|mucociliary clearance
1034072|NCT02950805|Safety|safety
1034073|NCT02950805|Tolerability|tolerability
1034074|NCT02950805|Pharmacokinetic|pharmacokinetic
1034075|NCT02950805|Cystic Fibrosis|cystic fibrosis
1034076|NCT02950805|Cross-Over Study|cross-over study
1034077|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
1034078|NCT02950792|NSCLC|nsclc
1034079|NCT02950766|Kidney Cancer|kidney cancer
1034080|NCT02950753|Elevated Serum Lactate|elevated serum lactate
1034081|NCT02950753|Serum lactate|serum lactate
1034082|NCT02950753|Ringer's Lactate|ringer's lactate
1034083|NCT02950753|Lactated Ringer's|lactated ringer's
1034084|NCT02950753|Hyperlactatemia|hyperlactatemia
1034085|NCT02950740|malnutrition|malnutrition
1034086|NCT02950727|orthognathic surgery|orthognathic surgery
1034087|NCT02950727|bicortical screws|bicortical screws
1034088|NCT02950727|monocortical plates|monocortical plates
1034089|NCT02950675|Burn patient|burn patient
1034090|NCT02950675|Developmental Disabilities|developmental disabilities
1034091|NCT02950675|Body function|body function
1034092|NCT02950675|Participation|participation
1034093|NCT02950675|Quality of Life|quality of life
1034094|NCT02950675|longitudinal study|longitudinal study
1034095|NCT02950636|Epilepsy|epilepsy
1034096|NCT02950610|Electronic nose|electronic nose
1034097|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
1034098|NCT02950610|NAFLD|nafld
1034099|NCT02950610|exhaled breath analysis|exhaled breath analysis
1034100|NCT02950610|Volatile organic compounds|volatile organic compounds
1034101|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
1034102|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
1034103|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
1034104|NCT02950532|Interspinous distance|interspinous distance
1034105|NCT02950532|Local kyphosis|local kyphosis
1034106|NCT02950506|Interictal|interictal
1034107|NCT02950506|Cognitive|cognitive
1034108|NCT02950506|Dysfunction|dysfunction
1034109|NCT02950506|tDCS|tdcs
1034110|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
1034111|NCT02950480|Mastectomy|mastectomy
1034112|NCT02950467|HIV/AIDS|hiv/aids
1034113|NCT02950467|Demoralization|demoralization
1034114|NCT02950467|Psilocybin|psilocybin
1034115|NCT02950467|Group therapy|group therapy
1034116|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
1034117|NCT02950454|Rehabilitation|rehabilitation
1034118|NCT02950454|Exercise|exercise
1672202|NCT00099619|diabetes|diabetes
1065246|NCT02759302|MRI|mri
1034119|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
1034120|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
1034121|NCT02950441|Skeletal muscle|skeletal muscle
1034122|NCT02950441|Metabolism|metabolism
1034123|NCT02950428|TAVI|tavi
1034124|NCT02950428|Aortic Stenosis|aortic stenosis
1034226|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
1034125|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
1034127|NCT02950389|on-line HFR|on-line hfr
1034128|NCT02950389|free light chains|free light chains
1034129|NCT02950389|toxins|toxins
1034130|NCT02950389|removal|removal
1034131|NCT02950389|hemodialysis|hemodialysis
1034132|NCT02950376|synthetic drugs|synthetic drugs
1034133|NCT02950376|virtual reality|virtual reality
1034134|NCT02950376|addiction evaluation|addiction evaluation
1034135|NCT02950376|physiological data|physiological data
1034136|NCT02950376|eye movement index|eye movement index
1034137|NCT02950363|Depression|depression
1034138|NCT02950363|Suicide|suicide
1034139|NCT02950363|Anxiety disorder|anxiety disorder
1034140|NCT02950363|Burn out|burn out
1034141|NCT02950363|Sleep quality|sleep quality
1034142|NCT02950363|Stress|stress
1034143|NCT02950350|Cervical cancer|cervical cancer
1034144|NCT02950350|Precision medicine|precision medicine
1034145|NCT02950350|Individualized treatment|individualized treatment
1034146|NCT02950350|Surgical staging|surgical staging
1034147|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
1034148|NCT02950324|Prehabilitation|prehabilitation
1034149|NCT02950324|Oesophago-gastric|oesophago-gastric
1034150|NCT02950324|Cancer|cancer
1034151|NCT02950324|Neo-adjuvant|neo-adjuvant
1034152|NCT02950324|Exercise|exercise
1034153|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
1034154|NCT02950324|Insulin resistance|insulin resistance
1034155|NCT02950298|Pompe|pompe
1034156|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
1034157|NCT02950298|Telemedicine|telemedicine
1034158|NCT02950298|Duke University Medical Center|duke university medical center
1034159|NCT02950259|Breast Cancer|breast cancer
1034160|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
1034161|NCT02950259|Male breast cancer|male breast cancer
1034162|NCT02950259|IRX-2|irx-2
1034163|NCT02950259|Immunotherapy|immunotherapy
1034164|NCT02950259|Triple Negative Breast Cancer|triple negative breast cancer
1034165|NCT02950233|postoperative pain|postoperative pain
1034166|NCT02950233|VATS|vats
1034167|NCT02950233|activities of daily living|activities of daily living
1034168|NCT02950233|quality of life|quality of life
1034169|NCT02950194|mesh|mesh
1034170|NCT02950194|rectus diastasis|rectus diastasis
1034171|NCT02950194|panniculectomy|panniculectomy
1034172|NCT02950194|abdominoplasty|abdominoplasty
1034173|NCT02950168|Diagnostic procedures|diagnostic procedures
1034174|NCT02950168|Interventional procedures|interventional procedures
1034175|NCT02950168|Planned or unplanned|planned or unplanned
1034176|NCT02950168|Edoxaban-treated population|edoxaban-treated population
1034177|NCT02950142|order sets|order sets
1034178|NCT02950142|decision support|decision support
1034179|NCT02950142|laboratory test|laboratory test
1034180|NCT02950142|primary care|primary care
1034181|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
1034182|NCT02950103|solid tumor|solid tumor
1034183|NCT02950103|phase II|phase ii
1034184|NCT02950103|phosphoethanolamine|phosphoethanolamine
1034185|NCT02950090|Knee symptoms|knee symptoms
1034186|NCT02950090|physical activity|physical activity
1034187|NCT02950090|Fitbit|fitbit
1034188|NCT02950090|Accelerometer|accelerometer
1034189|NCT02950090|remote coaching|remote coaching
1034190|NCT02950064|BRCA|brca
1034191|NCT02950064|BRCA1|brca1
1034192|NCT02950064|BRCA2|brca2
1034193|NCT02950064|Pancreatic cancer|pancreatic cancer
1034194|NCT02950064|Ovarian cancer|ovarian cancer
1034195|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
1034196|NCT02950064|Triple negative breast cancer|triple negative breast cancer
1034197|NCT02950064|Breast cancer|breast cancer
1034198|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
1034199|NCT02950051|CLL|cll
1034200|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
1034201|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1034202|NCT02950038|NSCLC|nsclc
1034203|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1034204|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1034205|NCT02950038|Ibrutinib|ibrutinib
1034206|NCT02950038|PCI-32765|pci-32765
1034207|NCT02950038|Imbruvica|imbruvica
1034208|NCT02950038|Nivolumab|nivolumab
1034209|NCT02950038|BMS-936558|bms-936558
1034210|NCT02950038|Opdivo|opdivo
1034211|NCT02950012|Healthy|healthy
1034212|NCT02950012|Bloating|bloating
1034213|NCT02950012|Abdominal Discomfort|abdominal discomfort
1034214|NCT02950012|Gas|gas
1034215|NCT02950012|Probiotic|probiotic
1034216|NCT02950012|Bacillus Subtillis|bacillus subtillis
1034217|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
1034218|NCT02949999|Voclosporin|voclosporin
1034219|NCT02949973|lupus nephritis|lupus nephritis
1034220|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
1034221|NCT02949973|voclosporin|voclosporin
1034222|NCT02949960|Eczema|eczema
1034223|NCT02949960|Dermatitis|dermatitis
1034224|NCT02949960|Skin Diseases|skin diseases
1034225|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
1034227|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
1034228|NCT02949960|Hypersensitivity|hypersensitivity
1034229|NCT02949960|Immune System Diseases|immune system diseases
1034230|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
1034231|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1034232|NCT02949947|GIST|gist
1034233|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
1034234|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
1034235|NCT02949947|Injectafer|injectafer
1034236|NCT02949947|Iron supplement|iron supplement
1034237|NCT02949947|Health Questionnaire|health questionnaire
1034238|NCT02949947|Survey|survey
1034239|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1034240|NCT02949908|Rebif|rebif
1034241|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
1034242|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
1034243|NCT02949882|Diarrhea|diarrhea
1034244|NCT02949882|Constipation|constipation
1034245|NCT02949882|Elderly|elderly
1034246|NCT02949882|Nursing Homes|nursing homes
1034247|NCT02949882|Probiotics|probiotics
1034248|NCT02949882|Bowel Habits|bowel habits
1034249|NCT02949830|RNAi therapeutic|rnai therapeutic
1034250|NCT02949830|Porphyria|porphyria
1034251|NCT02949830|AIP|aip
1034252|NCT02949830|Heme/Haem Arginate|heme/haem arginate
1034253|NCT02949791|cisplatin|cisplatin
1034254|NCT02949791|HIPEC|hipec
1034255|NCT02949791|Intra abdominal pressure|intra abdominal pressure
1034256|NCT02949791|tissue drug concentration|tissue drug concentration
1034257|NCT02949713|HIV|hiv
1034258|NCT02949713|infant feeding|infant feeding
1034259|NCT02949713|mHealth|mhealth
1034260|NCT02949713|behavioural intervention|behavioural intervention
1034261|NCT02949700|metformin|metformin
1034262|NCT02949700|head and neck cancer|head and neck cancer
1034263|NCT02949687|ileal interposition|ileal interposition
1034264|NCT02949687|metabolic surgery|metabolic surgery
1034265|NCT02949687|diabetes|diabetes
1034266|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
1034267|NCT02949648|Electronic cigarette|electronic cigarette
1034268|NCT02949635|Aged|aged
1034269|NCT02949635|Patient readmission|patient readmission
1034270|NCT02949635|Geriatric Assessment|geriatric assessment
1034271|NCT02949635|Mortality|mortality
1034272|NCT02949622|Metabolic syndrome|metabolic syndrome
1034273|NCT02949622|Mediterranean diet|mediterranean diet
1034274|NCT02949622|Stress|stress
1034275|NCT02949622|quality of life|quality of life
1034276|NCT02949622|psychological factors|psychological factors
1034277|NCT02949609|stroke|stroke
1034278|NCT02949609|mirror therapy|mirror therapy
1034279|NCT02949609|neurorehabilitation|neurorehabilitation
1034280|NCT02949596|quality of sexual life|quality of sexual life
1034281|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1034282|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1034283|NCT02949583|DENTAL PLAQUE|dental plaque
1034284|NCT02949583|MEDICINAL PLANTS|medicinal plants
1034285|NCT02949583|GINGIVITIS|gingivitis
1034286|NCT02949505|Prehabilitation|prehabilitation
1034287|NCT02949505|liver transplant|liver transplant
1034288|NCT02949505|functional capacity|functional capacity
1034289|NCT02949505|exercise|exercise
1034290|NCT02949492|Liver|liver
1034291|NCT02949492|Transplant|transplant
1034292|NCT02949492|Immunosuppression|immunosuppression
1034293|NCT02949479|sex offenses|sex offenses
1034294|NCT02949466|knee osteoarthritis|knee osteoarthritis
1034295|NCT02949466|triamcinolone|triamcinolone
1034296|NCT02949466|therapeutic effects|therapeutic effects
1034297|NCT02949453|suicide|suicide
1034298|NCT02949453|prevention|prevention
1034299|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
1034300|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
1034301|NCT02949427|Microbiome|microbiome
1034302|NCT02949427|Mycobiome|mycobiome
1034303|NCT02949427|Virome|virome
1034304|NCT02949427|Pediatric leukemia|pediatric leukemia
1034305|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
1034306|NCT02949414|Malacia|malacia
1034307|NCT02949414|Stenosis|stenosis
1034308|NCT02949414|Trachea|trachea
1034309|NCT02949414|Transplant|transplant
1034310|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
1034311|NCT02949349|Lupus Nephritis|lupus nephritis
1034312|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
1034313|NCT02949349|Azathioprine|azathioprine
1034314|NCT02949349|Maintenance Therapy|maintenance therapy
1034315|NCT02949349|Prednisolone|prednisolone
1065590|NCT02757339|DID|did
1034316|NCT02949349|Serum albumin|serum albumin
1034317|NCT02949349|Serum creatinine|serum creatinine
1034318|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
1034319|NCT02949323|children|children
1034320|NCT02949323|renal stone|renal stone
1034321|NCT02949323|metabolic evaluation|metabolic evaluation
1034322|NCT02949323|Mutational analysis|mutational analysis
1034323|NCT02949297|abdominal|abdominal
1034324|NCT02949297|aortic|aortic
1034325|NCT02949297|aneurysm|aneurysm
1034326|NCT02949271|epidural analgesia|epidural analgesia
1034327|NCT02949258|gastric cancer|gastric cancer
1034328|NCT02949258|Borrmann type 4|borrmann type 4
1034329|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1034330|NCT02949258|Intra-arterial administration|intra-arterial administration
1034331|NCT02949245|Spine|spine
1034332|NCT02949245|Surgery|surgery
1034333|NCT02949245|Prospective Studies|prospective studies
1034334|NCT02949245|Deformity|deformity
1034335|NCT02949245|Neurologic deficit|neurologic deficit
1034336|NCT02949180|Atrial fibrillation|atrial fibrillation
1034337|NCT02949180|Rhythm monitoring|rhythm monitoring
1034338|NCT02949180|Cardiovascular App|cardiovascular app
1034339|NCT02949180|m-health|m-health
1034340|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
1034341|NCT02949115|Red beetroot|red beetroot
1034342|NCT02949115|Dietary Nitrate|dietary nitrate
1034343|NCT02949115|Polyphenols|polyphenols
1034344|NCT02949115|Endothelial Function|endothelial function
1034345|NCT02949115|High-Fat Meal|high-fat meal
1034346|NCT02949115|Overweight|overweight
1034347|NCT02949115|Obesity|obesity
1034348|NCT02949115|Aging|aging
1034349|NCT02949115|Cardiometabolic|cardiometabolic
1034350|NCT02949089|safety|safety
1034351|NCT02949089|tolerability|tolerability
1034352|NCT02949089|rising multiple doses|rising multiple doses
1034353|NCT02949089|ACH04|ach04
1034354|NCT02949089|adult|adult
1034355|NCT02949089|male|male
1034356|NCT02949063|school lunch|school lunch
1034357|NCT02949063|occupational therapy|occupational therapy
1034358|NCT02949024|Diabetes mellitus|diabetes mellitus
1034359|NCT02949024|Diabetic retinopathy|diabetic retinopathy
1034360|NCT02949024|Microneedle|microneedle
1034361|NCT02949024|Microinjection|microinjection
1034362|NCT02949024|Triamcinolone|triamcinolone
1034363|NCT02949024|Choroid|choroid
1034364|NCT02949024|Choroid Injection|choroid injection
1034365|NCT02949024|Aflibercept|aflibercept
1034366|NCT02949024|Suprachoroidal|suprachoroidal
1034367|NCT02949011|Tamiflu®|tamiflu®
1034368|NCT02949011|Influenza|influenza
1034369|NCT02949011|Oseltamivir|oseltamivir
1034371|NCT02949011|S-033188|s-033188
1034372|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
1034373|NCT02948985|Cetuximab|cetuximab
1034374|NCT02948985|CTCs|ctcs
1034375|NCT02948985|ct DNA|ct dna
1034376|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
1034377|NCT02948972|endometriosis surgery|endometriosis surgery
1034378|NCT02948972|In vitro fertilization|in vitro fertilization
1034379|NCT02948946|lung cancer|lung cancer
1034380|NCT02948946|pancreatic cancer|pancreatic cancer
1034381|NCT02948933|Dengue Fever|dengue fever
1034382|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1034383|NCT02948933|Dengvaxia®|dengvaxia®
1034384|NCT02948920|ephedrine|ephedrine
1034385|NCT02948920|core temperature|core temperature
1034386|NCT02948920|tympanic temperature|tympanic temperature
1034387|NCT02948920|heat loss|heat loss
1034388|NCT02948920|spinal anesthesia|spinal anesthesia
1034389|NCT02948920|neuraxial|neuraxial
1034390|NCT02948920|hypothermia|hypothermia
1034391|NCT02948920|shivering|shivering
1034392|NCT02948881|Osteoporosis|osteoporosis
1034393|NCT02948881|bisphosphonates|bisphosphonates
1034394|NCT02948881|bone|bone
1034395|NCT02948868|Methamphetamine|methamphetamine
1034396|NCT02948868|MRI|mri
1034397|NCT02948868|South Africa|south africa
1034398|NCT02948868|Contingency Management|contingency management
1034399|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
1034400|NCT02948855|Thymoma|thymoma
1034401|NCT02948855|Autoimmune disease|autoimmune disease
1034402|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
1034403|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
1034404|NCT02948829|Drug therapy|drug therapy
1034405|NCT02948803|intervention|intervention
1034406|NCT02948803|mHealth|mhealth
1034407|NCT02948803|physical activity|physical activity
1034408|NCT02948803|active transport|active transport
1034409|NCT02948803|smartphone|smartphone
1034410|NCT02948803|application|application
1034411|NCT02948764|breast cancer|breast cancer
1034412|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
1034413|NCT02948764|pathological complete response|pathological complete response
1034414|NCT02948712|distress|distress
1034415|NCT02948712|survivorship|survivorship
1034416|NCT02948712|transition period|transition period
1034417|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1672203|NCT00099619|Amylin|amylin
1065625|NCT02757209|DPI|dpi
1034418|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1034419|NCT02948699|nutrition support|nutrition support
1034420|NCT02948699|nutrition assessment|nutrition assessment
1034421|NCT02948686|dentin bonding agents|dentin bonding agents
1034422|NCT02948686|tooth sensitivity|tooth sensitivity
1034423|NCT02948686|composite resin restoration|composite resin restoration
1034424|NCT02948673|type 2 diabetes|type 2 diabetes
1034425|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
1034426|NCT02948673|oxidative stress|oxidative stress
1034427|NCT02948673|antioxidant treatment|antioxidant treatment
1034431|NCT02948621|Quality of life|quality of life
1034432|NCT02948608|spondyloarthropathy|spondyloarthropathy
1034433|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
1034434|NCT02948608|spinal diseases|spinal diseases
1034435|NCT02948608|spondylitis|spondylitis
1034436|NCT02948608|spondylarthritis|spondylarthritis
1034437|NCT02948608|psoriasis|psoriasis
1034438|NCT02948608|uveitis|uveitis
1034439|NCT02948608|joint diseases|joint diseases
1034440|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1034441|NCT02948582|COPD|copd
1034442|NCT02948582|Emphysema|emphysema
1034443|NCT02948582|Chronic bronchitis|chronic bronchitis
1034444|NCT02948569|Obesity|obesity
1034445|NCT02948569|Hyperlipidemia|hyperlipidemia
1034446|NCT02948569|Impaired fasting glucose|impaired fasting glucose
1034447|NCT02948569|Insulin resistance|insulin resistance
1034448|NCT02948569|Hypertension|hypertension
1034449|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
1034450|NCT02948504|Small aneurysms|small aneurysms
1034451|NCT02948504|Risk of rupture|risk of rupture
1034452|NCT02948504|Natural history|natural history
1034453|NCT02948504|Endovascular Coiling|endovascular coiling
1034454|NCT02948504|Surgical clipping|surgical clipping
1034455|NCT02948491|Complementary Therapies|complementary therapies
1034456|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
1034457|NCT02948491|Child Development|child development
1034458|NCT02948491|Infants Premature|infants premature
1034459|NCT02948478|precariousness|precariousness
1034460|NCT02948478|care pathways|care pathways
1034461|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
1034462|NCT02948452|anorexia nervosa|anorexia nervosa
1034464|NCT02948452|reward|reward
1034465|NCT02948452|recurrence|recurrence
1034466|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
1034467|NCT02948439|pregnancy|pregnancy
1034468|NCT02948439|cardiovascular|cardiovascular
1034469|NCT02948439|nervous system|nervous system
1034470|NCT02948439|exercise|exercise
1034471|NCT02948426|Immunotherapy|immunotherapy
1034472|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
1034473|NCT02948426|Carcinomatosis|carcinomatosis
1034474|NCT02948426|CA125|ca125
1034479|NCT02948335|Microbial communities|microbial communities
1034480|NCT02948335|Hospital environment|hospital environment
1034481|NCT02948335|Disinfection|disinfection
1034482|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
1034483|NCT02948335|Bioburden|bioburden
1034484|NCT02948322|Acromegaly,|acromegaly,
1034485|NCT02948322|water retention|water retention
1034486|NCT02948322|myocardial fibrosis|myocardial fibrosis
1034487|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
1034488|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
1034489|NCT02948309|Primary diagnosis|primary diagnosis
1034490|NCT02948309|Relapse|relapse
1034491|NCT02948257|Vessel closure|vessel closure
1034492|NCT02948257|Antegrade access|antegrade access
1034493|NCT02948257|Femoral arteriotomy|femoral arteriotomy
1034494|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
1034495|NCT02948244|fshd|fshd
1034496|NCT02948244|creatine monohydrate|creatine monohydrate
1034497|NCT02948244|children|children
1034498|NCT02948244|pediatrics|pediatrics
1034499|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
1034500|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
1034501|NCT02948192|Preterm Delivery|preterm delivery
1034502|NCT02948192|Preterm Birth|preterm birth
1034503|NCT02948192|Vaginal Microbiome|vaginal microbiome
1034504|NCT02948192|Microbiome|microbiome
1034505|NCT02948192|Gut Microbiome|gut microbiome
1034506|NCT02948192|African American|african american
1034507|NCT02948192|Metabolomics|metabolomics
1034508|NCT02948192|Pregnancy|pregnancy
1034509|NCT02948166|remote endarterectomy|remote endarterectomy
1034510|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
1034511|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
1034512|NCT02948101|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
1034513|NCT02948101|Epithelial ovarian cancer|epithelial ovarian cancer
1034514|NCT02948101|Fallopian tube cancer|fallopian tube cancer
1034515|NCT02948101|Primary peritoneal cancer|primary peritoneal cancer
1034516|NCT02948101|PD 0360324|pd 0360324
1034517|NCT02948101|Cyclophosphamide|cyclophosphamide
1034518|NCT02948101|Cytoxan|cytoxan
1034519|NCT02948101|Neosar|neosar
1034520|NCT02948101|Pharmacokinetic testing|pharmacokinetic testing
1034521|NCT02948101|PK|pk
1034522|NCT02948101|Pharmacodynamic testing|pharmacodynamic testing
1034523|NCT02948101|PD|pd
1034524|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
1034525|NCT02948088|Disease registry|disease registry
1034526|NCT02948088|Routine clinical practice|routine clinical practice
1034527|NCT02948088|Real World Evidence|real world evidence
1034528|NCT02948062|ALD|ald
1034529|NCT02948062|Newborn Screening|newborn screening
1034530|NCT02948049|Accelerometer|accelerometer
1034531|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
1034532|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
1034533|NCT02948049|Physical Function|physical function
1034534|NCT02947997|Healthy Volunteers|healthy volunteers
1034535|NCT02947984|sphenoid region|sphenoid region
1034536|NCT02947984|parasellar area|parasellar area
1034537|NCT02947984|photon radiation therapy|photon radiation therapy
1034538|NCT02947984|proton radiation therapy|proton radiation therapy
1034539|NCT02947958|teleconsultation|teleconsultation
1034540|NCT02947958|urology|urology
1034541|NCT02947958|primary care|primary care
1034542|NCT02947958|tertiary care|tertiary care
1034543|NCT02947932|acute pancreatitis|acute pancreatitis
1034544|NCT02947932|post-ERCP|post-ercp
1034545|NCT02947932|endoscopy|endoscopy
1034546|NCT02947919|Perioperative Period|perioperative period
1034547|NCT02947919|Music|music
1034548|NCT02947906|Gait|gait
1034549|NCT02947906|Loading|loading
1034550|NCT02947906|Multiple Sclerosis|multiple sclerosis
1034551|NCT02947906|Plantar Pressure|plantar pressure
1034552|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
1034553|NCT02947880|autism, Bumetanide|autism, bumetanide
1034554|NCT02947854|Vaccine|vaccine
1034555|NCT02947854|Photochemical Internalisation|photochemical internalisation
1034556|NCT02947854|Immune Response|immune response
1034557|NCT02947854|Peptide vaccine|peptide vaccine
1034558|NCT02947854|Anti cancer vaccine|anti cancer vaccine
1034559|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1034560|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
1034561|NCT02947750|Hypertension|hypertension
1034562|NCT02947750|Kidney Disorder|kidney disorder
1034563|NCT02947750|Nephrology|nephrology
1034564|NCT02947750|Physiology|physiology
1034565|NCT02947737|Skin graft|skin graft
1034566|NCT02947724|chocolate cyst|chocolate cyst
1034567|NCT02947724|laparoscopy|laparoscopy
1034568|NCT02947724|surgicel|surgicel
1034569|NCT02947711|E2027|e2027
1034570|NCT02947711|Healthy participants|healthy participants
1034671|NCT02947152|CDH6|cdh6
1034571|NCT02947711|Pharmacokinetics|pharmacokinetics
1034572|NCT02947698|acute kidney injury|acute kidney injury
1034573|NCT02947698|weekend admission|weekend admission
1034574|NCT02947698|mortality|mortality
1034575|NCT02947685|breast cancer|breast cancer
1034576|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
1034577|NCT02947685|HER2+|her2+
1034578|NCT02947685|HR+|hr+
1034579|NCT02947685|metastatic breast cancer|metastatic breast cancer
1034580|NCT02947659|Body mass index|body mass index
1034581|NCT02947659|Academic stress|academic stress
1034582|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
1034583|NCT02947607|Human gut microbiome|human gut microbiome
1034584|NCT02947607|Colorectal cancer|colorectal cancer
1034585|NCT02947607|Colorectal adenoma|colorectal adenoma
1034586|NCT02947607|Gut bacteria|gut bacteria
1034587|NCT02947607|Metagenomics|metagenomics
1034588|NCT02947607|Metatranscriptomics|metatranscriptomics
1034589|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
1034590|NCT02947581|albendazole|albendazole
1034591|NCT02947581|praziquantel|praziquantel
1034592|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1034593|NCT02947568|Chronic Kidney Disease|chronic kidney disease
1034594|NCT02947568|Diabetes Mellitus|diabetes mellitus
1034595|NCT02947568|Cross-sectional|cross-sectional
1034596|NCT02947555|diabetes mellitus|diabetes mellitus
1034597|NCT02947555|atherosclerosis|atherosclerosis
1034598|NCT02947555|AGE|age
1034599|NCT02947555|lens autofluorescence|lens autofluorescence
1034600|NCT02947529|Hemiarthroplasty|hemiarthroplasty
1034601|NCT02947529|Intramedullary nail|intramedullary nail
1034602|NCT02947529|Tranexamic acid|tranexamic acid
1034603|NCT02947529|Transfusion|transfusion
1034604|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
1034605|NCT02947516|liver|liver
1034606|NCT02947516|biopsy|biopsy
1034607|NCT02947516|pain|pain
1034608|NCT02947503|Gestational Diabetes|gestational diabetes
1034609|NCT02947503|Insulin Resistance|insulin resistance
1034610|NCT02947503|Metformin|metformin
1034611|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
1034612|NCT02947503|Prevention of Complications|prevention of complications
1034613|NCT02947503|Long Term Study|long term study
1034614|NCT02947503|Mother and Child|mother and child
1034615|NCT02947503|Health Benefits|health benefits
1034616|NCT02947490|Blood pressure monitoring|blood pressure monitoring
1034617|NCT02947490|self BP monitoring|self bp monitoring
1034618|NCT02947490|self BP management|self bp management
1034619|NCT02947438|Renal anemia|renal anemia
1034620|NCT02947438|Haemodialysis|haemodialysis
1034621|NCT02947438|Maintenance phase|maintenance phase
1034622|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
1034623|NCT02947412|long-term follow-up|long-term follow-up
1034624|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
1034932|NCT02945332|exercise|exercise
1034625|NCT02947412|revisional surgery|revisional surgery
1034626|NCT02947399|Thyroid|thyroid
1034627|NCT02947399|I-124|i-124
1034628|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
1034629|NCT02947373|brain tumor|brain tumor
1034630|NCT02947373|children|children
1034631|NCT02947321|Radiofrequency ablation|radiofrequency ablation
1034632|NCT02947308|Anxiety|anxiety
1034633|NCT02947308|Depression|depression
1034634|NCT02947243|Virtual reality|virtual reality
1034635|NCT02947243|Immersive distraction|immersive distraction
1034636|NCT02947243|Oculus rift|oculus rift
1034637|NCT02947243|Virtual world|virtual world
1034638|NCT02947243|Virtual environment|virtual environment
1034639|NCT02947243|Procedural pain|procedural pain
1034640|NCT02947243|Procedural anxiety|procedural anxiety
1034641|NCT02947243|Acute pain|acute pain
1034642|NCT02947243|Pain management|pain management
1034643|NCT02947243|Anxiety|anxiety
1034644|NCT02947243|Children, Child|children, child
1034645|NCT02947243|Kid, Kids|kid, kids
1034646|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
1034647|NCT02947243|Young children|young children
1034648|NCT02947243|Burns|burns
1034649|NCT02947243|Burn injuries|burn injuries
1034650|NCT02947243|Burn unit|burn unit
1034651|NCT02947243|Physiotherapy|physiotherapy
1034652|NCT02947243|Physical therapy|physical therapy
1034653|NCT02947243|Burn dressing|burn dressing
1034654|NCT02947243|Dressing change|dressing change
1034655|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
1034656|NCT02947243|Clinical Research|clinical research
1034657|NCT02947243|Nursing Practice|nursing practice
1034658|NCT02947230|Mobility|mobility
1034659|NCT02947230|Aging|aging
1034660|NCT02947230|Knowledge Translation|knowledge translation
1034661|NCT02947230|Physical Activity|physical activity
1034662|NCT02947217|Immunology|immunology
1034663|NCT02947217|Pregnancy|pregnancy
1034664|NCT02947217|Implantation Rate|implantation rate
1034665|NCT02947217|Fertilization in Vitro|fertilization in vitro
1034666|NCT02947204|Bronchiolitis|bronchiolitis
1034667|NCT02947204|Length of Hospital Stay|length of hospital stay
1034668|NCT02947204|Clinical Trial|clinical trial
1034669|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
1034670|NCT02947152|HKT288|hkt288
1034674|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
1034675|NCT02947152|renal cell carcinoma|renal cell carcinoma
1034676|NCT02947152|RCC|rcc
1034677|NCT02947126|cystic fibrosis|cystic fibrosis
1034678|NCT02947126|mucociliary clearance|mucociliary clearance
1034679|NCT02947126|CFTR|cftr
1034680|NCT02947113|cancer|cancer
1034681|NCT02947100|Sickle Cell Disease|sickle cell disease
1034682|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
1034683|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
1034684|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
1034685|NCT02947087|Islet autotransplantation|islet autotransplantation
1034686|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
1034687|NCT02947074|Yoga|yoga
1034688|NCT02947074|Meditation|meditation
1034689|NCT02947074|Glutathione|glutathione
1034690|NCT02947074|Catecholamine|catecholamine
1034691|NCT02947074|polysomnography|polysomnography
1034692|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
1034693|NCT02947035|thyroid cancer|thyroid cancer
1034694|NCT02947035|thyroid nodule|thyroid nodule
1034695|NCT02947035|thyroidectomy|thyroidectomy
1034696|NCT02947035|personalized medicine|personalized medicine
1034697|NCT02947022|gadolinium|gadolinium
1034698|NCT02947022|deposition|deposition
1034699|NCT02947022|GBCA|gbca
1034700|NCT02947022|Extremity Pain|extremity pain
1034701|NCT02947022|Skin Pain|skin pain
1034702|NCT02947022|Chest Wall Pain|chest wall pain
1034703|NCT02946944|Pulmonary Embolism|pulmonary embolism
1034704|NCT02946944|sildenafil|sildenafil
1034705|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
1034706|NCT02946918|levothyroxine|levothyroxine
1034707|NCT02946853|Atrial Fibrillation|atrial fibrillation
1034708|NCT02946853|CRT|crt
1034709|NCT02946853|AV Junction Ablation|av junction ablation
1034710|NCT02946853|LVESV|lvesv
1034711|NCT02946827|FODMAPs diet|fodmaps diet
1034712|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
1034713|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
1034714|NCT02946814|essential oils|essential oils
1034715|NCT02946814|microscope, colfocal|microscope, colfocal
1034716|NCT02946814|dental plaque|dental plaque
1034717|NCT02946801|Biofilms|biofilms
1034718|NCT02946801|essential oils|essential oils
1034719|NCT02946801|alcohol|alcohol
1034720|NCT02946801|microscopy, confocal|microscopy, confocal
1034721|NCT02946801|mouthwashes|mouthwashes
1034722|NCT02946775|septicemia|septicemia
1034723|NCT02946775|bacteremia|bacteremia
1034724|NCT02946775|pneumonia|pneumonia
1034725|NCT02946775|meningitis|meningitis
1034728|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
1034729|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
1034730|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
1034731|NCT02946762|Treatment as Prevention|treatment as prevention
1034732|NCT02946749|Scar pregnancy|scar pregnancy
1034733|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
1034734|NCT02946749|Early diagnosis|early diagnosis
1034735|NCT02946749|Individualized treatment|individualized treatment
1034736|NCT02946736|Sleep|sleep
1034737|NCT02946736|Physical Health|physical health
1034738|NCT02946736|Psychological Health|psychological health
1034739|NCT02946736|Well-Being|well-being
1034740|NCT02946736|Employee|employee
1034741|NCT02946736|Actigraphy|actigraphy
1034742|NCT02946710|Alzheimer disease|alzheimer disease
1034743|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
1034744|NCT02946710|p75NTR-ECD|p75ntr-ecd
1034745|NCT02946697|Chinese|chinese
1034746|NCT02946697|cancer survivors|cancer survivors
1034747|NCT02946697|Quality of Life|quality of life
1034748|NCT02946697|Social Support|social support
1034749|NCT02946658|COPD, Emphysema|copd, emphysema
1034750|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
1034751|NCT02946619|expressive writing|expressive writing
1034752|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
1034753|NCT02946554|ACLF|aclf
1034754|NCT02946541|DA-1229|da-1229
1034755|NCT02946541|evogliptin|evogliptin
1034756|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
1034757|NCT02946541|Suganon|suganon
1034758|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
1034759|NCT02946515|Pediatrics|pediatrics
1034760|NCT02946489|cannabis|cannabis
1034761|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
1034762|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
1034763|NCT02946437|severe SAH|severe sah
1034764|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
1034765|NCT02946437|Sevoflurane|sevoflurane
1034766|NCT02946437|Postconditioning|postconditioning
1034767|NCT02946411|Hyperglycemia|hyperglycemia
1034768|NCT02946385|meningococcal disease|meningococcal disease
1034769|NCT02946385|meningitis|meningitis
1034770|NCT02946385|booster|booster
1034771|NCT02946385|antibody persistence|antibody persistence
1034772|NCT02946372|retina surgery|retina surgery
1034773|NCT02946372|macula|macula
1034774|NCT02946372|macular hole|macular hole
1034775|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
1034777|NCT02946372|autologous transplantation|autologous transplantation
1034778|NCT02946346|Human papillomaviruses|human papillomaviruses
1034779|NCT02946346|Clearance|clearance
1034780|NCT02946346|Kinetics|kinetics
1034781|NCT02946346|Ecology|ecology
1034782|NCT02946346|Bacterial vaginosis|bacterial vaginosis
1034783|NCT02946346|Immune response|immune response
1034784|NCT02946346|Microbiota|microbiota
1034785|NCT02946333|Multiple Myeloma|multiple myeloma
1034786|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
1034787|NCT02946333|QoLMMBuS|qolmmbus
1034788|NCT02946333|healthcare costs|healthcare costs
1034789|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
1034790|NCT02946281|self-management|self-management
1034791|NCT02946281|health behavior|health behavior
1034792|NCT02946281|cardiac disease|cardiac disease
1034793|NCT02946281|habits|habits
1034794|NCT02946281|lifestyle|lifestyle
1034795|NCT02946255|Psychosis|psychosis
1034796|NCT02946255|Psychosis NOS|psychosis nos
1034797|NCT02946255|Schizophrenia|schizophrenia
1034798|NCT02946255|Hospital discharge|hospital discharge
1034799|NCT02946255|Inpatient psychiatry|inpatient psychiatry
1034800|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
1034801|NCT02946177|Immunology|immunology
1034802|NCT02946177|Pregnancy|pregnancy
1034803|NCT02946177|Implantation Rate|implantation rate
1034804|NCT02946177|Fertilization in Vitro|fertilization in vitro
1034805|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
1034806|NCT02946151|Epilepsy|epilepsy
1034807|NCT02946151|Seizure monitoring|seizure monitoring
1034808|NCT02946151|Electroencephalography|electroencephalography
1034809|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
1034810|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
1034811|NCT02946138|GM-CSF|gm-csf
1034812|NCT02946138|immunotherapy|immunotherapy
1034813|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
1034815|NCT02946047|ART|art
1034816|NCT02946047|Antiretroviral|antiretroviral
1034817|NCT02946047|Therapy|therapy
1034818|NCT02946047|Reservoir|reservoir
1034819|NCT02946047|Cure|cure
1034820|NCT02946034|CKD|ckd
1034821|NCT02946034|HCV|hcv
1034822|NCT02946021|Lymphedema|lymphedema
1034823|NCT02946021|Cancer|cancer
1034824|NCT02946021|Head Cancer|head cancer
1034825|NCT02946021|Neck Cancer|neck cancer
1034826|NCT02945982|Portal Hypertension|portal hypertension
1034827|NCT02945982|Fuzheng Huayu|fuzheng huayu
1034828|NCT02945982|Hepatitis B|hepatitis b
1034829|NCT02945969|dietary sodium|dietary sodium
1034830|NCT02945969|albuminuria|albuminuria
1034831|NCT02945969|chronic kidney disease|chronic kidney disease
1034832|NCT02945956|Portal Hypertension|portal hypertension
1034833|NCT02945956|Fuzheng Huayu|fuzheng huayu
1034834|NCT02945956|Hepatitis B|hepatitis b
1034835|NCT02945930|Enbucrilate|enbucrilate
1034836|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
1034837|NCT02945930|Endoscopy|endoscopy
1034838|NCT02945930|Safety|safety
1034839|NCT02945930|Efficacy|efficacy
1034840|NCT02945891|mass screening|mass screening
1034841|NCT02945891|coverage|coverage
1034842|NCT02945891|self-sampling|self-sampling
1034843|NCT02945891|clinical validity|clinical validity
1034844|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
1034845|NCT02945839|Migraine|migraine
1034846|NCT02945839|emergency department|emergency department
1034847|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
1034848|NCT02945826|positron emission tomography|positron emission tomography
1034849|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
1034850|NCT02945813|Prostate Cancer|prostate cancer
1034851|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
1034852|NCT02945813|Phase II Trial|phase ii trial
1034853|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
1034854|NCT02945813|Metformin|metformin
1034855|NCT02945800|relapsed|relapsed
1034856|NCT02945800|refractory|refractory
1034857|NCT02945800|soft tissue|soft tissue
1034858|NCT02945800|bones and joints|bones and joints
1034859|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
1034860|NCT02945800|pediatric|pediatric
1034861|NCT02945787|Spanish speaking|spanish speaking
1034862|NCT02945787|self-help|self-help
1034863|NCT02945787|tobacco abstinence|tobacco abstinence
1034864|NCT02945787|public health|public health
1034865|NCT02945787|Forever Free|forever free
1034866|NCT02945787|Stop Smoking for Good|stop smoking for good
1034868|NCT02945774|MRI|mri
1034869|NCT02945774|Inflammation|inflammation
1034870|NCT02945774|Microglia|microglia
1034871|NCT02945774|FEPPA|feppa
1034872|NCT02945748|pediatric|pediatric
1034873|NCT02945748|cardiac output|cardiac output
1034874|NCT02945748|fluid responsiveness|fluid responsiveness
1034875|NCT02945748|critically ill|critically ill
1034876|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
1034877|NCT02945735|depression|depression
1034878|NCT02945735|cognitive bias modification|cognitive bias modification
1034879|NCT02945735|MDD|mdd
1034880|NCT02945735|major depressive disorder|major depressive disorder
1034881|NCT02945735|attention bias modification treatment|attention bias modification treatment
1034882|NCT02945722|Hemodialysis|hemodialysis
1034883|NCT02945722|S. Aureus|s. aureus
1034884|NCT02945722|Decolonization|decolonization
1034885|NCT02945722|Persistent carriage|persistent carriage
1034886|NCT02945709|PTSD|ptsd
1034887|NCT02945709|attention training|attention training
1034888|NCT02945709|cognitive bias modification|cognitive bias modification
1034889|NCT02945696|nerve block|nerve block
1034890|NCT02945696|laparoscopy|laparoscopy
1034891|NCT02945696|anesthesia|anesthesia
1034892|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
1034893|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
1034894|NCT02945644|trazodone|trazodone
1034895|NCT02945644|positive airway pressure|positive airway pressure
1034896|NCT02945644|adherence|adherence
1034897|NCT02945631|HPV|hpv
1034898|NCT02945631|Induction Chemotherapy|induction chemotherapy
1034899|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
1034900|NCT02945631|Oropharynx Cancer|oropharynx cancer
1034901|NCT02945618|cryotherapy|cryotherapy
1034902|NCT02945618|physical therapy|physical therapy
1034903|NCT02945592|Hemispatial Neglect|hemispatial neglect
1034904|NCT02945592|cueing|cueing
1034905|NCT02945592|egocentric-allocentric|egocentric-allocentric
1034906|NCT02945592|early rehabilitation|early rehabilitation
1034907|NCT02945592|parietal tDCS|parietal tdcs
1034908|NCT02945579|Breast Cancer|breast cancer
1034909|NCT02945579|Surveillance|surveillance
1034910|NCT02945579|Breast biopsy|breast biopsy
1034911|NCT02945579|Questionnaires|questionnaires
1034912|NCT02945579|Surveys|surveys
1034913|NCT02945540|Gestational diabetes|gestational diabetes
1034914|NCT02945540|Patient education|patient education
1034915|NCT02945540|Patient Satisfaction|patient satisfaction
1034916|NCT02945514|Healthy|healthy
1034917|NCT02945514|Diet|diet
1034918|NCT02945514|Microbiome|microbiome
1034919|NCT02945514|Personalized|personalized
1034920|NCT02945514|Custom|custom
1034921|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
1034922|NCT02945475|eating behavior|eating behavior
1034923|NCT02945475|sugar|sugar
1034924|NCT02945475|fructose|fructose
1034925|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
1034926|NCT02945449|Erectile Dysfunction|erectile dysfunction
1034927|NCT02945449|Diabetes|diabetes
1034928|NCT02945397|Return to work|return to work
1034929|NCT02945397|Work rehabilitation|work rehabilitation
1034930|NCT02945397|Sick-leave|sick-leave
1034931|NCT02945384|family well-being|family well-being
1034933|NCT02945332|activity|activity
1034934|NCT02945332|behavior|behavior
1034935|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
1034936|NCT02945306|Adenotonsillectomy|adenotonsillectomy
1034937|NCT02945306|Child|child
1034938|NCT02945293|Pain|pain
1034939|NCT02945293|Elderly|elderly
1034940|NCT02945293|Aged|aged
1034941|NCT02945293|Opioid|opioid
1034942|NCT02945293|Cognition|cognition
1034943|NCT02945293|Side-effects|side-effects
1034944|NCT02945293|Alcohol|alcohol
1034945|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
1034946|NCT02945293|Older|older
1034947|NCT02945280|apixaban|apixaban
1034948|NCT02945280|factor Xa inhibitors|factor xa inhibitors
1034949|NCT02945280|antithrombotic agent|antithrombotic agent
1034950|NCT02945280|deep vein thrombosis|deep vein thrombosis
1034951|NCT02945280|upper extremity|upper extremity
1034952|NCT02945267|Pancreatic Cancer|pancreatic cancer
1034953|NCT02945267|Unresectable|unresectable
1034954|NCT02945267|Maintenance Treatment|maintenance treatment
1034955|NCT02945254|sleep onset latency|sleep onset latency
1034956|NCT02945254|sleep quality|sleep quality
1034957|NCT02945254|insomnia|insomnia
1034958|NCT02945228|Genotype 2|genotype 2
1034959|NCT02945228|Paritaprevir|paritaprevir
1034960|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1034961|NCT02945228|Ritonavir|ritonavir
1034962|NCT02945228|Ombitasvir|ombitasvir
1034963|NCT02945189|Pregnancy|pregnancy
1034964|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
1034965|NCT02945150|hemodialysis|hemodialysis
1034966|NCT02945150|peritoneal dialysis|peritoneal dialysis
1034967|NCT02945150|renal failure|renal failure
1034968|NCT02945150|kidney transplant|kidney transplant
1034969|NCT02945085|older adults|older adults
1034970|NCT02945085|family caregivers|family caregivers
1034971|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
1034972|NCT02945072|Child Behavior|child behavior
1034973|NCT02945072|Problem Behavior|problem behavior
1034974|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
1034975|NCT02945059|Liver regeneration|liver regeneration
1034976|NCT02945059|portal vein embolization|portal vein embolization
1034977|NCT02945059|gelatin powder|gelatin powder
1034978|NCT02945059|liver surgery|liver surgery
1034979|NCT02945059|hepatectomy|hepatectomy
1034980|NCT02945033|Pi3k mutation|pi3k mutation
1034981|NCT02945033|Aspirin|aspirin
1034982|NCT02944968|Interventional|interventional
1034983|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
1034984|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1034985|NCT02944929|Spastic hemiparesis|spastic hemiparesis
1034986|NCT02944929|Stroke|stroke
1034987|NCT02944929|Self-rehabilitation|self-rehabilitation
1034988|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
1034989|NCT02944903|audit|audit
1034990|NCT02944903|Lung cancer|lung cancer
1034991|NCT02944903|screening practice|screening practice
1034992|NCT02944903|Egypt|egypt
1034993|NCT02944851|Blood donors|blood donors
1034994|NCT02944851|blood donation|blood donation
1034995|NCT02944851|traumatic blood loss|traumatic blood loss
1034996|NCT02944851|Trauma|trauma
1034997|NCT02944838|older adults|older adults
1034998|NCT02944838|physical activity|physical activity
1034999|NCT02944838|built environment|built environment
1035000|NCT02944825|Urolithiasis|urolithiasis
1035001|NCT02944825|UTI|uti
1035002|NCT02944786|Chronic pain|chronic pain
1035003|NCT02944786|Adolescents|adolescents
1035004|NCT02944786|School nurse|school nurse
1035005|NCT02944773|newborn|newborn
1035006|NCT02944773|facilitated tucking|facilitated tucking
1035007|NCT02944773|position|position
1035008|NCT02944773|weight|weight
1035009|NCT02944773|stress|stress
1035010|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
1035011|NCT02944734|Candesartan|candesartan
1035012|NCT02944734|Amlodipine|amlodipine
1035013|NCT02944734|Hypertension|hypertension
1035014|NCT02944734|Vascular Diseases|vascular diseases
1035015|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
1035016|NCT02944734|Antihypertensive Agents|antihypertensive agents
1035017|NCT02944734|Vasodilator Agents|vasodilator agents
1035018|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1035019|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
1035020|NCT02944734|Calcium Channel Blockers|calcium channel blockers
1035021|NCT02944721|Neuropathic Pain|neuropathic pain
1035022|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
1035023|NCT02944695|audit|audit
1035024|NCT02944695|infection control|infection control
1035025|NCT02944695|bronchoscopy unit|bronchoscopy unit
1035026|NCT02944695|Egypt|egypt
1035027|NCT02944682|Obstetrics|obstetrics
1035028|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
1035029|NCT02944682|Pediatrics|pediatrics
1035030|NCT02944682|Atherosclerosis|atherosclerosis
1035031|NCT02944682|Cancer|cancer
1035032|NCT02944682|Cardiovascular Disease|cardiovascular disease
1035033|NCT02944682|Public Health|public health
1035034|NCT02944682|Environmental Air Pollutants|environmental air pollutants
1035035|NCT02944656|Perioperative pain|perioperative pain
1035036|NCT02944656|Outpatient surgery|outpatient surgery
1035037|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
1035038|NCT02944656|Pain management|pain management
1035039|NCT02944630|quality of life|quality of life
1035040|NCT02944630|psychotherapy|psychotherapy
1035041|NCT02944630|psoriasis|psoriasis
1035042|NCT02944630|treatments|treatments
1035043|NCT02944578|Cancer|cancer
1035044|NCT02944578|HIV|hiv
1035045|NCT02944578|Oncology|oncology
1035046|NCT02944578|Infectious Diseases|infectious diseases
1035047|NCT02944578|HPV|hpv
1035048|NCT02944578|Preventive Medicine|preventive medicine
1035049|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
1035050|NCT02944539|Gastric cancer|gastric cancer
1035051|NCT02944526|suprascapular nerve|suprascapular nerve
1035052|NCT02944500|Brain|brain
1035053|NCT02944500|Liraglutide|liraglutide
1035054|NCT02944500|MRI|mri
1035055|NCT02944487|safety|safety
1035056|NCT02944487|pharmacokinetics|pharmacokinetics
1035057|NCT02944474|Pharmacokinetics|pharmacokinetics
1035058|NCT02944474|Safety|safety
1035059|NCT02944448|Osteoarthritis|osteoarthritis
1035060|NCT02944448|Hip|hip
1035061|NCT02944448|Knee|knee
1035062|NCT02944448|CR485|cr485
1035063|NCT02944448|Analgesic|analgesic
1035064|NCT02944448|Kappa opioid|kappa opioid
1035065|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
1035066|NCT02944435|Glutaminase|glutaminase
1035067|NCT02944435|CB-839|cb-839
1035068|NCT02944396|metastatic|metastatic
1035069|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
1035070|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
1035071|NCT02944396|veliparib|veliparib
1035072|NCT02944396|nivolumab|nivolumab
1035073|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
1035074|NCT02944396|carboplatin|carboplatin
1035075|NCT02944396|paclitaxel|paclitaxel
1035076|NCT02944396|pemetrexed|pemetrexed
1035077|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
1035078|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
1035079|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
1035080|NCT02944396|Immuno Oncology|immuno oncology
1035081|NCT02944396|Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|metastatic or advanced non-small cell lung cancer (nsclc)
1035082|NCT02944383|Hypertriglycerides|hypertriglycerides
1035083|NCT02944344|breast cancer|breast cancer
1035087|NCT02944344|palliative care|palliative care
1035088|NCT02944344|end of life|end of life
1035089|NCT02944344|advance directive|advance directive
1035090|NCT02944344|oncology|oncology
1035091|NCT02944344|caregiver|caregiver
1035092|NCT02944344|provider|provider
1035093|NCT02944344|coping|coping
1035094|NCT02944344|support|support
1035095|NCT02944344|online|online
1035096|NCT02944331|Steam ablation|steam ablation
1035097|NCT02944331|Endothermal ablation|endothermal ablation
1035098|NCT02944331|Varicose vein treatment|varicose vein treatment
1035099|NCT02944331|Venous insufficiency|venous insufficiency
1035100|NCT02944331|Saphenous vein reflux|saphenous vein reflux
1035101|NCT02944331|Recurrent varicosity|recurrent varicosity
1035102|NCT02944318|Physical Activity|physical activity
1035103|NCT02944318|Healthy Lifestyle|healthy lifestyle
1035104|NCT02944318|Academic performance|academic performance
1035105|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
1035106|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
1035107|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
1035108|NCT02944253|Diet, Reducing|diet, reducing
1035109|NCT02944253|Hunger|hunger
1035110|NCT02944253|Appetite Regulation|appetite regulation
1035111|NCT02944253|Ketogenic Diet|ketogenic diet
1035112|NCT02944253|Caloric Restriction|caloric restriction
1035113|NCT02944253|Weight Loss|weight loss
1035114|NCT02944253|Ketosis|ketosis
1035115|NCT02944214|Hyperuricemia|hyperuricemia
1035116|NCT02944214|Renal Function|renal function
1035117|NCT02944214|Chronic kidney disease|chronic kidney disease
1035118|NCT02944214|Febuxostat|febuxostat
1035119|NCT02944214|Benzbromarone|benzbromarone
1035120|NCT02944201|carvedilol|carvedilol
1035121|NCT02944201|biomarkers|biomarkers
1035122|NCT02944201|autonomic nerves|autonomic nerves
1672204|NCT00099619|Lilly|lilly
1035123|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
1035124|NCT02944188|right hemicolectomy|right hemicolectomy
1035125|NCT02944162|AML|aml
1035126|NCT02944162|CD33|cd33
1035127|NCT02944162|CAR-NK|car-nk
1035128|NCT02944136|cancer|cancer
1035129|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
1035130|NCT02944136|depression|depression
1035131|NCT02944136|quality of life|quality of life
1035132|NCT02944136|stress|stress
1035133|NCT02944136|dyadic function|dyadic function
1035134|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
1035135|NCT02944123|Half dose|half dose
1035136|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
1035137|NCT02944123|Acute coronary syndrome|acute coronary syndrome
1035138|NCT02944097|Bioavailability|bioavailability
1035139|NCT02944097|Pharmacokinetics|pharmacokinetics
1035140|NCT02944097|trans-resveratrol|trans-resveratrol
1035141|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
1035142|NCT02944097|Vineatrol 30|vineatrol 30
1035143|NCT02944084|Bioavailability|bioavailability
1035144|NCT02944084|Pharmacokinetics|pharmacokinetics
1035145|NCT02944084|Rice bran extract|rice bran extract
1035146|NCT02944084|Vitamin E|vitamin e
1035147|NCT02944084|Gamma-oryzanol|gamma-oryzanol
1035148|NCT02944084|Ferulic acid|ferulic acid
1035149|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
1035150|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1035151|NCT02944071|Peripheral Artery Disease|peripheral artery disease
1035152|NCT02944071|Drug-coated Balloon|drug-coated balloon
1035153|NCT02944058|Multiloc|multiloc
1035154|NCT02944058|Philos|philos
1035155|NCT02944058|Locking plate|locking plate
1035156|NCT02944058|Straight nail|straight nail
1035157|NCT02944058|Randomized controlled trial|randomized controlled trial
1035158|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
1035159|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
1035160|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
1035161|NCT02944019|Safety|safety
1035162|NCT02944019|Real World Evidence|real world evidence
1035163|NCT02944006|MRI|mri
1035164|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
1035165|NCT02943993|Real World Evidence|real world evidence
1035166|NCT02943993|Edoxaban|edoxaban
1035167|NCT02943993|Efficacy/Safety|efficacy/safety
1035168|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
1035169|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
1035170|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
1035171|NCT02943967|Aberrometry|aberrometry
1035172|NCT02943954|Fractional Flow Reserve|fractional flow reserve
1035173|NCT02943915|Spinal Cord|spinal cord
1035174|NCT02943915|Injury|injury
1035175|NCT02943915|Exoskeleton|exoskeleton
1035176|NCT02943915|Ekso|ekso
1035177|NCT02943915|Rehabilitation|rehabilitation
1035178|NCT02943902|immunogenicity|immunogenicity
1035179|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
1035180|NCT02943889|Liver cirrhosis|liver cirrhosis
1035181|NCT02943889|Stem cell therapy|stem cell therapy
1035182|NCT02943876|risk prediction|risk prediction
1035183|NCT02943876|risk score|risk score
1035184|NCT02943876|accuracy of risk perception|accuracy of risk perception
1035185|NCT02943876|self-help|self-help
1035186|NCT02943876|psychological distress|psychological distress
1035187|NCT02943850|stem cells|stem cells
1035188|NCT02943850|growth factor|growth factor
1035189|NCT02943850|ALS|als
1035190|NCT02943824|brachytherapy|brachytherapy
1035191|NCT02943824|machine learning|machine learning
1035192|NCT02943824|treatment planning|treatment planning
1035193|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
1035194|NCT02943811|endometrial cancer|endometrial cancer
1035195|NCT02943811|survival|survival
1035196|NCT02943811|uterine manipulator|uterine manipulator
1035197|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
1035198|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
1035199|NCT02943785|Anticoagulation|anticoagulation
1035200|NCT02943785|Atrial Fibrillation|atrial fibrillation
1035201|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
1035202|NCT02943746|Standard Protein Diet|standard protein diet
1035203|NCT02943746|High Protein Diet|high protein diet
1035204|NCT02943746|Growth|growth
1035205|NCT02943746|Body Composition|body composition
1035206|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
1035207|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
1035208|NCT02943746|Protein|protein
1035209|NCT02943746|Targeted Fortification|targeted fortification
1035210|NCT02943746|Human Milk Diet|human milk diet
1035211|NCT02943746|Prematurity|prematurity
1035212|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
1035213|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
1035214|NCT02943733|pNETs|pnets
1035215|NCT02943733|NETs|nets
1035216|NCT02943707|liver diseases|liver diseases
1035217|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
1035218|NCT02943694|TaTME|tatme
1035219|NCT02943694|Complications|complications
1035220|NCT02943694|Instrument|instrument
1035221|NCT02943642|MF|mf
1035222|NCT02943642|CTCL|ctcl
1035223|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1035224|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
1035225|NCT02943616|BVS|bvs
1035226|NCT02943616|Bioabsorbable|bioabsorbable
1035227|NCT02943616|Myocardial ischemia|myocardial ischemia
1035228|NCT02943616|Stent thrombosis|stent thrombosis
1035229|NCT02943616|Stents|stents
1035230|NCT02943603|mFOLFOX6|mfolfox6
1035231|NCT02943603|pembrolizumab|pembrolizumab
1035232|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
1035233|NCT02943551|Pediatrics|pediatrics
1035234|NCT02943551|Respiratory disease|respiratory disease
1035235|NCT02943551|antibiotic use|antibiotic use
1035236|NCT02943538|Crohn's Disease|crohn's disease
1035237|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
1035238|NCT02943538|Telemedicine|telemedicine
1035239|NCT02943525|vaginal packing|vaginal packing
1035240|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
1035241|NCT02943525|pain and satisfaction|pain and satisfaction
1035242|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
1035243|NCT02943486|Fitostimoline|fitostimoline
1035244|NCT02943486|MSC derivatives|msc derivatives
1035245|NCT02943486|Diabetes|diabetes
1035246|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
1035247|NCT02943473|myeloma|myeloma
1035248|NCT02943473|smoldering|smoldering
1035249|NCT02943473|ibrutinib|ibrutinib
1035250|NCT02943408|Veterans|veterans
1035251|NCT02943408|mental health|mental health
1035252|NCT02943408|Patient-Centered Care|patient-centered care
1035253|NCT02943382|MGD|mgd
1035254|NCT02943382|Autologous Serum|autologous serum
1035255|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
1035256|NCT02943382|Dry eye disease|dry eye disease
1035257|NCT02943382|FAB|fab
1035258|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
1035259|NCT02943369|cangrelor|cangrelor
1035260|NCT02943369|ticagrelor|ticagrelor
1035261|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
1035262|NCT02943369|acute myocardial infarction|acute myocardial infarction
1035263|NCT02943330|Depression|depression
1035264|NCT02943330|Cytokines|cytokines
1035265|NCT02943330|Hemodialysis|hemodialysis
1035266|NCT02943330|Interferon treatment|interferon treatment
1035267|NCT02943330|Hepatitis C|hepatitis c
1035268|NCT02943304|Pregnancy|pregnancy
1035269|NCT02943304|Fetal Development|fetal development
1035270|NCT02943304|Child Development|child development
1035271|NCT02943304|Developmental Disabilities|developmental disabilities
1035272|NCT02943304|Zika Virus Infection|zika virus infection
1035273|NCT02943291|Exercise therapy|exercise therapy
1035274|NCT02943291|Adipose tissue|adipose tissue
1035275|NCT02943291|Mitochondria|mitochondria
1035276|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
1035277|NCT02943265|Care Coordination|care coordination
1035278|NCT02943252|apatinib|apatinib
1035279|NCT02943252|S1|s1
1035280|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
1035281|NCT02943252|non-squamous|non-squamous
1035282|NCT02943213|Chlorpromazine|chlorpromazine
1035283|NCT02943213|Hydrochloride|hydrochloride
1035284|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
1035285|NCT02943213|Bioavailability|bioavailability
1035292|NCT02943213|South Africa|south africa
1035293|NCT02943213|Cycle|cycle
1035294|NCT02943213|Anti-Psychotic|anti-psychotic
1035295|NCT02943161|Obesity|obesity
1035296|NCT02943161|L-citrulline|l-citrulline
1035297|NCT02943109|patient portal|patient portal
1035298|NCT02943109|Health Information Technology|health information technology
1035299|NCT02943109|Electronic Health Records|electronic health records
1035300|NCT02943109|Inpatient Care|inpatient care
1035301|NCT02943109|Outpatient Care|outpatient care
1035302|NCT02943109|Patient Engagement|patient engagement
1035303|NCT02943070|Rezum|rezum
1035304|NCT02943070|Water Vapor Ablation|water vapor ablation
1035305|NCT02943031|bile duct tumor|bile duct tumor
1035306|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
1035307|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
1035308|NCT02942979|Facilitation|facilitation
1035309|NCT02942979|Implementation|implementation
1035310|NCT02942979|Homelessness|homelessness
1035311|NCT02942979|Substance Use Disorder|substance use disorder
1035312|NCT02942979|Mental Illness|mental illness
1035313|NCT02942979|Co-Occurring Disorders|co-occurring disorders
1035314|NCT02942979|Veterans|veterans
1035315|NCT02942979|Primary Care|primary care
1035316|NCT02942966|Angioplasty|angioplasty
1035317|NCT02942966|Below the Knee|below the knee
1035318|NCT02942966|PAD|pad
1035319|NCT02942966|Critical Limb Ischemia|critical limb ischemia
1066815|NCT02749565|OSA|osa
1035320|NCT02942966|Lesion|lesion
1035321|NCT02942966|Claudication|claudication
1035322|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
1035323|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
1035324|NCT02942927|Polypharmacy|polypharmacy
1035325|NCT02942927|Multimorbidity|multimorbidity
1035326|NCT02942927|Randomized Control Trial|randomized control trial
1035327|NCT02942927|Drug Discontinuation|drug discontinuation
1035328|NCT02942927|Patient Preference|patient preference
1035329|NCT02942927|eHealth|ehealth
1035330|NCT02942901|PET-CT|pet-ct
1035331|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
1035332|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
1035333|NCT02942888|MCI|mci
1035334|NCT02942888|NAD|nad
1035335|NCT02942888|nicotinamide riboside|nicotinamide riboside
1035336|NCT02942888|aging|aging
1035337|NCT02942875|upper limb|upper limb
1035338|NCT02942875|mirror therapy|mirror therapy
1035339|NCT02942875|rehabilitation|rehabilitation
1035340|NCT02942875|subacute|subacute
1035341|NCT02942849|Bemfola|bemfola
1035342|NCT02942849|r-hFSH|r-hfsh
1035343|NCT02942849|Oocytes|oocytes
1035344|NCT02942849|Pregnancy|pregnancy
1035345|NCT02942849|OHSS|ohss
1035346|NCT02942836|Respiration Rate Detection|respiration rate detection
1035347|NCT02942823|obesity|obesity
1035348|NCT02942823|child|child
1035349|NCT02942823|primary prevention|primary prevention
1035350|NCT02942823|serious game|serious game
1035351|NCT02942823|nutrition|nutrition
1035352|NCT02942823|physical activity|physical activity
1035353|NCT02942823|psychosocial|psychosocial
1035354|NCT02942823|stress|stress
1035355|NCT02942823|knowledge|knowledge
1035356|NCT02942823|diet|diet
1035357|NCT02942823|energy density|energy density
1035358|NCT02942823|beverages|beverages
1035359|NCT02942823|food pyramide|food pyramide
1035360|NCT02942732|Vitamin D|vitamin d
1035361|NCT02942732|Glucose|glucose
1035362|NCT02942732|HbA1C|hba1c
1035363|NCT02942732|Insulin resistance|insulin resistance
1035364|NCT02942732|Blood lipids|blood lipids
1035365|NCT02942693|Apatinib|apatinib
1035366|NCT02942693|Particle therapy|particle therapy
1035367|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
1035368|NCT02942641|Urethral catheter|urethral catheter
1035369|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
1035371|NCT02942641|pain|pain
1035372|NCT02942641|quality of life|quality of life
1035373|NCT02942641|hematuria|hematuria
1035374|NCT02942641|cloudy urine|cloudy urine
1035375|NCT02942589|Portion Size|portion size
1035376|NCT02942563|Local Advanced Rectal Cancer|local advanced rectal cancer
1035377|NCT02942563|Total Neoadjuvant Therapy|total neoadjuvant therapy
1035378|NCT02942563|FOLFOXIRI|folfoxiri
1035379|NCT02942498|behavior, cognitive|behavior, cognitive
1035380|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
1035381|NCT02942459|music therapy|music therapy
1035382|NCT02942459|double-blinded|double-blinded
1035383|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
1035384|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
1035385|NCT02942407|Renal dialysis|renal dialysis
1035386|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
1035387|NCT02942329|apatinib|apatinib
1035388|NCT02942329|Gastric Neoplasms|gastric neoplasms
1035389|NCT02942329|Gastric Cancer|gastric cancer
1035390|NCT02942329|Cancer of Stomach|cancer of stomach
1035391|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
1035392|NCT02942329|Liver Cancer, Adult|liver cancer, adult
1035393|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
1035395|NCT02942316|Reflex, Pupillary|reflex, pupillary
1035396|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
1035397|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
1035398|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
1035399|NCT02942290|Pharmacokinetic|pharmacokinetic
1035400|NCT02942290|Venetoclax|venetoclax
1035401|NCT02942290|Azacitidine|azacitidine
1035402|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
1035403|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
1035404|NCT02942290|Treatment-Naïve Higher-Risk|treatment-naïve higher-risk
1035405|NCT02942277|Malaria|malaria
1035406|NCT02942277|Reactogenicity|reactogenicity
1035407|NCT02942277|Antibody|antibody
1035408|NCT02942277|Direct Skin Feed|direct skin feed
1035409|NCT02942277|Mosquito|mosquito
1035410|NCT02942264|Brain Tumor|brain tumor
1035411|NCT02942264|Glioblastoma|glioblastoma
1035412|NCT02942264|Relapse|relapse
1035413|NCT02942264|Randomized|randomized
1035414|NCT02942264|temodar|temodar
1035415|NCT02942251|MDD|mdd
1035416|NCT02942251|big data analytics|big data analytics
1035417|NCT02942238|CME|cme
1035418|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
1035419|NCT02942238|D3|d3
1035420|NCT02942238|laparoscopy|laparoscopy
1035421|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1035422|NCT02942225|metabolomics|metabolomics
1035423|NCT02942225|neuropsychological deficits|neuropsychological deficits
1035424|NCT02942225|pathway analysis|pathway analysis
1035425|NCT02942212|Smoking Cessation|smoking cessation
1035426|NCT02942212|Nicotine patch|nicotine patch
1035427|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
1035429|NCT02942212|Nicoderm CQ|nicoderm cq
1035430|NCT02942212|Questionnaires|questionnaires
1035431|NCT02942212|Surveys|surveys
1035432|NCT02942212|Interviews|interviews
1035433|NCT02942212|Breath tests|breath tests
1035434|NCT02942173|CD45RA-depletion|cd45ra-depletion
1035435|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
1035436|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1035437|NCT02942121|surgery education|surgery education
1035438|NCT02942121|radical cystectomy|radical cystectomy
1035439|NCT02942121|cystectomy|cystectomy
1035543|NCT02941497|Peer Influence|peer influence
1035440|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
1035441|NCT02942108|piezolectric surgery|piezolectric surgery
1035442|NCT02942108|conventional surgery|conventional surgery
1035443|NCT02942108|lower third molars|lower third molars
1035444|NCT02942095|Advanced Solid Tumors|advanced solid tumors
1035445|NCT02942095|Metastatic cancer|metastatic cancer
1035446|NCT02942095|Ixazomib|ixazomib
1035447|NCT02942095|MLN9708|mln9708
1035448|NCT02942095|Erlotinib|erlotinib
1035449|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
1035450|NCT02942095|OSI-774|osi-774
1035451|NCT02942095|CP358774|cp358774
1035452|NCT02942095|Tarceva|tarceva
1035453|NCT02942043|Malignant pleural effusion|malignant pleural effusion
1035454|NCT02942043|Bevacizumab|bevacizumab
1035455|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
1035456|NCT02941991|Retinal Diseases|retinal diseases
1035457|NCT02941991|Macular Degeneration|macular degeneration
1035458|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
1035459|NCT02941991|hESC-RPE|hesc-rpe
1035460|NCT02941991|ASP7316|asp7316
1035461|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
1035462|NCT02941991|SMD|smd
1035463|NCT02941939|high intensity interval training|high intensity interval training
1035464|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
1035465|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
1035466|NCT02941926|advanced breast cancer|advanced breast cancer
1035467|NCT02941926|LEE011|lee011
1035468|NCT02941926|ribociclib|ribociclib
1035469|NCT02941926|letrozole|letrozole
1035470|NCT02941926|goserelin|goserelin
1035471|NCT02941926|CDK|cdk
1035472|NCT02941926|CDK4|cdk4
1035473|NCT02941926|CDK6|cdk6
1035474|NCT02941926|CDK4/6|cdk4/6
1035475|NCT02941926|Phase IIIb|phase iiib
1035476|NCT02941926|ER-positive|er-positive
1035477|NCT02941926|PR-positive|pr-positive
1035478|NCT02941926|premenopausal|premenopausal
1035479|NCT02941926|postmenopausal|postmenopausal
1035480|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
1035481|NCT02941900|Genetic Testing|genetic testing
1035482|NCT02941900|16-1243|16-1243
1035483|NCT02941887|Social behavior|social behavior
1035484|NCT02941887|Gingivitis|gingivitis
1035485|NCT02941887|Periodontitis|periodontitis
1035486|NCT02941887|Down's Syndrome|down's syndrome
1035487|NCT02941874|IRAP|irap
1035488|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
1035489|NCT02941874|Diagnostic biomarker|diagnostic biomarker
1035490|NCT02941874|Type 2 diabetes|type 2 diabetes
1035491|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
1035492|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
1035493|NCT02941861|Recurrence|recurrence
1035494|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
1035495|NCT02941783|Kovaltry|kovaltry
1035496|NCT02941783|hemophilia A|hemophilia a
1035497|NCT02941783|Japan|japan
1035498|NCT02941783|Post-marketing surveillance|post-marketing surveillance
1035499|NCT02941770|Adolescents|adolescents
1035500|NCT02941770|Overweight|overweight
1035501|NCT02941770|Obesity|obesity
1035502|NCT02941770|Weight Loss|weight loss
1035503|NCT02941770|Physical activity consultation|physical activity consultation
1035504|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
1035505|NCT02941770|Endothelial structure|endothelial structure
1035506|NCT02941770|Endothelial function|endothelial function
1035507|NCT02941757|Mediterranean Diet|mediterranean diet
1035508|NCT02941757|Firefighters|firefighters
1035509|NCT02941757|workplace|workplace
1035510|NCT02941757|Intervention|intervention
1035511|NCT02941757|obesity|obesity
1035512|NCT02941757|Randomized Control Trial|randomized control trial
1035513|NCT02941744|nivolumab|nivolumab
1035514|NCT02941744|ipilimumab|ipilimumab
1035515|NCT02941744|low fixed dose|low fixed dose
1035516|NCT02941744|adjuvant therapy|adjuvant therapy
1035517|NCT02941744|Melanoma|melanoma
1035518|NCT02941718|Smoking|smoking
1035519|NCT02941718|Smoking cessation|smoking cessation
1035520|NCT02941718|Nicotine|nicotine
1035521|NCT02941705|stem cell research|stem cell research
1035522|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
1035523|NCT02941640|Endoloop|endoloop
1035524|NCT02941640|Stapler|stapler
1035525|NCT02941640|Hem-o-lok clip|hem-o-lok clip
1035526|NCT02941640|DS clip|ds clip
1035527|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
1035528|NCT02941601|Lung Diseases|lung diseases
1035529|NCT02941601|Lung Cancer|lung cancer
1035530|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
1035531|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
1035532|NCT02941601|Antineoplastic Agents|antineoplastic agents
1035533|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
1035534|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
1035535|NCT02941536|Circulating Tumor Cells|circulating tumor cells
1035536|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
1035537|NCT02941497|Stress, Psychological|stress, psychological
1035538|NCT02941497|Obesity|obesity
1035539|NCT02941497|Physical Activity|physical activity
1035540|NCT02941497|Fruit|fruit
1035541|NCT02941497|Vegetables|vegetables
1035542|NCT02941497|Social Marketing|social marketing
1035544|NCT02941497|Community-Based Participatory Research|community-based participatory research
1035545|NCT02941471|Constipation|constipation
1035546|NCT02941471|Neuromodulation|neuromodulation
1035547|NCT02941471|Interferential|interferential
1035548|NCT02941471|Transabdominal|transabdominal
1035549|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
1035550|NCT02941419|Platelet lysate|platelet lysate
1035551|NCT02941419|Critical limb ischemia|critical limb ischemia
1035552|NCT02941419|Peripheral arterial disease|peripheral arterial disease
1035554|NCT02941406|Perimetry|perimetry
1035555|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
1035556|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
1035557|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
1035558|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
1035559|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
1035560|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
1035561|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1035562|NCT02941341|Bemfola|bemfola
1035563|NCT02941341|r-hFSH|r-hfsh
1035564|NCT02941341|ART|art
1035565|NCT02941341|Oocytes|oocytes
1035566|NCT02941341|OHSS|ohss
1035567|NCT02941341|Pregnancy|pregnancy
1035568|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
1035569|NCT02941315|Cardiomyopathy|cardiomyopathy
1035570|NCT02941315|Heart Failure|heart failure
1035571|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
1035572|NCT02941302|gliomas|gliomas
1035573|NCT02941302|biological boundary|biological boundary
1035574|NCT02941302|imaging border|imaging border
1035575|NCT02941302|operation|operation
1035576|NCT02941263|AMD|amd
1035577|NCT02941263|Georgraphic Atrophy|georgraphic atrophy
1035578|NCT02941263|Macular Degeneration|macular degeneration
1035579|NCT02941237|Pulse oximetry|pulse oximetry
1035580|NCT02941237|Children|children
1035581|NCT02941211|cervix|cervix
1035582|NCT02941211|cervical dilation|cervical dilation
1035583|NCT02941211|balloon catheter|balloon catheter
1035584|NCT02941172|Brown adipose tissue|brown adipose tissue
1035585|NCT02941172|Cannabinoid receptor|cannabinoid receptor
1035586|NCT02941172|PET imaging|pet imaging
1035587|NCT02941172|Metabolism|metabolism
1035588|NCT02941120|Cartilage defect|cartilage defect
1035589|NCT02941120|Knee|knee
1035590|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
1035591|NCT02941120|NOVOCART® Inject|novocart® inject
1035592|NCT02941107|Aboriginal|aboriginal
1035593|NCT02941107|Rotavirus|rotavirus
1035594|NCT02941107|Vaccine|vaccine
1035595|NCT02941107|Diarrhoea|diarrhoea
1035596|NCT02941081|iron supplement|iron supplement
1035597|NCT02941068|severe sepsis|severe sepsis
1035598|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
1035599|NCT02941068|surgical intensive care unit|surgical intensive care unit
1035600|NCT02941068|fungal infection|fungal infection
1035601|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
1035602|NCT02941055|Diet|diet
1035603|NCT02941055|Inflammation|inflammation
1035604|NCT02941055|Metabolomics|metabolomics
1035605|NCT02941029|Radiation|radiation
1035606|NCT02941029|Chemotherapy|chemotherapy
1035607|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
1035608|NCT02941003|Intraoperative frozen section|intraoperative frozen section
1035609|NCT02941003|Diagnostic criteria|diagnostic criteria
1035610|NCT02940977|Circulating tumor cell|circulating tumor cell
1035611|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
1035612|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
1035613|NCT02940977|Partin table|partin table
1035614|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1035615|NCT02940925|induction chemotherapy|induction chemotherapy
1035616|NCT02940912|Parkinson disease|parkinson disease
1035617|NCT02940912|Insomnia|insomnia
1067135|NCT02747563|PSA|psa
1035618|NCT02940912|Sleep disorders|sleep disorders
1035619|NCT02940912|Polysomnography|polysomnography
1035620|NCT02940912|Apomorphine|apomorphine
1035621|NCT02940912|Multiple sleep latency test|multiple sleep latency test
1035622|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
1035623|NCT02940873|severe hypoglycemia|severe hypoglycemia
1035624|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
1035625|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
1035626|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
1035627|NCT02940873|structured education|structured education
1035628|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
1035629|NCT02940847|blind technique|blind technique
1035630|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
1035631|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
1035632|NCT02940821|Tooth Whitening|tooth whitening
1035633|NCT02940808|Caffeine|caffeine
1035634|NCT02940808|EEG|eeg
1035635|NCT02940808|Theta/beta ratio|theta/beta ratio
1035636|NCT02940808|Eye-blink rates|eye-blink rates
1035637|NCT02940808|Cognitive control|cognitive control
1035640|NCT02940808|N-Back|n-back
1035641|NCT02940808|Prefrontal Cortex|prefrontal cortex
1035642|NCT02940795|breast feeding|breast feeding
1035643|NCT02940795|fructose|fructose
1035644|NCT02940769|depression|depression
1035645|NCT02940769|insomnia|insomnia
1035646|NCT02940769|light|light
1035647|NCT02940769|cortisol|cortisol
1035648|NCT02940769|melatonin|melatonin
1035649|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
1035650|NCT02940743|Hemodialysis|hemodialysis
1035651|NCT02940704|Reciproc|reciproc
1035652|NCT02940704|One Shape|one shape
1035653|NCT02940704|reciprocation|reciprocation
1035654|NCT02940704|continuous rotation|continuous rotation
1035655|NCT02940704|irreversible pulpitis|irreversible pulpitis
1035656|NCT02940704|postoperative pain|postoperative pain
1035657|NCT02940678|Trauma|trauma
1035658|NCT02940678|Clinical prediction models|clinical prediction models
1035659|NCT02940678|Transferability studies|transferability studies
1035660|NCT02940678|Sweden|sweden
1035661|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
1035665|NCT02940613|Rapid response|rapid response
1035666|NCT02940613|Eating Disorders|eating disorders
1035667|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
1035668|NCT02940613|Bulimia Nervosa|bulimia nervosa
1035669|NCT02940613|Binge Eating Disorder|binge eating disorder
1035670|NCT02940613|Purging Disorder|purging disorder
1035671|NCT02940600|normothermic perfusion|normothermic perfusion
1035672|NCT02940600|old donors|old donors
1035673|NCT02940600|extended criteria grafts|extended criteria grafts
1035674|NCT02940600|reconditioning|reconditioning
1035675|NCT02940587|Non Healing Wound|non healing wound
1035676|NCT02940574|Oxytocin|oxytocin
1035677|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
1035678|NCT02940548|non-dipper hypertension|non-dipper hypertension
1035679|NCT02940548|young|young
1035680|NCT02940548|middle-aged|middle-aged
1035681|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1035682|NCT02940548|arterial stiffness|arterial stiffness
1035683|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
1035684|NCT02940496|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1035685|NCT02940496|Advanced liver cancer|advanced liver cancer
1035686|NCT02940496|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1035687|NCT02940496|Pembrolizumab|pembrolizumab
1035688|NCT02940496|Keytruda|keytruda
1035689|NCT02940496|MK-3475|mk-3475
1035690|NCT02940496|SCH-900475|sch-900475
1035691|NCT02940496|Biomarkers|biomarkers
1035692|NCT02940483|Ependymoma|ependymoma
1035693|NCT02940457|tDCS|tdcs
1035695|NCT02940457|Working Memory|working memory
1035696|NCT02940457|fNIRS|fnirs
1035697|NCT02940418|Diabetes Mellitus|diabetes mellitus
1035698|NCT02940418|Type 1|type 1
1035699|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
1035700|NCT02940405|Ketorolac Premedication|ketorolac premedication
1035701|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
1035702|NCT02940405|Post-Endodontic Pain|post-endodontic pain
1035703|NCT02940405|Post-operative pain|post-operative pain
1035704|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
1035705|NCT02940405|Oral premedication|oral premedication
1035706|NCT02940392|Rezum|rezum
1035707|NCT02940340|infective endocarditis|infective endocarditis
1035708|NCT02940340|systemic microcirculation|systemic microcirculation
1035709|NCT02940327|ECMO|ecmo
1035710|NCT02940327|PPHN|pphn
1035711|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
1035712|NCT02940327|Markers of inflammation|markers of inflammation
1035713|NCT02940327|Mi-Ecmo|mi-ecmo
1035714|NCT02940249|Polyphenol|polyphenol
1035715|NCT02940249|Apple|apple
1035716|NCT02940249|Fruit|fruit
1035717|NCT02940249|Hyperglycaemia|hyperglycaemia
1035718|NCT02940249|Metabolic|metabolic
1035846|NCT02939638|Intracellular lipid|intracellular lipid
1035719|NCT02940223|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1035720|NCT02940223|Cancer-related fatigue|cancer-related fatigue
1035721|NCT02940223|Fish oil|fish oil
1035722|NCT02940223|Icosapent ethyl|icosapent ethyl
1035723|NCT02940223|Quality of life questionnaire|quality of life questionnaire
1035724|NCT02940223|Symptom questionnaire|symptom questionnaire
1035725|NCT02940223|Walk test|walk test
1035726|NCT02940223|Chair/stand test|chair/stand test
1035727|NCT02940223|Placebo|placebo
1035728|NCT02940223|Resistance exercises|resistance exercises
1035729|NCT02940223|Walking program|walking program
1035730|NCT02940223|Resistance training|resistance training
1035731|NCT02940223|Stretching exercises|stretching exercises
1035732|NCT02940223|Advanced cancer|advanced cancer
1035733|NCT02940197|overweight|overweight
1035734|NCT02940197|Caloric Restriction|caloric restriction
1035735|NCT02940184|Physiology|physiology
1035736|NCT02940171|burns|burns
1035737|NCT02940171|critically ill|critically ill
1035738|NCT02940171|surgery outcome|surgery outcome
1035739|NCT02940171|mortality|mortality
1035740|NCT02940158|lentils|lentils
1035741|NCT02940158|diabetes|diabetes
1035742|NCT02940158|glycemia|glycemia
1035743|NCT02940158|insulin|insulin
1035744|NCT02940158|glucose|glucose
1035745|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
1035746|NCT02940145|Interleukines|interleukines
1035747|NCT02940145|resistance training|resistance training
1035748|NCT02940145|phase angle|phase angle
1035749|NCT02940145|oxidative stress|oxidative stress
1035750|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
1035751|NCT02940106|closed vitrification|closed vitrification
1035752|NCT02940106|open vitrification|open vitrification
1035753|NCT02940067|prehabilitation|prehabilitation
1035754|NCT02940067|pancreatectomy|pancreatectomy
1035755|NCT02940067|nutrition|nutrition
1035756|NCT02940067|exercise|exercise
1035757|NCT02940054|Early diagnosis|early diagnosis
1035758|NCT02940041|Diagnosis|diagnosis
1035759|NCT02940041|Sonography|sonography
1035760|NCT02940041|Magnetic Ressonance|magnetic ressonance
1035761|NCT02940015|Quality Control|quality control
1035762|NCT02940015|Urine|urine
1035763|NCT02940015|Tissue|tissue
1035764|NCT02940015|Normal|normal
1035765|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
1035766|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
1035767|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
1035768|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
1035769|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
1035770|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
1035771|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
1035772|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
1035773|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
1035774|NCT02939989|Non-cirrhotics|non-cirrhotics
1035775|NCT02939989|Virologic failure|virologic failure
1035776|NCT02939989|Hepatitis C Virus Infection|hepatitis c virus infection
1035777|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1035778|NCT02939963|weaning|weaning
1035779|NCT02939963|mechanical ventilation|mechanical ventilation
1035780|NCT02939963|work of breathing|work of breathing
1035781|NCT02939963|automatic tube compensation|automatic tube compensation
1035782|NCT02939963|pressure support ventilation|pressure support ventilation
1035783|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
1035784|NCT02939872|DAPT|dapt
1035786|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1035787|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
1035788|NCT02939859|Multiple Sclerosis|multiple sclerosis
1035789|NCT02939859|Demyelinating Diseases|demyelinating diseases
1035790|NCT02939859|Nervous System Diseases|nervous system diseases
1035791|NCT02939859|Autoimmune Disorders|autoimmune disorders
1035792|NCT02939846|Safety|safety
1035793|NCT02939846|Solid tumor|solid tumor
1035794|NCT02939846|Trametinib|trametinib
1035795|NCT02939846|Pharmacokinetics|pharmacokinetics
1035796|NCT02939820|RNAi therapeutic|rnai therapeutic
1035797|NCT02939820|FAP|fap
1035798|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
1035799|NCT02939820|TTR|ttr
1035800|NCT02939820|Transthyretin|transthyretin
1035801|NCT02939820|Amyloidosis|amyloidosis
1035802|NCT02939807|Yeliva™|yeliva™
1035803|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
1035804|NCT02939807|ABC294640|abc294640
1035805|NCT02939807|hepatic neoplasms|hepatic neoplasms
1035806|NCT02939807|liver neoplasms|liver neoplasms
1035807|NCT02939807|hepatic cancer|hepatic cancer
1035808|NCT02939794|cardiac surgery|cardiac surgery
1035809|NCT02939794|hemoglobin|hemoglobin
1035810|NCT02939794|iron|iron
1035811|NCT02939755|Collaborative care intervention|collaborative care intervention
1035812|NCT02939755|Cancer|cancer
1035813|NCT02939755|Depression|depression
1035814|NCT02939755|Palliative care|palliative care
1035815|NCT02939755|Quality of life|quality of life
1035816|NCT02939755|Fatigue|fatigue
1035817|NCT02939755|Pain|pain
1035818|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
1035819|NCT02939742|complications of prematurity|complications of prematurity
1035820|NCT02939742|neonatal morbidity|neonatal morbidity
1035821|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
1035822|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
1035823|NCT02939742|betamethasone|betamethasone
1035824|NCT02939729|prehabilitation|prehabilitation
1035825|NCT02939729|physiotherapy|physiotherapy
1035826|NCT02939729|cardiac|cardiac
1035827|NCT02939729|thoracic|thoracic
1035828|NCT02939729|preoperative|preoperative
1035829|NCT02939716|small bowel|small bowel
1035830|NCT02939716|bloating|bloating
1035831|NCT02939716|flow|flow
1035832|NCT02939703|Adipose tissue|adipose tissue
1035833|NCT02939703|calorimetry|calorimetry
1035834|NCT02939703|energy expenditure|energy expenditure
1035835|NCT02939703|microbiome|microbiome
1035836|NCT02939690|Catheter|catheter
1035837|NCT02939690|Umbilical vein|umbilical vein
1035838|NCT02939690|Neonate|neonate
1035840|NCT02939664|weight loss|weight loss
1035841|NCT02939651|Metastatic|metastatic
1035842|NCT02939651|High grade|high grade
1035843|NCT02939638|Plant-based diet|plant-based diet
1035844|NCT02939638|Obesity|obesity
1035845|NCT02939638|Insulin sensitivity|insulin sensitivity
1035847|NCT02939638|Postprandial metabolism|postprandial metabolism
1035848|NCT02939638|Vegan diet|vegan diet
1035849|NCT02939638|Beta-cell function|beta-cell function
1035850|NCT02939612|Stress management|stress management
1035851|NCT02939612|App|app
1035852|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
1035853|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
1035854|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
1035855|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
1035856|NCT02939599|Shortness of breath|shortness of breath
1035857|NCT02939599|Dizziness|dizziness
1035858|NCT02939599|Fainting|fainting
1035859|NCT02939599|Leg swelling|leg swelling
1035860|NCT02939599|Cough|cough
1035861|NCT02939599|Angina pector|angina pector
1035862|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
1035863|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
1035864|NCT02939560|Autism|autism
1035865|NCT02939560|Depressive|depressive
1035866|NCT02939560|Depression|depression
1035867|NCT02939547|intravenous|intravenous
1035868|NCT02939547|cyclodextrin|cyclodextrin
1035869|NCT02939547|compassionate|compassionate
1035870|NCT02939547|Trappsol|trappsol
1035871|NCT02939534|Parkinson's disease|parkinson's disease
1035872|NCT02939534|autoimmunity|autoimmunity
1035873|NCT02939521|Pincer Nail|pincer nail
1035874|NCT02939521|Surgery|surgery
1035875|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
1035876|NCT02939508|Colon-originated lesions|colon-originated lesions
1035877|NCT02939508|Critical patient|critical patient
1035878|NCT02939508|Colonoscopic decompression|colonoscopic decompression
1035879|NCT02939508|Anticholinergic drugs|anticholinergic drugs
1035880|NCT02939495|Premature Ejaculation|premature ejaculation
1035881|NCT02939495|Erectile Dysfunction|erectile dysfunction
1035882|NCT02939495|DAP-SPEED|dap-speed
1035883|NCT02939495|Dapoxetine|dapoxetine
1035884|NCT02939495|Sildenafil|sildenafil
1035885|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
1035886|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
1035887|NCT02939456|prostate|prostate
1035888|NCT02939456|cancer|cancer
1035889|NCT02939456|MRI|mri
1035890|NCT02939417|Laminate veneers|laminate veneers
1035891|NCT02939417|Grape seed extract|grape seed extract
1035892|NCT02939417|Emax|emax
1035893|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
1035894|NCT02939404|Energy Intake|energy intake
1035895|NCT02939404|Energy Expenditure|energy expenditure
1035896|NCT02939404|Eating Behavior|eating behavior
1035897|NCT02939404|Cold Exposure|cold exposure
1035898|NCT02939378|ketogenic diet|ketogenic diet
1035899|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
1035900|NCT02939378|chemotherapy|chemotherapy
1035901|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1035902|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
1035903|NCT02939352|MRI, Functional|mri, functional
1035904|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1035905|NCT02939313|alcohol|alcohol
1035906|NCT02939313|addiction|addiction
1035907|NCT02939313|cTBS|ctbs
1035908|NCT02939300|Melanoma|melanoma
1035909|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
1035910|NCT02939287|autologous|autologous
1035911|NCT02939287|myeloma|myeloma
1035912|NCT02939287|transplant|transplant
1035913|NCT02939209|Rotator cuff repair|rotator cuff repair
1035914|NCT02939209|Interscalene block|interscalene block
1035915|NCT02939209|Hydromorphone|hydromorphone
1035916|NCT02939209|Pain|pain
1035917|NCT02939209|Rebound pain|rebound pain
1035918|NCT02939209|Acromioplasty|acromioplasty
1035920|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
1035921|NCT02939157|Primary Care|primary care
1035922|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
1035923|NCT02939131|Medication Management|medication management
1035924|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
1035925|NCT02939079|Multiple Sclerosis|multiple sclerosis
1035926|NCT02939079|Fingolimod|fingolimod
1035927|NCT02939079|Fish Oil|fish oil
1035928|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
1035929|NCT02939040|positive activities intervention|positive activities intervention
1035930|NCT02939040|peri-operative|peri-operative
1035931|NCT02939014|Drug therapy|drug therapy
1035932|NCT02938988|Periodontal Diseases|periodontal diseases
1035933|NCT02938988|Down Syndrome|down syndrome
1035934|NCT02938975|malaria|malaria
1035935|NCT02938975|personal protection|personal protection
1035936|NCT02938975|permethrin treated clothing|permethrin treated clothing
1035940|NCT02938949|Myocardial Infarction|myocardial infarction
1035941|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
1035942|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
1035944|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
1035945|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
1035946|NCT02938910|Cardiac fibrosis|cardiac fibrosis
1035947|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
1035948|NCT02938897|Telehealth|telehealth
1035949|NCT02938897|Weight loss|weight loss
1035950|NCT02938897|Diet quality|diet quality
1035951|NCT02938897|Behavioral counseling|behavioral counseling
1035952|NCT02938871|synbiotic|synbiotic
1035953|NCT02938871|infections|infections
1035954|NCT02938871|probiotics|probiotics
1035955|NCT02938871|liver transplantation|liver transplantation
1035956|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
1035957|NCT02938819|upper limbs|upper limbs
1035958|NCT02938819|physiotherapy|physiotherapy
1035959|NCT02938793|cancer, malignancy|cancer, malignancy
1035960|NCT02938780|Behavioral economics|behavioral economics
1035961|NCT02938780|Breast cancer survivors|breast cancer survivors
1035962|NCT02938780|nutrition|nutrition
1035963|NCT02938780|physical activity|physical activity
1035964|NCT02938767|peritoneal dialysis|peritoneal dialysis
1035965|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
1035966|NCT02938767|coronary flow reserve|coronary flow reserve
1035967|NCT02938767|cardiovascular mortality|cardiovascular mortality
1035968|NCT02938754|Hemiparesis|hemiparesis
1035969|NCT02938754|Functional independence|functional independence
1035970|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
1035971|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1035972|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
1035973|NCT02938741|stem-cell transplant|stem-cell transplant
1035974|NCT02938741|T-cell lymphoma|t-cell lymphoma
1035976|NCT02938728|AntiPD1|antipd1
1035977|NCT02938702|Active surveillance|active surveillance
1035978|NCT02938650|nitrolipid|nitrolipid
1035979|NCT02938650|microbiome|microbiome
1035980|NCT02938650|inflammation|inflammation
1035981|NCT02938650|cytokine|cytokine
1035985|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
1035986|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
1035987|NCT02938546|treatment response assessment|treatment response assessment
1035988|NCT02938520|Antiretroviral agent|antiretroviral agent
1035989|NCT02938520|Maintenance|maintenance
1035990|NCT02938520|rilpivirine|rilpivirine
1035991|NCT02938520|dolutegravir|dolutegravir
1035992|NCT02938520|TMC278|tmc278
1035993|NCT02938520|Triumeq|triumeq
1035994|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1035995|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
1035996|NCT02938520|GSK1265744|gsk1265744
1035998|NCT02938520|Tivicay|tivicay
1035999|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
1036000|NCT02938520|lamivudine|lamivudine
1036001|NCT02938520|integrase inhibitor|integrase inhibitor
1036002|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
1036003|NCT02938520|ART naïve|art naïve
1036004|NCT02938520|cabotegravir|cabotegravir
1036005|NCT02938520|abacavir|abacavir
1036006|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
1036007|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
1036008|NCT02938455|Hyperalgesia|hyperalgesia
1036009|NCT02938455|Opioids|opioids
1036010|NCT02938455|Postoperative pain|postoperative pain
1036011|NCT02938455|DNA methylation|dna methylation
1036012|NCT02938429|congenital|congenital
1036013|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
1036014|NCT02938390|Ultrasound|ultrasound
1036015|NCT02938351|Collaborative care intervention|collaborative care intervention
1036016|NCT02938351|kidney transplant|kidney transplant
1036017|NCT02938325|Electroencephalogram|electroencephalogram
1036018|NCT02938325|awareness|awareness
1036019|NCT02938286|Fractional laser|fractional laser
1036020|NCT02938286|Topical anesthesia|topical anesthesia
1036021|NCT02938286|Drug delivery|drug delivery
1036022|NCT02938286|CO2 laser|co2 laser
1036023|NCT02938286|Er:YAG laser|er:yag laser
1036024|NCT02938247|Malnutrition|malnutrition
1036025|NCT02938247|Geriatric subjects|geriatric subjects
1036026|NCT02938247|Nursing home|nursing home
1036027|NCT02938234|Malnutrition|malnutrition
1036028|NCT02938234|Geriatric subjects|geriatric subjects
1036029|NCT02938234|Nursing home|nursing home
1036030|NCT02938221|TeleStroke|telestroke
1036031|NCT02938221|HINTS|hints
1036032|NCT02938221|Diagnosis|diagnosis
1036033|NCT02938221|Telemedicine|telemedicine
1036034|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
1036035|NCT02938169|low back pain|low back pain
1036036|NCT02938169|surface EMG|surface emg
1036037|NCT02938169|exercise|exercise
1036038|NCT02938156|Hemophilia|hemophilia
1036039|NCT02938143|Jumpers knee|jumpers knee
1036040|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
1036041|NCT02938143|Jumping Athletes|jumping athletes
1036042|NCT02938143|UTE MRI|ute mri
1036043|NCT02938143|Exercise Therapy|exercise therapy
1036044|NCT02938143|NBA|nba
1036045|NCT02938117|obesity|obesity
1036046|NCT02938117|eccentric exercise|eccentric exercise
1036047|NCT02938117|body composition|body composition
1036048|NCT02938117|training program|training program
1036049|NCT02938091|Hispanics|hispanics
1036050|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
1036051|NCT02938091|Hepatic lipase|hepatic lipase
1036052|NCT02938052|Heart Failure|heart failure
1036053|NCT02938052|Positive Psychology|positive psychology
1036054|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
1036055|NCT02938039|laryngeal airways|laryngeal airways
1036056|NCT02938039|infants|infants
1036057|NCT02938039|neonates|neonates
1036058|NCT02938039|children|children
1036059|NCT02938039|anesthetized|anesthetized
1036060|NCT02938000|aerobic training|aerobic training
1036061|NCT02938000|stroke|stroke
1036062|NCT02938000|exercise|exercise
1036063|NCT02938000|stroke recovery|stroke recovery
1036064|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1036065|NCT02937974|Xuebijing|xuebijing
1036066|NCT02937948|Locally advanced|locally advanced
1036067|NCT02937922|Exercise|exercise
1036068|NCT02937922|Endothelium|endothelium
1036069|NCT02937922|Hypertension|hypertension
1036070|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
1036071|NCT02937922|Endothelial microparticle|endothelial microparticle
1036072|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
1036073|NCT02937883|Daily Activities|daily activities
1036074|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
1036075|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
1036076|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
1036077|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
1036078|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
1036079|NCT02937740|Hypogonadism|hypogonadism
1036080|NCT02937714|Teachers|teachers
1036081|NCT02937714|mental health literacy|mental health literacy
1036082|NCT02937714|school mental health promotion|school mental health promotion
1036083|NCT02937688|Parkinson's disease|parkinson's disease
1036084|NCT02937688|Deep Brain Stimulation|deep brain stimulation
1036085|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
1036086|NCT02937675|immunomodulator|immunomodulator
1036087|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
1036088|NCT02937649|Obesity|obesity
1036089|NCT02937649|Bariatric surgery|bariatric surgery
1036090|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
1036091|NCT02937649|Staple-line Leak|staple-line leak
1036092|NCT02937649|Bougie|bougie
1036093|NCT02937649|Calibration|calibration
1036094|NCT02937597|proficiency based progression|proficiency based progression
1036095|NCT02937597|feedback|feedback
1036096|NCT02937597|computer based assessment|computer based assessment
1036097|NCT02937597|non technical skills|non technical skills
1036098|NCT02937597|deteriorating patient|deteriorating patient
1036099|NCT02937597|ISBAR|isbar
1036101|NCT02937571|Lenalidomide|lenalidomide
1036102|NCT02937571|Dexamethasone|dexamethasone
1036103|NCT02937571|15-326|15-326
1036104|NCT02937558|hypoglycemia|hypoglycemia
1036105|NCT02937532|Fear of falling|fear of falling
1036106|NCT02937532|Fear avoidance behavior|fear avoidance behavior
1036107|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
1036108|NCT02937532|Rehabilitation|rehabilitation
1036109|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
1036110|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1672312|NCT00099294|Pancreas|pancreas
1036111|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
1036112|NCT02937506|propofol|propofol
1036113|NCT02937506|colonoscopy|colonoscopy
1036114|NCT02937506|patient satisfaction|patient satisfaction
1036115|NCT02937480|stroke|stroke
1036116|NCT02937480|physical activity|physical activity
1036117|NCT02937480|task performance|task performance
1036118|NCT02937480|clinical protocol|clinical protocol
1036119|NCT02937467|SWE|swe
1036120|NCT02937467|diagnosis|diagnosis
1036121|NCT02937454|Acute Heart Failure|acute heart failure
1036122|NCT02937454|Iron Deficiency|iron deficiency
1036123|NCT02937441|C10.228.140.187|c10.228.140.187
1036124|NCT02937428|vaccination|vaccination
1036125|NCT02937428|pain|pain
1036126|NCT02937428|fear|fear
1036127|NCT02937428|psychological intervention|psychological intervention
1036128|NCT02937415|carbon monoxide|carbon monoxide
1036129|NCT02937415|oxidative stress|oxidative stress
1036130|NCT02937415|waterpipe smoking|waterpipe smoking
1036131|NCT02937415|cigarette smoking|cigarette smoking
1036132|NCT02937415|pulmonary function test|pulmonary function test
1036133|NCT02937350|chronic kidney disease|chronic kidney disease
1036134|NCT02937350|vitamin d catabolism|vitamin d catabolism
1036135|NCT02937311|Taping, stroke|taping, stroke
1036136|NCT02937311|rehabilitation|rehabilitation
1036137|NCT02937311|shoulder pain|shoulder pain
1036138|NCT02937311|electrical stimulation|electrical stimulation
1036139|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
1036140|NCT02937298|Obesity|obesity
1036141|NCT02937298|Energy balance|energy balance
1036142|NCT02937298|Energy expenditure|energy expenditure
1036143|NCT02937298|berries|berries
1036144|NCT02937298|Sea Buckthorn|sea buckthorn
1036145|NCT02937298|Wild garlic|wild garlic
1036146|NCT02937272|TGF Beta|tgf beta
1036147|NCT02937233|Zika|zika
1036148|NCT02937233|Vaccine|vaccine
1036149|NCT02937233|ZPIV|zpiv
1036150|NCT02937207|Bronchial Asthma|bronchial asthma
1036151|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
1036152|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
1036153|NCT02937194|Oral health promotion|oral health promotion
1036154|NCT02937194|Randomized controlled trial|randomized controlled trial
1036155|NCT02937142|Behavior Therapy|behavior therapy
1036156|NCT02937142|Cognitive Therapy|cognitive therapy
1036157|NCT02937142|Adolescents|adolescents
1036158|NCT02937142|Psychotherapy, Group|psychotherapy, group
1036159|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
1036160|NCT02937129|Axillary thermometer|axillary thermometer
1036161|NCT02937129|Mercury glass thermometer|mercury glass thermometer
1036162|NCT02937129|Adult emergency department|adult emergency department
1036163|NCT02937103|Leukemia|leukemia
1036164|NCT02937103|Myeloid|myeloid
1036165|NCT02937103|CD123|cd123
1036166|NCT02937103|CAR-T|car-t
1036167|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
1036168|NCT02937090|Intestinal Microbiota|intestinal microbiota
1036169|NCT02937077|etiology|etiology
1036170|NCT02937038|Urine Biomarkers|urine biomarkers
1036171|NCT02937038|Child Nutrition|child nutrition
1036172|NCT02937038|Hydration|hydration
1036173|NCT02937038|Parent Nutrition Habits|parent nutrition habits
1036174|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
1036175|NCT02937025|Stroke|stroke
1036176|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
1036177|NCT02937025|Intervention|intervention
1036178|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
1036179|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
1036180|NCT02937012|Bezafibrate|bezafibrate
1036181|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
1036182|NCT02936973|simple obesity|simple obesity
1036183|NCT02936973|catgut implantation|catgut implantation
1036184|NCT02936934|Adverse Drug Reaction|adverse drug reaction
1036185|NCT02936934|Morphine|morphine
1036186|NCT02936934|Oxycodone|oxycodone
1036187|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
1036188|NCT02936921|Toxoplasma gondii|toxoplasma gondii
1036189|NCT02936921|Toxoplasmosis|toxoplasmosis
1036190|NCT02936921|congenital|congenital
1036191|NCT02936921|prenatal|prenatal
1036192|NCT02936921|screening|screening
1036193|NCT02936921|treatment|treatment
1036194|NCT02936921|diagnosis|diagnosis
1036195|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
1036196|NCT02936908|Muscular dystrophy|muscular dystrophy
1036197|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1036198|NCT02936908|Acute respiratory failure|acute respiratory failure
1036199|NCT02936908|respiratory care|respiratory care
1036200|NCT02936908|mechanical ventilation|mechanical ventilation
1036201|NCT02936908|weaning|weaning
1036202|NCT02936908|Intensive Care Unit|intensive care unit
1036203|NCT02936908|Critical Care|critical care
1036204|NCT02936908|Survival|survival
1036205|NCT02936882|ultrasonography|ultrasonography
1036206|NCT02936882|aspiration|aspiration
1036207|NCT02936882|emergency|emergency
1036208|NCT02936882|children|children
1036209|NCT02936882|antrum|antrum
1036210|NCT02936843|Pain|pain
1036211|NCT02936843|Inflammation|inflammation
1036212|NCT02936843|Diabetes Mellitus|diabetes mellitus
1036213|NCT02936843|Adult|adult
1036214|NCT02936843|Neuropathy|neuropathy
1036215|NCT02936817|HRCT|hrct
1036216|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
1036217|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
1036218|NCT02936817|CT scan|ct scan
1036219|NCT02936817|Computed Tomography|computed tomography
1036220|NCT02936817|COPD|copd
1036221|NCT02936817|sputum producing COPD patients|sputum producing copd patients
1036222|NCT02936817|Aerobika® device|aerobika® device
1036223|NCT02936804|early stage lung cancer|early stage lung cancer
1036224|NCT02936804|LDCT screening|ldct screening
1036225|NCT02936804|lung resection|lung resection
1036226|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
1036227|NCT02936804|peripheral biomarker|peripheral biomarker
1036328|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
1036239|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
1036241|NCT02936700|Suicide|suicide
1036242|NCT02936700|Randomized controlled trial|randomized controlled trial
1036243|NCT02936700|ACT|act
1036244|NCT02936700|fMRI|fmri
1036245|NCT02936687|blood flow|blood flow
1036246|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
1036247|NCT02936687|insulin|insulin
1036248|NCT02936687|vasodilation|vasodilation
1036249|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
1036250|NCT02936648|Hepatitis C|hepatitis c
1036251|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1036252|NCT02936635|ALS|als
1036253|NCT02936635|tirasemtiv|tirasemtiv
1036254|NCT02936609|healthcare access|healthcare access
1036255|NCT02936609|healthcare utilization|healthcare utilization
1036256|NCT02936609|preventive services|preventive services
1036257|NCT02936609|cancer survivors|cancer survivors
1036258|NCT02936531|evoked response potential|evoked response potential
1036259|NCT02936531|ERP|erp
1036260|NCT02936531|Brain Network Activation|brain network activation
1036261|NCT02936531|BNA|bna
1036262|NCT02936531|Biomarker|biomarker
1036263|NCT02936518|ankyloglossia|ankyloglossia
1036264|NCT02936518|breastfeeding|breastfeeding
1036265|NCT02936518|lip tie|lip tie
1036266|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
1036267|NCT02936505|cyclosporin|cyclosporin
1036268|NCT02936505|tacrolimus|tacrolimus
1036269|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1036270|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
1036271|NCT02936505|CLAD|clad
1036272|NCT02936492|Phase I|phase i
1036273|NCT02936492|Healthy volunteers|healthy volunteers
1036274|NCT02936466|Psychiatry|psychiatry
1036275|NCT02936466|Randomized controlled trial|randomized controlled trial
1036276|NCT02936466|Bipolar disorder|bipolar disorder
1036277|NCT02936466|Serious game|serious game
1036278|NCT02936466|Compliance|compliance
1036279|NCT02936466|Psychoeducation|psychoeducation
1036280|NCT02936453|Spinal Cord Injury|spinal cord injury
1036281|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
1036282|NCT02936453|Robot-assisted|robot-assisted
1036283|NCT02936440|acute kidney injury|acute kidney injury
1036284|NCT02936440|intensive care unit|intensive care unit
1036285|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
1036286|NCT02936414|Berberine|berberine
1036287|NCT02936414|Cytokine|cytokine
1036288|NCT02936414|CRP|crp
1036289|NCT02936414|Metabolism|metabolism
1036290|NCT02936414|Schizophrenia|schizophrenia
1036291|NCT02936388|uveal melanoma|uveal melanoma
1036292|NCT02936388|liver metastasis|liver metastasis
1036293|NCT02936388|chemoembolisation|chemoembolisation
1036294|NCT02936388|radioembolisation|radioembolisation
1036295|NCT02936375|lupus|lupus
1036296|NCT02936375|nephritis|nephritis
1036297|NCT02936375|iguratimod|iguratimod
1036298|NCT02936362|Bread|bread
1036299|NCT02936362|Microbiome|microbiome
1036300|NCT02936362|Blood tests|blood tests
1036301|NCT02936362|Sourdough bread|sourdough bread
1036302|NCT02936362|Dietary intervention|dietary intervention
1036303|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
1036304|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
1036305|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
1036306|NCT02936323|SCLC small cell lung cancer|sclc small cell lung cancer
1036307|NCT02936323|pancreatic neuroendocrine NET|pancreatic neuroendocrine net
1036308|NCT02936323|GI neuroendocrine NET|gi neuroendocrine net
1036309|NCT02936310|stress|stress
1036310|NCT02936310|mindfulness|mindfulness
1036311|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
1036312|NCT02936310|nurse|nurse
1036313|NCT02936310|HIV/AIDS|hiv/aids
1036314|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
1036315|NCT02936271|Sclerotherapy|sclerotherapy
1036316|NCT02936271|Vasculera|vasculera
1036317|NCT02936219|complementary feeding|complementary feeding
1036318|NCT02936219|breast milk|breast milk
1672313|NCT00099294|Cancer|cancer
1036319|NCT02936219|formula feeding|formula feeding
1036320|NCT02936219|combined feeding|combined feeding
1036321|NCT02936219|preterm infants|preterm infants
1036322|NCT02936219|body composition|body composition
1036323|NCT02936206|proliferation Index|proliferation index
1036324|NCT02936206|Tamoxifen|tamoxifen
1036325|NCT02936206|Fulvestrant|fulvestrant
1036326|NCT02936206|cyclinD1|cyclind1
1036327|NCT02936206|Breast cancer|breast cancer
1036329|NCT02936180|Flu vaccine|flu vaccine
1036330|NCT02936180|Influenza|influenza
1036331|NCT02936167|Ringer Lactate|ringer lactate
1036332|NCT02936167|Plasmalyte|plasmalyte
1036333|NCT02936167|Perioperative Period|perioperative period
1036334|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
1036335|NCT02936102|Phase I|phase i
1036336|NCT02936102|FAZ053|faz053
1036337|NCT02936102|PDR001|pdr001
1036338|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
1036339|NCT02936102|PD-L1|pd-l1
1036340|NCT02936102|PD-1|pd-1
1036341|NCT02936063|Head and neck surgery|head and neck surgery
1036342|NCT02936063|Scar cosmesis|scar cosmesis
1036343|NCT02936063|Surgical staples|surgical staples
1036344|NCT02936063|Sutures|sutures
1036345|NCT02936063|Patient satisfaction|patient satisfaction
1036346|NCT02936050|Echocardiography|echocardiography
1036347|NCT02936050|Telemedicine|telemedicine
1036348|NCT02936050|Nurses|nurses
1036349|NCT02936050|Decision support|decision support
1036350|NCT02936050|eHealth|ehealth
1036351|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
1036353|NCT02936037|EDSS|edss
1036354|NCT02936037|TW25|tw25
1036355|NCT02936037|multiple sclerosis|multiple sclerosis
1036356|NCT02935998|schizophrenia|schizophrenia
1036357|NCT02935998|agitation|agitation
1036358|NCT02935998|ziprasidone|ziprasidone
1036359|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
1036360|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
1036361|NCT02935985|multicenter|multicenter
1036362|NCT02935985|Emergency Department|emergency department
1036363|NCT02935985|Romania|romania
1036364|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
1036365|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
1036366|NCT02935920|PRO, follow up|pro, follow up
1036367|NCT02935894|oxygenated lipids|oxygenated lipids
1036368|NCT02935894|metabolic profiling|metabolic profiling
1036369|NCT02935894|sphingoid bases|sphingoid bases
1036370|NCT02935894|ceramides|ceramides
1036371|NCT02935894|endocannabinoids|endocannabinoids
1036372|NCT02935894|non-invasive sampling|non-invasive sampling
1036373|NCT02935868|Saliva|saliva
1036374|NCT02935855|Diabetic patients|diabetic patients
1036375|NCT02935855|nondiabetic patients|nondiabetic patients
1036376|NCT02935842|Parkinson's Disease|parkinson's disease
1036377|NCT02935842|Word Retrieval|word retrieval
1036378|NCT02935842|Apraxia Symptoms|apraxia symptoms
1036379|NCT02935842|Dysarthria|dysarthria
1036380|NCT02935829|energy intake|energy intake
1036381|NCT02935829|blood glucose|blood glucose
1036382|NCT02935829|carob flour|carob flour
1036383|NCT02935790|unresectable|unresectable
1036384|NCT02935790|melanoma|melanoma
1036385|NCT02935777|Pomegranate extract|pomegranate extract
1036386|NCT02935777|cognitive function|cognitive function
1036387|NCT02935777|cognition|cognition
1036388|NCT02935777|polyphenols|polyphenols
1036389|NCT02935777|memory|memory
1036390|NCT02935738|prednisolone|prednisolone
1036391|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
1036392|NCT02935738|sperm penetration assay|sperm penetration assay
1036393|NCT02935712|Safety|safety
1036394|NCT02935712|Tolerability|tolerability
1036395|NCT02935712|AZD8601|azd8601
1036396|NCT02935712|Type II Diabetes|type ii diabetes
1036397|NCT02935582|Topical|topical
1036398|NCT02935582|Real-world|real-world
1036399|NCT02935582|Local standard of care|local standard of care
1036400|NCT02935582|Non-interventional|non-interventional
1036401|NCT02935582|Calcipotriol|calcipotriol
1036402|NCT02935569|Alopecia|alopecia
1036403|NCT02935569|Radiotherapy|radiotherapy
1036404|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
1036405|NCT02935517|Color vision deficiency|color vision deficiency
1036406|NCT02935517|Color vision defects|color vision defects
1036407|NCT02935517|Vision disorders|vision disorders
1036408|NCT02935517|Sensation disorders|sensation disorders
1036409|NCT02935517|Neurologic manifestations|neurologic manifestations
1036410|NCT02935517|Nervous system diseases|nervous system diseases
1036411|NCT02935517|Eye diseases|eye diseases
1036412|NCT02935517|Signs and symptoms|signs and symptoms
1036413|NCT02935504|Depression|depression
1036417|NCT02935491|Aortic stenosis|aortic stenosis
1036418|NCT02935491|aortic stiffness|aortic stiffness
1036419|NCT02935491|calcifications|calcifications
1036420|NCT02935491|CT-scan|ct-scan
1036421|NCT02935491|Vascular impedance|vascular impedance
1036422|NCT02935478|bariatric surgery|bariatric surgery
1068153|NCT02741193|EMG|emg
1036423|NCT02935478|minimally invasive|minimally invasive
1036424|NCT02935478|Embolization|embolization
1036425|NCT02935478|ghrelin|ghrelin
1036426|NCT02935478|gastric artery embolization|gastric artery embolization
1036427|NCT02935452|Self-management|self-management
1036428|NCT02935452|Supportive self-management|supportive self-management
1036429|NCT02935452|Normalisation process theory|normalisation process theory
1036430|NCT02935452|Social networks|social networks
1036435|NCT02935439|Feasibility|feasibility
1036436|NCT02935426|cyanoacrylate|cyanoacrylate
1036437|NCT02935426|sutures|sutures
1036438|NCT02935400|porphyria|porphyria
1036439|NCT02935400|biomarkers|biomarkers
1036440|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
1036441|NCT02935374|children|children
1036442|NCT02935374|intestinal microbiome|intestinal microbiome
1036443|NCT02935374|microbiota|microbiota
1036444|NCT02935374|antimicrobial course|antimicrobial course
1036445|NCT02935374|amoxicillin|amoxicillin
1036446|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
1036447|NCT02935374|macrolide|macrolide
1036448|NCT02935322|Prevention|prevention
1036449|NCT02935309|rectum|rectum
1036450|NCT02935309|transrectal|transrectal
1036451|NCT02935309|carcinoma|carcinoma
1036452|NCT02935270|Stroke|stroke
1036453|NCT02935270|Neglect|neglect
1036454|NCT02935270|Rehabilitation|rehabilitation
1036455|NCT02935244|Epidemiology|epidemiology
1036460|NCT02935192|seasonal influenza|seasonal influenza
1036461|NCT02935192|vaccine|vaccine
1036462|NCT02935153|CD22|cd22
1036463|NCT02935153|CAR-T|car-t
1036464|NCT02935153|Leukemia|leukemia
1036465|NCT02935153|Lymphoma|lymphoma
1036466|NCT02935127|absorbable sutures|absorbable sutures
1036467|NCT02935114|Tooth Bleaching|tooth bleaching
1036468|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
1036469|NCT02935114|Tooth Whitening|tooth whitening
1036470|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
1036471|NCT02935114|Carbamide Peroxide|carbamide peroxide
1036472|NCT02935101|glucocorticoids|glucocorticoids
1036473|NCT02935101|craving|craving
1036474|NCT02935101|Heroin|heroin
1036475|NCT02935101|Cocaine|cocaine
1036476|NCT02935101|dependency|dependency
1036478|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
1036479|NCT02935062|Speech|speech
1036480|NCT02935062|Speech Therapy|speech therapy
1036481|NCT02935062|Speech Sound Disorders|speech sound disorders
1036482|NCT02935062|Phonological Disorders|phonological disorders
1036483|NCT02935062|Auditory Perception|auditory perception
1036484|NCT02935010|Helicobacter pylori|helicobacter pylori
1036485|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
1036486|NCT02935010|Tailored therapy|tailored therapy
1036487|NCT02935010|Empiric therapy|empiric therapy
1036488|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
1036489|NCT02934997|sepsis|sepsis
1036490|NCT02934997|septic shock|septic shock
1036491|NCT02934997|cholesterol|cholesterol
1036492|NCT02934997|high density lipoprotein|high density lipoprotein
1036493|NCT02934984|Pancreatic Cancer|pancreatic cancer
1036494|NCT02934984|recurrence|recurrence
1036495|NCT02934984|DNA|dna
1036496|NCT02934958|Colon Cancer Screening|colon cancer screening
1036497|NCT02934945|Budesonide/formoterol|budesonide/formoterol
1036498|NCT02934945|Typical asthma|typical asthma
1036499|NCT02934945|Cough variant asthma|cough variant asthma
1036500|NCT02934919|Nalmefene|nalmefene
1036501|NCT02934919|Impulse control disorders|impulse control disorders
1036502|NCT02934919|Parkinson's disease|parkinson's disease
1036503|NCT02934919|Tolerance|tolerance
1036504|NCT02934919|Efficacy|efficacy
1036505|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
1036506|NCT02934906|pregnancy|pregnancy
1036507|NCT02934906|human platelet allogantigen|human platelet allogantigen
1036508|NCT02934906|asian|asian
1036509|NCT02934906|Chinese|chinese
1036510|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
1036511|NCT02934854|GAMT deficiency|gamt deficiency
1036512|NCT02934854|GAMT and AGAT deficiencies|gamt and agat deficiencies
1036513|NCT02934854|Creatine Transporter Deficiency|creatine transporter deficiency
1036514|NCT02934854|Brain Creatine Transporter Deficiency|brain creatine transporter deficiency
1036515|NCT02934815|psychological intervention|psychological intervention
1036516|NCT02934815|breast cancer|breast cancer
1036517|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
1036518|NCT02934815|emotion regulation|emotion regulation
1036519|NCT02934815|social support|social support
1036520|NCT02934815|attachment|attachment
1036521|NCT02934815|quality of life|quality of life
1036522|NCT02934789|submucosal fibroids|submucosal fibroids
1036523|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
1036524|NCT02934789|quality of life|quality of life
1036525|NCT02934776|DTI|dti
1036526|NCT02934776|prostate cancer|prostate cancer
1036527|NCT02934776|MRI|mri
1036528|NCT02934750|pursed lip breathing|pursed lip breathing
1036529|NCT02934750|interstitial lund disease|interstitial lund disease
1036530|NCT02934750|exercise physiology|exercise physiology
1036531|NCT02934737|Obesity|obesity
1036532|NCT02934737|Diabetes Mellitus|diabetes mellitus
1037040|NCT02931721|Azospermia|azospermia
1036533|NCT02934724|HPV vaccines|hpv vaccines
1036534|NCT02934724|HPV-6|hpv-6
1036535|NCT02934724|HPV-11|hpv-11
1036536|NCT02934724|HPV-16|hpv-16
1036537|NCT02934724|HPV-18|hpv-18
1036538|NCT02934724|Gardasil|gardasil
1036539|NCT02934711|Multimorbidity|multimorbidity
1036540|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
1036541|NCT02934711|Caregivers|caregivers
1036542|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
1036543|NCT02934685|radiotherapy|radiotherapy
1036544|NCT02934646|Robotics|robotics
1036545|NCT02934646|Upper Extremity|upper extremity
1036546|NCT02934633|injury|injury
1036547|NCT02934633|child|child
1036548|NCT02934633|cars|cars
1036549|NCT02934633|pedestrians|pedestrians
1036550|NCT02934633|child safety|child safety
1036551|NCT02934633|interactive|interactive
1036552|NCT02934633|computer|computer
1036553|NCT02934633|prevention|prevention
1036554|NCT02934633|internet|internet
1036555|NCT02934633|CD-ROM|cd-rom
1036556|NCT02934620|pregnancy|pregnancy
1036557|NCT02934620|condom|condom
1036558|NCT02934620|HIV|hiv
1036559|NCT02934620|sexually transmitted infections|sexually transmitted infections
1036560|NCT02934607|Asthma|asthma
1036561|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1036562|NCT02934607|Spacer device|spacer device
1036563|NCT02934607|Symbicort|symbicort
1036564|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
1036565|NCT02934607|Relative bioavailability|relative bioavailability
1036566|NCT02934607|Crossover|crossover
1036567|NCT02934607|AstraZeneca|astrazeneca
1036568|NCT02934607|Safety|safety
1036569|NCT02934607|Activated charcoal|activated charcoal
1036570|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
1036571|NCT02934568|Ribociclib|ribociclib
1036572|NCT02934568|LEE011|lee011
1036573|NCT02934542|Laparoscope holder|laparoscope holder
1036574|NCT02934542|Colon resection|colon resection
1036575|NCT02934542|Right hemicolectomy|right hemicolectomy
1036576|NCT02934542|Left hemicolectomy|left hemicolectomy
1036577|NCT02934542|Sigmoid resection|sigmoid resection
1036578|NCT02934542|Anti-reflux|anti-reflux
1036579|NCT02934542|Hiatal hernia|hiatal hernia
1036580|NCT02934516|Obstructed labor|obstructed labor
1036581|NCT02934516|C section. push method|c section. push method
1036582|NCT02934516|reverse breech|reverse breech
1036583|NCT02934503|Chemotherapy|chemotherapy
1036584|NCT02934503|PD-L1|pd-l1
1036585|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
1036586|NCT02934503|PD-1|pd-1
1036587|NCT02934503|MK-3475|mk-3475
1036588|NCT02934477|Myelofibrosis|myelofibrosis
1036589|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1036590|NCT02934477|Medicare|medicare
1036591|NCT02934438|nitric oxide|nitric oxide
1036592|NCT02934438|Neo40 supplement,|neo40 supplement,
1036593|NCT02934438|exercise tolerance|exercise tolerance
1036594|NCT02934425|Pork|pork
1036595|NCT02934425|Refined carbohydrates|refined carbohydrates
1036596|NCT02934425|Satiety|satiety
1036597|NCT02934425|Glucose|glucose
1036598|NCT02934425|Insulin|insulin
1036599|NCT02934425|Breakfast|breakfast
1036600|NCT02934425|Lipoprotein lipids|lipoprotein lipids
1036601|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
1036602|NCT02934399|adrenal insufficiency|adrenal insufficiency
1036603|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
1036604|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
1036605|NCT02934399|cushing syndrome|cushing syndrome
1036606|NCT02934399|growth hormone deficiency|growth hormone deficiency
1036607|NCT02934399|acromegaly|acromegaly
1036608|NCT02934360|Lung Cancer|lung cancer
1036609|NCT02934360|Breast Cancer|breast cancer
1036610|NCT02934360|cell free DNA|cell free dna
1036611|NCT02934360|biomarker|biomarker
1036612|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
1036613|NCT02934334|major depression|major depression
1036614|NCT02934334|major depressive episode|major depressive episode
1036615|NCT02934334|biomarkers|biomarkers
1036616|NCT02934334|relapse|relapse
1036617|NCT02934334|near term relapse|near term relapse
1036618|NCT02934334|m-health|m-health
1036619|NCT02934321|Erythritol|erythritol
1036620|NCT02934321|Satiety Response|satiety response
1036621|NCT02934321|Ghrelin|ghrelin
1036622|NCT02934295|Rubeola|rubeola
1036623|NCT02934269|Healthy subjects|healthy subjects
1036624|NCT02934269|Safety|safety
1036625|NCT02934269|CC-90006|cc-90006
1036626|NCT02934269|Phase 1|phase 1
1036627|NCT02934269|Tolerability|tolerability
1036628|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
1036629|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
1036630|NCT02934256|Other NF2-related tumors|other nf2-related tumors
1036631|NCT02934243|Laryngeal Masks|laryngeal masks
1036633|NCT02934243|Risk factors|risk factors
1036634|NCT02934204|PCNSL|pcnsl
1036635|NCT02934204|DLBCL|dlbcl
1036636|NCT02934204|methotrexate|methotrexate
1036637|NCT02934204|temozolomide|temozolomide
1036638|NCT02934191|Tonsillectomy|tonsillectomy
1036639|NCT02934191|Post-operative complications|post-operative complications
1036640|NCT02934191|Post-operative pain|post-operative pain
1036641|NCT02934178|shigellosis|shigellosis
1036642|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
1036643|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
1036644|NCT02934178|Bacterial Infections|bacterial infections
1036645|NCT02934178|Gastroenteritis|gastroenteritis
1036646|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
1036647|NCT02934178|Digestive System Diseases|digestive system diseases
1036648|NCT02934178|Intestinal Diseases|intestinal diseases
1036649|NCT02934165|child safety|child safety
1036650|NCT02934165|injury|injury
1036651|NCT02934165|computer|computer
1036652|NCT02934165|prevention|prevention
1036653|NCT02934165|internet|internet
1036654|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
1036655|NCT02934152|Helicobacter pylori|helicobacter pylori
1036656|NCT02934139|N91115|n91115
1036657|NCT02934139|Cavosonstat|cavosonstat
1036658|NCT02934139|Healthy Volunteer|healthy volunteer
1036659|NCT02934113|weight loss|weight loss
1036660|NCT02934113|text messaging|text messaging
1036661|NCT02934113|workplace|workplace
1036662|NCT02934113|participatory approach|participatory approach
1036663|NCT02934113|health care workers|health care workers
1036664|NCT02934100|Calcaneal spur|calcaneal spur
1036665|NCT02934100|Heel spur|heel spur
1036666|NCT02934100|ESWT|eswt
1036667|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
1036668|NCT02934100|ultrasound therapy|ultrasound therapy
1036669|NCT02934100|electric field diathermy|electric field diathermy
1036670|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
1036671|NCT02934100|sham laser therapy|sham laser therapy
1036672|NCT02934087|snare technique|snare technique
1036673|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
1036674|NCT02934087|endovascular|endovascular
1036675|NCT02934087|aneurysm|aneurysm
1036676|NCT02934087|AAA|aaa
1036677|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1036678|NCT02934074|Limb Loss|limb loss
1036679|NCT02934074|Gait Variability|gait variability
1036680|NCT02934074|Phantom Sensation|phantom sensation
1036681|NCT02934074|Phantom Pain|phantom pain
1036682|NCT02934074|Peripheral Sensation|peripheral sensation
1036683|NCT02934061|Acute low back pain|acute low back pain
1036684|NCT02934022|Maraviroc|maraviroc
1036685|NCT02934022|HAART regimen|haart regimen
1036686|NCT02934022|Immunologic response|immunologic response
1036687|NCT02933996|immunosuppression|immunosuppression
1036688|NCT02933996|cardiac sugery|cardiac sugery
1036689|NCT02933996|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1036690|NCT02933996|postoperative|postoperative
1036691|NCT02933957|Vascular Evaluation|vascular evaluation
1036692|NCT02933957|influencing factor|influencing factor
1036693|NCT02933957|She Minority population|she minority population
1036694|NCT02933944|locally recurrent|locally recurrent
1036695|NCT02933918|Probiotics|probiotics
1036696|NCT02933918|Nasal Irrigation|nasal irrigation
1036697|NCT02933918|Healthy Volunteers|healthy volunteers
1036698|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
1036699|NCT02933801|Prostate Cancer|prostate cancer
1036700|NCT02933801|phase II trial|phase ii trial
1036701|NCT02933801|ODM-201|odm-201
1036702|NCT02933801|maintenance therapy|maintenance therapy
1036703|NCT02933788|cardiovascular disease|cardiovascular disease
1036704|NCT02933788|atherosclerosis|atherosclerosis
1036705|NCT02933723|influenza vaccine|influenza vaccine
1036706|NCT02933723|nursing home|nursing home
1036707|NCT02933723|influenza|influenza
1036708|NCT02933723|vaccination|vaccination
1036709|NCT02933723|immunity|immunity
1036710|NCT02933723|cell-mediated immunity|cell-mediated immunity
1036711|NCT02933723|humoral immunity|humoral immunity
1036712|NCT02933710|Japanese encephalitis|japanese encephalitis
1036713|NCT02933710|IMOJEV®|imojev®
1036714|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1036715|NCT02933697|Atrial Fibrillation|atrial fibrillation
1036716|NCT02933697|Kidney disease|kidney disease
1036717|NCT02933697|Anticoagulation|anticoagulation
1036718|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
1036719|NCT02933671|nerve block|nerve block
1036720|NCT02933645|Insulin|insulin
1036721|NCT02933645|Intranasal|intranasal
1036722|NCT02933645|Glucose/metabolism|glucose/metabolism
1036723|NCT02933645|Glucose homeostasis|glucose homeostasis
1036724|NCT02933632|Osteoarthritis|osteoarthritis
1036725|NCT02933632|Physiotherapy|physiotherapy
1036726|NCT02933632|Rehabilitation|rehabilitation
1036727|NCT02933632|Clinical Trials|clinical trials
1036728|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
1036729|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
1036730|NCT02933554|bariatric surgery|bariatric surgery
1036731|NCT02933554|minimally invasive|minimally invasive
1036732|NCT02933554|Embolization|embolization
1036733|NCT02933554|NASH|nash
1036734|NCT02933554|ghrelin|ghrelin
1036735|NCT02933554|gastric artery embolization|gastric artery embolization
1036736|NCT02933515|yoga|yoga
1036737|NCT02933515|occupational therapy|occupational therapy
1036738|NCT02933515|stroke|stroke
1036739|NCT02933463|children with high caries risk|children with high caries risk
1036740|NCT02933437|Brugada syndrome|brugada syndrome
1036741|NCT02933437|SCN5A|scn5a
1036742|NCT02933437|SCN10A|scn10a
1036743|NCT02933437|Ajmaline|ajmaline
1036744|NCT02933411|Bleeding Disorders|bleeding disorders
1036745|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
1036746|NCT02933359|cranial vault|cranial vault
1036747|NCT02933359|calvarial trauma|calvarial trauma
1036748|NCT02933359|calvarial reconstruction|calvarial reconstruction
1036749|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
1036750|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
1036751|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
1036752|NCT02933320|BI-1206|bi-1206
1036753|NCT02933320|CD32b|cd32b
1036754|NCT02933294|uniportal|uniportal
1036755|NCT02933294|lung cancer|lung cancer
1036756|NCT02933294|VATS|vats
1036757|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1036758|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
1036759|NCT02933268|ADPKD|adpkd
1036760|NCT02933268|Water|water
1036761|NCT02933268|Vasopressin|vasopressin
1036762|NCT02933268|Dietary|dietary
1036763|NCT02933255|Safety|safety
1036764|NCT02933255|Neoadjuvant|neoadjuvant
1036765|NCT02933255|Prostatectomy|prostatectomy
1036766|NCT02933255|Immunotherapy|immunotherapy
1036767|NCT02933255|Vaccine|vaccine
1036768|NCT02933242|Cancer|cancer
1036769|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
1036770|NCT02933177|Dementia|dementia
1036771|NCT02933177|Alzheimer disease|alzheimer disease
1036772|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
1036773|NCT02933177|non-drug intervention|non-drug intervention
1036774|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
1036775|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
1036776|NCT02933138|Triglycerides|triglycerides
1036777|NCT02933138|Lipolysis|lipolysis
1036778|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
1036779|NCT02933125|substance abuse|substance abuse
1036780|NCT02933125|group psychotherapy|group psychotherapy
1036781|NCT02933125|family therapy|family therapy
1036782|NCT02933125|longitudinal study|longitudinal study
1036783|NCT02933125|child and adolescent|child and adolescent
1036784|NCT02933112|Oral appliance therapy|oral appliance therapy
1036785|NCT02933086|Pregnant|pregnant
1036786|NCT02933086|Low Back Pain|low back pain
1036787|NCT02933086|Postural Control|postural control
1036788|NCT02933060|intravenous fluid|intravenous fluid
1036789|NCT02933060|headache|headache
1036790|NCT02933047|Hysterectomy|hysterectomy
1036791|NCT02933047|Patient satisfaction|patient satisfaction
1036792|NCT02933047|Rehabilitation|rehabilitation
1036793|NCT02933047|Laparoscopy|laparoscopy
1036794|NCT02933047|Return to work|return to work
1036795|NCT02933047|Exercise|exercise
1036796|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
1036797|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
1036798|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
1036799|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
1036800|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
1036801|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
1036802|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
1036803|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
1036804|NCT02933021|MGUS|mgus
1036805|NCT02933008|ACL|acl
1036806|NCT02933008|biofeedback|biofeedback
1036807|NCT02933008|injury prevention|injury prevention
1036808|NCT02933008|virtual reality|virtual reality
1036809|NCT02932995|Optical Coherence Tomography|optical coherence tomography
1036810|NCT02932995|Drug-Eluting Stent|drug-eluting stent
1036811|NCT02932982|primary care|primary care
1036812|NCT02932982|chest pain|chest pain
1036813|NCT02932982|dyspnea|dyspnea
1036814|NCT02932956|GPC3-Positive Solid Tumors|gpc3-positive solid tumors
1036815|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
1036816|NCT02932956|GPC3|gpc3
1036817|NCT02932956|Glypican|glypican
1036818|NCT02932930|QLB|qlb
1036819|NCT02932930|Abdominoplasty|abdominoplasty
1036820|NCT02932930|Quadratus lumborum block|quadratus lumborum block
1036821|NCT02932904|Drug therapy|drug therapy
1036822|NCT02932865|azoospermia|azoospermia
1036823|NCT02932865|male fertility|male fertility
1036824|NCT02932865|MD-TESE|md-tese
1036825|NCT02932865|miRNA|mirna
1036826|NCT02932865|piRNA|pirna
1036827|NCT02932865|male infertility|male infertility
1036828|NCT02932852|stem cell|stem cell
1036829|NCT02932852|mesenchymal|mesenchymal
1036830|NCT02932852|ADASc|adasc
1036831|NCT02932852|transplantation|transplantation
1036832|NCT02932852|cornea|cornea
1036833|NCT02932852|corneal defects|corneal defects
1036837|NCT02932839|Epilepsy surgery|epilepsy surgery
1036838|NCT02932839|Micro-electrode arrays|micro-electrode arrays
1037635|NCT02928185|16-1334|16-1334
1036839|NCT02932839|Single-neuron recordings|single-neuron recordings
1036840|NCT02932839|Electrocorticography|electrocorticography
1036841|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
1036842|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
1036843|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
1036844|NCT02932826|Cell Therapy|cell therapy
1036845|NCT02932800|Catheters|catheters
1036846|NCT02932800|Vascular Access Devices|vascular access devices
1036847|NCT02932800|Suture Techniques|suture techniques
1036848|NCT02932800|microbiota|microbiota
1036849|NCT02932800|Blood Circulation|blood circulation
1036851|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
1036852|NCT02932774|hay fever|hay fever
1036853|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
1036854|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
1036855|NCT02932761|vaginal repair|vaginal repair
1036856|NCT02932761|GnRHa|gnrha
1036857|NCT02932722|Propofol|propofol
1036858|NCT02932722|Sevoflurane|sevoflurane
1036859|NCT02932722|Preconditioning|preconditioning
1036860|NCT02932709|Emergency|emergency
1036861|NCT02932709|follow-up|follow-up
1036862|NCT02932709|nurse|nurse
1036863|NCT02932709|phone|phone
1036864|NCT02932709|suicide attempts|suicide attempts
1036865|NCT02932683|Resuscitation|resuscitation
1036866|NCT02932683|Neonatal|neonatal
1036867|NCT02932683|Education|education
1036868|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
1036869|NCT02932644|Cardiovascular event|cardiovascular event
1036870|NCT02932644|Cardiovascular mortality|cardiovascular mortality
1036871|NCT02932644|Vitamin D|vitamin d
1036872|NCT02932631|hemiparesis|hemiparesis
1036873|NCT02932631|STROKE|stroke
1036874|NCT02932631|neural plasticity|neural plasticity
1036875|NCT02932631|PHYSICAL THERAPY|physical therapy
1036876|NCT02932605|Schizophrenia|schizophrenia
1036877|NCT02932605|Cannabidiol|cannabidiol
1036878|NCT02932605|Magnetic Resonance Spectroscopy (1H-MRS)|magnetic resonance spectroscopy (1h-mrs)
1036879|NCT02932605|Microglia|microglia
1036880|NCT02932566|Heart failure|heart failure
1036881|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1036882|NCT02932566|Myocardial fibrosis|myocardial fibrosis
1036883|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
1036884|NCT02932566|Interstitial fibrosis|interstitial fibrosis
1036885|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1036886|NCT02932553|variant angina|variant angina
1036887|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
1036888|NCT02932553|vasospastic angina|vasospastic angina
1036889|NCT02932527|cannabis|cannabis
1036890|NCT02932501|Bisphosphonate|bisphosphonate
1036892|NCT02932501|Osteonecrosis|osteonecrosis
1036893|NCT02932501|Antiresorptive drugs|antiresorptive drugs
1036894|NCT02932501|Denosumab|denosumab
1036895|NCT02932488|PET-MR|pet-mr
1036896|NCT02932488|5-HT1B receptor|5-ht1b receptor
1036897|NCT02932488|Sumatriptan|sumatriptan
1036898|NCT02932488|phMRI|phmri
1036899|NCT02932488|[11C]AZ10419369|[11c]az10419369
1036900|NCT02932436|empagliflozin|empagliflozin
1036901|NCT02932436|diastolic function|diastolic function
1036902|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
1036903|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
1036904|NCT02932423|Overweight|overweight
1036905|NCT02932423|Obese|obese
1036906|NCT02932423|Sugar|sugar
1036907|NCT02932423|Water|water
1036908|NCT02932397|Ambulatory surgery|ambulatory surgery
1036909|NCT02932397|Perioperative outcomes|perioperative outcomes
1036910|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
1036911|NCT02932397|Prevention of coughing|prevention of coughing
1036912|NCT02932397|Propofol|propofol
1036913|NCT02932384|HIV|hiv
1036914|NCT02932384|Black/African American|black/african american
1036915|NCT02932384|Men|men
1036916|NCT02932384|Gay/bisexual|gay/bisexual
1036917|NCT02932384|Los Angeles|los angeles
1036918|NCT02932371|Cardiac output|cardiac output
1036919|NCT02932358|Intensive care units|intensive care units
1036920|NCT02932358|Delirium|delirium
1036921|NCT02932358|Cross infection|cross infection
1036922|NCT02932358|Mortality|mortality
1036923|NCT02932358|Length of stay|length of stay
1036924|NCT02932358|Burnout, Professional|burnout, professional
1036925|NCT02932358|Depression|depression
1036926|NCT02932358|Anxiety|anxiety
1036927|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
1036928|NCT02932332|shortness of breath|shortness of breath
1036929|NCT02932332|oxygen|oxygen
1036930|NCT02932332|breathing therapies|breathing therapies
1036931|NCT02932319|induction of labour|induction of labour
1036932|NCT02932319|nulliparous|nulliparous
1036933|NCT02932319|prolonged pregnancy|prolonged pregnancy
1036934|NCT02932319|foley catheter|foley catheter
1036935|NCT02932319|vaginal birth|vaginal birth
1036936|NCT02932280|Recurrent|recurrent
1036937|NCT02932280|Refractory Disease|refractory disease
1036938|NCT02932280|Neratinib|neratinib
1036942|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
1036943|NCT02932254|Rocuronium|rocuronium
1036944|NCT02932254|Sugammadex sodium|sugammadex sodium
1036945|NCT02932254|Magnesium|magnesium
1036946|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
1036947|NCT02932215|mobile health device|mobile health device
1036948|NCT02932215|substance abuse treatment|substance abuse treatment
1036949|NCT02932215|quality of life|quality of life
1036950|NCT02932215|lorcaserin|lorcaserin
1036951|NCT02932202|Obesity|obesity
1036952|NCT02932202|Pregnancy|pregnancy
1036953|NCT02932202|Weight Gain|weight gain
1036954|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
1036955|NCT02932189|Respiratory Muscle Training|respiratory muscle training
1036956|NCT02932189|Mortality Rate|mortality rate
1036957|NCT02932176|Arteries|arteries
1036958|NCT02932163|Chronic low back pain|chronic low back pain
1036959|NCT02932163|disability|disability
1036960|NCT02932163|endurance|endurance
1036961|NCT02932150|CHB|chb
1036962|NCT02932150|HBV|hbv
1036963|NCT02932137|SLE,IL-2|sle,il-2
1036964|NCT02932124|German Resuscitation Registry|german resuscitation registry
1036965|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1036966|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1036967|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
1036968|NCT02932111|IBS|ibs
1036969|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
1036970|NCT02932111|pain|pain
1036971|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
1036972|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
1036973|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1036974|NCT02932059|Metamemory|metamemory
1036975|NCT02932059|Schizophrenia|schizophrenia
1036976|NCT02932059|Aging|aging
1036977|NCT02932059|Learning|learning
1036978|NCT02932059|Judgement of learning|judgement of learning
1036979|NCT02932059|Sentence construction strategy|sentence construction strategy
1036980|NCT02932046|eating disorders|eating disorders
1036981|NCT02932046|anorexia nervosa|anorexia nervosa
1036982|NCT02932046|appetite|appetite
1036983|NCT02932020|disc herniation|disc herniation
1036984|NCT02932020|spinal stenosis|spinal stenosis
1036985|NCT02932007|persistent|persistent
1036986|NCT02932007|longstanding persistent|longstanding persistent
1036987|NCT02931994|dental floss|dental floss
1036988|NCT02931994|gingival embrasure|gingival embrasure
1036989|NCT02931994|oral hygiene|oral hygiene
1036990|NCT02931981|DKK4|dkk4
1036991|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1036992|NCT02931981|Biomarker|biomarker
1036993|NCT02931968|Monolithic Zirconia|monolithic zirconia
1036994|NCT02931968|Implant supported prosthesis|implant supported prosthesis
1036995|NCT02931968|Fixed partial denture|fixed partial denture
1036996|NCT02931955|allergy|allergy
1036997|NCT02931955|insect venom|insect venom
1036998|NCT02931955|pollen|pollen
1036999|NCT02931955|systems biology|systems biology
1037000|NCT02931942|AA|aa
1037001|NCT02931916|smart-phone|smart-phone
1037002|NCT02931916|assessment|assessment
1037003|NCT02931916|chronic ankle instability|chronic ankle instability
1037004|NCT02931903|implant supported restorations|implant supported restorations
1037005|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
1037006|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
1037007|NCT02931903|implant survival|implant survival
1037008|NCT02931903|peri-implant tissue response|peri-implant tissue response
1037009|NCT02931890|gastric cancer|gastric cancer
1037010|NCT02931890|radiotherapy|radiotherapy
1037011|NCT02931890|chemoradiotherapy|chemoradiotherapy
1037012|NCT02931877|Sevoflurane|sevoflurane
1037013|NCT02931877|Propofol|propofol
1037014|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
1037015|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
1037016|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1037017|NCT02931825|high risk|high risk
1037018|NCT02931825|surveillance|surveillance
1037019|NCT02931825|screening|screening
1037020|NCT02931825|colonoscopy|colonoscopy
1037021|NCT02931812|cirrhosis|cirrhosis
1037022|NCT02931812|reward system|reward system
1037023|NCT02931812|taste sensitivity|taste sensitivity
1037024|NCT02931812|chronic renal failure|chronic renal failure
1037025|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
1037026|NCT02931799|Crohn Disease|crohn disease
1037027|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
1037028|NCT02931799|Gastroenterology|gastroenterology
1037029|NCT02931799|Quality Improvement|quality improvement
1037030|NCT02931799|Post-Discharge|post-discharge
1037031|NCT02931786|core body temperature|core body temperature
1037032|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
1037033|NCT02931786|propofol|propofol
1037034|NCT02931786|ketofol|ketofol
1037035|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
1037036|NCT02931747|Bacopa Monnieri|bacopa monnieri
1037037|NCT02931747|Working memory|working memory
1037038|NCT02931747|Cognitive processing|cognitive processing
1037039|NCT02931747|Student|student
1037041|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
1037042|NCT02931721|Male infertility|male infertility
1037043|NCT02931721|Testis|testis
1037045|NCT02931708|Heart Failure|heart failure
1037046|NCT02931708|Diaphragm|diaphragm
1037047|NCT02931708|Electrical Stimulation|electrical stimulation
1037048|NCT02931695|post partum|post partum
1037049|NCT02931682|Creatine transporter|creatine transporter
1037050|NCT02931682|developmental delay|developmental delay
1037051|NCT02931682|intellectual disability|intellectual disability
1037052|NCT02931682|X-linked|x-linked
1037053|NCT02931682|language|language
1037054|NCT02931682|seizure|seizure
1037055|NCT02931682|observational|observational
1037056|NCT02931682|brain spectroscopy|brain spectroscopy
1037057|NCT02931656|Gestational Diabetes|gestational diabetes
1037058|NCT02931643|Spices|spices
1037059|NCT02931643|Functional food|functional food
1037060|NCT02931643|Cardiometabolic risk|cardiometabolic risk
1037061|NCT02931643|Metabolic syndrome|metabolic syndrome
1037062|NCT02931643|Inflammation|inflammation
1037063|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
1037064|NCT02931643|Acute|acute
1037065|NCT02931643|miRNA|mirna
1037066|NCT02931630|Whey protein|whey protein
1037067|NCT02931630|Dietary fibers|dietary fibers
1037068|NCT02931630|Wheat bran|wheat bran
1037069|NCT02931630|Arabinoxylan|arabinoxylan
1037070|NCT02931630|Postprandial lipaemia|postprandial lipaemia
1037071|NCT02931630|Body composition|body composition
1037072|NCT02931630|Blood pressure|blood pressure
1037073|NCT02931630|Metabolic rate|metabolic rate
1037074|NCT02931630|Insulin sensitivity|insulin sensitivity
1037075|NCT02931630|Metabolic syndrome|metabolic syndrome
1037076|NCT02931604|sinus wash|sinus wash
1037077|NCT02931604|sinus lavage|sinus lavage
1037078|NCT02931604|Sinusitis|sinusitis
1037079|NCT02931591|Small for gestational age|small for gestational age
1037080|NCT02931591|insulin sensitivity|insulin sensitivity
1037081|NCT02931591|IGF-1 response|igf-1 response
1037082|NCT02931591|growth hormone treatment|growth hormone treatment
1037083|NCT02931578|glycemic index|glycemic index
1037084|NCT02931552|Breast cancer|breast cancer
1037085|NCT02931552|Latinas|latinas
1037086|NCT02931552|Peer support counselor|peer support counselor
1037087|NCT02931552|Spanish speaking|spanish speaking
1037088|NCT02931552|Community based|community based
1037089|NCT02931552|Rural|rural
1037090|NCT02931526|Tigecycline|tigecycline
1037091|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1037092|NCT02931526|Pharmacokinetics|pharmacokinetics
1037093|NCT02931500|machine learning|machine learning
1037094|NCT02931500|cohort study|cohort study
1037095|NCT02931474|Growth Hormone|growth hormone
1037096|NCT02931474|Traumatic Brain Injury|traumatic brain injury
1037097|NCT02931474|Insomnia|insomnia
1037098|NCT02931474|Polysomnography|polysomnography
1037099|NCT02931474|NREM Sleep|nrem sleep
1037100|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
1037101|NCT02931448|Device assessment|device assessment
1037102|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
1037103|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
1037104|NCT02931422|HIV|hiv
1037105|NCT02931422|financial incentive|financial incentive
1037106|NCT02931422|pediatric HIV testing|pediatric hiv testing
1037107|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
1037108|NCT02931409|Static pulmonary compliance|static pulmonary compliance
1037109|NCT02931409|Lung Protective Ventilation|lung protective ventilation
1037110|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
1037111|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
1037112|NCT02931409|Procalcitonin|procalcitonin
1037113|NCT02931383|Liraglutide|liraglutide
1037114|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
1037115|NCT02931383|Osteoarthritis|osteoarthritis
1037116|NCT02931383|Obesity|obesity
1037117|NCT02931383|Ultrasound|ultrasound
1037118|NCT02931370|Osteoarthritis|osteoarthritis
1037119|NCT02931370|Obesity|obesity
1037120|NCT02931370|Ultrasound|ultrasound
1037121|NCT02931370|Liraglutide|liraglutide
1037122|NCT02931370|Liraglutide 3mg|liraglutide 3mg
1037123|NCT02931357|Treatment of teething in infants|treatment of teething in infants
1037124|NCT02931344|Osteoarthrtis|osteoarthrtis
1037125|NCT02931344|Obesity|obesity
1037126|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
1037127|NCT02931344|Liraglutide|liraglutide
1037128|NCT02931344|Biomarkers|biomarkers
1037129|NCT02931318|Organ donation|organ donation
1037130|NCT02931318|brain death|brain death
1037131|NCT02931318|public opinion|public opinion
1037132|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
1037133|NCT02931305|Osteoporosis|osteoporosis
1037134|NCT02931305|Cardiovascular diseases|cardiovascular diseases
1037135|NCT02931305|Phase 1|phase 1
1037136|NCT02931305|safety|safety
1037137|NCT02931305|tolerability|tolerability
1037138|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
1037139|NCT02931292|laparoscopy|laparoscopy
1037140|NCT02931292|bariatric surgery|bariatric surgery
1037141|NCT02931292|obesity surgery|obesity surgery
1037142|NCT02931292|metabolic surgery|metabolic surgery
1037143|NCT02931214|Healthy Subjects|healthy subjects
1037144|NCT02931214|Pharmacokinetics|pharmacokinetics
1037145|NCT02931214|Pharmacodynamics|pharmacodynamics
1037146|NCT02931201|Positron-Emission Tomography|positron-emission tomography
1037147|NCT02931201|Prognosis|prognosis
1037148|NCT02931188|Vascular Diseases|vascular diseases
1037149|NCT02931188|Lipids|lipids
1037150|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
1037151|NCT02931188|Anacetrapib|anacetrapib
1037152|NCT02931188|Cardiovascular Disease|cardiovascular disease
1037153|NCT02931188|Cholesterol|cholesterol
1037154|NCT02931175|ACTH gel|acth gel
1037155|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
1037156|NCT02931175|ACTHAR|acthar
1037157|NCT02931175|Posterior Uveitis|posterior uveitis
1037158|NCT02931175|Intermediate Uveitis|intermediate uveitis
1037159|NCT02931175|Pan Uveitis|pan uveitis
1037160|NCT02931175|Uveitis|uveitis
1037161|NCT02931149|platelet-rich plasma|platelet-rich plasma
1037162|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
1037163|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
1037164|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1037165|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
1037166|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
1037167|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
1037168|NCT02931110|Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)|chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
1037169|NCT02931110|Multiple myeloma (MM)|multiple myeloma (mm)
1037170|NCT02931097|Parkinson's disease|parkinson's disease
1037171|NCT02931097|Deep brain stimulation|deep brain stimulation
1037172|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
1037173|NCT02931058|Knee-extension exercise|knee-extension exercise
1037174|NCT02931058|Quadriceps exercise|quadriceps exercise
1037175|NCT02931058|Knee osteoarthritis|knee osteoarthritis
1037176|NCT02931058|Exercise adherence|exercise adherence
1037177|NCT02931058|Dose-response relationship|dose-response relationship
1037178|NCT02931058|Prehabilitation|prehabilitation
1037179|NCT02931045|extracellular vesicles|extracellular vesicles
1037180|NCT02931045|inflammation|inflammation
1037181|NCT02931045|thrombosis|thrombosis
1037182|NCT02931045|antiplatelet drugs|antiplatelet drugs
1037183|NCT02931032|nano receptor|nano receptor
1037184|NCT02931032|oral microbiology|oral microbiology
1037185|NCT02931032|dental caries|dental caries
1037186|NCT02931032|periodontal disease|periodontal disease
1037187|NCT02931019|fiberoptic|fiberoptic
1037188|NCT02931019|intubation|intubation
1037189|NCT02931019|posture|posture
1037190|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
1037191|NCT02930941|tranexamic acid|tranexamic acid
1037192|NCT02930941|epistaxis|epistaxis
1037193|NCT02930941|emergency medicine|emergency medicine
1037194|NCT02930941|intranasal|intranasal
1037195|NCT02930941|TXA|txa
1037196|NCT02930928|Anaesthesia|anaesthesia
1037197|NCT02930928|Anthropometry|anthropometry
1037198|NCT02930928|Body weight and measures|body weight and measures
1037199|NCT02930928|Development|development
1037200|NCT02930928|Emergency treatment|emergency treatment
1037201|NCT02930928|Patient safety|patient safety
1037202|NCT02930915|Head and Neck Cancer|head and neck cancer
1037203|NCT02930915|Radiotherapy|radiotherapy
1037204|NCT02930902|Pancreatic Cancer|pancreatic cancer
1037205|NCT02930902|Pembrolizumab|pembrolizumab
1037206|NCT02930902|MK3475|mk3475
1037207|NCT02930902|Paricalcitol|paricalcitol
1037208|NCT02930902|Zemplar|zemplar
1037209|NCT02930902|Gemcitabine|gemcitabine
1037210|NCT02930902|Hydrochloride Gemzar|hydrochloride gemzar
1037211|NCT02930902|Nab-paclitaxel|nab-paclitaxel
1037212|NCT02930902|Paclitaxel|paclitaxel
1037213|NCT02930902|Abraxane|abraxane
1037214|NCT02930902|ABI-007|abi-007
1037215|NCT02930902|Resectable Pancreatic Cancer|resectable pancreatic cancer
1037216|NCT02930889|Therapeutic Embolization|therapeutic embolization
1037217|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
1037218|NCT02930876|sarcopenia|sarcopenia
1037219|NCT02930876|cancer|cancer
1037220|NCT02930876|chemotherapy|chemotherapy
1037221|NCT02930876|palliative care|palliative care
1037222|NCT02930876|resistance training|resistance training
1037223|NCT02930733|Postoperative Analgesia|postoperative analgesia
1037224|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
1037225|NCT02930720|TAUS|taus
1037226|NCT02930720|breathing protocols and cough|breathing protocols and cough
1037227|NCT02930720|pelvic floor displacement|pelvic floor displacement
1037228|NCT02930720|women|women
1037229|NCT02930720|SUI|sui
1037230|NCT02930707|magnesium sulfate|magnesium sulfate
1037231|NCT02930707|postoperative pain|postoperative pain
1037232|NCT02930707|TAP block|tap block
1037233|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
1037234|NCT02930655|Fabry disease|fabry disease
1037235|NCT02930655|lucerastat|lucerastat
1037236|NCT02930642|Mindfulness|mindfulness
1037237|NCT02930642|Obesity|obesity
1037238|NCT02930642|Food insecurity|food insecurity
1037239|NCT02930642|Delay discounting|delay discounting
1037240|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
1037241|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
1037242|NCT02930603|Developmental Disabilities|developmental disabilities
1037243|NCT02930603|Body function and body structure|body function and body structure
1037244|NCT02930603|Participation|participation
1037245|NCT02930603|Life activities|life activities
1037246|NCT02930603|Quality of Life|quality of life
1037247|NCT02930577|treatment adherence|treatment adherence
1037248|NCT02930577|outpatient treatment|outpatient treatment
1037249|NCT02930577|drug dependence|drug dependence
1037250|NCT02930525|apnea|apnea
1037251|NCT02930525|children|children
1037252|NCT02930525|hypercarbia|hypercarbia
1037253|NCT02930525|procedural sedation|procedural sedation
1037254|NCT02930525|HFNC|hfnc
1037255|NCT02930512|Bone mineral density|bone mineral density
1037256|NCT02930512|Osteoporosis|osteoporosis
1037257|NCT02930512|Parkinson's disease|parkinson's disease
1037258|NCT02930512|Bone turnover markers|bone turnover markers
1037259|NCT02930486|Syndesmosis|syndesmosis
1037260|NCT02930486|Injury|injury
1037261|NCT02930486|Ankle|ankle
1037262|NCT02930486|Fracture|fracture
1037263|NCT02930486|Weber C|weber c
1037264|NCT02930473|Psychotherapy|psychotherapy
1037265|NCT02930473|Nursing|nursing
1037266|NCT02930473|Nursing Care|nursing care
1037267|NCT02930473|Nursing Model|nursing model
1037268|NCT02930473|Randomised Controlled Trial|randomised controlled trial
1037269|NCT02930434|Vitamin D|vitamin d
1037270|NCT02930434|cholecalciferol|cholecalciferol
1037271|NCT02930434|Antarctica|antarctica
1037272|NCT02930434|Chile|chile
1037273|NCT02930434|cathelicidin|cathelicidin
1037274|NCT02930434|bone metabolism|bone metabolism
1037275|NCT02930434|cardiovascular risk|cardiovascular risk
1037276|NCT02930421|mild COPD|mild copd
1037277|NCT02930421|Exercise training|exercise training
1037278|NCT02930421|Six minute walking distance|six minute walking distance
1037279|NCT02930421|Quality of life|quality of life
1037280|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
1037281|NCT02930395|Concussion|concussion
1037282|NCT02930395|Professional rugby players|professional rugby players
1037283|NCT02930395|S100B|s100b
1037284|NCT02930330|Exercise|exercise
1037285|NCT02930330|Interval training|interval training
1037286|NCT02930330|Blood platelets|blood platelets
1037287|NCT02930330|Platelet function tests|platelet function tests
1037288|NCT02930330|Physical fitness|physical fitness
1037289|NCT02930330|Rehabilitation|rehabilitation
1037290|NCT02930304|tennis elbow|tennis elbow
1037291|NCT02930304|pain|pain
1037292|NCT02930304|shock wave|shock wave
1037293|NCT02930304|kinesio taping|kinesio taping
1037294|NCT02930252|Self-expandable metal stent|self-expandable metal stent
1037295|NCT02930252|strictures|strictures
1037296|NCT02930252|biliary|biliary
1037297|NCT02930239|ACL-reconstruction|acl-reconstruction
1037298|NCT02930239|Gait rehabilitation|gait rehabilitation
1037299|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
1037300|NCT02930239|ACL-rehabilitation|acl-rehabilitation
1037301|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
1037302|NCT02930213|minimally conscious state|minimally conscious state
1037303|NCT02930213|circadian rhythms|circadian rhythms
1037304|NCT02930213|free-running period|free-running period
1037305|NCT02930200|Smoking Cessation|smoking cessation
1037306|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
1037307|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
1037308|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
1037309|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1037310|NCT02930161|Methionine|methionine
1037311|NCT02930161|Succinic acid|succinic acid
1037312|NCT02930148|mHealth|mhealth
1037313|NCT02930148|adolescents|adolescents
1037314|NCT02930148|quasi-experimental study|quasi-experimental study
1037315|NCT02930148|apps|apps
1037316|NCT02930148|lifestyles|lifestyles
1037317|NCT02930148|lifestyles knowledge|lifestyles knowledge
1037318|NCT02930148|dietary behaviour|dietary behaviour
1037319|NCT02930148|physical activity|physical activity
1037320|NCT02930148|sleeping behaviour|sleeping behaviour
1037321|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
1037322|NCT02930070|sepsis|sepsis
1037323|NCT02930070|qSOFA|qsofa
1037324|NCT02930070|SOFA|sofa
1037325|NCT02930070|diagnostic accuracy|diagnostic accuracy
1037326|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
1037327|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
1037328|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
1037329|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
1037330|NCT02930057|betamethasone|betamethasone
1037331|NCT02930057|dorsal root ganglion|dorsal root ganglion
1037332|NCT02930044|Emergency department|emergency department
1037333|NCT02930044|Insulin|insulin
1037334|NCT02930044|Adult|adult
1037335|NCT02930031|muscle injury|muscle injury
1037336|NCT02930031|exercise|exercise
1037337|NCT02930031|redox status|redox status
1037338|NCT02930031|immune cells|immune cells
1037339|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
1037340|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
1037341|NCT02930018|Neuroprotection|neuroprotection
1037342|NCT02930018|Tat-NR2B9c|tat-nr2b9c
1037343|NCT02930018|NA-1|na-1
1037344|NCT02930005|Psychotic|psychotic
1037345|NCT02930005|Schizophrenia|schizophrenia
1037346|NCT02930005|Schizoaffective|schizoaffective
1037347|NCT02930005|Bipolar|bipolar
1037348|NCT02929979|PTSD|ptsd
1037349|NCT02929979|Alcohol Use Disorder|alcohol use disorder
1037350|NCT02929979|Cognitive Training|cognitive training
1037351|NCT02929979|Veterans|veterans
1037352|NCT02929953|premature birth|premature birth
1037353|NCT02929953|risk factor|risk factor
1037727|NCT02927678|Osteomyelitis|osteomyelitis
1037354|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
1037355|NCT02929953|seasonality|seasonality
1037356|NCT02929953|prevalence|prevalence
1037357|NCT02929953|enteral feeding|enteral feeding
1037358|NCT02929953|immunomodulating medications|immunomodulating medications
1037359|NCT02929953|early onset|early onset
1037361|NCT02929914|Carious dentin|carious dentin
1037362|NCT02929914|Photodynamic Therapy|photodynamic therapy
1037363|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
1037364|NCT02929836|Ablation Linear Lesions|ablation linear lesions
1037365|NCT02929797|pancreatic cancer|pancreatic cancer
1037366|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
1037367|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
1037368|NCT02929784|Stroke|stroke
1037369|NCT02929771|Virtual Reality|virtual reality
1037370|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
1037371|NCT02929771|Pain|pain
1037372|NCT02929771|Children|children
1037373|NCT02929745|immunology, genetics|immunology, genetics
1037374|NCT02929667|Fluoxetine|fluoxetine
1037375|NCT02929641|Optical Enhancement technology|optical enhancement technology
1037376|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
1037377|NCT02929602|prescribing|prescribing
1037378|NCT02929602|effectiveness|effectiveness
1037379|NCT02929602|dental|dental
1037380|NCT02929602|opioid|opioid
1037381|NCT02929602|analgesic|analgesic
1037382|NCT02929576|metastatic|metastatic
1037383|NCT02929576|triple negative|triple negative
1037384|NCT02929550|Cardiovascular disease|cardiovascular disease
1037385|NCT02929550|Costs|costs
1037386|NCT02929550|Guidelines|guidelines
1037387|NCT02929550|Lipids|lipids
1037388|NCT02929550|Myocardial infarction|myocardial infarction
1037389|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1037390|NCT02929537|registration research|registration research
1037391|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
1037392|NCT02929524|Ketamine|ketamine
1037393|NCT02929524|Intranasal administration|intranasal administration
1037394|NCT02929524|Pediatric nursing|pediatric nursing
1037395|NCT02929498|GSK2879552|gsk2879552
1037396|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
1037397|NCT02929498|azacitidine|azacitidine
1037398|NCT02929498|hypomethylating agents|hypomethylating agents
1037399|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
1037400|NCT02929472|Physical Activity|physical activity
1037401|NCT02929472|Physical Fitness|physical fitness
1037402|NCT02929472|Intervention|intervention
1037403|NCT02929472|Children and Adolescents|children and adolescents
1037404|NCT02929459|Gut Microbiota|gut microbiota
1037405|NCT02929459|Riboflavin|riboflavin
1037406|NCT02929459|Vitamin B2|vitamin b2
1037407|NCT02929459|oGTT|ogtt
1037408|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
1037409|NCT02929446|mobilisation|mobilisation
1037410|NCT02929446|physiotherapy|physiotherapy
1037411|NCT02929433|disability|disability
1037412|NCT02929433|pain|pain
1037413|NCT02929433|Rotator Cuff Tear|rotator cuff tear
1037414|NCT02929433|rehabilitation|rehabilitation
1037415|NCT02929433|range of motion (ROM)|range of motion (rom)
1037416|NCT02929420|Multicenter|multicenter
1037417|NCT02929420|randomized|randomized
1037418|NCT02929420|open|open
1037419|NCT02929420|parallel controlled|parallel controlled
1672940|NCT00097032|cognition|cognition
1069419|NCT02733003|HIV|hiv
1037420|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
1037421|NCT02929381|Narrow Band Imaging|narrow band imaging
1037422|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
1037423|NCT02929381|Colonoscopy|colonoscopy
1037424|NCT02929381|Responsive Insertion Technology|responsive insertion technology
1037425|NCT02929381|Near Focus|near focus
1037426|NCT02929368|PICC-Line|picc-line
1037427|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
1037428|NCT02929355|duplex ultrasonography|duplex ultrasonography
1037429|NCT02929355|diabetes|diabetes
1037430|NCT02929355|vascular events|vascular events
1037431|NCT02929277|farm children|farm children
1037432|NCT02929277|non-farm children|non-farm children
1037433|NCT02929264|Healthy volunteer|healthy volunteer
1037434|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
1037435|NCT02929264|fMRI|fmri
1037436|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
1037437|NCT02929212|Gastric Bypass|gastric bypass
1037438|NCT02929212|Meal Texture|meal texture
1037439|NCT02929212|Meal Number|meal number
1037440|NCT02929212|GLP-1|glp-1
1037441|NCT02929212|Glucose|glucose
1037442|NCT02929134|Lymphedema|lymphedema
1037443|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
1037444|NCT02929134|Filariasis|filariasis
1037445|NCT02929134|Doxycycline|doxycycline
1037446|NCT02929121|Lymphedema|lymphedema
1037447|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
1037448|NCT02929121|Filariasis|filariasis
1037449|NCT02929121|Doxycycline|doxycycline
1037450|NCT02929108|hospice|hospice
1037451|NCT02929108|caregiver|caregiver
1037452|NCT02929082|magnetic resonance force|magnetic resonance force
1037453|NCT02929069|Minority Stress|minority stress
1037454|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1037455|NCT02929017|Fibrosis|fibrosis
1037457|NCT02929017|Caregivers|caregivers
1037458|NCT02929017|Pulmonary|pulmonary
1037459|NCT02929017|Palliative|palliative
1037460|NCT02929017|end of life|end of life
1037461|NCT02929017|Idiopathic|idiopathic
1037462|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1037463|NCT02929004|Local vibration training|local vibration training
1037464|NCT02929004|Ligamentoplasty|ligamentoplasty
1037465|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
1037466|NCT02929004|Corticospinal excitability|corticospinal excitability
1037467|NCT02929004|Elastography|elastography
1037468|NCT02929004|Knee extensor muscles|knee extensor muscles
1037469|NCT02929004|Readaptation|readaptation
1037470|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
1037471|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
1037472|NCT02928978|Premalignant Breast Disease|premalignant breast disease
1037473|NCT02928978|ALH|alh
1037474|NCT02928978|ADH|adh
1037475|NCT02928978|DCIS|dcis
1037476|NCT02928978|LCIS|lcis
1037477|NCT02928978|Breast Cancer Prevention|breast cancer prevention
1037478|NCT02928978|Ruxolitinib|ruxolitinib
1037479|NCT02928965|psychosis|psychosis
1037480|NCT02928965|schizophrenia|schizophrenia
1037481|NCT02928965|negative symptoms|negative symptoms
1037482|NCT02928965|minocycline|minocycline
1037483|NCT02928952|Mindfulness|mindfulness
1037484|NCT02928939|multimorbidity|multimorbidity
1037485|NCT02928939|multiple chronic conditions|multiple chronic conditions
1037486|NCT02928939|drug-drug interactions|drug-drug interactions
1037487|NCT02928939|drug-disease interactions|drug-disease interactions
1037488|NCT02928939|polypharmacy|polypharmacy
1037489|NCT02928939|Oral anticoagulants|oral anticoagulants
1037490|NCT02928939|Steroids|steroids
1037491|NCT02928913|sedentary|sedentary
1037492|NCT02928913|non-sedentary|non-sedentary
1037493|NCT02928913|populations|populations
1037494|NCT02928900|Adolescents|adolescents
1037495|NCT02928900|Clinical training|clinical training
1037496|NCT02928900|HIV care and treatment|hiv care and treatment
1037497|NCT02928900|Africa|africa
1037498|NCT02928861|Positron-Emission Tomography|positron-emission tomography
1037499|NCT02928861|Prognosis|prognosis
1037500|NCT02928835|Total knee arthroplasty|total knee arthroplasty
1037501|NCT02928835|Knee flexion|knee flexion
1037502|NCT02928835|Dynamic orthosis|dynamic orthosis
1037503|NCT02928822|stroke|stroke
1037504|NCT02928822|broca's aphasia|broca's aphasia
1037505|NCT02928822|priming|priming
1037506|NCT02928822|Intensive language-action therapy|intensive language-action therapy
1037507|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
1037508|NCT02928809|temporomandibular joint|temporomandibular joint
1037509|NCT02928809|temporomandibular disorder|temporomandibular disorder
1037510|NCT02928809|muscle fatigue|muscle fatigue
1037511|NCT02928809|low-level laser therapy|low-level laser therapy
1037512|NCT02928796|Attentional capacity|attentional capacity
1037513|NCT02928796|Working memory|working memory
1673707|NCT00094068|Gray Matter|gray matter
1037514|NCT02928796|Simulation-based training|simulation-based training
1037515|NCT02928796|Eye-tracking|eye-tracking
1037516|NCT02928796|Visual attention|visual attention
1037517|NCT02928796|Psychophysiological measurement|psychophysiological measurement
1037518|NCT02928796|Surgical simulation|surgical simulation
1037519|NCT02928796|Computer-based simulation|computer-based simulation
1037520|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
1037521|NCT02928783|Quality of Medical Care|quality of medical care
1037522|NCT02928783|Heart Failure|heart failure
1037523|NCT02928757|Care coordination|care coordination
1037524|NCT02928757|Complex care kids Ontario|complex care kids ontario
1037525|NCT02928757|Technology-dependent|technology-dependent
1037526|NCT02928757|Quality of life|quality of life
1037527|NCT02928744|Resistance|resistance
1037528|NCT02928744|Forced oscillations|forced oscillations
1037529|NCT02928744|Dyspnea|dyspnea
1037530|NCT02928731|Cancer|cancer
1037531|NCT02928731|Quality of life|quality of life
1037532|NCT02928731|Child|child
1037533|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
1037534|NCT02928718|Genetic variation|genetic variation
1037535|NCT02928705|analgesia|analgesia
1037536|NCT02928705|prehospital|prehospital
1037537|NCT02928705|telemedicine|telemedicine
1037538|NCT02928705|ambulance|ambulance
1037539|NCT02928705|opioids|opioids
1037540|NCT02928705|teleconsultation|teleconsultation
1037541|NCT02928705|tele-emergency medical services|tele-emergency medical services
1037542|NCT02928705|adverse events|adverse events
1037543|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
1037544|NCT02928692|Minocycline|minocycline
1037545|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1037546|NCT02928692|Postoperative delirium|postoperative delirium
1037547|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
1037548|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
1037549|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
1037550|NCT02928679|Liraglutide|liraglutide
1037551|NCT02928679|Obesity|obesity
1037552|NCT02928679|Osteoarthritis|osteoarthritis
1037553|NCT02928666|decision-support|decision-support
1037554|NCT02928666|ontology|ontology
1037555|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
1037556|NCT02928666|comorbidities|comorbidities
1037557|NCT02928653|energy intake|energy intake
1037558|NCT02928653|energy expenditure|energy expenditure
1037559|NCT02928653|appetite|appetite
1037560|NCT02928614|Osteoarthritis|osteoarthritis
1037561|NCT02928614|Obesity|obesity
1037562|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
1037563|NCT02928614|Liraglutide|liraglutide
1037564|NCT02928614|Biomarkers|biomarkers
1037565|NCT02928575|Glioblastoma|glioblastoma
1037566|NCT02928575|Sunitinib|sunitinib
1037567|NCT02928575|Temozolomide|temozolomide
1037568|NCT02928575|Radiation Therapy,|radiation therapy,
1037569|NCT02928575|MGMT|mgmt
1037570|NCT02928575|Biomarkers|biomarkers
1037571|NCT02928549|interviews|interviews
1037572|NCT02928549|16-1378|16-1378
1037573|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
1037574|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1037575|NCT02928497|Left atrial appendage|left atrial appendage
1037576|NCT02928484|Functional dyspepsia|functional dyspepsia
1037577|NCT02928484|Abdominal pain|abdominal pain
1037578|NCT02928484|Flatulence|flatulence
1037579|NCT02928484|Probiotics|probiotics
1037580|NCT02928484|Bifidobacterium|bifidobacterium
1037581|NCT02928484|Lactobacillus|lactobacillus
1037582|NCT02928471|Liraglutide|liraglutide
1037583|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
1037584|NCT02928471|Osteoarthritis|osteoarthritis
1037585|NCT02928471|Obesity|obesity
1037586|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
1037587|NCT02928471|Computed tomography|computed tomography
1037588|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
1037589|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
1037590|NCT02928445|dementia|dementia
1037591|NCT02928445|RVT-101|rvt-101
1037592|NCT02928445|intepirdine|intepirdine
1037593|NCT02928445|Lewy bodies|lewy bodies
1037594|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1037595|NCT02928432|Abiraterone acetate|abiraterone acetate
1037596|NCT02928432|Steroids Switch|steroids switch
1037597|NCT02928393|Stroke|stroke
1037598|NCT02928393|Motor impairment|motor impairment
1037599|NCT02928393|Stroke recovery|stroke recovery
1037600|NCT02928393|Middle cerebral artery stroke|middle cerebral artery stroke
1037601|NCT02928393|Fugl Meyer|fugl meyer
1037602|NCT02928393|Fugl-Meyer Motor Scale (FMMS)|fugl-meyer motor scale (fmms)
1037603|NCT02928354|Asthma|asthma
1037604|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1037605|NCT02928354|Healthy volunteers|healthy volunteers
1037606|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
1037607|NCT02928354|Bioavailability|bioavailability
1037608|NCT02928354|AZD7594|azd7594
1037609|NCT02928354|Safety|safety
1037610|NCT02928354|Tolerability|tolerability
1037611|NCT02928328|craniofacial pain|craniofacial pain
1037612|NCT02928328|masticatory muscle|masticatory muscle
1037613|NCT02928328|burning mouth syndrome|burning mouth syndrome
1037614|NCT02928328|temporomandibular disorders|temporomandibular disorders
1037615|NCT02928276|Rheumakit|rheumakit
1037616|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
1037617|NCT02928276|anti-TNF|anti-tnf
1037618|NCT02928237|tDCS|tdcs
1037619|NCT02928237|cancer liver|cancer liver
1037620|NCT02928237|chronic abdominal pain|chronic abdominal pain
1037622|NCT02928237|VDS|vds
1037623|NCT02928237|HAM-D|ham-d
1037624|NCT02928237|BPI|bpi
1037625|NCT02928237|analgesia|analgesia
1037626|NCT02928224|Colorectal cancer|colorectal cancer
1037627|NCT02928224|BRAF|braf
1037628|NCT02928224|BRAFV600E|brafv600e
1037629|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
1037630|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
1037631|NCT02928198|Cardiac Catheterization|cardiac catheterization
1037632|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
1037633|NCT02928185|training manuals|training manuals
1037634|NCT02928185|patients and caregivers|patients and caregivers
1037639|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
1037640|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
1037641|NCT02928172|Sedation|sedation
1037642|NCT02928172|General Anesthesia|general anesthesia
1037643|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
1037644|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
1037645|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
1037646|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
1037647|NCT02928159|LAP|lap
1037648|NCT02928159|LAP-ST|lap-st
1037649|NCT02928159|ECT|ect
1037650|NCT02928159|Mood disorders|mood disorders
1037651|NCT02928159|Psychotic disorders|psychotic disorders
1037652|NCT02928146|TAPP|tapp
1037653|NCT02928146|TEP|tep
1037654|NCT02928146|Lichtenstein|lichtenstein
1037655|NCT02928146|syntethic mesh|syntethic mesh
1037656|NCT02928146|hernioplasty|hernioplasty
1037657|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
1037658|NCT02928133|Congenital heart disease|congenital heart disease
1037659|NCT02928133|Atrial fibrillation|atrial fibrillation
1037660|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
1037661|NCT02928133|Thromboembolism|thromboembolism
1037662|NCT02928094|refractory angina|refractory angina
1037663|NCT02928094|myocardial ischemia|myocardial ischemia
1037664|NCT02928094|angiogenesis|angiogenesis
1037665|NCT02928068|telehealth|telehealth
1037666|NCT02928055|Stroke|stroke
1037667|NCT02928055|Shoulder Pain|shoulder pain
1037668|NCT02928055|Electrical stimulation|electrical stimulation
1037669|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
1037670|NCT02928055|Intramuscular stimulation|intramuscular stimulation
1037671|NCT02928029|Radium-223 dichloride|radium-223 dichloride
1037672|NCT02928029|bortezomib|bortezomib
1037673|NCT02928029|dexamethasone|dexamethasone
1037674|NCT02928029|early relapsed multiple myeloma|early relapsed multiple myeloma
1037675|NCT02928029|combination therapy multiple myeloma|combination therapy multiple myeloma
1037676|NCT02928016|carbohydrate counting method|carbohydrate counting method
1037677|NCT02928016|protein|protein
1037678|NCT02928016|fat|fat
1037679|NCT02928016|glucose|glucose
1037680|NCT02928016|type 1 diabetes|type 1 diabetes
1037681|NCT02928003|Lung surgery|lung surgery
1037682|NCT02927977|dry needling|dry needling
1037683|NCT02927977|exercise|exercise
1037684|NCT02927977|manual therapy|manual therapy
1037685|NCT02927951|Diabetes Mellitus|diabetes mellitus
1037686|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
1037687|NCT02927951|Diabetic Pain|diabetic pain
1037688|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
1037689|NCT02927873|Safety|safety
1037690|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
1037691|NCT02927873|Immunogenicity|immunogenicity
1037692|NCT02927873|Reactogenicity|reactogenicity
1037693|NCT02927873|Infants|infants
1037694|NCT02927873|Vaccine|vaccine
1037695|NCT02927860|sleep|sleep
1037696|NCT02927860|exercise|exercise
1037697|NCT02927860|activity|activity
1037698|NCT02927821|Adult Day Care Centers|adult day care centers
1037699|NCT02927821|Caregivers|caregivers
1037700|NCT02927808|Motivational Interviewing|motivational interviewing
1037701|NCT02927808|LDL-C|ldl-c
1037702|NCT02927808|LDL target|ldl target
1037703|NCT02927808|Medication adherence|medication adherence
1037704|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
1037705|NCT02927782|Lumbar|lumbar
1037706|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
1037707|NCT02927756|Discordant Lymphomas|discordant lymphomas
1037708|NCT02927756|Composite Lymphomas|composite lymphomas
1037709|NCT02927756|Follicular Lymphoma|follicular lymphoma
1037710|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
1037711|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
1674009|NCT00093067|Cubist|cubist
1037712|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
1037713|NCT02927717|2016 WHO Criteria|2016 who criteria
1037714|NCT02927717|Front-line treatment|front-line treatment
1037715|NCT02927717|Rituximab|rituximab
1037716|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
1037717|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
1037718|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
1037719|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
1037720|NCT02927691|Rehabilitation|rehabilitation
1037721|NCT02927691|Parkinson's disease|parkinson's disease
1037722|NCT02927691|Swallowing|swallowing
1037723|NCT02927691|Cough|cough
1037724|NCT02927691|Dysphagia|dysphagia
1037725|NCT02927691|Dystussia|dystussia
1037726|NCT02927678|Diabetic foot|diabetic foot
1037728|NCT02927678|Antibiotic treatment|antibiotic treatment
1037729|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
1037730|NCT02927665|Weight Loss|weight loss
1037731|NCT02927613|Home mechanical ventilation|home mechanical ventilation
1037732|NCT02927613|Mortality|mortality
1037733|NCT02927613|Complications|complications
1037734|NCT02927613|Developing country|developing country
1037735|NCT02927600|Glycemic response|glycemic response
1037736|NCT02927600|Glycemic index|glycemic index
1037737|NCT02927600|Meal intervention|meal intervention
1037738|NCT02927600|Chinese population|chinese population
1037740|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
1037741|NCT02927587|sedation|sedation
1037742|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
1037743|NCT02927574|angioplasty|angioplasty
1037744|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
1037745|NCT02927574|peripheral arterial disease|peripheral arterial disease
1037746|NCT02927574|intermittent claudication|intermittent claudication
1037747|NCT02927574|systematic review|systematic review
1037748|NCT02927574|meta-analysis|meta-analysis
1037749|NCT02927574|Paclitaxel|paclitaxel
1037750|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1037751|NCT02927522|Donepezil|donepezil
1037752|NCT02927522|Hip replacement|hip replacement
1037753|NCT02927522|Knee replacement|knee replacement
1037754|NCT02927496|Lymphedema|lymphedema
1037755|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
1037756|NCT02927496|Filariasis|filariasis
1037757|NCT02927496|Doxycycline|doxycycline
1037758|NCT02927483|Venous Insufficiency|venous insufficiency
1037759|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1037760|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
1037761|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
1037762|NCT02927457|Photoprovocation-PV|photoprovocation-pv
1037763|NCT02927457|GSK2646264|gsk2646264
1037764|NCT02927431|Anti-inflammatory|anti-inflammatory
1037765|NCT02927431|Danirixin|danirixin
1037766|NCT02927431|Influenza|influenza
1037767|NCT02927431|Hospitalized patients|hospitalized patients
1037768|NCT02927405|gabapentin|gabapentin
1037769|NCT02927405|TAP block|tap block
1037770|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
1037771|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
1037772|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
1037773|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
1037774|NCT02927366|Shortness of breath|shortness of breath
1037775|NCT02927366|Dizziness|dizziness
1037776|NCT02927366|Fainting|fainting
1037777|NCT02927366|Leg swelling|leg swelling
1037778|NCT02927366|Cough|cough
1037779|NCT02927366|Angina pector|angina pector
1037780|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
1037781|NCT02927340|Lung Cancer|lung cancer
1037782|NCT02927288|PTSD, mTBI|ptsd, mtbi
1037783|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
1037784|NCT02927262|First Complete Remission|first complete remission
1037785|NCT02927262|gilteritinib|gilteritinib
1037786|NCT02927262|FLT3/ITD|flt3/itd
1037787|NCT02927262|AML|aml
1037788|NCT02927262|ASP2215|asp2215
1037789|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
1037790|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1037791|NCT02927210|Healthy Men|healthy men
1037792|NCT02927210|Male Contraception|male contraception
1037793|NCT02927210|Androgen|androgen
1037794|NCT02927210|Dimethandrolone|dimethandrolone
1037795|NCT02927171|Skilled Nursing Facility|skilled nursing facility
1037796|NCT02927171|Post-Acute Care|post-acute care
1037797|NCT02927171|Older Adults|older adults
1037798|NCT02927171|Physical Function|physical function
1037799|NCT02927171|Rehabilitation|rehabilitation
1037800|NCT02927132|Drinking, Alcohol|drinking, alcohol
1037801|NCT02927119|thyroglobulin|thyroglobulin
1037802|NCT02927119|iodine|iodine
1037803|NCT02927119|pregnancy|pregnancy
1037804|NCT02927106|leukemia|leukemia
1037805|NCT02927106|myeloid|myeloid
1037806|NCT02927106|genomics|genomics
1037807|NCT02927080|FSHD|fshd
1674107|NCT00092222|KSHV-MCD|kshv-mcd
1037808|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
1037809|NCT02927028|energy availability|energy availability
1037810|NCT02927028|walnuts|walnuts
1037811|NCT02926989|Isotonic|isotonic
1037812|NCT02926989|Hypotonic|hypotonic
1037813|NCT02926989|Intravenous fluids|intravenous fluids
1037814|NCT02926976|Schizophrenia|schizophrenia
1037815|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
1037816|NCT02926911|Ductal Carcinoma|ductal carcinoma
1037817|NCT02926898|seizure|seizure
1037818|NCT02926898|tonic clonic|tonic clonic
1037819|NCT02926898|epilepsy|epilepsy
1037820|NCT02926898|myoclonic|myoclonic
1037821|NCT02926898|encephalopathy|encephalopathy
1037822|NCT02926885|liver|liver
1037823|NCT02926885|laparoscopy|laparoscopy
1037824|NCT02926885|Bariatric Surgery|bariatric surgery
1037825|NCT02926885|Esophagogastric Junction|esophagogastric junction
1037826|NCT02926885|obesity|obesity
1037827|NCT02926872|Screening|screening
1037828|NCT02926872|Hepatic Injury|hepatic injury
1037829|NCT02926872|Pediatric Patients|pediatric patients
1037830|NCT02926846|Peritoneal dialysis|peritoneal dialysis
1037831|NCT02926846|Lavage|lavage
1037832|NCT02926820|Huntington disease|huntington disease
1037833|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
1038038|NCT02925611|isoflurane|isoflurane
1037834|NCT02926820|cognitive dysfunction|cognitive dysfunction
1037835|NCT02926807|Atopic Dermatitis|atopic dermatitis
1037836|NCT02926807|Vascular Inflammation|vascular inflammation
1037837|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
1037838|NCT02926807|Ascending aorta|ascending aorta
1037839|NCT02926807|Pet scan|pet scan
1037840|NCT02926768|Cancer|cancer
1037841|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
1037842|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
1037843|NCT02926768|T790M|t790m
1037844|NCT02926768|NSCLC|nsclc
1037845|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
1037846|NCT02926768|EGFR|egfr
1037847|NCT02926768|EGFR inhibitor|egfr inhibitor
1037848|NCT02926768|Solid Tumors|solid tumors
1037849|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
1037850|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1037851|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
1037852|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
1037853|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1037854|NCT02926755|Angiography|angiography
1037855|NCT02926742|Thrombolysis|thrombolysis
1037856|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
1037857|NCT02926742|Pulmonary Embolism|pulmonary embolism
1037858|NCT02926742|Saddle PE|saddle pe
1037859|NCT02926742|Submassive PE|submassive pe
1037860|NCT02926742|Massive PE|massive pe
1037861|NCT02926742|Bilateral PE|bilateral pe
1037862|NCT02926729|Breast Cancer|breast cancer
1037863|NCT02926716|Stomach neoplasm|stomach neoplasm
1037864|NCT02926716|Endoscopy|endoscopy
1037865|NCT02926716|Narrow band imaging|narrow band imaging
1037867|NCT02926703|lactate|lactate
1037868|NCT02926703|creatine kinase|creatine kinase
1037869|NCT02926677|PTSD|ptsd
1037870|NCT02926677|Child Trauma|child trauma
1037871|NCT02926677|Cue-Centered Treatment|cue-centered treatment
1037872|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
1037873|NCT02926677|fNIRs|fnirs
1037874|NCT02926677|CCT|cct
1037875|NCT02926677|TF-CBT|tf-cbt
1037876|NCT02926677|Posttraumatic stress|posttraumatic stress
1037877|NCT02926677|NIRX|nirx
1037878|NCT02926625|Unspecific fever|unspecific fever
1037879|NCT02926625|Ethiopia|ethiopia
1037880|NCT02926625|iCCM|iccm
1037881|NCT02926625|CHW|chw
1037882|NCT02926625|HEW|hew
1037883|NCT02926599|High Fidelity Simulation|high fidelity simulation
1037884|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
1037885|NCT02926586|CBFβ-MYH11|cbfβ-myh11
1037886|NCT02926586|fludarabine|fludarabine
1037887|NCT02926586|cytarabine|cytarabine
1037888|NCT02926573|oral cavity|oral cavity
1037889|NCT02926573|oropharynx|oropharynx
1037890|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
1037891|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
1037892|NCT02926547|proteomics|proteomics
1037893|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1037894|NCT02926534|smoking|smoking
1037895|NCT02926534|prevalence|prevalence
1037896|NCT02926534|cross-sectional study|cross-sectional study
1037897|NCT02926534|Kazakhstan|kazakhstan
1037898|NCT02926521|nerve block catheter|nerve block catheter
1037899|NCT02926521|catheter fixation|catheter fixation
1037900|NCT02926521|catheter dressing|catheter dressing
1037901|NCT02926508|Reading|reading
1037902|NCT02926508|Learning|learning
1037903|NCT02926508|Cognition|cognition
1037904|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
1037905|NCT02926482|Buprenorphine|buprenorphine
1037906|NCT02926482|Addiction treatment|addiction treatment
1037907|NCT02926482|Extended-release naltrexone|extended-release naltrexone
1037908|NCT02926482|Opioid use disorder|opioid use disorder
1037909|NCT02926469|Virtual Reality|virtual reality
1037910|NCT02926469|Analgesia|analgesia
1037911|NCT02926469|Immersive Virtual Reality|immersive virtual reality
1037913|NCT02926469|Labor|labor
1037914|NCT02926469|Pain|pain
1037915|NCT02926443|Shoulder|shoulder
1037916|NCT02926443|Motor control|motor control
1037917|NCT02926443|Proprioception|proprioception
1037918|NCT02926443|Usual physiotherapy care|usual physiotherapy care
1037919|NCT02926443|Supervised exercise program|supervised exercise program
1037920|NCT02926404|Sagittal alignment|sagittal alignment
1037921|NCT02926404|Surgical planning|surgical planning
1037922|NCT02926404|Patient-specific|patient-specific
1037923|NCT02926404|Adult Spinal Deformity|adult spinal deformity
1037924|NCT02926352|LLLT|lllt
1037925|NCT02926352|LLLS|llls
1037926|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
1037927|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
1037928|NCT02926352|Low-Level Light Therapy|low-level light therapy
1037929|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
1037930|NCT02926352|Near-infrared light|near-infrared light
1037931|NCT02926352|Photobiomodulation|photobiomodulation
1037932|NCT02926352|Fear Extinction|fear extinction
1037933|NCT02926352|Exposure Therapy|exposure therapy
1037934|NCT02926352|Claustrophobia|claustrophobia
1037935|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
1038039|NCT02925611|desflurane|desflurane
1037936|NCT02926352|Fear of contamination|fear of contamination
1037937|NCT02926352|Fear of public speaking|fear of public speaking
1037938|NCT02926352|Anxiety sensitivity|anxiety sensitivity
1037939|NCT02926352|Cytochrome oxidase|cytochrome oxidase
1037940|NCT02926352|Memory consolidation|memory consolidation
1037941|NCT02926352|Cognitive enhancer|cognitive enhancer
1037942|NCT02926326|Healthy Male volunteers|healthy male volunteers
1037943|NCT02926313|RCT|rct
1037944|NCT02926313|Specialized seating|specialized seating
1037945|NCT02926313|Pressure ulcers|pressure ulcers
1037946|NCT02926300|crohn's disease|crohn's disease
1037947|NCT02926300|stem cell therapy|stem cell therapy
1037948|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
1037949|NCT02926300|hUCB-MSC|hucb-msc
1037950|NCT02926300|UCB-MSC|ucb-msc
1037951|NCT02926300|Umbilical cord Blood|umbilical cord blood
1037952|NCT02926300|Rheumatoid Arthritis|rheumatoid arthritis
1037953|NCT02926300|RA|ra
1037954|NCT02926300|Stem cell|stem cell
1037955|NCT02926300|Cell therapy|cell therapy
1037956|NCT02926300|Furestem|furestem
1037957|NCT02926300|Mesenchymal stem cell|mesenchymal stem cell
1037958|NCT02926300|MSC|msc
1037959|NCT02926287|prolapse surgery|prolapse surgery
1037960|NCT02926287|ambulatory surgery|ambulatory surgery
1037961|NCT02926274|whole blood|whole blood
1037962|NCT02926274|trauma|trauma
1037963|NCT02926274|transfusion|transfusion
1037964|NCT02926274|coagulopathy|coagulopathy
1037965|NCT02926248|Arthrofibrosis|arthrofibrosis
1037966|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
1037967|NCT02926209|colonoscopy|colonoscopy
1037968|NCT02926209|adenoma|adenoma
1037969|NCT02926209|polyp|polyp
1037970|NCT02926209|crc screening|crc screening
1037971|NCT02926196|ER-Negative|er-negative
1037972|NCT02926196|PR-Negative|pr-negative
1037973|NCT02926196|HER2-Negative|her2-negative
1037974|NCT02926144|Intratracheal intubation|intratracheal intubation
1037975|NCT02926144|videolaryngoscope|videolaryngoscope
1037976|NCT02926144|McGrath MAC|mcgrath mac
1037977|NCT02926131|stick test|stick test
1037978|NCT02926118|Glucose|glucose
1037979|NCT02926118|Continuous glucose monitor|continuous glucose monitor
1037980|NCT02926118|Glycemic load|glycemic load
1037981|NCT02926118|Dietary intervention|dietary intervention
1037982|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
1037983|NCT02926014|Dysphagia|dysphagia
1037984|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
1037985|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
1037986|NCT02926001|Taxes|taxes
1037987|NCT02926001|Beverages/economics|beverages/economics
1037988|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
1037989|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
1037990|NCT02926001|Economics|economics
1037991|NCT02926001|Energy Intake|energy intake
1037992|NCT02926001|Risk Factors|risk factors
1037993|NCT02925988|Critically ill|critically ill
1037994|NCT02925988|High risk neonates|high risk neonates
1037995|NCT02925949|Treatment|treatment
1037996|NCT02925949|Adherence|adherence
1037997|NCT02925949|Intervention|intervention
1037998|NCT02925949|MSM Couples|msm couples
1037999|NCT02925936|Radiography|radiography
1038000|NCT02925936|Radiation|radiation
1038001|NCT02925936|Diagnostic imaging|diagnostic imaging
1038002|NCT02925871|stroke|stroke
1038003|NCT02925871|rehabilitation|rehabilitation
1038004|NCT02925871|interdisciplinary health team|interdisciplinary health team
1038005|NCT02925871|patient-centered care|patient-centered care
1038006|NCT02925871|care transition|care transition
1038007|NCT02925858|Ketamine|ketamine
1038008|NCT02925858|Cardiac surgery|cardiac surgery
1038009|NCT02925858|Pain|pain
1038010|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
1038011|NCT02925832|Ropivacaine|ropivacaine
1038012|NCT02925832|Bupivacaine|bupivacaine
1038013|NCT02925832|Anaesthesia|anaesthesia
1038014|NCT02925832|Eye surgery blocks|eye surgery blocks
1038015|NCT02925832|Phacoemulsification|phacoemulsification
1038016|NCT02925819|Mitral regurgitation|mitral regurgitation
1038017|NCT02925819|Mitral stenosis|mitral stenosis
1038018|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
1038019|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
1038020|NCT02925780|Enamel defects|enamel defects
1038021|NCT02925780|Fluorosis|fluorosis
1038022|NCT02925741|bed linens|bed linens
1038023|NCT02925728|Finger-Food|finger-food
1038024|NCT02925702|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1038025|NCT02925702|Radium-223|radium-223
1038026|NCT02925702|Biomarkers|biomarkers
1038027|NCT02925663|executive functioning|executive functioning
1038028|NCT02925650|Alzheimer's Disease|alzheimer's disease
1038029|NCT02925650|SILK™|silk™
1038030|NCT02925650|Pharmacodynamics|pharmacodynamics
1038031|NCT02925650|Safety|safety
1038032|NCT02925650|Pharmacokinetics|pharmacokinetics
1038033|NCT02925624|ablation index|ablation index
1038034|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
1038035|NCT02925624|implantable loop recorder|implantable loop recorder
1038036|NCT02925611|Postoperative delirium|postoperative delirium
1038037|NCT02925611|spine surgery|spine surgery
1038040|NCT02925598|Laringeal masks|laringeal masks
1038041|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
1038042|NCT02925598|Intubation, intratracheal|intubation, intratracheal
1038043|NCT02925572|pediatric obesity|pediatric obesity
1038044|NCT02925572|eccentric exercise|eccentric exercise
1038045|NCT02925572|body composition|body composition
1038046|NCT02925572|training program|training program
1038047|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1038048|NCT02925559|Glycemic Variability|glycemic variability
1038049|NCT02925559|Dapagliflozin|dapagliflozin
1038050|NCT02925559|Gliclazide MR|gliclazide mr
1038051|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
1038052|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
1038053|NCT02925559|MAGE|mage
1038054|NCT02925546|Healthy|healthy
1038055|NCT02925546|Pharmacokinetics|pharmacokinetics
1038056|NCT02925546|Phase I|phase i
1038057|NCT02925546|GSK2798745|gsk2798745
1038058|NCT02925546|Tablet|tablet
1038059|NCT02925533|Bladder Cancer|bladder cancer
1038060|NCT02925533|Urothelial Cancer|urothelial cancer
1038061|NCT02925520|Cholestasis|cholestasis
1038062|NCT02925494|Uterine Fibroids|uterine fibroids
1038063|NCT02925494|Elagolix|elagolix
1038064|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
1038065|NCT02925494|Elagolix Sodium|elagolix sodium
1038066|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
1038067|NCT02925481|Yoga|yoga
1038068|NCT02925481|PTSD|ptsd
1038069|NCT02925481|mental health|mental health
1038070|NCT02925481|stillbirth|stillbirth
1038071|NCT02925468|orthodontics|orthodontics
1038072|NCT02925455|Hemiplegia|hemiplegia
1038073|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
1038074|NCT02925455|Video Games|video games
1038075|NCT02925455|Occupational Therapy|occupational therapy
1038076|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
1038077|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
1038078|NCT02925442|Genicular|genicular
1038079|NCT02925442|RFA|rfa
1038080|NCT02925442|C-RFA|c-rfa
1038081|NCT02925442|t-RFA|t-rfa
1038082|NCT02925442|total knee replacement|total knee replacement
1038083|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
1038084|NCT02925364|central pain processing|central pain processing
1038085|NCT02925364|anatomical MRI|anatomical mri
1038086|NCT02925364|fMRI|fmri
1038087|NCT02925325|Major depressive disorder|major depressive disorder
1038088|NCT02925325|Music therapy|music therapy
1038089|NCT02925325|Residual symptoms|residual symptoms
1038090|NCT02925286|gambling prevention|gambling prevention
1038091|NCT02925286|workplace policy|workplace policy
1038092|NCT02925273|dementia|dementia
1038093|NCT02925234|Molecular tumor profile|molecular tumor profile
1038094|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
1038095|NCT02925234|Antitumor drugs|antitumor drugs
1038096|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
1038097|NCT02925234|Drug Repositioning|drug repositioning
1038098|NCT02925234|Off-Label Use|off-label use
1038099|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
1038100|NCT02925221|Kidney Disease|kidney disease
1038101|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
1038102|NCT02925221|Quality of Life|quality of life
1038103|NCT02925195|Vitamin D|vitamin d
1038104|NCT02925195|cardiovascular disease|cardiovascular disease
1038105|NCT02925195|MESA|mesa
1038106|NCT02925195|genetics|genetics
1038107|NCT02925195|pharmacogenetics|pharmacogenetics
1070309|NCT02727582|MDR|mdr
1038108|NCT02925195|blood pressure|blood pressure
1038109|NCT02925195|biomarkers|biomarkers
1038110|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
1038111|NCT02925156|Activity Energy Expenditure|activity energy expenditure
1038112|NCT02925156|Doubly Labeled Water|doubly labeled water
1038113|NCT02925156|Physical Activity|physical activity
1038114|NCT02925156|Obesity|obesity
1038115|NCT02925156|Diabetes|diabetes
1038116|NCT02925156|Cardiovascular Disease|cardiovascular disease
1038117|NCT02925156|Adiponectin|adiponectin
1038118|NCT02925156|Leptin|leptin
1038119|NCT02925156|Ghrelin|ghrelin
1038120|NCT02925143|Residual nerve blockade|residual nerve blockade
1038121|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
1038122|NCT02925143|Residual curarization|residual curarization
1038123|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
1038124|NCT02925143|E-learning|e-learning
1038125|NCT02925143|Web based learning|web based learning
1038126|NCT02925117|ABT-494|abt-494
1038127|NCT02925117|Atopic Dermatitis|atopic dermatitis
1038128|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
1038129|NCT02925065|Parkinson's|parkinson's
1038130|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
1038131|NCT02925065|Guitar therapy|guitar therapy
1038132|NCT02925065|Upper extremity motor function|upper extremity motor function
1038133|NCT02925065|Hand dexterity|hand dexterity
1038134|NCT02925039|Rehabilitation|rehabilitation
1038135|NCT02925039|Geriatric|geriatric
1038136|NCT02925013|Omega 3|omega 3
1038137|NCT02925013|Lipids|lipids
1038138|NCT02925013|Pregnancy|pregnancy
1038139|NCT02925000|Advanced Malignancy|advanced malignancy
1038140|NCT02925000|lymphoma|lymphoma
1038141|NCT02925000|TLC178|tlc178
1038142|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
1038143|NCT02924922|renal cell carcinoma|renal cell carcinoma
1038144|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
1038145|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
1038146|NCT02924922|nephron sparing surgery|nephron sparing surgery
1038147|NCT02924922|warm ischemia time|warm ischemia time
1038148|NCT02924922|renal function loss|renal function loss
1038149|NCT02924870|health education|health education
1038150|NCT02924792|Intraosseous access|intraosseous access
1038151|NCT02924740|stress urinary incontinence|stress urinary incontinence
1038152|NCT02924740|quality of life|quality of life
1038153|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
1038154|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
1038155|NCT02924740|vaginal tampon training|vaginal tampon training
1038156|NCT02924727|Spontaneous AMI|spontaneous ami
1038157|NCT02924727|HF hospitalization|hf hospitalization
1038158|NCT02924727|outpatient HF|outpatient hf
1038159|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
1038160|NCT02924727|pulmonary congestion|pulmonary congestion
1038161|NCT02924727|STEMI|stemi
1038162|NCT02924727|NSTEMI|nstemi
1038163|NCT02924727|randomized clinical trial|randomized clinical trial
1038164|NCT02924727|LCZ696|lcz696
1038165|NCT02924727|ramipril|ramipril
1038166|NCT02924714|GIST|gist
1038167|NCT02924701|prognosis|prognosis
1038168|NCT02924688|umeclidinium bromide|umeclidinium bromide
1038169|NCT02924688|fluticasone furoate|fluticasone furoate
1038170|NCT02924688|vilanterol|vilanterol
1038171|NCT02924688|fixed dose combination|fixed dose combination
1038172|NCT02924688|lung function|lung function
1038173|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
1038174|NCT02924688|asthma|asthma
1038175|NCT02924688|closed triple therapy|closed triple therapy
1038176|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
1038177|NCT02924649|Brain injury|brain injury
1038178|NCT02924649|Early mobilisation|early mobilisation
1038179|NCT02924649|Consciousness|consciousness
1038180|NCT02924649|Cerebral blood flow|cerebral blood flow
1038181|NCT02924649|Blood pressure|blood pressure
1038182|NCT02924636|C-section|c-section
1038183|NCT02924636|Instrumental delivery|instrumental delivery
1038184|NCT02924636|Pregnancy complications|pregnancy complications
1038185|NCT02924636|Macrosomia|macrosomia
1038186|NCT02924636|Neonatal complications|neonatal complications
1038187|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
1038188|NCT02924558|Egg|egg
1038189|NCT02924558|Protein|protein
1038190|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
1038191|NCT02924558|Triglycerides|triglycerides
1038192|NCT02924558|Insulin sensitivity|insulin sensitivity
1038193|NCT02924558|Lipid triad|lipid triad
1038194|NCT02924506|cervical arthroplasty|cervical arthroplasty
1038195|NCT02924493|Endometriosis|endometriosis
1038196|NCT02924493|IBS|ibs
1038197|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
1038198|NCT02924493|low FODMAP diet|low fodmap diet
1038199|NCT02924493|FODMAPs|fodmaps
1038200|NCT02924493|visceral syndrome|visceral syndrome
1038201|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
1038202|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
1038203|NCT02924493|cross organ effect|cross organ effect
1038204|NCT02924480|invasive bladder cancer|invasive bladder cancer
1038205|NCT02924480|cystectomy|cystectomy
1038206|NCT02924480|high grade bladder cancer|high grade bladder cancer
1038207|NCT02924467|reminder systems|reminder systems
1038208|NCT02924467|Influenza vaccines|influenza vaccines
1038209|NCT02924454|metoprolol|metoprolol
1038210|NCT02924454|lipid emulsion|lipid emulsion
1038211|NCT02924454|pharmacodynamics|pharmacodynamics
1038212|NCT02924454|pharmacokinetics|pharmacokinetics
1038213|NCT02924441|Mammogram|mammogram
1038214|NCT02924441|Pain Management|pain management
1038215|NCT02924441|Lidocaine|lidocaine
1038216|NCT02924428|Acne|acne
1038217|NCT02924402|NHL|nhl
1038218|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
1038219|NCT02924402|Transformed Lymphoma|transformed lymphoma
1038220|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
1038221|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
1038222|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
1038223|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
1038224|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1038225|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
1038226|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
1038227|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1038228|NCT02924402|Extranodal Marginal Zone Lymphoma (MALT)|extranodal marginal zone lymphoma (malt)
1038229|NCT02924402|MALT Lymphoma|malt lymphoma
1038230|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
1038231|NCT02924402|Follicular Lymphoma|follicular lymphoma
1038327|NCT02923999|HIV|hiv
1038238|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
1038239|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
1038240|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
1038241|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
1038242|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
1038243|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
1038244|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
1038245|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
1038246|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
1038247|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
1038248|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
1038249|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
1038250|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
1038251|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
1038252|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
1038253|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
1038254|NCT02924402|PTLD|ptld
1038257|NCT02924402|High-grade Lymphoma|high-grade lymphoma
1038258|NCT02924402|Richter's Transformation|richter's transformation
1038259|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
1038260|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
1038261|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
1038262|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
1038263|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
1038264|NCT02924363|Mitra Clip|mitra clip
1038265|NCT02924363|Mitral Valve|mitral valve
1038266|NCT02924337|QT/QTC interval|qt/qtc interval
1038267|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
1038268|NCT02924337|Imeglimin|imeglimin
1038269|NCT02924337|Healthy Volunteers|healthy volunteers
1038270|NCT02924324|local Injection|local injection
1038271|NCT02924324|pain Medication|pain medication
1038272|NCT02924324|propofol|propofol
1038273|NCT02924324|ropivacaine|ropivacaine
1038274|NCT02924324|16-1417|16-1417
1038275|NCT02924311|Diabetic Macular Edema|diabetic macular edema
1038276|NCT02924272|Drug Therapy|drug therapy
1038277|NCT02924259|muscle soreness|muscle soreness
1038278|NCT02924259|pain|pain
1038279|NCT02924259|myofascial release|myofascial release
1038280|NCT02924246|immunity|immunity
1038281|NCT02924246|vaccination|vaccination
1038282|NCT02924246|milk|milk
1038283|NCT02924233|Squamous|squamous
1038284|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
1038285|NCT02924233|NSCLC|nsclc
1038286|NCT02924207|diabetes mellitus|diabetes mellitus
1038287|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
1038288|NCT02924181|contact force sensing catheter|contact force sensing catheter
1038289|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
1038299|NCT02924116|insomnia|insomnia
1038300|NCT02924116|sleep|sleep
1038301|NCT02924116|Bioboosti|bioboosti
1038302|NCT02924116|Biomobie|biomobie
1038303|NCT02924116|device|device
1038304|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
1038305|NCT02924103|staphylococcus aureus|staphylococcus aureus
1038306|NCT02924103|nasal vestibule|nasal vestibule
1038307|NCT02924103|contamination|contamination
1038308|NCT02924090|Major depressive disorder|major depressive disorder
1038309|NCT02924090|Etomidate|etomidate
1038310|NCT02924090|Ketamine|ketamine
1038311|NCT02924090|Hyperventilation|hyperventilation
1038312|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
1038313|NCT02924090|Depression|depression
1038314|NCT02924090|Anesthesia|anesthesia
1038315|NCT02924090|Nervous System Diseases|nervous system diseases
1038316|NCT02924090|Mental Disorders|mental disorders
1038317|NCT02924090|Electroencephalography|electroencephalography
1038318|NCT02924090|Cerebral Metabolism|cerebral metabolism
1038319|NCT02924038|low-grade glioma|low-grade glioma
1038320|NCT02924038|glioma|glioma
1038321|NCT02924038|immunotherapy|immunotherapy
1038322|NCT02924038|vaccine|vaccine
1038323|NCT02924038|WHO grade II|who grade ii
1038324|NCT02924012|post exercise hypotension|post exercise hypotension
1038325|NCT02924012|exercise|exercise
1038326|NCT02924012|video games|video games
1038328|NCT02923999|MAB|mab
1038329|NCT02923999|PLANT|plant
1038330|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
1038331|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
1038332|NCT02923947|Pharmacokinetics,|pharmacokinetics,
1038333|NCT02923947|Renal impairment,|renal impairment,
1038334|NCT02923947|Safety assessments,|safety assessments,
1038335|NCT02923947|Solid tumours,|solid tumours,
1038336|NCT02923947|EGFRm+|egfrm+
1038337|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
1038338|NCT02923908|Palatability|palatability
1038339|NCT02923908|Pediatrics|pediatrics
1038340|NCT02923908|Facial Recognition|facial recognition
1038341|NCT02923908|Taste|taste
1038342|NCT02923908|Facial Expressions|facial expressions
1038343|NCT02923882|Low-birth-weight|low-birth-weight
1038344|NCT02923882|Model kitchen|model kitchen
1038345|NCT02923882|Improved cookstove|improved cookstove
1038346|NCT02923869|Levobupivacaine|levobupivacaine
1038347|NCT02923869|Bupivacaine|bupivacaine
1038348|NCT02923869|Nerve Block|nerve block
1038349|NCT02923869|Cleft Palate|cleft palate
1038350|NCT02923856|Helicobacter pylori|helicobacter pylori
1038351|NCT02923856|Antibiotic resistance|antibiotic resistance
1038352|NCT02923856|Sequencing|sequencing
1038353|NCT02923843|frailty|frailty
1038354|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
1038355|NCT02923817|spinal cord injury|spinal cord injury
1038356|NCT02923817|autologous transplants|autologous transplants
1038357|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
1038358|NCT02923804|steatosis|steatosis
1038359|NCT02923804|NAFL|nafl
1038360|NCT02923804|NAFLD|nafld
1038361|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
1038362|NCT02923804|omega-3|omega-3
1038363|NCT02923804|EPA|epa
1038364|NCT02923804|DHA|dha
1038365|NCT02923804|fish oil|fish oil
1038366|NCT02923739|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1038367|NCT02923739|Ovarian Cancer|ovarian cancer
1038368|NCT02923739|Fallopian Tube Cancer|fallopian tube cancer
1038369|NCT02923739|Primary Peritoneal Cancer|primary peritoneal cancer
1038370|NCT02923739|relapsed/refractory|relapsed/refractory
1038371|NCT02923739|Platinum-resistant disease|platinum-resistant disease
1038372|NCT02923739|Paclitaxel|paclitaxel
1038373|NCT02923739|Taxol|taxol
1038374|NCT02923739|Bevacizumab|bevacizumab
1038375|NCT02923739|Avastin|avastin
1038376|NCT02923739|rhuMAb-VEGF|rhumab-vegf
1038377|NCT02923739|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1038378|NCT02923739|Emactuzumab|emactuzumab
1038379|NCT02923739|RO5509554|ro5509554
1038380|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
1038381|NCT02923726|Shock Therapy|shock therapy
1038382|NCT02923726|Primary Prevention|primary prevention
1038383|NCT02923700|platelet rich plasma|platelet rich plasma
1038384|NCT02923700|intra-articular injection|intra-articular injection
1038385|NCT02923700|leukocytes|leukocytes
1038386|NCT02923687|Ketorolac|ketorolac
1038387|NCT02923687|Root canal treatment|root canal treatment
1038388|NCT02923687|Pain|pain
1038389|NCT02923687|Premedication|premedication
1038390|NCT02923661|single implant|single implant
1038391|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
1038392|NCT02923635|Standard Wide Local Excision|standard wide local excision
1038393|NCT02923596|Keloid|keloid
1038394|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
1038395|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
1038396|NCT02923570|16-1416|16-1416
1038397|NCT02923544|Uterine Manipulator|uterine manipulator
1038398|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
1038399|NCT02923544|16-1397|16-1397
1038400|NCT02923518|Heart Screening|heart screening
1038401|NCT02923518|Master Athletes|master athletes
1038402|NCT02923518|Cardiovascular Disease|cardiovascular disease
1038403|NCT02923479|Rehabilitation|rehabilitation
1038404|NCT02923479|Robotics|robotics
1038405|NCT02923466|refractory solid tumor|refractory solid tumor
1721826|NCT00004580|Nevirapine|nevirapine
1038406|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
1038407|NCT02923427|i-gel|i-gel
1038408|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
1038409|NCT02923414|Cardioversion|cardioversion
1038410|NCT02923401|Exercise|exercise
1038411|NCT02923401|Biomarkers|biomarkers
1038412|NCT02923401|Breast cancer high risk|breast cancer high risk
1038413|NCT02923401|Treadmill|treadmill
1038414|NCT02923401|Stationary bicycle|stationary bicycle
1038415|NCT02923401|Questionnaires|questionnaires
1038416|NCT02923401|Surveys|surveys
1038417|NCT02923401|Motivational sessions|motivational sessions
1038418|NCT02923401|Phone calls|phone calls
1038419|NCT02923401|Printed materials|printed materials
1038420|NCT02923362|GERD|gerd
1038421|NCT02923362|Reflux|reflux
1038422|NCT02923362|Acid Reflux|acid reflux
1038423|NCT02923362|Heartburn|heartburn
1038424|NCT02923362|Regurgitation|regurgitation
1038425|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
1038426|NCT02923362|Hiatal Hernia|hiatal hernia
1038427|NCT02923362|LPR|lpr
1038428|NCT02923362|LINX|linx
1038429|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
1038430|NCT02923362|Antireflux Surgery|antireflux surgery
1038431|NCT02923362|Nissen|nissen
1038432|NCT02923349|Solid tumor|solid tumor
1038433|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
1038434|NCT02923349|ovarian cancer|ovarian cancer
1038435|NCT02923349|renal cell carcinoma|renal cell carcinoma
1038436|NCT02923349|melanoma|melanoma
1038437|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
1038438|NCT02923349|OX40|ox40
1038439|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
1038440|NCT02923336|liver cirrhosis|liver cirrhosis
1038441|NCT02923336|variceal bleeding|variceal bleeding
1038442|NCT02923336|non selective beta blockers|non selective beta blockers
1038443|NCT02923323|Neurocognitive Function|neurocognitive function
1038445|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
1038446|NCT02923323|Sleep|sleep
1038447|NCT02923297|parkinson|parkinson
1038448|NCT02923297|alpha-synuclein|alpha-synuclein
1038449|NCT02923297|GALIG|galig
1038450|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
1038451|NCT02923271|Driving|driving
1038452|NCT02923271|Teens|teens
1038453|NCT02923271|Texting|texting
1038454|NCT02923271|Cellphone|cellphone
1038455|NCT02923271|DriveID|driveid
1038456|NCT02923271|Motor vehicle accident|motor vehicle accident
1038457|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1038458|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
1038459|NCT02923258|High-Risk|high-risk
1038460|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
1038461|NCT02923219|Facial Rejuvenation|facial rejuvenation
1038462|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
1038463|NCT02923206|apheresis|apheresis
1038464|NCT02923206|pregnancy|pregnancy
1038465|NCT02923206|pre-eclampsia|pre-eclampsia
1038466|NCT02923206|PE|pe
1038467|NCT02923206|sFlt-1|sflt-1
1038468|NCT02923206|Pre-term|pre-term
1038469|NCT02923167|CP|cp
1038470|NCT02923167|Cerebral Palsy|cerebral palsy
1038471|NCT02923167|Robotic|robotic
1038472|NCT02923167|Hand|hand
1038473|NCT02923167|Rehabilitation|rehabilitation
1038474|NCT02923154|NASH|nash
1038475|NCT02923141|substance use|substance use
1038476|NCT02923141|trauma|trauma
1038478|NCT02923141|viral load|viral load
1038479|NCT02923141|women|women
1038480|NCT02923115|Venous thromboembolism|venous thromboembolism
1038481|NCT02923115|VTE|vte
1038482|NCT02923115|Pulmonary embolism|pulmonary embolism
1038483|NCT02923115|PE|pe
1038484|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
1038485|NCT02923102|Recovery|recovery
1038486|NCT02923102|Muscle soreness|muscle soreness
1038487|NCT02923102|Lemon Verbena|lemon verbena
1038488|NCT02923089|Diabetes|diabetes
1038489|NCT02923089|Lentils|lentils
1038490|NCT02923089|Pulses|pulses
1038491|NCT02923089|Postprandial glycemia|postprandial glycemia
1038492|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1038493|NCT02923063|Chronic Kidney Disease|chronic kidney disease
1038494|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
1038495|NCT02923063|Physical Performance|physical performance
1038496|NCT02923063|Exercise Intolerance|exercise intolerance
1038497|NCT02923063|Muscle Fatigue|muscle fatigue
1038498|NCT02922998|CD64 antigens|cd64 antigens
1038499|NCT02922998|Biomarkers|biomarkers
1038500|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1038501|NCT02922998|Interleukin-4|interleukin-4
1038502|NCT02922998|Interferon-gamma|interferon-gamma
1038503|NCT02922998|C-reactive protein|c-reactive protein
1038504|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
1038505|NCT02922998|procalcitonin|procalcitonin
1038506|NCT02922998|Cytokines|cytokines
1038507|NCT02922998|Patients|patients
1038508|NCT02922998|Human|human
1070780|NCT02724943|BMI|bmi
1038509|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1038510|NCT02922998|Sepsis|sepsis
1038511|NCT02922998|Infection|infection
1038512|NCT02922998|Antibiotics|antibiotics
1038513|NCT02922998|Intensive Care Units|intensive care units
1038514|NCT02922998|Point-of-Care Systems|point-of-care systems
1038515|NCT02922998|Bedside Testing|bedside testing
1038516|NCT02922985|Cesarean delivery|cesarean delivery
1038517|NCT02922985|Multimodal pain management|multimodal pain management
1038518|NCT02922972|Keloid scar|keloid scar
1038519|NCT02922972|Wound healing|wound healing
1038520|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
1038521|NCT02922972|RegenLab|regenlab
1038522|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
1038523|NCT02922959|Telephone intervention|telephone intervention
1038524|NCT02922959|secondary prevention|secondary prevention
1038525|NCT02922959|naloxone|naloxone
1038526|NCT02922946|entinostat|entinostat
1038527|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1038528|NCT02922946|HDAC|hdac
1038529|NCT02922933|entinostat|entinostat
1038530|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1038531|NCT02922933|HDAC|hdac
1038532|NCT02922868|Cystoscopy|cystoscopy
1038533|NCT02922868|EndoSheath|endosheath
1038534|NCT02922868|Infection Control|infection control
1038535|NCT02922868|Bacteriuria|bacteriuria
1038536|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1038537|NCT02922829|Food Insecurity|food insecurity
1038538|NCT02922829|Nutrition|nutrition
1038539|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
1038540|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
1038541|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
1038542|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
1038543|NCT02922816|Renal Transplant|renal transplant
1038544|NCT02922816|Colonization|colonization
1038546|NCT02922816|Antibiotic Resistance|antibiotic resistance
1038547|NCT02922816|Resistome|resistome
1038548|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
1038549|NCT02922790|smoker|smoker
1038550|NCT02922790|smoking|smoking
1038551|NCT02922790|cigarette|cigarette
1038552|NCT02922790|cessation|cessation
1038553|NCT02922790|DNA|dna
1038554|NCT02922790|DNA damage|dna damage
1038555|NCT02922790|blood draw|blood draw
1038556|NCT02922790|feedback|feedback
1038557|NCT02922790|cellular|cellular
1038558|NCT02922790|tobacco|tobacco
1038559|NCT02922790|tobacco smoke|tobacco smoke
1038560|NCT02922764|Solid malignancy|solid malignancy
1038561|NCT02922764|Lymphoma|lymphoma
1038562|NCT02922764|Solid tumor|solid tumor
1038563|NCT02922764|Melanoma|melanoma
1038564|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
1038565|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
1038566|NCT02922764|Triple Breast cancer|triple breast cancer
1038567|NCT02922764|NSCLC|nsclc
1038568|NCT02922764|EOC|eoc
1038569|NCT02922764|TNBC|tnbc
1038570|NCT02922764|LXR|lxr
1038571|NCT02922764|ApoE|apoe
1038572|NCT02922764|mBC|mbc
1038573|NCT02922764|Small cell lung cancer|small cell lung cancer
1038574|NCT02922764|Renal cell cancer|renal cell cancer
1038575|NCT02922764|Bladder cancer|bladder cancer
1038576|NCT02922764|SCLC|sclc
1038577|NCT02922764|RCC|rcc
1038578|NCT02922764|BLC|blc
1038579|NCT02922751|transient elastography|transient elastography
1038580|NCT02922751|pediatric liver disease|pediatric liver disease
1038581|NCT02922751|biliary atresia|biliary atresia
1038582|NCT02922751|Alagille Syndrome|alagille syndrome
1038583|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
1038584|NCT02922751|liver fibrosis|liver fibrosis
1038585|NCT02922751|cholestasis|cholestasis
1038586|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
1038587|NCT02922738|Technology Assessment|technology assessment
1038588|NCT02922673|human endotoxemia|human endotoxemia
1038589|NCT02922673|LPS|lps
1038590|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
1038591|NCT02922673|placebo|placebo
1038592|NCT02922673|endotoxin tolerance|endotoxin tolerance
1038593|NCT02922660|Ambulatory surgery|ambulatory surgery
1038594|NCT02922660|Ophthalmic|ophthalmic
1038595|NCT02922660|Inhalation anesthesia|inhalation anesthesia
1038596|NCT02922660|Desflurane|desflurane
1038597|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
1038598|NCT02922634|postoperative health outcomes|postoperative health outcomes
1038599|NCT02922634|older surgical patients|older surgical patients
1038600|NCT02922608|Education, Medical|education, medical
1038601|NCT02922543|Multiple Myeloma|multiple myeloma
1038602|NCT02922543|Teratogenicity|teratogenicity
1038603|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
1038604|NCT02922543|Neutropenia and infection|neutropenia and infection
1038605|NCT02922543|Venous thromboembolism|venous thromboembolism
1038606|NCT02922543|Allergic reactions|allergic reactions
1038607|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
1038608|NCT02922543|Peripheral neuropathy|peripheral neuropathy
1038609|NCT02922543|Cardiac failure|cardiac failure
1038610|NCT02922543|Arrhythmia|arrhythmia
1038611|NCT02922543|Renal failure|renal failure
1038612|NCT02922543|Myocardial infarction|myocardial infarction
1038613|NCT02922543|Interstitial lung disease|interstitial lung disease
1038614|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
1038615|NCT02922517|biomarkers|biomarkers
1038616|NCT02922517|echocardiography|echocardiography
1038617|NCT02922517|MRI imaging|mri imaging
1038618|NCT02922517|nuclear medicine|nuclear medicine
1038619|NCT02922504|First trimester abortion|first trimester abortion
1038620|NCT02922504|Surgical abortion|surgical abortion
1038621|NCT02922504|Music intervention|music intervention
1038622|NCT02922504|Local anesthesia|local anesthesia
1038623|NCT02922504|Pain|pain
1038624|NCT02922439|chronic disease|chronic disease
1038625|NCT02922439|multimorbidity|multimorbidity
1038626|NCT02922439|chronic disease self-management|chronic disease self-management
1038627|NCT02922439|tailored information|tailored information
1038628|NCT02922439|mobile applications|mobile applications
1038629|NCT02922426|ALKS 3831|alks 3831
1038630|NCT02922426|Samidorphan|samidorphan
1038631|NCT02922426|Olanzapine|olanzapine
1038632|NCT02922413|Porphyria|porphyria
1038633|NCT02922413|Heme|heme
1038634|NCT02922400|Autism|autism
1038635|NCT02922400|Traumatic Brain Injury|traumatic brain injury
1038636|NCT02922400|Schizophrenia|schizophrenia
1038637|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
1038638|NCT02922387|varenicline|varenicline
1038639|NCT02922387|COPD|copd
1038640|NCT02922387|asthma|asthma
1038641|NCT02922387|pneumonia|pneumonia
1038642|NCT02922387|smoking cessation|smoking cessation
1038643|NCT02922374|acute severe colitis|acute severe colitis
1038644|NCT02922374|corticosteroids|corticosteroids
1038645|NCT02922374|UCEIS|uceis
1038646|NCT02922374|fecal calprotectin|fecal calprotectin
1038647|NCT02922348|premature ovarian failure|premature ovarian failure
1038648|NCT02922348|hormone replacement|hormone replacement
1038649|NCT02922335|Antisocial Behavior|antisocial behavior
1038650|NCT02922335|Mental Illness|mental illness
1038651|NCT02922335|Emerging Adulthood|emerging adulthood
1038652|NCT02922335|Criminal Behavior|criminal behavior
1038653|NCT02922335|Serious Mental Illness|serious mental illness
1038654|NCT02922322|Mat Pilates|mat pilates
1038655|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
1038656|NCT02922322|Quality of life|quality of life
1038657|NCT02922322|Disability|disability
1038658|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
1038659|NCT02922283|T cell response|t cell response
1038660|NCT02922283|Interleukin 2|interleukin 2
1038661|NCT02922283|PET scan|pet scan
1038662|NCT02922283|Ipilimumab|ipilimumab
1038663|NCT02922283|Pembrolizumab|pembrolizumab
1038664|NCT02922283|Nivolumab|nivolumab
1038665|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
1038666|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
1038667|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
1038668|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
1038669|NCT02922244|herbal products|herbal products
1038670|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
1038671|NCT02922244|breast cancer|breast cancer
1038672|NCT02922244|radiotherapy|radiotherapy
1038673|NCT02922218|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1038674|NCT02922218|Enzalutamide|enzalutamide
1038675|NCT02922218|Biomarkers|biomarkers
1038676|NCT02922192|Anti-inflammatory|anti-inflammatory
1038677|NCT02922192|Biologics|biologics
1038678|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
1038679|NCT02922192|BBCIC|bbcic
1038680|NCT02922179|Insulin|insulin
1038681|NCT02922179|Diabetes|diabetes
1038682|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
1038683|NCT02922179|BBCIC|bbcic
1038684|NCT02922179|Descriptive analysis|descriptive analysis
1038685|NCT02922153|CryoAnalgesia|cryoanalgesia
1038686|NCT02922153|Thoracotomy|thoracotomy
1038687|NCT02922153|FEV1|fev1
1038689|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
1038690|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
1038691|NCT02922140|Acute coronary syndrome|acute coronary syndrome
1038692|NCT02922140|patient education and counselling|patient education and counselling
1038693|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
1038694|NCT02922127|Breast Cancer|breast cancer
1038695|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
1038696|NCT02922114|Ultrasonography|ultrasonography
1038697|NCT02922114|Clinical assesment|clinical assesment
1038698|NCT02922114|joint abnormalities|joint abnormalities
1038699|NCT02922088|Vein Graft Failure|vein graft failure
1038700|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1038701|NCT02922088|Vascular Grafts|vascular grafts
1038702|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
1038703|NCT02922088|Vein Graft Disease|vein graft disease
1038704|NCT02922088|Vein Graft Treatment|vein graft treatment
1038705|NCT02922088|Vein Graft Handling|vein graft handling
1038706|NCT02922075|gingival recession|gingival recession
1038707|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
1038708|NCT02922075|bone graft|bone graft
1038709|NCT02922075|connective tissue graft|connective tissue graft
1038710|NCT02922075|collagen matrix|collagen matrix
1038711|NCT02922062|lipids|lipids
1038712|NCT02922062|saturated fat|saturated fat
1038713|NCT02922062|palm oil|palm oil
1038714|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
1038715|NCT02922049|Barrett's esophagus|barrett's esophagus
1038716|NCT02922049|BORN|born
1038717|NCT02922049|Intestinal metaplasia|intestinal metaplasia
1038718|NCT02921997|A/H5N1|a/h5n1
1038719|NCT02921997|A/H7N9|a/h7n9
1038720|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
1038721|NCT02921997|influenza|influenza
1038722|NCT02921997|monovalent|monovalent
1038723|NCT02921997|pH1N1|ph1n1
1038724|NCT02921997|vaccines|vaccines
1038725|NCT02921984|Salivary Gland Tumors|salivary gland tumors
1038726|NCT02921984|Head and Neck Cancer|head and neck cancer
1039212|NCT02919046|CAR-T|car-t
1038729|NCT02921958|Parents of children with disabilities|parents of children with disabilities
1038730|NCT02921932|Physiotherapy|physiotherapy
1038731|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
1038732|NCT02921932|Perioperative Medicine|perioperative medicine
1038733|NCT02921932|Postoperative outcomes|postoperative outcomes
1038734|NCT02921932|Preoperative nutrition|preoperative nutrition
1038735|NCT02921932|Elderly, frail|elderly, frail
1038737|NCT02921906|Glucose|glucose
1038738|NCT02921906|Incretin|incretin
1038739|NCT02921906|GLP-1|glp-1
1038740|NCT02921906|Food|food
1038741|NCT02921867|ultrasound|ultrasound
1038742|NCT02921867|radiology|radiology
1038743|NCT02921867|simulation|simulation
1038744|NCT02921867|abdominal ultrasound|abdominal ultrasound
1038745|NCT02921867|medical education|medical education
1038747|NCT02921841|HIV prevention|hiv prevention
1038748|NCT02921841|computerized intervention|computerized intervention
1038749|NCT02921841|mental health treatment|mental health treatment
1038750|NCT02921828|Pomalyst|pomalyst
1038751|NCT02921828|Teratogenicity|teratogenicity
1038752|NCT02921828|bone marrow suppression|bone marrow suppression
1038753|NCT02921828|thromboembolism|thromboembolism
1038754|NCT02921828|peripheral neuropathy|peripheral neuropathy
1038755|NCT02921828|infection|infection
1038756|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
1038757|NCT02921828|somnolence|somnolence
1038758|NCT02921828|depressed level of consciousness|depressed level of consciousness
1038759|NCT02921828|confusion|confusion
1038760|NCT02921828|fatigue|fatigue
1038761|NCT02921828|dizziness|dizziness
1038762|NCT02921828|acute renal failure|acute renal failure
1038763|NCT02921828|heart failure|heart failure
1038764|NCT02921828|arrhythmia|arrhythmia
1038765|NCT02921828|interstitial pneumonia|interstitial pneumonia
1038766|NCT02921828|hypersensitivity|hypersensitivity
1038767|NCT02921828|hepatic function disorder|hepatic function disorder
1038768|NCT02921828|jaundice|jaundice
1038769|NCT02921815|Leukemia|leukemia
1038770|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
1038771|NCT02921815|Revlimid|revlimid
1038772|NCT02921802|Teratogenicity|teratogenicity
1038773|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
1038774|NCT02921802|Neutropenia and infection|neutropenia and infection
1038775|NCT02921802|Venous thromboembolism|venous thromboembolism
1038776|NCT02921802|Allergic reactions|allergic reactions
1038777|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
1038778|NCT02921802|Peripheral neuropathy|peripheral neuropathy
1038779|NCT02921802|Cardiac failure|cardiac failure
1038780|NCT02921802|Arrhythmia|arrhythmia
1038781|NCT02921802|Renal failure|renal failure
1038782|NCT02921802|Myocardial infarction|myocardial infarction
1038783|NCT02921802|Interstitial lung disease|interstitial lung disease
1038784|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
1038785|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
1038786|NCT02921789|Bleselumab|bleselumab
1038787|NCT02921789|ASKP1240|askp1240
1038788|NCT02921789|Efficacy and Safety|efficacy and safety
1038789|NCT02921776|Vidatalk|vidatalk
1038790|NCT02921776|App|app
1038791|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
1038792|NCT02921776|iPad|ipad
1038793|NCT02921776|Android|android
1038794|NCT02921776|Mechanical ventilation|mechanical ventilation
1038795|NCT02921776|Patient Communication|patient communication
1038796|NCT02921776|Critical Illness|critical illness
1038797|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
1071216|NCT02722668|AML|aml
1038801|NCT02921724|cancer|cancer
1038802|NCT02921724|oral drug|oral drug
1038803|NCT02921724|sunitinib|sunitinib
1038804|NCT02921724|capecitabine|capecitabine
1038805|NCT02921724|mobile app|mobile app
1038806|NCT02921659|nicotinamide riboside|nicotinamide riboside
1038807|NCT02921659|aging|aging
1038808|NCT02921659|arterial stiffness|arterial stiffness
1038809|NCT02921659|endothelial dysfunction|endothelial dysfunction
1038810|NCT02921646|energetic expenditure|energetic expenditure
1038811|NCT02921633|Immunization|immunization
1038812|NCT02921633|Behavioural insights|behavioural insights
1038813|NCT02921633|Children|children
1038814|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
1038815|NCT02921620|Diarrhea|diarrhea
1038816|NCT02921620|Abdominal pain|abdominal pain
1038817|NCT02921581|Dose painting|dose painting
1038818|NCT02921581|18F-FDG|18f-fdg
1038819|NCT02921581|Positron emission tomography|positron emission tomography
1038820|NCT02921581|Radiotherapy|radiotherapy
1038821|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
1038822|NCT02921529|Postoperative recovery|postoperative recovery
1038823|NCT02921529|colon surgery|colon surgery
1038824|NCT02921516|Adolescence|adolescence
1038825|NCT02921516|Adherence|adherence
1038826|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
1038827|NCT02921438|Heart Diseases|heart diseases
1038828|NCT02921438|Myocardial Ischemia|myocardial ischemia
1038829|NCT02921438|NSTE ACS|nste acs
1038830|NCT02921438|NSTEMI|nstemi
1038831|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
1038832|NCT02921438|Coronary Artery Disease|coronary artery disease
1038833|NCT02921425|lifestyle|lifestyle
1038834|NCT02921425|patient health record|patient health record
1038835|NCT02921425|Veterans|veterans
1038836|NCT02921425|prediabetes|prediabetes
1038837|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
1038838|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
1038839|NCT02921373|cancer immunotherapy|cancer immunotherapy
1038840|NCT02921373|prostate cancer|prostate cancer
1038841|NCT02921373|MRI|mri
1038842|NCT02921360|thrombolytic therapy|thrombolytic therapy
1038843|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
1038844|NCT02921360|aspirin|aspirin
1038845|NCT02921321|MRI|mri
1038846|NCT02921321|Muscular Dystrophy|muscular dystrophy
1038847|NCT02921321|Cardiac|cardiac
1038848|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
1038849|NCT02921308|Prematurity|prematurity
1038850|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1038851|NCT02921308|MRI|mri
1038852|NCT02921308|PFT|pft
1038853|NCT02921308|Emphysema|emphysema
1038854|NCT02921282|genes|genes
1038855|NCT02921282|cues|cues
1038856|NCT02921282|reward|reward
1038857|NCT02921282|smoking|smoking
1038858|NCT02921230|atherosclerosis|atherosclerosis
1038859|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
1038860|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
1038861|NCT02921230|stenting|stenting
1038862|NCT02921230|paclitaxel|paclitaxel
1038863|NCT02921217|Cardiovascular diseases|cardiovascular diseases
1038864|NCT02921217|abdominal visceral fat|abdominal visceral fat
1038865|NCT02921217|subcutaneous body fat|subcutaneous body fat
1038866|NCT02921217|body weight|body weight
1038867|NCT02921217|waist circumference|waist circumference
1038868|NCT02921217|lipid profile|lipid profile
1038869|NCT02921217|insulin resistance|insulin resistance
1038870|NCT02921217|glucose metabolism|glucose metabolism
1038871|NCT02921217|blood pressure|blood pressure
1038872|NCT02921217|inflammation|inflammation
1038873|NCT02921217|adiponectin|adiponectin
1038874|NCT02921217|leptin|leptin
1038875|NCT02921217|metabolomics|metabolomics
1038876|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
1038877|NCT02921204|Vitamin D|vitamin d
1038878|NCT02921204|Calcium|calcium
1038879|NCT02921204|Phytic Acid|phytic acid
1038880|NCT02921204|body weight|body weight
1038881|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
1038882|NCT02921191|G-CSFs|g-csfs
1038883|NCT02921191|biosimilar|biosimilar
1038884|NCT02921191|biologics|biologics
1038885|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
1038886|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
1038887|NCT02921191|bbcic|bbcic
1038888|NCT02921165|tooth extraction|tooth extraction
1038889|NCT02921165|tooth socket healing|tooth socket healing
1038890|NCT02921165|hypertension|hypertension
1038891|NCT02921165|rinses|rinses
1038892|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
1038893|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
1038894|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
1038895|NCT02921113|suPAR|supar
1038896|NCT02921113|Acute Kidney Injury|acute kidney injury
1038897|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
1038898|NCT02921113|Biomarker|biomarker
1071282|NCT02722122|CF|cf
1038899|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
1038900|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
1038901|NCT02921048|Ambient Air Pollution|ambient air pollution
1038902|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1038903|NCT02921035|Interferon beta-1a|interferon beta-1a
1038904|NCT02921035|Rebif®|rebif®
1038905|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
1038906|NCT02921022|Gemcitabine|gemcitabine
1038907|NCT02921022|Nab-paclitaxel|nab-paclitaxel
1038908|NCT02921022|PEGPH20|pegph20
1038909|NCT02921022|Rivaroxaban|rivaroxaban
1038910|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
1038911|NCT02921022|16-1066|16-1066
1038912|NCT02920996|NSCLC|nsclc
1038913|NCT02920996|MET|met
1038914|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
1038915|NCT02920996|MET mutation|met mutation
1038916|NCT02920996|NTRK rearrangement|ntrk rearrangement
1038917|NCT02920996|NTRK|ntrk
1038918|NCT02920996|targeted therapy|targeted therapy
1038919|NCT02920996|MET exon 14|met exon 14
1038920|NCT02920996|NTRK1|ntrk1
1038921|NCT02920996|NTRK2|ntrk2
1038922|NCT02920996|NTRK3|ntrk3
1038923|NCT02920996|merestinib|merestinib
1038924|NCT02920996|LY2801653|ly2801653
1038925|NCT02920918|Systolic Heart Failure|systolic heart failure
1038926|NCT02920918|Canagliflozin|canagliflozin
1039409|NCT02918045|Chitosan|chitosan
1038927|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
1038928|NCT02920918|Type 2 Diabetes|type 2 diabetes
1038929|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
1038930|NCT02920918|DPPIV inhibitor|dppiv inhibitor
1038931|NCT02920866|Functional strength integration|functional strength integration
1038932|NCT02920866|Rehabilitation|rehabilitation
1038933|NCT02920866|Hip arthroplasty|hip arthroplasty
1038934|NCT02920866|Physical function|physical function
1038935|NCT02920866|Muscle performance|muscle performance
1038936|NCT02920866|Movement compensations|movement compensations
1038937|NCT02920853|chronic pain|chronic pain
1038938|NCT02920827|HIV Infections|hiv infections
1038939|NCT02920827|HIV seronegativity|hiv seronegativity
1038940|NCT02920801|saxagliptin|saxagliptin
1038941|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
1038942|NCT02920801|flow-mediated dilation|flow-mediated dilation
1038943|NCT02920788|Rehabilitation|rehabilitation
1038944|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1038945|NCT02920749|anaesthesia|anaesthesia
1038946|NCT02920749|costs|costs
1038947|NCT02920749|recovery profiles|recovery profiles
1038948|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
1038949|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
1038950|NCT02920723|Training|training
1038951|NCT02920684|Early rehabilitation|early rehabilitation
1038952|NCT02920684|Mechanical ventilation|mechanical ventilation
1038953|NCT02920684|Physiotherapy|physiotherapy
1038954|NCT02920658|NAVS Naphthalan|navs naphthalan
1038955|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
1038956|NCT02920658|Topical treatment|topical treatment
1038957|NCT02920645|ICH|ich
1038958|NCT02920645|AVM|avm
1038959|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
1038960|NCT02920645|arterio-venous malformation|arterio-venous malformation
1038961|NCT02920645|AVICH|avich
1038962|NCT02920632|Parkinson|parkinson
1038963|NCT02920632|Cognitive training|cognitive training
1038964|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
1038965|NCT02920632|Brain networks|brain networks
1038966|NCT02920619|ultrasound|ultrasound
1038967|NCT02920619|muscle|muscle
1038968|NCT02920606|pulpotomy|pulpotomy
1038969|NCT02920606|pulpitis|pulpitis
1038970|NCT02920606|mature tooth|mature tooth
1038971|NCT02920606|tricalcium silicate|tricalcium silicate
1038972|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
1038973|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
1038974|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
1038975|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
1038976|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
1038977|NCT02920580|Seizure|seizure
1038978|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
1038979|NCT02920580|Ischemic Stroke|ischemic stroke
1038980|NCT02920580|Brain tumor|brain tumor
1038981|NCT02920554|gallbladder cancer|gallbladder cancer
1038982|NCT02920554|bisegmentectomy|bisegmentectomy
1038983|NCT02920515|epidemiology|epidemiology
1038984|NCT02920515|treatment|treatment
1038985|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
1038986|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
1038987|NCT02920489|severity of labor pain|severity of labor pain
1038988|NCT02920489|individualized administration|individualized administration
1038989|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
1038990|NCT02920476|lung|lung
1038991|NCT02920476|metastatic|metastatic
1038992|NCT02920476|carcinoma|carcinoma
1038993|NCT02920463|Anti-Infective agents|anti-infective agents
1038994|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
1038995|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
1038996|NCT02920463|De-escalation|de-escalation
1038997|NCT02920463|Critical care|critical care
1038998|NCT02920450|lung|lung
1038999|NCT02920450|carcinoma|carcinoma
1039000|NCT02920437|dietary salt|dietary salt
1039001|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
1039002|NCT02920437|blood pressure|blood pressure
1039003|NCT02920437|hypertension|hypertension
1039004|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
1039005|NCT02920346|Sjogren's syndrome|sjogren's syndrome
1039006|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
1039007|NCT02920346|Fetal Heart Block|fetal heart block
1039008|NCT02920333|stroke|stroke
1039009|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
1039010|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
1039011|NCT02920333|rehabilitation|rehabilitation
1039012|NCT02920333|lower extremities|lower extremities
1039013|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
1039014|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
1039015|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
1039016|NCT02920307|inguinal hernia|inguinal hernia
1039017|NCT02920307|laparoscopy|laparoscopy
1039018|NCT02920307|hernia repair|hernia repair
1039019|NCT02920307|herniorraphy|herniorraphy
1039804|NCT02915523|Entinostat|entinostat
1039020|NCT02920307|laparoscopic surgery|laparoscopic surgery
1039021|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
1039022|NCT02920268|dance-intervention|dance-intervention
1039023|NCT02920268|yoga|yoga
1039024|NCT02920268|adolescents|adolescents
1039025|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
1039026|NCT02920242|Travelers|travelers
1039027|NCT02920242|diarrhea|diarrhea
1039028|NCT02920242|rifaximin|rifaximin
1039029|NCT02920242|equivalence|equivalence
1039030|NCT02920229|68Ga-PSMA|68ga-psma
1039031|NCT02920229|HBED-PET/CT|hbed-pet/ct
1039032|NCT02920229|biochemical relapse|biochemical relapse
1039033|NCT02920229|prostate cancer|prostate cancer
1039034|NCT02920229|radically treated|radically treated
1039035|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
1039036|NCT02920216|Recurrence|recurrence
1039037|NCT02920216|Indocyanine Green|indocyanine green
1039038|NCT02920216|Salvage surgery|salvage surgery
1039039|NCT02920203|Sudden unexpected death|sudden unexpected death
1039040|NCT02920203|young subjects|young subjects
1039041|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
1039042|NCT02920203|sequencing|sequencing
1039043|NCT02920138|Obesity|obesity
1039044|NCT02920138|intraabdominal pressure|intraabdominal pressure
1039045|NCT02920138|cerebral oxymeter|cerebral oxymeter
1039046|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
1039047|NCT02920138|laparoscopy|laparoscopy
1039048|NCT02920125|Vascular disease|vascular disease
1039049|NCT02920112|Obesity|obesity
1039050|NCT02920112|Bariatric Surgery|bariatric surgery
1039051|NCT02920112|Bariatrics|bariatrics
1039052|NCT02920112|Cognitive Therapy|cognitive therapy
1039053|NCT02920112|Binge eating|binge eating
1039054|NCT02920099|Nutrition literacy|nutrition literacy
1039055|NCT02920073|Microbiota|microbiota
1039056|NCT02920073|anorexia nervosa|anorexia nervosa
1039057|NCT02920073|under nutrition|under nutrition
1039058|NCT02920073|inpatients|inpatients
1039059|NCT02920073|enteral nutrition|enteral nutrition
1039060|NCT02920060|RSE|rse
1039061|NCT02920047|Fimasartan|fimasartan
1039062|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
1039063|NCT02919982|Anticoagulant|anticoagulant
1039064|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
1039065|NCT02919982|Registries|registries
1039066|NCT02919969|Anal Cancer|anal cancer
1039067|NCT02919956|Single Ventricle|single ventricle
1039068|NCT02919956|Fontan|fontan
1039069|NCT02919904|prostate cancer|prostate cancer
1039070|NCT02919904|sleep|sleep
1039071|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
1039072|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
1039073|NCT02919891|IENFD|ienfd
1039074|NCT02919891|Chronic Pain|chronic pain
1039075|NCT02919891|Post-mastectomy|post-mastectomy
1039076|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
1039077|NCT02919891|PMPS|pmps
1039078|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
1039079|NCT02919891|CPSP|cpsp
1039080|NCT02919891|Mastectomy|mastectomy
1039081|NCT02919813|mindfulness group therapy|mindfulness group therapy
1039082|NCT02919813|vulvodynia|vulvodynia
1039083|NCT02919813|vulvar pain|vulvar pain
1039084|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
1039085|NCT02919761|persistant disease activity|persistant disease activity
1039086|NCT02919748|dementia|dementia
1039087|NCT02919748|cognitive decline|cognitive decline
1039088|NCT02919748|choral singing|choral singing
1722116|NCT00002406|RNA, Viral|rna, viral
1071567|NCT02720237|HIV|hiv
1039089|NCT02919748|health education program|health education program
1039090|NCT02919748|randomized controlled trial|randomized controlled trial
1039091|NCT02919735|Alopecia|alopecia
1039092|NCT02919735|Hair|hair
1039093|NCT02919735|Chemotherapy|chemotherapy
1039094|NCT02919735|Cancer|cancer
1039095|NCT02919722|Music therapy|music therapy
1039096|NCT02919722|sensorimotor cortex|sensorimotor cortex
1039097|NCT02919722|brain injury|brain injury
1039098|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
1039099|NCT02919683|Head and Neck Cancer|head and neck cancer
1039100|NCT02919670|Stem Cell Transplant|stem cell transplant
1039101|NCT02919644|vaccination|vaccination
1039102|NCT02919644|autologous dendritic cells|autologous dendritic cells
1039103|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
1039104|NCT02919644|curative resection|curative resection
1039105|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
1039106|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
1039107|NCT02919618|Ablation|ablation
1039108|NCT02919618|Noninvasive|noninvasive
1039109|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1039110|NCT02919605|pentamidine isothionate|pentamidine isothionate
1039111|NCT02919605|treatment|treatment
1039112|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
1039113|NCT02919553|wet-suction technique|wet-suction technique
1039114|NCT02919553|capillary technique|capillary technique
1039115|NCT02919553|fine needle aspiration|fine needle aspiration
1039116|NCT02919553|fine needle biopsy|fine needle biopsy
1039117|NCT02919514|fall prevention|fall prevention
1039118|NCT02919514|Aging|aging
1039119|NCT02919514|surfaces|surfaces
1039120|NCT02919475|JTE-051|jte-051
1039121|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
1039122|NCT02919475|Efficacy|efficacy
1039123|NCT02919475|Safety|safety
1039124|NCT02919475|Tolerability|tolerability
1039125|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
1039126|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1039127|NCT02919462|advanced stage IIIB|advanced stage iiib
1039128|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
1039129|NCT02919462|Treatment|treatment
1039130|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
1039131|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
1039132|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
1039133|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
1039134|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
1039135|NCT02919384|Embryonic development|embryonic development
1039136|NCT02919384|blastocyst stage|blastocyst stage
1039137|NCT02919345|Dapagliflozin|dapagliflozin
1039138|NCT02919345|Glibenclamide|glibenclamide
1039139|NCT02919345|Endothelial Function|endothelial function
1039140|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
1039141|NCT02919345|Flow Mediated Dilation|flow mediated dilation
1039142|NCT02919267|One lung ventilation|one lung ventilation
1039143|NCT02919267|Lung collapse|lung collapse
1039144|NCT02919267|Bronchial blocker|bronchial blocker
1039145|NCT02919267|Double lumen tube|double lumen tube
1039146|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
1039147|NCT02919267|VATS|vats
1039148|NCT02919267|DLT|dlt
1039149|NCT02919267|Thoracic surgery|thoracic surgery
1039150|NCT02919267|Video-assisted|video-assisted
1039151|NCT02919241|dental anxiety|dental anxiety
1039152|NCT02919241|cognitive therapy|cognitive therapy
1039153|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
1039154|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1039155|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1039156|NCT02919228|heart rate variability|heart rate variability
1039157|NCT02919228|blood pressure|blood pressure
1039158|NCT02919228|affect|affect
1039159|NCT02919228|mood|mood
1039160|NCT02919228|respiration|respiration
1039161|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
1039162|NCT02919228|systemic physiology|systemic physiology
1039163|NCT02919228|electro-dermal activity|electro-dermal activity
1039164|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
1039165|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
1039166|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1039167|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1039168|NCT02919189|heart rate variability|heart rate variability
1039169|NCT02919189|blood pressure|blood pressure
1039170|NCT02919189|affect|affect
1039171|NCT02919189|mood|mood
1039172|NCT02919189|respiration|respiration
1039173|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
1039174|NCT02919189|systemic physiology|systemic physiology
1039175|NCT02919189|electro-dermal activity|electro-dermal activity
1039176|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
1039177|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
1039178|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1039179|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1039180|NCT02919163|heart rate variability|heart rate variability
1039181|NCT02919163|blood pressure|blood pressure
1039182|NCT02919163|affect|affect
1039183|NCT02919163|mood|mood
1039184|NCT02919163|respiration|respiration
1039185|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
1039186|NCT02919163|systemic physiology|systemic physiology
1039187|NCT02919163|electro-dermal activity|electro-dermal activity
1039188|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
1039189|NCT02919150|Myofascial Trigger Points|myofascial trigger points
1039190|NCT02919150|Myotonometry|myotonometry
1039191|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
1039192|NCT02919150|Assessment|assessment
1039193|NCT02919150|Reliability|reliability
1039194|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
1039195|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1039196|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1039197|NCT02919137|heart rate variability|heart rate variability
1039198|NCT02919137|blood pressure|blood pressure
1039199|NCT02919137|affect|affect
1039200|NCT02919137|mood|mood
1039201|NCT02919137|respiration|respiration
1039202|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
1039203|NCT02919137|systemic physiology|systemic physiology
1039204|NCT02919137|electro-dermal activity|electro-dermal activity
1039205|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
1039206|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
1039207|NCT02919124|Anastomosis|anastomosis
1039208|NCT02919124|Ultrasonography|ultrasonography
1039209|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1039210|NCT02919059|DM|dm
1039211|NCT02919046|neuroblastoma|neuroblastoma
1039213|NCT02919033|randomized controlled trial|randomized controlled trial
1039214|NCT02919033|telemedicine|telemedicine
1039215|NCT02919033|hypertension|hypertension
1039216|NCT02919033|primary care|primary care
1039217|NCT02919033|medication adherence|medication adherence
1039218|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
1039219|NCT02919020|resistance exercise|resistance exercise
1039220|NCT02918968|enzalutamide|enzalutamide
1039221|NCT02918968|Xtandi|xtandi
1039222|NCT02918968|Prostate Cancer|prostate cancer
1039223|NCT02918955|head and neck cancer|head and neck cancer
1039224|NCT02918955|radiotherapy|radiotherapy
1039225|NCT02918955|chemotherapy|chemotherapy
1039226|NCT02918955|neck dissection|neck dissection
1039227|NCT02918955|surgery|surgery
1039228|NCT02918955|quality of life|quality of life
1039229|NCT02918955|toxicity|toxicity
1039230|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
1039231|NCT02918955|laryngeal cancer|laryngeal cancer
1039232|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
1039233|NCT02918929|First-in-human|first-in-human
1039234|NCT02918929|Single Ascending Dose|single ascending dose
1039235|NCT02918929|Multiple Ascending Dose|multiple ascending dose
1039236|NCT02918890|Pediatric|pediatric
1039237|NCT02918890|HABIT|habit
1039238|NCT02918890|CIMT|cimt
1039239|NCT02918890|Cerebral Palsy|cerebral palsy
1039240|NCT02918890|Hemiplegia|hemiplegia
1039241|NCT02918890|Children|children
1039242|NCT02918890|Therapy|therapy
1039243|NCT02918877|Volatile Anesthetics|volatile anesthetics
1039244|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
1039245|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
1039246|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
1039247|NCT02918877|Cardiac Surgery|cardiac surgery
1039248|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
1039249|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
1039250|NCT02918864|Oxytocin|oxytocin
1039251|NCT02918864|Social Skills|social skills
1039252|NCT02918864|Social cognitive skills|social cognitive skills
1039253|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
1039254|NCT02918864|Combination treatment|combination treatment
1039255|NCT02918864|Syntocinon|syntocinon
1039256|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
1039257|NCT02918864|emotion recognition|emotion recognition
1039258|NCT02918864|theory of mind|theory of mind
1039259|NCT02918838|HIV|hiv
1039260|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
1039261|NCT02918838|co-trimoxazole|co-trimoxazole
1039262|NCT02918838|SMS|sms
1039263|NCT02918838|Lottery incentive|lottery incentive
1039264|NCT02918838|mobile health|mobile health
1039265|NCT02918838|Uganda|uganda
1039266|NCT02918838|Youth|youth
1039267|NCT02918825|schizophrenia|schizophrenia
1039268|NCT02918825|clinical trial|clinical trial
1039269|NCT02918825|olanzapine|olanzapine
1039270|NCT02918825|paliperidone|paliperidone
1039271|NCT02918812|Hysterosalpingography|hysterosalpingography
1039272|NCT02918812|Pain relief|pain relief
1039273|NCT02918812|Infertility|infertility
1039274|NCT02918812|Intracervical block|intracervical block
1039275|NCT02918812|Diclofenac|diclofenac
1039276|NCT02918786|oxygen therapy|oxygen therapy
1039277|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
1039278|NCT02918786|extubation|extubation
1039279|NCT02918773|Pediatrics|pediatrics
1039280|NCT02918773|Emergency Medicine|emergency medicine
1039281|NCT02918773|Ear infection|ear infection
1039282|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
1039283|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
1039284|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
1039285|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
1039286|NCT02918708|vaccination|vaccination
1039287|NCT02918708|immunisation|immunisation
1039288|NCT02918708|pneumococcal|pneumococcal
1039289|NCT02918708|conjugate|conjugate
1039290|NCT02918695|Geriatric assessment|geriatric assessment
1039291|NCT02918695|Fit and frail elderly|fit and frail elderly
1039292|NCT02918695|Geriatric oncology|geriatric oncology
1039293|NCT02918656|Cochrane|cochrane
1039294|NCT02918656|Abstract|abstract
1039295|NCT02918656|Infographics|infographics
1039296|NCT02918656|Understanding|understanding
1039297|NCT02918643|Elderly|elderly
1039298|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
1039299|NCT02918630|E-cigarettes|e-cigarettes
1039300|NCT02918630|Schizophrenia|schizophrenia
1039301|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
1039302|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
1039303|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
1039304|NCT02918617|toothpaste|toothpaste
1039305|NCT02918617|tooth cream|tooth cream
1039306|NCT02918604|peripheral vein access|peripheral vein access
1039307|NCT02918604|infrared|infrared
1039308|NCT02918604|pediatric|pediatric
1039309|NCT02918578|Physical Inactivity|physical inactivity
1039310|NCT02918578|Behavior Change|behavior change
1039805|NCT02915523|Solid tumor|solid tumor
1039311|NCT02918526|Laryngeal masks|laryngeal masks
1039312|NCT02918513|Wellness|wellness
1039313|NCT02918513|Mental Wellness|mental wellness
1039314|NCT02918513|Well-Being|well-being
1039315|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
1039316|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
1039317|NCT02918474|Contralateral prophylactic breast cancer|contralateral prophylactic breast cancer
1039318|NCT02918474|CPM|cpm
1039319|NCT02918474|Breast cancer surgery|breast cancer surgery
1039320|NCT02918474|Breast Cancer|breast cancer
1039321|NCT02918474|Questionnaire|questionnaire
1039322|NCT02918474|Survey|survey
1039323|NCT02918474|Decision tool|decision tool
1039324|NCT02918474|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
1039325|NCT02918435|WE CARE|we care
1039326|NCT02918435|Pediatric practices|pediatric practices
1039327|NCT02918422|Diet Intervention|diet intervention
1039328|NCT02918422|Metabolic Syndrome|metabolic syndrome
1039329|NCT02918422|Feeding Study|feeding study
1039330|NCT02918422|Prediabetes|prediabetes
1039331|NCT02918396|Atrial Fibrillation|atrial fibrillation
1039332|NCT02918396|Atrial Fibrosis|atrial fibrosis
1039333|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
1039334|NCT02918396|Computational Modeling|computational modeling
1039335|NCT02918396|Rotor Anchor Sites|rotor anchor sites
1039336|NCT02918370|Alcohol Use Disorder|alcohol use disorder
1039337|NCT02918370|Bipolar Disorder|bipolar disorder
1039338|NCT02918370|Mood|mood
1039339|NCT02918370|Alcohol Craving|alcohol craving
1039340|NCT02918370|Aripiprazole|aripiprazole
1039341|NCT02918344|calcium phosphate paste|calcium phosphate paste
1039342|NCT02918305|denervation|denervation
1039343|NCT02918305|resistant hypertension|resistant hypertension
1039344|NCT02918292|Unrelated Cord Blood (UCB)|unrelated cord blood (ucb)
1039345|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
1039346|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1039347|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
1039348|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
1039349|NCT02918266|Drug Therapy|drug therapy
1039350|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
1039351|NCT02918227|Ejaculation|ejaculation
1039352|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1039353|NCT02918227|Prostate|prostate
1039354|NCT02918214|Septic Shock|septic shock
1039355|NCT02918214|echocardiography|echocardiography
1039356|NCT02918214|diastolic dysfunction|diastolic dysfunction
1039357|NCT02918214|Transthoracic|transthoracic
1039358|NCT02918214|Transesophageal|transesophageal
1039359|NCT02918214|hyperkinesia|hyperkinesia
1039360|NCT02918214|prognosis|prognosis
1039361|NCT02918201|Administration, topical|administration, topical
1039362|NCT02918201|Tranexamic Acid|tranexamic acid
1039363|NCT02918201|Postoperative Care|postoperative care
1039364|NCT02918201|Bandages|bandages
1039365|NCT02918201|Occlusive Dressings|occlusive dressings
1039366|NCT02918175|mHealth|mhealth
1039367|NCT02918162|pembrolizumab|pembrolizumab
1039368|NCT02918162|adenocarcinoma|adenocarcinoma
1039369|NCT02918162|gastric cancer|gastric cancer
1071901|NCT02718274|HIV|hiv
1039370|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
1039371|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
1039372|NCT02918149|Ultrasonography|ultrasonography
1039373|NCT02918149|Infant|infant
1039374|NCT02918149|Newborn|newborn
1039375|NCT02918149|Lumbar puncture|lumbar puncture
1039376|NCT02918149|Spinal puncture|spinal puncture
1039377|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
1039378|NCT02918123|Psoriasis|psoriasis
1039379|NCT02918123|Plaque psoriasis|plaque psoriasis
1039380|NCT02918123|Stem cell|stem cell
1039381|NCT02918123|Cell therapy|cell therapy
1039382|NCT02918123|Furestem|furestem
1039383|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
1039384|NCT02918123|MSC|msc
1039385|NCT02918123|Umbilical cord blood|umbilical cord blood
1039386|NCT02918123|hUCB-MSC|hucb-msc
1039387|NCT02918123|UCB-MSC|ucb-msc
1039388|NCT02918097|Cost effectiveness|cost effectiveness
1039389|NCT02918097|Bipolar disorder|bipolar disorder
1039390|NCT02918097|Depressive episodes|depressive episodes
1039391|NCT02918097|Quality of Life|quality of life
1039392|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
1039393|NCT02918084|early breast cancer|early breast cancer
1039394|NCT02918084|breast cancer|breast cancer
1039395|NCT02918084|aromatase inhibitor|aromatase inhibitor
1039396|NCT02918084|adjuvant|adjuvant
1039397|NCT02918084|post menopausal|post menopausal
1039398|NCT02918071|Asthma,|asthma,
1039399|NCT02918071|Bronchial Diseases,|bronchial diseases,
1039400|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
1039401|NCT02918071|Lung Diseases,|lung diseases,
1039402|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
1039403|NCT02918071|Benralizumab|benralizumab
1039404|NCT02918058|Frailty|frailty
1039405|NCT02918058|Deprescription|deprescription
1039406|NCT02918045|Tooth Extraction|tooth extraction
1039407|NCT02918045|Surgical Hemostasis|surgical hemostasis
1039408|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1039410|NCT02918032|Jordans anomaly|jordans anomaly
1039411|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
1039412|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
1039413|NCT02918032|ATGL gene|atgl gene
1039414|NCT02918032|CGI-58 gene|cgi-58 gene
1039415|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
1039416|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
1039417|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
1039418|NCT02917993|locally advanced|locally advanced
1039419|NCT02917993|metastatic|metastatic
1039420|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
1039421|NCT02917993|Janus kinase inhibition|janus kinase inhibition
1039422|NCT02917980|structural Heart Diseases|structural heart diseases
1039423|NCT02917980|surgical treatment|surgical treatment
1039424|NCT02917980|interventional treatment|interventional treatment
1039425|NCT02917980|hybrid treatment|hybrid treatment
1039426|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
1039427|NCT02917954|complex care needs|complex care needs
1039428|NCT02917954|seniors|seniors
1039429|NCT02917954|patient-centred care|patient-centred care
1039430|NCT02917954|goal-oriented care|goal-oriented care
1039431|NCT02917954|primary health care|primary health care
1039432|NCT02917954|implementation|implementation
1039433|NCT02917954|pragmatic trial|pragmatic trial
1039434|NCT02917954|health outcomes|health outcomes
1039435|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
1039436|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
1039437|NCT02917915|COPD|copd
1039438|NCT02917915|Emphysema|emphysema
1039439|NCT02917915|Chronic Bronchitis|chronic bronchitis
1039440|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
1039441|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
1039442|NCT02917902|student-run free clinic|student-run free clinic
1039443|NCT02917902|food supply|food supply
1039444|NCT02917902|food insecure|food insecure
1039445|NCT02917902|medically uninsured|medically uninsured
1039446|NCT02917902|medically underserved|medically underserved
1039447|NCT02917889|Caffeine|caffeine
1039448|NCT02917889|Autonomic Nervous System|autonomic nervous system
1039449|NCT02917889|Recovery|recovery
1039450|NCT02917889|Aerobic exercise|aerobic exercise
1039451|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
1039452|NCT02917876|Pregnancy|pregnancy
1039453|NCT02917876|Obesity|obesity
1039454|NCT02917876|Fluid shifts|fluid shifts
1039455|NCT02917876|Body composition|body composition
1039456|NCT02917876|Sleep|sleep
1039457|NCT02917863|Hypothyroidism|hypothyroidism
1039458|NCT02917863|Microbiota|microbiota
1039459|NCT02917863|Thyroid hormone|thyroid hormone
1039460|NCT02917863|L-Thyroxine|l-thyroxine
1039461|NCT02917863|Celiac disease|celiac disease
1039462|NCT02917850|stroke|stroke
1039463|NCT02917850|gait|gait
1039464|NCT02917850|hip flexors|hip flexors
1039465|NCT02917850|paresis|paresis
1039466|NCT02917850|hemiplegia|hemiplegia
1039467|NCT02917798|Genetic Testing|genetic testing
1039468|NCT02917798|16-919|16-919
1039469|NCT02917772|tailored immuno therapy|tailored immuno therapy
1039470|NCT02917772|Nivolumab|nivolumab
1039471|NCT02917772|Ipilimumab|ipilimumab
1039472|NCT02917772|boost|boost
1039473|NCT02917759|liver cancer|liver cancer
1039474|NCT02917759|biliary tract cancer|biliary tract cancer
1039475|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
1039476|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
1039477|NCT02917759|liver tumor|liver tumor
1039478|NCT02917759|biliary tumor|biliary tumor
1039479|NCT02917759|hepatoma|hepatoma
1039480|NCT02917759|liver mass|liver mass
1039481|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1039482|NCT02917746|Imiquimod|imiquimod
1039483|NCT02917746|Treatment|treatment
1039484|NCT02917746|Predictive biomarkers|predictive biomarkers
1039485|NCT02917720|TKI discontinuation|tki discontinuation
1039486|NCT02917707|CRC|crc
1039487|NCT02917707|liver metastasis|liver metastasis
1039488|NCT02917681|ALS|als
1039489|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
1039490|NCT02917681|intrathecal|intrathecal
1039491|NCT02917668|Obesity|obesity
1039492|NCT02917668|Hyperoxia|hyperoxia
1039493|NCT02917668|Hypercapnia|hypercapnia
1039494|NCT02917668|Postoperative complications|postoperative complications
1039495|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
1039496|NCT02917655|Education|education
1039497|NCT02917655|Quality of Life|quality of life
1039498|NCT02917655|Osteoarthritis|osteoarthritis
1039499|NCT02917655|Metabolic Syndrome|metabolic syndrome
1039500|NCT02917642|bacterial infection|bacterial infection
1039501|NCT02917642|endotoxin|endotoxin
1039502|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
1039503|NCT02917642|root canal treatment|root canal treatment
1039504|NCT02917590|Spinal cord injury|spinal cord injury
1039505|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
1039506|NCT02917564|Choroidal effusions|choroidal effusions
1039507|NCT02917564|Trabeculectomy|trabeculectomy
1039806|NCT02915523|Avelumab|avelumab
1039508|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
1039509|NCT02917525|Calcium metabolism|calcium metabolism
1039510|NCT02917525|Matrix Gla Protein|matrix gla protein
1039511|NCT02917525|Vitamin K2|vitamin k2
1039512|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1039513|NCT02917486|patient in intensive care|patient in intensive care
1039514|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
1039515|NCT02917473|Medical skin examination|medical skin examination
1039516|NCT02917473|Skin Self Examination|skin self examination
1039517|NCT02917473|Sun protection|sun protection
1039519|NCT02917460|Pediatric|pediatric
1039520|NCT02917460|Genomic|genomic
1039521|NCT02917460|Precision medicine|precision medicine
1039522|NCT02917460|Biorepository|biorepository
1039523|NCT02917447|PTSD|ptsd
1039524|NCT02917447|Women Veterans|women veterans
1039525|NCT02917447|Online intervention|online intervention
1039526|NCT02917434|Obesity|obesity
1039527|NCT02917434|Psoriatic arthritis|psoriatic arthritis
1039528|NCT02917434|Psoriasis|psoriasis
1039529|NCT02917434|Metabolic syndrome|metabolic syndrome
1039530|NCT02917434|Cardiovascular disease|cardiovascular disease
1039531|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
1039532|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
1039533|NCT02917356|Healing touch|healing touch
1039534|NCT02917356|Faith Healing|faith healing
1039535|NCT02917356|Pain|pain
1039536|NCT02917356|Joint stiffness|joint stiffness
1039537|NCT02917356|Functional status|functional status
1039538|NCT02917356|Mental health|mental health
1039539|NCT02917356|Osteoarthritis|osteoarthritis
1039540|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
1039541|NCT02917291|Trauma Spinal Cord|trauma spinal cord
1039542|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
1039543|NCT02917291|Neurosurgery|neurosurgery
1039544|NCT02917291|Cell Therapy|cell therapy
1039545|NCT02917291|ATMP|atmp
1039546|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
1039547|NCT02917291|SPINE|spine
1039548|NCT02917213|acute myocardial infarction|acute myocardial infarction
1039549|NCT02917213|cardiac embolism|cardiac embolism
1039550|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
1039551|NCT02917213|silent brain infarct|silent brain infarct
1039552|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
1039553|NCT02917174|asthma|asthma
1039554|NCT02917174|m-health|m-health
1039555|NCT02917174|asthma control|asthma control
1039556|NCT02917174|self-management|self-management
1039557|NCT02917161|Prostate|prostate
1039558|NCT02917161|Prostatic Neoplams|prostatic neoplams
1039559|NCT02917161|Therapeutic Embolization|therapeutic embolization
1039560|NCT02917161|Prostatectomy|prostatectomy
1039561|NCT02917122|Parkinson disease|parkinson disease
1333222|NCT01443936|Influenza Vaccine|influenza vaccine
1039562|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
1039563|NCT02917122|depression|depression
1039564|NCT02917122|dopamine transporter|dopamine transporter
1039565|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
1039566|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
1039567|NCT02917083|immunotherapy|immunotherapy
1039568|NCT02917083|CAR T-cells|car t-cells
1039569|NCT02917083|lymphoma|lymphoma
1039570|NCT02917083|Cyclophosphamide|cyclophosphamide
1039571|NCT02917083|fludarabine|fludarabine
1039572|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
1039573|NCT02917070|Turkey population|turkey population
1039574|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1039575|NCT02917031|Heart Failure|heart failure
1039576|NCT02917031|Saxagliptin|saxagliptin
1039577|NCT02917031|Sitagliptin|sitagliptin
1039578|NCT02917018|Dexmedetomidine|dexmedetomidine
1039579|NCT02917018|Stress response|stress response
1039580|NCT02917018|Emergence agitation|emergence agitation
1039581|NCT02917005|breast cancer|breast cancer
1039582|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
1039583|NCT02917005|palbociclib|palbociclib
1039584|NCT02917005|premenopausal|premenopausal
1039585|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
1039586|NCT02916992|familial pneumothorax|familial pneumothorax
1039587|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
1039588|NCT02916992|prevalence|prevalence
1039589|NCT02916992|FLCN mutation|flcn mutation
1039590|NCT02916992|Lung cysts|lung cysts
1039591|NCT02916992|BHD|bhd
1039592|NCT02916992|inherited disease|inherited disease
1039593|NCT02916992|genetic disease|genetic disease
1039594|NCT02916992|primary pneumothorax|primary pneumothorax
1039595|NCT02916992|CAT scan|cat scan
1039596|NCT02916992|CT scan|ct scan
1039597|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
1039598|NCT02916940|Diprophos|diprophos
1039599|NCT02916927|ketamine|ketamine
1039600|NCT02916927|emergency department|emergency department
1039601|NCT02916914|preterm|preterm
1039602|NCT02916914|feeding|feeding
1039603|NCT02916914|oral transition|oral transition
1039604|NCT02916901|Dyslipidemia|dyslipidemia
1039605|NCT02916901|CKD-519|ckd-519
1039606|NCT02916901|CETP inhibitor|cetp inhibitor
1039607|NCT02916901|ABPM|abpm
1039608|NCT02916888|Atopic dermatitis|atopic dermatitis
1039609|NCT02916888|Topical corticosteroid|topical corticosteroid
1039610|NCT02916888|Pediatric|pediatric
1039611|NCT02916888|Eczema|eczema
1039612|NCT02916888|Quality of life|quality of life
1039613|NCT02916875|Shared decision Making|shared decision making
1039614|NCT02916875|Follow-up|follow-up
1039615|NCT02916862|fiber|fiber
1039616|NCT02916862|calcium absorption|calcium absorption
1039617|NCT02916862|bone mass|bone mass
1039618|NCT02916862|adolescents|adolescents
1039619|NCT02916849|Accidental Falls|accidental falls
1039620|NCT02916849|Prevention & Control|prevention & control
1039621|NCT02916849|Exercise|exercise
1039822|NCT02915484|Cognition|cognition
1039622|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
1039623|NCT02916849|Aged|aged
1039624|NCT02916849|Aged 80 and over|aged 80 and over
1039625|NCT02916849|Smartphone|smartphone
1039626|NCT02916849|Computers|computers
1039627|NCT02916849|Computers handheld|computers handheld
1039628|NCT02916849|Motivation|motivation
1039629|NCT02916849|Postural balance|postural balance
1039630|NCT02916849|Health behaviour|health behaviour
1039631|NCT02916849|mHealth|mhealth
1039632|NCT02916849|eHealth|ehealth
1039633|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
1039634|NCT02916810|schizophrenia|schizophrenia
1039636|NCT02916797|Feedback|feedback
1039637|NCT02916797|Physical Therapy|physical therapy
1039638|NCT02916784|Sit-to-stand|sit-to-stand
1039639|NCT02916784|Walking devices|walking devices
1039640|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
1039641|NCT02916758|older adults|older adults
1039642|NCT02916758|community mobility|community mobility
1039643|NCT02916758|wellness|wellness
1039644|NCT02916758|isolation|isolation
1039645|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
1039646|NCT02916745|NSCLC|nsclc
1039647|NCT02916745|lung cancer|lung cancer
1039648|NCT02916745|lung carcinoma|lung carcinoma
1039649|NCT02916745|lung metastasis|lung metastasis
1039650|NCT02916732|asymptomatics|asymptomatics
1039651|NCT02916732|microcephaly|microcephaly
1039652|NCT02916732|abnormalities|abnormalities
1039653|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
1039654|NCT02916719|breast cancer|breast cancer
1039655|NCT02916719|MRI|mri
1039656|NCT02916693|Mirabegron|mirabegron
1039657|NCT02916693|Overactive Bladder|overactive bladder
1039658|NCT02916693|Erectile Dysfunction|erectile dysfunction
1039659|NCT02916693|Beta 3 agonist|beta 3 agonist
1039660|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
1039661|NCT02916641|Fuzhenghuayu|fuzhenghuayu
1039662|NCT02916628|smoking cessation|smoking cessation
1039663|NCT02916628|group counseling|group counseling
1039664|NCT02916628|acupressure|acupressure
1039665|NCT02916628|serotonin|serotonin
1039666|NCT02916628|depressive symptoms|depressive symptoms
1039667|NCT02916628|resilience|resilience
1039668|NCT02916537|prostate cancer|prostate cancer
1039669|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
1039670|NCT02916537|prostate neoplasms|prostate neoplasms
1039671|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
1039672|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
1039673|NCT02916524|Aphasia|aphasia
1039674|NCT02916524|Bilingualism|bilingualism
1039675|NCT02916524|Language therapy|language therapy
1039676|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
1039677|NCT02916524|Speech-language pathology|speech-language pathology
1039678|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
1039679|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
1039680|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
1039681|NCT02916485|vascular restoration therapy|vascular restoration therapy
1039682|NCT02916472|AYA|aya
1039683|NCT02916472|exercise|exercise
1039684|NCT02916472|cancer|cancer
1039685|NCT02916472|cybercycling|cybercycling
1039686|NCT02916407|Anesthesia|anesthesia
1039687|NCT02916407|Agitation|agitation
1039688|NCT02916407|Extubation|extubation
1039689|NCT02916316|Lymphoma|lymphoma
1039690|NCT02916316|Large B-Cell|large b-cell
1039691|NCT02916316|Cardiotoxicity|cardiotoxicity
1039692|NCT02916303|Schizophrenia|schizophrenia
1039693|NCT02916303|Psychosis|psychosis
1039694|NCT02916303|Effectiveness|effectiveness
1039695|NCT02916290|Fuzhenghuayu|fuzhenghuayu
1039696|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
1039697|NCT02916160|Chronic Heart failure|chronic heart failure
1039698|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
1039699|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
1039700|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
1039701|NCT02916108|Concussion|concussion
1039702|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
1039703|NCT02916108|EEG|eeg
1039704|NCT02916082|Cervical length|cervical length
1039705|NCT02916082|Prolonged pregnancy|prolonged pregnancy
1039706|NCT02916082|Vaginal birth|vaginal birth
1039707|NCT02916069|Spectroscopy|spectroscopy
1039708|NCT02916069|Transcranial Doppler|transcranial doppler
1039709|NCT02916069|Bispectral index|bispectral index
1039710|NCT02916069|Cardiac surgery|cardiac surgery
1039711|NCT02916056|Alzheimer's disease|alzheimer's disease
1039712|NCT02916056|RAGE|rage
1039713|NCT02916056|ADAS-cog|adas-cog
1039714|NCT02916056|CDR-sb|cdr-sb
1039715|NCT02916043|acute kidney injury|acute kidney injury
1039716|NCT02916043|cardiovascular surgery|cardiovascular surgery
1039717|NCT02916043|mortality|mortality
1039718|NCT02916030|Vitamin D|vitamin d
1039719|NCT02916030|Stroke|stroke
1039720|NCT02916030|Parathormone|parathormone
1039721|NCT02916017|Humira|humira
1039722|NCT02916017|Adalimumab|adalimumab
1039823|NCT02915484|Emotions|emotions
1039723|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
1039724|NCT02916004|Analgesia|analgesia
1039725|NCT02916004|Pain measurement|pain measurement
1039726|NCT02916004|Nociception|nociception
1039727|NCT02916004|Electromyography|electromyography
1039728|NCT02916004|Electrical stimulation|electrical stimulation
1039729|NCT02916004|Pupillometry|pupillometry
1039730|NCT02916004|Critical care|critical care
1039731|NCT02916004|Sedation|sedation
1039732|NCT02915991|Coronary catheterization|coronary catheterization
1039733|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
1039734|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1039735|NCT02915991|automated co-registration|automated co-registration
1039736|NCT02915939|Family caregiving|family caregiving
1039737|NCT02915939|Institutionalization|institutionalization
1039738|NCT02915939|Residential long-term care|residential long-term care
1039739|NCT02915939|Placement|placement
1039740|NCT02915939|Psychosocial support|psychosocial support
1039741|NCT02915939|Dementia|dementia
1039742|NCT02915939|Caregivers|caregivers
1039743|NCT02915939|Nursing homes|nursing homes
1039744|NCT02915939|Assisted Living Facilities|assisted living facilities
1039745|NCT02915939|Long-Term Care|long-term care
1039746|NCT02915939|Intervention Study|intervention study
1039747|NCT02915939|Psychosocial Support Systems|psychosocial support systems
1039748|NCT02915939|Social Support|social support
1039749|NCT02915939|Coping|coping
1039750|NCT02915900|In vitro fertilization|in vitro fertilization
1039751|NCT02915887|neck pain|neck pain
1039752|NCT02915887|chronic|chronic
1039753|NCT02915887|taping|taping
1039754|NCT02915887|kinematics|kinematics
1039755|NCT02915887|motion analysis|motion analysis
1039756|NCT02915887|physiotherapy|physiotherapy
1039757|NCT02915861|immune responses|immune responses
1039758|NCT02915861|vaccines|vaccines
1039759|NCT02915848|deep brain stimulation|deep brain stimulation
1039760|NCT02915848|local field potential|local field potential
1039761|NCT02915848|kinematic analysis|kinematic analysis
1039762|NCT02915835|Scleroderma|scleroderma
1039763|NCT02915835|Digital Ulcer|digital ulcer
1039764|NCT02915809|Influenza Vaccines|influenza vaccines
1039765|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
1039766|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1039767|NCT02915783|unresectable advanced|unresectable advanced
1039768|NCT02915783|metastatic|metastatic
1039769|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
1039770|NCT02915757|Depression|depression
1039771|NCT02915757|EDOR test|edor test
1039772|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
1039773|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
1039774|NCT02915744|Carcinoma|carcinoma
1039775|NCT02915731|Vitamin A stores|vitamin a stores
1039776|NCT02915731|Stable isotope dilution|stable isotope dilution
1039777|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
1039778|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
1039779|NCT02915718|immunoadsorption|immunoadsorption
1039780|NCT02915692|Foley|foley
1039781|NCT02915692|CAUTI|cauti
1039782|NCT02915692|ERASE CAUTI|erase cauti
1039783|NCT02915679|Suicidal behavior|suicidal behavior
1039784|NCT02915679|psychological and social pain|psychological and social pain
1039785|NCT02915679|physical pain|physical pain
1039786|NCT02915679|pain perception|pain perception
1039787|NCT02915666|Melanoma, skin|melanoma, skin
1039788|NCT02915627|Antishock Garment|antishock garment
1039789|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1039790|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
1039791|NCT02915614|exercise training|exercise training
1039792|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
1039793|NCT02915562|rehabilitation|rehabilitation
1039794|NCT02915562|exercise|exercise
1039795|NCT02915562|outcome measurement|outcome measurement
1039796|NCT02915549|premature infant|premature infant
1039797|NCT02915549|early progressive feeding|early progressive feeding
1039798|NCT02915536|iodine excess|iodine excess
1039799|NCT02915536|thyroid disease|thyroid disease
1039800|NCT02915536|children|children
1039801|NCT02915536|tolerable upper intake level|tolerable upper intake level
1039802|NCT02915523|Ovarian Cancer|ovarian cancer
1039803|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1039807|NCT02915523|SNDX-275|sndx-275
1039808|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
1039809|NCT02915523|Ovarian Diseases|ovarian diseases
1039810|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
1039811|NCT02915523|Peritoneal Cancer|peritoneal cancer
1039812|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
1039813|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1039814|NCT02915484|Apathy|apathy
1039815|NCT02915484|Stroke|stroke
1039816|NCT02915484|Empathy|empathy
1039817|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
1039818|NCT02915484|Depression|depression
1039819|NCT02915484|Anhedonia|anhedonia
1039820|NCT02915484|Prefrontal Cortex|prefrontal cortex
1039821|NCT02915484|Electroencephalography|electroencephalography
1039824|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
1039825|NCT02915484|Brain Diseases|brain diseases
1039826|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
1039827|NCT02915471|Adolescent|adolescent
1039828|NCT02915471|Online Peer Support|online peer support
1039829|NCT02915471|Managing Cancer|managing cancer
1039830|NCT02915471|Mentor|mentor
1039831|NCT02915458|Weaning|weaning
1039832|NCT02915458|Mechanical ventilation|mechanical ventilation
1039833|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
1039834|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
1039835|NCT02915432|Anti PD-1|anti pd-1
1039836|NCT02915432|JS001|js001
1039837|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
1039838|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1039839|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1039840|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1039841|NCT02915432|Simon's Two Stage|simon's two stage
1039842|NCT02915432|ORR|orr
1039843|NCT02915393|Chronic Gastritis|chronic gastritis
1039844|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
1039845|NCT02915393|Next Generation Sequencing|next generation sequencing
1039846|NCT02915393|Proteomics|proteomics
1039847|NCT02915393|Metabonomics|metabonomics
1039848|NCT02915367|HIV/AIDS|hiv/aids
1039849|NCT02915367|adherence|adherence
1039850|NCT02915367|women|women
1039851|NCT02915367|real time monitoring|real time monitoring
1039852|NCT02915367|risk|risk
1039853|NCT02915367|SMS|sms
1039854|NCT02915367|mHealth|mhealth
1039855|NCT02915315|blood pressure|blood pressure
1039856|NCT02915315|Hypertrophy|hypertrophy
1039857|NCT02915315|Left Ventricular|left ventricular
1039858|NCT02915315|arterial Stiffness|arterial stiffness
1039859|NCT02915315|Proteinuria|proteinuria
1039860|NCT02915315|baPWV|bapwv
1039861|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
1039862|NCT02915302|Influenza|influenza
1039863|NCT02915302|Influenza virus vaccine|influenza virus vaccine
1039864|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
1039865|NCT02915289|Caesarean section|caesarean section
1039866|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
1039867|NCT02915276|Blastocyst|blastocyst
1039868|NCT02915276|Human|human
1039869|NCT02915276|DNA|dna
1039870|NCT02915276|Blastocentesis|blastocentesis
1039871|NCT02915263|Diabetes Complications|diabetes complications
1039872|NCT02915263|Diabetes Mellitus|diabetes mellitus
1039873|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
1039874|NCT02915263|IGIV-C|igiv-c
1039875|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
1039876|NCT02915263|Gamunex-C|gamunex-c
1039877|NCT02915237|Veterans|veterans
1039878|NCT02915237|Gulf War Illness|gulf war illness
1039879|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
1039880|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
1039881|NCT02915211|Epilepsy|epilepsy
1039882|NCT02915211|Glut|glut
1039883|NCT02915211|Ketogenic|ketogenic
1039884|NCT02915211|Glucose|glucose
1039885|NCT02915198|Metformin|metformin
1039886|NCT02915198|Atherosclerosis|atherosclerosis
1039887|NCT02915198|Prediabetic State|prediabetic state
1039888|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1039889|NCT02915198|Coronary Artery Disease|coronary artery disease
1039890|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
1039891|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
1039892|NCT02915185|exercise|exercise
1039893|NCT02915185|rehabilitation|rehabilitation
1039894|NCT02915185|recovery of function|recovery of function
1039895|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
1039896|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
1039897|NCT02915172|Advanced Cancer|advanced cancer
1039898|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
1039899|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
1039900|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1039998|NCT02914730|medication adherence|medication adherence
1039999|NCT02914717|golimumab|golimumab
1039901|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
1039902|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1039903|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
1039904|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1039905|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
1039906|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
1039907|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
1039908|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
1040018|NCT02914652|Follow-up|follow-up
1039909|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
1039910|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
1039911|NCT02915172|Lenvatinib|lenvatinib
1039912|NCT02915172|E7080|e7080
1039913|NCT02915172|Lenvima|lenvima
1039914|NCT02915172|Capecitabine|capecitabine
1039915|NCT02915172|Xeloda|xeloda
1039916|NCT02915146|eczema|eczema
1039917|NCT02915146|phototherapy|phototherapy
1039918|NCT02915146|uva1|uva1
1039919|NCT02915146|uvb|uvb
1039920|NCT02915146|adults|adults
1039921|NCT02915146|children|children
1039922|NCT02915133|high myopia|high myopia
1039923|NCT02915133|myopia foveoschisis|myopia foveoschisis
1039924|NCT02915133|macular buckling|macular buckling
1039925|NCT02915120|Knee pain|knee pain
1039926|NCT02915120|osteoarthritis|osteoarthritis
1039927|NCT02915120|genicular nerve|genicular nerve
1039928|NCT02915120|ultrasonography|ultrasonography
1039929|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
1039930|NCT02915107|drug eluting stents|drug eluting stents
1039931|NCT02915107|coronary vascular healing|coronary vascular healing
1039932|NCT02915068|patient-provider communication|patient-provider communication
1039933|NCT02915068|Electronic Health Records|electronic health records
1039934|NCT02915068|Provider education|provider education
1039935|NCT02915055|Analgesic efficacy|analgesic efficacy
1039936|NCT02915055|knee arthroplasty|knee arthroplasty
1039937|NCT02915055|Opioid consumption|opioid consumption
1039938|NCT02915055|Pain Medicine|pain medicine
1039939|NCT02915055|Narcotics|narcotics
1039940|NCT02915055|Multimodal Analgesia|multimodal analgesia
1039941|NCT02915042|Pain|pain
1039942|NCT02915042|dexmedetomidine|dexmedetomidine
1039943|NCT02915042|postoperative|postoperative
1039944|NCT02915029|Native American|native american
1039945|NCT02915029|Community Health Representative|community health representative
1039946|NCT02915029|Home base|home base
1039947|NCT02915029|Diabetes|diabetes
1039948|NCT02915029|Point of care testing|point of care testing
1039949|NCT02915029|Patient Activation Measure|patient activation measure
1039950|NCT02915029|Patient preferences|patient preferences
1039951|NCT02915003|health care navigation|health care navigation
1039952|NCT02915003|health literacy|health literacy
1039953|NCT02915003|Affordable Care Act|affordable care act
1039954|NCT02914977|Relapsed|relapsed
1039955|NCT02914977|Refractory|refractory
1039957|NCT02914964|Quality of Life|quality of life
1039958|NCT02914964|Diet|diet
1039959|NCT02914951|Autism|autism
1039960|NCT02914951|Irritability|irritability
1039961|NCT02914951|Disruptive Behavior|disruptive behavior
1039962|NCT02914951|Aggression|aggression
1039963|NCT02914951|Behavior Therapy|behavior therapy
1039964|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
1039965|NCT02914951|Intellectual Disability|intellectual disability
1039966|NCT02914951|Cognitive Impairment|cognitive impairment
1039967|NCT02914925|CIT|cit
1039968|NCT02914925|ArmeoSpring|armeospring
1039969|NCT02914925|TMS|tms
1039970|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
1039971|NCT02914899|16-949|16-949
1039972|NCT02914886|Diabetes|diabetes
1039973|NCT02914886|Lipoatrophy|lipoatrophy
1039974|NCT02914886|children|children
1039975|NCT02914886|adolescents|adolescents
1039976|NCT02914886|adults|adults
1039977|NCT02914886|insulin therapy|insulin therapy
1039978|NCT02914873|prostate cancer|prostate cancer
1039979|NCT02914873|active surveillance|active surveillance
1039980|NCT02914873|standardised treatment triggers|standardised treatment triggers
1039981|NCT02914873|MRI|mri
1039982|NCT02914873|randomized|randomized
1039983|NCT02914821|consumption|consumption
1039984|NCT02914821|decision making|decision making
1039985|NCT02914821|policy|policy
1039986|NCT02914821|sweetened beverages|sweetened beverages
1039987|NCT02914821|taxes|taxes
1039988|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
1039989|NCT02914769|Depression|depression
1039990|NCT02914769|Ayahuasca|ayahuasca
1039991|NCT02914769|Psychedelics|psychedelics
1039992|NCT02914743|Oral health|oral health
1039993|NCT02914743|Diabetes|diabetes
1039994|NCT02914743|Interprofessionalism|interprofessionalism
1039995|NCT02914743|Periodontal disease|periodontal disease
1039996|NCT02914730|diabetes|diabetes
1039997|NCT02914730|insulin|insulin
1040000|NCT02914691|Type 2 diabetes|type 2 diabetes
1040001|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
1040002|NCT02914691|Proteomics|proteomics
1040003|NCT02914691|Albuminuria|albuminuria
1040004|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
1040005|NCT02914678|Emergency Medical Services|emergency medical services
1040006|NCT02914678|Analgesics|analgesics
1040007|NCT02914665|Heart failure|heart failure
1040008|NCT02914665|diuresis|diuresis
1040009|NCT02914665|dropsy|dropsy
1040010|NCT02914665|congestion|congestion
1040011|NCT02914665|elamipretide|elamipretide
1040012|NCT02914665|MTP-131|mtp-131
1040013|NCT02914665|Bendavia™|bendavia™
1040014|NCT02914652|Congenital Heart Disease|congenital heart disease
1040015|NCT02914652|Ventricular Septal Defect|ventricular septal defect
1040016|NCT02914652|Beta-2-agonists|beta-2-agonists
1040017|NCT02914652|Surgery|surgery
1040019|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
1040020|NCT02914626|Ranibizumab|ranibizumab
1040021|NCT02914626|Intraocular pressure|intraocular pressure
1040022|NCT02914626|anti-VEGF|anti-vegf
1040023|NCT02914626|intravitreal injection|intravitreal injection
1040024|NCT02914483|Myocardial Infarction|myocardial infarction
1040025|NCT02914483|Women|women
1040026|NCT02914483|Stress Management|stress management
1040027|NCT02914470|advanced|advanced
1040028|NCT02914431|Personalized Titanium Plate|personalized titanium plate
1040029|NCT02914431|Orthognathic Surgery|orthognathic surgery
1040030|NCT02914431|Maxilla Repositioning|maxilla repositioning
1040031|NCT02914431|Accuracy|accuracy
1040032|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
1040033|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
1040034|NCT02914418|Spinal Cord Injuries|spinal cord injuries
1040035|NCT02914418|Muscle Spasticity|muscle spasticity
1040036|NCT02914418|Pain|pain
1040037|NCT02914418|Spinal Cord|spinal cord
1040038|NCT02914418|Spinal Cord Diseases|spinal cord diseases
1040039|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
1040040|NCT02914405|ch14.18/CHO|ch14.18/cho
1040041|NCT02914405|Nivolumab|nivolumab
1040042|NCT02914392|case control study|case control study
1040043|NCT02914392|Environmental Factors|environmental factors
1040044|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
1040045|NCT02914366|Ambroxol|ambroxol
1040046|NCT02914366|Dementia|dementia
1040047|NCT02914366|Parkinson's disease|parkinson's disease
1040048|NCT02914366|Disease modifying treatment|disease modifying treatment
1040049|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
1040050|NCT02914366|GBA1|gba1
1040051|NCT02914353|Factor X!a|factor x!a
1040052|NCT02914353|anticoagulant|anticoagulant
1040053|NCT02914353|thromboembolism|thromboembolism
1040054|NCT02914353|venous thromboembolism|venous thromboembolism
1040055|NCT02914353|embolism and thrombosis|embolism and thrombosis
1040056|NCT02914353|enzyme inhibitors|enzyme inhibitors
1040057|NCT02914353|hematologic agent|hematologic agent
1040058|NCT02914327|CLL|cll
1040059|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
1040060|NCT02914327|Hsp90|hsp90
1040061|NCT02914327|BTK|btk
1040062|NCT02914327|Ibrutinib|ibrutinib
1040063|NCT02914314|epilepsy|epilepsy
1040064|NCT02914314|refractory partial seizures|refractory partial seizures
1040065|NCT02914249|Orange juice|orange juice
1040066|NCT02914249|Low-calorie diet|low-calorie diet
1040067|NCT02914249|Body composition|body composition
1040068|NCT02914249|Weight-loss|weight-loss
1040069|NCT02914249|Metabolic biomarkers|metabolic biomarkers
1040070|NCT02914249|Obese|obese
1040071|NCT02914236|Nasal valve|nasal valve
1040072|NCT02914236|Nasal airway obstruction|nasal airway obstruction
1040073|NCT02914210|TKR|tkr
1040074|NCT02914210|TKA|tka
1040075|NCT02914210|Knee|knee
1040076|NCT02914210|Surgery|surgery
1040077|NCT02914210|Replacement|replacement
1040078|NCT02914210|Rehabilitation|rehabilitation
1040079|NCT02914210|Virtual|virtual
1040080|NCT02914210|Physical Therapy|physical therapy
1040081|NCT02914210|Telerehabilitation|telerehabilitation
1040082|NCT02914197|Decision|decision
1040083|NCT02914197|Mammography|mammography
1040084|NCT02914197|Informed Choice|informed choice
1040085|NCT02914197|Full Information|full information
1040086|NCT02914197|Decision Aid|decision aid
1040087|NCT02914197|Self-efficacy|self-efficacy
1040088|NCT02914197|Shared decision making|shared decision making
1040089|NCT02914197|Over-detection|over-detection
1040090|NCT02914197|Over-diagnosis|over-diagnosis
1040091|NCT02914184|Safety|safety
1040092|NCT02914184|Healthy infants|healthy infants
1040093|NCT02914184|Immunogenicity|immunogenicity
1040094|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
1040095|NCT02914171|Myopathic right ventricle|myopathic right ventricle
1040096|NCT02914158|breast cancer|breast cancer
1040097|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
1040098|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
1040099|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
1040100|NCT02914119|Residual nerve blockade|residual nerve blockade
1040101|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
1040702|NCT02909842|vaccine|vaccine
1040102|NCT02914119|Residual curarization|residual curarization
1040103|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
1040104|NCT02914106|Neuroactive steroids|neuroactive steroids
1040105|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
1040106|NCT02914106|Patients|patients
1040107|NCT02914093|Hypercapnia|hypercapnia
1040108|NCT02914093|Physiotherapy|physiotherapy
1040109|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
1040110|NCT02914067|Pediatric brain tumors|pediatric brain tumors
1040111|NCT02914067|Cognitive deficits|cognitive deficits
1040112|NCT02914067|Resting state functional connectivity|resting state functional connectivity
1040113|NCT02914067|NIH toolbox|nih toolbox
1040114|NCT02914054|ITP|itp
1040115|NCT02914041|Kyphosis|kyphosis
1040116|NCT02914041|Kyphosis wall distance|kyphosis wall distance
1040117|NCT02914041|elderly|elderly
1040118|NCT02914028|TAP block|tap block
1040119|NCT02914028|subacute pain|subacute pain
1040120|NCT02914028|inguinal herniography|inguinal herniography
1040121|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
1040122|NCT02913937|pain|pain
1040123|NCT02913937|healing|healing
1040124|NCT02913937|apical periodontitis|apical periodontitis
1040125|NCT02913924|Marijuana|marijuana
1040126|NCT02913924|Treatment|treatment
1040127|NCT02913911|feedback|feedback
1040128|NCT02913898|learning|learning
1040129|NCT02913872|Spirometry|spirometry
1040130|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
1040131|NCT02913872|Primary Care|primary care
1040132|NCT02913859|prostate cancer|prostate cancer
1040133|NCT02913859|hormone-sensitive|hormone-sensitive
1040134|NCT02913859|metastasis|metastasis
1040135|NCT02913846|denutrition|denutrition
1040136|NCT02913846|hospital length of stay|hospital length of stay
1040137|NCT02913846|patient's autonomy|patient's autonomy
1040138|NCT02913833|Pain|pain
1040139|NCT02913833|Hospital length of stay|hospital length of stay
1040140|NCT02913833|Revalidation unit|revalidation unit
1040141|NCT02913781|Polar body removal|polar body removal
1040142|NCT02913781|ICSI|icsi
1040143|NCT02913781|Fertilization failure|fertilization failure
1040144|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
1040145|NCT02913729|breast cancer|breast cancer
1040146|NCT02913703|Ghrelin|ghrelin
1040147|NCT02913690|Hemodialysis|hemodialysis
1040148|NCT02913690|Tocotrienol|tocotrienol
1040149|NCT02913690|Vitamin E|vitamin e
1725684|NCT00000912|efavirenz|efavirenz
1040150|NCT02913677|feeding intolerance|feeding intolerance
1040151|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
1040152|NCT02913677|very low birth weight|very low birth weight
1040153|NCT02913677|preterm infant|preterm infant
1040154|NCT02913664|Dementia|dementia
1040155|NCT02913664|Alzheimer's Disease|alzheimer's disease
1040156|NCT02913664|Cognitive Function|cognitive function
1040157|NCT02913664|Blood Pressure|blood pressure
1040158|NCT02913664|Cholesterol|cholesterol
1040159|NCT02913664|Physical Activity|physical activity
1040160|NCT02913664|Exercise|exercise
1040161|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
1040162|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
1040163|NCT02913651|heart rate variability|heart rate variability
1040164|NCT02913651|parasympathetic activity|parasympathetic activity
1040165|NCT02913651|autonomic arousal response|autonomic arousal response
1040166|NCT02913625|Brachial plexus|brachial plexus
1040167|NCT02913625|Regional anesthesia|regional anesthesia
1040168|NCT02913625|Infraclavicular|infraclavicular
1040169|NCT02913625|Retroclavicular|retroclavicular
1040170|NCT02913625|Parasagittal|parasagittal
1040171|NCT02913625|Upper limb surgery|upper limb surgery
1040172|NCT02913625|Ultrasound guided block|ultrasound guided block
1040173|NCT02913625|Coracoid|coracoid
1040174|NCT02913612|Hemangioma|hemangioma
1040175|NCT02913612|Infantile Hemangioma|infantile hemangioma
1040176|NCT02913612|Pharmacokinetics|pharmacokinetics
1040177|NCT02913508|Drug therapy|drug therapy
1040178|NCT02913495|Progesterone|progesterone
1040179|NCT02913495|Prevention of preterm birth|prevention of preterm birth
1040180|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
1040181|NCT02913417|uveal melanoma|uveal melanoma
1040182|NCT02913417|liver metastases|liver metastases
1040183|NCT02913391|noninvasive ventilation|noninvasive ventilation
1040184|NCT02913391|myocardial revascularization|myocardial revascularization
1040185|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
1040186|NCT02913391|hypoxia|hypoxia
1040187|NCT02913391|positive end-expiratory pressure|positive end-expiratory pressure
1040188|NCT02913391|coronary artery bypass grafting|coronary artery bypass grafting
1040189|NCT02913391|extracorporeal circulation|extracorporeal circulation
1040190|NCT02913365|Haemoptysis|haemoptysis
1040191|NCT02913365|Hemoptysis|hemoptysis
1040192|NCT02913365|Airway bleeding|airway bleeding
1040193|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
1040194|NCT02913339|screening|screening
1040195|NCT02913339|telemedicine|telemedicine
1040196|NCT02913339|risk assessment|risk assessment
1040197|NCT02913339|prevention|prevention
1040198|NCT02913300|Lignocaine|lignocaine
1040199|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
1040200|NCT02913261|INC424|inc424
1040201|NCT02913261|ruxolitinib|ruxolitinib
1040203|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
1040205|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
1040206|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
1040207|NCT02913248|periodontitis|periodontitis
1040208|NCT02913248|saliva|saliva
1040209|NCT02913248|bacteria|bacteria
1040210|NCT02913235|biofilm|biofilm
1040211|NCT02913235|saliva|saliva
1040212|NCT02913235|bacteria|bacteria
1040213|NCT02913235|oral hygiene|oral hygiene
1040214|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
1040215|NCT02913222|labral tear|labral tear
1040216|NCT02913222|rehabilitation|rehabilitation
1040217|NCT02913183|acute stroke|acute stroke
1040218|NCT02913183|young health plasma|young health plasma
1040224|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
1040225|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
1040226|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
1040227|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
1040228|NCT02913001|Diet|diet
1040229|NCT02913001|glycemic index|glycemic index
1040230|NCT02913001|glycemic load|glycemic load
1040231|NCT02913001|Acne Vulgaris|acne vulgaris
1040232|NCT02912988|Subfertility|subfertility
1040233|NCT02912988|In-vitro fertilization|in-vitro fertilization
1040234|NCT02912988|Letrozole|letrozole
1040235|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
1040236|NCT02912949|First-in-human|first-in-human
1040237|NCT02912949|MCLA-128|mcla-128
1040238|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
1040239|NCT02912949|Immunologic Factors|immunologic factors
1040240|NCT02912949|Cytokines|cytokines
1040241|NCT02912936|medium chain triglyceride|medium chain triglyceride
1040243|NCT02912936|coconut oil|coconut oil
1040244|NCT02912936|MRI|mri
1040245|NCT02912936|PET|pet
1040246|NCT02912936|ketones|ketones
1040247|NCT02912923|Stroke|stroke
1040248|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
1040249|NCT02912923|Bimanual|bimanual
1040250|NCT02912923|Compensatory Movements|compensatory movements
1040251|NCT02912923|Hemiplegia|hemiplegia
1040252|NCT02912923|Kinematics|kinematics
1040253|NCT02912923|Reaching|reaching
1040254|NCT02912923|Trunk|trunk
1040255|NCT02912897|EBV-CTL|ebv-ctl
1040256|NCT02912897|Multiple sclerosis|multiple sclerosis
1040257|NCT02912897|cellular therapy|cellular therapy
1040258|NCT02912897|clinically isolated syndrome|clinically isolated syndrome
1040259|NCT02912871|subthalamotomy|subthalamotomy
1040260|NCT02912871|motor features|motor features
1040261|NCT02912871|deep brain stimulation|deep brain stimulation
1040262|NCT02912832|Diagnosis|diagnosis
1040263|NCT02912806|Knee Arthroplasty|knee arthroplasty
1040264|NCT02912806|Total knee replacement|total knee replacement
1040265|NCT02912806|Knee osteoarthritis|knee osteoarthritis
1040266|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
1040267|NCT02912806|Surgical Registries|surgical registries
1040268|NCT02912806|Shared Decision Making|shared decision making
1040269|NCT02912806|Patient Reported Outcomes|patient reported outcomes
1040270|NCT02912806|Patient Experience|patient experience
1040271|NCT02912806|Cohort Studies|cohort studies
1040272|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
1040273|NCT02912767|16-1001|16-1001
1040274|NCT02912702|Pegaspargase|pegaspargase
1040275|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1040276|NCT02912702|Epstein Barr virus|epstein barr virus
1040277|NCT02912702|initial treatment|initial treatment
1040278|NCT02912689|COPD|copd
1040279|NCT02912689|Non-invasive ventilation|non-invasive ventilation
1040280|NCT02912689|NAVA|nava
1040281|NCT02912676|Cancer|cancer
1040282|NCT02912676|Thioguanine|thioguanine
1040283|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1040284|NCT02912676|6 Mercaptopurine|6 mercaptopurine
1040285|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
1040286|NCT02912676|Denmark|denmark
1040287|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1040288|NCT02912650|ibuprofen|ibuprofen
1040289|NCT02912650|acetaminophen|acetaminophen
1040290|NCT02912650|pain|pain
1040291|NCT02912650|molar extraction|molar extraction
1040292|NCT02912624|Physical Examination|physical examination
1040293|NCT02912624|Diagnostic Imaging|diagnostic imaging
1040294|NCT02912624|Ultrasonography|ultrasonography
1040295|NCT02912624|Hemodynamics|hemodynamics
1040296|NCT02912624|Patient Outcome Assessment|patient outcome assessment
1040297|NCT02912624|Mortality|mortality
1040298|NCT02912585|colostrum|colostrum
1040299|NCT02912572|Endometrial Cancer|endometrial cancer
1040300|NCT02912546|Stroke, Acute|stroke, acute
1040301|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
1040302|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
1040303|NCT02912442|thyroid|thyroid
1040304|NCT02912442|infertility|infertility
1040305|NCT02912442|autoimmunity|autoimmunity
1040306|NCT02912442|pregnancy loss|pregnancy loss
1040307|NCT02912442|autoantibodies|autoantibodies
1040308|NCT02912364|Eslicarbazepine|eslicarbazepine
1040309|NCT02912364|Carbamazepine|carbamazepine
1040310|NCT02912364|cognition|cognition
1040311|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
1040312|NCT02912351|Total Knee Replacement|total knee replacement
1040313|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
1040314|NCT02912338|Sarcopenic obesity|sarcopenic obesity
1040315|NCT02912338|Body composition|body composition
1040316|NCT02912338|Physical function|physical function
1040317|NCT02912338|quality of life|quality of life
1040318|NCT02912338|long term care|long term care
1040319|NCT02912312|Malignant neoplasm of breast|malignant neoplasm of breast
1040320|NCT02912312|Lymphedema|lymphedema
1040321|NCT02912312|Standard regional nodal irradiation|standard regional nodal irradiation
1040322|NCT02912312|RNI|rni
1040323|NCT02912312|Shortened regional nodal irradiation|shortened regional nodal irradiation
1040324|NCT02912312|Radiation therapy|radiation therapy
1040326|NCT02912312|Arm swelling|arm swelling
1040327|NCT02912312|Questionnaires|questionnaires
1040328|NCT02912312|Surveys|surveys
1040329|NCT02912273|Geriatric assessment|geriatric assessment
1040330|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
1040331|NCT02912247|pharmacokinetics|pharmacokinetics
1040332|NCT02912247|safety|safety
1040333|NCT02912169|Alzheimer's Disease|alzheimer's disease
1040334|NCT02912169|Alzheimer's|alzheimer's
1040335|NCT02912169|Stem cell|stem cell
1040336|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
1040337|NCT02912169|ASC|asc
1040338|NCT02912169|ADSC|adsc
1040339|NCT02912156|Pharmacokinetic|pharmacokinetic
1040340|NCT02912130|Exercise|exercise
1040341|NCT02912130|Nutrition|nutrition
1040342|NCT02912130|Sarcopenia|sarcopenia
1040343|NCT02912130|Healthy Ageing|healthy ageing
1040344|NCT02912130|Elderly|elderly
1040345|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
1040346|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
1040347|NCT02912104|premature ovarian failure|premature ovarian failure
1040348|NCT02912104|Infertility|infertility
1040349|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
1040350|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
1040351|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
1040352|NCT02912052|Colon Cancer|colon cancer
1040353|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
1040354|NCT02912000|Dental Health Services|dental health services
1040355|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
1040356|NCT02912000|Tobacco control|tobacco control
1040357|NCT02912000|Pediatrics|pediatrics
1040358|NCT02912000|Parents|parents
1040359|NCT02911974|fine needle biopsy|fine needle biopsy
1040360|NCT02911974|EUS|eus
1040361|NCT02911974|solid pancreatic mass|solid pancreatic mass
1040362|NCT02911896|physical function|physical function
1040363|NCT02911896|critical care|critical care
1040364|NCT02911857|Canakinumab,|canakinumab,
1040365|NCT02911857|interleukin-1|interleukin-1
1040366|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
1040367|NCT02911857|TRAPS|traps
1040368|NCT02911857|HIDS|hids
1040369|NCT02911857|crFMF|crfmf
1040370|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
1040371|NCT02911857|extension study|extension study
1040372|NCT02911805|Exercise|exercise
1040373|NCT02911805|Retinal Degeneration|retinal degeneration
1040374|NCT02911805|Neuropharmacology|neuropharmacology
1040375|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1040376|NCT02911805|Biometry|biometry
1040377|NCT02911805|Immunochemistry|immunochemistry
1040378|NCT02911805|Molecular Biology|molecular biology
1040379|NCT02911805|Neurosciences|neurosciences
1040380|NCT02911805|Ophthalmology|ophthalmology
1040381|NCT02911792|hyperfiltering|hyperfiltering
1040382|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1040383|NCT02911766|Periodontal Index|periodontal index
1040384|NCT02911727|Cesarean section|cesarean section
1040385|NCT02911727|Postnatal Care|postnatal care
1040386|NCT02911714|Kidney Transplantation|kidney transplantation
1040387|NCT02911714|Delayed Graft Function|delayed graft function
1040388|NCT02911714|Acute Allograft Rejection|acute allograft rejection
1040389|NCT02911714|Acute Kidney Injury|acute kidney injury
1040390|NCT02911597|Ketamine|ketamine
1040391|NCT02911597|Naltrexone|naltrexone
1040392|NCT02911597|Treatment-Resistant|treatment-resistant
1040393|NCT02911597|TRD|trd
1040394|NCT02911545|Atrial fibrillation|atrial fibrillation
1040395|NCT02911545|Anticoagulation|anticoagulation
1040396|NCT02911545|Cardioversion|cardioversion
1040397|NCT02911532|pterygium|pterygium
1040398|NCT02911532|tissue engineering|tissue engineering
1040399|NCT02911532|atretoblepharia|atretoblepharia
1040400|NCT02911519|Schizophrenia|schizophrenia
1040401|NCT02911519|Patient Education|patient education
1040402|NCT02911493|sedentary time|sedentary time
1040403|NCT02911493|number of steps/day|number of steps/day
1040404|NCT02911493|mobility|mobility
1040405|NCT02911493|disability|disability
1040406|NCT02911428|Ebola|ebola
1040407|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
1040408|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
1040409|NCT02911428|Ebola Infection|ebola infection
1040410|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
1040411|NCT02911415|Ebola|ebola
1040412|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
1040413|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
1040414|NCT02911415|Ebola Infection|ebola infection
1040415|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
1040416|NCT02911311|conbercept|conbercept
1040417|NCT02911311|anti-VEGF agent|anti-vegf agent
1040418|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
1040419|NCT02911285|Alcohol|alcohol
1040420|NCT02911285|PTSD|ptsd
1040421|NCT02911285|Trauma|trauma
1040422|NCT02911285|Veteran|veteran
1040423|NCT02911285|Substance|substance
1040424|NCT02911285|Drug|drug
1040425|NCT02911285|Post Traumatic Stress Disorder|post traumatic stress disorder
1040426|NCT02911285|Military|military
1040427|NCT02911272|Partograph|partograph
1040428|NCT02911272|Best action line|best action line
1040429|NCT02911272|Prolonged labour prevention|prolonged labour prevention
1040430|NCT02911207|chronic ill patients|chronic ill patients
1040431|NCT02911207|Emotion management skill|emotion management skill
1040432|NCT02911207|Quality of Life|quality of life
1040433|NCT02911181|BIVA measurement|biva measurement
1040434|NCT02911181|SNAQ score|snaq score
1040435|NCT02911168|NERVE BLOCK|nerve block
1040436|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
1040437|NCT02911168|PAIN MANAGEMENT|pain management
1040438|NCT02911155|Cohort Study|cohort study
1040439|NCT02911155|Radiation|radiation
1040440|NCT02911155|Occupation|occupation
1040441|NCT02911142|Treatment Naive|treatment naive
1040442|NCT02911142|Immune Modulatory|immune modulatory
1040443|NCT02911142|Chemotherapy|chemotherapy
1040444|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
1040445|NCT02911142|PEL|pel
1040446|NCT02911129|Chronic Stroke|chronic stroke
1040447|NCT02911129|Neglect|neglect
1040448|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1040449|NCT02911129|Visual and Motor Integration|visual and motor integration
1040450|NCT02911129|Visual Fields|visual fields
1040451|NCT02911116|Panuveitis|panuveitis
1040452|NCT02911116|Intermediate Uveitis|intermediate uveitis
1040453|NCT02911116|Uveitis|uveitis
1040454|NCT02911103|Electrophysiology|electrophysiology
1040455|NCT02911103|Neurosurgery|neurosurgery
1040456|NCT02911103|Dystonia|dystonia
1040457|NCT02911103|Deep Brain Stimulation|deep brain stimulation
1040458|NCT02911090|Endometriosis|endometriosis
1040459|NCT02911090|Chronic pelvic pain|chronic pelvic pain
1040460|NCT02911090|Dyspareunia|dyspareunia
1040461|NCT02911077|Bacteria|bacteria
1040462|NCT02911064|Questionnaires|questionnaires
1040463|NCT02911064|Surveys|surveys
1040464|NCT02911064|Benign neoplasms|benign neoplasms
1040465|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1040466|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
1040467|NCT02911038|Complete denture|complete denture
1040468|NCT02911038|PMMA|pmma
1040469|NCT02911038|Stereolithography|stereolithography
1040470|NCT02911025|epilepsy|epilepsy
1040471|NCT02911025|sleep|sleep
1040472|NCT02911025|antiepileptic drugs|antiepileptic drugs
1040473|NCT02910986|Mammography|mammography
1040474|NCT02910986|Breast Density|breast density
1040475|NCT02910986|Hispanic|hispanic
1040476|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
1040477|NCT02910960|fine needle biopsy|fine needle biopsy
1040479|NCT02910960|solid pancreatic mass|solid pancreatic mass
1040480|NCT02910934|Indoor Residual Spray|indoor residual spray
1040482|NCT02910934|Insecticide Treated Net|insecticide treated net
1040483|NCT02910934|LLIN|llin
1040484|NCT02910934|ITN|itn
1040485|NCT02910921|Migraine|migraine
1040486|NCT02910921|Prediction|prediction
1040487|NCT02910921|Forecast|forecast
1040488|NCT02910921|App|app
1040489|NCT02910921|Fitbit|fitbit
1040490|NCT02910921|Individual|individual
1040491|NCT02910921|Algorithm|algorithm
1040492|NCT02910921|Machine Learning|machine learning
1040493|NCT02910921|Mayo Clinic|mayo clinic
1040494|NCT02910921|Allergan|allergan
1040495|NCT02910921|Second Opinion|second opinion
1040496|NCT02910908|Elderly|elderly
1040497|NCT02910908|ESRD prognosis|esrd prognosis
1040498|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
1040499|NCT02910882|Pancreas Cancer|pancreas cancer
1040500|NCT02910882|Unresectable|unresectable
1040501|NCT02910882|Chemoradiation|chemoradiation
1040502|NCT02910882|PEGPH20|pegph20
1040503|NCT02910843|rectal cancer|rectal cancer
1040504|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
1040505|NCT02910843|Regorafenib|regorafenib
1040506|NCT02910843|Capecitabine|capecitabine
1040507|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
1040508|NCT02910843|Phase Ib trial|phase ib trial
1040509|NCT02910804|GBM|gbm
1040510|NCT02910804|GRPR|grpr
1040511|NCT02910804|IRDye800|irdye800
1040512|NCT02910804|NIRF|nirf
1040513|NCT02910804|surgery|surgery
1040514|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
1040515|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
1040516|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
1040517|NCT02910726|16-1003|16-1003
1040518|NCT02910700|Melanoma|melanoma
1040519|NCT02910700|Metastatic Melanoma|metastatic melanoma
1040520|NCT02910700|BRAF- mutated metastatic melanoma|braf- mutated metastatic melanoma
1040521|NCT02910700|BRAF-wild type metastatic melanoma|braf-wild type metastatic melanoma
1040522|NCT02910700|Nivolumab|nivolumab
1040523|NCT02910700|BMS-936558|bms-936558
1040524|NCT02910700|Opdivo|opdivo
1040525|NCT02910700|Dabrafenib|dabrafenib
1040526|NCT02910700|Tafinlar|tafinlar
1040527|NCT02910700|GSK2118436|gsk2118436
1040528|NCT02910700|Trametinib|trametinib
1040529|NCT02910700|GSK1120212|gsk1120212
1040530|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
1040531|NCT02910687|Elderly|elderly
1040532|NCT02910687|Frailty|frailty
1040533|NCT02910687|Prognostic value|prognostic value
1040534|NCT02910661|Kidney Transplantation|kidney transplantation
1040535|NCT02910648|healthy|healthy
1040536|NCT02910648|BMI|bmi
1040537|NCT02910648|weight loss|weight loss
1040538|NCT02910648|sleep|sleep
1040539|NCT02910648|healthy sleeper|healthy sleeper
1040540|NCT02910648|overweight|overweight
1040541|NCT02910648|obese|obese
1040542|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
1040543|NCT02910622|breast|breast
1040544|NCT02910622|ovarian|ovarian
1040545|NCT02910622|cancer|cancer
1040546|NCT02910609|preterm|preterm
1040547|NCT02910609|patent ductus arterioles|patent ductus arterioles
1040548|NCT02910609|treatment|treatment
1040549|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
1040550|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
1040551|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
1040552|NCT02910557|EDC - electronic data capture|edc - electronic data capture
1040553|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
1040554|NCT02910557|HCP - health care provider|hcp - health care provider
1040555|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
1040556|NCT02910557|ICF - informed consent form|icf - informed consent form
1040557|NCT02910557|ICP - infected cell protein|icp - infected cell protein
1040558|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
1040559|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
1040560|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
1040561|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
1040562|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
1040563|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
1040564|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
1040565|NCT02910531|Cystinuria|cystinuria
1040566|NCT02910531|Kidney stone|kidney stone
1040567|NCT02910531|Alpha lipoic acid|alpha lipoic acid
1040568|NCT02910479|Body Temperature|body temperature
1040569|NCT02910479|Thermometers|thermometers
1040570|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
1040571|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
1040572|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
1040573|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
1040574|NCT02910427|stroke|stroke
1040575|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
1040576|NCT02910427|neurological performance|neurological performance
1040577|NCT02910414|Renal Denervation|renal denervation
1040578|NCT02910414|Alcohol|alcohol
1040579|NCT02910388|conization|conization
1040580|NCT02910388|LLETZ|lletz
1040581|NCT02910388|loop excision|loop excision
1040582|NCT02910388|randomized controlled trial|randomized controlled trial
1040583|NCT02910388|colposcopy|colposcopy
1040584|NCT02910388|direct colposcopic vision|direct colposcopic vision
1040585|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
1040586|NCT02910375|golimumab|golimumab
1040587|NCT02910375|drug monitoring|drug monitoring
1040588|NCT02910375|home based care|home based care
1040589|NCT02910349|valvular hear disease|valvular hear disease
1040590|NCT02910349|echocardiography|echocardiography
1040591|NCT02910349|magnetic resonance|magnetic resonance
1040592|NCT02910349|global longitudinal strain|global longitudinal strain
1040593|NCT02910349|T1 relaxation time|t1 relaxation time
1040594|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
1040595|NCT02910297|cannabidiol|cannabidiol
1040596|NCT02910297|Dravet Syndrome|dravet syndrome
1040597|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
1040599|NCT02910284|Herpes|herpes
1040600|NCT02910284|Genital Herpes|genital herpes
1040703|NCT02909842|probiotic|probiotic
1040601|NCT02910258|myelofibrosis|myelofibrosis
1040602|NCT02910258|pegylated interferon|pegylated interferon
1040603|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
1040604|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
1040605|NCT02910245|Thiopurine|thiopurine
1040606|NCT02910245|Efficacy|efficacy
1040607|NCT02910232|Rice starch|rice starch
1040608|NCT02910232|Porous composite|porous composite
1040609|NCT02910232|Biomaterial|biomaterial
1040610|NCT02910232|Bone regeneration|bone regeneration
1040611|NCT02910232|Clinical trial|clinical trial
1040612|NCT02910232|Hydroxyapatite|hydroxyapatite
1040613|NCT02910219|HER2|her2
1040614|NCT02910219|pertuzumab|pertuzumab
1040615|NCT02910219|trastuzumab|trastuzumab
1040616|NCT02910219|docetaxel|docetaxel
1040617|NCT02910219|paclitaxel|paclitaxel
1040618|NCT02910219|carboplatin|carboplatin
1040619|NCT02910219|crofelemer|crofelemer
1040620|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
1040621|NCT02910206|etomidate|etomidate
1040622|NCT02910206|propofol|propofol
1040623|NCT02910193|alcoholism|alcoholism
1040624|NCT02910193|genetics|genetics
1040625|NCT02910193|functional MRI|functional mri
1040626|NCT02910193|structural MRI|structural mri
1040627|NCT02910193|first-degree relatives|first-degree relatives
1040628|NCT02910180|Tissue Repository|tissue repository
1040629|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
1040630|NCT02910180|Stroke|stroke
1040631|NCT02910180|Aneurysm|aneurysm
1040632|NCT02910180|Arteriovenous malformation|arteriovenous malformation
1040633|NCT02910180|Fistula|fistula
1040634|NCT02910180|Intracranial Stenosis|intracranial stenosis
1040635|NCT02910180|Treatment|treatment
1040636|NCT02910180|Registry|registry
1040637|NCT02910180|Outcomes|outcomes
1040638|NCT02910141|Type 2 diabetes|type 2 diabetes
1040639|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1040640|NCT02910141|Meta-analysis|meta-analysis
1040641|NCT02910141|Insulin pump therapy|insulin pump therapy
1040642|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
1040643|NCT02910102|RVT-101|rvt-101
1040644|NCT02910102|intepirdine|intepirdine
1040645|NCT02910102|Alzheimer's disease|alzheimer's disease
1040646|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
1040647|NCT02910102|Lewy body dementia|lewy body dementia
1040648|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
1040649|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
1040650|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
1040651|NCT02910063|Blinatumomab|blinatumomab
1040652|NCT02910063|Leukemia|leukemia
1040653|NCT02910063|Standard of Care|standard of care
1040654|NCT02910063|SOC|soc
1040655|NCT02910063|Cancer|cancer
1040656|NCT02910063|Chemotherapy|chemotherapy
1040657|NCT02910050|androgen receptor|androgen receptor
1040658|NCT02910050|bicalutamide|bicalutamide
1040659|NCT02910050|aromatase inhibitors|aromatase inhibitors
1040660|NCT02910050|advanced breast cancer|advanced breast cancer
1040661|NCT02910050|letrozole|letrozole
1040662|NCT02910050|anastrozole|anastrozole
1040663|NCT02910050|exemestane|exemestane
1040664|NCT02910037|metagenomic next-generation sequencing|metagenomic next-generation sequencing
1040665|NCT02910037|microbiological diagnosis|microbiological diagnosis
1040666|NCT02910037|bacterial infections|bacterial infections
1040667|NCT02910037|viral infections|viral infections
1040668|NCT02910037|fungal infections|fungal infections
1040669|NCT02910037|parasitic infections|parasitic infections
1040670|NCT02909998|Biomarkers|biomarkers
1040671|NCT02909998|Genetic|genetic
1040672|NCT02909998|Chronic arthritis|chronic arthritis
1040673|NCT02909998|Treatment|treatment
1040674|NCT02909985|Infrared|infrared
1040675|NCT02909985|Dark Adaptation|dark adaptation
1040676|NCT02909985|Vision|vision
1040677|NCT02909985|Scotopic Threshold Response|scotopic threshold response
1040678|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
1040679|NCT02909985|Human|human
1040680|NCT02909959|sulforaphane|sulforaphane
1040681|NCT02909959|glucoraphanin|glucoraphanin
1040682|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
1040683|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
1040684|NCT02909946|nursing home|nursing home
1040685|NCT02909946|post-acute care|post-acute care
1040686|NCT02909946|long-term care|long-term care
1040687|NCT02909946|infection control|infection control
1040688|NCT02909920|Telerehabilitation|telerehabilitation
1040689|NCT02909920|Physiotherapy|physiotherapy
1040690|NCT02909920|Surgery|surgery
1040691|NCT02909920|Telemedicine|telemedicine
1040692|NCT02909894|Sedentary behaviour|sedentary behaviour
1040693|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
1040694|NCT02909881|polysaccharide|polysaccharide
1040695|NCT02909881|oxidation|oxidation
1040696|NCT02909881|endurance exercise|endurance exercise
1040697|NCT02909855|children|children
1040698|NCT02909855|psychological predictors|psychological predictors
1040699|NCT02909855|side-effects|side-effects
1040700|NCT02909855|vaccination|vaccination
1040701|NCT02909842|influenza|influenza
1040704|NCT02909842|immune response|immune response
1040705|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1040706|NCT02909829|Artificial Pancreas|artificial pancreas
1040707|NCT02909829|Closed-Loop Delivery|closed-loop delivery
1040709|NCT02909829|Adolescent|adolescent
1040710|NCT02909829|Missed Bolus|missed bolus
1040711|NCT02909803|glucose|glucose
1040712|NCT02909803|glycemic index|glycemic index
1040713|NCT02909803|lentil|lentil
1040714|NCT02909803|polyphenols|polyphenols
1040715|NCT02909803|metabolites|metabolites
1040716|NCT02909803|bioavailability|bioavailability
1040717|NCT02909777|Lymphoma|lymphoma
1040718|NCT02909777|Neuroblastoma|neuroblastoma
1040719|NCT02909777|Brain Tumor|brain tumor
1040720|NCT02909777|Solid Tumor|solid tumor
1040721|NCT02909764|Salty taste|salty taste
1040722|NCT02909764|Psychophysics|psychophysics
1040723|NCT02909764|Genetics|genetics
1040724|NCT02909764|Diet|diet
1040725|NCT02909764|Age|age
1040726|NCT02909725|Physical activity|physical activity
1040727|NCT02909725|Sedentary time|sedentary time
1040728|NCT02909725|Pregnancy|pregnancy
1040729|NCT02909725|Pregnant women|pregnant women
1040730|NCT02909725|Weight gain|weight gain
1040731|NCT02909712|sub-Saharan|sub-saharan
1040732|NCT02909712|dihydroartemisinin|dihydroartemisinin
1040734|NCT02909712|sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1040735|NCT02909712|antimalarials|antimalarials
1040736|NCT02909686|Gulf War Syndrome|gulf war syndrome
1040737|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
1040738|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
1040739|NCT02909673|adolescent behavior|adolescent behavior
1040740|NCT02909673|intimate partner violence|intimate partner violence
1040741|NCT02909673|youth risk behavior|youth risk behavior
1040742|NCT02909673|violence prevention|violence prevention
1040743|NCT02909673|teen dating violence|teen dating violence
1040744|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
1040745|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1040746|NCT02909556|TAVI|tavi
1725685|NCT00000911|Semen|semen
1040747|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
1040748|NCT02909556|Transfemoral access|transfemoral access
1040749|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
1040750|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
1040751|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
1040752|NCT02909452|entinostat|entinostat
1040753|NCT02909452|pembrolizumab|pembrolizumab
1040754|NCT02909452|solid tumor|solid tumor
1040755|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1040756|NCT02909426|Screening|screening
1040757|NCT02909426|Digital mammography|digital mammography
1040758|NCT02909426|Ultrasonography|ultrasonography
1040759|NCT02909426|Sensitivity|sensitivity
1040760|NCT02909426|Specificity|specificity
1040761|NCT02909413|desflurane|desflurane
1040762|NCT02909413|sevoflurane|sevoflurane
1040763|NCT02909400|mitochondrial|mitochondrial
1040764|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
1040765|NCT02909400|MELAS|melas
1040766|NCT02909400|MIDD|midd
1040767|NCT02909400|KH176|kh176
1040768|NCT02909400|Proof of Concept|proof of concept
1040769|NCT02909387|Epilepsy|epilepsy
1040770|NCT02909387|Seizure Disorder|seizure disorder
1040771|NCT02909374|Implementation|implementation
1040772|NCT02909374|fall prevention|fall prevention
1040773|NCT02909374|balance training|balance training
1040774|NCT02909348|Neoplasms|neoplasms
1040775|NCT02909348|Melanoma|melanoma
1040776|NCT02909348|Immunotherapy|immunotherapy
1040777|NCT02909348|Biomarkers|biomarkers
1040778|NCT02909309|Propofol|propofol
1040779|NCT02909309|Deep Sedation|deep sedation
1040780|NCT02909309|Anoxia|anoxia
1040781|NCT02909309|Hypercapnia|hypercapnia
1040782|NCT02909231|Patient Outcome Assessment|patient outcome assessment
1040783|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
1040784|NCT02909205|child|child
1040785|NCT02909205|gastrostomy|gastrostomy
1040786|NCT02909205|supportive care|supportive care
1040787|NCT02909205|educational program|educational program
1040788|NCT02909192|Parkinson's Disease|parkinson's disease
1040789|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
1040790|NCT02909192|Circadian Rhythms|circadian rhythms
1040791|NCT02909192|Light Therapy|light therapy
1040792|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
1040793|NCT02909153|Triferic|triferic
1040794|NCT02909153|ferric pyrophosphate citrate|ferric pyrophosphate citrate
1040795|NCT02909153|peritoneal dialysis|peritoneal dialysis
1040796|NCT02909153|anemia|anemia
1040797|NCT02909153|chronic kidney disease|chronic kidney disease
1040798|NCT02909153|FPC|fpc
1040799|NCT02909127|deglutition|deglutition
1040800|NCT02909127|deglutition disorders|deglutition disorders
1040801|NCT02909127|pediatric dysphagia|pediatric dysphagia
1040802|NCT02909127|swallowing|swallowing
1040803|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
1040804|NCT02909101|Working memory|working memory
1040805|NCT02909101|cognitive training|cognitive training
1040806|NCT02909101|HIV|hiv
1040807|NCT02909101|substance abuse|substance abuse
1040808|NCT02909088|stuttering|stuttering
1040809|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
1040810|NCT02909088|ecopipam|ecopipam
1040811|NCT02909075|PET/CT|pet/ct
1040812|NCT02909075|MRI|mri
1040813|NCT02909075|Assess Thymic Function|assess thymic function
1040814|NCT02909075|16-1244|16-1244
1040815|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
1040816|NCT02909062|16-493|16-493
1040817|NCT02909049|Prostate Biopsy|prostate biopsy
1040818|NCT02909049|Local Anesthesia|local anesthesia
1040819|NCT02909049|Pain|pain
1040820|NCT02909049|Biopsy of prostate|biopsy of prostate
1040821|NCT02909036|Melphalan|melphalan
1040822|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
1040823|NCT02909036|High Dose Therapy|high dose therapy
1040824|NCT02909036|16-875|16-875
1040825|NCT02909023|Hepatitis B Virus|hepatitis b virus
1040826|NCT02909023|Elispot test|elispot test
1040827|NCT02909023|T cellular immune response|t cellular immune response
1040828|NCT02908984|unilateral headache|unilateral headache
1040829|NCT02908984|cervical pain|cervical pain
1040830|NCT02908984|neck pain|neck pain
1040831|NCT02908984|voxel based morphometry|voxel based morphometry
1040832|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
1040833|NCT02908984|structural brain changes|structural brain changes
1040834|NCT02908984|rehabilitation|rehabilitation
1040835|NCT02908971|soy based formula|soy based formula
1040836|NCT02908971|overweight|overweight
1040837|NCT02908971|adrenarche,|adrenarche,
1040838|NCT02908971|gonadarache|gonadarache
1040839|NCT02908945|Ketamine|ketamine
1040840|NCT02908945|Anesthesia|anesthesia
1040841|NCT02908945|EEG|eeg
1040842|NCT02908945|NeuroSENSE|neurosense
1040843|NCT02908945|Pain|pain
1040844|NCT02908919|Colonoscopy|colonoscopy
1040845|NCT02908919|Picosulfate sodium|picosulfate sodium
1040846|NCT02908919|Polyethylene glycol|polyethylene glycol
1073785|NCT02706886|PH1|ph1
1040847|NCT02908919|Magnesium citrate|magnesium citrate
1040848|NCT02908919|Ascorbic acid|ascorbic acid
1040849|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
1040850|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
1040851|NCT02908880|MANTA, arterial closure device, large bore closure device|manta, arterial closure device, large bore closure device
1040852|NCT02908867|Sexuality|sexuality
1040853|NCT02908867|Spinal cord injuries|spinal cord injuries
1040854|NCT02908867|Complementary Therapies|complementary therapies
1040855|NCT02908867|Medicinal plants|medicinal plants
1040856|NCT02908854|Spices|spices
1040857|NCT02908854|Herbs|herbs
1040858|NCT02908854|Vegetables|vegetables
1040859|NCT02908854|National School Lunch Program|national school lunch program
1040860|NCT02908854|High school|high school
1040861|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
1040862|NCT02908828|Copepoda|copepoda
1040863|NCT02908828|Dietary Supplements|dietary supplements
1040864|NCT02908828|Fish Oils|fish oils
1040865|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
1040866|NCT02908828|Oxygen Consumption|oxygen consumption
1040867|NCT02908828|Calanus|calanus
1040868|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
1040869|NCT02908828|Zooplankton|zooplankton
1040870|NCT02908789|Photochemotherapy|photochemotherapy
1040871|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
1040872|NCT02908763|Peginterferon Alpha|peginterferon alpha
1040873|NCT02908750|oncology|oncology
1040874|NCT02908750|cancer|cancer
1040875|NCT02908750|non small cell lung cancer|non small cell lung cancer
1040876|NCT02908750|anticancer drug|anticancer drug
1040877|NCT02908750|lung neoplasms|lung neoplasms
1040878|NCT02908750|pharmacokinetics|pharmacokinetics
1040879|NCT02908750|AZD9291|azd9291
1040880|NCT02908750|osimertinib|osimertinib
1040881|NCT02908750|fexofenadine|fexofenadine
1040882|NCT02908750|TAGRISSO™|tagrisso™
1040883|NCT02908750|EGFR genes|egfr genes
1040884|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
1040885|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1040886|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
1040887|NCT02908659|intensive care unit|intensive care unit
1040888|NCT02908659|patient's monitoring|patient's monitoring
1040889|NCT02908659|respiratory rate|respiratory rate
1040890|NCT02908633|open angle glaucoma|open angle glaucoma
1040891|NCT02908633|canaloplasty|canaloplasty
1040892|NCT02908633|migs|migs
1040893|NCT02908633|abic|abic
1040894|NCT02908594|Nursing|nursing
1040895|NCT02908594|ESRD|esrd
1040896|NCT02908594|hemodialysis|hemodialysis
1040897|NCT02908594|intradialytic exercise|intradialytic exercise
1040898|NCT02908594|depression|depression
1040899|NCT02908594|fatigue|fatigue
1040900|NCT02908594|Quality Of Life|quality of life
1040901|NCT02908594|self-efficacy|self-efficacy
1040902|NCT02908594|resilience|resilience
1040903|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
1040904|NCT02908555|type 1 diabetes|type 1 diabetes
1040905|NCT02908555|adolescents|adolescents
1040906|NCT02908555|sleep|sleep
1040907|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
1040908|NCT02908490|Atherosclerosis|atherosclerosis
1040909|NCT02908464|Cardiac Surgery|cardiac surgery
1040910|NCT02908464|Delirium|delirium
1040911|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1040912|NCT02908451|Cancer|cancer
1040913|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
1040914|NCT02908451|AbGn-107|abgn-107
1040915|NCT02908451|Adenocarcinoma|adenocarcinoma
1040916|NCT02908451|Gastric|gastric
1040917|NCT02908451|Colorectal|colorectal
1040918|NCT02908451|Pancreatic|pancreatic
1040919|NCT02908412|Nerve Block|nerve block
1040920|NCT02908412|Spectrophotometry|spectrophotometry
1040921|NCT02908412|Bupivacaine|bupivacaine
1040922|NCT02908412|Spinal Surgery|spinal surgery
1040923|NCT02908412|Blood Loss, Surgical|blood loss, surgical
1040924|NCT02908386|Head and neck tumors|head and neck tumors
1040925|NCT02908386|Proton|proton
1040926|NCT02908386|Photon|photon
1040927|NCT02908386|replanning timing|replanning timing
1040928|NCT02908373|risk management|risk management
1040929|NCT02908373|nursing home|nursing home
1040930|NCT02908373|elderly|elderly
1040931|NCT02908373|care|care
1041220|NCT02906527|Cardiology|cardiology
1040932|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
1040933|NCT02908347|Plaque psoriasis|plaque psoriasis
1040934|NCT02908347|chronic|chronic
1040935|NCT02908347|moderate|moderate
1040936|NCT02908347|severe|severe
1040937|NCT02908347|Plaque|plaque
1040938|NCT02908308|Induced hypothermia|induced hypothermia
1040939|NCT02908308|Mild induced hypothermia|mild induced hypothermia
1040940|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
1040941|NCT02908308|Cardiac arrest|cardiac arrest
1040942|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1040943|NCT02908308|Mortality|mortality
1040944|NCT02908308|Neurological function|neurological function
1725686|NCT00000911|HIV-1|hiv-1
1040945|NCT02908308|Randomised clinical trial|randomised clinical trial
1040946|NCT02908282|tear film|tear film
1040947|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
1040948|NCT02908282|eye drops|eye drops
1040949|NCT02908269|Influenza|influenza
1040950|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
1040951|NCT02908269|Fluzone® High-Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high-dose, influenza vaccine (2016-2017 formulation)
1040953|NCT02908256|delta PP|delta pp
1040954|NCT02908256|vascular filling|vascular filling
1040955|NCT02908243|Hemophilia|hemophilia
1040956|NCT02908243|Primary prophylaxis|primary prophylaxis
1040957|NCT02908243|Pettersson Score|pettersson score
1040958|NCT02908243|Joint function study|joint function study
1040959|NCT02908243|Comorbidity|comorbidity
1040960|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
1040961|NCT02908217|Tocilizumab|tocilizumab
1040962|NCT02908217|Glucocorticoid|glucocorticoid
1040963|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
1040964|NCT02908204|efficacy|efficacy
1040965|NCT02908204|survival|survival
1040966|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
1040967|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
1040968|NCT02908087|Diabetes Type 1|diabetes type 1
1040969|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
1040970|NCT02908087|Liraglutide|liraglutide
1040971|NCT02908087|GLP-1 Analogue|glp-1 analogue
1040972|NCT02908087|Early diagnosis|early diagnosis
1040973|NCT02908074|Hypogonadotropic|hypogonadotropic
1040974|NCT02908074|hypogonadism|hypogonadism
1040975|NCT02908074|testosterone|testosterone
1040976|NCT02908061|Mesh Placement|mesh placement
1040977|NCT02908061|Radical Cystectomy|radical cystectomy
1040978|NCT02908061|16-1285|16-1285
1040979|NCT02908048|liver cancer|liver cancer
1040980|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
1040981|NCT02908048|cirrhosis|cirrhosis
1040982|NCT02908048|hepatitis|hepatitis
1040983|NCT02908048|bile duct cancer|bile duct cancer
1040984|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1040985|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
1040986|NCT02908048|hepatoma|hepatoma
1040987|NCT02908048|liver mass|liver mass
1040988|NCT02907983|Menopause|menopause
1040989|NCT02907983|Post-menopausal|post-menopausal
1040990|NCT02907970|Cervical cancer|cervical cancer
1040991|NCT02907970|Screening|screening
1040992|NCT02907970|Barriers|barriers
1040993|NCT02907931|hemodynamics|hemodynamics
1040994|NCT02907931|ultrasonography|ultrasonography
1040995|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1040996|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
1040997|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
1040998|NCT02907879|vasospasm|vasospasm
1040999|NCT02907879|DIND|dind
1041000|NCT02907879|infarction|infarction
1041001|NCT02907827|complete remission|complete remission
1041002|NCT02907827|cfDNA|cfdna
1041003|NCT02907827|DW-MRI|dw-mri
1041004|NCT02907827|surveillance|surveillance
1041005|NCT02907814|Uveitis|uveitis
1041103|NCT02907333|Conization|conization
1041006|NCT02907814|Optical Coherence Tomography|optical coherence tomography
1041007|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
1041008|NCT02907801|infants|infants
1041009|NCT02907801|perception-action approach|perception-action approach
1041010|NCT02907788|Cystic fibrosis|cystic fibrosis
1041011|NCT02907788|Neutrophils|neutrophils
1041012|NCT02907788|PMN|pmn
1041013|NCT02907788|Inflammation|inflammation
1041014|NCT02907788|Lung disease|lung disease
1041015|NCT02907788|PRAGMA|pragma
1041016|NCT02907762|Endovascular|endovascular
1041017|NCT02907762|EVAR|evar
1041018|NCT02907762|Neck Angulation|neck angulation
1041019|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1041020|NCT02907710|endostar|endostar
1041021|NCT02907710|chemoradiotherapy|chemoradiotherapy
1041022|NCT02907697|HIV/AIDS|hiv/aids
1041023|NCT02907697|adherence|adherence
1041024|NCT02907697|substance use|substance use
1041025|NCT02907697|HIV care continuum|hiv care continuum
1041026|NCT02907684|Cardiovascular disease|cardiovascular disease
1041027|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
1041028|NCT02907684|Diabetes|diabetes
1041029|NCT02907684|Almonds|almonds
1041030|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
1041031|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
1041032|NCT02907684|Snacking|snacking
1041033|NCT02907671|carpal tunnel injection|carpal tunnel injection
1041034|NCT02907671|corticosteroid|corticosteroid
1041035|NCT02907671|ultrasound-guided|ultrasound-guided
1041036|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
1041037|NCT02907658|Internet Use Disorder|internet use disorder
1041038|NCT02907658|Internet Gaming Disorder|internet gaming disorder
1041039|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
1041040|NCT02907658|Indicated Prevention|indicated prevention
1041041|NCT02907658|Adolescents|adolescents
1041042|NCT02907658|Internet Addiction|internet addiction
1041043|NCT02907632|Metoclopramide|metoclopramide
1041044|NCT02907632|Pro kinetic|pro kinetic
1041045|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
1041046|NCT02907632|Premature Infant|premature infant
1041047|NCT02907632|Low Birth Weight|low birth weight
1041048|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
1041049|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
1041050|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
1041051|NCT02907606|circulating tumor DNA|circulating tumor dna
1041052|NCT02907606|urine|urine
1041053|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1041054|NCT02907593|Pulmonary|pulmonary
1041055|NCT02907593|Surfactant|surfactant
1041056|NCT02907593|Steroids|steroids
1041057|NCT02907593|Extremely low gestational age|extremely low gestational age
1041058|NCT02907580|influenza|influenza
1041059|NCT02907580|vaccination|vaccination
1041060|NCT02907554|Preconditioning|preconditioning
1041061|NCT02907554|Tissue and organ procurement|tissue and organ procurement
1041062|NCT02907554|Cyclosporine A|cyclosporine a
1041063|NCT02907554|Kidney transplantation|kidney transplantation
1041064|NCT02907554|Delayed graft function|delayed graft function
1041065|NCT02907541|eLearning|elearning
1041066|NCT02907541|Quality Improvement Methods|quality improvement methods
1041067|NCT02907541|Knowledge Transfer|knowledge transfer
1041068|NCT02907541|Impact of learning|impact of learning
1041069|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
1041070|NCT02907489|post operative pain|post operative pain
1041071|NCT02907489|triple antibiotic paste|triple antibiotic paste
1041072|NCT02907489|intracanal medication|intracanal medication
1041073|NCT02907476|Vagal-gamma amino-butyric acid (GABA)|vagal-gamma amino-butyric acid (gaba)
1041074|NCT02907476|Yoga|yoga
1041075|NCT02907476|Walking|walking
1041076|NCT02907463|Aortic Valve Replacement|aortic valve replacement
1041077|NCT02907463|Aortic Stenosis|aortic stenosis
1041078|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
1041079|NCT02907463|Rapid deployment valves|rapid deployment valves
1041080|NCT02907437|Minocycline|minocycline
1041081|NCT02907437|Negative symptoms|negative symptoms
1041082|NCT02907437|Cognitive symptoms|cognitive symptoms
1041083|NCT02907437|Inflammation|inflammation
1041084|NCT02907411|Quadrivas|quadrivas
1041085|NCT02907411|Veins|veins
1041086|NCT02907411|Lipedema|lipedema
1041087|NCT02907411|Lymphedema|lymphedema
1041088|NCT02907398|Neurostimulation|neurostimulation
1041089|NCT02907398|Hypoglossal nerve|hypoglossal nerve
1041090|NCT02907398|Tongue|tongue
1041091|NCT02907398|Upper airway stimulation|upper airway stimulation
1041092|NCT02907398|Surgery|surgery
1041093|NCT02907385|Rectal Cancer|rectal cancer
1041094|NCT02907385|Low Anterior Resection|low anterior resection
1041095|NCT02907385|LifeSeal|lifeseal
1041096|NCT02907385|Surgical Sealant|surgical sealant
1041097|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
1041098|NCT02907372|cognitive complaints|cognitive complaints
1041099|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
1041100|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
1041101|NCT02907333|Condom use|condom use
1041102|NCT02907333|Human Papillomavirus|human papillomavirus
1041104|NCT02907307|LactiSal|lactisal
1041105|NCT02907307|Vaginal therapy|vaginal therapy
1041106|NCT02907294|PDE10 inhibitor|pde10 inhibitor
1041107|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
1041108|NCT02907294|Huntington's disease|huntington's disease
1041109|NCT02907294|psychiatric disorders|psychiatric disorders
1041110|NCT02907281|Multiple sclerosis,|multiple sclerosis,
1041111|NCT02907281|MS,|ms,
1041112|NCT02907281|Optical coherence tomography|optical coherence tomography
1041113|NCT02907281|OCT,|oct,
1041114|NCT02907281|RRMS|rrms
1041115|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
1041116|NCT02907255|Pulse oximetry|pulse oximetry
1041117|NCT02907255|vital signs monitoring|vital signs monitoring
1041118|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
1041119|NCT02907255|respiratory monitoring system|respiratory monitoring system
1041120|NCT02907242|stillbirth|stillbirth
1041121|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
1041122|NCT02907242|fetal growth restriction|fetal growth restriction
1041123|NCT02907216|Healthy Japanese infants|healthy japanese infants
1041124|NCT02907216|Safety|safety
1041221|NCT02906527|Oral anticoagulants|oral anticoagulants
1041525|NCT02904746|follow-up|follow-up
1041125|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
1041126|NCT02907216|Vaccination|vaccination
1041127|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
1041128|NCT02907216|Immunogenicity|immunogenicity
1041129|NCT02907190|pulses|pulses
1041130|NCT02907190|beans|beans
1041131|NCT02907190|blood glucose|blood glucose
1041132|NCT02907190|insulin|insulin
1041133|NCT02907112|meat intake|meat intake
1041134|NCT02907112|meat analogues|meat analogues
1041135|NCT02907112|LDL Cholesterol|ldl cholesterol
1041136|NCT02907112|HDL Cholesterol|hdl cholesterol
1041137|NCT02907099|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1041138|NCT02907099|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1041139|NCT02907099|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1041140|NCT02907099|BL-8040|bl-8040
1041141|NCT02907099|Pembrolizumab|pembrolizumab
1041142|NCT02907099|Keytruda|keytruda
1041143|NCT02907099|MK-3475|mk-3475
1041144|NCT02907099|SCH-900475|sch-900475
1041145|NCT02907099|Phone call|phone call
1041146|NCT02907060|prolonged pregnancy|prolonged pregnancy
1041147|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
1041148|NCT02906995|pharmacokinetics|pharmacokinetics
1041149|NCT02906995|nicotine absorption|nicotine absorption
1041150|NCT02906982|Periodontal diseases|periodontal diseases
1041151|NCT02906982|Periodontitis|periodontitis
1041152|NCT02906982|Gingivitis|gingivitis
1041153|NCT02906982|Teeth Whitening|teeth whitening
1041154|NCT02906982|Dental Plaque Index|dental plaque index
1041155|NCT02906982|Periodontal Index|periodontal index
1041156|NCT02906982|Teeth Whitening Agents|teeth whitening agents
1041157|NCT02906982|Tooth Discoloration|tooth discoloration
1041158|NCT02906982|Mean Probing Depth|mean probing depth
1041159|NCT02906982|Pocket Depth|pocket depth
1041160|NCT02906943|Molecular Profiling|molecular profiling
1041161|NCT02906943|Advanced Cancer|advanced cancer
1041162|NCT02906943|Advanced Solid Tumors|advanced solid tumors
1041163|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
1041164|NCT02906943|Next Generation Sequencing|next generation sequencing
1041165|NCT02906878|Intensive Care|intensive care
1041166|NCT02906878|Haematology|haematology
1041167|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
1041168|NCT02906839|cardiovascular risk|cardiovascular risk
1041169|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
1041170|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
1041171|NCT02906839|atrial fibrillation|atrial fibrillation
1041172|NCT02906826|Airway clearance technique|airway clearance technique
1041173|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
1041174|NCT02906826|Adherence|adherence
1041175|NCT02906813|Drug Therapy|drug therapy
1041176|NCT02906800|cisplatin|cisplatin
1041177|NCT02906800|head and neck cancer|head and neck cancer
1041178|NCT02906800|digoxin|digoxin
1041179|NCT02906787|Smoking Cessation|smoking cessation
1041180|NCT02906787|Weight Loss|weight loss
1041181|NCT02906761|asthma, aspirin|asthma, aspirin
1041182|NCT02906748|parathyroid autografting|parathyroid autografting
1041183|NCT02906748|thyroidectomy|thyroidectomy
1041184|NCT02906748|survival rate|survival rate
1041185|NCT02906748|hypoparathyroidism|hypoparathyroidism
1041186|NCT02906722|Nebulized colistin|nebulized colistin
1041187|NCT02906722|Intravenous colistin|intravenous colistin
1041188|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
1041189|NCT02906722|multidrug resistance|multidrug resistance
1041190|NCT02906722|Gram-negative bacteria|gram-negative bacteria
1041191|NCT02906696|Chronic myelogenous leukemia|chronic myelogenous leukemia
1041192|NCT02906696|CML|cml
1041193|NCT02906696|Chronic phase post frontline TKI failure|chronic phase post frontline tki failure
1041194|NCT02906696|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1041195|NCT02906696|TKI|tki
1041196|NCT02906696|Bosutinib|bosutinib
1041197|NCT02906696|SKI-606|ski-606
1041198|NCT02906696|Phone calls|phone calls
1041199|NCT02906696|Questionnaires|questionnaires
1041200|NCT02906696|Surveys|surveys
1041201|NCT02906683|Urinary Incontinence|urinary incontinence
1041202|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
1041203|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1041204|NCT02906670|Epithelial malignancies|epithelial malignancies
1041205|NCT02906657|Medication Reconciliation|medication reconciliation
1041206|NCT02906657|Adverse Drug Event|adverse drug event
1041207|NCT02906657|Elderly|elderly
1041208|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
1041209|NCT02906644|Nicotine addiction|nicotine addiction
1041210|NCT02906644|Cigarette smoking|cigarette smoking
1041211|NCT02906644|Smoking cessation|smoking cessation
1041212|NCT02906644|lorcaserin|lorcaserin
1041213|NCT02906644|Belviq|belviq
1041214|NCT02906644|Nicotine patches|nicotine patches
1041215|NCT02906631|encephalitis,|encephalitis,
1041216|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
1041217|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
1041218|NCT02906553|Nitric Oxide|nitric oxide
1041219|NCT02906553|Cognition|cognition
1041222|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
1041223|NCT02906527|Health insurance databases|health insurance databases
1041224|NCT02906527|Safety|safety
1041225|NCT02906527|Elderly|elderly
1041226|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
1041227|NCT02906514|Cardiac surgery|cardiac surgery
1041228|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
1041229|NCT02906501|Risperidone|risperidone
1041230|NCT02906501|ADHD|adhd
1041231|NCT02906501|DBD|dbd
1041232|NCT02906501|IGT|igt
1041233|NCT02906501|CNP|cnp
1041234|NCT02906501|Executive functions|executive functions
1041235|NCT02906488|Quality of life|quality of life
1041236|NCT02906475|Dermatitis, atopic|dermatitis, atopic
1041237|NCT02906475|prevention and control|prevention and control
1041238|NCT02906475|Infant|infant
1041239|NCT02906475|Skin care|skin care
1041240|NCT02906475|randomized controlled trial|randomized controlled trial
1041241|NCT02906462|Leonetti French law|leonetti french law
1041242|NCT02906462|Palliative care|palliative care
1041243|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
1041244|NCT02906436|Lung transplantation|lung transplantation
1041245|NCT02906436|ExVivo reconditionning|exvivo reconditionning
1041246|NCT02906423|Quality of Life|quality of life
1041247|NCT02906423|Patient-Centered Care|patient-centered care
1041248|NCT02906423|Patient Outcome Assessment|patient outcome assessment
1041249|NCT02906384|hippocampus avoidance|hippocampus avoidance
1041250|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
1041251|NCT02906384|functional MRI|functional mri
1041252|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
1041253|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
1041254|NCT02906345|Septic shock|septic shock
1041255|NCT02906345|Fresh frozen plasma|fresh frozen plasma
1041256|NCT02906306|Older adults|older adults
1041257|NCT02906306|Occupational Therapy|occupational therapy
1041258|NCT02906306|Self-Efficacy|self-efficacy
1041259|NCT02906306|Psychological Well-being|psychological well-being
1041260|NCT02906280|EBUS-TBNA|ebus-tbna
1041261|NCT02906241|African Americans|african americans
1041262|NCT02906241|prostate cancer|prostate cancer
1041263|NCT02906241|Minority|minority
1041264|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
1041265|NCT02906241|Cancer care|cancer care
1041266|NCT02906241|patient-physician communication|patient-physician communication
1041267|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
1041268|NCT02906228|non-ionizing radiation|non-ionizing radiation
1041269|NCT02906215|mHealth|mhealth
1041270|NCT02906215|implementation|implementation
1041271|NCT02906163|EGFR mutation positive|egfr mutation positive
1041272|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
1041273|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
1041274|NCT02906163|Thymalfasin|thymalfasin
1041275|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
1041276|NCT02906150|EGFR Wild Type|egfr wild type
1041277|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
1041278|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
1041279|NCT02906150|Thymalfasin|thymalfasin
1041280|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
1041281|NCT02906124|Lipid lowering therapies|lipid lowering therapies
1041282|NCT02906124|Pregnancy|pregnancy
1041283|NCT02906111|Estriol|estriol
1041284|NCT02906111|Prolapse|prolapse
1041285|NCT02906111|Quality of life|quality of life
1041286|NCT02906111|Vaginal health|vaginal health
1041287|NCT02906111|Vaginal surgery|vaginal surgery
1041288|NCT02906098|Gingivitis|gingivitis
1041289|NCT02906098|Adolescents|adolescents
1041290|NCT02906098|Oral hygiene|oral hygiene
1041291|NCT02906098|Oral health behavior|oral health behavior
1041292|NCT02906098|Periodontal infection control|periodontal infection control
1041293|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
1041294|NCT02906072|Obesity|obesity
1041295|NCT02906072|Body fat|body fat
1041399|NCT02905539|anemia|anemia
1041296|NCT02906072|Plant-based diet|plant-based diet
1041297|NCT02906072|Plant-based meal replacement|plant-based meal replacement
1041298|NCT02906059|RAS|ras
1041299|NCT02906059|KRAS|kras
1041300|NCT02906059|NRAS|nras
1041301|NCT02906059|BRAF|braf
1041302|NCT02906059|Mutated|mutated
1041303|NCT02906059|Wee1 inhibitor|wee1 inhibitor
1041304|NCT02906046|SCA 3|sca 3
1041305|NCT02906046|Ataxic Gait|ataxic gait
1041306|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
1041307|NCT02906033|Operating Rooms|operating rooms
1041308|NCT02906033|Quality of Life|quality of life
1041309|NCT02906033|Surgery-related anxiety|surgery-related anxiety
1041310|NCT02905994|Leukemia|leukemia
1041311|NCT02905981|IRIDA|irida
1041312|NCT02905981|Triferic|triferic
1041313|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
1041314|NCT02905981|Shohl's solution|shohl's solution
1041315|NCT02905968|Anastomotic leak|anastomotic leak
1041316|NCT02905968|Low rectal cancer|low rectal cancer
1041317|NCT02905929|sedentary behavior|sedentary behavior
1041318|NCT02905929|standing|standing
1041319|NCT02905929|sitting|sitting
1041320|NCT02905929|inclinometer|inclinometer
1041321|NCT02905864|Liraglutide|liraglutide
1041322|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
1041323|NCT02905864|Osteoarthritis|osteoarthritis
1041324|NCT02905864|Obesity|obesity
1041325|NCT02905799|Osteoarthritis|osteoarthritis
1041326|NCT02905799|Knee|knee
1041327|NCT02905799|Resveratrol|resveratrol
1041328|NCT02905799|Oral Treatment|oral treatment
1041329|NCT02905799|Pain|pain
1041330|NCT02905799|Trial|trial
1041331|NCT02905786|General Practice|general practice
1041332|NCT02905786|Nurse practitioner|nurse practitioner
1041333|NCT02905786|Natriuretic peptides|natriuretic peptides
1041334|NCT02905786|Clinical audit|clinical audit
1041335|NCT02905773|Intensity|intensity
1041336|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
1041337|NCT02905760|Right ventricular infarction|right ventricular infarction
1041338|NCT02905760|Diuretic|diuretic
1041339|NCT02905760|Fluid Expansion|fluid expansion
1041340|NCT02905747|Exercise Therapy|exercise therapy
1041341|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
1041342|NCT02905747|Knee osteoarthritis|knee osteoarthritis
1041343|NCT02905747|Physical Therapy Modalities|physical therapy modalities
1041344|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
1041345|NCT02905734|Tobacco|tobacco
1041346|NCT02905708|normothermia|normothermia
1041347|NCT02905708|hypothermia|hypothermia
1041348|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
1041349|NCT02905695|Episiotomy|episiotomy
1041350|NCT02905695|First-degree tear|first-degree tear
1041351|NCT02905669|distensibility|distensibility
1041352|NCT02905669|impedance planimetry|impedance planimetry
1041353|NCT02905669|esophagus|esophagus
1041354|NCT02905669|esophago-gastric junction|esophago-gastric junction
1041355|NCT02905669|pylorus|pylorus
1041356|NCT02905656|quitline|quitline
1041357|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
1041358|NCT02905656|tobacco intervention|tobacco intervention
1041359|NCT02905656|smokers not ready to quit|smokers not ready to quit
1041360|NCT02905643|Pseudoprogression|pseudoprogression
1041361|NCT02905643|Brain Cancer|brain cancer
1041362|NCT02905630|coronary flow reserve|coronary flow reserve
1041363|NCT02905630|angina|angina
1041364|NCT02905630|exercise training|exercise training
1041365|NCT02905617|Breast Augmentation|breast augmentation
1041366|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
1041367|NCT02905604|rTMS|rtms
1041368|NCT02905604|negative symptoms|negative symptoms
1041369|NCT02905604|intermittent theta burst|intermittent theta burst
1041370|NCT02905604|iTBS|itbs
1041371|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1041372|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
1041373|NCT02905604|dmPFC|dmpfc
1041374|NCT02905604|NIRS|nirs
1041375|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
1041376|NCT02905591|ascorbic acid|ascorbic acid
1041377|NCT02905591|radiation|radiation
1041378|NCT02905591|chemotherapy|chemotherapy
1041379|NCT02905591|carboplatin|carboplatin
1041380|NCT02905591|paclitaxel|paclitaxel
1041381|NCT02905578|Ascorbate|ascorbate
1041382|NCT02905578|Vitamin C|vitamin c
1041383|NCT02905578|Pharmacological ascorbate|pharmacological ascorbate
1041384|NCT02905578|Pharmacologic ascorbate|pharmacologic ascorbate
1041385|NCT02905578|Ascorbic Acid|ascorbic acid
1041386|NCT02905578|gemcitabine|gemcitabine
1041387|NCT02905578|nab-paclitaxel|nab-paclitaxel
1041388|NCT02905565|Multicenter|multicenter
1041389|NCT02905565|Randomized|randomized
1041390|NCT02905565|Double-Blind|double-blind
1041391|NCT02905565|Placebo-Controlled|placebo-controlled
1041392|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
1041393|NCT02905565|Safety|safety
1041394|NCT02905565|Efficacy|efficacy
1041395|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
1041396|NCT02905552|Infection|infection
1041397|NCT02905552|Risk Factors|risk factors
1041398|NCT02905539|Iron|iron
1041400|NCT02905539|phosphorus|phosphorus
1041401|NCT02905539|FGF-23|fgf-23
1041402|NCT02905526|Reproductive health|reproductive health
1041403|NCT02905513|Reproductive health|reproductive health
1041404|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
1041405|NCT02905500|Epidemiology|epidemiology
1041406|NCT02905500|Public Health|public health
1041407|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
1041408|NCT02905487|Obesity|obesity
1041409|NCT02905487|Adipocytokin|adipocytokin
1041410|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
1041411|NCT02905461|Reproductive health|reproductive health
1041412|NCT02905448|Obesity|obesity
1041413|NCT02905448|Body composition|body composition
1041414|NCT02905448|Atherosclerosis|atherosclerosis
1041415|NCT02905448|Insulin resistance|insulin resistance
1041416|NCT02905448|Hyperuricemia|hyperuricemia
1041417|NCT02905435|burns|burns
1041418|NCT02905435|autografts|autografts
1041419|NCT02905435|humans|humans
1041420|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
1041421|NCT02905435|dermal matrix|dermal matrix
1041422|NCT02905435|synthetic|synthetic
1041423|NCT02905422|physical activity|physical activity
1041424|NCT02905422|sleep|sleep
1041425|NCT02905422|nutrition|nutrition
1041426|NCT02905422|Soldier|soldier
1041427|NCT02905422|prevention|prevention
1041428|NCT02905422|remote monitoring|remote monitoring
1041429|NCT02905422|mobile technology|mobile technology
1041430|NCT02905396|small fiber neuropathy|small fiber neuropathy
1041431|NCT02905396|spinal cord stimulation|spinal cord stimulation
1041432|NCT02905396|treatment|treatment
1041433|NCT02905396|pain|pain
1041434|NCT02905370|Home Health|home health
1041435|NCT02905370|Rehabilitation|rehabilitation
1041436|NCT02905370|High Intensity|high intensity
1041437|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
1041438|NCT02905370|Functional Mobility|functional mobility
1041439|NCT02905370|Physical Function|physical function
1041440|NCT02905357|Myocardial Infarction|myocardial infarction
1041441|NCT02905357|Women|women
1041442|NCT02905357|Imaging|imaging
1041443|NCT02905305|cochlear implants|cochlear implants
1041444|NCT02905305|Dexamethasone|dexamethasone
1041445|NCT02905305|combined device|combined device
1041446|NCT02905279|spider phobia|spider phobia
1041447|NCT02905279|animal phobia|animal phobia
1041448|NCT02905279|exposure therapy|exposure therapy
1041449|NCT02905279|biofeedback|biofeedback
1041450|NCT02905279|relaxation training|relaxation training
1041451|NCT02905240|Autologous Protein Solution|autologous protein solution
1041452|NCT02905240|APS|aps
1041453|NCT02905240|intra-articular injection|intra-articular injection
1041454|NCT02905240|osteoarthritis|osteoarthritis
1041455|NCT02905227|Adult smokers|adult smokers
1041456|NCT02905227|Asthma|asthma
1041457|NCT02905227|Healthy volunteers|healthy volunteers
1041458|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
1041459|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
1041460|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
1041461|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
1041462|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
1041463|NCT02905149|Oncological|oncological
1041464|NCT02905149|Surgery|surgery
1041465|NCT02905149|Breast|breast
1041466|NCT02905149|Reconstruction|reconstruction
1041467|NCT02905136|autoantibodies|autoantibodies
1041468|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
1041469|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
1041470|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
1041471|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
1041472|NCT02905097|Knee replacement, Total|knee replacement, total
1041473|NCT02905097|Survival rate|survival rate
1041474|NCT02905097|Osseointegration|osseointegration
1041475|NCT02905097|Gait|gait
1041476|NCT02905071|mental health|mental health
1041477|NCT02905071|well-being at work|well-being at work
1041478|NCT02905071|screening|screening
1041479|NCT02905071|psychosocial risk|psychosocial risk
1041480|NCT02905071|psychometrics|psychometrics
1041481|NCT02905071|questionnaire|questionnaire
1041482|NCT02905071|job stress|job stress
1041483|NCT02905032|Afib|afib
1041484|NCT02905032|Atrial fib|atrial fib
1041485|NCT02905032|Shared|shared
1041486|NCT02905032|Decision|decision
1041487|NCT02905032|Making|making
1041489|NCT02905032|AF|af
1041490|NCT02905006|Psoriasis|psoriasis
1041491|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
1041492|NCT02905006|Bimekizumab|bimekizumab
1041493|NCT02904980|Quiet eye training|quiet eye training
1041494|NCT02904980|Visual Attention|visual attention
1041495|NCT02904954|Lung neoplasms|lung neoplasms
1041496|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
1041497|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
1041498|NCT02904954|Neoplasms|neoplasms
1041499|NCT02904954|Neoplasms by site|neoplasms by site
1041500|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
1041501|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
1041709|NCT02903472|genomics|genomics
1041502|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
1041503|NCT02904941|Children|children
1041504|NCT02904941|Skin Transplantation|skin transplantation
1041505|NCT02904941|Amniotic Membrane|amniotic membrane
1041506|NCT02904902|efficacy|efficacy
1041507|NCT02904902|safety|safety
1041508|NCT02904902|adalimumab|adalimumab
1041509|NCT02904902|japanese participants|japanese participants
1041510|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
1041511|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
1041512|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
1041513|NCT02904837|Randomized clinical trial|randomized clinical trial
1041514|NCT02904837|Parkinson's disease|parkinson's disease
1041515|NCT02904837|Mental practice|mental practice
1041516|NCT02904837|Gait|gait
1041517|NCT02904824|adipose tissue|adipose tissue
1041518|NCT02904824|adult stem cells|adult stem cells
1041519|NCT02904824|vocal cord paralysis|vocal cord paralysis
1041520|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
1041521|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
1041522|NCT02904798|sunscreen|sunscreen
1041523|NCT02904798|photoprotection|photoprotection
1041524|NCT02904798|visible light|visible light
1041526|NCT02904746|mental health appointment|mental health appointment
1041527|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
1041528|NCT02904707|Skin Graft|skin graft
1041529|NCT02904668|chronic pain|chronic pain
1041530|NCT02904642|SMS reminder|sms reminder
1041531|NCT02904642|incentive|incentive
1041532|NCT02904642|mobile phone|mobile phone
1041533|NCT02904642|Immunization|immunization
1041534|NCT02904590|IBD|ibd
1041535|NCT02904590|Infection|infection
1041536|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
1041537|NCT02904577|prospective collection|prospective collection
1041538|NCT02904564|drug delivery|drug delivery
1041539|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
1041540|NCT02904551|prospective study|prospective study
1041541|NCT02904551|free gingival graft|free gingival graft
1041542|NCT02904551|keratinized gingiva|keratinized gingiva
1041543|NCT02904551|dental implant|dental implant
1041544|NCT02904538|Dexamethasone|dexamethasone
1041545|NCT02904538|Regional anesthesia|regional anesthesia
1041546|NCT02904538|Front foot surgery|front foot surgery
1041547|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
1041548|NCT02904525|newly diagnosed|newly diagnosed
1041549|NCT02904525|MRI|mri
1041550|NCT02904499|Atrial Fibrillation|atrial fibrillation
1041551|NCT02904499|Anticoagulants|anticoagulants
1041552|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
1041553|NCT02904447|hemicap|hemicap
1041554|NCT02904447|hallux rigidus|hallux rigidus
1041555|NCT02904434|voriconazole|voriconazole
1041556|NCT02904434|absorption|absorption
1041557|NCT02904434|pharmacokinetic|pharmacokinetic
1041558|NCT02904434|grapefruit juice|grapefruit juice
1041559|NCT02904434|bioavailability|bioavailability
1041560|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
1041561|NCT02904434|pharmacokinetics|pharmacokinetics
1041562|NCT02904434|intestinal|intestinal
1041563|NCT02904421|scoliosis|scoliosis
1041564|NCT02904421|spinal deformity|spinal deformity
1041565|NCT02904421|vitamin D|vitamin d
1041566|NCT02904421|bone health|bone health
1041567|NCT02904408|quality of life|quality of life
1041568|NCT02904408|psychotherapy|psychotherapy
1041569|NCT02904408|hidradenitis|hidradenitis
1041570|NCT02904408|treatments|treatments
1041571|NCT02904356|OCD|ocd
1041572|NCT02904356|TMS|tms
1041573|NCT02904356|Neuromodulation|neuromodulation
1041574|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1041575|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1041576|NCT02904356|Imaging|imaging
1041577|NCT02904343|hemodialysis machine|hemodialysis machine
1041578|NCT02904343|quality|quality
1041579|NCT02904343|safety|safety
1041580|NCT02904343|domestic|domestic
1041581|NCT02904304|Flu|flu
1041582|NCT02904304|Treatment|treatment
1041583|NCT02904291|Bariatric surgery|bariatric surgery
1041584|NCT02904291|Gastrointestinal tract|gastrointestinal tract
1041585|NCT02904291|Biological availability|biological availability
1041586|NCT02904291|Pharmacokinetics|pharmacokinetics
1041587|NCT02904291|Amlodipine|amlodipine
1041588|NCT02904278|Mobile Application Intervention|mobile application intervention
1041589|NCT02904278|Teen Pocket PATH® [TPP]|teen pocket path® [tpp]
1041590|NCT02904278|Adherence|adherence
1041591|NCT02904278|Medical Management|medical management
1041592|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
1041593|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
1041594|NCT02904265|acetazolamide|acetazolamide
1041595|NCT02904265|diazepam|diazepam
1041596|NCT02904252|Transient elastography|transient elastography
1041597|NCT02904252|Fibrotest|fibrotest
1041598|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
1041599|NCT02904239|Incidental cardiac findings|incidental cardiac findings
1041600|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
1041601|NCT02904239|Management guidelines|management guidelines
1041602|NCT02904226|ICOS|icos
1041603|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
1041604|NCT02904226|JTX-2011|jtx-2011
1041605|NCT02904226|Anti-PD-1|anti-pd-1
1041606|NCT02904226|Nivolumab|nivolumab
1041607|NCT02904226|ICONIC|iconic
1041608|NCT02904226|Immunotherapy|immunotherapy
1041609|NCT02904226|Immuno-oncology|immuno-oncology
1041610|NCT02904226|Cancer|cancer
1041611|NCT02904226|Solid Tumor|solid tumor
1041612|NCT02904226|Dose Escalation|dose escalation
1041613|NCT02904226|Dose Expansion|dose expansion
1041614|NCT02904226|Anti-CTLA-4|anti-ctla-4
1041615|NCT02904226|Ipilimumab|ipilimumab
1041616|NCT02904226|Pembrolizumab|pembrolizumab
1041617|NCT02904213|vaccine|vaccine
1041618|NCT02904213|ComBe Five|combe five
1041619|NCT02904213|Vietnam|vietnam
1041620|NCT02904213|pentavalent|pentavalent
1041621|NCT02904135|Circulating Tumor Cells|circulating tumor cells
1041622|NCT02904070|Threat of|threat of
1041623|NCT02904044|School|school
1041624|NCT02904044|Sport|sport
1041625|NCT02904044|Injuries|injuries
1041626|NCT02904005|Suicide|suicide
1041627|NCT02904005|Prediction|prediction
1041628|NCT02904005|Prospective study|prospective study
1041629|NCT02904005|Suicide attempt|suicide attempt
1041630|NCT02904005|Risk management|risk management
1041631|NCT02903992|Frail Elderly|frail elderly
1041632|NCT02903992|sarcopenia|sarcopenia
1041633|NCT02903966|Tolerability|tolerability
1041634|NCT02903966|GSK2982772|gsk2982772
1041635|NCT02903966|Safety|safety
1041636|NCT02903966|Pharmacokinetics|pharmacokinetics
1041637|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
1041638|NCT02903966|Ulcerative colitis|ulcerative colitis
1041639|NCT02903966|Pharmacodynamics|pharmacodynamics
1041640|NCT02903914|Immuno-Oncology|immuno-oncology
1041641|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
1041642|NCT02903914|Tumor Metabolism|tumor metabolism
1041643|NCT02903914|Programmed cell death protein-1 (PD-1) inhibitor|programmed cell death protein-1 (pd-1) inhibitor
1041644|NCT02903914|Programmed death ligand 1 (PD-L1) inhibitor|programmed death ligand 1 (pd-l1) inhibitor
1041645|NCT02903914|Solid Tumors|solid tumors
1041646|NCT02903914|RCC|rcc
1041647|NCT02903914|MEL|mel
1041648|NCT02903914|NSCLC|nsclc
1041649|NCT02903914|Arginase|arginase
1041650|NCT02903914|Arginase Inhibitor|arginase inhibitor
1041651|NCT02903914|INCB001158 (CB-1158)|incb001158 (cb-1158)
1041652|NCT02903914|SCCHN|scchn
1041653|NCT02903914|GEJ|gej
1041654|NCT02903914|Immune Therapy|immune therapy
1041655|NCT02903901|Delirium|delirium
1041656|NCT02903862|Caregivers|caregivers
1041657|NCT02903862|Case Management|case management
1041658|NCT02903862|Alzheimer's Disease|alzheimer's disease
1041659|NCT02903862|Cognition|cognition
1041660|NCT02903862|Caregiver Burden|caregiver burden
1041661|NCT02903862|Depression|depression
1041662|NCT02903823|spinal cord injury|spinal cord injury
1041663|NCT02903823|cerebral palsy|cerebral palsy
1041664|NCT02903823|stroke|stroke
1041665|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
1041666|NCT02903797|Irisin|irisin
1041667|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
1041668|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
1041669|NCT02903771|Cantrixil|cantrixil
1041670|NCT02903771|Intraperitoneal|intraperitoneal
1041671|NCT02903719|Phrenic|phrenic
1041672|NCT02903719|Nerve block|nerve block
1041673|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
1041674|NCT02903719|Liver resection|liver resection
1041675|NCT02903706|gold miners|gold miners
1041676|NCT02903706|plasmodium carriers|plasmodium carriers
1041677|NCT02903706|artemisinine resistance|artemisinine resistance
1041678|NCT02903680|Relapse Prevention|relapse prevention
1041679|NCT02903680|Children|children
1041680|NCT02903667|bone grafting|bone grafting
1041681|NCT02903667|implantology|implantology
1041682|NCT02903667|oral surgery|oral surgery
1041683|NCT02903628|myopia|myopia
1041684|NCT02903615|glucose|glucose
1041685|NCT02903615|inflammation|inflammation
1041686|NCT02903602|sharing histories|sharing histories
1041687|NCT02903602|autobiographical memory|autobiographical memory
1041688|NCT02903602|health behavior|health behavior
1041689|NCT02903602|narrative communication|narrative communication
1041690|NCT02903602|community health workers|community health workers
1041691|NCT02903602|global health|global health
1041692|NCT02903602|maternal and child health|maternal and child health
1041693|NCT02903602|stunting|stunting
1041694|NCT02903537|Multiple Sclerosis|multiple sclerosis
1041695|NCT02903537|Dendritic Cells|dendritic cells
1041696|NCT02903537|Immune Tolerance|immune tolerance
1041697|NCT02903537|Myelin Proteins|myelin proteins
1041698|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
1041699|NCT02903511|Metformin|metformin
1041700|NCT02903511|total kidney volume|total kidney volume
1041701|NCT02903511|glomerular filtration rate|glomerular filtration rate
1041702|NCT02903498|disease control survival|disease control survival
1041703|NCT02903472|SCI|sci
1041704|NCT02903472|microbiome|microbiome
1041705|NCT02903472|metabolome|metabolome
1041706|NCT02903472|GI|gi
1041707|NCT02903472|UTI|uti
1041708|NCT02903472|DNA|dna
1041710|NCT02903472|infections|infections
1041711|NCT02903472|tetraplegic|tetraplegic
1041712|NCT02903472|paraplegic|paraplegic
1041713|NCT02903459|Central Fat|central fat
1041714|NCT02903459|Subcutaneous Fat|subcutaneous fat
1041715|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
1041716|NCT02903459|Cellulite|cellulite
1041717|NCT02903433|Avocado|avocado
1041718|NCT02903433|Cardiovascular disease|cardiovascular disease
1041719|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
1041720|NCT02903407|Intensive Care Units|intensive care units
1041721|NCT02903407|Deep Sedation|deep sedation
1041722|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
1041723|NCT02903368|Prostate Cancer|prostate cancer
1041724|NCT02903342|Fever|fever
1041725|NCT02903342|Febrile illness|febrile illness
1041726|NCT02903342|Children|children
1041727|NCT02903316|Fluid responsiveness|fluid responsiveness
1041728|NCT02903316|Perioperative|perioperative
1041729|NCT02903316|Extra systoles|extra systoles
1041730|NCT02903316|Coronary artery bypass|coronary artery bypass
1041731|NCT02903316|Systolic arterial pressure|systolic arterial pressure
1041732|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
1041733|NCT02903264|Obesity|obesity
1041734|NCT02903264|Periodontal Disease|periodontal disease
1041735|NCT02903251|Oxytocin|oxytocin
1726079|NCT00000864|Pregnancy|pregnancy
1074927|NCT02699736|HIV|hiv
1041736|NCT02903251|Administration, Intranasal|administration, intranasal
1041737|NCT02903251|Ethanol|ethanol
1041738|NCT02903238|placebo|placebo
1041739|NCT02903238|pain|pain
1041740|NCT02903238|osteoarthritis|osteoarthritis
1041741|NCT02903225|Heart rate variability|heart rate variability
1041742|NCT02903225|Systolic heart failure|systolic heart failure
1041743|NCT02903225|Physical exercise|physical exercise
1041744|NCT02903225|Parasympathetic indexes|parasympathetic indexes
1041745|NCT02903212|Apoptotic cells|apoptotic cells
1041746|NCT02903199|Whey Protein|whey protein
1041747|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
1041748|NCT02903199|Appetite Response|appetite response
1041749|NCT02903186|infants|infants
1041750|NCT02903186|minorities|minorities
1041751|NCT02903186|overfeeding|overfeeding
1041752|NCT02903186|WIC program|wic program
1041753|NCT02903186|feeding practices|feeding practices
1041754|NCT02903186|breastfeeding|breastfeeding
1041755|NCT02903173|respiratory depression|respiratory depression
1041756|NCT02903173|postpartum|postpartum
1041757|NCT02903173|neuraxial morphine|neuraxial morphine
1041758|NCT02903173|cesarean delivery|cesarean delivery
1041759|NCT02903160|Castration resistant|castration resistant
1041760|NCT02903160|Prostate cancer|prostate cancer
1041761|NCT02903160|Metastatic|metastatic
1041762|NCT02903160|First-line|first-line
1041763|NCT02903160|Treatment naive|treatment naive
1041764|NCT02903160|Rapidly cycling|rapidly cycling
1041765|NCT02903160|Non-cross resistant|non-cross resistant
1041766|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
1041767|NCT02903121|Unscheduled bleeding|unscheduled bleeding
1041768|NCT02903121|Long acting contraception|long acting contraception
1041769|NCT02903095|Single ascending dose|single ascending dose
1041770|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
1041771|NCT02903082|Sepsis|sepsis
1041772|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
1041773|NCT02903069|newly diagnosed|newly diagnosed
1041774|NCT02903069|malignant glioma|malignant glioma
1041775|NCT02903069|WHO Grade 4|who grade 4
1041776|NCT02903069|WHO Grade IV|who grade iv
1041777|NCT02903069|marizomib|marizomib
1041778|NCT02903069|MRZ|mrz
1041779|NCT02903069|TMZ|tmz
1041780|NCT02903069|RT|rt
1041781|NCT02903069|brain cancer|brain cancer
1041782|NCT02903069|proteasome inhibitor|proteasome inhibitor
1041783|NCT02903069|radiation|radiation
1041784|NCT02903069|temozolomide|temozolomide
1041785|NCT02903069|temodar|temodar
1041786|NCT02903069|chemotherapy|chemotherapy
1041787|NCT02903069|concurrent|concurrent
1041788|NCT02903069|adjuvant|adjuvant
1041789|NCT02903069|Optune|optune
1041790|NCT02903069|Novocure|novocure
1041791|NCT02903069|NovoTTF|novottf
1041792|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1041793|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
1041794|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
1041795|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
1041796|NCT02903043|MicroRNAs|micrornas
1041797|NCT02903043|Angiogenesis|angiogenesis
1041798|NCT02903043|Skeletal muscle|skeletal muscle
1041799|NCT02903043|COPD|copd
1041800|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
1041801|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
1041802|NCT02902978|E6130|e6130
1041803|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
1041804|NCT02902978|Phase 1|phase 1
1041805|NCT02902978|Pharmacokinetics|pharmacokinetics
1041806|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1041807|NCT02902965|Bortezomib|bortezomib
1041808|NCT02902965|Dexamethasone|dexamethasone
1041809|NCT02902965|Ibrutinib|ibrutinib
1042010|NCT02901418|pregnancy|pregnancy
1041810|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
1041811|NCT02902913|platelet reactivity|platelet reactivity
1041812|NCT02902913|phenolic|phenolic
1041813|NCT02902913|extra virgin olive oil|extra virgin olive oil
1041814|NCT02902913|cyclooxygenase|cyclooxygenase
1041815|NCT02902913|oleocanthal|oleocanthal
1041816|NCT02902913|oxylipin|oxylipin
1041817|NCT02902900|Multiple Myeloma|multiple myeloma
1041818|NCT02902900|Pomalidomide|pomalidomide
1041819|NCT02902900|Efficacy|efficacy
1041820|NCT02902835|Buprenorphine treatment|buprenorphine treatment
1041821|NCT02902835|Incarceration|incarceration
1041822|NCT02902835|Linkage Intervention|linkage intervention
1041823|NCT02902835|Opioid use disorder|opioid use disorder
1041824|NCT02902822|melanoma|melanoma
1041825|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
1041826|NCT02902822|mole|mole
1041827|NCT02902822|app|app
1041828|NCT02902822|cliccailneo|cliccailneo
1041829|NCT02902809|open-label study|open-label study
1041830|NCT02902809|tralokinumab|tralokinumab
1041831|NCT02902809|subcutaneous|subcutaneous
1041832|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
1041833|NCT02902809|asthma|asthma
1041834|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
1041835|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
1041836|NCT02902770|Pain|pain
1041837|NCT02902770|Lidocaine|lidocaine
1041838|NCT02902770|Ketorolac|ketorolac
1041839|NCT02902757|FDG|fdg
1041840|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
1041841|NCT02902705|White adipose tissue|white adipose tissue
1041842|NCT02902705|chronic kidney disease|chronic kidney disease
1041843|NCT02902705|uremia|uremia
1041844|NCT02902705|adipocytes|adipocytes
1041845|NCT02902692|brief|brief
1041846|NCT02902692|mindfulness|mindfulness
1041847|NCT02902666|Bioequivalence|bioequivalence
1041848|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
1041849|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
1041850|NCT02902653|misoprostol|misoprostol
1041851|NCT02902653|dinoprostonal|dinoprostonal
1041852|NCT02902653|induction|induction
1041853|NCT02902614|embryo biopsy|embryo biopsy
1041854|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
1041855|NCT02902614|animal pole|animal pole
1041856|NCT02902614|vegetal pole|vegetal pole
1041857|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
1041858|NCT02902614|embryo implantation|embryo implantation
1041859|NCT02902614|Blastomeres|blastomeres
1041860|NCT02902588|Blood-Brain Barrier|blood-brain barrier
1041861|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
1041862|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1041863|NCT02902588|Indocyanine green|indocyanine green
1041864|NCT02902575|Stomach Neoplasms|stomach neoplasms
1041865|NCT02902575|Laparoscopy|laparoscopy
1041866|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
1041867|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1041868|NCT02902549|Optical Coherence Tomography|optical coherence tomography
1041869|NCT02902549|Fluorescence Imaging|fluorescence imaging
1041870|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
1041871|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
1041872|NCT02902536|Myasthenia Gravis|myasthenia gravis
1041873|NCT02902510|yoga|yoga
1041874|NCT02902510|function|function
1041875|NCT02902510|Parkinson's disease|parkinson's disease
1041876|NCT02902510|gait|gait
1041877|NCT02902510|balance|balance
1041878|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1041879|NCT02902458|primary prevention|primary prevention
1041880|NCT02902458|psychological follow-up|psychological follow-up
1041881|NCT02902458|anxiety|anxiety
1041882|NCT02902458|depression|depression
1041883|NCT02902458|quality of life|quality of life
1041884|NCT02902445|Vaccine|vaccine
1041885|NCT02902445|Polymorphism|polymorphism
1041886|NCT02902432|endostar|endostar
1041887|NCT02902432|cisplatin|cisplatin
1041888|NCT02902393|Fibrinolysis|fibrinolysis
1041889|NCT02902393|tPA|tpa
1041890|NCT02902367|mobility|mobility
1041891|NCT02902367|exercise|exercise
1041892|NCT02902367|walking capacity|walking capacity
1041893|NCT02902367|fat mass|fat mass
1041894|NCT02902367|muscles|muscles
1041895|NCT02902341|Nutrition Therapy|nutrition therapy
1041896|NCT02902315|Muscle soreness|muscle soreness
1041897|NCT02902315|Free radicals|free radicals
1041898|NCT02902315|Ascorbic acid|ascorbic acid
1041899|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
1041900|NCT02902315|Cryotherapy|cryotherapy
1041901|NCT02902315|Exercise tolerance|exercise tolerance
1041902|NCT02902315|Resistance training|resistance training
1041903|NCT02902302|Bioequivalence|bioequivalence
1041904|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
1041905|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
1041906|NCT02902302|Oral Suspension|oral suspension
1041907|NCT02902289|Bioequivalence|bioequivalence
1041908|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
1041909|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
1041910|NCT02902289|Oral Suspension|oral suspension
1041911|NCT02902276|plasma citrulline|plasma citrulline
1041912|NCT02902276|lipopolysaccharide|lipopolysaccharide
1041913|NCT02902276|critically ill|critically ill
1041914|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
1041915|NCT02902263|Telemedecine|telemedecine
1041916|NCT02902263|Thrombolysis|thrombolysis
1041917|NCT02902250|Vertebroplasty|vertebroplasty
1041918|NCT02902250|Core decompression|core decompression
1041919|NCT02902250|Osteoporosis|osteoporosis
1041920|NCT02902211|ankle foot orthosis|ankle foot orthosis
1041921|NCT02902211|biomechanics|biomechanics
1041922|NCT02902211|mobility|mobility
1041923|NCT02902185|Chidamide|chidamide
1041924|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1041925|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
1041926|NCT02902185|Chronic HIV infections|chronic hiv infections
1041927|NCT02902185|HIV Eradication|hiv eradication
1041928|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
1041929|NCT02902159|Stress|stress
1041930|NCT02902159|Low Mood|low mood
1041931|NCT02902159|Mental Health|mental health
1042130|NCT02900664|Biomarkers|biomarkers
1041932|NCT02902159|Peer Support|peer support
1041934|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
1041935|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
1041936|NCT02902107|CivaSheet|civasheet
1041937|NCT02902107|16-605|16-605
1041938|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
1041939|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
1041940|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
1041941|NCT02902016|PPARgamma|ppargamma
1041942|NCT02902016|Lactose intolerance|lactose intolerance
1041943|NCT02902016|Lactase|lactase
1041944|NCT02901990|mumps|mumps
1041945|NCT02901990|immunity|immunity
1041946|NCT02901990|cohort study|cohort study
1041947|NCT02901990|children|children
1041948|NCT02901990|vaccine|vaccine
1041949|NCT02901977|Hypertension|hypertension
1041950|NCT02901977|Blood pressure|blood pressure
1041951|NCT02901977|Hemostasis|hemostasis
1041952|NCT02901977|Endothelial function|endothelial function
1041953|NCT02901951|adult subjects|adult subjects
1041954|NCT02901951|Hepatitis B antibody|hepatitis b antibody
1041955|NCT02901951|Hepatitis B|hepatitis b
1041956|NCT02901951|HBV|hbv
1041957|NCT02901925|ABY-029|aby-029
1041958|NCT02901925|Affibody|affibody
1041959|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
1041960|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1041961|NCT02901912|physical activity|physical activity
1041962|NCT02901912|sedentarism|sedentarism
1041963|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
1041964|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
1041965|NCT02901886|Smoking Cessation|smoking cessation
1041966|NCT02901886|Disease Activity|disease activity
1041967|NCT02901886|Clinical Prevention|clinical prevention
1041968|NCT02901808|NOMI|nomi
1041969|NCT02901808|Angiography|angiography
1041970|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
1041971|NCT02901782|Knee|knee
1041972|NCT02901782|Titanium Plate|titanium plate
1041973|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
1041974|NCT02901730|treatment|treatment
1041975|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
1041976|NCT02901626|Short cervix|short cervix
1041977|NCT02901626|Preterm delivery|preterm delivery
1041978|NCT02901626|Singletons|singletons
1041979|NCT02901626|Pregnancy|pregnancy
1041980|NCT02901626|Pessary|pessary
1041981|NCT02901600|DMBT1 expression|dmbt1 expression
1041982|NCT02901600|Colorectal cancer|colorectal cancer
1041983|NCT02901548|BCG refractory CIS|bcg refractory cis
1041984|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
1041985|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
1041986|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
1041987|NCT02901548|Medi4736|medi4736
1041988|NCT02901548|Durvalumab|durvalumab
1041989|NCT02901548|CIS of the bladder|cis of the bladder
1041990|NCT02901548|Bladder cancer|bladder cancer
1041991|NCT02901548|BCG Vaccine|bcg vaccine
1041992|NCT02901548|Bladder diseases|bladder diseases
1041993|NCT02901548|Urothelial diseases|urothelial diseases
1041994|NCT02901535|telemedicine|telemedicine
1041995|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1041996|NCT02901535|Primary Health care|primary health care
1041997|NCT02901535|spirometry|spirometry
1041998|NCT02901522|telemedicine|telemedicine
1041999|NCT02901522|asthma control test|asthma control test
1042000|NCT02901522|Primary Health care|primary health care
1042001|NCT02901522|spirometry|spirometry
1042002|NCT02901509|Chikungunya|chikungunya
1042003|NCT02901509|Quality of Life|quality of life
1042004|NCT02901483|Head and Neck|head and neck
1042005|NCT02901457|Body Image|body image
1042006|NCT02901418|chronic hepatitis B|chronic hepatitis b
1042007|NCT02901418|mother to child transmission|mother to child transmission
1042008|NCT02901418|interruption|interruption
1042009|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
1042011|NCT02901418|HBsAg|hbsag
1042012|NCT02901418|newborns|newborns
1042013|NCT02901405|sarcoma|sarcoma
1042014|NCT02901405|infection|infection
1042015|NCT02901405|negative pressure|negative pressure
1042016|NCT02901392|Male Urethral Slings|male urethral slings
1042017|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
1042018|NCT02901392|Prostatectomy|prostatectomy
1042019|NCT02901392|Radiotherapy|radiotherapy
1042020|NCT02901379|atorvastatin|atorvastatin
1042021|NCT02901379|myocardial edema|myocardial edema
1042022|NCT02901379|Follistatin-like 1|follistatin-like 1
1042023|NCT02901379|FSTL1|fstl1
1042024|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
1042025|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
1042026|NCT02901366|Mass balance|mass balance
1042027|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
1075323|NCT02697305|GIP|gip
1042028|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
1042029|NCT02901340|neonatal outcomes|neonatal outcomes
1042030|NCT02901340|Maternal hydration|maternal hydration
1042031|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
1042032|NCT02901327|Treadmill Walk|treadmill walk
1042033|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
1042034|NCT02901327|Pain Intensity|pain intensity
1042035|NCT02901327|Functional Disability|functional disability
1042036|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
1042037|NCT02901288|shortened regimen|shortened regimen
1042038|NCT02901288|clinical trial|clinical trial
1042039|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
1042040|NCT02901275|Analgesia|analgesia
1042041|NCT02901262|continuous EEG|continuous eeg
1042042|NCT02901249|Cost effectiveness|cost effectiveness
1042043|NCT02901249|Unipolar Depression|unipolar depression
1042044|NCT02901249|Major Depression Disorder|major depression disorder
1042045|NCT02901249|Quality of life disorder|quality of life disorder
1042046|NCT02901236|trabeculectomy|trabeculectomy
1042047|NCT02901236|glaucoma|glaucoma
1042048|NCT02901236|filtration surgery|filtration surgery
1042049|NCT02901236|wound healing|wound healing
1042050|NCT02901236|angiogenesis|angiogenesis
1042051|NCT02901236|mitomycin|mitomycin
1042052|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
1042053|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
1042054|NCT02901223|oncological safety|oncological safety
1042055|NCT02901223|patient satisfaction|patient satisfaction
1042056|NCT02901210|Recta prolapse|recta prolapse
1042057|NCT02901210|Intraoperative bleeding|intraoperative bleeding
1042058|NCT02901210|mucosal cauterization|mucosal cauterization
1042059|NCT02901197|capnography|capnography
1042060|NCT02901171|Smoking cessation|smoking cessation
1042061|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
1042062|NCT02901171|Smartphone|smartphone
1042063|NCT02901158|esophageal pressure|esophageal pressure
1042064|NCT02901158|chest wall elastance|chest wall elastance
1042065|NCT02901158|lung elastance|lung elastance
1042066|NCT02901158|transpulmonary pressure|transpulmonary pressure
1042067|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
1042068|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1042069|NCT02901106|Dimethyl fumarate|dimethyl fumarate
1042070|NCT02901093|Stapes surgery|stapes surgery
1042071|NCT02901093|Sensorineural complications|sensorineural complications
1042072|NCT02901093|Inner ear|inner ear
1042073|NCT02901093|Imaging|imaging
1042074|NCT02901093|Cone Beam CT|cone beam ct
1042075|NCT02901067|Fibrinolysis|fibrinolysis
1042076|NCT02901015|schizophrenia|schizophrenia
1042077|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
1042078|NCT02901002|Pain|pain
1042079|NCT02901002|Spontaneous sensations|spontaneous sensations
1042080|NCT02901002|interoception|interoception
1042081|NCT02900989|Psychiatry|psychiatry
1042082|NCT02900989|Pediatrics|pediatrics
1042083|NCT02900989|Suicide|suicide
1042084|NCT02900976|Organ Transplantation|organ transplantation
1042085|NCT02900963|Nutrition|nutrition
1042086|NCT02900963|Head and Neck Cancer|head and neck cancer
1042087|NCT02900950|cancer|cancer
1042088|NCT02900950|resection margin|resection margin
1042089|NCT02900950|pathology|pathology
1042090|NCT02900950|pancreas|pancreas
1042091|NCT02900937|Stents|stents
1042092|NCT02900937|Angioplasty|angioplasty
1042093|NCT02900937|Coronary Vessels|coronary vessels
1042094|NCT02900937|Coronary Artery Disease|coronary artery disease
1042095|NCT02900937|Angina Pectoris|angina pectoris
1042096|NCT02900937|Myocardial Ischemia|myocardial ischemia
1042097|NCT02900937|Myocardial Infarction|myocardial infarction
1042098|NCT02900937|Myocardial Revascularization|myocardial revascularization
1042099|NCT02900924|PAD|pad
1042100|NCT02900924|PVD|pvd
1042101|NCT02900924|SFA stent|sfa stent
1042102|NCT02900911|head and neck cancer|head and neck cancer
1042103|NCT02900911|dysphagia|dysphagia
1042104|NCT02900911|rehabilitation|rehabilitation
1042105|NCT02900911|radiation therapy|radiation therapy
1042106|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
1042107|NCT02900820|Primary Health Care|primary health care
1042108|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
1042109|NCT02900820|Respiratory Tract Infections|respiratory tract infections
1042110|NCT02900781|Arthroplasty|arthroplasty
1042111|NCT02900781|Physical Therapy|physical therapy
1042112|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
1042113|NCT02900768|Exercise|exercise
1042114|NCT02900768|Rehabilitation|rehabilitation
1042115|NCT02900768|Cancer|cancer
1042116|NCT02900755|Electroencephalography|electroencephalography
1042117|NCT02900755|Perampanel|perampanel
1042118|NCT02900742|lung cancer|lung cancer
1042119|NCT02900742|traditional Chinese medicine|traditional chinese medicine
1042120|NCT02900742|maintenance therapy|maintenance therapy
1042121|NCT02900742|chemotherapy|chemotherapy
1042122|NCT02900677|Pancreatic Cancer|pancreatic cancer
1042123|NCT02900677|Fatigue|fatigue
1042124|NCT02900677|Nutrition|nutrition
1042125|NCT02900677|Quality of Life|quality of life
1042126|NCT02900664|CRC|crc
1042127|NCT02900664|TNBC|tnbc
1042128|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
1042129|NCT02900664|Immunomodulation|immunomodulation
1042131|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
1042132|NCT02900664|PDR001|pdr001
1042133|NCT02900664|Immunotherapy|immunotherapy
1042134|NCT02900651|MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
1042135|NCT02900638|mentoring|mentoring
1042136|NCT02900638|children|children
1042137|NCT02900638|cardiovascular health|cardiovascular health
1042138|NCT02900612|dyslipidemias,|dyslipidemias,
1042139|NCT02900612|aging|aging
1042140|NCT02900612|water aerobics training|water aerobics training
1042141|NCT02900612|resistance aquatic training|resistance aquatic training
1042142|NCT02900612|lipid profile|lipid profile
1042143|NCT02900599|HIV|hiv
1042144|NCT02900599|Behavior|behavior
1042145|NCT02900547|Systolic Heart Failure|systolic heart failure
1042146|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
1042147|NCT02900534|grief|grief
1042148|NCT02900534|depression|depression
1042149|NCT02900534|bereavement|bereavement
1042150|NCT02900534|divorce|divorce
1042151|NCT02900534|online self-help|online self-help
1042152|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
1042153|NCT02900495|Bedwetting|bedwetting
1042154|NCT02900495|TENS|tens
1042155|NCT02900469|RANK|rank
1042156|NCT02900469|RANKL|rankl
1042157|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
1042158|NCT02900456|Registry|registry
1042159|NCT02900417|type 2 diabetes|type 2 diabetes
1042160|NCT02900417|gut microbiota|gut microbiota
1042161|NCT02900417|sitagliptin|sitagliptin
1042162|NCT02900378|physical activity|physical activity
1042163|NCT02900378|actigraphy|actigraphy
1042164|NCT02900378|sleep|sleep
1042165|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
1042166|NCT02900378|enalapril|enalapril
1042167|NCT02900378|heart failure|heart failure
1042168|NCT02900378|reduced ejection fraction|reduced ejection fraction
1042169|NCT02900378|randomized controlled trial|randomized controlled trial
1042170|NCT02900378|accelerometry|accelerometry
1042171|NCT02900365|trauma|trauma
1042172|NCT02900365|cataract|cataract
1042173|NCT02900365|lensectomy|lensectomy
1042174|NCT02900365|time|time
1042175|NCT02900365|early|early
1042176|NCT02900365|late|late
1042177|NCT02900352|Alcohol Use Disorder|alcohol use disorder
1042178|NCT02900352|Alcoholism|alcoholism
1042179|NCT02900352|Alcohol Dependence|alcohol dependence
1042180|NCT02900352|Zonisamide|zonisamide
1042181|NCT02900352|Alcohol Intoxication|alcohol intoxication
1042182|NCT02900352|Drinking Behaviors|drinking behaviors
1042183|NCT02900352|Anticonvulsants|anticonvulsants
1042184|NCT02900339|MRI|mri
1042185|NCT02900339|Sequence optimization|sequence optimization
1042186|NCT02900339|Healthy volunteers|healthy volunteers
1042187|NCT02900326|Exercise capacity|exercise capacity
1042188|NCT02900326|Mindfulness|mindfulness
1042189|NCT02900326|Quality of life|quality of life
1042190|NCT02900313|acute kidney injury|acute kidney injury
1042191|NCT02900313|cardiac surgery|cardiac surgery
1042192|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
1042193|NCT02900313|renal replacement therapy|renal replacement therapy
1042194|NCT02900313|renal recovery|renal recovery
1042195|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
1042196|NCT02900287|Survival|survival
1042197|NCT02900287|Cancer|cancer
1042198|NCT02900248|Biomarkers|biomarkers
1042199|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1042200|NCT02900248|Neoplasms|neoplasms
1042201|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
1042202|NCT02900235|Healthy|healthy
1042203|NCT02900209|Influenza|influenza
1042204|NCT02900209|Exacerbations|exacerbations
1042205|NCT02900196|Probiotics|probiotics
1042206|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
1042207|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
1042208|NCT02900196|Helicobacter pylori|helicobacter pylori
1042209|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
1042210|NCT02900157|Advanced Solid Tumor|advanced solid tumor
1042211|NCT02900157|Immunotherapy|immunotherapy
1042212|NCT02900157|MEDI9090|medi9090
1042213|NCT02900157|MEDI4736|medi4736
1042214|NCT02900157|Durvalumab|durvalumab
1042215|NCT02900118|Bone metastasis|bone metastasis
1042216|NCT02900118|PET-CT|pet-ct
1042217|NCT02900118|whole-body MRI|whole-body mri
1042218|NCT02900092|postmenopausal|postmenopausal
1042219|NCT02900092|women|women
1042220|NCT02900092|depression|depression
1042221|NCT02900079|malaria|malaria
1042222|NCT02900079|rapid diagnostic test|rapid diagnostic test
1042223|NCT02900079|travel|travel
1042224|NCT02900079|fever|fever
1042225|NCT02900079|self care|self care
1042226|NCT02900066|fever|fever
1042227|NCT02900066|traveler|traveler
1042228|NCT02900066|arbovirus|arbovirus
1042229|NCT02900066|rickettsia|rickettsia
1042230|NCT02900066|malaria|malaria
1042231|NCT02900066|filter paper|filter paper
1042232|NCT02900066|diagnosis|diagnosis
1042233|NCT02900001|myocardial infarction|myocardial infarction
1042234|NCT02900001|invasive strategy|invasive strategy
1042240|NCT02899975|Information and Fitness Software|information and fitness software
1042241|NCT02899975|Elderly|elderly
1042242|NCT02899975|WeTakeCare|wetakecare
1042243|NCT02899949|dapagliflozin|dapagliflozin
1042244|NCT02899949|type 2 diabetes|type 2 diabetes
1042245|NCT02899949|real-world data|real-world data
1042246|NCT02899936|Mass drug administration|mass drug administration
1042247|NCT02899936|Safety Data|safety data
1042248|NCT02899897|echocardiography|echocardiography
1042249|NCT02899884|Drug Therapy|drug therapy
1042250|NCT02899871|joint pain|joint pain
1042251|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
1042252|NCT02899858|Paralysis|paralysis
1042253|NCT02899858|ASIA A|asia a
1042254|NCT02899858|Device|device
1042255|NCT02899832|children|children
1042256|NCT02899832|spasms|spasms
1042257|NCT02899819|pesticides|pesticides
1042258|NCT02899819|exposure|exposure
1042259|NCT02899819|in utero|in utero
1042260|NCT02899806|Video Information|video information
1042261|NCT02899806|Satisfaction|satisfaction
1042262|NCT02899806|Anxiety|anxiety
1042263|NCT02899806|Epidural Analgesia|epidural analgesia
1042264|NCT02899806|Comprehension|comprehension
1042265|NCT02899806|delivery|delivery
1042266|NCT02899767|transfusion dependency|transfusion dependency
1042267|NCT02899767|transfusion intensity|transfusion intensity
1042268|NCT02899767|prognosis|prognosis
1042269|NCT02899767|chemotherapy|chemotherapy
1042270|NCT02899754|lung cancer|lung cancer
1042271|NCT02899754|decision support|decision support
1042272|NCT02899754|implementation|implementation
1042273|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
1042274|NCT02899689|Labor|labor
1042275|NCT02899689|Foley|foley
1042276|NCT02899689|Dilapan|dilapan
1042277|NCT02899689|Cervical Dilators|cervical dilators
1042278|NCT02899689|Induction|induction
1042279|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
1042280|NCT02899650|Eccentric exercise|eccentric exercise
1042281|NCT02899650|Masters athlete|masters athlete
1042282|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
1042283|NCT02899637|Rehabilitation|rehabilitation
1042284|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
1042285|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1042286|NCT02899611|Epilepsy|epilepsy
1042287|NCT02899585|Palliative care|palliative care
1042288|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
1042289|NCT02899546|Infections|infections
1042290|NCT02899546|Radiology|radiology
1042292|NCT02899533|Pulmonary hypertension|pulmonary hypertension
1042293|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1042294|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
1042295|NCT02899468|TBI|tbi
1042296|NCT02899468|Virtual Reality|virtual reality
1042297|NCT02899455|Hypertension|hypertension
1042298|NCT02899455|Hyperlipidemia|hyperlipidemia
1042299|NCT02899442|cardiovascular risk|cardiovascular risk
1042300|NCT02899442|Occupational Health|occupational health
1042301|NCT02899442|night work|night work
1042302|NCT02899442|Public Health|public health
1042303|NCT02899442|Preventive Health Services|preventive health services
1042304|NCT02899416|cardiovascular risk|cardiovascular risk
1042305|NCT02899416|young adulthood|young adulthood
1042306|NCT02899403|Cognitive Tasks|cognitive tasks
1042307|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
1042308|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
1042309|NCT02899403|Healthy Volunteers|healthy volunteers
1042310|NCT02899377|PET/CT|pet/ct
1042311|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
1042312|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
1042313|NCT02899377|11^C-MET|11^c-met
1042314|NCT02899377|18^F-FDG|18^f-fdg
1042315|NCT02899364|Sodium thiosulfate|sodium thiosulfate
1042316|NCT02899364|STEMI|stemi
1042317|NCT02899364|Infarct size|infarct size
1042318|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1042319|NCT02899364|Hydrogen sulfide|hydrogen sulfide
1042320|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
1042322|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
1042323|NCT02899286|PEG-BCT-100|peg-bct-100
1042324|NCT02899273|Early Childhood Caries|early childhood caries
1042325|NCT02899273|eye-tracking|eye-tracking
1042326|NCT02899273|children|children
1042327|NCT02899273|dentistry|dentistry
1042328|NCT02899273|face perception|face perception
1042329|NCT02899247|composite resin|composite resin
1042330|NCT02899247|surface sealant|surface sealant
1042331|NCT02899234|Nicotine|nicotine
1042332|NCT02899234|Electronic Cigarette|electronic cigarette
1042333|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
1042334|NCT02899195|Durvalumab|durvalumab
1042335|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
1042336|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
1042337|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
1042338|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
1042339|NCT02899091|Alzheimer's disease|alzheimer's disease
1042340|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
1042341|NCT02899052|Multiple Myeloma|multiple myeloma
1042342|NCT02899052|Refractory myeloma|refractory myeloma
1042343|NCT02899052|Relapsed myeloma|relapsed myeloma
1042344|NCT02899026|Glucocorticosteroids|glucocorticosteroids
1042345|NCT02899026|Sirukumab|sirukumab
1042346|NCT02899026|Prednisone|prednisone
1042347|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
1042348|NCT02899013|Perianal Lesions|perianal lesions
1042349|NCT02898987|HIV|hiv
1042350|NCT02898987|Hepatitis C|hepatitis c
1042351|NCT02898987|Comorbidities|comorbidities
1042352|NCT02898987|AIDS|aids
1042353|NCT02898948|procalcitonin|procalcitonin
1042354|NCT02898948|bacterial infection|bacterial infection
1042355|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
1042356|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
1042357|NCT02898844|dieting|dieting
1042358|NCT02898844|dyads|dyads
1042359|NCT02898844|psychological well-being|psychological well-being
1042360|NCT02898844|weight loss|weight loss
1042361|NCT02898844|cortisol|cortisol
1042362|NCT02898792|sensitivity, opioid|sensitivity, opioid
1042363|NCT02898753|GSD-II|gsd-ii
1042364|NCT02898753|Pompe Disease|pompe disease
1042365|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
1042366|NCT02898753|GAA|gaa
1042367|NCT02898740|Parkinson's disease|parkinson's disease
1042368|NCT02898740|exercise therapy|exercise therapy
1042369|NCT02898740|quality of life|quality of life
1042370|NCT02898701|Motor Learning|motor learning
1042371|NCT02898701|Dose of Motor Practice|dose of motor practice
1042372|NCT02898701|Postural Control|postural control
1042373|NCT02898701|Serial Reaction Time Task|serial reaction time task
1042374|NCT02898701|Retention|retention
1042375|NCT02898701|Transfer|transfer
1042376|NCT02898701|Overpractice|overpractice
1042377|NCT02898701|Overtraining|overtraining
1042378|NCT02898701|Overlearning|overlearning
1042379|NCT02898688|Influenza vaccine|influenza vaccine
1042380|NCT02898688|Pertussis vaccine|pertussis vaccine
1042381|NCT02898688|Perinatal vaccination|perinatal vaccination
1042382|NCT02898688|Infant vaccination|infant vaccination
1042383|NCT02898662|inhaled|inhaled
1042384|NCT02898662|TLR9 agonist|tlr9 agonist
1042385|NCT02898662|withdrawal design|withdrawal design
1042386|NCT02898662|loss of control|loss of control
1042387|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
1042388|NCT02898506|Diabetes Type 1|diabetes type 1
1042389|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
1042390|NCT02898506|Liraglutide|liraglutide
1042391|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
1042392|NCT02898506|GLP-1 Analogue|glp-1 analogue
1042393|NCT02898506|Dysglycemia|dysglycemia
1042394|NCT02898506|Prevention|prevention
1042395|NCT02898493|Validation of questionnaire|validation of questionnaire
1042396|NCT02898493|Quality of life|quality of life
1042397|NCT02898441|lung cancer screening|lung cancer screening
1042398|NCT02898441|low-dose CT|low-dose ct
1042399|NCT02898441|high-risk population|high-risk population
1042400|NCT02898415|HCC|hcc
1042401|NCT02898415|Liver Transplantation|liver transplantation
1042402|NCT02898415|AFP|afp
1042403|NCT02898415|Mortality|mortality
1042404|NCT02898415|Competing risk|competing risk
1042405|NCT02898415|Selection criteria|selection criteria
1042406|NCT02898415|Recurrence|recurrence
1042407|NCT02898376|spa care|spa care
1042408|NCT02898376|randomised controlled trial|randomised controlled trial
1042409|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
1042410|NCT02898376|late sequelae|late sequelae
1042411|NCT02898376|radiotherapy|radiotherapy
1042412|NCT02898363|Care of disabled population|care of disabled population
1042413|NCT02898363|Mental retardation|mental retardation
1042414|NCT02898363|Cancer screening|cancer screening
1042415|NCT02898363|Cancer prevention|cancer prevention
1042416|NCT02898324|Bullying|bullying
1042417|NCT02898324|KiVa program|kiva program
1042418|NCT02898324|Primary school students|primary school students
1042419|NCT02898311|CAD-CAM|cad-cam
1042420|NCT02898311|composite dental resin|composite dental resin
1042421|NCT02898311|Immediate dental implant loading|immediate dental implant loading
1042422|NCT02898259|Lenalidomide|lenalidomide
1042423|NCT02898259|Ixazomib|ixazomib
1042424|NCT02898259|Rituximab|rituximab
1042425|NCT02898246|heart failure|heart failure
1042426|NCT02898246|fear of physical activity|fear of physical activity
1042427|NCT02898246|motor activity|motor activity
1042428|NCT02898233|depression|depression
1042429|NCT02898233|internet-based|internet-based
1042430|NCT02898233|treatment|treatment
1042431|NCT02898233|low-level light therapy|low-level light therapy
1042432|NCT02898233|LLLT|lllt
1042433|NCT02898233|deprexis|deprexis
1042434|NCT02898194|Surrogate Decision-making|surrogate decision-making
1042435|NCT02898194|Health Care|health care
1042436|NCT02898194|Medical Decisions|medical decisions
1042437|NCT02898194|End of Life Care|end of life care
1042438|NCT02898168|stroke|stroke
1042439|NCT02898168|Rehabilitation|rehabilitation
1042440|NCT02898168|WalkAide (WA)|walkaide (wa)
1042441|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
1042638|NCT02896777|IVF|ivf
1042442|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
1042443|NCT02898155|primary care|primary care
1042444|NCT02898155|geographicvariation|geographicvariation
1042445|NCT02898142|Postprandial test|postprandial test
1042446|NCT02898142|Metabolic syndrime|metabolic syndrime
1042447|NCT02898142|HTG|htg
1042448|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
1042449|NCT02898129|housing|housing
1042450|NCT02898129|lung function test|lung function test
1042451|NCT02898116|ALK-rearranged|alk-rearranged
1042452|NCT02898116|ALK-positive|alk-positive
1042453|NCT02898116|ALK Inhibitor|alk inhibitor
1042454|NCT02898116|Ensartinib|ensartinib
1042455|NCT02898116|X-396|x-396
1042456|NCT02898116|anti-PD-L1|anti-pd-l1
1042457|NCT02898116|Durvalumab|durvalumab
1042458|NCT02898116|MEDI4736|medi4736
1042459|NCT02898116|ALK|alk
1042460|NCT02898090|Quality indicators|quality indicators
1042461|NCT02898090|Appropriateness|appropriateness
1042462|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
1042463|NCT02898090|Development and validation|development and validation
1042464|NCT02898090|Hospital information system|hospital information system
1042465|NCT02898090|Information Storage and Retrieval|information storage and retrieval
1042466|NCT02898090|Natural Language Processing|natural language processing
1042467|NCT02898077|Second line|second line
1042468|NCT02898077|Angiogenesis|angiogenesis
1042469|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
1042470|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
1042471|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
1042472|NCT02898012|temozolomide|temozolomide
1042473|NCT02898012|bevacizumab|bevacizumab
1042474|NCT02897973|Spinal loads|spinal loads
1042475|NCT02897973|Trunk muscle force|trunk muscle force
1042476|NCT02897973|Computational modeling|computational modeling
1042477|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
1042478|NCT02897960|wheezing|wheezing
1042479|NCT02897960|bronchiolitis|bronchiolitis
1042480|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
1042481|NCT02897947|Lumbosacral Region|lumbosacral region
1042482|NCT02897947|Surgery|surgery
1042483|NCT02897947|Registries|registries
1042484|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
1042485|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
1042486|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1042487|NCT02897843|cognition|cognition
1042488|NCT02897817|Methotrexate|methotrexate
1042489|NCT02897817|Treatment adherence|treatment adherence
1042490|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
1042491|NCT02897804|college students|college students
1042492|NCT02897778|entinostat|entinostat
1042493|NCT02897778|solid tumor|solid tumor
1042494|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1042495|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
1042496|NCT02897765|Immunotherapy|immunotherapy
1042497|NCT02897765|Personal Vaccine|personal vaccine
1042498|NCT02897765|Neoantigen|neoantigen
1042499|NCT02897765|Poly-ICLC|poly-iclc
1042500|NCT02897765|Peptide|peptide
1042501|NCT02897752|stroke|stroke
1042502|NCT02897752|Rehabilitation|rehabilitation
1042503|NCT02897752|WalkAide (WA)|walkaide (wa)
1042504|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
1042505|NCT02897713|mechanical ventilation|mechanical ventilation
1042506|NCT02897713|enteral nutrition|enteral nutrition
1042507|NCT02897713|feeding intolerance|feeding intolerance
1042508|NCT02897700|Chemotherapy|chemotherapy
1042509|NCT02897700|Safety|safety
1042510|NCT02897700|Tolerability|tolerability
1042511|NCT02897700|Efficacy|efficacy
1042512|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
1042513|NCT02897687|Social Skills|social skills
1042514|NCT02897687|Social Media|social media
1042515|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
1042516|NCT02897661|enteral nutrition|enteral nutrition
1042517|NCT02897622|Eating disorders|eating disorders
1042518|NCT02897622|severe and enduring|severe and enduring
1042519|NCT02897622|quality of life|quality of life
1042520|NCT02897622|case management|case management
1042521|NCT02897609|Beta-lactamine|beta-lactamine
1042522|NCT02897609|β-lactamine|β-lactamine
1042523|NCT02897570|ghrelin|ghrelin
1042524|NCT02897570|breakfast meal|breakfast meal
1042525|NCT02897570|P-300|p-300
1042526|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
1042527|NCT02897518|Videolaryngoscopes|videolaryngoscopes
1042528|NCT02897518|Intubation|intubation
1042529|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
1042530|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
1042531|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
1042532|NCT02897440|Femoral Neck Fracture|femoral neck fracture
1042533|NCT02897440|Hip Arthroplasty|hip arthroplasty
1042534|NCT02897440|Repairing of soft tissue|repairing of soft tissue
1042535|NCT02897427|Oropharyngeal cancer|oropharyngeal cancer
1042536|NCT02897427|Anal cancer|anal cancer
1042537|NCT02897427|Penile cancer|penile cancer
1042538|NCT02897427|Human papillomavirus|human papillomavirus
1042540|NCT02897427|HPV 16 E antigens|hpv 16 e antigens
1042541|NCT02897427|Oropharyngeal cancer screening|oropharyngeal cancer screening
1042542|NCT02897427|Dysplasia|dysplasia
1042543|NCT02897427|Ultrasound scans of throat and the lymph nodes in neck|ultrasound scans of throat and the lymph nodes in neck
1042544|NCT02897427|Anal cancer screening|anal cancer screening
1042545|NCT02897427|Anal pap test|anal pap test
1042546|NCT02897427|High-resolution anoscopy|high-resolution anoscopy
1042548|NCT02897427|Penile cancer screening|penile cancer screening
1042549|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
1042550|NCT02897401|nicotine|nicotine
1042551|NCT02897401|electronic cigarette|electronic cigarette
1042552|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
1042553|NCT02897362|ADHD|adhd
1042554|NCT02897362|Sleep|sleep
1042555|NCT02897362|Adolescents|adolescents
1042556|NCT02897362|Neurocognition|neurocognition
1042557|NCT02897362|Polysomnography|polysomnography
1042558|NCT02897310|critically ill patients|critically ill patients
1042559|NCT02897310|acute kidney injury|acute kidney injury
1042560|NCT02897310|renal replacement therapy|renal replacement therapy
1042561|NCT02897310|long term outcome|long term outcome
1042562|NCT02897284|Mindfulness-based|mindfulness-based
1042563|NCT02897284|Self-care|self-care
1042564|NCT02897284|Health workers|health workers
1042565|NCT02897284|Epigenetics|epigenetics
1042566|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
1042567|NCT02897258|Dialysis|dialysis
1042568|NCT02897258|Thrombosis|thrombosis
1042569|NCT02897258|Haemorrhage|haemorrhage
1042570|NCT02897245|Myelogenous|myelogenous
1042571|NCT02897245|Chronic|chronic
1042572|NCT02897245|BCR-ABL Positive|bcr-abl positive
1042573|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
1042574|NCT02897232|HPV|hpv
1042575|NCT02897232|Patient Acceptance|patient acceptance
1042576|NCT02897232|Physician Comfort|physician comfort
1042577|NCT02897232|Male Vaccination|male vaccination
1042578|NCT02897232|HPV Associated Cancers|hpv associated cancers
1042579|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
1042580|NCT02897219|ASP1941|asp1941
1042581|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
1042582|NCT02897206|Acute pancreatitis|acute pancreatitis
1042583|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
1042584|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
1042585|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
1042586|NCT02897206|Infection|infection
1042587|NCT02897206|Organ failure|organ failure
1042588|NCT02897180|tuberculosis|tuberculosis
1042589|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
1042590|NCT02897180|Food supplement|food supplement
1042591|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
1042592|NCT02897180|Nyaditum resae|nyaditum resae
1042593|NCT02897180|Efficacy trial|efficacy trial
1042594|NCT02897167|Psychosis|psychosis
1042595|NCT02897167|Antipsychotic Agents|antipsychotic agents
1042596|NCT02897167|Immunology|immunology
1042597|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
1042598|NCT02897141|HIV|hiv
1042599|NCT02897141|Health Management App|health management app
1042600|NCT02897141|HIV symptoms|hiv symptoms
1042601|NCT02897128|Sarcoma|sarcoma
1042602|NCT02897128|Radiation|radiation
1042603|NCT02897128|Wound healing|wound healing
1042604|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
1042605|NCT02897115|Humira|humira
1042606|NCT02897089|universal adhesive|universal adhesive
1042607|NCT02897089|fissure sealants|fissure sealants
1042608|NCT02897089|retention|retention
1042609|NCT02897063|midodrine|midodrine
1042610|NCT02897063|droxidopa|droxidopa
1042611|NCT02897063|splanchnic circulation|splanchnic circulation
1042612|NCT02897037|Bivalirudin|bivalirudin
1042613|NCT02897037|Acute myocardial infarction|acute myocardial infarction
1042614|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1042615|NCT02897024|Cerebral Palsy|cerebral palsy
1042616|NCT02897024|Motor Impairments|motor impairments
1042617|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
1042618|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
1042619|NCT02896985|Adalimumab|adalimumab
1726545|NCT00000781|Nevirapine|nevirapine
1042620|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
1042621|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
1042622|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
1042623|NCT02896972|vitrectomy|vitrectomy
1042624|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
1042625|NCT02896972|high myopia|high myopia
1042626|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
1042627|NCT02896920|Humira®|humira®
1042628|NCT02896920|Canada|canada
1042629|NCT02896816|Parkinson's|parkinson's
1042630|NCT02896803|Pancreatic Cancer|pancreatic cancer
1042631|NCT02896803|Chemotherapy|chemotherapy
1042632|NCT02896790|Cancer|cancer
1042633|NCT02896790|Oral Therapy|oral therapy
1042634|NCT02896790|Compliance|compliance
1042635|NCT02896790|Anthropology|anthropology
1042636|NCT02896790|Psychology|psychology
1042639|NCT02896777|live birth rate|live birth rate
1042640|NCT02896751|CPAP|cpap
1042641|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
1042642|NCT02896725|Venous leg ulcer|venous leg ulcer
1042643|NCT02896725|Acellular skin substitutes|acellular skin substitutes
1042644|NCT02896725|Keratin dressings|keratin dressings
1042645|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1042646|NCT02896699|diffusion of innovation|diffusion of innovation
1042647|NCT02896699|men who have sex with men|men who have sex with men
1042648|NCT02896699|LGBT|lgbt
1042649|NCT02896699|African American|african american
1042650|NCT02896699|Black|black
1042651|NCT02896699|HIV|hiv
1042652|NCT02896699|network analysis|network analysis
1042653|NCT02896699|network intervention|network intervention
1042654|NCT02896686|Ileostomy closure|ileostomy closure
1042655|NCT02896686|Polypropylene Mesh|polypropylene mesh
1042656|NCT02896686|Incisional hernia|incisional hernia
1042657|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
1042658|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1042659|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
1042660|NCT02896673|tidal volume (TV)|tidal volume (tv)
1042661|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
1042662|NCT02896621|Sleep Apnea|sleep apnea
1042663|NCT02896621|Hypertension|hypertension
1042664|NCT02896621|Chlortalidone|chlortalidone
1042665|NCT02896621|Diastolic function|diastolic function
1042666|NCT02896569|resurfacing|resurfacing
1042667|NCT02896569|ablation|ablation
1042668|NCT02896556|image analysis|image analysis
1042669|NCT02896543|dendritic cells|dendritic cells
1042670|NCT02896543|P-selectin|p-selectin
1042671|NCT02896504|Chemobrain|chemobrain
1042672|NCT02896504|Chemotherapy|chemotherapy
1042673|NCT02896504|Hormonal Therapy|hormonal therapy
1042674|NCT02896504|Neuroimaging|neuroimaging
1042675|NCT02896465|Children|children
1042676|NCT02896465|Diarrhea|diarrhea
1042677|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
1042678|NCT02896439|Traumatic|traumatic
1042679|NCT02896439|Acetabular|acetabular
1042680|NCT02896426|Parent training|parent training
1042681|NCT02896426|Preschoolers|preschoolers
1042682|NCT02896426|Behavior problems|behavior problems
1042683|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
1042684|NCT02896426|ODD|odd
1042685|NCT02896426|Conduct Disorder|conduct disorder
1042686|NCT02896426|CD|cd
1042687|NCT02896426|Children|children
1042688|NCT02896426|Parenting|parenting
1042689|NCT02896426|Collaborative Problem Solving|collaborative problem solving
1042690|NCT02896426|CPS|cps
1042691|NCT02896426|Disruptive behavior|disruptive behavior
1042692|NCT02896348|Hemiparesis|hemiparesis
1042693|NCT02896348|Stroke|stroke
1042694|NCT02896348|Rehabilitation|rehabilitation
1042695|NCT02896348|Home-based|home-based
1042696|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
1042697|NCT02896283|wound healing|wound healing
1042698|NCT02896283|low-level laser therapy|low-level laser therapy
1042699|NCT02896283|gingival recession|gingival recession
1042700|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
1042701|NCT02896270|Neprology|neprology
1042702|NCT02896257|Quality Improvement|quality improvement
1042703|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
1042704|NCT02896257|QuERI|queri
1042705|NCT02896257|Interventional|interventional
1042706|NCT02896257|Multicenter|multicenter
1042707|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
1042708|NCT02896257|Pneumonia|pneumonia
1042709|NCT02896257|Safety|safety
1042710|NCT02896257|De-implementation|de-implementation
1042711|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
1042712|NCT02896257|Lung Diseases|lung diseases
1042713|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
1042714|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
1042715|NCT02896244|Clostridium difficile|clostridium difficile
1042716|NCT02896244|Clostridium difficile infection|clostridium difficile infection
1042717|NCT02896244|antibiotics|antibiotics
1042718|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
1042719|NCT02896244|microbiome|microbiome
1042720|NCT02896244|microbiota|microbiota
1042721|NCT02896218|Vancomycin|vancomycin
1042722|NCT02896218|Critically Ill|critically ill
1042723|NCT02896218|Pharmacist|pharmacist
1042724|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
1042725|NCT02896218|Bayesian Methods|bayesian methods
1042726|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
1042727|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
1042728|NCT02896179|Multiple sclerosis|multiple sclerosis
1042729|NCT02896179|Gait rehabilitation|gait rehabilitation
1042730|NCT02896179|Quality of life|quality of life
1042731|NCT02896179|Virtual reality|virtual reality
1042732|NCT02896179|Cognitive deficit|cognitive deficit
1042733|NCT02896179|Robot assisted gait training|robot assisted gait training
1042734|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
1042735|NCT02896140|Type 2 diabetes|type 2 diabetes
1042736|NCT02896140|Obesity|obesity
1042739|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
1042740|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
1042741|NCT02896101|Mild to moderate|mild to moderate
1042742|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
1042743|NCT02896075|laughter|laughter
1042744|NCT02896049|neoplasms|neoplasms
1042745|NCT02896049|hyperthermia|hyperthermia
1042746|NCT02896036|Laparoscopic Entry|laparoscopic entry
1042747|NCT02896036|Veress Needle|veress needle
1042748|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
1042749|NCT02896036|Time|time
1042750|NCT02896036|Complications|complications
1042751|NCT02896023|predictors|predictors
1042752|NCT02896023|ovarian reserve|ovarian reserve
1042753|NCT02896023|infertile women|infertile women
1042754|NCT02896010|Mobile Health|mobile health
1042755|NCT02895997|mental fatigue|mental fatigue
1042756|NCT02895997|critical care|critical care
1042757|NCT02895984|Social network analysis|social network analysis
1042758|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
1042759|NCT02895984|College Students|college students
1042760|NCT02895971|Venous Thromboembolism|venous thromboembolism
1042761|NCT02895971|professional Practices|professional practices
1042762|NCT02895906|22q11.2 DS|22q11.2 ds
1042763|NCT02895880|Communication Tool|communication tool
1042764|NCT02895880|Cancer Survivors|cancer survivors
1042765|NCT02895880|Increase Statin|increase statin
1042766|NCT02895880|16-1128|16-1128
1042767|NCT02895854|Low risk prostate cancer|low risk prostate cancer
1042768|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
1042769|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
1042770|NCT02895854|Hypofractionated|hypofractionated
1042771|NCT02895854|Robotic external beam radiation|robotic external beam radiation
1042772|NCT02895854|Quality of life|quality of life
1042773|NCT02895841|oncology|oncology
1042774|NCT02895841|bone marrow transplant|bone marrow transplant
1042775|NCT02895841|sickle cell disease|sickle cell disease
1042776|NCT02895802|down syndrome|down syndrome
1042777|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
1042778|NCT02895789|oxidative capacity|oxidative capacity
1042779|NCT02895789|exercise tolerance|exercise tolerance
1042780|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
1042781|NCT02895789|SMA|sma
1042782|NCT02895789|six minute walk test|six minute walk test
1042783|NCT02895789|neuromuscular disease|neuromuscular disease
1042784|NCT02895789|ambulation|ambulation
1042785|NCT02895789|exercise|exercise
1042786|NCT02895789|mitochondria|mitochondria
1042787|NCT02895789|cycle ergometry|cycle ergometry
1042788|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
1042789|NCT02895763|QUALITY OF LIFE|quality of life
1042790|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
1042791|NCT02895750|diabetes type 2|diabetes type 2
1042792|NCT02895750|Metformin|metformin
1042793|NCT02895750|chronic kidney disease|chronic kidney disease
1042794|NCT02895750|CKD|ckd
1042795|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
1042796|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1042797|NCT02895724|secondary lymphedema|secondary lymphedema
1042798|NCT02895698|Cupping|cupping
1042799|NCT02895698|Dry cupping|dry cupping
1042800|NCT02895698|Myofascial trigger points|myofascial trigger points
1042801|NCT02895685|Simulation|simulation
1042802|NCT02895685|Self-regulated training|self-regulated training
1042803|NCT02895685|Education|education
1042804|NCT02895685|Open surgery|open surgery
1042805|NCT02895685|Dyad training|dyad training
1042806|NCT02895659|fluid management|fluid management
1042807|NCT02895659|critical illness|critical illness
1042815|NCT02895568|Antimalarial drug|antimalarial drug
1042816|NCT02895568|Resistance|resistance
1042817|NCT02895568|Republic of Chard|republic of chard
1042818|NCT02895555|ODI|odi
1333223|NCT01443936|H5N1 Influenza|h5n1 influenza
1042819|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
1042820|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
1042821|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
1042822|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
1042823|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
1042824|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
1042825|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
1042826|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
1042827|NCT02895451|Physical capacity|physical capacity
1042828|NCT02895451|Adherence|adherence
1042829|NCT02895451|Behavioral medicine|behavioral medicine
1042830|NCT02895438|Gluten-Sensitive|gluten-sensitive
1042831|NCT02895438|Diet, Gluten-Free|diet, gluten-free
1042832|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
1042833|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
1042834|NCT02895438|children|children
1042835|NCT02895425|Renal Transplant|renal transplant
1042843|NCT02895373|platelet inhibition|platelet inhibition
1042844|NCT02895373|alprostadil|alprostadil
1042845|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1042846|NCT02895373|bleeding|bleeding
1042847|NCT02895373|thromboembolic|thromboembolic
1042848|NCT02895334|CHD|chd
1042849|NCT02895334|Congenital Heart Disease|congenital heart disease
1042850|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
1042851|NCT02895321|potassium nitrate|potassium nitrate
1042852|NCT02895308|compliance|compliance
1042853|NCT02895295|Medicare Part D|medicare part d
1042854|NCT02895295|decision support|decision support
1042855|NCT02895295|prescription drugs|prescription drugs
1042856|NCT02895295|expert recommendation|expert recommendation
1042857|NCT02895295|health insurance choice|health insurance choice
1042858|NCT02895282|Obesity|obesity
1042859|NCT02895282|Chronobiology|chronobiology
1042860|NCT02895282|Circadian|circadian
1042861|NCT02895269|Complementary Alternative Providers|complementary alternative providers
1042862|NCT02895269|Collaborative Shared Care|collaborative shared care
1042863|NCT02895269|Primary Health Care Providers|primary health care providers
1042864|NCT02895269|Psychosis|psychosis
1042865|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
1042866|NCT02895230|Prostate cancer|prostate cancer
1042867|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
1042868|NCT02895230|Myocardial infarction|myocardial infarction
1042869|NCT02895230|Ischemic stroke|ischemic stroke
1042870|NCT02895217|Energy expenditure|energy expenditure
1042871|NCT02895217|Food intake|food intake
1042872|NCT02895217|Women|women
1042873|NCT02895217|aquacycling|aquacycling
1042874|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
1042875|NCT02895204|Natural killer cell activity|natural killer cell activity
1042876|NCT02895204|Immune function|immune function
1042877|NCT02895204|Pre-albumin|pre-albumin
1042878|NCT02895204|Interleukin-12|interleukin-12
1042879|NCT02895178|Breast cancer|breast cancer
1042880|NCT02895178|Survivors|survivors
1042881|NCT02895178|Exercise|exercise
1042882|NCT02895165|breast neoplasms|breast neoplasms
1042883|NCT02895165|fertility preservation|fertility preservation
1042884|NCT02895165|pregnancy|pregnancy
1042885|NCT02895152|COPD|copd
1042886|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1042887|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
1042888|NCT02895152|Activity Monitors|activity monitors
1042889|NCT02895152|Fitbit|fitbit
1042890|NCT02895152|Fitness Tracker|fitness tracker
1042891|NCT02895139|Additive Manufacture|additive manufacture
1042892|NCT02895139|Orthotic Insole|orthotic insole
1042893|NCT02895126|vulnerable family|vulnerable family
1042894|NCT02895113|Aspirin|aspirin
1042895|NCT02895113|Diabetes|diabetes
1042896|NCT02895113|Renal function|renal function
1042897|NCT02895113|Thromboxane|thromboxane
1042898|NCT02895100|ulcerative colitis|ulcerative colitis
1042899|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
1042900|NCT02895100|PROPEL|propel
1042901|NCT02895100|Propel Study|propel study
1043000|NCT02894411|MRI|mri
1042902|NCT02895087|diurnal variation|diurnal variation
1042903|NCT02895087|stress|stress
1042904|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
1042905|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
1042906|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
1042907|NCT02895009|Coronary Disease|coronary disease
1042908|NCT02895009|Radial artery occlusion|radial artery occlusion
1042909|NCT02895009|transradial coronary intervention|transradial coronary intervention
1042910|NCT02894996|pediatric|pediatric
1042911|NCT02894996|anesthesia|anesthesia
1042912|NCT02894996|fluid responsiveness|fluid responsiveness
1042913|NCT02894996|hemodynamic|hemodynamic
1042914|NCT02894983|wrist fracture|wrist fracture
1042915|NCT02894983|colles fracture|colles fracture
1042916|NCT02894983|non-operative|non-operative
1042917|NCT02894983|rehabilitation|rehabilitation
1042918|NCT02894944|Pancreatic cancer|pancreatic cancer
1042919|NCT02894944|Adenovirus|adenovirus
1042920|NCT02894944|Gene therapy|gene therapy
1042921|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
1042922|NCT02894931|dietary interventions|dietary interventions
1042923|NCT02894931|sugars|sugars
1042924|NCT02894931|amino acids|amino acids
1042925|NCT02894931|artificial sweeteners|artificial sweeteners
1042926|NCT02894931|atherosclerosis|atherosclerosis
1042927|NCT02894892|Electron Microscopy|electron microscopy
1042928|NCT02894892|Helicobacter pylori|helicobacter pylori
1042929|NCT02894892|Bismuth|bismuth
1042930|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
1042931|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1042932|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1042933|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
1042934|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
1042935|NCT02894814|Self administration|self administration
1042936|NCT02894814|Medication|medication
1042937|NCT02894814|Inpatient|inpatient
1042938|NCT02894814|Self-care|self-care
1042939|NCT02894814|Self-management|self-management
1042940|NCT02894814|Medical patients|medical patients
1042941|NCT02894749|hybrid rooms|hybrid rooms
1042942|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
1042943|NCT02894723|Hypertension,|hypertension,
1042944|NCT02894723|Nitric Oxide|nitric oxide
1042945|NCT02894723|L-Arginine|l-arginine
1042946|NCT02894723|Arterial Stiffness|arterial stiffness
1042947|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
1042948|NCT02894710|postoperative pain|postoperative pain
1042949|NCT02894710|intravenous lidocaine|intravenous lidocaine
1042950|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
1042951|NCT02894710|remifentanil|remifentanil
1042952|NCT02894710|patient controlled analgesia|patient controlled analgesia
1042953|NCT02894710|morphine consumption|morphine consumption
1042954|NCT02894710|ENT surgery|ent surgery
1042955|NCT02894632|MRI|mri
1042956|NCT02894632|Motion|motion
1042957|NCT02894632|Respiratory movement|respiratory movement
1042958|NCT02894632|Artifacts correction|artifacts correction
1042959|NCT02894619|urinary incontinence|urinary incontinence
1042960|NCT02894619|anal incontinence|anal incontinence
1042961|NCT02894619|sexuality|sexuality
1042962|NCT02894619|quality of life|quality of life
1042963|NCT02894606|Kidney Transplant|kidney transplant
1042964|NCT02894606|Immunology|immunology
1042965|NCT02894593|Antiplaque agents|antiplaque agents
1042966|NCT02894593|chemical plaque control|chemical plaque control
1042967|NCT02894593|oral hygiene|oral hygiene
1042968|NCT02894593|essential oils|essential oils
1042969|NCT02894593|alcohol|alcohol
1042970|NCT02894593|mouthwash|mouthwash
1042971|NCT02894541|Dyslipidemia|dyslipidemia
1042972|NCT02894541|CKD-519|ckd-519
1042973|NCT02894541|CETP inhibitor|cetp inhibitor
1042974|NCT02894541|Food Drug Interaction|food drug interaction
1042975|NCT02894528|Alveolar ridge|alveolar ridge
1042976|NCT02894528|guided bone regeneration|guided bone regeneration
1042977|NCT02894528|bone grafts|bone grafts
1042978|NCT02894502|Self-care|self-care
1043106|NCT02893878|England|england
1042979|NCT02894502|Motivational interviewing|motivational interviewing
1042980|NCT02894502|Heart failure|heart failure
1042981|NCT02894502|Caregivers|caregivers
1042982|NCT02894476|satisfaction with care|satisfaction with care
1042983|NCT02894476|outpatient care|outpatient care
1042984|NCT02894476|self-reported health status|self-reported health status
1042985|NCT02894476|alcohol dependence|alcohol dependence
1042986|NCT02894476|opioid dependence|opioid dependence
1042987|NCT02894463|dental care|dental care
1042988|NCT02894463|emeno|emeno
1042989|NCT02894463|abuse|abuse
1042990|NCT02894450|Atrial fibrillation|atrial fibrillation
1042991|NCT02894450|oral anticoagulant|oral anticoagulant
1042992|NCT02894450|bioassay|bioassay
1042993|NCT02894450|elderly subject|elderly subject
1042994|NCT02894437|prevention|prevention
1042995|NCT02894437|organization|organization
1042996|NCT02894437|pressure ulcers|pressure ulcers
1042997|NCT02894424|Inner limiting membrane|inner limiting membrane
1042998|NCT02894424|Microperimetry|microperimetry
1042999|NCT02894424|surgical's dye|surgical's dye
1043001|NCT02894411|Excyclotorsion|excyclotorsion
1043003|NCT02894398|HER2-|her2-
1043004|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
1043005|NCT02894398|Palbociclib|palbociclib
1043006|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
1043007|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
1043008|NCT02894398|Postmenopausal|postmenopausal
1043009|NCT02894372|Oral spray|oral spray
1043010|NCT02894372|Topical sprays|topical sprays
1043011|NCT02894372|Faringomoss|faringomoss
1043012|NCT02894372|Local phytotherapy|local phytotherapy
1043013|NCT02894359|Cervical spine|cervical spine
1043014|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
1727273|NCT00000664|Zidovudine|zidovudine
1043015|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
1043016|NCT02894359|ConeBeam.|conebeam.
1043017|NCT02894346|Motivation|motivation
1043018|NCT02894346|Teachers|teachers
1043019|NCT02894346|Physical activity|physical activity
1043020|NCT02894346|School|school
1043021|NCT02894333|Parkinson's disease|parkinson's disease
1043022|NCT02894333|Action-effect prediction|action-effect prediction
1043023|NCT02894333|Sensory attenuation|sensory attenuation
1043024|NCT02894333|Voluntary action|voluntary action
1043025|NCT02894320|Parkinson's disease|parkinson's disease
1043026|NCT02894320|Voluntary action|voluntary action
1043027|NCT02894320|Action-effect preactivation|action-effect preactivation
1043028|NCT02894320|Action-effect prediction|action-effect prediction
1043029|NCT02894307|Mechanical prosthesis|mechanical prosthesis
1043030|NCT02894307|Rivaroxaban|rivaroxaban
1043031|NCT02894294|malaria|malaria
1043032|NCT02894294|chemoprevention|chemoprevention
1043033|NCT02894294|season|season
1043034|NCT02894294|anemia|anemia
1043035|NCT02894294|impact|impact
1043036|NCT02894294|coverage|coverage
1043037|NCT02894294|children|children
1043038|NCT02894281|Pupillary light reflex|pupillary light reflex
1043039|NCT02894281|Multiple sclerosis|multiple sclerosis
1043040|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
1043041|NCT02894190|Adherence|adherence
1043045|NCT02894177|E02.880.820.950|e02.880.820.950
1043046|NCT02894164|Cystatin C|cystatin c
1043047|NCT02894164|Creatinine|creatinine
1043048|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
1043049|NCT02894125|Chronic Low Back Pain|chronic low back pain
1043050|NCT02894125|Old subject|old subject
1043051|NCT02894125|SPA Therapy|spa therapy
1043052|NCT02894125|Pain|pain
1043053|NCT02894125|Function|function
1043054|NCT02894125|Expectations|expectations
1043055|NCT02894125|Fears|fears
1043056|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
1043057|NCT02894112|blood flow|blood flow
1043058|NCT02894112|blood glucose|blood glucose
1043059|NCT02894112|triglycerides|triglycerides
1043060|NCT02894112|non-fat milk|non-fat milk
1043061|NCT02894112|dairy|dairy
1043062|NCT02894099|Aged|aged
1043063|NCT02894099|Sedentary Behaviour|sedentary behaviour
1043064|NCT02894099|Blood Glucose|blood glucose
1043065|NCT02894099|Insulin|insulin
1043066|NCT02894099|Inflammatory markers|inflammatory markers
1043067|NCT02894086|acute appendicitis|acute appendicitis
1043068|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
1043069|NCT02894073|obese patients|obese patients
1043070|NCT02894073|peripheral venous catheter|peripheral venous catheter
1043071|NCT02894060|Cardiovascular events|cardiovascular events
1043072|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
1043073|NCT02894034|optic nerve sheath|optic nerve sheath
1043074|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
1043075|NCT02894034|early phase|early phase
1043076|NCT02894034|prognostic|prognostic
1043077|NCT02894021|padding|padding
1043078|NCT02894021|lymphoceles|lymphoceles
1043079|NCT02894021|prevention|prevention
1043080|NCT02893995|PAH|pah
1043081|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
1043082|NCT02893995|Remodulin|remodulin
1043083|NCT02893995|6 Minute Walk Test|6 minute walk test
1043084|NCT02893969|Physical Activity|physical activity
1043085|NCT02893969|Rest|rest
1043086|NCT02893956|Echocardiography|echocardiography
1043087|NCT02893956|postural support|postural support
1043088|NCT02893956|preterm neonate|preterm neonate
1043089|NCT02893904|Propofol|propofol
1043090|NCT02893904|Sevoflurane|sevoflurane
1043091|NCT02893904|Bispectral Index|bispectral index
1043092|NCT02893904|Children|children
1043093|NCT02893904|Electroencephalographic signs|electroencephalographic signs
1043094|NCT02893891|Obesity|obesity
1043095|NCT02893891|Bariatric medicine|bariatric medicine
1043096|NCT02893891|Sleeve gastric resection|sleeve gastric resection
1043097|NCT02893891|Gastric plication|gastric plication
1043098|NCT02893891|Intragastric ballon|intragastric ballon
1043099|NCT02893891|Body composition|body composition
1043100|NCT02893891|Adipokines|adipokines
1043101|NCT02893891|Ghrelin|ghrelin
1043102|NCT02893891|Bone mineral density|bone mineral density
1043103|NCT02893891|Quality of life|quality of life
1043104|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
1043105|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
1043107|NCT02893878|Pilot study|pilot study
1043108|NCT02893865|Apnea syndrome|apnea syndrome
1043109|NCT02893865|Coronary artery disease|coronary artery disease
1043110|NCT02893865|Oxidative stress|oxidative stress
1043111|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
1043112|NCT02893865|Endothelial dysfunction|endothelial dysfunction
1043113|NCT02893839|Allergy|allergy
1043114|NCT02893839|cross-reactivity|cross-reactivity
1043115|NCT02893839|oral allergy syndrome|oral allergy syndrome
1043116|NCT02893839|potato|potato
1727460|NCT00000633|HIV-1|hiv-1
1076686|NCT02689869|GA101|ga101
1043117|NCT02893839|sensitization|sensitization
1043118|NCT02893826|Aneurysm|aneurysm
1043119|NCT02893826|Ruptured|ruptured
1043120|NCT02893826|nimodipine|nimodipine
1043121|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
1043122|NCT02893800|assistive technology|assistive technology
1043123|NCT02893800|dementia care|dementia care
1043124|NCT02893800|tracking technology|tracking technology
1043125|NCT02893800|locating systems|locating systems
1043126|NCT02893800|user experience|user experience
1043127|NCT02893787|Speckle Tracking|speckle tracking
1043128|NCT02893787|Anthracyclines|anthracyclines
1043129|NCT02893787|Chilhood cancers|chilhood cancers
1043130|NCT02893787|Myocardial function|myocardial function
1043131|NCT02893787|Echocardiography|echocardiography
1043132|NCT02893761|breast cancer|breast cancer
1043133|NCT02893761|survival|survival
1043134|NCT02893761|prognosis factors|prognosis factors
1043135|NCT02893748|colon|colon
1043136|NCT02893748|polyps|polyps
1043137|NCT02893748|cancer|cancer
1043138|NCT02893748|screening|screening
1043139|NCT02893735|Clinical Trial|clinical trial
1043140|NCT02893735|Composite resin|composite resin
1043141|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
1043142|NCT02893683|Paris Visual Learning Test|paris visual learning test
1043143|NCT02893683|visual memory|visual memory
1043144|NCT02893683|criterion validity|criterion validity
1043145|NCT02893657|MELD score|meld score
1043146|NCT02893657|hemodynamics|hemodynamics
1043147|NCT02893657|liver abnormalities|liver abnormalities
1043148|NCT02893566|overweight|overweight
1043149|NCT02893566|body mass index|body mass index
1043150|NCT02893566|university students|university students
1043151|NCT02893566|physical activity|physical activity
1043152|NCT02893566|sedentary behavior|sedentary behavior
1043153|NCT02893566|body composition|body composition
1043154|NCT02893566|Mi Band|mi band
1043155|NCT02893514|Drug Use|drug use
1043156|NCT02893488|dolutegravir|dolutegravir
1043157|NCT02893488|abacavir|abacavir
1043158|NCT02893488|relative bioavailability|relative bioavailability
1043159|NCT02893488|palatability|palatability
1043160|NCT02893488|GSK2619619|gsk2619619
1043161|NCT02893488|palatability questionnaire|palatability questionnaire
1043162|NCT02893488|lamivudine|lamivudine
1043163|NCT02893488|pediatric|pediatric
1043164|NCT02893488|calcium|calcium
1043165|NCT02893488|dispersible tablet|dispersible tablet
1043166|NCT02893462|data warehousing|data warehousing
1043167|NCT02893462|data aggregation|data aggregation
1043168|NCT02893462|data mining|data mining
1043169|NCT02893449|Parkinson|parkinson
1043170|NCT02893449|SAS-SR|sas-sr
1043171|NCT02893449|Social adaptation|social adaptation
1043172|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
1043173|NCT02893423|Ropivacaine|ropivacaine
1043174|NCT02893423|C-Section Analgesia|c-section analgesia
1043175|NCT02893423|Tap Block|tap block
1043176|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
1043177|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
1043178|NCT02893358|large arterial stiffness|large arterial stiffness
1043179|NCT02893358|microalbuminuria|microalbuminuria
1043180|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
1043181|NCT02893345|Community Participation|community participation
1043182|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
1043183|NCT02893345|Informatics, Clinical|informatics, clinical
1043184|NCT02893319|Infant Feeding|infant feeding
1043185|NCT02893319|Infant Growth|infant growth
1043186|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
1043187|NCT02893306|Multipotent stromal cell|multipotent stromal cell
1043188|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
1043189|NCT02893306|Insulin|insulin
1043190|NCT02893306|Pancreatic reserve|pancreatic reserve
1043191|NCT02893306|Disease progression|disease progression
1043192|NCT02893267|Stroke|stroke
1043193|NCT02893267|Shoulder Pain|shoulder pain
1043194|NCT02893267|Electrical stimulation|electrical stimulation
1043195|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
1043196|NCT02893267|Intramuscular stimulation|intramuscular stimulation
1043197|NCT02893267|Physical Therapy|physical therapy
1043198|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
1043199|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
1043200|NCT02893228|forced vital capacity|forced vital capacity
1043297|NCT02892773|lung volume|lung volume
1043201|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
1043202|NCT02893228|interscalene block|interscalene block
1043203|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
1043204|NCT02893202|PTSD|ptsd
1043205|NCT02893202|Equine assisted activities|equine assisted activities
1043206|NCT02893202|quality of life|quality of life
1043207|NCT02893189|CD19+|cd19+
1043208|NCT02893189|allogeneic transplant|allogeneic transplant
1043209|NCT02893189|relapse|relapse
1043210|NCT02893176|Lung Transplant|lung transplant
1043211|NCT02893176|Macitentan|macitentan
1043212|NCT02893176|CLAD|clad
1043214|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
1043215|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
1043216|NCT02893176|Organ Rejection|organ rejection
1043217|NCT02893163|Metabolic Syndrome|metabolic syndrome
1043218|NCT02893163|Cancer Risk|cancer risk
1043219|NCT02893163|Lifestyle Interventions|lifestyle interventions
1043220|NCT02893163|Primary Care|primary care
1043221|NCT02893163|Behavioural Change|behavioural change
1043222|NCT02893150|Mindful Eating|mindful eating
1043223|NCT02893150|Overweight|overweight
1043224|NCT02893150|Primary Care|primary care
1043225|NCT02893150|Randomized Clinical Trial|randomized clinical trial
1043226|NCT02893137|Tumour treating fields|tumour treating fields
1043227|NCT02893137|Optune|optune
1043228|NCT02893137|Craniectomy|craniectomy
1043229|NCT02893137|TTFields|ttfields
1043230|NCT02893124|chronic hepatitis B|chronic hepatitis b
1043231|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
1043232|NCT02893111|Bortezomib|bortezomib
1043233|NCT02893111|Velcade|velcade
1043234|NCT02893111|Proteasome inhibitor|proteasome inhibitor
1043235|NCT02893072|Diabetes, Gestational|diabetes, gestational
1043236|NCT02893072|Nutrition Therapy|nutrition therapy
1043237|NCT02893046|care pathway|care pathway
1043238|NCT02893046|hospital- private network|hospital- private network
1043239|NCT02893046|early consultation|early consultation
1043240|NCT02893033|Dysphagia|dysphagia
1043241|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1043242|NCT02893033|Stroke|stroke
1043338|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1043243|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
1043244|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
1043245|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
1043246|NCT02892968|Emergency Department|emergency department
1043247|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
1043248|NCT02892955|Heart Failure|heart failure
1043249|NCT02892955|LVAS|lvas
1043250|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
1043251|NCT02892955|Cardiomyopathy|cardiomyopathy
1043252|NCT02892955|Heart Disease|heart disease
1043253|NCT02892955|Cardiovascular Disease|cardiovascular disease
1043254|NCT02892955|Heart-assist devices|heart-assist devices
1043255|NCT02892955|Thoratec Corporation|thoratec corporation
1043256|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1043257|NCT02892942|Estradiol|estradiol
1043258|NCT02892942|Embryo implantation|embryo implantation
1043259|NCT02892942|Endometrial receptivity|endometrial receptivity
1043260|NCT02892942|Fertility preservation|fertility preservation
1043261|NCT02892929|Motivational Interviewing|motivational interviewing
1043262|NCT02892929|Hypertension|hypertension
1043263|NCT02892929|Nursing|nursing
1043264|NCT02892929|Randomized Controlled Trial|randomized controlled trial
1043265|NCT02892929|Life Style|life style
1043266|NCT02892916|Delirium|delirium
1043267|NCT02892916|Ketamine|ketamine
1043268|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
1043269|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
1043270|NCT02892903|Pressure wire (PW)|pressure wire (pw)
1043271|NCT02892903|Coronary angiography|coronary angiography
1043272|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
1043273|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
1043274|NCT02892877|Invasive mole|invasive mole
1043275|NCT02892877|Choriocarcinoma|choriocarcinoma
1043276|NCT02892877|Post-molar neoplasia|post-molar neoplasia
1043277|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
1043278|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
1043279|NCT02892877|hCG follow-up|hcg follow-up
1043280|NCT02892864|Bell's Palsy|bell's palsy
1043281|NCT02892864|Peripheral facial palsy|peripheral facial palsy
1043282|NCT02892851|STN-DBS|stn-dbs
1043283|NCT02892851|Craving|craving
1043284|NCT02892851|Cocaine addiction|cocaine addiction
1043285|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
1043286|NCT02892825|Music|music
1043287|NCT02892825|cataract surgery|cataract surgery
1043288|NCT02892825|topical anaesthesia|topical anaesthesia
1043289|NCT02892825|anxiety|anxiety
1043290|NCT02892825|hypertension|hypertension
1043291|NCT02892786|circulating tumor cell|circulating tumor cell
1043292|NCT02892786|CellSearch™ method|cellsearch™ method
1043293|NCT02892786|RT-PCR|rt-pcr
1043294|NCT02892773|electrical impedance tomography|electrical impedance tomography
1043295|NCT02892773|incentive spirometry|incentive spirometry
1043296|NCT02892773|EzPAP|ezpap
1043298|NCT02892773|atelectasis|atelectasis
1043299|NCT02892773|positive airway pressure|positive airway pressure
1043300|NCT02892773|pulmonary complication|pulmonary complication
1043301|NCT02892773|abdominal surgery|abdominal surgery
1043302|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
1043303|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
1043304|NCT02892747|Dietetics education|dietetics education
1043305|NCT02892747|Malnutrition|malnutrition
1043306|NCT02892721|CT Colonography|ct colonography
1043307|NCT02892721|Virtual colonoscopy|virtual colonoscopy
1043308|NCT02892721|Colorectal cancer|colorectal cancer
1043309|NCT02892721|Colon cancer|colon cancer
1043310|NCT02892721|Training|training
1043311|NCT02892708|supratentorial gliomas|supratentorial gliomas
1043312|NCT02892708|surgery|surgery
1043313|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1043314|NCT02892708|elderly|elderly
1043315|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
1043316|NCT02892630|Pregnancy|pregnancy
1043317|NCT02892617|Modic 1|modic 1
1043318|NCT02892617|low back pain|low back pain
1043319|NCT02892604|Type 1 diabetes|type 1 diabetes
1043320|NCT02892604|artificial pancreas|artificial pancreas
1043321|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
1043322|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
1043323|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
1043324|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
1043325|NCT02892513|Colorectal Surgery|colorectal surgery
1043326|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
1043327|NCT02892487|Quality of life|quality of life
1043328|NCT02892487|Radiotherapy|radiotherapy
1043329|NCT02892487|Dysphagia|dysphagia
1043330|NCT02892487|Oral cavity|oral cavity
1043331|NCT02892487|Oropharynx|oropharynx
1043332|NCT02892487|Hypopharynx|hypopharynx
1043333|NCT02892487|Larynx|larynx
1043334|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
1043335|NCT02892487|Toxicity|toxicity
1043336|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
1043337|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
1043838|NCT02889666|cisplatin|cisplatin
1043339|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
1043340|NCT02892461|Cesarean Section|cesarean section
1043341|NCT02892461|Umbilical Cord Milking|umbilical cord milking
1043342|NCT02892461|Randomized Controlled Trial|randomized controlled trial
1043343|NCT02892409|Drug Therapy|drug therapy
1043344|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
1043345|NCT02892331|exercise|exercise
1043346|NCT02892331|insulin resistance|insulin resistance
1043347|NCT02892331|mitochondrial function|mitochondrial function
1043348|NCT02892331|arterial stiffness|arterial stiffness
1043349|NCT02892331|exercise intensity|exercise intensity
1043350|NCT02892331|fitness|fitness
1043351|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
1043352|NCT02892305|Hepatectomy|hepatectomy
1043353|NCT02892305|Liver ablation|liver ablation
1043354|NCT02892305|Whipple|whipple
1043355|NCT02892279|Microneurography|microneurography
1043356|NCT02892279|Air pollution|air pollution
1043357|NCT02892266|Transplant recipients|transplant recipients
1043358|NCT02892266|Adolescents|adolescents
1043359|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
1043360|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
1043361|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
1043362|NCT02892253|near infrared imaging|near infrared imaging
1043363|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
1043364|NCT02892227|bedside echography|bedside echography
1043365|NCT02892162|atrial fibrillation|atrial fibrillation
1043366|NCT02892162|catheter ablation|catheter ablation
1043367|NCT02892149|AKB-6548|akb-6548
1043368|NCT02892149|Chronic kidney disease|chronic kidney disease
1043369|NCT02892149|anemia|anemia
1043370|NCT02892149|CKD|ckd
1043371|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
1043372|NCT02892149|renal impairment|renal impairment
1043373|NCT02892149|erythropoietin|erythropoietin
1043374|NCT02892149|kidney|kidney
1043375|NCT02892149|renal|renal
1043376|NCT02892149|oral anemia treatment|oral anemia treatment
1043377|NCT02892149|hemoglobin|hemoglobin
1043378|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
1043379|NCT02892149|HIF|hif
1043380|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1043381|NCT02892149|HIF-PHI|hif-phi
1043382|NCT02892149|efficacy|efficacy
1043383|NCT02892149|safety|safety
1043384|NCT02892149|Phase 3|phase 3
1043385|NCT02892149|cardiovascular|cardiovascular
1043386|NCT02892149|DD-CKD|dd-ckd
1043387|NCT02892123|HER2|her2
1043388|NCT02892123|bispecific antibody|bispecific antibody
1043389|NCT02892123|biparatopic antibody|biparatopic antibody
1043390|NCT02892123|breast cancer|breast cancer
1043391|NCT02892123|gastric cancer|gastric cancer
1043392|NCT02892123|gastroesophageal cancer|gastroesophageal cancer
1043393|NCT02892123|ovarian cancer|ovarian cancer
1043590|NCT02891031|Uric acid|uric acid
1043394|NCT02892123|non-small cell lung cancer|non-small cell lung cancer
1043395|NCT02892110|Marijuana use|marijuana use
1043396|NCT02892110|Varenicline/Chantix|varenicline/chantix
1043397|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
1043399|NCT02892097|neglect|neglect
1043400|NCT02892097|paresis|paresis
1333224|NCT01443936|Normal Volunteer|normal volunteer
1043401|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
1043402|NCT02892097|rehabilitation|rehabilitation
1043403|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
1043404|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
1043405|NCT02892084|rehabilitation|rehabilitation
1043406|NCT02892084|walking|walking
1043407|NCT02892084|kinetics|kinetics
1043408|NCT02892045|neuromuscular block|neuromuscular block
1043409|NCT02892045|monitoring|monitoring
1043410|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
1043411|NCT02891993|Cancer Care|cancer care
1043412|NCT02891980|Ad26|ad26
1043413|NCT02891980|Ebola|ebola
1043414|NCT02891980|immunogenicity response|immunogenicity response
1043415|NCT02891980|MVA-Multi Filo|mva-multi filo
1043416|NCT02891980|Omics|omics
1043417|NCT02891980|Zaire|zaire
1043418|NCT02891954|Glucosuria|glucosuria
1043419|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
1043420|NCT02891954|Canagliflozin|canagliflozin
1043421|NCT02891954|FGF23|fgf23
1043422|NCT02891954|Parathyroid hormone|parathyroid hormone
1043423|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
1043424|NCT02891954|Glucagon|glucagon
1043425|NCT02891954|Ketone bodies|ketone bodies
1043426|NCT02891954|Uric acid|uric acid
1043427|NCT02891954|Pharmacogenomics|pharmacogenomics
1043428|NCT02891928|Type 2 diabetes|type 2 diabetes
1043429|NCT02891928|Diabetic neuropathy|diabetic neuropathy
1043430|NCT02891928|Disorders of equilibrium|disorders of equilibrium
1043431|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
1043432|NCT02891928|Walking|walking
1043433|NCT02891915|Antimicrobial|antimicrobial
1043434|NCT02891915|Beta-Lactam|beta-lactam
1043435|NCT02891915|Pneumonia|pneumonia
1043436|NCT02891915|Short Course|short course
1043437|NCT02891915|Standard Course|standard course
1043438|NCT02891915|Therapy|therapy
1043439|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
1043440|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
1043441|NCT02891837|L-citrulline|l-citrulline
1043442|NCT02891837|pediatric|pediatric
1043443|NCT02891837|Lung Injury|lung injury
1043444|NCT02891837|Bypass|bypass
1043445|NCT02891837|Heart Defects|heart defects
1043446|NCT02891837|Clinical Sequelae|clinical sequelae
1043447|NCT02891824|PD-L1|pd-l1
1043448|NCT02891824|Atezolizumab|atezolizumab
1043449|NCT02891824|Randomized, double blinded|randomized, double blinded
1043450|NCT02891824|first or second late relapse|first or second late relapse
1043451|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
1043452|NCT02891824|progression-free survival|progression-free survival
1043453|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1043454|NCT02891811|carfilzomib|carfilzomib
1043455|NCT02891811|thalidomide|thalidomide
1043456|NCT02891811|lenalidomide|lenalidomide
1043457|NCT02891811|dexamethasone|dexamethasone
1043458|NCT02891811|transplant ineligible|transplant ineligible
1043459|NCT02891811|induction therapy|induction therapy
1043460|NCT02891811|maintenance|maintenance
1043461|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
1043462|NCT02891798|analgesia,|analgesia,
1043463|NCT02891798|buprenorphine|buprenorphine
1043464|NCT02891798|clonidine|clonidine
1043465|NCT02891798|dexamethasone|dexamethasone
1043466|NCT02891798|bupivacaine|bupivacaine
1043467|NCT02891798|nerve block|nerve block
1043468|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
1043469|NCT02891733|Neurotensin|neurotensin
1043470|NCT02891668|Basal Metabolic rate|basal metabolic rate
1043471|NCT02891668|Quality of life|quality of life
1043472|NCT02891668|Resting energy expenditure|resting energy expenditure
1043473|NCT02891668|Insulin resistance|insulin resistance
1043474|NCT02891668|Cognitive Function|cognitive function
1043475|NCT02891668|Body Composition|body composition
1043476|NCT02891642|malignancy|malignancy
1043477|NCT02891642|Pleural Effusion|pleural effusion
1043478|NCT02891642|Pleural Neoplasms|pleural neoplasms
1043479|NCT02891642|Ascites|ascites
1043480|NCT02891616|Melanoma|melanoma
1043481|NCT02891616|18F-FLT|18f-flt
1043482|NCT02891616|18F-FDG|18f-fdg
1043483|NCT02891616|PET/CT|pet/ct
1043484|NCT02891616|PET/MR|pet/mr
1043485|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
1043486|NCT02891577|shock|shock
1043487|NCT02891577|critically ill|critically ill
1043488|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
1043489|NCT02891551|Leukemia|leukemia
1043490|NCT02891551|Chronic|chronic
1043491|NCT02891551|Acute|acute
1043492|NCT02891551|Observational|observational
1043497|NCT02891538|EGCG|egcg
1043498|NCT02891538|Green Tea|green tea
1043499|NCT02891538|Colon Cancer|colon cancer
1043500|NCT02891512|Magnetic Fields|magnetic fields
1043501|NCT02891512|Pain|pain
1043502|NCT02891512|Paresthesia|paresthesia
1043503|NCT02891512|Visual Analogue Scale|visual analogue scale
1043504|NCT02891499|Miniscrews|miniscrews
1043505|NCT02891499|Mini-implants|mini-implants
1043506|NCT02891499|Temporal anchorage devices|temporal anchorage devices
1043507|NCT02891499|Bone screws|bone screws
1043508|NCT02891499|Stability|stability
1043509|NCT02891499|Displacement|displacement
1043510|NCT02891499|Low-level laser therapy|low-level laser therapy
1043511|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
1043512|NCT02891499|Resonance frequency analysis|resonance frequency analysis
1043513|NCT02891499|Orthodontic|orthodontic
1043514|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
1043515|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
1043516|NCT02891473|Posture|posture
1043517|NCT02891473|Pain|pain
1043518|NCT02891473|Muscle stretching|muscle stretching
1043519|NCT02891473|Mézières method|mézières method
1043520|NCT02891473|Camptocormia|camptocormia
1043521|NCT02891473|Trunk control|trunk control
1043522|NCT02891460|Mitomycin C|mitomycin c
1043523|NCT02891460|MMC|mmc
1043524|NCT02891460|NMIBC|nmibc
1043525|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1043526|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
1043527|NCT02891460|Drug retention|drug retention
1043528|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
1043529|NCT02891460|Urologic Neoplasms|urologic neoplasms
1043530|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
1043531|NCT02891460|Urologic Diseases|urologic diseases
1043532|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
1043533|NCT02891434|motor learning|motor learning
1043534|NCT02891434|motor abilities|motor abilities
1043535|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1043536|NCT02891395|imatinib Mesylate|imatinib mesylate
1043537|NCT02891395|Nilotinib|nilotinib
1043839|NCT02889666|carboplatin|carboplatin
1043538|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1043539|NCT02891382|Weight Loss|weight loss
1043540|NCT02891382|Financial Incentives|financial incentives
1043541|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1043542|NCT02891356|Adiponectin|adiponectin
1043543|NCT02891356|Bone remodelling markers|bone remodelling markers
1043544|NCT02891343|Cognitive Function|cognitive function
1043545|NCT02891343|Hypoxia|hypoxia
1043546|NCT02891343|Neurophysiological Function|neurophysiological function
1043547|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
1043548|NCT02891343|Healthy Subjects|healthy subjects
1043549|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
1043550|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1043551|NCT02891291|optical coherence tomography|optical coherence tomography
1043552|NCT02891278|Leukemia|leukemia
1043553|NCT02891278|Sertraline|sertraline
1043554|NCT02891278|Cytosine Arabinoside|cytosine arabinoside
1043555|NCT02891278|Relapsed AML|relapsed aml
1043556|NCT02891278|Refractory AML|refractory aml
1043557|NCT02891239|laser treatment|laser treatment
1043558|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
1043559|NCT02891226|IL-23|il-23
1043560|NCT02891226|biologic|biologic
1043561|NCT02891187|Postoperative Care|postoperative care
1043562|NCT02891187|Telephone follow-up|telephone follow-up
1043563|NCT02891187|Healthcare Value|healthcare value
1043564|NCT02891174|ibuprofen|ibuprofen
1043565|NCT02891174|acetaminophen|acetaminophen
1043566|NCT02891174|blood pressure|blood pressure
1043567|NCT02891174|post-partum|post-partum
1043568|NCT02891174|pain control|pain control
1043569|NCT02891174|pre-eclampsia|pre-eclampsia
1043570|NCT02891174|gestational hypertension|gestational hypertension
1043571|NCT02891161|durvalumab|durvalumab
1043572|NCT02891161|MEDI4736|medi4736
1043573|NCT02891161|anti-PD-L1|anti-pd-l1
1043574|NCT02891135|"WHO 'Treat all Antiretroviral Guidelines"|"who 'treat all antiretroviral guidelines"
1043575|NCT02891135|Simplified Algorithm for Treatment Eligibility (SLATE)|simplified algorithm for treatment eligibility (slate)
1043576|NCT02891096|respiratory complications|respiratory complications
1043577|NCT02891096|respiratory muscle strength|respiratory muscle strength
1043578|NCT02891096|discriminator|discriminator
1043579|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
1043580|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
1043581|NCT02891083|lymph node metastasis|lymph node metastasis
1043582|NCT02891083|surgery|surgery
1043583|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
1043587|NCT02891031|Rhus|rhus
1043588|NCT02891031|Medicine, Traditional|medicine, traditional
1043589|NCT02891031|Herbal medicine|herbal medicine
1043591|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
1043592|NCT02890927|Geriatric Nursing|geriatric nursing
1043593|NCT02890927|Geriatric co-management|geriatric co-management
1043594|NCT02890927|Geriatric team|geriatric team
1043595|NCT02890901|Escherichia coli|escherichia coli
1043596|NCT02890901|Bloodstream infections|bloodstream infections
1043597|NCT02890901|Severity|severity
1043598|NCT02890901|Score|score
1043599|NCT02890901|Host factors|host factors
1043600|NCT02890901|Microbiology|microbiology
1333225|NCT01443936|Adenovirus|adenovirus
1043601|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
1043602|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
1043603|NCT02890888|functional connectivity MRI|functional connectivity mri
1043604|NCT02890875|ethanol lock|ethanol lock
1043605|NCT02890875|parenteral nutrition|parenteral nutrition
1043606|NCT02890862|Kinematics|kinematics
1043607|NCT02890862|Activity of Daily living|activity of daily living
1043608|NCT02890862|3D motion analysis|3d motion analysis
1043609|NCT02890836|Blood pressure|blood pressure
1043610|NCT02890836|Hypertension|hypertension
1043611|NCT02890836|White coat hypertension|white coat hypertension
1043612|NCT02890836|Preeclampsia|preeclampsia
1043613|NCT02890836|Anti-hypertensiva|anti-hypertensiva
1043614|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
1043615|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
1043616|NCT02890823|Asian|asian
1043617|NCT02890810|Acupuncture|acupuncture
1043618|NCT02890810|Back Pain|back pain
1043619|NCT02890810|Chronic Pain|chronic pain
1043620|NCT02890797|bronchiolitis|bronchiolitis
1043621|NCT02890797|parenchymal condensation|parenchymal condensation
1043622|NCT02890797|chest X-ray|chest x-ray
1043623|NCT02890797|chest ultrasound|chest ultrasound
1043624|NCT02890771|Turmeric|turmeric
1043625|NCT02890771|Chronic periodontitis|chronic periodontitis
1043626|NCT02890758|Natural Killer Cell|natural killer cell
1043627|NCT02890758|ALT-803|alt-803
1043628|NCT02890745|Empagliflozin|empagliflozin
1043629|NCT02890745|Oxidative stress|oxidative stress
1043630|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
1043631|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
1043632|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
1043633|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
1043634|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
1043635|NCT02890706|Subtraction imaging|subtraction imaging
1043840|NCT02889666|oxaliplatin|oxaliplatin
1043636|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
1043637|NCT02890693|randomized controlled trial|randomized controlled trial
1043638|NCT02890693|lifestyle intervention|lifestyle intervention
1043639|NCT02890693|cardiovascular|cardiovascular
1043640|NCT02890693|metabolic|metabolic
1043641|NCT02890693|mental health|mental health
1043642|NCT02890693|depression|depression
1043643|NCT02890693|physical activity|physical activity
1043644|NCT02890693|dietary intervention|dietary intervention
1043645|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
1043646|NCT02890680|third molar|third molar
1043647|NCT02890680|bone regeneration|bone regeneration
1043648|NCT02890667|Cancer|cancer
1043649|NCT02890667|incidence|incidence
1043650|NCT02890667|health insurance data|health insurance data
1043651|NCT02890667|algorithms|algorithms
1043652|NCT02890654|Teenagers|teenagers
1043653|NCT02890654|Multidisciplinary approach|multidisciplinary approach
1043654|NCT02890654|Pain|pain
1043655|NCT02890654|Surgery|surgery
1043656|NCT02890628|Thai-Myanmar border|thai-myanmar border
1043657|NCT02890615|Survivors|survivors
1043658|NCT02890615|Self Care|self care
1043659|NCT02890589|Acute coronary syndrome|acute coronary syndrome
1043660|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
1043661|NCT02890576|cochlear implant|cochlear implant
1043662|NCT02890576|telemedicine|telemedicine
1043663|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
1043664|NCT02890563|Varicose veins|varicose veins
1043665|NCT02890563|Compression stockings|compression stockings
1043666|NCT02890563|Sclerotherapy|sclerotherapy
1043667|NCT02890563|Radiofrequency ablation|radiofrequency ablation
1043668|NCT02890550|Ciliopathy|ciliopathy
1043669|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
1043670|NCT02890550|ALMS1 gene|alms1 gene
1043671|NCT02890537|Osteonecrosis|osteonecrosis
1043672|NCT02890537|Femoral Head|femoral head
1043673|NCT02890537|Hip|hip
1043674|NCT02890537|Orthopedics|orthopedics
1043675|NCT02890537|Bone|bone
1043676|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
1043677|NCT02890524|aphthous stomatitis|aphthous stomatitis
1043678|NCT02890524|night guard|night guard
1043679|NCT02890524|inflammatory cytokine|inflammatory cytokine
1043680|NCT02890459|HIV|hiv
1043681|NCT02890459|incentives|incentives
1043682|NCT02890459|behavioral economics|behavioral economics
1043683|NCT02890446|attentional focus|attentional focus
1043684|NCT02890446|upper extremity|upper extremity
1043685|NCT02890446|hemiparesis|hemiparesis
1043686|NCT02890446|stroke|stroke
1043687|NCT02890394|Neck Pain|neck pain
1043688|NCT02890394|Suboccipital inhibition|suboccipital inhibition
1043689|NCT02890394|Physical Therapy|physical therapy
1043690|NCT02890368|CD47|cd47
1043691|NCT02890368|SIRPa|sirpa
1043692|NCT02890368|Immunotherapy|immunotherapy
1043693|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
1043694|NCT02890342|Propionic Acidemia|propionic acidemia
1043695|NCT02890342|Inborn Error of Metabolism|inborn error of metabolism
1043696|NCT02890342|Genetics|genetics
1043697|NCT02890342|Pccb|pccb
1043698|NCT02890342|Pcca|pcca
1043699|NCT02890290|Frail Elderly|frail elderly
1727981|NCT00018161|addiction|addiction
1077430|NCT02685098|MSCs|mscs
1043700|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
1043701|NCT02890290|physical function|physical function
1043702|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
1043703|NCT02890290|protein intake|protein intake
1043704|NCT02890290|seafood intake|seafood intake
1043705|NCT02890290|ageing|ageing
1043706|NCT02890290|old|old
1043707|NCT02890290|nutrition|nutrition
1043708|NCT02890290|frail|frail
1043709|NCT02890264|End stage renal disease|end stage renal disease
1043710|NCT02890264|Dialysis|dialysis
1043711|NCT02890251|Infant|infant
1043712|NCT02890251|Premature|premature
1043713|NCT02890251|Diseases|diseases
1043714|NCT02890238|Sildenafil Citrate|sildenafil citrate
1043715|NCT02890238|Induction of Ovulation|induction of ovulation
1043716|NCT02890238|Pregnancy Rate|pregnancy rate
1043717|NCT02890225|stones|stones
1043718|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
1043719|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
1043720|NCT02890186|narcotrend|narcotrend
1043721|NCT02890186|propofol|propofol
1043722|NCT02890186|remifentanil|remifentanil
1043723|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
1043724|NCT02890173|Essential hypertension|essential hypertension
1043725|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1043726|NCT02890173|Esaxerenone|esaxerenone
1043727|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1043728|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1043729|NCT02890147|SADs|sads
1043730|NCT02890147|Healthy Volunteers|healthy volunteers
1043731|NCT02890147|Molecular profiles|molecular profiles
1043732|NCT02890147|Omics Techniques|omics techniques
1043733|NCT02890134|SADs|sads
1043734|NCT02890134|Molecular Reclassification|molecular reclassification
1043735|NCT02890121|SADs|sads
1043736|NCT02890121|Molecular Reclassification|molecular reclassification
1043737|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
1043738|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
1043739|NCT02890108|Artificial sweeteners|artificial sweeteners
1043740|NCT02890108|Glucose intolerance|glucose intolerance
1043741|NCT02890082|Breast cancer|breast cancer
1043742|NCT02890082|fertility|fertility
1043743|NCT02890082|chemotherapy|chemotherapy
1043744|NCT02890069|PDR001|pdr001
1043745|NCT02890069|CRC|crc
1043746|NCT02890069|TNBC|tnbc
1043747|NCT02890069|NSCLC|nsclc
1043748|NCT02890069|RCC|rcc
1043749|NCT02890069|Immunomodulation|immunomodulation
1043750|NCT02890069|Biomarkers|biomarkers
1043751|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
1043752|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
1043753|NCT02890056|water consumption|water consumption
1043754|NCT02890056|dietary behaviors|dietary behaviors
1043755|NCT02890056|youth|youth
1043756|NCT02890043|spine|spine
1043757|NCT02890043|robot-assisted surgery|robot-assisted surgery
1043758|NCT02890043|pedicle screw|pedicle screw
1043759|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
1043760|NCT02890030|Ototoxicity|ototoxicity
1043761|NCT02890030|Neurotoxicity|neurotoxicity
1043762|NCT02890017|outpatient surgery|outpatient surgery
1043763|NCT02890017|urology medico-economic|urology medico-economic
1043764|NCT02890017|hotel|hotel
1043765|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1043766|NCT02890004|Neurointensive care|neurointensive care
1043767|NCT02890004|Observational registry|observational registry
1043768|NCT02889991|Myofascial pain.|myofascial pain.
1043769|NCT02889991|Myofascial trigger point.|myofascial trigger point.
1043770|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
1043771|NCT02889991|Deep dry needling.|deep dry needling.
1043772|NCT02889991|Local twitch response.|local twitch response.
1043773|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
1043774|NCT02889991|Needle grasp.|needle grasp.
1043775|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
1043776|NCT02889991|Elastography.|elastography.
1043777|NCT02889978|Cancer Screening|cancer screening
1043778|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1043779|NCT02889978|Deep Sequencing|deep sequencing
1043780|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
1043781|NCT02889965|Multiple sclerosis|multiple sclerosis
1043782|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
1043783|NCT02889965|Disease modifying drugs|disease modifying drugs
1043784|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
1043785|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
1043786|NCT02889952|near infrared imaging|near infrared imaging
1043787|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
1043995|NCT02888509|depression|depression
1043788|NCT02889939|rehabilitation|rehabilitation
1043789|NCT02889939|recovery of function|recovery of function
1043790|NCT02889939|environment|environment
1043791|NCT02889900|ovarian cancer|ovarian cancer
1043792|NCT02889887|Preterm|preterm
1043793|NCT02889887|Sensory Processing|sensory processing
1043794|NCT02889887|Motor Development|motor development
1043795|NCT02889874|Radiation therapy|radiation therapy
1043796|NCT02889874|omission|omission
1043797|NCT02889874|non-inferiority|non-inferiority
1043798|NCT02889874|breast cancer|breast cancer
1043799|NCT02889861|Uveal melanoma|uveal melanoma
1043800|NCT02889861|Cutaneous melanoma|cutaneous melanoma
1043801|NCT02889835|Class II|class ii
1043802|NCT02889835|molar and premolar|molar and premolar
1043803|NCT02889835|resin composite|resin composite
1043804|NCT02889835|adult|adult
1043805|NCT02889835|restoration|restoration
1043806|NCT02889809|Growth Velocity|growth velocity
1043807|NCT02889809|Prepubertal|prepubertal
1043808|NCT02889809|Asthma|asthma
1043809|NCT02889809|Paediatric|paediatric
1043810|NCT02889783|urodynamics|urodynamics
1043811|NCT02889783|urethral sensation|urethral sensation
1043812|NCT02889783|urethral pain|urethral pain
1043813|NCT02889757|tuberculosis|tuberculosis
1043814|NCT02889757|acetylcysteine|acetylcysteine
1043815|NCT02889757|hepatotoxicity|hepatotoxicity
1043816|NCT02889744|Temperature|temperature
1043817|NCT02889744|Hypothermia|hypothermia
1043818|NCT02889744|Brain|brain
1043819|NCT02889744|Oxygen|oxygen
1043820|NCT02889744|Prognosis|prognosis
1043821|NCT02889731|Suicide|suicide
1043822|NCT02889731|Heights|heights
1043823|NCT02889731|Suicide hot spots|suicide hot spots
1043824|NCT02889731|Bridges|bridges
1043825|NCT02889705|Ultrasonography|ultrasonography
1043826|NCT02889705|echotexture|echotexture
1043827|NCT02889705|K value|k value
1043828|NCT02889705|SCM muscles|scm muscles
1043829|NCT02889705|CMT infants|cmt infants
1043830|NCT02889692|lung cancer|lung cancer
1043831|NCT02889692|traditional Chinese medicine|traditional chinese medicine
1043832|NCT02889692|maintenance therapy|maintenance therapy
1043833|NCT02889692|targeted therapy|targeted therapy
1043834|NCT02889679|Colonoscopy|colonoscopy
1043835|NCT02889679|Polypectomy|polypectomy
1043836|NCT02889666|relapsed|relapsed
1043837|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
1043843|NCT02889640|Educational Achievement|educational achievement
1043844|NCT02889640|Individualized Tutoring|individualized tutoring
1043845|NCT02889640|Mathematics|mathematics
1043846|NCT02889640|Academic Mismatch|academic mismatch
1043847|NCT02889640|Achievement Gap|achievement gap
1043848|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
1043849|NCT02889627|Gut microbiota|gut microbiota
1043850|NCT02889627|Brain-gut axis|brain-gut axis
1043851|NCT02889627|Epilepsy|epilepsy
1043852|NCT02889588|Refractive Surgery|refractive surgery
1043853|NCT02889588|higher order aberrations|higher order aberrations
1043854|NCT02889562|apixaban|apixaban
1043855|NCT02889562|anticoagulant|anticoagulant
1043856|NCT02889562|CABG|cabg
1043857|NCT02889562|thrombosis|thrombosis
1043858|NCT02889562|fibrillation|fibrillation
1043859|NCT02889536|parastomal hernia|parastomal hernia
1043860|NCT02889536|ostomy|ostomy
1043861|NCT02889536|qualitative|qualitative
1043862|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
1043863|NCT02889536|symptoms|symptoms
1043864|NCT02889536|parastomal bulging|parastomal bulging
1043865|NCT02889523|Front line therapy|front line therapy
1043866|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
1043867|NCT02889523|60 to 80 years|60 to 80 years
1043868|NCT02889510|diabetes|diabetes
1043869|NCT02889510|liraglutide|liraglutide
1043870|NCT02889510|lung function|lung function
1043871|NCT02889497|vaccine|vaccine
1043872|NCT02889497|safety|safety
1043873|NCT02889497|immunogenicity|immunogenicity
1043874|NCT02889458|Chinese|chinese
1043875|NCT02889458|Breast Cancer|breast cancer
1043876|NCT02889458|Women|women
1043877|NCT02889419|Multiple Sclerosis|multiple sclerosis
1043878|NCT02889419|Disability|disability
1043879|NCT02889419|Underwear|underwear
1043880|NCT02889419|Urinary catheter|urinary catheter
1043881|NCT02889419|Self-catheterisation|self-catheterisation
1043882|NCT02889380|Infertility|infertility
1043883|NCT02889380|Cetrotide|cetrotide
1043884|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
1043885|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
1043886|NCT02889341|DNA fragmentation|dna fragmentation
1043887|NCT02889341|male fertility|male fertility
1043888|NCT02889341|Sperm parameters improvements|sperm parameters improvements
1043889|NCT02889315|PAH|pah
1043890|NCT02889315|treprostinil|treprostinil
1043891|NCT02889315|LenusPro|lenuspro
1043892|NCT02889315|implantable device|implantable device
1043893|NCT02889315|quality of life|quality of life
1043894|NCT02889289|traumatic brain injury|traumatic brain injury
1043895|NCT02889289|virtual reality|virtual reality
1043896|NCT02889289|Xbox kinect|xbox kinect
1043897|NCT02889289|balance|balance
1043898|NCT02889250|geriatric|geriatric
1043899|NCT02889250|depression|depression
1043900|NCT02889250|deep brain stimulation|deep brain stimulation
1043901|NCT02889250|subcallosal cingulate|subcallosal cingulate
1043902|NCT02889237|Fracture healing|fracture healing
1043903|NCT02889237|Calcium supplementation|calcium supplementation
1043904|NCT02889237|Vitamin D supplementation|vitamin d supplementation
1043905|NCT02889237|HR-pQCT|hr-pqct
1043906|NCT02889224|Obesity|obesity
1043907|NCT02889224|Cortisol|cortisol
1043908|NCT02889224|Hydrocortisone|hydrocortisone
1043909|NCT02889224|Endocannabinoïds|endocannabinoïds
1043910|NCT02889198|web-based tool|web-based tool
1043911|NCT02889198|child, preschool|child, preschool
1043912|NCT02889198|nutrition|nutrition
1043913|NCT02889198|implementation|implementation
1043914|NCT02889198|child care|child care
1043915|NCT02889185|Optical Coherence Tomography|optical coherence tomography
1043916|NCT02889185|Retinal camera|retinal camera
1043917|NCT02889159|photoaging|photoaging
1043918|NCT02889146|Intensive Care Units|intensive care units
1043919|NCT02889146|Physical Therapy Specialty|physical therapy specialty
1043920|NCT02889146|Critical illness|critical illness
1043921|NCT02889146|Muscle weakness|muscle weakness
1043922|NCT02889146|Bed rest|bed rest
1043923|NCT02889133|Iron deficiency|iron deficiency
1043924|NCT02889133|Transfusion|transfusion
1043925|NCT02889133|Blood donation|blood donation
1043926|NCT02889120|Drug advice by phone|drug advice by phone
1043927|NCT02889120|Teleprescription|teleprescription
1043928|NCT02889120|Medical call centre|medical call centre
1043929|NCT02889120|Out of hours call|out of hours call
1043930|NCT02889081|birth cohort|birth cohort
1043931|NCT02889081|prenatal|prenatal
1043932|NCT02889081|skin barrier|skin barrier
1043933|NCT02889081|atopic dermatitis|atopic dermatitis
1043934|NCT02889081|key nutritional factors|key nutritional factors
1043935|NCT02889016|PANS|pans
1043936|NCT02889016|PANDAS|pandas
1043937|NCT02888951|Diabetes|diabetes
1043938|NCT02888951|Diabetes Mellitus|diabetes mellitus
1043939|NCT02888951|Gastric Ultrasound|gastric ultrasound
1043940|NCT02888951|Preoperative fasting|preoperative fasting
1043941|NCT02888951|Empty Stomach|empty stomach
1043942|NCT02888951|Gastric Diabetes|gastric diabetes
1043943|NCT02888912|glass ionomer cement|glass ionomer cement
1043944|NCT02888912|composite resin|composite resin
1044448|NCT02885272|MRI|mri
1043945|NCT02888886|systemic inflammation|systemic inflammation
1043946|NCT02888873|composite resin|composite resin
1043947|NCT02888873|Clinical trial|clinical trial
1043948|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
1043949|NCT02888860|genetic susceptibility|genetic susceptibility
1043950|NCT02888860|candida infection|candida infection
1043951|NCT02888860|colonization|colonization
1043952|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
1043953|NCT02888834|elderly|elderly
1043954|NCT02888834|adverse drug reactions|adverse drug reactions
1043955|NCT02888834|hospitalized subjects|hospitalized subjects
1043956|NCT02888834|community-dwelling|community-dwelling
1043957|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
1043958|NCT02888808|women|women
1043959|NCT02888808|Nigeria|nigeria
1043960|NCT02888808|obesity|obesity
1043961|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
1043962|NCT02888795|osteoarthritis|osteoarthritis
1043963|NCT02888769|Coronary artery disease|coronary artery disease
1043964|NCT02888769|Text messages|text messages
1043965|NCT02888769|Blood pressure|blood pressure
1043966|NCT02888769|Lifestyle|lifestyle
1043967|NCT02888769|Risk factors|risk factors
1043968|NCT02888756|Immunotherapy|immunotherapy
1043969|NCT02888756|mRNA|mrna
1043970|NCT02888756|Lentivirus infection|lentivirus infection
1043971|NCT02888756|Virus disease|virus disease
1043972|NCT02888756|Sexually transmitted disease|sexually transmitted disease
1043973|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
1043974|NCT02888730|cystic fibrosis|cystic fibrosis
1043975|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
1043976|NCT02888730|Lung Diseases|lung diseases
1043977|NCT02888730|tobramycin|tobramycin
1043978|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
1043979|NCT02888704|Atopic dermatitis|atopic dermatitis
1043980|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
1043981|NCT02888678|ASPIRES|aspires
1043982|NCT02888652|Coronary Heart Disease|coronary heart disease
1043983|NCT02888652|PCI|pci
1043984|NCT02888652|Anti-Platelet Agents|anti-platelet agents
1043985|NCT02888613|mini-lumbotomy|mini-lumbotomy
1043986|NCT02888613|mini-laparotomy|mini-laparotomy
1043987|NCT02888613|retroperitoneal approach|retroperitoneal approach
1043988|NCT02888613|transperitoneal approach|transperitoneal approach
1043989|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
1043990|NCT02888535|primary immunodeficiency|primary immunodeficiency
1043991|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
1043992|NCT02888535|intensive care unit|intensive care unit
1043993|NCT02888535|infection|infection
1043994|NCT02888535|adult|adult
1043996|NCT02888509|anxiety disorder|anxiety disorder
1043997|NCT02888509|bipolar disorder|bipolar disorder
1043998|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
1043999|NCT02888483|physical activity|physical activity
1044000|NCT02888483|energy expenditure|energy expenditure
1044001|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
1044002|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
1044003|NCT02888457|acute otitis media|acute otitis media
1044004|NCT02888457|day-care centers|day-care centers
1044005|NCT02888431|pH|ph
1044006|NCT02888431|base deficit|base deficit
1044007|NCT02888431|lactate values|lactate values
1044008|NCT02888431|venous blood samples|venous blood samples
1044009|NCT02888431|arterial blood samples|arterial blood samples
1044010|NCT02888418|vaccine|vaccine
1044011|NCT02888418|safety|safety
1044012|NCT02888418|immunogenicity|immunogenicity
1044013|NCT02888405|Body Composition|body composition
1044014|NCT02888366|breast cancer|breast cancer
1044015|NCT02888366|breath test|breath test
1044016|NCT02888366|Menssana|menssana
1044017|NCT02888366|Ancillary|ancillary
1044018|NCT02888366|Mammography|mammography
1044019|NCT02888366|Rapid Point-of-care|rapid point-of-care
1044020|NCT02888366|Inflatable Bag|inflatable bag
1044021|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
1044022|NCT02888340|Acupuncture|acupuncture
1044023|NCT02888340|Emergency Department|emergency department
1044024|NCT02888340|Pain|pain
1044025|NCT02888314|mHealth|mhealth
1044026|NCT02888314|Pokemon Go|pokemon go
1044027|NCT02888288|adolescent|adolescent
1044028|NCT02888288|adolescence|adolescence
1044029|NCT02888288|HIV/AIDS|hiv/aids
1044030|NCT02888288|mental health|mental health
1044031|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
1044032|NCT02888262|Bipolar disorder|bipolar disorder
1044033|NCT02888262|Blood|blood
1044034|NCT02888262|Smartphone|smartphone
1044035|NCT02888262|Brain imaging|brain imaging
1044036|NCT02888262|Cognition|cognition
1044037|NCT02888262|Neuropsychology|neuropsychology
1044038|NCT02888249|Tobacco withdrawal|tobacco withdrawal
1044039|NCT02888249|Autonomic Agents|autonomic agents
1044040|NCT02888236|Psoriasis|psoriasis
1044041|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
1044042|NCT02888080|sarcoidosis|sarcoidosis
1044043|NCT02888080|canakinumab|canakinumab
1044044|NCT02888080|autoimmune diseases|autoimmune diseases
1044045|NCT02888080|granulomas|granulomas
1044449|NCT02885246|Panama|panama
1044046|NCT02888080|inflammation|inflammation
1044047|NCT02888080|lung function testing|lung function testing
1044048|NCT02888080|immunosuppressive agents|immunosuppressive agents
1044049|NCT02888080|interleukin|interleukin
1044050|NCT02888080|interleukin-1Beta|interleukin-1beta
1044051|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
1044052|NCT02888080|respiratory|respiratory
1044053|NCT02888080|pulmonary|pulmonary
1044054|NCT02888080|steroids|steroids
1044055|NCT02888080|corticosteroids|corticosteroids
1044056|NCT02888080|lung diseases|lung diseases
1044057|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
1044058|NCT02888041|Cervical ripening|cervical ripening
1044059|NCT02888041|Pregnancy|pregnancy
1044060|NCT02888041|Vaginal Administration|vaginal administration
1044061|NCT02888028|Remote ICD follow-up|remote icd follow-up
1044062|NCT02888028|HRQoL|hrqol
1044063|NCT02888028|Health related Quality of Life|health related quality of life
1044064|NCT02888028|Depression|depression
1044065|NCT02888028|anxiety|anxiety
1044066|NCT02888028|device acceptance|device acceptance
1044067|NCT02888028|telemedicine|telemedicine
1044068|NCT02888028|telemonitoring|telemonitoring
1044069|NCT02887989|Virtual Reality|virtual reality
1044070|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
1044071|NCT02887976|Prostate Cancer|prostate cancer
1044072|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
1044073|NCT02887976|metastatic|metastatic
1044074|NCT02887976|castrate resistant|castrate resistant
1044075|NCT02887963|Iron Deficiency|iron deficiency
1044076|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
1044077|NCT02887963|Pregnant Women|pregnant women
1044078|NCT02887963|Gestation|gestation
1044079|NCT02887963|China|china
1044080|NCT02887963|Epidemiology|epidemiology
1044081|NCT02887872|stroke|stroke
1044082|NCT02887872|upper extremity function|upper extremity function
1044083|NCT02887872|rehabilitation|rehabilitation
1044084|NCT02887820|ECMO|ecmo
1044085|NCT02887820|TEG|teg
1044086|NCT02887807|Cardiac arrest|cardiac arrest
1044087|NCT02887807|Shockable|shockable
1044088|NCT02887807|Cyclosporine|cyclosporine
1044089|NCT02887794|pitch discrimination|pitch discrimination
1044090|NCT02887794|auditory processing disorders|auditory processing disorders
1044091|NCT02887794|auditory perception|auditory perception
1044092|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
1044093|NCT02887794|theory of mind|theory of mind
1044094|NCT02887729|Polycystic disease|polycystic disease
1044095|NCT02887703|ataxia|ataxia
1044096|NCT02887703|balance training|balance training
1044097|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
1044098|NCT02887703|sensory augmentation|sensory augmentation
1728092|NCT00017823|Acupressure|acupressure
1044099|NCT02887703|cerebellar ataxia|cerebellar ataxia
1044101|NCT02887690|prosthetic limb|prosthetic limb
1044102|NCT02887690|upper extremity|upper extremity
1044103|NCT02887690|prosthesis|prosthesis
1044104|NCT02887677|Dapagliflozin|dapagliflozin
1044105|NCT02887677|Arterial Stiffness|arterial stiffness
1044106|NCT02887677|Aortic Pressure|aortic pressure
1044107|NCT02887651|cerebrale metastases|cerebrale metastases
1044108|NCT02887651|radiotherapy|radiotherapy
1044109|NCT02887651|surgery|surgery
1044110|NCT02887651|complete surgical resection|complete surgical resection
1044111|NCT02887651|resection|resection
1044236|NCT02886650|Paediatrics|paediatrics
1044112|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
1044113|NCT02887651|observation|observation
1044114|NCT02887586|Auricular Needling|auricular needling
1044115|NCT02887586|Mechanism Study|mechanism study
1044116|NCT02887586|Anorexia|anorexia
1044117|NCT02887586|Cancer|cancer
1044118|NCT02887573|Bowel preparation|bowel preparation
1044119|NCT02887573|Colorectal polyps|colorectal polyps
1044120|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
1044121|NCT02887560|Right ventricle|right ventricle
1044122|NCT02887560|Pulmonary transplantation|pulmonary transplantation
1044123|NCT02887560|Strain|strain
1044124|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
1044125|NCT02887495|scleroderma|scleroderma
1044126|NCT02887495|biorepository|biorepository
1044127|NCT02887482|DNA|dna
1044128|NCT02887482|Vaccine|vaccine
1044129|NCT02887469|Hyponatremia|hyponatremia
1044130|NCT02887469|Hypertonic saline|hypertonic saline
1044131|NCT02887469|Treatment|treatment
1044132|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
1044133|NCT02887430|foot reflexology|foot reflexology
1044134|NCT02887430|pain intensity|pain intensity
1044135|NCT02887430|health-related quality of life|health-related quality of life
1044136|NCT02887417|platelet activation|platelet activation
1044137|NCT02887391|hemodialysis|hemodialysis
1044138|NCT02887391|nutritional status|nutritional status
1044139|NCT02887378|bronchial biopsy|bronchial biopsy
1044140|NCT02887365|colon cancer|colon cancer
1044141|NCT02887365|MSI-L|msi-l
1044142|NCT02887365|MSS|mss
1044143|NCT02887365|Tegafur-Uracil|tegafur-uracil
1044144|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
1044145|NCT02887339|Informed Consent|informed consent
1044146|NCT02887339|Research donation request|research donation request
1044147|NCT02887339|Effective Communication|effective communication
1044148|NCT02887313|Rectal cancer|rectal cancer
1044149|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
1044150|NCT02887300|Quality of Health Care|quality of health care
1044151|NCT02887300|Psychological Stress|psychological stress
1044152|NCT02887300|Burnout|burnout
1044153|NCT02887300|Health Care Professional|health care professional
1044154|NCT02887300|Mantra Meditation|mantra meditation
1044155|NCT02887300|Health Care Economics|health care economics
1044156|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
1044157|NCT02887274|Sepsis|sepsis
1044158|NCT02887274|Severe Sepsis|severe sepsis
1044159|NCT02887274|Septic shock|septic shock
1044160|NCT02887274|Multiple organ failure|multiple organ failure
1044161|NCT02887261|Power Port|power port
1044162|NCT02887248|nab-paclitaxel|nab-paclitaxel
1044163|NCT02887248|gemcitabine|gemcitabine
1044164|NCT02887222|Epidural|epidural
1044165|NCT02887222|Labor analgesia|labor analgesia
1044166|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
1044167|NCT02887196|Breast Cancer|breast cancer
1044168|NCT02887183|Heart failure|heart failure
1044169|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
1044170|NCT02887183|HFrEF|hfref
1044171|NCT02887183|NT-proBNP|nt-probnp
1044172|NCT02887183|Cardiac remodeling|cardiac remodeling
1044173|NCT02887170|Adolescent|adolescent
1044174|NCT02887170|Lost to contact|lost to contact
1044175|NCT02887170|Recurrence|recurrence
1044176|NCT02887170|Long-term outcome|long-term outcome
1044177|NCT02887131|Subtalar arthritis|subtalar arthritis
1044178|NCT02887131|Subtalar instability|subtalar instability
1044179|NCT02887118|Erythrocytes|erythrocytes
1044180|NCT02887118|Sickle Cell Disease|sickle cell disease
1044181|NCT02887092|health determinants|health determinants
1044182|NCT02887092|epidemiology|epidemiology
1044183|NCT02887092|maintaining autonomy|maintaining autonomy
1044184|NCT02887092|psychology|psychology
1044185|NCT02887092|osteoarthritis|osteoarthritis
1044186|NCT02887092|perceived health|perceived health
1044187|NCT02887053|MRI|mri
1044188|NCT02887053|Healthy subjects|healthy subjects
1044189|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
1044190|NCT02887040|Antineoplaston therapy|antineoplaston therapy
1044191|NCT02887040|Radiation|radiation
1044192|NCT02887014|bowel preparation|bowel preparation
1044193|NCT02887014|colonoscopy|colonoscopy
1044194|NCT02887014|inpatients|inpatients
1044195|NCT02887014|cathartics|cathartics
1044196|NCT02887001|cost study|cost study
1044197|NCT02887001|clinical pharmacist|clinical pharmacist
1044297|NCT02886182|pregnancy|pregnancy
1044198|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
1044199|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
1044200|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
1044201|NCT02886936|transtibial amputees|transtibial amputees
1044202|NCT02886910|Chorioamnionitis|chorioamnionitis
1044203|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
1044204|NCT02886910|Antibiotics|antibiotics
1044205|NCT02886910|Clinical observation|clinical observation
1044206|NCT02886897|Refractory solid tumors|refractory solid tumors
1044207|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
1044208|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
1044209|NCT02886897|Combination immunotherapy|combination immunotherapy
1044210|NCT02886884|Diabetes|diabetes
1044211|NCT02886884|Endothelial dysfunction|endothelial dysfunction
1044212|NCT02886884|Stem cells|stem cells
1044213|NCT02886858|Depression|depression
1044214|NCT02886858|Moods disorders|moods disorders
1044215|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
1044216|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
1044217|NCT02886832|Prostate Health|prostate health
1044218|NCT02886819|Whole body vibration|whole body vibration
1044219|NCT02886819|Tonic vibration reflex|tonic vibration reflex
1044220|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
1044221|NCT02886806|closed loop|closed loop
1044222|NCT02886806|remifentanil|remifentanil
1044223|NCT02886806|propofol|propofol
1044224|NCT02886767|skin to skin contact|skin to skin contact
1044225|NCT02886754|Clinical Communication|clinical communication
1044226|NCT02886754|ISBAR|isbar
1044227|NCT02886754|Simulation|simulation
1044228|NCT02886754|Performance|performance
1044229|NCT02886754|Non technical skills|non technical skills
1044230|NCT02886754|Proficiency|proficiency
1044231|NCT02886741|campaign|campaign
1044232|NCT02886741|surgical site infection|surgical site infection
1044233|NCT02886741|orthopedic surgery|orthopedic surgery
1044234|NCT02886741|quality improvement|quality improvement
1044235|NCT02886741|infection control|infection control
1044237|NCT02886650|epilepsy surgery|epilepsy surgery
1044238|NCT02886650|genetic mutation|genetic mutation
1044239|NCT02886650|focal seizures|focal seizures
1044240|NCT02886637|A baumannii infection|a baumannii infection
1044241|NCT02886637|Immunosuppression|immunosuppression
1044242|NCT02886637|prognosis|prognosis
1044243|NCT02886637|immune function|immune function
1044244|NCT02886585|Brain Metastases|brain metastases
1044245|NCT02886559|demethylating agent|demethylating agent
1044246|NCT02886559|chidamide|chidamide
1044247|NCT02886533|Major haemorrhage|major haemorrhage
1044248|NCT02886533|Oral anticoagulation|oral anticoagulation
1044249|NCT02886533|Antiplatelet drugs|antiplatelet drugs
1044250|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
1044251|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
1044252|NCT02886520|Urinary incontinence|urinary incontinence
1044253|NCT02886520|Materials|materials
1044254|NCT02886520|Surgery|surgery
1044255|NCT02886520|Transobturator tape|transobturator tape
1044256|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
1044257|NCT02886520|Polypropylene|polypropylene
1044258|NCT02886481|thyroidectomy|thyroidectomy
1044259|NCT02886481|Electrophysiologic|electrophysiologic
1044260|NCT02886481|vocal cord movement|vocal cord movement
1044261|NCT02886429|dexmedetomidine|dexmedetomidine
1044262|NCT02886429|bupivacaine|bupivacaine
1044263|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
1044264|NCT02886429|pain|pain
1044265|NCT02886429|post-thoracotomy|post-thoracotomy
1044266|NCT02886416|HIV infection|hiv infection
1044267|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
1044268|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
1044269|NCT02886351|Moderate Sedation|moderate sedation
1044270|NCT02886351|Pediatric Dentistry|pediatric dentistry
1044271|NCT02886351|Anxiety|anxiety
1044272|NCT02886325|Receipt of Preventive Cancer Screening|receipt of preventive cancer screening
1044273|NCT02886299|Fibrates|fibrates
1044274|NCT02886299|Statins|statins
1044275|NCT02886299|Hemodialysis|hemodialysis
1044276|NCT02886299|Dyslipidemia|dyslipidemia
1044277|NCT02886299|Improved Oxidative Stress|improved oxidative stress
1044278|NCT02886299|Egypt|egypt
1044279|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
1044280|NCT02886273|Out-of-hospital|out-of-hospital
1044281|NCT02886273|Ventricular fibrillation|ventricular fibrillation
1044282|NCT02886273|Classification|classification
1044283|NCT02886273|Mechanisms|mechanisms
1044284|NCT02886273|Biomarkers|biomarkers
1044285|NCT02886234|HIV|hiv
1044286|NCT02886234|Mindfulness|mindfulness
1044287|NCT02886234|Adherence behaviors|adherence behaviors
1044288|NCT02886234|Stress|stress
1044289|NCT02886234|Depression|depression
1044290|NCT02886221|Hallux Valgus|hallux valgus
1044291|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
1044292|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
1333226|NCT01443936|Live Virus Vaccine|live virus vaccine
1044293|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
1044294|NCT02886221|First Ray|first ray
1044295|NCT02886221|Forefoot|forefoot
1044296|NCT02886182|chronic hepatitis B|chronic hepatitis b
1044298|NCT02886182|Cellular immune response|cellular immune response
1044299|NCT02886182|Clinical implications|clinical implications
1044300|NCT02886169|Sacha Inchi|sacha inchi
1044301|NCT02886169|High-fat meal|high-fat meal
1044302|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
1044304|NCT02886156|CPAP|cpap
1044305|NCT02886156|cognitive function|cognitive function
1044306|NCT02886156|gut microbiota|gut microbiota
1044307|NCT02886156|metabolomics|metabolomics
1044308|NCT02886130|Alpha-GPC|alpha-gpc
1044309|NCT02886130|Volleyball|volleyball
1044310|NCT02886130|Athletes|athletes
1044311|NCT02886130|Executive functions|executive functions
1044312|NCT02886130|Vertical jump|vertical jump
1044313|NCT02886130|Peak power|peak power
1044314|NCT02886104|synchronous|synchronous
1044315|NCT02886104|metachronous|metachronous
1044316|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
1044317|NCT02886104|resection|resection
1044318|NCT02886104|ablation|ablation
1044319|NCT02886091|Keloids|keloids
1044320|NCT02886091|Shaving|shaving
1044321|NCT02886091|Ears|ears
1044322|NCT02886091|Cryosurgery|cryosurgery
1044323|NCT02886091|Hypertrophic scars|hypertrophic scars
1044324|NCT02886065|Myeloma|myeloma
1044325|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
1044326|NCT02886052|Internet treatment|internet treatment
1044327|NCT02886052|Self-help treatment|self-help treatment
1044328|NCT02886052|Insomnia|insomnia
1044329|NCT02886052|ICBT|icbt
1044330|NCT02886052|CBT-i|cbt-i
1044331|NCT02886052|Bereavement|bereavement
1044332|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
1044333|NCT02886039|Neurologic outcome|neurologic outcome
1044334|NCT02886039|Electroencephalogram|electroencephalogram
1044335|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
1044336|NCT02886039|Synek classification|synek classification
1044337|NCT02886039|Cerebral performance category|cerebral performance category
1044338|NCT02886039|Hypothermia|hypothermia
1044339|NCT02886026|Laser|laser
1044340|NCT02886026|Bladder cancer|bladder cancer
1044341|NCT02886026|Treatment|treatment
1044342|NCT02886026|Outpatient|outpatient
1044343|NCT02886026|TUR-BT|tur-bt
1044344|NCT02886013|prevalence|prevalence
1044345|NCT02885974|Celecoxib|celecoxib
1044346|NCT02885974|Bladder Cancer|bladder cancer
1044347|NCT02885909|type 2 diabetes|type 2 diabetes
1044348|NCT02885909|inpatient|inpatient
1044349|NCT02885909|glucose control|glucose control
1044350|NCT02885909|continue glucose monitor|continue glucose monitor
1044351|NCT02885896|Call center|call center
1044352|NCT02885896|nurses|nurses
1044353|NCT02885896|pediatrics|pediatrics
1044354|NCT02885896|standardized messages|standardized messages
1044355|NCT02885896|family counseling|family counseling
1044356|NCT02885870|biomarker|biomarker
1044357|NCT02885870|spinal cord disease|spinal cord disease
1044358|NCT02885870|resonance imaging|resonance imaging
1044359|NCT02885870|electrophysiology|electrophysiology
1044360|NCT02885831|Abduction splint|abduction splint
1044361|NCT02885831|Pubo-femoral distance|pubo-femoral distance
1044362|NCT02885792|Schizophrenia|schizophrenia
1044363|NCT02885792|Cardiovascular disease|cardiovascular disease
1044364|NCT02885792|Premature mortality|premature mortality
1044365|NCT02885792|Arteriosclerosis|arteriosclerosis
1044366|NCT02885792|Risk factor|risk factor
1044367|NCT02885792|Intervention|intervention
1044368|NCT02885792|Treatment|treatment
1044369|NCT02885792|Somatic morbidity|somatic morbidity
1044371|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
1044372|NCT02885766|CML progression|cml progression
1044373|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
1044374|NCT02885766|PF-114|pf-114
1044375|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
1044376|NCT02885766|Major molecular response MMR|major molecular response mmr
1044377|NCT02885766|Complete molecular response CMR|complete molecular response cmr
1044378|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1044379|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
1044380|NCT02885753|colorectal|colorectal
1044381|NCT02885753|cancer|cancer
1044382|NCT02885753|metastasis|metastasis
1044383|NCT02885753|hepatic|hepatic
1044384|NCT02885701|postoperative dressing|postoperative dressing
1044385|NCT02885701|postoperative splint|postoperative splint
1044386|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
1044387|NCT02885688|Septic Shock|septic shock
1044388|NCT02885688|Sepsis|sepsis
1044389|NCT02885688|Standard of care|standard of care
1044390|NCT02885688|Liquid nutrition|liquid nutrition
1044391|NCT02885688|Metabolic support|metabolic support
1044392|NCT02885688|Enteral nutrition|enteral nutrition
1044393|NCT02885688|Insulin Drip|insulin drip
1044394|NCT02885688|Glucose Drip|glucose drip
1044395|NCT02885662|Primary aldosteronism|primary aldosteronism
1044396|NCT02885662|Hypertension|hypertension
1044397|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1044398|NCT02885662|Developmental Phase III|developmental phase iii
1044501|NCT02884856|color|color
1044399|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1044400|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
1044401|NCT02885597|Juanbi Pill|juanbi pill
1044402|NCT02885597|Methotrexate|methotrexate
1044403|NCT02885597|Active|active
1044404|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
1044405|NCT02885584|Mechanical ventilation|mechanical ventilation
1044406|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
1044407|NCT02885532|alcohol|alcohol
1044408|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
1044409|NCT02885519|Common Mental Disorders|common mental disorders
1044410|NCT02885519|Return to Work|return to work
1044411|NCT02885519|Mental Health Services|mental health services
1044412|NCT02885519|Psychological Stress|psychological stress
1044413|NCT02885519|Adjustment Disorder|adjustment disorder
1044414|NCT02885519|Burnout|burnout
1044415|NCT02885519|Integration|integration
1044416|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
1044417|NCT02885493|Parkinson march|parkinson march
1044418|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
1044419|NCT02885441|Inflammation|inflammation
1044420|NCT02885389|Infantile spasms|infantile spasms
1044421|NCT02885389|West syndrome|west syndrome
1044422|NCT02885389|variant|variant
1044423|NCT02885389|mutation|mutation
1044424|NCT02885389|CNV|cnv
1044425|NCT02885389|sequencing|sequencing
1044426|NCT02885376|Mucositis|mucositis
1044427|NCT02885337|Frail Elderly|frail elderly
1044428|NCT02885337|Arthroplasty|arthroplasty
1044429|NCT02885337|Frailty|frailty
1044430|NCT02885324|High Grade Glioma|high grade glioma
1044431|NCT02885324|Cabozantinib|cabozantinib
1044432|NCT02885324|GBM|gbm
1044433|NCT02885324|Children|children
1044434|NCT02885324|AA|aa
1044435|NCT02885311|Drinking|drinking
1044436|NCT02885311|Excessive drinking|excessive drinking
1044437|NCT02885311|Alcohol use disorders|alcohol use disorders
1044438|NCT02885311|Primary Care|primary care
1044439|NCT02885285|Parkinson's disease|parkinson's disease
1044440|NCT02885285|fatigue|fatigue
1044441|NCT02885285|anxiety|anxiety
1044442|NCT02885285|depression|depression
1044443|NCT02885285|exercise|exercise
1044444|NCT02885272|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
1044445|NCT02885272|Glioblastoma|glioblastoma
1044446|NCT02885272|FDG PET|fdg pet
1044447|NCT02885272|CT|ct
1044452|NCT02885246|Strain circulation|strain circulation
1044453|NCT02885246|Database|database
1044454|NCT02885233|Fall Prevention|fall prevention
1044455|NCT02885233|Multiple Sclerosis|multiple sclerosis
1044456|NCT02885233|Web-based education|web-based education
1044457|NCT02885233|Self-efficacy|self-efficacy
1044458|NCT02885207|Limbic encephalitis|limbic encephalitis
1044459|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
1044460|NCT02885194|Parkinson Disease|parkinson disease
1044461|NCT02885194|Pain|pain
1044462|NCT02885194|Deep Brain Stimulation|deep brain stimulation
1044463|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
1044464|NCT02885168|vasoreactivity|vasoreactivity
1044465|NCT02885168|recombinant activated protein C|recombinant activated protein c
1044466|NCT02885116|NHF|nhf
1044467|NCT02885116|pulmonary hypertension|pulmonary hypertension
1044468|NCT02885103|NHF|nhf
1044469|NCT02885103|nasal highflow|nasal highflow
1044470|NCT02885038|Platelet Transfusion|platelet transfusion
1044471|NCT02885025|hypersensitivity|hypersensitivity
1044472|NCT02885025|antioxidants|antioxidants
1044473|NCT02884999|trauma|trauma
1044474|NCT02884999|bleeding|bleeding
1044475|NCT02884999|coagulopathy|coagulopathy
1044476|NCT02884999|guidelines compliance|guidelines compliance
1044477|NCT02884999|recommendation|recommendation
1044478|NCT02884999|transfusion|transfusion
1044479|NCT02884986|Etoricoxib|etoricoxib
1044480|NCT02884986|Spinal anaesthesia|spinal anaesthesia
1044481|NCT02884986|Postoperative pain|postoperative pain
1044482|NCT02884973|congenital heart|congenital heart
1044483|NCT02884973|NIRS|nirs
1044484|NCT02884960|Uterine Fibroids|uterine fibroids
1044485|NCT02884960|Embolization|embolization
1044486|NCT02884947|Brain Neoplasms|brain neoplasms
1044487|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
1044488|NCT02884947|Neurosurgery|neurosurgery
1044489|NCT02884934|venous thromboembolism|venous thromboembolism
1044490|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
1044491|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
1044492|NCT02884921|Postoperative pain|postoperative pain
1044493|NCT02884921|Dental treatment|dental treatment
1044494|NCT02884921|Paracetamol|paracetamol
1044495|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
1044496|NCT02884895|Blind intubation|blind intubation
1044497|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
1044498|NCT02884882|Emotional change|emotional change
1044499|NCT02884869|Blind intubation,|blind intubation,
1044500|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
1044502|NCT02884856|dentistry|dentistry
1044503|NCT02884856|gender|gender
1044504|NCT02884843|Laryngeal Tube|laryngeal tube
1044505|NCT02884843|blind intubation|blind intubation
1044506|NCT02884843|fiberoptic|fiberoptic
1044507|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
1044508|NCT02884804|Immature platelet|immature platelet
1044509|NCT02884791|FGF21|fgf21
1044510|NCT02884791|Fibroblast growth factor|fibroblast growth factor
1044511|NCT02884791|fructose|fructose
1044512|NCT02884778|pain|pain
1044513|NCT02884778|monitoring|monitoring
1044514|NCT02884778|anesthesia|anesthesia
1044515|NCT02884765|mandibular condyle|mandibular condyle
1044516|NCT02884765|subcondylar|subcondylar
1044517|NCT02884765|mandible|mandible
1044518|NCT02884765|fracture|fracture
1044519|NCT02884700|Legionella|legionella
1044520|NCT02884700|Legionnaires' disease|legionnaires' disease
1044521|NCT02884700|Diagnosis|diagnosis
1044522|NCT02884700|Prognosis|prognosis
1044523|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1044524|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1044525|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1044526|NCT02884648|Ovarian Cancer|ovarian cancer
1044527|NCT02884648|Fallopian tube cancer|fallopian tube cancer
1044528|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
1044529|NCT02884648|Bevacizumab|bevacizumab
1044530|NCT02884648|Avastin|avastin
1044531|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1044532|NCT02884648|rhuMab-VEGF|rhumab-vegf
1044533|NCT02884635|Methotrexate|methotrexate
1044534|NCT02884635|ASP1707|asp1707
1044535|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
1044536|NCT02884622|Lung disease|lung disease
1044537|NCT02884622|Epigenetics|epigenetics
1044538|NCT02884622|DNA methylation|dna methylation
1044539|NCT02884622|Modifier genes|modifier genes
1044540|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
1044541|NCT02884596|irreversible pulpitis|irreversible pulpitis
1044542|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
1044543|NCT02884583|Food allergy|food allergy
1044544|NCT02884583|asthma|asthma
1044545|NCT02884583|Predictive factor|predictive factor
1044546|NCT02884583|Exacerbation|exacerbation
1044547|NCT02884583|Prevalence|prevalence
1044548|NCT02884570|Tracheotomy|tracheotomy
1044549|NCT02884570|Anxiety|anxiety
1044550|NCT02884570|Depression|depression
1044551|NCT02884570|Back Home|back home
1044552|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
1044553|NCT02884518|antipsychotics|antipsychotics
1044554|NCT02884518|positron emission tomography|positron emission tomography
1044555|NCT02884492|inflammation|inflammation
1044556|NCT02884492|aging|aging
1044557|NCT02884492|mild cognitive impairment|mild cognitive impairment
1044558|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
1044559|NCT02884427|Direct current|direct current
1044560|NCT02884427|Dynamometry|dynamometry
1044561|NCT02884427|Hand strength|hand strength
1044562|NCT02884427|Electrotherapy|electrotherapy
1044563|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1044564|NCT02884414|Knee Pathology|knee pathology
1044565|NCT02884375|Elderly|elderly
1044566|NCT02884375|Cancer|cancer
1044567|NCT02884375|Geriatric assessment|geriatric assessment
1044568|NCT02884375|Treatment|treatment
1044569|NCT02884375|Epidemiology|epidemiology
1044570|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
1044571|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
1044572|NCT02884349|Implant orientation|implant orientation
1044573|NCT02884349|Range of motion|range of motion
1044574|NCT02884310|Remifentanil|remifentanil
1044575|NCT02884310|Heart Rate Variability|heart rate variability
1044576|NCT02884310|Pupil dilation|pupil dilation
1044577|NCT02884310|SPI|spi
1044578|NCT02884284|breast cancer|breast cancer
1044579|NCT02884284|database|database
1044580|NCT02884271|CPR|cpr
1044581|NCT02884271|cardiac arrest|cardiac arrest
1044582|NCT02884271|operating room|operating room
1044583|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
1044584|NCT02884258|Obesity|obesity
1044585|NCT02884258|Bariatric Surgery|bariatric surgery
1044586|NCT02884258|Infertility|infertility
1044587|NCT02884258|Fertility Preservation|fertility preservation
1044588|NCT02884245|Fertility|fertility
1044589|NCT02884245|Reproductive processes|reproductive processes
1044590|NCT02884245|In vitro fertilization|in vitro fertilization
1044591|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1044592|NCT02884245|Estrogens|estrogens
1044593|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
1044594|NCT02884219|Early treatment|early treatment
1044595|NCT02884219|Expectative treatment|expectative treatment
1044596|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
1044597|NCT02884219|Preterm|preterm
1044598|NCT02884206|heart failure|heart failure
1044599|NCT02884206|cognition|cognition
1044600|NCT02884206|positron emission tomography|positron emission tomography
1044601|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
1044602|NCT02884206|LCZ696|lcz696
1044603|NCT02884206|valsartan|valsartan
1044604|NCT02884206|Chronic heart failure|chronic heart failure
1044605|NCT02884206|CHF|chf
1044606|NCT02884193|Cooling|cooling
1044607|NCT02884193|Cryotherapy|cryotherapy
1044608|NCT02884193|isometric Force|isometric force
1044609|NCT02884193|Palmar Grip|palmar grip
1044610|NCT02884193|Dynamometry|dynamometry
1044611|NCT02884180|Dexamethasone|dexamethasone
1044612|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1044613|NCT02884180|Revision|revision
1044614|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
1044615|NCT02884154|Biopsy|biopsy
1044616|NCT02884154|Gastrointestinal tract|gastrointestinal tract
1044617|NCT02884154|Subepithelial tumor|subepithelial tumor
1044618|NCT02884141|Renal Artery Obstruction|renal artery obstruction
1044619|NCT02884141|Carotid Artery Diseases|carotid artery diseases
1044620|NCT02884141|Genetic Association Studies|genetic association studies
1044621|NCT02884102|genetic sequencing|genetic sequencing
1044622|NCT02884102|relapsed|relapsed
1044623|NCT02884076|Hemorrhoids|hemorrhoids
1044624|NCT02884076|Sodergren score|sodergren score
1044625|NCT02884076|Validation|validation
1044626|NCT02884063|PGS|pgs
1044627|NCT02884063|PGD|pgd
1044628|NCT02884063|free embryo DNA|free embryo dna
1044629|NCT02884063|NGS|ngs
1044630|NCT02884037|NAFLD|nafld
1044631|NCT02884037|Rifaximin|rifaximin
1044632|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
1044633|NCT02884024|obesity|obesity
1044634|NCT02884024|inflammation|inflammation
1044635|NCT02884024|cancer risk|cancer risk
1044636|NCT02884011|Chronic antihypertensives|chronic antihypertensives
1044637|NCT02884011|Septic shock|septic shock
1044638|NCT02884011|Vasopressor|vasopressor
1044639|NCT02884011|Vasopressor dosing|vasopressor dosing
1044640|NCT02883998|home-based physical therapy|home-based physical therapy
1044641|NCT02883998|outpatient physical therapy|outpatient physical therapy
1044642|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
1044643|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
1044644|NCT02883998|osteoarthritis|osteoarthritis
1044645|NCT02883972|Immunization|immunization
1044646|NCT02883972|Behavioural insights|behavioural insights
1044647|NCT02883972|Children|children
1044648|NCT02883959|critically ill|critically ill
1044649|NCT02883959|mechanical ventilation|mechanical ventilation
1044650|NCT02883959|pain|pain
1044651|NCT02883959|nursing|nursing
1044652|NCT02883959|music|music
1044653|NCT02883842|Coronary artery disease|coronary artery disease
1044655|NCT02883842|Text messages|text messages
1044656|NCT02883777|Kidney Transplantation|kidney transplantation
1044657|NCT02883777|Low Glycemic Index|low glycemic index
1044658|NCT02883777|High Protein|high protein
1044659|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
1044660|NCT02883764|EPA|epa
1044661|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
1044662|NCT02883764|DHA|dha
1044663|NCT02883764|omega-3 index|omega-3 index
1044664|NCT02883751|diabetes mellitus|diabetes mellitus
1044665|NCT02883751|amputation stumps|amputation stumps
1044666|NCT02883751|diabetic foot|diabetic foot
1044667|NCT02883751|phototherapy|phototherapy
1044668|NCT02883751|clinical trial|clinical trial
1044669|NCT02883725|Esophageal atresia|esophageal atresia
1044670|NCT02883712|epilepsy|epilepsy
1044671|NCT02883712|pharmacoresistant|pharmacoresistant
1044672|NCT02883712|antiepileptic drug|antiepileptic drug
1044673|NCT02883712|pharmacokinetic|pharmacokinetic
1044674|NCT02883712|pharmacodynamic|pharmacodynamic
1044675|NCT02883712|pharmacogenetic|pharmacogenetic
1044676|NCT02883699|Breast cancer|breast cancer
1044677|NCT02883699|Prostate cancer|prostate cancer
1044678|NCT02883699|Exercise prescription|exercise prescription
1044679|NCT02883699|High intensity interval training|high intensity interval training
1044680|NCT02883699|Daily undulating periodization training|daily undulating periodization training
1044681|NCT02883699|Aerobic training|aerobic training
1044682|NCT02883699|Resistance training|resistance training
1044683|NCT02883699|Physical fitness|physical fitness
1044684|NCT02883699|Exercise|exercise
1044685|NCT02883686|depression|depression
1044686|NCT02883686|pregnancy|pregnancy
1044687|NCT02883686|behavioral activation|behavioral activation
1044688|NCT02883686|peer delivery|peer delivery
1044689|NCT02883686|effectiveness|effectiveness
1044690|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
1044691|NCT02883660|genetics|genetics
1044692|NCT02883660|Antidepressants|antidepressants
1044693|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
1044694|NCT02883634|Back pain|back pain
1044695|NCT02883634|spinal manipulation|spinal manipulation
1044696|NCT02883621|upper endoscopy|upper endoscopy
1044697|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
1044698|NCT02883621|esophagus|esophagus
1044699|NCT02883608|Papilla|papilla
1044700|NCT02883608|major duodenal papilla|major duodenal papilla
1044701|NCT02883608|ampulla of vater|ampulla of vater
1044702|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
1044703|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
1044704|NCT02883569|Low back pain|low back pain
1044705|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
1044706|NCT02883569|Spinal stenosis|spinal stenosis
1044707|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
1044708|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
1044709|NCT02883556|Carcinoma|carcinoma
1044710|NCT02883556|Squamous Cell|squamous cell
1044711|NCT02883556|Skin|skin
1044712|NCT02883556|pembrolizumab|pembrolizumab
1044713|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
1044714|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
1044715|NCT02883517|digital PCR|digital pcr
1044716|NCT02883517|liquid biopsy|liquid biopsy
1044717|NCT02883504|E/e' ratio|e/e' ratio
1044718|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
1044719|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
1044720|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
1044721|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
1044722|NCT02883465|failure extubation rate|failure extubation rate
1044723|NCT02883439|MP29-02|mp29-02
1044724|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
1044725|NCT02883413|Adolescents|adolescents
1044726|NCT02883413|Cognitive Flexibility|cognitive flexibility
1044727|NCT02883413|Behavioral Flexibility|behavioral flexibility
1044728|NCT02883387|DIEP flap|diep flap
1044729|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
1044730|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
1044731|NCT02883374|Chidamide|chidamide
1044732|NCT02883309|Hemodialysis|hemodialysis
1044733|NCT02883309|Skeletal muscle|skeletal muscle
1044734|NCT02883309|Exercise|exercise
1044735|NCT02883309|Rehabilitation|rehabilitation
1044736|NCT02883309|Disability Evaluation|disability evaluation
1044737|NCT02883257|Major Depression|major depression
1044738|NCT02883257|Major Depressive Disorder|major depressive disorder
1044739|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
1044740|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
1044741|NCT02883257|Biomarkers|biomarkers
1044742|NCT02883218|immunosuppression|immunosuppression
1044743|NCT02883218|community-acquired sepsis|community-acquired sepsis
1044744|NCT02883218|mortality|mortality
1044745|NCT02883192|Cesarean section|cesarean section
1044746|NCT02883192|spinal anesthesia|spinal anesthesia
1044747|NCT02883192|hypotension|hypotension
1044748|NCT02883192|ondansetron|ondansetron
1044749|NCT02883153|Zirconium-89|zirconium-89
1044750|NCT02883153|PET/CT|pet/ct
1044752|NCT02883153|girentuximab|girentuximab
1044753|NCT02883140|Sialography|sialography
1044754|NCT02883140|Cone-beam CT|cone-beam ct
1044755|NCT02883140|MRI sialography|mri sialography
1044756|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
1044757|NCT02883127|Motivational Interviewing|motivational interviewing
1044758|NCT02883127|Diet|diet
1044759|NCT02883127|Carbohydrates|carbohydrates
1044760|NCT02883127|Psychosocial factors|psychosocial factors
1044761|NCT02883114|PF-06648671|pf-06648671
1044763|NCT02883114|CYP3A|cyp3a
1044764|NCT02883114|drug interaction|drug interaction
1044765|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
1044766|NCT02883088|registry|registry
1044767|NCT02883088|Coronary artery disease|coronary artery disease
1044768|NCT02883036|tigecycline|tigecycline
1044769|NCT02883036|treatment|treatment
1044770|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
1044771|NCT02883036|metabolic characteristics|metabolic characteristics
1044772|NCT02883023|Bleomycin|bleomycin
1044773|NCT02883023|Electroporation|electroporation
1044774|NCT02883010|Surgical incision|surgical incision
1044775|NCT02883010|surgical complication|surgical complication
1044776|NCT02883010|NPWT|npwt
1044777|NCT02883010|negative pressure|negative pressure
1044778|NCT02883010|colorectal surgery|colorectal surgery
1044779|NCT02883010|dehisced|dehisced
1044780|NCT02882971|chronic pain|chronic pain
1044781|NCT02882971|rating scale|rating scale
1044782|NCT02882958|Radiology|radiology
1044783|NCT02882932|peritonitis|peritonitis
1044784|NCT02882932|solutions|solutions
1044785|NCT02882932|normal saline|normal saline
1044786|NCT02882932|infection|infection
1044787|NCT02882932|peritoneal lavage|peritoneal lavage
1044788|NCT02882906|Stroke|stroke
1044789|NCT02882906|Pain|pain
1044790|NCT02882906|Shoulder|shoulder
1044791|NCT02882867|Prospective|prospective
1044792|NCT02882867|Epidemiology|epidemiology
1044793|NCT02882867|Track and Field|track and field
1044794|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
1044795|NCT02882841|Mucosal Healing|mucosal healing
1044796|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
1044797|NCT02882815|IrisFIT PFO|irisfit pfo
1044798|NCT02882802|anger|anger
1044799|NCT02882802|aggression|aggression
1044800|NCT02882763|Early intervention|early intervention
1044801|NCT02882763|ECCE|ecce
1044802|NCT02882763|Intervention study|intervention study
1045098|NCT02881177|addiction|addiction
1044803|NCT02882763|Child development|child development
1044804|NCT02882763|At-risk families|at-risk families
1044805|NCT02882763|Psychosocial stress|psychosocial stress
1044806|NCT02882763|Prevention|prevention
1044807|NCT02882763|Educational opportunities|educational opportunities
1044808|NCT02882763|Randomized controlled trial|randomized controlled trial
1044809|NCT02882763|Evaluation|evaluation
1044810|NCT02882763|Parenting|parenting
1044811|NCT02882763|Parent-child interaction|parent-child interaction
1044812|NCT02882750|Lung Cancer|lung cancer
1044813|NCT02882750|Quality of Life|quality of life
1044814|NCT02882750|VATS|vats
1044815|NCT02882750|SABR|sabr
1044816|NCT02882698|Down syndrome|down syndrome
1044817|NCT02882698|motor skills|motor skills
1044818|NCT02882698|physiotherapy|physiotherapy
1044819|NCT02882698|mobile telephone|mobile telephone
1044820|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
1044821|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1044822|NCT02882685|Mini-gastric bypass|mini-gastric bypass
1044823|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
1044824|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
1044825|NCT02882646|stroke|stroke
1044826|NCT02882646|cerebral palsy|cerebral palsy
1044827|NCT02882646|rehabilitation|rehabilitation
1044828|NCT02882646|robotics|robotics
1044829|NCT02882646|therapy|therapy
1044830|NCT02882646|bilateral|bilateral
1044831|NCT02882633|lumbar plexus block|lumbar plexus block
1044832|NCT02882633|fascia iliac block|fascia iliac block
1044833|NCT02882633|quality of recovery score|quality of recovery score
1044834|NCT02882633|pain score|pain score
1044835|NCT02882620|Colorectal neoplasm|colorectal neoplasm
1044836|NCT02882620|Screening|screening
1044837|NCT02882620|Patient navigation|patient navigation
1044838|NCT02882620|Randomized controlled trial|randomized controlled trial
1044839|NCT02882620|Cost-benefit analysis|cost-benefit analysis
1044840|NCT02882620|Health behavior|health behavior
1044841|NCT02882620|Health equity|health equity
1044842|NCT02882620|American Indians|american indians
1044843|NCT02882620|Community-based participatory research|community-based participatory research
1044844|NCT02882620|Fecal occult blood test|fecal occult blood test
1044845|NCT02882607|HIV|hiv
1044846|NCT02882607|Prevention|prevention
1044847|NCT02882607|unintended pregnancy|unintended pregnancy
1044848|NCT02882607|Malawi|malawi
1044849|NCT02882607|adolescent women|adolescent women
1044850|NCT02882607|community|community
1044851|NCT02882607|rural|rural
1044852|NCT02882581|Metformin|metformin
1044853|NCT02882581|Pharmacokinetics|pharmacokinetics
1044854|NCT02882581|Organic cation transporter|organic cation transporter
1044855|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
1044856|NCT02882581|Pharmacogenetics|pharmacogenetics
1044857|NCT02882581|positron emission tomography|positron emission tomography
1044858|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
1044859|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1044860|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1044861|NCT02882542|heart rate variability|heart rate variability
1044862|NCT02882542|blood pressure|blood pressure
1044863|NCT02882542|affect|affect
1044864|NCT02882542|mood|mood
1044865|NCT02882542|respiration|respiration
1044866|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
1044867|NCT02882542|systemic physiology|systemic physiology
1044868|NCT02882542|electro-dermal activity|electro-dermal activity
1044869|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
1044870|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
1044871|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1044872|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1044873|NCT02882529|heart rate variability|heart rate variability
1044874|NCT02882529|blood pressure|blood pressure
1044875|NCT02882529|affect|affect
1044876|NCT02882529|mood|mood
1044877|NCT02882529|respiration|respiration
1044878|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
1044879|NCT02882529|systemic physiology|systemic physiology
1044880|NCT02882529|electro-dermal activity|electro-dermal activity
1044881|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
1044882|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
1044883|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
1044884|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
1044885|NCT02882516|heart rate variability|heart rate variability
1044886|NCT02882516|blood pressure|blood pressure
1044887|NCT02882516|affect|affect
1044888|NCT02882516|mood|mood
1044889|NCT02882516|respiration|respiration
1044890|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
1044891|NCT02882516|systemic physiology|systemic physiology
1044892|NCT02882516|electro-dermal activity|electro-dermal activity
1044893|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
1044894|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
1044895|NCT02882503|Radiofrequency ablation|radiofrequency ablation
1044896|NCT02882503|Pancreas|pancreas
1044897|NCT02882490|Tourette syndrome|tourette syndrome
1044898|NCT02882464|gingival recession|gingival recession
1044899|NCT02882464|mucogingival surgery|mucogingival surgery
1044900|NCT02882451|bile duct|bile duct
1044901|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1044902|NCT02882451|pinaverium bromide|pinaverium bromide
1044903|NCT02882425|selexipag|selexipag
1044904|NCT02882425|bioavailability|bioavailability
1044905|NCT02882412|effectiveness|effectiveness
1044906|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
1044907|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
1044908|NCT02882399|athletes|athletes
1044909|NCT02882373|Hypertensive diseases|hypertensive diseases
1044910|NCT02882373|Renal failure|renal failure
1044911|NCT02882373|High blood pressure|high blood pressure
1044912|NCT02882373|Proteinuria|proteinuria
1044913|NCT02882373|L-Arginine|l-arginine
1044915|NCT02882373|Phone call|phone call
1044916|NCT02882334|Focal Dystonia|focal dystonia
1044917|NCT02882334|Writer's cramp|writer's cramp
1044918|NCT02882321|Malignant Tumor of Lymphoid Hemopoietic and Related Tissue|malignant tumor of lymphoid hemopoietic and related tissue
1044919|NCT02882321|Acute myeloid leukemia|acute myeloid leukemia
1044921|NCT02882321|Relapsed/Refractory|relapsed/refractory
1044922|NCT02882321|IACS-010759|iacs-010759
1044923|NCT02882321|Phone Call follow up|phone call follow up
1044924|NCT02882282|Diseases of oral cavity salivary glands and jaws|diseases of oral cavity salivary glands and jaws
1044925|NCT02882282|High risk oral intra-epithelial neoplasias|high risk oral intra-epithelial neoplasias
1044926|NCT02882282|IEN|ien
1044927|NCT02882282|Oral pre-malignant lesion(s)|oral pre-malignant lesion(s)
1044928|NCT02882282|History of invasive oral cancer|history of invasive oral cancer
1044929|NCT02882282|Pembrolizumab|pembrolizumab
1044930|NCT02882282|Keytruda|keytruda
1044931|NCT02882282|MK-3475|mk-3475
1044932|NCT02882282|SCH-900475|sch-900475
1044933|NCT02882282|Observation only|observation only
1044934|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
1044935|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1044936|NCT02882256|laceration|laceration
1044937|NCT02882256|urinary tract infection|urinary tract infection
1044938|NCT02882256|minor head injury|minor head injury
1044939|NCT02882256|concussion|concussion
1044940|NCT02882217|Double-blind|double-blind
1044941|NCT02882217|Randomized|randomized
1044942|NCT02882217|Dose-escalating|dose-escalating
1044943|NCT02882217|Placebo-controlled|placebo-controlled
1044944|NCT02882217|Phase I|phase i
1044945|NCT02882217|Healthy volunteers|healthy volunteers
1044946|NCT02882217|Bronchial asthma|bronchial asthma
1044947|NCT02882217|Histamine glutarimide|histamine glutarimide
1044948|NCT02882217|EURRUS|eurrus
1045343|NCT02879773|Diagnosis|diagnosis
1044949|NCT02882191|contraception|contraception
1044950|NCT02882178|Prostate cancer|prostate cancer
1044951|NCT02882178|cabazitaxel|cabazitaxel
1044952|NCT02882178|consensus|consensus
1044953|NCT02882178|conformity|conformity
1044954|NCT02882178|prescription|prescription
1044955|NCT02882178|conditions of use|conditions of use
1044956|NCT02882165|COPD|copd
1044957|NCT02882165|Early Intervention|early intervention
1044958|NCT02882165|Risk|risk
1044959|NCT02882165|Stratification|stratification
1044960|NCT02882152|Analgesia|analgesia
1044961|NCT02882152|Nerve Block|nerve block
1044962|NCT02882152|Pain, Postoperative|pain, postoperative
1044963|NCT02882139|Electrical storm|electrical storm
1044964|NCT02882126|PAH|pah
1044965|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
1044966|NCT02882126|Remodulin|remodulin
1044967|NCT02882126|6 Minute Walk Test|6 minute walk test
1044968|NCT02882100|influenza|influenza
1044969|NCT02882100|vaccine|vaccine
1044970|NCT02882100|vaccination|vaccination
1044971|NCT02882100|nursing home|nursing home
1044972|NCT02882100|cluster randomized trial|cluster randomized trial
1044973|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
1044974|NCT02882061|neck pain|neck pain
1044975|NCT02882061|physical examination|physical examination
1044976|NCT02882061|thoracic manipulation|thoracic manipulation
1044977|NCT02882048|Opioid addiction|opioid addiction
1044978|NCT02882048|Opioid weaning|opioid weaning
1044979|NCT02882035|pain|pain
1044980|NCT02882035|patient comfort|patient comfort
1044981|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
1044982|NCT02882022|Audiometry|audiometry
1044983|NCT02881996|appendicitis|appendicitis
1044984|NCT02881996|pain|pain
1044985|NCT02881996|perforation|perforation
1044986|NCT02881983|alcohol use disorder|alcohol use disorder
1044987|NCT02881983|emotion processing|emotion processing
1044988|NCT02881983|abstinence|abstinence
1044989|NCT02881983|sympathetic system|sympathetic system
1044990|NCT02881983|parasympathetic system|parasympathetic system
1044991|NCT02881957|critical illness|critical illness
1044992|NCT02881957|craniocerebral trauma|craniocerebral trauma
1044993|NCT02881957|intracranial aneurysm|intracranial aneurysm
1044994|NCT02881957|spinal cord injuries|spinal cord injuries
1044995|NCT02881957|seizures|seizures
1044996|NCT02881957|meningitis|meningitis
1044998|NCT02881957|vitamin d deficiency|vitamin d deficiency
1044999|NCT02881957|cholecalciferol|cholecalciferol
1045000|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
1045001|NCT02881944|Gulf War Illness|gulf war illness
1045002|NCT02881944|Diet|diet
1045003|NCT02881944|IBS|ibs
1045004|NCT02881944|FODMAP|fodmap
1045005|NCT02881931|Huntington's disease|huntington's disease
1045006|NCT02881931|functional rating scale|functional rating scale
1045007|NCT02881931|cognitive pre-testing|cognitive pre-testing
1045008|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
1045009|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
1045010|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
1045011|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
1045012|NCT02881892|CAPD|capd
1045013|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
1045014|NCT02881892|Dialysis adequacy|dialysis adequacy
1045015|NCT02881866|Air hunger|air hunger
1045016|NCT02881866|Work/effort|work/effort
1045017|NCT02881866|Aerosolized|aerosolized
1045018|NCT02881866|Hypercapnia|hypercapnia
1045019|NCT02881866|Resistive load|resistive load
1045020|NCT02881866|Nebulised|nebulised
1045021|NCT02881853|healthy|healthy
1045022|NCT02881853|atopic|atopic
1045023|NCT02881827|Saliva|saliva
1045024|NCT02881827|Low-level laser therapy|low-level laser therapy
1045025|NCT02881827|Masseter muscle|masseter muscle
1045026|NCT02881827|Salivary glands|salivary glands
1045027|NCT02881814|Lung ultrasound|lung ultrasound
1045028|NCT02881814|Chest physiotherapy|chest physiotherapy
1045029|NCT02881814|Decision-making process|decision-making process
1045030|NCT02881814|Diagnostic|diagnostic
1045031|NCT02881801|accelerometry|accelerometry
1045032|NCT02881775|TMS|tms
1045033|NCT02881775|rTMS|rtms
1045034|NCT02881775|corticospinal|corticospinal
1045035|NCT02881775|quadriceps|quadriceps
1045036|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
1045037|NCT02881762|Maraviroc|maraviroc
1045038|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
1045039|NCT02881671|genetic|genetic
1045040|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
1045041|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
1045042|NCT02881658|Plant sterols|plant sterols
1045043|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
1045044|NCT02881658|Phytosterols|phytosterols
1045045|NCT02881658|Soya Beverage|soya beverage
1045046|NCT02881645|Intensive care units|intensive care units
1045047|NCT02881645|Nursing Care|nursing care
1045048|NCT02881645|Critical incidents|critical incidents
1045049|NCT02881645|Best practices|best practices
1045050|NCT02881619|Tooth bleaching|tooth bleaching
1045344|NCT02879760|Lung|lung
1045051|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
1045052|NCT02881567|Multiple Sclerosis|multiple sclerosis
1045053|NCT02881567|Daclizumab|daclizumab
1045054|NCT02881567|Tysabri-Switch|tysabri-switch
1045055|NCT02881528|Type 1 Diabetes|type 1 diabetes
1045056|NCT02881528|Juvenile Diabetes|juvenile diabetes
1045057|NCT02881502|granulocyte activation|granulocyte activation
1045058|NCT02881502|HDAC2|hdac2
1045059|NCT02881502|severe asthma|severe asthma
1045060|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
1045061|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
1045062|NCT02881424|Familiarity|familiarity
1045063|NCT02881424|Recollection|recollection
1045064|NCT02881424|Face Recognition|face recognition
1045065|NCT02881424|Alcohol dependence|alcohol dependence
1045066|NCT02881424|Social cognition|social cognition
1045067|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
1045068|NCT02881411|trigger points|trigger points
1045069|NCT02881411|feasibility study|feasibility study
1045070|NCT02881398|Mobile Health|mobile health
1045071|NCT02881398|Telemedicine|telemedicine
1045072|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
1045073|NCT02881385|Synchrony|synchrony
1045074|NCT02881385|Pressure Support Ventilation|pressure support ventilation
1045075|NCT02881372|oral food desensitization|oral food desensitization
1045076|NCT02881372|food elimination|food elimination
1045077|NCT02881372|food reintroduction|food reintroduction
1045078|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
1045079|NCT02881346|Plaque|plaque
1045080|NCT02881346|Topical|topical
1045081|NCT02881346|Calcipotriol|calcipotriol
1045082|NCT02881346|Foam|foam
1045084|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1045085|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
1045086|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1045087|NCT02881255|subcutaneous ICD|subcutaneous icd
1045088|NCT02881255|transvenous ICD|transvenous icd
1045089|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
1045090|NCT02881203|breast cancer|breast cancer
1045091|NCT02881203|radiation|radiation
1045092|NCT02881203|DIBH|dibh
1045093|NCT02881203|cardiac toxicity|cardiac toxicity
1045094|NCT02881177|oxytocin|oxytocin
1045095|NCT02881177|tolerability|tolerability
1045096|NCT02881177|HIV|hiv
1045097|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
1045099|NCT02881164|Glycemia|glycemia
1045100|NCT02881164|Satiety|satiety
1045101|NCT02881164|Insulin|insulin
1045102|NCT02881164|Breakfast|breakfast
1045103|NCT02881164|Low glycemic index|low glycemic index
1045104|NCT02881164|High glycemic index|high glycemic index
1045105|NCT02881151|Deep brain stimulation|deep brain stimulation
1045106|NCT02881151|DBS|dbs
1045107|NCT02881151|Central thalamus|central thalamus
1045108|NCT02881151|TBI|tbi
1045109|NCT02881151|Traumatic brain injury|traumatic brain injury
1045110|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1045111|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
1045112|NCT02881086|Nelarabine|nelarabine
1045113|NCT02881086|BCR-ABL|bcr-abl
1045114|NCT02881086|MRD|mrd
1045115|NCT02881086|PEG-Asparaginase|peg-asparaginase
1045116|NCT02881086|Rituximab|rituximab
1045117|NCT02881073|Placental Growth Factor|placental growth factor
1045118|NCT02881073|Maternal Morbidity|maternal morbidity
1045119|NCT02881073|Neonatal Morbidity|neonatal morbidity
1045120|NCT02881073|Pre-eclampsia|pre-eclampsia
1045121|NCT02881073|Heath Economics|heath economics
1045122|NCT02881060|Glucagon|glucagon
1045123|NCT02881060|Ethanol|ethanol
1045124|NCT02881034|Anemia|anemia
1045125|NCT02881034|Antiviral Agents|antiviral agents
1045126|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
1045127|NCT02881034|Hepatitis C|hepatitis c
1045128|NCT02881034|Ribavirin|ribavirin
1045129|NCT02881034|Telaprevir|telaprevir
1045130|NCT02881021|elastic tape|elastic tape
1045131|NCT02881021|kinesiology taping|kinesiology taping
1045132|NCT02881021|physiotherapy|physiotherapy
1045133|NCT02881021|rotator cuff|rotator cuff
1045134|NCT02881021|shoulder pain|shoulder pain
1045135|NCT02881021|tendon injuries|tendon injuries
1045136|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
1045137|NCT02880995|antipsychotics|antipsychotics
1045138|NCT02880995|positron emission tomography|positron emission tomography
1045139|NCT02880956|Early Alzheimer's Disease (AD)|early alzheimer's disease (ad)
1045140|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1045141|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
1045142|NCT02880956|Tau|tau
1045143|NCT02880956|Early dementia|early dementia
1045144|NCT02880956|Tauopathies|tauopathies
1045145|NCT02880956|AD|ad
1045146|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
1045147|NCT02880956|Memory loss|memory loss
1045148|NCT02880956|Nervous system diseases|nervous system diseases
1045149|NCT02880930|vitamin D|vitamin d
1045150|NCT02880917|Attention|attention
1045151|NCT02880917|Memory (short and long-term)|memory (short and long-term)
1045152|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
1045153|NCT02880917|Verbal fluency|verbal fluency
1045154|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
1045155|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
1045156|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
1045157|NCT02880878|ICH|ich
1045158|NCT02880878|Hemorrhage|hemorrhage
1045159|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
1045160|NCT02880878|Brain Diseases|brain diseases
1045161|NCT02880878|Central Nervous System Diseases|central nervous system diseases
1045162|NCT02880878|Nervous System Diseases|nervous system diseases
1045163|NCT02880878|Vascular Diseases|vascular diseases
1045164|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
1045165|NCT02880878|Pathologic Processes|pathologic processes
1045166|NCT02880878|MIPS|mips
1045167|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
1045168|NCT02880878|Neurosurgery|neurosurgery
1045169|NCT02880878|Medical Economic|medical economic
1045170|NCT02880878|Hospital Economics|hospital economics
1045171|NCT02880865|vaccine|vaccine
1045172|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
1045173|NCT02880852|Belimumab|belimumab
1045174|NCT02880852|Pharmacodynamics|pharmacodynamics
1045175|NCT02880852|safety tolerability|safety tolerability
1045176|NCT02880852|Pharmacokinetics|pharmacokinetics
1045177|NCT02880852|Chinese subjects|chinese subjects
1045178|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
1045179|NCT02880800|Analgesics, Opioid|analgesics, opioid
1045180|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
1045181|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
1045182|NCT02880774|Mandibular Movement|mandibular movement
1045183|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
1045184|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
1045185|NCT02880761|hemodialysis|hemodialysis
1045186|NCT02880761|chronic renal failure|chronic renal failure
1045187|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
1045188|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
1045189|NCT02880748|Adenoma miss rate|adenoma miss rate
1045190|NCT02880748|Polyps|polyps
1045191|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
1045192|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
1045193|NCT02880735|Respiratory Failure|respiratory failure
1045194|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
1045195|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
1045196|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
1045197|NCT02880722|Abdominal pain|abdominal pain
1045198|NCT02880696|Time Perception|time perception
1045199|NCT02880696|Tactile Perception|tactile perception
1045200|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1045201|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
1045202|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
1045203|NCT02880683|Sympathetic Fibers|sympathetic fibers
1045204|NCT02880683|Post Ganglionic|post ganglionic
1045205|NCT02880683|Congestive Heart Failure|congestive heart failure
1045206|NCT02880683|Heart Failure|heart failure
1045207|NCT02880670|Rheumatoid|rheumatoid
1045208|NCT02880657|superoxide dismutase|superoxide dismutase
1045209|NCT02880657|melon concentrate|melon concentrate
1045210|NCT02880657|oxidative stress|oxidative stress
1045211|NCT02880657|physical training|physical training
1045212|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
1045214|NCT02880644|CRVO|crvo
1045215|NCT02880618|Heart Failure|heart failure
1045216|NCT02880618|Reduced ejection fraction|reduced ejection fraction
1045217|NCT02880540|Adolescent|adolescent
1045218|NCT02880540|Bariatric|bariatric
1045219|NCT02880540|Obesity|obesity
1045220|NCT02880540|Pain|pain
1045221|NCT02880540|Opiate-sparing|opiate-sparing
1045222|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
1045223|NCT02880462|schizophrenia|schizophrenia
1045224|NCT02880462|sulforaphane|sulforaphane
1045225|NCT02880423|salpingectomy|salpingectomy
1045226|NCT02880423|cesarean section|cesarean section
1045227|NCT02880423|tubal ligation|tubal ligation
1045228|NCT02880423|morbidity|morbidity
1045229|NCT02880410|Glioblastoma|glioblastoma
1045230|NCT02880410|NeuroBlate|neuroblate
1045231|NCT02880410|LITT|litt
1045232|NCT02880410|Quality of Life|quality of life
1045233|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
1045234|NCT02880371|Advanced Solid Tumors|advanced solid tumors
1045235|NCT02880371|Pembrolizumab|pembrolizumab
1045236|NCT02880371|ARRY-382|arry-382
1045237|NCT02880371|CSF-1R|csf-1r
1045238|NCT02880371|CSF1R|csf1r
1045239|NCT02880371|cfms|cfms
1045240|NCT02880332|Chronic pain|chronic pain
1045241|NCT02880332|Endogenous Pain Processing|endogenous pain processing
1045242|NCT02880332|Central sensitization|central sensitization
1045243|NCT02880332|Pain neuroscience education|pain neuroscience education
1045244|NCT02880319|Bone Cancer|bone cancer
1045245|NCT02880293|transplant conditioning|transplant conditioning
1045246|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
1045345|NCT02879760|Cancer|cancer
1045247|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1045248|NCT02880254|body mass index change|body mass index change
1045249|NCT02880254|weight loss|weight loss
1045250|NCT02880254|patient compliance|patient compliance
1045251|NCT02880202|Massage Therapy|massage therapy
1045253|NCT02880202|Integrative Medicine|integrative medicine
1045254|NCT02880202|Palliative Care|palliative care
1045255|NCT02880202|Caregivers|caregivers
1045256|NCT02880189|Obesity NOS|obesity nos
1045257|NCT02880189|NASH|nash
1045258|NCT02880189|NASH with Fibrosis|nash with fibrosis
1045259|NCT02880189|Intragastric Balloon|intragastric balloon
1045260|NCT02880189|ORBERA|orbera
1045261|NCT02880189|ORBERA Intragastric Balloon|orbera intragastric balloon
1045262|NCT02880176|Behavioral Economics|behavioral economics
1045263|NCT02880176|Financial Incentives|financial incentives
1045264|NCT02880176|Bladder Cancer|bladder cancer
1045265|NCT02880176|Ambulation|ambulation
1045266|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
1045267|NCT02880176|Fitbit|fitbit
1045268|NCT02880176|Mobile Health|mobile health
1045269|NCT02880176|Radical Cystectomy|radical cystectomy
1045270|NCT02880150|elite climbers|elite climbers
1045271|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
1045272|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
1045273|NCT02880124|Exercise, Physical|exercise, physical
1045274|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
1045275|NCT02880124|Athletic Performance|athletic performance
1045276|NCT02880124|Sugar Maple|sugar maple
1045277|NCT02880111|Malignant Brain Tumor|malignant brain tumor
1045278|NCT02880111|patient sputum|patient sputum
1045279|NCT02880098|Neonatology|neonatology
1045280|NCT02880098|Troponin T|troponin t
1045281|NCT02880098|Standards|standards
1045282|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
1045283|NCT02880046|immune response|immune response
1045284|NCT02880046|T lymphocyte|t lymphocyte
1045285|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
1045286|NCT02880033|Parkinson's disease|parkinson's disease
1045287|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1045288|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
1045289|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
1045290|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
1045291|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
1045292|NCT02880007|3D dosimetry|3d dosimetry
1045293|NCT02880007|Prospective Studies|prospective studies
1045294|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
1045295|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
1045296|NCT02880007|Brachytherapy/methods|brachytherapy/methods
1045297|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
1045298|NCT02879968|tumor volume|tumor volume
1045299|NCT02879968|Head and Neck Cancer|head and neck cancer
1045300|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
1045301|NCT02879955|Carbohydrates|carbohydrates
1045302|NCT02879955|Gastric bypass|gastric bypass
1045303|NCT02879955|Bariatric Surgery|bariatric surgery
1045304|NCT02879955|Overweight|overweight
1045305|NCT02879942|Placental volume|placental volume
1045306|NCT02879942|First-trimester screening|first-trimester screening
1045307|NCT02879942|Ultrasound|ultrasound
1045308|NCT02879942|Preeclampsia|preeclampsia
1045309|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
1045310|NCT02879942|Biochemical markers|biochemical markers
1045311|NCT02879942|Uterine artery doppler|uterine artery doppler
1045312|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
1045313|NCT02879929|Quality of life|quality of life
1045314|NCT02879929|measurement|measurement
1045315|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
1045316|NCT02879929|development|development
1045317|NCT02879929|validation|validation
1045318|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
1045319|NCT02879903|Periodontal treatment|periodontal treatment
1045320|NCT02879903|Smokers|smokers
1045321|NCT02879877|First in human|first in human
1045322|NCT02879877|subjects|subjects
1045323|NCT02879864|fatigue|fatigue
1045324|NCT02879864|tiredness|tiredness
1045325|NCT02879864|luxo therapy|luxo therapy
1045326|NCT02879864|therapy by light|therapy by light
1045327|NCT02879851|ultrasound|ultrasound
1045328|NCT02879851|Koelis system|koelis system
1045329|NCT02879851|MRI|mri
1045330|NCT02879851|gold grain|gold grain
1045331|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
1045332|NCT02879812|Transplantation Surgery|transplantation surgery
1045333|NCT02879812|Nephrology|nephrology
1045334|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
1045335|NCT02879799|Family-centered care|family-centered care
1045336|NCT02879799|Family-integrated care|family-integrated care
1045337|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
1045338|NCT02879799|Premature|premature
1045339|NCT02879799|Infant|infant
1045340|NCT02879773|Respiratory Function Tests|respiratory function tests
1045341|NCT02879773|Computed tomography|computed tomography
1045342|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
1045346|NCT02879760|Chemotherapy|chemotherapy
1045347|NCT02879760|Oncolytic virus|oncolytic virus
1045348|NCT02879760|Immunotherapy|immunotherapy
1045349|NCT02879760|Pembrolizumab|pembrolizumab
1045350|NCT02879760|Keytruda|keytruda
1045351|NCT02879747|treatment|treatment
1045352|NCT02879747|growth hormone|growth hormone
1045353|NCT02879747|childhood|childhood
1045354|NCT02879747|short stature|short stature
1045355|NCT02879734|peritoneal dialysis|peritoneal dialysis
1045356|NCT02879734|laparoscopy|laparoscopy
1045357|NCT02879734|omentum|omentum
1045358|NCT02879721|Gastrointestinal|gastrointestinal
1045359|NCT02879708|Social Accountability|social accountability
1045360|NCT02879708|Healthcare Quality|healthcare quality
1045361|NCT02879708|Health System Strengthening|health system strengthening
1045362|NCT02879708|Child Health|child health
1045363|NCT02879708|Childhood pneumonia|childhood pneumonia
1045364|NCT02879708|Childhood diarrhea|childhood diarrhea
1045365|NCT02879682|glioma|glioma
1045366|NCT02879682|brain metastases|brain metastases
1045367|NCT02879682|nTMS|ntms
1045368|NCT02879630|pharmacokinetics|pharmacokinetics
1045369|NCT02879630|acyclovir|acyclovir
1045370|NCT02879604|cognitive remediation, cost-effectiveness analysis|cognitive remediation, cost-effectiveness analysis
1045371|NCT02879552|Upper blepharoplasty|upper blepharoplasty
1045372|NCT02879552|brassiere sutures|brassiere sutures
1045373|NCT02879552|tarsal platform show|tarsal platform show
1045374|NCT02879552|eyeshadow space|eyeshadow space
1045375|NCT02879552|brow fat span|brow fat span
1045376|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
1045377|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
1045378|NCT02879526|Chidamide|chidamide
1045379|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
1045380|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
1045381|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1045382|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1045383|NCT02879500|Clinical practice guidelines|clinical practice guidelines
1045384|NCT02879500|Randomized controlled trials|randomized controlled trials
1045385|NCT02879500|Prospective cohort studies|prospective cohort studies
1045386|NCT02879500|Body weight|body weight
1045387|NCT02879500|Body mass index|body mass index
1045388|NCT02879500|Adiposity|adiposity
1045389|NCT02879500|Overweight|overweight
1045390|NCT02879500|Obesity|obesity
1045391|NCT02879461|SURGERY|surgery
1045392|NCT02879461|REHABILITATION|rehabilitation
1045393|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1045394|NCT02879448|Left Atrial Appendage|left atrial appendage
1045395|NCT02879409|HbA1c variability|hba1c variability
1045396|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
1045397|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
1045398|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
1045399|NCT02879396|Older adults|older adults
1045400|NCT02879396|Avoidable admissions|avoidable admissions
1045401|NCT02879396|Assisted living home|assisted living home
1045402|NCT02879396|Emergency service calls|emergency service calls
1045403|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
1045404|NCT02879383|Type 2 Diabetes|type 2 diabetes
1045405|NCT02879370|Anastomotic Leak|anastomotic leak
1045406|NCT02879370|Rectal cancer|rectal cancer
1045407|NCT02879370|Double stapling technique|double stapling technique
1045408|NCT02879357|Care management|care management
1045409|NCT02879357|end of life|end of life
1045410|NCT02879357|advanced care planning|advanced care planning
1045411|NCT02879357|palliative care|palliative care
1045412|NCT02879331|pulmonary emphysema|pulmonary emphysema
1045413|NCT02879331|coils|coils
1045414|NCT02879331|cycloergometry|cycloergometry
1045415|NCT02879331|lung volume reduction|lung volume reduction
1045416|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1045417|NCT02879305|GSK1278863|gsk1278863
1045418|NCT02879305|daprodustat|daprodustat
1045419|NCT02879305|anemia|anemia
1045420|NCT02879305|chronic kidney disease|chronic kidney disease
1045421|NCT02879305|hemoglobin|hemoglobin
1045422|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
1045423|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
1045424|NCT02879279|Stroke|stroke
1045425|NCT02879279|Upper limb|upper limb
1045426|NCT02879279|Robotic rehabilitation|robotic rehabilitation
1045427|NCT02879266|Dengue Vaccine|dengue vaccine
1045428|NCT02879188|degenerative joint disease|degenerative joint disease
1045429|NCT02879188|total knee arthroplasty|total knee arthroplasty
1045430|NCT02879188|physical therapy|physical therapy
1045431|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
1045432|NCT02879149|Ankle Fusions|ankle fusions
1045433|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
1045434|NCT02879149|Autologous Bone Graft|autologous bone graft
1045435|NCT02879149|arthritis|arthritis
1045436|NCT02879149|ankle pain|ankle pain
1045437|NCT02879149|foot pain|foot pain
1045438|NCT02879149|hindfoot fracture|hindfoot fracture
1045439|NCT02879149|ankle fracture|ankle fracture
1045443|NCT02879110|Sulforaphane|sulforaphane
1045444|NCT02879110|clinic trial|clinic trial
1045445|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
1045446|NCT02879110|Efficacy|efficacy
1045447|NCT02879110|Safety|safety
1045448|NCT02879110|Mechanism|mechanism
1045449|NCT02879032|Treadmill Scores|treadmill scores
1045450|NCT02879032|Coronary Angiogram|coronary angiogram
1045451|NCT02879032|Coronary Artery Disease|coronary artery disease
1045452|NCT02879006|Chinese herbal therapy|chinese herbal therapy
1045453|NCT02879006|Oral immunotherapy|oral immunotherapy
1045454|NCT02879006|Food allergy|food allergy
1045455|NCT02879006|Omalizumab|omalizumab
1045456|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
1045457|NCT02878928|PGx|pgx
1045458|NCT02878928|Depression|depression
1045459|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
1045460|NCT02878928|IDgenetix|idgenetix
1045461|NCT02878928|AltheaDx|altheadx
1045462|NCT02878902|emergency|emergency
1045463|NCT02878902|coordination|coordination
1045464|NCT02878902|dialysis|dialysis
1045465|NCT02878824|Neurophysiology|neurophysiology
1045466|NCT02878824|Autonomic|autonomic
1045467|NCT02878824|Sensory|sensory
1045469|NCT02878824|Ethnicity|ethnicity
1045470|NCT02878824|Environment|environment
1045471|NCT02878811|heart failure|heart failure
1045472|NCT02878811|prospective|prospective
1045473|NCT02878811|cohort|cohort
1045474|NCT02878785|AML|aml
1045475|NCT02878746|Mirror therapy|mirror therapy
1045476|NCT02878746|Proprioception|proprioception
1045477|NCT02878746|Rehabilitation|rehabilitation
1045478|NCT02878746|Stroke|stroke
1045479|NCT02878746|Hemiplegia|hemiplegia
1045480|NCT02878720|ischemic stroke|ischemic stroke
1045481|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
1045482|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
1045483|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
1045484|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
1045485|NCT02878668|procalcitonin|procalcitonin
1045486|NCT02878668|post-operative|post-operative
1045487|NCT02878668|complication|complication
1045488|NCT02878668|CRP|crp
1045693|NCT02877303|G-CSF|g-csf
1045489|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
1045490|NCT02878655|dissection IIb sector|dissection iib sector
1045491|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
1045492|NCT02878564|HIV susceptibility|hiv susceptibility
1045493|NCT02878564|Genital immunology|genital immunology
1045494|NCT02878564|Mucosal immunology|mucosal immunology
1045495|NCT02878564|HIV entry assay|hiv entry assay
1045496|NCT02878564|Adult women|adult women
1045497|NCT02878512|Segmental Epidural|segmental epidural
1045498|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
1045499|NCT02878499|autism|autism
1045500|NCT02878499|autism spectrum disorder|autism spectrum disorder
1045501|NCT02878499|ASD|asd
1045502|NCT02878499|sleep|sleep
1045503|NCT02878499|Circadian|circadian
1045504|NCT02878499|Biological rhythms|biological rhythms
1045505|NCT02878499|melatonin|melatonin
1045506|NCT02878499|Cognition|cognition
1045507|NCT02878499|Behavior|behavior
1045508|NCT02878499|Longitudinal|longitudinal
1045509|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
1045510|NCT02878486|Physical activity|physical activity
1045511|NCT02878486|Alzheimer's disease|alzheimer's disease
1045512|NCT02878486|cognitive impairment|cognitive impairment
1045513|NCT02878486|sedentary behavior|sedentary behavior
1045514|NCT02878486|insulin sensitivity|insulin sensitivity
1045515|NCT02878460|HYPEROXIA|hyperoxia
1045516|NCT02878460|MECHANICAL VENTILATION|mechanical ventilation
1045517|NCT02878460|OXYGEN RESERVE INDEX|oxygen reserve index
1045518|NCT02878447|Haemoptysis|haemoptysis
1045519|NCT02878447|Radiotherapy|radiotherapy
1045520|NCT02878447|Tuberculosis|tuberculosis
1045521|NCT02878447|Aspergilloma|aspergilloma
1045522|NCT02878447|Bronchiectasis|bronchiectasis
1045523|NCT02878434|Cancer|cancer
1045524|NCT02878434|Fertility|fertility
1045525|NCT02878434|Pregnancy|pregnancy
1045526|NCT02878434|Chemotherapy|chemotherapy
1045527|NCT02878434|Radiotherapy|radiotherapy
1045528|NCT02878434|Long term|long term
1045529|NCT02878434|Follow up|follow up
1045530|NCT02878395|genomics|genomics
1045531|NCT02878395|epigenomics|epigenomics
1045532|NCT02878395|recurrence|recurrence
1045533|NCT02878382|PDT|pdt
1045534|NCT02878382|skin cancer|skin cancer
1045535|NCT02878382|calcipotriol|calcipotriol
1045536|NCT02878369|fluid replacement|fluid replacement
1045537|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
1045538|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
1045539|NCT02878330|Preterm Infants|preterm infants
1045540|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
1045541|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
1045542|NCT02878317|Skin autofluorescence|skin autofluorescence
1045543|NCT02878317|Renal Dialysis|renal dialysis
1045544|NCT02878304|Prognosis|prognosis
1045545|NCT02878304|Hand function|hand function
1045546|NCT02878304|Rehabilitation|rehabilitation
1045550|NCT02878278|Administration method|administration method
1045551|NCT02878265|malaria|malaria
1045552|NCT02878265|vitamin A|vitamin a
1045553|NCT02878265|Zinc|zinc
1045554|NCT02878265|Multivitamin|multivitamin
1045555|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
1045556|NCT02878239|knee osteoarthritis|knee osteoarthritis
1045557|NCT02878239|gait|gait
1045558|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
1045559|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
1045560|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
1045561|NCT02878161|predictive|predictive
1045562|NCT02878161|iTRAQ|itraq
1045563|NCT02878161|signal pathway|signal pathway
1045564|NCT02878148|Nephrolithiasis|nephrolithiasis
1045565|NCT02878148|Ureteral stone|ureteral stone
1045566|NCT02878148|Acute renal colic|acute renal colic
1045567|NCT02878148|Ultrasonography|ultrasonography
1045568|NCT02878148|Computed tomography|computed tomography
1079807|NCT02669446|Ectoin|ectoin
1045569|NCT02878148|Diagnosis|diagnosis
1045570|NCT02878122|ovarian cancer|ovarian cancer
1045571|NCT02878122|chemo resistance|chemo resistance
1045572|NCT02878122|predictive factors|predictive factors
1045573|NCT02878122|cohort study|cohort study
1045574|NCT02878122|bio bank|bio bank
1045575|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1045576|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
1045577|NCT02878096|nocturnal polyuria|nocturnal polyuria
1045578|NCT02878083|vedolizumab,|vedolizumab,
1045579|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
1045580|NCT02878083|biomarker|biomarker
1045581|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
1045582|NCT02878070|Spinal Cord Injuries|spinal cord injuries
1045583|NCT02878070|Telemedicine|telemedicine
1045584|NCT02878070|Health Behaviors|health behaviors
1045585|NCT02878057|Apatinib|apatinib
1045586|NCT02878057|HER-2 Negative|her-2 negative
1045587|NCT02878057|Chest wall Metastasis|chest wall metastasis
1045588|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
1045589|NCT02878057|Breast cancer|breast cancer
1045590|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
1045591|NCT02878031|Integrated Community Case Management|integrated community case management
1045592|NCT02878031|Community Health Worker|community health worker
1045593|NCT02878031|Nigeria|nigeria
1045594|NCT02878018|Cohort Study|cohort study
1045595|NCT02878018|Children|children
1045596|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
1045597|NCT02878018|Traditional Chinese Medicine|traditional chinese medicine
1045598|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
1045599|NCT02878005|blind intubation|blind intubation
1045600|NCT02878005|fiberoptic|fiberoptic
1045601|NCT02877992|Infertility|infertility
1045602|NCT02877992|Tachykinin|tachykinin
1045603|NCT02877992|Kisspeptin|kisspeptin
1045604|NCT02877940|ProSeal LMA|proseal lma
1045605|NCT02877940|LTS-D|lts-d
1045606|NCT02877940|i-gel|i-gel
1045607|NCT02877914|heart failure, retrospective|heart failure, retrospective
1045608|NCT02877888|cost effectiveness|cost effectiveness
1045609|NCT02877888|fluoride varnish|fluoride varnish
1045610|NCT02877888|dental caries|dental caries
1045611|NCT02877875|anxiety|anxiety
1045612|NCT02877875|depression|depression
1045613|NCT02877875|trauma|trauma
1045614|NCT02877875|behavior problems|behavior problems
1045615|NCT02877875|evidence-based treatments|evidence-based treatments
1045616|NCT02877875|manualized treatments|manualized treatments
1045617|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
1045618|NCT02877875|youth|youth
1045619|NCT02877875|mental health|mental health
1045620|NCT02877849|fMRI|fmri
1045621|NCT02877849|brain networks|brain networks
1045622|NCT02877849|biomarker|biomarker
1045623|NCT02877849|relapse|relapse
1045624|NCT02877849|alcohol|alcohol
1045625|NCT02877836|Dystonia|dystonia
1045626|NCT02877836|fMRI|fmri
1045627|NCT02877836|DTI|dti
1045628|NCT02877836|DBS|dbs
1045629|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
1045630|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
1045631|NCT02877823|Parent peer support|parent peer support
1045632|NCT02877784|screening|screening
1045633|NCT02877784|OPMD|opmd
1045634|NCT02877784|dysphagia|dysphagia
1045635|NCT02877784|dysarthria|dysarthria
1045636|NCT02877758|cutaneous aging|cutaneous aging
1045637|NCT02877758|skin rejuvenation|skin rejuvenation
1045638|NCT02877758|wrinkles|wrinkles
1045639|NCT02877732|Concussion|concussion
1045640|NCT02877732|Athletes|athletes
1045641|NCT02877732|Eye-tracking|eye-tracking
1045642|NCT02877732|Vision|vision
1045643|NCT02877706|Registry|registry
1045644|NCT02877693|ICD|icd
1045645|NCT02877693|Thoracic MRI Scan|thoracic mri scan
1045646|NCT02877693|tachycardia|tachycardia
1045647|NCT02877680|Strengths-based|strengths-based
1045648|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
1045649|NCT02877680|Adolescence|adolescence
1045650|NCT02877680|Resilience|resilience
1045651|NCT02877680|Family|family
1045652|NCT02877667|tattoo|tattoo
1045654|NCT02877654|Plasmatic zonulin|plasmatic zonulin
1045655|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
1045656|NCT02877654|Intestinal permeability|intestinal permeability
1045657|NCT02877641|Current Smoker|current smoker
1045658|NCT02877641|Former Smoker|former smoker
1045659|NCT02877628|pharmacokinetic|pharmacokinetic
1045660|NCT02877628|pharmacodynamic|pharmacodynamic
1045661|NCT02877628|tacrolimus|tacrolimus
1045662|NCT02877628|CYP3A5|cyp3a5
1045663|NCT02877628|liver transplantation|liver transplantation
1045664|NCT02877563|peripheral artery disease|peripheral artery disease
1045665|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
1045666|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
1045667|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
1045668|NCT02877550|Obinutuzumab|obinutuzumab
1045669|NCT02877550|Gazyva|gazyva
1045670|NCT02877550|Gazyvaro|gazyvaro
1045671|NCT02877550|Venetoclax|venetoclax
1045672|NCT02877550|Venclexta|venclexta
1045673|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
1045674|NCT02877446|Terminal heart failure|terminal heart failure
1045675|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
1045676|NCT02877433|Small diameter implant|small diameter implant
1045677|NCT02877433|Cross-arch prostheses|cross-arch prostheses
1045678|NCT02877420|Endoscopy|endoscopy
1045679|NCT02877420|Simulation Training|simulation training
1045680|NCT02877420|Non-technical Skills|non-technical skills
1045681|NCT02877381|Tranexamic Acid|tranexamic acid
1045682|NCT02877381|Blood Transfusion|blood transfusion
1045683|NCT02877342|Injury|injury
1045684|NCT02877342|Injuries|injuries
1045685|NCT02877342|Triage|triage
1045686|NCT02877329|psychological effects|psychological effects
1045687|NCT02877303|Leukemia|leukemia
1045688|NCT02877303|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1045689|NCT02877303|ALL|all
1045690|NCT02877303|Newly diagnosed B-Cell Lineage Acute lymphoblastic leukemia|newly diagnosed b-cell lineage acute lymphoblastic leukemia
1045691|NCT02877303|Blinatumomab|blinatumomab
1045692|NCT02877303|Blincyto|blincyto
1045694|NCT02877303|Filgrastim|filgrastim
1045695|NCT02877303|Neupogen|neupogen
1045696|NCT02877303|Pegfilgrastim|pegfilgrastim
1045697|NCT02877303|Neulasta|neulasta
1045698|NCT02877303|PEG-G-CSF|peg-g-csf
1045699|NCT02877303|Cyclophosphamide|cyclophosphamide
1045701|NCT02877303|Neosar|neosar
1045702|NCT02877303|Revimmune|revimmune
1045703|NCT02877303|Clafen|clafen
1045704|NCT02877303|Mesna|mesna
1045705|NCT02877303|Mesnex|mesnex
1045706|NCT02877303|Dexamethasone|dexamethasone
1045707|NCT02877303|Decadron|decadron
1045708|NCT02877303|Ofatumumab|ofatumumab
1045709|NCT02877303|Arzerra|arzerra
1045710|NCT02877303|Methotrexate|methotrexate
1045711|NCT02877303|MTX|mtx
1045712|NCT02877303|Doxorubicin|doxorubicin
1045713|NCT02877303|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1045714|NCT02877303|Adriamycin PFS|adriamycin pfs
1045715|NCT02877303|Adriamycin RDF|adriamycin rdf
1045716|NCT02877303|Adriamycin|adriamycin
1045717|NCT02877303|Rubex|rubex
1045718|NCT02877303|Vincristine|vincristine
1045719|NCT02877303|Oncovin|oncovin
1045720|NCT02877303|Vincasar PFS|vincasar pfs
1045721|NCT02877303|Vincristine Sulfate|vincristine sulfate
1045722|NCT02877303|LCR|lcr
1045723|NCT02877303|VCR|vcr
1045724|NCT02877303|Cytarabine|cytarabine
1045725|NCT02877303|ARA-C|ara-c
1045726|NCT02877303|Cytosar|cytosar
1045727|NCT02877303|DepoCyt|depocyt
1045728|NCT02877303|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1045729|NCT02877303|Arabino Sylcytosine|arabino sylcytosine
1045730|NCT02877303|Cytosine Arabinoside|cytosine arabinoside
1045731|NCT02877303|Rituximab|rituximab
1045732|NCT02877303|Rituxan|rituxan
1045733|NCT02877303|Leucovorin|leucovorin
1045734|NCT02877303|Citrovorum|citrovorum
1045735|NCT02877303|Wellcovorin|wellcovorin
1045736|NCT02877303|6-Mercaptopurine|6-mercaptopurine
1045737|NCT02877303|Mercaptopurine|mercaptopurine
1045738|NCT02877303|Purinethol|purinethol
1045739|NCT02877303|6-MP|6-mp
1045740|NCT02877303|Prednisone|prednisone
1045741|NCT02877303|Deltasone|deltasone
1045742|NCT02877303|Orasone|orasone
1045743|NCT02877303|Prednicen-M|prednicen-m
1045744|NCT02877290|COPD|copd
1045745|NCT02877290|NIRS|nirs
1045746|NCT02877290|NIV|niv
1045747|NCT02877290|Exercise|exercise
1045748|NCT02877264|Vapendavir|vapendavir
1045749|NCT02877264|Bioavailability|bioavailability
1045750|NCT02877264|Biological Availability|biological availability
1045751|NCT02877264|Volunteers|volunteers
1045752|NCT02877251|Venous Thromboembolism|venous thromboembolism
1045753|NCT02877251|Venous Thrombosis|venous thrombosis
1045754|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
1045755|NCT02877251|National Registry|national registry
1045756|NCT02877251|Mexico|mexico
1045757|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
1045758|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
1045759|NCT02877238|sevoflurane|sevoflurane
1045760|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
1045761|NCT02877212|ITP|itp
1045762|NCT02877212|Eltrombopag|eltrombopag
1045763|NCT02877212|Steroid refractory|steroid refractory
1045764|NCT02877212|Fc Receptor|fc receptor
1045765|NCT02877199|Hepatitis C|hepatitis c
1045766|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
1045767|NCT02877199|cirrhosis|cirrhosis
1045768|NCT02877199|triple therapy|triple therapy
1045769|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
1045770|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
1045771|NCT02877173|Intermittent Claudication|intermittent claudication
1045772|NCT02877121|interstitial lung disease|interstitial lung disease
1045773|NCT02877121|Respiratory Muscle Function|respiratory muscle function
1045774|NCT02877121|Neural Respiratory Drive|neural respiratory drive
1728930|NCT00010855|anesthesia|anesthesia
1045775|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
1045776|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
1045777|NCT02877056|Endoscopy|endoscopy
1045778|NCT02877056|Endoscopic biopsy|endoscopic biopsy
1045779|NCT02877056|Biomarkers|biomarkers
1045780|NCT02877056|Genes|genes
1045781|NCT02876991|choline positron emission tomography|choline positron emission tomography
1045782|NCT02876991|occult recurrence|occult recurrence
1045783|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
1045784|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
1045785|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
1045786|NCT02876952|high intensity exercise training|high intensity exercise training
1045787|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
1045788|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
1045789|NCT02876939|Familial Dysautonomia|familial dysautonomia
1045790|NCT02876939|proprioception|proprioception
1045791|NCT02876939|motor control|motor control
1045792|NCT02876939|sensory nervous system.|sensory nervous system.
1045793|NCT02876939|HSAN III|hsan iii
1045794|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
1045795|NCT02876926|HIV testing|hiv testing
1045796|NCT02876926|Self-testing|self-testing
1045797|NCT02876926|Counseling|counseling
1045798|NCT02876926|Referral|referral
1045799|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
1045800|NCT02876874|lymph nodes morphology|lymph nodes morphology
1045801|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
1045802|NCT02876861|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1045803|NCT02876861|upper tract urothelial carcinoma|upper tract urothelial carcinoma
1045804|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
1045805|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
1045806|NCT02876848|Breast Neoplasms|breast neoplasms
1045807|NCT02876848|Health Services for the Aged|health services for the aged
1045808|NCT02876848|Medical Informatics Applications|medical informatics applications
1045809|NCT02876848|Medication Adherence|medication adherence
1045810|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1045811|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
1045812|NCT02876848|Telemedicine|telemedicine
1045813|NCT02876835|hemoglobin|hemoglobin
1045814|NCT02876835|anemia|anemia
1045815|NCT02876835|non-dialysis|non-dialysis
1045816|NCT02876835|GSK1278863|gsk1278863
1045817|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1045818|NCT02876835|daprodustat|daprodustat
1045819|NCT02876835|chronic kidney disease|chronic kidney disease
1045820|NCT02876809|centenarians|centenarians
1045821|NCT02876809|geriatric|geriatric
1045822|NCT02876809|telomere length|telomere length
1045823|NCT02876809|progerin|progerin
1045824|NCT02876809|metagenome|metagenome
1045825|NCT02876809|metabolome|metabolome
1045826|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
1045828|NCT02876796|pharmacodynamic|pharmacodynamic
1045829|NCT02876796|pharmacokinetic|pharmacokinetic
1045830|NCT02876705|Patterns|patterns
1045831|NCT02876705|Pain|pain
1045832|NCT02876705|Cycling|cycling
1045833|NCT02876705|Running|running
1045834|NCT02876705|Exhaustion|exhaustion
1045835|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
1045836|NCT02876679|Transplantation|transplantation
1045837|NCT02876679|Graft vs Host Disease|graft vs host disease
1045838|NCT02876679|Cyclophosphamide|cyclophosphamide
1045839|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
1045840|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
1045841|NCT02876666|Spinal Cord Injuries|spinal cord injuries
1045842|NCT02876666|Health Behavior|health behavior
1045843|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
1045844|NCT02876653|Aging|aging
1045845|NCT02876653|Telomere length|telomere length
1045846|NCT02876614|radionuclide cisternography|radionuclide cisternography
1045847|NCT02876614|CSF leak|csf leak
1045848|NCT02876614|imaging|imaging
1045849|NCT02876601|Coagulation|coagulation
1045850|NCT02876601|Inflammation|inflammation
1045851|NCT02876601|Defibrotide|defibrotide
1045852|NCT02876601|Fibrinolysis|fibrinolysis
1045853|NCT02876588|Wrong-Patient Errors|wrong-patient errors
1045854|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
1045855|NCT02876562|Gingival Recession Coverage|gingival recession coverage
1045856|NCT02876549|G6PD|g6pd
1045857|NCT02876549|Primaquine|primaquine
1045858|NCT02876510|Ovarian Cancer|ovarian cancer
1045859|NCT02876510|Esophageal Cancer|esophageal cancer
1045860|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1045861|NCT02876510|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
1045862|NCT02876510|Gastric Cancer|gastric cancer
1045863|NCT02876458|Coronary angiogram|coronary angiogram
1045864|NCT02876458|Survival rate|survival rate
1045865|NCT02876458|Neurological sequel|neurological sequel
1045866|NCT02876445|Huntington's disease|huntington's disease
1045867|NCT02876445|Caregiver|caregiver
1045868|NCT02876445|ZARIT burden scale|zarit burden scale
1045994|NCT02875587|IVF-ET|ivf-et
1045869|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
1045870|NCT02876367|Epidemiology|epidemiology
1045871|NCT02876354|Hemodialysis|hemodialysis
1045872|NCT02876354|Vitamin k2|vitamin k2
1045873|NCT02876354|Vascular calcifications|vascular calcifications
1045874|NCT02876341|Chronic antihypertensives|chronic antihypertensives
1045875|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
1045876|NCT02876341|Septic shock|septic shock
1045877|NCT02876328|Ebola Vaccine|ebola vaccine
1045878|NCT02876315|innate immunity|innate immunity
1045879|NCT02876315|elderly adults|elderly adults
1045880|NCT02876315|multivitamin supplement|multivitamin supplement
1045881|NCT02876315|vitamin D|vitamin d
1045882|NCT02876315|vitamin C|vitamin c
1045883|NCT02876315|zinc|zinc
1045884|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
1045885|NCT02876302|Breast Cancer|breast cancer
1045886|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
1045887|NCT02876263|aortic diseases|aortic diseases
1045888|NCT02876263|aortic aneurysm|aortic aneurysm
1045889|NCT02876263|electroencephalography|electroencephalography
1045890|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
1045891|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
1045892|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
1045893|NCT02876263|Hypothermia, Induced|hypothermia, induced
1045894|NCT02876250|Lung transplantation|lung transplantation
1045895|NCT02876250|Cyclosporine|cyclosporine
1045896|NCT02876250|Postconditioning|postconditioning
1045897|NCT02876211|Renal disease|renal disease
1045898|NCT02876211|Erythropoiesis|erythropoiesis
1045899|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
1045900|NCT02876211|Iron|iron
1045901|NCT02876211|Klotho|klotho
1045902|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
1045903|NCT02876198|Retinal neovascularization|retinal neovascularization
1045904|NCT02876198|Anti-VEGF|anti-vegf
1045905|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
1045906|NCT02876185|Glaucoma surveillance|glaucoma surveillance
1045907|NCT02876185|Orthoptist|orthoptist
1045908|NCT02876172|PTSD|ptsd
1045909|NCT02876172|psychotherapy|psychotherapy
1045910|NCT02876172|MDMA|mdma
1045911|NCT02876172|dyad|dyad
1045912|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
1045913|NCT02876159|Vaccination|vaccination
1045914|NCT02876146|Albendazole|albendazole
1045915|NCT02876146|Benzimidazole|benzimidazole
1045916|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
1045917|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
1045918|NCT02876146|Liver Diseases|liver diseases
1045919|NCT02876107|Malignant neoplasm of breast|malignant neoplasm of breast
1045920|NCT02876107|Breast cancer|breast cancer
1045921|NCT02876107|Newly diagnosed primary triple-negative inflammatory breast cancer|newly diagnosed primary triple-negative inflammatory breast cancer
1045922|NCT02876107|Inflammatory breast cancer|inflammatory breast cancer
1045923|NCT02876107|IBC|ibc
1045924|NCT02876107|TN-IBC|tn-ibc
1045925|NCT02876107|Breast biopsy|breast biopsy
1045926|NCT02876107|Mammogram|mammogram
1045927|NCT02876107|Ultrasound|ultrasound
1045928|NCT02876107|Paclitaxel|paclitaxel
1045929|NCT02876107|Taxol|taxol
1045930|NCT02876107|Carboplatin|carboplatin
1045931|NCT02876107|Paraplatin|paraplatin
1045932|NCT02876107|Panitumumab|panitumumab
1045933|NCT02876107|Vectibix|vectibix
1045934|NCT02876107|Doxorubicin|doxorubicin
1045935|NCT02876107|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1045936|NCT02876107|Adriamycin PFS|adriamycin pfs
1045937|NCT02876107|Adriamycin RDF|adriamycin rdf
1045938|NCT02876107|Adriamycin|adriamycin
1045939|NCT02876107|Rubex|rubex
1045940|NCT02876107|Cyclophosphamide|cyclophosphamide
1045941|NCT02876107|Cytoxan|cytoxan
1045942|NCT02876107|Neosar|neosar
1045943|NCT02876055|Nerve Block/methods|nerve block/methods
1045944|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
1045945|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
1045946|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
1045947|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
1045948|NCT02876042|Heart Failure|heart failure
1045949|NCT02876042|Preserved Ejection Fraction|preserved ejection fraction
1045950|NCT02875938|left middle cerebral artery|left middle cerebral artery
1045951|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
1045952|NCT02875938|stroke|stroke
1045953|NCT02875925|blood coagulation|blood coagulation
1045954|NCT02875912|Family|family
1045955|NCT02875912|Care Rituals|care rituals
1045956|NCT02875912|End of Life|end of life
1045957|NCT02875912|Discordance of care|discordance of care
1045958|NCT02875860|CDH|cdh
1045959|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
1045960|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
1045961|NCT02875860|FETO|feto
1045962|NCT02875860|plug-unplug|plug-unplug
1045963|NCT02875860|GoldBal2|goldbal2
1045964|NCT02875860|Balloon|balloon
1045965|NCT02875860|Goldvalve Balloon|goldvalve balloon
1045966|NCT02875860|TOTAL|total
1045967|NCT02875795|linguistic|linguistic
1045968|NCT02875795|quality of life|quality of life
1045969|NCT02875782|Smoking Cessation|smoking cessation
1045970|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
1045971|NCT02875769|chlorhexidine|chlorhexidine
1045972|NCT02875769|oral aerosol|oral aerosol
1045973|NCT02875769|oral splatter|oral splatter
1045974|NCT02875769|mouthwash|mouthwash
1045975|NCT02875769|microbiology|microbiology
1045976|NCT02875704|DR|dr
1045977|NCT02875704|AMD|amd
1045978|NCT02875691|disease activity|disease activity
1045979|NCT02875652|circulation tumor DNA|circulation tumor dna
1045980|NCT02875652|choroidal melanoma|choroidal melanoma
1045981|NCT02875639|Ischemic Heart Failure|ischemic heart failure
1045982|NCT02875639|coronary artery disease|coronary artery disease
1045983|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
1045984|NCT02875613|Nasopharyngeal|nasopharyngeal
1045985|NCT02875613|PD-L1|pd-l1
1045986|NCT02875613|monoclonal antibody|monoclonal antibody
1045987|NCT02875613|Epstein-barr virus|epstein-barr virus
1045988|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
1045989|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
1045990|NCT02875587|OHSS|ohss
1045991|NCT02875587|Infertility|infertility
1045992|NCT02875587|Cabergoline|cabergoline
1045998|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
1045999|NCT02875535|adolescent|adolescent
1046000|NCT02875535|Suicide prevention|suicide prevention
1046001|NCT02875535|Implementation study|implementation study
1046002|NCT02875522|COPD|copd
1046003|NCT02875522|Exercise Training|exercise training
1046004|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
1046005|NCT02875522|Arterial Stiffness|arterial stiffness
1046006|NCT02875522|Echocardiography|echocardiography
1046007|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
1046008|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
1046009|NCT02875470|root planing/instrumentation|root planing/instrumentation
1046010|NCT02875470|cytokine(s)|cytokine(s)
1046011|NCT02875470|dental plaque|dental plaque
1046012|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
1046013|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
1046014|NCT02875405|postoperative|postoperative
1046015|NCT02875405|pericardiotomy|pericardiotomy
1046016|NCT02875405|prevention|prevention
1046017|NCT02875405|cardiac surgery|cardiac surgery
1046018|NCT02875405|left|left
1046019|NCT02875405|posterior|posterior
1046020|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
1046021|NCT02875379|Mechanical Ventilation|mechanical ventilation
1046022|NCT02875353|Post-Polypectomy|post-polypectomy
1046023|NCT02875353|Colon bleeding|colon bleeding
1046024|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
1046025|NCT02875327|SEER|seer
1046026|NCT02875327|Medicaid|medicaid
1046027|NCT02875327|Cancer|cancer
1046028|NCT02875327|Health Services Research|health services research
1046029|NCT02875327|Epidemiology|epidemiology
1046030|NCT02875301|Exercise|exercise
1046031|NCT02875301|Brain Health|brain health
1046032|NCT02875301|Dose Response|dose response
1046033|NCT02875301|Cognition|cognition
1046034|NCT02875262|intracranial aneurysm|intracranial aneurysm
1046035|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
1046036|NCT02875262|stroke|stroke
1046037|NCT02875262|chelator|chelator
1046038|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
1046039|NCT02875249|intestinal microbiome|intestinal microbiome
1046044|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
1046045|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
1046046|NCT02875197|Kinetics|kinetics
1046047|NCT02875197|Biomechanics|biomechanics
1046048|NCT02875197|Amputation|amputation
1046049|NCT02875197|Prosthesis|prosthesis
1046050|NCT02875197|Transtibial|transtibial
1046051|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
1046052|NCT02875184|Apremilast|apremilast
1046053|NCT02875184|CC-10004|cc-10004
1046054|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
1046055|NCT02875145|Corneal Transplantation|corneal transplantation
1046056|NCT02875145|Graft Survival|graft survival
1046057|NCT02875106|Sinus rhythm|sinus rhythm
1046058|NCT02875041|rehabilitation|rehabilitation
1046059|NCT02875041|balance|balance
1046060|NCT02875028|Coagulations|coagulations
1046061|NCT02875028|Platelets|platelets
1046062|NCT02875028|Inflammation|inflammation
1046063|NCT02875028|endotoxemia|endotoxemia
1046064|NCT02875028|vorapaxar|vorapaxar
1046065|NCT02875015|Anesthetics|anesthetics
1046066|NCT02875015|Anesthetic Effects|anesthetic effects
1046067|NCT02875015|Mid-urethral sling|mid-urethral sling
1046068|NCT02874976|sedentary lifestyle|sedentary lifestyle
1046069|NCT02874963|Diabetes|diabetes
1046070|NCT02874963|Oral Hygiene|oral hygiene
1046071|NCT02874963|Periodontal Surgery|periodontal surgery
1046072|NCT02874963|Periodontal Medicine|periodontal medicine
1046073|NCT02874950|Exercise|exercise
1046074|NCT02874937|Syncope|syncope
1046075|NCT02874937|Vasovagal|vasovagal
1046076|NCT02874937|Atomoxetine|atomoxetine
1046077|NCT02874924|Geriatrics|geriatrics
1046078|NCT02874911|Exergaming|exergaming
1046079|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
1046080|NCT02874911|Rare disease|rare disease
1046081|NCT02874911|Motor exercises|motor exercises
1046082|NCT02874911|Training|training
1046083|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
1046084|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
1046085|NCT02874885|LARC|larc
1046086|NCT02874885|Colorectal cancer|colorectal cancer
1046088|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
1046089|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
1046090|NCT02874885|Blood draws|blood draws
1046091|NCT02874885|Blood samples|blood samples
1046092|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
1046093|NCT02874885|CTC|ctc
1046094|NCT02874872|Nursing homes|nursing homes
1046095|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
1046096|NCT02874872|Antibiotic Resistance|antibiotic resistance
1046097|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
1046098|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
1046099|NCT02874833|Depression|depression
1046100|NCT02874833|Unipolar depression|unipolar depression
1046101|NCT02874833|Bipolar affective disorder|bipolar affective disorder
1046102|NCT02874833|Exercise|exercise
1046103|NCT02874833|Internet-based intervention|internet-based intervention
1046104|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
1046105|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
1046106|NCT02874820|BU99008|bu99008
1046107|NCT02874820|[11C]-BU99008|[11c]-bu99008
1046108|NCT02874820|Radionuclide Imaging|radionuclide imaging
1046109|NCT02874820|Molecular Imaging|molecular imaging
1046110|NCT02874807|Hyponatremia|hyponatremia
1046111|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
1046112|NCT02874794|Heart Failure|heart failure
1046113|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
1046114|NCT02874794|Central Aortic Stiffness|central aortic stiffness
1046115|NCT02874794|Vascular|vascular
1046116|NCT02874794|Echocardiogram|echocardiogram
1046117|NCT02874755|Quality of Care|quality of care
1046118|NCT02874755|Standardized Patients|standardized patients
1046119|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
1046120|NCT02874729|Biological Assay|biological assay
1046121|NCT02874716|Quality of Care|quality of care
1046122|NCT02874716|Standardized Patients|standardized patients
1046123|NCT02874677|Multiple sclerosis|multiple sclerosis
1046124|NCT02874677|Ventilatory threshold|ventilatory threshold
1046125|NCT02874677|Effort Reeducation|effort reeducation
1046126|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1046127|NCT02874651|EB Virus|eb virus
1046128|NCT02874651|DNA|dna
1046129|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
1046130|NCT02874651|Apatinib|apatinib
1046131|NCT02874612|Young Adults|young adults
1046132|NCT02874612|Psychosocial Functioning|psychosocial functioning
1046133|NCT02874573|Inflammation|inflammation
1046134|NCT02874573|Schizophrenia|schizophrenia
1046135|NCT02874560|CNS|cns
1046136|NCT02874560|Antipsychotic|antipsychotic
1046137|NCT02874560|Functional remission|functional remission
1046138|NCT02874560|Observational study|observational study
1046139|NCT02874560|FROGS|frogs
1046140|NCT02874560|PSP|psp
1046141|NCT02874560|Functioning|functioning
1046142|NCT02874560|Schizophrenia|schizophrenia
1046143|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
1046144|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
1046145|NCT02874508|non-cardiac surgery|non-cardiac surgery
1046146|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
1046147|NCT02874495|Crohn's disease|crohn's disease
1046148|NCT02874495|Rectal Distension|rectal distension
1046149|NCT02874495|Remission|remission
1046150|NCT02874495|Anticipation|anticipation
1046151|NCT02874495|Painful|painful
1046152|NCT02874482|Schizophrenia|schizophrenia
1046153|NCT02874482|Change blindness|change blindness
1046154|NCT02874482|Eye tracking|eye tracking
1046155|NCT02874482|Implicit response|implicit response
1046156|NCT02874469|sudden death|sudden death
1046157|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
1046158|NCT02874469|psychological distress|psychological distress
1046159|NCT02874469|diary|diary
1046160|NCT02874469|resuscitation|resuscitation
1046161|NCT02874456|Zyca virus|zyca virus
1046557|NCT02871752|couples|couples
1046162|NCT02874352|intensive care|intensive care
1046163|NCT02874352|tracheostomy|tracheostomy
1046164|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
1046165|NCT02874339|Respiratory failure|respiratory failure
1046166|NCT02874339|Hypercapnia|hypercapnia
1046167|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
1046168|NCT02874339|Non invasive ventilation|non invasive ventilation
1046169|NCT02874339|Emergency department|emergency department
1046170|NCT02874326|Sandostatin LAR|sandostatin lar
1046171|NCT02874326|Somatostatin|somatostatin
1046172|NCT02874326|Octreotide|octreotide
1046173|NCT02874313|CPAP|cpap
1046174|NCT02874313|Sleep apnea|sleep apnea
1046175|NCT02874313|Diabetes|diabetes
1046176|NCT02874313|Diabetic retinopathy|diabetic retinopathy
1046177|NCT02874287|Coronary Artery Disease|coronary artery disease
1046178|NCT02874287|Hydroxychloroquine|hydroxychloroquine
1046179|NCT02874274|Corticobasal syndrome|corticobasal syndrome
1046180|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
1046181|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
1046182|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
1046183|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
1046184|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
1046185|NCT02874222|aromatase inhibitors|aromatase inhibitors
1046186|NCT02874183|Heart Failure|heart failure
1046187|NCT02874183|HF|hf
1046188|NCT02874183|CHF|chf
1046189|NCT02874183|RCT|rct
1046190|NCT02874183|Self-efficacy|self-efficacy
1046191|NCT02874183|Pharmacy|pharmacy
1046192|NCT02874183|Pharmacist|pharmacist
1046193|NCT02874183|Transition of Care|transition of care
1046194|NCT02874183|Readmission|readmission
1046195|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
1046196|NCT02874131|Major Depressive Disorder|major depressive disorder
1046197|NCT02874131|Behavioral Activation|behavioral activation
1046198|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
1046199|NCT02874131|Comorbidity|comorbidity
1046200|NCT02874131|Military|military
1046201|NCT02874105|Medical treatment|medical treatment
1046202|NCT02874105|physiotherapy|physiotherapy
1046203|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
1046204|NCT02874092|Ticagrelor|ticagrelor
1046205|NCT02874066|Hepatitis C virus|hepatitis c virus
1046206|NCT02874066|Hemodialysis|hemodialysis
1046207|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
1046208|NCT02874053|Risk Perceptions|risk perceptions
1046209|NCT02874053|Medical Tradeoffs|medical tradeoffs
1046210|NCT02874053|Regulatory Focus|regulatory focus
1046211|NCT02874053|Integral Affect|integral affect
1046212|NCT02874027|gut microbiota|gut microbiota
1046213|NCT02874027|depression|depression
1046214|NCT02874027|gut-brain axis|gut-brain axis
1046215|NCT02874027|circadian rhythm|circadian rhythm
1046216|NCT02874027|Traumatic Brain Injury|traumatic brain injury
1046217|NCT02874001|psychology|psychology
1046218|NCT02874001|caregiver support time|caregiver support time
1046219|NCT02873975|Advanced Cancers|advanced cancers
1046220|NCT02873975|Solid tumors|solid tumors
1046221|NCT02873975|MYC amplification|myc amplification
1046222|NCT02873975|CCNE1 amplification|ccne1 amplification
1046223|NCT02873975|Rb loss|rb loss
1046224|NCT02873975|FBXW7 mutation|fbxw7 mutation
1046225|NCT02873975|BRCA1 mutation|brca1 mutation
1046226|NCT02873975|BRCA2 mutation|brca2 mutation
1046227|NCT02873975|PALB2 mutation|palb2 mutation
1046228|NCT02873975|RAD51C mutation|rad51c mutation
1046229|NCT02873975|RAD51D mutation|rad51d mutation
1046230|NCT02873975|ATR mutation|atr mutation
1046231|NCT02873975|ATM mutation|atm mutation
1046232|NCT02873975|CHK2 mutation|chk2 mutation
1046233|NCT02873975|Fanconi anemia|fanconi anemia
1046234|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
1046235|NCT02873949|immunology factors|immunology factors
1046236|NCT02873949|TREM|trem
1046237|NCT02873949|stress|stress
1046238|NCT02873923|clinical trial|clinical trial
1046239|NCT02873923|surrogate endpoints|surrogate endpoints
1046240|NCT02873923|meta analysis|meta analysis
1046241|NCT02873897|elderly|elderly
1046242|NCT02873858|elderly|elderly
1046243|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
1046244|NCT02873780|COPD|copd
1046245|NCT02873780|Evaluation|evaluation
1046246|NCT02873780|oxygen desaturation|oxygen desaturation
1046247|NCT02873780|exercise capacity|exercise capacity
1046248|NCT02873767|First in human|first in human
1046249|NCT02873767|Healthy volunteers|healthy volunteers
1046250|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
1046251|NCT02873741|Cancer|cancer
1046252|NCT02873741|AIDS|aids
1046253|NCT02873728|chronic ulcer|chronic ulcer
1046254|NCT02873728|diabetic ulcer|diabetic ulcer
1046255|NCT02873728|venous ulcer|venous ulcer
1046256|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
1046257|NCT02873715|Childhood weight control|childhood weight control
1046258|NCT02873702|Drug therapy|drug therapy
1046259|NCT02873689|Drug therapy|drug therapy
1046260|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
1046261|NCT02873650|Hepatic impairment|hepatic impairment
1046262|NCT02873650|Healthy volunteers|healthy volunteers
1046263|NCT02873650|Clinical pharmacology study|clinical pharmacology study
1046264|NCT02873650|DRB436|drb436
1046265|NCT02873650|dabrafenib|dabrafenib
1046266|NCT02873650|normal hepatic function|normal hepatic function
1046267|NCT02873650|impaired hepatic function|impaired hepatic function
1046268|NCT02873637|total knee replacement|total knee replacement
1046269|NCT02873637|anesthesia|anesthesia
1046270|NCT02873637|catheter|catheter
1046271|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
1046272|NCT02873598|Induction Chemotherapy|induction chemotherapy
1046273|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
1046274|NCT02873598|Dose Escalation|dose escalation
1046275|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
1046276|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
1046277|NCT02873572|Online poker|online poker
1046278|NCT02873572|Casino|casino
1046279|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
1046280|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
1046281|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
1046282|NCT02873559|older|older
1046283|NCT02873559|frail|frail
1046285|NCT02873559|progressive muscle training|progressive muscle training
1046286|NCT02873559|muscle training|muscle training
1046287|NCT02873559|exercise|exercise
1046288|NCT02873559|testosterone|testosterone
1047374|NCT02866097|iCCM-DHIS2|iccm-dhis2
1046289|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
1046290|NCT02873520|Chemotherapy|chemotherapy
1046291|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
1046292|NCT02873507|transplantation, liver|transplantation, liver
1046293|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
1046294|NCT02873494|cardiac output|cardiac output
1046295|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
1046296|NCT02873494|Impedance cardiography|impedance cardiography
1046297|NCT02873494|Child|child
1046298|NCT02873494|Physioflow|physioflow
1046299|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
1046300|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
1046301|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
1046302|NCT02873442|Advanced Liver Cancer|advanced liver cancer
1046303|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
1046304|NCT02873416|Chemotherapy|chemotherapy
1046305|NCT02873416|Advanced Lung Cancer|advanced lung cancer
1046306|NCT02873390|PD-1 Antibody|pd-1 antibody
1046307|NCT02873390|CAR-T Cells|car-t cells
1046308|NCT02873390|EGFR family|egfr family
1046309|NCT02873390|Advanced Malignancies|advanced malignancies
1046310|NCT02873377|Hispanics|hispanics
1046311|NCT02873377|Construction workers|construction workers
1046312|NCT02873377|Tobacco Quitline|tobacco quitline
1046313|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
1046314|NCT02873351|L-DOPA|l-dopa
1046315|NCT02873351|GPR143|gpr143
1046316|NCT02873351|PEDF|pedf
1046317|NCT02873351|VEGF|vegf
1046318|NCT02873325|ADV|adv
1046319|NCT02873325|CMV|cmv
1046320|NCT02873325|HSCT|hsct
1046321|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
1046322|NCT02873286|RSV Vaccines|rsv vaccines
1046323|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
1046324|NCT02873260|Dengue Vaccine|dengue vaccine
1046325|NCT02873234|Telemedicine|telemedicine
1046326|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
1046327|NCT02873234|Long-term study|long-term study
1046328|NCT02873234|Relapse rate|relapse rate
1046329|NCT02873234|Suicide rate|suicide rate
1046330|NCT02873234|Antidepressants|antidepressants
1046331|NCT02873208|Alkermes|alkermes
1046332|NCT02873208|ALKS 3831|alks 3831
1046333|NCT02873208|Samidorphan|samidorphan
1046334|NCT02873208|Schizophrenia|schizophrenia
1046335|NCT02873208|Safety|safety
1046336|NCT02873182|Intraoperative monitoring|intraoperative monitoring
1046337|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
1046338|NCT02873182|Autonomic nervous system|autonomic nervous system
1046339|NCT02873182|Spine surgery|spine surgery
1046340|NCT02873182|Pelvic surgery|pelvic surgery
1046341|NCT02873182|Sexual function|sexual function
1046342|NCT02873182|Bowel function|bowel function
1046343|NCT02873182|Bladder function|bladder function
1046344|NCT02873169|Left ventricular assist device|left ventricular assist device
1046345|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
1046346|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
1046347|NCT02873156|E2027|e2027
1046348|NCT02873156|Healthy participants|healthy participants
1046349|NCT02873156|Pharmacokinetics|pharmacokinetics
1046350|NCT02873156|Pharmacodynamics|pharmacodynamics
1046351|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
1046352|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
1046353|NCT02873117|prostate cancer|prostate cancer
1046354|NCT02873117|Symptomatic|symptomatic
1046355|NCT02873117|treated|treated
1046356|NCT02873013|prostate cancer|prostate cancer
1046357|NCT02873013|observational study|observational study
1046358|NCT02873000|incentive spirometry|incentive spirometry
1080816|NCT02663453|preterm|preterm
1046359|NCT02873000|outcome|outcome
1046360|NCT02873000|length of stay,|length of stay,
1046361|NCT02873000|hospital complication|hospital complication
1046362|NCT02873000|general internal medicine|general internal medicine
1046363|NCT02873000|hospital medicine|hospital medicine
1046364|NCT02873000|non-critically-ill|non-critically-ill
1046365|NCT02872974|Cardiovascular diseases|cardiovascular diseases
1046366|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
1046367|NCT02872974|Pediatrics|pediatrics
1046368|NCT02872974|Fetal programming|fetal programming
1046369|NCT02872974|Cohort study|cohort study
1046370|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
1046371|NCT02872948|Down Syndrome|down syndrome
1046372|NCT02872948|Digital PCR|digital pcr
1046373|NCT02872922|Endothelial function|endothelial function
1046374|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
1046375|NCT02872922|Vascular endothelium|vascular endothelium
1046376|NCT02872922|Nitric oxide|nitric oxide
1046377|NCT02872922|Ultrasound|ultrasound
1046378|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
1046379|NCT02872883|term pregnancy|term pregnancy
1046380|NCT02872883|management|management
1046381|NCT02872883|vaginal examination|vaginal examination
1046382|NCT02872883|induction of labour|induction of labour
1046383|NCT02872883|expectant management|expectant management
1046384|NCT02872870|language disorders|language disorders
1047375|NCT02866097|ZCAHRD|zcahrd
1046385|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
1046386|NCT02872831|Fine needle aspiration|fine needle aspiration
1046387|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
1046388|NCT02872818|Survivin|survivin
1046389|NCT02872818|Bcl-2|bcl-2
1046390|NCT02872818|Bax|bax
1046391|NCT02872818|c-Myc|c-myc
1046392|NCT02872818|Caspase-9|caspase-9
1046393|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
1046394|NCT02872818|endometrium cancer|endometrium cancer
1046395|NCT02872792|cycloergometer|cycloergometer
1046396|NCT02872753|Autologous Conditioned Plasma|autologous conditioned plasma
1046397|NCT02872753|meniscectomy|meniscectomy
1046398|NCT02872753|randomized controlled trial|randomized controlled trial
1046399|NCT02872753|intra-op injection|intra-op injection
1046400|NCT02872714|Urothelial carcinoma|urothelial carcinoma
1046401|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
1046402|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
1046403|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
1046404|NCT02872675|Asthma|asthma
1046405|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
1046406|NCT02872675|Gut Bacteria|gut bacteria
1046407|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
1046408|NCT02872675|Pulmonary Function|pulmonary function
1046409|NCT02872675|Prebiotics|prebiotics
1046410|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
1046411|NCT02872675|Gut Microbiota|gut microbiota
1046412|NCT02872675|Nutritional Intervention|nutritional intervention
1046413|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
1046414|NCT02872675|Systemic Inflammation|systemic inflammation
1046415|NCT02872675|Systemic Immune Function|systemic immune function
1046416|NCT02872675|Regulatory T Cells|regulatory t cells
1046417|NCT02872675|TH1 Cells|th1 cells
1046418|NCT02872675|TH2 Cells|th2 cells
1046419|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
1046420|NCT02872675|Acetate|acetate
1046421|NCT02872675|Propionate|propionate
1046422|NCT02872675|Butyrate|butyrate
1046423|NCT02872675|Metabolomics|metabolomics
1046424|NCT02872675|Airway Inflammation|airway inflammation
1046425|NCT02872675|Intestinal Permeability|intestinal permeability
1046426|NCT02872610|suicidal thoughts|suicidal thoughts
1046427|NCT02872610|suicidal ideation|suicidal ideation
1046428|NCT02872610|Internet intervention|internet intervention
1046429|NCT02872610|self-help|self-help
1046430|NCT02872571|islet of Langerhans|islet of langerhans
1046431|NCT02872571|transplantation|transplantation
1046432|NCT02872571|muscle|muscle
1046433|NCT02872506|Quality of life|quality of life
1046434|NCT02872506|Crohn's disease|crohn's disease
1046435|NCT02872506|Ileocecal resection|ileocecal resection
1046436|NCT02872506|Anti TNF|anti tnf
1046437|NCT02872493|obesity|obesity
1046438|NCT02872493|bariatric surgery|bariatric surgery
1046439|NCT02872493|bowel length|bowel length
1046440|NCT02872480|Concussion|concussion
1046441|NCT02872480|Exercise|exercise
1046442|NCT02872467|Cocaine|cocaine
1046443|NCT02872467|Mothers|mothers
1046444|NCT02872467|Pregnant women|pregnant women
1046445|NCT02872467|Postpartum women|postpartum women
1046446|NCT02872467|Oxytocin|oxytocin
1046447|NCT02872467|Substance use disorders|substance use disorders
1046448|NCT02872467|Substance abuse|substance abuse
1046449|NCT02872467|Prenatal substance use|prenatal substance use
1046450|NCT02872467|stress|stress
1046451|NCT02872454|Major Depression|major depression
1046452|NCT02872454|Text Messaging|text messaging
1046453|NCT02872454|Guided Self-Help|guided self-help
1046454|NCT02872402|gestational diabetes|gestational diabetes
1046455|NCT02872402|dietary modification|dietary modification
1046456|NCT02872402|weight loss|weight loss
1046457|NCT02872402|physical activity|physical activity
1046458|NCT02872402|breastfeeding|breastfeeding
1046459|NCT02872376|Anemia|anemia
1046460|NCT02872376|Crohn's disease|crohn's disease
1046461|NCT02872376|Ulcerative colitis|ulcerative colitis
1046462|NCT02872363|breast screening|breast screening
1046463|NCT02872363|breast cancer|breast cancer
1046464|NCT02872363|mammogram|mammogram
1046465|NCT02872363|uptake|uptake
1046466|NCT02872363|reminder|reminder
1046467|NCT02872363|text message|text message
1046468|NCT02872363|SMS|sms
1046469|NCT02872311|Vaccine|vaccine
1046470|NCT02872311|Influenza|influenza
1046471|NCT02872311|High Dose|high dose
1046472|NCT02872311|Adjuvanted|adjuvanted
1046473|NCT02872298|Severe|severe
1046474|NCT02872298|Refractory|refractory
1046475|NCT02872259|metastatic melanoma|metastatic melanoma
1046476|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
1046477|NCT02872181|Maternal Position|maternal position
1046478|NCT02872181|Tilt|tilt
1046479|NCT02872181|Left Uterine Displacement|left uterine displacement
1046480|NCT02872181|Cesarean Delivery|cesarean delivery
1046481|NCT02872181|Cesarean Section|cesarean section
1046482|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
1046483|NCT02872155|renal insufficiency|renal insufficiency
1046484|NCT02872155|computed tomography|computed tomography
1046485|NCT02872129|Fibromyalgia|fibromyalgia
1046486|NCT02872129|chronic widespread pain|chronic widespread pain
1046487|NCT02872129|follow-up|follow-up
1046488|NCT02872129|pain|pain
1046489|NCT02872129|fatigue|fatigue
1046490|NCT02872129|symptoms|symptoms
1046491|NCT02872129|workability|workability
1046492|NCT02872129|physical function|physical function
1046493|NCT02872090|COPD|copd
1046494|NCT02872090|bronchodilatators|bronchodilatators
1046495|NCT02872090|autonomic nervous system|autonomic nervous system
1046496|NCT02872090|cardiovascular system|cardiovascular system
1046497|NCT02872077|AA for NAS|aa for nas
1046498|NCT02872064|Early breast cancer|early breast cancer
1046499|NCT02872064|Photodynamic therapy|photodynamic therapy
1046500|NCT02872064|PDT|pdt
1046501|NCT02872064|Visudyne|visudyne
1046502|NCT02872064|Verteporfin|verteporfin
1046503|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
1046504|NCT02872051|Anxiety|anxiety
1046505|NCT02872051|Depression|depression
1046506|NCT02872051|Common Mental Disorders|common mental disorders
1046507|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
1046508|NCT02872051|Return to Work|return to work
1046509|NCT02872051|Mental Health Services|mental health services
1046510|NCT02872051|Integration|integration
1046511|NCT02871999|Acupuncture Therapy|acupuncture therapy
1046512|NCT02871999|Pain degree after surgery|pain degree after surgery
1046513|NCT02871973|parenting|parenting
1046514|NCT02871973|child development|child development
1046515|NCT02871973|language|language
1046516|NCT02871947|severe asthma|severe asthma
1046517|NCT02871934|Pharmacogenetics|pharmacogenetics
1046518|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
1046519|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
1046520|NCT02871934|Simvastatin|simvastatin
1046521|NCT02871934|Cardiovascular disease|cardiovascular disease
1046522|NCT02871934|Cholesterol|cholesterol
1046523|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
1046524|NCT02871934|Veterans|veterans
1046525|NCT02871934|Point-of-care|point-of-care
1046526|NCT02871921|Behavioral prevention|behavioral prevention
1046527|NCT02871921|social interaction|social interaction
1046528|NCT02871921|dementia|dementia
1046529|NCT02871921|MRI|mri
1046530|NCT02871895|sepsis|sepsis
1046531|NCT02871895|severe sepsis|severe sepsis
1046532|NCT02871895|septic shock|septic shock
1046533|NCT02871895|multiple organ failure|multiple organ failure
1046534|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
1046535|NCT02871869|CHOP protocol|chop protocol
1046536|NCT02871856|Screening|screening
1046537|NCT02871856|Computed tomography|computed tomography
1046538|NCT02871856|Lung cancer|lung cancer
1046539|NCT02871830|Physical activity|physical activity
1046540|NCT02871830|Walking|walking
1046541|NCT02871830|Intervention|intervention
1046542|NCT02871830|Adolescent girls|adolescent girls
1046543|NCT02871830|Randomised trial|randomised trial
1046544|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
1046545|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
1046546|NCT02871817|Amsler Grid|amsler grid
1046547|NCT02871817|Home Monitoring|home monitoring
1046548|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
1046549|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
1046550|NCT02871765|Patient education|patient education
1046551|NCT02871765|Knowledge|knowledge
1046552|NCT02871765|Life distress|life distress
1046553|NCT02871765|Quality of life|quality of life
1046554|NCT02871752|prostate cancer|prostate cancer
1046555|NCT02871752|active surveillance|active surveillance
1046556|NCT02871752|MBSR|mbsr
1046558|NCT02871752|health promotion|health promotion
1046559|NCT02871752|quality of life|quality of life
1046560|NCT02871752|mindfulness|mindfulness
1046561|NCT02871739|Communication skills training|communication skills training
1046562|NCT02871739|Shared Decision Making|shared decision making
1046563|NCT02871739|Decision making|decision making
1046564|NCT02871739|Decision Aids|decision aids
1046565|NCT02871739|lung cancer screening|lung cancer screening
1046566|NCT02871726|Prostate Cancer Detection|prostate cancer detection
1046567|NCT02871726|Prostate Biopsy|prostate biopsy
1046568|NCT02871726|Prostate Cancer|prostate cancer
1046569|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
1046570|NCT02871713|quadratus lumborum block|quadratus lumborum block
1046571|NCT02871700|stroke|stroke
1046572|NCT02871700|translational rehabilitation|translational rehabilitation
1046573|NCT02871700|mirror neuron system|mirror neuron system
1046574|NCT02871700|action observation|action observation
1046575|NCT02871700|mirror therapy|mirror therapy
1046576|NCT02871700|MEG|meg
1046577|NCT02871674|Behavioural interventions|behavioural interventions
1046578|NCT02871674|Sleep difficulties|sleep difficulties
1046579|NCT02871674|Children|children
1046580|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1046581|NCT02871674|Randomised controlled trial|randomised controlled trial
1046582|NCT02871674|Saudi Arabia|saudi arabia
1046583|NCT02871674|Behavioural Insomnia|behavioural insomnia
1046584|NCT02871661|vulvodynia|vulvodynia
1046585|NCT02871661|pelvic floor muscles|pelvic floor muscles
1046586|NCT02871661|kinesiotherapy|kinesiotherapy
1046587|NCT02871661|electrical therapy|electrical therapy
1046588|NCT02871661|physical therapy|physical therapy
1046589|NCT02871661|amitriptyline|amitriptyline
1046590|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
1046591|NCT02871648|Healthy|healthy
1046592|NCT02871609|Biofilm|biofilm
1046593|NCT02871609|Morbidity|morbidity
1046594|NCT02871609|Ureteral Catheterization|ureteral catheterization
1046595|NCT02871570|Hepatic Impairment|hepatic impairment
1046596|NCT02871570|Rivipansel|rivipansel
1046597|NCT02871544|BNP|bnp
1046598|NCT02871544|NGAL|ngal
1046599|NCT02871544|Sepsis|sepsis
1046600|NCT02871544|Mortality|mortality
1046601|NCT02871531|retinal detachment|retinal detachment
1046602|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
1046603|NCT02871531|vitrectomy|vitrectomy
1046604|NCT02871479|Atopic Dermatitis|atopic dermatitis
1046605|NCT02871479|Eczema|eczema
1046606|NCT02871453|Ischemic Stroke|ischemic stroke
1046607|NCT02871453|Motor Dysfunction|motor dysfunction
1046608|NCT02871453|Scalp Acupuncture|scalp acupuncture
1046609|NCT02871427|Lewy body dementia|lewy body dementia
1046610|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
1046611|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
1046612|NCT02871427|Visual hallucinations|visual hallucinations
1046613|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
1046614|NCT02871401|IPF|ipf
1046615|NCT02871401|Herpesvirus|herpesvirus
1046616|NCT02871401|Valganciclovir|valganciclovir
1046617|NCT02871388|Physical activity|physical activity
1046618|NCT02871388|Diet|diet
1046619|NCT02871388|Nutrition|nutrition
1046620|NCT02871388|Breast cancer prevention|breast cancer prevention
1046621|NCT02871388|Mammography screening|mammography screening
1046622|NCT02871375|myopia|myopia
1046623|NCT02871375|presbyopia|presbyopia
1046624|NCT02871349|Autism|autism
1046625|NCT02871349|ASD|asd
1046626|NCT02871336|Cata collection|cata collection
1046627|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
1046628|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
1046629|NCT02871297|adolescent|adolescent
1046630|NCT02871297|children|children
1046631|NCT02871284|cancer|cancer
1046632|NCT02871284|anticancer treatment|anticancer treatment
1046633|NCT02871284|exercise|exercise
1046634|NCT02871284|physical activity|physical activity
1046635|NCT02871284|sensorimotor training|sensorimotor training
1046636|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
1046637|NCT02871245|Acupuncture Therapy|acupuncture therapy
1046638|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
1046639|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
1046640|NCT02871219|Follicular lymphoma|follicular lymphoma
1046641|NCT02871219|Obinutuzumab|obinutuzumab
1046642|NCT02871219|GA101|ga101
1046643|NCT02871219|Gazyva|gazyva
1046644|NCT02871219|Lenalidomide|lenalidomide
1046645|NCT02871219|CC-5013|cc-5013
1046646|NCT02871219|Revlimid|revlimid
1046647|NCT02871193|paravertebral block|paravertebral block
1046648|NCT02871193|patient controlled analgesia|patient controlled analgesia
1046649|NCT02871193|ropivacaine|ropivacaine
1046650|NCT02871193|dexamethasone|dexamethasone
1046651|NCT02871180|Hypoglycemia|hypoglycemia
1046652|NCT02871180|Type 1 diabetes|type 1 diabetes
1046653|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
1046654|NCT02871128|Hemoglobin|hemoglobin
1046655|NCT02871128|serum iron|serum iron
1046656|NCT02871128|serum ferritin|serum ferritin
1046657|NCT02871128|Hematocrit|hematocrit
1046660|NCT02871102|mechanical ventilation|mechanical ventilation
1046661|NCT02871102|respiratory mechanics|respiratory mechanics
1046662|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
1046663|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
1046664|NCT02871102|tidal volume|tidal volume
1046665|NCT02871089|Type 1 Diabetes|type 1 diabetes
1046666|NCT02871089|Closed-loop glucose control|closed-loop glucose control
1046667|NCT02871089|Artificial Pancreas|artificial pancreas
1046668|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1046669|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
1046670|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
1046671|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
1046672|NCT02871089|Beta-cell function preservation|beta-cell function preservation
1046673|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
1046674|NCT02871050|Biobank|biobank
1046675|NCT02871050|biorepository|biorepository
1046676|NCT02871050|Castlebank|castlebank
1046677|NCT02871050|Castleman Disease|castleman disease
1046678|NCT02871050|CD|cd
1046679|NCT02871050|MCD|mcd
1046680|NCT02871050|iMCD|imcd
1046681|NCT02871050|Castleman|castleman
1046682|NCT02871050|Castleman's Disease|castleman's disease
1046683|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
1046684|NCT02871050|multicentric Castleman disease|multicentric castleman disease
1048275|NCT02861092|obesity|obesity
1046685|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
1046686|NCT02871024|Polymyxin B|polymyxin b
1046687|NCT02871024|Pneumonia|pneumonia
1046688|NCT02871024|Sepsis|sepsis
1046689|NCT02871024|Urinary tract infection|urinary tract infection
1046690|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
1046691|NCT02871011|Tinea Pedis|tinea pedis
1046692|NCT02871011|Nitric Oxide|nitric oxide
1046693|NCT02871011|Dermatomycoses|dermatomycoses
1046694|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
1046695|NCT02871011|Infectious|infectious
1046696|NCT02871011|Infection|infection
1046697|NCT02871011|Mycoses|mycoses
1046698|NCT02871011|Skin Diseases|skin diseases
1046699|NCT02871011|Foot Dermatoses|foot dermatoses
1046700|NCT02871011|Foot Diseases|foot diseases
1046701|NCT02871011|Pruritus|pruritus
1046702|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
1046703|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1046704|NCT02870946|Cardiogenic Shock|cardiogenic shock
1046705|NCT02870946|Renal Replacement Therapy|renal replacement therapy
1046706|NCT02870933|CD 133+|cd 133+
1046707|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
1046708|NCT02870933|CABG|cabg
1046709|NCT02870907|primary enucleation|primary enucleation
1046710|NCT02870907|retinoblastoma|retinoblastoma
1046711|NCT02870868|slow breathing|slow breathing
1046712|NCT02870868|yoga|yoga
1046713|NCT02870868|mind-body practicers|mind-body practicers
1046714|NCT02870842|ultrasonography|ultrasonography
1046715|NCT02870842|child|child
1046716|NCT02870842|perioperative period|perioperative period
1046717|NCT02870842|general anesthesia|general anesthesia
1046718|NCT02870842|lung|lung
1046719|NCT02870777|MRD|mrd
1046720|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
1046721|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
1046722|NCT02870764|Lp-PLA2|lp-pla2
1046723|NCT02870764|coronary artery disease|coronary artery disease
1046724|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
1046725|NCT02870751|ETEC|etec
1046726|NCT02870751|human challenge study|human challenge study
1046727|NCT02870751|heat stable toxin|heat stable toxin
1046728|NCT02870751|tourist diarrhea|tourist diarrhea
1046729|NCT02870751|diarrhea|diarrhea
1046730|NCT02870751|enterotoxigenic|enterotoxigenic
1046731|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
1046732|NCT02870712|perineal tear of first degree|perineal tear of first degree
1046733|NCT02870712|suture|suture
1046734|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
1046735|NCT02870686|ERCP|ercp
1046736|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
1046737|NCT02870673|acupuncture|acupuncture
1046738|NCT02870673|electrical stimulation|electrical stimulation
1046739|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
1046740|NCT02870608|Elastography|elastography
1046741|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
1046742|NCT02870543|Bruxism|bruxism
1046743|NCT02870543|Sleep bruxism|sleep bruxism
1046744|NCT02870543|Sleep related bruxism|sleep related bruxism
1046745|NCT02870543|Homeopathy|homeopathy
1046746|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
1046747|NCT02870504|treatment|treatment
1046748|NCT02870491|Child Diarrhea|child diarrhea
1046749|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1046750|NCT02870491|Oral Rehydration|oral rehydration
1046751|NCT02870491|ORS|ors
1046752|NCT02870491|Zinc|zinc
1046753|NCT02870491|Brac|brac
1046754|NCT02870491|Community Health Workers|community health workers
1046756|NCT02870465|outpatient versus operating room|outpatient versus operating room
1046757|NCT02870465|k wire infection|k wire infection
1046758|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
1046759|NCT02870452|Haemophilia|haemophilia
1046760|NCT02870452|RCT|rct
1046761|NCT02870452|Pain|pain
1046762|NCT02870452|Hemarthrosis|hemarthrosis
1046763|NCT02870452|Hypnosis|hypnosis
1046764|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1046765|NCT02870452|Quality of Life|quality of life
1046766|NCT02870452|Distress|distress
1046767|NCT02870452|Cytokines|cytokines
1046768|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
1046769|NCT02870413|telehealth|telehealth
1046770|NCT02870387|chronic illness|chronic illness
1046771|NCT02870387|children|children
1046772|NCT02870387|children with medical complexity|children with medical complexity
1046773|NCT02870387|medical home|medical home
1046774|NCT02870387|inpatient consultation|inpatient consultation
1046775|NCT02870335|low back|low back
1046776|NCT02870335|manual therapy|manual therapy
1046777|NCT02870335|stretching|stretching
1046778|NCT02870322|overweight|overweight
1046779|NCT02870322|obesity|obesity
1046780|NCT02870322|lifestyle prescription|lifestyle prescription
1046781|NCT02870322|prevention|prevention
1046782|NCT02870322|physical activity|physical activity
1046783|NCT02870322|healthy eating|healthy eating
1046784|NCT02870283|Cost effectiveness|cost effectiveness
1046785|NCT02870283|Bipolar disorder|bipolar disorder
1046786|NCT02870283|Mixed episodes|mixed episodes
1046787|NCT02870283|Quality of life|quality of life
1046788|NCT02870270|saliva|saliva
1046789|NCT02870270|microflora|microflora
1046790|NCT02870270|diet|diet
1046791|NCT02870270|quality of life|quality of life
1046792|NCT02870270|oral cancer|oral cancer
1046793|NCT02870244|Melanoma|melanoma
1046794|NCT02870244|Gene Therapy|gene therapy
1046795|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
1046796|NCT02870244|IL-2|il-2
1046797|NCT02870192|Rectal Prolapse|rectal prolapse
1046798|NCT02870179|Pulse Oximetry|pulse oximetry
1046799|NCT02870179|Temperature|temperature
1046800|NCT02870179|Respiratory Rate|respiratory rate
1046801|NCT02870179|Respiratory Gases|respiratory gases
1046802|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
1046803|NCT02870140|CAD|cad
1046804|NCT02870140|ACS|acs
1046805|NCT02870140|All comers|all comers
1046806|NCT02870140|PCI|pci
1046807|NCT02870114|Haemophilia|haemophilia
1046808|NCT02870114|Quality of Life|quality of life
1046809|NCT02870114|Distress|distress
1046810|NCT02870114|Hemarthrosis|hemarthrosis
1046811|NCT02870114|Pain|pain
1046812|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
1046813|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
1046814|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
1046815|NCT02870101|Sexually transmitted diseases|sexually transmitted diseases
1046816|NCT02870101|Pharynx|pharynx
1046817|NCT02870101|Rectum|rectum
1046818|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
1046819|NCT02870101|Bacterial Infections|bacterial infections
1046820|NCT02870101|Genital Diseases, Male|genital diseases, male
1046821|NCT02870101|Genital Diseases, Female|genital diseases, female
1046822|NCT02870062|Chlorhexidine baths|chlorhexidine baths
1046823|NCT02870062|Critical patient|critical patient
1046824|NCT02870062|Healthcare associated infections|healthcare associated infections
1046825|NCT02870062|Critical care environment|critical care environment
1046826|NCT02870062|Patient colonization|patient colonization
1046827|NCT02870049|early detection|early detection
1046828|NCT02869971|Prostatic artery embolization|prostatic artery embolization
1046829|NCT02869971|Combined Therapy|combined therapy
1046830|NCT02869971|IPSS|ipss
1046831|NCT02869958|Asthma|asthma
1046832|NCT02869958|Exacerbation|exacerbation
1046833|NCT02869958|Treatment|treatment
1046834|NCT02869958|Internet|internet
1046835|NCT02869958|Emergency care|emergency care
1046836|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
1046837|NCT02869945|genetic|genetic
1046838|NCT02869945|COMT Polymorphism|comt polymorphism
1046839|NCT02869945|gene|gene
1046840|NCT02869945|brain MRI|brain mri
1046841|NCT02869945|brain MPET|brain mpet
1046842|NCT02869841|laparotomy|laparotomy
1046843|NCT02869841|pain|pain
1046844|NCT02869841|rectus sheath block|rectus sheath block
1046845|NCT02869815|Methylene blue|methylene blue
1046846|NCT02869815|Indocyanine green|indocyanine green
1046847|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
1729254|NCT00007241|Exercise|exercise
1046848|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1046849|NCT02869815|Breast Neoplasms|breast neoplasms
1046850|NCT02869802|Cancer|cancer
1046851|NCT02869802|Pancreatic Cancer|pancreatic cancer
1046852|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
1046853|NCT02869802|PDAC|pdac
1046854|NCT02869802|Genomic Analysis|genomic analysis
1046855|NCT02869802|Molecular subtyping|molecular subtyping
1046857|NCT02869763|Steroid profile|steroid profile
1046858|NCT02869763|Pharmacokinetics|pharmacokinetics
1046859|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
1046860|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
1046861|NCT02869724|Drug|drug
1046862|NCT02869724|Divided prescription|divided prescription
1046863|NCT02869672|safety|safety
1046864|NCT02869672|immunogenicity|immunogenicity
1046865|NCT02869672|vaccine|vaccine
1046866|NCT02869659|obesity|obesity
1046867|NCT02869659|pre-diabetes|pre-diabetes
1046868|NCT02869659|overweight|overweight
1046869|NCT02869659|lifestyle change|lifestyle change
1046870|NCT02869659|glucose|glucose
1046871|NCT02869646|PTSD|ptsd
1046872|NCT02869646|acupuncture|acupuncture
1046873|NCT02869646|integrative medicine|integrative medicine
1046874|NCT02869464|Aneurysm|aneurysm
1046875|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
1046876|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1046877|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
1046878|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
1046879|NCT02869386|stroke|stroke
1046880|NCT02869386|prehospital|prehospital
1046881|NCT02869386|telemedicine|telemedicine
1046882|NCT02869386|thrombolysis|thrombolysis
1046883|NCT02869386|thrombectomy|thrombectomy
1046884|NCT02869386|endovascular treatment|endovascular treatment
1046885|NCT02869386|functional outcome|functional outcome
1046886|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
1046887|NCT02869347|acute kidney injury|acute kidney injury
1046888|NCT02869347|coronary angiography|coronary angiography
1046889|NCT02869347|contrast media|contrast media
1046890|NCT02869347|Conestat alfa|conestat alfa
1046891|NCT02869347|inflammation|inflammation
1046892|NCT02869308|Cardiomyopathy|cardiomyopathy
1046893|NCT02869308|Chemotherapy|chemotherapy
1046894|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
1046895|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
1046896|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
1046897|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
1046898|NCT02869256|practices evaluation|practices evaluation
1046899|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
1046900|NCT02869230|Breast cancer|breast cancer
1046901|NCT02869230|Non palpable breast lesions|non palpable breast lesions
1046902|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
1046903|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
1046904|NCT02869165|Postmenopausal|postmenopausal
1046905|NCT02869152|sentinel lymph node|sentinel lymph node
1046906|NCT02869152|lymphatic mapping|lymphatic mapping
1046907|NCT02869152|rectal tumor|rectal tumor
1046908|NCT02869152|rectal cancer|rectal cancer
1046909|NCT02869152|early stage|early stage
1046910|NCT02869139|Thirst|thirst
1046911|NCT02869139|Ice|ice
1046912|NCT02869139|Menthol|menthol
1046913|NCT02869139|Perioperative Nursing.|perioperative nursing.
1046914|NCT02869139|Recovery Room|recovery room
1046915|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
1046916|NCT02869126|thallium-201|thallium-201
1046917|NCT02869126|semiconductor camera|semiconductor camera
1046918|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
1046919|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
1046920|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
1046921|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
1046922|NCT02869074|von Willebrand factor gene|von willebrand factor gene
1046923|NCT02869074|next generation sequencing|next generation sequencing
1046924|NCT02869074|diagnosis|diagnosis
1046925|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
1046926|NCT02869061|Bladder neck obstruction|bladder neck obstruction
1046927|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
1046928|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
1046929|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
1046930|NCT02869061|Bladder neck contracture|bladder neck contracture
1046931|NCT02869061|Bladder neck stricture|bladder neck stricture
1046932|NCT02869061|Bladder neck stenosis|bladder neck stenosis
1046933|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
1046934|NCT02869061|Prostatectomy|prostatectomy
1046935|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
1729963|NCT00006070|TNF|tnf
1046936|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
1046937|NCT02869061|Adipose tissue|adipose tissue
1046938|NCT02869061|Stem cells|stem cells
1046939|NCT02869048|Biological Specimen Banks|biological specimen banks
1046940|NCT02869048|Innate Immunity|innate immunity
1046941|NCT02869048|Clinical Study|clinical study
1046942|NCT02869048|Complement system proteins|complement system proteins
1046943|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1046944|NCT02869048|Neurodegenerative disease|neurodegenerative disease
1047051|NCT02868489|Microbiota|microbiota
1046945|NCT02869048|Motor neuron disease|motor neuron disease
1046946|NCT02869035|PET|pet
1046947|NCT02869035|Serotonin|serotonin
1046948|NCT02869035|5-HT4R|5-ht4r
1046949|NCT02869035|MRI|mri
1046950|NCT02869035|fMRI|fmri
1046951|NCT02869035|EEG|eeg
1046952|NCT02869035|Cortisol awakening response|cortisol awakening response
1046953|NCT02869035|Oxidative stress|oxidative stress
1046954|NCT02869035|Mental health|mental health
1046955|NCT02869035|Prediction of treatment response|prediction of treatment response
1046956|NCT02869035|Inflammation|inflammation
1046957|NCT02869035|5-HTTLPR|5-httlpr
1046958|NCT02869035|Brain imaging|brain imaging
1046959|NCT02869035|Early life stress|early life stress
1046960|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
1046961|NCT02869035|Escitalopram|escitalopram
1046962|NCT02869035|Psychometrics|psychometrics
1046963|NCT02869035|Moderate depression|moderate depression
1046964|NCT02869035|Severe depression|severe depression
1046965|NCT02869035|ERP|erp
1046966|NCT02869035|rsfMRI|rsfmri
1046967|NCT02869035|11C-SB207145|11c-sb207145
1046968|NCT02869035|Sexual function|sexual function
1046969|NCT02869035|MDD|mdd
1046970|NCT02869035|Affective cognition|affective cognition
1046971|NCT02869035|Cold cognition|cold cognition
1046972|NCT02869035|Social cognition|social cognition
1046973|NCT02869035|Anxiety|anxiety
1046974|NCT02869009|stroke|stroke
1046975|NCT02869009|clopidogrel|clopidogrel
1046976|NCT02869009|antiplatelets|antiplatelets
1046977|NCT02868957|CAD|cad
1046978|NCT02868957|Digital imaging|digital imaging
1046979|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
1046980|NCT02868931|self-management|self-management
1046981|NCT02868931|empowerment|empowerment
1046982|NCT02868931|treatment and education program|treatment and education program
1046983|NCT02868931|insulin pump|insulin pump
1046984|NCT02868931|diabetes education|diabetes education
1046985|NCT02868866|physical activity|physical activity
1046986|NCT02868866|nutrition|nutrition
1046987|NCT02868866|fruits and vegetables|fruits and vegetables
1046988|NCT02868866|faith-based|faith-based
1046989|NCT02868866|churches|churches
1046990|NCT02868853|diet|diet
1046991|NCT02868853|weight loss|weight loss
1046992|NCT02868853|tracking|tracking
1046993|NCT02868853|mobile|mobile
1046994|NCT02868853|calories|calories
1046995|NCT02868840|stroke|stroke
1046996|NCT02868840|Tai ji|tai ji
1046997|NCT02868840|postural balance|postural balance
1046998|NCT02868840|cognition|cognition
1046999|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
1047000|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
1047001|NCT02868801|Pregabalin|pregabalin
1047002|NCT02868788|inflammation|inflammation
1047003|NCT02868788|insulin resistance|insulin resistance
1047004|NCT02868788|type 2 diabetes|type 2 diabetes
1047005|NCT02868788|obesity|obesity
1047006|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
1047007|NCT02868749|Hyaluronic Acid|hyaluronic acid
1047008|NCT02868749|histology|histology
1047009|NCT02868749|ultrasound|ultrasound
1047010|NCT02868749|subcutaneous|subcutaneous
1047011|NCT02868749|adipose tissue|adipose tissue
1047012|NCT02868723|cerebrovascular disease|cerebrovascular disease
1047013|NCT02868723|patient management|patient management
1047014|NCT02868723|stroke management|stroke management
1047015|NCT02868723|prognosis|prognosis
1047016|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
1047017|NCT02868723|Randomization|randomization
1047018|NCT02868710|primary prevention|primary prevention
1047019|NCT02868671|mild TBI|mild tbi
1047020|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
1047021|NCT02868671|Acupuncture|acupuncture
1047022|NCT02868658|Influenza|influenza
1047023|NCT02868658|health care workers|health care workers
1047024|NCT02868658|nosocomial|nosocomial
1047025|NCT02868658|asymptomatic|asymptomatic
1047026|NCT02868658|France|france
1047027|NCT02868632|Unresectable|unresectable
1047028|NCT02868632|Locally Advanced|locally advanced
1047029|NCT02868632|Non-Metastatic|non-metastatic
1047030|NCT02868619|fMRI|fmri
1047031|NCT02868619|Deep brain stimulation|deep brain stimulation
1047032|NCT02868619|Food|food
1047033|NCT02868619|Eating|eating
1047034|NCT02868619|Reward|reward
1047035|NCT02868580|ALS|als
1047036|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
1047037|NCT02868541|microorganisms|microorganisms
1047038|NCT02868541|pilgrim|pilgrim
1047039|NCT02868541|hajj|hajj
1047040|NCT02868528|advanced age women|advanced age women
1047041|NCT02868528|blastocyst culture|blastocyst culture
1047042|NCT02868528|PGS|pgs
1047043|NCT02868528|live birth rate|live birth rate
1047044|NCT02868502|Glaucoma|glaucoma
1047045|NCT02868502|Open Angle Glaucoma|open angle glaucoma
1047046|NCT02868502|Intra Ocular Pressure|intra ocular pressure
1047047|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
1047048|NCT02868502|Trabeculectomy|trabeculectomy
1047049|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
1047050|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
1047052|NCT02868463|oxygen tension|oxygen tension
1047053|NCT02868463|Female Urinary Microbiome|female urinary microbiome
1047054|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
1047055|NCT02868463|Urine Oxygen Level|urine oxygen level
1047056|NCT02868398|Ulcerative Colitis|ulcerative colitis
1047057|NCT02868398|Golimumab|golimumab
1047058|NCT02868398|Deep and prolonged remission|deep and prolonged remission
1047059|NCT02868385|Schistosomiasis|schistosomiasis
1047060|NCT02868385|Schistosoma mansoni|schistosoma mansoni
1047061|NCT02868385|Bilharzia|bilharzia
1047062|NCT02868372|Cesarean section|cesarean section
1047063|NCT02868372|Betadine|betadine
1047064|NCT02868372|Wound infection|wound infection
1047065|NCT02868320|SMS|sms
1047066|NCT02868320|text messaging|text messaging
1047067|NCT02868320|diabetes self management|diabetes self management
1047068|NCT02868320|glycemic control|glycemic control
1047069|NCT02868320|mHealth|mhealth
1047070|NCT02868320|mobile health|mobile health
1047071|NCT02868320|diabetes education|diabetes education
1047072|NCT02868281|Cluster Randomization|cluster randomization
1047073|NCT02868281|Peak Expiratory Flow|peak expiratory flow
1047074|NCT02868281|Forced Expiratory Volume|forced expiratory volume
1047075|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
1047076|NCT02868281|Asthma Control Test|asthma control test
1047077|NCT02868268|Neuroblastoma|neuroblastoma
1047078|NCT02868255|Biobank analyses|biobank analyses
1047079|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
1047080|NCT02868255|patient-derived cells|patient-derived cells
1047081|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
1047082|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
1047083|NCT02868242|Direct Acting Antiviral|direct acting antiviral
1047084|NCT02868242|Combination Therapy|combination therapy
1047085|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
1047086|NCT02868242|Liver Diseases|liver diseases
1047087|NCT02868242|Virus Diseases|virus diseases
1047088|NCT02868177|Prevention|prevention
1047089|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
1047090|NCT02868138|Sickle cell disease|sickle cell disease
1047091|NCT02868138|Hydroxyurea|hydroxyurea
1047092|NCT02868138|Compliance|compliance
1047093|NCT02868125|pertrochanteric|pertrochanteric
1047094|NCT02868125|radiography|radiography
1047095|NCT02868112|Cancer Care|cancer care
1047096|NCT02868112|Palliative Care|palliative care
1047097|NCT02868112|Geriatrics|geriatrics
1047098|NCT02868112|Quality of Life|quality of life
1047099|NCT02868086|Age-related macular degeneration|age-related macular degeneration
1047100|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
1047101|NCT02868047|chronic pancreatitis|chronic pancreatitis
1047102|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
1047103|NCT02868034|Low Back Pain|low back pain
1047104|NCT02868034|Spinal Manipulation|spinal manipulation
1047105|NCT02868034|Exercise|exercise
1047106|NCT02868021|Elderly|elderly
1047107|NCT02868021|Exercise|exercise
1047108|NCT02868008|multimodal imaging|multimodal imaging
1047109|NCT02868008|surgical risk|surgical risk
1047110|NCT02868008|arteriovenous malformations|arteriovenous malformations
1047111|NCT02867982|platform switching|platform switching
1047112|NCT02867982|crestal bone remodeling|crestal bone remodeling
1047113|NCT02867982|soft tissue thickness|soft tissue thickness
1047114|NCT02867982|dental implant|dental implant
1047115|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
1047116|NCT02867969|Exergaming|exergaming
1047117|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
1047118|NCT02867969|Rare disease|rare disease
1047119|NCT02867969|Motor exercises|motor exercises
1047120|NCT02867969|Premanifest stage|premanifest stage
1047121|NCT02867969|Training|training
1047122|NCT02867956|Ovarian cancer|ovarian cancer
1047123|NCT02867956|Apatinib|apatinib
1047124|NCT02867956|Etoposide|etoposide
1047125|NCT02867956|Chemotherapy|chemotherapy
1047126|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
1047127|NCT02867930|Echocardiography|echocardiography
1047128|NCT02867930|Transesophageal|transesophageal
1047129|NCT02867930|Dexmedetomidine|dexmedetomidine
1047130|NCT02867930|Ketamine|ketamine
1047131|NCT02867930|Propofol|propofol
1047132|NCT02867917|Fibers|fibers
1047133|NCT02867917|Constipation|constipation
1047134|NCT02867891|FLT3-ITD|flt3-itd
1047136|NCT02867891|allo-HSCT|allo-hsct
1047137|NCT02867839|Gastric cancer|gastric cancer
1047138|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
1047140|NCT02867839|Oxaliplatin|oxaliplatin
1047141|NCT02867826|Endoscopy|endoscopy
1047142|NCT02867826|Ampulla of Vater|ampulla of vater
1047143|NCT02867826|Duodenoscopy|duodenoscopy
1047144|NCT02867813|High Cholesterol|high cholesterol
1047145|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
1047146|NCT02867813|Lowering cholesterol|lowering cholesterol
1047147|NCT02867813|Lowering high cholesterol|lowering high cholesterol
1047148|NCT02867813|Hypercholesterolemia|hypercholesterolemia
1047149|NCT02867800|Sickle Cell Disease|sickle cell disease
1047150|NCT02867800|Graft Versus Host Disease|graft versus host disease
1047152|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1047153|NCT02867787|Shoulder Joint|shoulder joint
1047154|NCT02867787|A02.835.583.748|a02.835.583.748
1047155|NCT02867774|chronic pelvic pain|chronic pelvic pain
1047156|NCT02867774|central pain amplification|central pain amplification
1047157|NCT02867774|exercise|exercise
1047158|NCT02867774|physical activity|physical activity
1047159|NCT02867761|COPD|copd
1047160|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1047161|NCT02867761|Pulmonary Function Tests|pulmonary function tests
1047162|NCT02867761|Current Smoker|current smoker
1047163|NCT02867761|Former Smoker|former smoker
1047164|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1047165|NCT02867761|Respiratory Symptoms|respiratory symptoms
1047166|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
1047167|NCT02867735|Macular Edema|macular edema
1047168|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
1047169|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
1047170|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
1047171|NCT02867696|Bariatric Surgery|bariatric surgery
1047172|NCT02867696|Physical Activity|physical activity
1047173|NCT02867696|Weight Management|weight management
1047174|NCT02867696|Weight Loss|weight loss
1047175|NCT02867683|vibrotactile feedback|vibrotactile feedback
1047176|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
1047177|NCT02867683|balance|balance
1047178|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1047179|NCT02867644|conversational hypnosis|conversational hypnosis
1047180|NCT02867644|imaging|imaging
1047181|NCT02867644|care|care
1047182|NCT02867644|breast neoplasia|breast neoplasia
1047183|NCT02867644|anxiety|anxiety
1047184|NCT02867644|pain|pain
1047185|NCT02867631|Intervention study|intervention study
1047186|NCT02867631|Maternal obesity|maternal obesity
1047187|NCT02867631|Nutrition|nutrition
1047188|NCT02867631|Maternal child health|maternal child health
1047189|NCT02867514|tobacco|tobacco
1047190|NCT02867514|craving|craving
1047191|NCT02867514|tDCS|tdcs
1047192|NCT02867514|attentional tasks|attentional tasks
1047193|NCT02867501|venous distension|venous distension
1047194|NCT02867501|venous reflux|venous reflux
1047195|NCT02867488|carotenoids|carotenoids
1047196|NCT02867488|phylloquinone|phylloquinone
1047197|NCT02867488|tocopherols|tocopherols
1047198|NCT02867488|vitamin A|vitamin a
1047199|NCT02867384|Graft vs. Host Disease|graft vs. host disease
1047200|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
1047201|NCT02867319|safety|safety
1047202|NCT02867319|vaccine|vaccine
1047203|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
1047204|NCT02867306|Pharmacokinetics|pharmacokinetics
1047205|NCT02867306|ASP1707|asp1707
1047206|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1047207|NCT02867280|Sorafenib|sorafenib
1047208|NCT02867280|Microvascular invasion|microvascular invasion
1047209|NCT02867280|adjuvant therapy|adjuvant therapy
1047210|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
1047211|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
1047212|NCT02867254|candida|candida
1047213|NCT02867254|endodontic lesion|endodontic lesion
1047214|NCT02867254|diabetes|diabetes
1047215|NCT02867202|intrauterine balloon|intrauterine balloon
1047216|NCT02867202|intrauterine contraceptive device|intrauterine contraceptive device
1047217|NCT02867202|Asherman Syndrome|asherman syndrome
1047218|NCT02867189|anterior chamber flare|anterior chamber flare
1047219|NCT02867189|cataract|cataract
1047220|NCT02867189|intraocular pressure|intraocular pressure
1047221|NCT02867189|micro-instrument|micro-instrument
1047222|NCT02867189|photograph-based atlas|photograph-based atlas
1047223|NCT02867189|visual|visual
1047224|NCT02867189|training nurse|training nurse
1047225|NCT02867111|sperm selection|sperm selection
1047226|NCT02867111|ICSI|icsi
1047227|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
1047228|NCT02867098|healthy|healthy
1047229|NCT02867098|volunteer|volunteer
1047230|NCT02867085|MDS|mds
1047231|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
1047232|NCT02867033|desmoid tumour|desmoid tumour
1047233|NCT02867020|apalutamide|apalutamide
1047234|NCT02867020|abiraterone|abiraterone
1047235|NCT02867020|prostate cancer|prostate cancer
1047236|NCT02867007|KW-0761|kw-0761
1047237|NCT02867007|KHK2455|khk2455
1047238|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
1047239|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
1047240|NCT02867007|Mogamulizumab|mogamulizumab
1047241|NCT02867007|Oncology|oncology
1047242|NCT02867007|Anti-Tumor|anti-tumor
1047243|NCT02866994|Women|women
1047244|NCT02866981|Brain Metastases|brain metastases
1047245|NCT02866955|aromatase inhibitors|aromatase inhibitors
1047246|NCT02866955|Metastases|metastases
1047247|NCT02866929|orthodontics|orthodontics
1047248|NCT02866929|periodontics|periodontics
1047249|NCT02866929|piezosurgery|piezosurgery
1047250|NCT02866929|accelerated orthodontics|accelerated orthodontics
1047251|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
1047252|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
1047253|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
1047254|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
1047255|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
1047256|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
1047257|NCT02866890|seal pressure|seal pressure
1047258|NCT02866890|mechanical ventilation|mechanical ventilation
1047259|NCT02866877|augmented renal clearance|augmented renal clearance
1047260|NCT02866864|Allergen|allergen
1047261|NCT02866864|Veterinary|veterinary
1047262|NCT02866864|Allergy|allergy
1047263|NCT02866864|Animals|animals
1047264|NCT02866838|Tranexamic acid|tranexamic acid
1047265|NCT02866838|NOAC|noac
1047266|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
1047267|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
1047268|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
1047269|NCT02866825|Inflammation|inflammation
1047270|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1047271|NCT02866825|Pathologic Processes|pathologic processes
1047272|NCT02866825|Organ Dysfunction|organ dysfunction
1047273|NCT02866799|Multimorbidity|multimorbidity
1047274|NCT02866799|Primary Health Care|primary health care
1047275|NCT02866799|Polypharmacy|polypharmacy
1047276|NCT02866799|Comorbidity|comorbidity
1047277|NCT02866799|Medication Adherence|medication adherence
1047278|NCT02866799|Medication Appropriateness Index|medication appropriateness index
1047279|NCT02866799|Patient-Centered Care|patient-centered care
1047280|NCT02866773|Family|family
1047281|NCT02866773|well-being|well-being
1047282|NCT02866773|Physical activity|physical activity
1047283|NCT02866773|Diet|diet
1047284|NCT02866760|Smoking Cessation|smoking cessation
1047285|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
1047286|NCT02866734|Screening|screening
1047287|NCT02866734|Fee for screening|fee for screening
1047288|NCT02866734|Private practice|private practice
1047289|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
1047290|NCT02866695|Actinic Keratosis|actinic keratosis
1047291|NCT02866695|lung transplant|lung transplant
1047292|NCT02866695|kidney transplant|kidney transplant
1047293|NCT02866643|contraceptive implant|contraceptive implant
1047294|NCT02866643|postpartum contraception|postpartum contraception
1047295|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
1047296|NCT02866630|Sevoflurane|sevoflurane
1047297|NCT02866630|Desflurane|desflurane
1047298|NCT02866630|Coronary Sinus|coronary sinus
1047299|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
1047300|NCT02866630|Lactate|lactate
1047301|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
1047302|NCT02866617|Quality of Life|quality of life
1047303|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
1047304|NCT02866617|Orthodontic study model|orthodontic study model
1047305|NCT02866617|3D reconstructed study model|3d reconstructed study model
1047306|NCT02866604|Traumatic brain injury|traumatic brain injury
1047307|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
1047308|NCT02866591|mammography|mammography
1047309|NCT02866591|pain|pain
1047310|NCT02866591|quality of life|quality of life
1047311|NCT02866591|screening|screening
1047312|NCT02866591|image quality|image quality
1047313|NCT02866591|radiology|radiology
1047314|NCT02866526|adolescents|adolescents
1047315|NCT02866526|young adults|young adults
1047316|NCT02866448|Cardiovascular disease|cardiovascular disease
1047317|NCT02866448|Flavonoid|flavonoid
1047318|NCT02866448|Isoquercetin|isoquercetin
1047319|NCT02866448|Aspirin|aspirin
1047320|NCT02866448|Platelet function|platelet function
1047321|NCT02866448|Vascular function|vascular function
1047322|NCT02866448|Blood pressure|blood pressure
1047323|NCT02866435|MRI|mri
1047324|NCT02866422|OCD|ocd
1047325|NCT02866409|dexmedetomidine|dexmedetomidine
1047326|NCT02866409|nerve block|nerve block
1047327|NCT02866409|anesthesia infiltration|anesthesia infiltration
1047328|NCT02866396|chronic pain|chronic pain
1047329|NCT02866396|oxycodone|oxycodone
1047330|NCT02866396|pregabalin|pregabalin
1047331|NCT02866396|lumbar spine surgery|lumbar spine surgery
1047332|NCT02866396|multimodal analgesia|multimodal analgesia
1047333|NCT02866344|Microwave ablation|microwave ablation
1047334|NCT02866344|Ablation techniques|ablation techniques
1047335|NCT02866344|Operative surgical procedures|operative surgical procedures
1047336|NCT02866344|Hepatic resection|hepatic resection
1047337|NCT02866344|Surgery|surgery
1047338|NCT02866344|Outcomes assessment|outcomes assessment
1047339|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
1047340|NCT02866305|epidemiology|epidemiology
1047341|NCT02866305|genetics|genetics
1047342|NCT02866305|risk factors|risk factors
1047343|NCT02866292|Pelvic Floor|pelvic floor
1047344|NCT02866292|Pregnancy|pregnancy
1047345|NCT02866292|Physical Therapy Specialty|physical therapy specialty
1047346|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
1047545|NCT02865356|children|children
1047347|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
1047348|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
1047349|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
1047350|NCT02866227|Bacterial|bacterial
1047351|NCT02866227|Candidiasis|candidiasis
1047352|NCT02866227|Gel|gel
1047353|NCT02866227|Insert|insert
1047354|NCT02866227|TOL-463|tol-463
1047355|NCT02866227|Vaginal|vaginal
1047356|NCT02866227|Vaginitis|vaginitis
1047357|NCT02866227|Vaginoses|vaginoses
1047358|NCT02866227|Vulvovaginal|vulvovaginal
1047359|NCT02866201|Turista|turista
1047360|NCT02866175|percutaneous intervention|percutaneous intervention
1047361|NCT02866175|vitamin K antagonist|vitamin k antagonist
1047362|NCT02866149|Cancer|cancer
1047363|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
1047364|NCT02866149|circulating tumor DNA|circulating tumor dna
1047365|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
1047366|NCT02866097|integrated community case management|integrated community case management
1047367|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
1047368|NCT02866097|rapid diagnostic test|rapid diagnostic test
1047369|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
1047370|NCT02866097|amoxicillin|amoxicillin
1047371|NCT02866097|zinc|zinc
1047372|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
1047373|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
1047376|NCT02866084|vestibular migraines|vestibular migraines
1047377|NCT02866084|dizziness|dizziness
1047378|NCT02866084|migraine headache|migraine headache
1047379|NCT02866045|Subepithelial lesions|subepithelial lesions
1047380|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
1047381|NCT02866006|HPV|hpv
1047382|NCT02866006|Type 16, 18|type 16, 18
1047383|NCT02866006|E6E7|e6e7
1047384|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
1047385|NCT02865993|cesarean section|cesarean section
1047386|NCT02865993|cesarean section complications|cesarean section complications
1047387|NCT02865993|betadine irrigation|betadine irrigation
1047388|NCT02865980|inflammation, infection|inflammation, infection
1047389|NCT02865967|Decision Support Techniques|decision support techniques
1047390|NCT02865967|Delayed Diagnosis|delayed diagnosis
1047391|NCT02865967|Natural Language Processing|natural language processing
1047392|NCT02865967|Geographic Information Systems|geographic information systems
1047393|NCT02865941|Target Fortification|target fortification
1047394|NCT02865941|Breast milk analysis|breast milk analysis
1047395|NCT02865941|Nutrition|nutrition
1047396|NCT02865941|Macronutrient intake|macronutrient intake
1047397|NCT02865941|Protein accretion|protein accretion
1047398|NCT02865915|Acne|acne
1047399|NCT02865915|Hirsutism|hirsutism
1047400|NCT02865915|Menstrual Irregularity|menstrual irregularity
1047401|NCT02865915|Alopecia|alopecia
1047402|NCT02865902|Low level laser therapy|low level laser therapy
1047403|NCT02865902|wound healing|wound healing
1047404|NCT02865902|periodontology|periodontology
1047405|NCT02865889|laparoscopic surgery|laparoscopic surgery
1047406|NCT02865889|Uterine Neoplasms|uterine neoplasms
1047407|NCT02865876|Infectious keratitis|infectious keratitis
1047408|NCT02865876|Cross-linking|cross-linking
1047409|NCT02865863|Multivitamin|multivitamin
1047410|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
1047411|NCT02865863|Quality of Life|quality of life
1047412|NCT02865863|Mood|mood
1047413|NCT02865850|vadadustat|vadadustat
1047414|NCT02865850|AKB-6548|akb-6548
1047415|NCT02865850|anemia|anemia
1047416|NCT02865850|chronic kidney disease|chronic kidney disease
1047417|NCT02865850|CKD|ckd
1047418|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
1047419|NCT02865850|renal impairment|renal impairment
1047420|NCT02865850|erythropoietin|erythropoietin
1047421|NCT02865850|kidney|kidney
1047422|NCT02865850|renal|renal
1047423|NCT02865850|oral anemia treatment|oral anemia treatment
1047424|NCT02865850|hemoglobin|hemoglobin
1047425|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
1047426|NCT02865850|HIF|hif
1047427|NCT02865850|efficacy|efficacy
1047428|NCT02865850|safety|safety
1047429|NCT02865850|phase 3|phase 3
1047430|NCT02865850|cardiovascular|cardiovascular
1047431|NCT02865837|Brachytherapy|brachytherapy
1047432|NCT02865837|Organs at Risk|organs at risk
1047433|NCT02865837|Bladder volume|bladder volume
1047434|NCT02865837|Cervical cancer|cervical cancer
1047435|NCT02865824|Colonoscopy|colonoscopy
1047436|NCT02865811|Ovarian Cancer|ovarian cancer
1047437|NCT02865798|Heart Valve Diseases|heart valve diseases
1047438|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
1047439|NCT02865798|Heart Disease|heart disease
1047440|NCT02865798|Valvular Heart Diseases|valvular heart diseases
1047441|NCT02865785|recurrent implantation failure|recurrent implantation failure
1047442|NCT02865785|intralipid|intralipid
1047443|NCT02865785|uterine natural killer cells|uterine natural killer cells
1047444|NCT02865746|Steroids|steroids
1047445|NCT02865746|Pain measurement|pain measurement
1047446|NCT02865733|Remodulin®|remodulin®
1047546|NCT02865356|skin|skin
1047447|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
1047448|NCT02865733|univentricular physiology|univentricular physiology
1047449|NCT02865707|ulcerative colitis|ulcerative colitis
1047450|NCT02865707|prebiotics|prebiotics
1047451|NCT02865707|b-fructans|b-fructans
1047452|NCT02865707|inulin|inulin
1047453|NCT02865707|oligofructose|oligofructose
1047454|NCT02865707|intestinal microbiota|intestinal microbiota
1047455|NCT02865681|Infertility|infertility
1047456|NCT02865681|Gonadotropins|gonadotropins
1047457|NCT02865681|Menopur|menopur
1047458|NCT02865681|Ovarian stimulation|ovarian stimulation
1047459|NCT02865642|Stroke|stroke
1047460|NCT02865642|Serotonin|serotonin
1047461|NCT02865642|Hand Paresis|hand paresis
1047462|NCT02865616|CDI|cdi
1047463|NCT02865616|recurrent infection|recurrent infection
1047464|NCT02865616|MET-2|met-2
1047465|NCT02865616|C. difficile|c. difficile
1047466|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
1047467|NCT02865590|Bone Substitutes|bone substitutes
1047468|NCT02865590|Radiography, Panoramic|radiography, panoramic
1047469|NCT02865564|Probiotics|probiotics
1047470|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
1047471|NCT02865564|Infant, Newborn|infant, newborn
1047472|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
1047473|NCT02865564|Colic|colic
1047474|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
1047475|NCT02865564|Body Composition|body composition
1047476|NCT02865564|Bone Density|bone density
1048872|NCT02856945|knee|knee
1047477|NCT02865564|Randomized Controlled Trial|randomized controlled trial
1047478|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
1047479|NCT02865564|Pediatrics|pediatrics
1047480|NCT02865564|Feces|feces
1047481|NCT02865564|ultrasonography|ultrasonography
1047482|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1047483|NCT02865564|Electric Impedance|electric impedance
1047484|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
1047485|NCT02865538|Hot flashes|hot flashes
1047486|NCT02865538|Post-menopausal|post-menopausal
1047487|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
1047488|NCT02865525|Patient Education as Topic|patient education as topic
1047489|NCT02865525|Medication Adherence|medication adherence
1047490|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1047491|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1047492|NCT02865525|Heart failure|heart failure
1047493|NCT02865512|thoracic epidural injection|thoracic epidural injection
1047494|NCT02865512|patient position|patient position
1047495|NCT02865486|Gastric emptying|gastric emptying
1047496|NCT02865486|MRI|mri
1047497|NCT02865486|lipid emulsions|lipid emulsions
1047498|NCT02865486|breath test|breath test
1047499|NCT02865486|GI peptide hormones|gi peptide hormones
1047500|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
1047501|NCT02865473|PEX|pex
1047502|NCT02865460|Chronic Pain|chronic pain
1047503|NCT02865460|Cognitive Disorders|cognitive disorders
1047504|NCT02865460|Inflammation|inflammation
1047505|NCT02865460|Neurologic manifestations|neurologic manifestations
1047506|NCT02865460|Dementia|dementia
1047507|NCT02865460|Mental Disorders|mental disorders
1047508|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
1047509|NCT02865460|Pathologic Processes|pathologic processes
1047510|NCT02865460|Nervous System Diseases|nervous system diseases
1047511|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
1047512|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
1047513|NCT02865460|Pharmacologic Actions|pharmacologic actions
1047514|NCT02865460|Therapeutic Uses|therapeutic uses
1047515|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
1047516|NCT02865460|Gulf war illness|gulf war illness
1047517|NCT02865460|Chronic fatigue|chronic fatigue
1047518|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1047519|NCT02865447|DEXA|dexa
1047520|NCT02865447|DXA|dxa
1047521|NCT02865447|total hip arthroplasty|total hip arthroplasty
1047522|NCT02865447|PROFEMUR|profemur
1047523|NCT02865447|PRESERVE|preserve
1729964|NCT00006070|Etanercept|etanercept
1047524|NCT02865447|bone mineral density|bone mineral density
1047525|NCT02865447|BMD|bmd
1047526|NCT02865447|osteoarthritis|osteoarthritis
1047527|NCT02865447|THA|tha
1047528|NCT02865447|musculoskeletal disease|musculoskeletal disease
1047529|NCT02865408|Amino acids|amino acids
1047530|NCT02865408|critically-ill|critically-ill
1047531|NCT02865408|catabolic|catabolic
1047532|NCT02865408|nutrition|nutrition
1047533|NCT02865408|anabolic|anabolic
1047534|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
1047535|NCT02865382|Adenoma detection rate|adenoma detection rate
1047536|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
1047537|NCT02865382|Colonoscopy|colonoscopy
1047538|NCT02865369|chronic hepatitis C|chronic hepatitis c
1047539|NCT02865369|Daclatasvir|daclatasvir
1047540|NCT02865369|Asunaprevir|asunaprevir
1047541|NCT02865369|fibrosis|fibrosis
1047542|NCT02865369|transient elastography|transient elastography
1047543|NCT02865356|atopic dermatitis|atopic dermatitis
1047544|NCT02865356|eczema|eczema
1047548|NCT02865356|cyclosporine|cyclosporine
1047549|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
1047550|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
1047551|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
1047552|NCT02865330|Active Surveillance|active surveillance
1047553|NCT02865304|metastatic breast cancer|metastatic breast cancer
1047554|NCT02865304|HER-2-negative|her-2-negative
1047555|NCT02865304|endostar|endostar
1047556|NCT02865252|manual therapy|manual therapy
1047557|NCT02865252|mobilization with movement|mobilization with movement
1047558|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
1047559|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
1047560|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
1047561|NCT02865239|Prone Position|prone position
1047562|NCT02865239|Prospective Studies|prospective studies
1047563|NCT02865226|thoracic surgery|thoracic surgery
1047564|NCT02865226|thoracotomy|thoracotomy
1047565|NCT02865213|Open bite|open bite
1047566|NCT02865213|Molar intrusion|molar intrusion
1047567|NCT02865213|Temporary anchorage devices|temporary anchorage devices
1047568|NCT02865200|Nutrition|nutrition
1047569|NCT02865200|Public Health|public health
1047570|NCT02865187|Vitamin D|vitamin d
1047571|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
1047572|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
1047573|NCT02865187|PCOS|pcos
1047574|NCT02865187|sexual dysfunction|sexual dysfunction
1047575|NCT02865187|female sexual dysfunction|female sexual dysfunction
1047576|NCT02865187|low libido|low libido
1047577|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
1047578|NCT02865174|Floseal|floseal
1047579|NCT02865174|Tranexamic Acid|tranexamic acid
1047580|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
1047581|NCT02865135|HPV Related Head and Neck|hpv related head and neck
1047582|NCT02865135|Cervical|cervical
1047583|NCT02865135|Anal Cancer|anal cancer
1047584|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
1047585|NCT02865109|SMA|sma
1047586|NCT02865109|SMN|smn
1047587|NCT02865109|SMNRx|smnrx
1047588|NCT02865109|ISIS-SMNRx|isis-smnrx
1047589|NCT02865109|ISIS-SMN Rx|isis-smn rx
1047590|NCT02865109|ISIS 396443|isis 396443
1047591|NCT02865109|ISIS-396443|isis-396443
1047592|NCT02865109|ENDEAR|endear
1047593|NCT02865109|IONIS-SMNRx|ionis-smnrx
1047594|NCT02865109|IONIS-SMN Rx|ionis-smn rx
1047595|NCT02865109|EMBRACE|embrace
1047596|NCT02865109|NURTURE|nurture
1047597|NCT02865109|IONIS|ionis
1047598|NCT02865109|BIOGEN|biogen
1047599|NCT02865109|SHINE|shine
1047600|NCT02865109|Nusinersen|nusinersen
1047601|NCT02865070|premature|premature
1047602|NCT02865070|wireless vitals|wireless vitals
1047603|NCT02865070|vitals monitor|vitals monitor
1047604|NCT02865044|Fatty Acids|fatty acids
1047605|NCT02865044|Fish Oil|fish oil
1047606|NCT02865044|Marine Copepod|marine copepod
1047607|NCT02865044|Fatty Acid Absorption|fatty acid absorption
1047608|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
1047609|NCT02865018|Cetirizine|cetirizine
1047610|NCT02864992|lung|lung
1047611|NCT02864992|neoplasm|neoplasm
1047612|NCT02864992|cancer|cancer
1047613|NCT02864992|tumor|tumor
1047614|NCT02864992|adenocarcinoma|adenocarcinoma
1047615|NCT02864992|MET exon 14|met exon 14
1047616|NCT02864992|METex14|metex14
1047617|NCT02864992|pulmonary|pulmonary
1047618|NCT02864992|stage III|stage iii
1047619|NCT02864992|stage IV|stage iv
1047620|NCT02864992|c-Met|c-met
1047621|NCT02864992|cMET|cmet
1047622|NCT02864992|NSCLC|nsclc
1047623|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1047624|NCT02864966|Safety study|safety study
1047625|NCT02864966|new product|new product
1047626|NCT02864966|normal healthy skin.|normal healthy skin.
1047627|NCT02864953|Stroke|stroke
1047628|NCT02864953|Infarction|infarction
1729965|NCT00005937|MDS|mds
1082454|NCT02654431|ER/PR|er/pr
1047629|NCT02864953|Cerebrovascular Disorders|cerebrovascular disorders
1047630|NCT02864953|Brain Diseases|brain diseases
1047631|NCT02864953|Brain Edema Ischemia|brain edema ischemia
1047632|NCT02864953|Pathological Processes Necrosis|pathological processes necrosis
1047633|NCT02864953|Central Nervous System Diseases|central nervous system diseases
1047634|NCT02864953|Vascular Diseases|vascular diseases
1047635|NCT02864953|Cardiovascular Diseases|cardiovascular diseases
1047636|NCT02864953|Glyburide|glyburide
1047637|NCT02864953|Hypoglycemic Agents|hypoglycemic agents
1047638|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs
1047639|NCT02864940|Memory|memory
1047640|NCT02864940|aneurysm|aneurysm
1047641|NCT02864940|deficits|deficits
1047642|NCT02864940|trouble|trouble
1047643|NCT02864940|forgetful|forgetful
1047644|NCT02864940|ruptured|ruptured
1047645|NCT02864940|subarachnoid|subarachnoid
1047646|NCT02864940|hemorrhage|hemorrhage
1047647|NCT02864927|Meningitis|meningitis
1047648|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
1047649|NCT02864927|Meningococcal Infections|meningococcal infections
1047650|NCT02864927|Menactra®|menactra®
1048045|NCT02862418|Pulmonary|pulmonary
1047651|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
1047652|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
1047653|NCT02864888|QT/QTc interval|qt/qtc interval
1047654|NCT02864888|Radiation|radiation
1047655|NCT02864888|Antineoplaston therapy|antineoplaston therapy
1047656|NCT02864875|Fibrinogen|fibrinogen
1047657|NCT02864875|Tromboelastography|tromboelastography
1047658|NCT02864849|Rectal cancer|rectal cancer
1047659|NCT02864849|neoadjuvant|neoadjuvant
1047660|NCT02864849|radiotherapy|radiotherapy
1047661|NCT02864849|chemotherapy|chemotherapy
1047662|NCT02864849|toxicity|toxicity
1047663|NCT02864836|Copper|copper
1047664|NCT02864836|isotopic distribution|isotopic distribution
1047665|NCT02864836|cancer|cancer
1047666|NCT02864823|Scleromalacia perforans|scleromalacia perforans
1047667|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
1047668|NCT02864823|Perichondrium|perichondrium
1047669|NCT02864797|Health related quality of life|health related quality of life
1047670|NCT02864797|patient reported outcomes|patient reported outcomes
1047671|NCT02864797|cohort|cohort
1047672|NCT02864797|e-health|e-health
1047673|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
1047674|NCT02864771|ICD|icd
1047675|NCT02864771|Biological markers|biological markers
1047676|NCT02864745|early rehabilitation|early rehabilitation
1047677|NCT02864745|critically ill|critically ill
1047678|NCT02864745|muscle weakness|muscle weakness
1047679|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
1047777|NCT02864277|Length of hospital stay|length of hospital stay
1047680|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
1047681|NCT02864745|ICUAW|icuaw
1047682|NCT02864732|Low back pain|low back pain
1047683|NCT02864732|stabilization exercises|stabilization exercises
1047684|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1047685|NCT02864719|Heart arrest|heart arrest
1047686|NCT02864719|Cardiac arrest|cardiac arrest
1047687|NCT02864719|Fatigue|fatigue
1047688|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
1047689|NCT02864693|Transtibial Amputee|transtibial amputee
1047690|NCT02864693|Pacifica LP|pacifica lp
1047691|NCT02864693|Kinnex|kinnex
1047692|NCT02864680|cannabis|cannabis
1047693|NCT02864680|magnocellular pathway|magnocellular pathway
1047694|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
1047695|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
1047696|NCT02864654|Diabetic angiopathies|diabetic angiopathies
1047697|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
1047698|NCT02864654|Ischemic ulcers|ischemic ulcers
1047699|NCT02864654|Peripheral arterial disease|peripheral arterial disease
1047700|NCT02864654|Indirect revascularisation|indirect revascularisation
1047701|NCT02864654|Intramuscular injection|intramuscular injection
1047702|NCT02864654|Ankle-brachial index|ankle-brachial index
1047703|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
1047704|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
1047705|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
1047706|NCT02864654|Adipose tissue|adipose tissue
1047707|NCT02864654|Stem cells|stem cells
1047708|NCT02864641|chronic kidney disease|chronic kidney disease
1047709|NCT02864641|adolescents|adolescents
1047710|NCT02864641|renal disease|renal disease
1047711|NCT02864641|CKD|ckd
1047712|NCT02864628|RSV Vaccines|rsv vaccines
1047713|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
1047714|NCT02864615|renal cell carcinoma|renal cell carcinoma
1047715|NCT02864615|metastasis|metastasis
1047716|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
1047717|NCT02864615|targted therapy|targted therapy
1047718|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
1047719|NCT02864602|Regional anesthesia|regional anesthesia
1047720|NCT02864602|Adjuvant|adjuvant
1047721|NCT02864602|Dexamethasone|dexamethasone
1047722|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
1047723|NCT02864550|Men who have sex with men|men who have sex with men
1047724|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
1047725|NCT02864550|Doxycycline|doxycycline
1047726|NCT02864550|Tetracycline|tetracycline
1047727|NCT02864537|warfarin|warfarin
1047728|NCT02864537|self-management|self-management
1047729|NCT02864537|Conventional management|conventional management
1047730|NCT02864537|Training|training
1047731|NCT02864537|TTR|ttr
1047732|NCT02864537|Complications|complications
1047733|NCT02864537|Quality of life|quality of life
1047734|NCT02864524|Physical Therapy Modalities|physical therapy modalities
1047735|NCT02864524|Exercises|exercises
1047736|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
1047737|NCT02864485|Live donor liver transplantation|live donor liver transplantation
1047738|NCT02864459|Ultrasonography|ultrasonography
1047739|NCT02864459|Weaning|weaning
1047740|NCT02864433|cholera|cholera
1047741|NCT02864433|oral cholera vaccine|oral cholera vaccine
1047742|NCT02864433|diarrhea|diarrhea
1047743|NCT02864420|home hospital|home hospital
1047744|NCT02864420|acute care home|acute care home
1047745|NCT02864420|care redesign|care redesign
1048046|NCT02862405|Vision loss|vision loss
1047746|NCT02864420|delivery innovation|delivery innovation
1047747|NCT02864420|heart failure|heart failure
1047748|NCT02864420|pneumonia|pneumonia
1047749|NCT02864420|cellulitis|cellulitis
1047877|NCT02863575|third molar extraction|third molar extraction
1047750|NCT02864420|urinary tract infections|urinary tract infections
1047751|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1047752|NCT02864342|COPD|copd
1047753|NCT02864342|Respiratory|respiratory
1047754|NCT02864342|adherence|adherence
1047755|NCT02864342|medication reminders|medication reminders
1047756|NCT02864329|Male Infertility|male infertility
1047757|NCT02864329|micro RNAs|micro rnas
1047758|NCT02864329|small interfering RNAs|small interfering rnas
1047759|NCT02864329|miRNA|mirna
1047760|NCT02864329|siRNA|sirna
1047761|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
1047762|NCT02864316|Nivolumab|nivolumab
1047763|NCT02864316|Phase 2 study|phase 2 study
1047764|NCT02864303|Alzheimer's disease|alzheimer's disease
1047765|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
1047766|NCT02864303|Saliva|saliva
1047767|NCT02864303|Amyloid peptides|amyloid peptides
1047768|NCT02864303|Diagnosis|diagnosis
1047769|NCT02864290|Pharmacokinetics of AGS62P1|pharmacokinetics of ags62p1
1047770|NCT02864290|AGS62P1|ags62p1
1047771|NCT02864290|AML|aml
1047772|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
1047773|NCT02864277|Gynecology|gynecology
1047774|NCT02864277|Cancer|cancer
1047775|NCT02864277|General Surgery|general surgery
1047776|NCT02864277|Recovery Quality|recovery quality
1047778|NCT02864238|electronic milestone pathway|electronic milestone pathway
1047779|NCT02864238|cardiac valve surgery|cardiac valve surgery
1047781|NCT02864186|Quality of life|quality of life
1047782|NCT02864186|wound healing|wound healing
1047783|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1047784|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
1047785|NCT02864173|Postoperative delirium|postoperative delirium
1047786|NCT02864173|Cognitive outcome|cognitive outcome
1047787|NCT02864173|Neuropsychology|neuropsychology
1047788|NCT02864173|Genetics|genetics
1047789|NCT02864160|Language Concordance|language concordance
1047790|NCT02864160|Diabetes Self-Management|diabetes self-management
1047791|NCT02864160|Health Coaching|health coaching
1047792|NCT02864160|Latinos|latinos
1047793|NCT02864134|Optic neuritis|optic neuritis
1047794|NCT02864134|ganglion cell layer|ganglion cell layer
1047795|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
1047796|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
1047797|NCT02864121|biomarker of severity|biomarker of severity
1047798|NCT02864121|biomarker of evolution|biomarker of evolution
1047799|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1047800|NCT02864095|Epinephrine|epinephrine
1047801|NCT02864095|Tranexamic acid|tranexamic acid
1047802|NCT02864082|X-linked, lamellar|x-linked, lamellar
1047803|NCT02864043|Barrett's Esophagus|barrett's esophagus
1047804|NCT02864043|Barrett's|barrett's
1047805|NCT02864043|OCT|oct
1047806|NCT02864043|VLE|vle
1047807|NCT02864030|Eribulin mesylate|eribulin mesylate
1047808|NCT02864030|Halaven|halaven
1047809|NCT02864030|Polymorphisms|polymorphisms
1047810|NCT02864030|Tolerability|tolerability
1047811|NCT02864004|Parkinson disease|parkinson disease
1047812|NCT02864004|Quality of Life|quality of life
1047813|NCT02864004|Apomorphine infusion|apomorphine infusion
1047814|NCT02863978|Sepsis|sepsis
1047815|NCT02863978|Neonates|neonates
1047816|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
1047817|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
1047818|NCT02863926|BKA|bka
1047819|NCT02863926|amputation|amputation
1047820|NCT02863926|MarrowStim|marrowstim
1047821|NCT02863926|below knee amputation|below knee amputation
1047822|NCT02863926|wound complication|wound complication
1047823|NCT02863926|vascular disease|vascular disease
1047824|NCT02863926|critical limb ischemia|critical limb ischemia
1047825|NCT02863926|peripheral artery disease|peripheral artery disease
1047826|NCT02863926|AKA|aka
1047827|NCT02863926|stem cells|stem cells
1047828|NCT02863926|bone marrow|bone marrow
1047829|NCT02863887|Weight Loss|weight loss
1047830|NCT02863887|African American|african american
1047831|NCT02863887|Community Based|community based
1047832|NCT02863887|Mobile technology|mobile technology
1047833|NCT02863887|Translational science|translational science
1047834|NCT02863874|Perineal tear|perineal tear
1047835|NCT02863874|Labor|labor
1047836|NCT02863874|Triclosan|triclosan
1047837|NCT02863861|Sedation|sedation
1047838|NCT02863861|Pediatric Patients|pediatric patients
1047839|NCT02863822|Functional Dyspepsia|functional dyspepsia
1047840|NCT02863822|Low FODMAP|low fodmap
1047841|NCT02863822|Dietary Modification|dietary modification
1047842|NCT02863809|Keratolysis|keratolysis
1047843|NCT02863809|Corneal Melting|corneal melting
1047844|NCT02863809|Boston KPro|boston kpro
1047845|NCT02863809|Keratoprosthesis|keratoprosthesis
1047846|NCT02863770|endosonography|endosonography
1047847|NCT02863744|mmp-8|mmp-8
1047848|NCT02863744|early stages of wound healing|early stages of wound healing
1047849|NCT02863744|wound healing marker|wound healing marker
1047850|NCT02863731|postural changes|postural changes
1047851|NCT02863731|alternating postures|alternating postures
1047852|NCT02863731|Cognitive performance|cognitive performance
1047853|NCT02863731|Height-adjustable desk|height-adjustable desk
1047854|NCT02863731|Worksite|worksite
1047855|NCT02863718|CLL|cll
1047856|NCT02863692|CLL|cll
1047857|NCT02863692|B-PLL|b-pll
1047858|NCT02863692|T-PLL|t-pll
1047859|NCT02863692|SLL|sll
1047860|NCT02863692|T-NK-LGL|t-nk-lgl
1047861|NCT02863692|HCL|hcl
1047862|NCT02863692|Richter´s Transformation|richter´s transformation
1047863|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
1047864|NCT02863679|analgesia|analgesia
1047865|NCT02863679|intrauterine balloon|intrauterine balloon
1047866|NCT02863679|hysteroscope operation|hysteroscope operation
1047867|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
1047868|NCT02863653|social participation|social participation
1047869|NCT02863653|International Classification of Functioning|international classification of functioning
1047870|NCT02863640|Senile macular degeneration|senile macular degeneration
1047871|NCT02863640|Parkinson's disease|parkinson's disease
1047872|NCT02863627|Emergencies|emergencies
1047873|NCT02863627|newborn|newborn
1047874|NCT02863627|care|care
1047875|NCT02863601|Buprenorphine|buprenorphine
1047876|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
1047878|NCT02863575|ibuprofen|ibuprofen
1047879|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
1047880|NCT02863575|post-surgical dental pain|post-surgical dental pain
1047881|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
1047882|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
1047883|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
1047884|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
1047885|NCT02863510|Chronic kidney disease|chronic kidney disease
1047886|NCT02863471|Pancreas|pancreas
1047887|NCT02863471|Adenocarcinoma|adenocarcinoma
1047888|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1047889|NCT02863471|HIPEC|hipec
1047890|NCT02863471|Pancreatic surgery|pancreatic surgery
1047891|NCT02863471|Gemcitabine|gemcitabine
1047892|NCT02863458|MDS|mds
1047893|NCT02863458|AML|aml
1047894|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
1047895|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
1047896|NCT02863445|Obesity|obesity
1047897|NCT02863445|Body weight|body weight
1047898|NCT02863445|Emergency contraception|emergency contraception
1047899|NCT02863445|Levonogestrel|levonogestrel
1047900|NCT02863445|Ulipristal acetate|ulipristal acetate
1047901|NCT02863406|Dust rate|dust rate
1047902|NCT02863406|Microscopic analysis|microscopic analysis
1047903|NCT02863380|Individualized Medicine|individualized medicine
1047904|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1047905|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
1047906|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
1047907|NCT02863380|Functional Neuroimaging|functional neuroimaging
1047908|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
1047909|NCT02863263|foam dressing|foam dressing
1047910|NCT02863263|MedifoamⓇ|medifoamⓡ
1047911|NCT02863263|BetafoamⓇ|betafoamⓡ
1047912|NCT02863263|povidone iodine|povidone iodine
1047913|NCT02863237|brain injury|brain injury
1047914|NCT02863237|mechanical ventilation|mechanical ventilation
1047915|NCT02863237|weaning|weaning
1047916|NCT02863198|unexplained infertility|unexplained infertility
1047917|NCT02863198|endometrial injury|endometrial injury
1047918|NCT02863198|pregnancy|pregnancy
1047919|NCT02863185|chronic kidney disease|chronic kidney disease
1047920|NCT02863185|pitavastatin|pitavastatin
1047921|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
1047922|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
1047923|NCT02863172|Questionnaires|questionnaires
1047924|NCT02863172|Surveys|surveys
1047925|NCT02863172|Blood sample|blood sample
1047926|NCT02863172|Saliva sample|saliva sample
1047927|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
1047928|NCT02863146|alopecia|alopecia
1047929|NCT02863146|eribulin|eribulin
1047930|NCT02863120|Bupivacaine|bupivacaine
1047931|NCT02863120|Osteoarthritis|osteoarthritis
1047932|NCT02863120|Arthritis|arthritis
1047933|NCT02863120|Joint Diseases|joint diseases
1047934|NCT02863120|Ropivacaine|ropivacaine
1047935|NCT02863120|Anesthetics, Local|anesthetics, local
1047936|NCT02863120|Anesthetics|anesthetics
1047937|NCT02863107|Colon Cancer|colon cancer
1047938|NCT02863107|Rectal Cancer|rectal cancer
1047939|NCT02863107|Questionnaires|questionnaires
1047940|NCT02863107|Surveys|surveys
1047941|NCT02863107|Blood draw|blood draw
1047942|NCT02863094|schizophrenia|schizophrenia
1047943|NCT02863094|auditory hallucinations|auditory hallucinations
1047944|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
1047945|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
1047946|NCT02863068|Sickle cell disease|sickle cell disease
1047947|NCT02863068|sodium nitrite|sodium nitrite
1047948|NCT02863068|wound healing|wound healing
1047949|NCT02863068|Ulcer|ulcer
1047950|NCT02863055|MPM|mpm
1047951|NCT02863055|Unresectable|unresectable
1047952|NCT02863055|Phase II|phase ii
1047953|NCT02863055|Randomized|randomized
1047954|NCT02863055|Maintenance|maintenance
1047955|NCT02863029|Intestinal stem cells|intestinal stem cells
1047956|NCT02863016|dialysis|dialysis
1047957|NCT02863016|hemodiafiltration|hemodiafiltration
1047958|NCT02862990|Breast cancer|breast cancer
1047959|NCT02862990|Fertility|fertility
1047960|NCT02862964|back pain|back pain
1047961|NCT02862951|pregnancy|pregnancy
1047962|NCT02862925|fetal monitoring|fetal monitoring
1047963|NCT02862925|cesarean delivery|cesarean delivery
1047964|NCT02862925|obstetrics|obstetrics
1047965|NCT02862925|midwifery|midwifery
1047966|NCT02862925|developing countries|developing countries
1047967|NCT02862912|Chloroprocaine|chloroprocaine
1047968|NCT02862912|cervical cerclage|cervical cerclage
1047969|NCT02862912|spinal anesthesia|spinal anesthesia
1047970|NCT02862912|Bupivacaine|bupivacaine
1047971|NCT02862873|Spinal anaesthesia|spinal anaesthesia
1047972|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
1047973|NCT02862821|gambling addiction|gambling addiction
1047974|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
1047975|NCT02862808|Whole exome sequencing|whole exome sequencing
1047976|NCT02862808|Molecular diagnostic|molecular diagnostic
1047977|NCT02862808|Genetic counselling|genetic counselling
1047978|NCT02862795|colonoscopy|colonoscopy
1047979|NCT02862730|diabetes|diabetes
1047980|NCT02862730|closed-loop|closed-loop
1047981|NCT02862730|dual hormone|dual hormone
1047982|NCT02862730|exercise|exercise
1047983|NCT02862717|Cost effectiveness|cost effectiveness
1047984|NCT02862717|cost utility|cost utility
1047986|NCT02862717|hemodialysis|hemodialysis
1047987|NCT02862717|ICER|icer
1047988|NCT02862717|Markov model|markov model
1047989|NCT02862717|peritoneal dialysis|peritoneal dialysis
1047990|NCT02862691|toothache|toothache
1047991|NCT02862626|Diabetic children|diabetic children
1047992|NCT02862626|Mothers|mothers
1047993|NCT02862613|Precision Cells|precision cells
1047994|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
1047995|NCT02862613|Advanced Liver Cancer|advanced liver cancer
1047996|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1047997|NCT02862600|heart failure|heart failure
1047998|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1047999|NCT02862600|6 minute walk test|6 minute walk test
1048000|NCT02862600|perhexiline|perhexiline
1048378|NCT02860455|CO poisoning|co poisoning
1048001|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
1048002|NCT02862600|mixed ion channel effects|mixed ion channel effects
1048003|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
1048004|NCT02862600|calcium channel inhibition|calcium channel inhibition
1048005|NCT02862587|Precision Cells|precision cells
1048006|NCT02862587|Chemotherapy|chemotherapy
1048007|NCT02862587|Advanced Lung Cancer|advanced lung cancer
1048008|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
1048009|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
1048010|NCT02862574|TNF-IR|tnf-ir
1048011|NCT02862574|Methotrexate|methotrexate
1048012|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
1048013|NCT02862561|Chemotherapy|chemotherapy
1048014|NCT02862561|Advanced Malignancies|advanced malignancies
1048015|NCT02862522|uric acid|uric acid
1048016|NCT02862522|microvascular dysfunction|microvascular dysfunction
1048017|NCT02862522|inflammation|inflammation
1048018|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
1048019|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
1048020|NCT02862509|Vertex to floor position|vertex to floor position
1048021|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
1048022|NCT02862496|Bone Health|bone health
1048023|NCT02862496|Urine N-telopeptide|urine n-telopeptide
1048024|NCT02862496|Serum calcium|serum calcium
1048025|NCT02862496|Serum parathormone|serum parathormone
1048026|NCT02862496|Serum vit D|serum vit d
1048027|NCT02862470|Lovastatin|lovastatin
1048028|NCT02862470|Vildagliptin|vildagliptin
1048029|NCT02862470|Exosome|exosome
1048030|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
1048031|NCT02862470|Proteomics|proteomics
1048032|NCT02862470|Urine|urine
1048033|NCT02862470|Biological marker|biological marker
1048034|NCT02862457|Advanced Solid Tumors|advanced solid tumors
1048035|NCT02862457|PD-1|pd-1
1048036|NCT02862457|PD1|pd1
1048037|NCT02862457|Programmed Cell Death-1|programmed cell death-1
1048038|NCT02862457|Programmed Cell Death 1|programmed cell death 1
1048039|NCT02862457|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
1048040|NCT02862457|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
1048041|NCT02862457|PDL1|pdl1
1048042|NCT02862457|PDL2|pdl2
1048043|NCT02862418|MRI|mri
1048044|NCT02862418|UTE MRI|ute mri
1048047|NCT02862405|Object recognition|object recognition
1048048|NCT02862405|Space recognition|space recognition
1048049|NCT02862392|Scoliosis|scoliosis
1048050|NCT02862392|Adolescent|adolescent
1048051|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
1048052|NCT02862392|Predictive factors|predictive factors
1048053|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
1048054|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
1048055|NCT02862353|Validation new test|validation new test
1048056|NCT02862327|anaesthetic techniques|anaesthetic techniques
1048057|NCT02862327|regional anesthesia|regional anesthesia
1048058|NCT02862327|brachial plexus block|brachial plexus block
1048059|NCT02862327|Local Anesthetic|local anesthetic
1048060|NCT02862327|ropivacaine|ropivacaine
1048061|NCT02862327|analgesia|analgesia
1048062|NCT02862327|steroid|steroid
1048063|NCT02862327|dexamethasone|dexamethasone
1048064|NCT02862327|placebo|placebo
1048065|NCT02862327|adjuvant|adjuvant
1048066|NCT02862327|ultrasound guided|ultrasound guided
1048067|NCT02862314|Procalcitonin|procalcitonin
1048068|NCT02862301|Histone Deacetylases|histone deacetylases
1048069|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
1048070|NCT02862223|Coagulation|coagulation
1048071|NCT02862223|Circulatory Function|circulatory function
1048072|NCT02862223|Blood Pressure|blood pressure
1048073|NCT02862223|Inflammatory response|inflammatory response
1048074|NCT02862223|Blood Glucose|blood glucose
1048075|NCT02862223|Healthy vascular function|healthy vascular function
1048076|NCT02862210|Lithium|lithium
1048077|NCT02862210|Lithium Carbonate|lithium carbonate
1048078|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
1048079|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
1048080|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
1048081|NCT02862132|CD: Crohn's disease|cd: crohn's disease
1048082|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
1048083|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
1048084|NCT02862119|fractional flow reserve|fractional flow reserve
1048085|NCT02862119|all cause mortality|all cause mortality
1048086|NCT02862119|myocardial infarction|myocardial infarction
1048087|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
1048088|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
1048089|NCT02862106|HBeAg positive|hbeag positive
1048090|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
1048091|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
1048092|NCT02862067|SGLT2|sglt2
1048093|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
1048094|NCT02862067|systolic heart failure|systolic heart failure
1048095|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
1048096|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
1048097|NCT02862054|splenectomy|splenectomy
1048098|NCT02862054|unknown etiology|unknown etiology
1048099|NCT02862028|PD-1 antibody|pd-1 antibody
1048100|NCT02862028|CAR-T cells|car-t cells
1048101|NCT02862028|EGFR family|egfr family
1048102|NCT02862028|advanced solid tumor|advanced solid tumor
1048103|NCT02862002|opioid therapy|opioid therapy
1048104|NCT02862002|medical oncology.|medical oncology.
1048105|NCT02861989|osteoporosis|osteoporosis
1048106|NCT02861989|prevention|prevention
1048107|NCT02861989|care management|care management
1048108|NCT02861989|focus groups|focus groups
1048109|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
1048110|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
1083081|NCT02650570|Cancer|cancer
1048111|NCT02861950|hypospadias|hypospadias
1048112|NCT02861950|caudal|caudal
1048113|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
1048114|NCT02861950|penile nerve block|penile nerve block
1048115|NCT02861911|Muscle function|muscle function
1048116|NCT02861911|Oxidative stress|oxidative stress
1048117|NCT02861911|Quality of life|quality of life
1048118|NCT02861911|Physical activities|physical activities
1048119|NCT02861898|EGFR|egfr
1048120|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1048121|NCT02861898|EGFRvIII|egfrviii
1048122|NCT02861885|Colonoscopy|colonoscopy
1048123|NCT02861885|sessile serrated lesions|sessile serrated lesions
1048124|NCT02861885|chromoendoscopy|chromoendoscopy
1048125|NCT02861885|narrow band imaging|narrow band imaging
1048126|NCT02861885|Indigo Carmin®|indigo carmin®
1048127|NCT02861885|Pit pattern|pit pattern
1048128|NCT02861885|Kudo classification|kudo classification
1048129|NCT02861885|NICE classification|nice classification
1048130|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
1048131|NCT02861872|Ovarian|ovarian
1048132|NCT02861872|Ovarian cancer|ovarian cancer
1048133|NCT02861872|Chemotherapy|chemotherapy
1048134|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1048135|NCT02861872|pharmacokinetics|pharmacokinetics
1048136|NCT02861859|Breast cancer|breast cancer
1048137|NCT02861859|Breast Carcinoma|breast carcinoma
1048138|NCT02861859|Breast Tumors|breast tumors
1048139|NCT02861859|Chemotherapy|chemotherapy
1048140|NCT02861859|Antiemetic effects|antiemetic effects
1048141|NCT02861859|Antiemetic drugs|antiemetic drugs
1048142|NCT02861859|Drug Therapy|drug therapy
1048143|NCT02861846|epilepsy|epilepsy
1048144|NCT02861846|Alzheimer|alzheimer
1048145|NCT02861846|biomarkers|biomarkers
1048146|NCT02861846|predictive value|predictive value
1048147|NCT02861820|fMRI|fmri
1048148|NCT02861820|brain networks|brain networks
1048149|NCT02861820|biomarker|biomarker
1048150|NCT02861820|relapse|relapse
1048151|NCT02861820|stimulants|stimulants
1048152|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1048153|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
1048154|NCT02861794|Kinematics|kinematics
1048155|NCT02861794|RSA|rsa
1048156|NCT02861794|Knee arthroplasty|knee arthroplasty
1048157|NCT02861794|Implant stability|implant stability
1048158|NCT02861781|Bariatric surgery|bariatric surgery
1048159|NCT02861755|Depression|depression
1048160|NCT02861755|Depressive Disorder|depressive disorder
1048161|NCT02861755|Psychological Stress|psychological stress
1048162|NCT02861755|Behavioral Symptoms|behavioral symptoms
1048163|NCT02861755|Mental Disorders|mental disorders
1048164|NCT02861755|Mood Disorders|mood disorders
1048165|NCT02861729|Partial coverage restoration|partial coverage restoration
1048166|NCT02861729|Crown|crown
1048167|NCT02861729|Posterior teeth|posterior teeth
1048168|NCT02861729|All ceramic|all ceramic
1048169|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
1048170|NCT02861729|Lithium disilicate|lithium disilicate
1048171|NCT02861729|CAD/CAM|cad/cam
1048172|NCT02861690|Esophageal Cancer|esophageal cancer
1048173|NCT02861690|nedaplatin|nedaplatin
1048174|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
1048175|NCT02861638|Total hip replacement|total hip replacement
1048176|NCT02861638|Action observation treatment|action observation treatment
1048177|NCT02861638|Rehabilitation|rehabilitation
1048178|NCT02861638|Arthroplasty|arthroplasty
1048179|NCT02861612|peripheral nerves|peripheral nerves
1048180|NCT02861612|quadriplegia|quadriplegia
1048181|NCT02861612|nerve transfer|nerve transfer
1048182|NCT02861612|surgical procedures, operative|surgical procedures, operative
1048183|NCT02861612|hand|hand
1048184|NCT02861612|upper extremity|upper extremity
1048185|NCT02861612|quality of life|quality of life
1048186|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
1048187|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1048188|NCT02861573|mCRPC|mcrpc
1048189|NCT02861573|PD1|pd1
1048190|NCT02861573|PD-1|pd-1
1048191|NCT02861573|PDL1|pdl1
1048192|NCT02861573|PD-L1|pd-l1
1048193|NCT02861508|Ultrasonography|ultrasonography
1048194|NCT02861495|upper extremity fracture|upper extremity fracture
1048195|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
1048196|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
1048197|NCT02861456|Adolescent|adolescent
1048198|NCT02861456|Low Back Pain|low back pain
1048199|NCT02861456|Athlete|athlete
1048200|NCT02861430|colon cancer|colon cancer
1048201|NCT02861430|sentinel node|sentinel node
1048202|NCT02861417|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
1048203|NCT02861417|Acute myeloid leukemia|acute myeloid leukemia
1048204|NCT02861417|AML|aml
1048205|NCT02861417|Acute lymphocytic leukemia|acute lymphocytic leukemia
1048206|NCT02861417|ALL|all
1048207|NCT02861417|Chronic myeloid leukemia|chronic myeloid leukemia
1048208|NCT02861417|CML|cml
1048209|NCT02861417|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1048210|NCT02861417|CLL|cll
1048211|NCT02861417|Myelodysplastic syndrome|myelodysplastic syndrome
1048212|NCT02861417|MDS|mds
1048213|NCT02861417|Myeloproliferative syndrome|myeloproliferative syndrome
1048214|NCT02861417|Non-Hodgkins lymphoma|non-hodgkins lymphoma
1048215|NCT02861417|NHL|nhl
1048216|NCT02861417|Hodgkins lymphoma|hodgkins lymphoma
1048217|NCT02861417|HL|hl
1048218|NCT02861417|Multiple myeloma|multiple myeloma
1048219|NCT02861417|MM|mm
1048220|NCT02861417|Stem cell infusion|stem cell infusion
1048221|NCT02861417|Stem cell transplant|stem cell transplant
1048222|NCT02861417|Haploidentical donor|haploidentical donor
1048223|NCT02861417|Matched donor|matched donor
1048224|NCT02861417|Thiotepa|thiotepa
1048225|NCT02861417|Mycophenolate Mofetil|mycophenolate mofetil
1048226|NCT02861417|MMF|mmf
1048227|NCT02861417|CellCept|cellcept
1048228|NCT02861417|Busulfan|busulfan
1048229|NCT02861417|Busulfex|busulfex
1048230|NCT02861417|Myleran|myleran
1048231|NCT02861417|Fludarabine|fludarabine
1048232|NCT02861417|Fludarabine phosphate|fludarabine phosphate
1048233|NCT02861417|Fludara|fludara
1048234|NCT02861417|Mesna|mesna
1048235|NCT02861417|Mesnex|mesnex
1048236|NCT02861417|Cyclophosphamide|cyclophosphamide
1048237|NCT02861417|Cytoxan|cytoxan
1048238|NCT02861417|Neosar|neosar
1048239|NCT02861417|Tacrolimus|tacrolimus
1048240|NCT02861417|Prograf|prograf
1048241|NCT02861417|G-CSF|g-csf
1048242|NCT02861417|Filgrastim|filgrastim
1048243|NCT02861417|Neupogen|neupogen
1048244|NCT02861404|HPV|hpv
1048245|NCT02861378|anaesthesia, dental|anaesthesia, dental
1048246|NCT02861378|lidocaine|lidocaine
1048248|NCT02861352|DNA Integrity|dna integrity
1048249|NCT02861352|Gene Expression|gene expression
1048250|NCT02861352|diet zinc|diet zinc
1048251|NCT02861352|nutrition requirements|nutrition requirements
1048252|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
1048253|NCT02861300|CB-839|cb-839
1048254|NCT02861300|PIK3CA|pik3ca
1048255|NCT02861300|capecitabine|capecitabine
1048256|NCT02861248|Burn Scar|burn scar
1048257|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
1048258|NCT02861183|sodium hyaluronate|sodium hyaluronate
1048259|NCT02861183|OVT|ovt
1048260|NCT02861183|hyaluronic acid|hyaluronic acid
1048261|NCT02861170|Mindfulness|mindfulness
1048262|NCT02861170|Chronic Pain|chronic pain
1048263|NCT02861170|Chronic Hip Pain|chronic hip pain
1048264|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
1048265|NCT02861170|Disability|disability
1048266|NCT02861170|Quality of Life|quality of life
1048267|NCT02861157|Type 1 Diabetes|type 1 diabetes
1048268|NCT02861157|Adolescents|adolescents
1048269|NCT02861157|T1D|t1d
1048270|NCT02861131|Sugammadex|sugammadex
1048271|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
1048272|NCT02861118|Drug Therapy|drug therapy
1048273|NCT02861092|Serious adverse event|serious adverse event
1048274|NCT02861092|bone and joint infection|bone and joint infection
1048276|NCT02861092|dose adjustment|dose adjustment
1048277|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
1048278|NCT02861066|Wellbeing|wellbeing
1048279|NCT02861066|Treatment|treatment
1048280|NCT02861027|Osteoarthritis|osteoarthritis
1048281|NCT02861027|Total hip arthroplasty|total hip arthroplasty
1048282|NCT02861027|Physiotherapy|physiotherapy
1048283|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
1048284|NCT02861001|tracheotomy|tracheotomy
1048285|NCT02861001|bronchoscopy|bronchoscopy
1048286|NCT02861001|critical care|critical care
1048287|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
1048288|NCT02860975|Safety|safety
1048289|NCT02860975|Mitochondrial function|mitochondrial function
1048290|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
1048291|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
1048292|NCT02860949|Multimodal anesthesia|multimodal anesthesia
1048293|NCT02860949|Knee arthroplasty|knee arthroplasty
1048294|NCT02860949|Pain control|pain control
1048295|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
1048296|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
1048297|NCT02860923|exenatide|exenatide
1048298|NCT02860923|placebo|placebo
1048299|NCT02860923|multicenter trial|multicenter trial
1048300|NCT02860910|hot flashes|hot flashes
1048301|NCT02860910|postmenopause|postmenopause
1048302|NCT02860910|perimenopause|perimenopause
1048303|NCT02860832|Cyberbullying|cyberbullying
1048304|NCT02860832|Traditional bullying|traditional bullying
1048305|NCT02860832|Depression|depression
1048306|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
1048307|NCT02860819|PARP inhibition|parp inhibition
1048308|NCT02860819|Chemotherapy|chemotherapy
1048309|NCT02860819|Gemcitabine|gemcitabine
1048310|NCT02860819|Carboplatin|carboplatin
1048311|NCT02860793|PTK7|ptk7
1048312|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
1730149|NCT00005910|Laparoscopy|laparoscopy
1048313|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
1048314|NCT02860767|Antibiotic dosing|antibiotic dosing
1048315|NCT02860767|Reimplantation|reimplantation
1048316|NCT02860767|Knee-prothesis|knee-prothesis
1048317|NCT02860767|Hip-prothesis|hip-prothesis
1048318|NCT02860741|Sub-Clinical Depression|sub-clinical depression
1048320|NCT02860728|Resistance Training|resistance training
1048321|NCT02860728|Exercise Training|exercise training
1048322|NCT02860728|Dyspnea|dyspnea
1048323|NCT02860715|Safety|safety
1048324|NCT02860715|Pharmacodynamics|pharmacodynamics
1048325|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
1048326|NCT02860715|Immunogenicity|immunogenicity
1048327|NCT02860715|Pharmacokinetics|pharmacokinetics
1048328|NCT02860702|Single Ventricle|single ventricle
1048329|NCT02860702|Congenital Heart Defect|congenital heart defect
1048330|NCT02860689|Sexuality|sexuality
1048331|NCT02860689|Spinal cord injuries|spinal cord injuries
1048332|NCT02860689|Penile erection|penile erection
1048333|NCT02860689|erectile dysfunction|erectile dysfunction
1048334|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
1048335|NCT02860676|CLL|cll
1048336|NCT02860676|cancer|cancer
1048337|NCT02860676|UC-961|uc-961
1048338|NCT02860676|cirmtuzumab|cirmtuzumab
1048339|NCT02860637|Sexuality|sexuality
1048340|NCT02860637|Spinal cord injuries|spinal cord injuries
1048341|NCT02860637|Penile erection|penile erection
1048342|NCT02860637|erectile dysfunction|erectile dysfunction
1048343|NCT02860624|GERD|gerd
1048344|NCT02860611|Type 1 diabetes|type 1 diabetes
1048345|NCT02860611|Type 2 diabetes|type 2 diabetes
1048346|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
1048347|NCT02860598|ESAs|esas
1048348|NCT02860598|erythropoietin|erythropoietin
1048349|NCT02860598|AML|aml
1048351|NCT02860585|Metastatic breast cancer|metastatic breast cancer
1048352|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
1048353|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
1048354|NCT02860572|fluid therapy|fluid therapy
1048355|NCT02860572|oliguria|oliguria
1048356|NCT02860572|endothelial injury|endothelial injury
1048357|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1048358|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
1048359|NCT02860546|Refractory|refractory
1048360|NCT02860546|Metastatic|metastatic
1048361|NCT02860546|Colorectal cancer|colorectal cancer
1048362|NCT02860546|TAS-102|tas-102
1048363|NCT02860546|Nivolumab|nivolumab
1048364|NCT02860546|Microsatellite Stable|microsatellite stable
1048365|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
1048366|NCT02860533|Blood pressure|blood pressure
1048367|NCT02860533|smartphone App|smartphone app
1048368|NCT02860533|Hypertension|hypertension
1048369|NCT02860533|Stress testing|stress testing
1048370|NCT02860533|Prevention|prevention
1048371|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
1048372|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
1048373|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
1048374|NCT02860494|topical everolimus|topical everolimus
1048375|NCT02860494|seamless design|seamless design
1048376|NCT02860494|dose-escalation study|dose-escalation study
1048377|NCT02860494|m-TOR inhibitor|m-tor inhibitor
1048379|NCT02860455|CO-oximetry|co-oximetry
1048380|NCT02860455|Pulse oximetry|pulse oximetry
1048381|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
1048382|NCT02860455|Emergency Department|emergency department
1048383|NCT02860455|Sensitivity|sensitivity
1048384|NCT02860455|Specificity|specificity
1048385|NCT02860442|Alcohol misuse|alcohol misuse
1048386|NCT02860442|Smartphone app|smartphone app
1048387|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
1048388|NCT02860416|Neurology|neurology
1048389|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
1048390|NCT02860403|Motor imagery|motor imagery
1048391|NCT02860403|Magnetoencephalography|magnetoencephalography
1048392|NCT02860377|emergence agitation|emergence agitation
1048393|NCT02860377|emergence time|emergence time
1048394|NCT02860377|pediatric|pediatric
1048395|NCT02860351|subclavian vein|subclavian vein
1048396|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
1048397|NCT02860299|patients|patients
1048398|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
1048400|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
1048401|NCT02860273|HFNC|hfnc
1048402|NCT02860273|Aerobic capacity|aerobic capacity
1048403|NCT02860260|BDNF|bdnf
1048404|NCT02860247|antibiotic|antibiotic
1048405|NCT02860247|MALDI-TOF MS|maldi-tof ms
1048406|NCT02860247|susceptibility testing|susceptibility testing
1048407|NCT02860234|Rectal cancer|rectal cancer
1048408|NCT02860234|neoadjuvant|neoadjuvant
1048409|NCT02860234|radiotherapy|radiotherapy
1048410|NCT02860234|chemotherapy|chemotherapy
1048411|NCT02860234|organ preservation|organ preservation
1048412|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1048413|NCT02860221|Epinephrine|epinephrine
1048414|NCT02860221|Tranexamic acid|tranexamic acid
1048415|NCT02860208|Peri-Implantitis|peri-implantitis
1048416|NCT02860208|Surgical therapy|surgical therapy
1048417|NCT02860208|Follow-up|follow-up
1048418|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
1048419|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
1048420|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
1048421|NCT02860130|Acute Kidney Injury|acute kidney injury
1048422|NCT02860117|ketamine|ketamine
1048423|NCT02860117|continuous infusion|continuous infusion
1048424|NCT02860117|severe burned patients|severe burned patients
1048425|NCT02860104|microwave ablation|microwave ablation
1048426|NCT02860104|breast|breast
1048427|NCT02860104|multicenter|multicenter
1048428|NCT02860091|ropivacaine infusion|ropivacaine infusion
1048429|NCT02860091|regional anesthesia|regional anesthesia
1048430|NCT02860091|paravertebral block|paravertebral block
1048431|NCT02860078|pain|pain
1048432|NCT02860078|epidural|epidural
1048433|NCT02860078|ultrasound|ultrasound
1048434|NCT02860013|Telemedicine|telemedicine
1048435|NCT02860013|Effectiveness|effectiveness
1048436|NCT02860013|Cost-effectiveness|cost-effectiveness
1048437|NCT02859987|US|us
1048438|NCT02859987|Nursing Services|nursing services
1048439|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
1048440|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
1048441|NCT02859974|Respiratory retraining|respiratory retraining
1048442|NCT02859974|Respiratory disorders|respiratory disorders
1048443|NCT02859948|AML|aml
1048444|NCT02859935|HIV|hiv
1048445|NCT02859935|drug abuse|drug abuse
1048446|NCT02859935|MSM|msm
1048447|NCT02859935|Risk behavior|risk behavior
1048448|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
1049374|NCT02854007|Angioplasty|angioplasty
1048449|NCT02859935|Sexually transmitted infections|sexually transmitted infections
1048450|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
1048451|NCT02859857|Glioblastoma Multiforme|glioblastoma multiforme
1048452|NCT02859857|Solid Tumors|solid tumors
1048453|NCT02859857|Ependymoma|ependymoma
1048454|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
1048455|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
1048456|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
1048457|NCT02859662|ruptured aneurysm|ruptured aneurysm
1048458|NCT02859649|working memory|working memory
1048459|NCT02859649|short term memory|short term memory
1048460|NCT02859649|gesture|gesture
1048461|NCT02859584|Acute hepatitis|acute hepatitis
1048462|NCT02859584|acute liver failure|acute liver failure
1048463|NCT02859584|adrenal dysfunction|adrenal dysfunction
1048464|NCT02859584|salivary cortisol|salivary cortisol
1048465|NCT02859584|serum free cortisol|serum free cortisol
1048466|NCT02859545|chronic pain|chronic pain
1048467|NCT02859545|pain|pain
1048468|NCT02859545|validation|validation
1048469|NCT02859545|couples|couples
1048470|NCT02859545|romantic relationships|romantic relationships
1048471|NCT02859545|emotional validation|emotional validation
1048477|NCT02859480|Drug-Eluting Stents|drug-eluting stents
1048478|NCT02859480|Patient Outcome Assessment|patient outcome assessment
1048479|NCT02859480|Biomarkers|biomarkers
1048480|NCT02859480|Hyperlipidemias|hyperlipidemias
1048481|NCT02859480|Dyslipidemias|dyslipidemias
1048482|NCT02859480|Atherosclerosis|atherosclerosis
1048483|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1048484|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
1048485|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
1048486|NCT02859480|Lipid Regulating Agents|lipid regulating agents
1048487|NCT02859467|Physical Therapy Modalities|physical therapy modalities
1048488|NCT02859467|Exercise|exercise
1048489|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
1048490|NCT02859467|Bandages|bandages
1048491|NCT02859454|PD-L1 Expression|pd-l1 expression
1048492|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1048493|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
1048494|NCT02859454|Papillomatous Lesions|papillomatous lesions
1048495|NCT02859454|Monoclonal Antibody|monoclonal antibody
1048496|NCT02859441|Intravitreal Injection|intravitreal injection
1048497|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
1048498|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
1048499|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
1048500|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1048502|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
1048503|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
1048504|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
1048505|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
1048506|NCT02859402|Relapsed, refractory|relapsed, refractory
1048507|NCT02859402|Conditioning|conditioning
1048508|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1048509|NCT02859389|Leukemia|leukemia
1048510|NCT02859389|Down Syndrome|down syndrome
1048511|NCT02859389|Neurocognitive|neurocognitive
1048512|NCT02859389|Survivorship|survivorship
1048513|NCT02859389|Attention|attention
1048514|NCT02859389|Executive function|executive function
1048515|NCT02859389|Late effects|late effects
1048516|NCT02859376|Preterm infants|preterm infants
1048517|NCT02859376|Pain|pain
1048518|NCT02859376|Sucrose|sucrose
1048526|NCT02859337|obesity|obesity
1048527|NCT02859337|body weight|body weight
1048528|NCT02859337|BMI|bmi
1048529|NCT02859337|emergency contraception|emergency contraception
1048530|NCT02859337|levonorgestrel|levonorgestrel
1048531|NCT02859337|ulipristal acetate|ulipristal acetate
1048532|NCT02859324|CC-122|cc-122
1048533|NCT02859324|Nivolumab|nivolumab
1048534|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
1048535|NCT02859324|Phase 1/2|phase 1/2
1048536|NCT02859324|Safety|safety
1048537|NCT02859311|Recovery|recovery
1048538|NCT02859298|Premature Delivery|premature delivery
1048539|NCT02859298|Polarimetric Imaging|polarimetric imaging
1048540|NCT02859298|Polarimetric colposcope|polarimetric colposcope
1048541|NCT02859298|Diagnostic tool|diagnostic tool
1048542|NCT02859285|Arousal|arousal
1048543|NCT02859285|Orgasm|orgasm
1048544|NCT02859285|Clitoral|clitoral
1048545|NCT02859285|Estradiol|estradiol
1048546|NCT02859285|Post Menopausal|post menopausal
1048547|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
1048548|NCT02859233|Spinal Puncture|spinal puncture
1048549|NCT02859233|Dural puncture|dural puncture
1048550|NCT02859233|Nursing|nursing
1048551|NCT02859220|hemodialysis|hemodialysis
1048552|NCT02859220|PTH|pth
1048553|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
1048554|NCT02859207|E2609|e2609
1048555|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
1048556|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
1048557|NCT02859168|Neck|neck
1048558|NCT02859168|Shoulder|shoulder
1048559|NCT02859168|Manual Therapies|manual therapies
1048560|NCT02859142|Varenicline|varenicline
1048561|NCT02859129|Epanova|epanova
1048562|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
1048563|NCT02859129|Vascepa|vascepa
1048564|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
1048565|NCT02859129|Crestor|crestor
1048566|NCT02859129|rosuvastatin|rosuvastatin
1048567|NCT02859116|Metabolic diseases|metabolic diseases
1048568|NCT02859077|NSCLC|nsclc
1048569|NCT02859077|BIM|bim
1048570|NCT02859077|EGFR mutation|egfr mutation
1048571|NCT02859064|radioembolization|radioembolization
1048572|NCT02859064|somatostatin analogs|somatostatin analogs
1048573|NCT02859064|carcinoid|carcinoid
1048574|NCT02859064|neuroendocrine|neuroendocrine
1048575|NCT02859064|liver-directed therapy|liver-directed therapy
1048576|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
1048577|NCT02859025|Alveolar cleft|alveolar cleft
1048578|NCT02859025|Osteoplasty|osteoplasty
1048579|NCT02859025|Tissue engineering|tissue engineering
1048580|NCT02859025|Stem cells|stem cells
1048581|NCT02859025|Regenerative medicine|regenerative medicine
1048582|NCT02859025|Bone|bone
1048583|NCT02859025|Lateral ramus|lateral ramus
1048584|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
1048585|NCT02858999|treatment|treatment
1048586|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
1048587|NCT02858960|COPD|copd
1048588|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
1048589|NCT02858960|HFNC|hfnc
1048590|NCT02858960|Oxygen|oxygen
1048591|NCT02858947|composite resin|composite resin
1048592|NCT02858947|bulk-fill|bulk-fill
1048593|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
1048594|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
1048595|NCT02858934|Radiotherapy|radiotherapy
1048596|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
1048597|NCT02858921|Pembrolizumab|pembrolizumab
1048598|NCT02858921|Dabrafenib|dabrafenib
1048599|NCT02858921|Trametinib|trametinib
1048600|NCT02858921|Pathological response|pathological response
1048601|NCT02858921|RECIST|recist
1048602|NCT02858921|Immune response|immune response
1048603|NCT02858921|BRAF|braf
1048604|NCT02858921|Randomised|randomised
1048605|NCT02858921|Stage IIIB/C|stage iiib/c
1048606|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
1048607|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
1048608|NCT02858921|Metabolic Response|metabolic response
1048609|NCT02858895|High grade glioma|high grade glioma
1048610|NCT02858895|malignant glioma|malignant glioma
1048611|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
1048612|NCT02858895|recurrent GBM|recurrent gbm
1048613|NCT02858895|recurrent GB|recurrent gb
1048614|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
1048615|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1048616|NCT02858895|progressive glioblastoma|progressive glioblastoma
1048617|NCT02858895|Brain tumor|brain tumor
1048618|NCT02858895|Brain cancer|brain cancer
1048619|NCT02858895|immunotherapy|immunotherapy
1048620|NCT02858895|targeted|targeted
1048621|NCT02858895|IL4R|il4r
1048622|NCT02858843|genetics|genetics
1048623|NCT02858830|FPL|fpl
1048624|NCT02858830|adipose tissue|adipose tissue
1048625|NCT02858830|diabetes|diabetes
1048626|NCT02858830|dyslipidemia|dyslipidemia
1048627|NCT02858830|metabolic|metabolic
1048628|NCT02858830|hyperinsulinemia|hyperinsulinemia
1048629|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
1048631|NCT02858804|DHAP|dhap
1048632|NCT02858804|maintenance therapy|maintenance therapy
1048633|NCT02858778|Palliative Care|palliative care
1048634|NCT02858778|Emergency Department|emergency department
1048635|NCT02858752|Attention|attention
1048636|NCT02858752|Short-term memory|short-term memory
1048637|NCT02858752|Aural Memory|aural memory
1048638|NCT02858752|Visual Memory|visual memory
1048639|NCT02858752|Child|child
1048640|NCT02858752|EEG|eeg
1048641|NCT02858726|Hemodialysis|hemodialysis
1048642|NCT02858726|CR845|cr845
1048643|NCT02858726|Kappa opioid|kappa opioid
1048644|NCT02858726|Anti-itch|anti-itch
1048645|NCT02858713|psoriasis|psoriasis
1048646|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
1048647|NCT02858700|procalcitonin|procalcitonin
1048648|NCT02858635|Suicidal behaviour|suicidal behaviour
1048649|NCT02858635|Impulsivity|impulsivity
1048650|NCT02858635|Genetics|genetics
1048651|NCT02858635|Serotonin|serotonin
1048652|NCT02858622|pediatric|pediatric
1048653|NCT02858622|renal transplant|renal transplant
1048654|NCT02858622|pain|pain
1048655|NCT02858622|dual TAB|dual tab
1048656|NCT02858583|Chest Compression|chest compression
1048657|NCT02858583|Newborn|newborn
1048658|NCT02858583|Infant|infant
1048659|NCT02858583|Sustained Inflation|sustained inflation
1048660|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
1048759|NCT02857985|rotational angiography|rotational angiography
1048661|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
1048662|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
1048663|NCT02858518|anticoagulant|anticoagulant
1048664|NCT02858492|efficacy|efficacy
1048665|NCT02858492|safety|safety
1048666|NCT02858492|pharmacokinetics|pharmacokinetics
1048667|NCT02858492|pharmacodynamics|pharmacodynamics
1048668|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
1048669|NCT02858492|autoimmune|autoimmune
1048670|NCT02858453|Interstitial cystitis|interstitial cystitis
1048671|NCT02858453|Bladder pain syndrome|bladder pain syndrome
1048672|NCT02858453|Painful bladder syndrome|painful bladder syndrome
1048771|NCT02857881|de-epithelization|de-epithelization
1048673|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
1048674|NCT02858453|AQX-1125|aqx-1125
1048675|NCT02858453|SHIP1|ship1
1048676|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
1048677|NCT02858440|Primary dose|primary dose
1048678|NCT02858440|Reactogenicity|reactogenicity
1048679|NCT02858440|Immunogenicity|immunogenicity
1048680|NCT02858440|Booster dose|booster dose
1048681|NCT02858440|Combined vaccine|combined vaccine
1048682|NCT02858440|Russian Infants|russian infants
1048683|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
1048684|NCT02858427|cognitive inhibition|cognitive inhibition
1048685|NCT02858427|elderly|elderly
1048686|NCT02858427|suicide attempt|suicide attempt
1048687|NCT02858427|depression|depression
1048688|NCT02858388|Otitis Media with Effusion|otitis media with effusion
1048689|NCT02858388|Exudative otitis media|exudative otitis media
1048690|NCT02858375|quality of life|quality of life
1048691|NCT02858375|botulinum toxin|botulinum toxin
1048692|NCT02858375|provoked vulvodynia|provoked vulvodynia
1048693|NCT02858362|DMD|dmd
1048694|NCT02858362|Muscular Dystrophy|muscular dystrophy
1048695|NCT02858362|Utrophin|utrophin
1048696|NCT02858362|Duchenne|duchenne
1048697|NCT02858362|PhaseOut DMD|phaseout dmd
1048698|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
1048699|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
1048700|NCT02858336|Energy Deficiency|energy deficiency
1048701|NCT02858336|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
1048702|NCT02858336|Leptin|leptin
1048703|NCT02858323|Alloimmunization|alloimmunization
1048704|NCT02858323|Refractoriness|refractoriness
1048705|NCT02858323|Corrected Count Increment|corrected count increment
1048706|NCT02858323|HLA-Compatible|hla-compatible
1048707|NCT02858310|Vulvar High Grade Squamous Intraepithelial Lesion|vulvar high grade squamous intraepithelial lesion
1048708|NCT02858310|Vulvar Intraepithelial Neoplasia|vulvar intraepithelial neoplasia
1048709|NCT02858310|Vaccine|vaccine
1048710|NCT02858310|Immunotherapy|immunotherapy
1048711|NCT02858310|Human Papillomavirus|human papillomavirus
1048712|NCT02858297|Oral lichen planus|oral lichen planus
1048713|NCT02858297|Glucosamine|glucosamine
1048714|NCT02858297|IL-8|il-8
1048715|NCT02858258|MCL|mcl
1048716|NCT02858245|MitraClip|mitraclip
1048717|NCT02858245|Structural Heart Failure|structural heart failure
1048718|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
1048719|NCT02858245|Actigraphy|actigraphy
1048720|NCT02858232|MASCT-I|masct-i
1048721|NCT02858232|Solid Tumors|solid tumors
1048722|NCT02858219|Botulinum toxin|botulinum toxin
1048723|NCT02858219|Pain improvement|pain improvement
1048724|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
1048725|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
1048726|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1048727|NCT02858154|OSA|osa
1048728|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
1048729|NCT02858154|infants|infants
1048730|NCT02858154|high flow nasal cannula|high flow nasal cannula
1048731|NCT02858154|HFNC|hfnc
1048732|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
1048733|NCT02858141|pancreatic cancer|pancreatic cancer
1048734|NCT02858141|Database|database
1048735|NCT02858102|Schizophrenia|schizophrenia
1048736|NCT02858102|Psychosis|psychosis
1048737|NCT02858102|Obesity|obesity
1048738|NCT02858102|Neurocognition|neurocognition
1048739|NCT02858102|Depression|depression
1048740|NCT02858102|Bipolar disorder|bipolar disorder
1048741|NCT02858102|Metabolomics|metabolomics
1048742|NCT02858102|Biomarkers|biomarkers
1048743|NCT02858102|Hypertension|hypertension
1048744|NCT02858102|Dyslipidemia|dyslipidemia
1048745|NCT02858102|Hyperglycemia|hyperglycemia
1048746|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
1048747|NCT02858076|Anti-VEGF|anti-vegf
1048748|NCT02858076|Vitrectomy|vitrectomy
1048749|NCT02858063|Breast cancer|breast cancer
1048750|NCT02858063|Quality Of Life|quality of life
1048751|NCT02858063|Women|women
1048752|NCT02858063|Partner|partner
1048753|NCT02858011|behavior change communication|behavior change communication
1048754|NCT02858011|cash transfer|cash transfer
1048755|NCT02858011|household welfare|household welfare
1048756|NCT02858011|child nutrition status|child nutrition status
1048757|NCT02857985|Myocardial Infarction|myocardial infarction
1048758|NCT02857985|MRI|mri
1048760|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
1048761|NCT02857933|cerebral palsy|cerebral palsy
1048762|NCT02857933|motor impairments|motor impairments
1048763|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
1048764|NCT02857920|solid tumor|solid tumor
1048765|NCT02857920|NK Immunotherapy|nk immunotherapy
1048766|NCT02857907|Kidney transplantation|kidney transplantation
1048767|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
1048768|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1048769|NCT02857881|keratoconus|keratoconus
1048770|NCT02857881|photokeratectomy|photokeratectomy
1048772|NCT02857868|Hepatic Impairment|hepatic impairment
1048773|NCT02857868|ABL001|abl001
1048774|NCT02857868|Child-Pugh|child-pugh
1048775|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
1048776|NCT02857855|liver transplantation|liver transplantation
1048777|NCT02857855|postoperative infection|postoperative infection
1048778|NCT02857855|biliary complications|biliary complications
1048779|NCT02857855|patient survival|patient survival
1048780|NCT02857855|graft survival|graft survival
1048781|NCT02857855|supplemental oxygen|supplemental oxygen
1048782|NCT02857829|Cognition|cognition
1048783|NCT02857829|working memory|working memory
1048784|NCT02857829|nootropic|nootropic
1048785|NCT02857829|reaction time|reaction time
1048786|NCT02857829|healthy individuals|healthy individuals
1048787|NCT02857829|cognitive enhancement|cognitive enhancement
1048788|NCT02857803|Virtual Reality|virtual reality
1048789|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
1048790|NCT02857803|Motor Rehabilitation|motor rehabilitation
1048791|NCT02857803|Ecological validity|ecological validity
1048792|NCT02857803|Personalisation|personalisation
1048793|NCT02857790|Rotablation|rotablation
1048794|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
1048795|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
1048796|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1048798|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
1048799|NCT02857751|depression|depression
1048800|NCT02857751|PTSD|ptsd
1048801|NCT02857751|anxiety|anxiety
1048802|NCT02857751|surf therapy|surf therapy
1048803|NCT02857699|Quality of life|quality of life
1048804|NCT02857699|Phase I trials|phase i trials
1048805|NCT02857673|Children with Special Health Care Needs|children with special health care needs
1048806|NCT02857673|Violence Prevention|violence prevention
1048807|NCT02857660|Sarcopenia|sarcopenia
1048808|NCT02857660|Obesity|obesity
1048809|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
1048810|NCT02857660|Protein Supplementation|protein supplementation
1048811|NCT02857660|community dwelling men|community dwelling men
1048812|NCT02857647|Bariatric surgery|bariatric surgery
1048813|NCT02857647|Anxiety|anxiety
1048814|NCT02857647|Nutrition knowledge|nutrition knowledge
1048815|NCT02857647|Weight loss expectations|weight loss expectations
1048816|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
1048817|NCT02857634|diagnosis|diagnosis
1048818|NCT02857634|Cellvizio Dual Band|cellvizio dual band
1048819|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
1048820|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
1048821|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
1048822|NCT02857504|double lumen tube|double lumen tube
1048823|NCT02857504|hook|hook
1048824|NCT02857439|Trauma of the shoulder|trauma of the shoulder
1048825|NCT02857413|Xerostomia|xerostomia
1048826|NCT02857413|Radiotherapy|radiotherapy
1048827|NCT02857348|decision making|decision making
1048828|NCT02857348|heuristics|heuristics
1048829|NCT02857283|Air pollution|air pollution
1048830|NCT02857283|Air pollutant exposure|air pollutant exposure
1048831|NCT02857283|Ozone|ozone
1048832|NCT02857270|MAPK|mapk
1048833|NCT02857270|RAS|ras
1048834|NCT02857270|BRAF|braf
1048835|NCT02857257|IBS|ibs
1048836|NCT02857257|Microbiota|microbiota
1048837|NCT02857244|Freezing of Gait|freezing of gait
1048838|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
1048839|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
1048840|NCT02857179|bariatric surgery|bariatric surgery
1048841|NCT02857179|follow-up|follow-up
1048842|NCT02857179|weight loss|weight loss
1048843|NCT02857179|complications|complications
1048844|NCT02857179|comorbidities evolution|comorbidities evolution
1048845|NCT02857166|JS001|js001
1048846|NCT02857166|solid tumors|solid tumors
1048847|NCT02857153|MAP|map
1048848|NCT02857153|Blood loss|blood loss
1048849|NCT02857153|Postoperative delirium|postoperative delirium
1048850|NCT02857153|Elderly patients|elderly patients
1048851|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
1048852|NCT02857127|Low income population|low income population
1048853|NCT02857127|Motor Activity|motor activity
1048854|NCT02857127|Primary Health Care|primary health care
1048855|NCT02857088|depression|depression
1048856|NCT02857088|emotional reactivity|emotional reactivity
1048857|NCT02857036|rhythm|rhythm
1048858|NCT02857036|depression|depression
1049579|NCT02852772|HIV|hiv
1048859|NCT02857036|antidepressant treatment|antidepressant treatment
1048860|NCT02857023|Neurocognitive|neurocognitive
1048861|NCT02857023|Working memory|working memory
1048862|NCT02857023|Cogmed|cogmed
1048863|NCT02857023|Cognitive training|cognitive training
1048864|NCT02856984|Pregnancy|pregnancy
1048865|NCT02856984|Infant|infant
1048866|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
1048867|NCT02856971|TKA infection|tka infection
1048868|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
1048869|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
1048870|NCT02856945|fracture|fracture
1048871|NCT02856945|children|children
1048873|NCT02856945|clinical criteria|clinical criteria
1048874|NCT02856945|decision making|decision making
1048875|NCT02856906|Orofacial Pain|orofacial pain
1048876|NCT02856906|Electromyography|electromyography
1048877|NCT02856906|dental occlusion|dental occlusion
1048878|NCT02856893|AZD9291|azd9291
1048879|NCT02856893|Osimertinib|osimertinib
1048880|NCT02856893|Gefitinib|gefitinib
1048881|NCT02856893|NSCLC|nsclc
1048882|NCT02856893|liquid biopsy|liquid biopsy
1048883|NCT02856893|ctDNA|ctdna
1048884|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
1048885|NCT02856841|optimum cytoreduction|optimum cytoreduction
1048886|NCT02856815|Immuncell-LC|immuncell-lc
1048887|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
1048888|NCT02856789|Fibrin structure|fibrin structure
1048889|NCT02856789|Thromboelastography|thromboelastography
1048890|NCT02856789|Fibrin formation|fibrin formation
1048891|NCT02856789|Fibrinolysis|fibrinolysis
1048892|NCT02856789|TEG 5000|teg 5000
1048893|NCT02856789|TEG 6S|teg 6s
1048894|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
1048895|NCT02856789|Normal range|normal range
1048896|NCT02856776|Vitamin D|vitamin d
1048897|NCT02856776|Metabolomics|metabolomics
1048898|NCT02856776|Microbiota|microbiota
1048899|NCT02856776|Gene Expression|gene expression
1048900|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
1048901|NCT02856698|Acute heart failure|acute heart failure
1048902|NCT02856698|morphine|morphine
1048903|NCT02856698|midazolam|midazolam
1048904|NCT02856698|in-hospital mortality|in-hospital mortality
1048905|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
1048906|NCT02856620|cardiac mechanics|cardiac mechanics
1048907|NCT02856620|circulating biomarkers|circulating biomarkers
1048908|NCT02856620|frailty|frailty
1048909|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
1048910|NCT02856503|DCIS|dcis
1048911|NCT02856503|IBC|ibc
1048912|NCT02856503|Breast Cancer|breast cancer
1048913|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
1048914|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
1730150|NCT00005910|Insulinoma|insulinoma
1048915|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1048916|NCT02856412|Exercise|exercise
1048917|NCT02856412|Mindfulness|mindfulness
1048918|NCT02856399|methadone|methadone
1048919|NCT02856399|cancer pain|cancer pain
1048920|NCT02856399|long term effect|long term effect
1048921|NCT02856373|Denervation|denervation
1048922|NCT02856373|Renal Artery|renal artery
1048923|NCT02856360|Football|football
1048924|NCT02856360|Cleats|cleats
1048925|NCT02856360|Stiffness|stiffness
1048926|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
1048927|NCT02856347|PET F-DOPA|pet f-dopa
1048928|NCT02856347|18-FDOPA|18-fdopa
1048929|NCT02856334|chronic pelvic pain|chronic pelvic pain
1048930|NCT02856334|vulvodynia|vulvodynia
1048931|NCT02856334|pelvic pain|pelvic pain
1048932|NCT02856334|psychosocial factors|psychosocial factors
1048933|NCT02856334|central sensitization|central sensitization
1048934|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
1048935|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
1048936|NCT02856295|anti 10a|anti 10a
1048937|NCT02856269|Zinc|zinc
1048938|NCT02856256|Energy drink|energy drink
1048939|NCT02856256|Choroid|choroid
1048940|NCT02856230|Critical limb ischemia|critical limb ischemia
1048941|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
1048942|NCT02856230|drug-eluting balloon|drug-eluting balloon
1048943|NCT02856165|infant|infant
1048944|NCT02856165|oxygen therapy|oxygen therapy
1048945|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
1048946|NCT02856165|Bronchiolitis|bronchiolitis
1048947|NCT02856152|Healthy Volunteer|healthy volunteer
1048948|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
1048949|NCT02856139|peripheral retina|peripheral retina
1048950|NCT02856139|normal eyes|normal eyes
1048951|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1048952|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
1048953|NCT02856113|Drug therapy|drug therapy
1048954|NCT02856087|acute pain|acute pain
1048955|NCT02856087|postoperative|postoperative
1048956|NCT02856087|surgery|surgery
1048957|NCT02856048|GnRH agonist|gnrh agonist
1048958|NCT02856048|Ovarian reserve|ovarian reserve
1048959|NCT02856048|Fertility Preservation|fertility preservation
1048960|NCT02856048|Alkylating Agents|alkylating agents
1048961|NCT02856035|chronic stroke|chronic stroke
1048962|NCT02856035|functional MRI|functional mri
1048963|NCT02856035|functional NIRS|functional nirs
1048964|NCT02856035|motor learning|motor learning
1048965|NCT02856035|FES|fes
1048966|NCT02856035|upper extremity|upper extremity
1048967|NCT02856035|neural feedback|neural feedback
1048968|NCT02856035|arm/hand functional training|arm/hand functional training
1048969|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
1048970|NCT02856022|bladder pain syndrome|bladder pain syndrome
1048971|NCT02856022|intravesical irrigation|intravesical irrigation
1048972|NCT02855996|fatherhood|fatherhood
1048973|NCT02855996|father involvement|father involvement
1048974|NCT02855996|economic stability|economic stability
1048975|NCT02855996|co-parenting|co-parenting
1048976|NCT02855996|healthy relationships|healthy relationships
1048977|NCT02855996|father-child engagement|father-child engagement
1048978|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
1048979|NCT02855957|alpha-Hb pool|alpha-hb pool
1048980|NCT02855957|thalassemias|thalassemias
1048981|NCT02855957|diagnostic method|diagnostic method
1048982|NCT02855957|biomarker|biomarker
1048983|NCT02855944|ovarian cancer|ovarian cancer
1048984|NCT02855944|fallopian tube cancer|fallopian tube cancer
1048985|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
1048986|NCT02855944|peritoneal cancer|peritoneal cancer
1048987|NCT02855944|platinum sensitive|platinum sensitive
1048988|NCT02855944|relapsed disease|relapsed disease
1048989|NCT02855944|PARP Inhibitor|parp inhibitor
1048990|NCT02855944|PARP|parp
1048991|NCT02855944|rucaparib|rucaparib
1048992|NCT02855944|ruca|ruca
1048993|NCT02855944|homologous recombination|homologous recombination
1048994|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
1048995|NCT02855944|genomic scarring|genomic scarring
1048996|NCT02855944|loss of heterozygosity|loss of heterozygosity
1048997|NCT02855944|CO-338|co-338
1048998|NCT02855944|PF-01367338|pf-01367338
1048999|NCT02855944|PF 01367338|pf 01367338
1049000|NCT02855944|CO-338-043|co-338-043
1049001|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
1049002|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
1049254|NCT02854657|melanoma|melanoma
1049003|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
1049004|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
1049005|NCT02855944|gynecological cancer|gynecological cancer
1049006|NCT02855944|Clovis|clovis
1049007|NCT02855944|Clovis oncology|clovis oncology
1049008|NCT02855944|ARIEL2|ariel2
1049009|NCT02855944|ARIEL 2|ariel 2
1049010|NCT02855944|ARIEL-2|ariel-2
1049011|NCT02855944|ARIEL-3|ariel-3
1049012|NCT02855944|ARIEL 3|ariel 3
1049013|NCT02855944|ARIEL3|ariel3
1049014|NCT02855944|ARIEL4|ariel4
1049015|NCT02855944|ARIEL-4|ariel-4
1049016|NCT02855944|ARIEL 4|ariel 4
1049018|NCT02855944|advanced OC|advanced oc
1049019|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1049020|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
1049021|NCT02855944|Rubraca|rubraca
1049022|NCT02855944|High grade serous|high grade serous
1049023|NCT02855944|Partially platinum sensitive|partially platinum sensitive
1049024|NCT02855918|Psychiatry|psychiatry
1049025|NCT02855918|Depressive disorder|depressive disorder
1049026|NCT02855918|Suicidal behavior|suicidal behavior
1049027|NCT02855918|Genetics|genetics
1049028|NCT02855905|Exercise|exercise
1049029|NCT02855905|Cold Temperature|cold temperature
1049030|NCT02855892|GV1001|gv1001
1049031|NCT02855892|BPH|bph
1049032|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
1049033|NCT02855788|gastric cancer|gastric cancer
1049034|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
1049035|NCT02855788|metastatic|metastatic
1049036|NCT02855788|advanced|advanced
1049037|NCT02855736|Suicidal inpatients|suicidal inpatients
1049038|NCT02855736|Positive Psychology|positive psychology
1049039|NCT02855736|Gratitude|gratitude
1049040|NCT02855736|Psychological pain|psychological pain
1049041|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
1049042|NCT02855723|Sentinel lymph node|sentinel lymph node
1049043|NCT02855723|Lymph node dissection|lymph node dissection
1049044|NCT02855723|Equivalence|equivalence
1049045|NCT02855671|microcirculation|microcirculation
1049046|NCT02855671|thermal|thermal
1049047|NCT02855671|temperature|temperature
1049048|NCT02855658|Sjögren's syndrome|sjögren's syndrome
1049049|NCT02855658|Gan-Lu-Yin|gan-lu-yin
1049050|NCT02855658|Sang-Ju-Yin|sang-ju-yin
1049051|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
1049052|NCT02855658|Oxidative stress|oxidative stress
1049053|NCT02855658|Immune regulation|immune regulation
1049054|NCT02855658|Gene modulation|gene modulation
1049055|NCT02855658|SS-1|ss-1
1049056|NCT02855645|Trichosanthes root|trichosanthes root
1049155|NCT02855320|self-management|self-management
1049057|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
1049058|NCT02855645|Clinical trial|clinical trial
1049059|NCT02855632|G-CSF|g-csf
1049060|NCT02855632|adhesion reformation|adhesion reformation
1049061|NCT02855632|Asherman syndrome|asherman syndrome
1049062|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
1049063|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
1049064|NCT02855619|Weaning|weaning
1049065|NCT02855619|Intensive care unit|intensive care unit
1049066|NCT02855606|Oral PrEP|oral prep
1049067|NCT02855606|TGW|tgw
1049068|NCT02855606|Thai MSM|thai msm
1049069|NCT02855593|acupuncture|acupuncture
1049070|NCT02855580|Pharmacogenomic|pharmacogenomic
1049071|NCT02855580|child|child
1049072|NCT02855580|psychiatry|psychiatry
1049073|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
1049074|NCT02855580|Depression|depression
1049075|NCT02855580|Anxiety|anxiety
1049076|NCT02855580|CYP2D6|cyp2d6
1049077|NCT02855580|CYP2C19|cyp2c19
1049078|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1049079|NCT02855580|SSRI|ssri
1049080|NCT02855567|surgery|surgery
1049081|NCT02855567|acupuncture|acupuncture
1049082|NCT02855567|gynecology|gynecology
1049083|NCT02855567|pain|pain
1049084|NCT02855567|narcotics|narcotics
1049085|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
1049086|NCT02855541|Blood Glucose|blood glucose
1049087|NCT02855541|Physical Fitness|physical fitness
1049088|NCT02855541|Body Composition|body composition
1049089|NCT02855541|Lipids|lipids
1049090|NCT02855528|Tin Filter|tin filter
1049091|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
1049092|NCT02855528|Radiation dose reduction|radiation dose reduction
1049093|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
1049094|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
1049095|NCT02855515|VOTE classification|vote classification
1049096|NCT02855515|AHI|ahi
1049097|NCT02855515|BMI|bmi
1049098|NCT02855489|Condom Use|condom use
1049099|NCT02855489|HIV/STD|hiv/std
1049100|NCT02855489|Intervention|intervention
1049101|NCT02855489|Theory of Planned Behavior|theory of planned behavior
1049102|NCT02855489|Dismantling Study Design|dismantling study design
1049103|NCT02855463|Giant virus|giant virus
1049104|NCT02855463|Amoeba|amoeba
1049105|NCT02855424|stroke|stroke
1049106|NCT02855424|exercise capacity|exercise capacity
1049107|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
1049108|NCT02855385|Attitude|attitude
1049109|NCT02855385|Health seeking behaviour|health seeking behaviour
1049110|NCT02855385|Nigeria|nigeria
1049111|NCT02855385|Screening|screening
1049112|NCT02855385|high risk patients|high risk patients
1049113|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
1049114|NCT02855359|SGN-19A|sgn-19a
1049115|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
1049116|NCT02855359|DLBCL|dlbcl
1049117|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
1049118|NCT02855359|Antigens, CD19|antigens, cd19
1049119|NCT02855359|Hematologic Diseases|hematologic diseases
1049120|NCT02855359|Immune System Diseases|immune system diseases
1049121|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
1049122|NCT02855359|Immunotherapy|immunotherapy
1049123|NCT02855359|Lymphatic Diseases|lymphatic diseases
1049124|NCT02855359|Lymphoma|lymphoma
1049125|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
1049126|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1049127|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1049128|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
1049129|NCT02855359|Neoplasms|neoplasms
1049130|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
1049131|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
1049132|NCT02855359|Cyclophosphamide|cyclophosphamide
1049133|NCT02855359|Doxorubicin|doxorubicin
1049134|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
1049135|NCT02855359|Prednisone|prednisone
1049136|NCT02855359|Rituximab|rituximab
1049137|NCT02855359|Vincristine|vincristine
1049138|NCT02855359|Alkylating Agents|alkylating agents
1049139|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
1049140|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
1049141|NCT02855359|Antimitotic Agents|antimitotic agents
1049142|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1049143|NCT02855359|Antineoplastic Agents|antineoplastic agents
1049144|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
1049145|NCT02855359|Glucocorticoids|glucocorticoids
1049146|NCT02855359|Drug Therapy|drug therapy
1049147|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
1049148|NCT02855359|immunosuppressive agents|immunosuppressive agents
1049149|NCT02855333|Merendino procedure|merendino procedure
1049150|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
1049151|NCT02855320|Biologics safety|biologics safety
1049152|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
1049153|NCT02855320|Spondyloarthritis|spondyloarthritis
1049154|NCT02855320|patient education|patient education
1049156|NCT02855307|Closed-loop system|closed-loop system
1049157|NCT02855307|Artificial pancreas|artificial pancreas
1049158|NCT02855307|Exercise|exercise
1049159|NCT02855307|Hypoglycemia|hypoglycemia
1049160|NCT02855307|Insulin|insulin
1049161|NCT02855307|Type 1 diabetes|type 1 diabetes
1049162|NCT02855294|oral contraceptive pills|oral contraceptive pills
1049163|NCT02855294|Joint stability|joint stability
1049164|NCT02855268|Kidney disease|kidney disease
1049165|NCT02855268|Nephritis|nephritis
1049166|NCT02855268|Hereditary nephritis|hereditary nephritis
1049167|NCT02855268|Hereditary kidney disease|hereditary kidney disease
1049168|NCT02855229|Translational|translational
1049169|NCT02855229|Electrophysiology|electrophysiology
1049170|NCT02855216|Physiotherapy|physiotherapy
1049171|NCT02855216|Range of motion|range of motion
1049172|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
1049173|NCT02855190|Ga68-citrate|ga68-citrate
1049174|NCT02855190|FDG|fdg
1049175|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
1049176|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
1049177|NCT02855177|Hyperlipidemia|hyperlipidemia
1049178|NCT02855164|LJN452|ljn452
1049179|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1049180|NCT02855164|NASH|nash
1049181|NCT02855164|phase 2|phase 2
1049182|NCT02855164|adaptive design|adaptive design
1049183|NCT02855164|randomized|randomized
1049184|NCT02855151|EUS|eus
1049185|NCT02855138|isotretinoin|isotretinoin
1049186|NCT02855138|PCOS|pcos
1049187|NCT02855138|acne vulgaris|acne vulgaris
1049188|NCT02855125|NSCLC|nsclc
1049189|NCT02855125|phase 2 study|phase 2 study
1049190|NCT02855125|TAS-114|tas-114
1049191|NCT02855125|S-1|s-1
1049192|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
1049193|NCT02855073|Artz|artz
1049194|NCT02855034|child and infant|child and infant
1049195|NCT02855034|Blood samples|blood samples
1049196|NCT02855021|Dementia|dementia
1049197|NCT02855021|Cerebral metabolism|cerebral metabolism
1049198|NCT02855021|PET scan|pet scan
1049199|NCT02855008|Social Problem-Solving|social problem-solving
1049200|NCT02855008|Intellectual Disability|intellectual disability
1049201|NCT02855008|Problem Behaviors|problem behaviors
1049202|NCT02855008|Community based intervention|community based intervention
1049203|NCT02855008|Prevention|prevention
1049204|NCT02854956|phenotype|phenotype
1049205|NCT02854956|X-linked mental retardation|x-linked mental retardation
1049206|NCT02854956|neuronal networks|neuronal networks
1049207|NCT02854956|cognitive processes|cognitive processes
1049208|NCT02854930|Clinical death|clinical death
1049209|NCT02854930|state of consciousness|state of consciousness
1049210|NCT02854904|Immunomodulatory|immunomodulatory
1049211|NCT02854904|dexmedetomidine|dexmedetomidine
1049212|NCT02854904|anesthesia|anesthesia
1049213|NCT02854904|alpha-2 agonist|alpha-2 agonist
1049214|NCT02854904|arthrodesis|arthrodesis
1049215|NCT02854904|spinal fusion|spinal fusion
1049216|NCT02854904|Immune effect|immune effect
1049217|NCT02854904|double randomized clinical trials|double randomized clinical trials
1049218|NCT02854891|Effects|effects
1049219|NCT02854891|Heat|heat
1049220|NCT02854891|Light|light
1049221|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
1049222|NCT02854813|overactive bladder|overactive bladder
1049223|NCT02854813|coronary artery disease|coronary artery disease
1049224|NCT02854813|gensini score|gensini score
1049225|NCT02854800|varenicline|varenicline
1049226|NCT02854800|buprenorphine|buprenorphine
1049227|NCT02854787|Spinal anesthesia|spinal anesthesia
1049228|NCT02854787|cesarean|cesarean
1049229|NCT02854787|blood pressure|blood pressure
1049230|NCT02854787|Norepinephrine|norepinephrine
1049231|NCT02854787|Phenylephrine|phenylephrine
1049232|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
1049233|NCT02854735|Total body composition|total body composition
1049234|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
1049235|NCT02854735|Malnutrition|malnutrition
1049236|NCT02854735|Muscle quantification|muscle quantification
1049237|NCT02854722|deferasirox|deferasirox
1049238|NCT02854722|iron accumulation|iron accumulation
1049239|NCT02854696|Islet cell Transplantation|islet cell transplantation
1049240|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
1049241|NCT02854696|Cost-utility analysis|cost-utility analysis
1049242|NCT02854696|Type 1 Diabetes|type 1 diabetes
1049243|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
1049244|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
1049245|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
1049246|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
1049247|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
1049248|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
1049249|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
1049250|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
1049251|NCT02854670|capsaicin|capsaicin
1049252|NCT02854670|pain improvement|pain improvement
1049253|NCT02854670|provoked vulvodynia|provoked vulvodynia
1049255|NCT02854657|skin self-examination|skin self-examination
1049256|NCT02854631|Cirrhosis|cirrhosis
1049257|NCT02854631|Prednisone|prednisone
1049258|NCT02854631|Jaundice|jaundice
1049259|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1049260|NCT02854605|Fibrosis|fibrosis
1049261|NCT02854605|GS-9674|gs-9674
1049262|NCT02854592|rtPA|rtpa
1049263|NCT02854592|urokinase|urokinase
1049264|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
1049265|NCT02854579|progenitor cell|progenitor cell
1049266|NCT02854579|paracrine factor|paracrine factor
1049267|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
1049279|NCT02854501|Preeclampsia|preeclampsia
1049280|NCT02854501|poor placentation|poor placentation
1049281|NCT02854475|skin parameters|skin parameters
1049282|NCT02854475|cholesterol|cholesterol
1049283|NCT02854475|Raman spectroscopy|raman spectroscopy
1049284|NCT02854462|Language Development|language development
1049285|NCT02854462|Shared Picture Book reading|shared picture book reading
1049286|NCT02854462|Preschoolers|preschoolers
1049287|NCT02854462|Inference making|inference making
1049288|NCT02854449|Immune Marker|immune marker
1049289|NCT02854449|Immunologic Marker|immunologic marker
1049290|NCT02854449|Radiotherapy|radiotherapy
1049291|NCT02854449|Dose Hypofractionation|dose hypofractionation
1049292|NCT02854436|Prostate cancer|prostate cancer
1049293|NCT02854436|CRPC|crpc
1049294|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
1049295|NCT02854436|Prostate neoplasm|prostate neoplasm
1049296|NCT02854436|Galahad|galahad
1049297|NCT02854436|Niraparib|niraparib
1049298|NCT02854436|DNA anomalies|dna anomalies
1049299|NCT02854436|DNA defect|dna defect
1049300|NCT02854436|PARP inhibitor|parp inhibitor
1049301|NCT02854436|PARPi|parpi
1049302|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
1049303|NCT02854410|radiotherapy|radiotherapy
1049304|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1049305|NCT02854384|Epilepsy|epilepsy
1049306|NCT02854384|Mobile phone|mobile phone
1049307|NCT02854371|gadoxetic acid|gadoxetic acid
1049308|NCT02854371|T1 map|t1 map
1049309|NCT02854371|MRI|mri
1049310|NCT02854345|CZT camera|czt camera
1049311|NCT02854345|pinhole|pinhole
1049312|NCT02854332|Pain|pain
1049313|NCT02854332|Analgesic|analgesic
1049314|NCT02854332|Stimulation|stimulation
1049315|NCT02854332|Motor Cortex|motor cortex
1049316|NCT02854306|Bariatric surgery|bariatric surgery
1049317|NCT02854306|Mindfulness|mindfulness
1049318|NCT02854306|Obese|obese
1049319|NCT02854293|palliative care|palliative care
1049320|NCT02854293|cancer|cancer
1049321|NCT02854293|quality of life|quality of life
1049322|NCT02854280|Hypoxia|hypoxia
1049323|NCT02854280|Brain|brain
1049324|NCT02854280|Effort|effort
1049325|NCT02854267|organ procurement|organ procurement
1049326|NCT02854267|brain death|brain death
1049327|NCT02854267|organ donation|organ donation
1049328|NCT02854267|next of kins|next of kins
1049329|NCT02854254|phlebitis|phlebitis
1049330|NCT02854254|catheter|catheter
1049331|NCT02854254|congestive heart failure|congestive heart failure
1049332|NCT02854254|dobutamine|dobutamine
1049333|NCT02854241|MRI|mri
1049334|NCT02854241|HCC|hcc
1049335|NCT02854241|surveillance|surveillance
1049336|NCT02854228|Pituitary tumor|pituitary tumor
1049337|NCT02854228|pituitary carcinoma|pituitary carcinoma
1049338|NCT02854228|acromegaly|acromegaly
1049339|NCT02854228|cushing|cushing
1049340|NCT02854228|prolactinoma|prolactinoma
1049341|NCT02854163|Secukinumab|secukinumab
1049342|NCT02854163|Neutrophils|neutrophils
1049343|NCT02854163|Vitamin D|vitamin d
1049344|NCT02854124|Melanoma|melanoma
1049345|NCT02854124|Dissemination|dissemination
1049346|NCT02854124|Initiating stem cells|initiating stem cells
1049347|NCT02854098|BHJS, constipation|bhjs, constipation
1049348|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
1049349|NCT02854085|Art Therapy|art therapy
1049350|NCT02854085|Music Reminiscence Activity|music reminiscence activity
1049351|NCT02854085|Elderly|elderly
1049352|NCT02854072|GV1001|gv1001
1049353|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
1049354|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
1049355|NCT02854046|case-control study|case-control study
1049356|NCT02854046|cohort study|cohort study
1049357|NCT02854033|amyloid|amyloid
1049358|NCT02854033|plaques|plaques
1049359|NCT02854033|neuroimaging|neuroimaging
1049360|NCT02854033|biomarkers|biomarkers
1049361|NCT02854033|cognition disorder|cognition disorder
1049362|NCT02854033|early detection|early detection
1049363|NCT02854033|pre-dementia|pre-dementia
1049364|NCT02854033|dementia|dementia
1049365|NCT02854033|Alzheimer's disease|alzheimer's disease
1049366|NCT02854033|tau|tau
1049367|NCT02854020|Aircraft|aircraft
1049368|NCT02854020|Emergency|emergency
1049369|NCT02854020|First aid|first aid
1049370|NCT02854020|Cabin crew|cabin crew
1049371|NCT02854020|Burn|burn
1049372|NCT02854020|Cardiac arrest|cardiac arrest
1049373|NCT02854007|Coronary artery disease|coronary artery disease
1049375|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
1049376|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
1049378|NCT02853994|DEB|deb
1049379|NCT02853994|Sirolimus|sirolimus
1049380|NCT02853994|PCI|pci
1049381|NCT02853994|ISR|isr
1049382|NCT02853994|SVD|svd
1049383|NCT02853994|Restenosis|restenosis
1049384|NCT02853994|Bifurcation|bifurcation
1049385|NCT02853994|CAD|cad
1049386|NCT02853994|Coronary artery|coronary artery
1049387|NCT02853968|Unlock the Cell|unlock the cell
1049388|NCT02853968|Castleman's Disease|castleman's disease
1049389|NCT02853968|CD|cd
1049390|NCT02853968|Castleman Disease|castleman disease
1049391|NCT02853968|MCD|mcd
1049392|NCT02853968|iMCD|imcd
1049393|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
1049394|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
1049395|NCT02853968|multicentric Castleman disease|multicentric castleman disease
1049396|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
1049397|NCT02853929|Pertussis|pertussis
1049398|NCT02853929|Immunogenicity|immunogenicity
1049399|NCT02853929|Poliomyelitis|poliomyelitis
1049400|NCT02853929|Tetanus|tetanus
1049401|NCT02853929|Hepatitis B|hepatitis b
1049402|NCT02853929|Diptheria|diptheria
1049403|NCT02853903|solid tumor|solid tumor
1049404|NCT02853903|NK immunotherapy|nk immunotherapy
1049405|NCT02853890|Birth|birth
1049406|NCT02853890|obstetric analgesia|obstetric analgesia
1049407|NCT02853890|obstetric anesthesia|obstetric anesthesia
1049408|NCT02853864|Gender|gender
1049409|NCT02853864|Propofol|propofol
1049410|NCT02853864|Dexmedetomidine|dexmedetomidine
1049411|NCT02853864|Interaction|interaction
1049412|NCT02853851|Stress factors,|stress factors,
1049413|NCT02853851|intensive care units,|intensive care units,
1049414|NCT02853851|scale,|scale,
1049415|NCT02853851|quality of care|quality of care
1049416|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
1049417|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
1049418|NCT02853838|chest physiotherapy|chest physiotherapy
1049419|NCT02853812|tinnitus|tinnitus
1049420|NCT02853812|residual inhibition|residual inhibition
1049421|NCT02853786|cochlear implant|cochlear implant
1049422|NCT02853786|language environment|language environment
1049423|NCT02853786|speech therapy assessment|speech therapy assessment
1049424|NCT02853786|LENA technology|lena technology
1049425|NCT02853773|sweeteners|sweeteners
1049426|NCT02853773|sugar|sugar
1049427|NCT02853773|EEG|eeg
1049428|NCT02853773|food viewing|food viewing
1049429|NCT02853773|food intake|food intake
1049430|NCT02853747|arterial stiffness|arterial stiffness
1049431|NCT02853747|retinal vessels|retinal vessels
1049432|NCT02853747|physical activity|physical activity
1049433|NCT02853747|children|children
1049434|NCT02853708|E. coli|e. coli
1049435|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
1049436|NCT02853708|molecular epidemiology|molecular epidemiology
1049437|NCT02853708|risk factors|risk factors
1049438|NCT02853695|Hysteroscopy|hysteroscopy
1049439|NCT02853695|Diffusion|diffusion
1049440|NCT02853695|Implementation|implementation
1049441|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
1049442|NCT02853695|Operative hysteroscopy|operative hysteroscopy
1049443|NCT02853682|glycocalyx|glycocalyx
1049444|NCT02853682|capillary leak syndrome|capillary leak syndrome
1049445|NCT02853656|preterm birth|preterm birth
1049446|NCT02853656|gestation|gestation
1049447|NCT02853617|S. pneumoniae|s. pneumoniae
1049448|NCT02853617|N. meningitidis|n. meningitidis
1049449|NCT02853617|H. influenza|h. influenza
1049450|NCT02853617|B. pertussis|b. pertussis
1049451|NCT02853617|C. tetani|c. tetani
1049452|NCT02853617|MRSA|mrsa
1049453|NCT02853591|laparoscopy|laparoscopy
1049454|NCT02853591|hysterectomy|hysterectomy
1049455|NCT02853500|Liver Cancer|liver cancer
1049456|NCT02853487|Cluster headache|cluster headache
1049457|NCT02853487|actigraphy|actigraphy
1049458|NCT02853487|circadian rhythm|circadian rhythm
1049459|NCT02853461|biofilm|biofilm
1049460|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
1049461|NCT02853461|hip|hip
1049462|NCT02853461|endoprothesis|endoprothesis
1049463|NCT02853461|ceramic|ceramic
1049464|NCT02853461|bearing components|bearing components
1049465|NCT02853461|sonication|sonication
1049466|NCT02853461|low grade infection|low grade infection
1049467|NCT02853461|joint aspiration|joint aspiration
1049468|NCT02853448|Plasma|plasma
1049469|NCT02853448|Serum|serum
1049470|NCT02853448|Effective Blood Draws|effective blood draws
1049471|NCT02853435|Cross-over|cross-over
1049472|NCT02853435|Gepotidacin|gepotidacin
1049473|NCT02853435|Pharmacokinetics|pharmacokinetics
1049474|NCT02853435|Relative Bioavailability|relative bioavailability
1049475|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
1049476|NCT02853435|High shear wet granulation|high shear wet granulation
1049477|NCT02853396|internalised stigma|internalised stigma
1049478|NCT02853396|self stigma|self stigma
1049479|NCT02853396|inpatients|inpatients
1049480|NCT02853396|CBT|cbt
1049481|NCT02853396|Cognitive therapy|cognitive therapy
1049482|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
1049483|NCT02853357|Thoracic manipulation|thoracic manipulation
1049484|NCT02853357|Low back pain|low back pain
1049485|NCT02853357|Core strengthening|core strengthening
1049486|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
1049487|NCT02853344|PD1|pd1
1049488|NCT02853344|PD-1|pd-1
1049489|NCT02853344|PDL1|pdl1
1049490|NCT02853344|PD-L1|pd-l1
1049491|NCT02853331|PD1|pd1
1049492|NCT02853331|PD-1|pd-1
1049493|NCT02853331|PDL1|pdl1
1049494|NCT02853331|PD-L1|pd-l1
1049495|NCT02853331|VEGFR TKI|vegfr tki
1049496|NCT02853305|PD1|pd1
1049497|NCT02853305|PD-1|pd-1
1049498|NCT02853305|PDL1|pdl1
1049499|NCT02853305|PD-L1|pd-l1
1049500|NCT02853266|Kawasaki disease|kawasaki disease
1049501|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
1049502|NCT02853253|Preterm neonates|preterm neonates
1049503|NCT02853240|Cerebral palsy|cerebral palsy
1049504|NCT02853240|children|children
1049505|NCT02853240|muscle spasticity|muscle spasticity
1049506|NCT02853240|botulinum toxin injection|botulinum toxin injection
1049507|NCT02853227|Telemark score, reliability|telemark score, reliability
1049508|NCT02853214|Dysglobulinemia|dysglobulinemia
1049509|NCT02853214|Multiple Myeloma|multiple myeloma
1049510|NCT02853214|MGUS|mgus
1049511|NCT02853214|Waldenström|waldenström
1049512|NCT02853214|genetic factors|genetic factors
1049513|NCT02853214|Sequencing|sequencing
1049514|NCT02853201|Extubation|extubation
1049515|NCT02853201|Intercostal Muscles|intercostal muscles
1049516|NCT02853201|Diaphragm|diaphragm
1049517|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
1049518|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
1049519|NCT02853162|MRI|mri
1049520|NCT02853162|Renal cell carcinoma|renal cell carcinoma
1049521|NCT02853149|Spinal Cord Injury|spinal cord injury
1049522|NCT02853149|disability|disability
1049523|NCT02853149|obesity|obesity
1049524|NCT02853149|cardiometabolic|cardiometabolic
1049525|NCT02853149|Caregiver|caregiver
1049526|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
1049527|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
1049528|NCT02853084|IL-1 inhibitors|il-1 inhibitors
1049529|NCT02853084|HL2351|hl2351
1049530|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
1730331|NCT00005775|Glutamine|glutamine
1049531|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
1049532|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
1049533|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
1049534|NCT02853058|stillbirth|stillbirth
1049535|NCT02853058|hemorrhage|hemorrhage
1049536|NCT02853019|Emotion|emotion
1049537|NCT02853019|motivation|motivation
1049538|NCT02853019|cognition|cognition
1049539|NCT02853019|schizophrenia|schizophrenia
1049540|NCT02853006|Cancer lung|cancer lung
1049541|NCT02853006|Fluids|fluids
1049542|NCT02853006|LungCancerTest|lungcancertest
1049543|NCT02853006|radiological anomalies|radiological anomalies
1049544|NCT02853006|non-cancerous|non-cancerous
1049545|NCT02853006|carriers|carriers
1049546|NCT02853006|Patient reference|patient reference
1049547|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
1049548|NCT02852993|Survival|survival
1049549|NCT02852967|Skin Diseases|skin diseases
1049550|NCT02852967|Auto-Immune Diseases|auto-immune diseases
1049551|NCT02852967|Plaque|plaque
1049552|NCT02852967|Dermatology|dermatology
1049553|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
1049554|NCT02852954|Endometrial Cancer|endometrial cancer
1049555|NCT02852941|Impedance|impedance
1049556|NCT02852941|Kidney Transplantation|kidney transplantation
1049557|NCT02852928|ILD; chILD|ild; child
1049558|NCT02852915|Colonic Neoplasms|colonic neoplasms
1049559|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
1049560|NCT02852915|T4|t4
1049561|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
1049562|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
1049563|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
1049564|NCT02852902|Solid Organ Transplantation|solid organ transplantation
1049565|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
1049566|NCT02852902|Anti-Infective Agents|anti-infective agents
1049567|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
1049568|NCT02852876|Safety of ASP2151|safety of asp2151
1049569|NCT02852876|Phase 1|phase 1
1049570|NCT02852876|Pharmacokinetics|pharmacokinetics
1049571|NCT02852876|Healthy male subjects|healthy male subjects
1049572|NCT02852876|Tolerability|tolerability
1049573|NCT02852876|Food effect of ASP2151|food effect of asp2151
1049574|NCT02852811|Climacteric|climacteric
1049575|NCT02852811|Education|education
1049576|NCT02852811|Mental health|mental health
1049577|NCT02852811|Menopause|menopause
1049578|NCT02852772|Cognitive impairment|cognitive impairment
1049580|NCT02852772|Microalbuminuria|microalbuminuria
1049581|NCT02852772|Chronic kidney disease|chronic kidney disease
1049582|NCT02852720|Pharmacokinetics|pharmacokinetics
1049583|NCT02852720|levobupivacaine|levobupivacaine
1049584|NCT02852720|Pregnancy|pregnancy
1049585|NCT02852720|Cesarean section|cesarean section
1049586|NCT02852720|Electrocardiography|electrocardiography
1049587|NCT02852668|elderly|elderly
1049588|NCT02852668|strength training|strength training
1049589|NCT02852668|power training|power training
1049590|NCT02852668|functional capacity|functional capacity
1049591|NCT02852668|gait biomechanics|gait biomechanics
1049592|NCT02852655|Brain Tumor|brain tumor
1049593|NCT02852642|power training|power training
1049594|NCT02852642|plyometric training|plyometric training
1049595|NCT02852642|functional capacity|functional capacity
1049596|NCT02852629|decision-support sheet|decision-support sheet
1049597|NCT02852616|Course|course
1049598|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
1049599|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
1049600|NCT02852603|dissection|dissection
1049601|NCT02852603|aneurysm|aneurysm
1049602|NCT02852603|thoracic aorta|thoracic aorta
1049603|NCT02852590|Observational|observational
1049604|NCT02852590|Pediatric|pediatric
1049605|NCT02852590|Off-Label Use|off-label use
1049606|NCT02852590|Unlicensed drug use|unlicensed drug use
1049607|NCT02852590|Adverse Drug Reaction|adverse drug reaction
1049608|NCT02852590|Hospitalized Children|hospitalized children
1049609|NCT02852590|Pediatric inpatients|pediatric inpatients
1049610|NCT02852577|panic disorder|panic disorder
1049611|NCT02852577|agoraphobia|agoraphobia
1049612|NCT02852577|clonazepam|clonazepam
1049613|NCT02852577|paroxetine|paroxetine
1049614|NCT02852564|Non-Muscle|non-muscle
1049615|NCT02852564|Invasive|invasive
1049616|NCT02852564|Bladder|bladder
1049617|NCT02852564|Cancer|cancer
1049618|NCT02852564|Muscle|muscle
1049619|NCT02852564|Surgery|surgery
1049620|NCT02852564|Transurethral|transurethral
1049621|NCT02852564|Resection|resection
1049622|NCT02852564|Tumor|tumor
1049623|NCT02852564|Ethacrynic|ethacrynic
1049624|NCT02852564|Acid|acid
1049625|NCT02852564|Mitomycin|mitomycin
1049626|NCT02852564|Urine|urine
1049627|NCT02852564|NMIBC|nmibc
1049628|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
1049629|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
1049630|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
1049631|NCT02852499|environmental epidemiology|environmental epidemiology
1049632|NCT02852499|cohort|cohort
1049633|NCT02852499|atmospheric pollutant|atmospheric pollutant
1049634|NCT02852499|chemical pollutant|chemical pollutant
1049635|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
1049636|NCT02852499|big data|big data
1049637|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
1049638|NCT02852499|e-dohad and exposome|e-dohad and exposome
1049639|NCT02852486|BCR-ABL Positive|bcr-abl positive
1049640|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
1049641|NCT02852486|Imatinib|imatinib
1049642|NCT02852486|Pioglitazone|pioglitazone
1049643|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
1049644|NCT02852473|Radiotherapy|radiotherapy
1049645|NCT02852473|Proton Therapy|proton therapy
1049646|NCT02852382|scalp block|scalp block
1049647|NCT02852382|local infiltration|local infiltration
1049648|NCT02852330|Voltage tomography|voltage tomography
1049650|NCT02852304|transplant|transplant
1049651|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
1049652|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1049653|NCT02852278|ALS|als
1049654|NCT02852278|motor neuron diseases|motor neuron diseases
1049655|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
1049656|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
1049657|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
1049658|NCT02852265|oral contraceptive|oral contraceptive
1049659|NCT02852265|contraceptive implant|contraceptive implant
1049660|NCT02852265|contraception|contraception
1049661|NCT02852265|adherence|adherence
1049662|NCT02852265|adverse event|adverse event
1049663|NCT02852239|Renal impairment|renal impairment
1049664|NCT02852239|Healthy volunteers|healthy volunteers
1049665|NCT02852239|Clinical pharmacology study|clinical pharmacology study
1049666|NCT02852239|DRB436|drb436
1049667|NCT02852239|dabrafenib|dabrafenib
1049668|NCT02852239|normal renal function|normal renal function
1049669|NCT02852239|impaired renal function|impaired renal function
1049670|NCT02852213|AADC|aadc
1049671|NCT02852213|gene therapy|gene therapy
1049672|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
1049673|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
1049674|NCT02852148|Wound|wound
1049675|NCT02852148|Pressure Ulcer|pressure ulcer
1049676|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
1049677|NCT02852148|Venous Leg Ulcer|venous leg ulcer
1049678|NCT02852148|Burn|burn
1049679|NCT02852148|Quality of Life|quality of life
1049680|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
1049681|NCT02852135|lateral position|lateral position
1049687|NCT02852096|gastric cancer|gastric cancer
1049688|NCT02852096|Her2/neu|her2/neu
1049689|NCT02852096|dual paraffin blocks|dual paraffin blocks
1049690|NCT02852096|trastuzumab|trastuzumab
1049691|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
1049692|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
1049693|NCT02851979|premature newborns|premature newborns
1049694|NCT02851979|apneas prevention|apneas prevention
1049695|NCT02851979|olfactory stimulation|olfactory stimulation
1049696|NCT02851979|latin square design|latin square design
1049697|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
1049698|NCT02851966|Sperm Retrieval|sperm retrieval
1049699|NCT02851966|Infertility, Male|infertility, male
1049700|NCT02851966|Semen|semen
1049701|NCT02851966|Biomarkers|biomarkers
1049702|NCT02851966|Proteomics|proteomics
1049703|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
1049704|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
1049705|NCT02851940|Pain|pain
1049706|NCT02851940|Bleeding|bleeding
1049707|NCT02851940|Hemorrhoids|hemorrhoids
1049708|NCT02851940|Band Ligation|band ligation
1049709|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
1049710|NCT02851836|attachment|attachment
1049711|NCT02851836|adolescent|adolescent
1049712|NCT02851836|picture|picture
1049713|NCT02851823|Er-YAG lasers|er-yag lasers
1049714|NCT02851823|Nd-YAG lasers|nd-yag lasers
1049715|NCT02851823|chronic periodontitis|chronic periodontitis
1049716|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
1049717|NCT02851810|attachment|attachment
1049718|NCT02851810|oculomotor marker|oculomotor marker
1049719|NCT02851810|emotion regulation|emotion regulation
1049720|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
1049721|NCT02851784|ablation|ablation
1049722|NCT02851784|immunotherapy|immunotherapy
1049723|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
1049724|NCT02851732|Quality Improvement|quality improvement
1049725|NCT02851732|Cluster Analysis|cluster analysis
1049726|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
1049727|NCT02851719|Pelvic Floor|pelvic floor
1049728|NCT02851719|Exercise|exercise
1049729|NCT02851719|Patient Compliance|patient compliance
1049730|NCT02851706|Brain Tumor|brain tumor
1049732|NCT02851706|Astrocytoma|astrocytoma
1049733|NCT02851706|Brain Cancer|brain cancer
1049734|NCT02851706|Spine Cander|spine cander
1049735|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
1049736|NCT02851615|Self Care|self care
1049737|NCT02851615|Adolescent|adolescent
1049738|NCT02851615|Young Adult|young adult
1049739|NCT02851615|Disease Management|disease management
1049740|NCT02851615|Behavioral Activation|behavioral activation
1049741|NCT02851615|Peer Communication|peer communication
1049742|NCT02851576|Adenovirus|adenovirus
1049743|NCT02851550|liver|liver
1049744|NCT02851550|transplant|transplant
1049745|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
1049746|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
1049747|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
1049748|NCT02851472|prematurity|prematurity
1049749|NCT02851472|PRBC transfusion|prbc transfusion
1049750|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
1049751|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
1049752|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
1049753|NCT02851459|Vaccines|vaccines
1049758|NCT02851368|Indocyanine Green|indocyanine green
1049759|NCT02851368|Fluorescence Imaging|fluorescence imaging
1049760|NCT02851342|Cognition|cognition
1049761|NCT02851342|MEG|meg
1049762|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
1049763|NCT02851329|EGFR TKIs|egfr tkis
1049764|NCT02851329|progression-free survival|progression-free survival
1049765|NCT02851329|prognosis|prognosis
1049766|NCT02851329|computed tomography|computed tomography
1049767|NCT02851290|Hypospadias|hypospadias
1049768|NCT02851290|Caudal block|caudal block
1049769|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
1049770|NCT02851290|Anesthesia|anesthesia
1049771|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
1049772|NCT02851290|Urethral stricture|urethral stricture
1049773|NCT02851290|Meatal stenosis|meatal stenosis
1049774|NCT02851290|Glanular dehiscence|glanular dehiscence
1049775|NCT02851277|Peanut Allergy|peanut allergy
1049776|NCT02851277|ASP0892|asp0892
1049777|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
1049778|NCT02851264|optical enhancement technology|optical enhancement technology
1049779|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
1049780|NCT02851251|eye disease|eye disease
1049781|NCT02851251|neonatal eye disease|neonatal eye disease
1049782|NCT02851251|newborn|newborn
1049783|NCT02851251|screening|screening
1049784|NCT02851251|multicenter|multicenter
1049785|NCT02851134|genetic|genetic
1049786|NCT02851121|Neurophysiological|neurophysiological
1049787|NCT02851121|Perception-action|perception-action
1049788|NCT02851121|Link|link
1049789|NCT02851108|falciparum malaria|falciparum malaria
1049790|NCT02851108|sub saharan|sub saharan
1049792|NCT02851108|elimination disorder|elimination disorder
1049793|NCT02851082|Training Program|training program
1049794|NCT02851082|Endurance|endurance
1049795|NCT02851082|Von Willebrand factor|von willebrand factor
1049796|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
1049797|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
1049798|NCT02851069|Sustained Virological Response|sustained virological response
1049799|NCT02851069|Observational Study|observational study
1049800|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
1049801|NCT02851056|Myeloma|myeloma
1049802|NCT02851056|Vaccine|vaccine
1049803|NCT02851056|Dendritic cell|dendritic cell
1049804|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
1049805|NCT02851056|HCT|hct
1049806|NCT02851030|Child, Preschool|child, preschool
1049807|NCT02851030|Child Care|child care
1049808|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
1049809|NCT02850939|Breast cancer|breast cancer
1049810|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
1049811|NCT02850939|mHealth|mhealth
1049812|NCT02850926|Concussion|concussion
1049813|NCT02850926|Soccer|soccer
1049814|NCT02850926|Adolescent|adolescent
1049815|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1049816|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
1049817|NCT02850874|peritoneal disease|peritoneal disease
1049818|NCT02850848|Pharmacokinetic|pharmacokinetic
1049819|NCT02850835|Decision Aid|decision aid
1049820|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
1049821|NCT02850822|chemotherapy|chemotherapy
1049822|NCT02850809|radiofrequency ablation|radiofrequency ablation
1049823|NCT02850809|complications|complications
1049824|NCT02850796|Mindfulness|mindfulness
1049825|NCT02850796|self-compassion|self-compassion
1049826|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
1049827|NCT02850796|weight self-stigma|weight self-stigma
1049828|NCT02850796|quality-of-life|quality-of-life
1049829|NCT02850783|colon cancer|colon cancer
1049830|NCT02850757|Modified William's airway|modified william's airway
1049831|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
1049832|NCT02850757|U shape Guedls airway|u shape guedls airway
1049833|NCT02850757|oral airways|oral airways
1049834|NCT02850757|efficacy and safety|efficacy and safety
1049835|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
1049836|NCT02850705|Myelitis|myelitis
1049837|NCT02850705|Optic Neuritis|optic neuritis
1049838|NCT02850705|autoantibody|autoantibody
1049839|NCT02850705|demyelination|demyelination
1049840|NCT02850679|Atrial Fibrillation|atrial fibrillation
1049841|NCT02850679|Cardioversion|cardioversion
1049842|NCT02850666|social skills|social skills
1049843|NCT02850666|child|child
1049844|NCT02850666|theory of mind|theory of mind
1049845|NCT02850666|drama|drama
1049846|NCT02850666|occupational therapy|occupational therapy
1049847|NCT02850666|Speech-language pathology|speech-language pathology
1049848|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
1049849|NCT02850653|PCR|pcr
1049850|NCT02850653|Ocular sampling|ocular sampling
1049851|NCT02850627|acute coronary syndrome|acute coronary syndrome
1049852|NCT02850627|Tongguan capsule|tongguan capsule
1049853|NCT02850627|miRNAs|mirnas
1049854|NCT02850601|Oral lichen planus|oral lichen planus
1049855|NCT02850601|Dexamethasone solution|dexamethasone solution
1049856|NCT02850562|body composition,|body composition,
1049857|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
1049858|NCT02850562|sarcopenia|sarcopenia
1049859|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
1049860|NCT02850562|muscle density|muscle density
1049861|NCT02850562|elderly|elderly
1049862|NCT02850549|neck pain|neck pain
1049863|NCT02850549|cervical|cervical
1049864|NCT02850549|classification|classification
1049865|NCT02850549|outcomes|outcomes
1049866|NCT02850549|physical therapy|physical therapy
1049867|NCT02850536|Colorectal Cancer|colorectal cancer
1049868|NCT02850536|Liver Metastases|liver metastases
1049869|NCT02850536|Breast Cancer|breast cancer
1049870|NCT02850536|Gastric Cancer|gastric cancer
1049871|NCT02850536|Pancreas Cancer|pancreas cancer
1049872|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
1049873|NCT02850536|CAR-T|car-t
1049874|NCT02850536|Immunotherapy|immunotherapy
1049875|NCT02850510|Harsh discipline|harsh discipline
1049876|NCT02850510|parental competence|parental competence
1049877|NCT02850510|positive parenting|positive parenting
1050170|NCT02848820|Antibiotics|antibiotics
1049878|NCT02850497|optical coherence tomography|optical coherence tomography
1049879|NCT02850497|malapposition|malapposition
1049880|NCT02850497|endothelization|endothelization
1049881|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
1049882|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
1049883|NCT02850471|pulmonary protection|pulmonary protection
1049884|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
1049885|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
1049886|NCT02850432|Peripheral artery disease|peripheral artery disease
1050012|NCT02849678|Postoperative Pain|postoperative pain
1049887|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
1049888|NCT02850432|Cardiac function|cardiac function
1049889|NCT02850393|suppression mnemonic|suppression mnemonic
1049890|NCT02850393|emotional response|emotional response
1049891|NCT02850393|inhibitory control of failures|inhibitory control of failures
1049892|NCT02850393|neurological alterations|neurological alterations
1049893|NCT02850341|Physical Activity|physical activity
1049894|NCT02850341|Mental Health|mental health
1049895|NCT02850341|Health Behavior|health behavior
1049896|NCT02850341|Walking|walking
1049897|NCT02850341|Physical Exercise|physical exercise
1049898|NCT02850341|Mental disorder|mental disorder
1049899|NCT02850315|optimal coherence tomography|optimal coherence tomography
1049900|NCT02850315|myocardial reperfusion|myocardial reperfusion
1049901|NCT02850276|HIV disease|hiv disease
1049902|NCT02850276|gastrointestinal problems|gastrointestinal problems
1049903|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
1049904|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
1049905|NCT02850263|Diabetic Macular Edema|diabetic macular edema
1049906|NCT02850263|Aflibercept|aflibercept
1049907|NCT02850250|Observational|observational
1049908|NCT02850250|pharmacokinetic|pharmacokinetic
1049909|NCT02850250|cardiac|cardiac
1049910|NCT02850250|Cefuroxime|cefuroxime
1049911|NCT02850250|Paediatric|paediatric
1049912|NCT02850237|cerebral saturation|cerebral saturation
1049913|NCT02850237|capnography|capnography
1049914|NCT02850237|pre-hospital|pre-hospital
1049915|NCT02850198|ischemic stroke|ischemic stroke
1049916|NCT02850185|COPD|copd
1049917|NCT02850185|hydrogen|hydrogen
1049918|NCT02850172|nutrition|nutrition
1049919|NCT02850172|exercise|exercise
1049920|NCT02850172|inspiratory muscle training|inspiratory muscle training
1049921|NCT02850146|tau|tau
1049922|NCT02850146|cognition|cognition
1049923|NCT02850146|longitudinal|longitudinal
1049924|NCT02850146|cognitive decline|cognitive decline
1049925|NCT02850146|observational|observational
1049926|NCT02850146|imaging|imaging
1049927|NCT02850120|surgical mesh|surgical mesh
1049928|NCT02850120|observational study|observational study
1049929|NCT02850120|intraoperative complications|intraoperative complications
1049930|NCT02850120|postoperative complications|postoperative complications
1049931|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
1049932|NCT02850094|Physical activity|physical activity
1049933|NCT02850094|Exercise|exercise
1049934|NCT02850094|Financial Incentives|financial incentives
1049935|NCT02850081|Carotid endarterectomy|carotid endarterectomy
1049936|NCT02850081|CEA|cea
1049937|NCT02850081|stroke|stroke
1049938|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
1049939|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
1049940|NCT02850042|motor recovery|motor recovery
1049941|NCT02850042|human|human
1049942|NCT02850042|occupation-based practice|occupation-based practice
1049943|NCT02850042|motor training|motor training
1049944|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
1049945|NCT02850029|antimicrobial|antimicrobial
1049946|NCT02850029|intensive care units|intensive care units
1049947|NCT02850016|Romidepsin|romidepsin
1049948|NCT02850016|3BNC117|3bnc117
1049949|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
1049950|NCT02849977|POMC|pomc
1049951|NCT02849977|PCSK1|pcsk1
1049952|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
1049953|NCT02849964|Incidence|incidence
1049954|NCT02849964|Renal Replacement Therapy|renal replacement therapy
1049955|NCT02849964|Socioeconomic Factors|socioeconomic factors
1049956|NCT02849964|Clinical Practice Pattern|clinical practice pattern
1049957|NCT02849951|Colitis|colitis
1049958|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
1049959|NCT02849951|Ulcer|ulcer
1049960|NCT02849951|Colonic Diseases|colonic diseases
1049961|NCT02849951|Digestive System Diseases|digestive system diseases
1049962|NCT02849951|Gastroenteritis|gastroenteritis
1049963|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
1049964|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
1049965|NCT02849951|Intestinal Diseases|intestinal diseases
1049966|NCT02849951|Pathologic Processes|pathologic processes
1049967|NCT02849951|Mesalamine|mesalamine
1049968|NCT02849938|children with medical complexity|children with medical complexity
1049969|NCT02849938|Telemedicine|telemedicine
1049970|NCT02849938|Tracheostomy|tracheostomy
1049971|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
1049972|NCT02849925|Caries|caries
1049973|NCT02849925|Glass ionomer|glass ionomer
1049974|NCT02849925|Resin|resin
1049975|NCT02849886|GvHD|gvhd
1049976|NCT02849886|Suicide gene|suicide gene
1049977|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
1049978|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
1049979|NCT02849834|Neuropathic Pain|neuropathic pain
1049980|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
1049981|NCT02849834|Pharmacoresistant|pharmacoresistant
1049982|NCT02849834|rTMS|rtms
1049983|NCT02849808|Corneal Transplantation|corneal transplantation
1049984|NCT02849795|Obesity, Abdominal|obesity, abdominal
1049985|NCT02849795|Adipokines|adipokines
1049986|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
1049987|NCT02849782|Gait analysis|gait analysis
1049988|NCT02849782|Fampridine|fampridine
1049989|NCT02849782|Fatigue|fatigue
1049990|NCT02849782|Daily activity|daily activity
1049991|NCT02849782|Cognition|cognition
1049992|NCT02849756|Intensive care|intensive care
1049993|NCT02849756|elderly|elderly
1049994|NCT02849756|autonomy|autonomy
1049995|NCT02849756|Future|future
1049996|NCT02849756|older patients|older patients
1049997|NCT02849756|intensive care unit|intensive care unit
1049998|NCT02849743|oxytocin|oxytocin
1049999|NCT02849743|hypothalamic obesity|hypothalamic obesity
1050000|NCT02849743|craniopharyngioma|craniopharyngioma
1050001|NCT02849743|metabolism|metabolism
1050002|NCT02849730|Epi-PCA|epi-pca
1050003|NCT02849730|Patient controlled analgesia|patient controlled analgesia
1050004|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
1050005|NCT02849730|Elderly patient|elderly patient
1050006|NCT02849730|Side effect|side effect
1050007|NCT02849730|Postoperative pain|postoperative pain
1050008|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
1050009|NCT02849704|Pancreatic Function|pancreatic function
1050010|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
1050011|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
1050013|NCT02849678|Bowel Surgery|bowel surgery
1050014|NCT02849678|Regional Anesthesia|regional anesthesia
1050015|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
1050016|NCT02849652|Smoking cessation|smoking cessation
1050017|NCT02849652|Nicotine dependence|nicotine dependence
1050018|NCT02849652|Organizational change|organizational change
1050019|NCT02849652|Mental Healthcare|mental healthcare
1050020|NCT02849626|Partial-Onset Seizures|partial-onset seizures
1050021|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
1085536|NCT02636231|NPC|npc
1050022|NCT02849626|Adjunctive Therapy|adjunctive therapy
1050023|NCT02849626|Epilepsy|epilepsy
1050024|NCT02849613|cell therapy|cell therapy
1050025|NCT02849613|stem cell|stem cell
1050026|NCT02849613|transplantation|transplantation
1050027|NCT02849613|graft|graft
1050028|NCT02849613|recovery|recovery
1050029|NCT02849613|repair|repair
1050030|NCT02849613|stroke|stroke
1050031|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
1050032|NCT02849613|regenerative|regenerative
1050033|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
1050034|NCT02849587|Driving Under the Influence|driving under the influence
1050035|NCT02849587|Memory Impairment|memory impairment
1050036|NCT02849587|Reaction Time|reaction time
1050037|NCT02849587|Time Perception|time perception
1050038|NCT02849561|Pupillary light reflex|pupillary light reflex
1050039|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
1050040|NCT02849535|Oral chemotherapy|oral chemotherapy
1050041|NCT02849535|Relative dose intensity|relative dose intensity
1050042|NCT02849535|Health related program|health related program
1050043|NCT02849535|Secured drug intake|secured drug intake
1050044|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
1050045|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
1050046|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
1050047|NCT02849522|Open prostatectomy|open prostatectomy
1050048|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
1050049|NCT02849522|IPSS Score|ipss score
1050050|NCT02849522|IIEF Score|iief score
1050051|NCT02849522|Complications|complications
1050052|NCT02849522|Quality of Life|quality of life
1050053|NCT02849483|PONV|ponv
1050054|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
1050055|NCT02849483|vomiting|vomiting
1050056|NCT02849483|antiemetics|antiemetics
1050057|NCT02849483|nausea|nausea
1050058|NCT02849483|ramosetron|ramosetron
1050059|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
1050060|NCT02849470|PRP|prp
1050061|NCT02849470|SVF|svf
1050062|NCT02849470|Cell Therapy|cell therapy
1050063|NCT02849470|Alopecia|alopecia
1050064|NCT02849470|GF|gf
1050065|NCT02849444|renal function|renal function
1050066|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
1050067|NCT02849444|anti-MM therapy|anti-mm therapy
1050068|NCT02849431|mindfulness|mindfulness
1050069|NCT02849418|Botulinum toxin type A|botulinum toxin type a
1050070|NCT02849418|Urinary Incontinence|urinary incontinence
1050071|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
1050072|NCT02849392|Pistachio|pistachio
1050073|NCT02849392|Body composition|body composition
1050074|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
1050075|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
1050076|NCT02849392|Blood lipids|blood lipids
1050077|NCT02849392|Inflammatory markers|inflammatory markers
1050078|NCT02849392|Bone density|bone density
1050079|NCT02849392|Bone turnover markers|bone turnover markers
1050080|NCT02849392|Satiety|satiety
1050081|NCT02849379|tongue cancer|tongue cancer
1050082|NCT02849379|cryosurgery|cryosurgery
1050083|NCT02849379|NK immunotherapy|nk immunotherapy
1050084|NCT02849366|Sarcoma|sarcoma
1050085|NCT02849366|Cryosurgery|cryosurgery
1050086|NCT02849366|NK Immunotherapy|nk immunotherapy
1050087|NCT02849353|Ovarian Cancer|ovarian cancer
1050088|NCT02849353|cryosurgery|cryosurgery
1050089|NCT02849353|NK immunotherapy|nk immunotherapy
1050090|NCT02849340|Cervical Cancer|cervical cancer
1050091|NCT02849340|cryosurgery|cryosurgery
1050092|NCT02849340|NK immunotherapy|nk immunotherapy
1050093|NCT02849327|Pharyngeal cancer|pharyngeal cancer
1050094|NCT02849327|Cryosurgery|cryosurgery
1050095|NCT02849327|NK immunotherapy|nk immunotherapy
1050096|NCT02849314|laryngeal cancer|laryngeal cancer
1050097|NCT02849314|cryosurgery|cryosurgery
1050098|NCT02849314|NK immunotherapy|nk immunotherapy
1050099|NCT02849249|allergy|allergy
1050100|NCT02849249|Immunotherapy|immunotherapy
1050101|NCT02849249|SCIT|scit
1050102|NCT02849236|PECS block,|pecs block,
1050103|NCT02849236|pectoral block,|pectoral block,
1050104|NCT02849236|breast augmentation|breast augmentation
1050105|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
1050106|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1050107|NCT02849223|Working Memory|working memory
1050108|NCT02849197|pilonidal sinus|pilonidal sinus
1050109|NCT02849197|complication|complication
1050110|NCT02849197|recurrence|recurrence
1050111|NCT02849171|18F-fluorocholine (18F-FCH) PET|18f-fluorocholine (18f-fch) pet
1050112|NCT02849171|16-676|16-676
1050113|NCT02849171|High-grade Gliomas|high-grade gliomas
1050114|NCT02849158|Rectoscopy|rectoscopy
1050115|NCT02849158|Proctectomy|proctectomy
1050116|NCT02849158|Fibroblasts|fibroblasts
1050117|NCT02849145|Circulating tumor DNA|circulating tumor dna
1050118|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
1050119|NCT02849119|Partial nephrectomy|partial nephrectomy
1050120|NCT02849119|Transperitoneal|transperitoneal
1050121|NCT02849119|Retroperitoneal|retroperitoneal
1050122|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
1050123|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
1050124|NCT02849119|Nephrectomy|nephrectomy
1050125|NCT02849106|3D culture|3d culture
1050126|NCT02849106|chemogram|chemogram
1050127|NCT02849106|FOLFOX|folfox
1050128|NCT02849106|FOLFIRI|folfiri
1050129|NCT02849093|Optical coherence tomography|optical coherence tomography
1050130|NCT02849093|imaging of ocular structures|imaging of ocular structures
1050131|NCT02849067|ischaemic heart disease|ischaemic heart disease
1050132|NCT02849067|comedy session|comedy session
1050133|NCT02849067|laughter therapy|laughter therapy
1050134|NCT02849041|Circulating Tumor Cells|circulating tumor cells
1050135|NCT02849041|Lung|lung
1050136|NCT02849028|gut microbiota|gut microbiota
1050137|NCT02849028|sleep disorder|sleep disorder
1050138|NCT02849028|gut-brain axis|gut-brain axis
1050139|NCT02849028|circadian rhythm|circadian rhythm
1050140|NCT02849028|Traumatic Brain Injury|traumatic brain injury
1050141|NCT02849015|liver tumor|liver tumor
1050142|NCT02849015|cryosurgery|cryosurgery
1050143|NCT02849015|NK immunotherapy|nk immunotherapy
1050144|NCT02849002|Concussion|concussion
1050145|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
1050146|NCT02848989|Breast Cancer|breast cancer
1050147|NCT02848950|Metformin|metformin
1050148|NCT02848950|fecundability|fecundability
1050149|NCT02848950|uterine doppler|uterine doppler
1050150|NCT02848937|calcium balance|calcium balance
1050151|NCT02848937|dialysis|dialysis
1050152|NCT02848937|concentrate with citrate|concentrate with citrate
1050153|NCT02848924|prevalence|prevalence
1050154|NCT02848924|surgery|surgery
1050155|NCT02848924|Treatments|treatments
1050156|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1050157|NCT02848898|Focal Vibrations|focal vibrations
1050158|NCT02848898|Neurorehabilitation|neurorehabilitation
1050159|NCT02848898|Spasticity|spasticity
1050160|NCT02848898|Multiple Sclerosis|multiple sclerosis
1050161|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
1050162|NCT02848885|Anosognosia|anosognosia
1050163|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
1050164|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
1050165|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
1050166|NCT02848859|randomized controlled trial|randomized controlled trial
1050167|NCT02848846|Amputees|amputees
1050168|NCT02848820|Appendicitis|appendicitis
1050169|NCT02848820|Appendectomy|appendectomy
1050171|NCT02848781|Sudden Cardiac Death|sudden cardiac death
1050172|NCT02848781|ICD Therapy|icd therapy
1050173|NCT02848781|VT Ablation|vt ablation
1050174|NCT02848690|Sodium restriction|sodium restriction
1050175|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
1050176|NCT02848690|Low-sodium diet|low-sodium diet
1050177|NCT02848690|Adherence|adherence
1050178|NCT02848690|Educational intervention|educational intervention
1050179|NCT02848677|advanced glycation end-products|advanced glycation end-products
1050484|NCT02847156|viruses|viruses
1050180|NCT02848677|Cardiovascular disease|cardiovascular disease
1050181|NCT02848677|Low Sodium Diet|low sodium diet
1050182|NCT02848677|vascular inflammation|vascular inflammation
1050183|NCT02848638|PET, Yttrium-90|pet, yttrium-90
1050184|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1050185|NCT02848625|Yoga|yoga
1050186|NCT02848625|Quality of life|quality of life
1050187|NCT02848612|anticoagulation|anticoagulation
1050188|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
1050189|NCT02848612|interventional neuroradiology|interventional neuroradiology
1050190|NCT02848612|coil embolization|coil embolization
1050191|NCT02848599|postoperative analgesia|postoperative analgesia
1050192|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
1050194|NCT02848586|ECIGS|ecigs
1050195|NCT02848586|e-cigarettes|e-cigarettes
1050196|NCT02848586|lung inflammation|lung inflammation
1050197|NCT02848560|Cystic Fibrosis|cystic fibrosis
1050198|NCT02848560|orkambi|orkambi
1050199|NCT02848560|129Xe MRI|129xe mri
1050200|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
1050201|NCT02848560|LCI|lci
1050202|NCT02848560|CFTR modulator therapy|cftr modulator therapy
1050203|NCT02848534|fever|fever
1050204|NCT02848534|hyperthermia|hyperthermia
1050205|NCT02848534|inflammatory syndrome|inflammatory syndrome
1050206|NCT02848521|ADPKD|adpkd
1050207|NCT02848521|CKD|ckd
1050208|NCT02848521|Rapid progressor|rapid progressor
1050209|NCT02848521|quality of life|quality of life
1050210|NCT02848521|DCE|dce
1050211|NCT02848508|Metformin|metformin
1050212|NCT02848508|moderate renal failure|moderate renal failure
1050213|NCT02848508|severe renal failure|severe renal failure
1050214|NCT02848508|chronic kidney disease|chronic kidney disease
1050215|NCT02848508|hyperlactatemia|hyperlactatemia
1050216|NCT02848508|lactic acidosis|lactic acidosis
1050217|NCT02848495|Aneurysm|aneurysm
1050218|NCT02848495|Biocollection|biocollection
1050219|NCT02848495|Familial Form|familial form
1050220|NCT02848482|Photodynamic therapy|photodynamic therapy
1050221|NCT02848456|Manipulation, Spinal|manipulation, spinal
1050222|NCT02848456|H-Reflex|h-reflex
1050223|NCT02848456|Muscle Contraction|muscle contraction
1050224|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
1050225|NCT02848443|metastatic|metastatic
1050226|NCT02848443|colorectal|colorectal
1050227|NCT02848443|cancer|cancer
1050228|NCT02848443|oxaliplatin|oxaliplatin
1050229|NCT02848443|dose-escalation|dose-escalation
1050230|NCT02848443|Lonsurf|lonsurf
1050231|NCT02848443|nivolumab|nivolumab
1050232|NCT02848443|bevacizumab|bevacizumab
1050233|NCT02848430|Humulus lupulus|humulus lupulus
1050234|NCT02848404|Mild cognitive impairment|mild cognitive impairment
1050235|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
1050236|NCT02848404|Cognitive therapy|cognitive therapy
1050237|NCT02848404|Alzheimer's disease|alzheimer's disease
1050238|NCT02848404|Memory enhancement|memory enhancement
1050239|NCT02848404|Categorical language fluency|categorical language fluency
1050240|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
1050241|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
1050242|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
1050243|NCT02848378|Periodontal Disease|periodontal disease
1050244|NCT02848365|Measurement|measurement
1050245|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
1050246|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
1050247|NCT02848248|CD123 Antigen|cd123 antigen
1050248|NCT02848248|Drug Therapy|drug therapy
1050249|NCT02848248|AML|aml
1050250|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1050251|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1050252|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
1050253|NCT02848235|Kenya|kenya
1050254|NCT02848222|contact lens discomfort|contact lens discomfort
1050255|NCT02848222|dry eye disease|dry eye disease
1050256|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
1050257|NCT02848222|Bruder mask|bruder mask
1050258|NCT02848209|Peeling|peeling
1050259|NCT02848209|Histological skin changes|histological skin changes
1050260|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
1050261|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
1050262|NCT02848170|essential hypertension|essential hypertension
1050263|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1050264|NCT02848170|Developmental Phase III|developmental phase iii
1050265|NCT02848157|dexmedetomidine|dexmedetomidine
1050266|NCT02848157|pudendal block|pudendal block
1050267|NCT02848157|hypospadias|hypospadias
1050268|NCT02848144|Immunoparalysis|immunoparalysis
1050269|NCT02848144|immune response|immune response
1050270|NCT02848144|sepsis|sepsis
1050271|NCT02848144|toxic shock syndrome|toxic shock syndrome
1050272|NCT02848118|Hypoventilation|hypoventilation
1050273|NCT02848118|capnography|capnography
1050274|NCT02848118|bronchoscopy|bronchoscopy
1050275|NCT02848105|aGVHD|agvhd
1050276|NCT02848105|valproic acid|valproic acid
1050277|NCT02848092|Visual Attention|visual attention
1050278|NCT02848092|Automobile Driving|automobile driving
1050279|NCT02848001|CC-90009|cc-90009
1050280|NCT02848001|Hematologic Cancers|hematologic cancers
1050281|NCT02848001|Leukemia|leukemia
1050282|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
1050283|NCT02847988|muscle strength|muscle strength
1050284|NCT02847988|muscle function|muscle function
1050285|NCT02847988|functional status|functional status
1050286|NCT02847975|Becker|becker
1050287|NCT02847975|dystrophy|dystrophy
1050288|NCT02847975|sympatholysis|sympatholysis
1050289|NCT02847962|Fortified-blended foods|fortified-blended foods
1050290|NCT02847962|Extrusion|extrusion
1050291|NCT02847962|Sorghum|sorghum
1050292|NCT02847962|Cowpea|cowpea
1050293|NCT02847962|Vitamin A|vitamin a
1050294|NCT02847962|Iron|iron
1050295|NCT02847962|Protein|protein
1050296|NCT02847962|Food Aid|food aid
1050297|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
1050298|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
1050299|NCT02847962|Growth Velocity|growth velocity
1050300|NCT02847962|Stunting|stunting
1050301|NCT02847962|Wasting|wasting
1050302|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
1050303|NCT02847962|Complementary Feeding|complementary feeding
1050304|NCT02847962|Corn|corn
1050305|NCT02847962|Soy|soy
1050306|NCT02847962|Fortified Foods|fortified foods
1050307|NCT02847962|Food assistance|food assistance
1050308|NCT02847936|triclosan|triclosan
1050309|NCT02847936|sutures|sutures
1050310|NCT02847936|infection|infection
1050311|NCT02847923|Mobile Devices|mobile devices
1050312|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
1050313|NCT02847923|Cerebral Palsy|cerebral palsy
1050314|NCT02847910|tissue suction tube|tissue suction tube
1050315|NCT02847910|disposable instrument|disposable instrument
1050316|NCT02847910|induced abortion|induced abortion
1050317|NCT02847884|IBD|ibd
1050318|NCT02847884|Crohn's disease|crohn's disease
1050319|NCT02847884|Remicade|remicade
1050320|NCT02847884|Infliximab|infliximab
1050321|NCT02847884|Level|level
1050322|NCT02847884|Drug Level|drug level
1050323|NCT02847884|Children|children
1050324|NCT02847871|mobility|mobility
1050325|NCT02847871|exercise|exercise
1050326|NCT02847871|nutrition|nutrition
1050327|NCT02847871|primary care|primary care
1050328|NCT02847871|prevention|prevention
1050329|NCT02847871|care pathway|care pathway
1050330|NCT02847871|elderly patient|elderly patient
1050331|NCT02847858|unsafe sex|unsafe sex
1050332|NCT02847858|unprotected sex|unprotected sex
1050333|NCT02847858|adolescents|adolescents
1050334|NCT02847858|Latinas|latinas
1050335|NCT02847858|Hispanic|hispanic
1050336|NCT02847858|mobile health applications|mobile health applications
1050337|NCT02847858|unintended pregnancy|unintended pregnancy
1050338|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
1050339|NCT02847858|school-based health centers|school-based health centers
1050340|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
1050341|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
1050342|NCT02847845|red ginseng|red ginseng
1050343|NCT02847845|cortisol|cortisol
1050344|NCT02847845|anti-oxidant|anti-oxidant
1050345|NCT02847832|Adnexal Diseases|adnexal diseases
1050346|NCT02847832|Ovary|ovary
1050347|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
1050348|NCT02847832|Ovarian Cysts|ovarian cysts
1050349|NCT02847832|Ovarian Diseases|ovarian diseases
1050350|NCT02847832|Ultrasonography|ultrasonography
1050351|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
1050352|NCT02847832|Diagnosis|diagnosis
1050353|NCT02847832|Early Diagnosis|early diagnosis
1050354|NCT02847832|Early Detection of Cancer|early detection of cancer
1050355|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
1050356|NCT02847832|Genital Diseases, Female|genital diseases, female
1050357|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
1050358|NCT02847832|Cysts|cysts
1050359|NCT02847832|Endocrine System Diseases|endocrine system diseases
1050360|NCT02847832|Gonadal Disorders|gonadal disorders
1050361|NCT02847832|Neoplasms|neoplasms
1050362|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
1050363|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
1050364|NCT02847832|Simple Rules|simple rules
1050365|NCT02847832|Preoperative evaluation|preoperative evaluation
1050366|NCT02847832|Prediction Models|prediction models
1050367|NCT02847832|Logistic Regression Models|logistic regression models
1050368|NCT02847832|Mathematical Models|mathematical models
1050369|NCT02847832|Adnexal Masses|adnexal masses
1050370|NCT02847832|Ovarian Tumors|ovarian tumors
1050371|NCT02847832|Risk of Malignancy|risk of malignancy
1050372|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
1050883|NCT02844907|GLP-1|glp-1
1050373|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
1050374|NCT02847793|Depression|depression
1050375|NCT02847793|Dysphoria|dysphoria
1050376|NCT02847793|Gaze patterns|gaze patterns
1050377|NCT02847793|Eye-tracking|eye-tracking
1050378|NCT02847767|Liver Perfusion|liver perfusion
1050379|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
1050380|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
1050381|NCT02847754|bony metastases|bony metastases
1050382|NCT02847754|physical exercise|physical exercise
1050383|NCT02847741|Depression|depression
1050384|NCT02847741|Cholesterol|cholesterol
1050385|NCT02847741|Suicidal behavior|suicidal behavior
1050386|NCT02847741|Predictive factor|predictive factor
1050388|NCT02847715|PROM|prom
1050389|NCT02847715|Adverse event|adverse event
1050390|NCT02847715|QTool|qtool
1050391|NCT02847715|Aftercare|aftercare
1050392|NCT02847702|Osteoarthritis|osteoarthritis
1050393|NCT02847702|Pain|pain
1050394|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
1050395|NCT02847689|Premature Birth|premature birth
1050396|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
1050397|NCT02847689|Obstetric Labor Complications|obstetric labor complications
1050398|NCT02847689|Pregnancy Complications|pregnancy complications
1050399|NCT02847676|Peritoneal adhesions|peritoneal adhesions
1050400|NCT02847676|Stem cells|stem cells
1050402|NCT02847663|Cold|cold
1050403|NCT02847663|recovery|recovery
1050404|NCT02847650|Early Parkinson Disease|early parkinson disease
1050405|NCT02847650|Phase 2|phase 2
1050406|NCT02847637|Hemophilia A|hemophilia a
1050407|NCT02847637|Emicizumab|emicizumab
1050408|NCT02847611|Dynamometer mechanic|dynamometer mechanic
1050409|NCT02847611|Strength of prehension|strength of prehension
1050410|NCT02847611|Comparison|comparison
1050411|NCT02847611|Device|device
1050412|NCT02847611|Diagnosis|diagnosis
1050413|NCT02847611|Healthy Volunteers|healthy volunteers
1050414|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
1050415|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
1050416|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
1050417|NCT02847585|antioxidant|antioxidant
1050418|NCT02847585|inflammation|inflammation
1050419|NCT02847585|complementary therapy|complementary therapy
1050420|NCT02847533|resistant depression|resistant depression
1050421|NCT02847533|inflammation|inflammation
1050422|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
1050423|NCT02847507|HIV|hiv
1050424|NCT02847507|Hepatitis E|hepatitis e
1050425|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
1050426|NCT02847455|Ilaprazole|ilaprazole
1050427|NCT02847455|Proton pump inhibitor|proton pump inhibitor
1050428|NCT02847455|Duodenal ulcer|duodenal ulcer
1050429|NCT02847455|Acid suppression|acid suppression
1050430|NCT02847455|Randomized trial|randomized trial
1050431|NCT02847442|Ongentys|ongentys
1050432|NCT02847403|dysglycemia|dysglycemia
1050433|NCT02847403|MCI|mci
1050434|NCT02847403|exenatide LAR|exenatide lar
1050435|NCT02847403|GLP-1|glp-1
1050436|NCT02847390|diabetes mellitus|diabetes mellitus
1050437|NCT02847390|physician education|physician education
1050438|NCT02847390|nursing education|nursing education
1050439|NCT02847390|hyperglycemia|hyperglycemia
1050440|NCT02847390|hypoglycemia|hypoglycemia
1050441|NCT02847390|inpatient|inpatient
1050442|NCT02847390|hospital|hospital
1050443|NCT02847390|glycemic control|glycemic control
1050444|NCT02847364|chewing gum|chewing gum
1050445|NCT02847364|prevention|prevention
1050446|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
1050447|NCT02847338|Hypertension|hypertension
1050448|NCT02847312|Oat|oat
1050449|NCT02847312|Phenolic acid|phenolic acid
1050450|NCT02847312|Avenanthramide|avenanthramide
1050451|NCT02847312|FMD|fmd
1050452|NCT02847312|LDI|ldi
1050453|NCT02847312|Gut microbiota|gut microbiota
1050454|NCT02847312|Blood Pressure|blood pressure
1050455|NCT02847312|Renin Angiotensin|renin angiotensin
1050456|NCT02847312|Nitric Oxide|nitric oxide
1050457|NCT02847299|cough help|cough help
1050458|NCT02847299|mechanical insufflation|mechanical insufflation
1050459|NCT02847299|mechanical ventilation|mechanical ventilation
1050460|NCT02847299|neuromuscular diseases|neuromuscular diseases
1050461|NCT02847299|peak cough flow|peak cough flow
1050462|NCT02847273|NIRS|nirs
1050463|NCT02847273|Regional oxygen saturation|regional oxygen saturation
1050464|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
1050465|NCT02847247|healthy|healthy
1050466|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
1050467|NCT02847234|mediastinitis|mediastinitis
1050468|NCT02847221|cough peak flow|cough peak flow
1050469|NCT02847221|scheduled weaning trial|scheduled weaning trial
1050470|NCT02847221|scheduled extubation|scheduled extubation
1050471|NCT02847221|prognosis|prognosis
1050472|NCT02847208|cystic fibrosis|cystic fibrosis
1050473|NCT02847208|contraception|contraception
1050474|NCT02847208|gynaecological follow-up|gynaecological follow-up
1050475|NCT02847208|screening|screening
1050476|NCT02847208|Pap smear|pap smear
1050477|NCT02847208|counselling|counselling
1050478|NCT02847195|pediatric intensive care|pediatric intensive care
1050479|NCT02847195|pain assessment|pain assessment
1050480|NCT02847195|tracheal aspiration|tracheal aspiration
1050481|NCT02847195|sedation|sedation
1050482|NCT02847195|pupillometer|pupillometer
1050483|NCT02847156|cystic fibrosis|cystic fibrosis
1050485|NCT02847156|respiratory viral infection|respiratory viral infection
1050486|NCT02847156|children|children
1050487|NCT02847143|Attachement|attachement
1050488|NCT02847143|Oxytocin|oxytocin
1050489|NCT02847143|fMRI|fmri
1050490|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
1050491|NCT02847091|Ipragliflozin|ipragliflozin
1050492|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
1050493|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
1050494|NCT02847091|ASP1941|asp1941
1050495|NCT02847078|Coronary Disease|coronary disease
1050496|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
1050497|NCT02847078|secondary prevention|secondary prevention
1050498|NCT02847078|smart phone app|smart phone app
1050499|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
1050500|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
1050501|NCT02847026|Rotavirus|rotavirus
1050502|NCT02847026|Rotarix|rotarix
1050503|NCT02847026|RotaTeq|rotateq
1050504|NCT02847026|fIPV|fipv
1050505|NCT02847026|IPV|ipv
1050506|NCT02847013|Postcesarean Section|postcesarean section
1050507|NCT02847013|Postoperative|postoperative
1050508|NCT02847000|Decitabine|decitabine
1050509|NCT02847000|Tetrahydrouridine|tetrahydrouridine
1050510|NCT02847000|Epigenetic Therapy|epigenetic therapy
1050511|NCT02846987|Abemaciclib i|abemaciclib i
1050512|NCT02846987|LY2835219|ly2835219
1050513|NCT02846987|16-376|16-376
1050514|NCT02846974|Pulse Oximetry|pulse oximetry
1050515|NCT02846974|Free and Open Source|free and open source
1050516|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
1086092|NCT02633215|chronic|chronic
1050517|NCT02846961|biosimilar|biosimilar
1050518|NCT02846961|anti-drug antibody|anti-drug antibody
1050519|NCT02846961|trough drug concentration|trough drug concentration
1050520|NCT02846948|sepsis|sepsis
1050521|NCT02846948|echocardiography|echocardiography
1050522|NCT02846948|urgent|urgent
1050523|NCT02846948|abdominal surgery|abdominal surgery
1050524|NCT02846935|p16/CDKN2A|p16/cdkn2a
1050525|NCT02846935|TP53|tp53
1050527|NCT02846935|Decitabine|decitabine
1050528|NCT02846935|Tetrahydrouridine|tetrahydrouridine
1050529|NCT02846935|DEC|dec
1050530|NCT02846883|aneurysms|aneurysms
1050531|NCT02846857|Closed-loop system|closed-loop system
1050532|NCT02846857|Artificial pancreas|artificial pancreas
1050533|NCT02846857|Type 1 diabetes|type 1 diabetes
1050534|NCT02846857|Hypoglycemia|hypoglycemia
1050535|NCT02846857|Insulin|insulin
1050536|NCT02846857|Glucagon|glucagon
1050537|NCT02846831|Type 1 diabetes|type 1 diabetes
1050538|NCT02846831|Artificial pancreas|artificial pancreas
1050539|NCT02846831|Closed-loop system|closed-loop system
1050540|NCT02846831|Hypoglycemia|hypoglycemia
1050541|NCT02846831|Insulin|insulin
1050542|NCT02846818|Microdialysis|microdialysis
1050543|NCT02846818|Cardiac surgery|cardiac surgery
1050544|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
1050545|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
1050546|NCT02846818|Neurological complications|neurological complications
1050547|NCT02846779|Insulin persistence|insulin persistence
1050548|NCT02846779|Telepharmacy|telepharmacy
1050549|NCT02846766|advanced cancer|advanced cancer
1050550|NCT02846766|FGF|fgf
1050551|NCT02846766|FGFR|fgfr
1050552|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
1050553|NCT02846740|cranial electric stimulation|cranial electric stimulation
1050554|NCT02846740|suicide|suicide
1050555|NCT02846740|psychiatric inpatients|psychiatric inpatients
1050556|NCT02846727|Hypoperfusion|hypoperfusion
1050557|NCT02846727|Sepsis|sepsis
1050558|NCT02846714|Education|education
1050559|NCT02846714|Prevention and Control|prevention and control
1050560|NCT02846714|Behavioral Research|behavioral research
1050561|NCT02846701|Neuropathic pain|neuropathic pain
1050562|NCT02846701|Antidepressant|antidepressant
1050563|NCT02846701|Duloxetine|duloxetine
1050564|NCT02846701|Liquid Chromatography|liquid chromatography
1050565|NCT02846701|Mass Spectrometry|mass spectrometry
1050566|NCT02846675|SVF|svf
1050567|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
1050568|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
1050569|NCT02846675|knee|knee
1050570|NCT02846675|adipose|adipose
1050571|NCT02846662|depression|depression
1050572|NCT02846662|mobile technology|mobile technology
1050573|NCT02846662|community trial|community trial
1050574|NCT02846623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1050575|NCT02846623|CLL|cll
1050576|NCT02846623|Relapsed, Refractory|relapsed, refractory
1050577|NCT02846623|High-risk Untreated|high-risk untreated
1050578|NCT02846623|High-risk molecular features|high-risk molecular features
1050579|NCT02846623|Genetic mutation|genetic mutation
1050580|NCT02846623|17p/TP53 deletion|17p/tp53 deletion
1050581|NCT02846623|Obinutuzumab|obinutuzumab
1050582|NCT02846623|GA101|ga101
1050583|NCT02846623|Gazyva|gazyva
1050584|NCT02846623|Atezolizumab|atezolizumab
1050585|NCT02846623|MPDL3280A|mpdl3280a
1050586|NCT02846623|Tencentriq|tencentriq
1050587|NCT02846623|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1050588|NCT02846623|SLL|sll
1050590|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
1050591|NCT02846610|complications|complications
1050592|NCT02846610|epidural analgesia|epidural analgesia
1050593|NCT02846610|antibiotics|antibiotics
1050594|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
1050595|NCT02846597|Sustained lung inflation|sustained lung inflation
1050596|NCT02846597|Delivery room|delivery room
1050597|NCT02846584|CAR T|car t
1050598|NCT02846584|HSCT|hsct
1050599|NCT02846571|Islet Transplantation|islet transplantation
1050600|NCT02846571|Type 1 Diabetes|type 1 diabetes
1050601|NCT02846571|Immune Tolerance Induction|immune tolerance induction
1050602|NCT02846571|Diabetes Complications|diabetes complications
1050603|NCT02846571|Intraocular Transplantation|intraocular transplantation
1050604|NCT02846571|Eye Anterior Chamber|eye anterior chamber
1050605|NCT02846571|Kidney Transplantation|kidney transplantation
1050606|NCT02846571|Immunosuppression|immunosuppression
1050607|NCT02846571|Type 2 Diabetes|type 2 diabetes
1050608|NCT02846558|calorie restriction|calorie restriction
1050609|NCT02846558|weight loss|weight loss
1050610|NCT02846532|Thromboembolism|thromboembolism
1050611|NCT02846532|Fontan Procedure|fontan procedure
1050612|NCT02846532|Children|children
1050613|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
1050614|NCT02846493|Dexamethasone|dexamethasone
1050615|NCT02846467|Informed consent|informed consent
1050616|NCT02846467|Patient Education|patient education
1050617|NCT02846467|Mobile applications|mobile applications
1050618|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
1050619|NCT02846441|ALPPS|alpps
1050620|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
1050621|NCT02846441|SPECT|spect
1050622|NCT02846441|mebrofenin|mebrofenin
1050623|NCT02846415|Dementia|dementia
1050624|NCT02846415|Play and Playthings|play and playthings
1050625|NCT02846415|Cognition|cognition
1050626|NCT02846415|Memory|memory
1050627|NCT02846402|HIV testing|hiv testing
1050628|NCT02846402|Female sex workers|female sex workers
1050629|NCT02846402|HIV self-testing|hiv self-testing
1050630|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
1050631|NCT02846363|stroke|stroke
1050632|NCT02846363|public awareness campaign|public awareness campaign
1050633|NCT02846363|call to EMS|call to ems
1050634|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
1050635|NCT02846337|hemodialysis|hemodialysis
1050636|NCT02846337|peritoneal dialysis|peritoneal dialysis
1050637|NCT02846337|hemofiltration|hemofiltration
1050638|NCT02846337|composite endpoint|composite endpoint
1050639|NCT02846311|test|test
1050640|NCT02846311|winter|winter
1050641|NCT02846311|season|season
1050642|NCT02846298|Drug Monitoring|drug monitoring
1050643|NCT02846298|ICU|icu
1050644|NCT02846298|Pharmacokinetic|pharmacokinetic
1050645|NCT02846298|Pharmacodynamic|pharmacodynamic
1050646|NCT02846298|antibiotic|antibiotic
1050647|NCT02846298|Glycopeptides|glycopeptides
1050648|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
1050649|NCT02846285|Bleeding|bleeding
1050650|NCT02846259|intracranial aneurysm|intracranial aneurysm
1050651|NCT02846259|cerebral ischemia|cerebral ischemia
1050652|NCT02846259|aspirin|aspirin
1050653|NCT02846246|aged care|aged care
1050654|NCT02846246|health|health
1050655|NCT02846246|home care services|home care services
1050656|NCT02846246|person-centred care|person-centred care
1050657|NCT02846220|Medication Adherence|medication adherence
1050658|NCT02846220|Middle Aged 45-64|middle aged 45-64
1050659|NCT02846220|Aged 65-79|aged 65-79
1050660|NCT02846220|Aged, 80 and over|aged, 80 and over
1050661|NCT02846207|cerebral infarction|cerebral infarction
1050662|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
1050663|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
1050664|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
1050665|NCT02846194|Fibromyalgia|fibromyalgia
1050666|NCT02846194|Guided Imagery|guided imagery
1050667|NCT02846194|chronic pain|chronic pain
1050668|NCT02846155|preparation|preparation
1050669|NCT02846155|capsule endoscopy|capsule endoscopy
1050670|NCT02846129|multiple gestation|multiple gestation
1050671|NCT02846129|complications|complications
1050672|NCT02846129|cesarean delivery|cesarean delivery
1050673|NCT02846116|all ceramic crown|all ceramic crown
1050674|NCT02846116|Lithium disilicate|lithium disilicate
1050675|NCT02846116|e-max|e-max
1050676|NCT02846116|vita suprinity|vita suprinity
1050677|NCT02846077|sleep|sleep
1050678|NCT02846077|social networks|social networks
1050679|NCT02846077|undergraduates|undergraduates
1050680|NCT02846077|mood|mood
1050681|NCT02846077|circadian rhythms|circadian rhythms
1050682|NCT02846051|varicose vein|varicose vein
1050683|NCT02846051|physical activity|physical activity
1050684|NCT02846038|Pediatric cancer|pediatric cancer
1050685|NCT02846038|Childhood cancer|childhood cancer
1050686|NCT02846038|High-risk disease|high-risk disease
1050687|NCT02846038|Prognosis|prognosis
1050688|NCT02846038|Communication|communication
1050689|NCT02846038|Bad news|bad news
1050690|NCT02846038|Pediatric oncologist|pediatric oncologist
1050691|NCT02846038|Parent|parent
1050694|NCT02845999|natural killer cells|natural killer cells
1050695|NCT02845999|adoptive transfer|adoptive transfer
1050696|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
1050697|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
1050698|NCT02845986|Stomach Neoplasms|stomach neoplasms
1050699|NCT02845986|Laparoscopy|laparoscopy
1050700|NCT02845986|Spleen-Preserving|spleen-preserving
1050701|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
1050702|NCT02845973|gut microbiota|gut microbiota
1050703|NCT02845921|Propofol|propofol
1050704|NCT02845921|Hypotension|hypotension
1050705|NCT02845921|Induction of anaesthesia|induction of anaesthesia
1050706|NCT02845921|Leg elevation|leg elevation
1050707|NCT02845921|Leg wrapping|leg wrapping
1050708|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
1050709|NCT02845895|Comparison of two organizations|comparison of two organizations
1050710|NCT02845895|Indicator IPAQSS|indicator ipaqss
1050711|NCT02845856|recurrent lung cancer|recurrent lung cancer
1050712|NCT02845856|EGFR mutation|egfr mutation
1050713|NCT02845856|Cetuximab|cetuximab
1050714|NCT02845856|NK immunotherapy|nk immunotherapy
1050715|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
1050716|NCT02845843|MERS-CoV|mers-cov
1050717|NCT02845843|Clinical trial|clinical trial
1050718|NCT02845843|Lopinavir|lopinavir
1050719|NCT02845843|Ritonavir|ritonavir
1050720|NCT02845843|Interferon beta|interferon beta
1050721|NCT02845830|dementia|dementia
1050722|NCT02845830|elderly|elderly
1050723|NCT02845830|quality of life|quality of life
1050724|NCT02845830|assessment|assessment
1050725|NCT02845830|factor|factor
1050726|NCT02845830|trajectory|trajectory
1050727|NCT02845830|change|change
1050728|NCT02845830|early stage|early stage
1050729|NCT02845804|coronary artery disease|coronary artery disease
1050730|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
1050731|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
1050732|NCT02845778|melatonin|melatonin
1050733|NCT02845778|pharmacokinetics|pharmacokinetics
1050734|NCT02845765|Erectile Dysfunction|erectile dysfunction
1050735|NCT02845765|ED|ed
1050736|NCT02845765|Fundus Oculi|fundus oculi
1050737|NCT02845765|Retinal Vascularization|retinal vascularization
1050738|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
1050739|NCT02845765|IIEF|iief
1050740|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
1050741|NCT02845765|DVA|dva
1050742|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
1050743|NCT02845765|PDE5Is|pde5is
1050744|NCT02845739|kidney transplantation|kidney transplantation
1050745|NCT02845739|human papillomavirus|human papillomavirus
1050746|NCT02845687|nicotine addiction|nicotine addiction
1050747|NCT02845687|cigarette smoking|cigarette smoking
1050748|NCT02845661|Narcotrend index|narcotrend index
1050749|NCT02845661|OAA/S scale|oaa/s scale
1050750|NCT02845661|Dexmedetomidine|dexmedetomidine
1050751|NCT02845661|Sedation|sedation
1050752|NCT02845648|anticholinergics|anticholinergics
1050753|NCT02845648|awakener|awakener
1050754|NCT02845622|Hazelnut|hazelnut
1050755|NCT02845622|Cocoa|cocoa
1050756|NCT02845622|Flavonoid|flavonoid
1050757|NCT02845622|Lipids|lipids
1050758|NCT02845622|Vascular Reactivity|vascular reactivity
1050759|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
1050760|NCT02845609|Sialic acid|sialic acid
1050761|NCT02845609|Bleeding|bleeding
1050762|NCT02845583|Nursing|nursing
1050763|NCT02845583|Diagnosis Related Group|diagnosis related group
1050764|NCT02845583|Activity based costing|activity based costing
1050765|NCT02845557|Youth|youth
1050766|NCT02845557|Type 2 Diabetes|type 2 diabetes
1050767|NCT02845557|glucose homeostasis|glucose homeostasis
1050768|NCT02845557|incretin effect|incretin effect
1050769|NCT02845544|Postural Balance|postural balance
1050770|NCT02845531|Variant angina|variant angina
1050771|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
1050772|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1050773|NCT02845531|Optimal Medical Therapy|optimal medical therapy
1050774|NCT02845531|ICD|icd
1050775|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
1050776|NCT02845505|Computed Tomography|computed tomography
1050777|NCT02845492|Exercise|exercise
1050778|NCT02845492|Qigong|qigong
1050779|NCT02845492|Mind-Body|mind-body
1050780|NCT02845492|Fatigue|fatigue
1050781|NCT02845492|Cancer|cancer
1050782|NCT02845492|EEG|eeg
1050783|NCT02845492|HRV|hrv
1050784|NCT02845466|Venous Leg Ulcer|venous leg ulcer
1050785|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
1050786|NCT02845466|Wound Healing|wound healing
1050787|NCT02845466|Growth Factor|growth factor
1050788|NCT02845466|Protease Inhibitor|protease inhibitor
1050789|NCT02845453|youth|youth
1050790|NCT02845453|adolescent|adolescent
1050791|NCT02845453|young adult|young adult
1050792|NCT02845453|substance use disorder|substance use disorder
1050793|NCT02845453|bipolar disorder|bipolar disorder
1050794|NCT02845453|quetiapine|quetiapine
1050795|NCT02845440|Pragmatic Trial|pragmatic trial
1050796|NCT02845440|Community Health Workers|community health workers
1050797|NCT02845440|Academic Detailing|academic detailing
1050798|NCT02845427|Closed Suction Drain|closed suction drain
1050799|NCT02845427|Wound Hematoma|wound hematoma
1050800|NCT02845388|IVF|ivf
1050801|NCT02845362|Neuromuscular|neuromuscular
1050802|NCT02845362|dysphagia|dysphagia
1050803|NCT02845362|Swallowing disorders|swallowing disorders
1050804|NCT02845362|Questionnaire|questionnaire
1050805|NCT02845362|Assessment|assessment
1050806|NCT02845284|adolescent|adolescent
1050807|NCT02845284|reproductive health|reproductive health
1050808|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
1050809|NCT02845245|3D printing|3d printing
1050810|NCT02845245|pre-operative planning|pre-operative planning
1050811|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
1050812|NCT02845232|Therapy|therapy
1050813|NCT02845232|Blood transfusion|blood transfusion
1050814|NCT02845232|Cost-effectiveness|cost-effectiveness
1050815|NCT02845232|Prognosis|prognosis
1050816|NCT02845206|Total Knee Replacement|total knee replacement
1050817|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
1050818|NCT02845180|lipectomy|lipectomy
1050819|NCT02845180|panniculectomy|panniculectomy
1050820|NCT02845154|Ischemia reperfusion|ischemia reperfusion
1050821|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
1050822|NCT02845154|living donor liver transplantation|living donor liver transplantation
1050823|NCT02845154|patient outcome|patient outcome
1050825|NCT02845141|Revision surgery|revision surgery
1050826|NCT02845141|tunnel enlargement|tunnel enlargement
1050827|NCT02845141|bone substitute material|bone substitute material
1050828|NCT02845141|bone graft|bone graft
1050829|NCT02845115|Middle Ear Implant|middle ear implant
1050830|NCT02845115|laser velocimetry|laser velocimetry
1050831|NCT02845102|Chronic Illness|chronic illness
1050832|NCT02845102|Chronic Pain|chronic pain
1050833|NCT02845102|Depression|depression
1050834|NCT02845102|Comorbid Depression|comorbid depression
1050835|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
1050836|NCT02845102|Relational Agent Technology|relational agent technology
1050837|NCT02845102|CBT|cbt
1050838|NCT02845102|Virtual Counselor|virtual counselor
1050839|NCT02845076|Noninvasive ventilation|noninvasive ventilation
1050840|NCT02845076|Respiratory insufficiency|respiratory insufficiency
1050841|NCT02845076|Hypercapnia|hypercapnia
1050842|NCT02845076|ventilator weaning|ventilator weaning
1050843|NCT02845063|muscle plasticity|muscle plasticity
1050844|NCT02845063|exercise|exercise
1050845|NCT02845063|rehabilitation|rehabilitation
1050846|NCT02845063|perfusion|perfusion
1050847|NCT02845063|ACE|ace
1050848|NCT02845063|genotype|genotype
1050849|NCT02845063|hypertension|hypertension
1050850|NCT02845063|molecular biology|molecular biology
1050851|NCT02845050|neo-adjuvant|neo-adjuvant
1050852|NCT02845050|vinflunine|vinflunine
1050853|NCT02845050|cisplatin|cisplatin
1050854|NCT02845050|radical cystectomy|radical cystectomy
1050855|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
1050856|NCT02845050|JaNEO|janeo
1050857|NCT02845011|Cardio first angle|cardio first angle
1050858|NCT02845011|CPR|cpr
1050859|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
1050860|NCT02845011|Clinical trial|clinical trial
1050861|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
1050862|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
1050863|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
1050864|NCT02844985|Sexual Addiction|sexual addiction
1050865|NCT02844985|Genomics|genomics
1050866|NCT02844985|Personality|personality
1050867|NCT02844985|Polymorphism|polymorphism
1050868|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
1050869|NCT02844972|emergency treatment|emergency treatment
1050870|NCT02844959|Atrial Fibrillation|atrial fibrillation
1050871|NCT02844959|Biomarkers|biomarkers
1050872|NCT02844959|Inflammatory Response|inflammatory response
1050873|NCT02844959|C-reactive protein|c-reactive protein
1050874|NCT02844959|FGF2|fgf2
1050875|NCT02844959|MMP8|mmp8
1050876|NCT02844959|troponin I|troponin i
1050877|NCT02844959|body temperature|body temperature
1050878|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
1050879|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
1050880|NCT02844946|Veterans|veterans
1050881|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
1050882|NCT02844907|Incretins|incretins
1050884|NCT02844907|Exendin-9|exendin-9
1050885|NCT02844907|Insulin Resistance|insulin resistance
1050886|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
1050887|NCT02844868|stroke|stroke
1050888|NCT02844868|hemiplegia|hemiplegia
1050889|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1050890|NCT02844868|rehabilitation|rehabilitation
1050891|NCT02844868|lower extremity|lower extremity
1050892|NCT02844868|gait training|gait training
1050893|NCT02844855|Alzheimer|alzheimer
1050894|NCT02844855|Parkinson|parkinson
1050895|NCT02844855|Action memory|action memory
1050896|NCT02844842|mild or moderate|mild or moderate
1050897|NCT02844829|Prostate Cancer|prostate cancer
1050898|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
1050899|NCT02844777|topical ointment|topical ointment
1050900|NCT02844777|skin|skin
1050901|NCT02844777|hexokinase|hexokinase
1050902|NCT02844777|precancerous conditions|precancerous conditions
1050903|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
1050904|NCT02844712|Drug hypersensitivity|drug hypersensitivity
1050905|NCT02844712|Betalactam|betalactam
1050906|NCT02844712|Drug provocation test|drug provocation test
1050907|NCT02844699|prostate cancer|prostate cancer
1050908|NCT02844699|adenovirus|adenovirus
1050909|NCT02844699|TLR5|tlr5
1050910|NCT02844699|immunotherapy|immunotherapy
1050911|NCT02844699|Ad5|ad5
1050912|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
1050913|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
1050914|NCT02844673|Sickle cell disease|sickle cell disease
1050915|NCT02844673|Hydroxyurea|hydroxyurea
1050916|NCT02844673|Adherence|adherence
1050917|NCT02844673|randomized trial|randomized trial
1050918|NCT02844673|medication possession ratio|medication possession ratio
1050919|NCT02844660|Diabetes Mellitus|diabetes mellitus
1050920|NCT02844660|Foot Diseases|foot diseases
1050921|NCT02844660|Foot Ulcer|foot ulcer
1050922|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
1050923|NCT02844634|men who have sex with men|men who have sex with men
1050924|NCT02844634|HIV prevention|hiv prevention
1050925|NCT02844634|sexually transmitted infection|sexually transmitted infection
1050926|NCT02844634|syphilis|syphilis
1050927|NCT02844608|Health-related quality of life|health-related quality of life
1050928|NCT02844608|Oncology clinical practice|oncology clinical practice
1050929|NCT02844608|Electronic collection|electronic collection
1050930|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
1050931|NCT02844569|Dental Implants|dental implants
1050932|NCT02844569|Bone Grafting|bone grafting
1050933|NCT02844556|SMILE surgery|smile surgery
1050934|NCT02844556|FS-LASIK surgery|fs-lasik surgery
1050935|NCT02844556|multicenter|multicenter
1050936|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
1050937|NCT02844530|adults|adults
1050938|NCT02844517|Artificial Pancreas|artificial pancreas
1050939|NCT02844517|Closed Loop Control|closed loop control
1050940|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1050941|NCT02844504|Fatigue|fatigue
1050942|NCT02844504|Breast cancer|breast cancer
1050943|NCT02844504|Force|force
1050944|NCT02844504|Motor imagery|motor imagery
1050945|NCT02844504|Cancer Treatment|cancer treatment
1050946|NCT02844478|Caregiving|caregiving
1050947|NCT02844478|Family caregiving|family caregiving
1050948|NCT02844478|Stress|stress
1050949|NCT02844478|dementia caregiving|dementia caregiving
1050950|NCT02844478|Hispanics|hispanics
1050951|NCT02844478|Spanish|spanish
1050952|NCT02844478|Telomere|telomere
1050953|NCT02844465|epilepsy|epilepsy
1050954|NCT02844465|laser ablation|laser ablation
1050955|NCT02844465|Visualase|visualase
1050956|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
1050957|NCT02844452|Atopic Dermatitis|atopic dermatitis
1050958|NCT02844452|acupuncture|acupuncture
1050959|NCT02844452|visit frequency|visit frequency
1050960|NCT02844452|adult patient with AD|adult patient with ad
1050961|NCT02844426|synbiotic|synbiotic
1050962|NCT02844426|soluble dietary fiber|soluble dietary fiber
1050963|NCT02844426|slow transit constipation|slow transit constipation
1050964|NCT02844426|microbiota|microbiota
1050965|NCT02844387|cancer|cancer
1050966|NCT02844387|brain|brain
1050967|NCT02844387|arginine|arginine
1050968|NCT02844387|radiation|radiation
1050969|NCT02844374|Epilepsy|epilepsy
1050970|NCT02844374|Surgery candidate|surgery candidate
1050971|NCT02844374|EEG's Signal|eeg's signal
1050972|NCT02844361|high-risk|high-risk
1050973|NCT02844361|ASCT|asct
1050974|NCT02844348|Pain|pain
1050975|NCT02844348|Hypnosis|hypnosis
1050976|NCT02844348|Chronic Dialysis|chronic dialysis
1050977|NCT02844348|Arterial Disease|arterial disease
1050978|NCT02844335|Breast Cancer|breast cancer
1050979|NCT02844335|Cryosurgery|cryosurgery
1050980|NCT02844335|NK Immunotherapy|nk immunotherapy
1050981|NCT02844296|short-bout exercise|short-bout exercise
1050982|NCT02844296|craving|craving
1050983|NCT02844296|handgrip|handgrip
1051087|NCT02843789|Adipokines|adipokines
1050984|NCT02844296|smoking cessation|smoking cessation
1050986|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
1050987|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
1050988|NCT02844257|Transfusion dependency|transfusion dependency
1050989|NCT02844257|Transfusion intensity|transfusion intensity
1050990|NCT02844257|Prognosis|prognosis
1050991|NCT02844257|Chemotherapy|chemotherapy
1050992|NCT02844244|family well-being|family well-being
1050993|NCT02844244|positive psychology|positive psychology
1050994|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
1050995|NCT02844218|Chemotherapy|chemotherapy
1050996|NCT02844218|Low-intensity therapy|low-intensity therapy
1050997|NCT02844218|Older patients|older patients
1050998|NCT02844218|Prognosis|prognosis
1050999|NCT02844218|Supportive care|supportive care
1051000|NCT02844205|nursing care|nursing care
1051001|NCT02844205|observational scale|observational scale
1051002|NCT02844205|neonate|neonate
1051003|NCT02844205|premature infant|premature infant
1051004|NCT02844205|developmental care|developmental care
1051005|NCT02844192|Vancomycin|vancomycin
1051006|NCT02844192|under dosage|under dosage
1051007|NCT02844192|intensive care unit|intensive care unit
1051008|NCT02844192|pharmacokinetics|pharmacokinetics
1051009|NCT02844153|Metformin|metformin
1051010|NCT02844153|type 2 diabetes|type 2 diabetes
1051011|NCT02844153|chronic kidney disease|chronic kidney disease
1051012|NCT02844153|antidiabetic medications|antidiabetic medications
1051013|NCT02844153|lactic acidosis|lactic acidosis
1051014|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
1051015|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1051016|NCT02844114|Chemotherapy|chemotherapy
1051017|NCT02844114|Gemcitabine|gemcitabine
1051018|NCT02844114|Cisplatin|cisplatin
1051019|NCT02844088|meningococcus C|meningococcus c
1051020|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1051021|NCT02844075|pembrolizumab|pembrolizumab
1051022|NCT02844075|PD-1|pd-1
1051023|NCT02844075|neoadjuvant|neoadjuvant
1051024|NCT02844075|chemoradiation|chemoradiation
1051025|NCT02844049|Deep Brain Stimulation|deep brain stimulation
1051026|NCT02844049|Quality of Life|quality of life
1051027|NCT02844036|Distal Lesions|distal lesions
1051028|NCT02844036|Post-embolic HTP|post-embolic htp
1051029|NCT02844036|Angioplasty|angioplasty
1051030|NCT02844023|Arteritis|arteritis
1051031|NCT02844023|Biomarker|biomarker
1051032|NCT02844023|Horton disease|horton disease
1051033|NCT02843997|Bipolar disorder|bipolar disorder
1051034|NCT02843997|Endophenotype|endophenotype
1051035|NCT02843997|Family|family
1051036|NCT02843997|Autosomal dominant expression|autosomal dominant expression
1051037|NCT02843997|Sequencing|sequencing
1051038|NCT02843997|Heritability|heritability
1051039|NCT02843984|Amniocentesis|amniocentesis
1051040|NCT02843971|Water Drinking Test|water drinking test
1051041|NCT02843971|Intraocular Pressure|intraocular pressure
1051042|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
1051043|NCT02843958|Medical device|medical device
1051044|NCT02843958|Hemoptic|hemoptic
1051045|NCT02843958|Vitamin K antagonist|vitamin k antagonist
1051046|NCT02843958|Diagnostic in vitro|diagnostic in vitro
1051047|NCT02843945|brachytherapy|brachytherapy
1051048|NCT02843945|CivaSheet|civasheet
1051049|NCT02843945|CivaTech|civatech
1051050|NCT02843945|whipple|whipple
1051051|NCT02843945|radiation|radiation
1051052|NCT02843945|borderline resectable|borderline resectable
1051053|NCT02843945|locally advanced|locally advanced
1051054|NCT02843945|Pd-103|pd-103
1051055|NCT02843945|intraoperative radiation|intraoperative radiation
1051056|NCT02843932|Somatoform|somatoform
1051057|NCT02843932|Psychogenic|psychogenic
1051058|NCT02843919|Electrocardiography|electrocardiography
1051059|NCT02843919|Electroencephalography|electroencephalography
1051060|NCT02843919|Neural Correlates|neural correlates
1051061|NCT02843919|Mental Workload|mental workload
1051062|NCT02843906|alzheimer disease|alzheimer disease
1051063|NCT02843906|bipolar disorders|bipolar disorders
1051064|NCT02843906|mild cognitive impairement|mild cognitive impairement
1051065|NCT02843893|Pupillary|pupillary
1051066|NCT02843893|Reflexes|reflexes
1051067|NCT02843893|Analgesia|analgesia
1051068|NCT02843893|Sedation|sedation
1051069|NCT02843880|CMV reactivation|cmv reactivation
1051070|NCT02843880|CMV disease|cmv disease
1051071|NCT02843880|Predictive factors|predictive factors
1051072|NCT02843880|Critically ill patients|critically ill patients
1051073|NCT02843880|Septic shock|septic shock
1051074|NCT02843867|Transplantation|transplantation
1051075|NCT02843867|Immunology|immunology
1051076|NCT02843867|Atherosclerosis|atherosclerosis
1051077|NCT02843828|Exoskeleton Device|exoskeleton device
1051078|NCT02843828|elderly|elderly
1051079|NCT02843828|stroke|stroke
1051080|NCT02843828|gait rehabilitation|gait rehabilitation
1051081|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
1051082|NCT02843815|Cryosurgery|cryosurgery
1051083|NCT02843815|NK Immunotherapy|nk immunotherapy
1051084|NCT02843802|Metastatic liver cancer|metastatic liver cancer
1051085|NCT02843802|Cryosurgery|cryosurgery
1051086|NCT02843802|NK Immunotherapy|nk immunotherapy
1051088|NCT02843789|Tocilizumab|tocilizumab
1051089|NCT02843776|Palliative Care|palliative care
1051090|NCT02843776|Euthanasia|euthanasia
1051091|NCT02843776|Epidemiologic Studies|epidemiologic studies
1051092|NCT02843750|Rehabilitation|rehabilitation
1051093|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
1051094|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
1051095|NCT02843724|HbA1c >7.0%|hba1c >7.0%
1051096|NCT02843711|Lungcarta Panel|lungcarta panel
1051097|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
1051098|NCT02843672|metatarsalgia|metatarsalgia
1051099|NCT02843672|surgery|surgery
1051100|NCT02843672|weil|weil
1051102|NCT02843672|percutaneous|percutaneous
1051103|NCT02843672|DMMO|dmmo
1051104|NCT02843646|gait training|gait training
1051105|NCT02843646|stepping|stepping
1051106|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
1051107|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
1051108|NCT02843633|Drug Coated Stent|drug coated stent
1051109|NCT02843633|Drug Eluting Stent|drug eluting stent
1051110|NCT02843620|Native Collagen|native collagen
1051111|NCT02843620|Joint|joint
1051112|NCT02843620|Joint Discomfort|joint discomfort
1051113|NCT02843607|Kidney Cancer|kidney cancer
1051114|NCT02843607|Cryosurgery|cryosurgery
1051115|NCT02843607|NK Immunotherapy|nk immunotherapy
1051116|NCT02843581|Esophageal Cancer|esophageal cancer
1051117|NCT02843581|NK immunotherapy|nk immunotherapy
1051118|NCT02843581|Safety|safety
1051119|NCT02843581|Efficacy|efficacy
1051120|NCT02843555|Leukodystrophy|leukodystrophy
1051121|NCT02843555|Myelin Gene|myelin gene
1051122|NCT02843555|Myelin Protein|myelin protein
1051123|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
1051124|NCT02843555|Undiagnosed Disease|undiagnosed disease
1051125|NCT02843555|Schwann Cell|schwann cell
1051126|NCT02843555|White Matter Pathology|white matter pathology
1051127|NCT02843555|Motor Delay|motor delay
1051128|NCT02843555|Cognitive Regression|cognitive regression
1051129|NCT02843555|Motor Deterioration|motor deterioration
1051130|NCT02843555|Unknown Disease|unknown disease
1051131|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
1051132|NCT02843542|Hyperthyroidism|hyperthyroidism
1051133|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
1051134|NCT02843529|biomarkers|biomarkers
1051135|NCT02843529|CSF|csf
1051136|NCT02843529|EEG|eeg
1051137|NCT02843529|MRI|mri
1051138|NCT02843529|Digital biomarkers|digital biomarkers
1051139|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
1051140|NCT02843490|biomarker|biomarker
1051141|NCT02843490|ranibizumab|ranibizumab
1051142|NCT02843490|lucentis|lucentis
1051143|NCT02843438|Toxoplasmosis|toxoplasmosis
1051144|NCT02843438|Uveitis|uveitis
1051145|NCT02843438|Chorioretinitis|chorioretinitis
1051146|NCT02843438|Infection|infection
1051147|NCT02843425|Cancer Prevention|cancer prevention
1051148|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
1051149|NCT02843425|Canned beans|canned beans
1051150|NCT02843425|Questionnaires|questionnaires
1051151|NCT02843425|Surveys|surveys
1051152|NCT02843425|Stool samples|stool samples
1051153|NCT02843412|Gastric cancer|gastric cancer
1051154|NCT02843412|Her2/neu|her2/neu
1051155|NCT02843412|Dual paraffin blocks|dual paraffin blocks
1051156|NCT02843412|Trastuzumab|trastuzumab
1051157|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
1051158|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
1051159|NCT02843386|Uveal melanoma|uveal melanoma
1051160|NCT02843386|High risk of metastasis|high risk of metastasis
1051161|NCT02843386|Genomic high risk signature|genomic high risk signature
1051162|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
1051163|NCT02843360|public health|public health
1051164|NCT02843347|Biorepository|biorepository
1051165|NCT02843347|Genetics|genetics
1051166|NCT02843334|Fabry disease|fabry disease
1051167|NCT02843334|End Stage Renal Disease|end stage renal disease
1051168|NCT02843334|chronic dialysis|chronic dialysis
1051169|NCT02843334|alpha galactosidase A|alpha galactosidase a
1051170|NCT02843334|Lyso-GB3|lyso-gb3
1051171|NCT02843334|GLA mutation|gla mutation
1051172|NCT02843334|Prevalence|prevalence
1051173|NCT02843321|infection|infection
1051174|NCT02843308|hoarding disorder|hoarding disorder
1051175|NCT02843308|hoarding|hoarding
1051176|NCT02843308|clutter|clutter
1051177|NCT02843295|renal transplantation|renal transplantation
1051178|NCT02843295|immunology|immunology
1051179|NCT02843295|rejection|rejection
1051180|NCT02843269|RCT|rct
1051181|NCT02843269|Multi-component intervention|multi-component intervention
1051182|NCT02843269|Health personnel|health personnel
1051183|NCT02843269|Physical exercise training|physical exercise training
1051184|NCT02843230|Brain Tumor|brain tumor
1051185|NCT02843204|solid tumor|solid tumor
1051186|NCT02843204|anti-PD-L1|anti-pd-l1
1051187|NCT02843204|NK immunotherapy|nk immunotherapy
1051188|NCT02843191|Rectal Cancer|rectal cancer
1051189|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
1051190|NCT02843178|nutrition|nutrition
1051191|NCT02843178|food security|food security
1051192|NCT02843178|behavioral economics|behavioral economics
1051193|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
1051194|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
1051195|NCT02843139|Circulating microRNA|circulating microrna
1051196|NCT02843139|Childhood obesity|childhood obesity
1051197|NCT02843139|Adulthood diabetes|adulthood diabetes
1051198|NCT02843126|recurrent breast cancer|recurrent breast cancer
1051199|NCT02843126|Her-2 positive|her-2 positive
1051200|NCT02843126|Trastuzumab|trastuzumab
1051201|NCT02843126|NK immunotherapy|nk immunotherapy
1051202|NCT02843113|single father|single father
1051203|NCT02843113|parenting behavior|parenting behavior
1051204|NCT02843100|Crohn's Disease|crohn's disease
1051205|NCT02843100|Pediatric|pediatric
1051206|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
1051207|NCT02843100|Diet|diet
1051208|NCT02843100|Microbiome|microbiome
1051209|NCT02843087|Breastfeeding|breastfeeding
1051210|NCT02843087|Microbiome|microbiome
1051211|NCT02843087|BEACH|beach
1051212|NCT02843087|Human milk|human milk
1051213|NCT02843087|Pediatric Obesity|pediatric obesity
1051214|NCT02843074|B-cell tumors|b-cell tumors
1051215|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
1051216|NCT02843074|blood cancers|blood cancers
1051217|NCT02843061|B lymphoma|b lymphoma
1051218|NCT02843061|Rituximab|rituximab
1051219|NCT02843061|NK immunotherapy|nk immunotherapy
1051220|NCT02843048|Osteoporosis|osteoporosis
1051221|NCT02843048|Bariatric Surgery|bariatric surgery
1051222|NCT02843048|Physical exercise|physical exercise
1051223|NCT02843048|Obesity|obesity
1051224|NCT02843022|postpartum|postpartum
1051225|NCT02843022|nursing|nursing
1051226|NCT02843022|follow-up|follow-up
1051227|NCT02842983|Esmolol|esmolol
1051228|NCT02842983|Hypotension|hypotension
1051229|NCT02842983|Shock, Septic|shock, septic
1051230|NCT02842983|Sepsis|sepsis
1051231|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1051232|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
1051233|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
1051234|NCT02842983|Pharmacologic Actions|pharmacologic actions
1051235|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
1051236|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
1051237|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
1051238|NCT02842918|Neurodynamics|neurodynamics
1051239|NCT02842918|Sham|sham
1051240|NCT02842866|Meningitis|meningitis
1051241|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
1051242|NCT02842866|Meningococcal Infections|meningococcal infections
1051243|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
1051244|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
1051245|NCT02842853|Meningitis|meningitis
1051246|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
1051247|NCT02842853|Meningococcal Infections|meningococcal infections
1051248|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
1051249|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
1051250|NCT02842827|LSD1|lsd1
1051251|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
1051252|NCT02842814|Stable|stable
1051253|NCT02842814|Relapse Risk|relapse risk
1051254|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
1051255|NCT02842788|prone position|prone position
1051256|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1051257|NCT02842788|mechanical ventilation|mechanical ventilation
1051258|NCT02842788|ICU|icu
1051259|NCT02842788|prevalence|prevalence
1051260|NCT02842775|rehabilitation|rehabilitation
1051261|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
1051262|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
1051263|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
1051264|NCT02842762|Anesthesia|anesthesia
1051265|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
1051266|NCT02842736|endometrial ablation|endometrial ablation
1051267|NCT02842723|craniopharyngioma|craniopharyngioma
1051268|NCT02842723|protontherapy|protontherapy
1051269|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
1051270|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
1051271|NCT02842697|computed tomographic angiography|computed tomographic angiography
1051272|NCT02842671|autism|autism
1051273|NCT02842671|ambassador|ambassador
1051274|NCT02842658|Chemotherapy|chemotherapy
1051275|NCT02842658|Exercise|exercise
1051276|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
1051277|NCT02842645|Health|health
1051278|NCT02842645|Growth|growth
1051279|NCT02842580|colorectal|colorectal
1051280|NCT02842580|cancer|cancer
1051281|NCT02842580|metastasis|metastasis
1051282|NCT02842554|PDN|pdn
1051283|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
1051284|NCT02842554|Diabetes|diabetes
1051285|NCT02842502|Skin Substitutes|skin substitutes
1051286|NCT02842489|colonoscopy insertion|colonoscopy insertion
1051287|NCT02842489|tilt-down position|tilt-down position
1051288|NCT02842476|pulse oximetry|pulse oximetry
1051289|NCT02842437|dexmedetomidine|dexmedetomidine
1051290|NCT02842437|sepsis|sepsis
1051291|NCT02842437|respiration|respiration
1051292|NCT02842424|Ramipril|ramipril
1051293|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
1051294|NCT02842424|Claudication|claudication
1051295|NCT02842424|Myopathy|myopathy
1051296|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
1051297|NCT02842411|bowel preparation|bowel preparation
1051298|NCT02842411|chronic constipation|chronic constipation
1051299|NCT02842411|risk factor|risk factor
1051302|NCT02842398|street-crossing|street-crossing
1051303|NCT02842385|soft tissue thickness|soft tissue thickness
1051304|NCT02842385|dental implant|dental implant
1051305|NCT02842385|crestal bone loss|crestal bone loss
1051306|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
1051307|NCT02842372|GvHD|gvhd
1051308|NCT02842372|Ectoin|ectoin
1051309|NCT02842372|Dermatitis|dermatitis
1051310|NCT02842372|Inflammation of the skin|inflammation of the skin
1051311|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
1051312|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
1051313|NCT02842307|Acupuncture|acupuncture
1051314|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
1051316|NCT02842307|Vomiting|vomiting
1051317|NCT02842307|Cancer|cancer
1051318|NCT02842294|bevacizumab|bevacizumab
1051319|NCT02842294|health related quality of life|health related quality of life
1051320|NCT02842255|Sleep apnea|sleep apnea
1051321|NCT02842255|Oximeter|oximeter
1051322|NCT02842255|Calibration|calibration
1051323|NCT02842255|Oxygen partial pressure|oxygen partial pressure
1051324|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
1051325|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
1051326|NCT02842229|Multiple Myeloma|multiple myeloma
1051327|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
1051328|NCT02842229|Elderly Patients|elderly patients
1051329|NCT02842229|Haematological malignancy|haematological malignancy
1051330|NCT02842229|Elderly|elderly
1051331|NCT02842229|Health Status|health status
1051332|NCT02842229|Scale validation|scale validation
1051333|NCT02842229|Retrospective|retrospective
1051334|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
1051335|NCT02842216|Dietary supplements|dietary supplements
1051336|NCT02842203|colorectal cancer|colorectal cancer
1051337|NCT02842190|Neonatal|neonatal
1051338|NCT02842190|NIPPV|nippv
1051339|NCT02842190|BIPAP|bipap
1051340|NCT02842190|Extubation failure|extubation failure
1051341|NCT02842151|IOL|iol
1051342|NCT02842125|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
1051343|NCT02842125|solid tumors|solid tumors
1051344|NCT02842125|nivolumab|nivolumab
1051345|NCT02842125|Ad-P53|ad-p53
1051346|NCT02842125|metastatic|metastatic
1051347|NCT02842125|capecitabine|capecitabine
1051348|NCT02842125|pembrolizumab|pembrolizumab
1051349|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
1051350|NCT02842112|prognosis|prognosis
1051351|NCT02842112|stem cell harvest|stem cell harvest
1051352|NCT02842112|autologous transplant|autologous transplant
1051353|NCT02842112|leukemia stem cell|leukemia stem cell
1051354|NCT02842060|Prevention & Control|prevention & control
1051355|NCT02842060|Young Adult|young adult
1051356|NCT02842060|Internet|internet
1051357|NCT02842047|caregiver|caregiver
1051358|NCT02842047|end of life|end of life
1051359|NCT02842034|schizophrenia|schizophrenia
1051360|NCT02842034|rTMS|rtms
1051361|NCT02842008|Exercise Therapy|exercise therapy
1051362|NCT02842008|Shoulder pain|shoulder pain
1051363|NCT02842008|Shoulder injuries|shoulder injuries
1051364|NCT02842008|Shoulder function|shoulder function
1051365|NCT02842008|Prevention|prevention
1051366|NCT02842008|Wheelchair users|wheelchair users
1051367|NCT02841995|cGVHD|cgvhd
1051368|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1051369|NCT02841995|Immune System Diseases|immune system diseases
1051370|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
1051371|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
1051372|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
1051373|NCT02841995|Glucocorticoids|glucocorticoids
1051374|NCT02841995|Corticosteroids|corticosteroids
1051375|NCT02841969|Ulcer|ulcer
1051376|NCT02841969|Electrolysed|electrolysed
1051377|NCT02841969|Water|water
1051378|NCT02841943|Fluid responsiveness|fluid responsiveness
1051379|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
1051380|NCT02841943|Thoracic surgery|thoracic surgery
1051381|NCT02841943|Hypovolemia|hypovolemia
1051382|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
1051383|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
1051384|NCT02841943|hypercarbia|hypercarbia
1051385|NCT02841943|Carotid artery|carotid artery
1051386|NCT02841943|ultrasonography|ultrasonography
1051387|NCT02841943|Doppler|doppler
1051388|NCT02841930|Healthcare Access|healthcare access
1051389|NCT02841930|Undocumented Immigrants|undocumented immigrants
1051390|NCT02841930|Primary Prevention|primary prevention
1051391|NCT02841800|radiofrequency ablation|radiofrequency ablation
1051392|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
1051393|NCT02841787|Depression|depression
1051394|NCT02841787|Web-based intervention|web-based intervention
1051395|NCT02841787|Aging|aging
1051396|NCT02841787|Geriatrics|geriatrics
1051397|NCT02841787|Social network|social network
1051398|NCT02841787|Older adults|older adults
1051399|NCT02841748|Pembrolizumab|pembrolizumab
1051400|NCT02841748|HNSCC|hnscc
1051401|NCT02841735|brief intervention|brief intervention
1051402|NCT02841735|web-based interventions|web-based interventions
1051403|NCT02841735|harm reduction|harm reduction
1051404|NCT02841735|young adult|young adult
1051405|NCT02841735|college student|college student
1051406|NCT02841709|insomnia|insomnia
1051407|NCT02841709|elderly|elderly
1051408|NCT02841709|Polysomnography|polysomnography
1051409|NCT02841696|Heart failure|heart failure
1051410|NCT02841696|Systolic dysfunction|systolic dysfunction
1051412|NCT02841696|Arterial stiffness|arterial stiffness
1051413|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
1051414|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
1051415|NCT02841657|Visual work load|visual work load
1051416|NCT02841657|Nasa Task Load Index|nasa task load index
1051417|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
1051418|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
1051419|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
1051420|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
1051421|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1051422|NCT02841540|H3B-8800|h3b-8800
1051423|NCT02841501|Gene Expression Profiling|gene expression profiling
1051424|NCT02841501|Genome-Wide Association Study|genome-wide association study
1051425|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1051426|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
1051427|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
1051428|NCT02841462|thermal ablation|thermal ablation
1051429|NCT02841462|recurrent Bursitis|recurrent bursitis
1051430|NCT02841462|chronic Bursitis|chronic bursitis
1051431|NCT02841462|olecranon|olecranon
1051432|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
1051433|NCT02841449|Hydration|hydration
1051434|NCT02841449|Glycemic control|glycemic control
1051435|NCT02841449|Appetite|appetite
1051436|NCT02841449|Endocrinology|endocrinology
1051437|NCT02841436|irreversible electroporation|irreversible electroporation
1051438|NCT02841436|pancreatic cancer|pancreatic cancer
1051439|NCT02841423|physical status I-III;|physical status i-iii;
1051440|NCT02841423|age > 55 yr)|age > 55 yr)
1051441|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
1051442|NCT02841410|Food|food
1051443|NCT02841410|Emotion|emotion
1051444|NCT02841410|Health|health
1051445|NCT02841410|Nutrition|nutrition
1051446|NCT02841410|Heuristic|heuristic
1051447|NCT02841410|Reasoning|reasoning
1051448|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
1051449|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
1051450|NCT02841384|postural balance|postural balance
1051451|NCT02841384|knee|knee
1051452|NCT02841384|physiotherapy|physiotherapy
1051453|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
1051454|NCT02841371|serum creatinine|serum creatinine
1051455|NCT02841371|serum cystatin C|serum cystatin c
1051456|NCT02841371|chronic kidney disease|chronic kidney disease
1051457|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
1051458|NCT02841358|Psychiatric|psychiatric
1051459|NCT02841358|Psychotic disorders|psychotic disorders
1051460|NCT02841345|emotional processing|emotional processing
1051461|NCT02841345|action|action
1051462|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
1051463|NCT02841332|Positron emission tomography|positron emission tomography
1051464|NCT02841332|Fluoro misonidazole|fluoro misonidazole
1051465|NCT02841332|MRI multimodal|mri multimodal
1051466|NCT02841319|Virtual reality|virtual reality
1051467|NCT02841319|Hemiplegic|hemiplegic
1051468|NCT02841319|Cerebral Palsy|cerebral palsy
1051469|NCT02841319|upper extremity|upper extremity
1051470|NCT02841319|hand function|hand function
1051471|NCT02841293|Anorectal cancer|anorectal cancer
1051472|NCT02841293|perineal morbidity|perineal morbidity
1051473|NCT02841293|cost-utility analysis|cost-utility analysis
1051474|NCT02841293|biological meshes|biological meshes
1051475|NCT02841241|esmolol|esmolol
1051476|NCT02841241|adrenergic storm|adrenergic storm
1051477|NCT02841241|septic shock|septic shock
1051478|NCT02841228|SIB-IMRT|sib-imrt
1051479|NCT02841228|NSCLC|nsclc
1051480|NCT02841228|Radiochemothearpy|radiochemothearpy
1051481|NCT02841215|Gale|gale
1051482|NCT02841215|Severe forms of scabies|severe forms of scabies
1051483|NCT02841215|Oral parasitic drug|oral parasitic drug
1051484|NCT02841215|Ivermectin|ivermectin
1051485|NCT02841202|optical coherence tomography|optical coherence tomography
1051486|NCT02841202|oral contraceptive pills|oral contraceptive pills
1051487|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
1051488|NCT02841163|Patient Satisfaction|patient satisfaction
1051489|NCT02841163|Numeric Rating Scale|numeric rating scale
1051490|NCT02841124|Decision making|decision making
1051491|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
1051492|NCT02841085|Genetic|genetic
1051493|NCT02841085|Thrombophilia|thrombophilia
1051494|NCT02841059|quality of life|quality of life
1051495|NCT02841059|urinary incontinence|urinary incontinence
1051497|NCT02841046|stroke volume variation|stroke volume variation
1051498|NCT02841046|cardiac index|cardiac index
1051499|NCT02841046|non-severe patients|non-severe patients
1051500|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
1051501|NCT02841033|Daratumumab|daratumumab
1051502|NCT02840994|CV301, NSCLC, Pembrolizumab, Nivolumab|cv301, nsclc, pembrolizumab, nivolumab
1051503|NCT02840955|Atopic dermatitis|atopic dermatitis
1051504|NCT02840955|Staphylococcus aureus|staphylococcus aureus
1051505|NCT02840955|Microbiome|microbiome
1051506|NCT02840955|Staphefekt|staphefekt
1051507|NCT02840942|intravenous line|intravenous line
1051508|NCT02840942|robot|robot
1051509|NCT02840916|Laser acupuncture|laser acupuncture
1051510|NCT02840916|Postpartum weight retention|postpartum weight retention
1051511|NCT02840916|Obesity|obesity
1051512|NCT02840903|CTA|cta
1051513|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
1051514|NCT02840877|tuberculosis culture|tuberculosis culture
1051515|NCT02840877|alcohol use|alcohol use
1051516|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
1051517|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
1051518|NCT02840851|Hypercapnia|hypercapnia
1051519|NCT02840799|Heart Failure|heart failure
1051520|NCT02840799|Exercise Intolerance|exercise intolerance
1051521|NCT02840799|Ejection Fraction|ejection fraction
1051522|NCT02840786|stents|stents
1051523|NCT02840786|atherectomy|atherectomy
1051524|NCT02840786|femoral artery|femoral artery
1051525|NCT02840786|popliteal artery|popliteal artery
1051527|NCT02840773|OPG|opg
1051528|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
1051529|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
1051530|NCT02840760|rTMS|rtms
1051531|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
1051532|NCT02840747|Sézary Syndrome|sézary syndrome
1051533|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
1051534|NCT02840734|Kinesio taping|kinesio taping
1051535|NCT02840734|Obese adults|obese adults
1051536|NCT02840734|Muscular function|muscular function
1051537|NCT02840734|Fatigue|fatigue
1051538|NCT02840682|resource limited setting|resource limited setting
1051539|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
1051540|NCT02840669|Cardiomyopathy|cardiomyopathy
1051541|NCT02840643|hemispherectomy|hemispherectomy
1051542|NCT02840643|brain|brain
1051543|NCT02840643|hand function|hand function
1051544|NCT02840630|n3 LC-PUFA|n3 lc-pufa
1051545|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1051546|NCT02840630|South Asian|south asian
1051547|NCT02840630|HbA1c|hba1c
1051548|NCT02840630|Omega 3 status|omega 3 status
1051549|NCT02840617|ICG|icg
1051550|NCT02840617|prostate cancer|prostate cancer
1051551|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
1051552|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
1051553|NCT02840539|Bortezomib|bortezomib
1051554|NCT02840539|Cytarabine|cytarabine
1051555|NCT02840526|PVB|pvb
1051556|NCT02840526|PCA|pca
1051557|NCT02840526|nephrectomy|nephrectomy
1051558|NCT02840526|postoperative pain|postoperative pain
1051559|NCT02840513|Smartphone app|smartphone app
1051560|NCT02840513|CO self-monitoring|co self-monitoring
1051561|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
1051562|NCT02840500|Quality of life|quality of life
1051563|NCT02840500|Palliative Care Units|palliative care units
1051564|NCT02840487|Zika Infection|zika infection
1051565|NCT02840487|Flavivirus|flavivirus
1051566|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
1051567|NCT02840487|Immune Response|immune response
1051568|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
1051569|NCT02840474|HIV Viral Load|hiv viral load
1051570|NCT02840474|Antiviral|antiviral
1051571|NCT02840474|CD4 Count|cd4 count
1051572|NCT02840474|HIV-1 Infection|hiv-1 infection
1051573|NCT02840448|Williams Syndrome|williams syndrome
1051574|NCT02840448|Blood Flow|blood flow
1051575|NCT02840448|Brain|brain
1051576|NCT02840448|Arterial Stiffness|arterial stiffness
1051577|NCT02840435|Nicotine addiction|nicotine addiction
1051578|NCT02840435|Cigarette smoking|cigarette smoking
1051579|NCT02840422|Hyaluronic acid|hyaluronic acid
1051580|NCT02840422|Knee osteoarthritis|knee osteoarthritis
1051581|NCT02840422|Quality of life|quality of life
1051582|NCT02840396|language|language
1051583|NCT02840396|DLPFC|dlpfc
1051584|NCT02840396|rTMS|rtms
1051585|NCT02840396|Executive Functions|executive functions
1051686|NCT02839785|Children|children
1051586|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
1051587|NCT02840370|aphasia|aphasia
1051588|NCT02840370|language production|language production
1051589|NCT02840370|prefrontal cortex|prefrontal cortex
1051590|NCT02840357|Chronic inflammation|chronic inflammation
1051591|NCT02840357|Adults|adults
1051592|NCT02840357|overweight|overweight
1051593|NCT02840357|obese|obese
1051594|NCT02840344|Couple Functioning|couple functioning
1051595|NCT02840344|Stress Reduction|stress reduction
1051596|NCT02840331|Gastric carcinoma|gastric carcinoma
1051597|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
1051598|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
1051599|NCT02840331|Photodynamic therapy|photodynamic therapy
1051600|NCT02840331|St. John's Wort|st. john's wort
1051601|NCT02840331|Peritoneal metastasis|peritoneal metastasis
1051602|NCT02840318|Terminal care|terminal care
1051603|NCT02840318|Residential facilities|residential facilities
1051604|NCT02840318|Integrated health care systems|integrated health care systems
1051605|NCT02840318|Interdisciplinary health team|interdisciplinary health team
1051606|NCT02840318|Palliative care|palliative care
1051607|NCT02840305|Natural scenes|natural scenes
1051608|NCT02840305|Brain bases|brain bases
1051609|NCT02840305|Visual perception|visual perception
1051610|NCT02840305|MRI|mri
1051611|NCT02840292|Late Preterms|late preterms
1051612|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
1051613|NCT02840279|cognition|cognition
1051614|NCT02840279|dementia|dementia
1051615|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
1051616|NCT02840279|PDE4D|pde4d
1051617|NCT02840227|Cancer|cancer
1051618|NCT02840227|General anesthesia|general anesthesia
1051619|NCT02840227|Epidural anesthesia|epidural anesthesia
1051620|NCT02840201|biomarkers|biomarkers
1051621|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
1051622|NCT02840175|Treatment tapering|treatment tapering
1051623|NCT02840175|Oligoarticular|oligoarticular
1051624|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1051625|NCT02840175|Inactive disease|inactive disease
1051626|NCT02840175|Biologic therapy|biologic therapy
1051627|NCT02840162|prostate cancer|prostate cancer
1051628|NCT02840162|NSAIDs|nsaids
1051629|NCT02840162|chemoprevention|chemoprevention
1051630|NCT02840162|celecoxib|celecoxib
1051631|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
1051632|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
1051633|NCT02840136|Respiratory infection|respiratory infection
1051634|NCT02840136|Antibiotic therapy|antibiotic therapy
1051635|NCT02840136|LC-MS/MS|lc-ms/ms
1051636|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
1051637|NCT02840097|Brain injuries|brain injuries
1051638|NCT02840097|Wounds and injuries|wounds and injuries
1051639|NCT02840097|Hemorrhage|hemorrhage
1051640|NCT02840097|Tranexamic acid|tranexamic acid
1051641|NCT02840097|Child|child
1051642|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
1051643|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
1051644|NCT02840019|Fetal MRI|fetal mri
1051645|NCT02840019|Pregnancy|pregnancy
1051646|NCT02840019|Pregnant Women|pregnant women
1051647|NCT02840019|MRI Coil|mri coil
1051648|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
1051649|NCT02840019|Abnormal Fetuses|abnormal fetuses
1051650|NCT02840019|Typically Developing Fetuses|typically developing fetuses
1051651|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
1051652|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
1051653|NCT02840006|Vasodilator Agents|vasodilator agents
1051654|NCT02839993|tDCS effects|tdcs effects
1051655|NCT02839993|associative learning|associative learning
1051656|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
1051657|NCT02839915|Language Impairment|language impairment
1051658|NCT02839850|Arthroplasty|arthroplasty
1051659|NCT02839850|replacement|replacement
1051660|NCT02839850|Knee|knee
1051661|NCT02839850|function|function
1051662|NCT02839850|radiographic|radiographic
1051663|NCT02839850|survivorship|survivorship
1051664|NCT02839837|Depression|depression
1051665|NCT02839837|Depressive Disorder|depressive disorder
1051666|NCT02839837|Exercise|exercise
1051667|NCT02839837|Neuroplasticity|neuroplasticity
1051668|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
1051669|NCT02839837|Healthy Control|healthy control
1051670|NCT02839824|bowel cleansing|bowel cleansing
1051671|NCT02839824|bowel preparation|bowel preparation
1051672|NCT02839811|Betalactams|betalactams
1051673|NCT02839811|In vitro diagnosis|in vitro diagnosis
1051674|NCT02839798|sTMS|stms
1051675|NCT02839798|NEST|nest
1051676|NCT02839798|NeoSync|neosync
1051677|NCT02839798|synchronous|synchronous
1051678|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
1051680|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
1051681|NCT02839798|EEG|eeg
1051682|NCT02839798|bipolar|bipolar
1051683|NCT02839798|depression|depression
1051684|NCT02839785|Cerebral palsy|cerebral palsy
1051685|NCT02839785|Physiotherapy|physiotherapy
1051687|NCT02839785|Ibuprofen|ibuprofen
1051688|NCT02839785|Pain|pain
1051689|NCT02839785|Anxiety|anxiety
1051690|NCT02839772|podoconiosis|podoconiosis
1051691|NCT02839772|glycerine|glycerine
1051692|NCT02839772|RCT|rct
1051693|NCT02839772|SBF|sbf
1051694|NCT02839772|TEWL|tewl
1051695|NCT02839772|SC hydration|sc hydration
1051696|NCT02839759|Hearing loss|hearing loss
1051697|NCT02839759|Presbycusis|presbycusis
1051698|NCT02839759|Aging|aging
1051699|NCT02839759|Teleaudiology|teleaudiology
1051700|NCT02839733|Brain Imaging|brain imaging
1051701|NCT02839733|Adult|adult
1051702|NCT02839733|DNA Testing|dna testing
1051703|NCT02839733|Children|children
1051704|NCT02839694|Lung Resection|lung resection
1051705|NCT02839694|Surgery|surgery
1051706|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
1051707|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
1051708|NCT02839681|Immunotoxin|immunotoxin
1051709|NCT02839681|Immunotherapy|immunotherapy
1051710|NCT02839668|breast cancer|breast cancer
1051711|NCT02839668|angiogenesis|angiogenesis
1051712|NCT02839668|VEGF|vegf
1051713|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
1051714|NCT02839603|HIV co-infection|hiv co-infection
1051715|NCT02839603|Asymptomatic|asymptomatic
1051716|NCT02839590|Glaucoma|glaucoma
1051717|NCT02839590|Ocular hypertension|ocular hypertension
1051718|NCT02839590|Aqueous dynamics|aqueous dynamics
1051719|NCT02839564|chronic abdominal pain|chronic abdominal pain
1051720|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
1051721|NCT02839564|placebo|placebo
1051722|NCT02839551|Betalactams|betalactams
1051723|NCT02839551|Drug hypersensitivity|drug hypersensitivity
1051724|NCT02839551|Drug provocation test|drug provocation test
1051725|NCT02839551|Reactive dose|reactive dose
1051726|NCT02839538|infiltration|infiltration
1051727|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
1051728|NCT02839538|postoperative pain|postoperative pain
1051729|NCT02839525|Eccentric exercise|eccentric exercise
1051730|NCT02839525|Dietary supplement|dietary supplement
1051731|NCT02839525|Muscle damage|muscle damage
1051732|NCT02839499|seniors|seniors
1051733|NCT02839499|mixed food|mixed food
1051734|NCT02839499|normal texture food|normal texture food
1051735|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
1051736|NCT02839486|pharmacokinetics|pharmacokinetics
1051737|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
1051738|NCT02839447|semen|semen
1051739|NCT02839447|sperm|sperm
1051740|NCT02839447|oxidative stress|oxidative stress
1051741|NCT02839447|reactive oxygen species|reactive oxygen species
1051742|NCT02839447|idiopathic male infertility|idiopathic male infertility
1051743|NCT02839408|periodontitis|periodontitis
1051744|NCT02839408|azithromycin|azithromycin
1051745|NCT02839408|probiotic|probiotic
1051746|NCT02839395|screen illumination|screen illumination
1051747|NCT02839395|melatonin|melatonin
1051748|NCT02839395|body temperature|body temperature
1051749|NCT02839395|cognitive functioning|cognitive functioning
1051750|NCT02839395|light pollution|light pollution
1051751|NCT02839369|walking performance|walking performance
1051752|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
1051753|NCT02839330|Influenza|influenza
1051754|NCT02839330|Vaccine|vaccine
1051755|NCT02839330|Flu|flu
1051756|NCT02839330|Avian|avian
1051757|NCT02839330|Pandemic|pandemic
1051758|NCT02839330|H5N1|h5n1
1051759|NCT02839330|MF59|mf59
1051760|NCT02839317|Dysbiosis|dysbiosis
1051761|NCT02839317|Crohn's disease|crohn's disease
1051762|NCT02839317|Age|age
1051763|NCT02839278|Immunomodulation|immunomodulation
1051764|NCT02839226|ulcers|ulcers
1051765|NCT02839226|wounds|wounds
1051766|NCT02839226|diabetes|diabetes
1051767|NCT02839226|venous ulcers|venous ulcers
1051768|NCT02839226|arterial ulcers|arterial ulcers
1051769|NCT02839226|granulation tissue|granulation tissue
1051770|NCT02839226|protein kinase c|protein kinase c
1051771|NCT02839200|Insomnia|insomnia
1051772|NCT02839200|Polysomnography|polysomnography
1051773|NCT02839174|low carbohydrate diet|low carbohydrate diet
1051774|NCT02839161|Hookworm|hookworm
1051775|NCT02839161|Vaccine|vaccine
1051776|NCT02839161|Na-GST-1|na-gst-1
1051777|NCT02839161|Na-APR-1|na-apr-1
1051778|NCT02839161|Necator americanus|necator americanus
1051779|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
1051780|NCT02839122|Dutasteride|dutasteride
1051781|NCT02839122|Tadalafil|tadalafil
1051782|NCT02839070|Sleep|sleep
1051783|NCT02839070|Learning|learning
1051784|NCT02839070|Circadian Rhythms|circadian rhythms
1051785|NCT02839057|Axis fractures|axis fractures
1051786|NCT02839057|Elderly|elderly
1051787|NCT02839057|Mortality|mortality
1051788|NCT02839057|Surgical treatment|surgical treatment
1051789|NCT02839031|diabetes mellitus|diabetes mellitus
1051790|NCT02839031|glycaemia|glycaemia
1051791|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
1051792|NCT02839031|coping|coping
1051793|NCT02839031|parents|parents
1051794|NCT02839031|children|children
1051795|NCT02839005|Wound Closure Thechnical|wound closure thechnical
1051796|NCT02839005|Wound Healing|wound healing
1051797|NCT02838992|Cyclophosphamide|cyclophosphamide
1051798|NCT02838992|Umbilical Cord Blood|umbilical cord blood
1051799|NCT02838992|ATG|atg
1051800|NCT02838979|Glutamine|glutamine
1051801|NCT02838979|Chronic Kidney Disease|chronic kidney disease
1051802|NCT02838966|immunomodulation|immunomodulation
1051803|NCT02838966|immunonutrition|immunonutrition
1051804|NCT02838953|Ultrasonography|ultrasonography
1051805|NCT02838953|Respiratory Function Tests|respiratory function tests
1051806|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1051807|NCT02838953|Rehabilitation|rehabilitation
1051808|NCT02838927|Hypoparathyroidism|hypoparathyroidism
1051809|NCT02838927|Epidemiology|epidemiology
1051810|NCT02838927|Medication Therapy Management|medication therapy management
1051811|NCT02838914|Right atrium|right atrium
1051812|NCT02838914|Echocardiography|echocardiography
1051813|NCT02838914|Remodeling|remodeling
1051814|NCT02838888|Adenoma|adenoma
1051815|NCT02838888|computer|computer
1051816|NCT02838888|automatic|automatic
1051817|NCT02838888|polyp|polyp
1051818|NCT02838888|detection|detection
1730529|NCT00005011|Mood|mood
1051819|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
1051820|NCT02838862|MALDI-MS|maldi-ms
1051821|NCT02838862|Proteomics|proteomics
1051822|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
1051823|NCT02838862|Precision Medicine|precision medicine
1051824|NCT02838836|Cancer|cancer
1051825|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
1051826|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
1051827|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
1051828|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1051829|NCT02838823|triple negative breast cancer|triple negative breast cancer
1051830|NCT02838823|safety|safety
1051831|NCT02838810|peginterferon alfa|peginterferon alfa
1051832|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
1051833|NCT02838797|Parkinson's disease|parkinson's disease
1051834|NCT02838797|Gastroparesis|gastroparesis
1051835|NCT02838797|Constipation|constipation
1051836|NCT02838797|Prokinetic|prokinetic
1051837|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
1051838|NCT02838771|Swallowing Disorder|swallowing disorder
1051839|NCT02838771|Dysphagia|dysphagia
1051840|NCT02838758|Morton's neuroma|morton's neuroma
1051841|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
1051842|NCT02838758|forefoot pain|forefoot pain
1051843|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
1051844|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
1051845|NCT02838706|postoperative anemia|postoperative anemia
1051846|NCT02838706|perfusion index|perfusion index
1051847|NCT02838680|aortic stenosis|aortic stenosis
1051848|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
1051849|NCT02838654|cervical epidural space|cervical epidural space
1051850|NCT02838654|wave form analysis|wave form analysis
1051851|NCT02838615|spinal stenosis|spinal stenosis
1051852|NCT02838615|epidural steroid injection|epidural steroid injection
1051853|NCT02838602|carbon ions therapy|carbon ions therapy
1051854|NCT02838602|radiotherapy|radiotherapy
1051855|NCT02838602|radioresistant tumors|radioresistant tumors
1051856|NCT02838602|cancer|cancer
1051857|NCT02838602|randomized trial|randomized trial
1051858|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
1051859|NCT02838589|Ischemic Stroke|ischemic stroke
1051860|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
1051861|NCT02838563|Dementia|dementia
1051862|NCT02838563|Alzheimer|alzheimer
1051863|NCT02838563|Well-Being|well-being
1051864|NCT02838550|Physical Activity|physical activity
1051865|NCT02838550|Motivational Online Intervention|motivational online intervention
1051866|NCT02838550|Pedometers|pedometers
1051867|NCT02838537|Triptan|triptan
1051868|NCT02838537|Drug utilization|drug utilization
1051869|NCT02838537|Elderly|elderly
1051870|NCT02838537|Drug abuse|drug abuse
1051871|NCT02838537|Cardiovascular disease|cardiovascular disease
1051872|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
1051873|NCT02838524|Inspiratory Effort|inspiratory effort
1051874|NCT02838524|Mechanical Ventilation|mechanical ventilation
1051875|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
1051876|NCT02838498|ERCP|ercp
1051878|NCT02838498|Cannulation|cannulation
1051879|NCT02838498|Successful rate|successful rate
1051880|NCT02838498|Trainee|trainee
1051881|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
1051882|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
1051883|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
1051884|NCT02838290|Burnout|burnout
1051885|NCT02838290|Psychiatric morbidity|psychiatric morbidity
1051886|NCT02838290|Anxiety|anxiety
1051887|NCT02838290|Grief|grief
1051888|NCT02838290|Alcohol and drug use|alcohol and drug use
1051889|NCT02838277|lymphatic vessels|lymphatic vessels
1051890|NCT02838277|leaky vessels|leaky vessels
1051891|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
1051892|NCT02838212|adverse drug reaction|adverse drug reaction
1052388|NCT02835027|Surgery|surgery
1051893|NCT02838212|hospital mortality|hospital mortality
1051894|NCT02838212|incidence|incidence
1051895|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1051896|NCT02838199|TAVR|tavr
1051897|NCT02838199|TAVI|tavi
1051898|NCT02838199|SAVR|savr
1051899|NCT02838186|colonoscopy|colonoscopy
1051900|NCT02838186|right colon retroflexion|right colon retroflexion
1051901|NCT02838186|adenoma detection rate|adenoma detection rate
1051902|NCT02838186|feasibility|feasibility
1051903|NCT02838186|surveillance interval|surveillance interval
1051904|NCT02838160|educational strategies|educational strategies
1051905|NCT02838160|KAP|kap
1051906|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
1051907|NCT02838160|intensive care unit|intensive care unit
1051908|NCT02838160|follow-up study|follow-up study
1051910|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
1051911|NCT02838134|Early quality of recovery|early quality of recovery
1051912|NCT02838121|bisphosphonate|bisphosphonate
1051913|NCT02838121|Total hip replacement|total hip replacement
1051914|NCT02838121|functional outcomes|functional outcomes
1051915|NCT02838121|bone mineral density|bone mineral density
1051916|NCT02838095|nap|nap
1051917|NCT02838095|sleep restriction|sleep restriction
1051918|NCT02838095|recovery sleep|recovery sleep
1051919|NCT02838095|cognitive performance|cognitive performance
1051920|NCT02838095|subjective sleepiness|subjective sleepiness
1051921|NCT02838095|mood|mood
1051922|NCT02838095|neurobehavioural functions|neurobehavioural functions
1051923|NCT02838082|traumatic brain injury|traumatic brain injury
1051924|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
1051925|NCT02838082|circadian disruption|circadian disruption
1051926|NCT02838056|anesthesia, epidural|anesthesia, epidural
1051927|NCT02838056|skin temperature|skin temperature
1051928|NCT02838030|Preeclampsia|preeclampsia
1051929|NCT02838030|L-arginine|l-arginine
1051930|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
1051931|NCT02837991|Kidney Cancer|kidney cancer
1051932|NCT02837991|Celldex|celldex
1051933|NCT02837991|Dose Escalation|dose escalation
1051934|NCT02837991|Ovarian Cancer|ovarian cancer
1051935|NCT02837991|Ovarian Carcinoma|ovarian carcinoma
1051936|NCT02837991|Kidney Diseases|kidney diseases
1051937|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
1051938|NCT02837978|Tacrolimus|tacrolimus
1051939|NCT02837978|Treatment outcome|treatment outcome
1051940|NCT02837978|Safety|safety
1051941|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
1051942|NCT02837913|Perioperative Warming|perioperative warming
1051943|NCT02837887|Cancer|cancer
1051944|NCT02837887|Depression|depression
1051945|NCT02837874|Gastric cancer|gastric cancer
1051946|NCT02837874|gastrojejunostomy|gastrojejunostomy
1051947|NCT02837874|isoperistaltic|isoperistaltic
1051948|NCT02837874|antiperistaltic|antiperistaltic
1051949|NCT02837861|Metabolic Support|metabolic support
1051950|NCT02837861|Nutritional Support|nutritional support
1051951|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
1051952|NCT02837861|Enteral feedings|enteral feedings
1051953|NCT02837861|Parenteral feeding|parenteral feeding
1051954|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
1051955|NCT02837848|Exercises|exercises
1051956|NCT02837848|Coactivation|coactivation
1051957|NCT02837848|Strengthening|strengthening
1051958|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
1051959|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
1051960|NCT02837809|low-dose computed tomography|low-dose computed tomography
1051961|NCT02837809|lung|lung
1051962|NCT02837809|randomized controlled trial|randomized controlled trial
1051963|NCT02837809|neoplasms|neoplasms
1051964|NCT02837809|screening|screening
1051965|NCT02837809|smoking|smoking
1051966|NCT02837770|pain|pain
1051967|NCT02837770|intravitreal injection|intravitreal injection
1051968|NCT02837770|anti-VEGF|anti-vegf
1051969|NCT02837770|diclofenac eye drops|diclofenac eye drops
1051970|NCT02837770|oral diclofenac|oral diclofenac
1051971|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
1051972|NCT02837653|cardiovascular Risk|cardiovascular risk
1051973|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
1051974|NCT02837640|Levodopa|levodopa
1051975|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
1051976|NCT02837627|tube enteral feeding|tube enteral feeding
1051977|NCT02837627|preterm infants|preterm infants
1051978|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
1051979|NCT02837601|Shoulder Pain|shoulder pain
1051980|NCT02837601|Abdominal Pain|abdominal pain
1051981|NCT02837601|Pediatrics|pediatrics
1051982|NCT02837588|chronic pelvic pain|chronic pelvic pain
1051983|NCT02837588|trigger points|trigger points
1051984|NCT02837588|hiperthermy|hiperthermy
1051985|NCT02837575|HSV-2|hsv-2
1051986|NCT02837575|Genital Herpes|genital herpes
1051987|NCT02837575|Herpes|herpes
1051988|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
1051989|NCT02837562|Radiation exposure|radiation exposure
1051990|NCT02837562|Cardiac catheterization|cardiac catheterization
1051991|NCT02837523|Lysosomal Storage Diseases|lysosomal storage diseases
1051992|NCT02837497|pediatric|pediatric
1051993|NCT02837497|heart arrest|heart arrest
1051994|NCT02837471|Pedometer usability|pedometer usability
1051995|NCT02837471|Usability and feasibility|usability and feasibility
1051996|NCT02837471|web application|web application
1051997|NCT02837458|Electric current|electric current
1051998|NCT02837458|Nerve block|nerve block
1051999|NCT02837458|somatosensory evaluation|somatosensory evaluation
1052000|NCT02837432|Depression|depression
1052001|NCT02837432|Cortisol|cortisol
1052002|NCT02837432|Sadness|sadness
1052003|NCT02837432|Genetics|genetics
1052004|NCT02837432|Stress|stress
1052005|NCT02837419|extracorporeal life support|extracorporeal life support
1052006|NCT02837419|health related quality of life|health related quality of life
1052104|NCT02836665|Telemedicine|telemedicine
1052007|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
1052008|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
1052009|NCT02837380|Dry powder inhaler|dry powder inhaler
1052010|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
1052011|NCT02837367|nutrigenetics|nutrigenetics
1052012|NCT02837367|medical foods|medical foods
1052013|NCT02837367|obesity|obesity
1052014|NCT02837367|children|children
1052015|NCT02837367|adults|adults
1052016|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
1052017|NCT02837341|medical device|medical device
1052018|NCT02837328|Magnesium Supplementation|magnesium supplementation
1052019|NCT02837328|Magnesium|magnesium
1052020|NCT02837328|Dietary Supplement|dietary supplement
1052021|NCT02837328|Arrhythmia|arrhythmia
1052022|NCT02837302|Liver cirrhosis|liver cirrhosis
1052023|NCT02837302|Branched chain amino acid|branched chain amino acid
1052024|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
1052025|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
1052026|NCT02837289|therapy taping|therapy taping
1052027|NCT02837289|knee|knee
1052028|NCT02837289|physical therapy|physical therapy
1052029|NCT02837289|runners|runners
1052030|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
1052031|NCT02837276|Acute Kidney Injury|acute kidney injury
1052032|NCT02837276|Preterm infant|preterm infant
1052033|NCT02837250|HIV|hiv
1052034|NCT02837250|Substance Use|substance use
1052035|NCT02837224|retained surgical sponge|retained surgical sponge
1052036|NCT02837224|adverse event|adverse event
1052037|NCT02837185|Cervical dystonia|cervical dystonia
1052038|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
1052039|NCT02837185|Electromyography|electromyography
1052040|NCT02837185|TMS|tms
1052041|NCT02837185|EMG|emg
1052042|NCT02837159|colorectal cancer|colorectal cancer
1052043|NCT02837159|Health Life Style Habits|health life style habits
1052044|NCT02837159|Health|health
1052045|NCT02837146|RA|ra
1052046|NCT02837120|retrospective study|retrospective study
1052047|NCT02837120|acute myocardial infarction|acute myocardial infarction
1052048|NCT02837120|acute aortic dissection|acute aortic dissection
1052049|NCT02837120|pulmonary embolism|pulmonary embolism
1052050|NCT02837120|unstable angina|unstable angina
1052051|NCT02837068|Hemiplegia|hemiplegia
1052052|NCT02837068|shoulder pain|shoulder pain
1052053|NCT02837068|wheelchair|wheelchair
1052054|NCT02837068|stroke|stroke
1052055|NCT02837068|rehabilitation|rehabilitation
1052056|NCT02837055|intubation, intratracheal|intubation, intratracheal
1052057|NCT02837055|critical care|critical care
1052058|NCT02837042|penile cancer|penile cancer
1052059|NCT02837042|Pembrolizumab|pembrolizumab
1052060|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
1052061|NCT02837042|squamous cell cancer|squamous cell cancer
1052062|NCT02837016|Self-Control|self-control
1052063|NCT02837016|Biofeedback|biofeedback
1052064|NCT02837016|Respiration|respiration
1052065|NCT02837003|Drug-Eluting Stent|drug-eluting stent
1052066|NCT02836977|tegafur-uracil|tegafur-uracil
1052067|NCT02836925|hepatitis C|hepatitis c
1052068|NCT02836925|NHL|nhl
1052069|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
1052070|NCT02836912|Rehabilitation|rehabilitation
1052071|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
1052072|NCT02836834|immunotherapy|immunotherapy
1052073|NCT02836834|check point inhibitor|check point inhibitor
1052074|NCT02836834|PD-1 antibody|pd-1 antibody
1052075|NCT02836834|solid tumor|solid tumor
1052076|NCT02836834|lymphoma|lymphoma
1052077|NCT02836834|phase 1 trial|phase 1 trial
1052078|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
1052079|NCT02836808|Long term control|long term control
1052080|NCT02836808|Empowerment|empowerment
1052081|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1052082|NCT02836795|advanced solid tumors|advanced solid tumors
1052083|NCT02836795|safety|safety
1052084|NCT02836782|HIV/HCV|hiv/hcv
1052085|NCT02836782|Antiretroviral therapy|antiretroviral therapy
1052086|NCT02836782|HIV-DNA|hiv-dna
1052087|NCT02836782|Direct acting antiviral|direct acting antiviral
1052088|NCT02836769|Rehabilitation|rehabilitation
1052089|NCT02836769|Head and neck cancer|head and neck cancer
1052090|NCT02836769|Quality of life|quality of life
1052091|NCT02836769|self-efficacy|self-efficacy
1052092|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
1052093|NCT02836743|Melatonin|melatonin
1052094|NCT02836717|sacral nerve modulation|sacral nerve modulation
1052095|NCT02836717|quality of life|quality of life
1052096|NCT02836717|stimulator maintenance|stimulator maintenance
1052097|NCT02836717|SNM|snm
1052098|NCT02836691|Autonomic nervous system|autonomic nervous system
1052099|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
1052100|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
1052101|NCT02836691|Stress|stress
1052102|NCT02836665|Emergency Room|emergency room
1052103|NCT02836665|Manchester Triage System|manchester triage system
1052106|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
1052107|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
1052108|NCT02836600|notch inhibitor|notch inhibitor
1052109|NCT02836548|advanced melanoma|advanced melanoma
1052110|NCT02836548|BRAF V600 mutation|braf v600 mutation
1052111|NCT02836548|vorinostat|vorinostat
1052112|NCT02836548|HDAC inhibitor|hdac inhibitor
1052113|NCT02836535|complications|complications
1052114|NCT02836535|surgery|surgery
1052115|NCT02836522|Health-Related Symptom Index|health-related symptom index
1052116|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
1052117|NCT02836509|Low Back Pain|low back pain
1052118|NCT02836509|Ibuprofen|ibuprofen
1052119|NCT02836509|Paracetamol|paracetamol
1052120|NCT02836509|Emergency Medicine|emergency medicine
1052121|NCT02836496|Safety|safety
1052122|NCT02836496|Mepolizumab|mepolizumab
1052123|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
1052124|NCT02836496|HES flare|hes flare
1052125|NCT02836496|Efficacy|efficacy
1052126|NCT02836470|Post-operative Ileus|post-operative ileus
1052127|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
1052128|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
1052129|NCT02836470|Anastomosis|anastomosis
1052130|NCT02836470|Enterotomy|enterotomy
1052131|NCT02836470|Enterostomy|enterostomy
1052132|NCT02836470|Colorectal Surgery|colorectal surgery
1052133|NCT02836470|Intestines Surgery|intestines surgery
1052134|NCT02836431|Pediatric|pediatric
1052135|NCT02836431|Sedation|sedation
1052136|NCT02836431|Dexmedetomidine|dexmedetomidine
1052137|NCT02836418|FSHD|fshd
1052138|NCT02836418|LGMD|lgmd
1052139|NCT02836405|Autism|autism
1052140|NCT02836405|ASD|asd
1052141|NCT02836405|Autistic Disorder|autistic disorder
1052142|NCT02836405|Pervasive Development Disorders|pervasive development disorders
1052143|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
1052144|NCT02836405|Asperger's Syndrome|asperger's syndrome
1052145|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1052146|NCT02836405|TMS|tms
1052147|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
1052148|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
1052149|NCT02836379|Quality of life|quality of life
1052150|NCT02836379|Radiotherapy|radiotherapy
1052151|NCT02836366|Proximal humerus|proximal humerus
1052152|NCT02836366|Fracture|fracture
1052153|NCT02836366|Nailing|nailing
1052154|NCT02836340|neuroprotection|neuroprotection
1052155|NCT02836327|MRI|mri
1052156|NCT02836327|Multiple Sclerosis|multiple sclerosis
1052157|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
1052158|NCT02836327|Multimodel|multimodel
1052159|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
1052160|NCT02836314|Graft|graft
1052161|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
1052162|NCT02836314|platelet rich fibrin|platelet rich fibrin
1052163|NCT02836288|Ketamine|ketamine
1052164|NCT02836288|Treatment of Depression|treatment of depression
1052165|NCT02836275|Adnexal Diseases|adnexal diseases
1052166|NCT02836275|Ovary|ovary
1052167|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
1052168|NCT02836275|Ovarian Cysts|ovarian cysts
1052169|NCT02836275|Ovarian Diseases|ovarian diseases
1052170|NCT02836275|Ultrasonography|ultrasonography
1052171|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
1052172|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
1052173|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1052174|NCT02836275|Diagnosis|diagnosis
1052175|NCT02836275|Early Diagnosis|early diagnosis
1052176|NCT02836275|Early Detection of Cancer|early detection of cancer
1052177|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
1052178|NCT02836275|Genital Diseases, Female|genital diseases, female
1052179|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
1052180|NCT02836275|Cysts|cysts
1052181|NCT02836275|Endocrine System Diseases|endocrine system diseases
1052182|NCT02836275|Gonadal Disorders|gonadal disorders
1052183|NCT02836275|Neoplasms|neoplasms
1052184|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
1052680|NCT02833155|entinostat|entinostat
1052185|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
1052186|NCT02836275|Simple Rules|simple rules
1052187|NCT02836275|Preoperative Evaluation|preoperative evaluation
1052188|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
1052189|NCT02836275|Adnexal Masses|adnexal masses
1052190|NCT02836275|Ovarian Tumors|ovarian tumors
1052191|NCT02836249|Hepatitis|hepatitis
1052192|NCT02836249|Tenofovir|tenofovir
1052193|NCT02836249|Viread|viread
1052194|NCT02836236|Hepatitis|hepatitis
1052195|NCT02836236|Tenofovir|tenofovir
1052196|NCT02836236|Viread|viread
1052197|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
1052198|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
1052199|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
1052200|NCT02836119|Gut Microbiota|gut microbiota
1052201|NCT02836119|Gut Microbiome|gut microbiome
1052202|NCT02836119|Sleep|sleep
1052203|NCT02836119|Infancy|infancy
1052204|NCT02836119|Development|development
1052205|NCT02836106|Healthy Volunteers|healthy volunteers
1052206|NCT02836106|Obese Volunteers|obese volunteers
1052207|NCT02836093|Exercise|exercise
1052208|NCT02836093|Radiation Treatment|radiation treatment
1052209|NCT02836093|16-941|16-941
1052210|NCT02836080|Mental Health|mental health
1052211|NCT02836080|Randomized|randomized
1052212|NCT02836080|Pragmatic|pragmatic
1052213|NCT02836080|Integrated Collaborative Care|integrated collaborative care
1052214|NCT02836080|Addiction|addiction
1052215|NCT02836080|Youth|youth
1052216|NCT02836054|biomarkers|biomarkers
1052217|NCT02836054|CSF|csf
1052218|NCT02836054|MRI|mri
1052219|NCT02836054|Alzheimer's disease|alzheimer's disease
1052220|NCT02836054|bipolar disorder|bipolar disorder
1052221|NCT02836054|cognitive functions|cognitive functions
1052222|NCT02836041|assess sleep|assess sleep
1052223|NCT02836041|Sleep Deprivation|sleep deprivation
1052224|NCT02836041|16-866|16-866
1052225|NCT02836015|Shared Medical Visits|shared medical visits
1052226|NCT02836015|Spanish-speaking|spanish-speaking
1052227|NCT02835989|Community Paramedicine|community paramedicine
1052228|NCT02835989|Paramedic|paramedic
1052229|NCT02835989|Emergency Medical Services|emergency medical services
1052230|NCT02835989|High Frequency Callers|high frequency callers
1052231|NCT02835989|Lift Assists|lift assists
1052232|NCT02835963|acute heart failure|acute heart failure
1052233|NCT02835963|dyspnea|dyspnea
1052234|NCT02835963|predictive value|predictive value
1052235|NCT02835924|regorafenib|regorafenib
1052236|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
1052237|NCT02835872|fiber|fiber
1052238|NCT02835872|cholesterol|cholesterol
1052239|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
1052240|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
1052241|NCT02835846|Female Urinary Microbiome|female urinary microbiome
1052242|NCT02835846|Urinary Urgency|urinary urgency
1052243|NCT02835846|Estrogen|estrogen
1052244|NCT02835846|Nocturia|nocturia
1052245|NCT02835846|Incontinence|incontinence
1052246|NCT02835833|advanced solid tumors|advanced solid tumors
1052247|NCT02835833|Nintedanib|nintedanib
1052248|NCT02835833|Bevacizumab|bevacizumab
1052249|NCT02835833|dose escalation|dose escalation
1052250|NCT02835820|HIV|hiv
1052251|NCT02835820|Neurocognitive|neurocognitive
1052252|NCT02835820|Ketogenic Diet|ketogenic diet
1052253|NCT02835807|skin cancer|skin cancer
1052254|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
1052255|NCT02835781|Breast Implants|breast implants
1052256|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
1052257|NCT02835729|AML|aml
1052258|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
1052259|NCT02835716|ustekinumab|ustekinumab
1052260|NCT02835716|secukinumab|secukinumab
1052261|NCT02835716|P40 subunit|p40 subunit
1052262|NCT02835716|Interleukin IL-12|interleukin il-12
1052263|NCT02835716|Interleukin IL-23|interleukin il-23
1052264|NCT02835716|Apoprotein e4|apoprotein e4
1052265|NCT02835716|Interleukin IL-17A|interleukin il-17a
1052266|NCT02835703|Congenital heart disease|congenital heart disease
1052267|NCT02835703|Coarctation of aorta|coarctation of aorta
1052268|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
1052269|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
1052270|NCT02835703|Double arterial cannulation|double arterial cannulation
1052271|NCT02835690|PD1|pd1
1052272|NCT02835690|PD-1|pd-1
1052273|NCT02835690|PDL1|pdl1
1052274|NCT02835690|PD-L1|pd-l1
1052275|NCT02835677|Caregivers|caregivers
1052276|NCT02835677|Activities of Daily Living|activities of daily living
1052277|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
1052278|NCT02835664|Obesity|obesity
1052279|NCT02835664|Metabolic health|metabolic health
1052280|NCT02835664|Insulin resistance|insulin resistance
1052281|NCT02835664|Mitochondrial function|mitochondrial function
1052282|NCT02835664|Brown adipose tissue|brown adipose tissue
1052283|NCT02835664|Energy expenditure|energy expenditure
1052284|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
1052285|NCT02835664|Cardiovascular risk|cardiovascular risk
1052286|NCT02835664|Acetylcarnitine|acetylcarnitine
1052287|NCT02835651|Palmitic acid|palmitic acid
1052288|NCT02835651|Stearic acid|stearic acid
1052289|NCT02835651|HDL-metabolism|hdl-metabolism
1052290|NCT02835651|Human intervention study|human intervention study
1052291|NCT02835625|Diagnostic Imaging|diagnostic imaging
1052292|NCT02835625|Mammography|mammography
1052293|NCT02835625|Randomized Controlled Trial|randomized controlled trial
1052294|NCT02835625|Tomosynthesis|tomosynthesis
1052295|NCT02835625|Early performance measures|early performance measures
1052296|NCT02835625|Recall|recall
1052297|NCT02835625|Radiation dose|radiation dose
1052298|NCT02835625|Cancer detection|cancer detection
1052299|NCT02835625|Sensitivity|sensitivity
1052300|NCT02835625|Specificity|specificity
1052301|NCT02835625|Cost|cost
1052302|NCT02835625|Economy|economy
1052303|NCT02835586|paclitaxel|paclitaxel
1052304|NCT02835586|critical ischemia|critical ischemia
1052305|NCT02835586|restenosis|restenosis
1052306|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
1052307|NCT02835547|cardiovascular event|cardiovascular event
1052308|NCT02835547|risk factors|risk factors
1052309|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
1052310|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
1052311|NCT02835456|CAUTI|cauti
1052312|NCT02835456|Biofilm|biofilm
1052313|NCT02835456|Urinary tract infections|urinary tract infections
1052314|NCT02835456|micropattern|micropattern
1052315|NCT02835456|Catheter|catheter
1052316|NCT02835443|Ischemic Stroke|ischemic stroke
1052317|NCT02835443|Deep Brain Stimulation|deep brain stimulation
1052318|NCT02835443|DBS|dbs
1052319|NCT02835443|Physical Therapy|physical therapy
1052320|NCT02835443|Rehab|rehab
1052321|NCT02835443|Brain Stimulation|brain stimulation
1052322|NCT02835430|Coronally advanced flap|coronally advanced flap
1052323|NCT02835430|Gingival recession|gingival recession
1052324|NCT02835430|Bone, demineralized|bone, demineralized
1052325|NCT02835430|Bone, freeze-dried|bone, freeze-dried
1052326|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
1052327|NCT02835430|root coverage procedures|root coverage procedures
1052328|NCT02835417|fetal heart rate variability|fetal heart rate variability
1052329|NCT02835417|entropy|entropy
1052330|NCT02835417|multifractal analysis|multifractal analysis
1052331|NCT02835417|scattering transform|scattering transform
1052332|NCT02835417|sparse vector machine|sparse vector machine
1052333|NCT02835417|acidosis|acidosis
1052334|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
1052335|NCT02835378|prosthetic fitting|prosthetic fitting
1052336|NCT02835378|epidemiology|epidemiology
1052337|NCT02835378|clinical practices|clinical practices
1052338|NCT02835378|totally non-functional hand|totally non-functional hand
1052339|NCT02835365|baclofen|baclofen
1052340|NCT02835365|alcohol|alcohol
1052341|NCT02835365|withdrawal|withdrawal
1052342|NCT02835352|anxiety|anxiety
1052343|NCT02835326|Older Adults|older adults
1052344|NCT02835326|Weight Loss|weight loss
1052345|NCT02835326|Exercise|exercise
1052346|NCT02835326|Knee pain|knee pain
1052347|NCT02835300|Asthma|asthma
1052348|NCT02835300|Adolescents|adolescents
1052349|NCT02835300|e-Health|e-health
1052350|NCT02835300|Intervention|intervention
1052351|NCT02835274|parkinson disease|parkinson disease
1052352|NCT02835274|deep brain stimulation|deep brain stimulation
1052353|NCT02835274|directional stimulation|directional stimulation
1052354|NCT02835261|Obesity|obesity
1052355|NCT02835261|Metabolic Disorders|metabolic disorders
1052356|NCT02835209|spontaneous breathing test|spontaneous breathing test
1052357|NCT02835209|premature infant|premature infant
1052358|NCT02835209|work of breathing|work of breathing
1052359|NCT02835170|Immunoglobulin G|immunoglobulin g
1052360|NCT02835170|Treatment|treatment
1052361|NCT02835157|Normal saline|normal saline
1052362|NCT02835157|Balanced saline|balanced saline
1052363|NCT02835157|Septic shock|septic shock
1052364|NCT02835157|Children|children
1052365|NCT02835157|Hyperchloremia|hyperchloremia
1052366|NCT02835157|Acute kidney injury|acute kidney injury
1052367|NCT02835131|hyperinsulinemia|hyperinsulinemia
1052368|NCT02835131|hypoglycemia|hypoglycemia
1052369|NCT02835131|somatostatin|somatostatin
1052370|NCT02835131|pasireotide|pasireotide
1052371|NCT02835131|congenital|congenital
1052372|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
1052373|NCT02835066|Stage I|stage i
1052374|NCT02835066|Stage II|stage ii
1052375|NCT02835066|Stage IIIA|stage iiia
1052376|NCT02835066|Stage IIIB|stage iiib
1052377|NCT02835066|Stage IV|stage iv
1052378|NCT02835066|Non-Small Cell|non-small cell
1052379|NCT02835040|Corticosteroid|corticosteroid
1052380|NCT02835040|Antibiotic|antibiotic
1052381|NCT02835040|Early mobilization|early mobilization
1052382|NCT02835040|Malnutrition|malnutrition
1052383|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
1052384|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
1052385|NCT02835027|Thrombosis|thrombosis
1052386|NCT02835027|Emboli|emboli
1052387|NCT02835027|Endovascular surgery|endovascular surgery
1052392|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
1052394|NCT02835014|Mental Health|mental health
1052395|NCT02835014|Self efficacy|self efficacy
1052396|NCT02835014|parenting styles|parenting styles
1052397|NCT02834988|Endometrial Cancer|endometrial cancer
1052398|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
1052399|NCT02834988|SLND|slnd
1052400|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
1052401|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
1052402|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
1052403|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1052404|NCT02834897|EOS imagery|eos imagery
1052410|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
1052411|NCT02834819|bronchiolitis|bronchiolitis
1052412|NCT02834819|hypoxia|hypoxia
1052413|NCT02834819|hypertonic saline|hypertonic saline
1052414|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
1052415|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
1052416|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1052417|NCT02834780|H3B-6527|h3b-6527
1052418|NCT02834754|post-operative|post-operative
1052419|NCT02834715|Diabetes|diabetes
1052420|NCT02834715|Stevia|stevia
1052421|NCT02834715|insulin secretion|insulin secretion
1052422|NCT02834715|insulin sensitivity|insulin sensitivity
1052423|NCT02834715|Sweetener|sweetener
1052424|NCT02834702|sinew acupuncture|sinew acupuncture
1052425|NCT02834702|neck pain|neck pain
1052426|NCT02834702|chronic pain|chronic pain
1052427|NCT02834676|DiscoGel(R)|discogel(r)
1052428|NCT02834676|gelified ethanol|gelified ethanol
1052429|NCT02834676|percutaneous treatment|percutaneous treatment
1052430|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
1052431|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
1052432|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
1052433|NCT02834676|cervical|cervical
1052434|NCT02834637|HPV|hpv
1052435|NCT02834637|cervical cancer|cervical cancer
1052436|NCT02834637|vaccines|vaccines
1052437|NCT02834637|HPV vaccine|hpv vaccine
1052438|NCT02834637|dose reduction|dose reduction
1052439|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
1052440|NCT02834624|surfactant|surfactant
1052441|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
1052442|NCT02834624|inflammation|inflammation
1052443|NCT02834624|c-reactive protein|c-reactive protein
1052444|NCT02834624|lipid peroxidation|lipid peroxidation
1052445|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
1052446|NCT02834546|Sorafenib|sorafenib
1052447|NCT02834546|Toxicity|toxicity
1052448|NCT02834546|Plasmatic concentration|plasmatic concentration
1052449|NCT02834533|Lokomat;|lokomat;
1052450|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
1052451|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
1052452|NCT02834533|Virtual reality|virtual reality
1052453|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
1052454|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1052455|NCT02834481|Pain Care|pain care
1052456|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
1052457|NCT02834468|Dexamethasone|dexamethasone
1052458|NCT02834468|Rituximab|rituximab
1052459|NCT02834468|Cyclosporin|cyclosporin
1052460|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
1052461|NCT02834455|Thoracoscopy|thoracoscopy
1052462|NCT02834403|breast cancer|breast cancer
1052463|NCT02834403|nitric oxide synthase|nitric oxide synthase
1052464|NCT02834403|docetaxel|docetaxel
1052465|NCT02834403|L-NMMA|l-nmma
1052466|NCT02834390|AML|aml
1052467|NCT02834390|phase 1|phase 1
1052468|NCT02834390|hematology|hematology
1052469|NCT02834390|malignancy|malignancy
1052470|NCT02834390|newly diagnosed|newly diagnosed
1052471|NCT02834377|Cardiac Output|cardiac output
1052472|NCT02834377|Hemodynamics|hemodynamics
1052473|NCT02834377|Perioperative Care|perioperative care
1052474|NCT02834338|activity tracking|activity tracking
1052475|NCT02834338|postoperative recovery|postoperative recovery
1052476|NCT02834338|ERAS|eras
1052477|NCT02834338|fast-track surgery|fast-track surgery
1052478|NCT02834325|high flow nasal cannula|high flow nasal cannula
1052479|NCT02834325|success|success
1052480|NCT02834325|failure|failure
1052481|NCT02834325|ROX index|rox index
1052482|NCT02834312|Estetrol|estetrol
1052483|NCT02834312|Vasomotor symptoms|vasomotor symptoms
1052484|NCT02834312|Menopause|menopause
1052485|NCT02834260|absorbable implant|absorbable implant
1052486|NCT02834260|subconjunctival|subconjunctival
1052487|NCT02834260|immune rejection|immune rejection
1052488|NCT02834260|safety profile|safety profile
1052491|NCT02834234|peritoneum|peritoneum
1052492|NCT02834234|genomic|genomic
1052493|NCT02834234|CGH arrays|cgh arrays
1052494|NCT02834221|Femoral vein puncture|femoral vein puncture
1052495|NCT02834195|Cerebral palsy|cerebral palsy
1052496|NCT02834195|reliability|reliability
1052497|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
1052498|NCT02834195|classification|classification
1052499|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
1052500|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
1052501|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
1052502|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
1052503|NCT02834169|psammocarcinoma|psammocarcinoma
1052504|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
1052505|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
1052506|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
1052507|NCT02834169|registry|registry
1730530|NCT00005011|MRMD|mrmd
1052508|NCT02834169|population-based database|population-based database
1052509|NCT02834143|vascular|vascular
1052510|NCT02834143|Limb Ischemia|limb ischemia
1052511|NCT02834117|Ovulation Induction|ovulation induction
1052512|NCT02834117|quality of life|quality of life
1052513|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
1052516|NCT02834078|Pre Diabetes|pre diabetes
1052517|NCT02834078|Berberine|berberine
1052518|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
1052519|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
1052520|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
1052521|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1052522|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
1052523|NCT02834052|Immunotherapy|immunotherapy
1052524|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
1052525|NCT02834052|Immunostimulant|immunostimulant
1052526|NCT02834052|monoclonal antibody|monoclonal antibody
1052527|NCT02834052|TLR3 agonist|tlr3 agonist
1052528|NCT02834052|Immunologic factors|immunologic factors
1052529|NCT02834039|Tidal volume|tidal volume
1052530|NCT02834039|renal transplant|renal transplant
1052531|NCT02834039|donor|donor
1052532|NCT02834039|nephrectomy|nephrectomy
1052533|NCT02834039|ventilation|ventilation
1052534|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
1052535|NCT02834026|Muscle Strength|muscle strength
1052536|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
1052537|NCT02834026|Chronic Renal Disease|chronic renal disease
1052538|NCT02834026|Exercise|exercise
1052539|NCT02834026|Physical therapy modalities|physical therapy modalities
1052540|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
1052541|NCT02833987|Safety|safety
1052542|NCT02833987|Major bleed|major bleed
1052543|NCT02833987|Adverse events|adverse events
1052544|NCT02833974|GSK2245035|gsk2245035
1052545|NCT02833974|TLR7 agonist|tlr7 agonist
1052546|NCT02833974|allergic asthma|allergic asthma
1052547|NCT02833974|FEV1|fev1
1052548|NCT02833948|Heart Valve Disease|heart valve disease
1052549|NCT02833948|Randomized Controlled Trial|randomized controlled trial
1052550|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1052551|NCT02833948|TAVR|tavr
1052552|NCT02833948|Valve Thrombosis|valve thrombosis
1052553|NCT02833935|spinal cord injury|spinal cord injury
1052554|NCT02833935|physical activity|physical activity
1052555|NCT02833935|self-determination theory|self-determination theory
1052556|NCT02833935|life satisfaction|life satisfaction
1052557|NCT02833883|Enzalutamide|enzalutamide
1052558|NCT02833883|CC-115|cc-115
1052559|NCT02833883|16-074|16-074
1052561|NCT02833844|Hyperlipidemia|hyperlipidemia
1052562|NCT02833844|Dyslipidemia|dyslipidemia
1052563|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
1052564|NCT02833844|Inhibition|inhibition
1052565|NCT02833844|HIV infection|hiv infection
1052566|NCT02833844|Cluster of differentiation|cluster of differentiation
1052567|NCT02833844|Viral load|viral load
1052568|NCT02833805|immunosuppression|immunosuppression
1052569|NCT02833805|nonmyeloablative|nonmyeloablative
1052570|NCT02833805|non-myeloablative|non-myeloablative
1052571|NCT02833805|allogeneic|allogeneic
1052572|NCT02833805|tacrolimus|tacrolimus
1052573|NCT02833805|bone marrow|bone marrow
1052574|NCT02833805|bone marrow transplant|bone marrow transplant
1052575|NCT02833805|cyclophosphamide|cyclophosphamide
1052576|NCT02833805|thymoglobulin|thymoglobulin
1052577|NCT02833805|ATG|atg
1052578|NCT02833805|fludarabine|fludarabine
1052579|NCT02833766|Breast Cancer|breast cancer
1052580|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
1052581|NCT02833766|doxorubicin|doxorubicin
1052582|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1052583|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
1052584|NCT02833740|Mother MUAC|mother muac
1052585|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
1052586|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
1052587|NCT02833675|angioedema|angioedema
1052588|NCT02833675|C1Inhibitor|c1inhibitor
1052589|NCT02833675|bradykinin|bradykinin
1052590|NCT02833675|Histamin|histamin
1052591|NCT02833662|Hypoxia|hypoxia
1052592|NCT02833662|Perioperative outcomes|perioperative outcomes
1052593|NCT02833649|Keratoconus|keratoconus
1052594|NCT02833649|Crosslinking|crosslinking
1052595|NCT02833649|Toric ICL|toric icl
1052596|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
1052597|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
1052598|NCT02833610|Multiple Myeloma|multiple myeloma
1052599|NCT02833597|peripheral artery disease|peripheral artery disease
1052600|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
1052601|NCT02833597|claudication|claudication
1052602|NCT02833597|rowing ergometer|rowing ergometer
1052603|NCT02833584|Paracetamol|paracetamol
1052604|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1052605|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
1052606|NCT02833558|Bleeding|bleeding
1052607|NCT02833519|pregnant women|pregnant women
1052608|NCT02833519|exercise|exercise
1052609|NCT02833519|depression|depression
1052610|NCT02833519|anxiety|anxiety
1052808|NCT02832401|caffeine|caffeine
1052611|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
1052612|NCT02833493|Iron overload|iron overload
1052613|NCT02833493|Iron chelation therapy|iron chelation therapy
1052614|NCT02833493|Follow-up|follow-up
1052615|NCT02833467|Circulating Tumor DNA|circulating tumor dna
1052616|NCT02833467|Heterogeneous|heterogeneous
1052617|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
1052618|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1052619|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
1052620|NCT02833415|Visceral|visceral
1052621|NCT02833415|Obesity|obesity
1052622|NCT02833415|Adipose|adipose
1052623|NCT02833415|Diabetes|diabetes
1052624|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
1052625|NCT02833402|Urinary leakage|urinary leakage
1052626|NCT02833402|Urinary incontinence|urinary incontinence
1052627|NCT02833402|Urinary microbiome|urinary microbiome
1052628|NCT02833376|microbiota|microbiota
1052629|NCT02833376|ethanol|ethanol
1052630|NCT02833376|chlorhexidine|chlorhexidine
1052631|NCT02833363|gastric microbiota|gastric microbiota
1052632|NCT02833363|Helicobacter pylori|helicobacter pylori
1052633|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
1052634|NCT02833363|Atrophic gastritis|atrophic gastritis
1052635|NCT02833363|Intestinal metaplasia|intestinal metaplasia
1052636|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
1052637|NCT02833363|Gastric cancer|gastric cancer
1052638|NCT02833337|Bone|bone
1052639|NCT02833337|Maxilla|maxilla
1052640|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
1052641|NCT02833337|Regeneration|regeneration
1052642|NCT02833324|Postoperative Period|postoperative period
1052643|NCT02833324|Colorectal Surgery|colorectal surgery
1052644|NCT02833324|Surgery|surgery
1052645|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
1052646|NCT02833298|Sustained Virological Response|sustained virological response
1052647|NCT02833298|SVR|svr
1052648|NCT02833298|patient navigation|patient navigation
1052649|NCT02833298|screening|screening
1052650|NCT02833298|HCC|hcc
1052651|NCT02833298|HCV|hcv
1052652|NCT02833272|benzodiazepines|benzodiazepines
1052653|NCT02833272|Z-drugs|z-drugs
1052654|NCT02833259|Pneumonia|pneumonia
1052655|NCT02833259|Patient readmission|patient readmission
1052656|NCT02833259|Community-acquired infections|community-acquired infections
1052657|NCT02833259|Observational study|observational study
1052658|NCT02833259|Quality of health care|quality of health care
1052659|NCT02833259|Models, Statistical|models, statistical
1052660|NCT02833246|texting|texting
1052661|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
1052662|NCT02833246|16-810|16-810
1052663|NCT02833233|Early stage|early stage
1052664|NCT02833233|Resectable|resectable
1052665|NCT02833233|Ipilimumab|ipilimumab
1052666|NCT02833233|Nivolumab|nivolumab
1052667|NCT02833233|Cryoablation|cryoablation
1052668|NCT02833233|16-495|16-495
1052669|NCT02833220|blood pressure|blood pressure
1052670|NCT02833220|heart rate variability|heart rate variability
1052671|NCT02833220|single-pulse transcranial magnetic stimulation|single-pulse transcranial magnetic stimulation
1052672|NCT02833220|non-invasive brain stimulation|non-invasive brain stimulation
1052673|NCT02833207|blood flow|blood flow
1052674|NCT02833207|vasodilation|vasodilation
1052675|NCT02833207|Doppler Ultrasound|doppler ultrasound
1052676|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
1052677|NCT02833168|Neuromuscular disorders|neuromuscular disorders
1052678|NCT02833168|Sleep disordered breathing|sleep disordered breathing
1052679|NCT02833168|Dyspnea|dyspnea
1052681|NCT02833155|breast cancer|breast cancer
1052682|NCT02833142|Healthy Volunteer|healthy volunteer
1052683|NCT02833142|opicinumab|opicinumab
1052684|NCT02833116|radiculalgia|radiculalgia
1052685|NCT02833116|chronic pain|chronic pain
1052686|NCT02833116|quality of life|quality of life
1052687|NCT02833103|Pinaverium Bromide|pinaverium bromide
1052688|NCT02833103|cholecystectomy|cholecystectomy
1052689|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
1052690|NCT02833012|Healthy volunteers|healthy volunteers
1052691|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
1052692|NCT02833012|AC-1202|ac-1202
1052693|NCT02833012|AC-1204|ac-1204
1052694|NCT02833012|Pharmacokinetic|pharmacokinetic
1052695|NCT02833012|ketone body|ketone body
1052696|NCT02833012|Axona|axona
1052697|NCT02832999|Diabetes|diabetes
1052698|NCT02832999|GLP-1|glp-1
1052699|NCT02832999|Insulin secretion|insulin secretion
1052700|NCT02832999|insulin sensitivity|insulin sensitivity
1052701|NCT02832999|Africa|africa
1052702|NCT02832999|Liraglutide|liraglutide
1052703|NCT02832999|Vildaglipin|vildaglipin
1052704|NCT02832986|Frailty consultation|frailty consultation
1052705|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
1052706|NCT02832973|Natriuretic Agents|natriuretic agents
1052707|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
1052708|NCT02832973|Bisoprolol|bisoprolol
1052709|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
1052710|NCT02832960|Atherosclerosis|atherosclerosis
1052711|NCT02832960|Heart Failure|heart failure
1052712|NCT02832960|Cardiovascular imaging|cardiovascular imaging
1052713|NCT02832960|Randomized Controlled Trial|randomized controlled trial
1052714|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
1052715|NCT02832934|Atherosclerosis|atherosclerosis
1052716|NCT02832934|Heart Failure|heart failure
1052717|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
1052718|NCT02832934|Randomized Controlled Trial|randomized controlled trial
1052719|NCT02832921|Alzheimer's disease|alzheimer's disease
1052720|NCT02832921|virtual reality|virtual reality
1052721|NCT02832921|cognitive training|cognitive training
1052722|NCT02832895|Adults|adults
1052723|NCT02832895|Frontal bone window|frontal bone window
1052724|NCT02832895|Transcranial doppler|transcranial doppler
1052725|NCT02832882|HCC|hcc
1052726|NCT02832882|RFA|rfa
1052727|NCT02832869|Polyp detection rate|polyp detection rate
1052728|NCT02832869|Adenoma detection rate|adenoma detection rate
1052729|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
1052730|NCT02832830|bony metastases|bony metastases
1052731|NCT02832830|palliative radiotherapy|palliative radiotherapy
1052732|NCT02832817|Oxygen therapy|oxygen therapy
1052733|NCT02832817|Pulse oximeter|pulse oximeter
1052734|NCT02832817|Hypoxia|hypoxia
1052735|NCT02832817|Hypoxemia|hypoxemia
1052736|NCT02832817|Arterial blood gas|arterial blood gas
1052737|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
1052738|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
1052739|NCT02832791|HAMSTRING TENDON|hamstring tendon
1052740|NCT02832765|Palliative radiotherapy|palliative radiotherapy
1052741|NCT02832765|Bone metastases|bone metastases
1052742|NCT02832739|Technology acceptance|technology acceptance
1052743|NCT02832739|Usability|usability
1052744|NCT02832739|eHealth|ehealth
1052745|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
1052746|NCT02832739|prevention|prevention
1052747|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
1052748|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
1052749|NCT02832713|Knee osteoarthritis|knee osteoarthritis
1052750|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
1052751|NCT02832713|Hyaluronic acid|hyaluronic acid
1052752|NCT02832713|Pain|pain
1052753|NCT02832713|Function|function
1052754|NCT02832700|glycopeptides|glycopeptides
1052755|NCT02832700|dietary proteins|dietary proteins
1052756|NCT02832700|whey protein|whey protein
1052757|NCT02832700|caseinomacropeptide|caseinomacropeptide
1052758|NCT02832700|antiinflammatories|antiinflammatories
1052759|NCT02832700|human microbiome|human microbiome
1052760|NCT02832661|renal allograft|renal allograft
1052761|NCT02832661|graft injuries|graft injuries
1052762|NCT02832661|biopsy|biopsy
1052763|NCT02832661|biomarkers|biomarkers
1052764|NCT02832661|omics approach|omics approach
1052765|NCT02832635|brain metastasis|brain metastasis
1052766|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
1052767|NCT02832635|TMZ|tmz
1052768|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
1052769|NCT02832622|MultiPoint Pacing|multipoint pacing
1052770|NCT02832622|Heart Failure|heart failure
1052771|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1052772|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
1052773|NCT02832609|closing volume|closing volume
1052774|NCT02832609|expiratory flow limitation|expiratory flow limitation
1052775|NCT02832609|obesity|obesity
1052776|NCT02832609|orthopnea|orthopnea
1052777|NCT02832596|Anesthesia|anesthesia
1052778|NCT02832596|Blood pressure|blood pressure
1052779|NCT02832596|Plasma Volume|plasma volume
1052780|NCT02832596|Vasopressor agents|vasopressor agents
1052781|NCT02832596|Coronary artery bypass|coronary artery bypass
1052782|NCT02832596|Glycocalyx|glycocalyx
1052783|NCT02832596|ANP|anp
1052784|NCT02832596|Coagulation|coagulation
1052785|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
1052786|NCT02832557|Autism|autism
1052787|NCT02832557|Asperger's Syndrome|asperger's syndrome
1052788|NCT02832557|microRNA|microrna
1052789|NCT02832557|epigenetic|epigenetic
1052790|NCT02832557|biomarker|biomarker
1052791|NCT02832544|atrial fibrillation|atrial fibrillation
1052792|NCT02832544|stroke|stroke
1052793|NCT02832531|atrial fibrillation|atrial fibrillation
1052794|NCT02832531|stroke|stroke
1052795|NCT02832492|disorders of consciousness|disorders of consciousness
1052796|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
1052797|NCT02832492|pupil near response|pupil near response
1730531|NCT00005011|PMDD|pmdd
1052798|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
1052799|NCT02832453|High intensity physical exercise|high intensity physical exercise
1052800|NCT02832453|Primary health care|primary health care
1052801|NCT02832453|Behaviour change interventions|behaviour change interventions
1052802|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
1052803|NCT02832427|Heart valve surgery|heart valve surgery
1052804|NCT02832427|Postoperative morbidity|postoperative morbidity
1052805|NCT02832427|Operative mortality|operative mortality
1052806|NCT02832401|event-related potentials|event-related potentials
1052810|NCT02832401|schizophrenia|schizophrenia
1052811|NCT02832336|Caffeine|caffeine
1052812|NCT02832336|Caffeine citrate|caffeine citrate
1052813|NCT02832336|Neurological disorder|neurological disorder
1052814|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
1052815|NCT02832336|Orexin|orexin
1052816|NCT02832336|adenosine antagonist|adenosine antagonist
1052817|NCT02832323|hemodialysis|hemodialysis
1052818|NCT02832323|EPO|epo
1052819|NCT02832323|MIRCERA|mircera
1052820|NCT02832310|valsalva|valsalva
1052821|NCT02832258|Enterobacteria|enterobacteria
1052822|NCT02832258|Children|children
1052823|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
1052824|NCT02832258|Cystitis|cystitis
1052825|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
1052826|NCT02832232|Physiotherapy|physiotherapy
1052827|NCT02832232|Manual Therapy|manual therapy
1052828|NCT02832232|Neck Pain|neck pain
1052829|NCT02832219|Overweight|overweight
1052830|NCT02832219|Molecular hydrogen|molecular hydrogen
1052831|NCT02832219|Insulin|insulin
1052832|NCT02832206|Atrial fibrillation|atrial fibrillation
1052833|NCT02832206|Hybrid ablation|hybrid ablation
1052834|NCT02832180|Rheumatoid|rheumatoid
1052835|NCT02832141|Skin blood flow|skin blood flow
1052836|NCT02832141|Skin redness|skin redness
1052837|NCT02832141|Sympathetic nervous system|sympathetic nervous system
1052838|NCT02832141|Regional Blood Flow|regional blood flow
1052839|NCT02832128|Cochlear Implant|cochlear implant
1052840|NCT02832115|Radial Artery Spasm|radial artery spasm
1052841|NCT02832115|Cardiac Catheterization|cardiac catheterization
1052842|NCT02832115|Vascular Access Site Complications|vascular access site complications
1052843|NCT02832115|Vasodilator|vasodilator
1052844|NCT02832115|Nitroglycerine|nitroglycerine
1052845|NCT02832115|Lidocaine|lidocaine
1052846|NCT02832102|prognostic modelling|prognostic modelling
1052847|NCT02832102|radiomics|radiomics
1052848|NCT02832102|clinical decision support system|clinical decision support system
1052849|NCT02832102|big data analysis|big data analysis
1052850|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
1052851|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
1052852|NCT02832089|atrial fibrillation|atrial fibrillation
1052853|NCT02832089|rate reduction|rate reduction
1052854|NCT02832050|play|play
1052855|NCT02832050|therapy|therapy
1052856|NCT02832024|stents|stents
1052857|NCT02832024|atherectomy|atherectomy
1052858|NCT02832024|femoral artery|femoral artery
1052859|NCT02832024|popliteal artery|popliteal artery
1052860|NCT02832024|In-stent Restenosis|in-stent restenosis
1052861|NCT02831985|Child|child
1052862|NCT02831985|Middle ear ventilation|middle ear ventilation
1052863|NCT02831985|Follow-up studies|follow-up studies
1052864|NCT02831985|General practitioners|general practitioners
1052865|NCT02831972|Healthy Volunteers|healthy volunteers
1052866|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
1052867|NCT02831959|NSCLC|nsclc
1052868|NCT02831959|Brain metastases|brain metastases
1052869|NCT02831959|Treatment|treatment
1052870|NCT02831959|Minimal toxicity|minimal toxicity
1052871|NCT02831959|TTFields|ttfields
1052872|NCT02831959|TTF|ttf
1052873|NCT02831959|Tumor Treating Fields|tumor treating fields
1052874|NCT02831959|Novocure|novocure
1052875|NCT02831959|SRS|srs
1052876|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
1052877|NCT02831946|skin closure|skin closure
1052878|NCT02831946|intracuticular suture|intracuticular suture
1052880|NCT02831933|lung cancer|lung cancer
1052881|NCT02831933|metastatic|metastatic
1052882|NCT02831933|gene therapy|gene therapy
1052883|NCT02831933|immunotherapy|immunotherapy
1052884|NCT02831933|melanoma|melanoma
1052885|NCT02831933|uveal|uveal
1052886|NCT02831920|Prostate Cancer|prostate cancer
1052888|NCT02831920|CEUS|ceus
1052889|NCT02831920|Contrast Ultrasound|contrast ultrasound
1052890|NCT02831920|Fusion|fusion
1052891|NCT02831920|targeted biopsy|targeted biopsy
1052892|NCT02831907|Ultrasonography|ultrasonography
1052893|NCT02831907|Portal vein Doppler|portal vein doppler
1052894|NCT02831907|Renal Doppler|renal doppler
1052895|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
1052896|NCT02831907|Delirium|delirium
1052897|NCT02831907|Renal congestion|renal congestion
1052898|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
1052899|NCT02831894|insomnia|insomnia
1052900|NCT02831894|sedative hypnotics|sedative hypnotics
1052901|NCT02831894|hypnotic tapering|hypnotic tapering
1052902|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
1052903|NCT02831855|Tofacitinib|tofacitinib
1052904|NCT02831855|CP-690,550|cp-690,550
1052905|NCT02831855|Xeljanz|xeljanz
1052906|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
1052907|NCT02831855|withdrawal study|withdrawal study
1052908|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
1052909|NCT02831829|coronary artery disease|coronary artery disease
1052910|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
1052911|NCT02831764|tolerability|tolerability
1052912|NCT02831764|HIV 1|hiv 1
1052913|NCT02831764|efficacy|efficacy
1052914|NCT02831764|treatment naïve|treatment naïve
1052915|NCT02831764|two-drug regimen|two-drug regimen
1052916|NCT02831764|safety|safety
1052917|NCT02831764|non inferiority|non inferiority
1052918|NCT02831751|Influenza|influenza
1052919|NCT02831751|Human|human
1052920|NCT02831751|RNA Virus Infections|rna virus infections
1052921|NCT02831751|Immulogic|immulogic
1052922|NCT02831751|Immunogenic Factors|immunogenic factors
1052923|NCT02831751|Physiological Effects of Drug|physiological effects of drug
1052924|NCT02831751|Virus Diseases|virus diseases
1052925|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
1052926|NCT02831751|Infection|infection
1052927|NCT02831738|Fiber|fiber
1052928|NCT02831738|Polydextrose|polydextrose
1052929|NCT02831738|Glycemic Index|glycemic index
1052930|NCT02831712|NTBI|ntbi
1052931|NCT02831712|Iron status|iron status
1052932|NCT02831712|Iron supplement|iron supplement
1052935|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
1052936|NCT02831686|Ixazomib|ixazomib
1052937|NCT02831686|dexamethasone|dexamethasone
1052938|NCT02831686|15-310|15-310
1052939|NCT02831673|safety|safety
1052940|NCT02831673|treatment naïve|treatment naïve
1052941|NCT02831673|HIV 1|hiv 1
1052942|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
1052943|NCT02831673|non inferiority|non inferiority
1052944|NCT02831673|tolerability|tolerability
1052945|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
1052946|NCT02831673|efficacy|efficacy
1052947|NCT02831634|Breast cancer|breast cancer
1052948|NCT02831634|cutaneous melanoma|cutaneous melanoma
1052949|NCT02831621|overweight|overweight
1052950|NCT02831621|ectopic fat|ectopic fat
1052951|NCT02831621|exercise|exercise
1052952|NCT02831621|diet|diet
1052953|NCT02831582|Breast Cancer|breast cancer
1052954|NCT02831582|Postmenopausal|postmenopausal
1052955|NCT02831582|Stage IA|stage ia
1052956|NCT02831582|Stage IB|stage ib
1052957|NCT02831582|Stage IIA|stage iia
1052958|NCT02831582|Stage IIB|stage iib
1052959|NCT02831582|Stage IIIA|stage iiia
1052960|NCT02831582|Stage IIIB|stage iiib
1052961|NCT02831582|Stage IIIC|stage iiic
1052962|NCT02831556|Ultrasound|ultrasound
1052963|NCT02831556|Abdomen|abdomen
1052964|NCT02831556|Pelvis|pelvis
1052965|NCT02831556|3D|3d
1052966|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
1052967|NCT02831504|DM1|dm1
1052968|NCT02831504|Muscular Dystrophy|muscular dystrophy
1052969|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
1052970|NCT02831491|metastatic|metastatic
1052971|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
1052972|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
1052973|NCT02831465|Inspiratory capacity|inspiratory capacity
1052974|NCT02831465|healthy subjects|healthy subjects
1052975|NCT02831452|pelvic floor muscles|pelvic floor muscles
1052976|NCT02831452|evaluation|evaluation
1052977|NCT02831452|dynamometer|dynamometer
1052978|NCT02831452|perineometer|perineometer
1052979|NCT02831439|Choosing Wisely|choosing wisely
1052980|NCT02831439|Breast cancer|breast cancer
1052981|NCT02831439|Controlled trial|controlled trial
1052982|NCT02831439|High-value health care|high-value health care
1052983|NCT02831439|Health services research|health services research
1052984|NCT02831348|Asthma|asthma
1052985|NCT02831348|Allergic rhinitis|allergic rhinitis
1052986|NCT02831348|Rhinitis|rhinitis
1052987|NCT02831348|Pneumonia|pneumonia
1052988|NCT02831348|Cystic fibrosis|cystic fibrosis
1052989|NCT02831322|Transradial|transradial
1052990|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
1052991|NCT02831309|physical activity|physical activity
1052992|NCT02831296|SMA|sma
1052993|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
1052994|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
1052995|NCT02831283|inflammation|inflammation
1052996|NCT02831283|aging|aging
1052997|NCT02831283|mild cognitive impairment|mild cognitive impairment
1052998|NCT02831270|cardiac surgery|cardiac surgery
1052999|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
1053000|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
1053001|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1053002|NCT02831218|coronary artery disease|coronary artery disease
1053003|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1053004|NCT02831205|coronary artery disease|coronary artery disease
1053005|NCT02831166|Vascular closure devices|vascular closure devices
1053006|NCT02831166|Transradial approach|transradial approach
1053007|NCT02831166|Transfemoral approach|transfemoral approach
1053008|NCT02831140|Fast track|fast track
1053009|NCT02831140|rehabilitation|rehabilitation
1053010|NCT02831140|post operative complications|post operative complications
1053011|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
1053013|NCT02831101|Elderly|elderly
1053014|NCT02831101|Propofol|propofol
1053015|NCT02831101|Sufentanil|sufentanil
1053016|NCT02831101|Loss of consciousness|loss of consciousness
1053017|NCT02831088|Neu2000KWL|neu2000kwl
1053018|NCT02831088|Neuroprotection|neuroprotection
1053322|NCT02829619|Obesity|obesity
1053019|NCT02831088|endovascular therapy|endovascular therapy
1053020|NCT02831088|glutamate|glutamate
1053021|NCT02831088|free radical|free radical
1053022|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
1053023|NCT02831062|nutrition|nutrition
1053024|NCT02831062|progression|progression
1053025|NCT02831049|Reconsolidation|reconsolidation
1053026|NCT02831010|prematurity|prematurity
1053027|NCT02830971|standardized learning curve|standardized learning curve
1053028|NCT02830971|Nurse|nurse
1053029|NCT02830971|intensive care unit|intensive care unit
1053030|NCT02830971|Mastery|mastery
1053031|NCT02830971|Training|training
1053032|NCT02830971|Developing|developing
1053033|NCT02830971|Skills|skills
1053034|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
1053035|NCT02830919|Glucosamine sulfate|glucosamine sulfate
1053036|NCT02830919|Chondroitin sulfate|chondroitin sulfate
1053037|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
1053038|NCT02830906|Intrathecal Morphine|intrathecal morphine
1053039|NCT02830906|Ramosetron|ramosetron
1053040|NCT02830906|Ondansetron|ondansetron
1053041|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
1053042|NCT02830880|Imaging|imaging
1053043|NCT02830880|Nuclear medicine|nuclear medicine
1053044|NCT02830880|Oncology|oncology
1053045|NCT02830880|Radiology|radiology
1053046|NCT02830880|Urogenital disorders|urogenital disorders
1053047|NCT02830867|glutathione|glutathione
1053048|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
1053049|NCT02830867|autosomal inheritance|autosomal inheritance
1053050|NCT02830867|recessive|recessive
1053051|NCT02830841|RIPC|ripc
1053052|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
1053053|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
1053054|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
1053055|NCT02830815|General Anesthesia|general anesthesia
1053056|NCT02830815|Sevoflurane|sevoflurane
1053057|NCT02830815|Propofol|propofol
1053058|NCT02830815|Amplitude latency|amplitude latency
1053059|NCT02830815|Wave V|wave v
1053060|NCT02830776|dermatochalasis|dermatochalasis
1053061|NCT02830776|bimatoprost|bimatoprost
1053062|NCT02830776|blepharoplasty|blepharoplasty
1053063|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
1053064|NCT02830763|CNT-02|cnt-02
1053065|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
1053066|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
1053067|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
1053068|NCT02830737|No-touch RFA|no-touch rfa
1053069|NCT02830737|Traditional RFA|traditional rfa
1053070|NCT02830737|Recurrence rate|recurrence rate
1053071|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
1053072|NCT02830724|Renal Cell Cancer|renal cell cancer
1053073|NCT02830724|Cell Therapy|cell therapy
1053074|NCT02830724|CAR T Cells|car t cells
1053075|NCT02830711|happiness|happiness
1053076|NCT02830711|anger|anger
1053077|NCT02830711|sadness|sadness
1053078|NCT02830711|anticipation|anticipation
1053079|NCT02830698|Nervous System|nervous system
1053080|NCT02830698|Hypnosis|hypnosis
1053081|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
1053082|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
1053083|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
1053084|NCT02830633|laparoscopy|laparoscopy
1053085|NCT02830633|rectal cancer|rectal cancer
1053086|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
1053087|NCT02830568|Kidney transplantation|kidney transplantation
1053088|NCT02830568|Surgical procedures|surgical procedures
1053089|NCT02830568|Kidney living donors|kidney living donors
1053090|NCT02830568|Quality of life|quality of life
1053091|NCT02830542|Clostridium difficile|clostridium difficile
1053092|NCT02830542|C Diff|c diff
1053093|NCT02830542|CDI|cdi
1053094|NCT02830529|Mindfulness|mindfulness
1053095|NCT02830529|African American|african american
1053096|NCT02830529|fMRI|fmri
1053097|NCT02830477|Previously treated patients|previously treated patients
1053098|NCT02830451|Registry|registry
1053099|NCT02830451|Spine|spine
1053100|NCT02830451|Surgery|surgery
1053101|NCT02830451|Medical Oncology|medical oncology
1053102|NCT02830451|Radiation Oncology|radiation oncology
1053103|NCT02830451|Neoplasms|neoplasms
1053104|NCT02830451|Metastasis|metastasis
1053105|NCT02830451|Chemotherapy|chemotherapy
1053106|NCT02830451|Radiation Therapy|radiation therapy
1053107|NCT02830451|Tumor Markers|tumor markers
1053108|NCT02830438|kidney disease|kidney disease
1053109|NCT02830438|fibrosis|fibrosis
1053110|NCT02830438|ultrasound|ultrasound
1053111|NCT02830438|elastography|elastography
1053112|NCT02830425|Multimorbidity|multimorbidity
1053113|NCT02830425|Polypharmacy|polypharmacy
1053114|NCT02830425|Appropriateness|appropriateness
1053115|NCT02830425|STOPP|stopp
1053116|NCT02830425|START|start
1053117|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
1053118|NCT02830399|rTMS|rtms
1053421|NCT02829112|fasciitis|fasciitis
1053120|NCT02830399|Augmentation strategy|augmentation strategy
1053121|NCT02830373|LVIS stents|lvis stents
1053122|NCT02830373|Intracranial aneurysm|intracranial aneurysm
1053123|NCT02830373|Unruptured aneurysm|unruptured aneurysm
1053124|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
1053125|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
1053126|NCT02830360|VT Catheter ablation|vt catheter ablation
1053127|NCT02830360|ICD Therapy|icd therapy
1053128|NCT02830360|Ischemic Heart Disease|ischemic heart disease
1053129|NCT02830347|antibiotic resistance|antibiotic resistance
1053130|NCT02830347|oral microbiome|oral microbiome
1053131|NCT02830334|Suicide|suicide
1053132|NCT02830334|Youth Suicide|youth suicide
1053133|NCT02830308|Hormones|hormones
1053134|NCT02830308|Endocrine|endocrine
1053135|NCT02830308|Hypercortisolism|hypercortisolism
1053136|NCT02830308|Bone|bone
1053137|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
1053138|NCT02830295|body awareness therapy|body awareness therapy
1053139|NCT02830295|physical therapy|physical therapy
1053140|NCT02830295|movement therapy|movement therapy
1053141|NCT02830269|Neuro-ICU|neuro-icu
1053142|NCT02830269|Third ventricle|third ventricle
1053143|NCT02830269|Computer Tomography|computer tomography
1053144|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
1053145|NCT02830256|Intensive care unit|intensive care unit
1053146|NCT02830256|Neuro-ICU|neuro-icu
1053147|NCT02830256|Pain|pain
1053148|NCT02830256|Intubation|intubation
1053149|NCT02830256|critical care|critical care
1053150|NCT02830256|patients|patients
1053151|NCT02830217|STEMI|stemi
1053152|NCT02830217|primary PCI|primary pci
1053153|NCT02830217|sST2|sst2
1053154|NCT02830217|prognosis|prognosis
1053155|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
1053156|NCT02830204|mitral valve stenosis|mitral valve stenosis
1053157|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
1053158|NCT02830152|Stroke|stroke
1053159|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
1053160|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
1053161|NCT02830152|atrial fibrillation|atrial fibrillation
1053162|NCT02830152|oral anticoagulation|oral anticoagulation
1053163|NCT02830152|preventive therapy|preventive therapy
1053164|NCT02830126|Outcomes|outcomes
1053165|NCT02830126|Information technology|information technology
1053166|NCT02830113|periodontitis|periodontitis
1053167|NCT02830113|diabetes|diabetes
1053168|NCT02830113|prevention|prevention
1053169|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
1053170|NCT02830113|insulin resistance|insulin resistance
1053171|NCT02830100|Intern speech|intern speech
1053172|NCT02830100|Speech and visual imaging|speech and visual imaging
1053173|NCT02830100|Mind and oral drift|mind and oral drift
1053174|NCT02830100|Cognitive performance|cognitive performance
1053175|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
1053176|NCT02830087|randomized controlled trial|randomized controlled trial
1053177|NCT02830087|tourniquet|tourniquet
1053178|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
1053179|NCT02830087|total knee arthroplasty|total knee arthroplasty
1053180|NCT02830087|total knee replacement|total knee replacement
1053181|NCT02830087|pain, postoperative|pain, postoperative
1053182|NCT02830087|range of motion, articular|range of motion, articular
1053183|NCT02830087|blood loss, surgical|blood loss, surgical
1053184|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
1053185|NCT02830087|walking|walking
1053186|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
1053187|NCT02830087|wound healing/surgery|wound healing/surgery
1053188|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
1053189|NCT02830074|Spinal Cord Injuries|spinal cord injuries
1053190|NCT02830074|Sleep|sleep
1053191|NCT02830074|Quality of life|quality of life
1053192|NCT02830061|Cancer|cancer
1053193|NCT02830061|Teenage|teenage
1053194|NCT02830061|Young Adult|young adult
1053195|NCT02830061|Fertility|fertility
1053196|NCT02830061|Cryopreservation|cryopreservation
1053197|NCT02830061|Experience|experience
1053198|NCT02830048|diabetes|diabetes
1053199|NCT02830048|glibenclamide|glibenclamide
1089538|NCT02613390|MRI|mri
1053200|NCT02830048|glucagon|glucagon
1053201|NCT02830035|ultrasound guided|ultrasound guided
1053202|NCT02830035|spinal anesthesia|spinal anesthesia
1053203|NCT02830035|neuraxial block|neuraxial block
1053204|NCT02830035|paramedian|paramedian
1053205|NCT02830022|autism spectrum disorder|autism spectrum disorder
1053206|NCT02829996|glaucoma|glaucoma
1053207|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
1053208|NCT02829996|ocular hypertension|ocular hypertension
1053209|NCT02829996|adenosine agonist|adenosine agonist
1053210|NCT02829996|eye drop|eye drop
1053211|NCT02829996|trabodenoson|trabodenoson
1053212|NCT02829996|trabecular meshwork|trabecular meshwork
1053213|NCT02829983|clarithromycin|clarithromycin
1053214|NCT02829983|periodontal debridement|periodontal debridement
1053215|NCT02829983|aggressive periodontitis|aggressive periodontitis
1053216|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1053830|NCT02826200|Brain MRI|brain mri
1053217|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
1053218|NCT02829970|Substance-Related Disorders|substance-related disorders
1053219|NCT02829970|Motivational Interviewing|motivational interviewing
1053220|NCT02829970|Behavior Therapy|behavior therapy
1053221|NCT02829944|Cesarean section|cesarean section
1053222|NCT02829931|recurrent glioma|recurrent glioma
1053223|NCT02829931|high grade glioma|high grade glioma
1053224|NCT02829931|head and neck disease|head and neck disease
1053225|NCT02829931|grade III glioma|grade iii glioma
1053226|NCT02829931|grade IV glioma|grade iv glioma
1053227|NCT02829931|radiation therapy|radiation therapy
1053228|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
1053229|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
1053230|NCT02829918|digestive diseases|digestive diseases
1053231|NCT02829918|immunotherapy|immunotherapy
1053232|NCT02829905|mass screening|mass screening
1053233|NCT02829905|patient satisfaction|patient satisfaction
1053234|NCT02829905|radiography|radiography
1053235|NCT02829905|mammography|mammography
1053236|NCT02829879|Dentin Sensitivity|dentin sensitivity
1053237|NCT02829879|Arginin|arginin
1053238|NCT02829879|Potassium Nitrate|potassium nitrate
1053239|NCT02829879|Dentifrice|dentifrice
1053240|NCT02829879|RCT|rct
1053241|NCT02829853|SARCOIDOSIS|sarcoidosis
1053242|NCT02829853|GRANULOMA DISEASES|granuloma diseases
1053243|NCT02829853|GENETICS|genetics
1053244|NCT02829853|PREDISPOSITION|predisposition
1053245|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
1053246|NCT02829840|Leukemia|leukemia
1053247|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
1053248|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
1053249|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
1053250|NCT02829840|AML|aml
1053251|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
1053252|NCT02829840|MDS|mds
1053253|NCT02829840|Ponatinib|ponatinib
1053254|NCT02829840|Iclusig|iclusig
1053255|NCT02829840|AP24534|ap24534
1053256|NCT02829840|5-azacytidine|5-azacytidine
1053257|NCT02829840|Azacitidine|azacitidine
1053258|NCT02829840|5-aza|5-aza
1053259|NCT02829840|Vidaza|vidaza
1053260|NCT02829840|5-AZC|5-azc
1053261|NCT02829840|AZA-CR|aza-cr
1053262|NCT02829840|Ladakamycin|ladakamycin
1053263|NCT02829840|NSC-102816|nsc-102816
1053264|NCT02829840|Azacytidine|azacytidine
1053265|NCT02829827|Radiprodil|radiprodil
1053266|NCT02829827|Infantile spasms|infantile spasms
1053267|NCT02829827|IS|is
1053268|NCT02829827|Infantile|infantile
1053269|NCT02829827|Spasms|spasms
1053270|NCT02829827|Epilepsy|epilepsy
1053271|NCT02829827|Paediatrics|paediatrics
1053272|NCT02829827|Drug-resistant|drug-resistant
1053273|NCT02829827|West Syndrome|west syndrome
1053274|NCT02829827|Hypsarrhythmia|hypsarrhythmia
1053275|NCT02829814|Pain|pain
1053276|NCT02829814|Sleep|sleep
1053277|NCT02829814|Fibromyalgia|fibromyalgia
1053278|NCT02829814|FM|fm
1053279|NCT02829801|animal assisted therapy|animal assisted therapy
1053280|NCT02829801|well-being|well-being
1053281|NCT02829801|Alzheimer's Disease|alzheimer's disease
1053282|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
1053283|NCT02829788|laparoscopy|laparoscopy
1053284|NCT02829788|laparotomy|laparotomy
1053285|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
1053286|NCT02829788|staging|staging
1053287|NCT02829762|isolated|isolated
1053288|NCT02829762|at risk of isolation|at risk of isolation
1053289|NCT02829762|patients|patients
1053290|NCT02829749|Heart Valve Diseases|heart valve diseases
1053291|NCT02829749|Heart failure|heart failure
1053292|NCT02829749|Heart diseases|heart diseases
1053293|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
1053294|NCT02829736|lung neoplasm|lung neoplasm
1053295|NCT02829736|lung metastasis|lung metastasis
1053296|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
1053297|NCT02829736|fast-track surgery|fast-track surgery
1053298|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
1053299|NCT02829736|pain|pain
1053300|NCT02829736|lung function|lung function
1053301|NCT02829736|reasons for admission|reasons for admission
1053302|NCT02829723|Phase I/II|phase i/ii
1053303|NCT02829723|BLZ945|blz945
1053304|NCT02829723|PDR001|pdr001
1053305|NCT02829723|CSF-1R|csf-1r
1053306|NCT02829723|PD-1|pd-1
1053307|NCT02829710|Analgesia|analgesia
1053308|NCT02829710|intensive care units|intensive care units
1053309|NCT02829710|clinical protocol|clinical protocol
1053310|NCT02829710|deep sedation|deep sedation
1053311|NCT02829710|nursing assessment|nursing assessment
1053312|NCT02829697|Regional anaesthesia|regional anaesthesia
1053313|NCT02829671|Loneliness|loneliness
1053314|NCT02829671|Suicidal behavior|suicidal behavior
1053315|NCT02829671|Depression|depression
1053316|NCT02829645|eating disoders|eating disoders
1053317|NCT02829645|neuropsychology|neuropsychology
1053318|NCT02829645|pronostic|pronostic
1053319|NCT02829632|mobile technology|mobile technology
1053320|NCT02829632|feedback message|feedback message
1053321|NCT02829632|self-monitoring|self-monitoring
1053323|NCT02829619|Nutrigenetics|nutrigenetics
1053324|NCT02829619|Food Timing|food timing
1053325|NCT02829619|Weight loss|weight loss
1053326|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
1053327|NCT02829606|Central Scotoma|central scotoma
1053328|NCT02829606|Head Mounted Display|head mounted display
1053329|NCT02829580|endothelial function|endothelial function
1053330|NCT02829580|flow-mediated dilation|flow-mediated dilation
1053331|NCT02829580|vascular elastic properties|vascular elastic properties
1053332|NCT02829554|Emotion|emotion
1053333|NCT02829554|Judgment|judgment
1053334|NCT02829554|Decision Making|decision making
1053335|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
1053336|NCT02829502|Cerebrovascular disease|cerebrovascular disease
1053337|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
1053338|NCT02829489|nutrition|nutrition
1053339|NCT02829489|foregut tumors|foregut tumors
1053340|NCT02829489|patient related outcomes|patient related outcomes
1053341|NCT02829489|audit|audit
1053342|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
1053343|NCT02829476|Ghrelin|ghrelin
1053344|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
1053345|NCT02829450|congestive heart failure|congestive heart failure
1053346|NCT02829450|chronic kidney disease|chronic kidney disease
1053347|NCT02829398|cerebral ischemia|cerebral ischemia
1053348|NCT02829385|Apatinib|apatinib
1053349|NCT02829385|XELOX Regimen|xelox regimen
1053350|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
1053351|NCT02829346|Tranexamic acid|tranexamic acid
1053352|NCT02829346|Peri-articular injection|peri-articular injection
1053353|NCT02829346|Total knee arthroplasty|total knee arthroplasty
1053354|NCT02829346|Blood loss|blood loss
1053355|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
1053356|NCT02829333|analgesia|analgesia
1053357|NCT02829333|anesthesia|anesthesia
1053358|NCT02829333|leiomyomas|leiomyomas
1053359|NCT02829333|tumor|tumor
1053360|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
1053361|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
1053362|NCT02829320|efficacy|efficacy
1053363|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
1053364|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
1053365|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
1053366|NCT02829320|GSK1278863|gsk1278863
1053367|NCT02829307|89Zirconium|89zirconium
1053368|NCT02829307|Open label|open label
1053369|NCT02829307|Pharmacokinetics|pharmacokinetics
1053370|NCT02829307|Radioactive|radioactive
1053371|NCT02829307|Clearance|clearance
1053372|NCT02829307|Biodistribution|biodistribution
1053373|NCT02829281|knee osteoarthritis|knee osteoarthritis
1053374|NCT02829281|Intra-articular injection|intra-articular injection
1053375|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
1053376|NCT02829281|Corticosteroid|corticosteroid
1053377|NCT02829268|Wolfram syndrome|wolfram syndrome
1053378|NCT02829268|Diabetes Mellitus|diabetes mellitus
1053379|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
1053380|NCT02829268|Ataxia|ataxia
1053381|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
1053382|NCT02829255|High altitude|high altitude
1053383|NCT02829255|Cerebral autoregulation|cerebral autoregulation
1053384|NCT02829255|Transfer function analysis|transfer function analysis
1053385|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
1053386|NCT02829242|Somatic Saturation|somatic saturation
1053387|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
1053388|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
1053389|NCT02829242|Trendelenburg Position|trendelenburg position
1053390|NCT02829216|myelosuppression|myelosuppression
1053391|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
1053392|NCT02829203|Frailty|frailty
1053393|NCT02829203|Surgery|surgery
1053394|NCT02829190|External carotid artery|external carotid artery
1053395|NCT02829190|Facial artery|facial artery
1053396|NCT02829190|Lingual artery|lingual artery
1053397|NCT02829190|Superior thyroid artery|superior thyroid artery
1053398|NCT02829190|Internal maxillary artery|internal maxillary artery
1053399|NCT02829190|Phase-contrast MRI|phase-contrast mri
1053400|NCT02829190|Rate of flow|rate of flow
1053401|NCT02829190|Superficial temporal artery|superficial temporal artery
1053402|NCT02829177|Type 1 diabetes|type 1 diabetes
1053403|NCT02829177|Diabetic nephropathy|diabetic nephropathy
1053404|NCT02829177|Albuminuria|albuminuria
1053405|NCT02829177|Allopurinol|allopurinol
1053406|NCT02829164|Tonsillectomy|tonsillectomy
1053407|NCT02829164|primary IgA nephropathy|primary iga nephropathy
1053408|NCT02829164|primary nephropathy|primary nephropathy
1053410|NCT02829164|Berger's disease|berger's disease
1053411|NCT02829164|Purpura rheumatoid|purpura rheumatoid
1053412|NCT02829164|kidney failure|kidney failure
1053413|NCT02829151|Peripheral artery disease|peripheral artery disease
1053414|NCT02829151|Critical limb ischemia|critical limb ischemia
1053415|NCT02829151|Angioplasty|angioplasty
1053416|NCT02829151|Antiplatelet therapy|antiplatelet therapy
1053417|NCT02829125|Early rehabilitation|early rehabilitation
1053418|NCT02829125|abdominal surgery|abdominal surgery
1053420|NCT02829112|Shulman|shulman
1053422|NCT02829112|Shulman fasciitis|shulman fasciitis
1053423|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
1053424|NCT02829112|inflammatory disease|inflammatory disease
1053425|NCT02829112|prevalence|prevalence
1053426|NCT02829073|Tinnitus|tinnitus
1053427|NCT02829073|Double-blind|double-blind
1053428|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
1053429|NCT02829073|Oasis™|oasis™
1053430|NCT02829060|nephrolithiasis|nephrolithiasis
1053431|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
1053432|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
1053433|NCT02829060|Sepsis|sepsis
1053434|NCT02829034|pulmonary hypertension|pulmonary hypertension
1053435|NCT02829034|right ventricular function|right ventricular function
1053436|NCT02829034|ranolazine|ranolazine
1053437|NCT02829021|Sensitivity|sensitivity
1053438|NCT02829021|Specificity|specificity
1053439|NCT02829021|Breast cancer|breast cancer
1053440|NCT02829021|Mammography|mammography
1053441|NCT02829021|Thermography|thermography
1053442|NCT02829021|Infrared|infrared
1053443|NCT02829021|Dynamic|dynamic
1053444|NCT02829021|Diagnostic accuracy|diagnostic accuracy
1053445|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
1053446|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
1053447|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
1053448|NCT02829008|pemetrexed|pemetrexed
1053449|NCT02828995|Diabetes Mellitus|diabetes mellitus
1053450|NCT02828995|Stigma|stigma
1053451|NCT02828995|Social Determinants of Health|social determinants of health
1053452|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
1053453|NCT02828982|activity monitoring|activity monitoring
1053454|NCT02828982|muscle fatigue|muscle fatigue
1053455|NCT02828982|below knee amputation|below knee amputation
1053456|NCT02828969|Trajectory|trajectory
1053457|NCT02828969|Emergency room|emergency room
1053458|NCT02828969|Conduct disorder|conduct disorder
1053459|NCT02828969|Care management|care management
1053460|NCT02828956|eating disorders|eating disorders
1053461|NCT02828956|ANSOCQ|ansocq
1053462|NCT02828956|anorexia nervosa|anorexia nervosa
1053463|NCT02828878|Apoptosis|apoptosis
1053464|NCT02828878|FAS Ligand|fas ligand
1053465|NCT02828878|Bone marrow transplantation|bone marrow transplantation
1053466|NCT02828878|GvHD|gvhd
1053467|NCT02828878|Stem cells|stem cells
1053468|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
1053469|NCT02828865|irreversible electroporation|irreversible electroporation
1053470|NCT02828865|liver cancer|liver cancer
1053471|NCT02828852|pregnancy|pregnancy
1053472|NCT02828852|platelets|platelets
1053473|NCT02828839|Transperineal|transperineal
1053474|NCT02828839|Transrectal|transrectal
1053475|NCT02828839|Needle Guide|needle guide
1053476|NCT02828839|Biopsy|biopsy
1053477|NCT02828761|chest pain|chest pain
1053478|NCT02828761|calcium score|calcium score
1053479|NCT02828761|coronary calcium score|coronary calcium score
1053480|NCT02828761|coronary calcium scoring|coronary calcium scoring
1053481|NCT02828761|calcium scoring|calcium scoring
1053482|NCT02828761|cacs|cacs
1053484|NCT02828748|cannabinoids|cannabinoids
1053485|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
1053486|NCT02828722|Circadian rhythm|circadian rhythm
1053487|NCT02828722|Critical Illness|critical illness
1053489|NCT02828722|Environmental modulation|environmental modulation
1053490|NCT02828696|CAD-CAM composites|cad-cam composites
1053491|NCT02828696|Worn dentition|worn dentition
1053492|NCT02828696|minimally invasive treatment|minimally invasive treatment
1053493|NCT02828683|DES|des
1053494|NCT02828683|PCI|pci
1053495|NCT02828683|STEMI|stemi
1053496|NCT02828683|Interventional Cardiology|interventional cardiology
1053497|NCT02828657|ORBERA|orbera
1053498|NCT02828644|ADHD|adhd
1053500|NCT02828579|obesity|obesity
1053501|NCT02828579|bariatric surgery|bariatric surgery
1053502|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1053503|NCT02828553|Wearable device|wearable device
1053504|NCT02828553|Fitbit|fitbit
1053505|NCT02828553|Inpatient|inpatient
1053506|NCT02828540|HT047|ht047
1053507|NCT02828540|Pueraria lobata|pueraria lobata
1053508|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
1053509|NCT02828501|Pain Threshold|pain threshold
1053510|NCT02828436|Hypertension|hypertension
1053511|NCT02828436|High Blood Pressure|high blood pressure
1053512|NCT02828423|periodontal regeneration|periodontal regeneration
1053513|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
1053514|NCT02828410|IPAA|ipaa
1053515|NCT02828410|quality of life|quality of life
1053517|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
1053518|NCT02828332|Cohort|cohort
1053519|NCT02828306|stroke|stroke
1053520|NCT02828306|head trauma|head trauma
1053521|NCT02828306|Patient Specific Implant|patient specific implant
1053522|NCT02828306|skull defect|skull defect
1053523|NCT02828267|Tanzania|tanzania
1053524|NCT02828267|Alcohol Use|alcohol use
1053525|NCT02828267|Brief Intervention|brief intervention
1053526|NCT02828228|obesity|obesity
1053527|NCT02828228|weight loss|weight loss
1053934|NCT02825589|BIA|bia
1053528|NCT02828228|vitamin D deficiency|vitamin d deficiency
1053529|NCT02828228|body composition|body composition
1053530|NCT02828202|Melanoma|melanoma
1053531|NCT02828202|Skin|skin
1053532|NCT02828202|Biobank|biobank
1053533|NCT02828189|Physical Therapy Modalities|physical therapy modalities
1053534|NCT02828189|Breast Cancer Treatment|breast cancer treatment
1053535|NCT02828189|Exercise Therapy|exercise therapy
1053536|NCT02828189|Dyspnea|dyspnea
1053537|NCT02828176|cardiometry|cardiometry
1053538|NCT02828176|uterine displacement|uterine displacement
1053539|NCT02828111|Gorlin Syndrome|gorlin syndrome
1053540|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
1053541|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1053542|NCT02828111|Basal cell carcinoma|basal cell carcinoma
1053543|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
1053544|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
1053545|NCT02828098|aggressive solid tumors|aggressive solid tumors
1053546|NCT02828059|Caesarean section|caesarean section
1053547|NCT02828007|EIT|eit
1053548|NCT02828007|NIV|niv
1053549|NCT02827968|PDL-1|pdl-1
1053550|NCT02827942|pylori|pylori
1053551|NCT02827903|Metformin|metformin
1053552|NCT02827903|Rosuvastatin|rosuvastatin
1053553|NCT02827903|type 2 diabetes|type 2 diabetes
1053554|NCT02827903|dyslipidemia|dyslipidemia
1053555|NCT02827864|Mirror therapy|mirror therapy
1053556|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
1053557|NCT02827864|stroke|stroke
1053558|NCT02827864|neurorehabilitation|neurorehabilitation
1053559|NCT02827851|Damage of articular cartilage|damage of articular cartilage
1053560|NCT02827851|Cartilage degeneration|cartilage degeneration
1053561|NCT02827851|Intraarticular injection|intraarticular injection
1053562|NCT02827851|SVF|svf
1053563|NCT02827851|Stromal vascular fraction|stromal vascular fraction
1053564|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
1053565|NCT02827851|Adipose tissue|adipose tissue
1053566|NCT02827851|Stem cells|stem cells
1053567|NCT02827825|Neurosurgical|neurosurgical
1053568|NCT02827825|Intensive Care|intensive care
1053569|NCT02827799|heart failure|heart failure
1053570|NCT02827799|insomnia|insomnia
1053571|NCT02827799|sleep disorders|sleep disorders
1053572|NCT02827799|actigraphy|actigraphy
1053573|NCT02827799|cardiomyopathy|cardiomyopathy
1053574|NCT02827799|depression|depression
1053575|NCT02827799|sleepiness|sleepiness
1053576|NCT02827799|anxiety|anxiety
1053577|NCT02827799|fatigue|fatigue
1053578|NCT02827786|hepatic tumours|hepatic tumours
1053579|NCT02827773|Literacy|literacy
1053580|NCT02827747|Keratoconus progression|keratoconus progression
1053581|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
1053582|NCT02827747|Vitamin supplementation|vitamin supplementation
1053583|NCT02827682|IoC|ioc
1053584|NCT02827682|monitor|monitor
1053585|NCT02827682|elderly|elderly
1053586|NCT02827682|postoperative effectiveness|postoperative effectiveness
1053587|NCT02827656|Fertilization in vitro|fertilization in vitro
1053588|NCT02827656|Luteal Phase|luteal phase
1053589|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
1053590|NCT02827617|Ibrutinib|ibrutinib
1053591|NCT02827617|TP53|tp53
1053592|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1053593|NCT02827604|Caesarean section|caesarean section
1053594|NCT02827604|lower uterine segment|lower uterine segment
1053595|NCT02827604|sonography|sonography
1053596|NCT02827591|repeat cesarean section|repeat cesarean section
1053597|NCT02827591|lower uterine segment|lower uterine segment
1053598|NCT02827591|quantitative sonography|quantitative sonography
1053599|NCT02827565|colorectal cancer|colorectal cancer
1053600|NCT02827565|Kras mutation|kras mutation
1053601|NCT02827565|Nras mutation|nras mutation
1053602|NCT02827565|Braf mutation|braf mutation
1053603|NCT02827552|pediatric oncology|pediatric oncology
1053604|NCT02827552|radiotherapy|radiotherapy
1053605|NCT02827552|radiosensitivity|radiosensitivity
1053606|NCT02827513|Centanafadine|centanafadine
1053607|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
1053608|NCT02827513|Healthy participants|healthy participants
1053609|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
1053610|NCT02827448|Heart Transplantation|heart transplantation
1053611|NCT02827448|Perioperative|perioperative
1053612|NCT02827448|Acute Kidney Injury|acute kidney injury
1053613|NCT02827448|Renal|renal
1053614|NCT02827448|Kidney|kidney
1053615|NCT02827448|Total Artificial Heart|total artificial heart
1053616|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
1053617|NCT02827409|Delayed cord clamping|delayed cord clamping
1053618|NCT02827396|Disability|disability
1053619|NCT02827396|children|children
1053620|NCT02827396|parents|parents
1053621|NCT02827396|depression|depression
1053622|NCT02827396|knowledge|knowledge
1053623|NCT02827396|psychosocial intervention|psychosocial intervention
1053624|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
1053625|NCT02827344|Immune checkpoints|immune checkpoints
1053626|NCT02827344|Immunotherapy|immunotherapy
1053627|NCT02827344|lung cancer|lung cancer
1053628|NCT02827344|circulating tumor cells|circulating tumor cells
1053629|NCT02827344|immunocytochemistry|immunocytochemistry
1053630|NCT02827344|ISET|iset
1053631|NCT02827344|MDSC|mdsc
1053632|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1053633|NCT02827331|Benzodiazepines|benzodiazepines
1053634|NCT02827331|Fracture|fracture
1053635|NCT02827318|Blood glucose|blood glucose
1053636|NCT02827305|antiplaque|antiplaque
1053637|NCT02827305|antigingivitis|antigingivitis
1053638|NCT02827292|music|music
1053639|NCT02827292|inflammation|inflammation
1053640|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
1053641|NCT02827279|Emotion|emotion
1053642|NCT02827253|brain|brain
1053643|NCT02827253|haemodialysis|haemodialysis
1053644|NCT02827253|intradialytic hypotension|intradialytic hypotension
1053645|NCT02827240|Female sex workers|female sex workers
1053646|NCT02827240|HIV testing|hiv testing
1053647|NCT02827240|HIV self-test|hiv self-test
1053648|NCT02827227|HIV-infected patients|hiv-infected patients
1053649|NCT02827227|cART|cart
1053650|NCT02827227|immune restoration|immune restoration
1053651|NCT02827227|markers|markers
1053652|NCT02827214|Thoracolumbar spine|thoracolumbar spine
1053653|NCT02827214|Burst fractures|burst fractures
1053654|NCT02827214|Conservative treatment|conservative treatment
1053655|NCT02827214|Surgical treatment|surgical treatment
1053656|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
1053657|NCT02827201|pancreatic cancer|pancreatic cancer
1053658|NCT02827162|Dengue Fever|dengue fever
1053659|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
1053660|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
1053661|NCT02827149|HSCT|hsct
1053662|NCT02827149|high resolution HLA typing|high resolution hla typing
1053663|NCT02827149|unrelated donor|unrelated donor
1053664|NCT02827084|electromyography|electromyography
1053665|NCT02827084|torque|torque
1053666|NCT02827084|quadriceps muscle|quadriceps muscle
1053667|NCT02827058|Delivery, obstetric|delivery, obstetric
1053668|NCT02827058|Analgesia, Epidural|analgesia, epidural
1053669|NCT02827058|Injections, Epidural|injections, epidural
1053670|NCT02827058|Needles|needles
1053671|NCT02827058|Cesarean Section|cesarean section
1053672|NCT02827032|Hypertension|hypertension
1053673|NCT02827006|Bone graft|bone graft
1053674|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
1053675|NCT02827006|RCT|rct
1053676|NCT02827006|Xray|xray
1053677|NCT02827006|CT|ct
1053678|NCT02826993|PillCAM2|pillcam2
1053679|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
1053680|NCT02826967|Screening colonoscopy|screening colonoscopy
1053681|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
1053682|NCT02826954|Nasal Obstruction|nasal obstruction
1053683|NCT02826941|hypothermia treatment|hypothermia treatment
1053684|NCT02826915|newborn|newborn
1053685|NCT02826915|infant|infant
1053686|NCT02826915|child|child
1053687|NCT02826915|EEG|eeg
1053688|NCT02826915|NIRS|nirs
1053689|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
1053690|NCT02826902|desflurane|desflurane
1053691|NCT02826902|QoR-40|qor-40
1053692|NCT02826902|cosmetic lower limb lengthening|cosmetic lower limb lengthening
1053693|NCT02826889|Fluid responsiveness|fluid responsiveness
1053694|NCT02826889|corrected flow time|corrected flow time
1053695|NCT02826889|pleth variability index|pleth variability index
1053696|NCT02826889|prone position|prone position
1053697|NCT02826876|Laparoscopic surgery|laparoscopic surgery
1053698|NCT02826863|seizure|seizure
1053699|NCT02826863|tonic-atonic|tonic-atonic
1053700|NCT02826863|epilepsy|epilepsy
1053701|NCT02826863|myoclonic|myoclonic
1053702|NCT02826863|encephalopathy|encephalopathy
1053703|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
1053704|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
1053705|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
1053706|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
1053707|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
1053708|NCT02826824|agenesis|agenesis
1053709|NCT02826824|corpus callosum|corpus callosum
1053710|NCT02826811|Graft dysfunction|graft dysfunction
1053711|NCT02826811|Graft loss|graft loss
1053712|NCT02826811|kidney|kidney
1053713|NCT02826811|Transplantation|transplantation
1053714|NCT02826811|BKV|bkv
1053715|NCT02826811|Anti-BKV|anti-bkv
1053716|NCT02826811|Nephropathy|nephropathy
1053717|NCT02826811|Immunosuppression|immunosuppression
1053718|NCT02826811|Prognostic markers|prognostic markers
1053719|NCT02826798|VBI-1501A|vbi-1501a
1053720|NCT02826798|VBI-1501|vbi-1501
1053721|NCT02826798|prophylactic vaccine|prophylactic vaccine
1053722|NCT02826798|virus diseases|virus diseases
1053723|NCT02826798|cytomegalovirus|cytomegalovirus
1053724|NCT02826798|CMV|cmv
1053725|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
1053726|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
1053727|NCT02826798|Herpesviridae Infections|herpesviridae infections
1053728|NCT02826798|Phase 1|phase 1
1053729|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
1053730|NCT02826798|HHV5|hhv5
1053731|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
1053732|NCT02826798|VLP|vlp
1053733|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
1053734|NCT02826798|eVLP|evlp
1053735|NCT02826759|sphingolipid|sphingolipid
1053736|NCT02826759|diabetes mellitus|diabetes mellitus
1053737|NCT02826759|biomarker|biomarker
1053738|NCT02826759|obesity|obesity
1053739|NCT02826759|insulin resistance|insulin resistance
1053740|NCT02826733|preterm infants|preterm infants
1053741|NCT02826733|term infants|term infants
1053742|NCT02826733|hemispheric dominance|hemispheric dominance
1053743|NCT02826720|HDL cholesterol|hdl cholesterol
1053744|NCT02826720|Hyperlipidemia|hyperlipidemia
1053745|NCT02826720|LDL cholesterol|ldl cholesterol
1053746|NCT02826720|Periodontal disease|periodontal disease
1053747|NCT02826720|Triglyceride|triglyceride
1053748|NCT02826655|WF-OCT|wf-oct
1053749|NCT02826655|OCT|oct
1053750|NCT02826655|diabetic retinopathy|diabetic retinopathy
1053751|NCT02826655|diabetic macular edema|diabetic macular edema
1053752|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
1053753|NCT02826642|AML|aml
1053754|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
1053755|NCT02826642|MDS|mds
1053756|NCT02826642|IDH305|idh305
1053757|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
1053758|NCT02826629|Sensorimotor Integration|sensorimotor integration
1053759|NCT02826629|Schizophrenia|schizophrenia
1053760|NCT02826629|TMS|tms
1053761|NCT02826629|Oculomotor|oculomotor
1053762|NCT02826629|Motor Control|motor control
1053763|NCT02826616|Trimetazidine|trimetazidine
1053764|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
1053765|NCT02826616|Reperfusion injury|reperfusion injury
1053766|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
1053767|NCT02826603|Plaque psoriasis,|plaque psoriasis,
1053768|NCT02826603|secukinumab,|secukinumab,
1053769|NCT02826603|ustekinumab|ustekinumab
1053770|NCT02826564|radiotherapy|radiotherapy
1053771|NCT02826564|immunotherapy|immunotherapy
1053772|NCT02826512|BRCA1-like|brca1-like
1053773|NCT02826512|HER2 negative|her2 negative
1053774|NCT02826499|Pediguard|pediguard
1053775|NCT02826499|Pedicular screws|pedicular screws
1053776|NCT02826499|Fluoroscopy|fluoroscopy
1053777|NCT02826473|Dementia|dementia
1053778|NCT02826473|Dementia screening|dementia screening
1053779|NCT02826473|General Hospital|general hospital
1053780|NCT02826473|Inpatients|inpatients
1053781|NCT02826460|Transplant|transplant
1053782|NCT02826460|Adherence|adherence
1053783|NCT02826434|Breast Cancer|breast cancer
1053784|NCT02826434|vaccine|vaccine
1053785|NCT02826434|immunotherapy|immunotherapy
1053786|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
1053787|NCT02826434|triple negative breast cancer|triple negative breast cancer
1053788|NCT02826421|Intraocular lens|intraocular lens
1053789|NCT02826395|Prostate cancer|prostate cancer
1053790|NCT02826395|diagnostic|diagnostic
1053791|NCT02826395|imaging|imaging
1053792|NCT02826395|PET/CT|pet/ct
1053793|NCT02826395|Acetate carbon-11|acetate carbon-11
1053794|NCT02826369|Algorithms|algorithms
1053795|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
1053796|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
1053797|NCT02826369|Data Compression|data compression
1053798|NCT02826369|Breast Neoplasms|breast neoplasms
1053799|NCT02826356|Angioedema|angioedema
1053800|NCT02826356|Emergency treatment|emergency treatment
1053801|NCT02826356|Treatment availability|treatment availability
1053802|NCT02826356|Health Equity|health equity
1053803|NCT02826343|COPD|copd
1053804|NCT02826330|Crohn's Disease|crohn's disease
1053805|NCT02826330|Healthy relatives|healthy relatives
1053806|NCT02826330|Dysbiosis|dysbiosis
1053807|NCT02826330|Biomarkers|biomarkers
1053808|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
1053809|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
1053810|NCT02826304|Large uteri|large uteri
1053811|NCT02826291|OSNA|osna
1053812|NCT02826291|sentinel|sentinel
1053813|NCT02826291|lymph|lymph
1053814|NCT02826291|node|node
1053815|NCT02826291|endometrial|endometrial
1053816|NCT02826291|cancer|cancer
1053817|NCT02826278|Newborn genitalia|newborn genitalia
1053818|NCT02826278|reference charts|reference charts
1053819|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1053820|NCT02826213|Renal infusion|renal infusion
1053821|NCT02826213|Renal infusion device|renal infusion device
1053822|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1053823|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1053824|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
1053825|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
1053826|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
1053827|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
1053828|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
1053829|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
1053831|NCT02826187|Acetabular implant|acetabular implant
1053832|NCT02826161|Neoplasms|neoplasms
1053833|NCT02826161|Neoplasms by Site|neoplasms by site
1053834|NCT02826161|Lung Neoplasms|lung neoplasms
1053835|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
1053836|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
1053837|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
1053838|NCT02826096|Psychiatry|psychiatry
1053839|NCT02826096|psychological|psychological
1053840|NCT02826096|psychotherapy|psychotherapy
1053841|NCT02826096|randomize|randomize
1053842|NCT02826096|Biofeedback|biofeedback
1053843|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
1053844|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
1053845|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
1053846|NCT02826018|RNAi therapeutic|rnai therapeutic
1053847|NCT02826018|Hepatitis B|hepatitis b
1053848|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
1053849|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
1053850|NCT02826018|Hepatitis B Infection|hepatitis b infection
1053851|NCT02826018|HBV|hbv
1053852|NCT02825927|Dysphagia|dysphagia
1053853|NCT02825927|Oral screen|oral screen
1053854|NCT02825927|Intervention|intervention
1053855|NCT02825927|Oral Health|oral health
1053856|NCT02825927|Food Intake|food intake
1053857|NCT02825927|Quality of life|quality of life
1053858|NCT02825927|Elderly|elderly
1053859|NCT02825927|Short-term care facilities|short-term care facilities
1053860|NCT02825914|glycopeptides|glycopeptides
1053861|NCT02825914|human microbiome|human microbiome
1053862|NCT02825914|caseinomacropeptide|caseinomacropeptide
1053863|NCT02825914|whey protein|whey protein
1053864|NCT02825914|dietary proteins|dietary proteins
1053865|NCT02825849|endometrium|endometrium
1053866|NCT02825849|thin uterine lining|thin uterine lining
1053867|NCT02825849|uterine scarring|uterine scarring
1053868|NCT02825836|M7583|m7583
1053869|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
1053870|NCT02825836|Lymphoma|lymphoma
1053871|NCT02825836|Open|open
1053872|NCT02825836|Phase I|phase i
1053873|NCT02825810|breast cancer|breast cancer
1053874|NCT02825810|long-term survival|long-term survival
1053875|NCT02825810|motor control|motor control
1053876|NCT02825810|cervical pain|cervical pain
1053877|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
1053878|NCT02825797|3BNC117|3bnc117
1053879|NCT02825797|10-1074|10-1074
1053880|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
1053881|NCT02825758|Micronutrients|micronutrients
1053882|NCT02825758|restricted|restricted
1053883|NCT02825758|ketogenic|ketogenic
1053884|NCT02825758|diet|diet
1053885|NCT02825758|acceptability|acceptability
1053886|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
1053887|NCT02825732|Comorbidity|comorbidity
1053888|NCT02825732|Charlson comorbidity index|charlson comorbidity index
1053889|NCT02825732|Caregiver burden|caregiver burden
1053890|NCT02825732|Cohort|cohort
1053891|NCT02825732|Dementia|dementia
1053892|NCT02825732|Behavioral disorders|behavioral disorders
1053893|NCT02825732|Functional dependency|functional dependency
1053894|NCT02825719|Fibroid|fibroid
1053895|NCT02825719|Ulipristal|ulipristal
1053896|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
1053897|NCT02825719|Chinese|chinese
1053898|NCT02825706|Hemophilia|hemophilia
1053899|NCT02825706|Educational Physiotherapy|educational physiotherapy
1053900|NCT02825706|Pain|pain
1053901|NCT02825706|Quality of life|quality of life
1090382|NCT02608086|RCT|rct
1053902|NCT02825706|Illness Behaviour|illness behaviour
1053903|NCT02825706|Elbow|elbow
1053904|NCT02825680|Weight Loss|weight loss
1053905|NCT02825680|Body Weight Maintenance|body weight maintenance
1053906|NCT02825680|Quality Improvement|quality improvement
1053907|NCT02825667|Haemophilia|haemophilia
1053908|NCT02825667|Ankle|ankle
1053909|NCT02825667|Arthropathy|arthropathy
1053910|NCT02825667|Pain|pain
1053911|NCT02825667|Range of motion|range of motion
1053912|NCT02825667|Myofascial techniques|myofascial techniques
1053913|NCT02825654|Pulmonary|pulmonary
1053914|NCT02825654|Lung|lung
1053915|NCT02825654|Military and environmental exposures|military and environmental exposures
1053916|NCT02825654|Epidemiologic|epidemiologic
1053917|NCT02825654|Observational|observational
1053918|NCT02825654|Interview or questionnaire|interview or questionnaire
1053919|NCT02825654|Deployment related|deployment related
1053920|NCT02825654|Enduring Freedom|enduring freedom
1053921|NCT02825654|Iraqi Freedom|iraqi freedom
1053922|NCT02825615|radial artery cannulation|radial artery cannulation
1053923|NCT02825615|ultrasound guided|ultrasound guided
1053924|NCT02825615|first success rate|first success rate
1053925|NCT02825615|systolic blood pressure|systolic blood pressure
1053926|NCT02825615|shock|shock
1053927|NCT02825602|Vietnam veteran|vietnam veteran
1053928|NCT02825602|aging|aging
1053929|NCT02825602|health|health
1053930|NCT02825602|War Injury|war injury
1053931|NCT02825602|Conventional Warfare|conventional warfare
1053932|NCT02825602|Toxic Effect|toxic effect
1053933|NCT02825602|Chemical|chemical
1053935|NCT02825589|chronic hemodialysis|chronic hemodialysis
1053936|NCT02825589|sleep quality|sleep quality
1053937|NCT02825550|Hepatoma|hepatoma
1053938|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
1053939|NCT02825550|microsphere|microsphere
1053940|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
1053941|NCT02825472|Congenital Heart Disease|congenital heart disease
1053942|NCT02825472|Sport|sport
1053943|NCT02825472|Exercise training|exercise training
1053944|NCT02825459|abstinence|abstinence
1053945|NCT02825459|abuse liability|abuse liability
1053946|NCT02825459|electronic cigarette|electronic cigarette
1053947|NCT02825459|e-cigarette|e-cigarette
1053948|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
1053949|NCT02825459|harm reduction|harm reduction
1053950|NCT02825459|nicotine|nicotine
1053951|NCT02825459|nicotine dependence|nicotine dependence
1053952|NCT02825459|smoking|smoking
1053953|NCT02825459|smoking cessation|smoking cessation
1053954|NCT02825459|tobacco|tobacco
1053955|NCT02825459|vape|vape
1053956|NCT02825459|vaping|vaping
1053957|NCT02825459|withdrawal|withdrawal
1053958|NCT02825446|radio frequency denervation|radio frequency denervation
1053959|NCT02825446|tibial arteries|tibial arteries
1053960|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
1053961|NCT02825381|Arthroplasty|arthroplasty
1053962|NCT02825381|Hip|hip
1053963|NCT02825355|robotic surgery procedure|robotic surgery procedure
1053964|NCT02825355|indocyanine green|indocyanine green
1053965|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
1053966|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1053967|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
1053968|NCT02825316|Crohn's disease|crohn's disease
1053969|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
1053970|NCT02825316|Mediterranean diet|mediterranean diet
1053971|NCT02825316|microbiome|microbiome
1053972|NCT02825303|postural changes|postural changes
1053973|NCT02825303|Height adjustable desk|height adjustable desk
1053974|NCT02825303|Prolonged sitting|prolonged sitting
1053975|NCT02825303|Cognitive performance|cognitive performance
1053976|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
1053977|NCT02825290|Luteal support|luteal support
1053978|NCT02825290|Progesterone|progesterone
1053979|NCT02825290|Natural cycle|natural cycle
1053980|NCT02825290|Cryopreservation|cryopreservation
1053981|NCT02825290|IVF|ivf
1053982|NCT02825290|hCG|hcg
1053983|NCT02825290|GnRH-Agonist|gnrh-agonist
1053984|NCT02825290|Pregnancy rate|pregnancy rate
1053985|NCT02825277|3D Power Doppler|3d power doppler
1053986|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
1053987|NCT02825277|preeclampsia|preeclampsia
1053988|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
1053989|NCT02825277|placental morphology|placental morphology
1053990|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
1053991|NCT02825264|STARflo|starflo
1053992|NCT02825238|exercise|exercise
1053993|NCT02825238|osteoarthritis|osteoarthritis
1053994|NCT02825238|knee|knee
1053995|NCT02825238|patellofemoral pain|patellofemoral pain
1053996|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
1053997|NCT02825225|Biopsy|biopsy
1053998|NCT02825225|Anesthesia|anesthesia
1053999|NCT02825225|Detection|detection
1054000|NCT02825212|Hepatitis C|hepatitis c
1054001|NCT02825212|Cryoglobulinemia|cryoglobulinemia
1054002|NCT02825160|Iloprost|iloprost
1054003|NCT02825160|Ventavis|ventavis
1054004|NCT02825160|Prostacycline analogue|prostacycline analogue
1054005|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
1054006|NCT02825160|Japan|japan
1054007|NCT02825160|Post-marketing surveillance|post-marketing surveillance
1054008|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
1054009|NCT02825134|heart valve disease|heart valve disease
1054010|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
1054011|NCT02825134|aortic valve replacement|aortic valve replacement
1054012|NCT02825134|Randomized clinical trial|randomized clinical trial
1054013|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
1054014|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
1054015|NCT02825082|Emergency general surgery|emergency general surgery
1054016|NCT02825082|Geriatric|geriatric
1054017|NCT02825082|Outcomes|outcomes
1054018|NCT02825082|Frailty|frailty
1054019|NCT02825043|COPD|copd
1054020|NCT02825004|Burnout|burnout
1054021|NCT02825004|Health Care Workers|health care workers
1054022|NCT02825004|Coping Skills|coping skills
1054023|NCT02825004|Clinical Trial|clinical trial
1054024|NCT02824952|Tagrisso|tagrisso
1054025|NCT02824952|AZD9291|azd9291
1054026|NCT02824952|EGFRm|egfrm
1054027|NCT02824952|NSCLC|nsclc
1054028|NCT02824900|Vibration Stimuli|vibration stimuli
1054029|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
1054030|NCT02824887|Electroacupuncture|electroacupuncture
1054031|NCT02824887|Deep needling|deep needling
1054032|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
1054033|NCT02824887|Long term effect|long term effect
1054034|NCT02824887|Prospective cohort study|prospective cohort study
1054035|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
1054036|NCT02824848|infants|infants
1054037|NCT02824848|passive stretching|passive stretching
1054038|NCT02824848|perception-action approach|perception-action approach
1054039|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
1054040|NCT02824822|SUDEP|sudep
1054041|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
1054042|NCT02824822|Sudden Cardiac Death|sudden cardiac death
1054043|NCT02824822|Sleep|sleep
1054044|NCT02824822|Ion channel disease|ion channel disease
1054045|NCT02824822|Long QT syndrome|long qt syndrome
1054046|NCT02824822|Brugada|brugada
1054047|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
1054048|NCT02824809|hypogonadism|hypogonadism
1054049|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1054050|NCT02824809|Severity of Illness Index|severity of illness index
1054051|NCT02824809|Testosterone|testosterone
1054052|NCT02824796|ADHD|adhd
1054053|NCT02824783|colorectal surgery|colorectal surgery
1054054|NCT02824783|enhanced recovery|enhanced recovery
1054055|NCT02824757|interstitial lung disease|interstitial lung disease
1054056|NCT02824757|glucocorticcoid|glucocorticcoid
1054057|NCT02824757|glucose|glucose
1054058|NCT02824757|continuous glucose monitor|continuous glucose monitor
1054059|NCT02824744|Bronchiolitis|bronchiolitis
1054060|NCT02824744|High flow nasal canula|high flow nasal canula
1054061|NCT02824731|brain tumors|brain tumors
1054062|NCT02824731|proton radiotherapy|proton radiotherapy
1054063|NCT02824731|photon radiotherapy|photon radiotherapy
1054064|NCT02824718|Hypoparathyroidism|hypoparathyroidism
1054065|NCT02824718|PTH(1-34)|pth(1-34)
1054066|NCT02824718|Thiazides|thiazides
1054067|NCT02824718|Hypercalciuria|hypercalciuria
1054068|NCT02824718|Calcium sensing receptor|calcium sensing receptor
1054069|NCT02824705|Heart|heart
1054070|NCT02824705|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1054071|NCT02824705|pediatric critical care|pediatric critical care
1054072|NCT02824705|congenital heart disease|congenital heart disease
1054073|NCT02824679|Normal labour|normal labour
1054074|NCT02824679|Augmentation of labour|augmentation of labour
1054075|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
1054076|NCT02824653|acute GVHD|acute gvhd
1054077|NCT02824653|chronic GVHD|chronic gvhd
1054078|NCT02824653|steroid-refractory|steroid-refractory
1054079|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
1054080|NCT02824640|Addiction|addiction
1054081|NCT02824640|Adherence|adherence
1054082|NCT02824640|Adverse Effects|adverse effects
1054083|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
1054084|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
1054085|NCT02824640|Resistance Development|resistance development
1054086|NCT02824640|Methadone Clinic|methadone clinic
1054087|NCT02824640|Primary Care|primary care
1054088|NCT02824640|Directly Observed Therapy|directly observed therapy
1054089|NCT02824640|Randomized Controlled Trial|randomized controlled trial
1054090|NCT02824640|Resistance|resistance
1054091|NCT02824640|Reinfection|reinfection
1054092|NCT02824640|Treatment Outcome|treatment outcome
1054093|NCT02824640|Patient Navigation|patient navigation
1054094|NCT02824640|Multi-Site|multi-site
1054095|NCT02824640|Liver Disease|liver disease
1054096|NCT02824640|Intervention|intervention
1054097|NCT02824640|Sustained Viral Response|sustained viral response
1054098|NCT02824588|Pain|pain
1054099|NCT02824588|Working memory|working memory
1054100|NCT02824575|breast cancer|breast cancer
1054101|NCT02824575|chemotherapy|chemotherapy
1054102|NCT02824575|metastasis|metastasis
1054103|NCT02824575|tumor micro-environment|tumor micro-environment
1054104|NCT02824549|Flash glucose monitoring|flash glucose monitoring
1054105|NCT02824549|skin reactions|skin reactions
1054106|NCT02824549|usability|usability
1054107|NCT02824549|accuracy|accuracy
1054108|NCT02824536|3BNC117|3bnc117
1054109|NCT02824536|10-1074|10-1074
1054110|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
1054111|NCT02824536|HIV Prevention|hiv prevention
1054112|NCT02824523|asthma|asthma
1054113|NCT02824523|nasal polyps|nasal polyps
1054114|NCT02824523|aspirin sensitivity|aspirin sensitivity
1054115|NCT02824523|AERD|aerd
1054116|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
1054117|NCT02824484|Emotional disclosure|emotional disclosure
1054118|NCT02824484|Meaning|meaning
1054119|NCT02824484|Post-Traumatic Growth|post-traumatic growth
1054120|NCT02824484|Cancer|cancer
1054121|NCT02824471|Sickle Cell Disease|sickle cell disease
1054122|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
1054123|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
1054124|NCT02824458|VEGFR inhibitor|vegfr inhibitor
1054125|NCT02824458|NSCLC|nsclc
1054126|NCT02824406|Sickle Cell Anemia|sickle cell anemia
1054127|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
1054128|NCT02824406|Perfusion|perfusion
1054129|NCT02824406|Vasculopathy|vasculopathy
1054130|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
1054131|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
1054132|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
1054133|NCT02824367|Parkinson|parkinson
1054134|NCT02824367|Perfectionism|perfectionism
1054135|NCT02824341|Parkinson 's disease|parkinson 's disease
1054136|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
1054137|NCT02824341|Reward system|reward system
1054138|NCT02824341|Functional MRI|functional mri
1054139|NCT02824289|skin cancer|skin cancer
1054140|NCT02824289|prevention|prevention
1054141|NCT02824289|worksite|worksite
1054142|NCT02824289|policy|policy
1054143|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
1054144|NCT02824263|CPAP|cpap
1054145|NCT02824263|metabolism|metabolism
1054146|NCT02824250|Migraine|migraine
1054147|NCT02824250|Mindfulness|mindfulness
1054148|NCT02824250|MBSR|mbsr
1054149|NCT02824224|levonorgestrel|levonorgestrel
1054150|NCT02824224|breakthrough bleeding|breakthrough bleeding
1054151|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1054152|NCT02824198|Dengue Virus|dengue virus
1054153|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
1054154|NCT02824185|FCH-PET/MRI|fch-pet/mri
1054155|NCT02824185|primary HCC|primary hcc
1054156|NCT02824185|curative treatment|curative treatment
1054157|NCT02824185|resection|resection
1054158|NCT02824185|thermo-ablation|thermo-ablation
1054159|NCT02824185|transplantation|transplantation
1054160|NCT02824172|Cast immobilization|cast immobilization
1054161|NCT02824172|Complete rest|complete rest
1054162|NCT02824172|Osgood Schlatter|osgood schlatter
1054163|NCT02824159|ibrutinib|ibrutinib
1054164|NCT02824159|idelalisib|idelalisib
1054165|NCT02824159|side effect|side effect
1054166|NCT02824159|pharmacokinetic|pharmacokinetic
1054167|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
1054168|NCT02824146|atelectasis|atelectasis
1054169|NCT02824146|children|children
1054170|NCT02824146|lung ultrasound|lung ultrasound
1054171|NCT02824146|lung recruitment|lung recruitment
1054172|NCT02824133|Glioma grade III|glioma grade iii
1054173|NCT02824133|Glioma grade IV|glioma grade iv
1054174|NCT02824133|Glioma recurrent|glioma recurrent
1054175|NCT02824133|IDHwt|idhwt
1054176|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
1054177|NCT02824120|ischemic heart disease|ischemic heart disease
1054178|NCT02824120|laugh therapy|laugh therapy
1054179|NCT02824094|Expanded Access Protocol|expanded access protocol
1054180|NCT02824094|crizotinib|crizotinib
1054181|NCT02824094|Xalkori|xalkori
1054182|NCT02824094|ROS1|ros1
1054183|NCT02824094|Japanese|japanese
1054184|NCT02824094|A8081064|a8081064
1054185|NCT02824081|Psychiatry|psychiatry
1054186|NCT02824081|Depressive disorder|depressive disorder
1054187|NCT02824081|Suicide|suicide
1054188|NCT02824081|Inflammation|inflammation
1054189|NCT02824042|Phase 1|phase 1
1054190|NCT02824042|Solid tumors|solid tumors
1054191|NCT02824042|Mesothelin|mesothelin
1054192|NCT02824042|Itraconazole|itraconazole
1054193|NCT02824042|PK DDI|pk ddi
1054196|NCT02823977|dexmedetomidine|dexmedetomidine
1054197|NCT02823977|alcohol|alcohol
1730632|NCT00004984|prediction|prediction
1054198|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
1054199|NCT02823964|cystic fibrosis|cystic fibrosis
1054200|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
1054201|NCT02823912|Capsaicin|capsaicin
1054202|NCT02823912|Dyslipidemia|dyslipidemia
1054203|NCT02823912|Inflammatory cytokines|inflammatory cytokines
1054204|NCT02823899|cholera vaccine|cholera vaccine
1054205|NCT02823899|hikojima serotype|hikojima serotype
1054206|NCT02823899|randomized trial|randomized trial
1054207|NCT02823899|immunogenicity|immunogenicity
1054208|NCT02823886|myocardial infarction|myocardial infarction
1054210|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
1054211|NCT02823873|Hypertension|hypertension
1054212|NCT02823873|Pregnant|pregnant
1054213|NCT02823873|Preeclampsia|preeclampsia
1054214|NCT02823873|Gestational Hypertension|gestational hypertension
1054215|NCT02823873|Blood Pressure|blood pressure
1054216|NCT02823873|Pregnant Women|pregnant women
1054217|NCT02823873|Postpartum Women|postpartum women
1054218|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
1054219|NCT02823860|Biobanking|biobanking
1054220|NCT02823860|Biospecimen research|biospecimen research
1054221|NCT02823860|Prospective clinical database|prospective clinical database
1054222|NCT02823860|Tissue banking|tissue banking
1054223|NCT02823860|Quality of Life|quality of life
1054224|NCT02823860|various histological subtypes|various histological subtypes
1054225|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
1054226|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
1054228|NCT02823847|Carbon monoxide test|carbon monoxide test
1054229|NCT02823847|Self-help materials|self-help materials
1054230|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
1054231|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
1054232|NCT02823847|Oral Biopsy|oral biopsy
1054233|NCT02823834|osteoarthritis|osteoarthritis
1054234|NCT02823834|avascular necrosis|avascular necrosis
1054235|NCT02823834|ankylosis|ankylosis
1054236|NCT02823834|protrusio acetabuli|protrusio acetabuli
1054237|NCT02823834|painful hip dysplasia|painful hip dysplasia
1054238|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
1054239|NCT02823834|correction of functional deformity|correction of functional deformity
1054240|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
1054241|NCT02823821|Hemodialysis|hemodialysis
1054242|NCT02823821|Dialysate|dialysate
1054243|NCT02823821|Sodium|sodium
1054244|NCT02823821|Cluster-randomisation|cluster-randomisation
1054245|NCT02823795|Patient participation|patient participation
1054246|NCT02823795|Empowerment|empowerment
1054247|NCT02823795|Medication management|medication management
1054248|NCT02823795|Symptom management|symptom management
1054249|NCT02823795|Self determination theory|self determination theory
1054250|NCT02823795|Motivational Interviewing|motivational interviewing
1054251|NCT02823782|Laminar HP|laminar hp
1054252|NCT02823782|Complex HP|complex hp
1054255|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
1054256|NCT02823704|Sepsis|sepsis
1054257|NCT02823704|Chest pain|chest pain
1054258|NCT02823704|Abdominal pain|abdominal pain
1054259|NCT02823704|Electrolyte disturbances|electrolyte disturbances
1054260|NCT02823704|Stroke|stroke
1054261|NCT02823704|Triage|triage
1054262|NCT02823704|Risk for death|risk for death
1054263|NCT02823691|NETs|nets
1054264|NCT02823665|gastric bypass surgery|gastric bypass surgery
1054265|NCT02823665|Hypoglycemia|hypoglycemia
1054266|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
1054267|NCT02823665|glucose tolerance|glucose tolerance
1054268|NCT02823613|ENaC|enac
1054269|NCT02823613|Exosomes|exosomes
1054270|NCT02823613|Urinary biomarker|urinary biomarker
1054271|NCT02823613|Salt regulation|salt regulation
1054272|NCT02823600|retinal screening|retinal screening
1054273|NCT02823600|outpatient dialysis|outpatient dialysis
1054274|NCT02823587|Bronchiectasis|bronchiectasis
1054275|NCT02823587|Mucociliary clearance|mucociliary clearance
1054276|NCT02823587|Exercise|exercise
1054277|NCT02823587|Inflammation|inflammation
1054278|NCT02823535|military|military
1054279|NCT02823535|veteran|veteran
1054280|NCT02823535|military spouse|military spouse
1054281|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
1054282|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
1054283|NCT02823431|voiding efficiency|voiding efficiency
1054284|NCT02823431|detrusor underactivity|detrusor underactivity
1054285|NCT02823431|urodynamics|urodynamics
1054286|NCT02823418|primipara|primipara
1054287|NCT02823418|childbirth|childbirth
1054288|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
1054289|NCT02823418|postpartum depression|postpartum depression
1054290|NCT02823405|Advance malignancy|advance malignancy
1054392|NCT02822755|Adherence|adherence
1054291|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
1054292|NCT02823392|difficult intubation|difficult intubation
1054293|NCT02823392|predictors|predictors
1054294|NCT02823392|pediatric anesthesia|pediatric anesthesia
1054295|NCT02823379|physical activity|physical activity
1054296|NCT02823379|overweight|overweight
1054298|NCT02823379|exercise|exercise
1054299|NCT02823379|women|women
1054300|NCT02823379|African American|african american
1054301|NCT02823379|Smartphone|smartphone
1054302|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
1054303|NCT02823366|PBC|pbc
1054304|NCT02823366|UDCA|udca
1054305|NCT02823366|Fenofibrate|fenofibrate
1054306|NCT02823353|PBC|pbc
1054307|NCT02823353|UDCA|udca
1054308|NCT02823353|Fenofibrate|fenofibrate
1054309|NCT02823288|intimate partner violence|intimate partner violence
1054310|NCT02823288|masculinity|masculinity
1054311|NCT02823288|community mobilization|community mobilization
1054312|NCT02823288|social intervention|social intervention
1054313|NCT02823288|rape|rape
1054314|NCT02823262|Breast Cancer|breast cancer
1054315|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
1054316|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
1054317|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
1054318|NCT02823236|Keloid|keloid
1054319|NCT02823236|Scar|scar
1054320|NCT02823223|Endobronchial Valve|endobronchial valve
1054321|NCT02823197|determinants|determinants
1054322|NCT02823197|active transport|active transport
1054323|NCT02823197|intervention|intervention
1054324|NCT02823197|adolescents|adolescents
1054325|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
1054326|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
1054327|NCT02823171|Bioequivalence Study|bioequivalence study
1054328|NCT02823171|Healthy subjects|healthy subjects
1054329|NCT02823158|Parkinson Disease|parkinson disease
1054330|NCT02823158|Morbus Parkinson|morbus parkinson
1054331|NCT02823158|Basal Ganglia|basal ganglia
1054332|NCT02823158|Pallidal Stimulation|pallidal stimulation
1054333|NCT02823145|seizure|seizure
1054334|NCT02823145|tonic clonic|tonic clonic
1054337|NCT02823145|encephalopathy|encephalopathy
1054338|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
1054339|NCT02823119|Office hysteroscopy|office hysteroscopy
1054340|NCT02823119|Pain|pain
1054341|NCT02823093|vascular calcification|vascular calcification
1054342|NCT02823093|aortic calcification|aortic calcification
1054343|NCT02823093|vitamin K antagonist|vitamin k antagonist
1054344|NCT02823093|fluindione|fluindione
1054345|NCT02823093|warfarin|warfarin
1054346|NCT02823093|matrix gla protein|matrix gla protein
1054347|NCT02823067|Pemphigoid|pemphigoid
1054348|NCT02823067|Bullous pemphigoid|bullous pemphigoid
1054349|NCT02823067|Pruritus|pruritus
1054350|NCT02823067|Senile pruritus|senile pruritus
1054351|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
1054352|NCT02823054|elective surgery|elective surgery
1054353|NCT02823054|CABG|cabg
1054354|NCT02823054|One-lung ventilation|one-lung ventilation
1054355|NCT02823054|EZ Blockers|ez blockers
1054356|NCT02823054|pleural effusion|pleural effusion
1054357|NCT02823041|cognitive training|cognitive training
1054358|NCT02823041|aerobic exercise|aerobic exercise
1054359|NCT02823041|neurotrophic factors|neurotrophic factors
1054360|NCT02823041|randomized controlled trial|randomized controlled trial
1054361|NCT02823041|functional outcome|functional outcome
1054362|NCT02823028|Smoking|smoking
1054363|NCT02823028|Social Media|social media
1054364|NCT02823028|Twitter|twitter
1054365|NCT02823028|Behavior Change|behavior change
1054366|NCT02823028|Social Support|social support
1054367|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1054368|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
1054369|NCT02822989|Inflammation|inflammation
1054370|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
1054371|NCT02822963|Anticoagulants|anticoagulants
1054372|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
1054373|NCT02822911|elderly|elderly
1054374|NCT02822911|chronic alcoholism|chronic alcoholism
1054375|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
1054376|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
1054377|NCT02822898|Maintenance|maintenance
1054378|NCT02822898|Intravenous solutions|intravenous solutions
1054379|NCT02822898|Intravenous fluids|intravenous fluids
1054380|NCT02822898|Tonicity|tonicity
1054381|NCT02822898|Potassium|potassium
1054382|NCT02822898|Sodium|sodium
1054383|NCT02822898|Fluid retention|fluid retention
1054384|NCT02822872|infertility|infertility
1054385|NCT02822872|stress|stress
1054386|NCT02822872|scalp hair|scalp hair
1054387|NCT02822872|cortisol|cortisol
1054388|NCT02822846|Lung ultrasound|lung ultrasound
1054389|NCT02822846|Sliding lung|sliding lung
1054390|NCT02822846|Probe position|probe position
1054391|NCT02822755|Exercise|exercise
1054393|NCT02822755|Physical Therapy|physical therapy
1054394|NCT02822703|smoking cessation|smoking cessation
1054395|NCT02822703|tobacco use disorder|tobacco use disorder
1054396|NCT02822703|delay discounting|delay discounting
1054397|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1054398|NCT02822703|relapse prevention|relapse prevention
1054399|NCT02822690|palliative care|palliative care
1054400|NCT02822690|Quality of dying|quality of dying
1054401|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
1054402|NCT02822638|Myocardial infarction|myocardial infarction
1054403|NCT02822638|biomarkers|biomarkers
1054404|NCT02822638|STEMI|stemi
1054405|NCT02822625|Capsaicin|capsaicin
1054406|NCT02822625|QUTENZA®|qutenza®
1054407|NCT02822625|Hypnosis|hypnosis
1054408|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
1054409|NCT02822612|optical coherence tomography|optical coherence tomography
1054410|NCT02822612|optical imaging|optical imaging
1054411|NCT02822612|retinal imaging|retinal imaging
1054412|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
1054413|NCT02822586|CD30-positive|cd30-positive
1054414|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
1054415|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
1054416|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
1054417|NCT02822560|cost analysis|cost analysis
1054418|NCT02822560|procedure time|procedure time
1054419|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
1054420|NCT02822521|Mobile Health|mobile health
1054421|NCT02822521|Pain|pain
1054422|NCT02822521|Arthritis|arthritis
1054423|NCT02822495|Lymphoproliferative Disorders|lymphoproliferative disorders
1054424|NCT02822495|Epstein-Barr Virus|epstein-barr virus
1054425|NCT02822495|Epstein-Barr Viremia|epstein-barr viremia
1054426|NCT02822495|Post Transplant Lymphoproliferative Disorder|post transplant lymphoproliferative disorder
1054427|NCT02822495|EBV-PTLD|ebv-ptld
1054428|NCT02822495|Solid Organ Transplant|solid organ transplant
1054429|NCT02822495|Hematopoietic Cell Transplant|hematopoietic cell transplant
1054430|NCT02822495|primary immunodeficiency|primary immunodeficiency
1054431|NCT02822495|acquired immunodeficiency|acquired immunodeficiency
1054432|NCT02822495|Epstein-Barr Virus Lymphoma|epstein-barr virus lymphoma
1054433|NCT02822495|HIV/AIDS lymphoma|hiv/aids lymphoma
1054731|NCT02820454|AGuIX|aguix
1054434|NCT02822495|Rheumatoid arthritis AND lymphoma|rheumatoid arthritis and lymphoma
1054435|NCT02822495|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
1054436|NCT02822495|TNF-alpha inhibitors AND lymphoma|tnf-alpha inhibitors and lymphoma
1054437|NCT02822495|Inflammatory bowel disease AND lymphoma|inflammatory bowel disease and lymphoma
1054438|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
1054439|NCT02822456|dysphagia|dysphagia
1054440|NCT02822456|intermittent tube|intermittent tube
1054441|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
1054442|NCT02822430|Pain|pain
1054443|NCT02822430|Psychiatric disorders|psychiatric disorders
1054444|NCT02822417|Recover time|recover time
1054445|NCT02822404|kidney toxicity|kidney toxicity
1054446|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1054447|NCT02822378|Human|human
1054448|NCT02822378|Female|female
1054449|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
1054450|NCT02822326|Leukemia|leukemia
1054451|NCT02822326|CART CD19|cart cd19
1054452|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
1054453|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
1054454|NCT02822326|CD19 +|cd19 +
1054455|NCT02822326|Lymphoma|lymphoma
1054456|NCT02822235|Drug Therapy|drug therapy
1054457|NCT02822222|essential hypertension|essential hypertension
1054458|NCT02822222|hypertension|hypertension
1054459|NCT02822222|high blood pressure|high blood pressure
1054460|NCT02822222|cardiovascular diseases|cardiovascular diseases
1054461|NCT02822222|RMJH-111b|rmjh-111b
1054462|NCT02822222|magnesium|magnesium
1054463|NCT02822222|magnesium citrate|magnesium citrate
1054464|NCT02822222|calcium channel blockers|calcium channel blockers
1054465|NCT02822222|vasodilators|vasodilators
1054466|NCT02822222|antihypertensive agents|antihypertensive agents
1054467|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
1054468|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
1054469|NCT02822209|lung cancer quality of life|lung cancer quality of life
1054470|NCT02822144|ischemic stroke|ischemic stroke
1054471|NCT02822144|thrombectomy|thrombectomy
1054472|NCT02822144|anesthesia|anesthesia
1054473|NCT02822144|sedation|sedation
1054474|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
1054475|NCT02822066|Effectivity|effectivity
1054476|NCT02822066|safety|safety
1054477|NCT02822066|irreversible electroporation|irreversible electroporation
1054478|NCT02822066|liver|liver
1054479|NCT02822066|pancreas|pancreas
1054480|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
1054481|NCT02822040|Root Resorption|root resorption
1054482|NCT02822040|Panoramic Radiograph|panoramic radiograph
1054483|NCT02822001|Sugammadex|sugammadex
1054484|NCT02821975|Depression|depression
1054485|NCT02821975|Cognitive function|cognitive function
1054487|NCT02821962|Sedentary behaviour|sedentary behaviour
1054488|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
1054489|NCT02821949|Procalcitonin|procalcitonin
1054490|NCT02821936|positron emission tomography|positron emission tomography
1054491|NCT02821936|parametric imaging|parametric imaging
1054492|NCT02821936|lung cancer|lung cancer
1054493|NCT02821884|Stroke|stroke
1054494|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
1054495|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
1054496|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
1054497|NCT02821832|Tuberculosis|tuberculosis
1054498|NCT02821832|PET/CT Scanning|pet/ct scanning
1054499|NCT02821832|Immunological Markers|immunological markers
1054500|NCT02821832|4-Month Treatment Completion|4-month treatment completion
1054501|NCT02821819|ovarian stimulation|ovarian stimulation
1054502|NCT02821819|random|random
1054503|NCT02821819|egg donation|egg donation
1054504|NCT02821819|antagonist|antagonist
1054505|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
1054506|NCT02821806|Normal Volunteer|normal volunteer
1054507|NCT02821806|Donation|donation
1054508|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
1054509|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1054510|NCT02821780|Biospecimen Procurement|biospecimen procurement
1054511|NCT02821780|Laboratory Research Specimens|laboratory research specimens
1054512|NCT02821767|Pathogenesis|pathogenesis
1054513|NCT02821767|Ocular Disorders|ocular disorders
1054514|NCT02821767|Eye|eye
1054515|NCT02821767|Eye Diseases|eye diseases
1054516|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
1054517|NCT02821754|Monoclonal Antibody|monoclonal antibody
1054518|NCT02821754|CTLA-4|ctla-4
1054519|NCT02821754|Ablative Therapy|ablative therapy
1054520|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
1054521|NCT02821741|Sensory Stimulation|sensory stimulation
1054522|NCT02821728|Prostate|prostate
1054523|NCT02821728|Sulphate|sulphate
1054524|NCT02821728|ATP|atp
1054525|NCT02821728|PTEN|pten
1054526|NCT02821702|placenta accreta|placenta accreta
1054527|NCT02821702|cesarean section|cesarean section
1054528|NCT02821702|artery embolization|artery embolization
1054529|NCT02821689|Dermatopolymyositis|dermatopolymyositis
1054530|NCT02821689|Interstitial lung disease|interstitial lung disease
1054531|NCT02821689|Pirfenidone|pirfenidone
1054532|NCT02821637|teens|teens
1054533|NCT02821637|effort rehabilitation|effort rehabilitation
1054534|NCT02821637|quality of life|quality of life
1054535|NCT02821637|wellbeing|wellbeing
1054536|NCT02821637|physical skills assessment|physical skills assessment
1054537|NCT02821611|Student Stress|student stress
1054538|NCT02821611|Meditation|meditation
1054539|NCT02821611|Sleep Quality|sleep quality
1054540|NCT02821611|Blood Pressure|blood pressure
1054541|NCT02821559|Colorectal cancer|colorectal cancer
1054542|NCT02821559|raltitrexed|raltitrexed
1054543|NCT02821559|oxaliplatin|oxaliplatin
1054544|NCT02821559|bevacizumab|bevacizumab
1054545|NCT02821559|biweekly|biweekly
1054546|NCT02821559|triweekly|triweekly
1054547|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1054548|NCT02821520|Photodynamic Therapy|photodynamic therapy
1054549|NCT02821520|Conbercept|conbercept
1054550|NCT02821520|Efficacy|efficacy
1054551|NCT02821520|Safety|safety
1054552|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
1054554|NCT02821494|Vaccination|vaccination
1054555|NCT02821494|Immunotherapy|immunotherapy
1054556|NCT02821481|Neuromuscular|neuromuscular
1054557|NCT02821481|Supplementation|supplementation
1054558|NCT02821481|Elderly|elderly
1054559|NCT02821455|Isoflurane|isoflurane
1054560|NCT02821455|Sevoflurane|sevoflurane
1054561|NCT02821455|Bispectral Index|bispectral index
1054562|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
1054563|NCT02821442|Electroacupuncture|electroacupuncture
1054564|NCT02821442|Neuropathic Pain|neuropathic pain
1054565|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
1054566|NCT02821429|Respiratory weaning|respiratory weaning
1054567|NCT02821429|Pulmonary ventilation|pulmonary ventilation
1054569|NCT02821390|intravitreal injection|intravitreal injection
1054570|NCT02821390|pain|pain
1054571|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1054572|NCT02821390|anti-VEGF|anti-vegf
1054573|NCT02821390|nepafenac|nepafenac
1054574|NCT02821377|cirrhosis|cirrhosis
1054575|NCT02821377|ascites|ascites
1054576|NCT02821377|immunology|immunology
1054577|NCT02821377|inflammation|inflammation
1054578|NCT02821377|nutrition|nutrition
1054579|NCT02821351|Afib|afib
1054580|NCT02821338|Bioequivalence|bioequivalence
1054581|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
1054582|NCT02821338|Generic|generic
1054583|NCT02821338|Pharmacokinetic|pharmacokinetic
1054584|NCT02821299|Laryngeal transplantation|laryngeal transplantation
1054585|NCT02821299|Laryngeal function|laryngeal function
1054586|NCT02821299|Swallowing|swallowing
1054587|NCT02821299|Voice production|voice production
1054588|NCT02821299|Respiration|respiration
1054589|NCT02821299|Quality of life|quality of life
1054590|NCT02821247|Treatment Naïve Patients|treatment naïve patients
1054591|NCT02821234|Insomnia|insomnia
1054592|NCT02821234|Hyperarousal|hyperarousal
1054593|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
1054594|NCT02821169|sinus surgery|sinus surgery
1054595|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
1054596|NCT02821169|ropivacaine|ropivacaine
1054597|NCT02821169|local anesthesia|local anesthesia
1054598|NCT02821143|Telemedicine|telemedicine
1054599|NCT02821143|Nursing Home|nursing home
1054600|NCT02821143|Hospitalization|hospitalization
1054601|NCT02821130|Dyspnea|dyspnea
1054602|NCT02821130|Exercise|exercise
1054603|NCT02821130|Cystic Fibrosis|cystic fibrosis
1054604|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
1054605|NCT02821117|Sensing Technology|sensing technology
1054606|NCT02821104|Complement|complement
1054607|NCT02821104|endothelial function|endothelial function
1054608|NCT02821104|insulin sensitivity|insulin sensitivity
1054609|NCT02821104|adolescents|adolescents
1054610|NCT02821104|inflammation|inflammation
1054611|NCT02821078|phase-contrast MRI|phase-contrast mri
1054612|NCT02821078|blood flow|blood flow
1054613|NCT02821078|velocity mapping|velocity mapping
1054614|NCT02821078|abdominal imaging|abdominal imaging
1054615|NCT02821078|Quantitative MRI|quantitative mri
1054616|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
1054617|NCT02821000|PD1|pd1
1054618|NCT02821000|PD-1|pd-1
1054619|NCT02821000|PDL1|pdl1
1054620|NCT02821000|PD-L1|pd-l1
1054621|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
1054622|NCT02820961|Breast Neoplasms|breast neoplasms
1054623|NCT02820961|Breast Diseases|breast diseases
1054624|NCT02820961|Exemestane|exemestane
1054625|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
1054626|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
1054627|NCT02820961|entinostat|entinostat
1054628|NCT02820961|Cancer of the Breast|cancer of the breast
1054629|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
1054630|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
1054631|NCT02820961|Estrogen Receptor|estrogen receptor
1054632|NCT02820961|ER+ Breast Cancer|er+ breast cancer
1054633|NCT02820961|Breast Tumor|breast tumor
1054634|NCT02820935|Cytochrome P450|cytochrome p450
1054635|NCT02820935|Pharmacokinetics|pharmacokinetics
1054636|NCT02820935|CC-220|cc-220
1054637|NCT02820935|Healthy Subjects|healthy subjects
1054638|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
1054639|NCT02820922|anesthesia|anesthesia
1054640|NCT02820922|general anesthesia|general anesthesia
1054641|NCT02820922|regional anesthesia|regional anesthesia
1054642|NCT02820909|ultrasound guidance|ultrasound guidance
1054643|NCT02820909|emergency wards|emergency wards
1054644|NCT02820909|arterial and venous catheters|arterial and venous catheters
1054645|NCT02820909|femoral|femoral
1054646|NCT02820909|complications|complications
1054647|NCT02820870|Cardiovascular Disease|cardiovascular disease
1054648|NCT02820870|Quality Improvement|quality improvement
1054649|NCT02820870|Decision Support Tool|decision support tool
1054650|NCT02820870|Performance Measurement|performance measurement
1054651|NCT02820870|Primary Prevention|primary prevention
1054652|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
1054653|NCT02820857|Second-line treatment|second-line treatment
1054654|NCT02820857|Bevacizumab|bevacizumab
1054655|NCT02820857|Folfiri|folfiri
1054656|NCT02820844|Overactive bladder|overactive bladder
1054657|NCT02820844|Botulinum toxin type A|botulinum toxin type a
1054658|NCT02820844|Urinary incontinence|urinary incontinence
1054659|NCT02820831|Frail Elderly|frail elderly
1054660|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
1054661|NCT02820831|Risk Assessment|risk assessment
1054662|NCT02820831|Functional status|functional status
1054663|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
1054664|NCT02820818|pulmonary function test|pulmonary function test
1054665|NCT02820805|children|children
1054666|NCT02820805|dietary carbohydrates|dietary carbohydrates
1054667|NCT02820805|solanum tuberosum|solanum tuberosum
1054668|NCT02820805|cognition|cognition
1054669|NCT02820805|memory|memory
1054670|NCT02820805|emotions|emotions
1054671|NCT02820805|blood glucose|blood glucose
1054672|NCT02820779|Willis|willis
1054673|NCT02820779|Intracranial aneurysms|intracranial aneurysms
1054674|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
1054675|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
1054676|NCT02820766|Journey II BCS|journey ii bcs
1054677|NCT02820753|Universal Medication Schedule|universal medication schedule
1054678|NCT02820753|Health Literacy|health literacy
1054679|NCT02820753|Medication adherence|medication adherence
1054680|NCT02820740|Epilepsy|epilepsy
1054681|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
1054682|NCT02820740|Seizure|seizure
1054683|NCT02820740|NeuroBlate|neuroblate
1054684|NCT02820740|LITT|litt
1054685|NCT02820740|Quality of Life|quality of life
1054686|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
1054687|NCT02820701|Somatic Dysfunction|somatic dysfunction
1054688|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
1054689|NCT02820688|Local Anesthtetics|local anesthtetics
1054690|NCT02820688|Nerve Block|nerve block
1054691|NCT02820688|Bupivacaine|bupivacaine
1054692|NCT02820688|Prilocaine|prilocaine
1054693|NCT02820675|quality improvement|quality improvement
1054694|NCT02820675|routine data|routine data
1054695|NCT02820675|risk adjustment|risk adjustment
1054696|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
1054697|NCT02820675|quality of coding|quality of coding
1054698|NCT02820649|Exercise training|exercise training
1054699|NCT02820649|Endothelial function|endothelial function
1054700|NCT02820623|implementation|implementation
1054701|NCT02820623|fidelity|fidelity
1054702|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
1054703|NCT02820558|Neuropeptide|neuropeptide
1054704|NCT02820558|Therapy|therapy
1054705|NCT02820558|Onset|onset
1054706|NCT02820545|patient safety culture|patient safety culture
1054707|NCT02820545|hospital|hospital
1054708|NCT02820545|patient perception|patient perception
1054709|NCT02820545|healthcare professional perception|healthcare professional perception
1054710|NCT02820545|sociological|sociological
1054711|NCT02820545|qualitative|qualitative
1054712|NCT02820545|questionnaire construct|questionnaire construct
1054713|NCT02820545|psychometrics|psychometrics
1054714|NCT02820519|Neuropathic pain|neuropathic pain
1054715|NCT02820519|Loxapine|loxapine
1054716|NCT02820519|Antipsychotics|antipsychotics
1054717|NCT02820519|Co-Analgesics|co-analgesics
1054718|NCT02820519|Tolerability|tolerability
1054719|NCT02820519|Analgesic efficacy|analgesic efficacy
1054720|NCT02820506|robotic surgery procedures|robotic surgery procedures
1054721|NCT02820506|indocyanine green|indocyanine green
1054722|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
1054723|NCT02820480|stroke|stroke
1054724|NCT02820480|rehabilitation|rehabilitation
1054725|NCT02820480|robotics|robotics
1054726|NCT02820480|cerebral palsy|cerebral palsy
1054727|NCT02820480|therapy|therapy
1054728|NCT02820467|Indocyanine|indocyanine
1054729|NCT02820467|Angiography|angiography
1054730|NCT02820467|Ischemia|ischemia
1054732|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
1054733|NCT02820415|aneuploidy|aneuploidy
1054734|NCT02820415|next generation sequencing|next generation sequencing
1054735|NCT02820415|oocyte vitrification|oocyte vitrification
1054736|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
1054737|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
1054738|NCT02820402|Pregnancy|pregnancy
1054739|NCT02820402|Obesity|obesity
1054740|NCT02820402|Diet|diet
1054741|NCT02820402|Maternal/child health|maternal/child health
1054742|NCT02820402|Asthma/allergy|asthma/allergy
1054743|NCT02820402|Air pollution|air pollution
1054744|NCT02820402|Epigenetics|epigenetics
1054745|NCT02820402|Cognition/behavior|cognition/behavior
1054746|NCT02820376|4D computed tomography|4d computed tomography
1054747|NCT02820376|Kidney function tests|kidney function tests
1054748|NCT02820376|Living Donors|living donors
1054749|NCT02820363|wound|wound
1054750|NCT02820363|open fracture|open fracture
1054751|NCT02820363|fracture|fracture
1054752|NCT02820363|tibial|tibial
1054753|NCT02820350|Acute Renal Failure|acute renal failure
1054754|NCT02820350|Acute kidney injury|acute kidney injury
1054755|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1054756|NCT02820350|Selective cytopheretic device|selective cytopheretic device
1054757|NCT02820350|Pediatric|pediatric
1054758|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
1054759|NCT02820311|cardiac safety|cardiac safety
1054760|NCT02820272|Cold water|cold water
1054761|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
1054762|NCT02820272|pain|pain
1054763|NCT02820246|nutrition assessment|nutrition assessment
1054764|NCT02820246|nutrition therapy|nutrition therapy
1054765|NCT02820246|nutrition surveys|nutrition surveys
1054766|NCT02820246|patient outcome assessment|patient outcome assessment
1054767|NCT02820246|outcome and process assessment|outcome and process assessment
1054768|NCT02820246|benchmarking|benchmarking
1054769|NCT02820246|risk assessment|risk assessment
1054770|NCT02820246|scoring system|scoring system
1054771|NCT02820220|Knowledge|knowledge
1054772|NCT02820220|Programs|programs
1054773|NCT02820220|Patients|patients
1054774|NCT02820220|Students|students
1054775|NCT02820220|Nurses|nurses
1054776|NCT02820207|Carotid Artery Plaque|carotid artery plaque
1054777|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
1054778|NCT02820207|Plague Histopathology|plague histopathology
1054779|NCT02820181|tracheostomy ties|tracheostomy ties
1054780|NCT02820168|Designing|designing
1054781|NCT02820168|Patient-Oriented|patient-oriented
1054782|NCT02820168|Prescriptions|prescriptions
1054783|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
1054784|NCT02820142|biomarker|biomarker
1054785|NCT02820142|Renal Function|renal function
1054786|NCT02820129|polypharmacy|polypharmacy
1054787|NCT02820129|wallet card|wallet card
1054788|NCT02820129|medication|medication
1054789|NCT02820129|self-efficacy|self-efficacy
1054790|NCT02820129|patient enablement|patient enablement
1054791|NCT02820103|Patient delay|patient delay
1054792|NCT02820103|Behaviour change|behaviour change
1054793|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
1054794|NCT02820090|Inflammatory Factor|inflammatory factor
1054795|NCT02820090|Mechanical Ventilation|mechanical ventilation
1054796|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1054797|NCT02820051|bronchoscopy|bronchoscopy
1054798|NCT02820051|conscious sedation|conscious sedation
1054799|NCT02820051|midazolam|midazolam
1054800|NCT02820051|patient comfort|patient comfort
1054801|NCT02820051|propofol|propofol
1054802|NCT02820012|Scoliosis|scoliosis
1054803|NCT02820012|ST2R|st2r
1054804|NCT02819986|occupational functioning|occupational functioning
1054805|NCT02819986|Worries|worries
1054806|NCT02819986|Pain|pain
1054807|NCT02819986|Disability|disability
1054808|NCT02819973|Patient Education|patient education
1054809|NCT02819973|ICD|icd
1054810|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1054811|NCT02819973|Video|video
1054812|NCT02819973|Decision|decision
1054813|NCT02819973|Decision making|decision making
1054814|NCT02819960|probiotics|probiotics
1054815|NCT02819960|irinotecan|irinotecan
1054816|NCT02819960|diarrhea|diarrhea
1054817|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
1054818|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
1054819|NCT02819960|prevention|prevention
1054820|NCT02819960|chemotherapy|chemotherapy
1054821|NCT02819947|systemic sclerosis|systemic sclerosis
1054822|NCT02819947|cohort|cohort
1054823|NCT02819947|Korean|korean
1054824|NCT02819921|Hot Flashes|hot flashes
1054825|NCT02819921|Breast Neoplasms|breast neoplasms
1054826|NCT02819921|Tamoxifen|tamoxifen
1054827|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
1054828|NCT02819895|Phone Appointment Reminder|phone appointment reminder
1054829|NCT02819895|Immunization Rates|immunization rates
1054830|NCT02819895|mHealth|mhealth
1054831|NCT02819882|Unresectable|unresectable
1054832|NCT02819882|locally|locally
1054834|NCT02819882|metastatic disease|metastatic disease
1054835|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
1054836|NCT02819843|Radiotherapy|radiotherapy
1054837|NCT02819843|16-224|16-224
1054838|NCT02819830|Aerobic exercise|aerobic exercise
1054839|NCT02819830|Strength training|strength training
1054840|NCT02819830|Inflammation|inflammation
1054841|NCT02819830|cardiovascular disease|cardiovascular disease
1054842|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
1054843|NCT02819791|Cardiovascular|cardiovascular
1054844|NCT02819791|therapeutic education|therapeutic education
1054845|NCT02819778|Diagnosis|diagnosis
1054846|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
1054847|NCT02819778|Pediatrics|pediatrics
1054848|NCT02819778|S100B|s100b
1054849|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
1054850|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
1054851|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1054852|NCT02819726|an inadquate response to anti -TNF therapy|an inadquate response to anti -tnf therapy
1054853|NCT02819713|Prostate Biopsy|prostate biopsy
1054854|NCT02819713|NRS-score|nrs-score
1054855|NCT02819713|instillagel|instillagel
1054856|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
1054857|NCT02819700|behavioural disorders|behavioural disorders
1054858|NCT02819687|Phase I|phase i
1054859|NCT02819687|Healthy|healthy
1054860|NCT02819687|Pharmacokinetics|pharmacokinetics
1054861|NCT02819687|Pharmacodynamics|pharmacodynamics
1054862|NCT02819674|hypertension|hypertension
1054863|NCT02819674|early onset|early onset
1054864|NCT02819674|target organ damage|target organ damage
1054865|NCT02819661|Elective Caesarean Section|elective caesarean section
1054866|NCT02819661|obese women|obese women
1054867|NCT02819661|BMI≥30|bmi≥30
1054868|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
1054869|NCT02819648|symptomatic|symptomatic
1054870|NCT02819648|irreversible|irreversible
1054871|NCT02819635|ABT-494|abt-494
1054872|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
1054873|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
1054874|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
1054875|NCT02819570|Pregnancy|pregnancy
1054876|NCT02819570|PPROM|pprom
1054877|NCT02819570|EOS|eos
1054878|NCT02819544|Digestive System|digestive system
1054879|NCT02819531|Coronary Atherectomy|coronary atherectomy
1054880|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
1054882|NCT02819518|PD-1|pd-1
1054883|NCT02819518|PDL1|pdl1
1054884|NCT02819518|PD-L1|pd-l1
1054885|NCT02819505|beta-alanine|beta-alanine
1054886|NCT02819505|carnosine|carnosine
1054887|NCT02819505|neuromuscular|neuromuscular
1054888|NCT02819505|stimulation|stimulation
1054889|NCT02819505|skeletal muscle|skeletal muscle
1054890|NCT02819492|Adenoma|adenoma
1054891|NCT02819492|Colonoscopy|colonoscopy
1054892|NCT02819492|Withdrawal|withdrawal
1054893|NCT02819492|Proximal|proximal
1054894|NCT02819492|Observation Time|observation time
1054895|NCT02819479|Radiation necrosis|radiation necrosis
1054896|NCT02819479|Radiation adverse event|radiation adverse event
1054897|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
1054898|NCT02819479|Bevacizumab|bevacizumab
1054899|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
1054900|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
1054901|NCT02819466|intragastric volume|intragastric volume
1054902|NCT02819466|stomach|stomach
1054903|NCT02819466|fasting|fasting
1054904|NCT02819453|Corticosteroid|corticosteroid
1054905|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1054906|NCT02819427|Electroencephalography|electroencephalography
1054907|NCT02819427|children|children
1054908|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
1054909|NCT02819375|propofol|propofol
1054910|NCT02819375|ketamine|ketamine
1054911|NCT02819375|remifentanil|remifentanil
1054912|NCT02819349|Relapse Prevention|relapse prevention
1054913|NCT02819349|People with Schizophrenia|people with schizophrenia
1054914|NCT02819349|Text-Messaging|text-messaging
1054915|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
1054916|NCT02819336|urinary incontinence|urinary incontinence
1054917|NCT02819336|electroacupuncture|electroacupuncture
1054918|NCT02819336|stroke|stroke
1054919|NCT02819336|complications|complications
1054920|NCT02819336|randomized controlled trial|randomized controlled trial
1054921|NCT02819336|pilot projects|pilot projects
1054922|NCT02819284|Ocular Discomfort|ocular discomfort
1054923|NCT02819284|Pain|pain
1054924|NCT02819284|Corticosteroid|corticosteroid
1054925|NCT02819284|Hyperemia|hyperemia
1054926|NCT02819284|Dry Eye|dry eye
1054927|NCT02819219|Dietary Supplements|dietary supplements
1054928|NCT02819219|Exercise|exercise
1054929|NCT02819193|Breastfeeding|breastfeeding
1054930|NCT02819193|mother's milk|mother's milk
1054931|NCT02819193|breast milk|breast milk
1054932|NCT02819193|raw milk|raw milk
1054933|NCT02819193|neonate|neonate
1055035|NCT02818751|Anxiety|anxiety
1054934|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
1054935|NCT02819180|Influenza|influenza
1054936|NCT02819167|ischemic stroke|ischemic stroke
1054937|NCT02819167|brain reserve|brain reserve
1054938|NCT02819167|cognitive reserve|cognitive reserve
1054939|NCT02819167|cognitive prognosis|cognitive prognosis
1054940|NCT02819115|Influenza|influenza
1054941|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
1054942|NCT02819089|ACDF|acdf
1054943|NCT02819089|Dexmedetomidine|dexmedetomidine
1054944|NCT02819089|Anesthesia|anesthesia
1054945|NCT02819089|Agitation|agitation
1054946|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
1054947|NCT02819050|CPAP|cpap
1054948|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
1054949|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
1054950|NCT02819050|Premature infants|premature infants
1054951|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
1054952|NCT02819037|Gastric bypass|gastric bypass
1054953|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
1054954|NCT02819037|Gas chromatography|gas chromatography
1054955|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
1054956|NCT02819011|falls|falls
1054957|NCT02819011|Fall Prevention|fall prevention
1054958|NCT02819011|Frailty|frailty
1054959|NCT02819011|Concern for falls|concern for falls
1054960|NCT02819011|Footwear|footwear
1054961|NCT02819011|Mobility|mobility
1054962|NCT02818998|Diabetic macular edema|diabetic macular edema
1054963|NCT02818998|DME|dme
1054964|NCT02818959|Aortic Valve Disease|aortic valve disease
1054965|NCT02818959|Aortic Valve Replacement|aortic valve replacement
1054966|NCT02818959|Transcatheter|transcatheter
1054967|NCT02818959|Transfemoral|transfemoral
1054968|NCT02818959|Aortic Stenosis|aortic stenosis
1054969|NCT02818946|MRI|mri
1054970|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
1054971|NCT02818946|Breast Cancer|breast cancer
1054972|NCT02818933|24-hour diet recall|24-hour diet recall
1054973|NCT02818933|Adolescents|adolescents
1054974|NCT02818933|Web-based diet recall|web-based diet recall
1054975|NCT02818920|Pembrolizumab|pembrolizumab
1054976|NCT02818920|Neoadjuvant|neoadjuvant
1054977|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
1054978|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
1054979|NCT02818894|Total hip arthroplasty|total hip arthroplasty
1054980|NCT02818894|anterior total hip replacement|anterior total hip replacement
1054981|NCT02818881|aerobic|aerobic
1054982|NCT02818881|muscle activity|muscle activity
1054983|NCT02818881|energy expenditure|energy expenditure
1054984|NCT02818855|Root coverage|root coverage
1054985|NCT02818855|Gingival recession|gingival recession
1054986|NCT02818855|Plastic surgery|plastic surgery
1054987|NCT02818855|Connective tissue graft|connective tissue graft
1054988|NCT02818855|Mucograft|mucograft
1054989|NCT02818842|Database|database
1054990|NCT02818842|Birth defects|birth defects
1054991|NCT02818842|Neonatal pathologies|neonatal pathologies
1054992|NCT02818829|Adenocarcinoma|adenocarcinoma
1054993|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
1054994|NCT02818829|Fine-needle aspiration|fine-needle aspiration
1054995|NCT02818829|Biomarkers|biomarkers
1054996|NCT02818829|Epidemiology|epidemiology
1054997|NCT02818829|DNA tumors|dna tumors
1054998|NCT02818816|Brimonidine tartrate|brimonidine tartrate
1054999|NCT02818816|Intraocular pressure|intraocular pressure
1055000|NCT02818816|Prostate Cancer|prostate cancer
1055001|NCT02818816|Prostatectomy|prostatectomy
1055002|NCT02818803|propolis|propolis
1055003|NCT02818803|therapeutic|therapeutic
1055004|NCT02818803|miconazole|miconazole
1055005|NCT02818803|denture stomatitis|denture stomatitis
1055006|NCT02818790|mHealth|mhealth
1055007|NCT02818790|Motivational Interviewing|motivational interviewing
1055008|NCT02818790|Obesity|obesity
1055009|NCT02818790|Prevention|prevention
1055010|NCT02818790|Diet|diet
1055011|NCT02818790|Physical Activity|physical activity
1055012|NCT02818790|Health Preventive System|health preventive system
1055013|NCT02818777|Parkinson's Disease|parkinson's disease
1055014|NCT02818777|Tremor|tremor
1055015|NCT02818777|tolerability|tolerability
1055016|NCT02818777|safety|safety
1055017|NCT02818777|cognition|cognition
1055018|NCT02818777|anxiety|anxiety
1055019|NCT02818777|psychosis|psychosis
1055020|NCT02818777|mood|mood
1055021|NCT02818777|dyskinesia|dyskinesia
1055022|NCT02818777|cannabidiol|cannabidiol
1055023|NCT02818777|cannabis|cannabis
1055024|NCT02818777|efficacy|efficacy
1055025|NCT02818777|sleep|sleep
1055026|NCT02818777|motor symptoms|motor symptoms
1055027|NCT02818777|non-motor symptoms|non-motor symptoms
1055028|NCT02818777|quality of life|quality of life
1055029|NCT02818777|marijuana|marijuana
1055030|NCT02818764|serum biomarkers|serum biomarkers
1055031|NCT02818764|cerebral blood flow|cerebral blood flow
1055032|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
1055033|NCT02818764|Confusion Assessment Method|confusion assessment method
1055034|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
1055036|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
1055037|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
1055038|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
1055039|NCT02818738|Levamisole|levamisole
1055040|NCT02818738|Prednisone|prednisone
1055041|NCT02818738|Children|children
1055042|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
1055043|NCT02818673|diagnostic performances|diagnostic performances
1055044|NCT02818673|ascites|ascites
1055045|NCT02818647|tonsillectomy|tonsillectomy
1055046|NCT02818647|electrocautery|electrocautery
1055047|NCT02818647|postoperative pain|postoperative pain
1055048|NCT02818647|visual analogue scale|visual analogue scale
1055049|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
1055050|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
1055051|NCT02818608|Cerebral Stroke|cerebral stroke
1055052|NCT02818595|voice recognition|voice recognition
1055053|NCT02818582|Liberia|liberia
1055054|NCT02818582|EBV|ebv
1055055|NCT02818582|Semen|semen
1055056|NCT02818504|obesity|obesity
1055057|NCT02818504|dysglycemia|dysglycemia
1055058|NCT02818504|hypercholesterolemia|hypercholesterolemia
1055059|NCT02818504|lifestyle|lifestyle
1055060|NCT02818504|smoking|smoking
1055061|NCT02818504|physical activity|physical activity
1055062|NCT02818439|Old person|old person
1055063|NCT02818426|cancer immunotherapy|cancer immunotherapy
1055064|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
1055065|NCT02818426|telomerase|telomerase
1055066|NCT02818413|Stool microbiome|stool microbiome
1055067|NCT02818413|Stool metabolome|stool metabolome
1055068|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
1055069|NCT02818400|maxillofacial surgery|maxillofacial surgery
1055070|NCT02818400|face graft|face graft
1055071|NCT02818400|composite tissue|composite tissue
1055072|NCT02818400|stem cell infusion|stem cell infusion
1055073|NCT02818400|allotransplantation|allotransplantation
1055074|NCT02818400|microsurgery|microsurgery
1055075|NCT02818387|propofol|propofol
1055076|NCT02818387|midazolam|midazolam
1055077|NCT02818387|remifentanil|remifentanil
1055078|NCT02818387|combination|combination
1055079|NCT02818387|synergic|synergic
1055080|NCT02818387|pharmacodynamics|pharmacodynamics
1055081|NCT02818387|Loss of consciousness|loss of consciousness
1055082|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
1055083|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
1055084|NCT02818361|double-blinded|double-blinded
1055085|NCT02818361|randomized controlled trial|randomized controlled trial
1055086|NCT02818361|Tripterygium|tripterygium
1055087|NCT02818361|Administration|administration
1055089|NCT02818348|HIV infection|hiv infection
1055090|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
1055091|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
1055092|NCT02818348|Population PK analysis|population pk analysis
1055093|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
1055094|NCT02818296|Anxiety|anxiety
1055095|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
1055096|NCT02818283|hypercholesterolemia|hypercholesterolemia
1055097|NCT02818283|pretzels|pretzels
1055098|NCT02818283|nutritional study|nutritional study
1055099|NCT02818283|dietary soy|dietary soy
1055100|NCT02818283|antiretroviral therapy|antiretroviral therapy
1055101|NCT02818244|commercial heart monitors|commercial heart monitors
1055102|NCT02818244|accuracy|accuracy
1055103|NCT02818244|EKG|ekg
1055104|NCT02818244|varying degrees of exertion|varying degrees of exertion
1055105|NCT02818166|magnetic resonance|magnetic resonance
1055106|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
1055107|NCT02818153|Allergic rhinitis|allergic rhinitis
1055108|NCT02818140|Postoperative pain|postoperative pain
1055109|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
1055110|NCT02818140|Block|block
1055111|NCT02818140|Ropivacaine|ropivacaine
1055112|NCT02818140|TQL|tql
1055113|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1055114|NCT02818140|PNL|pnl
1055115|NCT02818140|Ultrasound-guided|ultrasound-guided
1055116|NCT02818114|PTSD|ptsd
1055117|NCT02818114|Prolonged Exposure|prolonged exposure
1055118|NCT02818114|Peer Support|peer support
1055119|NCT02818075|Peer support|peer support
1055120|NCT02818075|Postpartum Depression|postpartum depression
1055121|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
1055122|NCT02818062|Endophthalmitis|endophthalmitis
1055123|NCT02818062|Cytokines|cytokines
1055124|NCT02818062|Chemokines|chemokines
1055125|NCT02818062|Inflammation|inflammation
1055126|NCT02818062|Regulation|regulation
1055127|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
1055128|NCT02818010|physical activity|physical activity
1055129|NCT02818010|chronic kidney disease|chronic kidney disease
1055130|NCT02818010|nephrology|nephrology
1055131|NCT02818010|stage 3|stage 3
1055132|NCT02818010|stage 4|stage 4
1055133|NCT02818010|stage 5|stage 5
1055134|NCT02817997|patient registry|patient registry
1055135|NCT02817997|ACCELERATE study|accelerate study
1055136|NCT02817997|CD|cd
1055137|NCT02817997|MCD|mcd
1055140|NCT02817997|Castleman's Disease|castleman's disease
1055141|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
1055142|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
1055143|NCT02817997|multicentric Castleman disease|multicentric castleman disease
1055144|NCT02817984|Abdominoplasty|abdominoplasty
1055145|NCT02817971|feedback|feedback
1055146|NCT02817971|pneumonia|pneumonia
1055147|NCT02817971|quality of care|quality of care
1055148|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
1055149|NCT02817958|penile cancer|penile cancer
1055150|NCT02817958|squamous|squamous
1055151|NCT02817958|TIP chemotherapy|tip chemotherapy
1055152|NCT02817945|TATE-RGD|tate-rgd
1055153|NCT02817945|SSTR2|sstr2
1055154|NCT02817945|integrin αvβ3|integrin αvβ3
1055155|NCT02817919|Pharmacovigilance|pharmacovigilance
1055156|NCT02817919|Africa|africa
1055157|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
1055158|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
1055159|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
1055160|NCT02817893|abdominal surgery|abdominal surgery
1055161|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
1055162|NCT02817841|Estetrol|estetrol
1055163|NCT02817841|Drospirenone|drospirenone
1055164|NCT02817841|Prevention of pregnancy|prevention of pregnancy
1055165|NCT02817841|Oral contraception|oral contraception
1055166|NCT02817828|Estetrol|estetrol
1055167|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
1055168|NCT02817802|Registry|registry
1055169|NCT02817802|Magmaris|magmaris
1055170|NCT02817802|Coronary Artery Disease|coronary artery disease
1055171|NCT02817802|PCI|pci
1055172|NCT02817789|TAVI|tavi
1055173|NCT02817789|Antiplatelet agent|antiplatelet agent
1055174|NCT02817789|Ticagrelor|ticagrelor
1055175|NCT02817789|Cerebrovascular events|cerebrovascular events
1055176|NCT02817776|Interventional|interventional
1055177|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
1055178|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
1055179|NCT02817750|volunteers|volunteers
1055180|NCT02817750|Pharmacokinetics|pharmacokinetics
1055181|NCT02817724|Breast Neoplasms|breast neoplasms
1055182|NCT02817724|survivor|survivor
1055183|NCT02817724|occupational therapy|occupational therapy
1055184|NCT02817724|mobile applications|mobile applications
1055185|NCT02817724|Quality of Life|quality of life
1055186|NCT02817711|infection|infection
1055187|NCT02817711|bone and joint infection|bone and joint infection
1055188|NCT02817711|relapse|relapse
1055189|NCT02817711|adverse event|adverse event
1055190|NCT02817698|smoking|smoking
1055191|NCT02817698|cannabis|cannabis
1055192|NCT02817698|cocaine|cocaine
1055193|NCT02817685|surveillance|surveillance
1055194|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
1055195|NCT02817685|ultrasound|ultrasound
1055196|NCT02817685|cirrhosis|cirrhosis
1055197|NCT02817685|chronic hepatitis B|chronic hepatitis b
1055198|NCT02817672|Human|human
1055199|NCT02817672|Mental Disorders|mental disorders
1055200|NCT02817672|intervention|intervention
1055201|NCT02817672|digital health|digital health
1055202|NCT02817659|Glucagon|glucagon
1055203|NCT02817646|Intensive Care Unit|intensive care unit
1055204|NCT02817646|Critical Illness|critical illness
1055205|NCT02817646|Body composition|body composition
1055206|NCT02817646|Protein nutrition|protein nutrition
1055207|NCT02817633|Anitibodies|anitibodies
1055208|NCT02817633|TSR-022|tsr-022
1055209|NCT02817633|Advanced solid tumors|advanced solid tumors
1055210|NCT02817633|Metastatic solid tumors|metastatic solid tumors
1055211|NCT02817633|Immunotherapy|immunotherapy
1055212|NCT02817633|PD-1|pd-1
1055213|NCT02817633|Anti-PD-1|anti-pd-1
1055214|NCT02817633|colorectal cancer|colorectal cancer
1055215|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
1055216|NCT02817633|Melanoma|melanoma
1055217|NCT02817607|Sensation|sensation
1055218|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
1055219|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
1055220|NCT02817594|Sustained Virological Response|sustained virological response
1055221|NCT02817594|Observational Study|observational study
1055222|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
1055223|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
1055224|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
1055225|NCT02817581|Lactate|lactate
1055226|NCT02817581|Emergency Department|emergency department
1055227|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
1055228|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
1055229|NCT02817568|Gene expression|gene expression
1055230|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
1055231|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
1055232|NCT02817555|Anemia|anemia
1055233|NCT02817555|Hemodialysis|hemodialysis
1055234|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
1055235|NCT02817555|Cost|cost
1055236|NCT02817516|Drug Therapy|drug therapy
1055237|NCT02817503|hypertension|hypertension
1055238|NCT02817503|BP titration|bp titration
1055239|NCT02817503|intensive blood pressure control|intensive blood pressure control
1055240|NCT02817503|primary prevention|primary prevention
1055241|NCT02817503|China|china
1055242|NCT02817503|H-type Hypertension|h-type hypertension
1055243|NCT02817490|hypermobility|hypermobility
1055244|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1055245|NCT02817490|patient education program|patient education program
1055246|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
1055247|NCT02817451|Diphtheria|diphtheria
1055248|NCT02817451|Tetanus|tetanus
1055249|NCT02817451|Pertussis|pertussis
1055250|NCT02817451|Hepatitis B|hepatitis b
1055251|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
1055252|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
1055253|NCT02817425|S-1|s-1
1055254|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
1055255|NCT02817425|TEGAFOX|tegafox
1055256|NCT02817412|binge eating|binge eating
1055257|NCT02817412|obesity|obesity
1055258|NCT02817412|overeating|overeating
1055259|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1055260|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
1055261|NCT02817399|Gait analysis|gait analysis
1055262|NCT02817399|Physical therapy|physical therapy
1055263|NCT02817386|postoperative delirium|postoperative delirium
1055264|NCT02817386|microRNA|microrna
1055265|NCT02817373|IVF|ivf
1055266|NCT02817373|embryo transfer|embryo transfer
1055267|NCT02817373|ultrasound|ultrasound
1055268|NCT02817373|implantation|implantation
1055269|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
1055270|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
1055271|NCT02817334|breast cancer|breast cancer
1055272|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
1055273|NCT02817308|Salivas|salivas
1055274|NCT02817308|body fluids|body fluids
1055275|NCT02817269|Shoulder pain|shoulder pain
1055276|NCT02817269|Trigger points|trigger points
1055277|NCT02817269|Referred pain|referred pain
1055278|NCT02817269|Visual analogue scale|visual analogue scale
1055279|NCT02817191|age-related cataract|age-related cataract
1055280|NCT02817191|Holy-Comod|holy-comod
1055281|NCT02817191|Tears Naturale Forte|tears naturale forte
1055282|NCT02817191|phacoemulsification|phacoemulsification
1055283|NCT02817191|inflammatory mediators|inflammatory mediators
1055284|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
1055286|NCT02817152|low-level light therapy|low-level light therapy
1055287|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1055288|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
1055289|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
1055290|NCT02817126|Rectal Cancer|rectal cancer
1055291|NCT02817126|Intraoperative Complications|intraoperative complications
1055292|NCT02817126|Postoperative Complications|postoperative complications
1055293|NCT02817126|Recovery of Function|recovery of function
1055294|NCT02817126|Recurrence|recurrence
1055295|NCT02817126|Disease Progression|disease progression
1055296|NCT02817126|Survival|survival
1055297|NCT02817087|Stroke|stroke
1055298|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
1055299|NCT02817035|interstitial lung disease|interstitial lung disease
1055300|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1055301|NCT02817035|mechanical ventilation|mechanical ventilation
1055302|NCT02817035|expiratory delay|expiratory delay
1055303|NCT02817035|neural inspiratory time|neural inspiratory time
1055304|NCT02817022|Developmentally Supportive Care|developmentally supportive care
1055305|NCT02817009|Behavioral Health Intervention|behavioral health intervention
1055306|NCT02817009|Randomized Control Trial|randomized control trial
1055307|NCT02817009|Family Intervention|family intervention
1055308|NCT02817009|Nutrition|nutrition
1055309|NCT02817009|Weight Management|weight management
1055310|NCT02817009|Multidisciplinary Program|multidisciplinary program
1055311|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
1055312|NCT02816944|Laser ablation|laser ablation
1055313|NCT02816931|Treatment|treatment
1055314|NCT02816931|Drug Monitoring|drug monitoring
1055315|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
1055316|NCT02816931|Dried Blood Spot Method|dried blood spot method
1055317|NCT02816931|Pharmacokinetics|pharmacokinetics
1055318|NCT02816931|Pharmacodynamics|pharmacodynamics
1055319|NCT02816905|intraocular pressure|intraocular pressure
1055320|NCT02816905|topical steroids|topical steroids
1055321|NCT02816905|strabismus|strabismus
1055322|NCT02816892|aortic dissection|aortic dissection
1055323|NCT02816892|biomarkers|biomarkers
1055324|NCT02816892|diagnosis|diagnosis
1055325|NCT02816866|childhood cancer|childhood cancer
1055326|NCT02816866|survivorship care|survivorship care
1055327|NCT02816866|health services|health services
1055328|NCT02816866|barriers|barriers
1055329|NCT02816840|prostate cancer|prostate cancer
1055330|NCT02816840|radiotherapy|radiotherapy
1055334|NCT02816814|Lipidomic profile|lipidomic profile
1055335|NCT02816814|Vasomotor symptoms|vasomotor symptoms
1055336|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
1055337|NCT02816788|PTSD|ptsd
1055338|NCT02816788|Equine Assisted Therapy|equine assisted therapy
1055339|NCT02816775|hemodynamics|hemodynamics
1055340|NCT02816775|QT interval|qt interval
1055341|NCT02816762|CPAP|cpap
1055342|NCT02816762|Sleep apnea|sleep apnea
1055343|NCT02816762|Diabetes|diabetes
1055344|NCT02816762|Nephropathy|nephropathy
1055345|NCT02816762|Albuminuria|albuminuria
1055346|NCT02816749|Diabetic Foot|diabetic foot
1055347|NCT02816749|Wound Healing|wound healing
1055348|NCT02816749|Larva|larva
1055349|NCT02816749|Occlusive Dressings|occlusive dressings
1055350|NCT02816736|Heart Failure|heart failure
1055351|NCT02816736|Heart Diseases|heart diseases
1055352|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
1055353|NCT02816736|Valsartan|valsartan
1055354|NCT02816736|Entresto|entresto
1055355|NCT02816723|mindfulness|mindfulness
1055356|NCT02816723|aging|aging
1055357|NCT02816723|Veterans|veterans
1055359|NCT02816684|phobic disorders|phobic disorders
1055360|NCT02816684|anxiety disorders|anxiety disorders
1055361|NCT02816645|Parkinson's Disease|parkinson's disease
1055362|NCT02816645|Biomarker|biomarker
1055363|NCT02816645|Iron|iron
1055364|NCT02816645|R2*|r2*
1055365|NCT02816645|MRI|mri
1055366|NCT02816645|Patients|patients
1055367|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
1055368|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1055369|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
1055370|NCT02816632|Feedback Processing|feedback processing
1055371|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
1055372|NCT02816632|Cingulate Cortex|cingulate cortex
1055373|NCT02816632|Decision-making|decision-making
1730633|NCT00004984|prevention|prevention
1055374|NCT02816619|Parkinson's disease|parkinson's disease
1055375|NCT02816619|Physical activity|physical activity
1055376|NCT02816619|Physical exercise|physical exercise
1055377|NCT02816606|ACL reconstruction|acl reconstruction
1055378|NCT02816593|carbamide peroxide|carbamide peroxide
1055379|NCT02816593|Hydrogen peroxide|hydrogen peroxide
1055380|NCT02816593|Quality of life|quality of life
1055381|NCT02816554|Japanese Encephalitis|japanese encephalitis
1055383|NCT02816554|Vietnam|vietnam
1055384|NCT02816528|Antibiotics|antibiotics
1055385|NCT02816528|Primary care|primary care
1055386|NCT02816528|Stewardship|stewardship
1055387|NCT02816528|General practitioners|general practitioners
1055388|NCT02816515|Non interventional study|non interventional study
1055389|NCT02816515|Ectoin|ectoin
1055390|NCT02816515|Mouth wash|mouth wash
1055391|NCT02816515|Mucositis|mucositis
1055392|NCT02816515|Chemotherapy|chemotherapy
1055393|NCT02816515|Radiotherapy|radiotherapy
1055394|NCT02816502|childhood|childhood
1055395|NCT02816502|adversity|adversity
1055396|NCT02816450|Water|water
1055397|NCT02816450|Children|children
1055398|NCT02816450|Cognition|cognition
1055399|NCT02816450|Hydration|hydration
1055400|NCT02816424|Screening and Brief Intervention|screening and brief intervention
1055401|NCT02816424|Motivational Interviewing|motivational interviewing
1055402|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
1055403|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
1055404|NCT02816385|Myocardial contractility|myocardial contractility
1055405|NCT02816385|Cardioplegia|cardioplegia
1055406|NCT02816385|Induced|induced
1055407|NCT02816359|Position patient|position patient
1055408|NCT02816359|Esophageal pressure|esophageal pressure
1055409|NCT02816346|shigella|shigella
1055410|NCT02816320|hospital mortality|hospital mortality
1055411|NCT02816320|standardized mortality ratios|standardized mortality ratios
1055412|NCT02816320|patient safety|patient safety
1055413|NCT02816320|healthcare quality|healthcare quality
1055414|NCT02816320|hospital performance|hospital performance
1055415|NCT02816320|administrative data|administrative data
1055416|NCT02816281|Surgical case cancellation|surgical case cancellation
1055417|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
1055418|NCT02816242|Concept Map|concept map
1055419|NCT02816242|critical thinking|critical thinking
1055420|NCT02816242|medical student teaching|medical student teaching
1055421|NCT02816229|Haemoptysis|haemoptysis
1055422|NCT02816229|Aspergillus|aspergillus
1055423|NCT02816229|Endobronchial valve|endobronchial valve
1055424|NCT02816229|Interventional pulmonology|interventional pulmonology
1055425|NCT02816229|Tuberculosis|tuberculosis
1055426|NCT02816138|Geriatrics|geriatrics
1055427|NCT02816138|Depression|depression
1055428|NCT02816138|Elderly|elderly
1055429|NCT02816138|Cognition|cognition
1055430|NCT02816138|Memory|memory
1055431|NCT02816125|breast cancer|breast cancer
1055432|NCT02816125|fatty acids|fatty acids
1055433|NCT02816125|omega-3|omega-3
1055434|NCT02816060|pain measurement|pain measurement
1055435|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
1055436|NCT02816047|LifeVest|lifevest
1055437|NCT02816047|sudden death|sudden death
1055438|NCT02816047|defibrillator|defibrillator
1055439|NCT02816034|Learning|learning
1055440|NCT02816034|Cerebellum|cerebellum
1055441|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
1055442|NCT02816021|Metastatic melanoma|metastatic melanoma
1055443|NCT02816021|Advanced melanoma|advanced melanoma
1055444|NCT02816021|Azacitidine|azacitidine
1055445|NCT02816021|5-azacytidine|5-azacytidine
1055446|NCT02816021|5-aza|5-aza
1055447|NCT02816021|Vidaza|vidaza
1055448|NCT02816021|5-AZC|5-azc
1055449|NCT02816021|Ladakamycin|ladakamycin
1055450|NCT02816021|NSC-102816|nsc-102816
1055451|NCT02816021|Azacytidine|azacytidine
1055452|NCT02816021|Pembrolizumab|pembrolizumab
1055453|NCT02816021|Keytruda|keytruda
1055454|NCT02816021|MK-3475|mk-3475
1055455|NCT02816021|SCH-900475|sch-900475
1055456|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
1055457|NCT02816008|memory|memory
1055458|NCT02816008|attention|attention
1055459|NCT02816008|spatial neglect|spatial neglect
1055460|NCT02816008|executive dysfunctioning|executive dysfunctioning
1055461|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
1055462|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
1055463|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
1055464|NCT02815995|Adipocytic tumors|adipocytic tumors
1055465|NCT02815995|Vascular tumors|vascular tumors
1055466|NCT02815995|Leiomyosarcoma|leiomyosarcoma
1055467|NCT02815995|Angiosarcoma|angiosarcoma
1055468|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
1055469|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
1055470|NCT02815995|Synovial sarcoma|synovial sarcoma
1055471|NCT02815995|Osteosarcoma|osteosarcoma
1055472|NCT02815995|Other sarcoma histologies|other sarcoma histologies
1055473|NCT02815995|Durvalumab|durvalumab
1055474|NCT02815995|Tremelimumab|tremelimumab
1055475|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
1055476|NCT02815969|indol profile|indol profile
1055477|NCT02815969|catecholamines|catecholamines
1055478|NCT02815969|LC-MS/MS|lc-ms/ms
1055479|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
1055480|NCT02815956|randomized|randomized
1055481|NCT02815956|controlled study|controlled study
1055482|NCT02815930|High cost user (HCU)|high cost user (hcu)
1055483|NCT02815930|Healthcare utilization|healthcare utilization
1055484|NCT02815930|Healthcare expenditures|healthcare expenditures
1055485|NCT02815930|Medication use|medication use
1055486|NCT02815930|Medication expenditures|medication expenditures
1055487|NCT02815930|Multimorbidity|multimorbidity
1055488|NCT02815930|Observational study|observational study
1055489|NCT02815904|Neonates|neonates
1055490|NCT02815904|physical therapy|physical therapy
1055491|NCT02815904|neonatal intensive care units|neonatal intensive care units
1055492|NCT02815904|yakson touch|yakson touch
1055493|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
1055494|NCT02815865|Primiparous|primiparous
1055495|NCT02815865|Foley catheter|foley catheter
1055496|NCT02815865|Dinoprostone|dinoprostone
1055497|NCT02815865|Induction|induction
1055498|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
1055499|NCT02815852|biopsy|biopsy
1055500|NCT02815852|ultrasonography|ultrasonography
1055501|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
1055502|NCT02815839|urate transporter 1|urate transporter 1
1055503|NCT02815839|SHR4640|shr4640
1055504|NCT02815839|single ascending dose|single ascending dose
1055505|NCT02815839|pharmacokinetics|pharmacokinetics
1055506|NCT02815839|pharmacodynamics|pharmacodynamics
1055507|NCT02815813|Serious Mental Illness|serious mental illness
1055508|NCT02815813|Young Adults|young adults
1055509|NCT02815813|Obesity|obesity
1055510|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
1055511|NCT02815813|Physical Activity|physical activity
1055512|NCT02815813|Weight Loss|weight loss
1055513|NCT02815813|Fitness|fitness
1055514|NCT02815813|Peer Support|peer support
1055515|NCT02815813|Smartphone|smartphone
1055516|NCT02815813|Mobile Technology|mobile technology
1055517|NCT02815813|mHealth|mhealth
1055518|NCT02815813|Social Media|social media
1055519|NCT02815813|Facebook|facebook
1055520|NCT02815813|Lifestyle Intervention|lifestyle intervention
1055521|NCT02815800|Treatment|treatment
1055522|NCT02815800|Motor signs|motor signs
1055523|NCT02815800|Non motor signs|non motor signs
1055524|NCT02815800|Fluctuations|fluctuations
1055525|NCT02815800|Open labelled|open labelled
1055526|NCT02815787|SP2086|sp2086
1055527|NCT02815787|Glyburide|glyburide
1055528|NCT02815787|drug-drug interaction|drug-drug interaction
1055529|NCT02815774|SP2086|sp2086
1055530|NCT02815774|Renal Insufficiency|renal insufficiency
1055531|NCT02815774|Pharmacokinetic|pharmacokinetic
1055532|NCT02815748|SP2086|sp2086
1055533|NCT02815748|Metabolite identification|metabolite identification
1055534|NCT02815748|Material balance|material balance
1055535|NCT02815722|SP2086|sp2086
1055536|NCT02815722|Simvastatin|simvastatin
1055537|NCT02815722|drug-drug interaction|drug-drug interaction
1055538|NCT02815696|MRI T2 weighted|mri t2 weighted
1055539|NCT02815696|intervertebral disc|intervertebral disc
1055540|NCT02815696|glycosaminoglycans|glycosaminoglycans
1055541|NCT02815683|Bronchoscopy|bronchoscopy
1055542|NCT02815683|Emphysema|emphysema
1055543|NCT02815657|SP2086|sp2086
1055544|NCT02815657|Valsartan|valsartan
1055545|NCT02815657|Drug-drug Interaction|drug-drug interaction
1055546|NCT02815631|fractional flow reserve|fractional flow reserve
1055547|NCT02815631|cardiogoniometry|cardiogoniometry
1055548|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
1055549|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
1055550|NCT02815618|Neonatology|neonatology
1055552|NCT02815579|Food insecurity|food insecurity
1055553|NCT02815579|Microcredit loan|microcredit loan
1055554|NCT02815579|Agriculture|agriculture
1055555|NCT02815579|Livelihoods|livelihoods
1055556|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
1055557|NCT02815527|enteral nutrition|enteral nutrition
1055558|NCT02815527|intensive care unit|intensive care unit
1055559|NCT02815527|whey|whey
1055560|NCT02815527|protein|protein
1055561|NCT02815527|muscle mass|muscle mass
1055562|NCT02815527|leucin|leucin
1055563|NCT02815527|energy expenditure|energy expenditure
1055564|NCT02815514|aortic valve stenosis|aortic valve stenosis
1055565|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
1055566|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
1055567|NCT02815514|aortic valve replacement|aortic valve replacement
1055568|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
1055569|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
1055570|NCT02815501|Thyroid dysfunction|thyroid dysfunction
1055571|NCT02815501|obstetric complications|obstetric complications
1055572|NCT02815462|Frequent hospital admissions|frequent hospital admissions
1055573|NCT02815462|Risk stratification|risk stratification
1055574|NCT02815462|Readmissions|readmissions
1055575|NCT02815449|Iron fortification|iron fortification
1055576|NCT02815449|Bioavailability|bioavailability
1055577|NCT02815449|Nigeria|nigeria
1055578|NCT02815449|Women|women
1055579|NCT02815449|Bouillon cubes|bouillon cubes
1055580|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
1055581|NCT02815410|Levetiracetam|levetiracetam
1055582|NCT02815410|Temozolomide|temozolomide
1055583|NCT02815410|Survival outcome|survival outcome
1055584|NCT02815397|Double Hit DLBCL|double hit dlbcl
1055585|NCT02815319|Dexamethasone|dexamethasone
1055586|NCT02815319|Chemotherapy|chemotherapy
1055587|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
1055588|NCT02815306|Pirani score|pirani score
1055589|NCT02815306|infant|infant
1055590|NCT02815306|polyaxial brace|polyaxial brace
1055591|NCT02815293|EDE|ede
1055592|NCT02815293|evaporative dry eye|evaporative dry eye
1055593|NCT02815280|acne|acne
1055594|NCT02815267|acne|acne
1055595|NCT02815254|Physiotherapy|physiotherapy
1055596|NCT02815254|hip fracture|hip fracture
1055597|NCT02815254|rehabilitation|rehabilitation
1055598|NCT02815254|high dose exercise|high dose exercise
1055599|NCT02815254|low dose exercise|low dose exercise
1055600|NCT02815215|congenital clubfoot|congenital clubfoot
1055601|NCT02815189|pain|pain
1055602|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
1055603|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
1055604|NCT02815176|Choroid|choroid
1055605|NCT02815137|Digital PCR|digital pcr
1055606|NCT02815137|classical|classical
1055607|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
1055608|NCT02815137|mutation|mutation
1055609|NCT02815085|heart failure|heart failure
1055610|NCT02815085|mHealth|mhealth
1055611|NCT02815072|Fontan palliation|fontan palliation
1055612|NCT02815072|Marfan's syndrome|marfan's syndrome
1055613|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
1055614|NCT02815046|stress urinary incontinence|stress urinary incontinence
1055615|NCT02815046|Botulinum toxin A|botulinum toxin a
1055616|NCT02815046|Bulkamid|bulkamid
1055617|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
1055618|NCT02815033|Enzalutamide|enzalutamide
1055619|NCT02815033|Imaging|imaging
1055620|NCT02815033|PET/CT|pet/ct
1055621|NCT02815033|Whole body MRI|whole body mri
1055622|NCT02815033|Circulating tumour cells|circulating tumour cells
1055623|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
1055624|NCT02815020|Primary care|primary care
1055625|NCT02815020|Self-management support|self-management support
1055626|NCT02815020|Care coordination|care coordination
1055627|NCT02815020|Practice-based research network|practice-based research network
1055628|NCT02814994|Mechanical Ventilation|mechanical ventilation
1055629|NCT02814994|ARDS|ards
1055630|NCT02814994|Ventilator Strategy|ventilator strategy
1055631|NCT02814994|Outcome|outcome
1055632|NCT02814981|hydroxyzine|hydroxyzine
1055633|NCT02814981|Long QT|long qt
1055634|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
1055635|NCT02814968|Enzalutamide|enzalutamide
1055636|NCT02814968|Imaging|imaging
1055637|NCT02814968|PET/CT|pet/ct
1055638|NCT02814968|Whole body MRI|whole body mri
1055732|NCT02814513|Children|children
1055639|NCT02814968|Circulating tumour cells|circulating tumour cells
1055640|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
1055641|NCT02814955|atrial fibrillation|atrial fibrillation
1055642|NCT02814955|pulmonary veins|pulmonary veins
1055643|NCT02814955|oral anticoagulant|oral anticoagulant
1055644|NCT02814955|electrophysiology|electrophysiology
1055645|NCT02814955|anticoagulant drugs|anticoagulant drugs
1055646|NCT02814929|ROP|rop
1055647|NCT02814929|Risk factors|risk factors
1055648|NCT02814929|Incidence|incidence
1055649|NCT02814929|Turkey|turkey
1055650|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
1055651|NCT02814903|aldosterone|aldosterone
1055652|NCT02814903|cardiac surgery|cardiac surgery
1055653|NCT02814903|atrial fibrillation|atrial fibrillation
1055654|NCT02814903|galectin-3|galectin-3
1055655|NCT02814903|mitochondria|mitochondria
1055656|NCT02814903|ngal|ngal
1055657|NCT02814903|acute kidney failure|acute kidney failure
1055658|NCT02814903|epicardial fat|epicardial fat
1055659|NCT02814903|right atrial sample|right atrial sample
1055660|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
1055661|NCT02814890|Dexmedetomidine|dexmedetomidine
1055662|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
1055663|NCT02814890|Ropivacaine|ropivacaine
1055664|NCT02814890|Pain, Postoperative|pain, postoperative
1055665|NCT02814877|Antibiotic stewardship|antibiotic stewardship
1055666|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
1055667|NCT02814877|Antibiotic use|antibiotic use
1055668|NCT02814864|Hematology|hematology
1055669|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
1055670|NCT02814864|radiotherapy|radiotherapy
1092632|NCT02594488|ECG|ecg
1055671|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
1055672|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
1055673|NCT02814864|colitis|colitis
1055674|NCT02814864|bleeding|bleeding
1055675|NCT02814864|diarrhea|diarrhea
1055676|NCT02814864|pelvic radiation disease|pelvic radiation disease
1055677|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
1055678|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
1055679|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
1055776|NCT02814162|Adiponectin|adiponectin
1055680|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
1055681|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
1055682|NCT02814838|Beta cells function|beta cells function
1055683|NCT02814825|ViviGen|vivigen
1055684|NCT02814825|ACDF|acdf
1055685|NCT02814825|Cervical|cervical
1055686|NCT02814760|acute ischemic stroke|acute ischemic stroke
1055687|NCT02814760|stepped-wedge|stepped-wedge
1055688|NCT02814760|interactive training|interactive training
1055689|NCT02814760|implementation|implementation
1055690|NCT02814760|emergency department|emergency department
1055691|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
1055692|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
1055693|NCT02814734|Round Belly Sign|round belly sign
1055694|NCT02814734|Radiology|radiology
1055695|NCT02814734|CT findings|ct findings
1055696|NCT02814734|Intensive Care|intensive care
1055697|NCT02814708|Sepsis|sepsis
1055698|NCT02814708|Vaccination|vaccination
1055699|NCT02814695|Male infertility|male infertility
1055700|NCT02814695|oxidative stress|oxidative stress
1055701|NCT02814695|antioxidants|antioxidants
1055702|NCT02814695|probiotics|probiotics
1055703|NCT02814695|Vitamin E|vitamin e
1055704|NCT02814695|Baker's Yeast|baker's yeast
1055705|NCT02814682|palliative care|palliative care
1055706|NCT02814682|quality|quality
1055707|NCT02814682|indicator|indicator
1055708|NCT02814682|multi-dimensional|multi-dimensional
1055709|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
1055710|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1055711|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
1055712|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
1055713|NCT02814656|dry powder inhaler|dry powder inhaler
1055714|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
1055715|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
1055716|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
1055717|NCT02814643|Male and female adolescent patients|male and female adolescent patients
1055718|NCT02814643|severe asthma|severe asthma
1055719|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
1055720|NCT02814604|Star rating system|star rating system
1055721|NCT02814604|Traffic light rating system|traffic light rating system
1055722|NCT02814604|Consumer Behavior|consumer behavior
1055723|NCT02814604|Health Literacy|health literacy
1055724|NCT02814604|Mobile Apps|mobile apps
1055725|NCT02814604|Nutrition Labeling|nutrition labeling
1055726|NCT02814604|Healthy food choices|healthy food choices
1055727|NCT02814578|OCT|oct
1055728|NCT02814578|IVUS|ivus
1055729|NCT02814578|BVS|bvs
1055730|NCT02814565|Drug therapy|drug therapy
1055731|NCT02814526|exercise|exercise
1055735|NCT02814487|multiple sclerosis|multiple sclerosis
1055736|NCT02814487|MSFC|msfc
1055737|NCT02814487|application|application
1055738|NCT02814487|smartphone|smartphone
1055739|NCT02814474|PET/CT|pet/ct
1055740|NCT02814474|Heart failure|heart failure
1055741|NCT02814474|hydroxybutyrate|hydroxybutyrate
1055742|NCT02814435|Retina|retina
1055743|NCT02814435|Retinal Degeneration|retinal degeneration
1055744|NCT02814435|Quality of Life Measures|quality of life measures
1055745|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
1055746|NCT02814422|dementia|dementia
1055747|NCT02814422|Alzheimer's disease|alzheimer's disease
1055748|NCT02814422|mild cognition impairment|mild cognition impairment
1055749|NCT02814422|amyloid-beta|amyloid-beta
1055750|NCT02814396|Ventricular|ventricular
1055751|NCT02814396|CVD|cvd
1055752|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
1055753|NCT02814383|Prematurity|prematurity
1055754|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1055755|NCT02814383|Cerebral Perfusion|cerebral perfusion
1055756|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
1055757|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
1055758|NCT02814344|labour|labour
1055759|NCT02814331|Video-EEG|video-eeg
1055760|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1055761|NCT02814318|Vancomycin|vancomycin
1055762|NCT02814318|Penicillin|penicillin
1055763|NCT02814318|Clindamycin|clindamycin
1055764|NCT02814318|Group B streptococcal infection|group b streptococcal infection
1055765|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
1055766|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
1055767|NCT02814318|Intrapartum|intrapartum
1055768|NCT02814318|Prophylaxis|prophylaxis
1055769|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
1055770|NCT02814201|Motor slowing|motor slowing
1055771|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
1055772|NCT02814188|Exercise|exercise
1055773|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
1055774|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
1055775|NCT02814162|Predictive|predictive
1055777|NCT02814149|delayed implant|delayed implant
1055778|NCT02814149|esthetics|esthetics
1055779|NCT02814149|immediate implant|immediate implant
1055780|NCT02814149|bone augmentation|bone augmentation
1055781|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1055782|NCT02814123|Pramlintide|pramlintide
1055783|NCT02814123|Artificial Pancreas|artificial pancreas
1055784|NCT02814123|Closed-Loop System|closed-loop system
1055785|NCT02814123|Insulin|insulin
1055786|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
1055787|NCT02814110|muscular dystrophy|muscular dystrophy
1055788|NCT02814110|muscle strength|muscle strength
1055789|NCT02814110|children|children
1055790|NCT02814110|adolescents|adolescents
1055791|NCT02814097|Heart Failure|heart failure
1055792|NCT02814097|HFpEF|hfpef
1055793|NCT02814097|elamipretide|elamipretide
1055794|NCT02814097|MTP-131|mtp-131
1055795|NCT02814097|Bendavia™|bendavia™
1055796|NCT02814071|Early Feeding|early feeding
1055797|NCT02814071|Acute Pancreatitis|acute pancreatitis
1055798|NCT02814071|Pediatric|pediatric
1055799|NCT02814058|pharmacokinetics|pharmacokinetics
1055800|NCT02814058|Healthy Volunteers|healthy volunteers
1055801|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
1055802|NCT02814032|proteomic|proteomic
1055803|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
1055804|NCT02814019|respiratory function in DMD|respiratory function in dmd
1055805|NCT02814006|marital relationship|marital relationship
1055806|NCT02813993|infertility|infertility
1055807|NCT02813993|fertility awareness|fertility awareness
1055808|NCT02813993|preconceptional care|preconceptional care
1055809|NCT02813993|health interventions|health interventions
1055810|NCT02813993|couples|couples
1055811|NCT02813980|SUDEP|sudep
1055812|NCT02813980|Sudden cardiac death|sudden cardiac death
1055813|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
1055814|NCT02813980|Sleep|sleep
1055815|NCT02813980|Polysomnography|polysomnography
1055816|NCT02813980|Autonomic|autonomic
1055817|NCT02813980|Cardiovascular|cardiovascular
1055818|NCT02813941|Randomized controlled trial|randomized controlled trial
1055819|NCT02813941|Systematic review|systematic review
1055820|NCT02813941|Summary of finding tables|summary of finding tables
1055821|NCT02813941|GRADE|grade
1055822|NCT02813941|AHRQ|ahrq
1055823|NCT02813928|ColoRectal Cancer|colorectal cancer
1055824|NCT02813928|Cancerology|cancerology
1055825|NCT02813928|Translational Research|translational research
1055826|NCT02813928|ccfDNA|ccfdna
1055827|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
1055828|NCT02813889|infant|infant
1055829|NCT02813889|baby|baby
1055830|NCT02813889|developmental delay|developmental delay
1055831|NCT02813889|robotics|robotics
1055832|NCT02813889|cerebral palsy|cerebral palsy
1055833|NCT02813850|sickle cell disease|sickle cell disease
1055834|NCT02813850|oxygen therapy|oxygen therapy
1055836|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
1055837|NCT02813837|relapsed|relapsed
1055838|NCT02813837|refractory|refractory
1055839|NCT02813837|CD19+|cd19+
1055840|NCT02813837|leukemia|leukemia
1055841|NCT02813837|lymphoma|lymphoma
1055842|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
1055843|NCT02813811|Exacerbation frequency|exacerbation frequency
1055844|NCT02813798|Renal Insufficiency|renal insufficiency
1055845|NCT02813772|infants|infants
1055846|NCT02813772|colic|colic
1055847|NCT02813759|GLYCEMIA|glycemia
1055848|NCT02813759|SATIETY|satiety
1055849|NCT02813759|C PEPTIDE|c peptide
1055850|NCT02813759|PRELOAD|preload
1055851|NCT02813759|INSULIN|insulin
1055852|NCT02813746|Obesity|obesity
1055853|NCT02813746|Tobacco|tobacco
1055854|NCT02813746|Epigenetic|epigenetic
1055855|NCT02813746|Transcriptomic|transcriptomic
1055856|NCT02813746|microRNAs|micrornas
1055857|NCT02813746|miRNAs|mirnas
1055858|NCT02813733|thyroid surgery|thyroid surgery
1055859|NCT02813733|surgical outcomes|surgical outcomes
1055860|NCT02813733|patient safety|patient safety
1055861|NCT02813733|healthcare quality|healthcare quality
1055862|NCT02813733|surgeons performance|surgeons performance
1055863|NCT02813720|Erosions|erosions
1092889|NCT02592928|eHealth|ehealth
1055864|NCT02813720|Onycholysis|onycholysis
1055865|NCT02813720|HR-pQCT|hr-pqct
1055866|NCT02813720|Psoriatic arthritis|psoriatic arthritis
1055867|NCT02813707|Vitamins|vitamins
1055868|NCT02813707|Mineral|mineral
1055869|NCT02813707|Surgery|surgery
1055870|NCT02813694|Pneumonia|pneumonia
1055871|NCT02813694|CABP|cabp
1055873|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
1055874|NCT02813681|Acute Pain|acute pain
1055875|NCT02813681|ultrasonography|ultrasonography
1055876|NCT02813668|Nutrition|nutrition
1055877|NCT02813668|Occupational Health|occupational health
1055878|NCT02813655|tetracosactide|tetracosactide
1055879|NCT02813655|Synacthène®|synacthène®
1055880|NCT02813655|cosyntropin|cosyntropin
1055881|NCT02813655|post-dural syndrom|post-dural syndrom
1055984|NCT02813161|neuropathy|neuropathy
1055882|NCT02813655|post-dural puncture headache|post-dural puncture headache
1055883|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
1055884|NCT02813642|cardiovascular risk|cardiovascular risk
1055885|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
1055886|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
1055887|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
1055888|NCT02813629|Sickle Cell Disease|sickle cell disease
1055889|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
1055890|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
1055891|NCT02813603|EBUS-TBNA|ebus-tbna
1055892|NCT02813603|staging|staging
1055893|NCT02813603|lymph node metastases|lymph node metastases
1055894|NCT02813577|Legs|legs
1055895|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
1055896|NCT02813577|Experimental|experimental
1055897|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
1055898|NCT02813564|Autism|autism
1055899|NCT02813564|Cognitive Training|cognitive training
1055900|NCT02813564|Brain|brain
1055901|NCT02813564|fMRI|fmri
1055902|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
1055903|NCT02813538|Thrombelastography|thrombelastography
1055904|NCT02813538|Antithrombin proteins|antithrombin proteins
1055905|NCT02813538|Liver surgery|liver surgery
1055906|NCT02813538|Liver function tests|liver function tests
1055907|NCT02813525|Aortic Isthmus|aortic isthmus
1055908|NCT02813525|Isthmic Systolic Index|isthmic systolic index
1055909|NCT02813525|feasibility|feasibility
1055910|NCT02813525|reproducibility|reproducibility
1055911|NCT02813525|mortality|mortality
1055912|NCT02813525|delivery|delivery
1055913|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
1055914|NCT02813473|SYNTAX Score II|syntax score ii
1055915|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
1055916|NCT02813473|MSCT|msct
1055917|NCT02813473|Heart Team|heart team
1055918|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
1055919|NCT02813473|FFR|ffr
1055920|NCT02813473|FFR MSCT|ffr msct
1055921|NCT02813473|PCI|pci
1055922|NCT02813473|CABG|cabg
1055923|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
1055924|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
1055925|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
1055926|NCT02813434|Florbetapir|florbetapir
1055927|NCT02813434|18F-AV-45|18f-av-45
1055928|NCT02813434|poststroke|poststroke
1055929|NCT02813421|CGM|cgm
1055930|NCT02813382|bupivacaine|bupivacaine
1055931|NCT02813382|prilocaine|prilocaine
1055932|NCT02813382|2-chloroprocaine|2-chloroprocaine
1055933|NCT02813330|Women|women
1055934|NCT02813330|severe|severe
1055935|NCT02813330|low back ache|low back ache
1055936|NCT02813330|labor|labor
1055937|NCT02813317|Surgery|surgery
1055938|NCT02813317|Breast cancer|breast cancer
1055939|NCT02813317|Quality of life|quality of life
1055940|NCT02813317|Care pathway|care pathway
1055941|NCT02813317|Economic evaluation|economic evaluation
1055942|NCT02813304|Acute|acute
1055943|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
1055944|NCT02813304|exercise|exercise
1055945|NCT02813304|loading|loading
1055946|NCT02813304|ice|ice
1055947|NCT02813304|cryotherapy|cryotherapy
1055948|NCT02813304|randomised control trial|randomised control trial
1055949|NCT02813291|Motor imagery|motor imagery
1055950|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
1055951|NCT02813291|motor learning|motor learning
1055952|NCT02813291|aging|aging
1055953|NCT02813265|Ocular Discomfort|ocular discomfort
1055954|NCT02813265|Pain|pain
1055955|NCT02813265|Corticosteroid|corticosteroid
1055956|NCT02813265|Hyperemia|hyperemia
1055957|NCT02813265|Dry Eye|dry eye
1055958|NCT02813252|long-term follow-up|long-term follow-up
1055959|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
1055960|NCT02813252|JCAR015|jcar015
1055961|NCT02813239|IVF|ivf
1055962|NCT02813239|Dual trigger|dual trigger
1055963|NCT02813239|GnRH agonist|gnrh agonist
1055964|NCT02813239|hCG|hcg
1055965|NCT02813239|mature oocytes|mature oocytes
1055966|NCT02813226|castration-resistant|castration-resistant
1055967|NCT02813226|molecular imaging|molecular imaging
1055968|NCT02813226|abiraterone acetate|abiraterone acetate
1055969|NCT02813226|enzalutamide|enzalutamide
1055970|NCT02813226|metabolic response|metabolic response
1055971|NCT02813213|skin transplantation|skin transplantation
1055972|NCT02813213|grafting skin|grafting skin
1055973|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
1055974|NCT02813187|venous leg ulcer|venous leg ulcer
1055975|NCT02813187|venous|venous
1055976|NCT02813187|QCDR|qcdr
1055977|NCT02813187|quality measure|quality measure
1055978|NCT02813187|wound|wound
1055979|NCT02813187|Outcome|outcome
1055980|NCT02813187|Lymphedema|lymphedema
1055981|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
1055982|NCT02813161|diabetes|diabetes
1055983|NCT02813161|arterial disease|arterial disease
1055985|NCT02813161|amputation|amputation
1055986|NCT02813161|QCDR|qcdr
1055987|NCT02813161|quality measure|quality measure
1055988|NCT02813161|wound|wound
1055989|NCT02813096|HCC|hcc
1055990|NCT02813096|PVTT|pvtt
1055991|NCT02813096|Folofox4|folofox4
1055992|NCT02813096|Early Recurrence|early recurrence
1055993|NCT02813044|anesthesia|anesthesia
1055994|NCT02813044|intravenous|intravenous
1055995|NCT02813044|neurosurgery|neurosurgery
1055996|NCT02813044|pituitary neoplasm|pituitary neoplasm
1055997|NCT02813044|postoperative period|postoperative period
1055998|NCT02813031|functional meat products|functional meat products
1055999|NCT02813031|hypocaloric fats|hypocaloric fats
1056000|NCT02813031|diglyceride|diglyceride
1056001|NCT02813031|obesity|obesity
1056002|NCT02813018|child|child
1056003|NCT02813018|analgesia|analgesia
1056004|NCT02813018|epidural|epidural
1056005|NCT02813018|pain|pain
1056006|NCT02813018|postoperative|postoperative
1056007|NCT02813018|orthopedics|orthopedics
1056008|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
1056009|NCT02812966|peripheral arterial disease|peripheral arterial disease
1056010|NCT02812966|drug coated balloon|drug coated balloon
1056011|NCT02812927|Glycemic lability index|glycemic lability index
1056012|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
1056013|NCT02812927|intensive care|intensive care
1056014|NCT02812927|Insulin|insulin
1056015|NCT02812888|Hyperthyroidism|hyperthyroidism
1056016|NCT02812888|Betatrophin|betatrophin
1056017|NCT02812836|anorectal manometry|anorectal manometry
1056018|NCT02812836|children|children
1056019|NCT02812836|constipation|constipation
1056020|NCT02812823|manometry|manometry
1056021|NCT02812823|children|children
1056022|NCT02812823|constipation|constipation
1056023|NCT02812823|functional disorders|functional disorders
1056024|NCT02812797|Adipokines|adipokines
1056025|NCT02812797|Chronic Heart Failure|chronic heart failure
1056026|NCT02812797|Prognosis|prognosis
1056027|NCT02812784|Nephrocheck™|nephrocheck™
1056028|NCT02812784|acute kidney injury|acute kidney injury
1056029|NCT02812758|sedation depth|sedation depth
1056030|NCT02812758|indices of preload dependence|indices of preload dependence
1056031|NCT02812745|anaesthesia|anaesthesia
1056032|NCT02812732|HPV vaccination|hpv vaccination
1056033|NCT02812732|provider education|provider education
1056034|NCT02812667|Metastatic|metastatic
1056035|NCT02812667|NSCLC|nsclc
1056036|NCT02812667|nivolumab|nivolumab
1056037|NCT02812667|plinabulin|plinabulin
1056038|NCT02812667|BPI-2358|bpi-2358
1056039|NCT02812667|opdivo|opdivo
1056040|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
1056041|NCT02812667|cancer|cancer
1056042|NCT02812654|Sarcoma|sarcoma
1056043|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
1056044|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1056045|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
1056142|NCT02812147|Northera|northera
1056046|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
1056047|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
1056048|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1056049|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
1056050|NCT02812628|laparoscopic surgery|laparoscopic surgery
1056051|NCT02812628|abdominoperineal resection|abdominoperineal resection
1056052|NCT02812628|rectal cancer|rectal cancer
1056053|NCT02812628|individualized surgery|individualized surgery
1056054|NCT02812628|levator muscle|levator muscle
1056055|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
1056056|NCT02812602|Total Knee Replacement|total knee replacement
1056057|NCT02812602|Stitch|stitch
1056058|NCT02812602|Removal|removal
1056059|NCT02812602|Pain|pain
1056060|NCT02812589|MRI|mri
1056061|NCT02812576|Group B streptococcus|group b streptococcus
1056062|NCT02812576|Infants|infants
1056063|NCT02812576|China|china
1056064|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
1056065|NCT02812550|polyp detection rate|polyp detection rate
1056066|NCT02812550|colorectal cancer|colorectal cancer
1056067|NCT02812550|colorectal screening|colorectal screening
1093136|NCT02591654|FLT|flt
1056068|NCT02812550|adenoma detection rate|adenoma detection rate
1056069|NCT02812550|endoscopic innovations|endoscopic innovations
1056070|NCT02812537|Trajectories|trajectories
1056071|NCT02812537|emergency room|emergency room
1056072|NCT02812537|conduct disorder|conduct disorder
1056073|NCT02812537|care management|care management
1056074|NCT02812524|Immunotherapy|immunotherapy
1056075|NCT02812524|Yervoy|yervoy
1056076|NCT02812524|Head and neck cancer|head and neck cancer
1056077|NCT02812524|Pre-operative|pre-operative
1056078|NCT02812498|teleconsultation|teleconsultation
1056079|NCT02812498|insulin therapy|insulin therapy
1056080|NCT02812498|HbA1c|hba1c
1056081|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
1056082|NCT02812459|Kinesio taping|kinesio taping
1056083|NCT02812459|Exercise|exercise
1056084|NCT02812446|biofilm|biofilm
1056085|NCT02812446|staphylokinase|staphylokinase
1056086|NCT02812446|Staphylococcus aureus|staphylococcus aureus
1056087|NCT02812446|microarrays|microarrays
1056384|NCT02810795|Dynamic|dynamic
1056088|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
1056089|NCT02812446|bone and joint infection|bone and joint infection
1056090|NCT02812446|blood group|blood group
1056091|NCT02812433|birth asphyxia|birth asphyxia
1056092|NCT02812433|brain|brain
1056093|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1056094|NCT02812433|neonate|neonate
1056095|NCT02812433|neuroprotection|neuroprotection
1056096|NCT02812433|neurorestoration|neurorestoration
1056097|NCT02812433|newborn|newborn
1056098|NCT02812433|sildenafil|sildenafil
1056099|NCT02812420|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
1056100|NCT02812420|Urothelial Carcinoma|urothelial carcinoma
1056101|NCT02812420|Muscle-invasive, high-risk bladder cancer|muscle-invasive, high-risk bladder cancer
1056102|NCT02812420|Ineligible for neoadjuvant cisplatin-containing chemotherapies|ineligible for neoadjuvant cisplatin-containing chemotherapies
1056103|NCT02812420|Bladder cancer|bladder cancer
1056104|NCT02812420|Cystectomy|cystectomy
1056105|NCT02812420|Bladder cancer surgery|bladder cancer surgery
1056106|NCT02812420|Durvalumab|durvalumab
1056107|NCT02812420|MEDI4736|medi4736
1056108|NCT02812420|Tremelimumab|tremelimumab
1056109|NCT02812420|Phone calls|phone calls
1056110|NCT02812394|Parkinson's disease|parkinson's disease
1056111|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
1056112|NCT02812381|Trigger Points, movement|trigger points, movement
1056113|NCT02812355|off-pump|off-pump
1056114|NCT02812355|coronary artery bypass|coronary artery bypass
1056115|NCT02812355|heparinization|heparinization
1056116|NCT02812342|Alopecia|alopecia
1056117|NCT02812316|Myopia|myopia
1056118|NCT02812316|Scleral lens|scleral lens
1056119|NCT02812316|Astigmatism|astigmatism
1056120|NCT02812316|Presbyopia|presbyopia
1056121|NCT02812290|antibody mediated rejection, T cell mediated rejection|antibody mediated rejection, t cell mediated rejection
1056122|NCT02812277|anastrozole|anastrozole
1056123|NCT02812277|letrozole|letrozole
1056124|NCT02812277|postmenopausal patients|postmenopausal patients
1056125|NCT02812238|Inflammasome|inflammasome
1056126|NCT02812238|Sirt3|sirt3
1056127|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
1056128|NCT02812238|Fasting|fasting
1056129|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
1056130|NCT02812212|cortical transit time|cortical transit time
1056131|NCT02812186|Neuromuscular blockade|neuromuscular blockade
1056132|NCT02812173|urinary drainage|urinary drainage
1056133|NCT02812173|urethral catheter|urethral catheter
1056134|NCT02812173|suprapubic tube|suprapubic tube
1056135|NCT02812173|pain|pain
1056136|NCT02812173|discomfort|discomfort
1056137|NCT02812173|radical prostatectomy|radical prostatectomy
1056138|NCT02812173|robotic surgery|robotic surgery
1056139|NCT02812173|urinary infection|urinary infection
1056140|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
1056141|NCT02812147|L-DOPS|l-dops
1056143|NCT02812134|phosphorus supplementation|phosphorus supplementation
1056144|NCT02812134|FGF23|fgf23
1056145|NCT02812134|anorexic|anorexic
1056146|NCT02812134|adolescents|adolescents
1056147|NCT02812134|undernutrition|undernutrition
1056148|NCT02812108|intracranial aneurysm|intracranial aneurysm
1056149|NCT02812108|endovascular treatment|endovascular treatment
1056150|NCT02812108|recanalization|recanalization
1056151|NCT02812108|outcome|outcome
1056152|NCT02812108|hemodynamics|hemodynamics
1056153|NCT02812108|computational fluid dynamic|computational fluid dynamic
1056154|NCT02812108|stent|stent
1056155|NCT02812108|flow diversion|flow diversion
1056156|NCT02812082|Web-based|web-based
1056157|NCT02812082|patient education application|patient education application
1056158|NCT02812082|16-769|16-769
1056159|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
1056160|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1056161|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
1056162|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
1056163|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
1056164|NCT02812056|HPV|hpv
1056165|NCT02812056|Alisertib|alisertib
1056166|NCT02812056|MLN8237|mln8237
1056167|NCT02812056|TAK-228|tak-228
1056168|NCT02812056|MLN0128|mln0128
1056169|NCT02812043|onychomycosis|onychomycosis
1056170|NCT02812043|amorolfine|amorolfine
1056171|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
1056172|NCT02812043|fungal infection|fungal infection
1056173|NCT02812030|Observational Study|observational study
1056174|NCT02812030|aflibercept|aflibercept
1056175|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
1056176|NCT02812030|Visual Acuity|visual acuity
1056177|NCT02812017|educational intervention|educational intervention
1056178|NCT02812017|language development|language development
1056179|NCT02812017|postpartum|postpartum
1056180|NCT02812017|parental attachment|parental attachment
1056181|NCT02812017|achievement gap|achievement gap
1056182|NCT02812017|language gap|language gap
1056183|NCT02812017|school readiness|school readiness
1056184|NCT02812004|Vitreous Floaters|vitreous floaters
1056185|NCT02812004|Mouches Voulantes|mouches voulantes
1056186|NCT02811991|paracetamol|paracetamol
1056187|NCT02811991|post-operative analgesia|post-operative analgesia
1056188|NCT02811965|heel|heel
1056189|NCT02811965|pressure ulcer|pressure ulcer
1056190|NCT02811965|pressure mapping|pressure mapping
1056191|NCT02811952|bladder cancer|bladder cancer
1056192|NCT02811939|Cannabis|cannabis
1056193|NCT02811939|Marijuana|marijuana
1056194|NCT02811939|THC|thc
1056195|NCT02811939|Dronabinol|dronabinol
1056196|NCT02811939|Pregnenolone|pregnenolone
1056197|NCT02811939|PREG|preg
1056198|NCT02811939|Psychotic Disorders|psychotic disorders
1056199|NCT02811926|parastomal bulging|parastomal bulging
1056200|NCT02811926|peristomal bulging|peristomal bulging
1056201|NCT02811926|ileostomy|ileostomy
1056202|NCT02811926|colostomy|colostomy
1056203|NCT02811926|enterostomy|enterostomy
1056204|NCT02811926|incidence|incidence
1056205|NCT02811926|risk factor|risk factor
1056206|NCT02811913|sensory impairment|sensory impairment
1056207|NCT02811913|sensory deficit|sensory deficit
1056208|NCT02811913|upper limb|upper limb
1056209|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
1056210|NCT02811913|brain stimulation|brain stimulation
1056211|NCT02811913|rehabilitation|rehabilitation
1056212|NCT02811900|obesity surgery|obesity surgery
1056213|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
1056214|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
1056215|NCT02811900|excess weight loss|excess weight loss
1056216|NCT02811900|quality of life|quality of life
1056217|NCT02811874|diabetes education|diabetes education
1056218|NCT02811874|community health workers|community health workers
1056219|NCT02811874|diabetes control|diabetes control
1056220|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
1056221|NCT02811861|Lenvatinib|lenvatinib
1056222|NCT02811861|First-line RCC|first-line rcc
1056223|NCT02811861|Treatment-naive RCC|treatment-naive rcc
1056224|NCT02811861|Everolimus|everolimus
1056225|NCT02811861|Pembrolizumab|pembrolizumab
1056226|NCT02811861|Sunitinib|sunitinib
1056227|NCT02811861|Phase 3 RCC|phase 3 rcc
1056228|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
1056229|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
1056230|NCT02811822|GMI-1271|gmi-1271
1056231|NCT02811822|bortezomib|bortezomib
1056232|NCT02811822|carfilzomib|carfilzomib
1056233|NCT02811822|multiple myeloma|multiple myeloma
1056234|NCT02811809|Prostate cancer|prostate cancer
1056235|NCT02811809|Apalutamide|apalutamide
1056236|NCT02811809|IHT|iht
1056237|NCT02811809|BCR|bcr
1056238|NCT02811809|Biochemical recurrence|biochemical recurrence
1056239|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
1056240|NCT02811796|drug eluting stents|drug eluting stents
1056241|NCT02811796|flow fractional reserve|flow fractional reserve
1056242|NCT02811796|prognosis|prognosis
1056243|NCT02811796|angio-based FFR|angio-based ffr
1056244|NCT02811783|Pruritus|pruritus
1056245|NCT02811783|Mycosis Fungoides|mycosis fungoides
1056246|NCT02811783|CTCL|ctcl
1056247|NCT02811783|naloxone|naloxone
1056248|NCT02811783|opiate antagonist|opiate antagonist
1056249|NCT02811783|Sézary Syndrome|sézary syndrome
1056250|NCT02811718|Stress Management|stress management
1056251|NCT02811718|Resiliency|resiliency
1056252|NCT02811718|Skype|skype
1056253|NCT02811692|Database|database
1056254|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
1056255|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
1056256|NCT02811692|Retinal Diseases|retinal diseases
1056257|NCT02811692|Optic Nerve Diseases|optic nerve diseases
1056258|NCT02811692|Corneal Diseases|corneal diseases
1056259|NCT02811692|Vision Disorders|vision disorders
1056260|NCT02811679|Lymphoma|lymphoma
1056261|NCT02811653|Motor slowing|motor slowing
1056262|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
1730737|NCT00004729|LGS|lgs
1056263|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
1056264|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1056265|NCT02811627|Memantine|memantine
1056266|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
1056267|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
1056268|NCT02811614|minimally invasive surgery|minimally invasive surgery
1056269|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
1056270|NCT02811614|stereotactic aspiration|stereotactic aspiration
1056271|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1056272|NCT02811575|Coloscopy|coloscopy
1056273|NCT02811549|Cochlear Implant|cochlear implant
1056274|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
1056275|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
1056276|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
1056277|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
1056278|NCT02811549|Cochlear Implantation|cochlear implantation
1056279|NCT02811549|Listening Benefits|listening benefits
1056281|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
1056282|NCT02811549|Electrical Stimulation|electrical stimulation
1056383|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
1056283|NCT02811549|HiRes™ Ultra Implant with HiFocus™ Mid‐Scala electrode|hires™ ultra implant with hifocus™ mid‐scala electrode
1056284|NCT02811484|Obesity|obesity
1056285|NCT02811458|Panic Disorder|panic disorder
1056286|NCT02811458|Agoraphobia|agoraphobia
1056287|NCT02811458|Social Anxiety Disorder|social anxiety disorder
1056288|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
1056289|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1056290|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
1056291|NCT02811432|Kangaroo mother care|kangaroo mother care
1056292|NCT02811432|Neonates|neonates
1056293|NCT02811432|Low birth weight|low birth weight
1056294|NCT02811432|Unstable|unstable
1056295|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
1056296|NCT02811380|CVC|cvc
1056297|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
1056298|NCT02811380|CLABSI|clabsi
1056299|NCT02811380|Noble metal alloy coating|noble metal alloy coating
1056300|NCT02811380|CVC related thrombosis|cvc related thrombosis
1056301|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
1056302|NCT02811276|High-protein diet|high-protein diet
1056303|NCT02811276|Energy metabolism|energy metabolism
1056304|NCT02811276|Substrate oxidation|substrate oxidation
1056305|NCT02811250|Renal cancer|renal cancer
1056306|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
1056307|NCT02811185|PET|pet
1056308|NCT02811185|CT|ct
1056309|NCT02811185|PET/CT|pet/ct
1056310|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
1056311|NCT02811172|Biomarkers|biomarkers
1056312|NCT02811172|Triglycerides|triglycerides
1056313|NCT02811172|Cholesterol|cholesterol
1056314|NCT02811172|Prolactin|prolactin
1056315|NCT02811172|Glucose|glucose
1056316|NCT02811146|Heart Failure|heart failure
1056317|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
1056318|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
1056319|NCT02811133|inositol|inositol
1056320|NCT02811120|meningococcal|meningococcal
1056321|NCT02811120|conjugate|conjugate
1056322|NCT02811120|vaccine|vaccine
1056323|NCT02811120|quadrivalent|quadrivalent
1056324|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
1056325|NCT02811107|anxiety|anxiety
1056326|NCT02811107|pain|pain
1056327|NCT02811107|preoperative area|preoperative area
1056328|NCT02811107|premedication|premedication
1056329|NCT02811068|HPV|hpv
1056330|NCT02811068|vaccine|vaccine
1056331|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
1056332|NCT02811029|neurological|neurological
1056333|NCT02811029|difficulties|difficulties
1056334|NCT02811016|High Altitude|high altitude
1056335|NCT02811016|budesonide|budesonide
1056336|NCT02811016|hypoxia|hypoxia
1056337|NCT02811003|Insertional Achilles|insertional achilles
1056338|NCT02810990|bosutinib|bosutinib
1056339|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
1056340|NCT02810977|gastric volume|gastric volume
1056341|NCT02810977|gastric content|gastric content
1056342|NCT02810977|ultrasound|ultrasound
1056343|NCT02810977|perioperative fasting|perioperative fasting
1056344|NCT02810964|Schizophrenia|schizophrenia
1056345|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
1056346|NCT02810964|Sulforaphane|sulforaphane
1056347|NCT02810964|Sulforaphane supplement|sulforaphane supplement
1056348|NCT02810951|RDEB|rdeb
1056349|NCT02810938|Ablation|ablation
1056350|NCT02810938|Mifi technology|mifi technology
1056351|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
1056352|NCT02810899|child|child
1056353|NCT02810899|craniotomy|craniotomy
1056354|NCT02810899|intelligence tests|intelligence tests
1056355|NCT02810899|dexmedetomidine|dexmedetomidine
1056356|NCT02810899|Disruption|disruption
1056357|NCT02810899|Dehiscence|dehiscence
1056358|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
1056359|NCT02810886|Prostate Cancer|prostate cancer
1056360|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1056361|NCT02810847|Amblyopia|amblyopia
1056362|NCT02810847|strabismus|strabismus
1056363|NCT02810847|virtual reality|virtual reality
1056364|NCT02810847|computer games|computer games
1056365|NCT02810834|Executive Function|executive function
1056366|NCT02810834|Academic Performance|academic performance
1056367|NCT02810821|Gonadal hormones|gonadal hormones
1056368|NCT02810821|Gonadotropins|gonadotropins
1056369|NCT02810821|Cardiovascular diseases|cardiovascular diseases
1056370|NCT02810821|Lipids|lipids
1056371|NCT02810821|Obesity|obesity
1056372|NCT02810821|Atherosclerosis|atherosclerosis
1056373|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
1056374|NCT02810821|Metabolic syndrome|metabolic syndrome
1056375|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1056376|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
1056377|NCT02810808|Ranibizumab|ranibizumab
1056378|NCT02810808|Pro Re Nata|pro re nata
1056379|NCT02810795|Coronary|coronary
1056380|NCT02810795|Artery|artery
1056381|NCT02810795|Computed tomography|computed tomography
1056382|NCT02810795|FFR|ffr
1056385|NCT02810782|opiate dependence|opiate dependence
1056386|NCT02810782|withdrawal|withdrawal
1056387|NCT02810782|newborn|newborn
1056388|NCT02810730|pancreas|pancreas
1056389|NCT02810730|adenocarcinoma|adenocarcinoma
1056390|NCT02810704|Anticoagulant|anticoagulant
1056391|NCT02810704|Venous Thromboembolism|venous thromboembolism
1056392|NCT02810704|Pulmonary Embolism|pulmonary embolism
1056393|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
1056394|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
1056395|NCT02810691|Diabetes|diabetes
1056396|NCT02810691|Fiber|fiber
1056397|NCT02810691|Supplementation|supplementation
1056398|NCT02810691|Soluble fiber|soluble fiber
1056399|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
1056400|NCT02810691|Nutrition|nutrition
1056401|NCT02810678|Tuberculosis|tuberculosis
1056402|NCT02810665|Repeatability|repeatability
1056403|NCT02810665|Concordance|concordance
1056404|NCT02810665|Agreement|agreement
1056405|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
1056406|NCT02810665|numeric|numeric
1056407|NCT02810665|Landolt C|landolt c
1056408|NCT02810665|Roman alphabet|roman alphabet
1056409|NCT02810652|Cancer Surgery Care|cancer surgery care
1056410|NCT02810639|pain|pain
1056411|NCT02810587|Endophthalmitis|endophthalmitis
1056412|NCT02810587|Intravitreous injection|intravitreous injection
1056413|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1056414|NCT02810587|topical antibiotics|topical antibiotics
1056415|NCT02810561|Troponin|troponin
1056416|NCT02810535|Local IgE|local ige
1056417|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
1056418|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
1056419|NCT02810509|Wafarin|wafarin
1056420|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
1056421|NCT02810509|ischemic stroke|ischemic stroke
1056422|NCT02810483|Prader-Willi|prader-willi
1056423|NCT02810483|SPW|spw
1056424|NCT02810483|impulsivity|impulsivity
1056425|NCT02810483|eating disorders|eating disorders
1056426|NCT02810483|topiramate|topiramate
1056427|NCT02810457|Cancer|cancer
1056428|NCT02810457|Bevacizumab|bevacizumab
1056429|NCT02810457|Carboplatin|carboplatin
1056430|NCT02810457|Paclitaxel|paclitaxel
1056431|NCT02810418|Immunotoxin|immunotoxin
1056432|NCT02810418|Mesothelin|mesothelin
1056433|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
1056434|NCT02810418|Advanced Cancer|advanced cancer
1056435|NCT02810405|Sample|sample
1056436|NCT02810405|Storage|storage
1056437|NCT02810405|Molecular Profiling|molecular profiling
1056438|NCT02810405|Biopsy|biopsy
1056439|NCT02810405|Repository|repository
1056440|NCT02810379|informed consent|informed consent
1056441|NCT02810379|ERCP|ercp
1056442|NCT02810379|video|video
1056443|NCT02810366|Verbal Autopsy|verbal autopsy
1056444|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
1056445|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
1056446|NCT02810366|InterVA|interva
1056447|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
1056448|NCT02810366|Tariff|tariff
1056449|NCT02810366|InSilicoVA|insilicova
1056450|NCT02810366|Randomised Control Trial|randomised control trial
1056451|NCT02810366|SmartVA|smartva
1056452|NCT02810366|King-Lu|king-lu
1056453|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1056454|NCT02810327|AATD|aatd
1056455|NCT02810327|Alpha-1|alpha-1
1056456|NCT02810327|SERPINA1|serpina1
1056458|NCT02810327|Carrier|carrier
1056459|NCT02810327|Heterozygote|heterozygote
1056460|NCT02810327|Smoking|smoking
1056461|NCT02810327|COPD|copd
1056462|NCT02810327|Emphysema|emphysema
1056463|NCT02810327|Sequencing|sequencing
1056464|NCT02810301|gluten|gluten
1056465|NCT02810301|non-celiac|non-celiac
1056466|NCT02810301|gluten sensitivity|gluten sensitivity
1056467|NCT02810288|Airway anatomy|airway anatomy
1056468|NCT02810288|difficult intubation|difficult intubation
1056469|NCT02810288|congenital syndromes|congenital syndromes
1056470|NCT02810262|Lung cancer|lung cancer
1056471|NCT02810262|Bone metastases|bone metastases
1056472|NCT02810262|EGFR|egfr
1056473|NCT02810262|KRAS|kras
1056474|NCT02810262|Bone biomarkers|bone biomarkers
1056475|NCT02810262|Metabolic parameters|metabolic parameters
1056476|NCT02810249|African American YMSM|african american ymsm
1056477|NCT02810249|PrEP|prep
1056478|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
1056479|NCT02810249|Common Sense Model|common sense model
1056480|NCT02810249|Healthcare|healthcare
1056481|NCT02810249|HIV Prevention|hiv prevention
1056482|NCT02810236|Focal breast pain|focal breast pain
1056483|NCT02810236|Directed Ultrasound|directed ultrasound
1056484|NCT02810236|Reassurance|reassurance
1056485|NCT02810236|Anxiety|anxiety
1056486|NCT02810210|Zika|zika
1056487|NCT02810210|microcephaly|microcephaly
1056488|NCT02810210|congenital abnormalities|congenital abnormalities
1056489|NCT02810210|new-born|new-born
1056490|NCT02810210|infant|infant
1056491|NCT02810184|bone augmentation|bone augmentation
1056492|NCT02810184|long-term bone volume changes|long-term bone volume changes
1056493|NCT02810184|immediate provisional implant|immediate provisional implant
1056495|NCT02810171|social anxiety disorder|social anxiety disorder
1056496|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
1056497|NCT02810171|phobias|phobias
1056498|NCT02810171|fears|fears
1056499|NCT02810171|worry|worry
1056500|NCT02810145|traumatic brain injury|traumatic brain injury
1056501|NCT02810145|cerebral desaturation|cerebral desaturation
1056502|NCT02810145|intensive care|intensive care
1056503|NCT02810145|hemodynamics|hemodynamics
1056504|NCT02810145|Loss|loss
1056505|NCT02810145|Consciousness|consciousness
1056506|NCT02810106|Spect|spect
1056507|NCT02810106|Stress Test|stress test
1056508|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
1056509|NCT02810106|CT angiography|ct angiography
1056510|NCT02810093|Breast cancer|breast cancer
1056511|NCT02810093|Text mining|text mining
1056512|NCT02810093|Big Data|big data
1056513|NCT02810093|Machine Learning|machine learning
1056514|NCT02810054|regeneration|regeneration
1056515|NCT02810054|intrabony defects|intrabony defects
1056516|NCT02810054|enamel matrix derivative|enamel matrix derivative
1056517|NCT02810054|MIST|mist
1056518|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
1056519|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
1056520|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
1056521|NCT02810028|Inclusion-body myositis|inclusion-body myositis
1056522|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
1056523|NCT02810028|ACT|act
1056524|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
1056525|NCT02809937|aged|aged
1056526|NCT02809937|surgical procedures, operative|surgical procedures, operative
1056527|NCT02809937|delirium|delirium
1056528|NCT02809937|dexmedetomidine|dexmedetomidine
1056529|NCT02809937|long-term outcome|long-term outcome
1056530|NCT02809924|endotracheal intubation|endotracheal intubation
1056531|NCT02809924|teaching|teaching
1056532|NCT02809924|just-in-time|just-in-time
1056533|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
1056534|NCT02809885|Hepatitis E|hepatitis e
1056535|NCT02809885|Pediatric|pediatric
1056536|NCT02809885|Transplantation|transplantation
1056537|NCT02809885|Prevalence|prevalence
1056538|NCT02809820|ACS|acs
1056539|NCT02809820|Beta Blockers|beta blockers
1056540|NCT02809820|platelet aggregation|platelet aggregation
1056541|NCT02809820|light transmission aggregometry|light transmission aggregometry
1056542|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
1056543|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
1056544|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
1056545|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
1056546|NCT02809781|etanercept|etanercept
1056944|NCT02807454|Durvalumab|durvalumab
1056547|NCT02809768|Healthy participants|healthy participants
1056548|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
1056549|NCT02809768|Avatrombopag|avatrombopag
1056550|NCT02809755|Obesity|obesity
1056551|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
1056552|NCT02809755|band revision|band revision
1056553|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
1056554|NCT02809742|Pregnant|pregnant
1056555|NCT02809742|Labor|labor
1056556|NCT02809742|Epidural|epidural
1056557|NCT02809742|Analgesia|analgesia
1056558|NCT02809742|Intermittent|intermittent
1056559|NCT02809651|Infrascanner|infrascanner
1056560|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
1056561|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
1056562|NCT02809625|brucella spondylitis|brucella spondylitis
1056564|NCT02809599|dizziness|dizziness
1056565|NCT02809586|Alcohol|alcohol
1056566|NCT02809586|Teens|teens
1056567|NCT02809586|Young Adults|young adults
1056568|NCT02809586|Social Media|social media
1056569|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1056570|NCT02809573|PTCL|ptcl
1056571|NCT02809573|chidamide|chidamide
1056572|NCT02809573|CHOP|chop
1056573|NCT02809573|phase Ib|phase ib
1056574|NCT02809560|Lymphocytes Th2|lymphocytes th2
1056575|NCT02809560|Cav1 channels|cav1 channels
1056576|NCT02809534|Anlotinib|anlotinib
1056577|NCT02809534|AL3818|al3818
1056578|NCT02809508|Omega-3|omega-3
1056579|NCT02809508|Child nutrition|child nutrition
1056580|NCT02809508|Dietary recommendations|dietary recommendations
1056581|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
1056582|NCT02809508|Cognitive function|cognitive function
1056583|NCT02809508|Mental health|mental health
1056584|NCT02809482|Volunteers|volunteers
1056585|NCT02809443|Zika|zika
1056586|NCT02809443|Vaccine|vaccine
1056587|NCT02809443|DNA|dna
1056588|NCT02809391|Postural Balance|postural balance
1056589|NCT02809391|Gait|gait
1056590|NCT02809391|Foot Orthotic|foot orthotic
1056591|NCT02809391|Proprioception|proprioception
1056592|NCT02809391|Somatosensory|somatosensory
1056593|NCT02809365|insulin treated|insulin treated
1056594|NCT02809339|Chemotherapy|chemotherapy
1056595|NCT02809339|ovarian cancer|ovarian cancer
1056596|NCT02809339|Patient reported outcome|patient reported outcome
1056597|NCT02809339|Quality of Care|quality of care
1056598|NCT02809326|efficiency|efficiency
1056599|NCT02809326|exposure therapy|exposure therapy
1056600|NCT02809326|PTSD|ptsd
1056601|NCT02809326|combat|combat
1056602|NCT02809326|veterans|veterans
1056603|NCT02809313|gingivitis|gingivitis
1056604|NCT02809313|probiotic|probiotic
1056605|NCT02809313|non- surgical treatment|non- surgical treatment
1056606|NCT02809274|iron deficiency|iron deficiency
1056607|NCT02809274|polycythemia vera|polycythemia vera
1056608|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
1056609|NCT02809261|Perineural injection|perineural injection
1056610|NCT02809261|Dextrose|dextrose
1056611|NCT02809248|LTX Study|ltx study
1056612|NCT02809235|asthma|asthma
1056613|NCT02809235|smooth muscle|smooth muscle
1056614|NCT02809235|lauric acid|lauric acid
1056615|NCT02809235|dietary supplement|dietary supplement
1056616|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
1056617|NCT02809222|Ascorbic acid|ascorbic acid
1056618|NCT02809222|Oxidative stress|oxidative stress
1056619|NCT02809222|Preleukemia|preleukemia
1056620|NCT02809196|Food Habits|food habits
1056621|NCT02809196|Adolescents|adolescents
1056622|NCT02809196|Digital Communication|digital communication
1056623|NCT02809183|metabolic acidosis|metabolic acidosis
1056624|NCT02809183|serum bicarbonate|serum bicarbonate
1056625|NCT02809183|kidney disease|kidney disease
1056626|NCT02809131|CIED infection|cied infection
1056627|NCT02809118|Deafness|deafness
1056628|NCT02809118|Hearing Loss|hearing loss
1056629|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
1056630|NCT02809118|Ear Diseases|ear diseases
1056631|NCT02809118|Hearing Disorders|hearing disorders
1056632|NCT02809118|Nervous System Diseases|nervous system diseases
1056633|NCT02809118|Neurologic Manifestations|neurologic manifestations
1056634|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
1056635|NCT02809118|Sensation Disorders|sensation disorders
1056636|NCT02809118|Signs and Symptoms|signs and symptoms
1056637|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
1056638|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
1056639|NCT02809105|Chronic constipation|chronic constipation
1056640|NCT02809105|Linaclotide|linaclotide
1056641|NCT02809105|ASP0456|asp0456
1056642|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
1056643|NCT02809066|premenstrual syndrome|premenstrual syndrome
1056644|NCT02809066|calcium|calcium
1056645|NCT02809066|quality of life|quality of life
1056646|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
1056647|NCT02809014|Fluoride|fluoride
1056648|NCT02809014|Dental caries|dental caries
1056649|NCT02809014|Dentifrice|dentifrice
1056945|NCT02807454|Daratumumab|daratumumab
1056650|NCT02809001|Fat grafting|fat grafting
1056651|NCT02809001|Expansion-related complications|expansion-related complications
1056652|NCT02808988|Bisphosphonate|bisphosphonate
1056653|NCT02808988|osteoporosis|osteoporosis
1056654|NCT02808988|RANKL|rankl
1056655|NCT02808988|OPG|opg
1056656|NCT02808988|periodontitis|periodontitis
1056657|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
1056658|NCT02808975|axilla|axilla
1056659|NCT02808975|inguinal region|inguinal region
1056660|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
1056661|NCT02808975|adalimumab|adalimumab
1056662|NCT02808975|secondary intention|secondary intention
1056663|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
1056664|NCT02808949|Prevention|prevention
1056665|NCT02808949|Lactating Women|lactating women
1056666|NCT02808949|Healthy|healthy
1056667|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
1056668|NCT02808936|orthopedic surgery|orthopedic surgery
1056669|NCT02808936|ischemic heart disease|ischemic heart disease
1056670|NCT02808910|behavior|behavior
1056671|NCT02808910|food intake|food intake
1056672|NCT02808910|salt|salt
1056673|NCT02808910|vegetables|vegetables
1056674|NCT02808910|portion size|portion size
1056675|NCT02808910|weight loss|weight loss
1056676|NCT02808910|habits|habits
1056677|NCT02808897|Chest tubes|chest tubes
1056678|NCT02808897|Atrial fibrillation|atrial fibrillation
1056679|NCT02808897|Thoracic surgery|thoracic surgery
1056680|NCT02808897|Critical care|critical care
1056681|NCT02808858|MDS|mds
1056682|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
1056683|NCT02808845|coronary angiography|coronary angiography
1056684|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
1056685|NCT02808845|microalbuminuria|microalbuminuria
1056686|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1056687|NCT02808832|Cervical cancer screening|cervical cancer screening
1056688|NCT02808832|Provider intervention|provider intervention
1056689|NCT02808819|Asthma|asthma
1056690|NCT02808819|Bronchial Diseases|bronchial diseases
1056691|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
1056692|NCT02808819|Lung Diseases|lung diseases
1056693|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
1056694|NCT02808806|stroke|stroke
1056695|NCT02808806|cerebral infarction|cerebral infarction
1056696|NCT02808806|brain infarction|brain infarction
1056697|NCT02808806|ischemic stroke|ischemic stroke
1056698|NCT02808806|treatment|treatment
1056699|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
1056700|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
1056701|NCT02808806|delay|delay
1056702|NCT02808806|total system delay|total system delay
1056703|NCT02808806|pre-hospital delay|pre-hospital delay
1056704|NCT02808806|in-hospital delay|in-hospital delay
1056705|NCT02808806|feedback|feedback
1056706|NCT02808806|real-time feedback|real-time feedback
1056707|NCT02808806|visual feedback|visual feedback
1056708|NCT02808793|ISM|ism
1056709|NCT02808793|Mastocytosis|mastocytosis
1056710|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
1056711|NCT02808780|Ulcerative Colitis|ulcerative colitis
1056712|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
1056713|NCT02808780|Thiopurines|thiopurines
1056714|NCT02808780|Lymphoma|lymphoma
1056715|NCT02808780|Malignancies|malignancies
1056716|NCT02808767|Acute myocardial infarction|acute myocardial infarction
1056717|NCT02808767|Primary coronary intervention|primary coronary intervention
1056718|NCT02808767|Antiplatelet therapy|antiplatelet therapy
1056719|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
1056720|NCT02808728|Total Knee Replacement|total knee replacement
1056721|NCT02808728|Exparel|exparel
1056722|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
1056723|NCT02808728|Ropivacaine|ropivacaine
1056724|NCT02808728|Postoperative Pain Management|postoperative pain management
1056725|NCT02808702|Attention|attention
1056726|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
1056727|NCT02808702|Neuroimaging|neuroimaging
1056728|NCT02808689|Moderate|moderate
1056729|NCT02808689|Severe|severe
1056730|NCT02808676|Cognitive training|cognitive training
1056731|NCT02808676|Vitamin D|vitamin d
1056732|NCT02808676|Exercise|exercise
1056733|NCT02808637|Pain management|pain management
1056734|NCT02808637|vaccination|vaccination
1056735|NCT02808637|manual pressure|manual pressure
1056736|NCT02808637|needle aspiration|needle aspiration
1056737|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
1056738|NCT02808598|Clinical Trials|clinical trials
1056739|NCT02808598|Education|education
1056740|NCT02808598|Hispanic Americans|hispanic americans
1056741|NCT02808598|African Americans|african americans
1056742|NCT02808598|Health Disparities|health disparities
1056743|NCT02808598|Patient Participation|patient participation
1056744|NCT02808598|Refusal to Participate|refusal to participate
1056745|NCT02808572|chronic kidney disease|chronic kidney disease
1056746|NCT02808572|vascular calcifications|vascular calcifications
1056747|NCT02808572|cardiovascular risk|cardiovascular risk
1056748|NCT02808546|Gallbladder stone|gallbladder stone
1056749|NCT02808546|Risk factor|risk factor
1056750|NCT02808546|Case-control study|case-control study
1056751|NCT02808546|Obesity|obesity
1056752|NCT02808546|Hypertension|hypertension
1056753|NCT02808546|Alcohol consumption|alcohol consumption
1056754|NCT02808520|Social participation|social participation
1056755|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
1056756|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
1056757|NCT02808520|Social inequalities and cancer|social inequalities and cancer
1056758|NCT02808494|Preeclampsia|preeclampsia
1056759|NCT02808494|Fetal Growth Restriction|fetal growth restriction
1056760|NCT02808481|systemic sclerosis|systemic sclerosis
1056761|NCT02808481|cardiac disease|cardiac disease
1056762|NCT02808481|Heart transplantation|heart transplantation
1056763|NCT02808481|primitive cardiac damage|primitive cardiac damage
1056764|NCT02808468|Sexual assault|sexual assault
1056765|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
1056766|NCT02808468|Alcohol use|alcohol use
1056767|NCT02808468|Cognitive therapy|cognitive therapy
1056768|NCT02808429|Atacicept|atacicept
1056769|NCT02808429|IgA Nephropathy|iga nephropathy
1056770|NCT02808429|Berger´s disease|berger´s disease
1056771|NCT02808429|Glomerulonephritis|glomerulonephritis
1056772|NCT02808429|Proteinuria|proteinuria
1056773|NCT02808416|Solid tumors|solid tumors
1056774|NCT02808416|Brain metastases|brain metastases
1056775|NCT02808416|DC vaccine|dc vaccine
1056776|NCT02808416|Personalized vaccine|personalized vaccine
1056777|NCT02808416|Tumor antigens|tumor antigens
1056778|NCT02808416|PBMCs|pbmcs
1056779|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
1056780|NCT02808364|DC vaccine|dc vaccine
1056781|NCT02808364|tumor antigen|tumor antigen
1056782|NCT02808364|personalized vaccine|personalized vaccine
1056783|NCT02808299|statin|statin
1056784|NCT02808299|hepatitis B virus|hepatitis b virus
1056785|NCT02808273|Bemiparine|bemiparine
1056786|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
1056787|NCT02808273|Comparative study|comparative study
1056788|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
1056789|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
1056790|NCT02808260|biomarkers|biomarkers
1056791|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
1056792|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
1056793|NCT02808221|Heart failure|heart failure
1056794|NCT02808221|heart disease|heart disease
1056795|NCT02808221|left ventricular|left ventricular
1056796|NCT02808195|Cerebral Palsy|cerebral palsy
1056797|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
1056798|NCT02808195|Upper Extremity|upper extremity
1056799|NCT02808156|Cerebral Palsy,|cerebral palsy,
1056800|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
1056801|NCT02808156|Upper Extremity|upper extremity
1056802|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
1056803|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
1056804|NCT02808117|microfinance institution|microfinance institution
1056805|NCT02808117|MFI|mfi
1056806|NCT02808078|Instrumented treadmill|instrumented treadmill
1056807|NCT02808078|Augmented reality|augmented reality
1056808|NCT02808078|Neurorehabilitation|neurorehabilitation
1056809|NCT02808078|Gait disorders|gait disorders
1056810|NCT02808065|Kidney transplant|kidney transplant
1056811|NCT02808065|Kidney transplantation|kidney transplantation
1056812|NCT02808065|Renal transplant|renal transplant
1056813|NCT02808065|Renal transplantation|renal transplantation
1056814|NCT02808052|Bacterial infections|bacterial infections
1056815|NCT02808026|severe hypertension|severe hypertension
1056816|NCT02808026|grade III hypertension|grade iii hypertension
1056817|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1056818|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1056819|NCT02807987|Moderate renal impairment|moderate renal impairment
1056820|NCT02807987|Hypertension|hypertension
1056821|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
1056822|NCT02807974|Diabetic nephropathy|diabetic nephropathy
1056823|NCT02807974|Diabetic renal disease|diabetic renal disease
1056824|NCT02807974|Albuminuria|albuminuria
1056825|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1056826|NCT02807961|Translational read through|translational read through
1056827|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
1056828|NCT02807922|Palliative Care|palliative care
1056829|NCT02807922|zopiclone|zopiclone
1056830|NCT02807896|biomarker|biomarker
1056831|NCT02807896|pancreatic cancer|pancreatic cancer
1056832|NCT02807896|bile duct cancer|bile duct cancer
1056833|NCT02807896|miRNA|mirna
1056834|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1056835|NCT02807883|ALL|all
1056836|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
1056837|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
1056838|NCT02807883|Blinatumomab|blinatumomab
1056839|NCT02807883|Blincyto|blincyto
1056946|NCT02807454|Multiple Myeloma|multiple myeloma
1056840|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
1056841|NCT02807870|Parental training|parental training
1056842|NCT02807870|Preschool age|preschool age
1056843|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
1056844|NCT02807857|low-interventional observational study,|low-interventional observational study,
1056845|NCT02807857|CHF,|chf,
1056846|NCT02807857|heart failure,|heart failure,
1056847|NCT02807857|primary care,|primary care,
1056848|NCT02807857|ESC guidelines,|esc guidelines,
1056849|NCT02807857|Europe,|europe,
1056850|NCT02807857|NT-proBNP,|nt-probnp,
1056851|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
1056852|NCT02807844|Triple negative breast cancer|triple negative breast cancer
1056853|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
1056854|NCT02807844|Melanoma|melanoma
1056855|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
1056856|NCT02807844|Immuno oncology|immuno oncology
1056857|NCT02807844|Monoclonal antibody|monoclonal antibody
1056858|NCT02807844|PDR001|pdr001
1056859|NCT02807844|MCS110|mcs110
1056860|NCT02807831|Executive Function|executive function
1056861|NCT02807831|Language|language
1056862|NCT02807831|Preschool child|preschool child
1056863|NCT02807831|Development|development
1056864|NCT02807818|Child development|child development
1056865|NCT02807818|Infant|infant
1056866|NCT02807818|Mother-Child Relations|mother-child relations
1056867|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
1056868|NCT02807792|Perianal surgery|perianal surgery
1056869|NCT02807779|angioplasty|angioplasty
1056870|NCT02807779|peripheral artery disease|peripheral artery disease
1056871|NCT02807779|peripheral vascular disease|peripheral vascular disease
1056872|NCT02807779|atherosclerosis|atherosclerosis
1056873|NCT02807779|balloon angioplasty|balloon angioplasty
1056874|NCT02807779|dexamethasone|dexamethasone
1056875|NCT02807779|drug coated balloon|drug coated balloon
1056876|NCT02807779|paclitaxel|paclitaxel
1056877|NCT02807779|walking|walking
1056878|NCT02807779|claudication|claudication
1056879|NCT02807766|autism|autism
1056880|NCT02807766|Brain Plasticity|brain plasticity
1056881|NCT02807766|Behavioral Intervention|behavioral intervention
1056882|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
1056883|NCT02807753|Hemophilia|hemophilia
1056884|NCT02807753|Arthropathy|arthropathy
1056885|NCT02807753|Pediatric|pediatric
1056886|NCT02807740|Virtual Reality|virtual reality
1056887|NCT02807740|Rehabilitation|rehabilitation
1056888|NCT02807740|Cardiocirculatory system|cardiocirculatory system
1056889|NCT02807740|Parkinson Disease|parkinson disease
1056890|NCT02807688|health promotion|health promotion
1056891|NCT02807688|lifestyles|lifestyles
1056892|NCT02807688|physical comorbidity|physical comorbidity
1056893|NCT02807688|risk factors|risk factors
1056894|NCT02807688|behavioural change|behavioural change
1056895|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
1056896|NCT02807662|prenatal care|prenatal care
1056897|NCT02807636|Urothelial carcinoma|urothelial carcinoma
1056898|NCT02807636|Bladder cancer|bladder cancer
1056899|NCT02807636|Anti-PD-L1|anti-pd-l1
1056900|NCT02807636|Transitional carcinoma|transitional carcinoma
1056901|NCT02807636|Tecentriq|tecentriq
1056902|NCT02807636|Atezolizumab|atezolizumab
1056903|NCT02807636|IMvigor130|imvigor130
1056904|NCT02807610|Etomidate lipuro|etomidate lipuro
1056905|NCT02807610|Induction characteristics|induction characteristics
1056906|NCT02807584|Wound|wound
1056907|NCT02807584|burns|burns
1056908|NCT02807584|acute|acute
1056909|NCT02807584|chronic|chronic
1056910|NCT02807584|foam|foam
1056911|NCT02807584|adhesive|adhesive
1056912|NCT02807584|dressing|dressing
1056913|NCT02807571|Hand|hand
1056914|NCT02807558|AML|aml
1056915|NCT02807558|MDS|mds
1056916|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
1056917|NCT02807545|Schroth|schroth
1056918|NCT02807519|Oral health|oral health
1056919|NCT02807519|Saliva|saliva
1056920|NCT02807519|Biomarker|biomarker
1056921|NCT02807519|Cytokines|cytokines
1056922|NCT02807519|Cancer|cancer
1056923|NCT02807519|children|children
1056924|NCT02807506|elders|elders
1056925|NCT02807506|robotics|robotics
1056926|NCT02807506|low income population|low income population
1056927|NCT02807506|activities of daily living|activities of daily living
1056928|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
1056929|NCT02807506|social robotics|social robotics
1056930|NCT02807506|stroke|stroke
1056931|NCT02807506|aged|aged
1056932|NCT02807506|Retirement|retirement
1056933|NCT02807506|Housing for elderly|housing for elderly
1056934|NCT02807506|Homes for the aged|homes for the aged
1056935|NCT02807493|Pregnancy|pregnancy
1056936|NCT02807493|Labor and Delivery|labor and delivery
1056937|NCT02807493|Occlusal Support Device|occlusal support device
1056938|NCT02807467|reduction|reduction
1056939|NCT02807467|delirium|delirium
1056940|NCT02807467|duration|duration
1056941|NCT02807467|severity|severity
1056942|NCT02807454|Phase 2|phase 2
1056943|NCT02807454|Open-Label|open-label
1056947|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
1056948|NCT02807454|FUSION MM-003|fusion mm-003
1056949|NCT02807454|PD-L1|pd-l1
1056950|NCT02807441|Bleeding|bleeding
1056951|NCT02807441|Aspirin|aspirin
1056952|NCT02807441|Spine|spine
1056953|NCT02807441|Surgery|surgery
1056954|NCT02807428|post-surgical pain|post-surgical pain
1056955|NCT02807428|total knee arthroplasty|total knee arthroplasty
1094340|NCT02583880|ICU|icu
1056956|NCT02807428|total knee replacement|total knee replacement
1056957|NCT02807415|cystic fibrosis|cystic fibrosis
1056958|NCT02807415|CFTR|cftr
1056959|NCT02807415|CFTR modulation|cftr modulation
1056960|NCT02807415|sweat test|sweat test
1056961|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
1056962|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
1056963|NCT02807402|Ombitasvir|ombitasvir
1056964|NCT02807402|Dasabuvir|dasabuvir
1056965|NCT02807402|Paritaprevir|paritaprevir
1056966|NCT02807402|HCV|hcv
1056967|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
1056968|NCT02807363|endometriosis|endometriosis
1056969|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
1056970|NCT02807363|healthy volunteers|healthy volunteers
1056971|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
1056972|NCT02807350|Intermittent Exotropia|intermittent exotropia
1056973|NCT02807350|IXT|ixt
1056974|NCT02807350|overminus|overminus
1056975|NCT02807337|Oral mucositis|oral mucositis
1056976|NCT02807311|Malnutrition|malnutrition
1056977|NCT02807311|Undernutrition|undernutrition
1056978|NCT02807311|lung transplantation|lung transplantation
1056979|NCT02807311|artificial nutrition|artificial nutrition
1056980|NCT02807311|nutritional supplements|nutritional supplements
1056981|NCT02807311|enteral nutrition|enteral nutrition
1056982|NCT02807298|Intarligamentary|intarligamentary
1056983|NCT02807298|Articaine|articaine
1056984|NCT02807298|Lidocaine|lidocaine
1056985|NCT02807246|Probiotic|probiotic
1056986|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
1056987|NCT02807220|Imuneks|imuneks
1057091|NCT02806544|Breast neoplasms|breast neoplasms
1056988|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
1056989|NCT02807155|Transitional Care|transitional care
1056990|NCT02807155|Young Adult|young adult
1056991|NCT02807155|Guided Imagery|guided imagery
1056992|NCT02807116|Drug-Interaction Study|drug-interaction study
1056993|NCT02807103|Rituximab|rituximab
1056994|NCT02807103|remission induction|remission induction
1056995|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
1056996|NCT02807090|Low Back Pain|low back pain
1056997|NCT02807090|Exercise|exercise
1056998|NCT02807090|Dance Therapy|dance therapy
1056999|NCT02807090|Physical Therapy|physical therapy
1057000|NCT02807077|Healthy subjects|healthy subjects
1057001|NCT02807038|Respiratory Function Tests|respiratory function tests
1057002|NCT02807038|Air pollution|air pollution
1057003|NCT02807038|Pregnancy|pregnancy
1057004|NCT02807038|Spirometry|spirometry
1057005|NCT02807012|Home care services|home care services
1057006|NCT02807012|Nursing|nursing
1057007|NCT02807012|Clinical trial|clinical trial
1057008|NCT02807012|Geriatric nursing|geriatric nursing
1057009|NCT02807012|Family caregiver|family caregiver
1057010|NCT02807012|Aged|aged
1057011|NCT02806999|Heart disease|heart disease
1057012|NCT02806999|Postoperative period|postoperative period
1057013|NCT02806999|Hyperglycemia|hyperglycemia
1057014|NCT02806999|Berberine|berberine
1057015|NCT02806999|Insulin|insulin
1057016|NCT02806999|Clinical trials as topic|clinical trials as topic
1057017|NCT02806947|Acute GVHD|acute gvhd
1057018|NCT02806947|Standard-Risk|standard-risk
1057019|NCT02806947|Sirolimus|sirolimus
1057020|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
1057021|NCT02806947|Ann Arbor|ann arbor
1057022|NCT02806947|Biomarker|biomarker
1057023|NCT02806947|Steroid-Free|steroid-free
1057024|NCT02806921|Scleral Contact Lens|scleral contact lens
1057025|NCT02806921|Tear Proteases|tear proteases
1057026|NCT02806921|Tear Cytokines|tear cytokines
1057027|NCT02806908|Driving|driving
1057028|NCT02806895|Driving|driving
1057029|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
1057030|NCT02806856|tDCS|tdcs
1057031|NCT02806856|Acute|acute
1057032|NCT02806843|stroke|stroke
1057033|NCT02806843|hemiplegia|hemiplegia
1057034|NCT02806843|healthy|healthy
1057035|NCT02806843|robotics|robotics
1057036|NCT02806843|rehabilitation|rehabilitation
1057037|NCT02806843|therapy|therapy
1057038|NCT02806830|Intravitreal injection|intravitreal injection
1057039|NCT02806830|AMD|amd
1057040|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
1057041|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
1057042|NCT02806830|Myopia, Degenerative|myopia, degenerative
1057043|NCT02806830|eye drops|eye drops
1057044|NCT02806804|vaccine|vaccine
1057045|NCT02806804|safety|safety
1057046|NCT02806804|immunogenicity|immunogenicity
1057047|NCT02806791|Patients|patients
1057048|NCT02806778|cardiac arrest|cardiac arrest
1057049|NCT02806778|jugular venous oximetry|jugular venous oximetry
1057050|NCT02806778|hypoxic brain injury|hypoxic brain injury
1057051|NCT02806765|Dynamic Stability|dynamic stability
1057052|NCT02806765|Postural Stability|postural stability
1057053|NCT02806765|Gait Speed|gait speed
1730738|NCT00004728|stroke|stroke
1057054|NCT02806765|Hand Grip Strength|hand grip strength
1057055|NCT02806765|Timed Get-up and Go|timed get-up and go
1057056|NCT02806765|Older Adults|older adults
1057057|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1057058|NCT02806739|Soy protein|soy protein
1057059|NCT02806739|isoflavones|isoflavones
1057060|NCT02806739|gestational diabetes|gestational diabetes
1057061|NCT02806700|Diabetes|diabetes
1057062|NCT02806700|Social Media|social media
1057063|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
1057064|NCT02806687|gene therapy|gene therapy
1057065|NCT02806687|gemcitabine|gemcitabine
1057066|NCT02806687|chemosensitization|chemosensitization
1057067|NCT02806674|Helicobacter pylori|helicobacter pylori
1057068|NCT02806674|Antibiotic resistance|antibiotic resistance
1057069|NCT02806674|Sequencing|sequencing
1057070|NCT02806661|Robotic surgery|robotic surgery
1057071|NCT02806661|Vagus nerve preserving|vagus nerve preserving
1057072|NCT02806635|Relationship Distress|relationship distress
1057073|NCT02806635|Relationship Satisfaction|relationship satisfaction
1057074|NCT02806635|Marriage|marriage
1057075|NCT02806635|Web-based|web-based
1057076|NCT02806635|Internet|internet
1057077|NCT02806622|Sports|sports
1057078|NCT02806622|University|university
1057079|NCT02806622|Lower Extremity|lower extremity
1057080|NCT02806622|Hip Joint|hip joint
1057081|NCT02806609|football|football
1057082|NCT02806609|cryotherapy|cryotherapy
1057083|NCT02806609|balance|balance
1057084|NCT02806609|electromyography|electromyography
1057085|NCT02806557|Neoplasms|neoplasms
1057086|NCT02806557|Neutropenia|neutropenia
1057087|NCT02806557|drug therapy|drug therapy
1057088|NCT02806557|Hematologic tests|hematologic tests
1057089|NCT02806557|Point-of-care Systems|point-of-care systems
1057090|NCT02806557|Febrile neutropenia|febrile neutropenia
1057295|NCT02805140|sedentary|sedentary
1057092|NCT02806544|Breast cancer|breast cancer
1057093|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
1057094|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
1057095|NCT02806544|Tamoxifen|tamoxifen
1057096|NCT02806544|Low and middle income country|low and middle income country
1057097|NCT02806531|vaccine|vaccine
1057098|NCT02806531|safety|safety
1057099|NCT02806518|DIEP|diep
1057100|NCT02806518|Computed Tomography|computed tomography
1057101|NCT02806518|Doppler|doppler
1057102|NCT02806518|Thermography|thermography
1057103|NCT02806440|Low dose naltrexone|low dose naltrexone
1057104|NCT02806440|Pain|pain
1057105|NCT02806375|Myelofibrosis|myelofibrosis
1057106|NCT02806375|Ruxolitinib|ruxolitinib
1057107|NCT02806375|Cyclophosphamide|cyclophosphamide
1057108|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
1057109|NCT02806375|Immune System Diseases|immune system diseases
1057110|NCT02806375|Busulfan|busulfan
1057111|NCT02806375|Fludarabine|fludarabine
1057112|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1057113|NCT02806375|Myeloablative Agonists|myeloablative agonists
1057114|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1057115|NCT02806375|Allogeneic|allogeneic
1057116|NCT02806362|Non-cirrhotic|non-cirrhotic
1057117|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1057118|NCT02806362|moderate fibrosis|moderate fibrosis
1057119|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
1057120|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
1057121|NCT02806349|American ginseng|american ginseng
1057122|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
1057123|NCT02806336|exercise training|exercise training
1057124|NCT02806336|assistive device|assistive device
1057125|NCT02806336|weight loss|weight loss
1057126|NCT02806336|function|function
1057127|NCT02806336|mobility|mobility
1057128|NCT02806310|Aortic Valve|aortic valve
1057129|NCT02806310|Bicuspid|bicuspid
1057130|NCT02806297|cholecystectomy|cholecystectomy
1057131|NCT02806284|vaccination|vaccination
1057132|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
1057133|NCT02806271|Worry Postponement|worry postponement
1057134|NCT02806271|Stimulus Control|stimulus control
1057135|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
1057136|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1057137|NCT02806245|Cardiac Index|cardiac index
1057138|NCT02806245|Hemodynamics|hemodynamics
1057139|NCT02806245|Pediatrics|pediatrics
1057140|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
1057141|NCT02806232|Biltricide|biltricide
1057142|NCT02806219|Bioequivalence|bioequivalence
1057143|NCT02806219|Certolizumab pegol|certolizumab pegol
1057144|NCT02806219|Human Volunteers|human volunteers
1057145|NCT02806193|cardiovascular|cardiovascular
1057146|NCT02806193|cardiac|cardiac
1057147|NCT02806193|MRI|mri
1057151|NCT02806193|magnetic resonance|magnetic resonance
1057152|NCT02806193|imaging|imaging
1057153|NCT02806154|Cancer|cancer
1057154|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
1057155|NCT02806154|Elderly patients|elderly patients
1057156|NCT02806154|DEXA|dexa
1057157|NCT02806154|muscle mass|muscle mass
1057158|NCT02806141|Aerosolized colistin|aerosolized colistin
1057159|NCT02806141|Intravenous colistin|intravenous colistin
1057160|NCT02806128|cerebral infarction|cerebral infarction
1057161|NCT02806128|kallikrein|kallikrein
1057162|NCT02806128|KLK|klk
1057163|NCT02806089|chronic kidney disease|chronic kidney disease
1057164|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
1057165|NCT02806089|muscle strength|muscle strength
1057166|NCT02806089|muscle mass|muscle mass
1057167|NCT02806089|lean body mass|lean body mass
1057168|NCT02806089|physical activity|physical activity
1057169|NCT02806076|HCC|hcc
1057170|NCT02806076|RFA|rfa
1057171|NCT02806063|Prosthesis|prosthesis
1057172|NCT02806063|joint infection|joint infection
1057173|NCT02806063|perioperative samples|perioperative samples
1057174|NCT02806050|FES PET|fes pet
1057175|NCT02806050|Palbociclib|palbociclib
1057176|NCT02805985|Degenerative Disc Disease|degenerative disc disease
1057177|NCT02805985|Spondylolisthesis|spondylolisthesis
1057178|NCT02805985|Retrolisthesis|retrolisthesis
1057179|NCT02805972|Obesity|obesity
1057180|NCT02805972|Binge eating|binge eating
1057181|NCT02805868|Severe|severe
1057182|NCT02805868|Anemia|anemia
1057183|NCT02805868|Aplastic|aplastic
1057184|NCT02805868|Post-Polycythemic|post-polycythemic
1057185|NCT02805868|Transformation|transformation
1057186|NCT02805868|Thrombocythemia|thrombocythemia
1057187|NCT02805868|Essential|essential
1057188|NCT02805842|non adherence|non adherence
1057189|NCT02805842|Tacrolimus|tacrolimus
1057190|NCT02805842|Advagraf|advagraf
1057191|NCT02805829|NK cells|nk cells
1057192|NCT02805829|Trastuzumab|trastuzumab
1057193|NCT02805816|Celiac disease|celiac disease
1057194|NCT02805816|Tissue transglutaminase|tissue transglutaminase
1057195|NCT02805816|Histology|histology
1057196|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
1057197|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
1057198|NCT02805790|Elamipretide|elamipretide
1057199|NCT02805790|MTP-131|mtp-131
1057200|NCT02805790|Bendavia™|bendavia™
1057201|NCT02805764|obstructive sleep apnea|obstructive sleep apnea
1057202|NCT02805764|malocclusion|malocclusion
1057203|NCT02805764|polysomnography|polysomnography
1057204|NCT02805764|quality of life|quality of life
1057205|NCT02805751|Achilles|achilles
1057206|NCT02805751|Tendon|tendon
1057207|NCT02805751|Loading|loading
1057208|NCT02805751|Rehabilitation|rehabilitation
1057209|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
1057210|NCT02805738|tenofovir|tenofovir
1057211|NCT02805738|CKD-390|ckd-390
1057212|NCT02805725|Advanced solid tumor|advanced solid tumor
1057213|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
1057214|NCT02805725|Phase I/II trial|phase i/ii trial
1057215|NCT02805725|Dose escalation|dose escalation
1057216|NCT02805725|PK study|pk study
1057217|NCT02805712|Heart Failure|heart failure
1057218|NCT02805712|Palliative Care|palliative care
1057219|NCT02805699|Clinical Efficacy|clinical efficacy
1057220|NCT02805699|Baofeikang Granules|baofeikang granules
1057221|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
1057222|NCT02805686|Toxicity, Drug|toxicity, drug
1057223|NCT02805673|Osteopathy|osteopathy
1057224|NCT02805673|Support|support
1057225|NCT02805673|Treatment|treatment
1057226|NCT02805673|Pain|pain
1057227|NCT02805673|Quality of Life|quality of life
1057228|NCT02805660|MGCD0103|mgcd0103
1057229|NCT02805660|MEDI4736|medi4736
1057230|NCT02805660|Mocetinostat|mocetinostat
1057231|NCT02805660|Durvalumab|durvalumab
1057232|NCT02805660|HDAC Inhibitor|hdac inhibitor
1057233|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
1057234|NCT02805660|Phase 1|phase 1
1057235|NCT02805660|Phase 2|phase 2
1057236|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
1057237|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
1057238|NCT02805660|immunotherapy|immunotherapy
1057239|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
1057240|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
1057241|NCT02805634|nine holes peg|nine holes peg
1057242|NCT02805634|triple stimulation|triple stimulation
1057243|NCT02805634|multiple sclerosis|multiple sclerosis
1057244|NCT02805582|Peripheral Nerve Block|peripheral nerve block
1057245|NCT02805569|videolaryngoscope|videolaryngoscope
1057246|NCT02805569|intubation stylet|intubation stylet
1057247|NCT02805569|articulating stylet|articulating stylet
1057248|NCT02805569|difficult airway|difficult airway
1057249|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
1057250|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1057251|NCT02805517|Transplant Donors|transplant donors
1057252|NCT02805504|Bupivacaine|bupivacaine
1094882|NCT02580552|CTCL|ctcl
1057253|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1057254|NCT02805491|Hypospadias|hypospadias
1057255|NCT02805491|newborns|newborns
1094649|NCT02581839|CNS|cns
1057256|NCT02805491|pesticide|pesticide
1057257|NCT02805491|Picardie|picardie
1057258|NCT02805465|Heart Failure|heart failure
1057259|NCT02805465|Atrial Fibrillation|atrial fibrillation
1057260|NCT02805465|CRT|crt
1057261|NCT02805465|BiVP|bivp
1057262|NCT02805465|HBP|hbp
1057263|NCT02805387|labor dystocia|labor dystocia
1057264|NCT02805374|Pharmacokinetics|pharmacokinetics
1057265|NCT02805374|ASP1517|asp1517
1057266|NCT02805374|Food effect|food effect
1057267|NCT02805348|Kiklin|kiklin
1057268|NCT02805348|Bixalomer|bixalomer
1057269|NCT02805348|Chronic Kidney Disease|chronic kidney disease
1057270|NCT02805335|Central Venous Catheter|central venous catheter
1057271|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
1057272|NCT02805335|Economic evaluation|economic evaluation
1057273|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1057274|NCT02805309|Exercise|exercise
1057275|NCT02805309|Frailty|frailty
1057276|NCT02805309|Functional Outcomes|functional outcomes
1057277|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
1057278|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1057279|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
1057280|NCT02805244|JTZ-951|jtz-951
1057281|NCT02805244|Pharmacokinetics|pharmacokinetics
1057282|NCT02805244|14C-JTZ-951|14c-jtz-951
1057283|NCT02805244|Mass balance|mass balance
1057284|NCT02805244|Time course|time course
1057285|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
1057286|NCT02805192|Emergency Department|emergency department
1057287|NCT02805192|Estimation of age and weight|estimation of age and weight
1057288|NCT02805192|Size measurement|size measurement
1057289|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
1057290|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
1057291|NCT02805140|mother|mother
1057292|NCT02805140|social support|social support
1057293|NCT02805140|mobile app|mobile app
1057294|NCT02805140|videoconference|videoconference
1057296|NCT02805140|physical activity|physical activity
1057297|NCT02805127|Asthma|asthma
1057298|NCT02805127|COPD|copd
1057299|NCT02805127|Capnography|capnography
1057300|NCT02805114|Asthma|asthma
1057301|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1057302|NCT02805114|Capnography|capnography
1057303|NCT02805062|Trapped Lung|trapped lung
1057304|NCT02805036|alveolar recruitment|alveolar recruitment
1057305|NCT02805036|stroke volume/physiology|stroke volume/physiology
1057306|NCT02805036|cardiac output/physiology|cardiac output/physiology
1057307|NCT02804997|non-invasive ventilation|non-invasive ventilation
1057308|NCT02804997|cardiac surgery|cardiac surgery
1057309|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
1057310|NCT02804984|molecular defects|molecular defects
1057311|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1057312|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1057313|NCT02804958|Clinical outcomes|clinical outcomes
1057314|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
1057315|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
1057316|NCT02804945|ARDS|ards
1057317|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
1057318|NCT02804945|hMSCs|hmscs
1057319|NCT02804945|Placebo|placebo
1057320|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
1057321|NCT02804945|Standard of Care|standard of care
1057322|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
1057323|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
1057324|NCT02804880|Smoking cessation|smoking cessation
1057325|NCT02804880|Quit to Win|quit to win
1057326|NCT02804880|Brief intervention|brief intervention
1057327|NCT02804880|Personalized active referral|personalized active referral
1057328|NCT02804880|Instant messaging|instant messaging
1057329|NCT02804880|SMS|sms
1057330|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
1057331|NCT02804841|Vitamin D supplementation|vitamin d supplementation
1057332|NCT02804841|Cognitive function|cognitive function
1057333|NCT02804841|Physical function|physical function
1057334|NCT02804841|Successful ageing|successful ageing
1057335|NCT02804841|Prevention|prevention
1057336|NCT02804841|Cholecalciferol|cholecalciferol
1057337|NCT02804841|Dementia|dementia
1057338|NCT02804841|Muscle mass|muscle mass
1057339|NCT02804815|Aspirin|aspirin
1057340|NCT02804815|prostate|prostate
1057341|NCT02804815|colorectal|colorectal
1057342|NCT02804815|breast|breast
1057343|NCT02804815|gastro-oesophageal|gastro-oesophageal
1057344|NCT02804815|recurrence|recurrence
1057345|NCT02804789|Prevention|prevention
1057346|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1057347|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
1057348|NCT02804750|Cushing's Syndrome|cushing's syndrome
1057349|NCT02804750|Cushing's Disease|cushing's disease
1057350|NCT02804750|Cushings|cushings
1057351|NCT02804750|Hypercortisolemia|hypercortisolemia
1057352|NCT02804750|Cushingoid|cushingoid
1057353|NCT02804750|Type 2 Diabetes|type 2 diabetes
1057354|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
1057355|NCT02804750|Hypertension|hypertension
1057356|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
1057357|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
1057358|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
1057359|NCT02804750|Moon Facies|moon facies
1057360|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
1057361|NCT02804750|Adrenal Adenoma|adrenal adenoma
1057362|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
1057363|NCT02804750|Adrenal Autonomy|adrenal autonomy
1057364|NCT02804750|Cortisol|cortisol
1057365|NCT02804724|HIV|hiv
1057366|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
1057367|NCT02804724|Late diagnosis|late diagnosis
1057368|NCT02804672|Cardiovascular health|cardiovascular health
1057369|NCT02804672|Diet|diet
1057370|NCT02804672|Functional limitations|functional limitations
1057371|NCT02804672|Frailty|frailty
1057372|NCT02804672|Older adults|older adults
1057373|NCT02804659|micro-RNA|micro-rna
1057374|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
1057375|NCT02804646|Durative transfusion|durative transfusion
1057376|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
1057377|NCT02804633|IV acetaminophen|iv acetaminophen
1057378|NCT02804633|Colorectal Surgery|colorectal surgery
1057379|NCT02804633|Enhance Recovery|enhance recovery
1057380|NCT02804633|Opioid Consumption|opioid consumption
1057381|NCT02804633|Pain Management|pain management
1057382|NCT02804607|burn|burn
1057383|NCT02804607|child|child
1057384|NCT02804607|graft|graft
1057385|NCT02804607|development|development
1057386|NCT02804607|complications|complications
1057387|NCT02804607|autonomy|autonomy
1057388|NCT02804568|Schizophrenia|schizophrenia
1057389|NCT02804568|Alkermes|alkermes
1057390|NCT02804568|ALK 3831|alk 3831
1057391|NCT02804568|Samidorphan|samidorphan
1057392|NCT02804555|reactive oxygen species|reactive oxygen species
1057393|NCT02804555|elective cesarean section|elective cesarean section
1057394|NCT02804555|oxygen therapy|oxygen therapy
1057395|NCT02804555|newborn|newborn
1057396|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
1057397|NCT02804529|Laparoscopic entry|laparoscopic entry
1057398|NCT02804529|Meng's point|meng's point
1057399|NCT02804529|Veress needle|veress needle
1057400|NCT02804477|adherence|adherence
1057401|NCT02804477|opioid|opioid
1057402|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
1057403|NCT02804477|validation|validation
1057404|NCT02804425|Medical Education|medical education
1057405|NCT02804425|Simulation|simulation
1057406|NCT02804425|Anesthesia crisis management|anesthesia crisis management
1057407|NCT02804425|Learning outcomes|learning outcomes
1057408|NCT02804412|communication disorders|communication disorders
1057409|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
1057410|NCT02804412|stroke|stroke
1057411|NCT02804399|rifampin|rifampin
1057412|NCT02804399|pharmacokinetics|pharmacokinetics
1057413|NCT02804399|PF-06463922|pf-06463922
1057414|NCT02804399|drug interaction|drug interaction
1057415|NCT02804386|HCV|hcv
1057416|NCT02804386|safety|safety
1057417|NCT02804386|efficacy|efficacy
1057418|NCT02804386|EVR|evr
1057419|NCT02804386|SVR|svr
1057420|NCT02804373|oxytocin|oxytocin
1057421|NCT02804373|adults|adults
1057422|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
1057423|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
1057424|NCT02804347|Theta Burst Stimulation|theta burst stimulation
1057425|NCT02804321|catheter ablation|catheter ablation
1057426|NCT02804321|galectin 3|galectin 3
1057427|NCT02804321|ngal|ngal
1057428|NCT02804321|aldosterone|aldosterone
1057429|NCT02804321|atrial fibrillation|atrial fibrillation
1057430|NCT02804308|Combined Training|combined training
1057431|NCT02804308|Breast Cancer|breast cancer
1057432|NCT02804308|Body Composition|body composition
1057433|NCT02804308|Postmenopausal Women|postmenopausal women
1057434|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
1057435|NCT02804308|Quality of life|quality of life
1057436|NCT02804295|Prescription Drug|prescription drug
1057437|NCT02804295|Misuse|misuse
1057438|NCT02804269|Healthy Volunteer|healthy volunteer
1057439|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
1057440|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1057441|NCT02804269|ischemic heart disease|ischemic heart disease
1057442|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
1057443|NCT02804243|nasal high flow therapy|nasal high flow therapy
1057444|NCT02804243|rehabilitation|rehabilitation
1057445|NCT02804243|exercise endurance|exercise endurance
1057446|NCT02804178|ATR-101|atr-101
1057447|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
1057448|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
1057449|NCT02804178|CAH|cah
1057450|NCT02804165|Type 1 diabetes|type 1 diabetes
1057451|NCT02804165|Enterovirus|enterovirus
1057452|NCT02804165|Genetics|genetics
1057453|NCT02804165|Gene-Virus interaction|gene-virus interaction
1057454|NCT02804152|pregnancy|pregnancy
1057455|NCT02804152|pain|pain
1057456|NCT02804152|prescription opioid|prescription opioid
1057457|NCT02804139|Cesarean Section|cesarean section
1057458|NCT02804139|Postpartum issues|postpartum issues
1057459|NCT02804126|acute pain|acute pain
1057460|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
1057461|NCT02804126|quadratus lumborum block|quadratus lumborum block
1057462|NCT02804126|neuropathic pain|neuropathic pain
1057463|NCT02804100|Circulating Tumor DNA|circulating tumor dna
1057464|NCT02804100|Lung cancer|lung cancer
1057465|NCT02804100|Plasma DNA|plasma dna
1057466|NCT02804061|nutrition|nutrition
1057467|NCT02804061|exercise|exercise
1057468|NCT02804061|behavior change|behavior change
1057469|NCT02804061|adherence|adherence
1057470|NCT02804048|Dyspareunia|dyspareunia
1057471|NCT02804048|Pelvic floor muscles|pelvic floor muscles
1057472|NCT02804048|Women|women
1057473|NCT02804022|Respiratory Depression|respiratory depression
1057474|NCT02804009|anxiety|anxiety
1057475|NCT02804009|coronary angiography|coronary angiography
1057476|NCT02803957|Degenerative|degenerative
1057477|NCT02803957|Mitral Regurgitation|mitral regurgitation
1057478|NCT02803944|azithromycin|azithromycin
1057479|NCT02803944|cystic fibrosis|cystic fibrosis
1057480|NCT02803944|pulmonary function|pulmonary function
1057481|NCT02803931|Cardiogoniometry|cardiogoniometry
1057482|NCT02803931|Electrocardiography|electrocardiography
1057483|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
1057484|NCT02803879|cardiogoniometry|cardiogoniometry
1057485|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
1057486|NCT02803866|Parent training program|parent training program
1057487|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
1057488|NCT02803853|Native American|native american
1057489|NCT02803853|Obesity|obesity
1057490|NCT02803853|Multi level|multi level
1057491|NCT02803853|Policy|policy
1057498|NCT02803827|diarrhoea|diarrhoea
1057499|NCT02803827|gastroenteritis|gastroenteritis
1057500|NCT02803827|rapid diagnostics|rapid diagnostics
1057501|NCT02803827|probiotics|probiotics
1057502|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
1057503|NCT02803814|Pancreatic tumors|pancreatic tumors
1057504|NCT02803814|Periampullary tumors|periampullary tumors
1057505|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
1057506|NCT02803801|Parent perception of competence|parent perception of competence
1057507|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
1057508|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
1057509|NCT02803762|ADME|adme
1057510|NCT02803762|Pacritinib|pacritinib
1057511|NCT02803671|preterm neonates|preterm neonates
1057512|NCT02803671|EEG-NIRS|eeg-nirs
1057513|NCT02803658|smoking|smoking
1057514|NCT02803645|healthy subjects|healthy subjects
1057515|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
1057516|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
1057517|NCT02803645|markers of oxidative stress|markers of oxidative stress
1057518|NCT02803632|young|young
1057519|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
1057520|NCT02803632|actigraphic profile|actigraphic profile
1057521|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
1057522|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
1057523|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
1057524|NCT02803606|hypothermia|hypothermia
1057525|NCT02803606|routine care|routine care
1057526|NCT02803606|preterm neonates|preterm neonates
1057527|NCT02803593|a technology-based intervention|a technology-based intervention
1057528|NCT02803593|Asian American|asian american
1057529|NCT02803593|survivorship|survivorship
1057530|NCT02803541|chronic kidney disease|chronic kidney disease
1057531|NCT02803541|exercise|exercise
1057532|NCT02803541|pediatrics|pediatrics
1057533|NCT02803541|summer camp|summer camp
1057534|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
1057535|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
1057536|NCT02803515|ovarian cancer|ovarian cancer
1057537|NCT02803502|thrombin generation test|thrombin generation test
1057538|NCT02803502|factor VIII|factor viii
1057539|NCT02803502|hemophilia|hemophilia
1057540|NCT02803489|chronic heart failure|chronic heart failure
1057541|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1057542|NCT02803489|diabetes|diabetes
1057543|NCT02803476|PCO|pco
1057544|NCT02803476|Vitamin D|vitamin d
1057545|NCT02803476|Insulin resistance|insulin resistance
1057546|NCT02803463|peritoneal closure|peritoneal closure
1057547|NCT02803463|appendectomy|appendectomy
1731476|NCT00001955|TMJ|tmj
1057548|NCT02803463|postoperative pain|postoperative pain
1057549|NCT02803463|life quality|life quality
1057550|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
1057551|NCT02803450|spinal and epidural|spinal and epidural
1057552|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
1057553|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
1057554|NCT02803424|Autoflow|autoflow
1057555|NCT02803424|trendelenburg position|trendelenburg position
1057556|NCT02803424|pneumoperitoneum|pneumoperitoneum
1057561|NCT02803398|Compression bandages|compression bandages
1057562|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
1057563|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
1057564|NCT02803372|partial nephrectomy|partial nephrectomy
1057565|NCT02803372|acute kidney injury|acute kidney injury
1057566|NCT02803372|LiDCOrapid|lidcorapid
1057567|NCT02803372|circulatory management|circulatory management
1057568|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
1057569|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
1057570|NCT02803359|brainstem activity|brainstem activity
1057571|NCT02803346|sepsis|sepsis
1057572|NCT02803346|septic shock|septic shock
1057573|NCT02803346|immunosuppression|immunosuppression
1057574|NCT02803346|HLA-DR|hla-dr
1057575|NCT02803346|lymphopenia|lymphopenia
1057576|NCT02803333|NSCLC|nsclc
1057577|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1057578|NCT02803333|Lung Diseases|lung diseases
1057579|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
1057580|NCT02803320|Sunscreen active|sunscreen active
1057581|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
1057582|NCT02803307|TLC599|tlc599
1057583|NCT02803307|Dexamethasone|dexamethasone
1057585|NCT02803255|Injuries|injuries
1057586|NCT02803255|Spinal Cord|spinal cord
1057587|NCT02803242|copd|copd
1057588|NCT02803242|emphysema|emphysema
1057589|NCT02803242|bronchitis|bronchitis
1057590|NCT02803242|bronchiectasis|bronchiectasis
1057591|NCT02803203|Osimertinib|osimertinib
1057592|NCT02803203|bevacizumab|bevacizumab
1057593|NCT02803203|metastatic|metastatic
1057594|NCT02803203|16-033|16-033
1057595|NCT02803190|Spine curve|spine curve
1057596|NCT02803190|Posture|posture
1057597|NCT02803190|Fracture|fracture
1057598|NCT02803190|sarcopenia|sarcopenia
1057599|NCT02803190|Exercise|exercise
1057600|NCT02803177|large bone defect|large bone defect
1057601|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
1057602|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1057603|NCT02803151|Lymph node metastasis|lymph node metastasis
1057604|NCT02803151|T cell immunity|t cell immunity
1057605|NCT02803151|cell-free DNA|cell-free dna
1057606|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
1057607|NCT02803138|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
1057608|NCT02803138|Sustained Virological Response|sustained virological response
1057609|NCT02803138|Observational Study|observational study
1057610|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
1057611|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
1057612|NCT02803125|PTSD|ptsd
1057613|NCT02803125|Aging|aging
1057614|NCT02803125|Veteran|veteran
1057615|NCT02803125|Intervention|intervention
1057616|NCT02803086|Prostate cancer|prostate cancer
1057617|NCT02803086|Radiotherapy|radiotherapy
1057618|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
1057619|NCT02803086|Radiotoxicity|radiotoxicity
1057620|NCT02802982|Thrombocytopenia|thrombocytopenia
1057621|NCT02802982|Neonates|neonates
1057622|NCT02802956|Life participation|life participation
1057623|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
1057624|NCT02802917|Eye stinging potential|eye stinging potential
1057625|NCT02802904|Healthy subjects|healthy subjects
1057626|NCT02802891|Asthma|asthma
1057627|NCT02802891|Allergy|allergy
1057628|NCT02802891|Diagnosis|diagnosis
1057629|NCT02802891|Endocrine disruptors|endocrine disruptors
1057630|NCT02802891|Children|children
1057631|NCT02802839|Virtual Reality|virtual reality
1057632|NCT02802839|venipuncture|venipuncture
1057633|NCT02802826|Exercise|exercise
1057634|NCT02802826|Chemotherapy|chemotherapy
1057635|NCT02802826|Physical Activity|physical activity
1057636|NCT02802826|Breast Cancer|breast cancer
1057637|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
1057638|NCT02802813|Primaquine|primaquine
1057639|NCT02802787|Quality of life|quality of life
1057640|NCT02802787|Occupation|occupation
1057641|NCT02802787|Pain|pain
1057642|NCT02802787|Fatigue|fatigue
1057643|NCT02802774|Post-operative treatment|post-operative treatment
1057644|NCT02802748|Early Breast Cancer|early breast cancer
1057645|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
1057646|NCT02802748|Window-of-opportunity|window-of-opportunity
1057647|NCT02802748|PAM50|pam50
1057648|NCT02802748|Luminal A|luminal a
1057649|NCT02802748|Luminal B|luminal b
1057650|NCT02802748|proliferation signature|proliferation signature
1057651|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
1057652|NCT02802748|letrozole|letrozole
1057653|NCT02802735|Pharmacokinetics|pharmacokinetics
1057654|NCT02802735|Apremilast|apremilast
1057655|NCT02802735|Healthy Adult Male|healthy adult male
1057656|NCT02802735|Korean Subjects|korean subjects
1057657|NCT02802722|convalescence|convalescence
1057658|NCT02802722|inflammation|inflammation
1057659|NCT02802722|resolution|resolution
1057660|NCT02802722|vitamin D|vitamin d
1057661|NCT02802709|knee|knee
1057662|NCT02802696|Transfusion|transfusion
1057663|NCT02802696|Transfusion Medicine|transfusion medicine
1057664|NCT02802696|Diuretic|diuretic
1057665|NCT02802683|Hypotension|hypotension
1057666|NCT02802683|cesarean section|cesarean section
1057667|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
1057668|NCT02802657|Conbercept|conbercept
1057669|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
1057670|NCT02802657|Pro Re Nata|pro re nata
1057671|NCT02802631|Bacterial infections|bacterial infections
1057672|NCT02802618|Validity|validity
1057673|NCT02802618|Reliability|reliability
1057674|NCT02802618|Rehabilitation|rehabilitation
1057675|NCT02802618|Translation|translation
1057676|NCT02802618|Education|education
1057677|NCT02802579|obesity|obesity
1057678|NCT02802579|dual source CT|dual source ct
1057679|NCT02802579|coronary CT angiography|coronary ct angiography
1057680|NCT02802579|prognosis|prognosis
1057681|NCT02802579|bariatric surgery|bariatric surgery
1057682|NCT02802579|gastric bypass surgery|gastric bypass surgery
1057683|NCT02802579|coronary arterial disease|coronary arterial disease
1057684|NCT02802579|major adverse coronary event|major adverse coronary event
1057685|NCT02802566|Maternal Obesity|maternal obesity
1057686|NCT02802566|Inflammation|inflammation
1057687|NCT02802553|SmartGoggles|smartgoggles
1057790|NCT02802085|Knee Joint|knee joint
1057688|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
1057689|NCT02802553|indocyanine green|indocyanine green
1057690|NCT02802553|Cardio-Green|cardio-green
1057691|NCT02802553|Spy Elite|spy elite
1057692|NCT02802540|nabilone|nabilone
1057693|NCT02802540|anorexia|anorexia
1057694|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
1057695|NCT02802514|Gastrointestinal|gastrointestinal
1057696|NCT02802514|Glucagon like peptide|glucagon like peptide
1057697|NCT02802514|Nausea|nausea
1057698|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
1057699|NCT02802501|Safety|safety
1057700|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
1057701|NCT02802501|Efficacy|efficacy
1057702|NCT02802501|Tafenoquine|tafenoquine
1057703|NCT02802501|Superiority|superiority
1057704|NCT02802501|Primaquine|primaquine
1057705|NCT02802501|Radical cure|radical cure
1057706|NCT02802501|Vivax|vivax
1057707|NCT02802501|ACT|act
1057708|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
1057709|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1057710|NCT02802488|D-dimers|d-dimers
1057711|NCT02802488|Atrial fibrillation|atrial fibrillation
1057712|NCT02802475|antibodies|antibodies
1057713|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
1057714|NCT02802475|epilepsy|epilepsy
1057715|NCT02802475|limbic encephalitis|limbic encephalitis
1057716|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
1057717|NCT02802462|hemodynamic|hemodynamic
1057718|NCT02802462|Exercise|exercise
1057719|NCT02802462|HIIT|hiit
1057720|NCT02802449|Vitamin D|vitamin d
1057721|NCT02802449|Hypovitaminosis D|hypovitaminosis d
1057722|NCT02802449|HTN|htn
1057723|NCT02802423|TNBC|tnbc
1057724|NCT02802423|Breast cancer|breast cancer
1057725|NCT02802423|Triple negative|triple negative
1057726|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
1057727|NCT02802384|Paget's Disease of Bone|paget's disease of bone
1057728|NCT02802384|Healthy controls|healthy controls
1057729|NCT02802371|caregiver burden|caregiver burden
1057730|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
1057731|NCT02802371|elderly|elderly
1057732|NCT02802371|pharmaceutical care|pharmaceutical care
1057733|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
1057734|NCT02802371|psychosocial intervention|psychosocial intervention
1057735|NCT02802358|Falls|falls
1057736|NCT02802358|Functionality|functionality
1057737|NCT02802332|neonatal|neonatal
1057738|NCT02802332|preterm|preterm
1057739|NCT02802332|Nepal|nepal
1057740|NCT02802332|family-initiated identification|family-initiated identification
1057741|NCT02802332|basic newborn care|basic newborn care
1057742|NCT02802306|Angioplasty|angioplasty
1057743|NCT02802306|Peripheral Artery Disease|peripheral artery disease
1057744|NCT02802306|PAD|pad
1057745|NCT02802306|Lesion|lesion
1057746|NCT02802306|Claudication|claudication
1057747|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1057748|NCT02802293|Major Depressive Disorder|major depressive disorder
1057749|NCT02802280|endothelial dysfunction|endothelial dysfunction
1057750|NCT02802254|physical activity|physical activity
1057751|NCT02802254|patient feedback|patient feedback
1057752|NCT02802254|risk perception|risk perception
1057753|NCT02802254|pedometer|pedometer
1057754|NCT02802215|Diabetes Mellitus|diabetes mellitus
1057755|NCT02802215|Pregnancy|pregnancy
1057756|NCT02802202|Palpation|palpation
1057757|NCT02802202|Chronic Pain|chronic pain
1057758|NCT02802202|Muscle|muscle
1057759|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
1057760|NCT02802189|exercise|exercise
1057761|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
1057762|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
1057763|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
1057764|NCT02802163|transplant eligible|transplant eligible
1057765|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
1057766|NCT02802150|soy bean oil|soy bean oil
1057767|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
1057768|NCT02802150|dry eye disease|dry eye disease
1057769|NCT02802137|tafluprost|tafluprost
1057770|NCT02802137|dorzolamide|dorzolamide
1057771|NCT02802137|timolol|timolol
1057772|NCT02802137|FC|fc
1057773|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
1057774|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
1057775|NCT02802124|toxicity|toxicity
1057776|NCT02802124|efficacy|efficacy
1057777|NCT02802111|Beta Agonists|beta agonists
1057778|NCT02802111|Asthma|asthma
1057779|NCT02802111|Albuterol|albuterol
1057780|NCT02802111|Levalbuterol|levalbuterol
1057781|NCT02802098|Metastatic breast cancer|metastatic breast cancer
1057782|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
1057783|NCT02802098|Durvalumab|durvalumab
1057784|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
1057785|NCT02802085|Total Knee Replacement|total knee replacement
1057786|NCT02802085|TKA|tka
1057787|NCT02802085|TKR|tkr
1057788|NCT02802085|Stiffness of Knee|stiffness of knee
1057789|NCT02802085|Deformity|deformity
1057791|NCT02802085|Instability|instability
1057792|NCT02802085|Post-traumatic|post-traumatic
1057793|NCT02802085|Arthrosis|arthrosis
1057794|NCT02802046|FFRCT|ffrct
1057795|NCT02802046|Angina pectoris grade|angina pectoris grade
1057796|NCT02802046|Fractional flow reserve|fractional flow reserve
1057797|NCT02802046|CCTA|ccta
1057798|NCT02802033|Registry|registry
1057799|NCT02802033|Spine|spine
1057800|NCT02802033|Osteobiologics|osteobiologics
1057801|NCT02802033|Spinal Fusion|spinal fusion
1057802|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
1057803|NCT02801994|Inspiratory muscles|inspiratory muscles
1057804|NCT02801994|Electromyogram|electromyogram
1057805|NCT02801994|Mechanical ventilation|mechanical ventilation
1057806|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
1057807|NCT02801981|tolerability|tolerability
1057808|NCT02801981|healthy volunteers|healthy volunteers
1057809|NCT02801981|Cholestasis|cholestasis
1057810|NCT02801981|safety|safety
1057811|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
1057812|NCT02801955|tumor markers|tumor markers
1057813|NCT02801955|peritoneal cytology|peritoneal cytology
1057814|NCT02801942|Biomarker|biomarker
1057815|NCT02801942|Immune Profile|immune profile
1057816|NCT02801942|Biopsy|biopsy
1057817|NCT02801942|Leukocyte subsets|leukocyte subsets
1057818|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
1057819|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1057820|NCT02801916|Humans|humans
1057821|NCT02801916|Glycemic response|glycemic response
1057822|NCT02801916|Oat beta-glucan|oat beta-glucan
1057823|NCT02801877|Depression|depression
1057824|NCT02801877|Anxiety|anxiety
1057825|NCT02801877|Behavior Therapy|behavior therapy
1057826|NCT02801877|Technology Assisted|technology assisted
1057827|NCT02801877|Mobile Phone|mobile phone
1057828|NCT02801877|Cellular Phone|cellular phone
1057829|NCT02801877|Smartphone|smartphone
1057831|NCT02801877|Coach|coach
1057832|NCT02801864|tDCS|tdcs
1057833|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
1057834|NCT02801864|intensive speech therapy|intensive speech therapy
1057835|NCT02801864|chronic|chronic
1057836|NCT02801864|post stroke|post stroke
1057837|NCT02801864|aphasia|aphasia
1057838|NCT02801864|production|production
1057839|NCT02801864|language|language
1057840|NCT02801851|Delirium|delirium
1057841|NCT02801838|Inspiratory muscles|inspiratory muscles
1057842|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
1057843|NCT02801838|Electromyogram|electromyogram
1057844|NCT02801838|Mechanical ventilation|mechanical ventilation
1057845|NCT02801825|axillay artery|axillay artery
1057846|NCT02801825|cannulation|cannulation
1057847|NCT02801825|femoral artery|femoral artery
1057848|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
1057849|NCT02801799|Anaesthesia|anaesthesia
1057850|NCT02801799|Analgesia|analgesia
1057851|NCT02801799|Nerve blocks|nerve blocks
1057852|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
1057853|NCT02801799|Regional anaesthesia|regional anaesthesia
1057854|NCT02801799|therapeutic techniques|therapeutic techniques
1057855|NCT02801799|ropivacaine|ropivacaine
1057856|NCT02801799|nerve block duration|nerve block duration
1057857|NCT02801799|lower limb|lower limb
1057858|NCT02801799|Postoperative pain|postoperative pain
1057859|NCT02801786|Mammography|mammography
1057860|NCT02801786|Premedication|premedication
1057861|NCT02801786|Pain|pain
1057862|NCT02801786|Discomfort|discomfort
1057866|NCT02801773|non- surgical treatment|non- surgical treatment
1057867|NCT02801760|HIV|hiv
1057868|NCT02801760|Self-Consent|self-consent
1057869|NCT02801760|PrEP|prep
1057870|NCT02801760|Autonomous Research Consent|autonomous research consent
1057871|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
1057872|NCT02801747|HIV care continuum|hiv care continuum
1057873|NCT02801747|antiretroviral therapy|antiretroviral therapy
1057874|NCT02801747|engagement in HIV care|engagement in hiv care
1057875|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
1057876|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
1057877|NCT02801708|Atrial fibrillation|atrial fibrillation
1057878|NCT02801695|pre-eclampsia|pre-eclampsia
1057879|NCT02801695|citrulline|citrulline
1057880|NCT02801695|pregnancy|pregnancy
1057881|NCT02801669|anticoagulants|anticoagulants
1057882|NCT02801669|DU-176b|du-176b
1057883|NCT02801669|edoxaban|edoxaban
1057884|NCT02801669|factor Xa|factor xa
1057885|NCT02801669|oral|oral
1057886|NCT02801669|prevention|prevention
1057887|NCT02801669|atrial fibrillation|atrial fibrillation
1057888|NCT02801643|PET|pet
1057889|NCT02801643|dopamine|dopamine
1057890|NCT02801643|fMRI|fmri
1057891|NCT02801643|reward|reward
1057892|NCT02801617|Latanoprost|latanoprost
1057893|NCT02801617|Glaucoma|glaucoma
1057894|NCT02801617|Ocular hypertension|ocular hypertension
1057895|NCT02801617|Crossover study|crossover study
1057896|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1057897|NCT02801578|CLL|cll
1057898|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
1057899|NCT02801578|Ibrutinib|ibrutinib
1057900|NCT02801578|PCI-32765|pci-32765
1057901|NCT02801578|Imbruvica|imbruvica
1057902|NCT02801578|Pharmacodynamics|pharmacodynamics
1057903|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
1057904|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
1057905|NCT02801552|Immature permanent tooth|immature permanent tooth
1057906|NCT02801552|apical periodontitis|apical periodontitis
1057907|NCT02801513|mindfulness|mindfulness
1057908|NCT02801513|EEG|eeg
1057909|NCT02801513|error-related negativity|error-related negativity
1057910|NCT02801513|late positive potential|late positive potential
1057911|NCT02801513|long-range temporal correlations|long-range temporal correlations
1057912|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
1057913|NCT02801487|Carbon Ion Therapy|carbon ion therapy
1057914|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1057915|NCT02801435|EGFR inhibitor|egfr inhibitor
1057916|NCT02801435|topical agent|topical agent
1057917|NCT02801435|psoriasis|psoriasis
1057918|NCT02801435|phase 1|phase 1
1057919|NCT02801422|cannabis|cannabis
1057920|NCT02801422|fMRI|fmri
1057921|NCT02801422|addiction|addiction
1057922|NCT02801422|relapse|relapse
1057923|NCT02801409|Lung Cancer|lung cancer
1057924|NCT02801409|Surgical Resection|surgical resection
1057925|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
1057926|NCT02801409|Long-Term Outcome|long-term outcome
1057927|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
1057928|NCT02801357|opiate addiction|opiate addiction
1057929|NCT02801357|opiate dependence|opiate dependence
1057930|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
1057931|NCT02801357|buprenorphine|buprenorphine
1057932|NCT02801344|exercise|exercise
1057933|NCT02801344|performance|performance
1057934|NCT02801344|recovery|recovery
1057935|NCT02801344|muscle|muscle
1057936|NCT02801344|protein|protein
1057937|NCT02801331|Stochastic Resonance|stochastic resonance
1057938|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
1057939|NCT02801331|Drug Withdrawal|drug withdrawal
1057940|NCT02801331|Substance Abuse|substance abuse
1057941|NCT02801318|Patient|patient
1057942|NCT02801305|Scleroderma|scleroderma
1057943|NCT02801305|Diltiazem|diltiazem
1057944|NCT02801305|Nitroglycerin|nitroglycerin
1057945|NCT02801305|Topical|topical
1057946|NCT02801279|Cerebral Palsy|cerebral palsy
1057947|NCT02801279|Occupational Therapy|occupational therapy
1057948|NCT02801279|Upper Limb Motor Training|upper limb motor training
1057949|NCT02801266|Contraception|contraception
1057950|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
1057951|NCT02801266|Counseling|counseling
1057952|NCT02801266|Contraceptive Counseling|contraceptive counseling
1057953|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
1731477|NCT00001955|TMD|tmd
1057954|NCT02801227|premature rupture of membrane|premature rupture of membrane
1057955|NCT02801227|primipara|primipara
1057956|NCT02801227|term|term
1057957|NCT02801227|bishop|bishop
1057958|NCT02801214|cannabis|cannabis
1057959|NCT02801214|fMRI|fmri
1057960|NCT02801214|emotion|emotion
1057961|NCT02801201|sedation|sedation
1057962|NCT02801201|spinal anesthesia|spinal anesthesia
1057963|NCT02801162|arterial blood gas|arterial blood gas
1057964|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
1057965|NCT02801123|Psychosocial Oncology|psychosocial oncology
1058744|NCT02797067|Prophylaxis|prophylaxis
1057966|NCT02801123|Behavioural Medicine|behavioural medicine
1057967|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
1057968|NCT02801123|Tai Chi|tai chi
1057969|NCT02801123|Qigong|qigong
1057970|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1057971|NCT02801123|Yoga|yoga
1057972|NCT02801123|Preference-based trial|preference-based trial
1057973|NCT02801084|Reduced|reduced
1057974|NCT02801084|Environmental|environmental
1057975|NCT02801084|Stimulation|stimulation
1057976|NCT02801071|Post-Polio Syndrome|post-polio syndrome
1057977|NCT02801071|PPS|pps
1057978|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
1057979|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
1057980|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
1057981|NCT02800980|lymphocele|lymphocele
1057982|NCT02800980|sclerotherapy|sclerotherapy
1057983|NCT02800980|drainage|drainage
1057984|NCT02800980|percutaneous|percutaneous
1057985|NCT02800967|platelet activation|platelet activation
1057986|NCT02800967|platelet aggregation|platelet aggregation
1057987|NCT02800967|Aronia|aronia
1057988|NCT02800967|flow cytometry|flow cytometry
1057989|NCT02800967|polyphenols|polyphenols
1057990|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
1057991|NCT02800954|Multiple Myeloma|multiple myeloma
1057992|NCT02800954|bone lesions|bone lesions
1057993|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
1057994|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
1057995|NCT02800941|Oral anticoagulants|oral anticoagulants
1058485|NCT02798354|Thyrotropin|thyrotropin
1057996|NCT02800941|Major bleedings|major bleedings
1057997|NCT02800915|Spinal Cord Injury|spinal cord injury
1057998|NCT02800915|Pressure Ulcer|pressure ulcer
1057999|NCT02800915|Health Related Quality of Life|health related quality of life
1058000|NCT02800915|Telemedicine|telemedicine
1058001|NCT02800915|Service Innovation|service innovation
1058002|NCT02800915|Rehabilitation|rehabilitation
1058003|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
1058004|NCT02800915|User- participation|user- participation
1058005|NCT02800915|Activity and participation|activity and participation
1058006|NCT02800915|Health economics|health economics
1058007|NCT02800889|relapsed|relapsed
1058008|NCT02800889|refractory|refractory
1058009|NCT02800889|solid tumors|solid tumors
1058010|NCT02800850|Dementia|dementia
1058011|NCT02800850|Depression|depression
1058012|NCT02800850|Agitation|agitation
1058013|NCT02800850|Bright Light|bright light
1058014|NCT02800837|left main|left main
1058015|NCT02800837|stent|stent
1058016|NCT02800837|self-expandable|self-expandable
1058017|NCT02800837|DES|des
1058018|NCT02800837|Stentys|stentys
1058019|NCT02800811|FR104|fr104
1058020|NCT02800811|CD28|cd28
1058021|NCT02800811|immunomodulation|immunomodulation
1058022|NCT02800811|T regulatory cell|t regulatory cell
1058023|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
1058024|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
1058025|NCT02800798|Preeclampsia|preeclampsia
1058026|NCT02800798|Pregnancy|pregnancy
1058027|NCT02800798|Stopbang|stopbang
1058028|NCT02800772|pancreatic duct|pancreatic duct
1058029|NCT02800772|ERCP|ercp
1058030|NCT02800772|acetic acid|acetic acid
1058031|NCT02800746|Prognathic surgery|prognathic surgery
1058032|NCT02800746|intravenous iron|intravenous iron
1058033|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
1058034|NCT02800681|Asperger Syndrome|asperger syndrome
1058035|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
1058036|NCT02800681|Schizotypal disorder|schizotypal disorder
1058037|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
1058038|NCT02800681|Psychopathology|psychopathology
1058039|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
1058040|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
1058041|NCT02800681|Phenomenology|phenomenology
1058042|NCT02800681|Differential diagnosis|differential diagnosis
1058043|NCT02800681|Young Adult|young adult
1058044|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
1058045|NCT02800668|obesity|obesity
1058046|NCT02800668|weight loss therapy|weight loss therapy
1058047|NCT02800655|ARV treatment Naive|arv treatment naive
1058048|NCT02800655|Medication Adherence|medication adherence
1058049|NCT02800655|Digital Health Feedback System|digital health feedback system
1058050|NCT02800655|Proteus Digital Health|proteus digital health
1058051|NCT02800642|Bayer|bayer
1058052|NCT02800642|Aflibercept|aflibercept
1058053|NCT02800642|Eylea|eylea
1058054|NCT02800642|Intravitreal|intravitreal
1058055|NCT02800616|Academic Achievement|academic achievement
1058056|NCT02800616|Accelerometry|accelerometry
1058057|NCT02800616|Children|children
1058058|NCT02800616|Primary school Intervention|primary school intervention
1058059|NCT02800616|Nutrition|nutrition
1058060|NCT02800616|Obesity|obesity
1058061|NCT02800616|Physical Activity|physical activity
1058062|NCT02800616|Prevention|prevention
1058063|NCT02800616|School Health|school health
1058064|NCT02800603|preschool mental health|preschool mental health
1058065|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
1058066|NCT02800590|Adult participants|adult participants
1058067|NCT02800590|Sedation|sedation
1058068|NCT02800590|elective|elective
1058069|NCT02800525|Benign pigmented lesions|benign pigmented lesions
1058070|NCT02800525|Picosecond laser|picosecond laser
1058071|NCT02800525|Q-switched laser|q-switched laser
1058072|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
1058073|NCT02800512|cystocele|cystocele
1058074|NCT02800512|rectocele|rectocele
1058075|NCT02800512|enterocele|enterocele
1058076|NCT02800473|Bladder cancer|bladder cancer
1058077|NCT02800473|Hexvix|hexvix
1058078|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
1058079|NCT02800473|Cystoscopy|cystoscopy
1058080|NCT02800460|Subthalamic nucleus|subthalamic nucleus
1058081|NCT02800460|Basal ganglia|basal ganglia
1058082|NCT02800460|Parkinson disease|parkinson disease
1058083|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
1058084|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
1058085|NCT02800434|allograft|allograft
1058086|NCT02800434|hands|hands
1058087|NCT02800434|immunosuppression|immunosuppression
1058088|NCT02800434|fMRI|fmri
1058089|NCT02800395|Alzheimer|alzheimer
1058090|NCT02800395|oxydative stress|oxydative stress
1058091|NCT02800395|nutrition|nutrition
1058092|NCT02800395|biomarkers|biomarkers
1058093|NCT02800382|paraoxonase|paraoxonase
1058094|NCT02800382|lung diseases|lung diseases
1058095|NCT02800369|Human papillomavirus|human papillomavirus
1058096|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1058097|NCT02800369|zinc finger nuclease|zinc finger nuclease
1058098|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
1058099|NCT02800356|Geographic Atrophy|geographic atrophy
1058100|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
1058101|NCT02800356|Lasers|lasers
1058102|NCT02800356|PASCAL 577|pascal 577
1058103|NCT02800304|malnutrition|malnutrition
1058104|NCT02800304|food intake|food intake
1058105|NCT02800304|frailty|frailty
1058106|NCT02800291|food intake|food intake
1058107|NCT02800265|healthy volunteer|healthy volunteer
1058108|NCT02800265|healthy|healthy
1058109|NCT02800265|cancer prevention|cancer prevention
1058110|NCT02800265|prevention|prevention
1058111|NCT02800252|fatty acids|fatty acids
1058112|NCT02800252|aspirin|aspirin
1058113|NCT02800252|diabetes mellitus|diabetes mellitus
1058114|NCT02800252|chronic periodontitis|chronic periodontitis
1058115|NCT02800252|periodontal debridement|periodontal debridement
1058116|NCT02800200|platelet rich plasma|platelet rich plasma
1058117|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
1058118|NCT02800122|acute dyspnea|acute dyspnea
1058119|NCT02800122|emergency|emergency
1058120|NCT02800122|acute heart failure|acute heart failure
1058121|NCT02800109|Fetal growth|fetal growth
1058122|NCT02800109|Newborn growth|newborn growth
1058123|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
1058124|NCT02800070|gene therapy|gene therapy
1058125|NCT02800070|Fabry disease|fabry disease
1058126|NCT02800070|lentivirus|lentivirus
1058127|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
1058128|NCT02800018|hypothermia therapy|hypothermia therapy
1058129|NCT02800018|perinatal asphyxia|perinatal asphyxia
1058130|NCT02800005|gastric cancer|gastric cancer
1058131|NCT02800005|gastrectomy|gastrectomy
1058132|NCT02800005|laparotomy|laparotomy
1058133|NCT02800005|surgical outcome|surgical outcome
1058134|NCT02800005|survival|survival
1058135|NCT02800005|abdominal fat area|abdominal fat area
1058136|NCT02800005|Body Mass Index|body mass index
1058137|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
1058138|NCT02799953|consumer health information technology|consumer health information technology
1058139|NCT02799953|self-monitoring|self-monitoring
1058140|NCT02799953|randomized controlled trial|randomized controlled trial
1058141|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
1058142|NCT02799927|Primary Teeth|primary teeth
1058143|NCT02799927|Biodentine|biodentine
1058144|NCT02799927|Calcium Hydroxide|calcium hydroxide
1058145|NCT02799927|Split-Mouth design|split-mouth design
1058146|NCT02799901|advanced melanoma|advanced melanoma
1058147|NCT02799901|high dose radiotherapy|high dose radiotherapy
1058148|NCT02799901|Nivolumab|nivolumab
1058149|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
1731791|NCT00001880|Engraftment|engraftment
1058150|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1058151|NCT02799888|Acute Leukemia|acute leukemia
1058152|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
1058153|NCT02799888|Lymphoma|lymphoma
1058154|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
1058155|NCT02799875|permissive hypercapnia|permissive hypercapnia
1058156|NCT02799875|ventilator strategy|ventilator strategy
1058157|NCT02799862|metastatic|metastatic
1058158|NCT02799862|locally advanced|locally advanced
1058159|NCT02799862|unresectable|unresectable
1058160|NCT02799862|NSCLC|nsclc
1058161|NCT02799849|narcolepsy|narcolepsy
1058162|NCT02799849|metabolism|metabolism
1058163|NCT02799823|aortic stenosis|aortic stenosis
1058164|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1058165|NCT02799810|lung transplantation|lung transplantation
1058166|NCT02799810|psychosocial functioning|psychosocial functioning
1058167|NCT02799810|longitudinal|longitudinal
1058168|NCT02799810|TERS|ters
1058169|NCT02799810|adherence|adherence
1058170|NCT02799810|Quality of life|quality of life
1058171|NCT02799797|adductor canal block|adductor canal block
1058172|NCT02799784|tiotropium|tiotropium
1058173|NCT02799784|COPD|copd
1058174|NCT02799784|olodaterol|olodaterol
1058175|NCT02799784|Umeclidinium bromide|umeclidinium bromide
1058176|NCT02799784|efficacy|efficacy
1058177|NCT02799784|vilanterol|vilanterol
1058178|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
1058179|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
1058180|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
1058181|NCT02799745|Pathological Cancer Progression|pathological cancer progression
1058182|NCT02799745|Enzalutamide|enzalutamide
1058183|NCT02799745|Prostate Cancer|prostate cancer
1058184|NCT02799745|Active surveillance|active surveillance
1058185|NCT02799732|Feasibility Study|feasibility study
1058186|NCT02799732|HPV vaccine|hpv vaccine
1058187|NCT02799732|1Dose Trial|1dose trial
1058188|NCT02799719|Fat mass|fat mass
1058189|NCT02799719|hemodialysis patients|hemodialysis patients
1058190|NCT02799719|inflammation|inflammation
1058191|NCT02799719|adipocytokines|adipocytokines
1058192|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
1058193|NCT02799706|Prostate cancer|prostate cancer
1058194|NCT02799706|GnRH antagonist|gnrh antagonist
1058195|NCT02799706|GnRH agonist|gnrh agonist
1058196|NCT02799706|radiation therapy|radiation therapy
1058197|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
1058198|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
1058199|NCT02799693|Catheter Ablation|catheter ablation
1058200|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
1058201|NCT02799693|Intramural Needle Catheter|intramural needle catheter
1058202|NCT02799680|CART|cart
1058203|NCT02799680|AML|aml
1058204|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
1058205|NCT02799667|cesarean delivery|cesarean delivery
1058206|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
1058207|NCT02799641|Contraception|contraception
1058208|NCT02799641|IUD|iud
1058209|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
1058210|NCT02799641|lidocaine|lidocaine
1058211|NCT02799641|valium|valium
1058212|NCT02799641|diazepam|diazepam
1058213|NCT02799641|pain|pain
1058214|NCT02799641|VAS|vas
1058215|NCT02799641|visual analog scale|visual analog scale
1058216|NCT02799628|Trust|trust
1058217|NCT02799628|Low Back Pain|low back pain
1058218|NCT02799628|Treatment Outcome|treatment outcome
1058219|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
1058220|NCT02799576|Ultrasound|ultrasound
1058221|NCT02799576|Regional blockade|regional blockade
1058222|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
1058223|NCT02799550|CART|cart
1058224|NCT02799550|ALL|all
1058225|NCT02799550|elderly|elderly
1058226|NCT02799550|Relapsed|relapsed
1058227|NCT02799550|Refractory|refractory
1058228|NCT02799550|CD19+|cd19+
1058229|NCT02799511|biological markers|biological markers
1058230|NCT02799498|etanercept|etanercept
1058231|NCT02799498|healthy subject|healthy subject
1058232|NCT02799498|open-label|open-label
1058233|NCT02799498|randomized|randomized
1058234|NCT02799498|PK|pk
1058235|NCT02799498|auto-injection|auto-injection
1058236|NCT02799498|pharmacokinetic|pharmacokinetic
1058237|NCT02799472|GSK3196165|gsk3196165
1058238|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1058239|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
1058240|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
1058241|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
1058242|NCT02799472|Methotrexate|methotrexate
1058243|NCT02799459|Hypnoanesthesia|hypnoanesthesia
1058244|NCT02799459|Hypnosis|hypnosis
1058245|NCT02799459|conization|conization
1058246|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
1058247|NCT02799433|Water|water
1058248|NCT02799433|Physical activity|physical activity
1058249|NCT02799433|Child care|child care
1058250|NCT02799433|Weight change|weight change
1058251|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
1058252|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
1058253|NCT02799420|target biopsy|target biopsy
1058254|NCT02799381|carbidopa|carbidopa
1058255|NCT02799381|levodopa|levodopa
1058256|NCT02799381|efficacy|efficacy
1058257|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1058258|NCT02799381|Advanced Parkinson's Disease|advanced parkinson's disease
1058259|NCT02799303|screening|screening
1058260|NCT02799303|biopsy|biopsy
1058261|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
1058262|NCT02799303|prostate specific antigen|prostate specific antigen
1058263|NCT02799264|fasted|fasted
1058264|NCT02799264|healthy volunteers|healthy volunteers
1058265|NCT02799264|cabotegravir|cabotegravir
1058266|NCT02799264|high fat|high fat
1058267|NCT02799264|pharmacokinetics|pharmacokinetics
1058268|NCT02799264|randomized|randomized
1058269|NCT02799264|Phase I|phase i
1058270|NCT02799264|two way crossover|two way crossover
1058271|NCT02799251|lymphopenia|lymphopenia
1058272|NCT02799251|postoperative infection|postoperative infection
1058273|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
1058274|NCT02799251|digestive cancer surgery|digestive cancer surgery
1058275|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
1058276|NCT02799225|carbapenems|carbapenems
1058277|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
1058278|NCT02799212|Hepatectomy|hepatectomy
1058279|NCT02799212|Ascites|ascites
1058280|NCT02799212|Somatostatin|somatostatin
1058281|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
1058282|NCT02799186|haematoma|haematoma
1058283|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
1058284|NCT02799186|genetic analysis|genetic analysis
1058285|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
1058286|NCT02799173|cardiovascular calcification|cardiovascular calcification
1058287|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
1058288|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
1060673|NCT02786173|PVD|pvd
1058289|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
1058290|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
1058291|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
1058292|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1058293|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
1058294|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
1058295|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
1058296|NCT02799147|Immune System Diseases|immune system diseases
1058297|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
1058298|NCT02799147|Myeloablative Agonists|myeloablative agonists
1058299|NCT02799147|Busulfan|busulfan
1058300|NCT02799147|Fludarabine|fludarabine
1058301|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1058302|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
1058303|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
1058304|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
1058305|NCT02799134|high-order cognition|high-order cognition
1058306|NCT02799134|social cognition|social cognition
1058307|NCT02799108|children|children
1058308|NCT02799108|language|language
1058309|NCT02799108|NIRS|nirs
1058310|NCT02799095|Immunotherapy|immunotherapy
1058311|NCT02799095|IL-2|il-2
1058312|NCT02799095|Interleukin-2|interleukin-2
1058313|NCT02799095|Solid tumors|solid tumors
1058314|NCT02799056|Airway Extubation|airway extubation
1058315|NCT02799056|Ultrasonography|ultrasonography
1058316|NCT02799056|Ventilator Weaning|ventilator weaning
1058317|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
1058318|NCT02799017|Aphasia|aphasia
1058319|NCT02799017|Reading|reading
1058320|NCT02799017|Writing|writing
1058321|NCT02799017|Naming|naming
1058322|NCT02799017|Language|language
1058323|NCT02799017|Chronic post stroke|chronic post stroke
1058324|NCT02799017|Phonology|phonology
1058325|NCT02799017|Semantic Feature Analysis|semantic feature analysis
1058326|NCT02799017|Recovery|recovery
1058327|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
1058328|NCT02798978|pharmacokinetics|pharmacokinetics
1058329|NCT02798978|TLR4 agonist|tlr4 agonist
1058330|NCT02798978|cancer|cancer
1058331|NCT02798978|tolerability|tolerability
1058332|NCT02798978|GSK1795091|gsk1795091
1058333|NCT02798978|pharmacodynamics|pharmacodynamics
1058334|NCT02798978|safety|safety
1058335|NCT02798965|parvovirus genome|parvovirus genome
1058336|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
1058337|NCT02798952|Safety|safety
1058338|NCT02798952|Challenge dose|challenge dose
1058339|NCT02798952|Persistence|persistence
1058340|NCT02798952|Engerix B Kinder|engerix b kinder
1058341|NCT02798952|Infanrix hexa|infanrix hexa
1058342|NCT02798952|Immunogenicity|immunogenicity
1058343|NCT02798952|Adolescents|adolescents
1058344|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
1058345|NCT02798939|lactoferrin|lactoferrin
1058346|NCT02798939|procalcitonin|procalcitonin
1058347|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
1058348|NCT02798926|hypothermia|hypothermia
1058349|NCT02798926|central venous catheter placement|central venous catheter placement
1058350|NCT02798926|Polyethylene bag|polyethylene bag
1058351|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
1058944|NCT02796209|atomoxetine|atomoxetine
1058352|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
1058353|NCT02798900|Task-specific exercise|task-specific exercise
1058354|NCT02798900|Ultrasonic Waves|ultrasonic waves
1058355|NCT02798900|Biomechanics|biomechanics
1058356|NCT02798900|Gait|gait
1058357|NCT02798900|Rehabilitation|rehabilitation
1058358|NCT02798900|Exercise therapy|exercise therapy
1058359|NCT02798887|Regeneration|regeneration
1058360|NCT02798887|Bone regeneration|bone regeneration
1058361|NCT02798887|Grafting, Bone|grafting, bone
1058362|NCT02798887|Allograft|allograft
1058363|NCT02798887|Xenograft|xenograft
1058364|NCT02798874|Ticagrelor|ticagrelor
1058365|NCT02798874|No-reflow|no-reflow
1058366|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
1058367|NCT02798874|Reperfusion injury|reperfusion injury
1058368|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
1058369|NCT02798796|breast cancer|breast cancer
1058370|NCT02798796|conservative surgery|conservative surgery
1058371|NCT02798796|MRI|mri
1058372|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
1058373|NCT02798783|SLC26A4|slc26a4
1058374|NCT02798783|FOXI1|foxi1
1058375|NCT02798783|Temporal Bone|temporal bone
1058376|NCT02798731|Heart transplant|heart transplant
1058377|NCT02798731|Microvascular dysfunction|microvascular dysfunction
1058378|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
1058379|NCT02798731|Fractional flow reserve|fractional flow reserve
1058380|NCT02798731|Coronary flow reserve|coronary flow reserve
1058381|NCT02798731|Index of microvascular resistance|index of microvascular resistance
1058382|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
1058383|NCT02798705|Fractional flow reserve|fractional flow reserve
1060774|NCT02785484|Tobacco use|tobacco use
1058384|NCT02798705|Microvascular dysfunction|microvascular dysfunction
1058385|NCT02798705|Coronary flow reserve|coronary flow reserve
1058386|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
1058387|NCT02798692|Prevention|prevention
1058388|NCT02798666|Physical fitness|physical fitness
1058389|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
1058390|NCT02798666|Insulin sensitivity|insulin sensitivity
1058391|NCT02798666|High intensity interval training|high intensity interval training
1058392|NCT02798666|Continuous exercise training|continuous exercise training
1058393|NCT02798601|Cerebral edema|cerebral edema
1058394|NCT02798601|Hypernatremia|hypernatremia
1058395|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
1058396|NCT02798601|Intracranial pressure|intracranial pressure
1058397|NCT02798601|Mannitol|mannitol
1058398|NCT02798601|Hypertonic saline|hypertonic saline
1058399|NCT02798601|Mortality|mortality
1058400|NCT02798588|coma|coma
1058401|NCT02798588|prognosis|prognosis
1058402|NCT02798588|comparative study|comparative study
1058403|NCT02798588|functional imaging|functional imaging
1058404|NCT02798588|PET-MRI|pet-mri
1058405|NCT02798588|electrophysiology|electrophysiology
1058406|NCT02798575|COPD|copd
1058407|NCT02798575|invasive ventilation|invasive ventilation
1058408|NCT02798575|exacerbation|exacerbation
1058409|NCT02798575|home care|home care
1058410|NCT02798575|mechanical ventilation|mechanical ventilation
1058411|NCT02798575|unsuccessful weaning|unsuccessful weaning
1058412|NCT02798575|ventilatory parameters|ventilatory parameters
1058413|NCT02798562|low dose CT|low dose ct
1058414|NCT02798562|contrast-enhanced|contrast-enhanced
1058415|NCT02798562|breast cancer screening|breast cancer screening
1058416|NCT02798562|computer tomography|computer tomography
1058417|NCT02798549|HBV|hbv
1058418|NCT02798549|liver|liver
1058419|NCT02798536|Immunotoxin|immunotoxin
1058420|NCT02798536|Mesothelin|mesothelin
1058421|NCT02798536|Targeted Therapy|targeted therapy
1058422|NCT02798523|Methylprednisolone|methylprednisolone
1058423|NCT02798523|Immunologic|immunologic
1058424|NCT02798523|Infusion|infusion
1058425|NCT02798523|Topical|topical
1058426|NCT02798523|Intravenous|intravenous
1058427|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
1058428|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
1058429|NCT02798510|Chemoradiotherapy|chemoradiotherapy
1058430|NCT02798497|PVL|pvl
1058431|NCT02798497|Pneumonias|pneumonias
1058432|NCT02798497|Staphylococcus aureus|staphylococcus aureus
1058433|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
1058434|NCT02798484|Breast cancer|breast cancer
1058435|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
1058436|NCT02798471|Pediatric|pediatric
1058437|NCT02798471|Venous thrombolism|venous thrombolism
1058438|NCT02798471|Pulmonary embolism|pulmonary embolism
1058439|NCT02798458|Fabry's Disease|fabry's disease
1058440|NCT02798458|Fabry|fabry
1058441|NCT02798445|venous ulcer|venous ulcer
1058443|NCT02798445|juxta cures|juxta cures
1058444|NCT02798445|foam|foam
1058445|NCT02798445|laser|laser
1058446|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
1058447|NCT02798432|Hybrid|hybrid
1058448|NCT02798432|Cemented|cemented
1058449|NCT02798432|Fixation|fixation
1058450|NCT02798406|brain|brain
1058451|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
1058452|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
1058453|NCT02798406|CNS|cns
1058454|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
1058455|NCT02798406|DNX-2401|dnx-2401
1058456|NCT02798406|pembrolizumab|pembrolizumab
1058457|NCT02798406|KEYTRUDA|keytruda
1058458|NCT02798406|MK-3475|mk-3475
1058459|NCT02798406|SCH 900475|sch 900475
1058460|NCT02798406|lambrolizumab|lambrolizumab
1058461|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
1058462|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
1058463|NCT02798406|Alcyone|alcyone
1058464|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
1058465|NCT02798406|AMC|amc
1058466|NCT02798406|cannula|cannula
1058467|NCT02798406|MEMS cannula|mems cannula
1058468|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
1058469|NCT02798406|Delta-24|delta-24
1058470|NCT02798406|Delta-24-RGD|delta-24-rgd
1058471|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
1058472|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
1058473|NCT02798406|immunotherapy|immunotherapy
1058474|NCT02798406|monoclonal antibody|monoclonal antibody
1058475|NCT02798406|KEYNOTE-192|keynote-192
1058476|NCT02798367|insomnia|insomnia
1058477|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
1058478|NCT02798367|melatonin|melatonin
1058479|NCT02798354|Depression|depression
1058480|NCT02798354|Blood Pressure|blood pressure
1058481|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
1058482|NCT02798354|Streptococcal Infections|streptococcal infections
1058483|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
1058484|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
1058486|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
1058487|NCT02798315|Sustained Virological Response|sustained virological response
1058488|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
1058489|NCT02798315|Observational Study|observational study
1058490|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
1058491|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
1058492|NCT02798276|Myocardial infarction|myocardial infarction
1058493|NCT02798276|Cardiac regeneration|cardiac regeneration
1058494|NCT02798276|Cardiac surgery|cardiac surgery
1058495|NCT02798250|Type 1 diabetes|type 1 diabetes
1058496|NCT02798250|Artificial pancreas|artificial pancreas
1058497|NCT02798250|Closed-loop system|closed-loop system
1058498|NCT02798250|Postprandial glucose control|postprandial glucose control
1058499|NCT02798250|Hypoglycemia|hypoglycemia
1058500|NCT02798250|Insulin|insulin
1058501|NCT02798250|Glucagon|glucagon
1058502|NCT02798237|exercise|exercise
1058503|NCT02798237|walking|walking
1058504|NCT02798237|health|health
1058505|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
1058506|NCT02798224|CRC Screening|crc screening
1058507|NCT02798224|Rectum|rectum
1058508|NCT02798224|Colon|colon
1058509|NCT02798224|Screening|screening
1058510|NCT02798224|Populations at Risk|populations at risk
1058511|NCT02798224|CRC|crc
1058512|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
1058513|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
1058514|NCT02798159|Sexual Dysfunction|sexual dysfunction
1058515|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
1058516|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
1058517|NCT02798159|Sildenafil|sildenafil
1058518|NCT02798146|in-vitro fertilization|in-vitro fertilization
1058519|NCT02798146|luteal phase|luteal phase
1058520|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
1058521|NCT02798081|social inclusion|social inclusion
1058522|NCT02798081|serious games|serious games
1058523|NCT02798081|Information and communication technologies|information and communication technologies
1058524|NCT02798068|Steroids|steroids
1058525|NCT02798068|Cardiac surgery|cardiac surgery
1058526|NCT02798068|Endothelial dysfunction|endothelial dysfunction
1058527|NCT02798068|Glycocalyx|glycocalyx
1058528|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
1058529|NCT02798029|Brain Metastases|brain metastases
1732021|NCT00001827|p53 Peptide|p53 peptide
1058530|NCT02798029|Parenchymal Brain Metastases|parenchymal brain metastases
1058531|NCT02798029|Oligometastatic brain metastases|oligometastatic brain metastases
1058532|NCT02798029|Frameless Fractionated Stereotactic Radiation Therapy|frameless fractionated stereotactic radiation therapy
1058533|NCT02798029|FFSRT|ffsrt
1058534|NCT02798003|Cachexia|cachexia
1058535|NCT02798003|Food reward|food reward
1058536|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
1058537|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
1058538|NCT02797990|[N02.360]|[n02.360]
1058539|NCT02797990|[C25.775.650]|[c25.775.650]
1058540|NCT02797990|[C25.775.793]|[c25.775.793]
1058541|NCT02797990|[C25.775.635]|[c25.775.635]
1058542|NCT02797990|[C25.775.675]|[c25.775.675]
1058543|NCT02797990|[C25.775.300]|[c25.775.300]
1058544|NCT02797990|[C25.775.467]|[c25.775.467]
1058545|NCT02797990|[C25.775.225]|[c25.775.225]
1058546|NCT02797990|[C25.775.100]|[c25.775.100]
1058547|NCT02797990|[C25.775]|[c25.775]
1058548|NCT02797977|Replication Stress|replication stress
1058549|NCT02797977|Advanced solid tumors|advanced solid tumors
1058550|NCT02797977|CCNE1|ccne1
1058551|NCT02797977|TP53|tp53
1058552|NCT02797977|BRCA1|brca1
1058553|NCT02797977|BRCA2|brca2
1058554|NCT02797977|MYC|myc
1058555|NCT02797977|RAD50|rad50
1058556|NCT02797977|Fanconi anemia|fanconi anemia
1058557|NCT02797977|Cell Cycle|cell cycle
1058558|NCT02797977|Urothelial carcinoma|urothelial carcinoma
1058559|NCT02797977|Small cell lung cancer|small cell lung cancer
1058560|NCT02797977|Soft tissue sarcoma|soft tissue sarcoma
1058561|NCT02797977|Cervical/anogenital cancer|cervical/anogenital cancer
1058562|NCT02797977|Phase 1|phase 1
1058563|NCT02797977|Phase 2|phase 2
1058564|NCT02797977|Dose escalation|dose escalation
1058565|NCT02797977|Chk1 inhibitor|chk1 inhibitor
1058566|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
1058567|NCT02797977|Synthetic lethality|synthetic lethality
1058568|NCT02797977|Next-Generation Sequencing|next-generation sequencing
1058569|NCT02797977|Genetic biomarkers|genetic biomarkers
1058570|NCT02797964|Replication stress|replication stress
1058571|NCT02797964|Advanced solid tumors|advanced solid tumors
1058572|NCT02797964|CCNE1|ccne1
1058573|NCT02797964|TP53|tp53
1058574|NCT02797964|BRCA1|brca1
1058575|NCT02797964|BRCA2|brca2
1058576|NCT02797964|MYC|myc
1058577|NCT02797964|RAD50|rad50
1058578|NCT02797964|Fanconi anemia|fanconi anemia
1058579|NCT02797964|Cell cycle|cell cycle
1058580|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
1058581|NCT02797964|Platinum-Resistant or Intolerant High Grade Serious Ovarian Cancer|platinum-resistant or intolerant high grade serious ovarian cancer
1058582|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1058681|NCT02797457|Medical economic evaluation|medical economic evaluation
1058583|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1058584|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1058585|NCT02797964|Squamous Cell Carcinoma of the Anus|squamous cell carcinoma of the anus
1058586|NCT02797964|Phase 1|phase 1
1058587|NCT02797964|Phase 2|phase 2
1058588|NCT02797964|Dose escalation|dose escalation
1058589|NCT02797964|Chk1 inhibitor|chk1 inhibitor
1058590|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
1058591|NCT02797964|Synthetic lethality|synthetic lethality
1058592|NCT02797964|Next-Generation Sequencing|next-generation sequencing
1058593|NCT02797964|Genetic biomarkers|genetic biomarkers
1058594|NCT02797951|cluster headache|cluster headache
1058595|NCT02797951|headache|headache
1058596|NCT02797951|brain diseases|brain diseases
1058597|NCT02797951|central nervous system diseases|central nervous system diseases
1058598|NCT02797951|headache disorders|headache disorders
1058599|NCT02797951|headache disorders, primary|headache disorders, primary
1058600|NCT02797951|nervous system diseases|nervous system diseases
1058601|NCT02797951|neurologic manifestations|neurologic manifestations
1058602|NCT02797951|pain|pain
1058603|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
1058604|NCT02797925|Achilles tendon|achilles tendon
1058605|NCT02797925|Patella tendon|patella tendon
1058606|NCT02797925|Inflammation|inflammation
1058607|NCT02797925|Edema|edema
1058608|NCT02797925|Clinical|clinical
1058609|NCT02797925|Structural|structural
1058610|NCT02797912|pulmonary function|pulmonary function
1058611|NCT02797912|respiratory muscle function|respiratory muscle function
1058612|NCT02797912|body composition|body composition
1058613|NCT02797912|exercise tolerance|exercise tolerance
1058614|NCT02797886|Hemiplegia|hemiplegia
1058615|NCT02797886|Drop foot|drop foot
1058616|NCT02797886|Foot drop|foot drop
1058617|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
1058618|NCT02797860|Rocuronium|rocuronium
1058619|NCT02797860|Pregnant Women|pregnant women
1058620|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
1058621|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
1058622|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
1058623|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
1058624|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
1058625|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
1058626|NCT02797847|Familial Amyloidosis|familial amyloidosis
1058627|NCT02797847|RNAi therapeutic|rnai therapeutic
1058628|NCT02797834|Extracellular vesicles|extracellular vesicles
1058629|NCT02797834|Endometrial fluid|endometrial fluid
1058630|NCT02797834|Menstrual cycle|menstrual cycle
1058631|NCT02797834|Exosomes|exosomes
1058632|NCT02797834|Microvesicles|microvesicles
1058633|NCT02797834|Apoptotic bodies|apoptotic bodies
1058634|NCT02797821|HPP|hpp
1058635|NCT02797821|asfotase alfa|asfotase alfa
1058636|NCT02797808|OCD|ocd
1058637|NCT02797743|Healthy Volunteers|healthy volunteers
1058638|NCT02797730|Art Therapy|art therapy
1058639|NCT02797730|Caregiver's|caregiver's
1058640|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
1058641|NCT02797691|Depression|depression
1058642|NCT02797691|Anxiety|anxiety
1058643|NCT02797691|Pashto|pashto
1058644|NCT02797691|Pakistani|pakistani
1058645|NCT02797691|Afghan|afghan
1059450|NCT02793128|Low Grade|low grade
1058646|NCT02797652|Breast cancer|breast cancer
1058647|NCT02797652|ctDNA|ctdna
1058648|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1058649|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
1058650|NCT02797639|Intellectual Disability|intellectual disability
1058651|NCT02797639|Collaborative Consultation|collaborative consultation
1058652|NCT02797639|Participation|participation
1058653|NCT02797600|Appalachia|appalachia
1058654|NCT02797587|Alcohol Use|alcohol use
1058655|NCT02797587|Tobacco Use|tobacco use
1058656|NCT02797587|Smoking|smoking
1058657|NCT02797587|Inflammation|inflammation
1058658|NCT02797587|Coronary Heart Disease|coronary heart disease
1058659|NCT02797587|Russia|russia
1058660|NCT02797587|Varenicline|varenicline
1058661|NCT02797587|Cytisine|cytisine
1058662|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
1058663|NCT02797587|Partial Agonist Therapy|partial agonist therapy
1058664|NCT02797587|HIV|hiv
1058665|NCT02797587|Reynolds risk score|reynolds risk score
1058666|NCT02797587|VACS index|vacs index
1058667|NCT02797561|Fractional flow reserve|fractional flow reserve
1058668|NCT02797561|Tandem|tandem
1058669|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
1058670|NCT02797548|drug-eluting stent|drug-eluting stent
1058671|NCT02797548|antiplatelet therapy|antiplatelet therapy
1058672|NCT02797548|noncardiac surgery|noncardiac surgery
1058673|NCT02797509|Intensive Care Unit|intensive care unit
1058674|NCT02797496|Parkinson's disease|parkinson's disease
1058675|NCT02797496|Mild to moderate stage|mild to moderate stage
1058676|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
1058677|NCT02797496|Rehabilitation|rehabilitation
1058678|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
1058679|NCT02797457|Bilateral allograft|bilateral allograft
1058680|NCT02797457|Prosthetic forehands|prosthetic forehands
1058682|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
1058683|NCT02797405|radiation therapy|radiation therapy
1058684|NCT02797405|radiosensitivity|radiosensitivity
1058685|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
1058686|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
1058687|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
1058688|NCT02797392|Selective prevention|selective prevention
1058689|NCT02797392|Primary care|primary care
1058690|NCT02797392|Web based health risk assessment|web based health risk assessment
1058691|NCT02797392|Patient-centered health information system|patient-centered health information system
1058692|NCT02797392|Lifestyle intervention|lifestyle intervention
1058693|NCT02797392|preventive treatment|preventive treatment
1058694|NCT02797379|Psychoeducation|psychoeducation
1058695|NCT02797379|Self-help|self-help
1058696|NCT02797327|Molecular signature|molecular signature
1058697|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
1058698|NCT02797314|Type 2 diabetes|type 2 diabetes
1058699|NCT02797314|Bone quality|bone quality
1058700|NCT02797314|Bone biopsies|bone biopsies
1058701|NCT02797314|Vertebral fractures|vertebral fractures
1058702|NCT02797314|Osteodensitometry|osteodensitometry
1058703|NCT02797314|Trabecular Bone Score|trabecular bone score
1058704|NCT02797301|early reading skills|early reading skills
1058705|NCT02797249|preeclampsia|preeclampsia
1058706|NCT02797249|low dose aspirin|low dose aspirin
1058707|NCT02797249|prevention|prevention
1058708|NCT02797236|Phase I|phase i
1058709|NCT02797236|conjugate vaccine|conjugate vaccine
1058710|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
1058711|NCT02797236|safety|safety
1058712|NCT02797236|Immunogenicity|immunogenicity
1058713|NCT02797236|Healthy adults|healthy adults
1058714|NCT02797223|alopecia|alopecia
1058715|NCT02797223|chemotherapy|chemotherapy
1058716|NCT02797223|breast cancer|breast cancer
1058717|NCT02797158|TAVI|tavi
1058718|NCT02797158|Aortic stenosis|aortic stenosis
1058719|NCT02797158|Coronary artery disease|coronary artery disease
1058720|NCT02797158|Coronary angiography|coronary angiography
1058721|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
1732248|NCT00001725|Topiramate|topiramate
1058722|NCT02797158|Myocardial ischemia|myocardial ischemia
1058723|NCT02797158|SPECT|spect
1058724|NCT02797158|Coronary revascularization|coronary revascularization
1058725|NCT02797145|Digoxin|digoxin
1058726|NCT02797132|CF|cf
1058727|NCT02797119|Tranexamic acid|tranexamic acid
1058728|NCT02797119|Fibrinolysis|fibrinolysis
1058729|NCT02797119|Cesarean section|cesarean section
1058730|NCT02797119|Pharmacokinetics|pharmacokinetics
1058731|NCT02797119|D dimers|d dimers
1058732|NCT02797119|Fibrinogen|fibrinogen
1058733|NCT02797119|Plasmin|plasmin
1058734|NCT02797119|Transfusion|transfusion
1058735|NCT02797106|Drooling|drooling
1058736|NCT02797106|Cerebral palsy|cerebral palsy
1058737|NCT02797106|Botulinium toxin|botulinium toxin
1058738|NCT02797106|Practice survey of health professionals|practice survey of health professionals
1058739|NCT02797106|Children|children
1058740|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
1058741|NCT02797080|ACTIMMUNE|actimmune
1058742|NCT02797080|interferon y-1b|interferon y-1b
1058743|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
1058745|NCT02797067|Indomethacin|indomethacin
1058746|NCT02797067|Chronic pancreatitis|chronic pancreatitis
1058747|NCT02797054|HPV vaccination|hpv vaccination
1058748|NCT02797054|Vaccination decision-making|vaccination decision-making
1058749|NCT02797054|Tailored health messaging|tailored health messaging
1058750|NCT02797054|Barriers to vaccination|barriers to vaccination
1058751|NCT02797054|Attitudes|attitudes
1058752|NCT02797041|Multiple myeloma|multiple myeloma
1058753|NCT02797041|Bortezomib|bortezomib
1058754|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
1058755|NCT02797041|Rechallenge|rechallenge
1058756|NCT02797028|Hyperuricemia|hyperuricemia
1058757|NCT02797028|endothelial function|endothelial function
1058758|NCT02797028|anthocyanidins|anthocyanidins
1058759|NCT02797015|MS|ms
1058760|NCT02797015|RMS|rms
1058761|NCT02797015|Multiple Sclerosis|multiple sclerosis
1058762|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1058763|NCT02796976|arterial stiffness|arterial stiffness
1058764|NCT02796976|retinal vessels|retinal vessels
1058765|NCT02796976|physical activity|physical activity
1058766|NCT02796976|ageing|ageing
1058767|NCT02796963|HIV|hiv
1058768|NCT02796963|MSM|msm
1058769|NCT02796963|test uptake|test uptake
1058770|NCT02796963|crowdsourcing|crowdsourcing
1058771|NCT02796950|Acipimox|acipimox
1058772|NCT02796950|GLP-1|glp-1
1058773|NCT02796950|Insulin secretion|insulin secretion
1058774|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
1058775|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1058776|NCT02796937|AATD|aatd
1058777|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
1058778|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
1058779|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
1058877|NCT02796495|Nerve stimulation|nerve stimulation
1058780|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1058781|NCT02796924|Brain Stimulation|brain stimulation
1058782|NCT02796898|Prostate Cancer|prostate cancer
1058784|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
1058785|NCT02796859|Inflammation|inflammation
1058786|NCT02796859|Psychosis|psychosis
1058787|NCT02796859|Schizophrenia|schizophrenia
1058788|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
1058789|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
1058790|NCT02796833|Home parenteral nutrition|home parenteral nutrition
1058791|NCT02796833|Liver injury|liver injury
1058792|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
1058793|NCT02796833|Catheter-related infections|catheter-related infections
1058794|NCT02796833|Safety|safety
1058795|NCT02796820|Huaier Granule|huaier granule
1058796|NCT02796820|After radical surgery|after radical surgery
1058797|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
1058798|NCT02796820|Efficacy and safety|efficacy and safety
1058799|NCT02796794|Enteral nutrition|enteral nutrition
1058800|NCT02796794|Genistein|genistein
1058801|NCT02796794|Cytokine|cytokine
1058802|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
1058803|NCT02796755|Breast Cancer Treatment|breast cancer treatment
1058804|NCT02796755|Fatigue|fatigue
1058805|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
1058806|NCT02796755|Behavioral|behavioral
1058807|NCT02796755|Psychometrics|psychometrics
1058808|NCT02796755|Imaging Technology|imaging technology
1058809|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1058810|NCT02796742|SSTIs|sstis
1058811|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1058812|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
1058813|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
1058814|NCT02796742|Emergency Departments|emergency departments
1058815|NCT02796716|Wounded warriors|wounded warriors
1058816|NCT02796716|Battlefield infection|battlefield infection
1058817|NCT02796716|ESBL|esbl
1058818|NCT02796716|MRSA|mrsa
1058819|NCT02796716|KPC|kpc
1058820|NCT02796690|nasal carriage|nasal carriage
1058821|NCT02796690|Staphylococcus aureus|staphylococcus aureus
1058822|NCT02796690|good hygiene practices|good hygiene practices
1058823|NCT02796677|Safety|safety
1058824|NCT02796677|Efficacy|efficacy
1058825|NCT02796677|Aclidinium bromide|aclidinium bromide
1058826|NCT02796677|Formoterol fumarate|formoterol fumarate
1058827|NCT02796677|Tiotropium|tiotropium
1058828|NCT02796677|Bronchodilation|bronchodilation
1058829|NCT02796677|COPD|copd
1058830|NCT02796664|Ginseng|ginseng
1058831|NCT02796664|Stroke|stroke
1058832|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
1058833|NCT02796651|Perforomist|perforomist
1058834|NCT02796651|Pressair|pressair
1058835|NCT02796651|COPD|copd
1058836|NCT02796651|Cigarette smoking|cigarette smoking
1058837|NCT02796651|Formoterol fumarate|formoterol fumarate
1058838|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
1058839|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
1058840|NCT02796638|Acute Heart Failure|acute heart failure
1058841|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
1058842|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
1058843|NCT02796625|EEG|eeg
1058844|NCT02796625|healthy subjects|healthy subjects
1058845|NCT02796612|anxiety|anxiety
1058846|NCT02796612|breast cancer, suspected|breast cancer, suspected
1058847|NCT02796612|breast biopsy|breast biopsy
1058848|NCT02796612|empathy|empathy
1058849|NCT02796612|standardized and structured information|standardized and structured information
1058850|NCT02796612|anxiety reduction|anxiety reduction
1058851|NCT02796586|Refugee Health|refugee health
1058852|NCT02796586|Resettled Refugee|resettled refugee
1058853|NCT02796586|Family Planning|family planning
1058854|NCT02796586|Contraception|contraception
1058855|NCT02796586|Group Counseling|group counseling
1058856|NCT02796586|Group contraceptive counseling|group contraceptive counseling
1058857|NCT02796573|blended care|blended care
1058858|NCT02796573|CBT|cbt
1058859|NCT02796573|B-CBT|b-cbt
1058860|NCT02796573|depression|depression
1058861|NCT02796560|Drugs, Generic|drugs, generic
1058862|NCT02796560|Generic Equivalency|generic equivalency
1058863|NCT02796547|Episiotomy|episiotomy
1058864|NCT02796547|Levobupivacaine|levobupivacaine
1058865|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1058866|NCT02796521|malnutrition|malnutrition
1058867|NCT02796521|aging|aging
1058868|NCT02796521|diet therapy|diet therapy
1058869|NCT02796508|Healthy aging|healthy aging
1058870|NCT02796508|Cognitive training|cognitive training
1058871|NCT02796508|Video-games|video-games
1058872|NCT02796508|Attention|attention
1058873|NCT02796508|Working memory|working memory
1058874|NCT02796508|Wellbeing|wellbeing
1058875|NCT02796495|Neuroplasticity|neuroplasticity
1058876|NCT02796495|Sensory Feedback|sensory feedback
1058878|NCT02796495|Robotic Hand|robotic hand
1058879|NCT02796456|apelin|apelin
1058880|NCT02796456|colostrum|colostrum
1058881|NCT02796456|plasma|plasma
1058882|NCT02796456|glycemic markers|glycemic markers
1058883|NCT02796456|lipidic markers|lipidic markers
1058884|NCT02796456|pregnancy|pregnancy
1058885|NCT02796456|postpartum|postpartum
1058886|NCT02796443|acute cholecystitis|acute cholecystitis
1058887|NCT02796443|early versus delayed surgery|early versus delayed surgery
1058888|NCT02796430|Indirect calorimetry|indirect calorimetry
1058889|NCT02796430|critical care|critical care
1058890|NCT02796430|mechanical ventilation|mechanical ventilation
1058891|NCT02796430|energy expenditure|energy expenditure
1058892|NCT02796430|ICALIC study|icalic study
1058893|NCT02796404|home monitoring|home monitoring
1058894|NCT02796404|cardiac monitoring|cardiac monitoring
1058895|NCT02796391|nicotine|nicotine
1058896|NCT02796391|cigarettes|cigarettes
1058897|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
1058898|NCT02796391|smoking cessation|smoking cessation
1058899|NCT02796378|physical activity|physical activity
1058900|NCT02796378|statin therapy|statin therapy
1058901|NCT02796378|diabetes mellitus|diabetes mellitus
1058902|NCT02796378|cardiovascular disease|cardiovascular disease
1058903|NCT02796378|Q10-supplementation|q10-supplementation
1058904|NCT02796365|Exercise|exercise
1058905|NCT02796365|Cancer|cancer
1058906|NCT02796365|Cardiotoxicity|cardiotoxicity
1058907|NCT02796365|Cardiomyopathy|cardiomyopathy
1058908|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
1058909|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
1058910|NCT02796339|natural Mastiha|natural mastiha
1058911|NCT02796339|supplement|supplement
1058912|NCT02796326|tracheal stenosis|tracheal stenosis
1058913|NCT02796326|tracheal dilatation|tracheal dilatation
1058914|NCT02796326|ventilation|ventilation
1058915|NCT02796300|bioflo|bioflo
1058916|NCT02796300|Duramax catheter|duramax catheter
1058917|NCT02796300|dialysis|dialysis
1058918|NCT02796287|Amnesia|amnesia
1058919|NCT02796287|transient global amnesia|transient global amnesia
1058920|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
1058921|NCT02796261|Grade 3 Glioma|grade 3 glioma
1058922|NCT02796261|Glioma|glioma
1058923|NCT02796261|Eflornithine|eflornithine
1058924|NCT02796261|Brain Cancer|brain cancer
1058925|NCT02796261|Brain Tumor|brain tumor
1058926|NCT02796261|Neuro-oncology|neuro-oncology
1058927|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
1058928|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
1058929|NCT02796261|Progressive Glioma|progressive glioma
1058930|NCT02796261|Recurrent Glioma|recurrent glioma
1058931|NCT02796261|Malignant Glioma|malignant glioma
1058932|NCT02796261|Progressive Brain Tumor|progressive brain tumor
1058933|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
1058934|NCT02796248|type 1 diabetes|type 1 diabetes
1058935|NCT02796248|glucose control|glucose control
1058936|NCT02796248|stigma|stigma
1058937|NCT02796248|youth|youth
1058938|NCT02796222|Hemophilia|hemophilia
1058939|NCT02796222|Recombinant factor VIII|recombinant factor viii
1058940|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
1058941|NCT02796222|Recombinant factor IX|recombinant factor ix
1058942|NCT02796222|Patient-reported outcomes|patient-reported outcomes
1058943|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
1058945|NCT02796209|autonomic failure|autonomic failure
1058946|NCT02796196|Hematopoietic|hematopoietic
1058947|NCT02796196|Recipient|recipient
1058948|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
1058949|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
1058950|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
1058951|NCT02796144|schizophrenia|schizophrenia
1058952|NCT02796144|schizoaffective disorder|schizoaffective disorder
1058953|NCT02796144|overweight|overweight
1058954|NCT02796144|obesity|obesity
1058955|NCT02796144|weight loss|weight loss
1058956|NCT02796144|metformin|metformin
1058957|NCT02796144|lorcaserin|lorcaserin
1058958|NCT02796131|Phase I|phase i
1058959|NCT02796131|Healthy|healthy
1058960|NCT02796131|Pharmacodynamics|pharmacodynamics
1058961|NCT02796118|Pharmacokinetics|pharmacokinetics
1058962|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
1058963|NCT02796118|ASP2151|asp2151
1058964|NCT02796118|Safety|safety
1058965|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
1058966|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
1058967|NCT02796092|Chronic pelvic pain|chronic pelvic pain
1058968|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
1058969|NCT02796040|Parkinson's disease|parkinson's disease
1058970|NCT02796040|Impulse control disorders|impulse control disorders
1058971|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
1058972|NCT02796040|MRI|mri
1058973|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
1058974|NCT02796027|Health Services Research|health services research
1058975|NCT02795988|Secondary|secondary
1059681|NCT02791841|Rhythm|rhythm
1058977|NCT02795962|Emergency Medical Services|emergency medical services
1058978|NCT02795949|Enterobacteriaceae|enterobacteriaceae
1058979|NCT02795949|Bacteremia|bacteremia
1058980|NCT02795949|Escalation|escalation
1058981|NCT02795949|Bacterial resistance|bacterial resistance
1058982|NCT02795949|Bloodstream infection|bloodstream infection
1058983|NCT02795949|Recurrence|recurrence
1058986|NCT02795897|genetics|genetics
1058987|NCT02795897|genomics|genomics
1058988|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1058989|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
1058990|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
1058991|NCT02795897|motor neuron disease|motor neuron disease
1058992|NCT02795884|Lung cancer|lung cancer
1058993|NCT02795884|NSCLC|nsclc
1058994|NCT02795884|adjuvant treatment|adjuvant treatment
1058995|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1058996|NCT02795871|Prenatal treatment|prenatal treatment
1058997|NCT02795871|Dexamethasone|dexamethasone
1058998|NCT02795871|Neuropsychological assessment|neuropsychological assessment
1058999|NCT02795871|Cognitive development|cognitive development
1059000|NCT02795858|Carcinoid Tumors|carcinoid tumors
1059001|NCT02795806|Address|address
1059002|NCT02795793|appendicitis|appendicitis
1059003|NCT02795793|non-operative management|non-operative management
1059004|NCT02795793|children|children
1059005|NCT02795793|pediatric|pediatric
1059006|NCT02795754|GSK2838232|gsk2838232
1059008|NCT02795754|repeated dose escalation|repeated dose escalation
1059009|NCT02795754|immediate release tablet|immediate release tablet
1059010|NCT02795754|single dose escalation|single dose escalation
1059011|NCT02795715|tDCS|tdcs
1059012|NCT02795702|tDCS|tdcs
1059013|NCT02795676|Glomerular filtration rate|glomerular filtration rate
1059014|NCT02795676|Proteinuria|proteinuria
1059015|NCT02795676|PRX-102|prx-102
1059016|NCT02795676|pegunigalsidase alfa|pegunigalsidase alfa
1059017|NCT02795676|Fabry Disease|fabry disease
1059018|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1059019|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
1059020|NCT02795650|Metastatic|metastatic
1059021|NCT02795650|Pancreas|pancreas
1059022|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
1059023|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
1059024|NCT02795611|Family-centered|family-centered
1059025|NCT02795611|Autism spectrum disorder|autism spectrum disorder
1059026|NCT02795611|Occupational therapy|occupational therapy
1059027|NCT02795611|Participation|participation
1059028|NCT02795611|Play|play
1059029|NCT02795585|Fractional Flow Reserve|fractional flow reserve
1059030|NCT02795585|Coronary Artery Disease|coronary artery disease
1059031|NCT02795572|Breast Neoplasms|breast neoplasms
1059032|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
1059033|NCT02795559|Nutrition|nutrition
1059034|NCT02795559|Humans|humans
1059035|NCT02795559|Obesity|obesity
1059036|NCT02795559|Blood glucose|blood glucose
1059037|NCT02795559|Dietary fiber|dietary fiber
1059038|NCT02795559|Appetite|appetite
1059039|NCT02795559|Short chain fatty acids|short chain fatty acids
1059040|NCT02795546|periodontal regeneration|periodontal regeneration
1059041|NCT02795533|Cognitive function|cognitive function
1059042|NCT02795533|Quality of Life|quality of life
1059043|NCT02795507|cross education|cross education
1059044|NCT02795507|visual feedback|visual feedback
1059045|NCT02795468|Peripheral|peripheral
1059046|NCT02795468|Arterial|arterial
1059047|NCT02795468|Catheterization|catheterization
1059048|NCT02795455|Eating Disorders|eating disorders
1059049|NCT02795455|Food Avoidance|food avoidance
1059050|NCT02795455|Reward Learning|reward learning
1059051|NCT02795455|Reward System|reward system
1059052|NCT02795455|Family-based treatment|family-based treatment
1059053|NCT02795455|interoceptive exposure|interoceptive exposure
1059054|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
1059055|NCT02795429|Phase Ib/II|phase ib/ii
1059056|NCT02795429|INC280|inc280
1059057|NCT02795429|PDR001|pdr001
1059058|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
1059059|NCT02795429|PD-1|pd-1
1059060|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
1059061|NCT02795403|HCV, liver|hcv, liver
1059062|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
1059063|NCT02795390|MaZiRenWan|mazirenwan
1059064|NCT02795390|Randomized controlled trial|randomized controlled trial
1059065|NCT02795390|Constipation|constipation
1059066|NCT02795390|Palliative care in cancer|palliative care in cancer
1059067|NCT02795377|arterial hypertension|arterial hypertension
1059068|NCT02795377|microparticle|microparticle
1059069|NCT02795377|endothelial function|endothelial function
1059070|NCT02795364|High Grade Glioma|high grade glioma
1059071|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1059072|NCT02795364|Surgical resection|surgical resection
1059073|NCT02795364|Prognosis|prognosis
1059074|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
1059075|NCT02795325|PH1|ph1
1059076|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
1059077|NCT02795325|Kidney Stones|kidney stones
1059078|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
1059079|NCT02795325|Genetic Diseases|genetic diseases
1059080|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
1059081|NCT02795325|Metabolic Diseases|metabolic diseases
1059082|NCT02795325|Inborn Errors|inborn errors
1059083|NCT02795325|Urological Diseases|urological diseases
1059084|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
1059085|NCT02795325|Hyperoxaluria|hyperoxaluria
1059086|NCT02795325|AGT|agt
1059087|NCT02795325|RNAi|rnai
1059088|NCT02795325|siRNA|sirna
1059089|NCT02795325|DCR-PH1|dcr-ph1
1059090|NCT02795312|Cigarette Smoking|cigarette smoking
1059091|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1059092|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1059093|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
1059094|NCT02795286|In-center HD|in-center hd
1059095|NCT02795286|Sodium|sodium
1059096|NCT02795286|Isotonic Dialysis|isotonic dialysis
1059097|NCT02795273|Rhinitis|rhinitis
1059098|NCT02795273|Conjunctivitis|conjunctivitis
1059099|NCT02795273|Grass|grass
1059100|NCT02795273|Allergy|allergy
1059101|NCT02795260|ESAT6|esat6
1059102|NCT02795260|CFP10|cfp10
1059103|NCT02795260|skin test|skin test
1059104|NCT02795260|diagnostic test|diagnostic test
1059105|NCT02795195|re-irradiation|re-irradiation
1059106|NCT02795195|carbon ion therapy|carbon ion therapy
1059107|NCT02795182|Relapsed|relapsed
1059108|NCT02795182|Refractory|refractory
1059109|NCT02795156|regorafenib|regorafenib
1059110|NCT02795156|afatinib|afatinib
1059111|NCT02795156|targeted therapy|targeted therapy
1059112|NCT02795156|cabozantinib|cabozantinib
1059113|NCT02795143|TEN|ten
1059114|NCT02795104|RISE|rise
1059115|NCT02795091|clean supplies|clean supplies
1059116|NCT02795091|ICU floor|icu floor
1059117|NCT02795091|bacteria colony|bacteria colony
1059118|NCT02795091|catheter associated with infection|catheter associated with infection
1059119|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
1059120|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
1059121|NCT02795052|Neurologic Disease|neurologic disease
1059122|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
1059123|NCT02795052|Stroke|stroke
1059124|NCT02795052|Traumatic Brain Injury|traumatic brain injury
1059125|NCT02795052|Multiple Sclerosis|multiple sclerosis
1059126|NCT02795052|Parkinsons Disease|parkinsons disease
1059127|NCT02795052|Neuropathy|neuropathy
1059128|NCT02795052|Neurodegeneration|neurodegeneration
1059129|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
1059130|NCT02795052|Cerebral Ischemia|cerebral ischemia
1059131|NCT02795026|dry needling|dry needling
1059132|NCT02795026|vulvodynia|vulvodynia
1059133|NCT02795026|pelvic pain chronic|pelvic pain chronic
1059134|NCT02795013|Genetic studies|genetic studies
1059135|NCT02795013|Pediatric|pediatric
1059136|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
1059137|NCT02795000|nomogram|nomogram
1059138|NCT02794987|Bile duct|bile duct
1059139|NCT02794987|indeterminate stricture|indeterminate stricture
1059140|NCT02794987|cholangioscopy|cholangioscopy
1059141|NCT02794987|Spyglass|spyglass
1059142|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
1059143|NCT02794948|TCM intervention|tcm intervention
1059144|NCT02794935|inspiratory muscle training|inspiratory muscle training
1059145|NCT02794935|heart failure|heart failure
1059146|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
1059147|NCT02794922|Vitamin B|vitamin b
1059148|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
1059149|NCT02794922|trpv1|trpv1
1059150|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
1059151|NCT02794909|ED|ed
1059152|NCT02794909|Low and middle-income country|low and middle-income country
1059153|NCT02794909|Echocardiography|echocardiography
1059154|NCT02794909|Lung ultrasound|lung ultrasound
1059155|NCT02794909|Resuscitation|resuscitation
1059156|NCT02794857|ALS|als
1059157|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1059158|NCT02794857|Motor Neuron Disease|motor neuron disease
1059159|NCT02794857|Central Nervous System Diseases|central nervous system diseases
1059160|NCT02794857|Nervous System Diseases|nervous system diseases
1059161|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
1059162|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
1059163|NCT02794857|Inflammation|inflammation
1059164|NCT02794857|C-Reactive Protein|c-reactive protein
1059165|NCT02794831|NSAIDs|nsaids
1059166|NCT02794831|Bacterial Infections|bacterial infections
1059167|NCT02794831|Severity|severity
1059168|NCT02794831|Self Medication|self medication
1059169|NCT02794818|Prevention|prevention
1059170|NCT02794818|Nutrition|nutrition
1059171|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1059172|NCT02794792|ASP1941|asp1941
1059173|NCT02794792|Ipragliflozin|ipragliflozin
1059174|NCT02794779|cesarean section|cesarean section
1059175|NCT02794779|labor|labor
1059176|NCT02794779|oxytocin|oxytocin
1059177|NCT02794753|Trichotillomania|trichotillomania
1059178|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
1059179|NCT02794753|Cognitive Training|cognitive training
1059180|NCT02794753|Neuroplasticity|neuroplasticity
1059181|NCT02794753|Working Memory|working memory
1059182|NCT02794740|Osteoarthritis|osteoarthritis
1059183|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
1059184|NCT02794688|Non-lactating|non-lactating
1059185|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
1059186|NCT02794688|periductal mastitis|periductal mastitis
1059187|NCT02794688|ductal lavage|ductal lavage
1059188|NCT02794675|resectable|resectable
1059189|NCT02794675|Cesium 131|cesium 131
1059190|NCT02794675|brachytherapy|brachytherapy
1059191|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
1059192|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
1059193|NCT02794623|cochlear implants|cochlear implants
1059194|NCT02794623|hearing loss|hearing loss
1059195|NCT02794610|Tacrolimus|tacrolimus
1059196|NCT02794610|Ocular penetration|ocular penetration
1059198|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
1059199|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
1059200|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
1059201|NCT02794519|interleukin-6|interleukin-6
1059202|NCT02794519|Sirukumab|sirukumab
1059203|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
1059204|NCT02794519|asthma|asthma
1059205|NCT02794519|ACQ|acq
1059206|NCT02794506|Diabetes mellitus|diabetes mellitus
1059207|NCT02794506|Chronic periodontitis|chronic periodontitis
1059208|NCT02794506|Propolis|propolis
1059209|NCT02794480|ELLIPTA|ellipta
1059210|NCT02794480|metered dose inhaler|metered dose inhaler
1059211|NCT02794480|Dry powder inhaler|dry powder inhaler
1732599|NCT00001619|MRI|mri
1059212|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
1059213|NCT02794467|Adenomyosis|adenomyosis
1059214|NCT02794467|Safety|safety
1059215|NCT02794467|Epelsiban|epelsiban
1059216|NCT02794467|Tolerability|tolerability
1059217|NCT02794467|Proof of concept|proof of concept
1059218|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
1059219|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
1059220|NCT02794428|Atrophic gastritis|atrophic gastritis
1059221|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
1059222|NCT02794415|HIV|hiv
1059223|NCT02794415|disability|disability
1059224|NCT02794415|rehabilitation|rehabilitation
1059225|NCT02794415|exercise|exercise
1059226|NCT02794389|Acetylcysteine|acetylcysteine
1059227|NCT02794376|IBS|ibs
1059228|NCT02794350|RBANS-H|rbans-h
1059229|NCT02794350|Cochlear implantation|cochlear implantation
1059230|NCT02794350|Cognition|cognition
1059231|NCT02794350|Older adults|older adults
1059232|NCT02794350|RBANS|rbans
1059233|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
1059234|NCT02794272|GABA concentration|gaba concentration
1059235|NCT02794272|tDCS|tdcs
1059236|NCT02794259|GABA concentration|gaba concentration
1059237|NCT02794259|tDCS|tdcs
1059238|NCT02794233|Deep Brain Stimulation|deep brain stimulation
1059239|NCT02794233|Electric Impedance|electric impedance
1059240|NCT02794233|Parkinson disease|parkinson disease
1059241|NCT02794220|E-cigarette|e-cigarette
1059242|NCT02794220|healthy volunteer study|healthy volunteer study
1059243|NCT02794220|Pharmacokinetics|pharmacokinetics
1059244|NCT02794220|Nicorette|nicorette
1059245|NCT02794207|Pediatric|pediatric
1059246|NCT02794207|Cancer|cancer
1059247|NCT02794207|AML|aml
1059248|NCT02794207|Qualitative Interview|qualitative interview
1059249|NCT02794194|Chronic Ankle Instability|chronic ankle instability
1059250|NCT02794194|Whole Body Vibration|whole body vibration
1059251|NCT02794194|Proprioception|proprioception
1059252|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
1059253|NCT02794181|Dengue Virus|dengue virus
1059254|NCT02794181|Chikungunya Virus|chikungunya virus
1059255|NCT02794181|Natural History|natural history
1059256|NCT02794181|Blood Transfusion|blood transfusion
1059257|NCT02794142|hemodialysis|hemodialysis
1059258|NCT02794142|muscle dysfunction|muscle dysfunction
1059259|NCT02794142|mitochondria|mitochondria
1059260|NCT02794142|oxidative stress|oxidative stress
1059261|NCT02794142|inflammation|inflammation
1059262|NCT02794142|renal transplantation|renal transplantation
1059263|NCT02794103|Virtual reality|virtual reality
1059264|NCT02794103|Immersive distraction|immersive distraction
1059265|NCT02794103|Virtual world|virtual world
1059266|NCT02794103|Virtual environment|virtual environment
1059267|NCT02794103|Procedural pain|procedural pain
1059268|NCT02794103|Procedural anxiety|procedural anxiety
1059269|NCT02794103|Acute pain|acute pain
1059270|NCT02794103|Pain management|pain management
1059271|NCT02794103|Anxiety|anxiety
1059272|NCT02794103|Children, Child|children, child
1059273|NCT02794103|Kid, Kids|kid, kids
1059274|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
1059275|NCT02794103|Young children|young children
1059276|NCT02794103|Burns|burns
1059277|NCT02794103|Burn injuries|burn injuries
1059278|NCT02794103|Burn unit|burn unit
1059279|NCT02794103|Hydrotherapy|hydrotherapy
1059280|NCT02794103|Burn dressing|burn dressing
1059281|NCT02794103|Non-pharmacological|non-pharmacological
1059282|NCT02794103|Clinical Research|clinical research
1059283|NCT02794103|Nursing Practice|nursing practice
1059284|NCT02794090|Behavioral treatment|behavioral treatment
1059285|NCT02794090|Telephone coaching|telephone coaching
1059286|NCT02794090|Outpatient clinic|outpatient clinic
1059287|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
1059288|NCT02793947|Peri-incisional injection|peri-incisional injection
1059289|NCT02793947|Multimodal analgesia|multimodal analgesia
1059290|NCT02793947|Femur fracture|femur fracture
1059291|NCT02793934|Rehabilitation|rehabilitation
1059292|NCT02793934|ICF|icf
1059293|NCT02793934|Pilot project|pilot project
1059294|NCT02793934|Stroke|stroke
1059295|NCT02793934|Acute myocardial infarction|acute myocardial infarction
1059296|NCT02793934|Total hip replacement|total hip replacement
1059297|NCT02793921|Alteration|alteration
1059298|NCT02793921|Cognitive Function|cognitive function
1059299|NCT02793921|Exercise|exercise
1059300|NCT02793908|Endometriosis|endometriosis
1059301|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
1059302|NCT02793908|luteal phase|luteal phase
1059303|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
1059304|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
1059305|NCT02793895|Cardiac surgery|cardiac surgery
1059306|NCT02793895|Stroke prevention|stroke prevention
1059307|NCT02793895|Oral anticoagulation|oral anticoagulation
1059308|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
1333227|NCT01443936|Healthy Volunteer|healthy volunteer
1059309|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
1059310|NCT02793856|lung cancer|lung cancer
1059311|NCT02793856|immune checkpoint|immune checkpoint
1059312|NCT02793856|PD-1|pd-1
1059313|NCT02793856|CRISPER|crisper
1059314|NCT02793856|autologous cell infusion|autologous cell infusion
1059315|NCT02793830|medication adherence|medication adherence
1059317|NCT02793830|China|china
1059318|NCT02793830|heart disease|heart disease
1059319|NCT02793817|postsurgical|postsurgical
1059320|NCT02793817|postoperative|postoperative
1059321|NCT02793817|ocular|ocular
1059322|NCT02793817|cataract|cataract
1059323|NCT02793817|inflammation|inflammation
1059324|NCT02793817|pain|pain
1059325|NCT02793817|corticosteroid|corticosteroid
1059326|NCT02793804|HIV self-testing|hiv self-testing
1059327|NCT02793804|HIV|hiv
1059328|NCT02793804|Zambia|zambia
1059329|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
1059330|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
1059331|NCT02793778|Crohn's Disease|crohn's disease
1059332|NCT02793778|Digestive System Diseases|digestive system diseases
1059333|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
1059334|NCT02793778|Intestinal Diseases|intestinal diseases
1059335|NCT02793778|mucosal healing|mucosal healing
1059336|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
1059337|NCT02793778|Medical Food|medical food
1059338|NCT02793778|Nutritional intervention|nutritional intervention
1059339|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
1059340|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1059341|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1059342|NCT02793765|Metastatic disease|metastatic disease
1059343|NCT02793765|CRPC|crpc
1059344|NCT02793752|IVF|ivf
1059345|NCT02793752|In vitro fertilization|in vitro fertilization
1059346|NCT02793752|Cumulus Cells|cumulus cells
1059347|NCT02793752|Oocyte|oocyte
1059348|NCT02793752|Embryo|embryo
1059349|NCT02793752|Fertility|fertility
1059350|NCT02793739|Safety|safety
1059351|NCT02793739|Efficacy|efficacy
1059352|NCT02793739|Longevity|longevity
1059353|NCT02793726|Hip Prosthesis|hip prosthesis
1059354|NCT02793713|EBUS|ebus
1059355|NCT02793713|Prediction|prediction
1059356|NCT02793713|malignancy|malignancy
1059357|NCT02793713|lymph nodes|lymph nodes
1059358|NCT02793713|lung cancer|lung cancer
1059359|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
1059360|NCT02793700|Betamethasone|betamethasone
1059361|NCT02793674|effort of breathing|effort of breathing
1059362|NCT02793674|high flow nasal cannula|high flow nasal cannula
1059363|NCT02793674|respiratory distress|respiratory distress
1059364|NCT02793648|Depression|depression
1059365|NCT02793648|Elderly|elderly
1059366|NCT02793635|Paraplegia|paraplegia
1059367|NCT02793635|Gait|gait
1059368|NCT02793635|Exoskeleton|exoskeleton
1059369|NCT02793622|Chemoprevention|chemoprevention
1059370|NCT02793622|Malaria|malaria
1059371|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
1059372|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
1059373|NCT02793609|induction of labor|induction of labor
1059374|NCT02793609|double balloon catheter|double balloon catheter
1059375|NCT02793609|mechanical ripening|mechanical ripening
1059376|NCT02793505|metformin|metformin
1059377|NCT02793505|pregnancy outcomes|pregnancy outcomes
1059378|NCT02793505|birth defects|birth defects
1059379|NCT02793505|spontaneous abortion|spontaneous abortion
1059380|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
1059381|NCT02793466|Durvalumab|durvalumab
1059382|NCT02793466|solid tumors|solid tumors
1059383|NCT02793466|Immunotherapy|immunotherapy
1059384|NCT02793466|Check Point Inhibitor|check point inhibitor
1059385|NCT02793466|pediatrics|pediatrics
1059386|NCT02793466|children|children
1059387|NCT02793401|High Intensity Laser|high intensity laser
1059388|NCT02793401|Ultrasound|ultrasound
1059389|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
1059390|NCT02793375|Montelukast|montelukast
1059391|NCT02793375|Tonsillectomy|tonsillectomy
1059392|NCT02793349|angioplasty|angioplasty
1059393|NCT02793349|stents|stents
1059394|NCT02793349|polymers|polymers
1059395|NCT02793349|absorbable implants|absorbable implants
1059396|NCT02793271|Depression|depression
1059397|NCT02793271|Primary Health Care|primary health care
1059398|NCT02793271|Social Stigma|social stigma
1059399|NCT02793271|Stereotyping|stereotyping
1059400|NCT02793271|Health Care Quality|health care quality
1059401|NCT02793271|Access|access
1059402|NCT02793271|Evaluation|evaluation
1059403|NCT02793258|tDCS|tdcs
1059404|NCT02793258|neuromodulation|neuromodulation
1059405|NCT02793258|depression|depression
1059406|NCT02793258|cognition|cognition
1059407|NCT02793232|Safety|safety
1059408|NCT02793232|Tolerability|tolerability
1059409|NCT02793232|Pharmacokinetics|pharmacokinetics
1059410|NCT02793232|Alzheimer's disease|alzheimer's disease
1059411|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
1333228|NCT01443936|HV|hv
1059412|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1059413|NCT02793219|CRPC|crpc
1059414|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1059415|NCT02793219|Metastatic disease|metastatic disease
1059416|NCT02793206|Drusen|drusen
1059417|NCT02793206|SD-OCT|sd-oct
1059418|NCT02793167|acute kidney injury|acute kidney injury
1059419|NCT02793167|medication alert systems|medication alert systems
1059420|NCT02793154|gastric emptying|gastric emptying
1059421|NCT02793154|albiglutide|albiglutide
1059423|NCT02793154|exenatide|exenatide
1059424|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
1059425|NCT02793141|Pneumonia|pneumonia
1059426|NCT02793141|Intensive Care Unit|intensive care unit
1059427|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
1059428|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
1059429|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
1059430|NCT02793141|ICU|icu
1059431|NCT02793141|HAP|hap
1059432|NCT02793141|VAP|vap
1059433|NCT02793141|Critical Care|critical care
1059434|NCT02793128|TC-3|tc-3
1059435|NCT02793128|Mitogel|mitogel
1059436|NCT02793128|UTUC|utuc
1059437|NCT02793128|Ureteral|ureteral
1059438|NCT02793128|Upper Tract|upper tract
1059439|NCT02793128|Carcinoma|carcinoma
1059440|NCT02793128|Kidney|kidney
1059441|NCT02793128|Renal|renal
1059442|NCT02793128|Gel|gel
1059443|NCT02793128|Local|local
1059444|NCT02793128|Mitomycin C|mitomycin c
1059445|NCT02793128|Prolonged Release|prolonged release
1059446|NCT02793128|Slow Release|slow release
1059447|NCT02793128|Kidney Sparing|kidney sparing
1059448|NCT02793128|T1|t1
1059449|NCT02793128|T0|t0
1059451|NCT02793128|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
1059452|NCT02793128|TCC|tcc
1059453|NCT02793102|mental anorexia|mental anorexia
1059454|NCT02793102|sensory workshops|sensory workshops
1059455|NCT02793102|BMI|bmi
1059456|NCT02793076|Posture|posture
1059457|NCT02793076|Body image|body image
1059458|NCT02793076|Dancing|dancing
1059459|NCT02793076|Group|group
1059460|NCT02793076|Survivors|survivors
1059461|NCT02793063|Brittle Bone|brittle bone
1059462|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
1059463|NCT02793063|BBD|bbd
1059464|NCT02793063|OI|oi
1059465|NCT02793063|Congenital Abnormalities|congenital abnormalities
1059466|NCT02793063|Congenital Bone Disorder|congenital bone disorder
1059467|NCT02793063|Lobstein Syndrome|lobstein syndrome
1059468|NCT02793050|Trabectedin|trabectedin
1059469|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
1059470|NCT02793050|Observational|observational
1059471|NCT02793037|zirconia|zirconia
1059472|NCT02793037|resin bonded bridge|resin bonded bridge
1059473|NCT02793024|food shopping intervention|food shopping intervention
1059474|NCT02792972|Analgesic|analgesic
1059475|NCT02792972|Medicinal plants|medicinal plants
1059476|NCT02792972|Skin|skin
1059477|NCT02792972|Antimicrobial agents|antimicrobial agents
1059478|NCT02792972|Pain Measurement|pain measurement
1059479|NCT02792907|Foot Surgery|foot surgery
1059480|NCT02792907|Compliance|compliance
1059481|NCT02792907|Compressive Stockings|compressive stockings
1059482|NCT02792894|cluster randomized trial|cluster randomized trial
1059483|NCT02792894|developmental delays|developmental delays
1059484|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
1059485|NCT02792894|autism|autism
1059486|NCT02792894|intellectual disability|intellectual disability
1059487|NCT02792894|low resource settings|low resource settings
1059488|NCT02792894|family volunteers|family volunteers
1059489|NCT02792881|Stomach Neoplasms|stomach neoplasms
1059490|NCT02792881|Laparoscopy|laparoscopy
1059491|NCT02792881|Remnant gastric cancer|remnant gastric cancer
1059492|NCT02792855|Snifﬁng Position|snifﬁng position
1059493|NCT02792855|Simple Head Extension|simple head extension
1059494|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
1059495|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
1059496|NCT02792829|Lenvatinib|lenvatinib
1059497|NCT02792829|Lenvima|lenvima
1059498|NCT02792829|E7080|e7080
1059499|NCT02792829|Capsule formulation|capsule formulation
1059500|NCT02792829|Healthy volunteers|healthy volunteers
1059501|NCT02792803|POAG|poag
1059502|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
1059503|NCT02792803|Ocular Hypertension|ocular hypertension
1059504|NCT02792803|Xalatan|xalatan
1059505|NCT02792803|Latanoprost|latanoprost
1059506|NCT02792803|Ocular Hyperemia|ocular hyperemia
1059507|NCT02792803|IOP|iop
1059508|NCT02792803|Intraocular Pressure|intraocular pressure
1059509|NCT02792803|Allergan|allergan
1059510|NCT02792803|prostaglandin|prostaglandin
1059511|NCT02792790|Amyloidosis|amyloidosis
1059512|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
1059513|NCT02792777|Concept Mapping|concept mapping
1059514|NCT02792777|VOICe|voice
1059515|NCT02792777|Interviews|interviews
1333229|NCT01443923|Hepatitis|hepatitis
1059516|NCT02792777|Patient-Centered Research|patient-centered research
1059517|NCT02792764|port|port
1059518|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
1059519|NCT02792764|oncology|oncology
1059520|NCT02792751|Depth of anesthesia|depth of anesthesia
1059521|NCT02792751|BIS|bis
1059522|NCT02792751|ERCP|ercp
1059523|NCT02792751|Positive Regulation|positive regulation
1059524|NCT02792712|Acute myocardial infarction|acute myocardial infarction
1059525|NCT02792712|Antiplatelet agents|antiplatelet agents
1059526|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1059527|NCT02792686|Healthy Volunteers|healthy volunteers
1059528|NCT02792673|Embryo transfer media|embryo transfer media
1059529|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
1059530|NCT02792673|improvement of implantation|improvement of implantation
1059531|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
1059532|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
1059533|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
1059534|NCT02792634|Bariatric surgery|bariatric surgery
1059535|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1059536|NCT02792634|Obesity|obesity
1059537|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
1059538|NCT02792608|Brain Tumour Survivors|brain tumour survivors
1059539|NCT02792608|Depressive Symptoms|depressive symptoms
1059540|NCT02792608|Quality of Life|quality of life
1059541|NCT02792608|Perceived Stress|perceived stress
1059542|NCT02792608|Wellbeing|wellbeing
1059543|NCT02792608|Treatment|treatment
1059544|NCT02792582|Brain tumor|brain tumor
1059545|NCT02792582|Pediatrics|pediatrics
1059546|NCT02792582|Radiation therapy|radiation therapy
1059547|NCT02792582|Proton therapy|proton therapy
1059548|NCT02792582|Surgery|surgery
1059550|NCT02792569|Hippo Pathway|hippo pathway
1059551|NCT02792569|Follicle activation|follicle activation
1059552|NCT02792569|Low Responder|low responder
1059553|NCT02792569|POI|poi
1059554|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
1059555|NCT02792569|Poor Ovarian Response|poor ovarian response
1059556|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
1059557|NCT02792556|drug abortion|drug abortion
1059558|NCT02792556|urine pregnancy test|urine pregnancy test
1059559|NCT02792556|negative predictive value|negative predictive value
1059560|NCT02792556|check Top test|check top test
1059561|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
1059562|NCT02792543|nutrition|nutrition
1059563|NCT02792543|double enterostomy|double enterostomy
1059564|NCT02792543|chyme reinfusion|chyme reinfusion
1059565|NCT02792543|randomized controlled trial|randomized controlled trial
1059566|NCT02792439|Fitness|fitness
1059567|NCT02792439|Health kit|health kit
1059568|NCT02792439|Researchkit|researchkit
1059569|NCT02792439|Walking|walking
1059570|NCT02792426|Smoking Cessation|smoking cessation
1059571|NCT02792426|Nicotine Dependence|nicotine dependence
1059572|NCT02792426|Tobacco Dependence|tobacco dependence
1059573|NCT02792413|osteoporosis|osteoporosis
1059574|NCT02792413|chronic kidney disease|chronic kidney disease
1059575|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
1059576|NCT02792413|bone mineral density|bone mineral density
1059577|NCT02792413|vascular calcifications|vascular calcifications
1059578|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
1059785|NCT02791230|TTR|ttr
1059579|NCT02792387|right heart dysfunction|right heart dysfunction
1059580|NCT02792387|central venous pressure|central venous pressure
1059581|NCT02792387|eGFR|egfr
1059582|NCT02792387|low-flow theory|low-flow theory
1059583|NCT02792374|Dental patients|dental patients
1059584|NCT02792374|Psychological Profile|psychological profile
1059585|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
1059586|NCT02792361|Suction Drain|suction drain
1059587|NCT02792361|Benefits|benefits
1059588|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
1059589|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
1059590|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
1059591|NCT02792322|Cancer|cancer
1059592|NCT02792322|Oropharynx|oropharynx
1059593|NCT02792270|Surgery|surgery
1059594|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
1059595|NCT02792231|Ofatumumab|ofatumumab
1059596|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
1059597|NCT02792218|Ofatumumab|ofatumumab
1059598|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
1059599|NCT02792205|hematology|hematology
1059600|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
1059601|NCT02792166|Morbid obesity|morbid obesity
1059602|NCT02792166|Metabolic syndrome|metabolic syndrome
1059603|NCT02792166|Metabolic surgery|metabolic surgery
1059604|NCT02792166|Bariatric surgery|bariatric surgery
1059605|NCT02792166|SADI|sadi
1059606|NCT02792166|BPD-DS|bpd-ds
1059607|NCT02792153|estrogen|estrogen
1059608|NCT02792153|anxiety|anxiety
1059609|NCT02792153|amenorrhea|amenorrhea
1059610|NCT02792153|eating disorders|eating disorders
1059611|NCT02792140|Psychology|psychology
1059612|NCT02792140|Dreams|dreams
1059613|NCT02792127|Social Anxiety|social anxiety
1059614|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
1059615|NCT02792127|Online Program|online program
1059616|NCT02792114|T-Cell|t-cell
1059617|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
1059618|NCT02792114|CAR T cells|car t cells
1059619|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
1059620|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
1059621|NCT02792114|16-040|16-040
1059622|NCT02792114|immunotherapy|immunotherapy
1059624|NCT02792088|HBV|hbv
1059625|NCT02792075|Coronary Stenosis|coronary stenosis
1059626|NCT02792075|Intracoronary Imaging|intracoronary imaging
1059627|NCT02792075|VH-IVUS|vh-ivus
1059628|NCT02792075|OCT|oct
1059629|NCT02792075|NIRS|nirs
1059630|NCT02792075|gray scale IVUS|gray scale ivus
1059631|NCT02792062|Drug therapy|drug therapy
1059632|NCT02792023|Colorectal cancer|colorectal cancer
1059633|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
1059634|NCT02792010|T1rho MRI|t1rho mri
1059635|NCT02792010|hip|hip
1059636|NCT02792010|cartilage|cartilage
1059637|NCT02792010|Healthy participants|healthy participants
1059638|NCT02791997|Audition|audition
1059639|NCT02791997|Stroke|stroke
1059640|NCT02791997|Migraine|migraine
1059641|NCT02791997|Attention|attention
1059642|NCT02791997|Short-term memory,|short-term memory,
1059643|NCT02791997|Emotions|emotions
1059644|NCT02791997|EEG|eeg
1059645|NCT02791997|MEG|meg
1059646|NCT02791984|Suprasternal|suprasternal
1059647|NCT02791984|echography|echography
1059648|NCT02791984|fluid responsiveness|fluid responsiveness
1059649|NCT02791971|Contraception|contraception
1059650|NCT02791971|Birth control|birth control
1059651|NCT02791971|Social communication|social communication
1059652|NCT02791971|Adolescent|adolescent
1059653|NCT02791971|Social network|social network
1059654|NCT02791971|Health education|health education
1059655|NCT02791971|Reproductive health|reproductive health
1059656|NCT02791945|TBI|tbi
1059657|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
1059658|NCT02791945|Veterans|veterans
1059659|NCT02791945|co-occurring disorders|co-occurring disorders
1059660|NCT02791945|pharmacotherapy|pharmacotherapy
1059661|NCT02791932|Pregnancy|pregnancy
1059662|NCT02791932|Postpartum period|postpartum period
1059663|NCT02791932|Depression|depression
1059664|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
1059665|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
1059666|NCT02791906|Chronic Renal Diseases|chronic renal diseases
1059667|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
1059668|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
1059669|NCT02791906|Cardiac Failure|cardiac failure
1059670|NCT02791906|Congestive Heart Failure|congestive heart failure
1059671|NCT02791906|Heart Decompensation|heart decompensation
1059672|NCT02791906|Heart Failure, Congestive|heart failure, congestive
1059673|NCT02791906|Myocardial Failure|myocardial failure
1059674|NCT02791880|acute kidney injury|acute kidney injury
1059675|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1059676|NCT02791880|genomics|genomics
1059677|NCT02791880|biomarker|biomarker
1059678|NCT02791841|Reading|reading
1059679|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
1059680|NCT02791841|Music|music
1059682|NCT02791841|Action Video Games|action video games
1059683|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
1059684|NCT02791815|selexipag|selexipag
1059685|NCT02791815|pharmacokinetics|pharmacokinetics
1059686|NCT02791815|midazolam|midazolam
1059687|NCT02791802|Lipoprotein(a)|lipoprotein(a)
1059688|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
1059689|NCT02791802|CV disease|cv disease
1059690|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
1059691|NCT02791789|SEMATIC|sematic
1059692|NCT02791789|software|software
1059693|NCT02791776|scoliosis|scoliosis
1059694|NCT02791763|Renal Anemia|renal anemia
1059695|NCT02791763|Japanese|japanese
1059696|NCT02791763|chronic kidney disease|chronic kidney disease
1059697|NCT02791763|Peritoneal dialysis|peritoneal dialysis
1059698|NCT02791763|GSK1278863|gsk1278863
1059699|NCT02791763|Non-dialysis|non-dialysis
1059700|NCT02791750|hormone replacement therapy|hormone replacement therapy
1059701|NCT02791750|breast cancer|breast cancer
1059702|NCT02791750|follow up|follow up
1059703|NCT02791737|Hematologic Malignancy|hematologic malignancy
1059704|NCT02791737|Exercise|exercise
1059705|NCT02791737|Decreased Physical Activity|decreased physical activity
1059706|NCT02791711|Bronchiolitis|bronchiolitis
1059707|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
1059708|NCT02791711|HFNC|hfnc
1059709|NCT02791698|cortisol|cortisol
1059710|NCT02791698|hair|hair
1059711|NCT02791698|urinary|urinary
1059712|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
1059713|NCT02791672|Perioperative Care|perioperative care
1059714|NCT02791672|Breast Reconstruction|breast reconstruction
1059715|NCT02791659|radiation exposure|radiation exposure
1059716|NCT02791659|ERCP|ercp
1059717|NCT02791659|prone|prone
1059718|NCT02791659|left lateral decubitus|left lateral decubitus
1059719|NCT02791607|Circulating tumor cells|circulating tumor cells
1059720|NCT02791607|Head and neck cancer|head and neck cancer
1059721|NCT02791607|Survival Prognosis|survival prognosis
1059722|NCT02791607|P16Ink4A|p16ink4a
1059723|NCT02791607|HPV|hpv
1059724|NCT02791555|pradaxa|pradaxa
1059725|NCT02791555|warfarin|warfarin
1059726|NCT02791542|Asthma|asthma
1059727|NCT02791516|Osteoporosis.|osteoporosis.
1059728|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
1059729|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
1059730|NCT02791516|Bone Diseases.|bone diseases.
1059731|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
1059732|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
1059733|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
1059734|NCT02791503|Efficacy|efficacy
1059735|NCT02791503|Tumor ablation|tumor ablation
1059736|NCT02791503|Chemotherapy|chemotherapy
1059737|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
1059738|NCT02791477|Attune|attune
1059739|NCT02791464|Meditation|meditation
1059740|NCT02791464|TM|tm
1059741|NCT02791464|PTSD|ptsd
1059742|NCT02791464|Trauma|trauma
1059743|NCT02791464|Female Prisoners|female prisoners
1059744|NCT02791451|COPD|copd
1059745|NCT02791451|telemonitoring|telemonitoring
1059746|NCT02791451|exacerbation|exacerbation
1059747|NCT02791425|Brain-Computer Interface|brain-computer interface
1059748|NCT02791425|Intratracheal intubation|intratracheal intubation
1059749|NCT02791425|Mechanical ventilation|mechanical ventilation
1059750|NCT02791425|Nonverbal communication|nonverbal communication
1059751|NCT02791425|Critical illness|critical illness
1059752|NCT02791425|Electroencephalography|electroencephalography
1060255|NCT02788344|Angioplasty|angioplasty
1059753|NCT02791425|Visual Evoked Potential|visual evoked potential
1059754|NCT02791412|left main|left main
1059755|NCT02791412|unprotected|unprotected
1059756|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
1059757|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
1059758|NCT02791399|opioid safety|opioid safety
1059759|NCT02791399|opioid misuse|opioid misuse
1059760|NCT02791399|opioid abuse|opioid abuse
1059761|NCT02791399|patient-centered|patient-centered
1059762|NCT02791399|opioid|opioid
1059763|NCT02791399|opiate|opiate
1059764|NCT02791399|chronic pain|chronic pain
1059765|NCT02791399|primary care|primary care
1059766|NCT02791399|Veteran|veteran
1059767|NCT02791399|clinical care|clinical care
1059768|NCT02791360|Brain|brain
1059769|NCT02791360|Radiotherapy|radiotherapy
1059770|NCT02791360|MRI|mri
1059771|NCT02791360|Sequelae|sequelae
1059772|NCT02791334|PDL1|pdl1
1059773|NCT02791334|PD-L1|pd-l1
1059774|NCT02791295|Type 2 diabetes|type 2 diabetes
1059775|NCT02791295|lifestyle intervention|lifestyle intervention
1059776|NCT02791295|insulin pump treatment|insulin pump treatment
1059777|NCT02791295|body weight|body weight
1059778|NCT02791295|body composition|body composition
1059779|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1059780|NCT02791282|MRI|mri
1059781|NCT02791282|SPECT|spect
1059782|NCT02791230|amyloidosis|amyloidosis
1059783|NCT02791230|amyloid|amyloid
1059784|NCT02791230|transthyretin|transthyretin
1059793|NCT02791009|HF|hf
1059794|NCT02791009|HFrEF|hfref
1059795|NCT02791009|HFpEF|hfpef
1059796|NCT02791009|MRI|mri
1059797|NCT02791009|biomarker|biomarker
1059801|NCT02790983|Registry|registry
1059802|NCT02790983|Spine|spine
1059803|NCT02790983|Surgery|surgery
1059804|NCT02790983|Medical Oncology|medical oncology
1059805|NCT02790983|Radiation Oncology|radiation oncology
1059806|NCT02790983|Neoplasms|neoplasms
1059807|NCT02790944|Germline|germline
1059808|NCT02790944|Pancreatic|pancreatic
1059809|NCT02790944|Genetic Testing|genetic testing
1059810|NCT02790931|diabetic foot|diabetic foot
1059811|NCT02790931|therapeutic exercises|therapeutic exercises
1059812|NCT02790931|foot|foot
1059813|NCT02790931|preventive care|preventive care
1059814|NCT02790931|rehabilitation|rehabilitation
1059815|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
1059816|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
1059817|NCT02790918|MRI|mri
1059818|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
1059819|NCT02790905|Validation questionnaires|validation questionnaires
1059820|NCT02790905|Thai-Myanmar border|thai-myanmar border
1059821|NCT02790892|type 1 diabetes|type 1 diabetes
1059822|NCT02790892|type 2 diabetes|type 2 diabetes
1059823|NCT02790892|children|children
1059824|NCT02790892|adolescents|adolescents
1059825|NCT02790892|young adults|young adults
1059826|NCT02790892|youth|youth
1059827|NCT02790892|transition|transition
1059828|NCT02790892|art therapy|art therapy
1059829|NCT02790892|behavioral therapy|behavioral therapy
1059830|NCT02790879|Transitional care|transitional care
1059831|NCT02790879|teenagers|teenagers
1059832|NCT02790879|cystic fibrosis|cystic fibrosis
1059833|NCT02790879|pulmonary function|pulmonary function
1059834|NCT02790879|nutritional function|nutritional function
1059835|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
1059836|NCT02790866|Decision Aid|decision aid
1059837|NCT02790866|Informed Decision Making|informed decision making
1059838|NCT02790866|Shared Decision making|shared decision making
1059839|NCT02790866|Screening|screening
1059840|NCT02790853|Cancer of Head and Neck|cancer of head and neck
1059841|NCT02790853|Oral Potentially Malignant Disorders|oral potentially malignant disorders
1059842|NCT02790853|OPMD|opmd
1059843|NCT02790853|Multimodal Imaging|multimodal imaging
1059844|NCT02790853|Suspicious oral mucosal lesion|suspicious oral mucosal lesion
1059845|NCT02790853|Pathologic diagnosis of dysplasia|pathologic diagnosis of dysplasia
1059846|NCT02790853|History of resected oral cancer|history of resected oral cancer
1059847|NCT02790853|White Light Examination|white light examination
1059848|NCT02790853|WL|wl
1059849|NCT02790853|Wide-field auto-fluorescence imaging device PS2.1/PS3|wide-field auto-fluorescence imaging device ps2.1/ps3
1059850|NCT02790853|Proflavine Hemisulfate|proflavine hemisulfate
1059851|NCT02790853|High-Resolution Optical System|high-resolution optical system
1059852|NCT02790853|HRME|hrme
1059853|NCT02790853|Brush Biopsy|brush biopsy
1059854|NCT02790853|Tissue Biopsy|tissue biopsy
1059855|NCT02790840|Volunteers|volunteers
1059856|NCT02790801|chronic heart failure|chronic heart failure
1059857|NCT02790801|atrial fibrillation|atrial fibrillation
1059858|NCT02790801|anticoagulant|anticoagulant
1059859|NCT02790762|stem cells|stem cells
1059860|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
1059861|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
1059862|NCT02790762|Pneumoconiosis|pneumoconiosis
1059863|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
1059864|NCT02790749|Intra-articular pathology|intra-articular pathology
1060256|NCT02788318|Epilepsy|epilepsy
1059865|NCT02790749|Adult hip dysplasia|adult hip dysplasia
1059866|NCT02790749|Labral tear, hip|labral tear, hip
1059867|NCT02790749|Chondromalacia, hip|chondromalacia, hip
1059872|NCT02790697|Indirect calorimetry|indirect calorimetry
1059873|NCT02790697|ICALIC Study|icalic study
1059874|NCT02790697|Energy expenditure|energy expenditure
1059875|NCT02790697|VO2|vo2
1059876|NCT02790697|VCO2|vco2
1059877|NCT02790697|Respiratory quotient|respiratory quotient
1059878|NCT02790658|Grumixama|grumixama
1059879|NCT02790658|Urolithins|urolithins
1059880|NCT02790658|Anthocyanins|anthocyanins
1059881|NCT02790658|Metabolomic Approach|metabolomic approach
1059882|NCT02790658|Ellagitannins|ellagitannins
1059883|NCT02790658|Subjects|subjects
1059884|NCT02790645|Type 1 diabetes|type 1 diabetes
1059885|NCT02790645|Health technologies|health technologies
1059886|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1059887|NCT02790645|Telemedicine|telemedicine
1059888|NCT02790645|Glycemic variability|glycemic variability
1059889|NCT02790645|Inflammatory markers,|inflammatory markers,
1059890|NCT02790645|Oxidative stress|oxidative stress
1059891|NCT02790645|Depression|depression
1059892|NCT02790645|Quality of life|quality of life
1059893|NCT02790645|Cost-effectiveness|cost-effectiveness
1059894|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
1059895|NCT02790632|Nimodipine|nimodipine
1059896|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1059897|NCT02790567|diagnostic performance|diagnostic performance
1059898|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1059899|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
1059900|NCT02790567|immunoassay|immunoassay
1059901|NCT02790567|pretest scoring systems|pretest scoring systems
1059902|NCT02790567|4Ts score|4ts score
1059903|NCT02790567|HEP score|hep score
1059904|NCT02790541|aging|aging
1059905|NCT02790541|HBOT|hbot
1059906|NCT02790541|reverse|reverse
1059907|NCT02790541|angiogenesis|angiogenesis
1059908|NCT02790541|elderly|elderly
1059909|NCT02790541|mitochohndria|mitochohndria
1059910|NCT02790528|statin|statin
1059911|NCT02790528|vasospastic angina|vasospastic angina
1059912|NCT02790476|Safe|safe
1059913|NCT02790476|Prescribing|prescribing
1059914|NCT02790476|Opioids|opioids
1059915|NCT02790463|Allopurinol|allopurinol
1059916|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
1059917|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
1059918|NCT02790372|Nursing homes|nursing homes
1059919|NCT02790372|Norway|norway
1059920|NCT02790359|Carbon dioxide|carbon dioxide
1059922|NCT02790359|Colonoscopy|colonoscopy
1059923|NCT02790346|hemiparesis|hemiparesis
1059924|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
1059925|NCT02790320|Eribulin mesylate|eribulin mesylate
1059926|NCT02790320|Halaven|halaven
1059927|NCT02790320|Breast cancer|breast cancer
1059928|NCT02790307|multiple sclerosis|multiple sclerosis
1059929|NCT02790307|overactive bladder|overactive bladder
1733265|NCT00001406|Eosinophils|eosinophils
1098028|NCT02563405|CCB|ccb
1059930|NCT02790307|urinary incontinence|urinary incontinence
1059931|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
1059932|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
1059933|NCT02790268|Cionni Ring|cionni ring
1059934|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
1059935|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
1059936|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
1059937|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
1059938|NCT02790216|Image guided brachytherapy|image guided brachytherapy
1059939|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
1059940|NCT02790138|Drug Therapy|drug therapy
1059941|NCT02790112|Body Mass Index|body mass index
1059942|NCT02790112|Body Composition|body composition
1059943|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
1059944|NCT02790112|Bone Development|bone development
1059945|NCT02790112|Gonadal Disorders|gonadal disorders
1059946|NCT02790112|Fertility|fertility
1059947|NCT02790112|Overweight|overweight
1059948|NCT02790112|Obesity|obesity
1059949|NCT02790112|Menarche|menarche
1059950|NCT02790099|Pain|pain
1060073|NCT02789371|dry suction technique|dry suction technique
1059951|NCT02790099|Postoperative pain control|postoperative pain control
1059952|NCT02790099|Rectus sheath block|rectus sheath block
1059953|NCT02790099|Intrathecal morphine|intrathecal morphine
1059954|NCT02790099|Caesarean section|caesarean section
1059955|NCT02790086|hypothermia|hypothermia
1059956|NCT02790086|prevalence|prevalence
1059957|NCT02790086|perioperative|perioperative
1059958|NCT02790086|anemia|anemia
1059959|NCT02790086|myocardial injury|myocardial injury
1059960|NCT02790086|troponin T|troponin t
1059961|NCT02790086|noncardiac surgery|noncardiac surgery
1059962|NCT02790073|Calciphylaxis|calciphylaxis
1059963|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
1059964|NCT02790073|Dialysis|dialysis
1059965|NCT02790073|End Stage Renal Disease|end stage renal disease
1059966|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
1059967|NCT02790073|Calcification|calcification
1059968|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
1059969|NCT02790073|Calcinosis|calcinosis
1059970|NCT02790073|Metabolic Diseases|metabolic diseases
1059971|NCT02790060|diabetes|diabetes
1059972|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1059973|NCT02790047|Exercise Therapy|exercise therapy
1059974|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
1059975|NCT02790047|Physical Fitness|physical fitness
1059976|NCT02790047|Quality of Life|quality of life
1059977|NCT02790008|echocardiography|echocardiography
1059978|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
1059979|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
1059980|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
1059981|NCT02789982|PTSD|ptsd
1059982|NCT02789982|Trauma related disorders|trauma related disorders
1059983|NCT02789982|Reconsolidation blockade|reconsolidation blockade
1059984|NCT02789982|Paris attacks|paris attacks
1059985|NCT02789956|Internal connection|internal connection
1059986|NCT02789956|Cobalt/Chrome|cobalt/chrome
1059987|NCT02789956|Cad-cam Framework|cad-cam framework
1059988|NCT02789956|marginal bone level|marginal bone level
1059989|NCT02789943|IHD Normal EF|ihd normal ef
1059990|NCT02789930|Weight estimation|weight estimation
1059991|NCT02789930|Patient safety|patient safety
1059992|NCT02789917|ACS|acs
1059993|NCT02789917|Triple-Therapy|triple-therapy
1059994|NCT02789917|AF|af
1059995|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
1059996|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
1059997|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
1059998|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
1059999|NCT02789865|Acute appendicitis|acute appendicitis
1060000|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
1060001|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
1060002|NCT02789865|Endoscopic therapy|endoscopic therapy
1060003|NCT02789865|Appendectomy|appendectomy
1060004|NCT02789865|Antibiotic Therapy|antibiotic therapy
1060005|NCT02789787|Cleft Lip|cleft lip
1060006|NCT02789787|Palate|palate
1060007|NCT02789787|Class III|class iii
1060008|NCT02789787|Malocclusion|malocclusion
1060009|NCT02789787|Protraction|protraction
1060010|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
1060011|NCT02789761|Vascular function|vascular function
1060012|NCT02789761|cognitive function|cognitive function
1060013|NCT02789735|Pregnancy|pregnancy
1060014|NCT02789735|laser therapy|laser therapy
1060015|NCT02789735|persistent pain|persistent pain
1060016|NCT02789735|pelvic pain|pelvic pain
1060017|NCT02789722|Mate|mate
1060018|NCT02789722|Vascular protection|vascular protection
1060019|NCT02789722|Endothelial function|endothelial function
1060020|NCT02789722|Ilex paraguariensis|ilex paraguariensis
1060021|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
1060022|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
1060023|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
1060024|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
1060025|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
1060026|NCT02789644|Pharmacokinetics|pharmacokinetics
1060027|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
1060028|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
1060029|NCT02789592|Parkinson Disease|parkinson disease
1060030|NCT02789592|Randomized Controlled Trial|randomized controlled trial
1060031|NCT02789592|Clinical Trial|clinical trial
1060032|NCT02789592|Melatonin|melatonin
1060033|NCT02789592|Clonazepam|clonazepam
1060034|NCT02789579|prophylactic|prophylactic
1060035|NCT02789579|Urinary Tract Infections|urinary tract infections
1060036|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
1060037|NCT02789566|Primaquine|primaquine
1060038|NCT02789566|Pharmacokinetic|pharmacokinetic
1060039|NCT02789553|Glucose digestion|glucose digestion
1060040|NCT02789553|Bypass surgery|bypass surgery
1060041|NCT02789553|C13-glucose tracer|c13-glucose tracer
1060042|NCT02789553|Insulin secretion|insulin secretion
1060043|NCT02789540|COPD symptoms|copd symptoms
1060044|NCT02789527|healthy volunteers|healthy volunteers
1060045|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1060046|NCT02789514|paediatric|paediatric
1060047|NCT02789501|Catheter|catheter
1060048|NCT02789501|Dysfunctions|dysfunctions
1060049|NCT02789501|Blood Stream Infections|blood stream infections
1060050|NCT02789501|Haemodialysis|haemodialysis
1060051|NCT02789501|Taurolidine|taurolidine
1060052|NCT02789501|Tunneled|tunneled
1060053|NCT02789436|halitosis|halitosis
1060054|NCT02789436|chronic periodontitis|chronic periodontitis
1060055|NCT02789436|probiotic|probiotic
1060056|NCT02789410|Cesarean delivery|cesarean delivery
1060057|NCT02789410|Analgesia|analgesia
1060058|NCT02789410|Intrathecal opioids|intrathecal opioids
1060059|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
1060257|NCT02788318|SUDEP|sudep
1060060|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
1060061|NCT02789397|Rituximab|rituximab
1060062|NCT02789397|Azathioprine|azathioprine
1060063|NCT02789397|primary immunodeficiency|primary immunodeficiency
1060064|NCT02789397|GLIILD|gliild
1060065|NCT02789397|CVID|cvid
1060066|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
1060067|NCT02789384|CINSARC|cinsarc
1060068|NCT02789384|biomarker|biomarker
1060069|NCT02789384|efficacy|efficacy
1060070|NCT02789384|pronostic|pronostic
1060071|NCT02789371|EUS-FNA|eus-fna
1060072|NCT02789371|modified wet suction technique|modified wet suction technique
1060074|NCT02789358|cryotherapy|cryotherapy
1060075|NCT02789345|T790M|t790m
1060076|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
1060077|NCT02789332|carboplatin|carboplatin
1060078|NCT02789332|olaparib|olaparib
1060079|NCT02789332|pCR|pcr
1060080|NCT02789332|neoadjuvant|neoadjuvant
1060081|NCT02789332|triple-negative|triple-negative
1060178|NCT02788864|Primaquine|primaquine
1060082|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
1060083|NCT02789332|BRCA1/2|brca1/2
1060084|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
1060085|NCT02789332|breast cancer|breast cancer
1060086|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
1060087|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
1060088|NCT02789319|BGMS|bgms
1060089|NCT02789319|Diabetes|diabetes
1060090|NCT02789319|Patient Use|patient use
1060091|NCT02789306|Preventive therapy|preventive therapy
1060092|NCT02789306|Dental implants|dental implants
1060093|NCT02789293|Glaucoma|glaucoma
1060094|NCT02789293|Ultrasound|ultrasound
1060095|NCT02789293|Ciliary body|ciliary body
1060096|NCT02789267|Head and Neck Cancer|head and neck cancer
1060097|NCT02789267|Quality of Life|quality of life
1060098|NCT02789267|Dietary support|dietary support
1060099|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
1060100|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
1060101|NCT02789254|stem cell transplantation|stem cell transplantation
1060102|NCT02789254|complete remission|complete remission
1060103|NCT02789254|CD135|cd135
1060104|NCT02789254|antibodies|antibodies
1060105|NCT02789254|Leukemia|leukemia
1060106|NCT02789254|AML|aml
1060107|NCT02789254|Fc-optimized|fc-optimized
1060108|NCT02789241|Endotoxin|endotoxin
1060109|NCT02789241|healthy|healthy
1060110|NCT02789241|volunteers|volunteers
1060111|NCT02789241|males|males
1060112|NCT02789241|females|females
1060113|NCT02789215|Child care food costs|child care food costs
1060114|NCT02789215|Meal participation rates|meal participation rates
1060115|NCT02789215|Child and Adult Care Food Program|child and adult care food program
1060116|NCT02789202|dental caries|dental caries
1060117|NCT02789202|deciduous tooth|deciduous tooth
1060118|NCT02789176|Phenobarbital|phenobarbital
1060119|NCT02789176|EEG|eeg
1060120|NCT02789176|family impact|family impact
1060121|NCT02789176|neurodevelopment|neurodevelopment
1060122|NCT02789163|breast|breast
1060123|NCT02789163|ultrasound|ultrasound
1060124|NCT02789163|diagnostic exam|diagnostic exam
1060125|NCT02789163|automated volume breast scanner|automated volume breast scanner
1060126|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1060127|NCT02789124|fluid responsiveness|fluid responsiveness
1060128|NCT02789124|carotid artery flow time|carotid artery flow time
1060129|NCT02789124|passive leg raise|passive leg raise
1060130|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1060131|NCT02789098|Ventricular remodeling|ventricular remodeling
1060132|NCT02789098|Biomarkers|biomarkers
1060133|NCT02789098|Coronary endothelial function|coronary endothelial function
1060134|NCT02789098|Positron Emission Tomography|positron emission tomography
1060135|NCT02789085|TENS|tens
1060136|NCT02789085|ULF-TENS|ulf-tens
1060137|NCT02789085|ANS|ans
1060138|NCT02789085|Dentistry|dentistry
1060139|NCT02789085|TMD|tmd
1060140|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
1060141|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
1060142|NCT02789059|congenital myopathy|congenital myopathy
1060143|NCT02789059|motor neurone diseases|motor neurone diseases
1060144|NCT02789046|adult|adult
1060145|NCT02789046|vascular access|vascular access
1060146|NCT02789046|preoperative period|preoperative period
1060147|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
1060148|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
1060149|NCT02789033|chitosan|chitosan
1060150|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
1060151|NCT02789020|Rasagiline|rasagiline
1060152|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
1060153|NCT02788981|advanced breast cancer|advanced breast cancer
1060154|NCT02788981|nab-paclitaxel|nab-paclitaxel
1060155|NCT02788981|mifepristone|mifepristone
1060156|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
1060157|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
1060254|NCT02788344|Quality of health care|quality of health care
1060158|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
1060159|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
1060160|NCT02788968|Conflict detection|conflict detection
1060161|NCT02788968|Reasoning|reasoning
1060162|NCT02788955|Protein|protein
1060163|NCT02788955|Diet intervention|diet intervention
1060164|NCT02788955|Muscle|muscle
1060165|NCT02788955|Colorectal cancer|colorectal cancer
1060166|NCT02788942|Port|port
1060167|NCT02788942|Infection|infection
1060168|NCT02788942|cholecystectomy|cholecystectomy
1060169|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
1060170|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
1060171|NCT02788929|Fitbit Charge HR|fitbit charge hr
1060172|NCT02788916|Drug Therapy|drug therapy
1060173|NCT02788903|Obesity Counseling|obesity counseling
1060174|NCT02788864|Forest ranger|forest ranger
1060175|NCT02788864|P.falciparum|p.falciparum
1060176|NCT02788864|P.vivax|p.vivax
1060177|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
1060179|NCT02788851|Stimulant Medication|stimulant medication
1060180|NCT02788851|Exercise|exercise
1060181|NCT02788851|Functional Outcome|functional outcome
1060182|NCT02788851|Effectiveness|effectiveness
1060183|NCT02788851|Symptoms|symptoms
1060184|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
1060185|NCT02788838|Energy Intake|energy intake
1060186|NCT02788838|Commercials|commercials
1060187|NCT02788838|Children|children
1060188|NCT02788799|ST Elevation|st elevation
1060189|NCT02788799|LCX Artery|lcx artery
1060190|NCT02788786|chlorhexidine|chlorhexidine
1060191|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
1060192|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
1060193|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
1060194|NCT02788734|CTS|cts
1060195|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
1060196|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
1060197|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
1060198|NCT02788734|Pressure Palsies|pressure palsies
1060199|NCT02788734|CMT|cmt
1060200|NCT02788734|HNPP|hnpp
1060201|NCT02788708|paclitaxel|paclitaxel
1060202|NCT02788708|lenvatinib|lenvatinib
1060203|NCT02788695|Visual Nonspecific|visual nonspecific
1060204|NCT02788682|VDBP|vdbp
1060205|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
1060206|NCT02788682|interferon based therapy|interferon based therapy
1060207|NCT02788682|Egypt|egypt
1060208|NCT02788656|heart failure|heart failure
1060209|NCT02788656|neprilysin|neprilysin
1060210|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
1060211|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
1060212|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
1734405|NCT00000406|Depression|depression
1060213|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
1060214|NCT02788552|Neurological|neurological
1060215|NCT02788552|Diet and Nutrition|diet and nutrition
1060216|NCT02788552|Mental Health|mental health
1060217|NCT02788539|Chronic Pain|chronic pain
1060218|NCT02788539|mhealth|mhealth
1060219|NCT02788539|Integrative Medicine|integrative medicine
1060220|NCT02788539|MBSR|mbsr
1060221|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1060222|NCT02788539|Web based|web based
1060223|NCT02788539|Internet Based|internet based
1060224|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1060225|NCT02788526|Chemoembolization|chemoembolization
1060226|NCT02788526|Adjuvant therapy|adjuvant therapy
1060227|NCT02788526|Hepatocellular|hepatocellular
1060228|NCT02788526|Microvessels invasion|microvessels invasion
1060229|NCT02788500|Epidemiology|epidemiology
1060230|NCT02788500|Sports medicine|sports medicine
1060231|NCT02788500|Research protocol|research protocol
1060232|NCT02788500|Athletic injuries|athletic injuries
1060233|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
1060234|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
1060235|NCT02788448|Large hole closure device|large hole closure device
1060236|NCT02788396|STEMI|stemi
1060237|NCT02788396|PPCI|ppci
1060238|NCT02788396|post-dilatation|post-dilatation
1060239|NCT02788396|coronary microcirculation|coronary microcirculation
1060240|NCT02788370|Positive expiratory pressure|positive expiratory pressure
1060241|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
1060242|NCT02788370|Exercise|exercise
1060243|NCT02788370|Older people|older people
1060244|NCT02788357|motor training|motor training
1060245|NCT02788357|motor recovery|motor recovery
1060246|NCT02788357|human|human
1060247|NCT02788357|neuroplasticity|neuroplasticity
1060248|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
1060249|NCT02788344|Observational study|observational study
1060250|NCT02788344|Myocardial revascularization|myocardial revascularization
1060251|NCT02788344|Thrombolytic therapy|thrombolytic therapy
1060252|NCT02788344|Hospital mortality|hospital mortality
1060253|NCT02788344|Hemorrhage|hemorrhage
1060259|NCT02788292|acetylcysteine|acetylcysteine
1060260|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
1060261|NCT02788292|autologous fat grafting|autologous fat grafting
1060262|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
1060263|NCT02788266|Cervical lesion|cervical lesion
1060264|NCT02788266|gingival recession|gingival recession
1060265|NCT02788266|restorative materials|restorative materials
1060266|NCT02788253|Mallampati|mallampati
1060267|NCT02788253|Intubation difficult|intubation difficult
1060268|NCT02788253|Mask ventilation difficult|mask ventilation difficult
1060269|NCT02788227|Ebola Vaccine|ebola vaccine
1060270|NCT02788214|Gastric Cancer|gastric cancer
1060271|NCT02788214|Bacterial Risk Factors|bacterial risk factors
1060272|NCT02788214|DNA Methylation|dna methylation
1060273|NCT02788214|DNA Sequencing|dna sequencing
1060274|NCT02788214|Biobank|biobank
1060275|NCT02788201|COXEN|coxen
1060276|NCT02788201|Bladder Cancer|bladder cancer
1060277|NCT02788201|Molecular Profiles|molecular profiles
1060278|NCT02788201|Algorithm|algorithm
1060279|NCT02788201|Biomarkers|biomarkers
1060280|NCT02788188|First in Human|first in human
1060281|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
1060282|NCT02788188|Tc Bovine-Derived|tc bovine-derived
1060283|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
1060284|NCT02788175|HIV Immune Therapy|hiv immune therapy
1060285|NCT02788175|Monoclonal Antibody|monoclonal antibody
1060286|NCT02788175|Integrin|integrin
1060287|NCT02788149|Ultrasonography|ultrasonography
1060288|NCT02788149|Submental|submental
1060289|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
1060290|NCT02788149|Tongue base thickness|tongue base thickness
1060291|NCT02788149|Polysomnography|polysomnography
1060292|NCT02788123|De-Nol|de-nol
1060293|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
1060294|NCT02788123|Pantoprazole|pantoprazole
1060295|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
1060296|NCT02788123|Russia|russia
1060297|NCT02788097|blastocysts|blastocysts
1060298|NCT02788097|progesterone|progesterone
1060299|NCT02788097|implantation|implantation
1060300|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
1060301|NCT02788084|Next Generation Sequencing|next generation sequencing
1060302|NCT02788084|Cell free DNA|cell free dna
1060303|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
1060304|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
1060305|NCT02788071|Microbiota|microbiota
1060306|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1060307|NCT02788058|EGFR Positive|egfr positive
1060308|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
1060309|NCT02788058|Limited Metastases|limited metastases
1060310|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
1060311|NCT02787941|acute coronary syndrome|acute coronary syndrome
1060312|NCT02787941|medication adherence|medication adherence
1060313|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
1060314|NCT02787941|Vietnam|vietnam
1060315|NCT02787915|dendritic cells|dendritic cells
1060316|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
1060317|NCT02787915|DC vaccine|dc vaccine
1060318|NCT02787863|Pneumococcal vaccine|pneumococcal vaccine
1060319|NCT02787863|Polioxidonium|polioxidonium
1060320|NCT02787837|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1060321|NCT02787837|Abiraterone Acetate|abiraterone acetate
1060322|NCT02787837|Biomarkers|biomarkers
1060323|NCT02787824|iron deficiency|iron deficiency
1060324|NCT02787824|hemodialysis|hemodialysis
1060325|NCT02787811|IUI|iui
1060326|NCT02787811|Pregnancy rate|pregnancy rate
1060327|NCT02787811|predictors|predictors
1060328|NCT02787798|Nervous System|nervous system
1060329|NCT02787798|Cardiac disease|cardiac disease
1060330|NCT02787785|Subcutaneous|subcutaneous
1060331|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1060332|NCT02787785|MADIT|madit
1060333|NCT02787785|Diabetes|diabetes
1060334|NCT02787785|Myocardial Infarction|myocardial infarction
1060335|NCT02787759|stroke|stroke
1060336|NCT02787759|walking|walking
1060337|NCT02787759|balance|balance
1060338|NCT02787759|exercise|exercise
1060339|NCT02787746|AD|ad
1060340|NCT02787746|Donepezil|donepezil
1060341|NCT02787746|Safety|safety
1060342|NCT02787733|performance|performance
1060343|NCT02787733|recovery|recovery
1060344|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1060345|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
1060346|NCT02787720|Rehabilitation Plan|rehabilitation plan
1060347|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
1060348|NCT02787720|Survivor|survivor
1060349|NCT02787720|Randomized Controlled Trial|randomized controlled trial
1060350|NCT02787707|Breast cancer|breast cancer
1060351|NCT02787707|Traditional medicine|traditional medicine
1060352|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
1060353|NCT02787707|Bunium Persicum|bunium persicum
1060354|NCT02787707|Rhus Coriaria|rhus coriaria
1060355|NCT02787694|stroke|stroke
1060356|NCT02787694|walking|walking
1060359|NCT02787668|childhood obesity|childhood obesity
1060360|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1060361|NCT02787668|insulin resistance|insulin resistance
1060362|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
1060363|NCT02787655|Aging|aging
1060364|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
1060365|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
1060366|NCT02787629|D007440|d007440
1060367|NCT02787590|Neurology|neurology
1060368|NCT02787577|Sleep Duration|sleep duration
1060369|NCT02787577|Sleep Quality|sleep quality
1060370|NCT02787577|Body Composition|body composition
1060371|NCT02787577|Energy Intake|energy intake
1060372|NCT02787577|Energy Expenditure|energy expenditure
1060373|NCT02787577|Energy Balance|energy balance
1060374|NCT02787577|Cardiovascular Risk|cardiovascular risk
1060376|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
1060377|NCT02787538|Decision Aids|decision aids
1060379|NCT02787512|ERCP|ercp
1060380|NCT02787512|stent|stent
1060381|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
1060382|NCT02787499|Drug resistance|drug resistance
1060383|NCT02787499|Standard of care|standard of care
1060384|NCT02787499|sub-saharan africa|sub-saharan africa
1060385|NCT02787499|antiretroviral therapy|antiretroviral therapy
1060386|NCT02787499|diagnostics|diagnostics
1060387|NCT02787499|implementation|implementation
1060388|NCT02787486|Down syndrome|down syndrome
1060389|NCT02787486|Edwards syndrome|edwards syndrome
1060390|NCT02787486|Patau syndrome|patau syndrome
1060391|NCT02787486|Klinefelter syndrome|klinefelter syndrome
1060392|NCT02787486|DiGeorge syndrome|digeorge syndrome
1060393|NCT02787486|Chromosome Deletion|chromosome deletion
1060394|NCT02787486|Aneuploidy|aneuploidy
1060395|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
1060396|NCT02787473|Pemetrexed|pemetrexed
1060397|NCT02787473|Radiosensitivity|radiosensitivity
1060398|NCT02787460|Parenting|parenting
1060399|NCT02787460|Family Relations|family relations
1060400|NCT02787460|Marriage|marriage
1060401|NCT02787460|Relationships|relationships
1060402|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1060403|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
1060404|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
1060405|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
1060406|NCT02787434|African american men|african american men
1060407|NCT02787434|prostate cancer screening|prostate cancer screening
1734508|NCT00000389|Male|male
1060408|NCT02787434|web-based decision aid|web-based decision aid
1060409|NCT02787434|informed decision making|informed decision making
1060410|NCT02787434|shared decision-making|shared decision-making
1060411|NCT02787421|Reconstructive Surgery|reconstructive surgery
1060412|NCT02787421|Rhinoplasty|rhinoplasty
1060413|NCT02787382|cytomegalovirus|cytomegalovirus
1060415|NCT02787382|prenatal diagnosis|prenatal diagnosis
1060416|NCT02787382|congenital infections|congenital infections
1060417|NCT02787382|fetal abnormalities|fetal abnormalities
1060418|NCT02787382|echocardiography|echocardiography
1060419|NCT02787382|myocardial deformation|myocardial deformation
1060422|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
1060423|NCT02787330|pediatric cancer|pediatric cancer
1060424|NCT02787330|psychosocial|psychosocial
1060425|NCT02787330|siblings|siblings
1060426|NCT02787317|bivalirudin|bivalirudin
1060427|NCT02787317|myocardial injure|myocardial injure
1060428|NCT02787304|NAFLD activity score|nafld activity score
1060429|NCT02787304|ASBTi|asbti
1060430|NCT02787304|MRI PDFF|mri pdff
1060431|NCT02787304|NAS|nas
1060432|NCT02787304|NAFLD|nafld
1060433|NCT02787304|liver disease|liver disease
1060434|NCT02787304|ASBT|asbt
1060435|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
1060436|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1060437|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
1060438|NCT02787304|fatty liver|fatty liver
1060439|NCT02787304|NASH|nash
1060440|NCT02787278|rtPA|rtpa
1060441|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
1060442|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
1060443|NCT02787265|Virtual expert registry|virtual expert registry
1060444|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
1060445|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
1060572|NCT02786706|Intracranial Pressure|intracranial pressure
1060446|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
1060447|NCT02787213|proteomics|proteomics
1060448|NCT02787213|pregnancy|pregnancy
1060449|NCT02787213|biomarkers|biomarkers
1060450|NCT02787213|preterm birth|preterm birth
1060451|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
1060452|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
1060453|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
1060454|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
1060455|NCT02787174|Asthma|asthma
1060456|NCT02787174|Medication adherence|medication adherence
1060558|NCT02786771|Meditation|meditation
1060457|NCT02787174|Intervention study|intervention study
1060458|NCT02787161|Chronic Kidney Disease|chronic kidney disease
1060459|NCT02787161|Hemodialysis|hemodialysis
1060460|NCT02787161|Hemodiafiltration|hemodiafiltration
1060461|NCT02787161|Renal Replacement Therapy|renal replacement therapy
1060462|NCT02787161|Physical Activity|physical activity
1060463|NCT02787161|Accelerometer|accelerometer
1060464|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
1060465|NCT02787148|psychotherapy|psychotherapy
1060466|NCT02787148|cardiovascular health|cardiovascular health
1060467|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
1060468|NCT02787135|Delusions|delusions
1060469|NCT02787135|Schizophrenia|schizophrenia
1060470|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
1060471|NCT02787135|Emotion|emotion
1060472|NCT02787135|Emotion regulation|emotion regulation
1060473|NCT02787135|self-esteem|self-esteem
1060474|NCT02787135|sleep quality|sleep quality
1060475|NCT02787135|Efficacy of change|efficacy of change
1060476|NCT02787122|Schizophrenia|schizophrenia
1060477|NCT02787122|psychotic disorders|psychotic disorders
1060478|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
1060479|NCT02787122|emotion regulation|emotion regulation
1060480|NCT02787122|self-esteem|self-esteem
1060481|NCT02787122|randomized-controlled trial|randomized-controlled trial
1060482|NCT02787109|Safety|safety
1060483|NCT02787109|Immunogenicity|immunogenicity
1060484|NCT02787109|Phase I|phase i
1060485|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
1060486|NCT02787096|laxi-MRI|laxi-mri
1060487|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
1060488|NCT02787083|Interstitial Cystitis|interstitial cystitis
1060489|NCT02787044|influenza vaccine|influenza vaccine
1060490|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
1060491|NCT02787044|heart failure|heart failure
1060492|NCT02787044|myocardial infarction|myocardial infarction
1060493|NCT02787044|clinical trial|clinical trial
1060494|NCT02787031|hip fracture|hip fracture
1060495|NCT02787031|geriatric|geriatric
1060496|NCT02787031|epidemiology|epidemiology
1060497|NCT02787031|practice variation|practice variation
1060498|NCT02787031|anesthesia|anesthesia
1060499|NCT02787018|Brachial plexus block|brachial plexus block
1060500|NCT02787018|Ropivacaine|ropivacaine
1060501|NCT02787018|Dexmedetomidine|dexmedetomidine
1060502|NCT02787018|Dexamethasone|dexamethasone
1060503|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
1060504|NCT02787005|PD1|pd1
1060505|NCT02787005|PD-1|pd-1
1060506|NCT02787005|PDL1|pdl1
1060507|NCT02787005|PD-L1|pd-l1
1060508|NCT02786992|Misoprostol|misoprostol
1060509|NCT02786992|Oxytocin|oxytocin
1060510|NCT02786992|Carbetocin|carbetocin
1060511|NCT02786992|Prevention|prevention
1060512|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
1060513|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1060514|NCT02786979|Arteriosclerosis|arteriosclerosis
1060515|NCT02786979|beraprost|beraprost
1060516|NCT02786979|Aspirin|aspirin
1060517|NCT02786966|Cervical spine injuries|cervical spine injuries
1060518|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
1060519|NCT02786966|Emergency Medical Services|emergency medical services
1060520|NCT02786966|Paramedic|paramedic
1060521|NCT02786966|Cervical spine fracture|cervical spine fracture
1060522|NCT02786953|Sleep|sleep
1060523|NCT02786953|Adherence|adherence
1060524|NCT02786953|Diabetes Management|diabetes management
1060525|NCT02786953|Adolescent|adolescent
1060526|NCT02786940|remote|remote
1060527|NCT02786940|cardiac monitoring|cardiac monitoring
1060528|NCT02786940|mortality|mortality
1060529|NCT02786927|HANDIHALER|handihaler
1060530|NCT02786927|Dry Powder Inhaler|dry powder inhaler
1060531|NCT02786927|COPD|copd
1060532|NCT02786927|ELLIPTA|ellipta
1060533|NCT02786927|Inhaler preference attributes|inhaler preference attributes
1060534|NCT02786875|lifestyle|lifestyle
1060535|NCT02786875|low glycemic index diet|low glycemic index diet
1060536|NCT02786875|exercise|exercise
1060537|NCT02786875|vitamin D|vitamin d
1060538|NCT02786875|breast cancer|breast cancer
1060539|NCT02786875|Mediterranean diet|mediterranean diet
1060540|NCT02786862|mechanical ventilation|mechanical ventilation
1060541|NCT02786862|independent ventilation|independent ventilation
1060542|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
1060543|NCT02786862|thoracic anesthesia|thoracic anesthesia
1060544|NCT02786849|Electric Stimulation|electric stimulation
1060545|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
1060546|NCT02786836|acute liver failure|acute liver failure
1060547|NCT02786836|methacetin|methacetin
1060548|NCT02786836|breath test|breath test
1060549|NCT02786836|severe acute liver injury|severe acute liver injury
1060550|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
1060551|NCT02786836|ALFSG Registry|alfsg registry
1060552|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
1060553|NCT02786797|breast cancer|breast cancer
1060554|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
1060555|NCT02786797|cognitive impairment|cognitive impairment
1060556|NCT02786771|Stress Management|stress management
1060557|NCT02786771|Mindfulness|mindfulness
1060559|NCT02786771|Stress Resilience|stress resilience
1060560|NCT02786732|Psoriasis|psoriasis
1060561|NCT02786719|Sargramostim|sargramostim
1060562|NCT02786719|Cyclophosphamide|cyclophosphamide
1060563|NCT02786719|Topotecan|topotecan
1060564|NCT02786719|Cisplatin|cisplatin
1060565|NCT02786719|Dexrazoxane|dexrazoxane
1060566|NCT02786719|Doxorubicin|doxorubicin
1060567|NCT02786719|Etoposide|etoposide
1060568|NCT02786719|Filgrastim|filgrastim
1060569|NCT02786719|Vincristine|vincristine
1060570|NCT02786719|Mesna|mesna
1060571|NCT02786706|Traumatic Brain Injury|traumatic brain injury
1060573|NCT02786706|Ultrasonography|ultrasonography
1060574|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
1060575|NCT02786706|Intracranial Hypertension|intracranial hypertension
1060576|NCT02786706|Acute brain injuries|acute brain injuries
1060577|NCT02786693|TEP-scan|tep-scan
1060578|NCT02786654|Acute myocardial infarction|acute myocardial infarction
1060579|NCT02786654|mortality|mortality
1060580|NCT02786654|evidence-based care|evidence-based care
1060581|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1060582|NCT02786654|β blockers|β blockers
1060583|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1060584|NCT02786641|induction chemotherapy|induction chemotherapy
1060585|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
1060586|NCT02786641|docetaxel|docetaxel
1060587|NCT02786641|cisplatin|cisplatin
1060588|NCT02786641|xeloda|xeloda
1060589|NCT02786641|nomogram|nomogram
1060590|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
1060591|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
1060592|NCT02786589|Plasmodium vivax|plasmodium vivax
1060593|NCT02786589|Immunotherapy|immunotherapy
1060594|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
1060595|NCT02786576|Adalimumab|adalimumab
1060596|NCT02786563|power doppler (PD)|power doppler (pd)
1060597|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
1060598|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1060599|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
1060600|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
1060601|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
1060602|NCT02786537|Hepatitis C|hepatitis c
1060603|NCT02786524|Palliative Care|palliative care
1060604|NCT02786524|Triage|triage
1060605|NCT02786524|Symptom Evaluation|symptom evaluation
1060606|NCT02786524|Chemotherapy|chemotherapy
1060607|NCT02786524|Patient Distress|patient distress
1060608|NCT02786498|Tibial Shaft|tibial shaft
1060609|NCT02786498|Tibia|tibia
1060610|NCT02786498|Femoral Shaft|femoral shaft
1060611|NCT02786498|Femur|femur
1060612|NCT02786498|Vitamin D|vitamin d
1060613|NCT02786498|Fracture Healing|fracture healing
1060614|NCT02786485|BPX-501|bpx-501
1060615|NCT02786485|Rimiducid|rimiducid
1060616|NCT02786485|AP1903|ap1903
1060617|NCT02786485|Hematological malignancies|hematological malignancies
1060618|NCT02786485|Hematologic diseases|hematologic diseases
1060619|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
1060620|NCT02786485|Lymphomas|lymphomas
1060621|NCT02786485|Multiple myeloma|multiple myeloma
1060622|NCT02786472|Bystander behaviors|bystander behaviors
1060623|NCT02786472|Incoming students|incoming students
1060624|NCT02786472|CampusSave|campussave
1060625|NCT02786472|Prevention|prevention
1060626|NCT02786472|Sexual Assault|sexual assault
1060627|NCT02786472|Incapacitation|incapacitation
1060628|NCT02786459|Prostate|prostate
1060629|NCT02786459|Local Recurrence|local recurrence
1060630|NCT02786459|Radical Prostatectomy|radical prostatectomy
1060631|NCT02786446|Lidocaine gel|lidocaine gel
1060632|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
1060633|NCT02786446|Naproxen sodium|naproxen sodium
1060634|NCT02786446|Pain score|pain score
1060635|NCT02786420|pregnancy|pregnancy
1060636|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
1060637|NCT02786420|environmental air pollutants|environmental air pollutants
1060638|NCT02786407|overactive bladder|overactive bladder
1060639|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
1060640|NCT02786368|Food Production|food production
1060641|NCT02786368|Inadequacy|inadequacy
1060642|NCT02786368|Dietary zinc|dietary zinc
1060643|NCT02786368|Iron|iron
1060644|NCT02786368|vitamin A|vitamin a
1060645|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
1060646|NCT02786342|Sorafenib|sorafenib
1060648|NCT02786342|Angiogenesis|angiogenesis
1060649|NCT02786342|Polymorphisms|polymorphisms
1060650|NCT02786329|colorectal cancer|colorectal cancer
1060651|NCT02786329|TIVA|tiva
1060652|NCT02786329|sevoflurane|sevoflurane
1060653|NCT02786329|lidocaine|lidocaine
1060654|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1060655|NCT02786264|anesthesia|anesthesia
1060656|NCT02786264|conscious sedation|conscious sedation
1060657|NCT02786264|managed anesthesia care|managed anesthesia care
1060658|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
1060659|NCT02786199|Ultrasound|ultrasound
1060661|NCT02786199|Differentiation grade|differentiation grade
1060662|NCT02786199|Survival|survival
1060663|NCT02786186|Psoriasis|psoriasis
1060664|NCT02786186|Plaque Psoriasis|plaque psoriasis
1060665|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
1060666|NCT02786186|Cosentyx|cosentyx
1060667|NCT02786186|Secukinumab|secukinumab
1060668|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1060669|NCT02786186|PURE registry|pure registry
1060670|NCT02786186|Registry|registry
1060671|NCT02786173|PRIME|prime
1060672|NCT02786173|PAD|pad
1060674|NCT02786173|Observational|observational
1060675|NCT02786173|CLI|cli
1060676|NCT02786173|PRIME Registry|prime registry
1060677|NCT02786147|Breast Cancer|breast cancer
1060678|NCT02786147|Ovarian Cancer|ovarian cancer
1060679|NCT02786147|B-RST|b-rst
1060680|NCT02786121|hip replacement,|hip replacement,
1060681|NCT02786121|rehabilitation,|rehabilitation,
1060682|NCT02786121|early ambulation,|early ambulation,
1060683|NCT02786108|left gastric artery|left gastric artery
1060684|NCT02786108|embolization|embolization
1060685|NCT02786108|obesity|obesity
1060686|NCT02786095|Atrial fibrillation|atrial fibrillation
1060687|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
1060688|NCT02786095|NOAC|noac
1060689|NCT02786095|warfarin|warfarin
1060690|NCT02786095|coumadin|coumadin
1060691|NCT02786056|Respiratory Function Tests|respiratory function tests
1060692|NCT02786056|Lung|lung
1060693|NCT02785965|electroacupuncture|electroacupuncture
1060694|NCT02785965|lifestyle modification|lifestyle modification
1060695|NCT02785965|diet|diet
1060696|NCT02785965|exercise|exercise
1060697|NCT02785965|Dai Meridian|dai meridian
1060698|NCT02785926|pesticide exposure|pesticide exposure
1060699|NCT02785926|respiratory control|respiratory control
1060700|NCT02785926|sleep|sleep
1060701|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
1060702|NCT02785900|Antibody drug conjugate|antibody drug conjugate
1060703|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
1060704|NCT02785900|Drug therapy|drug therapy
1060705|NCT02785900|Immunotherapy|immunotherapy
1060706|NCT02785887|Breast cancer|breast cancer
1060707|NCT02785887|lung cancer|lung cancer
1060708|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
1060709|NCT02785887|Ovarian cancer|ovarian cancer
1060710|NCT02785887|Prostate cancer|prostate cancer
1060711|NCT02785887|bladder cancer|bladder cancer
1060712|NCT02785861|hormonal therapy|hormonal therapy
1060713|NCT02785861|walking|walking
1060714|NCT02785861|fatigue|fatigue
1060715|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
1060716|NCT02785809|Oral contraceptives|oral contraceptives
1060717|NCT02785809|long-term use|long-term use
1060718|NCT02785809|AMH|amh
1060719|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
1060720|NCT02785783|EndoRings™|endorings™
1060721|NCT02785757|adenocarcinoma|adenocarcinoma
1060722|NCT02785757|venous thromboembolism|venous thromboembolism
1060723|NCT02785757|thrombin generation assay|thrombin generation assay
1060724|NCT02785731|pelvic mass|pelvic mass
1060725|NCT02785731|ovarian cancer|ovarian cancer
1060726|NCT02785731|gynecological cancer|gynecological cancer
1060727|NCT02785731|risk prediction|risk prediction
1060728|NCT02785718|Contact system|contact system
1060729|NCT02785718|Factor XI deficiency|factor xi deficiency
1060730|NCT02785718|Factor XII deficiency|factor xii deficiency
1060731|NCT02785718|Global haemostasis assays|global haemostasis assays
1060732|NCT02785705|immunization|immunization
1060733|NCT02785705|vaccine schedule|vaccine schedule
1060734|NCT02785705|poliomyelitis|poliomyelitis
1060735|NCT02785705|polio|polio
1060736|NCT02785705|oral polio vaccine|oral polio vaccine
1060737|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
1060738|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
1060739|NCT02785692|IMRT and sarcoma|imrt and sarcoma
1060740|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
1060741|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
1060742|NCT02785692|postoperative complications|postoperative complications
1060743|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
1060744|NCT02785679|Allergy|allergy
1060745|NCT02785679|Cow's milk|cow's milk
1060746|NCT02785679|breast feeding|breast feeding
1060747|NCT02785679|Cow's milk formula|cow's milk formula
1060748|NCT02785679|prevention|prevention
1060749|NCT02785666|Men who have sex with men|men who have sex with men
1060750|NCT02785666|Elimination|elimination
1060751|NCT02785653|sevoflurane|sevoflurane
1060752|NCT02785653|rocuronium|rocuronium
1060753|NCT02785653|intubation|intubation
1060754|NCT02785627|Bone health|bone health
1060755|NCT02785627|Bone microarchitecture|bone microarchitecture
1060756|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
1060757|NCT02785588|MRI Scanner|mri scanner
1060758|NCT02785588|NICU|nicu
1060759|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
1060760|NCT02785549|Acute diverticulitis|acute diverticulitis
1060761|NCT02785549|Antibiotic|antibiotic
1060762|NCT02785549|Outpatient treatment|outpatient treatment
1060763|NCT02785536|minority health|minority health
1060764|NCT02785536|social class|social class
1060765|NCT02785536|healthcare disparities|healthcare disparities
1060766|NCT02785536|tobacco use disorder|tobacco use disorder
1060767|NCT02785497|Electrical stimulation|electrical stimulation
1060768|NCT02785497|wound healing|wound healing
1060769|NCT02785497|Polarity current|polarity current
1060770|NCT02785497|Burn|burn
1060771|NCT02785497|Chronic ulcer|chronic ulcer
1060772|NCT02785484|Cigarette smoking|cigarette smoking
1060773|NCT02785484|Smoking|smoking
1060775|NCT02785471|Suicide prevention|suicide prevention
1060776|NCT02785471|men's mental health|men's mental health
1060777|NCT02785471|depression|depression
1060778|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
1060779|NCT02785419|Rehabilitation|rehabilitation
1060780|NCT02785419|Upper Extremity|upper extremity
1060781|NCT02785419|Physical Therapy|physical therapy
1060782|NCT02785406|cocaine|cocaine
1060783|NCT02785406|sleep|sleep
1060784|NCT02785406|anxiety|anxiety
1060785|NCT02785406|craving|craving
1060786|NCT02785406|addiction|addiction
1060787|NCT02785406|orexin|orexin
1060788|NCT02785406|cue reactivity|cue reactivity
1060789|NCT02785406|suvorexant|suvorexant
1060790|NCT02785406|Belsomra|belsomra
1060791|NCT02785393|Methamphetamine|methamphetamine
1060792|NCT02785393|Dependence|dependence
1060793|NCT02785341|adapted physical activity|adapted physical activity
1060794|NCT02785328|Memory|memory
1060795|NCT02785328|sleep|sleep
1060796|NCT02785328|narcolepsy|narcolepsy
1060797|NCT02785328|apnea|apnea
1060798|NCT02785328|epilepsy|epilepsy
1060799|NCT02785302|Pediatric|pediatric
1060800|NCT02785302|HIV|hiv
1060801|NCT02785302|Transition|transition
1060802|NCT02785302|Adult Care|adult care
1060803|NCT02785263|Anal cancer|anal cancer
1060804|NCT02785263|Shared decision making|shared decision making
1060805|NCT02785250|vaccine|vaccine
1060806|NCT02785250|immunotherapy|immunotherapy
1060807|NCT02785250|IDO1 inhibitor|ido1 inhibitor
1060808|NCT02785250|ovarian|ovarian
1060809|NCT02785250|fallopian tube|fallopian tube
1060810|NCT02785250|peritoneal|peritoneal
1060811|NCT02785250|cancer|cancer
1060812|NCT02785250|recurrent|recurrent
1060813|NCT02785250|tumor|tumor
1060814|NCT02785250|measurable|measurable
1060815|NCT02785237|Drug-eluting stent|drug-eluting stent
1060816|NCT02785237|OCT|oct
1060817|NCT02785237|Re-endothelialization|re-endothelialization
1060818|NCT02785146|Huaier Granule|huaier granule
1060819|NCT02785146|After radical surgery|after radical surgery
1060820|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
1060821|NCT02785146|Efficacy and safety|efficacy and safety
1060822|NCT02785120|Phase 2|phase 2
1060823|NCT02785120|Efficacy|efficacy
1060824|NCT02785120|Safety|safety
1060825|NCT02785120|Ischemic Stroke|ischemic stroke
1060826|NCT02785107|Exercise|exercise
1060827|NCT02785107|Habit|habit
1060828|NCT02785107|MVPA|mvpa
1060829|NCT02785107|M-PAC|m-pac
1060830|NCT02785107|Automaticity|automaticity
1060831|NCT02785107|Physical Activity|physical activity
1060832|NCT02785094|Caesarean Section Rate|caesarean section rate
1060833|NCT02785094|Primigravida|primigravida
1060834|NCT02785081|Thoracic epidural|thoracic epidural
1060835|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
1060836|NCT02785081|Children|children
1060837|NCT02785068|Phase I|phase i
1060838|NCT02785068|Cancer|cancer
1060839|NCT02785068|EGFR|egfr
1060840|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
1060841|NCT02785068|Oncology|oncology
1060842|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
1060843|NCT02785068|Nal-IRI|nal-iri
1060844|NCT02785068|EGFR Inhibitor|egfr inhibitor
1060845|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
1060846|NCT02785068|Nanoliposome|nanoliposome
1060847|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
1060848|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
1060849|NCT02785016|Suburethral Sling|suburethral sling
1060850|NCT02785003|Colorectal Surgery|colorectal surgery
1060851|NCT02785003|Acute Pain|acute pain
1060852|NCT02785003|Pain|pain
1060853|NCT02785003|post-operative pain|post-operative pain
1060854|NCT02785003|ketamine|ketamine
1060855|NCT02784938|Employment|employment
1060856|NCT02784938|Mental Illness|mental illness
1060857|NCT02784938|Photovoice|photovoice
1060858|NCT02784912|Biomarkers|biomarkers
1060859|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
1060860|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
1060861|NCT02784912|Electrical Storm|electrical storm
1060862|NCT02784912|ST2|st2
1060863|NCT02784912|Galectin-3|galectin-3
1060864|NCT02784912|NT-proBNP|nt-probnp
1060865|NCT02784912|Iron Deficiency|iron deficiency
1060866|NCT02784912|hs-CRP|hs-crp
1060867|NCT02784912|hs-TnT|hs-tnt
1060868|NCT02784886|Placenta accreta|placenta accreta
1060869|NCT02784886|previous caesarean|previous caesarean
1060870|NCT02784886|placenta praevia|placenta praevia
1060871|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
1060872|NCT02784886|Biological markers|biological markers
1060873|NCT02784873|High intensity interval training|high intensity interval training
1060874|NCT02784873|Coronary heart disease|coronary heart disease
1060875|NCT02784873|Exercise training|exercise training
1060876|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
1060877|NCT02784873|Interval training|interval training
1060878|NCT02784860|colonoscopy|colonoscopy
1060879|NCT02784860|lidocaine|lidocaine
1060880|NCT02784860|propofol|propofol
1060881|NCT02784860|sedation|sedation
1060882|NCT02784834|CLL|cll
1060883|NCT02784834|cancer|cancer
1060884|NCT02784834|DMF|dmf
1060885|NCT02784834|SLL|sll
1060886|NCT02784834|dimethylfumarate|dimethylfumarate
1060887|NCT02784834|relapsed|relapsed
1060888|NCT02784834|refractory|refractory
1060889|NCT02784795|Notch Inhibitor|notch inhibitor
1060890|NCT02784782|Spinal|spinal
1060891|NCT02784782|Vertebral|vertebral
1060892|NCT02784782|Burstfracture|burstfracture
1060893|NCT02784782|Orthesis|orthesis
1060894|NCT02784782|Brace|brace
1060895|NCT02784782|Thoracolumbar|thoracolumbar
1060896|NCT02784756|Quantiferon-CMV|quantiferon-cmv
1060897|NCT02784756|solid organ transplant|solid organ transplant
1060898|NCT02784756|CMV Disease|cmv disease
1060899|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
1060900|NCT02784743|Anopheles|anopheles
1060901|NCT02784743|Albendazole|albendazole
1060902|NCT02784743|Ivermectin|ivermectin
1060903|NCT02784743|MDA|mda
1060904|NCT02784730|breast cancer|breast cancer
1060905|NCT02784730|chemotherapy|chemotherapy
1060906|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
1060907|NCT02784730|implantable device|implantable device
1060908|NCT02784730|randomized controlled trial|randomized controlled trial
1060909|NCT02784730|iterative placement|iterative placement
1060910|NCT02784730|Catheterization, Central Venous|catheterization, central venous
1060911|NCT02784717|rivaroxaban,|rivaroxaban,
1060912|NCT02784717|non-interventional,|non-interventional,
1060913|NCT02784717|atrial fibrillation,|atrial fibrillation,
1060914|NCT02784717|stroke prevention,|stroke prevention,
1060915|NCT02784665|CSC|csc
1060916|NCT02784665|Micropulse Laser|micropulse laser
1060917|NCT02784665|Traditional Laser|traditional laser
1060918|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
1060919|NCT02784626|Dexmedetomidine|dexmedetomidine
1060920|NCT02784626|Propofol|propofol
1060921|NCT02784626|Pain, Postoperative|pain, postoperative
1060922|NCT02784600|Partial-thickness|partial-thickness
1060923|NCT02784600|Full-thickness|full-thickness
1060924|NCT02784587|stellate ganglion block|stellate ganglion block
1060925|NCT02784587|cardiac surgery|cardiac surgery
1060926|NCT02784574|Rehabilitation|rehabilitation
1060927|NCT02784574|Aftercare|aftercare
1060928|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
1060929|NCT02784561|conditioning regimen|conditioning regimen
1060930|NCT02784561|acute leukemia|acute leukemia
1060931|NCT02784561|relapsed/refractory|relapsed/refractory
1060932|NCT02784509|Physical Activity|physical activity
1060933|NCT02784509|Sedentary Behavior|sedentary behavior
1060934|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
1060935|NCT02784509|Childhood and Adolescence|childhood and adolescence
1060936|NCT02784496|Myelofibrosis|myelofibrosis
1060937|NCT02784496|Primary Myelofibrosis|primary myelofibrosis
1060938|NCT02784496|PMF|pmf
1060939|NCT02784496|Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis|post polycythemia vera/essential thrombocythemia myelofibrosis
1060940|NCT02784496|Post-PV/ET MF|post-pv/et mf
1060941|NCT02784496|Ruxolitinib|ruxolitinib
1060942|NCT02784496|Jakafi|jakafi
1060943|NCT02784496|INCB018424|incb018424
1060944|NCT02784496|INC424|inc424
1060945|NCT02784496|Questionnaires|questionnaires
1060946|NCT02784496|Surveys|surveys
1060947|NCT02784444|NASH|nash
1060948|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
1060949|NCT02784405|stent implantation|stent implantation
1060950|NCT02784379|Mastalgia|mastalgia
1060951|NCT02784379|electromyography|electromyography
1060952|NCT02784379|Pectoral|pectoral
1060953|NCT02784366|Cancer immunotherapy|cancer immunotherapy
1060954|NCT02784366|Ipilimumab|ipilimumab
1060955|NCT02784353|Rehabilitation|rehabilitation
1060956|NCT02784353|Quality of life|quality of life
1060957|NCT02784353|Surgery|surgery
1060958|NCT02784353|Hepatic neoplasms|hepatic neoplasms
1060959|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
1060960|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
1060961|NCT02784340|Postoperative pain|postoperative pain
1060962|NCT02784340|dexamethasone|dexamethasone
1060963|NCT02784340|cesarean section|cesarean section
1060964|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
1060965|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
1060966|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
1060967|NCT02784314|Erectile function ;|erectile function ;
1060968|NCT02784314|Cost efficacy study|cost efficacy study
1060969|NCT02784288|head and neck neoplasms|head and neck neoplasms
1060970|NCT02784288|HPV|hpv
1060971|NCT02784288|human papilloma virus|human papilloma virus
1060972|NCT02784288|de-escalation|de-escalation
1060974|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
1060975|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
1060976|NCT02784262|Block|block
1060977|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
1060978|NCT02784249|Glaucoma|glaucoma
1060979|NCT02784249|glaucoma surgery|glaucoma surgery
1060980|NCT02784249|ab interno|ab interno
1060981|NCT02784223|F18-choline|f18-choline
1060982|NCT02784223|Surgery|surgery
1060983|NCT02784223|Indeterminate|indeterminate
1060984|NCT02784223|Thyroid node|thyroid node
1060985|NCT02784210|Multiple Sclerosis|multiple sclerosis
1060986|NCT02784210|Corticosteroids|corticosteroids
1060987|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
1060988|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
1060989|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
1060990|NCT02784158|Epithelial lung cancer|epithelial lung cancer
1060991|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
1060992|NCT02784158|Large cell carcinoma|large cell carcinoma
1060993|NCT02784158|Adenocarcinoma|adenocarcinoma
1060994|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
1060995|NCT02784158|Carcinoma|carcinoma
1060996|NCT02784158|Advanced Cancers|advanced cancers
1060997|NCT02784158|Brigatinib|brigatinib
1060998|NCT02784158|AP26113|ap26113
1060999|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
1061000|NCT02784119|liver graft|liver graft
1061001|NCT02784119|extended criteria donor|extended criteria donor
1061002|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
1061003|NCT02784106|M2951|m2951
1061004|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
1061005|NCT02784093|Chronic Constipation|chronic constipation
1061006|NCT02784093|Fecal impaction|fecal impaction
1061007|NCT02784093|Gastrografin|gastrografin
1061008|NCT02784093|Randomized Controlled Trial|randomized controlled trial
1061009|NCT02784080|Liver Transplantation|liver transplantation
1061010|NCT02784080|HLA alloantibodies|hla alloantibodies
1061011|NCT02784080|donor specific antibodies|donor specific antibodies
1061012|NCT02784080|Mortality|mortality
1061013|NCT02784080|Re-transplantation|re-transplantation
1061014|NCT02784080|Rejection|rejection
1061015|NCT02784080|Acute rejection|acute rejection
1061016|NCT02784080|Chronic rejection|chronic rejection
1061017|NCT02784080|Biliary complications|biliary complications
1061018|NCT02784080|Biliary stricture|biliary stricture
1061019|NCT02784080|Arterial thrombosis|arterial thrombosis
1061020|NCT02784080|Arterial stenosis|arterial stenosis
1061021|NCT02784080|Portal vein thrombosis|portal vein thrombosis
1061022|NCT02784080|Fibrosis|fibrosis
1061023|NCT02784080|Single antigen bead|single antigen bead
1061024|NCT02784080|Cross-match|cross-match
1061025|NCT02784041|knee arthroplasty|knee arthroplasty
1061026|NCT02784041|adductor canal block|adductor canal block
1061027|NCT02784041|periarticular infiltration|periarticular infiltration
1061028|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1061029|NCT02784028|SGM-101|sgm-101
1061030|NCT02783989|Endothelial function|endothelial function
1061031|NCT02783989|Inflammation|inflammation
1061032|NCT02783989|Genes related to vascular risk|genes related to vascular risk
1061033|NCT02783963|Coronary Artery Disease|coronary artery disease
1061034|NCT02783963|Coronary Thrombosis|coronary thrombosis
1061035|NCT02783963|Coronary Stenosis|coronary stenosis
1061036|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
1061037|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
1061038|NCT02783950|Genomics|genomics
1061039|NCT02783950|Adjuvant Treatment|adjuvant treatment
1061040|NCT02783937|Premature|premature
1061041|NCT02783937|Ovarian|ovarian
1061042|NCT02783937|Failure|failure
1061043|NCT02783937|Filgrastim|filgrastim
1061044|NCT02783924|vitamin D|vitamin d
1061045|NCT02783924|genomics|genomics
1061046|NCT02783924|proteomics|proteomics
1061047|NCT02783924|metabolomics|metabolomics
1061048|NCT02783924|adipose tissue|adipose tissue
1061049|NCT02783911|Clinical and Radiograph|clinical and radiograph
1061050|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
1061051|NCT02783859|Children|children
1061052|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
1061053|NCT02783859|Indigenous Population|indigenous population
1061054|NCT02783859|Hospitals|hospitals
1061055|NCT02783846|Propofol|propofol
1061056|NCT02783846|Dexmedetomidine|dexmedetomidine
1061057|NCT02783846|Dose|dose
1061058|NCT02783846|Bispectral index monitor|bispectral index monitor
1061059|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
1061060|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
1061061|NCT02783794|BP-C1|bp-c1
1061062|NCT02783794|CDBPA|cdbpa
1061063|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
1061064|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
1061065|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
1061066|NCT02783794|Platinum analogue|platinum analogue
1061067|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
1061068|NCT02783794|Breast cancer|breast cancer
1061070|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
1061071|NCT02783781|Biological data|biological data
1061072|NCT02783781|Preoperative biological variables|preoperative biological variables
1061073|NCT02783781|EuroSCORE II|euroscore ii
1061074|NCT02783781|Risk prediction|risk prediction
1061075|NCT02783768|E-cigarettes|e-cigarettes
1061076|NCT02783768|COPD|copd
1061077|NCT02783755|pain|pain
1061078|NCT02783755|coping|coping
1061079|NCT02783755|mhealth|mhealth
1061080|NCT02783755|Breast cancer|breast cancer
1061081|NCT02783742|provider-patient communication|provider-patient communication
1061082|NCT02783742|coaching|coaching
1061083|NCT02783742|feedback|feedback
1061085|NCT02783729|E2006|e2006
1061086|NCT02783729|Lemborexant|lemborexant
1061087|NCT02783729|zolpidem tartrate|zolpidem tartrate
1061088|NCT02783729|Ambien CR|ambien cr
1061089|NCT02783729|Insomnia|insomnia
1061090|NCT02783703|Insulin resistance|insulin resistance
1061091|NCT02783664|Breast Cancer|breast cancer
1061092|NCT02783664|BRCA1|brca1
1061093|NCT02783664|BRCA2|brca2
1061094|NCT02783664|stress|stress
1061095|NCT02783664|gene testing|gene testing
1061096|NCT02783664|genetic screening|genetic screening
1061097|NCT02783664|psychological support|psychological support
1061098|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
1061099|NCT02783664|Cancer Worry Scale|cancer worry scale
1061100|NCT02783664|Health Anxiety Inventory|health anxiety inventory
1061101|NCT02783664|gene mutations|gene mutations
1061102|NCT02783625|Duvelisib|duvelisib
1061103|NCT02783625|Romidepsin|romidepsin
1061104|NCT02783625|Bortezomib|bortezomib
1061105|NCT02783625|16-042|16-042
1061106|NCT02783573|dementia|dementia
1061107|NCT02783573|brain diseases|brain diseases
1734791|NCT00000368|Paroxetine|paroxetine
1061108|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
1061109|NCT02783573|central nervous system diseases|central nervous system diseases
1061110|NCT02783573|nervous system diseases|nervous system diseases
1061111|NCT02783573|mental disorders|mental disorders
1061112|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
1061113|NCT02783573|tauopathies|tauopathies
1061114|NCT02783573|memory|memory
1061115|NCT02783573|amyloid|amyloid
1061116|NCT02783560|Sleep|sleep
1061117|NCT02783560|Electrodermal Activity|electrodermal activity
1061118|NCT02783560|Mealtimes|mealtimes
1061119|NCT02783534|Acupuncture|acupuncture
1061120|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
1061121|NCT02783534|Randomized Controlled Trial|randomized controlled trial
1061122|NCT02783534|Placebo Effect|placebo effect
1061123|NCT02783521|Hispanic men|hispanic men
1061124|NCT02783521|Weight loss|weight loss
1061125|NCT02783521|Diet|diet
1061126|NCT02783521|Physical activity|physical activity
1061127|NCT02783521|Intervention|intervention
1061128|NCT02783508|Labor analgesia|labor analgesia
1061129|NCT02783508|Nitrous Oxide|nitrous oxide
1061130|NCT02783508|Meperidine|meperidine
1061131|NCT02783508|Multiparous|multiparous
1061132|NCT02783508|Visual analogue scale|visual analogue scale
1061133|NCT02783495|glioma|glioma
1061134|NCT02783495|neurocognitive|neurocognitive
1061135|NCT02783495|quality of life|quality of life
1061136|NCT02783456|renal hemodynamic|renal hemodynamic
1061137|NCT02783456|central hemodynamic|central hemodynamic
1061138|NCT02783456|pilot study|pilot study
1061139|NCT02783456|flight noise|flight noise
1061140|NCT02783456|healthy participant|healthy participant
1061141|NCT02783456|renal plasma flow|renal plasma flow
1061142|NCT02783456|filtration fraction|filtration fraction
1061143|NCT02783456|renal vascular resistance|renal vascular resistance
1061144|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
1061145|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
1061146|NCT02783430|Ketamine|ketamine
1061147|NCT02783430|Palliative care|palliative care
1061148|NCT02783430|Supportive care|supportive care
1061149|NCT02783430|Early palliative care|early palliative care
1061150|NCT02783430|Fast acting antidepressant|fast acting antidepressant
1061151|NCT02783430|End of life care|end of life care
1061152|NCT02783430|Cancer|cancer
1061153|NCT02783430|psychological distress|psychological distress
1061154|NCT02783430|antidepressant|antidepressant
1061155|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
1061156|NCT02783417|Visceral fat|visceral fat
1061157|NCT02783404|bacteraemia|bacteraemia
1061158|NCT02783404|endocarditis|endocarditis
1061159|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
1061160|NCT02783404|dentistry|dentistry
1061161|NCT02783378|impedance metry|impedance metry
1061162|NCT02783378|gaviscon|gaviscon
1061163|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
1061164|NCT02783339|Intracranial|intracranial
1061165|NCT02783339|Stent system|stent system
1061166|NCT02783339|Saccular aneurysm|saccular aneurysm
1061167|NCT02783339|Stent assisted coiling|stent assisted coiling
1061168|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
1061169|NCT02783326|Rehabilitation|rehabilitation
1061170|NCT02783326|Physical Therapy|physical therapy
1061171|NCT02783313|pathogen inactivation|pathogen inactivation
1061172|NCT02783313|platelets|platelets
1061173|NCT02783300|GSK3326595|gsk3326595
1061174|NCT02783300|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1061175|NCT02783300|Solid tumor|solid tumor
1061176|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1061177|NCT02783300|breast cancer|breast cancer
1061178|NCT02783300|bladder cancer|bladder cancer
1061179|NCT02783300|dose escalation|dose escalation
1061180|NCT02783287|Exercise adherence|exercise adherence
1061181|NCT02783287|Medication adherence|medication adherence
1061182|NCT02783287|Mobile health|mobile health
1061183|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
1061184|NCT02783261|radioembolization|radioembolization
1061185|NCT02783261|hypertrophy|hypertrophy
1061187|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
1061188|NCT02783248|Mitral Stenosis|mitral stenosis
1061189|NCT02783235|VIA|via
1061190|NCT02783235|Cervical Cancer|cervical cancer
1061191|NCT02783235|Training|training
1061192|NCT02783222|breast cancer|breast cancer
1061193|NCT02783222|elderly patients|elderly patients
1061194|NCT02783170|Tdap vaccine|tdap vaccine
1061195|NCT02783170|Flu vaccine|flu vaccine
1061196|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
1061197|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
1061198|NCT02783170|Whooping Cough|whooping cough
1061199|NCT02783170|Pertussis|pertussis
1061200|NCT02783170|Influenza|influenza
1061201|NCT02783157|Autonomic|autonomic
1061202|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
1061203|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
1061204|NCT02783144|Analgesia|analgesia
1099636|NCT02553525|GPi|gpi
1061205|NCT02783144|Dexamethasone|dexamethasone
1061206|NCT02783144|Levobupivacaine|levobupivacaine
1061207|NCT02783144|Ultrasound-guided|ultrasound-guided
1061208|NCT02783144|Tranversus Abdominis|tranversus abdominis
1061209|NCT02783131|inventions|inventions
1061210|NCT02783131|Simulation Training|simulation training
1061211|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
1061212|NCT02783131|Non Technical Skills|non technical skills
1061213|NCT02783131|teamwork|teamwork
1061214|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
1061215|NCT02783118|Depression|depression
1061216|NCT02783118|Prevention|prevention
1061217|NCT02783118|CBT|cbt
1061218|NCT02783118|Smartphone app|smartphone app
1061219|NCT02783105|Music therapy|music therapy
1061220|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
1061221|NCT02783105|Traumatic brain injury|traumatic brain injury
1061222|NCT02783079|Breast Cancer|breast cancer
1061223|NCT02783079|Prostate Cancer|prostate cancer
1061224|NCT02783079|Colon Cancer|colon cancer
1061225|NCT02783079|Lung Cancer|lung cancer
1061226|NCT02783079|Gynecologic Cancer|gynecologic cancer
1061227|NCT02783014|overactive bladder|overactive bladder
1061228|NCT02782988|Olfaction|olfaction
1061229|NCT02782988|CMV|cmv
1061230|NCT02782962|nystagmus|nystagmus
1061231|NCT02782962|vertigo|vertigo
1061232|NCT02782962|unsteadiness|unsteadiness
1061233|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
1061234|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
1061235|NCT02782923|Cervical Spine Surgery|cervical spine surgery
1061236|NCT02782923|Simulation|simulation
1061237|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
1061238|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
1061239|NCT02782897|perihematomal edema|perihematomal edema
1061240|NCT02782884|post-operative pain|post-operative pain
1061241|NCT02782871|Transfer|transfer
1061242|NCT02782871|Intra-hospital|intra-hospital
1061243|NCT02782871|Ventilator|ventilator
1061244|NCT02782871|Manual ventilation|manual ventilation
1061245|NCT02782871|Head and neck surgery|head and neck surgery
1061246|NCT02782858|Multiple Sclerosis|multiple sclerosis
1061247|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
1061248|NCT02782858|GNbAC1|gnbac1
1061249|NCT02782858|MRI|mri
1061250|NCT02782858|Monoclonal antibody|monoclonal antibody
1061251|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
1061252|NCT02782858|MS|ms
1061253|NCT02782858|RRMS|rrms
1061254|NCT02782858|HERV-W|herv-w
1061255|NCT02782832|Neuromuscular|neuromuscular
1061256|NCT02782832|Blockade|blockade
1061257|NCT02782832|Surgery|surgery
1061258|NCT02782819|Shock resuscitation|shock resuscitation
1061259|NCT02782819|colloid|colloid
1061260|NCT02782819|crystalloid|crystalloid
1061261|NCT02782793|Endoscopic|endoscopic
1061262|NCT02782793|Mucosal|mucosal
1061263|NCT02782793|Resection|resection
1061264|NCT02782780|insomnia|insomnia
1061265|NCT02782780|insomnia disorder|insomnia disorder
1061266|NCT02782780|Gulf War Illness|gulf war illness
1061267|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
1061268|NCT02782728|intimate partner violence|intimate partner violence
1061269|NCT02782728|reproductive coercion|reproductive coercion
1062289|NCT02777112|job coach|job coach
1061270|NCT02782728|women's health|women's health
1061271|NCT02782728|relationship abuse|relationship abuse
1061272|NCT02782702|Botulism Toxin|botulism toxin
1061273|NCT02782663|Crohn's Disease|crohn's disease
1061274|NCT02782663|Efficacy|efficacy
1061275|NCT02782663|Safety|safety
1061276|NCT02782663|Tolerability|tolerability
1061277|NCT02782663|ABT-494|abt-494
1061278|NCT02782650|Limits|limits
1061279|NCT02782650|Prenatal Counseling|prenatal counseling
1061280|NCT02782650|Decision-making|decision-making
1061281|NCT02782650|Foetal Complications|foetal complications
1061282|NCT02782650|Counseling|counseling
1061283|NCT02782650|Viability|viability
1061284|NCT02782637|limits of viability|limits of viability
1061285|NCT02782637|Prenatal Counseling|prenatal counseling
1061286|NCT02782637|Decision-making|decision-making
1061287|NCT02782637|Viability|viability
1061288|NCT02782637|Counseling|counseling
1061289|NCT02782611|Happiness|happiness
1061290|NCT02782611|Subjective Well-Being|subjective well-being
1061291|NCT02782611|Psychological Flourishing|psychological flourishing
1061292|NCT02782611|Well-Being|well-being
1061294|NCT02782611|Behavioral Change|behavioral change
1061295|NCT02782611|Life Satisfaction|life satisfaction
1061296|NCT02782611|Affect|affect
1061297|NCT02782611|Emotion|emotion
1061298|NCT02782611|Goals|goals
1061299|NCT02782611|Meaning in Life|meaning in life
1061300|NCT02782598|Negative|negative
1061301|NCT02782598|Atrioventricular|atrioventricular
1061302|NCT02782598|Hysteresis|hysteresis
1061303|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
1061304|NCT02782598|MultiPoint|multipoint
1061305|NCT02782585|neck pain|neck pain
1061306|NCT02782585|Manual therapy|manual therapy
1061307|NCT02782585|psychological interaction|psychological interaction
1061308|NCT02782572|Exercise|exercise
1061309|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
1061310|NCT02782572|Non-invasive ventilation|non-invasive ventilation
1061311|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
1061312|NCT02782520|Swan Ganz|swan ganz
1061313|NCT02782520|Fluid expansion|fluid expansion
1061314|NCT02782520|hypertonic saline solution|hypertonic saline solution
1061315|NCT02782507|pilot study|pilot study
1061316|NCT02782507|CBT trial|cbt trial
1061317|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
1061318|NCT02782468|Drug Therapy|drug therapy
1061319|NCT02782442|cognitive training|cognitive training
1061320|NCT02782429|ketamine|ketamine
1061321|NCT02782429|Cardiac Surgery|cardiac surgery
1061322|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
1061323|NCT02782416|Renal|renal
1061324|NCT02782416|Latent|latent
1061325|NCT02782416|Tuberculosis|tuberculosis
1061326|NCT02782403|Leukemia|leukemia
1061327|NCT02782403|Chronic Myeloid Leukemia|chronic myeloid leukemia
1061328|NCT02782403|CML|cml
1061329|NCT02782403|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
1061330|NCT02782403|CML-CP|cml-cp
1061331|NCT02782403|Chronic Myeloid Leukemia in Accelerated Phase|chronic myeloid leukemia in accelerated phase
1061332|NCT02782403|CML-AP|cml-ap
1061333|NCT02782403|Chronic Myeloid Leukemia in Blast Phase|chronic myeloid leukemia in blast phase
1061334|NCT02782403|CML-BP|cml-bp
1061335|NCT02782403|Axitinib|axitinib
1061336|NCT02782403|AG-013736|ag-013736
1061337|NCT02782403|Inlyta|inlyta
1061338|NCT02782403|Bosutinib|bosutinib
1061339|NCT02782403|SKI-606|ski-606
1061340|NCT02782390|Stainless dental crown|stainless dental crown
1061341|NCT02782390|Composite Resin|composite resin
1061342|NCT02782390|Primary teeth|primary teeth
1061343|NCT02782377|Faecal Incontinence|faecal incontinence
1061344|NCT02782377|Obstructive Defaecation|obstructive defaecation
1061345|NCT02782377|Rectal Prolapse|rectal prolapse
1061346|NCT02782364|Faecal Incontinence|faecal incontinence
1061347|NCT02782338|warfarin|warfarin
1061348|NCT02782338|Voltaren eye drops|voltaren eye drops
1061349|NCT02782338|INR|inr
1061350|NCT02782312|Bronchiectasis|bronchiectasis
1061351|NCT02782312|ICS+LABA|ics+laba
1061352|NCT02782299|Decision aid|decision aid
1061353|NCT02782299|Shared decision making|shared decision making
1061354|NCT02782299|Older adult patients|older adult patients
1061355|NCT02782299|Distal radius fracture|distal radius fracture
1061356|NCT02782286|ketorolac|ketorolac
1061357|NCT02782286|pain relieve|pain relieve
1061358|NCT02782286|morphine|morphine
1061359|NCT02782273|ketorolac|ketorolac
1061360|NCT02782273|pain relieve|pain relieve
1061361|NCT02782273|morphine|morphine
1061362|NCT02782221|lipolysis|lipolysis
1061363|NCT02782221|ATGL|atgl
1061364|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1061365|NCT02782182|FOLFIRINOX|folfirinox
1061366|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
1061367|NCT02782156|Process Evaluation|process evaluation
1061368|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
1061369|NCT02782143|delirium detection|delirium detection
1061370|NCT02782130|HIV|hiv
1061371|NCT02782130|YMSM|ymsm
1061372|NCT02782130|Trans women|trans women
1061373|NCT02782130|ART Adherence|art adherence
1061374|NCT02782130|Intervention|intervention
1062789|NCT02774356|Brainstem|brainstem
1061375|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
1061376|NCT02782104|Esketamine|esketamine
1061377|NCT02782104|JNJ-54135419|jnj-54135419
1061378|NCT02782091|MET|met
1061379|NCT02782091|Prognosis|prognosis
1061380|NCT02782091|Cognition|cognition
1061381|NCT02782091|Ecological|ecological
1061382|NCT02782091|Executive function|executive function
1061383|NCT02782078|osteoarticular infection|osteoarticular infection
1061384|NCT02782078|rifampicin|rifampicin
1061385|NCT02782078|clindamycin|clindamycin
1061386|NCT02782078|enzymatic induction|enzymatic induction
1061387|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
1061388|NCT02782065|validation|validation
1061389|NCT02782065|pediatrics|pediatrics
1061390|NCT02782065|asthma severity|asthma severity
1061391|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
1061392|NCT02782052|spirometry|spirometry
1061393|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
1061394|NCT02782052|bronchodilator|bronchodilator
1061395|NCT02782052|dyspnoea|dyspnoea
1061396|NCT02782052|Idiopathic|idiopathic
1061397|NCT02782052|heritable|heritable
1061398|NCT02782052|PAH|pah
1061399|NCT02782026|pulmonary hypertension|pulmonary hypertension
1061400|NCT02782026|early detection|early detection
1061401|NCT02782013|community acquired pneumonia|community acquired pneumonia
1061402|NCT02782013|CAP|cap
1061403|NCT02782013|disease progression|disease progression
1061404|NCT02782000|dementia|dementia
1061405|NCT02782000|early recognition|early recognition
1061406|NCT02782000|general practitioner|general practitioner
1061407|NCT02782000|training|training
1061408|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
1061409|NCT02781935|diffusion weighted MRI|diffusion weighted mri
1061410|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
1061411|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
1061412|NCT02781922|autologous cell therapy|autologous cell therapy
1061413|NCT02781922|functional single ventricle|functional single ventricle
1061414|NCT02781922|congenital heart disease|congenital heart disease
1061415|NCT02781909|NSAIDS|nsaids
1061416|NCT02781909|tuberculosis treatment|tuberculosis treatment
1061417|NCT02781909|anti-inflammatories|anti-inflammatories
1061418|NCT02781909|Host-directed therapies|host-directed therapies
1061419|NCT02781909|TB|tb
1061420|NCT02781896|TAVI|tavi
1061421|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
1061422|NCT02781896|TAVI simplification|tavi simplification
1061423|NCT02781896|aortic stenosis|aortic stenosis
1061424|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
1061425|NCT02781896|TAVR|tavr
1061426|NCT02781883|Liposomal Grb-2 treatment of AML|liposomal grb-2 treatment of aml
1061427|NCT02781883|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
1061428|NCT02781857|Exhaled Breath|exhaled breath
1061429|NCT02781857|Mass Spectrometry|mass spectrometry
1061430|NCT02781857|Fingerprinting|fingerprinting
1061431|NCT02781818|hidradenitis|hidradenitis
1061432|NCT02781818|intralesional|intralesional
1061433|NCT02781818|triamcinolone|triamcinolone
1061434|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
1061435|NCT02781779|Implant|implant
1061436|NCT02781766|Haemophilia A|haemophilia a
1061437|NCT02781766|prophylaxis|prophylaxis
1061438|NCT02781766|thrombin generation assay|thrombin generation assay
1061439|NCT02781766|factor VIII|factor viii
1061440|NCT02781766|prophylactic therapy|prophylactic therapy
1061441|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
1061442|NCT02781740|CPAP|cpap
1061443|NCT02781740|Sham CPAP|sham cpap
1061444|NCT02781740|CPAP withdrawal|cpap withdrawal
1061445|NCT02781740|suboptimal CPAP|suboptimal cpap
1061446|NCT02781727|Human Growth Hormone|human growth hormone
1061447|NCT02781727|hGH|hgh
1061448|NCT02781727|GHD|ghd
1061449|NCT02781727|rHGH|rhgh
1061450|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
1061451|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
1061452|NCT02781727|Somatropin|somatropin
1061453|NCT02781727|Prodrug|prodrug
1061454|NCT02781727|Growth Failure|growth failure
1061455|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
1061456|NCT02781727|Sustained Release|sustained release
1061457|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
1061458|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
1061459|NCT02781714|contraception|contraception
1061460|NCT02781714|postpartum period|postpartum period
1061461|NCT02781714|mobile health|mobile health
1061462|NCT02781714|mHealth|mhealth
1061463|NCT02781714|Kenya|kenya
1061464|NCT02781714|couples|couples
1061465|NCT02781675|Diet|diet
1061466|NCT02781675|Mediterranean|mediterranean
1061467|NCT02781675|Cholesterol|cholesterol
1061468|NCT02781675|Inflammation|inflammation
1061469|NCT02781662|Safety|safety
1061470|NCT02781662|Hospitalization|hospitalization
1061471|NCT02781662|Older Persons|older persons
1061472|NCT02781662|High-Risk|high-risk
1061473|NCT02781649|Renal|renal
1061474|NCT02781649|Transplants|transplants
1061475|NCT02781649|Hepatitis C|hepatitis c
1061476|NCT02781649|HCV-negative|hcv-negative
1061477|NCT02781649|Infected|infected
1061478|NCT02781649|Donors|donors
1061479|NCT02781636|Efficacy|efficacy
1061480|NCT02781636|Implantable|implantable
1061481|NCT02781636|Wireless|wireless
1061482|NCT02781636|Neuromodulation|neuromodulation
1061483|NCT02781636|Device|device
1061484|NCT02781636|Tibial|tibial
1061485|NCT02781623|Quadriceps|quadriceps
1061486|NCT02781623|Tibial Plateau|tibial plateau
1061487|NCT02781623|Fracture|fracture
1061488|NCT02781610|Cystic fibrosis|cystic fibrosis
1061489|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
1061490|NCT02781610|Antibiotic|antibiotic
1061491|NCT02781610|Treatment duration|treatment duration
1061492|NCT02781610|Lung infection|lung infection
1061493|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
1061494|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
1061495|NCT02781597|Hemoptysis|hemoptysis
1061496|NCT02781597|Tranexamic acid|tranexamic acid
1061497|NCT02781597|VAS score|vas score
1061498|NCT02781545|Child Development|child development
1061499|NCT02781545|Psychomotor Performance|psychomotor performance
1061500|NCT02781545|Newborns|newborns
1061502|NCT02781493|Prucalopride|prucalopride
1061503|NCT02781493|Polyethylene Glycol|polyethylene glycol
1061504|NCT02781493|bowel preparation|bowel preparation
1061505|NCT02781467|Acute Myeloid|acute myeloid
1061506|NCT02781467|Leukemia|leukemia
1061507|NCT02781467|PNK-007|pnk-007
1061508|NCT02781467|Human IL-2|human il-2
1061509|NCT02781467|RHIL-2|rhil-2
1061510|NCT02781467|Fludarabine|fludarabine
1061511|NCT02781467|Cyclophosphamide|cyclophosphamide
1061512|NCT02781454|SALS|sals
1061513|NCT02781454|Mexiletine|mexiletine
1061514|NCT02781454|TMS|tms
1061515|NCT02781454|NCS|ncs
1061516|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
1061517|NCT02781402|Normal BMI Individuals|normal bmi individuals
1061518|NCT02781402|Recovery Heart Rate|recovery heart rate
1061519|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
1061520|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
1061521|NCT02781376|Primary Care|primary care
1061522|NCT02781376|Computer Decision Support System|computer decision support system
1061523|NCT02781376|Guidelines|guidelines
1061524|NCT02781376|Snoring|snoring
1061525|NCT02781363|thoracic ultrasound|thoracic ultrasound
1061526|NCT02781363|children|children
1061527|NCT02781363|efficacy|efficacy
1061528|NCT02781363|emergency service|emergency service
1061529|NCT02781350|high fat diet|high fat diet
1061530|NCT02781350|insulinogenesis|insulinogenesis
1061531|NCT02781350|Fiber|fiber
1061532|NCT02781350|inflammation|inflammation
1061533|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
1061534|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1061535|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
1061536|NCT02781324|Estimated Blood Loss|estimated blood loss
1061537|NCT02781272|pelvic mass|pelvic mass
1061538|NCT02781272|ovarian cancer|ovarian cancer
1061539|NCT02781272|gynecological cancer|gynecological cancer
1061540|NCT02781272|risk prediction|risk prediction
1061541|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1061542|NCT02781259|Fluorescence|fluorescence
1061543|NCT02781259|Breast Neoplasms|breast neoplasms
1061544|NCT02781259|Indocyanine Green|indocyanine green
1061545|NCT02781220|MCI|mci
1061546|NCT02781220|Dementia|dementia
1061547|NCT02781220|amyloid PET|amyloid pet
1061548|NCT02781220|physician diagnosis|physician diagnosis
1061549|NCT02781220|Alzheimer's disease|alzheimer's disease
1061550|NCT02781220|AD|ad
1061551|NCT02781220|PET imaging|pet imaging
1061552|NCT02781220|Appropriate Use Criteria|appropriate use criteria
1061553|NCT02781220|patient-reported outcomes|patient-reported outcomes
1061554|NCT02781220|patient adherence|patient adherence
1061555|NCT02781207|syncope|syncope
1061556|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
1061557|NCT02781181|Stenting|stenting
1061558|NCT02781181|Protection device|protection device
1061559|NCT02781181|EPD usage|epd usage
1061560|NCT02781168|Premature newborn|premature newborn
1061561|NCT02781168|Cortisol|cortisol
1061562|NCT02781168|Stress|stress
1061563|NCT02781155|Health related quality of life|health related quality of life
1061564|NCT02781155|Moxibustion|moxibustion
1061565|NCT02781155|Cancer|cancer
1061566|NCT02781155|Chemotherapy|chemotherapy
1061567|NCT02781155|Neutropenia|neutropenia
1061568|NCT02781155|Anaemia|anaemia
1061569|NCT02781155|Thrombocytopenia|thrombocytopenia
1061570|NCT02781155|Self management|self management
1061571|NCT02781155|Wellbeing|wellbeing
1061572|NCT02781129|Memory|memory
1061573|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
1061574|NCT02781090|HIV|hiv
1061575|NCT02781090|Tobacco|tobacco
1061576|NCT02781090|Cigarette|cigarette
1061577|NCT02781090|Smoking|smoking
1061578|NCT02781090|Social Network|social network
1061579|NCT02781090|Internet|internet
1061580|NCT02781090|Cessation|cessation
1061581|NCT02781077|Stroke|stroke
1061582|NCT02781077|walking competency|walking competency
1062790|NCT02774356|Encoding|encoding
1061583|NCT02781077|Task-oriented exercise program|task-oriented exercise program
1061584|NCT02781077|Exercise intensity|exercise intensity
1061585|NCT02781012|Pancreatic Disease|pancreatic disease
1061586|NCT02781012|Pancreas|pancreas
1061587|NCT02781012|Borderline Resectable|borderline resectable
1061588|NCT02781012|Pancreatic Cancer|pancreatic cancer
1061589|NCT02781012|Pancreatitis|pancreatitis
1061590|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
1061591|NCT02781012|Healthy|healthy
1061592|NCT02781012|Healthy at risk|healthy at risk
1061593|NCT02780999|Osteoarthritis|osteoarthritis
1061594|NCT02780999|hand|hand
1061595|NCT02780999|orthotic|orthotic
1061596|NCT02780999|rehabilitation|rehabilitation
1061597|NCT02780986|female entertainment worker|female entertainment worker
1061598|NCT02780986|heterosexual men|heterosexual men
1061599|NCT02780986|entertainment establishment|entertainment establishment
1061600|NCT02780986|condom use|condom use
1061601|NCT02780986|sexually transmitted infection|sexually transmitted infection
1061602|NCT02780986|Singapore|singapore
1061603|NCT02780947|Ventricular tachycardia|ventricular tachycardia
1061604|NCT02780947|Ablation|ablation
1061605|NCT02780947|Myocardial Infarction|myocardial infarction
1061606|NCT02780947|Heart Failure|heart failure
1061607|NCT02780934|Pressure Dressing|pressure dressing
1061608|NCT02780934|Post-operative Care|post-operative care
1061609|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
1061610|NCT02780934|Mohs|mohs
1061611|NCT02780921|Prehabilitation|prehabilitation
1061612|NCT02780921|Oesophageal cancer|oesophageal cancer
1061613|NCT02780921|Gastric cancer|gastric cancer
1061614|NCT02780921|Fitness|fitness
1061615|NCT02780921|Preconditionning|preconditionning
1061616|NCT02780921|two parallel arms|two parallel arms
1061617|NCT02780895|Parkinson Disease|parkinson disease
1061618|NCT02780895|stereotactic surgery|stereotactic surgery
1061619|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
1061620|NCT02780882|Pasireotide|pasireotide
1061621|NCT02780882|Ectopic ACTH|ectopic acth
1061622|NCT02780882|SOM230|som230
1061623|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
1061624|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
1061625|NCT02780856|Demineralisation|demineralisation
1061626|NCT02780843|Stroke|stroke
1061627|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
1061628|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
1061629|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
1061630|NCT02780830|Lymphoma|lymphoma
1061631|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1061632|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
1061633|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
1061634|NCT02780830|Vistusertib|vistusertib
1061635|NCT02780830|AZD2014|azd2014
1061636|NCT02780830|Ibrutinib|ibrutinib
1061637|NCT02780830|Imbruvica|imbruvica
1061638|NCT02780791|Infertility|infertility
1061639|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
1061640|NCT02780791|Ovarian Follicle|ovarian follicle
1061641|NCT02780791|Ovary|ovary
1061642|NCT02780791|Tissue Transplantation|tissue transplantation
1061643|NCT02780791|Cryopreservation|cryopreservation
1061644|NCT02780791|Pelvis|pelvis
1061645|NCT02780791|Chemotherapy|chemotherapy
1061646|NCT02780791|Pregnancy Rate|pregnancy rate
1061647|NCT02780791|Folliculogenesis|folliculogenesis
1061648|NCT02780791|Endometrium|endometrium
1061649|NCT02780791|Estrogens|estrogens
1061650|NCT02780791|Progestins|progestins
1061651|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
1061652|NCT02780791|Estradiol|estradiol
1061653|NCT02780791|Progesterone|progesterone
1061654|NCT02780791|Hormones|hormones
1061655|NCT02780791|Maturation of Follicles|maturation of follicles
1061656|NCT02780791|Pregnant Women|pregnant women
1061657|NCT02780791|Premature Menopause|premature menopause
1061658|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
1061659|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
1061660|NCT02780791|Cytotoxic therapy|cytotoxic therapy
1061661|NCT02780791|Fertility Protection|fertility protection
1061662|NCT02780791|Reproductive Medicine|reproductive medicine
1061663|NCT02780791|Reproductive Techniques|reproductive techniques
1061664|NCT02780791|Reproductive Technology|reproductive technology
1061665|NCT02780791|Cryotherapy|cryotherapy
1061666|NCT02780791|Pregnancy|pregnancy
1061667|NCT02780739|Psychological Tests|psychological tests
1061668|NCT02780739|Neuropsychological Tests|neuropsychological tests
1061669|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1061670|NCT02780739|Exercise|exercise
1061671|NCT02780739|Circuit-Based Exercise|circuit-based exercise
1061672|NCT02780739|Video Games|video games
1061673|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
1061674|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1061675|NCT02780739|Cognition|cognition
1061676|NCT02780739|Executive Function|executive function
1061677|NCT02780739|Learning|learning
1061678|NCT02780739|Problem Solving|problem solving
1061679|NCT02780739|Transfer (Psychology)|transfer (psychology)
1061680|NCT02780739|Decision Making|decision making
1061681|NCT02780739|Brain|brain
1061682|NCT02780739|Gray Matter|gray matter
1061683|NCT02780739|White Matter|white matter
1061684|NCT02780726|Peritoneal dialysis|peritoneal dialysis
1061685|NCT02780726|Roxadustat|roxadustat
1061686|NCT02780726|Renal anemia|renal anemia
1061687|NCT02780726|ASP1517|asp1517
1061688|NCT02780713|Breast cancer|breast cancer
1061689|NCT02780713|Healthy volunteers|healthy volunteers
1061690|NCT02780713|Pharmacokinetics|pharmacokinetics
1061691|NCT02780713|AZD9496|azd9496
1061692|NCT02780713|Safety|safety
1061693|NCT02780713|Tolerability|tolerability
1061694|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
1061695|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
1061696|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1061697|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
1061698|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
1061699|NCT02780609|high-dose melphalan|high-dose melphalan
1061700|NCT02780609|selinexor|selinexor
1061701|NCT02780596|Infant|infant
1061702|NCT02780596|Toddler|toddler
1061703|NCT02780596|Primary Care|primary care
1061704|NCT02780570|SVPE|svpe
1061705|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
1061706|NCT02780570|plasmapheresis|plasmapheresis
1061707|NCT02780557|Vocabulary|vocabulary
1061708|NCT02780557|Book reading|book reading
1061709|NCT02780557|Infancy|infancy
1061710|NCT02780557|Parenting|parenting
1061711|NCT02780544|Infant, premature|infant, premature
1061712|NCT02780544|Pain|pain
1061713|NCT02780544|Stress, physiological|stress, physiological
1061714|NCT02780544|Stress, psychological|stress, psychological
1061715|NCT02780544|skin-to-skin contact|skin-to-skin contact
1061716|NCT02780518|oxygen|oxygen
1061717|NCT02780518|carbon dioxide|carbon dioxide
1061718|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
1061719|NCT02780492|Natural history|natural history
1061720|NCT02780492|Outcome measures|outcome measures
1061721|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
1061722|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
1061723|NCT02780492|Myoset|myoset
1061724|NCT02780492|Exon skipping|exon skipping
1061725|NCT02780479|Prednisone|prednisone
1061726|NCT02780479|Dexamethasone|dexamethasone
1061727|NCT02780479|Asthma exacerbation|asthma exacerbation
1061728|NCT02780479|Hospitalized|hospitalized
1061729|NCT02780466|Septic shock|septic shock
1061730|NCT02780466|Endotracheal intubation|endotracheal intubation
1061731|NCT02780466|Outcome|outcome
1061732|NCT02780440|Post Stroke Recovery|post stroke recovery
1061733|NCT02780440|Mirror Therapy|mirror therapy
1061734|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
1061735|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
1061736|NCT02780440|Stroke|stroke
1061737|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
1061738|NCT02780414|Hypertension|hypertension
1061739|NCT02780414|Proteinuria|proteinuria
1061740|NCT02780414|Thrombocytopenia|thrombocytopenia
1061741|NCT02780414|Renal Insufficiency|renal insufficiency
1061742|NCT02780414|Impaired Liver Function|impaired liver function
1061743|NCT02780414|Pulmonary Edema|pulmonary edema
1061744|NCT02780401|Stage I|stage i
1061745|NCT02780401|Stage II|stage ii
1061746|NCT02780401|Stage III|stage iii
1061747|NCT02780388|MEDI4920, CD40L, RA, rheumatoid arthritis|medi4920, cd40l, ra, rheumatoid arthritis
1061748|NCT02780375|Transcriptional Responses|transcriptional responses
1061749|NCT02780375|Radiation|radiation
1061750|NCT02780323|Celecoxib|celecoxib
1061751|NCT02780323|CELBESTA|celbesta
1061752|NCT02780310|Lenvatinib|lenvatinib
1061753|NCT02780310|15-327|15-327
1061754|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
1061755|NCT02780297|Dent Disease|dent disease
1061756|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
1061757|NCT02780297|cystinuria|cystinuria
1061758|NCT02780297|Lowe Syndrome|lowe syndrome
1061759|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
1061761|NCT02780297|APRTd|aprtd
1061762|NCT02780297|APRT|aprt
1061763|NCT02780297|hyperoxaluria|hyperoxaluria
1061764|NCT02780297|oxalate|oxalate
1061765|NCT02780297|oxalosis|oxalosis
1061766|NCT02780297|PH type 1|ph type 1
1061767|NCT02780297|PH type 2|ph type 2
1061768|NCT02780297|PH type 3|ph type 3
1061769|NCT02780297|Dents|dents
1061770|NCT02780297|Dent|dent
1061771|NCT02780297|Dent 1|dent 1
1061772|NCT02780297|Dent 2|dent 2
1061773|NCT02780297|APRT deficiency|aprt deficiency
1061774|NCT02780284|Gut Microbiota|gut microbiota
1061775|NCT02780284|Butyrate|butyrate
1061776|NCT02780284|Physical activity|physical activity
1061777|NCT02780271|Breast Cancer|breast cancer
1061778|NCT02780271|Cancer survivor|cancer survivor
1061779|NCT02780271|e-communication|e-communication
1061780|NCT02780271|diet and physical activity|diet and physical activity
1061781|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
1061782|NCT02780271|energy density|energy density
1061783|NCT02780245|Caesarean Section|caesarean section
1061784|NCT02780245|Tranexamic Acid|tranexamic acid
1061785|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
1061786|NCT02780245|Ecbolics|ecbolics
1061787|NCT02780232|Depression|depression
1061788|NCT02780232|Adolescence|adolescence
1061789|NCT02780232|Prevention|prevention
1061790|NCT02780232|Early intervention|early intervention
1061791|NCT02780232|E-Mental Health|e-mental health
1061792|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
1061793|NCT02780180|Heart Failure|heart failure
1061794|NCT02780180|Up-titration|up-titration
1061795|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
1061796|NCT02780180|Pharmacokinetics|pharmacokinetics
1061797|NCT02780180|Patient Safety|patient safety
1061798|NCT02780180|Treatment Efficacy|treatment efficacy
1061799|NCT02780167|Phase 2|phase 2
1061800|NCT02780167|randomized|randomized
1061801|NCT02780167|double-blind|double-blind
1061802|NCT02780167|placebo|placebo
1061803|NCT02780167|atopic dermatitis|atopic dermatitis
1061804|NCT02780167|safety|safety
1061805|NCT02780167|efficacy|efficacy
1061806|NCT02780167|JAK|jak
1061807|NCT02780167|janus kinase|janus kinase
1061808|NCT02780167|moderate|moderate
1061809|NCT02780167|severe|severe
1061810|NCT02780154|7G8 clone|7g8 clone
1061811|NCT02780154|NF54 strain|nf54 strain
1061812|NCT02780154|Non-immune|non-immune
1061813|NCT02780154|PCR|pcr
1061814|NCT02780154|PfSPZ Challenge|pfspz challenge
1061815|NCT02780154|Plasmodium falciparum|plasmodium falciparum
1061816|NCT02780154|qPCR|qpcr
1061817|NCT02780154|Sporozoites|sporozoites
1061818|NCT02780141|Renal anemia|renal anemia
1061819|NCT02780141|Roxadustat|roxadustat
1061820|NCT02780141|ASP1517|asp1517
1061821|NCT02780141|Hemodialysis|hemodialysis
1061822|NCT02780128|neuroblastoma|neuroblastoma
1061823|NCT02780128|cancer|cancer
1061824|NCT02780128|genetic profiling|genetic profiling
1061825|NCT02780128|ceritinib|ceritinib
1061826|NCT02780128|ribociclib|ribociclib
1061827|NCT02780128|trametinib|trametinib
1061828|NCT02780128|HDM201|hdm201
1061829|NCT02780102|ADHD|adhd
1061830|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
1061831|NCT02780102|Active Control Group|active control group
1061832|NCT02780102|Stimulant Medication|stimulant medication
1061833|NCT02780089|Metastatic|metastatic
1061834|NCT02780089|Unresectable|unresectable
1061835|NCT02780063|Dilation|dilation
1061836|NCT02780063|Intraocular|intraocular
1061837|NCT02780063|Ophthalmology|ophthalmology
1061838|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1061839|NCT02780050|manikins|manikins
1061840|NCT02780050|physical fitness|physical fitness
1061841|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
1061842|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
1061843|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
1061844|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
1061845|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
1061846|NCT02780024|Adjuvant Metformin|adjuvant metformin
1061847|NCT02780011|CD30+|cd30+
1061848|NCT02780011|Relapsed|relapsed
1061849|NCT02780011|Refractory|refractory
1061850|NCT02780011|ALCL|alcl
1061851|NCT02779985|Lycium Barbarum|lycium barbarum
1061852|NCT02779985|Energy expenditure|energy expenditure
1061853|NCT02779985|Postprandial metabolism|postprandial metabolism
1061854|NCT02779972|Cardiac Physiology|cardiac physiology
1061855|NCT02779972|Physiology|physiology
1061856|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
1061857|NCT02779933|Epidemiology|epidemiology
1061858|NCT02779933|Risk Factors|risk factors
1061859|NCT02779920|refractory gastroparesis|refractory gastroparesis
1061860|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
1061861|NCT02779907|Paediatric|paediatric
1061862|NCT02779907|Malawi|malawi
1061863|NCT02779894|Sleep Apnea|sleep apnea
1061864|NCT02779894|Communication Based Technology|communication based technology
1061865|NCT02779894|ICT|ict
1061866|NCT02779868|body composition|body composition
1061867|NCT02779868|functional capacity|functional capacity
1061868|NCT02779868|quality of life|quality of life
1061869|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1061870|NCT02779855|estrogen receptor|estrogen receptor
1061871|NCT02779855|progesterone receptor|progesterone receptor
1061872|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
1061873|NCT02779855|breast cancer tumors|breast cancer tumors
1061874|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
1061875|NCT02779790|Evidence-Based Medicine|evidence-based medicine
1061876|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
1061877|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
1061878|NCT02779790|Liquid Meal Replacements|liquid meal replacements
1061879|NCT02779790|Body Weight|body weight
1061880|NCT02779790|Systolic Blood Pressure|systolic blood pressure
1061881|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
1061882|NCT02779790|Fasting Blood Glucose|fasting blood glucose
1062791|NCT02774356|Pitch|pitch
1061883|NCT02779790|Fasting Blood Insulin|fasting blood insulin
1061884|NCT02779790|HbA1c|hba1c
1061885|NCT02779790|Total Cholesterol|total cholesterol
1061886|NCT02779790|Triglycerides|triglycerides
1061887|NCT02779790|LDL-C|ldl-c
1061888|NCT02779790|HDL-C|hdl-c
1061889|NCT02779790|Controlled Feeding Trials|controlled feeding trials
1061890|NCT02779764|Hemodialysis|hemodialysis
1061891|NCT02779764|ASP1517|asp1517
1061892|NCT02779764|Roxadustat|roxadustat
1061893|NCT02779764|Renal anemia|renal anemia
1061894|NCT02779725|Symptom Management|symptom management
1061895|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
1061896|NCT02779686|Macular Degeneration|macular degeneration
1061897|NCT02779686|Genetic testing|genetic testing
1061898|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
1061899|NCT02779686|Age-Related Maculopathies|age-related maculopathies
1061900|NCT02779660|Atrial Fibrillation|atrial fibrillation
1061901|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
1061902|NCT02779608|malignant ascites|malignant ascites
1061903|NCT02779582|Progesterone|progesterone
1061904|NCT02779582|Menstrual Flow|menstrual flow
1061905|NCT02779556|Health Literacy|health literacy
1061906|NCT02779556|Diabetes|diabetes
1061907|NCT02779543|In lab sleep studies|in lab sleep studies
1061908|NCT02779517|upper extremity|upper extremity
1061909|NCT02779517|stroke|stroke
1061910|NCT02779517|rehabilitation|rehabilitation
1061911|NCT02779517|robotics|robotics
1061912|NCT02779517|telepresence|telepresence
1061913|NCT02779517|elderly|elderly
1061914|NCT02779517|aged|aged
1061915|NCT02779517|Housing for the elderly|housing for the elderly
1061916|NCT02779517|retirement|retirement
1061917|NCT02779517|homes for the aged|homes for the aged
1061918|NCT02779491|fruit and vegetables|fruit and vegetables
1061919|NCT02779491|food intake|food intake
1061920|NCT02779491|knowledge|knowledge
1061921|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1061922|NCT02779478|cavitary|cavitary
1061923|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
1061924|NCT02779478|NTM|ntm
1061925|NCT02779465|vitamin D treatment|vitamin d treatment
1061926|NCT02779465|chronic hepatitis B|chronic hepatitis b
1061927|NCT02779452|neurodevelopment|neurodevelopment
1061928|NCT02779452|electroencephalography|electroencephalography
1061929|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
1061930|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
1061931|NCT02779426|Atopic dermatitis|atopic dermatitis
1061932|NCT02779426|Text Messages|text messages
1061933|NCT02779426|Health literacy|health literacy
1061934|NCT02779400|INR|inr
1061935|NCT02779400|coagulation|coagulation
1061936|NCT02779400|vitamin K antagonist|vitamin k antagonist
1061937|NCT02779387|GnRH-a|gnrh-a
1061938|NCT02779387|endometriosis|endometriosis
1061939|NCT02779387|efficiency|efficiency
1061940|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
1061941|NCT02779361|green tea|green tea
1061942|NCT02779361|steroid profile|steroid profile
1061943|NCT02779348|Nebicapone|nebicapone
1061944|NCT02779348|Warfarin|warfarin
1061945|NCT02779335|tube-fed|tube-fed
1061946|NCT02779335|Formula Tolerance|formula tolerance
1061947|NCT02779335|Pediatric Patients|pediatric patients
1061948|NCT02779322|gastric bypass|gastric bypass
1061949|NCT02779322|hospital charges|hospital charges
1061950|NCT02779322|mini gastric bypass|mini gastric bypass
1061951|NCT02779309|Frail Older Adults|frail older adults
1061952|NCT02779309|Mortality|mortality
1061953|NCT02779309|Home Care|home care
1061954|NCT02779309|Survival Analysis|survival analysis
1061955|NCT02779309|Clinical Prediction Rule|clinical prediction rule
1061956|NCT02779296|Cyanoacrylates|cyanoacrylates
1061957|NCT02779296|Mammaplasty|mammaplasty
1061958|NCT02779296|Mastectomy|mastectomy
1061959|NCT02779257|hypoglycemia|hypoglycemia
1061960|NCT02779244|Orthopedic|orthopedic
1061961|NCT02779244|Post-operative|post-operative
1061962|NCT02779244|Weight bearing|weight bearing
1061963|NCT02779244|Range of motion|range of motion
1061964|NCT02779218|Hemiplegia|hemiplegia
1061965|NCT02779205|Cell therapy|cell therapy
1061966|NCT02779205|Stromal Cells|stromal cells
1061967|NCT02779205|Stem cells|stem cells
1061968|NCT02779205|Adipose tissue|adipose tissue
1061969|NCT02779205|Children|children
1061970|NCT02779166|hip arthroscopy|hip arthroscopy
1061972|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
1061973|NCT02779140|BoNT|bont
1061974|NCT02779140|botulinum|botulinum
1061975|NCT02779140|Botulism|botulism
1061976|NCT02779140|Clostridium|clostridium
1061977|NCT02779140|Neurotoxin|neurotoxin
1061978|NCT02779140|NTM-1632|ntm-1632
1061979|NCT02779127|Smoking|smoking
1061980|NCT02779127|Endothelium|endothelium
1061981|NCT02779127|Passive smoking|passive smoking
1061982|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
1061983|NCT02779114|Remission|remission
1061984|NCT02779114|Dose reduction|dose reduction
1061985|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
1061986|NCT02779101|Pembrolizumab|pembrolizumab
1061987|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
1061988|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1061989|NCT02779036|Stroke|stroke
1061990|NCT02779036|task-oriented home exercise|task-oriented home exercise
1061991|NCT02779036|walking competency|walking competency
1061992|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
1061993|NCT02778997|Shunt|shunt
1061994|NCT02778997|CSF|csf
1061995|NCT02778997|Dysfunction|dysfunction
1061996|NCT02778997|Complication|complication
1061997|NCT02778984|Anesthesia|anesthesia
1061998|NCT02778984|facial mask|facial mask
1061999|NCT02778971|MCI|mci
1062000|NCT02778971|Dementia|dementia
1062001|NCT02778971|amyloid PET|amyloid pet
1062002|NCT02778971|physician diagnosis|physician diagnosis
1062003|NCT02778971|Alzheimer's disease|alzheimer's disease
1062005|NCT02778971|PET imaging|pet imaging
1062006|NCT02778971|Appropriate Use Criteria|appropriate use criteria
1062007|NCT02778971|patient-reported outcomes|patient-reported outcomes
1062008|NCT02778958|bariatric surgery|bariatric surgery
1062009|NCT02778958|morbid obesity|morbid obesity
1062010|NCT02778958|nonopioid analgesics|nonopioid analgesics
1062011|NCT02778945|spinal surgery|spinal surgery
1062012|NCT02778945|sugammadex|sugammadex
1062013|NCT02778945|deep neuromuscular block|deep neuromuscular block
1062014|NCT02778945|shear wave elastography|shear wave elastography
1734976|NCT00004458|autism|autism
1062015|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
1062016|NCT02778919|Endometriosis|endometriosis
1062017|NCT02778906|Abatacept|abatacept
1062018|NCT02778893|Conmana|conmana
1062019|NCT02778893|Thalidomide|thalidomide
1062020|NCT02778893|NSCLC|nsclc
1062021|NCT02778893|EGFR mutation|egfr mutation
1062022|NCT02778854|NSCLC|nsclc
1062023|NCT02778854|liquid biopsy|liquid biopsy
1062024|NCT02778854|driver mutation|driver mutation
1062025|NCT02778828|linezolide|linezolide
1062026|NCT02778828|tuberculosis|tuberculosis
1062027|NCT02778828|MDR-TB|mdr-tb
1062028|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
1062029|NCT02778802|Emphysema|emphysema
1062030|NCT02778802|COPD|copd
1062031|NCT02778776|Metformin|metformin
1062032|NCT02778776|Agave Inulin|agave inulin
1062033|NCT02778776|METS|mets
1062034|NCT02778776|Inflammation parameters|inflammation parameters
1062035|NCT02778776|Urodynamic parameters|urodynamic parameters
1062036|NCT02778776|Prostate hyperplasia|prostate hyperplasia
1062037|NCT02778763|Breast cancer|breast cancer
1062038|NCT02778763|TLR2|tlr2
1062039|NCT02778763|Neutropenia|neutropenia
1062040|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
1062041|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
1062042|NCT02778711|anti-IL-17|anti-il-17
1062043|NCT02778711|secukinumab|secukinumab
1062044|NCT02778672|bacterial pneumonia|bacterial pneumonia
1062045|NCT02778672|children|children
1062046|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
1062047|NCT02778672|thermal imaging|thermal imaging
1062048|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
1062049|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
1062050|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
1062051|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
1062052|NCT02778542|Automated Hovering|automated hovering
1062053|NCT02778542|Remote Monitoring|remote monitoring
1062054|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
1062055|NCT02778529|stroke|stroke
1062056|NCT02778529|amputees|amputees
1062057|NCT02778529|spinal cord injuries|spinal cord injuries
1062058|NCT02778529|cerebral palsy|cerebral palsy
1062059|NCT02778529|robotics|robotics
1062060|NCT02778529|rehabilitation|rehabilitation
1062061|NCT02778503|Tooth, Deciduous|tooth, deciduous
1062062|NCT02778503|Dentition, Permanent|dentition, permanent
1062063|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1062064|NCT02778503|Glass Ionomer Cements|glass ionomer cements
1062065|NCT02778503|Dental Caries|dental caries
1062066|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
1062067|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
1062068|NCT02778464|Pregnancy|pregnancy
1062069|NCT02778464|Stool markers|stool markers
1062070|NCT02778464|Calprotectin|calprotectin
1062071|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
1062072|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
1062073|NCT02778425|partial splenic embolization|partial splenic embolization
1062074|NCT02778412|Thyroid cancer|thyroid cancer
1062075|NCT02778412|Thyroid nodules|thyroid nodules
1062076|NCT02778412|Thyroid neoplasia|thyroid neoplasia
1062077|NCT02778412|Thyroiditis|thyroiditis
1062078|NCT02778399|Pelvic Pain|pelvic pain
1062079|NCT02778399|Endometriosis|endometriosis
1062080|NCT02778399|Dysmenorrhea|dysmenorrhea
1062081|NCT02778399|Dyspareunia|dyspareunia
1062082|NCT02778360|Attention deficit|attention deficit
1062083|NCT02778360|Neurofeedback|neurofeedback
1062084|NCT02778360|ADHD|adhd
1062085|NCT02778360|Methylphenidate|methylphenidate
1062086|NCT02778347|Palliative care|palliative care
1062087|NCT02778347|Need assessment|need assessment
1062088|NCT02778347|Tools|tools
1062089|NCT02778347|Validity|validity
1062090|NCT02778347|Quality of care|quality of care
1062091|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
1062092|NCT02778269|ECG|ecg
1062093|NCT02778269|CGM|cgm
1062094|NCT02778269|Hypoglycaemia|hypoglycaemia
1062095|NCT02778269|Sudden Cardiac Death|sudden cardiac death
1062096|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
1062097|NCT02778230|fiber|fiber
1062098|NCT02778230|gastrointestinal|gastrointestinal
1062099|NCT02778230|microbiota|microbiota
1062100|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1062101|NCT02778191|cisplatin|cisplatin
1062102|NCT02778191|carboplatin|carboplatin
1062103|NCT02778191|5-fluorouracil|5-fluorouracil
1062104|NCT02778087|motor recovery|motor recovery
1062105|NCT02778087|mirror therapy|mirror therapy
1062106|NCT02778087|upper extremity|upper extremity
1062107|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
1062108|NCT02778061|Intra Uterine Ball|intra uterine ball
1062109|NCT02778061|IUD|iud
1062110|NCT02778061|copper|copper
1062111|NCT02778061|contraception|contraception
1062112|NCT02778022|Child behavior disorders|child behavior disorders
1062113|NCT02778022|Parent child relationship|parent child relationship
1062114|NCT02778022|Primary care|primary care
1062115|NCT02778009|Medical student|medical student
1062116|NCT02778009|Activity Monitor|activity monitor
1062117|NCT02778009|Medical school|medical school
1062118|NCT02778009|Fitness|fitness
1062119|NCT02777996|screening|screening
1062120|NCT02777983|patient education|patient education
1062121|NCT02777983|low back pain|low back pain
1062122|NCT02777983|technology|technology
1062123|NCT02777970|Acute pain|acute pain
1062124|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
1062125|NCT02777970|Postoperative pain|postoperative pain
1062126|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
1062127|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
1062128|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
1062129|NCT02777970|Multimodal analgesia|multimodal analgesia
1062130|NCT02777970|Third molar extraction|third molar extraction
1062131|NCT02777970|Fixed drug combination|fixed drug combination
1062132|NCT02777970|Paracetamol|paracetamol
1062133|NCT02777970|Analgesics|analgesics
1062134|NCT02777957|Echocardiography|echocardiography
1062135|NCT02777957|Lung Transplantation|lung transplantation
1062136|NCT02777944|motivation|motivation
1062137|NCT02777944|attendance|attendance
1062138|NCT02777918|food intake|food intake
1062139|NCT02777905|late life|late life
1062140|NCT02777905|mindfulness meditation|mindfulness meditation
1062141|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1062142|NCT02777853|tea|tea
1062143|NCT02777853|cardiovascular|cardiovascular
1062144|NCT02777853|vascular|vascular
1062145|NCT02777853|metabolism|metabolism
1062146|NCT02777853|microcirculation|microcirculation
1062147|NCT02777853|physical inactivity|physical inactivity
1062148|NCT02777853|polyphenols|polyphenols
1062149|NCT02777853|conduit artery|conduit artery
1062150|NCT02777853|endothelial function|endothelial function
1062151|NCT02777853|cerebrovascular|cerebrovascular
1062152|NCT02777853|insulin sensitivity|insulin sensitivity
1062153|NCT02777827|Abediterol|abediterol
1062154|NCT02777827|Dry powder inhaler|dry powder inhaler
1062155|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
1062156|NCT02777827|Pharmacokinetic|pharmacokinetic
1062157|NCT02777827|Pharmacodynamic|pharmacodynamic
1062158|NCT02777827|Safety|safety
1062159|NCT02777814|colorectal cancer|colorectal cancer
1062160|NCT02777814|Entecavir|entecavir
1062161|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
1062162|NCT02777801|gastric cancer|gastric cancer
1062163|NCT02777801|hepatitis B carrier|hepatitis b carrier
1062164|NCT02777801|entecavir|entecavir
1062165|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
1062166|NCT02777775|NF1|nf1
1062167|NCT02777775|CNF|cnf
1062168|NCT02777775|PNF|pnf
1062169|NCT02777775|Skin Tumors|skin tumors
1062170|NCT02777736|Lymphoma, B cell|lymphoma, b cell
1062171|NCT02777736|Central nervous system relapse|central nervous system relapse
1062172|NCT02777736|Methotrexate|methotrexate
1062173|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
1062174|NCT02777723|Dry Eye Syndrome|dry eye syndrome
1062175|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
1062176|NCT02777723|CKD-350|ckd-350
1062177|NCT02777697|cancer treatment protocols|cancer treatment protocols
1062178|NCT02777697|chronic cancer pain|chronic cancer pain
1062179|NCT02777697|cognitive function|cognitive function
1062180|NCT02777697|quality of life|quality of life
1062181|NCT02777697|anxiety|anxiety
1062182|NCT02777697|depression|depression
1062183|NCT02777684|Physical activity|physical activity
1062184|NCT02777684|Knee osteoarthritis|knee osteoarthritis
1062185|NCT02777684|Non pharmacological treatment|non pharmacological treatment
1062186|NCT02777684|Qualitative study|qualitative study
1062792|NCT02774304|elastance|elastance
1062187|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
1062188|NCT02777619|Pharmacodynamic|pharmacodynamic
1062189|NCT02777619|Dexmedetomidine|dexmedetomidine
1062190|NCT02777619|Propofol|propofol
1062191|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
1062192|NCT02777606|Severe Sepsis|severe sepsis
1062193|NCT02777606|Sini Decoction|sini decoction
1062194|NCT02777606|Immune Function|immune function
1062195|NCT02777606|Mortality|mortality
1062196|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
1062197|NCT02777580|Primary PCI|primary pci
1062198|NCT02777554|Healthy Subjects|healthy subjects
1062199|NCT02777554|Apremilast|apremilast
1062200|NCT02777554|Pharmacokinetic|pharmacokinetic
1062201|NCT02777541|early enteral nutrition|early enteral nutrition
1062202|NCT02777541|children|children
1062203|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1062204|NCT02777515|electronic cigarette|electronic cigarette
1062205|NCT02777489|obesity|obesity
1062206|NCT02777489|perindopril|perindopril
1062207|NCT02777489|carboxypeptidase D|carboxypeptidase d
1062208|NCT02777489|genotyping|genotyping
1062209|NCT02777489|theranostic|theranostic
1062210|NCT02777450|low back pain|low back pain
1062211|NCT02777450|physical examination|physical examination
1062212|NCT02777450|local anesthesia|local anesthesia
1062213|NCT02777437|Colonic Neoplasms|colonic neoplasms
1062214|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
1062215|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1062216|NCT02777437|T4|t4
1062217|NCT02777411|Vaccines|vaccines
1062218|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
1062219|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
1062220|NCT02777398|Intra-spinal Canal|intra-spinal canal
1062221|NCT02777398|Tumor|tumor
1062222|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
1062223|NCT02777398|Clinical Trial|clinical trial
1062224|NCT02777398|Quadrant Channel|quadrant channel
1062225|NCT02777385|Head and Neck|head and neck
1062226|NCT02777385|Locally Advanced|locally advanced
1062227|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
1062228|NCT02777385|SCCHN|scchn
1062229|NCT02777385|Untreated|untreated
1062230|NCT02777385|High Risk|high risk
1062231|NCT02777385|Intermediate Risk|intermediate risk
1062232|NCT02777385|Radiation Therapy|radiation therapy
1062233|NCT02777385|Cisplatin|cisplatin
1062234|NCT02777372|Zoloft|zoloft
1062235|NCT02777372|PMS|pms
1062236|NCT02777372|Menses|menses
1062237|NCT02777359|patent foramen ovale|patent foramen ovale
1062238|NCT02777359|migraine|migraine
1062239|NCT02777359|treatment|treatment
1062240|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
1062241|NCT02777346|CHILD, PRESCHOOL|child, preschool
1062242|NCT02777346|CHILD|child
1062243|NCT02777346|INFANT|infant
1062244|NCT02777346|ADOLESCENT|adolescent
1062245|NCT02777346|SUTURES|sutures
1062246|NCT02777346|POLYGLACTIN 910|polyglactin 910
1062247|NCT02777346|POLYPROPYLENES|polypropylenes
1062248|NCT02777333|Simulation|simulation
1062249|NCT02777333|Arthroscopy|arthroscopy
1062250|NCT02777333|Motion analysis|motion analysis
1062251|NCT02777320|Sciatica|sciatica
1062252|NCT02777320|Ibuprofen|ibuprofen
1062253|NCT02777320|Paracetamol|paracetamol
1062254|NCT02777320|Emergency Medicine|emergency medicine
1062255|NCT02777307|Laparoscopic|laparoscopic
1062256|NCT02777307|Cholecistectomy|cholecistectomy
1062257|NCT02777307|Collection|collection
1062258|NCT02777307|Bleeding|bleeding
1062259|NCT02777307|reoperation|reoperation
1062260|NCT02777281|Shoulder Pain|shoulder pain
1062261|NCT02777281|Wheelchair|wheelchair
1062262|NCT02777281|Spinal Cord injury|spinal cord injury
1062263|NCT02777242|Hypogonadism|hypogonadism
1062264|NCT02777242|Testosterone enanthate|testosterone enanthate
1062265|NCT02777216|RDN|rdn
1062266|NCT02777203|morcellation|morcellation
1062267|NCT02777203|myomectomy|myomectomy
1062268|NCT02777203|hysterectomy|hysterectomy
1062269|NCT02777190|misoprostol|misoprostol
1062270|NCT02777190|cytotec|cytotec
1062271|NCT02777190|cervical ripening|cervical ripening
1062272|NCT02777190|labor, induced|labor, induced
1062273|NCT02777190|active labor|active labor
1062274|NCT02777138|Adipose tissue|adipose tissue
1062275|NCT02777138|Inflammation|inflammation
1062276|NCT02777138|Age Comparison|age comparison
1062277|NCT02777138|Macrophages|macrophages
1062278|NCT02777138|T-lymphocytes|t-lymphocytes
1062279|NCT02777138|Adipose Progenitors|adipose progenitors
1062280|NCT02777125|pediatrics|pediatrics
1062281|NCT02777125|metered dose inhalers|metered dose inhalers
1062282|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
1062283|NCT02777112|high-risk|high-risk
1062284|NCT02777112|early prevention|early prevention
1062285|NCT02777112|productivity|productivity
1062286|NCT02777112|return on investment|return on investment
1062287|NCT02777112|workplace|workplace
1062288|NCT02777112|e-mental health program|e-mental health program
1062290|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
1062291|NCT02777099|autonomic function|autonomic function
1062292|NCT02777099|heart rate variability|heart rate variability
1062293|NCT02777099|acute ischemic stroke|acute ischemic stroke
1062294|NCT02777099|prognosis|prognosis
1062295|NCT02777086|HIV|hiv
1062296|NCT02777086|Risk Behaviors|risk behaviors
1062297|NCT02777086|Decision-making|decision-making
1062298|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
1062299|NCT02777073|Insulin|insulin
1062300|NCT02777073|Type 1 Diabetes|type 1 diabetes
1062301|NCT02777073|glucose (sugar) control|glucose (sugar) control
1062302|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
1062303|NCT02777060|virtual reality|virtual reality
1062304|NCT02777060|sensor-based balance training|sensor-based balance training
1062306|NCT02777060|balance|balance
1062307|NCT02777047|Thromboembolism|thromboembolism
1062308|NCT02777047|Medication Safety|medication safety
1062309|NCT02777047|Hospital-community collaboration|hospital-community collaboration
1062310|NCT02777047|Pilot RCT|pilot rct
1062311|NCT02777047|Telehealth|telehealth
1062312|NCT02777034|Laparoscopy|laparoscopy
1062313|NCT02777034|Enhanced Recovery|enhanced recovery
1062314|NCT02777034|Fast-track|fast-track
1062315|NCT02777021|Pediatric|pediatric
1062316|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
1062317|NCT02777021|Quality of Life|quality of life
1062318|NCT02777021|Neutropenia Management|neutropenia management
1062319|NCT02777021|Patient Centered Outcomes|patient centered outcomes
1062320|NCT02777021|Chemotherapy|chemotherapy
1062321|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
1062322|NCT02776982|GERD|gerd
1062323|NCT02776982|Barrett's Esophagus|barrett's esophagus
1062324|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
1062325|NCT02776969|Papillary Carcinoma|papillary carcinoma
1062326|NCT02776969|Gene Hunting|gene hunting
1062327|NCT02776969|Familial|familial
1062328|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
1062329|NCT02776930|Injury Prediction|injury prediction
1062330|NCT02776930|Return to Work|return to work
1062331|NCT02776930|Injury Prevention|injury prevention
1062332|NCT02776917|metastatic breast cancer|metastatic breast cancer
1062333|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
1062334|NCT02776917|HER2/NEU negative|her2/neu negative
1062335|NCT02776904|Concussion|concussion
1062336|NCT02776904|Football player|football player
1062337|NCT02776904|Movement assessment|movement assessment
1062338|NCT02776904|Soccer player|soccer player
1062339|NCT02776891|lymphoma|lymphoma
1062340|NCT02776891|gallium citrate|gallium citrate
1062341|NCT02776891|PET|pet
1062342|NCT02776865|suprascapular nerve block|suprascapular nerve block
1062343|NCT02776813|CD20+|cd20+
1062344|NCT02776813|B-cell|b-cell
1062345|NCT02776813|ACTR087|actr087
1062346|NCT02776813|Relapsed|relapsed
1062347|NCT02776813|Refractory|refractory
1062348|NCT02776800|Wound|wound
1062349|NCT02776800|Surgical Wound|surgical wound
1062350|NCT02776800|Trauma Wound|trauma wound
1062351|NCT02776800|Home Health Care|home health care
1062352|NCT02776800|Home Health Nurse|home health nurse
1062353|NCT02776800|Pressure Ulcer|pressure ulcer
1062354|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
1062355|NCT02776800|Venous Leg Ulcer|venous leg ulcer
1062356|NCT02776800|Arterial Ulcer|arterial ulcer
1062357|NCT02776800|Wound Dehiscence|wound dehiscence
1062358|NCT02776800|Open Wound|open wound
1062359|NCT02776774|spine|spine
1062360|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
1062361|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
1062362|NCT02776748|Breastfeeding|breastfeeding
1062363|NCT02776748|Emtricitabine|emtricitabine
1062364|NCT02776748|Tenofovir|tenofovir
1062365|NCT02776748|Post-partum|post-partum
1062366|NCT02776748|HIV prevention|hiv prevention
1062367|NCT02776748|Women|women
1062368|NCT02776748|Pharmacokinetics|pharmacokinetics
1062369|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
1062370|NCT02776722|randomized controlled trial|randomized controlled trial
1062371|NCT02776722|Evidence-Based Medicine|evidence-based medicine
1062372|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
1062373|NCT02776722|postprandial|postprandial
1062374|NCT02776722|glycemic response|glycemic response
1062375|NCT02776722|glycemic control|glycemic control
1062376|NCT02776722|insulin sensitivity|insulin sensitivity
1062377|NCT02776722|beta-cell function|beta-cell function
1062378|NCT02776722|sugars|sugars
1062379|NCT02776722|fructose|fructose
1062380|NCT02776722|allulose|allulose
1062381|NCT02776722|tagatose|tagatose
1062382|NCT02776722|sorbose|sorbose
1062383|NCT02776696|Closed Loop|closed loop
1062384|NCT02776696|Artificial Pancreas|artificial pancreas
1062385|NCT02776644|renal cell carcinoma|renal cell carcinoma
1062386|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
1062387|NCT02776644|temsirolimus|temsirolimus
1062388|NCT02776644|sorafenib|sorafenib
1062389|NCT02776644|everolimus|everolimus
1062390|NCT02776644|interferon alpha|interferon alpha
1062391|NCT02776644|interleukin 2|interleukin 2
1063101|NCT02772406|Dysplasia|dysplasia
1062392|NCT02776592|Healthy Children|healthy children
1062393|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
1062394|NCT02776566|Anticoagulation|anticoagulation
1062395|NCT02776566|Anticoagulation Management|anticoagulation management
1062396|NCT02776566|Self-Testing|self-testing
1062397|NCT02776566|Self-Management|self-management
1062398|NCT02776566|Warfarin|warfarin
1062399|NCT02776566|Thromboembolism|thromboembolism
1062400|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
1062401|NCT02776566|Health Disparities|health disparities
1062402|NCT02776566|Minorities|minorities
1062403|NCT02776566|African American|african american
1062404|NCT02776566|Hispanic|hispanic
1062405|NCT02776566|Cardiovascular Disease|cardiovascular disease
1062406|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
1062407|NCT02776566|Tele-Health|tele-health
1062408|NCT02776566|Home Self-Testing|home self-testing
1062409|NCT02776527|Gastric cancer|gastric cancer
1062410|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
1062411|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
1062412|NCT02776527|Apatinib|apatinib
1062413|NCT02776527|disease free survival|disease free survival
1062414|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
1062415|NCT02776462|Eye Tracking|eye tracking
1062416|NCT02776462|Concussion|concussion
1062417|NCT02776462|Outcome Measures|outcome measures
1062418|NCT02776410|sustainable healthy eating|sustainable healthy eating
1062419|NCT02776410|consumer behaviour|consumer behaviour
1062420|NCT02776410|consumer attitudes|consumer attitudes
1062421|NCT02776384|Heart Failure|heart failure
1062422|NCT02776384|Biomarkers|biomarkers
1062423|NCT02776384|Echocardiography|echocardiography
1062424|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
1062425|NCT02776371|Helicobacter pylori|helicobacter pylori
1062426|NCT02776371|Sequential therapy|sequential therapy
1062427|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
1062428|NCT02776345|calcific tendonitis|calcific tendonitis
1062429|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
1062430|NCT02776332|breastfeeding|breastfeeding
1062431|NCT02776332|premature infants|premature infants
1062432|NCT02776332|manual expression|manual expression
1062433|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
1062434|NCT02776319|tobacco use disorder|tobacco use disorder
1062436|NCT02776280|water|water
1062437|NCT02776280|salt|salt
1062438|NCT02776280|oral fluids|oral fluids
1062439|NCT02776280|plaque|plaque
1062440|NCT02776280|dental caries|dental caries
1062441|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
1062442|NCT02776254|differentiated care|differentiated care
1062443|NCT02776241|ADPKD|adpkd
1062444|NCT02776241|total kidney volume|total kidney volume
1062445|NCT02776241|kidney disease|kidney disease
1062446|NCT02776189|Anaesthesia|anaesthesia
1062447|NCT02776189|MRI|mri
1062448|NCT02776189|Brain|brain
1062449|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
1062450|NCT02776176|hirschsprung disease|hirschsprung disease
1062451|NCT02776163|Salivary Gland Tumors|salivary gland tumors
1062452|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
1062453|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1062454|NCT02776163|High-Risk|high-risk
1062455|NCT02776163|Cisplatin|cisplatin
1062456|NCT02776163|Docetaxel|docetaxel
1062457|NCT02776150|probe melting curve|probe melting curve
1062458|NCT02776150|Drug resistance|drug resistance
1062459|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1062460|NCT02776137|Docetaxel|docetaxel
1062461|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1062462|NCT02776137|High-Risk|high-risk
1062463|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
1062464|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
1062465|NCT02776124|Nutritional status|nutritional status
1062466|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1062467|NCT02776124|Nutritional Counseling|nutritional counseling
1062468|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1062469|NCT02776124|oral nutritional supplements|oral nutritional supplements
1062470|NCT02776111|Kidney Transplant|kidney transplant
1062471|NCT02776098|Cystic Fibrosis|cystic fibrosis
1062472|NCT02776098|Glucose Intolerance|glucose intolerance
1062473|NCT02776098|Muscle Accrual|muscle accrual
1062474|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
1062475|NCT02776098|Healthy Controls|healthy controls
1062476|NCT02776098|Healthy Participants|healthy participants
1062477|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
1062478|NCT02776085|ultrasound|ultrasound
1062479|NCT02776085|shunt failure|shunt failure
1062480|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
1062481|NCT02776059|survival|survival
1062482|NCT02776059|pegfilgrastim|pegfilgrastim
1062483|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
1062484|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
1062485|NCT02776033|tolerability|tolerability
1062486|NCT02776033|safety|safety
1062487|NCT02776033|GSK2982772|gsk2982772
1062488|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
1062489|NCT02776033|psoriasis|psoriasis
1062490|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
1062491|NCT02775955|Pharmacokinetics|pharmacokinetics
1062492|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
1062493|NCT02775929|Emtricitabine|emtricitabine
1062494|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1062495|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
1062496|NCT02775929|HIV Prevention|hiv prevention
1062497|NCT02775929|FTC TDF|ftc tdf
1062498|NCT02775929|PrEP|prep
1062499|NCT02775929|HIV Infected Partners|hiv infected partners
1062500|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
1062501|NCT02775903|MEDI4736|medi4736
1062502|NCT02775903|Durvalumab|durvalumab
1062503|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
1062504|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
1062505|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1062506|NCT02775903|Azacitidine|azacitidine
1062508|NCT02775903|Efficacy|efficacy
1062509|NCT02775903|PD-L1|pd-l1
1062510|NCT02775877|PCOS|pcos
1062511|NCT02775877|letrozole|letrozole
1062512|NCT02775877|clomiphene|clomiphene
1062513|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1062514|NCT02775786|Pancreatic Cancer|pancreatic cancer
1062515|NCT02775773|TXA|txa
1062516|NCT02775773|PPH|pph
1062517|NCT02775760|brain|brain
1062518|NCT02775760|brain mapping|brain mapping
1062519|NCT02775760|cognition|cognition
1062520|NCT02775760|exercise|exercise
1062521|NCT02775760|physical activity|physical activity
1062522|NCT02775760|hippocampus|hippocampus
1062523|NCT02775760|entorhinal cortex|entorhinal cortex
1062524|NCT02775760|spatial navigation|spatial navigation
1062525|NCT02775760|learning|learning
1062526|NCT02775760|memory|memory
1062527|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
1062528|NCT02775760|functional neuroimaging|functional neuroimaging
1062529|NCT02775760|physical endurance|physical endurance
1062530|NCT02775760|physical fitness|physical fitness
1062531|NCT02775760|resistance training|resistance training
1062532|NCT02775760|walking|walking
1062533|NCT02775760|muscle stretching exercises|muscle stretching exercises
1062534|NCT02775760|exercise test|exercise test
1062535|NCT02775760|neuropsychological tests|neuropsychological tests
1062536|NCT02775760|executive function|executive function
1062537|NCT02775760|attention|attention
1062538|NCT02775760|body composition|body composition
1062539|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
1062540|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
1062541|NCT02775734|Clomiphene citrate|clomiphene citrate
1062542|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
1062543|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
1062544|NCT02775734|therapy|therapy
1062545|NCT02775721|Nursing Education|nursing education
1062546|NCT02775721|Weight Loss|weight loss
1062547|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
1062548|NCT02775695|pancreatic cancer|pancreatic cancer
1062549|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
1062550|NCT02775695|Doxycycline|doxycycline
1062551|NCT02775695|Metakaryote cells|metakaryote cells
1062552|NCT02775695|Eukaryotic cells|eukaryotic cells
1062553|NCT02775695|Cancer Stem Cells|cancer stem cells
1062554|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
1062555|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
1062556|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
1062557|NCT02775695|Tetracycline|tetracycline
1062558|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
1062559|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
1062560|NCT02775656|Cimzia®|cimzia®
1062561|NCT02775656|CZP|czp
1062562|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
1062563|NCT02775656|Autoimmune diseases|autoimmune diseases
1062564|NCT02775656|Pregnancy outcomes|pregnancy outcomes
1062565|NCT02775656|major congenital malformations|major congenital malformations
1062566|NCT02775656|birth outcomes|birth outcomes
1062567|NCT02775656|malformation|malformation
1062568|NCT02775656|birth defect|birth defect
1062569|NCT02775643|Melanoma|melanoma
1062570|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
1062571|NCT02775643|Congenital Melanoma|congenital melanoma
1062572|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
1062573|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
1062574|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
1062575|NCT02775604|fall risks at home|fall risks at home
1062576|NCT02775604|video technology|video technology
1062577|NCT02775604|home assessment|home assessment
1062578|NCT02775578|heart failure|heart failure
1062579|NCT02775578|coronary artery disease|coronary artery disease
1062580|NCT02775578|biomarkers|biomarkers
1062581|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
1062582|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
1062583|NCT02775552|Child Nutrition|child nutrition
1062584|NCT02775552|Breastfeeding|breastfeeding
1062585|NCT02775552|Complementary Feeding|complementary feeding
1062586|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
1062587|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
1062588|NCT02775552|Ethiopia|ethiopia
1062589|NCT02775539|Pulmonary hypertension|pulmonary hypertension
1062590|NCT02775539|Mirabegron|mirabegron
1062591|NCT02775539|Heart failure|heart failure
1062592|NCT02775539|B3 adrenergic|b3 adrenergic
1062593|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
1062594|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
1062595|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
1062596|NCT02775526|Burch colposuspension|burch colposuspension
1062597|NCT02775526|Urinary incontinence|urinary incontinence
1062598|NCT02775500|pregnancy|pregnancy
1062599|NCT02775500|apremilast|apremilast
1062600|NCT02775500|Otezla|otezla
1062601|NCT02775500|autoimmune disease|autoimmune disease
1062602|NCT02775500|psoriatic arthritis|psoriatic arthritis
1062603|NCT02775500|psoriasis|psoriasis
1062604|NCT02775500|TNF|tnf
1062605|NCT02775500|tumor necrosis factor|tumor necrosis factor
1062606|NCT02775500|birth outcome|birth outcome
1062607|NCT02775500|birth defect|birth defect
1062608|NCT02775487|COPD|copd
1062609|NCT02775487|Air quality|air quality
1062610|NCT02775474|Methadone|methadone
1062611|NCT02775474|Pain, Postoperative|pain, postoperative
1062612|NCT02775474|Chronic Pain|chronic pain
1062613|NCT02775474|Bariatric Surgery|bariatric surgery
1062614|NCT02775461|Pancreas Cancer|pancreas cancer
1062615|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
1062616|NCT02775461|Pancreatic Cyst|pancreatic cyst
1062617|NCT02775461|BRCA1|brca1
1062618|NCT02775461|BRCA2|brca2
1062619|NCT02775461|Lynch Syndrome|lynch syndrome
1062620|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
1062621|NCT02775461|ATM mutation|atm mutation
1062622|NCT02775461|FAMMM Syndrome|fammm syndrome
1062623|NCT02775461|Pancreatitis|pancreatitis
1062624|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
1062625|NCT02775461|Family History of Cancer|family history of cancer
1062626|NCT02775448|Homeopathy|homeopathy
1062627|NCT02775448|Carduus marianus|carduus marianus
1062628|NCT02775448|Dyslipidemia|dyslipidemia
1062629|NCT02775448|Climacteric|climacteric
1062630|NCT02775448|Obesity|obesity
1062631|NCT02775448|Triglycerides|triglycerides
1062632|NCT02775448|Cholesterol|cholesterol
1062633|NCT02775448|Insulin resistance|insulin resistance
1062634|NCT02775448|LDL-cholesterol|ldl-cholesterol
1062635|NCT02775448|HDL-cholesterol|hdl-cholesterol
1062636|NCT02775435|PD1|pd1
1062637|NCT02775435|PD-1|pd-1
1062638|NCT02775435|PDL1|pdl1
1062639|NCT02775435|PD-L1|pd-l1
1062640|NCT02775383|National MDS Study|national mds study
1062641|NCT02775383|MDS|mds
1062642|NCT02775383|Idiopathic|idiopathic
1062643|NCT02775383|cytopenia|cytopenia
1062644|NCT02775383|cytopenias|cytopenias
1062645|NCT02775383|ICUS|icus
1062646|NCT02775383|MDS/MPN|mds/mpn
1062647|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
1062648|NCT02775383|Biorepository|biorepository
1062649|NCT02775344|Laparoscopy|laparoscopy
1062650|NCT02775344|ovarian cystectomy|ovarian cystectomy
1062651|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
1062652|NCT02775331|shift scheduling|shift scheduling
1062653|NCT02775331|work-life interaction|work-life interaction
1062654|NCT02775331|working time control|working time control
1062655|NCT02775331|public sector|public sector
1062656|NCT02775318|Stellate Ganglion|stellate ganglion
1062657|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
1062658|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
1062659|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
1062660|NCT02775253|Brown adipose tissue|brown adipose tissue
1062661|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
1062662|NCT02775253|White adipose tissue|white adipose tissue
1062663|NCT02775240|Maribavir|maribavir
1062664|NCT02775214|Storz C-MAC|storz c-mac
1062665|NCT02775214|direct laryngoscopy|direct laryngoscopy
1062666|NCT02775214|pyloromyotomy|pyloromyotomy
1062667|NCT02775214|rapid sequence|rapid sequence
1062668|NCT02775201|plantaris|plantaris
1062669|NCT02775201|Tendinopathy|tendinopathy
1062670|NCT02775201|Achilles|achilles
1062671|NCT02775201|Release|release
1062672|NCT02775175|Ramadan|ramadan
1062673|NCT02775175|Fasting|fasting
1062674|NCT02775175|Nutrition|nutrition
1062675|NCT02775175|Quality of Life|quality of life
1062676|NCT02775136|brain injuries|brain injuries
1062677|NCT02775136|neurological monitoring|neurological monitoring
1062678|NCT02775084|n-3|n-3
1062679|NCT02775084|Polyunsaturated|polyunsaturated
1062680|NCT02775084|Fatty acids|fatty acids
1062681|NCT02775084|Antigens|antigens
1062682|NCT02775084|Cognition|cognition
1062683|NCT02775084|CD4|cd4
1062684|NCT02775045|EoE|eoe
1062685|NCT02775032|advance care planning|advance care planning
1062686|NCT02775032|general practice|general practice
1062687|NCT02775032|family practice|family practice
1062688|NCT02775032|palliative care|palliative care
1062689|NCT02775032|end-of-life care|end-of-life care
1062690|NCT02774967|root coverage|root coverage
1062691|NCT02774967|gingival recession|gingival recession
1062692|NCT02774967|periodontal surgery|periodontal surgery
1062693|NCT02774954|Change the cycle|change the cycle
1062694|NCT02774954|social learning theory|social learning theory
1062695|NCT02774954|people who inject drugs|people who inject drugs
1062696|NCT02774954|injection drug use|injection drug use
1062697|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
1062698|NCT02774954|Longitudinal cohort study|longitudinal cohort study
1062699|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
1062700|NCT02774928|COPD|copd
1062701|NCT02774928|ILD|ild
1062702|NCT02774928|OSA|osa
1062703|NCT02774902|Drug Therapy|drug therapy
1062704|NCT02774889|Falls Prevention|falls prevention
1062705|NCT02774889|Stepping On|stepping on
1062706|NCT02774889|Health Promotion|health promotion
1062707|NCT02774889|Implementation|implementation
1062708|NCT02774889|Health Maintenance|health maintenance
1062709|NCT02774876|Closed-loop system|closed-loop system
1062710|NCT02774876|Artificial pancreas|artificial pancreas
1062711|NCT02774876|Glucose control|glucose control
1062712|NCT02774876|Meal|meal
1062713|NCT02774850|Pediatric|pediatric
1062714|NCT02774850|Neutropenia Management|neutropenia management
1062715|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
1062716|NCT02774850|Chart Abstraction|chart abstraction
1062717|NCT02774850|Chemotherapy|chemotherapy
1062718|NCT02774837|nucleoside analogues|nucleoside analogues
1062719|NCT02774837|tenofovir|tenofovir
1062720|NCT02774837|telbivudine|telbivudine
1062721|NCT02774837|quantitative HBsAg|quantitative hbsag
1062722|NCT02774837|combination therapy|combination therapy
1062723|NCT02774798|Rectal Prolapse|rectal prolapse
1062724|NCT02774798|Rectal Intussuception|rectal intussuception
1062725|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1062726|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
1062727|NCT02774759|Obese|obese
1062728|NCT02774759|Weight loss intervention|weight loss intervention
1062729|NCT02774759|Resistance training|resistance training
1062730|NCT02774759|Aerobic exercise|aerobic exercise
1062731|NCT02774759|Questionnaires|questionnaires
1062732|NCT02774759|Surveys|surveys
1062733|NCT02774759|Accelerometer|accelerometer
1062734|NCT02774759|Fitness Test|fitness test
1062735|NCT02774759|Telephone Coaching|telephone coaching
1062736|NCT02774759|Video Chat Sessions|video chat sessions
1062737|NCT02774707|Dry eye|dry eye
1062738|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
1062739|NCT02774694|interventional pain management|interventional pain management
1062740|NCT02774668|gender|gender
1062741|NCT02774668|arterial stiffness|arterial stiffness
1062742|NCT02774668|blood pressure|blood pressure
1062743|NCT02774668|weight loss|weight loss
1062744|NCT02774668|uric acid|uric acid
1062745|NCT02774655|healthy volunteers|healthy volunteers
1062746|NCT02774655|patient compliance|patient compliance
1062747|NCT02774655|exercise|exercise
1062748|NCT02774655|motivation|motivation
1062749|NCT02774642|PTSD|ptsd
1062750|NCT02774642|insomnia|insomnia
1062751|NCT02774642|CBT-I|cbt-i
1062752|NCT02774642|Prolonged Exposure|prolonged exposure
1062753|NCT02774642|Veteran|veteran
1062754|NCT02774629|food allergy|food allergy
1062755|NCT02774629|skin prick test|skin prick test
1062756|NCT02774629|atopy patch test|atopy patch test
1062757|NCT02774590|Acne vulgaris|acne vulgaris
1062758|NCT02774590|Rosacea|rosacea
1062759|NCT02774577|Oxygen Consumption|oxygen consumption
1062760|NCT02774577|Aged|aged
1062761|NCT02774577|Whole Body Vibration|whole body vibration
1062762|NCT02774551|Body composition|body composition
1062763|NCT02774551|Muscle strength|muscle strength
1062764|NCT02774551|Health related quality of life|health related quality of life
1062765|NCT02774538|Cervical HPV infection|cervical hpv infection
1062766|NCT02774538|Oral HPV infection|oral hpv infection
1062767|NCT02774538|Sexually transmitted infection|sexually transmitted infection
1062768|NCT02774525|child welfare system|child welfare system
1062769|NCT02774525|parental substance use problem|parental substance use problem
1062770|NCT02774525|child maltreatment|child maltreatment
1062771|NCT02774525|parenting|parenting
1062772|NCT02774473|Metastatic|metastatic
1062773|NCT02774473|Rb+|rb+
1062774|NCT02774473|Breast Cancer|breast cancer
1062775|NCT02774408|backup ventilation|backup ventilation
1062776|NCT02774408|preterm infants|preterm infants
1062777|NCT02774408|functional residual capacity|functional residual capacity
1062778|NCT02774408|chronic lung disease|chronic lung disease
1062779|NCT02774382|Recurrence|recurrence
1062780|NCT02774382|Infection|infection
1062781|NCT02774369|cancer|cancer
1062782|NCT02774369|insomnia|insomnia
1062783|NCT02774369|sleep|sleep
1062784|NCT02774369|physical exercise|physical exercise
1062785|NCT02774369|aerobic|aerobic
1062786|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
1062787|NCT02774369|self-help|self-help
1062788|NCT02774369|RCT|rct
1062793|NCT02774304|fluid responsiveness|fluid responsiveness
1062794|NCT02774265|Fracture|fracture
1062795|NCT02774265|Prophylaxis|prophylaxis
1062796|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
1062797|NCT02774226|Kuvan|kuvan
1062798|NCT02774226|Antioxidant|antioxidant
1062799|NCT02774226|FEV1|fev1
1063004|NCT02772835|nCPAP|ncpap
1062800|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
1062801|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1062802|NCT02774187|Sorafenib|sorafenib
1062803|NCT02774174|Proximal Humerus|proximal humerus
1062804|NCT02774109|low back pain|low back pain
1062805|NCT02774109|fish oil|fish oil
1062806|NCT02774109|omega 3|omega 3
1062807|NCT02774096|Aortic dissection|aortic dissection
1062808|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
1062809|NCT02774096|Post-conditioning|post-conditioning
1062810|NCT02774083|older people|older people
1062811|NCT02774083|cognitive training|cognitive training
1062812|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
1062813|NCT02774057|Captafer®|captafer®
1062814|NCT02774057|Iron Sulfate|iron sulfate
1062815|NCT02774057|Iron deficiency anemia|iron deficiency anemia
1062816|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
1062817|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
1062818|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
1062819|NCT02774031|Laparoscopy|laparoscopy
1062820|NCT02774031|Prostatectomy|prostatectomy
1062821|NCT02774031|Cystectomy|cystectomy
1062822|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
1062823|NCT02774018|Mindfulness|mindfulness
1062824|NCT02774018|Elderly|elderly
1062825|NCT02774018|Psychopathology|psychopathology
1062826|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
1062827|NCT02773992|Itos|itos
1062828|NCT02773992|lung cancer|lung cancer
1062829|NCT02773979|challenge|challenge
1062830|NCT02773979|malaria|malaria
1062831|NCT02773979|P. falciparum|p. falciparum
1062832|NCT02773979|PfSPZ|pfspz
1062833|NCT02773979|sporozoites|sporozoites
1062834|NCT02773979|vaccine|vaccine
1062835|NCT02773953|CPAP|cpap
1062836|NCT02773953|Telemonitoring|telemonitoring
1062837|NCT02773927|Agave inulin|agave inulin
1062838|NCT02773927|Adiponectin|adiponectin
1062839|NCT02773927|Metabolic syndrome|metabolic syndrome
1062840|NCT02773927|Metformin|metformin
1062841|NCT02773927|Insulin resistance|insulin resistance
1062842|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
1062843|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
1062844|NCT02773914|Elderly|elderly
1062845|NCT02773914|Frailty|frailty
1062846|NCT02773914|Randomized controlled study|randomized controlled study
1062847|NCT02773901|intracranial pressure|intracranial pressure
1062848|NCT02773901|noninvasive monitoring|noninvasive monitoring
1062849|NCT02773901|lumbar puncture|lumbar puncture
1062850|NCT02773888|intracranial pressure|intracranial pressure
1062851|NCT02773888|noninvasive monitoring|noninvasive monitoring
1062852|NCT02773875|artificial pancreas|artificial pancreas
1062853|NCT02773862|brain injuries|brain injuries
1062854|NCT02773862|noninvasive monitoring|noninvasive monitoring
1062855|NCT02773862|intracranial pressure|intracranial pressure
1062856|NCT02773849|IFN|ifn
1062857|NCT02773849|BCG-unresponsive|bcg-unresponsive
1062858|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
1062859|NCT02773836|tobacco use|tobacco use
1062860|NCT02773836|e-cigarettes|e-cigarettes
1062861|NCT02773836|public policy|public policy
1062862|NCT02773836|ITC|itc
1062863|NCT02773823|obesity|obesity
1062864|NCT02773823|children|children
1062865|NCT02773823|cardiovascular health|cardiovascular health
1062866|NCT02773823|intervention study|intervention study
1062867|NCT02773797|Sedation|sedation
1062868|NCT02773797|Dexmedetomidine|dexmedetomidine
1062869|NCT02773771|Muscle Atrophy|muscle atrophy
1062870|NCT02773771|Critical Illness|critical illness
1062871|NCT02773771|Ultrasound|ultrasound
1062872|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
1062873|NCT02773771|ICU|icu
1062874|NCT02773680|respiration|respiration
1062875|NCT02773680|monitoring, physiologic|monitoring, physiologic
1062876|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
1062877|NCT02773654|shoulder|shoulder
1062878|NCT02773654|motion|motion
1062879|NCT02773654|measurement|measurement
1062880|NCT02773654|healthy shoulder|healthy shoulder
1062881|NCT02773654|shoulder motion|shoulder motion
1062882|NCT02773602|Analgesia|analgesia
1062883|NCT02773602|caudal analgesia|caudal analgesia
1062884|NCT02773602|ropivacaine|ropivacaine
1062885|NCT02773602|clonidine|clonidine
1062886|NCT02773602|dexamethasone|dexamethasone
1062887|NCT02773550|Multiple Myeloma|multiple myeloma
1062888|NCT02773524|Metastatic|metastatic
1062889|NCT02773524|Locally recurrent|locally recurrent
1062890|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
1062891|NCT02773524|Stomach|stomach
1062892|NCT02773524|Adenocarcinoma|adenocarcinoma
1062893|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
1062894|NCT02773472|colorectal|colorectal
1062895|NCT02773472|electroacupuncture|electroacupuncture
1062896|NCT02773472|laparoscopic surgery|laparoscopic surgery
1062897|NCT02773446|ETEC|etec
1062898|NCT02773446|Escherichia coli|escherichia coli
1062899|NCT02773446|enteritis|enteritis
1062900|NCT02773446|Challenge|challenge
1062901|NCT02773446|CS6|cs6
1062902|NCT02773446|Enterotoxigenic|enterotoxigenic
1062903|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
1062904|NCT02773407|Azithromycin|azithromycin
1062905|NCT02773407|Cotrimoxazole|cotrimoxazole
1062906|NCT02773407|Efficacy|efficacy
1062907|NCT02773407|Enteric fever|enteric fever
1062908|NCT02773407|Fever clearance time|fever clearance time
1062909|NCT02773394|Hepatitis C Virus|hepatitis c virus
1062910|NCT02773394|Observational|observational
1062911|NCT02773394|Brazil|brazil
1062912|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
1062913|NCT02773342|Neutropenic Patients|neutropenic patients
1062914|NCT02773342|Haematological Malignancies|haematological malignancies
1062915|NCT02773342|Chest Computed Tomography|chest computed tomography
1062916|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
1062917|NCT02773329|Cancer|cancer
1062918|NCT02773329|game-based exercise|game-based exercise
1062919|NCT02773329|exercise|exercise
1062920|NCT02773329|wearable sensors|wearable sensors
1062921|NCT02773329|balance|balance
1062922|NCT02773329|falls|falls
1062923|NCT02773329|virtual reality|virtual reality
1062924|NCT02773303|Neurofeedback|neurofeedback
1062925|NCT02773303|balance, postural|balance, postural
1062926|NCT02773303|postural equilibrium|postural equilibrium
1062927|NCT02773303|EEG|eeg
1062928|NCT02773290|Aplastic Anemia|aplastic anemia
1062929|NCT02773251|Postoperative adhesion|postoperative adhesion
1062930|NCT02773251|Laparoscopy|laparoscopy
1062931|NCT02773251|Adhesion barrier|adhesion barrier
1062932|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
1062933|NCT02773186|postoperative|postoperative
1062934|NCT02773186|behavioral changes|behavioral changes
1062935|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
1062936|NCT02773134|Post-operative Bracing|post-operative bracing
1062937|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
1062938|NCT02773134|Posterior Spine Fusion|posterior spine fusion
1062939|NCT02773134|Quality of Life|quality of life
1062940|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
1062941|NCT02773121|Cognition|cognition
1062942|NCT02773121|Learning|learning
1062943|NCT02773121|Memory|memory
1062944|NCT02773121|Executive Function|executive function
1062945|NCT02773121|Attention|attention
1062946|NCT02773121|Neuropsychological Tests|neuropsychological tests
1062947|NCT02773121|Physical Activity|physical activity
1062948|NCT02773121|Physical Fitness|physical fitness
1062949|NCT02773121|Exercise|exercise
1062950|NCT02773121|Resistance Training|resistance training
1062951|NCT02773121|Walking|walking
1062952|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
1062953|NCT02773121|Exercise Test|exercise test
1062954|NCT02773121|Balance|balance
1062955|NCT02773121|Flexibility|flexibility
1062956|NCT02773121|Body Composition|body composition
1062957|NCT02773095|Novartis Access|novartis access
1062958|NCT02773095|noncommunicable disease burden|noncommunicable disease burden
1062959|NCT02773095|medicine availability and price|medicine availability and price
1062960|NCT02773095|Kenya|kenya
1062961|NCT02773082|Treatment-Resistant|treatment-resistant
1062962|NCT02773082|Anxiety|anxiety
1062963|NCT02773056|transfemoral|transfemoral
1062964|NCT02773056|amputation|amputation
1062965|NCT02773056|perspiration|perspiration
1062966|NCT02773056|socket|socket
1062967|NCT02773056|socket comfort|socket comfort
1062968|NCT02773030|Multiple Myeloma|multiple myeloma
1062969|NCT02773030|Relapsed|relapsed
1062970|NCT02773030|Refractory|refractory
1062971|NCT02773030|Pharmacokinetics|pharmacokinetics
1062972|NCT02773030|Safety|safety
1062973|NCT02773030|Efficacy|efficacy
1062974|NCT02773030|CC-220|cc-220
1062975|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
1062976|NCT02773017|sedation|sedation
1062977|NCT02773017|age|age
1062978|NCT02773017|dexmedetomidine|dexmedetomidine
1062979|NCT02773004|Genomic test|genomic test
1062980|NCT02773004|Chemotherapy decision|chemotherapy decision
1062981|NCT02772978|decision making|decision making
1062982|NCT02772978|impulsivity|impulsivity
1062983|NCT02772926|Benfotiamine|benfotiamine
1062984|NCT02772926|Advanced glycation end products|advanced glycation end products
1062985|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
1062986|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
1062987|NCT02772900|Aging|aging
1062988|NCT02772900|Beetroot|beetroot
1062989|NCT02772900|Dietary Nitrate|dietary nitrate
1062990|NCT02772900|Functional Food|functional food
1062991|NCT02772900|Vascular Function|vascular function
1062992|NCT02772887|pregnancy|pregnancy
1062993|NCT02772887|type 2 diabetes|type 2 diabetes
1062994|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
1062995|NCT02772887|L-arginine|l-arginine
1062996|NCT02772887|L-citrulline|l-citrulline
1062997|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
1062998|NCT02772887|blood pressure|blood pressure
1062999|NCT02772874|fecal incontinence|fecal incontinence
1063000|NCT02772874|severity|severity
1063001|NCT02772874|ultrasound|ultrasound
1063002|NCT02772874|anorectal manometry|anorectal manometry
1063003|NCT02772874|classification|classification
1063005|NCT02772835|nHFOV|nhfov
1063006|NCT02772835|Preterm|preterm
1063007|NCT02772835|RDS|rds
1063008|NCT02772835|CO2 Elimination|co2 elimination
1063009|NCT02772809|stroke|stroke
1063010|NCT02772809|hemiplegia|hemiplegia
1063011|NCT02772809|rehabilitation|rehabilitation
1063012|NCT02772809|robotics|robotics
1063013|NCT02772809|neuroplasticity|neuroplasticity
1063014|NCT02772796|Pharmacokinetics|pharmacokinetics
1063015|NCT02772796|Healthy Volunteer Study|healthy volunteer study
1063016|NCT02772783|brain|brain
1063017|NCT02772783|fMRI|fmri
1063018|NCT02772783|carbohydrate|carbohydrate
1063019|NCT02772783|insulin clamp|insulin clamp
1063020|NCT02772783|intake regulation|intake regulation
1063021|NCT02772783|overweight|overweight
1063022|NCT02772783|glycemic index|glycemic index
1063023|NCT02772757|hearing loss|hearing loss
1063024|NCT02772757|hearing aids|hearing aids
1063025|NCT02772757|outcome assessment|outcome assessment
1063026|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
1063027|NCT02772744|Antiviral|antiviral
1063028|NCT02772744|Virologic Response|virologic response
1063029|NCT02772731|mastectomy|mastectomy
1063030|NCT02772718|Hypoglycemia|hypoglycemia
1063031|NCT02772705|Standardized Uptake Value|standardized uptake value
1063032|NCT02772705|Diagnosis|diagnosis
1063033|NCT02772679|Diabetes|diabetes
1063034|NCT02772679|Treg|treg
1063035|NCT02772679|Proluekin|proluekin
1063036|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
1063037|NCT02772666|Multiple sclerosis|multiple sclerosis
1063038|NCT02772666|Glaucoma|glaucoma
1063039|NCT02772653|Microcirculation|microcirculation
1063040|NCT02772653|Videomicroscopy|videomicroscopy
1063041|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1063042|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
1063043|NCT02772653|Thromboelastometry|thromboelastometry
1063044|NCT02772653|Trauma|trauma
1063045|NCT02772653|Resuscitation|resuscitation
1063046|NCT02772653|Hypovolemic shock|hypovolemic shock
1063047|NCT02772640|Hypercholesterolemia|hypercholesterolemia
1063048|NCT02772640|Rosuvastatin|rosuvastatin
1063049|NCT02772640|Statin|statin
1063050|NCT02772640|Ezetimibe|ezetimibe
1063051|NCT02772640|Compliance|compliance
1063052|NCT02772640|Cholesterol|cholesterol
1063053|NCT02772640|Secondary prevention|secondary prevention
1063054|NCT02772640|Coronary artery disease|coronary artery disease
1063055|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
1063056|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
1063057|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
1063058|NCT02772601|ABBV-066|abbv-066
1063059|NCT02772601|BI 655066|bi 655066
1063060|NCT02772601|risankizumab|risankizumab
1063061|NCT02772588|ARN-509|arn-509
1063062|NCT02772588|Abiraterone|abiraterone
1063063|NCT02772588|Leuprolide|leuprolide
1063064|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
1063065|NCT02772588|15-334|15-334
1063066|NCT02772588|apalutamide,|apalutamide,
1063067|NCT02772588|JNJ-56021927|jnj-56021927
1063068|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
1063069|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
1063070|NCT02772575|16-385|16-385
1063071|NCT02772562|prostate cancer|prostate cancer
1063072|NCT02772549|Diagnosis|diagnosis
1063073|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
1063074|NCT02772523|Primary Prevention|primary prevention
1063075|NCT02772510|Stroke|stroke
1063076|NCT02772510|Rehabilitation|rehabilitation
1063077|NCT02772510|Hand|hand
1063078|NCT02772510|Game|game
1063079|NCT02772510|Functional electrical stimulation|functional electrical stimulation
1063080|NCT02772510|Virtual reality|virtual reality
1063081|NCT02772497|DME|dme
1063082|NCT02772497|Anti VEGF|anti vegf
1063083|NCT02772497|VEGF trap|vegf trap
1063084|NCT02772497|Diabetes|diabetes
1063085|NCT02772497|Diabetic retinopathy|diabetic retinopathy
1063086|NCT02772497|ZALTRAP|zaltrap
1063087|NCT02772497|Ziv aflibercept|ziv aflibercept
1063088|NCT02772484|noninvasive monitoring|noninvasive monitoring
1063089|NCT02772471|intracranial pressure|intracranial pressure
1063090|NCT02772471|noninvasive monitoring|noninvasive monitoring
1063091|NCT02772458|Crohn's Disease|crohn's disease
1063092|NCT02772458|gut brain axis|gut brain axis
1063093|NCT02772458|reduced appetite|reduced appetite
1063094|NCT02772445|Empowerment|empowerment
1063095|NCT02772445|Caregiver|caregiver
1063096|NCT02772432|resiliency training|resiliency training
1063097|NCT02772432|parenting|parenting
1063098|NCT02772432|special learning disability|special learning disability
1063099|NCT02772406|ulcerative colitis|ulcerative colitis
1063100|NCT02772406|colonoscopy|colonoscopy
1063103|NCT02772367|cardiotoxicity|cardiotoxicity
1063104|NCT02772367|16-025|16-025
1063105|NCT02772354|Pediatric population, ablation|pediatric population, ablation
1063106|NCT02772341|Asthma|asthma
1063107|NCT02772341|Halotherapy|halotherapy
1063314|NCT02770989|Performance|performance
1102010|NCT02538978|CLI|cli
1063108|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
1063109|NCT02772341|Metacholine|metacholine
1063110|NCT02772328|Testing|testing
1063111|NCT02772328|Access|access
1063112|NCT02772315|genomics|genomics
1063113|NCT02772315|proteomics|proteomics
1063114|NCT02772315|metabolomics|metabolomics
1063115|NCT02772315|endocrine hypertension|endocrine hypertension
1063116|NCT02772315|primary aldosteronism|primary aldosteronism
1063117|NCT02772315|Cushing syndrom|cushing syndrom
1063118|NCT02772315|pheochromocytoma|pheochromocytoma
1063119|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
1063120|NCT02772289|Cesarean Section|cesarean section
1063121|NCT02772289|Scars|scars
1063122|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
1063123|NCT02772263|Paramedicine|paramedicine
1063124|NCT02772263|Community Paramedic|community paramedic
1063125|NCT02772263|Elderly|elderly
1063126|NCT02772250|bowel preparation|bowel preparation
1063127|NCT02772250|polyethylene glycol|polyethylene glycol
1063128|NCT02772250|face-to-face re-education|face-to-face re-education
1063129|NCT02772250|telephone re-education|telephone re-education
1063130|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
1063131|NCT02772237|concussion|concussion
1063132|NCT02772237|sports-related concussion|sports-related concussion
1063133|NCT02772237|mTBI|mtbi
1063134|NCT02772237|Riboflavin|riboflavin
1063135|NCT02772237|Vitamin B2|vitamin b2
1063136|NCT02772159|COPD|copd
1063137|NCT02772159|ADME|adme
1063138|NCT02772159|Healthy Normal Males|healthy normal males
1063139|NCT02772159|Phase 1|phase 1
1063140|NCT02772120|Infertility|infertility
1063141|NCT02772120|In vitro fertilization|in vitro fertilization
1063142|NCT02772120|Embryo transfer|embryo transfer
1063143|NCT02772120|Blastocyst|blastocyst
1063144|NCT02772120|Progesterone|progesterone
1063145|NCT02772120|Crinone|crinone
1063146|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
1063147|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
1063148|NCT02772094|glioblastoma|glioblastoma
1063149|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
1063150|NCT02772094|immunotherapy|immunotherapy
1063151|NCT02772094|dendritic cells|dendritic cells
1063152|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
1063153|NCT02772094|oncology|oncology
1063154|NCT02772094|neurology|neurology
1063155|NCT02772094|glioma|glioma
1063156|NCT02772094|brain tumor|brain tumor
1063157|NCT02772094|ADCTA-G|adcta-g
1063158|NCT02772055|Moxa smoke|moxa smoke
1063159|NCT02772055|Moxibustion|moxibustion
1063160|NCT02772055|Knee osteoarthritis|knee osteoarthritis
1063161|NCT02772042|Manual Therapy|manual therapy
1063162|NCT02772042|Physiotherapy|physiotherapy
1063163|NCT02772042|Manipulation|manipulation
1063164|NCT02771990|Back Pain|back pain
1063165|NCT02771964|outcome assessment|outcome assessment
1063166|NCT02771964|postoperative period|postoperative period
1063167|NCT02771951|Childhood|childhood
1063168|NCT02771951|Obesity|obesity
1063169|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
1063170|NCT02771925|Gabapentin|gabapentin
1063171|NCT02771925|Alcohol Dependence|alcohol dependence
1063172|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
1063173|NCT02771899|Spine|spine
1063174|NCT02771899|Scoliosis|scoliosis
1063175|NCT02771886|mindfulness|mindfulness
1063176|NCT02771886|urges|urges
1063177|NCT02771886|adolescents|adolescents
1063178|NCT02771886|risk behaviors|risk behaviors
1063179|NCT02771886|therapy intervention|therapy intervention
1063180|NCT02771860|denosumab|denosumab
1063181|NCT02771860|RANKL-blockade|rankl-blockade
1063182|NCT02771834|Postural balance|postural balance
1063183|NCT02771834|Osteoporosis|osteoporosis
1063184|NCT02771834|Postmenopause|postmenopause
1063185|NCT02771834|Vitamin D|vitamin d
1063186|NCT02771834|Kyfhosis|kyfhosis
1063187|NCT02771834|Muscle strength|muscle strength
1063188|NCT02771808|CABG|cabg
1063189|NCT02771795|HER2|her2
1063190|NCT02771795|Trastuzumab|trastuzumab
1063191|NCT02771795|Biosimilar|biosimilar
1063192|NCT02771795|Cancer|cancer
1063193|NCT02771795|Breast|breast
1063194|NCT02771795|Positive|positive
1063195|NCT02771782|BCG|bcg
1063196|NCT02771782|TDaP-IPV|tdap-ipv
1063197|NCT02771782|DPT Vaccine|dpt vaccine
1063198|NCT02771769|cell-free DNA|cell-free dna
1063199|NCT02771769|copy number instability|copy number instability
1063200|NCT02771769|liquid biopsy|liquid biopsy
1063201|NCT02771769|cancer|cancer
1063202|NCT02771756|Breast cancer|breast cancer
1063203|NCT02771756|Lung cancer|lung cancer
1063204|NCT02771756|Nutritional support|nutritional support
1063205|NCT02771756|Safety|safety
1063206|NCT02771756|Effectiveness|effectiveness
1063207|NCT02771743|Neuroblastoma|neuroblastoma
1063208|NCT02771743|High risk|high risk
1063412|NCT02770482|biomarkers|biomarkers
1063209|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
1063210|NCT02771691|Adolescent|adolescent
1063211|NCT02771652|Multiple Sclerosis|multiple sclerosis
1063212|NCT02771652|Quality of Life|quality of life
1063213|NCT02771652|exercise|exercise
1063214|NCT02771652|internet|internet
1063215|NCT02771639|Hip arthroplasty|hip arthroplasty
1063216|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
1063219|NCT02771626|MEL|mel
1063220|NCT02771626|NSCLC|nsclc
1063221|NCT02771626|Immuno-Oncology|immuno-oncology
1063222|NCT02771626|Tumor Metabolism|tumor metabolism
1063223|NCT02771626|Glutaminase|glutaminase
1063224|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
1063225|NCT02771613|Morbidity Mortality Review|morbidity mortality review
1063226|NCT02771613|medical simulation|medical simulation
1063227|NCT02771613|in situ simulation|in situ simulation
1063228|NCT02771613|multi professional simulation|multi professional simulation
1063229|NCT02771613|hospital adverse event|hospital adverse event
1063230|NCT02771600|Procedural pain|procedural pain
1063231|NCT02771600|Procedural anxiety|procedural anxiety
1063232|NCT02771600|Pediatrics|pediatrics
1063233|NCT02771600|Needle-related procedures|needle-related procedures
1063234|NCT02771587|alcohol|alcohol
1063235|NCT02771587|energy drink|energy drink
1063236|NCT02771587|coagulability|coagulability
1063237|NCT02771587|caffeine|caffeine
1063238|NCT02771587|taurine|taurine
1063239|NCT02771587|driving performance|driving performance
1063240|NCT02771574|Bariatric surgery complications|bariatric surgery complications
1063241|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
1063242|NCT02771574|Exendin (9-39)|exendin (9-39)
1063243|NCT02771574|GLP-1|glp-1
1063244|NCT02771561|Patent Foramen Ovale|patent foramen ovale
1063245|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
1063246|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
1063247|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
1063248|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
1063249|NCT02771561|Quality of life|quality of life
1063250|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
1063251|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
1063252|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
1063253|NCT02771548|Knee injuries|knee injuries
1063254|NCT02771548|Rehabilitation|rehabilitation
1063255|NCT02771548|Return to sport|return to sport
1063256|NCT02771548|Biomechanics|biomechanics
1063257|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
1063258|NCT02771509|CPB|cpb
1063259|NCT02771509|Cardiac Surgery|cardiac surgery
1063260|NCT02771509|Acute Kidney Injury|acute kidney injury
1063261|NCT02771470|Gut microflora|gut microflora
1063262|NCT02771470|Lung cancer|lung cancer
1063263|NCT02771470|Chemotherapy|chemotherapy
1063264|NCT02771470|Immunity|immunity
1063265|NCT02771470|Nutrition|nutrition
1063266|NCT02771457|Influximab|influximab
1063267|NCT02771457|IFX|ifx
1063268|NCT02771457|Remicade|remicade
1063269|NCT02771418|Carotid endarterectomy|carotid endarterectomy
1063270|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1063271|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
1063272|NCT02771366|neuroinflammation|neuroinflammation
1063273|NCT02771366|cognitive function|cognitive function
1063274|NCT02771366|aging adults|aging adults
1063275|NCT02771314|NSCLC|nsclc
1063276|NCT02771314|AZD9291|azd9291
1063277|NCT02771314|>= 2nd line|>= 2nd line
1063278|NCT02771314|liquid biopsy|liquid biopsy
1063279|NCT02771314|EGFR TKIs|egfr tkis
1063280|NCT02771314|EGFR mutant|egfr mutant
1063281|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
1063282|NCT02771288|Kawasaki disease|kawasaki disease
1063283|NCT02771288|optical coherence tomography|optical coherence tomography
1063284|NCT02771288|multislice computed tomography|multislice computed tomography
1063285|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
1063286|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
1063287|NCT02771249|HIV|hiv
1063288|NCT02771249|UGT1A1|ugt1a1
1063289|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
1063290|NCT02771236|Inherited Eye Disease|inherited eye disease
1063291|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
1063292|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
1063293|NCT02771210|Subcutaneous|subcutaneous
1063294|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
1063295|NCT02771210|Enthesitis|enthesitis
1063296|NCT02771210|Achilles tendon|achilles tendon
1063298|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
1063299|NCT02771158|critical care|critical care
1063300|NCT02771158|shock, septic|shock, septic
1063301|NCT02771158|sepsis|sepsis
1063302|NCT02771158|hypotension|hypotension
1063303|NCT02771158|midodrine|midodrine
1063304|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
1063305|NCT02771041|Hip prothesis|hip prothesis
1063306|NCT02771002|critically ill patients|critically ill patients
1063307|NCT02771002|septic shock|septic shock
1063308|NCT02771002|peripheral perfusion index|peripheral perfusion index
1063309|NCT02771002|capillary refill time|capillary refill time
1063310|NCT02771002|mottling score|mottling score
1102271|NCT02537145|pilot|pilot
1063311|NCT02771002|microcirculation|microcirculation
1063312|NCT02770989|Cardiac Ablation|cardiac ablation
1063313|NCT02770989|Safety|safety
1063315|NCT02770989|Laser|laser
1063316|NCT02770963|discogenic|discogenic
1063317|NCT02770963|Acupuncture Therapy|acupuncture therapy
1063318|NCT02770963|randomized controlled trial|randomized controlled trial
1063319|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
1063320|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
1063321|NCT02770924|cataract|cataract
1063322|NCT02770924|phacoemulsification|phacoemulsification
1063323|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
1063324|NCT02770924|IOL|iol
1063325|NCT02770911|Rectal Carcinoma|rectal carcinoma
1063326|NCT02770911|Laparoscopy|laparoscopy
1063327|NCT02770911|Anastomotic Leak|anastomotic leak
1063328|NCT02770911|Double-stapling technique|double-stapling technique
1063329|NCT02770898|probation|probation
1063330|NCT02770898|evidence-based|evidence-based
1063331|NCT02770898|well-being|well-being
1063332|NCT02770898|physical exercise|physical exercise
1063333|NCT02770898|family well-being|family well-being
1063334|NCT02770872|serum amyloid a|serum amyloid a
1063335|NCT02770872|lipoprotein|lipoprotein
1063336|NCT02770872|insulin resistance|insulin resistance
1063337|NCT02770872|dyslipidemia|dyslipidemia
1063338|NCT02770859|Achalasia|achalasia
1063339|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
1063340|NCT02770833|GI|gi
1063341|NCT02770833|Energy expenditure|energy expenditure
1063342|NCT02770833|Energy balance|energy balance
1063343|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
1063344|NCT02770833|Appetite regulating hormones|appetite regulating hormones
1063345|NCT02770833|Appetite sensations|appetite sensations
1063346|NCT02770833|Glucose allostatis|glucose allostatis
1063347|NCT02770833|Amino acid metabolism|amino acid metabolism
1063348|NCT02770833|Satiety|satiety
1063349|NCT02770833|Food preferences|food preferences
1063350|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
1063351|NCT02770807|AT|at
1063352|NCT02770807|EryDex system|erydex system
1063353|NCT02770807|Dexamethasone|dexamethasone
1063354|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
1063355|NCT02770781|survivors|survivors
1063356|NCT02770781|physical fitness|physical fitness
1063357|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
1063358|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
1063359|NCT02770742|patient satisfaction|patient satisfaction
1063360|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
1063361|NCT02770742|intestinal diseases|intestinal diseases
1063362|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
1063363|NCT02770729|endophthalmitis|endophthalmitis
1063364|NCT02770729|Vigamox|vigamox
1063365|NCT02770729|endothelial cell density|endothelial cell density
1063366|NCT02770677|Yoga|yoga
1063367|NCT02770677|COPD|copd
1063368|NCT02770677|rehabilitation|rehabilitation
1063369|NCT02770651|optical coherence tomography|optical coherence tomography
1063370|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
1063371|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
1063372|NCT02770638|Healthy|healthy
1063373|NCT02770638|Sport|sport
1063374|NCT02770638|Athlete|athlete
1063375|NCT02770638|Male|male
1063376|NCT02770638|University|university
1063377|NCT02770638|Adults|adults
1063378|NCT02770638|Rugby Football Union|rugby football union
1063379|NCT02770638|Professional|professional
1063380|NCT02770638|Competitive sport|competitive sport
1063381|NCT02770638|Scoop Stretcher|scoop stretcher
1063382|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
1063383|NCT02770638|Long back spinal board|long back spinal board
1063384|NCT02770638|Emergency Medical Services|emergency medical services
1063385|NCT02770638|Long backboard|long backboard
1063386|NCT02770638|Patient Extrication|patient extrication
1063387|NCT02770638|Triple Immobilisation|triple immobilisation
1063388|NCT02770638|Pre hospital Medicine|pre hospital medicine
1063389|NCT02770638|Rigid Cervical Collar|rigid cervical collar
1063390|NCT02770638|Pressure Testing|pressure testing
1063391|NCT02770638|Tissue Pressure Testing|tissue pressure testing
1063392|NCT02770638|Visual Analogue Scale|visual analogue scale
1063393|NCT02770638|Pressure Sores|pressure sores
1063394|NCT02770638|Pressure area damage|pressure area damage
1063395|NCT02770638|Tissue Viability|tissue viability
1063396|NCT02770638|Tissue Interface Pressure|tissue interface pressure
1063397|NCT02770638|Comfort|comfort
1063398|NCT02770638|Pain|pain
1063399|NCT02770625|Type I Gaucher|type i gaucher
1063400|NCT02770625|ISU302|isu302
1063401|NCT02770625|Imiglucerase|imiglucerase
1063402|NCT02770599|IBD|ibd
1063403|NCT02770599|HRQoL|hrqol
1063404|NCT02770599|QoC|qoc
1063405|NCT02770599|Adherence|adherence
1063406|NCT02770599|IBD nurse|ibd nurse
1063407|NCT02770599|MDT|mdt
1063408|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
1063409|NCT02770508|antiretroviral naive|antiretroviral naive
1063410|NCT02770508|dual therapy|dual therapy
1063411|NCT02770482|dementia|dementia
1063413|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
1063414|NCT02770469|Breast Cancer|breast cancer
1063415|NCT02770469|Korean Americans|korean americans
1063416|NCT02770469|Survivorship|survivorship
1063514|NCT02769754|LIVER|liver
1063419|NCT02770469|Perceived Stress|perceived stress
1063420|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
1063421|NCT02770443|Recovered LVEF|recovered lvef
1063423|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
1063424|NCT02770391|Steroid Metabolism|steroid metabolism
1063425|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
1063426|NCT02770391|ARN-509|arn-509
1063427|NCT02770378|Temozolomide|temozolomide
1063428|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
1063429|NCT02770352|retrospective chart review|retrospective chart review
1063430|NCT02770352|prospective chart review|prospective chart review
1063431|NCT02770352|fistula formation and repair|fistula formation and repair
1063432|NCT02770352|database|database
1063433|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
1063434|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
1063435|NCT02770339|Pharmacogenomics|pharmacogenomics
1063436|NCT02770339|Psychiatric crisis|psychiatric crisis
1063437|NCT02770339|Drug overdose|drug overdose
1063438|NCT02770339|Psychotropic medications|psychotropic medications
1063439|NCT02770326|Safety of Stool Transplant|safety of stool transplant
1063440|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
1063441|NCT02770326|15-337|15-337
1063442|NCT02770300|automatic|automatic
1063443|NCT02770300|personalized|personalized
1063444|NCT02770300|robotic therapy|robotic therapy
1063445|NCT02770261|DP-R208|dp-r208
1063446|NCT02770222|Pharmacokinetics|pharmacokinetics
1063447|NCT02770196|Community-Supported Agriculture|community-supported agriculture
1063448|NCT02770196|Local Food System|local food system
1063449|NCT02770196|Vegetable|vegetable
1063450|NCT02770196|Fruit|fruit
1063451|NCT02770196|Childhood Obesity|childhood obesity
1063452|NCT02770183|Myocardial stunning|myocardial stunning
1063453|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
1063454|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
1063455|NCT02770144|Child Quality of Life|child quality of life
1063456|NCT02770144|Financial Coaching|financial coaching
1063457|NCT02770144|Socioeconomic Status|socioeconomic status
1063458|NCT02770144|Social Determinants of Health|social determinants of health
1063461|NCT02770118|sleep restriction|sleep restriction
1063462|NCT02770118|obesity|obesity
1063463|NCT02770118|brown adipose tissue|brown adipose tissue
1063464|NCT02770105|L-theanine|l-theanine
1063465|NCT02770105|caffeine|caffeine
1063466|NCT02770105|selective attention|selective attention
1063467|NCT02770105|fMRI|fmri
1063468|NCT02770105|RVRT|rvrt
1063469|NCT02770079|Insulin sensitivity|insulin sensitivity
1063470|NCT02770053|Foraminal enlargement|foraminal enlargement
1063471|NCT02770053|Root canal treatment|root canal treatment
1063472|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
1063473|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
1063474|NCT02770027|Colon Surgery|colon surgery
1063475|NCT02770027|blood viscosity|blood viscosity
1063476|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
1063477|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1063478|NCT02770001|Admixture|admixture
1063479|NCT02770001|African American|african american
1063480|NCT02770001|African American Genetics|african american genetics
1063481|NCT02769988|Adolescents|adolescents
1063482|NCT02769988|Health Information Literacy|health information literacy
1063483|NCT02769988|Health Education|health education
1063484|NCT02769975|Endocrinology|endocrinology
1063485|NCT02769975|Obesity|obesity
1063486|NCT02769975|Pediatric|pediatric
1063487|NCT02769975|Growth Disorder|growth disorder
1063488|NCT02769975|Pubertal Development|pubertal development
1063489|NCT02769962|PARP Inhibitor|parp inhibitor
1063490|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
1063491|NCT02769962|Camptothecins|camptothecins
1063492|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
1063493|NCT02769949|Genetics|genetics
1063494|NCT02769949|Metabolic|metabolic
1063495|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
1063496|NCT02769949|Developmental Delay|developmental delay
1063497|NCT02769949|Genetic Counseling|genetic counseling
1063498|NCT02769936|Receptors|receptors
1063499|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
1063500|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
1063501|NCT02769923|Star ID syringe|star id syringe
1063502|NCT02769923|BCG needle syringe|bcg needle syringe
1063503|NCT02769923|fractional dose IPV|fractional dose ipv
1063504|NCT02769923|fIPV|fipv
1063505|NCT02769923|polio|polio
1063506|NCT02769923|Polio Endgame|polio endgame
1063508|NCT02769884|artificial pancreas|artificial pancreas
1063509|NCT02769832|Abraxane|abraxane
1063510|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
1063511|NCT02769832|SCLC|sclc
1063512|NCT02769832|Gemzar|gemzar
1063513|NCT02769819|Flexible fiberscope|flexible fiberscope
1063519|NCT02769715|Removable partial dentures|removable partial dentures
1063520|NCT02769715|partial edentulism|partial edentulism
1063521|NCT02769702|Uveitis|uveitis
1063522|NCT02769689|Multiple sclerosis|multiple sclerosis
1063523|NCT02769689|Natalizumab|natalizumab
1063524|NCT02769689|Fingolimod|fingolimod
1063525|NCT02769689|Methylprednisolone|methylprednisolone
1063526|NCT02769650|Coronary stenosis|coronary stenosis
1063527|NCT02769650|Drug-eluting stent|drug-eluting stent
1063528|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
1063529|NCT02769650|Ischemic Heart Disease|ischemic heart disease
1063530|NCT02769650|Chronic total occlusion|chronic total occlusion
1063531|NCT02769650|Right coronary artery|right coronary artery
1063532|NCT02769650|Stress-MRI|stress-mri
1063533|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
1063534|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
1063535|NCT02769624|Congenital heart disease|congenital heart disease
1063536|NCT02769598|Pain|pain
1063537|NCT02769598|Nociception|nociception
1063538|NCT02769598|Pediatric intensive care|pediatric intensive care
1063539|NCT02769598|Pain assessment scale|pain assessment scale
1063540|NCT02769598|ANI index|ani index
1063541|NCT02769585|Obesity|obesity
1063542|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1063543|NCT02769585|weight reduction|weight reduction
1063544|NCT02769572|Knee osteoarthritis|knee osteoarthritis
1063545|NCT02769572|moxibustion|moxibustion
1063546|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
1063547|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
1063548|NCT02769520|pembrolizumab|pembrolizumab
1063549|NCT02769494|Oral ulcer|oral ulcer
1063550|NCT02769494|Crohn's disease|crohn's disease
1063551|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
1063552|NCT02769455|Food Labelling|food labelling
1063553|NCT02769442|Intravenous|intravenous
1063554|NCT02769442|Catheter|catheter
1063555|NCT02769442|Puncture|puncture
1063556|NCT02769442|Peripheral Catheterization|peripheral catheterization
1063557|NCT02769442|First Stick Success|first stick success
1063558|NCT02769442|Contamination|contamination
1063559|NCT02769442|Terumo|terumo
1063560|NCT02769442|SurFlash|surflash
1063561|NCT02769416|spinal cord injury|spinal cord injury
1063562|NCT02769416|traumatic brain injury|traumatic brain injury
1063563|NCT02769403|Job Satisfaction|job satisfaction
1063564|NCT02769403|Job Performance|job performance
1063565|NCT02769403|Primary Care|primary care
1063566|NCT02769390|Analgesia|analgesia
1063567|NCT02769390|Bupivacaine|bupivacaine
1063568|NCT02769390|Clonidine|clonidine
1063569|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
1063570|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
1063571|NCT02769364|Eribulin|eribulin
1063572|NCT02769351|volume overload|volume overload
1063573|NCT02769351|heart failure|heart failure
1063574|NCT02769351|cardiac decompensation|cardiac decompensation
1063575|NCT02769351|ultrafiltration|ultrafiltration
1063576|NCT02769338|Implementation|implementation
1063577|NCT02769338|Quality Improvement|quality improvement
1063578|NCT02769338|Stroke|stroke
1063579|NCT02769338|Transient Ischemic Attack|transient ischemic attack
1063580|NCT02769338|TIA|tia
1063581|NCT02769338|System Redesign|system redesign
1063582|NCT02769338|QI Intervention|qi intervention
1063583|NCT02769325|atropine|atropine
1063584|NCT02769325|pain, postoperative|pain, postoperative
1063585|NCT02769312|Quality of Life|quality of life
1063586|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1063587|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1063588|NCT02769312|Feasibility studies|feasibility studies
1063589|NCT02769260|pyrosequencing|pyrosequencing
1063590|NCT02769260|16S DNA gene|16s dna gene
1063591|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
1063592|NCT02769260|bacterial viability|bacterial viability
1063593|NCT02769260|bacterial diversity|bacterial diversity
1063594|NCT02769247|naproxen|naproxen
1063595|NCT02769247|lidocaine|lidocaine
1063596|NCT02769247|intrauterine device|intrauterine device
1063597|NCT02769247|IUD|iud
1063598|NCT02769247|pain|pain
1063599|NCT02769234|EEG|eeg
1063600|NCT02769234|ERP|erp
1063601|NCT02769234|Event-related Potentials|event-related potentials
1063602|NCT02769234|Alzheimer's|alzheimer's
1063603|NCT02769234|P300|p300
1063604|NCT02769208|Air Pollution|air pollution
1063605|NCT02769208|Air Filtration|air filtration
1063606|NCT02769208|Exposure Assessment|exposure assessment
1063607|NCT02769208|HEPA Filter|hepa filter
1063608|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
1063609|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
1063610|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
1063611|NCT02769182|Older adults|older adults
1063612|NCT02769182|falls|falls
1063613|NCT02769182|cognition|cognition
1063614|NCT02769182|smart phone|smart phone
1063615|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
1063616|NCT02769143|Postmenopausal|postmenopausal
1063617|NCT02769143|Bone Density|bone density
1063619|NCT02769104|aromatase inhibitors|aromatase inhibitors
1063620|NCT02769104|chemotherapy|chemotherapy
1063621|NCT02769104|neoadjuvant|neoadjuvant
1063622|NCT02769104|postmenopausal|postmenopausal
1063623|NCT02769104|breast cancer|breast cancer
1063624|NCT02769078|Anticoagulation|anticoagulation
1063625|NCT02769065|Drug Therapy|drug therapy
1063626|NCT02769052|endometriosis|endometriosis
1063627|NCT02769052|dyspareunia|dyspareunia
1063628|NCT02769052|physical therapy|physical therapy
1063629|NCT02769052|sexuality|sexuality
1063630|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1063631|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
1063632|NCT02768987|exercise|exercise
1063633|NCT02768987|physical activity|physical activity
1063634|NCT02768987|behavior modification|behavior modification
1063635|NCT02768987|coping skills|coping skills
1063636|NCT02768987|self management|self management
1063637|NCT02768987|glycemic control|glycemic control
1063638|NCT02768987|overweight|overweight
1063639|NCT02768987|obesity|obesity
1063640|NCT02768987|body composition|body composition
1063641|NCT02768987|adherence|adherence
1063642|NCT02768961|sofosbuvir|sofosbuvir
1063643|NCT02768961|ledipasvir|ledipasvir
1063644|NCT02768961|ribavirin|ribavirin
1063645|NCT02768961|prisoner|prisoner
1063646|NCT02768961|hepatitis c|hepatitis c
1063647|NCT02768961|prevalence|prevalence
1063648|NCT02768961|hepatitis b|hepatitis b
1063649|NCT02768922|Telemedicine|telemedicine
1063650|NCT02768922|Telerehabilitation|telerehabilitation
1063651|NCT02768922|Speech and language therapy|speech and language therapy
1063652|NCT02768883|Childhood asthma|childhood asthma
1063653|NCT02768883|Latino|latino
1063654|NCT02768844|Stochastic Resonance|stochastic resonance
1063655|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
1063656|NCT02768844|Drug Withdrawal|drug withdrawal
1063657|NCT02768844|Substance Abuse|substance abuse
1063658|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
1063659|NCT02768805|Influenza|influenza
1063660|NCT02768805|Human|human
1063661|NCT02768805|RNA Virus Infections|rna virus infections
1063662|NCT02768805|Immunologic|immunologic
1063663|NCT02768805|Immunogenic Factors|immunogenic factors
1063664|NCT02768805|Physiological Effects of Drug|physiological effects of drug
1063665|NCT02768805|Virus Diseases|virus diseases
1063666|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
1063667|NCT02768805|Infection|infection
1063668|NCT02768779|hair|hair
1063669|NCT02768766|MEK inhibitor|mek inhibitor
1063670|NCT02768766|Selumetinib|selumetinib
1063671|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
1063672|NCT02768766|Uveal melanoma|uveal melanoma
1063673|NCT02768766|Melanoma|melanoma
1063674|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
1063675|NCT02768753|Robotic central neck dissection|robotic central neck dissection
1063676|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
1063677|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
1063678|NCT02768727|neurocognitive function|neurocognitive function
1063679|NCT02768727|neural inertia|neural inertia
1063680|NCT02768727|xenon gas|xenon gas
1063681|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
1063682|NCT02768701|Pembrolizumab|pembrolizumab
1063683|NCT02768701|cyclophosphamide|cyclophosphamide
1063684|NCT02768688|Human Brain|human brain
1063685|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1063686|NCT02768688|Dexmedetomidine|dexmedetomidine
1063687|NCT02768688|Cerebral blood flow|cerebral blood flow
1063688|NCT02768675|Kyphotic|kyphotic
1063689|NCT02768675|Corrective Surgery|corrective surgery
1063690|NCT02768675|Spinal fractures|spinal fractures
1063691|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
1063692|NCT02768610|dexmedetomidine|dexmedetomidine
1063693|NCT02768584|severe mental illness|severe mental illness
1063694|NCT02768584|nursing|nursing
1063695|NCT02768584|therapeutic alliance|therapeutic alliance
1063696|NCT02768584|psychiatric diseases|psychiatric diseases
1063697|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
1063698|NCT02768558|Lung Cancer|lung cancer
1063699|NCT02768558|NSCLC|nsclc
1063700|NCT02768558|Nivolumab|nivolumab
1063701|NCT02768545|Hepatitis C|hepatitis c
1063702|NCT02768545|Ezetimibe|ezetimibe
1063703|NCT02768545|Cholesterol|cholesterol
1063704|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
1063705|NCT02768545|Bile|bile
1063706|NCT02768545|Feces|feces
1063707|NCT02768532|Crohn's disease|crohn's disease
1063708|NCT02768532|Vedolizumab|vedolizumab
1063709|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
1063710|NCT02768532|Clinical response|clinical response
1063711|NCT02768532|Clinical remission|clinical remission
1063712|NCT02768519|Participants|participants
1063713|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
1063714|NCT02768480|Diabetes|diabetes
1063715|NCT02768480|phone calls|phone calls
1063716|NCT02768480|glycemic control|glycemic control
1063717|NCT02768467|Alloderm graft|alloderm graft
1063719|NCT02768467|Buccal Mucosa|buccal mucosa
1063720|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
1063721|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
1063722|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
1063723|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
1063724|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
1063725|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
1063726|NCT02768402|Primary MR|primary mr
1063727|NCT02768402|Secondary MR|secondary mr
1063728|NCT02768402|MR|mr
1063729|NCT02768402|Heart Failure|heart failure
1063730|NCT02768402|Structural Heart|structural heart
1063731|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
1063732|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
1063733|NCT02768402|Transseptal|transseptal
1063734|NCT02768402|Transcatheter|transcatheter
1063735|NCT02768389|Modified Atkins Diet|modified atkins diet
1063736|NCT02768389|MAD|mad
1063737|NCT02768389|Brain Tumor|brain tumor
1063738|NCT02768389|Glioblastoma|glioblastoma
1063739|NCT02768363|Immunotherapy|immunotherapy
1063740|NCT02768363|Tumor vaccine|tumor vaccine
1063741|NCT02768363|Immuno-oncology|immuno-oncology
1063742|NCT02768363|Cytotoxicity|cytotoxicity
1063743|NCT02768363|Prostate cancer|prostate cancer
1063744|NCT02768363|Active Surveillance|active surveillance
1063745|NCT02768350|lung collapse|lung collapse
1063746|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
1063747|NCT02768350|hemodynamic responses|hemodynamic responses
1063748|NCT02768350|ventilatory responses|ventilatory responses
1063749|NCT02768350|trauma patients|trauma patients
1063750|NCT02768337|brain metastasis|brain metastasis
1063751|NCT02768337|operable brain metastasis|operable brain metastasis
1063753|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
1063754|NCT02768324|Gut microbiota|gut microbiota
1063755|NCT02768324|Gut Flora|gut flora
1063756|NCT02768324|Intestinal Flora|intestinal flora
1063757|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
1063758|NCT02768298|Heart failure|heart failure
1063759|NCT02768298|systolic heart failure|systolic heart failure
1063760|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
1063761|NCT02768298|exercise capacity|exercise capacity
1063762|NCT02768285|apical patency|apical patency
1063763|NCT02768285|root canal treatment|root canal treatment
1063764|NCT02768233|Medication-overuse Headache|medication-overuse headache
1063765|NCT02768233|Educational Programme|educational programme
1063766|NCT02768233|Personality Profiles|personality profiles
1063767|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
1063768|NCT02768181|dietary supplements|dietary supplements
1063769|NCT02768168|Dezocine|dezocine
1063770|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
1063771|NCT02768168|Pain|pain
1063772|NCT02768168|Pruritus|pruritus
1063773|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
1063774|NCT02768116|Active Transfer of Plaque|active transfer of plaque
1063775|NCT02768103|upper extremity|upper extremity
1063776|NCT02768103|spinal cord injury|spinal cord injury
1063777|NCT02768103|surgical reconstruction|surgical reconstruction
1063778|NCT02768103|MRI, functional|mri, functional
1063779|NCT02768103|rehabilitation|rehabilitation
1063780|NCT02768077|melatonin|melatonin
1063781|NCT02768077|sleep disturbances|sleep disturbances
1063782|NCT02768025|smoking cessation|smoking cessation
1063783|NCT02768025|tobacco control|tobacco control
1063784|NCT02768025|acupuncture|acupuncture
1063785|NCT02768025|Korean Medicine|korean medicine
1063786|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
1063787|NCT02767999|Acute ischemic stroke|acute ischemic stroke
1063788|NCT02767986|Hispanic|hispanic
1063789|NCT02767986|Health Belief Model|health belief model
1063790|NCT02767986|Cultural Consensus Theory|cultural consensus theory
1063791|NCT02767986|Cancer Genetics|cancer genetics
1063792|NCT02767986|Qualitative|qualitative
1063793|NCT02767960|Tenascin-C|tenascin-c
1063794|NCT02767908|Tobacco|tobacco
1063795|NCT02767908|Smoking Cessation|smoking cessation
1063796|NCT02767869|Metabolic syndrome|metabolic syndrome
1063797|NCT02767869|central obesity|central obesity
1063798|NCT02767869|Banaba|banaba
1063799|NCT02767869|insulin secretion|insulin secretion
1063800|NCT02767869|insulin sensitivity|insulin sensitivity
1063801|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
1063802|NCT02767778|Acute ischemic stroke|acute ischemic stroke
1063803|NCT02767778|Neuroprotection|neuroprotection
1063804|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
1063805|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
1063806|NCT02767752|Adjuvant|adjuvant
1063807|NCT02767713|Cognition Disorders|cognition disorders
1063808|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
1063809|NCT02767713|dexamethasone|dexamethasone
1063810|NCT02767687|Postoperative Care|postoperative care
1063811|NCT02767687|Postoperative Period|postoperative period
1063812|NCT02767687|Heart Surgery|heart surgery
1063813|NCT02767674|R-Gemox|r-gemox
1063814|NCT02767674|R-miniCHOP|r-minichop
1064315|NCT02764554|Lenvima|lenvima
1063815|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
1063816|NCT02767661|metronomic capecitabine|metronomic capecitabine
1063817|NCT02767661|aromatase inhibitor|aromatase inhibitor
1063818|NCT02767661|first line treatment|first line treatment
1063819|NCT02767661|metastatic breast cancer|metastatic breast cancer
1063820|NCT02767648|cholestasis|cholestasis
1063821|NCT02767648|neonatal|neonatal
1063822|NCT02767648|infant|infant
1063823|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1063824|NCT02767596|treatment|treatment
1063825|NCT02767596|GLP-1|glp-1
1063826|NCT02767583|Neuropathology|neuropathology
1063827|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
1063828|NCT02767570|Arthritis|arthritis
1063829|NCT02767570|Joint Diseases|joint diseases
1063830|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
1063831|NCT02767570|Rheumatic Diseases|rheumatic diseases
1063832|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
1063833|NCT02767544|postoperative pain|postoperative pain
1063834|NCT02767544|local analgesia|local analgesia
1063835|NCT02767544|vaginal wound|vaginal wound
1063836|NCT02767479|eradication rates|eradication rates
1063837|NCT02767479|rabeprazole|rabeprazole
1063838|NCT02767479|esomeprazole|esomeprazole
1063839|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
1063840|NCT02767453|Closed suction drainage|closed suction drainage
1063841|NCT02767453|Glenohumeral|glenohumeral
1063842|NCT02767453|Drainage tube|drainage tube
1063843|NCT02767427|Infection Control|infection control
1063844|NCT02767427|Preoperative Care|preoperative care
1063845|NCT02767427|Chlorhexidine|chlorhexidine
1063846|NCT02767427|Pre-Surgical Wash|pre-surgical wash
1063847|NCT02767427|Spine Surgery|spine surgery
1063848|NCT02767427|Surgical site infections|surgical site infections
1063849|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
1063850|NCT02767401|PET-CT|pet-ct
1063851|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
1063852|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
1063853|NCT02767401|coronary artery disease|coronary artery disease
1063854|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
1063855|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1063856|NCT02767362|atorvastatin|atorvastatin
1063857|NCT02767362|endometrium|endometrium
1063858|NCT02767362|endometrial cancer|endometrial cancer
1063859|NCT02767310|Bioequivalence|bioequivalence
1063860|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
1063861|NCT02767284|Contrast Sensitivity|contrast sensitivity
1063862|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
1063863|NCT02767258|Dry eye|dry eye
1063864|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
1063865|NCT02767245|Thiamine|thiamine
1063866|NCT02767245|Congestive heart failure|congestive heart failure
1063867|NCT02767245|Atrial fibrillation|atrial fibrillation
1063868|NCT02767245|Graves' disease|graves' disease
1063869|NCT02767232|PHLO|phlo
1063870|NCT02767232|deep vein thrombosis|deep vein thrombosis
1063871|NCT02767232|deep venous thrombosis|deep venous thrombosis
1063872|NCT02767232|blood clot|blood clot
1063873|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
1063874|NCT02767232|thrombolysis|thrombolysis
1063875|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
1063876|NCT02767232|PTS|pts
1063877|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1063878|NCT02767232|rt-PA|rt-pa
1063879|NCT02767232|Activase|activase
1063880|NCT02767232|Alteplase|alteplase
1063881|NCT02767219|Ophthalmology|ophthalmology
1063882|NCT02767206|Transnasal endoscopy|transnasal endoscopy
1063883|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
1063884|NCT02767206|esophageal varices|esophageal varices
1063885|NCT02767206|gastric varices|gastric varices
1063886|NCT02767167|Cow's milk|cow's milk
1063887|NCT02767167|Iodine|iodine
1063888|NCT02767167|Selenium|selenium
1063889|NCT02767167|Women|women
1063890|NCT02767167|Child-bearing age|child-bearing age
1063891|NCT02767154|extracorporeal circulation|extracorporeal circulation
1063892|NCT02767141|Hunger|hunger
1063893|NCT02767141|food insecurity|food insecurity
1063894|NCT02767141|behaviors|behaviors
1063895|NCT02767128|pharmacokinetics|pharmacokinetics
1063896|NCT02767128|healthy adult volunteer|healthy adult volunteer
1063897|NCT02767102|Mediterranean diet|mediterranean diet
1063898|NCT02767102|indoleamine|indoleamine
1063899|NCT02767102|nutraceuticals|nutraceuticals
1063900|NCT02767102|nutrition|nutrition
1063901|NCT02767102|oxidative stress|oxidative stress
1063902|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
1063903|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
1063904|NCT02767076|real time|real time
1063905|NCT02767076|ultrasound|ultrasound
1063906|NCT02767076|knee surgeries|knee surgeries
1063907|NCT02767076|conventional|conventional
1063908|NCT02767050|DENTAL CARIES|dental caries
1063909|NCT02767050|TOBACCO USERS|tobacco users
1063910|NCT02767050|SMOKERS|smokers
1063911|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
1063912|NCT02767011|surgical site infection|surgical site infection
1063913|NCT02766985|FSHD|fshd
1063914|NCT02766985|muscular dystrophy|muscular dystrophy
1063915|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
1063916|NCT02766972|Surgical Clipping|surgical clipping
1063917|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
1063918|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
1063919|NCT02766959|airway physiology|airway physiology
1063920|NCT02766959|taste receptors|taste receptors
1063921|NCT02766959|tas2r|tas2r
1063922|NCT02766959|epithelial biology|epithelial biology
1063923|NCT02766959|upper respiratory disease|upper respiratory disease
1063924|NCT02766946|Mechanical Ventilation|mechanical ventilation
1063925|NCT02766933|tenofovir|tenofovir
1063926|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
1063927|NCT02766933|cirrhosis|cirrhosis
1063928|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
1063930|NCT02766881|Breast Conserving Surgery|breast conserving surgery
1063931|NCT02766855|cysteamine|cysteamine
1063932|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
1063933|NCT02766855|cystine crystals|cystine crystals
1063934|NCT02766842|SharkCore|sharkcore
1063935|NCT02766842|ProCore|procore
1063936|NCT02766829|spinal|spinal
1063937|NCT02766829|anesthesia|anesthesia
1063938|NCT02766829|sitting|sitting
1063939|NCT02766829|cross leg|cross leg
1063940|NCT02766829|spinal-bone contact|spinal-bone contact
1063941|NCT02766738|residential aged care|residential aged care
1063942|NCT02766738|mobility|mobility
1063943|NCT02766738|social participation|social participation
1063944|NCT02766738|functional capability|functional capability
1063945|NCT02766712|catheter ablation|catheter ablation
1063946|NCT02766712|atrial fibrillation|atrial fibrillation
1063947|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
1063948|NCT02766699|Doxorubicin|doxorubicin
1063949|NCT02766699|Glioblastoma|glioblastoma
1063950|NCT02766699|Neoplasms|neoplasms
1063951|NCT02766699|Neoplasms by Site|neoplasms by site
1063952|NCT02766699|Antineoplastic Agents|antineoplastic agents
1063953|NCT02766699|Drug Delivery Systems|drug delivery systems
1063954|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
1063955|NCT02766699|Nanoparticles|nanoparticles
1063956|NCT02766699|Disease Progression|disease progression
1063957|NCT02766699|Recurrence|recurrence
1063958|NCT02766699|Brain Neoplasms|brain neoplasms
1063959|NCT02766699|Immunotherapy|immunotherapy
1063960|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
1063961|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
1063962|NCT02766686|Prostate cancer|prostate cancer
1063963|NCT02766686|proton radiotherapy|proton radiotherapy
1063964|NCT02766686|photon radiotherapy|photon radiotherapy
1063965|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
1063966|NCT02766660|optical coherence tomography|optical coherence tomography
1063967|NCT02766647|Filgrastim|filgrastim
1063968|NCT02766634|filgrastim|filgrastim
1063969|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
1063970|NCT02766608|COPD|copd
1063971|NCT02766582|Ovarian|ovarian
1063972|NCT02766582|platinum|platinum
1063973|NCT02766582|pembrolizumab|pembrolizumab
1063974|NCT02766582|taxane|taxane
1063975|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
1063976|NCT02766543|prostate cancer|prostate cancer
1063977|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
1063978|NCT02766543|MRI-guided|mri-guided
1063979|NCT02766543|minimally invasive|minimally invasive
1063980|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
1063981|NCT02766491|Stretching|stretching
1063982|NCT02766465|Sickle Cell Disease|sickle cell disease
1063983|NCT02766465|Young Adults|young adults
1063984|NCT02766465|Phase II Trial|phase ii trial
1063985|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
1063986|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
1063987|NCT02766400|Stroke|stroke
1063988|NCT02766400|Rehabilitation|rehabilitation
1063989|NCT02766400|Cognition|cognition
1063990|NCT02766400|Disability|disability
1063991|NCT02766400|Intervention|intervention
1063992|NCT02766374|Asthma|asthma
1063993|NCT02766374|Biofeedback|biofeedback
1063994|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
1063995|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
1063996|NCT02766361|Bipolar disorder|bipolar disorder
1063997|NCT02766361|Psychotherapy|psychotherapy
1063998|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
1063999|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
1064000|NCT02766322|Alcohol metabolism|alcohol metabolism
1064001|NCT02766322|Bariatric surgery|bariatric surgery
1064002|NCT02766322|Effects of alcohol on driving|effects of alcohol on driving
1064003|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
1064004|NCT02766296|PTSD|ptsd
1064005|NCT02766296|trauma|trauma
1064006|NCT02766296|working memory|working memory
1064007|NCT02766296|working memory training|working memory training
1064008|NCT02766283|Children|children
1064009|NCT02766283|Iodinated contrast agents|iodinated contrast agents
1064010|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
1064011|NCT02766270|IDH|idh
1064012|NCT02766270|TERT|tert
1064013|NCT02766270|Chemoradiotherapy|chemoradiotherapy
1064014|NCT02766270|Temozolomide|temozolomide
1064015|NCT02766218|toddler obesity|toddler obesity
1064016|NCT02766218|responsive feeding|responsive feeding
1064017|NCT02766218|behavioral weight control|behavioral weight control
1064018|NCT02766218|pregnancy weight gain|pregnancy weight gain
1064019|NCT02766218|early life risk factors|early life risk factors
1064020|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
1064021|NCT02766205|Atrial fibrillation|atrial fibrillation
1064022|NCT02766205|prognostic score|prognostic score
1064023|NCT02766192|ketamine|ketamine
1064024|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
1064025|NCT02766192|PTSD|ptsd
1064026|NCT02766192|trauma memory|trauma memory
1064027|NCT02766192|memory extinction|memory extinction
1064028|NCT02766192|memory re-consolidation|memory re-consolidation
1064029|NCT02766192|metabolomics|metabolomics
1064030|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
1064031|NCT02766127|radiotherapy|radiotherapy
1064032|NCT02766114|CTS|cts
1064033|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
1064034|NCT02766114|Carpal tunnel release|carpal tunnel release
1064035|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
1064036|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
1064037|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
1064038|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
1064039|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
1064040|NCT02766114|CTRMTA|ctrmta
1064041|NCT02766114|OCTR|octr
1064042|NCT02766114|ECTR|ectr
1064043|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
1064044|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
1064045|NCT02766114|Syria|syria
1064046|NCT02766114|Cosmetic|cosmetic
1064047|NCT02766114|Safety|safety
1064048|NCT02766114|Rehabilitation,|rehabilitation,
1064049|NCT02766114|Complications|complications
1064050|NCT02766114|Surgery|surgery
1064051|NCT02766114|Satisfaction|satisfaction
1064052|NCT02766088|Dengue|dengue
1064053|NCT02766088|Household|household
1064054|NCT02766088|Southeast Asia|southeast asia
1064055|NCT02766088|Latin America|latin america
1064056|NCT02766088|Surveillance|surveillance
1064057|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
1064058|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
1064059|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1064060|NCT02766062|metabolic syndrome|metabolic syndrome
1064061|NCT02766062|propofol|propofol
1064062|NCT02766062|sevoflurane|sevoflurane
1064063|NCT02766049|HIV|hiv
1064064|NCT02766049|immunotherapy|immunotherapy
1064065|NCT02766049|clinical trial|clinical trial
1064066|NCT02766049|dendritic cell|dendritic cell
1064067|NCT02766036|Proteinuria|proteinuria
1064068|NCT02766036|Propolis|propolis
1064069|NCT02766036|Chronic Kidney Disease|chronic kidney disease
1064070|NCT02766023|CTV-05|ctv-05
1064071|NCT02766023|LACTIN-V|lactin-v
1064072|NCT02766023|Lactobacillus|lactobacillus
1064073|NCT02766023|MetroGel®|metrogel®
1064074|NCT02766023|Vaginitis|vaginitis
1064075|NCT02765997|AML|aml
1064076|NCT02765997|ALL|all
1064077|NCT02765997|MDS|mds
1064078|NCT02765984|implantation site|implantation site
1064079|NCT02765984|placental site|placental site
1064080|NCT02765984|Doppler|doppler
1064081|NCT02765971|chewing gums|chewing gums
1064082|NCT02765971|laxatives|laxatives
1064083|NCT02765971|bowel function|bowel function
1064084|NCT02765945|Exercise|exercise
1064085|NCT02765945|Osteoporosis|osteoporosis
1064086|NCT02765945|Cytokines|cytokines
1064087|NCT02765932|Hip|hip
1064088|NCT02765932|Knee|knee
1064089|NCT02765932|replacement|replacement
1064090|NCT02765932|surgery|surgery
1064091|NCT02765919|Carcinoma cervix|carcinoma cervix
1064092|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
1064093|NCT02765919|9 Gray|9 gray
1064094|NCT02765919|Brachytherapy|brachytherapy
1064095|NCT02765906|video|video
1064096|NCT02765906|educational tool|educational tool
1064097|NCT02765906|preeclampsia|preeclampsia
1064098|NCT02765906|hypertension|hypertension
1064099|NCT02765906|pregnancy|pregnancy
1064100|NCT02765906|patient education|patient education
1064101|NCT02765906|graphic card|graphic card
1064102|NCT02765906|eclampsia|eclampsia
1064103|NCT02765906|HELLP|hellp
1064104|NCT02765906|anxiety|anxiety
1064105|NCT02765906|anxiety assessment|anxiety assessment
1064106|NCT02765906|STAI 6|stai 6
1064107|NCT02765841|HoFH|hofh
1064109|NCT02765815|Knee replacement|knee replacement
1064110|NCT02765815|Arthritis|arthritis
1064111|NCT02765815|Knee|knee
1064112|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
1064113|NCT02765776|Raltegravir Potassium|raltegravir potassium
1064114|NCT02765776|Aged|aged
1064115|NCT02765776|Retrospective Study|retrospective study
1064116|NCT02765776|Medical Records|medical records
1064117|NCT02765750|Emergence agitation|emergence agitation
1064118|NCT02765711|ticagrelor|ticagrelor
1064119|NCT02765711|acute coronary syndrome|acute coronary syndrome
1064120|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
1064121|NCT02765672|Combat Veterans|combat veterans
1064122|NCT02765672|Automobile Driving|automobile driving
1064123|NCT02765672|Fitness to Drive|fitness to drive
1064125|NCT02765659|Prevention|prevention
1064126|NCT02765659|Implementation|implementation
1064127|NCT02765659|Community based participatory research|community based participatory research
1064128|NCT02765620|Positron-Emission Tomography|positron-emission tomography
1064129|NCT02765620|Response Criteria|response criteria
1064130|NCT02765620|solid tumor|solid tumor
1064131|NCT02765607|Blood circulation|blood circulation
1064132|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
1064133|NCT02765607|Homeostasis|homeostasis
1064134|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
1064135|NCT02765594|Kidney Diseases|kidney diseases
1064136|NCT02765594|Autoimmune Diseases|autoimmune diseases
1064137|NCT02765594|Glomerulonephritis|glomerulonephritis
1064138|NCT02765594|Nephritis|nephritis
1064139|NCT02765594|Immune System Diseases|immune system diseases
1064140|NCT02765594|Urologic Diseases|urologic diseases
1064141|NCT02765594|Hydroxychloroquine|hydroxychloroquine
1064142|NCT02765594|Anti-Infective Agents|anti-infective agents
1064143|NCT02765594|Antimalarials|antimalarials
1064144|NCT02765594|Antiparasitic Agents|antiparasitic agents
1064145|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
1064146|NCT02765594|Antirheumatic Agents|antirheumatic agents
1064147|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
1064148|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1064149|NCT02765594|Pharmacologic Actions|pharmacologic actions
1064150|NCT02765594|Therapeutic Uses|therapeutic uses
1064151|NCT02765594|interleukin-6|interleukin-6
1064152|NCT02765594|interferon-alpha|interferon-alpha
1064153|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
1064154|NCT02765581|Acupuncture|acupuncture
1064155|NCT02765581|Migraine without aura|migraine without aura
1064156|NCT02765581|Efficacy|efficacy
1064157|NCT02765581|Randomized controlled trial|randomized controlled trial
1064158|NCT02765581|Non-penetrating sham acupuncture|non-penetrating sham acupuncture
1064159|NCT02765568|Coronary Artery Disease|coronary artery disease
1064160|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1064161|NCT02765542|Depression|depression
1064162|NCT02765542|mHealth|mhealth
1064163|NCT02765542|Interactive Voice Response|interactive voice response
1064164|NCT02765542|Bolivia|bolivia
1064165|NCT02765542|Mental health|mental health
1064166|NCT02765529|Environmental Pollution|environmental pollution
1064167|NCT02765529|Fine particles|fine particles
1064168|NCT02765529|Biomarkers|biomarkers
1064169|NCT02765529|Elderly|elderly
1064170|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
1064171|NCT02765490|AL-335|al-335
1064172|NCT02765490|Odalasvir|odalasvir
1064173|NCT02765490|Simeprevir|simeprevir
1064174|NCT02765490|ODV|odv
1064175|NCT02765490|SMV|smv
1064176|NCT02765490|ACH-3102|ach-3102
1064177|NCT02765490|ACH-0143102|ach-0143102
1064178|NCT02765490|TMC435|tmc435
1064179|NCT02765477|Acute myocardial infarction|acute myocardial infarction
1064180|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1064181|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
1064182|NCT02765477|Electrocardiogram|electrocardiogram
1064183|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
1064184|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
1064185|NCT02765451|non-academic|non-academic
1064186|NCT02765451|health institution|health institution
1064187|NCT02765451|development|development
1064188|NCT02765451|clinical research|clinical research
1064189|NCT02765451|cancer|cancer
1064190|NCT02765451|private hospital|private hospital
1064191|NCT02765451|public hospital|public hospital
1064192|NCT02765451|northwestern france|northwestern france
1064193|NCT02765451|france|france
1064194|NCT02765451|hospitals|hospitals
1064195|NCT02765412|decision support|decision support
1064196|NCT02765412|patient preferences|patient preferences
1064197|NCT02765412|risk adjustment|risk adjustment
1064198|NCT02765386|Cochlear implants|cochlear implants
1064199|NCT02765386|Hybrid fittings|hybrid fittings
1064200|NCT02765386|Cross-over frequency|cross-over frequency
1064201|NCT02765373|aromatase inhibitors|aromatase inhibitors
1064202|NCT02765373|lipid levels|lipid levels
1064203|NCT02765360|EIT|eit
1064204|NCT02765360|NIV|niv
1064205|NCT02765308|Uveitis|uveitis
1064206|NCT02765308|Glaucoma|glaucoma
1064207|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
1064208|NCT02765295|Hydrogen|hydrogen
1064209|NCT02765295|Inhalation|inhalation
1064210|NCT02765295|bronchiectasis|bronchiectasis
1064211|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
1064213|NCT02765269|cancer pain|cancer pain
1064214|NCT02765269|mobile applications|mobile applications
1064215|NCT02765243|neuroblastoma|neuroblastoma
1064216|NCT02765243|GD2|gd2
1064217|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
1064218|NCT02765243|Immunotherapy|immunotherapy
1064219|NCT02765243|Cyclophosphamide|cyclophosphamide
1064220|NCT02765243|Fludarabine|fludarabine
1064221|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
1064222|NCT02765217|Children|children
1064223|NCT02765217|Prevention|prevention
1064224|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
1064225|NCT02765217|Probiotic|probiotic
1064226|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
1064227|NCT02765191|Norepinephrine|norepinephrine
1064228|NCT02765191|Fluid Therapy|fluid therapy
1064229|NCT02765191|Renal Circulation|renal circulation
1064230|NCT02765165|Phase 1|phase 1
1064231|NCT02765165|Phase 2|phase 2
1064232|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
1064233|NCT02765165|Glioblastoma|glioblastoma
1064234|NCT02765165|GBM|gbm
1064235|NCT02765165|Brain Tumor|brain tumor
1064236|NCT02765165|Brain Cancer|brain cancer
1064237|NCT02765165|Tumor|tumor
1064238|NCT02765165|Solid Tumor|solid tumor
1064239|NCT02765165|Tumour|tumour
1064240|NCT02765165|Lomustine|lomustine
1064241|NCT02765165|CCNU|ccnu
1064242|NCT02765165|CXCR4|cxcr4
1064243|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
1064244|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
1064245|NCT02765152|exercise|exercise
1064246|NCT02765152|rhythmic movement|rhythmic movement
1064247|NCT02765152|discrete movement|discrete movement
1064248|NCT02765100|Bipolar Disorder|bipolar disorder
1064249|NCT02765100|Obesity|obesity
1064250|NCT02765100|Depression|depression
1064251|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
1064252|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
1064253|NCT02765074|bone erosion|bone erosion
1064254|NCT02765074|bone microarchitecture|bone microarchitecture
1064255|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
1064256|NCT02765048|Adolescent girls|adolescent girls
1064257|NCT02765048|Child welfare|child welfare
1064258|NCT02765048|Trauma treatment|trauma treatment
1064259|NCT02765048|PTSD|ptsd
1064260|NCT02765048|Depression|depression
1064261|NCT02765048|Social problem-solving|social problem-solving
1064262|NCT02765009|Fluid overload|fluid overload
1064263|NCT02765009|Multiple organ failure|multiple organ failure
1064264|NCT02765009|Diuretics|diuretics
1064265|NCT02765009|Fluid restriction|fluid restriction
1064266|NCT02765009|Body weight|body weight
1064267|NCT02764983|Combat Veterans|combat veterans
1064268|NCT02764983|Automobile Driving|automobile driving
1064269|NCT02764983|Fitness to Drive|fitness to drive
1064270|NCT02764905|Diabetes|diabetes
1064271|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
1064272|NCT02764905|Self care management|self care management
1064273|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
1064274|NCT02764879|Root planning|root planning
1064275|NCT02764879|chronic periodontitis|chronic periodontitis
1064276|NCT02764866|Lung cancer|lung cancer
1064277|NCT02764866|Sleep apnea|sleep apnea
1064278|NCT02764866|Sleep disordered breathing|sleep disordered breathing
1064279|NCT02764853|HIV|hiv
1064280|NCT02764853|Black|black
1064281|NCT02764853|African American|african american
1064282|NCT02764853|Women|women
1064283|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
1064284|NCT02764853|Racism|racism
1064285|NCT02764853|Stigma|stigma
1064286|NCT02764853|Discrimination|discrimination
1064287|NCT02764853|Gender related stressors|gender related stressors
1064288|NCT02764853|Resilience|resilience
1064289|NCT02764853|Behavioral Medicine|behavioral medicine
1064290|NCT02764827|skin prick test|skin prick test
1064291|NCT02764827|grass and weed pollens|grass and weed pollens
1064292|NCT02764788|Auriculotherapy|auriculotherapy
1064293|NCT02764762|Drug Therapy|drug therapy
1064294|NCT02764749|vascular function|vascular function
1064295|NCT02764749|endothelial function|endothelial function
1064296|NCT02764749|polyphenols|polyphenols
1064297|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
1064298|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1064299|NCT02764671|safety|safety
1064300|NCT02764671|immunogenicity|immunogenicity
1064301|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
1064302|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
1064303|NCT02764619|Atrial remodelling|atrial remodelling
1064304|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
1064305|NCT02764619|T1 mapping|t1 mapping
1064306|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
1064307|NCT02764606|Lung Cancer|lung cancer
1064308|NCT02764606|Biomarkers|biomarkers
1064309|NCT02764606|Bone|bone
1064310|NCT02764606|Metastases|metastases
1064311|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1064312|NCT02764593|HNSCC|hnscc
1064313|NCT02764593|Nivolumab|nivolumab
1064314|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
1064318|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
1064319|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
1064320|NCT02764554|Progressive|progressive
1064321|NCT02764554|locally recurrent|locally recurrent
1064322|NCT02764554|metastatic|metastatic
1064323|NCT02764541|Breast Cancer|breast cancer
1064324|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
1064325|NCT02764528|Hygiene|hygiene
1064326|NCT02764515|Kunxian Capsule|kunxian capsule
1064327|NCT02764515|efficacy|efficacy
1064328|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
1064329|NCT02764515|Methotrexate|methotrexate
1064330|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
1064331|NCT02764476|psychogenic|psychogenic
1064332|NCT02764476|non-epileptic seizures|non-epileptic seizures
1064333|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
1064334|NCT02764476|PNES|pnes
1064335|NCT02764476|PMD|pmd
1064336|NCT02764476|virtual reality|virtual reality
1064337|NCT02764476|3D augmented reality|3d augmented reality
1064338|NCT02764476|mirror therapy|mirror therapy
1064339|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
1064340|NCT02764463|Resin cements|resin cements
1064341|NCT02764463|Survival|survival
1064342|NCT02764450|composite|composite
1064343|NCT02764450|restoration|restoration
1064344|NCT02764450|polymerization|polymerization
1064345|NCT02764424|Newborn|newborn
1064346|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
1064347|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
1064348|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
1064349|NCT02764411|Capillary malformations|capillary malformations
1064350|NCT02764411|Onrealtea|onrealtea
1064351|NCT02764411|port-wine stain|port-wine stain
1064352|NCT02764411|treatment|treatment
1064353|NCT02764411|topical|topical
1064354|NCT02764372|Arm rehabilitation|arm rehabilitation
1064355|NCT02764372|Serious games|serious games
1064356|NCT02764372|stroke|stroke
1064357|NCT02764372|Multiple sclerosis|multiple sclerosis
1064358|NCT02764346|Arthritis|arthritis
1064359|NCT02764346|Self-management|self-management
1064360|NCT02764346|Pain|pain
1064361|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
1064362|NCT02764333|Anti-PD-L1|anti-pd-l1
1064363|NCT02764333|vaccine|vaccine
1064364|NCT02764333|16-011|16-011
1064365|NCT02764294|anxiety|anxiety
1064366|NCT02764294|pain|pain
1064367|NCT02764294|satisfaction|satisfaction
1064368|NCT02764294|cystoscopy|cystoscopy
1064369|NCT02764294|music|music
1064370|NCT02764294|video|video
1064371|NCT02764294|stress ball|stress ball
1064372|NCT02764294|nursing|nursing
1064373|NCT02764268|Gastric Cancer|gastric cancer
1064374|NCT02764268|Pharmacokinetics|pharmacokinetics
1064375|NCT02764268|Dose titration|dose titration
1064376|NCT02764242|insect sting allergy|insect sting allergy
1064377|NCT02764242|recombinant venom allergen|recombinant venom allergen
1064378|NCT02764203|Dark Chocolate|dark chocolate
1064379|NCT02764203|Blood Pressure|blood pressure
1064380|NCT02764203|Wearable Devices|wearable devices
1064381|NCT02764203|Digital Health|digital health
1064382|NCT02764164|TDCS|tdcs
1064383|NCT02764151|GBM|gbm
1064384|NCT02764151|malignant glioma|malignant glioma
1064385|NCT02764151|glioma|glioma
1064386|NCT02764151|anaplastic glioma|anaplastic glioma
1064387|NCT02764151|astrocytoma|astrocytoma
1064388|NCT02764151|IDO|ido
1064389|NCT02764151|IDO1|ido1
1064390|NCT02764151|PF-06840003|pf-06840003
1064391|NCT02764138|poverty|poverty
1064392|NCT02764138|discrimination|discrimination
1064393|NCT02764125|Parkinson's Disease|parkinson's disease
1064394|NCT02764125|Wearing-off|wearing-off
1064395|NCT02764112|warfarin|warfarin
1064396|NCT02764073|Heart failure|heart failure
1064397|NCT02764073|Bioimpedance|bioimpedance
1064398|NCT02764073|Lung ultrasonography|lung ultrasonography
1064399|NCT02764060|Periodontitis|periodontitis
1064400|NCT02764060|Tongue coating|tongue coating
1064401|NCT02764060|Tongue cleaning|tongue cleaning
1064402|NCT02764060|Bacterial load|bacterial load
1064403|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1064404|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1064405|NCT02764047|NAFLD|nafld
1064406|NCT02764047|NASH|nash
1064407|NCT02764034|Low level Laser|low level laser
1064408|NCT02764034|Tissue culture|tissue culture
1064409|NCT02764034|Endometrial receptivity|endometrial receptivity
1064410|NCT02764021|HbA1c|hba1c
1064411|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
1064412|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
1064607|NCT02762851|Influenza|influenza
1064413|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
1064414|NCT02764021|Diabetes Mellitus|diabetes mellitus
1064415|NCT02764021|Metabolic Disorder|metabolic disorder
1064416|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
1064417|NCT02764021|Endocrine System Diseases|endocrine system diseases
1064418|NCT02764008|Postoperative Analgesia|postoperative analgesia
1064419|NCT02764008|Peritubal infiltration|peritubal infiltration
1064616|NCT02762747|Drain|drain
1064420|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
1064421|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
1064422|NCT02763995|HIV|hiv
1064423|NCT02763995|pharmaceutical care|pharmaceutical care
1064424|NCT02763995|older patients|older patients
1064425|NCT02763995|cardiovascular risk|cardiovascular risk
1064426|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
1064427|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
1064428|NCT02763982|peak oxygen uptake|peak oxygen uptake
1064429|NCT02763982|respiratory muscles|respiratory muscles
1064430|NCT02763982|quality of life|quality of life
1064431|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
1064432|NCT02763930|Cardiovascular disease|cardiovascular disease
1064433|NCT02763930|Blood pressure|blood pressure
1064434|NCT02763930|Hypertension|hypertension
1064435|NCT02763930|Dairy products|dairy products
1064436|NCT02763930|Milk|milk
1064437|NCT02763930|Cheese|cheese
1064438|NCT02763891|Balance|balance
1064439|NCT02763891|Mobility|mobility
1064440|NCT02763891|Trunk control|trunk control
1064441|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
1064442|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
1064443|NCT02763878|Distal gastric cancer|distal gastric cancer
1064444|NCT02763878|Nutrition status|nutrition status
1064445|NCT02763878|Postoperative complications|postoperative complications
1064446|NCT02763852|Parkinson's Disease|parkinson's disease
1064447|NCT02763852|Nebicapone|nebicapone
1064448|NCT02763839|Parkinson's disease|parkinson's disease
1064449|NCT02763839|Nebicapone|nebicapone
1064450|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1064451|NCT02763826|tDCS|tdcs
1064452|NCT02763800|Parkinson's disease|parkinson's disease
1064453|NCT02763800|Nebicapone|nebicapone
1064454|NCT02763774|coronary artery bypass|coronary artery bypass
1064455|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
1064456|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
1064457|NCT02763774|postoperative complications|postoperative complications
1064458|NCT02763774|physical fitness|physical fitness
1064459|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
1064460|NCT02763735|Right ventricle|right ventricle
1064461|NCT02763735|Right ventricular function|right ventricular function
1064462|NCT02763735|Metabolism|metabolism
1064463|NCT02763735|Non-invasive imaging|non-invasive imaging
1064464|NCT02763735|Healthy Subjects|healthy subjects
1064465|NCT02763722|atopic dermatitis|atopic dermatitis
1064466|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
1064467|NCT02763722|cosmetics|cosmetics
1064468|NCT02763722|transepidermal water loos|transepidermal water loos
1064469|NCT02763696|Metagenomics|metagenomics
1064470|NCT02763696|Vaginal microflora|vaginal microflora
1064471|NCT02763696|High-throughput sequencing|high-throughput sequencing
1064472|NCT02763683|Parkinsons Disease|parkinsons disease
1064473|NCT02763683|PET Imaging|pet imaging
1064474|NCT02763683|PIB|pib
1064475|NCT02763683|VAT|vat
1064476|NCT02763683|Dementia|dementia
1064477|NCT02763670|Heart failure|heart failure
1064478|NCT02763670|patient education as topic|patient education as topic
1064479|NCT02763670|patient care management|patient care management
1064480|NCT02763657|fMRI|fmri
1064481|NCT02763657|reasoning|reasoning
1064482|NCT02763657|development|development
1064483|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
1064484|NCT02763618|Neurofeedback|neurofeedback
1064485|NCT02763618|theta/beta ratio|theta/beta ratio
1064486|NCT02763618|multiple baseline|multiple baseline
1064487|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
1064488|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
1064489|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
1064490|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
1064491|NCT02763592|Knee surgery|knee surgery
1064492|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
1064493|NCT02763566|HER2-Negative|her2-negative
1064494|NCT02763566|CDK4|cdk4
1064495|NCT02763566|CDK6|cdk6
1064496|NCT02763553|Ketone Bodies|ketone bodies
1064497|NCT02763553|Enteral Nutrition|enteral nutrition
1064498|NCT02763553|Ketogenic Diet|ketogenic diet
1064499|NCT02763540|ILD|ild
1064500|NCT02763540|Pathology|pathology
1064501|NCT02763540|diagnosis|diagnosis
1064502|NCT02763540|lung biopsy|lung biopsy
1064503|NCT02763527|smoking cessation|smoking cessation
1064504|NCT02763501|bariatric surgery|bariatric surgery
1064505|NCT02763501|gastric bypass|gastric bypass
1064506|NCT02763501|intestinal obstruction|intestinal obstruction
1064507|NCT02763501|postoperative complication|postoperative complication
1064508|NCT02763501|methods|methods
1064509|NCT02763501|laparoscopy|laparoscopy
1064510|NCT02763488|blood flow restriction training|blood flow restriction training
1064511|NCT02763488|occlusion training|occlusion training
1064512|NCT02763488|total knee arthroplasty|total knee arthroplasty
1064513|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
1064514|NCT02763475|Killer Cells, Natural|killer cells, natural
1064515|NCT02763475|Consolidation treatment|consolidation treatment
1064516|NCT02763475|cytologic remission|cytologic remission
1064517|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
1064518|NCT02763475|allogeneic|allogeneic
1064519|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
1064520|NCT02763462|Acute Febrile Illness|acute febrile illness
1064521|NCT02763436|term infant, neonatal transition, cord clamping, NIRS, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume|term infant, neonatal transition, cord clamping, nirs, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume
1064522|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
1064523|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
1064524|NCT02763371|high GI lunch|high gi lunch
1064525|NCT02763371|low GI lunch|low gi lunch
1064526|NCT02763358|obesity|obesity
1064527|NCT02763358|weight loss|weight loss
1064528|NCT02763332|Fibromyalgia|fibromyalgia
1064529|NCT02763332|Efficacy|efficacy
1064530|NCT02763332|Taping|taping
1064531|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1064532|NCT02763319|bendamustine|bendamustine
1064533|NCT02763319|rituximab|rituximab
1064534|NCT02763319|combination therapy|combination therapy
1064535|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
1064536|NCT02763319|transplant ineligible|transplant ineligible
1064537|NCT02763293|pain|pain
1064538|NCT02763293|effectiveness|effectiveness
1064539|NCT02763293|manual therapy|manual therapy
1064540|NCT02763267|Insulin sensitivity|insulin sensitivity
1064541|NCT02763267|Insulin secretion|insulin secretion
1064542|NCT02763267|Pregnancy|pregnancy
1064543|NCT02763267|Placental proteins|placental proteins
1064544|NCT02763254|Epstein-Barr Virus|epstein-barr virus
1064545|NCT02763254|DLBCL|dlbcl
1064546|NCT02763254|PTLD|ptld
1064547|NCT02763254|EBV|ebv
1064548|NCT02763254|CIVIC|civic
1064549|NCT02763254|HL|hl
1064550|NCT02763254|T cell|t cell
1064551|NCT02763241|rhinitis|rhinitis
1064552|NCT02763228|Physical Activity|physical activity
1064553|NCT02763228|Breast Cancer|breast cancer
1064554|NCT02763228|minority|minority
1064555|NCT02763228|African American|african american
1064556|NCT02763202|transition of care|transition of care
1064557|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
1064558|NCT02763202|telemedicine|telemedicine
1064559|NCT02763202|emergency medical technician|emergency medical technician
1064560|NCT02763189|Mentoring|mentoring
1064561|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
1064562|NCT02763189|Training|training
1064563|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
1064564|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
1064565|NCT02763124|Pseudophakic|pseudophakic
1064566|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
1064567|NCT02763111|interleukin 17|interleukin 17
1064568|NCT02763111|monoclonal antibody|monoclonal antibody
1064569|NCT02763098|cardiovascular responses|cardiovascular responses
1064570|NCT02763098|analgesics opioid|analgesics opioid
1064571|NCT02763098|remifentanil|remifentanil
1064572|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
1064573|NCT02763046|NSAID|nsaid
1064574|NCT02763046|ASAS|asas
1064575|NCT02763046|Secukinumab|secukinumab
1064576|NCT02763046|Subcutaneous|subcutaneous
1064577|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
1064578|NCT02762994|interleukin 17|interleukin 17
1064579|NCT02762994|monoclonal antibody|monoclonal antibody
1064580|NCT02762994|psoriasis|psoriasis
1064581|NCT02762981|CORT125134|cort125134
1064582|NCT02762981|nabpaclitaxel|nabpaclitaxel
1064583|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
1064584|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
1064585|NCT02762981|GR Antagonist|gr antagonist
1064586|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
1064587|NCT02762981|Pancreatic Cancer|pancreatic cancer
1064588|NCT02762981|Solid Tumors|solid tumors
1064589|NCT02762955|adalimumab|adalimumab
1064590|NCT02762955|biosimilar|biosimilar
1064591|NCT02762955|BCD-057|bcd-057
1064592|NCT02762955|psoriasis|psoriasis
1064593|NCT02762955|tumor necrosis factor|tumor necrosis factor
1064594|NCT02762955|monoclonal antibody|monoclonal antibody
1064595|NCT02762942|cervical ripening|cervical ripening
1064596|NCT02762942|misoprostol|misoprostol
1064597|NCT02762942|supracervical balloon|supracervical balloon
1064598|NCT02762942|Foley catheter|foley catheter
1064599|NCT02762929|Analgesia|analgesia
1064600|NCT02762929|Bunionectomy|bunionectomy
1064601|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
1064602|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
1064603|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
1064604|NCT02762864|aspirin|aspirin
1064605|NCT02762864|ticagrelor|ticagrelor
1064606|NCT02762864|clopidogrel|clopidogrel
1064608|NCT02762851|Vaccine|vaccine
1064609|NCT02762851|Heart failure|heart failure
1064610|NCT02762851|Vascular|vascular
1064611|NCT02762799|neutrophil count|neutrophil count
1064612|NCT02762799|filgrastim|filgrastim
1064613|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
1064614|NCT02762747|Hernia, Inguinal|hernia, inguinal
1064615|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
1064618|NCT02762747|Laparoscopic|laparoscopic
1064619|NCT02762734|adolescent|adolescent
1064620|NCT02762734|suicide|suicide
1064621|NCT02762721|FGFR2 fusion|fgfr2 fusion
1064622|NCT02762721|iCCA|icca
1064623|NCT02762721|mixed HCC-CCA|mixed hcc-cca
1064624|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
1064625|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
1064626|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
1064627|NCT02762721|ArQule|arqule
1064628|NCT02762708|Bariatric Surgery|bariatric surgery
1064629|NCT02762708|Weight loss|weight loss
1064630|NCT02762695|Hypertension|hypertension
1064631|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1064632|NCT02762695|Case Management|case management
1064633|NCT02762669|Uterine contraction|uterine contraction
1064634|NCT02762669|Oxytocin desensitization|oxytocin desensitization
1064635|NCT02762643|DP-R213|dp-r213
1064636|NCT02762617|Healthy Volunteers|healthy volunteers
1064637|NCT02762617|Women's Health|women's health
1064638|NCT02762552|Stroke|stroke
1064639|NCT02762552|Etiology|etiology
1064640|NCT02762552|Recurrence|recurrence
1064641|NCT02762552|Transcranial holter|transcranial holter
1064642|NCT02762552|Microembolic signals|microembolic signals
1064643|NCT02762526|lipectomy|lipectomy
1064644|NCT02762526|abdominoplasty|abdominoplasty
1064645|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
1064646|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
1064647|NCT02762526|lung function|lung function
1064648|NCT02762526|respiratory muscles|respiratory muscles
1064649|NCT02762474|nab-paclitaxel|nab-paclitaxel
1064650|NCT02762474|IMRT|imrt
1064651|NCT02762474|esophageal cancer|esophageal cancer
1064652|NCT02762461|Fertilization in Vitro|fertilization in vitro
1064653|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
1064654|NCT02762461|Endometriosis|endometriosis
1064655|NCT02762422|endothelial function|endothelial function
1064656|NCT02762422|iron stores|iron stores
1064657|NCT02762422|red blood cell|red blood cell
1064658|NCT02762422|blood donation|blood donation
1064659|NCT02762409|critical care|critical care
1064660|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
1064661|NCT02762409|anxiety|anxiety
1064662|NCT02762409|quality of life|quality of life
1064663|NCT02762409|post traumatic stress|post traumatic stress
1064664|NCT02762409|discomforts|discomforts
1064665|NCT02762396|Young ischemic stroke|young ischemic stroke
1064666|NCT02762396|Risk factors|risk factors
1064667|NCT02762396|Causes|causes
1064668|NCT02762396|Consequences|consequences
1064669|NCT02762370|osteoarthritis|osteoarthritis
1064670|NCT02762370|knee|knee
1064671|NCT02762370|pain|pain
1064672|NCT02762370|diabetes|diabetes
1064673|NCT02762370|intra-articular|intra-articular
1064674|NCT02762370|injection|injection
1064675|NCT02762370|corticosteroid|corticosteroid
1064676|NCT02762357|Novosyn Quick|novosyn quick
1064677|NCT02762357|Episiotomy|episiotomy
1064678|NCT02762331|Vitamin C|vitamin c
1064679|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1064680|NCT02762331|Atrial Fibrillation|atrial fibrillation
1064681|NCT02762331|Cardiac Valve Repair|cardiac valve repair
1064682|NCT02762305|fall risk|fall risk
1064683|NCT02762305|RSVP bone builders|rsvp bone builders
1064684|NCT02762305|Group Exercise|group exercise
1064685|NCT02762305|Older adults|older adults
1064686|NCT02762305|Balance confidence|balance confidence
1064687|NCT02762305|life satisfaction|life satisfaction
1064688|NCT02762305|balance|balance
1064689|NCT02762292|Mechanical ventilation|mechanical ventilation
1064690|NCT02762292|Children|children
1064691|NCT02762292|Work of breathing|work of breathing
1064692|NCT02762279|Mechanical ventilation|mechanical ventilation
1064693|NCT02762279|Children|children
1064694|NCT02762279|Esophageal Pressure|esophageal pressure
1064695|NCT02762279|Pleural Pressure|pleural pressure
1064696|NCT02762240|Accreditation|accreditation
1064697|NCT02762240|Certification|certification
1064698|NCT02762240|General Practice|general practice
1064699|NCT02762240|Family Medicine|family medicine
1064700|NCT02762240|Randomized Controlled Trial|randomized controlled trial
1064701|NCT02762227|CEUS|ceus
1064702|NCT02762227|CT|ct
1064703|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
1064704|NCT02762227|adenoma|adenoma
1064705|NCT02762227|gallbladder cancer|gallbladder cancer
1064706|NCT02762214|Uterin manipulator|uterin manipulator
1064707|NCT02762214|Endometrial Cancer|endometrial cancer
1064708|NCT02762214|Laparoscopy|laparoscopy
1064709|NCT02762214|Robotic|robotic
1064710|NCT02762188|wet ARMD|wet armd
1064711|NCT02762188|VEGF|vegf
1064712|NCT02762188|intra vitreal injections|intra vitreal injections
1064713|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
1064714|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
1064715|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
1064716|NCT02762175|quality of life|quality of life
1064717|NCT02762162|antiplatelet|antiplatelet
1064718|NCT02762162|stent thrombosis|stent thrombosis
1064719|NCT02762149|Tsui Test|tsui test
1064721|NCT02762149|Epidural catheter|epidural catheter
1064723|NCT02762097|saline sonography|saline sonography
1064724|NCT02762097|infertility|infertility
1064725|NCT02762084|Gorlin Syndrome|gorlin syndrome
1064726|NCT02762084|Basal Cell|basal cell
1064727|NCT02762084|Nevus Syndrome|nevus syndrome
1064728|NCT02762084|BCNS|bcns
1064729|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1064730|NCT02762084|Basal cell carcinoma|basal cell carcinoma
1064731|NCT02762084|Hedgehog|hedgehog
1064732|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
1064733|NCT02762058|Acquired Brain Injury|acquired brain injury
1064734|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
1064735|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
1064736|NCT02762032|Skin Biopsy|skin biopsy
1064737|NCT02762032|PrimaVie|primavie
1064738|NCT02762032|Herbal Supplement|herbal supplement
1064739|NCT02762019|Stomatitis|stomatitis
1064740|NCT02762019|Laser|laser
1064741|NCT02762019|Children|children
1064742|NCT02762019|Chemotherapy|chemotherapy
1064743|NCT02762019|Treatment|treatment
1064744|NCT02762006|durvalumab|durvalumab
1064745|NCT02762006|tremelimumab|tremelimumab
1064746|NCT02762006|Phase Ib|phase ib
1064747|NCT02762006|Locally Advanced|locally advanced
1064748|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
1064749|NCT02761967|Physical activity|physical activity
1064750|NCT02761967|Pregnancy|pregnancy
1064751|NCT02761967|Childbirth|childbirth
1064752|NCT02761967|Postpartum period|postpartum period
1064753|NCT02761967|Exercise|exercise
1064754|NCT02761954|regional anesthesia|regional anesthesia
1064755|NCT02761954|caudal block|caudal block
1064756|NCT02761928|Facet Joint|facet joint
1064757|NCT02761928|Sacroiliac Joint|sacroiliac joint
1064758|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
1064759|NCT02761928|Injectables|injectables
1064760|NCT02761915|Neuroblastoma|neuroblastoma
1064761|NCT02761915|Immunotherapy|immunotherapy
1064762|NCT02761915|1RG-CART|1rg-cart
1064763|NCT02761915|Cyclophosphamide|cyclophosphamide
1064764|NCT02761915|Fludarabine|fludarabine
1064765|NCT02761915|CAR T-cells|car t-cells
1064766|NCT02761915|Anti-GD2|anti-gd2
1064767|NCT02761915|GD2|gd2
1064768|NCT02761915|CAR|car
1064769|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
1064770|NCT02761902|Children|children
1064771|NCT02761902|Polysomnography|polysomnography
1064772|NCT02761902|sleep|sleep
1064773|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
1064774|NCT02761902|Chinese|chinese
1064775|NCT02761863|Mesothelioma|mesothelioma
1064776|NCT02761863|CD 74|cd 74
1064777|NCT02761863|VEGF|vegf
1064778|NCT02761824|Quality of Life|quality of life
1064779|NCT02761824|Occupation|occupation
1064780|NCT02761772|Preimplantation Factor|preimplantation factor
1064781|NCT02761746|HIV|hiv
1064782|NCT02761746|Adherence|adherence
1064783|NCT02761746|Health Outcomes|health outcomes
1064784|NCT02761733|Shared Decision Making|shared decision making
1064785|NCT02761733|Case Management|case management
1064786|NCT02761733|Decision Aid|decision aid
1064787|NCT02761694|AKT1|akt1
1064788|NCT02761694|AKT2|akt2
1064789|NCT02761694|AKT3|akt3
1064790|NCT02761694|PI3K|pi3k
1064791|NCT02761694|PTEN-null|pten-null
1064792|NCT02761694|solid tumors|solid tumors
1064793|NCT02761694|cancer|cancer
1064794|NCT02761694|ARQ 751|arq 751
1064795|NCT02761694|ArQule|arqule
1064796|NCT02761694|PTEN|pten
1064797|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
1064798|NCT02761681|Mindfulness|mindfulness
1064799|NCT02761681|Guided self-help|guided self-help
1064800|NCT02761681|College students|college students
1064801|NCT02761681|Focused Interviews|focused interviews
1064802|NCT02761681|RCT Control Condition|rct control condition
1064803|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
1064804|NCT02761668|Pathological tooth migration|pathological tooth migration
1064805|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
1064806|NCT02761668|vertical infrabony defects|vertical infrabony defects
1064807|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
1064808|NCT02761668|orthodontic therapy|orthodontic therapy
1064809|NCT02761655|Dementia|dementia
1064810|NCT02761655|Medication Adherence|medication adherence
1064811|NCT02761655|Perspective Memory|perspective memory
1064812|NCT02761590|intermuscular fat|intermuscular fat
1064813|NCT02761590|circuit training|circuit training
1064814|NCT02761590|adipokines|adipokines
1064815|NCT02761590|inflammation|inflammation
1064816|NCT02761590|computed tomography scan|computed tomography scan
1064817|NCT02761577|Acetylcysteine|acetylcysteine
1064818|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
1064819|NCT02761577|Lipocalins|lipocalins
1064820|NCT02761577|Creatinine|creatinine
1064821|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
1064822|NCT02761564|Cardiac surgery|cardiac surgery
1064823|NCT02761564|Blood transfusion|blood transfusion
1064824|NCT02761564|ScvO2|scvo2
1064825|NCT02761538|obesity|obesity
1064826|NCT02761538|Overweight|overweight
1064924|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
1064925|NCT02761135|Side-fire|side-fire
1064926|NCT02761135|Prostate cancer|prostate cancer
1064927|NCT02761135|End-fire|end-fire
1064928|NCT02761083|Eye surgery|eye surgery
1064929|NCT02761083|Suture material|suture material
1064930|NCT02761083|Novosyn Quick|novosyn quick
1064931|NCT02761083|Vicryl Rapid|vicryl rapid
1064932|NCT02761070|glioblastoma|glioblastoma
1064933|NCT02761070|recurrent|recurrent
1064934|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
1064935|NCT02761070|bevacizumab|bevacizumab
1064936|NCT02761031|Heart rate variability|heart rate variability
1064937|NCT02761031|Electrocardiography|electrocardiography
1064938|NCT02761031|Observational study|observational study
1064939|NCT02761031|Non-interventional study|non-interventional study
1064940|NCT02761031|Risk assessment|risk assessment
1064941|NCT02761031|Perioperative|perioperative
1064942|NCT02761005|Eradication therapy|eradication therapy
1064943|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
1064944|NCT02761005|Personalized therapy|personalized therapy
1064945|NCT02760979|knee arthroplasty|knee arthroplasty
1064946|NCT02760953|Bladder Cancer|bladder cancer
1064947|NCT02760953|Cryoablation|cryoablation
1064948|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
1064949|NCT02760940|Anemia|anemia
1064950|NCT02760940|Crohn's disease|crohn's disease
1064951|NCT02760940|Ulcerative colitis|ulcerative colitis
1064952|NCT02760940|Oral iron|oral iron
1064953|NCT02760940|Quality of life|quality of life
1064954|NCT02760914|adipose tissue|adipose tissue
1064955|NCT02760914|inflammatory mediators|inflammatory mediators
1064956|NCT02760914|gene expression|gene expression
1064957|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
1064958|NCT02760875|Conservative treatment|conservative treatment
1064959|NCT02760875|early weight bearing|early weight bearing
1064960|NCT02760875|Achilles Tendon Length|achilles tendon length
1064961|NCT02760875|Ultrasound|ultrasound
1064962|NCT02760875|Foot Pressure Mapping|foot pressure mapping
1064963|NCT02760875|ATRA|atra
1064964|NCT02760875|Heel Raise Work|heel raise work
1064965|NCT02760849|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
1064966|NCT02760849|HBOC|hboc
1064967|NCT02760849|Deleterious mutation in ovarian cancer genes|deleterious mutation in ovarian cancer genes
1064968|NCT02760849|Changes in female sexual function|changes in female sexual function
1064969|NCT02760849|Salpingectomy with delayed oophorectomy|salpingectomy with delayed oophorectomy
1064970|NCT02760849|ISDO|isdo
1064971|NCT02760849|Risk-reducing salpingo-oophorectomy (RRSO)|risk-reducing salpingo-oophorectomy (rrso)
1064972|NCT02760849|RRSO|rrso
1064973|NCT02760849|Questionnaires|questionnaires
1064974|NCT02760849|Surveys|surveys
1064975|NCT02760836|Crohn's disease|crohn's disease
1064976|NCT02760836|disease outcomes|disease outcomes
1064977|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
1064978|NCT02760784|Conservative treatment|conservative treatment
1064979|NCT02760784|early weight bearing|early weight bearing
1064980|NCT02760784|Dynamic|dynamic
1064981|NCT02760784|ATRS|atrs
1064982|NCT02760784|ATRA|atra
1064983|NCT02760784|Heel Raise Work|heel raise work
1064984|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
1064985|NCT02760771|severe aortic stenosis|severe aortic stenosis
1064986|NCT02760771|pre-dilation|pre-dilation
1064987|NCT02760771|rapid pacing|rapid pacing
1064988|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
1064989|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
1064990|NCT02760758|NNI|nni
1064991|NCT02760758|HCV|hcv
1064992|NCT02760758|DAA|daa
1064993|NCT02760745|fever|fever
1064994|NCT02760745|shivering|shivering
1064995|NCT02760745|chills|chills
1064996|NCT02760745|rigors|rigors
1064997|NCT02760745|severe bacterial infection|severe bacterial infection
1104513|NCT02523326|PCR|pcr
1064998|NCT02760719|3% hypertonic solution|3% hypertonic solution
1064999|NCT02760719|duration of hospitalisation|duration of hospitalisation
1065000|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
1065001|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
1065002|NCT02760680|Chronic Heart Failure|chronic heart failure
1065003|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
1065004|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
1065005|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
1065006|NCT02760667|Laryngeal cancer|laryngeal cancer
1065007|NCT02760641|obesity|obesity
1065008|NCT02760641|low carbohydrate diet|low carbohydrate diet
1065009|NCT02760641|metabolism|metabolism
1065010|NCT02760641|body composition|body composition
1065011|NCT02760641|visceral fat|visceral fat
1065012|NCT02760641|older adults|older adults
1065013|NCT02760641|insulin sensitivity|insulin sensitivity
1065014|NCT02760615|Drug therapy|drug therapy
1065015|NCT02760602|anti-amyloid|anti-amyloid
1065016|NCT02760602|monoclonal antibody|monoclonal antibody
1065017|NCT02760589|ACL tear|acl tear
1065018|NCT02760589|ACL lesion|acl lesion
1065019|NCT02760589|ACL reconstruction|acl reconstruction
1065020|NCT02760589|InternalBrace|internalbrace
1065021|NCT02760589|functional performance test|functional performance test
1065022|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
1065023|NCT02760537|Liver Neoplasms|liver neoplasms
1065024|NCT02760537|Hepatitis B|hepatitis b
1065025|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
1065026|NCT02760537|Asian Americans|asian americans
1065027|NCT02760537|Lay health workers|lay health workers
1065028|NCT02760537|Community health workers|community health workers
1065029|NCT02760511|Randomized Controlled Trial|randomized controlled trial
1065030|NCT02760511|Anthocyanin|anthocyanin
1065031|NCT02760511|Antioxidants|antioxidants
1065032|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1065033|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
1065034|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
1065035|NCT02760485|activated B cell|activated b cell
1065036|NCT02760485|germinal center B-cell|germinal center b-cell
1065037|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
1065038|NCT02760485|JAK1 inhibitor|jak1 inhibitor
1065039|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
1065040|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
1065041|NCT02760472|Preterm|preterm
1065042|NCT02760472|Fatty acids|fatty acids
1065043|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1065044|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
1065045|NCT02760433|Olokizumab|olokizumab
1065046|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1065047|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
1065048|NCT02760407|subcutaneous|subcutaneous
1065049|NCT02760407|Olokizumab|olokizumab
1065050|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
1065051|NCT02760394|coronary bypass|coronary bypass
1065052|NCT02760394|refractory stable angina|refractory stable angina
1065053|NCT02760394|HBOT|hbot
1065054|NCT02760394|reperfusion|reperfusion
1065055|NCT02760394|neoangiogenesis|neoangiogenesis
1065056|NCT02760394|microvascular|microvascular
1065057|NCT02760394|myocardial perfusion|myocardial perfusion
1065058|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1065059|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
1065060|NCT02760368|subcutaneous|subcutaneous
1065061|NCT02760368|Olokizumab|olokizumab
1065062|NCT02760342|Pharmacokinetics|pharmacokinetics
1065063|NCT02760342|Metformin|metformin
1065064|NCT02760342|Drug-drug interaction|drug-drug interaction
1065065|NCT02760342|ASP015K|asp015k
1065066|NCT02760329|asthma|asthma
1065067|NCT02760329|COPD|copd
1065068|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1065069|NCT02760329|lung disease|lung disease
1065070|NCT02760329|chronic airways disease|chronic airways disease
1065071|NCT02760329|obstructive lung disease|obstructive lung disease
1065072|NCT02760316|Healthy Volunteers|healthy volunteers
1065073|NCT02760316|Obese|obese
1065074|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
1065075|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
1065076|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
1065077|NCT02760303|adolescents and young adults|adolescents and young adults
1065078|NCT02760303|stress reduction|stress reduction
1065079|NCT02760303|metabolic control|metabolic control
1065080|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
1065081|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
1065082|NCT02760290|Peak expiratory flow|peak expiratory flow
1065083|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
1065084|NCT02760277|vamorolone|vamorolone
1065085|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1065086|NCT02760264|vamorolone|vamorolone
1065087|NCT02760251|immunomodulation|immunomodulation
1065088|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
1065089|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
1065090|NCT02760238|registry|registry
1065091|NCT02760238|leukemia|leukemia
1065092|NCT02760238|Bone Marrow Diseases|bone marrow diseases
1065093|NCT02760238|Hematologic Diseases|hematologic diseases
1065094|NCT02760238|Neoplasms|neoplasms
1065095|NCT02760225|Pembrolizumab|pembrolizumab
1065096|NCT02760225|PET imaging|pet imaging
1065097|NCT02760225|Melanoma|melanoma
1065098|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
1065099|NCT02760212|Shockwave therapy|shockwave therapy
1065100|NCT02760212|fMRI|fmri
1065101|NCT02760212|blood biomarkers|blood biomarkers
1065102|NCT02760173|verticality perception|verticality perception
1065103|NCT02760147|Pressure Support Ventilation|pressure support ventilation
1065104|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
1065105|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
1065106|NCT02760121|Acetazolamide|acetazolamide
1065107|NCT02760121|Methazolamide|methazolamide
1065108|NCT02760121|Control of breathing|control of breathing
1065109|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
1065110|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
1065111|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
1065112|NCT02760108|Parkinson's disease|parkinson's disease
1065114|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
1065115|NCT02760095|environmental enteropathy|environmental enteropathy
1065116|NCT02760095|zinc|zinc
1065117|NCT02760095|vitamin A|vitamin a
1065118|NCT02760095|Bangladesh|bangladesh
1065119|NCT02760082|Multiple Sclerosis|multiple sclerosis
1065120|NCT02760082|Qualitative study|qualitative study
1065121|NCT02760082|Motivation|motivation
1065122|NCT02760056|Thyroid hormone|thyroid hormone
1065123|NCT02760056|Remyelination|remyelination
1065124|NCT02760004|Depression|depression
1065125|NCT02759991|Hepatitis E virus|hepatitis e virus
1065126|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
1065127|NCT02759978|Imaging|imaging
1065128|NCT02759978|Computed Tomography|computed tomography
1065129|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
1065130|NCT02759978|Positron Emission Tomography|positron emission tomography
1065131|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
1065132|NCT02759978|Microbiological diagnostics|microbiological diagnostics
1065133|NCT02759978|Sonication|sonication
1065134|NCT02759978|Drug Monitoring|drug monitoring
1065135|NCT02759978|Cardiac Surgery|cardiac surgery
1065136|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
1065137|NCT02759952|PDE6A|pde6a
1065138|NCT02759952|gene therapy trial|gene therapy trial
1065139|NCT02759939|Shared Decision-Making|shared decision-making
1065140|NCT02759939|Patient-Provider Communication|patient-provider communication
1065141|NCT02759926|Healthy volunteers|healthy volunteers
1065142|NCT02759926|Obesity|obesity
1065143|NCT02759926|Bitter|bitter
1065144|NCT02759913|neuromuscular diseases|neuromuscular diseases
1065145|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
1065146|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
1065147|NCT02759835|T790M Mutation|t790m mutation
1065148|NCT02759835|Local Ablative Therapies|local ablative therapies
1065149|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
1065150|NCT02759835|Acquired Resistance|acquired resistance
1065151|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
1065152|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
1065153|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
1065154|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1065155|NCT02759783|Radiotherapy|radiotherapy
1065156|NCT02759783|oligometastases|oligometastases
1065157|NCT02759783|SBRT|sbrt
1065158|NCT02759757|Kinesio Taping|kinesio taping
1065159|NCT02759757|Low back Pain|low back pain
1065160|NCT02759757|Electromyographic|electromyographic
1065161|NCT02759757|EMG|emg
1065162|NCT02759744|Thermal Ablation|thermal ablation
1065163|NCT02759744|Localized Prostate Cancer|localized prostate cancer
1065164|NCT02759744|Medtronic-Visualase|medtronic-visualase
1065165|NCT02759744|Thermal Damage|thermal damage
1065166|NCT02759744|PSA Levels|psa levels
1065167|NCT02759731|Murine Models|murine models
1065168|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
1065169|NCT02759731|Corticosteroids|corticosteroids
1065170|NCT02759731|Systemic Therapy|systemic therapy
1065171|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
1065172|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
1065173|NCT02759718|chromogranin A|chromogranin a
1065174|NCT02759705|fertility|fertility
1065175|NCT02759705|sexuality|sexuality
1065176|NCT02759705|male|male
1065177|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
1065178|NCT02759705|bladder exstrophy|bladder exstrophy
1065179|NCT02759705|epispadias|epispadias
1065180|NCT02759666|PARP|parp
1065181|NCT02759666|advanced solid tumor|advanced solid tumor
1065182|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
1065183|NCT02759640|Advanced solid tumors|advanced solid tumors
1065184|NCT02759627|Rehabilitation|rehabilitation
1065185|NCT02759627|Gait|gait
1065186|NCT02759627|Ambulation|ambulation
1065187|NCT02759627|Exercise Therapy|exercise therapy
1065188|NCT02759627|Physical Exertion|physical exertion
1065189|NCT02759627|Motor Skills|motor skills
1065190|NCT02759601|HDAC Inhibitor|hdac inhibitor
1065191|NCT02759601|Tefinostat|tefinostat
1065192|NCT02759601|Inflammation|inflammation
1065193|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
1065194|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
1065195|NCT02759588|GL-ONC1|gl-onc1
1065196|NCT02759588|oncolytic virus|oncolytic virus
1065197|NCT02759588|virotherapy|virotherapy
1065198|NCT02759588|Viral therapy|viral therapy
1065199|NCT02759588|immunotherapy|immunotherapy
1065200|NCT02759588|immune therapy|immune therapy
1065201|NCT02759588|vaccinia|vaccinia
1065202|NCT02759588|vaccinia virus|vaccinia virus
1065203|NCT02759588|Genelux|genelux
1065204|NCT02759588|ovarian cancer|ovarian cancer
1065205|NCT02759588|platinum resistant|platinum resistant
1065206|NCT02759588|platinum refractory|platinum refractory
1065207|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
1065208|NCT02759588|fallopian cancer|fallopian cancer
1065209|NCT02759588|cancer|cancer
1065210|NCT02759588|abdominal cancer|abdominal cancer
1065215|NCT02759588|neoplasms by histological type|neoplasms by histological type
1065216|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1065217|NCT02759588|Poxviridae infections|poxviridae infections
1065218|NCT02759588|Virus diseases|virus diseases
1065219|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
1065220|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
1065221|NCT02759549|Radiation Therapy|radiation therapy
1065222|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
1065223|NCT02759523|Portion Size|portion size
1065224|NCT02759523|Energy Intake|energy intake
1065225|NCT02759510|cardiac output|cardiac output
1065226|NCT02759510|norepinephrin|norepinephrin
1065227|NCT02759510|cesarean section|cesarean section
1065228|NCT02759484|CHWs|chws
1065229|NCT02759484|Health Education|health education
1065230|NCT02759484|Disease Self Management|disease self management
1065231|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
1065232|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
1065233|NCT02759432|high-intensity interval training|high-intensity interval training
1065234|NCT02759432|adolescents|adolescents
1065235|NCT02759432|physical fitness|physical fitness
1065236|NCT02759432|quality of life|quality of life
1065237|NCT02759432|school-based intervention|school-based intervention
1065238|NCT02759367|Nutrition|nutrition
1065239|NCT02759367|Potassium|potassium
1065240|NCT02759354|Immune response|immune response
1065241|NCT02759328|Stroke|stroke
1065242|NCT02759328|Rehabilitation|rehabilitation
1065243|NCT02759328|Serious games|serious games
1065244|NCT02759328|Virtual reality|virtual reality
1065245|NCT02759328|Xbox Kinect™|xbox kinect™
1065247|NCT02759302|LGMD|lgmd
1065248|NCT02759302|POMT2|pomt2
1065249|NCT02759289|Arsenic|arsenic
1065250|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
1065251|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
1065252|NCT02759276|Endothelial Function|endothelial function
1065253|NCT02759276|Microcirculation|microcirculation
1065254|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
1065255|NCT02759185|PTSD|ptsd
1065256|NCT02759185|marijuana|marijuana
1065257|NCT02759185|cannabis|cannabis
1065258|NCT02759185|sleep|sleep
1065259|NCT02759185|THC|thc
1065260|NCT02759185|CBD|cbd
1065261|NCT02759172|Suicide prevention|suicide prevention
1065262|NCT02759172|Jail|jail
1065263|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1065264|NCT02759120|IPF|ipf
1065265|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
1065266|NCT02759120|antimicrobial therapy|antimicrobial therapy
1065267|NCT02759120|doxycycline|doxycycline
1065268|NCT02759120|co-trimoxazole|co-trimoxazole
1065269|NCT02759094|GERD|gerd
1065270|NCT02759094|Implantable medical device|implantable medical device
1065271|NCT02759094|RefluxStop|refluxstop
1065272|NCT02759094|Reflux|reflux
1065273|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
1065274|NCT02759094|Laparoscopy|laparoscopy
1065275|NCT02759094|pH-Monitoring|ph-monitoring
1065276|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
1065277|NCT02759068|vegetative state|vegetative state
1065278|NCT02759068|minimally conscious state|minimally conscious state
1065279|NCT02759068|music|music
1065280|NCT02759068|preference|preference
1065281|NCT02758990|Food|food
1065282|NCT02758990|Nutrigenomics|nutrigenomics
1065283|NCT02758990|Precision Medicine|precision medicine
1065284|NCT02758990|Pharmacogenetics|pharmacogenetics
1065285|NCT02758990|Lifestyle|lifestyle
1065286|NCT02758977|Colorectal liver metastases|colorectal liver metastases
1065287|NCT02758977|Liver Surgery|liver surgery
1065289|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
1065290|NCT02758977|Surgical Oncology|surgical oncology
1065291|NCT02758977|Hepatectomy|hepatectomy
1065292|NCT02758964|TAVR|tavr
1065293|NCT02758964|TAVI|tavi
1065294|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1065295|NCT02758964|Intracranial Embolism|intracranial embolism
1065296|NCT02758951|Induction Chemotherapy|induction chemotherapy
1065297|NCT02758951|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1065298|NCT02758951|Molecular Targeted Therapy|molecular targeted therapy
1065299|NCT02758951|Colorectal Surgery|colorectal surgery
1065300|NCT02758951|Cytoreductive Surgery|cytoreductive surgery
1065301|NCT02758951|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
1065302|NCT02758951|Peritoneum|peritoneum
1065303|NCT02758951|Peritoneal Lavage|peritoneal lavage
1065304|NCT02758951|Peritoneal Cavity|peritoneal cavity
1065305|NCT02758951|Ascitic Fluid|ascitic fluid
1065500|NCT02757846|Radiomics|radiomics
1065306|NCT02758951|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
1065307|NCT02758951|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
1065308|NCT02758951|Drug Therapy, Combination|drug therapy, combination
1065309|NCT02758951|Drug Therapy|drug therapy
1065310|NCT02758951|Morbidity|morbidity
1065311|NCT02758951|Mortality|mortality
1065312|NCT02758951|Hospital Mortality|hospital mortality
1065313|NCT02758951|Chemically-Induced Disorders|chemically-induced disorders
1065314|NCT02758951|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
1065315|NCT02758951|Laparotomy|laparotomy
1065316|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
1065317|NCT02758899|Anterior cervical fusion|anterior cervical fusion
1065318|NCT02758860|Colonoscopy|colonoscopy
1065319|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
1065320|NCT02758860|Classification|classification
1065321|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
1065322|NCT02758834|Preterm Infants|preterm infants
1065323|NCT02758834|Phytosterols|phytosterols
1065324|NCT02758834|Parenteral Nutrition|parenteral nutrition
1065325|NCT02758821|C-reactive protein|c-reactive protein
1065326|NCT02758821|antibiotic|antibiotic
1065327|NCT02758795|protein|protein
1065328|NCT02758795|inflammation|inflammation
1065329|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
1065330|NCT02758743|smoking|smoking
1065331|NCT02758743|tobacco|tobacco
1065332|NCT02758743|smoking cessation|smoking cessation
1065333|NCT02758730|GBA mutation|gba mutation
1065334|NCT02758704|Intubation|intubation
1065335|NCT02758704|Neonatal|neonatal
1065336|NCT02758704|Teaching|teaching
1065337|NCT02758704|Stress|stress
1065338|NCT02758704|Simulation|simulation
1065339|NCT02758691|memory|memory
1065340|NCT02758691|insulin|insulin
1065341|NCT02758678|P-selectin|p-selectin
1065342|NCT02758678|Lung Cancer|lung cancer
1065343|NCT02758678|Raman Spectroscopy|raman spectroscopy
1065344|NCT02758665|CLL|cll
1065345|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1065346|NCT02758665|ibrutinib|ibrutinib
1065347|NCT02758665|venetoclax|venetoclax
1065348|NCT02758665|obinutuzumab|obinutuzumab
1065349|NCT02758665|TP53 Deletion|tp53 deletion
1065350|NCT02758652|chemoresistance|chemoresistance
1065351|NCT02758652|miRNA|mirna
1065352|NCT02758652|microRNA|microrna
1065353|NCT02758639|parental cancer|parental cancer
1065354|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
1065355|NCT02758639|psychosocial intervention|psychosocial intervention
1065356|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
1065357|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
1065358|NCT02758574|thrombolysis|thrombolysis
1065359|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
1065360|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
1065361|NCT02758561|decisional aid|decisional aid
1065362|NCT02758561|workshops|workshops
1065363|NCT02758561|urinary incontinence|urinary incontinence
1065364|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
1065365|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
1065366|NCT02758561|decisional conflict|decisional conflict
1065367|NCT02758548|Total IgE measurement|total ige measurement
1065368|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
1065369|NCT02758548|atopic conditions|atopic conditions
1065370|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
1065371|NCT02758522|Diabetes Mellitus|diabetes mellitus
1065372|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
1065373|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
1065374|NCT02758470|Muscle Fatigue|muscle fatigue
1065375|NCT02758470|Acetazolamide|acetazolamide
1065376|NCT02758470|Methazolamide|methazolamide
1065377|NCT02758457|cad/cam|cad/cam
1065378|NCT02758457|dental porcelain|dental porcelain
1065379|NCT02758457|zirconia|zirconia
1065380|NCT02758457|press on metal|press on metal
1065381|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
1065382|NCT02758444|environmental enteropathy|environmental enteropathy
1065383|NCT02758444|zinc absorption|zinc absorption
1065384|NCT02758444|Bangladesh|bangladesh
1065385|NCT02758444|toddlers|toddlers
1065386|NCT02758444|zinc isotope|zinc isotope
1065387|NCT02758431|testosterone|testosterone
1065388|NCT02758418|Adjustment disorders online|adjustment disorders online
1065389|NCT02758418|Psychological Treatments|psychological treatments
1065390|NCT02758418|Information and Communication Technologies|information and communication technologies
1065391|NCT02758418|Internet|internet
1065392|NCT02758405|Epidural|epidural
1065393|NCT02758405|Labor analgesia|labor analgesia
1065394|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
1065395|NCT02758392|Healthy|healthy
1065396|NCT02758392|JNJ-61178104|jnj-61178104
1065397|NCT02758392|Placebo|placebo
1065398|NCT02758392|Safety|safety
1065399|NCT02758379|coronary artery disease|coronary artery disease
1065400|NCT02758379|calcified lesions|calcified lesions
1065401|NCT02758379|lithotripsy|lithotripsy
1065402|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
1065403|NCT02758366|high grade glioma|high grade glioma
1065404|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1065405|NCT02758366|DIPG|dipg
1065406|NCT02758366|doxorubicin|doxorubicin
1065407|NCT02758366|temozolomide|temozolomide
1065408|NCT02758366|malignant glioma|malignant glioma
1065409|NCT02758366|Brainstem Glioma|brainstem glioma
1065410|NCT02758366|diffuse spinal glioma|diffuse spinal glioma
1065411|NCT02758366|bilateral thalamic glioma|bilateral thalamic glioma
1065412|NCT02758366|Anaplastic Astrocytoma|anaplastic astrocytoma
1065413|NCT02758366|Gliomatosis Cerebri|gliomatosis cerebri
1065414|NCT02758366|Midline Diffuse Glioma|midline diffuse glioma
1065415|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
1065416|NCT02758353|Nigeria|nigeria
1065417|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
1065418|NCT02758353|Scale up|scale up
1065419|NCT02758353|Primary Health Care|primary health care
1065420|NCT02758340|induction of labor|induction of labor
1065421|NCT02758340|misoprostol|misoprostol
1065422|NCT02758340|foley's balloon catheter|foley's balloon catheter
1065423|NCT02758327|Tear Osmolarity|tear osmolarity
1065424|NCT02758327|Keratitis Sicca|keratitis sicca
1065425|NCT02758327|Ocular Surface Disease|ocular surface disease
1065426|NCT02758327|TheraTears|theratears
1065427|NCT02758314|PD-1|pd-1
1065428|NCT02758314|PD-L1|pd-l1
1065429|NCT02758314|NSCLC|nsclc
1065430|NCT02758288|Kidney transplant|kidney transplant
1065431|NCT02758288|BK Viremia|bk viremia
1065432|NCT02758288|BK Nephropathy|bk nephropathy
1065433|NCT02758275|Medication adherence|medication adherence
1065434|NCT02758275|Patient compliance|patient compliance
1065435|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
1065436|NCT02758275|Hypertension|hypertension
1065437|NCT02758275|Nursing|nursing
1065438|NCT02758275|Nursing process|nursing process
1065439|NCT02758275|Teaching|teaching
1065440|NCT02758275|Randomized controlled trial|randomized controlled trial
1065441|NCT02758210|Bradycardia|bradycardia
1065442|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
1065443|NCT02758210|Smart Phone|smart phone
1065444|NCT02758210|Tablet|tablet
1065445|NCT02758197|Mindfulness|mindfulness
1065446|NCT02758197|Chronic Pain|chronic pain
1065447|NCT02758197|Quality of Life|quality of life
1065448|NCT02758197|Immune Function|immune function
1065449|NCT02758197|Cancer survivors|cancer survivors
1065450|NCT02758197|Disability|disability
1065451|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
1065452|NCT02758106|chest wall oscillation|chest wall oscillation
1065453|NCT02758106|acute respiratory failure|acute respiratory failure
1065454|NCT02758106|airway secretion|airway secretion
1065455|NCT02758080|Personalized medicine|personalized medicine
1065456|NCT02758080|Next generation sequencing|next generation sequencing
1065457|NCT02758041|Acne|acne
1065458|NCT02758028|Youth|youth
1065459|NCT02758028|Adventure-based training|adventure-based training
1065460|NCT02758028|WhatsApp messages|whatsapp messages
1065461|NCT02758015|betaine|betaine
1065462|NCT02758015|betaine hydrochloride|betaine hydrochloride
1065463|NCT02758015|healthy volunteer|healthy volunteer
1065464|NCT02758015|gastric pH|gastric ph
1065465|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
1065466|NCT02758002|ablation|ablation
1065467|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
1065468|NCT02757989|Low risk MDS|low risk mds
1065469|NCT02757989|Transplantation|transplantation
1065470|NCT02757963|Screening tool|screening tool
1065471|NCT02757963|International Prostate Symptom Score|international prostate symptom score
1065472|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
1065473|NCT02757963|BPO|bpo
1065474|NCT02757963|BPE|bpe
1065475|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
1065476|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
1065477|NCT02757963|LUTS|luts
1065478|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
1065479|NCT02757963|IPSS|ipss
1065480|NCT02757963|BPH|bph
1065481|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
1065482|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
1065483|NCT02757950|neonate related Adverse Events|neonate related adverse events
1065484|NCT02757950|Congenital anomaly|congenital anomaly
1065485|NCT02757950|RefortrixTM|refortrixtm
1065486|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
1065487|NCT02757937|Medication Adherence|medication adherence
1065488|NCT02757937|Self-efficacy|self-efficacy
1065489|NCT02757937|Behavior|behavior
1065490|NCT02757937|Diabetes|diabetes
1065491|NCT02757937|Diabetes Mellitus|diabetes mellitus
1065492|NCT02757911|XCGD|xcgd
1065493|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
1065494|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
1065495|NCT02757885|bone marrow transplant|bone marrow transplant
1065496|NCT02757872|Hypertension|hypertension
1065497|NCT02757872|Kidney Diseases|kidney diseases
1065498|NCT02757872|Vitamin D|vitamin d
1065499|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
1065501|NCT02757846|prognosis|prognosis
1065502|NCT02757846|medical images|medical images
1065503|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
1065504|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
1065505|NCT02757807|Erectile Dysfunction|erectile dysfunction
1065506|NCT02757781|Patient empowerment|patient empowerment
1065507|NCT02757781|Patient involvement|patient involvement
1065508|NCT02757781|Patient participation|patient participation
1065509|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
1065510|NCT02757781|Chronic diseases|chronic diseases
1065511|NCT02757768|Myrbetriq|myrbetriq
1065512|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1065513|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1065514|NCT02757768|Overactive Bladder|overactive bladder
1065515|NCT02757768|Betmiga|betmiga
1065516|NCT02757768|Mirabegron|mirabegron
1065517|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
1065518|NCT02757742|sudden cardiac death|sudden cardiac death
1065519|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
1065520|NCT02757742|cardiopathy|cardiopathy
1065521|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
1065522|NCT02757716|addiction remission|addiction remission
1065523|NCT02757716|addiction transfer|addiction transfer
1065524|NCT02757703|somatostatin|somatostatin
1065525|NCT02757703|variceal bleeding|variceal bleeding
1065526|NCT02757703|terlipressin|terlipressin
1065527|NCT02757664|achilles|achilles
1065528|NCT02757664|tendinopathy|tendinopathy
1065529|NCT02757664|Physical Therapy Modalities|physical therapy modalities
1065530|NCT02757664|High-Energy Shock Waves|high-energy shock waves
1065531|NCT02757612|laser diode, pain|laser diode, pain
1065532|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1065533|NCT02757586|XPO1|xpo1
1065534|NCT02757586|in vitro|in vitro
1065535|NCT02757586|in vivo|in vivo
1065536|NCT02757560|saturated fat|saturated fat
1065537|NCT02757560|acute insulin resistance|acute insulin resistance
1065538|NCT02757560|insulin suppression test|insulin suppression test
1065539|NCT02757560|dietary fatty acids|dietary fatty acids
1065540|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
1065541|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
1065542|NCT02757521|Nitrous Oxide|nitrous oxide
1065543|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
1065544|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
1065545|NCT02757482|Patient training|patient training
1065546|NCT02757482|Warfarin|warfarin
1065547|NCT02757482|International Normalized Ratio|international normalized ratio
1065548|NCT02757482|Nursing|nursing
1065549|NCT02757456|exercise|exercise
1065550|NCT02757456|hemodialysis|hemodialysis
1065551|NCT02757456|pulse wave velocity|pulse wave velocity
1065552|NCT02757456|micro RNAs|micro rnas
1065553|NCT02757443|Phosphocreatine|phosphocreatine
1065554|NCT02757443|Creatine Phosphate|creatine phosphate
1065555|NCT02757443|Neoton|neoton
1065556|NCT02757443|Phosphate, Creatine|phosphate, creatine
1065557|NCT02757443|Phosphorylcreatine|phosphorylcreatine
1065558|NCT02757404|botulinum toxin|botulinum toxin
1065559|NCT02757404|spasticity|spasticity
1065560|NCT02757404|injection technique|injection technique
1065561|NCT02757404|neuronox|neuronox
1065562|NCT02757404|meditoxin|meditoxin
1065563|NCT02757391|Advanced gastrointestinal malignancies|advanced gastrointestinal malignancies
1065564|NCT02757391|Metastatic gastrointestinal tumor|metastatic gastrointestinal tumor
1065565|NCT02757391|Adoptive T cell infusion|adoptive t cell infusion
1065566|NCT02757391|Cyclophosphamide|cyclophosphamide
1065568|NCT02757391|Neosar|neosar
1065569|NCT02757391|IL-2|il-2
1065570|NCT02757391|Aldesleukin|aldesleukin
1065571|NCT02757391|Interleukin-2|interleukin-2
1065572|NCT02757391|Proleukin|proleukin
1065573|NCT02757391|Pembrolizumab|pembrolizumab
1065574|NCT02757391|Keytruda|keytruda
1065575|NCT02757391|MK-3475|mk-3475
1065576|NCT02757391|SCH-900475|sch-900475
1065577|NCT02757391|Phone calls|phone calls
1065578|NCT02757378|Pain|pain
1065579|NCT02757378|Brain|brain
1065580|NCT02757378|Plasticity|plasticity
1065581|NCT02757378|Education|education
1065582|NCT02757378|Manual Therapy|manual therapy
1065583|NCT02757378|Straight Leg Raise|straight leg raise
1065584|NCT02757378|Remapping|remapping
1065585|NCT02757365|aspirin|aspirin
1065586|NCT02757352|ankylosing|ankylosing
1065587|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
1065588|NCT02757339|neurobiology|neurobiology
1065589|NCT02757339|PTSD|ptsd
1065591|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
1065592|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
1065593|NCT02757326|SK2 inhibitor|sk2 inhibitor
1065594|NCT02757326|SK2|sk2
1065595|NCT02757313|marijuana|marijuana
1065596|NCT02757313|driving|driving
1065597|NCT02757313|THC|thc
1065598|NCT02757313|cannabis|cannabis
1065599|NCT02757313|intoxication|intoxication
1065600|NCT02757313|MRI|mri
1065601|NCT02757287|Ovarian stimulation|ovarian stimulation
1065602|NCT02757287|LH inhibition|lh inhibition
1065603|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
1065604|NCT02757274|Male|male
1065605|NCT02757261|Bruxism|bruxism
1065606|NCT02757261|Child|child
1065607|NCT02757261|Occlusal splint|occlusal splint
1065608|NCT02757261|Bite force|bite force
1065609|NCT02757261|Acunpuncture|acunpuncture
1065610|NCT02757261|Laser|laser
1065611|NCT02757261|Muscle actvity|muscle actvity
1065612|NCT02757261|Salivary Cortisol|salivary cortisol
1065613|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
1065616|NCT02757235|burr hole evacuation|burr hole evacuation
1065617|NCT02757235|temperature|temperature
1065618|NCT02757209|ASTHMA|asthma
1065619|NCT02757209|COPD|copd
1065620|NCT02757209|budesonide|budesonide
1065621|NCT02757209|formoterol|formoterol
1065622|NCT02757209|Salmeterol|salmeterol
1065623|NCT02757209|Fluticasone|fluticasone
1065624|NCT02757209|Spiromax|spiromax
1065626|NCT02757209|Diskus|diskus
1065627|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
1065628|NCT02757196|Rituximab|rituximab
1065629|NCT02757196|methylprednisolone|methylprednisolone
1065630|NCT02757157|Hydrotherapy|hydrotherapy
1065631|NCT02757157|Walking|walking
1065632|NCT02757131|Mobility|mobility
1065633|NCT02757131|Elderly|elderly
1065634|NCT02757131|Hospitalized patient|hospitalized patient
1065635|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
1065636|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
1065637|NCT02757092|lung cancer|lung cancer
1065638|NCT02757092|Thoracoscopy|thoracoscopy
1065639|NCT02757079|Melatonin|melatonin
1065640|NCT02757079|NPC-15|npc-15
1065641|NCT02757079|Sleep disorders|sleep disorders
1065642|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
1065643|NCT02757079|Sleep latency|sleep latency
1065644|NCT02757079|DSM-5|dsm-5
1065645|NCT02757066|Melatonin|melatonin
1065646|NCT02757066|NPC-15|npc-15
1065647|NCT02757066|Sleep disorders|sleep disorders
1065648|NCT02757066|Autism spectrum disorders|autism spectrum disorders
1065649|NCT02757066|DSM-5|dsm-5
1065650|NCT02757053|Brain Concussion|brain concussion
1065651|NCT02757053|Brain Injuries|brain injuries
1065652|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
1065653|NCT02757053|Football|football
1065654|NCT02757053|Head Protective Devices|head protective devices
1065655|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
1065656|NCT02757053|Helmet|helmet
1065657|NCT02757053|Third party add-on|third party add-on
1065658|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1065659|NCT02757040|ibrutinib|ibrutinib
1065660|NCT02757040|arsenic trioxide|arsenic trioxide
1065661|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1065662|NCT02757027|CABG surgery|cabg surgery
1065663|NCT02757027|blood viscosity|blood viscosity
1065664|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
1065665|NCT02757001|Pulmonary Embolism|pulmonary embolism
1065666|NCT02756923|Male Infertility|male infertility
1065667|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
1065668|NCT02756910|open abdominal surgery|open abdominal surgery
1065669|NCT02756910|anesthesia, general|anesthesia, general
1065670|NCT02756897|Leukemia|leukemia
1065671|NCT02756897|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1065672|NCT02756897|CLL|cll
1065673|NCT02756897|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1065674|NCT02756897|SLL|sll
1065675|NCT02756897|Refractory and/or relapsed|refractory and/or relapsed
1065676|NCT02756897|Ibrutinib|ibrutinib
1065677|NCT02756897|PCI-32765|pci-32765
1065678|NCT02756897|Imbruvica|imbruvica
1065679|NCT02756897|Venetoclax|venetoclax
1065680|NCT02756897|ABT-199|abt-199
1065681|NCT02756897|GDC-0199|gdc-0199
1065682|NCT02756845|Non CNS Tumor|non cns tumor
1065683|NCT02756832|Drug Therapy|drug therapy
1065684|NCT02756819|Drug Therapy|drug therapy
1065685|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
1065686|NCT02756780|Remission|remission
1065687|NCT02756780|Carer|carer
1065688|NCT02756780|Psychological|psychological
1065689|NCT02756780|Bereaved|bereaved
1065690|NCT02756780|Cancer|cancer
1065691|NCT02756780|Breast|breast
1065692|NCT02756780|Prostate|prostate
1065693|NCT02756780|Colorectal|colorectal
1065694|NCT02756780|Music|music
1065695|NCT02756741|Cirrhosis|cirrhosis
1065696|NCT02756741|hepatitis B virus|hepatitis b virus
1065697|NCT02756741|Alcohol|alcohol
1065698|NCT02756741|varices|varices
1065699|NCT02756702|TKA|tka
1065700|NCT02756702|TKR|tkr
1065701|NCT02756702|All-Poly|all-poly
1065702|NCT02756702|posterior stabilized|posterior stabilized
1065703|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
1065704|NCT02756689|Transcervical catheter|transcervical catheter
1065705|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
1065706|NCT02756689|Cervical ripening|cervical ripening
1065707|NCT02756689|Induction of labor|induction of labor
1065708|NCT02756676|Parkinson Disease|parkinson disease
1065709|NCT02756676|Quality of Life|quality of life
1065710|NCT02756676|Rehabilitation|rehabilitation
1065711|NCT02756663|multiple myeloma|multiple myeloma
1065712|NCT02756663|MM|mm
1065713|NCT02756663|relapsed|relapsed
1065714|NCT02756663|relapsed and refractory|relapsed and refractory
1065715|NCT02756663|panobinostat|panobinostat
1065716|NCT02756663|LBH589|lbh589
1065717|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
1065718|NCT02756663|carfilzomib|carfilzomib
1065719|NCT02756663|proteasome inhibitor|proteasome inhibitor
1065720|NCT02756650|Behcet Disease|behcet disease
1065721|NCT02756650|Inflammation|inflammation
1065722|NCT02756650|Immune system|immune system
1065723|NCT02756650|Arthritis|arthritis
1065724|NCT02756611|Oncology|oncology
1065725|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1065726|NCT02756611|17p Deletion|17p deletion
1065727|NCT02756611|TP53 Mutation|tp53 mutation
1065728|NCT02756611|Relapsed|relapsed
1065729|NCT02756611|Refractory|refractory
1065730|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
1065731|NCT02756598|sufentanil|sufentanil
1065732|NCT02756598|propofol|propofol
1065733|NCT02756598|personality/stress test|personality/stress test
1065734|NCT02756598|fast-track|fast-track
1065735|NCT02756585|computed tomography|computed tomography
1065736|NCT02756585|perfusion imaging|perfusion imaging
1065737|NCT02756585|brain death|brain death
1065738|NCT02756585|traumatic brain injury|traumatic brain injury
1065739|NCT02756559|sepsis|sepsis
1065740|NCT02756559|microRNAs|micrornas
1065741|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
1065742|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
1065743|NCT02756520|diet, protein-restricted|diet, protein-restricted
1065744|NCT02756520|renal function|renal function
1065745|NCT02756507|anxiety symptoms|anxiety symptoms
1065746|NCT02756507|depression symptoms|depression symptoms
1065747|NCT02756507|internalizing symptoms|internalizing symptoms
1065748|NCT02756468|pancreatic cancer|pancreatic cancer
1065749|NCT02756468|procalcitonin|procalcitonin
1065750|NCT02756455|gastric cancer|gastric cancer
1065751|NCT02756455|procalcitonin|procalcitonin
1065752|NCT02756429|atrial fibrillation|atrial fibrillation
1065753|NCT02756429|stroke|stroke
1065754|NCT02756429|thromboembolism|thromboembolism
1065755|NCT02756429|inflammation|inflammation
1065756|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
1065757|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
1065758|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
1065759|NCT02756364|Drug Therapy|drug therapy
1065760|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
1065761|NCT02756299|Sleep Apnea|sleep apnea
1065762|NCT02756299|Positive Airway Pressure|positive airway pressure
1065763|NCT02756299|Patient Education|patient education
1065764|NCT02756286|Electroencephalography|electroencephalography
1065765|NCT02756286|Attention|attention
1065766|NCT02756273|ileostomy|ileostomy
1065767|NCT02756273|morbidity|morbidity
1065768|NCT02756273|colorectal surgery|colorectal surgery
1065769|NCT02756247|Buparlisib|buparlisib
1065770|NCT02756247|BKM120|bkm120
1065771|NCT02756247|Ibrutinib|ibrutinib
1065772|NCT02756247|16-009|16-009
1065773|NCT02756221|symptoms|symptoms
1065774|NCT02756208|vaccine|vaccine
1065775|NCT02756208|healthy volunteer|healthy volunteer
1065776|NCT02756195|Patient safety|patient safety
1065777|NCT02756195|adverse events|adverse events
1065778|NCT02756195|pediatric surgery|pediatric surgery
1065779|NCT02756195|quality improvement|quality improvement
1065780|NCT02756195|health systems|health systems
1065781|NCT02756195|observational study|observational study
1065782|NCT02756195|non-routine event|non-routine event
1065783|NCT02756195|National Surgical Improvement Program|national surgical improvement program
1065784|NCT02756169|Obesity|obesity
1065785|NCT02756169|Breastfeeding|breastfeeding
1065786|NCT02756169|Grow up|grow up
1065787|NCT02756169|Milk composition|milk composition
1065788|NCT02756169|Mexico|mexico
1065789|NCT02756156|interscalene|interscalene
1065790|NCT02756156|infraclavicular|infraclavicular
1065791|NCT02756156|humerus surgery|humerus surgery
1065792|NCT02756143|fetal heart|fetal heart
1065793|NCT02756143|cesarean section|cesarean section
1065794|NCT02756143|exercise|exercise
1065795|NCT02756143|pregnancy|pregnancy
1065796|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
1065797|NCT02756091|IAD|iad
1065798|NCT02756091|Stroke|stroke
1065799|NCT02756091|Observational Study|observational study
1065800|NCT02756065|Bipolar|bipolar
1065801|NCT02756065|schizophrenia|schizophrenia
1065802|NCT02756065|schizoaffective|schizoaffective
1065803|NCT02756026|Breast milk|breast milk
1065804|NCT02756026|mineral|mineral
1065805|NCT02756026|vitamin|vitamin
1065806|NCT02756013|chemotherapy dosing|chemotherapy dosing
1065807|NCT02756013|Body surface area|body surface area
1065808|NCT02756013|BSA|bsa
1065809|NCT02756013|paclitaxel|paclitaxel
1065810|NCT02756013|carboplatin|carboplatin
1065811|NCT02756013|dose dense|dose dense
1065812|NCT02756000|myocardial infarction|myocardial infarction
1065813|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
1065814|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
1065815|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
1065816|NCT02755961|End-stage renal disease|end-stage renal disease
1065817|NCT02755961|Phosphate binders|phosphate binders
1065818|NCT02755961|Hyperphosphatemia|hyperphosphatemia
1065819|NCT02755961|Dietary education|dietary education
1065820|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
1065821|NCT02755922|Treatment|treatment
1065822|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
1066219|NCT02753361|Ultrasound|ultrasound
1065823|NCT02755883|Physical activity|physical activity
1065824|NCT02755883|non-small lung cancer|non-small lung cancer
1065825|NCT02755883|positive affect|positive affect
1065826|NCT02755857|Prophylaxis|prophylaxis
1065827|NCT02755857|Bioavailability|bioavailability
1065828|NCT02755857|Pharmacokinetics|pharmacokinetics
1065829|NCT02755844|endometrial carcinomas|endometrial carcinomas
1065830|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
1065831|NCT02755844|metformin|metformin
1065832|NCT02755844|olaparib|olaparib
1065833|NCT02755844|dose-escalation study|dose-escalation study
1065834|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
1065835|NCT02755818|lipid|lipid
1065836|NCT02755818|insulin resistance|insulin resistance
1065837|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
1065838|NCT02755818|obesity|obesity
1065839|NCT02755805|Stroke|stroke
1065840|NCT02755805|Rehabilitation|rehabilitation
1065841|NCT02755805|Cognition|cognition
1065842|NCT02755805|Intervention|intervention
1065843|NCT02755805|Strategy training|strategy training
1065844|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
1065845|NCT02755792|Cognitive training|cognitive training
1065846|NCT02755792|Calligraphy|calligraphy
1065847|NCT02755792|Emotional calmness|emotional calmness
1065848|NCT02755792|Working memory|working memory
1065849|NCT02755753|Rebamipide|rebamipide
1065850|NCT02755740|female|female
1065851|NCT02755688|atrial fibrillation|atrial fibrillation
1065852|NCT02755688|catheter ablation|catheter ablation
1065853|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
1065854|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
1065855|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1065856|NCT02755662|mandibular repositioning device|mandibular repositioning device
1065857|NCT02755636|Health Behavior Change|health behavior change
1065858|NCT02755636|Primary Health Care|primary health care
1065859|NCT02755636|Patient Participation|patient participation
1065860|NCT02755636|Provider-Patient Communication|provider-patient communication
1065861|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
1065862|NCT02755636|Mobile Health|mobile health
1065863|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
1065864|NCT02755610|Checklist|checklist
1065865|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
1065866|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
1065867|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
1065868|NCT02755597|multiple myeloma|multiple myeloma
1065869|NCT02755584|Aging|aging
1065870|NCT02755584|Senescent Cells|senescent cells
1065871|NCT02755532|Pharmacokinetics|pharmacokinetics
1065872|NCT02755532|Bupivacaine|bupivacaine
1065873|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
1065874|NCT02755519|primary aldosteronism|primary aldosteronism
1065875|NCT02755519|confirmatory test|confirmatory test
1065876|NCT02755519|hypertension|hypertension
1065877|NCT02755506|Ultrasound elastography|ultrasound elastography
1065878|NCT02755506|Thoracic lesions|thoracic lesions
1065879|NCT02755506|EBUS-TBNA|ebus-tbna
1065880|NCT02755480|bone marrow transplant|bone marrow transplant
1065881|NCT02755480|infection|infection
1065882|NCT02755480|computed tomography|computed tomography
1065883|NCT02755480|radiation dose|radiation dose
1065884|NCT02755441|Diagnosis|diagnosis
1065885|NCT02755441|Prognosis|prognosis
1065886|NCT02755441|Biomarker|biomarker
1065887|NCT02755415|Rehabilitation|rehabilitation
1065888|NCT02755415|Robotic|robotic
1065889|NCT02755415|Gait|gait
1065890|NCT02755415|Quality of Life|quality of life
1065891|NCT02755389|Tracheal intubation|tracheal intubation
1065892|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
1065893|NCT02755389|Airway management|airway management
1065894|NCT02755389|Apneic oxygenation|apneic oxygenation
1065895|NCT02755363|COPD|copd
1065896|NCT02755363|residual volume|residual volume
1065897|NCT02755363|osteopathy|osteopathy
1065898|NCT02755363|hyperinflation|hyperinflation
1065899|NCT02755350|PrEP|prep
1065900|NCT02755350|HIV Prevention|hiv prevention
1065901|NCT02755350|combination prevention|combination prevention
1065902|NCT02755350|demonstration project|demonstration project
1065903|NCT02755337|adenocarcinoma|adenocarcinoma
1065904|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
1065905|NCT02755298|Treatment Outcome|treatment outcome
1065906|NCT02755298|Acetazolamide|acetazolamide
1065907|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
1065908|NCT02755259|Acetazolamide|acetazolamide
1065909|NCT02755259|Hemodynamics|hemodynamics
1065910|NCT02755246|subjective cognitive decline|subjective cognitive decline
1065911|NCT02755246|dementia|dementia
1065912|NCT02755246|lifestyle|lifestyle
1065913|NCT02755246|polyamine|polyamine
1065914|NCT02755246|memory|memory
1065915|NCT02755246|elderly|elderly
1065916|NCT02755246|prevention|prevention
1065917|NCT02755246|treatment|treatment
1065918|NCT02755246|dietary supplement|dietary supplement
1065919|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
1065920|NCT02755194|pharmacokinetics|pharmacokinetics
1065921|NCT02755194|Drug-in-milk|drug-in-milk
1066318|NCT02752867|treatment|treatment
1065922|NCT02755194|breastfeeding|breastfeeding
1065923|NCT02755194|drug safety|drug safety
1065924|NCT02755194|population pharmacokinetics|population pharmacokinetics
1065925|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
1065926|NCT02755155|SIRS|sirs
1065927|NCT02755155|Albumin, therapeutic|albumin, therapeutic
1065928|NCT02755116|Nausea|nausea
1065929|NCT02755116|Vomiting|vomiting
1065930|NCT02755103|Mindfulness|mindfulness
1065931|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
1065932|NCT02755103|Meditation|meditation
1065933|NCT02755090|nitrous|nitrous
1065934|NCT02755090|pain|pain
1065935|NCT02755077|Anesthesia induction|anesthesia induction
1065936|NCT02755077|Airway|airway
1065937|NCT02755077|Mask ventilation|mask ventilation
1065938|NCT02755038|postmenopausal women|postmenopausal women
1065939|NCT02755038|scalp hair|scalp hair
1065940|NCT02755038|estrogen|estrogen
1065941|NCT02755038|progesterone|progesterone
1065942|NCT02755025|Sepsis|sepsis
1065943|NCT02755025|SOFA score|sofa score
1065944|NCT02755025|Automated calculation|automated calculation
1065945|NCT02755012|Maternal Health|maternal health
1065946|NCT02755012|Guatemala|guatemala
1065947|NCT02755012|Indigenous Population|indigenous population
1065948|NCT02755012|Stunting|stunting
1065949|NCT02755012|Food Insecurity|food insecurity
1065950|NCT02755012|Poverty|poverty
1065951|NCT02755012|Social Support|social support
1065952|NCT02755012|Maternal Autonomy|maternal autonomy
1065953|NCT02755012|Paternal Support|paternal support
1065954|NCT02755012|Cortisol Rhythm|cortisol rhythm
1065955|NCT02754986|heart rate variability|heart rate variability
1065956|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
1065957|NCT02754960|Vascular malformation|vascular malformation
1065958|NCT02754960|Angiodysplasia|angiodysplasia
1065959|NCT02754960|Thalidomide|thalidomide
1065960|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
1065961|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
1065962|NCT02754947|Perioperative complications|perioperative complications
1065963|NCT02754947|Respiratory insufficiency|respiratory insufficiency
1065964|NCT02754947|ASA status|asa status
1065965|NCT02754934|chronic|chronic
1065966|NCT02754895|acute coronary syndrome|acute coronary syndrome
1065967|NCT02754895|health behavior|health behavior
1065968|NCT02754895|factorial design|factorial design
1065969|NCT02754895|positive psychology|positive psychology
1065970|NCT02754882|NSCLC|nsclc
1065971|NCT02754882|bevacizumab|bevacizumab
1065972|NCT02754882|avastin|avastin
1065973|NCT02754856|Colorectal Cancer|colorectal cancer
1065974|NCT02754856|Liver Metastases|liver metastases
1065975|NCT02754856|Resectable liver metastases|resectable liver metastases
1065976|NCT02754856|Tremelimumab|tremelimumab
1065977|NCT02754856|Fluorouracil|fluorouracil
1065978|NCT02754856|5-Fluorouracil|5-fluorouracil
1065979|NCT02754856|5-FU|5-fu
1065980|NCT02754856|Adrucil|adrucil
1065981|NCT02754856|Efudex|efudex
1065982|NCT02754856|Leucovorin|leucovorin
1065983|NCT02754856|Citrovorum|citrovorum
1065984|NCT02754856|Wellcovorin|wellcovorin
1065985|NCT02754856|Oxaliplatin|oxaliplatin
1065986|NCT02754856|Eloxatin|eloxatin
1065987|NCT02754856|Bevacizumab|bevacizumab
1065988|NCT02754856|Avastin|avastin
1065989|NCT02754856|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1065990|NCT02754856|MEDI4736|medi4736
1065991|NCT02754856|Durvalumab|durvalumab
1065992|NCT02754778|arterial stiffness|arterial stiffness
1065993|NCT02754778|preeclampsia|preeclampsia
1065994|NCT02754778|HELLP-syndrome|hellp-syndrome
1065995|NCT02754778|pulse wave velocity|pulse wave velocity
1065996|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
1065997|NCT02754778|skin autofluorescence|skin autofluorescence
1065998|NCT02754778|conditional workout|conditional workout
1065999|NCT02754778|postpartum|postpartum
1066000|NCT02754778|cardiovascular risk|cardiovascular risk
1066001|NCT02754778|pregnancy|pregnancy
1066002|NCT02754778|vicorder|vicorder
1066003|NCT02754778|age reader|age reader
1066004|NCT02754752|Malignant neoplasm of breast|malignant neoplasm of breast
1066005|NCT02754752|Electro-acupuncture|electro-acupuncture
1066006|NCT02754752|Questionnaires|questionnaires
1066007|NCT02754752|Surveys|surveys
1066008|NCT02754752|Standard of care|standard of care
1066009|NCT02754752|Chronic Pain|chronic pain
1066010|NCT02754739|Pravastatin|pravastatin
1066011|NCT02754739|Insulin Resistance|insulin resistance
1066012|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
1066013|NCT02754687|male contraception|male contraception
1066014|NCT02754687|healthy men|healthy men
1066015|NCT02754687|androgen|androgen
1066016|NCT02754687|Nortestosterone|nortestosterone
1066017|NCT02754687|Dodecylcarbonate|dodecylcarbonate
1066018|NCT02754687|11-Beta|11-beta
1066019|NCT02754687|11β|11β
1066020|NCT02754687|contraception|contraception
1066021|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
1066022|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
1066023|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
1066024|NCT02754622|Rehabilitation|rehabilitation
1066025|NCT02754609|Celiac Disease|celiac disease
1066026|NCT02754609|Necator americanus|necator americanus
1066027|NCT02754609|Helminths|helminths
1066028|NCT02754609|Autoimmunity|autoimmunity
1066029|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
1066030|NCT02754609|Randomized Controlled Trial|randomized controlled trial
1066031|NCT02754583|trachoma|trachoma
1066032|NCT02754583|soil transmitted helminths|soil transmitted helminths
1066033|NCT02754583|sanitation|sanitation
1066034|NCT02754583|face washing|face washing
1066035|NCT02754583|antibiotics|antibiotics
1066036|NCT02754570|Open-angle glaucoma|open-angle glaucoma
1066037|NCT02754570|Ocular hypertension|ocular hypertension
1066038|NCT02754570|Latanoprost|latanoprost
1066039|NCT02754570|Pilocarpine|pilocarpine
1066040|NCT02754544|Brain tumor|brain tumor
1066041|NCT02754544|Metastatic brain tumor|metastatic brain tumor
1066042|NCT02754544|Neurosurgery|neurosurgery
1066043|NCT02754544|Electrocorticogram|electrocorticogram
1066044|NCT02754544|ECoG|ecog
1066045|NCT02754544|Transcranial magnetic stimulation|transcranial magnetic stimulation
1066046|NCT02754544|TMS|tms
1066047|NCT02754544|Direct electrical stimulation|direct electrical stimulation
1066048|NCT02754544|DES|des
1066049|NCT02754544|Functional MRI|functional mri
1066050|NCT02754544|fMRI|fmri
1066051|NCT02754544|PMT High-Resolution Grids|pmt high-resolution grids
1066052|NCT02754544|CorTec High-Resolution Hybrid Grids|cortec high-resolution hybrid grids
1066053|NCT02754544|Digital glove|digital glove
1066054|NCT02754544|Neurological exam|neurological exam
1066055|NCT02754544|Ad-Tech Grids|ad-tech grids
1066056|NCT02754544|Grip Sensor|grip sensor
1066057|NCT02754531|Cole formula|cole formula
1066058|NCT02754531|Pediatric patients|pediatric patients
1066059|NCT02754531|intubation|intubation
1066060|NCT02754531|Ultrasonography|ultrasonography
1066061|NCT02754531|Endotracheal tube|endotracheal tube
1066062|NCT02754531|uncuffed|uncuffed
1066063|NCT02754531|pediatric|pediatric
1066064|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
1066065|NCT02754453|Weight Regain|weight regain
1066066|NCT02754453|Group Treatment|group treatment
1066067|NCT02754453|Weight Loss|weight loss
1066068|NCT02754427|Surveillance|surveillance
1066069|NCT02754427|Physiotherapy|physiotherapy
1066070|NCT02754427|Arm morbidity|arm morbidity
1066071|NCT02754414|platelets|platelets
1066072|NCT02754414|transfusion|transfusion
1066073|NCT02754414|cold storage|cold storage
1066074|NCT02754414|apheresis|apheresis
1066075|NCT02754401|public health|public health
1066076|NCT02754401|periodontitis|periodontitis
1066077|NCT02754401|self-reported questionnaire|self-reported questionnaire
1066078|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
1066079|NCT02754375|biological markers|biological markers
1066080|NCT02754375|rTMS|rtms
1066081|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
1066082|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
1066083|NCT02754349|pulse wave velocity|pulse wave velocity
1066084|NCT02754349|augmentation index|augmentation index
1066085|NCT02754349|central pulse pressure|central pulse pressure
1066086|NCT02754310|Education, medical|education, medical
1066087|NCT02754310|Simulation Training|simulation training
1066088|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
1066089|NCT02754297|Personalized|personalized
1066090|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
1066091|NCT02754297|PRRT|prrt
1066092|NCT02754297|177Lu-DOTATATE|177lu-dotatate
1066093|NCT02754297|177Lu-octreotate|177lu-octreotate
1066094|NCT02754245|multicenter study|multicenter study
1066095|NCT02754245|emergency department|emergency department
1066096|NCT02754245|overcrowding status|overcrowding status
1066097|NCT02754245|estimation tool|estimation tool
1066098|NCT02754245|validation|validation
1066099|NCT02754232|Physical training|physical training
1066100|NCT02754232|Telemedicine|telemedicine
1066101|NCT02754232|Daily activities|daily activities
1066102|NCT02754232|Cross sectoral|cross sectoral
1066103|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1066104|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
1066105|NCT02754180|adjuvant|adjuvant
1066106|NCT02754180|pancreatic cancer|pancreatic cancer
1066107|NCT02754180|R1 resection|r1 resection
1066108|NCT02754180|positive lymph nodes|positive lymph nodes
1066109|NCT02754167|Hepcidin|hepcidin
1066110|NCT02754167|hemoglobin|hemoglobin
1066111|NCT02754167|iron|iron
1066112|NCT02754167|anemia of chronic disease|anemia of chronic disease
1066113|NCT02754089|Body weight changes|body weight changes
1066114|NCT02754089|Medicine, Traditional|medicine, traditional
1066115|NCT02754089|Herbal medicine|herbal medicine
1066116|NCT02754089|Rhus|rhus
1066117|NCT02754089|Waist Circumference|waist circumference
1066118|NCT02754089|Waist-Hip Ratio|waist-hip ratio
1066119|NCT02754089|Body mass index|body mass index
1066319|NCT02752854|pain scores|pain scores
1066120|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
1066121|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
1066122|NCT02754011|HER2 negative|her2 negative
1066123|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
1066124|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
1066125|NCT02753998|Angioplasty|angioplasty
1066126|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
1066127|NCT02753920|voiding trial|voiding trial
1066128|NCT02753920|prolapse|prolapse
1066129|NCT02753894|Dose-finding|dose-finding
1066130|NCT02753894|Hemodialysis|hemodialysis
1066131|NCT02753894|ASP1585|asp1585
1066132|NCT02753894|Chronic kidney disease|chronic kidney disease
1066133|NCT02753868|Intradialytic exercise|intradialytic exercise
1066134|NCT02753868|Cardiac and arterial function|cardiac and arterial function
1066135|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
1066136|NCT02753842|Condoms|condoms
1066137|NCT02753842|Contraceptive Devices|contraceptive devices
1066138|NCT02753842|HIV|hiv
1066139|NCT02753816|Tranexamic Acid|tranexamic acid
1066140|NCT02753816|Burn|burn
1066141|NCT02753816|Surgery|surgery
1066142|NCT02753816|Tangential|tangential
1066143|NCT02753816|Excision|excision
1066144|NCT02753790|Brain|brain
1066145|NCT02753790|Metastasis|metastasis
1066146|NCT02753790|IMRT|imrt
1066147|NCT02753790|Radiation|radiation
1066148|NCT02753790|Cancer|cancer
1066149|NCT02753790|Hippocampus|hippocampus
1066150|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
1066151|NCT02753790|Quality of life|quality of life
1066152|NCT02753790|QOL|qol
1066153|NCT02753712|Small airway disease|small airway disease
1066154|NCT02753712|asthma|asthma
1066155|NCT02753699|Chronic hepatitis C|chronic hepatitis c
1066156|NCT02753686|HR+ HER2|hr+ her2
1066157|NCT02753686|postmenopausal|postmenopausal
1066158|NCT02753686|advanced breast cancer|advanced breast cancer
1066159|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
1066160|NCT02753686|metastatic|metastatic
1066161|NCT02753686|endocrine therapy|endocrine therapy
1066162|NCT02753686|targeted therapy|targeted therapy
1066163|NCT02753686|prospective|prospective
1066164|NCT02753686|observational|observational
1066165|NCT02753686|registry|registry
1066166|NCT02753686|real world setting|real world setting
1066167|NCT02753686|non-interventional|non-interventional
1066168|NCT02753686|Canadian|canadian
1066169|NCT02753673|Breast Conserving Therapy|breast conserving therapy
1066170|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
1066171|NCT02753673|16-325|16-325
1066172|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
1066173|NCT02753608|exhaled breath condensate|exhaled breath condensate
1066174|NCT02753608|volatile organic compounds|volatile organic compounds
1066175|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
1066176|NCT02753595|Eribulin Mesylate|eribulin mesylate
1066177|NCT02753595|E7389|e7389
1066178|NCT02753595|PEGPH20|pegph20
1066179|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
1066180|NCT02753595|High-Hyaluronan|high-hyaluronan
1066181|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
1066182|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
1066183|NCT02753569|PET/CT|pet/ct
1066184|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
1066185|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1066186|NCT02753556|COPD|copd
1066187|NCT02753556|ScreenFlow|screenflow
1066188|NCT02753556|Screening|screening
1066189|NCT02753556|Lung Disease|lung disease
1066190|NCT02753556|Mobile Health|mobile health
1066191|NCT02753556|Peak Flow Meter|peak flow meter
1066192|NCT02753556|Usability|usability
1066193|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
1066194|NCT02753517|extended hepatectomy|extended hepatectomy
1066195|NCT02753517|volumetry|volumetry
1066196|NCT02753504|Dyslipidemia|dyslipidemia
1066197|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
1066198|NCT02753478|hypothermia|hypothermia
1066199|NCT02753465|Rectal Neoplasms|rectal neoplasms
1066200|NCT02753465|anastomosis|anastomosis
1066201|NCT02753465|OS|os
1066202|NCT02753465|DFS|dfs
1066203|NCT02753465|LCA|lca
1066204|NCT02753465|laparoscopic surgery|laparoscopic surgery
1066205|NCT02753452|youth|youth
1066206|NCT02753452|disability|disability
1066207|NCT02753452|transition|transition
1066208|NCT02753452|life skills|life skills
1066209|NCT02753452|adolescence|adolescence
1066210|NCT02753413|Vaccine|vaccine
1066211|NCT02753413|Safety|safety
1066212|NCT02753413|Reactogenicity|reactogenicity
1066213|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
1066214|NCT02753387|mouthwash|mouthwash
1066215|NCT02753387|head and neck cancer|head and neck cancer
1066216|NCT02753387|chlorhexidine|chlorhexidine
1066217|NCT02753387|pathogens germs|pathogens germs
1066218|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
1066220|NCT02753361|regional blockade|regional blockade
1066221|NCT02753361|lipoma|lipoma
1066222|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
1066223|NCT02753322|Dual task training|dual task training
1066224|NCT02753322|Dual task interference|dual task interference
1066225|NCT02753322|Sub-acute stroke|sub-acute stroke
1066226|NCT02753322|Physiotherapy training|physiotherapy training
1066227|NCT02753322|Community ambulation|community ambulation
1066228|NCT02753322|Balance|balance
1066229|NCT02753309|BCG|bcg
1066230|NCT02753309|Rapamycin|rapamycin
1066231|NCT02753296|Cancer|cancer
1066232|NCT02753296|Fertility Preservation|fertility preservation
1066233|NCT02753296|Patient Decision Aid|patient decision aid
1066234|NCT02753283|Bone loss|bone loss
1066235|NCT02753283|Frail Geriatric Patients|frail geriatric patients
1066236|NCT02753283|Nursing Home Patients|nursing home patients
1066237|NCT02753283|Long-term Care Patients|long-term care patients
1066238|NCT02753283|Osteoporosis|osteoporosis
1066239|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
1066240|NCT02753257|stroke|stroke
1066241|NCT02753257|stroke mimic|stroke mimic
1066242|NCT02753244|Cognitive VideoGames|cognitive videogames
1066243|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
1066244|NCT02753179|Video Head Impulse Test|video head impulse test
1066245|NCT02753179|Covert-saccades|covert-saccades
1066246|NCT02753179|Quality of life|quality of life
1066247|NCT02753179|Dynamic visual acuity|dynamic visual acuity
1066248|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
1066249|NCT02753166|Emergency Department|emergency department
1066250|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
1066251|NCT02753127|Colonic Diseases|colonic diseases
1066252|NCT02753127|Digestive System Diseases|digestive system diseases
1066253|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
1066254|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
1066255|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1066256|NCT02753127|Intestinal Diseases|intestinal diseases
1066257|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
1066258|NCT02753127|Neoplasms|neoplasms
1066259|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
1066260|NCT02753127|Neoplasms by Site|neoplasms by site
1066261|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1066262|NCT02753127|Rectal Diseases|rectal diseases
1066263|NCT02753114|Ketamine|ketamine
1066264|NCT02753114|Intranasal|intranasal
1066265|NCT02753114|Emergency Medical Services|emergency medical services
1066266|NCT02753114|Pain|pain
1066267|NCT02753114|Analgesia|analgesia
1066268|NCT02753101|Positron Emission Tomography|positron emission tomography
1066269|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
1066270|NCT02753101|PET/MRI|pet/mri
1066271|NCT02753101|sigma-1 receptor|sigma-1 receptor
1066272|NCT02753101|radiopharmaceutical|radiopharmaceutical
1066273|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
1066274|NCT02753101|sciatica|sciatica
1066275|NCT02753101|chronic pain|chronic pain
1066276|NCT02753088|Equivalence|equivalence
1066277|NCT02753088|BCD-063|bcd-063
1066278|NCT02753088|Copaxone-Teva|copaxone-teva
1066279|NCT02753049|HIV|hiv
1066280|NCT02753049|AIDS|aids
1066281|NCT02753049|Adolescent|adolescent
1066282|NCT02753049|Adherence|adherence
1066283|NCT02753049|Retention|retention
1066284|NCT02753049|mHealth|mhealth
1066285|NCT02753036|cognition|cognition
1066286|NCT02753036|chemotherapy|chemotherapy
1066287|NCT02753036|polyneuropathy|polyneuropathy
1066288|NCT02753036|paclitaxel|paclitaxel
1066289|NCT02753036|cancer|cancer
1066290|NCT02753036|chemobrain|chemobrain
1066291|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
1066292|NCT02752932|Head and neck cancer|head and neck cancer
1066293|NCT02752932|Patient derived Xenograft|patient derived xenograft
1066294|NCT02752932|Chemotherapy|chemotherapy
1066295|NCT02752932|Metastases|metastases
1066296|NCT02752906|Meningitis|meningitis
1066297|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
1066298|NCT02752906|Meningococcal Infections|meningococcal infections
1066299|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
1066300|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
1066301|NCT02752893|estrogen|estrogen
1066302|NCT02752893|estrogen receptor|estrogen receptor
1066303|NCT02752893|ER+|er+
1066304|NCT02752893|HER2|her2
1066305|NCT02752893|HER2-|her2-
1066306|NCT02752893|HER2-negative|her2-negative
1066307|NCT02752893|xenograft|xenograft
1066308|NCT02752893|co-clinical|co-clinical
1066309|NCT02752893|mice|mice
1066310|NCT02752893|patient-derived xenograft|patient-derived xenograft
1066311|NCT02752893|patient-derived|patient-derived
1066312|NCT02752893|breast cancer|breast cancer
1066313|NCT02752893|precision medicine|precision medicine
1066314|NCT02752893|personalized medicine|personalized medicine
1066315|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
1066316|NCT02752867|Cognitive Impairment|cognitive impairment
1066317|NCT02752867|Acute cerebral infraction|acute cerebral infraction
1066320|NCT02752854|pressure algometer|pressure algometer
1066321|NCT02752854|healthy volunteer adults|healthy volunteer adults
1066322|NCT02752802|Contrast Media|contrast media
1066323|NCT02752802|Angiography|angiography
1066324|NCT02752789|alloantibodies|alloantibodies
1066325|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
1066326|NCT02752789|self-antigens|self-antigens
1066327|NCT02752789|chronic allograft function|chronic allograft function
1066328|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1066329|NCT02752763|Dry eye|dry eye
1066330|NCT02752763|isotretinoin, AS|isotretinoin, as
1066331|NCT02752763|Autologous serum|autologous serum
1066332|NCT02752724|major depressive disorder|major depressive disorder
1066333|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
1066334|NCT02752724|metabolomics|metabolomics
1066335|NCT02752724|treatment resistant depression|treatment resistant depression
1066336|NCT02752724|anesthesiology|anesthesiology
1066337|NCT02752724|ketamine|ketamine
1066338|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
1066339|NCT02752711|Minor head trauma|minor head trauma
1066340|NCT02752711|Children|children
1066341|NCT02752711|Clinical decision rule|clinical decision rule
1066342|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
1066343|NCT02752685|Abraxane|abraxane
1066344|NCT02752685|MK-3475|mk-3475
1066345|NCT02752672|dithranol|dithranol
1066346|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
1066347|NCT02752659|Monitoring|monitoring
1066348|NCT02752646|cataract|cataract
1066349|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
1066350|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
1066351|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
1066352|NCT02752620|low back pain|low back pain
1066353|NCT02752594|probiotic|probiotic
1066354|NCT02752594|mutans streptococci|mutans streptococci
1066355|NCT02752594|bacillus coagulans|bacillus coagulans
1066356|NCT02752594|caries|caries
1066357|NCT02752581|suction drain|suction drain
1066358|NCT02752581|knee arthroscopy|knee arthroscopy
1066359|NCT02752581|knee pain|knee pain
1066360|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
1066361|NCT02752555|Male factor managment|male factor managment
1066362|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
1066363|NCT02752529|Liver Transplantation|liver transplantation
1066364|NCT02752529|Individualized Therapy|individualized therapy
1066365|NCT02752529|Polymorphism|polymorphism
1066366|NCT02752477|Opioid-sparing|opioid-sparing
1066367|NCT02752464|Weight Loss|weight loss
1066368|NCT02752464|Health Status Disparities|health status disparities
1066369|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
1066370|NCT02752438|rescue|rescue
1066371|NCT02752438|newborn|newborn
1066372|NCT02752425|Speech disorders|speech disorders
1066373|NCT02752425|Speech therapy|speech therapy
1066374|NCT02752425|Visual feedback|visual feedback
1066375|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
1066376|NCT02752425|Central nervous system damage|central nervous system damage
1066377|NCT02752373|GTC Seizures|gtc seizures
1066378|NCT02752360|intestinal reconstruction|intestinal reconstruction
1066379|NCT02752360|end to end anastomosis|end to end anastomosis
1066380|NCT02752321|patient discharge|patient discharge
1066381|NCT02752321|patient engagement|patient engagement
1066382|NCT02752321|patient satisfaction|patient satisfaction
1066383|NCT02752321|continuity of patient care|continuity of patient care
1066384|NCT02752321|hospital discharge|hospital discharge
1066385|NCT02752321|health technology|health technology
1066386|NCT02752321|eDischarge|edischarge
1066387|NCT02752321|multimedia|multimedia
1066388|NCT02752321|mobile applications|mobile applications
1066389|NCT02752321|software applications|software applications
1066390|NCT02752321|portable electronic applications|portable electronic applications
1066391|NCT02752282|Family Planning|family planning
1066392|NCT02752282|LNG-IUS|lng-ius
1066393|NCT02752282|Health Education|health education
1066394|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
1066395|NCT02752243|acute leukemia|acute leukemia
1066396|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1066397|NCT02752243|Stem Cell Transplantation|stem cell transplantation
1066398|NCT02752230|Post operative pain|post operative pain
1066399|NCT02752230|Bariatric Surgery|bariatric surgery
1066400|NCT02752204|Relapsed|relapsed
1066401|NCT02752204|Refractory|refractory
1066402|NCT02752204|Lymphoma|lymphoma
1066403|NCT02752191|ferumoxytol|ferumoxytol
1066404|NCT02752178|Depression|depression
1066405|NCT02752178|Major depressive disorder|major depressive disorder
1066406|NCT02752178|MDD|mdd
1066407|NCT02752152|Counseling|counseling
1066408|NCT02752139|Sleep Disorders|sleep disorders
1066409|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
1066410|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
1066411|NCT02752139|Stroke|stroke
1066412|NCT02752126|Esophageal sparing|esophageal sparing
1066413|NCT02752126|Conventional radiotherapy|conventional radiotherapy
1066414|NCT02752126|Palliative radiation|palliative radiation
1066415|NCT02752126|Central lung tumors|central lung tumors
1066416|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
1066417|NCT02752113|Metformin|metformin
1066418|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
1066419|NCT02752113|HbA1c >= 7%|hba1c >= 7%
1066420|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
1066421|NCT02752100|Interventional Therapy|interventional therapy
1066422|NCT02752074|Melanoma|melanoma
1066423|NCT02752074|Metastatic Melanoma|metastatic melanoma
1066424|NCT02752035|AML|aml
1066425|NCT02752035|ASP2215|asp2215
1066426|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
1066427|NCT02752035|gilteritinib|gilteritinib
1066428|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1066429|NCT02752035|FLT3|flt3
1066430|NCT02752022|e-cigarettes|e-cigarettes
1066431|NCT02752022|nitrosamines|nitrosamines
1066432|NCT02752022|smoking cessation|smoking cessation
1066433|NCT02752009|Breast Cancer|breast cancer
1066434|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
1066435|NCT02751996|Chronic Hepatitis|chronic hepatitis
1066436|NCT02751996|HBV|hbv
1066437|NCT02751996|Double blind|double blind
1066438|NCT02751983|Suicide|suicide
1066439|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
1066440|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
1066441|NCT02751983|Brief Psychotherapy|brief psychotherapy
1066442|NCT02751983|Inpatients|inpatients
1066443|NCT02751970|Dental adhesive|dental adhesive
1066444|NCT02751970|adhesive systems|adhesive systems
1066445|NCT02751970|Dental Restoration Failure|dental restoration failure
1066446|NCT02751944|exercise-induced|exercise-induced
1066447|NCT02751944|joint pain|joint pain
1066448|NCT02751944|joint stiffness|joint stiffness
1066449|NCT02751944|post-menopausal|post-menopausal
1066450|NCT02751944|women|women
1066451|NCT02751944|cartilage turnover|cartilage turnover
1066452|NCT02751944|CTX-II|ctx-ii
1066453|NCT02751931|Pediatrics|pediatrics
1066454|NCT02751931|Urodynamics|urodynamics
1066455|NCT02751931|Mirabegron|mirabegron
1066456|NCT02751931|Phase 3|phase 3
1066457|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
1066458|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
1066459|NCT02751814|Childcare Center Regulations|childcare center regulations
1066460|NCT02751814|Physical Activity|physical activity
1066461|NCT02751814|Sedentary Behavior|sedentary behavior
1066462|NCT02751814|Screen-time Behavior|screen-time behavior
1066463|NCT02751788|childcare center regulations|childcare center regulations
1066464|NCT02751788|physical activity|physical activity
1066465|NCT02751788|sedentary behavior|sedentary behavior
1066466|NCT02751788|screen-time behavior|screen-time behavior
1066467|NCT02751775|Childcare center regulations|childcare center regulations
1066468|NCT02751775|Physical Activity|physical activity
1066469|NCT02751775|Sedentary Behavior|sedentary behavior
1066470|NCT02751775|Screen-Time Behavior|screen-time behavior
1066471|NCT02751775|Focus groups|focus groups
1066472|NCT02751723|cancer disease|cancer disease
1066473|NCT02751723|palliative care|palliative care
1066474|NCT02751723|palliative therapy|palliative therapy
1066475|NCT02751723|cancer|cancer
1066476|NCT02751723|patient´s needs|patient´s needs
1066477|NCT02751723|patient care|patient care
1066478|NCT02751723|disease burden|disease burden
1066479|NCT02751684|Rapid Sequence Induction|rapid sequence induction
1066480|NCT02751684|European|european
1066481|NCT02751684|Evaluation|evaluation
1066482|NCT02751684|EUROpE RSI|europe rsi
1066483|NCT02751684|Standards|standards
1066484|NCT02751684|RSI|rsi
1066485|NCT02751645|Pediatric|pediatric
1066486|NCT02751645|Cardiac|cardiac
1066487|NCT02751645|Surgery|surgery
1066488|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
1066489|NCT02751632|Prodrome|prodrome
1066490|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
1066491|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
1066492|NCT02751619|Lidocaine patch|lidocaine patch
1066493|NCT02751606|Ferumoxtran|ferumoxtran
1066494|NCT02751606|MRI Scans|mri scans
1066495|NCT02751593|pregnancy|pregnancy
1066496|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
1066497|NCT02751593|dexamethasone|dexamethasone
1066498|NCT02751528|Breast Cancer|breast cancer
1066499|NCT02751528|Breast Cancer male|breast cancer male
1066500|NCT02751528|Breast Neoplasms|breast neoplasms
1066501|NCT02751528|Breast Neoplasms male|breast neoplasms male
1066502|NCT02751528|Vaccine|vaccine
1066503|NCT02751528|HER2|her2
1066504|NCT02751528|Metastatic|metastatic
1066505|NCT02751528|Locally Advanced|locally advanced
1066506|NCT02751528|Unresectable|unresectable
1066507|NCT02751528|Solid Tumor|solid tumor
1066508|NCT02751528|Phase 1|phase 1
1066509|NCT02751528|Cancer Vaccine|cancer vaccine
1066510|NCT02751502|Children|children
1066511|NCT02751502|Pediatrics|pediatrics
1066512|NCT02751502|Arm|arm
1066513|NCT02751502|Upper limb|upper limb
1066514|NCT02751502|bimanual training|bimanual training
1066515|NCT02751502|physical training|physical training
1066516|NCT02751437|preterm|preterm
1066517|NCT02751437|arginine|arginine
1066518|NCT02751437|immune function|immune function
1066519|NCT02751437|nutrition|nutrition
1066520|NCT02751424|Multidrug-resistant|multidrug-resistant
1066521|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
1066522|NCT02751424|Safety|safety
1066523|NCT02751424|Pharmacokinetic|pharmacokinetic
1066524|NCT02751333|Esophageal stricture|esophageal stricture
1066525|NCT02751333|Esophageal leak|esophageal leak
1066526|NCT02751333|Esophageal perforation|esophageal perforation
1066527|NCT02751333|Esophageal fistula|esophageal fistula
1066528|NCT02751333|Endostitch|endostitch
1066529|NCT02751333|Esophageal stent|esophageal stent
1066530|NCT02751307|metformin|metformin
1066531|NCT02751307|clozapine|clozapine
1066532|NCT02751307|schizophrenia|schizophrenia
1066533|NCT02751307|metabolic traits|metabolic traits
1066534|NCT02751294|Healthy Volunteer|healthy volunteer
1066535|NCT02751294|Malaria|malaria
1066536|NCT02751294|Pharmacokinetics|pharmacokinetics
1066537|NCT02751294|Tafenoquine|tafenoquine
1066538|NCT02751281|pneumatic|pneumatic
1066539|NCT02751281|ultra-sonic|ultra-sonic
1066540|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1066541|NCT02751268|infraorbital nerve block|infraorbital nerve block
1066542|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
1066543|NCT02751268|septorhinoplasty|septorhinoplasty
1066544|NCT02751268|general anesthesia|general anesthesia
1066545|NCT02751268|postoperative analgesia|postoperative analgesia
1066546|NCT02751242|Diuretic Resistance|diuretic resistance
1066547|NCT02751242|Emergency Medicine|emergency medicine
1066548|NCT02751229|Mental illness|mental illness
1066549|NCT02751229|adolescents|adolescents
1066550|NCT02751229|intervention|intervention
1066551|NCT02751229|stigma|stigma
1066552|NCT02751229|disclosure|disclosure
1066553|NCT02751229|secrecy|secrecy
1066554|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
1066555|NCT02751216|EEG|eeg
1066556|NCT02751216|conditioned pain modulation|conditioned pain modulation
1066557|NCT02751177|KRAS gene mutation|kras gene mutation
1066558|NCT02751177|NRAS gene mutation|nras gene mutation
1066559|NCT02751177|BRAF gene mutation|braf gene mutation
1066560|NCT02751138|Immune phenotype|immune phenotype
1066561|NCT02751138|Cytokines|cytokines
1066562|NCT02751138|Genetic aberration|genetic aberration
1066563|NCT02751138|Overall survival|overall survival
1066564|NCT02751138|Progression free survival|progression free survival
1066565|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
1066566|NCT02751125|bone augmentation|bone augmentation
1066567|NCT02751125|bone regeneration|bone regeneration
1066568|NCT02751086|minimally invasive surgery|minimally invasive surgery
1066569|NCT02751086|gastrectomy|gastrectomy
1066570|NCT02751086|robotic surgery|robotic surgery
1066571|NCT02751086|laparoscopic surgery|laparoscopic surgery
1066572|NCT02751086|laparoscopy|laparoscopy
1066573|NCT02751086|robot-assisted|robot-assisted
1066574|NCT02751086|robotic|robotic
1066575|NCT02751086|robotic gastrectomy|robotic gastrectomy
1066576|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
1066577|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
1066578|NCT02751073|Microbiota|microbiota
1066579|NCT02751073|Proteome|proteome
1066580|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
1066581|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
1066582|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
1066583|NCT02751034|filler|filler
1066584|NCT02751034|Nasolabial Fold|nasolabial fold
1066585|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
1066586|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
1066587|NCT02750995|azacitidine|azacitidine
1066588|NCT02750995|peptide vaccine|peptide vaccine
1066589|NCT02750995|cancer testis antigen|cancer testis antigen
1066590|NCT02750995|cancer vaccine|cancer vaccine
1066591|NCT02750995|immunotherapy|immunotherapy
1066592|NCT02750995|combination therapy|combination therapy
1066593|NCT02750995|NY-ESO-1|ny-eso-1
1066594|NCT02750995|PRAME|prame
1066595|NCT02750995|MAGE-A3|mage-a3
1066596|NCT02750995|WT-1|wt-1
1066597|NCT02750995|vaccine|vaccine
1066598|NCT02750969|tinnitus|tinnitus
1066599|NCT02750969|lidocain patch|lidocain patch
1066600|NCT02750956|endocan protein|endocan protein
1066601|NCT02750956|VEGF A|vegf a
1066602|NCT02750956|TNF-alpha|tnf-alpha
1066603|NCT02750956|after treatment|after treatment
1066604|NCT02750930|Extension|extension
1066605|NCT02750930|Long-term Safety|long-term safety
1066606|NCT02750930|Pharmacodynamics|pharmacodynamics
1066607|NCT02750930|Albiglutide|albiglutide
1066608|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1066609|NCT02750917|postoperative pain|postoperative pain
1066610|NCT02750917|lornoxicam|lornoxicam
1066611|NCT02750917|etoricoxib|etoricoxib
1066612|NCT02750917|total knee arthroplasty|total knee arthroplasty
1066613|NCT02750904|Smoking Cessation|smoking cessation
1066614|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
1066615|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
1066616|NCT02750904|Bipolar Disorder|bipolar disorder
1066617|NCT02750891|high grade glioma|high grade glioma
1066618|NCT02750891|HGG|hgg
1066620|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
1066621|NCT02750865|biomedical technology|biomedical technology
1066622|NCT02750865|palliative care|palliative care
1066623|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
1066624|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
1066625|NCT02750800|Psoriatic arthritis|psoriatic arthritis
1066626|NCT02750800|Psoriasis|psoriasis
1066627|NCT02750800|Crohn's disease|crohn's disease
1066628|NCT02750800|Ulcerative colitis|ulcerative colitis
1066629|NCT02750800|Patient support program|patient support program
1066630|NCT02750800|Quality of life|quality of life
1066631|NCT02750800|Patient related outcomes|patient related outcomes
1066632|NCT02750800|Observational study|observational study
1066633|NCT02750722|Exercise|exercise
1066634|NCT02750722|Lung diffusion capacity|lung diffusion capacity
1066635|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
1066636|NCT02750722|Lung disease|lung disease
1066637|NCT02750709|HT-1|ht-1
1066638|NCT02750709|Tyrosinemia|tyrosinemia
1066639|NCT02750709|Nitisinone|nitisinone
1066640|NCT02750709|Bioequivalence|bioequivalence
1066641|NCT02750709|Healthy Volunteer|healthy volunteer
1066642|NCT02750709|Orfadin|orfadin
1066643|NCT02750696|Acetaminophen|acetaminophen
1066644|NCT02750696|Analgesia|analgesia
1066645|NCT02750696|Codeine|codeine
1066646|NCT02750696|Drug Combinations|drug combinations
1066647|NCT02750696|Endodontics|endodontics
1066648|NCT02750696|Periapical abscess|periapical abscess
1066649|NCT02750696|Randomized Controlled Trial|randomized controlled trial
1066650|NCT02750696|Tramadol|tramadol
1066651|NCT02750696|Visual analog scale|visual analog scale
1066652|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
1066653|NCT02750670|Lymphoma|lymphoma
1066654|NCT02750670|Non-Hodgkin's|non-hodgkin's
1106533|NCT02510989|Genes|genes
1066655|NCT02750670|CD20+|cd20+
1066656|NCT02750670|Obinutuzumab|obinutuzumab
1066657|NCT02750670|GDP Chemotherapy|gdp chemotherapy
1066658|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
1066659|NCT02750631|depression|depression
1066660|NCT02750631|melatonin|melatonin
1066661|NCT02750631|light therapy|light therapy
1066662|NCT02750631|Wake Therapy|wake therapy
1066663|NCT02750631|chronobiology|chronobiology
1066664|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
1066665|NCT02750540|Tenofovir enema|tenofovir enema
1066666|NCT02750423|Cardiology|cardiology
1066667|NCT02750423|Surgery|surgery
1066668|NCT02750397|HIV|hiv
1066669|NCT02750397|Kidney Transplant|kidney transplant
1066670|NCT02750397|Liver Transplant|liver transplant
1066671|NCT02750397|Transplant|transplant
1066672|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
1066673|NCT02750371|Pituitary adenoma|pituitary adenoma
1066674|NCT02750371|Hippocampus|hippocampus
1066675|NCT02750371|Irradiation|irradiation
1066676|NCT02750371|Autobiographical memory|autobiographical memory
1066677|NCT02750358|Enzalutamide|enzalutamide
1066678|NCT02750358|15-307|15-307
1066679|NCT02750345|HT-1|ht-1
1066680|NCT02750345|Tyrosinemia|tyrosinemia
1066681|NCT02750345|Nitisinone|nitisinone
1066682|NCT02750345|Bioavailability|bioavailability
1066683|NCT02750345|Healthy Volunteer|healthy volunteer
1066684|NCT02750345|Food-Effect|food-effect
1066685|NCT02750332|HT-1|ht-1
1066686|NCT02750332|Tyrosinemia|tyrosinemia
1066687|NCT02750332|Nitisinone|nitisinone
1066688|NCT02750332|Bioavailability|bioavailability
1066689|NCT02750332|Healthy Volunteer|healthy volunteer
1066690|NCT02750332|Food-Effect|food-effect
1066691|NCT02750319|Amiodarone|amiodarone
1066692|NCT02750319|N-Acetylcysteine|n-acetylcysteine
1066693|NCT02750319|16-307|16-307
1066694|NCT02750293|vitamin D|vitamin d
1066695|NCT02750293|blood pressure|blood pressure
1066696|NCT02750293|serum lipids|serum lipids
1066697|NCT02750293|glucose metabolism|glucose metabolism
1066698|NCT02750293|muscle function|muscle function
1066699|NCT02750293|arterial stiffness|arterial stiffness
1066700|NCT02750293|depression|depression
1066701|NCT02750293|psoriasis|psoriasis
1066702|NCT02750293|sleep|sleep
1066703|NCT02750293|bone density|bone density
1066704|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1066705|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
1066706|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1066707|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
1066708|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
1066709|NCT02750267|Pediatric|pediatric
1066716|NCT02750241|physical activity|physical activity
1066717|NCT02750241|support group|support group
1066718|NCT02750241|survivorship|survivorship
1066719|NCT02750215|MET exon 14 skipping|met exon 14 skipping
1066720|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
1066721|NCT02750202|Genital warts|genital warts
1066722|NCT02750202|HPV types|hpv types
1066723|NCT02750202|HPV vaccine|hpv vaccine
1066724|NCT02750202|Cervical cytology|cervical cytology
1066725|NCT02750202|Therapeutic vaccine|therapeutic vaccine
1066726|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
1066727|NCT02750176|Rehabilitation|rehabilitation
1066728|NCT02750176|Closed chain exercises|closed chain exercises
1066729|NCT02750137|Tetracaine|tetracaine
1066730|NCT02750124|participation|participation
1066731|NCT02750124|self sampling|self sampling
1066732|NCT02750124|Screening|screening
1066733|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
1066734|NCT02750085|Hemophilia A|hemophilia a
1066735|NCT02750085|pharmacokinetics|pharmacokinetics
1066736|NCT02750085|myPKFiT|mypkfit
1066737|NCT02750020|Telephone survey|telephone survey
1066738|NCT02749955|HIV prevention|hiv prevention
1066739|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
1066740|NCT02749955|Men who have sex with men|men who have sex with men
1066741|NCT02749955|Partner services|partner services
1066742|NCT02749955|Linkage to care|linkage to care
1066743|NCT02749955|Seronegative|seronegative
1066744|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
1066745|NCT02749942|Diabetes|diabetes
1066746|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
1066747|NCT02749942|Neuropathy|neuropathy
1066748|NCT02749942|Angiopathy|angiopathy
1066749|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
1066750|NCT02749916|SWI|swi
1066751|NCT02749916|MP-RAGE|mp-rage
1066752|NCT02749916|DANTE T1-SPACE|dante t1-space
1066759|NCT02749864|Hepatitis|hepatitis
1066760|NCT02749864|Prevalence|prevalence
1066761|NCT02749864|Epidemiology|epidemiology
1066762|NCT02749864|Infectious diseases|infectious diseases
1066763|NCT02749851|pregnancy|pregnancy
1066764|NCT02749851|growth restriction|growth restriction
1066765|NCT02749838|Cancer|cancer
1066766|NCT02749838|Genomic testing|genomic testing
1066767|NCT02749838|Genetic testing|genetic testing
1066768|NCT02749838|Molecular screening|molecular screening
1066769|NCT02749838|Molecular Profiling|molecular profiling
1066770|NCT02749838|Biomarker|biomarker
1066771|NCT02749838|Biopsy|biopsy
1066772|NCT02749838|Tumor sampling|tumor sampling
1066773|NCT02749838|Registry|registry
1066774|NCT02749825|Prostate|prostate
1066775|NCT02749825|Cancer|cancer
1066776|NCT02749825|Trelstar|trelstar
1066777|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
1066778|NCT02749760|elbow injuries|elbow injuries
1066779|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
1066780|NCT02749760|Tommy John's procedure|tommy john's procedure
1066781|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
1066782|NCT02749747|Menopause|menopause
1066783|NCT02749747|nonhormonal treatment|nonhormonal treatment
1066784|NCT02749747|sulpiride|sulpiride
1066785|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
1066786|NCT02749734|Subretinal transplantation|subretinal transplantation
1066787|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
1066788|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
1066789|NCT02749721|depression|depression
1066790|NCT02749721|brain network activation|brain network activation
1066791|NCT02749721|vortioxetine|vortioxetine
1066792|NCT02749708|IRX5183|irx5183
1066793|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
1066794|NCT02749708|high-risk MDS|high-risk mds
1066795|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
1066796|NCT02749682|Nyhus classification|nyhus classification
1066797|NCT02749682|constipation severity scale|constipation severity scale
1066798|NCT02749682|groin hernia|groin hernia
1066799|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
1066800|NCT02749669|elderly|elderly
1066801|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
1066802|NCT02749669|qualitative research|qualitative research
1066803|NCT02749669|economic evaluation|economic evaluation
1066804|NCT02749656|Scalp psoriasis|scalp psoriasis
1066805|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
1066806|NCT02749591|stroke rehabilitation|stroke rehabilitation
1066807|NCT02749591|spasticity|spasticity
1066808|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
1066809|NCT02749591|robot-assisted therapy|robot-assisted therapy
1066810|NCT02749591|mirror therapy|mirror therapy
1066811|NCT02749591|randomized controlled trial|randomized controlled trial
1066812|NCT02749565|asthma|asthma
1066813|NCT02749565|fibrocyte|fibrocyte
1066814|NCT02749565|airway remodeling|airway remodeling
1066816|NCT02749565|hypoxia|hypoxia
1066817|NCT02749539|Mastectomy|mastectomy
1066818|NCT02749539|Shoulder Pain|shoulder pain
1066819|NCT02749539|ROM|rom
1066820|NCT02749539|Kinesio Tape|kinesio tape
1066821|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
1066822|NCT02749500|Motor control|motor control
1066823|NCT02749487|Critical Care|critical care
1066824|NCT02749487|Neutrophils|neutrophils
1066825|NCT02749487|Lymphocytes|lymphocytes
1066826|NCT02749461|preterm infants|preterm infants
1066827|NCT02749461|pain|pain
1066828|NCT02749461|assessment|assessment
1066829|NCT02749461|contextual factors|contextual factors
1066830|NCT02749461|diagnostic accuracy|diagnostic accuracy
1066831|NCT02749435|Digital disease management tool|digital disease management tool
1066832|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
1066833|NCT02749435|HbA1c|hba1c
1066834|NCT02749435|Standard care|standard care
1066835|NCT02749435|PRO questionnaires|pro questionnaires
1066836|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
1066837|NCT02749422|cognitive dysfunction|cognitive dysfunction
1066838|NCT02749422|memory loss|memory loss
1066839|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
1066840|NCT02749422|rTMS|rtms
1066841|NCT02749422|Magstim Rapid2|magstim rapid2
1066842|NCT02749357|gait|gait
1066843|NCT02749357|robotic orthosis|robotic orthosis
1066844|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
1066845|NCT02749318|Behavior Modification|behavior modification
1066846|NCT02749318|Genetic Testing|genetic testing
1066847|NCT02749318|Risk Management|risk management
1066848|NCT02749318|Oral Health Care|oral health care
1066849|NCT02749292|rituximab|rituximab
1066850|NCT02749292|maintenance|maintenance
1066851|NCT02749292|remission|remission
1066852|NCT02749266|chiropractic, cognition|chiropractic, cognition
1066853|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
1066854|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
1066855|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
1066856|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
1066857|NCT02749201|Obesity|obesity
1066858|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
1066859|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
1066860|NCT02749188|Infant|infant
1066861|NCT02749188|Newborn|newborn
1066862|NCT02749188|Feasibility Studies|feasibility studies
1066863|NCT02749188|Bladder stimulation|bladder stimulation
1066864|NCT02749175|cricoid pressure|cricoid pressure
1066865|NCT02749149|Cardiac|cardiac
1066866|NCT02749149|Surgery|surgery
1066867|NCT02749149|Frailty|frailty
1066868|NCT02749149|Frail|frail
1066869|NCT02749149|Patients|patients
1066870|NCT02749149|Recovery|recovery
1066871|NCT02749149|Morbidity|morbidity
1066872|NCT02749149|Outcomes|outcomes
1066873|NCT02749149|Mortality|mortality
1066874|NCT02749149|Heart|heart
1066875|NCT02749149|Perioperative|perioperative
1066876|NCT02749149|Disability|disability
1066877|NCT02749149|WHODAS|whodas
1066878|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1066879|NCT02749136|Borderline resectable|borderline resectable
1066880|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1066881|NCT02749136|FOLFIRINOX|folfirinox
1066882|NCT02749110|Mass screening|mass screening
1066883|NCT02749110|Family medicine|family medicine
1066884|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
1066885|NCT02749110|Papanicolaou test|papanicolaou test
1066886|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
1066887|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
1066888|NCT02749110|Patient compliance|patient compliance
1066889|NCT02749110|Adult|adult
1066890|NCT02749110|Female|female
1066891|NCT02749110|Humans|humans
1066892|NCT02749110|Randomized controlled trial|randomized controlled trial
1066893|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
1066894|NCT02749084|T regulatory cell|t regulatory cell
1066895|NCT02749058|capsulectomy|capsulectomy
1066896|NCT02749058|capsulotomy|capsulotomy
1066897|NCT02749019|BBN-RGD|bbn-rgd
1066898|NCT02749019|GRPR|grpr
1066899|NCT02749019|integrin αvβ3|integrin αvβ3
1066900|NCT02749006|Bipolar disorder|bipolar disorder
1066901|NCT02749006|Depression|depression
1066902|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
1066903|NCT02749006|neuromodulatory technique|neuromodulatory technique
1066904|NCT02748967|Healthy|healthy
1066905|NCT02748967|ExPEC4V|expec4v
1066906|NCT02748967|JNJ-63871860|jnj-63871860
1066907|NCT02748967|Safety|safety
1066908|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
1066909|NCT02748941|HITS|hits
1066910|NCT02748941|GSM|gsm
1066911|NCT02748941|CEUS|ceus
1066912|NCT02748941|HR MRI|hr mri
1066913|NCT02748941|mi-RNA|mi-rna
1066914|NCT02748915|Cochlear Implant|cochlear implant
1066915|NCT02748915|ECAP|ecap
1066916|NCT02748915|EABR|eabr
1066917|NCT02748915|perceptual levels|perceptual levels
1066918|NCT02748915|hearing performances|hearing performances
1066919|NCT02748902|Verruca vulgaris|verruca vulgaris
1066920|NCT02748902|Common warts|common warts
1066921|NCT02748902|Verruca|verruca
1066922|NCT02748902|Warts|warts
1066923|NCT02748902|Papilloma virus|papilloma virus
1066924|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
1066925|NCT02748902|hands|hands
1066926|NCT02748889|SCLC|sclc
1066927|NCT02748889|Small Cell|small cell
1066928|NCT02748889|Lung Cancer|lung cancer
1066929|NCT02748889|MPDL3280A|mpdl3280a
1066930|NCT02748889|atezolizumab|atezolizumab
1066931|NCT02748863|psoriasis|psoriasis
1066932|NCT02748863|secukinumab|secukinumab
1066933|NCT02748863|pre-filled syringes|pre-filled syringes
1066934|NCT02748850|apheresis patients|apheresis patients
1066935|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
1066936|NCT02748811|elderly|elderly
1066937|NCT02748811|intervention study|intervention study
1066938|NCT02748811|geriatrics|geriatrics
1066939|NCT02748811|chemotherapy|chemotherapy
1066940|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
1066941|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
1066942|NCT02748772|Endostar|endostar
1066943|NCT02748772|Thalidomide|thalidomide
1066944|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1066945|NCT02748759|Continous Passive Motion|continous passive motion
1066946|NCT02748759|Manual Physical Therapy|manual physical therapy
1066947|NCT02748759|Range of Motion, Articular|range of motion, articular
1066948|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1066949|NCT02748759|Rehabilitation|rehabilitation
1066950|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
1066951|NCT02748746|Lymphedema|lymphedema
1066952|NCT02748746|Electric Impedance|electric impedance
1066953|NCT02748746|Breast Cancer|breast cancer
1066954|NCT02748733|Adapted APD|adapted apd
1066955|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
1066956|NCT02748733|Ultrafiltration|ultrafiltration
1066957|NCT02748733|Clearance rate|clearance rate
1066958|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
1066959|NCT02748720|Premature|premature
1066960|NCT02748720|Respiratory Function Monitor|respiratory function monitor
1066961|NCT02748694|Drug Therapy|drug therapy
1066962|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
1066963|NCT02748681|CPAP|cpap
1066964|NCT02748681|stroke|stroke
1066965|NCT02748681|telemedicine|telemedicine
1066966|NCT02748681|neurorehabilitation|neurorehabilitation
1066967|NCT02748681|systolic blood pressure|systolic blood pressure
1066968|NCT02748629|inguinal hernia|inguinal hernia
1066969|NCT02748629|mesh|mesh
1066970|NCT02748629|lichtenstein|lichtenstein
1066971|NCT02748629|hernia repair|hernia repair
1066972|NCT02748629|selfgripping mesh|selfgripping mesh
1066973|NCT02748616|Colitis|colitis
1066974|NCT02748616|Bile|bile
1066975|NCT02748577|Migraines|migraines
1066976|NCT02748577|Pain responses|pain responses
1066977|NCT02748551|Gastric cancer|gastric cancer
1066978|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
1066979|NCT02748551|laparoscopic surgery|laparoscopic surgery
1066980|NCT02748551|laparoscopic procedure|laparoscopic procedure
1066981|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
1066982|NCT02748551|multicenter trials|multicenter trials
1066983|NCT02748486|schizophrenia|schizophrenia
1066984|NCT02748486|randomized controlled trial|randomized controlled trial
1066985|NCT02748486|metacognitive training|metacognitive training
1066986|NCT02748486|single sessions|single sessions
1066987|NCT02748473|Pilates exercises|pilates exercises
1066988|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
1066989|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
1066990|NCT02748434|Subclinical|subclinical
1066991|NCT02748421|retina surgery|retina surgery
1066992|NCT02748421|image guided surgery|image guided surgery
1066993|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
1066994|NCT02748369|TCA cycle flux|tca cycle flux
1066995|NCT02748369|in vivo measurements|in vivo measurements
1066996|NCT02748369|Stable isotopes|stable isotopes
1066997|NCT02748369|Arteriovenous balance|arteriovenous balance
1066998|NCT02748369|Metabolome|metabolome
1066999|NCT02748369|Proteome|proteome
1067000|NCT02748369|Exosomes|exosomes
1067001|NCT02748356|Spina Bifida|spina bifida
1067002|NCT02748356|Spinal Cord Injury|spinal cord injury
1067003|NCT02748317|Spina Bifida|spina bifida
1067004|NCT02748317|Spinal Cord Injury|spinal cord injury
1067005|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1067006|NCT02748317|Probiotics|probiotics
1067007|NCT02748317|Intermittent Catheterization|intermittent catheterization
1067008|NCT02748291|Sedentary|sedentary
1067009|NCT02748291|Knee osteoarthritis|knee osteoarthritis
1067010|NCT02748291|Knee pain|knee pain
1067011|NCT02748291|Gonarthritis|gonarthritis
1067012|NCT02748291|Arthritis|arthritis
1067013|NCT02748291|Walking|walking
1067014|NCT02748291|Pedometer|pedometer
1067015|NCT02748291|Physical Activity|physical activity
1067016|NCT02748291|Activities of Daily Function|activities of daily function
1067017|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
1067018|NCT02748291|Improve pain|improve pain
1067019|NCT02748291|Decrease pain|decrease pain
1067020|NCT02748291|Improve function|improve function
1067021|NCT02748291|Increase function|increase function
1067022|NCT02748291|Activity Monitoring|activity monitoring
1067023|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
1067024|NCT02748278|subfertility|subfertility
1067025|NCT02748278|In-vitro fertilization|in-vitro fertilization
1067026|NCT02748239|diabetes self-management education|diabetes self-management education
1067027|NCT02748239|insulin therapy|insulin therapy
1067028|NCT02748174|Migraine|migraine
1067030|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
1067031|NCT02748161|DEB-TACE|deb-tace
1067032|NCT02748161|QED|qed
1067033|NCT02748148|Medication Therapy Management|medication therapy management
1067034|NCT02748148|Pharmacogenomics|pharmacogenomics
1067035|NCT02748122|Adolescents|adolescents
1067036|NCT02748122|Insulin|insulin
1067037|NCT02748122|T2DM|t2dm
1067038|NCT02748109|Physical Therapy|physical therapy
1067039|NCT02748109|Balance Disorder|balance disorder
1067040|NCT02748109|Concussion|concussion
1067041|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
1067042|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
1067043|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
1067044|NCT02748083|tDCS|tdcs
1067045|NCT02748083|schizophrenia|schizophrenia
1067046|NCT02748083|cognition|cognition
1067047|NCT02748083|fMRI|fmri
1067048|NCT02748031|Congenital cataracts|congenital cataracts
1067049|NCT02748031|Opacity location|opacity location
1067050|NCT02748031|Opacity shape|opacity shape
1067051|NCT02748031|Classification|classification
1067052|NCT02748031|Clinical applicability|clinical applicability
1067053|NCT02748005|Fenugreek seed extract|fenugreek seed extract
1067054|NCT02748005|testosterone|testosterone
1067055|NCT02748005|protodioscin|protodioscin
1067056|NCT02748005|hypogonadism|hypogonadism
1067057|NCT02747979|hemodialysis|hemodialysis
1067058|NCT02747979|hyperparathyroidism|hyperparathyroidism
1067059|NCT02747979|refractory pruritus|refractory pruritus
1067060|NCT02747979|ostalgia|ostalgia
1067061|NCT02747979|insomnia|insomnia
1067062|NCT02747979|CVD incidence|cvd incidence
1067063|NCT02747979|life quality|life quality
1067064|NCT02747966|access flow|access flow
1067065|NCT02747966|access recirculation|access recirculation
1067066|NCT02747966|cardiac output|cardiac output
1067067|NCT02747966|cardiac index|cardiac index
1067068|NCT02747966|hemodialysis|hemodialysis
1067069|NCT02747927|Drug therapy|drug therapy
1067070|NCT02747901|KINESIOTAPING|kinesiotaping
1067071|NCT02747901|COLD THERAPY|cold therapy
1067072|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
1067073|NCT02747888|Thyroid|thyroid
1067074|NCT02747875|pediatric|pediatric
1067075|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
1067076|NCT02747875|methadone|methadone
1067077|NCT02747875|fentanyl|fentanyl
1067078|NCT02747875|morphine|morphine
1067079|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
1067080|NCT02747862|AFAP|afap
1067081|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
1067082|NCT02747862|FAP|fap
1067083|NCT02747862|Chart review|chart review
1067084|NCT02747797|Advanced Cancer|advanced cancer
1067085|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
1067086|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
1067087|NCT02747797|FGFR|fgfr
1067088|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
1067089|NCT02747797|VEGFR|vegfr
1067090|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
1067091|NCT02747797|PDGFR|pdgfr
1067092|NCT02747797|metastatic malignancy|metastatic malignancy
1067093|NCT02747784|cognitive dysfunction|cognitive dysfunction
1067094|NCT02747784|cognitive training|cognitive training
1067095|NCT02747771|effectiveness|effectiveness
1067096|NCT02747771|trichotillomania|trichotillomania
1067097|NCT02747771|hair pulling|hair pulling
1067098|NCT02747771|habit reversal training|habit reversal training
1067099|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
1067100|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
1067101|NCT02747758|neuropathic pain|neuropathic pain
1067102|NCT02747758|neuralgia|neuralgia
1067103|NCT02747758|tDCS|tdcs
1067104|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
1067105|NCT02747745|Caregivers|caregivers
1067106|NCT02747745|Case Management|case management
1067107|NCT02747745|Community Dwelling|community dwelling
1067108|NCT02747706|peer mentor|peer mentor
1067109|NCT02747706|health coach|health coach
1067110|NCT02747706|parent support|parent support
1067111|NCT02747706|parent mentor|parent mentor
1067112|NCT02747680|type 1 diabetes|type 1 diabetes
1067113|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
1067114|NCT02747680|healthy control|healthy control
1067115|NCT02747667|iol dislocation|iol dislocation
1067116|NCT02747667|iol complication|iol complication
1067117|NCT02747667|intraocular lens|intraocular lens
1067118|NCT02747667|Implant or Graft|implant or graft
1067120|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
1067121|NCT02747628|Transdermal nicotine|transdermal nicotine
1067122|NCT02747628|Transdermal melatonin|transdermal melatonin
1067123|NCT02747628|Postoperative pain|postoperative pain
1067124|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1067248|NCT02746614|adaptive behavior|adaptive behavior
1067221|NCT02746965|randomized controlled trials|randomized controlled trials
1067222|NCT02746965|schizophrenia|schizophrenia
1067223|NCT02746965|cognition|cognition
1067224|NCT02746939|program evaluation|program evaluation
1067125|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
1067126|NCT02747602|Healthy volunteers|healthy volunteers
1067127|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
1067128|NCT02747602|AC-1204|ac-1204
1067129|NCT02747602|Pharmacokinetic|pharmacokinetic
1067130|NCT02747602|Ketone body|ketone body
1067131|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
1067132|NCT02747576|Social-cognition|social-cognition
1067133|NCT02747576|Healthy Volunteers|healthy volunteers
1067134|NCT02747563|prostate cancer|prostate cancer
1067136|NCT02747563|digital rectal examination|digital rectal examination
1067137|NCT02747472|GIP|gip
1067138|NCT02747472|GIP receptor antagonist|gip receptor antagonist
1067139|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
1067140|NCT02747433|robot-assisted therapy|robot-assisted therapy
1067141|NCT02747433|task-oriented training|task-oriented training
1067142|NCT02747433|motor learning|motor learning
1067143|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
1067144|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
1067145|NCT02747368|Age-related macular degeneration|age-related macular degeneration
1067146|NCT02747368|Ocusweep|ocusweep
1067147|NCT02747368|Driving health|driving health
1067148|NCT02747368|Visual field|visual field
1067149|NCT02747368|Contrast sensitivity|contrast sensitivity
1333230|NCT01443923|Immunological Response|immunological response
1067150|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1067151|NCT02747342|Monotherapy|monotherapy
1067152|NCT02747329|BuMA Supreme|buma supreme
1067153|NCT02747329|Xience V/Prime|xience v/prime
1067154|NCT02747329|OCT|oct
1067155|NCT02747329|neointima formation|neointima formation
1067156|NCT02747316|Iron bioavailability|iron bioavailability
1067157|NCT02747316|Hepcidin|hepcidin
1067158|NCT02747316|Iron absorption|iron absorption
1067159|NCT02747303|brain metastases|brain metastases
1067160|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
1067161|NCT02747290|BBN-RGD|bbn-rgd
1067162|NCT02747290|PET|pet
1067163|NCT02747290|integrin αvβ3|integrin αvβ3
1067164|NCT02747290|GRPR|grpr
1067165|NCT02747264|eRAPID|erapid
1067166|NCT02747264|PRO|pro
1067167|NCT02747264|PROM|prom
1067168|NCT02747264|Adverse event|adverse event
1067169|NCT02747264|QTool|qtool
1067170|NCT02747264|CTCAE|ctcae
1067171|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
1067172|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
1067173|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
1067174|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
1067175|NCT02747238|Pregnancy|pregnancy
1067176|NCT02747238|Epidural|epidural
1067177|NCT02747238|Labor|labor
1067178|NCT02747225|electrical properties|electrical properties
1067179|NCT02747225|malignant tissues|malignant tissues
1067180|NCT02747225|in vivo|in vivo
1067181|NCT02747212|electrical properties|electrical properties
1067182|NCT02747212|malignant tissues|malignant tissues
1067183|NCT02747212|ex vivo|ex vivo
1067184|NCT02747199|SYNERGY|synergy
1067185|NCT02747199|Neointimal formation|neointimal formation
1067186|NCT02747199|OCT|oct
1067187|NCT02747199|coronary angioscopy|coronary angioscopy
1067188|NCT02747199|coronary artery disease|coronary artery disease
1067189|NCT02747186|lidocaine, jaw|lidocaine, jaw
1067190|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
1067191|NCT02747160|Cancer|cancer
1067192|NCT02747160|Anxiety|anxiety
1067193|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
1067194|NCT02747160|Elderly|elderly
1067195|NCT02747160|Caregivers|caregivers
1067196|NCT02747121|External inspections|external inspections
1067197|NCT02747108|Veterans|veterans
1067198|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1067199|NCT02747108|Prediabetes|prediabetes
1067200|NCT02747108|Decision-making|decision-making
1067201|NCT02747108|Motivation|motivation
1067202|NCT02747108|Health Promotion|health promotion
1067203|NCT02747108|Prevention and Control|prevention and control
1067204|NCT02747095|CT|ct
1067205|NCT02747095|Spectral Images|spectral images
1067206|NCT02747082|endodontic retreatment|endodontic retreatment
1067207|NCT02747082|sodium hypochlorite|sodium hypochlorite
1067208|NCT02747082|chlorhexidine|chlorhexidine
1067209|NCT02747082|calcium hydroxide|calcium hydroxide
1067210|NCT02747082|Retreatment|retreatment
1067211|NCT02747069|Heart rate|heart rate
1067212|NCT02747069|Electronic Stethoscope|electronic stethoscope
1067213|NCT02747069|Electrocardiogram|electrocardiogram
1067214|NCT02747069|Resuscitation|resuscitation
1067215|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
1067216|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
1067217|NCT02747030|Retinal vein cannulation|retinal vein cannulation
1067218|NCT02747030|Ocriplasmin|ocriplasmin
1067219|NCT02747017|transplant|transplant
1067220|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
1068033|NCT02742233|Diabetes|diabetes
1067225|NCT02746939|health literacy|health literacy
1067226|NCT02746939|fitness|fitness
1067227|NCT02746939|nutrition|nutrition
1067228|NCT02746939|education|education
1067229|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
1067230|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
1067231|NCT02746861|peer mentor|peer mentor
1067232|NCT02746861|peer supporter|peer supporter
1067233|NCT02746861|peer coach|peer coach
1067234|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
1067235|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
1067236|NCT02746835|physical condition|physical condition
1067237|NCT02746835|self-efficacy|self-efficacy
1067238|NCT02746835|fall risk|fall risk
1067239|NCT02746835|exercise program|exercise program
1067240|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
1067241|NCT02746822|thrombus aspiration|thrombus aspiration
1067242|NCT02746679|Asherman syndrome|asherman syndrome
1067243|NCT02746679|Mindfulness|mindfulness
1067244|NCT02746679|Anxiety|anxiety
1067245|NCT02746679|Depression|depression
1067246|NCT02746679|Quality of Life|quality of life
1067247|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
1067249|NCT02746614|motor proficiency|motor proficiency
1067250|NCT02746614|psychomotor therapy|psychomotor therapy
1067251|NCT02746614|intellectual disability|intellectual disability
1067252|NCT02746588|miscarriage|miscarriage
1067253|NCT02746588|uterine abnormalities|uterine abnormalities
1067254|NCT02746588|Chronic infection|chronic infection
1067255|NCT02746562|Assisted reproduction|assisted reproduction
1067256|NCT02746562|In vitro fertilisation|in vitro fertilisation
1067257|NCT02746562|Frozen embryo transfer (FET)|frozen embryo transfer (fet)
1067258|NCT02746536|COPD|copd
1067259|NCT02746536|Inspiratory capacity|inspiratory capacity
1067260|NCT02746536|Exercise|exercise
1067262|NCT02746523|Concussion|concussion
1067263|NCT02746523|Biomarkers|biomarkers
1067264|NCT02746497|Menopause|menopause
1067265|NCT02746497|Hot flushes|hot flushes
1067266|NCT02746497|Acupuncture|acupuncture
1067267|NCT02746497|Randomized controlled trial|randomized controlled trial
1067268|NCT02746458|Blood Flow Restriction|blood flow restriction
1067269|NCT02746458|Muscle Weakness|muscle weakness
1067270|NCT02746458|Physical therapy techniques|physical therapy techniques
1067271|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
1067272|NCT02746445|Autism|autism
1067273|NCT02746445|ASD|asd
1067274|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
1067275|NCT02746432|CRC-Insulin|crc-insulin
1067276|NCT02746354|Chronic Pain|chronic pain
1067277|NCT02746354|Analgesics, Opioid|analgesics, opioid
1067278|NCT02746354|Primary Health Care|primary health care
1067279|NCT02746276|malnutrition|malnutrition
1067280|NCT02746276|antibiotics|antibiotics
1067281|NCT02746276|antimicrobial resistance|antimicrobial resistance
1067282|NCT02746276|pharmacokinetics|pharmacokinetics
1067283|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
1067284|NCT02746237|Serotonin|serotonin
1067285|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1067286|NCT02746237|Pharmacokinetics|pharmacokinetics
1067287|NCT02746237|Phase 1|phase 1
1067288|NCT02746237|Healthy Volunteers|healthy volunteers
1067289|NCT02746224|Colorectal cancer|colorectal cancer
1067290|NCT02746224|Colorectal surgery|colorectal surgery
1067291|NCT02746211|immunology|immunology
1067292|NCT02746211|pathogenicity|pathogenicity
1067293|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
1067294|NCT02746185|cancer|cancer
1067295|NCT02746185|venous thromboembolism|venous thromboembolism
1067296|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
1067297|NCT02746185|rivaroxaban|rivaroxaban
1067298|NCT02746172|cochlear implants|cochlear implants
1067299|NCT02746172|Mapping|mapping
1067300|NCT02746172|in-situ audiometry|in-situ audiometry
1067302|NCT02746107|oral anticoagulant|oral anticoagulant
1067303|NCT02746107|atrial fibrillation|atrial fibrillation
1067304|NCT02746107|stroke|stroke
1067305|NCT02746107|decision to treat|decision to treat
1067306|NCT02746081|BAY1436032|bay1436032
1067307|NCT02746081|Solid tumors|solid tumors
1067308|NCT02746081|IDH1|idh1
1067309|NCT02746081|Cancer|cancer
1067310|NCT02746081|Safety|safety
1067311|NCT02746081|Tolerability|tolerability
1067312|NCT02746081|Pharmacokinetics|pharmacokinetics
1067313|NCT02746081|Pharmacodynamics|pharmacodynamics
1067314|NCT02746081|Efficacy|efficacy
1067315|NCT02746081|Food-effect|food-effect
1067316|NCT02746068|Bone Marrow Lesions|bone marrow lesions
1067317|NCT02746068|AXS02|axs02
1067318|NCT02746068|Axsome|axsome
1067319|NCT02746068|Knee OA|knee oa
1067320|NCT02746068|Osteoarthritis|osteoarthritis
1067321|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
1067322|NCT02746042|Sinupret extract|sinupret extract
1067323|NCT02746042|herbal medicinal product|herbal medicinal product
1067326|NCT02745990|erythropoietin|erythropoietin
1067327|NCT02745990|preterm|preterm
1067328|NCT02745990|brain injury|brain injury
1067329|NCT02745990|cerebral palsy|cerebral palsy
1067330|NCT02745990|PVL|pvl
1067331|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
1067332|NCT02745951|cardioplegia|cardioplegia
1067333|NCT02745951|cardioprotection|cardioprotection
1067334|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
1067335|NCT02745951|heliox|heliox
1067336|NCT02745938|Exercise test|exercise test
1067337|NCT02745938|GDF-15|gdf-15
1067338|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
1067339|NCT02745925|Iron bioavailability|iron bioavailability
1067340|NCT02745925|Inflammation|inflammation
1067341|NCT02745925|Hepcidin|hepcidin
1067342|NCT02745925|Iron absorption|iron absorption
1067343|NCT02745912|Drug Therapy|drug therapy
1067344|NCT02745899|asthma|asthma
1067345|NCT02745899|cow milk|cow milk
1067346|NCT02745899|pulmonary function testing|pulmonary function testing
1067347|NCT02745899|children|children
1067348|NCT02745899|mucus|mucus
1067349|NCT02745860|selexipag|selexipag
1067350|NCT02745860|pharmacokinetics|pharmacokinetics
1067351|NCT02745821|coronary flow reserve|coronary flow reserve
1067352|NCT02745821|fractional flow reserve|fractional flow reserve
1067353|NCT02745821|diabetes mellitus|diabetes mellitus
1067354|NCT02745821|coronary artery disease|coronary artery disease
1067355|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
1067356|NCT02745821|coronary physiology|coronary physiology
1067357|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
1067358|NCT02745795|Motivational interview|motivational interview
1067359|NCT02745795|adolescents|adolescents
1067360|NCT02745795|obesity|obesity
1067361|NCT02745795|overweight|overweight
1067362|NCT02745795|physical activity|physical activity
1067363|NCT02745795|diet|diet
1067364|NCT02745782|Pulpitis|pulpitis
1067365|NCT02745782|Syncope|syncope
1067366|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
1067367|NCT02745756|Children|children
1067368|NCT02745756|Cancer|cancer
1067369|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
1067370|NCT02745743|Phase 1|phase 1
1067371|NCT02745743|Dose escalation|dose escalation
1067372|NCT02745743|Dose expansion|dose expansion
1067373|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
1067374|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
1067375|NCT02745717|Severe aplastic anemia|severe aplastic anemia
1067376|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
1067377|NCT02745717|cord blood transfusion|cord blood transfusion
1067378|NCT02745704|chronic hepatitis B|chronic hepatitis b
1067379|NCT02745704|peginterferon alfa|peginterferon alfa
1067380|NCT02745691|quality of life|quality of life
1067381|NCT02745691|psychometric validation|psychometric validation
1067382|NCT02745691|international field study|international field study
1067383|NCT02745691|patient-reported outcome (PRO)|patient-reported outcome (pro)
1067384|NCT02745678|Enema|enema
1067385|NCT02745678|Ulcerative Colitis|ulcerative colitis
1067386|NCT02745652|median nerve|median nerve
1067387|NCT02745652|wrist joint|wrist joint
1067388|NCT02745652|carpal tunnel|carpal tunnel
1067389|NCT02745639|rectal cancer|rectal cancer
1067390|NCT02745639|radiotherapy|radiotherapy
1067391|NCT02745639|chemotherapy|chemotherapy
1067392|NCT02745639|VMAT|vmat
1067393|NCT02745639|toxicity|toxicity
1067395|NCT02745600|Liver|liver
1067396|NCT02745600|Ablation Techniques|ablation techniques
1067397|NCT02745600|Treatment Simulation|treatment simulation
1067398|NCT02745600|Computer assisted therapy|computer assisted therapy
1067399|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
1067400|NCT02745561|Endostatin|endostatin
1067401|NCT02745561|Oxaliplatin|oxaliplatin
1067402|NCT02745561|Esophageal Cancer|esophageal cancer
1067596|NCT02744534|Oncology|oncology
1067403|NCT02745561|chemoradiotherapy|chemoradiotherapy
1067404|NCT02745548|Lung Cancer|lung cancer
1067405|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
1067406|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
1067407|NCT02745535|Hepatitis C relapse|hepatitis c relapse
1067408|NCT02745522|Placebo analgesia|placebo analgesia
1067409|NCT02745522|Working memory|working memory
1067410|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
1067411|NCT02745509|EIPL|eipl
1067412|NCT02745509|Gastric Cancer|gastric cancer
1067413|NCT02745496|Image-guided biopsy|image-guided biopsy
1067414|NCT02745496|Tumour detection|tumour detection
1067415|NCT02745496|Diagnostic|diagnostic
1067416|NCT02745496|Biomarkers|biomarkers
1067417|NCT02745483|RFA|rfa
1067418|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
1067419|NCT02745470|functional MRI|functional mri
1067420|NCT02745470|GLP-1|glp-1
1067421|NCT02745470|appetite|appetite
1067422|NCT02745470|activation of brain|activation of brain
1067423|NCT02745470|connectivity|connectivity
1067424|NCT02745444|Living kidney transplantation|living kidney transplantation
1067425|NCT02745444|Chronic kidney disease|chronic kidney disease
1067426|NCT02745444|Acute kidney injury|acute kidney injury
1067427|NCT02745431|Likeability|likeability
1067428|NCT02745431|Being liked|being liked
1067429|NCT02745405|Weight Stigma|weight stigma
1067430|NCT02745405|Cortisol Reactivity|cortisol reactivity
1067431|NCT02745405|Eating Behavior|eating behavior
1067432|NCT02745392|migraine|migraine
1067433|NCT02745392|migraine headache|migraine headache
1067434|NCT02745392|acute migraine|acute migraine
1067435|NCT02745392|acute migraine headache|acute migraine headache
1067436|NCT02745353|Cancer|cancer
1067437|NCT02745353|Constipation|constipation
1067438|NCT02745353|Opioid|opioid
1067439|NCT02745327|oral vaccination|oral vaccination
1067440|NCT02745327|nutrition|nutrition
1067441|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
1067442|NCT02745275|Peer Education|peer education
1067443|NCT02745275|Health Coaches|health coaches
1067444|NCT02745275|Community Dwelling Seniors|community dwelling seniors
1067445|NCT02745275|Health Literacy|health literacy
1067446|NCT02745275|Health Education|health education
1067447|NCT02745275|Healthy Ageing|healthy ageing
1067448|NCT02745236|Atrial Fibrillation|atrial fibrillation
1067449|NCT02745236|Health Related Quality of Life|health related quality of life
1067450|NCT02745236|Nurse Practitioner|nurse practitioner
1067451|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
1067452|NCT02745236|Patient Satisfaction|patient satisfaction
1067453|NCT02745171|Parkinson's disease|parkinson's disease
1067454|NCT02745171|Quality of life|quality of life
1067455|NCT02745171|Functional mobility|functional mobility
1067456|NCT02745171|Follow up|follow up
1067457|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
1067458|NCT02745158|FOP|fop
1067459|NCT02745158|International FOP Association|international fop association
1067460|NCT02745158|Patient Advocacy Group|patient advocacy group
1067461|NCT02745158|Patient Registry|patient registry
1067462|NCT02745158|Natural History|natural history
1067463|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
1067464|NCT02745158|Observational Database|observational database
1067465|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
1067466|NCT02745158|BMP|bmp
1067467|NCT02745158|Bone Growth|bone growth
1067468|NCT02745158|Joint|joint
1067469|NCT02745158|Mobility|mobility
1067470|NCT02745158|Flare-Up|flare-up
1067471|NCT02745158|Heterotopic Ossification|heterotopic ossification
1067472|NCT02745158|Ectopic Bone|ectopic bone
1067473|NCT02745158|Osteochondroma|osteochondroma
1067474|NCT02745158|Hallux Valgus|hallux valgus
1067475|NCT02745158|ALK2|alk2
1067476|NCT02745158|ACVR1|acvr1
1067477|NCT02745158|Activin A|activin a
1067478|NCT02745158|IFOPA|ifopa
1067479|NCT02745158|Activin A Receptor Type I|activin a receptor type i
1067480|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
1067481|NCT02745145|Double-Blind Method|double-blind method
1067482|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
1067483|NCT02745145|Systemic Scleroderma|systemic scleroderma
1067484|NCT02745145|Abituzumab|abituzumab
1067485|NCT02745145|Mycophenolate|mycophenolate
1067486|NCT02745145|Efficacy, Safety|efficacy, safety
1067487|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
1067488|NCT02745132|Neurocognition Disorders|neurocognition disorders
1067489|NCT02745132|Cognitive Impairments|cognitive impairments
1067490|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1067491|NCT02745132|MRI functional|mri functional
1067492|NCT02745132|Verbal fluency|verbal fluency
1067493|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
1067494|NCT02745093|Abortion induced|abortion induced
1067495|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
1067496|NCT02745093|safety|safety
1067497|NCT02745093|effectiveness|effectiveness
1067498|NCT02745093|misoprostol|misoprostol
1067696|NCT02744053|MBI|mbi
1067499|NCT02745093|mifepristone|mifepristone
1067500|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
1067501|NCT02745080|secukinumab|secukinumab
1067502|NCT02745080|adalimumab|adalimumab
1067503|NCT02745080|monoclonal antibody|monoclonal antibody
1067504|NCT02745080|CASPAR|caspar
1067505|NCT02745054|oral anticoagulants|oral anticoagulants
1067506|NCT02745054|bleeding|bleeding
1067507|NCT02745054|anticoagulation reversal|anticoagulation reversal
1067508|NCT02745041|Fibrinogen|fibrinogen
1067509|NCT02745041|Cryoprecipitate|cryoprecipitate
1067510|NCT02745028|delayed gastric emptying|delayed gastric emptying
1067511|NCT02745028|children|children
1067512|NCT02745028|monosodium glutamate|monosodium glutamate
1067513|NCT02745015|periodontitis|periodontitis
1067514|NCT02745015|diabetes|diabetes
1067515|NCT02745015|HbA1c|hba1c
1067516|NCT02745015|inflammation|inflammation
1067517|NCT02745002|Bronchoscopy|bronchoscopy
1067518|NCT02745002|Bronchoscopes|bronchoscopes
1067519|NCT02744989|Schizophrenia|schizophrenia
1067520|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
1067521|NCT02744989|Sham|sham
1067522|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
1067523|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
1068330|NCT02740114|Bupivacaine|bupivacaine
1067524|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
1067525|NCT02744976|Coronary artery disease|coronary artery disease
1067526|NCT02744976|Atherosclerosis|atherosclerosis
1067527|NCT02744976|Prediabetes|prediabetes
1067528|NCT02744976|Intravascular ultrasound|intravascular ultrasound
1067529|NCT02744976|Insulin resistance|insulin resistance
1067530|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
1067531|NCT02744976|Metformin|metformin
1067532|NCT02744950|pulley|pulley
1067533|NCT02744950|scalp defects|scalp defects
1067534|NCT02744911|speech problems|speech problems
1067535|NCT02744898|uterus|uterus
1067536|NCT02744898|gynecological|gynecological
1067537|NCT02744898|corpus uteri|corpus uteri
1067538|NCT02744872|lung transplantation|lung transplantation
1067539|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
1067540|NCT02744859|Decision Making|decision making
1067541|NCT02744859|Consumption|consumption
1067542|NCT02744859|Economics|economics
1067543|NCT02744846|antibiotics|antibiotics
1067544|NCT02744846|children|children
1067545|NCT02744846|pediatric|pediatric
1067546|NCT02744846|body mass index|body mass index
1067547|NCT02744846|Observational Study|observational study
1067548|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
1067549|NCT02744846|Obesity|obesity
1067550|NCT02744846|Growth Trajectory|growth trajectory
1067551|NCT02744846|Cohort Study|cohort study
1067552|NCT02744846|Electronic Medical Record|electronic medical record
1067553|NCT02744846|Qualitative Research|qualitative research
1067555|NCT02744807|intrauterine adhesions|intrauterine adhesions
1067556|NCT02744807|Chronic endometritis|chronic endometritis
1067557|NCT02744807|infections|infections
1067558|NCT02744807|Hysteroscopy|hysteroscopy
1067559|NCT02744781|Muscular Atrophy|muscular atrophy
1067560|NCT02744781|Asymmetry|asymmetry
1067561|NCT02744781|Athletes|athletes
1067562|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
1067563|NCT02744716|intrauterine balloon|intrauterine balloon
1067564|NCT02744716|uterine endometrial repair|uterine endometrial repair
1067565|NCT02744716|intrauterine adhesion|intrauterine adhesion
1067566|NCT02744716|aspirin|aspirin
1067567|NCT02744690|Eye Disease|eye disease
1067568|NCT02744690|Intraocular Pressure|intraocular pressure
1067569|NCT02744690|Visual Acuity|visual acuity
1067570|NCT02744690|Trabeculectomy|trabeculectomy
1067571|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
1067572|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
1067573|NCT02744677|Pulmonary Atresia|pulmonary atresia
1067574|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
1067575|NCT02744677|Truncus Arteriosus|truncus arteriosus
1067576|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
1067577|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
1067578|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
1067579|NCT02744677|TPV|tpv
1067580|NCT02744677|TPVR|tpvr
1067581|NCT02744677|TPVI|tpvi
1067582|NCT02744664|Lung Neoplasms|lung neoplasms
1067583|NCT02744664|EGFR mutation|egfr mutation
1067584|NCT02744664|Cryotherapy|cryotherapy
1067585|NCT02744664|Icotinib|icotinib
1067586|NCT02744638|bacterial vaginosis|bacterial vaginosis
1067587|NCT02744638|probiotics|probiotics
1067588|NCT02744638|Amsel Score|amsel score
1067589|NCT02744638|Nugent Score|nugent score
1067590|NCT02744599|Feasibility trial|feasibility trial
1067591|NCT02744586|Sexually transmitted infections|sexually transmitted infections
1067592|NCT02744586|Neglected tropical diseases|neglected tropical diseases
1067593|NCT02744586|Non-communicable diseases|non-communicable diseases
1067594|NCT02744534|Prostate Cancer|prostate cancer
1067595|NCT02744534|Imaging Technology|imaging technology
1067597|NCT02744534|Prostate Biopsy|prostate biopsy
1067598|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
1067599|NCT02744495|cardiac surgery|cardiac surgery
1067600|NCT02744495|corticoids|corticoids
1067601|NCT02744495|droperidol|droperidol
1067602|NCT02744495|antiemetics|antiemetics
1067603|NCT02744495|Postoperative Vomiting|postoperative vomiting
1067604|NCT02744495|Postoperative Nausea|postoperative nausea
1067605|NCT02744495|Postoperative Emesis|postoperative emesis
1067606|NCT02744495|prophylaxis|prophylaxis
1067607|NCT02744469|Tuberculosis|tuberculosis
1067608|NCT02744469|population structure|population structure
1067609|NCT02744469|implications|implications
1067610|NCT02744469|lineages|lineages
1067611|NCT02744469|spoligotyping|spoligotyping
1067612|NCT02744469|sputum|sputum
1067613|NCT02744469|resistance|resistance
1067614|NCT02744469|culture|culture
1067615|NCT02744469|diagnostics|diagnostics
1067616|NCT02744469|outcome|outcome
1067617|NCT02744469|new/retreatment patient|new/retreatment patient
1067618|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
1067619|NCT02744456|Norvasc|norvasc
1067620|NCT02744456|Cozaar|cozaar
1067621|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
1067622|NCT02744456|losartan potassium tablets|losartan potassium tablets
1067623|NCT02744456|Hypertension|hypertension
1067624|NCT02744456|High Blood Pressure|high blood pressure
1067625|NCT02744430|Medical expulsive therapy|medical expulsive therapy
1067626|NCT02744430|ureteral stone|ureteral stone
1067627|NCT02744430|stent pain|stent pain
1067628|NCT02744417|smoking cessation|smoking cessation
1067629|NCT02744417|tobacco|tobacco
1067630|NCT02744417|periodontal|periodontal
1067631|NCT02744417|subgingival microorganisms|subgingival microorganisms
1067632|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
1067633|NCT02744352|quality of recovery score|quality of recovery score
1067634|NCT02744352|pain score|pain score
1067635|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
1067636|NCT02744339|PH-HFpEF|ph-hfpef
1067637|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
1067638|NCT02744287|Non Resectable Pancreatic Cancer|non resectable pancreatic cancer
1067639|NCT02744287|BPX-601|bpx-601
1107788|NCT02503696|Cancer|cancer
1067640|NCT02744287|AP1903|ap1903
1067641|NCT02744287|CAR T|car t
1067642|NCT02744287|PSCA-CAR|psca-car
1067643|NCT02744274|acupuncture|acupuncture
1067644|NCT02744274|chemotherapy|chemotherapy
1067645|NCT02744274|peripheral neuropathy|peripheral neuropathy
1067646|NCT02744274|randomized clinical trial|randomized clinical trial
1067647|NCT02744274|numbness|numbness
1067648|NCT02744261|HIV|hiv
1067649|NCT02744261|STI|sti
1067650|NCT02744261|Primary Prevention|primary prevention
1067651|NCT02744261|Topical Microbicides|topical microbicides
1067652|NCT02744261|User Experience|user experience
1067653|NCT02744261|Drug Delivery Systems|drug delivery systems
1067654|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1067655|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
1067656|NCT02744196|rheumatism|rheumatism
1067657|NCT02744196|Acellbia|acellbia
1067658|NCT02744196|methotrexate|methotrexate
1067659|NCT02744196|biologic therapy|biologic therapy
1067660|NCT02744196|monoclonal antibody|monoclonal antibody
1067661|NCT02744196|rituximab|rituximab
1067662|NCT02744183|Exercise|exercise
1067663|NCT02744183|Fasted|fasted
1067664|NCT02744183|Glucose|glucose
1067665|NCT02744183|Energy Balance|energy balance
1067666|NCT02744170|COPD|copd
1067667|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
1067668|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
1067669|NCT02744170|oxygen therapy|oxygen therapy
1067670|NCT02744131|PCOS|pcos
1067671|NCT02744131|Metformin|metformin
1067672|NCT02744131|OCP|ocp
1067673|NCT02744131|metabolic parameters|metabolic parameters
1067674|NCT02744118|Media Use|media use
1067675|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
1067676|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
1067677|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
1067678|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
1067679|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
1067680|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
1067681|NCT02744079|diet|diet
1067682|NCT02744079|dietary intervention|dietary intervention
1067683|NCT02744079|carbohydrate restriction|carbohydrate restriction
1067684|NCT02744079|low carbohydrate|low carbohydrate
1067685|NCT02744079|fat restriction|fat restriction
1067686|NCT02744079|low fat|low fat
1067687|NCT02744079|cancer|cancer
1067688|NCT02744079|breast cancer|breast cancer
1067689|NCT02744079|pre-surgical window|pre-surgical window
1067690|NCT02744079|biomarker|biomarker
1067691|NCT02744053|Breast Cancer|breast cancer
1067692|NCT02744053|Malignant neoplasm of breast|malignant neoplasm of breast
1067693|NCT02744053|Triple Negative Breast Cancer|triple negative breast cancer
1067694|NCT02744053|TNBC|tnbc
1067695|NCT02744053|Tc99m Sestamibi Molecular Breast Imaging|tc99m sestamibi molecular breast imaging
1067697|NCT02744053|Dynamic Contrast Enhanced Molecular Resonance Imaging|dynamic contrast enhanced molecular resonance imaging
1067698|NCT02744053|DCE-MRI|dce-mri
1067699|NCT02744040|HIV reservoir|hiv reservoir
1067700|NCT02744040|alcohol|alcohol
1067701|NCT02744040|ART|art
1067702|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
1067703|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
1067704|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
1067705|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
1067706|NCT02743988|cerebral oxygenation|cerebral oxygenation
1067707|NCT02743988|NIRS|nirs
1067708|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
1067709|NCT02743988|bradycardia|bradycardia
1067710|NCT02743988|hypoxemia|hypoxemia
1067711|NCT02743988|cerebral perfusion|cerebral perfusion
1067712|NCT02743988|cardiac output|cardiac output
1067713|NCT02743988|apnea|apnea
1067714|NCT02743988|desaturation|desaturation
1067715|NCT02743988|oxygen saturation target range|oxygen saturation target range
1067716|NCT02743949|Drug therapy|drug therapy
1067717|NCT02743910|preoperative|preoperative
1067718|NCT02743910|neoadjuvant|neoadjuvant
1067719|NCT02743910|plasma tumor DNA|plasma tumor dna
1067720|NCT02743910|ptDNA|ptdna
1067721|NCT02743897|end-stage renal disease|end-stage renal disease
1067722|NCT02743871|FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps|fih, pharmacokinetics, pharmacodynamics, safety, tolerability, atopic dermatitis, chronic rhinosinusitis, nasal polyps
1067723|NCT02743858|Lymphedema|lymphedema
1067724|NCT02743858|Surveillance Program|surveillance program
1067725|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
1067726|NCT02743858|16-220|16-220
1067727|NCT02743845|Rare|rare
1067728|NCT02743845|Undiagnosed|undiagnosed
1067729|NCT02743845|Orphan Disease|orphan disease
1067730|NCT02743845|Genomic Sequencing|genomic sequencing
1067731|NCT02743832|Surgery, Oral|surgery, oral
1067732|NCT02743832|Tumor budding|tumor budding
1067733|NCT02743819|Melanoma|melanoma
1067734|NCT02743819|Pembrolizumab|pembrolizumab
1067735|NCT02743819|Ipilimumab|ipilimumab
1067736|NCT02743806|Drug Therapy|drug therapy
1067737|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
1067738|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
1067739|NCT02743793|longitudinal follow-up|longitudinal follow-up
1067740|NCT02743780|Ocular Hypertension|ocular hypertension
1067741|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
1067742|NCT02743780|POAG|poag
1067743|NCT02743780|Glaucoma|glaucoma
1067744|NCT02743767|Airway management|airway management
1067745|NCT02743767|General anaesthesia|general anaesthesia
1067746|NCT02743767|Critical incidents|critical incidents
1067747|NCT02743767|Complications|complications
1067748|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
1067749|NCT02743728|perinatal stroke|perinatal stroke
1067750|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
1067751|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
1067752|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
1067753|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
1067754|NCT02743728|infant|infant
1067755|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1067756|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
1067757|NCT02743715|Neuromodulation|neuromodulation
1067758|NCT02743702|Effectiveness|effectiveness
1067759|NCT02743702|Physical therapy modalities|physical therapy modalities
1067760|NCT02743702|neuromuscular diseases|neuromuscular diseases
1067761|NCT02743689|Postoperative|postoperative
1067762|NCT02743689|Cardiac surgery|cardiac surgery
1067763|NCT02743676|Avian Influenza|avian influenza
1067764|NCT02743663|pediatric|pediatric
1067765|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
1067766|NCT02743663|preschool|preschool
1067767|NCT02743663|asthma|asthma
1067768|NCT02743663|wheeze|wheeze
1067769|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
1067770|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
1067771|NCT02743637|Cancer|cancer
1067772|NCT02743637|Oncology|oncology
1067773|NCT02743637|Solid Tumors|solid tumors
1067774|NCT02743637|Phase 1|phase 1
1067775|NCT02743637|SDX-7320|sdx-7320
1067776|NCT02743637|SynDevRx|syndevrx
1067777|NCT02743637|MetAP2|metap2
1067778|NCT02743637|Breast|breast
1067779|NCT02743637|Post menopausal|post menopausal
1067780|NCT02743637|Colorectal|colorectal
1067781|NCT02743637|Pancreatic|pancreatic
1067782|NCT02743637|Ovarian|ovarian
1067783|NCT02743637|Endometrial|endometrial
1067784|NCT02743637|Esophageal|esophageal
1067785|NCT02743637|Lung|lung
1067786|NCT02743637|Renal|renal
1067787|NCT02743637|Prostate|prostate
1067788|NCT02743637|Liver|liver
1067789|NCT02743611|BPX-701|bpx-701
1067790|NCT02743611|AP1903|ap1903
1067791|NCT02743611|Rimiducid|rimiducid
1067792|NCT02743611|AML|aml
1067793|NCT02743611|MDS|mds
1067794|NCT02743611|Primary Refractory AML|primary refractory aml
1067795|NCT02743611|Relapsed AML|relapsed aml
1067797|NCT02743598|HIV infection|hiv infection
1067798|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
1067800|NCT02743598|Neurocognitive function|neurocognitive function
1067801|NCT02743572|premature infant|premature infant
1067802|NCT02743572|anemia|anemia
1067803|NCT02743572|iron-fortification|iron-fortification
1067804|NCT02743572|parenteral nutrition|parenteral nutrition
1067805|NCT02743572|randomized controlled trial|randomized controlled trial
1067806|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
1067807|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1067808|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1067809|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
1067810|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
1067811|NCT02743546|JNJ-64052781|jnj-64052781
1067812|NCT02743546|Ibrutinib|ibrutinib
1067813|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
1067814|NCT02743520|sleep apnea|sleep apnea
1067815|NCT02743481|Pesticide|pesticide
1067816|NCT02743481|Agriculture|agriculture
1067817|NCT02743481|Cancer|cancer
1067818|NCT02743481|Childhood|childhood
1067819|NCT02743481|Leukemia|leukemia
1067820|NCT02743468|Bronchoscopy|bronchoscopy
1067821|NCT02743468|Pollutants|pollutants
1068839|NCT02736669|body weight|body weight
1067822|NCT02743468|Human Pulmonary Cells|human pulmonary cells
1067823|NCT02743468|Cytochrome P450|cytochrome p450
1067824|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
1067825|NCT02743455|Fever|fever
1067826|NCT02743455|Immunogenicity|immunogenicity
1067827|NCT02743455|MVA-BN|mva-bn
1067828|NCT02743455|Reactogenicity|reactogenicity
1067829|NCT02743455|Vaccine|vaccine
1067830|NCT02743455|Yellow|yellow
1067831|NCT02743429|ch14.18/CHO|ch14.18/cho
1067832|NCT02743429|neuroblastoma|neuroblastoma
1067833|NCT02743429|long term infusion|long term infusion
1067834|NCT02743416|Screening|screening
1067835|NCT02743416|Stroke prevention|stroke prevention
1067836|NCT02743416|Cost effectiveness|cost effectiveness
1067837|NCT02743390|blood pressure|blood pressure
1067838|NCT02743390|inflammation|inflammation
1067839|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
1067843|NCT02743351|Cell Transplants|cell transplants
1067844|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
1067846|NCT02743351|Hematologic Malignancies|hematologic malignancies
1067847|NCT02743351|Hematologic Malignancy|hematologic malignancy
1067848|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
1067849|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1067850|NCT02743351|ALL|all
1067851|NCT02743351|AML|aml
1067852|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
1067853|NCT02743351|MDS|mds
1067854|NCT02743351|Allogeneic|allogeneic
1067855|NCT02743351|CML|cml
1067856|NCT02743351|Stem Cell Transplant|stem cell transplant
1067857|NCT02743351|Transplant|transplant
1067858|NCT02743338|Sleep Restriction|sleep restriction
1067859|NCT02743338|Sleep Compression|sleep compression
1067860|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
1067861|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
1067862|NCT02743312|Physical Activity|physical activity
1067863|NCT02743312|Neurorehabilitation|neurorehabilitation
1067864|NCT02743286|sedentary behavior|sedentary behavior
1067865|NCT02743286|sitting|sitting
1067866|NCT02743286|feasibility|feasibility
1067867|NCT02743286|endothelial function|endothelial function
1067868|NCT02743286|metabolism|metabolism
1067869|NCT02743260|phenotype|phenotype
1067870|NCT02743260|transporter|transporter
1067871|NCT02743260|cocktail|cocktail
1067872|NCT02743247|Healthy volunteer|healthy volunteer
1067873|NCT02743221|metastatic|metastatic
1067874|NCT02743221|colorectal|colorectal
1067875|NCT02743221|cancer|cancer
1067876|NCT02743221|untreated|untreated
1067877|NCT02743221|first-line|first-line
1067878|NCT02743221|S95005|s95005
1067879|NCT02743221|bevacizumab|bevacizumab
1067880|NCT02743221|capecitabine|capecitabine
1067881|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1067882|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
1067883|NCT02743208|Hip Prosthesis|hip prosthesis
1067884|NCT02743169|Geographic Information Systems|geographic information systems
1067885|NCT02743169|Spatial Analysis|spatial analysis
1067886|NCT02743169|Emergency Medical Services|emergency medical services
1067887|NCT02743156|IVUS|ivus
1067888|NCT02743156|Acute Renal Failure|acute renal failure
1067889|NCT02743156|Angioplasty|angioplasty
1067890|NCT02743156|stent|stent
1067891|NCT02743156|contrast|contrast
1067892|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
1067893|NCT02743156|intravascular ultrasound|intravascular ultrasound
1067894|NCT02743143|Exercise therapy|exercise therapy
1067895|NCT02743143|Cardiovascular disease|cardiovascular disease
1067896|NCT02743143|Risk|risk
1067897|NCT02743130|Berries|berries
1067898|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
1067899|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
1067900|NCT02743130|Sucrose|sucrose
1067901|NCT02743130|Inverted sugar|inverted sugar
1067902|NCT02743130|Postprandial glucose response|postprandial glucose response
1067903|NCT02743130|Postprandial insulin response|postprandial insulin response
1067904|NCT02743117|Trivalent|trivalent
1067905|NCT02743117|Influenza|influenza
1067906|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
1067907|NCT02743117|Vaccine|vaccine
1067908|NCT02743117|Prevention|prevention
1067909|NCT02743117|Healthy|healthy
1067910|NCT02743117|Monovalent|monovalent
1067911|NCT02743091|heart failure|heart failure
1067912|NCT02743091|survival|survival
1067913|NCT02743091|end-stage kidney disease|end-stage kidney disease
1067914|NCT02743078|Glioblastoma|glioblastoma
1067915|NCT02743078|Glioma|glioma
1067916|NCT02743078|Gliosarcoma|gliosarcoma
1067917|NCT02743078|Optune|optune
1067918|NCT02743078|TTFields|ttfields
1067919|NCT02743065|HepaSphere|hepasphere
1067920|NCT02743039|Low income|low income
1067921|NCT02743039|Education|education
1067922|NCT02743039|Poverty|poverty
1067923|NCT02743039|Children|children
1067924|NCT02743039|Parents|parents
1067925|NCT02743039|Head Start|head start
1067926|NCT02743000|fMRI|fmri
1067927|NCT02743000|emotion conflict task|emotion conflict task
1067928|NCT02743000|monetary incentive delay|monetary incentive delay
1067929|NCT02742974|Trauma|trauma
1109365|NCT02495220|pov|pov
1067930|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
1067931|NCT02742974|Perioperative|perioperative
1067932|NCT02742974|Complications|complications
1067933|NCT02742974|Hemodynamics|hemodynamics
1067934|NCT02742974|Operative procedures|operative procedures
1067935|NCT02742961|orthopedics|orthopedics
1067936|NCT02742961|anesthesiology|anesthesiology
1067937|NCT02742961|nerve block|nerve block
1067938|NCT02742961|length of stay|length of stay
1067939|NCT02742961|Patient readmission|patient readmission
1067940|NCT02742948|elective caesarean section|elective caesarean section
1067941|NCT02742948|antibiotics|antibiotics
1067942|NCT02742948|endometritis|endometritis
1067943|NCT02742922|self harm|self harm
1067944|NCT02742922|culturally adapted therapy|culturally adapted therapy
1067945|NCT02742922|problem solving therapy|problem solving therapy
1067946|NCT02742922|low and middle income countries|low and middle income countries
1067947|NCT02742896|Erectile dysfunction|erectile dysfunction
1067948|NCT02742896|cognitive function|cognitive function
1067949|NCT02742870|Diffusion MRI|diffusion mri
1067950|NCT02742870|ADC histograms|adc histograms
1067951|NCT02742870|Adnexal tumor|adnexal tumor
1067952|NCT02742844|phase I/IIa|phase i/iia
1067953|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
1067954|NCT02742844|ABCB5+|abcb5+
1067955|NCT02742844|APZ2|apz2
1067956|NCT02742844|chronic venous ulcer|chronic venous ulcer
1067957|NCT02742844|varicose ulcer|varicose ulcer
1067958|NCT02742844|skin ulcer|skin ulcer
1067959|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
1067960|NCT02742844|APZ2-II-01|apz2-ii-01
1067961|NCT02742844|autologous use|autologous use
1067962|NCT02742844|somatic cell therapy|somatic cell therapy
1067963|NCT02742818|forced-air warming|forced-air warming
1067964|NCT02742818|hypothermia|hypothermia
1067965|NCT02742818|endovascular surgery|endovascular surgery
1067966|NCT02742818|blanket|blanket
1067967|NCT02742805|hives|hives
1067968|NCT02742792|sleep apnea|sleep apnea
1067969|NCT02742792|elderly|elderly
1067970|NCT02742792|exercise|exercise
1067971|NCT02742766|Dose escalation study|dose escalation study
1067972|NCT02742766|Safety|safety
1067973|NCT02742766|Pharmacodynamics|pharmacodynamics
1067974|NCT02742766|Pharmacokinetics|pharmacokinetics
1067975|NCT02742766|GSK3008356|gsk3008356
1067976|NCT02742766|Tolerability|tolerability
1067977|NCT02742753|Otitis|otitis
1067978|NCT02742753|Vaccine|vaccine
1067979|NCT02742753|Sweden|sweden
1067980|NCT02742753|Database|database
1067981|NCT02742675|prostate cancer|prostate cancer
1067982|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
1067983|NCT02742675|local treatment|local treatment
1067984|NCT02742662|Obesity|obesity
1067985|NCT02742662|Overweight|overweight
1067986|NCT02742662|Prediabetes|prediabetes
1067987|NCT02742662|Smartphone application|smartphone application
1067988|NCT02742662|Technology|technology
1067989|NCT02742662|Weight Loss|weight loss
1067990|NCT02742662|Lifestyle Intervention|lifestyle intervention
1067991|NCT02742623|Cancer|cancer
1067992|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
1067993|NCT02742623|Pulmonary Embolism|pulmonary embolism
1067994|NCT02742584|cough stress test|cough stress test
1067995|NCT02742584|urodynamics|urodynamics
1067996|NCT02742584|pad test|pad test
1067997|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
1067998|NCT02742571|Denutrition|denutrition
1067999|NCT02742571|PINI score|pini score
1068000|NCT02742558|cholera vaccine|cholera vaccine
1068001|NCT02742558|randomized trial|randomized trial
1068002|NCT02742558|immunogenicity|immunogenicity
1068003|NCT02742506|Brain-damaged|brain-damaged
1068106|NCT02741596|Dyax|dyax
1068004|NCT02742506|Disorders of consciousness|disorders of consciousness
1068005|NCT02742506|Post-coma|post-coma
1068006|NCT02742506|consciousness|consciousness
1068007|NCT02742506|coma|coma
1068008|NCT02742506|vegetative state|vegetative state
1068009|NCT02742506|minimally conscious state|minimally conscious state
1068010|NCT02742506|music|music
1068011|NCT02742506|P300|p300
1068012|NCT02742493|relapse|relapse
1068013|NCT02742493|irregularity|irregularity
1068014|NCT02742493|recession|recession
1068015|NCT02742493|retention|retention
1068016|NCT02742480|stroke|stroke
1068017|NCT02742480|oral anticoagulants|oral anticoagulants
1068018|NCT02742480|cardioembolic|cardioembolic
1068019|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
1068020|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
1068021|NCT02742454|Extremely Preterm Infants|extremely preterm infants
1068022|NCT02742337|Epigenetic|epigenetic
1068023|NCT02742324|efficacy|efficacy
1068024|NCT02742324|safety|safety
1068025|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
1068026|NCT02742298|Electrical Impedance Myography|electrical impedance myography
1068027|NCT02742285|antimalarials|antimalarials
1068028|NCT02742285|blood samples|blood samples
1068029|NCT02742285|drug concentrations|drug concentrations
1068030|NCT02742285|pharmacokinetics|pharmacokinetics
1068031|NCT02742285|lumefantrine|lumefantrine
1068032|NCT02742285|healthy volunteers|healthy volunteers
1068034|NCT02742233|Wound Healing|wound healing
1068035|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
1068036|NCT02742220|intermittent claudication|intermittent claudication
1068037|NCT02742220|exercise|exercise
1068038|NCT02742220|blood pressure|blood pressure
1068039|NCT02742220|cardiovascular system|cardiovascular system
1068040|NCT02742194|ginger obesity|ginger obesity
1068041|NCT02742194|ginger inflammation|ginger inflammation
1068042|NCT02742194|treatment of obesity|treatment of obesity
1068043|NCT02742155|Family Research|family research
1068044|NCT02742116|Expanded carrier screening|expanded carrier screening
1068045|NCT02742090|CLL|cll
1068046|NCT02742025|Coronary Angiography|coronary angiography
1068047|NCT02742012|electroencephalogram|electroencephalogram
1068048|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
1068049|NCT02742012|respiratory monitoring|respiratory monitoring
1068050|NCT02741986|risk assessment|risk assessment
1068051|NCT02741986|sepsis|sepsis
1068052|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
1068053|NCT02741973|Yoga|yoga
1068054|NCT02741973|Stress|stress
1068055|NCT02741973|Adolescents|adolescents
1068056|NCT02741973|School|school
1068057|NCT02741973|Children|children
1068058|NCT02741960|metformin|metformin
1068059|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
1068060|NCT02741947|Parkinson|parkinson
1068061|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
1068062|NCT02741947|Levodopa|levodopa
1068063|NCT02741895|Biosensing Techniques|biosensing techniques
1068064|NCT02741895|Patient Readmission|patient readmission
1068065|NCT02741882|Microcephaly|microcephaly
1068066|NCT02741882|zika Virus|zika virus
1068067|NCT02741882|Case-control study|case-control study
1068068|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
1068069|NCT02741804|Memory|memory
1068070|NCT02741791|AXS-05|axs-05
1068071|NCT02741791|Major Depressive Disorder|major depressive disorder
1068072|NCT02741791|Treatment Resistant Depression|treatment resistant depression
1068073|NCT02741791|TRD|trd
1068074|NCT02741791|MDD|mdd
1068075|NCT02741791|Axsome|axsome
1068076|NCT02741791|NMDA receptor|nmda receptor
1068077|NCT02741791|Refractory depression|refractory depression
1068078|NCT02741791|Resistant depression|resistant depression
1068079|NCT02741791|Depression|depression
1068080|NCT02741778|Esophagogastric Junction|esophagogastric junction
1068081|NCT02741778|Adenocarcinoma|adenocarcinoma
1068082|NCT02741778|Cardia|cardia
1068083|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1068084|NCT02741765|Exercise|exercise
1068085|NCT02741765|Brain Plasticity|brain plasticity
1068086|NCT02741752|histomorphometry|histomorphometry
1068087|NCT02741739|Drug concentration|drug concentration
1068088|NCT02741739|REGN1033|regn1033
1068089|NCT02741739|blood|blood
1068090|NCT02741700|Adherence|adherence
1068091|NCT02741700|Disparities|disparities
1068092|NCT02741700|Patient Outcomes|patient outcomes
1068093|NCT02741687|stress hyperglycemia|stress hyperglycemia
1068094|NCT02741687|blood glucose|blood glucose
1068095|NCT02741674|Observational Study|observational study
1068096|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
1068097|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
1068098|NCT02741648|Digestive tract problems|digestive tract problems
1068099|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
1068100|NCT02741622|Exercise therapy|exercise therapy
1068101|NCT02741609|Borrelia|borrelia
1068102|NCT02741609|spirochetes|spirochetes
1068103|NCT02741609|culture|culture
1068104|NCT02741609|immunostaining|immunostaining
1068105|NCT02741596|DX-2930(SHP643)|dx-2930(shp643)
1068107|NCT02741596|Hereditary Angioedema|hereditary angioedema
1068108|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
1068109|NCT02741557|Bioequivalence|bioequivalence
1068110|NCT02741557|Dolutegravir|dolutegravir
1068111|NCT02741557|Rilpivirine|rilpivirine
1068112|NCT02741544|Second primary cancers|second primary cancers
1068113|NCT02741544|Cataracts|cataracts
1068114|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
1068115|NCT02741544|Revlimid capsules|revlimid capsules
1068116|NCT02741518|obesity|obesity
1068117|NCT02741518|FMT|fmt
1068118|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1068119|NCT02741505|sleep|sleep
1068120|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
1068121|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
1068122|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
1068123|NCT02741479|dancers|dancers
1068124|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
1068125|NCT02741427|Tooth discoloration|tooth discoloration
1068126|NCT02741427|Toothpaste|toothpaste
1068127|NCT02741427|Tooth bleaching|tooth bleaching
1068128|NCT02741427|Clinical trial|clinical trial
1068129|NCT02741414|Helicobacter pylori|helicobacter pylori
1068130|NCT02741414|Antibiotic resistance|antibiotic resistance
1068131|NCT02741414|Sequencing|sequencing
1068132|NCT02741414|Mechanism|mechanism
1068133|NCT02741401|Complementary therapies|complementary therapies
1068134|NCT02741401|Massage|massage
1068135|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
1068136|NCT02741388|selinexor|selinexor
1068137|NCT02741388|lymphoma|lymphoma
1068138|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
1068139|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
1068140|NCT02741349|Atrial fibrillation|atrial fibrillation
1068141|NCT02741349|Risk score|risk score
1068142|NCT02741323|HIV-infected with end-stage kidney disease|hiv-infected with end-stage kidney disease
1068143|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
1068144|NCT02741297|Chronic Pain|chronic pain
1068145|NCT02741232|analgesics, opioids|analgesics, opioids
1068146|NCT02741232|pectoral block|pectoral block
1068147|NCT02741206|psycho-education|psycho-education
1068148|NCT02741206|maternal depression|maternal depression
1068149|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
1068150|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
1068151|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
1068152|NCT02741193|Electromyography|electromyography
1068154|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
1068155|NCT02741167|cytoreductive surgery|cytoreductive surgery
1068156|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1068157|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
1068158|NCT02741128|Dengue Fever|dengue fever
1068159|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1068160|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
1068161|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
1068162|NCT02741115|Fontan|fontan
1068163|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
1068164|NCT02741115|Vascular Function|vascular function
1068165|NCT02741115|EndoPAT|endopat
1068166|NCT02741115|Myocardial Performance|myocardial performance
1068167|NCT02741102|Infertility|infertility
1068168|NCT02741102|AUFI|aufi
1068169|NCT02741089|Analgosedation|analgosedation
1068170|NCT02741089|Internal Quality Assurance|internal quality assurance
1068171|NCT02741063|oxytocin|oxytocin
1068172|NCT02741063|attentional bias|attentional bias
1068173|NCT02741063|Autism|autism
1068174|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
1068175|NCT02741011|Mentally Handicapped|mentally handicapped
1068176|NCT02740998|Microbiome|microbiome
1068177|NCT02740998|Progestin|progestin
1068178|NCT02740998|Long-acting contraception|long-acting contraception
1068179|NCT02740985|AZD4635|azd4635
1068180|NCT02740985|durvalumab|durvalumab
1068181|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
1068182|NCT02740985|advanced solid malignancies|advanced solid malignancies
1068183|NCT02740985|prostate cancer|prostate cancer
1068184|NCT02740985|colorectal cancer|colorectal cancer
1068185|NCT02740933|Brain Tumor Surgery|brain tumor surgery
1068186|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
1068187|NCT02740855|sclerotherapy|sclerotherapy
1068188|NCT02740855|ethanol|ethanol
1068189|NCT02740855|pulmonal hypertension|pulmonal hypertension
1068190|NCT02740790|Human papillomavirus|human papillomavirus
1068191|NCT02740790|vaccine|vaccine
1068192|NCT02740790|cervical infection|cervical infection
1068193|NCT02740790|cervical cancer|cervical cancer
1068194|NCT02740764|Functional autonomy level|functional autonomy level
1068195|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
1068196|NCT02740764|Cognitive disorders|cognitive disorders
1068197|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
1068198|NCT02740764|elderly|elderly
1068199|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
1068507|NCT02738788|airway|airway
1068200|NCT02740738|Knee Arthroplasty|knee arthroplasty
1068201|NCT02740738|Hip Arthroplasty|hip arthroplasty
1068202|NCT02740725|Amblyopia|amblyopia
1068203|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
1068204|NCT02740725|Patch Therapy|patch therapy
1068205|NCT02740712|rucaparib|rucaparib
1068206|NCT02740712|CO-338|co-338
1068207|NCT02740712|Clovis|clovis
1068208|NCT02740712|Clovis Oncology|clovis oncology
1068209|NCT02740712|PARP Inhibitor|parp inhibitor
1068210|NCT02740712|Drug-Drug Interaction|drug-drug interaction
1068211|NCT02740699|Cholesterol|cholesterol
1068212|NCT02740699|Heart Disease|heart disease
1068213|NCT02740699|CT Scan|ct scan
1068214|NCT02740699|Crestor|crestor
1068215|NCT02740699|Lipitor|lipitor
1068216|NCT02740686|COPD|copd
1068217|NCT02740686|Exercise|exercise
1068218|NCT02740686|Immunity|immunity
1068219|NCT02740686|Inflammation|inflammation
1068220|NCT02740686|Biomarkers|biomarkers
1068221|NCT02740660|Albuterol|albuterol
1068222|NCT02740660|Caffeine|caffeine
1068223|NCT02740660|Lean Body Mass|lean body mass
1068224|NCT02740660|Fat Mass|fat mass
1068225|NCT02740634|PCA|pca
1068226|NCT02740634|LPA|lpa
1068227|NCT02740595|nicotine|nicotine
1068228|NCT02740595|endothelial function|endothelial function
1068229|NCT02740595|oxidative stress|oxidative stress
1068230|NCT02740569|scleroderma|scleroderma
1068231|NCT02740569|sleep apnea|sleep apnea
1068232|NCT02740569|pulmonary disease|pulmonary disease
1068233|NCT02740556|Hepatitis C|hepatitis c
1068234|NCT02740556|Adherence|adherence
1068235|NCT02740556|Adheretech|adheretech
1068236|NCT02740556|HepCure|hepcure
1068237|NCT02740556|Telehealth|telehealth
1068238|NCT02740556|Health apps|health apps
1068239|NCT02740543|World Trade Center|world trade center
1068240|NCT02740543|WTC|wtc
1068241|NCT02740543|Induced Sputum|induced sputum
1068242|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
1068243|NCT02740504|Respiration rate|respiration rate
1108555|NCT02499744|RDS|rds
1068244|NCT02740465|ACE|ace
1068245|NCT02740465|Anxiety|anxiety
1068246|NCT02740465|COPD|copd
1068247|NCT02740452|Rupture|rupture
1068248|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
1068249|NCT02740452|Laxity knee|laxity knee
1068250|NCT02740452|Instability knee|instability knee
1068251|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
1068252|NCT02740400|guided sheath|guided sheath
1068253|NCT02740400|diagnosis|diagnosis
1068254|NCT02740400|accuracy|accuracy
1068255|NCT02740400|complication|complication
1068256|NCT02740374|ROTEM|rotem
1068257|NCT02740374|Thromboelastometry|thromboelastometry
1068258|NCT02740374|spine surgery|spine surgery
1068259|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
1068260|NCT02740374|blood loss|blood loss
1068261|NCT02740374|red blood cell transfusion|red blood cell transfusion
1068262|NCT02740335|anticoagulant reversal|anticoagulant reversal
1068263|NCT02740335|urgent surgery|urgent surgery
1068264|NCT02740335|invasive procedures|invasive procedures
1068265|NCT02740335|vitamin K|vitamin k
1068266|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
1068267|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
1068268|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
1068269|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
1068270|NCT02740309|childhood chronic disease|childhood chronic disease
1068271|NCT02740309|adolescent depression|adolescent depression
1068272|NCT02740309|adolescent anxiety|adolescent anxiety
1068273|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
1068274|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
1068275|NCT02740309|adolescent chronic disease|adolescent chronic disease
1068276|NCT02740309|childhood depression|childhood depression
1068277|NCT02740309|childhood anxiety|childhood anxiety
1068278|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
1068279|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
1068280|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
1068281|NCT02740270|advanced solid tumors|advanced solid tumors
1068282|NCT02740270|lymphomas|lymphomas
1068283|NCT02740270|GWN323|gwn323
1068284|NCT02740270|PDR001|pdr001
1068285|NCT02740270|advanced malignancies|advanced malignancies
1068286|NCT02740270|anti-GITR|anti-gitr
1068287|NCT02740270|anti-PD-1|anti-pd-1
1068288|NCT02740270|adults|adults
1068289|NCT02740231|viscosupplement|viscosupplement
1068290|NCT02740231|osteoarthritis|osteoarthritis
1068291|NCT02740231|knee|knee
1068292|NCT02740231|intra-articular injection|intra-articular injection
1068293|NCT02740231|arthritis|arthritis
1068294|NCT02740231|degenerative|degenerative
1068295|NCT02740218|Psoriasis|psoriasis
1068296|NCT02740218|Apremilast|apremilast
1068297|NCT02740218|APPRECIATE|appreciate
1068298|NCT02740218|Dermatology|dermatology
1068299|NCT02740218|Retrospective|retrospective
1068300|NCT02740218|Observational|observational
1068301|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
1068302|NCT02740179|Eplerenone|eplerenone
1068303|NCT02740179|Cardiovascular Disease|cardiovascular disease
1068304|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
1068305|NCT02740179|Coronary Vasculature|coronary vasculature
1068306|NCT02740179|Myocardial Inflammation|myocardial inflammation
1068307|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
1068308|NCT02740179|Atherosclerosis|atherosclerosis
1068309|NCT02740179|Aldosterone|aldosterone
1068310|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
1068311|NCT02740140|chronic coinfection|chronic coinfection
1068312|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
1068313|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
1068314|NCT02740127|Caudal nerve block|caudal nerve block
1068315|NCT02740127|CNB|cnb
1068316|NCT02740127|General anesthesia|general anesthesia
1068317|NCT02740127|GA|ga
1068318|NCT02740127|Ropivacaine|ropivacaine
1068319|NCT02740127|Naropin|naropin
1068320|NCT02740127|Epinephrine|epinephrine
1068321|NCT02740127|Decadron|decadron
1068322|NCT02740127|Dexamethasone|dexamethasone
1068323|NCT02740127|Clonidine|clonidine
1068324|NCT02740127|Propofol|propofol
1068325|NCT02740127|Diprivan|diprivan
1068326|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1068327|NCT02740114|Open gynecologic surgery|open gynecologic surgery
1068328|NCT02740114|Local wound infiltration|local wound infiltration
1068329|NCT02740114|Gynecologic cancer|gynecologic cancer
1068331|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
1068332|NCT02740114|Oxycodone|oxycodone
1068333|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
1068334|NCT02740114|OxyContin|oxycontin
1068335|NCT02740114|OxyIR|oxyir
1068336|NCT02740114|Roxicodone|roxicodone
1068337|NCT02740114|Questionnaires|questionnaires
1068338|NCT02740114|Surveys|surveys
1068339|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
1068340|NCT02740114|MDASI|mdasi
1068341|NCT02740114|Pill diary|pill diary
1068342|NCT02740114|Medication log|medication log
1068343|NCT02740101|oxytocin|oxytocin
1068344|NCT02740101|social reward|social reward
1068345|NCT02740101|social punishment|social punishment
1068346|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
1068347|NCT02740075|Transport ventilation|transport ventilation
1068348|NCT02740049|Epithelial Cells|epithelial cells
1068349|NCT02740010|MIOL|miol
1068350|NCT02740010|extended depth of focus|extended depth of focus
1068351|NCT02740010|cataract|cataract
1068352|NCT02740010|visual acuity|visual acuity
1068353|NCT02740010|halos|halos
1068354|NCT02739984|diabetes|diabetes
1068355|NCT02739984|type 2 diabetes|type 2 diabetes
1068356|NCT02739984|high blood cholesterol|high blood cholesterol
1068357|NCT02739984|hypercholesterolemia|hypercholesterolemia
1068358|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
1068359|NCT02739984|high cholesterol|high cholesterol
1068360|NCT02739984|statin intolerant|statin intolerant
1068361|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
1068362|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
1068363|NCT02739919|Kidney stones|kidney stones
1068364|NCT02739919|Renal Calculi|renal calculi
1068365|NCT02739880|Vaginal discomfort|vaginal discomfort
1068366|NCT02739880|Vaginal dryness|vaginal dryness
1068367|NCT02739867|occult cancer|occult cancer
1068368|NCT02739867|venous thromboembolism|venous thromboembolism
1068369|NCT02739867|tumor-educated platelets|tumor-educated platelets
1068370|NCT02739867|platelet RNA profiling|platelet rna profiling
1068371|NCT02739867|early diagnosis|early diagnosis
1068372|NCT02739867|screening|screening
1068373|NCT02739854|trauma|trauma
1068374|NCT02739854|atelectasis|atelectasis
1068375|NCT02739841|hemodynamic response|hemodynamic response
1068376|NCT02739828|Quality of life|quality of life
1068377|NCT02739815|Caesarean Section|caesarean section
1068378|NCT02739815|Tranexamic Acid|tranexamic acid
1068379|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
1068380|NCT02739815|Ecbolics|ecbolics
1068381|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
1068382|NCT02739763|PfSPZ|pfspz
1068383|NCT02739763|Semi-immune adults|semi-immune adults
1068384|NCT02739763|Kenya|kenya
1068385|NCT02739763|challenge|challenge
1068386|NCT02739763|CHMI|chmi
1068387|NCT02739763|malaria|malaria
1068388|NCT02739737|Bias|bias
1068389|NCT02739737|Orthopedics|orthopedics
1068390|NCT02739737|Peer Review|peer review
1068391|NCT02739698|ovarian cancer|ovarian cancer
1068392|NCT02739659|prostate carcinoma|prostate carcinoma
1068393|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
1068394|NCT02739659|efficacy|efficacy
1068395|NCT02739659|toxicity|toxicity
1068396|NCT02739633|Chemotherapy|chemotherapy
1068397|NCT02739633|Gemcitabine|gemcitabine
1068398|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
1068399|NCT02739633|Genexol-PM|genexol-pm
1068400|NCT02739633|Paclitaxel|paclitaxel
1068401|NCT02739607|emotional disorders|emotional disorders
1068402|NCT02739607|internet-delivered intervention|internet-delivered intervention
1068403|NCT02739607|anxiety|anxiety
1068404|NCT02739607|depression|depression
1068405|NCT02739607|transdiagnostic|transdiagnostic
1068406|NCT02739568|EDS|eds
1068407|NCT02739568|OSA|osa
1068408|NCT02739555|Osteoid osteoma|osteoid osteoma
1068409|NCT02739555|Bisphophonates|bisphophonates
1068410|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
1068411|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
1068412|NCT02739490|pelvis|pelvis
1068413|NCT02739490|Muscle strength|muscle strength
1068414|NCT02739477|Favipiravir|favipiravir
1068415|NCT02739477|Tolerance|tolerance
1068416|NCT02739477|Survivor|survivor
1068417|NCT02739477|Ebola Virus|ebola virus
1068418|NCT02739477|Genital reservoir|genital reservoir
1068419|NCT02739477|Guinea|guinea
1068420|NCT02739464|Burn|burn
1068421|NCT02739464|Exercise|exercise
1068422|NCT02739464|Ergometer|ergometer
1068423|NCT02739464|MP-10|mp-10
1068424|NCT02739451|immunocompromized patients|immunocompromized patients
1068425|NCT02739451|critically ill patients|critically ill patients
1068426|NCT02739438|Pulmonary inflammation|pulmonary inflammation
1068427|NCT02739438|Endothelial dysfunction|endothelial dysfunction
1068428|NCT02739438|Electronic Cigarettes|electronic cigarettes
1068429|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
1068430|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
1068431|NCT02739399|phenylephrine|phenylephrine
1068432|NCT02739399|alpha mimetics|alpha mimetics
1068840|NCT02736669|behavioral|behavioral
1068433|NCT02739399|pulse pressure variation|pulse pressure variation
1068434|NCT02739399|venous return|venous return
1068435|NCT02739347|tDCS|tdcs
1068436|NCT02739347|cognitive control|cognitive control
1068437|NCT02739347|working memory|working memory
1068438|NCT02739347|EEG|eeg
1068439|NCT02739347|gamma oscillations|gamma oscillations
1068440|NCT02739321|Autism|autism
1068441|NCT02739321|ASD|asd
1068442|NCT02739321|Sleep|sleep
1068443|NCT02739321|Mattress|mattress
1068444|NCT02739308|proprioception|proprioception
1068445|NCT02739308|ankle sprain|ankle sprain
1068446|NCT02739308|fencing|fencing
1068447|NCT02739269|ovarian response|ovarian response
1068448|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
1068449|NCT02739269|antral follicle count|antral follicle count
1068450|NCT02739256|voiding trial|voiding trial
1068451|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
1068452|NCT02739256|post-operative catheterization|post-operative catheterization
1068453|NCT02739204|Celecoxib|celecoxib
1068454|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
1068455|NCT02739204|Recurrence|recurrence
1068456|NCT02739204|Survival|survival
1068457|NCT02739204|Prognosis|prognosis
1068458|NCT02739191|NPWT|npwt
1068459|NCT02739165|Acute exacerbations|acute exacerbations
1068460|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1068461|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
1068462|NCT02739165|ART-123|art-123
1068463|NCT02739152|Sepsis|sepsis
1068464|NCT02739152|Severe sepsis|severe sepsis
1068465|NCT02739152|Infections|infections
1068466|NCT02739152|Worsening|worsening
1068467|NCT02739126|Diagnosis|diagnosis
1068468|NCT02739113|OMECs|omecs
1068469|NCT02739113|Cornea|cornea
1068470|NCT02739113|Amniotic membrane|amniotic membrane
1068471|NCT02739113|Collagenase|collagenase
1068472|NCT02739100|pharmacokinetics|pharmacokinetics
1068473|NCT02739100|bioequivalence|bioequivalence
1068474|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
1068475|NCT02739061|pathogenesis|pathogenesis
1068476|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
1068477|NCT02738996|Diabetes|diabetes
1068478|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
1068479|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
1068480|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
1068481|NCT02738983|Radiotherapy|radiotherapy
1068482|NCT02738983|wild type|wild type
1068483|NCT02738931|dolutegravir|dolutegravir
1068484|NCT02738931|lamivudine|lamivudine
1068485|NCT02738931|Bioavailability|bioavailability
1068486|NCT02738931|fixed dose combinations|fixed dose combinations
1068487|NCT02738918|Renal Transplant|renal transplant
1068488|NCT02738918|Anti HLA antibodies|anti hla antibodies
1068489|NCT02738918|Humoral rejection|humoral rejection
1068490|NCT02738892|Pregnancy|pregnancy
1068491|NCT02738892|Stillbirth|stillbirth
1068492|NCT02738892|Preterm birth|preterm birth
1068493|NCT02738866|breast cancer|breast cancer
1068494|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
1068495|NCT02738866|palbociclib|palbociclib
1068496|NCT02738866|fulvestrant|fulvestrant
1068497|NCT02738814|emergence agitation|emergence agitation
1068498|NCT02738814|emergence delirium|emergence delirium
1068499|NCT02738814|PAED scale|paed scale
1068500|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
1068501|NCT02738814|treatment|treatment
1068502|NCT02738814|pediatric|pediatric
1068503|NCT02738814|sevoflurane|sevoflurane
1068504|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1068505|NCT02738801|GLPG1690|glpg1690
1068506|NCT02738801|Autotaxin|autotaxin
1068508|NCT02738788|airway changes|airway changes
1068510|NCT02738788|prone position|prone position
1068511|NCT02738788|Trendelenburg position|trendelenburg position
1068512|NCT02738775|multiple sclerosis|multiple sclerosis
1068513|NCT02738762|intensive care|intensive care
1068514|NCT02738762|glutamine|glutamine
1068515|NCT02738762|length of stay|length of stay
1068516|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
1068517|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
1068518|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
1068519|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
1068520|NCT02738723|Radiation|radiation
1068521|NCT02738723|Chemotherapy|chemotherapy
1068522|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1068523|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
1068524|NCT02738697|Microvessels invasion|microvessels invasion
1068525|NCT02738697|Survival|survival
1068526|NCT02738697|Recurrence|recurrence
1068527|NCT02738684|lung cancer|lung cancer
1068528|NCT02738684|adenocarcinoma|adenocarcinoma
1068529|NCT02738684|EGFR|egfr
1068530|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
1068531|NCT02738671|functional MRI|functional mri
1068532|NCT02738671|olfactory function|olfactory function
1068533|NCT02738671|bariatric surgery|bariatric surgery
1068943|NCT02735993|Celution|celution
1068534|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
1068535|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
1068536|NCT02738619|allergic rhinitis|allergic rhinitis
1068537|NCT02738619|immunotherapy|immunotherapy
1068538|NCT02738619|vitamin D|vitamin d
1068539|NCT02738606|Colorectal Cancer|colorectal cancer
1068540|NCT02738606|Other diseases of intestines|other diseases of intestines
1068541|NCT02738606|Liver and Unresectable Pulmonary Metastases|liver and unresectable pulmonary metastases
1068542|NCT02738606|Resectable liver metastases|resectable liver metastases
1068543|NCT02738606|Liver resection|liver resection
1068544|NCT02738606|Chemotherapy|chemotherapy
1068546|NCT02738554|treatment cessation|treatment cessation
1068547|NCT02738554|HBsAg|hbsag
1068548|NCT02738554|HBcrAg|hbcrag
1068549|NCT02738554|nucleoside analogue|nucleoside analogue
1068550|NCT02738554|entecavir|entecavir
1068551|NCT02738554|tenofovir|tenofovir
1068552|NCT02738502|HIV|hiv
1068553|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
1068554|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
1068555|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
1068556|NCT02738463|ferritin LBW|ferritin lbw
1068557|NCT02738450|cognitive decline|cognitive decline
1068558|NCT02738437|osteogenesis|osteogenesis
1068559|NCT02738437|Positron-Emission Tomography|positron-emission tomography
1068560|NCT02738437|Radiostereometric analysis|radiostereometric analysis
1068561|NCT02738424|Low Back Pain|low back pain
1068562|NCT02738424|MRI|mri
1068563|NCT02738372|Chronic Pain|chronic pain
1068564|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
1068565|NCT02738372|Shoulder pain|shoulder pain
1068566|NCT02738372|Prognosis|prognosis
1068567|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
1068568|NCT02738359|colon cancer|colon cancer
1068569|NCT02738359|rectum cancer|rectum cancer
1068570|NCT02738359|colonoscopy|colonoscopy
1068571|NCT02738359|fecal immunological test|fecal immunological test
1068572|NCT02738359|colon capsule|colon capsule
1068573|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
1068574|NCT02738346|Topotecan|topotecan
1068575|NCT02738346|Etoposide|etoposide
1068576|NCT02738307|High Altitude|high altitude
1068577|NCT02738307|Attention|attention
1068578|NCT02738307|Cognitive Function|cognitive function
1068579|NCT02738307|Acclimatization|acclimatization
1068580|NCT02738307|Sleep|sleep
1068581|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
1068582|NCT02738255|Mouth breathing|mouth breathing
1068583|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
1068584|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
1068585|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
1068586|NCT02738242|Drop foot|drop foot
1068587|NCT02738242|Thigh muscle weakness|thigh muscle weakness
1068588|NCT02738203|Pain Management|pain management
1068589|NCT02738203|IUD insertion|iud insertion
1068590|NCT02738190|albumin|albumin
1068591|NCT02738190|fresh frozen plasma|fresh frozen plasma
1068592|NCT02738190|extracorporeal circulation|extracorporeal circulation
1068593|NCT02738190|cardiovascular surgery|cardiovascular surgery
1068594|NCT02738190|pediatric population|pediatric population
1068595|NCT02738177|misopristol|misopristol
1068596|NCT02738177|effox|effox
1068597|NCT02738177|cervical ripening|cervical ripening
1068598|NCT02738138|HCV Genotype 3|hcv genotype 3
1068599|NCT02738138|Non-cirrhotic|non-cirrhotic
1068600|NCT02738138|HCV Genotype 1|hcv genotype 1
1068601|NCT02738138|HCV Genotype 6|hcv genotype 6
1068602|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
1068603|NCT02738138|HCV Genotype 5|hcv genotype 5
1068604|NCT02738138|HCV Treatment Naive|hcv treatment naive
1068605|NCT02738138|HCV Genotype 4|hcv genotype 4
1068606|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
1068607|NCT02738138|HCV Genotype 2|hcv genotype 2
1068608|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
1068609|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
1068610|NCT02738125|Adalimumab|adalimumab
1068611|NCT02738125|Ulcerative Colitis|ulcerative colitis
1068612|NCT02738125|SOTHIS|sothis
1068613|NCT02738125|Effectiveness|effectiveness
1068614|NCT02738086|Amputation|amputation
1068615|NCT02738086|Physical Activity|physical activity
1068616|NCT02738086|Rehabilitation|rehabilitation
1068617|NCT02738034|Hypertension|hypertension
1068618|NCT02738034|Cognition|cognition
1068619|NCT02738034|Computerized Training|computerized training
1068620|NCT02738034|Cogmed|cogmed
1068621|NCT02738021|Psychosocial|psychosocial
1068622|NCT02738021|Psychotherapy|psychotherapy
1068623|NCT02738021|Maternal|maternal
1068624|NCT02737995|Iron deficiency|iron deficiency
1068625|NCT02737982|coronary heart disease|coronary heart disease
1068626|NCT02737982|gender|gender
1068627|NCT02737982|platelet|platelet
1068628|NCT02737982|microvascular dysfunction|microvascular dysfunction
1068629|NCT02737982|sexual hormones|sexual hormones
1068630|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
1068631|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
1068632|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
1068633|NCT02737943|Skin graft|skin graft
1068634|NCT02737943|Burn|burn
1068635|NCT02737943|MEBO|mebo
1068636|NCT02737943|Wound dressing|wound dressing
1068637|NCT02737943|Wound care|wound care
1068638|NCT02737943|Raw Area|raw area
1068639|NCT02737930|Acute ischemic stroke|acute ischemic stroke
1068640|NCT02737930|Homonymous hemianopia|homonymous hemianopia
1068641|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
1068642|NCT02737930|Visual field loss|visual field loss
1068643|NCT02737930|Post-stroke recovery|post-stroke recovery
1068644|NCT02737930|Fluoxetine|fluoxetine
1068645|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1068646|NCT02737904|Muscle spasticity|muscle spasticity
1068647|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
1068648|NCT02737865|Ultrasonography|ultrasonography
1068649|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
1068650|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
1068651|NCT02737813|isobaric marcaine|isobaric marcaine
1068652|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
1068653|NCT02737787|Second or Greater Remission|second or greater remission
1068654|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
1068655|NCT02737787|Montanide|montanide
1068656|NCT02737787|GM-CSF|gm-csf
1068657|NCT02737787|Nivolumab|nivolumab
1068658|NCT02737787|15-247|15-247
1068659|NCT02737774|Icotinib|icotinib
1068660|NCT02737774|chemotherapy|chemotherapy
1068661|NCT02737774|EGFR|egfr
1068662|NCT02737761|Heart Failure|heart failure
1068663|NCT02737761|Positive Psychology|positive psychology
1068664|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
1068665|NCT02737748|Donor Site Wounds|donor site wounds
1068666|NCT02737696|prescription opioid|prescription opioid
1068667|NCT02737696|prevention|prevention
1068668|NCT02737696|computer-based|computer-based
1068669|NCT02737696|adolescent|adolescent
1068670|NCT02737683|Disease|disease
1068671|NCT02737683|anxiety|anxiety
1068672|NCT02737683|depression|depression
1068673|NCT02737683|combine|combine
1068674|NCT02737683|negative emotional states|negative emotional states
1068675|NCT02737683|functional dyspepsia|functional dyspepsia
1068676|NCT02737657|Canagliflozin|canagliflozin
1068677|NCT02737657|Metformin|metformin
1068678|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1068679|NCT02737657|INVOKANA|invokana
1068680|NCT02737657|Sulfonylurea|sulfonylurea
1068681|NCT02737644|Congenital Heart Disease|congenital heart disease
1068682|NCT02737644|Key Nutritional Factors|key nutritional factors
1068683|NCT02737644|conception|conception
1068684|NCT02737644|pregnant|pregnant
1068685|NCT02737605|Esketamine|esketamine
1068686|NCT02737605|Healthy|healthy
1068687|NCT02737605|Pharmacokinetics|pharmacokinetics
1068688|NCT02737605|Electrocardiogram|electrocardiogram
1068689|NCT02737605|Repolarization|repolarization
1068690|NCT02737579|cardiac catheterization|cardiac catheterization
1068691|NCT02737579|cardiac MRI|cardiac mri
1068692|NCT02737566|Smoking Cessation|smoking cessation
1068693|NCT02737566|Financial Incentives|financial incentives
1068694|NCT02737566|Contingency Management|contingency management
1068695|NCT02737566|Vulnerable Populations|vulnerable populations
1068696|NCT02737566|Medically Uninsured|medically uninsured
1068697|NCT02737566|Medicaid|medicaid
1068698|NCT02737527|ultrasound|ultrasound
1068699|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
1068700|NCT02737514|adenoma detection rate|adenoma detection rate
1068701|NCT02737514|colonoscopy|colonoscopy
1068702|NCT02737514|water exchange|water exchange
1068703|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
1068704|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
1068705|NCT02737501|Epithelial lung cancer|epithelial lung cancer
1068706|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
1068707|NCT02737501|Large cell carcinoma|large cell carcinoma
1068708|NCT02737501|Adenocarcinoma|adenocarcinoma
1068709|NCT02737501|Carcinoma|carcinoma
1068710|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
1068711|NCT02737501|Advanced Cancers|advanced cancers
1068712|NCT02737501|Brigatinib|brigatinib
1068713|NCT02737501|AP26113|ap26113
1068714|NCT02737488|Therapy|therapy
1068715|NCT02737488|Trauma Systems Therapy|trauma systems therapy
1068716|NCT02737410|Resilience|resilience
1068717|NCT02737410|Coping|coping
1068718|NCT02737410|Psychosomatic|psychosomatic
1068719|NCT02737410|Hypnosis|hypnosis
1068720|NCT02737410|Construct Validation|construct validation
1068721|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
1068722|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1068723|NCT02737384|CD45RA|cd45ra
1068724|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
1068725|NCT02737384|pediatric transplantation|pediatric transplantation
1068726|NCT02737384|CD45RA depletion|cd45ra depletion
1068727|NCT02737358|nicotine|nicotine
1068728|NCT02737358|tobacco|tobacco
1068729|NCT02737358|smoking|smoking
1068730|NCT02737358|cessation|cessation
1068731|NCT02737358|N-acetylcysteine|n-acetylcysteine
1068733|NCT02737358|pharmacotherapy|pharmacotherapy
1068734|NCT02737358|relapse|relapse
1068735|NCT02737358|tobacco use disorder|tobacco use disorder
1068736|NCT02737345|fibrinolysis|fibrinolysis
1068737|NCT02737345|liver transplant|liver transplant
1068738|NCT02737345|thromboelastometry|thromboelastometry
1068739|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
1068740|NCT02737306|Allogeneic Stem-Cell Transplantation|allogeneic stem-cell transplantation
1068741|NCT02737280|infant|infant
1068742|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
1068743|NCT02737280|oxygen therapy|oxygen therapy
1068744|NCT02737280|bronchiolitis|bronchiolitis
1068745|NCT02737267|Genetics|genetics
1068746|NCT02737267|Polymorphism|polymorphism
1068747|NCT02737267|Epigenetics|epigenetics
1068748|NCT02737267|Metagenomics|metagenomics
1068749|NCT02737267|Metabolomics|metabolomics
1068750|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
1068751|NCT02737267|Precision nutrition|precision nutrition
1068752|NCT02737254|Attachment|attachment
1068753|NCT02737254|Oxytocin|oxytocin
1068754|NCT02737254|Cognitive bias modification|cognitive bias modification
1068755|NCT02737254|Middle childhood|middle childhood
1068756|NCT02737241|Prostate|prostate
1068757|NCT02737241|Laser|laser
1068758|NCT02737241|Enucleation|enucleation
1068759|NCT02737202|LAM|lam
1068760|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
1068761|NCT02737189|Ischemic Stroke|ischemic stroke
1068762|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
1068763|NCT02737176|Smoking Cessation|smoking cessation
1068764|NCT02737176|Mouth Diseases|mouth diseases
1068765|NCT02737176|Periodontal Diseases|periodontal diseases
1068766|NCT02737176|Leukoplakia|leukoplakia
1068767|NCT02737176|Keratosis|keratosis
1068768|NCT02737176|Implant|implant
1068769|NCT02737176|Lichen Planus|lichen planus
1068770|NCT02737163|Programmable shunts|programmable shunts
1068771|NCT02737163|Strata valve|strata valve
1068772|NCT02737124|Acetaminophen|acetaminophen
1068773|NCT02737124|Surgery|surgery
1068774|NCT02737124|Meniscectomy|meniscectomy
1068775|NCT02737098|PTSD|ptsd
1068776|NCT02737098|virtual care|virtual care
1068777|NCT02737098|implementation|implementation
1068778|NCT02737098|telepsychiatry|telepsychiatry
1068779|NCT02737098|telepsychology|telepsychology
1068780|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
1068781|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
1068782|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1068783|NCT02737072|immuno-oncology|immuno-oncology
1068784|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
1068785|NCT02737046|ATLL|atll
1068786|NCT02737033|ADHD|adhd
1068787|NCT02737033|Adults|adults
1068788|NCT02737033|Treatment|treatment
1068789|NCT02737033|Rhodiola|rhodiola
1068790|NCT02737020|ADHD|adhd
1068791|NCT02737020|Adults|adults
1068792|NCT02737020|Treatment|treatment
1068793|NCT02737020|Rhodiola rosea|rhodiola rosea
1068794|NCT02737007|Malaria|malaria
1068795|NCT02737007|Microdose|microdose
1068796|NCT02737007|GSK3191607|gsk3191607
1068797|NCT02736994|edentulous|edentulous
1068798|NCT02736994|patients|patients
1068799|NCT02736994|with full|with full
1068800|NCT02736981|Obesity|obesity
1068801|NCT02736981|Weight Loss|weight loss
1068802|NCT02736981|Young Adults|young adults
1068803|NCT02736968|Amebic|amebic
1068804|NCT02736968|Auranofin|auranofin
1068805|NCT02736968|GI Protozoa|gi protozoa
1068806|NCT02736968|Giardiasis|giardiasis
1068807|NCT02736968|Reprofiled|reprofiled
1068808|NCT02736890|Botulinum Toxin A|botulinum toxin a
1068809|NCT02736890|Neuropathic pain|neuropathic pain
1068810|NCT02736890|Spinal cord injury|spinal cord injury
1068811|NCT02736890|Pain management|pain management
1068812|NCT02736890|Rehabilitation|rehabilitation
1068813|NCT02736877|keratoconus|keratoconus
1068814|NCT02736877|bullous keratopathy|bullous keratopathy
1068815|NCT02736877|corneal dystrophy|corneal dystrophy
1068816|NCT02736851|disability|disability
1068817|NCT02736851|home|home
1068818|NCT02736851|stretching exercises|stretching exercises
1068819|NCT02736838|Pressure|pressure
1068820|NCT02736838|Pressure Ulcer|pressure ulcer
1068821|NCT02736838|Skin perfusion|skin perfusion
1068822|NCT02736838|Skin oxygenation|skin oxygenation
1068823|NCT02736812|Randomized controlled trial|randomized controlled trial
1068824|NCT02736812|Lyophilized Plasma|lyophilized plasma
1068825|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
1068826|NCT02736786|proton|proton
1068827|NCT02736773|Guided Bone|guided bone
1068828|NCT02736773|Pre-implant referred|pre-implant referred
1068829|NCT02736773|Regeneration|regeneration
1068830|NCT02736747|Stroke|stroke
1068831|NCT02736747|Muscle Spasticity|muscle spasticity
1068832|NCT02736747|Cryotherapy|cryotherapy
1068833|NCT02736747|Gait|gait
1068834|NCT02736747|Muscle Weakness|muscle weakness
1068835|NCT02736747|Proprioception|proprioception
1068836|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
1068837|NCT02736695|PPA|ppa
1068838|NCT02736669|weight loss|weight loss
1068841|NCT02736643|LDCT, screening|ldct, screening
1068842|NCT02736630|general anaesthesia|general anaesthesia
1068843|NCT02736630|elective surgery|elective surgery
1068844|NCT02736630|national epidemiology|national epidemiology
1068845|NCT02736630|turkey|turkey
1068846|NCT02736565|metastatic|metastatic
1068847|NCT02736565|askin tumor|askin tumor
1068848|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
1068849|NCT02736565|pNET|pnet
1068850|NCT02736565|sarcoma|sarcoma
1068851|NCT02736565|soft tissue|soft tissue
1068852|NCT02736552|Gastric cancer|gastric cancer
1068853|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
1068854|NCT02736552|S-1|s-1
1068855|NCT02736552|D2 resection|d2 resection
1068856|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
1068857|NCT02736526|surgical treatment|surgical treatment
1068858|NCT02736526|observation|observation
1068859|NCT02736513|Tagrisso|tagrisso
1068860|NCT02736513|AZD9291|azd9291
1068861|NCT02736513|EGFRm|egfrm
1068862|NCT02736513|brain metastases|brain metastases
1068863|NCT02736513|NSCLC|nsclc
1068864|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
1068865|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
1068866|NCT02736500|Radioisotope therapy|radioisotope therapy
1068867|NCT02736500|177Lu-DOTATATE|177lu-dotatate
1068868|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
1068869|NCT02736487|Air Pollution|air pollution
1068870|NCT02736487|Exposure Assessment|exposure assessment
1068871|NCT02736487|Filtration|filtration
1068872|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
1068873|NCT02736487|Respiratory Outcomes|respiratory outcomes
1068874|NCT02736487|Short-term Intervention|short-term intervention
1068875|NCT02736461|Orbital fractures|orbital fractures
1068876|NCT02736461|Strabismus|strabismus
1068877|NCT02736461|Predicting factors|predicting factors
1068878|NCT02736461|orbital floor fractures|orbital floor fractures
1068879|NCT02736448|GEP-NET tumors|gep-net tumors
1068880|NCT02736448|Lu-PRRT|lu-prrt
1068881|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
1068882|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
1068883|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
1068884|NCT02736448|low dose of capecitabine|low dose of capecitabine
1068885|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
1068886|NCT02736435|MR-HIFU|mr-hifu
1068887|NCT02736435|Fibroids|fibroids
1068888|NCT02736435|Leuprolide Acetate|leuprolide acetate
1068889|NCT02736357|Lymphoma|lymphoma
1068890|NCT02736357|Cohort|cohort
1068891|NCT02736357|non-Hodgkin|non-hodgkin
1068892|NCT02736344|coronary luminal diameter|coronary luminal diameter
1068893|NCT02736344|lesions|lesions
1068894|NCT02736344|vessels|vessels
1068895|NCT02736331|Cognitive performance|cognitive performance
1068896|NCT02736331|Metabolic control|metabolic control
1068897|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
1068898|NCT02736331|Anthocyanins|anthocyanins
1068899|NCT02736305|ovarian|ovarian
1068900|NCT02736305|regorafenib|regorafenib
1068901|NCT02736305|platinum resistant|platinum resistant
1068902|NCT02736305|clear cell|clear cell
1068903|NCT02736305|endometrioid|endometrioid
1068904|NCT02736266|Muscle-invasive|muscle-invasive
1068905|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
1068906|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
1068907|NCT02736266|Radical cystectomy|radical cystectomy
1068908|NCT02736253|foot amputation|foot amputation
1068909|NCT02736253|Osteomyelitis|osteomyelitis
1068910|NCT02736253|Diabetic Foot|diabetic foot
1068911|NCT02736227|liver transplantation|liver transplantation
1068912|NCT02736227|immunosuppression|immunosuppression
1068913|NCT02736227|everolimus|everolimus
1068914|NCT02736227|tacrolimus|tacrolimus
1068915|NCT02736227|kidney function|kidney function
1068916|NCT02736227|liver function|liver function
1068917|NCT02736227|biomarkers|biomarkers
1068918|NCT02736188|GNE Myopathy|gne myopathy
1068920|NCT02736188|Nonaka|nonaka
1068921|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1068922|NCT02736188|HIBM|hibm
1068923|NCT02736188|DMRV|dmrv
1068924|NCT02736188|QSM|qsm
1068925|NCT02736162|Perampanel|perampanel
1068926|NCT02736162|E2007|e2007
1068927|NCT02736162|Phase 4|phase 4
1068928|NCT02736162|Fycompa|fycompa
1068929|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
1068930|NCT02736136|parental stress|parental stress
1068931|NCT02736136|maternal sensitivity|maternal sensitivity
1068932|NCT02736136|mother-infant bond|mother-infant bond
1068933|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
1068934|NCT02736084|optimism|optimism
1068935|NCT02736084|positive affect|positive affect
1068936|NCT02736084|adherence|adherence
1068937|NCT02736084|health behavior|health behavior
1068938|NCT02736084|diabetes|diabetes
1068939|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
1068940|NCT02736006|decompression illness|decompression illness
1068941|NCT02736006|diving|diving
1068942|NCT02736006|occupational|occupational
1068945|NCT02735993|Heart Failure|heart failure
1068946|NCT02735993|Device|device
1068947|NCT02735980|SCLC|sclc
1068948|NCT02735980|LY2606368|ly2606368
1068949|NCT02735980|CHK1|chk1
1068950|NCT02735915|Immunogenicity|immunogenicity
1068951|NCT02735915|Safety|safety
1068952|NCT02735915|Long term follow-up|long term follow-up
1068953|NCT02735915|Adults|adults
1068954|NCT02735915|Herpes zoster|herpes zoster
1068955|NCT02735902|antivitamins K|antivitamins k
1068956|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1068957|NCT02735876|Btk|btk
1068958|NCT02735876|ACP-196|acp-196
1068959|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
1068960|NCT02735876|MCL|mcl
1068961|NCT02735811|Implantable defibrillator|implantable defibrillator
1068962|NCT02735811|Cardiomyopathies|cardiomyopathies
1068963|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
1068964|NCT02735720|endograft|endograft
1068965|NCT02735720|cardiac remodelling|cardiac remodelling
1068966|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
1068967|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
1068968|NCT02735720|MRI|mri
1068969|NCT02735694|Sleep apnea|sleep apnea
1068970|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
1068971|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
1068972|NCT02735694|Cycloserine|cycloserine
1068973|NCT02735694|Short-term potentiation|short-term potentiation
1068974|NCT02735668|Shoulder Pain|shoulder pain
1068975|NCT02735668|Pattern Motor|pattern motor
1068976|NCT02735668|Physical Therapy Modalities|physical therapy modalities
1068977|NCT02735668|Breast Cancer Treatment|breast cancer treatment
1068978|NCT02735655|endoscopy|endoscopy
1068979|NCT02735655|Education|education
1068980|NCT02735655|capsule endoscopy|capsule endoscopy
1068981|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1068982|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1068983|NCT02735655|colonoscopy|colonoscopy
1068984|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
1068985|NCT02735655|Global status|global status
1068986|NCT02735655|unmet need|unmet need
1068987|NCT02735616|heart rate variability|heart rate variability
1068988|NCT02735616|stroke|stroke
1068989|NCT02735577|Alcohol|alcohol
1068990|NCT02735577|Craving|craving
1068991|NCT02735577|Functional MRI|functional mri
1068992|NCT02735577|Cognitive control|cognitive control
1068993|NCT02735577|Risky decision-making|risky decision-making
1068994|NCT02735577|Disulfiram|disulfiram
1068995|NCT02735564|Weight Loss|weight loss
1068996|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
1068997|NCT02735564|gut microbiota|gut microbiota
1068998|NCT02735551|LARC|larc
1068999|NCT02735551|IUD|iud
1069000|NCT02735551|Contraceptive Implant|contraceptive implant
1069001|NCT02735551|Contraception|contraception
1069002|NCT02735551|Community college|community college
1069003|NCT02735525|telemedicine|telemedicine
1069004|NCT02735525|smartphone|smartphone
1069005|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
1069006|NCT02735499|Urinary bladder|urinary bladder
1069007|NCT02735499|EMDA|emda
1069008|NCT02735499|iontophoresis|iontophoresis
1069009|NCT02735499|electrophoresis|electrophoresis
1069010|NCT02735499|Urinary incontinence|urinary incontinence
1069011|NCT02735486|Ginger|ginger
1069012|NCT02735486|blood pressure|blood pressure
1069013|NCT02735486|flow mediated dilatation|flow mediated dilatation
1069014|NCT02735434|Health anxiety|health anxiety
1069015|NCT02735434|illness anxiety disorder|illness anxiety disorder
1069016|NCT02735434|ACT|act
1069017|NCT02735434|internet|internet
1069018|NCT02735421|acne|acne
1069019|NCT02735421|scars|scars
1069020|NCT02735395|Periodontal Diseases|periodontal diseases
1069021|NCT02735395|Metronidazole|metronidazole
1069022|NCT02735395|Amoxicillin|amoxicillin
1069023|NCT02735395|Chronic periodontitis|chronic periodontitis
1069024|NCT02735395|Root Planing|root planing
1069025|NCT02735382|Translational Medical Research|translational medical research
1069026|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
1069027|NCT02735382|Electronic Health Records|electronic health records
1069028|NCT02735382|Smoking|smoking
1069029|NCT02735382|Tobacco|tobacco
1069030|NCT02735382|Quitline|quitline
1069031|NCT02735330|CCP|ccp
1069032|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
1069033|NCT02735317|radiotherapy|radiotherapy
1069034|NCT02735317|oral mucositis (OM)|oral mucositis (om)
1069035|NCT02735291|Leukemia CAR-T|leukemia car-t
1069036|NCT02735265|Rehabilitation|rehabilitation
1069037|NCT02735265|Virtual reality|virtual reality
1069038|NCT02735252|Castration Resistant|castration resistant
1069039|NCT02735252|Metastatic|metastatic
1069040|NCT02735239|Oesophageal Cancer|oesophageal cancer
1069041|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
1069042|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
1069043|NCT02735239|Immunotherapy|immunotherapy
1069044|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
1069045|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
1069046|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
1069047|NCT02735226|stroke|stroke
1069048|NCT02735226|Shanghai Healthcare|shanghai healthcare
1069049|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
1069050|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
1069051|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
1069052|NCT02735213|Traditional laser Treatment|traditional laser treatment
1069053|NCT02735213|optical coherence tomography|optical coherence tomography
1069054|NCT02735174|Telehealth|telehealth
1069055|NCT02735174|Sensor cap|sensor cap
1069056|NCT02735174|School based care|school based care
1069057|NCT02735174|Community health|community health
1069058|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
1069059|NCT02735161|Sarcoidosis|sarcoidosis
1069060|NCT02735161|Fatigue|fatigue
1069061|NCT02735161|Exercise|exercise
1069062|NCT02735148|Postural balance|postural balance
1069063|NCT02735148|Accidental falls|accidental falls
1069064|NCT02735148|Rehabilitation|rehabilitation
1069065|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
1069066|NCT02735148|Walking|walking
1069067|NCT02735148|Mobility limitation|mobility limitation
1069068|NCT02735135|bedridden|bedridden
1069069|NCT02735109|VIN|vin
1069070|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
1069071|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
1069072|NCT02735096|Imbalance|imbalance
1069073|NCT02735070|Common cold treatment|common cold treatment
1069074|NCT02735057|oesophagus cancer|oesophagus cancer
1069075|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
1069076|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
1069077|NCT02734992|Migraines|migraines
1069078|NCT02734992|Tension-type Headache|tension-type headache
1069079|NCT02734992|Acceptance|acceptance
1069080|NCT02734979|lymphedema|lymphedema
1069081|NCT02734979|edema|edema
1069082|NCT02734966|Drug-Induced|drug-induced
1069083|NCT02734966|Acute Liver Injury|acute liver injury
1069084|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
1069085|NCT02734953|Exercise|exercise
1069086|NCT02734953|6 minute walk test|6 minute walk test
1069087|NCT02734953|CardioMems|cardiomems
1069088|NCT02734927|schizophrenia|schizophrenia
1069089|NCT02734927|motivation|motivation
1069090|NCT02734927|executive control|executive control
1069091|NCT02734901|polyphenols|polyphenols
1069092|NCT02734901|vascular function|vascular function
1069093|NCT02734901|endothelial function|endothelial function
1069094|NCT02734901|raspberry|raspberry
1069095|NCT02734888|arterial inflammation|arterial inflammation
1069096|NCT02734888|electronic cigarettes|electronic cigarettes
1069097|NCT02734888|PET scan|pet scan
1069098|NCT02734875|anticoagulants|anticoagulants
1069099|NCT02734875|NOACs|noacs
1069100|NCT02734875|warfarin|warfarin
1069101|NCT02734875|randomized designed delay|randomized designed delay
1069102|NCT02734875|intervention|intervention
1069103|NCT02734875|machine learning algorithm|machine learning algorithm
1069104|NCT02734875|primary care|primary care
1069105|NCT02734862|mycoses|mycoses
1069106|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1069107|NCT02734810|Cystic Fibrosis|cystic fibrosis
1069108|NCT02734810|Liprotamase|liprotamase
1069109|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
1069110|NCT02734771|DLBCL|dlbcl
1069111|NCT02734745|diabetes type 1|diabetes type 1
1069312|NCT02733666|Children|children
1069112|NCT02734745|flash glucose monitoring|flash glucose monitoring
1069113|NCT02734732|Prostate|prostate
1069114|NCT02734732|Biopsy|biopsy
1069115|NCT02734732|Infection|infection
1069116|NCT02734732|Prophylaxis|prophylaxis
1069117|NCT02734732|Antibiotic|antibiotic
1069118|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
1069119|NCT02734680|Pancreatic cancer|pancreatic cancer
1069120|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
1069121|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
1069122|NCT02734654|oxidative stress|oxidative stress
1069123|NCT02734654|lung lobectomy|lung lobectomy
1069124|NCT02734615|LSZ102|lsz102
1069125|NCT02734615|LEE011|lee011
1069126|NCT02734615|ribociclib|ribociclib
1069127|NCT02734615|Kisqali|kisqali
1069128|NCT02734615|BYL719|byl719
1069129|NCT02734615|alpelisib|alpelisib
1069130|NCT02734615|ER+ breast cancer|er+ breast cancer
1069131|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
1069132|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
1069133|NCT02734615|SERD|serd
1069134|NCT02734615|SERM|serm
1069135|NCT02734615|fulvestrant|fulvestrant
1069136|NCT02734615|tamoxifen|tamoxifen
1069137|NCT02734615|aromatase inhibitor|aromatase inhibitor
1069138|NCT02734615|ESR1|esr1
1069139|NCT02734615|estrogen receptor|estrogen receptor
1069140|NCT02734615|endocrine therapy|endocrine therapy
1069141|NCT02734602|depression|depression
1069142|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
1069143|NCT02734602|sv2a|sv2a
1069144|NCT02734602|ketamine|ketamine
1069146|NCT02734589|Ulcerative Colitis|ulcerative colitis
1069147|NCT02734589|Nutrition|nutrition
1069148|NCT02734589|microbiome|microbiome
1069149|NCT02734576|Venous Sinus Stenting|venous sinus stenting
1069150|NCT02734576|Dural Sinus Stenting|dural sinus stenting
1069151|NCT02734550|Sepsis|sepsis
1069152|NCT02734550|Invasive Candida Infection|invasive candida infection
1069153|NCT02734550|Biomarker|biomarker
1069154|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
1069155|NCT02734550|Antifungal therapy|antifungal therapy
1069156|NCT02734550|Intensive care medicine|intensive care medicine
1069157|NCT02734550|Critically ill|critically ill
1069158|NCT02734524|Natural killer cells|natural killer cells
1069159|NCT02734524|NSCLC|nsclc
1069160|NCT02734524|NCT|nct
1069161|NCT02734524|Combined therapy|combined therapy
1069162|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
1069163|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
1069164|NCT02734472|blood pressure|blood pressure
1069165|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
1069166|NCT02734472|Vascular Stiffness|vascular stiffness
1069167|NCT02734472|Proteinuria|proteinuria
1069168|NCT02734472|Carotid Artery Diseases|carotid artery diseases
1069169|NCT02734446|Bronchial Inflammation|bronchial inflammation
1069170|NCT02734446|Asthma|asthma
1069171|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
1069172|NCT02734446|Asthma Exacerbations|asthma exacerbations
1069173|NCT02734433|Advanced solid tumors|advanced solid tumors
1069174|NCT02734433|Asian subjects|asian subjects
1069175|NCT02734433|Developmental Phase I|developmental phase i
1069176|NCT02734420|Dental caries|dental caries
1069177|NCT02734420|PDT|pdt
1069178|NCT02734420|LLLT|lllt
1069179|NCT02734420|pediatric dentistry|pediatric dentistry
1069180|NCT02734394|exercise|exercise
1069181|NCT02734394|body composition|body composition
1069182|NCT02734394|metabolism|metabolism
1069183|NCT02734394|nutrition|nutrition
1069184|NCT02734381|elderly patients|elderly patients
1069185|NCT02734381|prevalence|prevalence
1069186|NCT02734381|emergency department use|emergency department use
1069187|NCT02734381|main presenting disease|main presenting disease
1069188|NCT02734355|atrial fibrillation|atrial fibrillation
1069189|NCT02734355|catheter ablation|catheter ablation
1069190|NCT02734355|left atrium|left atrium
1069191|NCT02734355|mechanical function|mechanical function
1069192|NCT02734355|contractility|contractility
1069193|NCT02734329|Nephron sparing surgery|nephron sparing surgery
1069194|NCT02734329|Zero ischemia|zero ischemia
1069195|NCT02734329|Warm ischemia|warm ischemia
1069196|NCT02734329|Laparoscopic|laparoscopic
1069197|NCT02734329|Radiofrequency ablation|radiofrequency ablation
1069198|NCT02734329|Microwave ablation|microwave ablation
1069199|NCT02734303|Dietary Radioactivity|dietary radioactivity
1069200|NCT02734303|Dietary Assessment|dietary assessment
1069201|NCT02734303|Retrospective Recall|retrospective recall
1069202|NCT02734303|Focus Group|focus group
1069203|NCT02734290|metastatic|metastatic
1069204|NCT02734290|Human epidermal growth factor receptor 2 (Her2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
1069205|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
1069206|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
1069207|NCT02734290|Immunotherapy|immunotherapy
1069208|NCT02734290|Breast Cancer|breast cancer
1069209|NCT02734277|Insulin|insulin
1069210|NCT02734277|Glucose Intolerance|glucose intolerance
1069211|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
1069212|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
1069213|NCT02734251|Healthy mood|healthy mood
1069214|NCT02734251|Stress management|stress management
1069215|NCT02734251|Relora|relora
1069216|NCT02734251|Healthy subjects|healthy subjects
1069217|NCT02734225|total knee replacement|total knee replacement
1069218|NCT02734225|total knee arthroplasty|total knee arthroplasty
1069219|NCT02734225|rehabilitation|rehabilitation
1069220|NCT02734225|physical therapy|physical therapy
1069221|NCT02734225|balance|balance
1069222|NCT02734212|Stigmatization|stigmatization
1069223|NCT02734199|Birth Control|birth control
1069224|NCT02734199|Contraception|contraception
1069225|NCT02734199|IUD|iud
1069226|NCT02734186|Filariasis|filariasis
1069227|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
1069228|NCT02734186|Coinfection|coinfection
1069229|NCT02734160|immunotherapy|immunotherapy
1069230|NCT02734160|check point inhibitors|check point inhibitors
1333231|NCT01443923|Virological Response|virological response
1069231|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
1069232|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
1069233|NCT02734121|breast cancer|breast cancer
1069234|NCT02734121|breast reconstruction|breast reconstruction
1069235|NCT02734121|shared decision making|shared decision making
1069236|NCT02734121|decision support intervention|decision support intervention
1069237|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
1069238|NCT02734082|stroke|stroke
1069239|NCT02734082|ischemia|ischemia
1069242|NCT02734043|bundled payment|bundled payment
1069243|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
1069244|NCT02734030|Quadriceps Femoris|quadriceps femoris
1069245|NCT02734030|Muscle Inhibition|muscle inhibition
1069246|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
1069247|NCT02734030|Muscle Architecture|muscle architecture
1069248|NCT02734030|Single Leg Squat|single leg squat
1069249|NCT02734030|Women Knee Pain|women knee pain
1069250|NCT02734004|MEDIOLA|mediola
1069251|NCT02734004|Olaparib|olaparib
1069252|NCT02734004|MEDI4736|medi4736
1069253|NCT02734004|Bevacizumab|bevacizumab
1069254|NCT02734004|Ovarian cancer|ovarian cancer
1069255|NCT02734004|Breast cancer|breast cancer
1069256|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
1069257|NCT02734004|Gastric Cancer|gastric cancer
1069258|NCT02734004|Phase I/II, Adults|phase i/ii, adults
1069259|NCT02734004|PDL-1|pdl-1
1069260|NCT02733978|Ozone oxygen|ozone oxygen
1069261|NCT02733978|ulcer healing|ulcer healing
1069262|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
1069263|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
1069264|NCT02733965|serious adverse events|serious adverse events
1069265|NCT02733965|medication reconciliation|medication reconciliation
1069266|NCT02733939|technology|technology
1069267|NCT02733939|informal care|informal care
1069268|NCT02733939|caregiver burden|caregiver burden
1069269|NCT02733913|atrial fibrillation|atrial fibrillation
1069270|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
1069271|NCT02733913|heart rate turbulence|heart rate turbulence
1069272|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
1069273|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
1069274|NCT02733900|femoral head|femoral head
1069275|NCT02733900|micro scanner|micro scanner
1069276|NCT02733900|Raman spectrometry|raman spectrometry
1069277|NCT02733900|MRI|mri
1069278|NCT02733861|dental implant|dental implant
1069279|NCT02733861|stability|stability
1069280|NCT02733861|implant stability quotient|implant stability quotient
1069281|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1069282|NCT02733848|Hypoglycemia|hypoglycemia
1069283|NCT02733848|Creon|creon
1069284|NCT02733822|opiate|opiate
1069285|NCT02733822|heroin|heroin
1069286|NCT02733822|opioid|opioid
1069287|NCT02733822|overdose|overdose
1069288|NCT02733822|naloxone|naloxone
1069289|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
1069290|NCT02733809|Sorafenib|sorafenib
1069291|NCT02733796|zika virus|zika virus
1069292|NCT02733796|semen analysis|semen analysis
1069293|NCT02733796|sexual transmission|sexual transmission
1069294|NCT02733757|Clonidine|clonidine
1069295|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
1069296|NCT02733757|IOP|iop
1069297|NCT02733757|OPP|opp
1069298|NCT02733757|OPA|opa
1069299|NCT02733744|Stem cell transplant|stem cell transplant
1069300|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
1069301|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
1069302|NCT02733718|Transfusion|transfusion
1069303|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
1069304|NCT02733705|Pain|pain
1069305|NCT02733705|TRUS biopsy|trus biopsy
1069306|NCT02733692|HIV|hiv
1069307|NCT02733692|STDs|stds
1069308|NCT02733692|web-based app|web-based app
1069309|NCT02733692|women|women
1069310|NCT02733666|Absorbable screw|absorbable screw
1069311|NCT02733666|Internal fixation|internal fixation
1069313|NCT02733653|Superficial Femoral Artery|superficial femoral artery
1069314|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
1069315|NCT02733653|Endovascular therapy|endovascular therapy
1069316|NCT02733653|Atherectomy|atherectomy
1069317|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
1069318|NCT02733588|hypoglycemia|hypoglycemia
1069319|NCT02733588|glucagon|glucagon
1069320|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
1069321|NCT02733588|hormones|hormones
1069322|NCT02733588|gastrointestinal agents|gastrointestinal agents
1069323|NCT02733588|bariatric surgery|bariatric surgery
1069324|NCT02733588|incretins|incretins
1069325|NCT02733536|endotracheal intubation|endotracheal intubation
1069326|NCT02733536|trauma|trauma
1069327|NCT02733536|paramedic|paramedic
1069328|NCT02733510|kidney transplantation|kidney transplantation
1069329|NCT02733510|subclinical rejection|subclinical rejection
1069330|NCT02733510|steroid pulse therapy|steroid pulse therapy
1069331|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
1069332|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
1069333|NCT02733471|Lidocaine|lidocaine
1069334|NCT02733471|Endoscopy|endoscopy
1069335|NCT02733471|Tolerance|tolerance
1069336|NCT02733393|Thoracotomy|thoracotomy
1069337|NCT02733393|Postoperative|postoperative
1069338|NCT02733393|Lidocaine|lidocaine
1069339|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
1069340|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1069341|NCT02733380|Relapsed and refractory|relapsed and refractory
1069342|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
1069344|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
1069345|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
1069346|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
1069347|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
1069348|NCT02733341|Pharmacodynamic|pharmacodynamic
1069349|NCT02733341|Antiplatelet|antiplatelet
1069350|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
1069351|NCT02733341|Cangrelor|cangrelor
1069352|NCT02733341|Ticagrelor|ticagrelor
1069353|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
1069354|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
1069355|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
1069356|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
1069357|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
1069358|NCT02733263|gut microbiota|gut microbiota
1069360|NCT02733263|diet quality|diet quality
1069361|NCT02733263|immunity|immunity
1069362|NCT02733250|NSCLC|nsclc
1069363|NCT02733250|Pembrolizumab|pembrolizumab
1069364|NCT02733250|Nab-paclitaxel|nab-paclitaxel
1069365|NCT02733237|oxytocin|oxytocin
1069366|NCT02733237|infidelity|infidelity
1069367|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
1069368|NCT02733211|Closed Loop|closed loop
1069369|NCT02733185|chelation|chelation
1069370|NCT02733172|Vulvodynia|vulvodynia
1069371|NCT02733172|Endophenotypes|endophenotypes
1069372|NCT02733172|functional MRI|functional mri
1069373|NCT02733159|Performance Status 2|performance status 2
1069374|NCT02733159|Pembrolizumab|pembrolizumab
1069375|NCT02733159|MK-3475|mk-3475
1069376|NCT02733133|Testosterone|testosterone
1069377|NCT02733133|AndroGel|androgel
1069378|NCT02733133|Transference|transference
1069379|NCT02733133|Women|women
1069380|NCT02733133|Children|children
1069381|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
1069382|NCT02733107|Apatinib|apatinib
1069383|NCT02733107|Etoposide|etoposide
1069384|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
1069385|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
1069386|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
1069387|NCT02733081|Family Planning|family planning
1069388|NCT02733081|International Family Planning|international family planning
1069389|NCT02733055|Postural Equilibrium|postural equilibrium
1069390|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
1069391|NCT02733055|Eye Movements|eye movements
1069392|NCT02733055|Saccades|saccades
1069393|NCT02733055|Pursuit, Smooth|pursuit, smooth
1069394|NCT02733042|Lymphoma|lymphoma
1069395|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1069396|NCT02733042|Durvalumab|durvalumab
1069397|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
1069398|NCT02733042|MEDI4736|medi4736
1069399|NCT02733042|Immune Checkpoint|immune checkpoint
1069400|NCT02733042|Lymphatic Disease|lymphatic disease
1069401|NCT02733042|B-Cell Malignancies|b-cell malignancies
1069402|NCT02733042|Abscopal Effect|abscopal effect
1069403|NCT02733042|Lenalidomide|lenalidomide
1069404|NCT02733042|Bendamustine|bendamustine
1069405|NCT02733042|Rituximab|rituximab
1069406|NCT02733042|Ibrutinib|ibrutinib
1069407|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
1069408|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
1069409|NCT02733042|Hodgkin Disease|hodgkin disease
1069410|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
1069411|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
1069412|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
1069413|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
1069414|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
1069415|NCT02733042|Immune System Diseases|immune system diseases
1069416|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
1069417|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
1069418|NCT02733003|Implementation Science|implementation science
1069420|NCT02733003|Sexual Risk|sexual risk
1069421|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
1069422|NCT02733003|Substance Abuse|substance abuse
1069423|NCT02733003|Violence and Victimization|violence and victimization
1069424|NCT02733003|Linkage to care|linkage to care
1069425|NCT02733003|Gender-based Violence|gender-based violence
1069426|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
1069427|NCT02732990|Training|training
1069428|NCT02732990|One-legged exercise|one-legged exercise
1069429|NCT02732990|Peripheral blood flow|peripheral blood flow
1069430|NCT02732990|Cardiac function|cardiac function
1069431|NCT02732990|Muscle metaboreflex|muscle metaboreflex
1069432|NCT02732964|satisfaction|satisfaction
1069433|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
1069434|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
1069435|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
1069436|NCT02732925|Conservative treatment|conservative treatment
1069437|NCT02732925|Sham procedure|sham procedure
1069438|NCT02732925|VCFs|vcfs
1069439|NCT02732925|Multiple Myeloma|multiple myeloma
1069440|NCT02732912|falls|falls
1069441|NCT02732912|sleep|sleep
1069442|NCT02732899|AMD|amd
1069443|NCT02732886|foam dressing|foam dressing
1069444|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
1069445|NCT02732860|molecular profiling|molecular profiling
1069446|NCT02732860|epigenetic analysis|epigenetic analysis
1069447|NCT02732860|drug sensitivity testing|drug sensitivity testing
1069448|NCT02732860|triple negative|triple negative
1069449|NCT02732860|metastatic|metastatic
1069450|NCT02732860|serous|serous
1069451|NCT02732847|Respiratory infections|respiratory infections
1069452|NCT02732847|Primary care|primary care
1069453|NCT02732847|Antibiotics|antibiotics
1069454|NCT02732847|Delayed prescriptions|delayed prescriptions
1069455|NCT02732834|Clinician-Patient Communication|clinician-patient communication
1069456|NCT02732834|16-001|16-001
1069457|NCT02732821|Gastroparesis|gastroparesis
1069458|NCT02732821|G-POEM|g-poem
1069459|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
1069460|NCT02732808|Double stimulations|double stimulations
1069461|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
1069462|NCT02732808|poor ovarian response|poor ovarian response
1069463|NCT02732782|Achilles tendon|achilles tendon
1069464|NCT02732782|isometric muscle training|isometric muscle training
1069465|NCT02732782|competitive sports|competitive sports
1069466|NCT02732782|strength training|strength training
1069467|NCT02732782|eccentric exercise|eccentric exercise
1069468|NCT02732782|isometric exercise|isometric exercise
1069469|NCT02732782|chronic condition|chronic condition
1069470|NCT02732782|regeneration|regeneration
1069471|NCT02732782|tendon|tendon
1069472|NCT02732782|tendon properties|tendon properties
1069473|NCT02732782|tendinopathy|tendinopathy
1069474|NCT02732782|tendinosis|tendinosis
1069475|NCT02732782|intervention|intervention
1069476|NCT02732782|training load|training load
1069477|NCT02732782|high performance sports|high performance sports
1069478|NCT02732756|ADHD|adhd
1069479|NCT02732756|Sleep|sleep
1069480|NCT02732756|Attention|attention
1069481|NCT02732756|Adolescence|adolescence
1069482|NCT02732743|childhod constipation|childhod constipation
1069483|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
1069484|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
1069485|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
1069486|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
1069487|NCT02732704|Aortic Valve Disease|aortic valve disease
1069488|NCT02732704|Aortic Regurgitation|aortic regurgitation
1069489|NCT02732691|Aortic Valve Disease|aortic valve disease
1069490|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
1069491|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
1069492|NCT02732613|Body weight|body weight
1069493|NCT02732613|Complication|complication
1069494|NCT02732600|Veterans|veterans
1069495|NCT02732600|Veterans Health|veterans health
1069496|NCT02732600|Patient Compliance|patient compliance
1069497|NCT02732600|Primary Health Care|primary health care
1069498|NCT02732600|Health Care Providers|health care providers
1069499|NCT02732600|Health Promotion|health promotion
1069500|NCT02732522|misoprostol|misoprostol
1069501|NCT02732522|induction of labor|induction of labor
1069502|NCT02732522|sublingual|sublingual
1069603|NCT02732015|Ondansetron|ondansetron
1069503|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1069504|NCT02732496|Tourette Syndrome|tourette syndrome
1069505|NCT02732496|Working Memory Training|working memory training
1069506|NCT02732483|gastric cancer|gastric cancer
1069507|NCT02732483|bleeding|bleeding
1069508|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1069509|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
1069510|NCT02732470|Qi Gong|qi gong
1069511|NCT02732470|Quality of life|quality of life
1069512|NCT02732457|HIV|hiv
1069513|NCT02732457|Persistence|persistence
1069514|NCT02732457|Reservoirs|reservoirs
1069515|NCT02732457|Stem Cell Transplant|stem cell transplant
1069516|NCT02732457|Functional Cure|functional cure
1069517|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
1069518|NCT02732444|Oxidative Stress|oxidative stress
1069519|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1069520|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
1069521|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
1069522|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
1069523|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
1069524|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
1069525|NCT02732418|subQ-subcutaneous|subq-subcutaneous
1069526|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1069527|NCT02732379|Aromatherapy|aromatherapy
1069528|NCT02732379|Quality of Health Care|quality of health care
1069529|NCT02732366|aged [MeSH term]|aged [mesh term]
1069530|NCT02732366|exercise [MeSH term]|exercise [mesh term]
1069531|NCT02732340|triple-branched stent graft|triple-branched stent graft
1069641|NCT02731794|inflammatory response|inflammatory response
1069532|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
1069533|NCT02732275|Relapsed non-hodgkin lymphoma.|relapsed non-hodgkin lymphoma.
1069534|NCT02732275|phase 1|phase 1
1069535|NCT02732275|oncology|oncology
1069536|NCT02732262|acute pain|acute pain
1069537|NCT02732262|postoperative|postoperative
1069538|NCT02732262|surgery|surgery
1069539|NCT02732249|Helicobacter pylori|helicobacter pylori
1069540|NCT02732249|Clarithromycin|clarithromycin
1069541|NCT02732249|Amoxicillin|amoxicillin
1069542|NCT02732249|Metronidazole|metronidazole
1069543|NCT02732249|Eradication|eradication
1069544|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
1069545|NCT02732236|Cohort|cohort
1069546|NCT02732236|Rituximab|rituximab
1069547|NCT02732236|HBV|hbv
1069548|NCT02732223|Atherosclerosis|atherosclerosis
1069549|NCT02732223|omega 3|omega 3
1069550|NCT02732223|plant sterols|plant sterols
1069551|NCT02732223|polyphenols|polyphenols
1069552|NCT02732184|AML|aml
1069553|NCT02732184|MDS|mds
1069554|NCT02732158|Novel laboratory methods|novel laboratory methods
1069555|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
1069556|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
1069557|NCT02732145|N-S-P scheme|n-s-p scheme
1069558|NCT02732145|Vulvoscopy Index|vulvoscopy index
1069559|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
1069560|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
1069561|NCT02732145|Lichen Planus|lichen planus
1069562|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
1069563|NCT02732145|Vulvodynia|vulvodynia
1069564|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
1069565|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
1069566|NCT02732145|Vulvar Diseases|vulvar diseases
1069567|NCT02732119|HR-positive|hr-positive
1069568|NCT02732119|HER2-negative|her2-negative
1069569|NCT02732119|Advanced breast cancer|advanced breast cancer
1069570|NCT02732119|LEE011|lee011
1069571|NCT02732119|ribociclib|ribociclib
1069572|NCT02732119|everolimus|everolimus
1069573|NCT02732119|Afinitor|afinitor
1069574|NCT02732119|exemestane|exemestane
1069575|NCT02732119|Aromasin|aromasin
1069576|NCT02732119|CDK|cdk
1069577|NCT02732119|CDK4|cdk4
1069578|NCT02732119|CDK6|cdk6
1069579|NCT02732119|CDK4/6|cdk4/6
1069580|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
1069581|NCT02732119|Phase III|phase iii
1069582|NCT02732119|ER-positive|er-positive
1069583|NCT02732119|PR-positive|pr-positive
1069584|NCT02732119|Postmenopausal|postmenopausal
1069585|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
1069586|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1069587|NCT02732080|microvascular obstruction|microvascular obstruction
1069588|NCT02732080|myocardial edema|myocardial edema
1069589|NCT02732080|microvascular resistance|microvascular resistance
1069590|NCT02732080|acute myocardial infarction|acute myocardial infarction
1069591|NCT02732067|Anesthesia|anesthesia
1069592|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
1069593|NCT02732015|Sarcoma|sarcoma
1069594|NCT02732015|Locally advanced|locally advanced
1069595|NCT02732015|High risk for relapse|high risk for relapse
1069596|NCT02732015|Metastatic|metastatic
1069597|NCT02732015|Questionnaires|questionnaires
1069598|NCT02732015|Surveys|surveys
1069599|NCT02732015|Rolapitant|rolapitant
1069600|NCT02732015|Fosaprepitant|fosaprepitant
1069601|NCT02732015|Dexamethasone|dexamethasone
1069602|NCT02732015|Decadron|decadron
1069605|NCT02732015|Doxorubicin|doxorubicin
1069606|NCT02732015|Adriamycin PFS|adriamycin pfs
1069607|NCT02732015|Adriamycin RDF|adriamycin rdf
1069608|NCT02732015|Rubex|rubex
1069609|NCT02732015|Mesna|mesna
1069610|NCT02732015|Mesnex|mesnex
1069611|NCT02732015|Ifosfamide|ifosfamide
1069612|NCT02732015|Ifex|ifex
1069613|NCT02732015|Vincristine|vincristine
1069614|NCT02732015|Nausea|nausea
1069615|NCT02732015|Vomiting|vomiting
1069616|NCT02732002|shoulder|shoulder
1069617|NCT02732002|rotator cuff- injury|rotator cuff- injury
1069618|NCT02732002|management|management
1069619|NCT02732002|rehabilitation model|rehabilitation model
1069620|NCT02731976|Gluten-Free diet|gluten-free diet
1069621|NCT02731976|Healthy individuals|healthy individuals
1069622|NCT02731963|Outcomes|outcomes
1069623|NCT02731963|Bowel preparation|bowel preparation
1069624|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
1069625|NCT02731924|Appendicitis|appendicitis
1069626|NCT02731924|Ultrasound|ultrasound
1069627|NCT02731924|Emergency Department|emergency department
1069628|NCT02731872|COPD|copd
1069629|NCT02731872|oxygen treatment|oxygen treatment
1069630|NCT02731872|quality of life|quality of life
1069631|NCT02731846|Efficacy|efficacy
1069632|NCT02731846|Triple therapy|triple therapy
1069633|NCT02731846|Parallel|parallel
1069634|NCT02731846|Respiratory|respiratory
1069635|NCT02731820|potassium citrate|potassium citrate
1069636|NCT02731807|TA-65|ta-65
1069637|NCT02731807|Telemorase|telemorase
1069638|NCT02731807|Dietary Supplement|dietary supplement
1069639|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
1069640|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
1069642|NCT02731794|cardiac dysfunction|cardiac dysfunction
1069643|NCT02731781|OUTCOME|outcome
1069644|NCT02731781|PROGNOSIS|prognosis
1069645|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
1069646|NCT02731781|CT SCAN|ct scan
1069647|NCT02731755|Oats|oats
1069648|NCT02731755|Phenolic acid|phenolic acid
1069649|NCT02731755|FMD|fmd
1069650|NCT02731755|LDI|ldi
1069651|NCT02731755|Renin angiotensin|renin angiotensin
1069652|NCT02731755|Nitric oxide|nitric oxide
1069653|NCT02731729|Ipilimumab|ipilimumab
1069654|NCT02731729|Nivolumab|nivolumab
1069655|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
1069656|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
1069657|NCT02731729|16-043|16-043
1069658|NCT02731703|overdenture|overdenture
1069659|NCT02731703|overlay|overlay
1069660|NCT02731703|implant supported|implant supported
1069661|NCT02731703|denture|denture
1069662|NCT02731703|dental prosthesis|dental prosthesis
1069663|NCT02731703|maxillary|maxillary
1069664|NCT02731690|GNE Myopathy|gne myopathy
1069665|NCT02731690|Nonaka|nonaka
1069666|NCT02731690|GNEM|gnem
1069667|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1069668|NCT02731690|HIBM|hibm
1069669|NCT02731690|DMRV|dmrv
1069670|NCT02731690|QSM|qsm
1069671|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
1069672|NCT02731664|Functional dyspepsia|functional dyspepsia
1069673|NCT02731664|Gastric emptying|gastric emptying
1069674|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
1069675|NCT02731638|cornea|cornea
1069676|NCT02731638|ulcer|ulcer
1069677|NCT02731638|fungal|fungal
1069678|NCT02731638|keratitis|keratitis
1069679|NCT02731625|Kettlebell training|kettlebell training
1069680|NCT02731625|High-intensity interval training|high-intensity interval training
1069681|NCT02731612|Bipolar Disorder|bipolar disorder
1069682|NCT02731612|Cognition|cognition
1069683|NCT02731612|Euthymic|euthymic
1069684|NCT02731612|Lurasidone|lurasidone
1069685|NCT02731599|Parkinson Disease|parkinson disease
1069686|NCT02731599|treadmill|treadmill
1069687|NCT02731599|Rehabilitation|rehabilitation
1069688|NCT02731586|Dental Implants|dental implants
1069689|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
1069690|NCT02731586|osseointegration|osseointegration
1069691|NCT02731586|primary stability|primary stability
1069692|NCT02731586|resonance frequency analysis|resonance frequency analysis
1069693|NCT02731586|RFA|rfa
1069694|NCT02731586|implants and stem cells|implants and stem cells
1069695|NCT02731586|use of stem cells|use of stem cells
1069696|NCT02731586|stem cells|stem cells
1069697|NCT02731573|Mediastenitis|mediastenitis
1069698|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
1069699|NCT02731560|RA|ra
1069700|NCT02731521|MRS Biomarkers|mrs biomarkers
1069701|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1069702|NCT02731508|Neuroplasticity|neuroplasticity
1069703|NCT02731482|Bronchiectasis|bronchiectasis
1069704|NCT02731482|Rehabilitation|rehabilitation
1069705|NCT02731482|Quality of Life|quality of life
1069706|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
1069707|NCT02731456|high altitude|high altitude
1069708|NCT02731456|cognition|cognition
1069709|NCT02731456|sleep|sleep
1069710|NCT02731443|dreaming|dreaming
1069711|NCT02731443|epilepsy|epilepsy
1069712|NCT02731443|neurosurgery|neurosurgery
1069713|NCT02731443|temporal lobectomy|temporal lobectomy
1069714|NCT02731378|erythropoietin|erythropoietin
1069715|NCT02731378|iron supplementation|iron supplementation
1069716|NCT02731378|inadequately responsive|inadequately responsive
1069717|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
1069718|NCT02731365|Parkinson's Disease|parkinson's disease
1069719|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
1069720|NCT02731300|Cathodal stimulation|cathodal stimulation
1333232|NCT01443923|Resistance Mutations|resistance mutations
1069721|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
1069722|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1069723|NCT02731235|Stroke|stroke
1069724|NCT02731235|stroke, acute|stroke, acute
1069725|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
1069726|NCT02731222|CEAP classification|ceap classification
1069727|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
1069728|NCT02731222|Onychodystrophy|onychodystrophy
1069729|NCT02731222|Body Mass Index|body mass index
1069730|NCT02731196|exercise|exercise
1069731|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
1069732|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
1069733|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
1069734|NCT02731183|Efficacy and safety|efficacy and safety
1069735|NCT02731170|Parkinson Disease|parkinson disease
1069736|NCT02731170|Advanced Stages|advanced stages
1069737|NCT02731170|Rehabilitation|rehabilitation
1069738|NCT02731144|Loss of Physical Function|loss of physical function
1069739|NCT02731118|glaucoma|glaucoma
1069740|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
1069741|NCT02731118|antisectory factor (AF)|antisectory factor (af)
1069742|NCT02731118|Salovum|salovum
1069743|NCT02731105|acne|acne
1069744|NCT02731105|vulgaris|vulgaris
1069745|NCT02731105|Clindamycin|clindamycin
1069746|NCT02731105|Tretinoin|tretinoin
1069747|NCT02731105|Adapalen|adapalen
1069748|NCT02731105|Benzoylperoxid|benzoylperoxid
1069749|NCT02731105|Epiduo|epiduo
1069750|NCT02731105|Acnatac|acnatac
1069751|NCT02731092|lactoferrin|lactoferrin
1069752|NCT02731092|very low birth weight infants|very low birth weight infants
1069753|NCT02731092|preterm infants|preterm infants
1069754|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
1069755|NCT02731053|Depression|depression
1069756|NCT02731053|Prevention|prevention
1069757|NCT02731053|Adolescents|adolescents
1069758|NCT02731053|School|school
1069759|NCT02731053|Effectiveness|effectiveness
1069760|NCT02731014|Dry Needling|dry needling
1069761|NCT02730975|pharmacokinetics|pharmacokinetics
1069762|NCT02730975|food-effect|food-effect
1069763|NCT02730975|fat diet|fat diet
1069764|NCT02730975|abiraterone acetate|abiraterone acetate
1069765|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
1069766|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
1069767|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
1069768|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
1069769|NCT02730923|Multicenter Trials|multicenter trials
1069770|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
1069771|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
1069772|NCT02730910|Bioavailability|bioavailability
1069773|NCT02730910|adults|adults
1069774|NCT02730897|Surgery|surgery
1069775|NCT02730897|Thoracotomy|thoracotomy
1069776|NCT02730897|VATS|vats
1069777|NCT02730884|Leukemia|leukemia
1069778|NCT02730884|Myelofibrosis|myelofibrosis
1069780|NCT02730884|Anemia|anemia
1069781|NCT02730884|Splenomegaly|splenomegaly
1069782|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
1069783|NCT02730884|post-PV|post-pv
1069784|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
1069785|NCT02730884|post-ET|post-et
1069786|NCT02730884|Rigosertib|rigosertib
1069787|NCT02730884|ON 01910.Na|on 01910.na
1069788|NCT02730884|Questionnaire|questionnaire
1069789|NCT02730884|Survey|survey
1069790|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
1069791|NCT02730858|Palliative Care|palliative care
1069792|NCT02730858|Breast Cancer|breast cancer
1069793|NCT02730858|End of life|end of life
1069794|NCT02730858|Health service research|health service research
1069795|NCT02730845|Elective|elective
1069796|NCT02730845|local anesthesia|local anesthesia
1069797|NCT02730845|knee arthroscopy|knee arthroscopy
1069798|NCT02730845|Dexmedetomidine|dexmedetomidine
1069799|NCT02730793|Cystic Fibrosis|cystic fibrosis
1069800|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
1069801|NCT02730754|Mood Disorders|mood disorders
1069802|NCT02730754|Illness Perception|illness perception
1069803|NCT02730754|Primary Care|primary care
1069804|NCT02730754|Medication Adherence|medication adherence
1069805|NCT02730741|diarrhoea|diarrhoea
1069806|NCT02730741|metfomin|metfomin
1069807|NCT02730741|type 2 diabetes|type 2 diabetes
1069808|NCT02730741|microbiota|microbiota
1069809|NCT02730728|adductor canal block|adductor canal block
1069810|NCT02730728|tinetti score|tinetti score
1069811|NCT02730728|time to up and go test|time to up and go test
1069812|NCT02730728|Ambulation distance|ambulation distance
1069813|NCT02730728|pain score|pain score
1069814|NCT02730728|quality of recovery score|quality of recovery score
1069815|NCT02730689|DP-R207|dp-r207
1069816|NCT02730689|Rosuvastatin|rosuvastatin
1069817|NCT02730689|Ezetimibe|ezetimibe
1069818|NCT02730676|electronic cigarettes|electronic cigarettes
1069819|NCT02730676|e-cigarette|e-cigarette
1069820|NCT02730676|combustible cigarette|combustible cigarette
1069821|NCT02730676|cigarette|cigarette
1069822|NCT02730676|menthol|menthol
1069823|NCT02730676|cig-alike|cig-alike
1069824|NCT02730676|subjective measures|subjective measures
1069825|NCT02730676|pharmacokinetics|pharmacokinetics
1069826|NCT02730676|craving|craving
1069827|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
1069828|NCT02730650|FACE-Q|face-q
1069829|NCT02730650|Platelet Rich Therapy|platelet rich therapy
1069830|NCT02730650|PRT|prt
1069831|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
1069832|NCT02730624|critically ill|critically ill
1069833|NCT02730624|severe sepsis|severe sepsis
1069834|NCT02730624|septic shock|septic shock
1069835|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
1069836|NCT02730611|Metabolic syndrome|metabolic syndrome
1069837|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
1069838|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
1069839|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
1069840|NCT02730585|C-reactive protein|c-reactive protein
1069841|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1069842|NCT02730572|Methylphenidate|methylphenidate
1069843|NCT02730559|Motivational Interviewing|motivational interviewing
1069844|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
1069845|NCT02730533|proton pump inhibitor|proton pump inhibitor
1069846|NCT02730533|bleeding|bleeding
1069847|NCT02730520|respiratory disease|respiratory disease
1069848|NCT02730520|allergen sensitization|allergen sensitization
1069849|NCT02730520|aging|aging
1069850|NCT02730520|skin tests|skin tests
1069851|NCT02730520|air allergens|air allergens
1069852|NCT02730494|mycosis|mycosis
1069853|NCT02730494|Candidiasis|candidiasis
1069854|NCT02730494|Lcr35®|lcr35®
1069855|NCT02730494|Lcr Regenerans®|lcr regenerans®
1069856|NCT02730455|Stroke|stroke
1069857|NCT02730351|Fluticasone furoate|fluticasone furoate
1069858|NCT02730351|activity monitoring|activity monitoring
1069859|NCT02730351|Vilanterol|vilanterol
1069860|NCT02730351|Cross-over|cross-over
1069861|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1069862|NCT02730351|exercise challenge|exercise challenge
1069863|NCT02730351|double-dummy|double-dummy
1069864|NCT02730351|asthma|asthma
1069865|NCT02730351|spirometry|spirometry
1069866|NCT02730351|fluticasone propionate|fluticasone propionate
1069867|NCT02730338|Castrate-Resistant|castrate-resistant
1069868|NCT02730325|CDI|cdi
1069869|NCT02730325|C. diff|c. diff
1069870|NCT02730325|Ulcerative Colitis|ulcerative colitis
1069871|NCT02730325|UC|uc
1069872|NCT02730325|IBD|ibd
1069873|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
1069874|NCT02730312|AML|aml
1069875|NCT02730312|B-ALL|b-all
1069876|NCT02730312|BPDCN|bpdcn
1069877|NCT02730312|CML|cml
1069878|NCT02730312|Blast Crisis|blast crisis
1069879|NCT02730286|human activity|human activity
1069880|NCT02730286|International Classification of Functioning|international classification of functioning
1069881|NCT02730260|Directive coaching|directive coaching
1069882|NCT02730260|Nondirective coaching|nondirective coaching
1069883|NCT02730260|smoking cessation quitline|smoking cessation quitline
1069884|NCT02730260|social support|social support
1069885|NCT02730247|ramucirumab|ramucirumab
1069886|NCT02730247|docetaxel|docetaxel
1069887|NCT02730221|Administrative workload|administrative workload
1069888|NCT02730221|Patient data management system|patient data management system
1069889|NCT02730221|Intensive Care Unit|intensive care unit
1069890|NCT02730221|Work sampling method|work sampling method
1069891|NCT02730221|Nursing Activity Score|nursing activity score
1069892|NCT02730182|postural control|postural control
1069893|NCT02730182|high altitude|high altitude
1069894|NCT02730169|Hypogonadotropic|hypogonadotropic
1069895|NCT02730169|hypogonadism|hypogonadism
1069896|NCT02730169|testosterone|testosterone
1069897|NCT02730143|Altitude|altitude
1069898|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
1069899|NCT02730130|Pembrolizumab|pembrolizumab
1069900|NCT02730130|Radiotherapy|radiotherapy
1069901|NCT02730130|16-032|16-032
1069902|NCT02730117|Acute kidney injury|acute kidney injury
1069903|NCT02730117|Furosemide stress test|furosemide stress test
1069904|NCT02730117|critical care|critical care
1069905|NCT02730078|Mood Disorders|mood disorders
1069906|NCT02730078|Self Care|self care
1069907|NCT02730078|Primary Care|primary care
1069908|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
1069909|NCT02730065|Lifestyle modification|lifestyle modification
1069910|NCT02730065|Physical activity|physical activity
1069911|NCT02730065|Primary prevention|primary prevention
1069912|NCT02730065|Aerobic dance|aerobic dance
1069913|NCT02730065|Cognition|cognition
1069914|NCT02730065|Depression|depression
1069915|NCT02730065|Activities of daily living|activities of daily living
1069916|NCT02730065|Cerebral autoregulation|cerebral autoregulation
1069917|NCT02730052|Blood pressure control|blood pressure control
1069918|NCT02730052|Hypertension|hypertension
1069919|NCT02730052|Office blood pressure|office blood pressure
1069920|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
1069921|NCT02730052|Telemonitoring|telemonitoring
1069922|NCT02730039|Cancer Care Providers|cancer care providers
1069923|NCT02730039|Psychotherapy|psychotherapy
1069924|NCT02730039|15-321|15-321
1069925|NCT02730026|Ketofrofen|ketofrofen
1069926|NCT02730026|Omeprazole|omeprazole
1069927|NCT02730026|Lower Third Molar|lower third molar
1069928|NCT02730026|Oral Surgery|oral surgery
1069929|NCT02730013|Older adults|older adults
1069930|NCT02730013|Square stepping exercise|square stepping exercise
1069931|NCT02730013|Mind-motor exercise|mind-motor exercise
1069932|NCT02730013|Long-term care|long-term care
1069933|NCT02730013|Global cognitive functioning|global cognitive functioning
1069934|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1069935|NCT02730000|Primary Teeth|primary teeth
1069936|NCT02730000|Clinical Efficacy|clinical efficacy
1069937|NCT02730000|Cost Analysis|cost analysis
1069938|NCT02730000|Glass Ionomer Cement|glass ionomer cement
1069939|NCT02729987|online|online
1069940|NCT02729987|internet|internet
1069941|NCT02729987|CBT|cbt
1069942|NCT02729987|Stress|stress
1069943|NCT02729987|Work|work
1069944|NCT02729987|Internet based treatment|internet based treatment
1069945|NCT02729974|thromboelastography|thromboelastography
1069947|NCT02729935|Bladder Discomfort|bladder discomfort
1069948|NCT02729909|Drug therapy|drug therapy
1069949|NCT02729870|Ketones|ketones
1069950|NCT02729870|Gastroenteritis|gastroenteritis
1069951|NCT02729844|Incidence|incidence
1069952|NCT02729844|Risk factors|risk factors
1069953|NCT02729844|Outcome|outcome
1069954|NCT02729831|decision making|decision making
1069955|NCT02729831|decision aids|decision aids
1069956|NCT02729831|decision quality instruments|decision quality instruments
1069957|NCT02729831|osteoarthritis|osteoarthritis
1069958|NCT02729831|shared decision making|shared decision making
1069959|NCT02729818|Retina|retina
1069960|NCT02729818|Microperimetry|microperimetry
1069961|NCT02729818|Visual Fields|visual fields
1069962|NCT02729805|ketamine|ketamine
1069963|NCT02729805|chronic pain|chronic pain
1069964|NCT02729805|mastectomy|mastectomy
1069965|NCT02729805|acute pain|acute pain
1069966|NCT02729792|depression|depression
1069967|NCT02729792|treatment resistance|treatment resistance
1069968|NCT02729792|biomarkers|biomarkers
1069969|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1069970|NCT02729766|Hyponatremia|hyponatremia
1069971|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
1069972|NCT02729740|Penumbra Smart coils|penumbra smart coils
1069973|NCT02729740|PC 400|pc 400
1069974|NCT02729740|AV malformations|av malformations
1069975|NCT02729740|AV fistulae|av fistulae
1069976|NCT02729688|Venous insufficiency|venous insufficiency
1069977|NCT02729688|Compression|compression
1069978|NCT02729688|Bandaging|bandaging
1069979|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
1069980|NCT02729597|neuromuscular disorders|neuromuscular disorders
1069981|NCT02729597|MRI|mri
1069982|NCT02729597|white matter|white matter
1069983|NCT02729597|brain|brain
1069984|NCT02729597|myotonic dystrophy|myotonic dystrophy
1069985|NCT02729558|brain metastases|brain metastases
1069986|NCT02729558|radiotherapy|radiotherapy
1069987|NCT02729558|resection|resection
1069988|NCT02729545|acupuncture, POCS|acupuncture, pocs
1069989|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
1069990|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
1069991|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
1069992|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
1069993|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
1069994|NCT02729506|transarterial radioembolization|transarterial radioembolization
1069995|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
1069996|NCT02729506|clinical trial|clinical trial
1069997|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
1069998|NCT02729467|Healthy|healthy
1069999|NCT02729467|JNJ-53718678|jnj-53718678
1070000|NCT02729467|Itraconazole|itraconazole
1070001|NCT02729467|Rifampicin|rifampicin
1070002|NCT02729467|Pharmacokinetics|pharmacokinetics
1070003|NCT02729428|Aging|aging
1070004|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
1070005|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
1070006|NCT02729428|Cognitive Function|cognitive function
1070007|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
1070008|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
1070009|NCT02729415|Hair Diseases|hair diseases
1070010|NCT02729415|Alopecia|alopecia
1070011|NCT02729402|Adults|adults
1070012|NCT02729389|Social Status|social status
1070013|NCT02729389|Hispanics|hispanics
1070014|NCT02729389|Energy Balance|energy balance
1070015|NCT02729389|Stress|stress
1070016|NCT02729376|Healthy Volunteers|healthy volunteers
1070017|NCT02729337|technology|technology
1070018|NCT02729337|adolescent|adolescent
1070019|NCT02729337|developing country|developing country
1070020|NCT02729337|hiv prevention|hiv prevention
1070021|NCT02729337|mHealth|mhealth
1070143|NCT02728622|endocrine treatment|endocrine treatment
1070022|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
1070023|NCT02729324|radiation dermatitis|radiation dermatitis
1070024|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
1070025|NCT02729311|exercise|exercise
1070026|NCT02729311|function|function
1070027|NCT02729311|quality of life|quality of life
1070028|NCT02729311|caregiver|caregiver
1070029|NCT02729298|Tolero|tolero
1070030|NCT02729298|Phase 1a / 1b|phase 1a / 1b
1070031|NCT02729298|First in human|first in human
1070032|NCT02729298|Solid Tumors with immunotherapy progression|solid tumors with immunotherapy progression
1070033|NCT02729298|AXL inhibitor|axl inhibitor
1070034|NCT02729298|Advanced Malignancy|advanced malignancy
1070035|NCT02729298|Cancer|cancer
1070036|NCT02729298|EGFR+ NSCLC with progression on ≤2 lines of oral TKIs|egfr+ nsclc with progression on ≤2 lines of oral tkis
1070037|NCT02729298|BRAF-Mutated CRC|braf-mutated crc
1070038|NCT02729298|KRAS-Mutated CRC|kras-mutated crc
1070039|NCT02729298|NRAS-Mutated CRC|nras-mutated crc
1070040|NCT02729298|Persistent/Recurrent Ovarian Cancer|persistent/recurrent ovarian cancer
1070041|NCT02729298|BRAF-Mutated Melanoma with immunotherapy progression|braf-mutated melanoma with immunotherapy progression
1070042|NCT02729259|VRD|vrd
1070136|NCT02728674|Gender bias|gender bias
1070043|NCT02729233|mucosal barrier function|mucosal barrier function
1070044|NCT02729220|Aging|aging
1070045|NCT02729220|Oxidative stress|oxidative stress
1070046|NCT02729220|Proteases|proteases
1070047|NCT02729220|Bronchoscopy|bronchoscopy
1070048|NCT02729207|NSAID Patch|nsaid patch
1070049|NCT02729168|Rabies|rabies
1070050|NCT02729168|Vaccine|vaccine
1070051|NCT02729168|Safety|safety
1070052|NCT02729168|INDIRAB|indirab
1070053|NCT02729168|Vietnam|vietnam
1070054|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
1070055|NCT02729155|Postconditioning|postconditioning
1070056|NCT02729155|Angioplasty|angioplasty
1070057|NCT02729155|Angiography|angiography
1070058|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
1070059|NCT02729142|HRpQCT|hrpqct
1070060|NCT02729142|transplant|transplant
1070061|NCT02729142|bone microarchitecture|bone microarchitecture
1070062|NCT02729129|Diesel exhaust|diesel exhaust
1070063|NCT02729129|Air pollution|air pollution
1070064|NCT02729129|Intervention|intervention
1070065|NCT02729129|Plethysmography|plethysmography
1070066|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
1070067|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
1070068|NCT02729116|Kidney Transplantation|kidney transplantation
1070069|NCT02729116|Urinary Tract Infections|urinary tract infections
1070070|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
1070071|NCT02729064|Intranasal Insulin|intranasal insulin
1070072|NCT02729064|Insulin concentration|insulin concentration
1070073|NCT02729064|Blood glucose|blood glucose
1070074|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
1070075|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
1070076|NCT02729064|Cardiac Surgery|cardiac surgery
1070077|NCT02729064|Thoracic Surgery|thoracic surgery
1070078|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1070079|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
1070080|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
1070081|NCT02729051|Closed triple therapy|closed triple therapy
1070082|NCT02729051|Placebo|placebo
1070083|NCT02729051|Open triple therapy|open triple therapy
1070084|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
1070085|NCT02729038|Normal Renal Function|normal renal function
1070086|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
1070087|NCT02729038|Pharmacokinetics|pharmacokinetics
1070088|NCT02729038|Gepotidacin|gepotidacin
1070089|NCT02729038|Renal Impairment|renal impairment
1070090|NCT02729025|Hyperlipidemia|hyperlipidemia
1070091|NCT02729025|Dyslipidemia|dyslipidemia
1070092|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
1070093|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
1070094|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
1070095|NCT02729012|Children|children
1070096|NCT02728999|Trendelenburg position|trendelenburg position
1070097|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
1070098|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
1070099|NCT02728986|Costs and Cost Analysis|costs and cost analysis
1070100|NCT02728986|Humans|humans
1070101|NCT02728986|Health Care Costs|health care costs
1070102|NCT02728986|varicose ulcer|varicose ulcer
1070103|NCT02728986|Compression Bandages|compression bandages
1070104|NCT02728973|colorectal resection|colorectal resection
1070105|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
1110993|NCT02485522|FI|fi
1070106|NCT02728973|Postoperative Complications|postoperative complications
1070107|NCT02728973|length of hospital stay|length of hospital stay
1070108|NCT02728947|Parkinson's Disease|parkinson's disease
1070109|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
1070110|NCT02728934|Golimumab|golimumab
1070111|NCT02728934|Infliximab|infliximab
1070112|NCT02728895|Drug Therapy|drug therapy
1070113|NCT02728882|Lymphoma CAR-T|lymphoma car-t
1070114|NCT02728843|Parkinson's disease|parkinson's disease
1070115|NCT02728843|Deferiprone|deferiprone
1070116|NCT02728830|gynecologic cancers|gynecologic cancers
1070117|NCT02728830|mullerian cancers|mullerian cancers
1070118|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
1070119|NCT02728817|Vascular access|vascular access
1070120|NCT02728817|Hemodialysis|hemodialysis
1070121|NCT02728817|Arteriovenous fistula|arteriovenous fistula
1070122|NCT02728817|Stenosis|stenosis
1070123|NCT02728817|Failure|failure
1070124|NCT02728752|DM|dm
1070125|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
1070126|NCT02728726|Neuromuscular Agents|neuromuscular agents
1070127|NCT02728713|Cranial manipulation|cranial manipulation
1070128|NCT02728713|Visual function|visual function
1070129|NCT02728687|peripheral neuropathy|peripheral neuropathy
1070130|NCT02728687|Diabetes|diabetes
1070131|NCT02728687|Pain|pain
1070132|NCT02728674|COPD|copd
1070133|NCT02728674|Breathlessness|breathlessness
1070134|NCT02728674|Symptom|symptom
1070135|NCT02728674|Opioids|opioids
1070137|NCT02728648|Pain Management|pain management
1070138|NCT02728648|Pharmacokinetics|pharmacokinetics
1070139|NCT02728648|Pharmacodynamics|pharmacodynamics
1070140|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
1070141|NCT02728622|ovarian cancer|ovarian cancer
1070142|NCT02728622|platinum-resistant|platinum-resistant
1070144|NCT02728622|chemotherapy|chemotherapy
1070145|NCT02728622|tamoxifen|tamoxifen
1070146|NCT02728583|Plant sterols|plant sterols
1070147|NCT02728583|Fish oil|fish oil
1070148|NCT02728583|Blood lipids|blood lipids
1070149|NCT02728570|flavonoids|flavonoids
1070150|NCT02728570|insulin resistance|insulin resistance
1070151|NCT02728570|plasma lipids|plasma lipids
1070152|NCT02728570|intestinal microbiome|intestinal microbiome
1070153|NCT02728570|intestinal inflammation|intestinal inflammation
1070154|NCT02728570|subclinical inflammation|subclinical inflammation
1070155|NCT02728557|Therapeutic alliance|therapeutic alliance
1070156|NCT02728557|Psychotherapy|psychotherapy
1070157|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
1070158|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
1070159|NCT02728557|Process research|process research
1070160|NCT02728557|Attachment theory|attachment theory
1070161|NCT02728557|Attachment orientation|attachment orientation
1070162|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
1070163|NCT02728466|flavanols|flavanols
1070164|NCT02728466|cocoa procyanidins|cocoa procyanidins
1070165|NCT02728466|vascular function|vascular function
1070166|NCT02728466|endothelial function|endothelial function
1070167|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
1070168|NCT02728427|Transurethral Catheterization|transurethral catheterization
1070169|NCT02728427|Rectal Cancer|rectal cancer
1070170|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
1070171|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
1070172|NCT02728401|inflammation|inflammation
1070173|NCT02728401|sepsis|sepsis
1070174|NCT02728401|pediatric|pediatric
1070175|NCT02728401|transcripts|transcripts
1070176|NCT02728401|serum proteins|serum proteins
1070177|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
1070178|NCT02728388|NF1|nf1
1070179|NCT02728388|Neurofibroma|neurofibroma
1070180|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
1070181|NCT02728362|tibial shaft fractures|tibial shaft fractures
1070182|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1070183|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
1070184|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1070185|NCT02728219|AFP conversion|afp conversion
1070186|NCT02728193|treatments|treatments
1070187|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
1070188|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
1070189|NCT02728180|Xingnaojing injection|xingnaojing injection
1070190|NCT02728180|Randomized Controlled Trial|randomized controlled trial
1070191|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
1070192|NCT02728167|Hepatectomy|hepatectomy
1070193|NCT02728167|Liver metastasis|liver metastasis
1070194|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
1070195|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
1070403|NCT02727010|Parenthood|parenthood
1070196|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
1070197|NCT02728128|Milrinone|milrinone
1070198|NCT02728115|Huntington's Disease|huntington's disease
1070199|NCT02728115|Stem Cell|stem cell
1070200|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
1070201|NCT02728102|Multiple Myeloma|multiple myeloma
1070202|NCT02728102|Lenalidomide|lenalidomide
1070203|NCT02728102|Maintenance Therapy|maintenance therapy
1070204|NCT02728102|Hematologic Disorders|hematologic disorders
1070205|NCT02728102|Vaccine|vaccine
1070206|NCT02728102|GM-CSF|gm-csf
1070207|NCT02728102|Transplant|transplant
1070208|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
1070209|NCT02728076|Breast Cancer|breast cancer
1070210|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
1070211|NCT02728037|Myofascial Trigger Points|myofascial trigger points
1070212|NCT02728037|Myofascial Pain|myofascial pain
1070213|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
1070214|NCT02727998|PTSD|ptsd
1070215|NCT02727972|depression|depression
1070216|NCT02727972|bipolar|bipolar
1070217|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
1070218|NCT02727972|mood disorders|mood disorders
1070219|NCT02727972|PET|pet
1070220|NCT02727972|mGluRr|mglurr
1070221|NCT02727972|glutamate system|glutamate system
1070222|NCT02727972|MRI|mri
1070223|NCT02727959|UC|uc
1070224|NCT02727959|CD|cd
1070225|NCT02727959|IBD|ibd
1070226|NCT02727894|Screening|screening
1070227|NCT02727894|pTNM|ptnm
1070228|NCT02727894|Metastasis|metastasis
1070229|NCT02727894|Chemotherapy|chemotherapy
1070230|NCT02727894|Resection Margins|resection margins
1070231|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
1070235|NCT02727842|cochlear implant|cochlear implant
1070236|NCT02727842|Sound Processor|sound processor
1070237|NCT02727803|Acute Myelogenous Leukemia|acute myelogenous leukemia
1070238|NCT02727803|AML|aml
1070239|NCT02727803|Myelodysplastic syndrome|myelodysplastic syndrome
1070240|NCT02727803|MDS|mds
1070241|NCT02727803|Multiple myeloma|multiple myeloma
1070242|NCT02727803|MM|mm
1070243|NCT02727803|Umbilical cord blood transplant|umbilical cord blood transplant
1070244|NCT02727803|UCB|ucb
1070245|NCT02727803|Natural killer cells|natural killer cells
1070246|NCT02727803|NK|nk
1070247|NCT02727803|Busulfan|busulfan
1070248|NCT02727803|Busulfex|busulfex
1070249|NCT02727803|Myleran|myleran
1070250|NCT02727803|Fludarabine|fludarabine
1070251|NCT02727803|Fludarabine Phosphate|fludarabine phosphate
1070252|NCT02727803|Fludara|fludara
1070253|NCT02727803|Clofarabine|clofarabine
1070254|NCT02727803|Clofarex|clofarex
1070255|NCT02727803|Clolar|clolar
1070256|NCT02727803|Rabbit ATB|rabbit atb
1070257|NCT02727803|ATG (Rabbit)|atg (rabbit)
1070258|NCT02727803|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
1070259|NCT02727803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
1070260|NCT02727803|rATG Thymoglobulin|ratg thymoglobulin
1070261|NCT02727803|Total Body Irradiation|total body irradiation
1070262|NCT02727803|TBI|tbi
1070263|NCT02727803|Radiation therapy|radiation therapy
1070264|NCT02727803|XRT|xrt
1070265|NCT02727803|Rituximab|rituximab
1070266|NCT02727803|Rituxan|rituxan
1070267|NCT02727803|Cyclophosphamide|cyclophosphamide
1070268|NCT02727803|Cytoxan|cytoxan
1070269|NCT02727803|Neosar|neosar
1070270|NCT02727803|Melphalan|melphalan
1070271|NCT02727803|Alkeran|alkeran
1070272|NCT02727777|Lymphoma|lymphoma
1070273|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
1070274|NCT02727777|MLN0128|mln0128
1070275|NCT02727777|Blood sugar|blood sugar
1070276|NCT02727777|Glucometer|glucometer
1070277|NCT02727777|TK228|tk228
1070278|NCT02727764|Arthritis|arthritis
1070279|NCT02727764|Gene therapy|gene therapy
1070280|NCT02727764|Phase Ib|phase ib
1070281|NCT02727764|Intra-articular|intra-articular
1070282|NCT02727738|Hyperthyroidism|hyperthyroidism
1070283|NCT02727738|Methimazole|methimazole
1070284|NCT02727738|Selenium|selenium
1070285|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
1070286|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
1070287|NCT02727699|Mild Dementia|mild dementia
1070288|NCT02727699|Actinogen|actinogen
1070289|NCT02727699|Alzheimer's Disease|alzheimer's disease
1070290|NCT02727699|Xanamem|xanamem
1070291|NCT02727699|Cortisol|cortisol
1070292|NCT02727699|UE2343|ue2343
1070293|NCT02727699|XanADu|xanadu
1070294|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
1070295|NCT02727673|cancer stem cells|cancer stem cells
1070296|NCT02727660|COPD|copd
1070297|NCT02727647|Moderate hemophilia A|moderate hemophilia a
1070298|NCT02727647|Severe hemophilia A|severe hemophilia a
1070299|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
1070300|NCT02727647|Low dose prophylaxis|low dose prophylaxis
1070301|NCT02727634|Hemodynamics|hemodynamics
1070404|NCT02727010|Child psychology|child psychology
1070302|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
1070303|NCT02727621|Dexmedetomidine|dexmedetomidine
1070304|NCT02727621|Cardiac|cardiac
1070305|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
1070306|NCT02727621|Sedation|sedation
1070307|NCT02727621|Propofol|propofol
1070308|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
1070310|NCT02727556|skin conductance response|skin conductance response
1070311|NCT02727556|facial muscle activity|facial muscle activity
1070312|NCT02727556|heart rate variability|heart rate variability
1070313|NCT02727556|eyetracking|eyetracking
1070314|NCT02727543|Hypertension|hypertension
1070315|NCT02727543|mHealth|mhealth
1070316|NCT02727543|Medication Non-adherence|medication non-adherence
1070317|NCT02727530|Infant Colic|infant colic
1070318|NCT02727530|Manual Therapy|manual therapy
1070319|NCT02727530|Effectiveness|effectiveness
1070320|NCT02727517|Resuscitation|resuscitation
1070321|NCT02727517|Cord clamping|cord clamping
1070322|NCT02727504|Aortic valve stenosis|aortic valve stenosis
1070323|NCT02727504|low flow|low flow
1070324|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
1070325|NCT02727491|opioid analgesics,|opioid analgesics,
1070326|NCT02727491|opioid consumption|opioid consumption
1070327|NCT02727491|adverse effects|adverse effects
1070328|NCT02727491|postoperative pain|postoperative pain
1070329|NCT02727491|tonsillectomy|tonsillectomy
1070330|NCT02727478|Balance|balance
1070331|NCT02727478|Rehabilitation|rehabilitation
1070332|NCT02727478|Exercise|exercise
1070333|NCT02727478|basal ganglia|basal ganglia
1070334|NCT02727478|Gait|gait
1070335|NCT02727478|Training|training
1070336|NCT02727478|physical activity|physical activity
1070337|NCT02727439|microvascular function|microvascular function
1070338|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
1070339|NCT02727439|exercise|exercise
1070340|NCT02727426|microvascular function|microvascular function
1070341|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
1070342|NCT02727426|high salt diet|high salt diet
1070343|NCT02727374|Fear to Fall|fear to fall
1070344|NCT02727374|Geriatric|geriatric
1070345|NCT02727374|Rehabilitation|rehabilitation
1070346|NCT02727374|Psychology|psychology
1070347|NCT02727361|Dystonia|dystonia
1070348|NCT02727361|Binding potential|binding potential
1070349|NCT02727361|FEOBV|feobv
1070350|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
1070351|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
1070352|NCT02727335|crizotinib|crizotinib
1070353|NCT02727309|Apatinib|apatinib
1070354|NCT02727309|Second-line Treatment|second-line treatment
1070355|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
1070356|NCT02727309|TACE|tace
1070357|NCT02727283|Healthy volunteer|healthy volunteer
1070358|NCT02727283|Safety|safety
1070359|NCT02727283|Pharmacokinetics|pharmacokinetics
1070360|NCT02727283|Dose escalation|dose escalation
1070361|NCT02727283|GSK3179106|gsk3179106
1070362|NCT02727283|Rearranged during Transfection|rearranged during transfection
1070363|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
1070364|NCT02727283|Adults|adults
1070365|NCT02727270|Movement disorders|movement disorders
1070366|NCT02727270|Metabolic Stress|metabolic stress
1070367|NCT02727257|Parkinson's disease|parkinson's disease
1070368|NCT02727257|rehabilitation|rehabilitation
1070369|NCT02727257|attention|attention
1070370|NCT02727257|executive functions|executive functions
1070371|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
1070372|NCT02727231|closed loop glucose control|closed loop glucose control
1070373|NCT02727231|hypoglycemia|hypoglycemia
1070374|NCT02727231|type 1 diabetes|type 1 diabetes
1070375|NCT02727231|HbA1C<7.5%|hba1c<7.5%
1070376|NCT02727166|intestinal gas|intestinal gas
1070377|NCT02727166|functional gut symptoms|functional gut symptoms
1070378|NCT02727166|intestinal sensitivity|intestinal sensitivity
1070379|NCT02727166|intestinal motility|intestinal motility
1070380|NCT02727153|Colonic cancer|colonic cancer
1070381|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
1070382|NCT02727153|Safety|safety
1070383|NCT02727114|skin thickness|skin thickness
1070384|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
1070385|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
1070386|NCT02727088|Dental Pulp Disease|dental pulp disease
1070387|NCT02727088|Endodontics|endodontics
1070388|NCT02727088|Pulp Capping|pulp capping
1070389|NCT02727088|Pulpotomy|pulpotomy
1070390|NCT02727088|Pulpectomy|pulpectomy
1070391|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
1070392|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
1070393|NCT02727075|Aged 75 Years and Older|aged 75 years and older
1070394|NCT02727062|pain|pain
1070395|NCT02727062|radiation|radiation
1070396|NCT02727062|head and neck cancer|head and neck cancer
1070397|NCT02727062|smartphone pain app|smartphone pain app
1070398|NCT02727062|OM Pain App|om pain app
1070399|NCT02727023|Healthy|healthy
1070400|NCT02727010|Motor disability|motor disability
1070401|NCT02727010|Motor impairment|motor impairment
1070402|NCT02727010|Pregnancy|pregnancy
1070405|NCT02726997|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1070406|NCT02726997|Ovarian Cancer|ovarian cancer
1070407|NCT02726997|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
1070408|NCT02726997|Fallopian Tube Cancer|fallopian tube cancer
1070409|NCT02726997|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
1070410|NCT02726997|Laparoscopy surgery|laparoscopy surgery
1070411|NCT02726997|Durvalumab|durvalumab
1070412|NCT02726997|MEDI4736|medi4736
1070413|NCT02726997|Carboplatin|carboplatin
1070414|NCT02726997|Paraplatin|paraplatin
1070415|NCT02726997|Paclitaxel|paclitaxel
1070416|NCT02726997|Taxol|taxol
1070417|NCT02726984|stroke|stroke
1070418|NCT02726984|carotid plaque|carotid plaque
1070419|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
1070420|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
1070421|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
1070422|NCT02726958|aortic valve replacement|aortic valve replacement
1070423|NCT02726958|percutaneous valve|percutaneous valve
1070424|NCT02726958|blood glucose variability|blood glucose variability
1070425|NCT02726958|TAVI|tavi
1070426|NCT02726932|Peritonitis|peritonitis
1070427|NCT02726932|Inflammatory Markers|inflammatory markers
1070428|NCT02726932|Patient Outcome Assessment|patient outcome assessment
1070429|NCT02726932|Classification|classification
1070430|NCT02726932|Multiple Organ Failure|multiple organ failure
1070431|NCT02726932|Intraabdominal Infections|intraabdominal infections
1070432|NCT02726919|focal epilepsy|focal epilepsy
1070433|NCT02726919|clobazam|clobazam
1070434|NCT02726906|Alzheimer's disease|alzheimer's disease
1070435|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
1070436|NCT02726906|Brain Imaging|brain imaging
1070437|NCT02726867|refractory status epilepticus|refractory status epilepticus
1070438|NCT02726867|levetiracetam|levetiracetam
1070439|NCT02726867|lacosamide|lacosamide
1070440|NCT02726867|ketamine|ketamine
1070441|NCT02726841|Thoracic aorta|thoracic aorta
1070442|NCT02726841|Abdominal aorta|abdominal aorta
1070443|NCT02726841|Stents|stents
1070444|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
1070445|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1070446|NCT02726763|Cognitive Training|cognitive training
1070447|NCT02726763|16-034|16-034
1070448|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
1070449|NCT02726750|MGUS|mgus
1070450|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
1070452|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
1070453|NCT02726750|Biomarker testing|biomarker testing
1070454|NCT02726750|Blood collection|blood collection
1070455|NCT02726750|Blood draw|blood draw
1070456|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
1070457|NCT02726737|irreversible pulpitis|irreversible pulpitis
1070458|NCT02726737|local anesthesia|local anesthesia
1070459|NCT02726737|sodium bicarbonate|sodium bicarbonate
1070460|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
1070461|NCT02726685|respiratory training|respiratory training
1070462|NCT02726685|functional performance|functional performance
1070463|NCT02726672|inspiratory muscles|inspiratory muscles
1070464|NCT02726672|multiple sclerosis|multiple sclerosis
1070465|NCT02726672|rehabilitation|rehabilitation
1070466|NCT02726646|Local Drug Delivery|local drug delivery
1070467|NCT02726646|Antibiotics|antibiotics
1070468|NCT02726646|Doxycycline|doxycycline
1070469|NCT02726646|Smokers|smokers
1070470|NCT02726646|Chronic Periodontitis|chronic periodontitis
1070471|NCT02726620|Decision support|decision support
1070472|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
1070473|NCT02726620|Decision Support Techniques|decision support techniques
1070474|NCT02726620|Hypotension|hypotension
1070475|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
1070476|NCT02726620|Acute Kidney Injury|acute kidney injury
1070477|NCT02726620|Postoperative Myocardial Injury|postoperative myocardial injury
1070478|NCT02726620|Postoperative Mortality|postoperative mortality
1070479|NCT02726620|Blood Pressure|blood pressure
1070480|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
1070481|NCT02726607|Kenya|kenya
1070482|NCT02726607|HITSystem 2.0|hitsystem 2.0
1070483|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
1070484|NCT02726607|Early Infant Diagnosis|early infant diagnosis
1070485|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
1070486|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
1070487|NCT02726568|EGFR-TKI|egfr-tki
1070488|NCT02726568|NSCLC|nsclc
1070489|NCT02726568|Icotinib|icotinib
1070490|NCT02726555|Red yeast rice|red yeast rice
1070491|NCT02726555|Atorvastatin|atorvastatin
1070492|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
1070493|NCT02726542|obesity|obesity
1070494|NCT02726542|adolescence|adolescence
1070495|NCT02726542|fatty liver|fatty liver
1070496|NCT02726542|growth hormone|growth hormone
1070497|NCT02726516|Performance|performance
1070498|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
1070499|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
1070500|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
1070501|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
1070502|NCT02726464|Pain Management|pain management
1070503|NCT02726464|Blood Platelets|blood platelets
1070504|NCT02726464|Therapeutics|therapeutics
1070505|NCT02726464|Inflammation|inflammation
1070506|NCT02726464|ThromboLUX|thrombolux
1070507|NCT02726464|Dynamic Light Scattering|dynamic light scattering
1070508|NCT02726399|Ramucirumab|ramucirumab
1070509|NCT02726399|Trastuzumab|trastuzumab
1070510|NCT02726399|Capecitabine|capecitabine
1070511|NCT02726399|Cisplatin|cisplatin
1070512|NCT02726399|HER2-Positive|her2-positive
1070513|NCT02726399|15-301|15-301
1070514|NCT02726360|Communication|communication
1070515|NCT02726360|15-316|15-316
1070516|NCT02726360|Physician|physician
1070517|NCT02726360|Use|use
1070518|NCT02726360|Non-English|non-english
1070519|NCT02726360|Language Skills|language skills
1070520|NCT02726334|Metastatic|metastatic
1070521|NCT02726308|Dexamethasone|dexamethasone
1070522|NCT02726308|Super-hydration|super-hydration
1070523|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1070524|NCT02726308|Nausea|nausea
1070525|NCT02726308|Vomiting|vomiting
1070526|NCT02726308|Postoperative|postoperative
1070527|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
1070528|NCT02726269|Levofloxacin|levofloxacin
1070529|NCT02726269|Antibiotic resistance|antibiotic resistance
1070530|NCT02726269|Clarithromycin|clarithromycin
1070531|NCT02726269|Mutations|mutations
1070532|NCT02726269|Fluorescence|fluorescence
1070533|NCT02726269|Hybridization|hybridization
1070534|NCT02726256|Diabetes|diabetes
1070535|NCT02726256|DM complication|dm complication
1070536|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
1070537|NCT02726243|Crohn's Disease|crohn's disease
1070538|NCT02726243|Ulcerative Colitis|ulcerative colitis
1070539|NCT02726243|colorectal cancer|colorectal cancer
1070540|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
1070541|NCT02726217|CareSmarts|caresmarts
1070542|NCT02726217|SMS-based mobile|sms-based mobile
1070543|NCT02726178|Apnea|apnea
1070544|NCT02726178|bradycardia|bradycardia
1070545|NCT02726178|immunization|immunization
1070546|NCT02726178|inflammation|inflammation
1070547|NCT02726178|preterms|preterms
1070548|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
1070549|NCT02726152|Acute appendicitis|acute appendicitis
1070550|NCT02726152|Appendiceal stump|appendiceal stump
1070551|NCT02726139|Factor VIII|factor viii
1070552|NCT02726139|inhibitor|inhibitor
1070553|NCT02726139|assay|assay
1070554|NCT02726126|Transdermal fentanyl|transdermal fentanyl
1070555|NCT02726126|Transdermal melatonin|transdermal melatonin
1070556|NCT02726126|Postoperative pain|postoperative pain
1070557|NCT02726126|lumber laminectomy|lumber laminectomy
1070558|NCT02726126|Relief|relief
1070559|NCT02726113|prostate cancer|prostate cancer
1070560|NCT02726113|vitamin D|vitamin d
1070561|NCT02726100|Telemedicine|telemedicine
1070562|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1070563|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
1070564|NCT02726100|Family Health Promoter|family health promoter
1070565|NCT02726100|Primary Health Care|primary health care
1070566|NCT02726087|Ministernotomy|ministernotomy
1070567|NCT02726087|aortic valve stenosis|aortic valve stenosis
1070568|NCT02726087|quality of life|quality of life
1070569|NCT02726087|satisfaction|satisfaction
1070570|NCT02726087|cardiac surgery|cardiac surgery
1070571|NCT02726074|epilepsy|epilepsy
1070572|NCT02726074|partial-onset seizures|partial-onset seizures
1070573|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
1070574|NCT02726035|Self-injurious behavior|self-injurious behavior
1070575|NCT02726035|Self mutilation|self mutilation
1070576|NCT02726035|naltrexone|naltrexone
1070577|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
1070578|NCT02725996|Natural Killer cells|natural killer cells
1070579|NCT02725983|Gingivitis|gingivitis
1070580|NCT02725983|Oral Hygiene|oral hygiene
1070581|NCT02725983|Intra oral camera|intra oral camera
1070582|NCT02725983|Self regulation|self regulation
1070583|NCT02725983|bleeding|bleeding
1070584|NCT02725970|HEALTH|health
1070585|NCT02725970|barriers|barriers
1070586|NCT02725970|facilitators|facilitators
1070587|NCT02725970|DGA|dga
1070588|NCT02725970|BMI|bmi
1070589|NCT02725970|Public Schools|public schools
1070590|NCT02725957|Bioblast|bioblast
1070591|NCT02725944|Cryptogenic stroke|cryptogenic stroke
1070592|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
1070593|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1070594|NCT02725931|COPD|copd
1070595|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
1070596|NCT02725931|Physical activity|physical activity
1070597|NCT02725931|Exercise|exercise
1070599|NCT02725918|EGFR-TKI failure|egfr-tki failure
1070600|NCT02725918|chemotherapy|chemotherapy
1070601|NCT02725905|Weight Management Counseling|weight management counseling
1070602|NCT02725905|Medical School Education|medical school education
1070603|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
1070604|NCT02725866|Observational Study|observational study
1070605|NCT02725866|Sustained Virological Response|sustained virological response
1070606|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
1070607|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
1070608|NCT02725866|Paritaprevir/r - Ombitasvir, ± Dasabuvir,|paritaprevir/r - ombitasvir, ± dasabuvir,
1070609|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
1070610|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1070611|NCT02725853|Arm Training|arm training
1070612|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1070613|NCT02725840|pulmonary vasculature|pulmonary vasculature
1070614|NCT02725840|radiation late effects|radiation late effects
1070615|NCT02725840|proton therapy|proton therapy
1070616|NCT02725814|Sucrose|sucrose
1070617|NCT02725814|Effectiveness|effectiveness
1070618|NCT02725814|Healthcare Delivery|healthcare delivery
1070619|NCT02725814|Neonates|neonates
1070620|NCT02725814|Nursing|nursing
1070621|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
1070622|NCT02725762|Dry AMD|dry amd
1070623|NCT02725762|Vision Loss|vision loss
1070624|NCT02725762|AMD|amd
1070625|NCT02725749|shoulder|shoulder
1070626|NCT02725749|low level laser therapy|low level laser therapy
1070627|NCT02725749|exercises|exercises
1070628|NCT02725710|uterine aspiration|uterine aspiration
1070629|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
1070630|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
1070631|NCT02725658|DOSI|dosi
1070632|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1070633|NCT02725645|Surface electromyography|surface electromyography
1070634|NCT02725645|children|children
1070635|NCT02725645|backpack|backpack
1070636|NCT02725632|Sodium channel|sodium channel
1070637|NCT02725632|splicing variant|splicing variant
1070638|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
1070639|NCT02725606|Neutropenia|neutropenia
1070640|NCT02725606|Breast Cancer|breast cancer
1070641|NCT02725606|GW003|gw003
1070642|NCT02725593|Diabetes Mellitus|diabetes mellitus
1070643|NCT02725593|Dapagliflozin|dapagliflozin
1070644|NCT02725593|Placebo|placebo
1070645|NCT02725593|Insulin resistance|insulin resistance
1070646|NCT02725593|Metabolic Diseases|metabolic diseases
1070647|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
1070648|NCT02725580|NCL|ncl
1070649|NCT02725580|Gene Transfer|gene transfer
1070650|NCT02725580|Gray Foundation|gray foundation
1070651|NCT02725541|HER2 equivocal|her2 equivocal
1070652|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
1070653|NCT02725541|Breast cancer|breast cancer
1070654|NCT02725502|T1DM|t1dm
1070655|NCT02725502|Linagliptin|linagliptin
1070656|NCT02725502|mix meal test|mix meal test
1070657|NCT02725489|Vigil|vigil
1070658|NCT02725489|durvalumab|durvalumab
1070659|NCT02725489|MEDI4736|medi4736
1070660|NCT02725489|PD-L1|pd-l1
1070661|NCT02725489|anti PD-L1|anti pd-l1
1070662|NCT02725489|immunotherapy|immunotherapy
1070663|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
1070664|NCT02725489|breast cancer|breast cancer
1070665|NCT02725489|ovarian cancer|ovarian cancer
1070666|NCT02725489|fallopian tube cancer|fallopian tube cancer
1070667|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
1070668|NCT02725489|uterine cancer|uterine cancer
1070669|NCT02725489|cervical cancer|cervical cancer
1070670|NCT02725489|endometrial cancer|endometrial cancer
1070671|NCT02725463|vestibular|vestibular
1070672|NCT02725463|implant|implant
1070673|NCT02725463|prosthesis|prosthesis
1070674|NCT02725463|labyrinth|labyrinth
1070675|NCT02725463|ototoxicity|ototoxicity
1070676|NCT02725463|gentamicin|gentamicin
1070677|NCT02725463|oscillopsia|oscillopsia
1070678|NCT02725463|disequilibrium|disequilibrium
1070679|NCT02725463|dizziness|dizziness
1070680|NCT02725463|vestibulopathy|vestibulopathy
1070681|NCT02725463|inner ear|inner ear
1070682|NCT02725450|Motor Imagery|motor imagery
1070683|NCT02725450|Fine motor skills|fine motor skills
1070684|NCT02725450|Disabled|disabled
1070685|NCT02725411|Chronic low back pain|chronic low back pain
1070686|NCT02725411|Chronic pain|chronic pain
1070687|NCT02725398|Buscopan|buscopan
1070688|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
1070689|NCT02725398|Imaging Quality|imaging quality
1070690|NCT02725385|No Evidence of Disease|no evidence of disease
1070691|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1070692|NCT02725372|PAH|pah
1070693|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
1070694|NCT02725372|iNO|ino
1070695|NCT02725372|long term oxygen therapy|long term oxygen therapy
1070696|NCT02725372|oxygen therapy|oxygen therapy
1070697|NCT02725359|Thyroidectomy pain|thyroidectomy pain
1070698|NCT02725359|Tizanidine|tizanidine
1070699|NCT02725359|Postoperative analgesia|postoperative analgesia
1070900|NCT02724254|HPV6|hpv6
1070700|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
1070701|NCT02725346|Surgical Planning Solution|surgical planning solution
1070702|NCT02725346|Acromioplasty|acromioplasty
1070703|NCT02725346|Shoulder Surgery|shoulder surgery
1070704|NCT02725346|Critical Shoulder Angle|critical shoulder angle
1070705|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
1070706|NCT02725333|Computer tomography|computer tomography
1070707|NCT02725333|Subtle or minor instability|subtle or minor instability
1070708|NCT02725333|Unstable painful shoulder|unstable painful shoulder
1070709|NCT02725333|Apprehension|apprehension
1070710|NCT02725333|Dislocation|dislocation
1070711|NCT02725333|Subluxation|subluxation
1070712|NCT02725333|Kinematics modeling|kinematics modeling
1070713|NCT02725333|Biomechanics|biomechanics
1070714|NCT02725333|Motion capture|motion capture
1070715|NCT02725333|3D simulation|3d simulation
1070716|NCT02725320|rotator cuff|rotator cuff
1070717|NCT02725320|shoulder reconstruction|shoulder reconstruction
1070718|NCT02725294|exacerbation|exacerbation
1070719|NCT02725294|access to care|access to care
1070720|NCT02725294|telemedicine|telemedicine
1070721|NCT02725268|Drug Therapy|drug therapy
1070722|NCT02725229|Postoperative pain|postoperative pain
1070723|NCT02725229|Parasternal block|parasternal block
1070724|NCT02725229|Sternotomy|sternotomy
1070726|NCT02725203|Cardiovascular risk management|cardiovascular risk management
1070727|NCT02725203|behaviour change techniques|behaviour change techniques
1070728|NCT02725203|self-management|self-management
1070729|NCT02725203|physical activity|physical activity
1070730|NCT02725203|nurse-led|nurse-led
1070731|NCT02725203|behaviour change wheel|behaviour change wheel
1070732|NCT02725203|primary care|primary care
1070733|NCT02725203|clustered RCT|clustered rct
1070734|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
1070735|NCT02725164|oxygen|oxygen
1070736|NCT02725164|nitrous oxide|nitrous oxide
1070737|NCT02725164|sevoflurane|sevoflurane
1070738|NCT02725164|carbon dioxide|carbon dioxide
1070739|NCT02725164|endotracheal tube|endotracheal tube
1070741|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
1070742|NCT02725151|acute|acute
1070743|NCT02725151|heart failure|heart failure
1070744|NCT02725151|management|management
1070745|NCT02725151|decompensation|decompensation
1070746|NCT02725138|Helicobacter pylori|helicobacter pylori
1070747|NCT02725138|probiotic|probiotic
1070748|NCT02725138|bacterial density|bacterial density
1070749|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
1070750|NCT02725099|STEMI|stemi
1070751|NCT02725060|POTS|pots
1070752|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
1070753|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
1070754|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
1070755|NCT02725047|Cryotherapy|cryotherapy
1070756|NCT02725047|Thermotherapy|thermotherapy
1070757|NCT02725047|Hypothermia|hypothermia
1070758|NCT02725047|Knee|knee
1070759|NCT02725047|Physiotherapy|physiotherapy
1070760|NCT02725021|tobacco prevention|tobacco prevention
1070761|NCT02725008|Asthma|asthma
1070762|NCT02725008|Pediatric|pediatric
1070763|NCT02725008|Emergency Department|emergency department
1070764|NCT02725008|Dexamethasone|dexamethasone
1070765|NCT02725008|Steroid|steroid
1070766|NCT02724982|Self esteem|self esteem
1070767|NCT02724982|Body mass index|body mass index
1070768|NCT02724969|text messaging|text messaging
1070769|NCT02724969|short message service|short message service
1070770|NCT02724956|supraglottic airway device (SGAD) insertion|supraglottic airway device (sgad) insertion
1070771|NCT02724956|SGAD|sgad
1070772|NCT02724956|ventilation and intubation|ventilation and intubation
1070897|NCT02724254|Viral Disease|viral disease
1070773|NCT02724956|gastric drainage channel|gastric drainage channel
1070774|NCT02724956|fiberoptic assessment|fiberoptic assessment
1070775|NCT02724943|child obesity|child obesity
1070776|NCT02724943|primary prevention|primary prevention
1070777|NCT02724943|primary care|primary care
1070778|NCT02724943|weight management|weight management
1070779|NCT02724943|child overweight|child overweight
1070781|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
1070782|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1070783|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
1070784|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
1070785|NCT02724878|Kidney Cancer|kidney cancer
1070786|NCT02724865|Oral Appliance Therapy|oral appliance therapy
1070787|NCT02724852|MMR|mmr
1070788|NCT02724852|vaccination|vaccination
1070789|NCT02724852|HIV|hiv
1070790|NCT02724852|Serologic response|serologic response
1070791|NCT02724826|Expectations|expectations
1070792|NCT02724826|Outcomes|outcomes
1070793|NCT02724826|Qigong|qigong
1070794|NCT02724826|Exercise therapy|exercise therapy
1070795|NCT02724826|Disability|disability
1070796|NCT02724826|Neck movements,|neck movements,
1070797|NCT02724800|Insomnia|insomnia
1070798|NCT02724800|Veterans|veterans
1070901|NCT02724254|HPV11|hpv11
1070799|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
1070800|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
1070801|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
1070802|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
1070803|NCT02724787|Veterans|veterans
1070804|NCT02724787|Aggression|aggression
1070805|NCT02724787|Emotion regulation|emotion regulation
1070806|NCT02724774|infants|infants
1070807|NCT02724774|mental health|mental health
1070808|NCT02724774|postpartum period|postpartum period
1070809|NCT02724748|Aggression|aggression
1070810|NCT02724748|Mental Health|mental health
1070811|NCT02724748|Education, Continuing|education, continuing
1070812|NCT02724735|Depression|depression
1070813|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1070814|NCT02724735|Major Depressive Disorder|major depressive disorder
1070815|NCT02724735|Neurogenesis|neurogenesis
1070816|NCT02724735|Synaptogenesis|synaptogenesis
1070817|NCT02724735|NSI-189|nsi-189
1070818|NCT02724735|Neuralstem|neuralstem
1070819|NCT02724722|melamine|melamine
1070820|NCT02724722|phthalate|phthalate
1070821|NCT02724709|Automatic Data Processing|automatic data processing
1070822|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
1070823|NCT02724709|Aortic Valve|aortic valve
1070824|NCT02724683|ascites|ascites
1070825|NCT02724683|drainage|drainage
1070826|NCT02724683|catheter|catheter
1070827|NCT02724683|symptoms|symptoms
1070828|NCT02724683|management|management
1070829|NCT02724683|quality of life|quality of life
1070830|NCT02724683|malignant|malignant
1070831|NCT02724683|cancer|cancer
1070832|NCT02724657|Child|child
1070833|NCT02724657|Breathing exercises|breathing exercises
1070834|NCT02724631|Clogged enteral access devices|clogged enteral access devices
1070835|NCT02724631|Occluded enteral access device|occluded enteral access device
1070836|NCT02724631|Enteral nutrition|enteral nutrition
1070837|NCT02724631|Enteral access device|enteral access device
1070838|NCT02724631|Tube Feeding|tube feeding
1070839|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
1070841|NCT02724618|Protection, Radiation|protection, radiation
1070842|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1070843|NCT02724618|Radiation Therapy|radiation therapy
1070844|NCT02724618|Prostate Cancer|prostate cancer
1070845|NCT02724605|RBCS,|rbcs,
1070846|NCT02724605|Transfusion,|transfusion,
1070847|NCT02724605|Pediatric|pediatric
1070848|NCT02724605|Changes|changes
1070849|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
1070850|NCT02724527|Cystic Fibrosis|cystic fibrosis
1070851|NCT02724527|N91115|n91115
1070852|NCT02724527|Cavosonstat|cavosonstat
1070853|NCT02724488|Advanced cancer|advanced cancer
1070854|NCT02724488|Advanced solid tumors|advanced solid tumors
1070855|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
1070856|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
1070857|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
1070858|NCT02724488|Head and Neck|head and neck
1070859|NCT02724488|Melanoma|melanoma
1070860|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
1070861|NCT02724488|Oral Cavity|oral cavity
1070862|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
1070863|NCT02724488|ICIs|icis
1070864|NCT02724488|ctDNA|ctdna
1070865|NCT02724488|Whole Exome Sequencing|whole exome sequencing
1070866|NCT02724488|Molecular Profiling|molecular profiling
1070867|NCT02724475|Laser Ablation|laser ablation
1070868|NCT02724475|Portal Vein Tumor|portal vein tumor
1070869|NCT02724475|Thrombus|thrombus
1070870|NCT02724462|smoking cessation|smoking cessation
1070871|NCT02724462|app for quitting smoking|app for quitting smoking
1070872|NCT02724449|IAD|iad
1070873|NCT02724449|Fecal incontinence|fecal incontinence
1070874|NCT02724436|Yittrium-90|yittrium-90
1070875|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
1070876|NCT02724423|epilepsy|epilepsy
1070877|NCT02724423|seizure|seizure
1070878|NCT02724410|appendectomy|appendectomy
1070879|NCT02724397|Colon cancer|colon cancer
1070880|NCT02724397|Diagnosis|diagnosis
1070881|NCT02724397|Adenoma|adenoma
1070882|NCT02724397|Serrated lesions|serrated lesions
1070883|NCT02724358|Carcinoma|carcinoma
1070884|NCT02724358|Hepatocellular|hepatocellular
1070885|NCT02724358|Notch1|notch1
1070886|NCT02724345|Cell keratin 18|cell keratin 18
1070887|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
1070888|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1070889|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
1070890|NCT02724319|clopidogrel|clopidogrel
1070891|NCT02724319|loss-of-function allele|loss-of-function allele
1111965|NCT02479698|HLA|hla
1070892|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
1070893|NCT02724254|Genital warts|genital warts
1070894|NCT02724254|HPV types|hpv types
1070895|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
1070896|NCT02724254|Papillomavirus Infections|papillomavirus infections
1070898|NCT02724254|Anogenital warts|anogenital warts
1070902|NCT02724254|Human papillomavirus infection|human papillomavirus infection
1070903|NCT02724254|HPV|hpv
1070904|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1070905|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
1070906|NCT02724254|Aviragen|aviragen
1070907|NCT02724241|nicotine|nicotine
1070908|NCT02724241|autonomic tone|autonomic tone
1070909|NCT02724241|oxidative stress|oxidative stress
1070910|NCT02724228|Achondroplasia|achondroplasia
1070911|NCT02724228|Dwarfism|dwarfism
1070912|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
1070913|NCT02724228|Bone Diseases|bone diseases
1070914|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
1070915|NCT02724215|Sleep Apnea|sleep apnea
1070916|NCT02724202|Curcumin|curcumin
1070917|NCT02724202|5FU|5fu
1070918|NCT02724202|5-fluorouracil|5-fluorouracil
1070919|NCT02724202|Adracil|adracil
1070920|NCT02724202|5FU Resistant|5fu resistant
1070921|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
1070922|NCT02724202|Colon Cancer|colon cancer
1070923|NCT02724189|electronic pre-assessment|electronic pre-assessment
1070924|NCT02724189|preoperative assessment|preoperative assessment
1070925|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
1070926|NCT02724163|Children|children
1070927|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
1070928|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
1070929|NCT02724163|Mitoxantrone|mitoxantrone
1070930|NCT02724163|Randomised controlled trial|randomised controlled trial
1070931|NCT02724163|Risk stratification|risk stratification
1070932|NCT02724163|Minimal residual disease|minimal residual disease
1070933|NCT02724163|Stem cell transplant|stem cell transplant
1070934|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
1070935|NCT02724150|Marginal Ulcer|marginal ulcer
1070936|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
1070937|NCT02724150|Peptic Ulcer|peptic ulcer
1070938|NCT02724137|Total Knee Replacement|total knee replacement
1070939|NCT02724137|Physical Therapy|physical therapy
1070940|NCT02724137|Fitbit®|fitbit®
1070941|NCT02724124|exercise muscle stretching|exercise muscle stretching
1070942|NCT02724124|electromyography|electromyography
1070943|NCT02724111|Neuromuscular blockade|neuromuscular blockade
1070944|NCT02724111|Surgical rating scale|surgical rating scale
1070945|NCT02724111|Rocuronium|rocuronium
1070946|NCT02724111|Sugammadex|sugammadex
1070947|NCT02724111|Spinal surgery|spinal surgery
1070948|NCT02724111|General anesthesia|general anesthesia
1070949|NCT02724098|Palliative Therapy|palliative therapy
1070950|NCT02724072|Thoracic Surgery|thoracic surgery
1070951|NCT02724072|Aortic Arch|aortic arch
1070952|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
1070953|NCT02724072|Performance Goal|performance goal
1070954|NCT02724046|Neisseria meningitidis|neisseria meningitidis
1070955|NCT02724046|Ciprofloxacin|ciprofloxacin
1070956|NCT02724046|Chemoprevention|chemoprevention
1070957|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
1070958|NCT02724033|Inner ear surgery|inner ear surgery
1070959|NCT02724020|Drug therapy|drug therapy
1070960|NCT02724007|Trauma|trauma
1070961|NCT02724007|India|india
1070962|NCT02724007|ICISS|iciss
1070963|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
1070964|NCT02723994|pediatric|pediatric
1070965|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
1070966|NCT02723994|JAK inhibitor|jak inhibitor
1070967|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
1070968|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
1070969|NCT02723955|Pembrolizumab|pembrolizumab
1070970|NCT02723955|KEYNOTE-478|keynote-478
1070971|NCT02723955|GSK3359609|gsk3359609
1070972|NCT02723955|Cohort expansion|cohort expansion
1070973|NCT02723955|Dose escalation|dose escalation
1070974|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
1070975|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
1070976|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
1070977|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
1070978|NCT02723929|transcranial ultrasound|transcranial ultrasound
1070979|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
1070980|NCT02723916|Parents|parents
1070981|NCT02723916|Child|child
1070982|NCT02723916|Preschool|preschool
1070983|NCT02723916|eHealth|ehealth
1070984|NCT02723903|somatization symptom score|somatization symptom score
1070985|NCT02723903|SSS checklist|sss checklist
1070986|NCT02723903|coronary angiography|coronary angiography
1070987|NCT02723903|Patient Health Questionnaire|patient health questionnaire
1070988|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
1070989|NCT02723877|TNBC|tnbc
1070990|NCT02723864|Pharmacodynamic|pharmacodynamic
1070991|NCT02723864|DNA Damage Repair|dna damage repair
1070992|NCT02723864|BRCA Null|brca null
1070993|NCT02723864|Apoptosis|apoptosis
1070994|NCT02723864|Combination Therapy|combination therapy
1070995|NCT02723838|Bladder|bladder
1070996|NCT02723838|Cancer|cancer
1070997|NCT02723838|REOLYSIN®|reolysin®
1070998|NCT02723838|Gemcitabine|gemcitabine
1070999|NCT02723838|Cisplatin|cisplatin
1071012|NCT02723786|Renal Transplantation|renal transplantation
1071013|NCT02723786|Prevention|prevention
1071014|NCT02723786|GSK1070806|gsk1070806
1071015|NCT02723773|Efficacy|efficacy
1071016|NCT02723773|Immunogenicity|immunogenicity
1071017|NCT02723773|Safety|safety
1071018|NCT02723773|Adults|adults
1071019|NCT02723773|Herpes zoster|herpes zoster
1071020|NCT02723747|myocardial ischemia|myocardial ischemia
1071021|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
1071022|NCT02723747|perfusion|perfusion
1071023|NCT02723747|software|software
1071024|NCT02723734|Decipher®|decipher®
1071025|NCT02723734|African-American men|african-american men
1071026|NCT02723734|prostate|prostate
1071027|NCT02723734|low risk PCa|low risk pca
1071028|NCT02723734|intermediate risk PCa|intermediate risk pca
1071029|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
1071030|NCT02723721|Lentigo maligna|lentigo maligna
1071031|NCT02723695|Cochlear implant|cochlear implant
1071032|NCT02723695|Perception|perception
1071033|NCT02723695|Posture|posture
1071034|NCT02723695|Quality of life|quality of life
1071035|NCT02723669|Relative Bioavailability|relative bioavailability
1071036|NCT02723656|smoking|smoking
1071037|NCT02723656|cancer|cancer
1071038|NCT02723656|cancer registry|cancer registry
1071039|NCT02723656|smoking cessation|smoking cessation
1071040|NCT02723643|Hypertension|hypertension
1071041|NCT02723643|Essential hypertension|essential hypertension
1071042|NCT02723643|Blood pressure|blood pressure
1071043|NCT02723643|Cardiovascular diseases|cardiovascular diseases
1071044|NCT02723630|Bioequivalence|bioequivalence
1071045|NCT02723630|Lenvatinib|lenvatinib
1071046|NCT02723630|Healthy Volunteers|healthy volunteers
1071047|NCT02723630|Lenvima|lenvima
1071048|NCT02723630|E7080|e7080
1071049|NCT02723591|FK506|fk506
1071050|NCT02723591|Kidney Transplantation|kidney transplantation
1071051|NCT02723591|Tacrolimus|tacrolimus
1071052|NCT02723591|Astagraf XL|astagraf xl
1071053|NCT02723552|preeclampsia|preeclampsia
1071054|NCT02723552|young adult hypertension|young adult hypertension
1071055|NCT02723552|preterm birth|preterm birth
1071161|NCT02722915|fMRI|fmri
1071056|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
1071057|NCT02723513|Proton MRI|proton mri
1071058|NCT02723513|Noble Gas MRI|noble gas mri
1071059|NCT02723513|Pulmonary Function|pulmonary function
1071060|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
1071061|NCT02723500|Pulmonary Function|pulmonary function
1071062|NCT02723487|TAP block|tap block
1071063|NCT02723487|pediatric|pediatric
1071064|NCT02723487|Laparoscopic|laparoscopic
1071065|NCT02723487|postoperative pain|postoperative pain
1071066|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
1071067|NCT02723474|Pulmonary Function|pulmonary function
1071068|NCT02723396|Parkinson's disease|parkinson's disease
1071069|NCT02723396|Sleep Benefit|sleep benefit
1071070|NCT02723383|alcoholism|alcoholism
1071071|NCT02723383|intensive care|intensive care
1071072|NCT02723383|Baclofen|baclofen
1071073|NCT02723383|restlessness|restlessness
1071074|NCT02723383|Delirium tremens|delirium tremens
1071075|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
1071076|NCT02723370|Quality of Healthcare|quality of healthcare
1071077|NCT02723370|Colorectal neoplasms|colorectal neoplasms
1071078|NCT02723370|Health Literacy|health literacy
1071079|NCT02723370|Teach-Back Communication|teach-back communication
1071080|NCT02723370|Evidence Based Practice|evidence based practice
1071081|NCT02723370|Colonoscopy|colonoscopy
1071082|NCT02723357|Financial Coaching|financial coaching
1071083|NCT02723357|Mental Health|mental health
1071084|NCT02723357|Social Determinants|social determinants
1071085|NCT02723357|Medical-Financial Partnership|medical-financial partnership
1071086|NCT02723357|Toxic Stress|toxic stress
1071087|NCT02723344|PTSD|ptsd
1071088|NCT02723344|Mild TBI|mild tbi
1071089|NCT02723344|Probiotic|probiotic
1071090|NCT02723344|Inflammation|inflammation
1071100|NCT02723318|Cognition|cognition
1071201|NCT02722733|G-CSF|g-csf
1071101|NCT02723318|Financial Coaching|financial coaching
1071102|NCT02723318|Social Determinants of Health|social determinants of health
1071103|NCT02723318|Socioeconomic Status|socioeconomic status
1071104|NCT02723305|Klinefelter syndrome|klinefelter syndrome
1071105|NCT02723305|XXY|xxy
1071106|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
1071107|NCT02723305|sex chromosome variation|sex chromosome variation
1071108|NCT02723305|hypogonadism|hypogonadism
1071109|NCT02723305|cardiometabolic|cardiometabolic
1071110|NCT02723305|body composition|body composition
1071111|NCT02723305|exercise capacity|exercise capacity
1071112|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
1071113|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
1071114|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
1071115|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
1071116|NCT02723266|Preconception Counseling|preconception counseling
1071117|NCT02723266|Reproductive Health|reproductive health
1071118|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
1071119|NCT02723253|rectal cancer|rectal cancer
1071120|NCT02723253|radiotherapy|radiotherapy
1071121|NCT02723253|chemotherapy|chemotherapy
1071122|NCT02723253|Raltitrexed|raltitrexed
1071123|NCT02723253|Oxaliplatin|oxaliplatin
1071124|NCT02723240|NUC-3373|nuc-3373
1071125|NCT02723240|Dose escalation|dose escalation
1071126|NCT02723240|Nucleotide Analogue|nucleotide analogue
1071127|NCT02723227|Parenting Stress|parenting stress
1071128|NCT02723227|Stress|stress
1071129|NCT02723227|Social Determinants|social determinants
1071130|NCT02723227|Socioeconomic status|socioeconomic status
1071131|NCT02723227|Financial Coaching|financial coaching
1071132|NCT02723175|Fibromyalgia|fibromyalgia
1071133|NCT02723175|Pain|pain
1071134|NCT02723136|Smartphone|smartphone
1071135|NCT02723136|Internship|internship
1071136|NCT02723136|Internal Medicine|internal medicine
1071137|NCT02723123|CPAP|cpap
1071138|NCT02723123|NIPPV|nippv
1071139|NCT02723123|Extubation failure|extubation failure
1071140|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
1071141|NCT02723123|NIV-NAVA|niv-nava
1071142|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
1071143|NCT02723084|Hepatitis C Virus|hepatitis c virus
1071144|NCT02723084|Non-cirrhotic|non-cirrhotic
1071145|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
1071146|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
1071147|NCT02723058|Depression|depression
1071148|NCT02723058|Homelessness|homelessness
1071149|NCT02723058|Primary care|primary care
1071150|NCT02723006|Drug Therapy|drug therapy
1071151|NCT02722954|malignancy|malignancy
1071152|NCT02722954|metastatic|metastatic
1071153|NCT02722954|Demcizumab|demcizumab
1071154|NCT02722954|Pembrolizumab|pembrolizumab
1071155|NCT02722954|Phase 1b|phase 1b
1071156|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
1071157|NCT02722941|autologous|autologous
1071158|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
1071159|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
1071160|NCT02722928|Intracranial surgery|intracranial surgery
1071162|NCT02722915|neurofeedback|neurofeedback
1071163|NCT02722915|hallucination|hallucination
1071164|NCT02722915|schizophrenia|schizophrenia
1071165|NCT02722902|Metabolic flexibility|metabolic flexibility
1071166|NCT02722902|Insulin sensitivity|insulin sensitivity
1071167|NCT02722889|Ascending aorta|ascending aorta
1071168|NCT02722889|Elongation of the aorta|elongation of the aorta
1071169|NCT02722889|Type A dissection|type a dissection
1071170|NCT02722889|Aortic rupture|aortic rupture
1071171|NCT02722889|Aortic length|aortic length
1071172|NCT02722876|Rehabilitation|rehabilitation
1071173|NCT02722876|Cross-education|cross-education
1071174|NCT02722850|breast cancer|breast cancer
1071175|NCT02722850|cancer survivorship|cancer survivorship
1071176|NCT02722850|dietary intake|dietary intake
1071177|NCT02722850|physical activity|physical activity
1071178|NCT02722850|quality of life|quality of life
1071179|NCT02722824|motor symptoms|motor symptoms
1071180|NCT02722811|Etanercept|etanercept
1071181|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
1071182|NCT02722811|TNF-α|tnf-α
1071183|NCT02722811|IL-1α|il-1α
1071184|NCT02722811|Subcutaneous Injection|subcutaneous injection
1071185|NCT02722785|Exercise training|exercise training
1071186|NCT02722785|Surgical complications|surgical complications
1071187|NCT02722785|Cancer prognosis|cancer prognosis
1071188|NCT02722785|Muscle function|muscle function
1071189|NCT02722785|Body composition|body composition
1071190|NCT02722785|Pulmonary function|pulmonary function
1071191|NCT02722785|Quality of life|quality of life
1071192|NCT02722772|Intra-Articular Injection|intra-articular injection
1071193|NCT02722772|Etanercept|etanercept
1071194|NCT02722772|TNF-α|tnf-α
1071195|NCT02722772|IL-1|il-1
1071196|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
1071197|NCT02722746|Epidural Analgesia|epidural analgesia
1071198|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
1071199|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1071200|NCT02722733|mobilization|mobilization
1071202|NCT02722733|filgrastim|filgrastim
1071203|NCT02722733|cytosine arabinoside|cytosine arabinoside
1071204|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
1071205|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
1071206|NCT02722720|Carotid stenosis|carotid stenosis
1071207|NCT02722720|Ischemic attack|ischemic attack
1071208|NCT02722720|Stroke|stroke
1071209|NCT02722720|Carotid stenting|carotid stenting
1071210|NCT02722720|Transradial approach|transradial approach
1071211|NCT02722720|Transfemoral approach|transfemoral approach
1071212|NCT02722720|Bleeding|bleeding
1071213|NCT02722720|Thromboembolism|thromboembolism
1071214|NCT02722720|Embolism|embolism
1071215|NCT02722720|Neurocognitive disorders|neurocognitive disorders
1071217|NCT02722668|ALL|all
1071218|NCT02722668|CML|cml
1071219|NCT02722668|CLL|cll
1071220|NCT02722668|SLL|sll
1071221|NCT02722655|Pediatrics|pediatrics
1071222|NCT02722629|COPD|copd
1071223|NCT02722629|Respiratory Aspiration|respiratory aspiration
1071224|NCT02722629|COPD acute exacerbation|copd acute exacerbation
1071225|NCT02722616|Ultrasound|ultrasound
1071226|NCT02722590|Epilepsy|epilepsy
1071227|NCT02722590|Partial-onset seizures|partial-onset seizures
1071228|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
1071229|NCT02722551|Mitral|mitral
1071230|NCT02722551|Regurgitation|regurgitation
1071231|NCT02722551|Insufficiency|insufficiency
1071232|NCT02722551|Degenerative|degenerative
1071233|NCT02722551|Functional|functional
1071234|NCT02722551|Primary|primary
1071235|NCT02722551|Secondary|secondary
1071236|NCT02722551|Organic|organic
1071237|NCT02722551|Transcatheter|transcatheter
1071238|NCT02722551|TMVR|tmvr
1071239|NCT02722551|TMVI|tmvi
1071240|NCT02722551|Heart valve|heart valve
1071241|NCT02722551|Mitral valve|mitral valve
1071242|NCT02722551|Transapical|transapical
1071243|NCT02722551|Transfemoral|transfemoral
1071244|NCT02722551|Transeptal|transeptal
1071245|NCT02722551|Severe|severe
1071246|NCT02722525|ADT|adt
1071247|NCT02722525|Prostate cancer|prostate cancer
1071248|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1071249|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
1071250|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1071251|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
1071252|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1071253|NCT02722499|African American|african american
1071254|NCT02722499|Blacks|blacks
1071255|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
1071256|NCT02722499|Randomized Control Trial|randomized control trial
1071257|NCT02722499|Controlled Clinical Trial|controlled clinical trial
1071258|NCT02722499|Behavioral Research|behavioral research
1071259|NCT02722499|Behavioral Medicine|behavioral medicine
1071260|NCT02722421|efavirenz|efavirenz
1071261|NCT02722421|levonorgestrel|levonorgestrel
1071262|NCT02722421|contraceptive implant|contraceptive implant
1071263|NCT02722408|LDL-C|ldl-c
1071264|NCT02722408|Lipid Regulator|lipid regulator
1071265|NCT02722382|Chronic Kidney Disease|chronic kidney disease
1071266|NCT02722291|presbyopia|presbyopia
1071267|NCT02722265|Essential hypertension|essential hypertension
1071268|NCT02722265|Long-term treatment|long-term treatment
1071269|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1071270|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
1071271|NCT02722239|Xigduo;|xigduo;
1071272|NCT02722239|bioequivalence;|bioequivalence;
1071273|NCT02722239|crossover;|crossover;
1071274|NCT02722239|Russia|russia
1071275|NCT02722226|High fidelity simulation|high fidelity simulation
1071276|NCT02722226|Sedation|sedation
1071277|NCT02722226|Medical education|medical education
1071278|NCT02722200|fMRI obesity|fmri obesity
1071279|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
1071280|NCT02722148|Diet Elimination Therapy|diet elimination therapy
1071281|NCT02722122|Cystic Fibrosis|cystic fibrosis
1071283|NCT02722122|AIR DNase™|air dnase™
1071284|NCT02722122|Digestive System Diseases|digestive system diseases
1071285|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
1071286|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
1071287|NCT02722122|Lung diseases|lung diseases
1071288|NCT02722122|Pancreatic Diseases|pancreatic diseases
1071289|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
1071290|NCT02722096|arteriovenous fistula|arteriovenous fistula
1071291|NCT02722096|regional anesthesia|regional anesthesia
1071292|NCT02722096|local anesthesia|local anesthesia
1071293|NCT02722096|early complication|early complication
1071294|NCT02722031|intensive care|intensive care
1071295|NCT02722031|prevalence|prevalence
1071296|NCT02722031|hypoxemia|hypoxemia
1071297|NCT02722031|ARDS|ards
1071298|NCT02722005|Health related quality of life|health related quality of life
1071299|NCT02722005|Financial Coaching|financial coaching
1071300|NCT02722005|Medical Financial Partnership|medical financial partnership
1071301|NCT02722005|Social Determinants of Health|social determinants of health
1071302|NCT02722005|Socioeconomic status|socioeconomic status
1071504|NCT02720627|anti-androgen|anti-androgen
1071303|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
1071304|NCT02721966|ASAS|asas
1071305|NCT02721966|axial|axial
1071306|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
1071307|NCT02721966|PsA|psa
1071308|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1071309|NCT02721966|MRI|mri
1071310|NCT02721927|refugees|refugees
1071311|NCT02721927|Syrian|syrian
1071312|NCT02721927|cost|cost
1071313|NCT02721927|visit|visit
1071314|NCT02721914|low-back pain|low-back pain
1071315|NCT02721914|massage therapy|massage therapy
1071316|NCT02721914|Gymnastics|gymnastics
1071317|NCT02721914|disability|disability
1071318|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
1071319|NCT02721901|Nutrition|nutrition
1071320|NCT02721901|Behavioral|behavioral
1071321|NCT02721862|gallstones|gallstones
1071322|NCT02721862|cholelithiasis|cholelithiasis
1071323|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
1071324|NCT02721797|hypermobility|hypermobility
1071325|NCT02721797|collagen|collagen
1071326|NCT02721797|joint|joint
1071327|NCT02721797|hyperflexation|hyperflexation
1071328|NCT02721784|MRI|mri
1071329|NCT02721784|Radiotherapy|radiotherapy
1071330|NCT02721758|Motivational Interviewing|motivational interviewing
1071331|NCT02721758|Health Behavior|health behavior
1071332|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
1071333|NCT02721732|Advanced Cancers|advanced cancers
1071334|NCT02721732|Rare tumors|rare tumors
1071335|NCT02721732|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1071336|NCT02721732|Anaplastic thyroid cancer|anaplastic thyroid cancer
1071337|NCT02721732|Adrenocortical carcinoma|adrenocortical carcinoma
1071338|NCT02721732|Medullary renal cell carcinoma|medullary renal cell carcinoma
1071339|NCT02721732|Carcinoma of unknown primary|carcinoma of unknown primary
1071340|NCT02721732|Penile carcinoma|penile carcinoma
1071341|NCT02721732|Thymoma|thymoma
1071342|NCT02721732|Testicular carcinoma|testicular carcinoma
1071343|NCT02721732|Paraganglioma-pheochromocytoma|paraganglioma-pheochromocytoma
1071344|NCT02721732|Pembrolizumab|pembrolizumab
1071345|NCT02721732|Keytruda|keytruda
1071346|NCT02721732|MK-3475|mk-3475
1071347|NCT02721732|SCH-900475|sch-900475
1071348|NCT02721719|Ulcerative Colitis|ulcerative colitis
1071349|NCT02721719|UC|uc
1071350|NCT02721719|Vedolizumab|vedolizumab
1071351|NCT02721719|Entyvio|entyvio
1071352|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
1071353|NCT02721719|IBD|ibd
1071354|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
1071355|NCT02721706|Nutrition assessment|nutrition assessment
1071356|NCT02721706|inpatients|inpatients
1071357|NCT02721706|cost-benefit analysis|cost-benefit analysis
1071358|NCT02721706|quality of life|quality of life
1071359|NCT02721706|body composition|body composition
1071360|NCT02721706|mass screening|mass screening
1071361|NCT02721693|Troponin|troponin
1071362|NCT02721693|Exercise|exercise
1071363|NCT02721667|Blood pressure|blood pressure
1071364|NCT02721667|Telemonitoring|telemonitoring
1071365|NCT02721667|Case management|case management
1071366|NCT02721667|Seniors|seniors
1071368|NCT02721654|Sodium chloride|sodium chloride
1071369|NCT02721654|Saline|saline
1071370|NCT02721654|Fluid resuscitation|fluid resuscitation
1071371|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
1071372|NCT02721654|Critically ill|critically ill
1071373|NCT02721654|Critical care|critical care
1071374|NCT02721628|Keratoconus|keratoconus
1071375|NCT02721615|intra spinal pressure|intra spinal pressure
1071376|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
1071377|NCT02721615|microdialysis|microdialysis
1071378|NCT02721615|duroplasty|duroplasty
1071379|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
1071380|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
1071381|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
1071382|NCT02721524|Ring Annuloplasty|ring annuloplasty
1071383|NCT02721524|Suture Annuloplasty|suture annuloplasty
1071384|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
1071385|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
1071386|NCT02721498|Airway clearance techniques|airway clearance techniques
1071387|NCT02721498|Outcome measures|outcome measures
1071388|NCT02721485|Ringer's Lactate|ringer's lactate
1071389|NCT02721485|Normal Saline|normal saline
1071390|NCT02721485|resuscitation fluids|resuscitation fluids
1071391|NCT02721485|hypovolemia|hypovolemia
1071392|NCT02721459|unresectable melanoma|unresectable melanoma
1071393|NCT02721459|stage III melanoma|stage iii melanoma
1071394|NCT02721459|stage IV melanoma|stage iv melanoma
1071395|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
1071396|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
1071397|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
1071398|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
1071399|NCT02721394|Challenging Behaviour|challenging behaviour
1071400|NCT02721394|Functional Communication Training|functional communication training
1071401|NCT02721394|Positive Behavioural Support|positive behavioural support
1071402|NCT02721394|Family carer training|family carer training
1071403|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
1071404|NCT02721381|Parent training|parent training
1071405|NCT02721381|Telehealth|telehealth
1071406|NCT02721381|RCT|rct
1071407|NCT02721355|Chronic gastritis|chronic gastritis
1071408|NCT02721355|Gastric ulcer|gastric ulcer
1071409|NCT02721355|Helicobacter pylori|helicobacter pylori
1071410|NCT02721355|IgY|igy
1071411|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
1071412|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
1071413|NCT02721329|OSA|osa
1071414|NCT02721329|Insomnia|insomnia
1071415|NCT02721329|CPAP|cpap
1071416|NCT02721329|SensAwake|sensawake
1071417|NCT02721290|Knee surgery|knee surgery
1071418|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
1071419|NCT02721277|Infant, newborn|infant, newborn
1071420|NCT02721277|Cholestasis|cholestasis
1071421|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
1071422|NCT02721251|exercise|exercise
1071423|NCT02721251|weight loss|weight loss
1071424|NCT02721251|sleep apnea|sleep apnea
1071425|NCT02721212|Robotic|robotic
1071426|NCT02721212|Stroke|stroke
1071427|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
1071428|NCT02721186|Malaria|malaria
1071429|NCT02721186|Plasmodium|plasmodium
1071430|NCT02721186|Mass drug administration|mass drug administration
1071431|NCT02721186|Malaria elimination|malaria elimination
1071432|NCT02721186|Zanzibar|zanzibar
1071433|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
1071434|NCT02721186|Single low dose Primaquine|single low dose primaquine
1071435|NCT02721173|Tazarotene|tazarotene
1071436|NCT02721173|Adapalene|adapalene
1071437|NCT02721173|Clindamycin|clindamycin
1071438|NCT02721160|performance-based financing|performance-based financing
1071439|NCT02721160|malnutrition|malnutrition
1071440|NCT02721160|impact evaluation|impact evaluation
1071441|NCT02721108|Mindfulness|mindfulness
1071442|NCT02721108|Headspace|headspace
1071443|NCT02721108|Psychological approaches|psychological approaches
1071444|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
1071445|NCT02721082|tobacco treatment|tobacco treatment
1071446|NCT02721069|Seizures|seizures
1071447|NCT02721069|Epilepsy|epilepsy
1071448|NCT02721043|Personalized vaccine|personalized vaccine
1071449|NCT02721043|Poly-ICLC|poly-iclc
1071450|NCT02721043|Immunotherapy|immunotherapy
1071451|NCT02721043|Cancer|cancer
1071452|NCT02721030|Heartfailure|heartfailure
1071453|NCT02721030|1-year mortality|1-year mortality
1071454|NCT02721030|heartfailure quality of life|heartfailure quality of life
1071455|NCT02721030|sub-Saharan Africa|sub-saharan africa
1071456|NCT02721017|Nuss|nuss
1071457|NCT02721017|Nuss Procedure|nuss procedure
1071458|NCT02721017|pectus excavatum|pectus excavatum
1071459|NCT02721017|cryoanalgesia|cryoanalgesia
1071460|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
1071461|NCT02721004|RoActemra|roactemra
1071462|NCT02721004|Tocilizumab|tocilizumab
1071463|NCT02720965|Pain Acute|pain acute
1071464|NCT02720965|Orthopedic Surgery|orthopedic surgery
1071465|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
1071466|NCT02720913|Time|time
1071467|NCT02720913|COR-KNOT|cor-knot
1071468|NCT02720913|Standard|standard
1071469|NCT02720913|Cost|cost
1071470|NCT02720887|pregnant women|pregnant women
1071471|NCT02720887|nanoparticles|nanoparticles
1071472|NCT02720887|amniotic fluid|amniotic fluid
1071473|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
1071474|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
1071475|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
1071476|NCT02720809|micronutrients|micronutrients
1071477|NCT02720809|blood pressure|blood pressure
1071478|NCT02720809|allergy|allergy
1071479|NCT02720809|lung function|lung function
1071480|NCT02720796|PDX|pdx
1071481|NCT02720796|TumorGraft|tumorgraft
1071482|NCT02720796|Patient derived xenograft|patient derived xenograft
1071483|NCT02720796|sarcoma|sarcoma
1071484|NCT02720783|Pharmacokinetics|pharmacokinetics
1071485|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
1071486|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
1071487|NCT02720783|Vaginal pessary|vaginal pessary
1071488|NCT02720783|Tolerability|tolerability
1071489|NCT02720770|growth hormone|growth hormone
1071490|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
1071491|NCT02720718|Laparoscopy|laparoscopy
1071492|NCT02720718|Suture Techniques|suture techniques
1071493|NCT02720718|Sutures|sutures
1071494|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
1071495|NCT02720692|Pain|pain
1071496|NCT02720692|Analgesia|analgesia
1071497|NCT02720692|N1539|n1539
1071498|NCT02720692|Phase 3|phase 3
1071499|NCT02720679|Genetics|genetics
1071500|NCT02720679|Whole genome sequencing|whole genome sequencing
1071501|NCT02720679|Pediatrics and hematology|pediatrics and hematology
1071502|NCT02720627|acne|acne
1071503|NCT02720627|cortexolone|cortexolone
1071505|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
1071506|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
1071507|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
1071508|NCT02720601|irinotecan|irinotecan
1071509|NCT02720601|capecitabine|capecitabine
1071510|NCT02720601|gemcitabine|gemcitabine
1071511|NCT02720601|biliary tract cancer|biliary tract cancer
1071512|NCT02720601|gallbladder cancer|gallbladder cancer
1071513|NCT02720601|second-line|second-line
1071514|NCT02720575|Vitamin D|vitamin d
1071515|NCT02720575|Bioavailability|bioavailability
1071516|NCT02720575|Fortified Bread|fortified bread
1071517|NCT02720536|Anemia.|anemia.
1071518|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
1071519|NCT02720536|Thalassemia|thalassemia
1071520|NCT02720536|Film coated tablet|film coated tablet
1071521|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
1071522|NCT02720523|ABT-494|abt-494
1071523|NCT02720523|Japanese|japanese
1071524|NCT02720523|Antirheumatic agents|antirheumatic agents
1071525|NCT02720510|multiple myeloma|multiple myeloma
1071526|NCT02720510|farydak|farydak
1071527|NCT02720510|panobinostat|panobinostat
1071528|NCT02720510|LBH589|lbh589
1071529|NCT02720510|ASCT|asct
1071530|NCT02720510|transplant|transplant
1071531|NCT02720471|local analgesia|local analgesia
1071532|NCT02720471|total hip replacement|total hip replacement
1071533|NCT02720471|local infiltrations|local infiltrations
1071534|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
1071535|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
1071536|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
1071537|NCT02720458|Sleep restriction|sleep restriction
1071538|NCT02720458|Stimulus control|stimulus control
1071539|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
1071540|NCT02720458|Z-drug|z-drug
1071541|NCT02720445|Alzheimer's Disease|alzheimer's disease
1071542|NCT02720445|Nicotine|nicotine
1071543|NCT02720445|Transdermal Patch|transdermal patch
1071544|NCT02720432|early intervention, infant|early intervention, infant
1071545|NCT02720419|drug eluting stent|drug eluting stent
1071546|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
1071547|NCT02720419|real world|real world
1071548|NCT02720380|Asthma|asthma
1071549|NCT02720380|Physical Therapy Specialty|physical therapy specialty
1071550|NCT02720380|Breathing Exercises|breathing exercises
1071551|NCT02720380|Child|child
1071552|NCT02720380|Clinical Trail|clinical trail
1071553|NCT02720302|Overweight|overweight
1071554|NCT02720302|Children|children
1071555|NCT02720302|Treatment|treatment
1071556|NCT02720302|Prevention|prevention
1071557|NCT02720302|Lifestyle intervention|lifestyle intervention
1071558|NCT02720289|injury prevention|injury prevention
1071559|NCT02720276|stroke|stroke
1071560|NCT02720276|exercise|exercise
1071561|NCT02720276|walking|walking
1071562|NCT02720276|mobility|mobility
1071563|NCT02720263|Schizophrenia|schizophrenia
1071564|NCT02720263|ASP4345|asp4345
1071665|NCT02719665|Vascular Disease|vascular disease
1071666|NCT02719665|Vascular Occlusion|vascular occlusion
1071565|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
1071566|NCT02720237|Alcohol use|alcohol use
1071568|NCT02720237|Viral Load|viral load
1071569|NCT02720237|ART|art
1071570|NCT02720211|headache|headache
1071571|NCT02720211|photophobia|photophobia
1071572|NCT02720211|migraine|migraine
1071573|NCT02720211|light sensitivity|light sensitivity
1071574|NCT02720211|tints|tints
1071575|NCT02720211|thin films|thin films
1071576|NCT02720146|Dry eye|dry eye
1071577|NCT02720133|ramadan fasting|ramadan fasting
1071578|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
1071579|NCT02720133|variation of hematological parameters|variation of hematological parameters
1071580|NCT02720133|verify now assay|verify now assay
1071581|NCT02720107|fingolimod,|fingolimod,
1071582|NCT02720107|Biomarker,|biomarker,
1071583|NCT02720107|Multiple sclerosis,|multiple sclerosis,
1071584|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1071585|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1071586|NCT02720094|PrEP|prep
1071587|NCT02720068|PD1|pd1
1071588|NCT02720068|PD-1|pd-1
1071589|NCT02720068|PDL1|pdl1
1071590|NCT02720068|PD-L1|pd-l1
1071591|NCT02720055|Distal Radius Fracture|distal radius fracture
1071592|NCT02720055|Outcomes|outcomes
1071593|NCT02720055|Psychological Intervention|psychological intervention
1071594|NCT02720029|aspiration|aspiration
1071595|NCT02720029|reflux|reflux
1071596|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
1071597|NCT02720016|Marital Therapy|marital therapy
1071598|NCT02720016|Veterans|veterans
1071599|NCT02720016|Telemedicine|telemedicine
1071600|NCT02720016|Couples|couples
1071601|NCT02720003|Atherosclerosis|atherosclerosis
1071602|NCT02720003|Superficial Femoral Artery|superficial femoral artery
1071603|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
1071604|NCT02719990|VRS-317|vrs-317
1071605|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
1071606|NCT02719990|Versartis|versartis
1071607|NCT02719990|somavaratan|somavaratan
1071608|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
1071609|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
1071610|NCT02719990|AGHD|aghd
1071611|NCT02719990|Growth Hormone Replacement|growth hormone replacement
1071612|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
1071613|NCT02719990|XTEN|xten
1071614|NCT02719964|Cognitive Training|cognitive training
1071615|NCT02719964|Traumatic Brain Injury|traumatic brain injury
1071616|NCT02719964|Video Games|video games
1071617|NCT02719951|autism|autism
1071618|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
1071619|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
1071620|NCT02719951|glutamate|glutamate
1071621|NCT02719925|magnesium deficiency|magnesium deficiency
1071622|NCT02719925|stress psycological|stress psycological
1071623|NCT02719925|sleep duration and quality|sleep duration and quality
1071624|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
1071625|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
1071626|NCT02719899|Sirtuin 3|sirtuin 3
1071627|NCT02719899|T-Cell Polarity|t-cell polarity
1071628|NCT02719899|Caloric Restriction|caloric restriction
1071629|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
1071630|NCT02719847|Lung cancer|lung cancer
1071631|NCT02719847|Non-Small Cell Lung|non-small cell lung
1071632|NCT02719847|NSCLC|nsclc
1071633|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
1071634|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
1071635|NCT02719847|EBUS-TBNA|ebus-tbna
1071636|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1071637|NCT02719821|Fatigue|fatigue
1071638|NCT02719821|Insomnia|insomnia
1071639|NCT02719821|Depression|depression
1071640|NCT02719821|Behavioral Intervention|behavioral intervention
1071641|NCT02719808|Vertical infection transmission|vertical infection transmission
1071642|NCT02719808|Tenofovir|tenofovir
1071643|NCT02719795|Breast Neoplasms|breast neoplasms
1071644|NCT02719795|Nerve block|nerve block
1071645|NCT02719795|Anesthesia|anesthesia
1071646|NCT02719769|Positive Blood Culture|positive blood culture
1071647|NCT02719743|children|children
1071648|NCT02719743|H5N1|h5n1
1071649|NCT02719743|observer-blind|observer-blind
1071650|NCT02719743|Influenza|influenza
1071651|NCT02719743|dose-ranging|dose-ranging
1071652|NCT02719717|VATS lobectomy|vats lobectomy
1071653|NCT02719717|vascular sealing|vascular sealing
1071654|NCT02719717|energy|energy
1071655|NCT02719717|pulmonary artery|pulmonary artery
1071656|NCT02719691|MLN0128|mln0128
1071657|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
1071658|NCT02719691|MLN8237|mln8237
1071659|NCT02719691|Aurora A inhibitor|aurora a inhibitor
1071660|NCT02719691|Alisertib|alisertib
1071661|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
1071662|NCT02719665|peripheral arterial disease|peripheral arterial disease
1071663|NCT02719665|claudication|claudication
1071664|NCT02719665|PAD|pad
1071667|NCT02719665|Vacular Calcification|vacular calcification
1071668|NCT02719665|intermittent claudication|intermittent claudication
1071669|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
1071670|NCT02719652|vulnerable plaque|vulnerable plaque
1071671|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
1071672|NCT02719626|senior|senior
1071673|NCT02719626|nutrition|nutrition
1071674|NCT02719626|home delivered meals|home delivered meals
1071675|NCT02719626|food safety|food safety
1071676|NCT02719626|emergency prep|emergency prep
1071677|NCT02719600|Virtual Reality|virtual reality
1071678|NCT02719587|saliva|saliva
1071679|NCT02719587|omega-3|omega-3
1071680|NCT02719574|AML|aml
1071681|NCT02719574|MDS|mds
1071682|NCT02719574|IDH1|idh1
1071683|NCT02719574|IDH|idh
1071684|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
1071685|NCT02719535|corneal biomechanics|corneal biomechanics
1071686|NCT02719483|Children|children
1071687|NCT02719483|Spasticity|spasticity
1071688|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
1071689|NCT02719483|Cerebral palsy|cerebral palsy
1071690|NCT02719483|Gross motor function|gross motor function
1071691|NCT02719470|Cognition Impairment|cognition impairment
1071692|NCT02719470|Rehabilitation|rehabilitation
1071693|NCT02719470|Parkinson's Disease|parkinson's disease
1071694|NCT02719457|Exercise testing|exercise testing
1071695|NCT02719457|COPD|copd
1071696|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
1071697|NCT02719418|Thromboembolism|thromboembolism
1071698|NCT02719418|Venous Thrombosis|venous thrombosis
1071699|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
1071700|NCT02719418|Chronic Renal Diseases|chronic renal diseases
1071701|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
1071702|NCT02719418|Renal Failure, Chronic|renal failure, chronic
1071703|NCT02719418|Venous Thromboembolism|venous thromboembolism
1071704|NCT02719418|Tinzaparin|tinzaparin
1071706|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
1071707|NCT02719405|milk|milk
1071708|NCT02719405|allergy|allergy
1071709|NCT02719405|tolerance|tolerance
1071710|NCT02719327|Alzheimer's disease|alzheimer's disease
1071711|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
1071712|NCT02719327|brain blood flow|brain blood flow
1071713|NCT02719327|cognition|cognition
1071714|NCT02719327|icosapent ethyl|icosapent ethyl
1071715|NCT02719327|Vascepa|vascepa
1071716|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
1071717|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
1071718|NCT02719262|Melamine|melamine
1071719|NCT02719262|Renal damage|renal damage
1071720|NCT02719262|Workplace intervention|workplace intervention
1071721|NCT02719249|ESRD|esrd
1071722|NCT02719249|Fabry disease|fabry disease
1071723|NCT02719236|Coxarthrosis|coxarthrosis
1071724|NCT02719236|Hip arthroplasty|hip arthroplasty
1071725|NCT02719236|Direct Anterior Approach|direct anterior approach
1071726|NCT02719236|Direct Lateral Approach|direct lateral approach
1071727|NCT02719223|Intradialytic hypotension|intradialytic hypotension
1071728|NCT02719223|hemodynamic parameters|hemodynamic parameters
1071729|NCT02719223|Hemodiafiltration|hemodiafiltration
1071730|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
1071731|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
1071732|NCT02719158|OTIPRIO|otiprio
1071733|NCT02719145|micro RNA|micro rna
1071734|NCT02719145|asthma|asthma
1071735|NCT02719145|COPD|copd
1071736|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
1071737|NCT02719106|real world data|real world data
1071738|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
1071739|NCT02719106|drug eluting stent|drug eluting stent
1071740|NCT02719093|Infertility Male|infertility male
1071741|NCT02719093|Receptors FSH|receptors fsh
1071742|NCT02719093|Varicocele|varicocele
1071743|NCT02719093|FSH therapy|fsh therapy
1071744|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
1071745|NCT02719067|neuropsychological function|neuropsychological function
1071746|NCT02719067|neuroimage|neuroimage
1071747|NCT02719067|developmental changes|developmental changes
1071748|NCT02719054|Depression|depression
1071749|NCT02719054|Child Development|child development
1071750|NCT02719054|Stimulation|stimulation
1071751|NCT02719054|CBT|cbt
1071752|NCT02719054|Bangladesh|bangladesh
1071753|NCT02719015|Melanoma|melanoma
1071754|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
1071755|NCT02719015|rAd.CD40L|rad.cd40l
1071756|NCT02719015|ISF35|isf35
1071757|NCT02719015|Intratumoral|intratumoral
1071758|NCT02719015|IT|it
1071759|NCT02719015|Pembrolizumab|pembrolizumab
1071760|NCT02719015|Keytruda|keytruda
1071761|NCT02719015|MK-3475|mk-3475
1071762|NCT02719015|SCH-900475|sch-900475
1071763|NCT02719015|MM|mm
1071764|NCT02718989|H-reflex|h-reflex
1071765|NCT02718989|TENS|tens
1071766|NCT02718989|Tone|tone
1071767|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
1072072|NCT02717390|Safety|safety
1071768|NCT02718976|Perioperative analgesia|perioperative analgesia
1071769|NCT02718950|Brown Adipose Tissue|brown adipose tissue
1071770|NCT02718950|Hypothalamic Activation|hypothalamic activation
1071771|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
1071772|NCT02718950|Basal Metabolic Rate|basal metabolic rate
1071773|NCT02718950|Liraglutide|liraglutide
1071774|NCT02718950|Victoza|victoza
1071775|NCT02718950|Body Composition|body composition
1071776|NCT02718950|Body weight|body weight
1071777|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
1071778|NCT02718937|Viral diseases|viral diseases
1071779|NCT02718937|Antiviral|antiviral
1071780|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
1071781|NCT02718937|RSV|rsv
1071782|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1071783|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
1071784|NCT02718937|Aviragen|aviragen
1071785|NCT02718924|Thromboelastometry|thromboelastometry
1071786|NCT02718924|pregnancy|pregnancy
1071787|NCT02718924|obesity|obesity
1071788|NCT02718898|genital|genital
1071789|NCT02718885|inulin-type fructans|inulin-type fructans
1071790|NCT02718885|hemodialysis|hemodialysis
1071791|NCT02718885|gut microbiome|gut microbiome
1071792|NCT02718885|mineral and bone disorder|mineral and bone disorder
1071793|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
1071794|NCT02718859|nature killer cell|nature killer cell
1071795|NCT02718859|irreversible electroporation|irreversible electroporation
1071796|NCT02718833|Multiple Myeloma|multiple myeloma
1071797|NCT02718833|Relapse|relapse
1071798|NCT02718807|Patient Care|patient care
1071799|NCT02718807|Education|education
1071800|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
1071801|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
1071802|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
1071803|NCT02718755|Hematologic malignancy|hematologic malignancy
1071804|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
1071805|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
1071806|NCT02718755|AML|aml
1071807|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1071808|NCT02718755|ALL|all
1071809|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
1071810|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
1071811|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
1071812|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
1071813|NCT02718755|CML|cml
1071814|NCT02718755|B-cell lymphoma|b-cell lymphoma
1071815|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
1071816|NCT02718755|CLL|cll
1071817|NCT02718755|Fludarabine|fludarabine
1071818|NCT02718755|Fludarabine phosphate|fludarabine phosphate
1071819|NCT02718755|Fludara|fludara
1071820|NCT02718755|Cytarabine|cytarabine
1071821|NCT02718755|Ara-C|ara-c
1071822|NCT02718755|Cytosar|cytosar
1071823|NCT02718755|DepoCyt|depocyt
1071824|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1071825|NCT02718729|Anastomotic leakage|anastomotic leakage
1071826|NCT02718729|Rectal cancer|rectal cancer
1071827|NCT02718729|Laparoscopic|laparoscopic
1071828|NCT02718729|Rectal resection|rectal resection
1071829|NCT02718716|ITP|itp
1071830|NCT02718690|H-Reflex|h-reflex
1071831|NCT02718690|Current Density|current density
1071832|NCT02718690|TENS|tens
1071833|NCT02718651|ALK rearrangement|alk rearrangement
1071834|NCT02718651|Circulating tumor DNA|circulating tumor dna
1071835|NCT02718651|Plasma DNA|plasma dna
1071836|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
1071837|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
1071838|NCT02718625|Pressure Ulcers|pressure ulcers
1071839|NCT02718625|Bed sores|bed sores
1071840|NCT02718625|Long-term care|long-term care
1071841|NCT02718625|Nursing home|nursing home
1071842|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
1071843|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
1071844|NCT02718586|Myokines|myokines
1071845|NCT02718586|Protein Energy Wasting|protein energy wasting
1071846|NCT02718586|Hemodialysis|hemodialysis
1071847|NCT02718573|Hepatitis C|hepatitis c
1071848|NCT02718573|Interferon-free|interferon-free
1071849|NCT02718573|DDA's|dda's
1071850|NCT02718547|Diabetes mellitus|diabetes mellitus
1071851|NCT02718547|Diabetic macular edema|diabetic macular edema
1071852|NCT02718547|Intra ocular pressure|intra ocular pressure
1071853|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
1071854|NCT02718547|Retinal perfusion|retinal perfusion
1071855|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
1071856|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
1071857|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
1071858|NCT02718469|Ebola|ebola
1071859|NCT02718469|VSV|vsv
1071860|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
1071861|NCT02718469|Vaccine|vaccine
1071862|NCT02718469|Zaire|zaire
1071863|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
1071864|NCT02718417|fallopian tube|fallopian tube
1071865|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
1071866|NCT02718404|MR-HIFU|mr-hifu
1071867|NCT02718404|bone metastases|bone metastases
1071868|NCT02718404|pain treatment|pain treatment
1071869|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
1071870|NCT02718391|Malignant Melanoma|malignant melanoma
1071871|NCT02718391|Adjuvant|adjuvant
1071872|NCT02718391|vaccin|vaccin
1071873|NCT02718391|therapy|therapy
1071874|NCT02718391|randomized trial|randomized trial
1071875|NCT02718391|observation|observation
1071876|NCT02718378|safety|safety
1071877|NCT02718378|pharmacokinetics|pharmacokinetics
1071878|NCT02718378|pharmacodynamics|pharmacodynamics
1071879|NCT02718378|randomized|randomized
1071880|NCT02718365|Lung Neoplasms|lung neoplasms
1071881|NCT02718365|Surgery|surgery
1071882|NCT02718365|VATS|vats
1071883|NCT02718365|GGO|ggo
1071884|NCT02718365|GGN|ggn
1071885|NCT02718365|Segmentectomy|segmentectomy
1071886|NCT02718365|Wedge Resection|wedge resection
1071887|NCT02718365|Prognosis|prognosis
1071888|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
1071889|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
1071890|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
1071891|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
1071892|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
1071893|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
1071894|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
1071895|NCT02718287|language development|language development
1071896|NCT02718287|socio-emotional development|socio-emotional development
1071897|NCT02718287|cognitive development|cognitive development
1071898|NCT02718287|motor skills|motor skills
1071899|NCT02718274|HIV self-testing|hiv self-testing
1071902|NCT02718248|self-harm|self-harm
1071903|NCT02718248|problem-solving therapy|problem-solving therapy
1071904|NCT02718248|emergency department|emergency department
1071905|NCT02718248|e-therapy|e-therapy
1071906|NCT02718248|suicide prevention|suicide prevention
1071907|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
1071908|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
1071910|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
1071911|NCT02718157|Antepartum women|antepartum women
1071912|NCT02718144|dose-escalation|dose-escalation
1071913|NCT02718144|safety|safety
1071914|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
1071915|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
1071916|NCT02718105|KIR HLA-C|kir hla-c
1071917|NCT02718105|ART|art
1071918|NCT02718066|HBI-8000|hbi-8000
1071919|NCT02718066|Nivolumab|nivolumab
1071920|NCT02718066|Melanoma|melanoma
1071921|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
1071922|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
1071923|NCT02718027|Hereditary Nephritis|hereditary nephritis
1071924|NCT02718027|Nephritis, Familial|nephritis, familial
1071925|NCT02718027|Hereditary Familial Congenital Hemorrhagic Nephritis|hereditary familial congenital hemorrhagic nephritis
1071926|NCT02718014|Non Surgical Therapy|non surgical therapy
1071927|NCT02718001|Mitral|mitral
1071928|NCT02718001|Regurgitation|regurgitation
1071929|NCT02718001|Insufficiency|insufficiency
1071930|NCT02718001|Degenerative|degenerative
1071931|NCT02718001|Functional|functional
1071932|NCT02718001|Primary|primary
1071933|NCT02718001|Secondary|secondary
1071934|NCT02718001|Organic|organic
1071935|NCT02718001|Transcatheter|transcatheter
1071936|NCT02718001|TMVR|tmvr
1071937|NCT02718001|TMVI|tmvi
1071938|NCT02718001|Heart Valve|heart valve
1071939|NCT02718001|Mitral Valve|mitral valve
1071940|NCT02718001|Transseptal|transseptal
1071941|NCT02718001|Trans-Septal|trans-septal
1071942|NCT02718001|Transeptal|transeptal
1071943|NCT02718001|Severe|severe
1071944|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
1071945|NCT02717988|healthy volunteers|healthy volunteers
1071946|NCT02717988|moderately to severely active|moderately to severely active
1071947|NCT02717975|Urinary retention|urinary retention
1071948|NCT02717975|trial removal of catheter|trial removal of catheter
1071949|NCT02717975|valve|valve
1071950|NCT02717962|Glioma|glioma
1071951|NCT02717962|Glioblastoma|glioblastoma
1071952|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
1071953|NCT02717962|GBM|gbm
1071954|NCT02717962|brain tumor|brain tumor
1071955|NCT02717962|brain cancer|brain cancer
1071956|NCT02717962|recurrent brain tumor|recurrent brain tumor
1071957|NCT02717962|recurrent brain cancer|recurrent brain cancer
1071958|NCT02717962|refractory brain tumor|refractory brain tumor
1071959|NCT02717962|refractory brain cancer|refractory brain cancer
1071960|NCT02717962|recurrent GBM|recurrent gbm
1071961|NCT02717962|refractory GBM|refractory gbm
1071962|NCT02717962|recurrent glioma|recurrent glioma
1071963|NCT02717962|refractory glioma|refractory glioma
1071964|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
1071965|NCT02717962|refractory glioblastoma|refractory glioblastoma
1072073|NCT02717390|Injury prevention|injury prevention
1071966|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1071967|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
1071968|NCT02717962|failed bevacizumab|failed bevacizumab
1071969|NCT02717962|temodar failure|temodar failure
1071970|NCT02717962|temozolomide failure|temozolomide failure
1071971|NCT02717949|hepatitis C|hepatitis c
1071972|NCT02717949|low-grade lymphoma|low-grade lymphoma
1071973|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
1071974|NCT02717936|dermatosurgery|dermatosurgery
1071975|NCT02717936|immunohistochemistry|immunohistochemistry
1071976|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
1071977|NCT02717923|maintenance treatment|maintenance treatment
1071978|NCT02717923|cetuximab|cetuximab
1071979|NCT02717910|Games|games
1071980|NCT02717910|Adolescent|adolescent
1071981|NCT02717910|Health education|health education
1071982|NCT02717910|Smoking|smoking
1071983|NCT02717910|Health literacy|health literacy
1071984|NCT02717884|AML|aml
1071985|NCT02717884|MDS|mds
1071986|NCT02717884|relapsed|relapsed
1071987|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
1071988|NCT02717884|epigenetic treatment|epigenetic treatment
1071989|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
1071990|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
1071991|NCT02717884|LSD1|lsd1
1071992|NCT02717884|refractory|refractory
1071993|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
1071994|NCT02717845|varus malignment|varus malignment
1071995|NCT02717845|osteoarthritis|osteoarthritis
1071996|NCT02717845|knee|knee
1071997|NCT02717819|Sarcopenia|sarcopenia
1071998|NCT02717819|Muscular atrophy|muscular atrophy
1072000|NCT02717819|Acute illness|acute illness
1072001|NCT02717819|Ageing|ageing
1072002|NCT02717819|Protein supplementation|protein supplementation
1072006|NCT02717767|pneumonia|pneumonia
1072007|NCT02717767|diagnosis|diagnosis
1072008|NCT02717767|prognosis|prognosis
1072009|NCT02717767|tracheal aspirate|tracheal aspirate
1072010|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
1072011|NCT02717663|Reinforcement|reinforcement
1072012|NCT02717663|Walking|walking
1072013|NCT02717663|Exercise|exercise
1072014|NCT02717663|Built Environment|built environment
1072015|NCT02717663|Adaptive|adaptive
1072016|NCT02717663|Financial incentive|financial incentive
1072017|NCT02717663|Walkability|walkability
1072018|NCT02717650|Exercise Testing|exercise testing
1072019|NCT02717650|Maximal Exercise Testing|maximal exercise testing
1072020|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
1072021|NCT02717650|Peak Exercise Capacity|peak exercise capacity
1072022|NCT02717650|Adults|adults
1072023|NCT02717650|Step Tests|step tests
1072024|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
1072025|NCT02717624|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1072026|NCT02717624|Btk|btk
1072027|NCT02717624|ACP-196|acp-196
1072028|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
1072029|NCT02717624|MCL|mcl
1072030|NCT02717624|acalabrutinib|acalabrutinib
1072031|NCT02717624|ACE-LY-106|ace-ly-106
1072034|NCT02717598|cold snare polypectomy|cold snare polypectomy
1072035|NCT02717598|hot snare polypectomy|hot snare polypectomy
1072036|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
1072037|NCT02717585|Chronic Pain|chronic pain
1072038|NCT02717585|Sleep Disturbance|sleep disturbance
1072039|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
1072040|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
1072041|NCT02717559|knee injuries / surgery|knee injuries / surgery
1072042|NCT02717559|outcomes research|outcomes research
1072043|NCT02717559|prospective studies|prospective studies
1072044|NCT02717559|osteoarthritis|osteoarthritis
1072045|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
1072046|NCT02717520|glass hybrid|glass hybrid
1072047|NCT02717520|composite|composite
1072048|NCT02717494|PPV-23|ppv-23
1072049|NCT02717494|PCV-10|pcv-10
1072050|NCT02717494|HIV|hiv
1072051|NCT02717494|Immunization|immunization
1072052|NCT02717494|Pregnancy|pregnancy
1072053|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
1072054|NCT02717442|Meniere's Disease|meniere's disease
1072055|NCT02717442|Vertigo|vertigo
1072056|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
1072057|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
1072058|NCT02717416|hemostatic powder|hemostatic powder
1072059|NCT02717403|Chronic Disease Management|chronic disease management
1072060|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
1072061|NCT02717403|Facebook|facebook
1072062|NCT02717403|Social networking|social networking
1072063|NCT02717403|Internet|internet
1072064|NCT02717403|Questionnaires|questionnaires
1072065|NCT02717403|Surveys|surveys
1072066|NCT02717403|Phone interview|phone interview
1072067|NCT02717390|Reading|reading
1072068|NCT02717390|Early Childhood development|early childhood development
1072069|NCT02717390|Talking|talking
1072070|NCT02717390|Playing|playing
1072071|NCT02717390|Praising|praising
1072075|NCT02717377|Physical Activity|physical activity
1072076|NCT02717338|blood donor|blood donor
1072077|NCT02717338|retention|retention
1072078|NCT02717338|motivation|motivation
1072079|NCT02717338|self-determination theory|self-determination theory
1072080|NCT02717247|tRNS|trns
1072081|NCT02717247|Food addiction,|food addiction,
1072082|NCT02717247|Obesity|obesity
1072083|NCT02717247|Craving|craving
1072084|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1072085|NCT02717182|self management program|self management program
1072086|NCT02717182|patient education|patient education
1072087|NCT02717182|self care program|self care program
1072088|NCT02717169|health promotion|health promotion
1072089|NCT02717169|health action process|health action process
1072090|NCT02717169|activity tracker|activity tracker
1072091|NCT02717169|sleep regulation|sleep regulation
1072092|NCT02717143|Acute myocarditis|acute myocarditis
1072093|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
1072094|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
1072095|NCT02717117|Motility|motility
1072096|NCT02717117|MRI|mri
1072097|NCT02717117|Gut peptides|gut peptides
1072098|NCT02717117|Feeding|feeding
1072100|NCT02717078|diet|diet
1072101|NCT02717078|carbohydrate|carbohydrate
1072102|NCT02717065|Neuromodulation|neuromodulation
1072103|NCT02717065|Noninvasive|noninvasive
1072104|NCT02717065|Plasticity|plasticity
1072106|NCT02717065|Hyperacusis|hyperacusis
1072107|NCT02717013|Muscle|muscle
1072108|NCT02717013|Bone|bone
1072109|NCT02717013|Fat|fat
1072110|NCT02716974|Lupron|lupron
1072111|NCT02716974|Bicalutamide|bicalutamide
1072112|NCT02716974|Docetaxel|docetaxel
1072113|NCT02716896|cystectomy|cystectomy
1072114|NCT02716896|radiation|radiation
1072115|NCT02716896|chemotherapy|chemotherapy
1072116|NCT02716883|keratitis|keratitis
1072117|NCT02716883|AMT|amt
1072118|NCT02716883|bacterial keratitis|bacterial keratitis
1072119|NCT02716883|medication|medication
1072120|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
1072121|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1072122|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1072123|NCT02716870|Clinical practice guidelines|clinical practice guidelines
1072124|NCT02716870|Clinical trials|clinical trials
1072125|NCT02716870|Dietary sugars|dietary sugars
1072126|NCT02716870|Fructose|fructose
1072127|NCT02716870|High fructose corn syrup|high fructose corn syrup
1072128|NCT02716870|Fruit|fruit
1072129|NCT02716870|Isocaloric|isocaloric
1072130|NCT02716870|Hypercaloric|hypercaloric
1072131|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
1072132|NCT02716870|Triglycerides|triglycerides
1072133|NCT02716870|Cholesterol|cholesterol
1072134|NCT02716870|Glycemic control|glycemic control
1072135|NCT02716870|Insulin resistance|insulin resistance
1072136|NCT02716870|Body weight|body weight
1072137|NCT02716870|Uric acid|uric acid
1072138|NCT02716870|Blood pressure|blood pressure
1072139|NCT02716870|Fatty liver|fatty liver
1072140|NCT02716870|Fasting|fasting
1072141|NCT02716870|Postprandial|postprandial
1072142|NCT02716844|Osteoporosis|osteoporosis
1072143|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
1072144|NCT02716844|Kinesiophobia|kinesiophobia
1072145|NCT02716844|Pain|pain
1072146|NCT02716831|Bulimia Nervosa|bulimia nervosa
1072147|NCT02716831|Eating Disorders|eating disorders
1072148|NCT02716831|Binge Eating|binge eating
1072149|NCT02716831|Bulimia|bulimia
1072150|NCT02716831|Purging|purging
1072151|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
1072152|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
1072153|NCT02716805|HDT/ASCT|hdt/asct
1072154|NCT02716805|CTLA-4|ctla-4
1072155|NCT02716805|PD-L1|pd-l1
1072156|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
1072157|NCT02716805|PBMC|pbmc
1072158|NCT02716805|ASCT|asct
1072159|NCT02716766|Sorafenib|sorafenib
1072160|NCT02716766|Drug Therapy|drug therapy
1072161|NCT02716740|Post-obesity surgery|post-obesity surgery
1072162|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
1072163|NCT02716740|Anabolic substance|anabolic substance
1072164|NCT02716740|Physical training|physical training
1072165|NCT02716740|Muscular mass|muscular mass
1072166|NCT02716740|Loss of weight|loss of weight
1072167|NCT02716714|Korean|korean
1072168|NCT02716701|Exercise|exercise
1072169|NCT02716688|Esophageal cancer|esophageal cancer
1072170|NCT02716688|Radiotherapy|radiotherapy
1072171|NCT02716688|elder|elder
1072172|NCT02716688|S-1|s-1
1072173|NCT02716675|HIV-1 Infections|hiv-1 infections
1072174|NCT02716649|Trauma|trauma
1072175|NCT02716649|ICISS|iciss
1072176|NCT02716649|India|india
1072177|NCT02716649|ICD-10|icd-10
1072178|NCT02716597|albumin, septic shock|albumin, septic shock
1072179|NCT02716571|Healthy Subjects|healthy subjects
1072180|NCT02716571|Healthy Participants|healthy participants
1072181|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
1072182|NCT02716545|Endoscopic Therapy|endoscopic therapy
1072184|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
1072185|NCT02716519|foot sore|foot sore
1072186|NCT02716519|type 2 diabetes|type 2 diabetes
1072187|NCT02716519|type 1 diabetes|type 1 diabetes
1072188|NCT02716519|DFU|dfu
1072189|NCT02716519|pressure ulcers|pressure ulcers
1072190|NCT02716519|bed sores|bed sores
1072191|NCT02716506|POP surgery|pop surgery
1072192|NCT02716493|Telerehabilitation|telerehabilitation
1072193|NCT02716480|Nutrition|nutrition
1072194|NCT02716480|Physical activity|physical activity
1072195|NCT02716480|Bariatric surgery|bariatric surgery
1072196|NCT02716480|Obesity|obesity
1072197|NCT02716480|Health technology|health technology
1072198|NCT02716480|Health-connected devices|health-connected devices
1072199|NCT02716467|nursing|nursing
1072200|NCT02716467|intercessory prayer|intercessory prayer
1072201|NCT02716467|spirituality|spirituality
1072202|NCT02716467|clinical trials|clinical trials
1072203|NCT02716454|Early surgery|early surgery
1072204|NCT02716454|Crohn's disease|crohn's disease
1072205|NCT02716454|Step-up therapy|step-up therapy
1072206|NCT02716415|neonates|neonates
1072207|NCT02716415|infants|infants
1072208|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
1072209|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
1072210|NCT02716402|cerebral thrombosis|cerebral thrombosis
1072211|NCT02716376|Head and neck neoplasms|head and neck neoplasms
1072212|NCT02716376|Radiotherapy|radiotherapy
1072213|NCT02716376|Otitis media|otitis media
1072214|NCT02716337|human milk target fortification|human milk target fortification
1072215|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1072216|NCT02716324|Shared-Decision Making|shared-decision making
1072217|NCT02716324|Care Manager|care manager
1072218|NCT02716324|Children|children
1072219|NCT02716324|Parents|parents
1072220|NCT02716324|Teachers|teachers
1072221|NCT02716311|EGFR|egfr
1072222|NCT02716311|Lung Cancer|lung cancer
1072223|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
1072224|NCT02716285|Abdominal pain|abdominal pain
1072225|NCT02716285|Targeted Delivery|targeted delivery
1072226|NCT02716285|Peppermint oil|peppermint oil
1072227|NCT02716272|mesothelioma|mesothelioma
1072228|NCT02716272|immunotherapy|immunotherapy
1072229|NCT02716272|nivolumab|nivolumab
1072230|NCT02716272|ipilimumab|ipilimumab
1072231|NCT02716259|Periodontitis|periodontitis
1072232|NCT02716259|Cardiovascular diseases|cardiovascular diseases
1072233|NCT02716259|Bacteremia|bacteremia
1072234|NCT02716259|Scaling and root planing|scaling and root planing
1072235|NCT02716259|Flow-mediated dilation|flow-mediated dilation
1072236|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
1072237|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
1072238|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
1072239|NCT02716246|MPS IIIA|mps iiia
1072240|NCT02716220|DREAMS 2G|dreams 2g
1072241|NCT02716220|Scaffold|scaffold
1072242|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
1072243|NCT02716220|Coronary Artery Disease|coronary artery disease
1072244|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
1072245|NCT02716207|CyberKnife|cyberknife
1072246|NCT02716207|Dose Escalation|dose escalation
1072247|NCT02716181|Atopic Dermatitis|atopic dermatitis
1072248|NCT02716181|Topical therapy|topical therapy
1072249|NCT02716168|Cancer|cancer
1072250|NCT02716168|tele-health|tele-health
1072251|NCT02716168|Shared care|shared care
1072252|NCT02716168|Continuity|continuity
1072253|NCT02716116|NSCLC|nsclc
1072254|NCT02716116|EGFR|egfr
1072255|NCT02716116|HER2|her2
1072256|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
1072257|NCT02716116|exon 20 insertions|exon 20 insertions
1072258|NCT02716116|exon 19 deletions|exon 19 deletions
1072259|NCT02716116|exon 21 substitution|exon 21 substitution
1072260|NCT02716116|T790M|t790m
1072261|NCT02716116|ErbB-2|erbb-2
1072262|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1072263|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
1072264|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
1072265|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
1072266|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1072267|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
1072268|NCT02716038|NSCLC|nsclc
1072269|NCT02716012|Oligonucleotide|oligonucleotide
1072270|NCT02716012|RNA|rna
1072271|NCT02716012|saRNA|sarna
1072272|NCT02716012|Fibrosis|fibrosis
1072273|NCT02716012|Cirrhosis|cirrhosis
1072274|NCT02715986|ECT|ect
1072275|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
1072276|NCT02715986|fMRI|fmri
1072277|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
1072278|NCT02715947|Methotrexate|methotrexate
1072279|NCT02715934|Diabetes Education|diabetes education
1072280|NCT02715934|Chronic Disease Management|chronic disease management
1072281|NCT02715934|Health Care Delivery|health care delivery
1072282|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
1072283|NCT02715934|Primary Care|primary care
1072286|NCT02715895|Body Weight Changes|body weight changes
1072287|NCT02715895|Infant Formula|infant formula
1072288|NCT02715895|Randomized Controlled Trial|randomized controlled trial
1072289|NCT02715882|Colorectal cancer|colorectal cancer
1072290|NCT02715882|TLR5|tlr5
1072291|NCT02715882|Immunotherapy|immunotherapy
1072292|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
1072293|NCT02715856|Bone metastases|bone metastases
1072294|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
1072295|NCT02715856|IM|im
1072296|NCT02715856|Physical tasks|physical tasks
1072297|NCT02715856|Surveys|surveys
1072298|NCT02715856|Questionnaires|questionnaires
1072299|NCT02715856|Smartphone|smartphone
1072300|NCT02715856|Tablet|tablet
1072301|NCT02715856|Telemedicine|telemedicine
1072302|NCT02715856|Telemonitoring|telemonitoring
1072303|NCT02715843|CD20|cd20
1072304|NCT02715843|immunotoxin|immunotoxin
1072305|NCT02715843|NHL|nhl
1072306|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1072307|NCT02715843|lymphoma|lymphoma
1072308|NCT02715843|cancer|cancer
1072309|NCT02715843|antibodies|antibodies
1072310|NCT02715843|immunotherapy|immunotherapy
1072311|NCT02715843|safety|safety
1072312|NCT02715843|pharmacokinetics|pharmacokinetics
1072313|NCT02715843|MT-3724|mt-3724
1072314|NCT02715843|relapsed|relapsed
1072315|NCT02715843|refractory|refractory
1072316|NCT02715817|Stroke|stroke
1072317|NCT02715817|Hemiparesis|hemiparesis
1072318|NCT02715817|Physical Therapy|physical therapy
1072319|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1072320|NCT02715817|Video Games|video games
1072321|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
1072322|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
1072323|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
1072324|NCT02715804|Nab-paclitaxel|nab-paclitaxel
1072325|NCT02715804|Gemcitabine|gemcitabine
1072326|NCT02715804|Metastatic|metastatic
1072327|NCT02715804|Stage IV|stage iv
1072328|NCT02715791|Self-Management|self-management
1072329|NCT02715791|Health Connectors|health connectors
1072330|NCT02715791|Volunteers|volunteers
1072331|NCT02715791|Technology|technology
1072332|NCT02715791|Interprofessional team|interprofessional team
1072333|NCT02715791|Chronic disease|chronic disease
1072334|NCT02715791|Self-efficacy|self-efficacy
1072335|NCT02715791|Patient-centredness|patient-centredness
1072336|NCT02715791|Community Engagement|community engagement
1072337|NCT02715739|Trauma|trauma
1072338|NCT02715739|India|india
1072339|NCT02715739|ICISS|iciss
1072340|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
1072341|NCT02715661|blood flow|blood flow
1072342|NCT02715661|brain health|brain health
1072343|NCT02715661|exercise|exercise
1072344|NCT02715661|endothelial activation|endothelial activation
1072345|NCT02715596|head and neck|head and neck
1072346|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
1072347|NCT02715596|body composition|body composition
1072348|NCT02715570|Aspergillus species|aspergillus species
1072349|NCT02715570|Filamentous fungi|filamentous fungi
1072350|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
1072351|NCT02715570|Anti-Infective Agents|anti-infective agents
1072352|NCT02715570|Antifungal Agents|antifungal agents
1072353|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
1072354|NCT02715570|Aspergillosis|aspergillosis
1072355|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
1072356|NCT02715570|Asthma|asthma
1072357|NCT02715544|Intervention|intervention
1072358|NCT02715544|Physical activity|physical activity
1072359|NCT02715544|Eating habit|eating habit
1072360|NCT02715544|Connectedness to nature|connectedness to nature
1072361|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
1072362|NCT02715518|Acute myocardial infarction|acute myocardial infarction
1072363|NCT02715518|Fractional flow reserve|fractional flow reserve
1072364|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
1072365|NCT02715518|Multivessel disease|multivessel disease
1072366|NCT02715518|STEMI|stemi
1072367|NCT02715518|NSTEMI|nstemi
1072368|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
1072369|NCT02715453|Frailty|frailty
1072370|NCT02715453|Acute myocardial infarction|acute myocardial infarction
1072371|NCT02715440|Benzodiazepines|benzodiazepines
1072372|NCT02715440|drugs|drugs
1072373|NCT02715440|withdrawal|withdrawal
1072374|NCT02715440|nursing home|nursing home
1072375|NCT02715440|elderly|elderly
1072376|NCT02715440|therapy elderly|therapy elderly
1072377|NCT02715440|Adverse Effect|adverse effect
1072378|NCT02715440|pharmacokinetics|pharmacokinetics
1072379|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
1072380|NCT02715375|asthma environment|asthma environment
1072381|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
1072382|NCT02715349|schizophrenia|schizophrenia
1072383|NCT02715349|psychoeducation|psychoeducation
1072384|NCT02715349|Vietnam|vietnam
1072385|NCT02715336|In vitro fertilization|in vitro fertilization
1072387|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
1072388|NCT02715336|ART|art
1072389|NCT02715336|OHSS|ohss
1072390|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
1072391|NCT02715336|dual triggering|dual triggering
1072392|NCT02715336|GnRH|gnrh
1072393|NCT02715323|dry eye|dry eye
1072394|NCT02715323|immunological profile|immunological profile
1072395|NCT02715323|autoimmune|autoimmune
1072396|NCT02715297|glioblastoma|glioblastoma
1072397|NCT02715297|GBM|gbm
1072398|NCT02715297|radiotherapy|radiotherapy
1072399|NCT02715297|Re-irradiation|re-irradiation
1072400|NCT02715297|progression|progression
1072401|NCT02715284|Metastatic solid tumors|metastatic solid tumors
1072402|NCT02715284|Advanced solid tumors|advanced solid tumors
1072403|NCT02715284|anti-PD-1|anti-pd-1
1072404|NCT02715284|TSR-042|tsr-042
1072405|NCT02715284|Immunotherapy|immunotherapy
1072406|NCT02715284|PD-1|pd-1
1072407|NCT02715284|Endometrial|endometrial
1072408|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
1072409|NCT02715284|MSI-High|msi-high
1072410|NCT02715245|home rehabilitation|home rehabilitation
1072993|NCT02711956|ZEN-3694|zen-3694
1072413|NCT02715245|chronic disease|chronic disease
1072414|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
1072415|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
1072416|NCT02715154|Cesarean Section|cesarean section
1072417|NCT02715154|Dexmedetomidine|dexmedetomidine
1072418|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
1072419|NCT02715115|Autism|autism
1072420|NCT02715115|Rett's syndrome|rett's syndrome
1072421|NCT02715115|Rett disorder|rett disorder
1072422|NCT02715115|Rett's disorder|rett's disorder
1072423|NCT02715115|Ataxia|ataxia
1072424|NCT02715102|lung cancer|lung cancer
1072425|NCT02715102|lung neoplasms|lung neoplasms
1072426|NCT02715102|lung nodules|lung nodules
1072427|NCT02715102|screening tests for cancer|screening tests for cancer
1072429|NCT02715089|Liver Neoplasms|liver neoplasms
1072430|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
1072431|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
1072432|NCT02715076|Thoracic Surgery|thoracic surgery
1072433|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
1072434|NCT02715076|Open Abdominal Surgery|open abdominal surgery
1072435|NCT02715076|Anesthesia, General|anesthesia, general
1072436|NCT02715050|phototherapy|phototherapy
1072437|NCT02715050|photobiostimulation|photobiostimulation
1072438|NCT02715050|muscle training|muscle training
1072439|NCT02715050|muscular adaptation|muscular adaptation
1072440|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
1072441|NCT02715037|acute tonsillitis|acute tonsillitis
1072442|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
1072443|NCT02715037|infectious mononucleosis|infectious mononucleosis
1072444|NCT02715037|microbiology|microbiology
1072445|NCT02715037|antibody development|antibody development
1072446|NCT02715024|Tamsulosin|tamsulosin
1072447|NCT02715024|Solifenacin|solifenacin
1072448|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
1072449|NCT02715024|Overactive bladder|overactive bladder
1072452|NCT02714998|ectopic pregnancy|ectopic pregnancy
1072453|NCT02714998|ovarian reserve|ovarian reserve
1072454|NCT02714998|salpingectomy|salpingectomy
1072455|NCT02714998|methotrexate|methotrexate
1072456|NCT02714985|chikungunya virus|chikungunya virus
1072457|NCT02714985|RT-PCR|rt-pcr
1072458|NCT02714985|urine|urine
1072459|NCT02714985|diagnosis|diagnosis
1072460|NCT02714946|Thyroid Nodule|thyroid nodule
1072461|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
1072462|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
1072463|NCT02714933|pulmonary|pulmonary
1072464|NCT02714933|parenchyma|parenchyma
1072465|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
1072466|NCT02714933|chest computed tomography|chest computed tomography
1072467|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
1072468|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
1072469|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
1072470|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
1072471|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1072472|NCT02714868|repeated measures|repeated measures
1072473|NCT02714868|matched comparison|matched comparison
1072474|NCT02714868|manualized intervention|manualized intervention
1072475|NCT02714868|self-determination|self-determination
1072476|NCT02714868|participation|participation
1072477|NCT02714868|advocacy|advocacy
1072478|NCT02714868|problem-solving|problem-solving
1072479|NCT02714868|commuinity participation|commuinity participation
1072480|NCT02714868|occupational therapy|occupational therapy
1072481|NCT02714868|environment|environment
1072482|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
1072483|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
1072484|NCT02714790|Minimal Residual Disease|minimal residual disease
1072485|NCT02714790|Wilms Tumor|wilms tumor
1072486|NCT02714777|General anesthesia|general anesthesia
1072487|NCT02714777|Autonomic nervous system|autonomic nervous system
1072488|NCT02714777|Children|children
1072489|NCT02714764|Alexander Disease|alexander disease
1072490|NCT02714738|Brachial plexus block|brachial plexus block
1072491|NCT02714738|Regional anesthesia|regional anesthesia
1072492|NCT02714738|Ultrasound|ultrasound
1072493|NCT02714725|Dexmedetomidine|dexmedetomidine
1072494|NCT02714725|Microcirculation|microcirculation
1072495|NCT02714725|On Pump|on pump
1072496|NCT02714725|CABG|cabg
1072497|NCT02714686|Fertility|fertility
1072498|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
1072499|NCT02714686|Family planning methods|family planning methods
1072500|NCT02714686|Birth Control|birth control
1072501|NCT02714686|Mass Media Campaign|mass media campaign
1072502|NCT02714686|Demand for contraception|demand for contraception
1072503|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
1073196|NCT02710591|Rimeporide|rimeporide
1072504|NCT02714686|Birth intervals|birth intervals
1072505|NCT02714647|motor learning|motor learning
1072506|NCT02714647|attention|attention
1072507|NCT02714647|priming|priming
1072508|NCT02714647|rehabilitation|rehabilitation
1072509|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1072510|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
1072511|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
1072512|NCT02714595|cefiderocol|cefiderocol
1072513|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
1072514|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
1072515|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
1072516|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
1072517|NCT02714595|Sepsis|sepsis
1072518|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
1072519|NCT02714595|S-649266|s-649266
1072520|NCT02714595|Gram-negative pathogens|gram-negative pathogens
1072521|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
1072522|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
1072523|NCT02714582|Shift report|shift report
1072524|NCT02714582|Bedside|bedside
1072525|NCT02714582|Nursing|nursing
1072526|NCT02714582|Matched controlled trial|matched controlled trial
1072527|NCT02714582|Mixed method|mixed method
1072528|NCT02714582|Patient participation|patient participation
1072529|NCT02714556|Lung volume|lung volume
1072530|NCT02714556|Lung Clearance Index|lung clearance index
1072531|NCT02714556|Functional Residual Capacity|functional residual capacity
1072532|NCT02714556|Respiratory function|respiratory function
1072533|NCT02714543|OSMF|osmf
1072534|NCT02714543|Aloevera|aloevera
1072535|NCT02714543|Hydrocortisone|hydrocortisone
1072536|NCT02714543|Hyaluronidase|hyaluronidase
1072537|NCT02714504|Prophylaxis|prophylaxis
1072538|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
1072539|NCT02714452|Person-centred care|person-centred care
1072540|NCT02714452|Thriving|thriving
1072541|NCT02714452|Satisfaction with care|satisfaction with care
1072542|NCT02714452|Residential aged care|residential aged care
1072543|NCT02714452|Caring environment|caring environment
1072544|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
1072545|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
1072546|NCT02714439|Abnormal Pap test|abnormal pap test
1072547|NCT02714439|Positive HPV test|positive hpv test
1072548|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
1072549|NCT02714439|Colposcopy|colposcopy
1072550|NCT02714439|Proflavine|proflavine
1072551|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
1072552|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
1072553|NCT02714439|HRME|hrme
1072554|NCT02714439|Human papillomavirus|human papillomavirus
1072555|NCT02714426|Cognitive Aging|cognitive aging
1072556|NCT02714426|Attention|attention
1072557|NCT02714426|Mindfulness|mindfulness
1072558|NCT02714413|D-allulose|d-allulose
1072559|NCT02714413|Caucasian|caucasian
1072560|NCT02714413|African American|african american
1072561|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
1072562|NCT02714400|Arousal threshold|arousal threshold
1072563|NCT02714400|Venlafaxine|venlafaxine
1072564|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
1072565|NCT02714374|GL-ONC1|gl-onc1
1072566|NCT02714374|Solid Organ Cancer|solid organ cancer
1072567|NCT02714374|Cancer|cancer
1072568|NCT02714374|Surgery|surgery
1072569|NCT02714374|Oncolytic Virus|oncolytic virus
1072570|NCT02714374|Soliris|soliris
1072571|NCT02714374|Metastatic melanoma|metastatic melanoma
1072572|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
1072573|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
1072574|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1072575|NCT02714374|Gallbladder cancer|gallbladder cancer
1072576|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
1072577|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
1072578|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
1072579|NCT02714374|Mesothelioma|mesothelioma
1072580|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
1072581|NCT02714374|Stage III or IV|stage iii or iv
1072582|NCT02714361|Iron deficiency|iron deficiency
1072583|NCT02714361|Vitamin D|vitamin d
1072584|NCT02714361|Iron absorption|iron absorption
1072585|NCT02714361|Hepcidin|hepcidin
1072586|NCT02714348|Helminth infection|helminth infection
1072587|NCT02714348|Vaccination|vaccination
1072588|NCT02714322|Adalimumab|adalimumab
1072589|NCT02714322|Biologics|biologics
1072590|NCT02714322|Biosimilar|biosimilar
1072591|NCT02714309|Postprandial glycemia|postprandial glycemia
1072592|NCT02714309|Metabolic health measures|metabolic health measures
1072593|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
1072594|NCT02714296|enteral feeding|enteral feeding
1072595|NCT02714296|sip feeding|sip feeding
1072596|NCT02714296|nutridrink|nutridrink
1072597|NCT02714296|nutridrink compact protein|nutridrink compact protein
1072598|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
1072599|NCT02714283|corticosteroids|corticosteroids
1072600|NCT02714283|macrolides|macrolides
1072601|NCT02714283|antibiotics|antibiotics
1072602|NCT02714205|Hot flash|hot flash
1072603|NCT02714153|Lead extraction|lead extraction
1072604|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
1072605|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
1072606|NCT02714127|Human Papillomavirus|human papillomavirus
1072607|NCT02714127|Biomarker|biomarker
1072608|NCT02714127|Self-sampling|self-sampling
1072609|NCT02714127|First-void urine|first-void urine
1072610|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
1072611|NCT02714127|Colposcopy|colposcopy
1072612|NCT02714114|Antibodies|antibodies
1072613|NCT02714114|Vaccination|vaccination
1072614|NCT02714114|Self-sampling|self-sampling
1072615|NCT02714114|First-void urine|first-void urine
1072616|NCT02714114|Serum|serum
1072617|NCT02714088|High-intensity interval training|high-intensity interval training
1072618|NCT02714088|Functional fitness|functional fitness
1072619|NCT02714088|Quality of life|quality of life
1072620|NCT02714088|Older adults|older adults
1072621|NCT02714062|Adolescent Obesity|adolescent obesity
1072622|NCT02714062|Childhood Obesity|childhood obesity
1072623|NCT02714062|Qsymia|qsymia
1072624|NCT02714062|Pharmacokinetics|pharmacokinetics
1072625|NCT02714062|VI-0521|vi-0521
1072626|NCT02714062|Phentermine|phentermine
1072627|NCT02714062|Topiramate|topiramate
1072628|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
1072629|NCT02714049|Addyi|addyi
1072630|NCT02714049|flibanserin|flibanserin
1072631|NCT02714049|low sexual desire|low sexual desire
1072632|NCT02714049|HSDD|hsdd
1072633|NCT02714036|ALS|als
1072634|NCT02714010|EGFR-TKI|egfr-tki
1072635|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
1072636|NCT02714010|brain metastasis|brain metastasis
1072637|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
1072638|NCT02713984|HER2 CAR-T|her2 car-t
1072639|NCT02713984|safety|safety
1072640|NCT02713984|efficiency|efficiency
1072641|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
1072642|NCT02713971|Rehabilitation|rehabilitation
1072643|NCT02713971|Balance|balance
1072644|NCT02713971|Gait|gait
1072645|NCT02713971|Biofeedback|biofeedback
1072646|NCT02713958|Telerehabilitation|telerehabilitation
1072647|NCT02713958|Elbow fractures|elbow fractures
1072648|NCT02713958|Arthrolysis|arthrolysis
1072649|NCT02713958|MediTouch|meditouch
1072650|NCT02713958|Occupational Therapy|occupational therapy
1072651|NCT02713958|Active exercises|active exercises
1072652|NCT02713945|Simvastatin|simvastatin
1072653|NCT02713945|Ras|ras
1072654|NCT02713945|MAPK|mapk
1072655|NCT02713932|Aortic valve stenosis|aortic valve stenosis
1072656|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
1072657|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1072658|NCT02713919|Cancer|cancer
1072659|NCT02713919|Outpatients|outpatients
1072660|NCT02713919|Family Caregivers|family caregivers
1072661|NCT02713893|Pharmacokinetics|pharmacokinetics
1072662|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
1072663|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
1072664|NCT02713893|Intravaginal cream|intravaginal cream
1072665|NCT02713893|Antimycotic|antimycotic
1072666|NCT02713893|Tolerability|tolerability
1072667|NCT02713880|Peripheral Nervous System Diseases|peripheral nervous system diseases
1072668|NCT02713880|Neuromuscular Diseases|neuromuscular diseases
1072669|NCT02713880|Metabolism, Inborn Errors|metabolism, inborn errors
1072670|NCT02713880|Genetic Diseases, Inborn|genetic diseases, inborn
1072671|NCT02713854|Subfertility|subfertility
1072672|NCT02713854|In-vitro fertilization|in-vitro fertilization
1072673|NCT02713854|BAP-EB|bap-eb
1072674|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
1072675|NCT02713854|Repeated implantation failure|repeated implantation failure
1072676|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
1072677|NCT02713828|Stage IIIb|stage iiib
1072678|NCT02713828|Stage IV|stage iv
1072779|NCT02713282|Schizophrenia|schizophrenia
1072679|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
1072680|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
1072681|NCT02713828|gpNMB-Expressing|gpnmb-expressing
1072682|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
1072683|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
1072684|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
1072685|NCT02713815|Glutamate/GABA|glutamate/gaba
1072686|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
1072687|NCT02713815|rTMS|rtms
1072688|NCT02713789|ED|ed
1072689|NCT02713776|High-Output Enterostomy|high-output enterostomy
1072690|NCT02713776|Pasireotide|pasireotide
1072691|NCT02713776|Somatostatin Analogues|somatostatin analogues
1072692|NCT02713763|Sunitinib|sunitinib
1072693|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
1072694|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1072695|NCT02713750|Hormonal Contraception|hormonal contraception
1072696|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
1072697|NCT02713750|Intrauterine Device|intrauterine device
1072698|NCT02713750|Pharmacokinetic|pharmacokinetic
1072699|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
1072700|NCT02713750|Reproductive Health|reproductive health
1072701|NCT02713737|hypoxemia|hypoxemia
1072702|NCT02713737|high-flow|high-flow
1072703|NCT02713737|atrial fibrillation|atrial fibrillation
1072704|NCT02713737|sleep|sleep
1072705|NCT02713711|Psoriasis|psoriasis
1072706|NCT02713711|balneotherapy|balneotherapy
1072707|NCT02713711|phototherapy|phototherapy
1072708|NCT02713711|balneophototherapy|balneophototherapy
1072709|NCT02713698|Anaesthetics|anaesthetics
1072710|NCT02713698|Intravenous|intravenous
1072711|NCT02713698|Propofol|propofol
1072712|NCT02713698|Pharmacokinetics|pharmacokinetics
1072713|NCT02713698|Pharmacodynamics|pharmacodynamics
1072714|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
1072715|NCT02713685|regional anesthesia|regional anesthesia
1072716|NCT02713685|lower limb surgery|lower limb surgery
1072717|NCT02713685|Bupivacaine|bupivacaine
1072718|NCT02713659|Literacy|literacy
1072719|NCT02713659|Child Development|child development
1072720|NCT02713659|Reading|reading
1072721|NCT02713646|MRI|mri
1072722|NCT02713646|Virtual Endoscopy|virtual endoscopy
1072723|NCT02713646|Pain Measurement|pain measurement
1072724|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
1072725|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
1072726|NCT02713568|Macrosomia|macrosomia
1072727|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
1072728|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
1072729|NCT02713568|Large-for-date fetus|large-for-date fetus
1072730|NCT02713529|Solid Tumor|solid tumor
1072731|NCT02713529|Pancreatic Cancer|pancreatic cancer
1072732|NCT02713529|Colorectal Cancer|colorectal cancer
1072733|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
1072734|NCT02713516|Anxiety|anxiety
1072735|NCT02713516|OCD|ocd
1072736|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
1072737|NCT02713516|Generalized Anxiety|generalized anxiety
1072738|NCT02713516|Social Phobia|social phobia
1072739|NCT02713516|Separation Anxiety|separation anxiety
1072740|NCT02713516|GAD|gad
1072741|NCT02713516|Youth|youth
1072742|NCT02713516|Teen|teen
1072743|NCT02713516|Therapy|therapy
1072744|NCT02713451|Oxygen|oxygen
1072745|NCT02713438|Physical activity|physical activity
1072746|NCT02713438|Planning|planning
1072747|NCT02713438|Implementation intention|implementation intention
1072748|NCT02713438|Quality of life|quality of life
1072749|NCT02713438|Body weight|body weight
1072750|NCT02713425|Anxiety|anxiety
1072751|NCT02713425|Social Phobia|social phobia
1072752|NCT02713425|Separation Anxiety|separation anxiety
1072753|NCT02713425|Generalized Anxiety|generalized anxiety
1072754|NCT02713425|GAD|gad
1072755|NCT02713425|Phobia|phobia
1072756|NCT02713425|video game|video game
1072757|NCT02713425|teen|teen
1072758|NCT02713425|youth|youth
1072759|NCT02713425|child|child
1072760|NCT02713425|adolescent|adolescent
1072761|NCT02713347|Quality of Life|quality of life
1072762|NCT02713347|Symptom Assessment|symptom assessment
1072763|NCT02713347|Palliative Care|palliative care
1072764|NCT02713347|Disease Management|disease management
1072765|NCT02713347|Delivery of Health Care|delivery of health care
1072766|NCT02713347|Advance Care Planning|advance care planning
1072767|NCT02713334|Decision Making|decision making
1072768|NCT02713334|Communication|communication
1072769|NCT02713334|16-080|16-080
1072770|NCT02713321|diabetes|diabetes
1072771|NCT02713321|vulnerable populations|vulnerable populations
1072772|NCT02713321|comorbidity|comorbidity
1072773|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
1072774|NCT02713321|Medicaid reform|medicaid reform
1072775|NCT02713321|health disparities|health disparities
1072776|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
1072777|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
1072778|NCT02713295|Plaque Psoriasis|plaque psoriasis
1072781|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
1072782|NCT02713269|Secondary Malignant Neoplasm of Vertebral Column|secondary malignant neoplasm of vertebral column
1072783|NCT02713269|Spine Metastases|spine metastases
1072784|NCT02713269|Epidural spinal cord compression|epidural spinal cord compression
1072785|NCT02713269|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
1072786|NCT02713269|SSRS|ssrs
1072787|NCT02713269|Thermal ablation|thermal ablation
1072788|NCT02713269|Symptom questionnaire|symptom questionnaire
1072789|NCT02713269|Surveys|surveys
1072790|NCT02713256|Graves' disease|graves' disease
1072791|NCT02713256|Hyperthyroidism|hyperthyroidism
1072792|NCT02713256|CFZ533|cfz533
1072793|NCT02713256|TSH|tsh
1072794|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
1072795|NCT02713243|FXR agonist,|fxr agonist,
1072796|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
1072797|NCT02713217|depressive disorder|depressive disorder
1072802|NCT02713217|post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1072804|NCT02713191|Sedation|sedation
1072805|NCT02713191|Dexmedetomidine|dexmedetomidine
1072806|NCT02713165|Gut Microbiota|gut microbiota
1072807|NCT02713139|vaginal|vaginal
1072808|NCT02713139|discharge|discharge
1072809|NCT02713139|women|women
1072810|NCT02713048|Cardiac arrest|cardiac arrest
1072811|NCT02713048|Troponin I|troponin i
1072812|NCT02713048|coronary anatomy|coronary anatomy
1072815|NCT02713009|Maternal body weight|maternal body weight
1072816|NCT02713009|Vitamin D|vitamin d
1072817|NCT02713009|Pregnancy|pregnancy
1072818|NCT02712996|Traumatic Brain Injury|traumatic brain injury
1072819|NCT02712996|Attention Deficit|attention deficit
1072820|NCT02712996|TBI|tbi
1072821|NCT02712996|Vyvanse|vyvanse
1072823|NCT02712918|Depression|depression
1072824|NCT02712918|Inpatient|inpatient
1072825|NCT02712918|Acute|acute
1072826|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
1072827|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1072828|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1072829|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1072830|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
1072831|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
1072832|NCT02712840|Single embryo transfer|single embryo transfer
1072833|NCT02712840|Freeze-all|freeze-all
1072834|NCT02712840|Fresh|fresh
1072835|NCT02712840|Vitrification|vitrification
1072836|NCT02712840|Clinical Pregnancy|clinical pregnancy
1072837|NCT02712840|Blastocyst|blastocyst
1072838|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
1072839|NCT02712801|HIV|hiv
1072840|NCT02712801|antiretroviral treatment|antiretroviral treatment
1072841|NCT02712801|child|child
1072842|NCT02712801|testing|testing
1072843|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1072844|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
1072845|NCT02712788|Milrinone|milrinone
1072846|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
1072847|NCT02712762|immunological profiles|immunological profiles
1072848|NCT02712749|Binaural Beat|binaural beat
1072849|NCT02712749|Elderly|elderly
1072850|NCT02712749|preoperative medication|preoperative medication
1072851|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1072852|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
1072853|NCT02712723|Stage II or III|stage ii or iii
1072854|NCT02712723|Letrozole|letrozole
1072855|NCT02712723|Femara|femara
1072856|NCT02712723|Ribociclib|ribociclib
1072857|NCT02712723|LEE011|lee011
1072858|NCT02712723|Neo-adjuvant|neo-adjuvant
1072859|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
1072860|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
1072861|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
1072862|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
1072863|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
1072864|NCT02712671|Quality of Life|quality of life
1072865|NCT02712593|Healthy participants|healthy participants
1072866|NCT02712593|Dietary supplement|dietary supplement
1072867|NCT02712593|Bioavailability|bioavailability
1072868|NCT02712593|Niagen™|niagen™
1072869|NCT02712593|Nicotinamide riboside|nicotinamide riboside
1072870|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
1072871|NCT02712580|pediatric burns|pediatric burns
1072872|NCT02712580|deep dermal wounds|deep dermal wounds
1072873|NCT02712580|wound healing|wound healing
1072874|NCT02712580|ChildPain Measurement|childpain measurement
1072875|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
1072876|NCT02712580|wireless electric stimulation|wireless electric stimulation
1072877|NCT02712580|wireless current stimulation|wireless current stimulation
1072878|NCT02712580|wireless technology|wireless technology
1072879|NCT02712580|children|children
1072880|NCT02712580|conservative treatment|conservative treatment
1072881|NCT02712580|deep dermal scalds|deep dermal scalds
1072882|NCT02712580|humans|humans
1072883|NCT02712580|deep dermal burns|deep dermal burns
1072884|NCT02712580|burns|burns
1072885|NCT02712580|wound healing process|wound healing process
1072886|NCT02712554|Pain|pain
1072887|NCT02712554|Nausea|nausea
1072888|NCT02712554|Vomiting|vomiting
1072889|NCT02712541|Caregiver burden Index|caregiver burden index
1072890|NCT02712528|bispectral index|bispectral index
1072891|NCT02712528|extubation|extubation
1072892|NCT02712528|recovery|recovery
1072893|NCT02712528|remifentanil|remifentanil
1072894|NCT02712489|HAART-treated participants|haart-treated participants
1072896|NCT02712489|Therapeutic immunization|therapeutic immunization
1072897|NCT02712476|Mannitol|mannitol
1072898|NCT02712476|Furosemid|furosemid
1072899|NCT02712476|Brain Relaxation|brain relaxation
1072900|NCT02712463|Schizophrenia|schizophrenia
1072901|NCT02712463|Oral antipsychotics|oral antipsychotics
1072902|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
1072903|NCT02712450|geriatric|geriatric
1072904|NCT02712450|emergency|emergency
1072905|NCT02712450|clinical pathway|clinical pathway
1072906|NCT02712450|regulation|regulation
1072907|NCT02712450|SAMU|samu
1072908|NCT02712450|training|training
1072909|NCT02712437|Insomnia|insomnia
1072910|NCT02712437|Quality of Life|quality of life
1072911|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
1072912|NCT02712424|Vaccine|vaccine
1072913|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
1072914|NCT02712372|Healthy male subjects|healthy male subjects
1072915|NCT02712372|Safety|safety
1072916|NCT02712372|Tolerability|tolerability
1072917|NCT02712372|Pharmacokinetics|pharmacokinetics
1072918|NCT02712372|Pharmacodynamics|pharmacodynamics
1072919|NCT02712359|Havrix|havrix
1072920|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
1072921|NCT02712359|Panama|panama
1072922|NCT02712359|Long-term persistence|long-term persistence
1072923|NCT02712359|Hepatitis|hepatitis
1072924|NCT02712346|Sickle Cell Anemia|sickle cell anemia
1072925|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
1072926|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
1072927|NCT02712346|Proteinuria|proteinuria
1072928|NCT02712346|Sickle nephropathy|sickle nephropathy
1072929|NCT02712333|PM2.5|pm2.5
1072930|NCT02712333|air purification|air purification
1072931|NCT02712333|randomized controlled trial|randomized controlled trial
1072932|NCT02712333|metabolomics|metabolomics
1072933|NCT02712333|Metabolites|metabolites
1072934|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
1072935|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
1072936|NCT02712320|Safety Extension|safety extension
1072937|NCT02712294|pulmonary hypertension|pulmonary hypertension
1072938|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
1072939|NCT02712294|capacity of the exercises|capacity of the exercises
1072940|NCT02712294|quality of life|quality of life
1072941|NCT02712281|Food Selectivity|food selectivity
1072942|NCT02712281|Autism MEAL Plan|autism meal plan
1072943|NCT02712281|Parent Education|parent education
1072944|NCT02712268|Polypharmacy|polypharmacy
1072945|NCT02712268|Clinical decision-making|clinical decision-making
1072946|NCT02712255|Physical activity|physical activity
1072947|NCT02712255|Quality of life|quality of life
1072948|NCT02712255|Planning|planning
1072949|NCT02712255|Implementation intentions|implementation intentions
1072950|NCT02712255|Cardiovascular disease|cardiovascular disease
1072951|NCT02712255|Diabetes|diabetes
1072952|NCT02712203|Measles vaccine|measles vaccine
1072953|NCT02712203|Priorix|priorix
1072954|NCT02712203|Priorix-Tetra|priorix-tetra
1072955|NCT02712203|Age at vaccination|age at vaccination
1072956|NCT02712177|vaccine safety|vaccine safety
1072957|NCT02712177|interaction|interaction
1072958|NCT02712164|Split-thickness skin graft|split-thickness skin graft
1072959|NCT02712164|STSG|stsg
1072960|NCT02712164|donor site|donor site
1072961|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
1072962|NCT02712164|NPWT|npwt
1072963|NCT02712164|dressing|dressing
1072964|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
1072965|NCT02712138|Hyperbilirubinemia|hyperbilirubinemia
1072966|NCT02712138|Unconjugated Benign Bilirubinemia|unconjugated benign bilirubinemia
1072967|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1072968|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
1072969|NCT02712060|Prevalence|prevalence
1072970|NCT02712060|Children|children
1072971|NCT02712060|Pediatric|pediatric
1072972|NCT02712060|Adolescents|adolescents
1072973|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
1072974|NCT02712047|Asthma|asthma
1072975|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
1072976|NCT02712047|cross-over|cross-over
1072977|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
1072978|NCT02712034|Buprenorphine|buprenorphine
1072979|NCT02712034|Methadone|methadone
1072980|NCT02712034|Naltrexone|naltrexone
1072981|NCT02712021|Cerebral Palsy|cerebral palsy
1072982|NCT02712021|Lycra|lycra
1072983|NCT02712021|Motor Function|motor function
1072984|NCT02712021|Static Balance|static balance
1072985|NCT02711995|botulinum toxin|botulinum toxin
1072986|NCT02711995|injection augmentation|injection augmentation
1072987|NCT02711995|essential voice tremor|essential voice tremor
1072988|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
1072989|NCT02711956|Phase 1b/2a|phase 1b/2a
1072990|NCT02711956|Prostate Cancer|prostate cancer
1072991|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
1072992|NCT02711956|ZEN003694|zen003694
1072994|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
1072995|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
1072996|NCT02711956|Bromodomain|bromodomain
1072997|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
1072998|NCT02711956|Enzalutamide|enzalutamide
1073000|NCT02711956|MDV3100|mdv3100
1073001|NCT02711956|Epigenetics|epigenetics
1073002|NCT02711930|intra-ocular pressure|intra-ocular pressure
1073003|NCT02711930|prone ventilation|prone ventilation
1073004|NCT02711917|Propofol|propofol
1073005|NCT02711917|Sevoflurane|sevoflurane
1073006|NCT02711917|Etomidate|etomidate
1073007|NCT02711917|Rocuronium|rocuronium
1073008|NCT02711917|BIS|bis
1073009|NCT02711917|Closed loop infusion system|closed loop infusion system
1073010|NCT02711904|Extubation|extubation
1073011|NCT02711904|Cough|cough
1073012|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
1073013|NCT02711891|fingerstick|fingerstick
1073014|NCT02711891|opioid|opioid
1073015|NCT02711891|heelstick|heelstick
1073016|NCT02711891|loperamide|loperamide
1073017|NCT02711891|topical opioid|topical opioid
1073018|NCT02711826|graft inflammation|graft inflammation
1073019|NCT02711826|Treg|treg
1073020|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
1073021|NCT02711826|darTregs|dartregs
1073022|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
1073023|NCT02711826|mTOR inhibitors|mtor inhibitors
1073024|NCT02711787|Hand|hand
1073025|NCT02711787|Paralysis|paralysis
1073026|NCT02711787|Stroke|stroke
1073027|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1073028|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
1073029|NCT02711709|Surgical ICU|surgical icu
1073030|NCT02711696|Celiac Disease,|celiac disease,
1073031|NCT02711696|Gluten Free Diet|gluten free diet
1073032|NCT02711696|Gluten contamination|gluten contamination
1073033|NCT02711670|nephrolithiasis|nephrolithiasis
1073034|NCT02711670|calcium stones|calcium stones
1073035|NCT02711670|kidney stones|kidney stones
1073036|NCT02711670|hypercalciuria|hypercalciuria
1073037|NCT02711670|thiazide|thiazide
1073038|NCT02711657|Fibrocytes|fibrocytes
1073039|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
1073040|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
1073041|NCT02711657|Asthma|asthma
1073042|NCT02711644|Pregnancy|pregnancy
1073043|NCT02711644|Prenatal|prenatal
1073044|NCT02711644|Nutrition|nutrition
1073045|NCT02711631|coronary angioplasty|coronary angioplasty
1073046|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
1073047|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
1073048|NCT02711605|ultrasound|ultrasound
1073049|NCT02711605|fat|fat
1073050|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
1073051|NCT02711566|Rehabilitation|rehabilitation
1073052|NCT02711566|Robot-assisted therapy|robot-assisted therapy
1073053|NCT02711501|post-operative pain|post-operative pain
1073054|NCT02711501|diode laser|diode laser
1073055|NCT02711488|school-based intervention|school-based intervention
1073056|NCT02711488|sedentary behavior|sedentary behavior
1073057|NCT02711488|physical activity|physical activity
1073058|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
1073059|NCT02711462|Healthy Subjects|healthy subjects
1073060|NCT02711449|acute surgery|acute surgery
1073061|NCT02711449|laparoscopy|laparoscopy
1073062|NCT02711371|addiction|addiction
1073063|NCT02711371|cannabis|cannabis
1073064|NCT02711371|fMRI|fmri
1073065|NCT02711345|LTT462|ltt462
1073066|NCT02711345|ERK|erk
1073067|NCT02711345|MAPK|mapk
1073068|NCT02711345|solid tumor|solid tumor
1073069|NCT02711267|Open Flow Microperfusion|open flow microperfusion
1073070|NCT02711241|Gastroenteritis|gastroenteritis
1073071|NCT02711241|Analgesia|analgesia
1073072|NCT02711241|Emergency department|emergency department
1073073|NCT02711189|Addiction|addiction
1073074|NCT02711189|Oxytocin|oxytocin
1073075|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1073076|NCT02711189|Alcohol|alcohol
1073077|NCT02711189|Cue Reactivity|cue reactivity
1073078|NCT02711137|Solid tumor|solid tumor
1073079|NCT02711137|lymphoma|lymphoma
1073080|NCT02711137|leukemia|leukemia
1073081|NCT02711137|AML|aml
1073082|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1073083|NCT02711137|multiple myeloma|multiple myeloma
1073084|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
1073085|NCT02711137|MDS/MPN|mds/mpn
1073086|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
1073087|NCT02711137|pancreatic cancer|pancreatic cancer
1073088|NCT02711137|colorectal cancer|colorectal cancer
1073089|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
1073090|NCT02711137|prostate cancer|prostate cancer
1073091|NCT02711137|breast cancer|breast cancer
1073092|NCT02711137|ovarian cancer|ovarian cancer
1073093|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1073094|NCT02711137|NUT midline carcinoma|nut midline carcinoma
1073095|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
1073096|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1073097|NCT02711137|double-hit|double-hit
1073098|NCT02711137|triple-hit|triple-hit
1073099|NCT02711137|myc|myc
1073100|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
1073101|NCT02711124|hemoglobin A1c|hemoglobin a1c
1073102|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
1073103|NCT02711124|impedance aggregometry|impedance aggregometry
1073104|NCT02711124|platelet reactivity|platelet reactivity
1073105|NCT02711124|clinical outcomes|clinical outcomes
1073106|NCT02711098|cardiac arrest|cardiac arrest
1073107|NCT02711098|hypothermia|hypothermia
1073108|NCT02711098|critical care|critical care
1073109|NCT02711059|hyperparathyroidism|hyperparathyroidism
1073110|NCT02711059|insulin resistance|insulin resistance
1073111|NCT02711020|Depressive symptoms|depressive symptoms
1073112|NCT02711020|Fibromyalgia|fibromyalgia
1073113|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
1073114|NCT02711020|Personal Constructs Therapy|personal constructs therapy
1073115|NCT02711020|Differential Efficacy|differential efficacy
1073116|NCT02711007|osteosarcoma|osteosarcoma
1073117|NCT02711007|metastasis|metastasis
1073118|NCT02711007|advanced|advanced
1073119|NCT02711007|apatinib|apatinib
1073120|NCT02710994|Immediate release omeprazole|immediate release omeprazole
1073121|NCT02710994|Integrated gastric acidity|integrated gastric acidity
1073122|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
1073123|NCT02710981|endometrium|endometrium
1073124|NCT02710981|clomiphene|clomiphene
1073125|NCT02710981|anovulation|anovulation
1073126|NCT02710968|FETO|feto
1073127|NCT02710916|Optical Coherence Tomography|optical coherence tomography
1073128|NCT02710916|Intraocular pressure|intraocular pressure
1073129|NCT02710916|Optic Nerve Head|optic nerve head
1073130|NCT02710916|Nerve fiber layer|nerve fiber layer
1073131|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
1073132|NCT02710903|Periodontitis|periodontitis
1073133|NCT02710903|SNP|snp
1073134|NCT02710903|Pathogenesis|pathogenesis
1073135|NCT02710903|IL29|il29
1073136|NCT02710903|IL28B|il28b
1073137|NCT02710890|Epilepsy|epilepsy
1073138|NCT02710890|pediatric|pediatric
1073139|NCT02710890|intravenous|intravenous
1073140|NCT02710890|children|children
1073141|NCT02710890|Lacosamide|lacosamide
1073142|NCT02710890|VIMPAT®|vimpat®
1073143|NCT02710890|seizure|seizure
1073144|NCT02710877|epidural analgesia|epidural analgesia
1073145|NCT02710877|patient controlled analgesia|patient controlled analgesia
1073146|NCT02710877|obstetric outcome|obstetric outcome
1073147|NCT02710864|Cytomegalovirus|cytomegalovirus
1073148|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
1073149|NCT02710851|condylomata acuminata|condylomata acuminata
1073150|NCT02710838|Early gastric cancer|early gastric cancer
1073151|NCT02710838|Infrared endoscope|infrared endoscope
1073152|NCT02710799|Endocrinology|endocrinology
1073153|NCT02710799|Referral list|referral list
1073154|NCT02710799|Teleconsultation|teleconsultation
1073155|NCT02710799|Telemedicine|telemedicine
1073156|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
1073157|NCT02710773|Gait|gait
1073158|NCT02710773|Randomized controlled trial|randomized controlled trial
1073159|NCT02710773|Chronic Stroke|chronic stroke
1073160|NCT02710773|Treadmill training|treadmill training
1073161|NCT02710760|Biomarkers|biomarkers
1073162|NCT02710760|Child Nutrition Sciences|child nutrition sciences
1073163|NCT02710760|Economics, Behavioral|economics, behavioral
1073164|NCT02710747|warfarin|warfarin
1073165|NCT02710747|Chinese patients|chinese patients
1073166|NCT02710747|heart valve replacement|heart valve replacement
1073167|NCT02710734|Urothelial|urothelial
1073168|NCT02710721|Fasting|fasting
1073169|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
1073170|NCT02710721|Complementary Therapies|complementary therapies
1073171|NCT02710721|Urology|urology
1073172|NCT02710708|birth control,|birth control,
1073173|NCT02710708|contraceptives safety,|contraceptives safety,
1073174|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
1073175|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
1073176|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
1073177|NCT02710682|Tendon Fenestration|tendon fenestration
1073178|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
1073179|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
1073180|NCT02710682|Ultrasonography|ultrasonography
1073181|NCT02710682|Elastography|elastography
1073182|NCT02710669|ablation|ablation
1073183|NCT02710656|Atherosclerosis|atherosclerosis
1073184|NCT02710656|SFA|sfa
1073185|NCT02710656|Poplitea|poplitea
1073186|NCT02710656|Drug coated balloon|drug coated balloon
1073187|NCT02710656|Angioplasty|angioplasty
1073188|NCT02710656|Restenosis|restenosis
1073189|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
1073190|NCT02710643|Follicular|follicular
1073191|NCT02710643|Lymphoma|lymphoma
1073192|NCT02710643|Grade 1|grade 1
1073193|NCT02710643|Grade 2|grade 2
1073194|NCT02710643|Grade 3A|grade 3a
1073195|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
1073197|NCT02710578|Alcohol impaired driving|alcohol impaired driving
1073198|NCT02710578|Driving simulation|driving simulation
1073199|NCT02710578|Residual effects of alcohol|residual effects of alcohol
1073200|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
1073201|NCT02710578|Young drivers|young drivers
1073202|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
1073203|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
1073204|NCT02710565|Cell line|cell line
1073205|NCT02710565|Lung cancer|lung cancer
1073206|NCT02710552|arterial hypertension|arterial hypertension
1073207|NCT02710552|antihypertensive drugs|antihypertensive drugs
1073208|NCT02710539|arterial hypertension|arterial hypertension
1073209|NCT02710539|antihypertensive drugs|antihypertensive drugs
1073210|NCT02710513|beta-glucans|beta-glucans
1073211|NCT02710513|gut microbiota|gut microbiota
1073212|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
1073213|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
1073214|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
1073216|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
1073217|NCT02710500|Miyoshi|miyoshi
1073218|NCT02710500|Gene Transfer|gene transfer
1073219|NCT02710500|Dysferlin|dysferlin
1073220|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
1073221|NCT02710474|preterm birth|preterm birth
1073222|NCT02710474|NICU|nicu
1073223|NCT02710474|neonatal|neonatal
1073224|NCT02710474|kangaroo care|kangaroo care
1073225|NCT02710474|separation stress|separation stress
1073226|NCT02710474|family nurture|family nurture
1073227|NCT02710474|maternal confidence|maternal confidence
1073228|NCT02710474|maternal competence|maternal competence
1073229|NCT02710474|calming cycle|calming cycle
1073230|NCT02710474|infant neurodevelopment|infant neurodevelopment
1073231|NCT02710474|infant psychological development|infant psychological development
1073232|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
1073233|NCT02710474|post-partum depression|post-partum depression
1073234|NCT02710461|Polyphenols|polyphenols
1073235|NCT02710461|Grape|grape
1073236|NCT02710461|Pomegranate|pomegranate
1073237|NCT02710461|Metabolic syndrome|metabolic syndrome
1073238|NCT02710461|Abdominal obesity|abdominal obesity
1073239|NCT02710461|Postprandial glucose|postprandial glucose
1073240|NCT02710461|Insulin resistance|insulin resistance
1073241|NCT02710435|Coronary Sinus|coronary sinus
1073242|NCT02710435|Reducer|reducer
1073243|NCT02710435|Refractory Angina|refractory angina
1073244|NCT02710435|Angina Pectoris|angina pectoris
1073245|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
1073246|NCT02710435|Chronic Stable Angina|chronic stable angina
1073247|NCT02710435|Persistent Angina|persistent angina
1073248|NCT02710435|Neovasc Reducer System|neovasc reducer system
1073249|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
1073250|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
1073251|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
1073252|NCT02710435|Chronic Angina|chronic angina
1073253|NCT02710435|End Stage Angina|end stage angina
1073254|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
1073255|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
1073256|NCT02710435|Chronic Refractory Angina|chronic refractory angina
1073257|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
1073258|NCT02710422|Prostate Cancer|prostate cancer
1073259|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
1073260|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
1073261|NCT02710422|RARP|rarp
1073262|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
1073263|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
1073264|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1073265|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
1073266|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1073267|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
1073268|NCT02710396|NSCLC|nsclc
1073269|NCT02710396|Cancer of Neck|cancer of neck
1073270|NCT02710396|Neoplasms, Head and Neck|neoplasms, head and neck
1073271|NCT02710396|Cancer of the Head|cancer of the head
1073272|NCT02710396|Cancer of the Head and Neck|cancer of the head and neck
1073273|NCT02710396|Head, Neck Neoplasms|head, neck neoplasms
1073274|NCT02710396|Bladder Cancer|bladder cancer
1073275|NCT02710396|Bladder Neoplasms|bladder neoplasms
1073276|NCT02710396|Malignant Tumor of Urinary Bladder|malignant tumor of urinary bladder
1073277|NCT02710396|Urinary Bladder Cancer|urinary bladder cancer
1073278|NCT02710396|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1073279|NCT02710396|Carcinoma, Transitional Cell|carcinoma, transitional cell
1073280|NCT02710370|Bariatric Surgery|bariatric surgery
1073281|NCT02710370|Gastric Bypass|gastric bypass
1073282|NCT02710370|Obesity/surgery|obesity/surgery
1073283|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
1073284|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
1073285|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
1073286|NCT02710370|Energy Metabolism|energy metabolism
1073287|NCT02710370|Glucose/metabolism|glucose/metabolism
1073288|NCT02710370|Jejunum/metabolism|jejunum/metabolism
1073289|NCT02710370|Metabolomics|metabolomics
1073290|NCT02710370|Gene Expression|gene expression
1073291|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
1073292|NCT02710357|Prostheses and Implants|prostheses and implants
1073293|NCT02710357|Denture, Complete, Lower|denture, complete, lower
1073294|NCT02710279|Psychiatry|psychiatry
1073295|NCT02710279|Depressive disorder|depressive disorder
1073296|NCT02710279|Suicide|suicide
1073297|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
1073298|NCT02710266|Hepatectomy|hepatectomy
1073299|NCT02710266|Postoperative Complications|postoperative complications
1073300|NCT02710253|Metastatic cancer|metastatic cancer
1073301|NCT02710253|Prior treatment with immunotherapy agent|prior treatment with immunotherapy agent
1073302|NCT02710253|Salvage radiation therapy|salvage radiation therapy
1073303|NCT02710253|Radiation therapy|radiation therapy
1073304|NCT02710253|XRT|xrt
1073305|NCT02710253|Progressive disease|progressive disease
1073306|NCT02710253|PD|pd
1073307|NCT02710253|Stereotactic radiation|stereotactic radiation
1073308|NCT02710253|External beam radiation|external beam radiation
1073309|NCT02710253|Whole brain radiation therapy|whole brain radiation therapy
1073310|NCT02710253|WBRT|wbrt
1073311|NCT02710214|Hot flash|hot flash
1073312|NCT02710214|Estrogen|estrogen
1073313|NCT02710214|Women|women
1073314|NCT02710149|CAR-T|car-t
1073315|NCT02710149|Leukemia|leukemia
1073316|NCT02710149|Lymphoma|lymphoma
1073317|NCT02710136|Asthma|asthma
1073318|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
1073319|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
1073320|NCT02710058|support group|support group
1073321|NCT02710058|15-246|15-246
1073322|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
1073323|NCT02710045|Immunity, Innate|immunity, innate
1073324|NCT02710045|Immunity, Non-Specific|immunity, non-specific
1073325|NCT02710045|Transcriptome|transcriptome
1073326|NCT02710045|Antibodies|antibodies
1073327|NCT02710045|Cytokines|cytokines
1073328|NCT02710045|Immunity, Cellular|immunity, cellular
1073329|NCT02710032|Transgender women|transgender women
1073330|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
1073331|NCT02710032|Adherence|adherence
1073332|NCT02710032|Peru|peru
1073333|NCT02710032|Social Networks|social networks
1073334|NCT02710019|substance use|substance use
1073335|NCT02710019|psychosis|psychosis
1073336|NCT02710019|youth|youth
1073337|NCT02710019|video game|video game
1073338|NCT02710006|Uterus|uterus
1073339|NCT02710006|Ultrasound|ultrasound
1073340|NCT02709980|Brain Injury|brain injury
1073341|NCT02709980|Insomnia|insomnia
1073342|NCT02709980|Sleep|sleep
1073343|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
1073344|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
1073345|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
1073346|NCT02709941|Blood Pressure|blood pressure
1073347|NCT02709928|Multiple ascending dose|multiple ascending dose
1073348|NCT02709850|ANGPTL-3|angptl-3
1073349|NCT02709837|bioavailability|bioavailability
1073350|NCT02709837|amino acid|amino acid
1073351|NCT02709837|carnosine|carnosine
1073352|NCT02709837|lycopene|lycopene
1073353|NCT02709837|mastication|mastication
1073354|NCT02709837|meat|meat
1073355|NCT02709798|Shenfu Injection|shenfu injection
1073356|NCT02709798|Reperfusion Injury|reperfusion injury
1073357|NCT02709798|Myocardial Protection|myocardial protection
1073358|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
1073359|NCT02709746|paediatric patients|paediatric patients
1073360|NCT02709733|Virtual Reality|virtual reality
1073361|NCT02709733|Negative Symptoms|negative symptoms
1073362|NCT02709720|Lung Cancer|lung cancer
1073363|NCT02709720|Cancer Lung Disease|cancer lung disease
1073364|NCT02709720|NORA|nora
1073365|NCT02709720|GECP 15/02|gecp 15/02
1073366|NCT02709720|Metronomic administration|metronomic administration
1073367|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
1073368|NCT02709681|Sickle Cell Disease|sickle cell disease
1073369|NCT02709681|Hydroxyurea|hydroxyurea
1073370|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
1073371|NCT02709655|paediatric|paediatric
1073372|NCT02709616|Glioblastoma|glioblastoma
1073373|NCT02709616|DC vaccine|dc vaccine
1073374|NCT02709616|tumor antigen|tumor antigen
1073375|NCT02709616|personalized vaccine|personalized vaccine
1073376|NCT02709551|corporate health management|corporate health management
1073377|NCT02709551|hrv|hrv
1073378|NCT02709551|mindfulness|mindfulness
1073379|NCT02709525|hyaluronic acid|hyaluronic acid
1073380|NCT02709525|bone repair|bone repair
1073381|NCT02709525|dental socket|dental socket
1073382|NCT02709525|cone beam computed tomography|cone beam computed tomography
1073383|NCT02709512|Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression|malignant pleural mesothelioma with low argininosuccinate synthetase 1 expression
1073384|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
1073388|NCT02709460|hematoma|hematoma
1073389|NCT02709460|complication|complication
1073390|NCT02709460|hysterectomy|hysterectomy
1073391|NCT02709447|Intimate Partner Violence|intimate partner violence
1073392|NCT02709447|Juvenile Delinquency|juvenile delinquency
1073393|NCT02709447|Sexual Behavior|sexual behavior
1073394|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
1073395|NCT02709421|Risk factors|risk factors
1073396|NCT02709421|Indomethacin|indomethacin
1073397|NCT02709408|Carbapenem resistance|carbapenem resistance
1073398|NCT02709408|Enterobacteriaceae|enterobacteriaceae
1073399|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
1073400|NCT02709408|Bloodstream infections|bloodstream infections
1073401|NCT02709408|Intrabdominal infections|intrabdominal infections
1073402|NCT02709408|Urinary tract infections|urinary tract infections
1073403|NCT02709408|Pneumonia|pneumonia
1073404|NCT02709408|Risk factors|risk factors
1073406|NCT02709408|Hospitalised patients|hospitalised patients
1073407|NCT02709408|Mortality|mortality
1073408|NCT02709408|Clinical response|clinical response
1073409|NCT02709408|Length of hospital stay|length of hospital stay
1073410|NCT02709369|HIRREM|hirrem
1073411|NCT02709369|Neuro-technology|neuro-technology
1073412|NCT02709369|Closed-loop|closed-loop
1073413|NCT02709369|Acoustic stimulation|acoustic stimulation
1073414|NCT02709369|Allostatic|allostatic
1073415|NCT02709369|heart rate variability|heart rate variability
1073416|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
1073417|NCT02709369|traumatic brain injury|traumatic brain injury
1073418|NCT02709369|sports concussion|sports concussion
1073419|NCT02709369|PTSD|ptsd
1073420|NCT02709369|hot flashes|hot flashes
1073421|NCT02709369|headache|headache
1073422|NCT02709369|insomnia|insomnia
1073423|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
1073424|NCT02709278|BCG|bcg
1073425|NCT02709278|Aerosol|aerosol
1073426|NCT02709278|Tuberculosis|tuberculosis
1073427|NCT02709278|Challenge|challenge
1073432|NCT02709213|Inflammatory chronic bowel disease|inflammatory chronic bowel disease
1073433|NCT02709213|ICBD|icbd
1073434|NCT02709213|Colorectal cancer|colorectal cancer
1073435|NCT02709213|Infectious colitis|infectious colitis
1073436|NCT02709187|DP-R208|dp-r208
1073437|NCT02709174|Pulmonary Embolism|pulmonary embolism
1073438|NCT02709174|Pregnancy|pregnancy
1073439|NCT02709174|D-Dimer|d-dimer
1073440|NCT02709161|neurofeedback|neurofeedback
1073441|NCT02709161|major depressive disorder|major depressive disorder
1073442|NCT02709161|amygdala|amygdala
1073443|NCT02709148|Parkinson's Disease|parkinson's disease
1073444|NCT02709070|highly-purified CTL|highly-purified ctl
1073445|NCT02709044|Acute pancreatitis|acute pancreatitis
1073446|NCT02709044|Fluid resuscitation|fluid resuscitation
1073447|NCT02709044|Crystalloids|crystalloids
1073448|NCT02709031|Cicletanine|cicletanine
1073449|NCT02709031|Magnesium|magnesium
1073450|NCT02709031|Metabolic disease|metabolic disease
1073451|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
1073452|NCT02709018|losartan|losartan
1073453|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
1073454|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
1073455|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
1073456|NCT02708992|Azithromycin|azithromycin
1073457|NCT02708992|Cefixime|cefixime
1073458|NCT02708992|Duration|duration
1073459|NCT02708992|High-Dose|high-dose
1073460|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
1073461|NCT02708992|Pharmacokinetics|pharmacokinetics
1073462|NCT02708992|Susceptibility|susceptibility
1073463|NCT02708979|Stress|stress
1073464|NCT02708979|Eating|eating
1073465|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
1073466|NCT02708966|Glycemic control|glycemic control
1073467|NCT02708927|social integration|social integration
1073468|NCT02708927|cognitive impairment|cognitive impairment
1073469|NCT02708927|emotional processing|emotional processing
1073470|NCT02708927|quality of life|quality of life
1073471|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
1073472|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
1073473|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
1073474|NCT02708901|Gut-Brain Axis|gut-brain axis
1073475|NCT02708901|Endophenotypes|endophenotypes
1073476|NCT02708888|Trunk|trunk
1073477|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
1073478|NCT02708888|Gait|gait
1073479|NCT02708888|Electromyography|electromyography
1073480|NCT02708888|Rehabilitation|rehabilitation
1073481|NCT02708888|Balance|balance
1073482|NCT02708875|Microvascular|microvascular
1073483|NCT02708875|Insulin resistance|insulin resistance
1073484|NCT02708875|Mixed Meal|mixed meal
1073485|NCT02708875|Glucose tolerance|glucose tolerance
1073486|NCT02708823|Postoperative delirium|postoperative delirium
1073487|NCT02708823|Risk assessment|risk assessment
1073488|NCT02708823|Clinical screening tool|clinical screening tool
1073489|NCT02708823|Tablet computer|tablet computer
1073490|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
1073491|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
1073492|NCT02708797|Cerebral autoregulation|cerebral autoregulation
1073493|NCT02708797|MRI|mri
1073494|NCT02708797|VBM|vbm
1073495|NCT02708797|Doppler Transcranial|doppler transcranial
1073496|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
1073497|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
1073498|NCT02708784|Muscular disorders|muscular disorders
1073499|NCT02708784|MR-imaging|mr-imaging
1073500|NCT02708784|Muscle strength|muscle strength
1073501|NCT02708784|Myopathies|myopathies
1073502|NCT02708745|communication|communication
1073503|NCT02708745|immunization|immunization
1073504|NCT02708719|COPD|copd
1073505|NCT02708719|MID|mid
1073506|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
1073507|NCT02708706|adhesive capsulitis|adhesive capsulitis
1073508|NCT02708706|hyaluronic acid|hyaluronic acid
1073509|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
1073510|NCT02708667|crizotinib|crizotinib
1073511|NCT02708667|hepatic toxicity|hepatic toxicity
1073512|NCT02708654|Remote monitoring|remote monitoring
1073513|NCT02708654|Incentives|incentives
1073514|NCT02708628|scar prevention|scar prevention
1073515|NCT02708628|sectio|sectio
1073516|NCT02708628|extract of allium cepae|extract of allium cepae
1073517|NCT02708628|allantoin|allantoin
1073518|NCT02708628|heparin|heparin
1073519|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
1073520|NCT02708602|genetic polymorphisms|genetic polymorphisms
1073521|NCT02708602|labor progress|labor progress
1073522|NCT02708563|meconium|meconium
1073523|NCT02708563|neonatal resuscitation|neonatal resuscitation
1073524|NCT02708498|Palliative care|palliative care
1073525|NCT02708498|Frail elderly|frail elderly
1073526|NCT02708498|Comorbidity|comorbidity
1073527|NCT02708498|Staff Development|staff development
1073528|NCT02708498|Nursing Homes|nursing homes
1073529|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
1073530|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
1073531|NCT02708472|Anxiety|anxiety
1073532|NCT02708472|Neurostimulation|neurostimulation
1073534|NCT02708446|Second Trimester|second trimester
1073535|NCT02708446|Abortion|abortion
1073536|NCT02708446|Misoprostol|misoprostol
1073537|NCT02708446|Sublingual|sublingual
1073538|NCT02708446|Buccal|buccal
1073539|NCT02708433|lidocaine, jaw|lidocaine, jaw
1073540|NCT02708420|Glidescope|glidescope
1073541|NCT02708420|Cardiovascular surgery|cardiovascular surgery
1073542|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
1073543|NCT02708420|Hemodynamic response|hemodynamic response
1073544|NCT02708420|Anesthesia|anesthesia
1073545|NCT02708381|Population 70 years and older|population 70 years and older
1073546|NCT02708381|Geriatric|geriatric
1073547|NCT02708381|Oncogeriatric|oncogeriatric
1073548|NCT02708381|Senior adult|senior adult
1073549|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
1073550|NCT02708329|Coronary stenosis|coronary stenosis
1073551|NCT02708329|Drug-eluting stent|drug-eluting stent
1073552|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
1073553|NCT02708329|Ischemic Heart Disease|ischemic heart disease
1073554|NCT02708329|Chronic total occlusion|chronic total occlusion
1073555|NCT02708329|Bifurcational lesion|bifurcational lesion
1073556|NCT02708329|Bifurcational stenting|bifurcational stenting
1073557|NCT02708303|Esophageal Reflux|esophageal reflux
1073558|NCT02708303|Gastric Acid Reflux|gastric acid reflux
1073559|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
1073560|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
1073561|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
1073562|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1073563|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
1073564|NCT02708303|Esophageal Hernia|esophageal hernia
1073565|NCT02708303|Hernia, Esophageal|hernia, esophageal
1073566|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
1073567|NCT02708303|Hiatal Hernia|hiatal hernia
1073568|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
1073569|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
1073570|NCT02708303|Hernia, Hiatus|hernia, hiatus
1073571|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
1073572|NCT02708303|Questionnaires|questionnaires
1073573|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
1073574|NCT02708277|intrauterine balloon|intrauterine balloon
1073575|NCT02708238|Infantile colics|infantile colics
1073576|NCT02708199|Drug resistance malaria|drug resistance malaria
1073577|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
1073578|NCT02708199|Asymptomatic malaria|asymptomatic malaria
1073579|NCT02708199|Serology|serology
1073580|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
1115389|NCT02460731|PSP|psp
1073581|NCT02708186|Lewy bodies|lewy bodies
1073582|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
1073883|NCT02706145|media|media
1073583|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
1073584|NCT02708173|vaccine|vaccine
1073585|NCT02708173|safety|safety
1073586|NCT02708134|Chest compressions|chest compressions
1073587|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1073588|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
1073589|NCT02708056|Sugammadex|sugammadex
1073590|NCT02708056|Rocuronium|rocuronium
1073591|NCT02708056|Infant patients|infant patients
1073592|NCT02708017|Subcostal TAP block|subcostal tap block
1073593|NCT02708017|Posterior TAP block|posterior tap block
1073594|NCT02708017|Ultrasound|ultrasound
1073595|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1073596|NCT02707991|Continuity of Patient Care|continuity of patient care
1073597|NCT02707991|Treatment Cascade|treatment cascade
1073598|NCT02707978|Dementia|dementia
1073599|NCT02707978|Brain Diseases|brain diseases
1073600|NCT02707978|Central Nervous System Diseases|central nervous system diseases
1073601|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
1073602|NCT02707978|tauopathies|tauopathies
1073603|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
1073604|NCT02707965|Generic brittle|generic brittle
1073605|NCT02707965|Anti-epileptic drug|anti-epileptic drug
1073606|NCT02707965|Bioequivalence|bioequivalence
1073607|NCT02707952|Compensated cirrhosis|compensated cirrhosis
1073608|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
1073609|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
1073610|NCT02707952|Non-cirrhotic|non-cirrhotic
1073611|NCT02707952|Hepatitis C virus|hepatitis c virus
1073612|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
1073613|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
1073614|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
1073615|NCT02707952|Renal impairment|renal impairment
1073616|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
1073617|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
1073618|NCT02707900|Vorinostat|vorinostat
1073619|NCT02707900|AGS-004|ags-004
1073620|NCT02707900|HIV virus|hiv virus
1073621|NCT02707900|AIDS|aids
1073622|NCT02707887|Mental Disorders|mental disorders
1073623|NCT02707887|Mood Disorders|mood disorders
1073624|NCT02707887|Behavioral Activation|behavioral activation
1073625|NCT02707861|HIV|hiv
1073626|NCT02707861|Resistant|resistant
1073627|NCT02707861|Salvage|salvage
1073628|NCT02707861|ibalizumab|ibalizumab
1073629|NCT02707861|antibody|antibody
1073630|NCT02707861|AIDS|aids
1073631|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
1073632|NCT02707822|tacrolimus|tacrolimus
1073633|NCT02707822|pharmacokinetics|pharmacokinetics
1073634|NCT02707822|gene polymorphism|gene polymorphism
1073635|NCT02707822|clinical factors|clinical factors
1073636|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
1073637|NCT02707783|stable and unstable angina|stable and unstable angina
1073638|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1073639|NCT02707783|BVS|bvs
1073640|NCT02707783|PCI|pci
1073641|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
1073642|NCT02707757|Haemodialysis|haemodialysis
1073643|NCT02707757|Anaemia|anaemia
1073644|NCT02707757|Iron|iron
1073645|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
1073646|NCT02707744|Heart Failure|heart failure
1073647|NCT02707744|Atrial Fibrillation|atrial fibrillation
1073648|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
1073649|NCT02707718|sepsis|sepsis
1073650|NCT02707718|biomarker|biomarker
1073651|NCT02707718|prognostic|prognostic
1073652|NCT02707718|emergency department|emergency department
1073653|NCT02707718|diagnosis|diagnosis
1073654|NCT02707692|HIV|hiv
1073655|NCT02707692|AIDS|aids
1073656|NCT02707692|Immune Stimulation|immune stimulation
1073657|NCT02707692|HIV Reservoir|hiv reservoir
1073658|NCT02707679|Knee|knee
1073659|NCT02707679|Mobilization|mobilization
1073660|NCT02707679|Taping|taping
1073661|NCT02707679|Function|function
1073662|NCT02707679|Balance|balance
1073663|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
1073664|NCT02707666|Pembrolizumab|pembrolizumab
1073665|NCT02707627|Pediatric|pediatric
1073666|NCT02707627|Laser|laser
1073667|NCT02707627|Burn|burn
1073668|NCT02707627|Scar|scar
1073669|NCT02707627|Photothermolysis|photothermolysis
1073670|NCT02707601|HIV|hiv
1073671|NCT02707601|HCV|hcv
1073672|NCT02707601|Antiretroviral therapy|antiretroviral therapy
1073673|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
1073674|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
1073675|NCT02707575|Keratin|keratin
1073676|NCT02707575|Ranibizumab|ranibizumab
1073677|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
1073678|NCT02707562|GLPG1837|glpg1837
1073679|NCT02707549|crystalloid solutions|crystalloid solutions
1073680|NCT02707549|acid-base imbalance|acid-base imbalance
1073681|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
1073682|NCT02707523|RSV|rsv
1074484|NCT02702479|Fasting|fasting
1073683|NCT02707523|respiratory support|respiratory support
1073684|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
1073685|NCT02707510|logotherapy|logotherapy
1073686|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
1073687|NCT02707510|metastatic breast cancer|metastatic breast cancer
1073688|NCT02707497|sepsis|sepsis
1073689|NCT02707497|thrombocytopenia|thrombocytopenia
1073690|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
1073691|NCT02707497|platelet|platelet
1073692|NCT02707497|28-day mortality|28-day mortality
1073693|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
1073694|NCT02707484|thalidomide|thalidomide
1073695|NCT02707484|Small intestinal bleeding|small intestinal bleeding
1073696|NCT02707458|apolipoprotein E|apolipoprotein e
1073697|NCT02707458|Alzheimer|alzheimer
1073698|NCT02707458|pre-clinical|pre-clinical
1073699|NCT02707458|pre-symptomatic|pre-symptomatic
1073700|NCT02707458|dose-finding|dose-finding
1073701|NCT02707458|prevention|prevention
1073702|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
1073703|NCT02707432|Community-Based Participatory Research|community-based participatory research
1073704|NCT02707432|African Americans|african americans
1073705|NCT02707419|Total knee replacement|total knee replacement
1073706|NCT02707419|Action observation treatment|action observation treatment
1073707|NCT02707419|Rehabilitation|rehabilitation
1073708|NCT02707393|stem cell transplantation|stem cell transplantation
1073709|NCT02707393|pediatrics|pediatrics
1073710|NCT02707354|GVHD|gvhd
1073711|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
1073712|NCT02707341|psoriasis|psoriasis
1073713|NCT02707341|disease registry|disease registry
1073714|NCT02707328|Gemcitabine|gemcitabine
1073715|NCT02707328|Gemzar|gemzar
1073716|NCT02707328|CyberKnife|cyberknife
1073717|NCT02707328|Cyber knife|cyber knife
1073718|NCT02707328|CK|ck
1073719|NCT02707328|abraxane|abraxane
1073720|NCT02707328|nab-paclitaxel|nab-paclitaxel
1073721|NCT02707315|Cyber Knife|cyber knife
1073722|NCT02707315|CyberKnife|cyberknife
1073723|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
1073724|NCT02707315|CK|ck
1073725|NCT02707276|Bipolar Depression|bipolar depression
1073726|NCT02707276|Geriatric|geriatric
1073727|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
1073728|NCT02707263|heparin|heparin
1073729|NCT02707250|pethidine|pethidine
1073730|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1073731|NCT02707250|bupivacaine|bupivacaine
1073732|NCT02707224|DP-R208|dp-r208
1073733|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
1073734|NCT02707172|Hand hygiene|hand hygiene
1073735|NCT02707172|Soaps|soaps
1073736|NCT02707172|N-of-1 design|n-of-1 design
1073737|NCT02707172|Cross-Over Studies|cross-over studies
1073738|NCT02707159|Circulating tumor cells|circulating tumor cells
1073739|NCT02707159|Nab-paclitaxel|nab-paclitaxel
1073740|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
1073741|NCT02707159|Gemcitabine|gemcitabine
1073742|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
1073743|NCT02707094|back|back
1073744|NCT02707094|pain|pain
1073745|NCT02707094|chronic|chronic
1073746|NCT02707068|Quality of Life|quality of life
1073747|NCT02707068|Self-help intervention|self-help intervention
1073748|NCT02707055|Alcohol Consumption|alcohol consumption
1073749|NCT02707055|Alcohol Treatment|alcohol treatment
1073750|NCT02707055|Alcoholism|alcoholism
1073751|NCT02707055|Ghrelin|ghrelin
1073752|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
1073753|NCT02707042|Microbiome|microbiome
1073754|NCT02707042|Amoxicillin|amoxicillin
1073755|NCT02707042|Azithromycin|azithromycin
1073756|NCT02707042|Metagenome|metagenome
1073757|NCT02707042|Metabolic|metabolic
1073758|NCT02707029|Screening Protocol|screening protocol
1073759|NCT02707029|Pain|pain
1073760|NCT02707029|Phenotypes|phenotypes
1073761|NCT02707016|Emergence delirium|emergence delirium
1073762|NCT02707016|Sevoflurane|sevoflurane
1073763|NCT02707016|Pediatric anesthesia|pediatric anesthesia
1073764|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
1073765|NCT02706977|Ophthalmology|ophthalmology
1073766|NCT02706964|metastasis|metastasis
1073767|NCT02706964|3D imaging|3d imaging
1073768|NCT02706964|early detection|early detection
1073769|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
1073770|NCT02706951|Arthritis|arthritis
1073771|NCT02706951|Joint Disease|joint disease
1073772|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
1073773|NCT02706951|antirheumatic agents|antirheumatic agents
1073774|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
1073775|NCT02706938|Head of bed elevation|head of bed elevation
1073776|NCT02706938|Quality of life|quality of life
1073777|NCT02706938|Nocturnal symptoms|nocturnal symptoms
1073778|NCT02706938|Lifestyle measures|lifestyle measures
1073779|NCT02706912|Stroke|stroke
1073780|NCT02706912|Hemiparesis|hemiparesis
1073781|NCT02706912|Activities of Daily Living|activities of daily living
1073782|NCT02706912|Virtual World|virtual world
1073783|NCT02706912|Occupational Therapy|occupational therapy
1073792|NCT02706873|Joint disease|joint disease
1073793|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
1073794|NCT02706873|Antirheumatic agents|antirheumatic agents
1073795|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
1073796|NCT02706847|Arthritis|arthritis
1073797|NCT02706847|Joint Disease|joint disease
1073798|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
1073799|NCT02706847|Antirheumatic agents|antirheumatic agents
1073800|NCT02706834|Drug therapy|drug therapy
1073801|NCT02706821|prediabetes|prediabetes
1073802|NCT02706821|blood glucose|blood glucose
1073803|NCT02706821|clinical trial|clinical trial
1073804|NCT02706808|chronic kidney disease|chronic kidney disease
1073805|NCT02706808|hemodialysis|hemodialysis
1073806|NCT02706808|conservative treatment|conservative treatment
1073807|NCT02706808|resistance starch|resistance starch
1073808|NCT02706795|Cervical dystonia|cervical dystonia
1073809|NCT02706795|Spasmodic torticollis|spasmodic torticollis
1073810|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
1073811|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
1073812|NCT02706678|FK506|fk506
1073813|NCT02706678|Renal transplant recipients|renal transplant recipients
1073814|NCT02706678|cyclosporin|cyclosporin
1073815|NCT02706665|Anesthetics|anesthetics
1073816|NCT02706665|Propofol|propofol
1073817|NCT02706665|Electroencephalography|electroencephalography
1073818|NCT02706665|SEDline monitor|sedline monitor
1073819|NCT02706652|Screening|screening
1073820|NCT02706652|Genotype|genotype
1073821|NCT02706652|Drug Dosing|drug dosing
1073822|NCT02706652|Trial Selection|trial selection
1073823|NCT02706639|Biospecimen Procurement|biospecimen procurement
1073824|NCT02706639|Laboratory Research Specimens|laboratory research specimens
1073825|NCT02706639|Sample Collection|sample collection
1073826|NCT02706639|Rare Diseases|rare diseases
1073827|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
1073828|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1073829|NCT02706574|Eye Tracking|eye tracking
1073830|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
1073831|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
1073832|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
1073833|NCT02706574|Computed Tomography Scan|computed tomography scan
1073834|NCT02706574|Outcome Measures|outcome measures
1073835|NCT02706561|15-317|15-317
1073836|NCT02706548|occupational therapy|occupational therapy
1073837|NCT02706548|medication adherence|medication adherence
1073838|NCT02706548|intervention studies|intervention studies
1073839|NCT02706535|Itraconazole|itraconazole
1073840|NCT02706535|Rifampicin|rifampicin
1073841|NCT02706535|Pharmacokinetics|pharmacokinetics
1073842|NCT02706535|Cross-over|cross-over
1073843|NCT02706496|aging of elderly|aging of elderly
1073844|NCT02706496|falling prevention|falling prevention
1073845|NCT02706496|electroencephalography|electroencephalography
1073846|NCT02706496|postural control|postural control
1073847|NCT02706496|biomechanics|biomechanics
1073848|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
1073849|NCT02706457|intensive care|intensive care
1073850|NCT02706457|functionality|functionality
1073851|NCT02706405|PD-L1|pd-l1
1073852|NCT02706405|immunotherapy|immunotherapy
1073853|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
1073861|NCT02706327|orthotic insoles|orthotic insoles
1073862|NCT02706327|pain|pain
1073863|NCT02706327|quality of life|quality of life
1073864|NCT02706327|athletic performance|athletic performance
1073865|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
1073866|NCT02706301|cancer pain|cancer pain
1073867|NCT02706301|psychological distress|psychological distress
1073868|NCT02706301|coping skills training|coping skills training
1073869|NCT02706301|symptom management|symptom management
1073870|NCT02706301|cancer survivorship|cancer survivorship
1073871|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
1073872|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
1073873|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
1073874|NCT02706197|Hypoxia|hypoxia
1073875|NCT02706197|OxyChip|oxychip
1073876|NCT02706184|gastric cancer|gastric cancer
1073877|NCT02706184|colorectal cancer|colorectal cancer
1073878|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
1073879|NCT02706184|5-Fluoruracil|5-fluoruracil
1073880|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
1073881|NCT02706145|social norms|social norms
1073882|NCT02706145|youth violence|youth violence
1073889|NCT02706119|insulin|insulin
1073890|NCT02706080|Antithrombotic agents|antithrombotic agents
1073891|NCT02706080|VKA|vka
1073892|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
1073893|NCT02706080|Antiplatelet|antiplatelet
1073894|NCT02706080|Bleeding|bleeding
1073895|NCT02706080|Emergency|emergency
1073896|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
1073897|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
1073898|NCT02706041|Definitive|definitive
1073899|NCT02706028|underwater ultrasound|underwater ultrasound
1073900|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
1073901|NCT02706015|Headache|headache
1073903|NCT02706015|Migraine|migraine
1073904|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
1073905|NCT02705898|alcohol use disorders|alcohol use disorders
1073906|NCT02705898|physical activity|physical activity
1073907|NCT02705898|women's health|women's health
1073908|NCT02705885|IgY|igy
1073909|NCT02705885|Periodontitis|periodontitis
1073910|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
1073911|NCT02705885|gingipains|gingipains
1073912|NCT02705885|Efficacy|efficacy
1073913|NCT02705872|Epidural|epidural
1073914|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
1073915|NCT02705872|Cesarian section|cesarian section
1073916|NCT02705872|Instrumented delivery|instrumented delivery
1073917|NCT02705846|BRCA1|brca1
1073918|NCT02705846|BRCA2|brca2
1073919|NCT02705846|Lynch Syndrome|lynch syndrome
1073920|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
1073921|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1073922|NCT02705807|safety|safety
1073923|NCT02705807|FLOLAN|flolan
1073924|NCT02705807|New Thermostable Formulation|new thermostable formulation
1073925|NCT02705807|dose adjustment|dose adjustment
1073926|NCT02705807|reformulated diluents|reformulated diluents
1073927|NCT02705807|currently marketed diluent|currently marketed diluent
1073928|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
1073929|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
1073930|NCT02705768|Carbamazepine|carbamazepine
1073931|NCT02705768|Oxcarbazepine|oxcarbazepine
1073932|NCT02705755|Neurogenic Orthostatic Hypotension (nOH)|neurogenic orthostatic hypotension (noh)
1073933|NCT02705755|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
1073934|NCT02705755|Pure Autonomic Failure|pure autonomic failure
1073935|NCT02705755|Parkinson Disease(PD)|parkinson disease(pd)
1073936|NCT02705755|nOH|noh
1073937|NCT02705755|MSA|msa
1073938|NCT02705755|PD|pd
1073939|NCT02705755|PAF|paf
1073940|NCT02705755|Orthostatic Hypotension|orthostatic hypotension
1073941|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
1073942|NCT02705742|Liver cirrhosis|liver cirrhosis
1073943|NCT02705742|Hepatitis C|hepatitis c
1073944|NCT02705729|dental caries|dental caries
1073945|NCT02705729|proximal surfaces|proximal surfaces
1073946|NCT02705729|posterior teeth|posterior teeth
1073947|NCT02705729|carious lesions|carious lesions
1073948|NCT02705729|tooth diseases|tooth diseases
1073949|NCT02705729|dental restorations|dental restorations
1073950|NCT02705729|glass-ionomer|glass-ionomer
1073951|NCT02705664|Onychomycosis|onychomycosis
1073952|NCT02705612|Cervical cancer|cervical cancer
1073953|NCT02705612|cisplatin|cisplatin
1073954|NCT02705612|nimotuzumab|nimotuzumab
1073955|NCT02705599|Ischemic stroke|ischemic stroke
1073956|NCT02705599|High resolution MRI|high resolution mri
1073957|NCT02705599|Perfusion|perfusion
1073958|NCT02705599|Mechanism|mechanism
1073959|NCT02705586|Movement disorders|movement disorders
1073960|NCT02705586|Metabolic Stress|metabolic stress
1073961|NCT02705547|Friedreich Ataxia|friedreich ataxia
1073962|NCT02705534|Hepatitis C|hepatitis c
1073963|NCT02705534|Cirrhosis|cirrhosis
1073964|NCT02705534|Sofosbuvir|sofosbuvir
1073965|NCT02705534|Ledipasvir|ledipasvir
1073966|NCT02705534|Ribavirin|ribavirin
1073967|NCT02705521|shoulder|shoulder
1073968|NCT02705521|impingement|impingement
1073969|NCT02705521|rehabilitation|rehabilitation
1073970|NCT02705521|physiotherapy|physiotherapy
1073971|NCT02705521|gamification|gamification
1073972|NCT02705521|activation|activation
1073973|NCT02705521|engagement|engagement
1073974|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
1073975|NCT02705508|nasal type|nasal type
1073976|NCT02705508|chemotherapy|chemotherapy
1073977|NCT02705508|radiotherapy|radiotherapy
1073988|NCT02705469|Phase 1|phase 1
1073989|NCT02705469|Prostate Cancer|prostate cancer
1073990|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
1073991|NCT02705469|ZEN003694|zen003694
1073992|NCT02705469|ZEN-3694|zen-3694
1073993|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
1073994|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
1073995|NCT02705469|Bromodomain|bromodomain
1073996|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
1073997|NCT02705469|Epigenetics|epigenetics
1073998|NCT02705456|Dental Caries|dental caries
1073999|NCT02705456|Tooth Paste|tooth paste
1074000|NCT02705456|Orthodontics|orthodontics
1074001|NCT02705456|Fluorides|fluorides
1074002|NCT02705417|arteriovenous fistula|arteriovenous fistula
1074003|NCT02705417|colour Doppler|colour doppler
1074004|NCT02705417|physical examination|physical examination
1074005|NCT02705417|renal dialysis|renal dialysis
1074006|NCT02705417|retrospective studies|retrospective studies
1074007|NCT02705404|multifocal|multifocal
1074008|NCT02705404|genetic|genetic
1074009|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
1074010|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
1074011|NCT02705404|ground glass opacity|ground glass opacity
1074012|NCT02705404|next generation sequencing|next generation sequencing
1074013|NCT02705378|Intensive care unit|intensive care unit
1074015|NCT02705378|Critical Illness|critical illness
1074016|NCT02705378|Constipation|constipation
1074017|NCT02705365|Lung Screening|lung screening
1074018|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
1074019|NCT02705365|Patient Navigation|patient navigation
1074020|NCT02705352|Skin graft|skin graft
1074021|NCT02705352|5-Fluorouracil|5-fluorouracil
1074022|NCT02705352|Periocular reconstruction|periocular reconstruction
1074023|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
1074024|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
1074025|NCT02705313|PRRT|prrt
1074026|NCT02705287|vitamin D|vitamin d
1074027|NCT02705287|half life|half life
1074028|NCT02705287|kinetics|kinetics
1074029|NCT02705261|child|child
1074030|NCT02705261|behavior therapy|behavior therapy
1074031|NCT02705261|cognitive therapy|cognitive therapy
1074032|NCT02705261|parent|parent
1074033|NCT02705261|anxiety|anxiety
1074034|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
1074035|NCT02705222|Dilatation and curettage|dilatation and curettage
1074036|NCT02705222|Hysteroscopy|hysteroscopy
1074037|NCT02705196|oncolytic|oncolytic
1074038|NCT02705196|adenovirus|adenovirus
1074039|NCT02705196|pancreatic|pancreatic
1074040|NCT02705196|cancer|cancer
1074041|NCT02705196|LOKON|lokon
1074042|NCT02705196|LOAd703|load703
1074043|NCT02705183|surgical treatment|surgical treatment
1074044|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
1074045|NCT02705183|quality of life|quality of life
1074046|NCT02705183|complications|complications
1074047|NCT02705183|survival|survival
1074048|NCT02705183|long bones|long bones
1074049|NCT02705170|index of microvascular resistance|index of microvascular resistance
1074050|NCT02705157|long bones|long bones
1074051|NCT02705157|survival|survival
1074052|NCT02705157|prognosis|prognosis
1074053|NCT02705157|treatment|treatment
1074054|NCT02705157|quality of life|quality of life
1074055|NCT02705131|Cervical radiculopathy|cervical radiculopathy
1074056|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
1074057|NCT02705118|radiofrequency ablation|radiofrequency ablation
1074058|NCT02705118|image fusion|image fusion
1074059|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
1074060|NCT02705105|Advanced Solid Tumors|advanced solid tumors
1074061|NCT02705105|KW-0761|kw-0761
1074062|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
1074063|NCT02705105|Anti-tumor|anti-tumor
1074064|NCT02705105|Mogamulizumab|mogamulizumab
1074065|NCT02705105|Nivolumab|nivolumab
1074066|NCT02705105|Oncology|oncology
1074067|NCT02705105|HCC|hcc
1074068|NCT02705105|Hepatocellular carcinoma|hepatocellular carcinoma
1074069|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1074070|NCT02705053|Artificial Pancreas|artificial pancreas
1074071|NCT02705053|Autoimmune Diseases|autoimmune diseases
1074072|NCT02705053|Diabetes Mellitus|diabetes mellitus
1074073|NCT02705053|Hyperglycemia|hyperglycemia
1074074|NCT02705053|Hypoglycemia|hypoglycemia
1074075|NCT02705040|male osteoporosis|male osteoporosis
1074076|NCT02705040|miRNA|mirna
1074077|NCT02705040|biomarker|biomarker
1074078|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
1074079|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
1074080|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1074081|NCT02705014|hypopituitarism|hypopituitarism
1074082|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
1074083|NCT02704962|schizophrenia|schizophrenia
1074084|NCT02704962|olanzapine|olanzapine
1074085|NCT02704962|trifluoperazine|trifluoperazine
1074090|NCT02704949|Ureteroscopy|ureteroscopy
1074091|NCT02704923|Atropine|atropine
1074092|NCT02704923|Pneumonia|pneumonia
1074093|NCT02704923|Ventilator|ventilator
1074094|NCT02704923|Adults|adults
1074095|NCT02704923|Intensive care unit.|intensive care unit.
1074096|NCT02704871|SeptiCyte|septicyte
1074097|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
1074098|NCT02704858|recurrent GBM|recurrent gbm
1074099|NCT02704845|Inflammatory back pain|inflammatory back pain
1074100|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
1074101|NCT02704845|Non-specific low back pain|non-specific low back pain
1074102|NCT02704845|Pain experience|pain experience
1074103|NCT02704845|Disability|disability
1074104|NCT02704845|Behavioural|behavioural
1074105|NCT02704845|Psychological|psychological
1074106|NCT02704845|Biopsychosocial|biopsychosocial
1074107|NCT02704845|Pain profiles|pain profiles
1074108|NCT02704832|Geriatric oncology|geriatric oncology
1074109|NCT02704832|Intervention|intervention
1074110|NCT02704832|Case management|case management
1074111|NCT02704819|Decision Support System|decision support system
1074112|NCT02704819|Dizziness|dizziness
1074113|NCT02704819|Vertigo|vertigo
1074114|NCT02704819|Balance|balance
1074115|NCT02704780|Retained placenta|retained placenta
1074116|NCT02704780|Misoprostol|misoprostol
1074117|NCT02704780|double blind|double blind
1074118|NCT02704780|Randomization|randomization
1074119|NCT02704780|Haemorrhage|haemorrhage
1074120|NCT02704715|postoperative pain|postoperative pain
1074121|NCT02704715|general anesthesia|general anesthesia
1074124|NCT02704676|Pre-Eclampsia|pre-eclampsia
1074125|NCT02704663|adnexal mass|adnexal mass
1074126|NCT02704663|laparoscopy|laparoscopy
1074127|NCT02704663|removal route|removal route
1074128|NCT02704663|postoperative pain|postoperative pain
1074129|NCT02704637|vasospasm|vasospasm
1074135|NCT02704585|Neonatal resuscitation|neonatal resuscitation
1074136|NCT02704585|Pulse oximetry|pulse oximetry
1074137|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
1074138|NCT02704572|cell-mediated immunity|cell-mediated immunity
1074139|NCT02704533|Plasmodium falciparum|plasmodium falciparum
1074140|NCT02704533|PfSPZ Vaccine|pfspz vaccine
1074141|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
1074142|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
1074143|NCT02704533|CHMI|chmi
1074144|NCT02704520|Rectal Cancer|rectal cancer
1074145|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
1074146|NCT02704520|Chemoradiotherapy|chemoradiotherapy
1074147|NCT02704520|Chemotherapy|chemotherapy
1074148|NCT02704520|Diagnostic Imaging|diagnostic imaging
1074149|NCT02704507|tretinoin|tretinoin
1074150|NCT02704507|topical steroid|topical steroid
1074151|NCT02704507|irritation|irritation
1074152|NCT02704507|retinoid induced irritation|retinoid induced irritation
1074153|NCT02704494|Resveratrol|resveratrol
1074154|NCT02704494|Diabetes mellitus|diabetes mellitus
1074155|NCT02704494|Diabetes complications|diabetes complications
1074156|NCT02704494|Diabetic nephropathies|diabetic nephropathies
1074157|NCT02704494|Proteinuria|proteinuria
1074158|NCT02704494|Albuminuria|albuminuria
1074159|NCT02704494|renal insufficiency|renal insufficiency
1074160|NCT02704481|mifepristone|mifepristone
1074161|NCT02704481|misoprostol|misoprostol
1074162|NCT02704481|medical abortion|medical abortion
1074163|NCT02704468|CAVI|cavi
1074164|NCT02704468|FGF-21|fgf-21
1074165|NCT02704468|arterial stiffness|arterial stiffness
1074166|NCT02704468|renal transplant|renal transplant
1074167|NCT02704455|children|children
1074168|NCT02704442|anesthesiology|anesthesiology
1074169|NCT02704442|ophthalmology|ophthalmology
1074170|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
1074171|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
1074172|NCT02704416|cardiac death|cardiac death
1074173|NCT02704403|Elafibranor|elafibranor
1074174|NCT02704403|NASH|nash
1074175|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1074176|NCT02704403|Fatty liver disease|fatty liver disease
1074177|NCT02704403|Fibrosis|fibrosis
1074178|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
1074179|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
1074180|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
1074181|NCT02704325|DMD|dmd
1074182|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1074183|NCT02704273|MTM|mtm
1074184|NCT02704273|XLMTM|xlmtm
1074185|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
1074186|NCT02704208|Medication Adherence|medication adherence
1074187|NCT02704208|Technology-based Intervention|technology-based intervention
1074188|NCT02704195|Parkinson disease|parkinson disease
1074189|NCT02704195|Deep brain stimulation|deep brain stimulation
1074190|NCT02704195|Freezing of Gait|freezing of gait
1074191|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
1074192|NCT02704169|head and neck cancer|head and neck cancer
1074193|NCT02704169|H&N cancer|h&n cancer
1074194|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
1074195|NCT02704156|CyberKnife|cyberknife
1074196|NCT02704156|Initial treatment|initial treatment
1074197|NCT02704130|Therapeutic Embolization|therapeutic embolization
1074198|NCT02704130|Ablation Techniques|ablation techniques
1074199|NCT02704130|Transarterial Embolization|transarterial embolization
1074200|NCT02704130|TAE|tae
1074201|NCT02704130|Microwave Ablation|microwave ablation
1074202|NCT02704130|MWA|mwa
1074203|NCT02704065|amyloidosis|amyloidosis
1074204|NCT02704065|renal transplantation|renal transplantation
1074205|NCT02704026|Body composition|body composition
1074206|NCT02704026|Nutritional status|nutritional status
1074207|NCT02704013|Neurotrophins|neurotrophins
1074208|NCT02704013|Nerve Growth Factor|nerve growth factor
1074209|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1074210|NCT02704013|Urinary Biomarkers|urinary biomarkers
1074211|NCT02704013|Urodynamics|urodynamics
1074212|NCT02704013|Anticholinergics|anticholinergics
1074213|NCT02704013|Children|children
1074214|NCT02703961|CCRT|ccrt
1074215|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
1074216|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
1074217|NCT02703909|morbid obesity|morbid obesity
1074218|NCT02703909|laparoscopic surgery|laparoscopic surgery
1074219|NCT02703909|neuromuscular blockade|neuromuscular blockade
1074220|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
1074221|NCT02703831|adult spine deformity|adult spine deformity
1074222|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
1074223|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
1074224|NCT02703805|Community program|community program
1074225|NCT02703805|Wellness|wellness
1074226|NCT02703805|Exercise|exercise
1074227|NCT02703805|Physical Activity|physical activity
1074228|NCT02703805|Education|education
1074229|NCT02703805|Stroke|stroke
1074230|NCT02703805|Self-management|self-management
1074231|NCT02703779|Multiple Myeloma|multiple myeloma
1074232|NCT02703779|Bortezomib|bortezomib
1074233|NCT02703779|Autologous|autologous
1074234|NCT02703779|Stem Cell|stem cell
1074235|NCT02703779|Purging|purging
1074236|NCT02703779|In-vivo purging|in-vivo purging
1074237|NCT02703779|Ex-vivo purging|ex-vivo purging
1074238|NCT02703779|Leukapheresis|leukapheresis
1074239|NCT02703779|Contaminated|contaminated
1074240|NCT02703779|Stem Cell Harvest|stem cell harvest
1074241|NCT02703779|Stem Cell Transplant|stem cell transplant
1074242|NCT02703779|Transplantation|transplantation
1074243|NCT02703727|polypharmacy|polypharmacy
1074244|NCT02703727|polymedication check|polymedication check
1074245|NCT02703727|anticoagulation treatment|anticoagulation treatment
1074246|NCT02703714|Advanced|advanced
1074247|NCT02703714|Locally-advanced|locally-advanced
1074248|NCT02703714|Not eligible for resection|not eligible for resection
1074249|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
1074250|NCT02703701|Patient Satisfaction|patient satisfaction
1074251|NCT02703701|Emergency Department efficiency|emergency department efficiency
1074252|NCT02703662|Biologic mesh|biologic mesh
1074253|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
1074254|NCT02703649|Aromatase inhibitor|aromatase inhibitor
1074255|NCT02703649|induction of ovulation|induction of ovulation
1074256|NCT02703636|Alzheimer's disease|alzheimer's disease
1074257|NCT02703623|Prostate cancer|prostate cancer
1074258|NCT02703623|Metastatic castration-resistant prostate cancer to the bone|metastatic castration-resistant prostate cancer to the bone
1074259|NCT02703623|mCRPC|mcrpc
1074260|NCT02703623|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1074261|NCT02703623|Biomarkers|biomarkers
1074262|NCT02703623|Abiraterone Acetate|abiraterone acetate
1074263|NCT02703623|Zytiga|zytiga
1074264|NCT02703623|Prednisone|prednisone
1074265|NCT02703623|ARN509|arn509
1074266|NCT02703623|Ipilimumab|ipilimumab
1074267|NCT02703623|Yervoy|yervoy
1074268|NCT02703623|BMS-734016|bms-734016
1074269|NCT02703623|MDX010|mdx010
1074270|NCT02703623|Cabazitaxel|cabazitaxel
1074271|NCT02703623|Jevtana|jevtana
1074272|NCT02703623|Carboplatin|carboplatin
1074273|NCT02703623|Paraplatin|paraplatin
1074274|NCT02703610|Pain|pain
1074275|NCT02703610|Elderly|elderly
1074276|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
1074277|NCT02703597|Smoking curiosity|smoking curiosity
1074278|NCT02703597|Smoking Cessation|smoking cessation
1074279|NCT02703597|Smoking Prevention|smoking prevention
1074280|NCT02703597|Health improvement|health improvement
1074406|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
1074281|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
1074282|NCT02703597|ASPIRE|aspire
1074283|NCT02703597|Game-based social activities|game-based social activities
1074284|NCT02703597|GSA's|gsa's
1074285|NCT02703597|Surveys|surveys
1074286|NCT02703597|Questionnaires|questionnaires
1074287|NCT02703597|Interviews|interviews
1074292|NCT02703571|TMT212|tmt212
1074293|NCT02703571|advanced solid tumors|advanced solid tumors
1074294|NCT02703571|pancreatic cancer|pancreatic cancer
1074295|NCT02703571|KRAS-mutant colorectal cancer|kras-mutant colorectal cancer
1074296|NCT02703571|colorectal cancer|colorectal cancer
1074297|NCT02703571|advanced pancreatic cancer|advanced pancreatic cancer
1074298|NCT02703571|metastatic pancreatic cancer|metastatic pancreatic cancer
1074299|NCT02703545|familial pancreas cancer|familial pancreas cancer
1074300|NCT02703545|pancreatic cyst|pancreatic cyst
1074301|NCT02703532|Therapy|therapy
1074302|NCT02703532|Rehabilitation|rehabilitation
1074303|NCT02703532|Caregiver|caregiver
1074304|NCT02703519|cesarean section, repeat|cesarean section, repeat
1074305|NCT02703519|uterine scar tissue|uterine scar tissue
1074306|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
1074307|NCT02703519|uterine rupture|uterine rupture
1074308|NCT02703519|placenta accreta|placenta accreta
1074309|NCT02703519|placenta percreta|placenta percreta
1074310|NCT02703519|placenta increta|placenta increta
1074311|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
1074312|NCT02703428|Abdominal|abdominal
1074313|NCT02703428|Aortic|aortic
1074314|NCT02703428|Aneurysm|aneurysm
1074315|NCT02703415|immune|immune
1074316|NCT02703415|interleukin|interleukin
1074317|NCT02703415|tramadol|tramadol
1074318|NCT02703415|postoperartive analgesia|postoperartive analgesia
1074319|NCT02703415|pediatric|pediatric
1074320|NCT02703415|caudal bupivacaine|caudal bupivacaine
1074321|NCT02703402|low back pain|low back pain
1074322|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
1074323|NCT02703389|knowledge translation|knowledge translation
1074324|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
1074325|NCT02703311|Valtech Cardio|valtech cardio
1074326|NCT02703311|Cardioband|cardioband
1074327|NCT02703311|Mitral Valve|mitral valve
1074328|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
1074329|NCT02703298|Safety and Tolerability|safety and tolerability
1074330|NCT02703298|Tumor Response|tumor response
1074331|NCT02703298|Oncology|oncology
1074335|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
1074336|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
1074337|NCT02703220|sleep apnea|sleep apnea
1074338|NCT02703220|chemoresponsiveness|chemoresponsiveness
1074339|NCT02703220|cerebrovascular response|cerebrovascular response
1074340|NCT02703220|hyperoxia|hyperoxia
1074341|NCT02703220|acetazolamide|acetazolamide
1074342|NCT02703220|finasteride|finasteride
1074343|NCT02703220|apneic threshold|apneic threshold
1074344|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
1074345|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
1074346|NCT02703207|COPD|copd
1074347|NCT02703207|Overlap syndrome|overlap syndrome
1074348|NCT02703207|quality of life|quality of life
1074349|NCT02703207|neurocognitive function|neurocognitive function
1074350|NCT02703207|sleepiness|sleepiness
1074351|NCT02703207|elderly|elderly
1074352|NCT02703194|IgG4-related disease|igg4-related disease
1074353|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
1074354|NCT02703194|Mikulicz disease|mikulicz disease
1074355|NCT02703194|Pancreatitis|pancreatitis
1074356|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
1074357|NCT02703194|Lymphadenopathy|lymphadenopathy
1074358|NCT02703181|Safety|safety
1074359|NCT02703181|Dose Escalation|dose escalation
1074360|NCT02703181|Repeat Dosing|repeat dosing
1074361|NCT02703181|Epelsiban|epelsiban
1074362|NCT02703181|Pharmacokinetics|pharmacokinetics
1074363|NCT02703181|Healthy Women Volunteers|healthy women volunteers
1074364|NCT02703181|Tolerability|tolerability
1074365|NCT02703181|Oxytocin|oxytocin
1074366|NCT02703168|Dental implants|dental implants
1074367|NCT02703142|esophagogastrostomy|esophagogastrostomy
1074368|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
1074369|NCT02703142|endoscopy|endoscopy
1074370|NCT02703129|Migraine|migraine
1074371|NCT02703129|Diet quality|diet quality
1074372|NCT02703129|Nutritional intervention|nutritional intervention
1074373|NCT02703129|Severity of disease|severity of disease
1074374|NCT02703129|Depressive symptoms|depressive symptoms
1074375|NCT02703116|HIV|hiv
1074376|NCT02703116|Substance Use|substance use
1074377|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1074378|NCT02703103|chest compression|chest compression
1074379|NCT02703103|adult|adult
1074380|NCT02703103|simulation|simulation
1074381|NCT02703064|Furocyst|furocyst
1074382|NCT02703064|PCOS|pcos
1074383|NCT02703038|cardiogenic shock|cardiogenic shock
1074384|NCT02703038|observatory|observatory
1074385|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
1074386|NCT02702973|Characteristic analysis|characteristic analysis
1074387|NCT02702960|FL-HCC|fl-hcc
1074388|NCT02702960|living donor liver transplant|living donor liver transplant
1074389|NCT02702960|HLA matched first degree relative|hla matched first degree relative
1074390|NCT02702960|Milan Criteria|milan criteria
1074391|NCT02702960|Ephraim Fuchs|ephraim fuchs
1074392|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
1074393|NCT02702960|fibrolamellar|fibrolamellar
1074394|NCT02702960|non-fibrolamellar|non-fibrolamellar
1074395|NCT02702947|BPH|bph
1074396|NCT02702947|Prunus Domestica extract|prunus domestica extract
1074397|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
1074398|NCT02702869|cleft lip|cleft lip
1074399|NCT02702869|cleft palate|cleft palate
1074400|NCT02702869|cleft lip and palate|cleft lip and palate
1074401|NCT02702869|cleft alveolus|cleft alveolus
1074402|NCT02702869|multidisciplinary team|multidisciplinary team
1074403|NCT02702869|interdisciplinary team|interdisciplinary team
1074404|NCT02702856|Prostate Cancer|prostate cancer
1074405|NCT02702856|Gleason Grade|gleason grade
1074407|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
1074408|NCT02702791|Physical activity|physical activity
1074409|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
1074410|NCT02702791|COPD|copd
1074411|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
1074412|NCT02702765|sCD163|scd163
1074413|NCT02702765|liver cirrhosis|liver cirrhosis
1074414|NCT02702765|disease severity|disease severity
1074415|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
1074416|NCT02702713|bioactive|bioactive
1074417|NCT02702713|enriched foods|enriched foods
1074418|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
1074419|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
1074420|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1074421|NCT02702687|Asthma|asthma
1074422|NCT02702687|Childhood Asthma|childhood asthma
1074423|NCT02702687|Bronchial Diseases|bronchial diseases
1074424|NCT02702687|Immune System Diseases|immune system diseases
1074425|NCT02702687|Lung Diseases|lung diseases
1074426|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
1074427|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
1074428|NCT02702687|Peak Flow Meter|peak flow meter
1074429|NCT02702687|Symptom Perception|symptom perception
1074430|NCT02702687|Illness Representation|illness representation
1074431|NCT02702661|Fascia Iliaca Block|fascia iliaca block
1074432|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
1074433|NCT02702661|Hip Arthroscopy|hip arthroscopy
1074434|NCT02702648|healthy subjects|healthy subjects
1074435|NCT02702648|first-in-man|first-in-man
1074436|NCT02702648|safety|safety
1074437|NCT02702622|bananas|bananas
1074438|NCT02702622|biofortified|biofortified
1074439|NCT02702622|carotenoids|carotenoids
1074440|NCT02702622|vitamin A|vitamin a
1074441|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
1074442|NCT02702583|Febrile Neutropenia|febrile neutropenia
1074443|NCT02702583|Solid Tumors|solid tumors
1074444|NCT02702583|Dental Infection|dental infection
1074445|NCT02702583|Oral Infection|oral infection
1074446|NCT02702557|Frail Elderly|frail elderly
1074447|NCT02702557|Elastic Band Exercises|elastic band exercises
1074448|NCT02702557|Unsupervised Exercises|unsupervised exercises
1074449|NCT02702557|Monitoring Technology|monitoring technology
1074450|NCT02702557|Bandcizer|bandcizer
1074451|NCT02702557|Adherence|adherence
1074452|NCT02702557|Feasibility|feasibility
1074453|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
1074454|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
1074455|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
1074456|NCT02702531|gynecologic|gynecologic
1074457|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
1074458|NCT02702505|Pulp|pulp
1074459|NCT02702505|pulpotomies|pulpotomies
1074460|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
1074461|NCT02702492|PAK4|pak4
1074462|NCT02702492|KPT-9274|kpt-9274
1074463|NCT02702492|Karyopharm|karyopharm
1074464|NCT02702492|NHL|nhl
1074465|NCT02702492|solid tumors|solid tumors
1074466|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
1074467|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1074468|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1074469|NCT02702479|Clinical practice guidelines|clinical practice guidelines
1074470|NCT02702479|Clinical trials|clinical trials
1074471|NCT02702479|Dietary sugars|dietary sugars
1074472|NCT02702479|Fructose|fructose
1074473|NCT02702479|High fructose corn syrup|high fructose corn syrup
1074474|NCT02702479|Isocaloric|isocaloric
1074475|NCT02702479|Hypercaloric|hypercaloric
1074476|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
1074477|NCT02702479|Triglycerides|triglycerides
1074478|NCT02702479|Cholesterol|cholesterol
1074479|NCT02702479|Glycemic control|glycemic control
1074480|NCT02702479|Body weight|body weight
1074481|NCT02702479|Uric acid|uric acid
1074482|NCT02702479|Blood pressure|blood pressure
1074483|NCT02702479|Fatty liver|fatty liver
1074485|NCT02702479|Postprandial|postprandial
1074486|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
1074487|NCT02702466|Spa treatment|spa treatment
1074488|NCT02702466|Randomized controlled trials|randomized controlled trials
1074489|NCT02702466|Education|education
1074490|NCT02702466|Self- management|self- management
1074491|NCT02702466|Self-care|self-care
1074492|NCT02702466|Exercise|exercise
1074493|NCT02702466|Non pharmacological treatment|non pharmacological treatment
1074494|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
1074495|NCT02702440|Sugars|sugars
1074496|NCT02702440|Liquid calories|liquid calories
1074497|NCT02702440|Solid calories|solid calories
1074498|NCT02702440|Clinical trials|clinical trials
1074499|NCT02702440|Body weight|body weight
1074500|NCT02702440|Body Mass Index|body mass index
1074501|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
1074502|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
1074503|NCT02702440|Clinical practice guidelines|clinical practice guidelines
1074504|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
1074505|NCT02702414|PD1|pd1
1074506|NCT02702414|PD-1|pd-1
1074507|NCT02702414|PDL1|pdl1
1074508|NCT02702414|PD-L1|pd-l1
1074509|NCT02702401|PD1|pd1
1074510|NCT02702401|PD-1|pd-1
1074511|NCT02702401|PDL1|pdl1
1074512|NCT02702401|PD-L1|pd-l1
1074513|NCT02702388|Lenvatinib|lenvatinib
1074514|NCT02702388|E7080|e7080
1074515|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
1074516|NCT02702388|Lenvima|lenvima
1074517|NCT02702388|Phase 2|phase 2
1074518|NCT02702388|RR-DTC|rr-dtc
1074519|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
1074520|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1074521|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1074522|NCT02702375|Clinical practice guidelines|clinical practice guidelines
1074523|NCT02702375|Prospective cohort studies|prospective cohort studies
1074524|NCT02702375|Dietary sugars|dietary sugars
1074525|NCT02702375|Fructose|fructose
1074526|NCT02702375|Sucrose|sucrose
1074527|NCT02702375|High fructose corn syrup|high fructose corn syrup
1074528|NCT02702375|HFCS|hfcs
1074529|NCT02702375|Cohort studies|cohort studies
1074530|NCT02702375|Prospective studies|prospective studies
1074531|NCT02702375|Diabetes Mellitus|diabetes mellitus
1074532|NCT02702375|Metabolic syndrome|metabolic syndrome
1074533|NCT02702375|Coronary heart disease|coronary heart disease
1074534|NCT02702375|Stroke|stroke
1074535|NCT02702375|Hypertension|hypertension
1074536|NCT02702375|Gout|gout
1074537|NCT02702362|disorders of consciousness|disorders of consciousness
1074538|NCT02702362|minimally conscious state|minimally conscious state
1074539|NCT02702362|traumatic brain injury|traumatic brain injury
1074540|NCT02702362|stroke|stroke
1074541|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
1074542|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
1074543|NCT02702323|pulmonary metastasis|pulmonary metastasis
1074544|NCT02702323|Apatinib|apatinib
1074545|NCT02702323|efficacy|efficacy
1074546|NCT02702323|safety|safety
1074547|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
1074548|NCT02702297|PPROM|pprom
1074549|NCT02702297|PROM|prom
1074550|NCT02702297|fetal membranes|fetal membranes
1074551|NCT02702297|premature rupture|premature rupture
1074552|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
1074553|NCT02702297|amniotic fluid|amniotic fluid
1074554|NCT02702297|amniotic infection|amniotic infection
1074555|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
1074556|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
1074557|NCT02702297|FIRS|firs
1074558|NCT02702284|Advance Directives|advance directives
1074559|NCT02702284|Healthcare power of attorney|healthcare power of attorney
1074560|NCT02702258|mindfulness|mindfulness
1074561|NCT02702258|blood pressure|blood pressure
1074562|NCT02702258|hypertension|hypertension
1074563|NCT02702258|prehypertension|prehypertension
1074564|NCT02702206|Shoulder pain|shoulder pain
1074565|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
1074566|NCT02702206|subacromial bursitis|subacromial bursitis
1074567|NCT02702206|intra-bursa injection|intra-bursa injection
1074568|NCT02702167|brain stimulation|brain stimulation
1074569|NCT02702167|rTMS|rtms
1074570|NCT02702154|brain stimulation|brain stimulation
1074571|NCT02702154|rTMS|rtms
1074572|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
1074573|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
1074574|NCT02702141|CD19|cd19
1074575|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1074576|NCT02702141|DLBCL|dlbcl
1074577|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
1074578|NCT02702128|Bleeding perioperative|bleeding perioperative
1074579|NCT02702128|EXACYL|exacyl
1074580|NCT02702128|Oorthognathism surgery|oorthognathism surgery
1074581|NCT02702128|Hematoma|hematoma
1074582|NCT02702115|gene specific targeted insertion|gene specific targeted insertion
1074583|NCT02702115|Mucopolysaccharidosis I|mucopolysaccharidosis i
1074584|NCT02702115|MPS I|mps i
1074585|NCT02702115|Hurler-Scheie syndrome|hurler-scheie syndrome
1074586|NCT02702115|Hurler|hurler
1074587|NCT02702115|Scheie syndrome|scheie syndrome
1074588|NCT02702115|gene therapy|gene therapy
1074589|NCT02702115|gene editing|gene editing
1074590|NCT02702115|zinc finger|zinc finger
1074591|NCT02702115|SB-318|sb-318
1074592|NCT02702115|rare|rare
1074593|NCT02702115|genetic|genetic
1074594|NCT02702115|DNA|dna
1074595|NCT02702115|Sangamo|sangamo
1074596|NCT02702115|Scheie|scheie
1074597|NCT02702115|Genome editing|genome editing
1074598|NCT02702115|Empowers|empowers
1074599|NCT02702115|Hurler syndrome|hurler syndrome
1074600|NCT02702076|Apomorphine|apomorphine
1074601|NCT02702050|Physiotherapy|physiotherapy
1074602|NCT02702050|Mechanical Stimulation|mechanical stimulation
1074603|NCT02702050|Mastectomy Scar|mastectomy scar
1074604|NCT02702024|efficacy|efficacy
1074605|NCT02702024|double incision technique|double incision technique
1074606|NCT02702024|uterus preserving surgery|uterus preserving surgery
1074607|NCT02701998|Ischemic Stroke|ischemic stroke
1074608|NCT02701998|Transient Ischemic Attack|transient ischemic attack
1074609|NCT02701998|Physical Activity|physical activity
1074610|NCT02701998|Sedentary Behavior|sedentary behavior
1074611|NCT02701998|Lifestyle|lifestyle
1074612|NCT02701998|Behavior|behavior
1074613|NCT02701959|Nitric oxide|nitric oxide
1074614|NCT02701959|Dietary intervention trail|dietary intervention trail
1074615|NCT02701946|Blood loss|blood loss
1074616|NCT02701946|Total knee arthroplasty|total knee arthroplasty
1074617|NCT02701946|Bandage|bandage
1074618|NCT02701946|Dressing|dressing
1074619|NCT02701920|Premature Birth|premature birth
1074620|NCT02701920|Infant|infant
1074621|NCT02701920|Heart rate|heart rate
1074622|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
1074623|NCT02701881|Drug-eluting Stent|drug-eluting stent
1074624|NCT02701881|Endovascular Therapy|endovascular therapy
1074625|NCT02701868|Infant Formula|infant formula
1074626|NCT02701829|taxi cab drivers|taxi cab drivers
1074627|NCT02701829|high blood pressure|high blood pressure
1074628|NCT02701829|16-038|16-038
1074629|NCT02701816|Peripheral Artery Disease|peripheral artery disease
1074630|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
1074631|NCT02701816|Nitinol Stent|nitinol stent
1074633|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
1074634|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
1074635|NCT02701764|dry eye symptoms|dry eye symptoms
1074636|NCT02701764|LASIK|lasik
1074637|NCT02701764|prevention|prevention
1074638|NCT02701712|magnetic resonance|magnetic resonance
1074639|NCT02701712|external beam radiotherapy|external beam radiotherapy
1074640|NCT02701712|brachytherapy|brachytherapy
1074641|NCT02701712|radiotherapy|radiotherapy
1074642|NCT02701699|Lung Cancer|lung cancer
1074643|NCT02701699|FAZA PET Imaging|faza pet imaging
1074644|NCT02701699|Lung Radiotherapy|lung radiotherapy
1074645|NCT02701686|smoking cessation|smoking cessation
1074646|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
1074647|NCT02701673|Busulfan|busulfan
1074648|NCT02701673|Busulfex|busulfex
1074649|NCT02701673|Myleran|myleran
1074650|NCT02701673|Caphosol|caphosol
1074651|NCT02701673|Glutamine|glutamine
1074652|NCT02701673|Enterex|enterex
1074653|NCT02701673|Glutapak-10|glutapak-10
1074654|NCT02701673|NutreStore|nutrestore
1074655|NCT02701673|Resource|resource
1074656|NCT02701673|GlutaSolve|glutasolve
1074657|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
1074658|NCT02701673|Sympt-X|sympt-x
1074659|NCT02701673|Pyridoxine|pyridoxine
1074660|NCT02701673|Belinostat|belinostat
1074661|NCT02701673|Azacitidine|azacitidine
1074662|NCT02701673|5-azacytidine|5-azacytidine
1074663|NCT02701673|5-aza|5-aza
1074664|NCT02701673|Azacytidine|azacytidine
1074665|NCT02701673|Vidaza|vidaza
1074666|NCT02701673|5-AZC|5-azc
1074667|NCT02701673|AZA-CR|aza-cr
1074668|NCT02701673|Ladakamycin|ladakamycin
1074669|NCT02701673|Gemcitabine|gemcitabine
1074670|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1074671|NCT02701673|Gemzar|gemzar
1074672|NCT02701673|Stem cell transplant|stem cell transplant
1074673|NCT02701673|SCT|sct
1074674|NCT02701673|Melphalan|melphalan
1074675|NCT02701673|Alkeran|alkeran
1074676|NCT02701660|Pharmaceutical Care|pharmaceutical care
1074677|NCT02701660|Adherence|adherence
1074678|NCT02701660|Polypharmacy|polypharmacy
1074679|NCT02701660|e-Health|e-health
1074680|NCT02701660|opioid substitution therapy|opioid substitution therapy
1074681|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1074682|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
1074683|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
1074684|NCT02701634|immune reconstitution|immune reconstitution
1074685|NCT02701634|Immune System Diseases|immune system diseases
1074686|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1074687|NCT02701634|SYK inhibitor|syk inhibitor
1074883|NCT02700126|propofol|propofol
1074688|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
1074689|NCT02701517|conditioning treatment|conditioning treatment
1074690|NCT02701517|alemtuzumab|alemtuzumab
1074691|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1074692|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
1074693|NCT02701504|sleep apnea|sleep apnea
1074694|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
1074695|NCT02701504|outcomes|outcomes
1074696|NCT02701465|Shoulder|shoulder
1074697|NCT02701465|Exercise therapy|exercise therapy
1074698|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
1074699|NCT02701426|Macrosomia|macrosomia
1074700|NCT02701426|Weight gain|weight gain
1074701|NCT02701426|Participation|participation
1074702|NCT02701426|Adhesion|adhesion
1074703|NCT02701426|Physical activity|physical activity
1074704|NCT02701426|Nutrition|nutrition
1074705|NCT02701413|Apex M|apex m
1074706|NCT02701413|Postpartum|postpartum
1074707|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
1074708|NCT02701387|bone implant interaction|bone implant interaction
1074709|NCT02701387|implant stability|implant stability
1074710|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
1074711|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
1074712|NCT02701374|TRK-700|trk-700
1074713|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
1074714|NCT02701361|mindfulness|mindfulness
1074715|NCT02701361|critical illness|critical illness
1074716|NCT02701361|intensive care unit|intensive care unit
1074717|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
1074718|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
1074719|NCT02701335|Osteoarthritis|osteoarthritis
1074720|NCT02701335|Hand|hand
1074721|NCT02701335|Rehabilitation|rehabilitation
1074722|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
1074723|NCT02701322|Fluoroscopy|fluoroscopy
1074724|NCT02701309|Iron deficiency|iron deficiency
1074725|NCT02701309|Child|child
1074726|NCT02701309|Infancy|infancy
1074727|NCT02701309|Preschool children|preschool children
1074728|NCT02701309|iron deficiency anemia|iron deficiency anemia
1074729|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
1074730|NCT02701270|Glycemic Index|glycemic index
1074731|NCT02701270|Dietary Fiber|dietary fiber
1074732|NCT02701257|Bionic Pancreas|bionic pancreas
1074733|NCT02701257|Insulin|insulin
1074734|NCT02701257|Glucagon|glucagon
1074735|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
1074736|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
1074737|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
1074738|NCT02701244|Brachytherapy|brachytherapy
1074739|NCT02701244|Breast Neoplasms|breast neoplasms
1074740|NCT02701244|Breast Diseases|breast diseases
1074741|NCT02701244|Neoplasms|neoplasms
1074742|NCT02701244|Neoplasms by Site|neoplasms by site
1074743|NCT02701231|lung cancer|lung cancer
1074744|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
1074745|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
1074746|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
1074747|NCT02701218|BPPV|bppv
1074748|NCT02701205|Plaque Psoriasis|plaque psoriasis
1074749|NCT02701205|Skin Disease|skin disease
1074750|NCT02701192|coccygodynia|coccygodynia
1074751|NCT02701192|coccygectomy|coccygectomy
1074752|NCT02701192|coccyx|coccyx
1074753|NCT02701179|Lignocaine|lignocaine
1074754|NCT02701166|Pruritus|pruritus
1074755|NCT02701166|itch|itch
1074756|NCT02701166|cholestasis|cholestasis
1074757|NCT02701075|peripheral neuropathy|peripheral neuropathy
1074758|NCT02701075|traumatic tissue injury|traumatic tissue injury
1074759|NCT02701075|radiculopathy|radiculopathy
1074760|NCT02701036|sporadic ataxia|sporadic ataxia
1074761|NCT02701036|MSAc|msac
1074762|NCT02701036|SAOA|saoa
1074763|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
1074764|NCT02701036|natural history|natural history
1074765|NCT02701010|behavioral therapy|behavioral therapy
1074766|NCT02701010|overactive bladder|overactive bladder
1074767|NCT02701010|urinary incontinence|urinary incontinence
1074768|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
1074769|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
1074770|NCT02700958|Stable coronary artery disease|stable coronary artery disease
1074771|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
1074772|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
1074773|NCT02700958|Functional properties of arteries|functional properties of arteries
1074774|NCT02700932|non-invasive|non-invasive
1074775|NCT02700906|Lateral epicondylitis|lateral epicondylitis
1074776|NCT02700906|tennis elbow|tennis elbow
1074777|NCT02700906|Lidocaine|lidocaine
1074778|NCT02700906|corticosteroid|corticosteroid
1074779|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
1074780|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
1074781|NCT02700880|new onset heart failure|new onset heart failure
1074782|NCT02700880|sudden cardiac death|sudden cardiac death
1074783|NCT02700867|intraosseous access|intraosseous access
1074784|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1074785|NCT02700867|paramedic|paramedic
1074786|NCT02700867|simulation|simulation
1074788|NCT02700854|Hypothermia treatment|hypothermia treatment
1074789|NCT02700854|Hypocapnia|hypocapnia
1074790|NCT02700854|Inhaled CO2|inhaled co2
1074791|NCT02700854|Neuroprotection|neuroprotection
1074792|NCT02700828|Hypothermia treatment|hypothermia treatment
1074793|NCT02700828|Circulatory failure|circulatory failure
1074794|NCT02700828|Neonatal hypotension|neonatal hypotension
1074795|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
1074796|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
1074797|NCT02700802|food insecurity|food insecurity
1074798|NCT02700802|informal caregiver health|informal caregiver health
1074799|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
1074800|NCT02700802|community resources|community resources
1074801|NCT02700789|diagnostic accuracy|diagnostic accuracy
1074802|NCT02700789|double decidual sac sign|double decidual sac sign
1074803|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
1074804|NCT02700776|screening mammogram|screening mammogram
1074805|NCT02700776|GP88|gp88
1074806|NCT02700776|breast cancer|breast cancer
1074807|NCT02700763|Brain metastasis|brain metastasis
1074808|NCT02700737|cardiovascular modeling|cardiovascular modeling
1074809|NCT02700737|aortic coarctation|aortic coarctation
1074810|NCT02700737|virtual stenting|virtual stenting
1074811|NCT02700698|Mitochondria|mitochondria
1074812|NCT02700698|women|women
1074813|NCT02700698|muscle|muscle
1074814|NCT02700698|PBMC|pbmc
1074815|NCT02700672|Ageing|ageing
1074816|NCT02700672|Cognition|cognition
1074817|NCT02700672|Executive Function|executive function
1074818|NCT02700672|Gait|gait
1074819|NCT02700620|emotional eating|emotional eating
1074820|NCT02700620|restrictive eating|restrictive eating
1074821|NCT02700620|body dissatisfaction|body dissatisfaction
1074822|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
1074823|NCT02700555|colorectal cancer|colorectal cancer
1074824|NCT02700555|diabetes|diabetes
1074825|NCT02700555|metabolic parameters|metabolic parameters
1074826|NCT02700555|Surveillance|surveillance
1074827|NCT02700542|asthma|asthma
1074828|NCT02700542|pest management|pest management
1074829|NCT02700503|Diabetes prevention|diabetes prevention
1074830|NCT02700503|type 2 diabetes|type 2 diabetes
1074831|NCT02700503|prediabetes|prediabetes
1074832|NCT02700503|family|family
1074833|NCT02700477|Type-2 Diabetic|type-2 diabetic
1074834|NCT02700477|HbA1c|hba1c
1074835|NCT02700477|FBS|fbs
1074836|NCT02700477|PPBS|ppbs
1074837|NCT02700477|C-peptide|c-peptide
1074838|NCT02700451|IV acetaminophen|iv acetaminophen
1074839|NCT02700451|IV Ketorolac|iv ketorolac
1074840|NCT02700451|Post-operative analgesia|post-operative analgesia
1074841|NCT02700451|Opioid use|opioid use
1074842|NCT02700425|Wide QRS|wide qrs
1074843|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
1074844|NCT02700399|Rehabilitation|rehabilitation
1074845|NCT02700386|Breast|breast
1074846|NCT02700386|Cancer|cancer
1074847|NCT02700386|Hypofractionated|hypofractionated
1074848|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
1074849|NCT02700386|Radiation Therapy|radiation therapy
1074850|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
1074851|NCT02700360|EC-18|ec-18
1074852|NCT02700360|Hematology|hematology
1074853|NCT02700360|Cancer|cancer
1074854|NCT02700360|Neutropenia|neutropenia
1074855|NCT02700334|Prediabetes|prediabetes
1074856|NCT02700334|Impaired fasting glucose|impaired fasting glucose
1074857|NCT02700334|Hyperglycemia|hyperglycemia
1074858|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
1074859|NCT02700334|Glucose intolerance|glucose intolerance
1074860|NCT02700334|Dapagliflozin|dapagliflozin
1074861|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
1074862|NCT02700334|SGLT2|sglt2
1074863|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
1074864|NCT02700321|preoxygenation|preoxygenation
1074865|NCT02700321|crash induction|crash induction
1074866|NCT02700308|Solid tumors|solid tumors
1074867|NCT02700308|Spine metastasis|spine metastasis
1074868|NCT02700308|Vertebroplasty|vertebroplasty
1074869|NCT02700308|kyphoplasty|kyphoplasty
1074870|NCT02700308|randomization|randomization
1074871|NCT02700295|Orthokeratology|orthokeratology
1074872|NCT02700282|Cystic fibrosis|cystic fibrosis
1074873|NCT02700282|Backpack carrying|backpack carrying
1074874|NCT02700282|Respiratory function|respiratory function
1074875|NCT02700282|Children|children
1074876|NCT02700256|surgery|surgery
1074877|NCT02700256|15-315|15-315
1074878|NCT02700243|Cystic Fibrosis|cystic fibrosis
1074879|NCT02700243|Exercise|exercise
1074880|NCT02700243|Fitbit|fitbit
1074881|NCT02700217|Donor Nephrectomy|donor nephrectomy
1074882|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
1074884|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
1074885|NCT02700126|cerebral aneurysm|cerebral aneurysm
1074886|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
1074887|NCT02700087|Laryngomalacia|laryngomalacia
1074888|NCT02700061|Induced Constraint Therapy|induced constraint therapy
1074889|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
1074890|NCT02700061|Neuroplasticity|neuroplasticity
1074891|NCT02700048|type 1 diabetes|type 1 diabetes
1074892|NCT02700048|hypoglycemia|hypoglycemia
1074893|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
1074894|NCT02700035|Intervention|intervention
1074895|NCT02700035|Prevention|prevention
1074896|NCT02700035|Randomized Controlled Trial|randomized controlled trial
1074897|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
1074898|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1074899|NCT02700022|Alisertib|alisertib
1074900|NCT02699905|Sepsis|sepsis
1074901|NCT02699905|Septic Shock|septic shock
1074902|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
1074903|NCT02699905|FFA2|ffa2
1074904|NCT02699905|GPR43|gpr43
1074905|NCT02699866|Small diameter implant|small diameter implant
1074906|NCT02699840|Meningitis|meningitis
1074907|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
1074908|NCT02699840|Meningococcal Infections|meningococcal infections
1074909|NCT02699840|Menactra®|menactra®
1074910|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
1074911|NCT02699827|Levobupivacaine|levobupivacaine
1074912|NCT02699827|Magnesium|magnesium
1074913|NCT02699827|Preeclampsia|preeclampsia
1074914|NCT02699827|Epidural|epidural
1074915|NCT02699814|Depression|depression
1074916|NCT02699814|Children|children
1074917|NCT02699814|Anxiety|anxiety
1074918|NCT02699775|Botulinum toxin injections|botulinum toxin injections
1074919|NCT02699775|Stroke|stroke
1074920|NCT02699775|3D motion analysis|3d motion analysis
1074921|NCT02699775|Gait pattern|gait pattern
1074922|NCT02699762|self rehabilitation|self rehabilitation
1074923|NCT02699762|stroke|stroke
1074924|NCT02699762|botulinum toxin injection|botulinum toxin injection
1074925|NCT02699762|arm functions|arm functions
1074926|NCT02699749|Drug Therapy|drug therapy
1074928|NCT02699736|HIV-1|hiv-1
1074929|NCT02699736|Hepatitis C|hepatitis c
1074930|NCT02699736|HCV|hcv
1074931|NCT02699736|prospective|prospective
1074932|NCT02699736|cohort|cohort
1074934|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1074935|NCT02699671|Routine Clinical Practice|routine clinical practice
1074936|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1074937|NCT02699671|Coronary Artery Disease|coronary artery disease
1074938|NCT02699671|drug eluting stent|drug eluting stent
1074939|NCT02699671|acute myocardial infarction|acute myocardial infarction
1074940|NCT02699658|levofloxacin|levofloxacin
1074941|NCT02699658|population pharmacokinetics|population pharmacokinetics
1074942|NCT02699658|pharmacodynamics|pharmacodynamics
1074943|NCT02699632|Survey|survey
1074944|NCT02699619|Undisplaced|undisplaced
1074945|NCT02699606|Tumor|tumor
1074946|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
1074947|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1074948|NCT02699606|Erdafitinib|erdafitinib
1074949|NCT02699606|Urothelial Cancer|urothelial cancer
1074950|NCT02699606|Esophageal Cancer|esophageal cancer
1074951|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
1074952|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
1074953|NCT02699580|scleral thinning|scleral thinning
1074954|NCT02699580|strabismus surgery|strabismus surgery
1074955|NCT02699567|taste perception|taste perception
1074956|NCT02699567|individual differences|individual differences
1074957|NCT02699567|fat|fat
1074958|NCT02699567|genetics|genetics
1074959|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
1074960|NCT02699541|Behavioural change theory|behavioural change theory
1074961|NCT02699541|IMB model|imb model
1074962|NCT02699541|Diabetes Type 2|diabetes type 2
1074963|NCT02699515|MSB0011359C|msb0011359c
1074964|NCT02699476|NFL|nfl
1074965|NCT02699476|veterans|veterans
1074966|NCT02699476|cognitive training|cognitive training
1074967|NCT02699476|TBI|tbi
1074968|NCT02699476|concussion|concussion
1074969|NCT02699437|Preeclampsia|preeclampsia
1074970|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
1074971|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
1074972|NCT02699385|Gastroenteritis|gastroenteritis
1074973|NCT02699385|Domperidone|domperidone
1074974|NCT02699385|Pediatric participants|pediatric participants
1074975|NCT02699372|Healthy Volunteers|healthy volunteers
1074976|NCT02699359|concussion|concussion
1074977|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
1074978|NCT02699346|concussion|concussion
1074979|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
1074980|NCT02699320|Short bowel syndrome|short bowel syndrome
1074981|NCT02699320|Intestinal microbiota|intestinal microbiota
1074982|NCT02699320|immune|immune
1074983|NCT02699307|physical activity|physical activity
1074984|NCT02699294|Pain Threshold|pain threshold
1074985|NCT02699294|Pectoralis Minor|pectoralis minor
1074986|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
1074987|NCT02699294|Physiotherapy|physiotherapy
1074988|NCT02699294|Rehabilitation|rehabilitation
1074989|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
1074990|NCT02699216|Macular Degeneration|macular degeneration
1074991|NCT02699216|Eye Diseases|eye diseases
1074992|NCT02699216|Retinal Degeneration|retinal degeneration
1074993|NCT02699216|Retinal Diseases|retinal diseases
1074994|NCT02699190|Leukodystrophy|leukodystrophy
1074995|NCT02699190|White Matter Disease|white matter disease
1074996|NCT02699190|Whole Genome Sequencing|whole genome sequencing
1074997|NCT02699190|WGS|wgs
1074998|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
1074999|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
1075000|NCT02699164|deep friction massage|deep friction massage
1075001|NCT02699164|exercise|exercise
1075002|NCT02699099|Children|children
1075003|NCT02699099|Infants|infants
1075004|NCT02699099|SB257049|sb257049
1075005|NCT02699099|Malaria|malaria
1075006|NCT02699099|Immunogenicity|immunogenicity
1075007|NCT02699099|Surveillance|surveillance
1075008|NCT02699099|Efficacy|efficacy
1075009|NCT02699099|Safety|safety
1075010|NCT02699099|Africa|africa
1075011|NCT02699099|Plasmodium falciparum|plasmodium falciparum
1075012|NCT02699073|colorectal cancer|colorectal cancer
1075013|NCT02699073|metastatic|metastatic
1075014|NCT02699073|regorafenib|regorafenib
1075015|NCT02699073|CHOI criteria|choi criteria
1075016|NCT02699073|RECIST criteria|recist criteria
1075017|NCT02699060|GERD|gerd
1075018|NCT02699060|Barrett`s esophagus|barrett`s esophagus
1075019|NCT02699060|macrophage|macrophage
1075020|NCT02699060|FSSG questionnaire|fssg questionnaire
1075021|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
1075022|NCT02699047|Fish oil|fish oil
1075023|NCT02699047|Oxidative stress|oxidative stress
1075024|NCT02699047|Inflammation|inflammation
1075025|NCT02699047|Quality of life|quality of life
1075026|NCT02699047|Nutritional status|nutritional status
1075027|NCT02699047|Colorectal cancer|colorectal cancer
1075028|NCT02699047|Stomach cancer|stomach cancer
1075029|NCT02699047|Chemotherapy|chemotherapy
1075030|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
1075031|NCT02699034|real-time MRI|real-time mri
1075032|NCT02699034|electrophysiology study|electrophysiology study
1075033|NCT02699034|atrial flutter ablation|atrial flutter ablation
1075034|NCT02699034|active tracking|active tracking
1075035|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
1075036|NCT02698982|elderly|elderly
1075037|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1075038|NCT02698982|postoperative delirium|postoperative delirium
1075039|NCT02698982|depth of anesthesia|depth of anesthesia
1075040|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
1075041|NCT02698969|Sugammadex|sugammadex
1075042|NCT02698969|Post-operative residual curarization|post-operative residual curarization
1075043|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
1075044|NCT02698956|SAPIEN 3 THV|sapien 3 thv
1075045|NCT02698956|TAVI|tavi
1075046|NCT02698956|Transfemoral|transfemoral
1075047|NCT02698956|Transaortic|transaortic
1075048|NCT02698956|Transapical|transapical
1075049|NCT02698956|Aortic valve|aortic valve
1075050|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
1075051|NCT02698930|Infective endocarditis|infective endocarditis
1075052|NCT02698930|acute kidney injury|acute kidney injury
1075053|NCT02698930|dexmedetomidine|dexmedetomidine
1075054|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
1075055|NCT02698917|Resuscitation|resuscitation
1075056|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
1075057|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1075058|NCT02698904|Relaxation Technique|relaxation technique
1075059|NCT02698904|Anxiety|anxiety
1075060|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
1075061|NCT02698878|Lupin Protein|lupin protein
1075062|NCT02698878|Glucose Metabolism|glucose metabolism
1075063|NCT02698878|GLUT4|glut4
1075064|NCT02698878|Muscle Unloading|muscle unloading
1075065|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1075066|NCT02698852|Drug eluting stents|drug eluting stents
1075067|NCT02698852|Interventional Cardiology|interventional cardiology
1075068|NCT02698839|Drug eluting stents|drug eluting stents
1075069|NCT02698839|Interventional Cardiology|interventional cardiology
1075070|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
1075071|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
1075072|NCT02698761|Sickle Cell Disease|sickle cell disease
1075073|NCT02698761|Decreasing Length of Stay|decreasing length of stay
1075074|NCT02698761|Comprehensive Care Plan|comprehensive care plan
1075075|NCT02698748|Chloroquine|chloroquine
1075076|NCT02698748|Malaria Elimination|malaria elimination
1075077|NCT02698748|P.falciparum|p.falciparum
1075078|NCT02698748|Clinical Trial|clinical trial
1075079|NCT02698748|Mozambique|mozambique
1075080|NCT02698748|Adults|adults
1075081|NCT02698709|Keratoconus|keratoconus
1075082|NCT02698709|Corneal Topography|corneal topography
1075083|NCT02698709|Diagnosis|diagnosis
1075084|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
1075085|NCT02698696|Cognitive Remediation|cognitive remediation
1075086|NCT02698696|Mood disorders|mood disorders
1075087|NCT02698696|Neuropsychology|neuropsychology
1075088|NCT02698683|Nutrition|nutrition
1075089|NCT02698683|Lymphocyte Count|lymphocyte count
1075090|NCT02698683|Immunoparalysis|immunoparalysis
1075091|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
1075092|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
1075093|NCT02698670|Cardiovascular Disease|cardiovascular disease
1075094|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
1075095|NCT02698670|Cardiac Mapping|cardiac mapping
1075096|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1075097|NCT02698657|Methotrexate|methotrexate
1075098|NCT02698657|ASP5094|asp5094
1075099|NCT02698631|Catheter Ablation|catheter ablation
1075100|NCT02698631|Radiofrequency|radiofrequency
1075101|NCT02698631|Fibrosis|fibrosis
1075102|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
1075103|NCT02698618|Diabetes|diabetes
1075105|NCT02698618|Microcirculation|microcirculation
1075106|NCT02698618|Ticagrelor|ticagrelor
1075107|NCT02698618|CFR|cfr
1075108|NCT02698618|FFR|ffr
1075109|NCT02698618|Coronary microcirculation|coronary microcirculation
1075110|NCT02698592|atrial flutter|atrial flutter
1075111|NCT02698592|ablation|ablation
1075112|NCT02698592|Thermocool SF catheter|thermocool sf catheter
1075113|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
1075114|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
1075115|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
1075116|NCT02698553|Major depressive disorder|major depressive disorder
1075117|NCT02698553|Extended release Bupropion|extended release bupropion
1075118|NCT02698527|lidocaine|lidocaine
1075119|NCT02698501|Asthma|asthma
1075120|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
1075121|NCT02698501|TSLP|tslp
1075122|NCT02698501|Mast cell|mast cell
1075127|NCT02698462|Advanced neoplasia|advanced neoplasia
1075128|NCT02698462|Colorectal cancer|colorectal cancer
1075129|NCT02698462|Population screening|population screening
1075130|NCT02698462|Family history|family history
1075131|NCT02698436|Acne|acne
1075132|NCT02698371|composite resins|composite resins
1075133|NCT02698371|dental restoration|dental restoration
1075134|NCT02698371|adhesives|adhesives
1075135|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
1075136|NCT02698371|clinical effectiveness|clinical effectiveness
1075137|NCT02698371|Adhese universal|adhese universal
1075138|NCT02698371|Futurabond U|futurabond u
1075139|NCT02698371|Futurabond DC|futurabond dc
1075140|NCT02698371|self-etch|self-etch
1075141|NCT02698371|multimode/universal|multimode/universal
1075142|NCT02698371|clinical trial|clinical trial
1075143|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
1075144|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
1075145|NCT02698319|Triage|triage
1075146|NCT02698319|Systematic Triage|systematic triage
1075147|NCT02698280|Bevacizumab|bevacizumab
1075148|NCT02698280|Nimustine|nimustine
1075149|NCT02698280|Pathology, Molecular|pathology, molecular
1075150|NCT02698254|Brain cancer|brain cancer
1075151|NCT02698254|Recurrent brain tumor|recurrent brain tumor
1075152|NCT02698254|Prior radiation treatment to brain|prior radiation treatment to brain
1075153|NCT02698254|Radiation therapy|radiation therapy
1075154|NCT02698254|XRT|xrt
1075155|NCT02698254|Questionnaires|questionnaires
1075156|NCT02698254|Surveys|surveys
1075157|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
1075158|NCT02698241|heart failure|heart failure
1075159|NCT02698241|integrated diagnostics|integrated diagnostics
1075160|NCT02698241|chronic medication management|chronic medication management
1075161|NCT02698228|anesthesia|anesthesia
1075162|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
1075163|NCT02698176|OTX015|otx015
1075164|NCT02698176|MK-8628|mk-8628
1075165|NCT02698163|Root Canal Therapy|root canal therapy
1075166|NCT02698150|Mitral regurgitation|mitral regurgitation
1075167|NCT02698150|Mitraclip|mitraclip
1075168|NCT02698150|Remote monitoring|remote monitoring
1075169|NCT02698150|Wearables|wearables
1075170|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
1075171|NCT02698098|Malaysia|malaysia
1075172|NCT02698098|Asia|asia
1075173|NCT02698098|Southeast Asia|southeast asia
1075174|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
1075175|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
1075176|NCT02698098|Methadone|methadone
1075177|NCT02698098|Drug Relapse|drug relapse
1075178|NCT02698098|Drug and Narcotic Control|drug and narcotic control
1075179|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
1075180|NCT02698098|Prisons|prisons
1075181|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
1075182|NCT02698085|physiotherapy|physiotherapy
1075183|NCT02698085|manual therapy|manual therapy
1075184|NCT02698072|Stiffness|stiffness
1075185|NCT02698072|Pain|pain
1075186|NCT02698072|Disfunction|disfunction
1075187|NCT02698046|Heart failure|heart failure
1075188|NCT02698046|Iron|iron
1075189|NCT02698046|Anemia|anemia
1075190|NCT02698046|Chronic disease|chronic disease
1075191|NCT02698033|food allergy|food allergy
1075192|NCT02698033|peanut|peanut
1075193|NCT02698033|food challenge|food challenge
1075194|NCT02698020|Newborn|newborn
1075195|NCT02698020|Anesthesia|anesthesia
1075196|NCT02698020|Oxygen|oxygen
1075197|NCT02698020|Hyperoxia|hyperoxia
1075198|NCT02697994|Sterile Water Injection|sterile water injection
1075199|NCT02697994|Midwifery|midwifery
1075200|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
1075201|NCT02697929|Rocuronium|rocuronium
1075202|NCT02697916|aspirin|aspirin
1075203|NCT02697916|ACSD|acsd
1075204|NCT02697916|PCORI|pcori
1075205|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
1075206|NCT02697903|C-reactive protein|c-reactive protein
1075207|NCT02697903|resistance training|resistance training
1075208|NCT02697903|Pomegranate supplementation|pomegranate supplementation
1075209|NCT02697903|pomegranate juice|pomegranate juice
1075210|NCT02697903|muscle damage response|muscle damage response
1075211|NCT02697786|Aortic valve surgery|aortic valve surgery
1075212|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
1075213|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
1075214|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
1075215|NCT02697773|tanezumab|tanezumab
1075216|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
1075217|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
1075218|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
1075219|NCT02697747|Ultrasound|ultrasound
1075220|NCT02697747|Palpation|palpation
1075221|NCT02697747|Analgesia|analgesia
1075222|NCT02697747|Epidural|epidural
1075223|NCT02697734|Cushing's disease|cushing's disease
1075224|NCT02697734|LCI699|lci699
1075225|NCT02697734|osilodrostat|osilodrostat
1075226|NCT02697734|Pituitary Gland|pituitary gland
1075227|NCT02697734|Adrenocorticotropic|adrenocorticotropic
1075228|NCT02697734|Hormone|hormone
1075229|NCT02697734|ACTH|acth
1075231|NCT02697721|Caregivers|caregivers
1075232|NCT02697721|Behavioral symptoms|behavioral symptoms
1075233|NCT02697721|Dementia|dementia
1075234|NCT02697721|Alzheimer disease|alzheimer disease
1075235|NCT02697721|Physical activity|physical activity
1075236|NCT02697721|Depressive symptoms|depressive symptoms
1075237|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
1075238|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
1075239|NCT02697695|chronic inflammation|chronic inflammation
1075240|NCT02697695|fatty liver index|fatty liver index
1075241|NCT02697669|Heart failure|heart failure
1075242|NCT02697669|myocardial perfusion|myocardial perfusion
1075243|NCT02697669|single-photon emission tomography|single-photon emission tomography
1075244|NCT02697643|clinical decision support|clinical decision support
1075245|NCT02697643|substance use|substance use
1075246|NCT02697643|opioid|opioid
1075247|NCT02697630|Uveal melanoma|uveal melanoma
1075248|NCT02697591|Solid tumor|solid tumor
1075249|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
1075250|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
1075251|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
1075252|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
1075253|NCT02697565|childhood obesity|childhood obesity
1075254|NCT02697565|obesity|obesity
1075255|NCT02697565|prevention|prevention
1075256|NCT02697565|nutrition|nutrition
1075257|NCT02697565|health|health
1075258|NCT02697565|preschool|preschool
1075259|NCT02697565|childcare|childcare
1075260|NCT02697565|role model|role model
1075261|NCT02697565|pediatric obesity|pediatric obesity
1075262|NCT02697565|weight|weight
1075263|NCT02697565|overweight|overweight
1075264|NCT02697565|early childhood|early childhood
1075265|NCT02697565|train the trainer|train the trainer
1075266|NCT02697526|radial artery|radial artery
1075267|NCT02697526|occlusion|occlusion
1075268|NCT02697526|functional|functional
1075269|NCT02697526|complications|complications
1075270|NCT02697526|consequences|consequences
1075271|NCT02697487|Depression|depression
1075272|NCT02697487|Cohort|cohort
1075273|NCT02697474|Hepatitis B|hepatitis b
1075274|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
1075275|NCT02697474|Euvax-B®|euvax-b®
1075276|NCT02697474|Hexaxim®|hexaxim®
1075277|NCT02697474|Infanrix® hexa|infanrix® hexa
1075278|NCT02697435|Chronic Low Back Pain|chronic low back pain
1075279|NCT02697435|Aged|aged
1075280|NCT02697435|Elderly|elderly
1075281|NCT02697435|Primary Care|primary care
1075282|NCT02697435|Assessment|assessment
1075283|NCT02697435|Lumbar|lumbar
1075284|NCT02697435|Spinal Stenosis|spinal stenosis
1075285|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
1075286|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
1075287|NCT02697435|Fibromyalgia|fibromyalgia
1075288|NCT02697435|Depression|depression
1075289|NCT02697435|Maladaptive Coping|maladaptive coping
1075290|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
1075291|NCT02697435|Insomnia|insomnia
1075292|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
1075293|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
1075294|NCT02697435|Anxiety|anxiety
1075295|NCT02697435|Dementia|dementia
1075296|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
1075297|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
1075298|NCT02697422|Peer health coach|peer health coach
1075299|NCT02697422|Systolic blood pressure|systolic blood pressure
1075300|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
1075301|NCT02697422|Lipid|lipid
1075302|NCT02697422|Health related quality of life|health related quality of life
1075303|NCT02697422|Health care utilization|health care utilization
1075304|NCT02697422|Medication adherence|medication adherence
1075305|NCT02697422|Physical activity|physical activity
1075306|NCT02697422|Nutrition|nutrition
1075307|NCT02697422|Alcohol use|alcohol use
1075308|NCT02697422|Stress management|stress management
1075309|NCT02697396|Social Marketing Campaign|social marketing campaign
1075310|NCT02697396|Mexican American Children|mexican american children
1075311|NCT02697396|16-069|16-069
1075312|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
1075313|NCT02697383|Dexamethasone|dexamethasone
1075314|NCT02697383|15-294|15-294
1075315|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
1075316|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
1075317|NCT02697357|Distress Among Caregivers|distress among caregivers
1075318|NCT02697357|15-219|15-219
1075319|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
1075320|NCT02697305|Insulin response|insulin response
1075321|NCT02697305|Incretin effect|incretin effect
1075322|NCT02697305|GLP-1|glp-1
1075324|NCT02697305|Valine|valine
1075325|NCT02697305|Leucine|leucine
1075327|NCT02697305|Branched chain amino acids|branched chain amino acids
1075328|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
1075329|NCT02697292|VGKC|vgkc
1075330|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
1075331|NCT02697292|Gamumex-C|gamumex-c
1075332|NCT02697279|Abscess|abscess
1075333|NCT02697279|Loop|loop
1075334|NCT02697279|Drainage|drainage
1075335|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
1075336|NCT02697253|Psychosocial Variables|psychosocial variables
1075337|NCT02697253|Behavioral Variables|behavioral variables
1075338|NCT02697253|Weight Loss|weight loss
1075339|NCT02697253|Food Intake|food intake
1075340|NCT02697253|GLP-1|glp-1
1075341|NCT02697253|Reinforcing Value of Food|reinforcing value of food
1075342|NCT02697253|Exendin 9-39|exendin 9-39
1075343|NCT02697240|sickle cell disease|sickle cell disease
1075344|NCT02697240|citrulline|citrulline
1075345|NCT02697227|Smoking cessation|smoking cessation
1075346|NCT02697227|Smoking behavior|smoking behavior
1075347|NCT02697227|Behavioral Activation Treatment|behavioral activation treatment
1075348|NCT02697227|BATS|bats
1075349|NCT02697227|Standard Smoking Cessation Counseling|standard smoking cessation counseling
1075351|NCT02697227|Nicotine Replacement Therapy|nicotine replacement therapy
1075352|NCT02697227|NRT|nrt
1075353|NCT02697227|Nicotine patch|nicotine patch
1075354|NCT02697227|Questionnaires|questionnaires
1075355|NCT02697227|Surveys|surveys
1075356|NCT02697227|CO Level|co level
1075357|NCT02697227|Cotinine Level|cotinine level
1075358|NCT02697227|Saliva test|saliva test
1075359|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
1075360|NCT02697214|accuracy|accuracy
1075361|NCT02697214|EKG|ekg
1075362|NCT02697214|varying degrees of exertion|varying degrees of exertion
1075363|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
1075364|NCT02697201|Insulin Resistance|insulin resistance
1075365|NCT02697188|testosterone|testosterone
1075366|NCT02697188|male hypogonadism|male hypogonadism
1075367|NCT02697188|low testosterone|low testosterone
1075368|NCT02697175|live video-colposcopy|live video-colposcopy
1075369|NCT02697175|cervical dysplasia|cervical dysplasia
1075370|NCT02697175|anxiety|anxiety
1075371|NCT02697175|randomized controlled trial|randomized controlled trial
1075372|NCT02697175|colposcopy|colposcopy
1075373|NCT02697162|Intermittent catheterisation|intermittent catheterisation
1075374|NCT02697162|Antiseptic|antiseptic
1075375|NCT02697162|Octenidine chloride|octenidine chloride
1075376|NCT02697162|Children|children
1075377|NCT02697149|ERCP|ercp
1075378|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
1075379|NCT02697149|gallstones|gallstones
1075380|NCT02697136|Low HDL|low hdl
1075381|NCT02697136|Low apoA-I|low apoa-i
1075382|NCT02697136|ABCA-1 mutations|abca-1 mutations
1075383|NCT02697136|ApoA-I mutations|apoa-i mutations
1075384|NCT02697123|Venous Thrombosis|venous thrombosis
1075385|NCT02697123|Pregnancy|pregnancy
1075386|NCT02697123|postpartum|postpartum
1075387|NCT02697123|antepartum|antepartum
1075388|NCT02697110|Cognition|cognition
1075389|NCT02697110|Brain Stimulation|brain stimulation
1075390|NCT02697110|Early Child Development|early child development
1075391|NCT02697097|Hip Muscle Strength|hip muscle strength
1075392|NCT02697097|FAI|fai
1075393|NCT02697071|Ketamine|ketamine
1075394|NCT02697071|Migraine|migraine
1075395|NCT02697071|Headache|headache
1075396|NCT02697071|Emergency Department|emergency department
1075397|NCT02697045|Schizophrenia|schizophrenia
1075398|NCT02697045|Quality of Life|quality of life
1075399|NCT02697045|Functionality|functionality
1075400|NCT02697045|Long Acting Injectable|long acting injectable
1075401|NCT02697045|Aripiprazole|aripiprazole
1075402|NCT02697045|Naturalistic|naturalistic
1075403|NCT02697045|Open-label|open-label
1075404|NCT02697045|Single Arm|single arm
1075405|NCT02697045|Uncontrolled Study|uncontrolled study
1075406|NCT02697032|FDHT|fdht
1075407|NCT02697032|PET|pet
1075408|NCT02697032|Breast cancer|breast cancer
1075409|NCT02697032|Bicalutamide|bicalutamide
1075410|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
1075411|NCT02696993|Metastatic Brain Cancer|metastatic brain cancer
1075412|NCT02696993|Non-small cell lung cancer with brain metastasis|non-small cell lung cancer with brain metastasis
1075413|NCT02696993|NSCLC|nsclc
1075414|NCT02696993|Intracranial disease|intracranial disease
1075415|NCT02696993|Stereotactic radiosurgery|stereotactic radiosurgery
1075416|NCT02696993|SRS|srs
1075417|NCT02696993|Whole brain radiation therapy|whole brain radiation therapy
1075418|NCT02696993|WBRT|wbrt
1075419|NCT02696993|Neurocognitive exam|neurocognitive exam
1075420|NCT02696993|Nivolumab|nivolumab
1075421|NCT02696993|BMS-936558|bms-936558
1075422|NCT02696993|Opdivo|opdivo
1075423|NCT02696993|Ipilimumab|ipilimumab
1075424|NCT02696993|Yervoy|yervoy
1075425|NCT02696993|BMS-734016|bms-734016
1075426|NCT02696993|MDX010|mdx010
1075427|NCT02696980|obesity|obesity
1075428|NCT02696980|asthma|asthma
1075429|NCT02696967|Heart Failure|heart failure
1075430|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
1075433|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
1075434|NCT02696889|Infertility|infertility
1075435|NCT02696889|Premature Ovarian Failure|premature ovarian failure
1075436|NCT02696889|Stem Cells|stem cells
1075437|NCT02696889|Amenorrhea|amenorrhea
1075438|NCT02696876|Cartilage|cartilage
1075439|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
1075440|NCT02696876|Microfracture|microfracture
1075441|NCT02696876|Knee|knee
1075442|NCT02696876|Defect|defect
1075443|NCT02696876|Injury|injury
1075444|NCT02696876|Stem cell|stem cell
1075445|NCT02696876|Autologous|autologous
1075446|NCT02696876|Minimally manipulated|minimally manipulated
1075447|NCT02696850|sinusitis|sinusitis
1075448|NCT02696850|rhinosinusitis|rhinosinusitis
1075449|NCT02696850|rhinitis|rhinitis
1075450|NCT02696850|nasal lavage|nasal lavage
1075451|NCT02696811|cancer|cancer
1075452|NCT02696811|inflammation|inflammation
1075453|NCT02696811|dietary intervention trial|dietary intervention trial
1075454|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
1075455|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
1075456|NCT02696759|Breast|breast
1075457|NCT02696759|Cancer|cancer
1075458|NCT02696733|TURBT|turbt
1075459|NCT02696733|ultrasound guided|ultrasound guided
1075460|NCT02696733|ONB|onb
1075461|NCT02696733|interadductor approach|interadductor approach
1075462|NCT02696720|lidocaine|lidocaine
1075463|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
1075464|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
1075465|NCT02696707|cardiac toxicities|cardiac toxicities
1075466|NCT02696668|multisensory exercises|multisensory exercises
1075467|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
1075468|NCT02696655|transplantation|transplantation
1075469|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
1075470|NCT02696629|Ventilatory control|ventilatory control
1075471|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
1075472|NCT02696629|Loop gain|loop gain
1075473|NCT02696629|Upper airway|upper airway
1075474|NCT02696629|Surgery|surgery
1075475|NCT02696603|Health app research|health app research
1075476|NCT02696603|mHealth research|mhealth research
1075477|NCT02696603|Mobile health research|mobile health research
1075575|NCT02696135|multi-omics|multi-omics
1075478|NCT02696603|Mobile application health research|mobile application health research
1075479|NCT02696564|COPD|copd
1075480|NCT02696564|emphysema|emphysema
1075481|NCT02696564|HRCT|hrct
1075482|NCT02696564|losartan|losartan
1075483|NCT02696551|Medical education|medical education
1075484|NCT02696551|Spondyloarthritis|spondyloarthritis
1075485|NCT02696551|Physician action|physician action
1075486|NCT02696538|Fall risk|fall risk
1075487|NCT02696538|Rehabiliation|rehabiliation
1075488|NCT02696538|Physical Therapy|physical therapy
1075489|NCT02696538|Functional Gait Assessment|functional gait assessment
1075490|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
1075491|NCT02696538|Berg Balance Scale|berg balance scale
1075492|NCT02696538|Psychometric properties|psychometric properties
1075493|NCT02696538|Validity|validity
1075494|NCT02696538|Inter-rater reliability|inter-rater reliability
1075495|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
1075496|NCT02696525|Circulating Tumor DNA|circulating tumor dna
1075497|NCT02696525|Lung cancer|lung cancer
1075498|NCT02696525|lead time|lead time
1075499|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
1075500|NCT02696512|Coma|coma
1075501|NCT02696512|Vegetative State|vegetative state
1075502|NCT02696512|Minimally Conscious State|minimally conscious state
1075503|NCT02696499|Uremic pruritus|uremic pruritus
1075504|NCT02696499|Pruritus|pruritus
1075505|NCT02696499|Chronic itch|chronic itch
1075506|NCT02696499|Itch|itch
1075507|NCT02696499|Hemodialysis|hemodialysis
1075508|NCT02696499|End-stage renal disease|end-stage renal disease
1075509|NCT02696473|Bioavailability|bioavailability
1075510|NCT02696473|Polyacetylenes|polyacetylenes
1075511|NCT02696473|Falcarinol|falcarinol
1075512|NCT02696473|Falcarindiol|falcarindiol
1075513|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
1075514|NCT02696473|Carrot|carrot
1075515|NCT02696473|Biological Availability|biological availability
1075516|NCT02696460|debridement|debridement
1075517|NCT02696460|analgesia|analgesia
1075518|NCT02696447|Radiation therapy|radiation therapy
1075519|NCT02696447|Thrombosis|thrombosis
1075520|NCT02696434|naltrexone|naltrexone
1075521|NCT02696434|VIVITROL|vivitrol
1075522|NCT02696434|buprenorphine|buprenorphine
1075523|NCT02696434|opioid|opioid
1075524|NCT02696434|addiction|addiction
1075525|NCT02696408|Mucositis|mucositis
1075526|NCT02696408|Low level laser therapy|low level laser therapy
1075527|NCT02696408|Autograft|autograft
1075528|NCT02696408|Allograft|allograft
1075529|NCT02696382|Veterans|veterans
1075530|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
1075531|NCT02696382|Gait Speed|gait speed
1075532|NCT02696382|Acute Hospitalization|acute hospitalization
1075828|NCT02694497|anorectal|anorectal
1075533|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
1075534|NCT02696356|HLA-A*02|hla-a*02
1075535|NCT02696343|somatosensory stimulation|somatosensory stimulation
1075536|NCT02696343|orocutaneous|orocutaneous
1075537|NCT02696343|gene expression|gene expression
1075538|NCT02696291|Dengue|dengue
1075539|NCT02696291|Arbovirus Infections|arbovirus infections
1075540|NCT02696291|Flaviviridae Infections|flaviviridae infections
1075541|NCT02696291|Flavivirus Infections|flavivirus infections
1075542|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
1075543|NCT02696291|RNA Virus Infections|rna virus infections
1075544|NCT02696291|Virus Diseases|virus diseases
1075545|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
1075546|NCT02696291|Pharmacologic Actions|pharmacologic actions
1075547|NCT02696291|Therapeutic Uses|therapeutic uses
1075548|NCT02696278|gut microbiota|gut microbiota
1075549|NCT02696278|obesity|obesity
1075550|NCT02696278|toddlers|toddlers
1075551|NCT02696278|fiber|fiber
1075552|NCT02696278|unsaturated fats|unsaturated fats
1075553|NCT02696265|Atrial Fibrillation|atrial fibrillation
1075554|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
1075555|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
1075556|NCT02696265|Ablation|ablation
1075557|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
1075558|NCT02696252|Endocrine System Diseases|endocrine system diseases
1075559|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
1075560|NCT02696252|Metabolic Diseases|metabolic diseases
1075561|NCT02696239|vaginal cuff closure|vaginal cuff closure
1075562|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
1075563|NCT02696200|Concussion|concussion
1075564|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1075565|NCT02696187|Feasibility|feasibility
1075566|NCT02696187|Health promotion tool|health promotion tool
1075567|NCT02696187|Self management|self management
1075568|NCT02696187|Evidence based care|evidence based care
1075569|NCT02696187|Knowledge transfer|knowledge transfer
1075570|NCT02696187|Implementation|implementation
1075571|NCT02696161|platelet rich plasma|platelet rich plasma
1075572|NCT02696161|Perineural injection therapy|perineural injection therapy
1075573|NCT02696135|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1075574|NCT02696135|clinical outcomes|clinical outcomes
1075576|NCT02696135|risk stratification|risk stratification
1075577|NCT02696122|Pain, postoperative|pain, postoperative
1075578|NCT02696122|Hernia, abdominal|hernia, abdominal
1075579|NCT02696122|Anesthesia, spinal|anesthesia, spinal
1075580|NCT02696122|Anesthesia, local|anesthesia, local
1075581|NCT02696122|Anesthesia, general|anesthesia, general
1075582|NCT02696122|Quality of life|quality of life
1075583|NCT02696122|Anesthesia recovery period|anesthesia recovery period
1075584|NCT02696122|Personal satisfaction|personal satisfaction
1075585|NCT02696122|Postoperative complications|postoperative complications
1075586|NCT02696122|Quality of recovery|quality of recovery
1075587|NCT02696109|Transition age youth|transition age youth
1075588|NCT02696109|Mental health|mental health
1075589|NCT02696109|Mental health services|mental health services
1075590|NCT02696109|Engagement|engagement
1075591|NCT02696070|Pain|pain
1075592|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
1075593|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
1075594|NCT02696070|PEMF|pemf
1075595|NCT02696070|PPDN|ppdn
1075596|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
1075597|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
1075598|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
1075599|NCT02696018|Diaphragm|diaphragm
1075600|NCT02696018|Ultrasound|ultrasound
1075601|NCT02696018|Critically ill patients|critically ill patients
1075602|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
1075603|NCT02695992|Beta blockers|beta blockers
1075604|NCT02695992|Calcium channel blockers|calcium channel blockers
1075605|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
1075606|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
1075607|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
1075608|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
1075609|NCT02695992|Heart Diseases|heart diseases
1075610|NCT02695992|Pathological processes|pathological processes
1075611|NCT02695992|Diltiazem|diltiazem
1075612|NCT02695992|Metoprolol|metoprolol
1075613|NCT02695992|Adrenergic Agents|adrenergic agents
1075614|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
1075615|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
1075616|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1075617|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
1075618|NCT02695992|Antihypertensive Agents|antihypertensive agents
1075619|NCT02695992|Autonomic Agents|autonomic agents
1075620|NCT02695992|Cardiovascular Agents|cardiovascular agents
1075621|NCT02695992|Membrane Transport Modulators|membrane transport modulators
1075622|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1075623|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
1075722|NCT02695316|Access to Health Care|access to health care
1075624|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
1075625|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
1075626|NCT02695992|Sympatholytics|sympatholytics
1075627|NCT02695992|Therapeutic Uses|therapeutic uses
1075628|NCT02695992|Vasodilator Agents|vasodilator agents
1075629|NCT02695992|Troponins|troponins
1075630|NCT02695992|NT-proBNP|nt-probnp
1075631|NCT02695992|Biomarkers|biomarkers
1075632|NCT02695953|PTSD|ptsd
1075633|NCT02695953|biomarker|biomarker
1075634|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
1075635|NCT02695914|Inflammatory markers|inflammatory markers
1075636|NCT02695901|Plaque index|plaque index
1075637|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
1075638|NCT02695901|Nanoparticles|nanoparticles
1075639|NCT02695875|Fibromyalgia|fibromyalgia
1075640|NCT02695875|Pain|pain
1075641|NCT02695875|Postural balance|postural balance
1075642|NCT02695875|Physical therapy|physical therapy
1075643|NCT02695875|Aquatic therapy|aquatic therapy
1075644|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1075645|NCT02695836|Audit and Feedback|audit and feedback
1075646|NCT02695836|Nursing Homes|nursing homes
1075647|NCT02695836|Organizational Context|organizational context
1075648|NCT02695836|Quality Improvement|quality improvement
1075649|NCT02695836|Care Aides|care aides
1075650|NCT02695836|Leadership|leadership
1075651|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
1075652|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
1075653|NCT02695823|intracranial hypertension|intracranial hypertension
1075654|NCT02695823|liver transplantation|liver transplantation
1075655|NCT02695823|transcranial Doppler|transcranial doppler
1075656|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
1075657|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
1075658|NCT02695797|Immunotherapy|immunotherapy
1075659|NCT02695771|bladder tumors|bladder tumors
1075660|NCT02695771|urinary tumors|urinary tumors
1075661|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
1075662|NCT02695771|NMIBC|nmibc
1075663|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
1075664|NCT02695732|Primary Prophylaxis|primary prophylaxis
1075665|NCT02695732|Carvedilol|carvedilol
1075666|NCT02695732|Endoscopy|endoscopy
1075667|NCT02695719|Drug therapy|drug therapy
1075668|NCT02695706|Diabetes|diabetes
1075669|NCT02695706|Skin acceptability|skin acceptability
1075670|NCT02695706|Clinical Research|clinical research
1075671|NCT02695680|Lung Cancer|lung cancer
1075672|NCT02695680|SBRT|sbrt
1075673|NCT02695680|Motion Management|motion management
1075674|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
1075675|NCT02695641|Arteriovenous Graft|arteriovenous graft
1118010|NCT02444611|BCG|bcg
1075676|NCT02695641|Bevacizumab|bevacizumab
1075677|NCT02695641|Hemodialysis|hemodialysis
1075678|NCT02695641|VEGF|vegf
1075679|NCT02695641|Avastin|avastin
1075680|NCT02695615|cesarean operation|cesarean operation
1075681|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
1075682|NCT02695615|pain|pain
1075683|NCT02695563|Amniocentesis|amniocentesis
1075684|NCT02695524|Rehabilitation|rehabilitation
1075685|NCT02695524|Shoulder|shoulder
1075686|NCT02695498|migraine with aura|migraine with aura
1075687|NCT02695498|migraine without aura|migraine without aura
1075688|NCT02695498|pain|pain
1075689|NCT02695498|controls|controls
1075690|NCT02695498|mind-body|mind-body
1075691|NCT02695485|dorsal digital island flap|dorsal digital island flap
1075692|NCT02695485|sensory reconstruction|sensory reconstruction
1075693|NCT02695472|Depression|depression
1075694|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1075695|NCT02695472|Major Depressive Disorder|major depressive disorder
1075696|NCT02695472|Neurogenesis|neurogenesis
1075697|NCT02695472|Synaptogenesis|synaptogenesis
1075698|NCT02695472|NSI-189|nsi-189
1075699|NCT02695472|Neuralstem|neuralstem
1075700|NCT02695433|Pre-diabetes|pre-diabetes
1075701|NCT02695433|Metabolic syndrome|metabolic syndrome
1075702|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
1075703|NCT02695433|Blood glucose|blood glucose
1075704|NCT02695433|Insulin response|insulin response
1075705|NCT02695433|HbA1c|hba1c
1075706|NCT02695433|Lipid|lipid
1075707|NCT02695433|Inflammation|inflammation
1075708|NCT02695420|Heart Failure|heart failure
1075709|NCT02695407|artery cannulation|artery cannulation
1075710|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
1075711|NCT02695342|Balance|balance
1075712|NCT02695342|Falls|falls
1075713|NCT02695342|Exercise|exercise
1075714|NCT02695342|COPD|copd
1075715|NCT02695329|navigation system|navigation system
1075716|NCT02695329|palm-sized|palm-sized
1075717|NCT02695329|total knee arthroplasty|total knee arthroplasty
1075718|NCT02695316|Migrants|migrants
1075719|NCT02695316|Communication Barriers|communication barriers
1075720|NCT02695316|Maternal Health Services|maternal health services
1075721|NCT02695316|Health Services Needs and Demand|health services needs and demand
1075723|NCT02695316|Professional-Patient Relations|professional-patient relations
1075724|NCT02695316|Eritrea|eritrea
1075725|NCT02695316|Kosovo|kosovo
1075726|NCT02695316|Switzerland|switzerland
1075727|NCT02695277|Atrial Fibrillation|atrial fibrillation
1075728|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
1075729|NCT02695277|Hybrid Procedure|hybrid procedure
1075730|NCT02695277|Catheter Ablation|catheter ablation
1075731|NCT02695264|intracranial pressure|intracranial pressure
1075732|NCT02695264|intracranial hypertension|intracranial hypertension
1075733|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
1075734|NCT02695199|Doppler Ultrasound|doppler ultrasound
1075735|NCT02695199|Laparoscopic|laparoscopic
1075736|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
1075737|NCT02695186|Intestinal metaplasia|intestinal metaplasia
1075738|NCT02695186|Metabolic syndrome|metabolic syndrome
1075739|NCT02695186|Oxidative stress|oxidative stress
1075740|NCT02695108|Scapula|scapula
1075741|NCT02695108|Neck|neck
1075742|NCT02695108|Pain|pain
1075743|NCT02695108|Therapy|therapy
1075744|NCT02695108|Kinematic|kinematic
1075745|NCT02695069|Complete Placenta Previa|complete placenta previa
1075746|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
1075747|NCT02695069|Cesarean Section|cesarean section
1075748|NCT02695069|Hemorrhage|hemorrhage
1075749|NCT02694991|surgery|surgery
1075750|NCT02694991|outcome|outcome
1075751|NCT02694991|pain|pain
1075752|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
1075753|NCT02694978|iron deficiency anemia|iron deficiency anemia
1075754|NCT02694978|IDA|ida
1075755|NCT02694978|ferumoxytol|ferumoxytol
1075756|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
1075757|NCT02694978|FCM|fcm
1075758|NCT02694978|Injectafer|injectafer
1075759|NCT02694978|Feraheme|feraheme
1075760|NCT02694978|Ferinject|ferinject
1075761|NCT02694926|adrenal crisis|adrenal crisis
1075762|NCT02694926|education programme|education programme
1075763|NCT02694887|Capillary blood|capillary blood
1075764|NCT02694887|Venous blood|venous blood
1075765|NCT02694887|Lactate|lactate
1075766|NCT02694887|Emergency Department|emergency department
1075767|NCT02694874|Adjunctive treatment|adjunctive treatment
1075768|NCT02694874|Severe malaria|severe malaria
1075769|NCT02694861|Angina Pectoris|angina pectoris
1075776|NCT02694783|Progressive Multifocal Encephalopathy (PML)|progressive multifocal encephalopathy (pml)
1075778|NCT02694770|GvHD|gvhd
1075779|NCT02694770|sr-aGvHD|sr-agvhd
1075780|NCT02694770|biologics|biologics
1075781|NCT02694770|monoclonal antibody|monoclonal antibody
1075782|NCT02694757|Ostom-i|ostom-i
1075783|NCT02694757|OIA device|oia device
1075784|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
1075785|NCT02694744|Hyperkalemia|hyperkalemia
1075786|NCT02694744|Potassium|potassium
1075787|NCT02694744|Chronic Kidney Disease|chronic kidney disease
1075788|NCT02694731|Craving|craving
1075789|NCT02694731|Mobile Apps|mobile apps
1075790|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
1075791|NCT02694705|Intubation|intubation
1075792|NCT02694705|Emergency Medicine|emergency medicine
1075793|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
1075794|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
1075795|NCT02694640|Breast cancer|breast cancer
1075796|NCT02694640|Exercise|exercise
1075797|NCT02694640|Physical activity|physical activity
1075798|NCT02694640|Community volunteers|community volunteers
1075799|NCT02694640|Peer mentors|peer mentors
1075800|NCT02694640|Peer coaches|peer coaches
1075801|NCT02694640|Social support|social support
1075802|NCT02694640|Exercise maintenance|exercise maintenance
1075803|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
1075804|NCT02694614|weight loss|weight loss
1075805|NCT02694614|individualised dietary coaching|individualised dietary coaching
1075806|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
1075807|NCT02694614|health behavior change|health behavior change
1075808|NCT02694588|Vedolizumab|vedolizumab
1075809|NCT02694588|Infliximab|infliximab
1075810|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
1075811|NCT02694549|Vascular Closure Devices|vascular closure devices
1075812|NCT02694549|Catheterization Closure Devices|catheterization closure devices
1075813|NCT02694549|Vascular Access Devices|vascular access devices
1075814|NCT02694523|Psoriasis|psoriasis
1075815|NCT02694523|Skin Diseases|skin diseases
1075816|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
1075817|NCT02694523|Adalimumab|adalimumab
1075818|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
1075819|NCT02694523|ABBV-066|abbv-066
1075820|NCT02694523|BI 655066|bi 655066
1075821|NCT02694523|Risankizumab|risankizumab
1075822|NCT02694510|Preterm infants|preterm infants
1075823|NCT02694510|Oxidative stress|oxidative stress
1075824|NCT02694510|Parenteral nutrition|parenteral nutrition
1075825|NCT02694497|transmission|transmission
1075826|NCT02694497|women|women
1075827|NCT02694497|genital|genital
1075829|NCT02694484|Cytomegalovirus|cytomegalovirus
1075830|NCT02694484|Stool sample|stool sample
1075831|NCT02694484|Healthy Volunteers|healthy volunteers
1075832|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
1075833|NCT02694471|Ageing|ageing
1075834|NCT02694471|Physical inactivity|physical inactivity
1075835|NCT02694471|Functional decline|functional decline
1075836|NCT02694471|Reconditioning|reconditioning
1075837|NCT02694458|Vancomycin|vancomycin
1075838|NCT02694458|Children|children
1075839|NCT02694458|Infection|infection
1075840|NCT02694458|Antibiotic|antibiotic
1075841|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1075842|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
1075843|NCT02694458|Pharmacokinetics|pharmacokinetics
1075844|NCT02694458|Pharmacodynamics|pharmacodynamics
1075845|NCT02694458|Bayesian approach|bayesian approach
1075846|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
1075847|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
1075848|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
1075849|NCT02694419|endometrium|endometrium
1075850|NCT02694406|Diagnosis|diagnosis
1075851|NCT02694367|genetic basis|genetic basis
1075852|NCT02694341|Management|management
1075853|NCT02694328|Alkermes|alkermes
1075854|NCT02694328|ALKS 3831|alks 3831
1075855|NCT02694328|Samidorphan|samidorphan
1075856|NCT02694328|Schizophrenia|schizophrenia
1075857|NCT02694328|Olanzapine|olanzapine
1075858|NCT02694328|Weight|weight
1075859|NCT02694302|Stroke|stroke
1075860|NCT02694250|cervical|cervical
1075861|NCT02694250|fusion|fusion
1075862|NCT02694250|radiculopathy|radiculopathy
1075863|NCT02694250|DTRAX|dtrax
1075864|NCT02694224|breast cancer|breast cancer
1075865|NCT02694224|triple negative|triple negative
1075866|NCT02694224|neoadjuvant|neoadjuvant
1075867|NCT02694211|work related stress|work related stress
1075868|NCT02694185|Medication Adherence|medication adherence
1075869|NCT02694185|Randomized Controlled Trial|randomized controlled trial
1075870|NCT02694185|Veterans|veterans
1075871|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
1075872|NCT02694172|healthy subjects|healthy subjects
1075873|NCT02694172|human microbiome|human microbiome
1075874|NCT02694172|cereal bar|cereal bar
1075875|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
1075876|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
1075877|NCT02694146|NSAIDs|nsaids
1075878|NCT02694146|WOMAC|womac
1075879|NCT02694133|telerehabilitation|telerehabilitation
1075880|NCT02694133|aphasia|aphasia
1075881|NCT02694133|speech therapy|speech therapy
1075882|NCT02694133|rehabilitation device|rehabilitation device
1075883|NCT02694133|visual action therapy|visual action therapy
1075884|NCT02694133|naming drills|naming drills
1075885|NCT02694094|cholesterol|cholesterol
1075886|NCT02694094|seizure|seizure
1075887|NCT02694094|epilepsy|epilepsy
1075888|NCT02694094|ketogenic|ketogenic
1075889|NCT02694094|diet|diet
1075890|NCT02694081|reflux|reflux
1075891|NCT02694081|residue|residue
1075892|NCT02694081|Gastric stasis|gastric stasis
1075893|NCT02694081|Emptying time|emptying time
1075894|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
1075895|NCT02694068|Genetic|genetic
1075896|NCT02694068|Peritoneal Membrane|peritoneal membrane
1075897|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
1075898|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
1075899|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1075900|NCT02694055|Community Health Workers|community health workers
1075901|NCT02694055|Community Case Management|community case management
1075902|NCT02694055|Proactive Case Detection|proactive case detection
1075903|NCT02694055|Under-five Child Mortality|under-five child mortality
1075904|NCT02694055|Access to Health Care|access to health care
1075905|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
1075906|NCT02694042|Crohn's disease|crohn's disease
1075907|NCT02694042|Ulcerative colitis|ulcerative colitis
1075908|NCT02694042|Web-based teaching and support|web-based teaching and support
1075909|NCT02694042|disease self-management|disease self-management
1075910|NCT02694042|peer support|peer support
1075911|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
1075912|NCT02694016|Neuroprotection|neuroprotection
1075913|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1075914|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
1075915|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
1075916|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
1075917|NCT02694003|Behavioural Insomnia|behavioural insomnia
1075918|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
1075919|NCT02693990|Tumor lining the brain|tumor lining the brain
1075920|NCT02693990|Meningioma|meningioma
1075921|NCT02693990|Brain Tumor|brain tumor
1075922|NCT02693977|OSA|osa
1075923|NCT02693977|sleep apnea|sleep apnea
1075924|NCT02693977|AT|at
1075925|NCT02693977|adenotonsillectomy|adenotonsillectomy
1075926|NCT02693977|pediatric|pediatric
1075927|NCT02693964|Type 1 Diabetes|type 1 diabetes
1075929|NCT02693964|Cardiovascular Risk|cardiovascular risk
1075930|NCT02693964|Bone Density|bone density
1075931|NCT02693951|gastric varices|gastric varices
1075932|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
1075933|NCT02693938|diabetes|diabetes
1075934|NCT02693938|menstrual cycle|menstrual cycle
1075935|NCT02693938|insulin|insulin
1075936|NCT02693912|efferocytosis|efferocytosis
1075937|NCT02693912|macrophage|macrophage
1075938|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
1075939|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
1075940|NCT02693873|Patient Education|patient education
1075941|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
1075942|NCT02693873|Disease Management|disease management
1075943|NCT02693873|Evidence-Based Health Care|evidence-based health care
1075944|NCT02693873|Pilot Study|pilot study
1075945|NCT02693847|HCV|hcv
1075946|NCT02693847|HIV|hiv
1075947|NCT02693847|Liver cirrhosis|liver cirrhosis
1075948|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
1075949|NCT02693847|Liver transplant|liver transplant
1075950|NCT02693847|Liver stiffness|liver stiffness
1075951|NCT02693847|Transient elastography|transient elastography
1075952|NCT02693834|foot drop|foot drop
1075953|NCT02693834|Subacute stroke|subacute stroke
1075954|NCT02693834|AFO|afo
1075955|NCT02693834|gait symmetry|gait symmetry
1075956|NCT02693834|Gait endurance|gait endurance
1075957|NCT02693821|Gabapentin|gabapentin
1075958|NCT02693821|prevention|prevention
1075959|NCT02693821|incidence|incidence
1075960|NCT02693808|Temporal hollowing|temporal hollowing
1075961|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
1075962|NCT02693808|Thyroid eye disease|thyroid eye disease
1075963|NCT02693795|myocardial infarction|myocardial infarction
1075964|NCT02693795|left ventricular remodeling|left ventricular remodeling
1075965|NCT02693782|Fibre|fibre
1075966|NCT02693782|Wheat Bran Extract|wheat bran extract
1075967|NCT02693782|Microbiota|microbiota
1075968|NCT02693782|Microbiota metabolites|microbiota metabolites
1075969|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
1075970|NCT02693743|suicidality|suicidality
1075971|NCT02693743|rTMS|rtms
1075972|NCT02693743|suicide ideation|suicide ideation
1075973|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
1075974|NCT02693730|IBS|ibs
1075975|NCT02693730|Ulcerative Colitis|ulcerative colitis
1075976|NCT02693730|UC|uc
1075977|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
1075978|NCT02693730|IBD|ibd
1075979|NCT02693730|Healthy Control|healthy control
1075980|NCT02693730|HC|hc
1075981|NCT02693730|Visceral Pain|visceral pain
1075982|NCT02693730|Gut|gut
1075983|NCT02693730|Neuroimaging|neuroimaging
1075984|NCT02693730|fMRI|fmri
1075985|NCT02693730|resting state|resting state
1075986|NCT02693730|structural MRI|structural mri
1075987|NCT02693730|functional MRI|functional mri
1075988|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
1075989|NCT02693730|MR Spectroscopy|mr spectroscopy
1075990|NCT02693717|Cancer of urethra|cancer of urethra
1075991|NCT02693717|Cancer of ureters|cancer of ureters
1075992|NCT02693717|MTAP-deficient bladder cancer|mtap-deficient bladder cancer
1075993|NCT02693717|MTAP wild-type bladder cancer|mtap wild-type bladder cancer
1075994|NCT02693717|Metastatic|metastatic
1075995|NCT02693717|Pemetrexed|pemetrexed
1075996|NCT02693717|LY231514|ly231514
1075997|NCT02693717|Alimta|alimta
1075998|NCT02693717|MTA|mta
1075999|NCT02693717|Multitargeted Antifolate|multitargeted antifolate
1076000|NCT02693717|NSC-698037|nsc-698037
1076001|NCT02693717|Folic Acid|folic acid
1076002|NCT02693717|Folinic Acid|folinic acid
1076003|NCT02693717|Vitamin B12|vitamin b12
1076004|NCT02693717|Dexamethasone|dexamethasone
1076005|NCT02693717|Decadron|decadron
1076006|NCT02693678|Proprioception|proprioception
1076007|NCT02693678|Doms|doms
1076008|NCT02693678|Pain|pain
1076009|NCT02693678|Massage|massage
1076010|NCT02693678|Diathermy|diathermy
1076011|NCT02693665|pediatric advance care planning|pediatric advance care planning
1076012|NCT02693665|adolescent|adolescent
1076013|NCT02693665|family|family
1076014|NCT02693665|palliative care|palliative care
1076015|NCT02693665|end of life|end of life
1076016|NCT02693665|communication|communication
1076017|NCT02693665|decision making|decision making
1076018|NCT02693665|surrogate decision maker|surrogate decision maker
1076019|NCT02693665|health care proxy|health care proxy
1076020|NCT02693665|intervention|intervention
1076021|NCT02693665|randomized clinical trial|randomized clinical trial
1076022|NCT02693665|cancer|cancer
1076023|NCT02693665|quality of life|quality of life
1076024|NCT02693665|spiritual|spiritual
1076025|NCT02693665|religion|religion
1076026|NCT02693665|treatment congruence|treatment congruence
1076027|NCT02693665|treatment preferences|treatment preferences
1076028|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
1076029|NCT02693639|PANX1|panx1
1076030|NCT02693639|Infection|infection
1076031|NCT02693639|Liver transplantation|liver transplantation
1076032|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
1076033|NCT02693626|'Happy Quit'|'happy quit'
1076034|NCT02693626|smoking cessation|smoking cessation
1076035|NCT02693613|Drug-drug interaction|drug-drug interaction
1076036|NCT02693613|Kremezin|kremezin
1076037|NCT02693613|Pharmacokinetics|pharmacokinetics
1076038|NCT02693613|ASP1517|asp1517
1076039|NCT02693600|Total Trapeziectomy|total trapeziectomy
1076040|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
1076041|NCT02693600|Ligamentoplasty|ligamentoplasty
1076042|NCT02693574|Helicobacter pylori|helicobacter pylori
1076043|NCT02693574|Helicobacter Infections|helicobacter infections
1076044|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
1076045|NCT02693561|Self-help book|self-help book
1076046|NCT02693561|Deep breathing|deep breathing
1076047|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
1076048|NCT02693548|Prognosis|prognosis
1076049|NCT02693548|Cardiovascular disease|cardiovascular disease
1076050|NCT02693535|cancer|cancer
1076051|NCT02693535|off-label|off-label
1076052|NCT02693535|precision medicine|precision medicine
1076053|NCT02693535|targeted therapy|targeted therapy
1076054|NCT02693496|ResearchKit|researchkit
1076055|NCT02693496|CT screening|ct screening
1076056|NCT02693496|Early Diagnosis|early diagnosis
1076057|NCT02693496|Lung Cancer|lung cancer
1076058|NCT02693392|Fenugreek seed extract|fenugreek seed extract
1076059|NCT02693392|HbA1c|hba1c
1076060|NCT02693392|Blood glucose|blood glucose
1076061|NCT02693379|cervical cancer|cervical cancer
1076062|NCT02693379|HPV|hpv
1076063|NCT02693379|VIA|via
1076064|NCT02693379|screening|screening
1076065|NCT02693379|smartphone|smartphone
1076066|NCT02693379|telemedicine|telemedicine
1076067|NCT02693366|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
1076068|NCT02693366|Glomerulosclerosis, Focal Segmental|glomerulosclerosis, focal segmental
1076069|NCT02693366|Renal Insufficiency, Chronic|renal insufficiency, chronic
1076070|NCT02693327|Gut Microbiome|gut microbiome
1076071|NCT02693327|Mental Disorder|mental disorder
1076072|NCT02693327|Dysbiosis|dysbiosis
1076073|NCT02693314|Jarro-Dophilus|jarro-dophilus
1076074|NCT02693314|probiotic|probiotic
1076075|NCT02693314|microbiota|microbiota
1076076|NCT02693314|gastrointestinal|gastrointestinal
1076077|NCT02693301|Asthma|asthma
1076078|NCT02693301|Respiratory symptoms|respiratory symptoms
1076079|NCT02693301|Exercise program|exercise program
1118508|NCT02441803|AML|aml
1076080|NCT02693301|Functional capacity|functional capacity
1076081|NCT02693301|Body composition|body composition
1076082|NCT02693288|Wrist fracture|wrist fracture
1076083|NCT02693288|postoperative pain|postoperative pain
1076084|NCT02693288|local anesthesia|local anesthesia
1076085|NCT02693275|Community Sampling|community sampling
1076086|NCT02693262|defibrillator|defibrillator
1076087|NCT02693262|heart failure|heart failure
1076088|NCT02693262|ICD|icd
1076089|NCT02693262|CRT-D|crt-d
1076090|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
1076091|NCT02693262|rate response|rate response
1076092|NCT02693262|CLS|cls
1076093|NCT02693262|closed-loop stimulation|closed-loop stimulation
1076094|NCT02693262|accelerometer|accelerometer
1076095|NCT02693262|chronotropic incompetence|chronotropic incompetence
1076096|NCT02693249|accidents|accidents
1076097|NCT02693249|adolescents|adolescents
1076098|NCT02693249|children|children
1076099|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
1076100|NCT02693223|stroke|stroke
1076101|NCT02693197|Hepatic Impairment|hepatic impairment
1076102|NCT02693145|HIV/AIDS|hiv/aids
1076103|NCT02693145|re-engagement in care|re-engagement in care
1076104|NCT02693145|data to care|data to care
1076105|NCT02693132|Obesity|obesity
1076106|NCT02693132|Exercise|exercise
1076107|NCT02693119|LHON|lhon
1076108|NCT02693119|Ocuvia™|ocuvia™
1076109|NCT02693119|elamipretide|elamipretide
1076110|NCT02693119|MTP-131|mtp-131
1076111|NCT02693041|Probiotics|probiotics
1076112|NCT02693041|inflammation|inflammation
1076113|NCT02693041|immunological response|immunological response
1076114|NCT02693041|preterm birth|preterm birth
1076115|NCT02693041|preeclampsia|preeclampsia
1076116|NCT02693028|Microbiome|microbiome
1076117|NCT02693028|probiotic|probiotic
1076118|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
1076119|NCT02692976|Dendritic Cells|dendritic cells
1076120|NCT02692976|Immunotherapy|immunotherapy
1076121|NCT02692976|Vaccines|vaccines
1076122|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
1076123|NCT02692937|Nerve Block|nerve block
1076124|NCT02692937|Exercise therapy|exercise therapy
1076125|NCT02692937|Physical Therapy Specialty|physical therapy specialty
1076126|NCT02692924|Pregnancy Complications|pregnancy complications
1076127|NCT02692924|Ultrasound|ultrasound
1076128|NCT02692911|Gallbaldder|gallbaldder
1076129|NCT02692911|Cancer|cancer
1076130|NCT02692911|Gallstones|gallstones
1076131|NCT02692911|Cholecystectomy|cholecystectomy
1076132|NCT02692911|Inflammation|inflammation
1076133|NCT02692898|Brain Tumor|brain tumor
1076134|NCT02692898|Molecular Pathology|molecular pathology
1076135|NCT02692898|Clinical Data|clinical data
1076136|NCT02692898|Imaging Data|imaging data
1076138|NCT02692885|Adipose Tissue|adipose tissue
1076139|NCT02692885|Brown Adipose Tissue|brown adipose tissue
1076140|NCT02692872|Alpha Thalassemia|alpha thalassemia
1076141|NCT02692872|alpha globin|alpha globin
1076142|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
1076143|NCT02692846|Cardiovascular Disease|cardiovascular disease
1076144|NCT02692846|Elastin Gene Mutation|elastin gene mutation
1076145|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
1076146|NCT02692833|Telomere|telomere
1076147|NCT02692833|Telomerase|telomerase
1076148|NCT02692833|DNA methylation|dna methylation
1076149|NCT02692833|Cell aging|cell aging
1076150|NCT02692833|Thoracic Surgery|thoracic surgery
1076151|NCT02692820|Preterm|preterm
1076152|NCT02692820|Probiotic|probiotic
1076153|NCT02692807|hip arthroscopy|hip arthroscopy
1076154|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
1076155|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
1076156|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
1076157|NCT02692794|sinusitis|sinusitis
1076158|NCT02692794|oximetry|oximetry
1076159|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
1076160|NCT02692781|Obesity|obesity
1076161|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
1076162|NCT02692768|total shoulder replacement|total shoulder replacement
1076163|NCT02692768|adult|adult
1076164|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
1076165|NCT02692755|African American|african american
1076166|NCT02692742|Chemotherapy|chemotherapy
1076167|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
1076168|NCT02692742|Supportive Care|supportive care
1076169|NCT02692742|Myelosuppression|myelosuppression
1076170|NCT02692742|CIN|cin
1076171|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
1076172|NCT02692703|Hepatitis C|hepatitis c
1076786|NCT02689349|implant|implant
1076175|NCT02692703|Non-cirrhotic|non-cirrhotic
1076176|NCT02692703|HCV Genotype 2|hcv genotype 2
1076177|NCT02692703|Renal Transplant|renal transplant
1076178|NCT02692703|HCV Treatment Naive|hcv treatment naive
1076179|NCT02692703|Post transplant|post transplant
1076180|NCT02692703|HCV Genotype 6|hcv genotype 6
1076181|NCT02692703|Liver Transplant|liver transplant
1076182|NCT02692703|HCV Genotype 5|hcv genotype 5
1076183|NCT02692703|HCV Genotype 4|hcv genotype 4
1076184|NCT02692703|Kidney Transplant|kidney transplant
1076185|NCT02692703|HCV Genotype 1|hcv genotype 1
1076187|NCT02692677|JNJ-42756493|jnj-42756493
1076188|NCT02692664|iliac side branch|iliac side branch
1076189|NCT02692651|vancomycin|vancomycin
1076190|NCT02692651|fidaxomicin|fidaxomicin
1076191|NCT02692651|CDI|cdi
1076192|NCT02692651|diarrhea|diarrhea
1076193|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
1076194|NCT02692599|safety|safety
1076195|NCT02692599|immunogenicity|immunogenicity
1076196|NCT02692599|infant|infant
1076197|NCT02692586|Thromboembolism|thromboembolism
1076198|NCT02692586|Thrombectomy|thrombectomy
1076199|NCT02692586|Right Heart Strain|right heart strain
1076200|NCT02692586|Submassive PE|submassive pe
1076201|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
1076202|NCT02692586|Massive PE|massive pe
1076205|NCT02692534|Anesthesia|anesthesia
1076206|NCT02692534|Cocaine Use|cocaine use
1076207|NCT02692508|cardiovascular MRI|cardiovascular mri
1076208|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
1076209|NCT02692508|giant negative T-wave|giant negative t-wave
1076210|NCT02692508|wall thickness|wall thickness
1076211|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
1076212|NCT02692508|Early Diagnosis|early diagnosis
1076213|NCT02692508|Prognosis|prognosis
1076214|NCT02692495|body odor|body odor
1076215|NCT02692495|halitosis|halitosis
1076216|NCT02692495|dysbiosis|dysbiosis
1076217|NCT02692495|leaky gut|leaky gut
1076218|NCT02692495|microbiome|microbiome
1076219|NCT02692495|PATM|patm
1076220|NCT02692495|breath odor|breath odor
1076221|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
1076222|NCT02692443|Congenital Heart Disease|congenital heart disease
1076223|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
1076224|NCT02692443|CHD|chd
1076225|NCT02692443|MRI|mri
1076226|NCT02692443|Neurodevelopmental|neurodevelopmental
1076227|NCT02692430|Portosystemic Shunt|portosystemic shunt
1076228|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
1076229|NCT02692430|Portal hypertension|portal hypertension
1076230|NCT02692430|Liver cirrhosis|liver cirrhosis
1076231|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
1076232|NCT02692417|female sexual dysfunction|female sexual dysfunction
1076233|NCT02692417|genital arousal disorder|genital arousal disorder
1076234|NCT02692417|sexual|sexual
1076235|NCT02692417|dysfunction|dysfunction
1076236|NCT02692417|female|female
1076237|NCT02692417|arousal|arousal
1076238|NCT02692417|electrical stimulation|electrical stimulation
1076239|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
1076240|NCT02692417|women|women
1076241|NCT02692404|Postpartum Depression|postpartum depression
1076447|NCT02691052|metastatic|metastatic
1076242|NCT02692404|Perinatal Depression|perinatal depression
1076243|NCT02692404|Pregnancy|pregnancy
1076244|NCT02692404|Anesthesia|anesthesia
1076245|NCT02692404|Obstetric|obstetric
1076246|NCT02692404|Pain|pain
1076247|NCT02692404|Analgesia|analgesia
1076248|NCT02692404|Epidural|epidural
1076249|NCT02692404|Midwife|midwife
1076250|NCT02692404|Infant Development|infant development
1076251|NCT02692404|Pain Management|pain management
1076252|NCT02692391|Acute pancreatitis|acute pancreatitis
1076253|NCT02692391|Indomethacin|indomethacin
1076254|NCT02692391|Organ failure|organ failure
1076255|NCT02692391|Prevention|prevention
1076256|NCT02692378|Haemodialysis|haemodialysis
1076257|NCT02692378|sodium bicarbonate|sodium bicarbonate
1076258|NCT02692378|potassium|potassium
1076259|NCT02692378|arrhythmia|arrhythmia
1076260|NCT02692378|muscle|muscle
1076261|NCT02692378|symptoms|symptoms
1076262|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
1076263|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
1076264|NCT02692339|Lenalidomide|lenalidomide
1076265|NCT02692339|Dexamethasone|dexamethasone
1076266|NCT02692339|Observational Study|observational study
1076267|NCT02692339|Safety of Len/Dex|safety of len/dex
1076268|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
1076269|NCT02692326|infant newborn|infant newborn
1076270|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
1076271|NCT02692313|epinephrine|epinephrine
1076272|NCT02692313|counterregulation|counterregulation
1076273|NCT02692313|dose responses|dose responses
1076274|NCT02692300|anesthesia|anesthesia
1076275|NCT02692300|delirium|delirium
1076276|NCT02692300|surgery|surgery
1076277|NCT02692300|electroencephalography|electroencephalography
1076278|NCT02692300|burst suppression|burst suppression
1076279|NCT02692300|PTSD|ptsd
1076280|NCT02692300|anxiety|anxiety
1076281|NCT02692300|depression|depression
1076282|NCT02692300|falls|falls
1076283|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
1076284|NCT02692274|Rural primary health care|rural primary health care
1076285|NCT02692274|Access|access
1076286|NCT02692274|Need|need
1076287|NCT02692274|Usage|usage
1076288|NCT02692274|Maternal Health|maternal health
1076289|NCT02692235|carnitine|carnitine
1076290|NCT02692235|leucine|leucine
1076291|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
1076292|NCT02692222|Captesia|captesia
1076293|NCT02692222|cardiac output monitoring|cardiac output monitoring
1076294|NCT02692209|Mammography|mammography
1076295|NCT02692196|Neurofeedback|neurofeedback
1076296|NCT02692196|Emotion processing|emotion processing
1076297|NCT02692196|Real-time|real-time
1076298|NCT02692196|fMRI|fmri
1076299|NCT02692183|Parkinson's disease|parkinson's disease
1076300|NCT02692183|ET|et
1076301|NCT02692183|EEG|eeg
1076302|NCT02692183|FUS|fus
1076303|NCT02692183|BNA|bna
1076304|NCT02692183|Essential tremor|essential tremor
1076305|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
1076306|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
1076307|NCT02692105|intermediate risk group|intermediate risk group
1076308|NCT02692105|brachytherapy|brachytherapy
1076309|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
1076310|NCT02692105|Quality of Life|quality of life
1076311|NCT02692092|Complications|complications
1076312|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
1076313|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
1076314|NCT02692079|Angiogenesis|angiogenesis
1076315|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
1076316|NCT02692079|Flap surgery|flap surgery
1076317|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
1076318|NCT02692040|obesity|obesity
1076319|NCT02692040|diabetes mellitus|diabetes mellitus
1076320|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
1076321|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
1076322|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
1076323|NCT02692027|Lesotho|lesotho
1076324|NCT02692027|Sub-sahara Africa|sub-sahara africa
1076325|NCT02692027|antiretroviral therapy|antiretroviral therapy
1076326|NCT02692027|AIDS|aids
1076327|NCT02692027|Test and treat|test and treat
1076328|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
1076329|NCT02691988|General practice|general practice
1076330|NCT02691988|Primary care|primary care
1076331|NCT02691988|Pharmacotherapy|pharmacotherapy
1076332|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
1076333|NCT02691936|Menopause|menopause
1076334|NCT02691936|Atrophic vaginitis|atrophic vaginitis
1076335|NCT02691923|High Grade Glioma|high grade glioma
1076336|NCT02691923|Low Grade Glioma|low grade glioma
1076337|NCT02691923|Brain Tumor|brain tumor
1076338|NCT02691910|malaria|malaria
1076339|NCT02691910|Plasmodium vivax|plasmodium vivax
1076340|NCT02691910|treatment|treatment
1076341|NCT02691910|Chloroquine|chloroquine
1076342|NCT02691910|Primaquine|primaquine
1076343|NCT02691897|Diabetes mellitus|diabetes mellitus
1076344|NCT02691897|Melatonin|melatonin
1076345|NCT02691897|Blood Glucose|blood glucose
1076346|NCT02691897|Therapeutics|therapeutics
1076347|NCT02691897|Pineal gland|pineal gland
1076348|NCT02691884|Heart Rate, Fetal|heart rate, fetal
1076349|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
1076350|NCT02691884|Transducers, Pressure|transducers, pressure
1076351|NCT02691858|Intussusception|intussusception
1076352|NCT02691819|jailed-balloon technique|jailed-balloon technique
1076353|NCT02691754|Paracetamol|paracetamol
1076354|NCT02691754|PPI|ppi
1076355|NCT02691754|Opioids|opioids
1076356|NCT02691754|NSAID|nsaid
1076357|NCT02691754|Drug Prescription|drug prescription
1076358|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
1076359|NCT02691702|Safety and Tolerability|safety and tolerability
1076360|NCT02691702|Pharmacokinetics|pharmacokinetics
1076361|NCT02691702|Pharmacodynamics|pharmacodynamics
1076362|NCT02691702|Melatonin|melatonin
1076363|NCT02691702|Plasma|plasma
1076364|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
1076365|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
1076366|NCT02691663|Geriatric|geriatric
1076367|NCT02691663|bicarbonate|bicarbonate
1076368|NCT02691650|serum cholinesterase|serum cholinesterase
1076369|NCT02691650|plasma cholinesterase|plasma cholinesterase
1076370|NCT02691650|pseudocholinesterase|pseudocholinesterase
1076371|NCT02691650|systemic inflammation|systemic inflammation
1076372|NCT02691650|SIRS|sirs
1076373|NCT02691650|polytrauma|polytrauma
1076374|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
1076375|NCT02691637|Eradication treatment|eradication treatment
1076376|NCT02691637|Reversibility|reversibility
1076377|NCT02691637|atrophic gastritis|atrophic gastritis
1076378|NCT02691637|intestinal metaplasia|intestinal metaplasia
1076379|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
1076380|NCT02691624|Breast cancer|breast cancer
1076381|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
1076382|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
1076383|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
1076384|NCT02691546|Older|older
1076385|NCT02691546|Geriatric assessment|geriatric assessment
1076386|NCT02691546|Biomarkers|biomarkers
1076387|NCT02691533|Acute|acute
1076388|NCT02691520|Treatment Resistant Depression|treatment resistant depression
1076389|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
1076390|NCT02691494|Elagolix|elagolix
1076391|NCT02691494|Elagolix Sodium|elagolix sodium
1076392|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
1076393|NCT02691494|Heavy menstrual bleeding|heavy menstrual bleeding
1076394|NCT02691494|Leiomyomata|leiomyomata
1076395|NCT02691494|Menorrhagia|menorrhagia
1076396|NCT02691494|ABT-620|abt-620
1076397|NCT02691494|Elagolix + E2/NETA|elagolix + e2/neta
1076398|NCT02691494|Elagolix + Norethindrone acetate|elagolix + norethindrone acetate
1076399|NCT02691494|HMB|hmb
1076400|NCT02691468|one lung ventilation|one lung ventilation
1076401|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
1076402|NCT02691468|displacement|displacement
1076403|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
1076404|NCT02691442|Peripheral nerve block|peripheral nerve block
1076405|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
1076406|NCT02691429|euterpe oleracea|euterpe oleracea
1076407|NCT02691429|chromovitrectomy|chromovitrectomy
1076408|NCT02691325|ELLIPTA|ellipta
1076409|NCT02691325|GSK2269557|gsk2269557
1076410|NCT02691325|Tolerability|tolerability
1076411|NCT02691325|Safety|safety
1076412|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
1076413|NCT02691325|Pharmacokinetics|pharmacokinetics
1076414|NCT02691312|type 1 diabetes|type 1 diabetes
1076415|NCT02691312|retinopathy|retinopathy
1076416|NCT02691299|NSCLC|nsclc
1076417|NCT02691260|obesity|obesity
1076418|NCT02691260|behavioral intervention|behavioral intervention
1076419|NCT02691260|diet|diet
1076420|NCT02691247|T1DM|t1dm
1076421|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1076422|NCT02691247|T regulatory cell|t regulatory cell
1076423|NCT02691247|Immunotherapy|immunotherapy
1076424|NCT02691247|Cell therapy|cell therapy
1076425|NCT02691247|T-Reg|t-reg
1076426|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
1076427|NCT02691208|acupuncture|acupuncture
1076428|NCT02691208|breast cancer|breast cancer
1076429|NCT02691208|rehabilitation|rehabilitation
1076430|NCT02691208|pain|pain
1076431|NCT02691195|Ultrasound|ultrasound
1076432|NCT02691195|Serratus Plane Block|serratus plane block
1076433|NCT02691195|Quality of recovery|quality of recovery
1076434|NCT02691156|Hematofluorometer|hematofluorometer
1076435|NCT02691130|influenza|influenza
1076436|NCT02691130|vaccine|vaccine
1076437|NCT02691130|universal|universal
1076438|NCT02691130|peptide|peptide
1076439|NCT02691130|prime|prime
1076440|NCT02691130|boost|boost
1076441|NCT02691130|HAI|hai
1076442|NCT02691130|CMI|cmi
1076443|NCT02691130|UNISEC|unisec
1076444|NCT02691117|Alopecia Areata|alopecia areata
1076445|NCT02691117|Garlic concentrate|garlic concentrate
1076446|NCT02691052|pancreatic cancer|pancreatic cancer
1076449|NCT02691026|Pembrolizumab|pembrolizumab
1076450|NCT02691000|depression|depression
1076451|NCT02691000|depressive symptoms|depressive symptoms
1076452|NCT02691000|stage b heart failure|stage b heart failure
1076453|NCT02691000|bright white light|bright white light
1076454|NCT02691000|light therapy|light therapy
1076455|NCT02690987|tobacco|tobacco
1076456|NCT02690987|GLP1|glp1
1076457|NCT02690987|ghrelin|ghrelin
1076458|NCT02690987|alcohol|alcohol
1076459|NCT02690987|appetite|appetite
1076460|NCT02690987|reward|reward
1076461|NCT02690987|addiction|addiction
1076462|NCT02690987|hormone|hormone
1076463|NCT02690987|cigarette|cigarette
1076464|NCT02690987|fMRI|fmri
1076465|NCT02690974|HFrEF,|hfref,
1076466|NCT02690974|ACEi,|acei,
1076467|NCT02690974|ACE inhibitor,|ace inhibitor,
1076468|NCT02690974|ARBs,|arbs,
1076469|NCT02690974|systolic heart failure,|systolic heart failure,
1076470|NCT02690974|chronic heart failure,|chronic heart failure,
1076471|NCT02690974|CHF,|chf,
1076472|NCT02690974|reduced EF,|reduced ef,
1076473|NCT02690974|Ejection Fraction|ejection fraction
1076474|NCT02690961|Healthy|healthy
1076475|NCT02690935|grass pollen|grass pollen
1076476|NCT02690935|homeopathy|homeopathy
1076477|NCT02690935|placebo|placebo
1076478|NCT02690935|quality of life|quality of life
1076479|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
1076480|NCT02690909|Resistant Hypertension|resistant hypertension
1076481|NCT02690909|Renal Denervation|renal denervation
1076482|NCT02690896|caregiver burden|caregiver burden
1076887|NCT02688777|Exercise|exercise
1076483|NCT02690896|caregiver support groups|caregiver support groups
1076484|NCT02690870|tamoxifen|tamoxifen
1076485|NCT02690870|clomiphene|clomiphene
1076486|NCT02690870|mild stimulation|mild stimulation
1076487|NCT02690870|poor ovarian response|poor ovarian response
1076488|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
1076489|NCT02690831|Asthma|asthma
1076490|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
1076491|NCT02690831|Manual Therapies|manual therapies
1076492|NCT02690818|Tuberculosis|tuberculosis
1076493|NCT02690818|Latent Tuberculosis|latent tuberculosis
1076494|NCT02690818|Texting|texting
1076495|NCT02690818|Adherence|adherence
1076496|NCT02690818|Medication|medication
1076497|NCT02690792|Healthy|healthy
1076498|NCT02690792|NAFLD|nafld
1076499|NCT02690792|NASH|nash
1076500|NCT02690792|Liver Metabolism|liver metabolism
1076501|NCT02690792|Vitamin E|vitamin e
1076502|NCT02690766|Cancer|cancer
1076503|NCT02690766|Breast Cancer|breast cancer
1076504|NCT02690766|Endometrial cancer,|endometrial cancer,
1076505|NCT02690766|Type 2 Diabetes|type 2 diabetes
1076506|NCT02690753|Repositioning|repositioning
1076507|NCT02690753|Incontinence care|incontinence care
1076508|NCT02690753|Prevention|prevention
1076509|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
1076510|NCT02690727|Fasting|fasting
1076511|NCT02690727|Fed condition|fed condition
1076512|NCT02690727|Pharmacokinetics|pharmacokinetics
1076513|NCT02690701|psoriasis|psoriasis
1076514|NCT02690701|plaque psoriasis|plaque psoriasis
1076515|NCT02690701|secukinumab|secukinumab
1076516|NCT02690701|AIN457|ain457
1076517|NCT02690701|biologic|biologic
1076518|NCT02690701|monoclonal antibody|monoclonal antibody
1076519|NCT02690688|Pulse Pressure Variation|pulse pressure variation
1076520|NCT02690688|NIRS|nirs
1076521|NCT02690688|Pneumoperitoneum|pneumoperitoneum
1076522|NCT02690688|Abdominal surgery|abdominal surgery
1076523|NCT02690675|Neurodevelopment|neurodevelopment
1076524|NCT02690675|Bayley Scale|bayley scale
1076525|NCT02690675|Growth|growth
1076526|NCT02690675|Iron fortification|iron fortification
1076527|NCT02690662|Obesity|obesity
1076528|NCT02690662|Kidney stones|kidney stones
1076529|NCT02690662|Diet|diet
1076530|NCT02690649|anticoagulants|anticoagulants
1076531|NCT02690649|Personal Health Records|personal health records
1076532|NCT02690623|hospitalist|hospitalist
1076533|NCT02690623|pediatric inpatient care|pediatric inpatient care
1076534|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
1076535|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
1076536|NCT02690597|Pain|pain
1076537|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
1076538|NCT02690597|Anxiety|anxiety
1076539|NCT02690584|Psychotherapy|psychotherapy
1076540|NCT02690571|Air Pollution|air pollution
1076541|NCT02690571|Biodiesel exhaust|biodiesel exhaust
1076542|NCT02690571|Bronchoscopy|bronchoscopy
1076543|NCT02690571|Metabolomics|metabolomics
1076544|NCT02690558|muscle-invasive|muscle-invasive
1076545|NCT02690545|CAR T cells|car t cells
1076546|NCT02690545|CD30|cd30
1076547|NCT02690545|Lymphoma|lymphoma
1076548|NCT02690545|T Lymphocytes|t lymphocytes
1076549|NCT02690532|Celiac|celiac
1076550|NCT02690532|Gluten|gluten
1076551|NCT02690532|Sensitivity|sensitivity
1076552|NCT02690532|Permeability|permeability
1076553|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
1076554|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
1076555|NCT02690532|Digestive System Diseases|digestive system diseases
1076556|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
1076557|NCT02690519|GLPG1837|glpg1837
1076558|NCT02690506|pregabalin|pregabalin
1076559|NCT02690506|spinal anesthesia|spinal anesthesia
1076560|NCT02690480|fulvestrant|fulvestrant
1076561|NCT02690480|palbociclib|palbociclib
1076562|NCT02690480|metastases|metastases
1076563|NCT02690480|postmenopausal|postmenopausal
1076564|NCT02690480|breast cancer|breast cancer
1076565|NCT02690480|hormone receptor positive|hormone receptor positive
1076566|NCT02690467|Insulin therapy|insulin therapy
1076567|NCT02690467|Needle|needle
1076568|NCT02690454|ticagrelor|ticagrelor
1076569|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
1076570|NCT02690454|platelet function tests|platelet function tests
1076571|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
1076572|NCT02690454|the VerifyNow® device|the verifynow® device
1076573|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
1076574|NCT02690454|pharmacokinetics|pharmacokinetics
1076575|NCT02690454|pharmacodynamics|pharmacodynamics
1076576|NCT02690454|Multiplate® ADPtest|multiplate® adptest
1076577|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
1076578|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
1076579|NCT02690441|GAD|gad
1076580|NCT02690441|CBT|cbt
1076581|NCT02690441|Physical exercise|physical exercise
1076582|NCT02690441|Older adults|older adults
1076583|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
1076584|NCT02690428|Laser Coagulation|laser coagulation
1076585|NCT02690428|Laser Therapy|laser therapy
1076586|NCT02690389|Acupuncture|acupuncture
1076587|NCT02690389|Flumazenil|flumazenil
1076588|NCT02690389|Narcotrend|narcotrend
1076589|NCT02690389|General Anaesthesia|general anaesthesia
1076590|NCT02690389|Sedation|sedation
1119133|NCT02438462|Imaging|imaging
1076591|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
1076593|NCT02690337|oncology|oncology
1076594|NCT02690337|refractory|refractory
1076595|NCT02690337|no standard treatment|no standard treatment
1076596|NCT02690272|kidney transplant|kidney transplant
1076597|NCT02690272|psychic process|psychic process
1076598|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1076599|NCT02690233|endothelial dysfunction|endothelial dysfunction
1076600|NCT02690233|surgery|surgery
1076601|NCT02690233|cardiovascular complications|cardiovascular complications
1076602|NCT02690233|EndoPat|endopat
1076603|NCT02690233|myocardial injury|myocardial injury
1076604|NCT02690233|myocardial infarction|myocardial infarction
1076605|NCT02690220|polypropylene mesh|polypropylene mesh
1076606|NCT02690220|prolapse|prolapse
1076607|NCT02690220|cystocele|cystocele
1076608|NCT02690220|surgical mesh|surgical mesh
1076609|NCT02690207|Herpes Zoster|herpes zoster
1076610|NCT02690207|Safety|safety
1076611|NCT02690207|Adults|adults
1076612|NCT02690207|Cross-vaccination|cross-vaccination
1076613|NCT02690194|Buddhify|buddhify
1076614|NCT02690194|Stress|stress
1076615|NCT02690194|Anxiety|anxiety
1076616|NCT02690194|Relaxation Technique|relaxation technique
1076617|NCT02690168|Fasting|fasting
1076618|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
1076619|NCT02690168|Neuroimaging|neuroimaging
1076620|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
1076621|NCT02690155|Prevention|prevention
1076622|NCT02690155|Stroke|stroke
1076623|NCT02690129|progesterone|progesterone
1076624|NCT02690129|threatened abortion|threatened abortion
1076625|NCT02690116|Meditative movement|meditative movement
1076626|NCT02690116|Breast cancer survivors|breast cancer survivors
1076627|NCT02690116|Qigong|qigong
1076628|NCT02690116|Tai Chi Easy|tai chi easy
1076629|NCT02690116|Fatigue|fatigue
1076630|NCT02690103|Arabinoxylan|arabinoxylan
1076631|NCT02690103|HCV|hcv
1076632|NCT02690103|Viremia|viremia
1076633|NCT02690103|Biobran|biobran
1076634|NCT02690103|PEG interferon|peg interferon
1076635|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
1076636|NCT02690090|Prophylaxis|prophylaxis
1076637|NCT02690090|Critically ill adults|critically ill adults
1076638|NCT02690077|Patient Satisfaction|patient satisfaction
1076639|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
1076640|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
1076641|NCT02690064|Endothelial Function|endothelial function
1076642|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
1076643|NCT02690064|Flow Mediated Dilation|flow mediated dilation
1076644|NCT02690064|Antioxidant|antioxidant
1076645|NCT02690064|FEV1|fev1
1076646|NCT02690038|AECOPD|aecopd
1076647|NCT02690038|COPD|copd
1076648|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
1076649|NCT02689986|Cold agglutinin|cold agglutinin
1076650|NCT02689986|Cold agglutinin disease|cold agglutinin disease
1076651|NCT02689986|Anemia|anemia
1076652|NCT02689986|Hemolytic|hemolytic
1076653|NCT02689986|Autoimmune|autoimmune
1076654|NCT02689986|Bendamustine|bendamustine
1076655|NCT02689986|Rituximab|rituximab
1076656|NCT02689973|adolescence|adolescence
1076658|NCT02689973|physical activity|physical activity
1076659|NCT02689973|psychosocial intervention|psychosocial intervention
1076660|NCT02689973|self-efficacy|self-efficacy
1076661|NCT02689973|planning|planning
1076662|NCT02689960|addison disease|addison disease
1076663|NCT02689960|adrenal crisis|adrenal crisis
1076664|NCT02689960|prednisone|prednisone
1076665|NCT02689934|hypercholesterolemia|hypercholesterolemia
1076666|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
1076667|NCT02689934|red yeast rice|red yeast rice
1076668|NCT02689934|monacolin K|monacolin k
1076669|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
1076670|NCT02689908|Thorax CT|thorax ct
1076671|NCT02689908|Low Dose|low dose
1076672|NCT02689908|Body Mass Index|body mass index
1076673|NCT02689908|Neck Circumference|neck circumference
1076674|NCT02689895|adolescents|adolescents
1076675|NCT02689895|second line treatment failure|second line treatment failure
1076676|NCT02689895|adherence|adherence
1076677|NCT02689895|drug resistance|drug resistance
1076678|NCT02689882|nicotinamide riboside|nicotinamide riboside
1076679|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
1076680|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
1076681|NCT02689869|indolent lymphoma|indolent lymphoma
1076682|NCT02689869|novel agents|novel agents
1076683|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
1076684|NCT02689869|ibrutinib|ibrutinib
1076685|NCT02689869|obinutuzumab|obinutuzumab
1076687|NCT02689843|Inflammation|inflammation
1076691|NCT02689843|Cyproterone|cyproterone
1076692|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
1076693|NCT02689843|Androgen Antagonists|androgen antagonists
1076694|NCT02689843|Metformin|metformin
1076695|NCT02689843|Thiazolidinediones|thiazolidinediones
1076696|NCT02689843|Pioglitazone|pioglitazone
1076701|NCT02689804|Emergency contraception|emergency contraception
1076702|NCT02689791|Appetite|appetite
1076703|NCT02689791|Food Intake|food intake
1076704|NCT02689791|Satiety Hormones|satiety hormones
1076705|NCT02689778|Pirfenidone|pirfenidone
1076706|NCT02689778|Diabetic nephropathy|diabetic nephropathy
1076707|NCT02689752|mass balance|mass balance
1076708|NCT02689752|14C|14c
1076709|NCT02689713|Burn Pain|burn pain
1076710|NCT02689713|Hyperalgesia|hyperalgesia
1076711|NCT02689713|TRPV1|trpv1
1076712|NCT02689713|OLAMs|olams
1076713|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
1076714|NCT02689700|Varicella Zoster Virus|varicella zoster virus
1076715|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
1076716|NCT02689700|Pregnancy|pregnancy
1076717|NCT02689700|Gestational age|gestational age
1076718|NCT02689622|Hematology|hematology
1076719|NCT02689622|Elderly|elderly
1076720|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
1076721|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1076722|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
1076723|NCT02689609|Hypothyroidism|hypothyroidism
1076724|NCT02689609|Predictors|predictors
1076725|NCT02689583|Helicobacter pylori|helicobacter pylori
1076726|NCT02689583|Antibiotic resistance|antibiotic resistance
1076727|NCT02689583|Sequencing|sequencing
1076728|NCT02689583|Mechanism|mechanism
1076729|NCT02689583|Cause|cause
1076730|NCT02689570|type 1 diabetes|type 1 diabetes
1076731|NCT02689570|coronary artery calcifications|coronary artery calcifications
1076732|NCT02689570|diastolic dysfunction|diastolic dysfunction
1076733|NCT02689570|adipokines|adipokines
1076734|NCT02689570|visceral adipose tissue|visceral adipose tissue
1076735|NCT02689544|exercise muscle stretching|exercise muscle stretching
1076736|NCT02689544|range of motion|range of motion
1076737|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
1076738|NCT02689544|electromyography|electromyography
1076739|NCT02689518|AMD|amd
1076740|NCT02689518|Wet AMD|wet amd
1076741|NCT02689518|Macular degeneration|macular degeneration
1076742|NCT02689518|Wet macular degeneration|wet macular degeneration
1076743|NCT02689518|Neovascularization|neovascularization
1076744|NCT02689518|Retina|retina
1076745|NCT02689518|Retinal degeneration|retinal degeneration
1076746|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
1076747|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
1076748|NCT02689466|Adult|adult
1076749|NCT02689466|Acetylcholine|acetylcholine
1076750|NCT02689466|Movement Disorder|movement disorder
1076751|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1076752|NCT02689466|PET Imaging|pet imaging
1076753|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
1076754|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
1076755|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
1076756|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
1076757|NCT02689440|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1076758|NCT02689440|CML|cml
1076759|NCT02689440|Ph-positive chronic myelogenous leukemia|ph-positive chronic myelogenous leukemia
1076760|NCT02689440|BCR-ABL positive chronic myelogenous leukemia|bcr-abl positive chronic myelogenous leukemia
1076767|NCT02689427|Breast cancer|breast cancer
1076768|NCT02689427|Invasive carcinoma of the breast|invasive carcinoma of the breast
1076769|NCT02689427|Triple-negative breast cancer|triple-negative breast cancer
1076770|NCT02689427|TNBC|tnbc
1076771|NCT02689427|Enzalutamide|enzalutamide
1076772|NCT02689427|MDV3100|mdv3100
1076773|NCT02689427|XTANDI|xtandi
1076774|NCT02689427|Paclitaxel|paclitaxel
1076775|NCT02689427|Taxol|taxol
1076776|NCT02689414|Atherosclerosis|atherosclerosis
1076777|NCT02689401|Esophageal Cancer|esophageal cancer
1076778|NCT02689401|lymph nodes tumor|lymph nodes tumor
1076779|NCT02689388|analgesia|analgesia
1076780|NCT02689388|regional analgesia|regional analgesia
1076781|NCT02689388|femoral nerve block|femoral nerve block
1076782|NCT02689388|older persons|older persons
1076783|NCT02689388|frail|frail
1076784|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
1076785|NCT02689349|hearing|hearing
1076787|NCT02689349|moderate degree|moderate degree
1076788|NCT02689349|severe degree|severe degree
1076789|NCT02689310|Wound Care|wound care
1076790|NCT02689310|Medical Grade Honey|medical grade honey
1076791|NCT02689310|Pressure Ulcers|pressure ulcers
1076792|NCT02689284|Stomach Cancer|stomach cancer
1076793|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
1076794|NCT02689284|Gastric Cancer|gastric cancer
1076795|NCT02689284|Cancer of the Stomach|cancer of the stomach
1076796|NCT02689284|Cancer of Stomach|cancer of stomach
1076797|NCT02689284|Stomach|stomach
1076798|NCT02689284|Pembrolizumab|pembrolizumab
1076799|NCT02689284|Keytruda|keytruda
1076800|NCT02689284|HER2+|her2+
1076802|NCT02689284|HER2 positive|her2 positive
1076803|NCT02689284|Metastatic|metastatic
1076804|NCT02689284|Margetuximab|margetuximab
1076805|NCT02689284|Immunotherapy|immunotherapy
1076806|NCT02689284|Trastuzumab|trastuzumab
1076807|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
1076808|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
1076809|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
1076810|NCT02689284|Pembro|pembro
1076811|NCT02689284|PD-L1|pd-l1
1076812|NCT02689284|PD-1|pd-1
1076814|NCT02689284|Tumor|tumor
1076815|NCT02689284|Cancer|cancer
1076816|NCT02689271|MRI|mri
1076817|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
1076818|NCT02689271|Biomarkers|biomarkers
1076819|NCT02689271|Fluidics|fluidics
1076820|NCT02689271|Diffusion MRI|diffusion mri
1076821|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
1076822|NCT02689206|Chronic kidney disease|chronic kidney disease
1076823|NCT02689206|Efficacy|efficacy
1076824|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
1076825|NCT02689206|GSK1278863|gsk1278863
1076826|NCT02689206|Safety|safety
1076827|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
1076828|NCT02689206|Pharmacokinetics|pharmacokinetics
1076829|NCT02689193|Proteomics|proteomics
1076830|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
1076831|NCT02689193|Salmonellosis|salmonellosis
1076832|NCT02689180|heart failure|heart failure
1076833|NCT02689180|diuretics|diuretics
1076834|NCT02689180|furosemide|furosemide
1076835|NCT02689167|renal cell carcinoma|renal cell carcinoma
1076836|NCT02689167|sunitinib|sunitinib
1076837|NCT02689167|metastatic|metastatic
1076838|NCT02689167|schedule|schedule
1076839|NCT02689167|toxicity|toxicity
1076840|NCT02689167|safety|safety
1076841|NCT02689154|Pediatric Obesity|pediatric obesity
1076842|NCT02689154|Food Addiction|food addiction
1076843|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
1076844|NCT02689154|Weight Management|weight management
1076845|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
1076846|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
1076847|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
1076848|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1076849|NCT02689128|Anesthesia|anesthesia
1076850|NCT02689128|postoperative|postoperative
1076851|NCT02689128|nausea|nausea
1076852|NCT02689128|vomiting|vomiting
1076853|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
1076854|NCT02689115|IKK epsilon|ikk epsilon
1076855|NCT02689102|Optical coherence tomography|optical coherence tomography
1076856|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
1076857|NCT02689076|Patient transfer|patient transfer
1076858|NCT02689076|Patient care management|patient care management
1076859|NCT02689076|Health information exchange|health information exchange
1076860|NCT02689063|Analgesic|analgesic
1076861|NCT02689024|Nerve block|nerve block
1076862|NCT02689024|Analgesia|analgesia
1076863|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
1076864|NCT02689011|Femoral Nerve Block|femoral nerve block
1076865|NCT02689011|Epidural Analgesia|epidural analgesia
1076866|NCT02689011|Urinary Retention|urinary retention
1076867|NCT02689011|Lumbar Epidural|lumbar epidural
1076868|NCT02688998|HER2 negative|her2 negative
1076869|NCT02688959|motor attention training|motor attention training
1076873|NCT02688855|Bone Growth Stimulator|bone growth stimulator
1076874|NCT02688855|Ankle Fracture|ankle fracture
1076875|NCT02688829|stents,percutaneous coronary intervention|stents,percutaneous coronary intervention
1076876|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
1076877|NCT02688816|Xpert HPV|xpert hpv
1076878|NCT02688816|OncoE6|oncoe6
1076879|NCT02688816|screening|screening
1076880|NCT02688803|HER2 Negative|her2 negative
1076881|NCT02688790|Dalbavancin|dalbavancin
1076882|NCT02688790|DALVANCE®|dalvance®
1076883|NCT02688790|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
1076884|NCT02688777|Rehabilitation|rehabilitation
1076885|NCT02688777|Gait|gait
1076886|NCT02688777|Postural Balance|postural balance
1076888|NCT02688777|Accidental Falls|accidental falls
1076889|NCT02688777|Kinesiology, Applied|kinesiology, applied
1076890|NCT02688764|PA21|pa21
1076891|NCT02688764|phosphate binder|phosphate binder
1076892|NCT02688712|IIA|iia
1076893|NCT02688712|Xeloda|xeloda
1076894|NCT02688712|radiation therapy|radiation therapy
1076895|NCT02688712|LY2157299|ly2157299
1076896|NCT02688712|tumor resection|tumor resection
1076897|NCT02688712|capecitabine|capecitabine
1076899|NCT02688712|Fluorouracil|fluorouracil
1076900|NCT02688712|IIB|iib
1076901|NCT02688712|IIC|iic
1076902|NCT02688712|IV|iv
1076903|NCT02688712|neoadjuvant|neoadjuvant
1076904|NCT02688712|Rectal cancer|rectal cancer
1076905|NCT02688712|Immunotherapy|immunotherapy
1076906|NCT02688660|Pediatrics|pediatrics
1076907|NCT02688660|Neuroimaging|neuroimaging
1076908|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
1076909|NCT02688647|Fibrosis|fibrosis
1076910|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
1076911|NCT02688647|Lung Diseases|lung diseases
1076912|NCT02688634|Cleft Palate Surgery|cleft palate surgery
1076913|NCT02688634|Antibiotic treatment|antibiotic treatment
1076914|NCT02688621|weight loss|weight loss
1076915|NCT02688621|financial incentives|financial incentives
1076916|NCT02688621|internet weight loss|internet weight loss
1076917|NCT02688595|Infant, Newborn|infant, newborn
1076918|NCT02688595|Ultrasonography|ultrasonography
1076919|NCT02688582|Target Controlled Infusion|target controlled infusion
1076920|NCT02688582|Pharmacokinetics|pharmacokinetics
1076921|NCT02688582|Cefepime|cefepime
1076922|NCT02688582|critically ill patients|critically ill patients
1076923|NCT02688556|KCS|kcs
1076924|NCT02688556|dry eye|dry eye
1076925|NCT02688556|cyclosporine|cyclosporine
1076926|NCT02688543|radio frequency treatment|radio frequency treatment
1076927|NCT02688543|genicular nerves|genicular nerves
1076928|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
1076929|NCT02688504|labelled medicines|labelled medicines
1076930|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
1076931|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
1076932|NCT02688478|Phthalate|phthalate
1076933|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
1076934|NCT02688478|Airway responsiveness|airway responsiveness
1076935|NCT02688478|Allergies|allergies
1076936|NCT02688452|strenuous exercise|strenuous exercise
1076937|NCT02688452|muscle soreness|muscle soreness
1076938|NCT02688413|Virtual reality|virtual reality
1076939|NCT02688413|Stroke|stroke
1076940|NCT02688413|Neurorehabilitation|neurorehabilitation
1076941|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
1076942|NCT02688413|Training games|training games
1076943|NCT02688400|Osteoarthritis|osteoarthritis
1076944|NCT02688400|Knee|knee
1076945|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
1076946|NCT02688400|Diacerein|diacerein
1076947|NCT02688400|Celecoxib|celecoxib
1076948|NCT02688400|Phase III|phase iii
1076949|NCT02688400|Phase IV|phase iv
1076950|NCT02688400|Phase III-IV|phase iii-iv
1076951|NCT02688400|Canada|canada
1076952|NCT02688400|Spain|spain
1076953|NCT02688400|Austria|austria
1076954|NCT02688400|Czech Republic|czech republic
1076955|NCT02688400|WOMAC|womac
1076956|NCT02688387|Ambrisentan|ambrisentan
1076957|NCT02688387|Bioavailability|bioavailability
1076958|NCT02688387|Tadalafil|tadalafil
1076959|NCT02688387|Fixed Dose combination|fixed dose combination
1076960|NCT02688322|sulbactam|sulbactam
1076961|NCT02688322|pharmacokinetics|pharmacokinetics
1076962|NCT02688322|pharmacodynamics|pharmacodynamics
1076963|NCT02688322|Acinetobacter infections|acinetobacter infections
1076964|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
1076965|NCT02688257|Ultrasound|ultrasound
1076966|NCT02688257|Breast Cancer|breast cancer
1076967|NCT02688244|complicated appendicitis|complicated appendicitis
1076968|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
1076969|NCT02688244|irrigation|irrigation
1076970|NCT02688244|suction|suction
1076971|NCT02688244|abdominal abscess|abdominal abscess
1076972|NCT02688231|Multiple Sclerosis|multiple sclerosis
1076973|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
1076974|NCT02688218|exercise|exercise
1076975|NCT02688218|artificial pancreas|artificial pancreas
1076976|NCT02688218|hypoglycemia|hypoglycemia
1076977|NCT02688218|type 1 diabetes|type 1 diabetes
1076978|NCT02688205|Cyriax's functional examination|cyriax's functional examination
1076979|NCT02688205|Ultrasound|ultrasound
1076980|NCT02688205|Correlation|correlation
1076981|NCT02688205|Resisted test|resisted test
1076982|NCT02688153|Aortic Valve Replacement|aortic valve replacement
1076983|NCT02688153|Aortic Stenosis|aortic stenosis
1076984|NCT02688153|EDWARDS INTUITY|edwards intuity
1076985|NCT02688140|APL|apl
1076986|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
1076987|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
1076988|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
1076989|NCT02688140|newly diagnosed|newly diagnosed
1076990|NCT02688140|high-risk|high-risk
1076991|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
1076992|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
1076993|NCT02688075|Canagliflozin|canagliflozin
1076994|NCT02688075|Observational Study|observational study
1076995|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
1076996|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1076997|NCT02688036|dose fractionation|dose fractionation
1076998|NCT02688023|5-fluorouracil|5-fluorouracil
1076999|NCT02688023|Irinotecan|irinotecan
1077000|NCT02688023|Oxaliplatin|oxaliplatin
1077001|NCT02688023|Colorectal cancer|colorectal cancer
1077002|NCT02688023|neoadjuvant|neoadjuvant
1077003|NCT02688023|chemotherapy|chemotherapy
1077004|NCT02688010|noise|noise
1077005|NCT02688010|sound|sound
1077006|NCT02688010|cycled light|cycled light
1077007|NCT02688010|preterm infants|preterm infants
1077008|NCT02688010|neonatal care|neonatal care
1077009|NCT02688010|growth|growth
1077010|NCT02688010|visual development|visual development
1077011|NCT02687984|Schizophrenia|schizophrenia
1077012|NCT02687984|Long-acting Risperidone|long-acting risperidone
1077013|NCT02687984|Atrigel|atrigel
1077014|NCT02687958|GEP/ NEC|gep/ nec
1077015|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
1077016|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1077017|NCT02687919|diet (gluten-free)|diet (gluten-free)
1077018|NCT02687919|diet therapy|diet therapy
1077019|NCT02687919|quality of life|quality of life
1077020|NCT02687893|Sleep|sleep
1077021|NCT02687893|Exercise|exercise
1077022|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
1077023|NCT02687867|Prevention|prevention
1077024|NCT02687867|Stroke|stroke
1077025|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
1077026|NCT02687854|Prevention|prevention
1077027|NCT02687854|Stroke|stroke
1077028|NCT02687841|acute kidney injury|acute kidney injury
1077029|NCT02687841|indoxylsulfate|indoxylsulfate
1077030|NCT02687841|p-cresol|p-cresol
1077031|NCT02687841|AST-120|ast-120
1077032|NCT02687828|Intestinal Behcet's disease (BD)|intestinal behcet's disease (bd)
1077033|NCT02687828|Adalimumab|adalimumab
1077034|NCT02687828|Safety|safety
1077035|NCT02687828|Effectiveness|effectiveness
1077036|NCT02687828|AMORE study|amore study
1077037|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
1077038|NCT02687802|respiratory mechanics|respiratory mechanics
1077039|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
1077040|NCT02687802|artificial, ventilation|artificial, ventilation
1077041|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
1077043|NCT02687776|Copeptin, human|copeptin, human
1077044|NCT02687763|vaccines|vaccines
1077045|NCT02687763|ProQuad|proquad
1077046|NCT02687763|immunosuppressed|immunosuppressed
1077047|NCT02687763|solid organ transplant|solid organ transplant
1077048|NCT02687763|MMRV|mmrv
1077049|NCT02687737|Tongue|tongue
1077050|NCT02687737|Genioglossus|genioglossus
1077051|NCT02687737|genioglossus recruitment|genioglossus recruitment
1077052|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
1077053|NCT02687711|Epilepsy|epilepsy
1077054|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
1077055|NCT02687711|add-on therapy|add-on therapy
1077056|NCT02687685|Skin to Skin Contact|skin to skin contact
1077057|NCT02687685|Infant, Newborn|infant, newborn
1077058|NCT02687607|Endovascular|endovascular
1077059|NCT02687607|Brain aneurysm|brain aneurysm
1077060|NCT02687607|Ruptured aneurysm|ruptured aneurysm
1077061|NCT02687542|Parkinson Disease|parkinson disease
1077062|NCT02687542|Motor Fluctuation|motor fluctuation
1077063|NCT02687529|Tuberculosis|tuberculosis
1077064|NCT02687529|TB|tb
1077065|NCT02687516|Treatment|treatment
1077066|NCT02687516|Child|child
1077067|NCT02687516|Obesity|obesity
1077068|NCT02687516|Behavioral treatment|behavioral treatment
1077069|NCT02687503|Immune system|immune system
1077070|NCT02687503|Probiotics|probiotics
1077071|NCT02687464|Pediatric Surgery|pediatric surgery
1077072|NCT02687464|Pediatrics|pediatrics
1077073|NCT02687464|Randomized controlled trial,|randomized controlled trial,
1077074|NCT02687464|Antibiotics|antibiotics
1077075|NCT02687464|Cost effectiveness|cost effectiveness
1077076|NCT02687451|Surgical Pain|surgical pain
1077271|NCT02686164|Phase 1|phase 1
1077077|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
1077078|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
1077079|NCT02687425|Pioglitazone|pioglitazone
1077080|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
1077081|NCT02687412|Fast-track surgery|fast-track surgery
1077082|NCT02687412|Gynecological oncology|gynecological oncology
1077083|NCT02687412|Hospitalization post-operation|hospitalization post-operation
1077084|NCT02687412|Complication|complication
1077085|NCT02687399|knee arthroplasty|knee arthroplasty
1077086|NCT02687386|Recurrent|recurrent
1077087|NCT02687386|Refractory|refractory
1077088|NCT02687373|Plasmodium falciparum|plasmodium falciparum
1077089|NCT02687373|PfSPZ Vaccine|pfspz vaccine
1077090|NCT02687308|Prostatic cancer|prostatic cancer
1077091|NCT02687308|Radical prostatectomy|radical prostatectomy
1077092|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
1077093|NCT02687282|Modified Mallampati score|modified mallampati score
1077094|NCT02687282|Cesarean delivery|cesarean delivery
1077095|NCT02687269|myocardial protection|myocardial protection
1077096|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
1077097|NCT02687243|pediatrics|pediatrics
1077098|NCT02687243|anxiety|anxiety
1077099|NCT02687243|anesthesia|anesthesia
1077100|NCT02687243|preoperative|preoperative
1077101|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
1077102|NCT02687217|Wound Site Infection|wound site infection
1077103|NCT02687217|Appendicitis|appendicitis
1077104|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
1077105|NCT02687113|ablation|ablation
1077106|NCT02687113|fusion|fusion
1077107|NCT02687100|intubation|intubation
1077108|NCT02687100|intensive care|intensive care
1077109|NCT02687100|cardiac surgery|cardiac surgery
1077110|NCT02687100|sore throat|sore throat
1077111|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
1077112|NCT02687074|HFNC|hfnc
1077113|NCT02687074|Respiratory Failure|respiratory failure
1077114|NCT02687074|Intubation|intubation
1077115|NCT02687074|Mortality|mortality
1077116|NCT02687061|Recall study|recall study
1077117|NCT02687061|Lost to follow-up|lost to follow-up
1077118|NCT02687048|mindful meditation|mindful meditation
1077119|NCT02687035|S3iCAP|s3icap
1077120|NCT02687035|SAPIEN 3|sapien 3
1077121|NCT02687035|Transfemoral|transfemoral
1077122|NCT02687035|Commander|commander
1077123|NCT02687035|Certitude|certitude
1077124|NCT02687035|TAVR|tavr
1077125|NCT02687035|TAVI|tavi
1077126|NCT02687035|Aortic stenosis|aortic stenosis
1077127|NCT02687035|THV|thv
1077128|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
1077129|NCT02687035|TVT|tvt
1077130|NCT02687035|TVTR|tvtr
1077131|NCT02687009|colon cancer|colon cancer
1077132|NCT02687009|Wnt pathway|wnt pathway
1077133|NCT02687009|Frizzled|frizzled
1077134|NCT02686996|carnosine|carnosine
1077135|NCT02686996|Insulin sensitivity|insulin sensitivity
1077136|NCT02686996|low grade inflammation|low grade inflammation
1077137|NCT02686996|Oxidative stress|oxidative stress
1077138|NCT02686996|Advanced glycation|advanced glycation
1077139|NCT02686996|Type 2 diabetes|type 2 diabetes
1077140|NCT02686996|Cardiovascular disease|cardiovascular disease
1077141|NCT02686970|Family|family
1077142|NCT02686970|Quality|quality
1077143|NCT02686970|Validate|validate
1077144|NCT02686970|ICU|icu
1077145|NCT02686944|GIST|gist
1077146|NCT02686931|Developmental delayed|developmental delayed
1077147|NCT02686931|Orthopedic disease|orthopedic disease
1077148|NCT02686931|Longitudinal study|longitudinal study
1077149|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
1077150|NCT02686892|Crohns disease|crohns disease
1077151|NCT02686892|ulcerative colitis|ulcerative colitis
1077152|NCT02686892|incidence|incidence
1077153|NCT02686892|epidemiology|epidemiology
1077154|NCT02686879|hyperopes|hyperopes
1077155|NCT02686879|axial length|axial length
1077156|NCT02686879|peripheral defocus|peripheral defocus
1077157|NCT02686853|Intrathecal administration|intrathecal administration
1077158|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
1077159|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
1077160|NCT02686814|Valvular heart disease|valvular heart disease
1077161|NCT02686814|Severe aortic stenosis|severe aortic stenosis
1077162|NCT02686814|Aortic valve replacement|aortic valve replacement
1077163|NCT02686801|nutrition|nutrition
1077164|NCT02686801|prematurity|prematurity
1077165|NCT02686801|body composition|body composition
1077166|NCT02686788|multiple sclerosis|multiple sclerosis
1077167|NCT02686788|relapsing remitting|relapsing remitting
1077168|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
1077169|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
1077170|NCT02686762|NASH|nash
1077171|NCT02686736|internet-based educational intervention|internet-based educational intervention
1077172|NCT02686736|risky sexual behaviors|risky sexual behaviors
1077173|NCT02686736|prevention|prevention
1077174|NCT02686723|ACL injury|acl injury
1077175|NCT02686723|Return to sport|return to sport
1077176|NCT02686723|Motion analysis|motion analysis
1077177|NCT02686723|Isokinetic evaluation|isokinetic evaluation
1077178|NCT02686723|Risk factor|risk factor
1077179|NCT02686697|L-Carnosine|l-carnosine
1077180|NCT02686697|Schizophrenia|schizophrenia
1077181|NCT02686697|Psychosis|psychosis
1077182|NCT02686697|Cognition|cognition
1077183|NCT02686671|Bursitis|bursitis
1077184|NCT02686671|Injections|injections
1077185|NCT02686671|Shoulder Pain|shoulder pain
1077186|NCT02686658|Geographic Atrophy (GA)|geographic atrophy (ga)
1077187|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
1077188|NCT02686658|AMD|amd
1077189|NCT02686658|Zimura|zimura
1077190|NCT02686658|Anti-inflammatory|anti-inflammatory
1077191|NCT02686658|complement factor C5 inhibitor|complement factor c5 inhibitor
1077192|NCT02686658|ARC1905|arc1905
1077193|NCT02686658|avacincaptad pegol|avacincaptad pegol
1077194|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
1077195|NCT02686632|Denture Stomatitis|denture stomatitis
1077196|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
1077197|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
1077198|NCT02686632|Oral Candidiasis|oral candidiasis
1077199|NCT02686632|Palatal inflammation|palatal inflammation
1077200|NCT02686593|Clofarabine|clofarabine
1077201|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
1077202|NCT02686567|transanal drainage tube|transanal drainage tube
1077203|NCT02686567|anastomotic leakage|anastomotic leakage
1077204|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
1077205|NCT02686567|rectal cancer|rectal cancer
1077206|NCT02686554|Biomarker|biomarker
1077207|NCT02686528|total hip arthroplasty|total hip arthroplasty
1077208|NCT02686528|hip precautions|hip precautions
1077209|NCT02686528|posterior approach|posterior approach
1077210|NCT02686515|balance|balance
1077211|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
1077212|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
1077213|NCT02686463|laparoscopy|laparoscopy
1077214|NCT02686463|laparotomy|laparotomy
1077215|NCT02686437|shoulder dysfunction|shoulder dysfunction
1077216|NCT02686437|kinesiology tape|kinesiology tape
1077217|NCT02686437|rehabilitation|rehabilitation
1077218|NCT02686424|MAGE-A3 protein|mage-a3 protein
1077219|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
1077220|NCT02686424|WT1 Proteins|wt1 proteins
1077221|NCT02686424|PRAME protein|prame protein
1077222|NCT02686411|Benign neoplasms|benign neoplasms
1077223|NCT02686411|In situ neoplasms|in situ neoplasms
1077224|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
1077225|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
1077226|NCT02686411|Palliative care unit|palliative care unit
1077227|NCT02686411|PCU|pcu
1077228|NCT02686411|Questionnaires|questionnaires
1077229|NCT02686411|Surveys|surveys
1077230|NCT02686398|Influenza Vaccines|influenza vaccines
1077231|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
1077232|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
1077233|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
1077234|NCT02686359|physiology|physiology
1077235|NCT02686359|pain|pain
1077236|NCT02686359|analgesia|analgesia
1077237|NCT02686359|saliva|saliva
1077238|NCT02686359|opiorphin|opiorphin
1077239|NCT02686346|Relapsed|relapsed
1077240|NCT02686346|Refractory|refractory
1077241|NCT02686333|Meditation|meditation
1077242|NCT02686333|Dialysis|dialysis
1077243|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
1077244|NCT02686320|Elderly|elderly
1077245|NCT02686320|infections|infections
1077246|NCT02686320|cardio-vascular disease|cardio-vascular disease
1077247|NCT02686320|osteoporosis|osteoporosis
1077248|NCT02686320|cancer|cancer
1077249|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1077250|NCT02686268|ALS|als
1077251|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
1077252|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
1077253|NCT02686268|Natural history|natural history
1077254|NCT02686268|Biomarkers|biomarkers
1077255|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
1077256|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
1077257|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
1077258|NCT02686242|cesarean section|cesarean section
1077259|NCT02686242|spinal anesthesia|spinal anesthesia
1077260|NCT02686242|general anesthesia|general anesthesia
1077261|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
1077262|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
1077263|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
1077264|NCT02686177|Type 2 diabetes|type 2 diabetes
1077265|NCT02686177|Angiogenesis|angiogenesis
1077266|NCT02686177|Liraglutide|liraglutide
1077267|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
1077268|NCT02686164|Lenvatinib|lenvatinib
1077269|NCT02686164|Lenvima|lenvima
1077270|NCT02686164|E7080|e7080
1077272|NCT02686164|Solid tumors|solid tumors
1077273|NCT02686164|Midazolam|midazolam
1077274|NCT02686164|CYP3A4|cyp3a4
1077275|NCT02686151|Letrozole|letrozole
1077276|NCT02686151|OHSS|ohss
1077277|NCT02686099|Rigid Fixation|rigid fixation
1077278|NCT02686099|Sternal Plating|sternal plating
1077279|NCT02686099|Sternal Closure|sternal closure
1077280|NCT02686099|Sternalock|sternalock
1077281|NCT02686073|BMI|bmi
1077282|NCT02686073|progress of labor|progress of labor
1077283|NCT02686073|nulliparous women|nulliparous women
1077284|NCT02686047|Knee osteoarthritis|knee osteoarthritis
1077285|NCT02686047|Hyaluronic acid|hyaluronic acid
1077286|NCT02686047|Viscosupplementation|viscosupplementation
1077287|NCT02686034|Migraine|migraine
1333233|NCT01443923|Viral Kinetics|viral kinetics
1077288|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
1077289|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
1077290|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
1077291|NCT02686034|gammaCore|gammacore
1077292|NCT02686034|episodic migraine|episodic migraine
1077293|NCT02685982|Unipolar|unipolar
1077294|NCT02685982|Depression|depression
1077295|NCT02685982|Depressive Disorder|depressive disorder
1077296|NCT02685982|Behavioural Symptoms|behavioural symptoms
1077297|NCT02685982|Mood Disorder|mood disorder
1077298|NCT02685982|Adjunctive Therapy|adjunctive therapy
1077299|NCT02685982|Music Therapy|music therapy
1077300|NCT02685982|Brain Stimulation|brain stimulation
1077301|NCT02685969|Prevention|prevention
1077302|NCT02685969|Positron Emission Tomography|positron emission tomography
1077303|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
1077304|NCT02685878|urinary continence|urinary continence
1077305|NCT02685878|prevalence of depression|prevalence of depression
1077306|NCT02685878|reproductive outcomes|reproductive outcomes
1077307|NCT02685878|quality of life|quality of life
1077308|NCT02685878|HIV status|hiv status
1077309|NCT02685878|obstetric fistula|obstetric fistula
1077310|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
1077311|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
1077312|NCT02685826|Open-label|open-label
1077313|NCT02685826|Phase 1/2|phase 1/2
1077314|NCT02685826|Durvalumab|durvalumab
1077315|NCT02685826|MEDI4736|medi4736
1077316|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
1077317|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
1077318|NCT02685826|Multiple Myeloma|multiple myeloma
1077319|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
1077320|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
1077322|NCT02685813|Ultra sound|ultra sound
1077323|NCT02685813|birth defects|birth defects
1077324|NCT02685787|Care-giver burden|care-giver burden
1077325|NCT02685787|Dementia|dementia
1077326|NCT02685787|Alzheimer's disease|alzheimer's disease
1077327|NCT02685787|Care-giver depression|care-giver depression
1077328|NCT02685787|Care-giver anxiety|care-giver anxiety
1077329|NCT02685709|Octreotide Capsules|octreotide capsules
1077330|NCT02685709|Acromegaly|acromegaly
1077331|NCT02685709|Somatostatin|somatostatin
1077332|NCT02685709|Mpowered|mpowered
1077333|NCT02685709|OOC-ACM-302|ooc-acm-302
1077334|NCT02685683|Crohn's Disease|crohn's disease
1077335|NCT02685683|GED-0301|ged-0301
1077336|NCT02685683|Open-label|open-label
1077337|NCT02685683|Pharmacodynamic|pharmacodynamic
1077338|NCT02685683|Mongersen|mongersen
1077339|NCT02685644|endometrioma|endometrioma
1077340|NCT02685644|laparoscopy|laparoscopy
1077341|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
1077342|NCT02685644|ovarian reserve|ovarian reserve
1077343|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
1077344|NCT02685631|Colorectal cancer|colorectal cancer
1077345|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
1077346|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
1077347|NCT02685631|Breast cancer|breast cancer
1077348|NCT02685631|Tumor of unknown primary|tumor of unknown primary
1077349|NCT02685631|Pancreatic cancer|pancreatic cancer
1077350|NCT02685605|Glioblastoma|glioblastoma
1077351|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
1077352|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
1077353|NCT02685592|Lentigo Maligna|lentigo maligna
1077354|NCT02685592|Photodynamic Therapy|photodynamic therapy
1077355|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
1077356|NCT02685566|Mammography|mammography
1077357|NCT02685540|Anesthesia|anesthesia
1077358|NCT02685540|mortality|mortality
1077359|NCT02685514|HIFU|hifu
1077360|NCT02685514|Graves' disease|graves' disease
1077361|NCT02685514|treatment|treatment
1077362|NCT02685475|Diabetes mellitus|diabetes mellitus
1077363|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
1077364|NCT02685475|Block duration|block duration
1077365|NCT02685475|Time-to-first pain|time-to-first pain
1077366|NCT02685475|Postoperative analgesia|postoperative analgesia
1077367|NCT02685449|diabetes type 1|diabetes type 1
1077368|NCT02685449|insulin pump|insulin pump
1077369|NCT02685449|prandial insulin requirement|prandial insulin requirement
1077370|NCT02685449|pure protein meal|pure protein meal
1077371|NCT02685449|high protein meal|high protein meal
1077372|NCT02685449|square bolus|square bolus
1077373|NCT02685449|square-wave bolus|square-wave bolus
1077374|NCT02685449|insulin bolus|insulin bolus
1077375|NCT02685449|dietary protein|dietary protein
1077376|NCT02685423|Amblyopia|amblyopia
1077377|NCT02685423|Lazy Eye|lazy eye
1077378|NCT02685423|Anisometropia|anisometropia
1077379|NCT02685384|healthcare access|healthcare access
1077380|NCT02685384|healthcare utilization|healthcare utilization
1077381|NCT02685384|health expenditures|health expenditures
1077382|NCT02685384|preventive services|preventive services
1077383|NCT02685384|biomarkers|biomarkers
1077384|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
1077385|NCT02685358|Primary Health Care|primary health care
1077386|NCT02685358|Mobile Applications|mobile applications
1077387|NCT02685358|Veterans|veterans
1077388|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1077389|NCT02685345|sitagliptin|sitagliptin
1077390|NCT02685345|adult|adult
1077391|NCT02685345|Phase 2|phase 2
1077392|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
1077393|NCT02685254|Group Therapy|group therapy
1077394|NCT02685254|Structured Skills Training|structured skills training
1077395|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
1077396|NCT02685241|Exhaled breath|exhaled breath
1077397|NCT02685241|Biomarker|biomarker
1077398|NCT02685215|intensive care unit|intensive care unit
1077399|NCT02685215|muscular dystrophy|muscular dystrophy
1077400|NCT02685215|mortality|mortality
1077401|NCT02685215|prognosis|prognosis
1077402|NCT02685215|tracheostomy|tracheostomy
1077403|NCT02685202|orofacial pain|orofacial pain
1077404|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
1077405|NCT02685202|temporomandibular disorder|temporomandibular disorder
1077406|NCT02685202|oral appliance|oral appliance
1077407|NCT02685202|upper airway collapse|upper airway collapse
1077408|NCT02685176|hypothermia|hypothermia
1077409|NCT02685176|rewarming|rewarming
1077410|NCT02685176|non-shivering|non-shivering
1077411|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
1077412|NCT02685150|Gastric juice|gastric juice
1077413|NCT02685150|Functional dyspepsia|functional dyspepsia
1077414|NCT02685150|Acid reflux disease|acid reflux disease
1077415|NCT02685150|Bile reflux|bile reflux
1077416|NCT02685137|Kernicterus|kernicterus
1077417|NCT02685137|Neonatal Jaundice|neonatal jaundice
1077418|NCT02685137|Newborn Jaundice|newborn jaundice
1077419|NCT02685137|Hyperbilirubinemia|hyperbilirubinemia
1077420|NCT02685137|Stannsoporfin|stannsoporfin
1077421|NCT02685111|Breast cancer|breast cancer
1077422|NCT02685111|Adjuvant|adjuvant
1077423|NCT02685111|Docetaxel|docetaxel
1077424|NCT02685111|Adriamycin|adriamycin
1077425|NCT02685111|Cyclophosphamide|cyclophosphamide
1077426|NCT02685111|Neutropenia|neutropenia
1077427|NCT02685111|Filgrastim|filgrastim
1077428|NCT02685111|Pegfilgrastim|pegfilgrastim
1077429|NCT02685098|Stem cells|stem cells
1077431|NCT02685098|Mesenchymal|mesenchymal
1077432|NCT02685098|Amputation|amputation
1077433|NCT02685098|BKA|bka
1077434|NCT02685098|below knee amputation|below knee amputation
1077435|NCT02685098|CHAMP|champ
1077436|NCT02685072|Smoking Cessation|smoking cessation
1077437|NCT02685072|Nicotine Cessation|nicotine cessation
1077438|NCT02685059|breast cancer|breast cancer
1077439|NCT02685059|Medi4736|medi4736
1077440|NCT02685059|Anti PD-L1|anti pd-l1
1077441|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
1077442|NCT02685059|Placebo|placebo
1077443|NCT02685059|triple negative|triple negative
1077444|NCT02685033|Osteomyelitis|osteomyelitis
1077445|NCT02685033|dalbavancin|dalbavancin
1077446|NCT02685033|antibiotic|antibiotic
1077447|NCT02685020|Healthy|healthy
1077448|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
1077449|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
1077450|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
1077451|NCT02685020|Vaccine|vaccine
1077452|NCT02685020|Placebo|placebo
1077453|NCT02685020|Glycoprotein|glycoprotein
1077454|NCT02685020|IPCAVD010|ipcavd010
1077455|NCT02685007|minimal invasive surgery|minimal invasive surgery
1077456|NCT02684994|Trauma|trauma
1077457|NCT02684994|Sexual assault|sexual assault
1077458|NCT02684994|Sexual abuse|sexual abuse
1077459|NCT02684994|Physical assault|physical assault
1077460|NCT02684994|Physical abuse|physical abuse
1077461|NCT02684994|PTSD|ptsd
1077462|NCT02684994|Interpersonal Violence|interpersonal violence
1077463|NCT02684994|Women|women
1077464|NCT02684955|cardiac arrest|cardiac arrest
1077465|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
1077466|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
1077467|NCT02684955|prognostication|prognostication
1077468|NCT02684942|Meperidine|meperidine
1077469|NCT02684942|Fentanyl|fentanyl
1077470|NCT02684942|Pain management|pain management
1077471|NCT02684942|brachytherapy|brachytherapy
1077472|NCT02684929|insulin resistance|insulin resistance
1077473|NCT02684929|bcaa|bcaa
1077474|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
1077475|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
1077476|NCT02684916|Children|children
1077477|NCT02684916|Pediatric|pediatric
1077478|NCT02684916|Headache|headache
1077479|NCT02684903|Child Abuse|child abuse
1077480|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
1077481|NCT02684903|Evidenced Based Intervention|evidenced based intervention
1077482|NCT02684903|Self-control|self-control
1077483|NCT02684877|Fatigue|fatigue
1077484|NCT02684877|Quality of life|quality of life
1077485|NCT02684877|Critically ill patients|critically ill patients
1077486|NCT02684864|biomarker|biomarker
1077487|NCT02684864|inflammation|inflammation
1077488|NCT02684864|knee|knee
1077489|NCT02684864|prognosis|prognosis
1077490|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
1077491|NCT02684825|Stroke|stroke
1077492|NCT02684825|ischemic stroke|ischemic stroke
1077493|NCT02684825|atrial fibrillation|atrial fibrillation
1077494|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
1077495|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
1077496|NCT02684825|implantable loop recorder|implantable loop recorder
1077497|NCT02684825|antithrombotics|antithrombotics
1077498|NCT02684825|anticoagulants|anticoagulants
1077499|NCT02684825|stroke subtype|stroke subtype
1077500|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
1077501|NCT02684825|lacunar stroke|lacunar stroke
1077502|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
1077503|NCT02684812|recurrent bleeding|recurrent bleeding
1077504|NCT02684812|tranexamic acid|tranexamic acid
1077505|NCT02684773|Hemodialysis|hemodialysis
1077506|NCT02684773|Left Ventricular Mass|left ventricular mass
1077507|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
1077508|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
1077509|NCT02684747|Healthy Volunteers|healthy volunteers
1077510|NCT02684747|Sports Medicine|sports medicine
1077511|NCT02684747|Athletes|athletes
1077512|NCT02684747|Anti-doping|anti-doping
1077513|NCT02684734|Ulcerative Colitis|ulcerative colitis
1077515|NCT02684734|Cytomegalovirus|cytomegalovirus
1077516|NCT02684734|CMV|cmv
1077517|NCT02684721|rehabilitation|rehabilitation
1077518|NCT02684721|physical capacity|physical capacity
1077519|NCT02684721|quality of life|quality of life
1077520|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
1077521|NCT02684695|Imaging biomarker|imaging biomarker
1077522|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
1077523|NCT02684682|Toothbrushing|toothbrushing
1077524|NCT02684682|Gingivitis|gingivitis
1077525|NCT02684682|Dental Plaque|dental plaque
1077526|NCT02684682|Periodontal Diseases|periodontal diseases
1077527|NCT02684682|Clinical Trial|clinical trial
1077528|NCT02684669|burn injury|burn injury
1077529|NCT02684669|controlled trial|controlled trial
1077530|NCT02684669|latent sensitization|latent sensitization
1077531|NCT02684669|naloxone|naloxone
1077532|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
1077533|NCT02684669|volunteers|volunteers
1077534|NCT02684656|Oxalate|oxalate
1077535|NCT02684656|Inflammation|inflammation
1077536|NCT02684656|Hemodiafiltration|hemodiafiltration
1077537|NCT02684656|Hemodialysis|hemodialysis
1077538|NCT02684656|Oxalate Blood Sample|oxalate blood sample
1077539|NCT02684643|individualised therapy|individualised therapy
1077540|NCT02684643|hyperphosphatemia|hyperphosphatemia
1077541|NCT02684643|hemodialysis|hemodialysis
1077542|NCT02684643|clinical trials|clinical trials
1077543|NCT02684643|restricted phosphate diet|restricted phosphate diet
1077544|NCT02684643|phosphate binders|phosphate binders
1077545|NCT02684565|pre-diabetes|pre-diabetes
1077546|NCT02684565|blood glucose regulation|blood glucose regulation
1077547|NCT02684565|branching chain amino acids|branching chain amino acids
1077548|NCT02684565|diabetes|diabetes
1077549|NCT02684565|lower blood sugar|lower blood sugar
1077550|NCT02684513|Well-being|well-being
1077551|NCT02684513|Quality of Recovery|quality of recovery
1077552|NCT02684513|Maternal complications|maternal complications
1077553|NCT02684500|aSAH|asah
1077554|NCT02684487|vitamin D|vitamin d
1077555|NCT02684487|vitamin D3|vitamin d3
1077556|NCT02684487|sepsis|sepsis
1077557|NCT02684487|severe sepsis|severe sepsis
1077558|NCT02684487|critical illness|critical illness
1077559|NCT02684487|ICU|icu
1077560|NCT02684396|Drug therapy|drug therapy
1077561|NCT02684383|Dengue Vaccine|dengue vaccine
1077562|NCT02684370|Psoriasis|psoriasis
1077563|NCT02684370|Skin Diseases|skin diseases
1077564|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
1077565|NCT02684370|ustekinumab|ustekinumab
1077566|NCT02684370|Dermatologic Agents|dermatologic agents
1077567|NCT02684370|ABBV-066|abbv-066
1077568|NCT02684370|BI 655066|bi 655066
1077569|NCT02684370|risankizumab|risankizumab
1077570|NCT02684357|ABBV-066|abbv-066
1077571|NCT02684357|BI 655066|bi 655066
1077572|NCT02684357|risankizumab|risankizumab
1077573|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
1077574|NCT02684292|PD1|pd1
1077575|NCT02684292|PD-1|pd-1
1077576|NCT02684292|PDL1|pdl1
1077577|NCT02684292|PD-L1|pd-l1
1077578|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
1077579|NCT02684253|Nivolumab|nivolumab
1077580|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
1077581|NCT02684253|15-253|15-253
1077582|NCT02684227|Endometrial cancer|endometrial cancer
1077583|NCT02684227|Advanced Stage Endometrioid Endometrial Cancer|advanced stage endometrioid endometrial cancer
1077584|NCT02684227|Recurrent Endometrioid Endometrial Cancer|recurrent endometrioid endometrial cancer
1077585|NCT02684227|Enzalutamide|enzalutamide
1077586|NCT02684227|MDV3100|mdv3100
1120387|NCT02431273|IVR|ivr
1077587|NCT02684227|XTANDI|xtandi
1077588|NCT02684227|Carboplatin|carboplatin
1077589|NCT02684227|Paclitaxel|paclitaxel
1077590|NCT02684227|Taxol|taxol
1077591|NCT02684214|food security|food security
1077592|NCT02684201|Phantom Limb|phantom limb
1077593|NCT02684201|Upper Amputee|upper amputee
1077594|NCT02684201|Electrodes|electrodes
1077595|NCT02684201|Implant|implant
1077596|NCT02684201|Pain|pain
1077597|NCT02684175|Audiometry|audiometry
1077598|NCT02684175|Cochlear Implants|cochlear implants
1077599|NCT02684175|Adult|adult
1077600|NCT02684175|Telemedicine|telemedicine
1077601|NCT02684175|Health Services Accessibility|health services accessibility
1077602|NCT02684175|Rural Population|rural population
1077603|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
1077604|NCT02684162|Leukemia|leukemia
1077605|NCT02684162|Myeloproliferative Diseases|myeloproliferative diseases
1077606|NCT02684162|Acute myelogenous leukemia|acute myelogenous leukemia
1077607|NCT02684162|AML|aml
1077608|NCT02684162|Myelodysplastic syndrome|myelodysplastic syndrome
1077609|NCT02684162|MDS|mds
1077610|NCT02684162|Donor lymphocyte infusion|donor lymphocyte infusion
1077611|NCT02684162|DLI|dli
1077612|NCT02684162|Allogeneic stem cell transplant|allogeneic stem cell transplant
1077613|NCT02684162|Stem cell transplantation|stem cell transplantation
1077614|NCT02684162|AlloSCT|allosct
1077615|NCT02684149|Intensive care|intensive care
1077616|NCT02684149|Arterial puncture|arterial puncture
1077617|NCT02684149|Cross-over|cross-over
1077618|NCT02684149|Relational touch|relational touch
1077619|NCT02684149|Pain|pain
1077620|NCT02684136|insomnia|insomnia
1077621|NCT02684136|fibromyalgia|fibromyalgia
1077622|NCT02684136|polysomnography|polysomnography
1077623|NCT02684136|pain management|pain management
1077624|NCT02684123|Alopecia areata|alopecia areata
1077625|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
1077626|NCT02684084|Diabetic Macular Edema|diabetic macular edema
1077627|NCT02684084|Ozurdex|ozurdex
1077628|NCT02684084|Lucentis|lucentis
1077629|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
1077630|NCT02684058|Malignant glioma|malignant glioma
1077631|NCT02684058|BRAF mutant positive|braf mutant positive
1077632|NCT02684058|High grade glioma|high grade glioma
1077633|NCT02684058|Low grade glioma|low grade glioma
1077634|NCT02684058|Dabrafenib|dabrafenib
1077635|NCT02684058|Trametinib|trametinib
1077636|NCT02684058|Pediatrics|pediatrics
1077637|NCT02684058|Brain neoplasma|brain neoplasma
1077638|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
1077639|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
1077640|NCT02684032|PI3K/mTOR|pi3k/mtor
1077641|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
1077642|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
1077643|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
1077644|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1077645|NCT02684019|sedation|sedation
1077646|NCT02684019|dexmedetomidine|dexmedetomidine
1077647|NCT02684019|propofol|propofol
1077648|NCT02684019|Magnesium sulphate|magnesium sulphate
1077649|NCT02684019|Bispectral index monitoring|bispectral index monitoring
1077650|NCT02684006|Cancer|cancer
1077651|NCT02684006|renal cell cancer|renal cell cancer
1077652|NCT02684006|kidney disease|kidney disease
1077653|NCT02684006|kidney neoplasms|kidney neoplasms
1077654|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
1077655|NCT02683915|Acute kidney injury|acute kidney injury
1077656|NCT02683915|Perinatal asphyxia|perinatal asphyxia
1077657|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
1077658|NCT02683915|Serum NGAL|serum ngal
1077659|NCT02683915|Serum cystatin-C|serum cystatin-c
1077660|NCT02683902|prediabetes|prediabetes
1077661|NCT02683902|tDCS|tdcs
1077662|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
1077663|NCT02683902|obesity|obesity
1077664|NCT02683902|diabetes|diabetes
1077665|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
1077666|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
1077667|NCT02683837|Reflex, Pupillary|reflex, pupillary
1077668|NCT02683837|remifentanil|remifentanil
1077669|NCT02683811|adolescence|adolescence
1077670|NCT02683811|prevention|prevention
1077671|NCT02683811|wellbeing|wellbeing
1077672|NCT02683811|evaluation|evaluation
1077673|NCT02683811|effectiveness|effectiveness
1077674|NCT02683811|school-based program|school-based program
1077675|NCT02683798|Weight loss maintenance|weight loss maintenance
1077676|NCT02683785|Pain intensity|pain intensity
1077677|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
1077678|NCT02683785|GSK3196165|gsk3196165
1077679|NCT02683785|AUSCAN|auscan
1077680|NCT02683785|GM-CSF|gm-csf
1077681|NCT02683785|Numerical Rating Scale|numerical rating scale
1077682|NCT02683772|NIV, NIPPV, ventilation|niv, nippv, ventilation
1120531|NCT02430493|ACS|acs
1077683|NCT02683746|Pharmacodynamics|pharmacodynamics
1077684|NCT02683746|Safety|safety
1077685|NCT02683746|Albiglutide|albiglutide
1077686|NCT02683746|Tolerability|tolerability
1077786|NCT02682862|smoker|smoker
1077687|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1077688|NCT02683746|Efficacy|efficacy
1077689|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
1077690|NCT02683707|Blood Platelets|blood platelets
1077691|NCT02683707|Fentanyl|fentanyl
1077692|NCT02683694|Epiretinal membrane|epiretinal membrane
1077693|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
1077694|NCT02683694|macular holes|macular holes
1077695|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
1077696|NCT02683668|Inhalers|inhalers
1077697|NCT02683668|Tiotropium|tiotropium
1077698|NCT02683629|Parkinson's Disease|parkinson's disease
1077699|NCT02683629|Xenotransplantation|xenotransplantation
1077700|NCT02683629|choroid plexus|choroid plexus
1077701|NCT02683603|colistin|colistin
1077702|NCT02683603|aerosol|aerosol
1077703|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
1077704|NCT02683603|nephrotoxicity|nephrotoxicity
1077705|NCT02683603|intravenous|intravenous
1077706|NCT02683590|Sternectomie|sternectomie
1077707|NCT02683590|Ceramic Implant|ceramic implant
1077708|NCT02683590|Bones Tumors|bones tumors
1077709|NCT02683538|RFA|rfa
1077710|NCT02683525|Allogeneic|allogeneic
1077711|NCT02683525|Sitagliptin|sitagliptin
1077712|NCT02683499|Tooth preparation|tooth preparation
1077713|NCT02683499|Prosthodontics|prosthodontics
1077714|NCT02683447|Continuing Medical Education|continuing medical education
1077715|NCT02683447|Simulation|simulation
1077716|NCT02683447|Non-technical Skills|non-technical skills
1077717|NCT02683447|Crisis Resource Management|crisis resource management
1077718|NCT02683434|soccer|soccer
1077719|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
1077720|NCT02683421|tilmanocept|tilmanocept
1077721|NCT02683421|imaging|imaging
1077722|NCT02683395|PLX51107|plx51107
1077723|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
1077724|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
1077725|NCT02683395|Neoplasms|neoplasms
1077726|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
1077727|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
1077728|NCT02683356|Stents|stents
1077729|NCT02683330|PD|pd
1077730|NCT02683330|Parkinson's|parkinson's
1077731|NCT02683317|DHA|dha
1077732|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
1077733|NCT02683291|Kidney transplantation|kidney transplantation
1077734|NCT02683291|sirolimus|sirolimus
1077735|NCT02683291|cytomegalovirus|cytomegalovirus
1077736|NCT02683291|aged|aged
1077737|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
1077738|NCT02683252|perfusion|perfusion
1077739|NCT02683252|quantitative|quantitative
1077740|NCT02683213|fluoxetine|fluoxetine
1077741|NCT02683213|outcome|outcome
1077742|NCT02683213|depression|depression
1077743|NCT02683213|plasticity|plasticity
1077744|NCT02683187|insulin secretion|insulin secretion
1077745|NCT02683187|GLP-1|glp-1
1077746|NCT02683187|alpha cell|alpha cell
1077747|NCT02683187|paracrine effect|paracrine effect
1077748|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
1077749|NCT02683174|syncope|syncope
1077750|NCT02683122|Organ dysfunction scores|organ dysfunction scores
1077751|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
1077752|NCT02683122|Intensive care units|intensive care units
1077753|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
1077754|NCT02683070|Pudendal nerve block|pudendal nerve block
1077755|NCT02683070|Tramadol|tramadol
1077756|NCT02683070|Randomized controlled trial|randomized controlled trial
1077757|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
1077758|NCT02683044|Erectile dysfunction|erectile dysfunction
1077759|NCT02683044|Low-Density Shock Waves|low-density shock waves
1077760|NCT02683044|Randomized Clinical Trial|randomized clinical trial
1077761|NCT02683031|fertilization arrest|fertilization arrest
1077762|NCT02683031|Cleavage failure|cleavage failure
1077763|NCT02683031|Embryonic development|embryonic development
1077764|NCT02683031|Calcium ionophore|calcium ionophore
1077765|NCT02683005|treatment|treatment
1077766|NCT02683005|pharmacokinetics|pharmacokinetics
1077767|NCT02682979|therapeutic limitation code|therapeutic limitation code
1077768|NCT02682979|emergency unit admittance|emergency unit admittance
1077769|NCT02682966|troponin|troponin
1077770|NCT02682966|coronary artery disease|coronary artery disease
1077771|NCT02682966|pulmonary embolism|pulmonary embolism
1077772|NCT02682966|Computed Tomography Angiography|computed tomography angiography
1077773|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
1077774|NCT02682927|seizure|seizure
1077775|NCT02682927|tonic-atonic|tonic-atonic
1077776|NCT02682927|clonic|clonic
1077777|NCT02682927|epilepsy|epilepsy
1077778|NCT02682927|myoclonic|myoclonic
1077779|NCT02682927|encephalopathy|encephalopathy
1077780|NCT02682914|Psychological distress|psychological distress
1077781|NCT02682914|Stroke etiology|stroke etiology
1077782|NCT02682914|Young patients|young patients
1077783|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
1077784|NCT02682862|tiotropium|tiotropium
1077785|NCT02682862|olodaterol|olodaterol
1077787|NCT02682862|cigarette|cigarette
1077788|NCT02682862|bronchodilator|bronchodilator
1077789|NCT02682836|physical activity|physical activity
1077790|NCT02682836|chemotherapy|chemotherapy
1077792|NCT02682810|HIV|hiv
1077793|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
1077794|NCT02682810|Alere Q|alere q
1077795|NCT02682810|diagnostic|diagnostic
1077796|NCT02682810|children|children
1077797|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
1077798|NCT02682758|xenon|xenon
1077799|NCT02682758|transpulmonary pressure|transpulmonary pressure
1077800|NCT02682758|electrical impedance tomography|electrical impedance tomography
1077801|NCT02682758|tidal volume|tidal volume
1077802|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
1077803|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
1077804|NCT02682732|PET/CT Scan|pet/ct scan
1077805|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
1077806|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1077807|NCT02682719|Hypertension|hypertension
1077808|NCT02682719|Cardiovascular prevention|cardiovascular prevention
1077809|NCT02682719|Left atrial volume index|left atrial volume index
1077810|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
1077811|NCT02682719|LCZ696|lcz696
1077812|NCT02682719|Valsartan|valsartan
1077813|NCT02682719|Sacubitril|sacubitril
1077814|NCT02682706|brown adipose tissue|brown adipose tissue
1077815|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
1077816|NCT02682706|energy expenditure|energy expenditure
1077817|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
1077818|NCT02682680|diabetes|diabetes
1077819|NCT02682680|hyperlipidaemia|hyperlipidaemia
1077820|NCT02682680|colesevelam|colesevelam
1077821|NCT02682680|ezetimibe|ezetimibe
1077822|NCT02682680|LDL cholesterol|ldl cholesterol
1077823|NCT02682680|glycated hemoglobin|glycated hemoglobin
1077824|NCT02682667|Apheresis Products|apheresis products
1077825|NCT02682667|Immunological|immunological
1077826|NCT02682667|Diverse Malignan|diverse malignan
1077827|NCT02682667|Premalignant|premalignant
1077828|NCT02682667|Protein|protein
1077829|NCT02682654|Pain|pain
1077830|NCT02682654|Ankle|ankle
1077831|NCT02682654|Knee|knee
1077832|NCT02682654|Brace|brace
1077833|NCT02682615|Cardiac Index|cardiac index
1077834|NCT02682615|Noninvasive|noninvasive
1077835|NCT02682615|esCCO|escco
1077836|NCT02682615|PiCCO|picco
1077837|NCT02682615|Thermodilution|thermodilution
1077838|NCT02682602|total hip arthroplasty|total hip arthroplasty
1077839|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
1077840|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
1077841|NCT02682589|Laparoscopic|laparoscopic
1077842|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
1077843|NCT02682576|flow-mediated dilation|flow-mediated dilation
1077844|NCT02682576|endothelium|endothelium
1077845|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
1077846|NCT02682550|polytrauma|polytrauma
1077847|NCT02682550|hemorrhagic shock|hemorrhagic shock
1077848|NCT02682550|sepsis|sepsis
1077849|NCT02682550|MODS|mods
1077850|NCT02682537|Resting energy expenditure|resting energy expenditure
1077851|NCT02682537|Calorie requirements|calorie requirements
1077852|NCT02682537|Indirect Calorimetry|indirect calorimetry
1077853|NCT02682511|Ifetroban|ifetroban
1077854|NCT02682511|Scleroderma|scleroderma
1077855|NCT02682511|Systemic Sclerosis|systemic sclerosis
1077856|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
1077857|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
1077858|NCT02682485|Rectal Cancer|rectal cancer
1077859|NCT02682485|low anterior resection|low anterior resection
1077860|NCT02682485|SES|ses
1077861|NCT02682485|SES-DTA|ses-dta
1077862|NCT02682485|anastomotic leak|anastomotic leak
1077863|NCT02682485|anastomotic healing|anastomotic healing
1077864|NCT02682485|intestinal healing|intestinal healing
1077865|NCT02682485|anastomosis|anastomosis
1077866|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
1077867|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
1077868|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
1077869|NCT02682459|chronic kidney disease|chronic kidney disease
1077870|NCT02682459|ACE-inhibitors|ace-inhibitors
1077871|NCT02682459|fibrosis|fibrosis
1077872|NCT02682446|Early gastric cancer|early gastric cancer
1077873|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
1077874|NCT02682446|serum pepsinogen|serum pepsinogen
1077875|NCT02682446|Helicobacter pylori|helicobacter pylori
1077876|NCT02682407|IgAN|igan
1077878|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
1077879|NCT02682407|Lupus Nephritis|lupus nephritis
1077880|NCT02682394|Cancer of pancreas|cancer of pancreas
1077881|NCT02682394|steatosis|steatosis
1077882|NCT02682394|MRI|mri
1077883|NCT02682381|Teduglutide|teduglutide
1077884|NCT02682381|pediatric|pediatric
1077885|NCT02682381|GLP-2|glp-2
1077888|NCT02682381|short gut syndrome|short gut syndrome
1077890|NCT02682381|SBS|sbs
1077891|NCT02682381|parenteral nutrition|parenteral nutrition
1077894|NCT02682329|Peroxide|peroxide
1077895|NCT02682316|undergoing laparotomy|undergoing laparotomy
1077896|NCT02682316|15-309|15-309
1077897|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
1077898|NCT02682303|balance|balance
1077899|NCT02682303|posturography|posturography
1077900|NCT02682290|SPUTUM|sputum
1077901|NCT02682290|RHEOLOGY|rheology
1077902|NCT02682277|obesity|obesity
1077903|NCT02682277|body weight|body weight
1077904|NCT02682277|overweight|overweight
1077905|NCT02682277|weight loss|weight loss
1077906|NCT02682277|polyglucosamine|polyglucosamine
1077907|NCT02682277|L112|l112
1077908|NCT02682277|caloric restriction|caloric restriction
1077909|NCT02682277|physical activity|physical activity
1077910|NCT02682264|acne|acne
1077911|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
1077912|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1077913|NCT02682225|Esketamine|esketamine
1077914|NCT02682225|Placebo|placebo
1077915|NCT02682225|Racemic ketamine|racemic ketamine
1077916|NCT02682225|Pharmacokinetics|pharmacokinetics
1077917|NCT02682212|Pelvic floor|pelvic floor
1077918|NCT02682212|obstetrics|obstetrics
1077919|NCT02682212|perineal tear|perineal tear
1077920|NCT02682212|physiotherapy|physiotherapy
1077921|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
1077922|NCT02682186|Locoregional anesthesia|locoregional anesthesia
1077923|NCT02682186|Pectoral nerve block|pectoral nerve block
1077924|NCT02682186|Pain|pain
1077925|NCT02682186|Postoperative analgesia|postoperative analgesia
1077926|NCT02682160|bariatric surgery|bariatric surgery
1077927|NCT02682134|Sore Throat|sore throat
1077928|NCT02682134|Intubation|intubation
1077929|NCT02682134|Xylocaine|xylocaine
1077930|NCT02682134|Dexamethasone|dexamethasone
1077931|NCT02682108|Hepatitis B|hepatitis b
1077932|NCT02682108|Hepatitis C|hepatitis c
1077933|NCT02682108|Fibrosis, Liver|fibrosis, liver
1077934|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
1077935|NCT02682095|Hypertension|hypertension
1077936|NCT02682095|Blood Pressure Control|blood pressure control
1077937|NCT02682095|Adherence|adherence
1077938|NCT02682095|Mixed Methods|mixed methods
1077939|NCT02682082|Pancreatic cancer|pancreatic cancer
1077940|NCT02682082|Pain Management|pain management
1077941|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
1077942|NCT02682082|Bupivacaine|bupivacaine
1077943|NCT02682082|Palliative treatment|palliative treatment
1077944|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
1077945|NCT02682069|venous leg ulcer|venous leg ulcer
1077946|NCT02682069|fluorescence imaging|fluorescence imaging
1077947|NCT02682069|wound imaging|wound imaging
1077948|NCT02682056|Pediatrics|pediatrics
1077949|NCT02682056|Endocrinology|endocrinology
1077950|NCT02682056|Adolescent|adolescent
1077951|NCT02682056|Microneedle|microneedle
1077952|NCT02682030|Airway Clearance Devices|airway clearance devices
1077953|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
1077954|NCT02682030|Cough Assist|cough assist
1077955|NCT02682017|Seaweed|seaweed
1077956|NCT02682017|Pork|pork
1077957|NCT02682017|Fucoidan|fucoidan
1077958|NCT02682017|Laminarin|laminarin
1077959|NCT02682017|Functional Food|functional food
1077960|NCT02682017|Antioxidant activity|antioxidant activity
1077961|NCT02681913|Cardioplegia|cardioplegia
1077962|NCT02681913|Cardiac Surgery|cardiac surgery
1077963|NCT02681913|Adenosine|adenosine
1077964|NCT02681913|Therapeutic Uses|therapeutic uses
1077965|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
1077966|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
1077967|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
1077968|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
1077969|NCT02681874|dietary pattern|dietary pattern
1077970|NCT02681874|stress|stress
1077971|NCT02681874|nutrition|nutrition
1077972|NCT02681874|health|health
1077973|NCT02681874|obesity|obesity
1077974|NCT02681874|children|children
1077975|NCT02681874|minority|minority
1077976|NCT02681874|pre-schoolers|pre-schoolers
1077977|NCT02681861|Pharmacodynamics|pharmacodynamics
1077978|NCT02681861|Pharmacokinetics|pharmacokinetics
1077979|NCT02681861|ASP6294|asp6294
1077980|NCT02681861|Maximum tolerated dose|maximum tolerated dose
1077981|NCT02681861|Healthy subjects|healthy subjects
1077982|NCT02681848|Primary care attendance|primary care attendance
1077983|NCT02681848|All-cause|all-cause
1077984|NCT02681848|Cause specific|cause specific
1077985|NCT02681848|Hospital attendance|hospital attendance
1077986|NCT02681822|Genome-wide association studies|genome-wide association studies
1077987|NCT02681822|Environmental factors|environmental factors
1077988|NCT02681822|Behavioral Assessment|behavioral assessment
1077989|NCT02681822|Pathway analysis|pathway analysis
1077990|NCT02681783|aflibercept|aflibercept
1077991|NCT02681770|kidney transplantation|kidney transplantation
1077992|NCT02681770|adherence|adherence
1077993|NCT02681770|quality of life|quality of life
1077994|NCT02681770|couples|couples
1077995|NCT02681770|fundamental frequency|fundamental frequency
1077996|NCT02681770|communication|communication
1077997|NCT02681770|social support|social support
1077998|NCT02681757|pediatric hand burn|pediatric hand burn
1077999|NCT02681757|pediatric foot burn|pediatric foot burn
1078000|NCT02681757|mepitel Ag|mepitel ag
1078001|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
1078002|NCT02681718|A1C≥9%|a1c≥9%
1078003|NCT02681718|minorities|minorities
1078004|NCT02681718|economically disadvantaged|economically disadvantaged
1078005|NCT02681692|colonoscopy|colonoscopy
1078006|NCT02681692|colonoscopy education|colonoscopy education
1078007|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
1078008|NCT02681692|Colonic Diseases|colonic diseases
1078009|NCT02681666|FODMAP Diet|fodmap diet
1078010|NCT02681666|Bowel Habit|bowel habit
1078011|NCT02681666|Rome IV Criteria|rome iv criteria
1078012|NCT02681666|Mindfulness|mindfulness
1078013|NCT02681666|Abdominal pain|abdominal pain
1078014|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
1078015|NCT02681653|Statins|statins
1078016|NCT02681653|Septic Shock|septic shock
1078017|NCT02681614|Imaging|imaging
1078018|NCT02681614|Prostate|prostate
1078019|NCT02681614|Multiparametric MRI|multiparametric mri
1078020|NCT02681614|brachytherapy|brachytherapy
1078021|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
1078022|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
1078023|NCT02681562|olaparib|olaparib
1078024|NCT02681510|medication tolerability|medication tolerability
1078025|NCT02681497|canagliflozin|canagliflozin
1078026|NCT02681497|diabetes|diabetes
1078027|NCT02681497|SGLT2|sglt2
1078028|NCT02681497|real-world data|real-world data
1078029|NCT02681471|Monopolar|monopolar
1078030|NCT02681471|Bipolar|bipolar
1078031|NCT02681471|TURP syndrome|turp syndrome
1078032|NCT02681471|hyponatremia|hyponatremia
1078033|NCT02681432|HIPEC|hipec
1078034|NCT02681432|ovarian cancer|ovarian cancer
1078035|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
1078036|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
1078037|NCT02681380|simulated patient|simulated patient
1078038|NCT02681380|Balint|balint
1078039|NCT02681380|empathy|empathy
1078040|NCT02681380|medical student|medical student
1078041|NCT02681367|Recurrent implantation failure|recurrent implantation failure
1078042|NCT02681367|Freeze all policy|freeze all policy
1078043|NCT02681367|endometrial receptivity|endometrial receptivity
1078044|NCT02681367|implantation|implantation
1078045|NCT02681367|clinical outcome|clinical outcome
1078046|NCT02681354|elderly|elderly
1078047|NCT02681289|infant|infant
1078048|NCT02681289|risk|risk
1078049|NCT02681289|rehabilitation|rehabilitation
1078050|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
1078051|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
1078052|NCT02681250|Zirconium|zirconium
1078053|NCT02681250|Randomized Controlled Trial|randomized controlled trial
1078054|NCT02681250|Dental Implants|dental implants
1078055|NCT02681250|Dental Material|dental material
1078056|NCT02681250|Titanium|titanium
1078057|NCT02681211|migraine headache|migraine headache
1078058|NCT02681211|acupuncture|acupuncture
1078059|NCT02681198|Healthy|healthy
1078060|NCT02681198|Lofexidine|lofexidine
1078061|NCT02681198|Paroxetine|paroxetine
1078062|NCT02681198|Volunteer|volunteer
1078063|NCT02681172|CSF|csf
1078064|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
1078065|NCT02681172|HAS recommendations|has recommendations
1078066|NCT02681159|Anesthesia|anesthesia
1078067|NCT02681146|education|education
1078068|NCT02681146|physiotherapy|physiotherapy
1078069|NCT02681133|Physical activity level|physical activity level
1078070|NCT02681133|Knee osteoarthritis|knee osteoarthritis
1078071|NCT02681133|Non pharmacological treatment|non pharmacological treatment
1078072|NCT02681133|Survey|survey
1078073|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
1078074|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
1078075|NCT02681133|Function|function
1078076|NCT02681120|Biomarkers|biomarkers
1078077|NCT02681120|Breast imaging|breast imaging
1078078|NCT02681107|Radiation therapy|radiation therapy
1078079|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
1078179|NCT02680548|foot pain|foot pain
1078080|NCT02681107|Breast conserving surgery|breast conserving surgery
1078081|NCT02681107|Stage 1|stage 1
1333234|NCT01443923|Hepatitis C|hepatitis c
1078082|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
1078083|NCT02681094|saxagliptin,|saxagliptin,
1078084|NCT02681094|dapagliflozin,|dapagliflozin,
1078085|NCT02681094|metformin|metformin
1078086|NCT02681081|Neuroplasticity|neuroplasticity
1078087|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
1078088|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
1078089|NCT02681055|NASH|nash
1078090|NCT02681055|NAFLD|nafld
1078091|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
1078092|NCT02681016|Calypso|calypso
1078093|NCT02681016|Xience|xience
1078094|NCT02681016|Coronary stenosis|coronary stenosis
1078095|NCT02681016|Drug-eluting stent|drug-eluting stent
1078096|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
1078097|NCT02681016|Ischemic Heart Disease|ischemic heart disease
1078098|NCT02680977|Mucuna pruriens|mucuna pruriens
1078099|NCT02680977|Levodopa|levodopa
1078100|NCT02680951|Pediatric|pediatric
1078101|NCT02680951|Adolescent|adolescent
1078102|NCT02680912|Bi syndrome|bi syndrome
1078103|NCT02680899|science education|science education
1078104|NCT02680899|health promotion|health promotion
1078105|NCT02680899|mental health promotion|mental health promotion
1078106|NCT02680899|stigmatization|stigmatization
1078107|NCT02680899|behavioral intervention|behavioral intervention
1078108|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
1078109|NCT02680886|Children / Adults|children / adults
1078110|NCT02680886|Novosyn Quick|novosyn quick
1078111|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
1078112|NCT02680847|Pediatric|pediatric
1078113|NCT02680847|pain indication|pain indication
1078114|NCT02680847|controlled release oxycodone|controlled release oxycodone
1078115|NCT02680834|venous stasis ulcer|venous stasis ulcer
1078116|NCT02680834|wound|wound
1078117|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
1078118|NCT02680821|Laxity|laxity
1078119|NCT02680821|Knee|knee
1078120|NCT02680821|Rupture|rupture
1078121|NCT02680821|ALL|all
1078122|NCT02680795|UGT1A1*28|ugt1a1*28
1078123|NCT02680795|Belinostat|belinostat
1078124|NCT02680795|beleodaq|beleodaq
1078125|NCT02680795|wild type genotypes|wild type genotypes
1078126|NCT02680795|heterozygous genotypes|heterozygous genotypes
1078127|NCT02680795|homozygous genotypes|homozygous genotypes
1078128|NCT02680782|Healthy Volunteers|healthy volunteers
1078129|NCT02680782|Comparison|comparison
1078130|NCT02680782|Once-Daily|once-daily
1078131|NCT02680782|Twice-Daily|twice-daily
1078132|NCT02680782|X4P-001|x4p-001
1078133|NCT02680756|Iron Deficiency|iron deficiency
1078134|NCT02680756|Anaemia|anaemia
1078135|NCT02680756|Crohn's Disease|crohn's disease
1078136|NCT02680756|Deficiency Diseases|deficiency diseases
1078137|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
1078138|NCT02680756|Intestinal Diseases|intestinal diseases
1078139|NCT02680730|Autonomic nervous system|autonomic nervous system
1078140|NCT02680730|Auditory processing disorder|auditory processing disorder
1078141|NCT02680730|Social behavior|social behavior
1078142|NCT02680691|infratentorial stroke|infratentorial stroke
1078143|NCT02680691|robot|robot
1078144|NCT02680691|postural balance|postural balance
1078145|NCT02680691|Rehabilitation|rehabilitation
1078146|NCT02680652|CVID|cvid
1078147|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
1078148|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
1078149|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
1078150|NCT02680613|Behaviour Change|behaviour change
1078151|NCT02680613|Secondary Prevention|secondary prevention
1078152|NCT02680613|mHealth|mhealth
1078153|NCT02680587|Prostate Cancer|prostate cancer
1078154|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1078155|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
1078156|NCT02680587|Oligometastasis|oligometastasis
1078157|NCT02680574|vadadustat|vadadustat
1078158|NCT02680574|AKB-6548|akb-6548
1078159|NCT02680574|Chronic kidney disease|chronic kidney disease
1078160|NCT02680574|anemia|anemia
1078161|NCT02680574|CKD|ckd
1078162|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
1078163|NCT02680574|renal impairment|renal impairment
1078164|NCT02680574|erythropoietin|erythropoietin
1078165|NCT02680574|kidney|kidney
1078166|NCT02680574|renal|renal
1078167|NCT02680574|oral anemia treatment|oral anemia treatment
1078168|NCT02680574|hemoglobin|hemoglobin
1078169|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
1078170|NCT02680574|HIF|hif
1078171|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1078172|NCT02680574|HIF-PHI|hif-phi
1078173|NCT02680574|efficacy|efficacy
1078174|NCT02680574|safety|safety
1078175|NCT02680574|Phase 3|phase 3
1078176|NCT02680574|cardiovascular|cardiovascular
1078177|NCT02680574|NDD-CKD|ndd-ckd
1078178|NCT02680548|ankle pain|ankle pain
1078180|NCT02680548|methylprednisolone|methylprednisolone
1078181|NCT02680548|neuropathic pain|neuropathic pain
1078182|NCT02680522|Parkinson's disease|parkinson's disease
1078183|NCT02680522|Heart Rate Variability|heart rate variability
1078184|NCT02680522|Physiotherapy|physiotherapy
1078185|NCT02680496|Robot-Assistance|robot-assistance
1078186|NCT02680496|Gait [MeSH]|gait [mesh]
1078187|NCT02680496|Energy Consumption|energy consumption
1078188|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
1078189|NCT02680496|Stroke [MeSH]|stroke [mesh]
1078190|NCT02680483|Atrial fibrillation|atrial fibrillation
1078191|NCT02680483|Registry|registry
1078192|NCT02680483|Middle East|middle east
1078193|NCT02680483|Jordan|jordan
1078194|NCT02680483|risk factors|risk factors
1078195|NCT02680483|in hospital management|in hospital management
1078196|NCT02680483|long term management|long term management
1078197|NCT02680470|Tuberculosis|tuberculosis
1078198|NCT02680470|Management|management
1078199|NCT02680470|Observed therapy|observed therapy
1078200|NCT02680444|Mindfulness|mindfulness
1078201|NCT02680444|Primary Promotion|primary promotion
1078202|NCT02680444|Mental Health|mental health
1078203|NCT02680444|Well-being|well-being
1078204|NCT02680444|Positive Reappraisal|positive reappraisal
1078205|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
1078206|NCT02680392|Continuous adductor canal block|continuous adductor canal block
1078207|NCT02680392|Postoperative pain|postoperative pain
1078208|NCT02680392|Functional recovery|functional recovery
1078209|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
1078210|NCT02680379|Fragile X Syndrome|fragile x syndrome
1078211|NCT02680379|Autism|autism
1078212|NCT02680379|FMR1|fmr1
1078213|NCT02680379|FRAXA|fraxa
1078214|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
1078215|NCT02680314|unripe cervix|unripe cervix
1078216|NCT02680301|Wet Wraps|wet wraps
1078217|NCT02680301|Topical Steroid|topical steroid
1078218|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
1078219|NCT02680275|Chronic endometritis|chronic endometritis
1078220|NCT02680275|Miscarriage|miscarriage
1078221|NCT02680275|Infertility|infertility
1078222|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
1078223|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
1078224|NCT02680236|Pain|pain
1078225|NCT02680236|Cancer|cancer
1078226|NCT02680236|Chemotherapy|chemotherapy
1078227|NCT02680236|Anxiety|anxiety
1078228|NCT02680236|Depression|depression
1078229|NCT02680236|Isolation|isolation
1078230|NCT02680197|COPD|copd
1078231|NCT02680184|Malignant melanoma|malignant melanoma
1078232|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
1078233|NCT02680171|Prism Adaptation|prism adaptation
1078234|NCT02680171|Stroke|stroke
1078235|NCT02680171|Spatial Neglect|spatial neglect
1078236|NCT02680145|Pessary|pessary
1078237|NCT02680145|Prolapse|prolapse
1078238|NCT02680145|Cystocele|cystocele
1078239|NCT02680106|Nanofibers|nanofibers
1078240|NCT02680106|Dressing|dressing
1078241|NCT02680106|Donor site|donor site
1078242|NCT02680106|Polycaprolactone|polycaprolactone
1078243|NCT02680067|Healthy Individual|healthy individual
1078244|NCT02680067|Lymphatic Transport|lymphatic transport
1078245|NCT02680067|Near InfraRed|near infrared
1078246|NCT02680067|Imaging|imaging
1078247|NCT02680067|Indocyanine Green|indocyanine green
1078248|NCT02680067|ICG|icg
1078249|NCT02680067|NIR|nir
1078250|NCT02680067|NIR-ICG|nir-icg
1078251|NCT02680067|MSImager|msimager
1078252|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
1078253|NCT02680015|PEERS|peers
1078254|NCT02680015|friendships|friendships
1078255|NCT02680015|brain|brain
1078256|NCT02679989|Insulin sensitivity|insulin sensitivity
1078257|NCT02679989|Weight loss|weight loss
1078258|NCT02679989|Intermittent fasting|intermittent fasting
1078259|NCT02679989|Sympathetic nervous system|sympathetic nervous system
1078260|NCT02679950|Next generation genome sequencing|next generation genome sequencing
1078261|NCT02679950|Late relapse|late relapse
1078262|NCT02679950|Genetic profiles|genetic profiles
1078263|NCT02679937|U.S. Military|u.s. military
1078264|NCT02679937|Overweight|overweight
1078265|NCT02679937|Obesity|obesity
1078266|NCT02679937|Service Members|service members
1078267|NCT02679937|Prevention|prevention
1078268|NCT02679911|Onychomycosis|onychomycosis
1078269|NCT02679898|Arterial function|arterial function
1078270|NCT02679898|Whole-body vibration training|whole-body vibration training
1078271|NCT02679898|Aortic blood pressures|aortic blood pressures
1078272|NCT02679898|Wave reflection|wave reflection
1078273|NCT02679898|Muscle strength|muscle strength
1078274|NCT02679898|Endothelial function|endothelial function
1078275|NCT02679898|Blood flow|blood flow
1078276|NCT02679872|Non-technical skills|non-technical skills
1078277|NCT02679872|Patient safety|patient safety
1078278|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
1078279|NCT02679872|Operating theatre team|operating theatre team
1078280|NCT02679872|Operating room|operating room
1078281|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
1078283|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
1078284|NCT02679846|monitoring VEEG|monitoring veeg
1078285|NCT02679846|safety|safety
1078286|NCT02679846|adverse event|adverse event
1078287|NCT02679846|standardized protocol|standardized protocol
1078288|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
1078289|NCT02679833|Anemia|anemia
1078290|NCT02679833|Vegan diet|vegan diet
1078291|NCT02679833|Subclinical|subclinical
1078292|NCT02679833|Metabolic functional markers|metabolic functional markers
1078293|NCT02679833|Holotranscobalamin|holotranscobalamin
1078294|NCT02679833|Methylmalonic acid|methylmalonic acid
1078295|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
1078296|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
1078297|NCT02679742|older people|older people
1078298|NCT02679742|muscle mass|muscle mass
1078299|NCT02679742|muscle strength|muscle strength
1078300|NCT02679742|post-acute|post-acute
1078301|NCT02679729|inhaled dose|inhaled dose
1078302|NCT02679729|intravenous dose|intravenous dose
1078303|NCT02679729|healthy subjects|healthy subjects
1078304|NCT02679729|safety|safety
1078305|NCT02679729|tolerability|tolerability
1078306|NCT02679729|pharmacokinetics|pharmacokinetics
1078307|NCT02679729|AZD5634|azd5634
1078308|NCT02679729|jet nebulizer|jet nebulizer
1078309|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1078310|NCT02679677|Randomized controlled trial|randomized controlled trial
1078311|NCT02679677|Physical activity|physical activity
1078312|NCT02679638|breast cancer|breast cancer
1078313|NCT02679638|treatment choice|treatment choice
1078314|NCT02679638|factor|factor
1078315|NCT02679638|perception|perception
1078316|NCT02679573|Pneumonia|pneumonia
1078317|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
1078318|NCT02679547|Appendix|appendix
1078319|NCT02679547|Breastfeeding|breastfeeding
1078320|NCT02679547|Adult|adult
1078321|NCT02679534|pain|pain
1078322|NCT02679534|thoracic surgery|thoracic surgery
1078323|NCT02679534|massage|massage
1078324|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
1078325|NCT02679521|Painful Heel|painful heel
1078326|NCT02679521|Plantar fasciitis|plantar fasciitis
1078327|NCT02679508|Esophagitis|esophagitis
1078328|NCT02679495|early gastric cancer|early gastric cancer
1078329|NCT02679495|lifestyle|lifestyle
1078330|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
1078331|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
1078332|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
1078333|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
1078334|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
1078335|NCT02679443|Chemotherapy|chemotherapy
1078336|NCT02679443|Pemetrexed|pemetrexed
1078337|NCT02679443|Vitamin B12|vitamin b12
1078338|NCT02679443|Folate|folate
1078339|NCT02679443|Supplementation|supplementation
1078340|NCT02679443|Cytopenia|cytopenia
1078341|NCT02679417|Aminotransferase|aminotransferase
1078342|NCT02679417|Fibrosis, liver|fibrosis, liver
1078343|NCT02679417|Anthropometry|anthropometry
1078344|NCT02679417|Exercise|exercise
1078345|NCT02679404|Biological aortic valves|biological aortic valves
1078346|NCT02679404|Mechanical aortic valves|mechanical aortic valves
1078347|NCT02679404|Aortic conduits|aortic conduits
1078348|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
1078349|NCT02679391|Abdominoplasty|abdominoplasty
1078350|NCT02679391|Early complications|early complications
1078351|NCT02679391|Guidelines|guidelines
1078352|NCT02679391|Sequelae|sequelae
1078353|NCT02679391|bariatric patients|bariatric patients
1078354|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
1078355|NCT02679300|Chronic Low Back Pain|chronic low back pain
1078356|NCT02679300|Virtual Reality|virtual reality
1078357|NCT02679300|Serious Gaming|serious gaming
1078358|NCT02679300|Exercise Therapy|exercise therapy
1078359|NCT02679300|Distraction|distraction
1078360|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
1078361|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
1078362|NCT02679287|USS Virginia|uss virginia
1078363|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1078364|NCT02679287|Insulin Pump|insulin pump
1078365|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
1078366|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
1078367|NCT02679261|Aortic dilation|aortic dilation
1078368|NCT02679261|Statins|statins
1078369|NCT02679261|Aortic degeneration|aortic degeneration
1078370|NCT02679248|Pre-hypertension|pre-hypertension
1078371|NCT02679248|Mild hypertension|mild hypertension
1078372|NCT02679248|Dietary supplement|dietary supplement
1078373|NCT02679248|Efficacy|efficacy
1078374|NCT02679248|Nitric oxide|nitric oxide
1078375|NCT02679248|Neo40 Daily|neo40 daily
1078376|NCT02679170|ALK+|alk+
1333236|NCT01443910|Body Weight|body weight
1078377|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
1078378|NCT02679157|Depression|depression
1078379|NCT02679157|Anxiety|anxiety
1078381|NCT02679157|Health-related quality of life|health-related quality of life
1078382|NCT02679157|ICU survivorship|icu survivorship
1078383|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
1078384|NCT02679131|beleodaq|beleodaq
1078385|NCT02679131|renal impairment|renal impairment
1078386|NCT02679131|belinostat|belinostat
1078387|NCT02679131|hematological malignancies|hematological malignancies
1078388|NCT02679118|intestinal perforation|intestinal perforation
1078389|NCT02679118|bariatric surgery|bariatric surgery
1078390|NCT02679118|gastric bypass|gastric bypass
1078391|NCT02679118|gastric perforation|gastric perforation
1078392|NCT02679118|colonic perforation|colonic perforation
1078393|NCT02679092|Induced Abortion|induced abortion
1078394|NCT02679092|Mifepristone|mifepristone
1078395|NCT02679092|Dilation and Evacuation|dilation and evacuation
1078396|NCT02679092|Cervical Preparation|cervical preparation
1078397|NCT02679092|Osmotic Dilators|osmotic dilators
1078398|NCT02679092|Misoprostol|misoprostol
1078399|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
1078400|NCT02678962|bilateral implantation|bilateral implantation
1078401|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
1078402|NCT02678897|Pain Management|pain management
1078403|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1078404|NCT02678884|Radiation therapy|radiation therapy
1078405|NCT02678884|Head and Neck Cancers|head and neck cancers
1078406|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
1078407|NCT02678871|Left atrial appendage|left atrial appendage
1078408|NCT02678858|social cognition|social cognition
1078409|NCT02678858|social skills|social skills
1078410|NCT02678858|cognitive remediation|cognitive remediation
1078411|NCT02678858|functional outcome|functional outcome
1078412|NCT02678858|treatment adherence|treatment adherence
1078414|NCT02678767|Dementia|dementia
1078415|NCT02678767|Neuroimaging|neuroimaging
1078416|NCT02678702|Sleep|sleep
1078417|NCT02678702|Depression|depression
1078418|NCT02678702|Comorbid Insomnia|comorbid insomnia
1078419|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
1078420|NCT02678702|Sleep Restriction|sleep restriction
1078421|NCT02678702|Stimulus Control therapy|stimulus control therapy
1078422|NCT02678702|Relaxation|relaxation
1078423|NCT02678676|Drug Therapy|drug therapy
1078424|NCT02678663|Colon polyp|colon polyp
1078425|NCT02678663|Polypectomy|polypectomy
1078426|NCT02678663|Cold snare|cold snare
1078427|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
1078428|NCT02678650|Volatile Anesthetics|volatile anesthetics
1078429|NCT02678650|MicroRNA|microrna
1078430|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
1078431|NCT02678650|Internal Mammary Artery|internal mammary artery
1078432|NCT02678650|Ascending Aorta|ascending aorta
1078433|NCT02678637|MRI|mri
1078434|NCT02678637|CCSA|ccsa
1078435|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
1078436|NCT02678637|Strength|strength
1078437|NCT02678637|Calf muscle|calf muscle
1078438|NCT02678611|Healthy participants|healthy participants
1078439|NCT02678611|Dietary supplement|dietary supplement
1078440|NCT02678611|Safety|safety
1078441|NCT02678611|Tolerability|tolerability
1078442|NCT02678611|Older Adults|older adults
1078443|NCT02678611|Basis|basis
1078444|NCT02678611|Nicotinamide riboside|nicotinamide riboside
1078445|NCT02678611|Pterostilbene|pterostilbene
1078446|NCT02678598|Micafungin|micafungin
1078447|NCT02678598|Candida|candida
1078448|NCT02678598|Aspergillosis|aspergillosis
1078449|NCT02678598|Antifungal|antifungal
1078450|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
1078451|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
1078452|NCT02678559|Lung recruitment|lung recruitment
1078453|NCT02678559|Preload dependency|preload dependency
1078454|NCT02678559|Cardiac surgery|cardiac surgery
1078455|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
1078456|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
1078457|NCT02678533|Fanconi Anemia|fanconi anemia
1078458|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
1078459|NCT02678533|G-CSF|g-csf
1078460|NCT02678533|Plerixafor|plerixafor
1078461|NCT02678533|gene therapy|gene therapy
1078462|NCT02678520|Prostate Cancer|prostate cancer
1078463|NCT02678520|Post Operative|post operative
1078464|NCT02678520|Radiation|radiation
1078465|NCT02678520|Prostatectomy|prostatectomy
1078466|NCT02678520|3-D CRT|3-d crt
1078467|NCT02678520|IMRT|imrt
1078468|NCT02678520|RT|rt
1078469|NCT02678520|CRT|crt
1078470|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
1078471|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1078472|NCT02678520|Hormone|hormone
1078473|NCT02678520|Surgery|surgery
1078474|NCT02678520|Hormonal Therapy|hormonal therapy
1078475|NCT02678494|Spinal Cord Injury|spinal cord injury
1078476|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
1078477|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
1078478|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
1078479|NCT02678455|Dengue Virus|dengue virus
1078480|NCT02678416|comparison|comparison
1078481|NCT02678403|peripheral artery disease|peripheral artery disease
1078482|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1078483|NCT02678403|walking ability|walking ability
1078484|NCT02678403|endothelial function|endothelial function
1078485|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
1078486|NCT02678364|Vitamin D status|vitamin d status
1078487|NCT02678364|RCT|rct
1078488|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
1078489|NCT02678312|systemic left ventricle,|systemic left ventricle,
1078490|NCT02678312|reduced ejection fraction|reduced ejection fraction
1078491|NCT02678286|Abdominoplasty|abdominoplasty
1078492|NCT02678286|Pain|pain
1078493|NCT02678286|Analgesia|analgesia
1078494|NCT02678286|N1539|n1539
1078495|NCT02678286|Phase 3|phase 3
1078496|NCT02678273|population|population
1078497|NCT02678273|Singapore|singapore
1078498|NCT02678260|Advanced malignancies|advanced malignancies
1078499|NCT02678260|PDR001|pdr001
1078500|NCT02678260|Japanese patients|japanese patients
1078501|NCT02678260|adults|adults
1078502|NCT02678247|prosthesis|prosthesis
1078503|NCT02678247|prosthetic socket|prosthetic socket
1078504|NCT02678247|transfemoral amputation|transfemoral amputation
1078505|NCT02678247|socket comfort|socket comfort
1078506|NCT02678247|gait biomechanics|gait biomechanics
1078507|NCT02678156|Dura mater substitute|dura mater substitute
1078508|NCT02678156|Graft|graft
1078509|NCT02678156|Lyoplant|lyoplant
1078510|NCT02678156|Lyostypt|lyostypt
1078511|NCT02678156|Lyoplant onlay|lyoplant onlay
1078512|NCT02678156|Xenograft|xenograft
1078513|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
1078514|NCT02678130|Bone Disease|bone disease
1078515|NCT02678130|Musculoskeletal disease|musculoskeletal disease
1078516|NCT02678130|Spinal disease|spinal disease
1078517|NCT02678104|Dry Socket|dry socket
1078518|NCT02678104|Honey|honey
1078519|NCT02678104|Tooth Extraction|tooth extraction
1078520|NCT02678078|cancer|cancer
1078521|NCT02678078|diagnosis|diagnosis
1078522|NCT02678078|biopsy|biopsy
1078523|NCT02678078|chemotherapy drugs|chemotherapy drugs
1078524|NCT02678078|tumor|tumor
1078525|NCT02678052|Drug therapy|drug therapy
1078526|NCT02677961|sarcoma|sarcoma
1078527|NCT02677961|registry|registry
1078528|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
1078529|NCT02677922|Leukemia|leukemia
1078530|NCT02677922|Azacitidine|azacitidine
1078531|NCT02677922|AG-120|ag-120
1078532|NCT02677922|AG-221|ag-221
1078533|NCT02677909|Parenteral Nutrition|parenteral nutrition
1078534|NCT02677909|Critical Care|critical care
1078535|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
1078536|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
1078537|NCT02677896|Xtandi|xtandi
1078538|NCT02677896|Enzalutamide|enzalutamide
1078539|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
1078540|NCT02677870|Kuvan|kuvan
1078541|NCT02677870|Amish|amish
1078542|NCT02677831|Physical functioning|physical functioning
1078543|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
1078544|NCT02677831|Frailty|frailty
1078545|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
1078546|NCT02677818|Ischemic stroke|ischemic stroke
1078547|NCT02677818|Antithrombotic therapy|antithrombotic therapy
1078548|NCT02677818|Bleeding|bleeding
1078549|NCT02677766|Occupational Therapy|occupational therapy
1078550|NCT02677766|Complex patients|complex patients
1078551|NCT02677766|Randomized controlled trial|randomized controlled trial
1078552|NCT02677766|Occupational performance problem|occupational performance problem
1078553|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
1078554|NCT02677740|MRI|mri
1078555|NCT02677740|MRS|mrs
1078556|NCT02677740|rTMS|rtms
1078557|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
1078558|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1078559|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
1078560|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
1078561|NCT02677688|adoptive therapy|adoptive therapy
1078562|NCT02677688|phase 1 -2|phase 1 -2
1078563|NCT02677662|Diesel exhaust|diesel exhaust
1078564|NCT02677662|Oxidative stress|oxidative stress
1078565|NCT02677662|Systemic inflammation|systemic inflammation
1078566|NCT02677662|Air pollution|air pollution
1078567|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
1078568|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
1078569|NCT02677636|Eczema|eczema
1078570|NCT02677636|Dermatitis|dermatitis
1078571|NCT02677636|Pruritus|pruritus
1078572|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
1078573|NCT02677636|Hypersensitivity|hypersensitivity
1078574|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
1078575|NCT02677636|Immune System Diseases|immune system diseases
1078576|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
1078577|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
1078578|NCT02677636|Skin Diseases|skin diseases
1078582|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
1078583|NCT02677610|Eczema|eczema
1078584|NCT02677610|Dermatitis|dermatitis
1078585|NCT02677610|Pruritus|pruritus
1078586|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
1078587|NCT02677610|Hypersensitivity|hypersensitivity
1078588|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
1078589|NCT02677610|Immune System Diseases|immune system diseases
1078590|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
1078591|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
1078592|NCT02677610|Skin Diseases|skin diseases
1078593|NCT02677610|Itching|itching
1078594|NCT02677610|Rash|rash
1078595|NCT02677610|Steroid|steroid
1078596|NCT02677584|caffeine|caffeine
1078597|NCT02677584|apnea|apnea
1078598|NCT02677584|preterm infant|preterm infant
1078599|NCT02677558|Pregnancy|pregnancy
1078600|NCT02677558|Obesity|obesity
1078601|NCT02677558|Echocardiography|echocardiography
1078602|NCT02677519|ADHD|adhd
1078603|NCT02677519|children|children
1078604|NCT02677519|methylphenidate|methylphenidate
1078605|NCT02677506|elbow|elbow
1078606|NCT02677480|Microflora|microflora
1078607|NCT02677480|Probiotics|probiotics
1078608|NCT02677480|Hyposalivation|hyposalivation
1078609|NCT02677480|Lactobacilli|lactobacilli
1078610|NCT02677480|Mutans streptococci|mutans streptococci
1078611|NCT02677480|pH-rising components|ph-rising components
1078612|NCT02677454|Blood Glucose|blood glucose
1078613|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1078614|NCT02677428|Veterans|veterans
1078615|NCT02677428|world wide web|world wide web
1078616|NCT02677428|Counseling|counseling
1078617|NCT02677428|Workman's Compensation|workman's compensation
1078618|NCT02677415|Ischemic Stroke|ischemic stroke
1078619|NCT02677415|Anesthesia|anesthesia
1078620|NCT02677415|Endovascular Procedures|endovascular procedures
1078621|NCT02677402|femoral vein|femoral vein
1078622|NCT02677402|saphenous vein|saphenous vein
1078623|NCT02677402|hydrostatic pressure|hydrostatic pressure
1078624|NCT02677402|temperature|temperature
1078625|NCT02677402|recovery|recovery
1078626|NCT02677363|Elderly|elderly
1078627|NCT02677363|Older|older
1078628|NCT02677363|Adults|adults
1078629|NCT02677363|Resistant Exercise|resistant exercise
1078630|NCT02677363|Strength Training|strength training
1078631|NCT02677363|Cognitive function|cognitive function
1078632|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1078634|NCT02677272|Nursing home|nursing home
1078635|NCT02677272|emergency department|emergency department
1078636|NCT02677272|inappropriate transfer|inappropriate transfer
1078637|NCT02677272|elderly|elderly
1078638|NCT02677259|luteal phase|luteal phase
1078639|NCT02677259|estradiol|estradiol
1078640|NCT02677259|pregnancy rate|pregnancy rate
1078641|NCT02677246|Bone marrow transplantation|bone marrow transplantation
1078642|NCT02677246|Children|children
1078643|NCT02677246|Bone complications|bone complications
1078644|NCT02677246|Denosumab.|denosumab.
1078645|NCT02677181|ATG|atg
1078646|NCT02677181|Matched sibling donor|matched sibling donor
1078647|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1078648|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
1078649|NCT02677168|sleep apnea|sleep apnea
1078650|NCT02677168|OSA|osa
1078651|NCT02677168|cNEP|cnep
1078652|NCT02677168|continuous negative external pressure|continuous negative external pressure
1078653|NCT02677155|Follicular lymphoma|follicular lymphoma
1078654|NCT02677155|Intranodal therapy|intranodal therapy
1078655|NCT02677155|Autologous dendritic cells|autologous dendritic cells
1078656|NCT02677155|Rituximab|rituximab
1078657|NCT02677155|Immunotherapy|immunotherapy
1078658|NCT02677155|Cancer vaccine|cancer vaccine
1078659|NCT02677155|Anti-PD1|anti-pd1
1078660|NCT02677155|Pembrolizumab|pembrolizumab
1078661|NCT02677155|Radiotherapy|radiotherapy
1078662|NCT02677142|pediatric|pediatric
1078663|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
1078664|NCT02677142|Social Skills Rating System|social skills rating system
1078665|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
1078666|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
1078667|NCT02677090|Fiber tolerability|fiber tolerability
1078668|NCT02677090|Children|children
1078669|NCT02677077|RRMS|rrms
1078670|NCT02677077|MRI|mri
1078671|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1078672|NCT02677064|Identify Barriers|identify barriers
1078673|NCT02677064|16-024|16-024
1078674|NCT02677038|Pancreatic Cancer|pancreatic cancer
1078675|NCT02677038|Stage IV pancreatic ductal adenocarcinoma (PDAC) with BRCAness|stage iv pancreatic ductal adenocarcinoma (pdac) with brcaness
1078676|NCT02677038|PDAC|pdac
1078677|NCT02677038|Metastatic adenocarcinoma of the pancreas|metastatic adenocarcinoma of the pancreas
1078678|NCT02677038|Family history of breast cancer|family history of breast cancer
1078679|NCT02677038|Family history of ovarian cancer|family history of ovarian cancer
1078680|NCT02677038|Family history of pancreatic cancer|family history of pancreatic cancer
1078983|NCT02675153|stricture|stricture
1078681|NCT02677038|Family history of gastric cancer|family history of gastric cancer
1078682|NCT02677038|Family history of prostate cancer|family history of prostate cancer
1078683|NCT02677038|Olaparib|olaparib
1078684|NCT02677038|Lynparza|lynparza
1078685|NCT02677025|HIV|hiv
1078686|NCT02677025|Sexual Risk|sexual risk
1078687|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
1078688|NCT02677025|Substance Abuse|substance abuse
1078689|NCT02677025|Violence and Victimization|violence and victimization
1078690|NCT02677012|Autologous fat grafting|autologous fat grafting
1078691|NCT02677012|AFG|afg
1078692|NCT02677012|Reconstructive surgery|reconstructive surgery
1078693|NCT02677012|Fatty tissue processing|fatty tissue processing
1078694|NCT02676986|Primary Breast Cancer|primary breast cancer
1078695|NCT02676986|ER|er
1078696|NCT02676986|AR|ar
1078697|NCT02676986|TNBC|tnbc
1078698|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
1078699|NCT02676973|POP|pop
1078700|NCT02676973|vault prolapse|vault prolapse
1078701|NCT02676973|cystocele|cystocele
1078702|NCT02676973|vaginal prolapse|vaginal prolapse
1078703|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
1078704|NCT02676921|sinus membrane|sinus membrane
1078705|NCT02676921|osteogenic|osteogenic
1078706|NCT02676908|endovenous ablation|endovenous ablation
1078707|NCT02676908|laser|laser
1078708|NCT02676908|radiofrequency|radiofrequency
1078709|NCT02676908|stockings|stockings
1078710|NCT02676882|Depressive Disorder|depressive disorder
1078711|NCT02676882|Depression|depression
1078712|NCT02676882|Antidepressants|antidepressants
1078713|NCT02676882|Pregnancy|pregnancy
1078714|NCT02676882|Folate|folate
1078715|NCT02676882|Dietary Supplements|dietary supplements
1078716|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
1078717|NCT02676882|Women's Health|women's health
1078718|NCT02676882|Vitamins|vitamins
1078719|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
1078720|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
1078721|NCT02676817|colitis|colitis
1078722|NCT02676817|endoscopy|endoscopy
1078723|NCT02676804|Exercise|exercise
1078724|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
1078725|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1078726|NCT02676778|E7777|e7777
1078727|NCT02676778|Phase 2|phase 2
1078728|NCT02676765|Allergic rhinitis|allergic rhinitis
1078729|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
1078730|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
1078731|NCT02676752|head and neck cancer|head and neck cancer
1078732|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
1078733|NCT02676726|extraperitoneal|extraperitoneal
1078734|NCT02676726|transperitoneal|transperitoneal
1078735|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
1078736|NCT02676726|endometrial cancer|endometrial cancer
1078737|NCT02676726|ovarian cancer|ovarian cancer
1078738|NCT02676726|surgical staging|surgical staging
1078739|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
1078740|NCT02676713|Chinese Herbal|chinese herbal
1078741|NCT02676700|Urinary stress incontinence|urinary stress incontinence
1078742|NCT02676700|pelvic floor muscle|pelvic floor muscle
1078743|NCT02676700|Kaatsu training|kaatsu training
1078744|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
1078745|NCT02676661|peri-implant disease|peri-implant disease
1078746|NCT02676661|risk factors|risk factors
1078747|NCT02676661|prevalence|prevalence
1078748|NCT02676622|Crohn's Disease|crohn's disease
1078749|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
1078750|NCT02676622|Cyclophosphamide|cyclophosphamide
1078751|NCT02676622|IL-2|il-2
1078752|NCT02676622|Aldesleukin|aldesleukin
1078753|NCT02676622|Proleukin|proleukin
1078754|NCT02676622|PCDAI|pcdai
1078755|NCT02676609|Type 1 diabetes|type 1 diabetes
1078756|NCT02676609|Smart phone application|smart phone application
1078757|NCT02676609|carbohydrate counting|carbohydrate counting
1078758|NCT02676609|meal insulin dose|meal insulin dose
1078759|NCT02676583|pain|pain
1078760|NCT02676583|tonsillectomy|tonsillectomy
1078761|NCT02676583|tonsillar fossa|tonsillar fossa
1078762|NCT02676583|suture|suture
1078763|NCT02676583|tonsil fossa closure|tonsil fossa closure
1078764|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
1078765|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1078766|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1078767|NCT02676544|PAE|pae
1078768|NCT02676544|BPH|bph
1078769|NCT02676544|LUTS|luts
1078770|NCT02676544|Prostate Artery Embolization|prostate artery embolization
1078771|NCT02676544|Embospheres|embospheres
1078772|NCT02676531|Walking Meditation|walking meditation
1078773|NCT02676531|Vascular Function|vascular function
1078774|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
1078775|NCT02676531|Breast Cancer Patients|breast cancer patients
1078776|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
1078777|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
1078778|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
1078779|NCT02676518|glucose intolerance|glucose intolerance
1078780|NCT02676518|metabolic syndrome|metabolic syndrome
1078781|NCT02676466|Mobility|mobility
1078782|NCT02676440|Oral Health|oral health
1078783|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
1078784|NCT02676388|Slow Transit Constipation|slow transit constipation
1078785|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
1078786|NCT02676388|Fresh FMT|fresh fmt
1078787|NCT02676349|mFolfirinox|mfolfirinox
1078788|NCT02676349|Chemoradiotherapy|chemoradiotherapy
1078789|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
1078790|NCT02676349|Borderline|borderline
1078791|NCT02676336|FBC|fbc
1078792|NCT02676336|cyclic mastalgia|cyclic mastalgia
1078793|NCT02676336|breast discomfort|breast discomfort
1078794|NCT02676323|Maximum tolerated dose|maximum tolerated dose
1078795|NCT02676323|Childhood leukemia|childhood leukemia
1078796|NCT02676323|Hematological malignancies|hematological malignancies
1078797|NCT02676297|inhalation|inhalation
1078798|NCT02676297|anticholinergic|anticholinergic
1078799|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
1078800|NCT02676245|Prenatal Education|prenatal education
1078801|NCT02676245|Residual Specimens|residual specimens
1078802|NCT02676232|Online Intervention|online intervention
1078803|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
1078804|NCT02676232|Children|children
1078805|NCT02676193|Tobacco Smoking|tobacco smoking
1078806|NCT02676193|Cigarettes|cigarettes
1078807|NCT02676193|Packaging|packaging
1078808|NCT02676193|Text messaging|text messaging
1078809|NCT02676193|Graphic Images|graphic images
1078810|NCT02676193|Sensor-Based Assessments|sensor-based assessments
1078811|NCT02676167|HIV prevention|hiv prevention
1078812|NCT02676167|men who have sex with men|men who have sex with men
1078813|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
1078814|NCT02676167|PrEP|prep
1078815|NCT02676167|Greece|greece
1078816|NCT02676167|people who inject drugs|people who inject drugs
1078817|NCT02676154|Episodic Hypertension|episodic hypertension
1078818|NCT02676154|Spinal Cord Injury|spinal cord injury
1078819|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
1078820|NCT02676154|Blood Pressure|blood pressure
1078821|NCT02676154|Fesoterodine|fesoterodine
1078822|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
1078823|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
1078824|NCT02676154|Urodynamic Studies|urodynamic studies
1078825|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
1078826|NCT02676154|Cerebral Blood Flow|cerebral blood flow
1078827|NCT02676128|HIV|hiv
1078828|NCT02676128|Medication Adherence|medication adherence
1078829|NCT02676128|Mobile Health|mobile health
1078830|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
1078831|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
1078832|NCT02676102|barber shops|barber shops
1078833|NCT02676102|organ transplant|organ transplant
1078834|NCT02676102|transplants|transplants
1078835|NCT02676102|organ donor registration|organ donor registration
1078836|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
1078837|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
1078838|NCT02676063|predictive factors|predictive factors
1078839|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
1078840|NCT02676011|Atropine|atropine
1078841|NCT02676011|Succinycholine|succinycholine
1078842|NCT02676011|Laparoscopy|laparoscopy
1078843|NCT02676011|Gynecology|gynecology
1078844|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
1078845|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
1078846|NCT02675959|stem cell transplantation|stem cell transplantation
1078847|NCT02675959|sickle cell disease|sickle cell disease
1078848|NCT02675959|haploidentical|haploidentical
1078849|NCT02675959|defibrotide|defibrotide
1078850|NCT02675946|WNT inhibitor|wnt inhibitor
1078851|NCT02675920|surveillance|surveillance
1078852|NCT02675920|ultrasonography|ultrasonography
1078853|NCT02675920|computed tomography|computed tomography
1078854|NCT02675907|Bunion|bunion
1078855|NCT02675907|Bunionectomy|bunionectomy
1078856|NCT02675907|Pain|pain
1078857|NCT02675907|Analgesia|analgesia
1078858|NCT02675907|N1539|n1539
1078859|NCT02675907|Phase 3|phase 3
1078860|NCT02675894|RFA|rfa
1078861|NCT02675881|RFA|rfa
1078862|NCT02675868|noradrenaline|noradrenaline
1078863|NCT02675868|vasopressin|vasopressin
1078864|NCT02675868|phenylephrine|phenylephrine
1078865|NCT02675868|endotoxemia|endotoxemia
1078866|NCT02675868|Lipopolysaccharide|lipopolysaccharide
1078867|NCT02675868|vasopressor|vasopressor
1078868|NCT02675855|Grafix|grafix
1078869|NCT02675829|HER2 mutant|her2 mutant
1078870|NCT02675829|HER2 amplified|her2 amplified
1078871|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
1078872|NCT02675829|15-335|15-335
1078873|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
1078874|NCT02675816|OSA|osa
1078875|NCT02675816|neurostimulation|neurostimulation
1078876|NCT02675816|hypoglossal nerve|hypoglossal nerve
1078877|NCT02675816|tongue|tongue
1078984|NCT02675114|Sapien 3|sapien 3
1078878|NCT02675816|upper airway stimulation|upper airway stimulation
1078879|NCT02675816|surgery|surgery
1078880|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
1078881|NCT02675790|hydroxyurea|hydroxyurea
1078882|NCT02675790|sub-Saharan Africa|sub-saharan africa
1078883|NCT02675790|secondary stroke prevention|secondary stroke prevention
1078884|NCT02675777|Alcohol misuse|alcohol misuse
1078885|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
1078886|NCT02675777|Alcoholism|alcoholism
1078887|NCT02675777|Alcohol dependence|alcohol dependence
1078888|NCT02675777|Alcohol abuse|alcohol abuse
1078889|NCT02675777|Risky drinking|risky drinking
1078890|NCT02675764|hand function|hand function
1078891|NCT02675751|myopia|myopia
1078892|NCT02675673|Enteral Feeding|enteral feeding
1078893|NCT02675673|G-Tube|g-tube
1078894|NCT02675673|GJ Tube|gj tube
1078895|NCT02675660|kinetic data|kinetic data
1078896|NCT02675660|volunteers|volunteers
1078897|NCT02675608|vaccine efficacy|vaccine efficacy
1078898|NCT02675608|inflammation|inflammation
1078899|NCT02675608|aging|aging
1078900|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1078901|NCT02675608|flu vaccine|flu vaccine
1078902|NCT02675569|Vascular access|vascular access
1078903|NCT02675569|Hemodialysis|hemodialysis
1078904|NCT02675569|Kidney failure|kidney failure
1078905|NCT02675569|Catheter|catheter
1078906|NCT02675569|Fistula|fistula
1078907|NCT02675556|Depression|depression
1078908|NCT02675530|NMDA|nmda
1078909|NCT02675530|glutamate|glutamate
1078910|NCT02675530|schizophrenia|schizophrenia
1078911|NCT02675504|scary scale|scary scale
1078912|NCT02675491|Advanced solid tumor|advanced solid tumor
1078913|NCT02675491|DS-6051b|ds-6051b
1078914|NCT02675491|ROS1|ros1
1078915|NCT02675491|NTRK|ntrk
1078916|NCT02675491|refractory to standard therapy|refractory to standard therapy
1078917|NCT02675491|no standard therapy|no standard therapy
1078918|NCT02675478|AML|aml
1078919|NCT02675478|phase 1|phase 1
1078920|NCT02675478|oncology|oncology
1078921|NCT02675465|Pompe, rhGAA|pompe, rhgaa
1078922|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
1078923|NCT02675426|Arthritis|arthritis
1078924|NCT02675426|Joint Disease|joint disease
1078925|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
1078926|NCT02675426|Antirheumatic agents|antirheumatic agents
1078927|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
1078928|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
1078929|NCT02675413|Tecfidera|tecfidera
1078930|NCT02675413|Multiple Sclerosis|multiple sclerosis
1078931|NCT02675413|Relapsing MS|relapsing ms
1078932|NCT02675413|RRMS|rrms
1078933|NCT02675413|Mechanism of Action|mechanism of action
1078934|NCT02675400|ADHD|adhd
1078935|NCT02675400|ADD|add
1078936|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1078937|NCT02675400|Attention|attention
1078938|NCT02675400|Hyperactivity|hyperactivity
1078939|NCT02675374|Cardiac surgery|cardiac surgery
1078940|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
1078941|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
1078942|NCT02675374|H1 blockers|h1 blockers
1078943|NCT02675374|norepinephrine|norepinephrine
1078944|NCT02675374|histamine release|histamine release
1078945|NCT02675361|Transfer to adult care|transfer to adult care
1078946|NCT02675361|Continuity of patient care|continuity of patient care
1078947|NCT02675361|Transition program|transition program
1078948|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
1078949|NCT02675296|outcome|outcome
1078950|NCT02675283|Point of care test|point of care test
1078951|NCT02675283|Diagnosis|diagnosis
1078952|NCT02675283|Case finding|case finding
1078953|NCT02675257|Diabetes mellitus|diabetes mellitus
1078954|NCT02675257|Affective disorders|affective disorders
1078955|NCT02675257|Depressive symptoms|depressive symptoms
1078956|NCT02675257|Diabetes distress|diabetes distress
1078957|NCT02675257|Hyperglycaemia|hyperglycaemia
1078958|NCT02675257|Dysglycaemia|dysglycaemia
1078959|NCT02675257|Glycaemic control|glycaemic control
1078960|NCT02675257|Self-care behaviour|self-care behaviour
1078961|NCT02675257|Quality of Life|quality of life
1078962|NCT02675257|Diabetes acceptance|diabetes acceptance
1078963|NCT02675257|Diabetes complications|diabetes complications
1078964|NCT02675257|Low-grade inflammation|low-grade inflammation
1078965|NCT02675257|Inflammatory markers|inflammatory markers
1078966|NCT02675257|Stress reactivity|stress reactivity
1078967|NCT02675257|Health-care costs|health-care costs
1078968|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
1078969|NCT02675192|sarcopenia|sarcopenia
1078970|NCT02675192|elderly|elderly
1078971|NCT02675192|muscle biopsy|muscle biopsy
1078972|NCT02675166|Childhood cancer|childhood cancer
1078973|NCT02675166|Sequels|sequels
1078974|NCT02675166|Complications|complications
1078975|NCT02675166|Surgery|surgery
1078976|NCT02675166|Radiotherapy|radiotherapy
1078977|NCT02675166|Chemotherapy|chemotherapy
1078978|NCT02675166|Cancer|cancer
1078979|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
1078980|NCT02675153|stenosis|stenosis
1078981|NCT02675153|sirolimus|sirolimus
1078982|NCT02675153|rapamycin|rapamycin
1078985|NCT02675114|cardiovascular disease|cardiovascular disease
1078986|NCT02675114|heart disease|heart disease
1078987|NCT02675114|aortic stenosis|aortic stenosis
1078988|NCT02675114|SAVR|savr
1078989|NCT02675114|TAVR|tavr
1078990|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
1078991|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
1078992|NCT02675088|radiotherapy regimen|radiotherapy regimen
1078993|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1078994|NCT02675075|Voice|voice
1078995|NCT02675075|Voice Quality|voice quality
1078996|NCT02675075|Total Lung Capacity|total lung capacity
1078997|NCT02675062|Accelerometry|accelerometry
1078998|NCT02675062|Osteoarthritis|osteoarthritis
1078999|NCT02675062|Habitual physical activity|habitual physical activity
1079000|NCT02675062|Sedentary behaviour|sedentary behaviour
1079001|NCT02675062|Knee arthroplasty|knee arthroplasty
1079002|NCT02675049|Intranasal|intranasal
1079003|NCT02675049|Dexmedetomidine|dexmedetomidine
1079004|NCT02675049|Anaesthesia|anaesthesia
1079005|NCT02675049|Breast Lumpectomy|breast lumpectomy
1079006|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
1079007|NCT02674997|Goal setting|goal setting
1079008|NCT02674997|Feasibility|feasibility
1079009|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
1079010|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
1079011|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
1079012|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
1079013|NCT02674958|aspirin|aspirin
1079014|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
1079015|NCT02674958|alcohol septal ablation|alcohol septal ablation
1079016|NCT02674945|fitbit|fitbit
1079017|NCT02674945|activity tracker|activity tracker
1079018|NCT02674945|sleep|sleep
1079019|NCT02674945|quality of life|quality of life
1079020|NCT02674919|Repeated-sprint ability|repeated-sprint ability
1079021|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
1079022|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
1079023|NCT02674893|BMI>27|bmi>27
1079024|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
1079025|NCT02674841|Adolescent|adolescent
1079026|NCT02674841|Physical therapy modalities|physical therapy modalities
1079027|NCT02674841|Exercise intervention|exercise intervention
1079028|NCT02674841|Auditive feedback|auditive feedback
1079029|NCT02674841|Visual feedback|visual feedback
1079030|NCT02674815|Exercise|exercise
1079031|NCT02674815|Preoperative|preoperative
1079032|NCT02674815|High Intensity Interval Training|high intensity interval training
1079033|NCT02674815|Colorectal|colorectal
1079034|NCT02674815|Thoracic|thoracic
1079035|NCT02674815|Postoperative|postoperative
1079036|NCT02674802|Reinfection|reinfection
1079037|NCT02674802|Eradication therapy|eradication therapy
1079038|NCT02674802|C-urea breath test|c-urea breath test
1079039|NCT02674802|Helicobacter Pylori|helicobacter pylori
1079040|NCT02674789|Exercise|exercise
1079041|NCT02674789|Athletes|athletes
1079042|NCT02674789|Ionized Magnesium|ionized magnesium
1079043|NCT02674789|Variation|variation
1079044|NCT02674789|Blood|blood
1079045|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
1079046|NCT02674763|AML|aml
1079047|NCT02674763|IMGN779|imgn779
1079048|NCT02674763|ImmunoGen|immunogen
1079049|NCT02674763|Phase 1|phase 1
1079050|NCT02674763|Relapsed|relapsed
1079051|NCT02674763|Refractory|refractory
1079052|NCT02674763|CD33|cd33
1079053|NCT02674763|Dose Escalation|dose escalation
1079054|NCT02674763|Dose Expansion|dose expansion
1079055|NCT02674750|DLBCL|dlbcl
1079056|NCT02674750|MYC|myc
1079057|NCT02674724|Resistance Training|resistance training
1079058|NCT02674724|Postural Balance|postural balance
1079059|NCT02674724|Exercise|exercise
1079060|NCT02674711|patient education|patient education
1079061|NCT02674711|low back pain|low back pain
1079062|NCT02674711|post-surgical pain|post-surgical pain
1079063|NCT02674711|chronic opioid use|chronic opioid use
1079064|NCT02674711|Neck Pain|neck pain
1079065|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
1079066|NCT02674672|safety|safety
1122298|NCT02421133|elderly|elderly
1079067|NCT02674672|efficacy|efficacy
1079068|NCT02674659|resistance training, PCSK9, coronary artery bypass|resistance training, pcsk9, coronary artery bypass
1079069|NCT02674633|ADHD|adhd
1079070|NCT02674594|Anticoagulation|anticoagulation
1079071|NCT02674568|SCLC|sclc
1079072|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
1079073|NCT02674568|DLL3|dll3
1079074|NCT02674568|Relapsed|relapsed
1079075|NCT02674568|Refractory|refractory
1079076|NCT02674555|Phase 1|phase 1
1079077|NCT02674555|Metabolism|metabolism
1079078|NCT02674555|Excretion|excretion
1079079|NCT02674555|Absorption|absorption
1079080|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
1079081|NCT02674555|Pharmacokinetics|pharmacokinetics
1079082|NCT02674555|naquotinib|naquotinib
1079083|NCT02674555|Oncology|oncology
1079084|NCT02674542|Family planning|family planning
1079085|NCT02674542|Birth spacing|birth spacing
1079086|NCT02674529|Depression|depression
1079087|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
1079088|NCT02674529|MDD|mdd
1079089|NCT02674529|Neurofeedback|neurofeedback
1079090|NCT02674516|antisocial behavior|antisocial behavior
1079091|NCT02674516|aggression|aggression
1079092|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
1079093|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1079094|NCT02674516|associated risk factors|associated risk factors
1079095|NCT02674503|Walking|walking
1079096|NCT02674503|Hospitalization|hospitalization
1079097|NCT02674503|Randomized controlled trial|randomized controlled trial
1079098|NCT02674490|aphasia, language|aphasia, language
1079099|NCT02674373|gastric cancer|gastric cancer
1079100|NCT02674373|biomarker|biomarker
1079101|NCT02674373|Circulating tumor DNA|circulating tumor dna
1079102|NCT02674373|Chemotherapy|chemotherapy
1079103|NCT02674373|Prognosis|prognosis
1079104|NCT02674373|Predictive|predictive
1079105|NCT02674334|orthopedic procedures|orthopedic procedures
1079106|NCT02674321|Tourette Syndrome|tourette syndrome
1079107|NCT02674321|adolescents|adolescents
1079108|NCT02674308|Drug therapy|drug therapy
1079109|NCT02674295|Healthy|healthy
1079110|NCT02674295|JNJ-54135419|jnj-54135419
1079111|NCT02674295|Esketamine|esketamine
1079112|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1079113|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
1079114|NCT02674282|sports medicine|sports medicine
1079115|NCT02674282|soccer|soccer
1079116|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
1079117|NCT02674282|return to play|return to play
1079118|NCT02674269|Overactive bladder|overactive bladder
1079119|NCT02674269|Botox|botox
1079120|NCT02674269|TC-3 Gel|tc-3 gel
1079121|NCT02674269|Intravesical|intravesical
1079122|NCT02674269|UroGen Pharma|urogen pharma
1079123|NCT02674269|Botulinum Toxin|botulinum toxin
1079124|NCT02674269|Urgency|urgency
1079125|NCT02674269|OAB|oab
1079126|NCT02674269|Incontinence|incontinence
1079127|NCT02674269|I-QOL|i-qol
1079128|NCT02674269|KHQ|khq
1079129|NCT02674269|TBS|tbs
1079130|NCT02674269|RTG|rtg
1079131|NCT02674256|health|health
1079132|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
1079133|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
1079134|NCT02674243|Malignant pleural effusion|malignant pleural effusion
1079135|NCT02674243|Pleurodesis|pleurodesis
1079136|NCT02674243|Talc|talc
1079137|NCT02674243|Iodopovidone solution|iodopovidone solution
1079138|NCT02674243|Povidone-iodine|povidone-iodine
1079139|NCT02674204|Statin therapy|statin therapy
1079140|NCT02674204|trastuzumab|trastuzumab
1079141|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
1079142|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
1079143|NCT02674126|Cardiac Surgery|cardiac surgery
1079144|NCT02674126|Maternal sound|maternal sound
1079145|NCT02674126|Cortisol|cortisol
1079146|NCT02674126|Blood sugar|blood sugar
1079147|NCT02674126|Stress|stress
1079148|NCT02674061|PD1|pd1
1079149|NCT02674061|PD-1|pd-1
1079150|NCT02674061|PDL1|pdl1
1079151|NCT02674061|PD-L1|pd-l1
1079152|NCT02674035|Abdominoplasty|abdominoplasty
1079153|NCT02674035|Sutures|sutures
1079154|NCT02674035|Abdominal deformities|abdominal deformities
1079155|NCT02674035|Plication|plication
1079156|NCT02674035|Monofilament nylon suture|monofilament nylon suture
1079157|NCT02674035|Barbed suture|barbed suture
1079158|NCT02674022|Maternal Health|maternal health
1079159|NCT02674022|Autistic Disorder|autistic disorder
1079160|NCT02674022|Metabolism|metabolism
1079161|NCT02674022|Folic Acid|folic acid
1079162|NCT02673996|antibody|antibody
1079163|NCT02673996|autoimmune|autoimmune
1079164|NCT02673996|adrenergic|adrenergic
1079165|NCT02673996|autonomic|autonomic
1079166|NCT02673983|Intestinal|intestinal
1079167|NCT02673983|Biopsy|biopsy
1079168|NCT02673983|full thickness|full thickness
1079169|NCT02673983|endoscopic|endoscopic
1079170|NCT02673970|Melanoma|melanoma
1079171|NCT02673931|Open Heart Surgery|open heart surgery
1079172|NCT02673931|Organ protection|organ protection
1079173|NCT02673918|Rehabilitation|rehabilitation
1079174|NCT02673918|Home-Based Intervention|home-based intervention
1079175|NCT02673905|nasal chondrocytes|nasal chondrocytes
1079176|NCT02673905|articular chondral lesions|articular chondral lesions
1079177|NCT02673905|tissue engineering|tissue engineering
1079178|NCT02673905|femoral condyle|femoral condyle
1079179|NCT02673905|trochlea|trochlea
1079180|NCT02673892|discharge|discharge
1079181|NCT02673892|transitions|transitions
1079182|NCT02673892|patient experience|patient experience
1079183|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
1079184|NCT02673866|Diabetes|diabetes
1079185|NCT02673866|Pregabalin|pregabalin
1079186|NCT02673866|Spontaneous Pain|spontaneous pain
1079187|NCT02673866|Hyperalgesia|hyperalgesia
1079188|NCT02673866|Allodynia|allodynia
1079189|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
1079190|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
1079191|NCT02673853|Supraglottic airway|supraglottic airway
1079192|NCT02673853|Mini-dose atracurium|mini-dose atracurium
1079385|NCT02672449|Carbon ions|carbon ions
1079193|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
1079194|NCT02673840|dengue fever|dengue fever
1079195|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
1079196|NCT02673840|ketotifen|ketotifen
1079197|NCT02673840|vascular leakage|vascular leakage
1079198|NCT02673840|pleural effusion|pleural effusion
1079199|NCT02673840|plasma leakage|plasma leakage
1079200|NCT02673801|Referral and Consultation|referral and consultation
1079201|NCT02673801|Orthopedics|orthopedics
1079202|NCT02673775|Macrophage|macrophage
1079203|NCT02673749|Lactose maldigestion|lactose maldigestion
1079204|NCT02673749|Dairy intolerance|dairy intolerance
1079205|NCT02673749|Intolerance to milk|intolerance to milk
1079206|NCT02673749|Intolerance to dairy|intolerance to dairy
1079207|NCT02673749|Milk intolerance|milk intolerance
1079208|NCT02673749|GI disorder|gi disorder
1079209|NCT02673749|Lactose metabolism|lactose metabolism
1079210|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
1079211|NCT02673736|PLX73086|plx73086
1079212|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
1079213|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
1079214|NCT02673736|Joint Diseases|joint diseases
1079215|NCT02673736|Neoplasms|neoplasms
1079216|NCT02673736|Synovitis|synovitis
1079217|NCT02673723|docozine|docozine
1079218|NCT02673697|Sutureless valve|sutureless valve
1079219|NCT02673658|infant development, early intervention|infant development, early intervention
1079220|NCT02673645|Educational Achievement|educational achievement
1079221|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
1079222|NCT02673632|Ovarian stimulation|ovarian stimulation
1079223|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
1079224|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1079225|NCT02673619|Topical|topical
1079226|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
1079227|NCT02673619|Umeclidinium|umeclidinium
1079228|NCT02673593|Safety|safety
1079229|NCT02673593|Pharmacokinetics|pharmacokinetics
1079230|NCT02673593|Food Effect|food effect
1079231|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
1079232|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
1079233|NCT02673554|Incretin|incretin
1079234|NCT02673554|Insulin secretion|insulin secretion
1079235|NCT02673554|Tachyphylaxis|tachyphylaxis
1079236|NCT02673528|appendectomy|appendectomy
1079237|NCT02673528|laparoscopy|laparoscopy
1079238|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
1079239|NCT02673528|cost utility|cost utility
1079240|NCT02673515|Alternate Day Fasting|alternate day fasting
1079241|NCT02673502|Carbohydrate drink|carbohydrate drink
1079242|NCT02673502|Post operative complication|post operative complication
1079243|NCT02673502|insulin resistance|insulin resistance
1079244|NCT02673502|Fasting blood glucose|fasting blood glucose
1079245|NCT02673437|Acute coronary syndrome|acute coronary syndrome
1079246|NCT02673411|elastography|elastography
1079247|NCT02673411|ultrasonography|ultrasonography
1079248|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
1079249|NCT02673359|Preterm labor|preterm labor
1079250|NCT02673359|Short cervix|short cervix
1079251|NCT02673359|Progesterone|progesterone
1079252|NCT02673359|Cervical cerclage|cervical cerclage
1079253|NCT02673333|Pembrolizumab|pembrolizumab
1079254|NCT02673333|15-286|15-286
1079255|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
1079256|NCT02673320|Delay of Surgery|delay of surgery
1079257|NCT02673320|Decompressive Surgery|decompressive surgery
1079258|NCT02673320|Canal Stenosis|canal stenosis
1079259|NCT02673320|Schneider Syndrom|schneider syndrom
1079260|NCT02673320|Quality of life|quality of life
1079261|NCT02673320|Functional Outcome|functional outcome
1079262|NCT02673281|walnuts|walnuts
1079263|NCT02673281|brain|brain
1079264|NCT02673281|appetite|appetite
1079265|NCT02673281|energy intake|energy intake
1079266|NCT02673281|obesity|obesity
1079267|NCT02673255|Plasma|plasma
1079268|NCT02673255|Plasma Donor|plasma donor
1079269|NCT02673255|Plasma Donation|plasma donation
1079270|NCT02673255|Tetanus|tetanus
1079271|NCT02673255|Td|td
1079272|NCT02673255|Immunoglobulin|immunoglobulin
1079273|NCT02673255|Hyper-immunization|hyper-immunization
1079274|NCT02673229|Santyl|santyl
1079275|NCT02673229|Burn|burn
1079276|NCT02673229|Partial Thickness Burn|partial thickness burn
1079277|NCT02673229|Second Degree Burn|second degree burn
1079278|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
1079279|NCT02673229|Scar Appearance|scar appearance
1079280|NCT02673203|glucose monitoring|glucose monitoring
1079281|NCT02673203|hunger levels|hunger levels
1079282|NCT02673203|food intake|food intake
1079283|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
1079284|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
1079285|NCT02673177|urinary function|urinary function
1079286|NCT02673177|sexual function|sexual function
1079287|NCT02673177|sphincter- preservation|sphincter- preservation
1079288|NCT02673177|low rectal cancer|low rectal cancer
1079289|NCT02673164|Heart failure|heart failure
1079290|NCT02673164|stem cell|stem cell
1079291|NCT02673164|adipose derived stem cell|adipose derived stem cell
1079292|NCT02673164|Stem cell therapy|stem cell therapy
1079293|NCT02673164|ischemic heart disease|ischemic heart disease
1079294|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
1079295|NCT02673112|Concussion|concussion
1079296|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
1079297|NCT02673112|post concussion syndrome|post concussion syndrome
1079299|NCT02673099|HDF online|hdf online
1079300|NCT02673099|ESRD|esrd
1079301|NCT02673099|Hemodialysis|hemodialysis
1079302|NCT02673099|oxidative stress|oxidative stress
1079303|NCT02673099|quality of life|quality of life
1079304|NCT02673099|Hemodialysis treatment|hemodialysis treatment
1079305|NCT02673086|retroclavicular approach|retroclavicular approach
1079306|NCT02673086|coracoid approach|coracoid approach
1079307|NCT02673086|ultrasound|ultrasound
1079308|NCT02673086|upper limb surgery|upper limb surgery
1079309|NCT02673086|needle visibility|needle visibility
1079310|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
1079311|NCT02673073|Heart failure|heart failure
1079312|NCT02673073|patient's diary|patient's diary
1079313|NCT02673073|self awareness|self awareness
1079314|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
1079315|NCT02672969|smoke evacuation system|smoke evacuation system
1079316|NCT02672969|surgical smoke|surgical smoke
1079317|NCT02672943|Parkinson disease|parkinson disease
1079318|NCT02672943|Autonomic nervous system|autonomic nervous system
1079319|NCT02672943|MicroRNA|microrna
1079320|NCT02672943|Inflammation|inflammation
1079321|NCT02672943|Oxidative stress|oxidative stress
1079322|NCT02672943|noradrenergic network|noradrenergic network
1079323|NCT02672943|Rehabilitation treatment|rehabilitation treatment
1079324|NCT02672930|calcium gluconate|calcium gluconate
1079325|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
1079326|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
1079327|NCT02672904|vocal cord|vocal cord
1079328|NCT02672904|carcinoma|carcinoma
1079329|NCT02672904|ktp laser|ktp laser
1079330|NCT02672904|co2 laser|co2 laser
1079331|NCT02672904|endoscopic surgery|endoscopic surgery
1079332|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
1079333|NCT02672891|Uterine Tamponade|uterine tamponade
1079334|NCT02672891|Condom Catheter|condom catheter
1079335|NCT02672878|In-stent restenosis|in-stent restenosis
1079336|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
1079337|NCT02672878|Stent|stent
1079338|NCT02672878|Drug-eluting stent|drug-eluting stent
1079339|NCT02672878|Coronary angiography|coronary angiography
1079340|NCT02672852|ABBV-066|abbv-066
1079341|NCT02672852|BI 655066|bi 655066
1079342|NCT02672852|risankizumab|risankizumab
1079343|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
1079344|NCT02672813|Breast surgery|breast surgery
1079345|NCT02672813|Ropivacaine|ropivacaine
1079346|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
1079347|NCT02672787|Antihypertensive adherence|antihypertensive adherence
1079348|NCT02672787|Emergency medicine|emergency medicine
1079349|NCT02672787|Antihypertensives|antihypertensives
1079350|NCT02672748|garden|garden
1079351|NCT02672748|Native American|native american
1079352|NCT02672748|BMI|bmi
1079353|NCT02672748|Emotional health|emotional health
1079354|NCT02672748|Physical health|physical health
1079355|NCT02672735|corrective exercise program|corrective exercise program
1079356|NCT02672735|movement efficiency|movement efficiency
1079357|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
1079358|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
1079359|NCT02672709|Renal Dialysis|renal dialysis
1079360|NCT02672696|Navigation|navigation
1079361|NCT02672696|Gamma Nail|gamma nail
1079362|NCT02672657|Health-Related Quality of life|health-related quality of life
1079363|NCT02672657|Cancer|cancer
1079364|NCT02672657|Elderly|elderly
1079365|NCT02672657|Caregivers|caregivers
1079366|NCT02672618|heart failure|heart failure
1079367|NCT02672618|infrared thermal imaging|infrared thermal imaging
1079368|NCT02672592|Metabolic syndrome X|metabolic syndrome x
1079369|NCT02672592|Hypogonadism|hypogonadism
1079370|NCT02672592|Testosterone|testosterone
1079371|NCT02672592|Inflammation|inflammation
1079372|NCT02672592|Obesity|obesity
1079373|NCT02672566|Fetal Growth Retardation|fetal growth retardation
1079374|NCT02672566|enoxaparin|enoxaparin
1079375|NCT02672553|Aortic Valve Replacement|aortic valve replacement
1079376|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
1079377|NCT02672540|Sickle Cell|sickle cell
1079378|NCT02672540|Anemia|anemia
1079379|NCT02672540|VOC|voc
1079380|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
1079772|NCT02669667|MEDI9314|medi9314
1079381|NCT02672501|immunotherapy|immunotherapy
1079382|NCT02672501|CAR-T|car-t
1079383|NCT02672501|leukemia|leukemia
1079384|NCT02672449|Prostate cancer|prostate cancer
1079386|NCT02672449|Radiobiology|radiobiology
1079387|NCT02672449|Radiotherapy|radiotherapy
1079388|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
1079389|NCT02672436|Diabetes Mellitus|diabetes mellitus
1079390|NCT02672436|Wound Healing|wound healing
1079391|NCT02672397|Epidural|epidural
1079392|NCT02672397|Ethnicity|ethnicity
1079393|NCT02672397|Education|education
1079394|NCT02672397|Labor|labor
1079395|NCT02672397|obstetrical analgesia|obstetrical analgesia
1079396|NCT02672384|Intensive care unit|intensive care unit
1079397|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
1079398|NCT02672384|Chronic periodontitis|chronic periodontitis
1079399|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
1079400|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1079401|NCT02672358|NSCLC|nsclc
1079402|NCT02672358|dabrafenib|dabrafenib
1079403|NCT02672358|trametinib|trametinib
1079404|NCT02672358|Japanese patients|japanese patients
1079405|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
1079406|NCT02672358|stage IV|stage iv
1079407|NCT02672345|Sevoflurane|sevoflurane
1079408|NCT02672345|MicroRNAs|micrornas
1079409|NCT02672345|Inflammatory Response|inflammatory response
1079410|NCT02672345|Cytokines|cytokines
1079411|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
1079412|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
1079413|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
1079414|NCT02672241|Radiation Therapy|radiation therapy
1079415|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
1079416|NCT02672202|Chronic Pain|chronic pain
1079417|NCT02672202|Pain Modulation Profile|pain modulation profile
1079418|NCT02672202|CPM|cpm
1079419|NCT02672202|acute post operative pain|acute post operative pain
1079420|NCT02672189|Climacteric symptoms|climacteric symptoms
1079421|NCT02672189|Menopause|menopause
1079422|NCT02672189|Breast Cancer Survivors|breast cancer survivors
1079423|NCT02672189|Internet-based|internet-based
1079424|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
1079425|NCT02672189|Psychosocial intervention|psychosocial intervention
1079426|NCT02672176|Diabetes mellitus|diabetes mellitus
1079427|NCT02672176|Motivational Interviewing|motivational interviewing
1079428|NCT02672176|Mobile Health Technology|mobile health technology
1079429|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
1079430|NCT02672163|autologous micrografts|autologous micrografts
1079431|NCT02672163|heart failure|heart failure
1079432|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
1079433|NCT02672163|cell therapy|cell therapy
1079434|NCT02672163|atrial appendage|atrial appendage
1079435|NCT02672163|epicardial cell delivery|epicardial cell delivery
1079436|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
1079437|NCT02672150|system change|system change
1079438|NCT02672150|interagency collaboration|interagency collaboration
1079439|NCT02672150|substance use|substance use
1079440|NCT02672150|treatment services|treatment services
1079441|NCT02672150|data-driven decision making|data-driven decision making
1079442|NCT02672150|juvenile justice|juvenile justice
1079443|NCT02672150|adolescents|adolescents
1079444|NCT02672150|justice-involved youth|justice-involved youth
1079445|NCT02672150|cluster randomized trial|cluster randomized trial
1079446|NCT02672137|myocardial infarction|myocardial infarction
1079447|NCT02672137|knowledge transfer|knowledge transfer
1079448|NCT02672137|acute coronary syndromes|acute coronary syndromes
1079449|NCT02672020|pheochromocytoma|pheochromocytoma
1079450|NCT02672020|paraganglioma|paraganglioma
1079451|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
1079452|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
1079453|NCT02671994|Geriatric Assessment|geriatric assessment
1079454|NCT02671994|G8 screening|g8 screening
1079455|NCT02671994|Oncologic treatment|oncologic treatment
1079457|NCT02671968|hypoglycemic events|hypoglycemic events
1079458|NCT02671955|Advanced Cancer|advanced cancer
1079459|NCT02671955|JNJ-61610588|jnj-61610588
1079460|NCT02671942|roflumilast|roflumilast
1079461|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
1079462|NCT02671864|Incretin-based therapy|incretin-based therapy
1079463|NCT02671864|GLP1|glp1
1079464|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
1079465|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
1079466|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
1079467|NCT02671851|Ultrasound Guidance|ultrasound guidance
1079468|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
1079469|NCT02671851|Time to First Pain|time to first pain
1079470|NCT02671851|Postoperative Analgesia|postoperative analgesia
1079471|NCT02671825|Pharmacokinetics|pharmacokinetics
1079472|NCT02671812|dental implant|dental implant
1079473|NCT02671812|patient satisfaction|patient satisfaction
1079474|NCT02671812|treatment outcome|treatment outcome
1079475|NCT02671812|cytokine profile|cytokine profile
1079476|NCT02671812|risk factor|risk factor
1079477|NCT02671812|risk predictor|risk predictor
1079478|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
1079479|NCT02671786|Severe Underweight|severe underweight
1079480|NCT02671786|IAP Grade III-IV|iap grade iii-iv
1079481|NCT02671786|Severe Stunting|severe stunting
1079482|NCT02671786|Village Health Workers|village health workers
1079483|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
1079484|NCT02671773|Microbiota|microbiota
1079485|NCT02671760|Short-term insomnia|short-term insomnia
1079486|NCT02671760|difficulty sleeping|difficulty sleeping
1079487|NCT02671760|sedative|sedative
1079488|NCT02671760|hypnotic|hypnotic
1079489|NCT02671734|endoscopy|endoscopy
1079490|NCT02671682|Immunoadsorption|immunoadsorption
1079491|NCT02671682|Plasmapheresis|plasmapheresis
1079492|NCT02671656|Uricemia|uricemia
1079493|NCT02671630|Cognitive function|cognitive function
1079494|NCT02671630|Depression|depression
1079495|NCT02671630|Quality of life|quality of life
1079496|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
1079497|NCT02671630|Randomized controlled trial|randomized controlled trial
1079498|NCT02671617|Abdominal Cavity|abdominal cavity
1079499|NCT02671617|Aged|aged
1079500|NCT02671604|acute renal failure|acute renal failure
1079501|NCT02671604|prostatectomy|prostatectomy
1079502|NCT02671604|minimal invasive surgery|minimal invasive surgery
1079503|NCT02671578|nitrous oxide|nitrous oxide
1079504|NCT02671578|conscious sedation|conscious sedation
1079505|NCT02671578|pain|pain
1079506|NCT02671578|anxiety|anxiety
1079507|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
1079508|NCT02671565|Total knee replacement|total knee replacement
1079509|NCT02671565|Observational study|observational study
1079510|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
1079511|NCT02671565|Comparative effectiveness|comparative effectiveness
1079512|NCT02671539|gene therapy|gene therapy
1079513|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
1079514|NCT02671539|rAAV2.REP1|raav2.rep1
1079515|NCT02671513|Melanoma|melanoma
1079516|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
1079517|NCT02671487|Problem Behavior|problem behavior
1079518|NCT02671487|Aggression|aggression
1079519|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
1079520|NCT02671487|Adolescents|adolescents
1079521|NCT02671448|Homebound|homebound
1079522|NCT02671448|Homecare|homecare
1079523|NCT02671448|15-022|15-022
1079524|NCT02671435|Colorectal cancer, colon cancer, CRC, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic|colorectal cancer, colon cancer, crc, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic
1079525|NCT02671396|Virtual Reality|virtual reality
1079526|NCT02671396|Postural Stability|postural stability
1079527|NCT02671396|Balance Training|balance training
1079528|NCT02671396|Parkinson's Disease|parkinson's disease
1079529|NCT02671383|Antiretroviral Agents|antiretroviral agents
1079530|NCT02671383|Treatment|treatment
1079531|NCT02671383|Viral Load|viral load
1079532|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
1079533|NCT02671318|cytomegalovirus|cytomegalovirus
1079534|NCT02671318|sirolimus|sirolimus
1079535|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
1079536|NCT02671318|kidney transplant|kidney transplant
1079537|NCT02671318|conversion|conversion
1079538|NCT02671305|delayed cord clamping|delayed cord clamping
1079539|NCT02671305|cord milking|cord milking
1079540|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
1079541|NCT02671292|Loss of Control Eating|loss of control eating
1079542|NCT02671292|Binge Eating|binge eating
1079543|NCT02671292|Obesity|obesity
1079544|NCT02671292|Prevention|prevention
1079545|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
1079546|NCT02671292|Adolescent|adolescent
1079547|NCT02671266|Oxytocin|oxytocin
1079548|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
1079549|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
1079550|NCT02671240|Parkinson disease|parkinson disease
1079551|NCT02671240|behavioral addiction|behavioral addiction
1079552|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
1079553|NCT02671240|dopamine agonist|dopamine agonist
1079554|NCT02671214|guar gum|guar gum
1079555|NCT02671214|konjac mannan|konjac mannan
1079556|NCT02671214|blood glucose|blood glucose
1079557|NCT02671214|legume flour|legume flour
1079558|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
1079559|NCT02671188|Psoriatic arthritis|psoriatic arthritis
1079560|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
1079561|NCT02671188|Monoclonal antibody|monoclonal antibody
1079562|NCT02671188|psoriasis|psoriasis
1079563|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
1079564|NCT02671162|Pruritus|pruritus
1079565|NCT02671162|End-Stage Renal Disease|end-stage renal disease
1079566|NCT02671110|weight loss treatment|weight loss treatment
1079567|NCT02671110|Obesity|obesity
1079568|NCT02671084|Sevoflurane|sevoflurane
1079569|NCT02671084|Ck-MB|ck-mb
1079570|NCT02671071|Cervix Cancer|cervix cancer
1079571|NCT02671058|bioavailability|bioavailability
1079572|NCT02671045|lung cancer|lung cancer
1079573|NCT02671045|genomic profile|genomic profile
1079574|NCT02671045|targeted therapy|targeted therapy
1079575|NCT02671045|FoundationOne|foundationone
1079576|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
1079577|NCT02670980|Retina Implant|retina implant
1079578|NCT02670980|Visual Prosthesis|visual prosthesis
1079579|NCT02670941|aromatherapy|aromatherapy
1079580|NCT02670941|chemotherapy|chemotherapy
1079581|NCT02670941|ginger|ginger
1079582|NCT02670941|lavender|lavender
1079583|NCT02670941|orange|orange
1079584|NCT02670941|jojoba|jojoba
1079585|NCT02670941|essential oils|essential oils
1079586|NCT02670941|cancer|cancer
1079587|NCT02670928|Diabetes|diabetes
1079588|NCT02670928|lifestyle change|lifestyle change
1079589|NCT02670928|weight management|weight management
1079590|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
1079591|NCT02670889|Urea Cycle Disorder|urea cycle disorder
1079592|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
1079593|NCT02670850|Family caregiver|family caregiver
1079594|NCT02670850|Intervention program|intervention program
1079595|NCT02670850|Elders|elders
1079596|NCT02670811|Hypertension|hypertension
1079597|NCT02670811|Fermented Milk|fermented milk
1079598|NCT02670811|Clinical Study|clinical study
1079599|NCT02670811|Randomized|randomized
1079600|NCT02670811|Double-blind|double-blind
1079601|NCT02670798|neuromuscular|neuromuscular
1079602|NCT02670798|scoliosis|scoliosis
1079603|NCT02670772|Antiretroviral Agents|antiretroviral agents
1079604|NCT02670746|Pancreatic Cancer|pancreatic cancer
1079605|NCT02670746|Observational|observational
1079606|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
1079607|NCT02670746|Abraxane|abraxane
1079608|NCT02670746|ABI-007|abi-007
1079609|NCT02670746|Gemcitabine|gemcitabine
1079610|NCT02670746|Non-interventional|non-interventional
1079611|NCT02670746|Netherlands|netherlands
1079612|NCT02670746|Quality of Life|quality of life
1079613|NCT02670733|mechanical ventilation|mechanical ventilation
1079614|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
1079615|NCT02670720|BCX4161|bcx4161
1079616|NCT02670720|avoralstat|avoralstat
1079617|NCT02670720|HAE|hae
1079618|NCT02670720|hereditary angioedema|hereditary angioedema
1079619|NCT02670720|prophylaxis|prophylaxis
1079620|NCT02670707|vinblastine|vinblastine
1079621|NCT02670707|prednisone|prednisone
1079622|NCT02670707|cytarabine|cytarabine
1079623|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
1079624|NCT02670694|Rett Syndrome|rett syndrome
1079625|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
1079626|NCT02670694|Angelman Syndrome|angelman syndrome
1079627|NCT02670694|Sleep Problems|sleep problems
1079628|NCT02670681|Exercise|exercise
1079629|NCT02670681|Aerobic Exercise|aerobic exercise
1079630|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
1079631|NCT02670655|Ablative fractional laser|ablative fractional laser
1079632|NCT02670655|Iontophoresis|iontophoresis
1079633|NCT02670655|Actinic keratosis|actinic keratosis
1079634|NCT02670655|Photodynamic therapy|photodynamic therapy
1079635|NCT02670629|Pediatric orthopedics|pediatric orthopedics
1079636|NCT02670577|stage I|stage i
1079637|NCT02670577|stage II|stage ii
1079638|NCT02670577|HER2 positive|her2 positive
1079639|NCT02670577|Triple Negative|triple negative
1079640|NCT02670564|pharmacogenetics|pharmacogenetics
1079641|NCT02670564|busulfan|busulfan
1079642|NCT02670564|treosulfan|treosulfan
1079643|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1079644|NCT02670564|fludarabine|fludarabine
1079645|NCT02670564|pediatric patients|pediatric patients
1079646|NCT02670564|TBI|tbi
1079647|NCT02670564|leukemia|leukemia
1079648|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
1079649|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
1079650|NCT02670564|Immune System disease|immune system disease
1079651|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
1079652|NCT02670564|stem cell transplantation|stem cell transplantation
1079653|NCT02670564|children and adolescent|children and adolescent
1079654|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
1079655|NCT02670564|NCT01949129 add-on|nct01949129 add-on
1079656|NCT02670564|ALL SCTped FORUM|all sctped forum
1079657|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
1079658|NCT02670525|Matched targeted therapy|matched targeted therapy
1079659|NCT02670512|End-Stage Renal Disease|end-stage renal disease
1079660|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
1079661|NCT02670512|Telehomecare|telehomecare
1079662|NCT02670512|Telehome Monitoring|telehome monitoring
1079663|NCT02670486|Overactive bladder|overactive bladder
1079664|NCT02670486|Urge urinary incontinence|urge urinary incontinence
1079665|NCT02670486|Urodynamics|urodynamics
1079666|NCT02670408|Heart transplant|heart transplant
1079667|NCT02670408|global gene expression|global gene expression
1079668|NCT02670408|molecular diagnostics|molecular diagnostics
1079669|NCT02670395|Healthy|healthy
1079670|NCT02670395|JNJ-54416076|jnj-54416076
1079671|NCT02670395|Ascending Dose|ascending dose
1079672|NCT02670369|Sedentary time|sedentary time
1079673|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
1079674|NCT02670356|fish oil|fish oil
1079677|NCT02670356|krill oil|krill oil
1079678|NCT02670356|Metabolic Syndrome|metabolic syndrome
1079679|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
1079680|NCT02670330|Simplex|simplex
1079681|NCT02670330|Recessive Dystrophic|recessive dystrophic
1079682|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
1079683|NCT02670317|DLBCL|dlbcl
1079684|NCT02670317|large B cell lymphoma|large b cell lymphoma
1079685|NCT02670317|NHL|nhl
1079686|NCT02670304|letrozole|letrozole
1079687|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
1079688|NCT02670291|auditory hallucinations|auditory hallucinations
1079689|NCT02670291|schizophrenia|schizophrenia
1079690|NCT02670291|cTBS|ctbs
1079691|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
1079692|NCT02670265|malnutrition|malnutrition
1079693|NCT02670265|parenteral nutrition|parenteral nutrition
1079694|NCT02670265|weight loss|weight loss
1079695|NCT02670265|pancreatic cancer|pancreatic cancer
1079696|NCT02670265|biliary tract cancer|biliary tract cancer
1079697|NCT02670265|quality of life|quality of life
1079698|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1079699|NCT02670226|Muscle metabolism|muscle metabolism
1079700|NCT02670226|Metabolomics|metabolomics
1079701|NCT02670226|Transcriptomics|transcriptomics
1079702|NCT02670200|psychooncology|psychooncology
1079703|NCT02670200|mental health support|mental health support
1079704|NCT02670200|ICBT|icbt
1079705|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
1079706|NCT02670200|depression|depression
1079707|NCT02670200|online-therapy|online-therapy
1079708|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
1079709|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
1079710|NCT02670187|MERS CoV, Vaccine, DNA|mers cov, vaccine, dna
1079711|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
1079712|NCT02670174|Overhead athletes|overhead athletes
1079713|NCT02670174|Kinetic chain|kinetic chain
1079714|NCT02670174|Exercise treatment|exercise treatment
1079715|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
1079716|NCT02670148|Low back pain|low back pain
1079717|NCT02670148|Trunk muscle strength|trunk muscle strength
1079718|NCT02670148|Balance|balance
1079719|NCT02670148|Active military personnel|active military personnel
1079720|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
1079721|NCT02670122|TACE|tace
1079722|NCT02670096|acetazolamide|acetazolamide
1079723|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
1079724|NCT02670096|Sleep Apnea|sleep apnea
1079725|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
1079726|NCT02670031|Hypertension|hypertension
1079727|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
1079728|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
1079729|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
1079730|NCT02669992|Ileostomy|ileostomy
1079731|NCT02669979|elderly|elderly
1079732|NCT02669979|oral care|oral care
1079733|NCT02669966|Kidney Transplantation|kidney transplantation
1079734|NCT02669940|Ombitasvir|ombitasvir
1079735|NCT02669940|Dasabuvir|dasabuvir
1079736|NCT02669940|Paritaprevir|paritaprevir
1079737|NCT02669927|hip surgery|hip surgery
1079738|NCT02669927|frail older people|frail older people
1079739|NCT02669901|Opioid-Related Disorders|opioid-related disorders
1079740|NCT02669901|Naloxone|naloxone
1079741|NCT02669901|Harm Reduction|harm reduction
1079742|NCT02669901|Drug Overdose Deaths|drug overdose deaths
1079743|NCT02669901|Opioid Misuse|opioid misuse
1079744|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
1079745|NCT02669901|Universal Precautions|universal precautions
1079746|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
1079747|NCT02669888|Indigo Naturalis|indigo naturalis
1079748|NCT02669888|Atopic Dermatitis|atopic dermatitis
1079749|NCT02669888|TCM|tcm
1079750|NCT02669823|Diagnosis|diagnosis
1079751|NCT02669797|Childhood Obesity|childhood obesity
1079752|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
1079753|NCT02669797|Video Feedback|video feedback
1079754|NCT02669771|Xtandi|xtandi
1079755|NCT02669771|MDV3100|mdv3100
1079756|NCT02669771|long term use|long term use
1079757|NCT02669771|enzalutamide|enzalutamide
1079758|NCT02669758|Alkermes|alkermes
1079759|NCT02669758|ALKS 3831|alks 3831
1079760|NCT02669758|Samidorphan|samidorphan
1079761|NCT02669758|Schizophrenia|schizophrenia
1079762|NCT02669758|Safety|safety
1079763|NCT02669745|Chinese women|chinese women
1079764|NCT02669745|Breast cancer|breast cancer
1079765|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1079766|NCT02669732|Adult|adult
1079767|NCT02669732|Developmental Phase II|developmental phase ii
1079768|NCT02669719|Lung Cancer|lung cancer
1079769|NCT02669719|Chemotherapy|chemotherapy
1079770|NCT02669719|Immunotherapy|immunotherapy
1079771|NCT02669693|Olives, oleuropein|olives, oleuropein
1079774|NCT02669667|Tolerability|tolerability
1079775|NCT02669667|Pharmacokinetics|pharmacokinetics
1079776|NCT02669667|Immunogenicity|immunogenicity
1079777|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
1079778|NCT02669615|multiple myeloma|multiple myeloma
1079779|NCT02669615|Melphalan HCl|melphalan hcl
1079780|NCT02669615|Autologous Transplantation|autologous transplantation
1079781|NCT02669602|Nutritional epidemiology|nutritional epidemiology
1079782|NCT02669602|Prospective|prospective
1079783|NCT02669589|CRRT|crrt
1079784|NCT02669589|AKI|aki
1079785|NCT02669589|anticoagulation|anticoagulation
1079786|NCT02669589|KDIGO|kdigo
1079787|NCT02669576|Breast cancer|breast cancer
1079788|NCT02669576|meopausal syptoms|meopausal syptoms
1079789|NCT02669576|mind body medecine|mind body medecine
1079790|NCT02669576|yoga|yoga
1079791|NCT02669576|acupuncture|acupuncture
1079792|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
1079793|NCT02669550|Disposcope endoscope|disposcope endoscope
1079794|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
1079795|NCT02669511|DLBCL|dlbcl
1079796|NCT02669485|ICG|icg
1079797|NCT02669485|colectomy|colectomy
1079798|NCT02669485|anastomotic leak|anastomotic leak
1079799|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
1079800|NCT02669485|surgical decision|surgical decision
1079801|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1079802|NCT02669459|Imiquimod|imiquimod
1079803|NCT02669459|Human papillomavirus|human papillomavirus
1079804|NCT02669459|quality of life|quality of life
1079805|NCT02669459|biological markers|biological markers
1079806|NCT02669446|Non interventional study|non interventional study
1079808|NCT02669446|Lozenges|lozenges
1079809|NCT02669446|pharyngitis|pharyngitis
1079810|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
1079811|NCT02669433|Lewy bodies|lewy bodies
1079812|NCT02669433|intepirdine|intepirdine
1079813|NCT02669433|RVT-101|rvt-101
1079814|NCT02669433|dementia|dementia
1079815|NCT02669381|Phenylalanine|phenylalanine
1079816|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
1079817|NCT02669381|Stable isotopes|stable isotopes
1079818|NCT02669355|White coat physician attire|white coat physician attire
1079819|NCT02669342|Infection|infection
1079820|NCT02669342|Urinary Catheter|urinary catheter
1079821|NCT02669342|Sharklet|sharklet
1079822|NCT02669316|diet|diet
1079823|NCT02669303|Subacromial injection|subacromial injection
1079824|NCT02669303|methylprednisolone|methylprednisolone
1079825|NCT02669303|treatment|treatment
1079826|NCT02669303|Platelet-rich plasma|platelet-rich plasma
1079827|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine
1079828|NCT02669251|Optimal Biologic Dose|optimal biologic dose
1079829|NCT02669251|Safety|safety
1079830|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
1079831|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
1079832|NCT02669251|FEV1|fev1
1079833|NCT02669225|18 F florbetaben|18 f florbetaben
1079834|NCT02669225|Sleep Deprivation|sleep deprivation
1079835|NCT02669225|rested wakefulness|rested wakefulness
1079836|NCT02669225|glymphatic system|glymphatic system
1079837|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
1079838|NCT02669212|Lyme Disease|lyme disease
1079839|NCT02669212|Healthy Volunteers|healthy volunteers
1079840|NCT02669212|Movement Disorder|movement disorder
1079841|NCT02669186|analgesia|analgesia
1079842|NCT02669186|cancer|cancer
1079843|NCT02669186|natural killer cell|natural killer cell
1079844|NCT02669186|opioid|opioid
1079845|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
1079846|NCT02669173|brain tumor|brain tumor
1079847|NCT02669173|MDSC|mdsc
1079848|NCT02669173|GBM|gbm
1079849|NCT02669173|recurrent|recurrent
1079850|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
1079851|NCT02669160|Minors|minors
1079852|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
1079853|NCT02669160|Exoskeleton Device|exoskeleton device
1079854|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
1079855|NCT02669134|optimization|optimization
1079856|NCT02669134|heart failure|heart failure
1079857|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
1079858|NCT02669121|Drug therapy|drug therapy
1079859|NCT02669108|testis|testis
1079860|NCT02669108|spermatogenesis|spermatogenesis
1079861|NCT02669082|Drug Therapy|drug therapy
1079862|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
1079863|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine
1079864|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
1079865|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
1079866|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
1079867|NCT02668991|Autism Behavior Inventory|autism behavior inventory
1079868|NCT02668978|lung surgery|lung surgery
1079869|NCT02668978|air leak|air leak
1079870|NCT02668978|prevention|prevention
1079871|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
1079872|NCT02668913|gynaecology|gynaecology
1079873|NCT02668913|Oncology|oncology
1079874|NCT02668900|Feasibility trial|feasibility trial
1079875|NCT02668900|Cardiovascular disease|cardiovascular disease
1079876|NCT02668900|Decision Support|decision support
1079877|NCT02668900|Patient Decision Aid|patient decision aid
1079878|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1079879|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
1079880|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
1079881|NCT02668874|Isolation|isolation
1079882|NCT02668874|permanent teeth|permanent teeth
1079883|NCT02668874|children|children
1079884|NCT02668874|Isolite®|isolite®
1079885|NCT02668874|Dental caries|dental caries
1079886|NCT02668848|Stroke|stroke
1079887|NCT02668848|Dehydration|dehydration
1079888|NCT02668848|Fluid therapy|fluid therapy
1079889|NCT02668770|Advanced Cancers|advanced cancers
1079890|NCT02668770|Melanoma|melanoma
1079891|NCT02668770|Advanced solid malignancies|advanced solid malignancies
1079892|NCT02668770|Metastatic|metastatic
1079893|NCT02668770|MGN1703|mgn1703
1079894|NCT02668770|Ipilimumab|ipilimumab
1079895|NCT02668770|Yervoy|yervoy
1079896|NCT02668770|BMS-734016|bms-734016
1079897|NCT02668770|MDX010|mdx010
1079898|NCT02668770|Refractory|refractory
1079899|NCT02668770|Relapsed|relapsed
1079900|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
1079901|NCT02668718|prostatectomy|prostatectomy
1079902|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
1079903|NCT02668679|Dream Doctors|dream doctors
1079904|NCT02668679|Medical Clown|medical clown
1079905|NCT02668679|Pediatrics|pediatrics
1079906|NCT02668679|Sedation|sedation
1079907|NCT02668679|Endoscopy|endoscopy
1079908|NCT02668666|Palbociclib|palbociclib
1079909|NCT02668666|Tamoxifen|tamoxifen
1079910|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
1079911|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
1079912|NCT02668653|FLT3-ITD positive|flt3-itd positive
1079913|NCT02668653|Chemotherapy|chemotherapy
1079914|NCT02668653|Induction chemotherapy|induction chemotherapy
1079915|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
1079916|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
1079917|NCT02668653|Quizartinib|quizartinib
1079918|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
1079919|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
1079920|NCT02668653|AC220|ac220
1079921|NCT02668653|FLT3-ITD|flt3-itd
1079922|NCT02668653|AML|aml
1079923|NCT02668640|Quality of life (QOL)|quality of life (qol)
1079924|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1079925|NCT02668640|Work productivity|work productivity
1079926|NCT02668640|Adalimumab|adalimumab
1079927|NCT02668627|Stroke|stroke
1079928|NCT02668627|Collateral status|collateral status
1079929|NCT02668627|Endovascular treatment|endovascular treatment
1079930|NCT02668614|Detection|detection
1079931|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
1079932|NCT02668601|Childhood Obesity|childhood obesity
1079933|NCT02668601|Offspring|offspring
1079934|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1079935|NCT02668562|acute coronary syndrome|acute coronary syndrome
1079936|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
1079937|NCT02668562|ticagrelor|ticagrelor
1079938|NCT02668562|antiplatelet therapy|antiplatelet therapy
1079939|NCT02668562|platelet function testing|platelet function testing
1079940|NCT02668536|sunscreen|sunscreen
1079941|NCT02668536|melanoma|melanoma
1079942|NCT02668536|improved protection from uv rays|improved protection from uv rays
1079943|NCT02668523|Presbyopia|presbyopia
1079944|NCT02668523|Corneal Inlay|corneal inlay
1079945|NCT02668523|Pseudophakic|pseudophakic
1079946|NCT02668523|Pseudophakia|pseudophakia
1079947|NCT02668510|Heel Pain|heel pain
1079948|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
1079949|NCT02668510|ESWT|eswt
1079950|NCT02668510|shock wave|shock wave
1079951|NCT02668510|Soldiers|soldiers
1079952|NCT02668510|Platelet rich plasma|platelet rich plasma
1079953|NCT02668510|PRP|prp
1079954|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
1079955|NCT02668510|Military|military
1079956|NCT02668497|Movement disorders|movement disorders
1079957|NCT02668497|Botulinum toxin type A|botulinum toxin type a
1079958|NCT02668497|Tremor|tremor
1079959|NCT02668497|Kinematics|kinematics
1079960|NCT02668484|TAVI|tavi
1079961|NCT02668484|trans-femoral|trans-femoral
1079962|NCT02668484|Sapien|sapien
1079963|NCT02668484|Lotus|lotus
1079964|NCT02668445|Concurrent|concurrent
1079965|NCT02668445|muscle|muscle
1079966|NCT02668445|glycogen|glycogen
1079967|NCT02668445|molecular|molecular
1079968|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
1079969|NCT02668380|Apatinib|apatinib
1079970|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
1079971|NCT02668380|Non-interventionalStudy|non-interventionalstudy
1079972|NCT02668367|Viral Diseases|viral diseases
1079973|NCT02668367|Antiviral|antiviral
1079974|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
1079978|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
1079979|NCT02668367|Aviragen|aviragen
1079983|NCT02668302|Steroid-eluting implant|steroid-eluting implant
1079984|NCT02668302|Mometasone furoate|mometasone furoate
1079985|NCT02668276|Prostatic neoplasms|prostatic neoplasms
1079986|NCT02668276|Oncotype DX|oncotype dx
1079987|NCT02668276|Treatment Decisions|treatment decisions
1079988|NCT02668263|Breast cancer|breast cancer
1079989|NCT02668263|mastectomy|mastectomy
1079990|NCT02668263|seromas|seromas
1079991|NCT02668211|osteoarthritis|osteoarthritis
1079992|NCT02668211|radiostereometric analysis|radiostereometric analysis
1079993|NCT02668211|correction of functional deformity|correction of functional deformity
1079994|NCT02668211|procedures|procedures
1079995|NCT02668211|total hip arthroplasty|total hip arthroplasty
1079996|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
1079997|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
1079998|NCT02668172|pegvisomant|pegvisomant
1079999|NCT02668172|pasireotide LAR|pasireotide lar
1080000|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
1080001|NCT02668146|essential tremor|essential tremor
1080002|NCT02668146|Perampanel|perampanel
1080003|NCT02668146|clinical trial|clinical trial
1080004|NCT02668133|zinc deficiency|zinc deficiency
1080005|NCT02668133|zinc absorption|zinc absorption
1080006|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
1080007|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
1080008|NCT02668120|placenta|placenta
1080009|NCT02668120|case-control study|case-control study
1080010|NCT02668094|propofol|propofol
1080011|NCT02668094|lidocaine|lidocaine
1080012|NCT02668094|pregabalin|pregabalin
1080013|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
1080014|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
1080015|NCT02668081|Metagenomics|metagenomics
1080016|NCT02668068|Pneumoconiosis|pneumoconiosis
1080017|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
1080018|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
1080019|NCT02668055|TB4|tb4
1080020|NCT02668055|Difficult to heal|difficult to heal
1080021|NCT02668029|Oxygen therapy|oxygen therapy
1080022|NCT02668003|Prevention trial|prevention trial
1080023|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
1080024|NCT02668003|CWP|cwp
1080025|NCT02668003|Chronic widespread pain|chronic widespread pain
1080026|NCT02668003|RCT|rct
1080027|NCT02668003|Fibromyalgia|fibromyalgia
1080028|NCT02668003|Prevention|prevention
1080029|NCT02667990|metatarsalgia|metatarsalgia
1080030|NCT02667990|pedobar|pedobar
1080031|NCT02667990|foot|foot
1080032|NCT02667990|stiletto|stiletto
1080033|NCT02667990|insoles|insoles
1080034|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
1080035|NCT02667951|Elderly|elderly
1080036|NCT02667951|Dementia|dementia
1080037|NCT02667951|Intervention program|intervention program
1080038|NCT02667925|ovarian cancer|ovarian cancer
1080039|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1080040|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
1080041|NCT02667899|disorders of consciousness|disorders of consciousness
1080042|NCT02667899|deep brain stimulation|deep brain stimulation
1080043|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
1080044|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
1080045|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
1080046|NCT02667860|outcomes|outcomes
1080047|NCT02667860|length of stay|length of stay
1080048|NCT02667860|analgesia|analgesia
1080049|NCT02667860|aesthetic|aesthetic
1080050|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
1080051|NCT02667860|laparoscopic|laparoscopic
1080052|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
1080053|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
1080054|NCT02667834|social cognition|social cognition
1080055|NCT02667834|cognitive remediation|cognitive remediation
1080056|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
1080057|NCT02667782|Dementia|dementia
1080058|NCT02667782|Caregiving|caregiving
1080059|NCT02667782|Burden|burden
1080060|NCT02667782|Stress|stress
1080061|NCT02667782|Anxiety|anxiety
1080062|NCT02667782|Depression|depression
1080063|NCT02667782|Community care|community care
1080064|NCT02667756|biomarker|biomarker
1080065|NCT02667756|inflammation|inflammation
1080066|NCT02667756|prognosis|prognosis
1080067|NCT02667756|knee|knee
1080068|NCT02667743|NSCLC|nsclc
1080069|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
1080070|NCT02667691|superoxyde dismutase|superoxyde dismutase
1080071|NCT02667691|melon concentrate|melon concentrate
1080072|NCT02667691|oxydative stress|oxydative stress
1080073|NCT02667691|overweight women|overweight women
1080074|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
1080075|NCT02667652|T2DM|t2dm
1080076|NCT02667652|RYGB|rygb
1080078|NCT02667639|safety|safety
1080391|NCT02665624|Colonoscopy|colonoscopy
1080079|NCT02667639|tolerability|tolerability
1080080|NCT02667639|RPH-104|rph-104
1080081|NCT02667639|RPH104|rph104
1080082|NCT02667626|Breast cancer survivor|breast cancer survivor
1080083|NCT02667626|Cancer survivorship|cancer survivorship
1080084|NCT02667626|Survivorship care plan|survivorship care plan
1080085|NCT02667626|Vaginal dryness|vaginal dryness
1080086|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
1080087|NCT02667626|Vasomotor symptom|vasomotor symptom
1080088|NCT02667626|Infertility|infertility
1080089|NCT02667626|Family planning|family planning
1080090|NCT02667613|motor skill learning|motor skill learning
1080091|NCT02667613|functional changes|functional changes
1080092|NCT02667613|neuroplastic changes|neuroplastic changes
1080093|NCT02667600|Cesarean|cesarean
1080094|NCT02667600|Blood Loss|blood loss
1080095|NCT02667600|Triton|triton
1080096|NCT02667574|basal cell carcinoma|basal cell carcinoma
1080097|NCT02667574|surgery|surgery
1080098|NCT02667574|stage|stage
1080099|NCT02667574|vismodegib|vismodegib
1080100|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
1080101|NCT02667509|Evolutionary Model|evolutionary model
1080102|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
1080103|NCT02667483|DMD|dmd
1080104|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
1080105|NCT02667483|Exon skipping|exon skipping
1080106|NCT02667470|Solifenacin|solifenacin
1080107|NCT02667470|Overactive bladder|overactive bladder
1080108|NCT02667431|SUI|sui
1080109|NCT02667418|Clostridium|clostridium
1080110|NCT02667418|Difficile|difficile
1080111|NCT02667418|Fidaxomicin|fidaxomicin
1080112|NCT02667418|Vancomycin|vancomycin
1080113|NCT02667418|Recurrent|recurrent
1080114|NCT02667418|Pulse|pulse
1080115|NCT02667418|Taper|taper
1080116|NCT02667392|Stroke|stroke
1080117|NCT02667392|Gait|gait
1080118|NCT02667392|Walking|walking
1080119|NCT02667392|Rehabilitation|rehabilitation
1080120|NCT02667392|Exercise|exercise
1080121|NCT02667392|Exercise Therapy|exercise therapy
1080122|NCT02667392|Physical Therapy Modalities|physical therapy modalities
1080123|NCT02667392|Exercise Movement Techniques|exercise movement techniques
1080124|NCT02667379|Cat|cat
1080125|NCT02667379|allergy|allergy
1080126|NCT02667379|dander|dander
1080127|NCT02667379|Fel d 1|fel d 1
1080128|NCT02667379|Felis domesticus|felis domesticus
1080129|NCT02667366|mild and moderate depression|mild and moderate depression
1080130|NCT02667353|electroconvulsive|electroconvulsive
1080131|NCT02667353|hippocampus|hippocampus
1080132|NCT02667353|elderly|elderly
1080133|NCT02667353|working mechanism|working mechanism
1080134|NCT02667340|exercise|exercise
1080135|NCT02667340|carbohydrate|carbohydrate
1080136|NCT02667340|Superstarch|superstarch
1080137|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
1080138|NCT02667327|diabetic complications|diabetic complications
1080139|NCT02667327|diabetes|diabetes
1080140|NCT02667327|wound healing|wound healing
1080141|NCT02667327|Granexin gel|granexin gel
1080142|NCT02667327|FirstString Research|firststring research
1080143|NCT02667314|Cognition|cognition
1080144|NCT02667314|Cognitive Aging|cognitive aging
1080145|NCT02667314|Dementia|dementia
1080146|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
1080147|NCT02667314|Cognitive Therapy|cognitive therapy
1080148|NCT02667314|Cognitive Reserve|cognitive reserve
1080149|NCT02667314|Cognitive Enrichment|cognitive enrichment
1080150|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
1080151|NCT02667275|seborrheic keratosis|seborrheic keratosis
1080152|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
1080153|NCT02667236|seborrheic keratosis|seborrheic keratosis
1080154|NCT02667223|pharmacokinetics|pharmacokinetics
1080155|NCT02667223|pharmacodynamics|pharmacodynamics
1080156|NCT02667223|RN316|rn316
1080157|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
1080158|NCT02667145|hand osteoarthritis|hand osteoarthritis
1080159|NCT02667145|self care program|self care program
1080160|NCT02667145|assistive tecnology|assistive tecnology
1080161|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
1080162|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
1080163|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
1080164|NCT02667093|Acute Leukemia|acute leukemia
1080165|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
1080166|NCT02667093|AML|aml
1080167|NCT02667080|Semen quality|semen quality
1080168|NCT02667080|Sexual Abstinence|sexual abstinence
1080169|NCT02667080|sperm motility|sperm motility
1080170|NCT02667080|DNA fragmentation|dna fragmentation
1080171|NCT02667015|Substance Use Disorders|substance use disorders
1080172|NCT02667015|Anxiety|anxiety
1080173|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
1080174|NCT02667015|Brief Intervention|brief intervention
1080175|NCT02667015|Treatment|treatment
1080176|NCT02666989|Depression|depression
1080177|NCT02666989|Placebo|placebo
1080178|NCT02666989|Open-label|open-label
1080179|NCT02666989|Clinical practice|clinical practice
1080180|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
1080181|NCT02666963|RTA 901|rta 901
1080182|NCT02666963|RTA 901 capsules|rta 901 capsules
1080183|NCT02666898|Residual disease|residual disease
1080184|NCT02666885|Personalized Medicine|personalized medicine
1080185|NCT02666885|Radiation Oncology|radiation oncology
1080186|NCT02666885|Functional Imaging|functional imaging
1080187|NCT02666885|Biomarker|biomarker
1080188|NCT02666885|Decision Support System|decision support system
1080189|NCT02666885|Radiomics|radiomics
1080190|NCT02666872|Vaccination|vaccination
1080191|NCT02666872|Infant|infant
1080192|NCT02666872|Parents|parents
1080193|NCT02666872|Intention|intention
1080194|NCT02666846|UVB Pain Model|uvb pain model
1080195|NCT02666846|PK|pk
1080196|NCT02666846|Topical|topical
1080197|NCT02666846|NSAIDs|nsaids
1080198|NCT02666833|Skin Cancer|skin cancer
1080199|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
1080200|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
1080201|NCT02666833|Mohs Surgery|mohs surgery
1080202|NCT02666833|Imaging|imaging
1080203|NCT02666807|NF-κB|nf-κb
1080204|NCT02666807|Ginger|ginger
1080205|NCT02666794|analgesia|analgesia
1080206|NCT02666794|fetal bradycardia|fetal bradycardia
1080207|NCT02666794|hypertonic uterine|hypertonic uterine
1080208|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
1080209|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
1080210|NCT02666716|pharmacokinetics|pharmacokinetics
1080211|NCT02666716|fluconazole|fluconazole
1080212|NCT02666716|invasive fungal infection|invasive fungal infection
1080213|NCT02666716|candidiasis|candidiasis
1080214|NCT02666716|intensive care unit|intensive care unit
1080215|NCT02666703|cardiac surgery|cardiac surgery
1080216|NCT02666703|systemic inflammatory response|systemic inflammatory response
1080217|NCT02666703|immunoadsorption|immunoadsorption
1080218|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
1080219|NCT02666664|hyperlipidemia|hyperlipidemia
1080220|NCT02666664|cholesterol|cholesterol
1080221|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
1080222|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1080223|NCT02666664|ASCVD|ascvd
1080224|NCT02666664|HeFH|hefh
1080225|NCT02666664|LDL|ldl
1080226|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1080227|NCT02666612|Patients|patients
1080228|NCT02666599|F-18-FDG|f-18-fdg
1080229|NCT02666599|neoplasm|neoplasm
1080230|NCT02666599|probe|probe
1080231|NCT02666599|positron|positron
1080232|NCT02666599|diagnosis|diagnosis
1080233|NCT02666599|surgery|surgery
1080234|NCT02666599|radioguided surgery|radioguided surgery
1080235|NCT02666573|drug therapy|drug therapy
1080236|NCT02666573|Photosensitizing Agents|photosensitizing agents
1080237|NCT02666573|therapeutic use|therapeutic use
1080238|NCT02666560|Auditory Cueing|auditory cueing
1080239|NCT02666560|Gait|gait
1080240|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
1080241|NCT02666547|18F-FDG|18f-fdg
1080242|NCT02666547|18F-FET|18f-fet
1080243|NCT02666547|PET/CT|pet/ct
1080244|NCT02666547|neoangiogenesis|neoangiogenesis
1080245|NCT02666534|Ablative fractional laser|ablative fractional laser
1080246|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
1080247|NCT02666534|photodynamic therapy|photodynamic therapy
1080248|NCT02666521|Primary Health Care|primary health care
1080249|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
1080250|NCT02666508|plaque score|plaque score
1080251|NCT02666508|C-reactive protein|c-reactive protein
1080252|NCT02666495|Schema Therapy|schema therapy
1080253|NCT02666482|smoking|smoking
1080254|NCT02666482|stop smoking|stop smoking
1080255|NCT02666482|tobacco use cessation|tobacco use cessation
1080256|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
1080257|NCT02666443|brachial plexus|brachial plexus
1080258|NCT02666443|supraclavicular|supraclavicular
1080259|NCT02666443|duration|duration
1080260|NCT02666443|dexamethasone|dexamethasone
1080261|NCT02666443|block|block
1080262|NCT02666417|Iron fortification|iron fortification
1080263|NCT02666417|Anemia|anemia
1080264|NCT02666417|Iron Deficiency|iron deficiency
1080265|NCT02666417|Iron Absorption|iron absorption
1080266|NCT02666417|Prebiotics|prebiotics
1080267|NCT02666417|Stable isotopes|stable isotopes
1080268|NCT02666404|Volume Resuscitation|volume resuscitation
1080269|NCT02666404|Shock|shock
1080270|NCT02666404|Body Impedance Measurement|body impedance measurement
1080271|NCT02666404|Renal Resistive Index|renal resistive index
1080272|NCT02666404|Acute Kidney Injury|acute kidney injury
1080273|NCT02666404|Renal Replacement Therapy|renal replacement therapy
1080274|NCT02666378|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1080275|NCT02666365|anesthesia|anesthesia
1080276|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
1080475|NCT02665117|Liver fat|liver fat
1080277|NCT02666365|surgical site infections|surgical site infections
1080278|NCT02666339|Hortitherapy|hortitherapy
1080279|NCT02666339|Care-garden|care-garden
1080280|NCT02666339|Anxiety|anxiety
1080281|NCT02666339|Therapeutic alliance|therapeutic alliance
1080282|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
1080283|NCT02666326|Prehospital emergency care|prehospital emergency care
1080284|NCT02666326|Biological markers|biological markers
1080285|NCT02666326|Copeptin|copeptin
1080286|NCT02666326|Troponin|troponin
1080287|NCT02666326|Rule-out|rule-out
1080288|NCT02666326|Point-of-Care systems|point-of-care systems
1080289|NCT02666326|Infarction|infarction
1080290|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
1080291|NCT02666326|Heart Diseases|heart diseases
1080292|NCT02666326|Ischemia|ischemia
1080293|NCT02666326|Myocardial Ischemia|myocardial ischemia
1080294|NCT02666326|copeptins|copeptins
1080295|NCT02666326|Troponin T|troponin t
1080296|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
1080297|NCT02666326|High sensitivity troponin|high sensitivity troponin
1080298|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
1080299|NCT02666287|Fluticasone furoate|fluticasone furoate
1080300|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1080301|NCT02666287|Batefenterol|batefenterol
1080302|NCT02666287|Dry Powder Inhaler|dry powder inhaler
1080303|NCT02666287|Respiratory|respiratory
1080304|NCT02666287|Pharmacokinetics|pharmacokinetics
1080305|NCT02666287|Ellipta|ellipta
1080306|NCT02666287|Healthy Subjects|healthy subjects
1080307|NCT02666274|carbapenem resistance|carbapenem resistance
1080308|NCT02666274|bacterial carriage|bacterial carriage
1080309|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
1080310|NCT02666222|hearing loss|hearing loss
1080311|NCT02666222|sensorineural|sensorineural
1080312|NCT02666222|hearing implant|hearing implant
1080313|NCT02666209|Multiple Myeloma|multiple myeloma
1080314|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
1080315|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
1080316|NCT02666183|cancer|cancer
1080317|NCT02666183|caregiver|caregiver
1080318|NCT02666183|videoconferencing|videoconferencing
1080319|NCT02666157|atrial fibrillation|atrial fibrillation
1080320|NCT02666157|stroke|stroke
1080321|NCT02666157|systemic embolism|systemic embolism
1080322|NCT02666157|bleeding|bleeding
1080323|NCT02666157|oral anticoagulant|oral anticoagulant
1080324|NCT02666131|diabetic foot ulcer|diabetic foot ulcer
1080325|NCT02666131|diabetic complications|diabetic complications
1080326|NCT02666131|diabetes|diabetes
1080327|NCT02666131|wound healing|wound healing
1080328|NCT02666131|Granexin gel|granexin gel
1080329|NCT02666131|FirstString Research|firststring research
1080330|NCT02666118|pain|pain
1080331|NCT02666118|pain management|pain management
1080332|NCT02666118|shoulder repair|shoulder repair
1080333|NCT02666118|nerve blockade|nerve blockade
1080334|NCT02666118|regional anesthesia|regional anesthesia
1080335|NCT02666118|pediatrics|pediatrics
1080336|NCT02666105|NSCLC|nsclc
1080338|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
1080339|NCT02666092|Western Blot|western blot
1080340|NCT02666092|ImmunoCAP|immunocap
1080341|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
1080342|NCT02666027|Fluid monitoring|fluid monitoring
1080343|NCT02666014|PONV|ponv
1080344|NCT02666014|nausea|nausea
1080345|NCT02666014|vomiting|vomiting
1080346|NCT02666014|sugammadex|sugammadex
1080347|NCT02666014|neostigmine|neostigmine
1080348|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1080349|NCT02665975|Tinnitus treatment|tinnitus treatment
1080350|NCT02665975|Internet-intervention|internet-intervention
1080351|NCT02665975|CBT|cbt
1080352|NCT02665962|newly diagnosed patients|newly diagnosed patients
1080353|NCT02665936|epidural analgesia|epidural analgesia
1080354|NCT02665871|vaccine|vaccine
1080355|NCT02665871|safety|safety
1080356|NCT02665871|intranasal administration|intranasal administration
1080357|NCT02665806|Ciclesonide|ciclesonide
1080358|NCT02665806|Fluticasone propionate|fluticasone propionate
1080359|NCT02665806|Nasal Polyposis|nasal polyposis
1080360|NCT02665806|Chronic Sinuitis|chronic sinuitis
1080361|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
1080362|NCT02665793|Peanut allergy|peanut allergy
1080363|NCT02665793|Food allergy|food allergy
1080364|NCT02665793|Thresholds|thresholds
1080365|NCT02665793|Anaphylaxis|anaphylaxis
1080366|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
1080367|NCT02665767|Telesonography, Appendix|telesonography, appendix
1080368|NCT02665754|Allergic rhinitis|allergic rhinitis
1080369|NCT02665754|Injection, intralymphatic|injection, intralymphatic
1080370|NCT02665754|Immunotherapy|immunotherapy
1080371|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
1080372|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
1080373|NCT02665754|Dogs|dogs
1080374|NCT02665754|Cats|cats
1080474|NCT02665117|Muscle Magnesium|muscle magnesium
1080379|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
1080380|NCT02665715|Glucagon|glucagon
1080381|NCT02665715|Peptide YY|peptide yy
1080382|NCT02665715|Ghrelin|ghrelin
1080383|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control,|diabetic macular edema, ranibizumab, visual acuity, diabetic control,
1080390|NCT02665624|Bowel cleansing|bowel cleansing
1080392|NCT02665624|Stewed apricot juice|stewed apricot juice
1080393|NCT02665624|Senna|senna
1080394|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
1080395|NCT02665585|carotid disease|carotid disease
1080396|NCT02665585|stroke|stroke
1080397|NCT02665585|stent|stent
1080398|NCT02665585|carotid stenting|carotid stenting
1080399|NCT02665572|renal transplantation|renal transplantation
1080400|NCT02665572|defunctionalized bladder|defunctionalized bladder
1080401|NCT02665572|bladder recycling|bladder recycling
1080402|NCT02665559|HIV|hiv
1080403|NCT02665559|Hypogonadism|hypogonadism
1080404|NCT02665559|Metabolic Syndrom|metabolic syndrom
1080405|NCT02665559|Reservoirs|reservoirs
1080406|NCT02665559|Osteodensitometry|osteodensitometry
1080407|NCT02665559|Erectil dysfonction|erectil dysfonction
1080408|NCT02665559|Depression|depression
1080409|NCT02665546|Dyspnea|dyspnea
1080410|NCT02665546|pulmonary hypertension|pulmonary hypertension
1080411|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
1080412|NCT02665546|exercise test|exercise test
1080413|NCT02665533|pain measurement|pain measurement
1080414|NCT02665533|edema|edema
1080415|NCT02665533|trismus|trismus
1080416|NCT02665520|stem cells injections|stem cells injections
1080417|NCT02665520|erectile dysfunction|erectile dysfunction
1080418|NCT02665507|Photobiomodulation|photobiomodulation
1080419|NCT02665507|Aviation|aviation
1080420|NCT02665481|Exercise|exercise
1080421|NCT02665481|Mindfulness|mindfulness
1080422|NCT02665481|Education|education
1080423|NCT02665481|Elderly|elderly
1080424|NCT02665468|Supported adoption|supported adoption
1080425|NCT02665468|Secure messaging|secure messaging
1080426|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
1080427|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
1080428|NCT02665455|Diabetes Mellitus|diabetes mellitus
1080429|NCT02665455|Sensing Technology|sensing technology
1080430|NCT02665442|Esophageal Stylet|esophageal stylet
1080431|NCT02665442|EsoSure|esosure
1080432|NCT02665442|Atrial Fibrillation|atrial fibrillation
1080433|NCT02665442|Catheter Ablation|catheter ablation
1080434|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
1080435|NCT02665429|Emergency Medicine|emergency medicine
1080436|NCT02665390|lung cancer|lung cancer
1080437|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
1080438|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
1080439|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
1080440|NCT02665338|fMRI|fmri
1080441|NCT02665338|cue craving|cue craving
1080442|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
1080443|NCT02665325|cognitive function|cognitive function
1080444|NCT02665312|cardiotoxicity|cardiotoxicity
1080445|NCT02665312|fluoropyrimidine|fluoropyrimidine
1080446|NCT02665312|colorectal cancer|colorectal cancer
1080447|NCT02665299|colon cancer|colon cancer
1080448|NCT02665299|colon polyps|colon polyps
1080449|NCT02665299|colon adenomas|colon adenomas
1080450|NCT02665299|colonoscopy|colonoscopy
1080451|NCT02665299|circulating tumor DNA|circulating tumor dna
1080452|NCT02665234|Dry Eye|dry eye
1080453|NCT02665221|Multiple Sclerosis|multiple sclerosis
1080454|NCT02665221|erythema|erythema
1080455|NCT02665208|cigarettes|cigarettes
1080456|NCT02665208|smoking|smoking
1080457|NCT02665208|opiate-dependence|opiate-dependence
1080458|NCT02665208|alcohol|alcohol
1080459|NCT02665208|detoxification|detoxification
1080460|NCT02665182|orchitis|orchitis
1080461|NCT02665182|testicular diseases|testicular diseases
1080462|NCT02665169|Postural Balance|postural balance
1080463|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
1080464|NCT02665169|Morbidity|morbidity
1080465|NCT02665169|Exercise|exercise
1080466|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
1080467|NCT02665130|COPD|copd
1080468|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
1080469|NCT02665117|Hypokalemia|hypokalemia
1080470|NCT02665117|Isoprostanes|isoprostanes
1080471|NCT02665117|Insulin resistance|insulin resistance
1080472|NCT02665117|Aldosterone|aldosterone
1080473|NCT02665117|Hepatic fat|hepatic fat
1080476|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
1080478|NCT02665104|NIRS|nirs
1080479|NCT02665104|Carotid endarterectomy|carotid endarterectomy
1080480|NCT02665078|Lung Cancer|lung cancer
1080481|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
1080482|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
1080483|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
1080484|NCT02665065|Bone Marrow Cell Transplantation|bone marrow cell transplantation
1080485|NCT02665065|Transplantation, Bone Marrow|transplantation, bone marrow
1080486|NCT02665065|HCT|hct
1080487|NCT02665065|HSCT|hsct
1080488|NCT02665065|Refractory AML|refractory aml
1080489|NCT02665065|Relapsed AML|relapsed aml
1080490|NCT02665065|BC8|bc8
1080491|NCT02665065|I-131|i-131
1080492|NCT02665065|Iomab|iomab
1080493|NCT02665065|Iomab-B|iomab-b
1080494|NCT02665065|CD45|cd45
1080495|NCT02665065|Iodine|iodine
1080496|NCT02665065|Iodine-131|iodine-131
1080497|NCT02665065|131-I|131-i
1080500|NCT02665065|radioimmunotherapy|radioimmunotherapy
1080501|NCT02665052|Rehabilitation|rehabilitation
1080502|NCT02665052|Motor Recovery|motor recovery
1080503|NCT02665052|upper extremity|upper extremity
1080504|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
1080505|NCT02664961|TRC105|trc105
1080506|NCT02664961|CD105|cd105
1080507|NCT02664961|Endoglin|endoglin
1080508|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
1080509|NCT02664961|GTN|gtn
1080510|NCT02664961|Bevacizumab|bevacizumab
1080511|NCT02664961|Avastin|avastin
1080512|NCT02664948|early follow-up|early follow-up
1080513|NCT02664948|geriatrics|geriatrics
1080514|NCT02664935|NSCLC|nsclc
1080515|NCT02664935|Lung Cancer|lung cancer
1080516|NCT02664935|Adenocarcinoma|adenocarcinoma
1080517|NCT02664935|Matrix|matrix
1080518|NCT02664935|SMP2|smp2
1080519|NCT02664935|Umbrella Trial Design|umbrella trial design
1080520|NCT02664935|Multi-arm|multi-arm
1080521|NCT02664922|Electrophysiology|electrophysiology
1080522|NCT02664922|Anesthetics|anesthetics
1080523|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
1080524|NCT02664909|Tranexamic Acid|tranexamic acid
1080525|NCT02664909|Topical|topical
1080526|NCT02664909|Blood Transfusion|blood transfusion
1080527|NCT02664896|Knee pain|knee pain
1080528|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
1080529|NCT02664870|synovial fluid|synovial fluid
1080530|NCT02664870|biomarkers|biomarkers
1080531|NCT02664857|Vitamin D|vitamin d
1080532|NCT02664857|Postoperative Pain|postoperative pain
1080533|NCT02664857|Mental Motor Retardation|mental motor retardation
1080534|NCT02664844|Obesity|obesity
1080535|NCT02664844|Appetite regulation|appetite regulation
1080536|NCT02664844|Insulin sensitivity|insulin sensitivity
1080537|NCT02664844|Adolescents|adolescents
1080538|NCT02664844|Exercise|exercise
1080539|NCT02664831|cardiac arrest|cardiac arrest
1080540|NCT02664831|inflammation|inflammation
1080541|NCT02664831|obesity|obesity
1080542|NCT02664831|neuregulin|neuregulin
1080543|NCT02664831|lipids|lipids
1080544|NCT02664818|Heart failure|heart failure
1080545|NCT02664818|China|china
1080546|NCT02664818|Registry|registry
1080547|NCT02664818|Characteristic|characteristic
1080548|NCT02664818|Outcome|outcome
1080549|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
1080550|NCT02664792|PET/CT|pet/ct
1080551|NCT02664792|18F-FDG|18f-fdg
1080552|NCT02664766|Heavy drinking|heavy drinking
1080553|NCT02664766|Heavy drinking cessation|heavy drinking cessation
1080554|NCT02664766|Alcohol abuse|alcohol abuse
1080555|NCT02664766|alcohol use disorder|alcohol use disorder
1080556|NCT02664740|Phage Therapy|phage therapy
1080557|NCT02664727|alcohol|alcohol
1080558|NCT02664727|alcohol abuse|alcohol abuse
1080559|NCT02664727|alcohol dependence|alcohol dependence
1080560|NCT02664727|alcohol use disorder|alcohol use disorder
1080561|NCT02664727|heavy drinking|heavy drinking
1080562|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
1080686|NCT02664077|Adjuvant therapy|adjuvant therapy
1080563|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
1080564|NCT02664688|spondylolisthesis|spondylolisthesis
1080565|NCT02664688|low back pain|low back pain
1080566|NCT02664688|stabilization exercise|stabilization exercise
1080567|NCT02664662|Breast cancer|breast cancer
1080568|NCT02664662|Health literacy|health literacy
1080569|NCT02664662|Tailored education|tailored education
1080570|NCT02664662|Rehabilitation|rehabilitation
1080571|NCT02664662|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
1080572|NCT02664649|TAVR|tavr
1080573|NCT02664649|Apixaban|apixaban
1080574|NCT02664649|Anticoagulant|anticoagulant
1080575|NCT02664649|VKA|vka
1080576|NCT02664649|Antiplatelet therapy|antiplatelet therapy
1080577|NCT02664649|Aortic stenosis|aortic stenosis
1080578|NCT02664610|hypertension treatment|hypertension treatment
1080579|NCT02664610|stroke prevention|stroke prevention
1080580|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
1080581|NCT02664597|MRI|mri
1080582|NCT02664597|adnexal masses|adnexal masses
1080583|NCT02664519|Chronic Kidney Disease|chronic kidney disease
1080584|NCT02664519|Functional sympatholysis|functional sympatholysis
1080585|NCT02664519|Exercise training|exercise training
1080586|NCT02664519|Exercise intolerance|exercise intolerance
1080587|NCT02664519|Handgrip exercise|handgrip exercise
1080588|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
1080589|NCT02664519|Lower body negative pressure|lower body negative pressure
1080590|NCT02664493|kidney transplantation|kidney transplantation
1080591|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
1080592|NCT02664493|steroid pulse therapy|steroid pulse therapy
1080593|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
1080594|NCT02664480|ovulation|ovulation
1080595|NCT02664454|Elderly|elderly
1080596|NCT02664454|Health care organization|health care organization
1080597|NCT02664454|Primary care|primary care
1080598|NCT02664441|Obesity|obesity
1080599|NCT02664441|Drug intervention|drug intervention
1080600|NCT02664441|Children|children
1080601|NCT02664441|Adolescents|adolescents
1080602|NCT02664441|Young adults|young adults
1080603|NCT02664441|Hypothalamic lesion|hypothalamic lesion
1080604|NCT02664441|Change of weight status|change of weight status
1080605|NCT02664441|Food intake|food intake
1080606|NCT02664441|Energy expenditure|energy expenditure
1080607|NCT02664441|Hormonal changes|hormonal changes
1080608|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
1080609|NCT02664441|Bydureon|bydureon
1080610|NCT02664441|Weight Loss|weight loss
1080611|NCT02664441|Energy balance|energy balance
1080612|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
1080613|NCT02664402|Palliative Care|palliative care
1080614|NCT02664402|Pain|pain
1080615|NCT02664402|Community Health|community health
1080616|NCT02664376|sarcopenia|sarcopenia
1080617|NCT02664376|geriatry|geriatry
1080618|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
1080619|NCT02664311|Jet Ventilation|jet ventilation
1080620|NCT02664311|Atrial Fibrillation|atrial fibrillation
1080621|NCT02664298|severely atrophic jaw|severely atrophic jaw
1080622|NCT02664298|cranial bone-graft|cranial bone-graft
1080623|NCT02664298|dental implants|dental implants
1080624|NCT02664298|immediate loading|immediate loading
1080625|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
1080626|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
1080627|NCT02664298|dental prosthesis|dental prosthesis
1080628|NCT02664298|implant supported|implant supported
1080629|NCT02664298|provisional implants|provisional implants
1080630|NCT02664298|temporary implants|temporary implants
1080631|NCT02664298|one-stage surgery|one-stage surgery
1080632|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
1080633|NCT02664298|maxilla|maxilla
1080634|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
1080635|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
1080636|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
1080637|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
1080638|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
1080639|NCT02664246|risk factors|risk factors
1080640|NCT02664246|incidence|incidence
1080641|NCT02664233|Diabetes|diabetes
1080642|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1080643|NCT02664233|obesity|obesity
1080644|NCT02664233|self-monitoring|self-monitoring
1080645|NCT02664233|goal setting|goal setting
1080646|NCT02664233|mobile health|mobile health
1080647|NCT02664233|connected health|connected health
1080648|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
1080649|NCT02664207|Myelomeningocele repair|myelomeningocele repair
1080650|NCT02664207|Open Neural Tube Defect|open neural tube defect
1080651|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
1080652|NCT02664207|Open Fetal Surgery|open fetal surgery
1080653|NCT02664207|Elevated body mass index|elevated body mass index
1080654|NCT02664194|Hypothermia|hypothermia
1080655|NCT02664194|Rewarming|rewarming
1080656|NCT02664194|Myocardial Infarction|myocardial infarction
1080657|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
1080658|NCT02664181|Cancer|cancer
1080659|NCT02664181|Nivolumab|nivolumab
1080660|NCT02664181|Decitabine|decitabine
1080661|NCT02664181|Tetrahydrouridine|tetrahydrouridine
1080662|NCT02664155|Renal insufficiency|renal insufficiency
1080663|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
1080664|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
1080665|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
1080666|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
1080667|NCT02664155|Heparins|heparins
1080668|NCT02664142|General Surgery|general surgery
1080669|NCT02664142|Child|child
1080670|NCT02664142|Anaesthesia|anaesthesia
1080671|NCT02664142|Depth of anaesthesia|depth of anaesthesia
1080672|NCT02664142|BIS monitoring|bis monitoring
1080673|NCT02664129|schizophrenia|schizophrenia
1080674|NCT02664129|awareness|awareness
1080675|NCT02664129|insight|insight
1080676|NCT02664129|video|video
1080677|NCT02664129|self-observation|self-observation
1080678|NCT02664116|Severe Migraine Headache|severe migraine headache
1080679|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
1080680|NCT02664090|prone ventilation|prone ventilation
1080681|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
1080682|NCT02664077|NSABP|nsabp
1080683|NCT02664077|Colon cancer|colon cancer
1080684|NCT02664077|Regorafenib|regorafenib
1080685|NCT02664077|Stage III|stage iii
1080687|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
1080688|NCT02664038|AUD|aud
1080689|NCT02664038|Neuropsychology|neuropsychology
1080690|NCT02664038|Cognitive Remediation|cognitive remediation
1080691|NCT02664025|teaching vaginal examination|teaching vaginal examination
1080692|NCT02664012|adoption|adoption
1080693|NCT02664012|electronic cigarettes|electronic cigarettes
1080694|NCT02664012|e-cigarettes|e-cigarettes
1080695|NCT02664012|menthol|menthol
1080696|NCT02664012|combustible cigarettes|combustible cigarettes
1080697|NCT02664012|nicotine polacrilex|nicotine polacrilex
1080698|NCT02664012|own brand cigarette|own brand cigarette
1080699|NCT02664012|subjective measures|subjective measures
1080700|NCT02664012|pharmacokinetics|pharmacokinetics
1080701|NCT02664012|pharmacodynamics|pharmacodynamics
1080702|NCT02664012|cigarette|cigarette
1080703|NCT02663999|dose proportionality|dose proportionality
1080704|NCT02663999|diazepam nasal spray|diazepam nasal spray
1080705|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
1080706|NCT02663973|Breast cancer|breast cancer
1080707|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
1080708|NCT02663960|Protocol|protocol
1080709|NCT02663960|Filter lifespan|filter lifespan
1080710|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
1080711|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
1080712|NCT02663947|intracranial pressure|intracranial pressure
1080713|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
1080714|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
1080715|NCT02663921|Melanin|melanin
1080716|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
1080717|NCT02663882|smoking|smoking
1080718|NCT02663882|self control|self control
1080719|NCT02663804|Total Knee Arthroplasty|total knee arthroplasty
1080720|NCT02663804|Patient Satisfaction|patient satisfaction
1080721|NCT02663804|PROMs|proms
1080722|NCT02663804|Implant Design|implant design
1080723|NCT02663791|Alcohol|alcohol
1080724|NCT02663791|Aortic stiffness|aortic stiffness
1080725|NCT02663791|Arterial stiffness|arterial stiffness
1080726|NCT02663791|Pulse wave velocity|pulse wave velocity
1080727|NCT02663791|Longitudinal|longitudinal
1080728|NCT02663752|deferasirox|deferasirox
1080729|NCT02663752|MDS|mds
1080730|NCT02663752|RNA expression|rna expression
1080731|NCT02663752|predictive biomarker|predictive biomarker
1080732|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
1080733|NCT02663739|Malperfusion|malperfusion
1080734|NCT02663739|Rupture|rupture
1080735|NCT02663739|Acute disease|acute disease
1080736|NCT02663739|Endovascular procedures|endovascular procedures
1080737|NCT02663726|Physically inactive|physically inactive
1080738|NCT02663726|Older adults|older adults
1080739|NCT02663713|Pharmacodynamics|pharmacodynamics
1080740|NCT02663713|Ticagrelor|ticagrelor
1080741|NCT02663713|Clopidogrel|clopidogrel
1080742|NCT02663713|MI|mi
1080743|NCT02663700|Burkina Faso|burkina faso
1080744|NCT02663700|healthy adults|healthy adults
1080745|NCT02663700|Irradiated|irradiated
1080746|NCT02663700|malaria|malaria
1080747|NCT02663700|PfSPZ Vaccine|pfspz vaccine
1080748|NCT02663700|Sanaria|sanaria
1080749|NCT02663700|Sporozoite|sporozoite
1080750|NCT02663700|Vaccine|vaccine
1080751|NCT02663674|CAP|cap
1080752|NCT02663674|Coccidioidomycosis|coccidioidomycosis
1080753|NCT02663674|Community Acquired Pneumonia|community acquired pneumonia
1080755|NCT02663674|Fluconazole|fluconazole
1080756|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
1080757|NCT02663674|Pneumonia|pneumonia
1080758|NCT02663674|Valley Fever|valley fever
1080759|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
1080760|NCT02663661|TrialNet|trialnet
1080761|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
1080762|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
1080763|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
1080764|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
1080765|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
1080766|NCT02663609|Cushing's Syndrome|cushing's syndrome
1080767|NCT02663609|Mifepristone|mifepristone
1080768|NCT02663609|Adrenal|adrenal
1080769|NCT02663609|Retrospective|retrospective
1080770|NCT02663609|Chart Review|chart review
1080771|NCT02663596|Pediatric|pediatric
1080772|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1080773|NCT02663596|Dialysis|dialysis
1080774|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
1080775|NCT02663596|Pharmacokinetics|pharmacokinetics
1080776|NCT02663596|Pharmacodynamics|pharmacodynamics
1080878|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
1080777|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
1080778|NCT02663583|OPSCC|opscc
1080779|NCT02663583|Actigraph accelerometer|actigraph accelerometer
1080780|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
1080781|NCT02663583|MDASI-HN|mdasi-hn
1080782|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
1080783|NCT02663583|IMPT|impt
1080784|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
1080785|NCT02663583|TORS|tors
1080786|NCT02663583|Surveys|surveys
1080787|NCT02663583|Questionnaires|questionnaires
1080788|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
1080789|NCT02663544|Diabetes|diabetes
1080790|NCT02663544|Metabolic syndrome|metabolic syndrome
1080791|NCT02663544|Obesity|obesity
1080792|NCT02663544|NAFLD|nafld
1080793|NCT02663518|T-Cell|t-cell
1080794|NCT02663518|CTCL|ctcl
1080795|NCT02663518|PTCL|ptcl
1080796|NCT02663518|ALL|all
1080797|NCT02663518|Rituximab|rituximab
1080798|NCT02663518|Nivolumab|nivolumab
1080801|NCT02663518|Hematologic Malignancies|hematologic malignancies
1080802|NCT02663518|Lymphoma|lymphoma
1080803|NCT02663518|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1080804|NCT02663518|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1080805|NCT02663518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1080806|NCT02663518|CD47|cd47
1080807|NCT02663492|Acupuncture|acupuncture
1080808|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
1080809|NCT02663492|chemotherapy|chemotherapy
1080810|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
1080811|NCT02663492|nursing care|nursing care
1080812|NCT02663466|pilonidal sinus|pilonidal sinus
1080813|NCT02663466|Limberg flap|limberg flap
1080814|NCT02663466|off-midline closure concept|off-midline closure concept
1080815|NCT02663466|recurrence|recurrence
1080817|NCT02663453|parenteral nutrition|parenteral nutrition
1080818|NCT02663453|cholestasis|cholestasis
1080819|NCT02663453|fish oil|fish oil
1080820|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
1080821|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
1080822|NCT02663427|gastric cancer screening|gastric cancer screening
1080823|NCT02663427|helicobacter pylori|helicobacter pylori
1080824|NCT02663427|gastrin|gastrin
1080825|NCT02663375|TAVI|tavi
1080826|NCT02663375|Aortic Stenosis|aortic stenosis
1080827|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1080828|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1080829|NCT02663375|Transapical Access|transapical access
1080830|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
1080831|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1080832|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
1080833|NCT02663323|Coronary Artery Disease|coronary artery disease
1080834|NCT02663323|MeRes-1 Extend|meres-1 extend
1080835|NCT02663323|MeRes100|meres100
1080836|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
1080837|NCT02663310|spinal cord injury|spinal cord injury
1080838|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
1080839|NCT02663310|surgical decompression|surgical decompression
1080840|NCT02663310|untethering|untethering
1080841|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
1080842|NCT02663297|CAR T cells|car t cells
1080843|NCT02663297|CD30|cd30
1080844|NCT02663297|Lymphoma|lymphoma
1080845|NCT02663297|T Lymphocytes|t lymphocytes
1080846|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
1080847|NCT02663245|glycemic control|glycemic control
1080848|NCT02663232|V600 BRAF mutation|v600 braf mutation
1080849|NCT02663232|Metastatic melanoma|metastatic melanoma
1080850|NCT02663219|MSM|msm
1080851|NCT02663219|ART|art
1080852|NCT02663219|CCM|ccm
1080853|NCT02663219|DAIDS|daids
1080854|NCT02663219|HPTN|hptn
1080855|NCT02663219|ACA|aca
1080856|NCT02663219|PAF|paf
1080857|NCT02663219|PEP|pep
1080858|NCT02663219|RDS|rds
1080859|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
1080860|NCT02663206|achalasia|achalasia
1080861|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
1080862|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
1080863|NCT02663206|Botulinum toxin injection|botulinum toxin injection
1080864|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
1080865|NCT02663193|Prostate Cancer|prostate cancer
1080866|NCT02663193|Observational study|observational study
1080867|NCT02663193|Enzalutamide|enzalutamide
1080868|NCT02663193|Abiraterone Acetate|abiraterone acetate
1080869|NCT02663193|Prednisone|prednisone
1080870|NCT02663193|Tolerability|tolerability
1080871|NCT02663154|Aromatherapy|aromatherapy
1080872|NCT02663102|Safety|safety
1080873|NCT02663102|Post-marketing|post-marketing
1080874|NCT02663102|Korea|korea
1080875|NCT02663102|Drug utilization study|drug utilization study
1080876|NCT02663102|Fluarix Tetra|fluarix tetra
1080877|NCT02663089|total radioactivity|total radioactivity
1081077|NCT02661919|Bed alarm|bed alarm
1080879|NCT02663089|Pharmacokinetics|pharmacokinetics
1080880|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1080881|NCT02663089|Microtracer|microtracer
1080882|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
1080883|NCT02663063|Hospice Palliative Care|hospice palliative care
1080884|NCT02663050|Dysmenorrhea|dysmenorrhea
1080885|NCT02663050|kinesio tape|kinesio tape
1080886|NCT02663037|Segmentation|segmentation
1080887|NCT02663037|Health needs|health needs
1080888|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
1080889|NCT02662972|Nerve block|nerve block
1080890|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
1080891|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
1080892|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
1080893|NCT02662907|Head and Neck Cancer|head and neck cancer
1080894|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
1080896|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
1080897|NCT02662907|EMST|emst
1080898|NCT02662907|Dysphagia therapy|dysphagia therapy
1080899|NCT02662907|Modified barium swallow|modified barium swallow
1080900|NCT02662907|Neurocognitive exams|neurocognitive exams
1080901|NCT02662907|Questionnaires|questionnaires
1080902|NCT02662907|Surveys|surveys
1080903|NCT02662907|Digital Manometer|digital manometer
1080904|NCT02662868|Breast cancer|breast cancer
1080905|NCT02662868|Metastasis|metastasis
1080906|NCT02662842|infusion set|infusion set
1080907|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1080908|NCT02662829|Lesotho|lesotho
1080909|NCT02662829|tuberculosis|tuberculosis
1080910|NCT02662829|TB|tb
1080911|NCT02662829|HIV|hiv
1080912|NCT02662829|adherence|adherence
1080913|NCT02662829|community-based intervention|community-based intervention
1080914|NCT02662829|retention|retention
1080915|NCT02662816|Glutathione|glutathione
1080916|NCT02662816|Liver|liver
1080917|NCT02662816|Muscle|muscle
1080918|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
1080919|NCT02662816|Healthy human|healthy human
1080920|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
1080921|NCT02662803|GAD|gad
1080922|NCT02662803|physical exercise|physical exercise
1080923|NCT02662803|aerobe exercise|aerobe exercise
1080924|NCT02662803|mental disorder|mental disorder
1080925|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
1080926|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
1080927|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
1080928|NCT02662777|esophageal perforation|esophageal perforation
1080929|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
1080930|NCT02662777|esophageal leak|esophageal leak
1080931|NCT02662777|endoscopy|endoscopy
1080932|NCT02662738|Blood glucose|blood glucose
1080933|NCT02662725|melanoma|melanoma
1080934|NCT02662725|brain metastasis|brain metastasis
1080935|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
1080936|NCT02662725|Ipilimumab|ipilimumab
1080937|NCT02662725|survival|survival
1080938|NCT02662725|safety|safety
1080939|NCT02662725|efficacy|efficacy
1080940|NCT02662712|Healthy|healthy
1080941|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
1080942|NCT02662712|JNJ-56136379|jnj-56136379
1080943|NCT02662712|Placebo|placebo
1080944|NCT02662699|Anemia|anemia
1080945|NCT02662699|Hematologic Diseases|hematologic diseases
1080946|NCT02662699|Erythrocytes|erythrocytes
1080947|NCT02662699|Hemoglobin|hemoglobin
1080948|NCT02662699|Hemolytic|hemolytic
1080949|NCT02662686|Embryo Implantation|embryo implantation
1080950|NCT02662686|Mitochondrial genes|mitochondrial genes
1080951|NCT02662686|Mitochondrial DNA|mitochondrial dna
1080952|NCT02662686|MitoScore|mitoscore
1080953|NCT02662686|Embryo selection|embryo selection
1080954|NCT02662686|Embryo viability|embryo viability
1080955|NCT02662686|Embryo biomarker|embryo biomarker
1080956|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
1080957|NCT02662673|HIFU|hifu
1080958|NCT02662673|Prostate Cancer|prostate cancer
1080959|NCT02662673|Focal|focal
1080960|NCT02662673|Quality of life|quality of life
1080961|NCT02662673|Index study|index study
1080962|NCT02662647|demethylating agent|demethylating agent
1080963|NCT02662647|lymphocyte infusion|lymphocyte infusion
1080964|NCT02662634|NSCLC|nsclc
1080965|NCT02662634|resectable|resectable
1080966|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
1080967|NCT02662634|immunotherapy|immunotherapy
1080968|NCT02662634|autologous|autologous
1080969|NCT02662634|dendritic cell|dendritic cell
1080970|NCT02662621|personalized care|personalized care
1080971|NCT02662621|early diagnosis|early diagnosis
1080972|NCT02662621|ovarian cancer|ovarian cancer
1080973|NCT02662621|breast cancer|breast cancer
1080974|NCT02662621|lung cancer|lung cancer
1080975|NCT02662621|Early Detection|early detection
1080976|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
1080977|NCT02662608|Brontictuzumab|brontictuzumab
1080978|NCT02662595|mHealth|mhealth
1080979|NCT02662595|mobile phones|mobile phones
1080980|NCT02662595|measles vaccination|measles vaccination
1080981|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1080982|NCT02662582|CK-2127107|ck-2127107
1080983|NCT02662582|COPD|copd
1080984|NCT02662543|rotavirus,|rotavirus,
1080985|NCT02662543|acute gastroenteritis|acute gastroenteritis
1080986|NCT02662543|vaccination|vaccination
1080987|NCT02662543|Estonia|estonia
1080988|NCT02662543|impact|impact
1080989|NCT02662543|severity scales|severity scales
1080990|NCT02662517|Neurotrophins|neurotrophins
1080991|NCT02662517|Stem Cells|stem cells
1080992|NCT02662517|Prematurity|prematurity
1080993|NCT02662504|mesothelioma|mesothelioma
1080994|NCT02662504|multimodal treatment|multimodal treatment
1080995|NCT02662504|PDT|pdt
1080996|NCT02662504|pleura|pleura
1080997|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
1080998|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1081101|NCT02661789|fMRI|fmri
1080999|NCT02662478|laparoscopic surgery|laparoscopic surgery
1081000|NCT02662465|Interventional|interventional
1081001|NCT02662465|Treatment|treatment
1081002|NCT02662465|Laser|laser
1081003|NCT02662439|Heart Failure|heart failure
1081004|NCT02662439|Bioimpedance analysis|bioimpedance analysis
1081005|NCT02662439|Fluid overload|fluid overload
1081006|NCT02662426|Seasonal Influenza|seasonal influenza
1081007|NCT02662426|Lingdancao|lingdancao
1081008|NCT02662426|RCT|rct
1081009|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
1081010|NCT02662322|Communication|communication
1081011|NCT02662322|Confusion|confusion
1081012|NCT02662322|Intravenous Catheterization|intravenous catheterization
1081013|NCT02662322|Comfort|comfort
1081014|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
1081015|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
1081016|NCT02662283|IGA Nephropathy|iga nephropathy
1081017|NCT02662283|proteinurien|proteinurien
1081018|NCT02662283|Reh-acteoside|reh-acteoside
1081019|NCT02662283|Prednisolone|prednisolone
1081020|NCT02662270|Fibromyalgia|fibromyalgia
1081021|NCT02662270|QEEG|qeeg
1081022|NCT02662270|Brain activity|brain activity
1081023|NCT02662270|fMRI|fmri
1081024|NCT02662270|Diagnosis|diagnosis
1081025|NCT02662257|Sevoflurane|sevoflurane
1081026|NCT02662257|Propofol|propofol
1081027|NCT02662257|Aged|aged
1081028|NCT02662257|Neoplasm|neoplasm
1081029|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
1081030|NCT02662257|Delirium|delirium
1081031|NCT02662257|Postoperative Complications|postoperative complications
1081032|NCT02662257|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1081033|NCT02662231|Surgical Site Infection|surgical site infection
1081034|NCT02662231|General Surgery|general surgery
1081035|NCT02662231|Laparotomy|laparotomy
1081036|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1081037|NCT02662231|Developing Countries|developing countries
1081038|NCT02662231|International Cooperation|international cooperation
1081039|NCT02662231|Specialties, Surgical|specialties, surgical
1081040|NCT02662231|Developed Countries|developed countries
1081041|NCT02662231|Quality of Health Care|quality of health care
1081042|NCT02662179|Elderly patients|elderly patients
1081043|NCT02662179|Onco-geriatrics|onco-geriatrics
1081044|NCT02662179|Fried criteria|fried criteria
1081045|NCT02662166|bladder cancer|bladder cancer
1081046|NCT02662166|MRI|mri
1081047|NCT02662166|TUR-BT|tur-bt
1081048|NCT02662166|cystectomy|cystectomy
1081049|NCT02662166|chemotherapy|chemotherapy
1081050|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
1081051|NCT02662075|electronic cigarettes|electronic cigarettes
1081052|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
1081053|NCT02662023|Healthy Human Volunteers|healthy human volunteers
1081054|NCT02662010|AGEs|ages
1081055|NCT02662010|glycemic control|glycemic control
1081056|NCT02662010|T2DM|t2dm
1081057|NCT02661997|Tai Chi|tai chi
1081058|NCT02661997|Wellness|wellness
1081059|NCT02661997|Mind-body|mind-body
1081060|NCT02661997|Gulf War Illness|gulf war illness
1081061|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
1081062|NCT02661997|GWVI|gwvi
1081063|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
1081064|NCT02661958|acne vulgaris|acne vulgaris
1081065|NCT02661958|acne|acne
1081066|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
1081067|NCT02661945|tumor margin|tumor margin
1081068|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
1081069|NCT02661932|Fertility preservation|fertility preservation
1081070|NCT02661932|letrozole|letrozole
1081071|NCT02661932|Ovarian stimulation|ovarian stimulation
1081072|NCT02661919|Epilepsy|epilepsy
1081073|NCT02661919|Seizure|seizure
1081074|NCT02661919|Seizures|seizures
1081075|NCT02661919|Mattress monitor|mattress monitor
1081076|NCT02661919|Bed monitor|bed monitor
1081078|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
1081079|NCT02661919|GTC|gtc
1081080|NCT02661893|Healthy|healthy
1081081|NCT02661893|JNJ-42847922|jnj-42847922
1081082|NCT02661893|Rifampin|rifampin
1081083|NCT02661893|Pharmacokinetics|pharmacokinetics
1081084|NCT02661867|Childbirth|childbirth
1081085|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
1081086|NCT02661867|Urinary incontinence|urinary incontinence
1081087|NCT02661867|Fecal incontinence|fecal incontinence
1081088|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
1081089|NCT02661854|Vaccine|vaccine
1081090|NCT02661854|Immunotherapy|immunotherapy
1081091|NCT02661854|Mite|mite
1081092|NCT02661854|Allergy|allergy
1081093|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
1081094|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
1081095|NCT02661789|Mental health|mental health
1081096|NCT02661789|Brain Imaging|brain imaging
1081097|NCT02661789|Steroid hormones|steroid hormones
1081098|NCT02661789|Serotonin|serotonin
1081099|NCT02661789|PET|pet
1081100|NCT02661789|MRI|mri
1081105|NCT02661776|natural killer cell|natural killer cell
1081106|NCT02661776|head and neck cancer|head and neck cancer
1081107|NCT02661776|opioid|opioid
1081108|NCT02661763|Rheumatic heart disease|rheumatic heart disease
1081109|NCT02661750|Cleansing the colon|cleansing the colon
1081110|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
1081111|NCT02661685|Cancer immunotherapy|cancer immunotherapy
1081112|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
1081113|NCT02661685|Natural killer cells|natural killer cells
1081114|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
1081115|NCT02661672|Neurosurgery|neurosurgery
1081116|NCT02661659|mesothelioma|mesothelioma
1081117|NCT02661659|multipeptide vaccine|multipeptide vaccine
1081118|NCT02661659|S-588210|s-588210
1081119|NCT02661646|Chronic Swelling|chronic swelling
1081120|NCT02661646|Leg Lymphedema|leg lymphedema
1081121|NCT02661646|Primary Lymphedema|primary lymphedema
1081122|NCT02661646|Secondary Lymphedema|secondary lymphedema
1081123|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
1081124|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
1081125|NCT02661594|TQT|tqt
1081126|NCT02661594|amisulpride|amisulpride
1081127|NCT02661594|volunteer|volunteer
1081128|NCT02661594|ECG|ecg
1081129|NCT02661581|Diabetes|diabetes
1081130|NCT02661581|Peer Leader Support|peer leader support
1081131|NCT02661529|Shunt|shunt
1081132|NCT02661529|Echocardiogram|echocardiogram
1081133|NCT02661490|Norovirus|norovirus
1081134|NCT02661464|Healthy|healthy
1081135|NCT02661464|Ebola viruses|ebola viruses
1081136|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
1081137|NCT02661464|Filoviruses|filoviruses
1081138|NCT02661464|Safety|safety
1081139|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1081140|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
1081141|NCT02661464|Hemorrhagic fever|hemorrhagic fever
1081142|NCT02661451|Valve|valve
1081143|NCT02661438|Usability Test|usability test
1081144|NCT02661425|IBS-D|ibs-d
1081145|NCT02661425|IBS|ibs
1081146|NCT02661412|immediate loading|immediate loading
1081147|NCT02661412|biological stability|biological stability
1081148|NCT02661412|mechanical stability|mechanical stability
1081149|NCT02661412|long-term|long-term
1081150|NCT02661412|marginal bone level|marginal bone level
1081151|NCT02661412|maxilla|maxilla
1081152|NCT02661412|immediate placement|immediate placement
1081153|NCT02661412|dental implant|dental implant
1081154|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
1081155|NCT02661399|CIPN|cipn
1081156|NCT02661373|Antimalarial|antimalarial
1081157|NCT02661373|First-in-Human|first-in-human
1081158|NCT02661373|Pharmacokinetic|pharmacokinetic
1081159|NCT02661360|swaddling|swaddling
1081160|NCT02661347|First Episode|first episode
1081161|NCT02661347|Schizophreniform|schizophreniform
1081162|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
1081163|NCT02661347|Psychosis|psychosis
1081164|NCT02661347|Schizophrenia|schizophrenia
1081165|NCT02661347|tDCS|tdcs
1081166|NCT02661347|Risperidone|risperidone
1081167|NCT02661347|Anti-psychotic medication|anti-psychotic medication
1081168|NCT02661334|creatine|creatine
1081169|NCT02661334|creatine monohydrate|creatine monohydrate
1081170|NCT02661334|supplement|supplement
1081171|NCT02661334|exercise|exercise
1081172|NCT02661334|fitness|fitness
1081173|NCT02661282|Glioblastoma|glioblastoma
1081174|NCT02661282|Gliosarcoma|gliosarcoma
1081175|NCT02661282|Brain tumor|brain tumor
1081176|NCT02661282|Cytomegalovirus stimulated adoptive T cells|cytomegalovirus stimulated adoptive t cells
1081177|NCT02661282|CMV|cmv
1081178|NCT02661282|Temozolomide|temozolomide
1081180|NCT02661282|TMZ|tmz
1081181|NCT02661282|Phone call|phone call
1081182|NCT02661282|T cell infusion|t cell infusion
1081183|NCT02661282|Surgery|surgery
1081184|NCT02661256|pharyngeal swallow|pharyngeal swallow
1081185|NCT02661256|airway compromise|airway compromise
1081186|NCT02661256|NICU|nicu
1081187|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
1081188|NCT02661243|Dental Implants|dental implants
1081189|NCT02661230|exergaming|exergaming
1081190|NCT02661230|intensive care unit|intensive care unit
1081191|NCT02661230|feasibility acceptability|feasibility acceptability
1081192|NCT02661230|heart|heart
1081193|NCT02661230|brain function|brain function
1081194|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
1081195|NCT02661217|Reduced ejection fraction|reduced ejection fraction
1081196|NCT02661217|Pre-discharge treatment|pre-discharge treatment
1081197|NCT02661217|Post-discharge treatment|post-discharge treatment
1081198|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
1081199|NCT02661217|HFrEF|hfref
1081200|NCT02661191|asthma|asthma
1081201|NCT02661191|vitamin D|vitamin d
1081202|NCT02661191|exacerbations|exacerbations
1081203|NCT02661191|airway obstruction|airway obstruction
1081204|NCT02661178|Parasitic Diseases|parasitic diseases
1081205|NCT02661178|Helminthiasis|helminthiasis
1081206|NCT02661178|Nematode Infections|nematode infections
1081207|NCT02661178|Secernentea Infections|secernentea infections
1081208|NCT02661178|Spirurida Infections|spirurida infections
1081209|NCT02661178|Filariasis|filariasis
1081210|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
1081211|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
1081212|NCT02661178|Skin Diseases|skin diseases
1081213|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
1081214|NCT02661178|Depsipeptides|depsipeptides
1081215|NCT02661178|Emodepside|emodepside
1081216|NCT02661178|Neglected disease|neglected disease
1081217|NCT02661178|Africa|africa
1081218|NCT02661178|New drug|new drug
1081219|NCT02661178|Oral drug|oral drug
1081220|NCT02661178|Parasite|parasite
1081221|NCT02661178|Anthelmintic drug|anthelmintic drug
1081222|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
1081223|NCT02661178|Single ascending dose|single ascending dose
1081224|NCT02661178|Volunteers|volunteers
1081225|NCT02661178|Phase 1|phase 1
1081226|NCT02661178|Safety|safety
1081227|NCT02661178|Tolerability|tolerability
1081228|NCT02661178|Pharmacokinetics|pharmacokinetics
1081229|NCT02661178|Relative bioavailability|relative bioavailability
1081230|NCT02661178|Onchocerciasis|onchocerciasis
1081231|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
1081232|NCT02661139|jaw reconstruction|jaw reconstruction
1081233|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
1081234|NCT02661139|quality of life|quality of life
1081235|NCT02661113|Brain|brain
1081236|NCT02661113|CNS Disease|cns disease
1081237|NCT02661113|CNS|cns
1081238|NCT02661113|Intracranial Supratentorial GBM|intracranial supratentorial gbm
1081239|NCT02661113|Gliosarcoma|gliosarcoma
1081240|NCT02661113|GS|gs
1081241|NCT02661113|Glioblastoma|glioblastoma
1081242|NCT02661113|GBM|gbm
1081243|NCT02661113|Dasatinib|dasatinib
1081244|NCT02661113|Sprycel|sprycel
1081245|NCT02661113|Temozolomide|temozolomide
1081246|NCT02661113|TMZ|tmz
1081247|NCT02661113|Temodar|temodar
1081248|NCT02661113|Radiation Therapy|radiation therapy
1081249|NCT02661113|Radiotherapy|radiotherapy
1081250|NCT02661113|RT|rt
1081251|NCT02661100|Vaccine|vaccine
1081252|NCT02661100|NY-ESO-1|ny-eso-1
1081253|NCT02661100|DEC-205|dec-205
1081254|NCT02661100|Poly-ICLC|poly-iclc
1081255|NCT02661100|Pembrolizumab|pembrolizumab
1081256|NCT02661100|Cancer|cancer
1081257|NCT02661087|submucosal myoma|submucosal myoma
1081258|NCT02661087|hysteroscopic resection|hysteroscopic resection
1081259|NCT02661087|bipolar energy|bipolar energy
1081260|NCT02661087|monopolar energy|monopolar energy
1081261|NCT02661074|Fisherman|fisherman
1081262|NCT02661074|Fish industry|fish industry
1081263|NCT02661061|ketamine|ketamine
1081264|NCT02661061|glutamate|glutamate
1081265|NCT02661061|relapse prevention|relapse prevention
1081266|NCT02661035|AML|aml
1081267|NCT02661035|ALL|all
1081268|NCT02661035|CML|cml
1081269|NCT02661035|MDS|mds
1081270|NCT02661035|CLL|cll
1081271|NCT02661035|SLL|sll
1081272|NCT02661035|NHL|nhl
1081273|NCT02661009|NSCLC|nsclc
1081274|NCT02661009|EGFR|egfr
1081275|NCT02661009|EGFR-TKI|egfr-tki
1081276|NCT02661009|PCR|pcr
1081277|NCT02660970|Iberogast|iberogast
1081278|NCT02660970|Acupressure|acupressure
1081279|NCT02660970|gut-brain-axis|gut-brain-axis
1081280|NCT02660957|Smoking cessation|smoking cessation
1081281|NCT02660931|Pediatrics|pediatrics
1081282|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
1081283|NCT02660905|HCV|hcv
1081284|NCT02660905|HIV|hiv
1081285|NCT02660905|Hep C|hep c
1081286|NCT02660905|Hepatitis C|hepatitis c
1081287|NCT02660905|HCV positive|hcv positive
1081288|NCT02660892|IAAO|iaao
1081289|NCT02660892|Threonine|threonine
1081290|NCT02660892|Children|children
1081291|NCT02660879|Education|education
1081292|NCT02660879|Inhaler|inhaler
1081293|NCT02660866|intermittent claudication|intermittent claudication
1081294|NCT02660866|randomized controlled trial|randomized controlled trial
1081295|NCT02660853|Exacerbations|exacerbations
1081296|NCT02660814|Chemerin|chemerin
1081297|NCT02660814|Interleukin-6|interleukin-6
1081298|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
1081299|NCT02660801|spinal manipulation|spinal manipulation
1081300|NCT02660801|spinal mobilization|spinal mobilization
1081301|NCT02660801|spinal stiffness|spinal stiffness
1081302|NCT02660788|6-24 months overdue|6-24 months overdue
1081303|NCT02660788|screening mammography|screening mammography
1081304|NCT02660775|schizophrenia|schizophrenia
1081305|NCT02660736|Albiglutide|albiglutide
1081306|NCT02660736|Randomized|randomized
1081307|NCT02660736|Pharmacokinetics|pharmacokinetics
1081308|NCT02660736|GSK716155|gsk716155
1081309|NCT02660736|Bioequivalence study|bioequivalence study
1081310|NCT02660723|M01.774.500|m01.774.500
1081311|NCT02660723|Volunteers|volunteers
1081312|NCT02660710|single arm phase 2|single arm phase 2
1081313|NCT02660710|safety and efficacy|safety and efficacy
1081315|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
1081316|NCT02660684|Prograf|prograf
1081317|NCT02660684|Graft versus host disease|graft versus host disease
1081318|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1081319|NCT02660684|Prophylaxis|prophylaxis
1081320|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
1081321|NCT02660645|Cysview|cysview
1081322|NCT02660645|Hexaminolevulinate|hexaminolevulinate
1081323|NCT02660645|Hexvix|hexvix
1081324|NCT02660645|NMIBC|nmibc
1081325|NCT02660645|BLCC|blcc
1081326|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
1081327|NCT02660645|Cystoscopy|cystoscopy
1081328|NCT02660645|TURBT|turbt
1081329|NCT02660645|TUR|tur
1081330|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
1081331|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
1081332|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
1081333|NCT02660593|Diabetes Mellitus|diabetes mellitus
1081334|NCT02660593|Chinese medicine|chinese medicine
1081335|NCT02660593|exercise|exercise
1081336|NCT02660593|diet|diet
1081337|NCT02660580|Adalimumab|adalimumab
1081338|NCT02660580|MSB11022|msb11022
1081339|NCT02660580|Psoriasis|psoriasis
1081340|NCT02660580|Phase III|phase iii
1081341|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
1081342|NCT02660567|PPH|pph
1081343|NCT02660567|atonic|atonic
1081344|NCT02660567|new maneuver|new maneuver
1081345|NCT02660554|Pneumonia|pneumonia
1081346|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1081347|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
1081348|NCT02660554|Intensive care units|intensive care units
1081349|NCT02660554|Drug Resistance|drug resistance
1081350|NCT02660541|Dressing for burn wounds|dressing for burn wounds
1081351|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
1081352|NCT02660515|wrist arthroscopy|wrist arthroscopy
1081353|NCT02660489|CRTH2 antagonist|crth2 antagonist
1081354|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
1081355|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
1081356|NCT02660489|OC459|oc459
1081357|NCT02660489|Allergic asthma|allergic asthma
1081358|NCT02660489|Eosinophilia|eosinophilia
1081359|NCT02660476|Diet|diet
1081360|NCT02660476|Middle East and North Africa country|middle east and north africa country
1081361|NCT02660476|Health|health
1081362|NCT02660476|Complication|complication
1081363|NCT02660476|Cardiovascular disease|cardiovascular disease
1081364|NCT02660476|Obesity|obesity
1081365|NCT02660476|Stress|stress
1081366|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
1081367|NCT02660463|incidence|incidence
1081368|NCT02660463|risk factors|risk factors
1081369|NCT02660437|COPD|copd
1081370|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
1081371|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
1081372|NCT02660437|Cognitive dysfunction|cognitive dysfunction
1081373|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
1081374|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
1081375|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
1081376|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
1081377|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
1081378|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
1081379|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
1081380|NCT02660411|Sevoflurane|sevoflurane
1081381|NCT02660411|Propofol|propofol
1081382|NCT02660411|Aged|aged
1081383|NCT02660411|Neoplasm|neoplasm
1081384|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
1081385|NCT02660411|Long-term survival|long-term survival
1081386|NCT02660385|pain|pain
1081387|NCT02660385|insomnia|insomnia
1081388|NCT02660385|cardiac failure|cardiac failure
1081389|NCT02660385|sleep|sleep
1081390|NCT02660385|fatigue|fatigue
1081391|NCT02660385|heart disease|heart disease
1081392|NCT02660385|anxiety|anxiety
1081393|NCT02660385|actigraphy|actigraphy
1081394|NCT02660385|psychomotor vigilance|psychomotor vigilance
1081395|NCT02660385|six minute walk|six minute walk
1081396|NCT02660385|depression|depression
1081397|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
1081398|NCT02660385|self-management|self-management
1081399|NCT02660385|self-care|self-care
1081400|NCT02660346|IL-10|il-10
1081401|NCT02660346|MRSA|mrsa
1081402|NCT02660346|Bacteremia|bacteremia
1081403|NCT02660333|Obesity|obesity
1081404|NCT02660333|Inflammation|inflammation
1081405|NCT02660333|Nutritional status|nutritional status
1081406|NCT02660333|Prebiotic|prebiotic
1081407|NCT02660333|Synbiotic|synbiotic
1081408|NCT02660307|stress|stress
1081409|NCT02660307|work|work
1081410|NCT02660307|employees|employees
1081411|NCT02660307|mindfulness|mindfulness
1081412|NCT02660307|depression|depression
1081413|NCT02660307|anxiety|anxiety
1081414|NCT02660268|Clinical pathway|clinical pathway
1081415|NCT02660268|Infection|infection
1081416|NCT02660268|Hip|hip
1081417|NCT02660268|Prosthesis|prosthesis
1081418|NCT02660255|CBD|cbd
1081419|NCT02660255|Epidiolex|epidiolex
1081420|NCT02660255|Myoclonic|myoclonic
1081421|NCT02660255|Brain Disease|brain disease
1081422|NCT02660255|Central Nervous System Disease|central nervous system disease
1081423|NCT02660255|GWP42003|gwp42003
1081424|NCT02660242|T1D|t1d
1081425|NCT02660242|Type 1 Diabetes|type 1 diabetes
1081426|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
1081427|NCT02660242|Adults|adults
1081428|NCT02660242|Exercise|exercise
1081429|NCT02660242|Hypoglycemia|hypoglycemia
1081430|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
1081431|NCT02660216|minimally invasive|minimally invasive
1081432|NCT02660216|le fort I osteotomy|le fort i osteotomy
1081433|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
1081434|NCT02660216|accuracy|accuracy
1081435|NCT02660203|chest physiotherapy|chest physiotherapy
1081436|NCT02660203|post operative period|post operative period
1081437|NCT02660203|forced expiration|forced expiration
1081438|NCT02660203|pleural drainage duration|pleural drainage duration
1081439|NCT02660164|Concussion|concussion
1081440|NCT02660125|ICSI|icsi
1081441|NCT02660125|endometrial injury|endometrial injury
1081442|NCT02660125|implantation rate|implantation rate
1081443|NCT02660086|Weight|weight
1081444|NCT02660086|Prevention|prevention
1081445|NCT02660086|Food choice|food choice
1081446|NCT02660086|Nutrition|nutrition
1081447|NCT02660086|Behavior change|behavior change
1081448|NCT02660086|Behavioral economics|behavioral economics
1081449|NCT02660086|Feedback|feedback
1081450|NCT02660086|Incentives|incentives
1081451|NCT02660060|Pramipexole|pramipexole
1081452|NCT02660060|Bioequivalence|bioequivalence
1081453|NCT02660060|Pharmacokinetics|pharmacokinetics
1081454|NCT02660047|South Asian descent|south asian descent
1081455|NCT02660034|Dose Escalation|dose escalation
1081456|NCT02660034|Dose Expansion|dose expansion
1081457|NCT02660034|BGB-A317|bgb-a317
1081458|NCT02660034|BGB-290|bgb-290
1081459|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
1081460|NCT02660021|orthognathic surgery|orthognathic surgery
1081461|NCT02659995|glycemic variability|glycemic variability
1081462|NCT02659995|infection|infection
1081463|NCT02659956|Multiple Sclerosis|multiple sclerosis
1081464|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
1081465|NCT02659943|Gene Therapy|gene therapy
1081466|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
1081467|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1081468|NCT02659943|T-cell infusion|t-cell infusion
1081469|NCT02659943|Residual Malignancy|residual malignancy
1081470|NCT02659930|HIV|hiv
1081471|NCT02659930|AIDS|aids
1081472|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
1081473|NCT02659917|glass-ionomer cement|glass-ionomer cement
1081474|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
1081475|NCT02659917|pit and fissure sealants|pit and fissure sealants
1081476|NCT02659904|Free gingival graft|free gingival graft
1081477|NCT02659904|Palatal donor site healing|palatal donor site healing
1081478|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
1081479|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
1081480|NCT02659852|bilateral metal stent|bilateral metal stent
1081481|NCT02659852|stent in stent|stent in stent
1081482|NCT02659852|side by side|side by side
1081483|NCT02659839|Cancer|cancer
1081484|NCT02659839|Intensive care unit|intensive care unit
1081485|NCT02659839|Mortality|mortality
1081583|NCT02659358|Fitbit|fitbit
1081486|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
1081488|NCT02659826|Gait Training|gait training
1081489|NCT02659826|Central Nervous System Excitability|central nervous system excitability
1081490|NCT02659826|Healthy|healthy
1081492|NCT02659774|Smoking cessation interventions|smoking cessation interventions
1081493|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
1081494|NCT02659761|Injection drug use|injection drug use
1081495|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
1081496|NCT02659761|Dolutegravir|dolutegravir
1081497|NCT02659761|Tolerability|tolerability
1081498|NCT02659761|Adherence|adherence
1081499|NCT02659761|Efficacy|efficacy
1081500|NCT02659748|Bioactive fatty acids|bioactive fatty acids
1081501|NCT02659748|Insulin sensitivity|insulin sensitivity
1081502|NCT02659748|Diet|diet
1081503|NCT02659748|Milk fat|milk fat
1081504|NCT02659748|Lipid metabolism|lipid metabolism
1081505|NCT02659748|Inflammation markers|inflammation markers
1081506|NCT02659748|Fecal microbiota composition|fecal microbiota composition
1081507|NCT02659735|Influenza A virus|influenza a virus
1081508|NCT02659735|JNJ-63623872|jnj-63623872
1081509|NCT02659735|Healthy|healthy
1081510|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
1081511|NCT02659722|Bone Disease|bone disease
1081512|NCT02659722|Musculoskeletal disease|musculoskeletal disease
1081513|NCT02659722|Spinal disease|spinal disease
1081514|NCT02659709|Glaucoma|glaucoma
1081515|NCT02659709|Smartphone|smartphone
1081516|NCT02659709|Tablet|tablet
1081517|NCT02659709|Application|application
1081518|NCT02659631|P-cadherin|p-cadherin
1081519|NCT02659631|PF-06671008|pf-06671008
1081520|NCT02659631|solid tumors|solid tumors
1081521|NCT02659631|lung cancer|lung cancer
1081522|NCT02659631|breast cancer|breast cancer
1081523|NCT02659631|colorectal cancer|colorectal cancer
1081524|NCT02659631|NSCLC|nsclc
1081525|NCT02659631|TNBC|tnbc
1081526|NCT02659631|CRC|crc
1081527|NCT02659631|neoplasms|neoplasms
1081528|NCT02659631|Triple negative breast cancer|triple negative breast cancer
1081529|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
1081530|NCT02659618|Asthma|asthma
1081531|NCT02659605|pre-term birth|pre-term birth
1081532|NCT02659605|delayed cord clamping|delayed cord clamping
1081533|NCT02659605|skin to skin|skin to skin
1081534|NCT02659592|fertility preservation|fertility preservation
1081535|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
1081536|NCT02659592|ovarian endocrine function|ovarian endocrine function
1081537|NCT02659592|assisted reproductive technology|assisted reproductive technology
1081538|NCT02659592|pregnancy and live birth|pregnancy and live birth
1081539|NCT02659579|Shared Book Reading|shared book reading
1081540|NCT02659579|Vocabulary|vocabulary
1081541|NCT02659579|Language Development|language development
1081542|NCT02659579|Young Children|young children
1081543|NCT02659579|Randomised Control Trial|randomised control trial
1081544|NCT02659566|Markers|markers
1081545|NCT02659566|Parasitemia|parasitemia
1081546|NCT02659566|Coartem|coartem
1081547|NCT02659566|Plasmodium|plasmodium
1081548|NCT02659566|Infection|infection
1568423|NCT00505895|Multiple Myeloma|multiple myeloma
1081549|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
1081550|NCT02659540|Ipilimumab|ipilimumab
1081551|NCT02659540|Nivolumab|nivolumab
1081552|NCT02659540|Radiotherapy|radiotherapy
1081553|NCT02659514|Poziotinib|poziotinib
1081554|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
1081555|NCT02659514|HER2-positive|her2-positive
1081556|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
1081557|NCT02659501|Breast reconstruction|breast reconstruction
1081558|NCT02659501|Bupivacaine|bupivacaine
1081559|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
1081560|NCT02659501|Postoperative analgesia|postoperative analgesia
1081561|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
1081562|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
1081563|NCT02659462|Fontan|fontan
1081564|NCT02659462|Fontan Palliation|fontan palliation
1081565|NCT02659462|functional capacity|functional capacity
1081566|NCT02659449|hands|hands
1081567|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
1081568|NCT02659423|Bystanding behaviors|bystanding behaviors
1081569|NCT02659423|Campus|campus
1081570|NCT02659423|Prevention|prevention
1081571|NCT02659423|Sexual Assault|sexual assault
1081572|NCT02659423|CampusSave|campussave
1081573|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
1081574|NCT02659410|Organic solvents|organic solvents
1081575|NCT02659397|LDL-cholesterol|ldl-cholesterol
1081576|NCT02659397|Hypercholesterolemia|hypercholesterolemia
1081577|NCT02659397|ETC-1002|etc-1002
1081578|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
1081579|NCT02659397|Atorvastatin|atorvastatin
1081580|NCT02659358|Advanced solid malignancy|advanced solid malignancy
1081581|NCT02659358|Activity monitor|activity monitor
1081582|NCT02659358|Biosensor|biosensor
1081584|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
1081585|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
1081586|NCT02659358|Performance Status|performance status
1081587|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
1081588|NCT02659345|Art Therapy|art therapy
1081589|NCT02659345|Chemotherapy|chemotherapy
1081590|NCT02659319|Child overweight|child overweight
1081591|NCT02659319|Child obesity|child obesity
1081592|NCT02659319|Family dynamics|family dynamics
1081593|NCT02659319|Peer relationships|peer relationships
1081594|NCT02659319|Family intervention|family intervention
1081595|NCT02659319|School intervention|school intervention
1081596|NCT02659319|Parenting|parenting
1081597|NCT02659293|Multiple myeloma|multiple myeloma
1081598|NCT02659293|stem-cell transplant|stem-cell transplant
1081599|NCT02659293|Symptomatic myeloma|symptomatic myeloma
1081600|NCT02659293|lenalidomide|lenalidomide
1081601|NCT02659293|carfilzomib|carfilzomib
1081602|NCT02659293|dexamethasone|dexamethasone
1081603|NCT02659280|telerehabilitation|telerehabilitation
1081604|NCT02659267|Health Promotion|health promotion
1081605|NCT02659267|Physical Activity|physical activity
1081606|NCT02659267|Eating habits|eating habits
1081607|NCT02659267|Health System|health system
1081608|NCT02659267|Users from Health Academy Program|users from health academy program
1081609|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
1081714|NCT02658825|Healthy|healthy
1081610|NCT02659241|Molecular results|molecular results
1081612|NCT02659241|RNA|rna
1081613|NCT02659241|Protein expression|protein expression
1081614|NCT02659241|AZD1775|azd1775
1081615|NCT02659215|Hyaluronic Acid|hyaluronic acid
1081616|NCT02659215|Cartilage Repair|cartilage repair
1081617|NCT02659215|Knee|knee
1081618|NCT02659202|Exercise|exercise
1081619|NCT02659202|Heart Failure|heart failure
1081620|NCT02659202|Blood Pressure|blood pressure
1081621|NCT02659163|cardiometabolic risk|cardiometabolic risk
1081622|NCT02659163|obesity|obesity
1081623|NCT02659163|mHealth|mhealth
1081624|NCT02659163|health behaviors|health behaviors
1081625|NCT02659150|tocilizumab|tocilizumab
1081626|NCT02659150|subcutaneous injection|subcutaneous injection
1081627|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
1081628|NCT02659150|plaque inflammation|plaque inflammation
1081629|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
1081630|NCT02659150|joint inflammation|joint inflammation
1081631|NCT02659150|FDG-PET|fdg-pet
1081632|NCT02659150|PET-MR|pet-mr
1081633|NCT02659150|ACTEMRA|actemra
1081634|NCT02659137|LBBB|lbbb
1081635|NCT02659137|TAVI|tavi
1081636|NCT02659124|facial laser|facial laser
1081637|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
1081638|NCT02659124|total ablative resurfacing|total ablative resurfacing
1081639|NCT02659124|EpiFix|epifix
1081640|NCT02659124|rhytides|rhytides
1081641|NCT02659124|wrinkles|wrinkles
1081642|NCT02659124|AmnioFix|amniofix
1081643|NCT02659111|Exercise Therapy|exercise therapy
1081644|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
1081645|NCT02659098|Geographic Atrophy|geographic atrophy
1081646|NCT02659098|Macular Degeneration|macular degeneration
1081647|NCT02659098|CNTO 2476|cnto 2476
1081648|NCT02659085|Depressive Disorder, Major|depressive disorder, major
1081649|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
1081650|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
1081651|NCT02659085|Infusions, Intravenous|infusions, intravenous
1081652|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
1081653|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
1081654|NCT02659085|Treatment Outcome|treatment outcome
1081655|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
1081656|NCT02659046|Traumatic Brain Injury|traumatic brain injury
1081657|NCT02659033|microbiota|microbiota
1081658|NCT02659033|resistant bacteria|resistant bacteria
1081660|NCT02659007|balance|balance
1081661|NCT02658968|Radioimmunotherapy|radioimmunotherapy
1081662|NCT02658968|Lu-177|lu-177
1081663|NCT02658968|Phase I study|phase i study
1081664|NCT02658968|Betalutin|betalutin
1081665|NCT02658968|ARC|arc
1081666|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
1081667|NCT02658968|HH1|hh1
1081668|NCT02658968|Rituximab|rituximab
1081669|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
1081670|NCT02658968|Lilotomab|lilotomab
1081671|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
1081672|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
1081673|NCT02658968|Lymphoma|lymphoma
1081674|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1081675|NCT02658968|Immune System Diseases|immune system diseases
1081676|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
1081677|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1081678|NCT02658968|Lymphatic Diseases|lymphatic diseases
1081679|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
1081680|NCT02658968|Neoplasms|neoplasms
1081681|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
1081682|NCT02658968|DLBCL|dlbcl
1081683|NCT02658968|Refractory DLBCL|refractory dlbcl
1081684|NCT02658968|Relapsed DLBCL|relapsed dlbcl
1081685|NCT02658955|Abdominal wall closure|abdominal wall closure
1081686|NCT02658942|renal stones|renal stones
1081687|NCT02658942|lower calyx|lower calyx
1081688|NCT02658942|Ureteroscopy|ureteroscopy
1081689|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
1081690|NCT02658942|Holmium laser|holmium laser
1081691|NCT02658942|Adult|adult
1081692|NCT02658942|Kidney|kidney
1081693|NCT02658903|Foley|foley
1081694|NCT02658903|Infection|infection
1081695|NCT02658903|Hospital acquired|hospital acquired
1081696|NCT02658903|catheter associated|catheter associated
1081697|NCT02658903|urinary|urinary
1081698|NCT02658877|Xolair|xolair
1081699|NCT02658877|corticosteroids|corticosteroids
1081700|NCT02658877|asthma|asthma
1081701|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
1081702|NCT02658864|lafutidine tablet|lafutidine tablet
1081703|NCT02658864|pharmacokinetics|pharmacokinetics
1081704|NCT02658864|food|food
1081705|NCT02658864|safety|safety
1081706|NCT02658864|healthy subjects|healthy subjects
1081707|NCT02658851|lymphocele|lymphocele
1081708|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
1081709|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
1081710|NCT02658851|PLND|plnd
1081711|NCT02658851|RARP|rarp
1081712|NCT02658851|prostatectomy|prostatectomy
1081713|NCT02658851|Patel|patel
1081715|NCT02658825|JNJ-63623872|jnj-63623872
1081716|NCT02658825|Moxifloxacin|moxifloxacin
1081717|NCT02658812|Breast Cancer|breast cancer
1081718|NCT02658812|Inflammatory breast cancer|inflammatory breast cancer
1081719|NCT02658812|IBC|ibc
1081720|NCT02658812|Non-inflammatory breast cancer|non-inflammatory breast cancer
1081721|NCT02658812|Inoperable local recurrence|inoperable local recurrence
1081722|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec
1081723|NCT02658812|T-VEC|t-vec
1081724|NCT02658812|OncoVEX GM-CSF|oncovex gm-csf
1081725|NCT02658799|periodontitis|periodontitis
1081726|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
1081727|NCT02658760|Femoral Fractures|femoral fractures
1081728|NCT02658721|Systemic Tramadol|systemic tramadol
1081729|NCT02658721|Adjunct Tramadol|adjunct tramadol
1081730|NCT02658721|Lidocain|lidocain
1081731|NCT02658695|ICSI|icsi
1081732|NCT02658695|embryo transfer|embryo transfer
1081733|NCT02658695|air bubbles depth|air bubbles depth
1081734|NCT02658669|Insomnia|insomnia
1081735|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
1081736|NCT02658656|Exoskeleton|exoskeleton
1081737|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
1081738|NCT02658630|arm rehabilitation|arm rehabilitation
1081739|NCT02658630|recovery of function|recovery of function
1081740|NCT02658617|Empathy|empathy
1081741|NCT02658617|Interoceptive Awareness|interoceptive awareness
1081742|NCT02658617|fMRI|fmri
1081743|NCT02658617|MRS|mrs
1081744|NCT02658591|Food intake|food intake
1081745|NCT02658591|Satiety|satiety
1081746|NCT02658591|Appetite|appetite
1081747|NCT02658591|Glycemia|glycemia
1081748|NCT02658591|Faba bean|faba bean
1081749|NCT02658591|Protein|protein
1081750|NCT02658591|Snack|snack
1081751|NCT02658565|Intraoperative Consultation|intraoperative consultation
1081752|NCT02658552|HIFU|hifu
1081753|NCT02658552|Benign thyroid nodule|benign thyroid nodule
1081754|NCT02658552|Low risk|low risk
1081755|NCT02658552|New treatment|new treatment
1081756|NCT02658539|Body fat distribution|body fat distribution
1081757|NCT02658539|Bone mineral density|bone mineral density
1081758|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1081759|NCT02658526|cognition|cognition
1081760|NCT02658526|anesthesia|anesthesia
1081761|NCT02658526|surgery|surgery
1081762|NCT02658526|stress|stress
1081763|NCT02658526|child|child
1081764|NCT02658500|early infant feeding|early infant feeding
1081765|NCT02658500|infant intestinal flora|infant intestinal flora
1081766|NCT02658500|infant health|infant health
1081767|NCT02658474|Chronic pain|chronic pain
1081768|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
1081769|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
1081770|NCT02658474|Group treatment|group treatment
1081771|NCT02658435|Malaria|malaria
1081772|NCT02658435|Retinal|retinal
1081773|NCT02658435|Ophthalmic|ophthalmic
1081774|NCT02658435|Plasmodium. vivax|plasmodium. vivax
1081775|NCT02658435|Tafenoquine|tafenoquine
1081776|NCT02658435|Pharmacodynamic|pharmacodynamic
1081777|NCT02658409|CCIV|cciv
1081778|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
1081779|NCT02658409|Influenza vaccine|influenza vaccine
1081780|NCT02658409|Vaccination|vaccination
1081781|NCT02658396|Multiple Myeloma|multiple myeloma
1081782|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
1081783|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
1081784|NCT02658370|physical exercises|physical exercises
1081785|NCT02658370|physical therapy|physical therapy
1081786|NCT02658370|Wii game console|wii game console
1081787|NCT02658370|patients perspective|patients perspective
1081788|NCT02658344|Stem cell|stem cell
1081789|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
1081790|NCT02658344|osteoarthritis|osteoarthritis
1081791|NCT02658344|degenerative arthritis|degenerative arthritis
1081792|NCT02658344|biostar|biostar
1081793|NCT02658344|Rbio|rbio
1081794|NCT02658331|Ebola Virus Disease|ebola virus disease
1081795|NCT02658331|Rapid Diagnosis|rapid diagnosis
1081796|NCT02658331|Point of care|point of care
1081797|NCT02658331|Molecular platform|molecular platform
1081798|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
1081799|NCT02658318|airway obstruction|airway obstruction
1081800|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
1081801|NCT02658305|transoral approach|transoral approach
1081802|NCT02658305|transbuccal approach|transbuccal approach
1081803|NCT02658305|postoperative complications|postoperative complications
1081804|NCT02658292|fungus|fungus
1081805|NCT02658292|antifungal|antifungal
1081806|NCT02658292|skin infection|skin infection
1081807|NCT02658292|hair infection|hair infection
1081808|NCT02658292|dermatophyte|dermatophyte
1081809|NCT02658292|scalp|scalp
1081810|NCT02658292|skin|skin
1081811|NCT02658292|eyebrows|eyebrows
1081812|NCT02658292|eyelashes|eyelashes
1081813|NCT02658292|hair|hair
1081814|NCT02658292|Trichophyton|trichophyton
1081815|NCT02658292|Microsporum|microsporum
1081816|NCT02658292|Endothrix|endothrix
1081818|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
1081819|NCT02658279|15-227|15-227
1081820|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
1081821|NCT02658266|resistance training|resistance training
1081822|NCT02658266|adult|adult
1081823|NCT02658266|muscle strength|muscle strength
1081824|NCT02658266|muscle endurance|muscle endurance
1081825|NCT02658266|muscle metabolism|muscle metabolism
1081826|NCT02658253|Placental malaria vaccine|placental malaria vaccine
1081827|NCT02658253|Plasmodium|plasmodium
1081828|NCT02658253|PRIMALVAC|primalvac
1081829|NCT02658240|Nerve block|nerve block
1081830|NCT02658240|Periarticular infiltration|periarticular infiltration
1081831|NCT02658240|Ropivacaine|ropivacaine
1081832|NCT02658240|Pain|pain
1081833|NCT02658214|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic
1081834|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
1081835|NCT02658188|ASP8825|asp8825
1081836|NCT02658188|XP13512|xp13512
1081837|NCT02658110|Postprandial glycemia|postprandial glycemia
1081838|NCT02658110|Metabolic health measures|metabolic health measures
1081839|NCT02658097|Lung Cancer|lung cancer
1081840|NCT02658097|pembrolizumab|pembrolizumab
1081841|NCT02658097|focal radiation|focal radiation
1081842|NCT02658097|RT|rt
1081843|NCT02658084|HER2-Positive|her2-positive
1081844|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
1081845|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
1081846|NCT02658071|cataract|cataract
1081847|NCT02658071|ocular pressure|ocular pressure
1081848|NCT02658058|Ultrasound|ultrasound
1081849|NCT02658058|Spinal anesthesia|spinal anesthesia
1081850|NCT02658058|Elderly|elderly
1081851|NCT02658058|Landmark|landmark
1081852|NCT02658045|oxygen saturation|oxygen saturation
1081853|NCT02658045|monitoring|monitoring
1081854|NCT02658045|oximeter|oximeter
1081855|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
1081856|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1081857|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
1081858|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
1081859|NCT02658006|Ultrasonography|ultrasonography
1081860|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
1081861|NCT02658006|Portal vein Doppler|portal vein doppler
1081862|NCT02658006|Lung ultrasound|lung ultrasound
1081863|NCT02658006|Positive fluid balance|positive fluid balance
1081864|NCT02658006|Mixed venous saturation|mixed venous saturation
1081865|NCT02657993|Breast Neoplasms|breast neoplasms
1081866|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
1081867|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
1081868|NCT02657993|Hypnosis|hypnosis
1081869|NCT02657993|Medication Adherence|medication adherence
1081870|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
1081871|NCT02657993|Treatment Outcomes|treatment outcomes
1081872|NCT02657980|Major Depressive Disorder|major depressive disorder
1081873|NCT02657980|tDCS|tdcs
1081875|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
1081876|NCT02657954|Homeless persons|homeless persons
1081877|NCT02657954|Veterans|veterans
1081878|NCT02657954|Mental disorders|mental disorders
1081879|NCT02657954|Cognition|cognition
1081880|NCT02657954|Rehabilitation|rehabilitation
1081881|NCT02657941|Schizophrenia|schizophrenia
1081882|NCT02657941|Obesity|obesity
1081883|NCT02657941|Metabolic Syndrome|metabolic syndrome
1081884|NCT02657915|FF-VEP|ff-vep
1081885|NCT02657915|mfVEP|mfvep
1081985|NCT02657369|Lenvima|lenvima
1081886|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
1081887|NCT02657915|BIIB033|biib033
1081888|NCT02657915|AON|aon
1081889|NCT02657889|PARP inhibitor|parp inhibitor
1081890|NCT02657889|PD-1|pd-1
1081891|NCT02657889|Niraparib|niraparib
1081892|NCT02657889|Pembrolizumab|pembrolizumab
1081893|NCT02657889|Keynote|keynote
1081894|NCT02657889|TOPACIO|topacio
1081895|NCT02657837|CF|cf
1081896|NCT02657837|Multiple Breath Washout|multiple breath washout
1081897|NCT02657837|Lung Clearance Index|lung clearance index
1081898|NCT02657837|Pediatrics|pediatrics
1081899|NCT02657824|Ejection fraction|ejection fraction
1081900|NCT02657824|mitral valve|mitral valve
1081901|NCT02657824|e-point septal separation|e-point septal separation
1081902|NCT02657811|Time-Lapse Imaging|time-lapse imaging
1081903|NCT02657811|Embryo Culture Techniques|embryo culture techniques
1081904|NCT02657811|Fertilization in Vitro|fertilization in vitro
1081905|NCT02657811|Embryology|embryology
1081906|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
1081907|NCT02657811|Infertility|infertility
1081908|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
1081909|NCT02657772|Target Ultra coils|target ultra coils
1081910|NCT02657772|small aneurysms|small aneurysms
1081911|NCT02657746|blood pressure monitoring|blood pressure monitoring
1081912|NCT02657746|high blood pressure|high blood pressure
1081913|NCT02657746|cardiovascular disease|cardiovascular disease
1081914|NCT02657746|Antihypertensive agents|antihypertensive agents
1081915|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
1082215|NCT02655965|PECS bloc|pecs bloc
1081916|NCT02657746|community health care workers|community health care workers
1081917|NCT02657746|cost-effectiveness|cost-effectiveness
1081918|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
1081919|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
1081920|NCT02657707|stent|stent
1081921|NCT02657707|stenosis|stenosis
1081922|NCT02657707|artery|artery
1081923|NCT02657707|carotid|carotid
1081924|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
1081925|NCT02657668|Emotion Focused Therapy|emotion focused therapy
1081926|NCT02657668|Stress|stress
1081927|NCT02657668|Resilience|resilience
1081928|NCT02657668|Coping Strategies|coping strategies
1081929|NCT02657655|Parkinson's Disease|parkinson's disease
1081930|NCT02657655|Dyskinesia|dyskinesia
1081931|NCT02657655|Tremor|tremor
1081932|NCT02657655|Symptom Management|symptom management
1081933|NCT02657655|Technology|technology
1081934|NCT02657655|Wearable Sensors|wearable sensors
1081935|NCT02657655|Continuous Monitoring|continuous monitoring
1081936|NCT02657655|Mobility|mobility
1081937|NCT02657642|drug related problems, elderly|drug related problems, elderly
1081938|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
1081939|NCT02657577|Women|women
1081940|NCT02657577|Infants and Children|infants and children
1081941|NCT02657551|Thyroid Cancer|thyroid cancer
1081942|NCT02657538|Interproximal caries|interproximal caries
1081943|NCT02657538|Enamel caries|enamel caries
1081944|NCT02657538|Caries detection|caries detection
1081945|NCT02657538|Caries diagnostics|caries diagnostics
1081946|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
1081947|NCT02657538|DIAGNOcam|diagnocam
1081948|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
1081949|NCT02657499|healthcare access|healthcare access
1081950|NCT02657499|utilization|utilization
1081951|NCT02657499|expenditures|expenditures
1081952|NCT02657499|preventive services|preventive services
1081953|NCT02657486|BGJ398|bgj398
1081954|NCT02657486|15-090|15-090
1081955|NCT02657460|chemotherapy|chemotherapy
1081956|NCT02657460|microparticle|microparticle
1081957|NCT02657460|malignant pleural effusion|malignant pleural effusion
1081958|NCT02657447|Radioimmunotherapy|radioimmunotherapy
1081959|NCT02657447|Lu-177|lu-177
1081960|NCT02657447|Phase I study|phase i study
1081961|NCT02657447|Betalutin|betalutin
1081962|NCT02657447|ARC|arc
1081963|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
1081964|NCT02657447|HH1|hh1
1081965|NCT02657447|Rituximab|rituximab
1081966|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
1081967|NCT02657447|Lymphoma|lymphoma
1081968|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
1081969|NCT02657447|Immune System Diseases|immune system diseases
1081970|NCT02657447|Follicular Lymphoma|follicular lymphoma
1081971|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
1081972|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
1081973|NCT02657447|Lymphatic Diseases|lymphatic diseases
1081974|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
1081975|NCT02657447|Neoplasms|neoplasms
1081976|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
1081977|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1081978|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
1081979|NCT02657447|Lilotomab|lilotomab
1081980|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
1081981|NCT02657382|Biofeedback|biofeedback
1081982|NCT02657382|Myocardial Imaging|myocardial imaging
1081983|NCT02657369|Lenvatinib|lenvatinib
1081984|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
1081986|NCT02657369|E7080|e7080
1081987|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
1081988|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1081989|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
1081990|NCT02657356|Bardoxolone methyl|bardoxolone methyl
1081991|NCT02657356|PAH|pah
1081992|NCT02657356|RTA 402|rta 402
1081993|NCT02657356|6-minute walk distance|6-minute walk distance
1081994|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
1081995|NCT02657330|Locally Advanced|locally advanced
1081996|NCT02657330|Metastatic|metastatic
1081997|NCT02657317|chronic pain|chronic pain
1081998|NCT02657317|pain management|pain management
1081999|NCT02657317|trauma|trauma
1082000|NCT02657317|ptsd|ptsd
1082001|NCT02657317|tbi|tbi
1082002|NCT02657317|opioid medication|opioid medication
1082003|NCT02657304|Sleep Apnea|sleep apnea
1082004|NCT02657304|CPAP|cpap
1082005|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
1082006|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
1082007|NCT02657252|telangiectasis|telangiectasis
1082008|NCT02657252|varicose veins|varicose veins
1082009|NCT02657252|veins|veins
1082010|NCT02657252|glucose|glucose
1082011|NCT02657252|sclerotherapy|sclerotherapy
1082012|NCT02657239|Physical Function|physical function
1082013|NCT02657213|Diabetes, Type 1|diabetes, type 1
1082014|NCT02657213|Hypoglycemia|hypoglycemia
1082522|NCT02654054|Menorrhagia|menorrhagia
1082015|NCT02657213|Insulin Infusion Systems|insulin infusion systems
1082016|NCT02657200|miscarriage|miscarriage
1082017|NCT02657200|Flanders|flanders
1082018|NCT02657200|spontaneous abortion|spontaneous abortion
1082019|NCT02657200|KAP|kap
1082020|NCT02657200|midwives|midwives
1082021|NCT02657174|third molar|third molar
1082022|NCT02657174|auriculotherapy|auriculotherapy
1082023|NCT02657174|inflammation|inflammation
1082024|NCT02657174|pain|pain
1082025|NCT02657122|Single ascending dose|single ascending dose
1082026|NCT02657122|SAD|sad
1082027|NCT02657122|multiple ascending dose|multiple ascending dose
1082028|NCT02657122|MAD|mad
1082029|NCT02657122|Phase 1|phase 1
1082030|NCT02657122|first-in-human|first-in-human
1082031|NCT02657122|volunteers|volunteers
1082032|NCT02657122|TD-1473|td-1473
1082033|NCT02657109|valve replacement|valve replacement
1082034|NCT02657109|physical therapy|physical therapy
1082035|NCT02657109|early mobilization|early mobilization
1082036|NCT02657096|Chronic Periodontitis|chronic periodontitis
1082037|NCT02657096|Hybenx|hybenx
1082038|NCT02657096|Desiccant agent|desiccant agent
1082039|NCT02657096|Healing|healing
1082040|NCT02657096|Microbiology|microbiology
1082041|NCT02657096|Periodontal Diseases|periodontal diseases
1082042|NCT02657096|Periodontitis|periodontitis
1082043|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
1082044|NCT02657070|Stroke|stroke
1082045|NCT02657070|learned non-use|learned non-use
1082046|NCT02657070|Virtual Reality|virtual reality
1082047|NCT02657070|Hemiparesis|hemiparesis
1082048|NCT02657057|neuromodulation|neuromodulation
1082049|NCT02657057|electrical estimulation|electrical estimulation
1082050|NCT02657057|percutaneous|percutaneous
1082051|NCT02657057|transcutaneous|transcutaneous
1082053|NCT02657044|EMR|emr
1082054|NCT02657044|ESD|esd
1082055|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
1082056|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
1082057|NCT02657044|colorectal adenomas|colorectal adenomas
1082058|NCT02657031|Headache, Migraine|headache, migraine
1082059|NCT02656992|Bronchiectasis|bronchiectasis
1082060|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
1082061|NCT02656979|Glaucoma|glaucoma
1082062|NCT02656979|Blood flow|blood flow
1082063|NCT02656979|Pseudoexfoliation|pseudoexfoliation
1082064|NCT02656979|Intraocular pressure|intraocular pressure
1082065|NCT02656979|Brain perfusion|brain perfusion
1082066|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
1082067|NCT02656953|VDU workers|vdu workers
1082068|NCT02656953|VDU lenses|vdu lenses
1082069|NCT02656953|Neck complaints|neck complaints
1082070|NCT02656953|Visual complaints|visual complaints
1082071|NCT02656940|obesity|obesity
1082072|NCT02656940|lipids|lipids
1082073|NCT02656940|energy expenditure|energy expenditure
1082074|NCT02656940|gene expression|gene expression
1082075|NCT02656927|Spinal Cord Injury|spinal cord injury
1082076|NCT02656927|Yoga|yoga
1082077|NCT02656927|Psychological Flexibility|psychological flexibility
1082078|NCT02656927|Mindfulness|mindfulness
1082079|NCT02656927|Pain|pain
1082080|NCT02656849|Solid Tumor|solid tumor
1082081|NCT02656823|ANKYLOS|ankylos
1082082|NCT02656823|Simplant|simplant
1082083|NCT02656823|maxilla|maxilla
1082084|NCT02656823|edentulous|edentulous
1082085|NCT02656823|short implants|short implants
1082086|NCT02656797|Leishmania major|leishmania major
1082087|NCT02656797|Leishmania tropica|leishmania tropica
1082088|NCT02656797|Amphotericin B|amphotericin b
1082089|NCT02656771|THA|tha
1082090|NCT02656771|Hip|hip
1082091|NCT02656771|arthroplasties|arthroplasties
1082093|NCT02656745|Cigarette Smoking|cigarette smoking
1082094|NCT02656745|Tobacco Smoking|tobacco smoking
1082095|NCT02656745|Nicotine|nicotine
1082096|NCT02656745|Drug|drug
1082097|NCT02656745|Addiction|addiction
1082098|NCT02656745|Tobacco|tobacco
1082099|NCT02656719|tracheostomy|tracheostomy
1082100|NCT02656719|complications|complications
1082101|NCT02656719|ultrasound|ultrasound
1082102|NCT02656719|bronchoscopy|bronchoscopy
1082103|NCT02656706|Adjuvant melanoma|adjuvant melanoma
1082104|NCT02656706|Advanced melanoma|advanced melanoma
1082105|NCT02656693|Weight Reduction Programs|weight reduction programs
1082106|NCT02656693|Weight Loss Programs|weight loss programs
1082107|NCT02656693|Obesity|obesity
1082108|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
1082109|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1082110|NCT02656667|sit to stand test COPD|sit to stand test copd
1082111|NCT02656667|quadriceps strengthening|quadriceps strengthening
1082112|NCT02656602|Computer Assisted Instruction|computer assisted instruction
1082113|NCT02656602|Patient Counselling|patient counselling
1082114|NCT02656602|Endoscopy|endoscopy
1082115|NCT02656589|breast cancer|breast cancer
1082116|NCT02656589|herceptin|herceptin
1082117|NCT02656589|microRNA|microrna
1082118|NCT02656576|Human Papillomavirus|human papillomavirus
1082119|NCT02656576|oropharynx biopsy|oropharynx biopsy
1082120|NCT02656576|tonsillar lesion|tonsillar lesion
1082121|NCT02656550|Uterine Transplant|uterine transplant
1082122|NCT02656550|AUI|aui
1082123|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
1082124|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
1082125|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
1082126|NCT02656511|hyperacute infection|hyperacute infection
1082127|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
1082128|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
1082129|NCT02656472|Inflammatory response|inflammatory response
1082130|NCT02656472|Tranexamic acid|tranexamic acid
1082131|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
1082132|NCT02656459|gene expression|gene expression
1082133|NCT02656446|Neuraxial|neuraxial
1082134|NCT02656446|Ultrasound|ultrasound
1082135|NCT02656433|QEEG|qeeg
1082136|NCT02656433|ERP|erp
1082137|NCT02656433|tRNS|trns
1082138|NCT02656433|Brain injury|brain injury
1082139|NCT02656433|Motor Impairment|motor impairment
1082140|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
1082141|NCT02656433|electroencephalogram|electroencephalogram
1082142|NCT02656407|Functional Ultrasound|functional ultrasound
1082143|NCT02656407|Intraoperative|intraoperative
1082144|NCT02656407|Brain|brain
1082145|NCT02656407|Doppler|doppler
1082146|NCT02656407|Ultrasound|ultrasound
1082147|NCT02656394|ocular surface disease|ocular surface disease
1082148|NCT02656394|glaucoma medications|glaucoma medications
1082149|NCT02656381|Sarcoidosis|sarcoidosis
1082150|NCT02656381|Behcet's Disease|behcet's disease
1082151|NCT02656381|Natural History Study|natural history study
1082152|NCT02656381|Biological Specimens|biological specimens
1082153|NCT02656381|Immune System|immune system
1082154|NCT02656355|Gait Initiation|gait initiation
1082155|NCT02656355|Freezing of gait|freezing of gait
1082156|NCT02656355|Balance training|balance training
1082157|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
1082158|NCT02656342|OCD|ocd
1082159|NCT02656329|Heart Failure (HF)|heart failure (hf)
1082160|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
1082161|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1082162|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
1082163|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
1082164|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
1082165|NCT02656329|123I-iobenguane|123i-iobenguane
1082166|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
1082167|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
1082168|NCT02656329|All-cause mortality|all-cause mortality
1082169|NCT02656329|Cardiac mortality|cardiac mortality
1082170|NCT02656251|biofilms|biofilms
1082171|NCT02656251|cross over trial|cross over trial
1082172|NCT02656251|chlorhexidine|chlorhexidine
1082173|NCT02656238|CTEPH|cteph
1082174|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
1082175|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1082176|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
1082177|NCT02656238|BPA|bpa
1082178|NCT02656238|PEA|pea
1082179|NCT02656225|postpartum anemia|postpartum anemia
1082180|NCT02656225|hemoglobin|hemoglobin
1082181|NCT02656225|iron metabolism|iron metabolism
1082182|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
1082183|NCT02656225|Ejiao|ejiao
1082184|NCT02656212|epicatechin|epicatechin
1082185|NCT02656212|pre-diabetes|pre-diabetes
1082186|NCT02656199|Diaphragm|diaphragm
1082187|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
1082188|NCT02656173|Tamsulosin|tamsulosin
1082189|NCT02656173|Overactive bladder|overactive bladder
1082190|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
1082191|NCT02656173|Mirabegron|mirabegron
1082192|NCT02656147|Leukemia|leukemia
1082193|NCT02656147|Lymphoma|lymphoma
1082194|NCT02656147|CAR γδT|car γδt
1082195|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
1082196|NCT02656121|PCOS, vitamin D|pcos, vitamin d
1082197|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
1082198|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
1082199|NCT02656017|kidney disease|kidney disease
1082200|NCT02656017|polycystic kidney disease|polycystic kidney disease
1082201|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
1082202|NCT02656017|kidney cysts|kidney cysts
1082204|NCT02656004|Eucalyptus|eucalyptus
1082205|NCT02656004|Autonomic nervous system|autonomic nervous system
1082206|NCT02656004|Isometric resistance exercise|isometric resistance exercise
1082207|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1082208|NCT02655991|Ambulatory Care|ambulatory care
1082209|NCT02655991|Telemedicine|telemedicine
1082210|NCT02655991|Remote Consultation|remote consultation
1082211|NCT02655991|Health Services Accessibility|health services accessibility
1082212|NCT02655965|Breast cancer|breast cancer
1082213|NCT02655965|lumpectomy|lumpectomy
1082214|NCT02655965|mastectomy|mastectomy
1082216|NCT02655939|Gonarthrosis|gonarthrosis
1082217|NCT02655926|OCD|ocd
1082218|NCT02655926|DBS|dbs
1082219|NCT02655926|Deep Brain Stimulation|deep brain stimulation
1082220|NCT02655913|Sodium ascorbate|sodium ascorbate
1082221|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
1082222|NCT02655913|Oncothermia|oncothermia
1082223|NCT02655913|Immune function|immune function
1082224|NCT02655913|Life quality|life quality
1082225|NCT02655913|Tumor marker|tumor marker
1082226|NCT02655913|Survival time|survival time
1082227|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
1082228|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
1082229|NCT02655874|Seasonal Influenza|seasonal influenza
1082230|NCT02655874|Antibody response|antibody response
1082231|NCT02655874|Influenza Vaccines|influenza vaccines
1082232|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
1082233|NCT02655874|Elderly|elderly
1082234|NCT02655874|immunosenescence|immunosenescence
1082235|NCT02655874|Tropics|tropics
1082236|NCT02655848|Popeye|popeye
1082237|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
1082238|NCT02655848|Arthroscopy|arthroscopy
1082239|NCT02655848|Functional result|functional result
1126311|NCT02399917|MDS|mds
1082240|NCT02655835|mindfulness|mindfulness
1082241|NCT02655835|meditation|meditation
1082242|NCT02655835|internet|internet
1082243|NCT02655822|NSCLC|nsclc
1082244|NCT02655822|MEL|mel
1082245|NCT02655822|RCC|rcc
1082246|NCT02655822|TNBC|tnbc
1082247|NCT02655822|Triple Negative Breast Neoplasms|triple negative breast neoplasms
1082248|NCT02655822|Neoplasms|neoplasms
1082249|NCT02655822|CRC|crc
1082250|NCT02655822|Lung Cancer|lung cancer
1082251|NCT02655822|Kidney Cancer|kidney cancer
1082252|NCT02655822|Colon Cancer|colon cancer
1082253|NCT02655822|Rectal Cancer|rectal cancer
1082254|NCT02655822|Skin Cancer|skin cancer
1082255|NCT02655822|Breast Cancer|breast cancer
1082256|NCT02655822|mCRPC|mcrpc
1082257|NCT02655822|Prostate Cancer|prostate cancer
1082258|NCT02655796|Accidental Falls|accidental falls
1082259|NCT02655796|Risk Assessment|risk assessment
1082260|NCT02655796|Frail Elderly|frail elderly
1082261|NCT02655783|induction of labor|induction of labor
1082262|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
1082263|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
1082264|NCT02655744|Chemotherapy|chemotherapy
1082265|NCT02655744|Neurotoxicity|neurotoxicity
1082266|NCT02655718|ACS|acs
1082267|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
1082268|NCT02655705|Cyclosporine|cyclosporine
1082269|NCT02655705|Methotrexate|methotrexate
1082270|NCT02655692|PTSD|ptsd
1082271|NCT02655692|Ketamine|ketamine
1082272|NCT02655692|Veteran|veteran
1082273|NCT02655692|Military|military
1082274|NCT02655692|Clinical Trial|clinical trial
1082275|NCT02655679|eczema|eczema
1082276|NCT02655640|illness perceptions|illness perceptions
1082277|NCT02655627|Type 2 DM|type 2 dm
1082278|NCT02655627|internet based exercise training|internet based exercise training
1082279|NCT02655627|group exercise training|group exercise training
1082280|NCT02655627|glycemic control|glycemic control
1082281|NCT02655575|dizziness|dizziness
1082282|NCT02655575|cognitive therapy|cognitive therapy
1082283|NCT02655575|primary care|primary care
1082284|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
1082285|NCT02655575|chronic|chronic
1082286|NCT02655484|COPD|copd
1082287|NCT02655484|noninvasive ventilation|noninvasive ventilation
1082288|NCT02655484|exercise|exercise
1082289|NCT02655484|CO2 rebreathing|co2 rebreathing
1082290|NCT02655458|Multiple Myeloma|multiple myeloma
1082291|NCT02655458|Induction Therapy|induction therapy
1082292|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
1082293|NCT02655458|ASCT|asct
1082294|NCT02655458|Auto-SCT|auto-sct
1082295|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
1082296|NCT02655406|Foam sclerotherapy|foam sclerotherapy
1082297|NCT02655406|Compression|compression
1082298|NCT02655367|MRI|mri
1082299|NCT02655367|oats|oats
1082300|NCT02655367|porridge|porridge
1082301|NCT02655367|satiety|satiety
1082302|NCT02655367|GI hormones|gi hormones
1082303|NCT02655367|processing|processing
1082304|NCT02655341|Dehydration|dehydration
1082305|NCT02655341|Primary PCI|primary pci
1082306|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
1082307|NCT02655341|Bioimpedance|bioimpedance
1082308|NCT02655341|Renal Angiography|renal angiography
1082309|NCT02655328|asthma|asthma
1082310|NCT02655328|athlete|athlete
1082311|NCT02655315|Parkinson|parkinson
1082312|NCT02655315|Deferiprone|deferiprone
1082313|NCT02655315|Chelation|chelation
1082314|NCT02655302|Interleukin-17|interleukin-17
1082315|NCT02655302|Interleukin-22|interleukin-22
1082316|NCT02655302|Microbiota|microbiota
1082317|NCT02655302|Exacerbations|exacerbations
1082318|NCT02655302|Immunity|immunity
1082319|NCT02655302|Mucosal|mucosal
1082320|NCT02655276|microencapsulated glycine|microencapsulated glycine
1082321|NCT02655276|attentional performance|attentional performance
1082322|NCT02655276|motoric activity|motoric activity
1082323|NCT02655276|hyperactivity|hyperactivity
1082324|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
1082325|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
1082326|NCT02655198|fenfluramine|fenfluramine
1082327|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
1082328|NCT02655185|Lipids|lipids
1082329|NCT02655185|Atrial Fibrillation|atrial fibrillation
1082330|NCT02655185|Heart Failure|heart failure
1082331|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
1082332|NCT02655172|perception-action binding,|perception-action binding,
1082333|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
1082334|NCT02655159|Breast Cancer|breast cancer
1082335|NCT02655159|Metastatic breast cancer|metastatic breast cancer
1082336|NCT02655159|nab-paclitaxel|nab-paclitaxel
1082337|NCT02655159|Abraxane|abraxane
1082338|NCT02655159|Observational|observational
1082339|NCT02655159|Retrospective|retrospective
1082340|NCT02655159|AMBER|amber
1082341|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
1082342|NCT02655120|Femoral head necrosis|femoral head necrosis
1082343|NCT02655120|Autologous Bone Marrow|autologous bone marrow
1082344|NCT02655120|BMP7|bmp7
1082345|NCT02655107|blood gas monitoring|blood gas monitoring
1082346|NCT02655107|non-invasive|non-invasive
1082347|NCT02655107|hemoglobin|hemoglobin
1082348|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
1082349|NCT02655081|Urinary diversion|urinary diversion
1082350|NCT02655081|Bladder Neoplasm|bladder neoplasm
1082351|NCT02655081|Nutritional Supplement|nutritional supplement
1082352|NCT02655081|Cystectomy|cystectomy
1082353|NCT02655068|Head and Neck Cancer|head and neck cancer
1082354|NCT02655068|Definitive Therapy|definitive therapy
1082355|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
1082356|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
1082357|NCT02655055|apheresis|apheresis
1082358|NCT02655055|citrate anticoagulation|citrate anticoagulation
1082359|NCT02655055|blood donor|blood donor
1082360|NCT02655055|bone|bone
1082361|NCT02655016|Ovarian Cancer|ovarian cancer
1082362|NCT02655016|PARP Inhibitor|parp inhibitor
1082364|NCT02655016|HRD positive|hrd positive
1082365|NCT02655016|PRIMA|prima
1082366|NCT02655016|PRIMA Clinical Trial|prima clinical trial
1082367|NCT02655016|PRIMA Study|prima study
1082368|NCT02655003|behavioral symptoms|behavioral symptoms
1082369|NCT02655003|psychological symptoms|psychological symptoms
1082370|NCT02655003|dementia|dementia
1082371|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
1082372|NCT02654990|multiple myeloma|multiple myeloma
1082373|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
1082374|NCT02654990|LBH589|lbh589
1082375|NCT02654990|panobinostat|panobinostat
1082376|NCT02654990|bortezomib|bortezomib
1082377|NCT02654990|dexamethasone|dexamethasone
1082378|NCT02654951|Stroke|stroke
1082379|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
1082380|NCT02654951|Bimanual|bimanual
1082381|NCT02654951|Compensatory movements|compensatory movements
1082382|NCT02654951|Hemiplegia|hemiplegia
1082383|NCT02654951|Kinematics|kinematics
1082384|NCT02654951|Reaching|reaching
1082385|NCT02654951|Trunk|trunk
1082386|NCT02654938|prostate cancer|prostate cancer
1082387|NCT02654938|adenovirus|adenovirus
1082388|NCT02654938|TLR5|tlr5
1082389|NCT02654938|immunotherapy|immunotherapy
1082390|NCT02654912|malaria|malaria
1082391|NCT02654912|elimination|elimination
1082392|NCT02654912|surveillance and response|surveillance and response
1082393|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
1082394|NCT02654899|Healthy subjects|healthy subjects
1082395|NCT02654899|Single Ascending Dose|single ascending dose
1082396|NCT02654899|Hyperlipidemia|hyperlipidemia
1082397|NCT02654899|Dyslipidemia|dyslipidemia
1082398|NCT02654886|exercise|exercise
1082399|NCT02654886|Pompe disease|pompe disease
1082400|NCT02654886|Pompe|pompe
1082401|NCT02654873|histopathology|histopathology
1082402|NCT02654873|gallbladder|gallbladder
1082403|NCT02654873|specimen|specimen
1082404|NCT02654847|vasopressor|vasopressor
1082405|NCT02654847|blood pressure|blood pressure
1082406|NCT02654847|Cesarean section|cesarean section
1082407|NCT02654847|spinal anesthesia|spinal anesthesia
1082408|NCT02654821|Melanoma|melanoma
1082409|NCT02654821|TCR|tcr
1082410|NCT02654808|gynecology|gynecology
1082411|NCT02654808|laparoscopy|laparoscopy
1082412|NCT02654808|pneumoperitoneum|pneumoperitoneum
1082413|NCT02654808|CO2 absorption|co2 absorption
1082414|NCT02654756|Risk Assessment|risk assessment
1082415|NCT02654704|Personalized Medicine|personalized medicine
1082416|NCT02654704|Precision Medicine|precision medicine
1082417|NCT02654691|Chemotherapy|chemotherapy
1082418|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
1082419|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
1082420|NCT02654600|cardiac surgery|cardiac surgery
1082421|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
1082422|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1082423|NCT02654587|NSCLC|nsclc
1082424|NCT02654587|Immunotherapy|immunotherapy
1082425|NCT02654587|Cancer vaccine|cancer vaccine
1082426|NCT02654587|Metastasis|metastasis
1082427|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
1082428|NCT02654574|Functional autonomy level|functional autonomy level
1082429|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
1082430|NCT02654574|The Functional autonomy level|the functional autonomy level
1082431|NCT02654561|Severe sepsis|severe sepsis
1082432|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
1082433|NCT02654561|Unfractionated heparin|unfractionated heparin
1082434|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
1082435|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1082436|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1082437|NCT02654535|Clinical practice guidelines|clinical practice guidelines
1082438|NCT02654535|Clinical trials|clinical trials
1082439|NCT02654535|Tree Nuts|tree nuts
1082440|NCT02654535|Peanuts|peanuts
1082441|NCT02654535|Body weight|body weight
1082442|NCT02654535|Prospective cohort studies|prospective cohort studies
1082443|NCT02654496|Gut Microbiota|gut microbiota
1082444|NCT02654496|Weight Regain|weight regain
1082445|NCT02654496|Gastric Bypass|gastric bypass
1082446|NCT02654457|Immunohistochemical|immunohistochemical
1082447|NCT02654457|Ki-67|ki-67
1082448|NCT02654457|Breast cancer|breast cancer
1082449|NCT02654457|IHC|ihc
1082450|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
1082451|NCT02654444|Her2/Neu|her2/neu
1082452|NCT02654444|Breast cancer|breast cancer
1082453|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
1082455|NCT02654431|Breast cancer|breast cancer
1082456|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
1082457|NCT02654418|adenomas|adenomas
1082458|NCT02654418|polyps|polyps
1082459|NCT02654405|HDAC inhibitors|hdac inhibitors
1082460|NCT02654405|Inflammation|inflammation
1082461|NCT02654392|Omega-3|omega-3
1082462|NCT02654392|Omega-6|omega-6
1082463|NCT02654392|Exercise Performance|exercise performance
1082464|NCT02654366|Syringe exchange|syringe exchange
1082465|NCT02654366|HIV risk reduction|hiv risk reduction
1082466|NCT02654366|Drug-free community support|drug-free community support
1082467|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
1082468|NCT02654327|Extracorporeal|extracorporeal
1082469|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1082470|NCT02654327|Protective Lung Ventilation|protective lung ventilation
1082471|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
1082472|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
1082473|NCT02654327|Lung|lung
1082474|NCT02654327|Lung Injury|lung injury
1082475|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
1082476|NCT02654301|Xylose|xylose
1082477|NCT02654301|prediabetes|prediabetes
1082478|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
1082479|NCT02654301|glucose|glucose
1082480|NCT02654288|pancreatic cancer|pancreatic cancer
1082481|NCT02654288|gemcitabine|gemcitabine
1082482|NCT02654288|chemotherapy|chemotherapy
1082483|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
1082484|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
1082485|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
1082486|NCT02654249|hemorroidectomy|hemorroidectomy
1082487|NCT02654249|THD|thd
1082488|NCT02654249|LigaSure|ligasure
1082489|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
1082490|NCT02654223|Vaccine|vaccine
1082491|NCT02654223|Immunotherapy|immunotherapy
1082492|NCT02654223|Grass pollen|grass pollen
1082493|NCT02654223|Allergy|allergy
1082494|NCT02654210|birth cohort|birth cohort
1082495|NCT02654210|infectious diseases|infectious diseases
1082496|NCT02654210|microbiome|microbiome
1082497|NCT02654210|immune system|immune system
1082498|NCT02654210|immune response|immune response
1082499|NCT02654184|Right lateral|right lateral
1082500|NCT02654184|Induction|induction
1082501|NCT02654184|Children|children
1082502|NCT02654184|Anesthesia|anesthesia
1082503|NCT02654171|RSV|rsv
1082504|NCT02654171|AK0529|ak0529
1082505|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
1082506|NCT02654145|mepolizumab|mepolizumab
1082507|NCT02654145|Omalizumab|omalizumab
1082508|NCT02654145|SGRQ|sgrq
1082509|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
1082510|NCT02654145|ACQ|acq
1082511|NCT02654145|exacerbations|exacerbations
1082512|NCT02654106|multiple brain metastases|multiple brain metastases
1082513|NCT02654106|large brain metastases|large brain metastases
1082514|NCT02654106|meningeal metastases|meningeal metastases
1082515|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
1082516|NCT02654106|temozolomide|temozolomide
1082517|NCT02654054|Elagolix|elagolix
1082518|NCT02654054|Elagolix Sodium|elagolix sodium
1082519|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
1082520|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
1082521|NCT02654054|Leiomyomata|leiomyomata
1082524|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
1082525|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
1082526|NCT02654054|HMB|hmb
1082527|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
1082528|NCT02654015|neurosurgery|neurosurgery
1082529|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
1082530|NCT02653937|IBS|ibs
1082531|NCT02653937|MUPS|mups
1082532|NCT02653937|FSS|fss
1082533|NCT02653937|shigyakusan|shigyakusan
1082534|NCT02653937|Katsumi's points|katsumi's points
1082535|NCT02653937|Nakatani's N line|nakatani's n line
1082536|NCT02653924|Suture|suture
1082537|NCT02653924|bacteria|bacteria
1082538|NCT02653911|Acupuncture|acupuncture
1082539|NCT02653898|Malaria|malaria
1082540|NCT02653898|Antimalarials|antimalarials
1082541|NCT02653898|Malaria Elimination|malaria elimination
1082542|NCT02653898|Mass Drug Administration|mass drug administration
1082543|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
1082544|NCT02653898|Mobile population|mobile population
1082545|NCT02653898|Drug resistance|drug resistance
1082546|NCT02653898|Focused screening and treatment|focused screening and treatment
1082547|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
1082548|NCT02653898|Mass screening and treatment|mass screening and treatment
1082549|NCT02653898|Primaquine|primaquine
1082550|NCT02653898|Malaria transmission|malaria transmission
1082551|NCT02653898|Permethrin insecticide|permethrin insecticide
1082552|NCT02653898|Thai-Cambodian border|thai-cambodian border
1082553|NCT02653898|Cambodia|cambodia
1082554|NCT02653898|AFRIMS|afrims
1082555|NCT02653885|cardiac surgery|cardiac surgery
1082556|NCT02653885|open heart surgery|open heart surgery
1082557|NCT02653885|hemogram|hemogram
1082558|NCT02653872|Non-randomized|non-randomized
1082559|NCT02653872|Verapamil|verapamil
1082560|NCT02653872|Itraconazole|itraconazole
1082561|NCT02653872|Diltiazem|diltiazem
1082562|NCT02653872|Safety|safety
1082563|NCT02653872|Tolerability|tolerability
1082564|NCT02653872|Pharmacokinetics|pharmacokinetics
1082565|NCT02653859|CTC|ctc
1082566|NCT02653859|PCR|pcr
1082567|NCT02653833|Becker|becker
1082568|NCT02653833|Muscular Dystrophy|muscular dystrophy
1082569|NCT02653833|Skeletal Muscle|skeletal muscle
1082570|NCT02653833|blood flow|blood flow
1082571|NCT02653833|Ultrasound|ultrasound
1082572|NCT02653807|manual therapy|manual therapy
1082573|NCT02653807|osteopathy|osteopathy
1082574|NCT02653807|mobilization with movement|mobilization with movement
1082575|NCT02653807|ankle|ankle
1082576|NCT02653807|stiffness|stiffness
1082577|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
1082578|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
1082579|NCT02653768|Exercise|exercise
1082580|NCT02653755|Breast Cancer Radiation|breast cancer radiation
1082581|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
1082582|NCT02653755|Radiotherapy Omission|radiotherapy omission
1082583|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
1082584|NCT02653729|first episode|first episode
1082585|NCT02653716|New Orleans Intervention Model|new orleans intervention model
1082586|NCT02653716|Case Management|case management
1082587|NCT02653716|Maltreatment|maltreatment
1082588|NCT02653716|Child|child
1082589|NCT02653664|Chronic Pain|chronic pain
1082590|NCT02653664|Sleep|sleep
1082591|NCT02653651|Ketamine|ketamine
1082592|NCT02653651|Lidocaine|lidocaine
1082593|NCT02653651|Nephrectomy|nephrectomy
1082594|NCT02653651|Chronic pain|chronic pain
1082595|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
1082596|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
1082597|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
1082598|NCT02653638|Cognitive Function|cognitive function
1082599|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
1082600|NCT02653638|Aging|aging
1082601|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1082602|NCT02653612|surgery|surgery
1082603|NCT02653612|folate receptor|folate receptor
1082604|NCT02653586|resilience|resilience
1082605|NCT02653586|prevention program|prevention program
1082606|NCT02653586|body image|body image
1082607|NCT02653586|self esteem|self esteem
1082608|NCT02653573|young adult|young adult
1082609|NCT02653560|Potassium|potassium
1082610|NCT02653560|Magnesium|magnesium
1082611|NCT02653560|Citrate|citrate
1082612|NCT02653560|DASH|dash
1082613|NCT02653547|tinnitus|tinnitus
1082614|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
1082615|NCT02653547|rTMS|rtms
1082616|NCT02653547|multisite stimulation|multisite stimulation
1082617|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
1082618|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
1082619|NCT02653534|mortality|mortality
1082620|NCT02653521|Esophageal Cancer|esophageal cancer
1082621|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
1082622|NCT02653508|BMI: Body Mass Index|bmi: body mass index
1082623|NCT02653508|obesity|obesity
1082624|NCT02653508|adolescents|adolescents
1082625|NCT02653508|overweight|overweight
1082626|NCT02653508|CI:confidence interval|ci:confidence interval
1082627|NCT02653508|CDC: Center Disease Control|cdc: center disease control
1082628|NCT02653482|heart failure|heart failure
1082629|NCT02653482|dapagliflozin|dapagliflozin
1082630|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
1082631|NCT02653456|excimer laser|excimer laser
1082632|NCT02653456|percutaneous catheter|percutaneous catheter
1082633|NCT02653456|photoablation|photoablation
1082634|NCT02653456|chronic total occlusion|chronic total occlusion
1082635|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
1082636|NCT02653443|INTERCEPT|intercept
1082637|NCT02653443|Platelet|platelet
1082638|NCT02653443|Pathogen Inactivation|pathogen inactivation
1082639|NCT02653443|Platelets Components Stored|platelets components stored
1082640|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
1082641|NCT02653430|obesity|obesity
1082642|NCT02653430|BMI|bmi
1082643|NCT02653430|efficacy|efficacy
1082644|NCT02653430|bariatric surgery|bariatric surgery
1082645|NCT02653430|gut flora|gut flora
1082646|NCT02653430|fMRI|fmri
1082647|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
1082648|NCT02653391|FCED|fced
1082649|NCT02653391|Ocuvia™|ocuvia™
1082650|NCT02653391|MTP-131|mtp-131
1082651|NCT02653352|randomized controlled trials|randomized controlled trials
1082652|NCT02653352|soft drinks|soft drinks
1082653|NCT02653352|hypercholesterolemia|hypercholesterolemia
1082654|NCT02653352|serum cholesterol|serum cholesterol
1082655|NCT02653352|blood glucose|blood glucose
1082656|NCT02653352|overweight|overweight
1082657|NCT02653352|carbonated beverages|carbonated beverages
1082658|NCT02653339|traditional Chinese medicine|traditional chinese medicine
1082659|NCT02653339|Loratadine|loratadine
1082660|NCT02653339|questionnaire survey|questionnaire survey
1082661|NCT02653326|Tertiary Prevention|tertiary prevention
1082662|NCT02653326|Telerehabilitation|telerehabilitation
1082663|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
1082664|NCT02653274|MRI|mri
1082665|NCT02653274|blood glucose|blood glucose
1082666|NCT02653274|satiety|satiety
1082667|NCT02653274|breakfast|breakfast
1082668|NCT02653274|porridge|porridge
1082669|NCT02653274|grains|grains
1082670|NCT02653261|tranexamic acid|tranexamic acid
1082671|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
1082672|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
1082673|NCT02653261|Hemorrhage|hemorrhage
1082674|NCT02653261|Blood Transfusion|blood transfusion
1082675|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
1082676|NCT02653222|Computer Tomography guidance|computer tomography guidance
1082677|NCT02653222|Denervation|denervation
1082678|NCT02653222|Kidney Transplantation|kidney transplantation
1082679|NCT02653222|Dialysis|dialysis
1082680|NCT02653209|Type 2 diabetes|type 2 diabetes
1082681|NCT02653209|Stratification|stratification
1082682|NCT02653209|Biomarkers|biomarkers
1082683|NCT02653209|Pharmacogenetics|pharmacogenetics
1082684|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
1082685|NCT02653209|Thiazolidinediones|thiazolidinediones
1082686|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
1082687|NCT02653170|acute stroke|acute stroke
1082688|NCT02653170|care transitions|care transitions
1082689|NCT02653170|patient engagement|patient engagement
1082690|NCT02653170|patient education|patient education
1082691|NCT02653170|caregivers|caregivers
1082692|NCT02653170|social workers|social workers
1082693|NCT02653157|multidrug resistance|multidrug resistance
1082694|NCT02653157|burns|burns
1082695|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
1082696|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
1082697|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
1082698|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
1082699|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
1082700|NCT02653131|Short bowel syndrome|short bowel syndrome
1082701|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
1082702|NCT02653066|recruitment|recruitment
1082703|NCT02653040|Lighting|lighting
1082704|NCT02653040|Inpatients|inpatients
1082705|NCT02653040|Recovery|recovery
1082706|NCT02653040|Sleep|sleep
1082707|NCT02653027|Genetics|genetics
1082708|NCT02652988|tDCS|tdcs
1082709|NCT02652988|chronic pain|chronic pain
1082710|NCT02652988|fibromyalgia|fibromyalgia
1082711|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
1082712|NCT02652923|lymphosonography|lymphosonography
1082713|NCT02652923|breast cancer|breast cancer
1082714|NCT02652897|bleeding|bleeding
1082715|NCT02652897|clotting tests|clotting tests
1082716|NCT02652897|neurosurgery|neurosurgery
1082717|NCT02652897|clotting time|clotting time
1082718|NCT02652897|maximum clot firmness|maximum clot firmness
1082719|NCT02652897|kinetics|kinetics
1082720|NCT02652897|lysis|lysis
1082721|NCT02652897|primary hemostasis|primary hemostasis
1082722|NCT02652897|platelet dysfunction|platelet dysfunction
1082724|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
1082725|NCT02652884|steroids|steroids
1082726|NCT02652884|total thyroidectomy|total thyroidectomy
1082727|NCT02652871|Leukemia|leukemia
1082728|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
1082729|NCT02652871|AML|aml
1082730|NCT02652871|Relapsed or Refractory|relapsed or refractory
1082731|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
1082732|NCT02652871|LY2510924|ly2510924
1082733|NCT02652871|Idarubicin|idarubicin
1082734|NCT02652871|Idamycin|idamycin
1082735|NCT02652871|Cytarabine|cytarabine
1082736|NCT02652871|Ara-C|ara-c
1082737|NCT02652871|Cytosar|cytosar
1082738|NCT02652871|DepoCyt|depocyt
1082739|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1082740|NCT02652819|Chronic Kidney Disease|chronic kidney disease
1082741|NCT02652806|Chronic Kidney Disease|chronic kidney disease
1082742|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
1082743|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
1082744|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
1082745|NCT02652780|Eye Diseases|eye diseases
1082746|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
1082747|NCT02652780|Inborn Genetic Disease|inborn genetic disease
1082748|NCT02652780|Genetic Therapy|genetic therapy
1082749|NCT02652780|Intravitreal Injections|intravitreal injections
1082750|NCT02652780|Mitochondrial Disease|mitochondrial disease
1082751|NCT02652780|AAV2 Vectors|aav2 vectors
1082752|NCT02652780|Nervous System Diseases|nervous system diseases
1082753|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
1082754|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
1082755|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
1082756|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
1082757|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
1082758|NCT02652767|Eye Diseases|eye diseases
1082759|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
1082760|NCT02652767|Inborn Genetic Disease|inborn genetic disease
1082761|NCT02652767|Genetic Therapy|genetic therapy
1082762|NCT02652767|Intravitreal Injections|intravitreal injections
1082763|NCT02652767|Mitochondrial Disease|mitochondrial disease
1082764|NCT02652767|AAV2 Vectors|aav2 vectors
1082765|NCT02652767|Nervous System Diseases|nervous system diseases
1082766|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
1082767|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
1082768|NCT02652754|Granexin|granexin
1082769|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
1082770|NCT02652754|pharmacokinetic study|pharmacokinetic study
1082771|NCT02652754|FirstString Research|firststring research
1082772|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
1082773|NCT02652689|pulmonary embolism|pulmonary embolism
1082774|NCT02652689|pulmonary disease|pulmonary disease
1082775|NCT02652689|Lung Doppler signals|lung doppler signals
1082776|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
1082777|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
1082778|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
1082779|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
1082780|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
1082781|NCT02652663|colorectal cancer|colorectal cancer
1082782|NCT02652663|liver|liver
1082784|NCT02652663|contrast|contrast
1082785|NCT02652663|gadoxetic acid|gadoxetic acid
1082786|NCT02652650|Healthy|healthy
1082787|NCT02652650|JNJ-63623872|jnj-63623872
1082788|NCT02652650|Ethinylestradiol|ethinylestradiol
1082789|NCT02652650|Norethindrone|norethindrone
1082790|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
1082791|NCT02652611|Complications|complications
1082792|NCT02652611|SI Screw Stabilization|si screw stabilization
1082793|NCT02652585|Alcoholism|alcoholism
1082794|NCT02652585|alcohol self-administration|alcohol self-administration
1082795|NCT02652572|Granexin|granexin
1082796|NCT02652572|venous leg ulcer|venous leg ulcer
1082797|NCT02652572|pharmacokinetic study|pharmacokinetic study
1082798|NCT02652572|FirstString Research|firststring research
1082799|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1082800|NCT02652559|Non-invasive ventilation|non-invasive ventilation
1082801|NCT02652559|Home initiation|home initiation
1082802|NCT02652546|HIV/AIDS|hiv/aids
1082803|NCT02652546|Immune Activation|immune activation
1082804|NCT02652546|Anti-Inflammatory|anti-inflammatory
1082805|NCT02652546|TNF|tnf
1082806|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
1082807|NCT02652520|Kidney transplantation|kidney transplantation
1082808|NCT02652520|Organ preservation|organ preservation
1082809|NCT02652507|Sedation|sedation
1082810|NCT02652507|MRI|mri
1082811|NCT02652507|Dexmedetomidine|dexmedetomidine
1082812|NCT02652507|Ketamine|ketamine
1082813|NCT02652507|General anesthesia|general anesthesia
1082814|NCT02652507|MRI of Brain|mri of brain
1082815|NCT02652507|MRI of Brain/Spine|mri of brain/spine
1082816|NCT02652494|Psoriasis|psoriasis
1082817|NCT02652494|Observational|observational
1082820|NCT02652494|Non-Interventional|non-interventional
1082821|NCT02652494|The Netherlands|the netherlands
1082822|NCT02652455|cutaneous|cutaneous
1082823|NCT02652455|unresectable|unresectable
1082824|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
1082825|NCT02652442|dizziness|dizziness
1082826|NCT02652442|postural balance|postural balance
1082827|NCT02652442|rehabilitation|rehabilitation
1082828|NCT02652429|PAH|pah
1568424|NCT00505895|Fludarabine|fludarabine
1082829|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1082830|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
1082831|NCT02652429|iNO|ino
1082832|NCT02652403|Denture, Complete|denture, complete
1082833|NCT02652403|Mouth, Edentulous|mouth, edentulous
1082834|NCT02652351|Stem cell|stem cell
1082835|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
1082836|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
1082837|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
1082838|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
1082839|NCT02652338|dietary supplement|dietary supplement
1082840|NCT02652312|Dexmedetomidine|dexmedetomidine
1082841|NCT02652312|Desflurane|desflurane
1082842|NCT02652312|Bispectral Index BIS|bispectral index bis
1082843|NCT02652299|Fibrocytes|fibrocytes
1082844|NCT02652299|Synovial biopsy|synovial biopsy
1082845|NCT02652286|VATS|vats
1082846|NCT02652286|Energy sealing|energy sealing
1082847|NCT02652247|trauma|trauma
1082848|NCT02652247|ventilator|ventilator
1082849|NCT02652247|surgical ICU|surgical icu
1082850|NCT02652208|decision making|decision making
1082851|NCT02652208|decision aids|decision aids
1082852|NCT02652208|shared decision making|shared decision making
1082853|NCT02652208|stable angina|stable angina
1082854|NCT02652208|cardiology|cardiology
1082855|NCT02652195|Neural correlates|neural correlates
1082856|NCT02652195|oxytocin administration|oxytocin administration
1082857|NCT02652156|transversus abdominis plane|transversus abdominis plane
1082858|NCT02652156|postoperative|postoperative
1082859|NCT02652156|pain|pain
1082860|NCT02652143|in vivo culture|in vivo culture
1082861|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
1082862|NCT02652104|Advanced|advanced
1082863|NCT02652104|Deep brain stimulation|deep brain stimulation
1082864|NCT02652091|Adherence|adherence
1082865|NCT02652091|Persistence|persistence
1082866|NCT02652091|Patient satisfaction|patient satisfaction
1082867|NCT02652065|Psoriasis|psoriasis
1082868|NCT02652065|Microcirculation|microcirculation
1082869|NCT02652065|TRPV1|trpv1
1082870|NCT02652026|dental root planing and scaling|dental root planing and scaling
1082871|NCT02652026|periodontal disease|periodontal disease
1082872|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
1082873|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
1082874|NCT02651974|neoplasm|neoplasm
1082875|NCT02651974|colorectal|colorectal
1082876|NCT02651974|cancer|cancer
1082877|NCT02651974|uninsured|uninsured
1082878|NCT02651974|FIT|fit
1082879|NCT02651974|fecal immunochemical test|fecal immunochemical test
1082880|NCT02651961|Total hip prosthesis|total hip prosthesis
1082881|NCT02651961|Total knee prosthesis|total knee prosthesis
1082882|NCT02651961|Chronic infection|chronic infection
1082883|NCT02651961|One stage exchange|one stage exchange
1082884|NCT02651961|Two stage exchange|two stage exchange
1082885|NCT02651961|Cost-effectiveness|cost-effectiveness
1082886|NCT02651935|Respiration, Artificial|respiration, artificial
1082887|NCT02651935|weaning|weaning
1082888|NCT02651935|critical care|critical care
1082889|NCT02651922|Nervous restlessness|nervous restlessness
1082890|NCT02651922|Pascoflair|pascoflair
1082891|NCT02651922|Passiflora incarnata|passiflora incarnata
1082892|NCT02651922|Benzodiazepine|benzodiazepine
1082893|NCT02651883|Cervical cancer screening|cervical cancer screening
1082894|NCT02651883|HPV testing|hpv testing
1082895|NCT02651883|Self-collection|self-collection
1082896|NCT02651870|Hypertension|hypertension
1082897|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
1082898|NCT02651844|Antiprogestins|antiprogestins
1082899|NCT02651844|Mifepristone|mifepristone
1082900|NCT02651844|Neoadjuvant|neoadjuvant
1082901|NCT02651844|Breast cancer|breast cancer
1082902|NCT02651831|ICMs|icms
1082903|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
1082904|NCT02651818|Goiter|goiter
1082905|NCT02651818|Thyroid disease|thyroid disease
1082906|NCT02651818|Struma|struma
1082907|NCT02651805|Palliative Care|palliative care
1082908|NCT02651805|Respiratory Secretion|respiratory secretion
1082909|NCT02651792|ketamine|ketamine
1082910|NCT02651792|propofol|propofol
1082911|NCT02651792|pethidine|pethidine
1082912|NCT02651792|ERCP|ercp
1082913|NCT02651792|endoscopist|endoscopist
1082914|NCT02651740|Rifaximin|rifaximin
1082915|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
1082916|NCT02651740|Gut microbiota|gut microbiota
1082917|NCT02651610|PPHM 1401|pphm 1401
1082918|NCT02651610|bavituximab|bavituximab
1082919|NCT02651610|Peregrine|peregrine
1082920|NCT02651610|Breast Cancer|breast cancer
1082921|NCT02651610|HER-2 Negative|her-2 negative
1082922|NCT02651610|HER2 Negative|her2 negative
1082923|NCT02651597|Oatmeal|oatmeal
1082924|NCT02651597|Beta glucan|beta glucan
1082925|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
1082926|NCT02651597|Blood Glucose|blood glucose
1082927|NCT02651571|Knee|knee
1082928|NCT02651571|Replacement|replacement
1082929|NCT02651571|Prosthesis|prosthesis
1082930|NCT02651571|Mobile-bearing|mobile-bearing
1127240|NCT02394223|PSA|psa
1082931|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
1082932|NCT02651532|inflammation|inflammation
1082933|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
1082934|NCT02651519|bispectral index|bispectral index
1082935|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
1082936|NCT02651519|Stellate-ganglion block|stellate-ganglion block
1082937|NCT02651506|Lung cancer biopsy|lung cancer biopsy
1082938|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
1082939|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
1082940|NCT02651480|Diet, Vegetarian|diet, vegetarian
1082941|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
1082942|NCT02651480|Quality of Life|quality of life
1082943|NCT02651480|Glycemic Index|glycemic index
1082944|NCT02651454|metabolic syndrome|metabolic syndrome
1082945|NCT02651454|Daesiho-tang|daesiho-tang
1082946|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
1082947|NCT02651454|Korean medicine|korean medicine
1082948|NCT02651441|D-CIK|d-cik
1082949|NCT02651441|lung cancer|lung cancer
1082950|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
1082951|NCT02651428|Catheter-Related Infections|catheter-related infections
1082952|NCT02651428|Central Venous Catheter|central venous catheter
1082953|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
1082954|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
1082955|NCT02651415|mCRC|mcrc
1082956|NCT02651415|Regorafenib|regorafenib
1082957|NCT02651415|Stivarga|stivarga
1082958|NCT02651415|Perindopril|perindopril
1082959|NCT02651415|Perindopril erbumine|perindopril erbumine
1082960|NCT02651415|Coversyl|coversyl
1082961|NCT02651402|Anxiety Disorders|anxiety disorders
1082962|NCT02651402|Internalizing|internalizing
1082963|NCT02651402|Anxiety|anxiety
1082964|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
1082965|NCT02651389|Vision test|vision test
1082966|NCT02651376|Immunodeficiency|immunodeficiency
1082967|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
1082968|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
1082969|NCT02651350|Recurrence|recurrence
1082970|NCT02651350|Methylprednisolone|methylprednisolone
1082971|NCT02651285|G-CSF|g-csf
1082972|NCT02651285|BLASTOCYST|blastocyst
1082973|NCT02651285|IVF|ivf
1082974|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
1082975|NCT02651272|Sickle Cell Disease|sickle cell disease
1082976|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1082977|NCT02651272|Macitentan|macitentan
1082978|NCT02651194|Treatment-naïve|treatment-naïve
1082979|NCT02651194|HCV Gentoype 2|hcv gentoype 2
1082980|NCT02651194|Non-cirrhotic|non-cirrhotic
1082981|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
1082982|NCT02651194|HCV Gentoype 5|hcv gentoype 5
1082983|NCT02651194|HCV Gentoype 4|hcv gentoype 4
1082984|NCT02651194|HCV Gentoype 6|hcv gentoype 6
1083082|NCT02650570|Cachexia|cachexia
1082985|NCT02651194|HCV Gentoype 1|hcv gentoype 1
1082986|NCT02651194|Compensated cirrhotic|compensated cirrhotic
1082987|NCT02651194|Treatment-experienced|treatment-experienced
1082988|NCT02651194|HCV Gentoype 3|hcv gentoype 3
1082989|NCT02651168|Diabetic Macular Edema|diabetic macular edema
1082990|NCT02651168|Ocular Cytokines|ocular cytokines
1082991|NCT02651168|aflibercept|aflibercept
1082992|NCT02651168|ranibizumab|ranibizumab
1082993|NCT02651155|Drug therapy|drug therapy
1082994|NCT02651129|noise|noise
1082995|NCT02651129|obstetric|obstetric
1082996|NCT02651129|operating rooms|operating rooms
1082997|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
1082998|NCT02651090|contraindication for CECT|contraindication for cect
1082999|NCT02651090|contraindication for CEMRI|contraindication for cemri
1083000|NCT02651090|liver pathology|liver pathology
1083001|NCT02651090|renal failure|renal failure
1083002|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
1083003|NCT02651090|sonazoid|sonazoid
1083004|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
1083005|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
1083006|NCT02651064|fruits and vegetables|fruits and vegetables
1083007|NCT02651064|price incentive|price incentive
1083008|NCT02651051|Postprandial glycemia|postprandial glycemia
1083009|NCT02651051|Metabolic health measures|metabolic health measures
1083010|NCT02650973|Bioequivalence|bioequivalence
1083011|NCT02650947|Sucralose|sucralose
1083012|NCT02650947|Insulin Secretion|insulin secretion
1083013|NCT02650947|Insulin Sensitivity|insulin sensitivity
1083014|NCT02650947|Incretin|incretin
1083015|NCT02650947|Gut Microbiota|gut microbiota
1083016|NCT02650947|Food and Eating Behaviour|food and eating behaviour
1083017|NCT02650947|Healthy Volunteers|healthy volunteers
1083018|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
1083019|NCT02650908|Lesion|lesion
1083020|NCT02650908|Meniscus|meniscus
1083021|NCT02650908|Avivement|avivement
1083022|NCT02650908|Suturing area|suturing area
1083023|NCT02650882|Respiratory muscles|respiratory muscles
1083024|NCT02650882|athletic performance|athletic performance
1083025|NCT02650882|handball|handball
1083026|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
1083027|NCT02650869|probiotics|probiotics
1083028|NCT02650869|very low birth weight|very low birth weight
1083029|NCT02650856|Blood loss|blood loss
1083030|NCT02650856|Tranexamic acid|tranexamic acid
1083031|NCT02650856|Platelet rich plasma|platelet rich plasma
1083032|NCT02650856|Total knee arthroplasty|total knee arthroplasty
1083033|NCT02650843|Parkinsonism|parkinsonism
1083034|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
1083035|NCT02650843|SPECT|spect
1083036|NCT02650830|type 2 diabetes|type 2 diabetes
1083037|NCT02650830|prediabetes|prediabetes
1083038|NCT02650830|bile acids profile|bile acids profile
1083039|NCT02650830|GLP-1|glp-1
1083040|NCT02650830|FGF-19|fgf-19
1083041|NCT02650804|Cancer|cancer
1083042|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
1083043|NCT02650778|Breast Cancer|breast cancer
1083044|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
1083045|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
1083046|NCT02650765|Brain injury|brain injury
1083047|NCT02650765|Head injury|head injury
1083048|NCT02650765|Computed tomography|computed tomography
1083049|NCT02650765|Emergency department|emergency department
1083050|NCT02650752|Lapatinib|lapatinib
1083051|NCT02650752|Capecitabine|capecitabine
1083052|NCT02650752|HER2|her2
1083053|NCT02650752|15-278|15-278
1083054|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1083055|NCT02650687|Elderly, geriatric|elderly, geriatric
1083056|NCT02650687|Anesthesia|anesthesia
1083057|NCT02650687|Anesthetic depth|anesthetic depth
1083058|NCT02650687|Bispectral index monitor|bispectral index monitor
1083059|NCT02650687|Function|function
1083060|NCT02650687|Recovery after surgery|recovery after surgery
1083061|NCT02650687|Surgery|surgery
1083062|NCT02650674|glycemic & insulin response|glycemic & insulin response
1083063|NCT02650674|SDS|sds
1083064|NCT02650674|cereal product|cereal product
1083065|NCT02650674|Nutrition|nutrition
1083066|NCT02650674|Carbohydrate|carbohydrate
1083067|NCT02650674|Absorption|absorption
1083068|NCT02650674|Intestine|intestine
1083069|NCT02650661|Cancer survivors|cancer survivors
1083070|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
1083071|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
1083072|NCT02650648|rIL-2|ril-2
1083073|NCT02650648|15-272|15-272
1083074|NCT02650622|Metabolism|metabolism
1083075|NCT02650622|Genetics|genetics
1083076|NCT02650622|Metabolomics|metabolomics
1083077|NCT02650622|Genomics|genomics
1083078|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
1083079|NCT02650609|surgical treatment|surgical treatment
1083080|NCT02650609|corticosteroids|corticosteroids
1083083|NCT02650557|coronary slow flow|coronary slow flow
1083084|NCT02650557|P-wave dispersion|p-wave dispersion
1083085|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1083086|NCT02650544|Depression|depression
1083087|NCT02650544|mirtazapine|mirtazapine
1083088|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
1083089|NCT02650531|Follow up studies|follow up studies
1083090|NCT02650531|Risk factors|risk factors
1083091|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
1083092|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
1083093|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
1083094|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
1083095|NCT02650492|Laser Coagulation|laser coagulation
1083096|NCT02650492|Laser Therapy|laser therapy
1083097|NCT02650453|Stent|stent
1083098|NCT02650453|Angioplasty|angioplasty
1083099|NCT02650453|Endophlebectomy|endophlebectomy
1083100|NCT02650440|robotics|robotics
1083101|NCT02650440|locomotion|locomotion
1083102|NCT02650440|gait|gait
1083103|NCT02650440|walking|walking
1083104|NCT02650440|rehabilitation|rehabilitation
1083105|NCT02650414|Biological: CART 22|biological: cart 22
1083106|NCT02650401|TRK|trk
1083107|NCT02650401|Tyrosine kinase|tyrosine kinase
1083108|NCT02650401|NTRK|ntrk
1083109|NCT02650401|NTRK1|ntrk1
1083110|NCT02650401|NTRK2|ntrk2
1083111|NCT02650401|NTRK3|ntrk3
1083112|NCT02650401|ROS1|ros1
1083113|NCT02650401|ALK|alk
1083114|NCT02650401|Pediatric|pediatric
1083115|NCT02650401|Relapsed|relapsed
1083116|NCT02650401|Refractory|refractory
1083117|NCT02650401|Solid Tumor|solid tumor
1083118|NCT02650401|Metastatic Cancer|metastatic cancer
1083119|NCT02650401|Gene rearrangement|gene rearrangement
1083120|NCT02650401|Neuroblastoma|neuroblastoma
1083121|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
1083122|NCT02650401|Secretory breast cancer|secretory breast cancer
1083123|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
1568425|NCT00505895|Fludara|fludara
1127462|NCT02392754|ECG|ecg
1083124|NCT02650401|Pontine glioma|pontine glioma
1083125|NCT02650401|Brain tumors|brain tumors
1083126|NCT02650401|CNS tumors|cns tumors
1083127|NCT02650401|Sarcoma|sarcoma
1083128|NCT02650401|Ewing sarcoma|ewing sarcoma
1083129|NCT02650401|Glial tumors|glial tumors
1083130|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
1083131|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
1083132|NCT02650401|Medulloblastoma|medulloblastoma
1083133|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
1083134|NCT02650362|spinal cord stimulation|spinal cord stimulation
1083135|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
1083136|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
1083137|NCT02650349|spinal cord stimulation|spinal cord stimulation
1083138|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
1083139|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
1083140|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
1083141|NCT02650297|Breast cancer|breast cancer
1083142|NCT02650297|Body image|body image
1083143|NCT02650271|adjuvant|adjuvant
1083144|NCT02650271|entecavir|entecavir
1083145|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
1083146|NCT02650271|hepatic resection|hepatic resection
1083147|NCT02650245|breath|breath
1083148|NCT02650245|gastroenterology|gastroenterology
1083149|NCT02650245|ammonia|ammonia
1083150|NCT02650245|blood|blood
1083151|NCT02650245|protein|protein
1083152|NCT02650245|cirrhosis|cirrhosis
1083153|NCT02650245|encephalopathy|encephalopathy
1083154|NCT02650232|Volunteers|volunteers
1083155|NCT02650206|diabetes|diabetes
1083156|NCT02650206|macrophage|macrophage
1083157|NCT02650206|inflammation|inflammation
1083158|NCT02650206|adipose tissue|adipose tissue
1083159|NCT02650206|weight loss|weight loss
1083160|NCT02650206|liraglutide|liraglutide
1083161|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
1083162|NCT02650180|Rehabilitation|rehabilitation
1083163|NCT02650154|sedation|sedation
1083164|NCT02650154|children|children
1083165|NCT02650154|infants|infants
1083166|NCT02650154|ketamine|ketamine
1083167|NCT02650154|neurotoxicity|neurotoxicity
1083168|NCT02650128|Coronary Artery Disease|coronary artery disease
1083169|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
1083170|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
1083171|NCT02650089|Resistance Exercise|resistance exercise
1083172|NCT02650089|Postexercise Hypotension|postexercise hypotension
1083173|NCT02650089|Sympathovagal balance|sympathovagal balance
1083174|NCT02650089|Professor|professor
1083175|NCT02650011|Chronic liver disease|chronic liver disease
1083176|NCT02650011|Liver cirrhosis|liver cirrhosis
1083177|NCT02649998|Fursemide|fursemide
1083178|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
1083179|NCT02649998|Heart Decompensation|heart decompensation
1083180|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
1083181|NCT02649998|Clinical Efficacy|clinical efficacy
1083182|NCT02649972|Cobimetinib|cobimetinib
1083196|NCT02649855|Vaccine|vaccine
1083197|NCT02649855|Immunotherapy|immunotherapy
1083198|NCT02649855|Immune Response|immune response
1083199|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
1083200|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
1083201|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
1083202|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
1083203|NCT02649816|Pit and fissure sealants|pit and fissure sealants
1083204|NCT02649816|Dental Caries|dental caries
1083205|NCT02649816|Prevention|prevention
1083206|NCT02649816|Dental undergraduate students|dental undergraduate students
1083207|NCT02649816|patient's caries risk|patient's caries risk
1083208|NCT02649803|pediatric|pediatric
1083209|NCT02649803|asthma control|asthma control
1083210|NCT02649803|community|community
1083211|NCT02649790|Multiple Myeloma|multiple myeloma
1083212|NCT02649790|Karyopharm|karyopharm
1083213|NCT02649790|KPT-8602|kpt-8602
1083214|NCT02649790|MM|mm
1083215|NCT02649790|Phase 1|phase 1
1083216|NCT02649790|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
1083217|NCT02649790|Myelodysplastic Syndrome|myelodysplastic syndrome
1083218|NCT02649790|MDS|mds
1083219|NCT02649790|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1083220|NCT02649790|mCRPC|mcrpc
1083221|NCT02649790|CRC|crc
1083222|NCT02649777|oxidative stress|oxidative stress
1083237|NCT02649751|Cystic Fibrosis|cystic fibrosis
1083238|NCT02649751|Roscovitine|roscovitine
1083239|NCT02649751|Seliciclib|seliciclib
1083240|NCT02649751|CYC202|cyc202
1083241|NCT02649738|keratoconus|keratoconus
1083242|NCT02649738|corneal tissue inlay|corneal tissue inlay
1083243|NCT02649699|Primary Brain Cancer|primary brain cancer
1083244|NCT02649673|lung carcinoma|lung carcinoma
1083245|NCT02649673|topotecan|topotecan
1083246|NCT02649673|Hycamtin|hycamtin
1083247|NCT02649673|ovarian neoplasms|ovarian neoplasms
1083248|NCT02649673|LCL161|lcl161
1083249|NCT02649673|IAP inhibitors|iap inhibitors
1083250|NCT02649660|Fabry Disease|fabry disease
1083251|NCT02649660|Platelets|platelets
1083252|NCT02649660|Lipidomics|lipidomics
1083253|NCT02649660|Sphingolipids|sphingolipids
1083254|NCT02649660|α-Galactosidase A|α-galactosidase a
1083255|NCT02649660|Globotriaosylceramide|globotriaosylceramide
1083257|NCT02649660|GL-3|gl-3
1083258|NCT02649660|CD77|cd77
1083259|NCT02649660|Alpha-galactosidase|alpha-galactosidase
1083260|NCT02649660|Platelet activation|platelet activation
1083261|NCT02649660|Lysosomal storage disease|lysosomal storage disease
1083262|NCT02649660|LysoGb3|lysogb3
1083263|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
1083264|NCT02649660|Platelet function|platelet function
1083265|NCT02649660|CD62P|cd62p
1083266|NCT02649660|P-selectin|p-selectin
1083267|NCT02649647|Rectal cancer|rectal cancer
1083268|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
1083269|NCT02649647|Chemoradiotherapy|chemoradiotherapy
1083270|NCT02649647|Resection margin|resection margin
1083271|NCT02649647|Bowel function|bowel function
1083272|NCT02649647|Anastomosis|anastomosis
1083273|NCT02649634|Motivational Interviewing|motivational interviewing
1083274|NCT02649634|Obesity|obesity
1083275|NCT02649634|Weight Loss|weight loss
1083276|NCT02649634|Behavioral Medicine|behavioral medicine
1083277|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
1083278|NCT02649595|Homeless|homeless
1083279|NCT02649595|Homelessness|homelessness
1083280|NCT02649595|Respite care|respite care
1083281|NCT02649595|EQ-5D|eq-5d
1083282|NCT02649595|Quality of life questionnaire|quality of life questionnaire
1083283|NCT02649595|Economic evaluation|economic evaluation
1083284|NCT02649595|Cost-utility analysis|cost-utility analysis
1083285|NCT02649582|Dendritic cells|dendritic cells
1083286|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
1083287|NCT02649582|Adjuvant therapy|adjuvant therapy
1083288|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
1083289|NCT02649556|Conventional cigarette|conventional cigarette
1083290|NCT02649556|Exposure response|exposure response
1083291|NCT02649556|Smoking|smoking
1083292|NCT02649556|Tobacco Heating System|tobacco heating system
1083293|NCT02649543|Surgical Wound Infection|surgical wound infection
1083294|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
1083295|NCT02649543|Wound Closure Techniques|wound closure techniques
1083296|NCT02649543|Laparotomy.|laparotomy.
1083297|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
1083298|NCT02649517|decompensated heart failure|decompensated heart failure
1083299|NCT02649517|ischemic heart disease|ischemic heart disease
1083300|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
1083301|NCT02649491|Radiotherapy|radiotherapy
1083302|NCT02649491|Chemotherapy|chemotherapy
1083303|NCT02649491|Metabonomics|metabonomics
1083304|NCT02649491|Electronic Sensing|electronic sensing
1083305|NCT02649491|GI Toxicity|gi toxicity
1083306|NCT02649452|Whole body Vibration|whole body vibration
1083307|NCT02649439|Vaccine|vaccine
1083308|NCT02649439|PSA|psa
1083309|NCT02649439|Surveillance|surveillance
1083310|NCT02649439|Immunotherapy|immunotherapy
1083311|NCT02649426|denervation|denervation
1083312|NCT02649426|resistant hypertension|resistant hypertension
1083313|NCT02649426|essential hypertension|essential hypertension
1083314|NCT02649361|Anlotinib|anlotinib
1083315|NCT02649335|Non selective beta blockers|non selective beta blockers
1083316|NCT02649335|Ascites|ascites
1083317|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
1083318|NCT02649309|Postconditioning|postconditioning
1083319|NCT02649309|Angioplasty|angioplasty
1083320|NCT02649270|Tolerability|tolerability
1083321|NCT02649270|Safety|safety
1083322|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
1083323|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
1083324|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
1083325|NCT02649257|IOL rotation|iol rotation
1083326|NCT02649257|capsular tension ring|capsular tension ring
1083327|NCT02649257|IOL rotational stability|iol rotational stability
1083328|NCT02649218|QGE031|qge031
1083329|NCT02649218|chronic|chronic
1083330|NCT02649218|spontaneous|spontaneous
1083331|NCT02649218|Urticaria|urticaria
1083332|NCT02649218|CSU|csu
1083333|NCT02649218|adults|adults
1083334|NCT02649218|Safety|safety
1083335|NCT02649192|Children|children
1083336|NCT02649192|Vitamin Supplements|vitamin supplements
1083337|NCT02649192|Influenza virus vaccine|influenza virus vaccine
1083338|NCT02649166|Essential tremor|essential tremor
1083339|NCT02649166|Kinetic tremor|kinetic tremor
1083340|NCT02649166|Intention tremor|intention tremor
1083341|NCT02649140|24-hour urine|24-hour urine
1083342|NCT02649140|Calcium oxalate|calcium oxalate
1083343|NCT02649140|Vinegar|vinegar
1083346|NCT02649088|microcirculation|microcirculation
1083347|NCT02649088|tissue oxygenation|tissue oxygenation
1083349|NCT02649075|IBD|ibd
1083350|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
1083351|NCT02649075|Crohn's|crohn's
1083352|NCT02649075|Crohns|crohns
1083353|NCT02649075|SBI|sbi
1083354|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
1083355|NCT02649075|EnteraGam|enteragam
1083356|NCT02649010|Type 1 Diabetes|type 1 diabetes
1083357|NCT02649010|Type 2 Diabetes|type 2 diabetes
1083358|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
1083359|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
1083360|NCT02648997|Atypical Meningioma|atypical meningioma
1083361|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
1083362|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
1083363|NCT02648971|knee|knee
1083364|NCT02648971|arthroscopy|arthroscopy
1083365|NCT02648971|portal|portal
1083366|NCT02648971|meniscus|meniscus
1083367|NCT02648971|cartilage injury|cartilage injury
1083368|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1083369|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
1083370|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
1083371|NCT02648932|haplo-cord search|haplo-cord search
1083372|NCT02648932|matched unrelated donor search|matched unrelated donor search
1083373|NCT02648893|iron|iron
1083374|NCT02648893|zinc|zinc
1083375|NCT02648893|vitamin A|vitamin a
1083376|NCT02648893|biofortified|biofortified
1083377|NCT02648893|efficacy|efficacy
1083378|NCT02648893|India|india
1083379|NCT02648893|infant|infant
1083380|NCT02648893|trial|trial
1083381|NCT02648880|Exercise|exercise
1083382|NCT02648880|Physical Activity|physical activity
1083383|NCT02648841|gastric cancer|gastric cancer
1083384|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
1083385|NCT02648828|Judgment|judgment
1083386|NCT02648828|risk assessment|risk assessment
1083387|NCT02648828|clinical deterioration|clinical deterioration
1083388|NCT02648828|cardiac arrest|cardiac arrest
1083389|NCT02648828|Rothman Index|rothman index
1083390|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
1083391|NCT02648815|Sepsis|sepsis
1083392|NCT02648815|Infection|infection
1083393|NCT02648815|Drainage|drainage
1083394|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
1083395|NCT02648802|Cavity shave margin|cavity shave margin
1083396|NCT02648802|Proportion of positive margins|proportion of positive margins
1083397|NCT02648789|Primary oral cancer|primary oral cancer
1083398|NCT02648789|DNA methylation|dna methylation
1083399|NCT02648789|Recurrence oral cancer|recurrence oral cancer
1083400|NCT02648776|hypnotic agents|hypnotic agents
1083401|NCT02648776|sleep disorders|sleep disorders
1083402|NCT02648776|elderly|elderly
1083403|NCT02648750|self-management|self-management
1083404|NCT02648750|rehabilitation|rehabilitation
1083405|NCT02648737|Parkinson's disease|parkinson's disease
1083406|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
1083407|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
1083408|NCT02648737|social phobia|social phobia
1083409|NCT02648737|cerebral connectivity|cerebral connectivity
1083410|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
1083411|NCT02648724|MET Gene Amplification|met gene amplification
1083412|NCT02648724|MET Amplification|met amplification
1083413|NCT02648724|Wild-type|wild-type
1083414|NCT02648724|NSCLC|nsclc
1083415|NCT02648724|METex14|metex14
1083416|NCT02648724|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
1083417|NCT02648711|solid tumors|solid tumors
1083418|NCT02648698|chronic endometritis|chronic endometritis
1083419|NCT02648698|CD138|cd138
1083420|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
1083421|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
1083422|NCT02648685|overall glycaemia|overall glycaemia
1083423|NCT02648633|Brain Cancer|brain cancer
1083424|NCT02648633|Immunotherapy|immunotherapy
1083425|NCT02648633|Nivolumab|nivolumab
1083426|NCT02648633|Radiosurgery|radiosurgery
1083427|NCT02648633|Gamma Knife|gamma knife
1083428|NCT02648620|Paclitaxel|paclitaxel
1083429|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1083430|NCT02648620|PAD|pad
1083431|NCT02648620|Peripheral Artery Disease|peripheral artery disease
1083432|NCT02648620|Pharmacokinetics|pharmacokinetics
1083433|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
1083434|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
1083435|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
1083436|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
1083437|NCT02648607|Physiotherapy|physiotherapy
1083438|NCT02648607|Physical Therapy|physical therapy
1083439|NCT02648607|Orthoses|orthoses
1083440|NCT02648607|Orthosis|orthosis
1083441|NCT02648607|Orthotic Devices|orthotic devices
1083442|NCT02648594|lung|lung
1083443|NCT02648594|thoracoscopy|thoracoscopy
1083444|NCT02648594|hook wire localization|hook wire localization
1083445|NCT02648581|Behçet|behçet
1083446|NCT02648581|ulcers|ulcers
1083450|NCT02648568|Sleepwalking|sleepwalking
1083451|NCT02648568|sleep terrors|sleep terrors
1083452|NCT02648568|arousal disorders|arousal disorders
1083453|NCT02648568|F513 (CIM-10)|f513 (cim-10)
1083454|NCT02648568|F514 (CIM-10)|f514 (cim-10)
1083455|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
1083456|NCT02648529|rolandic epilepsy|rolandic epilepsy
1083457|NCT02648529|brain development|brain development
1083458|NCT02648529|DTI|dti
1083459|NCT02648529|functional MRI|functional mri
1083460|NCT02648529|structural MRI|structural mri
1083461|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
1083462|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
1083463|NCT02648516|Immune Reconstitution|immune reconstitution
1083464|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
1083465|NCT02648503|Sugammadex|sugammadex
1083466|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
1083467|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
1083468|NCT02648464|Hydroxychloroquine|hydroxychloroquine
1083469|NCT02648464|anti-inflammatory|anti-inflammatory
1083470|NCT02648464|Myocardial infarction|myocardial infarction
1083471|NCT02648464|cardiovascular diseases|cardiovascular diseases
1083472|NCT02648438|AZD7594|azd7594
1083473|NCT02648438|Bioavailability|bioavailability
1083474|NCT02648438|Healthy male subjects|healthy male subjects
1083475|NCT02648438|Safety|safety
1083476|NCT02648438|Tolerability|tolerability
1083477|NCT02648438|Pharmacokinetics|pharmacokinetics
1083478|NCT02648438|Monodose inhaler|monodose inhaler
1083479|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
1083480|NCT02648425|ASLAN001|aslan001
1083481|NCT02648399|thyroid carcinoma|thyroid carcinoma
1084173|NCT02643979|Sedation|sedation
1083482|NCT02648399|center lymph node dissection|center lymph node dissection
1083483|NCT02648360|exercise|exercise
1083484|NCT02648360|diet|diet
1083485|NCT02648360|patients, underserved|patients, underserved
1083486|NCT02648360|text messaging|text messaging
1083487|NCT02648347|vadadustat|vadadustat
1083488|NCT02648347|AKB-6548|akb-6548
1083489|NCT02648347|Chronic kidney disease|chronic kidney disease
1083490|NCT02648347|anemia|anemia
1083491|NCT02648347|CKD|ckd
1083492|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
1083493|NCT02648347|renal impairment|renal impairment
1083494|NCT02648347|erythropoietin|erythropoietin
1083495|NCT02648347|kidney|kidney
1083496|NCT02648347|renal|renal
1083497|NCT02648347|oral anemia treatment|oral anemia treatment
1083498|NCT02648347|hemoglobin|hemoglobin
1083499|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
1083500|NCT02648347|HIF|hif
1083501|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1083502|NCT02648347|HIF-PHI|hif-phi
1083503|NCT02648347|efficacy|efficacy
1083504|NCT02648347|safety|safety
1083505|NCT02648347|Phase 3|phase 3
1083506|NCT02648347|cardiovascular|cardiovascular
1083507|NCT02648347|NDD-CKD|ndd-ckd
1083508|NCT02648334|Drug-Coated Balloon|drug-coated balloon
1083509|NCT02648334|Superficial Femoral artery|superficial femoral artery
1083510|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
1083511|NCT02648321|Motivational Interviewing|motivational interviewing
1083512|NCT02648321|Exercise|exercise
1083513|NCT02648308|Education, Medical|education, medical
1083514|NCT02648282|vaccine|vaccine
1083515|NCT02648282|immunotherapy|immunotherapy
1083516|NCT02648282|antibody|antibody
1083517|NCT02648282|PD-1|pd-1
1083518|NCT02648282|radiation|radiation
1083519|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
1083520|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
1083521|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
1083522|NCT02648243|Qatar|qatar
1083523|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
1083524|NCT02648243|Pharmacist|pharmacist
1083525|NCT02648243|Medication burden|medication burden
1083526|NCT02648243|Mortality|mortality
1083527|NCT02648243|Readmission|readmission
1083528|NCT02648243|Adherence|adherence
1083529|NCT02648243|Impact|impact
1083530|NCT02648230|Ischemia|ischemia
1083531|NCT02648230|Fractional Flow Reserve|fractional flow reserve
1083532|NCT02648230|Stent|stent
1083533|NCT02648191|Obesity|obesity
1083534|NCT02648191|Bariatric Surgery|bariatric surgery
1083535|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
1083536|NCT02648191|Weight loss|weight loss
1083537|NCT02648191|Autonomic nervous system|autonomic nervous system
1083538|NCT02648113|Myocardial Infarction|myocardial infarction
1083539|NCT02648113|Anemia|anemia
1083540|NCT02648113|Blood Transfusion|blood transfusion
1083541|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
1083542|NCT02648100|Basal subtype|basal subtype
1083543|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
1083544|NCT02648100|Nanostring|nanostring
1083545|NCT02648074|asthma|asthma
1083546|NCT02648074|eosinophils|eosinophils
1083547|NCT02648074|airway smooth muscle|airway smooth muscle
1083548|NCT02648074|airway remodelling|airway remodelling
1083549|NCT02648074|integrins|integrins
1083550|NCT02648074|cytokines|cytokines
1083551|NCT02648061|Blood circulation|blood circulation
1083552|NCT02648061|Follow-up studies|follow-up studies
1083553|NCT02648061|Biological markers|biological markers
1083554|NCT02648061|Hemodynamics|hemodynamics
1083555|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1083556|NCT02648048|Vismodegib|vismodegib
1083557|NCT02648048|Pirfenidone|pirfenidone
1083558|NCT02648022|Care Integration|care integration
1083559|NCT02648022|Hepatitis C|hepatitis c
1083560|NCT02648022|Substance Use Disorder|substance use disorder
1083561|NCT02648022|PTSD|ptsd
1083562|NCT02647970|Energy metabolism|energy metabolism
1083563|NCT02647957|acute ischemic stroke|acute ischemic stroke
1083564|NCT02647957|quality|quality
1083565|NCT02647905|type 1 diabetes|type 1 diabetes
1083566|NCT02647905|type 2 diabetes|type 2 diabetes
1083567|NCT02647905|CGM|cgm
1083568|NCT02647905|implantable|implantable
1083569|NCT02647905|accuracy|accuracy
1083570|NCT02647905|longevity|longevity
1083571|NCT02647866|4083-002|4083-002
1083572|NCT02647866|Intestinal Diseases|intestinal diseases
1083573|NCT02647866|Ulcerative Colitis|ulcerative colitis
1083574|NCT02647866|UC|uc
1083575|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
1083576|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
1083577|NCT02647840|dysphonia|dysphonia
1083578|NCT02647840|voice therapy|voice therapy
1083579|NCT02647827|Acupuncture|acupuncture
1083580|NCT02647827|Metformin|metformin
1083581|NCT02647827|Glucose metabolism|glucose metabolism
1083582|NCT02647827|Hba1c|hba1c
1083583|NCT02647814|Parent activation|parent activation
1083584|NCT02647814|Text-messages|text-messages
1083585|NCT02647814|LEP|lep
1083586|NCT02647814|Latino populations|latino populations
1083587|NCT02647814|pediatrics|pediatrics
1083588|NCT02647801|Network approach|network approach
1083589|NCT02647801|mindfulness|mindfulness
1083590|NCT02647801|self-control|self-control
1083591|NCT02647801|ambulatory assessment|ambulatory assessment
1083592|NCT02647788|Pain, Postoperative|pain, postoperative
1083593|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
1083594|NCT02647723|Omega-3|omega-3
1083595|NCT02647723|Fatty acid|fatty acid
1083596|NCT02647723|docosahexaenoic|docosahexaenoic
1083597|NCT02647723|Pregnant|pregnant
1083598|NCT02647723|neurodevelopment|neurodevelopment
1083599|NCT02647723|stress|stress
1083600|NCT02647723|urban|urban
1083601|NCT02647723|african-american|african-american
1083602|NCT02647723|supplement|supplement
1083603|NCT02647723|nutrition|nutrition
1083604|NCT02647723|mental health|mental health
1083605|NCT02647710|HIV Prevention|hiv prevention
1083606|NCT02647710|Juvenile Justice|juvenile justice
1083607|NCT02647710|Sexual Health|sexual health
1083608|NCT02647710|Evidence Based Intervention|evidence based intervention
1083609|NCT02647697|UCB3491|ucb3491
1083610|NCT02647697|Phase 1|phase 1
1083611|NCT02647697|Pharmacokinetics|pharmacokinetics
1083612|NCT02647697|Radiprodil|radiprodil
1083613|NCT02647697|Healthy volunteers|healthy volunteers
1083614|NCT02647684|Cancer|cancer
1083615|NCT02647684|Parenting|parenting
1083616|NCT02647684|Self-directed Triple P|self-directed triple p
1083617|NCT02647671|Colon polyp|colon polyp
1083618|NCT02647671|Colorectal cancer|colorectal cancer
1083619|NCT02647671|Chemoprevention|chemoprevention
1083620|NCT02647671|Natural product|natural product
1083621|NCT02647658|acute low back pain|acute low back pain
1083622|NCT02647658|primary care|primary care
1083623|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
1083624|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
1083625|NCT02647658|comparative effectiveness|comparative effectiveness
1083626|NCT02647658|secondary prevention|secondary prevention
1083627|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
1083628|NCT02647632|failure to DAA|failure to daa
1083629|NCT02647619|Primary Dd disase|primary dd disase
1083630|NCT02647619|MCP joint|mcp joint
1083631|NCT02647580|Growth|growth
1083632|NCT02647580|Children|children
1083633|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
1083634|NCT02647580|Gut Microbiota|gut microbiota
1083635|NCT02647567|Cognitive|cognitive
1083636|NCT02647567|Aerobic Exercise|aerobic exercise
1083637|NCT02647567|Performance|performance
1083638|NCT02647554|sepsis|sepsis
1083639|NCT02647554|septic shock|septic shock
1083640|NCT02647554|Ulinastatin|ulinastatin
1083641|NCT02647554|adult|adult
1083642|NCT02647554|China|china
1083643|NCT02647541|Children|children
1083644|NCT02647541|Congenital heart disease|congenital heart disease
1083645|NCT02647541|Nutritional status|nutritional status
1083646|NCT02647541|Bioelectrical impedance|bioelectrical impedance
1083647|NCT02647476|immunonutrition|immunonutrition
1083648|NCT02647476|gastric cancer|gastric cancer
1083649|NCT02647476|enteral nutrition|enteral nutrition
1083650|NCT02647463|Attachment|attachment
1083651|NCT02647463|Cortisol|cortisol
1083652|NCT02647463|Parent sensitivity|parent sensitivity
1083653|NCT02647411|Prevalence|prevalence
1083655|NCT02647398|Cancer survivors|cancer survivors
1083656|NCT02647398|training|training
1083657|NCT02647398|exercise|exercise
1083658|NCT02647398|cancer-related fatigue|cancer-related fatigue
1083659|NCT02647385|serratus anterior plane block|serratus anterior plane block
1083660|NCT02647385|pectoral nerve block|pectoral nerve block
1083661|NCT02647385|breast surgery|breast surgery
1083662|NCT02647385|cancer|cancer
1083663|NCT02647385|analgesia|analgesia
1083664|NCT02647385|inflammatory cytokines|inflammatory cytokines
1083665|NCT02647372|parkinson|parkinson
1083666|NCT02647372|deep brain stimulation|deep brain stimulation
1083667|NCT02647372|globus pallidus|globus pallidus
1083668|NCT02647372|subthalamic nucleus|subthalamic nucleus
1083669|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
1083670|NCT02647320|interventional|interventional
1083671|NCT02647320|double blind|double blind
1083672|NCT02647320|phase 2|phase 2
1083673|NCT02647281|Single dose|single dose
1083674|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
1083675|NCT02647281|Pharmacokinetics|pharmacokinetics
1083676|NCT02647281|Safety|safety
1083677|NCT02647281|GSK3389404|gsk3389404
1083678|NCT02647281|Tolerability|tolerability
1083679|NCT02647268|Uterine contraction|uterine contraction
1083680|NCT02647268|Oxytocin|oxytocin
1083681|NCT02647268|Magnesium sulphate|magnesium sulphate
1083682|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
1083683|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
1083684|NCT02647255|randomized controlled trial|randomized controlled trial
1083685|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
1083686|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
1083687|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
1083688|NCT02647216|anxiety|anxiety
1083689|NCT02647216|depression|depression
1083690|NCT02647203|Fluoride toothpaste|fluoride toothpaste
1083691|NCT02647203|Root caries|root caries
1083692|NCT02647203|Randomized clinical trial|randomized clinical trial
1083693|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
1083694|NCT02647190|15-107|15-107
1083695|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
1083696|NCT02647164|Circulating tumor cells|circulating tumor cells
1083697|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
1083698|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
1083699|NCT02647112|Bladder cancer|bladder cancer
1083700|NCT02647112|Urine|urine
1083701|NCT02647112|Methylation|methylation
1083702|NCT02647099|Aspirin|aspirin
1083703|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
1083704|NCT02647086|Eczema|eczema
1083705|NCT02647073|Mobile Monitoring|mobile monitoring
1083706|NCT02647073|Post-Opioid Consumption|post-opioid consumption
1083707|NCT02647073|Vital Signs|vital signs
1083708|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1083709|NCT02647060|right ventricle function|right ventricle function
1083710|NCT02647060|cardio output|cardio output
1083711|NCT02647060|pulmonary hypertension|pulmonary hypertension
1083712|NCT02647060|quality of life|quality of life
1083713|NCT02647047|spinal analgesia|spinal analgesia
1083714|NCT02647047|epidural analgesia|epidural analgesia
1083715|NCT02647047|laparotomic liver resection|laparotomic liver resection
1083716|NCT02647047|ERAS|eras
1083717|NCT02647047|length of stay|length of stay
1083718|NCT02647021|physical therapy|physical therapy
1083719|NCT02647021|cancer rehabilitation|cancer rehabilitation
1083720|NCT02647021|exercise|exercise
1083721|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
1083722|NCT02646982|Alzheimer's disease|alzheimer's disease
1083723|NCT02646982|Vascular function|vascular function
1083724|NCT02646982|Neuroinflammation|neuroinflammation
1083725|NCT02646956|Sweet Taste|sweet taste
1083726|NCT02646956|Psychophysics|psychophysics
1083727|NCT02646956|Genetics|genetics
1083728|NCT02646956|Diet|diet
1083729|NCT02646956|Age|age
1083730|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
1083731|NCT02646943|Cohort|cohort
1083732|NCT02646943|Biomarkers|biomarkers
1083733|NCT02646943|Cardiomyopathy|cardiomyopathy
1083734|NCT02646930|chronic endometritis|chronic endometritis
1083735|NCT02646930|invitro fertilization|invitro fertilization
1083736|NCT02646930|spontaneous abortion|spontaneous abortion
1083737|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
1083738|NCT02646878|Type 1 Diabetes|type 1 diabetes
1083739|NCT02646878|Type 2 Diabetes|type 2 diabetes
1083740|NCT02646878|Harmony Sensor|harmony sensor
1083741|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
1083742|NCT02646878|CGM|cgm
1083743|NCT02646865|social phobia|social phobia
1083744|NCT02646865|compassion|compassion
1083745|NCT02646865|shame|shame
1083746|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1083747|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1083748|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1083749|NCT02646839|KIR-Favorable|kir-favorable
1083750|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
1083939|NCT02645409|Radical nephrectomy|radical nephrectomy
1083751|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1083752|NCT02646800|Micafungin|micafungin
1083753|NCT02646800|Candidiasis|candidiasis
1083754|NCT02646800|Aspergillosis|aspergillosis
1083755|NCT02646800|Antifungal|antifungal
1083756|NCT02646774|Aspergillosis|aspergillosis
1083757|NCT02646774|Antifungal|antifungal
1083758|NCT02646774|Micafungin|micafungin
1083759|NCT02646748|Advanced|advanced
1083760|NCT02646670|diabetic macular edema|diabetic macular edema
1083761|NCT02646670|aflibercept|aflibercept
1083762|NCT02646670|ranibizumab|ranibizumab
1083763|NCT02646605|Depression|depression
1083764|NCT02646605|AIDS|aids
1083765|NCT02646605|HIV|hiv
1083766|NCT02646579|Orthopedics|orthopedics
1083767|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
1083768|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
1083769|NCT02646488|cholesterol|cholesterol
1083770|NCT02646488|smoking|smoking
1083771|NCT02646488|aspirin|aspirin
1083772|NCT02646488|chronic care model|chronic care model
1083773|NCT02646475|renin-angiotensin system|renin-angiotensin system
1083774|NCT02646475|angiotensin|angiotensin
1083775|NCT02646475|insulin resistance|insulin resistance
1083776|NCT02646475|blood pressure|blood pressure
1083777|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
1083778|NCT02646449|Major Depressive Disorder|major depressive disorder
1083779|NCT02646449|Alcohol Use Disorder|alcohol use disorder
1083780|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
1083781|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
1083782|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
1083783|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
1083784|NCT02646423|Decision tool|decision tool
1083785|NCT02646423|Shared decision making|shared decision making
1083786|NCT02646410|malaria|malaria
1083787|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
1083788|NCT02646410|immunity|immunity
1083789|NCT02646410|resistance|resistance
1083790|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1083791|NCT02646410|amodiaquine|amodiaquine
1083792|NCT02646410|delivery method|delivery method
1083793|NCT02646397|glomerular filtration rate|glomerular filtration rate
1083794|NCT02646397|hypertension|hypertension
1083795|NCT02646345|Checklist|checklist
1083796|NCT02646345|Mortality|mortality
1083797|NCT02646345|Latin America|latin america
1083798|NCT02646345|Surgery|surgery
1083799|NCT02646345|Morbidity|morbidity
1083800|NCT02646332|Helicobacter pylori|helicobacter pylori
1083801|NCT02646332|Eradication rate|eradication rate
1083802|NCT02646306|shoulder|shoulder
1083803|NCT02646306|proprioception|proprioception
1083804|NCT02646306|movement|movement
1083805|NCT02646306|reaching|reaching
1083806|NCT02646280|Low back pain|low back pain
1083807|NCT02646280|interoceptive awareness|interoceptive awareness
1083808|NCT02646280|motor imagery|motor imagery
1083809|NCT02646280|massage|massage
1083810|NCT02646267|Atrial fibrillation|atrial fibrillation
1083811|NCT02646267|Dabigatran|dabigatran
1083812|NCT02646267|Warfarin|warfarin
1083813|NCT02646267|Anticoagulation|anticoagulation
1083814|NCT02646267|Elderly|elderly
1083815|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
1083816|NCT02646241|stomach neoplasm|stomach neoplasm
1083817|NCT02646241|biopsy|biopsy
1083818|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
1083819|NCT02646150|distal perfusion|distal perfusion
1083820|NCT02646150|Critical Limb Ischemia|critical limb ischemia
1083821|NCT02646150|endovascular revascularization|endovascular revascularization
1083822|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
1083823|NCT02646111|"Triple Therapy"|"triple therapy"
1083824|NCT02646111|"PI Failure"|"pi failure"
1083825|NCT02646111|"Genotype 1"|"genotype 1"
1083826|NCT02646098|NHL|nhl
1083827|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
1083828|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1083829|NCT02646072|diabetes mellitus|diabetes mellitus
1083830|NCT02646072|aqueous humor|aqueous humor
1083831|NCT02646072|inflammatory cytokines|inflammatory cytokines
1083832|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
1083833|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
1083956|NCT02645344|Unilateral neglect|unilateral neglect
1083834|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1083835|NCT02646046|Emergency Medical Services|emergency medical services
1083836|NCT02646046|Cell phones|cell phones
1083837|NCT02646046|Simulation Training|simulation training
1083838|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
1083839|NCT02646020|pruritus|pruritus
1083840|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
1083841|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
1083842|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1083843|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
1083940|NCT02645396|Cytomegalovirus|cytomegalovirus
1084232|NCT02643524|Adult|adult
1083844|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
1083845|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
1083846|NCT02645994|Target Controlled Infusion|target controlled infusion
1083847|NCT02645981|Donafeinb|donafeinb
1083848|NCT02645981|Sorafenib|sorafenib
1083849|NCT02645981|Phase 3|phase 3
1083850|NCT02645981|Overall Survival|overall survival
1083851|NCT02645968|Pneumology|pneumology
1083852|NCT02645968|Registry|registry
1083853|NCT02645968|EXCITING|exciting
1083854|NCT02645968|Interstitial lung disease|interstitial lung disease
1083855|NCT02645968|ILD|ild
1083856|NCT02645942|Carnitine|carnitine
1083857|NCT02645942|placebo|placebo
1083858|NCT02645942|risk factors|risk factors
1083859|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
1083860|NCT02645916|Korean medicine|korean medicine
1083861|NCT02645916|DSGOST|dsgost
1083862|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
1083863|NCT02645903|living liver transplantation|living liver transplantation
1083864|NCT02645903|postoperative analgesia|postoperative analgesia
1083865|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1083866|NCT02645890|Healthy Male Volunteer|healthy male volunteer
1083867|NCT02645890|Tamsulosin|tamsulosin
1083868|NCT02645890|Tadalafil|tadalafil
1083869|NCT02645877|Pre-hospital Care|pre-hospital care
1083870|NCT02645877|Diseases Spectrum|diseases spectrum
1083871|NCT02645877|Call Demands|call demands
1083872|NCT02645877|Emergency Response Time|emergency response time
1083873|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1083874|NCT02645864|Apatinib|apatinib
1083875|NCT02645864|Irinotecan|irinotecan
1083876|NCT02645851|Fluid Therapy|fluid therapy
1083877|NCT02645851|Plasma Substitutes|plasma substitutes
1083878|NCT02645851|Fluid Balance|fluid balance
1083879|NCT02645838|Motivational Interviewing|motivational interviewing
1083880|NCT02645838|Smoking Cessation|smoking cessation
1084174|NCT02643979|Bariatric|bariatric
1083881|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
1083882|NCT02645812|Fatigue|fatigue
1083883|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
1083884|NCT02645812|Primary care|primary care
1083885|NCT02645812|General Practitioners|general practitioners
1083886|NCT02645786|thyroid neoplasms|thyroid neoplasms
1083887|NCT02645786|heart|heart
1083888|NCT02645786|thyroxine|thyroxine
1083889|NCT02645786|thyrotoxicosis|thyrotoxicosis
1083890|NCT02645708|RIRS|rirs
1083891|NCT02645708|EPVL|epvl
1083892|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
1083893|NCT02645708|Randomized Controlled Trial|randomized controlled trial
1083894|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
1083895|NCT02645695|Chest Physiotherapy|chest physiotherapy
1083896|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
1083897|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
1083898|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
1083899|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
1083900|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
1083901|NCT02645656|Curcumin|curcumin
1083902|NCT02645643|medical students|medical students
1083903|NCT02645643|professionalism|professionalism
1083904|NCT02645643|medical education|medical education
1083905|NCT02645643|study emotion|study emotion
1083906|NCT02645630|Cervical spine|cervical spine
1083907|NCT02645630|Spinal manipulation|spinal manipulation
1083908|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
1083909|NCT02645591|Prostate cancer|prostate cancer
1083910|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
1083911|NCT02645591|dHACM|dhacm
1083912|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
1083913|NCT02645591|RARP|rarp
1083914|NCT02645591|AmnioFix®|amniofix®
1083915|NCT02645591|Sexual function score|sexual function score
1083916|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
1083917|NCT02645591|Questionnaire|questionnaire
1083918|NCT02645591|Survey|survey
1083919|NCT02645578|Coma|coma
1083920|NCT02645578|traumatic brain injury|traumatic brain injury
1083921|NCT02645578|median nerve stimulation|median nerve stimulation
1083922|NCT02645552|Traumatic brain injury|traumatic brain injury
1083923|NCT02645539|Heart failure|heart failure
1083924|NCT02645539|Bridge-to-transplant|bridge-to-transplant
1083925|NCT02645539|circulatory support|circulatory support
1083926|NCT02645539|VAD|vad
1083927|NCT02645539|IABP|iabp
1083928|NCT02645513|mHealth|mhealth
1083929|NCT02645513|text message|text message
1083930|NCT02645513|case management|case management
1083931|NCT02645500|Physical Activity|physical activity
1083932|NCT02645500|Family well-being|family well-being
1083933|NCT02645448|Resistance Exercise|resistance exercise
1083934|NCT02645448|Diabetes Mellitus|diabetes mellitus
1083935|NCT02645448|Heart Rate Variability|heart rate variability
1083936|NCT02645409|Fluorescence|fluorescence
1083937|NCT02645409|Imaging|imaging
1083938|NCT02645409|Partial nephrectomy|partial nephrectomy
1083941|NCT02645383|Pattern scan laser|pattern scan laser
1083942|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1083943|NCT02645383|Pain|pain
1083944|NCT02645370|Migraine|migraine
1083945|NCT02645370|Danzhen|danzhen
1083946|NCT02645370|Topiramate|topiramate
1083947|NCT02645370|Headache diary APP|headache diary app
1083948|NCT02645370|preventive treatment|preventive treatment
1083949|NCT02645357|Oncology Patients|oncology patients
1083950|NCT02645357|evidence-based|evidence-based
1083951|NCT02645357|computerized|computerized
1083952|NCT02645357|decision|decision
1083953|NCT02645357|support system|support system
1083954|NCT02645357|linked|linked
1083955|NCT02645357|electronic health records|electronic health records
1083957|NCT02645344|Right hemiplegia|right hemiplegia
1083958|NCT02645318|Circulating Tumor DNA|circulating tumor dna
1083959|NCT02645318|Lung cancer|lung cancer
1083960|NCT02645318|Targeted sequencing|targeted sequencing
1083961|NCT02645305|Safety and Efficacy|safety and efficacy
1083962|NCT02645305|Adipose stem cells|adipose stem cells
1083963|NCT02645305|Stem Cell therapy|stem cell therapy
1083964|NCT02645279|newborn|newborn
1083965|NCT02645279|MRI|mri
1083966|NCT02645279|oral 30% glucose|oral 30% glucose
1083967|NCT02645253|Safety|safety
1083968|NCT02645253|Pharmacokinetics|pharmacokinetics
1083969|NCT02645253|Pharmacodynamics|pharmacodynamics
1083970|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
1083971|NCT02645253|Healthy male subjects|healthy male subjects
1083972|NCT02645201|probiotic|probiotic
1083973|NCT02645188|Electromyography|electromyography
1083974|NCT02645188|Exercise|exercise
1083975|NCT02645175|Paclitaxel|paclitaxel
1083976|NCT02645175|docetaxel|docetaxel
1083977|NCT02645175|vinorelbine|vinorelbine
1083978|NCT02645175|eribulin|eribulin
1083979|NCT02645162|Pakistan|pakistan
1085769|NCT02634931|TSC|tsc
1083980|NCT02645162|Early Child Development, Care and Education|early child development, care and education
1083981|NCT02645162|Youth Leaders|youth leaders
1083982|NCT02645149|Metastatic Melanoma|metastatic melanoma
1083983|NCT02645149|Molecular Testing|molecular testing
1083984|NCT02645149|Targeted Therapy|targeted therapy
1083985|NCT02645123|spinal mobilization|spinal mobilization
1083986|NCT02645123|manual therapy|manual therapy
1083987|NCT02645123|gait analysis|gait analysis
1083988|NCT02645123|low back pain|low back pain
1083989|NCT02645123|chronic|chronic
1083990|NCT02645097|Adult|adult
1083991|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
1083992|NCT02645097|saphenous|saphenous
1083993|NCT02645071|physical activity|physical activity
1083994|NCT02645071|family well being,|family well being,
1083995|NCT02645071|health|health
1083996|NCT02645058|Ureterorenoscopy|ureterorenoscopy
1083997|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
1083998|NCT02645045|Dry eye|dry eye
1083999|NCT02645045|Lipiview|lipiview
1084000|NCT02645045|Tear Lipid Layer|tear lipid layer
1084001|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
1084002|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
1084003|NCT02645032|Vi-DT|vi-dt
1084004|NCT02645032|Safety|safety
1084005|NCT02645032|Immunogenicuty|immunogenicuty
1084006|NCT02645006|falls|falls
1084007|NCT02645006|elderly|elderly
1084008|NCT02645006|Exercise,Physical|exercise,physical
1084009|NCT02645006|vitamin d|vitamin d
1084010|NCT02645006|home hazards|home hazards
1084011|NCT02645006|mediterranean diet|mediterranean diet
1084012|NCT02645006|body mass index|body mass index
1084013|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
1084014|NCT02645006|vitamin D intake|vitamin d intake
1084015|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
1084016|NCT02644980|Target Controlled Infusion|target controlled infusion
1084017|NCT02644967|ILLUMINATE- 204|illuminate- 204
1084018|NCT02644954|psoriasis|psoriasis
1084019|NCT02644954|Metformin|metformin
1084020|NCT02644928|Chronic kidney disease|chronic kidney disease
1084021|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
1084022|NCT02644928|Caloric restriction|caloric restriction
1084023|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
1084024|NCT02644915|Edaravone|edaravone
1084025|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
1084026|NCT02644902|maternal depression|maternal depression
1084027|NCT02644902|postconflict|postconflict
1084028|NCT02644902|THP|thp
1084029|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
1084030|NCT02644889|NSCLC|nsclc
1084031|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
1084032|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
1084033|NCT02644876|High risk patients|high risk patients
1084034|NCT02644876|Postoperative period|postoperative period
1084035|NCT02644876|Postoperative complications|postoperative complications
1084036|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
1084037|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1084038|NCT02644824|Cardiac Index|cardiac index
1084039|NCT02644824|Hemodynamics|hemodynamics
1084040|NCT02644824|Pediatrics|pediatrics
1084041|NCT02644811|Miniscrew|miniscrew
1084042|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
1084043|NCT02644811|mini-implants|mini-implants
1084044|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
1084045|NCT02644798|ARDS|ards
1084046|NCT02644798|Gene polymorphism|gene polymorphism
1084047|NCT02644785|cardiac by-pass|cardiac by-pass
1084048|NCT02644785|protamine|protamine
1084049|NCT02644785|tryptase|tryptase
1084050|NCT02644785|hypotension|hypotension
1084051|NCT02644785|anaphylaxis|anaphylaxis
1084052|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
1084053|NCT02644772|Clinical problems in COPD|clinical problems in copd
1084054|NCT02644759|Stem Cells|stem cells
1084055|NCT02644759|Transplantation|transplantation
1084056|NCT02644759|Immunomodulation|immunomodulation
1084057|NCT02644759|CD34|cd34
1084058|NCT02644759|CD133|cd133
1084059|NCT02644759|ClinicMACS|clinicmacs
1084060|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
1084061|NCT02644746|acupuncture|acupuncture
1084062|NCT02644746|randomized controlled trial|randomized controlled trial
1084063|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
1084064|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
1084065|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
1084066|NCT02644655|safety|safety
1084067|NCT02644655|prognosis|prognosis
1084068|NCT02644616|tolvaptan|tolvaptan
1084069|NCT02644616|safety and efficacy|safety and efficacy
1084070|NCT02644616|left heart valves replacement|left heart valves replacement
1084071|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
1084072|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
1084073|NCT02644590|Melatonin|melatonin
1086262|NCT02632383|Transition|transition
1084074|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
1084075|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
1084076|NCT02644577|Metformin|metformin
1084077|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
1084078|NCT02644577|bipolar disorder|bipolar disorder
1084079|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
1084080|NCT02644564|Rotator cuff tear|rotator cuff tear
1084081|NCT02644564|Ultrasonography|ultrasonography
1084082|NCT02644538|HBsAg clearance|hbsag clearance
1084083|NCT02644525|Cameroon|cameroon
1084084|NCT02644525|Filaricidal|filaricidal
1084085|NCT02644525|Randomized|randomized
1084086|NCT02644525|Ivermectin|ivermectin
1084087|NCT02644525|Worm|worm
1084088|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
1084089|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
1084090|NCT02644434|Randomized Clinical Trial|randomized clinical trial
1084091|NCT02644421|Neuropathic Pain|neuropathic pain
1084092|NCT02644421|Sciatica|sciatica
1084093|NCT02644408|Chemoradiotherapy|chemoradiotherapy
1084094|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
1084095|NCT02644408|Megestrol|megestrol
1084096|NCT02644382|breast cancer|breast cancer
1084097|NCT02644382|decision making|decision making
1084098|NCT02644382|surgery|surgery
1084099|NCT02644382|qualitative|qualitative
1084100|NCT02644317|Motor development delay|motor development delay
1084101|NCT02644317|balance|balance
1084102|NCT02644317|flatfoot|flatfoot
1084103|NCT02644317|shoe insert|shoe insert
1084104|NCT02644291|medulloblastoma|medulloblastoma
1084105|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
1084106|NCT02644291|high grade glioma|high grade glioma
1084107|NCT02644291|glioblastoma|glioblastoma
1084108|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
1084109|NCT02644278|VX15-984-001|vx15-984-001
1084110|NCT02644278|VX-984|vx-984
1084111|NCT02644278|M9831|m9831
1084112|NCT02644278|Advanced Solid Tumor|advanced solid tumor
1084113|NCT02644278|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1084114|NCT02644265|Acute acquired brain injury|acute acquired brain injury
1084115|NCT02644265|Disorders of consciousness|disorders of consciousness
1084116|NCT02644265|Traumatic brain injury|traumatic brain injury
1084117|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
1084118|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
1084119|NCT02644265|Stroke|stroke
1084120|NCT02644265|Vegetative state|vegetative state
1084121|NCT02644265|Minimal conscious state|minimal conscious state
1084122|NCT02644265|Locked-in syndrome|locked-in syndrome
1084123|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
1084124|NCT02644265|Electroencephalography|electroencephalography
1084125|NCT02644174|Obesity|obesity
1084126|NCT02644174|Lung function test|lung function test
1084127|NCT02644174|Bariatric surgery|bariatric surgery
1084128|NCT02644161|stroke|stroke
1084129|NCT02644161|depression|depression
1084130|NCT02644161|stroke sequelae|stroke sequelae
1084131|NCT02644161|acupuncture|acupuncture
1084132|NCT02644161|DCEAS|dceas
1084134|NCT02644161|LAS|las
1084135|NCT02644135|Healthy volunteer|healthy volunteer
1084136|NCT02644122|advanced cancer|advanced cancer
1084137|NCT02644122|metastatic cancer|metastatic cancer
1084138|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1084139|NCT02644122|SCCHN|scchn
1084140|NCT02644122|gene mutation|gene mutation
1084141|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
1084142|NCT02644122|PIK3CG|pik3cg
1084143|NCT02644122|AKT and mTOR|akt and mtor
1084144|NCT02644122|PIK3CA gene|pik3ca gene
1084145|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
1084146|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
1084147|NCT02644096|Rehabilitation|rehabilitation
1084148|NCT02644096|RCT|rct
1084149|NCT02644096|User Involvement|user involvement
1084150|NCT02644096|Self-Rated Health|self-rated health
1084151|NCT02644070|Alveolar bone loss|alveolar bone loss
1084152|NCT02644070|Alveoloplasty|alveoloplasty
1084153|NCT02644070|Bone remodeling|bone remodeling
1084154|NCT02644070|Xenograft|xenograft
1084155|NCT02644070|Tooth socket|tooth socket
1084156|NCT02644070|Dental implant|dental implant
1084157|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
1084158|NCT02644044|methotrexate|methotrexate
1084159|NCT02644031|Instrumentation|instrumentation
1084160|NCT02644031|Post-operative pain|post-operative pain
1084161|NCT02644031|Root canal preparation|root canal preparation
1084162|NCT02644018|Ingavirin|ingavirin
1084163|NCT02644018|Common Cold|common cold
1084164|NCT02644018|Influenza|influenza
1084165|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
1084166|NCT02644018|pediatric clinical trial|pediatric clinical trial
1084167|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
1084168|NCT02643979|Ketamine|ketamine
1084169|NCT02643979|Propofol|propofol
1084170|NCT02643979|Ketofol|ketofol
1084171|NCT02643979|Obese|obese
1084172|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1084175|NCT02643966|whole breast ultrasound|whole breast ultrasound
1084176|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
1084177|NCT02643966|breast density|breast density
1084178|NCT02643966|breast cancer screening|breast cancer screening
1084179|NCT02643953|Maternal Health|maternal health
1084180|NCT02643953|Maternal Mortality|maternal mortality
1084181|NCT02643953|Global Health|global health
1084182|NCT02643953|RCT|rct
1084183|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1084184|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1084185|NCT02643940|Cardiac MRI|cardiac mri
1084186|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
1084187|NCT02643875|myopia control|myopia control
1084188|NCT02643875|orthokeratology|orthokeratology
1084189|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
1084190|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
1084191|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
1084192|NCT02643810|exercise training|exercise training
1084193|NCT02643797|diabetes|diabetes
1084194|NCT02643797|medical assistant|medical assistant
1084195|NCT02643797|health coach|health coach
1084196|NCT02643797|glycemic control|glycemic control
1084197|NCT02643797|pragmatic trial|pragmatic trial
1084198|NCT02643784|acute ischemic stroke|acute ischemic stroke
1084199|NCT02643771|Dental Scaling|dental scaling
1084200|NCT02643771|Blood Glucose|blood glucose
1084201|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1084202|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
1084203|NCT02643745|acute kidney injury|acute kidney injury
1084204|NCT02643745|cardiac surgery|cardiac surgery
1084205|NCT02643732|Activity|activity
1084206|NCT02643719|migraine|migraine
1084207|NCT02643719|topiramate|topiramate
1084208|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
1084209|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
1084210|NCT02643706|Gene polymorphism|gene polymorphism
1084211|NCT02643693|Conventional cigarette|conventional cigarette
1084212|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
1084213|NCT02643693|e-cigarette|e-cigarette
1084214|NCT02643693|VUSE|vuse
1084215|NCT02643693|Combustible cigarette|combustible cigarette
1084216|NCT02643680|Biocellulose|biocellulose
1084217|NCT02643680|Silk sericin|silk sericin
1084218|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
1084219|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
1084220|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
1084221|NCT02643654|interleukin-1alpha|interleukin-1alpha
1084222|NCT02643641|Grass pollen allergy|grass pollen allergy
1084223|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
1084224|NCT02643641|allergy vaccine|allergy vaccine
1084225|NCT02643641|dose regimen|dose regimen
1084226|NCT02643615|Visual Evoked Potentials|visual evoked potentials
1084227|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
1084228|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
1084229|NCT02643589|antithymocyte globulin|antithymocyte globulin
1084230|NCT02643563|Brachial Plexus Block|brachial plexus block
1084231|NCT02643563|Anesthetics, Local|anesthetics, local
1084234|NCT02643524|controlled ankle movement|controlled ankle movement
1084235|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
1084236|NCT02643498|15-109|15-109
1084237|NCT02643472|neonate|neonate
1084238|NCT02643472|newborn|newborn
1084239|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
1084240|NCT02643472|NICU|nicu
1084241|NCT02643472|NICU discharge|nicu discharge
1084242|NCT02643472|parent navigator|parent navigator
1084243|NCT02643472|peer to peer|peer to peer
1084244|NCT02643472|peer coaching|peer coaching
1084245|NCT02643459|Triage|triage
1084246|NCT02643459|Risk stratification|risk stratification
1084247|NCT02643459|Acute care|acute care
1084248|NCT02643459|suPAR|supar
1084249|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
1084250|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
1084251|NCT02643446|Immunity|immunity
1084252|NCT02643446|Seroconversion|seroconversion
1084253|NCT02643433|Immunogenicity|immunogenicity
1084254|NCT02643433|Coadministration|coadministration
1084255|NCT02643433|Measles|measles
1084256|NCT02643433|Rubella|rubella
1084257|NCT02643433|Japanese encephalitis|japanese encephalitis
1084258|NCT02643433|Vaccine|vaccine
1084259|NCT02643420|Neutropenia|neutropenia
1084260|NCT02643420|Breast Cancer|breast cancer
1084261|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
1084262|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
1084263|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
1084264|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
1084265|NCT02643407|nedaplatin|nedaplatin
1084266|NCT02643407|cisplatin|cisplatin
1084267|NCT02643407|docetaxel|docetaxel
1084268|NCT02643394|Acetaminophen|acetaminophen
1084269|NCT02643394|Postoperative pain|postoperative pain
1084270|NCT02643394|Sinus Surgery|sinus surgery
1084271|NCT02643381|etomidate|etomidate
1084272|NCT02643381|ketamine|ketamine
1084273|NCT02643381|endotracheal intubation|endotracheal intubation
1084274|NCT02643381|anesthesia induction medications|anesthesia induction medications
1084275|NCT02643368|Polio|polio
1084276|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
1084277|NCT02643368|oral polio vaccine|oral polio vaccine
1084278|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
1084279|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
1084280|NCT02643355|Opiate Withdrawal|opiate withdrawal
1084281|NCT02643355|Emergency Department|emergency department
1084282|NCT02643342|myopia control|myopia control
1084283|NCT02643342|orthokeratology|orthokeratology
1084284|NCT02643303|Durvalumab|durvalumab
1084285|NCT02643303|MEDI4736|medi4736
1084286|NCT02643303|Tremelimumab|tremelimumab
1084287|NCT02643303|PolyICLC|polyiclc
1084288|NCT02643303|Hiltonol|hiltonol
1084289|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
1084290|NCT02643303|Metastatic Melanoma|metastatic melanoma
1084291|NCT02643303|In Situ|in situ
1084292|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
1084293|NCT02643303|PD-L1 Antibody|pd-l1 antibody
1084294|NCT02643303|TLR3 Agonist|tlr3 agonist
1084295|NCT02643290|Adult Scoliosis|adult scoliosis
1084296|NCT02643290|Pain Management|pain management
1084297|NCT02643290|Orthosis|orthosis
1084298|NCT02643264|insula|insula
1084299|NCT02643264|alcohol addiction|alcohol addiction
1084300|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
1084301|NCT02643251|Diabetes Mellitus|diabetes mellitus
1084302|NCT02643251|Pain|pain
1084303|NCT02643251|Foot Pain|foot pain
1084304|NCT02643251|Neuropathy|neuropathy
1084305|NCT02643160|Trunk Training|trunk training
1084306|NCT02643160|Motor Function|motor function
1084307|NCT02643147|Heart Failure|heart failure
1084308|NCT02643147|Renal Failure|renal failure
1084309|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
1084310|NCT02643147|Loop diuretics|loop diuretics
1084311|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
1084312|NCT02643134|ESWL|eswl
1084313|NCT02643134|EPVL|epvl
1568426|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
1084314|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
1084315|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
1084316|NCT02643108|Lateral episiotomy|lateral episiotomy
1084317|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
1084318|NCT02643108|Vacuum extraction|vacuum extraction
1084319|NCT02643108|Anal incontinence|anal incontinence
1084321|NCT02643069|Frailty tools|frailty tools
1084322|NCT02643069|Clinical settings|clinical settings
1084323|NCT02643069|Disability|disability
1084324|NCT02643069|Quality of life|quality of life
1084325|NCT02643069|Functional Autonomy|functional autonomy
1084326|NCT02643043|Next Generation Sequencing|next generation sequencing
1084327|NCT02643043|Genomic Analysis|genomic analysis
1084328|NCT02643017|cognitive function|cognitive function
1084329|NCT02643017|desflurane|desflurane
1084330|NCT02643017|dexmedetomidine|dexmedetomidine
1084331|NCT02642978|minimally invasive surgery|minimally invasive surgery
1084332|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
1084333|NCT02642978|robotic surgery|robotic surgery
1084334|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
1084335|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
1084336|NCT02642926|menorrhagia|menorrhagia
1084337|NCT02642926|higham PBAC score|higham pbac score
1084338|NCT02642926|endometrial ablation|endometrial ablation
1084339|NCT02642926|bipolar energy|bipolar energy
1084340|NCT02642926|monopolar energy|monopolar energy
1084341|NCT02642913|Enzalutamide|enzalutamide
1084342|NCT02642913|Sorafenib|sorafenib
1084343|NCT02642913|15-279|15-279
1084344|NCT02642900|Complete denture|complete denture
1084345|NCT02642900|Candida spp|candida spp
1084346|NCT02642900|Photodynamic therapy|photodynamic therapy
1084347|NCT02642887|gingival recession|gingival recession
1084348|NCT02642887|tunnel technique|tunnel technique
1084349|NCT02642887|Miller Class I and II|miller class i and ii
1084350|NCT02642835|mesh|mesh
1084351|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
1084352|NCT02642822|Cytomegalovirus|cytomegalovirus
1084353|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
1084354|NCT02642796|Lumbosacral plexus|lumbosacral plexus
1084355|NCT02642796|surgical wound|surgical wound
1084356|NCT02642796|postoperative analgesia|postoperative analgesia
1084357|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
1084358|NCT02642783|laxatives|laxatives
1084359|NCT02642783|sensory evaluation|sensory evaluation
1084360|NCT02642783|acceptability|acceptability
1084361|NCT02642783|colonoscopy|colonoscopy
1084362|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
1084363|NCT02642757|alcohol drinking|alcohol drinking
1084364|NCT02642757|hazardous alcohol use|hazardous alcohol use
1086762|NCT02629809|Valtrex|valtrex
1084365|NCT02642757|risky alcohol consumption|risky alcohol consumption
1084366|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
1084367|NCT02642731|total knee arthroplasty|total knee arthroplasty
1084368|NCT02642731|Kidney function|kidney function
1084369|NCT02642731|Renal markers|renal markers
1084370|NCT02642718|preemptive analgesia|preemptive analgesia
1084371|NCT02642718|postoperative pain|postoperative pain
1084372|NCT02642718|NSAIDs|nsaids
1084373|NCT02642718|ketorolac|ketorolac
1084374|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
1084375|NCT02642692|ACL reconstruction|acl reconstruction
1084376|NCT02642692|Single bundle|single bundle
1084377|NCT02642692|Clinical results|clinical results
1084378|NCT02642692|Soccer players|soccer players
1084379|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
1084380|NCT02642666|Attention|attention
1084381|NCT02642666|Hyperactivity|hyperactivity
1084382|NCT02642666|Impulsivity|impulsivity
1084383|NCT02642666|Yoga|yoga
1084384|NCT02642666|Preschool|preschool
1084385|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
1084386|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
1084387|NCT02642653|Fragile X Syndrome|fragile x syndrome
1084388|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
1084389|NCT02642653|Intellectual Disability|intellectual disability
1084390|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
1084391|NCT02642653|FXS|fxs
1084392|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
1084393|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
1084394|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
1084395|NCT02642653|Chromosome Disorders|chromosome disorders
1084396|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
1084397|NCT02642562|Intravenous iron|intravenous iron
1084398|NCT02642562|PROBE design|probe design
1084399|NCT02642536|Veteran|veteran
1084400|NCT02642523|natriuretic peptide|natriuretic peptide
1084401|NCT02642523|insulin|insulin
1084402|NCT02642523|lipolysis|lipolysis
1084403|NCT02642523|hormones|hormones
1084404|NCT02642523|metabolism|metabolism
1084405|NCT02642497|postoperative analgesia|postoperative analgesia
1084406|NCT02642497|ketamine|ketamine
1084407|NCT02642497|total thyroidectomy|total thyroidectomy
1084408|NCT02642471|sentinel lymph node|sentinel lymph node
1084409|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
1084410|NCT02642471|cervical carcinoma|cervical carcinoma
1084411|NCT02642471|surgery|surgery
1084412|NCT02642471|radiotherapy|radiotherapy
1084413|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
1084414|NCT02642432|HCV Genotype 1|hcv genotype 1
1084415|NCT02642432|HCV Genotype 4|hcv genotype 4
1084416|NCT02642432|HCV Genotype 2|hcv genotype 2
1084417|NCT02642432|Cirrhotic|cirrhotic
1084418|NCT02642432|Interferon-Free|interferon-free
1084419|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
1084420|NCT02642432|HCV Genotype 5|hcv genotype 5
1084421|NCT02642432|Hepatitis C|hepatitis c
1084422|NCT02642432|HCV Genotype 6|hcv genotype 6
1084423|NCT02642393|SURE-PD3|sure-pd3
1084424|NCT02642393|Parkinson's disease|parkinson's disease
1084425|NCT02642393|PD|pd
1084426|NCT02642393|Inosine|inosine
1084427|NCT02642393|Urate|urate
1084428|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
1084430|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
1084431|NCT02642328|VO2Max|vo2max
1084432|NCT02642328|Aerobic Exercise|aerobic exercise
1084433|NCT02642328|Physical Conditioning|physical conditioning
1084434|NCT02642302|VO2Max|vo2max
1084435|NCT02642302|Aerobic Exercise|aerobic exercise
1084436|NCT02642302|Physical Conditioning|physical conditioning
1084437|NCT02642289|Probiotics|probiotics
1084438|NCT02642276|exercise training|exercise training
1084439|NCT02642250|safety|safety
1084440|NCT02642250|efficacy|efficacy
1084441|NCT02642237|Fluenz|fluenz
1084442|NCT02642237|innate immune response|innate immune response
1084443|NCT02642237|endotoxin tolerance|endotoxin tolerance
1084444|NCT02642237|priming|priming
1084445|NCT02642224|Violence|violence
1084446|NCT02642224|firearm|firearm
1084447|NCT02642224|guns|guns
1084448|NCT02642224|homicide|homicide
1084449|NCT02642224|trauma|trauma
1084450|NCT02642224|injury|injury
1084451|NCT02642198|NiBP|nibp
1084452|NCT02642185|microwave|microwave
1084453|NCT02642185|ablation|ablation
1084454|NCT02642185|resection|resection
1084455|NCT02642185|liver|liver
1084456|NCT02642185|colorectal|colorectal
1084457|NCT02642185|survival|survival
1084458|NCT02642185|metastasis|metastasis
1084459|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
1084460|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1084461|NCT02642107|elective neck irradiation|elective neck irradiation
1084462|NCT02642081|NSAIDs|nsaids
1084463|NCT02642081|Heart failure|heart failure
1084464|NCT02642081|Acute kidney injury|acute kidney injury
1084465|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
1084466|NCT02642068|Neuropsychology|neuropsychology
1084467|NCT02642068|Neurophysiology|neurophysiology
1084468|NCT02642068|Neuroimaging|neuroimaging
1084469|NCT02642068|Follow-up|follow-up
1084470|NCT02642055|ADHD|adhd
1084471|NCT02642055|Neurofeedback|neurofeedback
1084472|NCT02642055|Biofeedback|biofeedback
1084473|NCT02642055|Neuro+|neuro+
1084474|NCT02642055|Go/no-go|go/no-go
1084475|NCT02642055|Attention training|attention training
1084476|NCT02642029|time perception|time perception
1084477|NCT02642029|executive function|executive function
1084478|NCT02642029|psychosis|psychosis
1084479|NCT02642029|mood symptoms|mood symptoms
1084480|NCT02642016|KTN0158|ktn0158
1084481|NCT02642016|Advanced Cancer|advanced cancer
1084482|NCT02642016|Phase 1|phase 1
1084483|NCT02642016|Monoclonal Antibody|monoclonal antibody
1084484|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
1084485|NCT02641925|Metabolic syndrome|metabolic syndrome
1084486|NCT02641925|gastric cancer|gastric cancer
1084487|NCT02641925|omentectomy|omentectomy
1084488|NCT02641899|Adult|adult
1084489|NCT02641899|Male|male
1084490|NCT02641899|Female|female
1084491|NCT02641899|Volunteers|volunteers
1084492|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
1084493|NCT02641886|Cognitive Impairment|cognitive impairment
1084494|NCT02641886|Acute cerebral infraction|acute cerebral infraction
1084495|NCT02641886|prevention|prevention
1084496|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
1084497|NCT02641873|mCRC|mcrc
1084498|NCT02641847|triple negative breast cancer|triple negative breast cancer
1084499|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
1084500|NCT02641847|chemotherapy|chemotherapy
1084501|NCT02641847|high risk|high risk
1084502|NCT02641834|diet|diet
1084503|NCT02641834|vegetarian|vegetarian
1084504|NCT02641834|cardiovascular risk|cardiovascular risk
1084505|NCT02641795|cochlear implantation|cochlear implantation
1084506|NCT02641795|robotics|robotics
1084507|NCT02641795|image guidance|image guidance
1084508|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
1084509|NCT02641756|HIV reservoir|hiv reservoir
1129223|NCT02382991|Kenevo|kenevo
1084510|NCT02641756|phylogenetic analysis|phylogenetic analysis
1084511|NCT02641756|sequencing|sequencing
1084512|NCT02641730|Guselkumab|guselkumab
1084513|NCT02641730|CNTO 1959|cnto 1959
1084514|NCT02641730|Placebo|placebo
1084515|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
1084516|NCT02641717|patient-collected|patient-collected
1084517|NCT02641717|self-collected|self-collected
1084518|NCT02641717|vaginitis|vaginitis
1084519|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
1084520|NCT02641717|candidiasis|candidiasis
1084521|NCT02641717|trichomonas|trichomonas
1084522|NCT02641717|vaginal discharge|vaginal discharge
1084523|NCT02641678|Atrial Fibrillation|atrial fibrillation
1084524|NCT02641678|stroke|stroke
1084525|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
1084526|NCT02641678|automated ECG analysis|automated ecg analysis
1084527|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
1084528|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
1084529|NCT02641626|cardiac arrest|cardiac arrest
1084530|NCT02641626|survival|survival
1084531|NCT02641626|neurologic prognosis|neurologic prognosis
1084532|NCT02641626|coronariography|coronariography
1084533|NCT02641626|hypothermia|hypothermia
1084534|NCT02641587|Smoking|smoking
1084535|NCT02641587|Combustible cigarette|combustible cigarette
1084536|NCT02641587|Reduced exposure|reduced exposure
1084537|NCT02641587|Confinement|confinement
1084538|NCT02641587|Ambulatory|ambulatory
1084539|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
1084540|NCT02641561|Pancreatitis|pancreatitis
1084541|NCT02641561|ERCP|ercp
1084542|NCT02641561|Indomethacin|indomethacin
1084543|NCT02641561|Lactated ringer's|lactated ringer's
1084544|NCT02641522|T1D|t1d
1084545|NCT02641522|Type 1 diabetes|type 1 diabetes
1084546|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
1084547|NCT02641496|PTSD|ptsd
1084548|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
1084549|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
1084550|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
1084551|NCT02641496|CPAP|cpap
1084552|NCT02641496|Cognition|cognition
1084553|NCT02641496|Memory|memory
1084554|NCT02641496|Quality of Life|quality of life
1084555|NCT02641496|Self Efficacy|self efficacy
1084556|NCT02641496|CBT|cbt
1084557|NCT02641496|OSA|osa
1084558|NCT02641496|Sleep Apnea|sleep apnea
1084559|NCT02641496|Education|education
1084560|NCT02641496|Psychotherapy|psychotherapy
1084561|NCT02641496|Post Traumatic Stress Disorder|post traumatic stress disorder
1084562|NCT02641496|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1084563|NCT02641496|Therapy|therapy
1084564|NCT02641457|rubeosis iridis|rubeosis iridis
1084565|NCT02641457|glaucoma|glaucoma
1084566|NCT02641457|ranibizumab|ranibizumab
1084567|NCT02641457|aflibercept|aflibercept
1084568|NCT02641431|radiofrequency ablation|radiofrequency ablation
1084569|NCT02641431|mapping|mapping
1084570|NCT02641431|sudden death|sudden death
1084571|NCT02641431|syncope|syncope
1084572|NCT02641418|Exercise|exercise
1084573|NCT02641405|Gait analysis|gait analysis
1084574|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
1084575|NCT02641405|Parkinson|parkinson
1084576|NCT02641392|Crohn's Disease|crohn's disease
1084577|NCT02641392|GED 0301|ged 0301
1084578|NCT02641392|Mongersen|mongersen
1084579|NCT02641392|Safety|safety
1084581|NCT02641353|Apremilast|apremilast
1084582|NCT02641353|Healthy volunteers|healthy volunteers
1084583|NCT02641353|Bioavailability|bioavailability
1084584|NCT02641353|Food effect|food effect
1084585|NCT02641353|Pharmacokinetic|pharmacokinetic
1084586|NCT02641327|Inhospital patients|inhospital patients
1084587|NCT02641314|high risk neuroblastoma|high risk neuroblastoma
1084588|NCT02641301|obesity|obesity
1084589|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
1084590|NCT02641301|pharmacokinetics|pharmacokinetics
1084591|NCT02641301|Pain|pain
1084592|NCT02641301|morphine|morphine
1084593|NCT02641275|Parental stress|parental stress
1084594|NCT02641275|Muscular Dystrophies|muscular dystrophies
1084595|NCT02641275|Coping|coping
1084596|NCT02641275|Parental support|parental support
1084597|NCT02641262|Myocardial Infarction|myocardial infarction
1084598|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
1084599|NCT02641262|Drug Therapy|drug therapy
1084600|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1084601|NCT02641236|Acute GVH Disease|acute gvh disease
1084602|NCT02641210|Chronic periodontitis|chronic periodontitis
1084603|NCT02641210|Hepcidin|hepcidin
1084604|NCT02641210|Hemoglobin|hemoglobin
1084605|NCT02641210|Inflammation|inflammation
1084606|NCT02641197|flow-mediated dilation|flow-mediated dilation
1084607|NCT02641197|AngioDefender|angiodefender
1084608|NCT02641197|device precision|device precision
1084609|NCT02641197|repeatability|repeatability
1084610|NCT02641197|reproducibility|reproducibility
1084611|NCT02641197|cardiovascular diseases|cardiovascular diseases
1084612|NCT02641184|Myocardial Infarction|myocardial infarction
1084613|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
1084614|NCT02641184|Heart Diseases|heart diseases
1084615|NCT02641184|Infarction|infarction
1084616|NCT02641184|Diabetes|diabetes
1084617|NCT02641158|HIV|hiv
1084618|NCT02641158|Hepatitis C|hepatitis c
1084619|NCT02641158|Substance users|substance users
1084620|NCT02641158|Drug users|drug users
1084621|NCT02641145|amyloidosis|amyloidosis
1084622|NCT02641145|F-18 florbetapir|f-18 florbetapir
1084623|NCT02641145|Positron emission tomography|positron emission tomography
1084624|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1084625|NCT02641119|Albumin|albumin
1084626|NCT02641119|Resuscitation|resuscitation
1084627|NCT02641106|Telemedicine|telemedicine
1084628|NCT02641106|Mobile Phone|mobile phone
1084629|NCT02641106|Adherence|adherence
1084630|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
1084631|NCT02641106|Directly Observed Therapy|directly observed therapy
1084632|NCT02641106|Video DOT|video dot
1084633|NCT02641041|Japanese|japanese
1084634|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
1084635|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
1084636|NCT02641015|UTI|uti
1084637|NCT02641002|CC-90002|cc-90002
1084638|NCT02641002|Monoclonal|monoclonal
1084639|NCT02641002|Antibody|antibody
1084640|NCT02641002|CD47|cd47
1084641|NCT02641002|Hematologic Cancers|hematologic cancers
1084642|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
1084643|NCT02641002|AML|aml
1084644|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
1084645|NCT02641002|MDS|mds
1084646|NCT02641002|Blood disorder|blood disorder
1084647|NCT02640989|Influenza Vaccine|influenza vaccine
1084648|NCT02640989|Safety|safety
1084649|NCT02640989|Immunogenicity|immunogenicity
1084650|NCT02640976|in vitro fertilization|in vitro fertilization
1084651|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1084652|NCT02640976|poor ovarian response|poor ovarian response
1084653|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
1084654|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
1084655|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
1084656|NCT02640963|exercise|exercise
1084657|NCT02640963|older adults|older adults
1084658|NCT02640963|physical performance|physical performance
1084659|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
1084660|NCT02640937|biofilm formation|biofilm formation
1084661|NCT02640937|antibiotic resistance|antibiotic resistance
1084662|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
1084663|NCT02640937|risk factor|risk factor
1084664|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
1084665|NCT02640924|Proton therapy|proton therapy
1084666|NCT02640924|Radiation therapy|radiation therapy
1084667|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
1084668|NCT02640872|sarcopenia|sarcopenia
1084669|NCT02640872|sarcopenic obesity|sarcopenic obesity
1084670|NCT02640872|osteoporosis|osteoporosis
1084671|NCT02640872|fracture|fracture
1084672|NCT02640872|cardiovascular disease|cardiovascular disease
1084673|NCT02640872|mortality|mortality
1084674|NCT02640846|Levosimendan|levosimendan
1084675|NCT02640846|Milrinone|milrinone
1084676|NCT02640846|Myocardial strain|myocardial strain
1084677|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
1084678|NCT02640833|Refractory Lymphoma|refractory lymphoma
1084679|NCT02640833|Relapsed Leukemia|relapsed leukemia
1084681|NCT02640820|Verruca Vulgaris|verruca vulgaris
1084682|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
1084683|NCT02640807|immune reconstitution|immune reconstitution
1084684|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1084685|NCT02640794|Antithrombotic treatment|antithrombotic treatment
1084686|NCT02640794|Clopidogrel|clopidogrel
1084687|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
1084688|NCT02640794|Myocardial Infarction|myocardial infarction
1084689|NCT02640794|Ischemic stroke|ischemic stroke
1084690|NCT02640794|Major bleeding|major bleeding
1084691|NCT02640768|in-hospital diabetes|in-hospital diabetes
1084692|NCT02640768|clinical and management model|clinical and management model
1084693|NCT02640755|Radiolabelled|radiolabelled
1084694|NCT02640729|Lewy body dementia|lewy body dementia
1084695|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
1084696|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
1084697|NCT02640729|Lewy bodies|lewy bodies
1084698|NCT02640729|Visual hallucinations|visual hallucinations
1084699|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
1084700|NCT02640690|Yoga|yoga
1084701|NCT02640690|Cognitive Therapy|cognitive therapy
1084702|NCT02640690|Chronic Pain|chronic pain
1084703|NCT02640690|Veterans|veterans
1084704|NCT02640690|cytokines|cytokines
1084705|NCT02640690|acoustic startle reflex|acoustic startle reflex
1084833|NCT02640131|feasibility study|feasibility study
1568427|NCT00505895|Melphalan|melphalan
1129469|NCT02381457|22q|22q
1084706|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
1084707|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
1084708|NCT02640664|laser ablation therapy|laser ablation therapy
1084709|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
1084710|NCT02640664|preterm infants|preterm infants
1084711|NCT02640664|RAINBOW|rainbow
1084712|NCT02640638|Racial disparities|racial disparities
1084713|NCT02640625|HIV|hiv
1084714|NCT02640625|Probiotics|probiotics
1084715|NCT02640625|Microbiota|microbiota
1084716|NCT02640625|Mucosal immunology|mucosal immunology
1084717|NCT02640625|Gut biopsy|gut biopsy
1084718|NCT02640599|Vestibular|vestibular
1084719|NCT02640599|Rehabilitation|rehabilitation
1084720|NCT02640560|Children|children
1084721|NCT02640560|Allergy|allergy
1084722|NCT02640560|Peanuts|peanuts
1084723|NCT02640560|Hazelnuts|hazelnuts
1084724|NCT02640560|Walnuts|walnuts
1084725|NCT02640560|Mollusks|mollusks
1084726|NCT02640560|Shellfish|shellfish
1084727|NCT02640560|Food|food
1084728|NCT02640547|Fibrosis|fibrosis
1084729|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
1084730|NCT02640547|Cirrhosis|cirrhosis
1084731|NCT02640547|Work Ability|work ability
1084732|NCT02640547|Dasabuvir|dasabuvir
1084733|NCT02640547|Quality of Life|quality of life
1084734|NCT02640547|Observational Study|observational study
1084735|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
1084736|NCT02640534|Prostate cancer|prostate cancer
1084737|NCT02640534|Cancer of the prostate|cancer of the prostate
1084738|NCT02640534|Metformin|metformin
1084739|NCT02640534|Enzalutamide|enzalutamide
1084740|NCT02640534|Xtandi|xtandi
1084741|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
1084742|NCT02640534|phase II|phase ii
1084743|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
1084744|NCT02640495|Treatment Efficacy|treatment efficacy
1084745|NCT02640495|drug resistance|drug resistance
1084746|NCT02640495|Artemisinin|artemisinin
1084747|NCT02640482|Treatment-Naive|treatment-naive
1084748|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
1084749|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
1084750|NCT02640482|Treatment-Experienced|treatment-experienced
1084751|NCT02640482|Non-cirrhotic|non-cirrhotic
1084752|NCT02640469|chlorhexidine|chlorhexidine
1084753|NCT02640469|sterility|sterility
1084754|NCT02640469|sterile hands|sterile hands
1084755|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
1084756|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
1084757|NCT02640456|peritonsillar abscess|peritonsillar abscess
1084758|NCT02640456|bacteriology|bacteriology
1084759|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
1084760|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
1084761|NCT02640417|Vitamin B1|vitamin b1
1084762|NCT02640417|Vitamin B6|vitamin b6
1084763|NCT02640417|Vitamin B12|vitamin b12
1084764|NCT02640404|Meningitis|meningitis
1084765|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
1084766|NCT02640404|Meningococcal Infections|meningococcal infections
1084767|NCT02640404|Menactra®|menactra®
1084768|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
1084769|NCT02640391|Ulcerative colitis|ulcerative colitis
1084770|NCT02640391|fecal calprotectin|fecal calprotectin
1084771|NCT02640391|mucosal healing|mucosal healing
1084772|NCT02640365|cancer|cancer
1084773|NCT02640365|GERCOR|gercor
1084774|NCT02640365|unresectable|unresectable
1084775|NCT02640365|MM-398|mm-398
1084776|NCT02640365|CPT-11|cpt-11
1084777|NCT02640365|colorectal|colorectal
1084778|NCT02640365|non colorectal|non colorectal
1084779|NCT02640326|Urinary Catheterization|urinary catheterization
1084780|NCT02640326|Randomized Controlled Trial|randomized controlled trial
1084781|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1084782|NCT02640326|Quality Improvement|quality improvement
1084783|NCT02640326|Evidence-Based Practice|evidence-based practice
1084784|NCT02640326|Post-operative complications|post-operative complications
1084785|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
1084786|NCT02640313|[F18] choline|[f18] choline
1084787|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
1084788|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
1084789|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
1084790|NCT02640274|Directive Counseling|directive counseling
1084791|NCT02640274|Self Care|self care
1084792|NCT02640261|r-hLH|r-hlh
1084793|NCT02640261|Cytokines|cytokines
1084794|NCT02640261|Follicular Fluid|follicular fluid
1084795|NCT02640235|Hemostasis|hemostasis
1084796|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
1084797|NCT02640235|Traumacel|traumacel
1084798|NCT02640235|Traumastem|traumastem
1084799|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
1084800|NCT02640235|General Surgery|general surgery
1084801|NCT02640235|Vascular Surgery|vascular surgery
1084802|NCT02640196|Laryngoscope|laryngoscope
1084803|NCT02640196|Macintosh|macintosh
1084804|NCT02640196|Glidescope|glidescope
1084805|NCT02640196|King Vision|king vision
1084806|NCT02640196|Airtraq|airtraq
1084807|NCT02640196|Double Lumen Tube|double lumen tube
1084808|NCT02640157|interferon free|interferon free
1084809|NCT02640157|Hepatitis C|hepatitis c
1084810|NCT02640157|daclatasvir|daclatasvir
1084811|NCT02640157|Sovaldi|sovaldi
1084812|NCT02640157|HCV|hcv
1084813|NCT02640157|Hepatitis C Virus|hepatitis c virus
1084814|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
1084815|NCT02640157|Hep C|hep c
1084816|NCT02640157|sofosbuvir|sofosbuvir
1084817|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
1084818|NCT02640157|Daklinza|daklinza
1084819|NCT02640144|Hyaluronic acid|hyaluronic acid
1084820|NCT02640144|Knee arthroscopy|knee arthroscopy
1084821|NCT02640144|pain reduction|pain reduction
1084822|NCT02640144|swelling|swelling
1084823|NCT02640144|osteoarthritis|osteoarthritis
1084824|NCT02640144|cartilage lesion|cartilage lesion
1084825|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
1084826|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
1084827|NCT02640131|prostate cancer|prostate cancer
1084828|NCT02640131|radical prostatectomy|radical prostatectomy
1084829|NCT02640131|survivorship|survivorship
1084830|NCT02640131|quality of life|quality of life
1084831|NCT02640131|erectile dysfunction|erectile dysfunction
1084832|NCT02640131|sexual dysfunction|sexual dysfunction
1084834|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
1084835|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
1084836|NCT02640014|Food allergy|food allergy
1084837|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
1084838|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
1084839|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
1084840|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
1084841|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
1084842|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
1084843|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
1084844|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
1084845|NCT02639962|culprit lesion|culprit lesion
1084846|NCT02639962|arteriosclerosis|arteriosclerosis
1084847|NCT02639962|cardiac CT|cardiac ct
1084848|NCT02639923|TBI|tbi
1084849|NCT02639923|microRNA|microrna
1084850|NCT02639923|S-100B|s-100b
1084851|NCT02639910|CD19|cd19
1084852|NCT02639910|MOR208|mor208
1084853|NCT02639910|MOR00208|mor00208
1084854|NCT02639910|CLL|cll
1084855|NCT02639910|SLL|sll
1084856|NCT02639910|COSMOS|cosmos
1084857|NCT02639871|Huntington disease|huntington disease
1084858|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
1084859|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
1084860|NCT02639832|Breast Cancer|breast cancer
1084861|NCT02639832|Natural Killer Cells|natural killer cells
1084862|NCT02639832|BRCA Mutation|brca mutation
1084863|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
1084864|NCT02639819|Stroke|stroke
1084865|NCT02639819|Cerebrovascular|cerebrovascular
1084866|NCT02639806|stroke|stroke
1084867|NCT02639806|endovascular|endovascular
1084868|NCT02639806|thrombectomy|thrombectomy
1084869|NCT02639806|ischemic stroke|ischemic stroke
1084870|NCT02639806|general anesthetic|general anesthetic
1084871|NCT02639806|local anesthetic|local anesthetic
1084872|NCT02639806|recanalization|recanalization
1084873|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
1084874|NCT02639767|Pemetrexed|pemetrexed
1084875|NCT02639767|Cisplatin|cisplatin
1084876|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1084877|NCT02639767|15-304|15-304
1084878|NCT02639741|Melatonin|melatonin
1084879|NCT02639741|Vitamin C|vitamin c
1084880|NCT02639741|Morphine consumption|morphine consumption
1084881|NCT02639728|Bowel surgery|bowel surgery
1084882|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
1084883|NCT02639702|Clozapine|clozapine
1084884|NCT02639702|Dosing|dosing
1084885|NCT02639702|Once daily|once daily
1084886|NCT02639702|Regimen|regimen
1084887|NCT02639702|Schizophrenia|schizophrenia
1084888|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
1084889|NCT02639689|Walkaide|walkaide
1084890|NCT02639676|Infant|infant
1084891|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1084892|NCT02639676|Premature|premature
1084893|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
1084894|NCT02639650|paclitaxel|paclitaxel
1084895|NCT02639650|cisplatin|cisplatin
1084896|NCT02639650|carboplatin|carboplatin
1084897|NCT02639650|chemotherapy|chemotherapy
1084898|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1084899|NCT02639637|Sitagliptin|sitagliptin
1084900|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
1084901|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
1084902|NCT02639637|Enalaprilat|enalaprilat
1084903|NCT02639637|Neuropeptide Y|neuropeptide y
1084904|NCT02639624|hemodialysis|hemodialysis
1084905|NCT02639624|kidney|kidney
1084906|NCT02639624|dialysis|dialysis
1084907|NCT02639611|Breast Expanders|breast expanders
1084908|NCT02639598|chronic migraine|chronic migraine
1084909|NCT02639598|prophylaxis|prophylaxis
1084910|NCT02639598|flunarizine|flunarizine
1084911|NCT02639598|topiramate|topiramate
1084912|NCT02639585|daclatasvir|daclatasvir
1084913|NCT02639585|asunaprevir|asunaprevir
1084914|NCT02639533|fibromyalgia|fibromyalgia
1084915|NCT02639533|pregabalin|pregabalin
1084916|NCT02639533|cortical excitability|cortical excitability
1084917|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
1084918|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
1084919|NCT02639481|traumatic brain injury|traumatic brain injury
1084920|NCT02639481|stroke|stroke
1084921|NCT02639481|disorders of consciousness|disorders of consciousness
1084922|NCT02639481|rehabilitation|rehabilitation
1084923|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
1084924|NCT02639416|severe acute malnutrition|severe acute malnutrition
1084925|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
1084926|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
1084927|NCT02639403|Rectal cancer|rectal cancer
1084928|NCT02639403|Radiotherapy|radiotherapy
1084929|NCT02639403|Occlusion|occlusion
1084930|NCT02639390|Robotics|robotics
1084931|NCT02639390|upper extremity|upper extremity
1084932|NCT02639390|neurorehabilitation|neurorehabilitation
1084933|NCT02639390|movement therapy|movement therapy
1084934|NCT02639377|Dental Implantation|dental implantation
1084935|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
1084938|NCT02639325|Brain Cancer|brain cancer
1084939|NCT02639325|Seizure Disorder|seizure disorder
1084940|NCT02639325|Seizures|seizures
1084941|NCT02639312|Cranofacial|cranofacial
1084942|NCT02639312|Microsomia|microsomia
1084943|NCT02639312|Mandibular|mandibular
1084944|NCT02639312|Facial Defects|facial defects
1084945|NCT02639312|Hasburg Jaw|hasburg jaw
1084946|NCT02639299|Subjects|subjects
1084947|NCT02639299|Venipuncture|venipuncture
1084948|NCT02639299|Research|research
1084949|NCT02639299|Evaluate|evaluate
1084950|NCT02639299|Recruit|recruit
1084951|NCT02639286|Lipodystrophy|lipodystrophy
1084952|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
1084953|NCT02639273|Nalmefene|nalmefene
1084954|NCT02639273|fMRI|fmri
1084955|NCT02639273|Incentive Salience|incentive salience
1084956|NCT02639273|Reward Processing|reward processing
1084957|NCT02639273|Aversive Event Processing|aversive event processing
1084958|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
1084959|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
1084960|NCT02639260|Sialic Acid|sialic acid
1084961|NCT02639260|Proteinuria|proteinuria
1084962|NCT02639247|Chronic|chronic
1084963|NCT02639208|Breast Cancer I|breast cancer i
1084964|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
1084965|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
1084966|NCT02639182|Axitinib|axitinib
1084967|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1084968|NCT02639182|AGS-16C3F|ags-16c3f
1084969|NCT02639169|music therapy|music therapy
1084970|NCT02639169|Distress|distress
1084971|NCT02639169|Mood|mood
1084972|NCT02639169|HSCT|hsct
1084973|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
1084974|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
1084975|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
1084976|NCT02639130|Gastric emptying|gastric emptying
1084977|NCT02639130|Glucagon|glucagon
1084978|NCT02639130|Incretin|incretin
1084979|NCT02639130|Insulin Secretion|insulin secretion
1084980|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
1084981|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
1084982|NCT02639104|neck pain|neck pain
1084983|NCT02639104|cervical lordosis|cervical lordosis
1084984|NCT02639104|long thoracic nerve|long thoracic nerve
1084985|NCT02639091|Phase 1|phase 1
1084986|NCT02639091|Solid tumors|solid tumors
1084987|NCT02639091|Mesothelioma|mesothelioma
1084988|NCT02639091|Lung cancer|lung cancer
1084989|NCT02639091|Pemetrexed|pemetrexed
1084990|NCT02639091|Cisplatin|cisplatin
1084991|NCT02639078|Single ascending dose|single ascending dose
1084992|NCT02639078|volunteers|volunteers
1084993|NCT02639078|Phase 1|phase 1
1084994|NCT02639078|first-in-human|first-in-human
1084995|NCT02639078|TD-0714|td-0714
1084996|NCT02639065|Durvalumab|durvalumab
1084997|NCT02639065|MEDI4736|medi4736
1084998|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
1084999|NCT02639052|Itch|itch
1085000|NCT02639052|Botox|botox
1085001|NCT02639052|Healthy Volunteers|healthy volunteers
1085002|NCT02638987|Dry needling|dry needling
1085003|NCT02638987|office workers|office workers
1085004|NCT02638987|myofascial pain|myofascial pain
1085005|NCT02638987|electromyography|electromyography
1085006|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1085007|NCT02638961|physical therapy|physical therapy
1085008|NCT02638961|exercise capacity|exercise capacity
1085009|NCT02638961|quality of life|quality of life
1085010|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
1085011|NCT02638935|VTIQ|vtiq
1085012|NCT02638935|Elastography|elastography
1085013|NCT02638935|Breast Cancer|breast cancer
1085014|NCT02638935|BI-RADS|bi-rads
1085015|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
1085016|NCT02638935|Breast Lesion|breast lesion
1085017|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
1085018|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
1085019|NCT02638896|Etanercept|etanercept
1085020|NCT02638896|Sulfasalazine|sulfasalazine
1085021|NCT02638896|Efficacy|efficacy
1085022|NCT02638896|Safety|safety
1085023|NCT02638896|dose|dose
1085024|NCT02638896|reduction|reduction
1085025|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
1085026|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1085027|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
1085028|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
1085029|NCT02638844|echocardiography|echocardiography
1085030|NCT02638831|Pain|pain
1085031|NCT02638831|Gonarthrosis|gonarthrosis
1085032|NCT02638831|Low Back Pain|low back pain
1085033|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
1085034|NCT02638831|Ketoprofen|ketoprofen
1085035|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
1085036|NCT02638818|Whipple|whipple
1085037|NCT02638779|Septic shock|septic shock
1085038|NCT02638779|severe trauma|severe trauma
1085039|NCT02638779|severe burn|severe burn
1085040|NCT02638779|major surgery|major surgery
1085041|NCT02638779|immunosuppression|immunosuppression
1085042|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
1085043|NCT02638766|metastatic|metastatic
1085044|NCT02638766|unresectable|unresectable
1085045|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
1085046|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
1085047|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
1085048|NCT02638753|education on pain biology|education on pain biology
1085049|NCT02638753|education on pain neuroscience|education on pain neuroscience
1085050|NCT02638753|hypnosis|hypnosis
1085051|NCT02638727|vascular disease|vascular disease
1085052|NCT02638727|endothelial function|endothelial function
1085053|NCT02638727|L-Citrulline|l-citrulline
1085054|NCT02638714|Optic Neuropathies|optic neuropathies
1085055|NCT02638714|Stem Cell Therapy|stem cell therapy
1085056|NCT02638675|financial health incentives|financial health incentives
1085057|NCT02638675|physical activity|physical activity
1085058|NCT02638675|behavioral economics|behavioral economics
1085059|NCT02638675|randomized control trial|randomized control trial
1085060|NCT02638675|workplace health|workplace health
1085061|NCT02638649|lung ultrasound|lung ultrasound
1085062|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
1085063|NCT02638636|Randomized controlled trial|randomized controlled trial
1085064|NCT02638636|Exposure therapy|exposure therapy
1085065|NCT02638636|Fibromyalgia|fibromyalgia
1085066|NCT02638623|Knee Arthroplasty|knee arthroplasty
1085067|NCT02638623|Hip Arthroplasty|hip arthroplasty
1085068|NCT02638584|Ilaprazole|ilaprazole
1085069|NCT02638584|Gastric Adenoma|gastric adenoma
1085070|NCT02638584|Early Gastric Cancer|early gastric cancer
1085071|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
1085072|NCT02638532|Fat Pad|fat pad
1085073|NCT02638532|Fat Pad Atrophy|fat pad atrophy
1085074|NCT02638532|Foot|foot
1085075|NCT02638532|Feet|feet
1085076|NCT02638532|Heel|heel
1085077|NCT02638532|Forefoot|forefoot
1085078|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
1085079|NCT02638493|HIV|hiv
1085080|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
1085081|NCT02638493|antiretroviral therapy|antiretroviral therapy
1085082|NCT02638493|Prevention|prevention
1085083|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
1085084|NCT02638454|Exercise|exercise
1085085|NCT02638454|Anabolic Resistance|anabolic resistance
1085086|NCT02638454|Skeletal Muscle|skeletal muscle
1085087|NCT02638454|microRNA|microrna
1085088|NCT02638441|psychological health|psychological health
1085089|NCT02638441|women|women
1085090|NCT02638441|anxiety|anxiety
1085091|NCT02638441|depression|depression
1085092|NCT02638415|HVPG|hvpg
1085093|NCT02638402|glycosylation|glycosylation
1085094|NCT02638402|mucin|mucin
1085095|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
1085096|NCT02638402|ovarian cancer|ovarian cancer
1085097|NCT02638402|endometrial cancer|endometrial cancer
1085098|NCT02638376|Keraroconus|keraroconus
1085099|NCT02638376|keratectasia|keratectasia
1085100|NCT02638376|treatment|treatment
1085101|NCT02638350|lung ultrasound|lung ultrasound
1085102|NCT02638350|Pulmonary Edema|pulmonary edema
1130009|NCT02378701|MDS|mds
1085103|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
1085104|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
1085105|NCT02638337|menopause|menopause
1085106|NCT02638259|Biosimilars|biosimilars
1085107|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
1085108|NCT02638259|Etanercept|etanercept
1085109|NCT02638233|CHC|chc
1085110|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
1085111|NCT02638233|Hepatitis C|hepatitis c
1085112|NCT02638233|Sofosbuvir|sofosbuvir
1085113|NCT02638233|Ledipasvir|ledipasvir
1085114|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
1085115|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
1085116|NCT02638220|CTX Prevalence Study|ctx prevalence study
1085117|NCT02638220|CTX|ctx
1085118|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
1085119|NCT02638220|Cataracts|cataracts
1085120|NCT02638220|Bilateral Cataracts|bilateral cataracts
1085121|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
1085122|NCT02638220|Observational Study|observational study
1085123|NCT02638220|Ophthalmology|ophthalmology
1085124|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
1085125|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1085126|NCT02638194|smoking|smoking
1085127|NCT02638194|secondhand smoke|secondhand smoke
1085128|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
1085129|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
1085130|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
1085131|NCT02638181|trabecular meshwork|trabecular meshwork
1085132|NCT02638181|open-angle glaucoma|open-angle glaucoma
1085133|NCT02638142|loop diuretic|loop diuretic
1085134|NCT02638142|heart failure|heart failure
1085135|NCT02638142|renal dysfunction|renal dysfunction
1085136|NCT02638142|congestion signs|congestion signs
1085137|NCT02638142|BNP|bnp
1085138|NCT02638129|Drug therapy|drug therapy
1085139|NCT02638116|Ibrutinib|ibrutinib
1085140|NCT02638116|Proton pump inhibitors|proton pump inhibitors
1085141|NCT02638116|Pharmacokinetics|pharmacokinetics
1085142|NCT02638116|Drug Interaction|drug interaction
1085143|NCT02638090|advanced lung cancer|advanced lung cancer
1085144|NCT02638090|immune therapy naive|immune therapy naive
1085145|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
1085146|NCT02638090|NSCLC|nsclc
1085147|NCT02638090|Stage IV lung cancer|stage iv lung cancer
1085148|NCT02638090|pembrolizumab|pembrolizumab
1085149|NCT02638090|vorinostat|vorinostat
1085150|NCT02638090|immunogenicity|immunogenicity
1085151|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
1085152|NCT02638077|the initial management|the initial management
1085153|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1085154|NCT02638051|Malignant Ascites|malignant ascites
1085155|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
1085156|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
1085157|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
1085158|NCT02637921|bed rest|bed rest
1085159|NCT02637921|bone metabolism|bone metabolism
1085160|NCT02637908|Mindfulness|mindfulness
1085161|NCT02637908|Parents|parents
1085162|NCT02637908|Families|families
1085163|NCT02637895|PTSD,|ptsd,
1085164|NCT02637895|trauma|trauma
1085165|NCT02637895|stress disorder|stress disorder
1085166|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
1086763|NCT02629796|Biomarker|biomarker
1085167|NCT02637895|anxiety disorder|anxiety disorder
1085168|NCT02637869|Health Expenditures|health expenditures
1085169|NCT02637869|Prospective Payment System|prospective payment system
1085170|NCT02637869|Health Care Utilization|health care utilization
1085171|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1085173|NCT02637843|angiography|angiography
1085174|NCT02637843|angioplasty|angioplasty
1085175|NCT02637843|randomized|randomized
1085176|NCT02637843|sheath|sheath
1085177|NCT02637843|slender|slender
1085178|NCT02637791|Stroke|stroke
1085179|NCT02637791|Rehabilitation|rehabilitation
1085180|NCT02637791|Virtual Reality|virtual reality
1085181|NCT02637778|nutrient profiles|nutrient profiles
1085182|NCT02637778|menu plans|menu plans
1085183|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
1085184|NCT02637778|SFA|sfa
1085185|NCT02637778|MUFA|mufa
1085186|NCT02637778|PUFA|pufa
1085187|NCT02637778|cardiovascular risk|cardiovascular risk
1085188|NCT02637765|Breast Cancer|breast cancer
1085189|NCT02637765|Physical Activity|physical activity
1085190|NCT02637765|Quality of life|quality of life
1085191|NCT02637752|Pediatric Obesity|pediatric obesity
1085192|NCT02637752|Body Mass Index|body mass index
1085193|NCT02637752|Dentistry|dentistry
1085194|NCT02637739|hysteroscope|hysteroscope
1085195|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
1085196|NCT02637726|Target Controlled Infusion|target controlled infusion
1085197|NCT02637726|Propofol|propofol
1085198|NCT02637726|Bispectral index|bispectral index
1085199|NCT02637726|Children|children
1085200|NCT02637713|GERD|gerd
1085201|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
1085202|NCT02637713|reflux|reflux
1085203|NCT02637713|morbidly obese|morbidly obese
1085204|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
1085205|NCT02637700|Painful Neuropathy|painful neuropathy
1085206|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
1085207|NCT02637687|Pediatric|pediatric
1085208|NCT02637687|NTRK1|ntrk1
1085209|NCT02637687|NTRK2|ntrk2
1085210|NCT02637687|NTRK3|ntrk3
1085211|NCT02637687|Fusion|fusion
1085212|NCT02637687|Tumors|tumors
1085213|NCT02637687|Solid Tumors|solid tumors
1085214|NCT02637687|CNS Tumors|cns tumors
1085215|NCT02637687|Central Nervous System Tumors|central nervous system tumors
1085216|NCT02637687|NTRK Fusion Positive|ntrk fusion positive
1085217|NCT02637687|TRKA|trka
1085218|NCT02637687|TRKB|trkb
1085219|NCT02637687|TRKC|trkc
1085220|NCT02637687|Infantile Fibrosarcoma|infantile fibrosarcoma
1085221|NCT02637687|NTRK Gene Rearrangements|ntrk gene rearrangements
1085222|NCT02637687|TRK Fusion|trk fusion
1085223|NCT02637687|NTRK1 fusion|ntrk1 fusion
1085224|NCT02637687|NTRK2 fusion|ntrk2 fusion
1085225|NCT02637687|NTRK3 fusion|ntrk3 fusion
1085226|NCT02637687|NTRK1 gene rearrangement|ntrk1 gene rearrangement
1085227|NCT02637687|NTRK2 gene rearrangement|ntrk2 gene rearrangement
1085228|NCT02637687|NTRK3 gene rearrangement|ntrk3 gene rearrangement
1085229|NCT02637687|ETV6-NTRK3|etv6-ntrk3
1085230|NCT02637687|ETV6|etv6
1085231|NCT02637687|ETV6 fusion|etv6 fusion
1085232|NCT02637687|ETV6 gene rearrangement|etv6 gene rearrangement
1085233|NCT02637687|Solid CNS tumor|solid cns tumor
1085234|NCT02637687|Primary CNS tumor|primary cns tumor
1085235|NCT02637687|Advanced CNS tumor|advanced cns tumor
1085236|NCT02637687|Metastatic CNS tumor|metastatic cns tumor
1085237|NCT02637687|Metastatic infantile fibrosarcoma|metastatic infantile fibrosarcoma
1085238|NCT02637687|Advanced infantile fibrosarcoma|advanced infantile fibrosarcoma
1085239|NCT02637687|Fibrosarcoma|fibrosarcoma
1085240|NCT02637687|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
1085241|NCT02637687|Congenital nephroma|congenital nephroma
1085242|NCT02637687|Thyroid|thyroid
1085243|NCT02637687|Larotrectinib|larotrectinib
1085244|NCT02637687|Solid tumors Cancer of Unknown primary|solid tumors cancer of unknown primary
1085245|NCT02637674|allotransplantation|allotransplantation
1085246|NCT02637661|earlobe crease|earlobe crease
1085247|NCT02637661|acute myocardial infarction|acute myocardial infarction
1085248|NCT02637661|risk factor|risk factor
1085249|NCT02637635|Mammaplasty|mammaplasty
1085250|NCT02637635|Transplantation, Autologous|transplantation, autologous
1085251|NCT02637635|Mastectomy|mastectomy
1085252|NCT02637635|Breast Implants|breast implants
1085253|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
1085254|NCT02637622|conjoint analysis|conjoint analysis
1085255|NCT02637622|stated-preference methods|stated-preference methods
1085256|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
1085257|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
1085258|NCT02637622|patient preference|patient preference
1085259|NCT02637622|diabetes|diabetes
1085260|NCT02637609|conjoint analysis|conjoint analysis
1085261|NCT02637609|stated-preference methods|stated-preference methods
1085262|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
1085263|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
1085264|NCT02637609|patient priority|patient priority
1085265|NCT02637609|diabetes|diabetes
1085266|NCT02637583|conjugate vaccine|conjugate vaccine
1085267|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
1085268|NCT02637570|healthy male athletes|healthy male athletes
1085269|NCT02637570|18-35 years old|18-35 years old
1085270|NCT02637531|IPI-549|ipi-549
1085271|NCT02637531|Phase 1|phase 1
1085272|NCT02637531|Advanced Solid Tumor|advanced solid tumor
1085273|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
1085274|NCT02637531|Melanoma|melanoma
1085275|NCT02637531|PI3K|pi3k
1085276|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
1085277|NCT02637531|Triple Negative Breast Cancer|triple negative breast cancer
1085278|NCT02637531|Adrenocortical Carcinoma|adrenocortical carcinoma
1085279|NCT02637531|Mesothelioma|mesothelioma
1085280|NCT02637518|Frailty|frailty
1085281|NCT02637518|Frailty screening tools|frailty screening tools
1085282|NCT02637518|Clinical settings|clinical settings
1085283|NCT02637518|Social settings|social settings
1085284|NCT02637518|Geriatrics|geriatrics
1085285|NCT02637518|Functional autonomy|functional autonomy
1085286|NCT02637518|Disability|disability
1085287|NCT02637505|Articular cartilage|articular cartilage
1085288|NCT02637505|Focal cartilage injury|focal cartilage injury
1085289|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
1085290|NCT02637505|Knee cartilage|knee cartilage
1085291|NCT02637505|Microfracture|microfracture
1085292|NCT02637505|Debridement|debridement
1568428|NCT00505895|Alkeran|alkeran
1085293|NCT02637492|Critical limb ischaemia|critical limb ischaemia
1085294|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
1085295|NCT02637492|Clinical prediction|clinical prediction
1085296|NCT02637492|Ankle pressure|ankle pressure
1085297|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
1085298|NCT02637492|Toe pressure|toe pressure
1085299|NCT02637492|Microcirculation|microcirculation
1085300|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
1085301|NCT02637427|Fresh frozen plasma|fresh frozen plasma
1085302|NCT02637427|Bleeding|bleeding
1085303|NCT02637414|Stress|stress
1085304|NCT02637414|Well-being|well-being
1085305|NCT02637414|Positive psychology|positive psychology
1085306|NCT02637388|Appetite|appetite
1085307|NCT02637388|Beta-glucans|beta-glucans
1085308|NCT02637388|Energy Intake|energy intake
1085309|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
1085310|NCT02637388|Glucose|glucose
1085311|NCT02637388|Insulin|insulin
1085312|NCT02637388|Incretins|incretins
1085313|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
1085314|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
1085315|NCT02637323|osteoarthritis|osteoarthritis
1085316|NCT02637323|knee|knee
1085317|NCT02637323|pain|pain
1085318|NCT02637323|corticosteroid|corticosteroid
1085319|NCT02637323|intra-articular|intra-articular
1085320|NCT02637323|injection|injection
1085321|NCT02637284|Healthy volunteers|healthy volunteers
1085322|NCT02637271|Calorie restriction|calorie restriction
1085323|NCT02637271|Meal replacement|meal replacement
1085324|NCT02637271|fMRI|fmri
1085325|NCT02637271|Food-cue reactivity|food-cue reactivity
1085326|NCT02637271|Obesity|obesity
1085327|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
1085328|NCT02637258|neurological outcome|neurological outcome
1085329|NCT02637258|OHCA|ohca
1085330|NCT02637245|diabetic macular edema|diabetic macular edema
1085331|NCT02637245|diabetic retinopathy|diabetic retinopathy
1085332|NCT02637206|Healthy Japanese|healthy japanese
1085333|NCT02637206|GSK2894512|gsk2894512
1085334|NCT02637206|skin safety|skin safety
1085335|NCT02637180|osteoporosis|osteoporosis
1085336|NCT02637180|fracture|fracture
1085337|NCT02637180|liaison service|liaison service
1085338|NCT02637167|Heart failure|heart failure
1085339|NCT02637167|inflammation|inflammation
1085340|NCT02637167|rifaximin|rifaximin
1085341|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
1085342|NCT02637167|gut microbiota|gut microbiota
1085343|NCT02637154|Adolescent|adolescent
1085344|NCT02637154|Type 1 diabetes|type 1 diabetes
1085345|NCT02637154|Metabolic control|metabolic control
1085346|NCT02637154|Motivational interviewing|motivational interviewing
1085347|NCT02637141|celiac|celiac
1085348|NCT02637141|gluten|gluten
1085349|NCT02637141|IL-15|il-15
1085350|NCT02637141|AMG 714|amg 714
1085351|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
1085352|NCT02637128|MALAWI|malawi
1085353|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
1085354|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
1085355|NCT02637115|Gut microbiota|gut microbiota
1085356|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
1085357|NCT02637076|Xyrem|xyrem
1085358|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
1085359|NCT02637076|positron emission tomography|positron emission tomography
1085360|NCT02637076|dopamine|dopamine
1085361|NCT02637063|Lifestyle behavior change|lifestyle behavior change
1085362|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
1085363|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
1085364|NCT02637050|CTEPH|cteph
1085365|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
1085366|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
1085367|NCT02637037|bioequivalence|bioequivalence
1085368|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
1085369|NCT02637037|pharmacokinetic|pharmacokinetic
1085370|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1085371|NCT02637037|safety|safety
1085372|NCT02637024|Breast Cancer|breast cancer
1085373|NCT02637024|DCIS|dcis
1085374|NCT02637024|Radiotherapy|radiotherapy
1085375|NCT02637024|Partial breast irradiation|partial breast irradiation
1085376|NCT02637024|Radiation fractions|radiation fractions
1085377|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
1085378|NCT02637011|intensive care medicine|intensive care medicine
1085379|NCT02637011|critical illness|critical illness
1085380|NCT02637011|long-term outcomes|long-term outcomes
1085381|NCT02637011|quality of life|quality of life
1085382|NCT02637011|return to work|return to work
1085383|NCT02637011|quality of care|quality of care
1085384|NCT02636972|TLR2|tlr2
1085385|NCT02636972|TLR4|tlr4
1085386|NCT02636972|Biomarker|biomarker
1085387|NCT02636972|TLR responsiveness|tlr responsiveness
1085388|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
1085389|NCT02636972|Inflammatory pain|inflammatory pain
1085390|NCT02636933|Asthma|asthma
1085391|NCT02636933|Allergic Rhinitis|allergic rhinitis
1085392|NCT02636933|Children|children
1085393|NCT02636933|Atopy|atopy
1085394|NCT02636920|Asthma|asthma
1085395|NCT02636920|Children|children
1085396|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
1085397|NCT02636855|Screening|screening
1085398|NCT02636855|Metastatic|metastatic
1085399|NCT02636855|Previously Treated|previously treated
1085400|NCT02636855|NY-ESO-1|ny-eso-1
1085401|NCT02636855|MAGE A10|mage a10
1085402|NCT02636855|MAGE-A4|mage-a4
1085403|NCT02636842|Schizophrenia|schizophrenia
1085404|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
1085405|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
1085406|NCT02636842|Aripiprazole|aripiprazole
1085407|NCT02636842|ALKS 9072|alks 9072
1085408|NCT02636842|Alkermes|alkermes
1085409|NCT02636803|trichuris|trichuris
1085410|NCT02636803|hookworms|hookworms
1085411|NCT02636803|Ascaris|ascaris
1085412|NCT02636777|low back pain|low back pain
1085413|NCT02636777|chronic pain|chronic pain
1085414|NCT02636777|self-management|self-management
1085415|NCT02636777|longitudinal study|longitudinal study
1085416|NCT02636777|predictive modelling|predictive modelling
1085417|NCT02636751|Prehabilitation|prehabilitation
1085418|NCT02636751|Telemedicine|telemedicine
1085419|NCT02636751|Osteoarthritis|osteoarthritis
1085420|NCT02636751|Arthroplasty|arthroplasty
1085421|NCT02636751|Hip|hip
1085422|NCT02636751|Knee|knee
1085423|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
1085424|NCT02636725|ASPS|asps
1085425|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
1085426|NCT02636725|STS|sts
1085427|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
1085428|NCT02636686|DMD|dmd
1085429|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1085430|NCT02636686|Drisapersen|drisapersen
1085431|NCT02636686|Kyndrisa|kyndrisa
1085432|NCT02636686|exon-skipping|exon-skipping
1085433|NCT02636686|exon-51|exon-51
1085434|NCT02636686|BMN-051-302|bmn-051-302
1085436|NCT02636660|Critical care|critical care
1085437|NCT02636660|Mechanical Ventilation|mechanical ventilation
1085438|NCT02636660|Quality of Life|quality of life
1085439|NCT02636660|Stressors|stressors
1085440|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
1085441|NCT02636660|Nursing|nursing
1085442|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
1085443|NCT02636647|fecal transplant|fecal transplant
1085444|NCT02636647|cirrhosis|cirrhosis
1085445|NCT02636634|diagnostic strategy|diagnostic strategy
1085446|NCT02636634|brain metastases|brain metastases
1085447|NCT02636634|radiation necrosis|radiation necrosis
1085448|NCT02636634|relapse|relapse
1085449|NCT02636634|PET-FET and MSR|pet-fet and msr
1085450|NCT02636634|radiosurgery|radiosurgery
1085451|NCT02636621|Fatigue|fatigue
1085452|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
1085453|NCT02636621|flow limitation|flow limitation
1085454|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
1085455|NCT02636608|Dasabuvir|dasabuvir
1085456|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
1085457|NCT02636608|Observational Study|observational study
1085458|NCT02636608|Quality of Life|quality of life
1085459|NCT02636608|Fibrosis|fibrosis
1085460|NCT02636608|Cirrhosis|cirrhosis
1085461|NCT02636608|Work Ability|work ability
1085462|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
1085463|NCT02636595|Hepatitis C|hepatitis c
1085464|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
1085465|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
1085466|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
1085467|NCT02636556|thymoma|thymoma
1085468|NCT02636556|thymic carcinoma|thymic carcinoma
1085469|NCT02636556|chemoradiotherapy|chemoradiotherapy
1085470|NCT02636556|inoperable|inoperable
1085471|NCT02636543|genetic diagnosis|genetic diagnosis
1085472|NCT02636543|information|information
1085473|NCT02636543|letter model|letter model
1085474|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
1085475|NCT02636504|Pulp vitality|pulp vitality
1085476|NCT02636504|Pulp testing|pulp testing
1085477|NCT02636439|Diastolic heart failure|diastolic heart failure
1085478|NCT02636439|Heart Failure|heart failure
1085479|NCT02636439|Elderly|elderly
1085480|NCT02636439|Obesity|obesity
1085481|NCT02636426|phase I study|phase i study
1085482|NCT02636426|sorafenib|sorafenib
1085483|NCT02636426|high-dose schedule|high-dose schedule
1085484|NCT02636426|pharmacokinetics|pharmacokinetics
1085485|NCT02636426|drug monitoring|drug monitoring
1085486|NCT02636400|Infertility|infertility
1085487|NCT02636400|endometriosis|endometriosis
1085488|NCT02636348|Calcium|calcium
1085489|NCT02636348|Vitamin D|vitamin d
1085490|NCT02636322|Lymphoma|lymphoma
1085491|NCT02636322|High Risk Diffuse Large B-Cell Lymphoma|high risk diffuse large b-cell lymphoma
1085492|NCT02636322|DLBCL|dlbcl
1085493|NCT02636322|Rituximab|rituximab
1085494|NCT02636322|Rituxan|rituxan
1085495|NCT02636322|Ibrutinib|ibrutinib
1085496|NCT02636322|PCI-32765|pci-32765
1085497|NCT02636322|Imbruvica|imbruvica
1085498|NCT02636322|Lenalidomide|lenalidomide
1085499|NCT02636322|CC-5013|cc-5013
1085500|NCT02636322|Revlimid|revlimid
1085501|NCT02636322|Etoposide|etoposide
1085502|NCT02636322|VePesid|vepesid
1085503|NCT02636322|Prednisone|prednisone
1085504|NCT02636322|Vincristine|vincristine
1085505|NCT02636322|Oncovin|oncovin
1085506|NCT02636322|Cyclophosphamide|cyclophosphamide
1085507|NCT02636322|Cytoxan|cytoxan
1085508|NCT02636322|Neosar|neosar
1085509|NCT02636322|Doxorubicin|doxorubicin
1085510|NCT02636322|Hydroxydaunorubicin|hydroxydaunorubicin
1085511|NCT02636322|Adriamycin PFS|adriamycin pfs
1085512|NCT02636322|Adriamycin RDF|adriamycin rdf
1085513|NCT02636322|Adriamycin|adriamycin
1085514|NCT02636322|Rubex|rubex
1085515|NCT02636309|ergonomics|ergonomics
1085516|NCT02636309|multifaceted intervention|multifaceted intervention
1085517|NCT02636309|industry|industry
1085518|NCT02636309|physiotherapy|physiotherapy
1085519|NCT02636309|physical exercises|physical exercises
1085520|NCT02636309|workplace|workplace
1085521|NCT02636309|acupuncture|acupuncture
1085522|NCT02636309|work|work
1085523|NCT02636309|quality of life|quality of life
1085524|NCT02636309|absenteeism|absenteeism
1085525|NCT02636309|efficiency|efficiency
1085526|NCT02636309|musculoskeletal pain|musculoskeletal pain
1085527|NCT02636309|WMSD|wmsd
1085528|NCT02636296|Pilates method|pilates method
1085529|NCT02636296|elderly|elderly
1085530|NCT02636296|postural balance|postural balance
1085531|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
1085532|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
1085533|NCT02636231|Endostar|endostar
1085534|NCT02636231|IMRT|imrt
1085535|NCT02636231|recurrent|recurrent
1085537|NCT02636218|Ketamine|ketamine
1085538|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
1085539|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1085540|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
1085541|NCT02636166|Pregnancy|pregnancy
1085542|NCT02636153|phosphorus,dietary|phosphorus,dietary
1085543|NCT02636153|circadian rhythm|circadian rhythm
1085544|NCT02636153|phosphorus|phosphorus
1085545|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
1085546|NCT02636062|Coronary disease|coronary disease
1085547|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
1085548|NCT02636062|Endothelial dysfunction|endothelial dysfunction
1085549|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
1085550|NCT02636049|pharmacokinetics|pharmacokinetics
1085551|NCT02636049|healthy adult volunteer|healthy adult volunteer
1085552|NCT02635997|osteoporosis|osteoporosis
1085553|NCT02635997|ibandronate|ibandronate
1085554|NCT02635997|vitamine D|vitamine d
1085555|NCT02635997|calcium|calcium
1085556|NCT02635997|bone mineral density|bone mineral density
1085557|NCT02635997|health-related quality of life|health-related quality of life
1085558|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
1085559|NCT02635971|randomized controlled trial|randomized controlled trial
1085560|NCT02635971|chemotherapy|chemotherapy
1085561|NCT02635958|Body Mass Index|body mass index
1085562|NCT02635958|BMI|bmi
1085563|NCT02635958|InBody|inbody
1085564|NCT02635958|iDXA|idxa
1085565|NCT02635958|validation|validation
1085566|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
1085567|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
1085568|NCT02635945|COPD|copd
1085569|NCT02635945|asthma|asthma
1085570|NCT02635919|Nicotine addiction|nicotine addiction
1085571|NCT02635919|Cigarette smoking|cigarette smoking
1085572|NCT02635919|Smoking cessation|smoking cessation
1085573|NCT02635919|Quit smoking|quit smoking
1085574|NCT02635906|BED REST|bed rest
1085575|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
1085576|NCT02635893|SCI|sci
1085577|NCT02635867|vital pulp|vital pulp
1085578|NCT02635867|reversible pulpitis|reversible pulpitis
1085579|NCT02635867|pulp capping|pulp capping
1085580|NCT02635867|deep cavity|deep cavity
1085581|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
1085582|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
1085583|NCT02635854|platelet activation|platelet activation
1085584|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
1085585|NCT02635841|PKAN|pkan
1085586|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
1085587|NCT02635841|NBIA|nbia
1085588|NCT02635841|Deferiprone|deferiprone
1085589|NCT02635841|Ferriprox|ferriprox
1085590|NCT02635828|Palonosetron|palonosetron
1085591|NCT02635828|Craniotomy|craniotomy
1085592|NCT02635828|Nausea|nausea
1085593|NCT02635828|Vomiting|vomiting
1085594|NCT02635802|remifentanil|remifentanil
1085595|NCT02635802|analgesia|analgesia
1085596|NCT02635802|intensive care units|intensive care units
1085597|NCT02635789|Sirolimus|sirolimus
1085598|NCT02635789|Skin lesions|skin lesions
1085599|NCT02635789|TSC|tsc
1085600|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
1085601|NCT02635789|NPC-12G|npc-12g
1085602|NCT02635789|Angiofibroma|angiofibroma
1085603|NCT02635789|Hypomelanotic macule|hypomelanotic macule
1085604|NCT02635789|Plaque|plaque
1085605|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
1085606|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
1085607|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
1085608|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
1085609|NCT02635776|Oral Immunotherapy|oral immunotherapy
1085610|NCT02635776|Peanut Allergy|peanut allergy
1085611|NCT02635776|Allergy|allergy
1085612|NCT02635776|Peanut-Allergic Children|peanut-allergic children
1085613|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
1085614|NCT02635776|Desensitization|desensitization
1085615|NCT02635763|nerve block|nerve block
1085616|NCT02635763|general anesthesia|general anesthesia
1085617|NCT02635763|hip fracture|hip fracture
1085618|NCT02635763|recovery|recovery
1085619|NCT02635724|Acute uncomplicated|acute uncomplicated
1085620|NCT02635724|Elderly|elderly
1085621|NCT02635685|Atrial fibrillation|atrial fibrillation
1085622|NCT02635685|Stroke|stroke
1085623|NCT02635685|Clinical Decision Support|clinical decision support
1085624|NCT02635685|Anticoagulants|anticoagulants
1085625|NCT02635672|Solid tumors|solid tumors
1085626|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
1085627|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
1085628|NCT02635633|partial epilepsy|partial epilepsy
1085629|NCT02635633|unifocal neocortical|unifocal neocortical
1085630|NCT02635633|treatment resistant|treatment resistant
1085631|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
1085632|NCT02635633|thetaburst stimulation|thetaburst stimulation
1085633|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
1085634|NCT02635607|GnRH antagonist|gnrh antagonist
1085635|NCT02635607|fixed protocol|fixed protocol
1085636|NCT02635607|flexible protocol|flexible protocol
1085637|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
1085734|NCT02635113|falls|falls
1085638|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
1085639|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
1085640|NCT02635503|colorectal cancer|colorectal cancer
1085641|NCT02635503|laparoscopic surgery|laparoscopic surgery
1085642|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
1085643|NCT02635503|Inflammatory response|inflammatory response
1085644|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
1085645|NCT02635451|vitamin c|vitamin c
1085646|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
1085647|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
1085648|NCT02635412|Placenta|placenta
1085649|NCT02635412|Accreta|accreta
1085650|NCT02635412|Morbidly|morbidly
1085651|NCT02635412|Adherent Placenta|adherent placenta
1085652|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
1085653|NCT02635386|PCOS|pcos
1085654|NCT02635386|GLP1 agonists|glp1 agonists
1085655|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
1085656|NCT02635373|Calciphylaxis|calciphylaxis
1085657|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
1085658|NCT02635373|Renal insufficiency|renal insufficiency
1085659|NCT02635373|ESRD|esrd
1085660|NCT02635373|Calcification|calcification
1085661|NCT02635373|Chronic kidney disease|chronic kidney disease
1085662|NCT02635373|Dialysis|dialysis
1085663|NCT02635373|Vascular disease|vascular disease
1085664|NCT02635360|advanced|advanced
1085665|NCT02635360|cervical cancer|cervical cancer
1085666|NCT02635360|pembrolizumab|pembrolizumab
1085667|NCT02635360|chemoradiation|chemoradiation
1085668|NCT02635360|immunotherapy|immunotherapy
1085669|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
1085670|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
1085671|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
1085672|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
1085673|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
1085674|NCT02635347|Brain Death Organ Donor|brain death organ donor
1085675|NCT02635321|MRI|mri
1085676|NCT02635321|LGMD|lgmd
1085677|NCT02635321|GMPPB|gmppb
1085678|NCT02635308|hip fracture|hip fracture
1085679|NCT02635308|physical function|physical function
1085680|NCT02635308|muscle function|muscle function
1085681|NCT02635308|symmetry|symmetry
1085682|NCT02635295|Clinical practicum|clinical practicum
1085683|NCT02635295|Nursing student|nursing student
1085684|NCT02635295|Nurse teacher|nurse teacher
1085685|NCT02635295|Mobile technology|mobile technology
1085686|NCT02635295|Cooperation|cooperation
1085687|NCT02635295|Nurse competence|nurse competence
1085688|NCT02635269|Ergometry|ergometry
1085689|NCT02635269|Stable isotope tracers|stable isotope tracers
1085690|NCT02635256|hypofractionation|hypofractionation
1085691|NCT02635256|prostate cancer|prostate cancer
1085692|NCT02635256|radiotherapy|radiotherapy
1085693|NCT02635230|Atrial Fibrillations|atrial fibrillations
1085694|NCT02635230|Heart Valve Prostheses|heart valve prostheses
1085695|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
1085696|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
1085697|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1085698|NCT02635230|Coronary Artery Diseases|coronary artery diseases
1085699|NCT02635230|Myocardial Infarction|myocardial infarction
1085700|NCT02635230|Ischemic stroke|ischemic stroke
1085701|NCT02635230|Bleeding|bleeding
1085702|NCT02635230|Thrombosis|thrombosis
1085703|NCT02635230|Myocardial Ischemia|myocardial ischemia
1085704|NCT02635230|Heart Diseases|heart diseases
1085705|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
1085706|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
1085707|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1085708|NCT02635230|Aspirin|aspirin
1085709|NCT02635230|Clopidogrel|clopidogrel
1085710|NCT02635230|Ticagrelor|ticagrelor
1085711|NCT02635230|Prasugrel|prasugrel
1085712|NCT02635230|Antithrombotic treatment|antithrombotic treatment
1085713|NCT02635230|Oral anticoagulation|oral anticoagulation
1085714|NCT02635230|Warfarin|warfarin
1085715|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
1085716|NCT02635230|Apixaban|apixaban
1085717|NCT02635230|Rivaroxaban|rivaroxaban
1085718|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
1085719|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
1085720|NCT02635217|Colonoscopy|colonoscopy
1085721|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
1085722|NCT02635217|Patient satisfaction|patient satisfaction
1085723|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
1085724|NCT02635191|Helicobacter pylori|helicobacter pylori
1085725|NCT02635191|Therapy|therapy
1085726|NCT02635191|Children|children
1085727|NCT02635139|meal skipping|meal skipping
1085728|NCT02635139|isocaloric diet|isocaloric diet
1085729|NCT02635139|macronutrient oxidation|macronutrient oxidation
1085730|NCT02635139|glucose homeostasis|glucose homeostasis
1085731|NCT02635139|arterial stiffness|arterial stiffness
1085732|NCT02635113|balance|balance
1085733|NCT02635113|gait|gait
1085735|NCT02635113|sensory deficits|sensory deficits
1085736|NCT02635113|vibration|vibration
1085737|NCT02635113|visual acuity|visual acuity
1085738|NCT02635113|dizziness|dizziness
1085739|NCT02635113|postural control|postural control
1085740|NCT02635113|proprioceptive function|proprioceptive function
1085741|NCT02635113|stereoacuity|stereoacuity
1085742|NCT02635113|depth perception|depth perception
1085743|NCT02635113|vestibular dysfunction|vestibular dysfunction
1085744|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
1085745|NCT02635100|Sleep Apnea|sleep apnea
1085746|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
1085747|NCT02635048|Kidney stones|kidney stones
1085748|NCT02635048|Efficacy|efficacy
1085749|NCT02635048|Safety|safety
1085750|NCT02635022|Fracture|fracture
1085751|NCT02635022|Sarcopenia|sarcopenia
1085752|NCT02635022|Osteoporosis|osteoporosis
1085753|NCT02635022|Care management|care management
1085754|NCT02635022|Medication adherence|medication adherence
1085755|NCT02634983|COPD|copd
1085756|NCT02634983|Smokers|smokers
1085757|NCT02634983|Ex-smokers|ex-smokers
1085758|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
1085759|NCT02634957|phonomicrosurgery|phonomicrosurgery
1085760|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
1085761|NCT02634957|voice rest|voice rest
1085762|NCT02634957|vhi-10|vhi-10
1085763|NCT02634957|CPP|cpp
1085764|NCT02634944|Concussion|concussion
1085765|NCT02634944|Vestibular|vestibular
1085766|NCT02634944|Ocular-Motor|ocular-motor
1085767|NCT02634931|Sirolimus|sirolimus
1085768|NCT02634931|Skin lesions|skin lesions
1085770|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
1085771|NCT02634931|NPC-12G|npc-12g
1085772|NCT02634931|Angiofibroma|angiofibroma
1085773|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
1085774|NCT02634931|Plaque|plaque
1085775|NCT02634918|ultrasound,|ultrasound,
1085776|NCT02634918|ultrasonography|ultrasonography
1085777|NCT02634918|hemophilic joint|hemophilic joint
1085778|NCT02634918|Doppler|doppler
1085779|NCT02634905|atopic dermatitis|atopic dermatitis
1085780|NCT02634905|Therapeutic patient education|therapeutic patient education
1085781|NCT02634905|pediatric dermatology|pediatric dermatology
1085782|NCT02634892|Sacral|sacral
1085783|NCT02634892|Overlay Mattress|overlay mattress
1085784|NCT02634892|Cooling|cooling
1085785|NCT02634866|hypertension|hypertension
1085786|NCT02634866|exercise|exercise
1085787|NCT02634866|diastolic heart failure|diastolic heart failure
1085788|NCT02634853|Dry Eye|dry eye
1085789|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
1085790|NCT02634840|neurosensory disturbance|neurosensory disturbance
1085791|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
1085792|NCT02634840|mandibular surgery|mandibular surgery
1085793|NCT02634840|neurosensory function|neurosensory function
1085794|NCT02634801|Fumaderm|fumaderm
1085795|NCT02634788|Post-Surgical Pain|post-surgical pain
1085796|NCT02634788|Bunionectomy|bunionectomy
1085797|NCT02634775|Pediatrics|pediatrics
1085798|NCT02634775|Nephrology|nephrology
1085799|NCT02634775|Dialysis|dialysis
1085800|NCT02634749|Nordic countries|nordic countries
1085801|NCT02634749|Eating behavior|eating behavior
1085802|NCT02634749|Human microbiome|human microbiome
1085803|NCT02634749|Child nutrition|child nutrition
1085804|NCT02634749|Metabolic profile|metabolic profile
1085805|NCT02634749|Body composition|body composition
1085806|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
1085807|NCT02634697|Atrial Fibrillation|atrial fibrillation
1085808|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
1085809|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
1085810|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
1085811|NCT02634697|Quality of Life|quality of life
1085812|NCT02634697|AF|af
1085813|NCT02634697|QOL|qol
1085814|NCT02634697|3RP|3rp
1085815|NCT02634684|Schizophrenia|schizophrenia
1085816|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
1085817|NCT02634684|Mental Disorders|mental disorders
1085818|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
1085819|NCT02634684|Antiparkinson Agents|antiparkinson agents
1085820|NCT02634684|Central Nervous System Agents|central nervous system agents
1085821|NCT02634684|Dopamine Agents|dopamine agents
1085822|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
1085823|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
1085824|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1085825|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
1085826|NCT02634684|Pharmacologic Actions|pharmacologic actions
1085827|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
1085828|NCT02634684|Therapeutic Uses|therapeutic uses
1085829|NCT02634684|Prepulse inhibition|prepulse inhibition
1085830|NCT02634684|Neurocognition|neurocognition
1085831|NCT02634684|Working memory|working memory
1085832|NCT02634684|Dextroamphetamine|dextroamphetamine
1085833|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
1085834|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
1085835|NCT02634684|Sensory discrimination learning|sensory discrimination learning
1085836|NCT02634684|Targeted Cognitive Training|targeted cognitive training
1085837|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
1085838|NCT02634671|schizophrenia|schizophrenia
1085839|NCT02634671|Facial emotions|facial emotions
1085840|NCT02634619|urethral stricture|urethral stricture
1085841|NCT02634606|Cholesterol|cholesterol
1085842|NCT02634593|nutrition|nutrition
1085843|NCT02634580|Japanese|japanese
1085844|NCT02634580|High cholesterol|high cholesterol
1085845|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
1085846|NCT02634580|Lowering cholesterol|lowering cholesterol
1085847|NCT02634580|Lowering high cholesterol|lowering high cholesterol
1085848|NCT02634580|Hypercholesterolemia|hypercholesterolemia
1085849|NCT02634580|Statin intolerant|statin intolerant
1085850|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
1085851|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
1085852|NCT02634502|radiofrequency|radiofrequency
1085853|NCT02634502|chemotherapy|chemotherapy
1085854|NCT02634502|microRNA|microrna
1085855|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
1085856|NCT02634489|Overactive bladder|overactive bladder
1085857|NCT02634489|Urinary incontinence|urinary incontinence
1085858|NCT02634489|Omnic OCAS®|omnic ocas®
1085859|NCT02634489|Vesicare®|vesicare®
1085860|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
1085861|NCT02634489|Solifenacin succinate|solifenacin succinate
1085862|NCT02634476|Alcohol|alcohol
1085863|NCT02634476|Substance use disorder|substance use disorder
1085864|NCT02634476|cognitive bias|cognitive bias
1085865|NCT02634476|behavioral intervention|behavioral intervention
1085866|NCT02634476|computerised training|computerised training
1085867|NCT02634463|Immunoassay|immunoassay
1085868|NCT02634463|Antipsychotic|antipsychotic
1085869|NCT02634463|Aripiprazole|aripiprazole
1085870|NCT02634463|Olanzapine|olanzapine
1085871|NCT02634463|Paliperidone|paliperidone
1085872|NCT02634463|Risperidone|risperidone
1085873|NCT02634450|HIV|hiv
1085874|NCT02634450|Diagnostic|diagnostic
1085875|NCT02634450|children|children
1085876|NCT02634424|Hemophilia A|hemophilia a
1085877|NCT02634424|Prophylaxy|prophylaxy
1085878|NCT02634424|Pharmacokinetic|pharmacokinetic
1085879|NCT02634424|Bayesian|bayesian
1085880|NCT02634411|Ventilator Associated|ventilator associated
1085881|NCT02634411|Pneumonia|pneumonia
1085882|NCT02634411|Antibiotic treatment|antibiotic treatment
1085883|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
1085884|NCT02634372|Bipolar Disorder|bipolar disorder
1085885|NCT02634372|Traumatic event|traumatic event
1085886|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
1085887|NCT02634372|Supportive therapy|supportive therapy
1085888|NCT02634372|Relapse prevention|relapse prevention
1085889|NCT02634346|Alkermes|alkermes
1085890|NCT02634346|ALKS 3831|alks 3831
1085891|NCT02634346|Samidorphan|samidorphan
1085892|NCT02634346|Schizophrenia|schizophrenia
1085893|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
1085894|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1085895|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
1085896|NCT02634320|Alkermes|alkermes
1085897|NCT02634320|ARISTADA|aristada
1085898|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
1085899|NCT02634320|Schizophrenia|schizophrenia
1085900|NCT02634307|Multiple Sclerosis|multiple sclerosis
1085901|NCT02634307|MS|ms
1085902|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1085903|NCT02634307|RRMS|rrms
1085904|NCT02634307|dimethyl fumarate|dimethyl fumarate
1085905|NCT02634307|DMF|dmf
1085906|NCT02634294|Hematological Neoplasms|hematological neoplasms
1085907|NCT02634294|recurrence|recurrence
1085908|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1085909|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
1085910|NCT02634294|Graft vs Host Disease|graft vs host disease
1085911|NCT02634268|randomized controlled trial|randomized controlled trial
1085912|NCT02634268|diet|diet
1085913|NCT02634268|exercise|exercise
1085914|NCT02634268|obesity|obesity
1085915|NCT02634268|overweight|overweight
1085916|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1085917|NCT02634268|lifestyle|lifestyle
1085918|NCT02634255|rocuronium|rocuronium
1085919|NCT02634255|onset time|onset time
1085920|NCT02634255|anxiety|anxiety
1085921|NCT02634242|Si Wu Tang|si wu tang
1085922|NCT02634242|antioxidation|antioxidation
1085923|NCT02634242|anthropometric measurements|anthropometric measurements
1085924|NCT02634242|liver|liver
1085925|NCT02634242|skin|skin
1085926|NCT02634229|monogenic diabetes|monogenic diabetes
1085927|NCT02634229|MODY|mody
1085928|NCT02634229|beta-cell|beta-cell
1085929|NCT02634229|insulin secretion|insulin secretion
1085930|NCT02634216|Hyperglycemia|hyperglycemia
1085931|NCT02634216|Capros|capros
1085932|NCT02634216|Type 1 Diabetes|type 1 diabetes
1085933|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
1085934|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
1085935|NCT02634203|Riociguat|riociguat
1085936|NCT02634190|Cervical cancer screening|cervical cancer screening
1085937|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
1085938|NCT02634190|Aptima HPV Assay|aptima hpv assay
1085939|NCT02634177|Genotyping|genotyping
1085940|NCT02634177|Genecept Assay™|genecept assay™
1085941|NCT02634164|leucine|leucine
1085942|NCT02634164|isoleucine|isoleucine
1085943|NCT02634151|LDL‐C|ldl‐c
1085944|NCT02634151|Lipid Regulator|lipid regulator
1085945|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
1085946|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
1085947|NCT02634112|anastomotic leakage|anastomotic leakage
1085948|NCT02634112|rectal cancer surgery|rectal cancer surgery
1085949|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
1085950|NCT02634099|major pediatric surgery|major pediatric surgery
1085951|NCT02634099|hemoglobin measurement|hemoglobin measurement
1085952|NCT02634086|Coronary artery disease|coronary artery disease
1085953|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
1085954|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
1085955|NCT02634086|Medication therapy|medication therapy
1085956|NCT02634073|Lamivudine|lamivudine
1085957|NCT02634073|Safety|safety
1085958|NCT02634073|Sorbitol|sorbitol
1085959|NCT02634073|Pharmacokinetics|pharmacokinetics
1085960|NCT02634060|adalimumab|adalimumab
1085961|NCT02634060|fecal calprotectin|fecal calprotectin
1085962|NCT02634060|home based|home based
1085963|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
1085964|NCT02634047|videolaryngoscope|videolaryngoscope
1085965|NCT02634047|oropharyngeal injury|oropharyngeal injury
1085966|NCT02634008|Pangenotypic|pangenotypic
1085967|NCT02634008|Treatment|treatment
1085968|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1085969|NCT02633956|NAFLD|nafld
1085970|NCT02633956|Fatty Liver Disease|fatty liver disease
1085971|NCT02633956|NASH|nash
1085972|NCT02633930|helicobacter pylori|helicobacter pylori
1085973|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
1085974|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
1085975|NCT02633917|Low back pain|low back pain
1085976|NCT02633917|Motor control|motor control
1085977|NCT02633917|Joint mobilization|joint mobilization
1085978|NCT02633904|Hip Dislocation|hip dislocation
1085979|NCT02633904|Congenital|congenital
1085980|NCT02633904|osteotomy|osteotomy
1085981|NCT02633904|Femur Head Necrosis|femur head necrosis
1085982|NCT02633891|neuropathies|neuropathies
1085983|NCT02633891|metabolic diseases|metabolic diseases
1085984|NCT02633891|nervous system diseases|nervous system diseases
1085985|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
1085986|NCT02633865|patient characteristics|patient characteristics
1085987|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
1085988|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
1085989|NCT02633839|Adults|adults
1085990|NCT02633826|alloreactive T cell|alloreactive t cell
1085991|NCT02633826|donor-specific antibody|donor-specific antibody
1085992|NCT02633813|Bioequivalence|bioequivalence
1085993|NCT02633813|Tinea pedis|tinea pedis
1085994|NCT02633813|Naftin|naftin
1085995|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
1085996|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
1085997|NCT02633800|Head and neck cancer|head and neck cancer
1085998|NCT02633800|Neoplasms by site|neoplasms by site
1085999|NCT02633787|Meningitis|meningitis
1086000|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
1086001|NCT02633787|Meningococcal Infections|meningococcal infections
1086002|NCT02633787|Menactra®|menactra®
1086003|NCT02633761|Fetal death|fetal death
1086004|NCT02633761|mifepristone|mifepristone
1086005|NCT02633761|misoprostol|misoprostol
1086006|NCT02633735|Clinical Decision Support|clinical decision support
1086007|NCT02633696|Clinical trial|clinical trial
1086008|NCT02633696|Phase I|phase i
1086009|NCT02633696|Healthy volunteers|healthy volunteers
1086010|NCT02633696|Clinical Pharmacology|clinical pharmacology
1086011|NCT02633696|Bioavailability|bioavailability
1086012|NCT02633696|Silybin|silybin
1086013|NCT02633696|Liver Trasplantation|liver trasplantation
1086014|NCT02633683|Restless Legs Syndrome|restless legs syndrome
1086016|NCT02633657|Restless Legs Syndrome|restless legs syndrome
1086017|NCT02633657|RLS|rls
1086018|NCT02633644|Heart Failure|heart failure
1086019|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
1086020|NCT02633644|Heart Diseases|heart diseases
1086021|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
1086022|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
1086023|NCT02633592|Balloon Expulsion|balloon expulsion
1086024|NCT02633592|Position|position
1086025|NCT02633579|Healthy volunteers|healthy volunteers
1086026|NCT02633566|Flatfoot|flatfoot
1086027|NCT02633566|orthoses|orthoses
1086028|NCT02633566|children|children
1086030|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
1086031|NCT02633553|complete resection|complete resection
1086032|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
1086033|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
1086034|NCT02633514|thymoma|thymoma
1086035|NCT02633514|thymic carcinoma|thymic carcinoma
1086036|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
1086037|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
1086038|NCT02633514|incomplete resection|incomplete resection
1086039|NCT02633475|interleukin-10|interleukin-10
1086040|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1086041|NCT02633449|tDCS|tdcs
1086042|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
1086043|NCT02633436|esophageal cancer|esophageal cancer
1086044|NCT02633436|SLC1A5|slc1a5
1086045|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
1086046|NCT02633423|Mechanical ventilation|mechanical ventilation
1086047|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
1086048|NCT02633423|Best PEEP|best peep
1086049|NCT02633397|SCD|scd
1086050|NCT02633397|Sickle Cell Disease|sickle cell disease
1086051|NCT02633397|Riociguat|riociguat
1086052|NCT02633397|Adempas|adempas
1086053|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
1086054|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
1086055|NCT02633384|Surgical neonates|surgical neonates
1086056|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
1086057|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
1086058|NCT02633319|Parenting|parenting
1086764|NCT02629796|CIDP|cidp
1086060|NCT02633319|Economic strengthening|economic strengthening
1086061|NCT02633319|Early childhood development|early childhood development
1086062|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
1086063|NCT02633319|Pilot evaluation|pilot evaluation
1086065|NCT02633293|Treprostinil|treprostinil
1086066|NCT02633293|PH|ph
1086067|NCT02633293|ILD|ild
1086068|NCT02633293|CPFE|cpfe
1086069|NCT02633293|6 Minute Walk Test|6 minute walk test
1086070|NCT02633267|social anxiety|social anxiety
1086071|NCT02633267|unemployment|unemployment
1086072|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
1086073|NCT02633267|group therapy|group therapy
1086074|NCT02633267|work|work
1086075|NCT02633267|vocation|vocation
1086076|NCT02633241|pediatrics|pediatrics
1086077|NCT02633241|sedation|sedation
1086078|NCT02633241|dexmedetomidine|dexmedetomidine
1086079|NCT02633241|propofol|propofol
1086081|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
1086082|NCT02633228|Binocular Trifocality|binocular trifocality
1086083|NCT02633228|Cataract Surgery|cataract surgery
1086084|NCT02633228|Spectacle Independence|spectacle independence
1086085|NCT02633228|Intermediate Vision|intermediate vision
1086086|NCT02633228|Photopic Vision|photopic vision
1086087|NCT02633228|Mesopic Vision|mesopic vision
1086088|NCT02633228|Scotopic Vision|scotopic vision
1086089|NCT02633228|Binocular Vision|binocular vision
1086090|NCT02633215|motor recovery|motor recovery
1086091|NCT02633215|neuroplasticity|neuroplasticity
1086093|NCT02633215|human|human
1086094|NCT02633215|sensory|sensory
1086095|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1086096|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1086097|NCT02633202|intermediate risk|intermediate risk
1086098|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1086099|NCT02633189|stage IV|stage iv
1086100|NCT02633189|stage IIIB|stage iiib
1086101|NCT02633189|EGFR mutation|egfr mutation
1086102|NCT02633189|non-squamous|non-squamous
1086103|NCT02633189|liquid biopsy|liquid biopsy
1086104|NCT02633189|erlotinib|erlotinib
1086105|NCT02633189|bevacizumab|bevacizumab
1086106|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
1086107|NCT02633163|Stem Cell|stem cell
1086108|NCT02633163|Lupus|lupus
1086109|NCT02633150|Obesity|obesity
1086110|NCT02633150|insulinoresistant|insulinoresistant
1086111|NCT02633150|menopausal women|menopausal women
1086112|NCT02633150|polyphenol|polyphenol
1086113|NCT02633137|Lenalidomide|lenalidomide
1086114|NCT02633137|15-196|15-196
1086115|NCT02633124|Premature infants|premature infants
1086116|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
1086117|NCT02633124|Infusion device|infusion device
1086118|NCT02633124|Neonatal intensive care|neonatal intensive care
1086119|NCT02633124|Central Venous Catheter|central venous catheter
1086120|NCT02633124|Drug Infusion Systems|drug infusion systems
1086121|NCT02633111|DNA Sequencing|dna sequencing
1086122|NCT02633111|15-180|15-180
1086123|NCT02633098|Artesunate|artesunate
1086124|NCT02633098|Artemisinins|artemisinins
1086125|NCT02633098|Antimalarial|antimalarial
1086126|NCT02633098|Neoadjuvant|neoadjuvant
1086127|NCT02633098|Pre-operative|pre-operative
1086128|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
1086129|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
1086130|NCT02633072|Binocular Trifocality|binocular trifocality
1086131|NCT02633072|Cataract Surgery|cataract surgery
1086625|NCT02630459|Headache|headache
1086132|NCT02633072|Spectacle Independence|spectacle independence
1086133|NCT02633072|Intermediate Vision|intermediate vision
1086134|NCT02633072|Photopic Vision|photopic vision
1086135|NCT02633072|Mesopic Vision|mesopic vision
1086136|NCT02633072|Scotopic Vision|scotopic vision
1086137|NCT02633072|Binocular Vision|binocular vision
1086138|NCT02633046|FSGS|fsgs
1086139|NCT02633046|primary FSGS|primary fsgs
1086140|NCT02633046|idiopathic FSGS|idiopathic fsgs
1086141|NCT02633033|Multiple Sclerosis|multiple sclerosis
1086142|NCT02633033|Relapsing-Remitting|relapsing-remitting
1086143|NCT02633033|Acthar|acthar
1086144|NCT02633033|Corticotropin|corticotropin
1086145|NCT02633033|MS|ms
1086146|NCT02632981|Interleukin-32|interleukin-32
1086147|NCT02632981|periodontitis|periodontitis
1086148|NCT02632955|arteriovenous fistula|arteriovenous fistula
1086149|NCT02632955|hemodialysis|hemodialysis
1086150|NCT02632955|drug coated balloon|drug coated balloon
1086151|NCT02632942|arteriovenous fistula|arteriovenous fistula
1086152|NCT02632942|hemodialysis|hemodialysis
1086153|NCT02632942|maturation|maturation
1086154|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
1086155|NCT02632929|wound healing|wound healing
1086156|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
1086157|NCT02632877|pirfenidone|pirfenidone
1086158|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
1086159|NCT02632877|ketanserin|ketanserin
1086160|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
1086161|NCT02632851|inhalation|inhalation
1086162|NCT02632851|isotonic saline|isotonic saline
1086163|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
1086164|NCT02632851|Ectoin|ectoin
1086165|NCT02632851|bronchitis|bronchitis
1086166|NCT02632851|respiratory tract infection|respiratory tract infection
1086167|NCT02632838|Hypertension|hypertension
1086168|NCT02632838|mHealth|mhealth
1086169|NCT02632838|underserved community|underserved community
1086170|NCT02632825|Nasal High Flow|nasal high flow
1086171|NCT02632825|gas exchange|gas exchange
1086172|NCT02632825|newborn|newborn
1086173|NCT02632799|Nasal High Flow|nasal high flow
1086174|NCT02632799|CPAP|cpap
1086175|NCT02632799|airway pressure|airway pressure
1086176|NCT02632799|newborn|newborn
1086177|NCT02632786|amyloidosis|amyloidosis
1086178|NCT02632786|ntprobnp|ntprobnp
1086179|NCT02632786|NEOD001|neod001
1086180|NCT02632786|Prothena|prothena
1086181|NCT02632786|PRONTO|pronto
1086182|NCT02632786|amyloid|amyloid
1086183|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
1086184|NCT02632786|immunotherapy|immunotherapy
1086185|NCT02632773|Language Intervention|language intervention
1086186|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
1086187|NCT02632734|alveolar bone preservation|alveolar bone preservation
1086188|NCT02632734|coral grafting device|coral grafting device
1086189|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
1086190|NCT02632708|AML|aml
1086191|NCT02632708|Untreated AML|untreated aml
1086192|NCT02632708|De novo AML|de novo aml
1086193|NCT02632708|Secondary AML|secondary aml
1086194|NCT02632708|Newly diagnosed AML|newly diagnosed aml
1086195|NCT02632708|IDH1|idh1
1086196|NCT02632708|IDH2|idh2
1086197|NCT02632708|Induction therapy|induction therapy
1086198|NCT02632708|Consolidation therapy|consolidation therapy
1086199|NCT02632708|IDH|idh
1086200|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
1086201|NCT02632669|Focal brachytherapy|focal brachytherapy
1086202|NCT02632669|Seed implant|seed implant
1086203|NCT02632669|Quality of life|quality of life
1086204|NCT02632669|Toxicity|toxicity
1086205|NCT02632643|TMD|tmd
1086206|NCT02632643|HYPERTONIA|hypertonia
1086207|NCT02632643|PARAFUNCTIONS|parafunctions
1086208|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
1086209|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
1086210|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
1086211|NCT02632630|Acute Care hospitals|acute care hospitals
1086212|NCT02632617|Heart Valve Diseases|heart valve diseases
1086213|NCT02632617|Coronary Artery Disease|coronary artery disease
1086214|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
1086215|NCT02632617|Preoperative Procedure|preoperative procedure
1086216|NCT02632565|osteoarthritis|osteoarthritis
1086217|NCT02632565|lidocaine|lidocaine
1086218|NCT02632565|pain|pain
1086219|NCT02632565|ultrasound|ultrasound
1086220|NCT02632552|care transition|care transition
1086221|NCT02632552|technology|technology
1086222|NCT02632552|chronic heart failure|chronic heart failure
1086223|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1086224|NCT02632552|virtual nurse|virtual nurse
1086225|NCT02632552|texting|texting
1086226|NCT02632552|informatics|informatics
1086227|NCT02632552|Veterans|veterans
1086228|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
1086229|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
1086230|NCT02632539|manual air-impingement operation|manual air-impingement operation
1086231|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
1086232|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
1086626|NCT02630459|Prophylaxis|prophylaxis
1086233|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
1086234|NCT02632526|Placebo-controlled|placebo-controlled
1086235|NCT02632526|Safety|safety
1086236|NCT02632526|Tolerability|tolerability
1086237|NCT02632526|Pharmacokinetics|pharmacokinetics
1086238|NCT02632526|Pharmacodynamics|pharmacodynamics
1086239|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
1086240|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
1086241|NCT02632500|Cardiac Arrest|cardiac arrest
1086242|NCT02632500|Training|training
1086243|NCT02632474|HIV Infections|hiv infections
1086244|NCT02632474|Tenofovir|tenofovir
1086245|NCT02632474|Efavirenz|efavirenz
1086246|NCT02632461|Diet|diet
1086247|NCT02632461|Weight Loss|weight loss
1086248|NCT02632461|Tracking|tracking
1086249|NCT02632461|Calories|calories
1086250|NCT02632448|Metastatic cancer|metastatic cancer
1086251|NCT02632448|Advanced cancer|advanced cancer
1086252|NCT02632448|Recurrent cancer|recurrent cancer
1086253|NCT02632448|Colorectal neoplasms|colorectal neoplasms
1086254|NCT02632448|Triple negative breast cancer|triple negative breast cancer
1086255|NCT02632448|Ovarian neoplasms|ovarian neoplasms
1086256|NCT02632448|Colon neoplasms|colon neoplasms
1086257|NCT02632448|Rectal neoplasms|rectal neoplasms
1086258|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
1086259|NCT02632448|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1086260|NCT02632435|HER2 positive|her2 positive
1086261|NCT02632383|Diabetes type 1|diabetes type 1
1086263|NCT02632383|Telemedicine|telemedicine
1086264|NCT02632383|mHealth app|mhealth app
1086265|NCT02632383|Youth|youth
1086266|NCT02632383|Self-management|self-management
1086267|NCT02632370|Malignant Gliomas|malignant gliomas
1086268|NCT02632370|5-ALA|5-ala
1086269|NCT02632370|tumor resection|tumor resection
1086270|NCT02632370|malignant tumor|malignant tumor
1086271|NCT02632357|Neurodynamics|neurodynamics
1086272|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
1086273|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
1086274|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
1086275|NCT02632344|Human papillomavirus|human papillomavirus
1086276|NCT02632344|Virally-related diseases|virally-related diseases
1086277|NCT02632331|Food effect|food effect
1086278|NCT02632331|Pharmacokinetics|pharmacokinetics
1086279|NCT02632331|ASP8825|asp8825
1086280|NCT02632331|XP13512|xp13512
1086281|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
1086282|NCT02632305|nab-paclitaxel|nab-paclitaxel
1086283|NCT02632305|cisplatin|cisplatin
1086284|NCT02632305|gemcitabine|gemcitabine
1086285|NCT02632279|Parkinson's disease|parkinson's disease
1086286|NCT02632279|Deep Brain Stimulation|deep brain stimulation
1086287|NCT02632279|Subthalamic nucleus|subthalamic nucleus
1086288|NCT02632279|Tryptophan depletion|tryptophan depletion
1086289|NCT02632279|Serotonin|serotonin
1086290|NCT02632266|prematurity|prematurity
1086291|NCT02632266|growth|growth
1086292|NCT02632266|nutrition|nutrition
1086293|NCT02632266|human milk fortifier|human milk fortifier
1086294|NCT02632253|exercise therapy|exercise therapy
1086295|NCT02632253|GUCH|guch
1086296|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
1086297|NCT02632253|HIIT|hiit
1086298|NCT02632253|MICE|mice
1086299|NCT02632240|gingival recession|gingival recession
1086300|NCT02632240|mucogingival surgery|mucogingival surgery
1086301|NCT02632240|collagen matrix|collagen matrix
1086302|NCT02632240|connective tissue graft|connective tissue graft
1086303|NCT02632240|tunnel technique|tunnel technique
1086304|NCT02632214|Face processing|face processing
1086305|NCT02632214|asymmetry|asymmetry
1086306|NCT02632214|deaf|deaf
1086307|NCT02632214|fMRI|fmri
1086308|NCT02632201|gastric cancer|gastric cancer
1086309|NCT02632201|liver metastasis|liver metastasis
1086310|NCT02632201|PIK-HER2 cells|pik-her2 cells
1086311|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
1086312|NCT02632188|Recurrence|recurrence
1086313|NCT02632188|Metastasis|metastasis
1086314|NCT02632188|liver cancer|liver cancer
1086315|NCT02632175|Ulcerative Colitis|ulcerative colitis
1086316|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
1086317|NCT02632136|Laparoscopic|laparoscopic
1086318|NCT02632136|TAP Block|tap block
1086319|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
1086320|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1086321|NCT02632123|outcome|outcome
1086322|NCT02632123|prognosis|prognosis
1086323|NCT02632123|survival|survival
1086324|NCT02632110|Actinic Keratosis|actinic keratosis
1086325|NCT02632097|inguinal hernia|inguinal hernia
1086326|NCT02632097|mesh fixation|mesh fixation
1086327|NCT02632097|glue|glue
1086328|NCT02632097|cyanoacrylate|cyanoacrylate
1086329|NCT02632097|Lichtenstein|lichtenstein
1086330|NCT02632097|ambulatory surgery|ambulatory surgery
1086331|NCT02632071|Breast Cancer|breast cancer
1086332|NCT02632071|Breast Carcinoma|breast carcinoma
1086333|NCT02632071|Breast tumors|breast tumors
1086334|NCT02632071|Cancer of the Breast|cancer of the breast
1086335|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
1086336|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
1086337|NCT02632071|Unresectable breast cancer|unresectable breast cancer
1086338|NCT02632045|Breast Neoplasms|breast neoplasms
1086339|NCT02632045|Breast Cancer|breast cancer
1086340|NCT02632045|Breast Carcinoma|breast carcinoma
1086341|NCT02632045|Breast tumors|breast tumors
1086342|NCT02632045|Cancer of the Breast|cancer of the breast
1086343|NCT02632032|Type 1 diabetes|type 1 diabetes
1086344|NCT02632032|children|children
1086345|NCT02632032|diabetes camps|diabetes camps
1086346|NCT02632032|glycemic control|glycemic control
1086347|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
1086348|NCT02632019|dendritic cell|dendritic cell
1086349|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
1086350|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
1086351|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
1086352|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1086353|NCT02631993|Psoralen|psoralen
1086354|NCT02631993|UVA|uva
1086355|NCT02631993|Time-to-treatment|time-to-treatment
1086356|NCT02631993|GVL|gvl
1086357|NCT02631980|Hepcidin|hepcidin
1086358|NCT02631967|Crohn disease|crohn disease
1086359|NCT02631967|ileocecal resection|ileocecal resection
1086360|NCT02631967|anastomosis|anastomosis
1086361|NCT02631967|Kono|kono
1086765|NCT02629796|IVIG|ivig
1086362|NCT02631928|biphasic human insulin|biphasic human insulin
1086363|NCT02631928|biosimilar|biosimilar
1086364|NCT02631902|Community-based intervention|community-based intervention
1086365|NCT02631902|Exercise program|exercise program
1086366|NCT02631902|Dietary intervention program|dietary intervention program
1086367|NCT02631902|Health promotion|health promotion
1086368|NCT02631902|Subjective well-being|subjective well-being
1086369|NCT02631902|Cardiovascular risk|cardiovascular risk
1086370|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
1086371|NCT02631876|Fallopian tube cancer|fallopian tube cancer
1131621|NCT02369263|DVT|dvt
1086372|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
1086373|NCT02631876|IMGN853|imgn853
1086374|NCT02631876|ADC|adc
1086375|NCT02631876|Antibody drug conjugate|antibody drug conjugate
1086376|NCT02631876|ImmunoGen|immunogen
1086377|NCT02631876|Antibody|antibody
1086378|NCT02631876|Folate receptor alpha|folate receptor alpha
1086379|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
1086380|NCT02631876|Phase 3|phase 3
1086381|NCT02631876|platinum-resistant|platinum-resistant
1086382|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
1086383|NCT02631850|gaming|gaming
1086384|NCT02631850|virtual reality|virtual reality
1086385|NCT02631850|upper extremity|upper extremity
1086386|NCT02631850|CI therapy|ci therapy
1086387|NCT02631850|rehabilitation|rehabilitation
1086388|NCT02631850|stroke|stroke
1086389|NCT02631850|hemiparesis|hemiparesis
1086390|NCT02631850|therapy|therapy
1086391|NCT02631837|NOTES|notes
1086392|NCT02631837|Laparoscopic surgery|laparoscopic surgery
1086393|NCT02631824|fragility fractures|fragility fractures
1086394|NCT02631824|hip fractures|hip fractures
1086395|NCT02631824|augmentation|augmentation
1086396|NCT02631824|tip-apex distance|tip-apex distance
1086397|NCT02631811|acute leukaemia|acute leukaemia
1086398|NCT02631811|supportive / palliative care|supportive / palliative care
1086399|NCT02631785|ANXIETY|anxiety
1086400|NCT02631785|CBT|cbt
1086401|NCT02631785|fMRI|fmri
1086402|NCT02631785|Fear conditioning|fear conditioning
1086403|NCT02631785|Fear extinction|fear extinction
1086404|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
1086405|NCT02631720|Chronic Lung Allograft Dysfunction (CLAD)|chronic lung allograft dysfunction (clad)
1086406|NCT02631720|Restrictive chronic lung allograft dysfunction (RCLAD)|restrictive chronic lung allograft dysfunction (rclad)
1086407|NCT02631720|Bronchiolitis Obliterans Syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
1086408|NCT02631720|CLAD risk factors|clad risk factors
1086409|NCT02631720|observational study|observational study
1086410|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
1086411|NCT02631629|Vitamin D|vitamin d
1086412|NCT02631629|Fortification|fortification
1086413|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
1086414|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
1086415|NCT02631616|68Ga-DOTATET|68ga-dotatet
1086416|NCT02631616|PET/CT|pet/ct
1086417|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
1086418|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
1086419|NCT02631590|gall bladder|gall bladder
1086420|NCT02631590|advanced biliary cancer|advanced biliary cancer
1086421|NCT02631590|unresectable|unresectable
1086422|NCT02631590|locally advanced|locally advanced
1086423|NCT02631590|metastatic disease|metastatic disease
1086424|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
1086425|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1086426|NCT02631538|Subcutaneous|subcutaneous
1086427|NCT02631538|Rituximab|rituximab
1086428|NCT02631538|Intravenous|intravenous
1086429|NCT02631538|Safety|safety
1086430|NCT02631538|Efficacy|efficacy
1086431|NCT02631538|Sjogren's syndrome|sjogren's syndrome
1086432|NCT02631538|Belimumab|belimumab
1086433|NCT02631525|Airway extubation|airway extubation
1086434|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
1086435|NCT02631525|Desflurane|desflurane
1086436|NCT02631525|Propofol|propofol
1086437|NCT02631525|Intravenous anesthesia|intravenous anesthesia
1086438|NCT02631525|Balanced Anesthesia|balanced anesthesia
1086439|NCT02631499|Circulating Tumor Cells|circulating tumor cells
1086440|NCT02631499|Hepatoectomy|hepatoectomy
1086441|NCT02631499|TACE|tace
1086442|NCT02631499|prognosis|prognosis
1086443|NCT02631499|relapse|relapse
1086444|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1086445|NCT02631486|Rotator Cuff Tears|rotator cuff tears
1086446|NCT02631447|Metastatic Melanoma|metastatic melanoma
1086447|NCT02631447|BRAF mutation|braf mutation
1086448|NCT02631408|spinal fusion|spinal fusion
1086449|NCT02631408|topical antibiotics|topical antibiotics
1086450|NCT02631408|vancomycin|vancomycin
1086451|NCT02631408|surgical site infection|surgical site infection
1086452|NCT02631395|Exercise movement techniques|exercise movement techniques
1086453|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
1086454|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
1086455|NCT02631330|Geriatric Assessment|geriatric assessment
1087260|NCT02627456|Malaria|malaria
1086456|NCT02631330|Physical Education and Training|physical education and training
1086457|NCT02631317|acute ischemic stroke|acute ischemic stroke
1086458|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
1086459|NCT02631317|process reengineering|process reengineering
1086460|NCT02631317|door-to-needle time|door-to-needle time
1086461|NCT02631304|Postoperative delirium|postoperative delirium
1086462|NCT02631304|Cholinesterase activity|cholinesterase activity
1086463|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
1086464|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
1086465|NCT02631304|Elderly patients|elderly patients
1086466|NCT02631304|Cardiac surgery|cardiac surgery
1086467|NCT02631265|Type 1 diabetes|type 1 diabetes
1086468|NCT02631265|Exercise|exercise
1086469|NCT02631265|Hypoglycemia|hypoglycemia
1086470|NCT02631265|Insulin pump|insulin pump
1086471|NCT02631252|Leukemia|leukemia
1086472|NCT02631252|Acute Myelogenous|acute myelogenous
1086473|NCT02631252|Phase I|phase i
1086474|NCT02631252|Mitoxantrone|mitoxantrone
1086475|NCT02631252|Etoposide|etoposide
1086476|NCT02631252|Hydroxychloroquine|hydroxychloroquine
1086477|NCT02631252|Relapsed|relapsed
1086478|NCT02631252|Autophagy inhibitor|autophagy inhibitor
1086479|NCT02631252|AML|aml
1086480|NCT02631252|Relapsed AML|relapsed aml
1086481|NCT02631200|Advance Care Planning|advance care planning
1086482|NCT02631200|Palliative care|palliative care
1086483|NCT02631200|Frail Elderly|frail elderly
1086484|NCT02631200|Renal Dialysis|renal dialysis
1086485|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
1086486|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
1086487|NCT02631135|Dexmedetomidine|dexmedetomidine
1086488|NCT02631135|cognitive functions|cognitive functions
1086489|NCT02631135|MMSE|mmse
1086490|NCT02631122|Retroclavicular|retroclavicular
1086491|NCT02631122|Supraclavicular|supraclavicular
1086492|NCT02631122|Diagphram|diagphram
1086493|NCT02631122|hemiparesis|hemiparesis
1086494|NCT02631122|nerve block|nerve block
1086495|NCT02631122|regional anesthesia|regional anesthesia
1086496|NCT02631122|anesthesiology|anesthesiology
1086497|NCT02631109|Pegaspargase|pegaspargase
1086498|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1086499|NCT02631109|Epstein Barr virus|epstein barr virus
1086500|NCT02631070|Luspatercept|luspatercept
1086501|NCT02631070|Transfusion dependent|transfusion dependent
1086502|NCT02631070|Lower risk|lower risk
1086503|NCT02631070|Low risk|low risk
1086504|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
1086505|NCT02631070|ESA refractory|esa refractory
1086506|NCT02631070|ESA intolerant|esa intolerant
1086507|NCT02631070|ESA ineligible|esa ineligible
1086508|NCT02631070|ACE-536|ace-536
1086509|NCT02631070|Anemia|anemia
1086510|NCT02631070|Ring Sideroblasts|ring sideroblasts
1086511|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
1086512|NCT02631070|MEDALIST|medalist
1086513|NCT02631070|MDS|mds
1086514|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
1086515|NCT02631044|JCAR017|jcar017
1086516|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
1086517|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
1086518|NCT02631044|CAR|car
1086519|NCT02631044|CAR T cells|car t cells
1086520|NCT02631044|autologous T cell therapy|autologous t cell therapy
1086521|NCT02631044|cell therapy|cell therapy
1086522|NCT02631044|NHL|nhl
1086523|NCT02631031|Chronokinetics|chronokinetics
1086524|NCT02631031|chronodynamics|chronodynamics
1086525|NCT02631031|chronopharmacology|chronopharmacology
1086526|NCT02631031|valsartan|valsartan
1086527|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
1086528|NCT02631005|exercise|exercise
1086529|NCT02630992|ear infections|ear infections
1086530|NCT02630992|antibiotics|antibiotics
1086531|NCT02630992|antibiotic resistance|antibiotic resistance
1086532|NCT02630992|pediatrics|pediatrics
1086533|NCT02630992|infants|infants
1086534|NCT02630992|children|children
1086535|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
1086536|NCT02630966|Drug therapy|drug therapy
1086537|NCT02630953|Physical Activity|physical activity
1086538|NCT02630953|Latinas|latinas
1086539|NCT02630953|Spanish-language|spanish-language
1086540|NCT02630953|Text-Message|text-message
1086541|NCT02630953|English-language|english-language
1086542|NCT02630953|Exercise|exercise
1086543|NCT02630927|Safety and Tolerability|safety and tolerability
1086544|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
1086545|NCT02630927|Healthy Volunteer|healthy volunteer
1086546|NCT02630927|Pyruvate Kinase|pyruvate kinase
1086547|NCT02630927|Rare Genetic|rare genetic
1086548|NCT02630914|Epicardial surgical removal|epicardial surgical removal
1086549|NCT02630914|Closure of the left atrial|closure of the left atrial
1086550|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
1086551|NCT02630888|Bipolar Disorder|bipolar disorder
1086552|NCT02630888|Memantine|memantine
1086553|NCT02630888|Lithium|lithium
1086554|NCT02630888|Aripiprazole|aripiprazole
1086555|NCT02630888|Quetiapine|quetiapine
1086556|NCT02630888|Central Nervous System Agents|central nervous system agents
1086557|NCT02630888|Therapeutic Uses|therapeutic uses
1086558|NCT02630888|Pharmacologic Actions|pharmacologic actions
1086559|NCT02630888|Psychotropic Drugs|psychotropic drugs
1086560|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
1086561|NCT02630862|oxidative stress|oxidative stress
1086562|NCT02630862|atherosclerosis|atherosclerosis
1086563|NCT02630862|carotid stenosis|carotid stenosis
1086564|NCT02630862|oxysterols|oxysterols
1086565|NCT02630862|vitamin E|vitamin e
1086566|NCT02630862|lipid peroxidation|lipid peroxidation
1086567|NCT02630862|antioxidants|antioxidants
1086568|NCT02630862|aspirin|aspirin
1086569|NCT02630862|dipyridamole|dipyridamole
1086570|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
1086571|NCT02630836|stem cells|stem cells
1086572|NCT02630836|elderly|elderly
1086573|NCT02630836|allogeneic|allogeneic
1086574|NCT02630836|bone marrow|bone marrow
1086575|NCT02630836|bone regeneration|bone regeneration
1086576|NCT02630836|fracture|fracture
1086577|NCT02630797|Bone Health|bone health
1086578|NCT02630797|Calcium|calcium
1086579|NCT02630797|Osteoporosis|osteoporosis
1086580|NCT02630797|Polyphenolics|polyphenolics
1086581|NCT02630784|Non-invasive ventilation|non-invasive ventilation
1086582|NCT02630784|NIV ventilator|niv ventilator
1086583|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
1086584|NCT02630784|ICU ventilator|icu ventilator
1086585|NCT02630784|Respiratory acidosis|respiratory acidosis
1086586|NCT02630784|ICU|icu
1086587|NCT02630758|depression|depression
1086588|NCT02630758|yoga|yoga
1086589|NCT02630758|mindfulness|mindfulness
1086590|NCT02630745|endodontic treatment|endodontic treatment
1086591|NCT02630745|open flap debridement|open flap debridement
1086592|NCT02630732|Back School|back school
1086593|NCT02630732|Brain School|brain school
1086594|NCT02630732|Lumbar surgery|lumbar surgery
1086595|NCT02630732|Education|education
1086596|NCT02630719|headache|headache
1086597|NCT02630628|Lupus Nephritis|lupus nephritis
1086598|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
1086599|NCT02630628|tacrolimus|tacrolimus
1086600|NCT02630615|Circulating tumor cells|circulating tumor cells
1086601|NCT02630589|tinnitus|tinnitus
1086602|NCT02630589|auditory brainstem implant|auditory brainstem implant
1086603|NCT02630589|electrical stimulation|electrical stimulation
1086604|NCT02630576|electromyography|electromyography
1086605|NCT02630576|neuromuscular blockade|neuromuscular blockade
1086606|NCT02630550|Cardiac output|cardiac output
1086607|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
1086608|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
1086609|NCT02630550|Vascular cross-clamping|vascular cross-clamping
1086610|NCT02630550|Endarterectomy|endarterectomy
1086611|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
1086612|NCT02630550|Cardiography, Impedance|cardiography, impedance
1086613|NCT02630537|Cytomegalovirus|cytomegalovirus
1086614|NCT02630537|Epstein- Barr virus|epstein- barr virus
1086615|NCT02630537|Cell-mediated immunity|cell-mediated immunity
1086616|NCT02630537|T-Track® CMV|t-track® cmv
1086617|NCT02630537|T-Track® EBV|t-track® ebv
1086618|NCT02630537|hemodialysis|hemodialysis
1086619|NCT02630537|ELISpot|elispot
1086620|NCT02630498|pain|pain
1086621|NCT02630498|surgical|surgical
1086622|NCT02630498|brachial plexus|brachial plexus
1086623|NCT02630485|Randomized Controlled Trial|randomized controlled trial
1086624|NCT02630459|Migraine Prevention|migraine prevention
1086627|NCT02630446|respite care|respite care
1086628|NCT02630446|effectiveness|effectiveness
1086629|NCT02630446|cost-effectiveness|cost-effectiveness
1086630|NCT02630446|support|support
1086631|NCT02630446|caregiver|caregiver
1086632|NCT02630446|dementia|dementia
1086633|NCT02630446|community-based|community-based
1086634|NCT02630433|Biliary pancreatitis|biliary pancreatitis
1086635|NCT02630433|Cholecystectomy|cholecystectomy
1086636|NCT02630394|sickle cell disease|sickle cell disease
1086637|NCT02630394|acute chest syndrome|acute chest syndrome
1086638|NCT02630381|high-energy shock waves|high-energy shock waves
1086639|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
1086640|NCT02630368|Advanced Breast Cancer|advanced breast cancer
1086641|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
1086642|NCT02630368|Efficacy and safety|efficacy and safety
1086643|NCT02630342|Mock Scanner|mock scanner
1086644|NCT02630342|Child Life Specialist|child life specialist
1086645|NCT02630342|Patient Preparation|patient preparation
1086646|NCT02630342|Child, Preschool|child, preschool
1086647|NCT02630342|Child|child
1086648|NCT02630342|Anxiety|anxiety
1086649|NCT02630342|Human|human
1086650|NCT02630342|Anesthesia, General|anesthesia, general
1086651|NCT02630329|NOTES|notes
1086652|NCT02630329|Benign adnexal disease|benign adnexal disease
1086653|NCT02630329|Laparoscopy|laparoscopy
1086654|NCT02630316|Treprostinil|treprostinil
1086655|NCT02630316|PH|ph
1086656|NCT02630316|ILD|ild
1086657|NCT02630316|CPFE|cpfe
1086658|NCT02630316|6 Minute Walk Test|6 minute walk test
1086659|NCT02630303|light emitting diode-red light|light emitting diode-red light
1086660|NCT02630303|LED-RL|led-rl
1086661|NCT02630303|high fluence|high fluence
1086662|NCT02630303|skin fibrosis|skin fibrosis
1086663|NCT02630303|wound healing|wound healing
1086664|NCT02630303|scar|scar
1086665|NCT02630303|keloid|keloid
1086666|NCT02630303|RCT|rct
1086667|NCT02630290|Brachial plexus block|brachial plexus block
1086668|NCT02630290|Dexmedetomidine|dexmedetomidine
1086669|NCT02630290|Ropivacaine|ropivacaine
1086670|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
1086671|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
1086672|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1086673|NCT02630277|High Risk PDR|high risk pdr
1086674|NCT02630277|aflibercept|aflibercept
1086675|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
1086676|NCT02630264|clinical trial|clinical trial
1086677|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
1086678|NCT02630264|randomized|randomized
1086679|NCT02630251|Cancer|cancer
1086680|NCT02630251|Safety|safety
1086681|NCT02630251|GSK2820151|gsk2820151
1086682|NCT02630251|Dose escalation|dose escalation
1086683|NCT02630251|Tolerability|tolerability
1086684|NCT02630251|Pharmacodynamics|pharmacodynamics
1086685|NCT02630251|Pharmacokinetics|pharmacokinetics
1086686|NCT02630238|Exercise|exercise
1086687|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
1086688|NCT02630225|case management|case management
1086689|NCT02630225|motivational interviewing|motivational interviewing
1086690|NCT02630212|Aortic dissection|aortic dissection
1086691|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
1086692|NCT02630212|Risk factor|risk factor
1086693|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
1086694|NCT02630173|endodontic treatment|endodontic treatment
1086695|NCT02630173|scaling|scaling
1086696|NCT02630173|root planning|root planning
1086697|NCT02630147|Late preterm|late preterm
1086698|NCT02630147|Vanilla|vanilla
1086699|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
1086700|NCT02630108|HCC|hcc
1086701|NCT02630108|TACE|tace
1086702|NCT02630108|Thermal Ablation|thermal ablation
1086703|NCT02630108|Safety/Efficacy|safety/efficacy
1086704|NCT02630095|anticoagulation|anticoagulation
1086705|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
1086706|NCT02630082|HIV Seronegativity|hiv seronegativity
1086707|NCT02630082|Immune Response, Mucosal|immune response, mucosal
1086708|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
1086709|NCT02630069|adolescents|adolescents
1086710|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
1086711|NCT02630004|Mucositis|mucositis
1086712|NCT02630004|Head and Neck cancer|head and neck cancer
1086713|NCT02630004|Chemoradiation|chemoradiation
1086714|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
1086715|NCT02629991|Hyperphagia|hyperphagia
1086716|NCT02629978|pulmonary|pulmonary
1086717|NCT02629978|lung|lung
1086718|NCT02629978|cancer|cancer
1086719|NCT02629978|carcinoma|carcinoma
1086720|NCT02629978|nodule|nodule
1086721|NCT02629978|malignant|malignant
1086722|NCT02629978|radiofrequency ablation|radiofrequency ablation
1086723|NCT02629978|RFA|rfa
1086724|NCT02629952|glucose tolerance|glucose tolerance
1086725|NCT02629952|type 2 diabetes|type 2 diabetes
1086726|NCT02629952|blueberry tea|blueberry tea
1086727|NCT02629900|Weight Loss|weight loss
1086728|NCT02629900|Intermittent fasting|intermittent fasting
1086729|NCT02629887|supraglottic airway|supraglottic airway
1086730|NCT02629887|neonatal resuscitation|neonatal resuscitation
1086731|NCT02629887|ventilation|ventilation
1086732|NCT02629887|term infant|term infant
1086733|NCT02629874|EA-230|ea-230
1086734|NCT02629874|Inflammatory response|inflammatory response
1086735|NCT02629874|Kidney Injury|kidney injury
1086736|NCT02629874|Endotoxemia|endotoxemia
1086737|NCT02629848|Drug therapy|drug therapy
1086738|NCT02629809|Leukemia|leukemia
1086739|NCT02629809|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1086740|NCT02629809|CLL|cll
1086741|NCT02629809|Mutated immunoglobulin heavy chair variable region|mutated immunoglobulin heavy chair variable region
1086742|NCT02629809|IGHV|ighv
1086743|NCT02629809|non-del(17p) fluorescence in-situ hybridization|non-del(17p) fluorescence in-situ hybridization
1086744|NCT02629809|FISH|fish
1086745|NCT02629809|Obinutuzumab|obinutuzumab
1086746|NCT02629809|GA101|ga101
1086747|NCT02629809|Gazyva|gazyva
1086748|NCT02629809|Fludarabine|fludarabine
1086749|NCT02629809|Fludarabine Phosphate|fludarabine phosphate
1086750|NCT02629809|Fludara|fludara
1086751|NCT02629809|Cyclophosphamide|cyclophosphamide
1086752|NCT02629809|Cytoxan|cytoxan
1086753|NCT02629809|Neosar|neosar
1086754|NCT02629809|Ibrutinib|ibrutinib
1086755|NCT02629809|PCI-32765|pci-32765
1086756|NCT02629809|Imbruvica|imbruvica
1086757|NCT02629809|Allopurinol|allopurinol
1086758|NCT02629809|Lopurin|lopurin
1086759|NCT02629809|Zurinol|zurinol
1086760|NCT02629809|Zyloprim|zyloprim
1086761|NCT02629809|Valacyclovir|valacyclovir
1086766|NCT02629796|treatment response|treatment response
1086767|NCT02629757|High-grade glioma|high-grade glioma
1086768|NCT02629757|chemotherapy|chemotherapy
1086769|NCT02629757|β-elemene|β-elemene
1086770|NCT02629731|foot|foot
1086771|NCT02629731|ankle|ankle
1086772|NCT02629731|osteoarthritis|osteoarthritis
1086773|NCT02629731|flat foot|flat foot
1086774|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1086775|NCT02629718|radical surgery|radical surgery
1086776|NCT02629718|cervical carcinoma|cervical carcinoma
1086777|NCT02629653|carotid endarterectomy|carotid endarterectomy
1086778|NCT02629653|stroke|stroke
1086779|NCT02629653|hypothermia|hypothermia
1086780|NCT02629653|endovascular cooling|endovascular cooling
1086781|NCT02629640|vCJD|vcjd
1086782|NCT02629640|prion disease|prion disease
1086783|NCT02629640|dementia|dementia
1086784|NCT02629640|old-age|old-age
1086785|NCT02629640|surveillance|surveillance
1086786|NCT02629640|brain banking|brain banking
1086787|NCT02629640|public health|public health
1086788|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
1086789|NCT02629627|Leucine|leucine
1086790|NCT02629627|visceral fat area|visceral fat area
1086791|NCT02629627|Epicardial Fat|epicardial fat
1086792|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
1086793|NCT02629601|physical activity|physical activity
1086794|NCT02629601|financial incentives|financial incentives
1086795|NCT02629601|behavioral economics|behavioral economics
1086796|NCT02629588|Coma|coma
1086797|NCT02629588|Persistent Vegetative State|persistent vegetative state
1086798|NCT02629588|Sensory Stimulation|sensory stimulation
1086799|NCT02629497|platelets|platelets
1086800|NCT02629497|12-lipoxygenase|12-lipoxygenase
1086801|NCT02629497|fatty acids|fatty acids
1086802|NCT02629497|DGLA|dgla
1086803|NCT02629497|DHA|dha
1086804|NCT02629497|EPA|epa
1086805|NCT02629497|12-LOX|12-lox
1086806|NCT02629484|echocardiography|echocardiography
1086807|NCT02629484|hip fracture|hip fracture
1086808|NCT02629484|surgery|surgery
1086809|NCT02629484|outcomes|outcomes
1086810|NCT02629432|MRI|mri
1086811|NCT02629432|COPD|copd
1086812|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
1086813|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
1086814|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
1086815|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
1086816|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
1086817|NCT02629406|HIF|hif
1086818|NCT02629406|hypoxia|hypoxia
1086819|NCT02629406|chemoreflex|chemoreflex
1086820|NCT02629406|baroreflex|baroreflex
1086821|NCT02629406|MIR210|mir210
1086822|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
1086823|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
1086824|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
1086825|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
1086826|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
1086827|NCT02629393|aldehyde oxidase|aldehyde oxidase
1086828|NCT02629380|meniscectomy|meniscectomy
1086829|NCT02629380|hyaluronic acid|hyaluronic acid
1086830|NCT02629380|intra-op injection|intra-op injection
1086831|NCT02629380|randomized controlled trial|randomized controlled trial
1086832|NCT02629380|placebo|placebo
1086833|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
1086834|NCT02629328|CardioCel|cardiocel
1086836|NCT02629328|Tri-leaflet repair|tri-leaflet repair
1086837|NCT02629328|Aortic valves|aortic valves
1086838|NCT02629289|HSP-130|hsp-130
1086839|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
1086840|NCT02629289|Pegfilgrastim|pegfilgrastim
1086841|NCT02629276|neck pain|neck pain
1086842|NCT02629276|arm pain|arm pain
1086843|NCT02629276|neurodynamic tests|neurodynamic tests
1086844|NCT02629276|quantitative sensory testing|quantitative sensory testing
1086845|NCT02629276|somatosensory profile|somatosensory profile
1086846|NCT02629250|proximal femoral fracture|proximal femoral fracture
1086847|NCT02629250|goal-directed therapy|goal-directed therapy
1086848|NCT02629250|myocardial injury|myocardial injury
1086849|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
1086850|NCT02629250|elders|elders
1086851|NCT02629250|stroke volume maximization|stroke volume maximization
1086852|NCT02629237|glaucoma surgery|glaucoma surgery
1086853|NCT02629237|educational intervention|educational intervention
1086854|NCT02629237|satisfaction|satisfaction
1086855|NCT02629237|rural|rural
1086856|NCT02629224|Impaired renal function|impaired renal function
1086857|NCT02629224|Haemodialysis|haemodialysis
1086858|NCT02629224|ASP8825|asp8825
1086859|NCT02629224|XP13512|xp13512
1086860|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
1086861|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
1086862|NCT02629211|Crohn Disease|crohn disease
1086863|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
1087467|NCT02626273|fat|fat
1086864|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
1086865|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
1086866|NCT02629211|AB Device|ab device
1086867|NCT02629211|Pediatric IBD|pediatric ibd
1086868|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
1086869|NCT02629198|Vitamin D|vitamin d
1086870|NCT02629185|Bone|bone
1086871|NCT02629185|Vitamin D|vitamin d
1086872|NCT02629185|Cardiovascular|cardiovascular
1086873|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1086874|NCT02629172|Paritaprevir|paritaprevir
1086875|NCT02629172|Ombitasvir|ombitasvir
1086876|NCT02629172|Ritonavir|ritonavir
1086877|NCT02629172|Genotype 1|genotype 1
1086878|NCT02629159|Musculoskeletal disease|musculoskeletal disease
1086879|NCT02629159|Arthritis|arthritis
1086880|NCT02629159|Joint disease|joint disease
1086881|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
1086882|NCT02629159|Antirheumatic agents|antirheumatic agents
1086883|NCT02629146|Midazolam|midazolam
1086884|NCT02629146|Fentanyl|fentanyl
1086885|NCT02629133|Intimate Partner Violence|intimate partner violence
1086886|NCT02629133|Sheltered Battered Women|sheltered battered women
1086887|NCT02629133|Substance Use|substance use
1086888|NCT02629120|Chronic Granulomatous Disease|chronic granulomatous disease
1086889|NCT02629120|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1086890|NCT02629120|Graft Versus Host Disease|graft versus host disease
1086891|NCT02629120|Matched Unrelated Donor BMT|matched unrelated donor bmt
1086892|NCT02629120|Nonmyeloablative Conditioning Regimen|nonmyeloablative conditioning regimen
1086893|NCT02629107|Sleep|sleep
1086894|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1086895|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
1086896|NCT02629094|Hepatic Steatosis|hepatic steatosis
1086897|NCT02629094|Cardiac Steatosis|cardiac steatosis
1086898|NCT02629094|Aldosterone|aldosterone
1086899|NCT02629094|Eplerenone|eplerenone
1086900|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
1086901|NCT02629081|heartburn|heartburn
1086902|NCT02629081|GERD|gerd
1086903|NCT02629081|NERD|nerd
1086904|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
1086905|NCT02629068|Adolescent|adolescent
1086906|NCT02629068|Social Support|social support
1086907|NCT02629068|Social Media|social media
1086908|NCT02629068|Parents|parents
1086909|NCT02629068|Shame|shame
1086910|NCT02629068|Stigma|stigma
1086911|NCT02629055|Non-invasive ventilation|non-invasive ventilation
1086912|NCT02629055|Respiratory electromyography|respiratory electromyography
1086913|NCT02629042|Anesthesia|anesthesia
1086914|NCT02629042|Corticosteroids|corticosteroids
1086915|NCT02629042|Dental Emergency|dental emergency
1086916|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
1086917|NCT02629042|Mandibulae|mandibulae
1086918|NCT02629042|Pain Management|pain management
1086919|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
1086920|NCT02629003|Positron Emission Tomography|positron emission tomography
1086921|NCT02629003|Serotonin|serotonin
1086922|NCT02629003|5-HT2A|5-ht2a
1086923|NCT02629003|Radioligand|radioligand
1086924|NCT02629003|Radiation dosimetry|radiation dosimetry
1086925|NCT02629003|Radiation dosage|radiation dosage
1086926|NCT02628964|smoking|smoking
1086927|NCT02628964|cigarettes|cigarettes
1086928|NCT02628938|Halitosis|halitosis
1086929|NCT02628938|Oral Malodor|oral malodor
1086930|NCT02628938|Miswak|miswak
1086931|NCT02628938|Salvadora Persica|salvadora persica
1086932|NCT02628925|mass screening|mass screening
1086933|NCT02628925|Nursing diagnosis|nursing diagnosis
1087334|NCT02626962|melanoma|melanoma
1086934|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
1086935|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
1086936|NCT02628912|Long-Term Survivors|long-term survivors
1086937|NCT02628912|15-277|15-277
1086939|NCT02628912|Survivors|survivors
1086940|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
1086941|NCT02628886|pneumococcal carriage|pneumococcal carriage
1086942|NCT02628873|HSG|hsg
1086943|NCT02628873|HyCoSy|hycosy
1086944|NCT02628873|Contraception|contraception
1086945|NCT02628873|Essure|essure
1086946|NCT02628873|Saline Infused sonography|saline infused sonography
1086947|NCT02628873|SIS|sis
1086948|NCT02628873|Air bubbles|air bubbles
1086949|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
1086950|NCT02628860|Ferinject®|ferinject®
1086951|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
1086952|NCT02628847|stroke|stroke
1086953|NCT02628847|rehabilitation|rehabilitation
1086954|NCT02628847|motor skills|motor skills
1086955|NCT02628847|sildenafil citrate|sildenafil citrate
1086956|NCT02628847|White matter|white matter
1086957|NCT02628834|Loading|loading
1086958|NCT02628834|Gait|gait
1086959|NCT02628834|Multiple Sclerosis|multiple sclerosis
1086960|NCT02628834|Manual Therapy|manual therapy
1086961|NCT02628808|autism|autism
1086962|NCT02628808|asperger|asperger
1086963|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
1086964|NCT02628808|gene|gene
1086965|NCT02628808|polymorphism|polymorphism
1086966|NCT02628808|mutation|mutation
1086967|NCT02628795|total hip arthroplasty|total hip arthroplasty
1086968|NCT02628795|total knee arthroplasty|total knee arthroplasty
1086969|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
1086970|NCT02628782|Vascular Closure Device|vascular closure device
1086971|NCT02628769|Solithromycin|solithromycin
1086972|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1086973|NCT02628769|Inflammation|inflammation
1086974|NCT02628769|Macrolide|macrolide
1086975|NCT02628730|Atrial Fibrillation|atrial fibrillation
1086976|NCT02628730|Ablation|ablation
1086977|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
1086978|NCT02628730|Ablation Index|ablation index
1086979|NCT02628717|Hepatitis C|hepatitis c
1086980|NCT02628717|sofosbuvir|sofosbuvir
1086981|NCT02628717|ledipasvir|ledipasvir
1086982|NCT02628717|daclatasvir|daclatasvir
1086983|NCT02628717|simeprevir|simeprevir
1086984|NCT02628704|Karyopharm|karyopharm
1086985|NCT02628704|selinexor|selinexor
1086986|NCT02628704|KPT-330|kpt-330
1086987|NCT02628704|multiple myeloma|multiple myeloma
1086988|NCT02628704|SCORE|score
1086989|NCT02628678|Prebiotic|prebiotic
1086991|NCT02628678|fructooligosaccharide|fructooligosaccharide
1086992|NCT02628678|polyglycan|polyglycan
1086993|NCT02628678|microbiome|microbiome
1086994|NCT02628678|microbiota|microbiota
1086995|NCT02628678|Healthy Volunteers|healthy volunteers
1086996|NCT02628652|Microbiome|microbiome
1086997|NCT02628652|FOS|fos
1086998|NCT02628652|polyglycan|polyglycan
1086999|NCT02628652|prebiotic|prebiotic
1087000|NCT02628652|Healthy Volunteers|healthy volunteers
1087001|NCT02628626|Incontinence|incontinence
1087002|NCT02628626|Diarrhea|diarrhea
1087003|NCT02628626|Bile acid|bile acid
1087004|NCT02628626|Microbiome|microbiome
1087005|NCT02628613|Breast cancer|breast cancer
1087006|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1087007|NCT02628613|TEKT4|tekt4
1087008|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
1087009|NCT02628587|Clopidogrel|clopidogrel
1087010|NCT02628587|Platelet reactivity|platelet reactivity
1087011|NCT02628574|Metastatic|metastatic
1087012|NCT02628574|Stage III or IV|stage iii or iv
1087013|NCT02628574|recurrent|recurrent
1087014|NCT02628574|refractory|refractory
1087015|NCT02628574|solid tumors|solid tumors
1087016|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
1087017|NCT02628522|ADRC|adrc
1087018|NCT02628522|Celution|celution
1087019|NCT02628509|Acquired Von Willebrand|acquired von willebrand
1087020|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
1087021|NCT02628509|mechanical circulatory support|mechanical circulatory support
1087022|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
1087023|NCT02628457|occupation ratio|occupation ratio
1087024|NCT02628457|pseudoatrophy|pseudoatrophy
1087025|NCT02628444|Dengue Fever|dengue fever
1087026|NCT02628444|Dengue virus|dengue virus
1087027|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1087028|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
1087029|NCT02628418|Rehabilitation|rehabilitation
1087030|NCT02628418|Robotics|robotics
1087031|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1087032|NCT02628392|Adult|adult
1087033|NCT02628392|Developmental Phase II|developmental phase ii
1087034|NCT02628379|Genomic Testing|genomic testing
1087035|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
1087036|NCT02628379|CUP|cup
1087037|NCT02628366|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1087335|NCT02626949|HIV|hiv
1087038|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
1087039|NCT02628366|Cardiovascular Events|cardiovascular events
1087040|NCT02628366|Mortality|mortality
1087041|NCT02628353|Cardiovascular diseases|cardiovascular diseases
1087042|NCT02628353|endothelial function|endothelial function
1087043|NCT02628353|systolic blood pressure|systolic blood pressure
1087044|NCT02628353|metabolomics|metabolomics
1087045|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
1087046|NCT02628353|bioavailability|bioavailability
1087047|NCT02628353|phenolic compounds|phenolic compounds
1087048|NCT02628353|hypertension|hypertension
1087049|NCT02628327|glaucoma care|glaucoma care
1087050|NCT02628327|quality of life|quality of life
1087051|NCT02628327|patient satisfaction|patient satisfaction
1087052|NCT02628301|Obesity|obesity
1087053|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1087054|NCT02628301|Hypercaloric diet|hypercaloric diet
1087055|NCT02628301|Microcirculation|microcirculation
1087056|NCT02628301|Microvascular dysfunction|microvascular dysfunction
1087057|NCT02628301|Insulin Resistance|insulin resistance
1087058|NCT02628301|Insulin Sensitivity|insulin sensitivity
1087059|NCT02628301|Insulin signaling|insulin signaling
1087060|NCT02628262|Macular hole|macular hole
1087061|NCT02628236|Actinic keratosis|actinic keratosis
1087062|NCT02628223|glaucoma|glaucoma
1087063|NCT02628223|Elevated IOP|elevated iop
1087064|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
1087065|NCT02628223|SLT|slt
1087468|NCT02626247|elderly|elderly
1087066|NCT02628223|open angle glaucoma|open angle glaucoma
1132509|NCT02364063|child|child
1087067|NCT02628223|ocular hypertension|ocular hypertension
1087068|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
1087069|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
1087070|NCT02628223|Pseudoexfoliation|pseudoexfoliation
1087071|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
1087072|NCT02628158|Epiretinal membrane|epiretinal membrane
1087073|NCT02628145|Sarcopenia|sarcopenia
1087074|NCT02628145|aging|aging
1087075|NCT02628145|resistance training|resistance training
1087076|NCT02628145|physical functioning|physical functioning
1087077|NCT02628132|triple negative|triple negative
1087078|NCT02628132|breast cancer|breast cancer
1087079|NCT02628132|durvalumab|durvalumab
1087080|NCT02628132|paclitaxel|paclitaxel
1087081|NCT02628132|safety|safety
1087082|NCT02628132|efficacy|efficacy
1087083|NCT02628132|PD-L1|pd-l1
1087084|NCT02628132|PD-1|pd-1
1087085|NCT02628132|Metastatic|metastatic
1087086|NCT02628132|AstraZeneca|astrazeneca
1087087|NCT02628132|MEDI4736|medi4736
1087088|NCT02628119|Hemodialysis|hemodialysis
1087089|NCT02628119|vascular access|vascular access
1087090|NCT02628119|access flow|access flow
1087091|NCT02628080|Hypoxia|hypoxia
1087093|NCT02628067|PDL1|pdl1
1087094|NCT02628067|PD-1|pd-1
1087095|NCT02628067|PD-L1|pd-l1
1087096|NCT02628067|MSI|msi
1087097|NCT02628067|microsatellite instability|microsatellite instability
1087098|NCT02628067|MMR|mmr
1087099|NCT02628067|mismatch repair|mismatch repair
1087100|NCT02628067|anal carcinoma|anal carcinoma
1087101|NCT02628067|anal cancer|anal cancer
1087102|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
1087103|NCT02628067|biliary cancer|biliary cancer
1087104|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
1087105|NCT02628067|bile duct cancer|bile duct cancer
1087106|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
1087107|NCT02628067|carcinoid tumor|carcinoid tumor
1087108|NCT02628067|endometrial carcinoma|endometrial carcinoma
1087109|NCT02628067|endometrial cancer|endometrial cancer
1087110|NCT02628067|cervical carcinoma|cervical carcinoma
1087111|NCT02628067|cervical cancer|cervical cancer
1087112|NCT02628067|vulvar carcinoma|vulvar carcinoma
1087113|NCT02628067|vulvar cancer|vulvar cancer
1087114|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
1087115|NCT02628067|small cell lung cancer|small cell lung cancer
1087116|NCT02628067|SCLC|sclc
1087117|NCT02628067|mesothelioma|mesothelioma
1087118|NCT02628067|thyroid carcinoma|thyroid carcinoma
1087119|NCT02628067|thyroid cancer|thyroid cancer
1087120|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
1087121|NCT02628067|salivary gland cancer|salivary gland cancer
1087122|NCT02628067|salivary cancer|salivary cancer
1087123|NCT02628067|parotid gland cancer|parotid gland cancer
1087124|NCT02628067|advanced solid tumors|advanced solid tumors
1087125|NCT02628054|PSG|psg
1087126|NCT02628054|Typhoid Vaccine|typhoid vaccine
1087127|NCT02628054|Depression|depression
1087128|NCT02628054|Inflammation|inflammation
1087129|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
1087130|NCT02628041|HDR Monotherapy|hdr monotherapy
1087131|NCT02628041|LDR monotherapy|ldr monotherapy
1087132|NCT02628015|Theory of Mind|theory of mind
1087133|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
1087134|NCT02628002|antigravity treadmill|antigravity treadmill
1087135|NCT02628002|bruce protocol|bruce protocol
1087136|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
1087137|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
1087138|NCT02628002|cardiac catheterization|cardiac catheterization
1087139|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
1087140|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
1087141|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
1087142|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
1087143|NCT02627937|Polysomnography|polysomnography
1087144|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
1087145|NCT02627924|Work productivity|work productivity
1087146|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
1087147|NCT02627898|Green tea extract|green tea extract
1087148|NCT02627898|Arterial stiffness|arterial stiffness
1087149|NCT02627898|PWVao|pwvao
1087150|NCT02627885|internet treatment|internet treatment
1087151|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
1087152|NCT02627885|level of functioning|level of functioning
1087153|NCT02627885|quality of life|quality of life
1087154|NCT02627833|induced Sputum|induced sputum
1087155|NCT02627833|lung clearance index|lung clearance index
1087156|NCT02627833|miRNA|mirna
1087157|NCT02627833|inflammation|inflammation
1087158|NCT02627833|chronic lung disease|chronic lung disease
1087159|NCT02627820|Senile|senile
1087160|NCT02627820|ATTRwt|attrwt
1087161|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
1087162|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1087163|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
1087164|NCT02627807|Clinical target volume|clinical target volume
1087165|NCT02627807|Clinical trial|clinical trial
1087166|NCT02627794|Middle Meatus|middle meatus
1087167|NCT02627794|Synechiae|synechiae
1087168|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
1087169|NCT02627794|Silastic spacer|silastic spacer
1087170|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
1087171|NCT02627781|acute appendicitis|acute appendicitis
1087172|NCT02627781|Alvarado Score|alvarado score
1087173|NCT02627781|negative appendectomy|negative appendectomy
1087174|NCT02627781|right abdominal pain|right abdominal pain
1087175|NCT02627768|STELARA|stelara
1087176|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
1087177|NCT02627768|Ustekinumab|ustekinumab
1087178|NCT02627755|videolaryngoscopy|videolaryngoscopy
1087179|NCT02627755|difficult airway management|difficult airway management
1087180|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
1087181|NCT02627716|Joint crisis plan|joint crisis plan
1087182|NCT02627716|Schizophrenia|schizophrenia
1087183|NCT02627716|Primary care|primary care
1087184|NCT02627677|CML|cml
1087185|NCT02627677|CP-CML|cp-cml
1087186|NCT02627677|Leukemia|leukemia
1087187|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
1087188|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1087189|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
1087190|NCT02627677|Neoplasms|neoplasms
1087191|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
1087192|NCT02627677|Bone Marrow Diseases|bone marrow diseases
1087193|NCT02627677|Hematologic Diseases|hematologic diseases
1087194|NCT02627664|Idiopathic early|idiopathic early
1087195|NCT02627664|Parkinson's Disease|parkinson's disease
1087196|NCT02627638|osteopathy|osteopathy
1087197|NCT02627638|complementary therapy|complementary therapy
1087198|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
1087199|NCT02627625|inhalation|inhalation
1087200|NCT02627625|anticholinergic|anticholinergic
1087201|NCT02627612|veteran|veteran
1087202|NCT02627612|mentorship|mentorship
1087203|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
1087204|NCT02627612|treatment|treatment
1087205|NCT02627612|PTSD|ptsd
1087206|NCT02627612|Suicide|suicide
1087207|NCT02627612|Criminal Activity|criminal activity
1087208|NCT02627599|COPD|copd
1087209|NCT02627599|LTOT|ltot
1087210|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
1087211|NCT02627599|Oxygen Conserving Device|oxygen conserving device
1087212|NCT02627599|Quality of Life|quality of life
1087213|NCT02627599|Six Minute Walk Distance|six minute walk distance
1087214|NCT02627599|Portable Oxygen Source|portable oxygen source
1087215|NCT02627599|Oxygen Saturation|oxygen saturation
1087216|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
1087217|NCT02627599|BRVB-OCD|brvb-ocd
1087218|NCT02627599|Pulse Oximetry|pulse oximetry
1087219|NCT02627586|exercise therapy|exercise therapy
1087220|NCT02627586|left ventricular remodeling|left ventricular remodeling
1087221|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
1087222|NCT02627586|high-intensity interval training|high-intensity interval training
1087223|NCT02627573|Cyclophosphamide|cyclophosphamide
1087224|NCT02627573|Thymoglobulin|thymoglobulin
1087225|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
1087226|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
1087227|NCT02627573|Immune System Diseases|immune system diseases
1087228|NCT02627573|Busulfan|busulfan
1087229|NCT02627573|Fludarabine|fludarabine
1087230|NCT02627573|Tacrolimus|tacrolimus
1087231|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
1087336|NCT02626949|AIDS|aids
1087232|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1087233|NCT02627573|Myeloablative Agonists|myeloablative agonists
1087234|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1087235|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
1087236|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
1087237|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
1087238|NCT02627560|Administration, topical|administration, topical
1087239|NCT02627560|Tranexamic acid|tranexamic acid
1087240|NCT02627560|Postoperative care|postoperative care
1087241|NCT02627560|Mastectomy|mastectomy
1087242|NCT02627547|Flavanones|flavanones
1087243|NCT02627547|Endurance-trained athletes|endurance-trained athletes
1087244|NCT02627547|Biological availability|biological availability
1087245|NCT02627534|Photodynamic therapy|photodynamic therapy
1087246|NCT02627534|Ultrasonic debridement|ultrasonic debridement
1087247|NCT02627534|Chronic periodontitis|chronic periodontitis
1087248|NCT02627534|Type 2 diabetes|type 2 diabetes
1087249|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
1087250|NCT02627508|Autism|autism
1087251|NCT02627508|Pregnenolone|pregnenolone
1087252|NCT02627495|maladaptive plasticity|maladaptive plasticity
1087253|NCT02627495|Limb amputation|limb amputation
1087254|NCT02627495|phantom limb pain|phantom limb pain
1087255|NCT02627495|tDCS|tdcs
1568429|NCT00505895|Stem Cell Infusion|stem cell infusion
1087256|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
1087257|NCT02627469|Microbiota|microbiota
1087258|NCT02627469|aged|aged
1087259|NCT02627469|oral health|oral health
1087261|NCT02627456|Cryopreserved|cryopreserved
1087262|NCT02627456|Infection|infection
1087264|NCT02627456|Immunization|immunization
1087265|NCT02627417|ITP|itp
1087266|NCT02627417|Dapsone|dapsone
1087267|NCT02627404|Bipolar disorders|bipolar disorders
1087268|NCT02627404|Genetic|genetic
1087269|NCT02627404|Biomarkers|biomarkers
1087270|NCT02627404|Circadian rhythm|circadian rhythm
1087271|NCT02627391|Aortic valve|aortic valve
1087272|NCT02627391|Stenosis|stenosis
1087273|NCT02627391|Surgery|surgery
1087274|NCT02627365|ART|art
1087275|NCT02627365|mobile messaging|mobile messaging
1087276|NCT02627365|behaviour|behaviour
1087277|NCT02627365|motivation|motivation
1087278|NCT02627352|Glaucoma|glaucoma
1087279|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
1087280|NCT02627352|Intraocular Pressure|intraocular pressure
1087281|NCT02627339|Contrast Sensitivity|contrast sensitivity
1087282|NCT02627326|chlorhexidine|chlorhexidine
1087283|NCT02627326|endodontic treatment|endodontic treatment
1087284|NCT02627313|Feasibility Studies|feasibility studies
1087285|NCT02627300|PID|pid
1087286|NCT02627261|residual disease|residual disease
1087287|NCT02627235|Physical Activity|physical activity
1087288|NCT02627235|Cancer Prevention|cancer prevention
1087289|NCT02627222|Pro-vitamin A|pro-vitamin a
1087290|NCT02627222|Cassava|cassava
1087291|NCT02627222|Vitamin A deficiency|vitamin a deficiency
1087292|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
1087293|NCT02627222|Preschool children|preschool children
1087294|NCT02627222|Nigeria|nigeria
1087295|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
1087296|NCT02627209|Lysozyme|lysozyme
1087297|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
1087298|NCT02627209|Behcet's disease|behcet's disease
1087299|NCT02627209|Sarcoidosis|sarcoidosis
1087300|NCT02627209|Syphilis|syphilis
1087301|NCT02627209|Tuberculosis|tuberculosis
1087302|NCT02627209|Ocular inflammation|ocular inflammation
1087303|NCT02627196|Heart Failure|heart failure
1087304|NCT02627196|BAROSTIM NEO®|barostim neo®
1087305|NCT02627196|Baroreceptor|baroreceptor
1087306|NCT02627196|Baroreflex|baroreflex
1087307|NCT02627196|Baroreflex Activation Therapy™|baroreflex activation therapy™
1087308|NCT02627196|New York Heart Associate Class III Heart Failure|new york heart associate class iii heart failure
1087309|NCT02627183|Atrial Fibrillation|atrial fibrillation
1087310|NCT02627170|Adults|adults
1087311|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1087312|NCT02627144|Avastin|avastin
1087313|NCT02627144|Bevacizumab|bevacizumab
1087314|NCT02627131|Autism|autism
1087315|NCT02627131|Stem Cells|stem cells
1087316|NCT02627105|weight loss|weight loss
1087317|NCT02627066|Exercise|exercise
1087318|NCT02627066|Nutrition|nutrition
1087319|NCT02627066|Hemodialysis|hemodialysis
1087320|NCT02627014|Chronic Migraine|chronic migraine
1087321|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
1087322|NCT02627014|Physical Therapy|physical therapy
1087323|NCT02627014|Manual Therapy|manual therapy
1087324|NCT02627014|Home physical Therapy|home physical therapy
1087325|NCT02626988|Diet Diversity|diet diversity
1087326|NCT02626988|Biodiversity|biodiversity
1087327|NCT02626988|Agrobiodiversity|agrobiodiversity
1087328|NCT02626988|Nutrition|nutrition
1087329|NCT02626988|Vietnam|vietnam
1087330|NCT02626975|knee|knee
1087331|NCT02626975|short hamstring autograft|short hamstring autograft
1087332|NCT02626975|ligament|ligament
1087333|NCT02626975|MRI|mri
1087338|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
1087339|NCT02626949|Stress|stress
1087340|NCT02626949|Intervention|intervention
1087341|NCT02626949|Inflammation|inflammation
1087342|NCT02626936|Type 1 diabetes|type 1 diabetes
1087343|NCT02626936|Artificial pancreas|artificial pancreas
1087344|NCT02626936|Closed-loop system|closed-loop system
1087345|NCT02626936|Postprandial glucose control|postprandial glucose control
1087346|NCT02626936|Hypoglycemia|hypoglycemia
1087347|NCT02626936|Insulin|insulin
1087348|NCT02626936|Glucagon|glucagon
1087349|NCT02626910|Disability|disability
1087350|NCT02626910|Activity of Daily Living|activity of daily living
1087351|NCT02626910|Patient Satisfaction|patient satisfaction
1087352|NCT02626897|Sarcoidosis|sarcoidosis
1087353|NCT02626897|Daily activity|daily activity
1087354|NCT02626897|Exercise|exercise
1087355|NCT02626897|Accelerometer|accelerometer
1087356|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
1087357|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
1087358|NCT02626845|GPA|gpa
1087359|NCT02626845|Rituximab|rituximab
1087360|NCT02626845|Rituxan|rituxan
1087361|NCT02626845|ENT GPA|ent gpa
1087362|NCT02626832|vasopressin|vasopressin
1087363|NCT02626832|AVP|avp
1087364|NCT02626832|NMDA|nmda
1087365|NCT02626832|osmolality|osmolality
1087366|NCT02626819|Obesity|obesity
1087367|NCT02626819|Weight Management|weight management
1087368|NCT02626819|Primary Care|primary care
1087369|NCT02626819|Health Coach|health coach
1087370|NCT02626819|iPad|ipad
1087371|NCT02626819|Goal Setting|goal setting
1087372|NCT02626819|5As|5as
1087373|NCT02626819|technology|technology
1087374|NCT02626806|exercise test|exercise test
1087375|NCT02626806|HS -troponin|hs -troponin
1087376|NCT02626806|Coronary artery disease|coronary artery disease
1087377|NCT02626793|Plaque psoriasis|plaque psoriasis
1087378|NCT02626793|Apremilast|apremilast
1087379|NCT02626793|Otezla®|otezla®
1087380|NCT02626793|LAPIS-Pso|lapis-pso
1087381|NCT02626793|Observational|observational
1087382|NCT02626793|CC-10004|cc-10004
1087383|NCT02626793|non-interventional|non-interventional
1087384|NCT02626793|Germany|germany
1087385|NCT02626767|high-intensity interval training|high-intensity interval training
1087386|NCT02626767|adolescents|adolescents
1087387|NCT02626767|school-based exercise|school-based exercise
1087388|NCT02626767|cardiometabolic health|cardiometabolic health
1087389|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
1087390|NCT02626702|immune modulators|immune modulators
1087391|NCT02626702|IVF outcomes|ivf outcomes
1087392|NCT02626702|relationship|relationship
1087393|NCT02626689|Beta-Thalassemia|beta-thalassemia
1087394|NCT02626689|Quality of Life|quality of life
1087395|NCT02626689|Healthcare Utilization|healthcare utilization
1087396|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
1087397|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
1087398|NCT02626689|Standard of care|standard of care
1087399|NCT02626689|TransQoL|transqol
1087400|NCT02626689|SF36v2|sf36v2
1087401|NCT02626689|Fact-An|fact-an
1087402|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
1087403|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
1087404|NCT02626637|children with cancer|children with cancer
1087405|NCT02626637|fatigue|fatigue
1087406|NCT02626637|physical activity|physical activity
1087407|NCT02626598|facial wrinkles|facial wrinkles
1087408|NCT02626598|photoaging|photoaging
1087409|NCT02626585|rhinoplasty|rhinoplasty
1087410|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
1087411|NCT02626585|edema|edema
1087412|NCT02626585|draping|draping
1087413|NCT02626585|postoperative edema|postoperative edema
1087414|NCT02626585|nasal skin thickness|nasal skin thickness
1087415|NCT02626585|supratip fullness|supratip fullness
1087416|NCT02626585|postoperative swelling|postoperative swelling
1087417|NCT02626533|Cytokines|cytokines
1087418|NCT02626507|ER+/HER2|er+/her2
1087419|NCT02626481|Multiple Myeloma|multiple myeloma
1087420|NCT02626481|Cancer|cancer
1087421|NCT02626481|refractory|refractory
1087422|NCT02626481|daratumumab|daratumumab
1087423|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
1087424|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
1087425|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1087426|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
1087427|NCT02626442|Cognition|cognition
1087428|NCT02626442|Exercise|exercise
1087429|NCT02626416|Telemedicine|telemedicine
1087430|NCT02626403|vegetative state|vegetative state
1087431|NCT02626403|minimally conscious state|minimally conscious state
1087432|NCT02626403|disorder of consciousness|disorder of consciousness
1087433|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
1087434|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
1087435|NCT02626403|neuromodulation|neuromodulation
1087436|NCT02626377|Informal caregivers|informal caregivers
1087437|NCT02626377|Elderly|elderly
1087438|NCT02626377|Quality of life|quality of life
1087439|NCT02626377|Cost effectiveness|cost effectiveness
1087440|NCT02626377|Cohort study|cohort study
1087441|NCT02626377|Randomized study|randomized study
1087442|NCT02626351|postnatal|postnatal
1087443|NCT02626312|Liver Cancer|liver cancer
1087444|NCT02626312|Impaired Liver Function|impaired liver function
1087445|NCT02626312|Liver tumors|liver tumors
1087446|NCT02626312|Hepatocellular carcinoma|hepatocellular carcinoma
1087447|NCT02626312|HCC|hcc
1087448|NCT02626312|Cholangiocarcinoma|cholangiocarcinoma
1087449|NCT02626312|Liver metastases|liver metastases
1087450|NCT02626312|Low functional liver volume|low functional liver volume
1087451|NCT02626312|Radiation therapy|radiation therapy
1087452|NCT02626312|XRT|xrt
1087453|NCT02626312|Chemotherapy|chemotherapy
1087454|NCT02626312|Questionnaire|questionnaire
1087455|NCT02626312|Survey|survey
1087456|NCT02626312|High dose radiotherapy|high dose radiotherapy
1087457|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
1087458|NCT02626286|HIV|hiv
1087459|NCT02626286|Men who have sex with men|men who have sex with men
1087460|NCT02626273|obesity|obesity
1087461|NCT02626273|adolescents|adolescents
1087462|NCT02626273|physical activity|physical activity
1087463|NCT02626273|adipocytes|adipocytes
1087464|NCT02626273|osteocytes|osteocytes
1087465|NCT02626273|weight loss|weight loss
1087466|NCT02626273|bone|bone
1087469|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
1087470|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
1087471|NCT02626195|malnutrition|malnutrition
1087472|NCT02626195|nutrition|nutrition
1087473|NCT02626195|nutritional support|nutritional support
1087474|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
1087475|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
1087476|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
1087477|NCT02626169|inflammation|inflammation
1087478|NCT02626169|atherosclerosis|atherosclerosis
1087479|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
1087480|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
1087481|NCT02626130|Kidney Cancer|kidney cancer
1087482|NCT02626130|Tremelimumab|tremelimumab
1087483|NCT02626130|Cryoablation|cryoablation
1087484|NCT02626130|Cryoprobe|cryoprobe
1087485|NCT02626104|lactoferrin|lactoferrin
1087486|NCT02626104|clostridium difficile|clostridium difficile
1087487|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
1087488|NCT02626104|children|children
1087489|NCT02626104|antibiotic therapy|antibiotic therapy
1087490|NCT02626104|diarrhoea|diarrhoea
1087491|NCT02626091|Anastomotic perfusion|anastomotic perfusion
1087492|NCT02626091|ICG Fluorescence|icg fluorescence
1087493|NCT02626091|Enhanced reality|enhanced reality
1087494|NCT02626091|Left-sided colonic resection|left-sided colonic resection
1087495|NCT02626078|Malnutrition|malnutrition
1087496|NCT02626078|Food practices|food practices
1087497|NCT02626078|Elderly|elderly
1087498|NCT02626078|Nursing Home|nursing home
1087499|NCT02626078|Aging|aging
1087500|NCT02626078|Nutritional status|nutritional status
1087501|NCT02626078|Quality of life|quality of life
1087502|NCT02626065|Melanoma|melanoma
1087503|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
1087504|NCT02626065|Immune modulation|immune modulation
1087505|NCT02626065|BRAF|braf
1087506|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
1087507|NCT02626052|mastoid vibration test|mastoid vibration test
1087508|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
1087509|NCT02626039|CTCs|ctcs
1087510|NCT02626039|cfDNA|cfdna
1087511|NCT02626039|genomics|genomics
1087512|NCT02626039|somatic mutations|somatic mutations
1087513|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
1087514|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
1087515|NCT02625961|PD1|pd1
1087516|NCT02625961|PDL1|pdl1
1087517|NCT02625961|PD-L1|pd-l1
1087518|NCT02625961|PD-1|pd-1
1087519|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
1087520|NCT02625948|tranexamic acid|tranexamic acid
1087521|NCT02625948|spot sign|spot sign
1087522|NCT02625935|Prosigna|prosigna
1087523|NCT02625935|estrogen receptor positive|estrogen receptor positive
1087524|NCT02625935|node negative|node negative
1087525|NCT02625935|HER2 negative|her2 negative
1087526|NCT02625922|Serelaxin,|serelaxin,
1087527|NCT02625922|Chronic heart failure,|chronic heart failure,
1087528|NCT02625922|Spiroergometry,|spiroergometry,
1087529|NCT02625922|Troponin,|troponin,
1087530|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
1087531|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
1087532|NCT02625896|Aviation|aviation
1087533|NCT02625896|Parachuting|parachuting
1087534|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
1087535|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
1087536|NCT02625857|JNJ-64041809|jnj-64041809
1087751|NCT02624635|Pain|pain
1087537|NCT02625857|Listeria monocytogenes|listeria monocytogenes
1087538|NCT02625831|ficolin-3|ficolin-3
1087539|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
1087540|NCT02625831|lupus nephritis|lupus nephritis
1087541|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1087542|NCT02625831|biomarker|biomarker
1087543|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
1087544|NCT02625818|Prognosis|prognosis
1087545|NCT02625818|Biological markers|biological markers
1087546|NCT02625818|Anxiety|anxiety
1087547|NCT02625818|Panic|panic
1087548|NCT02625818|Psychomotor Agitation|psychomotor agitation
1087549|NCT02625818|Self-injurious Behavior|self-injurious behavior
1087550|NCT02625792|Post ESD ulcer|post esd ulcer
1087551|NCT02625792|Bleeding|bleeding
1087552|NCT02625792|Prophylaxis|prophylaxis
1087553|NCT02625779|Bipolar depression|bipolar depression
1087554|NCT02625779|Cytidine|cytidine
1087555|NCT02625779|Creatine|creatine
1087556|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1087557|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
1087558|NCT02625766|LC pelvic fracture|lc pelvic fracture
1087559|NCT02625766|Complications|complications
1087560|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
1087562|NCT02625753|analgesia|analgesia
1087563|NCT02625753|opioid|opioid
1087564|NCT02625727|knee osteoarthritis|knee osteoarthritis
1087565|NCT02625727|hyaluronic acid|hyaluronic acid
1087566|NCT02625727|corticosteroid|corticosteroid
1087567|NCT02625727|intra-articular injection|intra-articular injection
1087568|NCT02625727|therapeutic effect|therapeutic effect
1087569|NCT02625701|operative mortality|operative mortality
1087570|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
1087571|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
1087572|NCT02625701|surgical site infection|surgical site infection
1087573|NCT02625701|acute kidney injury|acute kidney injury
1087574|NCT02625701|body weight|body weight
1087575|NCT02625662|muscular dystrophy|muscular dystrophy
1087576|NCT02625662|natural history|natural history
1087577|NCT02625662|genetic profilling|genetic profilling
1087578|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1087579|NCT02625649|obesity|obesity
1087580|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
1087581|NCT02625649|diabetic nephropathy|diabetic nephropathy
1087582|NCT02625649|diabetic retinopathy|diabetic retinopathy
1087583|NCT02625623|Avelumab|avelumab
1087584|NCT02625623|Gastric cancer|gastric cancer
1087585|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
1087586|NCT02625610|Avelumab|avelumab
1087587|NCT02625610|Cancer|cancer
1087588|NCT02625610|Unresectable|unresectable
1087589|NCT02625610|Locally advanced|locally advanced
1087590|NCT02625610|Metastatic|metastatic
1087591|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
1087592|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
1087593|NCT02625584|Shared Book Reading|shared book reading
1087594|NCT02625584|Dialogic Reading|dialogic reading
1087595|NCT02625584|Language Development|language development
1087596|NCT02625584|Syntax|syntax
1087597|NCT02625584|Vocabulary|vocabulary
1087598|NCT02625584|Young Children|young children
1087599|NCT02625584|Randomised Control Trial|randomised control trial
1087600|NCT02625584|Language Intervention|language intervention
1087601|NCT02625558|riociguat|riociguat
1087602|NCT02625558|saph|saph
1087603|NCT02625558|sarcoidosis|sarcoidosis
1087604|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
1087605|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
1087606|NCT02625532|Follicular phase|follicular phase
1087607|NCT02625532|Luteal phase|luteal phase
1087608|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
1087609|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
1087610|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
1087611|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR) gene polymorphism|receptor n680s follicle-stimulating hormone receptor (fshr) gene polymorphism
1087612|NCT02625519|Oocyte donors|oocyte donors
1087613|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
1087614|NCT02625493|Patient Preference|patient preference
1087615|NCT02625493|Radial access|radial access
1087616|NCT02625493|Femoral access|femoral access
1087617|NCT02625493|Coronary angiography|coronary angiography
1087618|NCT02625493|Shared decision making|shared decision making
1087619|NCT02625467|Keratoconus|keratoconus
1087620|NCT02625454|Acetaminophen|acetaminophen
1087621|NCT02625454|Labor|labor
1087622|NCT02625454|Intrapartum Fever|intrapartum fever
1087623|NCT02625454|Maternal Fever|maternal fever
1087624|NCT02625454|Fetal Tachycardia|fetal tachycardia
1087625|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
1087626|NCT02625441|Breast cancer|breast cancer
1087627|NCT02625441|docetaxel|docetaxel
1087628|NCT02625441|pertuzumab|pertuzumab
1087629|NCT02625441|trastuzumab|trastuzumab
1087630|NCT02625441|HER2|her2
1087631|NCT02625402|decision making|decision making
1087632|NCT02625402|decision aids|decision aids
1087633|NCT02625402|decision quality instruments|decision quality instruments
1087634|NCT02625402|osteoarthritis|osteoarthritis
1087635|NCT02625402|shared decision making|shared decision making
1087636|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
1087637|NCT02625363|Glycemic Index|glycemic index
1087638|NCT02625363|Water Intake|water intake
1087639|NCT02625363|Glycemic Response|glycemic response
1087640|NCT02625350|instant noodle|instant noodle
1087641|NCT02625350|water content|water content
1087642|NCT02625350|glycemic index|glycemic index
1087643|NCT02625350|serving method|serving method
1087644|NCT02625298|periapical diseases|periapical diseases
1087645|NCT02625298|dental injuries|dental injuries
1087647|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
1087648|NCT02625272|right colon cancer|right colon cancer
1087649|NCT02625272|complete mesocolic excision|complete mesocolic excision
1087650|NCT02625272|no touch isolation|no touch isolation
1087651|NCT02625272|recurrence|recurrence
1087652|NCT02625272|overall survival|overall survival
1087653|NCT02625259|Drug therapy|drug therapy
1087654|NCT02625246|bronchiectasis|bronchiectasis
1087655|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
1087656|NCT02625246|lung|lung
1087657|NCT02625246|pulmonary|pulmonary
1087658|NCT02625246|interstitial lung disease|interstitial lung disease
1087754|NCT02624622|omphalitis|omphalitis
1087669|NCT02625168|Efficacy|efficacy
1087671|NCT02625155|Pharmacogenomics|pharmacogenomics
1087672|NCT02625155|Urine Drug Testing|urine drug testing
1087673|NCT02625155|antidepressants|antidepressants
1087674|NCT02625155|benzodiazepines|benzodiazepines
1087675|NCT02625155|opioids|opioids
1087676|NCT02625155|muscle relaxants|muscle relaxants
1087677|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
1087678|NCT02625155|TDRAE|tdrae
1087679|NCT02625142|Morning Rounds|morning rounds
1087680|NCT02625142|Patient-centered Care|patient-centered care
1087681|NCT02625142|Hospital Medicine|hospital medicine
1087682|NCT02625142|Pediatrics|pediatrics
1087683|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
1087684|NCT02625116|Cohort|cohort
1087685|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
1087686|NCT02625090|Drug-resistance|drug-resistance
1087687|NCT02625090|focal epilepsy|focal epilepsy
1087688|NCT02625090|partial-onset seizures|partial-onset seizures
1087689|NCT02625077|Valvuloplasty|valvuloplasty
1087690|NCT02625077|Fundoplication|fundoplication
1087691|NCT02625077|Acid reflux|acid reflux
1087692|NCT02625077|GERD|gerd
1087693|NCT02625077|Reflux disease|reflux disease
1087694|NCT02625077|Hiatal hernia|hiatal hernia
1087695|NCT02625064|ARDS|ards
1087696|NCT02625064|biomarkers|biomarkers
1087697|NCT02625064|proteomic|proteomic
1087698|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
1087699|NCT02625012|Vitiligo|vitiligo
1087700|NCT02625012|Melanocytes|melanocytes
1087701|NCT02625012|Pigmentation|pigmentation
1087702|NCT02624999|Head and Neck Cancer|head and neck cancer
1087703|NCT02624999|SCCHN|scchn
1087704|NCT02624999|R/M SCCHN|r/m scchn
1087705|NCT02624999|Carcinoma|carcinoma
1087706|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
1087707|NCT02624973|personalized medicine|personalized medicine
1087708|NCT02624947|RSV|rsv
1087709|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
1087710|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
1087711|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
1087712|NCT02624882|antibiotics|antibiotics
1087724|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
1087725|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
1087726|NCT02624804|Diabetes|diabetes
1087727|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
1087728|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
1087729|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
1087730|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
1087731|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
1087732|NCT02624726|1st line|1st line
1087733|NCT02624726|FOLFIRI|folfiri
1087734|NCT02624726|Aflibercept|aflibercept
1087735|NCT02624726|mCRC|mcrc
1087736|NCT02624713|eating disorder|eating disorder
1087737|NCT02624713|childhood obesity|childhood obesity
1087738|NCT02624713|family based treatment|family based treatment
1087739|NCT02624700|ER-negative|er-negative
1087740|NCT02624700|PgR-negative|pgr-negative
1087741|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
1087742|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
1087743|NCT02624700|HER2-negative|her2-negative
1087744|NCT02624661|Trigeminal ganglion|trigeminal ganglion
1087745|NCT02624661|Glycerol|glycerol
1087746|NCT02624661|Nerve block|nerve block
1087747|NCT02624648|Sexual Dysfunction|sexual dysfunction
1087748|NCT02624648|Postmenopausal women|postmenopausal women
1087749|NCT02624648|Sexual desire|sexual desire
1087750|NCT02624635|Manual Therapy|manual therapy
1087753|NCT02624635|Muscle Strength|muscle strength
1087755|NCT02624622|neonate|neonate
1087756|NCT02624622|developing countries|developing countries
1087757|NCT02624596|OCD|ocd
1087758|NCT02624583|Fasting|fasting
1087759|NCT02624583|Clopidogrel|clopidogrel
1087760|NCT02624570|AML|aml
1087761|NCT02624570|FLT3|flt3
1087762|NCT02624570|ITD|itd
1087763|NCT02624570|TKD|tkd
1087764|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
1087765|NCT02624570|induction|induction
1087766|NCT02624570|consolidation|consolidation
1087767|NCT02624570|continuation|continuation
1087768|NCT02624570|EAP|eap
1087769|NCT02624570|ETP|etp
1087770|NCT02624570|midostaurin|midostaurin
1087771|NCT02624570|PKC412|pkc412
1087772|NCT02624557|Hepatic impairment|hepatic impairment
1087773|NCT02624557|Healthy volunteers|healthy volunteers
1133409|NCT02358980|HFR|hfr
1087774|NCT02624557|Clinical pharmacology study|clinical pharmacology study
1087775|NCT02624557|BYL719|byl719
1087776|NCT02624557|alpelisib|alpelisib
1087777|NCT02624531|NACT|nact
1087778|NCT02624531|Cervical cancer|cervical cancer
1087779|NCT02624531|Fertility sparing|fertility sparing
1087780|NCT02624531|Pregnancy|pregnancy
1087781|NCT02624531|Treatment Strategy|treatment strategy
1087782|NCT02624479|Pharmacokinetics|pharmacokinetics
1087783|NCT02624466|Pediatrics|pediatrics
1087784|NCT02624466|Nephrology|nephrology
1087785|NCT02624466|Dialysis|dialysis
1087786|NCT02624453|cryptococcus|cryptococcus
1087787|NCT02624453|IMMY LFA|immy lfa
1087788|NCT02624453|meningitis|meningitis
1087789|NCT02624453|antigen|antigen
1087790|NCT02624440|Multiple Myeloma|multiple myeloma
1087791|NCT02624440|Infection|infection
1087792|NCT02624440|Clarithromycin|clarithromycin
1087793|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1087794|NCT02624427|Glaucoma|glaucoma
1087795|NCT02624427|Intraocular Pressure|intraocular pressure
1087796|NCT02624388|Genistein|genistein
1087797|NCT02624388|Soy|soy
1087798|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
1087799|NCT02624388|Pediatric Cancer|pediatric cancer
1087800|NCT02624388|Isoflavone|isoflavone
1087801|NCT02624362|Odor|odor
1087802|NCT02624362|trigger|trigger
1087803|NCT02624362|inflammation|inflammation
1087804|NCT02624362|nocebo|nocebo
1087805|NCT02624336|periodontal disease|periodontal disease
1087806|NCT02624336|caries|caries
1087807|NCT02624323|ultrasonography|ultrasonography
1087808|NCT02624323|catheterization|catheterization
1087809|NCT02624323|central line|central line
1087810|NCT02624323|mechanical ventilation|mechanical ventilation
1087811|NCT02624323|intensive care|intensive care
1087812|NCT02624323|axillary vein|axillary vein
1087813|NCT02624323|jugular vein|jugular vein
1087814|NCT02624323|randomization|randomization
1087815|NCT02624297|Coronary artery disease|coronary artery disease
1087816|NCT02624297|Chemoreceptors|chemoreceptors
1087817|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
1087818|NCT02624297|Exercise|exercise
1087819|NCT02624271|gastric cancer|gastric cancer
1087820|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
1087821|NCT02624271|blood test|blood test
1087822|NCT02624232|Anorectal malformation|anorectal malformation
1087823|NCT02624232|Anorectal atresia|anorectal atresia
1087824|NCT02624232|anorectal stenosis|anorectal stenosis
1087825|NCT02624232|Follow-Up Studies|follow-up studies
1087826|NCT02624219|A/H5N8|a/h5n8
1087827|NCT02624219|AS03|as03
1087828|NCT02624219|Controlled|controlled
1087829|NCT02624219|Double-Blind|double-blind
1087830|NCT02624219|Immunogenicity|immunogenicity
1087831|NCT02624219|Inactivated|inactivated
1087832|NCT02624219|Influenza|influenza
1087833|NCT02624219|MF59|mf59
1087834|NCT02624219|Monovalent|monovalent
1087835|NCT02624219|Randomized|randomized
1087836|NCT02624219|Reactogenicity|reactogenicity
1087837|NCT02624219|Safety|safety
1087838|NCT02624219|Trial|trial
1087839|NCT02624219|Vaccine|vaccine
1087840|NCT02624193|Treatment Adherence|treatment adherence
1087841|NCT02624193|Mental Health|mental health
1087842|NCT02624193|Well-being|well-being
1087843|NCT02624193|Emerging Adults|emerging adults
1087844|NCT02624193|Youth|youth
1087845|NCT02624128|head and neck cancer|head and neck cancer
1087846|NCT02624128|valproic acid|valproic acid
1087847|NCT02624128|recurrent|recurrent
1087848|NCT02624128|metastatic|metastatic
1087849|NCT02624102|Major depressive disorder|major depressive disorder
1087850|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
1087851|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
1087852|NCT02624102|Behavioral activation|behavioral activation
1087853|NCT02624076|unexplained infertility|unexplained infertility
1087854|NCT02624076|Acupuncture|acupuncture
1087855|NCT02624050|ACEI|acei
1087856|NCT02624050|ARB|arb
1087857|NCT02624050|Hypotension|hypotension
1087858|NCT02624050|General Anesthesia|general anesthesia
1087859|NCT02624050|Methohexital|methohexital
1087860|NCT02624050|Propofol|propofol
1087861|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
1087862|NCT02624037|Crohn's Disease|crohn's disease
1087965|NCT02623530|Critical thinking|critical thinking
1087863|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
1087864|NCT02624037|Remicade, Infliximab|remicade, infliximab
1087865|NCT02623998|Diabetes|diabetes
1087866|NCT02623998|Insulin|insulin
1087867|NCT02623998|Glargine|glargine
1087868|NCT02623998|Metformin|metformin
1087869|NCT02623998|Sitagliptin|sitagliptin
1087870|NCT02623998|Diet|diet
1087871|NCT02623998|Excercise|excercise
1087872|NCT02623998|Lifestyle|lifestyle
1087873|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
1087874|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
1087875|NCT02623959|Advanced Cancers|advanced cancers
1087876|NCT02623959|Malignant pleural effusions|malignant pleural effusions
1087877|NCT02623959|MPE|mpe
1087878|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
1087879|NCT02623959|IPC|ipc
1087880|NCT02623959|Questionnaires|questionnaires
1087881|NCT02623959|Surveys|surveys
1087882|NCT02623959|Fentanyl patch|fentanyl patch
1087883|NCT02623959|Fentanyl by vein|fentanyl by vein
1087884|NCT02623959|Sublimaze|sublimaze
1087885|NCT02623959|Doxycycline|doxycycline
1087886|NCT02623959|Vibramycin|vibramycin
1087887|NCT02623959|Periostat|periostat
1087888|NCT02623959|Doryx|doryx
1087889|NCT02623959|:Phone calls|:phone calls
1087890|NCT02623946|motor evoked potentials|motor evoked potentials
1087891|NCT02623933|HDR monotherapy|hdr monotherapy
1087892|NCT02623933|MRI guidance|mri guidance
1087893|NCT02623933|Intraprostatic lesion|intraprostatic lesion
1087894|NCT02623933|dose paining|dose paining
1087895|NCT02623894|Vascular aging.|vascular aging.
1087896|NCT02623894|Arterial stiffness.|arterial stiffness.
1087897|NCT02623894|Lifestyles.|lifestyles.
1087898|NCT02623894|Vascular structure.|vascular structure.
1087899|NCT02623894|Telomere length,|telomere length,
1087900|NCT02623894|Psychological factors.|psychological factors.
1087901|NCT02623894|Inflammatory factors.|inflammatory factors.
1087902|NCT02623894|Oxidative stress|oxidative stress
1087903|NCT02623881|Cervical pessary|cervical pessary
1087904|NCT02623881|Vaginal progesterone|vaginal progesterone
1087905|NCT02623881|Twins|twins
1087906|NCT02623881|Premature birth|premature birth
1087907|NCT02623855|Parks|parks
1087908|NCT02623855|Well-being|well-being
1087909|NCT02623855|Stress|stress
1087910|NCT02623855|Physical Activity|physical activity
1087911|NCT02623855|Nature|nature
1087912|NCT02623855|Greenspace|greenspace
1087913|NCT02623842|urinary incontinence|urinary incontinence
1087914|NCT02623842|woman|woman
1087915|NCT02623842|radiofrequency|radiofrequency
1087916|NCT02623829|scar prophylaxis|scar prophylaxis
1087917|NCT02623829|Botulinum Toxin|botulinum toxin
1087918|NCT02623764|Alzheimer´s disease|alzheimer´s disease
1087919|NCT02623764|Lewy body dementia|lewy body dementia
1087920|NCT02623764|Parkinson dementia|parkinson dementia
1087921|NCT02623764|EEG|eeg
1087922|NCT02623764|Cholinergic index|cholinergic index
1087923|NCT02623725|Dengue Fever|dengue fever
1087924|NCT02623725|Dengue virus|dengue virus
1087925|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1087926|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
1087927|NCT02623699|IONIS-SOD1Rx|ionis-sod1rx
1087928|NCT02623699|SOD1|sod1
1087929|NCT02623699|ALS|als
1087930|NCT02623686|Sleep|sleep
1087931|NCT02623686|ICU|icu
1087932|NCT02623686|Massage Therapy|massage therapy
1087933|NCT02623686|Inhalation Patch|inhalation patch
1087934|NCT02623660|Inflammation|inflammation
1087935|NCT02623660|Edema|edema
1087936|NCT02623660|Arthroplasty|arthroplasty
1087937|NCT02623660|Rehabilitation|rehabilitation
1087938|NCT02623660|Replacement|replacement
1087939|NCT02623660|Knee|knee
1087940|NCT02623660|Total Knee Replacement|total knee replacement
1087941|NCT02623660|Pain, Postoperative|pain, postoperative
1087942|NCT02623660|Exercise Therapy|exercise therapy
1087943|NCT02623660|Therapeutics|therapeutics
1087944|NCT02623660|Early Ambulation|early ambulation
1087945|NCT02623660|Myofunctional Therapy|myofunctional therapy
1087946|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
1087947|NCT02623660|Orthopedic Procedures|orthopedic procedures
1087948|NCT02623660|Wound Healing|wound healing
1087949|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
1087950|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
1087951|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
1087952|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
1087953|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
1087954|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1087955|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
1087956|NCT02623595|abscopal effect|abscopal effect
1087957|NCT02623595|safety|safety
1087958|NCT02623595|immunotherapy|immunotherapy
1087959|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
1087960|NCT02623556|ESAT6-CFP10|esat6-cfp10
1087961|NCT02623556|skin test|skin test
1087962|NCT02623556|diagnostic test|diagnostic test
1087964|NCT02623530|Nursing education research|nursing education research
1087966|NCT02623530|Decision Making|decision making
1087967|NCT02623517|CIED|cied
1087968|NCT02623517|AF|af
1087969|NCT02623517|arrhythmia|arrhythmia
1087970|NCT02623517|atrial fibrillation|atrial fibrillation
1087971|NCT02623517|cardiac device|cardiac device
1087972|NCT02623517|pacemaker|pacemaker
1087973|NCT02623517|defibrillator|defibrillator
1087974|NCT02623504|Carbamazepine|carbamazepine
1087975|NCT02623504|Equetro|equetro
1087976|NCT02623504|Bipolar I Disorder|bipolar i disorder
1087977|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
1087978|NCT02623491|JNJ-55375515|jnj-55375515
1087979|NCT02623491|Healthy|healthy
1087980|NCT02623491|Placebo|placebo
1087981|NCT02623439|hematologic malignancies|hematologic malignancies
1087982|NCT02623426|uveitic macular edema|uveitic macular edema
1087983|NCT02623426|uveitis|uveitis
1087984|NCT02623400|preterm birth|preterm birth
1087985|NCT02623400|perinatal stress|perinatal stress
1087986|NCT02623400|growth and development|growth and development
1087987|NCT02623387|paravertebral block|paravertebral block
1087988|NCT02623348|dialysis|dialysis
1087989|NCT02623348|end-stage renal disease|end-stage renal disease
1087990|NCT02623335|patient decision making|patient decision making
1087991|NCT02623335|surgical decision making|surgical decision making
1087992|NCT02623335|question prompt list|question prompt list
1087993|NCT02623335|shared decision making|shared decision making
1087994|NCT02623335|decision support techniques|decision support techniques
1087995|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
1087996|NCT02623257|circulating tumor DNA|circulating tumor dna
1087997|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
1087998|NCT02623244|ovarian endometrioma|ovarian endometrioma
1087999|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
1088000|NCT02623244|sexual dysfunction|sexual dysfunction
1088001|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
1088002|NCT02623218|traumatic brain injury|traumatic brain injury
1088003|NCT02623218|acupuncture|acupuncture
1088004|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
1088005|NCT02623166|Pneumonia|pneumonia
1088006|NCT02623166|Fever|fever
1088007|NCT02623166|Diarrhoea|diarrhoea
1088008|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
1088009|NCT02623140|Outcomes|outcomes
1088010|NCT02623127|Thymic carcinoma|thymic carcinoma
1088011|NCT02623127|Sunitinib|sunitinib
1088012|NCT02623127|Metastatic|metastatic
1088013|NCT02623127|Recurrent|recurrent
1088014|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
1088015|NCT02623101|Basal cell carcinoma|basal cell carcinoma
1088016|NCT02623101|Biopsy|biopsy
1088017|NCT02623101|Diagnostics|diagnostics
1088018|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
1088019|NCT02623088|Endothelial dysfunction|endothelial dysfunction
1088020|NCT02623088|Arterial stiffness|arterial stiffness
1088021|NCT02623088|PAP therapies|pap therapies
1088022|NCT02623049|New oral anticoagulants|new oral anticoagulants
1088023|NCT02623049|Blood levels|blood levels
1088024|NCT02623049|Octogenarians|octogenarians
1088025|NCT02623036|chronotherapy|chronotherapy
1088026|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1088027|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1088028|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
1088029|NCT02623010|Ibrutinib|ibrutinib
1088030|NCT02623010|Elderly|elderly
1088031|NCT02623010|Maintenance|maintenance
1088032|NCT02622997|HPV self-sampling|hpv self-sampling
1088033|NCT02622971|phototherapy|phototherapy
1088034|NCT02622971|cryotherapy|cryotherapy
1088035|NCT02622971|exercise|exercise
1088036|NCT02622971|fatigue|fatigue
1088037|NCT02622971|recovery|recovery
1088038|NCT02622958|Social Anxiety Disorder|social anxiety disorder
1088039|NCT02622958|Social Phobia|social phobia
1088040|NCT02622958|Performance Anxiety|performance anxiety
1088041|NCT02622958|Social Anxiety|social anxiety
1088042|NCT02622958|Anxiety|anxiety
1088043|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
1088044|NCT02622906|Pasireotide|pasireotide
1088045|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
1088046|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
1088047|NCT02622867|Maltodextrin|maltodextrin
1088048|NCT02622867|Probiotics|probiotics
1088049|NCT02622867|Randomized Controlled Trial|randomized controlled trial
1088050|NCT02622854|plasma exchange|plasma exchange
1088051|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
1088052|NCT02622841|First in man|first in man
1088053|NCT02622841|Spinal metastases|spinal metastases
1088054|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
1088055|NCT02622841|Palliative care|palliative care
1088056|NCT02622841|Safety|safety
1088057|NCT02622841|Surgical stabilisation|surgical stabilisation
1088058|NCT02622828|wheelchairs|wheelchairs
1088059|NCT02622828|social participation|social participation
1088060|NCT02622815|Hypercoagulation|hypercoagulation
1088061|NCT02622815|Thrombosis|thrombosis
1088062|NCT02622815|Cancer Risk Assessment|cancer risk assessment
1088063|NCT02622815|Cancer Prognosis|cancer prognosis
1088064|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
1088065|NCT02622802|transplacental transfer|transplacental transfer
1088066|NCT02622802|paracetamol|paracetamol
1088067|NCT02622802|erythromycin|erythromycin
1088068|NCT02622802|azithromycin|azithromycin
1088069|NCT02622789|Spinal alignment|spinal alignment
1088070|NCT02622789|Kinematics|kinematics
1088071|NCT02622789|Pilates|pilates
1088072|NCT02622789|Physical Therapy|physical therapy
1088073|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
1088074|NCT02622750|triple-branched stent graft|triple-branched stent graft
1088075|NCT02622750|total arch replace|total arch replace
1088076|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
1088077|NCT02622737|Parkinson disease|parkinson disease
1088078|NCT02622737|Accidental Falls|accidental falls
1088079|NCT02622737|Exercise therapy|exercise therapy
1088080|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1088081|NCT02622724|ARDS, human|ards, human
1088082|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1088083|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
1088084|NCT02622711|breast cancer|breast cancer
1088085|NCT02622711|obesity|obesity
1088086|NCT02622711|weight control|weight control
1088087|NCT02622711|exercise and physical fitness|exercise and physical fitness
1088088|NCT02622672|Antioxidation|antioxidation
1088089|NCT02622672|Anti-inflammation|anti-inflammation
1088090|NCT02622672|Blood glucose|blood glucose
1088091|NCT02622672|Blood lipids|blood lipids
1088092|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
1088093|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
1088094|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
1088095|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
1088096|NCT02622607|ZOL|zol
1088097|NCT02622607|Prevention|prevention
1088098|NCT02622607|lung cancer|lung cancer
1088099|NCT02622529|Awake craniotomy|awake craniotomy
1088100|NCT02622529|Psychological consequences|psychological consequences
1088101|NCT02622529|Fear and Anxiety|fear and anxiety
1088102|NCT02622516|Rehabilitation|rehabilitation
1088103|NCT02622516|Physical Therapy Specialty|physical therapy specialty
1088104|NCT02622516|Postural Balance|postural balance
1088105|NCT02622516|Vertigo|vertigo
1088106|NCT02622516|Dizziness|dizziness
1088107|NCT02622438|FSHD|fshd
1088108|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
1088109|NCT02622438|Muscle function|muscle function
1088110|NCT02622438|Antioxidants|antioxidants
1088111|NCT02622438|Oxidative stress|oxidative stress
1088112|NCT02622438|Quality of life|quality of life
1088113|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
1088114|NCT02622438|Co-morbidity|co-morbidity
1088115|NCT02622425|Carotenoid|carotenoid
1088116|NCT02622425|Bacillus|bacillus
1088117|NCT02622425|Microbiota|microbiota
1088118|NCT02622425|Cardiovascular health|cardiovascular health
1088119|NCT02622412|Quality of Life|quality of life
1088120|NCT02622412|Palliative Therapy|palliative therapy
1088121|NCT02622412|Outpatient Services|outpatient services
1088122|NCT02622386|Psoriasis|psoriasis
1088123|NCT02622373|Pea Pod|pea pod
1088124|NCT02622373|Body composition|body composition
1088125|NCT02622308|Arterial leg ulcers|arterial leg ulcers
1088126|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
1088127|NCT02622308|Peripheral Circulation|peripheral circulation
1088128|NCT02622308|Wound healing|wound healing
1088129|NCT02622308|Peripheral blood flow|peripheral blood flow
1088130|NCT02622295|metabolism|metabolism
1088131|NCT02622295|glucose|glucose
1088132|NCT02622295|osteoporosis|osteoporosis
1088133|NCT02622295|secondary health conditions|secondary health conditions
1088134|NCT02622295|quality of life|quality of life
1088135|NCT02622295|standing|standing
1088136|NCT02622295|electrical stimulation|electrical stimulation
1088137|NCT02622295|diabetes|diabetes
1088138|NCT02622295|insulin|insulin
1088139|NCT02622295|skeletal muscle|skeletal muscle
1088140|NCT02622282|physical activity|physical activity
1088141|NCT02622282|physical inactivity|physical inactivity
1088142|NCT02622282|PAD|pad
1088143|NCT02622282|Diabetes|diabetes
1088144|NCT02622282|High blood pressure|high blood pressure
1088145|NCT02622282|High cholesterol|high cholesterol
1088146|NCT02622282|Smoking|smoking
1088147|NCT02622269|Urography|urography
1088148|NCT02622269|Radiation dosage|radiation dosage
1088149|NCT02622269|image enhancement|image enhancement
1088150|NCT02622256|Social Media|social media
1088151|NCT02622256|Twitter|twitter
1088152|NCT02622256|Hypertension|hypertension
1088153|NCT02622256|Cardiovascular|cardiovascular
1088154|NCT02622256|CVD|cvd
1088155|NCT02622256|HTN|htn
1088156|NCT02622230|Uygur Medicine|uygur medicine
1088157|NCT02622217|anesthesiology|anesthesiology
1088158|NCT02622217|non technical kills|non technical kills
1088159|NCT02622191|Glaucoma|glaucoma
1088160|NCT02622191|Optical Coherence Tomography|optical coherence tomography
1088161|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
1088162|NCT02622191|Visual Field|visual field
1088163|NCT02622165|health promotion|health promotion
1088164|NCT02622165|nutrition|nutrition
1088165|NCT02622165|intervention|intervention
1088166|NCT02622165|adolescents|adolescents
1088167|NCT02622165|serious game|serious game
1088168|NCT02622152|Right lateral|right lateral
1088169|NCT02622152|Oxygenation|oxygenation
1088170|NCT02622152|Cardiac|cardiac
1088171|NCT02622152|Congenital|congenital
1088172|NCT02622152|Pediatric|pediatric
1088173|NCT02622152|Postoperative|postoperative
1088174|NCT02622139|Photoacoustics|photoacoustics
1088175|NCT02622139|Optoacoustics|optoacoustics
1088176|NCT02622139|Ultrasound|ultrasound
1088177|NCT02622126|Preloading|preloading
1088178|NCT02622126|Colloid|colloid
1088179|NCT02622126|Cesarean section|cesarean section
1088180|NCT02622126|D-dimer|d-dimer
1088181|NCT02622126|Hypotension|hypotension
1088182|NCT02622113|insulin resistance|insulin resistance
1088183|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1088184|NCT02622100|Routine Clinical Practice|routine clinical practice
1088185|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1088186|NCT02622100|Coronary Artery Disease|coronary artery disease
1088187|NCT02622100|drug eluting stent|drug eluting stent
1088188|NCT02622074|PD1|pd1
1088189|NCT02622074|PD-1|pd-1
1088190|NCT02622074|PDL1|pdl1
1088191|NCT02622074|PD-L1|pd-l1
1088192|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
1088193|NCT02622048|Mental Health|mental health
1088194|NCT02622048|Psychosis|psychosis
1088195|NCT02622048|Parent|parent
1088196|NCT02622035|Virtual Reality Technology|virtual reality technology
1088197|NCT02622035|Methodology|methodology
1088198|NCT02622022|randomised|randomised
1088199|NCT02622022|placebo controlled|placebo controlled
1088200|NCT02622022|clinical trial|clinical trial
1088201|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
1088202|NCT02621996|Surface Electromyography|surface electromyography
1088203|NCT02621996|Hypotonia|hypotonia
1088204|NCT02621996|Patient Positioning|patient positioning
1088205|NCT02621983|Schizophrenia|schizophrenia
1088206|NCT02621983|Exercise|exercise
1088207|NCT02621983|Cognition|cognition
1088208|NCT02621905|Prophylaxis|prophylaxis
1088209|NCT02621905|Steady-State|steady-state
1088210|NCT02621905|Bioavailability|bioavailability
1088211|NCT02621866|hypertension|hypertension
1088212|NCT02621866|ultraviolet|ultraviolet
1088213|NCT02621853|Steatosis|steatosis
1088214|NCT02621827|vitamin D|vitamin d
1088215|NCT02621827|Africa|africa
1088216|NCT02621814|Infant|infant
1088217|NCT02621814|Growth|growth
1088218|NCT02621814|Body Weight Changes|body weight changes
1088219|NCT02621814|Infant Formula|infant formula
1088220|NCT02621814|Randomized Controlled Trial|randomized controlled trial
1088221|NCT02621788|mind/body medicine|mind/body medicine
1088222|NCT02621788|3RP|3rp
1088223|NCT02621788|stress management|stress management
1088224|NCT02621788|resident burnout|resident burnout
1088225|NCT02621775|Stress management|stress management
1088226|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
1088227|NCT02621775|Self-help|self-help
1088228|NCT02621775|e-health|e-health
1088229|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
1088230|NCT02621736|children|children
1088231|NCT02621736|desmopressin|desmopressin
1088232|NCT02621736|copeptin|copeptin
1088233|NCT02621723|Preventability|preventability
1088234|NCT02621697|dual task|dual task
1088235|NCT02621697|aging|aging
1088236|NCT02621671|Healthy Volunteers|healthy volunteers
1088237|NCT02621658|Colorectal Cancer|colorectal cancer
1088238|NCT02621658|Colonoscopy|colonoscopy
1088239|NCT02621658|Adenoma Detection Rate|adenoma detection rate
1088240|NCT02621658|Bowel Preparation|bowel preparation
1088241|NCT02621658|Time to Cecal Intubation|time to cecal intubation
1088242|NCT02621645|monochorionic|monochorionic
1088243|NCT02621645|TRAP|trap
1088244|NCT02621645|acardiac twin|acardiac twin
1088245|NCT02621632|Compression therapy|compression therapy
1088246|NCT02621619|Older adults|older adults
1088247|NCT02621619|Elderly|elderly
1088248|NCT02621619|Acute pain|acute pain
1088249|NCT02621619|IV acetaminophen|iv acetaminophen
1088250|NCT02621619|IV hydromorphone|iv hydromorphone
1088251|NCT02621619|Analgesia|analgesia
1088252|NCT02621619|Adjunctive analgesia|adjunctive analgesia
1088253|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
1088254|NCT02621593|Dry eye symptoms|dry eye symptoms
1088255|NCT02621593|Intense Pulsed Light|intense pulsed light
1088256|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
1088257|NCT02621554|Memory|memory
1088258|NCT02621554|Resveratrol|resveratrol
1088259|NCT02621554|elderly|elderly
1088260|NCT02621554|cognition|cognition
1088261|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
1088262|NCT02621541|pancreas|pancreas
1088263|NCT02621541|diagnosis|diagnosis
1088264|NCT02621541|positron emission tomography|positron emission tomography
1088265|NCT02621528|CeraFlex occluder|ceraflex occluder
1088266|NCT02621515|Nivolumab|nivolumab
1088380|NCT02620852|prevention|prevention
1088267|NCT02621515|Brain metastasis|brain metastasis
1088268|NCT02621515|Melanoma|melanoma
1088273|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
1088274|NCT02621489|Endothelialization|endothelialization
1088275|NCT02621489|Cardiac Function|cardiac function
1088276|NCT02621489|Exenatide|exenatide
1088277|NCT02621489|Optical Coherence Tomography|optical coherence tomography
1088278|NCT02621450|chronic renal failure|chronic renal failure
1088279|NCT02621450|hypertension|hypertension
1088280|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
1088281|NCT02621437|pain|pain
1088282|NCT02621437|quality of life|quality of life
1088283|NCT02621437|osteopathy|osteopathy
1088284|NCT02621437|oncology|oncology
1088285|NCT02621437|surgery|surgery
1088286|NCT02621437|breast|breast
1088287|NCT02621424|dementia|dementia
1088288|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1088289|NCT02621424|RTMS|rtms
1088290|NCT02621424|CVLT|cvlt
1088291|NCT02621411|Substance abuse|substance abuse
1088292|NCT02621411|Emergency operation|emergency operation
1088293|NCT02621411|Preoperative screen|preoperative screen
1088294|NCT02621320|Vitamin D|vitamin d
1088295|NCT02621320|Exercise Performance|exercise performance
1088296|NCT02621320|Wheelchair Athletes|wheelchair athletes
1088297|NCT02621320|Indoor sports|indoor sports
1088298|NCT02621320|Wingate|wingate
1088299|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
1088300|NCT02621307|postprandial glycemia|postprandial glycemia
1088301|NCT02621307|subjective appetite|subjective appetite
1088302|NCT02621307|Salba|salba
1088303|NCT02621307|Flax|flax
1088304|NCT02621294|Protein|protein
1088305|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
1088306|NCT02621294|athletes|athletes
1088307|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
1088308|NCT02621281|Kidney Transplantation|kidney transplantation
1088309|NCT02621281|Delayed graft function|delayed graft function
1088310|NCT02621281|perfusion pressure|perfusion pressure
1088311|NCT02621229|Optimal rate of refeeding|optimal rate of refeeding
1088312|NCT02621229|inpatients|inpatients
1088313|NCT02621229|hospitalized|hospitalized
1088314|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
1088315|NCT02621190|circulating tumor cells|circulating tumor cells
1088316|NCT02621190|predictive factor|predictive factor
1088317|NCT02621151|combination therapy|combination therapy
1088318|NCT02621151|immunotherapy|immunotherapy
1088319|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
1088320|NCT02621099|handheld gamma camera|handheld gamma camera
1088321|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
1088322|NCT02621073|lower extremity|lower extremity
1088323|NCT02621073|status-post ORIF|status-post orif
1088324|NCT02621060|Chlorogenic acid|chlorogenic acid
1088325|NCT02621060|Control glucose|control glucose
1088326|NCT02621060|Insulin Secretion|insulin secretion
1088327|NCT02621060|Insulin Sensitivity|insulin sensitivity
1088328|NCT02621047|Healthy volunteer|healthy volunteer
1088329|NCT02621047|Alectinib|alectinib
1088330|NCT02621047|Hepatic impairment|hepatic impairment
1088331|NCT02621034|Root canal treatment|root canal treatment
1088332|NCT02621034|pain|pain
1088333|NCT02621034|endodontic instruments|endodontic instruments
1088338|NCT02621008|diabetes|diabetes
1088339|NCT02621008|hypertension|hypertension
1088340|NCT02621008|obesity|obesity
1088341|NCT02621008|mobile phone|mobile phone
1088342|NCT02621008|stress|stress
1088343|NCT02621008|healthy living|healthy living
1088344|NCT02621008|pre-diabetes|pre-diabetes
1088345|NCT02620995|hypertension|hypertension
1088346|NCT02620995|endothelial dysfunction|endothelial dysfunction
1088347|NCT02620995|erectile dysfunction|erectile dysfunction
1088348|NCT02620995|sildenafil|sildenafil
1088349|NCT02620982|Shockwave|shockwave
1088350|NCT02620982|vascular ED|vascular ed
1088351|NCT02620982|Organic ED|organic ed
1088352|NCT02620969|Paediatrics|paediatrics
1088353|NCT02620969|Haemodialysis|haemodialysis
1088354|NCT02620969|Kinetics|kinetics
1088355|NCT02620943|Anemia|anemia
1088356|NCT02620943|Pregnancy Outcome|pregnancy outcome
1088357|NCT02620943|Pregnancy|pregnancy
1088358|NCT02620943|Dietary Diversity|dietary diversity
1088359|NCT02620943|Birth Weight|birth weight
1088360|NCT02620930|Sleep Disorders|sleep disorders
1088361|NCT02620930|Sleep Apnea|sleep apnea
1088362|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
1088363|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
1088364|NCT02620917|type 1 diabetes|type 1 diabetes
1088365|NCT02620917|CSII|csii
1088366|NCT02620904|mifepristone|mifepristone
1088367|NCT02620904|randomized controlled trial|randomized controlled trial
1088368|NCT02620904|vaginal delivery|vaginal delivery
1088369|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
1088370|NCT02620904|induction of labor|induction of labor
1088374|NCT02620878|SAP therapy|sap therapy
1088375|NCT02620878|children|children
1088376|NCT02620878|adolescents|adolescents
1088377|NCT02620878|type 1 diabetes|type 1 diabetes
1088378|NCT02620852|Breast screening|breast screening
1088379|NCT02620852|mammography|mammography
1088381|NCT02620852|risk assessment|risk assessment
1088382|NCT02620852|DCIS|dcis
1088383|NCT02620852|Breast cancer|breast cancer
1088384|NCT02620852|Wisdom|wisdom
1088385|NCT02620839|CDKN2A-p16 Positive|cdkn2a-p16 positive
1088386|NCT02620839|Locally Advanced Solid Neoplasm|locally advanced solid neoplasm
1088387|NCT02620839|Metastatic Malignant Solid Neoplasm|metastatic malignant solid neoplasm
1088392|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1088393|NCT02620800|Adenocarcinoma|adenocarcinoma
1088394|NCT02620800|Open-label|open-label
1088395|NCT02620800|Phase 1/2|phase 1/2
1088396|NCT02620800|Metronomic|metronomic
1088397|NCT02620800|Chemotherapy|chemotherapy
1088399|NCT02620800|nab-paclitaxel|nab-paclitaxel
1088400|NCT02620800|Abraxane|abraxane
1088401|NCT02620800|gemcitabine|gemcitabine
1088402|NCT02620800|Gemzar|gemzar
1088403|NCT02620800|bevacizumab|bevacizumab
1088404|NCT02620800|Avastin|avastin
1088405|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
1088406|NCT02620800|leucovorin|leucovorin
1088407|NCT02620800|oxaliplatin|oxaliplatin
1088408|NCT02620800|Eloxatin|eloxatin
1088409|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
1088410|NCT02620722|tourniquet|tourniquet
1088411|NCT02620722|safety|safety
1088412|NCT02620722|personalized|personalized
1088413|NCT02620722|surgery|surgery
1088414|NCT02620709|Native Hawaiians|native hawaiians
1088415|NCT02620709|Community-based participatory research|community-based participatory research
1088416|NCT02620709|Health disparities|health disparities
1088417|NCT02620709|Minority populations|minority populations
1088418|NCT02620709|Chronic disease|chronic disease
1088419|NCT02620683|lidocaine, jaw|lidocaine, jaw
1088420|NCT02620670|Physical Activity|physical activity
1088421|NCT02620670|Glycemic Variability|glycemic variability
1088422|NCT02620644|no retinopathy|no retinopathy
1088423|NCT02620631|Morphine|morphine
1088424|NCT02620631|TKA|tka
1088425|NCT02620631|Pain|pain
1088426|NCT02620631|TKR|tkr
1088427|NCT02620631|Arthroplasty|arthroplasty
1088428|NCT02620618|Safety|safety
1088429|NCT02620618|Efficacy|efficacy
1088430|NCT02620618|intravitreal infliximab|intravitreal infliximab
1088431|NCT02620618|ocular behcets|ocular behcets
1088432|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
1088433|NCT02620605|Cabergoline|cabergoline
1088434|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
1088435|NCT02620592|Healthy Subject|healthy subject
1088436|NCT02620592|ZYDPLA1|zydpla1
1088437|NCT02620592|DPPIV inhibitor|dppiv inhibitor
1088438|NCT02620592|Pharmacokinetics|pharmacokinetics
1088439|NCT02620592|Safety|safety
1088440|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
1088441|NCT02620579|Personalized Education|personalized education
1088442|NCT02620566|caudal block|caudal block
1088443|NCT02620566|local wound infiltration|local wound infiltration
1088444|NCT02620566|hernia repair|hernia repair
1088445|NCT02620553|Type 1 Diabetes|type 1 diabetes
1088446|NCT02620553|Diabetes|diabetes
1088447|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
1088448|NCT02620540|Broselow Tape|broselow tape
1088449|NCT02620540|Weight estimation|weight estimation
1088450|NCT02620540|Patient safety|patient safety
1088451|NCT02620527|Circulating Tumor DNA|circulating tumor dna
1088452|NCT02620527|Cancer|cancer
1088453|NCT02620527|Neoplasms|neoplasms
1088454|NCT02620527|Genomic Testing|genomic testing
1088455|NCT02620527|FoundationOne|foundationone
1088456|NCT02620527|Cell Free DNA|cell free dna
1088457|NCT02620527|ctDNA|ctdna
1088458|NCT02620527|cfDNA|cfdna
1088459|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
1088460|NCT02620514|Inflammation|inflammation
1088461|NCT02620501|EGD|egd
1088462|NCT02620501|topical lidocaine|topical lidocaine
1088463|NCT02620501|recovery time|recovery time
1088464|NCT02620501|intravenous sedation|intravenous sedation
1088465|NCT02620488|Pain Perception|pain perception
1088466|NCT02620488|Autonomic Nervous System|autonomic nervous system
1088467|NCT02620488|Sickle Cell Disease|sickle cell disease
1088468|NCT02620488|Hypnosis|hypnosis
1088469|NCT02620488|Guided Imagery|guided imagery
1088470|NCT02620462|Postural Balance|postural balance
1088471|NCT02620462|Pain|pain
1088472|NCT02620462|Gait|gait
1088473|NCT02620462|Physical Activity Level|physical activity level
1088474|NCT02620449|phosphorus|phosphorus
1088475|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
1088478|NCT02620436|Mother Shelters|mother shelters
1088479|NCT02620436|Maternity Waiting Homes|maternity waiting homes
1088480|NCT02620423|Pancreatic|pancreatic
1088481|NCT02620423|Cancer|cancer
1088482|NCT02620423|REOLYSIN®|reolysin®
1088483|NCT02620423|Chemotherapy|chemotherapy
1088484|NCT02620423|Pembrolizumab|pembrolizumab
1088485|NCT02620423|KEYTRUDA®|keytruda®
1088486|NCT02620423|Pelareorep|pelareorep
1088487|NCT02620423|Reovirus|reovirus
1088488|NCT02620423|Oncolytic virus|oncolytic virus
1088489|NCT02620410|OAB|oab
1088490|NCT02620384|Metolazone|metolazone
1088491|NCT02620384|Heart Failure|heart failure
1088492|NCT02620358|Mechanical Ventilation|mechanical ventilation
1088493|NCT02620358|Weaning|weaning
1088495|NCT02620319|bronchoscopy|bronchoscopy
1088496|NCT02620319|polydioxanone|polydioxanone
1088497|NCT02620319|absorbable implants|absorbable implants
1088498|NCT02620319|stents|stents
1088499|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
1088500|NCT02620267|Mismatch Negativity|mismatch negativity
1088501|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1088503|NCT02620267|tDCS|tdcs
1088504|NCT02620254|mastocytosis|mastocytosis
1088505|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
1088506|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
1088507|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
1088508|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
1088509|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
1088510|NCT02620254|systemic mastocytosis|systemic mastocytosis
1088511|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
1088512|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
1088513|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
1088514|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
1088515|NCT02620254|mast cell leukemia|mast cell leukemia
1088516|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
1088517|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
1088518|NCT02620241|positioning|positioning
1088519|NCT02620228|Bioimpedance|bioimpedance
1088520|NCT02620228|Biopsy|biopsy
1088521|NCT02620228|Liver tumour|liver tumour
1088522|NCT02620228|Biopsy needle guidance|biopsy needle guidance
1088523|NCT02620202|Troponin|troponin
1088524|NCT02620202|Myocardial infarction|myocardial infarction
1088525|NCT02620150|HIV|hiv
1088526|NCT02620150|AIDS|aids
1088527|NCT02620150|Depression|depression
1088528|NCT02620150|SSRI|ssri
1088529|NCT02620150|Escitalopram|escitalopram
1088530|NCT02620150|Immunity|immunity
1088531|NCT02620085|Graves' disease|graves' disease
1088532|NCT02620085|Hyperthyroidism|hyperthyroidism
1088533|NCT02620085|Personality traits|personality traits
1088534|NCT02620072|Type 1 diabetes|type 1 diabetes
1088535|NCT02620072|T1D|t1d
1088536|NCT02620072|diabetes mellitus|diabetes mellitus
1088537|NCT02620072|oral insulin|oral insulin
1088538|NCT02620072|oral tolerance|oral tolerance
1088539|NCT02620072|autoantigen|autoantigen
1088540|NCT02620072|self tolerance|self tolerance
1088541|NCT02620072|prevention|prevention
1088542|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
1088543|NCT02620072|juvenile diabetes|juvenile diabetes
1088544|NCT02620072|dysglycemia|dysglycemia
1088545|NCT02620059|Postpartum Period|postpartum period
1088546|NCT02620046|Drug therapy|drug therapy
1088547|NCT02620033|Prostatectomy|prostatectomy
1088548|NCT02620033|Yoga therapy|yoga therapy
1088549|NCT02620033|Health related quality of life|health related quality of life
1088550|NCT02620007|Adult|adult
1088551|NCT02620007|AIEC|aiec
1088552|NCT02619994|MDR tuberculosis|mdr tuberculosis
1088553|NCT02619994|linezolid|linezolid
1088554|NCT02619994|delamanid|delamanid
1088555|NCT02619994|Korea|korea
1088556|NCT02619968|Chronic renal failure|chronic renal failure
1088557|NCT02619968|Arteriovenous fistula|arteriovenous fistula
1088558|NCT02619968|Isometric exercises|isometric exercises
1088559|NCT02619968|Vascular endothelium|vascular endothelium
1088560|NCT02619955|hepcidin deficiency|hepcidin deficiency
1088561|NCT02619955|genetic|genetic
1088562|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
1088563|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
1088564|NCT02619929|Oral Vinorelbine|oral vinorelbine
1088565|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
1088566|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
1088567|NCT02619916|Cancer|cancer
1088568|NCT02619916|Depression|depression
1088569|NCT02619916|MBCT|mbct
1088570|NCT02619916|CBT|cbt
1088571|NCT02619890|Adult Glioma|adult glioma
1088572|NCT02619890|MRI|mri
1088872|NCT02617914|ECMO|ecmo
1088577|NCT02619799|magnesium sulphate|magnesium sulphate
1088578|NCT02619799|intrathecal route|intrathecal route
1088579|NCT02619799|midazolam|midazolam
1088580|NCT02619773|Colorectal Surgery|colorectal surgery
1088581|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
1088582|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1088583|NCT02619747|pH monitoring|ph monitoring
1088584|NCT02619734|Cell Therapy|cell therapy
1088585|NCT02619734|Sickle cell disease|sickle cell disease
1088586|NCT02619734|Autologous implantation|autologous implantation
1088587|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
1088588|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
1088589|NCT02619721|PINS SNS OAB|pins sns oab
1088590|NCT02619708|immersive preoperative experience|immersive preoperative experience
1088591|NCT02619695|ketoprofen|ketoprofen
1088593|NCT02619695|low back pain|low back pain
1088594|NCT02619695|emergency department|emergency department
1088595|NCT02619669|Neoadjuvant|neoadjuvant
1088596|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
1088597|NCT02619669|Letrozole|letrozole
1088598|NCT02619669|ER+|er+
1088599|NCT02619669|HER2-|her2-
1088600|NCT02619656|PEG|peg
1088601|NCT02619656|CO2 insufflation|co2 insufflation
1088602|NCT02619656|Room Air insufflation|room air insufflation
1088603|NCT02619656|pneumoperitoneum|pneumoperitoneum
1088604|NCT02619617|Cluster Headache|cluster headache
1088605|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
1088606|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
1088607|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
1088608|NCT02619578|QoQ-40|qoq-40
1088609|NCT02619578|MMSE|mmse
1088610|NCT02619578|VAS|vas
1088611|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
1088612|NCT02619565|mutations|mutations
1088613|NCT02619565|overall survival|overall survival
1088614|NCT02619565|prognosis|prognosis
1088615|NCT02619513|Paravertebral Blocks|paravertebral blocks
1088616|NCT02619513|Dexmedetomidine|dexmedetomidine
1088617|NCT02619513|Analgesia|analgesia
1088618|NCT02619513|Inflammatory response|inflammatory response
1088619|NCT02619513|Thoracotomy|thoracotomy
1088620|NCT02619474|Parent Satisfaction|parent satisfaction
1088621|NCT02619474|Patient Satisfaction|patient satisfaction
1088622|NCT02619474|Whiteboard|whiteboard
1088623|NCT02619474|Communication|communication
1088624|NCT02619448|inoperable|inoperable
1088625|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
1088626|NCT02619435|RAS-mutant|ras-mutant
1088627|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
1088628|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
1088629|NCT02619422|Acute coronary syndrome|acute coronary syndrome
1088630|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
1088631|NCT02619396|radiofrequency power|radiofrequency power
1088632|NCT02619396|lesion size index|lesion size index
1088633|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
1088634|NCT02619383|HBOT|hbot
1088635|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
1088636|NCT02619383|DCE|dce
1088637|NCT02619383|ED|ed
1088638|NCT02619383|erectile dysfunction|erectile dysfunction
1088639|NCT02619370|advance care planning|advance care planning
1088640|NCT02619370|advance directive|advance directive
1088641|NCT02619370|caregiving|caregiving
1088642|NCT02619357|Asthma|asthma
1088643|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
1088644|NCT02619357|step counts|step counts
1088645|NCT02619357|Exercise|exercise
1088646|NCT02619357|energy expenditure|energy expenditure
1088647|NCT02619357|COPD|copd
1088648|NCT02619357|indirect calorimetry|indirect calorimetry
1088649|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
1088650|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
1088651|NCT02619318|standard occupational therapy|standard occupational therapy
1088652|NCT02619292|cancer survivor|cancer survivor
1088653|NCT02619292|immune function|immune function
1088654|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
1088655|NCT02619266|Acupuncture|acupuncture
1088656|NCT02619266|Megestrol acetate|megestrol acetate
1088657|NCT02619266|Poor Appetite|poor appetite
1088658|NCT02619266|Anorexia|anorexia
1088659|NCT02619266|Randomized Controlled Trial|randomized controlled trial
1088660|NCT02619253|Immunotherapy|immunotherapy
1088661|NCT02619253|Safety|safety
1088662|NCT02619253|Pharmacodynamics|pharmacodynamics
1088663|NCT02619253|Efficacy|efficacy
1088664|NCT02619214|Oxidative Stress|oxidative stress
1088665|NCT02619214|Oxygen|oxygen
1088666|NCT02619214|General Anesthesia|general anesthesia
1088667|NCT02619201|vomiting in children|vomiting in children
1088668|NCT02619201|ondansetron|ondansetron
1088669|NCT02619201|metoclopramide|metoclopramide
1088670|NCT02619201|antiemetics|antiemetics
1088671|NCT02619188|Nutrition|nutrition
1088672|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
1088673|NCT02619188|Prealbumin|prealbumin
1088674|NCT02619188|Questionnaire|questionnaire
1088675|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
1088676|NCT02619162|adjuvant letrozole|adjuvant letrozole
1088677|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
1088678|NCT02619136|Blood Transfusion|blood transfusion
1088679|NCT02619123|breast density|breast density
1088680|NCT02619123|breast cancer|breast cancer
1088681|NCT02619123|risk-based screening|risk-based screening
1088682|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
1088683|NCT02619123|premenopausal women|premenopausal women
1088684|NCT02619110|Chronic Stroke|chronic stroke
1088685|NCT02619110|cardiopulmonary|cardiopulmonary
1088686|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
1088687|NCT02619084|Tourette Syndrome|tourette syndrome
1088688|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
1088689|NCT02619084|STN|stn
1088690|NCT02619084|Deep Brain Stimulation|deep brain stimulation
1088691|NCT02619084|DBS|dbs
1088692|NCT02619084|Tic|tic
1088794|NCT02618499|umbilical cord clamping|umbilical cord clamping
1088693|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
1088694|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
1088695|NCT02619058|NKT|nkt
1088696|NCT02619058|metastatic melanoma|metastatic melanoma
1088697|NCT02619032|remifentanil|remifentanil
1088698|NCT02619032|fentanyl|fentanyl
1088699|NCT02619032|dental surgery|dental surgery
1088700|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
1088701|NCT02619006|Myelination|myelination
1088702|NCT02619006|Ferritin|ferritin
1088703|NCT02619006|Umbilical cord clamping|umbilical cord clamping
1088704|NCT02619006|Umbilical Cord Milking|umbilical cord milking
1088705|NCT02619006|Placental Transfusion|placental transfusion
1088706|NCT02619006|Brain Development|brain development
1088707|NCT02618993|mandibular nerve block|mandibular nerve block
1088708|NCT02618993|mandibular osteotomy|mandibular osteotomy
1088709|NCT02618980|acute coronary syndrome|acute coronary syndrome
1088710|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
1088711|NCT02618980|endoscopy|endoscopy
1088712|NCT02618967|Lupus|lupus
1088713|NCT02618967|Healthy Volunteer|healthy volunteer
1088714|NCT02618967|Safety Study|safety study
1088715|NCT02618967|Placebo Control|placebo control
1088716|NCT02618967|Phase 1|phase 1
1088717|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
1088718|NCT02618954|Articular ultrasound|articular ultrasound
1088719|NCT02618954|Synovitis|synovitis
1088720|NCT02618954|Relapse risk|relapse risk
1088721|NCT02618928|HCV|hcv
1088722|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
1088723|NCT02618915|gene therapy|gene therapy
1088724|NCT02618915|Hemophilia B|hemophilia b
1088725|NCT02618902|patient safety|patient safety
1088726|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
1088727|NCT02618902|tolDC|toldc
1088728|NCT02618850|metabolic response|metabolic response
1088729|NCT02618850|chemotherapy|chemotherapy
1088730|NCT02618850|PET|pet
1088731|NCT02618837|NSTEMI|nstemi
1088732|NCT02618837|NSTEACS|nsteacs
1088733|NCT02618837|prasugrel|prasugrel
1088734|NCT02618837|ticagrelor|ticagrelor
1088735|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
1088736|NCT02618811|sarcopenia|sarcopenia
1088737|NCT02618811|myosteatosis|myosteatosis
1088738|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
1088739|NCT02618811|colorectal cancer|colorectal cancer
1088740|NCT02618811|minimally invasive surgery|minimally invasive surgery
1088741|NCT02618811|complications|complications
1088742|NCT02618798|chronic liver disease|chronic liver disease
1088743|NCT02618798|CLD|cld
1088744|NCT02618798|platelet function|platelet function
1088745|NCT02618785|Hysterosalpingography|hysterosalpingography
1088746|NCT02618785|antispasmodic drug|antispasmodic drug
1088747|NCT02618785|infertile women|infertile women
1088748|NCT02618772|Pediatrics|pediatrics
1088749|NCT02618772|Laceration|laceration
1088750|NCT02618772|Anxiety|anxiety
1088751|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
1088752|NCT02618746|Telemonitoring|telemonitoring
1088753|NCT02618746|Home Rehabilitation|home rehabilitation
1088754|NCT02618746|Exacerbations|exacerbations
1088755|NCT02618746|Physical Activity|physical activity
1088756|NCT02618746|COPD|copd
1088757|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
1088758|NCT02618720|Colorectal surgery|colorectal surgery
1088759|NCT02618720|Surgical Site Infection|surgical site infection
1088760|NCT02618720|Postoperative morbidity|postoperative morbidity
1088761|NCT02618707|Lactate|lactate
1088762|NCT02618707|Congenital cardiac defect|congenital cardiac defect
1088763|NCT02618707|CPB|cpb
1088764|NCT02618707|Pediatric|pediatric
1088765|NCT02618694|adrenal|adrenal
1088766|NCT02618694|supra-renal|supra-renal
1088767|NCT02618694|adrenalectomy|adrenalectomy
1088768|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
1088769|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
1088770|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
1088771|NCT02618681|earlobe crease|earlobe crease
1088772|NCT02618681|acute myocardial infarction|acute myocardial infarction
1088773|NCT02618655|TBDs；diagnosis|tbds；diagnosis
1088774|NCT02618642|muscle contraction|muscle contraction
1088775|NCT02618642|electrodiagnostic|electrodiagnostic
1088776|NCT02618642|i/t curve|i/t curve
1088777|NCT02618603|Stroke|stroke
1088778|NCT02618603|Should pain|should pain
1088779|NCT02618603|Botulinum Toxin|botulinum toxin
1088780|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
1088781|NCT02618590|EGFR mutant type|egfr mutant type
1088782|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
1088783|NCT02618577|Anticoagulation|anticoagulation
1088784|NCT02618577|atrial high rate episodes|atrial high rate episodes
1088785|NCT02618577|Atrial Fibrillation|atrial fibrillation
1088786|NCT02618577|VKA|vka
1088787|NCT02618577|NOAC|noac
1088788|NCT02618551|Thermoplasty|thermoplasty
1088789|NCT02618551|Severe asthma|severe asthma
1088790|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
1088791|NCT02618499|birth|birth
1088792|NCT02618499|oxytocin|oxytocin
1088793|NCT02618499|placental transfusion|placental transfusion
1090105|NCT02609698|DES|des
1088795|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
1088796|NCT02618473|motion artifacts|motion artifacts
1088797|NCT02618473|motion correction algorithm|motion correction algorithm
1088798|NCT02618473|diagnostic utility|diagnostic utility
1088799|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
1088800|NCT02618460|healthy volunteers|healthy volunteers
1088801|NCT02618460|renal diffusion|renal diffusion
1088802|NCT02618460|renal perfusion|renal perfusion
1088803|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
1088804|NCT02618317|renal dialysis|renal dialysis
1088805|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
1088806|NCT02618304|Lipiview|lipiview
1088807|NCT02618304|Tear Lipid Layer|tear lipid layer
1088808|NCT02618291|primary health care|primary health care
1088809|NCT02618265|stroke|stroke
1088810|NCT02618265|secondary prevention|secondary prevention
1088811|NCT02618265|platelet response polymorphism|platelet response polymorphism
1088812|NCT02618265|mobile terminal|mobile terminal
1088813|NCT02618252|difficult IV access|difficult iv access
1088814|NCT02618252|ultrasound|ultrasound
1088815|NCT02618252|veinviewer|veinviewer
1088816|NCT02618252|near infrared device|near infrared device
1088817|NCT02618239|intestinal gas|intestinal gas
1088818|NCT02618239|Healthy subjects|healthy subjects
1088819|NCT02618239|microbiota|microbiota
1088820|NCT02618239|prebiotics|prebiotics
1088821|NCT02618226|Traumatic Brain Injury|traumatic brain injury
1088822|NCT02618226|TBI|tbi
1088823|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
1088824|NCT02618226|ONUS|onus
1088825|NCT02618226|Intracranial pressure|intracranial pressure
1088826|NCT02618226|ICP|icp
1088827|NCT02618226|Intracranial hypertension|intracranial hypertension
1088828|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
1088829|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
1088830|NCT02618213|Bronchiolitis|bronchiolitis
1088831|NCT02618213|Children|children
1088832|NCT02618200|Prostate cancer|prostate cancer
1088833|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
1088834|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
1088835|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
1088836|NCT02618109|leukemia relapse|leukemia relapse
1088837|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
1088838|NCT02618096|membrane sweeping|membrane sweeping
1088839|NCT02618096|dinoprostone|dinoprostone
1088840|NCT02618096|multiparas|multiparas
1088841|NCT02618096|labor induction|labor induction
1088842|NCT02618096|cesarean delivery|cesarean delivery
1088843|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
1088844|NCT02618044|Obesity|obesity
1088845|NCT02618044|Esophageal manometry|esophageal manometry
1088846|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
1088847|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
1088848|NCT02618031|capillary index score|capillary index score
1088849|NCT02618031|acute ischemic stroke|acute ischemic stroke
1088850|NCT02618031|collateral circulation|collateral circulation
1088851|NCT02618031|cerebral ischemia|cerebral ischemia
1088852|NCT02618031|diagnostic imaging|diagnostic imaging
1088853|NCT02618018|astigmatism|astigmatism
1088854|NCT02618018|toric intraocular lens|toric intraocular lens
1088855|NCT02618005|Astronauts|astronauts
1088856|NCT02618005|Probiotics|probiotics
1088857|NCT02618005|Immune function|immune function
1088858|NCT02618005|Intestinal microbiota|intestinal microbiota
1088859|NCT02617966|Retina|retina
1088860|NCT02617966|Retinal Degeneration|retinal degeneration
1088861|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
1088862|NCT02617966|Stargardt's Disease|stargardt's disease
1088863|NCT02617966|Dark Adaptation|dark adaptation
1088864|NCT02617953|Tinnitus|tinnitus
1088865|NCT02617953|EEG|eeg
1088866|NCT02617953|ERP|erp
1088867|NCT02617940|dental caries|dental caries
1088868|NCT02617940|primary tooth|primary tooth
1088869|NCT02617940|resin-based sealants|resin-based sealants
1088870|NCT02617914|ARDS|ards
1088871|NCT02617914|PEEP|peep
1088873|NCT02617901|Bone age|bone age
1088874|NCT02617901|Greulich & Pyle|greulich & pyle
1088875|NCT02617901|TW3|tw3
1088876|NCT02617901|Radiography|radiography
1088877|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1088878|NCT02617888|radiation|radiation
1088879|NCT02617888|cardiac computed tomography|cardiac computed tomography
1088880|NCT02617888|CCTA|ccta
1088881|NCT02617888|breast shielding|breast shielding
1088882|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
1088883|NCT02617888|MPS|mps
1088884|NCT02617888|Invasive coronary angiography|invasive coronary angiography
1088885|NCT02617888|ICA|ica
1088886|NCT02617875|Pre-hospital|pre-hospital
1088887|NCT02617875|Emergency medical system|emergency medical system
1088888|NCT02617875|Telemedicine|telemedicine
1088889|NCT02617875|Tele consultation|tele consultation
1088890|NCT02617875|Remote treatment|remote treatment
1088891|NCT02617862|Diagnostic imaging|diagnostic imaging
1088892|NCT02617862|Retina|retina
1088893|NCT02617862|Pediatrics|pediatrics
1088894|NCT02617810|Healthy|healthy
1088895|NCT02617810|JNJ-42847922|jnj-42847922
1088896|NCT02617810|Midazolam|midazolam
1088897|NCT02617810|Warfarin|warfarin
1088898|NCT02617810|Pharmacokinetics|pharmacokinetics
1088899|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
1088900|NCT02617797|Radiofrequency|radiofrequency
1088901|NCT02617797|Women|women
1088902|NCT02617758|Healthy|healthy
1088903|NCT02617758|Bioequivalence Study|bioequivalence study
1088904|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
1088905|NCT02617758|DURAGESIC|duragesic
1088906|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
1088907|NCT02617732|glucose variability|glucose variability
1088908|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
1088909|NCT02617732|traditional Chinese medicine|traditional chinese medicine
1088910|NCT02617706|Anorectal surgeries|anorectal surgeries
1088911|NCT02617706|infection|infection
1088912|NCT02617706|topical oxygen|topical oxygen
1088913|NCT02617680|Desflurane|desflurane
1088914|NCT02617680|end tidal concentration|end tidal concentration
1088915|NCT02617680|age|age
1088916|NCT02617680|anesthesia|anesthesia
1088917|NCT02617641|Secondary Prevention|secondary prevention
1088918|NCT02617641|Walking|walking
1088919|NCT02617641|Health Behavior|health behavior
1088920|NCT02617641|Internet|internet
1088921|NCT02617641|eHealth|ehealth
1088922|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
1088923|NCT02617641|Multicenter Study|multicenter study
1088924|NCT02617641|Randomized Controlled Trial|randomized controlled trial
1088925|NCT02617641|Intervention Studies|intervention studies
1088926|NCT02617641|Motivation|motivation
1088927|NCT02617641|Self Efficacy|self efficacy
1088928|NCT02617641|Theory, Nursing|theory, nursing
1088929|NCT02617641|Theory, Psychological|theory, psychological
1088930|NCT02617641|Nursing Research|nursing research
1088931|NCT02617628|opioid addiction|opioid addiction
1088932|NCT02617615|MB-110|mb-110
1088933|NCT02617602|Congenital heart defect|congenital heart defect
1088934|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
1088935|NCT02617602|Goal directed therapy|goal directed therapy
1088936|NCT02617602|Acute heart failure|acute heart failure
1088937|NCT02617563|spondylolisthesis|spondylolisthesis
1088938|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
1088939|NCT02617563|minimal invasive|minimal invasive
1088940|NCT02617563|Spinal Fusion|spinal fusion
1088941|NCT02617563|MAST procedure|mast procedure
1088942|NCT02617563|Lumbar fusion|lumbar fusion
1088943|NCT02617524|dedicated sheath|dedicated sheath
1088944|NCT02617498|living donor liver transplantation|living donor liver transplantation
1088945|NCT02617459|Safety|safety
1088946|NCT02617459|efficacy|efficacy
1088947|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
1088948|NCT02617459|Chinese patients|chinese patients
1088949|NCT02617446|safety|safety
1088950|NCT02617446|efficacy|efficacy
1088951|NCT02617446|istaroxime|istaroxime
1088952|NCT02617407|Dental Plaque|dental plaque
1088953|NCT02617407|Gingivitis|gingivitis
1088954|NCT02617407|Bacterial Infection|bacterial infection
1088955|NCT02617407|Oral Hygiene|oral hygiene
1088956|NCT02617407|HSCT|hsct
1088957|NCT02617407|Oral Microbiome|oral microbiome
1088958|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
1088959|NCT02617342|Intervention|intervention
1088960|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
1088961|NCT02617342|Social Skills|social skills
1088962|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
1088963|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
1088964|NCT02617303|elderly|elderly
1088965|NCT02617303|accidental falls|accidental falls
1088966|NCT02617303|osteoporosis|osteoporosis
1088967|NCT02617303|fractures|fractures
1088968|NCT02617303|Primary Care|primary care
1088969|NCT02617303|Randomized clinical trial|randomized clinical trial
1088970|NCT02617303|Otago exercise programme|otago exercise programme
1088971|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1088972|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1088973|NCT02617277|AZD1775|azd1775
1088974|NCT02617277|MEDI4736|medi4736
1088975|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
1088976|NCT02617277|Advanced Solid Tumours|advanced solid tumours
1088977|NCT02617277|Durvalumab|durvalumab
1088978|NCT02617238|arterial stiffness|arterial stiffness
1088979|NCT02617238|cardiovascular risk|cardiovascular risk
1088980|NCT02617238|cardiovascular events|cardiovascular events
1088981|NCT02617238|renal events|renal events
1088982|NCT02617212|dental implant|dental implant
1088983|NCT02617212|bone preservation|bone preservation
1088984|NCT02617212|definitive abutment|definitive abutment
1088985|NCT02617212|one abutment one time|one abutment one time
1088986|NCT02617199|epidural anesthesia|epidural anesthesia
1088987|NCT02617199|pain management|pain management
1088988|NCT02617199|microcirculation|microcirculation
1088989|NCT02617160|Insulin Pump Treatment|insulin pump treatment
1088990|NCT02617160|Type 1 Diabetes|type 1 diabetes
1088991|NCT02617160|Insulin Pump Setting|insulin pump setting
1088992|NCT02617160|Pump Advisor|pump advisor
1088993|NCT02617108|uterine septum|uterine septum
1088994|NCT02617108|intrauterine adhesions|intrauterine adhesions
1088995|NCT02617108|Foley balloon|foley balloon
1088996|NCT02617082|breast cancer|breast cancer
1088997|NCT02617082|partial breast irradiation|partial breast irradiation
1088998|NCT02617082|DCIS|dcis
1088999|NCT02617069|Atrial fibrillation|atrial fibrillation
1089000|NCT02617069|botulinum toxin|botulinum toxin
1089001|NCT02617056|electrodermal response|electrodermal response
1089002|NCT02617043|breast cancer|breast cancer
1089003|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
1089004|NCT02617017|Parkinson disease|parkinson disease
1089005|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
1089006|NCT02616952|Stress urinary incontinence|stress urinary incontinence
1089007|NCT02616952|Chinese Herb|chinese herb
1089008|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
1089009|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
1089010|NCT02616939|Multidetector computed tomography|multidetector computed tomography
1089011|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
1089012|NCT02616926|hepatectomy|hepatectomy
1089013|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
1089014|NCT02616926|radiofrequency ablation|radiofrequency ablation
1089015|NCT02616874|HIV infection|hiv infection
1089016|NCT02616874|Early treatment|early treatment
1089017|NCT02616874|Romidepsin|romidepsin
1089018|NCT02616874|HDACi|hdaci
1089019|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
1089020|NCT02616874|HIVconsv|hivconsv
1089021|NCT02616874|HIV reservoir|hiv reservoir
1089022|NCT02616874|Population PK/PD analysis|population pk/pd analysis
1089023|NCT02616848|Everolimus|everolimus
1089024|NCT02616848|eribulin|eribulin
1089025|NCT02616822|hypertension|hypertension
1089026|NCT02616822|endothelium|endothelium
1089027|NCT02616822|resveratrol|resveratrol
1089028|NCT02616822|clinical trials|clinical trials
1089029|NCT02616783|HIV 1 Infection|hiv 1 infection
1089030|NCT02616783|HIV|hiv
1089031|NCT02616783|Virologically-Suppressed|virologically-suppressed
1089032|NCT02616744|aromatase inhibitors|aromatase inhibitors
1089033|NCT02616744|breast cancer|breast cancer
1089034|NCT02616744|bone mineral density|bone mineral density
1089035|NCT02616692|HCC|hcc
1089036|NCT02616692|Patient preferences|patient preferences
1089037|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
1089038|NCT02616666|Randomised|randomised
1089039|NCT02616666|Pragmatic|pragmatic
1089040|NCT02616666|Standard of Care|standard of care
1089041|NCT02616666|Dapagliflozin|dapagliflozin
1089042|NCT02616666|FORXIGA|forxiga
1089043|NCT02616640|Multiple Myeloma|multiple myeloma
1089044|NCT02616640|Relapsed|relapsed
1089045|NCT02616640|Refractory|refractory
1089046|NCT02616640|MEDI4736|medi4736
1089047|NCT02616640|Durvalumab|durvalumab
1089048|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
1089049|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
1089050|NCT02616640|PD-L1|pd-l1
1089051|NCT02616627|bone mineral density|bone mineral density
1089052|NCT02616627|chronic dialysis|chronic dialysis
1089053|NCT02616627|end-stage renal disease|end-stage renal disease
1089054|NCT02616627|body composition analysis|body composition analysis
1089055|NCT02616627|sarcopenia|sarcopenia
1089056|NCT02616588|advanced stage cancer,|advanced stage cancer,
1089057|NCT02616588|patient navigator,|patient navigator,
1089058|NCT02616588|social work|social work
1089059|NCT02616575|home care|home care
1089060|NCT02616575|monitoring system|monitoring system
1089061|NCT02616575|risk assessment|risk assessment
1089062|NCT02616575|telehealth|telehealth
1089063|NCT02616536|Flipped classroom|flipped classroom
1089064|NCT02616536|Teaching methods|teaching methods
1089065|NCT02616536|Knowledge gain|knowledge gain
1089066|NCT02616523|dexmedetomidine|dexmedetomidine
1089067|NCT02616523|lidocaine|lidocaine
1089068|NCT02616523|neuropathic pain|neuropathic pain
1089069|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
1089070|NCT02616523|cognitive function|cognitive function
1089071|NCT02616497|aspirin|aspirin
1089072|NCT02616497|triflusal|triflusal
1089073|NCT02616497|antiplatelet drugs|antiplatelet drugs
1089074|NCT02616497|atherothrombosis|atherothrombosis
1089075|NCT02616497|secondary prevention|secondary prevention
1089076|NCT02616497|bleeding|bleeding
1089077|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
1089078|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
1089079|NCT02616471|Cheese|cheese
1089080|NCT02616471|Dairy|dairy
1089081|NCT02616471|Saturated fat|saturated fat
1089082|NCT02616471|Blood lipid concentrations|blood lipid concentrations
1089083|NCT02616471|Lipoprotein particle size|lipoprotein particle size
1089084|NCT02616471|Metabolic Syndrome|metabolic syndrome
1089085|NCT02616471|Insulin sensitivity|insulin sensitivity
1089086|NCT02616471|Blood glucose concentrations|blood glucose concentrations
1089087|NCT02616445|Xanamem|xanamem
1089088|NCT02616432|Tomosynthesis|tomosynthesis
1089089|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
1089090|NCT02616432|Breast Imaging|breast imaging
1090106|NCT02609698|DAPT|dapt
1089091|NCT02616432|Full-field digital mammography|full-field digital mammography
1089092|NCT02616432|Breast screening|breast screening
1089093|NCT02616419|Emergency Department|emergency department
1089094|NCT02616419|Procedural pain|procedural pain
1089095|NCT02616419|Procedural anxiety|procedural anxiety
1089096|NCT02616419|Needle-related procedures|needle-related procedures
1089097|NCT02616419|Clinical Nursing Research|clinical nursing research
1089098|NCT02616419|Nursing practice|nursing practice
1089099|NCT02616419|Non-pharmacological method|non-pharmacological method
1089100|NCT02616406|recovery of function|recovery of function
1089101|NCT02616380|Quality of life (QOL)|quality of life (qol)
1089102|NCT02616380|Work productivity|work productivity
1089103|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1089104|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
1089105|NCT02616315|Drug therapy|drug therapy
1089106|NCT02616302|Drug therapy|drug therapy
1089107|NCT02616276|Glycemic Index|glycemic index
1089108|NCT02616276|Postprandial Period|postprandial period
1089109|NCT02616276|Vascular Stiffness|vascular stiffness
1089110|NCT02616276|Blood glucose|blood glucose
1089111|NCT02616276|Cognition|cognition
1089112|NCT02616237|Chinese population|chinese population
1089113|NCT02616237|acupressure|acupressure
1089114|NCT02616237|physical activity|physical activity
1089115|NCT02616237|nutrition|nutrition
1089116|NCT02616237|Facebook|facebook
1089117|NCT02616198|glass ionomers|glass ionomers
1089118|NCT02616198|surface coating|surface coating
1089119|NCT02616198|clinical trial|clinical trial
1089120|NCT02616120|Herbal therapy|herbal therapy
1089121|NCT02616120|Parkinson's Disease|parkinson's disease
1089122|NCT02616120|Non-motor Symptoms|non-motor symptoms
1089123|NCT02616120|Randomized controlled trial|randomized controlled trial
1089124|NCT02616107|Caregiver|caregiver
1089125|NCT02616107|Self-management|self-management
1089126|NCT02616107|Care options|care options
1089127|NCT02616107|Goals of care|goals of care
1089128|NCT02616107|Breast cancer|breast cancer
1089129|NCT02616107|Palliative care|palliative care
1089130|NCT02616081|Urinary Bladder|urinary bladder
1089131|NCT02616081|Neurogenic|neurogenic
1089132|NCT02616081|Quality of Life|quality of life
1089133|NCT02616081|Spinal cord injury|spinal cord injury
1089134|NCT02616081|incontinence|incontinence
1089135|NCT02616081|Bladder|bladder
1089136|NCT02616042|Centella asiatica|centella asiatica
1089137|NCT02616042|bamboo salt|bamboo salt
1089138|NCT02616042|dentifrice|dentifrice
1089139|NCT02616003|Morbid Obesity|morbid obesity
1089140|NCT02616003|Giant Obese|giant obese
1089141|NCT02616003|Preoperative Procedure|preoperative procedure
1089142|NCT02616003|Liraglutide|liraglutide
1089143|NCT02616003|Leucine|leucine
1089144|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
1089145|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
1089146|NCT02615977|Functional imaging|functional imaging
1089147|NCT02615977|Relapse risk|relapse risk
1089148|NCT02615977|Behavioural Intervention|behavioural intervention
1089149|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
1089150|NCT02615951|Genes|genes
1089151|NCT02615951|Cell surface proteins|cell surface proteins
1089152|NCT02615951|Nutrient transporters|nutrient transporters
1089153|NCT02615951|Chemokine receptors|chemokine receptors
1089154|NCT02615899|Older Adults, Falls|older adults, falls
1089155|NCT02615886|rice bran|rice bran
1089156|NCT02615886|infants|infants
1089157|NCT02615886|stool metabolome|stool metabolome
1089158|NCT02615886|stool microbiome|stool microbiome
1089159|NCT02615886|dietary intervention|dietary intervention
1089160|NCT02615873|Parkinson's Disease|parkinson's disease
1089161|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
1089162|NCT02615873|Carbidopa|carbidopa
1089163|NCT02615873|Levodopa|levodopa
1089164|NCT02615873|Accordion|accordion
1089165|NCT02615860|HIV-infection|hiv-infection
1089166|NCT02615860|anal cancer (AC)|anal cancer (ac)
1089167|NCT02615860|anal cancer prevention|anal cancer prevention
1089168|NCT02615860|anal dysplasia|anal dysplasia
1089269|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
1089169|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
1089170|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
1089171|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
1089172|NCT02615860|electrocautery (ECA)|electrocautery (eca)
1089173|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
1089174|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
1089175|NCT02615678|neuropathy|neuropathy
1089176|NCT02615678|peripheral|peripheral
1089177|NCT02615678|chemotherapy|chemotherapy
1089178|NCT02615678|breast cancer|breast cancer
1135138|NCT02348788|Vivax|vivax
1089179|NCT02615665|NK-cells|nk-cells
1089180|NCT02615665|T-cells|t-cells
1089181|NCT02615639|HPDC-T cells|hpdc-t cells
1089182|NCT02615639|CHB|chb
1089183|NCT02615639|immuno therapy|immuno therapy
1089184|NCT02615626|Visfatin|visfatin
1089185|NCT02615626|GCF|gcf
1089186|NCT02615626|serum|serum
1089187|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
1089188|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
1089189|NCT02615600|tinnitus|tinnitus
1089190|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
1089191|NCT02615600|tRNS|trns
1089192|NCT02615600|auditory cortex|auditory cortex
1089193|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
1089194|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
1089195|NCT02615561|Safety|safety
1089196|NCT02615561|Efficacy|efficacy
1089197|NCT02615561|Atopic dermatitis|atopic dermatitis
1089198|NCT02615561|Cosmetic products|cosmetic products
1089199|NCT02615548|exercises|exercises
1089200|NCT02615535|traumatic brain injury|traumatic brain injury
1089201|NCT02615522|primary TKR|primary tkr
1089202|NCT02615496|Health Care Surveys|health care surveys
1089203|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1089204|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
1089205|NCT02615470|Shingles|shingles
1089206|NCT02615470|Pharmacy|pharmacy
1089207|NCT02615470|Vaccine|vaccine
1089208|NCT02615470|Immunization|immunization
1089209|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
1089210|NCT02615444|Overweight|overweight
1089211|NCT02615444|Waist Circumference|waist circumference
1089212|NCT02615444|Blood Pressure|blood pressure
1089213|NCT02615444|Cholesterol|cholesterol
1089214|NCT02615444|Oat beta glucan|oat beta glucan
1089215|NCT02615392|RCT|rct
1089216|NCT02615392|Park Prescription|park prescription
1089217|NCT02615392|Park Use|park use
1089218|NCT02615392|Physical Activity|physical activity
1089219|NCT02615392|Health Promotion|health promotion
1089220|NCT02615392|Health Behavior|health behavior
1089221|NCT02615392|Mental Well-Being|mental well-being
1089222|NCT02615392|Body composition|body composition
1089223|NCT02615392|Blood levels|blood levels
1089224|NCT02615392|Accelerometry|accelerometry
1089225|NCT02615392|Improving general physical and mental health|improving general physical and mental health
1089226|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
1089227|NCT02615379|infection|infection
1089228|NCT02615379|topical oxygen|topical oxygen
1089229|NCT02615340|delirium|delirium
1089230|NCT02615340|melatonin|melatonin
1089231|NCT02615340|pharmacokinetics|pharmacokinetics
1089232|NCT02615340|feasibility|feasibility
1089233|NCT02615340|prevention|prevention
1089234|NCT02615327|Fiber|fiber
1089235|NCT02615327|Polydextrose|polydextrose
1089236|NCT02615327|Glycemic Index|glycemic index
1089237|NCT02615314|migraine|migraine
1089238|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
1089239|NCT02615288|Vitamin D|vitamin d
1089240|NCT02615275|Head and Neck Cancer|head and neck cancer
1089241|NCT02615275|Bioelectrical impedance analysis|bioelectrical impedance analysis
1089242|NCT02615275|BIA|bia
1089243|NCT02615275|Eight-electrode BIA device|eight-electrode bia device
1089244|NCT02615275|SECA mBCA|seca mbca
1089245|NCT02615275|Computed tomography|computed tomography
1089246|NCT02615275|CT|ct
1089247|NCT02615275|Positron emission tomography|positron emission tomography
1089248|NCT02615275|PET|pet
1089249|NCT02615275|Symptom questionnaire|symptom questionnaire
1089250|NCT02615275|Survey|survey
1089251|NCT02615275|Radiation therapy|radiation therapy
1089252|NCT02615275|RT|rt
1089253|NCT02615275|XRT|xrt
1089254|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
1089255|NCT02615262|Dexamethasone|dexamethasone
1089256|NCT02615262|Steroids|steroids
1089257|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
1089258|NCT02615262|Congenital heart defects|congenital heart defects
1089259|NCT02615262|Infants|infants
1089260|NCT02615197|PTSD|ptsd
1089261|NCT02615197|Multi-diagnostic|multi-diagnostic
1089262|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
1089263|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
1089264|NCT02615184|Drug therapy|drug therapy
1089265|NCT02615158|Feeding practices|feeding practices
1089266|NCT02615158|Diet|diet
1089267|NCT02615158|Physical activity|physical activity
1089268|NCT02615158|Prevention|prevention
1089270|NCT02615145|Dasabuvir|dasabuvir
1089271|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
1089272|NCT02615145|Observational Study|observational study
1089273|NCT02615145|Quality of life|quality of life
1089274|NCT02615145|Work-ability|work-ability
1089275|NCT02615145|Fibrosis|fibrosis
1089276|NCT02615145|Cirrhosis|cirrhosis
1089277|NCT02615119|heartbeat|heartbeat
1089278|NCT02615119|respiration|respiration
1089279|NCT02615119|interoception|interoception
1089280|NCT02615119|anxiety|anxiety
1089281|NCT02615119|eating|eating
1089282|NCT02615106|Radiation Therapy|radiation therapy
1089283|NCT02615106|Neuroblastoma|neuroblastoma
1089284|NCT02615067|Diagnostic|diagnostic
1089285|NCT02615067|Active surveillance|active surveillance
1089286|NCT02615067|Very low risk|very low risk
1089287|NCT02615067|Imaging|imaging
1089288|NCT02615067|PSMA|psma
1089289|NCT02615067|SPECT/CT|spect/ct
1089290|NCT02615067|99mTc|99mtc
1089291|NCT02615067|Newly Diagnosed|newly diagnosed
1089292|NCT02615067|Prostatectomy|prostatectomy
1089293|NCT02615067|Biopsy|biopsy
1089294|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
1089295|NCT02615054|15-258|15-258
1089296|NCT02615041|Meropenem|meropenem
1089297|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1089298|NCT02615041|population pharmacokinetics|population pharmacokinetics
1089299|NCT02615041|pharmacokinetics|pharmacokinetics
1089300|NCT02615041|pharmacodynamics|pharmacodynamics
1089301|NCT02615028|Force plate, Balance ability|force plate, balance ability
1089302|NCT02615015|Deoxyribonuclease|deoxyribonuclease
1089303|NCT02615002|Cognition|cognition
1089304|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
1089305|NCT02615002|Sleep|sleep
1089306|NCT02614989|Tremor|tremor
1089307|NCT02614989|Thalamotomy|thalamotomy
1089308|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
1089309|NCT02614963|Clostridium Butyricum|clostridium butyricum
1089310|NCT02614911|Early Onset Entheropathy|early onset entheropathy
1089311|NCT02614833|Hormone receptor positive|hormone receptor positive
1089312|NCT02614820|Ischemic preconditioning|ischemic preconditioning
1089313|NCT02614820|sefety|sefety
1089314|NCT02614820|efficacy|efficacy
1089316|NCT02614807|Dietary Supplement|dietary supplement
1089317|NCT02614794|Tucatinib|tucatinib
1089318|NCT02614794|Capecitabine|capecitabine
1089319|NCT02614794|Trastuzumab|trastuzumab
1089320|NCT02614794|Xeloda|xeloda
1089321|NCT02614794|Herceptin|herceptin
1089322|NCT02614794|Breast Cancer|breast cancer
1089323|NCT02614794|ARRY-380|arry-380
1089324|NCT02614794|ONT-380|ont-380
1089325|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
1089326|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
1089327|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1089328|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
1089329|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
1089330|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
1089331|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
1089332|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
1089333|NCT02614794|Breast Carcinoma|breast carcinoma
1089334|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
1089335|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
1089336|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
1089337|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
1089338|NCT02614768|Glucose Monitoring System|glucose monitoring system
1089339|NCT02614755|Older Adults Volunteers|older adults volunteers
1089340|NCT02614755|Seniors|seniors
1089341|NCT02614755|Brain Performance Test|brain performance test
1089342|NCT02614729|High Protein|high protein
1089343|NCT02614729|Satiety|satiety
1089344|NCT02614729|Appetite Control|appetite control
1089345|NCT02614729|Protein Distribution|protein distribution
1089346|NCT02614729|Cognitive Function|cognitive function
1089347|NCT02614729|Ad libitum Food Intake|ad libitum food intake
1089348|NCT02614729|Obesity prevention|obesity prevention
1089349|NCT02614729|Obesity treatment|obesity treatment
1089350|NCT02614703|Barrett's Esophagus|barrett's esophagus
1089351|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
1089352|NCT02614690|Fracture of the upper limb|fracture of the upper limb
1089353|NCT02614677|Disability Evaluation System|disability evaluation system
1089354|NCT02614677|SF-12|sf-12
1089355|NCT02614677|ICF model|icf model
1089356|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
1089357|NCT02614599|ADD|add
1089358|NCT02614599|ADHD|adhd
1089359|NCT02614599|Proteins|proteins
1089360|NCT02614599|Dietary|dietary
1089361|NCT02614599|Nutrition|nutrition
1089362|NCT02614599|QEEG|qeeg
1089363|NCT02614599|ERP|erp
1089364|NCT02614599|ICA|ica
1089365|NCT02614586|Drug Therapy|drug therapy
1089366|NCT02614573|Dependent|dependent
1089367|NCT02614573|Aged, 80 and over|aged, 80 and over
1089368|NCT02614573|Aged|aged
1089773|NCT02611921|Autism|autism
1089369|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
1089370|NCT02614560|AML|aml
1089371|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
1089372|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
1089373|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1089374|NCT02614482|Children|children
1089375|NCT02614482|Antimuscarinics|antimuscarinics
1089376|NCT02614482|Antocholinergics|antocholinergics
1089377|NCT02614482|Overactive bladder|overactive bladder
1089378|NCT02614443|Depression|depression
1089379|NCT02614443|Anxiety|anxiety
1089380|NCT02614443|Stress|stress
1089381|NCT02614443|Online interventions|online interventions
1089382|NCT02614443|University students|university students
1089383|NCT02614443|CBT|cbt
1089384|NCT02614430|Rehabilitation|rehabilitation
1089385|NCT02614430|Prediction|prediction
1089386|NCT02614430|Inflammation|inflammation
1089387|NCT02614404|Plasmodium falciparum|plasmodium falciparum
1089388|NCT02614404|Uncomplicated malarial|uncomplicated malarial
1089389|NCT02614404|imatinib mesylate|imatinib mesylate
1089390|NCT02614404|antimalarials|antimalarials
1089391|NCT02614391|Procedural pain|procedural pain
1089392|NCT02614391|Phlebotomy|phlebotomy
1089393|NCT02614391|Distraction|distraction
1089394|NCT02614391|Videogame|videogame
1089395|NCT02614391|Computer tablet|computer tablet
1089396|NCT02614391|Child|child
1089397|NCT02614378|abortive effect|abortive effect
1089398|NCT02614326|Depression|depression
1089399|NCT02614326|Cognitive risk factors|cognitive risk factors
1089400|NCT02614326|Autobiographical memory|autobiographical memory
1089401|NCT02614326|Cognitive bias|cognitive bias
1089402|NCT02614326|Relapse prevention|relapse prevention
1089403|NCT02614313|Fructose|fructose
1089404|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
1089405|NCT02614313|Breath test|breath test
1089406|NCT02614313|Placebo|placebo
1089407|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
1089408|NCT02614300|chest physiotherapy|chest physiotherapy
1089409|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
1089410|NCT02614300|exercise tolerance|exercise tolerance
1089411|NCT02614300|bronchiectasis|bronchiectasis
1089412|NCT02614300|respiratory therapy|respiratory therapy
1089413|NCT02614287|prevention|prevention
1089414|NCT02614287|prophylaxis|prophylaxis
1089415|NCT02614287|headache|headache
1089416|NCT02614274|knee|knee
1089417|NCT02614274|pain|pain
1089418|NCT02614274|osteoarthritis|osteoarthritis
1089419|NCT02614274|nutraceutical|nutraceutical
1089420|NCT02614274|nutrition|nutrition
1089421|NCT02614274|supplement|supplement
1089422|NCT02614274|non-surgical|non-surgical
1089423|NCT02614274|biomarker|biomarker
1089424|NCT02614274|joint health|joint health
1089425|NCT02614261|prevention|prevention
1089426|NCT02614261|prophylaxis|prophylaxis
1089427|NCT02614261|headache|headache
1089428|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
1089429|NCT02614235|Syncope|syncope
1089430|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
1089431|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
1089432|NCT02614222|Peripheral Nerve Block|peripheral nerve block
1089433|NCT02614222|Clear Guide ONE|clear guide one
1089434|NCT02614222|Needle path|needle path
1089435|NCT02614222|Needle Guidance|needle guidance
1089436|NCT02614222|Ultrasound|ultrasound
1089437|NCT02614209|ED|ed
1089438|NCT02614209|BNP|bnp
1089439|NCT02614196|prevention|prevention
1089440|NCT02614196|prophylaxis|prophylaxis
1089441|NCT02614196|headache|headache
1089442|NCT02614183|prevention|prevention
1089443|NCT02614183|prophylaxis|prophylaxis
1089444|NCT02614183|headache|headache
1089445|NCT02614157|rectal cancer|rectal cancer
1089446|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
1089447|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
1089448|NCT02614157|total mesorectal excision|total mesorectal excision
1089449|NCT02614157|surgery|surgery
1089450|NCT02614157|recurrence|recurrence
1089451|NCT02614157|metastasis|metastasis
1089452|NCT02614157|overall survival|overall survival
1089453|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
1089454|NCT02614144|Mortality|mortality
1089455|NCT02614118|Endodontic treatment|endodontic treatment
1089456|NCT02614118|non steroid|non steroid
1089457|NCT02614118|pain|pain
1089458|NCT02614118|pre medication|pre medication
1089459|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
1089460|NCT02614092|memory impairment|memory impairment
1089461|NCT02614092|Physical Activity|physical activity
1089462|NCT02614092|Exercise|exercise
1089463|NCT02614092|Cognitive Training|cognitive training
1089464|NCT02614092|Veterans|veterans
1089465|NCT02614092|Older Adults|older adults
1089466|NCT02614079|lumbago|lumbago
1089467|NCT02614079|low back pain|low back pain
1089468|NCT02614079|leg pain|leg pain
1089469|NCT02614040|crystalloid|crystalloid
1089470|NCT02614040|acute kidney injury|acute kidney injury
1089471|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
1089472|NCT02613988|Glioblastoma|glioblastoma
1089473|NCT02613988|MRI|mri
1089477|NCT02613949|stimulation|stimulation
1089478|NCT02613936|traumatic brain injury|traumatic brain injury
1089479|NCT02613936|post concussive symptoms|post concussive symptoms
1089480|NCT02613936|depression|depression
1089481|NCT02613936|executive dysfunction|executive dysfunction
1089482|NCT02613936|brain stimulation|brain stimulation
1089483|NCT02613923|Breast Cancer|breast cancer
1089484|NCT02613923|GO! to sleep|go! to sleep
1089486|NCT02613910|Ofatumumab|ofatumumab
1089487|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
1089488|NCT02613910|Long-Term Extension Study|long-term extension study
1089489|NCT02613845|Postoperative delirium|postoperative delirium
1089490|NCT02613845|Cardiac surgery|cardiac surgery
1089491|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
1089492|NCT02613845|Risk factor|risk factor
1089493|NCT02613832|Noncooperative patients|noncooperative patients
1089494|NCT02613806|Dexmedetomidine|dexmedetomidine
1089495|NCT02613806|Coughing Response|coughing response
1089698|NCT02612389|Meditative Movement|meditative movement
1089496|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
1089497|NCT02613806|Thyroid Surgery|thyroid surgery
1089498|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
1089499|NCT02613793|Neurological dysfunction|neurological dysfunction
1089500|NCT02613793|Saccadic reaction time|saccadic reaction time
1089501|NCT02613728|Colorectal cancer|colorectal cancer
1089502|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
1089503|NCT02613728|Polyp(s)|polyp(s)
1089504|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
1089505|NCT02613728|RecoverMI|recovermi
1089506|NCT02613728|Fluid diary|fluid diary
1089507|NCT02613728|Questionnaires|questionnaires
1089508|NCT02613728|Surveys|surveys
1089509|NCT02613728|RecoverMI device|recovermi device
1089510|NCT02613715|Flavonoids|flavonoids
1089511|NCT02613715|Anthocyanins|anthocyanins
1089512|NCT02613715|Blackberry Juice|blackberry juice
1089513|NCT02613715|Bioavailability|bioavailability
1089514|NCT02613715|Obesity|obesity
1089515|NCT02613702|Free gingival graft|free gingival graft
1089516|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
1089517|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
1089518|NCT02613637|lung cancer|lung cancer
1089519|NCT02613637|registry study|registry study
1089520|NCT02613637|Biological Disease Profile|biological disease profile
1089521|NCT02613624|KMC in community|kmc in community
1089522|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
1089523|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
1089524|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
1089525|NCT02613546|Women|women
1089526|NCT02613520|PfSPZ Vaccine|pfspz vaccine
1089527|NCT02613520|Plasmodium falciparum|plasmodium falciparum
1089528|NCT02613494|clozapine|clozapine
1089529|NCT02613494|hypersalivation|hypersalivation
1089530|NCT02613494|refractory schizophrenia|refractory schizophrenia
1089531|NCT02613468|Pregnancy|pregnancy
1089532|NCT02613468|Low birth weight|low birth weight
1089533|NCT02613468|Gingivitis|gingivitis
1089534|NCT02613468|Inflammation|inflammation
1089535|NCT02613468|Periodontitis|periodontitis
1089536|NCT02613390|Epidural metastasis|epidural metastasis
1089537|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
1089539|NCT02613390|Guidance system|guidance system
1089540|NCT02613390|Spinal surgery|spinal surgery
1089541|NCT02613390|Questionnaires|questionnaires
1089542|NCT02613390|Surveys|surveys
1089543|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
1089544|NCT02613351|Exercise Tolerance|exercise tolerance
1089545|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
1089546|NCT02613325|Melanoma|melanoma
1089547|NCT02613325|Imaging|imaging
1089548|NCT02613325|Pigmented Lesions|pigmented lesions
1089549|NCT02613325|Melanoma Management|melanoma management
1089550|NCT02613247|Viscosupplementation|viscosupplementation
1089551|NCT02613247|Hyaluronic acid|hyaluronic acid
1089552|NCT02613247|Synvisc|synvisc
1089553|NCT02613247|Synvisc-One|synvisc-one
1089554|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
1089555|NCT02613247|PFPS|pfps
1089556|NCT02613247|Anterior knee pain|anterior knee pain
1089557|NCT02613247|Runner's knee|runner's knee
1089558|NCT02613234|Epilepsy|epilepsy
1089559|NCT02613234|128-Channel EEG|128-channel eeg
1089560|NCT02613234|Dipole Localization|dipole localization
1089561|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1089562|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
1089563|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
1089564|NCT02613195|oxidative stress|oxidative stress
1089565|NCT02613195|organ preservation|organ preservation
1089566|NCT02613195|Hydrogen|hydrogen
1089567|NCT02613195|Kidney Transplantation|kidney transplantation
1089571|NCT02613156|laparoscopic|laparoscopic
1089572|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
1089573|NCT02613156|recurrence|recurrence
1089574|NCT02613143|malignant glaucoma|malignant glaucoma
1089575|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
1089576|NCT02613091|volunteers|volunteers
1089577|NCT02613078|Children|children
1089578|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
1089579|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
1089580|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
1089581|NCT02613078|Probiotic|probiotic
1089582|NCT02613065|Ad libitum|ad libitum
1089583|NCT02613065|Energy balance|energy balance
1089584|NCT02613065|Protein|protein
1089585|NCT02613039|oral contraceptives|oral contraceptives
1089586|NCT02613039|female sexuality|female sexuality
1089587|NCT02613026|Breast tumor|breast tumor
1089588|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1089589|NCT02613026|Pathological complete remission|pathological complete remission
1089590|NCT02612987|CBT|cbt
1089591|NCT02612987|Internet based|internet based
1089592|NCT02612974|Qurse mafasil|qurse mafasil
1089593|NCT02612974|leech therapy|leech therapy
1089594|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
1089900|NCT02611037|Respiratory|respiratory
1089595|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
1089596|NCT02612961|Normal Saline|normal saline
1089597|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
1089598|NCT02612922|Influenza|influenza
1089599|NCT02612909|Avian Influenza|avian influenza
1089600|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
1089601|NCT02612909|IVAC|ivac
1089602|NCT02612896|Taenia solium|taenia solium
1089603|NCT02612896|control|control
1089604|NCT02612896|elimination|elimination
1089605|NCT02612896|One Health|one health
1089606|NCT02612883|Flux measurement|flux measurement
1089607|NCT02612870|Breast Cancer|breast cancer
1089608|NCT02612870|Sentinel Node|sentinel node
1089609|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
1089610|NCT02612870|Breast Surgery|breast surgery
1089611|NCT02612857|dermatomyositis|dermatomyositis
1089612|NCT02612857|IMO-8400|imo-8400
1089613|NCT02612857|Pioneer|pioneer
1089614|NCT02612818|coelioscopy|coelioscopy
1089615|NCT02612766|celiac disease|celiac disease
1089616|NCT02612766|oat|oat
1089617|NCT02612766|gluten free diet|gluten free diet
1089618|NCT02612753|Aphasia|aphasia
1089619|NCT02612753|Speaking therapy|speaking therapy
1089620|NCT02612753|Language therapy|language therapy
1089621|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
1089622|NCT02612740|Bio Oss|bio oss
1089623|NCT02612740|critical-size defect|critical-size defect
1089624|NCT02612740|bone grafting|bone grafting
1089625|NCT02612740|cyst|cyst
1089626|NCT02612740|CT bone analysis|ct bone analysis
1089627|NCT02612740|alveolar bone|alveolar bone
1089628|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
1089629|NCT02612714|diabetes|diabetes
1089630|NCT02612714|hypercholesterolemia|hypercholesterolemia
1089631|NCT02612714|sexual dysfunction|sexual dysfunction
1089632|NCT02612714|statin|statin
1089633|NCT02612714|testosterone|testosterone
1089634|NCT02612701|Myocardial perfusion|myocardial perfusion
1089635|NCT02612701|Electronic cigarettes|electronic cigarettes
1089636|NCT02612701|Cigarettes|cigarettes
1089637|NCT02612701|Cigarette smoking|cigarette smoking
1089638|NCT02612688|Advance Care Planning|advance care planning
1089639|NCT02612688|Advance Directives|advance directives
1089640|NCT02612688|Alzheimer Disease|alzheimer disease
1089641|NCT02612688|Dementia|dementia
1089642|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
1089643|NCT02612688|Enteral Nutrition|enteral nutrition
1089644|NCT02612688|Heart Failure|heart failure
1089645|NCT02612688|Hospices|hospices
1089646|NCT02612688|Hospitalization|hospitalization
1089647|NCT02612688|Instructional Films and Videos|instructional films and videos
1089648|NCT02612688|Intubation|intubation
1089649|NCT02612688|Nursing Homes|nursing homes
1089650|NCT02612688|Parenteral Nutrition|parenteral nutrition
1089651|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
1089652|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1089653|NCT02612688|Randomized Controlled Trials|randomized controlled trials
1089654|NCT02612688|Resuscitation Orders|resuscitation orders
1089655|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
1089656|NCT02612662|AZD4076|azd4076
1089657|NCT02612662|Healthy male subjects|healthy male subjects
1089658|NCT02612662|Safety|safety
1089659|NCT02612662|Subcutaneous|subcutaneous
1089660|NCT02612662|Tolerability|tolerability
1089661|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
1089662|NCT02612649|YM060|ym060
1089663|NCT02612649|Ramosetron|ramosetron
1089664|NCT02612649|Survey|survey
1089665|NCT02612636|Delirium|delirium
1089666|NCT02612636|Ear Plug|ear plug
1089667|NCT02612636|Eye Mask|eye mask
1089668|NCT02612636|Mechanical ventilation|mechanical ventilation
1089669|NCT02612636|Sleep|sleep
1089670|NCT02612597|before and after bedrest|before and after bedrest
1089671|NCT02612597|healthy untrained|healthy untrained
1089672|NCT02612597|before and after exercise training|before and after exercise training
1089673|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
1089674|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
1089675|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
1089676|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
1089677|NCT02612545|Piperaquine|piperaquine
1089678|NCT02612545|Mefloquine|mefloquine
1089679|NCT02612493|obesity surgery|obesity surgery
1089680|NCT02612493|type I diabetes|type i diabetes
1089681|NCT02612493|weight loss|weight loss
1089682|NCT02612493|insulin dosage|insulin dosage
1089683|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
1089684|NCT02612480|endotoxin|endotoxin
1089686|NCT02612480|ticagrelor|ticagrelor
1089687|NCT02612480|clopidogrel|clopidogrel
1089688|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
1089689|NCT02612480|placebo|placebo
1089690|NCT02612467|start back tool|start back tool
1089691|NCT02612467|stratified care|stratified care
1089692|NCT02612467|targeted treatment|targeted treatment
1089693|NCT02612454|Eczema|eczema
1089694|NCT02612441|stroke|stroke
1089695|NCT02612389|COPD|copd
1089696|NCT02612389|Qigong|qigong
1089697|NCT02612389|ANS|ans
1089699|NCT02612389|Flight Attendants|flight attendants
1089700|NCT02612389|Secondhand Smoke|secondhand smoke
1089701|NCT02612389|Nicotine|nicotine
1089702|NCT02612389|Blood Pressure|blood pressure
1089703|NCT02612389|6 minute walk test|6 minute walk test
1089704|NCT02612363|septic shock|septic shock
1089705|NCT02612363|sedation|sedation
1089706|NCT02612363|microcirculation|microcirculation
1089707|NCT02612350|ctDNA|ctdna
1089708|NCT02612350|high risk for developing cancer|high risk for developing cancer
1089709|NCT02612350|Plasma|plasma
1089710|NCT02612350|Relative Risk|relative risk
1089711|NCT02612350|Early Detection of Cancer|early detection of cancer
1089712|NCT02612350|Cancer Screening Tests|cancer screening tests
1089713|NCT02612350|Cancer Screening|cancer screening
1089714|NCT02612337|Meniere's Disease|meniere's disease
1089715|NCT02612337|Vertigo|vertigo
1089716|NCT02612324|adolescents|adolescents
1089717|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
1089718|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
1089719|NCT02612324|place-based programs|place-based programs
1089720|NCT02612324|health education|health education
1089721|NCT02612298|Essential Hypertension|essential hypertension
1089722|NCT02612298|Arotinolol|arotinolol
1089723|NCT02612298|Morning Blood Pressure|morning blood pressure
1089724|NCT02612233|Pain|pain
1089725|NCT02612220|liver resection|liver resection
1089726|NCT02612181|dexmedetomidine|dexmedetomidine
1089727|NCT02612181|microcirculation|microcirculation
1089728|NCT02612181|septic shock|septic shock
1089729|NCT02612168|Diagnosis|diagnosis
1089730|NCT02612168|skin imaging|skin imaging
1089731|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1089732|NCT02612155|autologous cord blood cells|autologous cord blood cells
1089733|NCT02612155|newborn infants|newborn infants
1089734|NCT02612129|NPC1|npc1
1089735|NCT02612129|Niemann-Pick Type C|niemann-pick type c
1089736|NCT02612129|Niemann-Pick|niemann-pick
1089737|NCT02612129|arimoclomol|arimoclomol
1089738|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
1089739|NCT02612129|lysosomal storage disease|lysosomal storage disease
1089740|NCT02612129|NPC2|npc2
1089741|NCT02612129|NP-C|np-c
1089742|NCT02612103|Biochemical markers|biochemical markers
1089743|NCT02612090|Nutrition|nutrition
1089744|NCT02612090|Polyphenols|polyphenols
1089745|NCT02612090|Berries|berries
1089746|NCT02612090|Lipid Panels|lipid panels
1089747|NCT02612051|patients|patients
1089748|NCT02612051|FTIH|ftih
1089749|NCT02612051|healthy volunteers|healthy volunteers
1089750|NCT02612051|GSK3008348|gsk3008348
1089751|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
1089752|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1089753|NCT02612051|PET|pet
1089754|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
1089755|NCT02612038|Expiratory flow limitation|expiratory flow limitation
1089756|NCT02612012|breast cancer|breast cancer
1089757|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
1089758|NCT02612012|axillary radiotherapy|axillary radiotherapy
1089759|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
1089760|NCT02611986|Airway management|airway management
1089761|NCT02611986|video laryngoscope|video laryngoscope
1089762|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
1089763|NCT02611973|Aspirin|aspirin
1089764|NCT02611960|PD-1|pd-1
1089765|NCT02611960|PD1|pd1
1089766|NCT02611960|PD-L1|pd-l1
1089767|NCT02611960|PDL1|pdl1
1089768|NCT02611947|emphysema|emphysema
1089769|NCT02611947|airway remodelling|airway remodelling
1089770|NCT02611947|multidetector computed tomography|multidetector computed tomography
1089771|NCT02611921|Ketamine|ketamine
1089772|NCT02611921|Social Impairment|social impairment
1089774|NCT02611921|Autistic Disorder|autistic disorder
1089775|NCT02611908|CLL|cll
1089776|NCT02611908|cancer|cancer
1089777|NCT02611908|obinutuzumab|obinutuzumab
1089778|NCT02611908|ibrutinib|ibrutinib
1089779|NCT02611908|SLL|sll
1089780|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
1089781|NCT02611895|HAART|haart
1089782|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
1089783|NCT02611895|Ongoing HIV infection|ongoing hiv infection
1089784|NCT02611856|twin to twin,|twin to twin,
1089785|NCT02611856|transfusion syndrome|transfusion syndrome
1089786|NCT02611843|peer support|peer support
1089787|NCT02611843|web-based treatment|web-based treatment
1089788|NCT02611843|veterans|veterans
1089789|NCT02611843|PTSD|ptsd
1089790|NCT02611843|Substance Use Disorders|substance use disorders
1089791|NCT02611830|Drug therapy|drug therapy
1089792|NCT02611817|Drug therapy|drug therapy
1089793|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
1089794|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
1089795|NCT02611713|Duodopa/Duopa|duodopa/duopa
1089796|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
1089797|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
1089798|NCT02611713|OFF time|off time
1089799|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
1089800|NCT02611713|dyskinesia|dyskinesia
1089801|NCT02611713|tremor|tremor
1089802|NCT02611713|Quality of Life|quality of life
1089803|NCT02611713|Observational|observational
1089804|NCT02611713|Long-term|long-term
1089805|NCT02611713|Caregiver Burden|caregiver burden
1089806|NCT02611713|effectiveness|effectiveness
1089807|NCT02611713|fluctuations|fluctuations
1089808|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
1089809|NCT02611635|Patient treatment preference|patient treatment preference
1089810|NCT02611635|NOAC|noac
1089811|NCT02611635|VKA|vka
1089812|NCT02611583|TENS|tens
1089813|NCT02611570|Lung cancer|lung cancer
1089814|NCT02611570|Low dose computed tomography|low dose computed tomography
1089815|NCT02611570|Screening|screening
1089816|NCT02611570|Non-smoker|non-smoker
1089817|NCT02611570|Gender issue|gender issue
1089818|NCT02611557|MRI|mri
1089819|NCT02611557|lymphedema|lymphedema
1089820|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
1089821|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
1089822|NCT02611544|Fear of Cancer Return|fear of cancer return
1089823|NCT02611544|Breast Cancer Survivor|breast cancer survivor
1089824|NCT02611544|Breast Cancer Remission|breast cancer remission
1089825|NCT02611518|Healthy|healthy
1089826|NCT02611518|JNJ-54861911|jnj-54861911
1089827|NCT02611518|Rosuvastatin|rosuvastatin
1089828|NCT02611518|Metformin|metformin
1089829|NCT02611505|Healthy|healthy
1089830|NCT02611505|Esketamine|esketamine
1089831|NCT02611505|Hepatic Impairment|hepatic impairment
1089832|NCT02611505|Pharmacokinetics|pharmacokinetics
1089833|NCT02611479|patient reported outcomes|patient reported outcomes
1089834|NCT02611466|Osteoarthritis|osteoarthritis
1089835|NCT02611466|ASP7962|asp7962
1089836|NCT02611453|choledocholithiasis|choledocholithiasis
1089837|NCT02611453|ERCP|ercp
1089838|NCT02611453|cholangiography|cholangiography
1089839|NCT02611453|biliary stricture|biliary stricture
1089840|NCT02611453|bile ducts|bile ducts
1089841|NCT02611453|carbon dioxide|carbon dioxide
1089842|NCT02611440|ischemic stroke|ischemic stroke
1089843|NCT02611440|medication adherence|medication adherence
1089844|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
1089845|NCT02611427|spine|spine
1089846|NCT02611427|lumbar|lumbar
1089847|NCT02611427|postoperative|postoperative
1089848|NCT02611427|physical activity|physical activity
1089849|NCT02611414|functional dyspepsia|functional dyspepsia
1089850|NCT02611414|tDCS|tdcs
1089851|NCT02611401|multiple sclerosis|multiple sclerosis
1089852|NCT02611401|depression|depression
1089853|NCT02611401|mindfulness|mindfulness
1089854|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
1089855|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
1089856|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
1089857|NCT02611336|Acromegaly|acromegaly
1089858|NCT02611297|Cryoprobes|cryoprobes
1089859|NCT02611297|Cryobiopsy|cryobiopsy
1089860|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
1089861|NCT02611284|Beractant|beractant
1089862|NCT02611284|Feasibility Studies|feasibility studies
1089863|NCT02611284|Infant, Premature|infant, premature
1089864|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
1089865|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
1089866|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
1089867|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
1089868|NCT02611258|Cushing's Syndrome|cushing's syndrome
1089869|NCT02611245|Thoracic Duct|thoracic duct
1089870|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
1089871|NCT02611232|Diabetes Type 1|diabetes type 1
1089872|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
1089873|NCT02611232|Liraglutide|liraglutide
1089874|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
1089875|NCT02611232|GLP-1 Analogue|glp-1 analogue
1089876|NCT02611206|rTMS|rtms
1089877|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
1089878|NCT02611154|Healthy Volunteers|healthy volunteers
1089879|NCT02611154|Sports Medicine|sports medicine
1089880|NCT02611154|Men's Health|men's health
1089881|NCT02611154|Athletes|athletes
1089882|NCT02611154|Anti-Doping|anti-doping
1089883|NCT02611141|Retromolar Intubation|retromolar intubation
1089884|NCT02611115|Pulmonary Embolism|pulmonary embolism
1089885|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
1089886|NCT02611115|Radiation Dosage|radiation dosage
1089887|NCT02611115|Contrast Media|contrast media
1089888|NCT02611115|Individualized Medicine|individualized medicine
1089889|NCT02611089|Muscle connective tissue|muscle connective tissue
1089890|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
1089891|NCT02611089|Limb development|limb development
1089892|NCT02611076|smoking cessation|smoking cessation
1089893|NCT02611076|self-help|self-help
1089894|NCT02611076|Spanish language|spanish language
1089895|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
1089896|NCT02611050|patient decision aid|patient decision aid
1089897|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
1089899|NCT02611037|Unresectable|unresectable
1089901|NCT02611037|Intrathoracic|intrathoracic
1089902|NCT02611037|Transarterial|transarterial
1089903|NCT02611037|Chemoperfusion|chemoperfusion
1089904|NCT02611024|lurbinectedin|lurbinectedin
1089905|NCT02611024|PM01183|pm01183
1089906|NCT02611024|tumors|tumors
1089907|NCT02611024|cancer|cancer
1089908|NCT02611024|Pharma Mar|pharma mar
1089909|NCT02611011|Congo Red Dot Test|congo red dot test
1089910|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
1089911|NCT02610985|Hysterectomy|hysterectomy
1089912|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
1089913|NCT02610972|Congo Red test GV-005|congo red test gv-005
1089914|NCT02610946|pediatric|pediatric
1089915|NCT02610946|adolescent|adolescent
1089916|NCT02610946|compliance|compliance
1089917|NCT02610933|vascular calcification|vascular calcification
1089918|NCT02610933|hemodialysis|hemodialysis
1089919|NCT02610933|rivaroxaban|rivaroxaban
1089920|NCT02610933|vitamin K2|vitamin k2
1089921|NCT02610894|postoperative symptom management|postoperative symptom management
1089922|NCT02610894|symptom management|symptom management
1089923|NCT02610894|mHealth application|mhealth application
1089924|NCT02610868|Cerebral Palsy|cerebral palsy
1089925|NCT02610868|ALS|als
1089926|NCT02610868|Stroke|stroke
1089927|NCT02610868|Neuroleptics|neuroleptics
1089928|NCT02610803|stroke|stroke
1089929|NCT02610803|ischemic stroke|ischemic stroke
1089930|NCT02610803|recurrent stroke|recurrent stroke
1089931|NCT02610803|atrial fibrillation|atrial fibrillation
1089932|NCT02610803|premature atrial complexes|premature atrial complexes
1089933|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
1089934|NCT02610803|cardiac telemetry|cardiac telemetry
1089935|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
1089936|NCT02610777|Drug Therapy|drug therapy
1089937|NCT02610764|Circulating Tumor Cells|circulating tumor cells
1089938|NCT02610764|Response evaluation|response evaluation
1089939|NCT02610751|Maternal Smoking|maternal smoking
1089940|NCT02610751|Female Fetal Testosterone|female fetal testosterone
1089941|NCT02610751|Anogenital Distance|anogenital distance
1089942|NCT02610751|Maternal Testosterone|maternal testosterone
1089943|NCT02610751|Maternal Cotinine|maternal cotinine
1089944|NCT02610712|ketamine|ketamine
1089945|NCT02610712|treatment-resistant|treatment-resistant
1089946|NCT02610712|depression|depression
1089947|NCT02610712|spectroscopy|spectroscopy
1089948|NCT02610712|neuroinflammation|neuroinflammation
1089949|NCT02610686|Plasmodium vivax|plasmodium vivax
1089950|NCT02610686|recurrence|recurrence
1089951|NCT02610686|drug resistance|drug resistance
1089952|NCT02610634|Parkinson's disease|parkinson's disease
1089953|NCT02610634|Older adults|older adults
1089954|NCT02610634|Vision|vision
1089955|NCT02610634|Cognition|cognition
1089956|NCT02610634|Visual cues|visual cues
1089957|NCT02610634|Eye-tracking|eye-tracking
1089958|NCT02610634|Gait|gait
1089959|NCT02610634|Saccades|saccades
1089960|NCT02610634|Dual task|dual task
1089961|NCT02610634|Visual sampling|visual sampling
1089962|NCT02610621|Clinically node negative|clinically node negative
1089963|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
1089964|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
1089965|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
1089966|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
1089967|NCT02610595|Effectiveness|effectiveness
1089968|NCT02610595|Safety|safety
1089969|NCT02610582|CNGA3-linked|cnga3-linked
1089970|NCT02610569|Colonic capsule|colonic capsule
1089971|NCT02610569|ulcerative colitis|ulcerative colitis
1089972|NCT02610569|mucosal healing|mucosal healing
1089973|NCT02610569|endoscopic score|endoscopic score
1089974|NCT02610556|NPC|npc
1089975|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
1089976|NCT02610556|docetaxel|docetaxel
1089977|NCT02610556|cisplatin|cisplatin
1089978|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
1089979|NCT02610530|type 2 diabetes|type 2 diabetes
1089980|NCT02610530|metabolic surgery|metabolic surgery
1089981|NCT02610530|medical treatment|medical treatment
1089982|NCT02610517|Hazardous alcohol use|hazardous alcohol use
1089983|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
1089984|NCT02610517|Pharmacotherapy|pharmacotherapy
1089985|NCT02610504|degenerative arthritis|degenerative arthritis
1089986|NCT02610465|Computed Tomography|computed tomography
1089987|NCT02610465|Image Reconstruction|image reconstruction
1089988|NCT02610465|Iterative Reconstruction|iterative reconstruction
1089989|NCT02610452|clown therapy|clown therapy
1089990|NCT02610387|tDCS|tdcs
1089991|NCT02610387|stroke|stroke
1089992|NCT02610387|Spasticity|spasticity
1089993|NCT02610374|Gut microbiota composition|gut microbiota composition
1089994|NCT02610348|Hepatitis B|hepatitis b
1089995|NCT02610348|Hexaxim®|hexaxim®
1089996|NCT02610348|Hexyon®|hexyon®
1089997|NCT02610348|Hexacima®|hexacima®
1089998|NCT02610348|Prevnar®|prevnar®
1089999|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
1090000|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
1090001|NCT02610309|family-based crisis intervention|family-based crisis intervention
1090104|NCT02609698|Clopidogrel|clopidogrel
1090002|NCT02610309|adolescent suicide|adolescent suicide
1090003|NCT02610283|AKI|aki
1090004|NCT02610270|Sport|sport
1090005|NCT02610270|fatty acid|fatty acid
1090006|NCT02610270|omega 3|omega 3
1090007|NCT02610257|Parkinson's disease|parkinson's disease
1090008|NCT02610257|Freezing of gait|freezing of gait
1090009|NCT02610257|Motor blocks|motor blocks
1090010|NCT02610257|Somatosensory|somatosensory
1090011|NCT02610257|Proprioception|proprioception
1090012|NCT02610257|Muscle vibration|muscle vibration
1090013|NCT02610257|Handwriting|handwriting
1090014|NCT02610231|Parkinson's disease|parkinson's disease
1090015|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
1090016|NCT02610218|Cell free DNA|cell free dna
1090017|NCT02610218|Circulating tumor cell|circulating tumor cell
1090018|NCT02610218|Therapeutic efficacy|therapeutic efficacy
1090019|NCT02610205|Caring touch|caring touch
1090020|NCT02610205|Tactile massage|tactile massage
1090021|NCT02610205|Healing touch|healing touch
1090022|NCT02610192|Autologous Protein Solution|autologous protein solution
1090023|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
1090024|NCT02610192|Female|female
1090025|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
1090026|NCT02610114|zygotes|zygotes
1090027|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
1090028|NCT02610114|Infertility|infertility
1090029|NCT02610088|Diabetes|diabetes
1090030|NCT02610088|Atherosclerosis|atherosclerosis
1090031|NCT02610088|Cardiovascular disease|cardiovascular disease
1090032|NCT02610088|Endothelial dysfunction|endothelial dysfunction
1090033|NCT02610088|Vascular function|vascular function
1090034|NCT02610088|Dapagliflozin|dapagliflozin
1090035|NCT02610088|Gliclazide|gliclazide
1090036|NCT02610075|AZD1775|azd1775
1090037|NCT02610075|Metastatic solid tumors|metastatic solid tumors
1090038|NCT02610075|Ovarian cancer|ovarian cancer
1090039|NCT02610062|AML|aml
1090040|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
1090041|NCT02610049|PTSD|ptsd
1090042|NCT02610036|diabetes|diabetes
1090043|NCT02610036|foot ulcer|foot ulcer
1090044|NCT02610010|NPC|npc
1090045|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
1090046|NCT02610010|IMRT|imrt
1090047|NCT02610010|stage II|stage ii
1090048|NCT02609997|Intraocular lens|intraocular lens
1090049|NCT02609984|immunotherapy|immunotherapy
1090050|NCT02609984|CMB305|cmb305
1090051|NCT02609984|LV305|lv305
1090052|NCT02609984|GLA-SE|gla-se
1090053|NCT02609984|Atezolizumab|atezolizumab
1090054|NCT02609984|NY-ESO-1|ny-eso-1
1090055|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
1090056|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
1090057|NCT02609945|Migraine attacks|migraine attacks
1090058|NCT02609932|Interferon-gamma|interferon-gamma
1090059|NCT02609932|innate immunity|innate immunity
1090060|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
1090061|NCT02609919|safety|safety
1090062|NCT02609906|proximal humerus|proximal humerus
1090063|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
1090064|NCT02609906|MultiLoc|multiloc
1090065|NCT02609906|Philos augmented|philos augmented
1090066|NCT02609893|HCV|hcv
1090067|NCT02609880|Psycho-Oncology|psycho-oncology
1090068|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
1090069|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
1090070|NCT02609880|Gynecologic Cancer|gynecologic cancer
1090071|NCT02609880|Insomnia|insomnia
1090072|NCT02609880|Pain|pain
1090073|NCT02609880|Distress|distress
1090074|NCT02609880|Cortisol|cortisol
1090075|NCT02609880|Cytokines|cytokines
1090076|NCT02609854|herniated disc|herniated disc
1090077|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
1090078|NCT02609854|ultrasound|ultrasound
1090079|NCT02609854|CLBP|clbp
1090080|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
1090081|NCT02609828|Multiple myeloma|multiple myeloma
1090082|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
1090083|NCT02609789|JNJ-55920839|jnj-55920839
1090084|NCT02609789|Healthy Volunteers|healthy volunteers
1090085|NCT02609789|CNTO 6358|cnto 6358
1090086|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1090087|NCT02609776|JNJ-61186372|jnj-61186372
1090088|NCT02609776|First-in-Human|first-in-human
1090089|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
1090090|NCT02609776|cMet Antibody|cmet antibody
1090091|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
1090092|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
1090093|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
1090094|NCT02609737|Pet scan|pet scan
1090096|NCT02609737|15-161|15-161
1090097|NCT02609724|breast cancer|breast cancer
1090098|NCT02609724|lymphedema|lymphedema
1090099|NCT02609724|manual lymph drainage|manual lymph drainage
1090100|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
1090101|NCT02609698|Stent|stent
1090102|NCT02609698|Polymer-free|polymer-free
1090103|NCT02609698|Antiplatelet therapy|antiplatelet therapy
1090107|NCT02609685|Thyroid cancer|thyroid cancer
1090108|NCT02609685|Active surveillance|active surveillance
1090109|NCT02609685|PTMC|ptmc
1090110|NCT02609672|Exercise|exercise
1090111|NCT02609672|Resilience|resilience
1090112|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
1090113|NCT02609646|Anti-Infective Agents|anti-infective agents
1090114|NCT02609646|Pharmacokinetics|pharmacokinetics
1090115|NCT02609646|Critically ill patients|critically ill patients
1090116|NCT02609594|human amniotic membrane|human amniotic membrane
1090117|NCT02609594|compression therapy|compression therapy
1090118|NCT02609594|venous leg ulcer|venous leg ulcer
1090119|NCT02609581|Non Interventional Study|non interventional study
1090120|NCT02609581|NIS|nis
1090121|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
1090122|NCT02609581|allergen|allergen
1090123|NCT02609581|Mites|mites
1090124|NCT02609568|Children|children
1090125|NCT02609568|Head injury|head injury
1090126|NCT02609568|Salivary biomarker|salivary biomarker
1090127|NCT02609568|Trauma Brain Injury|trauma brain injury
1090128|NCT02609555|TEM|tem
1090129|NCT02609555|Rectopexy|rectopexy
1090130|NCT02609555|rectal prolapse|rectal prolapse
1090131|NCT02609542|oral language|oral language
1090132|NCT02609542|STOL|stol
1090133|NCT02609542|memory|memory
1090134|NCT02609542|eye tracking|eye tracking
1090135|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
1090136|NCT02609529|Pediatrics|pediatrics
1090137|NCT02609529|Nutrition|nutrition
1090138|NCT02609516|Multimorbidity|multimorbidity
1090139|NCT02609516|Health inequalities|health inequalities
1090140|NCT02609516|Ageing|ageing
1090141|NCT02609516|Mortality|mortality
1090142|NCT02609477|Recreational stimulant users|recreational stimulant users
1090143|NCT02609477|Recreational Drug Users|recreational drug users
1090144|NCT02609451|quality of life|quality of life
1090145|NCT02609451|feasibility|feasibility
1090146|NCT02609451|safety|safety
1090147|NCT02609451|protective ileostomy closure|protective ileostomy closure
1090148|NCT02609438|worksite|worksite
1090149|NCT02609438|intervention|intervention
1090150|NCT02609438|sitting|sitting
1090151|NCT02609399|Influenza|influenza
1090152|NCT02609399|Antiviral treatment|antiviral treatment
1090153|NCT02609399|Emergency department|emergency department
1090154|NCT02609399|Influenza therapeutics|influenza therapeutics
1090155|NCT02609399|Rapid influenza testing|rapid influenza testing
1090156|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
1090157|NCT02609386|Immunotherapy|immunotherapy
1090158|NCT02609386|Cancer|cancer
1090159|NCT02609386|Oral Cavity|oral cavity
1090160|NCT02609373|shiftwork|shiftwork
1090161|NCT02609373|sleep hygiene|sleep hygiene
1090162|NCT02609373|prevention|prevention
1090163|NCT02609373|intervention|intervention
1090164|NCT02609373|occupational|occupational
1090165|NCT02609373|biological|biological
1090166|NCT02609373|breast cancer|breast cancer
1090167|NCT02609373|lifestyle|lifestyle
1090168|NCT02609360|Acute Respiratory Failure|acute respiratory failure
1090169|NCT02609360|ARDS|ards
1090170|NCT02609360|ECMO|ecmo
1090171|NCT02609360|Lung transplantation|lung transplantation
1090172|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
1090173|NCT02609347|Manual Therapy|manual therapy
1090174|NCT02609347|Ankle Fracture|ankle fracture
1090175|NCT02609347|Hindfoot Fracture|hindfoot fracture
1090176|NCT02609321|Paravertebral|paravertebral
1090177|NCT02609321|Single injection|single injection
1090178|NCT02609321|Breast surgery|breast surgery
1090179|NCT02609321|Analgesia|analgesia
1090180|NCT02609308|ankle sprain|ankle sprain
1090181|NCT02609308|platelet-rich plasma|platelet-rich plasma
1090182|NCT02609308|ankle injuries|ankle injuries
1090183|NCT02609295|α-linolenic acid|α-linolenic acid
1136388|NCT02341807|CHM|chm
1090184|NCT02609295|perilla oil|perilla oil
1090185|NCT02609295|aPTT|aptt
1090186|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
1090187|NCT02609295|Lp-PLA2|lp-pla2
1090188|NCT02609282|Sedentary behaviour|sedentary behaviour
1090189|NCT02609282|sitting|sitting
1090190|NCT02609282|workplace|workplace
1090191|NCT02609282|prompts|prompts
1090192|NCT02609256|Intracranial hypertension|intracranial hypertension
1090193|NCT02609256|cerebral herniation|cerebral herniation
1090194|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
1090195|NCT02609256|fatality|fatality
1090196|NCT02609256|disability|disability
1090197|NCT02609243|prediabetes|prediabetes
1090198|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
1090199|NCT02609243|obesity|obesity
1090200|NCT02609243|NAFLD|nafld
1090201|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
1090202|NCT02609217|elective|elective
1090203|NCT02609217|cesarean|cesarean
1090204|NCT02609178|artificial crown|artificial crown
1090205|NCT02609178|biomorphic|biomorphic
1090206|NCT02609178|functional generated path|functional generated path
1090207|NCT02609178|muscle-action theory|muscle-action theory
1090208|NCT02609178|anatomic theory|anatomic theory
1090209|NCT02609126|osteoarthritis|osteoarthritis
1090210|NCT02609126|knee|knee
1090311|NCT02608437|SGI-110|sgi-110
1090211|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
1090212|NCT02609074|bone substitute|bone substitute
1090213|NCT02609074|CPC|cpc
1090214|NCT02609074|rhBMP-2|rhbmp-2
1090215|NCT02609048|PBC|pbc
1090216|NCT02609022|Myasthenia Gravis|myasthenia gravis
1090217|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
1090218|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
1090219|NCT02609022|Safety|safety
1090220|NCT02609022|Immunogenic response|immunogenic response
1090221|NCT02609022|First-in-Human|first-in-human
1090222|NCT02609022|Proof-of-Concept|proof-of-concept
1090223|NCT02609022|Myasterix|myasterix
1090224|NCT02609009|Back Pain|back pain
1090225|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1090226|NCT02609009|Spinal Manipulation|spinal manipulation
1090227|NCT02608983|Seaweed|seaweed
1090228|NCT02608983|Hydrocolloid|hydrocolloid
1090229|NCT02608983|Functional Food|functional food
1090230|NCT02608983|Dietary Fibre|dietary fibre
1090231|NCT02608983|Prebiotic|prebiotic
1090232|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
1090233|NCT02608983|Alginate|alginate
1090234|NCT02608983|Agar|agar
1090235|NCT02608983|HYFFI|hyffi
1090236|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
1090237|NCT02608983|subjects|subjects
1090238|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
1090239|NCT02608892|Breastfeeding|breastfeeding
1090240|NCT02608892|Skin to skin care|skin to skin care
1090241|NCT02608892|Sucrose|sucrose
1090242|NCT02608892|Newborn screening|newborn screening
1090243|NCT02608892|Blood test|blood test
1090244|NCT02608892|Neonate|neonate
1090245|NCT02608892|Infant|infant
1090246|NCT02608892|Knowledge translation|knowledge translation
1090247|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
1090248|NCT02608879|microbiome|microbiome
1090249|NCT02608879|radiation therapy|radiation therapy
1090250|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1090251|NCT02608866|spine metastasis|spine metastasis
1090252|NCT02608840|slow-wave sleep|slow-wave sleep
1090253|NCT02608840|cognition|cognition
1090254|NCT02608840|auditory stimulation|auditory stimulation
1090255|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
1090256|NCT02608788|postoperative sore throat|postoperative sore throat
1090257|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
1090258|NCT02608788|general anesthesia|general anesthesia
1090259|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
1090260|NCT02608775|ANI|ani
1090261|NCT02608775|SPI|spi
1090262|NCT02608775|Autonomic balance|autonomic balance
1090263|NCT02608775|Nociception measurement|nociception measurement
1090264|NCT02608762|Pediatric brain tumors|pediatric brain tumors
1090265|NCT02608762|Radiation therapy|radiation therapy
1090266|NCT02608762|Neurobehavioral functions|neurobehavioral functions
1090267|NCT02608762|Proton radiotherapy|proton radiotherapy
1090268|NCT02608749|Osteoporosis|osteoporosis
1090269|NCT02608749|Fall|fall
1090270|NCT02608749|Fracture|fracture
1090271|NCT02608749|Sacopenia|sacopenia
1090272|NCT02608749|Body Composition|body composition
1090273|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1090274|NCT02608736|histone deacetylases|histone deacetylases
1090275|NCT02608736|valproic acid|valproic acid
1090276|NCT02608736|acetylation|acetylation
1090277|NCT02608736|chemoprevention|chemoprevention
1090278|NCT02608736|DNA methyltransferase|dna methyltransferase
1090279|NCT02608736|methylation|methylation
1090280|NCT02608723|shock wave|shock wave
1090281|NCT02608723|plantar fasciitis|plantar fasciitis
1090282|NCT02608723|placebo effect|placebo effect
1090283|NCT02608723|nocebo effect|nocebo effect
1090284|NCT02608684|immunotherapy|immunotherapy
1090285|NCT02608684|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
1090286|NCT02608684|immune checkpoint inhibitors|immune checkpoint inhibitors
1090287|NCT02608671|Episiotomy|episiotomy
1090288|NCT02608671|continuous suture|continuous suture
1090289|NCT02608671|Skin adhesive tape|skin adhesive tape
1090290|NCT02608658|Cirrhosis|cirrhosis
1090292|NCT02608658|SBP|sbp
1090293|NCT02608632|Renal denervation|renal denervation
1090294|NCT02608632|Ablation|ablation
1090295|NCT02608619|18F-fluorocholine|18f-fluorocholine
1090296|NCT02608619|Pet imaging|pet imaging
1090297|NCT02608619|Biopsy|biopsy
1090298|NCT02608619|15-268|15-268
1090299|NCT02608580|pediatric hospital care|pediatric hospital care
1090300|NCT02608580|adult hospital care|adult hospital care
1090301|NCT02608580|sickle cell disease|sickle cell disease
1090302|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
1090303|NCT02608554|Taichi|taichi
1090304|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
1090305|NCT02608476|acne|acne
1090306|NCT02608463|neuropathic pain|neuropathic pain
1090307|NCT02608463|pregnancy|pregnancy
1090308|NCT02608450|acne|acne
1090309|NCT02608437|melanoma|melanoma
1090310|NCT02608437|ipilimumab|ipilimumab
1090312|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
1090313|NCT02608424|Autonomic nervous system|autonomic nervous system
1090314|NCT02608424|Inflammation|inflammation
1090315|NCT02608424|Parkinson's disease|parkinson's disease
1090316|NCT02608424|Spectral analysis|spectral analysis
1090317|NCT02608424|Heart rate variability|heart rate variability
1090318|NCT02608424|Blood pressure variability|blood pressure variability
1090319|NCT02608398|obesity|obesity
1090320|NCT02608398|weight-loss|weight-loss
1090321|NCT02608398|metabonomics|metabonomics
1090322|NCT02608398|gut microbiome|gut microbiome
1090323|NCT02608372|Seaweed|seaweed
1090324|NCT02608372|Insulin|insulin
1090325|NCT02608372|Glucose tolerance|glucose tolerance
1090326|NCT02608372|C-peptide|c-peptide
1090327|NCT02608372|Appetide|appetide
1090328|NCT02608372|Metabolomics|metabolomics
1090329|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
1090330|NCT02608359|Abiraterone Acetate|abiraterone acetate
1090331|NCT02608359|Zytiga|zytiga
1090332|NCT02608346|Circulating tumor DNA|circulating tumor dna
1090333|NCT02608346|BRCA1 mutation|brca1 mutation
1090334|NCT02608346|Circulating tumor cells|circulating tumor cells
1090335|NCT02608333|Early intervention|early intervention
1090336|NCT02608333|ESDM|esdm
1090337|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
1090338|NCT02608320|Healthy|healthy
1090339|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
1090340|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
1090341|NCT02608320|DURAGESIC|duragesic
1090342|NCT02608320|Fentanyl|fentanyl
1090343|NCT02608307|Treatment Decision-Making|treatment decision-making
1090344|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
1090345|NCT02608294|stroke|stroke
1090346|NCT02608294|gait|gait
1090347|NCT02608294|balance|balance
1090348|NCT02608281|Spectral Mammography|spectral mammography
1090349|NCT02608281|Dual energy|dual energy
1090350|NCT02608281|Contrast enhanced|contrast enhanced
1090351|NCT02608268|Solid tumors|solid tumors
1090352|NCT02608268|Melanoma|melanoma
1090353|NCT02608268|Non small cell lung cancer|non small cell lung cancer
1090354|NCT02608268|NSCLC|nsclc
1090355|NCT02608268|Renal cell carcinoma|renal cell carcinoma
1090356|NCT02608268|RCC|rcc
1090357|NCT02608268|Phase I-Ib/II|phase i-ib/ii
1090358|NCT02608268|MBG453|mbg453
1090359|NCT02608268|PDR001|pdr001
1090360|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
1090361|NCT02608268|PD-1|pd-1
1090362|NCT02608268|TIM-3|tim-3
1090363|NCT02608164|Healthy adults|healthy adults
1090364|NCT02608151|neurodevelopement|neurodevelopement
1090365|NCT02608151|Very preterm infant|very preterm infant
1090366|NCT02608138|iodine|iodine
1090367|NCT02608138|urine|urine
1090368|NCT02608138|children|children
1090369|NCT02608138|schools|schools
1090370|NCT02608138|cognitive performance|cognitive performance
1090371|NCT02608138|salt fortification|salt fortification
1090372|NCT02608125|FGFR|fgfr
1090373|NCT02608099|Atrial fibrillation|atrial fibrillation
1090374|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1090375|NCT02608099|Catheter ablation|catheter ablation
1090376|NCT02608099|Apixaban|apixaban
1090377|NCT02608099|Warfarin|warfarin
1090378|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
1090379|NCT02608086|PTSD|ptsd
1090380|NCT02608086|Trauma|trauma
1090381|NCT02608086|Emergency|emergency
1090383|NCT02608086|Psychological First Aid|psychological first aid
1090384|NCT02608021|Alzheimer's Disease|alzheimer's disease
1090385|NCT02608021|MRI|mri
1090386|NCT02608008|3D-Ultrasound|3d-ultrasound
1090387|NCT02608008|Live X-rays|live x-rays
1090388|NCT02608008|EchoNavigator System|echonavigator system
1090389|NCT02607982|Esophageal cancer|esophageal cancer
1090390|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1090391|NCT02607982|Oxaliplatin|oxaliplatin
1090392|NCT02607982|Paclitaxel|paclitaxel
1090393|NCT02607982|Survival|survival
1090394|NCT02607982|Toxicity|toxicity
1090395|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
1090396|NCT02607956|HIV|hiv
1090397|NCT02607943|acute stroke|acute stroke
1090398|NCT02607943|hyperglycemia|hyperglycemia
1090399|NCT02607943|regular insulin|regular insulin
1090400|NCT02607943|long-acting insulin|long-acting insulin
1090401|NCT02607930|HIV|hiv
1090402|NCT02607917|Cardiovascular Disease|cardiovascular disease
1090403|NCT02607904|Cannabidiol|cannabidiol
1090404|NCT02607904|GWP42003-P|gwp42003-p
1090405|NCT02607904|Epidiolex|epidiolex
1090406|NCT02607904|Stiripentol|stiripentol
1090407|NCT02607904|Valproate|valproate
1090408|NCT02607891|Cannabidiol|cannabidiol
1090409|NCT02607891|GWP42003-P|gwp42003-p
1090410|NCT02607891|Epidiolex|epidiolex
1090411|NCT02607891|Stiripentol|stiripentol
1090412|NCT02607891|Valproate|valproate
1090413|NCT02607878|Cardiac arrest|cardiac arrest
1090414|NCT02607878|Coma|coma
1090415|NCT02607878|Prognosis|prognosis
1090416|NCT02607878|Automated pupillometry|automated pupillometry
1090417|NCT02607878|EEG|eeg
1090418|NCT02607878|Evoked potentials|evoked potentials
1090419|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
1090420|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
1090421|NCT02607852|Burns|burns
1090422|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
1090423|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
1090424|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
1090425|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
1090426|NCT02607774|Plaque psoriasis|plaque psoriasis
1090427|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
1090428|NCT02607774|midazolam|midazolam
1090429|NCT02607774|secukinumab|secukinumab
1090430|NCT02607761|infertility|infertility
1090431|NCT02607761|fertility awareness|fertility awareness
1090432|NCT02607761|health interventions|health interventions
1090433|NCT02607761|young adults|young adults
1090434|NCT02607748|18F-NaF PET|18f-naf pet
1090435|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
1090436|NCT02607748|Coronary CTA|coronary cta
1090437|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
1090438|NCT02607644|Intubation|intubation
1090439|NCT02607644|Ventilation|ventilation
1090440|NCT02607644|Cardiac arrest|cardiac arrest
1090441|NCT02607644|prehospital|prehospital
1090442|NCT02607644|Laryngeal Masks|laryngeal masks
1090443|NCT02607644|Laryngeal Tube|laryngeal tube
1090444|NCT02607644|airway management|airway management
1090445|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
1090446|NCT02607631|Pembrolizumab|pembrolizumab
1090447|NCT02607605|lung cancer|lung cancer
1090448|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
1090449|NCT02607605|cell-free DNA|cell-free dna
1090450|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
1090451|NCT02607592|overall toxicity value|overall toxicity value
1090452|NCT02607566|Diabetes|diabetes
1090453|NCT02607566|Yoga|yoga
1090454|NCT02607566|Walking|walking
1090455|NCT02607566|Stress|stress
1090456|NCT02607540|Chemoradiotherapy|chemoradiotherapy
1090457|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
1090458|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
1090459|NCT02607501|coil embolization|coil embolization
1090460|NCT02607501|bifurcation|bifurcation
1090461|NCT02607488|Obese patients|obese patients
1090462|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
1090463|NCT02607475|telesonography|telesonography
1090464|NCT02607475|ultrasound|ultrasound
1090465|NCT02607475|robotic telesonography|robotic telesonography
1090466|NCT02607449|MDR TB|mdr tb
1090467|NCT02607449|Tuberculosis|tuberculosis
1090468|NCT02607410|Type 2 diabetes|type 2 diabetes
1090469|NCT02607410|sitagliptin|sitagliptin
1090470|NCT02607410|NPH insulin|nph insulin
1090471|NCT02607410|GLP-1|glp-1
1090472|NCT02607371|Patient treatment preference|patient treatment preference
1090473|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
1090474|NCT02607371|NOAC|noac
1090475|NCT02607371|VKA|vka
1090476|NCT02607358|Clopidogrel|clopidogrel
1090477|NCT02607358|acetacylic acid|acetacylic acid
1090478|NCT02607358|antiplatelet therapy|antiplatelet therapy
1090479|NCT02607358|HOTPR|hotpr
1090480|NCT02607358|VerifyNow|verifynow
1090481|NCT02607332|single-center|single-center
1090482|NCT02607332|prospective|prospective
1090483|NCT02607332|single-arm|single-arm
1090484|NCT02607332|open-label|open-label
1090485|NCT02607332|phase II|phase ii
1090486|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
1090487|NCT02607319|Implantation|implantation
1090586|NCT02606539|methotrxate|methotrxate
1090488|NCT02607319|low molecular weight heparin|low molecular weight heparin
1090489|NCT02607319|In vitro Fertilization|in vitro fertilization
1090490|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
1090491|NCT02607319|Pregnancy|pregnancy
1090492|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
1090493|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
1090494|NCT02607293|Gonal-f|gonal-f
1090495|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
1090496|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
1090497|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
1090498|NCT02607280|renal impairment|renal impairment
1090499|NCT02607267|EOSS|eoss
1090500|NCT02607267|Metabolic Surgery|metabolic surgery
1090501|NCT02607267|postoperative outcome|postoperative outcome
1090502|NCT02607267|30 - day mortality|30 - day mortality
1090503|NCT02607241|drug-coated balloon|drug-coated balloon
1090504|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
1090505|NCT02607241|fractional flow reserve|fractional flow reserve
1090506|NCT02607241|optical coherence tomography|optical coherence tomography
1090507|NCT02607150|Spinal Fusion|spinal fusion
1090508|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
1090509|NCT02607150|Blood Transfusion|blood transfusion
1090510|NCT02607124|DIPG|dipg
1090511|NCT02607111|Dalteparin|dalteparin
1090512|NCT02607111|Dosage|dosage
1090513|NCT02607111|Home Hemodialysis|home hemodialysis
1090612|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
1090806|NCT02605200|Pediatrics|pediatrics
1090514|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
1090515|NCT02607046|rehabilitation|rehabilitation
1090516|NCT02607046|exercise training|exercise training
1090517|NCT02607033|Exercise|exercise
1090518|NCT02607033|Weight Loss|weight loss
1090519|NCT02607033|Mobility Limitation|mobility limitation
1090520|NCT02607007|Dairy|dairy
1090521|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
1090522|NCT02607007|Satiety|satiety
1090523|NCT02607007|Food Intake|food intake
1090524|NCT02607007|Insulin|insulin
1090525|NCT02607007|Milk|milk
1090526|NCT02607007|Greek yogurt|greek yogurt
1090527|NCT02607007|Cheese|cheese
1090528|NCT02607007|Soy beverage|soy beverage
1090529|NCT02606994|oral mucositis|oral mucositis
1090530|NCT02606994|chemotherapy|chemotherapy
1090531|NCT02606994|toothpaste|toothpaste
1090532|NCT02606981|Water treatment|water treatment
1090533|NCT02606981|Child growth|child growth
1090534|NCT02606981|Enteric infection|enteric infection
1090535|NCT02606955|Bioimpedance|bioimpedance
1090536|NCT02606955|Dry weight|dry weight
1090537|NCT02606955|Hemodialysis|hemodialysis
1090538|NCT02606955|Resistance|resistance
1090539|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
1090540|NCT02606942|patella|patella
1090541|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
1090542|NCT02606916|S-1|s-1
1090543|NCT02606916|DDP|ddp
1090544|NCT02606916|elderly patients|elderly patients
1090545|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
1090546|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
1090547|NCT02606890|Atrial Fibrillation|atrial fibrillation
1090548|NCT02606890|Stroke|stroke
1090549|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
1090550|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
1090551|NCT02606786|stabilization exercises|stabilization exercises
1090552|NCT02606773|vitamin C supplementation|vitamin c supplementation
1090553|NCT02606760|Nail psoriasis|nail psoriasis
1090554|NCT02606747|DPN|dpn
1090555|NCT02606747|fall|fall
1090556|NCT02606747|fMRI|fmri
1090557|NCT02606747|balance|balance
1090558|NCT02606721|Food Hypersensitivity|food hypersensitivity
1090559|NCT02606721|Oral Food Challenge|oral food challenge
1090560|NCT02606721|Skin Prick Test|skin prick test
1090561|NCT02606721|Food Biomarkers|food biomarkers
1090562|NCT02606695|Spine Surgery Patients|spine surgery patients
1090563|NCT02606682|Phase 1|phase 1
1090564|NCT02606682|Safety|safety
1090565|NCT02606682|Tolerability|tolerability
1090566|NCT02606682|Pharmacokinetics|pharmacokinetics
1090567|NCT02606682|Parkinson's Disease|parkinson's disease
1090568|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
1090569|NCT02606617|Mosapride|mosapride
1090570|NCT02606617|blood glucose|blood glucose
1090571|NCT02606617|serum lipid|serum lipid
1090572|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
1090573|NCT02606604|Cycling|cycling
1090574|NCT02606591|Electroencephalograph|electroencephalograph
1090575|NCT02606591|EEG|eeg
1090576|NCT02606591|Hair sample|hair sample
1090577|NCT02606591|Cognitive tests|cognitive tests
1090578|NCT02606591|Cortisol analysis|cortisol analysis
1090579|NCT02606591|Brain activity|brain activity
1090580|NCT02606591|Stress hormones|stress hormones
1090581|NCT02606552|drug eluting stent|drug eluting stent
1090582|NCT02606552|atrial appendage closure|atrial appendage closure
1090583|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
1090584|NCT02606539|hystrectomy|hystrectomy
1090585|NCT02606539|chemotherapy|chemotherapy
1090587|NCT02606513|Computed Tomography Urography|computed tomography urography
1090588|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
1090590|NCT02606487|Exacerbation|exacerbation
1090591|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
1090592|NCT02606487|Pediatrics|pediatrics
1090593|NCT02606487|Lung Clearance Index|lung clearance index
1090594|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
1090595|NCT02606461|selinexor|selinexor
1090596|NCT02606461|KCP-330|kcp-330
1090597|NCT02606461|Karyopharm|karyopharm
1090598|NCT02606461|Phase 2 / 3|phase 2 / 3
1090599|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
1090600|NCT02606461|liposarcoma|liposarcoma
1090601|NCT02606448|pain control|pain control
1090602|NCT02606448|patient satisfaction|patient satisfaction
1090603|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
1090604|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1090605|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1090606|NCT02606422|neurodegeneration|neurodegeneration
1090607|NCT02606422|language therapy|language therapy
1090608|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
1090609|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
1090610|NCT02606318|Occupational Therapy|occupational therapy
1090611|NCT02606318|Quality of Life|quality of life
1090613|NCT02606305|Fallopian tube cancer|fallopian tube cancer
1090614|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
1090615|NCT02606305|IMGN853|imgn853
1090616|NCT02606305|ADC|adc
1090617|NCT02606305|Antibody drug conjugate|antibody drug conjugate
1090618|NCT02606305|ImmunoGen|immunogen
1090619|NCT02606305|Antibody|antibody
1090620|NCT02606305|Phase 1|phase 1
1090621|NCT02606305|Folate receptor alpha|folate receptor alpha
1090622|NCT02606253|loop diuretics|loop diuretics
1090623|NCT02606253|thiazide diuretics|thiazide diuretics
1090624|NCT02606253|vasopressin antagonists|vasopressin antagonists
1090625|NCT02606253|diuretic resistance|diuretic resistance
1090626|NCT02606253|heart failure|heart failure
1090627|NCT02606227|Pregnant smokers|pregnant smokers
1090628|NCT02606227|smoking cessation|smoking cessation
1090629|NCT02606227|financial incentives|financial incentives
1090630|NCT02606227|control group|control group
1090631|NCT02606227|randomized study|randomized study
1090632|NCT02606214|Tuberculosis|tuberculosis
1090633|NCT02606214|TBA-354|tba-354
1090634|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
1090635|NCT02606214|TB|tb
1090636|NCT02606201|stress urinary incontinence|stress urinary incontinence
1090637|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
1090638|NCT02606201|myofiber|myofiber
1090639|NCT02606201|autologous|autologous
1090640|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
1090641|NCT02606201|autologous serum|autologous serum
1090642|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
1090643|NCT02606188|Bronchoscopy|bronchoscopy
1090644|NCT02606188|Oxygen therapy|oxygen therapy
1090645|NCT02606175|health literacy|health literacy
1090646|NCT02606175|patient medication knowledge|patient medication knowledge
1090647|NCT02606175|kidney transplantation|kidney transplantation
1090648|NCT02606175|medication adherence|medication adherence
1090649|NCT02606175|kidney transplant|kidney transplant
1090650|NCT02606175|renal transplantation|renal transplantation
1090651|NCT02606149|Lung cancer|lung cancer
1090652|NCT02606149|chemotherapy outcome|chemotherapy outcome
1090653|NCT02606149|ethics|ethics
1090654|NCT02606149|information|information
1090655|NCT02606136|Duchenne|duchenne
1090656|NCT02606136|muscular|muscular
1090657|NCT02606136|dystrophy|dystrophy
1090658|NCT02606136|DMD|dmd
1090659|NCT02606136|non-ambulatory|non-ambulatory
1090660|NCT02606123|Prostate Cancer|prostate cancer
1090661|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1090662|NCT02606110|ReBuilder|rebuilder
1090663|NCT02606110|breast cancer|breast cancer
1090664|NCT02606110|chemotherapy induced|chemotherapy induced
1090665|NCT02606084|Renal Impairment|renal impairment
1090666|NCT02606084|Healthy|healthy
1090667|NCT02606084|Esketamine|esketamine
1090668|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
1090669|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
1090670|NCT02606045|menorrhagia|menorrhagia
1090671|NCT02606045|VWD|vwd
1090672|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
1090673|NCT02606032|Antibiotics|antibiotics
1090674|NCT02606019|Pentraxin 3|pentraxin 3
1090675|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1090676|NCT02606019|dengue|dengue
1090677|NCT02606006|Physical Therapy Modalities|physical therapy modalities
1090678|NCT02606006|Motivation|motivation
1090679|NCT02606006|Patient Participation|patient participation
1090680|NCT02606006|Animal Assisted Therapy|animal assisted therapy
1090681|NCT02605993|complement inhibitor|complement inhibitor
1090682|NCT02605967|PDR001,|pdr001,
1090683|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
1090684|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
1090685|NCT02605967|locally advanced,|locally advanced,
1090686|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
1090687|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
1090688|NCT02605954|HIV 1 Infection|hiv 1 infection
1090689|NCT02605954|HIV|hiv
1090690|NCT02605954|Virologically-Suppressed|virologically-suppressed
1090691|NCT02605954|Antiretroviral agents|antiretroviral agents
1090692|NCT02605941|DNA methylation|dna methylation
1090693|NCT02605941|Cervical cancer|cervical cancer
1090694|NCT02605928|Arthritis|arthritis
1090695|NCT02605928|Bioimpedance|bioimpedance
1090696|NCT02605928|Glucocorticoid|glucocorticoid
1090697|NCT02605928|Intra-articular injection|intra-articular injection
1090698|NCT02605928|Needle Guidance|needle guidance
1090699|NCT02605902|Chronic tic disorders|chronic tic disorders
1090700|NCT02605902|Tourette syndrome|tourette syndrome
1090701|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1090702|NCT02605863|Enzalutamide|enzalutamide
1090703|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
1090704|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
1090705|NCT02605850|heart health|heart health
1090706|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
1090707|NCT02605811|brain metastases|brain metastases
1090708|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
1090709|NCT02605811|temozolomide|temozolomide
1090710|NCT02605785|PSP|psp
1090711|NCT02605733|Premature infant|premature infant
1090712|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
1090713|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
1090714|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
1090715|NCT02605707|Transplantation|transplantation
1090716|NCT02605707|Stroke|stroke
1090717|NCT02605681|midkine|midkine
1090718|NCT02605681|endothelial injury|endothelial injury
1090719|NCT02605681|sepsis|sepsis
1090720|NCT02605668|Anxiety Disorders|anxiety disorders
1090721|NCT02605668|Extinction Learning|extinction learning
1090722|NCT02605668|Optimized Extinction|optimized extinction
1090723|NCT02605668|Behavioral Therapy|behavioral therapy
1090724|NCT02605668|Massed Confrontation|massed confrontation
1090725|NCT02605668|Social Anxiety Disorder|social anxiety disorder
1090726|NCT02605668|Specific Phobia|specific phobia
1090727|NCT02605668|Panic Disorder|panic disorder
1090728|NCT02605668|Agoraphobia|agoraphobia
1090729|NCT02605655|obesity|obesity
1090730|NCT02605655|hyperlipidemia|hyperlipidemia
1090731|NCT02605655|hyperglycemia|hyperglycemia
1090732|NCT02605642|Inflectra|inflectra
1090733|NCT02605642|Infliximab|infliximab
1090734|NCT02605642|Observational|observational
1090735|NCT02605642|Remicade|remicade
1090736|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
1090737|NCT02605577|late preterm infants|late preterm infants
1090738|NCT02605577|nutrition|nutrition
1090739|NCT02605577|systemic management|systemic management
1090740|NCT02605525|IgAN|igan
1090741|NCT02605512|Radiotherapy|radiotherapy
1090742|NCT02605512|Echocardiography|echocardiography
1090743|NCT02605512|Strain strain rate|strain strain rate
1090744|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
1090745|NCT02605512|Segments of coronary arteries|segments of coronary arteries
1090746|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
1090747|NCT02605512|Biomarkers|biomarkers
1090748|NCT02605512|Heart dosimetry|heart dosimetry
1090749|NCT02605486|palbociclib|palbociclib
1090750|NCT02605486|bicalutamide|bicalutamide
1090751|NCT02605486|AR(+)|ar(+)
1090752|NCT02605486|15-207|15-207
1090753|NCT02605473|Melanoma|melanoma
1090754|NCT02605473|Malignant melanoma|malignant melanoma
1090755|NCT02605473|Unresectable|unresectable
1090756|NCT02605473|Decitabine|decitabine
1090757|NCT02605473|PEG Interferon Alpha-2b|peg interferon alpha-2b
1090758|NCT02605473|PEG Intron|peg intron
1090759|NCT02605473|5-Aza-Deoxycytidine|5-aza-deoxycytidine
1090760|NCT02605473|Dacogen|dacogen
1090761|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
1090762|NCT02605460|Conditioning Regimen|conditioning regimen
1090763|NCT02605434|Parkinson's Disease|parkinson's disease
1090764|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
1090765|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
1090766|NCT02605434|Carbidopa|carbidopa
1090767|NCT02605434|Levodopa|levodopa
1090768|NCT02605434|Accordion|accordion
1090769|NCT02605434|Accordance|accordance
1090770|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
1090771|NCT02605421|Neuroblastoma|neuroblastoma
1090772|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
1137147|NCT02337335|ESAs|esas
1090773|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
1090774|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
1090775|NCT02605421|PBSC|pbsc
1090776|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
1090777|NCT02605395|Bioequivalence|bioequivalence
1090778|NCT02605395|Fed condition|fed condition
1090779|NCT02605395|PARIET 20 mg|pariet 20 mg
1090780|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
1090781|NCT02605395|Rabeprazole|rabeprazole
1090782|NCT02605382|Dental Implantation|dental implantation
1090783|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
1090784|NCT02605356|Radium-223 dichloride|radium-223 dichloride
1090785|NCT02605356|bortezomib|bortezomib
1090786|NCT02605356|dexamethasone|dexamethasone
1090787|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
1090788|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
1090789|NCT02605343|PGx|pgx
1090790|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
1090791|NCT02605343|Pain Management|pain management
1090792|NCT02605343|AltheaDx|altheadx
1090793|NCT02605343|Post-Operative Pain Management|post-operative pain management
1090794|NCT02605317|Emergency Physicians|emergency physicians
1090795|NCT02605317|Consulting Physicians|consulting physicians
1090796|NCT02605317|WhatsApp|whatsapp
1090797|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
1090798|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
1090799|NCT02605265|Irinotecan|irinotecan
1090800|NCT02605265|UGT1A1|ugt1a1
1090801|NCT02605252|Chronic hepatitis B|chronic hepatitis b
1090802|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
1090803|NCT02605252|Nucleotide analogue|nucleotide analogue
1090804|NCT02605200|Diabetes|diabetes
1090805|NCT02605200|Endocrinology|endocrinology
1090808|NCT02605187|postoperative pain|postoperative pain
1090809|NCT02605187|patient choice|patient choice
1090810|NCT02605161|Blood brain barrier|blood brain barrier
1090811|NCT02605161|movement disorder|movement disorder
1090812|NCT02605161|deep brain stimulation|deep brain stimulation
1090813|NCT02605161|essential tremor|essential tremor
1090814|NCT02605161|cervical dystonia|cervical dystonia
1090815|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
1090816|NCT02605161|neostriatum|neostriatum
1090817|NCT02605148|Islet autoimmunity|islet autoimmunity
1090818|NCT02605148|gluten free diet|gluten free diet
1090819|NCT02605148|prediabetes|prediabetes
1090820|NCT02605148|prevention|prevention
1090821|NCT02605148|type 1 diabetes|type 1 diabetes
1090822|NCT02605148|glucose tolerance test|glucose tolerance test
1090823|NCT02605122|pneumonia|pneumonia
1090824|NCT02605122|macrolide|macrolide
1090825|NCT02605122|pediatric|pediatric
1090826|NCT02605109|MERS-CoV|mers-cov
1090827|NCT02605109|Infection control|infection control
1090828|NCT02605109|Case-control studies|case-control studies
1090829|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
1090830|NCT02605083|Cancer|cancer
1090831|NCT02605083|Neoplasm|neoplasm
1090832|NCT02605083|Solid Tumor|solid tumor
1090833|NCT02605083|Breast|breast
1090834|NCT02605083|Head and Neck|head and neck
1090835|NCT02605083|Lung|lung
1090836|NCT02605083|Pancreatic|pancreatic
1090837|NCT02605083|Hepatic|hepatic
1090838|NCT02605083|Melanoma|melanoma
1090839|NCT02605083|Colon|colon
1090840|NCT02605083|Renal|renal
1090841|NCT02605083|Thyroid|thyroid
1090842|NCT02605083|Prostate|prostate
1090843|NCT02605083|Ovarian|ovarian
1090844|NCT02605083|MNK1|mnk1
1090845|NCT02605083|MNK2|mnk2
1090846|NCT02605083|eIF4E|eif4e
1090847|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
1090848|NCT02604992|Comparative Bioavailability|comparative bioavailability
1090849|NCT02604966|P. falciparum|p. falciparum
1090850|NCT02604966|resistance to artemisinin|resistance to artemisinin
1090851|NCT02604966|Central Vietnam|central vietnam
1090852|NCT02604953|glaucoma|glaucoma
1090853|NCT02604953|VEP|vep
1090854|NCT02604953|PERG|perg
1090855|NCT02604953|SD-tVEP|sd-tvep
1090856|NCT02604953|ss-PERG|ss-perg
1090857|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
1090858|NCT02604940|Dexmedetomidine|dexmedetomidine
1090859|NCT02604940|Bariatric Surgery|bariatric surgery
1090860|NCT02604901|medication adherence|medication adherence
1090861|NCT02604901|community pharmacies|community pharmacies
1090862|NCT02604901|screening and brief intervention|screening and brief intervention
1090863|NCT02604888|Baldness|baldness
1090864|NCT02604888|Alopecia Areata|alopecia areata
1090865|NCT02604888|Alopecia|alopecia
1090866|NCT02604888|Hair loss|hair loss
1090867|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
1090868|NCT02604784|Chemotherapy|chemotherapy
1090869|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1090870|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
1090871|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
1090872|NCT02604667|Biomarkers|biomarkers
1090873|NCT02604667|Mechanisms|mechanisms
1090874|NCT02604667|Transcranial Doppler|transcranial doppler
1090875|NCT02604641|skin rejuvenation|skin rejuvenation
1090876|NCT02604641|anti-ageing effects|anti-ageing effects
1091480|NCT02601417|Cholangitis|cholangitis
1090877|NCT02604641|minimal erythema dose|minimal erythema dose
1090878|NCT02604641|dermis structure|dermis structure
1090879|NCT02604641|physiological skin condition|physiological skin condition
1090880|NCT02604641|wrinkling|wrinkling
1090881|NCT02604641|dry skin|dry skin
1090882|NCT02604628|Pneumonia|pneumonia
1090883|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
1090884|NCT02604628|Stepped wedge|stepped wedge
1090885|NCT02604628|Antibiotic|antibiotic
1090886|NCT02604615|Chemoradiotherapy|chemoradiotherapy
1090887|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
1090888|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
1090889|NCT02604615|Chinese|chinese
1090890|NCT02604615|Randomized Controlled Trials|randomized controlled trials
1090891|NCT02604602|PPH|pph
1090892|NCT02604589|Catheters, Indwelling|catheters, indwelling
1090893|NCT02604589|Infusion Pumps|infusion pumps
1090894|NCT02604589|Anesthesia, Local|anesthesia, local
1090895|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
1090896|NCT02604589|Bupivacaine|bupivacaine
1090897|NCT02604576|functional dyspepsia|functional dyspepsia
1090898|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1090899|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
1090900|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
1090901|NCT02604524|Closed Loop Control|closed loop control
1090902|NCT02604524|Insulin Pump|insulin pump
1090903|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1090904|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1090905|NCT02604485|Hypoglycemia|hypoglycemia
1090906|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
1090907|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1090908|NCT02604472|induction chemotherapy|induction chemotherapy
1090909|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1090910|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1090911|NCT02604446|Analgesics|analgesics
1090912|NCT02604446|Administration and dosage|administration and dosage
1090913|NCT02604446|Knee|knee
1090914|NCT02604446|Postoperational care|postoperational care
1090915|NCT02604446|Pain management|pain management
1090916|NCT02604433|ACE-536|ace-536
1090917|NCT02604433|Safety|safety
1090918|NCT02604433|Efficacy|efficacy
1090919|NCT02604433|Placebo|placebo
1090920|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
1090921|NCT02604433|Beta -Thalassemia|beta -thalassemia
1090922|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
1090923|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
1090924|NCT02604394|Angioplasty|angioplasty
1090925|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1090926|NCT02604394|Myocardial Salvage Index|myocardial salvage index
1090927|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
1090928|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
1090929|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
1090930|NCT02604381|Osteoarthritis|osteoarthritis
1090931|NCT02604381|Knee|knee
1090932|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
1090933|NCT02604381|Ginkgo Biloba|ginkgo biloba
1090934|NCT02604381|WOMAC|womac
1090935|NCT02604381|Joint Health Wellness|joint health wellness
1090936|NCT02604381|Interleukin-1-beta|interleukin-1-beta
1090937|NCT02604368|hemoglobin SS|hemoglobin ss
1090938|NCT02604368|hemoglobin SC|hemoglobin sc
1090939|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
1090940|NCT02604329|low level laser therapy|low level laser therapy
1090941|NCT02604329|oral mucositis|oral mucositis
1090942|NCT02604329|child|child
1090943|NCT02604316|Overweight and Obesity|overweight and obesity
1090944|NCT02604316|Appetite|appetite
1090945|NCT02604316|Gut hormones and obesity|gut hormones and obesity
1090946|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
1090947|NCT02604316|SmartPill|smartpill
1090948|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1090949|NCT02604303|RhoA|rhoa
1090950|NCT02604303|Biomarker|biomarker
1090951|NCT02604290|Kinesio taping|kinesio taping
1090952|NCT02604290|Neuromuscular taping|neuromuscular taping
1090953|NCT02604290|Targeted treatment|targeted treatment
1090954|NCT02604290|Chronic low back pain|chronic low back pain
1090955|NCT02604290|Randomised controlled trial|randomised controlled trial
1090956|NCT02604277|Psychology|psychology
1090957|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
1090958|NCT02604225|Anaethesiology|anaethesiology
1090959|NCT02604186|Spasticity|spasticity
1090960|NCT02604186|Botulinum Toxin|botulinum toxin
1090961|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
1090962|NCT02604134|silver nitrate|silver nitrate
1090963|NCT02604134|children|children
1090964|NCT02604134|dental caries|dental caries
1090965|NCT02604134|medical management|medical management
1090966|NCT02604134|quality of life|quality of life
1090967|NCT02604121|oral cavity|oral cavity
1090968|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
1090969|NCT02604108|physical activity|physical activity
1090970|NCT02604108|healthy diet|healthy diet
1090977|NCT02604043|supraglottic pH|supraglottic ph
1090978|NCT02604017|HCV GT1|hcv gt1
1090979|NCT02604017|Non-cirrhotic|non-cirrhotic
1090980|NCT02604017|RBV Free|rbv free
1090981|NCT02604017|Without cirrhosis|without cirrhosis
1090982|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
1090983|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
1090984|NCT02604017|IFN free|ifn free
1090985|NCT02604017|Hepatitis C|hepatitis c
1090986|NCT02604017|Ribavirin Free|ribavirin free
1090987|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
1090988|NCT02604017|HCV|hcv
1090989|NCT02604017|Hepatitis C virus|hepatitis c virus
1090990|NCT02604017|DAA|daa
1090991|NCT02604004|lamivudine|lamivudine
1090992|NCT02604004|bioequivalence test|bioequivalence test
1090993|NCT02604004|pharmacokinetics|pharmacokinetics
1090994|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
1090995|NCT02604004|3TC|3tc
1090996|NCT02604004|LC-MS/MS|lc-ms/ms
1090997|NCT02604004|mass spectrometry|mass spectrometry
1090998|NCT02603991|children and adolescents|children and adolescents
1090999|NCT02603991|Prospective cohort study|prospective cohort study
1091000|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
1091001|NCT02603991|PINS|pins
1091002|NCT02603952|Influenza|influenza
1091003|NCT02603952|Influenza A|influenza a
1091004|NCT02603952|Flu|flu
1091005|NCT02603952|Flu A|flu a
1091006|NCT02603939|Pain|pain
1091007|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
1091008|NCT02603913|Pre-eclampsia|pre-eclampsia
1091009|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
1091010|NCT02603913|Preterm birth|preterm birth
1091011|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
1091012|NCT02603913|Oxidative stress|oxidative stress
1091013|NCT02603900|Adductor Canal Catheter|adductor canal catheter
1091014|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1091015|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
1091023|NCT02603874|Fluoroscopy|fluoroscopy
1091024|NCT02603874|Spinal Fusion|spinal fusion
1091025|NCT02603874|Wrong Level Surgery|wrong level surgery
1091026|NCT02603848|Inguinal surgery|inguinal surgery
1091027|NCT02603848|Hernia Repair|hernia repair
1091028|NCT02603848|Orchidopexy|orchidopexy
1091029|NCT02603848|Hydrocele|hydrocele
1091030|NCT02603848|Pediatric|pediatric
1091031|NCT02603848|Post-operative pain|post-operative pain
1091032|NCT02603848|Morphine sulfate|morphine sulfate
1091033|NCT02603848|Ibuprofen|ibuprofen
1091034|NCT02603835|SSO2 Therapy|sso2 therapy
1091035|NCT02603835|Acute myocardial infarction|acute myocardial infarction
1091036|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
1091037|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
1091038|NCT02603835|Left main coronary artery|left main coronary artery
1091039|NCT02603835|Myocardial infarction|myocardial infarction
1091040|NCT02603835|Heart attack|heart attack
1091041|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
1091042|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
1091043|NCT02603835|PCI|pci
1091044|NCT02603835|Stent|stent
1091045|NCT02603835|Stenting|stenting
1091046|NCT02603835|Stents|stents
1091047|NCT02603835|Angioplasty|angioplasty
1091048|NCT02603835|LMCA|lmca
1091049|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
1091050|NCT02603796|3-Dimensional|3-dimensional
1091051|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
1091052|NCT02603796|nasal changes|nasal changes
1091053|NCT02603757|Vitamin D|vitamin d
1091054|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
1091055|NCT02603718|Stroke|stroke
1091056|NCT02603718|On-line EEG|on-line eeg
1091057|NCT02603718|BEI index|bei index
1091058|NCT02603718|Attention|attention
1091059|NCT02603718|Rehabilitation|rehabilitation
1091060|NCT02603705|chronic pain|chronic pain
1091061|NCT02603705|opioid|opioid
1091062|NCT02603705|oxycodone|oxycodone
1091063|NCT02603705|non cancer pain|non cancer pain
1091064|NCT02603705|moderate to severe|moderate to severe
1091065|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
1091066|NCT02603692|Progressive brain tumor|progressive brain tumor
1091067|NCT02603692|PROMIS|promis
1091068|NCT02603692|Quality of life|quality of life
1091685|NCT02600260|enoxaparin|enoxaparin
1137563|NCT02334670|HIV|hiv
1091069|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
1091070|NCT02603666|cystic fibrosis|cystic fibrosis
1091071|NCT02603666|elastography|elastography
1091072|NCT02603666|liver biopsy|liver biopsy
1091073|NCT02603614|Chronic Heart Failure|chronic heart failure
1091074|NCT02603614|Renal Insufficiency|renal insufficiency
1091075|NCT02603614|Natriuretic Peptides|natriuretic peptides
1091076|NCT02603614|Cenderitide|cenderitide
1091077|NCT02603601|Randomized controlled trial|randomized controlled trial
1091078|NCT02603601|Mindfulness|mindfulness
1091079|NCT02603601|Obesity|obesity
1091080|NCT02603588|Acupuncture|acupuncture
1091081|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
1091082|NCT02603588|Nasal ventilation|nasal ventilation
1091083|NCT02603588|Neuropeptides|neuropeptides
1091084|NCT02603575|Caspofungin|caspofungin
1091085|NCT02603575|corticosteroids|corticosteroids
1091086|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
1091087|NCT02603575|Immunocompromised|immunocompromised
1091088|NCT02603575|Non-HIV|non-hiv
1091089|NCT02603575|respiratory failure|respiratory failure
1091090|NCT02603562|FSHD|fshd
1091091|NCT02603536|Text Messaging|text messaging
1091092|NCT02603536|Harm Reduction|harm reduction
1091093|NCT02603523|accidental falls|accidental falls
1091094|NCT02603523|older people|older people
1091095|NCT02603523|dance|dance
1091096|NCT02603523|randomized controlled trial|randomized controlled trial
1091097|NCT02603497|ASP015K|asp015k
1091098|NCT02603497|impaired renal function|impaired renal function
1091099|NCT02603497|Pharmacokinetics|pharmacokinetics
1091100|NCT02603471|HIV+|hiv+
1091101|NCT02603471|Alcohol dependence|alcohol dependence
1091102|NCT02603471|Mobile Technology|mobile technology
1091103|NCT02603458|Schizophrenia|schizophrenia
1091104|NCT02603458|Naurex|naurex
1091105|NCT02603458|Intravenous Treatment|intravenous treatment
1091106|NCT02603458|NRX-1074|nrx-1074
1091107|NCT02603445|BCL201|bcl201
1091108|NCT02603445|idelalisib|idelalisib
1091109|NCT02603445|Follicular lymphoma|follicular lymphoma
1091110|NCT02603445|FL|fl
1091111|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
1091112|NCT02603445|MCL|mcl
1091113|NCT02603432|Bladder cancer|bladder cancer
1091114|NCT02603432|Urologic neoplasms|urologic neoplasms
1091115|NCT02603432|urothelial carcinoma|urothelial carcinoma
1091116|NCT02603432|PD-L1|pd-l1
1091117|NCT02603432|programmed cell death protein|programmed cell death protein
1091118|NCT02603432|maintenance treatment|maintenance treatment
1091119|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
1091120|NCT02603419|post-allogeneic HSCT|post-allogeneic hsct
1091121|NCT02603419|anti PD-L1|anti pd-l1
1091122|NCT02603419|Phase 1|phase 1
1091123|NCT02603419|PK|pk
1091124|NCT02603419|Receptor occupancy|receptor occupancy
1091125|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
1091126|NCT02603393|COPD, QVA149|copd, qva149
1091127|NCT02603380|Delirium|delirium
1091128|NCT02603380|Feasibility study|feasibility study
1091129|NCT02603380|software application|software application
1091130|NCT02603380|qualitative|qualitative
1091131|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
1091132|NCT02603328|Statins|statins
1091133|NCT02603328|MRI|mri
1091134|NCT02603328|Permeability|permeability
1091135|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
1091136|NCT02603302|rectal cancer|rectal cancer
1091137|NCT02603302|radiotherapy|radiotherapy
1091138|NCT02603302|escalated dose|escalated dose
1091139|NCT02603302|interval|interval
1091140|NCT02603276|hypercholesterolemia|hypercholesterolemia
1091141|NCT02603276|dietary supplements|dietary supplements
1091142|NCT02603276|red yeast rice|red yeast rice
1091143|NCT02603276|plant sterols|plant sterols
1091144|NCT02603263|social norms|social norms
1091145|NCT02603263|healthy eating|healthy eating
1091146|NCT02603263|vegetables|vegetables
1091147|NCT02603263|field study|field study
1091148|NCT02603250|Anemia|anemia
1091149|NCT02603250|Iron deficiency|iron deficiency
1091150|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
1091151|NCT02603211|breast cancer|breast cancer
1091152|NCT02603198|third molar|third molar
1091153|NCT02603198|tooth extraction|tooth extraction
1091154|NCT02603198|impacted tooth|impacted tooth
1091155|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
1091156|NCT02603172|GSK3039294|gsk3039294
1091157|NCT02603172|GSK2315698|gsk2315698
1091158|NCT02603172|systemic amyloidosis|systemic amyloidosis
1091159|NCT02603172|CPHPC|cphpc
1091160|NCT02603172|dose-escalation|dose-escalation
1091161|NCT02603159|Chemoradiotherapy|chemoradiotherapy
1091162|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
1091163|NCT02603159|Capecitabine|capecitabine
1091164|NCT02603146|RA prevention|ra prevention
1091165|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
1091166|NCT02603146|anti-CCP|anti-ccp
1091167|NCT02603133|healthcare|healthcare
1091168|NCT02603133|burnout|burnout
1091169|NCT02603133|resilience|resilience
1091170|NCT02603133|fatigue|fatigue
1091171|NCT02603133|NICU|nicu
1091172|NCT02603133|safety culture|safety culture
1091173|NCT02603133|quality of care|quality of care
1091174|NCT02603081|Meniere's|meniere's
1091175|NCT02603081|hearing loss|hearing loss
1091176|NCT02603081|vertigo|vertigo
1091177|NCT02603081|tinnitus|tinnitus
1091178|NCT02603081|ebselen|ebselen
1091179|NCT02603055|Safety|safety
1091180|NCT02603055|immunogenicity|immunogenicity
1091181|NCT02603055|Hepatitis E|hepatitis e
1091182|NCT02603029|skin rejuvenation|skin rejuvenation
1091183|NCT02603029|anti-ageing effects|anti-ageing effects
1091184|NCT02603029|minimal erythema dose|minimal erythema dose
1091185|NCT02603029|dermis structure|dermis structure
1091186|NCT02603029|physiological skin condition|physiological skin condition
1091187|NCT02603029|wrinkling|wrinkling
1091188|NCT02603016|Clinical Nutrition|clinical nutrition
1091189|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
1091190|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
1091191|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
1091192|NCT02602990|Cerebral|cerebral
1091193|NCT02602990|Arteriovenous|arteriovenous
1091194|NCT02602990|Malformation|malformation
1091195|NCT02602990|Embolization|embolization
1091196|NCT02602990|Endovascular|endovascular
1091197|NCT02602977|inflammation|inflammation
1091198|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
1091199|NCT02602938|aspirin|aspirin
1091200|NCT02602938|circulating tumor cells|circulating tumor cells
1091201|NCT02602938|metastatic breast cancer|metastatic breast cancer
1091202|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
1091203|NCT02602899|PINS|pins
1091204|NCT02602899|Deep Brain Stimulator|deep brain stimulator
1091205|NCT02602899|Refractory Epilepsy|refractory epilepsy
1091206|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
1091207|NCT02602860|SV2A|sv2a
1091208|NCT02602860|Levetiracetam|levetiracetam
1091209|NCT02602860|Brivaracetam|brivaracetam
1091211|NCT02602847|Liver transplantation|liver transplantation
1091212|NCT02602847|HBV|hbv
1091213|NCT02602847|cccDNA|cccdna
1091214|NCT02602834|exercise test|exercise test
1091215|NCT02602834|biological markers|biological markers
1091216|NCT02602808|acute pancreatitis|acute pancreatitis
1091217|NCT02602808|non-coding RNA|non-coding rna
1091218|NCT02602808|biological markers|biological markers
1091219|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
1091220|NCT02602795|Opiate Dependence|opiate dependence
1091221|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
1091222|NCT02602795|HIV|hiv
1091223|NCT02602795|Extended release naltrexone|extended release naltrexone
1091224|NCT02602756|Choroid Melanoma|choroid melanoma
1091225|NCT02602743|sedation|sedation
1091226|NCT02602743|remifentanyl|remifentanyl
1091227|NCT02602743|pediatric patient|pediatric patient
1091228|NCT02602743|colonoscopy|colonoscopy
1091229|NCT02602730|Cigarette smoking|cigarette smoking
1091230|NCT02602730|Smoking, Tobacco|smoking, tobacco
1091231|NCT02602730|postpartum|postpartum
1091232|NCT02602730|internet|internet
1091233|NCT02602730|interactive|interactive
1091234|NCT02602730|coach|coach
1091235|NCT02602717|follicular origin|follicular origin
1091236|NCT02602691|Heart transplantation|heart transplantation
1091237|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
1091238|NCT02602691|Medico-economic study|medico-economic study
1091239|NCT02602678|Children.|children.
1091240|NCT02602678|prone position|prone position
1091241|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
1091242|NCT02602678|syncytial virus|syncytial virus
1091243|NCT02602678|work of breathing|work of breathing
1091244|NCT02602678|intrinsic PEEP|intrinsic peep
1091245|NCT02602665|catheter placement|catheter placement
1091246|NCT02602652|geometric mean titer|geometric mean titer
1091247|NCT02602652|seroprotection|seroprotection
1091248|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
1091249|NCT02602652|JE-CV|je-cv
1091250|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
1091251|NCT02602626|Human Papillomavirus|human papillomavirus
1091252|NCT02602626|HPV|hpv
1091253|NCT02602626|Postpartum|postpartum
1091254|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
1091255|NCT02602587|Dendrogenin A|dendrogenin a
1091256|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
1091257|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
1091258|NCT02602587|5alpha-diol|5alpha-diol
1091259|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
1091260|NCT02602587|oxysterols|oxysterols
1091261|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1091262|NCT02602574|Pancreatitis|pancreatitis
1091263|NCT02602574|Heat-Shock Proteins|heat-shock proteins
1091264|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
1091265|NCT02602574|C-Reactive Protein|c-reactive protein
1091266|NCT02602574|procalcitonin|procalcitonin
1091267|NCT02602574|Interleukin-1 beta|interleukin-1 beta
1137833|NCT02333058|ALL|all
1091268|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
1091269|NCT02602574|Killer Cells, Natural|killer cells, natural
1091270|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
1091271|NCT02602561|HMB|hmb
1091272|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
1091273|NCT02602561|ACL|acl
1091274|NCT02602561|surgery|surgery
1091275|NCT02602561|muscle mass|muscle mass
1091276|NCT02602548|Propionibacterium acnes|propionibacterium acnes
1091277|NCT02602548|shoulder surgery|shoulder surgery
1091278|NCT02602548|infection|infection
1091279|NCT02602496|Diet|diet
1091280|NCT02602496|Whole grain|whole grain
1091281|NCT02602496|Fruits|fruits
1091282|NCT02602496|Vegetables|vegetables
1091283|NCT02602496|Gut health|gut health
1091284|NCT02602496|Anti-inflammatory|anti-inflammatory
1091285|NCT02602483|temporomandibular|temporomandibular
1091286|NCT02602483|joint|joint
1091287|NCT02602483|pain|pain
1091288|NCT02602483|ibuprofen|ibuprofen
1091289|NCT02602483|magnesium|magnesium
1091290|NCT02602483|vitamin C|vitamin c
1091291|NCT02602457|Atrial Fibrillation|atrial fibrillation
1091292|NCT02602444|ticagrelor|ticagrelor
1091293|NCT02602444|STEMI|stemi
1091294|NCT02602444|NSTEMI|nstemi
1091295|NCT02602444|pharmacokinetics|pharmacokinetics
1091296|NCT02602444|pharmacodynamics|pharmacodynamics
1091297|NCT02602431|laser|laser
1091298|NCT02602431|third molar|third molar
1091299|NCT02602431|low laser|low laser
1091300|NCT02602431|inflammatory response|inflammatory response
1091301|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1091302|NCT02602418|working memory training|working memory training
1091303|NCT02602418|brain function|brain function
1091304|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1091305|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
1091306|NCT02602405|Return to work|return to work
1091307|NCT02602405|Registries|registries
1091308|NCT02602405|Norway|norway
1091309|NCT02602392|Self management|self management
1091310|NCT02602392|Education|education
1091311|NCT02602392|Children|children
1091312|NCT02602392|Caregivers|caregivers
1091313|NCT02602392|Health Care Providers|health care providers
1091314|NCT02602379|Pain|pain
1091315|NCT02602379|Monitoring|monitoring
1091729|NCT02599896|Half-Life|half-life
1091316|NCT02602379|Analgesia Nociception Index|analgesia nociception index
1091317|NCT02602379|NoL|nol
1091318|NCT02602379|Nociception Level|nociception level
1091319|NCT02602379|Remifentanil|remifentanil
1091320|NCT02602366|HIV|hiv
1091321|NCT02602366|DCE|dce
1091322|NCT02602366|MPT|mpt
1091323|NCT02602366|Microbicide|microbicide
1091324|NCT02602327|radioembolization|radioembolization
1091325|NCT02602327|Yttrium-90|yttrium-90
1091326|NCT02602327|90Y|90y
1091327|NCT02602327|Resin microspheres|resin microspheres
1091328|NCT02602327|Tas-102|tas-102
1091329|NCT02602327|Lonsurf|lonsurf
1091330|NCT02602327|SIR-Sphere|sir-sphere
1091331|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
1091332|NCT02602314|Nilotinib|nilotinib
1091333|NCT02602314|Imatinib|imatinib
1091334|NCT02602301|oxytocin|oxytocin
1091335|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
1091336|NCT02602223|Tooth Socket|tooth socket
1091337|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
1091338|NCT02602223|Membranes|membranes
1091339|NCT02602210|cirrhosis|cirrhosis
1091340|NCT02602210|liver|liver
1091341|NCT02602210|corticosteroids|corticosteroids
1091342|NCT02602210|hypotension|hypotension
1091343|NCT02602210|sepsis|sepsis
1091344|NCT02602210|cortisol|cortisol
1091345|NCT02602197|Paracetamol|paracetamol
1091346|NCT02602197|Dexketoprofen|dexketoprofen
1091347|NCT02602197|postoperative pain|postoperative pain
1091348|NCT02602197|septoplasty|septoplasty
1091349|NCT02602184|skin regeneration|skin regeneration
1091350|NCT02602184|re-epithelialization|re-epithelialization
1091351|NCT02602184|split thickness wounds|split thickness wounds
1091352|NCT02602184|Abdominoplasty|abdominoplasty
1091353|NCT02602158|breath test|breath test
1091354|NCT02602158|lipid emulsions|lipid emulsions
1091355|NCT02602158|MRI|mri
1091356|NCT02602158|gastric emptying|gastric emptying
1091357|NCT02602145|femoral|femoral
1091358|NCT02602145|popliteal|popliteal
1091359|NCT02602145|stent|stent
1091360|NCT02602145|modeling|modeling
1091361|NCT02602145|flexion|flexion
1091362|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
1091363|NCT02602132|CLAMPING|clamping
1091364|NCT02602132|REMOVAL|removal
1091365|NCT02602106|Aquatic activities|aquatic activities
1091366|NCT02602106|Aerobic exercise|aerobic exercise
1091367|NCT02602106|Resistance exercise|resistance exercise
1091368|NCT02602106|Pregnancy|pregnancy
1091369|NCT02602106|Maternal weight gain|maternal weight gain
1091370|NCT02602106|birthweight|birthweight
1091371|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
1091372|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
1091373|NCT02602093|Micro Discectomy|micro discectomy
1091374|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
1091375|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
1091376|NCT02602054|preterm infants|preterm infants
1091377|NCT02602054|surgical treatment|surgical treatment
1091378|NCT02602054|pharmacological treatment|pharmacological treatment
1091379|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
1091380|NCT02602028|Colchicine|colchicine
1091381|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
1091382|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
1091383|NCT02601976|Ribavirin|ribavirin
1091384|NCT02601976|Hepatitis C Virus|hepatitis c virus
1091385|NCT02601976|Sustained Virological Response|sustained virological response
1091386|NCT02601976|End of Treatment Response|end of treatment response
1091387|NCT02601976|Unipeg|unipeg
1091388|NCT02601976|Ribazole|ribazole
1091389|NCT02601924|Anesthesia|anesthesia
1091390|NCT02601924|injection|injection
1091391|NCT02601924|pain|pain
1091392|NCT02601924|pressure massage|pressure massage
1091393|NCT02601924|topical gel|topical gel
1091394|NCT02601911|Failure|failure
1091395|NCT02601911|Injection|injection
1091396|NCT02601911|Ketorolac|ketorolac
1091397|NCT02601911|Premedication|premedication
1091398|NCT02601885|Relapsing-remitting|relapsing-remitting
1091399|NCT02601885|Secondary progressive|secondary progressive
1091400|NCT02601885|Relapsing forms|relapsing forms
1091401|NCT02601833|Caries|caries
1091402|NCT02601833|Cavity|cavity
1091403|NCT02601820|patient-reported outcomes|patient-reported outcomes
1091404|NCT02601820|observational|observational
1091405|NCT02601820|HCV|hcv
1091406|NCT02601820|Hepatitis|hepatitis
1091407|NCT02601820|Hepatitis C|hepatitis c
1091408|NCT02601820|Chronic Liver Disease|chronic liver disease
1091409|NCT02601820|Liver Disease|liver disease
1091410|NCT02601820|Liver|liver
1091411|NCT02601820|Infectious Disease|infectious disease
1091412|NCT02601820|Hep C|hep c
1091413|NCT02601820|HepC|hepc
1091414|NCT02601820|PROs|pros
1091415|NCT02601807|Back|back
1091416|NCT02601807|Pain|pain
1091417|NCT02601807|PSWT|pswt
1091418|NCT02601807|ActiPatch|actipatch
1091419|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
1091420|NCT02601794|Breast Cancer|breast cancer
1091421|NCT02601794|mHealth|mhealth
1091422|NCT02601794|Mindfulness|mindfulness
1091423|NCT02601794|Complementary Therapies|complementary therapies
1091424|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
1091425|NCT02601781|STEMI|stemi
1091426|NCT02601781|Primary PCI|primary pci
1091427|NCT02601768|ASD II|asd ii
1091428|NCT02601768|transcatheter closure|transcatheter closure
1091429|NCT02601768|percutaneous closure|percutaneous closure
1091430|NCT02601768|3D TEE|3d tee
1091431|NCT02601768|balloon-sizing|balloon-sizing
1091432|NCT02601742|zinc|zinc
1091433|NCT02601742|Duration|duration
1091434|NCT02601729|Type 1 diabetes|type 1 diabetes
1091435|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
1091436|NCT02601729|observational study|observational study
1091437|NCT02601729|insulin pump|insulin pump
1091438|NCT02601729|Belgium|belgium
1091439|NCT02601716|Plasmodium falciparum|plasmodium falciparum
1091440|NCT02601716|PfSPZ Vaccine|pfspz vaccine
1091441|NCT02601716|Sporozoites|sporozoites
1091442|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
1091443|NCT02601690|Rye Grass|rye grass
1091444|NCT02601690|Ragweed|ragweed
1091445|NCT02601690|Cat|cat
1091446|NCT02601690|House Dust Mite|house dust mite
1091447|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
1091448|NCT02601677|Deep Brain Stimulation|deep brain stimulation
1091449|NCT02601677|Nucleus accumbens|nucleus accumbens
1091450|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
1091451|NCT02601651|Lidocaine infusion|lidocaine infusion
1091452|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
1091453|NCT02601625|Tolerability|tolerability
1091454|NCT02601625|Anifrolumab|anifrolumab
1091455|NCT02601625|Subcutaneous injection|subcutaneous injection
1091456|NCT02601625|Intravenous infusion|intravenous infusion
1091457|NCT02601599|Smoking Cessation|smoking cessation
1091458|NCT02601599|Tobacco Use Cessation|tobacco use cessation
1091459|NCT02601599|Motivational Interviewing|motivational interviewing
1091460|NCT02601599|Students, Medical|students, medical
1091461|NCT02601599|Randomized Controlled Trial|randomized controlled trial
1091462|NCT02601560|Coronary Artery Disease|coronary artery disease
1091463|NCT02601560|CAD|cad
1091464|NCT02601547|Positron-Emission Tomography|positron-emission tomography
1091465|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
1091466|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
1091467|NCT02601534|sedentary behaviour|sedentary behaviour
1091468|NCT02601534|physical activity|physical activity
1091469|NCT02601508|deep NM block|deep nm block
1091470|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
1091471|NCT02601508|bridion|bridion
1091472|NCT02601482|Glycemic control|glycemic control
1091473|NCT02601482|exercise|exercise
1091474|NCT02601482|Interval Training|interval training
1091475|NCT02601456|Amputation, Traumatic|amputation, traumatic
1091476|NCT02601456|Biomechanics|biomechanics
1091477|NCT02601456|Asymmetry|asymmetry
1091478|NCT02601456|Amputee Running|amputee running
1091479|NCT02601456|Prolonged Effort|prolonged effort
1091481|NCT02601417|Bile culture|bile culture
1091482|NCT02601391|STEPPS-HI|stepps-hi
1091483|NCT02601391|personality disorder|personality disorder
1091484|NCT02601391|evaluation|evaluation
1091485|NCT02601391|forensic|forensic
1091486|NCT02601378|Uveal melanoma|uveal melanoma
1091487|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
1091489|NCT02601378|LXS196|lxs196
1091490|NCT02601378|PKC inhibitor|pkc inhibitor
1091491|NCT02601378|HDM201|hdm201
1091492|NCT02601378|HDM2 inhibitor|hdm2 inhibitor
1091493|NCT02601378|dose escalation|dose escalation
1091494|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
1091495|NCT02601300|Ulcerative Colitis|ulcerative colitis
1091496|NCT02601300|GED-0301|ged-0301
1091497|NCT02601300|Mongersen|mongersen
1091498|NCT02601300|Efficacy|efficacy
1091499|NCT02601300|Safety|safety
1091500|NCT02601261|pregnant|pregnant
1091501|NCT02601261|gestational ages|gestational ages
1091502|NCT02601261|hospitalized|hospitalized
1091503|NCT02601261|problem of pregnancy|problem of pregnancy
1091504|NCT02601248|safety, PK|safety, pk
1091505|NCT02601235|nasal congestion|nasal congestion
1091506|NCT02601222|chronic eczema|chronic eczema
1091507|NCT02601222|efficacy and safety|efficacy and safety
1091508|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
1091509|NCT02601196|Leiomyoma|leiomyoma
1091510|NCT02601196|Infertility|infertility
1091511|NCT02601196|IVF|ivf
1091512|NCT02601196|Ulipristal acetate|ulipristal acetate
1091513|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
1091514|NCT02601170|Platelet Rich Plasma|platelet rich plasma
1091515|NCT02601170|Hemophilia|hemophilia
1091516|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
1091517|NCT02601157|stent|stent
1091518|NCT02601157|polymer|polymer
1091519|NCT02601157|antiplatelet therapy|antiplatelet therapy
1091520|NCT02601157|clopidogrel|clopidogrel
1091521|NCT02601144|DBS|dbs
1091522|NCT02601144|VFS|vfs
1091523|NCT02601144|FOG|fog
1091524|NCT02601131|platelet count|platelet count
1091525|NCT02601131|platelet transfusion|platelet transfusion
1091526|NCT02601131|complement factors|complement factors
1091527|NCT02601131|endothelial markers|endothelial markers
1091528|NCT02601131|stem cell transplantation|stem cell transplantation
1091529|NCT02601105|gotu kola|gotu kola
1091530|NCT02601105|centella asiatica|centella asiatica
1091531|NCT02601092|Mini Gastric Bypass|mini gastric bypass
1091532|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1091533|NCT02601092|RCT|rct
1091534|NCT02601079|Biopsy|biopsy
1091535|NCT02601079|Diagnostics|diagnostics
1091536|NCT02601079|Genetic analysis|genetic analysis
1091537|NCT02601066|LMNA|lmna
1091538|NCT02601066|Sudden Death|sudden death
1091539|NCT02601066|Neuromuscular|neuromuscular
1091540|NCT02601040|Safety|safety
1091541|NCT02601040|Immunogenicity|immunogenicity
1091542|NCT02601040|Vaccine|vaccine
1091543|NCT02601040|Hepatitis A|hepatitis a
1091544|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
1091545|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
1091546|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
1091547|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
1091548|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
1091549|NCT02600949|Pancreatic cancer|pancreatic cancer
1091550|NCT02600949|Colorectal Cancer|colorectal cancer
1091551|NCT02600949|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1091552|NCT02600949|PDA|pda
1091553|NCT02600949|CRC|crc
1091554|NCT02600949|Personalized peptide vaccine|personalized peptide vaccine
1091555|NCT02600949|Phone call|phone call
1091556|NCT02600949|Advanced/metastatic|advanced/metastatic
1091557|NCT02600936|venous outflow obstruction|venous outflow obstruction
1091558|NCT02600936|peripheral venous disease|peripheral venous disease
1091559|NCT02600936|vein stent|vein stent
1091560|NCT02600936|Wallstent|wallstent
1091561|NCT02600936|registry|registry
1091562|NCT02600936|May Thurner|may thurner
1091563|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
1091564|NCT02600910|Manual Wheelchair|manual wheelchair
1091565|NCT02600910|Shoulder injury|shoulder injury
1091566|NCT02600910|Shoulder function|shoulder function
1091567|NCT02600910|rotator cuff|rotator cuff
1091568|NCT02600910|Tendinopathy|tendinopathy
1091569|NCT02600910|Spinal cord injury|spinal cord injury
1091570|NCT02600910|Shoulder pain|shoulder pain
1091571|NCT02600910|Shoulder impingement|shoulder impingement
1091572|NCT02600871|Abscess|abscess
1091573|NCT02600871|Antiseptic|antiseptic
1091574|NCT02600871|Provodine|provodine
1091575|NCT02600871|Povidone-Iodine|povidone-iodine
1091576|NCT02600819|end stage renal disease (ESRD)|end stage renal disease (esrd)
1091577|NCT02600819|hemodialysis (HD)|hemodialysis (hd)
1091578|NCT02600819|open-label|open-label
1091579|NCT02600819|HIV-1 Infection|hiv-1 infection
1091580|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
1091581|NCT02600806|Procalcitonin|procalcitonin
1091582|NCT02600806|Outpatients|outpatients
1091583|NCT02600806|Outcomes|outcomes
1091584|NCT02600806|Azithromycin|azithromycin
1091585|NCT02600806|Fluoroquinolones|fluoroquinolones
1091586|NCT02600780|Febuxostat|febuxostat
1091587|NCT02600780|Efficacy|efficacy
1091588|NCT02600780|Safety|safety
1091589|NCT02600780|Allopurinol|allopurinol
1091590|NCT02600780|Hyperuricemia|hyperuricemia
1091591|NCT02600780|Zurig|zurig
1091592|NCT02600780|Getz Pharma|getz pharma
1091593|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
1091594|NCT02600741|Schizophrenia|schizophrenia
1091595|NCT02600741|Caregiver|caregiver
1091596|NCT02600741|Psycho-education and skills training|psycho-education and skills training
1091597|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
1091598|NCT02600741|Oral Antipsychotic|oral antipsychotic
1091599|NCT02600728|Parkinson Disease|parkinson disease
1091600|NCT02600728|Gait|gait
1091601|NCT02600728|cues|cues
1091602|NCT02600728|memory|memory
1091603|NCT02600728|training|training
1091604|NCT02600702|Home base exercise|home base exercise
1091605|NCT02600689|Pulmonary rehab|pulmonary rehab
1091606|NCT02600689|Exergame|exergame
1091607|NCT02600689|Home-based|home-based
1091608|NCT02600637|stroke|stroke
1091609|NCT02600637|depression|depression
1091610|NCT02600637|anxiety|anxiety
1091611|NCT02600637|mindfulness|mindfulness
1091612|NCT02600637|meditation|meditation
1091613|NCT02600572|balance, postural|balance, postural
1091614|NCT02600572|postural equilibrium|postural equilibrium
1091615|NCT02600572|mental speed|mental speed
1091616|NCT02600572|isometric exercise|isometric exercise
1091617|NCT02600572|eccentric exercise|eccentric exercise
1091618|NCT02600559|Otitis media|otitis media
1091619|NCT02600559|Ear infection|ear infection
1091620|NCT02600559|Tympanostomy tubes|tympanostomy tubes
1091621|NCT02600533|minority group recruitment|minority group recruitment
1091622|NCT02600533|stages of implementation|stages of implementation
1091623|NCT02600533|clinical trials education|clinical trials education
1091624|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
1091625|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
1091626|NCT02600481|myocardial injuries|myocardial injuries
1091627|NCT02600481|troponin T(TnT)|troponin t(tnt)
1091628|NCT02600481|Trendelenburg position|trendelenburg position
1091629|NCT02600481|chest CT scan|chest ct scan
1091630|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
1091631|NCT02600481|robot-assisted surgery|robot-assisted surgery
1091632|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
1091633|NCT02600442|Chemotherapy|chemotherapy
1091634|NCT02600442|Positron-Emission Tomography|positron-emission tomography
1091635|NCT02600442|PET-CT|pet-ct
1091636|NCT02600442|FDG|fdg
1091637|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
1091638|NCT02600442|Diagnosis|diagnosis
1091639|NCT02600442|Prognosis|prognosis
1091640|NCT02600442|Pathological complete response|pathological complete response
1091641|NCT02600442|molecular biology|molecular biology
1091642|NCT02600442|proliferation genes|proliferation genes
1091643|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
1091644|NCT02600429|NK|nk
1091645|NCT02600403|Visual Evoked Potentials|visual evoked potentials
1091646|NCT02600403|Optical Coherence Tomography|optical coherence tomography
1091647|NCT02600403|Visual Fields|visual fields
1091648|NCT02600390|Leg Ulcer|leg ulcer
1091649|NCT02600390|LU|lu
1091650|NCT02600390|SANGUINATE|sanguinate
1091651|NCT02600390|QOL|qol
1091652|NCT02600390|SCD|scd
1091653|NCT02600390|Sickle Cell Disease|sickle cell disease
1091654|NCT02600390|Sickle Cell|sickle cell
1091655|NCT02600390|Anemia|anemia
1091656|NCT02600390|Leg Wound|leg wound
1091657|NCT02600390|Leg|leg
1091658|NCT02600390|Skin Lesion|skin lesion
1091659|NCT02600364|Aneurysm|aneurysm
1091660|NCT02600364|intracerebral|intracerebral
1091661|NCT02600364|stroke|stroke
1091662|NCT02600364|p64|p64
1091663|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1091664|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
1091665|NCT02600351|Ribavirin|ribavirin
1091666|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
1091667|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1091668|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1091669|NCT02600338|Clinical practice guidelines|clinical practice guidelines
1091670|NCT02600338|Clinical trials|clinical trials
1091671|NCT02600338|Legumes|legumes
1091672|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
1091673|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
1091674|NCT02600338|Blood pressure|blood pressure
1091675|NCT02600325|Acute Hepatitis C|acute hepatitis c
1138330|NCT02330094|SAH|sah
1091676|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
1091677|NCT02600325|Grazoprevir|grazoprevir
1091678|NCT02600325|Elbasvir|elbasvir
1091679|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
1091680|NCT02600286|Neurology|neurology
1091681|NCT02600260|thrombophilia|thrombophilia
1091682|NCT02600260|thrombosis|thrombosis
1091683|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
1091684|NCT02600260|venous thrombosis|venous thrombosis
1091686|NCT02600260|risk assessment|risk assessment
1091687|NCT02600260|deep vein thrombosis|deep vein thrombosis
1091688|NCT02600260|pulmonary embolism|pulmonary embolism
1091689|NCT02600260|hospitalization|hospitalization
1091690|NCT02600247|Total knee arthroplasty|total knee arthroplasty
1091691|NCT02600247|Duloxetine|duloxetine
1091692|NCT02600221|ACOS|acos
1091693|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
1091694|NCT02600195|Nosocomial Infections|nosocomial infections
1091695|NCT02600195|Quality Improvement|quality improvement
1091696|NCT02600182|Thoracic surgery|thoracic surgery
1091697|NCT02600182|Non-invasive ventilation|non-invasive ventilation
1091698|NCT02600182|Physiotherapy|physiotherapy
1091699|NCT02600143|Melanoma|melanoma
1091700|NCT02600143|Colitis|colitis
1091701|NCT02600143|Ipilimumab|ipilimumab
1091702|NCT02600143|Nivolumab|nivolumab
1091703|NCT02600143|Pembrolizumab|pembrolizumab
1091704|NCT02600091|Anxiety|anxiety
1091705|NCT02600091|Depression|depression
1091706|NCT02600091|Type 1 Diabetes|type 1 diabetes
1091707|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
1091708|NCT02600091|Glycaemic control|glycaemic control
1091709|NCT02600078|hypoxia|hypoxia
1091710|NCT02600078|ataxia|ataxia
1091711|NCT02600013|incomplete motor SCI|incomplete motor sci
1091712|NCT02600013|robotic gait training|robotic gait training
1091713|NCT02600013|exoskeleton|exoskeleton
1091714|NCT02600013|rehabilitation tool|rehabilitation tool
1091715|NCT02600013|EKSO-GT|ekso-gt
1091716|NCT02599961|Glut 1 DS|glut 1 ds
1091717|NCT02599935|Nutritional status|nutritional status
1091718|NCT02599935|MNA|mna
1091719|NCT02599935|GSA|gsa
1091720|NCT02599909|Tumor Microenvironment|tumor microenvironment
1091721|NCT02599909|100 Trillion Microbial Cells|100 trillion microbial cells
1091722|NCT02599909|Liver Tumors|liver tumors
1091723|NCT02599909|Intestinal Microbiota|intestinal microbiota
1091724|NCT02599909|Immune Regulation|immune regulation
1091725|NCT02599896|Dose Escalation|dose escalation
1091726|NCT02599896|HIV Prevention|hiv prevention
1091727|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
1091728|NCT02599896|Open-Label|open-label
1091730|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1091731|NCT02599883|Diagnostic Imaging|diagnostic imaging
1091732|NCT02599883|Disease Management|disease management
1091733|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
1091734|NCT02599883|Cost-Utility Analysis|cost-utility analysis
1091735|NCT02599870|PGx|pgx
1091736|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
1091737|NCT02599870|IDgenetix|idgenetix
1091738|NCT02599870|Pain Management|pain management
1091739|NCT02599870|AltheaDx|altheadx
1091740|NCT02599870|Post-Operative Pain Management|post-operative pain management
1091741|NCT02599844|acute kidney injury|acute kidney injury
1091742|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
1091743|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
1091744|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
1091745|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
1091746|NCT02599831|Comparative study|comparative study
1091747|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
1091748|NCT02599779|Renal cell cancer|renal cell cancer
1091749|NCT02599779|SBRT|sbrt
1091750|NCT02599779|Pembrolizumab|pembrolizumab
1091751|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
1091752|NCT02599740|Blood glucose|blood glucose
1091753|NCT02599727|balance, postural|balance, postural
1091754|NCT02599727|postural equilibrium|postural equilibrium
1091755|NCT02599727|heart rate|heart rate
1091756|NCT02599727|blood pressure|blood pressure
1091757|NCT02599727|pulse oxygenation|pulse oxygenation
1091758|NCT02599727|mental speed|mental speed
1091759|NCT02599714|AZD2014|azd2014
1091760|NCT02599714|Palbociclib|palbociclib
1091761|NCT02599714|Fulvestrant|fulvestrant
1091762|NCT02599714|Hormonal Therapy|hormonal therapy
1091763|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
1091764|NCT02599714|Breast Cancer|breast cancer
1091765|NCT02599701|Delta Sleep|delta sleep
1091766|NCT02599701|Growth Hormone|growth hormone
1091767|NCT02599701|IGF-1|igf-1
1091768|NCT02599675|Muscle|muscle
1091769|NCT02599675|Vitamin D|vitamin d
1091770|NCT02599675|Strength|strength
1091771|NCT02599675|Endurance|endurance
1091772|NCT02599675|Muscle fiber|muscle fiber
1091773|NCT02599662|Cancer|cancer
1091774|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
1091775|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
1091776|NCT02599649|MDS|mds
1091777|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
1091778|NCT02599649|High Risk MDS|high risk mds
1091779|NCT02599649|Lirilumab|lirilumab
1091780|NCT02599649|Nivolumab|nivolumab
1091781|NCT02599649|BMS-936558|bms-936558
1091782|NCT02599649|Opdivo|opdivo
1091783|NCT02599649|Azacitidine|azacitidine
1091784|NCT02599649|5-azacytidine|5-azacytidine
1091785|NCT02599649|5-aza|5-aza
1091786|NCT02599649|Vidaza|vidaza
1091787|NCT02599649|5-AZC|5-azc
1091788|NCT02599649|AZA-CR|aza-cr
1091789|NCT02599649|Ladakamycin|ladakamycin
1091790|NCT02599649|NSC-102816|nsc-102816
1091791|NCT02599649|Azacytidine|azacytidine
1091792|NCT02599623|Incarcerated|incarcerated
1091793|NCT02599623|Anesthesia|anesthesia
1091794|NCT02599623|Hernia|hernia
1091795|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
1091796|NCT02599584|behaviour|behaviour
1091797|NCT02599558|EOE|eoe
1091798|NCT02599532|Apixaban|apixaban
1091799|NCT02599532|Pharmacokinetics|pharmacokinetics
1091800|NCT02599532|Pharmacodynamics|pharmacodynamics
1091801|NCT02599506|breast cancer|breast cancer
1091802|NCT02599506|fear of recurrence|fear of recurrence
1091803|NCT02599506|longitudinal study|longitudinal study
1091804|NCT02599506|radiation therapy|radiation therapy
1091805|NCT02599506|emotional concerns|emotional concerns
1091806|NCT02599506|trajectory|trajectory
1091807|NCT02599506|psychological constructs|psychological constructs
1091808|NCT02599506|diary keeping|diary keeping
1091809|NCT02599480|HFpEF|hfpef
1091810|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
1091811|NCT02599480|cardiac remodeling,|cardiac remodeling,
1091812|NCT02599467|Nerve Pain|nerve pain
1091813|NCT02599467|Electromyography|electromyography
1091814|NCT02599467|Median Nerve|median nerve
1091815|NCT02599467|Breast Neoplasms|breast neoplasms
1091816|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
1091817|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
1091818|NCT02599350|Ventilation|ventilation
1091819|NCT02599350|Gas exchange|gas exchange
1091820|NCT02599350|V/Q ratio|v/q ratio
1091821|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
1091822|NCT02599337|bioequivalence|bioequivalence
1091823|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
1091824|NCT02599298|sleep|sleep
1091825|NCT02599298|treatment|treatment
1091826|NCT02599259|Stroke|stroke
1091827|NCT02599259|Oral anticoagulants|oral anticoagulants
1091829|NCT02599259|wireless monitoring|wireless monitoring
1091830|NCT02599259|Warfarin|warfarin
1091831|NCT02599259|Xarelto|xarelto
1091832|NCT02599259|compliance|compliance
1091833|NCT02599259|adherence|adherence
1091834|NCT02599259|monitoring|monitoring
1091835|NCT02599259|directly observed therapy|directly observed therapy
1091836|NCT02599259|DOT|dot
1091837|NCT02599259|mobile device|mobile device
1091838|NCT02599259|electronic monitoring|electronic monitoring
1091839|NCT02599259|artificial intelligence|artificial intelligence
1091840|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
1091841|NCT02599259|adherence monitoring methods|adherence monitoring methods
1091842|NCT02599259|nonadherence|nonadherence
1091843|NCT02599259|non-adherence|non-adherence
1091844|NCT02599246|Home ventilator|home ventilator
1091845|NCT02599246|FiO2|fio2
1091846|NCT02599246|O2|o2
1091847|NCT02599246|NIV|niv
1091848|NCT02599246|COPD|copd
1091849|NCT02599233|pain trajectory|pain trajectory
1091850|NCT02599181|Perineural cathether|perineural cathether
1091851|NCT02599181|Catheter infection|catheter infection
1091852|NCT02599168|dexmedetomidine|dexmedetomidine
1091853|NCT02599168|propofol|propofol
1091854|NCT02599168|BIS|bis
1091855|NCT02599168|CLADS|clads
1091856|NCT02599155|crystalloid|crystalloid
1091857|NCT02599155|colloid|colloid
1091858|NCT02599155|children|children
1091859|NCT02599155|infant|infant
1091860|NCT02599155|cardiac surgery|cardiac surgery
1091861|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
1091862|NCT02599142|open-face shells|open-face shells
1091863|NCT02599129|Alopecia areata|alopecia areata
1091864|NCT02599116|cytoreductive surgery|cytoreductive surgery
1091865|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1091866|NCT02599116|microbiome|microbiome
1091867|NCT02599090|Glioblastoma|glioblastoma
1091868|NCT02599090|Gliosarcoma|gliosarcoma
1091869|NCT02599090|Brain Cancer|brain cancer
1091870|NCT02599090|Sorafenib|sorafenib
1091871|NCT02599090|Temozolomide|temozolomide
1091872|NCT02599090|Radiation|radiation
1091873|NCT02599090|Radiotherapy|radiotherapy
1091874|NCT02599090|XRT|xrt
1091875|NCT02599077|oral contraceptives|oral contraceptives
1091876|NCT02599077|endometrioma|endometrioma
1091877|NCT02599077|dienogest|dienogest
1091878|NCT02599064|Age-related macular degeneration|age-related macular degeneration
1091879|NCT02599064|RXI-109|rxi-109
1091880|NCT02599064|NVAMD|nvamd
1091881|NCT02599064|Retinal scarring|retinal scarring
1091882|NCT02599064|Subretinal scarring|subretinal scarring
1091883|NCT02599064|Retinal fibrosis|retinal fibrosis
1091884|NCT02599064|Subretinal fibrosis|subretinal fibrosis
1091885|NCT02599064|Eye diseases|eye diseases
1091886|NCT02599038|NAFLD|nafld
1091887|NCT02599038|NASH|nash
1091888|NCT02599038|Serine|serine
1091889|NCT02599038|Glutathione|glutathione
1092876|NCT02593058|Apathy|apathy
1091894|NCT02598973|Parkinson Disease|parkinson disease
1091895|NCT02598973|exercise|exercise
1091896|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
1091897|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
1091898|NCT02598947|Glenohumeral joint|glenohumeral joint
1091899|NCT02598947|exercise|exercise
1091900|NCT02598921|Assisted reproductive technology|assisted reproductive technology
1091902|NCT02598882|Videogame|videogame
1091903|NCT02598882|energy expenditure|energy expenditure
1091904|NCT02598882|electromyography|electromyography
1091905|NCT02598882|rehabilitation|rehabilitation
1091906|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
1091907|NCT02598856|Emergency Treatment|emergency treatment
1091908|NCT02598856|Morphine Derivates|morphine derivates
1091909|NCT02598856|Heroin|heroin
1091910|NCT02598856|Antidotes|antidotes
1091911|NCT02598856|Administration, Intravenous|administration, intravenous
1091912|NCT02598856|Pharmacology|pharmacology
1091913|NCT02598856|Naloxone|naloxone
1091914|NCT02598856|Healthy volunteers|healthy volunteers
1091915|NCT02598856|Administration, intramuscular|administration, intramuscular
1091916|NCT02598856|Administration, intranasal|administration, intranasal
1091917|NCT02598830|Cachexia|cachexia
1091918|NCT02598830|Vitamin D|vitamin d
1091919|NCT02598830|Muscle|muscle
1091920|NCT02598830|Strength training|strength training
1091921|NCT02598804|Physical activity level|physical activity level
1091922|NCT02598804|Knee osteoarthritis|knee osteoarthritis
1091923|NCT02598804|Randomized controlled trials|randomized controlled trials
1091924|NCT02598804|Alternate month design study|alternate month design study
1091925|NCT02598804|Self-management|self-management
1091926|NCT02598804|Self-care|self-care
1091927|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
1091928|NCT02598804|Education|education
1091929|NCT02598804|Non pharmacological treatment|non pharmacological treatment
1091930|NCT02598791|incretin hormones|incretin hormones
1091931|NCT02598791|GIP|gip
1091932|NCT02598791|GLP-1|glp-1
1091933|NCT02598765|Glaucoma|glaucoma
1091934|NCT02598765|Trabeculectomy|trabeculectomy
1091935|NCT02598765|Eye Disease|eye disease
1091936|NCT02598765|Intraocular Pressure|intraocular pressure
1091937|NCT02598765|Visual Acuity|visual acuity
1091938|NCT02598752|functional performance testing|functional performance testing
1091939|NCT02598752|exercise fitness testing|exercise fitness testing
1091940|NCT02598752|15-274|15-274
1091941|NCT02598739|Physical exercise|physical exercise
1091942|NCT02598739|Psoriatic arthritis|psoriatic arthritis
1091943|NCT02598739|Quality of life|quality of life
1091944|NCT02598700|total hip arthroplasty|total hip arthroplasty
1091945|NCT02598700|imaging|imaging
1091946|NCT02598700|arthritis|arthritis
1091947|NCT02598700|surgical technique|surgical technique
1091948|NCT02598674|acute kidney injury|acute kidney injury
1091951|NCT02598648|FXR|fxr
1091952|NCT02598648|RIPK3|ripk3
1091953|NCT02598648|Neonates|neonates
1091954|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1091955|NCT02598648|Acute Lung Injury|acute lung injury
1091956|NCT02598635|Cholecalciferol|cholecalciferol
1091957|NCT02598635|peritoneal dialysis|peritoneal dialysis
1091958|NCT02598635|FGF23|fgf23
1091959|NCT02598635|Calcium|calcium
1091960|NCT02598635|Phosphorus|phosphorus
1091961|NCT02598609|Adverse event|adverse event
1091962|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
1091963|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
1091964|NCT02598609|Extravasation injury|extravasation injury
1091965|NCT02598609|Medication error|medication error
1091966|NCT02598609|Central venous catheter complication|central venous catheter complication
1091967|NCT02598609|Unprogrammed extubation|unprogrammed extubation
1091968|NCT02598596|Refractory gout|refractory gout
1091969|NCT02598596|Chronic gout|chronic gout
1091970|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1091971|NCT02598583|PNH|pnh
1091972|NCT02598583|complement inhibitor|complement inhibitor
1091973|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
1091974|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
1091975|NCT02598570|Duvelisib|duvelisib
1091976|NCT02598570|Japanese|japanese
1091977|NCT02598570|Refractory Lymphoma|refractory lymphoma
1091981|NCT02598492|Mechanical Ventilator|mechanical ventilator
1091982|NCT02598479|Cancer|cancer
1091983|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
1091984|NCT02598479|IPT|ipt
1091985|NCT02598479|IPTLD|iptld
1091986|NCT02598479|Nutrition therapy|nutrition therapy
1091987|NCT02598427|Breast Cancer|breast cancer
1091988|NCT02598427|HER2 Positive|her2 positive
1091989|NCT02598427|HER2+|her2+
1091990|NCT02598427|Brain Metastases|brain metastases
1091991|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
1091992|NCT02598427|Intrathecal Treatment|intrathecal treatment
1091993|NCT02598427|Lumbar Puncture|lumbar puncture
1091994|NCT02598427|Pertuzumab|pertuzumab
1091995|NCT02598427|Trastuzumab|trastuzumab
1091996|NCT02598427|Advanced Breast Cancer|advanced breast cancer
1091997|NCT02598427|Duke University|duke university
1091998|NCT02598414|Colorectal Disease|colorectal disease
1091999|NCT02598414|Robotic Surgery|robotic surgery
1092000|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
1092001|NCT02598414|Anastomotic Leak|anastomotic leak
1092002|NCT02598414|Short-term Outcomes|short-term outcomes
1092003|NCT02598388|Healthy|healthy
1092004|NCT02598388|Vaccine|vaccine
1092005|NCT02598388|Ebola viruses|ebola viruses
1092006|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
1092007|NCT02598388|Filoviruses|filoviruses
1092008|NCT02598388|Hemorrhagic fever|hemorrhagic fever
1092009|NCT02598388|Monovalent vaccine|monovalent vaccine
1092010|NCT02598388|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1092011|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
1092012|NCT02598388|Safety|safety
1092013|NCT02598388|Immunogenicity|immunogenicity
1092014|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
1092015|NCT02598362|ciprofloxacin|ciprofloxacin
1092016|NCT02598362|pharmacokinetics|pharmacokinetics
1092017|NCT02598362|excretion|excretion
1092018|NCT02598362|clearance|clearance
1092019|NCT02598362|infant|infant
1092020|NCT02598362|children|children
1092021|NCT02598362|adolescent|adolescent
1092022|NCT02598349|Unresectable|unresectable
1092023|NCT02598349|Borderline resectable|borderline resectable
1092024|NCT02598336|Structured Light Plethysmography|structured light plethysmography
1092025|NCT02598336|Spirometry|spirometry
1092026|NCT02598336|Pneumotachograph|pneumotachograph
1092027|NCT02598297|Ruxolitinib|ruxolitinib
1092028|NCT02598297|INC424|inc424
1092029|NCT02598297|early myelofibrosis|early myelofibrosis
1092030|NCT02598297|High molecular risk mutations|high molecular risk mutations
1092031|NCT02598297|HMR|hmr
1092032|NCT02598284|Preventive measures|preventive measures
1092033|NCT02598284|Quality Improvement|quality improvement
1092034|NCT02598271|Acute Kidney Injury|acute kidney injury
1092035|NCT02598271|Cardiac Surgery|cardiac surgery
1092036|NCT02598258|Sauna|sauna
1092037|NCT02598258|Cold water bath|cold water bath
1092038|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
1092039|NCT02598219|Sentinel node|sentinel node
1092040|NCT02598206|food effect|food effect
1092041|NCT02598206|healthy volunteers|healthy volunteers
1092042|NCT02598206|pharmacokinetics|pharmacokinetics
1092043|NCT02598206|CCR2i|ccr2i
1092044|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
1092045|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
1092046|NCT02598089|Seasonal Influenza|seasonal influenza
1092047|NCT02598089|Trivalent Vaccine|trivalent vaccine
1092048|NCT02598089|Inactivated Vaccine|inactivated vaccine
1092049|NCT02598050|postoperative health outcomes|postoperative health outcomes
1092050|NCT02598050|older surgical patients|older surgical patients
1092051|NCT02598037|Obesity|obesity
1092052|NCT02598037|Polymorphism|polymorphism
1092053|NCT02598037|Hormones|hormones
1092054|NCT02597985|Frailty|frailty
1092055|NCT02597959|ergonomic risk factors|ergonomic risk factors
1092056|NCT02597959|allied health professionals|allied health professionals
1092057|NCT02597959|surgical care|surgical care
1092058|NCT02597881|natural history|natural history
1092059|NCT02597868|therapy|therapy
1092060|NCT02597868|Capecitabine|capecitabine
1092061|NCT02597868|breast cancer|breast cancer
1092062|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
1092063|NCT02597842|TEAS|teas
1092064|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
1092065|NCT02597829|Mucosal Healing|mucosal healing
1092066|NCT02597829|Certolizumab pegol|certolizumab pegol
1092067|NCT02597803|Dry Eye Syndrome|dry eye syndrome
1092068|NCT02597803|Dry Eye|dry eye
1092069|NCT02597803|DES|des
1092070|NCT02597790|endothelial function|endothelial function
1092071|NCT02597790|cardiovascular risk|cardiovascular risk
1092072|NCT02597790|HIV|hiv
1092073|NCT02597790|Hepatitis C|hepatitis c
1092074|NCT02597790|metabolic disease|metabolic disease
1092075|NCT02597790|inflammation|inflammation
1092076|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
1092077|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
1092078|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
1092079|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
1092080|NCT02597764|Deep breathing|deep breathing
1093274|NCT02590796|Inattention|inattention
1092081|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
1092082|NCT02597751|DCD|dcd
1092083|NCT02597751|Neuroimaging|neuroimaging
1092084|NCT02597751|Rehabilitation|rehabilitation
1092085|NCT02597725|Urodynamics|urodynamics
1092086|NCT02597725|Late effects|late effects
1092087|NCT02597725|Urinary Incontinence|urinary incontinence
1092088|NCT02597712|acid reflux|acid reflux
1092089|NCT02597712|intragastric pH|intragastric ph
1092090|NCT02597712|gastrin|gastrin
1092091|NCT02597712|hypergastrinemia|hypergastrinemia
1092092|NCT02597699|Termination of pregnancy|termination of pregnancy
1092093|NCT02597699|Feticide|feticide
1092094|NCT02597699|Fetal pain|fetal pain
1092095|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
1092096|NCT02597699|Fetal asystole|fetal asystole
1092097|NCT02597699|Fetopathologic analysis|fetopathologic analysis
1092098|NCT02597660|patellar tendinopathy|patellar tendinopathy
1092099|NCT02597660|somatropin|somatropin
1092100|NCT02597660|jumper's knee|jumper's knee
1092101|NCT02597647|immunology|immunology
1092102|NCT02597647|Microbiota|microbiota
1092103|NCT02597582|LigaSure|ligasure
1092104|NCT02597582|Neck dissection|neck dissection
1092105|NCT02597582|Operative duration|operative duration
1092106|NCT02597582|Postoperative drainage|postoperative drainage
1092107|NCT02597582|Postoperative pain|postoperative pain
1092108|NCT02597569|stroke|stroke
1092109|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
1092110|NCT02597569|health services accessibility|health services accessibility
1092111|NCT02597569|cognitive impairment|cognitive impairment
1092112|NCT02597569|rehabilitation|rehabilitation
1092113|NCT02597569|integrated knowledge translation|integrated knowledge translation
1092114|NCT02597569|interrupted time series|interrupted time series
1092115|NCT02597569|The CO-OP Approach|the co-op approach
1092116|NCT02597556|Albendazole|albendazole
1092117|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
1092118|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
1092119|NCT02597556|Coinfection|coinfection
1092120|NCT02597556|Diarrhea|diarrhea
1092121|NCT02597556|Helminths|helminths
1092122|NCT02597556|Necator americanus|necator americanus
1092123|NCT02597556|Microbiota|microbiota
1092124|NCT02597556|Trichuris trichiura|trichuris trichiura
1092125|NCT02597543|heart transplantation|heart transplantation
1092126|NCT02597543|cardiac MRI|cardiac mri
1092127|NCT02597543|graft rejection|graft rejection
1092128|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
1092129|NCT02597543|allograft vasculopathy|allograft vasculopathy
1092130|NCT02597530|TEAS|teas
1092131|NCT02597530|anesthesia|anesthesia
1092132|NCT02597517|gastritis|gastritis
1092133|NCT02597517|chromoendoscopy|chromoendoscopy
1092134|NCT02597517|magnification|magnification
1092135|NCT02597517|Helicobacter pylori|helicobacter pylori
1092136|NCT02597517|Atrophic gastritis|atrophic gastritis
1092137|NCT02597491|Smoking,|smoking,
1092138|NCT02597491|Smoking cessation|smoking cessation
1092139|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
1092140|NCT02597491|Lung cancer screening|lung cancer screening
1092141|NCT02597478|Advanced Cancers|advanced cancers
1092142|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
1092143|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
1092144|NCT02597478|FSS|fss
1092145|NCT02597478|Questionnaires|questionnaires
1092146|NCT02597478|Surveys|surveys
1092147|NCT02597478|Mental Abilities Test|mental abilities test
1092148|NCT02597478|Phone Call|phone call
1092149|NCT02597478|Shuttle Walk Test|shuttle walk test
1092150|NCT02597452|breast lump|breast lump
1092151|NCT02597452|breast exam|breast exam
1092152|NCT02597452|breast cancer screening|breast cancer screening
1092153|NCT02597452|breast lump detection|breast lump detection
1092154|NCT02597439|Ultra-high risk|ultra-high risk
1092155|NCT02597439|UHR|uhr
1092156|NCT02597439|psychosis|psychosis
1092157|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1092158|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
1092159|NCT02597426|Post treatment|post treatment
1092160|NCT02597374|Electroencephalography|electroencephalography
1092161|NCT02597374|mu rhythm|mu rhythm
1092162|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
1092163|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
1092164|NCT02597374|Child|child
1092165|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
1092166|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
1092167|NCT02597348|Liver|liver
1092168|NCT02597348|Metastasis|metastasis
1092169|NCT02597348|Colorectal cancer|colorectal cancer
1092170|NCT02597348|Liver transplantation|liver transplantation
1092171|NCT02597335|Glioma|glioma
1092172|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
1092173|NCT02597335|Spectroscopy MRI|spectroscopy mri
1092174|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
1092175|NCT02597335|Free circulating DNA|free circulating dna
1092176|NCT02597322|Axitinib|axitinib
1092177|NCT02597322|T2a Renal tumor|t2a renal tumor
1092178|NCT02597322|organ confined tumors|organ confined tumors
1092179|NCT02597322|nephron sparing surgery|nephron sparing surgery
1092180|NCT02597322|nephron sparing procedure|nephron sparing procedure
1092181|NCT02597322|radical nephrectomy|radical nephrectomy
1092182|NCT02597283|Bifurcation lesions|bifurcation lesions
1092183|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
1092184|NCT02597283|Randomized controlled trial|randomized controlled trial
1092185|NCT02597270|Hepatitis C virus|hepatitis c virus
1092186|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
1092187|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
1092188|NCT02597231|Delirium|delirium
1092189|NCT02597231|Melatonin|melatonin
1092190|NCT02597218|Hepatectomy|hepatectomy
1092191|NCT02597218|Prophylaxis|prophylaxis
1092192|NCT02597205|Medical adherence|medical adherence
1092193|NCT02597205|Lifestyle modification|lifestyle modification
1092194|NCT02597205|Mobile Health|mobile health
1092195|NCT02597205|Secondary Prevention|secondary prevention
1092196|NCT02597192|gingivitis|gingivitis
1092197|NCT02597192|gingival inflammation|gingival inflammation
1092198|NCT02597192|probiotics|probiotics
1092199|NCT02597192|Bacillus|bacillus
1092200|NCT02597075|Colorectal Cancer|colorectal cancer
1092201|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
1092202|NCT02597075|Physical Activity|physical activity
1092203|NCT02597075|Quality of life|quality of life
1092204|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
1092205|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
1092206|NCT02596984|Intensive Care Unit|intensive care unit
1092207|NCT02596984|Shock|shock
1092208|NCT02596984|Antifungal agent|antifungal agent
1092209|NCT02596984|Pharmacokinetics|pharmacokinetics
1092210|NCT02596984|Sepsis|sepsis
1092211|NCT02596932|Intrapartum|intrapartum
1092212|NCT02596893|Crohn's Disease|crohn's disease
1092213|NCT02596893|GED-0301|ged-0301
1092214|NCT02596893|Mongersen|mongersen
1092215|NCT02596893|IBD|ibd
1092216|NCT02596893|Safety|safety
1092217|NCT02596893|Efficacy|efficacy
1092218|NCT02596880|Hepatitis C|hepatitis c
1092219|NCT02596880|Cirrhosis|cirrhosis
1092220|NCT02596880|Sofosbuvir|sofosbuvir
1092221|NCT02596880|Daclatasvir|daclatasvir
1092222|NCT02596880|Ribavirin|ribavirin
1092223|NCT02596867|B adrenergic pathway|b adrenergic pathway
1092224|NCT02596867|B Blocker|b blocker
1092225|NCT02596841|Lung diffusing capacity|lung diffusing capacity
1092226|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
1092227|NCT02596828|molecular targeted therapy|molecular targeted therapy
1092228|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
1092229|NCT02596828|mTOR Inhibitor|mtor inhibitor
1092230|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
1092231|NCT02596828|temozolomide|temozolomide
1092232|NCT02596828|irinotecan|irinotecan
1092233|NCT02596828|dasatinib|dasatinib
1092234|NCT02596828|rapamycin|rapamycin
1092235|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
1092236|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
1092237|NCT02596763|Off-label prescription|off-label prescription
1092238|NCT02596763|Alcoholism|alcoholism
1092239|NCT02596763|Pharmacovigilance|pharmacovigilance
1092240|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
1092241|NCT02596763|Baclofen|baclofen
1092242|NCT02596737|health|health
1092243|NCT02596737|work|work
1092244|NCT02596737|lifestyle|lifestyle
1092245|NCT02596737|behavior|behavior
1092246|NCT02596737|management|management
1092247|NCT02596737|stress|stress
1092248|NCT02596737|physical activity|physical activity
1092249|NCT02596737|nutrition|nutrition
1092250|NCT02596737|mortality|mortality
1092251|NCT02596737|morbidity|morbidity
1092252|NCT02596737|public health|public health
1092253|NCT02596724|Breast Cancer|breast cancer
1092254|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
1092255|NCT02596711|Cancer Prevention|cancer prevention
1092256|NCT02596711|Tobacco Use Cessation|tobacco use cessation
1092257|NCT02596711|Nicotine Patch|nicotine patch
1092258|NCT02596711|NRT|nrt
1092259|NCT02596711|Questionnaires|questionnaires
1092260|NCT02596711|Surveys|surveys
1092261|NCT02596711|Carbon Monoxide Test|carbon monoxide test
1092262|NCT02596711|CO|co
1092263|NCT02596711|Health Education|health education
1092264|NCT02596711|Handouts|handouts
1092265|NCT02596711|Pamphlets|pamphlets
1092266|NCT02596711|Counseling sessions|counseling sessions
1092267|NCT02596698|Mood Disorder|mood disorder
1092268|NCT02596672|physical activity|physical activity
1092269|NCT02596672|older adults|older adults
1092270|NCT02596672|retirement homes|retirement homes
1092271|NCT02596672|walking|walking
1092272|NCT02596672|feasibility study|feasibility study
1092273|NCT02596659|lateral epicondylosis|lateral epicondylosis
1092274|NCT02596659|lateral epicondylitis|lateral epicondylitis
1092275|NCT02596659|shockwave|shockwave
1092276|NCT02596659|sonoelastography|sonoelastography
1092277|NCT02596659|tennis elbow|tennis elbow
1092278|NCT02596659|pain intensity|pain intensity
1092279|NCT02596659|grip strength|grip strength
1092280|NCT02596659|upper limb function|upper limb function
1092281|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
1092282|NCT02596620|Helicobacter pylori|helicobacter pylori
1092283|NCT02596620|Proton pump inhibitor|proton pump inhibitor
1092284|NCT02596620|Eradication|eradication
1092285|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
1092286|NCT02596594|IUGR|iugr
1092287|NCT02596594|severe IUGR|severe iugr
1092288|NCT02596594|brain sparing|brain sparing
1092289|NCT02596594|fetal nutrition|fetal nutrition
1092290|NCT02596594|Prolongation|prolongation
1092291|NCT02596594|pregnancy|pregnancy
1092292|NCT02596594|neonatal outcome|neonatal outcome
1092293|NCT02596581|periodontitis|periodontitis
1092294|NCT02596581|diabetes mellitus|diabetes mellitus
1092295|NCT02596581|chemerin|chemerin
1092296|NCT02596581|interleukin-6|interleukin-6
1092297|NCT02596503|young adults|young adults
1092298|NCT02596503|adolescents|adolescents
1092299|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
1092300|NCT02596490|NSCLC|nsclc
1092301|NCT02596490|Couples-based meditation program|couples-based meditation program
1092302|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
1092303|NCT02596490|Questionnaires|questionnaires
1092304|NCT02596490|Surveys|surveys
1092305|NCT02596490|Metastatic lung cancer|metastatic lung cancer
1092306|NCT02596490|Quality of life|quality of life
1092307|NCT02596490|QOL|qol
1092308|NCT02596477|Heart failure|heart failure
1092309|NCT02596412|children|children
1092310|NCT02596412|botulinum toxin|botulinum toxin
1092311|NCT02596412|augmented reality|augmented reality
1092312|NCT02596412|Pain|pain
1092313|NCT02596399|Healthy volunteers|healthy volunteers
1092314|NCT02596399|DSTA4637S|dsta4637s
1092315|NCT02596360|Antinociception|antinociception
1092316|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
1092317|NCT02596360|Dextromethorphan|dextromethorphan
1092318|NCT02596360|NMDA-receptors|nmda-receptors
1092319|NCT02596360|Pharmacogenetic|pharmacogenetic
1092320|NCT02596360|CYP3A4 gene|cyp3a4 gene
1092321|NCT02596360|MDR1 gene|mdr1 gene
1092322|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
1092323|NCT02596334|monotherapy|monotherapy
1092324|NCT02596334|dolutegravir|dolutegravir
1092325|NCT02596321|House Dust Mite|house dust mite
1092326|NCT02596308|Plague vaccine|plague vaccine
1092327|NCT02596308|Immunogenicity|immunogenicity
1092328|NCT02596308|Safety|safety
1092329|NCT02596282|neonatal male circumcision|neonatal male circumcision
1092330|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
1092331|NCT02596282|Rakai, Uganda|rakai, uganda
1092332|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
1092333|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
1092334|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1092335|NCT02596243|High-Risk HPV|high-risk hpv
1092336|NCT02596243|HPV infection|hpv infection
1092337|NCT02596243|precancer Diseases|precancer diseases
1092338|NCT02596243|Double Blind|double blind
1092339|NCT02596243|Safety/Efficacy|safety/efficacy
1092340|NCT02596217|ABBV-066|abbv-066
1092341|NCT02596217|BI 655066|bi 655066
1092342|NCT02596217|risankizumab|risankizumab
1092343|NCT02596165|validation|validation
1092344|NCT02596165|pulse wave analysis|pulse wave analysis
1092345|NCT02596165|blood pressure monitoring|blood pressure monitoring
1092346|NCT02596152|balance|balance
1092347|NCT02596152|strength|strength
1092348|NCT02596152|barriers towards exercise|barriers towards exercise
1092349|NCT02596152|quality of life|quality of life
1092350|NCT02596152|body dissatisfaction|body dissatisfaction
1092351|NCT02596152|executive functions|executive functions
1092352|NCT02596152|eating behavior|eating behavior
1092353|NCT02596152|fitness|fitness
1092354|NCT02596126|Polypill|polypill
1092355|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
1092356|NCT02596126|Cardiovascular Disease|cardiovascular disease
1092357|NCT02596126|Myocardial Infarction|myocardial infarction
1092358|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
1092359|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
1092360|NCT02596126|Adherence|adherence
1092361|NCT02596126|SECURE|secure
1092362|NCT02596126|Elderly|elderly
1092363|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
1092364|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
1092365|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
1092366|NCT02596126|Randomized Trial|randomized trial
1092367|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
1092368|NCT02596113|colorectal cancer|colorectal cancer
1092369|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
1092370|NCT02596113|screening colorectal cancer|screening colorectal cancer
1092371|NCT02596100|Bioequivalence|bioequivalence
1092372|NCT02596009|COPD|copd
1092373|NCT02596009|Cachexia due to chronic obstructive pulmonary disease|cachexia due to chronic obstructive pulmonary disease
1092374|NCT02596009|wasting syndrome|wasting syndrome
1092375|NCT02596009|Loss of weight|loss of weight
1092376|NCT02596009|muscle atrophy|muscle atrophy
1092377|NCT02596009|loss of body mass|loss of body mass
1092378|NCT02596009|signficant loss of appetite|signficant loss of appetite
1092379|NCT02596009|cachectic syndrome|cachectic syndrome
1092381|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
1092382|NCT02595983|ATTR Amyloidosis|attr amyloidosis
1092383|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
1092384|NCT02595983|RNAi therapeutic|rnai therapeutic
1092385|NCT02595970|Psoriasis|psoriasis
1092386|NCT02595970|Secukinumab|secukinumab
1092387|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
1092388|NCT02595970|CAIN457A|cain457a
1092389|NCT02595970|AIN457AFR01|ain457afr01
1092390|NCT02595970|AIN457A|ain457a
1092391|NCT02595957|Exome Sequencing|exome sequencing
1092392|NCT02595957|Incidental or Secondary Findings|incidental or secondary findings
1092393|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
1092394|NCT02595827|Pediatrics|pediatrics
1092395|NCT02595827|Epidemiology|epidemiology
1092396|NCT02595827|Fever|fever
1092397|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
1092398|NCT02595827|Randomized Controlled Trial|randomized controlled trial
1092399|NCT02595814|Registry|registry
1092400|NCT02595814|Heart failure|heart failure
1092401|NCT02595814|Hospitalized|hospitalized
1092402|NCT02595814|Global|global
1092403|NCT02595814|Morbidity|morbidity
1092404|NCT02595814|Mortality|mortality
1092405|NCT02595814|Quality of life|quality of life
1092406|NCT02595814|AHF|ahf
1092407|NCT02595775|endoscopy measures|endoscopy measures
1092408|NCT02595775|audit and feedback|audit and feedback
1092409|NCT02595775|quality improvement|quality improvement
1092410|NCT02595775|randomized controlled trial|randomized controlled trial
1092411|NCT02595775|Colonoscopy|colonoscopy
1092412|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
1092413|NCT02595710|Bartonellosis|bartonellosis
1092414|NCT02595684|Obesity|obesity
1092415|NCT02595684|Tadalfil|tadalfil
1092416|NCT02595684|Insulin secretion|insulin secretion
1092417|NCT02595684|Insulin sensitivity|insulin sensitivity
1092418|NCT02595671|Digital coaching|digital coaching
1092419|NCT02595671|Sustainable weight loss|sustainable weight loss
1092420|NCT02595671|Self-determination theory|self-determination theory
1092421|NCT02595671|Obesity|obesity
1092422|NCT02595671|Overweight|overweight
1092423|NCT02595671|Diet|diet
1092424|NCT02595671|Physical activity|physical activity
1092425|NCT02595645|colorectal adenoma|colorectal adenoma
1092426|NCT02595645|colorectal cancer|colorectal cancer
1092427|NCT02595645|next generation sequencing|next generation sequencing
1092428|NCT02595645|liquid biopsy|liquid biopsy
1092429|NCT02595645|screening colonoscopy|screening colonoscopy
1092430|NCT02595645|surveillance strategies|surveillance strategies
1092431|NCT02595619|AKI|aki
1093040|NCT02592330|CALEC|calec
1092432|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
1092433|NCT02595619|Renal Replacement Therapy|renal replacement therapy
1092434|NCT02595619|Mechanical Ventilation|mechanical ventilation
1092435|NCT02595606|dry eye syndromes|dry eye syndromes
1092436|NCT02595606|diabetes mellitus|diabetes mellitus
1092437|NCT02595593|Trauma|trauma
1092438|NCT02595593|Rib Plate|rib plate
1092439|NCT02595593|Rib Fixation|rib fixation
1092440|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1092441|NCT02595567|Liver disease|liver disease
1092442|NCT02595567|Pleural effusion|pleural effusion
1092443|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
1092444|NCT02595541|pediatric|pediatric
1092445|NCT02595541|cardiac|cardiac
1092446|NCT02595541|sildenfil|sildenfil
1092447|NCT02595541|milrinone|milrinone
1092448|NCT02595541|pulmonary hypertension|pulmonary hypertension
1092449|NCT02595489|Leukodystrophy|leukodystrophy
1092450|NCT02595489|ABCD1|abcd1
1092451|NCT02595489|Demyelination|demyelination
1092452|NCT02595489|Inflammation|inflammation
1092453|NCT02595489|ALD|ald
1092454|NCT02595489|Vitamin D|vitamin d
1092455|NCT02595489|Oxidative Stress|oxidative stress
1092456|NCT02595489|X- linked|x- linked
1092457|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
1092458|NCT02595476|analgesia|analgesia
1092459|NCT02595476|pupillometry|pupillometry
1092460|NCT02595476|general anesthesia|general anesthesia
1092461|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
1092462|NCT02595437|dialysis|dialysis
1092463|NCT02595437|pediatric|pediatric
1092464|NCT02595437|chronic kidney disease|chronic kidney disease
1092465|NCT02595411|Children|children
1092466|NCT02595411|Rehabilitation|rehabilitation
1092467|NCT02595411|Upper Limb|upper limb
1092468|NCT02595411|Assessments|assessments
1092469|NCT02595411|Outcome Measures|outcome measures
1092470|NCT02595398|Uveitis|uveitis
1092471|NCT02595398|UME|ume
1092472|NCT02595398|Posterior Uveitis|posterior uveitis
1092473|NCT02595398|Anterior Uveitis|anterior uveitis
1092474|NCT02595398|Intermediate Uveitis|intermediate uveitis
1092475|NCT02595398|Panuveitis|panuveitis
1092476|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
1092477|NCT02595398|Triamcinolone|triamcinolone
1092478|NCT02595398|Choroid|choroid
1092479|NCT02595398|Choroidal Injection|choroidal injection
1092480|NCT02595398|Suprachoroidal|suprachoroidal
1092481|NCT02595398|Microneedle|microneedle
1092482|NCT02595398|Microinjection|microinjection
1092483|NCT02595359|endophthalmitis|endophthalmitis
1092484|NCT02595359|antibiotic therapy|antibiotic therapy
1092485|NCT02595359|cataract surgery|cataract surgery
1092486|NCT02595359|prevention|prevention
1092487|NCT02595333|repeat cesarean section|repeat cesarean section
1092488|NCT02595333|pain|pain
1092489|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
1092490|NCT02595307|Risk Recall|risk recall
1092491|NCT02595307|Pamphlet|pamphlet
1092492|NCT02595307|Brochure|brochure
1092493|NCT02595307|Patient satisfaction|patient satisfaction
1092494|NCT02595307|Informed Consent|informed consent
1092495|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
1092496|NCT02595281|neoadjuvant|neoadjuvant
1092497|NCT02595281|ROMA|roma
1092498|NCT02595281|Ca125|ca125
1092500|NCT02595281|biomarker|biomarker
1092501|NCT02595268|Healthy|healthy
1092502|NCT02595268|Pitavastatin|pitavastatin
1092503|NCT02595268|JNJ-63623872|jnj-63623872
1092504|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
1092505|NCT02595203|Bioavailability|bioavailability
1092506|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
1092507|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
1092509|NCT02595190|Medicine conservative treatment|medicine conservative treatment
1092510|NCT02595190|Surgical treatment|surgical treatment
1092511|NCT02595177|multifocal IOL|multifocal iol
1092512|NCT02595177|monovision|monovision
1092513|NCT02595177|hybrid monovision|hybrid monovision
1092514|NCT02595177|spectacles independence|spectacles independence
1092515|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
1092516|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
1092517|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
1092518|NCT02595138|zoledronic acid|zoledronic acid
1092519|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
1092520|NCT02595138|adjuvant treatment|adjuvant treatment
1092521|NCT02595125|intrauterine device|intrauterine device
1092522|NCT02595125|contraceptive method|contraceptive method
1092523|NCT02595125|direct technique|direct technique
1092524|NCT02595125|torpedo technique|torpedo technique
1092525|NCT02595125|verbal numeric scale|verbal numeric scale
1092526|NCT02595112|staphylococcal infections|staphylococcal infections
1092527|NCT02595112|nasal carriage|nasal carriage
1092528|NCT02595112|nasal cavity|nasal cavity
1092529|NCT02595112|Staphylococcus aureus|staphylococcus aureus
1092620|NCT02594553|Primary Health Care|primary health care
1092621|NCT02594553|Child|child
1092530|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
1092531|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
1092532|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
1092533|NCT02595021|Ovarian cancer|ovarian cancer
1092534|NCT02595021|Complications|complications
1092535|NCT02595021|One-year disease-free survival|one-year disease-free survival
1092536|NCT02595021|Stage IIIc|stage iiic
1092537|NCT02595021|Stage IV|stage iv
1092538|NCT02594982|Delirium|delirium
1092539|NCT02594982|intensive care nursing|intensive care nursing
1092540|NCT02594982|Acute acquired brain injury|acute acquired brain injury
1092541|NCT02594982|neurointensive care|neurointensive care
1092542|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
1092543|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
1092544|NCT02594969|atopic dermatitis|atopic dermatitis
1092545|NCT02594956|nasogastric decompression|nasogastric decompression
1092546|NCT02594943|Diagnostics|diagnostics
1092547|NCT02594943|Biopsy|biopsy
1092548|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
1092549|NCT02594930|synovial biopsy|synovial biopsy
1092550|NCT02594930|knee arthroplasty|knee arthroplasty
1092551|NCT02594930|infection|infection
1092552|NCT02594904|G6PD Deficiency|g6pd deficiency
1092553|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
1092554|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
1092555|NCT02594904|Indirect Bilirubin|indirect bilirubin
1092556|NCT02594891|cholangitis|cholangitis
1092557|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1092558|NCT02594891|complication|complication
1092559|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
1139393|NCT02324244|ICU|icu
1092560|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
1092561|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
1092562|NCT02594878|SAPHO syndrome|sapho syndrome
1092563|NCT02594878|Whole body MRI|whole body mri
1092564|NCT02594878|Pamidronate|pamidronate
1092565|NCT02594878|Inflammatory bone disease|inflammatory bone disease
1092566|NCT02594878|Autoinflammatory disease|autoinflammatory disease
1092567|NCT02594865|Enteral Nutrition|enteral nutrition
1092568|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
1092569|NCT02594839|interstitial lung disease|interstitial lung disease
1092570|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
1092571|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1092572|NCT02594839|stem cells|stem cells
1092573|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
1092574|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
1092575|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
1092576|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
1092577|NCT02594735|inflammatory myopathies|inflammatory myopathies
1092578|NCT02594735|Orencia|orencia
1092579|NCT02594735|Abatacept|abatacept
1092580|NCT02594722|COPD|copd
1092581|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
1092582|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
1092583|NCT02594696|Major depression and Cancer|major depression and cancer
1092584|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
1092585|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
1092586|NCT02594696|Lung Cancer|lung cancer
1092587|NCT02594696|Breast Cancer|breast cancer
1092588|NCT02594696|Head and Neck cancer|head and neck cancer
1092589|NCT02594696|GI cancer|gi cancer
1092590|NCT02594696|Schizophrenia|schizophrenia
1092591|NCT02594696|Bipolar disorder|bipolar disorder
1092592|NCT02594670|acupoints|acupoints
1092593|NCT02594670|insomnia|insomnia
1092594|NCT02594670|acupuncture|acupuncture
1092595|NCT02594670|randomized controlled trial|randomized controlled trial
1092596|NCT02594657|Eccentric|eccentric
1092597|NCT02594657|Ergometer|ergometer
1092598|NCT02594657|Pedal rate|pedal rate
1092599|NCT02594657|Oxygen consumption|oxygen consumption
1092600|NCT02594657|Only health volunteers|only health volunteers
1092601|NCT02594631|Urethral stones|urethral stones
1092602|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
1092603|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
1092604|NCT02594631|Visual lithotripsy|visual lithotripsy
1092605|NCT02594631|bladder stone|bladder stone
1092606|NCT02594592|Osteoporosis|osteoporosis
1092607|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
1092608|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
1092609|NCT02594592|Asians|asians
1092610|NCT02594566|Cytomegalovirus|cytomegalovirus
1092611|NCT02594566|Vaccine|vaccine
1092612|NCT02594566|Congenital Infection|congenital infection
1092613|NCT02594553|Antibiotics|antibiotics
1092614|NCT02594553|Children|children
1092615|NCT02594553|General Practitioner|general practitioner
1092616|NCT02594553|GP|gp
1092617|NCT02594553|After-hours care|after-hours care
1092618|NCT02594553|Out-of-hours care|out-of-hours care
1092619|NCT02594553|Booklet|booklet
1092622|NCT02594527|Older people|older people
1092623|NCT02594527|Physical activity|physical activity
1092624|NCT02594527|Hospital|hospital
1092625|NCT02594514|cardiovascular risk|cardiovascular risk
1092626|NCT02594514|metabolic profile|metabolic profile
1092627|NCT02594488|Myocardial infarction|myocardial infarction
1092628|NCT02594488|Autonomic nervous system|autonomic nervous system
1092629|NCT02594488|Risk stratification|risk stratification
1092630|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
1092631|NCT02594488|Sudden cardiac death|sudden cardiac death
1092633|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
1092634|NCT02594462|contraception|contraception
1092635|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
1092636|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
1092637|NCT02594436|Actinic Keratosis|actinic keratosis
1092638|NCT02594436|topical|topical
1092639|NCT02594436|ingenol mebutate|ingenol mebutate
1092640|NCT02594436|Picato®|picato®
1092641|NCT02594384|Phase 1|phase 1
1092642|NCT02594384|Safety|safety
1092643|NCT02594384|Apilimod dimesylate|apilimod dimesylate
1092644|NCT02594384|Pharmacokinetics|pharmacokinetics
1092645|NCT02594384|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1092646|NCT02594384|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1092647|NCT02594358|Caffeine|caffeine
1092648|NCT02594332|eosinophilic asthma|eosinophilic asthma
1092649|NCT02594332|mepolizumab|mepolizumab
1092650|NCT02594332|treatment|treatment
1092651|NCT02594306|drug addiction|drug addiction
1092652|NCT02594306|Heroin|heroin
1092653|NCT02594306|craving|craving
1092654|NCT02594306|event related potential|event related potential
1092655|NCT02594306|crystal methamphetamine|crystal methamphetamine
1092656|NCT02594267|PTCL|ptcl
1092657|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1092658|NCT02594267|Folotyn|folotyn
1092659|NCT02594267|Pralatrexate|pralatrexate
1092660|NCT02594267|CHOP|chop
1092661|NCT02594241|Ventral hernia|ventral hernia
1092662|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
1092663|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
1092664|NCT02594241|Steroid|steroid
1092665|NCT02594215|Overgrowth|overgrowth
1092666|NCT02594202|Specimen Collection|specimen collection
1092667|NCT02594202|Carcinogenesis|carcinogenesis
1092677|NCT02594176|Pain|pain
1092678|NCT02594176|NSAID|nsaid
1092679|NCT02594176|Sequessome|sequessome
1092680|NCT02594137|Decompressive craniectomy|decompressive craniectomy
1092681|NCT02594137|Brain Edema|brain edema
1092682|NCT02594124|Spinal Muscular Atrophy|spinal muscular atrophy
1092683|NCT02594124|SMA|sma
1092684|NCT02594124|SMN|smn
1092685|NCT02594124|SMNRx|smnrx
1092686|NCT02594124|ISIS-SMNRx|isis-smnrx
1092687|NCT02594124|ISIS-SMN Rx|isis-smn rx
1092688|NCT02594124|ISIS 396443|isis 396443
1092689|NCT02594124|SHINE|shine
1092690|NCT02594124|IONIS-SMNRx|ionis-smnrx
1092691|NCT02594124|IONIS-SMN Rx|ionis-smn rx
1092692|NCT02594124|Spinraza|spinraza
1092693|NCT02594124|nusinersen|nusinersen
1092694|NCT02594111|inflammation|inflammation
1092695|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
1092696|NCT02594111|coronary artery disease|coronary artery disease
1092697|NCT02594111|colchicine|colchicine
1092698|NCT02594098|Atopic dermatitis|atopic dermatitis
1092699|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
1092700|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
1092701|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
1092702|NCT02594020|suspected caries|suspected caries
1092703|NCT02594020|initial enamel lesions|initial enamel lesions
1092704|NCT02594007|telehealth|telehealth
1092705|NCT02594007|heart failure|heart failure
1092706|NCT02593994|Onyx|onyx
1092707|NCT02593994|drug eluting stent|drug eluting stent
1092708|NCT02593994|Routine Clinical Practice|routine clinical practice
1092709|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1092710|NCT02593994|Coronary Artery Disease|coronary artery disease
1092711|NCT02593981|sleep|sleep
1092712|NCT02593981|fruit|fruit
1092713|NCT02593981|honey|honey
1092714|NCT02593981|geriatric|geriatric
1092715|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
1092716|NCT02593929|head and neck cancer|head and neck cancer
1092717|NCT02593929|operable|operable
1092718|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
1092719|NCT02593890|Breast Cancer|breast cancer
1092720|NCT02593890|Breast Surgery|breast surgery
1092721|NCT02593890|Mastectomy|mastectomy
1092722|NCT02593890|Lumpectomy|lumpectomy
1092723|NCT02593890|Post-operative|post-operative
1092724|NCT02593890|Bra|bra
1092725|NCT02593890|Lingerie|lingerie
1092726|NCT02593890|Body Image|body image
1092727|NCT02593890|Psycho-social|psycho-social
1092728|NCT02593890|Impact|impact
1092729|NCT02593877|Trauma|trauma
1092730|NCT02593877|Hemostasis|hemostasis
1092731|NCT02593877|Resuscitation|resuscitation
1092732|NCT02593877|Coagulopathy|coagulopathy
1092733|NCT02593877|Transfusion|transfusion
1092835|NCT02593266|Children|children
1092734|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
1092735|NCT02593851|JNJ-53718678|jnj-53718678
1092736|NCT02593851|Placebo|placebo
1092737|NCT02593851|Infants|infants
1092738|NCT02593812|Learning|learning
1092739|NCT02593812|Practice|practice
1092740|NCT02593799|Liver cirrhosis|liver cirrhosis
1092741|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
1092742|NCT02593799|Endoscopy|endoscopy
1092743|NCT02593773|Interferon gamma|interferon gamma
1092744|NCT02593747|Allergy|allergy
1092745|NCT02593708|HER2+|her2+
1092746|NCT02593695|Anorexia Nervosa|anorexia nervosa
1092747|NCT02593695|Deep Brain Stimulation|deep brain stimulation
1092748|NCT02593695|Nucleus accumbens|nucleus accumbens
1092749|NCT02593656|protein ingestion|protein ingestion
1092750|NCT02593656|resistance exercise|resistance exercise
1092751|NCT02593656|interval exercise|interval exercise
1092752|NCT02593656|stretching exercise|stretching exercise
1092753|NCT02593656|endurance exercise|endurance exercise
1092754|NCT02593643|Major Depressive Disorder|major depressive disorder
1092755|NCT02593643|Bipolar Disorder|bipolar disorder
1092756|NCT02593643|Depression|depression
1092757|NCT02593643|Suicide|suicide
1092758|NCT02593643|Suicidal Ideation|suicidal ideation
1092759|NCT02593643|Ketamine|ketamine
1092760|NCT02593643|Midazolam|midazolam
1092761|NCT02593643|Inpatients|inpatients
1092762|NCT02593617|Energy Drinks|energy drinks
1092763|NCT02593617|Alcohol Drinking|alcohol drinking
1092764|NCT02593617|Substance Use|substance use
1092765|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
1092766|NCT02593604|Wide excision|wide excision
1092767|NCT02593604|Quality of Life|quality of life
1092768|NCT02593604|Sexual Function|sexual function
1092769|NCT02593539|APDS|apds
1092770|NCT02593539|Safety|safety
1092771|NCT02593539|Pharmacokinetics|pharmacokinetics
1092772|NCT02593539|GSK2269557|gsk2269557
1092773|NCT02593539|PASLI|pasli
1092774|NCT02593513|Embryo Transfer|embryo transfer
1092775|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
1092776|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
1092777|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
1092778|NCT02593487|Coronary Artery Disease|coronary artery disease
1092779|NCT02593487|Hyperlipidemia|hyperlipidemia
1092780|NCT02593487|Rosuvastatin|rosuvastatin
1092781|NCT02593487|Lipoproteins|lipoproteins
1092782|NCT02593487|high-density lipoprotein|high-density lipoprotein
1092783|NCT02593487|HDL2|hdl2
1092784|NCT02593474|Adolescent|adolescent
1092785|NCT02593474|Youth|youth
1092786|NCT02593461|Embryo Transfer|embryo transfer
1092787|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
1092788|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
1092789|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
1092790|NCT02593448|Anoxia|anoxia
1092791|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
1092792|NCT02593435|Breast Cancer|breast cancer
1092793|NCT02593435|Chinese high risk group|chinese high risk group
1092794|NCT02593422|ovarian cancer|ovarian cancer
1092795|NCT02593422|expressive writing|expressive writing
1092796|NCT02593422|writing interventions|writing interventions
1092797|NCT02593422|psychosocial support|psychosocial support
1092798|NCT02593409|HIV-1|hiv-1
1092799|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1092800|NCT02593409|immune response|immune response
1092801|NCT02593396|sexual dysfunctions|sexual dysfunctions
1092802|NCT02593396|erectile dysfunctions|erectile dysfunctions
1092803|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
1092804|NCT02593383|safety|safety
1092805|NCT02593383|efficacy|efficacy
1092806|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
1092807|NCT02593370|Perioperative analgesia|perioperative analgesia
1092808|NCT02593357|endothelial function|endothelial function
1092809|NCT02593357|COPD|copd
1092810|NCT02593357|pulmonary function|pulmonary function
1092811|NCT02593344|asthma, endothelial function|asthma, endothelial function
1092812|NCT02593318|energy metabolism|energy metabolism
1092813|NCT02593318|oxaloacetate|oxaloacetate
1092814|NCT02593305|nitrate|nitrate
1092815|NCT02593305|blood flow|blood flow
1092816|NCT02593305|blood pressure|blood pressure
1092817|NCT02593305|vascular function|vascular function
1092818|NCT02593305|hypoxia|hypoxia
1092819|NCT02593292|Clinical pathway|clinical pathway
1092820|NCT02593292|Electronic Health Records|electronic health records
1092821|NCT02593292|Maternal Health Services & administration|maternal health services & administration
1092822|NCT02593292|Patient Access to Records|patient access to records
1092823|NCT02593292|Patient Satisfaction|patient satisfaction
1092824|NCT02593292|Prenatal Care/methods|prenatal care/methods
1092825|NCT02593279|Asthma|asthma
1092826|NCT02593279|phenotype|phenotype
1092827|NCT02593279|small|small
1092828|NCT02593279|airway|airway
1092829|NCT02593279|proximal|proximal
1092830|NCT02593279|dysfunction|dysfunction
1092831|NCT02593266|Prevention|prevention
1092832|NCT02593266|Family|family
1092833|NCT02593266|Intervention|intervention
1092834|NCT02593266|Depression|depression
1092836|NCT02593253|Quality Improvement|quality improvement
1092837|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
1092838|NCT02593253|Hospital Medicine|hospital medicine
1092839|NCT02593240|Energy|energy
1092840|NCT02593240|Presenteeism|presenteeism
1092841|NCT02593240|Absenteeism|absenteeism
1092842|NCT02593240|Cardiometabolic health|cardiometabolic health
1092843|NCT02593240|Obesity|obesity
1092844|NCT02593240|Overweight|overweight
1092845|NCT02593240|Weight Loss|weight loss
1092846|NCT02593240|Quality of Life|quality of life
1092847|NCT02593240|Weight Control|weight control
1092848|NCT02593240|Eating Behavior|eating behavior
1092849|NCT02593240|Food Cravings|food cravings
1092850|NCT02593240|Hunger|hunger
1092851|NCT02593240|Worksite Wellness|worksite wellness
1092852|NCT02593227|TNBC|tnbc
1092853|NCT02593214|Condoms, Female|condoms, female
1092854|NCT02593214|Contraception, Barrier|contraception, barrier
1092855|NCT02593175|Triple-Negative Breast Cancer|triple-negative breast cancer
1092856|NCT02593175|TNBC|tnbc
1092857|NCT02593175|Panitumumab|panitumumab
1092858|NCT02593175|Vectibix|vectibix
1092859|NCT02593175|Paclitaxel|paclitaxel
1092860|NCT02593175|Taxol|taxol
1092861|NCT02593175|Carboplatin|carboplatin
1092862|NCT02593175|Paraplatin|paraplatin
1092863|NCT02593175|Biopsy|biopsy
1092864|NCT02593175|Fine-needle aspiration|fine-needle aspiration
1092865|NCT02593175|FNA|fna
1092866|NCT02593136|Vitamins|vitamins
1092867|NCT02593136|Public Health|public health
1092868|NCT02593136|Nutrition|nutrition
1092869|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
1092870|NCT02593084|Resistance Training|resistance training
1092871|NCT02593084|Exercise|exercise
1092872|NCT02593084|Walking|walking
1092873|NCT02593084|Safety|safety
1092874|NCT02593084|Feasibility Studies|feasibility studies
1092875|NCT02593058|Anhedonia|anhedonia
1092877|NCT02593058|Negative symptoms|negative symptoms
1092878|NCT02593058|Anticipatory pleasure|anticipatory pleasure
1092879|NCT02593058|Savoring|savoring
1092880|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
1092881|NCT02593006|Joint Diseases|joint diseases
1092882|NCT02593006|Juvenile Arthritis|juvenile arthritis
1092883|NCT02593006|treatment|treatment
1092884|NCT02593006|biologic therapy|biologic therapy
1092885|NCT02593006|comparative effectiveness|comparative effectiveness
1092886|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1092887|NCT02592967|JNJ-64041757|jnj-64041757
1092888|NCT02592967|Listeria monocytogenes|listeria monocytogenes
1092890|NCT02592928|Spirometry|spirometry
1092891|NCT02592928|Lung Function|lung function
1092892|NCT02592928|Primary Care|primary care
1092893|NCT02592928|Telehealth|telehealth
1092894|NCT02592928|Integrated Care|integrated care
1092895|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
1092896|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
1092897|NCT02592902|laryngeal cyst|laryngeal cyst
1092898|NCT02592902|phonosurgery|phonosurgery
1092899|NCT02592902|oesophageal impedance|oesophageal impedance
1092900|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
1092901|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
1092902|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
1092903|NCT02592876|Antigens, CD19|antigens, cd19
1092904|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
1092905|NCT02592876|Drug Therapy|drug therapy
1092906|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
1092907|NCT02592876|Hematologic Diseases|hematologic diseases
1092908|NCT02592876|Immune System Diseases|immune system diseases
1092909|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
1092910|NCT02592876|Immunotherapy|immunotherapy
1092911|NCT02592876|Lymphatic Diseases|lymphatic diseases
1092912|NCT02592876|Lymphoma|lymphoma
1092913|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
1092914|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1092915|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1092916|NCT02592876|Monomethylauristatin F|monomethylauristatin f
1092917|NCT02592876|Neoplasms|neoplasms
1092918|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
1092919|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
1092920|NCT02592876|Rituximab|rituximab
1092921|NCT02592876|Ifosfamide|ifosfamide
1092922|NCT02592876|Carboplatin|carboplatin
1092923|NCT02592876|Etoposide|etoposide
1092924|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
1092925|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
1092926|NCT02592850|Randomized Controlled Trial|randomized controlled trial
1092927|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
1092928|NCT02592837|EBUS|ebus
1092929|NCT02592837|TBNA|tbna
1092930|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
1092931|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
1092932|NCT02592837|Lung cancer|lung cancer
1092933|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
1092934|NCT02592811|Cholangiopancreatography|cholangiopancreatography
1093039|NCT02592343|lyophilized|lyophilized
1092935|NCT02592811|therapeutic strategy|therapeutic strategy
1092936|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
1092937|NCT02592772|menthol|menthol
1092938|NCT02592772|nicotine|nicotine
1092939|NCT02592772|reduced nicotine|reduced nicotine
1092940|NCT02592772|smoking|smoking
1092941|NCT02592772|cigarette|cigarette
1092942|NCT02592772|cigarettes|cigarettes
1092943|NCT02592772|men smoking|men smoking
1092944|NCT02592772|smoking research|smoking research
1092945|NCT02592772|nicotine dependence|nicotine dependence
1092946|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
1092947|NCT02592720|Fractional Flow Reserve|fractional flow reserve
1092948|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
1092949|NCT02592681|menstrual migraine|menstrual migraine
1092950|NCT02592681|acupuncture|acupuncture
1092951|NCT02592681|acupressure|acupressure
1092952|NCT02592655|tourniquet|tourniquet
1092953|NCT02592655|arterial|arterial
1092954|NCT02592655|pre-hospital|pre-hospital
1092955|NCT02592655|SOFTT-W|softt-w
1092956|NCT02592655|Battle Wrap|battle wrap
1092957|NCT02592655|windlass|windlass
1092958|NCT02592655|exsanguination|exsanguination
1092959|NCT02592655|hemorrhage|hemorrhage
1092960|NCT02592655|amputation|amputation
1092961|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
1092962|NCT02592642|neurogenic claudication|neurogenic claudication
1092963|NCT02592642|non-operative|non-operative
1092964|NCT02592642|treatment|treatment
1092965|NCT02592642|outcomes|outcomes
1092966|NCT02592642|clinical trial|clinical trial
1092967|NCT02592629|subacromial injection|subacromial injection
1092968|NCT02592629|rotator cuff disease|rotator cuff disease
1092969|NCT02592629|steroid injection|steroid injection
1092970|NCT02592616|Exercise|exercise
1092971|NCT02592616|Appetite|appetite
1092972|NCT02592616|Energy intake|energy intake
1092973|NCT02592603|Serrated lesions|serrated lesions
1092974|NCT02592603|Surveillance|surveillance
1092975|NCT02592603|Colorectal cancer|colorectal cancer
1092976|NCT02592603|Endocuff|endocuff
1092977|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
1092978|NCT02592603|Colonoscopy|colonoscopy
1092979|NCT02592590|Exercise|exercise
1092980|NCT02592590|Physical Activity|physical activity
1092981|NCT02592590|Smartphone|smartphone
1092982|NCT02592590|Technology|technology
1092983|NCT02592577|Previously Treated|previously treated
1092984|NCT02592577|Cell Therapy|cell therapy
1092985|NCT02592577|T Cell Therapy|t cell therapy
1092986|NCT02592577|MAGE-A10|mage-a10
1092987|NCT02592577|Immuno-oncology|immuno-oncology
1092988|NCT02592577|T Cell Receptor|t cell receptor
1092989|NCT02592577|Metastatic|metastatic
1092990|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
1092991|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
1092992|NCT02592564|Telomerase|telomerase
1092993|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
1092994|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
1092995|NCT02592538|radiofrequency ablation|radiofrequency ablation
1092996|NCT02592538|S-1|s-1
1092997|NCT02592512|Hypoxia|hypoxia
1092998|NCT02592512|hypercapnia|hypercapnia
1092999|NCT02592499|HM III|hm iii
1093000|NCT02592499|survival|survival
1093001|NCT02592499|LVAD|lvad
1093002|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
1093003|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
1093004|NCT02592486|immunogenicity|immunogenicity
1093005|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
1093006|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1093007|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1093008|NCT02592473|BPH|bph
1093009|NCT02592473|PAE|pae
1093010|NCT02592473|LUTS|luts
1093011|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
1093012|NCT02592447|CML|cml
1093013|NCT02592447|chronic phase CML|chronic phase cml
1093014|NCT02592447|leukemia|leukemia
1093015|NCT02592434|Arthritis|arthritis
1093016|NCT02592434|Pediatric|pediatric
1093017|NCT02592434|Tofacitinib|tofacitinib
1093018|NCT02592434|Long-term|long-term
1093019|NCT02592434|JIA|jia
1093020|NCT02592434|polyarticular|polyarticular
1093021|NCT02592434|CP-690,550|cp-690,550
1093022|NCT02592434|Xeljanz|xeljanz
1093023|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1093024|NCT02592395|electrochemotherapy|electrochemotherapy
1093025|NCT02592395|electroporation|electroporation
1093026|NCT02592395|radiogenomics|radiogenomics
1093027|NCT02592395|imaging|imaging
1093028|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1093029|NCT02592356|Full-body dual-energy x-ray absorptiometry|full-body dual-energy x-ray absorptiometry
1093030|NCT02592356|DXA|dxa
1093031|NCT02592356|Body measurement|body measurement
1093032|NCT02592356|Weight of participant|weight of participant
1093033|NCT02592356|Questionnaires|questionnaires
1093034|NCT02592356|Surveys|surveys
1093035|NCT02592356|Chemotherapy|chemotherapy
1093036|NCT02592356|Advanced Cancers|advanced cancers
1093037|NCT02592356|Endocrine Tumor|endocrine tumor
1093038|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
1093041|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
1093042|NCT02592330|LSCD|lscd
1093043|NCT02592317|JNJ-56021927|jnj-56021927
1093044|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
1093045|NCT02592291|Mobile health|mobile health
1093046|NCT02592291|Apps|apps
1093047|NCT02592291|Applications|applications
1093048|NCT02592291|Smart phone|smart phone
1093049|NCT02592291|mHealth|mhealth
1093050|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
1093051|NCT02592291|Self-Management|self-management
1093052|NCT02592291|Self-Care|self-care
1093053|NCT02592278|Dental Caries|dental caries
1093054|NCT02592278|Fluoride Varnish|fluoride varnish
1093055|NCT02592278|Preschool child|preschool child
1093056|NCT02592278|Prevention|prevention
1093057|NCT02592239|Functional brain MRI|functional brain mri
1093058|NCT02592239|functional dyspepsia|functional dyspepsia
1093059|NCT02592239|hedonic response|hedonic response
1093060|NCT02592200|Female|female
1093061|NCT02592200|Constipation|constipation
1093062|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
1093063|NCT02592200|Probiotics|probiotics
1093064|NCT02592187|Life-logging|life-logging
1093065|NCT02592187|Cognitive Training|cognitive training
1093066|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
1093067|NCT02592187|Memory|memory
1093068|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
1093069|NCT02592187|Portable camera|portable camera
1093070|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
1093071|NCT02592135|Acute Heart Failure|acute heart failure
1093072|NCT02592122|Mechanical ventilation|mechanical ventilation
1093073|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1093074|NCT02592122|Airway resistance|airway resistance
1093757|NCT02587832|RDS|rds
1093075|NCT02592122|Bronchial dilation test|bronchial dilation test
1093076|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
1093077|NCT02592109|Linear Programming|linear programming
1093078|NCT02592109|Nutritional Status|nutritional status
1093079|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
1093080|NCT02592109|Malondialdehyde|malondialdehyde
1093081|NCT02592109|alpha-Tocopherol|alpha-tocopherol
1093082|NCT02592096|safety and bioavailability|safety and bioavailability
1093083|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
1093084|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
1093085|NCT02592044|pain|pain
1093086|NCT02592044|anxiety|anxiety
1093087|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
1093088|NCT02592005|pollution|pollution
1093089|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
1093090|NCT02591979|Primary Health Care|primary health care
1093091|NCT02591940|cardiovascular modeling|cardiovascular modeling
1093092|NCT02591940|aortic coarctation|aortic coarctation
1093093|NCT02591940|aortic valve disease|aortic valve disease
1093094|NCT02591927|myocardial infarction|myocardial infarction
1093095|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
1093096|NCT02591901|Spinal Cord Injuries|spinal cord injuries
1093097|NCT02591901|Multiple Sclerosis|multiple sclerosis
1093098|NCT02591901|Transverse Myelitis|transverse myelitis
1093099|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
1093100|NCT02591901|Feasibility Study|feasibility study
1093101|NCT02591901|Urinary Tract Infection|urinary tract infection
1093102|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
1093103|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
1093104|NCT02591875|Atrial Flutter|atrial flutter
1093105|NCT02591836|LDL‐C|ldl‐c
1093106|NCT02591836|Lipid Regulator|lipid regulator
1093107|NCT02591797|pain|pain
1093108|NCT02591797|Infant Behavior|infant behavior
1093109|NCT02591797|Heart rate|heart rate
1093110|NCT02591797|Dental Anxiety|dental anxiety
1093111|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
1093112|NCT02591771|Adrenaline|adrenaline
1093113|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
1093114|NCT02591771|Inotropes|inotropes
1093115|NCT02591758|Hexo-Skin|hexo-skin
1093116|NCT02591758|Hexoskin|hexoskin
1093117|NCT02591758|NOVA-SKIN|nova-skin
1093118|NCT02591758|angina|angina
1093119|NCT02591758|biometric vest|biometric vest
1093120|NCT02591706|Single missing tooth|single missing tooth
1093121|NCT02591706|Implants|implants
1093122|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
1093123|NCT02591706|Bone thickness|bone thickness
1093124|NCT02591706|Thickness of soft tissue|thickness of soft tissue
1093125|NCT02591693|Family Caregivers|family caregivers
1093126|NCT02591693|Occupational Therapy|occupational therapy
1093127|NCT02591693|Activities of Daily Living|activities of daily living
1093128|NCT02591667|Colorectal cancer|colorectal cancer
1093129|NCT02591667|Peritoneal metastasis|peritoneal metastasis
1093130|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1093131|NCT02591667|5-Fluorouracil|5-fluorouracil
1093132|NCT02591667|Oxaliplatin|oxaliplatin
1093133|NCT02591667|Irinotecan|irinotecan
1093134|NCT02591667|Bevacizumab|bevacizumab
1093135|NCT02591667|Histopathological response|histopathological response
1093137|NCT02591654|Pembrolizumab|pembrolizumab
1093138|NCT02591654|Metastatic Melanoma|metastatic melanoma
1093139|NCT02591654|MK-3475|mk-3475
1093140|NCT02591641|pre-hospital transport|pre-hospital transport
1093141|NCT02591641|shear force|shear force
1093142|NCT02591641|tissue interface pressure|tissue interface pressure
1093143|NCT02591628|Hypertension|hypertension
1093144|NCT02591628|Thiazide diuretics|thiazide diuretics
1093145|NCT02591589|Hyperoxia|hyperoxia
1093146|NCT02591589|Delirium|delirium
1093147|NCT02591589|Normoxic|normoxic
1093148|NCT02591589|t-MoCA|t-moca
1093149|NCT02591576|Diabetes|diabetes
1093150|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
1093151|NCT02591576|non-STEMI|non-stemi
1093152|NCT02591576|Excess mortality|excess mortality
1093153|NCT02591576|Relative survival|relative survival
1093154|NCT02591550|chronic cough|chronic cough
1093155|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
1093156|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
1093157|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
1093158|NCT02591498|cognitive training|cognitive training
1093159|NCT02591485|PTSD prevention|ptsd prevention
1093160|NCT02591485|Acute stress disorder|acute stress disorder
1093161|NCT02591485|Attention training|attention training
1093162|NCT02591485|Cognitive bias modification|cognitive bias modification
1093164|NCT02591446|TMS|tms
1093165|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
1093166|NCT02591446|Plasticity|plasticity
1093167|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
1093168|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
1093169|NCT02591381|urinary stress incontinence|urinary stress incontinence
1093170|NCT02591355|Platelet Rich Plasma|platelet rich plasma
1093171|NCT02591355|Hair Loss|hair loss
1093172|NCT02591342|femoral neck fracture|femoral neck fracture
1093173|NCT02591342|hip arthroplasty|hip arthroplasty
1093174|NCT02591342|complication|complication
1093175|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
1093176|NCT02591316|nutrition|nutrition
1093177|NCT02591316|physical activity|physical activity
1093178|NCT02591316|breast cancer survivor|breast cancer survivor
1093179|NCT02591316|cognition|cognition
1093180|NCT02591303|Insomnia|insomnia
1093181|NCT02591303|Stress|stress
1093182|NCT02591303|Real-life stressful events|real-life stressful events
1093183|NCT02591290|Meningitis|meningitis
1093184|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
1093185|NCT02591290|Meningococcal Infections|meningococcal infections
1093186|NCT02591290|Menactra®|menactra®
1093187|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
1093188|NCT02591277|Hepatitis C virus|hepatitis c virus
1093189|NCT02591277|observational|observational
1093190|NCT02591277|post-marketing|post-marketing
1093191|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
1093192|NCT02591277|Japan|japan
1093193|NCT02591238|smoking|smoking
1093194|NCT02591238|melatonin|melatonin
1093195|NCT02591238|vascular injury|vascular injury
1093196|NCT02591225|left atrial thrombus size|left atrial thrombus size
1093197|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
1093198|NCT02591225|silent cerebral embolism|silent cerebral embolism
1093199|NCT02591212|Bystanding behaviors|bystanding behaviors
1093200|NCT02591212|Campus|campus
1093201|NCT02591212|Prevention|prevention
1093202|NCT02591212|Sexual Assault|sexual assault
1093203|NCT02591212|CampusSave|campussave
1093204|NCT02591173|Autonomic|autonomic
1093205|NCT02591173|Hypertension|hypertension
1093206|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
1093207|NCT02591134|weight loss|weight loss
1093208|NCT02591134|NNS|nns
1093209|NCT02591134|beverages|beverages
1093210|NCT02591134|diet|diet
1093211|NCT02591134|appetite|appetite
1093212|NCT02591134|satiety|satiety
1093213|NCT02591134|weight control|weight control
1093214|NCT02591108|train of four|train of four
1093215|NCT02591108|neuromuscular blockade|neuromuscular blockade
1093216|NCT02591108|surgery|surgery
1093217|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
1093218|NCT02591069|vegetative state|vegetative state
1093219|NCT02591069|minimally conscious state|minimally conscious state
1093220|NCT02591069|akinetic mutism|akinetic mutism
1093221|NCT02591069|consciousness|consciousness
1093222|NCT02591069|connectivity|connectivity
1093223|NCT02591043|Pelvic|pelvic
1093224|NCT02591043|Treatment Outcome|treatment outcome
1093225|NCT02591030|Bile Duct Cancer|bile duct cancer
1093226|NCT02591030|phase II/III|phase ii/iii
1093227|NCT02591030|Modified folfirinox|modified folfirinox
1093228|NCT02591030|Gemcis|gemcis
1093229|NCT02591004|Neuroprotection|neuroprotection
1093230|NCT02591004|calcium channel blockers|calcium channel blockers
1093231|NCT02591004|magnesium sulhate|magnesium sulhate
1093232|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
1093233|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
1093234|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
1093235|NCT02590978|adult|adult
1093236|NCT02590952|safety, PK|safety, pk
1093334|NCT02590393|Cigarette smoking|cigarette smoking
1093237|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1093238|NCT02590913|fructose|fructose
1093239|NCT02590913|metabolism|metabolism
1093240|NCT02590913|acute|acute
1093241|NCT02590900|pharmacokinetics|pharmacokinetics
1093242|NCT02590900|pregnancy|pregnancy
1093243|NCT02590900|oral contraceptives|oral contraceptives
1093244|NCT02590900|oestradiol|oestradiol
1093245|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
1093246|NCT02590874|Cognition|cognition
1093247|NCT02590874|Memory|memory
1093248|NCT02590874|Depression|depression
1093249|NCT02590874|Depressive disorder|depressive disorder
1093250|NCT02590874|Antidepressive agents|antidepressive agents
1093251|NCT02590874|Duloxetine|duloxetine
1093252|NCT02590874|Cymbalta|cymbalta
1093253|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
1093254|NCT02590861|Partial Dentures|partial dentures
1093255|NCT02590861|Dental Implants|dental implants
1093256|NCT02590861|Quality of Life|quality of life
1093257|NCT02590861|Partial Edentulism|partial edentulism
1093258|NCT02590848|Walnut intake|walnut intake
1093259|NCT02590848|Brain development|brain development
1093260|NCT02590848|Nutritional intervention|nutritional intervention
1093261|NCT02590848|Healthy adolescents|healthy adolescents
1093262|NCT02590835|Adult patients|adult patients
1093263|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
1093264|NCT02590822|Diabetes|diabetes
1093265|NCT02590822|T2DM|t2dm
1093266|NCT02590822|young adults|young adults
1093267|NCT02590822|heart|heart
1093268|NCT02590822|weight loss|weight loss
1093269|NCT02590822|MRI|mri
1093270|NCT02590822|exercise|exercise
1093271|NCT02590822|diastolic function|diastolic function
1093272|NCT02590809|Left ventricular obstruction|left ventricular obstruction
1093273|NCT02590796|Delirium|delirium
1093275|NCT02590796|Medical device|medical device
1093276|NCT02590796|Software application|software application
1093277|NCT02590796|Validation study|validation study
1093278|NCT02590796|Diagnosis|diagnosis
1093279|NCT02590796|Dementia|dementia
1093280|NCT02590783|treatment|treatment
1093281|NCT02590757|non-invasive ventilation|non-invasive ventilation
1093282|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
1093283|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
1093284|NCT02590744|Emergence Agitation|emergence agitation
1093285|NCT02590744|eye patch|eye patch
1093286|NCT02590744|preschool children|preschool children
1093287|NCT02590653|STEMI|stemi
1093288|NCT02590653|myocardial strain|myocardial strain
1093289|NCT02590653|atorvastatin|atorvastatin
1093290|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
1093291|NCT02590601|PPCM|ppcm
1093292|NCT02590601|Bromocriptine|bromocriptine
1093293|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
1093294|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
1093295|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
1093296|NCT02590575|renal replacement therapy|renal replacement therapy
1093297|NCT02590575|Prismalung|prismalung
1093298|NCT02590575|ARDS|ards
1093299|NCT02590575|hypercapnia|hypercapnia
1093300|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
1093301|NCT02590575|ventilated|ventilated
1093302|NCT02590575|Hypercapnic|hypercapnic
1093303|NCT02590549|Keratoconus|keratoconus
1093304|NCT02590549|riboflavin|riboflavin
1093305|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
1093306|NCT02590549|intrasromal ring|intrasromal ring
1093307|NCT02590536|Sildenafil|sildenafil
1093308|NCT02590536|Fetal growth Restriction|fetal growth restriction
1093309|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
1093310|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
1093311|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
1093312|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
1093313|NCT02590471|Breakage of stent|breakage of stent
1093314|NCT02590458|Breast Cancer|breast cancer
1093315|NCT02590458|Short Breast MRI Scan|short breast mri scan
1093316|NCT02590458|SBMRI|sbmri
1093317|NCT02590458|Routine MRI|routine mri
1093318|NCT02590458|High risk for breast cancer|high risk for breast cancer
1093319|NCT02590458|Screening|screening
1093320|NCT02590432|Immunogenicity|immunogenicity
1093321|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
1093322|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
1093323|NCT02590432|Linaclotide|linaclotide
1093324|NCT02590432|Linzess|linzess
1093325|NCT02590406|Morbid Obesity|morbid obesity
1093326|NCT02590406|Bariatric Surgery|bariatric surgery
1093327|NCT02590406|Pre-Oxygenation|pre-oxygenation
1093328|NCT02590406|Anesthesia Induction|anesthesia induction
1093329|NCT02590406|Positive pressure ventilation|positive pressure ventilation
1093330|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
1093331|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
1093332|NCT02590406|Anesthesia, General|anesthesia, general
1093333|NCT02590393|Nicotine addiction|nicotine addiction
1093335|NCT02590393|E-cigarettes|e-cigarettes
1093336|NCT02590380|Adolescent|adolescent
1093337|NCT02590380|paediatric|paediatric
1093338|NCT02590380|pediatric|pediatric
1093339|NCT02590380|scoliosis|scoliosis
1093340|NCT02590380|spine deformity|spine deformity
1093341|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
1093342|NCT02590367|HD6610 granule|hd6610 granule
1093343|NCT02590367|colorectal cancer|colorectal cancer
1093344|NCT02590354|Treatment interruption|treatment interruption
1093345|NCT02590354|functional cure|functional cure
1093346|NCT02590341|myocarditis|myocarditis
1093347|NCT02590341|children|children
1093348|NCT02590341|adolescents|adolescents
1093349|NCT02590341|registry|registry
1093350|NCT02590341|multi-center|multi-center
1093351|NCT02590341|pediatric|pediatric
1093352|NCT02590341|heart failure|heart failure
1093353|NCT02590341|inflammatory heart disease|inflammatory heart disease
1093354|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
1140406|NCT02319005|FAC|fac
1093355|NCT02590328|Neonatal Screening|neonatal screening
1093356|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
1093357|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1093358|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
1093359|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
1093360|NCT02590315|BC|bc
1093361|NCT02590302|Clinical pathway|clinical pathway
1093362|NCT02590302|Mental Health|mental health
1093363|NCT02590302|Emergency Department|emergency department
1093364|NCT02590302|Paediatric|paediatric
1093365|NCT02590302|Risk assessment|risk assessment
1093366|NCT02590302|Service integration|service integration
1093367|NCT02590302|Transitions in care|transitions in care
1093368|NCT02590302|Implementation|implementation
1093369|NCT02590302|Scoring tools|scoring tools
1093370|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
1093371|NCT02590276|frontotemporal Dementia|frontotemporal dementia
1093372|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1093373|NCT02590276|Biomarkers|biomarkers
1093374|NCT02590276|brain Imaging PET|brain imaging pet
1093375|NCT02590263|WHO grade III|who grade iii
1093376|NCT02590263|WHO grade IV|who grade iv
1093377|NCT02590237|Laryngoscopy|laryngoscopy
1093378|NCT02590237|Video Laryngoscopy|video laryngoscopy
1093379|NCT02590211|experimental study|experimental study
1093380|NCT02590211|cognitive mechanisms|cognitive mechanisms
1093381|NCT02590211|poker|poker
1093382|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
1093383|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
1093384|NCT02590081|Normal saline|normal saline
1093385|NCT02590081|Destrose 5%|destrose 5%
1093386|NCT02590081|Blood pressure|blood pressure
1093387|NCT02590081|Interdialytic weight gain|interdialytic weight gain
1093388|NCT02590081|thirst level|thirst level
1093389|NCT02590081|End Stage Renal Failure|end stage renal failure
1093390|NCT02589990|health|health
1093391|NCT02589990|muscle strength|muscle strength
1093392|NCT02589990|exercise genomics|exercise genomics
1093393|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
1093394|NCT02589977|positron-emission tomography|positron-emission tomography
1093395|NCT02589977|echocardiography|echocardiography
1093396|NCT02589977|myocardial blood flow|myocardial blood flow
1093397|NCT02589977|energy metabolism|energy metabolism
1093398|NCT02589964|probiotics|probiotics
1093399|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
1093400|NCT02589964|clostridium difficile|clostridium difficile
1093401|NCT02589925|deep brain stimulation|deep brain stimulation
1093402|NCT02589925|subthalamic nucleus|subthalamic nucleus
1093403|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
1093404|NCT02589886|Self-help|self-help
1093405|NCT02589886|Education|education
1093406|NCT02589886|e-Health|e-health
1093407|NCT02589873|Lifestyle Intervention|lifestyle intervention
1093408|NCT02589873|Workplace|workplace
1093409|NCT02589873|Diabetes Prevention|diabetes prevention
1093410|NCT02589860|Stem Cell Transplantation|stem cell transplantation
1093411|NCT02589847|Clostridium difficile|clostridium difficile
1093412|NCT02589847|C diff|c diff
1093413|NCT02589847|CDI|cdi
1093414|NCT02589847|CDAD|cdad
1093415|NCT02589847|Fecal transplant|fecal transplant
1093416|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
1093417|NCT02589847|diarrhea|diarrhea
1093418|NCT02589847|FMT|fmt
1093419|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
1093420|NCT02589847|microbiota suspension|microbiota suspension
1093421|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
1093422|NCT02589847|C diff diarrhea|c diff diarrhea
1093423|NCT02589808|pre-operative|pre-operative
1093424|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
1093425|NCT02589808|handheld|handheld
1093426|NCT02589795|safety|safety
1093427|NCT02589795|immunogenicity|immunogenicity
1093428|NCT02589795|HIV vaccine|hiv vaccine
1093429|NCT02589782|bedaquiline|bedaquiline
1093430|NCT02589782|Nitroimidazoles|nitroimidazoles
1093431|NCT02589782|diarylquinolines|diarylquinolines
1093432|NCT02589782|linezolid|linezolid
1093435|NCT02589782|moxifloxacin|moxifloxacin
1093436|NCT02589756|obesity|obesity
1093437|NCT02589756|persistent organic pollutants|persistent organic pollutants
1093438|NCT02589756|metabolic syndrome|metabolic syndrome
1093439|NCT02589743|clinical trial|clinical trial
1093440|NCT02589743|pit and fissure sealants|pit and fissure sealants
1093441|NCT02589743|tooth eruption|tooth eruption
1093442|NCT02589743|retention|retention
1093443|NCT02589743|adhesive system|adhesive system
1093444|NCT02589743|intermediary layer|intermediary layer
1093445|NCT02589730|Smartphone app|smartphone app
1093446|NCT02589730|diabetic management|diabetic management
1093447|NCT02589730|lifestyle behaviors|lifestyle behaviors
1093448|NCT02589730|medication management|medication management
1093449|NCT02589678|AIDS|aids
1093450|NCT02589678|Immunology|immunology
1093451|NCT02589678|Public Health|public health
1093452|NCT02589678|Female sex workers|female sex workers
1093453|NCT02589678|Single mothers|single mothers
1093454|NCT02589665|IL-23 antibody|il-23 antibody
1093455|NCT02589652|Pegylated interferon|pegylated interferon
1093456|NCT02589652|Entecavir|entecavir
1093457|NCT02589600|Bone loss|bone loss
1093458|NCT02589600|Frail Geriatric Women|frail geriatric women
1093459|NCT02589600|Nursing Home Patients|nursing home patients
1093460|NCT02589600|Long-term Care Patients|long-term care patients
1093461|NCT02589600|Osteoporosis|osteoporosis
1093462|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
1093463|NCT02589561|hearing loss|hearing loss
1093464|NCT02589561|hearing aids|hearing aids
1093465|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
1093466|NCT02589548|Hodgkin Disease|hodgkin disease
1093467|NCT02589509|Event-related potentials|event-related potentials
1093468|NCT02589509|Attention|attention
1093469|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
1093470|NCT02589509|Independent activities of daily living|independent activities of daily living
1093471|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
1093472|NCT02589470|memory|memory
1093473|NCT02589470|epilepsy|epilepsy
1093474|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
1093475|NCT02589457|Healthy Male Volunteer|healthy male volunteer
1093476|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1093477|NCT02589444|Clinical Endocrinology|clinical endocrinology
1093478|NCT02589444|Immunology|immunology
1093479|NCT02589444|Inflammation|inflammation
1093480|NCT02589444|Microbiology|microbiology
1093481|NCT02589444|Respiratory Disorders|respiratory disorders
1093482|NCT02589444|Vitamins|vitamins
1093483|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
1093484|NCT02589418|Manual acupuncture|manual acupuncture
1093485|NCT02589418|Experimental dental pain|experimental dental pain
1093486|NCT02589418|Psychophysics|psychophysics
1093487|NCT02589418|Autonomic nervous system|autonomic nervous system
1093488|NCT02589418|Subjective pain ratings|subjective pain ratings
1093489|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
1093490|NCT02589379|soft and hard pancreas|soft and hard pancreas
1093491|NCT02589366|Lymphoseek|lymphoseek
1093492|NCT02589366|endometrial cancer|endometrial cancer
1093493|NCT02589366|sentinel lymph node|sentinel lymph node
1093494|NCT02589366|lymph node dissection|lymph node dissection
1093495|NCT02589275|TNX-102 SL|tnx-102 sl
1093496|NCT02589275|bedtime|bedtime
1093497|NCT02589275|sublingual|sublingual
1093498|NCT02589275|3-month|3-month
1093499|NCT02589275|long term safety|long term safety
1093500|NCT02589275|long term efficacy|long term efficacy
1093501|NCT02589275|Fibromyalgia|fibromyalgia
1093502|NCT02589236|Cystic Fibrosis|cystic fibrosis
1093503|NCT02589236|N91115|n91115
1093504|NCT02589236|Cavosonstat|cavosonstat
1093505|NCT02589223|multisensory stimulation|multisensory stimulation
1093506|NCT02589210|Diabetes Mellitus|diabetes mellitus
1093507|NCT02589210|Foot Disease|foot disease
1093508|NCT02589210|Foot Ulcer|foot ulcer
1093509|NCT02589197|osteoarthritis|osteoarthritis
1093510|NCT02589197|correction of functional deformity|correction of functional deformity
1093511|NCT02589197|procedures|procedures
1093512|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
1093513|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
1093514|NCT02589197|total knee arthroplasty|total knee arthroplasty
1093515|NCT02589197|Healthy Volunteers|healthy volunteers
1093516|NCT02589197|electromyography|electromyography
1093517|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
1093518|NCT02589184|balance, postural|balance, postural
1093519|NCT02589184|postural equilibrium|postural equilibrium
1093520|NCT02589184|pain scale|pain scale
1093521|NCT02589184|range of motion|range of motion
1093522|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
1093523|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1093524|NCT02589145|DLBCL|dlbcl
1093525|NCT02589145|Busulfan|busulfan
1093526|NCT02589145|Busulfex|busulfex
1093527|NCT02589145|Myleran|myleran
1093528|NCT02589145|Lenalidomide|lenalidomide
1093529|NCT02589145|CC-5013|cc-5013
1093530|NCT02589145|Revlimid|revlimid
1093531|NCT02589145|Vorinostat|vorinostat
1093532|NCT02589145|SAHA|saha
1093633|NCT02588651|Leukemia|leukemia
1093533|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1093534|NCT02589145|MSK-390|msk-390
1093535|NCT02589145|Zolinza|zolinza
1093536|NCT02589145|Gemcitabine|gemcitabine
1093537|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1093538|NCT02589145|Gemzar|gemzar
1093539|NCT02589145|Melphalan|melphalan
1093540|NCT02589145|Alkeran|alkeran
1093541|NCT02589145|Rituximab|rituximab
1093542|NCT02589145|Rituxan|rituxan
1093543|NCT02589145|Dexamethasone|dexamethasone
1093544|NCT02589145|Decadron|decadron
1093545|NCT02589145|Glutamine|glutamine
1093546|NCT02589145|Enterex|enterex
1093547|NCT02589145|Glutapack-10|glutapack-10
1093548|NCT02589145|NutreStore|nutrestore
1140646|NCT02317549|sepsis|sepsis
1093549|NCT02589145|Resource|resource
1093550|NCT02589145|GlutaSolve|glutasolve
1093551|NCT02589145|Sympt-X G.I.|sympt-x g.i.
1093552|NCT02589145|Symptx-X|symptx-x
1093553|NCT02589145|Pyridoxine|pyridoxine
1093554|NCT02589145|Enoxaparin|enoxaparin
1093555|NCT02589145|Lovenox Injection|lovenox injection
1093556|NCT02589145|Palifermin|palifermin
1093557|NCT02589145|Kepivance|kepivance
1093558|NCT02589119|cryptoglandular|cryptoglandular
1093559|NCT02589119|perianal fistula|perianal fistula
1093560|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
1093561|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
1093562|NCT02589093|Analgesia|analgesia
1093563|NCT02589093|Monitoring|monitoring
1093564|NCT02589093|Analgesia Nociception Index|analgesia nociception index
1093565|NCT02589093|ANI|ani
1093566|NCT02589093|PhysioDoloris|physiodoloris
1093567|NCT02589093|Pain|pain
1093568|NCT02589041|intraneural sciatic block|intraneural sciatic block
1093569|NCT02589028|diabetes mellitus|diabetes mellitus
1093759|NCT02587806|RRMS|rrms
1093571|NCT02589028|glucose level|glucose level
1093572|NCT02589028|GLP-1|glp-1
1093573|NCT02589028|GIP|gip
1093574|NCT02589028|premeal protein|premeal protein
1093575|NCT02589015|morbid obesity|morbid obesity
1093576|NCT02589015|neck circumference|neck circumference
1093577|NCT02589015|difficult mask ventilation|difficult mask ventilation
1093578|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
1093579|NCT02589002|sucralose|sucralose
1093580|NCT02589002|insulin sensitivity|insulin sensitivity
1093581|NCT02589002|beta-cell response|beta-cell response
1093582|NCT02589002|appetite regulating hormone|appetite regulating hormone
1093583|NCT02588976|Activated clotting time|activated clotting time
1093584|NCT02588976|Sonoclot|sonoclot
1093585|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
1093586|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
1093587|NCT02588963|health promotion|health promotion
1093588|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
1093589|NCT02588963|infant|infant
1093590|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
1093591|NCT02588924|Parkinson Disease|parkinson disease
1093592|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
1093593|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
1093594|NCT02588911|Operative Surgical Procedure|operative surgical procedure
1093595|NCT02588911|Saphenous Vein|saphenous vein
1093596|NCT02588885|physical therapy|physical therapy
1093597|NCT02588885|psychotherapy|psychotherapy
1093598|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
1093599|NCT02588885|pelvic pain|pelvic pain
1093600|NCT02588885|posttraumatic stress|posttraumatic stress
1093601|NCT02588885|PTSD|ptsd
1093602|NCT02588885|chronic pain|chronic pain
1093603|NCT02588872|platelet-rich plasma|platelet-rich plasma
1093604|NCT02588872|hyaluronic acid|hyaluronic acid
1093605|NCT02588859|T2DM, Diabetes|t2dm, diabetes
1093606|NCT02588846|Prostate|prostate
1093607|NCT02588846|Radiotherapy|radiotherapy
1093608|NCT02588846|IGRT|igrt
1093609|NCT02588846|VMAT|vmat
1093610|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
1093611|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
1093612|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
1093613|NCT02588820|HIV|hiv
1093614|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
1093615|NCT02588768|Low-level laser therapy|low-level laser therapy
1093616|NCT02588768|Light emitting diodes|light emitting diodes
1093617|NCT02588768|Rugby|rugby
1093618|NCT02588768|Field test|field test
1093619|NCT02588768|Photobiomodulation|photobiomodulation
1093620|NCT02588755|Chemoembolization|chemoembolization
1093621|NCT02588755|Therapeutic|therapeutic
1093622|NCT02588755|Tegafur|tegafur
1093623|NCT02588742|elderly ICU patients|elderly icu patients
1093624|NCT02588729|Gestational diabetes|gestational diabetes
1093625|NCT02588729|app|app
1093626|NCT02588729|RCT|rct
1093627|NCT02588729|diet|diet
1093628|NCT02588729|physical activity|physical activity
1093629|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
1093630|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
1093631|NCT02588664|Early Supported Discharge|early supported discharge
1093632|NCT02588651|Lymphoma|lymphoma
1093634|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
1093635|NCT02588638|NGS|ngs
1093636|NCT02588638|Quality of life|quality of life
1093637|NCT02588638|Diagnosis|diagnosis
1093638|NCT02588638|Rare disease|rare disease
1093639|NCT02588638|Next-generation sequencing|next-generation sequencing
1093640|NCT02588612|Previously Treated|previously treated
1093641|NCT02588612|Cell Therapy|cell therapy
1093642|NCT02588612|T Cell Therapy|t cell therapy
1093643|NCT02588612|NY-ESO-1|ny-eso-1
1093644|NCT02588612|Immuno-oncology|immuno-oncology
1093645|NCT02588612|T Cell Receptor|t cell receptor
1093647|NCT02588586|3BNC117|3bnc117
1093648|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
1093649|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
1093650|NCT02588547|Shivering|shivering
1093651|NCT02588547|Granisetron|granisetron
1093652|NCT02588547|Spinal|spinal
1093653|NCT02588547|Cesarean section|cesarean section
1093654|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
1093655|NCT02588508|perineal tear|perineal tear
1093656|NCT02588508|pain|pain
1093657|NCT02588508|pelvic floor|pelvic floor
1093658|NCT02588508|Labour|labour
1093659|NCT02588495|Ultrasound|ultrasound
1093660|NCT02588495|Gastric area|gastric area
1093661|NCT02588495|Accuracy|accuracy
1093662|NCT02588495|Aspirate|aspirate
1093663|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
1093664|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
1093665|NCT02588469|pediatric obesity|pediatric obesity
1093666|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
1093667|NCT02588469|physical exercise|physical exercise
1093668|NCT02588469|compression socks|compression socks
1093669|NCT02588469|rostral fluid shift|rostral fluid shift
1093670|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
1093671|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
1093672|NCT02588339|Hematologic disorder|hematologic disorder
1093673|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1093674|NCT02588326|Bioequivalence|bioequivalence
1093675|NCT02588326|Suspension nasal spray|suspension nasal spray
1093676|NCT02588326|Mometasone furoate|mometasone furoate
1093677|NCT02588326|Pharmacokinetics|pharmacokinetics
1093678|NCT02588326|Particle size distribution|particle size distribution
1093679|NCT02588274|Chronic prostatitis|chronic prostatitis
1093680|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
1093681|NCT02588274|acupuncture|acupuncture
1093682|NCT02588274|placebo needle|placebo needle
1093683|NCT02588274|randomized controlled trial|randomized controlled trial
1093684|NCT02588261|erlotinib|erlotinib
1093685|NCT02588261|EGFR mutation|egfr mutation
1093686|NCT02588261|naquotinib|naquotinib
1093687|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1093688|NCT02588261|ASP8273|asp8273
1093689|NCT02588261|gefitinib|gefitinib
1093690|NCT02588183|atrial fibrillation|atrial fibrillation
1093691|NCT02588183|catheter ablation|catheter ablation
1093692|NCT02588183|pulmonary vein|pulmonary vein
1093693|NCT02588183|cryoenergy|cryoenergy
1093694|NCT02588183|cryoablation|cryoablation
1093695|NCT02588183|ArcticFront|arcticfront
1093696|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
1093697|NCT02588157|McGrath X-Blade|mcgrath x-blade
1093698|NCT02588157|Glidescope|glidescope
1093699|NCT02588157|Macintosh|macintosh
1093700|NCT02588144|Parkinson's disease|parkinson's disease
1093701|NCT02588144|freezing of gait|freezing of gait
1093702|NCT02588144|deep brain stimulation|deep brain stimulation
1093703|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
1093704|NCT02588144|subthalamic nucleus|subthalamic nucleus
1093705|NCT02588131|tremelimumab|tremelimumab
1093706|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
1093707|NCT02588131|malignant mesothelioma|malignant mesothelioma
1093708|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
1093709|NCT02588092|Camidanlumab tesirine|camidanlumab tesirine
1093710|NCT02588079|Dental Fear|dental fear
1093711|NCT02588079|Dental Phobia|dental phobia
1093712|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
1093713|NCT02588079|specific phobia|specific phobia
1093714|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
1093715|NCT02588079|Self Efficacy|self efficacy
1093716|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
1093717|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
1093718|NCT02588040|Recover-L-PRP|recover-l-prp
1093719|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
1093720|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
1093721|NCT02587936|Chronic|chronic
1093722|NCT02587936|Risk prediction model|risk prediction model
1093723|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
1093724|NCT02587936|Pragmatic trial|pragmatic trial
1093725|NCT02587936|Cluster randomization|cluster randomization
1093726|NCT02587936|Collaborative care|collaborative care
1093727|NCT02587936|clinical informatics|clinical informatics
1093728|NCT02587936|Chronic kidney disease|chronic kidney disease
1093729|NCT02587936|hypertension|hypertension
1093730|NCT02587936|high BP|high bp
1093731|NCT02587936|diabetes|diabetes
1093732|NCT02587897|Ultrasonography|ultrasonography
1093733|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
1093734|NCT02587897|Ergonomics|ergonomics
1093735|NCT02587897|Work Related Injury|work related injury
1093736|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
1093737|NCT02587884|Recurrence|recurrence
1093738|NCT02587884|Microvascular Invasion|microvascular invasion
1093739|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
1093740|NCT02587858|NBIA|nbia
1093741|NCT02587858|PKAN|pkan
1093742|NCT02587858|brain iron|brain iron
1093743|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
1093744|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
1093745|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
1093746|NCT02587858|PLAN|plan
1093747|NCT02587858|INAD|inad
1093748|NCT02587858|PLA2G6-associated neurodegeneration|pla2g6-associated neurodegeneration
1093749|NCT02587858|BPAN|bpan
1093750|NCT02587858|Beta-propeller Protein-associated neurodegenration|beta-propeller protein-associated neurodegenration
1093751|NCT02587858|WDR45|wdr45
1093752|NCT02587858|PLA2G6|pla2g6
1093753|NCT02587845|total hip arthroplasty|total hip arthroplasty
1093754|NCT02587845|transexamic acid|transexamic acid
1093755|NCT02587832|cpap|cpap
1093756|NCT02587832|HHHFNC|hhhfnc
1093760|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
1093761|NCT02587793|primary culture|primary culture
1093762|NCT02587793|fine-needle aspiration|fine-needle aspiration
1093763|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
1093764|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
1093765|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
1093766|NCT02587741|glucose fluctuation|glucose fluctuation
1093767|NCT02587741|oxidative stress|oxidative stress
1093768|NCT02587741|Insulin|insulin
1093769|NCT02587741|Oral drugs|oral drugs
1093770|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
1093771|NCT02587728|Amyloidosis|amyloidosis
1093772|NCT02587715|RRMS|rrms
1093773|NCT02587702|Term Infants|term infants
1093774|NCT02587624|atrial fibrillation|atrial fibrillation
1093775|NCT02587624|catheter ablation|catheter ablation
1093776|NCT02587624|remote magnetic navigation|remote magnetic navigation
1093777|NCT02587598|leukemia|leukemia
1093778|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1093779|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
1093780|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
1093781|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
1093782|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1093783|NCT02587598|lymphomas|lymphomas
1093784|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
1093785|NCT02587598|PIM kinases|pim kinases
1093786|NCT02587559|physical therapy|physical therapy
1093787|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
1093788|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
1093789|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
1093790|NCT02587546|laser treatment|laser treatment
1093791|NCT02587546|decannulation|decannulation
1093792|NCT02587546|voice|voice
1093793|NCT02587546|swallowing|swallowing
1093794|NCT02587533|Baroreflex|baroreflex
1093795|NCT02587533|Chemoreflex|chemoreflex
1093796|NCT02587533|Autonomic nervous system|autonomic nervous system
1093797|NCT02587533|Sympathetic activity|sympathetic activity
1093798|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
1093799|NCT02587533|Microneurography|microneurography
1093800|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
1093801|NCT02587533|Resistant hypertension|resistant hypertension
1093802|NCT02587533|Device-based therapy|device-based therapy
1093803|NCT02587520|Tetanus|tetanus
1093804|NCT02587520|Diphtheria|diphtheria
1093805|NCT02587520|Pertussis|pertussis
1093806|NCT02587520|SP0173|sp0173
1093807|NCT02587520|Tdap vaccine|tdap vaccine
1093808|NCT02587481|Acute coronary syndrom|acute coronary syndrom
1093809|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1093810|NCT02587481|Myocardial infarction|myocardial infarction
1093811|NCT02587481|Blood based biomarkers|blood based biomarkers
1093812|NCT02587468|phenolics|phenolics
1093813|NCT02587468|absorption|absorption
1093814|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
1093815|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
1093816|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
1093817|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
1093819|NCT02587442|Amifostine|amifostine
1093820|NCT02587442|Radio-protectants|radio-protectants
1093821|NCT02587416|Pharmacokinetics|pharmacokinetics
1093822|NCT02587416|Lipid Regulator|lipid regulator
1093823|NCT02587390|Pharmacokinetics|pharmacokinetics
1093824|NCT02587390|Lipid Regulator|lipid regulator
1093825|NCT02587364|Pharmacokinetics|pharmacokinetics
1093826|NCT02587364|Lipid Regulator|lipid regulator
1093827|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1093828|NCT02587351|COPD|copd
1093829|NCT02587351|Exacerbation|exacerbation
1093830|NCT02587351|Lung function|lung function
1093831|NCT02587351|Cardiac|cardiac
1093832|NCT02587351|Cardiovascular|cardiovascular
1093833|NCT02587351|Beta blockers|beta blockers
1093834|NCT02587351|Metoprolol succinate|metoprolol succinate
1093835|NCT02587351|Smoking|smoking
1093836|NCT02587338|Subjective Memory Impairment|subjective memory impairment
1093837|NCT02587338|tDCS|tdcs
1093838|NCT02587338|NIRS|nirs
1093839|NCT02587338|Cognitive Training|cognitive training
1093840|NCT02587338|Working Memory|working memory
1093841|NCT02587286|mHealth|mhealth
1093842|NCT02587286|Telemedicine|telemedicine
1093843|NCT02587286|Randomized Controlled Trial|randomized controlled trial
1093844|NCT02587286|Glucose control|glucose control
1093845|NCT02587273|Critical care|critical care
1093846|NCT02587273|Intensive Care|intensive care
1093847|NCT02587273|Fentanyl|fentanyl
1093848|NCT02587273|Pharmacokinetics|pharmacokinetics
1093849|NCT02587273|Multiple Organ Failure|multiple organ failure
1093850|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
1093851|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1093852|NCT02587260|Endothelial function|endothelial function
1093853|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
1093854|NCT02587260|Endopath|endopath
1093855|NCT02587234|motor recovery|motor recovery
1093859|NCT02587234|afferent input|afferent input
1093860|NCT02587234|motor training|motor training
1093861|NCT02587208|circumcision|circumcision
1093862|NCT02587208|plastibell|plastibell
1093863|NCT02587208|infants|infants
1093864|NCT02587208|open sleeve|open sleeve
1093865|NCT02587195|Multiple Sclerosis|multiple sclerosis
1093866|NCT02587169|liposarcoma|liposarcoma
1093867|NCT02587169|leiomyosarcoma|leiomyosarcoma
1093868|NCT02587169|retroperitoneum|retroperitoneum
1093869|NCT02587169|chondrosarcoma|chondrosarcoma
1093870|NCT02587156|Required dietary protein|required dietary protein
1093871|NCT02587156|Amino acid|amino acid
1093872|NCT02587156|Splanchnic extraction|splanchnic extraction
1093873|NCT02587130|intractable pain|intractable pain
1093874|NCT02587130|pressure ulcer|pressure ulcer
1093875|NCT02587130|bed sore|bed sore
1093876|NCT02587130|palliative medicine|palliative medicine
1093877|NCT02587130|ketamine|ketamine
1093878|NCT02587130|pain management|pain management
1093879|NCT02587117|Antioxidant|antioxidant
1093880|NCT02587117|Lycopene|lycopene
1093881|NCT02587117|Prednisolone|prednisolone
1093882|NCT02587104|Diabetes Mellitus|diabetes mellitus
1093883|NCT02587104|Foot Diseases|foot diseases
1093884|NCT02587104|Foot Ulcer|foot ulcer
1093885|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
1093886|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
1093887|NCT02587052|graft loss|graft loss
1093888|NCT02587052|graft survival|graft survival
1093889|NCT02587039|delirium|delirium
1093890|NCT02587039|heart|heart
1093891|NCT02587039|valve|valve
1093892|NCT02587039|graft|graft
1093893|NCT02587039|surgery|surgery
1093894|NCT02587039|coronary|coronary
1093895|NCT02587026|Biorepository|biorepository
1093896|NCT02587026|Precision Genomics|precision genomics
1093897|NCT02587000|adenomyosis|adenomyosis
1093898|NCT02587000|ulipristal acetate|ulipristal acetate
1093899|NCT02587000|sonography|sonography
1093900|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
1093901|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
1093902|NCT02586987|Selumetinib|selumetinib
1093903|NCT02586987|Tremelimumab|tremelimumab
1093904|NCT02586987|MEDI4736|medi4736
1093905|NCT02586987|Safety|safety
1093906|NCT02586987|Tolerability|tolerability
1093907|NCT02586987|Pharmacokinetics|pharmacokinetics
1093908|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
1093909|NCT02586987|Disease progression|disease progression
1093910|NCT02586974|CO2 insufflation|co2 insufflation
1093911|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
1093912|NCT02586974|laparoscopy|laparoscopy
1093913|NCT02586974|hypothermia|hypothermia
1093914|NCT02586974|cytokine response|cytokine response
1093915|NCT02586961|randomized prospective study|randomized prospective study
1093916|NCT02586961|complication rate|complication rate
1093917|NCT02586961|bronchiolitis|bronchiolitis
1093918|NCT02586961|children|children
1093919|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
1093921|NCT02586935|Autism|autism
1093922|NCT02586909|Alzheimer's disease|alzheimer's disease
1093923|NCT02586909|RVT-101|rvt-101
1093924|NCT02586909|donepezil|donepezil
1093925|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
1093926|NCT02586883|Bronchial potential difference|bronchial potential difference
1093927|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
1093930|NCT02586844|NET|net
1093931|NCT02586844|PanNET|pannet
1093932|NCT02586844|Molecular profiling|molecular profiling
1093933|NCT02586844|Transcriptome sequencing|transcriptome sequencing
1093934|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1093935|NCT02586831|Hypoglycemia|hypoglycemia
1093936|NCT02586831|Autoimmune Diseases|autoimmune diseases
1093937|NCT02586831|Diabetes Mellitus|diabetes mellitus
1093938|NCT02586805|DX-2930|dx-2930
1093939|NCT02586805|Hereditary Angioedema|hereditary angioedema
1093940|NCT02586805|Dyax|dyax
1093941|NCT02586792|H7N7|h7n7
1093942|NCT02586792|H7N9|h7n9
1093943|NCT02586792|Influenza|influenza
1093944|NCT02586792|Intramusclar|intramusclar
1093945|NCT02586792|Non-adjuvanted|non-adjuvanted
1093946|NCT02586792|Open-Label|open-label
1093947|NCT02586792|sub-study|sub-study
1093948|NCT02586792|Vaccine|vaccine
1093949|NCT02586779|Referral and consultation|referral and consultation
1093950|NCT02586779|emergency department|emergency department
1093951|NCT02586779|WhatsApp|whatsapp
1093952|NCT02586766|Youth Violence|youth violence
1093953|NCT02586727|Radiation Retinopathy|radiation retinopathy
1093954|NCT02586727|aflibercept|aflibercept
1093955|NCT02586688|child depression|child depression
1093956|NCT02586688|depression|depression
1093957|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1093958|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
1093959|NCT02586688|TMS|tms
1093960|NCT02586688|adolescent depression|adolescent depression
1093961|NCT02586675|ER+ breast cancer|er+ breast cancer
1093962|NCT02586675|PR+ breast cancer|pr+ breast cancer
1093963|NCT02586675|hormone receptor positive|hormone receptor positive
1093964|NCT02586675|HER2- breast cancer|her2- breast cancer
1093965|NCT02586675|HER2 negative|her2 negative
1093966|NCT02586675|locally advanced|locally advanced
1093967|NCT02586675|metastatic|metastatic
1093968|NCT02586662|scapular dyskinesis|scapular dyskinesis
1093969|NCT02586662|kinematics|kinematics
1093970|NCT02586649|tiotropium bromide|tiotropium bromide
1093971|NCT02586636|Metformin|metformin
1093972|NCT02586636|OCT1|oct1
1093973|NCT02586610|Pembrolizumab|pembrolizumab
1093974|NCT02586610|Chemoradiation|chemoradiation
1093975|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
1093976|NCT02586610|MK-3475|mk-3475
1093977|NCT02586597|Stroke|stroke
1093978|NCT02586597|PAS|pas
1093979|NCT02586597|TMS|tms
1093980|NCT02586597|cortical excitability|cortical excitability
1093981|NCT02586597|plasticity|plasticity
1093982|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
1093983|NCT02586571|Body Composition|body composition
1093984|NCT02586571|Breast Feeding|breast feeding
1093985|NCT02586571|Growth|growth
1093986|NCT02586571|Infant|infant
1093987|NCT02586571|Milk, Human|milk, human
1093988|NCT02586571|Nutritional Sciences|nutritional sciences
1093989|NCT02586571|Weaning|weaning
1093990|NCT02586532|Detection|detection
1093991|NCT02586532|Cancer|cancer
1093992|NCT02586532|Antibody|antibody
1093993|NCT02586532|Biopsy|biopsy
1093994|NCT02586532|Registry|registry
1093995|NCT02586519|wearable technology|wearable technology
1093996|NCT02586519|Orpyx|orpyx
1093997|NCT02586519|SurroSense Rx|surrosense rx
1093998|NCT02586519|smart insole|smart insole
1093999|NCT02586519|TCC|tcc
1094000|NCT02586519|total contact cast|total contact cast
1094001|NCT02586519|insole|insole
1094002|NCT02586519|removable cast walker|removable cast walker
1094003|NCT02586519|RCW|rcw
1094004|NCT02586506|correct use of inhaler|correct use of inhaler
1094005|NCT02586506|dose left|dose left
1094006|NCT02586506|ease of use|ease of use
1094007|NCT02586506|ELLIPTA|ellipta
1094008|NCT02586506|Asthma|asthma
1094009|NCT02586493|Placebo|placebo
1094010|NCT02586493|ELLIPTA inhaler|ellipta inhaler
1094011|NCT02586493|Correct use|correct use
1094012|NCT02586493|COPD|copd
1094013|NCT02586493|Ease of use|ease of use
1094014|NCT02586480|bradycardia|bradycardia
1094015|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
1094016|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
1094017|NCT02586441|EEG|eeg
1094018|NCT02586441|Depth of anesthesia|depth of anesthesia
1094019|NCT02586415|endovascular|endovascular
1094020|NCT02586415|endovascular procedure|endovascular procedure
1094021|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
1094022|NCT02586402|ESAs CKD|esas ckd
1094023|NCT02586363|Entecavir|entecavir
1094024|NCT02586363|Food effect|food effect
1094025|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
1094026|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
1094027|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
1094028|NCT02586285|Recurrence|recurrence
1094029|NCT02586272|Embryo Transfer|embryo transfer
1094030|NCT02586272|assisted reproductive technology|assisted reproductive technology
1094031|NCT02586246|CDP870|cdp870
1094032|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
1094033|NCT02586246|Long-term|long-term
1094034|NCT02586207|Larynx|larynx
1094035|NCT02586207|Squamous Cell|squamous cell
1094036|NCT02586207|Oral cavity|oral cavity
1094037|NCT02586207|Oropharynx|oropharynx
1094038|NCT02586207|Hypopharynx|hypopharynx
1094039|NCT02586194|Impaired hepatic function|impaired hepatic function
1094040|NCT02586194|Pharmacokinetics|pharmacokinetics
1094041|NCT02586194|ASP015K|asp015k
1094042|NCT02586168|Insulin Resistance|insulin resistance
1094043|NCT02586168|Lipid Regulator|lipid regulator
1094044|NCT02586142|spasticity|spasticity
1094045|NCT02586142|claw toe|claw toe
1094046|NCT02586142|ultrasounds guidance|ultrasounds guidance
1094047|NCT02586142|botulinum toxin|botulinum toxin
1094048|NCT02586142|stretching exercise|stretching exercise
1094049|NCT02586090|Pediatric Obesity|pediatric obesity
1094050|NCT02586090|Lifestyle Intervention|lifestyle intervention
1094051|NCT02586090|Family-based Intervention|family-based intervention
1094052|NCT02586090|Motivational Interviewing|motivational interviewing
1094053|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
1094054|NCT02586064|Veterans|veterans
1094055|NCT02586064|Psychotherapy|psychotherapy
1094056|NCT02586064|Randomized Controlled Trial|randomized controlled trial
1094057|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
1094058|NCT02585973|AZD1775|azd1775
1094059|NCT02585973|Cisplatin|cisplatin
1094060|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1094061|NCT02585973|HNSCC|hnscc
1094062|NCT02585973|Chemoradiotherapy|chemoradiotherapy
1094063|NCT02585973|Radiotherapy|radiotherapy
1094065|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1094066|NCT02585947|Tenofovir|tenofovir
1094067|NCT02585934|Alzheimer's disease|alzheimer's disease
1094068|NCT02585934|RVT-101|rvt-101
1094069|NCT02585934|donepezil|donepezil
1094070|NCT02585934|intepirdine|intepirdine
1094071|NCT02585934|dementia|dementia
1094072|NCT02585921|Urban Health|urban health
1094073|NCT02585895|LDL-C Apheresis|ldl-c apheresis
1094074|NCT02585895|Hypercholesterolemia|hypercholesterolemia
1094075|NCT02585895|Elevated Cholesterol|elevated cholesterol
1094076|NCT02585895|High Cholesterol|high cholesterol
1094077|NCT02585895|PCSK9 mutations|pcsk9 mutations
1094078|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
1094079|NCT02585895|evolocumab|evolocumab
1094080|NCT02585895|Repatha|repatha
1094081|NCT02585869|Lipid Regulator|lipid regulator
1094082|NCT02585869|TG|tg
1094083|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
1094084|NCT02585856|Photodynamic therapy|photodynamic therapy
1094085|NCT02585843|Heart Failure|heart failure
1094086|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
1094087|NCT02585843|Loop diuretic resistance|loop diuretic resistance
1094088|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
1094089|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
1094090|NCT02585791|electronic cigarette|electronic cigarette
1094091|NCT02585791|airway inflammation|airway inflammation
1094092|NCT02585791|nasal potential difference|nasal potential difference
1094093|NCT02585726|Varicose Veins|varicose veins
1094094|NCT02585726|Great Saphenous Vein|great saphenous vein
1094095|NCT02585726|Venous Insufficiency|venous insufficiency
1094096|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
1094097|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
1094098|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
1094099|NCT02585622|immune response|immune response
1094100|NCT02585622|allogeneic|allogeneic
1094101|NCT02585622|disease progression|disease progression
1094102|NCT02585609|Sleep|sleep
1094103|NCT02585583|Deep Brain|deep brain
1094104|NCT02585583|Essential tremor|essential tremor
1094105|NCT02585583|Parkinson Disease|parkinson disease
1094106|NCT02585583|Tremor|tremor
1094107|NCT02585583|Radiosurgery|radiosurgery
1094108|NCT02585583|Thalamotomy|thalamotomy
1094109|NCT02585583|deep brain stimulation|deep brain stimulation
1094110|NCT02585583|DBS|dbs
1094111|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
1094112|NCT02585570|shoulder|shoulder
1094113|NCT02585570|phenylephrine|phenylephrine
1094114|NCT02585570|hypotension|hypotension
1094115|NCT02585544|genital prolapse|genital prolapse
1094116|NCT02585544|day-care management|day-care management
1094117|NCT02585544|vaginal route|vaginal route
1094118|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
1094119|NCT02585531|Bronchiolitis|bronchiolitis
1094120|NCT02585531|Dexamethasone|dexamethasone
1094121|NCT02585531|Epinephrine|epinephrine
1094122|NCT02585531|Hypertonic saline|hypertonic saline
1094123|NCT02585427|Diabetes|diabetes
1094124|NCT02585427|Obesity|obesity
1094125|NCT02585427|metabolic disorders|metabolic disorders
1094126|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
1094127|NCT02585362|palliative|palliative
1094128|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
1094129|NCT02585336|Metabolic health|metabolic health
1094130|NCT02585336|Soft drinks|soft drinks
1094131|NCT02585323|Physical activity|physical activity
1094132|NCT02585323|Osteoarthritis|osteoarthritis
1094133|NCT02585323|Knee|knee
1094134|NCT02585323|Exercise|exercise
1094135|NCT02585323|Arthritis|arthritis
1094136|NCT02585310|PRBC transfusion|prbc transfusion
1094138|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
1094139|NCT02585232|Behavioral sciences|behavioral sciences
1094140|NCT02585232|Counseling|counseling
1094141|NCT02585232|Intervention Studies|intervention studies
1094142|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
1094143|NCT02585232|Telemedicine|telemedicine
1094144|NCT02585232|Mindfulness|mindfulness
1094145|NCT02585206|Mobile Phone|mobile phone
1094146|NCT02585206|Text Messaging|text messaging
1094147|NCT02585206|Internet|internet
1094148|NCT02585206|Tobacco Use|tobacco use
1094149|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
1094150|NCT02585180|Surveillance|surveillance
1094151|NCT02585180|Subglottic-secretions|subglottic-secretions
1094152|NCT02585180|Critically ill patients|critically ill patients
1094153|NCT02585180|Prevention|prevention
1094155|NCT02585167|anal fistula|anal fistula
1094156|NCT02585167|sphincter reconstruction|sphincter reconstruction
1094157|NCT02585154|Deep Brain Stimulation|deep brain stimulation
1094158|NCT02585128|Delirium|delirium
1094159|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
1094160|NCT02585128|Elderly|elderly
1094161|NCT02585102|Vegetables|vegetables
1094162|NCT02585089|Hypertension|hypertension
1094864|NCT02580760|Silicone|silicone
1094163|NCT02585089|active biopeptide|active biopeptide
1094164|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
1094165|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
1094166|NCT02585089|cured-pork ham|cured-pork ham
1094167|NCT02585076|Stroke prevention|stroke prevention
1094168|NCT02585076|Risk assessment|risk assessment
1094169|NCT02585063|independent prescribing,|independent prescribing,
1094170|NCT02585063|optometrist|optometrist
1094171|NCT02585063|acute care|acute care
1094172|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
1094173|NCT02585050|neurological outcome|neurological outcome
1094174|NCT02585050|live discharged ratio|live discharged ratio
1094176|NCT02585024|cytisine|cytisine
1094177|NCT02585024|Pharmacokinetics|pharmacokinetics
1094178|NCT02585011|Hemiarthroplasty|hemiarthroplasty
1094179|NCT02585011|Anesthesia, Local|anesthesia, local
1094180|NCT02585011|Pain, Postoperative|pain, postoperative
1094181|NCT02584972|Postural control|postural control
1094182|NCT02584972|Gait|gait
1094183|NCT02584972|Children|children
1094184|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
1094185|NCT02584933|ALK|alk
1094186|NCT02584933|Malignancies|malignancies
1094187|NCT02584907|Critically ill|critically ill
1094188|NCT02584907|Diet|diet
1094189|NCT02584907|Blood glucose|blood glucose
1094190|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1094191|NCT02584894|trauma exposure|trauma exposure
1094192|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
1094193|NCT02584855|Spondyloarthritis|spondyloarthritis
1094194|NCT02584855|Spondylarthropathy|spondylarthropathy
1094195|NCT02584816|BRV-PV|brv-pv
1094196|NCT02584816|Rotavirus vaccine|rotavirus vaccine
1094197|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
1094198|NCT02584816|interference with routine immunization|interference with routine immunization
1094199|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1094200|NCT02584790|Narrow band imaging|narrow band imaging
1094201|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1094202|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1094203|NCT02584738|Asthma|asthma
1094204|NCT02584738|Exacerbation|exacerbation
1094205|NCT02584738|Nebulization|nebulization
1094206|NCT02584738|Magnesium|magnesium
1094207|NCT02584738|Pediatric|pediatric
1094208|NCT02584725|Tranexamic Acid|tranexamic acid
1094209|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
1094210|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
1094211|NCT02584660|Rivaroxaban|rivaroxaban
1094212|NCT02584660|JNJ39039039|jnj39039039
1094213|NCT02584660|Pulmonary embolism|pulmonary embolism
1094214|NCT02584647|Unresectable|unresectable
1094215|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
1094216|NCT02584634|NSCLC|nsclc
1094217|NCT02584634|ALK|alk
1094218|NCT02584634|avelumab|avelumab
1094219|NCT02584634|crizotinib|crizotinib
1094220|NCT02584634|PF-06463922|pf-06463922
1094221|NCT02584595|Tachycardia|tachycardia
1094222|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
1094223|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
1094224|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
1094225|NCT02584595|Heart Diseases|heart diseases
1094226|NCT02584582|Glucagon|glucagon
1094227|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
1094228|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
1094229|NCT02584582|Incretins|incretins
1094230|NCT02584569|Drug therapy|drug therapy
1094231|NCT02584530|ultrasound|ultrasound
1094232|NCT02584530|PICC line|picc line
1094233|NCT02584530|neonate|neonate
1094234|NCT02584517|Vasculitis|vasculitis
1141520|NCT02312921|child|child
1094235|NCT02584517|Autoimmune disease|autoimmune disease
1094733|NCT02581397|cough|cough
1094236|NCT02584517|Connective tissue disease|connective tissue disease
1094237|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
1094238|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
1094239|NCT02584517|Immune disorder|immune disorder
1094240|NCT02584517|Rheumatic disease|rheumatic disease
1094241|NCT02584504|Non-statin LMT|non-statin lmt
1094242|NCT02584504|Low dose statin|low dose statin
1094243|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
1094244|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
1094245|NCT02584478|Combination Therapy|combination therapy
1094246|NCT02584439|ivabradine|ivabradine
1094247|NCT02584439|heart rate|heart rate
1094248|NCT02584439|aging|aging
1094249|NCT02584439|visco-elasticity|visco-elasticity
1094250|NCT02584426|Cefazolin|cefazolin
1094251|NCT02584400|prostatic tumors|prostatic tumors
1094252|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
1094253|NCT02584400|hypoxia|hypoxia
1094254|NCT02584400|phase II trial|phase ii trial
1094255|NCT02584400|esophageal tumors|esophageal tumors
1094256|NCT02584400|rectal tumors|rectal tumors
1094257|NCT02584400|brain metastases|brain metastases
1094258|NCT02584400|primary brain tumors|primary brain tumors
1094259|NCT02584374|iliac vein compression|iliac vein compression
1094260|NCT02584361|Hearing loss|hearing loss
1094261|NCT02584361|Cochlear implant|cochlear implant
1094262|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
1094263|NCT02584335|wound treatment|wound treatment
1094264|NCT02584335|lidocaine|lidocaine
1094265|NCT02584335|pain reduction|pain reduction
1094266|NCT02584335|local anesthetic|local anesthetic
1094267|NCT02584283|Liver Transplantation|liver transplantation
1094268|NCT02584283|Donation after Circulatory Death|donation after circulatory death
1094269|NCT02584283|Machine Perfusion|machine perfusion
1094270|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
1094271|NCT02584231|Desmopressin|desmopressin
1094272|NCT02584231|Paediatrics|paediatrics
1094273|NCT02584231|urinary concentration test|urinary concentration test
1094274|NCT02584205|inspiratory muscle training|inspiratory muscle training
1094275|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
1094276|NCT02584205|functional capacity|functional capacity
1094277|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
1094278|NCT02584166|Morbidity|morbidity
1094279|NCT02584166|Mortality|mortality
1094280|NCT02584166|conferences|conferences
1094281|NCT02584166|human science|human science
1094282|NCT02584153|Hernia|hernia
1094283|NCT02584153|Ventral|ventral
1094284|NCT02584153|Incisional|incisional
1094285|NCT02584153|Abdominal|abdominal
1094286|NCT02584153|Herniorrhaphy|herniorrhaphy
1094287|NCT02584153|Recurrence|recurrence
1094288|NCT02584153|laparotomy|laparotomy
1094289|NCT02584153|prevention|prevention
1094290|NCT02584140|PrEP|prep
1094291|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1094292|NCT02584140|HIV Prevention|hiv prevention
1094293|NCT02584127|Smoking|smoking
1094294|NCT02584127|cessation|cessation
1094295|NCT02584127|Internet program|internet program
1094296|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
1094297|NCT02584088|NovaSure|novasure
1094298|NCT02584088|Ablation|ablation
1094299|NCT02584088|Menorrhagia|menorrhagia
1094300|NCT02584088|Endometrium|endometrium
1094301|NCT02584049|Osteopathic treatment|osteopathic treatment
1094302|NCT02584049|Care-induced Pain|care-induced pain
1094303|NCT02584049|Pain|pain
1094304|NCT02584049|Elderly|elderly
1094305|NCT02584036|influenza|influenza
1094306|NCT02584036|vaccine|vaccine
1094307|NCT02584036|public health|public health
1094308|NCT02584036|preventable disease|preventable disease
1094309|NCT02584036|vaccine history|vaccine history
1094310|NCT02584036|point-of-care|point-of-care
1094311|NCT02584023|ultrasonography|ultrasonography
1094312|NCT02584023|infant|infant
1094313|NCT02584023|perioperative period|perioperative period
1094314|NCT02584023|general anesthesia|general anesthesia
1094315|NCT02584010|Postoperative scars|postoperative scars
1094316|NCT02584010|Cicatrix|cicatrix
1094317|NCT02584010|Cicatrization|cicatrization
1094318|NCT02583997|To suture or not to suture....|to suture or not to suture....
1094319|NCT02583997|Tooth extraction|tooth extraction
1094320|NCT02583997|Third molar|third molar
1094321|NCT02583971|Direct current cardioversion|direct current cardioversion
1094322|NCT02583971|Medical management|medical management
1094323|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
1094324|NCT02583945|acute kidney injury|acute kidney injury
1094325|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
1094326|NCT02583945|nephrotoxic medication|nephrotoxic medication
1094327|NCT02583932|Randomized controlled trial|randomized controlled trial
1094328|NCT02583932|Psychological|psychological
1094329|NCT02583932|Meaning|meaning
1094330|NCT02583932|Existential|existential
1094331|NCT02583932|Quality of life|quality of life
1094332|NCT02583932|Intervention|intervention
1094333|NCT02583932|Cancer|cancer
1094334|NCT02583932|Advanced disease|advanced disease
1094335|NCT02583932|New diagnosis|new diagnosis
1094336|NCT02583880|nutritional status|nutritional status
1094337|NCT02583880|malnutrition|malnutrition
1094338|NCT02583880|energy intake|energy intake
1094339|NCT02583880|caloric deficit|caloric deficit
1094341|NCT02583880|hospital|hospital
1094342|NCT02583880|enteral nutrition|enteral nutrition
1094343|NCT02583880|parenteral nutrition|parenteral nutrition
1094344|NCT02583880|nutrition|nutrition
1094345|NCT02583854|Coronary angiography|coronary angiography
1094346|NCT02583854|Transradial|transradial
1094347|NCT02583854|Patient experience|patient experience
1094349|NCT02583854|Compression device|compression device
1094350|NCT02583802|MHD|mhd
1094351|NCT02583802|ear pills|ear pills
1094352|NCT02583802|Shengmai capsule|shengmai capsule
1094353|NCT02583802|Chinese medicine treatment|chinese medicine treatment
1094354|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
1094355|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
1094356|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
1094357|NCT02583776|preterm infants|preterm infants
1094358|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
1094359|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
1094360|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
1094361|NCT02583763|Echocardiography|echocardiography
1094362|NCT02583763|Velocity Vector Imaging|velocity vector imaging
1094363|NCT02583763|Heart Function Tests|heart function tests
1094364|NCT02583750|glucose metabolism|glucose metabolism
1094365|NCT02583750|sleep deprivation|sleep deprivation
1094366|NCT02583737|bone|bone
1094367|NCT02583737|maxillary sinus|maxillary sinus
1094368|NCT02583672|Gaucher Disease|gaucher disease
1094369|NCT02583659|Gastric cancer|gastric cancer
1094370|NCT02583659|First-line chemotherapy|first-line chemotherapy
1094371|NCT02583659|Biomarker|biomarker
1094372|NCT02583646|Obesity|obesity
1094373|NCT02583646|Puberty|puberty
1094374|NCT02583646|Ultrasound|ultrasound
1094375|NCT02583646|Pediatric|pediatric
1094376|NCT02583620|high myopia|high myopia
1094377|NCT02583568|breast cancer|breast cancer
1094378|NCT02583568|image-guided surgery|image-guided surgery
1094379|NCT02583555|Quality of Life|quality of life
1094380|NCT02583555|Health Care Utilization|health care utilization
1094381|NCT02583542|breast|breast
1094382|NCT02583542|lung|lung
1094383|NCT02583542|squamous|squamous
1094384|NCT02583542|KRAS|kras
1094385|NCT02583542|AZD|azd
1094386|NCT02583542|selumetinib|selumetinib
1094387|NCT02583529|Parkinson Disease|parkinson disease
1094388|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
1094389|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
1094390|NCT02583503|Total knee arthroplasty|total knee arthroplasty
1094391|NCT02583503|Total knee replacement|total knee replacement
1094392|NCT02583503|TKA|tka
1094393|NCT02583503|TKR|tkr
1094394|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
1094395|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
1094396|NCT02583490|ECT|ect
1094397|NCT02583490|Depression|depression
1094398|NCT02583490|Suicidal Ideation|suicidal ideation
1094399|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
1094400|NCT02583438|Gut Microbiota|gut microbiota
1094401|NCT02583438|inflammatory marker|inflammatory marker
1094402|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
1094403|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
1094404|NCT02583399|Pain|pain
1094405|NCT02583399|Fever|fever
1094406|NCT02583386|mobility|mobility
1094407|NCT02583386|falls|falls
1094408|NCT02583386|fall prevention|fall prevention
1094409|NCT02583386|gait and balance|gait and balance
1094410|NCT02583386|automatic fall detector|automatic fall detector
1094411|NCT02583373|Pneumonia|pneumonia
1094412|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
1094413|NCT02583373|Pneumolysin|pneumolysin
1094414|NCT02583360|Infant|infant
1094415|NCT02583360|Feeding difficulties|feeding difficulties
1094416|NCT02583360|Dysphagia|dysphagia
1094417|NCT02583334|acupuncture|acupuncture
1094418|NCT02583334|fibromyalgia|fibromyalgia
1094419|NCT02583334|rheumatism|rheumatism
1094420|NCT02583334|clinical trial|clinical trial
1094421|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
1094422|NCT02583321|oral care|oral care
1094423|NCT02583321|mechanical ventilation|mechanical ventilation
1094424|NCT02583321|critically ill patients|critically ill patients
1094425|NCT02583321|tracheal secretions|tracheal secretions
1094426|NCT02583321|subglottic secretions|subglottic secretions
1094427|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
1094428|NCT02583308|Surveillance|surveillance
1094429|NCT02583308|Subglottic-secretions|subglottic-secretions
1094430|NCT02583308|Critically ill patients|critically ill patients
1094431|NCT02583308|Prevention|prevention
1094432|NCT02583295|Awareness|awareness
1094433|NCT02583295|Cardiac Surgery|cardiac surgery
1094434|NCT02583295|Maternal|maternal
1094435|NCT02583295|Pediatric|pediatric
1094436|NCT02583295|Sound|sound
1094437|NCT02583295|Music|music
1094438|NCT02583243|Opioid dependence|opioid dependence
1094439|NCT02583243|HIV/AIDS|hiv/aids
1094440|NCT02583243|Hepatitis C|hepatitis c
1094441|NCT02583243|Severe mental illness|severe mental illness
1094442|NCT02583243|Injection Drug Use|injection drug use
1094443|NCT02583230|Antidepressant Medication|antidepressant medication
1094444|NCT02583230|Adherence|adherence
1094445|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
1094446|NCT02583230|Telemedicine|telemedicine
1094447|NCT02583230|Primary Care|primary care
1094448|NCT02583217|Laryngeal mask|laryngeal mask
1094449|NCT02583217|Ketamine|ketamine
1094450|NCT02583217|Remifentanyl|remifentanyl
1094451|NCT02583165|advanced solid tumors|advanced solid tumors
1094452|NCT02583165|immunotherapy|immunotherapy
1094453|NCT02583165|immuno-oncology|immuno-oncology
1094454|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
1094455|NCT02583126|Teenager|teenager
1094456|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
1094457|NCT02583113|Total Knee Replacement|total knee replacement
1094458|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
1094459|NCT02583087|Barrett esophagus|barrett esophagus
1094460|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
1094461|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
1094462|NCT02583074|deep brain stimulation|deep brain stimulation
1094463|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
1094464|NCT02583074|dystonia|dystonia
1094465|NCT02583035|cancer|cancer
1094466|NCT02583035|geriatric|geriatric
1094467|NCT02582996|Headache|headache
1094468|NCT02582996|Aura|aura
1094469|NCT02582996|Migraine|migraine
1094470|NCT02582996|Moderate to Severe|moderate to severe
1094471|NCT02582957|ARDS|ards
1094472|NCT02582957|Shock Lung|shock lung
1094473|NCT02582957|Acute Chest Syndrome|acute chest syndrome
1094474|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1094475|NCT02582957|Respiratory insufficiency|respiratory insufficiency
1094476|NCT02582957|Trauma|trauma
1094477|NCT02582918|Randomized Controlled Trial|randomized controlled trial
1094478|NCT02582918|Mass Screening|mass screening
1094479|NCT02582905|Alcohol Use Disorder|alcohol use disorder
1094480|NCT02582905|Bipolar Disorder|bipolar disorder
1094481|NCT02582905|Mood|mood
1094482|NCT02582905|Alcohol craving|alcohol craving
1094483|NCT02582905|Pregnenolone|pregnenolone
1094484|NCT02582905|Citicoline|citicoline
1094485|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1094486|NCT02582879|CLL|cll
1094487|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
1094488|NCT02582879|SLL|sll
1094489|NCT02582866|Lacosamide|lacosamide
1094490|NCT02582866|Vimpat|vimpat
1094491|NCT02582866|Epilepsy|epilepsy
1094492|NCT02582866|Partial onset seizures|partial onset seizures
1094493|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
1094494|NCT02582866|Monotherapy|monotherapy
1094495|NCT02582866|AED|aed
1094496|NCT02582853|GBS|gbs
1094497|NCT02582853|AIDP|aidp
1094498|NCT02582853|Spinal fluid|spinal fluid
1094499|NCT02582853|sCD163|scd163
1094500|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
1094501|NCT02582827|Advanced Solid Tumors|advanced solid tumors
1094502|NCT02582827|solid tumor|solid tumor
1094503|NCT02582827|lymphoma|lymphoma
1094626|NCT02582034|Internal Radiation Therapy|internal radiation therapy
1094504|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
1094505|NCT02582801|PET/CT|pet/ct
1094506|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
1094507|NCT02582801|breast cancer|breast cancer
1094508|NCT02582762|Nail gel|nail gel
1094509|NCT02582762|Nail surface abnormality|nail surface abnormality
1094510|NCT02582762|Efficacy|efficacy
1094511|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
1094512|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
1094513|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
1094514|NCT02582749|Placebo|placebo
1094515|NCT02582736|Antipsychotics|antipsychotics
1094516|NCT02582736|Drug side effects|drug side effects
1094517|NCT02582736|Psychosis|psychosis
1094518|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
1094519|NCT02582736|Diabetes|diabetes
1094520|NCT02582736|Epidemiology|epidemiology
1094521|NCT02582736|Database research|database research
1094522|NCT02582736|CNODES|cnodes
1094523|NCT02582697|Germ Cell|germ cell
1094524|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
1094525|NCT02582671|Real World Effectiveness|real world effectiveness
1094526|NCT02582658|Paritaprevir|paritaprevir
1094527|NCT02582658|Dasabuvir|dasabuvir
1094528|NCT02582658|Ombitasvir|ombitasvir
1094529|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
1094530|NCT02582658|HCV|hcv
1094531|NCT02582645|impaction|impaction
1094532|NCT02582645|impacted canine|impacted canine
1094533|NCT02582645|palatally|palatally
1094534|NCT02582645|open window|open window
1094535|NCT02582645|closed window|closed window
1094536|NCT02582645|management|management
1094537|NCT02582632|Hepatitis C Virus|hepatitis c virus
1094538|NCT02582632|Interferon-Free|interferon-free
1094539|NCT02582632|Ribavirin-Free|ribavirin-free
1094540|NCT02582632|Hepatitis C|hepatitis c
1094541|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
1094542|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
1094543|NCT02582606|Insulin Resistance|insulin resistance
1094544|NCT02582606|Meal pattern|meal pattern
1094545|NCT02582606|Obese|obese
1094546|NCT02582593|Cognitive Aging|cognitive aging
1094547|NCT02582593|Neuromodulation|neuromodulation
1094548|NCT02582593|Low Level Light Therapy|low level light therapy
1094549|NCT02582593|Near Infrared Light|near infrared light
1094550|NCT02582593|Neurostimulation|neurostimulation
1094551|NCT02582580|pelvic floor|pelvic floor
1094552|NCT02582580|perineal trauma|perineal trauma
1094553|NCT02582580|physiotherapy|physiotherapy
1094554|NCT02582580|perineal integrity|perineal integrity
1094555|NCT02582567|Pregnant Women|pregnant women
1094556|NCT02582567|Quality of Life|quality of life
1094557|NCT02582567|Exercise|exercise
1094558|NCT02582567|Sleep|sleep
1094559|NCT02582567|Fetal Research|fetal research
1094560|NCT02582567|Diet, Mediterranean|diet, mediterranean
1094561|NCT02582567|Physical Fitness|physical fitness
1094562|NCT02582567|Oxidative stress|oxidative stress
1094563|NCT02582567|Inflammation|inflammation
1094564|NCT02582528|cognitive remediation|cognitive remediation
1094565|NCT02582528|cognition|cognition
1094567|NCT02582528|mental health|mental health
1094568|NCT02582528|functional outcome|functional outcome
1094569|NCT02582515|d-cycloserine|d-cycloserine
1094570|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
1094571|NCT02582515|habit reversal training|habit reversal training
1094572|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
1094573|NCT02582502|HBOT|hbot
1094574|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
1094575|NCT02582502|Pressurized Oxygen|pressurized oxygen
1094576|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
1094577|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
1094578|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
1094579|NCT02582476|Bumetanide|bumetanide
1094580|NCT02582476|Periodic Paralysis|periodic paralysis
1094581|NCT02582463|Risk Assessment|risk assessment
1094582|NCT02582463|Hospitals|hospitals
1094583|NCT02582463|Pharmacists|pharmacists
1094584|NCT02582463|Medication Systems|medication systems
1094585|NCT02582463|Patient Selection|patient selection
1094586|NCT02582463|Prognosis research|prognosis research
1094587|NCT02582450|Haemophilia|haemophilia
1094588|NCT02582450|Adherence of Treatment|adherence of treatment
1094589|NCT02582450|Knowledge of Illness|knowledge of illness
1094590|NCT02582450|Medical-patient Relationship|medical-patient relationship
1094591|NCT02582450|Illness Behavior|illness behavior
1094592|NCT02582450|Treatment Difficulties|treatment difficulties
1094593|NCT02582450|Veritas|veritas
1094594|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
1094595|NCT02582411|Healthy Subjects|healthy subjects
1094596|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1094597|NCT02582385|Cytokines|cytokines
1094598|NCT02582385|Neuropathology|neuropathology
1094599|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
1094600|NCT02582346|MRI|mri
1094601|NCT02582346|Neurography|neurography
1094602|NCT02582346|Tractography|tractography
1094603|NCT02582346|Pelvic nerves|pelvic nerves
1094604|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
1094605|NCT02582203|Vancomycin|vancomycin
1094606|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
1094607|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
1094608|NCT02582190|electrical cardioversion|electrical cardioversion
1094609|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
1094610|NCT02582177|Fungal infection|fungal infection
1094611|NCT02582177|Skin infection|skin infection
1094612|NCT02582177|Dermatophytoses|dermatophytoses
1094613|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
1094614|NCT02582164|Swept Source OCT|swept source oct
1094615|NCT02582138|physical frailty|physical frailty
1094616|NCT02582138|sarcopenia|sarcopenia
1094617|NCT02582138|exercise|exercise
1094618|NCT02582138|nutrition|nutrition
1094619|NCT02582138|information and communications technology|information and communications technology
1094620|NCT02582125|ONO-4538|ono-4538
1094621|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1094622|NCT02582047|influenza vaccine|influenza vaccine
1094623|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
1094624|NCT02582047|simultaneous vaccination|simultaneous vaccination
1094625|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
1094752|NCT02581384|Pulmonary Metastasis|pulmonary metastasis
1094627|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
1094628|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1094629|NCT02582021|Coronary angiography|coronary angiography
1094734|NCT02581397|expectorant|expectorant
1094630|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
1094631|NCT02581995|Diabetic macular edema|diabetic macular edema
1094632|NCT02581995|Intravitreal injection|intravitreal injection
1094633|NCT02581982|Urothelial cancer|urothelial cancer
1094634|NCT02581982|Bladder cancer|bladder cancer
1094635|NCT02581982|Immunotherapy|immunotherapy
1094636|NCT02581982|Paclitaxel|paclitaxel
1094637|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
1094638|NCT02581956|Immunology|immunology
1094639|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
1094640|NCT02581891|nAMD)|namd)
1094641|NCT02581878|Thorium-227|thorium-227
1094642|NCT02581878|BAY1862864 Injection|bay1862864 injection
1094643|NCT02581878|Safety|safety
1094644|NCT02581878|Pharmacokinetics|pharmacokinetics
1094645|NCT02581878|CD22|cd22
1094646|NCT02581878|Radioimmunotherapy|radioimmunotherapy
1094647|NCT02581839|eribulin|eribulin
1094648|NCT02581839|central nervous system|central nervous system
1094650|NCT02581839|Eribulin Mesylate|eribulin mesylate
1094651|NCT02581839|Halaven|halaven
1094652|NCT02581813|Bone health|bone health
1094653|NCT02581813|Body composition|body composition
1094654|NCT02581813|Dairy foods|dairy foods
1094655|NCT02581813|Exercise|exercise
1094656|NCT02581813|inflammation|inflammation
1094657|NCT02581813|nutrition intervention|nutrition intervention
1094658|NCT02581813|weight management|weight management
1094659|NCT02581774|induction|induction
1094660|NCT02581774|cesarean delivery|cesarean delivery
1094661|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
1094662|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
1094663|NCT02581735|Haemophilia|haemophilia
1094664|NCT02581735|Adherence|adherence
1094665|NCT02581735|Prophylaxis treatment|prophylaxis treatment
1094666|NCT02581735|Quality of Life|quality of life
1094667|NCT02581735|Illness Behavior|illness behavior
1094668|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
1094669|NCT02581735|uPatient|upatient
1094670|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
1094671|NCT02581709|Feasibility study|feasibility study
1094672|NCT02581709|Cognition|cognition
1094673|NCT02581709|Chemotherapy|chemotherapy
1094674|NCT02581709|Neoplasms|neoplasms
1094675|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
1094676|NCT02581618|ischemic preconditioning|ischemic preconditioning
1094677|NCT02581618|myocardial injury|myocardial injury
1094678|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
1094679|NCT02581592|Hepatic Impairment|hepatic impairment
1094680|NCT02581592|Hepatitis|hepatitis
1094681|NCT02581592|Liver Cirrhosis|liver cirrhosis
1094682|NCT02581579|Tuberculosis|tuberculosis
1094683|NCT02581579|Tregs|tregs
1094684|NCT02581579|Tolerance|tolerance
1094685|NCT02581579|Probiotic|probiotic
1094686|NCT02581579|Mycobacteria|mycobacteria
1094687|NCT02581540|Troponin|troponin
1094688|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
1094689|NCT02581540|MACE|mace
1094690|NCT02581540|risk stratification|risk stratification
1094691|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
1094692|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
1094693|NCT02581540|GRACE|grace
1094694|NCT02581540|TIMI|timi
1094695|NCT02581540|HEART|heart
1094696|NCT02581514|decision algorithm|decision algorithm
1094697|NCT02581501|Xeloda|xeloda
1094698|NCT02581501|Gemcitabine|gemcitabine
1094699|NCT02581501|Abraxane|abraxane
1094700|NCT02581501|Pancreatic Cancer|pancreatic cancer
1094701|NCT02581501|Metastatic Cancer|metastatic cancer
1094702|NCT02581501|Phase I|phase i
1094703|NCT02581501|5-FU|5-fu
1094704|NCT02581501|Capecitabine|capecitabine
1094705|NCT02581501|Gemzar|gemzar
1094706|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
1094707|NCT02581501|Chemotherapy|chemotherapy
1094708|NCT02581488|Diabetes|diabetes
1094709|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
1094710|NCT02581488|foot sore|foot sore
1094711|NCT02581488|type 2 diabetes|type 2 diabetes
1094712|NCT02581488|type 1 diabetes|type 1 diabetes
1094713|NCT02581488|neuropathy|neuropathy
1094714|NCT02581488|DFU|dfu
1094715|NCT02581475|Adenoma detection rate|adenoma detection rate
1094716|NCT02581475|Colonoscopy|colonoscopy
1094717|NCT02581475|Withdrawal time|withdrawal time
1094718|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
1094719|NCT02581449|hemodialysis|hemodialysis
1094720|NCT02581449|oxidative stress|oxidative stress
1094721|NCT02581449|dyslipidemia|dyslipidemia
1094722|NCT02581436|Prediction test|prediction test
1094723|NCT02581436|genetic transcription profile|genetic transcription profile
1094724|NCT02581436|Transplant follow-up|transplant follow-up
1094725|NCT02581436|Chronic index|chronic index
1094726|NCT02581436|Graft Function|graft function
1094727|NCT02581410|Zostavax®|zostavax®
1094728|NCT02581410|≥ 65 years of age|≥ 65 years of age
1094729|NCT02581410|Herpes Zoster|herpes zoster
1094730|NCT02581410|Shingles|shingles
1094731|NCT02581410|Immunogenicity|immunogenicity
1094732|NCT02581410|Safety|safety
1094735|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
1094736|NCT02581397|respiratory tract infections|respiratory tract infections
1094737|NCT02581397|antitussive agents|antitussive agents
1094738|NCT02581384|Ewing Sarcoma|ewing sarcoma
1094739|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
1094740|NCT02581384|Wilms Tumor|wilms tumor
1094741|NCT02581384|Rhabdomyosarcoma of Mediastinum|rhabdomyosarcoma of mediastinum
1094742|NCT02581384|Ewing's Sarcoma Metastatic|ewing's sarcoma metastatic
1094743|NCT02581384|Ewing Family of Tumors|ewing family of tumors
1094744|NCT02581384|Ewing's Tumor Metastatic|ewing's tumor metastatic
1094745|NCT02581384|Osteosarcoma, Metastatic|osteosarcoma, metastatic
1094746|NCT02581384|Osteosarcoma in Children|osteosarcoma in children
1094747|NCT02581384|Rhabdoid Tumor|rhabdoid tumor
1094748|NCT02581384|Lung Metastasis|lung metastasis
1094749|NCT02581384|Radiation for Children|radiation for children
1094750|NCT02581384|SBRT for children|sbrt for children
1094751|NCT02581384|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1094753|NCT02581384|Lung Metastasis in Children|lung metastasis in children
1094754|NCT02581384|Pulmonary Metastasis in Children|pulmonary metastasis in children
1094755|NCT02581384|Comfort Care|comfort care
1094865|NCT02580760|Transgender|transgender
1094763|NCT02581371|paretic limb|paretic limb
1094764|NCT02581371|stroke|stroke
1094765|NCT02581371|ischemic stroke|ischemic stroke
1094766|NCT02581371|rehabilitation|rehabilitation
1094767|NCT02581371|Frenchay Arm Test|frenchay arm test
1094768|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
1094769|NCT02581371|Barthel index|barthel index
1094770|NCT02581358|scoliosis|scoliosis
1094771|NCT02581358|spinal deformity|spinal deformity
1094772|NCT02581358|Cobb angle|cobb angle
1094773|NCT02581358|assessment|assessment
1094774|NCT02581358|ultrasound|ultrasound
1094775|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
1094776|NCT02581345|Psoriasis|psoriasis
1094777|NCT02581332|behavioral intervention|behavioral intervention
1094778|NCT02581254|Snare|snare
1094779|NCT02581254|Polypectomy|polypectomy
1094780|NCT02581241|QT interval prolongation|qt interval prolongation
1094781|NCT02581215|mFOLFIRINOX|mfolfirinox
1094782|NCT02581215|Ramucirumab|ramucirumab
1094783|NCT02581202|antiretroviral therapy|antiretroviral therapy
1094784|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
1094785|NCT02581189|Effectiveness|effectiveness
1094786|NCT02581189|Influence of adherence|influence of adherence
1094787|NCT02581189|Genotype 1 or 4|genotype 1 or 4
1094788|NCT02581189|Patient reported outcomes|patient reported outcomes
1094789|NCT02581163|Effectiveness|effectiveness
1094790|NCT02581163|Influence of adherence|influence of adherence
1094791|NCT02581150|Outpatient hospitalization|outpatient hospitalization
1094792|NCT02581150|Randomized trial|randomized trial
1094793|NCT02581150|Peripheral arterial disease|peripheral arterial disease
1094794|NCT02581150|Endovascular treatment|endovascular treatment
1094795|NCT02581150|Health Economics|health economics
1094796|NCT02581124|JTZ-951|jtz-951
1094797|NCT02581124|Lapatinib|lapatinib
1094798|NCT02581124|Pharmacokinetics|pharmacokinetics
1094799|NCT02581085|Tocotrienol|tocotrienol
1094800|NCT02581085|Vitamin E|vitamin e
1094801|NCT02581059|Regorafenib|regorafenib
1094802|NCT02581059|American Ginseng|american ginseng
1094803|NCT02581059|Fatigue|fatigue
1094804|NCT02581020|Hepatitis C|hepatitis c
1094805|NCT02581020|Follow-up|follow-up
1094806|NCT02581020|Observation|observation
1094807|NCT02581020|Japanese|japanese
1094818|NCT02580994|Extended Disease Small Cell Lung Cancer|extended disease small cell lung cancer
1094819|NCT02580994|phase II|phase ii
1094820|NCT02580994|randomized|randomized
1094821|NCT02580994|pembrolizumab|pembrolizumab
1094822|NCT02580994|cross-over|cross-over
1094823|NCT02580994|etoposide|etoposide
1094824|NCT02580994|cisplatin|cisplatin
1094825|NCT02580994|carboplatin|carboplatin
1094826|NCT02580994|rechallenge|rechallenge
1094827|NCT02580981|Cancer|cancer
1094828|NCT02580981|Oncology|oncology
1094829|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1094830|NCT02580981|ALL|all
1094831|NCT02580981|Genomics|genomics
1094832|NCT02580981|Genetics|genetics
1094833|NCT02580981|Sequencing|sequencing
1094834|NCT02580981|DNA|dna
1094835|NCT02580981|RNA|rna
1094836|NCT02580981|Ph-like|ph-like
1094837|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
1094838|NCT02580968|Migraine|migraine
1094839|NCT02580968|Acupuncture Therapy|acupuncture therapy
1094840|NCT02580929|Radiotherapy|radiotherapy
1094841|NCT02580929|General Surgery|general surgery
1094842|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
1094843|NCT02580916|outcome assessment|outcome assessment
1094844|NCT02580916|quality of life|quality of life
1094845|NCT02580877|oral insulin|oral insulin
1094846|NCT02580838|Stroke|stroke
1094847|NCT02580838|Spasticity|spasticity
1094848|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
1094849|NCT02580825|Childhood obesity|childhood obesity
1094850|NCT02580825|Ground reaction force|ground reaction force
1094851|NCT02580825|Knee pain|knee pain
1094852|NCT02580812|Perinatal listeriosis|perinatal listeriosis
1094853|NCT02580812|Neurological impairment|neurological impairment
1094856|NCT02580812|Neurotropism|neurotropism
1094857|NCT02580812|Listeria monocytogenes|listeria monocytogenes
1094858|NCT02580812|Intellectual Quotient|intellectual quotient
1094859|NCT02580773|Sickle cell disease|sickle cell disease
1094860|NCT02580773|Anemia|anemia
1094861|NCT02580773|Rare disease|rare disease
1094862|NCT02580773|Reanimation|reanimation
1094863|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
1094866|NCT02580760|Dermatology|dermatology
1094867|NCT02580760|Blood contamination|blood contamination
1094868|NCT02580760|Adverse event after injection|adverse event after injection
1094869|NCT02580734|burning mouth syndrome|burning mouth syndrome
1094870|NCT02580734|treatment|treatment
1094871|NCT02580734|oral chronic pain|oral chronic pain
1094872|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
1094873|NCT02580721|dental implant|dental implant
1094874|NCT02580721|marginal bone loss|marginal bone loss
1094875|NCT02580721|soft tissue|soft tissue
1094876|NCT02580643|Autologous Protein Solution|autologous protein solution
1094877|NCT02580643|Osteoarthritis|osteoarthritis
1094878|NCT02580643|Intra-articular Injection|intra-articular injection
1094879|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
1094880|NCT02580565|sickle cell disease|sickle cell disease
1094881|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1094883|NCT02580552|Mycosis Fungoides|mycosis fungoides
1094884|NCT02580552|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1094885|NCT02580552|CLL|cll
1094886|NCT02580552|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1094887|NCT02580552|DLBCL|dlbcl
1094888|NCT02580552|Adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1094889|NCT02580552|ATLL|atll
1094890|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
1094891|NCT02580539|T cell|t cell
1094892|NCT02580539|Epstein-Barr Virus|epstein-barr virus
1094893|NCT02580513|Circadian Rhythm|circadian rhythm
1094894|NCT02580513|Circadian Misalignment|circadian misalignment
1094895|NCT02580513|Insulin Sensitivity|insulin sensitivity
1094896|NCT02580500|Epidural anesthesia|epidural anesthesia
1094897|NCT02580500|Spinal anesthesia|spinal anesthesia
1094898|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
1094899|NCT02580487|acute appendicitis|acute appendicitis
1094900|NCT02580487|pain management|pain management
1094901|NCT02580487|analgesics|analgesics
1094902|NCT02580487|pediatric patients|pediatric patients
1094903|NCT02580487|laparoscopy|laparoscopy
1094904|NCT02580487|open surgery|open surgery
1094905|NCT02580461|family caregivers|family caregivers
1094906|NCT02580461|cancer|cancer
1094907|NCT02580461|exercise intervention|exercise intervention
1094908|NCT02580461|center based|center based
1094909|NCT02580448|Breast Cancer|breast cancer
1094910|NCT02580448|Breast|breast
1094911|NCT02580448|Advanced Breast Cancer|advanced breast cancer
1094912|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
1094913|NCT02580448|CYP17|cyp17
1094914|NCT02580448|Male Breast Cancer|male breast cancer
1094915|NCT02580448|Triple Negative Cancer|triple negative cancer
1094916|NCT02580448|ER+ Breast Cancer|er+ breast cancer
1094917|NCT02580435|multiple sclerosis|multiple sclerosis
1094918|NCT02580435|microbiome|microbiome
1094919|NCT02580435|prediction|prediction
1094920|NCT02580435|outcome|outcome
1094921|NCT02580422|Echocardiography|echocardiography
1094922|NCT02580409|health care utilization|health care utilization
1094923|NCT02580409|health care costs|health care costs
1094924|NCT02580383|Radiofrequency ablation|radiofrequency ablation
1094925|NCT02580383|RF-MB|rf-mb
1094926|NCT02580383|Lumbar RF|lumbar rf
1094927|NCT02580383|Facet joint syndrome|facet joint syndrome
1094928|NCT02580383|Multifidus twitching|multifidus twitching
1094929|NCT02580383|Sensory stimulation|sensory stimulation
1094930|NCT02580370|REALISE 1|realise 1
1094931|NCT02580357|Connective tissue graft|connective tissue graft
1094932|NCT02580357|Gingival recession|gingival recession
1094933|NCT02580357|Low level laser therapy|low level laser therapy
1094934|NCT02580305|SUVN-502|suvn-502
1094935|NCT02580305|5-HT6|5-ht6
1094936|NCT02580305|Phase 2|phase 2
1094937|NCT02580305|Cognition|cognition
1094938|NCT02580305|Donepezil|donepezil
1094939|NCT02580305|Memantine|memantine
1094940|NCT02580305|Alzheimer's Disease|alzheimer's disease
1094941|NCT02580279|Breast Neoplasms|breast neoplasms
1094942|NCT02580279|prevention & control|prevention & control
1094943|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
1094944|NCT02580279|Dermatitis|dermatitis
1094945|NCT02580266|Kidney|kidney
1094946|NCT02580266|Diabetes|diabetes
1094947|NCT02580240|septic shock|septic shock
1094948|NCT02580240|hydrocortisone|hydrocortisone
1094949|NCT02580240|mortality|mortality
1094950|NCT02580227|Tranexamic Acid|tranexamic acid
1094951|NCT02580227|Blood Transfusions|blood transfusions
1094952|NCT02580188|Neuromuscular blockade|neuromuscular blockade
1094953|NCT02580188|Sugammadex|sugammadex
1094954|NCT02580188|Laparoscopic surgery|laparoscopic surgery
1094955|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
1094956|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
1094957|NCT02580136|Tumor|tumor
1094958|NCT02580136|Skull Base Surgery|skull base surgery
1094959|NCT02580136|Sinonasal Cancer|sinonasal cancer
1094960|NCT02580110|no specific condition|no specific condition
1094961|NCT02580097|Arterial Spin Labeling|arterial spin labeling
1094962|NCT02580097|Ischemic stroke|ischemic stroke
1094963|NCT02580097|Collateral Circulation|collateral circulation
1094964|NCT02580097|Perfusion imaging|perfusion imaging
1094965|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
1094966|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
1094967|NCT02580084|Hybrid Intervention|hybrid intervention
1094968|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
1094969|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
1094970|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1094971|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
1094972|NCT02580071|immune reconstitution|immune reconstitution
1094973|NCT02580071|clinical trial|clinical trial
1094974|NCT02580071|ALL|all
1094975|NCT02580071|AML|aml
1094976|NCT02580058|platinum resistant|platinum resistant
1094977|NCT02580058|platinum refractory|platinum refractory
1094978|NCT02580045|metastatic cancer|metastatic cancer
1094979|NCT02580045|lumbar puncture|lumbar puncture
1094980|NCT02580045|advanced cancer|advanced cancer
1094981|NCT02580045|brain metastases|brain metastases
1094982|NCT02580045|chemotherapy|chemotherapy
1094983|NCT02580045|endocrine therapy|endocrine therapy
1094984|NCT02580045|HER2 targeted therapy|her2 targeted therapy
1094985|NCT02580045|immune therapy|immune therapy
1094986|NCT02580045|anti-cancer therapy|anti-cancer therapy
1094987|NCT02580045|blood brain barrier|blood brain barrier
1094988|NCT02580045|pharmacokinetics|pharmacokinetics
1094989|NCT02580045|Duke University|duke university
1094990|NCT02580045|brain metastasis|brain metastasis
1094991|NCT02580019|Cellular therapy|cellular therapy
1094992|NCT02580019|Stroke|stroke
1094993|NCT02580019|Neuronal Plasticity|neuronal plasticity
1094994|NCT02580019|Recovery|recovery
1094995|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
1094996|NCT02580019|Transplantation|transplantation
1094997|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
1094998|NCT02580019|Ischemia|ischemia
1094999|NCT02580019|Brain Infarction|brain infarction
1095000|NCT02580019|Brain Ischemia|brain ischemia
1095001|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
1095002|NCT02579993|Cornea|cornea
1095003|NCT02579993|Limbal stem cell|limbal stem cell
1095004|NCT02579967|Haploidentical|haploidentical
1095005|NCT02579967|Autoimmunity|autoimmunity
1095006|NCT02579967|Immune Dysregulation|immune dysregulation
1095007|NCT02579967|Congenital|congenital
1095008|NCT02579967|Opportunistic Infection|opportunistic infection
1095009|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
1095010|NCT02579941|Pregnant women at term|pregnant women at term
1095011|NCT02579941|Tranexamic acid|tranexamic acid
1095012|NCT02579928|Ketamine|ketamine
1095013|NCT02579928|Depression|depression
1095014|NCT02579928|Major Depressive Disorder|major depressive disorder
1095015|NCT02579928|Anxiety|anxiety
1095016|NCT02579928|School refusal|school refusal
1095017|NCT02579928|Suicide|suicide
1095018|NCT02579928|Generalized Anxiety|generalized anxiety
1095019|NCT02579928|Suicidal Ideation|suicidal ideation
1095020|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
1095021|NCT02579902|inflammation|inflammation
1095022|NCT02579902|oxidative stress|oxidative stress
1095023|NCT02579902|clinical signs|clinical signs
1095024|NCT02579902|vitamin D3|vitamin d3
1095025|NCT02579889|Closed Loop Stimulation|closed loop stimulation
1095026|NCT02579889|Atrial Fibrillation|atrial fibrillation
1095027|NCT02579889|Stroke|stroke
1095028|NCT02579889|Heart Failure|heart failure
1095029|NCT02579889|Pacemaker|pacemaker
1095030|NCT02579889|ICD|icd
1095031|NCT02579876|Milk Allergy|milk allergy
1095032|NCT02579876|Viaskin Milk|viaskin milk
1095033|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
1095034|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
1095035|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
1095036|NCT02579863|PD1|pd1
1095037|NCT02579863|PD-1|pd-1
1095038|NCT02579863|PD-L1|pd-l1
1095039|NCT02579863|PDL1|pdl1
1095040|NCT02579850|COPD|copd
1095041|NCT02579850|COPD Exacerbation|copd exacerbation
1095042|NCT02579850|EXACT-PRO|exact-pro
1095043|NCT02579837|screening|screening
1095044|NCT02579824|Myeloma|myeloma
1095045|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
1095046|NCT02579824|Multiple Myeloma|multiple myeloma
1095047|NCT02579824|MM|mm
1095048|NCT02579824|DS-3032b|ds-3032b
1095049|NCT02579811|Kidney|kidney
1095050|NCT02579811|Cancer|cancer
1095051|NCT02579811|Axitinib|axitinib
1095052|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
1095053|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
1095054|NCT02579798|Bariatric surgery|bariatric surgery
1095055|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
1095056|NCT02579798|Obesity|obesity
1095057|NCT02579785|Family Planning|family planning
1095060|NCT02579785|Behaviour Change Communication|behaviour change communication
1095061|NCT02579785|Menstrual Regulation|menstrual regulation
1095062|NCT02579785|Postabortion|postabortion
1095063|NCT02579785|Bangladesh|bangladesh
1095064|NCT02579759|PXT3003|pxt3003
1095065|NCT02579746|hypertension|hypertension
1095066|NCT02579746|immigrant|immigrant
1095067|NCT02579746|dietary intervention|dietary intervention
1095068|NCT02579746|lifestyle modification|lifestyle modification
1095069|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
1095070|NCT02579720|Pollinex® Quattro|pollinex® quattro
1095071|NCT02579707|Healthy Volunteers|healthy volunteers
1095072|NCT02579681|Cognition|cognition
1095073|NCT02579681|Tecfidera|tecfidera
1095074|NCT02579681|RRMS|rrms
1095075|NCT02579681|BG00012|bg00012
1095076|NCT02579642|Moderate to severe depression|moderate to severe depression
1095077|NCT02579642|Monopolar|monopolar
1095078|NCT02579642|Bipolar|bipolar
1095079|NCT02579642|Ketamine|ketamine
1095080|NCT02579642|ECT|ect
1095081|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
1095082|NCT02579642|NMDA|nmda
1095083|NCT02579629|Analgesia|analgesia
1095084|NCT02579629|Cesarean section|cesarean section
1095085|NCT02579629|Opiates|opiates
1095086|NCT02579616|Lenvatinib|lenvatinib
1095087|NCT02579616|E7080|e7080
1095088|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
1095089|NCT02579616|BTC|btc
1095090|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
1095091|NCT02579616|Lenvima|lenvima
1095092|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
1095093|NCT02579538|Thoracotomy|thoracotomy
1095094|NCT02579538|Mastectomy|mastectomy
1095095|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
1095096|NCT02579538|Persistent Pain|persistent pain
1095097|NCT02579538|Cognitive Flexibility|cognitive flexibility
1095098|NCT02579525|septic shock|septic shock
1095099|NCT02579525|tissue perfusion|tissue perfusion
1095100|NCT02579525|macrocirculatory|macrocirculatory
1095101|NCT02579525|mean arterial pressure|mean arterial pressure
1095102|NCT02579525|vasopressor use|vasopressor use
1095103|NCT02579525|days alive free of organ support|days alive free of organ support
1095104|NCT02579499|Coronary artery disease|coronary artery disease
1095105|NCT02579499|LDL choelsterol|ldl choelsterol
1095106|NCT02579499|Statin|statin
1095107|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
1095108|NCT02579460|Barrett's esophagus|barrett's esophagus
1095109|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1095110|NCT02579434|CYP3A|cyp3a
1095111|NCT02579408|NAFLD|nafld
1095112|NCT02579408|LDLT|ldlt
1095113|NCT02579408|steatosis|steatosis
1095114|NCT02579408|CAP|cap
1095115|NCT02579408|transient elastography|transient elastography
1095116|NCT02579382|HBV|hbv
1095117|NCT02579382|Hepatitis|hepatitis
1095118|NCT02579382|Liver Disease|liver disease
1095119|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
1095120|NCT02579369|stem cell|stem cell
1095121|NCT02579317|Baroreflex mechanism|baroreflex mechanism
1095122|NCT02579317|Alcohol Use Disorder|alcohol use disorder
1095123|NCT02579317|Substance Use Disorder|substance use disorder
1095124|NCT02579317|Heart Rate Variability|heart rate variability
1095125|NCT02579317|Breathing|breathing
1095126|NCT02579291|Stroke|stroke
1095127|NCT02579291|Dry needling|dry needling
1095128|NCT02579291|Spasticity|spasticity
1095129|NCT02579291|Motor function|motor function
1095130|NCT02579291|Stabilometry|stabilometry
1095131|NCT02579278|EMVI|emvi
1095132|NCT02579278|Extramural Venous Invasion|extramural venous invasion
1095133|NCT02579278|mrEMVI|mremvi
1095134|NCT02579278|Rectal Cancer|rectal cancer
1095135|NCT02579278|ctDNA|ctdna
1095136|NCT02579278|Neoplasm DNA|neoplasm dna
1095137|NCT02579278|MRI|mri
1095138|NCT02579265|Parenteral nutrition|parenteral nutrition
1095139|NCT02579265|Neonates|neonates
1095140|NCT02579265|Infants|infants
1095141|NCT02579265|Lipid emulsions|lipid emulsions
1095142|NCT02579265|Intravenous|intravenous
1095143|NCT02579252|vaccine|vaccine
1095144|NCT02579252|tau protein|tau protein
1142656|NCT02306369|ICBT|icbt
1095145|NCT02579252|active|active
1095146|NCT02579252|immunization|immunization
1095147|NCT02579252|KLH|klh
1095148|NCT02579252|immunotherapy|immunotherapy
1095149|NCT02579252|tau|tau
1095150|NCT02579239|LGMD2B|lgmd2b
1095151|NCT02579239|FSHD|fshd
1095152|NCT02579226|AZD2811|azd2811
1095153|NCT02579226|Advanced solid tumours|advanced solid tumours
1095154|NCT02579226|Small-cell lung cancer|small-cell lung cancer
1095155|NCT02579213|electronic nose|electronic nose
1095156|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
1095157|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
1095158|NCT02579161|Kidney Stones|kidney stones
1095159|NCT02579161|Antibiotics|antibiotics
1095160|NCT02579148|erectile dysfunction|erectile dysfunction
1095161|NCT02579148|stem cell|stem cell
1095162|NCT02579148|collagen scaffold|collagen scaffold
1095163|NCT02579135|Condoms|condoms
1095164|NCT02579135|Sexual Abstinence|sexual abstinence
1095165|NCT02579135|Sexual Communication|sexual communication
1095166|NCT02579122|Reviparin|reviparin
1095167|NCT02579122|Bridging|bridging
1095168|NCT02579122|Phenprocoumon|phenprocoumon
1095169|NCT02579096|Gout|gout
1095170|NCT02579096|Allopurinol|allopurinol
1095171|NCT02579096|Febuxostat|febuxostat
1095172|NCT02579096|CKD|ckd
1095173|NCT02579070|Diabetic Foot|diabetic foot
1095174|NCT02579070|foot temperature|foot temperature
1095175|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
1095176|NCT02579057|Congestive heart failure|congestive heart failure
1095177|NCT02579057|Furosemide|furosemide
1095178|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
1095179|NCT02579031|Stents|stents
1095180|NCT02579031|Drug-Eluting Stents|drug-eluting stents
1095181|NCT02579031|Coronary Artery Disease|coronary artery disease
1095182|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
1095183|NCT02579018|Anorexia Nervosa|anorexia nervosa
1095184|NCT02579018|Exercise|exercise
1095185|NCT02579018|Healthy Adults|healthy adults
1095186|NCT02579018|Physical Activity|physical activity
1095187|NCT02579005|Radiation|radiation
1095188|NCT02579005|Immune response|immune response
1095189|NCT02579005|Anti-tumor|anti-tumor
1095190|NCT02579005|Lung Cancer|lung cancer
1095191|NCT02578992|intubating stylet|intubating stylet
1095192|NCT02578992|head and neck position|head and neck position
1095193|NCT02578979|atrial fibrillation|atrial fibrillation
1095194|NCT02578979|ischemic stroke|ischemic stroke
1095195|NCT02578979|electrocardiogram|electrocardiogram
1095196|NCT02578979|holter|holter
1095197|NCT02578966|Early Childhood Caries|early childhood caries
1095198|NCT02578966|Randomized clinical trial|randomized clinical trial
1095199|NCT02578966|Motivational Interviewing|motivational interviewing
1095200|NCT02578953|Bioequivalence|bioequivalence
1095201|NCT02578953|Fasted state|fasted state
1095202|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
1095203|NCT02578953|Dutasteride|dutasteride
1095204|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
1095205|NCT02578914|seasonal allergies|seasonal allergies
1095206|NCT02578914|ragweed allergy|ragweed allergy
1095207|NCT02578914|grass allergy|grass allergy
1095208|NCT02578914|tree allergy|tree allergy
1095209|NCT02578914|NS2|ns2
1095210|NCT02578914|Aldeyra|aldeyra
1095211|NCT02578901|Thrombocytopenia|thrombocytopenia
1095212|NCT02578901|Tranexamic Acid|tranexamic acid
1095213|NCT02578901|TXA|txa
1095214|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
1095215|NCT02578875|Sequence Technique|sequence technique
1095216|NCT02578875|Infectious Disease|infectious disease
1095217|NCT02578875|Pathogen Detection|pathogen detection
1095218|NCT02578875|Diagnostic|diagnostic
1095219|NCT02578836|Weight Loss|weight loss
1095220|NCT02578836|Overweight|overweight
1095221|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
1095222|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
1095223|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
1095224|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
1095225|NCT02578823|unconsciousness|unconsciousness
1095226|NCT02578823|brain injury|brain injury
1095227|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
1095228|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
1095229|NCT02578797|Genital Diseases, Male|genital diseases, male
1095230|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
1095231|NCT02578797|Neoplasms|neoplasms
1095232|NCT02578797|Neoplasms by Site|neoplasms by site
1095233|NCT02578797|Prostatic Diseases|prostatic diseases
1095234|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
1095235|NCT02578784|Dialysis|dialysis
1095236|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
1095237|NCT02578758|Positive affect regulation|positive affect regulation
1095238|NCT02578706|HIV|hiv
1095239|NCT02578706|Aspirin|aspirin
1095240|NCT02578706|Clopidogrel|clopidogrel
1095241|NCT02578706|Platelet|platelet
1095242|NCT02578706|Inflammation|inflammation
1095243|NCT02578706|Cardiovascular disease|cardiovascular disease
1095244|NCT02578706|Arachidonic acid|arachidonic acid
1095245|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
1095246|NCT02578706|ADP inhibitor|adp inhibitor
1095247|NCT02578706|Immune activation|immune activation
1095248|NCT02578706|Monocyte|monocyte
1095249|NCT02578706|Coagulation|coagulation
1095250|NCT02578706|Thrombogenicity|thrombogenicity
1095252|NCT02578680|PD-1|pd-1
1095253|NCT02578680|PDL1|pdl1
1095254|NCT02578680|PD-L1|pd-l1
1095255|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1095256|NCT02578641|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
1095257|NCT02578641|NPC|npc
1095258|NCT02578641|immunotherapy|immunotherapy
1095259|NCT02578641|Nasopharyngeal Cancer|nasopharyngeal cancer
1095260|NCT02578641|Nose Cancer|nose cancer
1095261|NCT02578641|Cell therapy|cell therapy
1095262|NCT02578641|Head and Neck Cancer|head and neck cancer
1095263|NCT02578641|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
1095264|NCT02578641|chemotherapy|chemotherapy
1095265|NCT02578641|Epstein-Barr Virus|epstein-barr virus
1095266|NCT02578576|Diagnostic Techniques|diagnostic techniques
1095267|NCT02578576|Digestive System|digestive system
1095268|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
1095269|NCT02578550|Darunavir|darunavir
1095270|NCT02578550|Cobicistat|cobicistat
1095271|NCT02578550|Emtricitabine|emtricitabine
1095669|NCT02576431|LOXO-101|loxo-101
1095272|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
1095273|NCT02578550|Healthy participants|healthy participants
1095274|NCT02578537|Ticagrelor|ticagrelor
1095275|NCT02578537|Pharmacokinetics|pharmacokinetics
1095276|NCT02578537|NSTE-ACS|nste-acs
1095278|NCT02578524|cataract satisfaction|cataract satisfaction
1095279|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
1095280|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
1095281|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
1095282|NCT02578511|IXAZOMIB|ixazomib
1095283|NCT02578511|POMP/D|pomp/d
1095284|NCT02578511|Phase I|phase i
1095285|NCT02578511|Early Phase|early phase
1095286|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1095287|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1095288|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
1095289|NCT02578511|ALL|all
1095290|NCT02578498|glucagon|glucagon
1095291|NCT02578498|Carbohydrate diet|carbohydrate diet
1095292|NCT02578472|Healthy|healthy
1095293|NCT02578472|JNJ-42847922|jnj-42847922
1095294|NCT02578472|zolpidem|zolpidem
1095295|NCT02578472|Placebo|placebo
1095296|NCT02578459|Cancer pain|cancer pain
1095297|NCT02578459|Intrathecal therapy|intrathecal therapy
1095298|NCT02578459|Pain|pain
1095299|NCT02578459|Pancreatic cancer|pancreatic cancer
1095300|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
1095301|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
1095302|NCT02578394|Gout|gout
1095303|NCT02578394|Kidney|kidney
1095304|NCT02578394|Depo-Medrone|depo-medrone
1095305|NCT02578394|Anakinra|anakinra
1095306|NCT02578381|pressure wire|pressure wire
1095307|NCT02578381|coronary angiogram|coronary angiogram
1095308|NCT02578381|validation|validation
1095309|NCT02578368|gastric cancer|gastric cancer
1095310|NCT02578368|perioperative|perioperative
1095311|NCT02578368|FLOT|flot
1095312|NCT02578368|limited metastatic|limited metastatic
1095313|NCT02578368|GEJ cancer|gej cancer
1095314|NCT02578355|Atherosclerosis|atherosclerosis
1095315|NCT02578355|Coronary Artery Disease|coronary artery disease
1095316|NCT02578355|Cardiovascular Disease|cardiovascular disease
1095317|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
1095318|NCT02578355|CCTA|ccta
1095319|NCT02578355|Myocardial Infarction|myocardial infarction
1095320|NCT02578355|MI|mi
1095321|NCT02578355|OPeRA|opera
1095322|NCT02578329|Mediterranean diet|mediterranean diet
1095323|NCT02578329|blood fatty acid|blood fatty acid
1095324|NCT02578329|Coronary Artery Disease|coronary artery disease
1095325|NCT02578316|Advanced Solid Tumors|advanced solid tumors
1095326|NCT02578316|Lymphomas|lymphomas
1095327|NCT02578303|sleep apnea|sleep apnea
1095328|NCT02578303|phase-contrast MRI|phase-contrast mri
1095329|NCT02578303|cerebral blood flow|cerebral blood flow
1095330|NCT02578303|vascular risk factor|vascular risk factor
1095331|NCT02578303|dementia|dementia
1095332|NCT02578290|decision support systems|decision support systems
1095333|NCT02578290|clinical|clinical
1095334|NCT02578238|Korea|korea
1095335|NCT02578238|Humira|humira
1095336|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
1095337|NCT02578225|Heart|heart
1095338|NCT02578225|Chronic|chronic
1095339|NCT02578225|Failure|failure
1095340|NCT02578225|MI|mi
1095341|NCT02578225|real life|real life
1095342|NCT02578225|Turkey|turkey
1095343|NCT02578160|pain|pain
1142914|NCT02305121|Nail|nail
1095344|NCT02578160|infant behaviour|infant behaviour
1095345|NCT02578160|heart rate|heart rate
1095346|NCT02578160|dental anxiety|dental anxiety
1095347|NCT02578147|risky sexual behavior|risky sexual behavior
1095348|NCT02578147|early intervention|early intervention
1095349|NCT02578121|Relapsed|relapsed
1095350|NCT02578121|Response Rate|response rate
1095351|NCT02578121|Progression free|progression free
1095352|NCT02578082|Renal Impairment|renal impairment
1095353|NCT02578082|Renal Insufficiency|renal insufficiency
1095354|NCT02578069|Ischemic Stroke|ischemic stroke
1095355|NCT02578069|Intracranial Stenting|intracranial stenting
1095356|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
1095357|NCT02578056|urinary incontinence|urinary incontinence
1095358|NCT02578017|Sickle Cell Disease|sickle cell disease
1095359|NCT02578017|Hydroxyurea|hydroxyurea
1095360|NCT02578017|Adherence|adherence
1095361|NCT02578004|Difficult|difficult
1095362|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
1095363|NCT02578004|significantly different|significantly different
1095364|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
1095556|NCT02576990|PDL1|pdl1
1095365|NCT02577965|Optical Coherence Tomography|optical coherence tomography
1095366|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
1095367|NCT02577965|Thrombus histopathology|thrombus histopathology
1095368|NCT02577965|Gender differences|gender differences
1095369|NCT02577952|lipodystrophy|lipodystrophy
1095370|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
1095371|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
1095372|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
1095373|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
1095374|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
1095375|NCT02577952|partial lipodystrophy|partial lipodystrophy
1095376|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
1095377|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
1095378|NCT02577913|contraception|contraception
1095379|NCT02577913|contraceptive patch|contraceptive patch
1095380|NCT02577913|Levonorgestrel|levonorgestrel
1095381|NCT02577913|gestodene|gestodene
1095382|NCT02577913|safety|safety
1095383|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
1095384|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
1095385|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
1095386|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
1095387|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
1095388|NCT02577835|Hypertension|hypertension
1095389|NCT02577835|Arterial Stiffness|arterial stiffness
1095390|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
1095391|NCT02577796|radial artery spasm|radial artery spasm
1095392|NCT02577796|radial artery occlusion|radial artery occlusion
1095393|NCT02577796|radial access|radial access
1095394|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1095395|NCT02577770|Acupuncture|acupuncture
1095396|NCT02577770|caffeine|caffeine
1095397|NCT02577770|pain|pain
1095398|NCT02577757|Languages network|languages network
1095399|NCT02577757|Functional MRI|functional mri
1095400|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
1095401|NCT02577731|Trauma|trauma
1095402|NCT02577705|food insecurity|food insecurity
1095403|NCT02577705|adverse childhood experiences|adverse childhood experiences
1095404|NCT02577705|violence exposure|violence exposure
1095405|NCT02577705|trauma|trauma
1095406|NCT02577705|poverty|poverty
1095407|NCT02577705|TANF|tanf
1095408|NCT02577705|assets|assets
1095409|NCT02577705|depression|depression
1095410|NCT02577705|randomized control trial|randomized control trial
1095411|NCT02577679|Dentistry|dentistry
1095412|NCT02577653|balance, postural|balance, postural
1095413|NCT02577653|postural equilibrium|postural equilibrium
1095414|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
1095415|NCT02577614|Aortic Valve Repair|aortic valve repair
1095416|NCT02577614|Coronary Re-Implantation|coronary re-implantation
1095417|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
1095418|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
1095419|NCT02577614|Transfusion|transfusion
1095420|NCT02577601|Emergency contraception|emergency contraception
1095421|NCT02577601|Birth Control Pills|birth control pills
1095422|NCT02577588|p53 Antigen|p53 antigen
1095423|NCT02577588|T cell therapy|t cell therapy
1095424|NCT02577588|autologous|autologous
1095425|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
1095426|NCT02577575|Oxytocin|oxytocin
1095427|NCT02577575|Syntocinon|syntocinon
1095428|NCT02577575|Social Cognition|social cognition
1095429|NCT02577575|Schizophrenia|schizophrenia
1095430|NCT02577549|Knee Pain|knee pain
1095431|NCT02577549|Exercise|exercise
1095432|NCT02577549|Diet|diet
1095433|NCT02577549|Weight Loss|weight loss
1095434|NCT02577536|Pregnancy outcome|pregnancy outcome
1095435|NCT02577536|Neonatal outcome|neonatal outcome
1095436|NCT02577536|Birth weight|birth weight
1095437|NCT02577536|Weight gain|weight gain
1095438|NCT02577536|Physical disability|physical disability
1095439|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
1095440|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
1095441|NCT02577510|nerve stimulator|nerve stimulator
1095442|NCT02577510|ultrasound|ultrasound
1095443|NCT02577484|Fractional Flow Reserve|fractional flow reserve
1095444|NCT02577484|Rapid Exchange|rapid exchange
1095445|NCT02577484|Catheter|catheter
1095446|NCT02577471|Constipation|constipation
1095447|NCT02577471|pregnancy|pregnancy
1095448|NCT02577471|delivery|delivery
1095449|NCT02577432|spinal anesthesia|spinal anesthesia
1095450|NCT02577419|breast milk|breast milk
1095451|NCT02577419|chylothorax|chylothorax
1095452|NCT02577419|infants|infants
1095453|NCT02577419|cardiac surgery|cardiac surgery
1095454|NCT02577419|modified fat breast milk|modified fat breast milk
1095455|NCT02577406|AG-221|ag-221
1095456|NCT02577406|CC-90007|cc-90007
1095457|NCT02577406|Efficacy|efficacy
1095458|NCT02577406|Safety|safety
1095459|NCT02577406|Leukemia|leukemia
1095460|NCT02577406|Acute myeloid meukemia|acute myeloid meukemia
1095461|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
1095462|NCT02577406|Enasidenib|enasidenib
1095463|NCT02577393|Lung Neoplasms|lung neoplasms
1095464|NCT02577393|esophagitis|esophagitis
1095465|NCT02577393|Prevention & Control|prevention & control
1095466|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
1095467|NCT02577367|Hypothyroidism|hypothyroidism
1095670|NCT02576431|Loxo|loxo
1095468|NCT02577367|Tube Feeding|tube feeding
1095469|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
1095470|NCT02577302|Chronic Tibial nerve stimulation|chronic tibial nerve stimulation
1095471|NCT02577302|Wireless PNS|wireless pns
1095472|NCT02577302|neuromodulation|neuromodulation
1095473|NCT02577289|simultaneous implantation|simultaneous implantation
1095474|NCT02577289|Dental implant|dental implant
1095475|NCT02577289|Open sinus Lifting|open sinus lifting
1095476|NCT02577289|PRF|prf
1095477|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
1095478|NCT02577276|stroke|stroke
1095479|NCT02577276|remote monitoring|remote monitoring
1095480|NCT02577276|hemiparesis|hemiparesis
1095481|NCT02577250|ketamine|ketamine
1095482|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
1095483|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
1095484|NCT02577250|anxiety disorders|anxiety disorders
1095485|NCT02577250|mental disorders|mental disorders
1095486|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
1095487|NCT02577250|analgesics|analgesics
1095488|NCT02577250|anesthetics|anesthetics
1095489|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
1095490|NCT02577250|anesthetics, general|anesthetics, general
1095491|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
1095492|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
1095493|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
1095494|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
1095495|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
1095496|NCT02577250|neurotransmitter agents|neurotransmitter agents
1095497|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
1095498|NCT02577250|pharmacologic actions|pharmacologic actions
1095499|NCT02577250|physiological effects of drugs|physiological effects of drugs
1095500|NCT02577250|psychotropic drugs|psychotropic drugs
1095501|NCT02577250|sensory system agents|sensory system agents
1095502|NCT02577250|central nervous system agents|central nervous system agents
1095503|NCT02577250|central nervous system depressants|central nervous system depressants
1095504|NCT02577250|depression|depression
1095505|NCT02577250|depressive disorder|depressive disorder
1095506|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
1095507|NCT02577250|behavioral symptoms|behavioral symptoms
1095508|NCT02577250|mood disorders|mood disorders
1095509|NCT02577250|therapeutic uses|therapeutic uses
1095510|NCT02577237|caregiver|caregiver
1095511|NCT02577237|simulation|simulation
1095512|NCT02577224|Patient-led care|patient-led care
1095513|NCT02577224|Botulinum toxin|botulinum toxin
1095514|NCT02577224|Dystonia|dystonia
1095515|NCT02577224|Randomised controlled trial|randomised controlled trial
1095516|NCT02577224|Acceptability|acceptability
1095517|NCT02577211|Critically ill|critically ill
1095518|NCT02577211|Enteral nutrition|enteral nutrition
1095519|NCT02577172|Testicular cancer|testicular cancer
1095520|NCT02577172|Physical Exercise|physical exercise
1095521|NCT02577172|Chemotherapy|chemotherapy
1095522|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
1095523|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1095524|NCT02577159|dyslipidemia|dyslipidemia
1095525|NCT02577159|remnants|remnants
1095526|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
1095527|NCT02577146|stone|stone
1095528|NCT02577146|ureter|ureter
1095529|NCT02577146|ultrasound|ultrasound
1095530|NCT02577133|colic|colic
1095531|NCT02577133|probiotic|probiotic
1095532|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
1095533|NCT02577133|prevention|prevention
1095534|NCT02577120|Epiceram|epiceram
1095535|NCT02577120|Ceramiseal|ceramiseal
1095536|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
1095537|NCT02577107|ranibizumab,|ranibizumab,
1095538|NCT02577107|conbercept,|conbercept,
1095539|NCT02577107|plasma VEGF|plasma vegf
1095540|NCT02577107|PK|pk
1095541|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
1095542|NCT02577055|Multiple leiomyoma|multiple leiomyoma
1095543|NCT02577055|Uterine Artery Embolization|uterine artery embolization
1095544|NCT02577055|Surgery|surgery
1095545|NCT02577055|childbearing age|childbearing age
1095546|NCT02577055|Fertility|fertility
1095547|NCT02577055|Noninferiority trial|noninferiority trial
1095548|NCT02577042|Raltegravir|raltegravir
1095549|NCT02577042|protease inhibitors|protease inhibitors
1095550|NCT02577042|darunavir|darunavir
1095551|NCT02577042|inflammation|inflammation
1095552|NCT02577042|statins|statins
1095553|NCT02577042|comorbidities|comorbidities
1095554|NCT02576990|PD1|pd1
1095555|NCT02576990|PD-1|pd-1
1095560|NCT02576977|Multiple Myeloma|multiple myeloma
1095561|NCT02576938|Atopic Eczema|atopic eczema
1095562|NCT02576912|Cannabis|cannabis
1095563|NCT02576912|Marijuana|marijuana
1095564|NCT02576912|THC|thc
1095565|NCT02576912|Pregnenolone|pregnenolone
1095566|NCT02576912|Psychotic Disorders|psychotic disorders
1095567|NCT02576912|PREG|preg
1095568|NCT02576899|smoking cessation|smoking cessation
1095569|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
1095570|NCT02576899|tobacco|tobacco
1095571|NCT02576899|treatment|treatment
1095572|NCT02576899|smoking|smoking
1095573|NCT02576899|mindfulness|mindfulness
1095574|NCT02576899|acceptance|acceptance
1095575|NCT02576899|functioning|functioning
1095576|NCT02576886|supine|supine
1095577|NCT02576886|prone|prone
1095578|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
1095579|NCT02576886|radiation exposure|radiation exposure
1095580|NCT02576886|pre-screening tool|pre-screening tool
1095581|NCT02576873|Survival|survival
1095582|NCT02576873|Hemodiafiltration|hemodiafiltration
1095583|NCT02576873|End-stage renal disease|end-stage renal disease
1095584|NCT02576873|Hemodialysis|hemodialysis
1095585|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
1095586|NCT02576795|Haemophilia A|haemophilia a
1095587|NCT02576795|Gene Therapy|gene therapy
1095588|NCT02576795|Clotting Disorders|clotting disorders
1095589|NCT02576795|Blood Disorder|blood disorder
1095590|NCT02576782|regional anesthesia|regional anesthesia
1095591|NCT02576782|dexamethasone|dexamethasone
1095592|NCT02576782|bupivacaine|bupivacaine
1095593|NCT02576782|femoral|femoral
1095594|NCT02576782|sciatic|sciatic
1095595|NCT02576769|Basal cell carcinoma|basal cell carcinoma
1095596|NCT02576769|Pigmentation|pigmentation
1095597|NCT02576769|Melanocyte|melanocyte
1095598|NCT02576769|Melanin|melanin
1095599|NCT02576769|Skin cancer|skin cancer
1095600|NCT02576756|Risk on aspiration|risk on aspiration
1095601|NCT02576756|Postoperative|postoperative
1095602|NCT02576756|Difficult Intubation|difficult intubation
1095603|NCT02576743|Stroke|stroke
1095604|NCT02576743|AVM|avm
1095605|NCT02576743|Aneurysm|aneurysm
1095606|NCT02576717|MS|ms
1095607|NCT02576717|RMS|rms
1095608|NCT02576717|Multiple Sclerosis|multiple sclerosis
1095609|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1095610|NCT02576691|cardiac arrest|cardiac arrest
1095611|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
1095612|NCT02576691|cardiogenic shock|cardiogenic shock
1095613|NCT02576691|outcome|outcome
1095614|NCT02576678|Psoriasis|psoriasis
1095615|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
1095616|NCT02576678|Plaque Psoriasis|plaque psoriasis
1095617|NCT02576678|CC-10004|cc-10004
1095618|NCT02576678|Apremilast|apremilast
1095619|NCT02576678|Pharmacokinetics|pharmacokinetics
1095620|NCT02576678|Open-label|open-label
1095621|NCT02576678|Safety|safety
1095622|NCT02576678|Pediatric|pediatric
1095623|NCT02576665|Anaplastic Astrocytoma, Glioblastoma|anaplastic astrocytoma, glioblastoma
1095624|NCT02576652|bone biopsy|bone biopsy
1095625|NCT02576652|tetracycline|tetracycline
1095626|NCT02576652|demeclocycline|demeclocycline
1095627|NCT02576652|total hip replacement|total hip replacement
1095628|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
1095629|NCT02576639|Amyloid Beta,|amyloid beta,
1095630|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
1095631|NCT02576639|beta secretase|beta secretase
1095632|NCT02576626|Nebulizer|nebulizer
1095633|NCT02576626|DPI|dpi
1095634|NCT02576626|COPD|copd
1095635|NCT02576626|indacaterol|indacaterol
1095636|NCT02576626|ipratropium|ipratropium
1095637|NCT02576626|glycopyrronium|glycopyrronium
1095638|NCT02576626|salbutamol|salbutamol
1095639|NCT02576626|Breezhaler|breezhaler
1095640|NCT02576626|Nebuliser|nebuliser
1095641|NCT02576626|Hyperinflation|hyperinflation
1095642|NCT02576626|Dyspnea|dyspnea
1095643|NCT02576626|SABA|saba
1095644|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
1095645|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
1095646|NCT02576626|LAMA|lama
1095647|NCT02576626|FEV1|fev1
1095648|NCT02576574|Avelumab|avelumab
1095649|NCT02576574|MSB0010718C|msb0010718c
1095650|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
1095651|NCT02576561|human papillomavirus|human papillomavirus
1095652|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1095653|NCT02576561|Cold Knife Conization|cold knife conization
1095654|NCT02576561|hysterectomy|hysterectomy
1095655|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
1095656|NCT02576561|LEEP|leep
1095657|NCT02576561|HSIL|hsil
1095658|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
1095659|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
1095660|NCT02576496|multiple myeloma|multiple myeloma
1095661|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
1095662|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1095663|NCT02576496|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1095664|NCT02576470|swallowing|swallowing
1095665|NCT02576470|stroke|stroke
1095666|NCT02576470|dysphagia|dysphagia
1095667|NCT02576470|deglutition|deglutition
1095668|NCT02576431|NTRK Fusion Positive|ntrk fusion positive
1095671|NCT02576431|TRK|trk
1095672|NCT02576431|TRK Fusion|trk fusion
1095673|NCT02576431|NTRK1|ntrk1
1095674|NCT02576431|NTRK2|ntrk2
1095675|NCT02576431|NTRK3|ntrk3
1095676|NCT02576431|TRKA|trka
1095677|NCT02576431|TRKB|trkb
1095678|NCT02576431|TRKC|trkc
1095679|NCT02576431|ETV6|etv6
1095680|NCT02576431|NTRK|ntrk
1095681|NCT02576431|larotrectinib|larotrectinib
1095682|NCT02576431|fusion|fusion
1095683|NCT02576431|tumors|tumors
1095684|NCT02576431|CNS tumors|cns tumors
1095685|NCT02576431|solid tumors|solid tumors
1095686|NCT02576431|central nervous system tumors|central nervous system tumors
1095687|NCT02576431|solid CNS tumors|solid cns tumors
1095688|NCT02576431|primary CNS tumor|primary cns tumor
1095689|NCT02576431|Advanced CNS tumor|advanced cns tumor
1095690|NCT02576431|Metastatic CNS tumor|metastatic cns tumor
1095691|NCT02576431|NTRK1 fusion|ntrk1 fusion
1095692|NCT02576431|NTRK2 fusion|ntrk2 fusion
1095693|NCT02576431|NTRK3 fusion|ntrk3 fusion
1095694|NCT02576431|ETV6-NTRK3|etv6-ntrk3
1095695|NCT02576431|ETV6 fusion|etv6 fusion
1095696|NCT02576418|Partosure TTD test|partosure ttd test
1095697|NCT02576418|CL|cl
1095698|NCT02576418|ART|art
1095699|NCT02576418|SN|sn
1095700|NCT02576418|SP|sp
1095701|NCT02576418|PPV|ppv
1095702|NCT02576418|NPV|npv
1095703|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
1095704|NCT02576379|Mortality|mortality
1095705|NCT02576379|Labour market affiliation|labour market affiliation
1095706|NCT02576379|Modified Rankin Scale|modified rankin scale
1095707|NCT02576327|Lymphoma|lymphoma
1095708|NCT02576327|Aprepitant|aprepitant
1095709|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
1095710|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
1095711|NCT02576327|Hematological Malignancies|hematological malignancies
1095712|NCT02576301|AML|aml
1095713|NCT02576301|MDS|mds
1095714|NCT02576288|Sitagliptin|sitagliptin
1095715|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
1095716|NCT02576288|Carotid stiffness|carotid stiffness
1095717|NCT02576288|Pro-inflammatory|pro-inflammatory
1095718|NCT02576288|Pro-atherogenic|pro-atherogenic
1095719|NCT02576288|M1 macrophages|m1 macrophages
1095720|NCT02576275|Phase 3|phase 3
1095721|NCT02576275|iNHL|inhl
1095722|NCT02576275|Follicular Lymphoma|follicular lymphoma
1095723|NCT02576275|FL|fl
1095724|NCT02576275|PI3K|pi3k
1095725|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1095726|NCT02576275|SLL|sll
1095727|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
1095728|NCT02576275|MZL|mzl
1095729|NCT02576249|osteoarthritis|osteoarthritis
1095730|NCT02576249|injection|injection
1095731|NCT02576249|steroid|steroid
1095732|NCT02576249|anesthetic|anesthetic
1095733|NCT02576236|Naïve patient|naïve patient
1095734|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
1095735|NCT02576236|Endoscopy|endoscopy
1095736|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
1095737|NCT02576236|Urea breath test|urea breath test
1095738|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
1095739|NCT02576197|mild to moderate|mild to moderate
1095740|NCT02576197|probiotic|probiotic
1095741|NCT02576184|Incisional hernia|incisional hernia
1095742|NCT02576184|Stoma|stoma
1095743|NCT02576184|rectal cancer|rectal cancer
1095744|NCT02576184|synthetic mesh|synthetic mesh
1095745|NCT02576184|biologic mesh|biologic mesh
1095746|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
1095747|NCT02576171|guided self-help|guided self-help
1095748|NCT02576171|adolescent|adolescent
1095749|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1095750|NCT02576067|Inflammation reduction|inflammation reduction
1095751|NCT02576041|driving simulator|driving simulator
1095752|NCT02576028|Total Hip Replacement|total hip replacement
1095753|NCT02576028|Manipulation Therapy|manipulation therapy
1095754|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1095755|NCT02575989|Trauma|trauma
1095756|NCT02575989|Prehospital|prehospital
1095757|NCT02575989|Hypothermia|hypothermia
1095758|NCT02575976|Rehabilitation|rehabilitation
1095759|NCT02575976|Coronary artery disease|coronary artery disease
1095760|NCT02575976|Patient Education|patient education
1095761|NCT02575976|Randomized Controlled Trial|randomized controlled trial
1095762|NCT02575976|Protocol|protocol
1095763|NCT02575937|low glycemic diet|low glycemic diet
1095764|NCT02575937|diabetes|diabetes
1095765|NCT02575924|media|media
1095766|NCT02575924|blastocyst|blastocyst
1095767|NCT02575924|male infertility|male infertility
1095768|NCT02575924|poor responders|poor responders
1095769|NCT02575924|pgs|pgs
1095770|NCT02575859|HIPEC|hipec
1095874|NCT02575339|Nexavar|nexavar
1095771|NCT02575859|peritoneal lavage|peritoneal lavage
1095772|NCT02575833|Angina|angina
1095773|NCT02575833|Stable Angina|stable angina
1095774|NCT02575833|Cardiovascular Disease|cardiovascular disease
1095775|NCT02575833|Exercise-induced Angina|exercise-induced angina
1095776|NCT02575807|Ovarian cancer|ovarian cancer
1095777|NCT02575807|Fallopian cancer|fallopian cancer
1095778|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
1095779|NCT02575755|Azithromycin|azithromycin
1095780|NCT02575755|Piperaquine|piperaquine
1095781|NCT02575755|IPTp|iptp
1095782|NCT02575755|Pharmacokinetics|pharmacokinetics
1095783|NCT02575755|Efficacy|efficacy
1095784|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
1095785|NCT02575729|local steroid injection|local steroid injection
1095786|NCT02575729|sonography|sonography
1095787|NCT02575729|sonography-guided|sonography-guided
1095788|NCT02575716|McGrath®|mcgrath®
1095789|NCT02575716|Videolaryngoscope|videolaryngoscope
1095790|NCT02575716|intubating condition|intubating condition
1095791|NCT02575716|muscle relaxant|muscle relaxant
1095792|NCT02575716|intubation|intubation
1095793|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
1095794|NCT02575677|labor pain|labor pain
1095795|NCT02575677|oxycodone|oxycodone
1095796|NCT02575664|Pain|pain
1095797|NCT02575664|Arthroplasty|arthroplasty
1095798|NCT02575664|Buprenorphine|buprenorphine
1095799|NCT02575651|PARP|parp
1095800|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
1095801|NCT02575651|Fluzoparib|fluzoparib
1095802|NCT02575651|Ovarian Cancer|ovarian cancer
1095803|NCT02575651|BRCA|brca
1095804|NCT02575625|Liver steatosis|liver steatosis
1095805|NCT02575625|Steatohepatitis|steatohepatitis
1095806|NCT02575625|Fibroscan|fibroscan
1095807|NCT02575599|Self-management|self-management
1095808|NCT02575599|web-based|web-based
1095809|NCT02575599|quantitative approach|quantitative approach
1095810|NCT02575586|Trigger Points|trigger points
1095811|NCT02575586|Dry needling|dry needling
1095812|NCT02575586|Torque|torque
1095813|NCT02575586|H-Reflex|h-reflex
1095814|NCT02575573|resuscitation decision|resuscitation decision
1095815|NCT02575560|Progression-Free Survival|progression-free survival
1095816|NCT02575547|Nutritional Status|nutritional status
1095817|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
1095818|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
1095819|NCT02575482|SUVN-D4010|suvn-d4010
1095820|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
1095821|NCT02575482|first in human|first in human
1095822|NCT02575482|safety|safety
1095823|NCT02575482|pharmacokinetics|pharmacokinetics
1095824|NCT02575482|tolerability|tolerability
1095825|NCT02575482|single dose|single dose
1095826|NCT02575482|repeat dose|repeat dose
1095827|NCT02575417|advance care planning|advance care planning
1095828|NCT02575417|end-of-life care|end-of-life care
1095829|NCT02575417|health games|health games
1095830|NCT02575417|Family caregivers|family caregivers
1095831|NCT02575417|Advance directives|advance directives
1095832|NCT02575404|Metastatic|metastatic
1095833|NCT02575404|Keytruda|keytruda
1095834|NCT02575404|pembrolizumab|pembrolizumab
1095835|NCT02575404|GR-MD-02|gr-md-02
1095836|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
1095837|NCT02575404|Immunotherapy|immunotherapy
1095838|NCT02575391|L-Glutamine|l-glutamine
1095839|NCT02575391|chemotherapy|chemotherapy
1095840|NCT02575391|radiotherapy|radiotherapy
1095841|NCT02575391|therapeutic toxicity|therapeutic toxicity
1095842|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
1095843|NCT02575378|Maintenance Treatment|maintenance treatment
1095844|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
1095845|NCT02575378|Clinical Trial|clinical trial
1095846|NCT02575378|efficacy|efficacy
1095847|NCT02575378|safety|safety
1095848|NCT02575365|RRMS,|rrms,
1095849|NCT02575365|Cognition,|cognition,
1095850|NCT02575365|brain,|brain,
1095851|NCT02575365|Fingolimod,|fingolimod,
1095852|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
1095853|NCT02575365|neurodegeneration,|neurodegeneration,
1095854|NCT02575365|Brain atrophy,|brain atrophy,
1095855|NCT02575365|gray matter atrophy,|gray matter atrophy,
1095856|NCT02575365|thalamic atrophy,|thalamic atrophy,
1095857|NCT02575365|biomarkers,|biomarkers,
1095858|NCT02575365|BICAMS Battery,|bicams battery,
1095859|NCT02575352|Bone Substitute|bone substitute
1095860|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
1095861|NCT02575352|GRAFTYS|graftys
1095862|NCT02575352|GRAFTYS®HBS|graftys®hbs
1095863|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
1095864|NCT02575352|Bone void filler|bone void filler
1095865|NCT02575352|Bone growth|bone growth
1095866|NCT02575352|Registry|registry
1095867|NCT02575352|Bone defect|bone defect
1095868|NCT02575352|Revision arthroplasty|revision arthroplasty
1095869|NCT02575352|Arthrodesis|arthrodesis
1095870|NCT02575339|MLN0128|mln0128
1095871|NCT02575339|Sapanisertib|sapanisertib
1095872|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
1095873|NCT02575339|INK128|ink128
1095876|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
1095877|NCT02575313|L-Glutamine|l-glutamine
1095878|NCT02575313|chemotherapy|chemotherapy
1095879|NCT02575313|radiotherapy|radiotherapy
1095880|NCT02575313|therapeutic toxicity|therapeutic toxicity
1095881|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
1095882|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
1095883|NCT02575300|pancreatic NETs|pancreatic nets
1095884|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
1095885|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
1095886|NCT02575274|Peri-implantitis|peri-implantitis
1095887|NCT02575274|Peri-implant disease|peri-implant disease
1095888|NCT02575274|Dental implants|dental implants
1095889|NCT02575274|Guided bone regeneration|guided bone regeneration
1095890|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
1095891|NCT02575261|EphA2|epha2
1095892|NCT02575261|malignant glioma|malignant glioma
1095893|NCT02575248|dienogest|dienogest
1095894|NCT02575248|infertility|infertility
1095895|NCT02575248|endometriosis|endometriosis
1095896|NCT02575235|Sarcopenia|sarcopenia
1095897|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
1095898|NCT02575222|Immunotherapy|immunotherapy
1095899|NCT02575222|PD-1|pd-1
1095900|NCT02575222|anti-PD-1|anti-pd-1
1095901|NCT02575222|antibody|antibody
1095902|NCT02575222|Kidney Cancer|kidney cancer
1095903|NCT02575222|RCC|rcc
1095904|NCT02575222|non-metastatic|non-metastatic
1095905|NCT02575196|Cardiac arrest|cardiac arrest
1095906|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1095907|NCT02575196|CPR|cpr
1095908|NCT02575196|cerebral blood flow|cerebral blood flow
1095909|NCT02575196|cerebral perfusion|cerebral perfusion
1095910|NCT02575183|Waterpipe smoking|waterpipe smoking
1095911|NCT02575183|Nicotine dependence|nicotine dependence
1095912|NCT02575183|Smoking cessation|smoking cessation
1095913|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
1095914|NCT02575183|Behavioral therapy|behavioral therapy
1095915|NCT02575170|amino acid|amino acid
1095916|NCT02575170|cesarean delivery|cesarean delivery
1095917|NCT02575170|hypothermia|hypothermia
1095918|NCT02575131|satiety|satiety
1095919|NCT02575131|overweight|overweight
1095920|NCT02575131|breakfast|breakfast
1095921|NCT02575131|ecological validity|ecological validity
1095922|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
1095923|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
1095924|NCT02575092|Coronary angiography|coronary angiography
1095925|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
1095926|NCT02575092|Hypertension|hypertension
1095927|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
1095928|NCT02575066|pazopanib|pazopanib
1095929|NCT02575066|radiotherapy|radiotherapy
1095930|NCT02575053|latex allergy|latex allergy
1095931|NCT02575053|latex hypersensitivity|latex hypersensitivity
1095932|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
1095933|NCT02575053|latex safe protocol|latex safe protocol
1095934|NCT02575001|Type 1 diabetes|type 1 diabetes
1095935|NCT02575001|Children and adolescents|children and adolescents
1095936|NCT02575001|Stress|stress
1095937|NCT02575001|Genetic factors|genetic factors
1095938|NCT02575001|Psychological background|psychological background
1095939|NCT02574988|drug allergy|drug allergy
1095940|NCT02574988|drug hypersensitivity|drug hypersensitivity
1095941|NCT02574988|adverse drug reactions|adverse drug reactions
1095942|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
1095943|NCT02574949|radiation|radiation
1095944|NCT02574949|fluoroscopy|fluoroscopy
1095945|NCT02574949|diagnostic|diagnostic
1095946|NCT02574936|karydakis modification|karydakis modification
1095947|NCT02574936|pilonidal sinus|pilonidal sinus
1095948|NCT02574936|complication|complication
1095949|NCT02574923|Cerebral Palsy|cerebral palsy
1095950|NCT02574923|Stem Cells|stem cells
1095952|NCT02574871|Chronic stress|chronic stress
1095953|NCT02574871|Perceived stress|perceived stress
1095954|NCT02574871|Psychological distress|psychological distress
1095955|NCT02574832|Pain|pain
1095956|NCT02574832|Surgery|surgery
1095957|NCT02574832|Pregnancy|pregnancy
1095958|NCT02574832|Anesthesia|anesthesia
1095959|NCT02574819|opioid-induced constipation|opioid-induced constipation
1095960|NCT02574806|BNP|bnp
1095961|NCT02574806|Reference values|reference values
1095962|NCT02574806|Newborn|newborn
1095963|NCT02574806|Ventricular function|ventricular function
1095964|NCT02574806|Stress|stress
1095965|NCT02574806|Pediatrics|pediatrics
1095966|NCT02574806|Biomarkers|biomarkers
1095967|NCT02574793|Glucose Fluctuation|glucose fluctuation
1095968|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
1095969|NCT02574793|Cushing Syndrome|cushing syndrome
1095970|NCT02574780|lymphedema|lymphedema
1095971|NCT02574780|complex physical therapy|complex physical therapy
1095972|NCT02574780|muscle strength|muscle strength
1095973|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
1095974|NCT02574754|warfarin|warfarin
1095975|NCT02574754|pharmacokinetics|pharmacokinetics
1096175|NCT02573844|meteorism|meteorism
1095976|NCT02574754|bioequivalence|bioequivalence
1095977|NCT02574754|healthy volunteer|healthy volunteer
1095978|NCT02574728|Pediatrics|pediatrics
1095979|NCT02574728|Brain Tumors|brain tumors
1096275|NCT02573324|Brain Tumor|brain tumor
1095980|NCT02574728|Neuroblastoma|neuroblastoma
1095981|NCT02574728|Osteosarcoma|osteosarcoma
1095982|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
1095983|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
1095984|NCT02574728|Wilms Tumors|wilms tumors
1095985|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
1095986|NCT02574702|superficial surgical site infection|superficial surgical site infection
1095987|NCT02574702|loop ileostomy|loop ileostomy
1095988|NCT02574702|Ileostomy closure|ileostomy closure
1095989|NCT02574689|Physical Activity|physical activity
1095990|NCT02574689|Cancer Prevention|cancer prevention
1095991|NCT02574637|MEDI2070|medi2070
1095992|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
1095993|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
1095994|NCT02574637|IL-23|il-23
1095995|NCT02574598|PDL1|pdl1
1095996|NCT02574598|monoclonal antibody|monoclonal antibody
1095997|NCT02574585|Spinal cord injury|spinal cord injury
1095998|NCT02574585|Paraplegia|paraplegia
1095999|NCT02574585|Stem cells|stem cells
1096000|NCT02574585|Mesenchymal cells|mesenchymal cells
1096001|NCT02574572|Spinal cord injury|spinal cord injury
1096002|NCT02574572|Mesenchymal cells|mesenchymal cells
1096003|NCT02574572|Stem cells|stem cells
1096004|NCT02574559|Caregiver|caregiver
1096005|NCT02574559|Stress|stress
1096006|NCT02574559|Depression|depression
1096007|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
1096008|NCT02574559|Compassion Meditation|compassion meditation
1096009|NCT02574546|Mastectomy|mastectomy
1096010|NCT02574533|Immunotherapy|immunotherapy
1096011|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
1096012|NCT02574533|Keytruda|keytruda
1096013|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
1096014|NCT02574533|vaccine|vaccine
1096015|NCT02574533|FANG|fang
1096016|NCT02574533|Vigil|vigil
1096017|NCT02574520|Post-operative pain|post-operative pain
1096018|NCT02574520|opioid|opioid
1096019|NCT02574520|opioid reduction|opioid reduction
1096020|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1096021|NCT02574520|laparoscopic surgery|laparoscopic surgery
1096022|NCT02574520|bupivacaine|bupivacaine
1096023|NCT02574520|extended release|extended release
1096024|NCT02574520|locally acting analgesic|locally acting analgesic
1096025|NCT02574507|breast cancer|breast cancer
1096026|NCT02574507|weight management|weight management
1096027|NCT02574507|couples|couples
1096028|NCT02574507|symptom management|symptom management
1096029|NCT02574481|atherosclerosis|atherosclerosis
1096030|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
1096031|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
1096032|NCT02574481|lower extremities|lower extremities
1096033|NCT02574481|stenting|stenting
1096034|NCT02574481|paclitaxel|paclitaxel
1096035|NCT02574468|Dexamethasone|dexamethasone
1096036|NCT02574468|Direct pulp capping|direct pulp capping
1096037|NCT02574468|MTA|mta
1096038|NCT02574468|pulpotomy|pulpotomy
1096039|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1096040|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1096041|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1096042|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
1096043|NCT02574429|Borderline Personality Disorder|borderline personality disorder
1096044|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
1096045|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
1096046|NCT02574429|Group Therapy|group therapy
1096047|NCT02574429|Comorbidity|comorbidity
1096048|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
1096049|NCT02574416|Health behaviour|health behaviour
1096050|NCT02574416|Health outcomes|health outcomes
1096051|NCT02574416|Diet quality|diet quality
1096052|NCT02574416|Physical function|physical function
1096053|NCT02574416|Lifestyle|lifestyle
1096054|NCT02574416|Older adults|older adults
1096055|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
1096056|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
1096057|NCT02574390|ALS|als
1096058|NCT02574390|stem cell|stem cell
1096059|NCT02574390|biomarker|biomarker
1096060|NCT02574390|disease progression|disease progression
1096061|NCT02574364|abdomen CT|abdomen ct
1096062|NCT02574364|open appendicectomy|open appendicectomy
1096063|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
1096064|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
1096065|NCT02574299|dyslexia|dyslexia
1096066|NCT02574299|training|training
1096067|NCT02574299|auditory rehabilitation|auditory rehabilitation
1096068|NCT02574299|hearing loss|hearing loss
1096069|NCT02574299|evoked potentials|evoked potentials
1096070|NCT02574299|dichotic|dichotic
1096071|NCT02574299|plasticity|plasticity
1096072|NCT02574299|noise|noise
1096073|NCT02574247|Audiology|audiology
1096176|NCT02573844|flatulence|flatulence
1096074|NCT02574247|Auditory Pathways|auditory pathways
1096075|NCT02574247|Auditory Perception|auditory perception
1096076|NCT02574247|Brain Stem|brain stem
1096077|NCT02574247|Cochlea|cochlea
1096078|NCT02574247|Ear, Inner|ear, inner
1096079|NCT02574247|Efferent Pathways|efferent pathways
1096080|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
1096081|NCT02574247|Learning|learning
1096082|NCT02574247|Neurons, Efferent|neurons, efferent
1096083|NCT02574247|Speech Perception|speech perception
1096084|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
1096085|NCT02574234|inflammation|inflammation
1096087|NCT02574208|Adult outpatients|adult outpatients
1096088|NCT02574208|Paris, France|paris, france
1096089|NCT02574195|Diabetes Mellitus|diabetes mellitus
1096090|NCT02574195|microvascular complications|microvascular complications
1096091|NCT02574195|macrovascular complications|macrovascular complications
1096092|NCT02574195|epidemiology|epidemiology
1096093|NCT02574195|Russia|russia
1096094|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
1096095|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
1096096|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
1096097|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
1096098|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
1096099|NCT02574143|Prognosis|prognosis
1096100|NCT02574143|Prospective Study|prospective study
1096101|NCT02574143|Quality of Life|quality of life
1096102|NCT02574143|Radiology|radiology
1096103|NCT02574143|Rehabilitation|rehabilitation
1096104|NCT02574143|Registry;|registry;
1096105|NCT02574143|Signs and Symptoms|signs and symptoms
1096106|NCT02574143|Therapy|therapy
1096107|NCT02574143|Bronchiectiasis|bronchiectiasis
1096108|NCT02574143|Diagnosis|diagnosis
1096109|NCT02574143|Epidemiology|epidemiology
1096110|NCT02574143|Etiology|etiology
1096111|NCT02574143|Longitudinal Study|longitudinal study
1096112|NCT02574143|Microbiology|microbiology
1096113|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
1096114|NCT02574104|Patient simulation|patient simulation
1096115|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
1096116|NCT02574104|Human factors|human factors
1096117|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
1096118|NCT02574091|EGFR inhibitor|egfr inhibitor
1096119|NCT02574091|topical agent|topical agent
1096120|NCT02574091|psoriasis|psoriasis
1096121|NCT02574091|phase 1|phase 1
1096122|NCT02574065|crying|crying
1096123|NCT02574065|colicky|colicky
1096124|NCT02574065|infants|infants
1096125|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
1096126|NCT02574052|Menu Labelling;|menu labelling;
1096127|NCT02574052|Nutrition Education;|nutrition education;
1096128|NCT02574052|dietary assessment tools;|dietary assessment tools;
1096129|NCT02574039|volunteers|volunteers
1096130|NCT02574039|oat|oat
1096131|NCT02574039|phenolic acid|phenolic acid
1096132|NCT02574039|bioavailability|bioavailability
1096133|NCT02574026|MEG|meg
1096134|NCT02574026|EEG|eeg
1096135|NCT02574026|MRI|mri
1096136|NCT02574026|Brain mapping|brain mapping
1096137|NCT02574026|functional imaging|functional imaging
1096138|NCT02574026|brain computer interface|brain computer interface
1096139|NCT02573974|undernutrition|undernutrition
1096140|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
1096141|NCT02573974|skeletal muscle|skeletal muscle
1096142|NCT02573974|energy metabolism|energy metabolism
1096143|NCT02573948|People who inject drugs|people who inject drugs
1096144|NCT02573948|Vietnam|vietnam
1096145|NCT02573948|Community support groups|community support groups
1096146|NCT02573935|Multiple Myeloma|multiple myeloma
1096147|NCT02573935|Clarithromycin|clarithromycin
1096148|NCT02573935|Induction Chemotherapy|induction chemotherapy
1096149|NCT02573935|Transplantation, Autologous|transplantation, autologous
1096150|NCT02573922|constipation|constipation
1096151|NCT02573922|opioid|opioid
1096152|NCT02573922|Oxycodone|oxycodone
1096153|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
1096154|NCT02573922|spine surgery|spine surgery
1096155|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
1096156|NCT02573883|Vulva|vulva
1096157|NCT02573883|Lichen Sclerosus|lichen sclerosus
1096158|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
1096159|NCT02573883|Mona Lisa Laser|mona lisa laser
1096160|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
1096161|NCT02573883|Vulvodynia|vulvodynia
1096162|NCT02573870|COPD|copd
1096163|NCT02573870|DPI|dpi
1096164|NCT02573870|Batefenterol|batefenterol
1096165|NCT02573870|Fluticasone Furoate|fluticasone furoate
1096166|NCT02573857|Induced blood stage malaria|induced blood stage malaria
1096167|NCT02573857|Transmission|transmission
1096168|NCT02573857|Gametocytemia|gametocytemia
1096169|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
1096170|NCT02573844|abdominal pain|abdominal pain
1096171|NCT02573844|rome III criteria|rome iii criteria
1096172|NCT02573844|abdominal distension|abdominal distension
1096173|NCT02573844|consistency of stools|consistency of stools
1096174|NCT02573844|stool frequency|stool frequency
1096177|NCT02573844|abdominal discomfort|abdominal discomfort
1096178|NCT02573844|proklama|proklama
1096179|NCT02573844|probiotics|probiotics
1096180|NCT02573844|alga klamath|alga klamath
1096181|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
1096182|NCT02573844|prebiotics|prebiotics
1096183|NCT02573844|colitis ulcerosa|colitis ulcerosa
1096184|NCT02573831|labor|labor
1096185|NCT02573831|pain|pain
1096186|NCT02573831|oxycodone|oxycodone
1096187|NCT02573831|placenta|placenta
1096188|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
1096189|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
1096190|NCT02573805|erectile dysfunction|erectile dysfunction
1096191|NCT02573805|Chinese males|chinese males
1096192|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
1096193|NCT02573779|human milk|human milk
1096194|NCT02573779|enteral nutrition|enteral nutrition
1096195|NCT02573779|microbiome|microbiome
1096196|NCT02573779|Microbiota|microbiota
1096197|NCT02573766|Neurofeedback training|neurofeedback training
1096198|NCT02573766|EEG|eeg
1096199|NCT02573766|electroencephalograph|electroencephalograph
1096200|NCT02573766|Questionnaires|questionnaires
1096201|NCT02573766|Surveys|surveys
1096202|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
1096203|NCT02573766|CIPN|cipn
1096204|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
1096205|NCT02573740|Alzheimer's Disease|alzheimer's disease
1096206|NCT02573714|Ketamine|ketamine
1096207|NCT02573714|Intranasal|intranasal
1096208|NCT02573714|Pain crisis|pain crisis
1096209|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
1096210|NCT02573714|Sickle cell disease|sickle cell disease
1096211|NCT02573701|Schizophrenia|schizophrenia
1096212|NCT02573701|Adolescents|adolescents
1096213|NCT02573701|Treatment|treatment
1096214|NCT02573701|Guidelines|guidelines
1096215|NCT02573688|Obesity|obesity
1096216|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
1096217|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
1096218|NCT02573675|hemodialysis|hemodialysis
1096219|NCT02573675|peritoneal dialysis|peritoneal dialysis
1096220|NCT02573662|Metabolic complications|metabolic complications
1096221|NCT02573662|Type 2 diabetes|type 2 diabetes
1096222|NCT02573662|Sedentary lifestyle|sedentary lifestyle
1096223|NCT02573662|Low grade inflammation|low grade inflammation
1096224|NCT02573662|Lipid metabolism|lipid metabolism
1096225|NCT02573662|Glucose metabolism|glucose metabolism
1096226|NCT02573662|Bone metabolism|bone metabolism
1096227|NCT02573662|Physical inactivity|physical inactivity
1096228|NCT02573623|Immunology diagnosis test|immunology diagnosis test
1096229|NCT02573623|Children|children
1096230|NCT02573623|Zambia|zambia
1096231|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
1096232|NCT02573571|cytokines|cytokines
1096233|NCT02573571|microbiome|microbiome
1096234|NCT02573545|liver|liver
1096235|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
1096236|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
1096237|NCT02573532|perioperative|perioperative
1096238|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
1096239|NCT02573532|prognosis|prognosis
1096240|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
1096241|NCT02573519|3D-Transit|3d-transit
1096242|NCT02573519|Diabetes Mellitus|diabetes mellitus
1096243|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
1096244|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
1096245|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
1096246|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
1096247|NCT02573506|Consolidation chemotherapy|consolidation chemotherapy
1096248|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
1096249|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
1096250|NCT02573467|muscle wasting,|muscle wasting,
1096251|NCT02573467|extension study,|extension study,
1096252|NCT02573467|BYM338,|bym338,
1096253|NCT02573467|bimagrumab,|bimagrumab,
1096254|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
1096255|NCT02573428|Eye Gaze|eye gaze
1096256|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
1096257|NCT02573428|Autism|autism
1096258|NCT02573402|electric stimulation|electric stimulation
1096259|NCT02573402|urodynamic study|urodynamic study
1096260|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
1096261|NCT02573376|HIV|hiv
1096262|NCT02573376|Hepatitis C|hepatitis c
1096263|NCT02573376|Drug Abuse|drug abuse
1096264|NCT02573376|Hepatitis C Virus|hepatitis c virus
1096265|NCT02573376|sofosbuvir|sofosbuvir
1096266|NCT02573376|ledipasvir|ledipasvir
1096267|NCT02573376|pharmacology|pharmacology
1096268|NCT02573376|pharmacokinetics|pharmacokinetics
1096269|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
1096270|NCT02573324|Epithelial Growth Factor Receptor (EGFR)|epithelial growth factor receptor (egfr)
1096271|NCT02573324|Temozolomide|temozolomide
1096273|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
1096274|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
1096276|NCT02573324|Brain Tumor Group|brain tumor group
1096277|NCT02573324|EGFRvIII|egfrviii
1096278|NCT02573324|EGFR Amplified|egfr amplified
1096279|NCT02573324|First Line Therapy|first line therapy
1096280|NCT02573324|Brain Cancer|brain cancer
1096281|NCT02573298|cryotherapy|cryotherapy
1096282|NCT02573298|power Doppler score|power doppler score
1096283|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
1096284|NCT02573298|pain VAS|pain vas
1096285|NCT02573259|efficacy|efficacy
1096286|NCT02573259|safety|safety
1096287|NCT02573259|pharmacokinetics|pharmacokinetics
1096288|NCT02573259|pharmacodynamics|pharmacodynamics
1096289|NCT02573259|open label|open label
1096290|NCT02573259|dose response|dose response
1096291|NCT02573259|multiple ascending dose|multiple ascending dose
1096292|NCT02573259|immunogenicity|immunogenicity
1096293|NCT02573259|recommended phase 2 dose|recommended phase 2 dose
1096294|NCT02573259|subcutaneous|subcutaneous
1096295|NCT02573246|neurostimulation|neurostimulation
1096296|NCT02573246|cognitive restructuring|cognitive restructuring
1096297|NCT02573246|TMS|tms
1096298|NCT02573246|emotion regulation|emotion regulation
1096299|NCT02573246|MRI|mri
1096300|NCT02573246|Emotional Memory Task|emotional memory task
1096301|NCT02573246|Reappraisal|reappraisal
1096302|NCT02573246|Distraction|distraction
1096303|NCT02573194|Appetite|appetite
1096304|NCT02573194|Amino acids|amino acids
1096305|NCT02573194|Protein Source|protein source
1096306|NCT02573168|Pharmacogenomic|pharmacogenomic
1096307|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
1096308|NCT02573168|Pharmacogenomics|pharmacogenomics
1096309|NCT02573168|Genetic Testing|genetic testing
1096310|NCT02573168|Genetics|genetics
1096311|NCT02573168|GeneSight|genesight
1096312|NCT02573168|Enhanced GeneSight|enhanced genesight
1096313|NCT02573168|Psychotropic|psychotropic
1096314|NCT02573155|Pharmacokinetics|pharmacokinetics
1096315|NCT02573155|Pharmacodynamics|pharmacodynamics
1096316|NCT02573155|AZD8871|azd8871
1096317|NCT02573155|Safety|safety
1096318|NCT02573155|Tolerability|tolerability
1096319|NCT02573155|mild persistent asthma|mild persistent asthma
1096320|NCT02573155|moderate to severe COPD|moderate to severe copd
1096321|NCT02573142|obesity|obesity
1096322|NCT02573142|treatment|treatment
1096323|NCT02573142|community|community
1096324|NCT02573142|integrated|integrated
1096325|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
1096326|NCT02573129|Mediterranean diet|mediterranean diet
1096327|NCT02573129|red meat|red meat
1096328|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
1096329|NCT02573116|endothelial dysfunction|endothelial dysfunction
1096330|NCT02573116|periodontitis|periodontitis
1096331|NCT02573090|Occlusal caries|occlusal caries
1096332|NCT02573090|Resin based fissure sealant|resin based fissure sealant
1096333|NCT02573090|Composite resin restoration|composite resin restoration
1096334|NCT02573090|Effectiveness|effectiveness
1096335|NCT02573090|Longevity|longevity
1096336|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
1096337|NCT02573077|Cancer|cancer
1096338|NCT02573038|Aflibercept|aflibercept
1096339|NCT02573038|choroidal neovascularization|choroidal neovascularization
1096340|NCT02573038|angioid streaks|angioid streaks
1096341|NCT02573038|young patient|young patient
1096342|NCT02572999|Aged|aged
1096343|NCT02572999|Frail|frail
1096344|NCT02572999|Functional decline|functional decline
1096345|NCT02572999|Impairment|impairment
1096346|NCT02572999|valvular heart disease|valvular heart disease
1096347|NCT02572999|Cohort|cohort
1096348|NCT02572999|risk factors|risk factors
1096349|NCT02572947|Dolutegravir|dolutegravir
1096350|NCT02572947|HIV infection|hiv infection
1096351|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
1096352|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
1096353|NCT02572947|Integrase Inhibitors|integrase inhibitors
1096354|NCT02572947|Pharmacologic Actions|pharmacologic actions
1096355|NCT02572947|Therapeutic Uses|therapeutic uses
1096356|NCT02572934|Testicular cancer|testicular cancer
1096357|NCT02572934|Survivorship|survivorship
1096358|NCT02572934|late adverse treatment effects|late adverse treatment effects
1096359|NCT02572921|Positive Psychotherapy|positive psychotherapy
1096360|NCT02572921|Depression|depression
1096361|NCT02572921|Happiness|happiness
1096362|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
1096363|NCT02572895|Cranberry|cranberry
1096364|NCT02572895|Proanthocyanidins|proanthocyanidins
1096365|NCT02572895|Urinary catabolites|urinary catabolites
1096366|NCT02572882|hemodialysis|hemodialysis
1096367|NCT02572882|p-inulin|p-inulin
1096368|NCT02572882|gut microbiome|gut microbiome
1096369|NCT02572869|Mandible Reconstruction|mandible reconstruction
1096370|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
1096371|NCT02572869|Quality of Life|quality of life
1096372|NCT02572869|15-244|15-244
1096373|NCT02572856|Feasibility|feasibility
1096374|NCT02572856|continuous glucose monitor|continuous glucose monitor
1096375|NCT02572856|surgery|surgery
1096376|NCT02572843|NSCLC|nsclc
1096379|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
1096380|NCT02572843|immunotherapy|immunotherapy
1096381|NCT02572843|anti-PD-L1|anti-pd-l1
1096382|NCT02572830|Reconsolidation|reconsolidation
1096383|NCT02572830|EMDR|emdr
1096384|NCT02572830|PTSD|ptsd
1096385|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
1096386|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
1096387|NCT02572804|rectus sheath catheter|rectus sheath catheter
1096388|NCT02572804|epidural|epidural
1096389|NCT02572713|Parkinson's Disease|parkinson's disease
1096390|NCT02572713|alpha-synuclein|alpha-synuclein
1096391|NCT02572713|biomarker|biomarker
1096392|NCT02572687|metastatic|metastatic
1096393|NCT02572687|advanced|advanced
1096394|NCT02572687|immuno-oncology|immuno-oncology
1096395|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1096396|NCT02572687|angiogenesis|angiogenesis
1096397|NCT02572687|PD-1|pd-1
1096398|NCT02572687|PD-L1|pd-l1
1096399|NCT02572674|Bipolar disorder|bipolar disorder
1096400|NCT02572674|relapse risk factors|relapse risk factors
1096401|NCT02572674|prospective follow up|prospective follow up
1096402|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
1096403|NCT02572648|Cardiomyopathy|cardiomyopathy
1096404|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1096405|NCT02572635|Pneumococcal Infection|pneumococcal infection
1096406|NCT02572635|Phase I|phase i
1096407|NCT02572635|Immunogenicity|immunogenicity
1096408|NCT02572635|Safety|safety
1096409|NCT02572635|Vaccination|vaccination
1096410|NCT02572622|exercise|exercise
1096411|NCT02572622|deep friction massage|deep friction massage
1096412|NCT02572622|spinal decompression|spinal decompression
1096413|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
1096414|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
1096415|NCT02572596|Thrombopoietin|thrombopoietin
1096416|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
1096417|NCT02572583|Influenza|influenza
1096418|NCT02572570|Adult dental care|adult dental care
1096419|NCT02572557|Spray Cryotherapy|spray cryotherapy
1096420|NCT02572544|young healthy adults|young healthy adults
1096421|NCT02572544|single pinhole glasses|single pinhole glasses
1096422|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
1096423|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
1096424|NCT02572531|Wound Healing|wound healing
1096425|NCT02572531|Third Molar|third molar
1096426|NCT02572531|Postoperative Complications|postoperative complications
1096427|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
1096428|NCT02572505|HIV-Discordant|hiv-discordant
1096429|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
1096430|NCT02572492|Multiple Myeloma|multiple myeloma
1096431|NCT02572492|Recurrence|recurrence
1096432|NCT02572492|Carfilzomib|carfilzomib
1096433|NCT02572492|Salvage Therapy|salvage therapy
1096434|NCT02572492|Transplantation, Autologous|transplantation, autologous
1096435|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
1096436|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
1096437|NCT02572466|End-stage renal disease|end-stage renal disease
1096438|NCT02572466|hemodialysis|hemodialysis
1096439|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
1096440|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
1096441|NCT02572401|Sexually transmitted disease|sexually transmitted disease
1096442|NCT02572401|Behavioral intervention|behavioral intervention
1096443|NCT02572401|Randomized controlled trial|randomized controlled trial
1096444|NCT02572401|Text messages|text messages
1096445|NCT02572401|Social cognitive theory|social cognitive theory
1096446|NCT02572401|Theory of planned behavior|theory of planned behavior
1096447|NCT02572401|Sexual behavior|sexual behavior
1096448|NCT02572401|African Americans|african americans
1096449|NCT02572401|Men|men
1096450|NCT02572349|Healthy Subjects|healthy subjects
1096451|NCT02572310|total knee arthroplasty|total knee arthroplasty
1096452|NCT02572297|epilepsy|epilepsy
1096453|NCT02572297|SUDEP|sudep
1096454|NCT02572297|SpO2|spo2
1096455|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1096456|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
1096457|NCT02572284|Preoperative SBRT|preoperative sbrt
1096458|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
1096459|NCT02572284|Prostatectomy|prostatectomy
1096460|NCT02572284|Quality of Life|quality of life
1096461|NCT02572271|Autologous augmentation|autologous augmentation
1096462|NCT02572271|Mastopexy|mastopexy
1096463|NCT02572271|Massive weight loss|massive weight loss
1096464|NCT02572245|Healthy Subjects|healthy subjects
1096465|NCT02572245|Device|device
1096466|NCT02572245|PK|pk
1096467|NCT02572245|Phase 1|phase 1
1096468|NCT02572245|Bioequivalence|bioequivalence
1096469|NCT02572245|Adalimumab|adalimumab
1096470|NCT02572245|Single Dose|single dose
1096471|NCT02572193|achalasia|achalasia
1096472|NCT02572193|surgery|surgery
1096473|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
1096474|NCT02572167|Antigens, CD30|antigens, cd30
1096475|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
1096476|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
1096477|NCT02572167|Immunotherapy|immunotherapy
1096478|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
1096479|NCT02572115|After-Hours Care|after-hours care
1096480|NCT02572115|Primary Care|primary care
1096481|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
1096482|NCT02572115|Denmark|denmark
1096483|NCT02572115|Questionnaires|questionnaires
1096484|NCT02572115|Patient Satisfaction|patient satisfaction
1096485|NCT02572115|Patient feeling of safety|patient feeling of safety
1096486|NCT02572115|Triage/standards|triage/standards
1096487|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
1096488|NCT02572115|Humans|humans
1096489|NCT02572115|Male|male
1096490|NCT02572115|Female|female
1096491|NCT02572115|Hotlines|hotlines
1096492|NCT02572115|telenursing|telenursing
1096493|NCT02572115|Night Care/utilization|night care/utilization
1096494|NCT02572115|postal service|postal service
1096496|NCT02572102|Blood Pressure|blood pressure
1096497|NCT02572102|Energy Drinks|energy drinks
1096498|NCT02572102|Panax Ginseng|panax ginseng
1096499|NCT02572037|Premature ejaculation|premature ejaculation
1096500|NCT02572037|Dapoxetine|dapoxetine
1096501|NCT02572037|local anaesthetics|local anaesthetics
1096502|NCT02572037|nerve electrophysiology|nerve electrophysiology
1096503|NCT02572011|Lower limb amputation|lower limb amputation
1096504|NCT02572011|Transtibial|transtibial
1096505|NCT02572011|Balance|balance
1096506|NCT02572011|Postural Control|postural control
1096507|NCT02572011|Limits of Stability|limits of stability
1096508|NCT02572011|Rehabilitation|rehabilitation
1096509|NCT02572011|Home-based intervention|home-based intervention
1096510|NCT02572011|Nintendo Wii|nintendo wii
1096511|NCT02572011|Balance Board|balance board
1096512|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
1096513|NCT02571985|iliac aneurysm|iliac aneurysm
1096514|NCT02571985|branch|branch
1096515|NCT02571985|connections|connections
1096516|NCT02571985|endovascular graft|endovascular graft
1096517|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
1096518|NCT02571985|Aneurysm|aneurysm
1096519|NCT02571985|Vascular Diseases|vascular diseases
1096520|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
1096521|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
1096522|NCT02571972|topical aqueous suppression|topical aqueous suppression
1096523|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1096524|NCT02571972|macular edema|macular edema
1096525|NCT02571972|intravitreal injection|intravitreal injection
1096526|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1096527|NCT02571959|Obesity|obesity
1096528|NCT02571959|Pharmacology|pharmacology
1096529|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
1096530|NCT02571933|Pediatrics|pediatrics
1096531|NCT02571933|Pain Scale|pain scale
1096532|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
1096533|NCT02571933|Cameroon|cameroon
1096534|NCT02571920|cardiac surgery|cardiac surgery
1096535|NCT02571920|cardiac output|cardiac output
1096536|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
1096537|NCT02571907|Iliac aneurysm|iliac aneurysm
1096538|NCT02571907|Branch|branch
1096539|NCT02571907|Connections|connections
1096540|NCT02571907|Endovascular graft|endovascular graft
1096541|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
1096542|NCT02571907|Aneurysm|aneurysm
1096543|NCT02571907|Vascular Diseases|vascular diseases
1096544|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
1096545|NCT02571881|constipation|constipation
1096546|NCT02571881|oxycodone|oxycodone
1096547|NCT02571881|caesarean section|caesarean section
1096548|NCT02571855|insomnia|insomnia
1096549|NCT02571855|Pharmacokinetics|pharmacokinetics
1096550|NCT02571855|Safety|safety
1096551|NCT02571855|Pharmacodynamics|pharmacodynamics
1096552|NCT02571855|Healthy|healthy
1096553|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
1096554|NCT02571842|Rituximab|rituximab
1096555|NCT02571829|Liposarcoma|liposarcoma
1096556|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
1096557|NCT02571829|CDK4|cdk4
1096558|NCT02571829|CDK6|cdk6
1096559|NCT02571829|LEE011|lee011
1096560|NCT02571829|ribociclib|ribociclib
1096561|NCT02571816|ASP2215|asp2215
1096562|NCT02571816|Healthy|healthy
1096563|NCT02571816|Hepatic Impairment|hepatic impairment
1096564|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
1096565|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
1096566|NCT02571803|coronary artery disease|coronary artery disease
1096567|NCT02571803|atherosclerosis|atherosclerosis
1096568|NCT02571803|DASH diet|dash diet
1096569|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
1096570|NCT02571777|Asthma|asthma
1096571|NCT02571725|Ovarian cancer|ovarian cancer
1096572|NCT02571725|Fallopian tube cancer|fallopian tube cancer
1096573|NCT02571725|Peritoneal cancer|peritoneal cancer
1096574|NCT02571725|PARP|parp
1096576|NCT02571725|Immunotherapy|immunotherapy
1096578|NCT02571725|Tremelimumab|tremelimumab
1096579|NCT02571725|CTLA4|ctla4
1096580|NCT02571673|Survivorship|survivorship
1096581|NCT02571673|Quality of Life|quality of life
1096582|NCT02571673|HN-STAR web-based|hn-star web-based
1096583|NCT02571673|15-245|15-245
1096584|NCT02571660|vitamin d levels|vitamin d levels
1096585|NCT02571660|exacerbation of asthma|exacerbation of asthma
1096586|NCT02571660|asthma control|asthma control
1096587|NCT02571634|intranasal fentanyl|intranasal fentanyl
1096588|NCT02571634|conscious sedation|conscious sedation
1096589|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
1096590|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
1096591|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
1096592|NCT02571595|insomnia|insomnia
1096593|NCT02571595|cognitive Impairment|cognitive impairment
1096594|NCT02571595|concentration|concentration
1096595|NCT02571595|productivity|productivity
1096596|NCT02571582|Predictors of mortality|predictors of mortality
1096597|NCT02571543|Ibuprofen|ibuprofen
1096598|NCT02571543|IVF|ivf
1096599|NCT02571543|minimal stimulation|minimal stimulation
1096600|NCT02571543|modified natural-cycle|modified natural-cycle
1096601|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
1096602|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
1096603|NCT02571543|Oocyte Retrieval|oocyte retrieval
1096604|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
1096605|NCT02571517|Respiratory viral infection.|respiratory viral infection.
1096606|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
1096607|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
1096608|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
1096609|NCT02571504|Memory|memory
1096610|NCT02571504|Concentration|concentration
1096611|NCT02571478|Military Couples|military couples
1096612|NCT02571478|Marriage|marriage
1096613|NCT02571478|Primary Care|primary care
1096614|NCT02571478|Marriage Intervention|marriage intervention
1096615|NCT02571478|Air Force|air force
1096616|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
1096617|NCT02571465|passive leg raising|passive leg raising
1096618|NCT02571465|stroke volume variation|stroke volume variation
1096619|NCT02571465|pulse pressure variation|pulse pressure variation
1096620|NCT02571452|Veteran|veteran
1096621|NCT02571452|Insomnia|insomnia
1096622|NCT02571452|Primary Healthcare|primary healthcare
1096623|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
1096624|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
1096625|NCT02571413|oral presentation|oral presentation
1096626|NCT02571413|allergic rhinitis|allergic rhinitis
1096627|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
1096628|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
1096629|NCT02571400|Risk|risk
1096630|NCT02571400|Opioid analgesics|opioid analgesics
1096631|NCT02571400|Opioid-related disorders|opioid-related disorders
1096632|NCT02571400|Surgery|surgery
1096633|NCT02571400|Post-operative care|post-operative care
1096634|NCT02571400|Post-operative period|post-operative period
1096635|NCT02571400|Post-operative complications|post-operative complications
1096636|NCT02571400|Opioid Use disorders|opioid use disorders
1096637|NCT02571400|Pain, post-operative|pain, post-operative
1096638|NCT02571400|Opiate Addiction|opiate addiction
1096639|NCT02571387|Motivation|motivation
1096640|NCT02571387|Impulsive eating|impulsive eating
1096641|NCT02571387|Mindfulness|mindfulness
1096642|NCT02571387|Self-help|self-help
1096643|NCT02571387|Physical activity|physical activity
1096644|NCT02571387|Weight-loss|weight-loss
1096645|NCT02571374|symbiotic|symbiotic
1096646|NCT02571374|colorectal cancer|colorectal cancer
1096647|NCT02571361|Acetaminophen|acetaminophen
1096648|NCT02571361|Ibuprofen|ibuprofen
1096649|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1096650|NCT02571309|Self-management|self-management
1096651|NCT02571309|Asthma|asthma
1096652|NCT02571309|Patient education|patient education
1096653|NCT02571309|Health literacy|health literacy
1096654|NCT02571309|Health-related quality of life|health-related quality of life
1096655|NCT02571309|Asthma control|asthma control
1096656|NCT02571309|Adherence|adherence
1096657|NCT02571296|Preterm Birth|preterm birth
1096658|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
1096659|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
1096660|NCT02571283|Total Knee Replacement|total knee replacement
1096661|NCT02571283|Exparel|exparel
1096662|NCT02571283|Cocktail Injection|cocktail injection
1096663|NCT02571283|Pain Management|pain management
1096664|NCT02571270|Exercise|exercise
1096665|NCT02571270|quality of life|quality of life
1096666|NCT02571270|healthy|healthy
1096667|NCT02571270|cardiac remodeling|cardiac remodeling
1096668|NCT02571257|LDL-C|ldl-c
1096669|NCT02571257|Lipid Regulator|lipid regulator
1096769|NCT02570685|friendships|friendships
1096670|NCT02571244|Tobacco Use Disorder|tobacco use disorder
1097372|NCT02567253|Cisplatin|cisplatin
1096671|NCT02571244|Hospitalized patients|hospitalized patients
1096672|NCT02571244|Text message|text message
1096673|NCT02571244|Motivational Interview|motivational interview
1096674|NCT02571244|Substance-Related Disorders|substance-related disorders
1096675|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
1096676|NCT02571218|atrial fibrillation|atrial fibrillation
1096677|NCT02571218|mapping|mapping
1096678|NCT02571218|substrate|substrate
1096679|NCT02571218|ablation|ablation
1096680|NCT02571205|testosterone|testosterone
1096681|NCT02571205|pubertal delay|pubertal delay
1096682|NCT02571192|ADME|adme
1096683|NCT02571179|Labor pain|labor pain
1096684|NCT02571179|Fentanyl|fentanyl
1096685|NCT02571179|Transmucosal|transmucosal
1096686|NCT02571153|Intravenous anesthesia|intravenous anesthesia
1096687|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
1096688|NCT02571153|Postoperative pain|postoperative pain
1096689|NCT02571153|Patient satisfaction|patient satisfaction
1096690|NCT02571153|Quality of health care|quality of health care
1096691|NCT02571153|Ketamine|ketamine
1096692|NCT02571114|Glycemic Responses|glycemic responses
1096693|NCT02571114|Metabolic Responses|metabolic responses
1096694|NCT02571114|Males|males
1096695|NCT02571114|Females|females
1096696|NCT02571101|Clomipramine|clomipramine
1096697|NCT02571101|Premature ejaculation|premature ejaculation
1096698|NCT02571101|CDFR0812|cdfr0812
1096699|NCT02571101|Sildenafil|sildenafil
1096700|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
1096701|NCT02571088|Sports Training|sports training
1096702|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
1096703|NCT02571088|Lactate|lactate
1096704|NCT02571075|auricular|auricular
1096705|NCT02571075|acupuncture|acupuncture
1096706|NCT02571075|pain|pain
1096707|NCT02571062|bioequivalence|bioequivalence
1096708|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
1096709|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
1096710|NCT02571036|PDGFR-alpha|pdgfr-alpha
1096711|NCT02571036|KIT|kit
1096712|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
1096713|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
1096714|NCT02571036|DCC-2618|dcc-2618
1096715|NCT02571036|melanoma|melanoma
1096716|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
1096717|NCT02571023|Skull Base Trauma|skull base trauma
1096718|NCT02571023|microscope surgery|microscope surgery
1096719|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
1096720|NCT02571010|static mechanical allodynia|static mechanical allodynia
1096721|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
1096722|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
1096723|NCT02570997|Alzheimer's Disease|alzheimer's disease
1096724|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
1096725|NCT02570971|mannitol|mannitol
1096726|NCT02570971|treatment|treatment
1096727|NCT02570958|robotic surgery|robotic surgery
1096728|NCT02570958|indocyanine green|indocyanine green
1096729|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
1096730|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
1096731|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
1096732|NCT02570919|Prostate cancer|prostate cancer
1096733|NCT02570919|IGRT|igrt
1096734|NCT02570919|Hypofractionation|hypofractionation
1096735|NCT02570919|Extreme|extreme
1096736|NCT02570919|Single Fraction|single fraction
1096737|NCT02570919|Urethral Sparing|urethral sparing
1096738|NCT02570919|MRI|mri
1096739|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
1096740|NCT02570867|glaucoma|glaucoma
1096741|NCT02570867|brain function|brain function
1096742|NCT02570867|fMRI|fmri
1096743|NCT02570854|Anemia|anemia
1096744|NCT02570841|Heat pain threshold|heat pain threshold
1096745|NCT02570841|Cold pain threshold|cold pain threshold
1096746|NCT02570841|Mechanical pain threshold|mechanical pain threshold
1096747|NCT02570841|High dose Capsaicin|high dose capsaicin
1096748|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
1096749|NCT02570815|lung cancer|lung cancer
1096750|NCT02570815|segmentectomy|segmentectomy
1096751|NCT02570815|robotic surgery|robotic surgery
1096752|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
1096753|NCT02570815|IC-GREEN|ic-green
1096754|NCT02570815|indocyanine green|indocyanine green
1096755|NCT02570815|early-stage lung cancer|early-stage lung cancer
1096756|NCT02570776|Helicobacter pylori|helicobacter pylori
1096757|NCT02570776|UBT|ubt
1096758|NCT02570776|Sensitivity|sensitivity
1096759|NCT02570776|specificity|specificity
1096760|NCT02570776|prevalence|prevalence
1096761|NCT02570763|neurostimulation|neurostimulation
1096762|NCT02570763|comorbidity|comorbidity
1096763|NCT02570763|tDCS|tdcs
1096764|NCT02570763|CBT|cbt
1096765|NCT02570763|anxiety|anxiety
1096766|NCT02570763|alcohol|alcohol
1096767|NCT02570685|Gratitude Intervention|gratitude intervention
1096768|NCT02570685|positive emotion|positive emotion
1096770|NCT02570685|positive psychology|positive psychology
1096771|NCT02570685|life satisfaction|life satisfaction
1096772|NCT02570659|WAD|wad
1096773|NCT02570659|Whiplash|whiplash
1096774|NCT02570659|Information Video|information video
1096775|NCT02570633|Migraine|migraine
1096776|NCT02570633|Ginger|ginger
1096777|NCT02570633|Prophylactic treatment|prophylactic treatment
1096778|NCT02570594|Cognition|cognition
1096779|NCT02570594|Autobiographical|autobiographical
1096780|NCT02570594|memoryCognitive|memorycognitive
1096781|NCT02570594|remediation|remediation
1096782|NCT02570581|volonteeres|volonteeres
1096783|NCT02570568|Venepuncture|venepuncture
1096784|NCT02570568|Transillumination|transillumination
1096785|NCT02570555|driving|driving
1096786|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
1096787|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1096788|NCT02570542|15-193|15-193
1096789|NCT02570529|Pancreatic cancer|pancreatic cancer
1096790|NCT02570529|Chemoradiotherapy|chemoradiotherapy
1096791|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
1096792|NCT02570529|Albis|albis
1096793|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
1096794|NCT02570516|Narrow band imaging|narrow band imaging
1096795|NCT02570516|Colonoscopy|colonoscopy
1096796|NCT02570490|fusidic acid|fusidic acid
1096797|NCT02570490|skin infection|skin infection
1096798|NCT02570451|cognitive impairment|cognitive impairment
1096799|NCT02570451|post surgical outcomes|post surgical outcomes
1096800|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
1096801|NCT02570438|postoperative outcomes|postoperative outcomes
1096802|NCT02570438|older surgical patients|older surgical patients
1096803|NCT02570386|In-vitro fertilization|in-vitro fertilization
1096804|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
1096805|NCT02570386|fresh embryo transfer|fresh embryo transfer
1096806|NCT02570373|Healthy|healthy
1096807|NCT02570373|Guselkumab|guselkumab
1096808|NCT02570347|Snake Envenomation|snake envenomation
1096809|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
1096810|NCT02570347|Viperidae|viperidae
1096811|NCT02570334|early ART|early art
1096812|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
1096813|NCT02570321|Cornea|cornea
1096814|NCT02570321|Ulcer|ulcer
1096815|NCT02570321|Infectious keratitis|infectious keratitis
1096816|NCT02570321|Bacterial|bacterial
1096817|NCT02570321|Fungal|fungal
1096818|NCT02570295|Army|army
1096819|NCT02570295|Sport|sport
1096820|NCT02570295|Physical Fitness|physical fitness
1096821|NCT02570295|Injuries|injuries
1096822|NCT02570295|Psychological Tests|psychological tests
1096823|NCT02570295|Attrition|attrition
1096824|NCT02570282|Female|female
1096825|NCT02570256|stroke|stroke
1096826|NCT02570256|upper extremity|upper extremity
1096827|NCT02570256|motor exploration|motor exploration
1096828|NCT02570256|error augmentation|error augmentation
1096829|NCT02570256|robotic rehabilitation|robotic rehabilitation
1096830|NCT02570243|heparin|heparin
1096831|NCT02570243|radial artery|radial artery
1096832|NCT02570230|Thoracotomy|thoracotomy
1096833|NCT02570230|Postoperative pain|postoperative pain
1096834|NCT02570230|Ketamine|ketamine
1096835|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
1096836|NCT02570178|clinical trial|clinical trial
1096837|NCT02570178|accidental falls|accidental falls
1096838|NCT02570178|postural balance|postural balance
1096839|NCT02570178|elderly|elderly
1096840|NCT02570178|primary Health Care|primary health care
1096841|NCT02570165|efficacy|efficacy
1096842|NCT02570165|dry powder inhaler|dry powder inhaler
1096843|NCT02570165|vilanterol|vilanterol
1096844|NCT02570165|batefenterol|batefenterol
1096845|NCT02570152|Dengue|dengue
1096846|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
1096847|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
1096848|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
1096849|NCT02570126|Immunogenicity|immunogenicity
1096850|NCT02570126|Varicella|varicella
1096851|NCT02570126|Safety|safety
1096852|NCT02570126|Human serum albumin|human serum albumin
1096853|NCT02570126|Healthy children|healthy children
1096854|NCT02570126|12 to 23 months|12 to 23 months
1096855|NCT02570100|Cancer Stem Cells|cancer stem cells
1096856|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
1096857|NCT02570087|Coronary Angioplasty|coronary angioplasty
1096858|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
1096859|NCT02570061|recruitment|recruitment
1096860|NCT02570061|comprehension|comprehension
1096861|NCT02570061|satisfaction|satisfaction
1096862|NCT02570061|informed consent|informed consent
1096863|NCT02570061|telephone|telephone
1096864|NCT02570035|Mirabegron|mirabegron
1096865|NCT02570035|Overactive Bladder|overactive bladder
1096866|NCT02570035|Cardiovascular Disease|cardiovascular disease
1096867|NCT02570022|Pain control|pain control
1096868|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
1096869|NCT02570022|exparel|exparel
1096870|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
1096871|NCT02570009|couples|couples
1096872|NCT02570009|weight loss treatment|weight loss treatment
1096873|NCT02570009|home environment|home environment
1096874|NCT02569970|Epilepsy|epilepsy
1096875|NCT02569970|SUDEP|sudep
1096876|NCT02569970|fluoxetine|fluoxetine
1096877|NCT02569970|placebo|placebo
1096878|NCT02569970|SpO2|spo2
1096879|NCT02569918|Neuroplasticity|neuroplasticity
1096880|NCT02569918|Sensory Feedback|sensory feedback
1096881|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
1096882|NCT02569918|Robotic hand|robotic hand
1096883|NCT02569905|flurbiprofen|flurbiprofen
1096884|NCT02569905|Parecoxib sodium|parecoxib sodium
1096885|NCT02569905|Postoperative Shivering|postoperative shivering
1096886|NCT02569879|Boostrix™|boostrix™
1096887|NCT02569879|Bagota|bagota
1096888|NCT02569879|maternal vaccination|maternal vaccination
1096889|NCT02569879|Pertussis|pertussis
1096890|NCT02569879|Mortality|mortality
1096891|NCT02569879|Morbidity|morbidity
1096892|NCT02569866|plastic surgery|plastic surgery
1096893|NCT02569866|mammaplasty|mammaplasty
1096894|NCT02569866|wound infection|wound infection
1096895|NCT02569866|prophylaxis|prophylaxis
1096896|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
1096897|NCT02569827|Treatment|treatment
1096898|NCT02569827|Phase Ib/IIa|phase ib/iia
1096899|NCT02569827|single centre|single centre
1096900|NCT02569827|double-blind|double-blind
1096901|NCT02569827|placebo-controlled|placebo-controlled
1096902|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
1096903|NCT02569827|Modipafant|modipafant
1096904|NCT02569827|Celgosivir|celgosivir
1096905|NCT02569788|re-irradiation|re-irradiation
1096906|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
1096907|NCT02569775|Cerebral Palsy|cerebral palsy
1096908|NCT02569775|Stem Cells|stem cells
1096909|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
1096910|NCT02569762|Artificial Sweeteners|artificial sweeteners
1096911|NCT02569762|Glucose Metabolism|glucose metabolism
1096912|NCT02569762|Microbiota|microbiota
1096913|NCT02569762|Dysbiosis|dysbiosis
1096914|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
1096915|NCT02569645|Rectal cancer|rectal cancer
1096916|NCT02569645|Rosuvastatin|rosuvastatin
1096917|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
1096918|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
1096919|NCT02569632|Factor H-binding Protein|factor h-binding protein
1096920|NCT02569619|Physical Activity|physical activity
1096921|NCT02569619|Mental Health|mental health
1096922|NCT02569619|Physical Exercise|physical exercise
1096923|NCT02569619|Mental disorder|mental disorder
1096924|NCT02569619|Promotion|promotion
1096925|NCT02569606|consumption of blood|consumption of blood
1096926|NCT02569606|consumption of coagulation products|consumption of coagulation products
1096927|NCT02569606|coagulation algorithm|coagulation algorithm
1096928|NCT02569606|trauma related transfusion|trauma related transfusion
1096929|NCT02569580|anti-lice treatment|anti-lice treatment
1096930|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
1096931|NCT02569567|Transient Elastography(TE)|transient elastography(te)
1096932|NCT02569567|Liver cirrhosis|liver cirrhosis
1096933|NCT02569554|PF-06463922|pf-06463922
1096934|NCT02569554|rabeprazole|rabeprazole
1096935|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
1096936|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
1096937|NCT02569554|food effect|food effect
1096938|NCT02569541|fusidic acid|fusidic acid
1096939|NCT02569541|prosthetic joint infections|prosthetic joint infections
1096940|NCT02569541|bone infections|bone infections
1096941|NCT02569541|osteomyelitis|osteomyelitis
1096942|NCT02569528|atrial fibrillation|atrial fibrillation
1096943|NCT02569528|anticoagulation|anticoagulation
1096944|NCT02569476|BGB-3111|bgb-3111
1096945|NCT02569476|Obinutuzumab|obinutuzumab
1096947|NCT02569476|Lymphoma|lymphoma
1096948|NCT02569476|Leukemia|leukemia
1096949|NCT02569476|Therapeutic uses|therapeutic uses
1096950|NCT02569450|Surgery|surgery
1096951|NCT02569450|Performance|performance
1096952|NCT02569450|Outcome|outcome
1096953|NCT02569450|Control chart|control chart
1096954|NCT02569437|doxycycline|doxycycline
1096955|NCT02569437|oral methylprednisone|oral methylprednisone
1096956|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
1096957|NCT02569424|PEEP level|peep level
1096958|NCT02569424|Trendelenburg position|trendelenburg position
1096959|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
1096960|NCT02569424|central venous catheter|central venous catheter
1096961|NCT02569398|Alzheimer disease|alzheimer disease
1096962|NCT02569398|Atabecestat|atabecestat
1096963|NCT02569398|Dementia|dementia
1096964|NCT02569385|Weaning TTE|weaning tte
1096965|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
1096966|NCT02569346|Triumeq|triumeq
1096967|NCT02569346|Pharmacokinetics|pharmacokinetics
1096968|NCT02569346|Crushing|crushing
1096969|NCT02569346|Drip feed|drip feed
1096970|NCT02569333|ulcerative colitis|ulcerative colitis
1096971|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
1096972|NCT02569333|education|education
1096973|NCT02569333|patient-reported outcomes|patient-reported outcomes
1098861|NCT02558413|Antiviral|antiviral
1096974|NCT02569307|At Risk of Mental State|at risk of mental state
1096975|NCT02569307|Prodromal Phase|prodromal phase
1096976|NCT02569307|Psychosis|psychosis
1096977|NCT02569294|group interventions|group interventions
1096978|NCT02569294|emotional distress|emotional distress
1096979|NCT02569294|breast cancer|breast cancer
1096980|NCT02569294|yoga|yoga
1096981|NCT02569294|hypnosis|hypnosis
1096982|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
1096983|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
1096984|NCT02569281|Eccentric exercise|eccentric exercise
1096985|NCT02569281|Pressure pain|pressure pain
1096986|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
1096987|NCT02569268|Arteriosclerosis|arteriosclerosis
1096988|NCT02569268|Vascular function|vascular function
1096989|NCT02569268|Vascular disease early detection system|vascular disease early detection system
1096990|NCT02569229|children|children
1096991|NCT02569229|cystic fibrosis|cystic fibrosis
1096992|NCT02569229|glucose intolerance|glucose intolerance
1096993|NCT02569229|continuous glucose measurement|continuous glucose measurement
1096994|NCT02569216|Electrical Inhibition|electrical inhibition
1096995|NCT02569216|Preterm Birth|preterm birth
1096996|NCT02569216|Premature Birth|premature birth
1096997|NCT02569216|Preterm Labor|preterm labor
1096998|NCT02569216|Premature Labor|premature labor
1096999|NCT02569216|tocolytic|tocolytic
1097000|NCT02569216|uterus|uterus
1097001|NCT02569177|myocardial infarction|myocardial infarction
1097002|NCT02569177|cardiac surgery|cardiac surgery
1097003|NCT02569177|troponin|troponin
1097004|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
1097005|NCT02569138|Balance|balance
1097006|NCT02569138|Footwear|footwear
1097007|NCT02569138|Shoes|shoes
1097008|NCT02569138|Falls|falls
1097009|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
1097010|NCT02569099|stroke survivors|stroke survivors
1097011|NCT02569099|caregivers|caregivers
1097012|NCT02569099|burden of care|burden of care
1097013|NCT02569099|quality of life|quality of life
1097014|NCT02569099|function|function
1097015|NCT02569099|community reintegration|community reintegration
1097016|NCT02569099|caregiver training|caregiver training
1097017|NCT02569086|Sepsis|sepsis
1097018|NCT02569086|Therapeutic Drug Monitoring|therapeutic drug monitoring
1097019|NCT02569086|Beta-lactams|beta-lactams
1097020|NCT02569086|Pharmacokinetics|pharmacokinetics
1097021|NCT02569073|Functional Chest Pain|functional chest pain
1097022|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
1097023|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
1097024|NCT02569060|diabetes mellitus|diabetes mellitus
1097025|NCT02569060|community intervention|community intervention
1097026|NCT02569060|intervention|intervention
1097027|NCT02569060|randomized|randomized
1097028|NCT02569060|dietary intervention|dietary intervention
1097029|NCT02569060|self-management support|self-management support
1097030|NCT02569060|food bank|food bank
1097031|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
1097032|NCT02569047|Occlusoproximal|occlusoproximal
1097033|NCT02569047|Primary Teeth|primary teeth
1097034|NCT02569047|Glass Ionomer Cements|glass ionomer cements
1097035|NCT02569047|Hall Technique|hall technique
1097036|NCT02569021|Parkinsons Disease|parkinsons disease
1097037|NCT02569021|Essential Tremor|essential tremor
1097038|NCT02569021|DBS|dbs
1097039|NCT02569021|Depp Brain Stimulation|depp brain stimulation
1097040|NCT02569008|Fluid Challenge|fluid challenge
1097041|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
1097042|NCT02569008|Fluid therapy|fluid therapy
1097043|NCT02568995|postoperative pain|postoperative pain
1097044|NCT02568995|morphine|morphine
1097045|NCT02568995|total hip arthroplasty|total hip arthroplasty
1097046|NCT02568995|femoral nerve block|femoral nerve block
1097047|NCT02568982|Cushing's disease|cushing's disease
1097048|NCT02568982|Quality of life|quality of life
1097049|NCT02568982|Metabolic|metabolic
1097050|NCT02568982|patients with Cushing's disease|patients with cushing's disease
1097051|NCT02568982|cardiovascular|cardiovascular
1097052|NCT02568982|thromboembolic|thromboembolic
1097053|NCT02568982|bone complications|bone complications
1097054|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
1097055|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
1097056|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
1097057|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1097058|NCT02568917|Composite Resins|composite resins
1097059|NCT02568917|Primary Teeth|primary teeth
1097060|NCT02568917|Permanent Teeth|permanent teeth
1097061|NCT02568917|Clinical Effectiveness|clinical effectiveness
1097062|NCT02568917|Cost Analysis|cost analysis
1097063|NCT02568878|Depression|depression
1097064|NCT02568878|Anxiety|anxiety
1097065|NCT02568878|Methamphetamine dependence|methamphetamine dependence
1097066|NCT02568852|D-dimer|d-dimer
1097067|NCT02568852|Fibrinogen|fibrinogen
1099128|NCT02556645|Combat|combat
1097068|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1097069|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
1097070|NCT02568826|Low Back Pain|low back pain
1097071|NCT02568826|Muscle relaxant|muscle relaxant
1097072|NCT02568813|epilepsy|epilepsy
1097073|NCT02568813|depression|depression
1097074|NCT02568813|mood disorder|mood disorder
1097075|NCT02568813|anxiety|anxiety
1097076|NCT02568813|cyclothymia|cyclothymia
1097077|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
1097078|NCT02568787|NAFLD|nafld
1097079|NCT02568787|cytokines|cytokines
1097080|NCT02568787|interleukin (IL)|interleukin (il)
1097081|NCT02568787|interferon (IFN)|interferon (ifn)
1097082|NCT02568787|liver function test (LFTS)|liver function test (lfts)
1097083|NCT02568787|nutrition|nutrition
1097084|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
1097085|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
1097086|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
1097087|NCT02568774|Post-stroke|post-stroke
1097088|NCT02568761|Snoring|snoring
1097089|NCT02568761|Sleep apnea|sleep apnea
1097090|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
1097091|NCT02568761|Speech therapy|speech therapy
1097092|NCT02568761|Injection snoreplasty|injection snoreplasty
1097093|NCT02568761|Ethanol|ethanol
1097094|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
1097095|NCT02568735|Dexketoprofen|dexketoprofen
1097096|NCT02568735|Etoricoxib|etoricoxib
1097097|NCT02568735|hip arthroplasty|hip arthroplasty
1097098|NCT02568735|pain|pain
1097099|NCT02568722|Renal replacement therapy|renal replacement therapy
1097100|NCT02568722|Acute kidney injury|acute kidney injury
1097101|NCT02568722|Dialysis|dialysis
1097102|NCT02568722|Hemodialysis|hemodialysis
1097103|NCT02568722|Critical illness|critical illness
1097104|NCT02568709|Oxytocin|oxytocin
1097105|NCT02568709|Syntocinon|syntocinon
1097106|NCT02568709|Social Cognition|social cognition
1097107|NCT02568709|Schizophrenia|schizophrenia
1097108|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
1097109|NCT02568696|kidney transplantation|kidney transplantation
1097110|NCT02568696|renal transplantation|renal transplantation
1097111|NCT02568696|fibrinolysis|fibrinolysis
1097112|NCT02568696|cell mediated rejection|cell mediated rejection
1097113|NCT02568696|coagulation|coagulation
1097114|NCT02568696|delayed graft function|delayed graft function
1097115|NCT02568696|Halloran criteria|halloran criteria
1097116|NCT02568696|graft rejection|graft rejection
1097117|NCT02568696|thrombin generation|thrombin generation
1097118|NCT02568696|fibrin generation|fibrin generation
1097119|NCT02568683|DLBCL|dlbcl
1097120|NCT02568683|Relapsed|relapsed
1097121|NCT02568683|Refractory|refractory
1097122|NCT02568644|Migraine|migraine
1097123|NCT02568644|Ginger|ginger
1097124|NCT02568644|Acute treatment|acute treatment
1097125|NCT02568631|Autistic Disorder|autistic disorder
1097126|NCT02568618|Military|military
1097127|NCT02568618|Genomics|genomics
1097128|NCT02568618|Pain|pain
1097129|NCT02568605|Dietary intervention|dietary intervention
1097130|NCT02568605|Prebiotic fibre|prebiotic fibre
1097131|NCT02568605|Weight loss|weight loss
1097132|NCT02568605|Gut microbiota|gut microbiota
1097133|NCT02568605|Obesity|obesity
1097134|NCT02568605|Liver fat|liver fat
1097135|NCT02568605|Hepatic fibrosis|hepatic fibrosis
1097136|NCT02568540|Hepatitis C|hepatitis c
1097137|NCT02568540|Smartphone|smartphone
1097138|NCT02568540|app|app
1097139|NCT02568540|Tracker|tracker
1097140|NCT02568540|C Tracker|c tracker
1097141|NCT02568527|LSCD|lscd
1097142|NCT02568527|SLET|slet
1097143|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
1097144|NCT02568527|PLGA|plga
1097145|NCT02568514|mhealth|mhealth
1097146|NCT02568514|text messaging|text messaging
1097147|NCT02568514|secure text messaging|secure text messaging
1097148|NCT02568514|communication|communication
1097149|NCT02568501|diabetes|diabetes
1097150|NCT02568501|adolescent|adolescent
1097151|NCT02568501|young adult|young adult
1097152|NCT02568501|behavioral economics|behavioral economics
1097153|NCT02568501|financial incentives|financial incentives
1097154|NCT02568501|social incentives|social incentives
1097155|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
1097156|NCT02568462|Stents|stents
1097157|NCT02568462|Angioplasty|angioplasty
1097158|NCT02568462|Coronary Vessels|coronary vessels
1097159|NCT02568462|Coronary Artery Disease|coronary artery disease
1097160|NCT02568462|Angina Pectoris|angina pectoris
1097161|NCT02568462|Myocardial Ischemia|myocardial ischemia
1097162|NCT02568462|Myocardial Infarction|myocardial infarction
1097163|NCT02568462|Myocardial Revascularization|myocardial revascularization
1097164|NCT02568410|Mast Cells|mast cells
1097165|NCT02568410|Blood Platelets|blood platelets
1097166|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
1097167|NCT02568371|biobank|biobank
1097168|NCT02568371|DNA|dna
1097169|NCT02568371|genetic|genetic
1098830|NCT02558595|Vitamin B3|vitamin b3
1097170|NCT02568371|young adults|young adults
1097171|NCT02568371|cohort study|cohort study
1097172|NCT02568345|Dose-Response Relationship|dose-response relationship
1097173|NCT02568345|Drug|drug
1097174|NCT02568345|Obesity|obesity
1097175|NCT02568345|Cyclodextrins|cyclodextrins
1097176|NCT02568267|Entrectinib|entrectinib
1097177|NCT02568267|RXDX-101|rxdx-101
1097178|NCT02568267|TrkA|trka
1097179|NCT02568267|TrkB|trkb
1097180|NCT02568267|TrkC|trkc
1097181|NCT02568267|NTRK1|ntrk1
1097182|NCT02568267|NTRK2|ntrk2
1097183|NCT02568267|NTRK3|ntrk3
1097184|NCT02568267|ROS1|ros1
1097185|NCT02568267|ALK|alk
1097186|NCT02568267|Trk Fusions|trk fusions
1097187|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
1097188|NCT02568267|ROS1 Fusions|ros1 fusions
1097189|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
1097190|NCT02568267|ALK Fusions|alk fusions
1097191|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
1097192|NCT02568267|Basket study|basket study
1097193|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
1097194|NCT02568267|Colorectal cancer|colorectal cancer
1097195|NCT02568267|Salivary gland cancers|salivary gland cancers
1097196|NCT02568267|Primary brain tumors|primary brain tumors
1097197|NCT02568267|Melanoma|melanoma
1097198|NCT02568267|Sarcomas|sarcomas
1097199|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
1097200|NCT02568267|Renal cell cancer|renal cell cancer
1097201|NCT02568267|Pancreatic cancer|pancreatic cancer
1097202|NCT02568267|Breast cancer|breast cancer
1097203|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
1097204|NCT02568267|Head & Neck cancers|head & neck cancers
1097205|NCT02568267|Ovarian cancer|ovarian cancer
1097206|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
1097207|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1097208|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
1097209|NCT02568241|Relapse|relapse
1097210|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
1097211|NCT02568228|Triacylglycerols|triacylglycerols
1097212|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
1097213|NCT02568228|Krill oil|krill oil
1097214|NCT02568228|Fish|fish
1097215|NCT02568228|Healthy Volunteers|healthy volunteers
1097216|NCT02568215|HIV-1 Infections|hiv-1 infections
1097217|NCT02568189|Sepsis|sepsis
1097218|NCT02568189|Gastroenteritis|gastroenteritis
1097219|NCT02568189|Dehydration|dehydration
1097220|NCT02568189|Ultrasound|ultrasound
1097221|NCT02568189|Ultrasonography|ultrasonography
1097222|NCT02568189|Inferior Vena Cava|inferior vena cava
1097223|NCT02568176|Healthy|healthy
1097224|NCT02568176|Pharmacokinetics|pharmacokinetics
1097225|NCT02568176|Esketamine|esketamine
1097226|NCT02568176|JNJ-54135419|jnj-54135419
1097227|NCT02568176|Midazolam|midazolam
1097228|NCT02568176|Bupropion|bupropion
1097229|NCT02568137|mobile health|mobile health
1097230|NCT02568137|Behavior change|behavior change
1097231|NCT02568137|Africa|africa
1097232|NCT02568124|Tranexamic acid|tranexamic acid
1097233|NCT02568124|Cyklokapron|cyklokapron
1097234|NCT02568124|Conservative management|conservative management
1097235|NCT02568124|Medical management|medical management
1097236|NCT02568111|erythema|erythema
1097237|NCT02568111|PLEGRIDY|plegridy
1097238|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
1097239|NCT02568111|MS|ms
1097240|NCT02568111|RRMS|rrms
1097241|NCT02568098|Drug combination|drug combination
1097242|NCT02568098|Ivermectin|ivermectin
1097243|NCT02568098|Primaquine|primaquine
1097244|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
1097245|NCT02568098|Albendazole|albendazole
1097246|NCT02568098|Pharmacokinetics|pharmacokinetics
1097247|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
1097248|NCT02568098|Healthy adult subject|healthy adult subject
1097249|NCT02568072|exercise|exercise
1097250|NCT02568072|cardiac remodelling|cardiac remodelling
1097251|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
1097252|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
1097253|NCT02567981|chronic undernutrition|chronic undernutrition
1097254|NCT02567981|anemia|anemia
1097255|NCT02567981|micronutrient supplement|micronutrient supplement
1097256|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
1097257|NCT02567877|hypothyroidism|hypothyroidism
1097258|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
1097259|NCT02567877|cognitive function|cognitive function
1097260|NCT02567877|thyroidectomy|thyroidectomy
1097261|NCT02567877|levothyroxine|levothyroxine
1097262|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
1097263|NCT02567851|PET scans|pet scans
1097264|NCT02567851|Lymphoma|lymphoma
1097265|NCT02567825|ear infection|ear infection
1097266|NCT02567825|antibiotics|antibiotics
1097267|NCT02567825|infants|infants
1097268|NCT02567825|children|children
1097269|NCT02567825|pediatrics|pediatrics
1097270|NCT02567825|tympanostomy tubes|tympanostomy tubes
1097271|NCT02567799|Lung Neoplasms|lung neoplasms
1097272|NCT02567773|Itraconazole|itraconazole
1097273|NCT02567773|GSK2881078|gsk2881078
1097274|NCT02567773|CYP3A4|cyp3a4
1097373|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
1097275|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
1097276|NCT02567773|Safety|safety
1097277|NCT02567773|Pharmacokinetics|pharmacokinetics
1097278|NCT02567773|Tolerability|tolerability
1097279|NCT02567760|MP1|mp1
1097280|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
1097281|NCT02567760|menopausal women|menopausal women
1097282|NCT02567747|Colombia|colombia
1097283|NCT02567747|otitis|otitis
1097284|NCT02567747|Database|database
1097285|NCT02567747|pneumonia|pneumonia
1097286|NCT02567734|irreversible electroporation|irreversible electroporation
1097287|NCT02567734|ablation|ablation
1097288|NCT02567734|neoplasms|neoplasms
1097289|NCT02567734|cancer|cancer
1097290|NCT02567734|carcinoma|carcinoma
1097291|NCT02567734|NanoKnife|nanoknife
1097292|NCT02567734|Ablation Techniques|ablation techniques
1097293|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
1097294|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
1097295|NCT02567721|Post marketing product surveillance|post marketing product surveillance
1097296|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
1097297|NCT02567721|Influenza Vaccine|influenza vaccine
1097298|NCT02567721|Computerized Medical Record System|computerized medical record system
1097299|NCT02567721|United Kingdom|united kingdom
1097300|NCT02567721|Primary Health Care|primary health care
1097301|NCT02567708|GSK2269557|gsk2269557
1097302|NCT02567708|Asthma|asthma
1097303|NCT02567708|Pharmacokinetics|pharmacokinetics
1097304|NCT02567708|Safety|safety
1097305|NCT02567708|Adults|adults
1097306|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
1097307|NCT02567708|Efficacy|efficacy
1097308|NCT02567682|anemia, sickle cell|anemia, sickle cell
1097309|NCT02567669|radiotherapy|radiotherapy
1097310|NCT02567656|CTCL|ctcl
1097311|NCT02567656|PTCL|ptcl
1097312|NCT02567656|RP6530|rp6530
1097313|NCT02567643|Brain|brain
1097314|NCT02567643|CNS|cns
1097315|NCT02567643|Metastases|metastases
1097316|NCT02567630|Cerebral Palsy|cerebral palsy
1097317|NCT02567630|physical|physical
1097318|NCT02567630|sensory|sensory
1145390|NCT02291224|condoms|condoms
1097319|NCT02567630|motor impairments|motor impairments
1097320|NCT02567630|upper extremity|upper extremity
1097321|NCT02567630|Constraint-Induced Movement Therapy|constraint-induced movement therapy
1097322|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
1097323|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
1097324|NCT02567552|endometrial receptivity|endometrial receptivity
1097325|NCT02567552|endometrial predecidualization|endometrial predecidualization
1097326|NCT02567552|endometrial genomics|endometrial genomics
1097327|NCT02567552|endometrial receptivity array|endometrial receptivity array
1097328|NCT02567526|food and fluid intake|food and fluid intake
1097329|NCT02567526|nursing home residents|nursing home residents
1097330|NCT02567526|staffing|staffing
1097331|NCT02567513|food and fluid intake|food and fluid intake
1097332|NCT02567513|nursing homes|nursing homes
1097333|NCT02567500|emotional|emotional
1097334|NCT02567500|auditory hallucinations|auditory hallucinations
1097335|NCT02567500|non-psychotic children|non-psychotic children
1097336|NCT02567474|chronic lung disease|chronic lung disease
1097337|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
1097338|NCT02567461|clopidogrel|clopidogrel
1097339|NCT02567461|aspirin|aspirin
1097340|NCT02567461|edoxaban|edoxaban
1097341|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
1097342|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1097343|NCT02567448|Overlap syndrome|overlap syndrome
1097344|NCT02567448|Pcrit|pcrit
1097345|NCT02567448|Critical closing pressure|critical closing pressure
1097346|NCT02567383|head and neck cancer|head and neck cancer
1097347|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
1097348|NCT02567383|radiotherapy|radiotherapy
1097349|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
1097350|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
1097351|NCT02567357|parent training|parent training
1097352|NCT02567357|autism|autism
1097353|NCT02567357|intellectual disability|intellectual disability
1097354|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
1097355|NCT02567357|Fragile X syndrome|fragile x syndrome
1097356|NCT02567357|web-based training|web-based training
1097357|NCT02567357|Down syndrome|down syndrome
1097358|NCT02567344|Cannabis|cannabis
1097359|NCT02567344|rTMS|rtms
1097360|NCT02567344|Craving|craving
1097361|NCT02567344|Decision making|decision making
1097362|NCT02567318|Pain|pain
1097363|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
1097364|NCT02567318|Healthy volunteers|healthy volunteers
1097365|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
1097366|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
1097367|NCT02567292|Neonatal|neonatal
1097368|NCT02567292|Pediatric Disorders|pediatric disorders
1097369|NCT02567253|Cytoreductive surgery|cytoreductive surgery
1097370|NCT02567253|(H)ipec|(h)ipec
1097371|NCT02567253|Ovarian cancer|ovarian cancer
1097374|NCT02567253|Pharmacokinetics|pharmacokinetics
1097375|NCT02567253|Pharmacodynamics|pharmacodynamics
1097376|NCT02567214|dyspnea|dyspnea
1097377|NCT02567214|exercise|exercise
1097378|NCT02567214|shuttle test|shuttle test
1097379|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
1097380|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
1097381|NCT02567214|indacaterol|indacaterol
1097382|NCT02567214|glycopyrronium|glycopyrronium
1097383|NCT02567214|tiotropium|tiotropium
1097384|NCT02567201|Voluntary attention|voluntary attention
1097385|NCT02567201|Electroencephalogram|electroencephalogram
1097386|NCT02567201|Brain-computer interface|brain-computer interface
1097387|NCT02567201|Disorders of consciousness|disorders of consciousness
1097388|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
1097389|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
1097390|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
1097391|NCT02567162|Cerebrovascular disease|cerebrovascular disease
1097392|NCT02567162|Stroke|stroke
1097393|NCT02567149|Wart|wart
1097394|NCT02567110|Mid-life Depression|mid-life depression
1097395|NCT02567110|Bipolar Disorder|bipolar disorder
1097396|NCT02567110|DSM-5 MDE|dsm-5 mde
1097397|NCT02567110|Inflammation|inflammation
1097398|NCT02567110|CNS Glutamate|cns glutamate
1097399|NCT02567084|Bone substitute|bone substitute
1097400|NCT02567084|benign bone cyst|benign bone cyst
1097401|NCT02567084|ceramic|ceramic
1097402|NCT02567084|remodelling|remodelling
1097403|NCT02567071|C-section|c-section
1097404|NCT02567071|Microbiota|microbiota
1097405|NCT02567058|Achilles tendon|achilles tendon
1097406|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
1097407|NCT02567045|Colonoscopy|colonoscopy
1097408|NCT02567045|Screening uptake|screening uptake
1097409|NCT02567045|Screening participation|screening participation
1097410|NCT02567045|Familiar risk|familiar risk
1097411|NCT02567045|Colorectal Cancer|colorectal cancer
1097412|NCT02567032|Oxytocin|oxytocin
1097413|NCT02567032|Syntocinon|syntocinon
1097414|NCT02567032|Social Cognition|social cognition
1097415|NCT02567032|Schizophrenia|schizophrenia
1097416|NCT02567032|Psychosis|psychosis
1097417|NCT02567032|Schizoaffective Disorder|schizoaffective disorder
1097418|NCT02567032|Schizophreniform Disorder|schizophreniform disorder
1097419|NCT02567032|Psychotic Disorders|psychotic disorders
1097420|NCT02567006|vaccines|vaccines
1097421|NCT02567006|reminders|reminders
1097422|NCT02567006|immunization timeliness|immunization timeliness
1097423|NCT02567006|vaccine coverage|vaccine coverage
1097424|NCT02566980|depression|depression
1097425|NCT02566980|mood disorder|mood disorder
1097426|NCT02566980|post-partum depression|post-partum depression
1097427|NCT02566980|suicidality|suicidality
1097428|NCT02566980|post-partum suicidality|post-partum suicidality
1097429|NCT02566980|perinatal depression|perinatal depression
1097430|NCT02566980|perinatal mood disorder|perinatal mood disorder
1097431|NCT02566980|inflammation|inflammation
1097432|NCT02566980|kynurenine pathway|kynurenine pathway
1097433|NCT02566980|glutamate|glutamate
1097434|NCT02566954|radiology|radiology
1097435|NCT02566954|3D measurement|3d measurement
1097436|NCT02566954|lower limb|lower limb
1097437|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
1097438|NCT02566941|critical illness myopathy|critical illness myopathy
1097439|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1097440|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
1097441|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
1097442|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1097443|NCT02566928|Recurrence|recurrence
1097444|NCT02566928|Practice Based Research Network|practice based research network
1097445|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
1097446|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
1097447|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
1097448|NCT02566928|Household Transmission|household transmission
1097449|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
1097450|NCT02566889|Infliximab|infliximab
1097451|NCT02566889|Pediatric Participants|pediatric participants
1097452|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
1097453|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
1097454|NCT02566889|Dose Escalation|dose escalation
1097455|NCT02566876|Children|children
1097456|NCT02566876|Abdominal Pain|abdominal pain
1097457|NCT02566876|Functional Dyspepsia|functional dyspepsia
1097458|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
1097459|NCT02566876|Quality of Life|quality of life
1097460|NCT02566863|dexmedetomidine|dexmedetomidine
1097461|NCT02566863|heart rate|heart rate
1097462|NCT02566863|heart rate variability|heart rate variability
1097463|NCT02566837|ultrasound|ultrasound
1097464|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
1097465|NCT02566837|botulinum toxin|botulinum toxin
1097466|NCT02566772|Prostate Cancer|prostate cancer
1097467|NCT02566759|Drug therapy|drug therapy
1097468|NCT02566733|remifentanil|remifentanil
1097469|NCT02566720|amantadine|amantadine
1097470|NCT02566720|tractography|tractography
1097472|NCT02566720|coma|coma
1097473|NCT02566720|abi|abi
1097474|NCT02566720|tbi|tbi
1097475|NCT02566720|traumatic brain injury|traumatic brain injury
1097476|NCT02566720|acquired brain injury|acquired brain injury
1097477|NCT02566668|Asthma|asthma
1097478|NCT02566668|Severe Asthma|severe asthma
1097479|NCT02566668|IL-10|il-10
1097480|NCT02566668|IL-27|il-27
1097481|NCT02566668|IL-13|il-13
1097482|NCT02566668|Epithelial Cells|epithelial cells
1097483|NCT02566668|T lymphocytes|t lymphocytes
1097484|NCT02566668|Interferon-g|interferon-g
1097485|NCT02566629|microbiota community|microbiota community
1097486|NCT02566629|IBS|ibs
1097487|NCT02566603|ITP|itp
1097488|NCT02566603|Thrombocytopenia|thrombocytopenia
1097489|NCT02566577|Chronic anemia|chronic anemia
1097490|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
1097491|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
1097492|NCT02566551|Prostatic artery embolization|prostatic artery embolization
1097493|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
1097494|NCT02566538|Cohort study|cohort study
1097495|NCT02566538|psychometric tests|psychometric tests
1097496|NCT02566538|cognitive function|cognitive function
1097497|NCT02566538|cardiovascular risk|cardiovascular risk
1097498|NCT02566538|prediction algorithm|prediction algorithm
1097499|NCT02566525|CytoSorb device|cytosorb device
1097500|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
1097501|NCT02566525|inflammation|inflammation
1097502|NCT02566525|extracorporeal bypass|extracorporeal bypass
1097503|NCT02566512|Tracheostomy|tracheostomy
1097504|NCT02566512|weaning|weaning
1097505|NCT02566512|respiratory failure|respiratory failure
1097506|NCT02566512|cough strength|cough strength
1097507|NCT02566499|Medical imaging|medical imaging
1097508|NCT02566499|Microwaves|microwaves
1097509|NCT02566473|Patient reported outcomes|patient reported outcomes
1097510|NCT02566473|Osteoarthritis|osteoarthritis
1097511|NCT02566473|Total joint replacement|total joint replacement
1097512|NCT02566460|Lactate clearance|lactate clearance
1097513|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
1097514|NCT02566460|septic shock|septic shock
1097515|NCT02566460|haemodynamic therapy|haemodynamic therapy
1097516|NCT02566434|Dietary Supplements|dietary supplements
1097517|NCT02566395|Stem Cell Transplantation|stem cell transplantation
1097518|NCT02566395|Haploidentical Donors|haploidentical donors
1097519|NCT02566369|Efficacy|efficacy
1097520|NCT02566369|Safety|safety
1097521|NCT02566369|Acne vulgaris|acne vulgaris
1097522|NCT02566356|Oxytocin|oxytocin
1097523|NCT02566356|Syntocinon|syntocinon
1097524|NCT02566356|Social Cognition|social cognition
1097525|NCT02566356|Schizophrenia|schizophrenia
1097526|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1097527|NCT02566343|Spirometry|spirometry
1097528|NCT02566343|Exercise Test|exercise test
1097529|NCT02566343|Blood Gas Analysis|blood gas analysis
1097530|NCT02566343|Respiratory Function Tests|respiratory function tests
1097531|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
1097532|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
1097533|NCT02566330|EndoBarrier|endobarrier
1097534|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
1097535|NCT02566291|laryngeal mask|laryngeal mask
1097536|NCT02566291|airway leakage|airway leakage
1097537|NCT02566291|airway morbidity|airway morbidity
1097538|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
1097539|NCT02566278|Pcrit|pcrit
1097540|NCT02566278|Upper airway collapsibility|upper airway collapsibility
1097541|NCT02566265|influenza|influenza
1097542|NCT02566265|multiple myeloma|multiple myeloma
1097543|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1097544|NCT02566252|Safety|safety
1097545|NCT02566252|tolerability|tolerability
1097546|NCT02566239|aging|aging
1097547|NCT02566239|ORCATECH|orcatech
1097548|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
1097549|NCT02566239|Life Lab|life lab
1097550|NCT02566239|Living Lab|living lab
1097551|NCT02566239|in-home assessment|in-home assessment
1097552|NCT02566239|technology and aging|technology and aging
1097553|NCT02566213|volunteers|volunteers
1097554|NCT02566200|Acute coronary syndrome|acute coronary syndrome
1097555|NCT02566200|Cardiology|cardiology
1097556|NCT02566174|Cancer Caregivers|cancer caregivers
1097557|NCT02566174|Cancer Patients|cancer patients
1097558|NCT02566174|Role Adjustment|role adjustment
1097559|NCT02566174|Mutuality|mutuality
1097560|NCT02566174|Well-Being|well-being
1097561|NCT02566161|Genetics|genetics
1097562|NCT02566161|Genomics|genomics
1097563|NCT02566148|Life-event survey|life-event survey
1097564|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
1097565|NCT02566135|C-LMA|c-lma
1097566|NCT02566135|I-gel|i-gel
1097567|NCT02566135|ventilating bougie|ventilating bougie
1097568|NCT02566135|intubation|intubation
1099221|NCT02556203|TAVI|tavi
1097569|NCT02566096|major abdominal cancer|major abdominal cancer
1098545|NCT02560324|Insomnia|insomnia
1097570|NCT02566070|Enteral feeding|enteral feeding
1097571|NCT02566070|Continuous gastric feeding|continuous gastric feeding
1097572|NCT02566070|Bolus gastric feeding|bolus gastric feeding
1097573|NCT02566044|Cystic Fibrosis|cystic fibrosis
1097574|NCT02566031|COPD|copd
1097575|NCT02566031|open-label|open-label
1097576|NCT02566031|QVA149|qva149
1097577|NCT02566031|symptomatic|symptomatic
1097578|NCT02566031|tiotropium|tiotropium
1097579|NCT02566018|elderly|elderly
1097580|NCT02566005|Misoprostol|misoprostol
1097581|NCT02566005|Induction|induction
1097582|NCT02566005|Foley|foley
1097583|NCT02565992|Pembrolizumab|pembrolizumab
1097584|NCT02565992|Coxsackievirus A21|coxsackievirus a21
1097585|NCT02565992|melanoma|melanoma
1097586|NCT02565992|CAVATAK|cavatak
1097587|NCT02565992|CVA21|cva21
1097588|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
1097589|NCT02565979|Resveratrol|resveratrol
1097590|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1097591|NCT02565979|Insulin Resistance|insulin resistance
1097592|NCT02565979|Metabolic Diseases|metabolic diseases
1097593|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
1097594|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
1097595|NCT02565927|Trachea|trachea
1097596|NCT02565927|Stent|stent
1097597|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
1097598|NCT02565888|Hepatitis C|hepatitis c
1097599|NCT02565888|HIV|hiv
1097600|NCT02565888|atazanavir|atazanavir
1097601|NCT02565888|ritonavir|ritonavir
1097602|NCT02565888|daclatasvir|daclatasvir
1097603|NCT02565888|cobicistat|cobicistat
1097604|NCT02565875|Efficiency, Organizational|efficiency, organizational
1097605|NCT02565875|Simulation|simulation
1097606|NCT02565875|Communication|communication
1097607|NCT02565875|Laparoscopy|laparoscopy
1097608|NCT02565875|Medical Education|medical education
1097609|NCT02565862|HCV|hcv
1097610|NCT02565862|Diabetes Mellitus|diabetes mellitus
1097611|NCT02565862|Daclatasvir|daclatasvir
1097612|NCT02565862|Metformin|metformin
1097613|NCT02565862|drug-drug interaction|drug-drug interaction
1097614|NCT02565862|pharmacokinetics|pharmacokinetics
1097615|NCT02565836|Vitamin K 1|vitamin k 1
1097616|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
1097617|NCT02565836|warfarin|warfarin
1097618|NCT02565823|Exercise|exercise
1097619|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
1097620|NCT02565771|Childhood cancer|childhood cancer
1097621|NCT02565771|Cancer|cancer
1097622|NCT02565771|Sequels|sequels
1097623|NCT02565771|Surgery|surgery
1097624|NCT02565771|Complications|complications
1097625|NCT02565771|Chemotherapy|chemotherapy
1097626|NCT02565771|Radiotherapy|radiotherapy
1097627|NCT02565758|Cancer|cancer
1097628|NCT02565758|Advanced Solid Tumors|advanced solid tumors
1097629|NCT02565758|Neoplasm|neoplasm
1097630|NCT02565758|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
1097631|NCT02565758|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1097632|NCT02565758|carcinoma of the breast|carcinoma of the breast
1097633|NCT02565758|antibody drug conjugate|antibody drug conjugate
1097634|NCT02565745|Prevention|prevention
1097635|NCT02565745|Pressure ulcers|pressure ulcers
1097636|NCT02565745|Clinical trial|clinical trial
1097637|NCT02565745|Nursing|nursing
1097638|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
1097639|NCT02565680|acute urticaria|acute urticaria
1097640|NCT02565680|glucocorticoids|glucocorticoids
1097641|NCT02565680|antihistamines|antihistamines
1097642|NCT02565680|prurit|prurit
1097643|NCT02565680|itch score|itch score
1097644|NCT02565680|rash|rash
1097645|NCT02565667|low rectal carcinoma|low rectal carcinoma
1097646|NCT02565667|anastomosis|anastomosis
1097647|NCT02565667|anterior rectal resection|anterior rectal resection
1097648|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
1097649|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
1097650|NCT02565654|Rifaximin|rifaximin
1097651|NCT02565602|Calcium metabolism|calcium metabolism
1097652|NCT02565602|Osteoporosis|osteoporosis
1097653|NCT02565602|Postmenopausal women|postmenopausal women
1097654|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
1097655|NCT02565563|EMDR|emdr
1097656|NCT02565563|Mechanisms|mechanisms
1097657|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
1097658|NCT02565550|Microbiota Community|microbiota community
1097659|NCT02565550|FODMAPs|fodmaps
1097660|NCT02565550|IBS|ibs
1097661|NCT02565524|schizophrenia|schizophrenia
1097662|NCT02565524|early dissociative disorder|early dissociative disorder
1097663|NCT02565524|genetic|genetic
1097664|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
1097665|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
1097666|NCT02565498|Extremity|extremity
1099420|NCT02554812|TGCT/PVNS|tgct/pvns
1097669|NCT02565485|pulse pressure|pulse pressure
1097670|NCT02565485|fetal heart rate|fetal heart rate
1097671|NCT02565485|epidural analgesia|epidural analgesia
1097673|NCT02565485|preload|preload
1097674|NCT02565485|fluid bolus|fluid bolus
1097675|NCT02565485|central hypovolemia|central hypovolemia
1097676|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
1097677|NCT02565459|kidney transplantation|kidney transplantation
1097678|NCT02565459|tolerance|tolerance
1097679|NCT02565433|brain metastases|brain metastases
1097680|NCT02565433|Gamma Knife|gamma knife
1097681|NCT02565433|Radiosurgery|radiosurgery
1097682|NCT02565433|Quality of Life|quality of life
1097683|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
1097684|NCT02565342|Clavicle|clavicle
1097685|NCT02565303|cesarean delivery|cesarean delivery
1097686|NCT02565303|ropivacaine|ropivacaine
1097687|NCT02565303|minimum effective dose|minimum effective dose
1097688|NCT02565303|dose-response relationship|dose-response relationship
1097689|NCT02565303|intrathecal|intrathecal
1097690|NCT02565303|intervertebral space|intervertebral space
1097691|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
1097692|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
1097693|NCT02565290|inflammation|inflammation
1097694|NCT02565251|sepsis|sepsis
1097695|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
1097696|NCT02565251|septic shock|septic shock
1097697|NCT02565251|volemic resuscitation|volemic resuscitation
1097698|NCT02565251|fluid resuscitation|fluid resuscitation
1097699|NCT02565212|Montelukast|montelukast
1097700|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
1097701|NCT02565212|allergic rhinitis|allergic rhinitis
1097702|NCT02565212|mometasone furoate|mometasone furoate
1097703|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1097704|NCT02565173|glaucoma|glaucoma
1145881|NCT02288572|obesity|obesity
1097705|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
1097706|NCT02565173|ocular hypertension|ocular hypertension
1097707|NCT02565173|adenosine agonist|adenosine agonist
1097708|NCT02565173|eye drop|eye drop
1097709|NCT02565173|trabodenoson|trabodenoson
1097710|NCT02565173|trabecular meshwork|trabecular meshwork
1097711|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
1097712|NCT02565121|Olfactory perception|olfactory perception
1097713|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
1097714|NCT02565121|Steroids|steroids
1097715|NCT02565121|Education|education
1097716|NCT02565108|Cannabidiol|cannabidiol
1097717|NCT02565108|GWP42003-P|gwp42003-p
1097718|NCT02565108|Clobazam|clobazam
1097719|NCT02565108|Epidiolex|epidiolex
1097720|NCT02565082|Hemostatic potential|hemostatic potential
1097721|NCT02565082|Sickle cell disease|sickle cell disease
1097722|NCT02565082|Thrombin generation test|thrombin generation test
1097723|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
1097724|NCT02565043|Negative Pressure Wound Therapy|negative pressure wound therapy
1097725|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
1097726|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
1097727|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
1097728|NCT02565030|Operable disease|operable disease
1097729|NCT02565030|In-operable disease|in-operable disease
1097730|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
1097731|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
1097732|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
1097733|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
1097734|NCT02565030|Prostacyclin analogues|prostacyclin analogues
1097735|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
1097736|NCT02565030|Sildenafil|sildenafil
1097737|NCT02565030|Tadalafil|tadalafil
1097738|NCT02565030|Bosentan|bosentan
1097739|NCT02565030|Ambrisentan|ambrisentan
1097740|NCT02565030|Macitentan|macitentan
1097741|NCT02565030|Iloprost|iloprost
1097742|NCT02565030|Riociguat|riociguat
1097743|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1097744|NCT02565017|IBM Watson|ibm watson
1097745|NCT02565017|Clinical Decision Support System|clinical decision support system
1097746|NCT02565017|Patient Preferences|patient preferences
1097747|NCT02565017|15-226|15-226
1097748|NCT02565004|Genetic|genetic
1097749|NCT02565004|Sample Collection|sample collection
1097754|NCT02564978|Age-Related Macular Degeneration|age-related macular degeneration
1097755|NCT02564978|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1097756|NCT02564978|Geographic Atrophy|geographic atrophy
1097757|NCT02564978|Minocycline|minocycline
1097758|NCT02564978|Atrophic Macular Degeneration|atrophic macular degeneration
1097759|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
1099727|NCT02552901|flow sensor|flow sensor
1097760|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
1097761|NCT02564952|Cannabidiol|cannabidiol
1097762|NCT02564952|GWP42003-P|gwp42003-p
1097763|NCT02564952|Clobazam|clobazam
1097764|NCT02564952|Epidiolex|epidiolex
1097765|NCT02564939|prevention|prevention
1097766|NCT02564926|DM|dm
1098653|NCT02559674|Pancreas|pancreas
1097767|NCT02564913|tongue diagnosis|tongue diagnosis
1097768|NCT02564913|heart rate variability|heart rate variability
1097769|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
1097770|NCT02564900|Advanced solid tumors|advanced solid tumors
1097771|NCT02564900|phase 1|phase 1
1097772|NCT02564900|oncology|oncology
1097773|NCT02564900|HER2|her2
1097774|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
1097775|NCT02564887|dysphagia|dysphagia
1097776|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
1097777|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
1097778|NCT02564887|IOPI|iopi
1097779|NCT02564861|pharmacokinetics|pharmacokinetics
1097780|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
1097781|NCT02564848|Invasive breast cancer|invasive breast cancer
1097782|NCT02564848|estrogen-positive|estrogen-positive
1097783|NCT02564822|migraine disorders|migraine disorders
1097784|NCT02564822|cortical excitability|cortical excitability
1097785|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
1097786|NCT02564822|electroencephalography|electroencephalography
1097787|NCT02564796|Erythropoetin|erythropoetin
1097788|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
1097789|NCT02564796|Transfusion|transfusion
1097790|NCT02564796|Congenital Heart Disease|congenital heart disease
1097791|NCT02564731|children|children
1097792|NCT02564731|prognosis|prognosis
1097793|NCT02564718|Pediatric|pediatric
1097794|NCT02564679|bariatric surgery|bariatric surgery
1097795|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
1097796|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
1097797|NCT02564666|sorafenib|sorafenib
1097798|NCT02564666|telephone counseling|telephone counseling
1097799|NCT02564640|videolaryngoscope|videolaryngoscope
1097800|NCT02564640|direct laryngoscope|direct laryngoscope
1097801|NCT02564640|hemodynamic changes|hemodynamic changes
1097802|NCT02564640|elderly patients|elderly patients
1097803|NCT02564601|intervention|intervention
1097804|NCT02564601|cognition|cognition
1097805|NCT02564601|aging|aging
1097806|NCT02564601|piano training|piano training
1097807|NCT02564601|computer brain training|computer brain training
1097808|NCT02564575|Ebolavirus|ebolavirus
1097809|NCT02564562|PF-06463922|pf-06463922
1097810|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
1097811|NCT02564562|Human ADME|human adme
1097812|NCT02564562|Radiolabel|radiolabel
1097813|NCT02564562|Mass Balance|mass balance
1097814|NCT02564562|Pharmacokinetics|pharmacokinetics
1097815|NCT02564549|low risk prostate cancer|low risk prostate cancer
1097816|NCT02564523|Healthy|healthy
1097817|NCT02564523|Vaccine|vaccine
1097818|NCT02564523|Ebola viruses|ebola viruses
1097819|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
1097820|NCT02564523|Filoviruses|filoviruses
1097821|NCT02564523|Hemorrhagic fever|hemorrhagic fever
1097822|NCT02564523|Monovalent vaccine|monovalent vaccine
1097823|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1097824|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
1097825|NCT02564523|Safety|safety
1097826|NCT02564523|Immunogenicity|immunogenicity
1097827|NCT02564484|Cancer Therapy|cancer therapy
1097828|NCT02564484|Pharmacogenomics|pharmacogenomics
1097829|NCT02564484|Drug Response|drug response
1097830|NCT02564484|Genetic Variants|genetic variants
1097831|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
1097832|NCT02564484|Cancer Survivor|cancer survivor
1097833|NCT02564432|amputee|amputee
1097834|NCT02564354|Cystic Fibrosis|cystic fibrosis
1097835|NCT02564354|CF|cf
1097836|NCT02564354|ΔF508|δf508
1097837|NCT02564354|CFTR|cftr
1097838|NCT02564354|QR-010|qr-010
1097839|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
1097840|NCT02564354|RNA therapy|rna therapy
1097841|NCT02564354|F508del|f508del
1097842|NCT02564354|NPD|npd
1097843|NCT02564354|nasal potential difference|nasal potential difference
1097844|NCT02564341|HIV Infection|hiv infection
1097845|NCT02564341|Pain|pain
1097846|NCT02564341|Collaborative Care|collaborative care
1097847|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
1097848|NCT02564341|Addiction|addiction
1097849|NCT02564341|Analgesics, Opioid|analgesics, opioid
1097850|NCT02564328|Stroke|stroke
1097851|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
1097852|NCT02564328|Transplantation|transplantation
1097853|NCT02564315|Smoking|smoking
1097854|NCT02564315|Cessation|cessation
1097855|NCT02564315|Tobacco|tobacco
1097856|NCT02564315|Relapse|relapse
1097857|NCT02564302|PVI|pvi
1097858|NCT02564302|Atrial Fibrillation|atrial fibrillation
1097859|NCT02564302|MUSE Headband|muse headband
1097860|NCT02564302|Mindfulness|mindfulness
1097861|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
1097862|NCT02564289|Plethysmography|plethysmography
1097863|NCT02564289|Snus|snus
1097864|NCT02564289|Arterial Stiffness|arterial stiffness
1097865|NCT02564289|EPC|epc
1097866|NCT02564276|Indocyanine Green|indocyanine green
1097867|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1097868|NCT02564263|PD1|pd1
1097869|NCT02564263|PD-L1|pd-l1
1097870|NCT02564263|PDL1|pdl1
1097871|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
1097872|NCT02564237|Group A streptococcal|group a streptococcal
1097873|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
1097874|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
1097875|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
1097876|NCT02564159|malnutrition|malnutrition
1097877|NCT02564159|muscle ultrasound|muscle ultrasound
1097878|NCT02564159|intensive care unit|intensive care unit
1097879|NCT02564159|mechanical ventilation|mechanical ventilation
1097880|NCT02564159|albumin|albumin
1097881|NCT02564159|prealbumin|prealbumin
1097882|NCT02564159|nutrition|nutrition
1097883|NCT02564055|Vehicle-Controlled|vehicle-controlled
1097884|NCT02564055|GSK2894512|gsk2894512
1097885|NCT02564055|Double blind|double blind
1097886|NCT02564055|Dose-finding|dose-finding
1097887|NCT02564055|Atopic Dermatitis|atopic dermatitis
1097888|NCT02564042|Double blind|double blind
1097889|NCT02564042|Dose-finding|dose-finding
1097890|NCT02564042|Vehicle-Controlled|vehicle-controlled
1097891|NCT02564042|GSK2894512|gsk2894512
1097892|NCT02564042|Plaque Psoriasis|plaque psoriasis
1097893|NCT02563977|Breast reconstruction|breast reconstruction
1097894|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
1097895|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
1097896|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
1097897|NCT02563964|Myocardial infarction|myocardial infarction
1097898|NCT02563964|vulnerable plaque|vulnerable plaque
1097899|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
1097900|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
1097901|NCT02563964|Biomarkers|biomarkers
1097902|NCT02563951|Nausea|nausea
1097903|NCT02563951|Vomiting|vomiting
1097904|NCT02563951|Chemotherapy|chemotherapy
1097905|NCT02563951|Radiation therapy|radiation therapy
1097906|NCT02563925|Brain Irradiation|brain irradiation
1097907|NCT02563925|Tremelimumab|tremelimumab
1097908|NCT02563925|15-038|15-038
1097909|NCT02563912|Children|children
1097910|NCT02563912|resuscitation|resuscitation
1097911|NCT02563912|simulation|simulation
1097912|NCT02563912|medication error|medication error
1097913|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
1097914|NCT02563899|GSK573719|gsk573719
1097915|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
1097916|NCT02563899|Topical|topical
1097917|NCT02563899|PRO|pro
1097918|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
1097919|NCT02563899|Umeclidinium|umeclidinium
1097920|NCT02563821|Termination of pregancy|termination of pregancy
1097921|NCT02563821|Third trimester|third trimester
1097922|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
1097923|NCT02563821|Continuous epidural infusion|continuous epidural infusion
1097924|NCT02563821|Epidural analgesia|epidural analgesia
1097925|NCT02563821|Legally induced abortion|legally induced abortion
1097926|NCT02563795|Spinal anesthesia|spinal anesthesia
1097927|NCT02563795|Cesarean|cesarean
1097928|NCT02563795|Maternal hypotension|maternal hypotension
1097929|NCT02563769|Cocaine|cocaine
1097930|NCT02563769|Clavulanic Acid|clavulanic acid
1097931|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
1097932|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
1097933|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
1097934|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
1097935|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
1097936|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
1097937|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
1097938|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
1097939|NCT02563743|Sick-leave|sick-leave
1097940|NCT02563743|Return to work|return to work
1097941|NCT02563743|Occupational health|occupational health
1097942|NCT02563743|Common mental disorder|common mental disorder
1097943|NCT02563743|Depression|depression
1097944|NCT02563743|Anxiety disorders|anxiety disorders
1097945|NCT02563743|Adjustment disorders|adjustment disorders
1097946|NCT02563743|Problem solving therapy|problem solving therapy
1097947|NCT02563743|Occupational Health Services|occupational health services
1097948|NCT02563743|Randomized controlled trial|randomized controlled trial
1097949|NCT02563743|Intervention studies|intervention studies
1097950|NCT02563743|Occupational stress|occupational stress
1097951|NCT02563730|Cryobiopsy|cryobiopsy
1097952|NCT02563730|lung biopsy|lung biopsy
1099928|NCT02551900|Warm Water|warm water
1097953|NCT02563730|interstitial lung disease|interstitial lung disease
1097954|NCT02563717|Resuscitation|resuscitation
1097955|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
1097956|NCT02563717|Infant, Extremely Premature|infant, extremely premature
1098654|NCT02559674|Pancreatic|pancreatic
1097957|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
1097958|NCT02563717|Intubation|intubation
1097959|NCT02563704|Artesunate|artesunate
1097960|NCT02563704|Quinine|quinine
1097961|NCT02563704|Efficacy|efficacy
1097962|NCT02563704|Malaria|malaria
1097963|NCT02563704|Children|children
1097964|NCT02563704|Cameroon|cameroon
1097965|NCT02563652|Abdomen/surgery|abdomen/surgery
1097966|NCT02563652|Biological markers|biological markers
1097967|NCT02563652|Length of stay|length of stay
1097968|NCT02563652|Postoperative care|postoperative care
1097969|NCT02563652|Anesthesia recovery period|anesthesia recovery period
1097970|NCT02563652|Prognosis|prognosis
1097971|NCT02563639|newly diagnosed|newly diagnosed
1097972|NCT02563639|paroxysmal|paroxysmal
1097973|NCT02563639|persistent|persistent
1097974|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
1097975|NCT02563626|prognosis|prognosis
1097976|NCT02563626|outcomes|outcomes
1097977|NCT02563626|management|management
1097978|NCT02563626|incidence|incidence
1097979|NCT02563626|heart failure|heart failure
1097980|NCT02563626|acute coronary syndrome|acute coronary syndrome
1097981|NCT02563626|death|death
1097982|NCT02563613|community-based intervention|community-based intervention
1097983|NCT02563613|family holistic health|family holistic health
1097984|NCT02563613|positive psychology|positive psychology
1097985|NCT02563613|physical exercise|physical exercise
1097986|NCT02563613|healthy diet|healthy diet
1097987|NCT02563587|Laughter|laughter
1097988|NCT02563587|children|children
1097989|NCT02563587|postoperative|postoperative
1097990|NCT02563587|pain|pain
1097991|NCT02563587|anxiety|anxiety
1097992|NCT02563587|cortisol|cortisol
1097993|NCT02563574|Alcohol and brain function|alcohol and brain function
1097994|NCT02563574|HIV and brain function|hiv and brain function
1097995|NCT02563574|Motivational Interviewing|motivational interviewing
1097996|NCT02563561|Bladder Cancer|bladder cancer
1097997|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1097998|NCT02563561|Apaziquone|apaziquone
1097999|NCT02563561|TURBT|turbt
1098000|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
1098001|NCT02563522|non healing ulcers|non healing ulcers
1098002|NCT02563522|VM202|vm202
1098003|NCT02563522|Diabetic ulcers|diabetic ulcers
1098004|NCT02563522|foot ulcers|foot ulcers
1098005|NCT02563509|HIV|hiv
1098006|NCT02563509|cellular immunity therapy|cellular immunity therapy
1098007|NCT02563509|functional cure|functional cure
1098008|NCT02563496|pharmacokinetic|pharmacokinetic
1098009|NCT02563496|pediatric|pediatric
1098010|NCT02563496|Tafenoquine|tafenoquine
1098011|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
1098012|NCT02563496|G6PD deficiency|g6pd deficiency
1098013|NCT02563483|caregivers|caregivers
1098014|NCT02563483|anxiety|anxiety
1098015|NCT02563483|depression|depression
1098016|NCT02563483|yoga|yoga
1098017|NCT02563483|meditation|meditation
1098018|NCT02563483|stress|stress
1098019|NCT02563457|diabetic patients|diabetic patients
1098020|NCT02563457|periodontal treatment|periodontal treatment
1098021|NCT02563457|glycaemic control|glycaemic control
1098022|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
1098023|NCT02563431|shoulder pain|shoulder pain
1098024|NCT02563431|prevention program|prevention program
1098025|NCT02563418|video oculography|video oculography
1098026|NCT02563405|alpha receptor blocker|alpha receptor blocker
1098027|NCT02563405|uric acid|uric acid
1098029|NCT02563405|blood pressure variability|blood pressure variability
1098030|NCT02563366|kidney transplantation|kidney transplantation
1098031|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
1098032|NCT02563366|poor early graft function|poor early graft function
1098033|NCT02563366|delayed graft function|delayed graft function
1098034|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
1098035|NCT02563366|donation after cardiac death|donation after cardiac death
1098036|NCT02563353|whole body vibration|whole body vibration
1098037|NCT02563353|PTH|pth
1098038|NCT02563340|kidney transplantation|kidney transplantation
1098039|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
1098040|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
1098041|NCT02563340|donor specific antibody|donor specific antibody
1098042|NCT02563340|acute rejection|acute rejection
1098043|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
1098044|NCT02563314|Pulmonary Disease|pulmonary disease
1098045|NCT02563314|Chronic Obstructive|chronic obstructive
1098046|NCT02563314|Renal Doppler|renal doppler
1098047|NCT02563314|Oxygen|oxygen
1098048|NCT02563314|Hypercapnia|hypercapnia
1098049|NCT02563288|esmolol|esmolol
1098050|NCT02563288|dexmedetomidine|dexmedetomidine
1098051|NCT02563288|opioids|opioids
1098052|NCT02563197|Device study|device study
1098053|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
1099929|NCT02551900|Cold Water|cold water
1098054|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
1098055|NCT02563197|T-326 Inhaler|t-326 inhaler
1098056|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
1098057|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
1098058|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
1098059|NCT02563158|liver resection|liver resection
1098060|NCT02563158|blood inflow control|blood inflow control
1098061|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
1098062|NCT02563158|inflammatory response|inflammatory response
1098063|NCT02563158|randomized controlled trial|randomized controlled trial
1098064|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
1098065|NCT02563132|colonoscopy|colonoscopy
1098066|NCT02563132|carbon dioxide|carbon dioxide
1098067|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
1098068|NCT02563093|Influenza|influenza
1098069|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
1098070|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
1098071|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
1098072|NCT02563080|exocrine insufficiency|exocrine insufficiency
1098073|NCT02563080|acute pancreatitis|acute pancreatitis
1098074|NCT02563080|severe|severe
1098075|NCT02563080|moderately severe|moderately severe
1098076|NCT02563067|Asthma|asthma
1098077|NCT02563067|QAW039|qaw039
1098078|NCT02563028|Visual Evoked Potentials|visual evoked potentials
1098079|NCT02563028|Microdiscectomy|microdiscectomy
1098080|NCT02563028|SightSaver|sightsaver
1098081|NCT02563015|Infant|infant
1098082|NCT02563015|Vitamin D|vitamin d
1098083|NCT02563015|Deficiency|deficiency
1098084|NCT02563015|Lean Mass|lean mass
1098085|NCT02563002|PD1|pd1
1098086|NCT02563002|PDL1|pdl1
1098087|NCT02563002|PD-L1|pd-l1
1098088|NCT02562924|MEDIHONEY|medihoney
1098089|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
1098090|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1098091|NCT02562911|cystic fibrosis|cystic fibrosis
1098092|NCT02562911|menstrual cycle|menstrual cycle
1098093|NCT02562911|puberty|puberty
1098094|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
1098095|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
1098096|NCT02562885|Electroencephalography|electroencephalography
1098097|NCT02562885|Sleep, slow wave|sleep, slow wave
1098098|NCT02562872|Controlled|controlled
1098099|NCT02562872|Human|human
1098100|NCT02562872|Malaria|malaria
1098101|NCT02562872|Infection|infection
1098102|NCT02562872|Healthy|healthy
1098103|NCT02562872|Volunteer|volunteer
1098104|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
1098105|NCT02562846|response prediction|response prediction
1098106|NCT02562846|cognitive side effects|cognitive side effects
1098107|NCT02562833|Osteoarthritis|osteoarthritis
1098108|NCT02562833|Self-management|self-management
1098109|NCT02562833|Multi-Component Exercise|multi-component exercise
1098110|NCT02562807|Urinary Incontinence|urinary incontinence
1098111|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
1098112|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1098113|NCT02562794|refugee|refugee
1098114|NCT02562781|postoperative complications|postoperative complications
1098115|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1098116|NCT02562781|oxygen|oxygen
1098117|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1098118|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
1098119|NCT02562755|Sorafenib|sorafenib
1098120|NCT02562755|GM-CSF therapy|gm-csf therapy
1098121|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
1098122|NCT02562755|Oncology|oncology
1098123|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
1098124|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
1098125|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
1098126|NCT02562742|Hepatitis C virus|hepatitis c virus
1098127|NCT02562742|observational|observational
1098128|NCT02562742|post-marketing|post-marketing
1098129|NCT02562742|sofosbuvir|sofosbuvir
1098130|NCT02562742|Infection|infection
1098131|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
1098132|NCT02562690|Coronary Artery Disease|coronary artery disease
1098133|NCT02562690|Myocardial Ischemia|myocardial ischemia
1098134|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
1098135|NCT02562690|Coronary Thrombosis|coronary thrombosis
1098136|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
1098137|NCT02562638|NPO|npo
1098138|NCT02562638|NBM|nbm
1098139|NCT02562638|pre-procedure|pre-procedure
1098140|NCT02562638|cardiac|cardiac
1098141|NCT02562599|Induction Chemotherapy|induction chemotherapy
1098142|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1098143|NCT02562586|Suction|suction
1098144|NCT02562586|Arthroplasty|arthroplasty
1098145|NCT02562586|Replacement|replacement
1098146|NCT02562586|Hip|hip
1098147|NCT02562534|ECG|ecg
1098148|NCT02562534|MRI|mri
1098149|NCT02562534|rythm troubles|rythm troubles
1098150|NCT02562534|conductive troubles|conductive troubles
1098151|NCT02562534|ECG artifacts|ecg artifacts
1098152|NCT02562534|Database|database
1098153|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
1098154|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
1098155|NCT02562508|vaccine|vaccine
1098156|NCT02562508|adolescent girl|adolescent girl
1098157|NCT02562508|bridging trial|bridging trial
1098158|NCT02562508|non-inferiority|non-inferiority
1098159|NCT02562495|severe cerebral pathology|severe cerebral pathology
1098160|NCT02562495|Ultrasound|ultrasound
1098161|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
1098162|NCT02562482|Antibody Response|antibody response
1098163|NCT02562482|Immune Response|immune response
1098164|NCT02562482|Healthy Volunteer|healthy volunteer
1098165|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
1098166|NCT02562482|Chikungunya Virus|chikungunya virus
1098167|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
1098168|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1098169|NCT02562456|Composite Resins|composite resins
1098170|NCT02562456|Primary Teeth|primary teeth
1098171|NCT02562456|Clinical Efficacy|clinical efficacy
1098172|NCT02562456|Cost Analysis|cost analysis
1098173|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
1098175|NCT02562430|Placebo response|placebo response
1098176|NCT02562391|atrial fibrillation|atrial fibrillation
1098177|NCT02562391|ablation|ablation
1098178|NCT02562391|thoracoscopy|thoracoscopy
1098179|NCT02562391|left atrial appendage|left atrial appendage
1098180|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
1146511|NCT02284581|MBC|mbc
1098181|NCT02562365|ovarian cancer|ovarian cancer
1098182|NCT02562352|polypharmacy|polypharmacy
1098183|NCT02562352|multimorbidity|multimorbidity
1098184|NCT02562352|randomized controlled trial|randomized controlled trial
1098185|NCT02562352|drug discontinuation|drug discontinuation
1098186|NCT02562352|patient preference|patient preference
1098187|NCT02562352|eHealth|ehealth
1098188|NCT02562274|Menopause|menopause
1098189|NCT02562274|Cognitive impairment|cognitive impairment
1098190|NCT02562274|Working memory|working memory
1098191|NCT02562274|Bone formation markers|bone formation markers
1098192|NCT02562274|Osteoporosis|osteoporosis
1098193|NCT02562261|sepsis|sepsis
1098194|NCT02562261|platelet|platelet
1098195|NCT02562261|platelet reactivity|platelet reactivity
1098196|NCT02562261|P2Y12|p2y12
1098197|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
1098198|NCT02562222|migraine disorders|migraine disorders
1098199|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
1098200|NCT02562222|electric stimulation therapy|electric stimulation therapy
1098201|NCT02562222|pain|pain
1098202|NCT02562222|rehabilitation|rehabilitation
1098203|NCT02562209|Obesity|obesity
1098204|NCT02562209|Abdominal adiposity|abdominal adiposity
1098205|NCT02562209|High protein diet|high protein diet
1098206|NCT02562196|migraine disorders|migraine disorders
1098207|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
1098208|NCT02562196|electric stimulation therapy|electric stimulation therapy
1098209|NCT02562196|pain|pain
1098210|NCT02562170|breast|breast
1098211|NCT02562170|reconstruction|reconstruction
1098212|NCT02562170|mesh|mesh
1098213|NCT02562170|acellular dermal matrix|acellular dermal matrix
1098214|NCT02562131|PET-MR|pet-mr
1098215|NCT02562131|recidive|recidive
1098216|NCT02562131|PET/MR imaging|pet/mr imaging
1098217|NCT02562131|18F-Fluciclovine|18f-fluciclovine
1098218|NCT02562131|radical treatment|radical treatment
1098219|NCT02562131|recurrence|recurrence
1098220|NCT02562105|Intensive care unit|intensive care unit
1098221|NCT02562105|Hematological malignancy|hematological malignancy
1098222|NCT02562105|Acute respiratory failure|acute respiratory failure
1098223|NCT02562105|Prognosis|prognosis
1098224|NCT02562105|Mechanical ventilation|mechanical ventilation
1098225|NCT02562092|AIDS|aids
1098226|NCT02562092|Health Promotion|health promotion
1098227|NCT02562079|T lymphocyte|t lymphocyte
1098228|NCT02562079|OX40/OX40L|ox40/ox40l
1098229|NCT02562040|Pediatrics|pediatrics
1098230|NCT02562040|Primary Snoring|primary snoring
1098231|NCT02562040|Adenotonsillectomy|adenotonsillectomy
1098232|NCT02562001|Spinal Cord Injuries|spinal cord injuries
1098233|NCT02562001|gait training|gait training
1098234|NCT02562001|robotic|robotic
1098235|NCT02562001|Lokomat|lokomat
1098236|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1098237|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
1098238|NCT02562001|Electroencephalography|electroencephalography
1098239|NCT02562001|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
1098240|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
1098241|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
1098242|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
1098243|NCT02561962|Multiple Myeloma|multiple myeloma
1098244|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
1098245|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
1098246|NCT02561949|Depression/therapy|depression/therapy
1098247|NCT02561949|Developing Countries|developing countries
1098655|NCT02559674|Cancer|cancer
1098248|NCT02561949|Interpersonal Relations|interpersonal relations
1098249|NCT02561949|Life Change Events|life change events
1098250|NCT02561949|Psychotherapy, group|psychotherapy, group
1098251|NCT02561949|Resilience, Psychological|resilience, psychological
1098252|NCT02561949|Sierra Leone|sierra leone
1098253|NCT02561949|Survivors/psychology|survivors/psychology
1098254|NCT02561949|Social Adjustment|social adjustment
1098255|NCT02561949|Social Behavior|social behavior
1098256|NCT02561949|War|war
1098257|NCT02561936|Healthy|healthy
1098258|NCT02561936|EUDRANT|eudrant
1098259|NCT02561936|Rilpivirine|rilpivirine
1098260|NCT02561923|Healthy|healthy
1098261|NCT02561923|Rivaroxaban|rivaroxaban
1098262|NCT02561923|XARELTO|xarelto
1098263|NCT02561910|Inguinal hernia repair|inguinal hernia repair
1098264|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
1098265|NCT02561910|TAPP|tapp
1098266|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
1098267|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
1098268|NCT02561871|Healthy participants|healthy participants
1098269|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
1098270|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
1098271|NCT02561832|breast cancer|breast cancer
1098272|NCT02561819|Short Bowel Syndrome|short bowel syndrome
1098273|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
1098274|NCT02561819|Body Composition|body composition
1098275|NCT02561819|Parenteral Nutrition|parenteral nutrition
1098276|NCT02561819|Intestinal Failure|intestinal failure
1098277|NCT02561780|Mental Health Knowledge|mental health knowledge
1098278|NCT02561780|Stigma|stigma
1098279|NCT02561780|Mental Health Literacy|mental health literacy
1098280|NCT02561767|kidney transplantation|kidney transplantation
1098281|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
1098282|NCT02561767|donation after citizen's death|donation after citizen's death
1098283|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
1098284|NCT02561767|renal function recovery|renal function recovery
1098285|NCT02561754|Diet|diet
1098286|NCT02561754|Obesity|obesity
1098287|NCT02561754|Adolescents|adolescents
1098288|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
1098289|NCT02561728|Helmet|helmet
1098290|NCT02561728|Hangar|hangar
1098291|NCT02561728|P-Pod|p-pod
1098292|NCT02561728|Plagiocephaly|plagiocephaly
1098293|NCT02561728|Surgery|surgery
1098294|NCT02561715|Parkinson's|parkinson's
1098295|NCT02561715|Anosognosia|anosognosia
1098297|NCT02561715|Deep Brain Surgery|deep brain surgery
1098298|NCT02561689|Occlusal caries|occlusal caries
1098299|NCT02561689|Resin fissure sealant|resin fissure sealant
1098300|NCT02561689|Longevity|longevity
1098301|NCT02561689|Effectiveness|effectiveness
1098302|NCT02561676|Mindfulness|mindfulness
1098303|NCT02561676|Spinal Cord Injury|spinal cord injury
1098304|NCT02561663|microcirculation|microcirculation
1098305|NCT02561663|blood pressure|blood pressure
1098306|NCT02561663|pulse wave analysis|pulse wave analysis
1098307|NCT02561663|pulse wave velocity|pulse wave velocity
1098308|NCT02561637|Case management|case management
1098309|NCT02561624|mHealth|mhealth
1098310|NCT02561624|Text message|text message
1098311|NCT02561611|Pedal Desk|pedal desk
1098312|NCT02561611|Workplace Intervention|workplace intervention
1098313|NCT02561611|Physical Activity|physical activity
1098314|NCT02561611|Energy Expenditure|energy expenditure
1098315|NCT02561546|concurrent|concurrent
1098316|NCT02561520|platelet rich plasma|platelet rich plasma
1098317|NCT02561520|platelet poor plasma|platelet poor plasma
1098318|NCT02561520|ocular GVHD|ocular gvhd
1098319|NCT02561455|Advanced solid tumors|advanced solid tumors
1098320|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
1098321|NCT02561455|gilteritinib|gilteritinib
1098322|NCT02561455|ASP2215|asp2215
1098323|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
1098324|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
1098325|NCT02561416|Neuroimaging|neuroimaging
1098326|NCT02561416|Cytokines|cytokines
1098327|NCT02561416|Randomized Controlled Trial|randomized controlled trial
1098328|NCT02561416|Cost-effectiveness|cost-effectiveness
1098329|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
1098330|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
1098331|NCT02561403|aging|aging
1098332|NCT02561403|cognitive training|cognitive training
1098333|NCT02561403|Cognitive Aging|cognitive aging
1098334|NCT02561377|resistance training|resistance training
1098335|NCT02561377|Prediabetic state|prediabetic state
1098336|NCT02561377|Metabolomics|metabolomics
1098337|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
1098338|NCT02561351|bronchial asthma|bronchial asthma
1098339|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
1100118|NCT02550600|ECMO|ecmo
1098340|NCT02561351|asthma exacerbation|asthma exacerbation
1098341|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
1098342|NCT02561325|Blood pressure|blood pressure
1098343|NCT02561325|Sodium Chloride|sodium chloride
1098344|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
1098345|NCT02561299|Drug-coated Balloons|drug-coated balloons
1098346|NCT02561299|Calcified Lesions|calcified lesions
1098347|NCT02561299|Orbital Atherectomy|orbital atherectomy
1098348|NCT02561299|Below the Knee|below the knee
1098349|NCT02561299|Paclitaxel|paclitaxel
1098350|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
1098351|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
1098352|NCT02561286|Sexually transmitted disease|sexually transmitted disease
1098353|NCT02561286|Men who have sex with men|men who have sex with men
1098354|NCT02561286|African Americans|african americans
1098355|NCT02561286|Behavioral intervention|behavioral intervention
1098356|NCT02561286|Randomized controlled trial|randomized controlled trial
1098357|NCT02561286|Sexual behavior|sexual behavior
1098358|NCT02561286|Mediation analysis|mediation analysis
1098359|NCT02561286|Social cognitive theory|social cognitive theory
1098360|NCT02561286|Theory of planned behavior|theory of planned behavior
1098361|NCT02561247|Acute Kidney Injury|acute kidney injury
1098362|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1098363|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
1098364|NCT02561247|Prismaflex|prismaflex
1098365|NCT02561247|Pediatric|pediatric
1098366|NCT02561221|primary care|primary care
1098367|NCT02561221|pragmatic trial|pragmatic trial
1098368|NCT02561221|weight loss|weight loss
1098369|NCT02561221|overweight|overweight
1098370|NCT02561221|diet|diet
1098371|NCT02561221|physical activity|physical activity
1098372|NCT02561221|PCORI|pcori
1098373|NCT02561208|Patient adherence|patient adherence
1098374|NCT02561208|Mobile Health|mobile health
1098375|NCT02561208|HPV DNA Tests|hpv dna tests
1098376|NCT02561208|Self-collected|self-collected
1098377|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
1098378|NCT02561169|antiviral|antiviral
1098379|NCT02561169|oseltamivir|oseltamivir
1098380|NCT02561156|Drug therapy|drug therapy
1098381|NCT02561143|cachexia|cachexia
1098382|NCT02561143|nutrition supplementation|nutrition supplementation
1098383|NCT02561143|IAtta|iatta
1098384|NCT02561143|palliative care|palliative care
1098385|NCT02561143|quality of life|quality of life
1098386|NCT02561130|Diabetes|diabetes
1098387|NCT02561130|Insulin|insulin
1098388|NCT02561130|Glargine|glargine
1098389|NCT02561130|Metformin|metformin
1098390|NCT02561130|Forxiga|forxiga
1098391|NCT02561130|Diet|diet
1098392|NCT02561130|Exercise|exercise
1098393|NCT02561130|Lifestyle|lifestyle
1098394|NCT02561104|cataract|cataract
1098395|NCT02561104|phacoemulsification|phacoemulsification
1098396|NCT02561104|laser-assisted surgery|laser-assisted surgery
1098397|NCT02561104|femtosecond laser|femtosecond laser
1098398|NCT02561091|Deafness|deafness
1098399|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
1098400|NCT02561091|Ear Diseases|ear diseases
1098401|NCT02561091|Hearing Disorders|hearing disorders
1098402|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
1098403|NCT02561091|Sensation Disorders|sensation disorders
1098404|NCT02561091|Signs and Symptoms|signs and symptoms
1098405|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
1098406|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
1098407|NCT02561078|insulin pumps|insulin pumps
1098408|NCT02561078|concentrated insulin|concentrated insulin
1098409|NCT02561078|OmniPod|omnipod
1098410|NCT02561065|Health Lifestyle|health lifestyle
1098411|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
1098412|NCT02561065|Health Behavior|health behavior
1098413|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
1098414|NCT02561065|Intervention Studies|intervention studies
1098415|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
1098416|NCT02561065|Motivational Interview|motivational interview
1098417|NCT02561065|Preventive health services|preventive health services
1098418|NCT02561065|Health education|health education
1098419|NCT02561065|Physical activity|physical activity
1098420|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
1098421|NCT02561065|Workplace|workplace
1098422|NCT02561026|Frozen plasma|frozen plasma
1098424|NCT02561026|procedures|procedures
1098425|NCT02561000|Platelets|platelets
1098426|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1098427|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
1098428|NCT02561000|Hemorrhage|hemorrhage
1098429|NCT02560961|Kinesio Taping|kinesio taping
1098430|NCT02560961|Soccer|soccer
1098431|NCT02560961|Hop Test|hop test
1098432|NCT02560961|Vertical Jump|vertical jump
1098433|NCT02560935|primary stroke prevention|primary stroke prevention
1098434|NCT02560935|hydroxyurea|hydroxyurea
1098435|NCT02560935|low income country|low income country
1098436|NCT02560935|sub-Saharan Africa|sub-saharan africa
1098437|NCT02560922|Osteoarthritis|osteoarthritis
1098438|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
1098439|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
1098440|NCT02560896|Family|family
1098441|NCT02560896|History|history
1098442|NCT02560896|Pancreas|pancreas
1098443|NCT02560896|Cancer|cancer
1098444|NCT02560896|Genetic|genetic
1098445|NCT02560883|Hairy Cell|hairy cell
1098446|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
1098447|NCT02560857|organ rejection|organ rejection
1098448|NCT02560857|global immunity|global immunity
1098449|NCT02560831|Osteoarthritis|osteoarthritis
1098450|NCT02560831|Therapeutic exercises|therapeutic exercises
1098451|NCT02560831|Pain|pain
1098452|NCT02560831|Muscle strength|muscle strength
1098453|NCT02560831|Postural balance|postural balance
1098454|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
1098455|NCT02560779|TRC105|trc105
1098456|NCT02560779|CD105|cd105
1098457|NCT02560779|Endoglin|endoglin
1098458|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
1098459|NCT02560779|HCC|hcc
1098460|NCT02560779|TKI|tki
1098461|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1098462|NCT02560779|Sorafenib|sorafenib
1098463|NCT02560779|Nexavar|nexavar
1098464|NCT02560766|Restless Leg Syndrome|restless leg syndrome
1098465|NCT02560766|RLS|rls
1098466|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
1098467|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
1098468|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
1098469|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
1098470|NCT02560714|SIJ Fusion|sij fusion
1098471|NCT02560714|SI Joint|si joint
1098472|NCT02560714|SIJ|sij
1098473|NCT02560701|high-deductible health plans|high-deductible health plans
1098474|NCT02560701|medication adherence|medication adherence
1098475|NCT02560688|drug interaction|drug interaction
1098476|NCT02560688|clopidogrel|clopidogrel
1098477|NCT02560688|healthy subjects|healthy subjects
1098478|NCT02560675|Whiplash Injury Pain|whiplash injury pain
1098479|NCT02560675|Chronic Pain|chronic pain
1098480|NCT02560675|TBI|tbi
1098481|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
1098482|NCT02560636|Muscle Invasive|muscle invasive
1098483|NCT02560636|Metastatic|metastatic
1098484|NCT02560636|Advanced|advanced
1098485|NCT02560623|Barrett's|barrett's
1098486|NCT02560623|esophagus|esophagus
1098487|NCT02560623|reflux|reflux
1098488|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
1098489|NCT02560597|epilepsy|epilepsy
1098490|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
1098491|NCT02560597|status epilepticus|status epilepticus
1098492|NCT02560597|treatment resistant|treatment resistant
1098493|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1098494|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1098495|NCT02560584|NMIBC|nmibc
1098496|NCT02560584|Cysview|cysview
1098497|NCT02560558|Immunosuppression|immunosuppression
1098498|NCT02560558|Transplantation Immunology|transplantation immunology
1098499|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1098500|NCT02560532|cerebral vasospasm|cerebral vasospasm
1098501|NCT02560532|clazosentan|clazosentan
1098502|NCT02560519|human serum albumin solution|human serum albumin solution
1098503|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
1098504|NCT02560493|BMIz|bmiz
1098505|NCT02560493|Exergaming|exergaming
1098506|NCT02560493|Cardiovascular Disease|cardiovascular disease
1098507|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
1098508|NCT02560454|Cognitive Remediation|cognitive remediation
1098509|NCT02560454|Working Memory Training|working memory training
1098510|NCT02560454|Cognitive training|cognitive training
1098511|NCT02560428|Mixed Methods|mixed methods
1098512|NCT02560428|Cardiovascular Health|cardiovascular health
1098513|NCT02560428|Implementation Evaluation|implementation evaluation
1098514|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
1098515|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
1098516|NCT02560415|Serious Game|serious game
1098517|NCT02560415|Controlled trial|controlled trial
1098518|NCT02560415|Denver model|denver model
1098519|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
1098520|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
1098521|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
1098522|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1098523|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
1098524|NCT02560389|Exposure Therapy|exposure therapy
1098525|NCT02560389|Fear Extinction|fear extinction
1098526|NCT02560376|PET/CT|pet/ct
1098527|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
1098528|NCT02560363|AZD9977|azd9977
1098529|NCT02560363|Safety|safety
1098530|NCT02560363|Tolerability|tolerability
1098531|NCT02560363|Pharmacokinetics|pharmacokinetics
1098532|NCT02560363|Food effect|food effect
1098533|NCT02560363|AZD9977 capsules|azd9977 capsules
1098534|NCT02560363|AZD9977 suspension|azd9977 suspension
1098535|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
1100119|NCT02550600|ECLA|ecla
1098539|NCT02560337|Relapse|relapse
1098540|NCT02560337|Recurrence|recurrence
1098541|NCT02560337|Chemotherapy resistance|chemotherapy resistance
1098542|NCT02560324|Ramelteon|ramelteon
1098543|NCT02560324|Nicotine|nicotine
1098544|NCT02560324|Nicotine dependence|nicotine dependence
1098546|NCT02560324|Tobacco Dependence|tobacco dependence
1098547|NCT02560285|Risk assessment|risk assessment
1098548|NCT02560285|Mortality|mortality
1098549|NCT02560285|Morbidity|morbidity
1098550|NCT02560285|Risk factor|risk factor
1098551|NCT02560272|vaccine|vaccine
1098552|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
1098553|NCT02560259|knee pain|knee pain
1098554|NCT02560246|Microbiome|microbiome
1098555|NCT02560233|Neurofeedback|neurofeedback
1098556|NCT02560233|Stress|stress
1098557|NCT02560233|fMRI|fmri
1098558|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
1098559|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
1098560|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
1098561|NCT02560233|Cortisol|cortisol
1098562|NCT02560233|EEG|eeg
1098563|NCT02560233|Heart rate variability|heart rate variability
1098564|NCT02560233|Blood pressure|blood pressure
1098565|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
1568430|NCT00505895|Stem Cell Transfusion|stem cell transfusion
1098566|NCT02560181|recurrent prostate cancer, HDR whole gland salvage|recurrent prostate cancer, hdr whole gland salvage
1098567|NCT02560168|Coronary artery disease|coronary artery disease
1098568|NCT02560168|iECG|iecg
1098569|NCT02560168|MyoVista|myovista
1098570|NCT02560168|Heart Test Labs|heart test labs
1098571|NCT02560168|Wavelet analysis|wavelet analysis
1098572|NCT02560168|Surface electrocardiogram|surface electrocardiogram
1098573|NCT02560155|Orthopedic surgery|orthopedic surgery
1098574|NCT02560155|Surgical site infection|surgical site infection
1098575|NCT02560155|Decolonization|decolonization
1098576|NCT02560155|Staphylococcus aureus|staphylococcus aureus
1098582|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
1098583|NCT02560116|Optison|optison
1098584|NCT02560090|Diabetes|diabetes
1098585|NCT02560077|cognitive|cognitive
1098586|NCT02560077|memory|memory
1098587|NCT02560077|physical fitness|physical fitness
1098588|NCT02560077|psychological fitness|psychological fitness
1098589|NCT02560077|elderly|elderly
1098590|NCT02560077|middle aged|middle aged
1098591|NCT02560051|Prostate Cancer|prostate cancer
1098592|NCT02560051|Advanced|advanced
1098593|NCT02560051|Local Failures|local failures
1098594|NCT02560038|Urothelial Cancer|urothelial cancer
1098595|NCT02560038|Bladder Cancer|bladder cancer
1098596|NCT02560038|Metastatic|metastatic
1098597|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
1098598|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
1098599|NCT02560012|RCC|rcc
1098600|NCT02560012|Personalized therapy|personalized therapy
1098601|NCT02560012|targeted inhibitors|targeted inhibitors
1098602|NCT02559999|Healthy Volunteers|healthy volunteers
1098603|NCT02559999|Pain|pain
1098604|NCT02559999|EEG|eeg
1098605|NCT02559973|Buprenorphine|buprenorphine
1098606|NCT02559973|opioid use disorder|opioid use disorder
1098607|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
1098608|NCT02559869|Biofluid|biofluid
1098609|NCT02559869|ALS|als
1098610|NCT02559869|MRI|mri
1098611|NCT02559869|PET|pet
1098612|NCT02559869|Imaging|imaging
1098613|NCT02559869|Biomarkers|biomarkers
1098614|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1098615|NCT02559869|TRACK ALS|track als
1098616|NCT02559869|pathology|pathology
1098617|NCT02559843|pomegranate|pomegranate
1098618|NCT02559843|diabetes|diabetes
1098619|NCT02559843|oxidative stress|oxidative stress
1098620|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
1098621|NCT02559817|Linzess|linzess
1098622|NCT02559791|Reslizumab|reslizumab
1098623|NCT02559791|Eosinophils|eosinophils
1098624|NCT02559791|Asthma|asthma
1098625|NCT02559791|Airway inflammation|airway inflammation
1098626|NCT02559791|Prednisone|prednisone
1098627|NCT02559765|physiotherapy|physiotherapy
1098628|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
1098629|NCT02559765|rehabilitation|rehabilitation
1098630|NCT02559765|rehabilitation services|rehabilitation services
1098631|NCT02559739|Stroke|stroke
1098632|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
1098633|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
1098634|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
1098635|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1098636|NCT02559739|Insomnia|insomnia
1098637|NCT02559739|Restless Legs Syndrome|restless legs syndrome
1098638|NCT02559739|Sleep Deprivation|sleep deprivation
1098640|NCT02559713|Lactation|lactation
1098641|NCT02559713|Lactating Women|lactating women
1098642|NCT02559713|Vedolizumab|vedolizumab
1098643|NCT02559713|Colitis Ulcerative|colitis ulcerative
1098644|NCT02559713|Crohn Disease|crohn disease
1098645|NCT02559713|Crohn's|crohn's
1098646|NCT02559700|Healthy Ageing|healthy ageing
1098647|NCT02559687|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
1098648|NCT02559687|PD1|pd1
1098649|NCT02559687|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
1098650|NCT02559687|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
1098651|NCT02559687|PDL1|pdl1
1098652|NCT02559687|PDL2|pdl2
1098656|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
1098657|NCT02559674|Immunotherapy|immunotherapy
1098658|NCT02559674|Immunotherapeutic|immunotherapeutic
1098659|NCT02559674|Interleukin-15|interleukin-15
1098660|NCT02559674|Gemcitabine|gemcitabine
1098661|NCT02559674|Nab-paclitaxel|nab-paclitaxel
1098662|NCT02559674|Solid Tumor|solid tumor
1098663|NCT02559674|Metastatic Disease|metastatic disease
1098664|NCT02559674|Combination Immunotherapy|combination immunotherapy
1098665|NCT02559583|Multiple Myeloma|multiple myeloma
1098666|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1098667|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1098668|NCT02559570|Functional constipation in children|functional constipation in children
1098669|NCT02559570|Linzess|linzess
1098670|NCT02559544|failed prior endocrine therapy|failed prior endocrine therapy
1098671|NCT02559518|Cerebellum|cerebellum
1098672|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1098673|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1098674|NCT02559518|Motor Learning|motor learning
1098675|NCT02559518|Serial Reaction Time Task|serial reaction time task
1098676|NCT02559518|HandwritingTask|handwritingtask
1098677|NCT02559505|natural influenza infection|natural influenza infection
1098678|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
1098679|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
1098680|NCT02559505|infants|infants
1098681|NCT02559505|children|children
1098682|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
1098686|NCT02559401|Eloquent cortex|eloquent cortex
1098687|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1098688|NCT02559349|SBRT|sbrt
1098689|NCT02559336|Palliative Care|palliative care
1098690|NCT02559336|Cancer|cancer
1098691|NCT02559336|Health Services Research|health services research
1098692|NCT02559310|Pneumonia|pneumonia
1098693|NCT02559310|CABP|cabp
1098694|NCT02559310|CAP|cap
1098695|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
1098696|NCT02559297|Regulatory T cells|regulatory t cells
1098697|NCT02559297|Sevoflurane|sevoflurane
1098698|NCT02559297|Desflurane|desflurane
1098699|NCT02559297|Cytokines|cytokines
1098700|NCT02559297|Flow cytometry|flow cytometry
1098701|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
1098702|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
1098703|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
1098704|NCT02559284|Postoperative Care / methods|postoperative care / methods
1098705|NCT02559284|Quality of life|quality of life
1098706|NCT02559180|Diabetes|diabetes
1098707|NCT02559180|Macular Edema|macular edema
1098708|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
1098709|NCT02559141|haemodynamic optimization|haemodynamic optimization
1098710|NCT02559141|cardiac index|cardiac index
1098711|NCT02559141|non-invasive|non-invasive
1098712|NCT02559141|pulse pressure variation|pulse pressure variation
1098713|NCT02559128|Insulin Resistance|insulin resistance
1098714|NCT02559128|Chronic Heart Failure|chronic heart failure
1098715|NCT02559128|Type 2 Diabetes|type 2 diabetes
1098716|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
1098717|NCT02559115|68Ga-RM2|68ga-rm2
1098718|NCT02559115|PET/CT scan|pet/ct scan
1098719|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
1098720|NCT02559115|14-146|14-146
1098721|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
1098722|NCT02559102|General anaesthesia|general anaesthesia
1098723|NCT02559102|Neurodevelopment|neurodevelopment
1098724|NCT02559102|Infants|infants
1098725|NCT02559102|Neonates|neonates
1098726|NCT02559076|Overweight|overweight
1098727|NCT02559076|Obesity|obesity
1098728|NCT02559076|Preschool children|preschool children
1098729|NCT02559076|United Arab Emirates|united arab emirates
1098730|NCT02559076|Dietary patterns|dietary patterns
1098731|NCT02559076|BMI z-scores|bmi z-scores
1098732|NCT02559063|cognitive training|cognitive training
1098740|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
1098741|NCT02559024|liver lesion|liver lesion
1098742|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
1098743|NCT02559024|MEDI6469|medi6469
1098744|NCT02559024|Immunotherapy|immunotherapy
1098745|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
1098746|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
1098747|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
1098748|NCT02558985|Pulmonary Compliance|pulmonary compliance
1098749|NCT02558985|Casting|casting
1098750|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
1098751|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
1098752|NCT02558972|Fainting|fainting
1098753|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
1098754|NCT02558972|Droxidopa|droxidopa
1098755|NCT02558972|Northera|northera
1098756|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
1098757|NCT02558933|Prenatal exposure|prenatal exposure
1098758|NCT02558933|Biomarkers|biomarkers
1098759|NCT02558933|Oxidative stress|oxidative stress
1098760|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
1098761|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
1098762|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1098763|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1098764|NCT02558920|Clinical practice guidelines|clinical practice guidelines
1098765|NCT02558920|Clinical trials|clinical trials
1098766|NCT02558920|Dietary sugars|dietary sugars
1098767|NCT02558920|Fructose|fructose
1098768|NCT02558920|Sucrose|sucrose
1098769|NCT02558920|High fructose corn syrup|high fructose corn syrup
1098770|NCT02558920|Isocaloric|isocaloric
1098771|NCT02558920|Hypercaloric|hypercaloric
1098772|NCT02558920|Body weight|body weight
1098773|NCT02558920|Prospective cohort studies|prospective cohort studies
1098774|NCT02558907|geriatrics|geriatrics
1098775|NCT02558907|cancer|cancer
1098776|NCT02558907|MMS test|mms test
1098777|NCT02558907|MoCA test|moca test
1098778|NCT02558907|cognitive evaluation|cognitive evaluation
1098779|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
1098780|NCT02558881|screening|screening
1098781|NCT02558881|colorectal cancer|colorectal cancer
1098782|NCT02558881|colon capsule|colon capsule
1098783|NCT02558881|virtual colonoscopy|virtual colonoscopy
1098784|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
1098785|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
1098786|NCT02558855|Transversus Abdominis|transversus abdominis
1098787|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
1098788|NCT02558803|HPV Vaccinations|hpv vaccinations
1098789|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
1098790|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1098791|NCT02558790|ADHD|adhd
1098792|NCT02558790|Attention Deficit Disorder|attention deficit disorder
1098794|NCT02558790|Magnesium|magnesium
1098795|NCT02558777|Delirium|delirium
1098796|NCT02558777|Pilot Study|pilot study
1098797|NCT02558777|Nurse intervention|nurse intervention
1098798|NCT02558777|Hospitalization|hospitalization
1098799|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1098800|NCT02558751|aging HIV|aging hiv
1098801|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
1098802|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
1098803|NCT02558712|screening|screening
1098804|NCT02558712|tele-ophthalmology|tele-ophthalmology
1098805|NCT02558686|trigger points|trigger points
1098806|NCT02558686|disability|disability
1098807|NCT02558686|post-dry needling soreness|post-dry needling soreness
1098808|NCT02558686|eccentric exercise|eccentric exercise
1098809|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
1098810|NCT02558673|Biomarkers|biomarkers
1098811|NCT02558673|Production|production
1098812|NCT02558673|Metabolism|metabolism
1098813|NCT02558673|Gut microbiome|gut microbiome
1098814|NCT02558673|Healthy|healthy
1098815|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
1098816|NCT02558660|economic incentive|economic incentive
1098825|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
1098826|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
1098827|NCT02558608|recurrence|recurrence
1098828|NCT02558595|PKD|pkd
1098829|NCT02558595|Kidney disease|kidney disease
1098831|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
1098832|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1098833|NCT02558582|Rehabilitation|rehabilitation
1098834|NCT02558582|Oxygen|oxygen
1098835|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
1098836|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
1098837|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
1098838|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
1098839|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
1098840|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
1098841|NCT02558517|Corticosteroids|corticosteroids
1098842|NCT02558517|Chronic disease|chronic disease
1098843|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1098844|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
1098845|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1098846|NCT02558491|Insulin Pump|insulin pump
1098847|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
1098848|NCT02558491|Exercise|exercise
1098849|NCT02558491|Glucose Variability|glucose variability
1098850|NCT02558491|Decision Support System|decision support system
1098851|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
1098852|NCT02558478|Whole exome sequencing|whole exome sequencing
1098853|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
1098854|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
1098855|NCT02558452|registry|registry
1098856|NCT02558452|tacrolimus once daily|tacrolimus once daily
1098857|NCT02558426|Chronic Venous Disease|chronic venous disease
1098858|NCT02558426|Estrogen receptors|estrogen receptors
1098859|NCT02558426|GPER|gper
1098860|NCT02558413|Viral Diseases|viral diseases
1098862|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
1098863|NCT02558413|RSV|rsv
1098864|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
1098865|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1098866|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
1098867|NCT02558413|Aviragen|aviragen
1098868|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
1098869|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
1098870|NCT02558257|Advanced Cancers|advanced cancers
1098871|NCT02558257|Survey|survey
1098872|NCT02558257|Questionnaire|questionnaire
1147382|NCT02279823|topical|topical
1098873|NCT02558244|Childhood Cancer|childhood cancer
1098874|NCT02558244|Image-defined Risk Factors|image-defined risk factors
1098875|NCT02558244|Pediatric Oncology|pediatric oncology
1098876|NCT02558192|LGG|lgg
1098877|NCT02558192|Probiotics|probiotics
1098878|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
1098879|NCT02558192|pediatrics|pediatrics
1098880|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
1099129|NCT02556645|Psychological Treatment|psychological treatment
1098881|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
1098882|NCT02558153|drug eluting balloon|drug eluting balloon
1098883|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
1098884|NCT02558127|asthma|asthma
1098885|NCT02558127|cystic fibrosis|cystic fibrosis
1098886|NCT02558101|Screening|screening
1098887|NCT02558101|Early detection|early detection
1098888|NCT02558101|Health inequality|health inequality
1098889|NCT02558101|Uptake|uptake
1098890|NCT02558088|salmeterol|salmeterol
1098891|NCT02558088|pharmacokinetics|pharmacokinetics
1098892|NCT02558088|doping|doping
1098893|NCT02558088|beta2-agonists|beta2-agonists
1098894|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
1098895|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
1098896|NCT02558062|Distal lung|distal lung
1098897|NCT02558049|Patient decision aid|patient decision aid
1098898|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
1098899|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
1098900|NCT02558023|URAPIDIL|urapidil
1098901|NCT02558023|NICARDIPINE|nicardipine
1098902|NCT02558010|Methadone|methadone
1098903|NCT02558010|Gabapentin|gabapentin
1098904|NCT02558010|Postoperative Pain|postoperative pain
1098905|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
1098906|NCT02558010|Pediatric|pediatric
1098907|NCT02557997|HIV reservoir|hiv reservoir
1098908|NCT02557997|HIV-1 DNA|hiv-1 dna
1098909|NCT02557997|Immune activation|immune activation
1098910|NCT02557997|Monocyte function|monocyte function
1098911|NCT02557997|Activation biomarkers|activation biomarkers
1098912|NCT02557984|Dopamine|dopamine
1098913|NCT02557984|Opioid|opioid
1098914|NCT02557984|Reward|reward
1098915|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
1098916|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
1098917|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
1098918|NCT02557932|Helicobacter|helicobacter
1098919|NCT02557906|Acellular dermal matrix|acellular dermal matrix
1098920|NCT02557906|ADM|adm
1098921|NCT02557906|SurgiMend|surgimend
1098922|NCT02557906|Breast reconstruction|breast reconstruction
1098923|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
1098929|NCT02557841|Cerebellum|cerebellum
1098930|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1098931|NCT02557841|Motor Learning|motor learning
1098932|NCT02557841|Serial Reaction Time Task|serial reaction time task
1098933|NCT02557841|Handwriting|handwriting
1098934|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1098935|NCT02557815|Emotion Regulation|emotion regulation
1098936|NCT02557815|Craving|craving
1098937|NCT02557789|Absolute bioavailability|absolute bioavailability
1098938|NCT02557789|Pharmacokinetics|pharmacokinetics
1098939|NCT02557776|BRCA1|brca1
1098940|NCT02557776|BRCA2|brca2
1098941|NCT02557776|hereditary breast cancer|hereditary breast cancer
1098942|NCT02557776|genetic counseling|genetic counseling
1098943|NCT02557763|Oxford UKA|oxford uka
1098944|NCT02557763|anterior knee pain|anterior knee pain
1098945|NCT02557763|lateral facet of patella|lateral facet of patella
1098946|NCT02557750|Childhood Cancer|childhood cancer
1098947|NCT02557750|Pediatric Oncology|pediatric oncology
1098948|NCT02557737|stroke|stroke
1098949|NCT02557737|upper extremity|upper extremity
1098950|NCT02557737|spasticity|spasticity
1098951|NCT02557737|botulinum toxin|botulinum toxin
1098952|NCT02557737|ultrasonography|ultrasonography
1098953|NCT02557737|electric stimulation|electric stimulation
1098954|NCT02557711|spasticity|spasticity
1098955|NCT02557711|stroke|stroke
1098956|NCT02557711|ultrasound elastography|ultrasound elastography
1098957|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
1098958|NCT02557659|Low Profile|low profile
1098959|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1098960|NCT02557659|Endovascular|endovascular
1098961|NCT02557594|Hepatitis B|hepatitis b
1098962|NCT02557568|nasal carriage|nasal carriage
1098963|NCT02557568|Staphylococcus aureus|staphylococcus aureus
1098964|NCT02557568|hemodialysis patients|hemodialysis patients
1098965|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
1098966|NCT02557529|Head and Neck Cancer|head and neck cancer
1098967|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
1098968|NCT02557529|Exercise Training|exercise training
1098969|NCT02557529|Progressive Resistance Training|progressive resistance training
1098970|NCT02557529|Weight loss|weight loss
1098971|NCT02557529|Lean Body Mass|lean body mass
1568431|NCT00505895|SCT|sct
1098972|NCT02557529|Body Composition|body composition
1098973|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
1098974|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
1098975|NCT02557464|semantic memory|semantic memory
1098976|NCT02557464|eye movements|eye movements
1098977|NCT02557464|reading|reading
1098978|NCT02557438|Bone|bone
1098979|NCT02557438|Child Health|child health
1098980|NCT02557438|Nutrition|nutrition
1098981|NCT02557425|malaria|malaria
1098982|NCT02557425|infant|infant
1098983|NCT02557425|pregnancy|pregnancy
1098984|NCT02557425|prophylaxis|prophylaxis
1098985|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
1098986|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1098987|NCT02557425|behavior|behavior
1098988|NCT02557425|neurodevelopment|neurodevelopment
1098989|NCT02557425|cognitive|cognitive
1098990|NCT02557399|Clindamycin|clindamycin
1098992|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
1098993|NCT02557399|Acne Vulgaris|acne vulgaris
1098994|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
1098995|NCT02557386|Adductor canal|adductor canal
1098996|NCT02557386|Nerve block|nerve block
1098997|NCT02557373|rice bran|rice bran
1098998|NCT02557373|infants|infants
1098999|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
1099000|NCT02557373|dietary intervention|dietary intervention
1099001|NCT02557360|liver injury|liver injury
1099002|NCT02557360|detoxification|detoxification
1099003|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
1099004|NCT02557360|quality of life|quality of life
1099005|NCT02557334|Strawberry Powder|strawberry powder
1099130|NCT02556645|Military|military
1099006|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
1099007|NCT02557269|Pollenosis|pollenosis
1099008|NCT02557269|Congestion|congestion
1099009|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
1099010|NCT02557269|Nasal Decongestant|nasal decongestant
1099011|NCT02557269|Nasal Antihistamine|nasal antihistamine
1099012|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
1099013|NCT02557256|Childhood Cancer|childhood cancer
1099014|NCT02557256|Abdominal Tumors|abdominal tumors
1099015|NCT02557256|Pelvic Tumors|pelvic tumors
1099016|NCT02557256|Pediatric Oncology|pediatric oncology
1099030|NCT02557113|cement leakage|cement leakage
1099031|NCT02557113|cement augmentation|cement augmentation
1099032|NCT02557113|vertebral body fracture|vertebral body fracture
1099033|NCT02557113|vertebral cavity|vertebral cavity
1099034|NCT02557113|vertebroplasty|vertebroplasty
1099035|NCT02557048|Childhood Cancer|childhood cancer
1099036|NCT02557048|Head and Neck Tumors|head and neck tumors
1099037|NCT02557048|Pediatric Oncology|pediatric oncology
1099038|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
1099039|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1099040|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1099041|NCT02557022|Clinical practice guidelines|clinical practice guidelines
1099042|NCT02557022|Glycemic index|glycemic index
1099043|NCT02557022|Glycemic load|glycemic load
1099044|NCT02557022|Body weight|body weight
1099045|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
1099046|NCT02557022|Cardiovascular disease|cardiovascular disease
1099047|NCT02557009|Hemodynamics|hemodynamics
1099048|NCT02557009|Central Venous Pressure|central venous pressure
1099049|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
1099050|NCT02557009|Cardiac Output|cardiac output
1099051|NCT02556983|Appendicitis|appendicitis
1099052|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
1099053|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
1099054|NCT02556983|Computer Simulation|computer simulation
1099055|NCT02556944|Depth of focus|depth of focus
1099056|NCT02556931|immunosuppression|immunosuppression
1099057|NCT02556931|nonmyeloablative|nonmyeloablative
1099058|NCT02556931|non-myeloablative|non-myeloablative
1099059|NCT02556931|allogeneic|allogeneic
1099060|NCT02556931|tacrolimus|tacrolimus
1099061|NCT02556931|peripheral blood|peripheral blood
1099062|NCT02556931|cyclophosphamide|cyclophosphamide
1099063|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
1099064|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
1099065|NCT02556918|Type 2 Diabetes|type 2 diabetes
1099066|NCT02556905|Multiple Myeloma|multiple myeloma
1099067|NCT02556905|Revlimid|revlimid
1099068|NCT02556905|Lenalidomide|lenalidomide
1099069|NCT02556905|Observational|observational
1099070|NCT02556905|Korea|korea
1099071|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
1099072|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
1099073|NCT02556892|Ibrutinib|ibrutinib
1099074|NCT02556892|PCI-32765|pci-32765
1099075|NCT02556892|JNJ-54179060|jnj-54179060
1099076|NCT02556879|Liver transplantation|liver transplantation
1099077|NCT02556879|Graft failure|graft failure
1099078|NCT02556879|Donor specific antibodies|donor specific antibodies
1099079|NCT02556853|Ultrasound|ultrasound
1099080|NCT02556853|Double lumen tube|double lumen tube
1099081|NCT02556840|Monogenic diabetes|monogenic diabetes
1099082|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
1099083|NCT02556840|MODY|mody
1099084|NCT02556840|Pregnancy|pregnancy
1099085|NCT02556840|Gestational diabetes|gestational diabetes
1099086|NCT02556840|Glucokinase|glucokinase
1099087|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
1099088|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
1099089|NCT02556827|demodex|demodex
1099090|NCT02556827|oxidative stress|oxidative stress
1099091|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
1099092|NCT02556814|ITP|itp
1099093|NCT02556814|Caffeic Acid|caffeic acid
1099094|NCT02556814|dexamethasone|dexamethasone
1099095|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
1099096|NCT02556801|Dose range finding|dose range finding
1099097|NCT02556801|Grass pollen|grass pollen
1099098|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
1099099|NCT02556801|Immunogenicity|immunogenicity
1099100|NCT02556788|Efficacy|efficacy
1099101|NCT02556788|Safety|safety
1099102|NCT02556788|Acne vulgaris|acne vulgaris
1099103|NCT02556762|Esophageal cancer|esophageal cancer
1099104|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
1099105|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
1099106|NCT02556762|Chemotherapy|chemotherapy
1099107|NCT02556762|Survival|survival
1099108|NCT02556749|Cranberries|cranberries
1099109|NCT02556749|blood pressure|blood pressure
1099110|NCT02556749|cholesterol|cholesterol
1099111|NCT02556749|SphygmoCor|sphygmocor
1099112|NCT02556736|gene therapy|gene therapy
1099113|NCT02556736|optogenetics|optogenetics
1099114|NCT02556736|channelrhodopsin|channelrhodopsin
1099115|NCT02556736|retina|retina
1099116|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
1099119|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
1099120|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
1099121|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1099123|NCT02556658|Smartpilot View|smartpilot view
1099124|NCT02556658|Hip fracture surgery|hip fracture surgery
1099125|NCT02556658|Depth of anaesthesia|depth of anaesthesia
1099126|NCT02556658|Intraoperative hypotension|intraoperative hypotension
1099127|NCT02556658|Quality of anaesthesia|quality of anaesthesia
1099131|NCT02556645|Psychotherapy|psychotherapy
1099132|NCT02556645|Trauma|trauma
1099133|NCT02556645|Posttraumatic Stress|posttraumatic stress
1099134|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
1099135|NCT02556619|Liver Cancer|liver cancer
1099136|NCT02556619|Randomized Control Trial|randomized control trial
1099137|NCT02556619|Palliative Care|palliative care
1099138|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
1099139|NCT02556619|Palliative Therapy|palliative therapy
1099140|NCT02556606|ketamine|ketamine
1099141|NCT02556606|depression|depression
1099142|NCT02556606|treatment resistant|treatment resistant
1099143|NCT02556606|treatment resistant depression|treatment resistant depression
1099144|NCT02556606|late life depression|late life depression
1099145|NCT02556606|depression in the elderly|depression in the elderly
1099146|NCT02556606|geriatric depression|geriatric depression
1099147|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
1099148|NCT02556593|IMRT|imrt
1099149|NCT02556593|erlotinib|erlotinib
1099150|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
1099151|NCT02556580|albumin|albumin
1099152|NCT02556580|surgery|surgery
1099153|NCT02556580|inflammation|inflammation
1099154|NCT02556580|volume kinetics|volume kinetics
1099155|NCT02556567|Sleep patterns|sleep patterns
1099156|NCT02556567|Physical activity|physical activity
1099157|NCT02556567|Fitbit|fitbit
1099158|NCT02556515|CMC1|cmc1
1099159|NCT02556515|arthritis|arthritis
1099160|NCT02556515|degenerative arthritis|degenerative arthritis
1099161|NCT02556515|thumb|thumb
1099162|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
1099163|NCT02556515|total joint replacement|total joint replacement
1099164|NCT02556489|immunological memory|immunological memory
1099165|NCT02556476|critical care|critical care
1099166|NCT02556476|intensive care|intensive care
1099167|NCT02556476|health related quality of life|health related quality of life
1099168|NCT02556476|cost benefit analysis|cost benefit analysis
1099169|NCT02556463|MEDI9197|medi9197
1099170|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
1099171|NCT02556463|Durvalumab|durvalumab
1099172|NCT02556463|MEDI4736|medi4736
1099173|NCT02556463|Imfinzi|imfinzi
1099174|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
1099175|NCT02556437|MMN|mmn
1099176|NCT02556424|Ophthalmology|ophthalmology
1099177|NCT02556424|Uveitic macular edema|uveitic macular edema
1099178|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
1099179|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
1099180|NCT02556372|AIH|aih
1099182|NCT02556372|autoimmune|autoimmune
1099183|NCT02556372|hepatitis|hepatitis
1099184|NCT02556346|CD20|cd20
1099185|NCT02556346|immunotoxin|immunotoxin
1099186|NCT02556346|CLL|cll
1099187|NCT02556346|SLL|sll
1099188|NCT02556346|leukemia|leukemia
1099189|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
1099190|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
1099191|NCT02556346|MT-3724|mt-3724
1099192|NCT02556346|relapsed|relapsed
1099193|NCT02556346|refractory|refractory
1099194|NCT02556346|immunotherapy|immunotherapy
1099195|NCT02556346|cancer|cancer
1099196|NCT02556346|antibodies|antibodies
1099197|NCT02556346|safety|safety
1099198|NCT02556346|pharmacokinetics|pharmacokinetics
1099199|NCT02556333|TAF|taf
1099200|NCT02556333|F/TAF|f/taf
1099201|NCT02556333|antiretroviral therapy|antiretroviral therapy
1099202|NCT02556333|TDF|tdf
1099203|NCT02556333|directly observed therapy|directly observed therapy
1099204|NCT02556294|HIV risk behavior|hiv risk behavior
1099205|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
1099206|NCT02556268|Controlled, Stratified Design|controlled, stratified design
1099207|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
1099208|NCT02556255|Peripheral Artery Disease|peripheral artery disease
1099209|NCT02556255|PAD|pad
1099210|NCT02556255|Atherosclerosis|atherosclerosis
1099211|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
1099212|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
1099213|NCT02556255|PVD|pvd
1099214|NCT02556242|vector control|vector control
1099215|NCT02556242|insecticide|insecticide
1099219|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
1099220|NCT02556203|TAVR|tavr
1099222|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
1099223|NCT02556177|TBI|tbi
1099224|NCT02556177|MR|mr
1099225|NCT02556177|mTBI|mtbi
1099226|NCT02556177|NFL|nfl
1099227|NCT02556177|MRI|mri
1099228|NCT02556164|Electroacupuncture|electroacupuncture
1099229|NCT02556164|Body Worn Sensor|body worn sensor
1099230|NCT02556164|Gait|gait
1099231|NCT02556164|Balance|balance
1099232|NCT02556138|Intragastric Balloon|intragastric balloon
1099233|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
1099234|NCT02556138|Weight Loss|weight loss
1099235|NCT02556138|BMI >35|bmi >35
1099236|NCT02556125|SCI|sci
1099237|NCT02556125|Respiratory impairment|respiratory impairment
1099238|NCT02556125|Diaphragm pacing|diaphragm pacing
1099239|NCT02556125|Diaphragm stimulation|diaphragm stimulation
1099240|NCT02556073|asthma control|asthma control
1099241|NCT02556073|adherence|adherence
1099242|NCT02556073|asthma self management plan|asthma self management plan
1099243|NCT02556073|airway inflammation|airway inflammation
1099244|NCT02556060|ketamine use disorder|ketamine use disorder
1099245|NCT02556060|lamotrigine|lamotrigine
1099246|NCT02556060|craving|craving
1099247|NCT02556008|Children|children
1099248|NCT02556008|Epilepsy|epilepsy
1099249|NCT02556008|Cannabidiol|cannabidiol
1099250|NCT02555995|AMD|amd
1099251|NCT02555995|OCT|oct
1099252|NCT02555982|Essential Head tremor|essential head tremor
1099253|NCT02555982|Botulinum toxin injections|botulinum toxin injections
1099254|NCT02555982|Quality of life|quality of life
1099255|NCT02555982|Embarrassment assessment|embarrassment assessment
1099256|NCT02555956|Macular grid|macular grid
1099257|NCT02555956|Subthreshold|subthreshold
1099258|NCT02555956|diabetic macular edema|diabetic macular edema
1099259|NCT02555956|decrease in visual acuity|decrease in visual acuity
1099260|NCT02555891|Prescriptions|prescriptions
1099261|NCT02555891|Epidemiology|epidemiology
1099262|NCT02555891|Health Administration Databases|health administration databases
1099263|NCT02555891|Elderly|elderly
1099264|NCT02555891|STOPP/START criteria|stopp/start criteria
1099265|NCT02555878|Cancer|cancer
1099266|NCT02555878|Rivaroxaban|rivaroxaban
1099267|NCT02555878|Venous thromboembolism|venous thromboembolism
1099268|NCT02555865|etiology|etiology
1099269|NCT02555865|children|children
1099270|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
1099271|NCT02555852|Pneumonia|pneumonia
1099272|NCT02555852|NSAIDs|nsaids
1099273|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
1099274|NCT02555852|Drug safety|drug safety
1099275|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
1099276|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
1099277|NCT02555839|Pomalidomide|pomalidomide
1099278|NCT02555839|Imnovid|imnovid
1099279|NCT02555839|Non-interventional|non-interventional
1099280|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1099281|NCT02555813|nab-Paclitaxel|nab-paclitaxel
1099282|NCT02555813|Gemcitabine|gemcitabine
1099283|NCT02555813|Non-interventional|non-interventional
1099284|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
1099287|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
1099288|NCT02555787|FK506E|fk506e
1099289|NCT02555787|Tacrolimus|tacrolimus
1099290|NCT02555787|Observational|observational
1099291|NCT02555787|Kidney transplantation|kidney transplantation
1099292|NCT02555787|Advagraf|advagraf
1099293|NCT02555774|subjective memory impairment|subjective memory impairment
1099294|NCT02555774|cognitive training|cognitive training
1099295|NCT02555735|pancreatic cancer|pancreatic cancer
1099296|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
1099297|NCT02555696|nab-paclitaxel|nab-paclitaxel
1099298|NCT02555696|Abraxane|abraxane
1099300|NCT02555683|QAW039|qaw039
1099301|NCT02555670|Muscles|muscles
1099302|NCT02555670|Intensive Care|intensive care
1099303|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
1099304|NCT02555670|Electric Impedance|electric impedance
1099305|NCT02555657|PD1|pd1
1099306|NCT02555657|PD-1|pd-1
1099307|NCT02555657|PDL1|pdl1
1099308|NCT02555657|PD-LI|pd-li
1099309|NCT02555644|cancer|cancer
1099310|NCT02555631|type 2 diabetes|type 2 diabetes
1099311|NCT02555631|prevention|prevention
1099312|NCT02555631|men|men
1099313|NCT02555618|Vaccine|vaccine
1099314|NCT02555605|children|children
1099315|NCT02555605|dexmedetomidine|dexmedetomidine
1099316|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
1099317|NCT02555605|deep sedation|deep sedation
1099318|NCT02555605|adverse respiratory events|adverse respiratory events
1099319|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
1099320|NCT02555553|Mobile Mental Health|mobile mental health
1099321|NCT02555553|Binge Eating|binge eating
1099322|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
1099323|NCT02555553|Eating Disorder Treatment|eating disorder treatment
1099324|NCT02555553|Self-monitoring|self-monitoring
1099325|NCT02555553|Eating Disorders|eating disorders
1099326|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
1099327|NCT02555501|children|children
1099328|NCT02555501|cancer|cancer
1099329|NCT02555501|stomatitis|stomatitis
1099330|NCT02555501|clinical trial|clinical trial
1099331|NCT02555501|laser therapy, low-level|laser therapy, low-level
1099332|NCT02555501|methylene blue|methylene blue
1099333|NCT02555501|photochemotherapy|photochemotherapy
1099334|NCT02555475|Hepatitis C|hepatitis c
1099335|NCT02555475|primary care|primary care
1099336|NCT02555397|Prostate Cancer|prostate cancer
1099337|NCT02555397|Locally Recurrent|locally recurrent
1099338|NCT02555397|Gene Therapy|gene therapy
1099339|NCT02555397|IL-12|il-12
1099340|NCT02555397|Adenovirus|adenovirus
1099341|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
1099342|NCT02555371|mepolizumab|mepolizumab
1099343|NCT02555371|asthma exacerbation|asthma exacerbation
1099344|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
1099345|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
1099346|NCT02555319|Pulmonary Valve|pulmonary valve
1099347|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
1099348|NCT02555319|Congenital Heart Disease|congenital heart disease
1099349|NCT02555306|Macular Degeneration|macular degeneration
1099350|NCT02555293|Liver resection|liver resection
1099351|NCT02555293|fibrosis|fibrosis
1099352|NCT02555293|inflammation|inflammation
1099353|NCT02555293|Rifaximin|rifaximin
1099354|NCT02555267|geriatric assessment|geriatric assessment
1099355|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1099356|NCT02555267|activity of daily living|activity of daily living
1099357|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
1099358|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
1099359|NCT02555254|cardiac arrest|cardiac arrest
1099360|NCT02555254|targeted temperature management|targeted temperature management
1099361|NCT02555254|hypothermia induced|hypothermia induced
1099362|NCT02555254|shockable rhythm|shockable rhythm
1099363|NCT02555241|ASD, Children|asd, children
1099364|NCT02555228|simethicone|simethicone
1099365|NCT02555228|gastroscopy|gastroscopy
1099366|NCT02555228|McNalley score|mcnalley score
1099367|NCT02555215|Pediatrics|pediatrics
1099368|NCT02555202|dyspnea|dyspnea
1099369|NCT02555163|bladder cancer, laser|bladder cancer, laser
1099370|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1099371|NCT02555137|pulmonary embolism|pulmonary embolism
1099372|NCT02555137|pulmonary hypertension|pulmonary hypertension
1099373|NCT02555137|screening|screening
1099374|NCT02555137|echocardiography|echocardiography
1099375|NCT02555124|Healthy|healthy
1099376|NCT02555124|JNJ-42847922|jnj-42847922
1099377|NCT02555111|thrombosis|thrombosis
1099378|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
1099379|NCT02555059|Ciprofloxacin|ciprofloxacin
1099380|NCT02555059|Japan|japan
1099381|NCT02555059|Post-marketing surveillance|post-marketing surveillance
1099382|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1099383|NCT02555046|Endovascular Procedures|endovascular procedures
1099384|NCT02555046|Local Anesthesia|local anesthesia
1099385|NCT02555046|General Anesthesia|general anesthesia
1099386|NCT02555033|Instability resistance training|instability resistance training
1099387|NCT02555033|unstable surface|unstable surface
1099388|NCT02555033|elderly people|elderly people
1099389|NCT02554994|ASPRA cohort|aspra cohort
1099390|NCT02554994|multifactorial intervention|multifactorial intervention
1099391|NCT02554994|Medicaid services|medicaid services
1099392|NCT02554994|Geriatric disorder|geriatric disorder
1099393|NCT02554994|Short Physical Performance Battery|short physical performance battery
1099394|NCT02554929|Social Anxiety Disorder|social anxiety disorder
1099395|NCT02554929|Selective Mutism|selective mutism
1099396|NCT02554929|CBT|cbt
1099397|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
1099398|NCT02554916|Mobility decline|mobility decline
1099399|NCT02554903|LVAD|lvad
1099400|NCT02554890|Acute|acute
1099401|NCT02554890|Heart Failure|heart failure
1099402|NCT02554890|reduced ejection fraction|reduced ejection fraction
1099403|NCT02554890|NTproBNP|ntprobnp
1099404|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
1099405|NCT02554838|Specific phobia|specific phobia
1099406|NCT02554838|Fear of Falling|fear of falling
1099407|NCT02554838|Life-space area|life-space area
1099408|NCT02554812|anti PD-L1|anti pd-l1
1099409|NCT02554812|anti 4-1BB|anti 4-1bb
1099410|NCT02554812|OX40 agonist|ox40 agonist
1099411|NCT02554812|anti M-CSF|anti m-csf
1099412|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1099413|NCT02554812|melanoma|melanoma
1099414|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
1099415|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1099416|NCT02554812|gastric cancer|gastric cancer
1099417|NCT02554812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1099418|NCT02554812|bladder cancer|bladder cancer
1099419|NCT02554812|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1099421|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
1099422|NCT02554773|Hemophilia|hemophilia
1099423|NCT02554773|RNAi therapeutic|rnai therapeutic
1099424|NCT02554721|Healthy Volunteers|healthy volunteers
1099425|NCT02554708|Aneurysm|aneurysm
1099426|NCT02554708|bifurcation|bifurcation
1099427|NCT02554708|wide neck|wide neck
1099428|NCT02554708|pCONus|pconus
1099429|NCT02554708|intracerebral|intracerebral
1099430|NCT02554708|stroke|stroke
1099431|NCT02554695|adrenergic|adrenergic
1099432|NCT02554682|Adolescent Health|adolescent health
1099433|NCT02554682|Sexual Health|sexual health
1099434|NCT02554682|Parent-Teen Communication|parent-teen communication
1099435|NCT02554682|Teen Driving|teen driving
1099436|NCT02554682|Alcohol Prevention|alcohol prevention
1099437|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
1099438|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
1099439|NCT02554643|intermittent exercise|intermittent exercise
1099440|NCT02554643|continuous exercise|continuous exercise
1099441|NCT02554643|blood glucose|blood glucose
1099442|NCT02554643|intramyocellular lipids|intramyocellular lipids
1099443|NCT02554643|diabetes|diabetes
1099444|NCT02554643|gene expression|gene expression
1099445|NCT02554617|healthy people|healthy people
1099446|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
1099447|NCT02554617|factors|factors
1099448|NCT02554604|HDL|hdl
1099449|NCT02554604|Preeclampsia|preeclampsia
1099450|NCT02554604|saliva|saliva
1099451|NCT02554578|mHealth|mhealth
1099452|NCT02554578|multidisciplinary team|multidisciplinary team
1099453|NCT02554578|immunosuppressive medication|immunosuppressive medication
1099454|NCT02554578|pharmaceutical care|pharmaceutical care
1099455|NCT02554578|adherence|adherence
1099456|NCT02554578|heart transplant|heart transplant
1099457|NCT02554578|recipients|recipients
1099458|NCT02554565|Patients with cervical cancer|patients with cervical cancer
1099459|NCT02554552|Osteoarthritis|osteoarthritis
1099460|NCT02554526|hemophilia A|hemophilia a
1099461|NCT02554526|inhibitor|inhibitor
1099462|NCT02554526|bypassing therapy|bypassing therapy
1099463|NCT02554526|factor VIII|factor viii
1099464|NCT02554513|Apraxia of Speech|apraxia of speech
1099465|NCT02554513|Treatment|treatment
1099466|NCT02554487|stroke|stroke
1099467|NCT02554487|sleep disordered breathing|sleep disordered breathing
1099468|NCT02554487|sleep apnea|sleep apnea
1099469|NCT02554487|infarct volume|infarct volume
1099470|NCT02554487|penumbra|penumbra
1099471|NCT02554474|Physical activity|physical activity
1099472|NCT02554474|Exercise|exercise
1099473|NCT02554474|Rheumatoid|rheumatoid
1099474|NCT02554474|Arthritis|arthritis
1099475|NCT02554474|Lupus|lupus
1099476|NCT02554474|SLE|sle
1099477|NCT02554448|Circulating Tumor Cells|circulating tumor cells
1099478|NCT02554448|rectal Neoplasms|rectal neoplasms
1099479|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
1099480|NCT02554435|physical activity|physical activity
1099481|NCT02554435|activity monitor|activity monitor
1099482|NCT02554435|older adults|older adults
1099483|NCT02554435|5 A's counseling|5 a's counseling
1100181|NCT02550171|Cohort|cohort
1099484|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
1099485|NCT02554409|Pregnancy Registry|pregnancy registry
1099486|NCT02554409|Influenza|influenza
1099487|NCT02554396|ophthalmology|ophthalmology
1099488|NCT02554396|vision|vision
1099489|NCT02554396|ocular|ocular
1099490|NCT02554383|pediatrics|pediatrics
1099491|NCT02554383|antibiotics|antibiotics
1099492|NCT02554383|placebo|placebo
1099493|NCT02554344|CIN3|cin3
1099494|NCT02554344|Squamous CIN3|squamous cin3
1099495|NCT02554331|Gait|gait
1099496|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
1099497|NCT02554331|Parkinson's disease|parkinson's disease
1099498|NCT02554331|Follow-up|follow-up
1099499|NCT02554318|Tempeh|tempeh
1099500|NCT02554318|Body weight|body weight
1099501|NCT02554318|Handgrip strength|handgrip strength
1099502|NCT02554318|6MWT|6mwt
1099503|NCT02554318|Supplementation|supplementation
1099504|NCT02554318|Wasting|wasting
1099505|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
1099506|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
1099507|NCT02554305|Bypass Grafting|bypass grafting
1099508|NCT02554227|Spondylodiscitis|spondylodiscitis
1099509|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
1099510|NCT02554227|infection|infection
1099511|NCT02554227|cytokine profiles|cytokine profiles
1099512|NCT02554227|lumbar spine|lumbar spine
1099513|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
1099514|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
1099515|NCT02554188|Dietary Intervention|dietary intervention
1099516|NCT02554188|Fasting-mimicking|fasting-mimicking
1099517|NCT02554188|Influenza Vaccines|influenza vaccines
1099518|NCT02554175|Propofol|propofol
1099519|NCT02554175|Schnider model|schnider model
1099520|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
1099521|NCT02554149|total hip|total hip
1099522|NCT02554149|stem version|stem version
1099523|NCT02554149|replacement|replacement
1099524|NCT02554149|hip|hip
1099525|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
1099526|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
1099527|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
1099528|NCT02554097|cost-effective analysis|cost-effective analysis
1099529|NCT02554058|Spinal cord injury|spinal cord injury
1099530|NCT02554058|rehabilitation|rehabilitation
1099531|NCT02554058|cycling|cycling
1099532|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
1099533|NCT02554032|innominate artery cannulation|innominate artery cannulation
1099534|NCT02554032|axillary artery cannulation|axillary artery cannulation
1099535|NCT02554032|aortic surgery|aortic surgery
1099536|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
1099537|NCT02554019|SLE, Lupus|sle, lupus
1099538|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
1099539|NCT02553993|Stroke|stroke
1099540|NCT02553993|Cognition|cognition
1099541|NCT02553993|Exergames|exergames
1099542|NCT02553993|Weight shifting|weight shifting
1099543|NCT02553993|Balance|balance
1099544|NCT02553993|Rehabilitation|rehabilitation
1099545|NCT02553980|Physical activity|physical activity
1099546|NCT02553980|Information technology|information technology
1099547|NCT02553980|Middle-aged|middle-aged
1099548|NCT02553980|Health promotion|health promotion
1099549|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1099550|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
1099551|NCT02553967|Breast Q questionnaire|breast q questionnaire
1099552|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
1099553|NCT02553954|Senescence markers|senescence markers
1099554|NCT02553915|Omega-3|omega-3
1099555|NCT02553915|EPA|epa
1099556|NCT02553915|Depression|depression
1099557|NCT02553915|Overweight|overweight
1099558|NCT02553915|Inflammation|inflammation
1099559|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
1099560|NCT02553902|Positional therapy|positional therapy
1099561|NCT02553902|MAD|mad
1099562|NCT02553902|Oral appliance|oral appliance
1099563|NCT02553902|Sleep position trainer|sleep position trainer
1099564|NCT02553902|POSA|posa
1099565|NCT02553876|neurostimulation|neurostimulation
1099566|NCT02553876|dorsal root ganglion|dorsal root ganglion
1099567|NCT02553876|hand pain|hand pain
1099568|NCT02553876|upper limb pain|upper limb pain
1099569|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
1099570|NCT02553863|acupuncture|acupuncture
1099571|NCT02553863|pain|pain
1099572|NCT02553863|cost-effectiveness|cost-effectiveness
1099573|NCT02553837|Healthy Volunteers|healthy volunteers
1099574|NCT02553824|binge eating|binge eating
1099575|NCT02553824|bulimia nervosa|bulimia nervosa
1099576|NCT02553824|binge eating disorder|binge eating disorder
1099577|NCT02553824|eating disorder treatment|eating disorder treatment
1099578|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
1099579|NCT02553811|clinical examination|clinical examination
1099580|NCT02553811|diagnosis|diagnosis
1099581|NCT02553811|clinical trial|clinical trial
1099582|NCT02553811|median nerve compression|median nerve compression
1099583|NCT02553811|accuracy|accuracy
1099584|NCT02553811|ultrasonography|ultrasonography
1099585|NCT02553811|electromyography|electromyography
1099586|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
1099587|NCT02553785|BioVentrix|bioventrix
1099588|NCT02553785|Revivent|revivent
1099589|NCT02553785|Revivent TC|revivent tc
1099590|NCT02553759|observed action|observed action
1099591|NCT02553759|range of motion|range of motion
1099592|NCT02553759|mirror neuron|mirror neuron
1099593|NCT02553746|Ultrasound|ultrasound
1099594|NCT02553746|Spinal anesthesia|spinal anesthesia
1099595|NCT02553746|Epidural anesthesia|epidural anesthesia
1099596|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
1099597|NCT02553733|Beetroot juice|beetroot juice
1099598|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
1099599|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
1099600|NCT02553694|OSA, Apnea|osa, apnea
1099601|NCT02553668|Proteomics|proteomics
1099602|NCT02553668|Oxygen|oxygen
1099603|NCT02553668|Pathways|pathways
1099604|NCT02553642|Tumor Mutation|tumor mutation
1099605|NCT02553642|Nivolumab|nivolumab
1099606|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
1099607|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
1099608|NCT02553642|15-126|15-126
1099609|NCT02553590|Non Interventional Study|non interventional study
1099610|NCT02553590|NIS|nis
1099611|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
1099612|NCT02553590|allergen|allergen
1099613|NCT02553590|tree|tree
1099614|NCT02553590|birch|birch
1099615|NCT02553590|alder|alder
1099616|NCT02553577|prenatal|prenatal
1099617|NCT02553577|cytokines|cytokines
1099618|NCT02553538|cancer screening|cancer screening
1099619|NCT02553538|patient navigation|patient navigation
1099620|NCT02553525|Deep Brain Stimulation|deep brain stimulation
1100318|NCT02549534|Paclitaxel|paclitaxel
1099621|NCT02553525|Movement Disorders|movement disorders
1099622|NCT02553525|Parkinson Disease|parkinson disease
1099623|NCT02553525|Essential Tremor|essential tremor
1099624|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
1099625|NCT02553525|Globus Pallidus|globus pallidus
1099626|NCT02553525|Thalamus|thalamus
1099627|NCT02553525|Tremor|tremor
1099628|NCT02553525|Bradykinesia|bradykinesia
1099629|NCT02553525|Temporal Pattern|temporal pattern
1099630|NCT02553525|Electrical Stimulation|electrical stimulation
1099631|NCT02553525|Neuromodulation|neuromodulation
1099632|NCT02553525|PD|pd
1099633|NCT02553525|ET|et
1099634|NCT02553525|MS|ms
1099635|NCT02553525|STN|stn
1099637|NCT02553525|DBS|dbs
1099638|NCT02553525|Nervous System Diseases|nervous system diseases
1099639|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
1099640|NCT02553499|Solid tumor|solid tumor
1099641|NCT02553499|PD1|pd1
1099642|NCT02553499|PD-L1|pd-l1
1099643|NCT02553499|PDL1|pdl1
1099644|NCT02553486|adoption|adoption
1099645|NCT02553486|children|children
1099646|NCT02553486|quality of life|quality of life
1099647|NCT02553460|Infants|infants
1099648|NCT02553434|pigtail catheter|pigtail catheter
1099649|NCT02553434|small-bore catheter|small-bore catheter
1099650|NCT02553434|trauma|trauma
1099651|NCT02553434|hemothorax|hemothorax
1099652|NCT02553421|infiltration|infiltration
1099653|NCT02553421|extravasation|extravasation
1099654|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
1099655|NCT02553356|Female Subjects|female subjects
1099656|NCT02553343|Influenza|influenza
1099657|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
1099658|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
1099659|NCT02553330|Hair loss|hair loss
1099660|NCT02553330|alopecia areata|alopecia areata
1099661|NCT02553330|alopecia totalis|alopecia totalis
1099662|NCT02553330|alopecia universalis|alopecia universalis
1099663|NCT02553330|JAK inhibitors|jak inhibitors
1099664|NCT02553330|topical hair growth|topical hair growth
1099665|NCT02553278|abdominoplasty|abdominoplasty
1099666|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
1099667|NCT02553265|Norepinephrine|norepinephrine
1099668|NCT02553265|Sympathetic nervous system|sympathetic nervous system
1099669|NCT02553265|Autonomic nervous system|autonomic nervous system
1099670|NCT02553265|Blood pressure variability|blood pressure variability
1099671|NCT02553265|Hypertension|hypertension
1099672|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
1099673|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
1099674|NCT02553265|Clinical trial|clinical trial
1099675|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
1099676|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
1099677|NCT02553239|Atrial Fibrillation|atrial fibrillation
1099678|NCT02553239|Paroxysmal|paroxysmal
1099679|NCT02553239|Cryoablation|cryoablation
1099680|NCT02553226|Active phase of labour|active phase of labour
1099681|NCT02553226|Discontinuation|discontinuation
1099682|NCT02553226|Caesarean section|caesarean section
1099683|NCT02553200|intubated patients|intubated patients
1100578|NCT02547948|Lymphoma|lymphoma
1099684|NCT02553200|secretion clearance|secretion clearance
1099685|NCT02553200|lung function|lung function
1099686|NCT02553200|breathing exercise|breathing exercise
1099687|NCT02553161|Depression|depression
1099688|NCT02553148|prevalence|prevalence
1099689|NCT02553148|epidemiology|epidemiology
1099690|NCT02553148|palliative care|palliative care
1099691|NCT02553148|pediatric|pediatric
1099692|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
1099693|NCT02553122|Blood Loss|blood loss
1099694|NCT02553122|Tranexamic Acid|tranexamic acid
1099695|NCT02553122|Evicel|evicel
1099696|NCT02553109|small paraclinoid|small paraclinoid
1099697|NCT02553096|exacerbations|exacerbations
1099698|NCT02553096|self-management support|self-management support
1099699|NCT02553096|software application|software application
1099700|NCT02553031|Application of MR-PET|application of mr-pet
1099701|NCT02553005|Acupuncture|acupuncture
1099702|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
1099703|NCT02553005|Quality of life|quality of life
1099704|NCT02553005|Hand Strength|hand strength
1099705|NCT02552979|atopic dermatitis|atopic dermatitis
1099706|NCT02552979|atopic patch test|atopic patch test
1099708|NCT02552927|Jaundice|jaundice
1099709|NCT02552927|Phototherapy|phototherapy
1099710|NCT02552914|Colli-Pee|colli-pee
1099711|NCT02552914|STI|sti
1099712|NCT02552914|first-void urine|first-void urine
1099713|NCT02552901|hepatic|hepatic
1099714|NCT02552901|liver|liver
1099715|NCT02552901|LFT|lft
1099716|NCT02552901|hepatic assessment|hepatic assessment
1099717|NCT02552901|ICG dye|icg dye
1099718|NCT02552901|indocyanine green dye|indocyanine green dye
1099719|NCT02552901|Diagnostic Green|diagnostic green
1099720|NCT02552901|Pulsion|pulsion
1099721|NCT02552901|Akorn|akorn
1099722|NCT02552901|Cardiox|cardiox
1099723|NCT02552901|anazen|anazen
1099724|NCT02552901|essence|essence
1099725|NCT02552901|dye detection monitor|dye detection monitor
1099726|NCT02552901|Earpads|earpads
1099728|NCT02552901|scaphoid fossa|scaphoid fossa
1099729|NCT02552901|liver disease|liver disease
1099730|NCT02552901|acute hepatic failure|acute hepatic failure
1099731|NCT02552901|AHF|ahf
1099732|NCT02552901|NASH|nash
1099733|NCT02552901|hepatitis C|hepatitis c
1099734|NCT02552901|cirrhosis|cirrhosis
1099735|NCT02552901|MELD|meld
1099736|NCT02552901|pulse dye densitometry|pulse dye densitometry
1099737|NCT02552901|liver transplant|liver transplant
1099738|NCT02552901|fluorescence|fluorescence
1099739|NCT02552901|near infra-red|near infra-red
1099740|NCT02552901|serial blood draws|serial blood draws
1099741|NCT02552901|PDR|pdr
1099742|NCT02552901|plasma disappearance rate|plasma disappearance rate
1099743|NCT02552901|R15|r15
1099744|NCT02552901|k coefficient|k coefficient
1099745|NCT02552901|transcutaneously|transcutaneously
1099746|NCT02552901|liver donor|liver donor
1099747|NCT02552901|liver dysfunction|liver dysfunction
1099748|NCT02552901|Child-Pugh|child-pugh
1099749|NCT02552901|AST|ast
1099750|NCT02552901|ALT|alt
1099751|NCT02552901|GGT|ggt
1099752|NCT02552901|alk phos|alk phos
1099753|NCT02552901|prothrombin time|prothrombin time
1099754|NCT02552901|albumin|albumin
1099755|NCT02552901|serum ICG|serum icg
1099756|NCT02552901|liver function tests|liver function tests
1099757|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
1099758|NCT02552888|Inflammation|inflammation
1099759|NCT02552875|Acceleromyography|acceleromyography
1099760|NCT02552875|staircase phenomenon|staircase phenomenon
1099761|NCT02552875|tetanic stimulation|tetanic stimulation
1099762|NCT02552797|Shared Decision Making|shared decision making
1099763|NCT02552797|CAMHS|camhs
1099764|NCT02552758|violence|violence
1099765|NCT02552758|PET|pet
1099766|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
1099767|NCT02552758|schizophrenia|schizophrenia
1099768|NCT02552758|patient|patient
1099769|NCT02552719|Injustice Experience|injustice experience
1099770|NCT02552719|Questionnaire|questionnaire
1099771|NCT02552719|Validation|validation
1099772|NCT02552719|German translation|german translation
1099773|NCT02552706|probiotics|probiotics
1099774|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
1099775|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
1099776|NCT02552706|gut microflora|gut microflora
1099777|NCT02552706|TLR|tlr
1099778|NCT02552706|NF-KB|nf-kb
1099779|NCT02552706|inflammatory factors|inflammatory factors
1099780|NCT02552693|Enhancing retention|enhancing retention
1099781|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
1099782|NCT02552680|Quality of life|quality of life
1099783|NCT02552680|Health Education|health education
1099784|NCT02552667|Asthma|asthma
1099785|NCT02552667|Allergic rhinitis|allergic rhinitis
1148523|NCT02273102|AML|aml
1099786|NCT02552628|Wilson's Disease|wilson's disease
1099787|NCT02552628|Deep Brain Stimulation|deep brain stimulation
1099788|NCT02552628|dystonia|dystonia
1099789|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
1099790|NCT02552602|HIV|hiv
1099791|NCT02552602|Multivitamins|multivitamins
1100580|NCT02547896|codeine|codeine
1099792|NCT02552589|clinical trial, phase III|clinical trial, phase iii
1099793|NCT02552589|plaque index|plaque index
1099794|NCT02552589|gingivitis index|gingivitis index
1099795|NCT02552589|fluoride|fluoride
1099796|NCT02552589|toothpaste|toothpaste
1099797|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
1099798|NCT02552550|swallowing, speech|swallowing, speech
1099799|NCT02552550|quality of life|quality of life
1099800|NCT02552524|pathological gambling|pathological gambling
1099801|NCT02552524|rTMS|rtms
1099802|NCT02552524|cognitive tests|cognitive tests
1099803|NCT02552524|autonomic nervous system|autonomic nervous system
1099804|NCT02552524|craving|craving
1099805|NCT02552472|Asthma|asthma
1099806|NCT02552472|Inhaler Use|inhaler use
1099807|NCT02552472|Adherence|adherence
1099808|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1099809|NCT02552459|dexmedetomidine|dexmedetomidine
1099810|NCT02552459|patient controlled analgesia|patient controlled analgesia
1099811|NCT02552433|nutritional deficiencies|nutritional deficiencies
1099812|NCT02552433|plastic surgery|plastic surgery
1099813|NCT02552433|post-bariatric|post-bariatric
1099814|NCT02552433|protein|protein
1099815|NCT02552433|skin surplus|skin surplus
1099816|NCT02552420|infrared thermal imaging|infrared thermal imaging
1099817|NCT02552420|deep venous thrombosis|deep venous thrombosis
1099818|NCT02552407|thrombectomy|thrombectomy
1099819|NCT02552407|acute coronary syndromes|acute coronary syndromes
1099820|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
1099821|NCT02552407|STEMI|stemi
1099822|NCT02552381|Cancer|cancer
1099823|NCT02552381|Thromboembolic event|thromboembolic event
1099824|NCT02552381|Fibrin Structure|fibrin structure
1099825|NCT02552381|LMWH|lmwh
1099826|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
1099827|NCT02552368|BCI|bci
1099828|NCT02552368|Stroke|stroke
1099829|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
1099830|NCT02552368|paresis|paresis
1099831|NCT02552368|hemiparesis|hemiparesis
1099832|NCT02552329|mild cognitive impairment|mild cognitive impairment
1099834|NCT02552329|cognitive functions|cognitive functions
1099835|NCT02552316|microbiome|microbiome
1099836|NCT02552316|bacteria|bacteria
1099837|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
1099838|NCT02552316|light therapy|light therapy
1099839|NCT02552277|Diabetic|diabetic
1099840|NCT02552277|PDA-002|pda-002
1099841|NCT02552277|Placenta-Derived Cells|placenta-derived cells
1099842|NCT02552277|Peripheral neuropathy|peripheral neuropathy
1099843|NCT02552277|Neuropathy|neuropathy
1099844|NCT02552277|Double-Blind|double-blind
1099845|NCT02552277|Safety|safety
1099846|NCT02552277|Efficacy|efficacy
1099847|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
1099848|NCT02552238|Lumason|lumason
1099849|NCT02552238|Dobutamine stress echo|dobutamine stress echo
1099850|NCT02552238|stress echo|stress echo
1099851|NCT02552238|coronary artery disease|coronary artery disease
1099852|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
1099853|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
1099854|NCT02552212|axSpA|axspa
1099855|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
1099856|NCT02552212|Anti TNF-alpha|anti tnf-alpha
1099857|NCT02552212|Certolizumab Pegol|certolizumab pegol
1099858|NCT02552212|Nr-axSpA|nr-axspa
1099859|NCT02552212|Non-radiographic|non-radiographic
1099860|NCT02552212|Spondylarthropathies|spondylarthropathies
1099861|NCT02552212|Arthritis|arthritis
1099862|NCT02552212|Spinal Diseases|spinal diseases
1099863|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
1099864|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1099865|NCT02552160|Fixed-dose Combination|fixed-dose combination
1099866|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
1099867|NCT02552160|Inhaler|inhaler
1099868|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
1099869|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
1099870|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
1099871|NCT02552147|Autism spectrum disorder|autism spectrum disorder
1099872|NCT02552147|Aggression|aggression
1099873|NCT02552147|Irritability|irritability
1099874|NCT02552147|Nicotine|nicotine
1099875|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
1099876|NCT02552147|Nicotinic agonist|nicotinic agonist
1099877|NCT02552147|Adult autism|adult autism
1099878|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
1099879|NCT02552121|ovary cancer|ovary cancer
1099880|NCT02552121|cervix cancer|cervix cancer
1099881|NCT02552121|endometrium cancer|endometrium cancer
1099882|NCT02552121|bladder cancer|bladder cancer
1099883|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
1099884|NCT02552121|esophagus cancer|esophagus cancer
1099885|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
1099886|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
1099986|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
1099887|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
1099888|NCT02552043|Cystic fibrosis|cystic fibrosis
1099889|NCT02552043|Exercise capacity|exercise capacity
1099890|NCT02552043|Interactive gaming console|interactive gaming console
1099891|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
1099892|NCT02552017|adenoma detection rate|adenoma detection rate
1099893|NCT02552017|Endocuff|endocuff
1099894|NCT02552017|Endocuff Vision|endocuff vision
1099895|NCT02552017|colonoscopy|colonoscopy
1099896|NCT02552017|bowel cancer screening|bowel cancer screening
1099897|NCT02552017|bowel cancer|bowel cancer
1099898|NCT02552004|pCLE|pcle
1099899|NCT02552004|Digestive surgery|digestive surgery
1099900|NCT02552004|Endocrine surgery|endocrine surgery
1099901|NCT02551991|Pancreatic cancer|pancreatic cancer
1099902|NCT02551991|MM-398|mm-398
1099903|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
1099904|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
1099905|NCT02551978|obesity|obesity
1099906|NCT02551978|child|child
1099907|NCT02551978|primary prevention|primary prevention
1099908|NCT02551978|serious game|serious game
1099909|NCT02551978|nutrition|nutrition
1099910|NCT02551978|physical activity|physical activity
1099911|NCT02551978|psychosocial|psychosocial
1099912|NCT02551978|stress|stress
1099913|NCT02551978|knowledge|knowledge
1099914|NCT02551978|diet|diet
1099915|NCT02551965|Cancer|cancer
1099916|NCT02551965|Patient|patient
1099917|NCT02551965|Oncology|oncology
1099918|NCT02551965|Caregiver|caregiver
1099919|NCT02551952|Games|games
1099920|NCT02551952|Cognitive Tests|cognitive tests
1099921|NCT02551952|General Anesthesia|general anesthesia
1099922|NCT02551952|Surgery|surgery
1099923|NCT02551913|Psychological Theory|psychological theory
1099924|NCT02551913|adolescents|adolescents
1099925|NCT02551900|Type 2 Diabetes|type 2 diabetes
1099926|NCT02551900|Vascular Function|vascular function
1099927|NCT02551900|Water Exercise|water exercise
1099930|NCT02551887|HPV Vaccinations|hpv vaccinations
1099931|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
1099932|NCT02551848|Movement disorders|movement disorders
1099933|NCT02551848|Botulinum toxin type A|botulinum toxin type a
1099934|NCT02551848|Kinematics|kinematics
1099935|NCT02551835|ODIN|odin
1099936|NCT02551835|Meta-analysis|meta-analysis
1099937|NCT02551835|Cholecalciferol|cholecalciferol
1099938|NCT02551835|25(OH)D|25(oh)d
1099939|NCT02551835|Subgroup effects|subgroup effects
1099940|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
1099941|NCT02551796|lenticule extraction|lenticule extraction
1099942|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
1099943|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
1099944|NCT02551796|tear|tear
1099945|NCT02551796|inflammatory mediators|inflammatory mediators
1099946|NCT02551783|urethral stricture|urethral stricture
1099947|NCT02551783|urethroplasty|urethroplasty
1099948|NCT02551783|buccal mucosa|buccal mucosa
1099949|NCT02551783|graft|graft
1099950|NCT02551757|Rehabilitation|rehabilitation
1099951|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
1099952|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
1099953|NCT02551744|proton pump inhibitor|proton pump inhibitor
1099954|NCT02551744|thienopyridine|thienopyridine
1099955|NCT02551744|clopidogrel|clopidogrel
1099956|NCT02551744|prevention|prevention
1099957|NCT02551679|Stem cells|stem cells
1099958|NCT02551679|Endothelial progenitor cells|endothelial progenitor cells
1099959|NCT02551679|Autologous cells|autologous cells
1099960|NCT02551679|Vascular disease|vascular disease
1099961|NCT02551679|Peripheral arterial disease|peripheral arterial disease
1099962|NCT02551679|Regenerative medicine|regenerative medicine
1099963|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1099964|NCT02551653|Biodistribution|biodistribution
1099965|NCT02551653|Positron Emission Tomography|positron emission tomography
1099966|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
1099967|NCT02551653|Healthy subjects|healthy subjects
1099968|NCT02551614|lipopolysaccharide|lipopolysaccharide
1099969|NCT02551614|COPD|copd
1099970|NCT02551614|neutrophil|neutrophil
1099971|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
1099972|NCT02551601|optical coherence tomography|optical coherence tomography
1099973|NCT02551601|enhanced depth imaging|enhanced depth imaging
1099974|NCT02551588|fibrosis|fibrosis
1099975|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
1099976|NCT02551549|Subjects|subjects
1099977|NCT02551536|Allergic rhinitis|allergic rhinitis
1099978|NCT02551536|montelukast|montelukast
1099979|NCT02551536|fexofenadine|fexofenadine
1099980|NCT02551536|levocetrizine|levocetrizine
1099981|NCT02551510|Skin Adhesive|skin adhesive
1099982|NCT02551510|Suture|suture
1099983|NCT02551510|Port Incisions|port incisions
1099984|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
1099985|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
1100180|NCT02550171|DNA|dna
1099987|NCT02551471|Pelvic recurrence|pelvic recurrence
1099988|NCT02551471|Benchmarking France Australia|benchmarking france australia
1099989|NCT02551432|pembrolizumab|pembrolizumab
1099990|NCT02551432|paclitaxel|paclitaxel
1099991|NCT02551419|mild cognitive impairment|mild cognitive impairment
1099992|NCT02551419|ketones|ketones
1099993|NCT02551419|medium chain triglycerides|medium chain triglycerides
1099994|NCT02551419|Positron emission tomography|positron emission tomography
1099995|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
1099996|NCT02551419|cognition|cognition
1099997|NCT02551419|brain|brain
1099998|NCT02551419|neuroimaging|neuroimaging
1099999|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
1100000|NCT02551406|capno-oxymetry|capno-oxymetry
1100001|NCT02551393|Older adults|older adults
1100002|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
1100003|NCT02551367|letrozole|letrozole
1100004|NCT02551354|Labor, Obstetric|labor, obstetric
1100005|NCT02551354|pain|pain
1100006|NCT02551354|pupil diameter|pupil diameter
1100007|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
1100008|NCT02551341|prostatectomy|prostatectomy
1100009|NCT02551341|robotic|robotic
1100010|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
1100011|NCT02551315|HR-pQCT|hr-pqct
1100012|NCT02551315|DXA|dxa
1100013|NCT02551315|bone mineral density|bone mineral density
1100014|NCT02551315|bone turnover markers|bone turnover markers
1100015|NCT02551315|urinary pentosidine|urinary pentosidine
1100016|NCT02551289|MRI|mri
1100017|NCT02551289|Gluten|gluten
1100018|NCT02551289|Imaging|imaging
1100019|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
1100020|NCT02551263|Breast Cancer|breast cancer
1100021|NCT02551263|Eribulin|eribulin
1100022|NCT02551263|HER2-negative|her2-negative
1100023|NCT02551263|hormone-resistant|hormone-resistant
1100024|NCT02551263|inoperable|inoperable
1100025|NCT02551263|recurrent metastatic|recurrent metastatic
1100319|NCT02549534|Taxol|taxol
1100026|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
1100027|NCT02551250|surveillance|surveillance
1100028|NCT02551250|liver cirrhosis|liver cirrhosis
1100029|NCT02551250|ultrasonography|ultrasonography
1100030|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
1100031|NCT02551237|Elderly patient|elderly patient
1100032|NCT02551237|Radiotherapy|radiotherapy
1100033|NCT02551237|Radio chemotherapy|radio chemotherapy
1100034|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
1100035|NCT02551224|COPD|copd
1100036|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
1100037|NCT02551198|oral sulfate solution|oral sulfate solution
1100038|NCT02551198|bowel preparation|bowel preparation
1100039|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
1100040|NCT02551133|Dexamethasone|dexamethasone
1100041|NCT02551133|mastectomy|mastectomy
1100042|NCT02551133|persistent surgical pain|persistent surgical pain
1100043|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
1100044|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
1100045|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
1100046|NCT02551120|Quality of Life|quality of life
1100047|NCT02551120|Bone Mineral Density|bone mineral density
1100048|NCT02551120|Muscle strength|muscle strength
1100049|NCT02551120|Cardiovascular indices|cardiovascular indices
1100050|NCT02551055|Drug Therapy|drug therapy
1100051|NCT02551042|Digital Ulcers|digital ulcers
1100052|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
1100053|NCT02551042|Factor XIII|factor xiii
1100054|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
1100055|NCT02551029|Brainstem|brainstem
1100056|NCT02551029|Solitary Nucleus|solitary nucleus
1100057|NCT02551029|Visceral Nervous System|visceral nervous system
1100058|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
1100059|NCT02550977|Contraception|contraception
1100060|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
1100061|NCT02550977|Safety|safety
1100062|NCT02550977|Efficacy|efficacy
1100063|NCT02550977|Pharmacokinetic|pharmacokinetic
1100064|NCT02550964|Autoimmune Disease|autoimmune disease
1100065|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
1100066|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
1100067|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
1100068|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
1100069|NCT02550964|Toxic Maculopathy|toxic maculopathy
1100070|NCT02550925|Cancer survivors|cancer survivors
1100071|NCT02550886|Work Burden|work burden
1100072|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
1100073|NCT02550886|Anesthesiology|anesthesiology
1100074|NCT02550886|Perioperative Care|perioperative care
1100075|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
1100076|NCT02550860|parenteral nutrition|parenteral nutrition
1100077|NCT02550860|skin barrier function|skin barrier function
1100078|NCT02550860|essential fatty acids|essential fatty acids
1100079|NCT02550860|transepidermal water loss|transepidermal water loss
1100080|NCT02550847|MR/PET|mr/pet
1100081|NCT02550847|pancreatic cancer|pancreatic cancer
1100082|NCT02550834|Core stability|core stability
1100083|NCT02550834|Indoors curling exercises|indoors curling exercises
1100084|NCT02550834|Motivation|motivation
1100085|NCT02550821|Physical activity levels|physical activity levels
1100086|NCT02550821|Bronchiectasis|bronchiectasis
1100087|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
1100088|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
1100089|NCT02550782|postoperative analgesia|postoperative analgesia
1100090|NCT02550769|Transanal NOTES|transanal notes
1100091|NCT02550769|Transanal TME|transanal tme
1100092|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
1100093|NCT02550769|Surgery|surgery
1100094|NCT02550743|Stage II|stage ii
1100095|NCT02550743|Stage III|stage iii
1100096|NCT02550743|Stage IV|stage iv
1100097|NCT02550743|metastatic|metastatic
1100098|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
1100099|NCT02550717|Bleeding,|bleeding,
1100100|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
1100101|NCT02550717|Cardiovascular|cardiovascular
1100102|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
1100103|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
1100104|NCT02550704|Intestinal permeability|intestinal permeability
1100105|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
1100106|NCT02550704|Low grade inflammation|low grade inflammation
1100107|NCT02550678|Untreated nBCC|untreated nbcc
1100108|NCT02550678|Low-Risk|low-risk
1100109|NCT02550665|Alzheimer's disease|alzheimer's disease
1100110|NCT02550665|donepezil|donepezil
1100111|NCT02550626|delirium|delirium
1100112|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
1100113|NCT02550626|spine surgery|spine surgery
1100114|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
1100115|NCT02550600|ARDS|ards
1100116|NCT02550600|Acute lung impairment|acute lung impairment
1100117|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
1100120|NCT02550600|Murray-score|murray-score
1100121|NCT02550600|SOFA-score|sofa-score
1100122|NCT02550587|Patient Satisfaction|patient satisfaction
1100123|NCT02550587|anesthesia Care|anesthesia care
1100124|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
1100125|NCT02550561|PTNS|ptns
1100126|NCT02550561|IC|ic
1100127|NCT02550548|Incretins|incretins
1100128|NCT02550548|GLP-1|glp-1
1100129|NCT02550548|GIP|gip
1100130|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
1100131|NCT02550535|Gene Therapy|gene therapy
1100132|NCT02550535|WT1 TCR|wt1 tcr
1100133|NCT02550535|Gene modified T cels|gene modified t cels
1100134|NCT02550522|without associated head injury|without associated head injury
1100135|NCT02550509|stroke|stroke
1100136|NCT02550509|Botulinum toxin|botulinum toxin
1100137|NCT02550509|Muscle alterations|muscle alterations
1100138|NCT02550483|Healthy volunteers|healthy volunteers
1100139|NCT02550444|Clonidine|clonidine
1100140|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
1100141|NCT02550379|Social Anxiety|social anxiety
1100142|NCT02550379|Social Phobia|social phobia
1100143|NCT02550379|Depression|depression
1100144|NCT02550379|Emotion Recognition Training|emotion recognition training
1100145|NCT02550366|Cardiac MRI|cardiac mri
1100146|NCT02550366|Accelerate imaging|accelerate imaging
1100147|NCT02550366|coronary artery disease|coronary artery disease
1100148|NCT02550353|lenticule extraction|lenticule extraction
1100149|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
1100150|NCT02550353|tear|tear
1100151|NCT02550353|inflammatory mediators|inflammatory mediators
1100152|NCT02550340|Arrhythmia|arrhythmia
1100153|NCT02550340|Alcohol|alcohol
1100154|NCT02550340|ECG|ecg
1100155|NCT02550327|resectable|resectable
1100156|NCT02550327|potentially resectable|potentially resectable
1100157|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1100158|NCT02550327|PDAC|pdac
1100159|NCT02550301|mean platelet volume|mean platelet volume
1100160|NCT02550262|Epidural|epidural
1100161|NCT02550262|Labor analgesia|labor analgesia
1100162|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
1100163|NCT02550236|Children|children
1100164|NCT02550236|Obesity|obesity
1100165|NCT02550236|Pregnancy|pregnancy
1100166|NCT02550236|Growth|growth
1100167|NCT02550236|Lifestyle|lifestyle
1568533|NCT00505505|Postoperative Mortality|postoperative mortality
1100168|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
1100169|NCT02550236|Birth|birth
1100170|NCT02550236|Development|development
1100171|NCT02550210|Breast Conserving Surgery|breast conserving surgery
1100172|NCT02550210|Breast Imaging|breast imaging
1100173|NCT02550210|Breast Diagnostics|breast diagnostics
1100174|NCT02550197|Influenza|influenza
1100175|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
1100176|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
1100177|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
1100178|NCT02550171|Biobank|biobank
1100179|NCT02550171|Genetics|genetics
1100182|NCT02550171|normal control|normal control
1100183|NCT02550158|Crohn's Disease|crohn's disease
1100184|NCT02550158|Ulcerative Colitis|ulcerative colitis
1100185|NCT02550158|Educational program|educational program
1100186|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
1100187|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
1100188|NCT02550158|IBD|ibd
1100189|NCT02550145|Hyperinsulinemic|hyperinsulinemic
1100190|NCT02550145|post-bariatric surgery|post-bariatric surgery
1100191|NCT02550132|electromyography|electromyography
1100192|NCT02550132|biomechanical phenomena|biomechanical phenomena
1100193|NCT02550132|dose-response relationship|dose-response relationship
1100194|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
1100195|NCT02550132|spinal manipulation|spinal manipulation
1100196|NCT02550106|CHRONIC SPONTANEOUS URTICARIA, OMALIZUMAB, URTICARIA CONTROL TEST|chronic spontaneous urticaria, omalizumab, urticaria control test
1100197|NCT02550093|Volunteers|volunteers
1100198|NCT02550067|HIV infection|hiv infection
1100199|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
1100200|NCT02550067|Contraception|contraception
1100201|NCT02550067|DMPA|dmpa
1100202|NCT02550067|Copper IUD|copper iud
1100203|NCT02550067|Levonorgestrel implant|levonorgestrel implant
1100204|NCT02550067|IUD|iud
1100205|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
1100206|NCT02550041|cystic fibrosis|cystic fibrosis
1100207|NCT02550028|Neonates|neonates
1100208|NCT02550028|Seizure|seizure
1100209|NCT02550015|Exercise training|exercise training
1100210|NCT02550015|Oxygen consumption|oxygen consumption
1100211|NCT02549989|LY3023414|ly3023414
1100212|NCT02549989|15-079|15-079
1100213|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
1100214|NCT02549976|Crohn's Disease|crohn's disease
1100215|NCT02549976|Digestive Damage|digestive damage
1100216|NCT02549976|Lemann Index|lemann index
1100217|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
1100218|NCT02549950|Peizo-corticission|peizo-corticission
1100219|NCT02549924|Resveratrol|resveratrol
1100220|NCT02549924|Glycemic Variability|glycemic variability
1100222|NCT02549911|chemotherapy|chemotherapy
1100223|NCT02549911|surgery|surgery
1100224|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
1100225|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
1100226|NCT02549885|Migraine disorders|migraine disorders
1100227|NCT02549885|Muscle stretching exercises|muscle stretching exercises
1100228|NCT02549872|Dementia|dementia
1100229|NCT02549872|Validity|validity
1100230|NCT02549872|Mortality|mortality
1100231|NCT02549872|Electronic health records|electronic health records
1100232|NCT02549859|DBS|dbs
1100233|NCT02549859|Low frequency stimulation|low frequency stimulation
1100234|NCT02549859|Dysphagia|dysphagia
1100235|NCT02549859|Freezing of gait|freezing of gait
1100236|NCT02549833|low-grade glioma|low-grade glioma
1100237|NCT02549833|WHO grade II|who grade ii
1100238|NCT02549833|vaccine|vaccine
1100239|NCT02549833|immunotherapy|immunotherapy
1100240|NCT02549833|glioma|glioma
1100241|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
1100242|NCT02549820|Tracheal Occlusion|tracheal occlusion
1100243|NCT02549807|Vascular hemiplegia|vascular hemiplegia
1100244|NCT02549807|2D ultrasound|2d ultrasound
1100245|NCT02549807|Muscle elasticity|muscle elasticity
1100246|NCT02549807|Pennation angle|pennation angle
1100247|NCT02549794|low concentration contrast agent|low concentration contrast agent
1100248|NCT02549794|Low dose contrast agent|low dose contrast agent
1100249|NCT02549794|computed tomography|computed tomography
1100250|NCT02549781|pathological gambler|pathological gambler
1100251|NCT02549781|Go-Nogo test|go-nogo test
1100252|NCT02549768|Dexmedetomidine|dexmedetomidine
1100253|NCT02549768|Pituitary|pituitary
1100254|NCT02549768|Transsphenoidal|transsphenoidal
1100255|NCT02549768|Cortisol|cortisol
1100256|NCT02549742|Electrochemotherapy|electrochemotherapy
1100257|NCT02549742|head neck cancer|head neck cancer
1100258|NCT02549742|bleomycin|bleomycin
1100259|NCT02549716|Acetaminophen|acetaminophen
1100260|NCT02549716|interleukin-6|interleukin-6
1100261|NCT02549716|interleukin-1|interleukin-1
1100262|NCT02549716|thromboxane A2|thromboxane a2
1100263|NCT02549703|multiple sclerosis|multiple sclerosis
1100264|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
1100265|NCT02549703|mitochondria|mitochondria
1100266|NCT02549703|neurodegeneration|neurodegeneration
1100267|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
1100268|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
1100269|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
1100270|NCT02549651|DLBCL|dlbcl
1100271|NCT02549651|MEDI4736|medi4736
1100272|NCT02549651|durvalumab|durvalumab
1100273|NCT02549651|tremelimumab|tremelimumab
1100274|NCT02549651|AZD9150|azd9150
1100275|NCT02549651|anti-PD-L1|anti-pd-l1
1100276|NCT02549651|anti-CTLA-4|anti-ctla-4
1100277|NCT02549651|immunotherapy|immunotherapy
1100278|NCT02549651|IMTC|imtc
1100279|NCT02549651|STAT3|stat3
1100280|NCT02549625|Single right ventricular failure|single right ventricular failure
1100281|NCT02549612|Conductive hearing loss|conductive hearing loss
1100282|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
1100283|NCT02549612|middle ear effusion|middle ear effusion
1100284|NCT02549599|Digital and mobile health|digital and mobile health
1100285|NCT02549599|Sexual and reproductive health|sexual and reproductive health
1100286|NCT02549599|Adolescents and young adults|adolescents and young adults
1100287|NCT02549586|solid organ transplant|solid organ transplant
1100288|NCT02549586|immune tolerance|immune tolerance
1100289|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
1100290|NCT02549586|blood and marrow transplant|blood and marrow transplant
1100291|NCT02549586|autoimmune disease|autoimmune disease
1100292|NCT02549573|Motor Symptoms|motor symptoms
1100293|NCT02549573|Parkinson's disease|parkinson's disease
1100294|NCT02549573|Apokyn|apokyn
1100295|NCT02549573|Apomorphine|apomorphine
1100296|NCT02549573|PD|pd
1100297|NCT02549560|tDCS|tdcs
1100298|NCT02549560|Cardiac Surgery|cardiac surgery
1100299|NCT02549547|anxiety|anxiety
1100300|NCT02549547|depression|depression
1100301|NCT02549547|exercise|exercise
1100302|NCT02549547|group|group
1100303|NCT02549547|group medical visit|group medical visit
1100304|NCT02549547|mood disorder|mood disorder
1100305|NCT02549547|physical activity|physical activity
1100306|NCT02549547|primary care|primary care
1100307|NCT02549534|Taxane|taxane
1100308|NCT02549534|Neuropathy|neuropathy
1100309|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
1100310|NCT02549534|Breast Cancer|breast cancer
1100311|NCT02549534|Local skin heating|local skin heating
1100312|NCT02549534|Axon reflex|axon reflex
1100313|NCT02549534|Axon flare|axon flare
1100314|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
1100315|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
1100316|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
1100317|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
1100320|NCT02549521|calcium|calcium
1100321|NCT02549521|magnesium|magnesium
1100322|NCT02549521|vitamin D|vitamin d
1100323|NCT02549521|bone turnover markers|bone turnover markers
1100324|NCT02549482|Central volume deficit|central volume deficit
1100325|NCT02549482|Head-up tilt|head-up tilt
1100326|NCT02549482|Systolic pressure variation|systolic pressure variation
1100327|NCT02549456|natural orifice surgery|natural orifice surgery
1100328|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
1100329|NCT02549456|taTME|tatme
1100330|NCT02549443|Catabolic response|catabolic response
1100331|NCT02549443|Amino Acids|amino acids
1100332|NCT02549443|Insulin|insulin
1100333|NCT02549430|Advanced breast cancer|advanced breast cancer
1100334|NCT02549430|Postmenopausal|postmenopausal
1100335|NCT02549430|ER positive|er positive
1100336|NCT02549430|Her2 negative|her2 negative
1100337|NCT02549378|microcirculation|microcirculation
1100338|NCT02549378|confocal microscopy|confocal microscopy
1100339|NCT02549378|hypocapnia|hypocapnia
1100340|NCT02549326|Vitamin D|vitamin d
1100341|NCT02549313|brain lesion|brain lesion
1100342|NCT02549313|intracranial pressure|intracranial pressure
1100343|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
1100344|NCT02549300|connective tissue massage|connective tissue massage
1100345|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
1100346|NCT02549274|Cervicalgia|cervicalgia
1100347|NCT02549274|self-rehabilitation|self-rehabilitation
1100348|NCT02549274|physiotherapy|physiotherapy
1100349|NCT02549261|nimotuzumab|nimotuzumab
1100350|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
1100351|NCT02549261|radiochemotherapy|radiochemotherapy
1100352|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
1100353|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
1100354|NCT02549248|nanoparticles|nanoparticles
1100355|NCT02549248|lung|lung
1100356|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
1100357|NCT02549248|bronchial washings|bronchial washings
1100358|NCT02549235|IVF|ivf
1100359|NCT02549235|Miscarriage|miscarriage
1100360|NCT02549235|Uterine septum|uterine septum
1100361|NCT02549222|pathogen reduction|pathogen reduction
1100362|NCT02549222|INTERCEPT|intercept
1100363|NCT02549222|platelet|platelet
1100364|NCT02549222|pulmonary|pulmonary
1100365|NCT02549222|ARDS|ards
1100366|NCT02549222|hematology|hematology
1100367|NCT02549222|oncology|oncology
1100368|NCT02549222|assisted ventilation|assisted ventilation
1100369|NCT02549222|transfusion of platelet components|transfusion of platelet components
1100370|NCT02549222|hematology-oncology patients|hematology-oncology patients
1100371|NCT02549209|Pembrolizumab|pembrolizumab
1100372|NCT02549209|Keytruda|keytruda
1100373|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
1100374|NCT02549209|Carboplatin|carboplatin
1100375|NCT02549209|Paclitaxel|paclitaxel
1100376|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
1100377|NCT02549170|Autoimmune Diseases|autoimmune diseases
1100378|NCT02549170|Polyneuropathies|polyneuropathies
1100379|NCT02549170|Nervous System Diseases|nervous system diseases
1100380|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
1100381|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
1100382|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
1100383|NCT02549170|Immunoglobulins|immunoglobulins
1100384|NCT02549170|Immune System Diseases|immune system diseases
1100385|NCT02549170|Demyelinating Diseases|demyelinating diseases
1100386|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
1100387|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
1100388|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
1100389|NCT02549105|EMLA CREAM|emla cream
1100390|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
1100391|NCT02549105|PAIN RELIEF|pain relief
1100392|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1100393|NCT02549092|levodopa|levodopa
1100394|NCT02549092|carbidopa|carbidopa
1100395|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
1100396|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
1100397|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
1100398|NCT02549092|efficacy|efficacy
1100399|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
1100400|NCT02549066|renal blood flow|renal blood flow
1100401|NCT02549066|renal function|renal function
1100402|NCT02549066|renal oxygenation|renal oxygenation
1100403|NCT02549001|Onychomycosis|onychomycosis
1100404|NCT02549001|Nail fungus|nail fungus
1100405|NCT02548975|Cardiac surgery|cardiac surgery
1100406|NCT02548975|Risk factors|risk factors
1100407|NCT02548975|Postoperative delirium|postoperative delirium
1100408|NCT02548962|Multiple Myeloma|multiple myeloma
1100409|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1100410|NCT02548962|PCI-32765|pci-32765
1100411|NCT02548962|Pomalidomide|pomalidomide
1100412|NCT02548962|Dexamethasone|dexamethasone
1100413|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
1100414|NCT02548962|Ibrutinib|ibrutinib
1100415|NCT02548936|Cholesterol, LDL|cholesterol, ldl
1100416|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
1100417|NCT02548936|Atherosclerosis|atherosclerosis
1100418|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
1100419|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1100420|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
1100421|NCT02548858|Perineorrhaphy|perineorrhaphy
1100422|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
1100423|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
1100424|NCT02548858|Body image|body image
1100425|NCT02548845|hyponatremia|hyponatremia
1100426|NCT02548845|SIADH|siadh
1100427|NCT02548845|Oncologic patients|oncologic patients
1100428|NCT02548832|Berberine|berberine
1100429|NCT02548832|Bezafibrate|bezafibrate
1100430|NCT02548806|Clonidine|clonidine
1100431|NCT02548793|Cardiac Arrest|cardiac arrest
1100433|NCT02548793|Family-centered Care|family-centered care
1100434|NCT02548793|Health Literacy|health literacy
1100435|NCT02548793|Health Education|health education
1100436|NCT02548793|Education Dissemination|education dissemination
1100437|NCT02548780|unresectable|unresectable
1100438|NCT02548767|High fructose corn syrup|high fructose corn syrup
1100439|NCT02548767|Sugar|sugar
1100440|NCT02548754|atrial fibrillation|atrial fibrillation
1100441|NCT02548754|neuromodulation|neuromodulation
1100442|NCT02548754|inflammation|inflammation
1100443|NCT02548741|Metformin|metformin
1100444|NCT02548741|diabetes|diabetes
1100445|NCT02548741|type 2 diabetes|type 2 diabetes
1100446|NCT02548741|diabetes complications|diabetes complications
1100447|NCT02548741|methylglyoxal|methylglyoxal
1100448|NCT02548741|Prediabetes|prediabetes
1100449|NCT02548728|Opioid Dependence|opioid dependence
1100450|NCT02548728|Opioid Withdrawal|opioid withdrawal
1100451|NCT02548728|Opioid|opioid
1100452|NCT02548728|Oxytocin|oxytocin
1100453|NCT02548728|OT (oxytocin)|ot (oxytocin)
1100454|NCT02548728|Intranasal administration|intranasal administration
1100455|NCT02548715|thyroxine|thyroxine
1100456|NCT02548715|Otolaryngology|otolaryngology
1100457|NCT02548702|Sport|sport
1100458|NCT02548702|type 2 diabetes|type 2 diabetes
1100459|NCT02548702|community intervention programme|community intervention programme
1100460|NCT02548702|Fit4life|fit4life
1100461|NCT02548702|Exercise|exercise
1100462|NCT02548689|alopecia|alopecia
1100463|NCT02548689|hair loss|hair loss
1100464|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1100465|NCT02548663|sport therapy|sport therapy
1100466|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
1100467|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
1100468|NCT02548650|myocardial infarction|myocardial infarction
1100469|NCT02548650|diabetes mellitus|diabetes mellitus
1100470|NCT02548650|vorapaxar|vorapaxar
1100471|NCT02548650|peripheral arterial disease|peripheral arterial disease
1100472|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
1100473|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
1100475|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
1100476|NCT02548572|RP|rp
1100477|NCT02548416|Atelectasis|atelectasis
1100478|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
1100479|NCT02548416|Oxygenation|oxygenation
1100480|NCT02548416|Anaesthesia|anaesthesia
1100481|NCT02548416|Computed tomography|computed tomography
1100482|NCT02548403|Bowel preparation|bowel preparation
1100483|NCT02548403|Simethicone|simethicone
1100484|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
1100485|NCT02548390|Phase 1/1b|phase 1/1b
1100486|NCT02548390|open-label|open-label
1100487|NCT02548390|dose-escalation|dose-escalation
1100488|NCT02548390|pharmacokinetics|pharmacokinetics
1100489|NCT02548390|solid tumor|solid tumor
1100490|NCT02548390|metastatic cancer|metastatic cancer
1100491|NCT02548390|chemotherapy|chemotherapy
1100492|NCT02548390|nano formulation|nano formulation
1100493|NCT02548390|alkylator|alkylator
1100494|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
1100495|NCT02548377|Surgical Flaps|surgical flaps
1100496|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
1100497|NCT02548377|Hemostasis|hemostasis
1100498|NCT02548377|Thrombosis|thrombosis
1100499|NCT02548377|Immune System|immune system
1100500|NCT02548377|Reperfusion Injury|reperfusion injury
1100501|NCT02548364|Vitamin D|vitamin d
1100502|NCT02548364|Myocardial Infarction|myocardial infarction
1100503|NCT02548364|Ventricular remodeling|ventricular remodeling
1100504|NCT02548364|Biomarkers|biomarkers
1100505|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
1100506|NCT02548312|Readers' perceptions|readers' perceptions
1100507|NCT02548299|Diabetes|diabetes
1100508|NCT02548299|Cooking|cooking
1100509|NCT02548299|Nutrition|nutrition
1100510|NCT02548299|Lifestyle Medicine|lifestyle medicine
1100511|NCT02548286|Hypertension|hypertension
1100512|NCT02548286|Healthy male volunteer|healthy male volunteer
1100513|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
1100516|NCT02548247|Stool frequency|stool frequency
1100517|NCT02548247|Bowel motor function|bowel motor function
1100518|NCT02548247|Orafti® Inulin|orafti® inulin
1100519|NCT02548247|Dietary Fiber|dietary fiber
1100520|NCT02548234|Stroke|stroke
1100521|NCT02548234|Randomized control trial|randomized control trial
1100522|NCT02548234|Mirror therapy|mirror therapy
1100523|NCT02548234|Bilateral arm training|bilateral arm training
1100524|NCT02548234|Comparative efficacy research|comparative efficacy research
1100525|NCT02548234|Neurorehabilitation|neurorehabilitation
1100526|NCT02548221|Thoracentesis|thoracentesis
1100527|NCT02548221|Pleural Effusions|pleural effusions
1100528|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
1100529|NCT02548221|Lung volume measurements|lung volume measurements
1100530|NCT02548195|GEMOX|gemox
1100531|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1100532|NCT02548195|adjuvant therapy|adjuvant therapy
1100533|NCT02548195|oxaliplatin|oxaliplatin
1100534|NCT02548195|gemcitabine|gemcitabine
1100535|NCT02548195|capecitabine|capecitabine
1100536|NCT02548195|curative surgery|curative surgery
1100537|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
1100538|NCT02548169|FOLFIRINOX|folfirinox
1100539|NCT02548169|nab-paclitaxel|nab-paclitaxel
1100540|NCT02548169|gemcitabine|gemcitabine
1100541|NCT02548117|Testosterone therapy|testosterone therapy
1100542|NCT02548117|erythrocytosis|erythrocytosis
1100543|NCT02548117|finasteride|finasteride
1100544|NCT02548091|non invasive ventilation|non invasive ventilation
1100545|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
1100546|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
1100547|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
1100548|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
1100549|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
1100550|NCT02548065|Balneotherapy|balneotherapy
1100551|NCT02548065|Vetriolo Water|vetriolo water
1100552|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
1100553|NCT02548052|Plaque type psoriasis|plaque type psoriasis
1100554|NCT02548052|psoriasis plaque test|psoriasis plaque test
1100555|NCT02548052|Topical|topical
1100556|NCT02548052|GSK2981278|gsk2981278
1100557|NCT02548039|Anovulatory|anovulatory
1100558|NCT02548039|Clomiphene|clomiphene
1100559|NCT02548026|meal frequency|meal frequency
1100560|NCT02548026|eating frequency|eating frequency
1100561|NCT02548026|ingestive frequency|ingestive frequency
1100562|NCT02548026|positive energy balance|positive energy balance
1100563|NCT02548026|satiety|satiety
1100564|NCT02548026|appetite|appetite
1100565|NCT02548026|hunger|hunger
1100566|NCT02547987|breast cancer|breast cancer
1100567|NCT02547987|triple negative|triple negative
1100568|NCT02547987|TNBC|tnbc
1100569|NCT02547987|triple negative breast cancer|triple negative breast cancer
1100570|NCT02547974|Safety|safety
1100571|NCT02547974|Immunogenicity|immunogenicity
1100572|NCT02547974|Reactogenicity|reactogenicity
1100573|NCT02547961|breast cancer|breast cancer
1100574|NCT02547961|HER2|her2
1100575|NCT02547961|CAR-T cell|car-t cell
1100576|NCT02547948|CD19|cd19
1100577|NCT02547948|CAR T Cells|car t cells
1100582|NCT02547896|impacted third molar tooth|impacted third molar tooth
1100583|NCT02547883|Statins|statins
1100584|NCT02547883|Elderly|elderly
1100585|NCT02547883|Mortality|mortality
1100586|NCT02547883|Quality of life|quality of life
1100587|NCT02547883|Randomized trial|randomized trial
1100588|NCT02547883|Cost effectiveness study|cost effectiveness study
1100589|NCT02547883|Primary care|primary care
1100590|NCT02547870|Rilpivirine|rilpivirine
1100591|NCT02547870|Healthy participants|healthy participants
1100592|NCT02547857|Pelvic ultrasound|pelvic ultrasound
1100593|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
1100594|NCT02547818|Early stage AD|early stage ad
1100595|NCT02547818|MCI|mci
1100596|NCT02547818|aMCI|amci
1100597|NCT02547818|prodromal|prodromal
1100598|NCT02547818|Memory loss|memory loss
1100599|NCT02547818|Memory problems|memory problems
1100600|NCT02547818|Aging|aging
1100601|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
1100602|NCT02547818|Early AD|early ad
1100603|NCT02547805|Urine Oxalate|urine oxalate
1100604|NCT02547805|Nephrolithiasis|nephrolithiasis
1100605|NCT02547805|Kidney Stones|kidney stones
1100606|NCT02547805|Hyperoxaluria|hyperoxaluria
1100607|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
1100608|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
1100609|NCT02547805|Urological Diseases|urological diseases
1100610|NCT02547805|Kidney Diseases|kidney diseases
1100611|NCT02547805|Supersaturation|supersaturation
1100612|NCT02547805|Dietary Oxalate|dietary oxalate
1100613|NCT02547792|Influenza B|influenza b
1100614|NCT02547779|crystalloid|crystalloid
1100615|NCT02547779|acute kidney injury|acute kidney injury
1100616|NCT02547766|Ventricular Assist Device|ventricular assist device
1100617|NCT02547766|Recovery of Function|recovery of function
1100618|NCT02547753|Tooth extraction|tooth extraction
1100619|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
1100620|NCT02547753|Postoperative complications|postoperative complications
1100621|NCT02547740|macula|macula
1100622|NCT02547740|visual fields|visual fields
1100623|NCT02547740|optical coherence tomography|optical coherence tomography
1100624|NCT02547740|glaucoma progression|glaucoma progression
1100625|NCT02547740|retinal ganglion cells|retinal ganglion cells
1100626|NCT02547727|rabies vaccination|rabies vaccination
1100627|NCT02547714|cyclosporine A|cyclosporine a
1100628|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
1100629|NCT02547610|patients|patients
1100630|NCT02547597|Beta-blockers|beta-blockers
1100631|NCT02547597|Anti-anginal effect|anti-anginal effect
1100632|NCT02547597|Lipid metabolism|lipid metabolism
1100633|NCT02547597|Glucose metabolism|glucose metabolism
1100634|NCT02547571|Outpatient|outpatient
1100635|NCT02547558|Indacaterol|indacaterol
1100636|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
1100637|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
1100638|NCT02547532|COPD|copd
1100639|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1100640|NCT02547532|microbioma|microbioma
1100641|NCT02547519|Type 1 diabetes|type 1 diabetes
1100642|NCT02547519|T1D|t1d
1100643|NCT02547519|diabetes mellitus|diabetes mellitus
1100644|NCT02547519|oral insulin|oral insulin
1100645|NCT02547519|oral tolerance|oral tolerance
1100646|NCT02547519|autoantigen|autoantigen
1100647|NCT02547519|self tolerance|self tolerance
1100648|NCT02547519|prevention|prevention
1100649|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
1100650|NCT02547519|juvenile diabetes|juvenile diabetes
1100651|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
1100652|NCT02547506|group exercise|group exercise
1100653|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
1100654|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
1100655|NCT02547480|liver|liver
1100656|NCT02547480|metastatic|metastatic
1100657|NCT02547467|mortality|mortality
1100658|NCT02547415|Pain, Chronic|pain, chronic
1100659|NCT02547415|children|children
1100660|NCT02547376|Telomeres|telomeres
1100661|NCT02547376|Telomerase|telomerase
1100662|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
1100663|NCT02547285|biomechanics of walking|biomechanics of walking
1100664|NCT02547285|footwear|footwear
1100665|NCT02547272|Intensive care|intensive care
1100666|NCT02547272|S Aureus|s aureus
1100667|NCT02547259|schizophrenia|schizophrenia
1100668|NCT02547259|memory|memory
1100669|NCT02547259|pain|pain
1100670|NCT02547246|bulimia|bulimia
1100671|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1100672|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
1100673|NCT02547194|saphenous vein|saphenous vein
1100674|NCT02547194|no-touch technique|no-touch technique
1100675|NCT02547181|Fracture|fracture
1100676|NCT02547181|Follow-up|follow-up
1100677|NCT02547181|metacarpal|metacarpal
1100678|NCT02547168|Atrial Fibrillation|atrial fibrillation
1100679|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
1100680|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
1100681|NCT02547168|Lung Resection|lung resection
1101775|NCT02540395|IFN-γ|ifn-γ
1100682|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
1100683|NCT02547142|Prospective Pre-Post Evaluation|prospective pre-post evaluation
1100684|NCT02547142|Early Palliative care|early palliative care
1100685|NCT02547142|FACT-E questionnaire|fact-e questionnaire
1100686|NCT02547142|HADS questionnaire|hads questionnaire
1100687|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
1100688|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
1100689|NCT02547103|Mupirocin ointment|mupirocin ointment
1100690|NCT02547103|Normal saline|normal saline
1100691|NCT02547103|Peritonitis|peritonitis
1100692|NCT02547103|Peritoneal dialysis|peritoneal dialysis
1100693|NCT02547064|intubation|intubation
1100694|NCT02547064|stylet|stylet
1100695|NCT02547064|videolaryngoscope|videolaryngoscope
1100696|NCT02547038|Helicobacter pylori|helicobacter pylori
1100697|NCT02547038|Eradication rate|eradication rate
1100698|NCT02547025|Helicobacter pylori|helicobacter pylori
1100699|NCT02547025|third-line therapy|third-line therapy
1100700|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
1100701|NCT02547025|Eradication|eradication
1100702|NCT02547012|Helicobacter pylori|helicobacter pylori
1100703|NCT02547012|Eradication rate|eradication rate
1100704|NCT02547012|Rescue treatment|rescue treatment
1100705|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
1100706|NCT02546999|Walking|walking
1100707|NCT02546986|CC-486|cc-486
1100708|NCT02546986|Azacitidine|azacitidine
1100709|NCT02546986|Oral azacitidine|oral azacitidine
1100710|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
1100711|NCT02546986|Hypomethylation|hypomethylation
1100712|NCT02546986|Hypomethylating agent|hypomethylating agent
1100713|NCT02546986|Epigenetic|epigenetic
1100714|NCT02546986|MK-3475|mk-3475
1100715|NCT02546986|Pembrolizumab|pembrolizumab
1100716|NCT02546986|Keytruda|keytruda
1100717|NCT02546986|PD-1|pd-1
1100718|NCT02546986|PD-L1|pd-l1
1100719|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
1100720|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
1100721|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
1100722|NCT02546986|NSCLC|nsclc
1100723|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
1100724|NCT02546960|Healthy|healthy
1100725|NCT02546960|JNJ-63871860|jnj-63871860
1100726|NCT02546960|ExPEC4V|expec4v
1100727|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1100728|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
1100729|NCT02546947|Atracurium|atracurium
1100730|NCT02546947|Mechanical ventilation|mechanical ventilation
1100731|NCT02546947|ARDS|ards
1100732|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
1100733|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
1100734|NCT02546934|triple negative breast cancer|triple negative breast cancer
1100735|NCT02546934|fine line chemotherapy|fine line chemotherapy
1100736|NCT02546921|IgE antibody|ige antibody
1100737|NCT02546921|Folate receptor|folate receptor
1100738|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
1100739|NCT02546921|First in class|first in class
1100740|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
1100741|NCT02546908|Non-interventional|non-interventional
1100742|NCT02546908|Observational|observational
1100743|NCT02546895|head and neck cancer patients|head and neck cancer patients
1100744|NCT02546895|clinical data|clinical data
1100745|NCT02546895|tissue collection|tissue collection
1100746|NCT02546895|prospective registration|prospective registration
1100747|NCT02546895|patients|patients
1100748|NCT02546882|stromal vascular fraction|stromal vascular fraction
1100749|NCT02546882|skin graft|skin graft
1100750|NCT02546843|rocuronium|rocuronium
1100751|NCT02546843|sugammadex|sugammadex
1100752|NCT02546843|pediatric anesthesia|pediatric anesthesia
1100753|NCT02546843|cisatracurium|cisatracurium
1100754|NCT02546843|surgical conditions|surgical conditions
1100755|NCT02546817|Treatment|treatment
1100756|NCT02546817|Tx|tx
1100757|NCT02546817|Prevent|prevent
1100758|NCT02546778|Radio frequency|radio frequency
1100759|NCT02546778|Female|female
1100760|NCT02546778|Humans|humans
1100761|NCT02546778|Esthetics|esthetics
1100762|NCT02546765|analgesics|analgesics
1100763|NCT02546765|cardiac surgery|cardiac surgery
1100764|NCT02546765|sedation|sedation
1100765|NCT02546739|Leukemia|leukemia
1100766|NCT02546739|Lymphoma|lymphoma
1100767|NCT02546739|CAR T|car t
1100768|NCT02546726|heat therapy|heat therapy
1100769|NCT02546726|steam-room|steam-room
1100770|NCT02546726|aerobic exercise|aerobic exercise
1100771|NCT02546726|hypertension|hypertension
1100772|NCT02546726|multiple behavior change|multiple behavior change
1100773|NCT02546726|lifestyle modification|lifestyle modification
1100774|NCT02546713|dental implants|dental implants
1100775|NCT02546687|Anastomotic Leak|anastomotic leak
1100776|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
1100777|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
1100778|NCT02546674|Nilotinib|nilotinib
1101776|NCT02540382|TIPS|tips
1100779|NCT02546674|Molecular Response|molecular response
1100780|NCT02546674|MR4.5|mr4.5
1100781|NCT02546661|Durvalumab|durvalumab
1100782|NCT02546661|Olaparib|olaparib
1100783|NCT02546661|Vistusertib|vistusertib
1100784|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
1100785|NCT02546661|MIBC|mibc
1100786|NCT02546661|BISCAY|biscay
1100787|NCT02546661|MEDI4736|medi4736
1100788|NCT02546661|AZD4547|azd4547
1100789|NCT02546661|AZD2281|azd2281
1100790|NCT02546661|AZD1775|azd1775
1100791|NCT02546661|AZD2014|azd2014
1100792|NCT02546661|AZD9150|azd9150
1100793|NCT02546622|Factor|factor
1100794|NCT02546622|Coagulation|coagulation
1100795|NCT02546622|Inhibitor|inhibitor
1100796|NCT02546622|HTC|htc
1100797|NCT02546622|Bleeding|bleeding
1100798|NCT02546557|CABG|cabg
1100799|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1100800|NCT02546544|Linsitinib|linsitinib
1100801|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
1100802|NCT02546544|Ewing Sarcoma|ewing sarcoma
1100803|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
1100804|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
1100805|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
1100806|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
1100807|NCT02546518|Conductive hearing loss|conductive hearing loss
1100808|NCT02546518|Middle ear effusion|middle ear effusion
1100809|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
1100810|NCT02546505|Consumer behavior|consumer behavior
1100811|NCT02546505|Nutrition Labeling|nutrition labeling
1100812|NCT02546479|Mortality|mortality
1100813|NCT02546479|Radiation|radiation
1100814|NCT02546479|Spine deformities|spine deformities
1100815|NCT02546466|low back pain|low back pain
1100816|NCT02546466|functional taping|functional taping
1100817|NCT02546466|balance|balance
1100818|NCT02546466|posture|posture
1100819|NCT02546466|rehabilitation|rehabilitation
1100820|NCT02546466|psychosocial factors|psychosocial factors
1100821|NCT02546466|minimal intervention strategy|minimal intervention strategy
1100822|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
1100823|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
1100824|NCT02546414|China|china
1100825|NCT02546375|Bosutinib|bosutinib
1100826|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
1100827|NCT02546375|retrospective|retrospective
1100828|NCT02546375|observational|observational
1100829|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1100830|NCT02546349|airway inflammation|airway inflammation
1100831|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
1100832|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
1100833|NCT02546336|Ultrasound Guidance|ultrasound guidance
1100834|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
1100835|NCT02546336|Hip Denervation|hip denervation
1100836|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
1100837|NCT02546297|LAMA,ICS+LABA|lama,ics+laba
1100838|NCT02546284|CMML|cmml
1100839|NCT02546258|Fungal Nail|fungal nail
1100840|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
1100841|NCT02546232|metastatic breast cancer|metastatic breast cancer
1100842|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
1100843|NCT02546219|EoE|eoe
1100844|NCT02546219|integrins|integrins
1100845|NCT02546206|Bifidobacterium|bifidobacterium
1100846|NCT02546206|Gingivitis|gingivitis
1100847|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
1100848|NCT02546206|Interleukin-1beta|interleukin-1beta
1100849|NCT02546206|Probiotics|probiotics
1100850|NCT02546180|Patient education|patient education
1100851|NCT02546180|Preoperative anxiety|preoperative anxiety
1100853|NCT02546154|Anaemia|anaemia
1100854|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
1100855|NCT02546154|Kidney Diseases|kidney diseases
1100856|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
1100857|NCT02546154|Fatigue|fatigue
1100858|NCT02546076|Keloid|keloid
1100859|NCT02546076|Hypertrophic scars|hypertrophic scars
1100860|NCT02546076|Er-YAG Lasers|er-yag lasers
1100861|NCT02546050|Gut microbiota|gut microbiota
1100862|NCT02546050|metformin|metformin
1100863|NCT02546050|Metabolism|metabolism
1100864|NCT02546050|Metagenomics|metagenomics
1100865|NCT02546050|Metabolomics|metabolomics
1100866|NCT02546037|coagulation|coagulation
1100867|NCT02546037|haemodialysis|haemodialysis
1100868|NCT02546024|Major depressive disorder|major depressive disorder
1100869|NCT02546024|late-onset|late-onset
1100870|NCT02546024|treatment response|treatment response
1100871|NCT02546024|predictors|predictors
1100872|NCT02546024|moderators|moderators
1100873|NCT02545998|Telehealthcare|telehealthcare
1100874|NCT02545985|sirolimus|sirolimus
1100875|NCT02545985|coronary stent|coronary stent
1100876|NCT02545985|Prolim|prolim
1100877|NCT02545972|immunosuppression|immunosuppression
1100878|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
1102080|NCT02538445|Cognition|cognition
1100879|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
1100880|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
1100881|NCT02545959|lumbar puncture|lumbar puncture
1100882|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
1100883|NCT02545959|Rituximab|rituximab
1100884|NCT02545946|traditional incision and drainage|traditional incision and drainage
1100885|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
1100886|NCT02545946|vessel loop|vessel loop
1100887|NCT02545946|emergency department|emergency department
1100888|NCT02545946|pediatrics|pediatrics
1100889|NCT02545933|prasugrel|prasugrel
1100890|NCT02545933|ticagrelor|ticagrelor
1100891|NCT02545933|vorapaxar|vorapaxar
1100892|NCT02545920|haemodialysis|haemodialysis
1100893|NCT02545920|hypotension|hypotension
1100894|NCT02545907|Amyloidosis|amyloidosis
1100895|NCT02545907|AL Amyloidosis|al amyloidosis
1100896|NCT02545855|myAIRVO2|myairvo2
1100897|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
1100898|NCT02545855|home oxygen therapy|home oxygen therapy
1100899|NCT02545855|HOT|hot
1100900|NCT02545790|coarctation of aorta|coarctation of aorta
1100901|NCT02545790|aortic stenosis|aortic stenosis
1100902|NCT02545790|biomarkers|biomarkers
1100903|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
1100904|NCT02545777|Acute gouty arthritis|acute gouty arthritis
1100905|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
1100906|NCT02545777|soaking|soaking
1100907|NCT02545777|wet wrapping|wet wrapping
1100908|NCT02545764|Gait Analysis|gait analysis
1100909|NCT02545764|Knee Adduction Moment|knee adduction moment
1100910|NCT02545764|Physiotherapy|physiotherapy
1100911|NCT02545764|Obesity|obesity
1100912|NCT02545751|Esophageal cancer|esophageal cancer
1100913|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
1100914|NCT02545751|Radiotherapy|radiotherapy
1100915|NCT02545751|Thymalfasin|thymalfasin
1100916|NCT02545751|ZADAXIN's®|zadaxin's®
1100917|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1100918|NCT02545725|Colorectal Cancer|colorectal cancer
1100919|NCT02545725|Quality of life|quality of life
1100920|NCT02545725|Questionnaires|questionnaires
1100921|NCT02545712|Ethanol|ethanol
1100922|NCT02545712|Propylene glycol|propylene glycol
1100923|NCT02545712|Benzyl alcohol|benzyl alcohol
1100924|NCT02545712|Acesulfam potassium|acesulfam potassium
1100925|NCT02545712|Aspartame|aspartame
1100926|NCT02545712|Glycerin|glycerin
1100927|NCT02545712|Sorbitol|sorbitol
1100928|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
1100929|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
1100930|NCT02545712|Patients|patients
1100931|NCT02545699|Adenoma|adenoma
1100932|NCT02545699|Polyp|polyp
1100933|NCT02545699|CRC|crc
1100934|NCT02545699|Colonoscopy|colonoscopy
1100935|NCT02545699|Detection Yield|detection yield
1100936|NCT02545673|Intervention Studies|intervention studies
1100937|NCT02545673|Access to Health Care|access to health care
1100938|NCT02545673|Social Stigma|social stigma
1100939|NCT02545673|Social Support|social support
1100940|NCT02545634|probiotic|probiotic
1100941|NCT02545634|ADHD|adhd
1100942|NCT02545634|anxiety|anxiety
1100943|NCT02545634|digestive health|digestive health
1100944|NCT02545634|children|children
1100945|NCT02545634|attention deficit|attention deficit
1100946|NCT02545634|gut brain axis|gut brain axis
1100947|NCT02545634|nutritional supplement|nutritional supplement
1100948|NCT02545634|microbiome|microbiome
1100949|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
1100950|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1100951|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
1100952|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
1100953|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
1100954|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
1100955|NCT02545621|Inflammasome|inflammasome
1100956|NCT02545595|General anaesthesia|general anaesthesia
1100957|NCT02545595|Curarization with rocuronium|curarization with rocuronium
1100958|NCT02545556|Liver Cancer|liver cancer
1100959|NCT02545556|HepaSphere|hepasphere
1100960|NCT02545556|cryosurgery|cryosurgery
1100961|NCT02545530|renal dialysis|renal dialysis
1100962|NCT02545530|hypertension|hypertension
1100963|NCT02545530|clonidine|clonidine
1100964|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
1100965|NCT02545504|Stomach cancer|stomach cancer
1100966|NCT02545491|CCD|ccd
1100967|NCT02545491|Child development|child development
1100968|NCT02545491|daycare|daycare
1100969|NCT02545491|caregiver|caregiver
1100970|NCT02545478|septic shock|septic shock
1100971|NCT02545478|infection|infection
1100972|NCT02545478|inflammation|inflammation
1100973|NCT02545478|pathologic process|pathologic process
1100974|NCT02545478|biomarkers|biomarkers
1100975|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1100976|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
1100977|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
1100978|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
1100979|NCT02545465|Switch of therapy|switch of therapy
1100980|NCT02545465|Titration phase|titration phase
1100981|NCT02545465|Retrospective chart review|retrospective chart review
1100982|NCT02545439|Alkermes|alkermes
1100983|NCT02545439|Samidorphan|samidorphan
1100984|NCT02545439|ALKS 5461|alks 5461
1100985|NCT02545439|Healthy Volunteer|healthy volunteer
1100986|NCT02545439|Pharmacokinetics|pharmacokinetics
1100987|NCT02545426|myocardial stunning|myocardial stunning
1100988|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
1100989|NCT02545426|nutritional status|nutritional status
1100990|NCT02545426|hemodinamic|hemodinamic
1100991|NCT02545426|hemodialysis|hemodialysis
1100992|NCT02545374|chronic wound|chronic wound
1100993|NCT02545374|tablet|tablet
1100994|NCT02545374|telemedicine|telemedicine
1100995|NCT02545374|wounds consultation|wounds consultation
1100996|NCT02545374|Smartphone|smartphone
1100997|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
1100998|NCT02545296|paediatrics|paediatrics
1100999|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
1101000|NCT02545270|surgical rating scale|surgical rating scale
1101001|NCT02545257|Aged people|aged people
1101002|NCT02545257|Home care|home care
1101003|NCT02545257|Drug related problems, DRPs|drug related problems, drps
1101004|NCT02545257|Coordinated medication management model|coordinated medication management model
1101135|NCT02544373|MS|ms
1101800|NCT02540187|haemophilia|haemophilia
1101005|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
1101006|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
1101007|NCT02545205|Rehabilitation|rehabilitation
1101008|NCT02545205|Robotics|robotics
1101009|NCT02545192|PTSD|ptsd
1101010|NCT02545166|Stroke|stroke
1101011|NCT02545166|Purines|purines
1101012|NCT02545166|SMARTChip|smartchip
1101013|NCT02545166|Ischaemia|ischaemia
1101014|NCT02545166|Carotid endarterectomy|carotid endarterectomy
1101015|NCT02545166|Biosensor|biosensor
1101016|NCT02545140|risk factors|risk factors
1101017|NCT02545140|screening|screening
1101018|NCT02545140|adolescents|adolescents
1101019|NCT02545127|inadequate milk production|inadequate milk production
1101020|NCT02545114|Hyponatremia|hyponatremia
1101021|NCT02545114|SIADH, stroke|siadh, stroke
1101022|NCT02545114|SAH; ICH|sah; ich
1101023|NCT02545114|AIS|ais
1101024|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
1101025|NCT02545101|tolvaptan|tolvaptan
1101026|NCT02545088|Rehabilitation|rehabilitation
1101027|NCT02545088|Robotics|robotics
1101028|NCT02545049|Type 2 Diabetes|type 2 diabetes
1101029|NCT02545049|Kidney diseases|kidney diseases
1101030|NCT02545036|chronic kidney disease|chronic kidney disease
1101031|NCT02545036|Daycare|daycare
1101032|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
1101033|NCT02544984|prophylactic macrolides|prophylactic macrolides
1101034|NCT02544984|RSV|rsv
1101035|NCT02544984|chronic lung disease|chronic lung disease
1101036|NCT02544984|respiratory infections|respiratory infections
1101037|NCT02544958|Enlarged pores|enlarged pores
1101038|NCT02544958|Er:YAG laser|er:yag laser
1101039|NCT02544945|Radiotherapy|radiotherapy
1101040|NCT02544932|anticoagulant|anticoagulant
1101041|NCT02544932|atherosclerosis|atherosclerosis
1101042|NCT02544932|endothelium|endothelium
1101043|NCT02544919|SMOF|smof
1150126|NCT02263716|Sepsis|sepsis
1101044|NCT02544919|neurological complications|neurological complications
1101045|NCT02544919|neurotoxicity|neurotoxicity
1101046|NCT02544919|liver transplantation|liver transplantation
1101047|NCT02544919|Lipid emulsions|lipid emulsions
1101048|NCT02544906|recipients|recipients
1101049|NCT02544880|HNSCC|hnscc
1101050|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1101051|NCT02544880|Tadalafil|tadalafil
1101052|NCT02544880|PDE5 Inhibition|pde5 inhibition
1101053|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
1101054|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
1101055|NCT02544880|Recurrent HNSCC|recurrent hnscc
1101056|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
1101057|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
1101058|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
1101059|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
1101060|NCT02544828|Osteoarthritis|osteoarthritis
1101061|NCT02544828|knee arthroplasty|knee arthroplasty
1101062|NCT02544828|iron|iron
1101063|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
1101064|NCT02544776|pco|pco
1101065|NCT02544776|Amlodipine|amlodipine
1101066|NCT02544737|Esophageal cancer|esophageal cancer
1101067|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
1101068|NCT02544737|Apatinib|apatinib
1101069|NCT02544724|Relapsed|relapsed
1101070|NCT02544724|Refractory|refractory
1101071|NCT02544724|DLBCL|dlbcl
1101072|NCT02544724|Chemotherapy|chemotherapy
1101073|NCT02544711|Pelvis|pelvis
1101074|NCT02544711|Surgical resection|surgical resection
1101075|NCT02544711|Patient specific instrument|patient specific instrument
1101076|NCT02544698|vaccine|vaccine
1101077|NCT02544698|safety|safety
1101078|NCT02544685|Febrile neutropenia|febrile neutropenia
1101079|NCT02544685|Synbiotic|synbiotic
1101080|NCT02544685|Probiotic|probiotic
1101081|NCT02544685|Prebiotic|prebiotic
1101082|NCT02544685|Safety|safety
1101083|NCT02544685|Cancer|cancer
1101084|NCT02544685|Oncology|oncology
1101085|NCT02544685|Chemotherapy|chemotherapy
1101086|NCT02544685|Symbiotic|symbiotic
1101087|NCT02544659|Treatment|treatment
1101088|NCT02544659|Bisphosphonates|bisphosphonates
1101089|NCT02544659|Response rate|response rate
1101090|NCT02544646|trabeculectomy|trabeculectomy
1101091|NCT02544633|Mirati|mirati
1101092|NCT02544633|MGCD265|mgcd265
1101093|NCT02544633|MET|met
1101094|NCT02544633|NSCLC|nsclc
1101095|NCT02544607|Ketamine|ketamine
1101096|NCT02544607|Depression|depression
1101097|NCT02544607|Anxious Depression|anxious depression
1101098|NCT02544607|MRI|mri
1101099|NCT02544568|high fat|high fat
1101100|NCT02544568|high protein|high protein
1101101|NCT02544568|high carbohydrate|high carbohydrate
1101102|NCT02544568|insulin|insulin
1101103|NCT02544568|glucose|glucose
1101104|NCT02544555|Peripheral arterial disease|peripheral arterial disease
1101105|NCT02544555|Atherosclerosis|atherosclerosis
1101106|NCT02544555|Intraluminal approach|intraluminal approach
1101107|NCT02544555|Subintimal approach|subintimal approach
1101108|NCT02544542|Mild Hypothermia|mild hypothermia
1101113|NCT02544490|MicroRNAs|micrornas
1101114|NCT02544490|Diagnosis|diagnosis
1101115|NCT02544490|Prognosis|prognosis
1101116|NCT02544464|osteoarthritis|osteoarthritis
1101117|NCT02544464|knee arthroplasty|knee arthroplasty
1101118|NCT02544464|iron|iron
1101119|NCT02544412|Mindfulness|mindfulness
1101120|NCT02544412|School Teachers|school teachers
1101121|NCT02544412|preservice teachers|preservice teachers
1101122|NCT02544412|teacher education|teacher education
1101123|NCT02544399|Bone microarchitecture|bone microarchitecture
1101124|NCT02544399|Playing golf|playing golf
1101125|NCT02544399|Walkers|walkers
1101126|NCT02544386|bone microarchitecture|bone microarchitecture
1101127|NCT02544386|hemiplegia|hemiplegia
1101128|NCT02544373|OSA|osa
1101129|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
1101130|NCT02544373|Cognition|cognition
1101131|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
1101132|NCT02544373|Memory|memory
1101133|NCT02544373|Positive Aiway Pressure|positive aiway pressure
1101134|NCT02544373|CPAP|cpap
1101136|NCT02544360|photoaging mobile apps|photoaging mobile apps
1101137|NCT02544360|adolescent smoking|adolescent smoking
1101138|NCT02544360|tobacco prevention|tobacco prevention
1101139|NCT02544360|school-based prevention|school-based prevention
1101140|NCT02544360|adolescent health|adolescent health
1101141|NCT02544360|school health|school health
1101142|NCT02544360|smoking|smoking
1101143|NCT02544360|tobacco|tobacco
1101144|NCT02544347|vaspin|vaspin
1101145|NCT02544347|omentin|omentin
1101146|NCT02544347|diabetes mellitus|diabetes mellitus
1101147|NCT02544347|chronic periodontitis|chronic periodontitis
1101148|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
1101149|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
1101150|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
1101151|NCT02544334|Metagenome|metagenome
1101152|NCT02544334|microbiome|microbiome
1101153|NCT02544308|Solitary, Bone|solitary, bone
1101154|NCT02544282|Analgesics|analgesics
1101155|NCT02544282|Opioid|opioid
1101156|NCT02544282|Mastectomy|mastectomy
1101157|NCT02544282|Segmental Mastectomy|segmental mastectomy
1101158|NCT02544282|Pecs II|pecs ii
1101159|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
1101160|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
1101161|NCT02544269|Hemodynamics|hemodynamics
1101162|NCT02544256|Microcirculation|microcirculation
1101163|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
1101164|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
1101165|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
1101166|NCT02544256|Vasospasms|vasospasms
1101167|NCT02544230|granulocyte transfusions|granulocyte transfusions
1101168|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
1101169|NCT02544191|male infertility|male infertility
1101170|NCT02544178|radiotherapy|radiotherapy
1101171|NCT02544178|neurocognitive defect|neurocognitive defect
1101172|NCT02544178|leukoencephalopathy|leukoencephalopathy
1101173|NCT02544165|smoking|smoking
1101174|NCT02544165|caffeine intake|caffeine intake
1101175|NCT02544165|haemodynamic parameters|haemodynamic parameters
1101176|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
1101177|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
1101178|NCT02544087|fire-heat syndrome|fire-heat syndrome
1101179|NCT02544087|blood stasis syndrome|blood stasis syndrome
1101180|NCT02544087|method of clearing heat|method of clearing heat
1102674|NCT02534077|omegaven|omegaven
1101181|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
1101187|NCT02544035|Childhood Growth and Development|childhood growth and development
1101188|NCT02544035|Development|development
1101189|NCT02544022|Pain Scale|pain scale
1101190|NCT02544022|QOL|qol
1101191|NCT02544022|Tool Validation|tool validation
1101192|NCT02544022|Cognitive Interviews|cognitive interviews
1101193|NCT02544009|Energy Expenditure|energy expenditure
1101194|NCT02544009|Obesity|obesity
1101195|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
1101196|NCT02543996|Sample Collection|sample collection
1101197|NCT02543996|Laboratory Research Specimens|laboratory research specimens
1101198|NCT02543996|Biospecimen Procurement|biospecimen procurement
1101199|NCT02543996|Rare Diseases|rare diseases
1101200|NCT02543983|Neurobiology|neurobiology
1101201|NCT02543983|Suicide|suicide
1101202|NCT02543983|Ketamine|ketamine
1101203|NCT02543983|Major Depression Disorder|major depression disorder
1101204|NCT02543983|Biomarkers|biomarkers
1101205|NCT02543957|ERCP|ercp
1101206|NCT02543957|Cholangitis|cholangitis
1101207|NCT02543957|Bacteremia|bacteremia
1101208|NCT02543957|Antibiotics|antibiotics
1101209|NCT02543931|turmeric|turmeric
1101210|NCT02543931|curcumin|curcumin
1101211|NCT02543931|curcuminoids|curcuminoids
1101212|NCT02543931|arthritis|arthritis
1101213|NCT02543931|methotrexate|methotrexate
1101214|NCT02543892|Vaccine|vaccine
1101215|NCT02543879|AML|aml
1101216|NCT02543879|BET Inhibitor|bet inhibitor
1101217|NCT02543879|FT-1101|ft-1101
1101218|NCT02543879|Acute Leukemia|acute leukemia
1101219|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
1101220|NCT02543879|NHL|nhl
1101221|NCT02543879|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1101222|NCT02543840|Quality Improvement|quality improvement
1101223|NCT02543840|Organization of Services|organization of services
1101224|NCT02543840|Implementation|implementation
1101225|NCT02543827|Vaccine|vaccine
1101226|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
1101227|NCT02543788|optic neuritis|optic neuritis
1101228|NCT02543788|vision|vision
1101229|NCT02543788|quality of life|quality of life
1101230|NCT02543788|pathophysiology|pathophysiology
1101231|NCT02543775|Cervical Cancer|cervical cancer
1101232|NCT02543775|Sentinel Lymph Node|sentinel lymph node
1101233|NCT02543775|Lymphadenectomy|lymphadenectomy
1101234|NCT02543762|Chromoendoscopy|chromoendoscopy
1101235|NCT02543762|Ulcerative Colitis|ulcerative colitis
1101236|NCT02543762|Crohn disease|crohn disease
1101237|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
1101238|NCT02543749|CML|cml
1101239|NCT02543749|DC vaccine|dc vaccine
1101240|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
1101241|NCT02543684|glycemic response|glycemic response
1101242|NCT02543684|diabetes|diabetes
1101243|NCT02543684|insulinemic response|insulinemic response
1101244|NCT02543684|mixed meals|mixed meals
1101245|NCT02543684|glycemic index|glycemic index
1101246|NCT02543671|vitamin D status|vitamin d status
1101247|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
1101248|NCT02543671|cheese|cheese
1101249|NCT02543671|Randomized controlled trial|randomized controlled trial
1101250|NCT02543671|postmenopausal women|postmenopausal women
1101251|NCT02543671|enriched|enriched
1101252|NCT02543671|vitamin D3|vitamin d3
1101253|NCT02543658|Acute Pancreatitis|acute pancreatitis
1101254|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
1101255|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
1101256|NCT02543658|Curative Effect|curative effect
1101257|NCT02543658|Security|security
1101258|NCT02543658|Neostigmine|neostigmine
1101259|NCT02543632|heart failure|heart failure
1101260|NCT02543632|parachute|parachute
1101261|NCT02543632|partitioning device|partitioning device
1101262|NCT02543593|tDCS|tdcs
1101263|NCT02543580|mastectomy|mastectomy
1101264|NCT02543580|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1101265|NCT02543580|acute pain|acute pain
1101266|NCT02543580|chronic pain|chronic pain
1101267|NCT02543567|Ebola viruses|ebola viruses
1101268|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
1101269|NCT02543567|Filoviruses|filoviruses
1101270|NCT02543567|Monovalent vaccine|monovalent vaccine
1101271|NCT02543567|Safety|safety
1101272|NCT02543567|Immunogenicity|immunogenicity
1101273|NCT02543567|Ebola vaccine|ebola vaccine
1101274|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1101275|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
1101276|NCT02543567|Healthy participants|healthy participants
1101277|NCT02543541|Palliative Care|palliative care
1101278|NCT02543541|Supportive Care|supportive care
1101279|NCT02543541|Caregiver|caregiver
1101280|NCT02543541|Phase I|phase i
1101281|NCT02543515|following hysteroscopy|following hysteroscopy
1101282|NCT02543502|Periodontitis|periodontitis
1101283|NCT02543502|atherosclerosis|atherosclerosis
1101284|NCT02543502|Heart Disease|heart disease
1101285|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
1101286|NCT02543450|Chronic stroke|chronic stroke
1101287|NCT02543450|Participation|participation
1101288|NCT02543450|Walking ability|walking ability
1101289|NCT02543385|S Ketamine|s ketamine
1101290|NCT02543385|Morphine|morphine
1101291|NCT02543385|Consumption|consumption
1101292|NCT02543372|concerned significant other|concerned significant other
1101293|NCT02543372|problem gambling|problem gambling
1101294|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
1101295|NCT02543372|behavioral couples therapy|behavioral couples therapy
1101296|NCT02543359|Training|training
1101297|NCT02543359|Implementation|implementation
1101298|NCT02543359|Community-Based Mental Health Services|community-based mental health services
1101299|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
1101300|NCT02543359|Children|children
1101301|NCT02543333|Acute Asthma,|acute asthma,
1101302|NCT02543320|Head and Neck Cancer|head and neck cancer
1101303|NCT02543320|LORETA|loreta
1101304|NCT02543320|Low Resolution Electromagnetic Tomography|low resolution electromagnetic tomography
1101305|NCT02543320|Pain|pain
1101306|NCT02543320|Radiotherapy|radiotherapy
1101307|NCT02543320|Electroencephalograph|electroencephalograph
1101308|NCT02543320|EEG|eeg
1101309|NCT02543320|Questionnaires|questionnaires
1101310|NCT02543320|Surveys|surveys
1101311|NCT02543320|Neurofeedback training|neurofeedback training
1101312|NCT02543307|Hip Replacement|hip replacement
1101313|NCT02543307|Spinal Diseases|spinal diseases
1101314|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
1101315|NCT02543307|Nursing|nursing
1101316|NCT02543307|Nurse-led|nurse-led
1101317|NCT02543307|Pathways|pathways
1101318|NCT02543307|Patient Satisfaction|patient satisfaction
1101319|NCT02543307|Quality of Nursing Care|quality of nursing care
1101320|NCT02543294|Heart Failure|heart failure
1101321|NCT02543294|Echocardiogram|echocardiogram
1101322|NCT02543294|ECHO|echo
1101323|NCT02543294|Electrocardiogram|electrocardiogram
1101324|NCT02543294|ECG|ecg
1101325|NCT02543294|Questionnaire|questionnaire
1101326|NCT02543294|Survey|survey
1101327|NCT02543294|Telephone Follow-Up|telephone follow-up
1101328|NCT02543294|HF|hf
1101329|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
1101330|NCT02543294|CILVD|cilvd
1101331|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
1101332|NCT02543294|LVEF|lvef
1101333|NCT02543268|Ebola viruses|ebola viruses
1101334|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
1101335|NCT02543268|Filoviruses|filoviruses
1101336|NCT02543268|Monovalent vaccine|monovalent vaccine
1101337|NCT02543268|Safety|safety
1101338|NCT02543268|Immunogenicity|immunogenicity
1101339|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1101340|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
1101341|NCT02543268|Healthy participants|healthy participants
1101342|NCT02543255|High risk|high risk
1101343|NCT02543242|Urinary Incontinence|urinary incontinence
1101344|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
1101345|NCT02543242|Urge Incontinence|urge incontinence
1101346|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
1101347|NCT02543242|Female Pelvic Health|female pelvic health
1101348|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
1101349|NCT02543203|Relaxation|relaxation
1101350|NCT02543190|Care Transition|care transition
1101351|NCT02543190|Readmission|readmission
1101352|NCT02543190|Rehospitalization|rehospitalization
1101353|NCT02543177|NSTEMI, CKD|nstemi, ckd
1101354|NCT02543164|Glycemic Index|glycemic index
1101355|NCT02543164|glycemic response|glycemic response
1101356|NCT02543151|Biliary stricture|biliary stricture
1101357|NCT02543151|Cholangioscopy|cholangioscopy
1101358|NCT02543151|Spyglass|spyglass
1101359|NCT02543151|Liver transplant|liver transplant
1101360|NCT02543125|very low birth weight|very low birth weight
1101361|NCT02543125|respiratory distress|respiratory distress
1101362|NCT02543125|NHFOV|nhfov
1101363|NCT02543125|NIPPV|nippv
1101364|NCT02543099|endothelial function|endothelial function
1101365|NCT02543099|policosanol|policosanol
1101366|NCT02543099|efficacy|efficacy
1101367|NCT02543099|safety|safety
1101368|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
1101369|NCT02543021|Colitis|colitis
1101370|NCT02543021|Dysplasia|dysplasia
1101371|NCT02543021|Chromoendoscopy|chromoendoscopy
1101372|NCT02543008|Asymptomatic individuals|asymptomatic individuals
1101373|NCT02542982|tDCS|tdcs
1101374|NCT02542982|motor recovery|motor recovery
1101375|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
1101376|NCT02542956|Breast Surgery|breast surgery
1101377|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
1101378|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
1101379|NCT02542930|Radiotherapy|radiotherapy
1101380|NCT02542930|Thymalfasin|thymalfasin
1101381|NCT02542930|ZADAXIN's®|zadaxin's®
1101382|NCT02542891|e-health|e-health
1101383|NCT02542891|depressive disorder|depressive disorder
1101384|NCT02542891|cost-effectiveness|cost-effectiveness
1101385|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
1101386|NCT02542878|myofascial release|myofascial release
1101387|NCT02542878|back extensors endurance|back extensors endurance
1101388|NCT02542878|foam roller|foam roller
1101389|NCT02542878|sport|sport
1101390|NCT02542852|HIV-1|hiv-1
1101391|NCT02542839|Botulinum Toxin|botulinum toxin
1101392|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1101393|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
1101394|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
1101395|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
1101396|NCT02542826|Dyspnea|dyspnea
1101397|NCT02542813|Pharmacokinetics|pharmacokinetics
1101398|NCT02542813|safety|safety
1101399|NCT02542813|tolerability|tolerability
1101400|NCT02542813|oxytocin|oxytocin
1101401|NCT02542787|MS|ms
1101402|NCT02542787|Spasticity|spasticity
1101403|NCT02542787|VSN16R|vsn16r
1101404|NCT02542774|Diabetes mellitus|diabetes mellitus
1101405|NCT02542774|Stroke|stroke
1101406|NCT02542774|Myocardial infarction|myocardial infarction
1101407|NCT02542774|Stable angina pectoris|stable angina pectoris
1101408|NCT02542774|Heart failure|heart failure
1101409|NCT02542774|Quality of care|quality of care
1101410|NCT02542748|norepinephrine|norepinephrine
1101411|NCT02542748|ephedrine|ephedrine
1101412|NCT02542722|lifestyle modification|lifestyle modification
1101413|NCT02542722|olive oil|olive oil
1101414|NCT02542722|Mediterranean diet|mediterranean diet
1101415|NCT02542683|congenital heart diseases|congenital heart diseases
1101416|NCT02542683|cognition|cognition
1101417|NCT02542683|adaptive behavior|adaptive behavior
1101418|NCT02542683|physical activity|physical activity
1101419|NCT02542683|neurodevelopment|neurodevelopment
1101420|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
1101421|NCT02542618|Depression|depression
1101422|NCT02542618|Treatment|treatment
1101423|NCT02542618|IBSR|ibsr
1101424|NCT02542618|CBT|cbt
1101425|NCT02542605|Migraine|migraine
1101426|NCT02542605|Headache|headache
1101427|NCT02542605|Migraine Headache|migraine headache
1101428|NCT02542605|Headache, Migraine|headache, migraine
1101429|NCT02542605|Amgen|amgen
1101430|NCT02542592|Glucocorticoids|glucocorticoids
1101431|NCT02542592|Immune Signaling|immune signaling
1101432|NCT02542592|Recovery|recovery
1101433|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
1101434|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
1101435|NCT02542540|physical exercise training|physical exercise training
1101436|NCT02542540|Wii|wii
1101437|NCT02542540|muscular strength|muscular strength
1101438|NCT02542514|PCNSL|pcnsl
1101439|NCT02542514|IOL|iol
1101440|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
1101441|NCT02542462|rotavirus vaccine|rotavirus vaccine
1101442|NCT02542449|Green tea|green tea
1101443|NCT02542449|weight maintenance|weight maintenance
1101444|NCT02542449|obesity|obesity
1101445|NCT02542449|fat mass|fat mass
1101446|NCT02542384|abdominal surgery|abdominal surgery
1101447|NCT02542384|laparoscopy|laparoscopy
1101448|NCT02542384|Hysterectomy|hysterectomy
1101449|NCT02542384|Prostatectomy|prostatectomy
1101450|NCT02542384|Hemi-colectomy|hemi-colectomy
1101451|NCT02542384|Ventral Hernia repair|ventral hernia repair
1101452|NCT02542384|CR845|cr845
1101453|NCT02542384|analgesic|analgesic
1101454|NCT02542384|kappa opioid|kappa opioid
1101455|NCT02542384|partial bowel resection|partial bowel resection
1101456|NCT02542371|HIV|hiv
1101457|NCT02542371|Atherosclerosis|atherosclerosis
1101458|NCT02542371|Tilmanocept|tilmanocept
1101459|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
1101460|NCT02542345|MRI coronarography|mri coronarography
1101461|NCT02542332|lung cancer screening|lung cancer screening
1101462|NCT02542332|statistical background|statistical background
1101463|NCT02542306|Blood loss|blood loss
1101464|NCT02542306|coagulopathy|coagulopathy
1101465|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
1101466|NCT02542306|transfusion|transfusion
1101467|NCT02542293|NSCLC|nsclc
1101468|NCT02542293|PDL1|pdl1
1101469|NCT02542293|MEDI4736|medi4736
1101470|NCT02542293|Durvalumab|durvalumab
1101471|NCT02542293|Tremelimumab|tremelimumab
1101472|NCT02542293|OS|os
1101473|NCT02542267|Bare Metal Stent|bare metal stent
1101474|NCT02542267|In-Stent Restenosis|in-stent restenosis
1101475|NCT02542241|Open abdomen|open abdomen
1101476|NCT02542241|hypertonic saline solution|hypertonic saline solution
1101477|NCT02542241|intensive care|intensive care
1101478|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
1101479|NCT02542228|Quality of Life survey|quality of life survey
1101480|NCT02542176|Metabolic Syndrome|metabolic syndrome
1101481|NCT02542176|Grape|grape
1101482|NCT02542176|HDL|hdl
1101483|NCT02542176|Lipoproteins|lipoproteins
1101484|NCT02542137|Small cell lung cancer|small cell lung cancer
1101485|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
1101486|NCT02542137|ZADAXIN|zadaxin
1101487|NCT02542137|radiotherapy|radiotherapy
1101488|NCT02542137|Thymalfasin|thymalfasin
1101489|NCT02542124|CTCL|ctcl
1101490|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
1101491|NCT02542124|Mycosis fungoides|mycosis fungoides
1101492|NCT02542124|Sézary syndrome|sézary syndrome
1101493|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
1101494|NCT02542124|T Cell|t cell
1101495|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1101496|NCT02542085|incisional hernia|incisional hernia
1101497|NCT02542085|laparoscopic repair|laparoscopic repair
1101498|NCT02542085|hybrid repair|hybrid repair
1101499|NCT02542085|seroma|seroma
1101500|NCT02542085|recurrent hernia|recurrent hernia
1101501|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
1101502|NCT02542007|intracoronary stent|intracoronary stent
1101503|NCT02542007|drug eluting stent|drug eluting stent
1101504|NCT02542007|sirolimus|sirolimus
1101505|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
1101506|NCT02541981|Heart transplant|heart transplant
1101507|NCT02541981|renal insufficiency|renal insufficiency
1101508|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1101509|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
1101510|NCT02541929|Alzheimer's disease|alzheimer's disease
1101511|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
1101512|NCT02541929|brain health|brain health
1101513|NCT02541929|memory|memory
1101514|NCT02541929|fish oil|fish oil
1101515|NCT02541929|cognition|cognition
1101516|NCT02541929|DHA|dha
1101517|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
1101518|NCT02541929|brain|brain
1101519|NCT02541916|Transplantation Tolerance|transplantation tolerance
1101520|NCT02541916|Immune Tolerance|immune tolerance
1101521|NCT02541916|Transplantation|transplantation
1101522|NCT02541916|Liver Transplantation|liver transplantation
1101523|NCT02541916|Biological Markers|biological markers
1101524|NCT02541916|Gene Expression|gene expression
1101525|NCT02541916|Immunosuppression|immunosuppression
1101526|NCT02541916|Immunology|immunology
1101527|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
1101528|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
1101529|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
1101530|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1101531|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
1101532|NCT02541903|Gilotrif|gilotrif
1101533|NCT02541890|Rehabilitation|rehabilitation
1101534|NCT02541890|Return to Work|return to work
1101535|NCT02541864|Helicobacter pylori|helicobacter pylori
1101536|NCT02541864|Hybrid therapy|hybrid therapy
1101537|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
1101538|NCT02541864|Eradication|eradication
1101539|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
1101540|NCT02541838|diabetes|diabetes
1101541|NCT02541838|balance control|balance control
1101542|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
1101543|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1101544|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1101545|NCT02541812|Error processing|error processing
1101546|NCT02541799|informed consent|informed consent
1101547|NCT02541799|telemedicine|telemedicine
1101548|NCT02541799|research methods|research methods
1101549|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
1101550|NCT02541786|rabeprazole|rabeprazole
1101551|NCT02541786|Helicobacter pylori|helicobacter pylori
1101552|NCT02541786|triple therapy|triple therapy
1101553|NCT02541773|Chronic Heart Failure|chronic heart failure
1101554|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1101555|NCT02541773|Vascular Biomarker|vascular biomarker
1101556|NCT02541773|miRNA|mirna
1101557|NCT02541773|Extracellular Matrix|extracellular matrix
1101558|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
1101559|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
1101560|NCT02541773|Body Composition|body composition
1101561|NCT02541734|SPECT|spect
1101562|NCT02541734|radiopeptides|radiopeptides
1101563|NCT02541734|gelofusine|gelofusine
1101564|NCT02541734|Beta cell|beta cell
1101565|NCT02541695|Experimental challenge trial|experimental challenge trial
1101566|NCT02541669|Drug therapy|drug therapy
1101567|NCT02541656|Preload dependence indices|preload dependence indices
1101568|NCT02541656|pulse pressure variation|pulse pressure variation
1101569|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
1101570|NCT02541656|stroke volume variation|stroke volume variation
1101571|NCT02541656|laparoscopy|laparoscopy
1101572|NCT02541656|pneumoperitoneum|pneumoperitoneum
1101573|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1101574|NCT02541630|Mindfulness|mindfulness
1101575|NCT02541591|post cardiac arrest|post cardiac arrest
1101576|NCT02541591|hemodynamics|hemodynamics
1101577|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
1101578|NCT02541552|Knee arthroscopy|knee arthroscopy
1101579|NCT02541552|Quadriceps weakness|quadriceps weakness
1101580|NCT02541552|ropivacaine|ropivacaine
1101581|NCT02541552|saphenous nerve block|saphenous nerve block
1101582|NCT02541552|Adductor canal|adductor canal
1101583|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
1101584|NCT02541526|mirtazepine|mirtazepine
1101585|NCT02541513|paliparidone|paliparidone
1101586|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
1101587|NCT02541500|minocycline|minocycline
1101588|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
1101589|NCT02541474|Controlled trial|controlled trial
1101590|NCT02541474|Matched|matched
1101591|NCT02541474|Before-After design|before-after design
1101592|NCT02541474|Prospective|prospective
1101593|NCT02541474|complex interventions|complex interventions
1101594|NCT02541461|Procedure: Laparoscopic gastrectomy with Billroth I|procedure: laparoscopic gastrectomy with billroth i
1101595|NCT02541461|Procedure: Laparoscopic gastrectomy with Roux-en-Y|procedure: laparoscopic gastrectomy with roux-en-y
1101596|NCT02541461|Other: Body composition measurement|other: body composition measurement
1101597|NCT02541461|Other: Lipid profile|other: lipid profile
1101598|NCT02541435|Radiotherapy|radiotherapy
1101599|NCT02541435|Biological markers|biological markers
1101600|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
1101601|NCT02541435|Echocardiography|echocardiography
1101602|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
1101603|NCT02541435|Risk factors|risk factors
1101604|NCT02541435|Heart|heart
1101605|NCT02541435|Quality of Life|quality of life
1101606|NCT02541409|directly observed therapy|directly observed therapy
1101607|NCT02541409|sofosbuvir|sofosbuvir
1101608|NCT02541409|ribavirin|ribavirin
1101609|NCT02541409|pegylated interferon|pegylated interferon
1101610|NCT02541409|resource-limited setting|resource-limited setting
1101611|NCT02541396|Bunion|bunion
1101612|NCT02541396|Bunionectomy|bunionectomy
1101613|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
1101614|NCT02541383|daratumumab|daratumumab
1101615|NCT02541357|Colorectal Surgery|colorectal surgery
1101616|NCT02541331|IgE-dependent asthma|ige-dependent asthma
1101617|NCT02541318|peri-menopausal women|peri-menopausal women
1101618|NCT02541318|sleep disturbances|sleep disturbances
1101619|NCT02541318|Dao-in exercise|dao-in exercise
1101620|NCT02541318|body constitution|body constitution
1101621|NCT02541305|falls prevention|falls prevention
1101622|NCT02541305|proprioception|proprioception
1101623|NCT02541305|physical condition|physical condition
1101624|NCT02541266|Imaging|imaging
1101625|NCT02541266|Questionnaire|questionnaire
1101626|NCT02541240|resilience|resilience
1101627|NCT02541240|optimism|optimism
1101628|NCT02541240|stress|stress
1101629|NCT02541240|coping|coping
1101630|NCT02541240|curriculum|curriculum
1101631|NCT02541201|Plant sterols|plant sterols
1101632|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
1101633|NCT02541201|Phytosterols|phytosterols
1101634|NCT02541188|Breast cancer|breast cancer
1101635|NCT02541175|Electrocardiography|electrocardiography
1101636|NCT02541175|Automation|automation
1101637|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
1101638|NCT02541175|Atrial Fibrillation|atrial fibrillation
1101639|NCT02541175|Atrial Flutter|atrial flutter
1101640|NCT02541175|Atrial Premature Complexes|atrial premature complexes
1101641|NCT02541175|Esophagus|esophagus
1101642|NCT02541136|exercise|exercise
1101643|NCT02541136|resilience|resilience
1101644|NCT02541136|physiotherapy|physiotherapy
1101645|NCT02541136|fMRI|fmri
1101646|NCT02541123|Traumatic Brain Injury|traumatic brain injury
1101647|NCT02541123|Head Injury|head injury
1101648|NCT02541084|Age-related macular degeneration|age-related macular degeneration
1101649|NCT02541084|Caregiver burden|caregiver burden
1101650|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
1101651|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
1101652|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
1101653|NCT02541058|Conotruncal Defects|conotruncal defects
1101654|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
1101655|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
1101656|NCT02541058|deletion|deletion
1101657|NCT02541058|duplication|duplication
1101658|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1101659|NCT02541045|metadoxine|metadoxine
1101660|NCT02541045|efficacy|efficacy
1101661|NCT02541045|therapy|therapy
1101662|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
1101663|NCT02541006|FEV1|fev1
1101665|NCT02541006|AUC 0-24|auc 0-24
1101666|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
1101667|NCT02541006|tiotropium|tiotropium
1101668|NCT02540993|Type 2 Diabetes|type 2 diabetes
1101669|NCT02540993|Kidney diseases|kidney diseases
1101670|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
1101671|NCT02540967|Brain and spine|brain and spine
1101672|NCT02540967|Body and extremities|body and extremities
1101673|NCT02540967|Gadobutrol|gadobutrol
1101674|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1101675|NCT02540954|Eylea treatment|eylea treatment
1101676|NCT02540954|Treat and Extend|treat and extend
1101677|NCT02540954|Intravitreal|intravitreal
1101678|NCT02540902|Knee replacement|knee replacement
1101679|NCT02540902|Knee arthroplasty|knee arthroplasty
1101680|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
1101681|NCT02540902|Bone density|bone density
1101682|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
1101683|NCT02540863|exercise therapy|exercise therapy
1101684|NCT02540863|randomized controlled trial|randomized controlled trial
1101685|NCT02540850|septin 9|septin 9
1101686|NCT02540850|SEPT9|sept9
1101687|NCT02540850|colorectal cancer|colorectal cancer
1101688|NCT02540850|CRC|crc
1101689|NCT02540850|screening|screening
1101690|NCT02540850|methylation|methylation
1101691|NCT02540850|adenoma|adenoma
1101692|NCT02540850|polyps|polyps
1101693|NCT02540850|FIT|fit
1101694|NCT02540850|FOBT|fobt
1101695|NCT02540850|colonoscopy|colonoscopy
1101696|NCT02540824|Apatinib|apatinib
1101697|NCT02540824|RET|ret
1101698|NCT02540824|gene fusion|gene fusion
1101699|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
1101700|NCT02540798|Anxiety|anxiety
1101701|NCT02540798|Urodynamics|urodynamics
1101702|NCT02540798|Symptom reproducibility|symptom reproducibility
1101703|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
1101704|NCT02540798|Women|women
1101705|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
1101706|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
1101707|NCT02540785|lenticule extraction|lenticule extraction
1101708|NCT02540785|inflammatory mediators|inflammatory mediators
1101709|NCT02540772|Confabulations|confabulations
1101710|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
1101711|NCT02540772|Memory|memory
1101712|NCT02540759|Buglossoides arvensis|buglossoides arvensis
1101713|NCT02540759|vegetable oil|vegetable oil
1101714|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
1101715|NCT02540759|participants|participants
1101716|NCT02540746|Emotional Dysregulation|emotional dysregulation
1101717|NCT02540746|Early Intervention|early intervention
1101718|NCT02540746|Youth Mental Health|youth mental health
1101719|NCT02540746|Staging|staging
1101720|NCT02540746|Motivational Enhancement|motivational enhancement
1101721|NCT02540746|Family Connections|family connections
1101722|NCT02540746|Family Skills Training|family skills training
1101723|NCT02540733|cerebral infarction|cerebral infarction
1101724|NCT02540733|diabetes|diabetes
1101725|NCT02540733|rehabilitation|rehabilitation
1101726|NCT02540733|MRI|mri
1101727|NCT02540681|Transtibial amputation|transtibial amputation
1101728|NCT02540681|Prosthetic fit|prosthetic fit
1101729|NCT02540681|Prosthetic alignment|prosthetic alignment
1101730|NCT02540655|Stem Cells|stem cells
1101731|NCT02540655|Adult Stem Cells|adult stem cells
1101732|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
1101733|NCT02540655|Steminent|steminent
1101734|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1101735|NCT02540629|Emergency Medicine|emergency medicine
1101736|NCT02540616|MdDS|mdds
1101737|NCT02540616|TES|tes
1101738|NCT02540616|TMS|tms
1101739|NCT02540590|microcirculation|microcirculation
1101740|NCT02540590|wound healing|wound healing
1101741|NCT02540590|tunnel technique|tunnel technique
1101742|NCT02540590|gingival recession|gingival recession
1101743|NCT02540590|Mucograft|mucograft
1101744|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
1101745|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
1101746|NCT02540538|Interleukin-2|interleukin-2
1101747|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
1101748|NCT02540538|Non-responders|non-responders
1101749|NCT02540525|stress incontinence|stress incontinence
1101750|NCT02540525|transobturator sling|transobturator sling
1101751|NCT02540525|single-incision mini-sling|single-incision mini-sling
1101752|NCT02540499|lung cancer|lung cancer
1101753|NCT02540499|breath hold|breath hold
1101754|NCT02540499|radiotherapy|radiotherapy
1101755|NCT02540486|Type 2 diabetes|type 2 diabetes
1101756|NCT02540486|T2DM|t2dm
1101757|NCT02540473|Resilience|resilience
1101758|NCT02540447|Liver transplantation|liver transplantation
1101759|NCT02540447|Graft rinse|graft rinse
1101760|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
1101761|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
1101762|NCT02540434|ROTEM|rotem
1101763|NCT02540434|Cardiac Surgery|cardiac surgery
1101764|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
1101765|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1101766|NCT02540421|human papillomavirus|human papillomavirus
1101767|NCT02540421|conization|conization
1101768|NCT02540408|Occupational COPD|occupational copd
1101769|NCT02540408|Pathophysiology|pathophysiology
1101770|NCT02540408|Exercise limitation|exercise limitation
1101771|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
1101772|NCT02540408|Arterial stiffness|arterial stiffness
1101773|NCT02540395|Kidney transplantation|kidney transplantation
1101774|NCT02540395|Immunosuppression|immunosuppression
1101777|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
1101778|NCT02540382|Portasystemic Shunt|portasystemic shunt
1101779|NCT02540369|Diabetic macular edema|diabetic macular edema
1101780|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
1101781|NCT02540343|Translation|translation
1101782|NCT02540343|Validation|validation
1101783|NCT02540343|Orebro-G|orebro-g
1101784|NCT02540291|E7046|e7046
1101785|NCT02540291|Advanced malignancies|advanced malignancies
1101786|NCT02540291|malignancies|malignancies
1101787|NCT02540265|Bunion|bunion
1101788|NCT02540265|Bunionectomy|bunionectomy
1101789|NCT02540265|Pain|pain
1101790|NCT02540265|Analgesia|analgesia
1101791|NCT02540265|N1539|n1539
1101792|NCT02540252|Lower Limb Amputation|lower limb amputation
1101793|NCT02540252|Nutrition|nutrition
1101794|NCT02540252|Eating|eating
1101795|NCT02540252|Inflammation|inflammation
1101796|NCT02540252|Nursing|nursing
1101797|NCT02540226|Tranexamic Acid|tranexamic acid
1101798|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
1101799|NCT02540226|Total Knee Replacement|total knee replacement
1101801|NCT02540187|TFPI|tfpi
1101802|NCT02540187|thrombin generation|thrombin generation
1101803|NCT02540187|hemorrhagic score|hemorrhagic score
1101804|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
1101805|NCT02540174|addiction treatment|addiction treatment
1101806|NCT02540161|Sym004|sym004
1101807|NCT02540161|Glioblastoma|glioblastoma
1101808|NCT02540161|Desjardins|desjardins
1101809|NCT02540161|Pro00063483|pro00063483
1101810|NCT02540161|Symphogen|symphogen
1101811|NCT02540161|Duke Cancer Institute|duke cancer institute
1101812|NCT02540135|high grade glioma|high grade glioma
1101813|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
1101814|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
1101815|NCT02540135|flourescein|flourescein
1101816|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
1101817|NCT02540135|intraoperative MRI|intraoperative mri
1101818|NCT02540135|iMRI|imri
1101819|NCT02540109|Stroke|stroke
1101820|NCT02540109|Anomia|anomia
1101821|NCT02540096|mental practice|mental practice
1101822|NCT02540096|motor imagery|motor imagery
1101823|NCT02540096|hemiparesis|hemiparesis
1101824|NCT02540096|stroke|stroke
1101825|NCT02540096|gait|gait
1101826|NCT02540096|mobility|mobility
1101827|NCT02540070|Adductor canal Block|adductor canal block
1101828|NCT02540070|ultrasound|ultrasound
1101829|NCT02540070|periarticular injections|periarticular injections
1101830|NCT02540070|Dexmedetomidine|dexmedetomidine
1101831|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
1101832|NCT02539979|IV Paracetamol|iv paracetamol
1568534|NCT00505505|Postoperative Morbidity|postoperative morbidity
1101833|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
1101834|NCT02539979|Preventative Pain Management|preventative pain management
1101835|NCT02539940|Below-the-knee|below-the-knee
1101836|NCT02539914|Virtual reality|virtual reality
1101837|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
1101838|NCT02539914|Positive emotion stimuli|positive emotion stimuli
1101839|NCT02539901|cochlear implant|cochlear implant
1101840|NCT02539901|Developmental Psychology|developmental psychology
1101841|NCT02539901|cognitive development|cognitive development
1101842|NCT02539901|communicative development|communicative development
1101843|NCT02539901|perceptual development|perceptual development
1101844|NCT02539901|deaf child|deaf child
1101845|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
1101846|NCT02539862|Insomnia|insomnia
1101847|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
1101848|NCT02539836|children's obesity|children's obesity
1101849|NCT02539836|gut microbiome|gut microbiome
1101850|NCT02539836|body mass index|body mass index
1101851|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
1101852|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
1101853|NCT02539784|stimulation|stimulation
1101854|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
1101855|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
1101856|NCT02539771|priapism|priapism
1101857|NCT02539758|acute angle closure|acute angle closure
1101858|NCT02539758|ocular massage|ocular massage
1101859|NCT02539745|vitamin D|vitamin d
1101860|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
1101861|NCT02539732|Weaning|weaning
1101862|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
1101863|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
1101864|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
1101865|NCT02539719|Platinum-Resistant|platinum-resistant
1101866|NCT02539719|Refractory|refractory
1101867|NCT02539680|Phosphate transporter|phosphate transporter
1101869|NCT02539680|duodenal biopsies|duodenal biopsies
1101870|NCT02539602|High school|high school
1101871|NCT02539602|Longitudnal|longitudnal
1101872|NCT02539602|Sexual initiation|sexual initiation
1101873|NCT02539602|Contraception|contraception
1101874|NCT02539602|Adolescents|adolescents
1101875|NCT02539602|Pregnancy prevention|pregnancy prevention
1101876|NCT02539602|Sexual health|sexual health
1101877|NCT02539576|pharmacokinetics|pharmacokinetics
1101878|NCT02539576|Healthy subjects|healthy subjects
1101879|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
1101880|NCT02539576|Japanese|japanese
1101881|NCT02539576|Fixed-dose combination|fixed-dose combination
1101882|NCT02539576|safety|safety
1101883|NCT02539563|labor duration|labor duration
1101884|NCT02539550|PF-06266047|pf-06266047
1101885|NCT02539550|safety|safety
1101886|NCT02539550|tolerability|tolerability
1101887|NCT02539550|pharmacokinetics|pharmacokinetics
1101888|NCT02539550|first-in-human|first-in-human
1101889|NCT02539550|healthy volunteers|healthy volunteers
1101890|NCT02539550|PDE4|pde4
1101891|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
1101892|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
1101893|NCT02539537|FOLFIRINOX|folfirinox
1101894|NCT02539524|clinical impact|clinical impact
1101895|NCT02539524|anxiety|anxiety
1101896|NCT02539524|quality of life|quality of life
1101898|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
1101899|NCT02539498|Parathyroid Hormone|parathyroid hormone
1101900|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
1101901|NCT02539498|Bone densitometry|bone densitometry
1101902|NCT02539498|Bone microarchitecture|bone microarchitecture
1101903|NCT02539446|Aging|aging
1101904|NCT02539446|External focus|external focus
1101905|NCT02539446|Internal focus|internal focus
1101906|NCT02539446|Attention|attention
1101907|NCT02539446|Posture balance|posture balance
1101908|NCT02539446|Parkinson's disease|parkinson's disease
1101909|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
1101910|NCT02539407|Children|children
1101911|NCT02539407|Anti-infectives|anti-infectives
1101912|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
1101913|NCT02539407|Fluoroquinolone|fluoroquinolone
1101914|NCT02539407|Fungal|fungal
1101915|NCT02539407|Antiviral|antiviral
1101916|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
1101917|NCT02539394|Dysphagia|dysphagia
1101918|NCT02539394|ACDF|acdf
1101919|NCT02539368|Infliximab|infliximab
1101920|NCT02539368|Observational|observational
1101921|NCT02539368|Follow-up|follow-up
1101922|NCT02539368|Safety|safety
1101923|NCT02539368|Effectiveness|effectiveness
1101924|NCT02539355|Insulin resistance|insulin resistance
1101925|NCT02539355|Diabetes|diabetes
1101926|NCT02539355|Cancer|cancer
1101927|NCT02539355|Obesity|obesity
1101928|NCT02539355|Inflammation|inflammation
1101929|NCT02539342|Oral Mucositis|oral mucositis
1101930|NCT02539342|Cancer|cancer
1101931|NCT02539342|Chemotherapy|chemotherapy
1101932|NCT02539329|neuropathy|neuropathy
1101933|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
1101934|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
1101935|NCT02539316|Parenteral Nutrition|parenteral nutrition
1101936|NCT02539290|Unexplained infertility|unexplained infertility
1101937|NCT02539290|Infertility|infertility
1101938|NCT02539290|Tubal flushing|tubal flushing
1101939|NCT02539290|Uterine flushing|uterine flushing
1101940|NCT02539290|Live birth|live birth
1101941|NCT02539290|Pregnancy|pregnancy
1101942|NCT02539290|Randomized controlled trial|randomized controlled trial
1101943|NCT02539290|Saline|saline
1101944|NCT02539290|Physiological saline|physiological saline
1101945|NCT02539264|All patients registered for A PSG|all patients registered for a psg
1101946|NCT02539264|polysomnography|polysomnography
1101947|NCT02539251|Early Child Development|early child development
1101948|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
1101949|NCT02539251|Validation|validation
1101950|NCT02539238|Medical Education|medical education
1101951|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1101952|NCT02539238|feedback|feedback
1101953|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
1101954|NCT02539212|microwave|microwave
1101955|NCT02539212|radiofrequency|radiofrequency
1101956|NCT02539212|ablation|ablation
1101957|NCT02539160|coronary artery disease|coronary artery disease
1101958|NCT02539160|diabetes mellitus|diabetes mellitus
1101959|NCT02539160|chronic kidney disease|chronic kidney disease
1101960|NCT02539160|ticagrelor|ticagrelor
1101961|NCT02539147|lipopolysaccharide|lipopolysaccharide
1101962|NCT02539147|sepsis|sepsis
1101963|NCT02539147|caspase-4 and -5|caspase-4 and -5
1101964|NCT02539147|monocytes|monocytes
1101965|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
1101966|NCT02539134|Drug therapy|drug therapy
1101967|NCT02539121|Labor|labor
1101968|NCT02539121|Acupuncture|acupuncture
1101969|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
1101970|NCT02539121|Placental expulsion time|placental expulsion time
1101971|NCT02539121|Postpartum blood loss|postpartum blood loss
1101972|NCT02539108|Influenza|influenza
1101973|NCT02539108|Influenza virus vaccine|influenza virus vaccine
1102081|NCT02538432|Disease Progression|disease progression
1101974|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
1101975|NCT02539095|intra-articular injection|intra-articular injection
1101976|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
1101977|NCT02539095|collagen|collagen
1101978|NCT02539095|knee joint pain|knee joint pain
1101979|NCT02539082|collagen|collagen
1101980|NCT02539082|collagen injection|collagen injection
1101981|NCT02539082|plantar fasciitis|plantar fasciitis
1101982|NCT02539069|cartilage defects|cartilage defects
1101983|NCT02539069|Chondron|chondron
1101984|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
1101985|NCT02539069|arthroscopy|arthroscopy
1101986|NCT02539056|cartilage defects|cartilage defects
1101987|NCT02539056|Chondron|chondron
1101988|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
1101989|NCT02539043|Lipolysis|lipolysis
1101990|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
1101991|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
1101992|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
1101993|NCT02539043|Waist Circumference|waist circumference
1101999|NCT02539030|microfracture|microfracture
1102000|NCT02539030|modified microfracture|modified microfracture
1102001|NCT02539030|collagen|collagen
1102002|NCT02539017|cellular immune therapy|cellular immune therapy
1102003|NCT02539017|triple negative breast cancer|triple negative breast cancer
1102004|NCT02539017|adjuvant therapy|adjuvant therapy
1102005|NCT02539004|kidney stones|kidney stones
1102006|NCT02539004|ureteral stones|ureteral stones
1102007|NCT02538991|Bulkamid|bulkamid
1102008|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
1102009|NCT02538991|Women|women
1102017|NCT02538952|GeneXpert|genexpert
1102018|NCT02538952|Tuberculosis|tuberculosis
1102019|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
1102020|NCT02538952|Diagnostic accuracy|diagnostic accuracy
1102021|NCT02538952|Impact|impact
1102022|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
1102023|NCT02538913|Exercise|exercise
1102024|NCT02538913|Pelvic floor|pelvic floor
1102025|NCT02538913|Prehabilitation|prehabilitation
1102026|NCT02538913|Fecal incontinence|fecal incontinence
1102027|NCT02538913|Urinary incontinence|urinary incontinence
1102028|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
1102029|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
1102030|NCT02538822|aortic aneurysm|aortic aneurysm
1102031|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
1102032|NCT02538822|ATA|ata
1102033|NCT02538822|dynamic imaging|dynamic imaging
1102034|NCT02538822|mechanical testing|mechanical testing
1102035|NCT02538796|Anorexia Nervosa|anorexia nervosa
1102036|NCT02538796|Cognition|cognition
1102037|NCT02538796|Conscious|conscious
1102038|NCT02538796|Non-Conscious|non-conscious
1102039|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
1102040|NCT02538705|Ulcers|ulcers
1102041|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
1102042|NCT02538679|tap block|tap block
1102043|NCT02538679|regional anesthesia|regional anesthesia
1102044|NCT02538679|colorectal surgery|colorectal surgery
1102045|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
1102046|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
1102047|NCT02538627|Heregulin-positive|heregulin-positive
1102048|NCT02538627|EGFR|egfr
1102049|NCT02538627|ErbB3|erbb3
1102050|NCT02538627|Phase I|phase i
1102051|NCT02538627|Oncology|oncology
1102052|NCT02538627|Cancer|cancer
1102053|NCT02538627|IGF-1|igf-1
1102054|NCT02538627|MEKinhibitor|mekinhibitor
1102055|NCT02538627|IGF-1R inhibitor|igf-1r inhibitor
1102056|NCT02538627|KRAS|kras
1102057|NCT02538627|NRAS|nras
1102058|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
1102059|NCT02538601|PTSD|ptsd
1102060|NCT02538601|Cigarette Smoking|cigarette smoking
1102061|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
1102062|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
1102063|NCT02538601|CBT|cbt
1102064|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
1102065|NCT02538601|World Trade Center|world trade center
1102066|NCT02538588|Healthy Volunteers|healthy volunteers
1102067|NCT02538575|Cystic Fibrosis|cystic fibrosis
1102068|NCT02538575|Adults|adults
1102069|NCT02538575|6-minute walk test|6-minute walk test
1102070|NCT02538497|NBO|nbo
1102071|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
1102072|NCT02538497|postpartum depression|postpartum depression
1102073|NCT02538497|postnatal depression|postnatal depression
1102074|NCT02538497|child development|child development
1102075|NCT02538497|parent-child interaction|parent-child interaction
1102076|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
1102077|NCT02538458|Infant|infant
1102078|NCT02538445|Schizophrenia|schizophrenia
1102079|NCT02538445|Memory|memory
1102082|NCT02538432|Non-Responsive Disease|non-responsive disease
1102083|NCT02538432|Advanced Disease|advanced disease
1102084|NCT02538406|Adenoma|adenoma
1102085|NCT02538406|withdrawal time|withdrawal time
1102086|NCT02538406|Colonoscopy|colonoscopy
1102087|NCT02538380|Lung cancer|lung cancer
1102088|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
1102089|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
1102090|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
1102091|NCT02538328|laparoscopy|laparoscopy
1102092|NCT02538328|obesity|obesity
1102093|NCT02538328|harmonic scalpel|harmonic scalpel
1102094|NCT02538328|ligasure|ligasure
1102095|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
1102096|NCT02538302|Minirin|minirin
1102097|NCT02538302|Oxybutynin|oxybutynin
1102098|NCT02538302|Nocturnal enuresis|nocturnal enuresis
1102099|NCT02538289|Dyspnea|dyspnea
1102100|NCT02538289|Palliative Care|palliative care
1102101|NCT02538289|Heart Failure|heart failure
1102102|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
1102103|NCT02538289|Opioids|opioids
1102104|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
1102105|NCT02538250|Oral nutritional supplement|oral nutritional supplement
1102106|NCT02538250|supplementation|supplementation
1102107|NCT02538250|adult patients|adult patients
1102108|NCT02538224|Periodontitis|periodontitis
1102109|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
1102110|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
1102111|NCT02538198|maintenance|maintenance
1102112|NCT02538198|15-129|15-129
1102113|NCT02538172|Cell-mediated immunity|cell-mediated immunity
1102114|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
1102115|NCT02538172|Transplantation|transplantation
1102116|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
1102117|NCT02538159|Bacteraemia|bacteraemia
1102118|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
1102119|NCT02538146|pain|pain
1102120|NCT02538146|depression|depression
1102121|NCT02538146|cytokines|cytokines
1102122|NCT02538146|well-being|well-being
1102123|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
1102124|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
1102125|NCT02538133|diagnosis|diagnosis
1102126|NCT02538094|Cognitive Enhancement|cognitive enhancement
1102127|NCT02538094|tDCS|tdcs
1102128|NCT02538094|stimulation|stimulation
1102130|NCT02538094|Multiple Sclerosis|multiple sclerosis
1102131|NCT02538094|Encephalitis|encephalitis
1102132|NCT02538081|schizophrenia|schizophrenia
1102133|NCT02538081|olanzapine|olanzapine
1102134|NCT02538081|risperidone|risperidone
1102135|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
1102136|NCT02538081|cognition|cognition
1102137|NCT02538068|Purpose in Life|purpose in life
1102138|NCT02538068|Self-determination|self-determination
1102139|NCT02538068|Physical activity|physical activity
1102140|NCT02538068|Self-monitoring|self-monitoring
1102141|NCT02538068|Behavior change|behavior change
1102142|NCT02538055|Community Health Workers|community health workers
1102143|NCT02538055|Diabetes Mellitus|diabetes mellitus
1102144|NCT02538055|Chronic Pain|chronic pain
1102145|NCT02538029|Dual tasking|dual tasking
1102146|NCT02538016|Cystinuria|cystinuria
1102147|NCT02538016|Kidney Stones|kidney stones
1102148|NCT02537964|chlorhexidine|chlorhexidine
1102149|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
1102150|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
1102151|NCT02537925|radiosensitivity|radiosensitivity
1102152|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1102153|NCT02537912|peanut skin|peanut skin
1102154|NCT02537912|body fat|body fat
1102155|NCT02537912|blood glucose|blood glucose
1102156|NCT02537912|waistline|waistline
1102157|NCT02537912|body weight|body weight
1102158|NCT02537886|PCOR|pcor
1102159|NCT02537873|Cocaine Use Disorder|cocaine use disorder
1102160|NCT02537847|Sitafloxacin|sitafloxacin
1102161|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
1102162|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
1102163|NCT02537847|Ertapenem|ertapenem
1102164|NCT02537795|Deep Brain Stimulation|deep brain stimulation
1102165|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
1102166|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1102167|NCT02537782|Heart Failure|heart failure
1102168|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
1102169|NCT02537782|Echocardiography|echocardiography
1102170|NCT02537782|Apical rocking|apical rocking
1102171|NCT02537782|Septal flash|septal flash
1102172|NCT02537769|LVAD|lvad
1102173|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
1102174|NCT02537769|Heart failure|heart failure
1102175|NCT02537769|Transplant|transplant
1102176|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
1102277|NCT02537106|Brain Tumors|brain tumors
1102177|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
1102178|NCT02537769|Mild|mild
1102179|NCT02537769|Moderate|moderate
1102180|NCT02537743|Patient Reported Outcomes|patient reported outcomes
1102181|NCT02537704|Obesity|obesity
1102182|NCT02537704|Translational|translational
1102183|NCT02537704|Diabetes Prevention Program|diabetes prevention program
1102184|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
1102185|NCT02537652|Central blood pressure|central blood pressure
1102684|NCT02534051|pregnancy|pregnancy
1102186|NCT02537652|Transient ischaemic attack|transient ischaemic attack
1102187|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
1102188|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1102189|NCT02537600|BRAF mutation|braf mutation
1102190|NCT02537600|Brain metastasis|brain metastasis
1102191|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
1102192|NCT02537587|Blood glucose|blood glucose
1102193|NCT02537587|Blood insulin|blood insulin
1102194|NCT02537587|Humans|humans
1102195|NCT02537587|Postprandial|postprandial
1102196|NCT02537587|Carbohydrate|carbohydrate
1102197|NCT02537587|Protein|protein
1102198|NCT02537587|Resistant starch|resistant starch
1102199|NCT02537587|Sugar|sugar
1102200|NCT02537574|Alkermes|alkermes
1102201|NCT02537574|Buprenorphine|buprenorphine
1102202|NCT02537574|Naltrexone|naltrexone
1102203|NCT02537574|Vivitrol|vivitrol
1102204|NCT02537574|Opioid Use|opioid use
1102205|NCT02537574|Opiates|opiates
1102206|NCT02537574|Dependence|dependence
1102207|NCT02537574|Abuse|abuse
1102208|NCT02537574|Heroin|heroin
1102209|NCT02537574|Painkillers|painkillers
1102210|NCT02537574|Substance Abuse|substance abuse
1102211|NCT02537496|Alzheimer's Disease|alzheimer's disease
1102212|NCT02537496|Brain stimulation|brain stimulation
1102213|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1102214|NCT02537496|Neuroplasticity|neuroplasticity
1102215|NCT02537496|cognitive enhancement|cognitive enhancement
1102216|NCT02537496|TMS-EEG|tms-eeg
1102217|NCT02537496|rTMS|rtms
1102218|NCT02537496|PAS|pas
1102219|NCT02537431|KRN23|krn23
1102220|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
1102221|NCT02537431|XLH|xlh
1102222|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
1102223|NCT02537379|Hepatitis C virus|hepatitis c virus
1102224|NCT02537379|observational|observational
1102225|NCT02537379|post-marketing|post-marketing
1102226|NCT02537379|sofosbuvir|sofosbuvir
1102227|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
1102228|NCT02537353|Hemospray|hemospray
1102229|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
1102230|NCT02537340|PET/MR|pet/mr
1102231|NCT02537340|MRI|mri
1102232|NCT02537340|Rectal cancer|rectal cancer
1102233|NCT02537340|EMVI|emvi
1102234|NCT02537340|FDG|fdg
1102235|NCT02537327|Recurrent caries|recurrent caries
1102236|NCT02537327|Secondary caries|secondary caries
1102237|NCT02537327|Dental composite|dental composite
1102238|NCT02537327|Dental amalgam|dental amalgam
1102239|NCT02537314|Normal Body Weight|normal body weight
1102240|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1102241|NCT02537301|social networking|social networking
1102242|NCT02537301|group chat|group chat
1102243|NCT02537288|VA106483|va106483
1102244|NCT02537288|fedovapagon|fedovapagon
1102245|NCT02537288|males|males
1102246|NCT02537288|females|females
1102247|NCT02537288|moxifloxacin|moxifloxacin
1102248|NCT02537288|TQT|tqt
1102249|NCT02537288|QT/QTC|qt/qtc
1102250|NCT02537288|ECG|ecg
1102251|NCT02537288|Nocturia|nocturia
1102252|NCT02537262|carbohydrate|carbohydrate
1102253|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
1102254|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
1102255|NCT02537249|dexmedetomidine|dexmedetomidine
1102256|NCT02537249|quality of recovery|quality of recovery
1102257|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
1102258|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
1102259|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
1102260|NCT02537236|Cardiac Risk|cardiac risk
1102261|NCT02537236|Dyslipidemia|dyslipidemia
1102262|NCT02537171|Apatinib|apatinib
1102263|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
1102264|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
1102265|NCT02537158|sorafenib|sorafenib
1102266|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1102267|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
1102268|NCT02537158|microvascular invasion|microvascular invasion
1102269|NCT02537145|compliance|compliance
1102270|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
1102272|NCT02537145|human microbiome|human microbiome
1102273|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
1102274|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1102275|NCT02537132|adaptation|adaptation
1102276|NCT02537132|home care|home care
1102278|NCT02537106|Microcirculation|microcirculation
1102279|NCT02537106|Osmotherapy|osmotherapy
1102280|NCT02537106|Hypertonic NaCl|hypertonic nacl
1102281|NCT02537106|Natremia|natremia
1102282|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1102283|NCT02537080|Nimodipin|nimodipin
1102284|NCT02537080|Anesthesia|anesthesia
1102285|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
1102286|NCT02537067|Chondron|chondron
1102287|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
1102288|NCT02537054|Choroidal neovascularization|choroidal neovascularization
1102289|NCT02537054|Angioid streaks|angioid streaks
1102290|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
1102291|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
1102292|NCT02537054|aflibercept|aflibercept
1102293|NCT02537028|MSC2364447C|msc2364447c
1102294|NCT02537028|Phase 1|phase 1
1102295|NCT02537028|BTK inhibitor|btk inhibitor
1102296|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
1102297|NCT02537028|M2951|m2951
1102298|NCT02537028|Lupus|lupus
1102299|NCT02537002|PF-05230907|pf-05230907
1102300|NCT02537002|Pharmacokinetics|pharmacokinetics
1102301|NCT02537002|Pharmacodynamic|pharmacodynamic
1102302|NCT02537002|Immunogenicity|immunogenicity
1102303|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
1102304|NCT02536989|blood clot|blood clot
1102305|NCT02536989|dose|dose
1102306|NCT02536976|mirabegron|mirabegron
1102307|NCT02536950|bionic pancreas|bionic pancreas
1102308|NCT02536950|closed-loop control|closed-loop control
1102309|NCT02536950|artificial pancreas|artificial pancreas
1102310|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1102311|NCT02536885|Blood pressure|blood pressure
1102312|NCT02536885|Anesthesia|anesthesia
1102313|NCT02536872|infection overactive bladder|infection overactive bladder
1102314|NCT02536846|Healthy volunteers|healthy volunteers
1102315|NCT02536846|antipsychotic drugs|antipsychotic drugs
1102316|NCT02536846|brain metabolism|brain metabolism
1102317|NCT02536833|OA|oa
1102318|NCT02536833|Samumed|samumed
1102319|NCT02536781|Anthocyanin|anthocyanin
1102320|NCT02536781|Inflammation|inflammation
1102321|NCT02536781|Orthodontic treatment|orthodontic treatment
1102322|NCT02536768|Medication adherence|medication adherence
1102324|NCT02536768|Counseling|counseling
1102325|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
1102326|NCT02536742|Breast Cancer|breast cancer
1102327|NCT02536742|Metastatic|metastatic
1102328|NCT02536742|HER2 negative|her2 negative
1102329|NCT02536742|Palbociclib|palbociclib
1102330|NCT02536716|Dental Implant|dental implant
1102331|NCT02536690|propofol|propofol
1102332|NCT02536690|midazolam|midazolam
1102333|NCT02536690|remifentanil|remifentanil
1102334|NCT02536690|combination|combination
1102335|NCT02536690|synergic|synergic
1102336|NCT02536690|pharmacodynamics|pharmacodynamics
1102337|NCT02536690|Loss of consciousness|loss of consciousness
1102338|NCT02536677|Acute Chest Pain|acute chest pain
1102339|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
1102340|NCT02536677|Evaluation and Management|evaluation and management
1102341|NCT02536677|Decision Aid|decision aid
1102342|NCT02536677|Healthcare Utilization|healthcare utilization
1102343|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
1102344|NCT02536638|urine protein|urine protein
1102345|NCT02536638|pregnancy|pregnancy
1102346|NCT02536638|pyelonephritis|pyelonephritis
1102347|NCT02536638|kidney infection|kidney infection
1102348|NCT02536625|everolimus|everolimus
1102349|NCT02536625|NK|nk
1102350|NCT02536625|metastatic|metastatic
1102351|NCT02536612|Motivation|motivation
1102352|NCT02536612|Behavioral Economics|behavioral economics
1102353|NCT02536612|Conditional Economic Incentives|conditional economic incentives
1102354|NCT02536612|Conditional cash transfers|conditional cash transfers
1102355|NCT02536612|Contingency management|contingency management
1102356|NCT02536599|Febrile Neutropenia|febrile neutropenia
1102357|NCT02536599|Childhood Cancer|childhood cancer
1102358|NCT02536599|Pediatric Oncology|pediatric oncology
1102359|NCT02536599|Fever|fever
1102360|NCT02536599|Neutropenia|neutropenia
1102361|NCT02536573|Total hip replacement|total hip replacement
1102362|NCT02536560|intestinal microbiota|intestinal microbiota
1102363|NCT02536560|antibiotics|antibiotics
1102364|NCT02536560|infant|infant
1102365|NCT02536560|allergy|allergy
1102366|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
1102367|NCT02536547|sepsis|sepsis
1102368|NCT02536547|lung ultrasound|lung ultrasound
1102369|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
1102370|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1102371|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1102372|NCT02536456|screening|screening
1102373|NCT02536456|counseling|counseling
1102374|NCT02536456|follow-up|follow-up
1102375|NCT02536456|cardiovascular disease|cardiovascular disease
1102376|NCT02536456|population-based project|population-based project
1102377|NCT02536456|China|china
1102378|NCT02536443|heart failure|heart failure
1102379|NCT02536443|prognosis|prognosis
1102380|NCT02536443|clinical characteristics|clinical characteristics
1102381|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
1102382|NCT02536430|Ketorolac|ketorolac
1102383|NCT02536430|Success rate|success rate
1102384|NCT02536417|Melatonin|melatonin
1102385|NCT02536417|Delirium prevention|delirium prevention
1102386|NCT02536417|End-of-life|end-of-life
1103396|NCT02530307|fMRI|fmri
1102387|NCT02536352|Fluoride Supplementation|fluoride supplementation
1102388|NCT02536352|Prenatal Vitamin|prenatal vitamin
1102389|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
1102390|NCT02536352|Prenatal Nutrition|prenatal nutrition
1102391|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
1102392|NCT02536287|total parathyroidectomy|total parathyroidectomy
1102393|NCT02536287|autotransplantation|autotransplantation
1102394|NCT02536287|morbidity|morbidity
1102395|NCT02536287|recurrence|recurrence
1102396|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
1102397|NCT02536261|Prolactinoma|prolactinoma
1102398|NCT02536261|dopamine agonist|dopamine agonist
1102399|NCT02536261|withdrawal|withdrawal
1102400|NCT02536261|cavernous sinus|cavernous sinus
1102401|NCT02536248|sitagliptin|sitagliptin
1102402|NCT02536248|diabetes|diabetes
1102403|NCT02536248|inflammation|inflammation
1102404|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
1102405|NCT02536183|Solid tumors|solid tumors
1102406|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
1102407|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
1102408|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
1102409|NCT02536183|ThermoDox|thermodox
1102410|NCT02536183|relapsed sarcoma|relapsed sarcoma
1102411|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
1102412|NCT02536183|Osteosarcoma|osteosarcoma
1102413|NCT02536183|Neuroblastoma|neuroblastoma
1102414|NCT02536183|Wilms Tumor|wilms tumor
1102415|NCT02536183|Hepatic Tumor|hepatic tumor
1102416|NCT02536183|Germ Cell Tumors|germ cell tumors
1102417|NCT02536170|Arginine Therapy|arginine therapy
1102418|NCT02536157|Volar plate|volar plate
1102419|NCT02536144|colon capsule|colon capsule
1102420|NCT02536144|magnetic|magnetic
1102421|NCT02536144|maneuverability|maneuverability
1102422|NCT02536144|colonoscopy|colonoscopy
1102423|NCT02536131|Psychosomatics|psychosomatics
1102424|NCT02536131|Gastroenterology|gastroenterology
1102425|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
1102426|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1102427|NCT02536105|ADHD|adhd
1102428|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
1102429|NCT02536040|silver diamine fluoride|silver diamine fluoride
1102430|NCT02536040|diammine silver fluoride|diammine silver fluoride
1102431|NCT02536040|children|children
1102432|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
1102433|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
1102434|NCT02536027|sepsis|sepsis
1102435|NCT02536027|acute kidney injury|acute kidney injury
1102436|NCT02536014|Dexmedetomidine|dexmedetomidine
1102437|NCT02536014|pneumoperitoneum|pneumoperitoneum
1102438|NCT02536014|trendelenburg position|trendelenburg position
1102439|NCT02536014|QTc interval|qtc interval
1102440|NCT02536014|Tp-e interval|tp-e interval
1102441|NCT02536014|robotic prostatectomy|robotic prostatectomy
1102442|NCT02536001|Vaginal mesh|vaginal mesh
1102443|NCT02536001|Total vaginal length|total vaginal length
1102444|NCT02536001|Quality of life|quality of life
1102445|NCT02535988|Colorectal Cancer|colorectal cancer
1102446|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
1102447|NCT02535988|ZADAXIN|zadaxin
1102448|NCT02535988|Abscopal Effect|abscopal effect
1102449|NCT02535988|Radiotherapy|radiotherapy
1102450|NCT02535962|PFAPA|pfapa
1102451|NCT02535936|Cerebral Palsy|cerebral palsy
1102452|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
1102453|NCT02535923|Mental Disorders|mental disorders
1102454|NCT02535923|Insomnia Disorder|insomnia disorder
1102455|NCT02535910|vitamin D3|vitamin d3
1102456|NCT02535910|25(OH)D3|25(oh)d3
1102457|NCT02535910|vitamin D status|vitamin d status
1102458|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
1102459|NCT02535884|Huntington Disease|huntington disease
1102460|NCT02535884|DBS|dbs
1102461|NCT02535884|Chorea|chorea
1102462|NCT02535858|Anxiety|anxiety
1102463|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
1102464|NCT02535819|Cataract surgery|cataract surgery
1102465|NCT02535806|Relapsed, Refractory|relapsed, refractory
1102466|NCT02535767|Primaquine|primaquine
1102467|NCT02535741|Knee Replacement|knee replacement
1102468|NCT02535741|Arthroplasty|arthroplasty
1102469|NCT02535728|Frail Elderly|frail elderly
1102470|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
1102471|NCT02535728|Risk Assessment|risk assessment
1102472|NCT02535728|Quality of Life|quality of life
1102473|NCT02535715|Oral Insulin|oral insulin
1102474|NCT02535702|fMRI|fmri
1102475|NCT02535702|EEG|eeg
1102476|NCT02535689|Anti-DNA Antibody|anti-dna antibody
1102477|NCT02535689|Tofacitinib|tofacitinib
1102478|NCT02535689|Lupus|lupus
1102479|NCT02535689|Safety|safety
1102480|NCT02535676|schizophrenia|schizophrenia
1102481|NCT02535676|transcranial stimulation|transcranial stimulation
1102482|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
1103500|NCT02529813|Autologous|autologous
1102483|NCT02535663|Natural killer cell activity|natural killer cell activity
1102484|NCT02535663|interleukin-12|interleukin-12
1102485|NCT02535663|interferon-gamma|interferon-gamma
1102486|NCT02535663|immune function|immune function
1102487|NCT02535663|inflammatory|inflammatory
1102488|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
1102489|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1102490|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
1102491|NCT02535546|Pneumonia|pneumonia
1102492|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
1102493|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
1102494|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
1102495|NCT02535533|Kidney cancer|kidney cancer
1102496|NCT02535533|Selenium (Se)|selenium (se)
1102497|NCT02535507|pyrotinib|pyrotinib
1102498|NCT02535507|HER2|her2
1102499|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
1102500|NCT02535507|Phase II|phase ii
1102501|NCT02535481|epidermal graft|epidermal graft
1102502|NCT02535481|suction blister|suction blister
1102503|NCT02535481|blister graft|blister graft
1102504|NCT02535481|suction graft|suction graft
1102505|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
1102506|NCT02535390|cognitive remediation|cognitive remediation
1102507|NCT02535390|vocational outcomes|vocational outcomes
1102508|NCT02535377|Cryodamage|cryodamage
1102509|NCT02535377|microarrays|microarrays
1102510|NCT02535377|Insemination|insemination
1102511|NCT02535377|sperm|sperm
1151986|NCT02252900|MRI|mri
1102512|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1102513|NCT02535364|ALL|all
1102514|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
1102515|NCT02535364|CAR|car
1102516|NCT02535364|CAR T cells|car t cells
1102517|NCT02535364|JCAR015|jcar015
1102518|NCT02535364|autologous T cell therapy|autologous t cell therapy
1102519|NCT02535364|cell therapy|cell therapy
1102520|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
1102521|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
1102522|NCT02535351|First line treatment|first line treatment
1102523|NCT02535299|telomere-telomerase|telomere-telomerase
1102524|NCT02535299|Par-4|par-4
1102525|NCT02535299|GLP-1|glp-1
1102526|NCT02535299|metformin|metformin
1102527|NCT02535273|dexmedetomidine|dexmedetomidine
1102528|NCT02535273|prone position|prone position
1102529|NCT02535273|spine surgery|spine surgery
1102530|NCT02535273|Minimally invasive|minimally invasive
1102531|NCT02535273|local anesthesia|local anesthesia
1102532|NCT02535260|Pregnancy|pregnancy
1102533|NCT02535221|Premenopausal Patients|premenopausal patients
1102534|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
1102535|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
1102536|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
1102537|NCT02535065|Low Profile|low profile
1102538|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1102539|NCT02535065|Endovascular|endovascular
1102540|NCT02535039|Elderly|elderly
1102541|NCT02535039|cognitive retention disorder|cognitive retention disorder
1102542|NCT02535039|methylprednisolone|methylprednisolone
1102543|NCT02534974|Critical care|critical care
1102544|NCT02534974|Trauma patients|trauma patients
1102545|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
1102546|NCT02534961|Radiofrequency ablation|radiofrequency ablation
1102547|NCT02534961|Antibiotics|antibiotics
1102548|NCT02534948|mindfulness|mindfulness
1102549|NCT02534948|MABT|mabt
1102550|NCT02534948|social anxiety|social anxiety
1102551|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
1102552|NCT02534948|group therapy|group therapy
1102553|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
1102554|NCT02534935|Safety|safety
1102555|NCT02534935|Tolerability Study|tolerability study
1102556|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
1102557|NCT02534935|Healthy Toddlers|healthy toddlers
1102558|NCT02534935|Neisseria meningitidis|neisseria meningitidis
1102559|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
1102560|NCT02534909|PNH|pnh
1102561|NCT02534870|Volunteer|volunteer
1102562|NCT02534857|randomized double blinded study|randomized double blinded study
1102563|NCT02534857|live birth rate|live birth rate
1102564|NCT02534857|IVF treatment|ivf treatment
1102565|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
1102566|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
1102567|NCT02534844|neurologic disease|neurologic disease
1102568|NCT02534844|gross motor dysfunction|gross motor dysfunction
1102569|NCT02534844|fine motor dysfunction|fine motor dysfunction
1102570|NCT02534844|dysphagia|dysphagia
1102571|NCT02534844|swallowing problems|swallowing problems
1102572|NCT02534844|cognitive dysfunction|cognitive dysfunction
1102573|NCT02534844|gait abnormalities|gait abnormalities
1102574|NCT02534844|pediatrics|pediatrics
1102575|NCT02534727|Tuberculosis|tuberculosis
1102576|NCT02534727|Non-Tuberculous Mycobacterim|non-tuberculous mycobacterim
1102577|NCT02534727|Xpert/MDR-RIF|xpert/mdr-rif
1102578|NCT02534727|TDM|tdm
1102579|NCT02534701|stroke|stroke
1102580|NCT02534701|clot retrieval system|clot retrieval system
1102581|NCT02534701|recanalization|recanalization
1102582|NCT02534649|Molecular profiling|molecular profiling
1102583|NCT02534649|Genomic alteration|genomic alteration
1102584|NCT02534649|Advanced cancer|advanced cancer
1102585|NCT02534610|preemptive|preemptive
1102586|NCT02534610|postoperative pain|postoperative pain
1102587|NCT02534610|etoricoxib|etoricoxib
1102588|NCT02534584|acute kidney injury|acute kidney injury
1102589|NCT02534584|outcome|outcome
1102590|NCT02534584|mortality|mortality
1102591|NCT02534584|care-bundle|care-bundle
1102592|NCT02534558|MicroRNA-29|microrna-29
1102593|NCT02534558|shoulder stiffness|shoulder stiffness
1102594|NCT02534558|mir-29a|mir-29a
1102595|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
1102596|NCT02534545|ischemia|ischemia
1102597|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
1102598|NCT02534545|stroke|stroke
1102599|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
1102600|NCT02534506|Advanced malignant tumors|advanced malignant tumors
1102601|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
1102602|NCT02534480|Amyloid|amyloid
1102603|NCT02534415|Antiinflammatory|antiinflammatory
1102604|NCT02534415|Gingiva|gingiva
1102605|NCT02534415|Hyaluronic acid|hyaluronic acid
1102606|NCT02534415|Palate|palate
1102607|NCT02534415|Transplants|transplants
1102608|NCT02534415|Wound healing|wound healing
1102609|NCT02534402|Biomarkers|biomarkers
1102610|NCT02534402|Genomics|genomics
1102611|NCT02534402|Prednisone|prednisone
1102612|NCT02534389|rectal cancer|rectal cancer
1102613|NCT02534389|inflammation|inflammation
1102615|NCT02534389|fish oil|fish oil
1102616|NCT02534389|nutritional status|nutritional status
1102617|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
1102618|NCT02534363|Cognition|cognition
1102619|NCT02534363|Psychosis|psychosis
1102620|NCT02534363|Antipsychotic Agents|antipsychotic agents
1102621|NCT02534363|Treatment|treatment
1102622|NCT02534363|Effectiveness|effectiveness
1102623|NCT02534363|Aripiprazole|aripiprazole
1102624|NCT02534363|Quetiapine|quetiapine
1102625|NCT02534363|Ziprasidone|ziprasidone
1102626|NCT02534363|Neurocognition|neurocognition
1102627|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1102628|NCT02534350|Antiviral|antiviral
1102629|NCT02534350|Lung Transplant|lung transplant
1102630|NCT02534324|Hypertension|hypertension
1102631|NCT02534324|Emergency|emergency
1102632|NCT02534298|single sided deafness.|single sided deafness.
1102633|NCT02534298|Auditory plasticity|auditory plasticity
1102634|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
1102635|NCT02534298|Cochlear implants|cochlear implants
1102636|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
1102637|NCT02534298|Lateralization index|lateralization index
1102638|NCT02534298|Dichotic hearing|dichotic hearing
1102639|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
1102640|NCT02534285|Hearing|hearing
1102641|NCT02534285|Noise, Occupational|noise, occupational
1102642|NCT02534246|Core tissue biopsy|core tissue biopsy
1102643|NCT02534246|Core needle biopsy|core needle biopsy
1102644|NCT02534246|EUS|eus
1102645|NCT02534246|Fine needle biopsy|fine needle biopsy
1102646|NCT02534246|Fine needle aspiration|fine needle aspiration
1102647|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
1102648|NCT02534233|early esophageal cancer|early esophageal cancer
1102649|NCT02534220|Toothbrushing|toothbrushing
1102650|NCT02534220|Oral hygiene|oral hygiene
1102651|NCT02534220|Dental hygiene|dental hygiene
1102652|NCT02534194|Gestation|gestation
1102653|NCT02534194|Premature|premature
1102654|NCT02534194|Infants|infants
1102655|NCT02534181|Refeeding Syndrome|refeeding syndrome
1102656|NCT02534181|Cancer|cancer
1102657|NCT02534168|genetic polymorphisms|genetic polymorphisms
1102658|NCT02534155|MitraClip®|mitraclip®
1102659|NCT02534155|MR|mr
1102660|NCT02534155|DMR|dmr
1102661|NCT02534155|high-risk patients|high-risk patients
1102662|NCT02534155|mitral regurgitation|mitral regurgitation
1102663|NCT02534155|surgery|surgery
1102664|NCT02534155|intermediate risk patients|intermediate risk patients
1102665|NCT02534129|breast cancer|breast cancer
1102666|NCT02534129|radiation|radiation
1102667|NCT02534129|dermatitis|dermatitis
1102668|NCT02534116|abdominal reconstruction|abdominal reconstruction
1102669|NCT02534090|Premature|premature
1102670|NCT02534090|Preterm|preterm
1102671|NCT02534090|Necrotizing|necrotizing
1102672|NCT02534090|Enterocolitis|enterocolitis
1102673|NCT02534090|NIRS|nirs
1102676|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1102677|NCT02534064|Menopause|menopause
1102678|NCT02534064|Osteoporosis|osteoporosis
1102679|NCT02534064|Hip fractures|hip fractures
1102680|NCT02534064|vitamin D deficiency|vitamin d deficiency
1102681|NCT02534051|clinical care path|clinical care path
1102682|NCT02534051|care pathway|care pathway
1102683|NCT02534051|obesity|obesity
1102685|NCT02534038|Disinhibition|disinhibition
1102686|NCT02533986|Berry|berry
1102687|NCT02533986|Inflammation|inflammation
1102688|NCT02533986|Cognition|cognition
1102689|NCT02533986|Polyphenols|polyphenols
1102690|NCT02533986|Appetite|appetite
1102691|NCT02533986|Glucose metabolism|glucose metabolism
1102692|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
1102693|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1102694|NCT02533947|Hematological Malignancies|hematological malignancies
1102695|NCT02533947|Exercise Intervention|exercise intervention
1102696|NCT02533947|Cognitive Function|cognitive function
1102697|NCT02533947|Fatigue|fatigue
1102698|NCT02533947|Randomized Controlled Trial|randomized controlled trial
1102699|NCT02533934|HIV|hiv
1102700|NCT02533934|Hepatitis C|hepatitis c
1102701|NCT02533934|Liver Disease|liver disease
1102702|NCT02533934|HCV Treatment|hcv treatment
1102703|NCT02533934|transplant|transplant
1102704|NCT02533921|Palliative Care|palliative care
1102705|NCT02533921|Parkinson's Disease|parkinson's disease
1102706|NCT02533869|low-dose computed tomography|low-dose computed tomography
1102707|NCT02533817|Fructose|fructose
1102708|NCT02533817|Insulin|insulin
1102709|NCT02533817|Postprandial lipemia|postprandial lipemia
1102710|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
1102711|NCT02533817|Ethnicity|ethnicity
1102713|NCT02533804|wellness|wellness
1102714|NCT02533804|life expectancy|life expectancy
1102715|NCT02533804|quality of life|quality of life
1102716|NCT02533804|performance|performance
1102717|NCT02533804|religion|religion
1102718|NCT02533804|skin|skin
1102719|NCT02533804|cardiovascular|cardiovascular
1102720|NCT02533804|joints|joints
1102721|NCT02533804|bone|bone
1102722|NCT02533804|respiration|respiration
1102723|NCT02533804|pain|pain
1102724|NCT02533804|nervous system diseases|nervous system diseases
1102725|NCT02533804|oral health|oral health
1102726|NCT02533804|behavior|behavior
1102727|NCT02533804|child|child
1102728|NCT02533804|depression|depression
1102729|NCT02533804|mood|mood
1102730|NCT02533804|panic|panic
1102731|NCT02533804|sleep|sleep
1102732|NCT02533804|stress|stress
1102733|NCT02533804|nutrition|nutrition
1102734|NCT02533804|exercise|exercise
1102735|NCT02533804|life change events|life change events
1102736|NCT02533804|personality|personality
1102737|NCT02533804|employment|employment
1102738|NCT02533804|social networking|social networking
1102739|NCT02533804|time management|time management
1102740|NCT02533804|residence characteristics|residence characteristics
1102741|NCT02533791|Safety|safety
1102742|NCT02533791|immunogenicity|immunogenicity
1102743|NCT02533791|Ebola vaccine|ebola vaccine
1102744|NCT02533791|boosting|boosting
1102745|NCT02533765|Cisplatin-resistant|cisplatin-resistant
1102746|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
1102747|NCT02533765|Salvage treatment|salvage treatment
1102748|NCT02533765|olaparib|olaparib
1102749|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
1102750|NCT02533752|Watchman device|watchman device
1102751|NCT02533752|LAA Closure|laa closure
1102752|NCT02533726|Bed Sores|bed sores
1102753|NCT02533726|Bedsores|bedsores
1102754|NCT02533726|Decubitus Ulcer|decubitus ulcer
1102755|NCT02533726|Pressure Sore|pressure sore
1102756|NCT02533713|rehabilitation|rehabilitation
1102757|NCT02533713|bone strength|bone strength
1102758|NCT02533713|quality of life|quality of life
1102759|NCT02533687|prostate|prostate
1102760|NCT02533687|transurethral resection|transurethral resection
1102761|NCT02533687|bipolar|bipolar
1102762|NCT02533687|monopolar|monopolar
1102763|NCT02533661|Effectiveness|effectiveness
1102764|NCT02533661|Genes|genes
1102765|NCT02533661|Intervention|intervention
1102766|NCT02533661|Neurodevelopment|neurodevelopment
1102767|NCT02533661|Prematurity|prematurity
1102768|NCT02533661|Preschool Age|preschool age
1102769|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
1102770|NCT02533648|insulin sensitivity|insulin sensitivity
1102771|NCT02533648|insulin resistance|insulin resistance
1102772|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
1102773|NCT02533648|skeletal muscle|skeletal muscle
1102774|NCT02533648|xanthine oxidase|xanthine oxidase
1102775|NCT02533648|allopurinol|allopurinol
1102776|NCT02533622|progressive mobility|progressive mobility
1102777|NCT02533583|pulse oximetry|pulse oximetry
1102778|NCT02533583|clinical assessment|clinical assessment
1102779|NCT02533583|neonate|neonate
1102780|NCT02533583|lung disease|lung disease
1102781|NCT02533570|Lupus|lupus
1102782|NCT02533557|brachial plexus block|brachial plexus block
1102783|NCT02533557|nerve stimulator|nerve stimulator
1102784|NCT02533557|ultrasound|ultrasound
1102785|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1102786|NCT02533505|Respiratory|respiratory
1102787|NCT02533505|COPD|copd
1102788|NCT02533505|O2 Consumption|o2 consumption
1102789|NCT02533492|total knee replacement|total knee replacement
1102790|NCT02533492|vicryl plus|vicryl plus
1102791|NCT02533492|surgical site infection|surgical site infection
1102792|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
1102793|NCT02533414|kidney stone|kidney stone
1102794|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
1102795|NCT02533414|ureteral access sheath|ureteral access sheath
1102796|NCT02533414|kidney function|kidney function
1102797|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1102798|NCT02533388|stress response|stress response
1102799|NCT02533375|efficacy|efficacy
1102800|NCT02533375|safety|safety
1102801|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
1102802|NCT02533349|prokinetics|prokinetics
1102803|NCT02533349|proton pump inhibitor|proton pump inhibitor
1102804|NCT02533336|Malaria control|malaria control
1102805|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
1102806|NCT02533336|Malaria incidence|malaria incidence
1102807|NCT02533336|Randomized Trial|randomized trial
1102808|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
1102809|NCT02533323|induction chemotherapy|induction chemotherapy
1102810|NCT02533323|survival|survival
1102811|NCT02533310|Specific phobia|specific phobia
1102812|NCT02533310|Exposure therapy|exposure therapy
1102813|NCT02533310|Virtual reality|virtual reality
1102814|NCT02533310|Randomized controlled trial|randomized controlled trial
1102815|NCT02533297|standardization,|standardization,
1102816|NCT02533297|performance clinical skills|performance clinical skills
1102817|NCT02533297|nursing|nursing
1102818|NCT02533297|learning curve|learning curve
1102819|NCT02533271|rectal cancer|rectal cancer
1102820|NCT02533271|short-term radiotherapy|short-term radiotherapy
1102821|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1102822|NCT02533271|total mesorectal excision|total mesorectal excision
1102823|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
1102824|NCT02533245|Exercise Training|exercise training
1102825|NCT02533245|Quality of Life|quality of life
1102826|NCT02533245|Patient Reported Outcomes|patient reported outcomes
1102827|NCT02533245|Organ Transplantation|organ transplantation
1102828|NCT02533232|Schizophrenia|schizophrenia
1102829|NCT02533232|Anti-inflammatory|anti-inflammatory
1102830|NCT02533232|Clozapine|clozapine
1102831|NCT02533232|Minocycline|minocycline
1102832|NCT02533232|Psychosis NOS|psychosis nos
1102833|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
1102834|NCT02533219|PET/CT|pet/ct
1102835|NCT02533219|PET/MRI|pet/mri
1102836|NCT02533219|[18F]-DOPA|[18f]-dopa
1102837|NCT02533219|PET/MR|pet/mr
1102838|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
1102839|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
1102840|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
1102841|NCT02533180|Liver allograft recipient|liver allograft recipient
1102842|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
1102843|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
1102844|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
1102845|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
1102846|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
1102847|NCT02533128|Triple low|triple low
1102848|NCT02533128|Anesthetic overdose|anesthetic overdose
1102849|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
1102850|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
1102851|NCT02533128|Perioperative risk stratification|perioperative risk stratification
1102852|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
1102853|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
1102854|NCT02533115|VYXEOS|vyxeos
1102855|NCT02533102|Pharmacokinetics|pharmacokinetics
1102856|NCT02533102|E7050|e7050
1102857|NCT02533102|Healthy Subjects|healthy subjects
1102858|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
1102859|NCT02533050|acute coronary event|acute coronary event
1102860|NCT02533050|cognitive functions|cognitive functions
1102861|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
1102862|NCT02533011|Sepsis|sepsis
1102863|NCT02533011|Heparin Binding Protein|heparin binding protein
1102864|NCT02532998|Pharmacodynamics|pharmacodynamics
1102865|NCT02532998|AZD9977|azd9977
1102866|NCT02532998|Safety|safety
1102867|NCT02532998|Tolerability|tolerability
1102868|NCT02532998|Pharmacokinetics|pharmacokinetics
1102869|NCT02532998|Eplerenone|eplerenone
1102870|NCT02532998|Fludrocortisone|fludrocortisone
1102871|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
1102872|NCT02532985|dietary fiber|dietary fiber
1102873|NCT02532985|clinical trial|clinical trial
1102874|NCT02532985|healthy subjects|healthy subjects
1102875|NCT02532933|Replacement, Knee|replacement, knee
1102876|NCT02532920|Natural history|natural history
1102877|NCT02532920|Atopic dermatitis|atopic dermatitis
1102878|NCT02532920|Atopic march|atopic march
1102880|NCT02532894|endothelial dysfunction|endothelial dysfunction
1102881|NCT02532894|microvesicles|microvesicles
1102882|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
1102883|NCT02532894|electronic cigarettes|electronic cigarettes
1102884|NCT02532842|Schizophrenia|schizophrenia
1102885|NCT02532842|Paliperidone palmitate|paliperidone palmitate
1102886|NCT02532816|stunting|stunting
1102887|NCT02532816|indonesia|indonesia
1102888|NCT02532803|Cancer|cancer
1102889|NCT02532803|Rectum|rectum
1102890|NCT02532803|Rectal Cancer|rectal cancer
1102891|NCT02532803|Polyps|polyps
1102892|NCT02532790|Mild proteinuria|mild proteinuria
1102893|NCT02532764|cystic fibrosis|cystic fibrosis
1102894|NCT02532764|ΔF508|δf508
1102895|NCT02532764|RNA therapies|rna therapies
1102896|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
1102897|NCT02532764|CFTR|cftr
1102898|NCT02532764|F508del|f508del
1102899|NCT02532764|CF|cf
1102900|NCT02532764|RNA therapy|rna therapy
1102901|NCT02532738|efficacy of MSC|efficacy of msc
1102902|NCT02532738|refractory|refractory
1102903|NCT02532725|heat stress response|heat stress response
1102904|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
1102906|NCT02532725|middle aged|middle aged
1102907|NCT02532725|heat-shock response|heat-shock response
1102908|NCT02532712|EC-18|ec-18
1102909|NCT02532712|Hematology|hematology
1102910|NCT02532712|Cancer|cancer
1102911|NCT02532712|Neutropenia|neutropenia
1102912|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
1102913|NCT02532699|blood pressure|blood pressure
1102914|NCT02532699|adenosine|adenosine
1102915|NCT02532699|antrosterol|antrosterol
1102916|NCT02532699|clinical trial|clinical trial
1102917|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
1102918|NCT02532686|Treatment resistant|treatment resistant
1102919|NCT02532686|DAAOI|daaoi
1102920|NCT02532686|NMDA|nmda
1102921|NCT02532634|ramosetron|ramosetron
1102922|NCT02532634|palonosetron|palonosetron
1102923|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
1102924|NCT02532582|nerve compression|nerve compression
1102925|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
1102926|NCT02532517|CODMAN ENTERPRISE® Vascular Reconstruction Device|codman enterprise® vascular reconstruction device
1102927|NCT02532517|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
1102928|NCT02532517|Cerebral Aneurysms|cerebral aneurysms
1102929|NCT02532504|postnatal depression|postnatal depression
1102930|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
1102931|NCT02532504|Traditional Birth Attendants|traditional birth attendants
1102932|NCT02532504|low income country|low income country
1102933|NCT02532491|Psychosis|psychosis
1102934|NCT02532491|Antipsychotic Agents|antipsychotic agents
1102935|NCT02532491|Treatment|treatment
1102936|NCT02532491|Effectiveness|effectiveness
1102937|NCT02532491|Aripiprazole|aripiprazole
1102938|NCT02532491|Risperidone|risperidone
1102939|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
1102940|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
1102941|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
1102942|NCT02532452|T-Cells|t-cells
1102943|NCT02532452|Donor|donor
1102944|NCT02532452|BK virus (BKV)|bk virus (bkv)
1102945|NCT02532439|fracture osteoporosis|fracture osteoporosis
1102946|NCT02532439|bone microarchitecture|bone microarchitecture
1102947|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
1102948|NCT02532439|Bone fragility|bone fragility
1102949|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
1102950|NCT02532439|Spondyloarthritis|spondyloarthritis
1102951|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
1102952|NCT02532439|constitutional thinness|constitutional thinness
1102953|NCT02532439|anorexia nervosa|anorexia nervosa
1102954|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1102955|NCT02532426|Muscle biopsy|muscle biopsy
1102956|NCT02532426|Chronic hypoxia|chronic hypoxia
1102957|NCT02532426|OXYPHEN|oxyphen
1102958|NCT02532426|Oxydative phenotype|oxydative phenotype
1102959|NCT02532426|Exercise|exercise
1102960|NCT02532400|Breast Neoplasms|breast neoplasms
1102961|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
1102962|NCT02532400|Ovarian Function Suppression|ovarian function suppression
1102963|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1102964|NCT02532374|nicotine absorption|nicotine absorption
1102965|NCT02532374|nicotine containing product|nicotine containing product
1102966|NCT02532374|adult smoker|adult smoker
1102967|NCT02532374|Nicorette|nicorette
1102968|NCT02532374|nicotine delivery system|nicotine delivery system
1102969|NCT02532361|Sterilization|sterilization
1102970|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
1102971|NCT02532361|Tubal Ligation|tubal ligation
1102972|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
1102973|NCT02532348|HIV|hiv
1102974|NCT02532348|antiretroviral therapy|antiretroviral therapy
1102975|NCT02532348|platelets|platelets
1102976|NCT02532348|Immune activation|immune activation
1102977|NCT02532348|Inflammatory state|inflammatory state
1102978|NCT02532335|FXR|fxr
1102979|NCT02532335|bile acids|bile acids
1102980|NCT02532335|FGF19|fgf19
1102981|NCT02532335|C4|c4
1102982|NCT02532335|gut microbiota|gut microbiota
1102983|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
1102984|NCT02532309|Rosuvastatin|rosuvastatin
1102985|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
1102986|NCT02532309|Crestor|crestor
1102987|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
1102988|NCT02532283|Influenza A virus|influenza a virus
1102989|NCT02532283|JNJ-63623872|jnj-63623872
1102990|NCT02532283|Oseltamivir|oseltamivir
1102991|NCT02532270|obstetric|obstetric
1102992|NCT02532270|anesthesia|anesthesia
1102993|NCT02532270|hypotension|hypotension
1102994|NCT02532270|arterial pressure|arterial pressure
1102995|NCT02532270|measurement techniques|measurement techniques
1102996|NCT02532257|Lymphoma|lymphoma
1102997|NCT02532257|Follicular Lymphoma|follicular lymphoma
1102998|NCT02532257|FL|fl
1102999|NCT02532257|Previously untreated|previously untreated
1103000|NCT02532257|Lenalidomide|lenalidomide
1103001|NCT02532257|CC-5013|cc-5013
1103002|NCT02532257|Revlimid|revlimid
1103003|NCT02532257|Rituximab|rituximab
1103004|NCT02532257|Rituxan|rituxan
1103005|NCT02532257|Ibrutinib|ibrutinib
1103006|NCT02532257|PCI-32765|pci-32765
1103007|NCT02532257|Imbruvica|imbruvica
1103008|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
1103009|NCT02532231|Leukemia|leukemia
1103010|NCT02532231|Acute myeloid leukemia|acute myeloid leukemia
1103011|NCT02532231|AML|aml
1103012|NCT02532231|High risk for relapse|high risk for relapse
1103013|NCT02532231|Nivolumab|nivolumab
1103014|NCT02532231|BMS-936558|bms-936558
1103015|NCT02532231|Opdivo|opdivo
1103016|NCT02532192|Lymphoma|lymphoma
1103017|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1103018|NCT02532192|DLBCL|dlbcl
1103019|NCT02532192|Relapsed|relapsed
1103020|NCT02532192|Refractory|refractory
1103021|NCT02532192|Belinostat|belinostat
1103022|NCT02532192|Rituximab|rituximab
1103023|NCT02532192|Rituxan|rituxan
1103024|NCT02532192|Cisplatin|cisplatin
1103025|NCT02532192|Platinol-AQ|platinol-aq
1103026|NCT02532192|Platinol|platinol
1103027|NCT02532192|CDDP|cddp
1103028|NCT02532192|Cytarabine|cytarabine
1103029|NCT02532192|Ara-C|ara-c
1103030|NCT02532192|Cytosar|cytosar
1103031|NCT02532192|DepoCyt|depocyt
1103032|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1103033|NCT02532192|Dexamethasone|dexamethasone
1103034|NCT02532192|Decadron|decadron
1103035|NCT02532192|Ciprofloxacin|ciprofloxacin
1103036|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
1103037|NCT02532192|Cipro|cipro
1103038|NCT02532192|Fluconazole|fluconazole
1103039|NCT02532192|Diflucan|diflucan
1103040|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
1103041|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
1103042|NCT02532179|mouse specific IgE|mouse specific ige
1103043|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
1103044|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
1103045|NCT02532166|narrow band imaging|narrow band imaging
1103046|NCT02532166|Chromoendoscopy|chromoendoscopy
1103047|NCT02532166|Lugol|lugol
1103048|NCT02532153|Suicidal Ideation|suicidal ideation
1103049|NCT02532153|Suicide|suicide
1103050|NCT02532153|Suicidal Thoughts|suicidal thoughts
1103051|NCT02532153|Depression|depression
1103052|NCT02532153|Ketamine|ketamine
1103053|NCT02532127|Low-dose risk|low-dose risk
1103054|NCT02532075|COPD|copd
1103055|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
1103056|NCT02532062|lung cancer risk|lung cancer risk
1103057|NCT02532062|cigarette smokers|cigarette smokers
1103058|NCT02532049|Malaria|malaria
1103059|NCT02532049|Vaccine|vaccine
1103060|NCT02532049|Immune Response|immune response
1103061|NCT02532036|MVA85A|mva85a
1103062|NCT02532036|Tuberculosis|tuberculosis
1103063|NCT02532036|Vaccine|vaccine
1103064|NCT02532036|Aerosol|aerosol
1103065|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
1103066|NCT02532023|curcumin|curcumin
1103067|NCT02532023|COX-2|cox-2
1103068|NCT02532023|iNOs|inos
1103069|NCT02532023|VCAM-1|vcam-1
1103070|NCT02532023|ICAM-1|icam-1
1103071|NCT02532023|IL-1β|il-1β
1103072|NCT02532023|IL-6|il-6
1103073|NCT02532023|TNF-α|tnf-α
1103074|NCT02532023|hsCRP|hscrp
1103075|NCT02532023|migraine|migraine
1103076|NCT02531997|self-image|self-image
1103077|NCT02531997|sexual health|sexual health
1103078|NCT02531997|breast cancer|breast cancer
1103079|NCT02531997|gynecologic cancer|gynecologic cancer
1103080|NCT02531997|ovarian cancer|ovarian cancer
1103081|NCT02531997|cervical cancer|cervical cancer
1103082|NCT02531997|uterine cancer|uterine cancer
1103083|NCT02531997|mind body|mind body
1103084|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
1103085|NCT02531997|hypnosis|hypnosis
1103501|NCT02529813|Allogeneic|allogeneic
1103096|NCT02531893|Frustration|frustration
1103097|NCT02531893|Interpretation Bias|interpretation bias
1103098|NCT02531893|Emotional Judgment|emotional judgment
1103099|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
1103100|NCT02531893|Exposure|exposure
1103101|NCT02531893|Research Psychotherapy|research psychotherapy
1103102|NCT02531880|MRI|mri
1103103|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
1103104|NCT02531880|Seizure Disorder|seizure disorder
1103105|NCT02531880|Seizures|seizures
1103106|NCT02531880|Epileptic Focus|epileptic focus
1103107|NCT02531867|HPP|hpp
1103108|NCT02531867|Bone Disease|bone disease
1103109|NCT02531867|Soft Bones|soft bones
1103110|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
1103111|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
1103112|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
1103113|NCT02531867|Rickets|rickets
1103114|NCT02531867|Osteomalacia|osteomalacia
1103115|NCT02531815|safety|safety
1103116|NCT02531815|tolerability|tolerability
1103117|NCT02531815|pharmacokinetics|pharmacokinetics
1103118|NCT02531815|pharmacodynamics|pharmacodynamics
1103119|NCT02531815|Phase 1|phase 1
1103120|NCT02531815|first in human|first in human
1103121|NCT02531815|monoclonal antibody|monoclonal antibody
1103122|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
1103123|NCT02531815|japanese|japanese
1103124|NCT02531802|ETEC diarrhea|etec diarrhea
1103125|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
1103126|NCT02531776|Diabetes|diabetes
1103127|NCT02531776|Needle|needle
1103128|NCT02531776|Pen needle|pen needle
1103129|NCT02531763|mHealth|mhealth
1103130|NCT02531763|behavioral economics|behavioral economics
1103131|NCT02531763|social incentives|social incentives
1103132|NCT02531750|Metabolism|metabolism
1103133|NCT02531750|Bone metabolism|bone metabolism
1103134|NCT02531750|Glucose Metabolism|glucose metabolism
1103135|NCT02531750|Lipid metabolism|lipid metabolism
1103136|NCT02531750|Low grade inflamation|low grade inflamation
1103137|NCT02531724|acute kidney injury|acute kidney injury
1103138|NCT02531724|cardiac surgery|cardiac surgery
1103139|NCT02531724|renal blood flow|renal blood flow
1103140|NCT02531724|levosimendan|levosimendan
1103141|NCT02531711|Lumbosacral|lumbosacral
1103142|NCT02531711|radicular|radicular
1103143|NCT02531685|dmLT|dmlt
1103144|NCT02531685|Enteric|enteric
1103145|NCT02531685|Escherichia coli Infections|escherichia coli infections
1103146|NCT02531685|Shigella|shigella
1103147|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
1103148|NCT02531672|11C-choline|11c-choline
1103149|NCT02531672|Positron Emission Tomography|positron emission tomography
1103150|NCT02531672|15-117|15-117
1103151|NCT02531646|pulmonary nodule|pulmonary nodule
1103152|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
1103153|NCT02531620|prehabilitation|prehabilitation
1103154|NCT02531620|colorectal surgery|colorectal surgery
1103155|NCT02531555|chronic periodontitis|chronic periodontitis
1103156|NCT02531555|dental scaling|dental scaling
1103157|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
1103158|NCT02531555|lasers|lasers
1103159|NCT02531555|periodontal pocket|periodontal pocket
1103160|NCT02531555|root planing|root planing
1103171|NCT02531503|Asthma remission|asthma remission
1103172|NCT02531503|Predicting factors|predicting factors
1103173|NCT02531503|Children|children
1103174|NCT02531464|family caregiver|family caregiver
1103175|NCT02531464|quality of life|quality of life
1103176|NCT02531464|supportive care|supportive care
1103177|NCT02531464|distress screening|distress screening
1103178|NCT02531464|needs assessment|needs assessment
1103179|NCT02531451|Muscle mass|muscle mass
1103180|NCT02531451|strength|strength
1103181|NCT02531451|NSAID|nsaid
1103182|NCT02531451|Ibuprofen|ibuprofen
1103183|NCT02531451|resistance exercise|resistance exercise
1103184|NCT02531425|TNBC|tnbc
1103185|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
1103186|NCT02531412|Acute kidney injury|acute kidney injury
1103187|NCT02531412|Critically ill cancer patients|critically ill cancer patients
1103188|NCT02531412|Spironolactone|spironolactone
1103189|NCT02531399|flicker induced changes|flicker induced changes
1103190|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
1103191|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
1103192|NCT02531308|lymphoma|lymphoma
1103193|NCT02531282|Patient education as topic|patient education as topic
1103194|NCT02531282|Health promotion|health promotion
1103195|NCT02531282|Patient participation|patient participation
1103196|NCT02531282|Self efficacy|self efficacy
1103197|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
1103198|NCT02531243|prodrome|prodrome
1103199|NCT02531243|family therapy|family therapy
1103200|NCT02531243|clinical high risk|clinical high risk
1103201|NCT02531204|ASP1585|asp1585
1103202|NCT02531204|Bioequivalence|bioequivalence
1103203|NCT02531204|Pharmacodynamic|pharmacodynamic
1103204|NCT02531204|Phosphate binder|phosphate binder
1103205|NCT02531204|Bixalomer|bixalomer
1103206|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
1103207|NCT02531191|ASP015K|asp015k
1103208|NCT02531191|JAK inhibitor|jak inhibitor
1103209|NCT02531191|bioequivalence study|bioequivalence study
1103210|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
1103211|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
1103212|NCT02531139|Anesthesia|anesthesia
1103213|NCT02531139|Blood pressure|blood pressure
1103214|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
1103215|NCT02531074|Mobile Applications|mobile applications
1103216|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
1103217|NCT02531061|bDMARDs|bdmards
1103218|NCT02531061|biotherapy|biotherapy
1103219|NCT02531061|remission|remission
1103220|NCT02531061|erosion|erosion
1103221|NCT02531048|healthy volunteers|healthy volunteers
1103222|NCT02530957|Intubation|intubation
1103223|NCT02530957|Preoxygenation|preoxygenation
1103224|NCT02530957|Complications|complications
1103225|NCT02530957|Non invasive ventilation|non invasive ventilation
1103226|NCT02530957|High flow nasal cannula|high flow nasal cannula
1103227|NCT02530944|Lupus|lupus
1103228|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1103229|NCT02530944|genetic|genetic
1103230|NCT02530944|online|online
1103231|NCT02530944|genome wide association|genome wide association
1103232|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
1103233|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
1103234|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
1103235|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
1103236|NCT02530905|Exon Skipping|exon skipping
1103237|NCT02530892|embryo|embryo
1103238|NCT02530892|in vitro fertilization|in vitro fertilization
1103239|NCT02530892|IVF|ivf
1103240|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
1103241|NCT02530840|HbA1c|hba1c
1103242|NCT02530840|peers|peers
1103243|NCT02530827|energy expenditure|energy expenditure
1103244|NCT02530827|doubly labeled water|doubly labeled water
1103245|NCT02530827|accelerometer|accelerometer
1103246|NCT02530827|HIV|hiv
1103247|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
1103248|NCT02530814|organochlorine compounds|organochlorine compounds
1103249|NCT02530814|pesticides|pesticides
1103250|NCT02530788|Heart Failure|heart failure
1103251|NCT02530788|Cardiac Surgery|cardiac surgery
1103252|NCT02530788|Ventricular Assist Device|ventricular assist device
1103253|NCT02530788|Selenium|selenium
1103254|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
1103255|NCT02530762|dietary fiber|dietary fiber
1103256|NCT02530762|clinical trial|clinical trial
1103257|NCT02530762|healthy subjects|healthy subjects
1103258|NCT02530749|Surgery|surgery
1103259|NCT02530749|Frailty|frailty
1103260|NCT02530736|Gait speed|gait speed
1103261|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
1103262|NCT02530723|power training|power training
1103263|NCT02530723|high-speed training|high-speed training
1103264|NCT02530723|high-velocity training|high-velocity training
1103265|NCT02530723|function|function
1103266|NCT02530723|older adults|older adults
1103267|NCT02530723|older women|older women
1103268|NCT02530697|Leishmaniasis|leishmaniasis
1103269|NCT02530697|Mucocutaneous|mucocutaneous
1103270|NCT02530697|Miltefosine|miltefosine
1103271|NCT02530697|Pentoxifylline|pentoxifylline
1103272|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
1103273|NCT02530671|manual toothbrush|manual toothbrush
1103274|NCT02530658|Genetic Predisposition|genetic predisposition
1103275|NCT02530658|Pediatric|pediatric
1103276|NCT02530658|Genomic Analysis|genomic analysis
1103277|NCT02530658|Heritable Disease|heritable disease
1103278|NCT02530658|Cancer Risk|cancer risk
1103279|NCT02530658|Genetic Counseling|genetic counseling
1103280|NCT02530658|DNA|dna
1103281|NCT02530658|Clinical Genomics|clinical genomics
1103282|NCT02530658|Clinical Decision-Making|clinical decision-making
1103283|NCT02530658|Treatment Planning|treatment planning
1103284|NCT02530632|microperfusion|microperfusion
1103285|NCT02530632|temperature|temperature
1103286|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
1103287|NCT02530632|anesthesia|anesthesia
1103288|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
1103289|NCT02530580|GABA modulator|gaba modulator
1103290|NCT02530580|AZD7325|azd7325
1103291|NCT02530580|Object manipulation|object manipulation
1103292|NCT02530580|Cutaneous sensation|cutaneous sensation
1103293|NCT02530580|Manual dexterity|manual dexterity
1103294|NCT02530567|portal pressure|portal pressure
1103295|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
1103296|NCT02530567|azygos blood flow|azygos blood flow
1103297|NCT02530554|Pilot Projects|pilot projects
1103298|NCT02530515|Leukemia|leukemia
1103299|NCT02530515|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1103301|NCT02530515|T-cells|t-cells
1103302|NCT02530515|Immune cells|immune cells
1103303|NCT02530515|Rituximab|rituximab
1103304|NCT02530515|Rituxan|rituxan
1103305|NCT02530515|Cyclophosphamide|cyclophosphamide
1103306|NCT02530515|Cytoxan|cytoxan
1103307|NCT02530515|Neosar|neosar
1103308|NCT02530515|Fludarabine Phosphate|fludarabine phosphate
1103309|NCT02530515|Fludarabine|fludarabine
1103310|NCT02530515|Fludara|fludara
1103311|NCT02530515|Bendamustine|bendamustine
1103312|NCT02530515|Bendamustine Hydrochloride|bendamustine hydrochloride
1103313|NCT02530515|Bendamustine HCL|bendamustine hcl
1103314|NCT02530515|CEP-18083|cep-18083
1103315|NCT02530515|SDX-105|sdx-105
1103316|NCT02530515|Treanda|treanda
1103317|NCT02530515|Lenalidomide|lenalidomide
1103318|NCT02530515|CC-5013|cc-5013
1103319|NCT02530515|Revlimid|revlimid
1103320|NCT02530489|Breast Cancer|breast cancer
1103321|NCT02530489|Triple negative breast cancer|triple negative breast cancer
1103322|NCT02530489|TNBC|tnbc
1103323|NCT02530489|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
1103324|NCT02530489|MPDL3280A|mpdl3280a
1103325|NCT02530489|Nab-paclitaxel|nab-paclitaxel
1103326|NCT02530489|Paclitaxel|paclitaxel
1103327|NCT02530489|Abraxane|abraxane
1103328|NCT02530489|ABI-007|abi-007
1103329|NCT02530476|Leukemia|leukemia
1103330|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
1103332|NCT02530476|Relapsed/Refractory|relapsed/refractory
1103333|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
1103334|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
1103335|NCT02530476|MDS|mds
1103336|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1103337|NCT02530476|CMML|cmml
1103338|NCT02530476|Selinexor|selinexor
1103339|NCT02530476|KPT-330|kpt-330
1103340|NCT02530476|Sorafenib|sorafenib
1103341|NCT02530476|Nexavar|nexavar
1103342|NCT02530476|BAY 43-9006|bay 43-9006
1103343|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
1103344|NCT02530463|Leukemia|leukemia
1103345|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
1103346|NCT02530463|MDS|mds
1103347|NCT02530463|Nivolumab|nivolumab
1103348|NCT02530463|BMS-936558|bms-936558
1103349|NCT02530463|Opdivo|opdivo
1103350|NCT02530463|Ipilimumab|ipilimumab
1103351|NCT02530463|Yervoy|yervoy
1103352|NCT02530463|BMS-734016|bms-734016
1103353|NCT02530463|MDX010|mdx010
1103354|NCT02530463|5-azacitidine|5-azacitidine
1103355|NCT02530463|Azacitidine|azacitidine
1103356|NCT02530463|5-AZA|5-aza
1103357|NCT02530463|Vidaza|vidaza
1103358|NCT02530463|5-AZC|5-azc
1103359|NCT02530463|AZA-CR|aza-cr
1103360|NCT02530463|Ladakamycin|ladakamycin
1103361|NCT02530463|NSC-102816|nsc-102816
1103362|NCT02530463|Azacytidine|azacytidine
1103363|NCT02530450|children|children
1103364|NCT02530450|poor adherence|poor adherence
1103365|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
1103366|NCT02530437|Esophageal Cancer|esophageal cancer
1103367|NCT02530437|Adenocarcinoma of the Esophagus|adenocarcinoma of the esophagus
1103368|NCT02530437|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
1103369|NCT02530437|Chemoradiation|chemoradiation
1103370|NCT02530437|LY2940680|ly2940680
1103371|NCT02530437|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
1103372|NCT02530437|Taxol|taxol
1103373|NCT02530437|Carboplatin|carboplatin
1103374|NCT02530437|Paraplatin|paraplatin
1103375|NCT02530437|Radiation therapy|radiation therapy
1103376|NCT02530437|XRT|xrt
1103377|NCT02530437|External beam|external beam
1103378|NCT02530437|Endoscopy|endoscopy
1103379|NCT02530424|HER2-positive|her2-positive
1103380|NCT02530424|ER-positive|er-positive
1103381|NCT02530424|invasive|invasive
1103382|NCT02530424|CDK4,6|cdk4,6
1103383|NCT02530424|Palbociclib|palbociclib
1103384|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
1103385|NCT02530411|Hormone resistance|hormone resistance
1103386|NCT02530411|vandetanib|vandetanib
1103387|NCT02530411|fulvestrant|fulvestrant
1103388|NCT02530359|septic acute kidney injury|septic acute kidney injury
1103389|NCT02530359|pirfenidone|pirfenidone
1103390|NCT02530320|Palbociclib|palbociclib
1103391|NCT02530320|oligodendroglioma|oligodendroglioma
1103392|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
1103393|NCT02530307|Stroke,|stroke,
1103394|NCT02530307|Rehabilitation|rehabilitation
1103395|NCT02530307|Ischemic|ischemic
1103397|NCT02530268|psoriatic arthritis|psoriatic arthritis
1103398|NCT02530268|spondyloarthritis|spondyloarthritis
1103399|NCT02530268|disease registry|disease registry
1103400|NCT02530255|retinal amyloid|retinal amyloid
1103401|NCT02530255|Retinal amyloid index|retinal amyloid index
1103402|NCT02530255|Alzheimer disease|alzheimer disease
1103403|NCT02530255|telomere attrition|telomere attrition
1103404|NCT02530255|telomere activation|telomere activation
1103405|NCT02530242|Sickle Cell Anemia|sickle cell anemia
1103406|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
1103407|NCT02530229|septic arthritis|septic arthritis
1103408|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
1103409|NCT02530203|spinal cord stimulation|spinal cord stimulation
1103410|NCT02530203|CABG|cabg
1103413|NCT02530177|Nail Changes|nail changes
1103414|NCT02530177|Hair Changes|hair changes
1103415|NCT02530177|15-198|15-198
1103416|NCT02530164|tDCS|tdcs
1103417|NCT02530164|SSRI|ssri
1103418|NCT02530151|Hip arthroscopy|hip arthroscopy
1103419|NCT02530151|Intra-articular injection|intra-articular injection
1103420|NCT02530151|Morphine|morphine
1103421|NCT02530151|Clonidine|clonidine
1103422|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
1103423|NCT02530073|FETO|feto
1103424|NCT02530073|tracheal occlusion|tracheal occlusion
1103425|NCT02530060|Healthy|healthy
1103426|NCT02530060|Rilpivirine|rilpivirine
1103427|NCT02530060|Tenofovir|tenofovir
1103428|NCT02530060|Emtricitabine|emtricitabine
1103429|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1103430|NCT02530047|Ovarian cancer|ovarian cancer
1103431|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
1103432|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
1103433|NCT02530047|MSC-INFb|msc-infb
1103434|NCT02530047|Questionnaires|questionnaires
1103435|NCT02530047|Surveys|surveys
1103436|NCT02530034|Leukemia|leukemia
1103437|NCT02530034|Advanced Hematologic Malignancies|advanced hematologic malignancies
1103438|NCT02530034|Myelodysplastic syndrome|myelodysplastic syndrome
1103440|NCT02530034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1103441|NCT02530034|CMML|cmml
1103442|NCT02530034|Acute myeloid leukemia|acute myeloid leukemia
1103444|NCT02530034|Myelofibrosis|myelofibrosis
1103445|NCT02530034|Hu8F4|hu8f4
1103446|NCT02530021|Ischemic heart disease|ischemic heart disease
1103447|NCT02530021|Heart rate variability|heart rate variability
1103448|NCT02530021|Exercise Strss Test|exercise strss test
1103449|NCT02529956|Psoriasis|psoriasis
1103450|NCT02529956|UCB4940|ucb4940
1103451|NCT02529943|Spinal Stenosis|spinal stenosis
1103452|NCT02529943|Motor Evoked Potential|motor evoked potential
1103453|NCT02529930|HSIL|hsil
1103454|NCT02529930|CIN 2/3|cin 2/3
1103455|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
1103456|NCT02529930|Human Papillomavirus|human papillomavirus
1103457|NCT02529930|Immunotherapy|immunotherapy
1103458|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1103459|NCT02529891|COPD|copd
1103460|NCT02529891|Volatile Organic Compounds|volatile organic compounds
1103461|NCT02529891|Exacerbation|exacerbation
1103462|NCT02529878|gastric caner|gastric caner
1103463|NCT02529878|Apatinib|apatinib
1103464|NCT02529878|S1|s1
1103465|NCT02529878|conversion therapy|conversion therapy
1103466|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
1103467|NCT02529865|Cell Transplantation|cell transplantation
1103468|NCT02529852|Lymphoma|lymphoma
1103469|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1103470|NCT02529852|DLBCL|dlbcl
1103471|NCT02529852|Lenalidomide|lenalidomide
1103472|NCT02529852|CC-5013|cc-5013
1103473|NCT02529852|Revlimid|revlimid
1103474|NCT02529852|Obinutuzumab|obinutuzumab
1103475|NCT02529852|GA101|ga101
1103476|NCT02529852|Gazyva|gazyva
1103477|NCT02529852|Cyclophosphamide|cyclophosphamide
1103478|NCT02529852|Cytoxan|cytoxan
1103479|NCT02529852|Neosar|neosar
1103480|NCT02529852|Doxorubicin|doxorubicin
1103481|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1103482|NCT02529852|Adriamycin PFS|adriamycin pfs
1103483|NCT02529852|Adriamycin RDF|adriamycin rdf
1103484|NCT02529852|Adriamycin|adriamycin
1103485|NCT02529852|Rubex|rubex
1103486|NCT02529852|Vincristine|vincristine
1103487|NCT02529852|Prednisone|prednisone
1103488|NCT02529839|MS|ms
1103489|NCT02529839|BMT|bmt
1103490|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
1103491|NCT02529813|Leukemia|leukemia
1103492|NCT02529813|Lymphoma|lymphoma
1103493|NCT02529813|Advanced Lymphoid Malignancies|advanced lymphoid malignancies
1103494|NCT02529813|CD19+ lymphoid malignancy|cd19+ lymphoid malignancy
1103495|NCT02529813|Multiple myeloma|multiple myeloma
1103496|NCT02529813|MM|mm
1103497|NCT02529813|CD19-specific T cells|cd19-specific t cells
1103498|NCT02529813|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
1103499|NCT02529813|CAR T cells|car t cells
1103502|NCT02529813|Fludarabine|fludarabine
1103503|NCT02529813|Fludarabine phosphate|fludarabine phosphate
1103504|NCT02529813|Cyclophosphamide|cyclophosphamide
1103505|NCT02529813|Cytoxan|cytoxan
1103506|NCT02529813|Neosar|neosar
1103507|NCT02529813|nonviral|nonviral
1103508|NCT02529813|non-viral|non-viral
1103509|NCT02529813|DNA plasmids|dna plasmids
1103510|NCT02529761|HCC|hcc
1103511|NCT02529761|sorafenib|sorafenib
1103512|NCT02529761|TACE|tace
1103513|NCT02529761|overall survival|overall survival
1103514|NCT02529696|accelerometer|accelerometer
1103515|NCT02529696|RASS|rass
1103516|NCT02529683|Nuvaring|nuvaring
1103517|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
1103518|NCT02529683|Kenya|kenya
1103519|NCT02529683|adherence|adherence
1103520|NCT02529683|acceptability|acceptability
1103521|NCT02529683|immunological effects|immunological effects
1103622|NCT02529202|Analgesics|analgesics
1103522|NCT02529670|Low Level Laser Therapy|low level laser therapy
1103523|NCT02529670|Low Back Pain|low back pain
1103524|NCT02529670|Diagnosis|diagnosis
1103525|NCT02529670|Genetic|genetic
1103526|NCT02529670|Clinical trial|clinical trial
1103527|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
1103528|NCT02529657|inflammation|inflammation
1103529|NCT02529657|cytokines|cytokines
1103530|NCT02529657|wound healing|wound healing
1103531|NCT02529657|laminectomy|laminectomy
1103532|NCT02529657|clinical study|clinical study
1103533|NCT02529644|HIV Screening|hiv screening
1103534|NCT02529644|African American|african american
1103535|NCT02529644|Church|church
1103536|NCT02529631|Polyglucosamine|polyglucosamine
1103537|NCT02529631|L 112|l 112
1103538|NCT02529631|overweight,|overweight,
1103539|NCT02529631|obesity|obesity
1103540|NCT02529631|orlistat|orlistat
1103541|NCT02529631|weight reduction|weight reduction
1103542|NCT02529605|dietary supplement|dietary supplement
1103543|NCT02529605|pharmacokinetics|pharmacokinetics
1103544|NCT02529605|Healthy Volunteers|healthy volunteers
1103545|NCT02529592|Sickness behavior|sickness behavior
1103546|NCT02529592|Cytokines|cytokines
1103547|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
1103548|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
1103549|NCT02529579|patient safety|patient safety
1103550|NCT02529579|therapeutic effect|therapeutic effect
1103551|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
1103552|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
1103553|NCT02529566|Adjacent Segment Disease|adjacent segment disease
1103554|NCT02529566|Autologous Bone Marrow|autologous bone marrow
1103555|NCT02529566|Lower Back Pain|lower back pain
1103556|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
1103557|NCT02529566|Stem Cells|stem cells
1103558|NCT02529566|Lumbar disk|lumbar disk
1103559|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
1103560|NCT02529566|Stabilization|stabilization
1103561|NCT02529566|CLBP|clbp
1103562|NCT02529566|Autograft|autograft
1103563|NCT02529566|Allograft|allograft
1103564|NCT02529566|Autograft versus Allograft|autograft versus allograft
1103565|NCT02529566|Facet Joint|facet joint
1103566|NCT02529566|Radicular Pain|radicular pain
1103567|NCT02529566|Adipose|adipose
1103568|NCT02529566|Disc Replacement|disc replacement
1103569|NCT02529566|Facet Joint Replacement|facet joint replacement
1103570|NCT02529553|bladder cancer|bladder cancer
1103571|NCT02529540|Myopia|myopia
1103572|NCT02529540|self-refraction|self-refraction
1103573|NCT02529540|glasses|glasses
1103574|NCT02529540|spectacles|spectacles
1103575|NCT02529514|Baclofen|baclofen
1103576|NCT02529514|Cardiac Surgery|cardiac surgery
1103577|NCT02529514|Polysomnography|polysomnography
1103578|NCT02529514|Intensive Care Units|intensive care units
1103579|NCT02529514|Sleep|sleep
1103580|NCT02529449|ASP1941|asp1941
1103581|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
1103582|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
1103583|NCT02529436|overuse antidepressant|overuse antidepressant
1103584|NCT02529436|dementia|dementia
1103585|NCT02529423|food intake|food intake
1103586|NCT02529423|food-related behaviour|food-related behaviour
1103587|NCT02529423|obesity|obesity
1103588|NCT02529423|socioeconomic environment|socioeconomic environment
1103589|NCT02529423|depression|depression
1103590|NCT02529423|nutritional strategies|nutritional strategies
1103591|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
1103592|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
1103593|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
1103594|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
1103595|NCT02529358|Maintenance intervention|maintenance intervention
1103596|NCT02529358|Text messages|text messages
1103597|NCT02529358|Emotion Regulation|emotion regulation
1103598|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
1103599|NCT02529319|atrial fibrillation|atrial fibrillation
1103600|NCT02529319|ablation|ablation
1103601|NCT02529306|men|men
1103602|NCT02529280|Latinas|latinas
1103603|NCT02529280|Breast Cancer|breast cancer
1103604|NCT02529280|Clinical Trials|clinical trials
1103605|NCT02529280|Participation|participation
1103606|NCT02529267|Cohort Studies|cohort studies
1103607|NCT02529267|intimate partner violence|intimate partner violence
1103608|NCT02529267|orthopaedic surgery|orthopaedic surgery
1103609|NCT02529267|epidemiology|epidemiology
1103610|NCT02529267|outcomes in fracture care|outcomes in fracture care
1103611|NCT02529254|post graduate surgical education|post graduate surgical education
1103612|NCT02529254|video coaching|video coaching
1103613|NCT02529254|Surgical education|surgical education
1103614|NCT02529254|coaching|coaching
1103615|NCT02529202|Dexmedetomidine|dexmedetomidine
1103616|NCT02529202|Neonate|neonate
1103617|NCT02529202|Pharmacokinetics|pharmacokinetics
1103618|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
1103619|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
1103620|NCT02529202|Adrenergic Agents|adrenergic agents
1103621|NCT02529202|Adrenergic Agonists|adrenergic agonists
1103623|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
1103624|NCT02529202|Central Nervous System Agents|central nervous system agents
1103625|NCT02529202|Central Nervous System Depressants|central nervous system depressants
1103626|NCT02529189|Stable Angina|stable angina
1103627|NCT02529189|Angioplasty|angioplasty
1103628|NCT02529189|Optical Coherence Tomography|optical coherence tomography
1103629|NCT02529189|Nitrate|nitrate
1103630|NCT02529176|telemetry|telemetry
1103631|NCT02529176|cardiac monitoring|cardiac monitoring
1103632|NCT02529163|Integrated Care Pathway|integrated care pathway
1103633|NCT02529163|Acute Psychotic Episode|acute psychotic episode
1103634|NCT02529163|Randomised Control Trial|randomised control trial
1103635|NCT02529124|Ageing|ageing
1103636|NCT02529124|Body Composition|body composition
1103637|NCT02529124|Nutrition|nutrition
1103638|NCT02529124|Physical Activity|physical activity
1103639|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
1103640|NCT02529111|Percutaneous closure|percutaneous closure
1103641|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
1103642|NCT02529098|Lens implantation|lens implantation
1103643|NCT02529098|pseudophakia|pseudophakia
1103644|NCT02529020|mouthguard|mouthguard
1103645|NCT02529020|ventilation|ventilation
1103646|NCT02529020|anaerobic power|anaerobic power
1103647|NCT02529020|ergogenic effects|ergogenic effects
1103648|NCT02529007|Colonoscopy|colonoscopy
1103649|NCT02529007|early cancer detection|early cancer detection
1103650|NCT02529007|cancer screening|cancer screening
1103651|NCT02528994|Dietary supplements|dietary supplements
1103652|NCT02528994|Metabolism|metabolism
1103653|NCT02528981|GBS|gbs
1103654|NCT02528981|Probiotics|probiotics
1103655|NCT02528981|Group B Streptococcal|group b streptococcal
1103656|NCT02528981|Pregnancy|pregnancy
1103657|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
1103658|NCT02528968|Haemophilia|haemophilia
1103659|NCT02528955|Head and neck cancer|head and neck cancer
1103660|NCT02528955|postoperative|postoperative
1103661|NCT02528955|radiotherapy|radiotherapy
1103662|NCT02528955|de-intensification|de-intensification
1103663|NCT02528942|Lung cancer|lung cancer
1103664|NCT02528942|Radiation therapy|radiation therapy
1103665|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
1103666|NCT02528890|group B streptococcus|group b streptococcus
1103667|NCT02528890|GBS|gbs
1103668|NCT02528864|biomarker|biomarker
1103669|NCT02528864|cancer metabolism|cancer metabolism
1103670|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
1103671|NCT02528864|endometrial cancer|endometrial cancer
1103672|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
1103673|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1103674|NCT02528864|uterine malignancy|uterine malignancy
1103675|NCT02528851|CPAP|cpap
1103676|NCT02528851|preterm|preterm
1103677|NCT02528851|cardiac output|cardiac output
1103678|NCT02528838|Myeloma|myeloma
1103679|NCT02528838|Non-interventional|non-interventional
1103680|NCT02528838|Observational|observational
1103681|NCT02528838|Lenalidomide|lenalidomide
1103682|NCT02528838|REVIEW|review
1103683|NCT02528838|Post-authorization|post-authorization
1103684|NCT02528838|Netherlands|netherlands
1103685|NCT02528786|Drug therapy|drug therapy
1103686|NCT02528734|pneumothorax|pneumothorax
1103687|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
1103688|NCT02528708|coagulation|coagulation
1103689|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
1103690|NCT02528695|Adipose tissue|adipose tissue
1103691|NCT02528695|type 2 diabetes|type 2 diabetes
1103692|NCT02528682|dendritic cells|dendritic cells
1103693|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
1103694|NCT02528682|vaccination|vaccination
1103695|NCT02528682|stem cell transplantation|stem cell transplantation
1103696|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
1103697|NCT02528669|accelerometer|accelerometer
1103698|NCT02528669|patient ambulation|patient ambulation
1103699|NCT02528656|Pectus Excavatum|pectus excavatum
1103700|NCT02528656|Pectus Carinatum|pectus carinatum
1103701|NCT02528656|Vacuum Bell|vacuum bell
1103702|NCT02528656|Dynamic compression system|dynamic compression system
1103703|NCT02528656|Hearth variability|hearth variability
1103704|NCT02528656|Autonomic Nervous System|autonomic nervous system
1103706|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1103707|NCT02528643|enzalutamide|enzalutamide
1103708|NCT02528643|Xtandi|xtandi
1103709|NCT02528643|ASP9785|asp9785
1103710|NCT02528604|Catheter Ablation|catheter ablation
1103711|NCT02528604|Permanent pacemaker|permanent pacemaker
1103712|NCT02528604|AV node ablation|av node ablation
1103713|NCT02528604|Electrical Cardioversion|electrical cardioversion
1103714|NCT02528604|Implantable loop recorder|implantable loop recorder
1103715|NCT02528591|patient|patient
1103716|NCT02528591|renal transplant|renal transplant
1103717|NCT02528578|healthy volunteers|healthy volunteers
1103718|NCT02528539|Prevention|prevention
1103719|NCT02528539|lymphedema|lymphedema
1103720|NCT02528539|acupuncture|acupuncture
1103721|NCT02528539|self-management|self-management
1103722|NCT02528526|Hypoxia|hypoxia
1103723|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
1103724|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
1103725|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
1103726|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
1103727|NCT02528526|Treatment|treatment
1103728|NCT02528513|sedation|sedation
1103729|NCT02528513|Midazolam|midazolam
1103730|NCT02528513|Propofol|propofol
1103731|NCT02528513|Dexmedetomidine|dexmedetomidine
1103732|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
1103733|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1103734|NCT02528487|Psychiatric Disorders|psychiatric disorders
1103735|NCT02528461|Sofosbuvir|sofosbuvir
1103736|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
1103737|NCT02528461|liver cirrhosis|liver cirrhosis
1103738|NCT02528448|Vasoactive hormones|vasoactive hormones
1153577|NCT02245347|TB|tb
1103739|NCT02528448|bio markers|bio markers
1103740|NCT02528448|salt regulation|salt regulation
1103741|NCT02528448|Renal variables|renal variables
1103742|NCT02528435|Methotrexate|methotrexate
1103743|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
1103744|NCT02528383|Vagifem|vagifem
1103745|NCT02528370|COPD exacerbation|copd exacerbation
1103746|NCT02528370|Telemedicine|telemedicine
1103747|NCT02528370|Intervention Studies|intervention studies
1103748|NCT02528370|Patient Readmission|patient readmission
1103749|NCT02528357|mAb|mab
1103750|NCT02528357|GSK3174998|gsk3174998
1103751|NCT02528357|anticancer agent|anticancer agent
1103752|NCT02528357|checkpoint|checkpoint
1103753|NCT02528357|OX40|ox40
1103754|NCT02528357|Pembrolizumab|pembrolizumab
1103755|NCT02528357|MK-3475-167|mk-3475-167
1103756|NCT02528357|solid tumor|solid tumor
1103757|NCT02528357|immunotherapy|immunotherapy
1103758|NCT02528357|KEYNOTE-167|keynote-167
1103759|NCT02528357|monoclonal antibody|monoclonal antibody
1103760|NCT02528357|antitumor|antitumor
1103761|NCT02528344|High Intensity Interval Training|high intensity interval training
1103762|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1103763|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
1103764|NCT02528305|High-intensity Interval Training|high-intensity interval training
1103765|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
1103766|NCT02528292|Anti-TNF|anti-tnf
1103767|NCT02528292|Ultrasound|ultrasound
1103768|NCT02528292|Synovial histomorphology|synovial histomorphology
1103769|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
1103770|NCT02528279|Plasmodium ovale|plasmodium ovale
1103771|NCT02528279|relapse|relapse
1103772|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
1103773|NCT02528279|mixed species malaria|mixed species malaria
1103774|NCT02528279|non-falciparum malaria|non-falciparum malaria
1103775|NCT02528253|Chronic low back pain|chronic low back pain
1103776|NCT02528253|Chronic pain|chronic pain
1103777|NCT02528240|platelets|platelets
1103778|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
1103779|NCT02528201|Celecoxib|celecoxib
1103780|NCT02528201|Diclofenac|diclofenac
1103781|NCT02528162|gestational diabetes|gestational diabetes
1103782|NCT02528162|education|education
1103783|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
1103784|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
1103785|NCT02528149|renal artery aneurysms|renal artery aneurysms
1103786|NCT02528149|non atheromatous|non atheromatous
1103787|NCT02528149|dysplastic|dysplastic
1103788|NCT02528149|anatomopathologic|anatomopathologic
1103789|NCT02528149|genetic|genetic
1103790|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
1103791|NCT02528123|Femtosecond laser|femtosecond laser
1103792|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
1103793|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1103794|NCT02528071|ALS|als
1103795|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
1103796|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
1103797|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
1103798|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
1103799|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
1103802|NCT02528006|Titanium Bridges|titanium bridges
1103803|NCT02528006|Operation|operation
1103804|NCT02527980|electronic cigarettes|electronic cigarettes
1103805|NCT02527980|nicotine dependence|nicotine dependence
1103806|NCT02527980|smoking|smoking
1103807|NCT02527980|tobacco use|tobacco use
1103808|NCT02527967|colorectal cancer|colorectal cancer
1103809|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
1103810|NCT02527967|perioperative care|perioperative care
1103811|NCT02527967|fast-track surgery|fast-track surgery
1103812|NCT02527967|laparoscopy|laparoscopy
1103813|NCT02527967|minimally invasive surgery|minimally invasive surgery
1103814|NCT02527967|complications|complications
1103815|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
1103816|NCT02527954|aneuploidy|aneuploidy
1103817|NCT02527954|embryos|embryos
1103818|NCT02527954|spermatozoa|spermatozoa
1103819|NCT02527941|Genital immunology|genital immunology
1103820|NCT02527941|HIV susceptibility|hiv susceptibility
1103821|NCT02527941|Microbiome|microbiome
1103822|NCT02527941|Bacterial vaginosis|bacterial vaginosis
1103823|NCT02527941|Virus entry assay|virus entry assay
1103824|NCT02527928|pharmacoeconomics|pharmacoeconomics
1103825|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
1103826|NCT02527902|Autonomic nervous system|autonomic nervous system
1103827|NCT02527902|ANS|ans
1103828|NCT02527889|Exercise|exercise
1103829|NCT02527889|blood flow velocity|blood flow velocity
1103830|NCT02527889|tissue oxygenation|tissue oxygenation
1103831|NCT02527889|BCRL|bcrl
1103832|NCT02527876|Exercise|exercise
1103833|NCT02527876|Smoking|smoking
1103834|NCT02527863|Tolvaptan|tolvaptan
1103835|NCT02527863|L-NMMA|l-nmma
1103836|NCT02527863|ADPKD|adpkd
1103837|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
1103838|NCT02527824|oxaliplatin|oxaliplatin
1103839|NCT02527824|irinotecan|irinotecan
1103840|NCT02527824|S-1|s-1
1103841|NCT02527811|ulinastatin|ulinastatin
1103842|NCT02527811|CPB|cpb
1103843|NCT02527811|pediatric|pediatric
1103844|NCT02527785|stomach neoplasm|stomach neoplasm
1103845|NCT02527785|oxaliplatin|oxaliplatin
1103846|NCT02527785|irinotecan|irinotecan
1103847|NCT02527785|S-1|s-1
1103848|NCT02527720|Mindfulness|mindfulness
1103849|NCT02527720|Therapy|therapy
1103850|NCT02527720|Problem Drinking|problem drinking
1103851|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
1103852|NCT02527694|Emergency medical services|emergency medical services
1103853|NCT02527694|Resuscitation|resuscitation
1103854|NCT02527512|Scoliosis|scoliosis
1103855|NCT02527512|Spine fusion|spine fusion
1103856|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
1103857|NCT02527486|COPD|copd
1103858|NCT02527486|Asthma|asthma
1103859|NCT02527486|ACOS|acos
1103860|NCT02527486|Bronchiectasis|bronchiectasis
1103864|NCT02527447|Measurable Residual Disease|measurable residual disease
1103865|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
1103866|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
1103867|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
1103868|NCT02527395|Experimental pain|experimental pain
1103869|NCT02527395|Men|men
1103870|NCT02527369|Fat Reduction|fat reduction
1103871|NCT02527369|Lipolysis|lipolysis
1103872|NCT02527330|Myocardial iron deposition|myocardial iron deposition
1103873|NCT02527330|T2* imaging|t2* imaging
1103874|NCT02527330|heart failure|heart failure
1103875|NCT02527317|Early|early
1103876|NCT02527291|Cytomegalovirus|cytomegalovirus
1103877|NCT02527291|Interleukin|interleukin
1103878|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
1103879|NCT02527291|CMV antibodies|cmv antibodies
1103880|NCT02527252|Massage|massage
1103881|NCT02527252|Craniosacral|craniosacral
1103882|NCT02527252|Disability Evaluation|disability evaluation
1103883|NCT02527252|Randomized Controlled Trial|randomized controlled trial
1103884|NCT02527187|Immune System Diseases|immune system diseases
1103885|NCT02527187|Prick Test|prick test
1103886|NCT02527187|Betula verrucosa|betula verrucosa
1103887|NCT02527135|SMS|sms
1103888|NCT02527135|Text messages|text messages
1103889|NCT02527135|Young women|young women
1103890|NCT02527135|HIV|hiv
1103891|NCT02527122|Immune System Diseases|immune system diseases
1103892|NCT02527122|Prick Test|prick test
1103893|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
1103894|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
1103895|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
1103896|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
1103897|NCT02527096|HIV-1|hiv-1
1103898|NCT02527096|efficacy|efficacy
1103899|NCT02527096|safety|safety
1103900|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
1104000|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
1103901|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
1103902|NCT02527057|Response|response
1103903|NCT02527044|Coronary Artery Bypass|coronary artery bypass
1103904|NCT02527044|Flow Reserve|flow reserve
1103905|NCT02527031|Emergency Medical Services|emergency medical services
1103906|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1103907|NCT02527018|OBGYN|obgyn
1103908|NCT02527018|Nexfin|nexfin
1103909|NCT02527018|Hypertensive|hypertensive
1103910|NCT02527018|Hemodynamic|hemodynamic
1103911|NCT02527005|IPT|ipt
1103912|NCT02527005|malaria|malaria
1103913|NCT02527005|pregnant|pregnant
1103914|NCT02527005|HIV positive|hiv positive
1103915|NCT02526979|OAB|oab
1103916|NCT02526979|overactive bladder|overactive bladder
1103917|NCT02526979|Myrbetric|myrbetric
1103918|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1103919|NCT02526979|Betanis|betanis
1103920|NCT02526979|Myrbetriq|myrbetriq
1103921|NCT02526979|NDO|ndo
1103922|NCT02526979|YM178|ym178
1103923|NCT02526979|mirabegron|mirabegron
1103924|NCT02526979|Betmiga|betmiga
1103925|NCT02526953|anal cancer|anal cancer
1103926|NCT02526953|chemoradiation|chemoradiation
1103927|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1103928|NCT02526953|paclitaxel|paclitaxel
1103929|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
1103930|NCT02526940|HIV|hiv
1103931|NCT02526940|HAART|haart
1103932|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
1103933|NCT02526940|GALT|galt
1103934|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
1103935|NCT02526940|reservoir|reservoir
1103936|NCT02526940|rectum|rectum
1103937|NCT02526927|Anorexia Nervosa|anorexia nervosa
1103938|NCT02526927|microarchitecture|microarchitecture
1103939|NCT02526927|prepubertal|prepubertal
1103940|NCT02526914|social cognition|social cognition
1103941|NCT02526914|oxytocin|oxytocin
1103942|NCT02526914|vasopressin|vasopressin
1103943|NCT02526914|decision making|decision making
1103944|NCT02526914|social decision making|social decision making
1103945|NCT02526914|economic games|economic games
1103946|NCT02526888|pharmacokinetic|pharmacokinetic
1103947|NCT02526888|interaction|interaction
1103948|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
1103949|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
1103950|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
1103951|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
1103952|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
1103953|NCT02526862|nursing assessment|nursing assessment
1103954|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
1103955|NCT02526849|Slow Transit Constipation|slow transit constipation
1103956|NCT02526849|Randomized Controlled Trial|randomized controlled trial
1103957|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
1103958|NCT02526810|glargine|glargine
1103959|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
1103960|NCT02526810|blood glucose control|blood glucose control
1103961|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
1103962|NCT02526810|Oxidative Stress|oxidative stress
1103963|NCT02526797|prostate biopsy|prostate biopsy
1103964|NCT02526797|prostate cancer|prostate cancer
1103965|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
1103966|NCT02526797|Neoplasm staging|neoplasm staging
1103967|NCT02526771|lymph node dissection|lymph node dissection
1103968|NCT02526758|Pulmonary disease|pulmonary disease
1103969|NCT02526758|chronic obstructive|chronic obstructive
1103970|NCT02526758|small airway|small airway
1103971|NCT02526745|vaccine|vaccine
1103972|NCT02526745|safety|safety
1103973|NCT02526745|immunogenicity|immunogenicity
1103974|NCT02526732|NASH|nash
1103975|NCT02526732|fatty Liver|fatty liver
1103976|NCT02526732|VO2 max|vo2 max
1103977|NCT02526732|M30 antigen|m30 antigen
1103978|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
1103979|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
1103980|NCT02526719|nipple sparing|nipple sparing
1103981|NCT02526719|BRCA1 Protein|brca1 protein
1103982|NCT02526706|Bleb filtration|bleb filtration
1103983|NCT02526706|VisionBlue|visionblue
1103984|NCT02526680|OrCam|orcam
1103985|NCT02526680|Low-vision device|low-vision device
1103986|NCT02526680|End-stage glaucoma|end-stage glaucoma
1103987|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
1103988|NCT02526641|sCD163|scd163
1103989|NCT02526641|Portal hypertension|portal hypertension
1103990|NCT02526641|Metabolic liver function|metabolic liver function
1103991|NCT02526641|Cirrhosis|cirrhosis
1103992|NCT02526628|Testosterone|testosterone
1103993|NCT02526628|Neurocognition|neurocognition
1103994|NCT02526615|rosiglitazone|rosiglitazone
1103995|NCT02526615|metformin|metformin
1103996|NCT02526615|muscle|muscle
1103997|NCT02526576|Facial Atrophy|facial atrophy
1103998|NCT02526576|Autologous|autologous
1103999|NCT02526576|Adult|adult
1104001|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
1104002|NCT02526576|Collagenase|collagenase
1104003|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
1104004|NCT02526550|IMOJEV|imojev
1104005|NCT02526550|CD.JEVAX|cd.jevax
1104006|NCT02526550|Booster|booster
1104007|NCT02526550|Thai children|thai children
1104008|NCT02526550|Immunogenicity|immunogenicity
1104009|NCT02526550|Safety|safety
1104010|NCT02526550|Interchangeability|interchangeability
1104011|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
1104012|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
1104013|NCT02526537|Gefitinib|gefitinib
1104014|NCT02526537|NSCLC|nsclc
1104015|NCT02526537|postoperative|postoperative
1104016|NCT02526537|stage Ib|stage ib
1104017|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
1104018|NCT02526485|heparin|heparin
1104019|NCT02526485|thrombocytopenia|thrombocytopenia
1104020|NCT02526485|genomics|genomics
1104021|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
1104022|NCT02526446|Chinese|chinese
1104023|NCT02526446|caregiver stress|caregiver stress
1104222|NCT02525133|bupivacaine|bupivacaine
1104024|NCT02526446|self-administered acupressure|self-administered acupressure
1104025|NCT02526433|depression|depression
1104026|NCT02526433|mental wellbeing|mental wellbeing
1104027|NCT02526433|motherhood|motherhood
1104028|NCT02526433|music|music
1104029|NCT02526433|alternative therapies|alternative therapies
1104030|NCT02526420|VRS-317|vrs-317
1104031|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
1104032|NCT02526420|Versartis|versartis
1104033|NCT02526420|somavaratan|somavaratan
1104034|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
1104035|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
1153871|NCT02243904|Lead|lead
1104036|NCT02526420|AGHD|aghd
1104037|NCT02526420|Growth Hormone Replacement|growth hormone replacement
1104038|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
1104039|NCT02526420|XTEN|xten
1104040|NCT02526407|postnatal depression|postnatal depression
1104041|NCT02526407|mental wellbeing|mental wellbeing
1104042|NCT02526407|baby blues|baby blues
1104043|NCT02526407|mothers|mothers
1104044|NCT02526407|music|music
1104045|NCT02526407|alternative therapies|alternative therapies
1104046|NCT02526355|Maternal depression|maternal depression
1104047|NCT02526355|Mobile phone based intervention|mobile phone based intervention
1104048|NCT02526355|Learning Through Play|learning through play
1104049|NCT02526355|CBT|cbt
1104050|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
1104051|NCT02526316|cervical cancer|cervical cancer
1104052|NCT02526316|vulvar cancer|vulvar cancer
1104053|NCT02526316|vaginal cancer|vaginal cancer
1104054|NCT02526316|penile cancer|penile cancer
1104055|NCT02526316|anal cancer|anal cancer
1104056|NCT02526316|head and neck cancer|head and neck cancer
1104057|NCT02526277|RLS|rls
1104058|NCT02526264|stoma|stoma
1104059|NCT02526264|quality of life|quality of life
1104060|NCT02526251|IBD|ibd
1104061|NCT02526251|Fecal calprotectin|fecal calprotectin
1104062|NCT02526251|Microbiome|microbiome
1104063|NCT02526251|Dysbiosis|dysbiosis
1104064|NCT02526251|Disease activity|disease activity
1104065|NCT02526251|telemedicine|telemedicine
1104066|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
1104067|NCT02526238|trunk rotation|trunk rotation
1104068|NCT02526225|acute ischemic stroke|acute ischemic stroke
1104069|NCT02526225|safety and effectiveness|safety and effectiveness
1104070|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
1104071|NCT02526212|opioid use disorder|opioid use disorder
1104072|NCT02526212|group counseling|group counseling
1104073|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
1104074|NCT02526199|Local anesthetics|local anesthetics
1104075|NCT02526199|Perineural nerve blocks|perineural nerve blocks
1104076|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
1104077|NCT02526160|KRN23|krn23
1104078|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
1104079|NCT02526160|XLH|xlh
1104080|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
1104081|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
1104082|NCT02526095|Esophagus|esophagus
1104083|NCT02526095|Surgery|surgery
1104084|NCT02526082|cardiovascular disease|cardiovascular disease
1104085|NCT02526082|frailty|frailty
1104086|NCT02526082|quality of life|quality of life
1104087|NCT02526082|mortality|mortality
1104088|NCT02526082|prevention|prevention
1104089|NCT02526030|psychosis|psychosis
1104090|NCT02526030|antipsychotic agents|antipsychotic agents
1104091|NCT02526030|treatment|treatment
1104092|NCT02526030|effectiveness|effectiveness
1104093|NCT02526004|Cystic Fibrosis|cystic fibrosis
1104094|NCT02526004|Microbiome|microbiome
1104095|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
1104096|NCT02526004|Resistance|resistance
1104097|NCT02526004|Pathogen Host Interaction|pathogen host interaction
1104098|NCT02525991|schizophrenia|schizophrenia
1104099|NCT02525991|bipolar disorder|bipolar disorder
1104100|NCT02525978|Heart Rate|heart rate
1104101|NCT02525965|Wide resection margin|wide resection margin
1104102|NCT02525965|Recurrence|recurrence
1104103|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
1104104|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1104105|NCT02525952|Hepatectomy|hepatectomy
1104106|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
1104107|NCT02525952|Scoring System|scoring system
1104108|NCT02525913|Breast|breast
1104109|NCT02525913|Mastectomy|mastectomy
1104110|NCT02525874|Tecfidera|tecfidera
1104111|NCT02525874|DMF|dmf
1104112|NCT02525874|dimethyl fumarate|dimethyl fumarate
1104113|NCT02525757|Lung Cancer|lung cancer
1104114|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
1104115|NCT02525757|NSCLC|nsclc
1104116|NCT02525757|Unresectable|unresectable
1104117|NCT02525757|MPDL3280A|mpdl3280a
1104118|NCT02525757|Carboplatin|carboplatin
1104119|NCT02525757|Paraplatin|paraplatin
1104120|NCT02525757|Paclitaxel|paclitaxel
1104121|NCT02525757|Taxol|taxol
1104122|NCT02525757|Radiation therapy|radiation therapy
1104123|NCT02525757|XRT|xrt
1104124|NCT02525731|HIV Infection|hiv infection
1104125|NCT02525731|Pain|pain
1104126|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
1104127|NCT02525731|Addiction|addiction
1104128|NCT02525731|Analgesics, Opioid|analgesics, opioid
1104129|NCT02525718|Breast Reconstruction|breast reconstruction
1104130|NCT02525718|Mastectomy|mastectomy
1104131|NCT02525705|infants|infants
1104132|NCT02525705|oesophageal atresia|oesophageal atresia
1104133|NCT02525705|dumping syndrome|dumping syndrome
1104134|NCT02525705|prevalence|prevalence
1153979|NCT02243436|HL|hl
1104135|NCT02525705|Type III and IV|type iii and iv
1104136|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
1104137|NCT02525705|early hyperglycemia|early hyperglycemia
1104138|NCT02525705|late hypoglycemia|late hypoglycemia
1104139|NCT02525653|Albumin-Bound|albumin-bound
1104140|NCT02525653|Paclitaxel|paclitaxel
1104141|NCT02525653|Gemcitabine|gemcitabine
1104142|NCT02525653|15-054|15-054
1104143|NCT02525640|Single sided hearing loss|single sided hearing loss
1104144|NCT02525640|Single sided deafness|single sided deafness
1104145|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
1104146|NCT02525536|Drug Therapy|drug therapy
1104147|NCT02525510|Mild Hypothermia|mild hypothermia
1104148|NCT02525510|Machine Perfusion|machine perfusion
1104149|NCT02525510|Kidney Transplantation|kidney transplantation
1104150|NCT02525497|Automated PD|automated pd
1104151|NCT02525497|Effectiveness|effectiveness
1104152|NCT02525497|Safety|safety
1104153|NCT02525497|Manipulability|manipulability
1104154|NCT02525458|antimicrobial|antimicrobial
1104155|NCT02525458|biofilms|biofilms
1104156|NCT02525458|acrylic resin|acrylic resin
1104157|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
1104158|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
1104159|NCT02525458|split-mouth design|split-mouth design
1104160|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
1104161|NCT02525445|placebo effects|placebo effects
1104162|NCT02525445|communication|communication
1104163|NCT02525445|acupuncture therapy|acupuncture therapy
1104164|NCT02525445|relaxation|relaxation
1104165|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
1104166|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
1104167|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
1104168|NCT02525393|Rehabilitation|rehabilitation
1104169|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
1104170|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
1104171|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
1104172|NCT02525380|DC Bead TACE|dc bead tace
1104173|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
1104174|NCT02525367|Parkinson's disease|parkinson's disease
1104175|NCT02525367|Multiple Sclerosis|multiple sclerosis
1104176|NCT02525367|Depressed Elderly|depressed elderly
1104177|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
1104178|NCT02525367|Online Cognitive Training|online cognitive training
1104179|NCT02525354|arachidonic aci|arachidonic aci
1104180|NCT02525354|adiposity|adiposity
1104181|NCT02525354|atopy|atopy
1104182|NCT02525341|Yoga|yoga
1104183|NCT02525341|exercises|exercises
1104184|NCT02525341|knee osteoarthritis|knee osteoarthritis
1104185|NCT02525341|older adults|older adults
1104186|NCT02525328|Constitutional Thinness|constitutional thinness
1104187|NCT02525328|linkage study|linkage study
1104188|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
1104189|NCT02525315|Schizophrenia|schizophrenia
1104190|NCT02525315|auditory hallucinations|auditory hallucinations
1104191|NCT02525315|TMS|tms
1104192|NCT02525302|DMD|dmd
1104193|NCT02525302|neuromuscular|neuromuscular
1104194|NCT02525302|Duchenne|duchenne
1104195|NCT02525289|mobility|mobility
1104196|NCT02525289|coronary artery bypass|coronary artery bypass
1104197|NCT02525289|positioning|positioning
1104198|NCT02525289|body|body
1104199|NCT02525263|Neo-Kidney Augment|neo-kidney augment
1104200|NCT02525263|Type 2 Diabetes|type 2 diabetes
1104201|NCT02525263|Chronic Kidney Disease|chronic kidney disease
1104202|NCT02525263|Cell Therapy|cell therapy
1104203|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
1104204|NCT02525198|Mild cognitive impairment|mild cognitive impairment
1104205|NCT02525198|Subjective memory impairment|subjective memory impairment
1104206|NCT02525198|Dementia|dementia
1104207|NCT02525198|Flavonoids|flavonoids
1104208|NCT02525198|Fatty acids|fatty acids
1104209|NCT02525198|Cognition|cognition
1104210|NCT02525198|Gut microflora|gut microflora
1104211|NCT02525172|immune modulation therapy|immune modulation therapy
1104212|NCT02525172|acid α-glucosidase|acid α-glucosidase
1104213|NCT02525172|antibody|antibody
1104214|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
1104215|NCT02525159|premenopause|premenopause
1104216|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
1104217|NCT02525146|HIV|hiv
1104218|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
1104219|NCT02525146|ARTAS|artas
1104220|NCT02525133|post operative pain|post operative pain
1104221|NCT02525133|hernioplasty|hernioplasty
1104223|NCT02525120|Disc herniation|disc herniation
1104224|NCT02525120|Herniated disc|herniated disc
1104225|NCT02525120|Triojection|triojection
1104226|NCT02525120|Ozone|ozone
1104227|NCT02525120|Lumbar spine|lumbar spine
1104228|NCT02525120|Leg pain|leg pain
1104229|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
1104230|NCT02525094|Eczema|eczema
1104231|NCT02525081|Microvascular Angina|microvascular angina
1104232|NCT02525081|therapy|therapy
1104233|NCT02525068|enzalutamide|enzalutamide
1104234|NCT02525068|AZD5363|azd5363
1104235|NCT02525068|Prostate|prostate
1104236|NCT02525055|Flu|flu
1104237|NCT02525055|Influenza|influenza
1104238|NCT02525055|Human Viral Challenge Model|human viral challenge model
1104239|NCT02525055|Wild-Type|wild-type
1104240|NCT02525055|H3N2|h3n2
1104241|NCT02525055|H1N1|h1n1
1104242|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
1104243|NCT02525055|intra-seasonal vaccines|intra-seasonal vaccines
1104244|NCT02525055|antiviral|antiviral
1104245|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
1104246|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
1104247|NCT02525042|RNA|rna
1104248|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
1104249|NCT02525042|Lod score|lod score
1104250|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
1104251|NCT02525029|GVHD|gvhd
1104252|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
1104253|NCT02525003|vitamin D|vitamin d
1104254|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
1104255|NCT02525003|vitamin D2|vitamin d2
1104256|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
1104257|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
1104258|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
1104259|NCT02525003|randomized controlled trial|randomized controlled trial
1104260|NCT02525003|vitamin D3|vitamin d3
1104261|NCT02525003|bioavailability|bioavailability
1104262|NCT02524990|Medical abortion|medical abortion
1104263|NCT02524990|pregnancy tests|pregnancy tests
1104264|NCT02524964|left ventricular remodeling|left ventricular remodeling
1104265|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1104266|NCT02524964|acute myocardial infarction|acute myocardial infarction
1104267|NCT02524938|Dietary polyphenols|dietary polyphenols
1104268|NCT02524938|Protein glycation|protein glycation
1104269|NCT02524925|fast track surgery|fast track surgery
1104270|NCT02524925|eras program|eras program
1104271|NCT02524925|hepatectomy|hepatectomy
1104272|NCT02524925|pancreatectomy|pancreatectomy
1104273|NCT02524925|NPY|npy
1104274|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
1104275|NCT02524925|postoperative stress|postoperative stress
1104276|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
1104277|NCT02524899|SPD|spd
1104278|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
1104279|NCT02524899|CRT|crt
1104280|NCT02524899|guanfacine|guanfacine
1104281|NCT02524899|cognitive impairment|cognitive impairment
1104282|NCT02524899|working memory|working memory
1104283|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
1104284|NCT02524899|neuropsychological testing|neuropsychological testing
1104285|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
1104286|NCT02524899|Personality Disorders|personality disorders
1104287|NCT02524886|Deep Brain Simulation|deep brain simulation
1104288|NCT02524886|Psychiatric|psychiatric
1104289|NCT02524886|Side-effects|side-effects
1104290|NCT02524860|Prostate Cancer|prostate cancer
1104291|NCT02524860|Biopsy|biopsy
1104292|NCT02524860|Focal Healthcare|focal healthcare
1104293|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
1104294|NCT02524860|High Risk Cancer|high risk cancer
1104295|NCT02524860|Imaging|imaging
1104296|NCT02524860|Diagnostic|diagnostic
1104297|NCT02524860|Ultrasound|ultrasound
1104397|NCT02524015|contraversive pushing|contraversive pushing
1104298|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
1104299|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
1104300|NCT02524860|Focal-Fusion Bx|focal-fusion bx
1104301|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
1104302|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
1104303|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
1104304|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
1104305|NCT02524769|Urinary Incontinence|urinary incontinence
1104306|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
1104307|NCT02524743|Rocuronium|rocuronium
1104308|NCT02524743|lidocaine|lidocaine
1104309|NCT02524743|acetaminophen,|acetaminophen,
1104310|NCT02524743|pain|pain
1104311|NCT02524743|injection|injection
1104312|NCT02524717|Hepatic Impairment|hepatic impairment
1104313|NCT02524717|JNJ-56021927|jnj-56021927
1104314|NCT02524704|Cystic fibrosis|cystic fibrosis
1104315|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
1104316|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
1104317|NCT02524626|Postoperative ileus|postoperative ileus
1104318|NCT02524561|mammographic density|mammographic density
1104319|NCT02524561|abnormal mammogram|abnormal mammogram
1104320|NCT02524561|biopsy|biopsy
1104321|NCT02524548|Aromatase inhibitors|aromatase inhibitors
1104322|NCT02524548|Reminder Systems|reminder systems
1104323|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
1104324|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
1104325|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
1104326|NCT02524509|Chonodron|chonodron
1104327|NCT02524509|Microfracture|microfracture
1104328|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
1104329|NCT02524509|cartilage defect of knee|cartilage defect of knee
1104330|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
1104331|NCT02524444|malaria|malaria
1104332|NCT02524444|pregnant|pregnant
1104333|NCT02524444|HIV positive|hiv positive
1104334|NCT02524444|Prevention|prevention
1104335|NCT02524431|Mitochondria|mitochondria
1104336|NCT02524431|trabeculectomy|trabeculectomy
1104337|NCT02524431|trabecular meshwork|trabecular meshwork
1104338|NCT02524431|Glaucoma surgery|glaucoma surgery
1104339|NCT02524418|Main Pancreatic Duct|main pancreatic duct
1104340|NCT02524392|independent medical evaluation|independent medical evaluation
1104341|NCT02524392|sick leave|sick leave
1104342|NCT02524392|sickness absence|sickness absence
1104343|NCT02524392|physician primary care|physician primary care
1104344|NCT02524392|general practitioner|general practitioner
1104345|NCT02524392|family physician|family physician
1104346|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
1104347|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
1104348|NCT02524353|cardiac surgery|cardiac surgery
1104349|NCT02524340|JIA|jia
1104350|NCT02524340|Arthritis|arthritis
1104351|NCT02524340|pJIA|pjia
1104352|NCT02524340|PCATS|pcats
1104353|NCT02524301|anorexia nervosa|anorexia nervosa
1104354|NCT02524301|opioid receptors|opioid receptors
1104355|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
1104356|NCT02524301|diprenorphine|diprenorphine
1104357|NCT02524262|atrohpic gastritis|atrohpic gastritis
1104358|NCT02524262|acetaldehyde|acetaldehyde
1104359|NCT02524262|ethanol|ethanol
1104360|NCT02524262|L-cysteine|l-cysteine
1104361|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
1104362|NCT02524223|medically assisted procreation|medically assisted procreation
1104363|NCT02524210|volunteers|volunteers
1104364|NCT02524197|Hip|hip
1104365|NCT02524197|Knee|knee
1104366|NCT02524197|Arthritis|arthritis
1104367|NCT02524197|pain|pain
1104368|NCT02524197|CR845|cr845
1104369|NCT02524197|kappa opioid|kappa opioid
1104370|NCT02524171|crime|crime
1104371|NCT02524171|mental health|mental health
1104372|NCT02524171|substance abuse|substance abuse
1104373|NCT02524171|homelessness|homelessness
1104374|NCT02524171|Veterans|veterans
1104375|NCT02524158|Yoga|yoga
1104376|NCT02524158|Mind-Body Therapies|mind-body therapies
1104377|NCT02524158|Chronic Low Back Pain|chronic low back pain
1104378|NCT02524158|Military Veterans|military veterans
1104379|NCT02524158|VA patients|va patients
1104380|NCT02524080|Ambulance|ambulance
1104381|NCT02524080|Trust|trust
1104382|NCT02524080|Patients|patients
1104383|NCT02524080|Healthcare chain|healthcare chain
1104384|NCT02524054|Dyspnea|dyspnea
1104385|NCT02524054|Hospitalized patients|hospitalized patients
1104386|NCT02524054|Ambulatory outpatients|ambulatory outpatients
1104387|NCT02524054|Shortness of breath|shortness of breath
1104388|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1104389|NCT02524054|Pulmonary disease|pulmonary disease
1104390|NCT02524041|Hyperparathyroidism|hyperparathyroidism
1104391|NCT02524041|microarchitecture|microarchitecture
1104392|NCT02524041|periostin|periostin
1104393|NCT02524028|Atrial Fibrillation|atrial fibrillation
1104394|NCT02524028|fMRI|fmri
1104395|NCT02524015|stroke|stroke
1104396|NCT02524015|pusher syndrome|pusher syndrome
1104398|NCT02524015|lateropulsion|lateropulsion
1104399|NCT02524015|rehabilitation|rehabilitation
1104400|NCT02524015|physical therapy|physical therapy
1104401|NCT02524002|Abnormal Labor|abnormal labor
1104402|NCT02524002|Prolonged Induction|prolonged induction
1104403|NCT02524002|Ketosis|ketosis
1104404|NCT02524002|Diet|diet
1104405|NCT02523989|arsenic|arsenic
1104406|NCT02523989|heavy metal|heavy metal
1104407|NCT02523976|Acute|acute
1104408|NCT02523976|Leukemia|leukemia
1104409|NCT02523976|Lymphoid|lymphoid
1104410|NCT02523976|Philadelphia chromosome|philadelphia chromosome
1104411|NCT02523976|dasatinib|dasatinib
1104412|NCT02523963|family work shop|family work shop
1104413|NCT02523937|Pulmonary Embolism|pulmonary embolism
1104414|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
1104415|NCT02523937|Soluble Fibrin|soluble fibrin
1104416|NCT02523937|D-Dimers|d-dimers
1104417|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
1104418|NCT02523911|Suprep|suprep
1104419|NCT02523911|Simethicone|simethicone
1104420|NCT02523911|Colorectal cancer screening|colorectal cancer screening
1104421|NCT02523911|Routine colonoscopy|routine colonoscopy
1104422|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
1104423|NCT02523911|Bowel cleansing|bowel cleansing
1104424|NCT02523911|Mass screening|mass screening
1104425|NCT02523898|Clomiphene|clomiphene
1104426|NCT02523898|infertility|infertility
1104427|NCT02523898|insuline resistant|insuline resistant
1104428|NCT02523898|metformine|metformine
1104429|NCT02523898|PCOS|pcos
1104430|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
1104431|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
1104432|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
1104433|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1104434|NCT02523872|Fluid overload|fluid overload
1104435|NCT02523872|Acute respiratory failure|acute respiratory failure
1104436|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
1104437|NCT02523872|Medication administration|medication administration
1104438|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
1104439|NCT02523846|background morphine infusion|background morphine infusion
1104440|NCT02523846|patient re-education|patient re-education
1104441|NCT02523781|preeclampsia|preeclampsia
1104442|NCT02523781|information pamphlet|information pamphlet
1104443|NCT02523781|patient education|patient education
1104444|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
1104445|NCT02523755|respiratory function|respiratory function
1104446|NCT02523755|electrical impedance tomography|electrical impedance tomography
1104447|NCT02523729|lactation|lactation
1104448|NCT02523729|human milk|human milk
1104449|NCT02523729|maltz|maltz
1104450|NCT02523729|antioxidant|antioxidant
1104451|NCT02523716|Hypoxic conditioning|hypoxic conditioning
1104452|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
1104453|NCT02523651|Periodontal Diseases|periodontal diseases
1104454|NCT02523651|Bone Regeneration|bone regeneration
1104455|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
1104456|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
1104457|NCT02523638|Polycythemia Vera|polycythemia vera
1104458|NCT02523638|PEN-PV|pen-pv
1104459|NCT02523638|PROUD-PV|proud-pv
1104460|NCT02523638|CONTINUATION-PV|continuation-pv
1104461|NCT02523638|AOP Orphan|aop orphan
1104462|NCT02523638|Polycythemia|polycythemia
1104463|NCT02523638|Hematologic Diseases|hematologic diseases
1104464|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
1104465|NCT02523638|Bone Marrow Diseases|bone marrow diseases
1104466|NCT02523638|Interferon-alpha|interferon-alpha
1104467|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
1104468|NCT02523625|Ultrasound|ultrasound
1104469|NCT02523599|post operative pain|post operative pain
1104470|NCT02523599|hernioplasty|hernioplasty
1104471|NCT02523599|bupivacaine|bupivacaine
1104472|NCT02523586|oxygen concentration|oxygen concentration
1104473|NCT02523586|oxygen therapy|oxygen therapy
1104474|NCT02523586|oxygen delivery|oxygen delivery
1104475|NCT02523586|oxygen masks|oxygen masks
1104476|NCT02523560|Telerehabilitation|telerehabilitation
1104477|NCT02523560|Home Monitoring|home monitoring
1104478|NCT02523560|Heart Failure|heart failure
1104479|NCT02523547|entecavir|entecavir
1104480|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
1104481|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
1104482|NCT02523495|biomarker|biomarker
1104483|NCT02523482|Prescriptions|prescriptions
1104484|NCT02523482|Epidemiology|epidemiology
1104485|NCT02523482|STOPP/START Criteria|stopp/start criteria
1104486|NCT02523482|Beers Criteria|beers criteria
1104487|NCT02523456|Early warning score|early warning score
1104488|NCT02523456|Cardiac arrest|cardiac arrest
1104489|NCT02523443|Epidural Analgesia|epidural analgesia
1104490|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
1104491|NCT02523443|15-148|15-148
1104492|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1104493|NCT02523430|HepaSphere|hepasphere
1104494|NCT02523417|Breast Cancer|breast cancer
1104495|NCT02523417|HepaSphere|hepasphere
1104496|NCT02523404|Lung Cancer|lung cancer
1104497|NCT02523404|HepaSphere|hepasphere
1104498|NCT02523378|Advanced Cancers|advanced cancers
1104499|NCT02523378|Recurrent|recurrent
1104500|NCT02523378|Locally advanced|locally advanced
1104501|NCT02523378|Metastatic|metastatic
1104502|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
1104504|NCT02523378|Survey|survey
1104505|NCT02523378|Interview|interview
1104506|NCT02523378|Symptom questionnaire|symptom questionnaire
1104507|NCT02523365|Cervical Carcinoma|cervical carcinoma
1104508|NCT02523365|HepaSphere|hepasphere
1104509|NCT02523326|Genomic DNA|genomic dna
1104510|NCT02523326|chronic periodontitis|chronic periodontitis
1104511|NCT02523326|saliva|saliva
1104512|NCT02523326|mouthwash|mouthwash
1104514|NCT02523326|genotyping|genotyping
1104515|NCT02523326|sequencing|sequencing
1104516|NCT02523235|moderate pain|moderate pain
1104517|NCT02523235|severe pain|severe pain
1104518|NCT02523235|surgery|surgery
1104519|NCT02523235|postop analgesia|postop analgesia
1104520|NCT02523235|TKA|tka
1104521|NCT02523235|adductor catheter|adductor catheter
1104522|NCT02523235|poplital catheter|poplital catheter
1104523|NCT02523235|foot/ankle surgery|foot/ankle surgery
1104524|NCT02523222|dextrose gel|dextrose gel
1104525|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
1104526|NCT02523222|late preterm infant|late preterm infant
1104527|NCT02523222|large for gestational age|large for gestational age
1104528|NCT02523222|small for gestational age|small for gestational age
1104529|NCT02523222|prophylactic|prophylactic
1104530|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
1104531|NCT02523209|Osteoporosis|osteoporosis
1104532|NCT02523209|chronic kidney disease|chronic kidney disease
1104533|NCT02523209|kidney transplantation|kidney transplantation
1104534|NCT02523209|fracture risk|fracture risk
1104535|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
1104536|NCT02523196|HepQuant-SHUNT|hepquant-shunt
1104537|NCT02523196|Liver Function|liver function
1104538|NCT02523183|Epilepsy|epilepsy
1104539|NCT02523183|Marijuana|marijuana
1104540|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
1104541|NCT02523144|echo|echo
1104542|NCT02523144|TTE|tte
1104543|NCT02523131|Type 1 diabetes|type 1 diabetes
1104544|NCT02523131|Closed-loop glucose control|closed-loop glucose control
1104545|NCT02523131|Artificial Pancreas|artificial pancreas
1104546|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1104547|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
1104548|NCT02523131|threshold suspend|threshold suspend
1104549|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
1104550|NCT02523092|sarcoidosis|sarcoidosis
1104551|NCT02523092|Acthar|acthar
1104552|NCT02523092|CXCL9|cxcl9
1104553|NCT02523092|chemokine ligand 9|chemokine ligand 9
1104554|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
1104555|NCT02523053|Recurrence|recurrence
1104556|NCT02523053|Microvascular Invasion|microvascular invasion
1104557|NCT02523053|5-Fluorouracil|5-fluorouracil
1104558|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
1104559|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
1104560|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
1104561|NCT02522988|cancer-related fatigue|cancer-related fatigue
1104562|NCT02522975|biosimilar epoetin|biosimilar epoetin
1104563|NCT02522975|efficacy|efficacy
1104564|NCT02522975|safety|safety
1104565|NCT02522975|immunogenicity|immunogenicity
1104566|NCT02522975|renal anaemia|renal anaemia
1104567|NCT02522962|physical therapy|physical therapy
1104568|NCT02522962|group-based|group-based
1104569|NCT02522962|core stability|core stability
1104570|NCT02522962|balance|balance
1104571|NCT02522962|movement quality|movement quality
1104572|NCT02522962|somatosensory stimulation|somatosensory stimulation
1104573|NCT02522962|coordination|coordination
1104574|NCT02522923|Physical Therapy Modalities|physical therapy modalities
1104575|NCT02522923|Primary Care|primary care
1104576|NCT02522923|Health Services Research|health services research
1104577|NCT02522884|Angioplasty|angioplasty
1104578|NCT02522884|Peripheral Artery Disease|peripheral artery disease
1104579|NCT02522884|PAD|pad
1104580|NCT02522884|Lesion|lesion
1104581|NCT02522884|Claudication|claudication
1104582|NCT02522858|premedication|premedication
1104583|NCT02522858|dexmedetomidine|dexmedetomidine
1104584|NCT02522858|anesthesia, spinal|anesthesia, spinal
1104585|NCT02522845|Varicose Veins|varicose veins
1104586|NCT02522845|Compression Stockings|compression stockings
1104587|NCT02522845|Laser Ablation|laser ablation
1104588|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1104589|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1104590|NCT02522819|acute stroke|acute stroke
1104591|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
1104592|NCT02522806|Endometrial biopsy|endometrial biopsy
1104593|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
1104594|NCT02522806|first IVF|first ivf
1104595|NCT02522806|antagonist protocol|antagonist protocol
1104596|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
1104597|NCT02522793|skin lesion|skin lesion
1104598|NCT02522728|Knee|knee
1104599|NCT02522728|Arthroplasty|arthroplasty
1104600|NCT02522728|Implant|implant
1104601|NCT02522689|kidney stone|kidney stone
1104602|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
1104603|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
1104604|NCT02522689|micro PCNL|micro pcnl
1104605|NCT02522676|kidney stone|kidney stone
1104606|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
1104607|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
1104608|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
1104609|NCT02522676|mini PCNL|mini pcnl
1104610|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
1104611|NCT02522676|micro PCNL|micro pcnl
1104612|NCT02522663|telephone support|telephone support
1104613|NCT02522663|discharge management|discharge management
1104614|NCT02522663|readmission|readmission
1104615|NCT02522663|aortic valve replacement|aortic valve replacement
1104616|NCT02522650|amiloride|amiloride
1104818|NCT02521311|eye pain|eye pain
1104617|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
1104618|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
1104619|NCT02522650|proteinuria|proteinuria
1104620|NCT02522637|exercise|exercise
1104621|NCT02522637|training|training
1104622|NCT02522637|endurance|endurance
1104623|NCT02522624|Health insurance|health insurance
1104624|NCT02522624|Health services accessibility|health services accessibility
1104625|NCT02522624|Decision making|decision making
1104626|NCT02522624|Health literacy|health literacy
1104627|NCT02522611|Palliative Care|palliative care
1104628|NCT02522611|Adults|adults
1104629|NCT02522611|Cancer Pain|cancer pain
1104630|NCT02522611|Nerve Block|nerve block
1104631|NCT02522611|Quality of Life|quality of life
1104632|NCT02522585|expectant management|expectant management
1104634|NCT02522585|immunohistochemistry|immunohistochemistry
1104635|NCT02522585|regression|regression
1104636|NCT02522585|progression|progression
1104637|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1104638|NCT02522572|Renal Transplantation|renal transplantation
1104639|NCT02522572|Desensitization|desensitization
1104640|NCT02522572|plerixafor|plerixafor
1104641|NCT02522572|bortezomib|bortezomib
1104642|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
1104643|NCT02522520|Exercise intervention|exercise intervention
1104644|NCT02522520|Health counselling|health counselling
1104645|NCT02522520|Symptom management|symptom management
1104646|NCT02522481|Lumason|lumason
1104647|NCT02522481|Dobutamine stress echo|dobutamine stress echo
1104648|NCT02522481|stress echo|stress echo
1104649|NCT02522481|coronary artery disease|coronary artery disease
1104650|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
1104651|NCT02522403|distal radius fracture|distal radius fracture
1104652|NCT02522403|laser acupuncture|laser acupuncture
1104653|NCT02522403|rehabilitation|rehabilitation
1104654|NCT02522390|data collection|data collection
1104655|NCT02522390|personal health services|personal health services
1104656|NCT02522390|personal health records|personal health records
1104657|NCT02522390|do-it-yourself|do-it-yourself
1104658|NCT02522390|nutrition researchers|nutrition researchers
1104659|NCT02522390|cohort studies|cohort studies
1104660|NCT02522390|databases, factual|databases, factual
1104661|NCT02522390|self-quantification methods|self-quantification methods
1104662|NCT02522377|Ketamine|ketamine
1104663|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
1104664|NCT02522377|Major Depressive Disorder|major depressive disorder
1104665|NCT02522377|Treatment Resistant Depression|treatment resistant depression
1104666|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
1104667|NCT02522377|Severe depression|severe depression
1104668|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
1104669|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
1104670|NCT02522312|Dry Eye|dry eye
1104671|NCT02522299|double-blind|double-blind
1104672|NCT02522299|PI3Kdelta|pi3kdelta
1104673|NCT02522299|GSK2269557|gsk2269557
1104674|NCT02522299|exacerbation|exacerbation
1104675|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1104676|NCT02522299|randomised|randomised
1104677|NCT02522299|placebo-controlled|placebo-controlled
1104678|NCT02522286|patient engagement|patient engagement
1104679|NCT02522286|physician's role|physician's role
1104680|NCT02522286|patient- centered care|patient- centered care
1104681|NCT02522286|communication|communication
1104682|NCT02522273|Obstetric|obstetric
1104683|NCT02522273|Midwifery|midwifery
1104684|NCT02522273|Fetal blood sample|fetal blood sample
1104685|NCT02522273|Lactate|lactate
1104686|NCT02522273|Handheld meter|handheld meter
1104687|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
1104688|NCT02522234|Neutropenia|neutropenia
1104689|NCT02522234|Chemotherapy|chemotherapy
1104690|NCT02522221|chronic anticoagulation|chronic anticoagulation
1104691|NCT02522221|vitamin K antagonist|vitamin k antagonist
1104692|NCT02522221|mechanical heart valve|mechanical heart valve
1104693|NCT02522221|CYP2C9|cyp2c9
1104694|NCT02522221|warfarin|warfarin
1104695|NCT02522221|tecarfarin|tecarfarin
1104696|NCT02522221|chronic kidney disease|chronic kidney disease
1104697|NCT02522195|shift work|shift work
1104698|NCT02522195|nutritional status|nutritional status
1104699|NCT02522195|nursing professionals|nursing professionals
1104700|NCT02522195|meal distribution|meal distribution
1104701|NCT02522195|food intake|food intake
1104702|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
1104703|NCT02522182|Nurse's Role|nurse's role
1104704|NCT02522143|self-harm|self-harm
1104705|NCT02522143|self-mutilation|self-mutilation
1104706|NCT02522143|cutting|cutting
1104707|NCT02522117|Kidney Transplantation|kidney transplantation
1104708|NCT02522117|Atorvastatin|atorvastatin
1104709|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
1104710|NCT02522117|Interleukin|interleukin
1104711|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
1104712|NCT02522078|misoprostol|misoprostol
1104713|NCT02522078|abortion|abortion
1104714|NCT02522065|Hypokinesia|hypokinesia
1104819|NCT02521311|vision loss|vision loss
1104715|NCT02522065|Patient Outcome Assessment|patient outcome assessment
1104716|NCT02522013|post-dural puncture headache|post-dural puncture headache
1104717|NCT02522013|Aminophylline|aminophylline
1104718|NCT02521948|MANTA|manta
1104719|NCT02521948|Arterial Closure Device|arterial closure device
1104720|NCT02521948|Large Bore Closure Device|large bore closure device
1104721|NCT02521909|Root Canal length|root canal length
1104722|NCT02521909|Electronic apex locator|electronic apex locator
1104723|NCT02521909|Endodontics|endodontics
1104724|NCT02521870|Skin Cancer|skin cancer
1104725|NCT02521870|Skin Tumors|skin tumors
1104726|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1104727|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
1104728|NCT02521857|Alkermes|alkermes
1104729|NCT02521857|Samidorphan|samidorphan
1104730|NCT02521857|ALKS 5461|alks 5461
1104731|NCT02521857|Healthy Volunteer|healthy volunteer
1104732|NCT02521857|Pharmacokinetics|pharmacokinetics
1104733|NCT02521844|solid tumors|solid tumors
1104734|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
1104735|NCT02521831|Circumcision|circumcision
1104736|NCT02521818|cognition|cognition
1104737|NCT02521818|dementia|dementia
1104738|NCT02521818|neuropsychological|neuropsychological
1104739|NCT02521818|elderly|elderly
1104740|NCT02521818|nutrition|nutrition
1104741|NCT02521818|diet|diet
1104742|NCT02521805|Appetite|appetite
1104743|NCT02521805|Protein|protein
1104744|NCT02521805|Protein quality|protein quality
1104745|NCT02521805|Dietary fibre|dietary fibre
1104746|NCT02521805|Satiety|satiety
1104747|NCT02521792|Open-label study|open-label study
1104748|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
1104749|NCT02521792|Efficacy and safety|efficacy and safety
1104750|NCT02521792|Heterotopic ossification|heterotopic ossification
1104751|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
1104752|NCT02521792|Flare-up|flare-up
1104753|NCT02521792|Palovarotene|palovarotene
1104754|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
1104755|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
1104756|NCT02521792|Clementia|clementia
1104757|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
1104758|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
1104759|NCT02521792|FOP|fop
1104760|NCT02521779|Inflammation|inflammation
1104761|NCT02521779|Endotoxemia|endotoxemia
1104762|NCT02521779|Lipopolysaccharide|lipopolysaccharide
1104763|NCT02521779|Diet|diet
1104764|NCT02521779|Fat|fat
1104765|NCT02521779|Postprandial|postprandial
1104766|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
1104767|NCT02521753|Obesity|obesity
1104768|NCT02521753|Metformin|metformin
1104769|NCT02521753|Magnesium|magnesium
1104770|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
1104771|NCT02521740|biological marker|biological marker
1104772|NCT02521740|frailty|frailty
1104773|NCT02521740|burden|burden
1104774|NCT02521740|nutrition|nutrition
1104775|NCT02521740|elderly|elderly
1104776|NCT02521714|Revlimid|revlimid
1104777|NCT02521714|lenalidomide|lenalidomide
1104778|NCT02521714|bioavailability|bioavailability
1104779|NCT02521714|healthy volunteers|healthy volunteers
1104780|NCT02521714|food effect|food effect
1104781|NCT02521714|pharmacokinetics|pharmacokinetics
1104782|NCT02521662|Electronic Cigarettes|electronic cigarettes
1104783|NCT02521662|Nicotine Patch|nicotine patch
1104784|NCT02521662|Smoking Cessation|smoking cessation
1104785|NCT02521649|Gastric Cancer|gastric cancer
1104786|NCT02521649|G17DT|g17dt
1104787|NCT02521649|PAS|pas
1104788|NCT02521649|Insegia|insegia
1104789|NCT02521649|Gastrimmune|gastrimmune
1104790|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
1104791|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
1104792|NCT02521623|Breast Implant|breast implant
1104793|NCT02521584|Liver transplant recipient|liver transplant recipient
1104794|NCT02521558|Cognitive rehabilitation|cognitive rehabilitation
1104795|NCT02521558|Mobile electronic application|mobile electronic application
1104796|NCT02521558|Memory tasks|memory tasks
1104797|NCT02521545|Oral Remyelination|oral remyelination
1104798|NCT02521519|Facet induced pain|facet induced pain
1104799|NCT02521519|Myofascial pain|myofascial pain
1104800|NCT02521519|Trigger points|trigger points
1104801|NCT02521519|Low back pain|low back pain
1104802|NCT02521454|policing|policing
1104803|NCT02521454|resilience|resilience
1104804|NCT02521454|implicit bias|implicit bias
1104805|NCT02521454|violence|violence
1104806|NCT02521441|Neutropenia|neutropenia
1104807|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
1104808|NCT02521441|G-CSF|g-csf
1104809|NCT02521363|Implantable Microdevice|implantable microdevice
1104810|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
1104811|NCT02521363|HER2-Positive|her2-positive
1104812|NCT02521363|Triple Negative|triple negative
1104813|NCT02521363|15-127|15-127
1104814|NCT02521350|Acute Kidney Injury|acute kidney injury
1104815|NCT02521350|Surgery|surgery
1104816|NCT02521350|Perioperative care|perioperative care
1104817|NCT02521311|multiple sclerosis|multiple sclerosis
1104820|NCT02521259|anesthetic depth|anesthetic depth
1104821|NCT02521259|emergence agitation|emergence agitation
1104822|NCT02521220|L-citrulline|l-citrulline
1104823|NCT02521220|Endothelial dysfunction|endothelial dysfunction
1104824|NCT02521194|Advanced Cancers|advanced cancers
1104825|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
1104826|NCT02521194|Questionnaire|questionnaire
1104827|NCT02521194|Survey|survey
1104828|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
1104829|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
1104830|NCT02521168|congenital heart disease|congenital heart disease
1104831|NCT02521168|time to extubation|time to extubation
1104832|NCT02521155|Oral health literacy intervention|oral health literacy intervention
1104833|NCT02521155|oral hygiene behavior|oral hygiene behavior
1104834|NCT02521142|OCT Angiography|oct angiography
1104835|NCT02521116|retinal oxygenation|retinal oxygenation
1104836|NCT02521116|retinal vessel diameters|retinal vessel diameters
1104837|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
1104838|NCT02521116|Oxymap T1|oxymap t1
1104839|NCT02521077|Ascorbic Acid|ascorbic acid
1104840|NCT02521077|Breast Neoplasms|breast neoplasms
1104841|NCT02521077|Fatigue|fatigue
1104842|NCT02521064|IBD|ibd
1104843|NCT02521064|enteral nutrition|enteral nutrition
1104844|NCT02521064|corticosteroids|corticosteroids
1104845|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1104846|NCT02521051|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
1104847|NCT02521051|ALK|alk
1104848|NCT02521051|Brain metastases|brain metastases
1104849|NCT02521012|Depression|depression
1104850|NCT02521012|Depressive symptoms|depressive symptoms
1104851|NCT02521012|Vitamin D|vitamin d
1104852|NCT02521012|Intervention|intervention
1104853|NCT02520986|Sexually transmitted disease|sexually transmitted disease
1104854|NCT02520986|Genital Warts|genital warts
1104855|NCT02520986|Venereal Warts|venereal warts
1104856|NCT02520960|Catheter Ablation|catheter ablation
1104857|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
1104858|NCT02520960|Radiofrequency|radiofrequency
1104859|NCT02520947|desflurane|desflurane
1104860|NCT02520947|BIS|bis
1104861|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
1104862|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
1104863|NCT02520934|Miglustat|miglustat
1104864|NCT02520934|Gaucher Disease|gaucher disease
1104865|NCT02520921|Diabetes mellitus|diabetes mellitus
1104866|NCT02520921|Acute coronary syndrome|acute coronary syndrome
1104867|NCT02520921|Coronary artery disease|coronary artery disease
1104868|NCT02520921|Aspirin|aspirin
1104869|NCT02520921|Secondary prevention|secondary prevention
1104870|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1104871|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1104872|NCT02520895|Follicular Lymphoma|follicular lymphoma
1104873|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1104874|NCT02520895|MALT Lymphoma|malt lymphoma
1104875|NCT02520895|T Cell Lymphoma|t cell lymphoma
1104876|NCT02520895|Immune Repertoire|immune repertoire
1104877|NCT02520895|Infection|infection
1104878|NCT02520895|relapse|relapse
1104879|NCT02520895|survival|survival
1104880|NCT02520895|treatment response|treatment response
1104881|NCT02520895|VJ rearrangement|vj rearrangement
1104882|NCT02520882|PET/CT|pet/ct
1104883|NCT02520882|Bombesin|bombesin
1104884|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
1104885|NCT02520882|68Gallium labeling|68gallium labeling
1104886|NCT02520830|blueberry polyphenols|blueberry polyphenols
1104887|NCT02520830|Polyphenol metabolites|polyphenol metabolites
1104888|NCT02520830|endothelial function|endothelial function
1104889|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
1104890|NCT02520830|Vascular function|vascular function
1104891|NCT02520830|Healthy men|healthy men
1104892|NCT02520817|Antioxidants|antioxidants
1104893|NCT02520817|Zinc|zinc
1104894|NCT02520817|Truck drivers|truck drivers
1104895|NCT02520804|balanced salt solution|balanced salt solution
1104896|NCT02520765|Obesity Index, ICSI|obesity index, icsi
1104897|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
1104898|NCT02520739|olive oil|olive oil
1104899|NCT02520739|phenolic compounds|phenolic compounds
1104900|NCT02520739|triterpenes|triterpenes
1104901|NCT02520739|oxidation and inflammation|oxidation and inflammation
1104902|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
1104903|NCT02520726|PTSD|ptsd
1104904|NCT02520726|Sertraline|sertraline
1104905|NCT02520726|Burns|burns
1104906|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
1104907|NCT02520648|Back pain|back pain
1104908|NCT02520648|Manual therapy|manual therapy
1104909|NCT02520635|prognosis|prognosis
1104910|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
1104911|NCT02520609|Metabolomics|metabolomics
1104912|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1104913|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1104914|NCT02520609|Energy Expenditure|energy expenditure
1104915|NCT02520596|Raspberries|raspberries
1104916|NCT02520596|Anthocyanins|anthocyanins
1104917|NCT02520596|Ellagitannins|ellagitannins
1104920|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
1104921|NCT02520492|intracranial pressure|intracranial pressure
1104922|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
1104923|NCT02520479|nasal type|nasal type
1104924|NCT02520479|radiotherapy|radiotherapy
1104925|NCT02520479|chemotherapy|chemotherapy
1104926|NCT02520440|Citrulline|citrulline
1104929|NCT02520440|Calprotectina|calprotectina
1104930|NCT02520440|intraabdominal pressure|intraabdominal pressure
1104931|NCT02520427|Amgen|amgen
1104932|NCT02520427|Phase 1|phase 1
1104933|NCT02520427|Clinical Trial|clinical trial
1104934|NCT02520427|Oncology/Hematology|oncology/hematology
1104935|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
1104936|NCT02520427|Immunotherapy|immunotherapy
1104937|NCT02520310|Mitral Regurgitation|mitral regurgitation
1104938|NCT02520310|mitral valve surgery|mitral valve surgery
1104939|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
1104940|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
1104941|NCT02520310|Heart Valve Disease|heart valve disease
1104942|NCT02520297|Pain|pain
1104943|NCT02520297|Long bone|long bone
1104944|NCT02520297|Fracture|fracture
1104945|NCT02520271|Mood Disorders|mood disorders
1104946|NCT02520271|Motivational Interview|motivational interview
1104947|NCT02520271|Behavioral Activation|behavioral activation
1104948|NCT02520258|artificial sweeteners|artificial sweeteners
1104949|NCT02520258|obesity|obesity
1104950|NCT02520258|diabetes|diabetes
1104951|NCT02520258|metabolic syndrome|metabolic syndrome
1104952|NCT02520258|aspartame|aspartame
1104953|NCT02520232|chronic exercise|chronic exercise
1104954|NCT02520232|genetic polymorphisms|genetic polymorphisms
1104955|NCT02520232|brain imagery|brain imagery
1104956|NCT02520232|executive functions|executive functions
1104957|NCT02520232|alzheimer's disease|alzheimer's disease
1104958|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
1104959|NCT02520193|Early mobilisation|early mobilisation
1104960|NCT02520193|Invasive ventilation|invasive ventilation
1104961|NCT02520193|Ventilator free days|ventilator free days
1104962|NCT02520193|Intensive Care Unit|intensive care unit
1104963|NCT02520167|Gestational weight gain|gestational weight gain
1104964|NCT02520154|Ovarian Cancer|ovarian cancer
1104965|NCT02520154|Metastatic Ovarian Cancer|metastatic ovarian cancer
1104966|NCT02520154|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
1104967|NCT02520154|Advanced stage ovarian cancer|advanced stage ovarian cancer
1104968|NCT02520154|Carboplatin|carboplatin
1104969|NCT02520154|Paraplatin|paraplatin
1104970|NCT02520154|Paclitaxel|paclitaxel
1104971|NCT02520154|Taxol|taxol
1104972|NCT02520154|Pembrolizumab|pembrolizumab
1104973|NCT02520154|Keytruda|keytruda
1104974|NCT02520154|MK-3475|mk-3475
1104975|NCT02520154|SCH-900475|sch-900475
1104976|NCT02520141|Biliary cancer|biliary cancer
1104977|NCT02520141|Advanced biliary cancers|advanced biliary cancers
1104978|NCT02520141|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1104979|NCT02520141|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
1104980|NCT02520141|Gallbladder cancer|gallbladder cancer
1104981|NCT02520141|Received prior chemotherapy|received prior chemotherapy
1104982|NCT02520141|Ramucirumab|ramucirumab
1104983|NCT02520141|IMC-1121B|imc-1121b
1104984|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1104985|NCT02520128|Radiotherapy|radiotherapy
1104986|NCT02520089|platelet-rich plasma|platelet-rich plasma
1104987|NCT02520089|bone grafting|bone grafting
1104988|NCT02520089|pseudoarthrosis|pseudoarthrosis
1104989|NCT02520076|Islet Transplantation|islet transplantation
1104990|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
1104991|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
1104992|NCT02520063|neoadjuvant|neoadjuvant
1104993|NCT02520063|everolimus|everolimus
1104994|NCT02520063|TRC105|trc105
1104995|NCT02520063|letrozole|letrozole
1104996|NCT02520050|Type 2 diabetes|type 2 diabetes
1104997|NCT02520050|Obesity|obesity
1104998|NCT02520050|Nutrition|nutrition
1104999|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
1105000|NCT02520037|Fluid responsiveness|fluid responsiveness
1105001|NCT02520037|Volume responsiveness|volume responsiveness
1105002|NCT02520037|Hemodynamics|hemodynamics
1105003|NCT02520024|self-directed care|self-directed care
1105004|NCT02520024|serious mental illness|serious mental illness
1105005|NCT02520011|Refractory AML|refractory aml
1105006|NCT02520011|Relapsed AML|relapsed aml
1105007|NCT02520011|AML|aml
1105008|NCT02520011|Newly diagnosed high-risk AML|newly diagnosed high-risk aml
1105009|NCT02519998|Biomarkers|biomarkers
1155103|NCT02237781|AMH|amh
1105010|NCT02519998|Electrocardiography|electrocardiography
1105011|NCT02519998|Balance|balance
1105012|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
1105013|NCT02519998|Cortisol|cortisol
1105014|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
1105015|NCT02519998|Electroencephalography|electroencephalography
1105016|NCT02519998|Optical coherence tomography|optical coherence tomography
1105017|NCT02519998|Von Frey Testing|von frey testing
1105018|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
1105019|NCT02519985|Corneal thickness|corneal thickness
1105020|NCT02519985|Epithelial thickness|epithelial thickness
1105021|NCT02519985|Angle diameter|angle diameter
1105022|NCT02519985|Sulcus diameter|sulcus diameter
1105023|NCT02519985|Anterior chamber depth|anterior chamber depth
1105024|NCT02519985|Repeatability|repeatability
1105025|NCT02519985|Reproducibility|reproducibility
1105026|NCT02519972|Low dose CT screening|low dose ct screening
1105027|NCT02519972|Family history of lung cancer|family history of lung cancer
1105028|NCT02519946|Heart Transplantation|heart transplantation
1105029|NCT02519946|Tonometry|tonometry
1105030|NCT02519946|Exercise Test|exercise test
1105031|NCT02519946|Diet|diet
1105032|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
1105033|NCT02519946|Telemedicine|telemedicine
1105034|NCT02519946|Pediatrics|pediatrics
1105035|NCT02519946|Health Behavior|health behavior
1105036|NCT02519946|Physical Fitness|physical fitness
1105037|NCT02519946|Exercise Movement Techniques|exercise movement techniques
1105038|NCT02519946|Adolescent Behavior|adolescent behavior
1105039|NCT02519946|Child Behavior|child behavior
1105040|NCT02519933|hemodialysis|hemodialysis
1105041|NCT02519933|vascular access|vascular access
1105042|NCT02519907|Nerve Stimulation|nerve stimulation
1105043|NCT02519907|Neuroplasticity|neuroplasticity
1105044|NCT02519907|Sensory Feedback|sensory feedback
1105045|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
1105046|NCT02519881|microfracture|microfracture
1105047|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
1105048|NCT02519881|collagen|collagen
1105049|NCT02519868|Neuromodulation|neuromodulation
1105050|NCT02519868|Local anaesthetics|local anaesthetics
1105051|NCT02519829|Suture|suture
1105052|NCT02519829|Skin staples|skin staples
1105053|NCT02519829|Vicryl|vicryl
1105054|NCT02519829|Monocryl|monocryl
1105055|NCT02519816|post stem cell transplantation|post stem cell transplantation
1105056|NCT02519816|Steroid refractory|steroid refractory
1105057|NCT02519816|dependent chronic|dependent chronic
1105058|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
1105059|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
1105060|NCT02519764|hydration protocol|hydration protocol
1105061|NCT02519764|natremia|natremia
1105062|NCT02519764|Volunteers|volunteers
1105063|NCT02519725|Family|family
1105064|NCT02519725|PTSD|ptsd
1105065|NCT02519725|Anxiety disorders|anxiety disorders
1105066|NCT02519725|Depression disorders|depression disorders
1105067|NCT02519725|Qualitative research|qualitative research
1105068|NCT02519712|Induction Chemotherapy|induction chemotherapy
1105069|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
1105070|NCT02519712|Haploidentical Related Donors|haploidentical related donors
1105071|NCT02519712|15-141|15-141
1105072|NCT02519660|Ralydan|ralydan
1105073|NCT02519660|EMLA cream|emla cream
1105074|NCT02519660|Procedural pain|procedural pain
1105075|NCT02519660|Phlebotomy|phlebotomy
1105076|NCT02519660|Child|child
1105077|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
1105078|NCT02519634|SMP|smp
1105079|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
1105080|NCT02519634|RIRS|rirs
1105081|NCT02519634|Randomized Controlled Trial|randomized controlled trial
1105082|NCT02519634|RCT|rct
1105083|NCT02519621|diabetic ulcer|diabetic ulcer
1105084|NCT02519621|pressure ulcer|pressure ulcer
1105085|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
1105086|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
1105087|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1105193|NCT02519075|TARE|tare
1105088|NCT02519608|stable coronary artery disease|stable coronary artery disease
1105089|NCT02519608|ticagrelor|ticagrelor
1105090|NCT02519608|clopidogrel|clopidogrel
1105091|NCT02519608|endothelial function|endothelial function
1105092|NCT02519608|inflammation|inflammation
1105093|NCT02519608|platelet reactivity|platelet reactivity
1105094|NCT02519595|Procedural sedation|procedural sedation
1105095|NCT02519595|ketamine|ketamine
1105096|NCT02519595|children|children
1105097|NCT02519582|Colorectal Cancer|colorectal cancer
1105098|NCT02519582|S100A4|s100a4
1105099|NCT02519556|Probiotics|probiotics
1105100|NCT02519556|Inflammation|inflammation
1105101|NCT02519556|Awareness|awareness
1105102|NCT02519556|Immune tolerance|immune tolerance
1105103|NCT02519543|insulin resistance|insulin resistance
1105104|NCT02519530|Positive Youth Development|positive youth development
1105105|NCT02519530|Teen Outreach|teen outreach
1105106|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
1105107|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
1105108|NCT02519504|Cognitive disorders|cognitive disorders
1105109|NCT02519478|football|football
1105110|NCT02519478|Training Techniques|training techniques
1105111|NCT02519478|education|education
1105112|NCT02519478|Athletic Injuries|athletic injuries
1105113|NCT02519478|Brain Concussion|brain concussion
1105114|NCT02519465|nasal cannula|nasal cannula
1105115|NCT02519465|Inhalation Devices|inhalation devices
1105116|NCT02519452|Multiple Myeloma|multiple myeloma
1105117|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
1105118|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
1105119|NCT02519439|Partial Onset Seizures|partial onset seizures
1105120|NCT02519439|complex partial seizures|complex partial seizures
1105121|NCT02519439|simple partial seizures|simple partial seizures
1105122|NCT02519439|anticonvulsant|anticonvulsant
1105123|NCT02519439|ganaxolone|ganaxolone
1105124|NCT02519439|neurosteroid|neurosteroid
1105125|NCT02519439|Marinus|marinus
1105126|NCT02519439|epilepsy|epilepsy
1105127|NCT02519426|Third molar|third molar
1105128|NCT02519426|Classification|classification
1105129|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
1105130|NCT02519426|Lingual nerve injuries|lingual nerve injuries
1105131|NCT02519426|Mandibular canal|mandibular canal
1105132|NCT02519413|lymphocyte|lymphocyte
1105133|NCT02519413|serious infections|serious infections
1105134|NCT02519413|opportunistic infections|opportunistic infections
1105135|NCT02519413|Relapsing Forms|relapsing forms
1105136|NCT02519400|amitriptyline|amitriptyline
1105137|NCT02519400|cyp2d6|cyp2d6
1105138|NCT02519400|cyp2c19|cyp2c19
1105139|NCT02519374|Fiber tolerability|fiber tolerability
1105140|NCT02519374|Children|children
1105141|NCT02519361|elderly|elderly
1105142|NCT02519361|immune response|immune response
1105143|NCT02519361|acute infection|acute infection
1105144|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
1105145|NCT02519348|Immunotherapy|immunotherapy
1105146|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
1105147|NCT02519348|Tremelimumab|tremelimumab
1105148|NCT02519348|MEDI4736|medi4736
1105149|NCT02519348|Durvalumab|durvalumab
1105150|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
1105151|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
1105152|NCT02519322|Melanoma|melanoma
1105153|NCT02519322|Oligometastatic melanoma|oligometastatic melanoma
1105154|NCT02519322|Resectable|resectable
1105155|NCT02519322|Nivolumab|nivolumab
1105156|NCT02519322|BMS-936558|bms-936558
1105157|NCT02519322|Opdivo|opdivo
1105158|NCT02519322|Ipilimumab|ipilimumab
1105159|NCT02519322|Yervoy|yervoy
1105160|NCT02519322|BMS-734016|bms-734016
1105161|NCT02519322|MDX010|mdx010
1105163|NCT02519283|HF|hf
1105164|NCT02519283|ED|ed
1105165|NCT02519283|ER|er
1105166|NCT02519283|Emergency Department|emergency department
1105167|NCT02519283|Emergency Room|emergency room
1105168|NCT02519257|CAD|cad
1105169|NCT02519257|VHD|vhd
1105170|NCT02519257|Thy-1|thy-1
1105171|NCT02519244|Multiple Sclerosis|multiple sclerosis
1105172|NCT02519244|Ambulation|ambulation
1105173|NCT02519244|Rehabilitation|rehabilitation
1105174|NCT02519244|Wearable Robotic Devices|wearable robotic devices
1105175|NCT02519231|IUD|iud
1105176|NCT02519231|naproxen|naproxen
1105177|NCT02519231|bleeding|bleeding
1105178|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
1105179|NCT02519153|PDE5i|pde5i
1105180|NCT02519153|Sildinafil|sildinafil
1105181|NCT02519140|Gastric cancer|gastric cancer
1105182|NCT02519140|colon cancer|colon cancer
1105183|NCT02519140|EMR|emr
1105184|NCT02519140|biopsy|biopsy
1105185|NCT02519140|bariatric surgery|bariatric surgery
1105186|NCT02519114|M Myeloma|m myeloma
1105187|NCT02519114|KIR ligand mismatch|kir ligand mismatch
1105188|NCT02519114|Haploidentical|haploidentical
1105189|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
1105190|NCT02519088|Total Hip Replacement|total hip replacement
1105191|NCT02519088|Patient Blood Management|patient blood management
1105192|NCT02519075|Hepatocarcinoma|hepatocarcinoma
1105194|NCT02519075|response assessment|response assessment
1105195|NCT02519062|Carcinoma|carcinoma
1105196|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
1105197|NCT02519062|FDG PET|fdg pet
1105198|NCT02519062|hypoxia markers|hypoxia markers
1105199|NCT02519062|immune markers|immune markers
1105200|NCT02519049|Mesothelioma|mesothelioma
1105201|NCT02519049|11C-methionine PET|11c-methionine pet
1105202|NCT02519049|talc pleurodesis|talc pleurodesis
1105203|NCT02519036|Huntington's Disease|huntington's disease
1105204|NCT02519036|HTTRx|httrx
1105205|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
1105206|NCT02518997|Preterm Infants|preterm infants
1105207|NCT02518997|Bedside Reading aloud|bedside reading aloud
1105208|NCT02518997|Parental wellbeing|parental wellbeing
1105209|NCT02518997|Parental Bonding|parental bonding
1105210|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
1105211|NCT02518945|Type 1 Diabetes|type 1 diabetes
1105212|NCT02518945|Liraglutide|liraglutide
1105213|NCT02518945|Dapagliflozin|dapagliflozin
1105214|NCT02518945|Triple Therapy|triple therapy
1105215|NCT02518919|Children|children
1105216|NCT02518919|Emergency Department|emergency department
1105217|NCT02518919|Sedation|sedation
1105218|NCT02518906|Psychotherapy|psychotherapy
1105219|NCT02518906|psychotherapy process|psychotherapy process
1105220|NCT02518906|therapeutic alliance|therapeutic alliance
1105221|NCT02518906|psychotherapeutic change|psychotherapeutic change
1105222|NCT02518906|psychophysiology|psychophysiology
1105223|NCT02518893|Military Personnel|military personnel
1105224|NCT02518893|Air Force Personnel|air force personnel
1105225|NCT02518893|Army Personnel|army personnel
1105226|NCT02518893|Navy Personnel|navy personnel
1105227|NCT02518893|Armed Forces Personnel|armed forces personnel
1105228|NCT02518893|Marines|marines
1105229|NCT02518893|Soldiers|soldiers
1105230|NCT02518893|Sailors|sailors
1105231|NCT02518893|Airmen|airmen
1105232|NCT02518893|Decision Making|decision making
1105233|NCT02518893|Research Subjects|research subjects
1105234|NCT02518893|Life Experiences|life experiences
1105235|NCT02518893|Patient Participation|patient participation
1105236|NCT02518893|Refusal to Participate|refusal to participate
1105237|NCT02518893|Healthcare Research|healthcare research
1105238|NCT02518893|Qualitative Research|qualitative research
1105239|NCT02518893|Interview|interview
1105240|NCT02518893|Interviews, Telephone|interviews, telephone
1105241|NCT02518893|Ethics, Research|ethics, research
1105242|NCT02518867|Cerebral palsy|cerebral palsy
1105243|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
1105244|NCT02518841|ThermaWedge TM|thermawedge tm
1105245|NCT02518841|stretches|stretches
1105246|NCT02518828|Acute Heart Failure|acute heart failure
1105247|NCT02518802|Gefitinib|gefitinib
1105248|NCT02518802|Pemetrexed|pemetrexed
1105249|NCT02518802|Synchronous therapy|synchronous therapy
1105250|NCT02518802|Adjuvent therapy|adjuvent therapy
1105251|NCT02518789|myoclonus|myoclonus
1105252|NCT02518789|Etomidate|etomidate
1105253|NCT02518789|Dexmedetomidine|dexmedetomidine
1105254|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1105255|NCT02518750|Salvage Regimen|salvage regimen
1105256|NCT02518750|Re-Induction Therapy|re-induction therapy
1105257|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
1105258|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
1105259|NCT02518737|Receptor Deficiency|receptor deficiency
1105260|NCT02518711|symptoms of ADHD|symptoms of adhd
1105261|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
1105262|NCT02518698|Patients with bone metastases|patients with bone metastases
1105263|NCT02518685|Obesity|obesity
1105264|NCT02518685|Weight loss|weight loss
1105265|NCT02518685|Device|device
1105266|NCT02518685|Non-surgical|non-surgical
1105267|NCT02518685|Endoscopic|endoscopic
1105268|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
1105269|NCT02518685|TPS|tps
1105270|NCT02518659|hypomagnesemia|hypomagnesemia
1105271|NCT02518659|hypocalcemia|hypocalcemia
1105272|NCT02518659|inulin|inulin
1105273|NCT02518659|FOS|fos
1105274|NCT02518659|PPI|ppi
1105275|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
1105276|NCT02518646|Delirium|delirium
1105277|NCT02518646|Intensive care unit|intensive care unit
1105278|NCT02518646|Adult|adult
1105279|NCT02518646|Clinical prediction|clinical prediction
1105280|NCT02518633|obesity|obesity
1105281|NCT02518633|hypoxia|hypoxia
1105282|NCT02518633|adipose tissue|adipose tissue
1105283|NCT02518607|Safety and Tolerability|safety and tolerability
1105284|NCT02518607|Male Volunteers|male volunteers
1105285|NCT02518594|women|women
1105286|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
1105287|NCT02518594|carrying twins|carrying twins
1105288|NCT02518594|short cervix|short cervix
1105289|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
1105290|NCT02518516|Acute kidney injury|acute kidney injury
1105291|NCT02518516|Kidney diseases|kidney diseases
1105292|NCT02518516|Renal failure|renal failure
1105293|NCT02518503|Diabetes Mellitus|diabetes mellitus
1105294|NCT02518503|Statins|statins
1105487|NCT02517190|volunteers|volunteers
1105295|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1105296|NCT02518477|breast cancer surgery|breast cancer surgery
1105297|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
1105298|NCT02518477|resistance training|resistance training
1105299|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
1105300|NCT02518464|headache|headache
1105301|NCT02518464|chronic|chronic
1105302|NCT02518464|migraine|migraine
1105303|NCT02518464|right to left shunt|right to left shunt
1105304|NCT02518451|antihypertensive|antihypertensive
1105305|NCT02518451|bioequivalence|bioequivalence
1105306|NCT02518451|formulation|formulation
1105307|NCT02518451|pharmakokinetic|pharmakokinetic
1105308|NCT02518451|valsartan|valsartan
1105309|NCT02518451|subjects|subjects
1105310|NCT02518451|Fasting conditions|fasting conditions
1105311|NCT02518438|Tramadol|tramadol
1105312|NCT02518438|Postoperative analgesia|postoperative analgesia
1105313|NCT02518438|Infiltration|infiltration
1105314|NCT02518438|Cesarean section|cesarean section
1105315|NCT02518412|Alzheimers disease|alzheimers disease
1105316|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1105317|NCT02518412|Neuromodulation|neuromodulation
1105318|NCT02518412|Neuropsychology|neuropsychology
1105319|NCT02518399|Blood vessels|blood vessels
1105320|NCT02518399|Heat|heat
1105321|NCT02518399|Cardiovascular diseases|cardiovascular diseases
1105322|NCT02518386|emergency department|emergency department
1105323|NCT02518386|epidemiology|epidemiology
1105324|NCT02518386|prehospital care|prehospital care
1105325|NCT02518386|dispatch|dispatch
1105326|NCT02518386|acute self poisoning|acute self poisoning
1105327|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
1105328|NCT02518360|OSTEOPATHY|osteopathy
1105329|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
1105330|NCT02518360|POSTURAL BALANCE|postural balance
1105331|NCT02518334|type two diabetes|type two diabetes
1105332|NCT02518334|glycemic control|glycemic control
1105333|NCT02518321|Toileting|toileting
1105334|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
1105335|NCT02518321|Rehabilitation|rehabilitation
1105336|NCT02518321|Assistive Devices|assistive devices
1105337|NCT02518321|Activities of Daily Living|activities of daily living
1105338|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
1105339|NCT02518282|Acute myocardial infarction|acute myocardial infarction
1105340|NCT02518282|Heart valvular surgery|heart valvular surgery
1105341|NCT02518282|Cardiac surgery|cardiac surgery
1105342|NCT02518269|hip|hip
1105343|NCT02518269|arthroplasty|arthroplasty
1105344|NCT02518269|G7|g7
1105345|NCT02518269|EchoBimetric|echobimetric
1105346|NCT02518269|E1|e1
1105347|NCT02518269|ceramic|ceramic
1105348|NCT02518269|Arcom XL|arcom xl
1105349|NCT02518256|Neoplasms|neoplasms
1105350|NCT02518256|Glandular and Epithelial|glandular and epithelial
1105351|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
1105352|NCT02518256|Ovarian cancer|ovarian cancer
1105353|NCT02518204|cognitive assessment|cognitive assessment
1105354|NCT02518204|neuropsychological assessment|neuropsychological assessment
1105355|NCT02518204|Brain Performance Test|brain performance test
1105356|NCT02518204|computerized assessment|computerized assessment
1105357|NCT02518191|GnRHa|gnrha
1105358|NCT02518191|ovarian function|ovarian function
1105359|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
1105360|NCT02518178|NFC|nfc
1105361|NCT02518178|randomization|randomization
1105362|NCT02518178|RCT|rct
1105363|NCT02518178|mHealth|mhealth
1105364|NCT02518178|maternal and child health|maternal and child health
1105365|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
1105366|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
1105367|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
1105368|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
1105369|NCT02518165|Cognitive Domain Memory|cognitive domain memory
1105370|NCT02518165|Sleep Quality|sleep quality
1105371|NCT02518165|Sleep Efficiency|sleep efficiency
1105372|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
1105373|NCT02518126|LIF IUGR|lif iugr
1105374|NCT02518087|CPB|cpb
1105375|NCT02518087|oXiris®|oxiris®
1105376|NCT02518087|CS-AKI|cs-aki
1105377|NCT02518087|SIRS|sirs
1105378|NCT02518087|Cytokines|cytokines
1105379|NCT02518087|LPS|lps
1105380|NCT02518087|AKI|aki
1105381|NCT02518074|volunteers|volunteers
1105382|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
1105383|NCT02518048|Psoriasis|psoriasis
1105384|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
1105385|NCT02518022|Hypoglycemia|hypoglycemia
1105386|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1105387|NCT02518022|Alcohol|alcohol
1105388|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
1105389|NCT02518022|Nutrition|nutrition
1105390|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
1105391|NCT02517970|infant feeding|infant feeding
1105392|NCT02517970|breast-feeding|breast-feeding
1105393|NCT02517970|bottle-feeding|bottle-feeding
1105394|NCT02517970|feeding interactions|feeding interactions
1105395|NCT02517970|maternal feeding practices|maternal feeding practices
1105396|NCT02517957|Xiashi surgical|xiashi surgical
1105397|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
1105398|NCT02517918|Advanced solid tumor|advanced solid tumor
1105399|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
1105400|NCT02517918|Phase I trial|phase i trial
1105401|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
1105402|NCT02517918|Biomarkers study|biomarkers study
1155613|NCT02235701|mesna|mesna
1105403|NCT02517879|ITNs|itns
1105404|NCT02517879|malaria prevention|malaria prevention
1105405|NCT02517866|Drug therapy|drug therapy
1105406|NCT02517827|common femoral artery|common femoral artery
1105407|NCT02517827|drug-coated balloon|drug-coated balloon
1105408|NCT02517827|surgical endarterectomy|surgical endarterectomy
1105409|NCT02517801|anthocyanins|anthocyanins
1105410|NCT02517801|Post-menopausal women|post-menopausal women
1105411|NCT02517801|endothelial function|endothelial function
1105412|NCT02517801|vascular function|vascular function
1105413|NCT02517775|polyphenols|polyphenols
1105414|NCT02517775|vascular function|vascular function
1105415|NCT02517775|endothelial function|endothelial function
1105416|NCT02517775|cranberry|cranberry
1105417|NCT02517775|healthy|healthy
1105418|NCT02517723|Borderline Personality Disorder|borderline personality disorder
1105419|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
1105420|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
1105421|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
1105422|NCT02517684|Crohn's disease|crohn's disease
1105423|NCT02517684|pediatric|pediatric
1105424|NCT02517684|infliximab|infliximab
1105425|NCT02517684|top-down|top-down
1105426|NCT02517684|TISKids|tiskids
1105427|NCT02517671|Fitness|fitness
1105428|NCT02517671|Run time|run time
1105429|NCT02517671|VO2max|vo2max
1105430|NCT02517671|VEGF|vegf
1105431|NCT02517671|Central blood pressure|central blood pressure
1105432|NCT02517671|Augmentation Index|augmentation index
1105433|NCT02517671|Pulse wave analysis|pulse wave analysis
1105434|NCT02517632|Physical activity|physical activity
1105435|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
1105436|NCT02517619|Iontophoresis|iontophoresis
1105437|NCT02517619|Ophthalmology|ophthalmology
1105438|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
1105439|NCT02517593|BCRAT|bcrat
1105440|NCT02517593|IBIS|ibis
1105441|NCT02517593|PRS|prs
1105442|NCT02517593|breast cancer|breast cancer
1105443|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
1105444|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
1105445|NCT02517528|(HCV) Infection|(hcv) infection
1105446|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
1105447|NCT02517515|HCV Infection|hcv infection
1105448|NCT02517515|Chronic Hepatitis C Virus|chronic hepatitis c virus
1105449|NCT02517515|Hepatitis C Virus (HCV) Genotype 1b|hepatitis c virus (hcv) genotype 1b
1105450|NCT02517502|DHA|dha
1105451|NCT02517502|Omega-3|omega-3
1105452|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1105453|NCT02517502|chemotherapy|chemotherapy
1105454|NCT02517502|breast cancer|breast cancer
1105455|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
1105456|NCT02517489|Hydrocortisone|hydrocortisone
1105457|NCT02517489|Corticosteroids|corticosteroids
1105458|NCT02517463|Emergency contraception|emergency contraception
1105459|NCT02517463|ulipristal acetate|ulipristal acetate
1105460|NCT02517463|efficacy|efficacy
1105461|NCT02517450|Subjects|subjects
1105462|NCT02517411|COPD|copd
1105463|NCT02517411|physiotherapy|physiotherapy
1105464|NCT02517411|Stable disease|stable disease
1105465|NCT02517398|Solid tumor|solid tumor
1105466|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
1105467|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
1105468|NCT02517346|CPAP compliance|cpap compliance
1105469|NCT02517346|Telemonitoring|telemonitoring
1105470|NCT02517346|Standard management|standard management
1105471|NCT02517346|Cost effectiveness|cost effectiveness
1105472|NCT02517333|Motor skill proficiency|motor skill proficiency
1105473|NCT02517333|movement difficulties|movement difficulties
1105474|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
1105475|NCT02517333|Low physical fitness|low physical fitness
1105476|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
1105477|NCT02517294|Nasotracheal intubation|nasotracheal intubation
1105478|NCT02517294|adenoid size|adenoid size
1105479|NCT02517294|epistaxis|epistaxis
1105480|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
1105481|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
1105482|NCT02517255|Failed Thrombolysis|failed thrombolysis
1105483|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
1105484|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1105485|NCT02517229|volunteers|volunteers
1105486|NCT02517216|volunteers|volunteers
1105488|NCT02517177|volunteers|volunteers
1105489|NCT02517151|iron|iron
1105490|NCT02517151|fatigue|fatigue
1105491|NCT02517151|crohn's disease|crohn's disease
1105492|NCT02517151|ulcerative colitis|ulcerative colitis
1105493|NCT02517151|IBD|ibd
1105494|NCT02517138|volunteers|volunteers
1105495|NCT02517112|volunteers|volunteers
1105496|NCT02517099|Preschool|preschool
1105497|NCT02517099|Wheeze|wheeze
1105498|NCT02517099|Moderate|moderate
1105499|NCT02517099|Severe|severe
1105500|NCT02517086|blood circulation|blood circulation
1105501|NCT02517073|mechanical ventilation|mechanical ventilation
1105502|NCT02517073|epidemiology|epidemiology
1105503|NCT02517073|intensive care unit|intensive care unit
1105504|NCT02517073|national survey|national survey
1105505|NCT02517060|Social perceptions|social perceptions
1105506|NCT02517008|non-monetary incentive|non-monetary incentive
1105507|NCT02517008|institutional delivery|institutional delivery
1105508|NCT02516982|mHealth|mhealth
1105509|NCT02516982|Telemedicine|telemedicine
1105510|NCT02516982|Perinatal depression|perinatal depression
1105511|NCT02516982|Screening|screening
1105512|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
1105513|NCT02516982|Whooley Questions|whooley questions
1105514|NCT02516982|Data collection|data collection
1105515|NCT02516982|Mood disorders|mood disorders
1105516|NCT02516982|Mental health|mental health
1105517|NCT02516982|Antenatal care|antenatal care
1105518|NCT02516982|Prenatal Care|prenatal care
1105519|NCT02516956|Breakfast|breakfast
1105520|NCT02516956|Food choices|food choices
1105521|NCT02516956|Lunch|lunch
1105522|NCT02516956|Eating habits|eating habits
1105523|NCT02516956|Appetite|appetite
1105524|NCT02516956|Neural activation|neural activation
1105525|NCT02516956|Attention|attention
1105526|NCT02516956|Glucose|glucose
1105527|NCT02516956|Insulin|insulin
1105528|NCT02516956|fMRI|fmri
1105529|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
1105530|NCT02516930|health promotion|health promotion
1105531|NCT02516930|crowdsourcing|crowdsourcing
1105532|NCT02516904|Subjects|subjects
1105533|NCT02516891|treatment|treatment
1105534|NCT02516891|stent|stent
1105535|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
1105536|NCT02516878|acupuncture|acupuncture
1105537|NCT02516878|Chinese Medicine|chinese medicine
1105538|NCT02516878|obesity|obesity
1105539|NCT02516865|postpartum|postpartum
1105540|NCT02516865|physical activity|physical activity
1105541|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
1105542|NCT02516839|Overweight|overweight
1105543|NCT02516839|Obesity|obesity
1105544|NCT02516839|Overeating|overeating
1105545|NCT02516839|Body Mass Index|body mass index
1105546|NCT02516839|Weight|weight
1105547|NCT02516839|Treatment|treatment
1105548|NCT02516839|Cravings|cravings
1105549|NCT02516839|Intervention|intervention
1105550|NCT02516839|Behavioral Treatment|behavioral treatment
1105551|NCT02516813|M3814|m3814
1105552|NCT02516813|Advanced solid tumors|advanced solid tumors
1105553|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
1105554|NCT02516813|Radiotherapy|radiotherapy
1105555|NCT02516813|Chemotherapy|chemotherapy
1105556|NCT02516787|volunteers|volunteers
1105557|NCT02516761|Fibromyalgia|fibromyalgia
1105558|NCT02516748|optical diagnosis|optical diagnosis
1105559|NCT02516748|narrow band image|narrow band image
1105560|NCT02516644|Parkinson Disease|parkinson disease
1105561|NCT02516644|Mobility|mobility
1105562|NCT02516644|Balance|balance
1105563|NCT02516644|Virtual Reality|virtual reality
1105564|NCT02516644|treadmill training|treadmill training
1105565|NCT02516631|Labour, induced|labour, induced
1105566|NCT02516631|Misoprostol|misoprostol
1105567|NCT02516631|Pharmacokinetics|pharmacokinetics
1105568|NCT02516631|Cardiotocography|cardiotocography
1105569|NCT02516631|Safety|safety
1105570|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
1105571|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
1105572|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
1105573|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
1105574|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
1105575|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
1105576|NCT02516540|Mediterranean diet|mediterranean diet
1105577|NCT02516540|Structured exercise training|structured exercise training
1105578|NCT02516540|prevention|prevention
1105579|NCT02516514|Blood culture|blood culture
1105580|NCT02516514|Bacteremia|bacteremia
1105581|NCT02516514|Single sampling|single sampling
1105582|NCT02516501|Ketogenic Diet|ketogenic diet
1105583|NCT02516501|Body composition|body composition
1105584|NCT02516501|Radiation therapy|radiation therapy
1105585|NCT02516436|Bunavail|bunavail
1105586|NCT02516436|Suboxone|suboxone
1105587|NCT02516436|Heroin|heroin
1105588|NCT02516436|Zubsolv|zubsolv
1105589|NCT02516436|Buprenorphine|buprenorphine
1105590|NCT02516436|Naloxone|naloxone
1105591|NCT02516436|Opioids|opioids
1105592|NCT02516436|Addiction|addiction
1105594|NCT02516397|body fat mass reduction|body fat mass reduction
1105595|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
1105596|NCT02516384|Ulcerative Colitis|ulcerative colitis
1105597|NCT02516345|Physical activity|physical activity
1105598|NCT02516345|Financial incentives|financial incentives
1105600|NCT02516345|Parents|parents
1155961|NCT02234037|AML|aml
1105601|NCT02516345|RCT|rct
1105602|NCT02516345|Wireless pedometer|wireless pedometer
1105603|NCT02516306|Presbyopia|presbyopia
1105604|NCT02516306|Vision|vision
1105605|NCT02516306|UNR844|unr844
1105606|NCT02516280|Total knee replacement|total knee replacement
1105607|NCT02516280|Cold|cold
1105608|NCT02516280|Neurocryostimulation|neurocryostimulation
1105609|NCT02516280|CO2 cryotherapy|co2 cryotherapy
1105610|NCT02516280|mobility|mobility
1105611|NCT02516267|platelet aggregability|platelet aggregability
1105612|NCT02516267|acute coronary syndrome|acute coronary syndrome
1105613|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
1105614|NCT02516254|vitamin D|vitamin d
1105615|NCT02516254|fortified bread|fortified bread
1105616|NCT02516254|efficacy|efficacy
1105617|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
1105620|NCT02516189|Microcirculation|microcirculation
1105621|NCT02516189|Electromyography|electromyography
1105622|NCT02516189|Motor Activity|motor activity
1105623|NCT02516176|stroke|stroke
1105624|NCT02516176|cerebral vascular accident|cerebral vascular accident
1105625|NCT02516176|balance|balance
1105626|NCT02516176|treadmill|treadmill
1105627|NCT02516176|falls|falls
1105628|NCT02516176|hemiparesis|hemiparesis
1105629|NCT02516150|Type 1 Diabetes|type 1 diabetes
1105630|NCT02516150|Bionic Pancreas|bionic pancreas
1105631|NCT02516150|Artificial Pancreas|artificial pancreas
1105632|NCT02516150|Insulin|insulin
1105633|NCT02516150|Glucagon|glucagon
1105634|NCT02516150|Alcohol|alcohol
1105635|NCT02516150|Alcohol Clamp|alcohol clamp
1105636|NCT02516137|Dry needling|dry needling
1105637|NCT02516124|Autoimmune diseases|autoimmune diseases
1105638|NCT02516124|Systemic sclerosis|systemic sclerosis
1105639|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
1105640|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
1105641|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
1105642|NCT02516059|oxycodone|oxycodone
1105643|NCT02516059|oral naloxone|oral naloxone
1105644|NCT02516059|radical cystectomy|radical cystectomy
1105645|NCT02516059|bowel function|bowel function
1105646|NCT02516059|pain|pain
1105647|NCT02516033|Atrial Fibrillation|atrial fibrillation
1105648|NCT02516033|Hybrid Ablation|hybrid ablation
1105649|NCT02516033|Efficacy|efficacy
1105650|NCT02516033|Risk Profile|risk profile
1105651|NCT02516033|Biomarkers|biomarkers
1105652|NCT02516020|IVF|ivf
1105653|NCT02516020|ICSI|icsi
1105654|NCT02516020|culture media|culture media
1105655|NCT02516020|sequential|sequential
1105656|NCT02515981|tobacco dependence|tobacco dependence
1105657|NCT02515981|smoking cessation|smoking cessation
1105658|NCT02515981|mental health|mental health
1105659|NCT02515981|cardiovascular disease|cardiovascular disease
1105660|NCT02515981|obesity|obesity
1105661|NCT02515955|Healthy|healthy
1105662|NCT02515955|JNJ-54175446|jnj-54175446
1105663|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
1105664|NCT02515929|Periodontal Disease|periodontal disease
1105665|NCT02515903|Endoscopy|endoscopy
1105666|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
1105667|NCT02515903|surgery|surgery
1105668|NCT02515903|stereotactic aspiration|stereotactic aspiration
1105669|NCT02515903|Key-hole approach|key-hole approach
1105670|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
1105671|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
1105672|NCT02515903|Agitation-aspiration device|agitation-aspiration device
1105673|NCT02515890|midazolam|midazolam
1105674|NCT02515890|dexmedetomidine|dexmedetomidine
1105675|NCT02515890|memory|memory
1105676|NCT02515890|ketamine|ketamine
1105677|NCT02515864|Male and Female Volunteers|male and female volunteers
1105678|NCT02515786|Chronic respiratory failure|chronic respiratory failure
1105679|NCT02515786|Oxygen therapy|oxygen therapy
1105680|NCT02515786|Nasal catheter|nasal catheter
1105681|NCT02515786|Mucociliary clearance|mucociliary clearance
1105682|NCT02515747|Lipoprotein(a)|lipoprotein(a)
1105683|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
1105684|NCT02515747|apo(a)|apo(a)
1105685|NCT02515747|prognosis|prognosis
1105686|NCT02515747|myocardial infarction|myocardial infarction
1105687|NCT02515747|cardiovascular death|cardiovascular death
1105688|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1105689|NCT02515734|FOLFOXIRI|folfoxiri
1105690|NCT02515734|Bmab|bmab
1105691|NCT02515734|Cmab|cmab
1105692|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
1105693|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
1105995|NCT02513784|Esophagus|esophagus
1105694|NCT02515617|Critically ill patients|critically ill patients
1105695|NCT02515617|Cost-utility analysis|cost-utility analysis
1105696|NCT02515617|Prevention|prevention
1105697|NCT02515591|Healthy volunteer|healthy volunteer
1105698|NCT02515591|Respiratory|respiratory
1105699|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
1105700|NCT02515578|Primary Health Care|primary health care
1105701|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
1105702|NCT02515578|Quality Improvement|quality improvement
1105703|NCT02515565|pneumonia|pneumonia
1105704|NCT02515565|Exacerbation|exacerbation
1105705|NCT02515565|physiotherapy|physiotherapy
1105706|NCT02515565|hospitalization|hospitalization
1105707|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
1105708|NCT02515539|Mitral Regurgitation|mitral regurgitation
1105709|NCT02515539|Mitral Insufficiency|mitral insufficiency
1105710|NCT02515539|Transapical|transapical
1105711|NCT02515539|Transfemoral|transfemoral
1105712|NCT02515513|Pancreas|pancreas
1105713|NCT02515513|Pancreas Cancer|pancreas cancer
1105714|NCT02515513|Muscle Biopsy|muscle biopsy
1105715|NCT02515513|Cachexia|cachexia
1105716|NCT02515513|Muscle Cachexia|muscle cachexia
1105717|NCT02515500|cigarette reduction|cigarette reduction
1105718|NCT02515500|digital health|digital health
1105719|NCT02515500|mobile health|mobile health
1105720|NCT02515500|technology|technology
1105721|NCT02515500|Quitbit|quitbit
1105722|NCT02515500|mHealth|mhealth
1105723|NCT02515500|smoking cessation|smoking cessation
1105724|NCT02515500|quit smoking|quit smoking
1105725|NCT02515500|self-regulation|self-regulation
1105726|NCT02515487|Post-chemotherapy|post-chemotherapy
1105727|NCT02515487|cognitive impairment|cognitive impairment
1105728|NCT02515474|Cholangiopancreatography|cholangiopancreatography
1105729|NCT02515474|Endoscopic|endoscopic
1105730|NCT02515474|Common bile duct|common bile duct
1105731|NCT02515474|Complication|complication
1105732|NCT02515474|Recurrence|recurrence
1105733|NCT02515474|Laparoscopic|laparoscopic
1105734|NCT02515461|Diabetes mellitus|diabetes mellitus
1105735|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
1105736|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
1105737|NCT02515448|VAP|vap
1105738|NCT02515448|Critical care|critical care
1105739|NCT02515448|Pharmacokinetics|pharmacokinetics
1105740|NCT02515448|Gentamicin|gentamicin
1105741|NCT02515435|apatinib|apatinib
1105742|NCT02515435|NSCLC|nsclc
1105743|NCT02515435|safety|safety
1105744|NCT02515435|efficacy|efficacy
1105745|NCT02515422|Caesarean Section|caesarean section
1105746|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
1105747|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
1105748|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
1105749|NCT02515409|Children|children
1105750|NCT02515409|Non invasive ventilation|non invasive ventilation
1105751|NCT02515409|Treatment|treatment
1105752|NCT02515383|Adolescent Cancer|adolescent cancer
1105753|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
1105754|NCT02515383|MDASI|mdasi
1105755|NCT02515383|Surveys|surveys
1105756|NCT02515383|Questionnaires|questionnaires
1105757|NCT02515383|Interviews|interviews
1105758|NCT02515383|Symptoms|symptoms
1105759|NCT02515370|Option B plus|option b plus
1105760|NCT02515370|HIV infected women|hiv infected women
1105761|NCT02515357|Sleep Disorders|sleep disorders
1105762|NCT02515357|Metabolic Syndrome|metabolic syndrome
1105763|NCT02515357|Mediterranean Diet|mediterranean diet
1105764|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
1105765|NCT02515344|Patients|patients
1105766|NCT02515344|early detection of cancer|early detection of cancer
1105767|NCT02515344|patient compliance|patient compliance
1105768|NCT02515331|resistant hypertension|resistant hypertension
1105769|NCT02515318|COPD|copd
1105770|NCT02515318|Exacerbation|exacerbation
1105771|NCT02515318|Hospitalisation|hospitalisation
1105772|NCT02515318|Physiotherapy|physiotherapy
1105773|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
1105774|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
1105775|NCT02515292|morbidity|morbidity
1105776|NCT02515266|protein|protein
1105777|NCT02515266|growth|growth
1105778|NCT02515266|head circumference|head circumference
1105779|NCT02515253|Breast Pain|breast pain
1105780|NCT02515253|Mastalgia|mastalgia
1105781|NCT02515253|Bras|bras
1105782|NCT02515253|Breast Support|breast support
1105783|NCT02515227|peptide|peptide
1105784|NCT02515227|vaccine|vaccine
1105785|NCT02515227|Montanide ISA-51|montanide isa-51
1105786|NCT02515227|pembrolizumab|pembrolizumab
1105787|NCT02515227|PD-1|pd-1
1105788|NCT02515227|KEYTRUDA|keytruda
1105789|NCT02515214|bariatric surgery|bariatric surgery
1105790|NCT02515214|reproduction|reproduction
1105791|NCT02515175|HSV|hsv
1105792|NCT02515175|Herpes|herpes
1105793|NCT02515175|Genital Herpes|genital herpes
1105794|NCT02515175|Vaccine|vaccine
1105795|NCT02515162|conization|conization
1105796|NCT02515162|LLETZ|lletz
1105797|NCT02515162|cervical dysplasia|cervical dysplasia
1105798|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1105799|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
1105800|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
1105801|NCT02515149|linkage to care|linkage to care
1105802|NCT02515149|point of care diagnostics|point of care diagnostics
1105803|NCT02515149|point of care CD4|point of care cd4
1105804|NCT02515149|HIV care cascade|hiv care cascade
1105805|NCT02515149|Kenya|kenya
1105806|NCT02515123|intensive care unit|intensive care unit
1105807|NCT02515123|malnutrition|malnutrition
1105808|NCT02515123|GI motility|gi motility
1105809|NCT02515123|nutritional intake|nutritional intake
1105810|NCT02515110|lumpectomy|lumpectomy
1105811|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
1105812|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
1105813|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
1105814|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
1105815|NCT02515110|HER2/Neu Negative|her2/neu negative
1105816|NCT02515110|HER2/Neu Positive|her2/neu positive
1105817|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
1105818|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
1105819|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
1105820|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
1105821|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
1105920|NCT02514252|Metastatic|metastatic
1105822|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
1105823|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
1105824|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
1105825|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
1105826|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
1105827|NCT02515045|Cataract|cataract
1105828|NCT02515045|Surgery|surgery
1105829|NCT02515045|Prophylaxis|prophylaxis
1105830|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
1105831|NCT02515019|Bispectral index|bispectral index
1105832|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
1105833|NCT02514993|Sternal fracture|sternal fracture
1105834|NCT02514993|Thoracic spine fracture|thoracic spine fracture
1105835|NCT02514993|Thoracic cage injury|thoracic cage injury
1105836|NCT02514967|SLE|sle
1105837|NCT02514967|Lupus|lupus
1105838|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1105839|NCT02514967|Autoimmune Diseases|autoimmune diseases
1105840|NCT02514967|A-623|a-623
1105841|NCT02514967|Blisibimod|blisibimod
1105842|NCT02514967|Nephritis|nephritis
1105843|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
1105844|NCT02514902|Acute Stroke|acute stroke
1105845|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
1105846|NCT02514902|Point of Care (POC)|point of care (poc)
1105847|NCT02514902|Biomarker|biomarker
1105848|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
1105849|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
1105850|NCT02514798|COPD|copd
1105851|NCT02514798|HFNC|hfnc
1105852|NCT02514798|work of breathing|work of breathing
1105853|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
1105854|NCT02514746|Flavivirus Infections|flavivirus infections
1105855|NCT02514733|kidney|kidney
1105856|NCT02514733|transplant|transplant
1105857|NCT02514655|Tracheal intubation|tracheal intubation
1105858|NCT02514655|Cuff pressure|cuff pressure
1105859|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
1105860|NCT02514655|Intensive care unit|intensive care unit
1105861|NCT02514655|Tracheal injuries|tracheal injuries
1105862|NCT02514629|Hypogonadism|hypogonadism
1105863|NCT02514629|Obesity|obesity
1105864|NCT02514629|Erectile Dysfunction|erectile dysfunction
1105865|NCT02514629|Testosterone|testosterone
1105866|NCT02514629|Metformin|metformin
1105867|NCT02514629|Weight Loss|weight loss
1105868|NCT02514629|Insulin Resistance|insulin resistance
1105869|NCT02514616|Reflux|reflux
1105870|NCT02514616|Reflux disease|reflux disease
1105871|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
1105872|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
1105873|NCT02514603|Neoplasm metastasis|neoplasm metastasis
1105874|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
1105875|NCT02514603|CHK1|chk1
1105876|NCT02514603|CHK1 inhibitor|chk1 inhibitor
1105877|NCT02514551|stomach cancer|stomach cancer
1105878|NCT02514512|Lung Cancer|lung cancer
1105879|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
1105880|NCT02514512|MLC Tracking|mlc tracking
1105881|NCT02514512|Radiotherapy|radiotherapy
1105882|NCT02514499|patients|patients
1105883|NCT02514460|stents|stents
1105884|NCT02514460|atherectomy|atherectomy
1105885|NCT02514460|femoral artery|femoral artery
1105886|NCT02514460|popliteal artery|popliteal artery
1105887|NCT02514447|SCLC|sclc
1105888|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1105889|NCT02514421|electrochemotherapy|electrochemotherapy
1105890|NCT02514421|electroporation|electroporation
1105891|NCT02514421|radiogenomics|radiogenomics
1105892|NCT02514421|imaging|imaging
1105996|NCT02513784|Endoscopy|endoscopy
1105893|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1105894|NCT02514395|linguistic validation|linguistic validation
1105895|NCT02514395|KOOS|koos
1156272|NCT02232490|AFP|afp
1105896|NCT02514395|Marathi translation|marathi translation
1105897|NCT02514356|behavioral economics|behavioral economics
1105898|NCT02514356|antiretroviral adherence|antiretroviral adherence
1105899|NCT02514356|SMS|sms
1105900|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
1105901|NCT02514356|Adolescents|adolescents
1105902|NCT02514356|Uganda|uganda
1105903|NCT02514356|HIV|hiv
1105904|NCT02514343|radius fracture|radius fracture
1105905|NCT02514343|magnesium sulfate|magnesium sulfate
1105906|NCT02514343|rehabilitation|rehabilitation
1105907|NCT02514343|bupivacaine|bupivacaine
1105908|NCT02514330|Drop Jump|drop jump
1105909|NCT02514330|High Intensity Interval Training|high intensity interval training
1105910|NCT02514330|Muscle Fatigue|muscle fatigue
1105911|NCT02514330|Aerobic Performance|aerobic performance
1105912|NCT02514278|Organ preservation|organ preservation
1105913|NCT02514278|Local excision|local excision
1105914|NCT02514278|Radiochemotherapy|radiochemotherapy
1105915|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1105916|NCT02514278|Folfirinox|folfirinox
1105917|NCT02514278|Tumour response|tumour response
1105918|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
1105919|NCT02514252|Advanced Cancers|advanced cancers
1105921|NCT02514252|Recurrent cancer|recurrent cancer
1105922|NCT02514252|Incurable cancer|incurable cancer
1105923|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
1105924|NCT02514252|FSS|fss
1105925|NCT02514252|Questionnaires|questionnaires
1105926|NCT02514252|Surveys|surveys
1105927|NCT02514252|Mental ability tests|mental ability tests
1105928|NCT02514252|Phone calls|phone calls
1105929|NCT02514252|Study diary|study diary
1105930|NCT02514252|Pain control|pain control
1105931|NCT02514226|microbiology|microbiology
1105932|NCT02514226|halitosis|halitosis
1105933|NCT02514213|PSA|psa
1105934|NCT02514187|Osteogenesis|osteogenesis
1105935|NCT02514161|Smokers|smokers
1105936|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
1105937|NCT02514148|patient education|patient education
1105938|NCT02514148|therapeutic exercise|therapeutic exercise
1105939|NCT02514148|manual therapy|manual therapy
1105940|NCT02514109|neuronopathy|neuronopathy
1105941|NCT02514109|antibodies|antibodies
1105942|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
1105943|NCT02514083|Ibrutinib|ibrutinib
1105944|NCT02514083|Fludarabine|fludarabine
1105945|NCT02514083|BTK Inhibitor|btk inhibitor
1105946|NCT02514083|T-Cell Modulation|t-cell modulation
1105947|NCT02514070|LDL-C|ldl-c
1105948|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
1105949|NCT02514070|PCSK9|pcsk9
1105950|NCT02514070|HDL-C|hdl-c
1105951|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
1105952|NCT02514018|Immune Activation|immune activation
1105953|NCT02514018|HIV Vaccine|hiv vaccine
1105954|NCT02514018|Mucosal Immunity|mucosal immunity
1105955|NCT02514005|Trigger points|trigger points
1105956|NCT02514005|Manual therapy|manual therapy
1105957|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
1105958|NCT02514005|Dry needling|dry needling
1105959|NCT02513992|ictal SPECT|ictal spect
1105960|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
1105961|NCT02513979|Acute postoperative pain|acute postoperative pain
1105962|NCT02513979|Chronic postoperative pain|chronic postoperative pain
1105963|NCT02513979|Abdominal surgery|abdominal surgery
1105964|NCT02513953|Endometriosis|endometriosis
1105965|NCT02513953|Mesosalpinx|mesosalpinx
1105966|NCT02513953|Broad Ligament|broad ligament
1105967|NCT02513953|Laparoscopy|laparoscopy
1105968|NCT02513940|Torsades de pointes|torsades de pointes
1105969|NCT02513940|Testosterone|testosterone
1105970|NCT02513940|Progesterone|progesterone
1105971|NCT02513940|Clinical trial|clinical trial
1105972|NCT02513940|Risk reduction|risk reduction
1105973|NCT02513940|Electrocardiography|electrocardiography
1105974|NCT02513927|Blood pressure variability|blood pressure variability
1105975|NCT02513927|CCB|ccb
1105976|NCT02513927|beta-receptor blockers|beta-receptor blockers
1105977|NCT02513927|heart rate|heart rate
1105978|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
1105979|NCT02513901|Chidamide|chidamide
1105980|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1105981|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
1105982|NCT02513901|Chronic HIV infections|chronic hiv infections
1105983|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
1105984|NCT02513901|HIV Eradication|hiv eradication
1105985|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
1105986|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
1105987|NCT02513862|transfusion|transfusion
1105988|NCT02513849|esophagus|esophagus
1105989|NCT02513849|gastroscopy|gastroscopy
1105990|NCT02513849|tamoxifen|tamoxifen
1105991|NCT02513836|opioids|opioids
1105992|NCT02513823|blood pressure|blood pressure
1105993|NCT02513823|vitamin D|vitamin d
1105994|NCT02513784|Microbiome|microbiome
1105997|NCT02513784|Mouthwash|mouthwash
1105998|NCT02513771|Sitagliptin|sitagliptin
1105999|NCT02513771|Inflammation|inflammation
1106000|NCT02513771|Immune activation|immune activation
1106001|NCT02513771|Viral suppression|viral suppression
1106002|NCT02513771|HIV-1|hiv-1
1106003|NCT02513771|Immunology biomarkers|immunology biomarkers
1106004|NCT02513771|sCD14|scd14
1106005|NCT02513758|HIV patients|hiv patients
1106006|NCT02513758|Genital HIV penetration|genital hiv penetration
1106007|NCT02513745|cataract|cataract
1106008|NCT02513745|toric|toric
1106009|NCT02513745|phacoemulsification|phacoemulsification
1106010|NCT02513732|Drug Eluting Stent|drug eluting stent
1106011|NCT02513732|Coronary Stent|coronary stent
1106012|NCT02513732|Everolimus|everolimus
1106013|NCT02513732|Stent Thrombosis|stent thrombosis
1106014|NCT02513719|drug eluting stent|drug eluting stent
1106015|NCT02513719|stent|stent
1106016|NCT02513719|real world|real world
1106017|NCT02513693|Anesthesia|anesthesia
1106018|NCT02513693|Rocuronium|rocuronium
1106019|NCT02513693|Sugammadex|sugammadex
1106020|NCT02513693|Neostigmine|neostigmine
1106021|NCT02513693|TOF|tof
1106022|NCT02513693|Radical Prostatectomy|radical prostatectomy
1106023|NCT02513693|Robotic Surgery|robotic surgery
1106024|NCT02513693|Accelerometry|accelerometry
1106025|NCT02513680|Skin Aging|skin aging
1106026|NCT02513680|laser phototherapy|laser phototherapy
1106128|NCT02513212|Sensitivity|sensitivity
1106027|NCT02513680|Rejuvenation|rejuvenation
1106028|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
1106029|NCT02513680|Female|female
1106030|NCT02513680|Humans|humans
1106031|NCT02513680|Esthetics|esthetics
1106032|NCT02513680|Phototherapy|phototherapy
1106033|NCT02513680|facial rejuvenation|facial rejuvenation
1106034|NCT02513654|tolerability|tolerability
1106035|NCT02513654|repeat dosing|repeat dosing
1106036|NCT02513654|safety|safety
1106037|NCT02513654|healthy Chinese subjects|healthy chinese subjects
1106038|NCT02513654|Pharmacokinetics|pharmacokinetics
1106039|NCT02513654|lamotrigine|lamotrigine
1106040|NCT02513628|Cardiac arrest|cardiac arrest
1106041|NCT02513628|neuroprognostication|neuroprognostication
1106042|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
1106043|NCT02513628|outcome|outcome
1106044|NCT02513628|ultrasonography|ultrasonography
1106045|NCT02513615|Fibrosis|fibrosis
1106046|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
1106047|NCT02513615|Epigenetics|epigenetics
1106048|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
1106049|NCT02513615|Glucose exposure|glucose exposure
1106050|NCT02513602|implantology|implantology
1106051|NCT02513602|kidney|kidney
1106052|NCT02513602|renal disease|renal disease
1106053|NCT02513602|edentulism|edentulism
1106054|NCT02513602|tooth loss|tooth loss
1106055|NCT02513589|Positron emission tomography|positron emission tomography
1106056|NCT02513589|Carotid plaque|carotid plaque
1106057|NCT02513589|Inflammation|inflammation
1106058|NCT02513589|Stroke|stroke
1106059|NCT02513576|Sternal instability|sternal instability
1106060|NCT02513576|physical therapy|physical therapy
1106061|NCT02513576|Respiratory muscle strength|respiratory muscle strength
1106062|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
1106063|NCT02513524|hypertension|hypertension
1106064|NCT02513524|adherence|adherence
1106065|NCT02513524|resistant hypertension|resistant hypertension
1106066|NCT02513524|blood pressure|blood pressure
1106067|NCT02513524|non-adherence|non-adherence
1106068|NCT02513511|difficult airway|difficult airway
1106069|NCT02513511|awake intubation|awake intubation
1106070|NCT02513485|Inflammation|inflammation
1106071|NCT02513485|Anhedonia|anhedonia
1106072|NCT02513485|Psychomotor retardation|psychomotor retardation
1106073|NCT02513472|Eribulin Mesylate|eribulin mesylate
1106074|NCT02513472|Pembrolizumab|pembrolizumab
1106075|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
1106076|NCT02513472|mTNBC|mtnbc
1106077|NCT02513459|ABBV-066|abbv-066
1106078|NCT02513459|BI 655066|bi 655066
1106079|NCT02513459|risankizumab|risankizumab
1106080|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
1106081|NCT02513420|levator ani avulsion|levator ani avulsion
1106082|NCT02513420|perineal muscle training|perineal muscle training
1106083|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
1106084|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
1106085|NCT02513394|Palbociclib|palbociclib
1106086|NCT02513368|aesthetic|aesthetic
1106087|NCT02513368|connective tissue graft|connective tissue graft
1106088|NCT02513368|mucosa thickness|mucosa thickness
1106089|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
1106090|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
1106091|NCT02513329|Breast Cancer|breast cancer
1106092|NCT02513329|Anti-estrogens|anti-estrogens
1106093|NCT02513329|Hot Flushes|hot flushes
1106094|NCT02513329|Tamoxifen|tamoxifen
1106095|NCT02513329|Aromatase inhibitors|aromatase inhibitors
1106096|NCT02513329|Hot Flashes|hot flashes
1106097|NCT02513316|Microbleeds|microbleeds
1106098|NCT02513303|Dialysis|dialysis
1106099|NCT02513303|End Stage Renal Disease|end stage renal disease
1106100|NCT02513303|End Stage Kidney Disease|end stage kidney disease
1106101|NCT02513303|ESRD|esrd
1106102|NCT02513303|Chronic Kidney Failure|chronic kidney failure
1106103|NCT02513303|Chronic Renal Failure|chronic renal failure
1106104|NCT02513303|Chronic Kidney Disease|chronic kidney disease
1106105|NCT02513303|Hemodialysis|hemodialysis
1106106|NCT02513303|Vascular Access|vascular access
1106107|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
1106108|NCT02513303|AV Fistula|av fistula
1106109|NCT02513303|AVF|avf
1106110|NCT02513303|Nephrology|nephrology
1106111|NCT02513303|Vascular Surgery|vascular surgery
1106112|NCT02513303|Dialysis Access|dialysis access
1106113|NCT02513290|quality of life|quality of life
1106114|NCT02513290|allergic rhinitis|allergic rhinitis
1106115|NCT02513290|bilastine|bilastine
1106116|NCT02513290|loratadine|loratadine
1106117|NCT02513290|clinical trial|clinical trial
1106118|NCT02513277|type 2 diabetes|type 2 diabetes
1106119|NCT02513277|impaired glucose regulation|impaired glucose regulation
1106120|NCT02513277|intellectual disability|intellectual disability
1106121|NCT02513277|learning disability|learning disability
1106122|NCT02513277|screening|screening
1106123|NCT02513277|prevention|prevention
1106124|NCT02513277|lifestyle education|lifestyle education
1106125|NCT02513264|Registry|registry
1106126|NCT02513264|Asthma|asthma
1106127|NCT02513264|Inner City Asthma Consortium (ICAC) study eligibility|inner city asthma consortium (icac) study eligibility
1106129|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
1106130|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
1106131|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1106132|NCT02513199|HCC|hcc
1106133|NCT02513199|TACE|tace
1106134|NCT02513199|SBRT|sbrt
1106135|NCT02513173|low back pain|low back pain
1106136|NCT02513173|verbal instruction|verbal instruction
1106137|NCT02513173|lumbar multifidus|lumbar multifidus
1106138|NCT02513173|ultrasound imaging|ultrasound imaging
1106139|NCT02513173|Muscle thickness|muscle thickness
1106140|NCT02513134|IOL power calculations|iol power calculations
1106141|NCT02513134|Intraoperative|intraoperative
1106142|NCT02513134|OCT|oct
1106143|NCT02513134|Refractive outcome|refractive outcome
1106144|NCT02513134|Biometry|biometry
1106145|NCT02513121|NAFLD|nafld
1106146|NCT02513121|Steatohepatitis|steatohepatitis
1106147|NCT02513121|NASH|nash
1106148|NCT02513121|Liver|liver
1106149|NCT02513121|Diet|diet
1106150|NCT02513121|Pediatric|pediatric
1106151|NCT02513121|Adolescent|adolescent
1106152|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
1106153|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1106154|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
1106155|NCT02513017|cardiovascular disease|cardiovascular disease
1106156|NCT02513017|insomnia|insomnia
1106157|NCT02513017|preference|preference
1106158|NCT02513017|acceptability|acceptability
1106159|NCT02512978|myocardial infarction|myocardial infarction
1106160|NCT02512978|hypothyroidism|hypothyroidism
1106161|NCT02512978|levothyroxine|levothyroxine
1106162|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1106163|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
1106164|NCT02512978|myocardial fibrosis|myocardial fibrosis
1106165|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
1106166|NCT02512978|cardiac function|cardiac function
1106167|NCT02512952|Periodontal regeneration|periodontal regeneration
1106168|NCT02512952|Growth factors|growth factors
1106169|NCT02512939|tuberculosis|tuberculosis
1106170|NCT02512939|diagnostic test|diagnostic test
1106171|NCT02512926|Solid Tumors|solid tumors
1106172|NCT02512926|Leukemia|leukemia
1106173|NCT02512926|Relapsed|relapsed
1106174|NCT02512926|Refractory|refractory
1106175|NCT02512913|Smoking Cessation|smoking cessation
1106176|NCT02512913|Intervention|intervention
1106177|NCT02512913|Pregnancy|pregnancy
1106178|NCT02512913|Postnatal|postnatal
1106179|NCT02512900|Asthma|asthma
1106180|NCT02512887|Hypospadias|hypospadias
1106181|NCT02512887|Caudal Block|caudal block
1106182|NCT02512887|Dorsal Penile Block|dorsal penile block
1106183|NCT02512887|Anesthesia|anesthesia
1106184|NCT02512887|Complications|complications
1106185|NCT02512887|Post-operative|post-operative
1106186|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
1106187|NCT02512887|Glans dehiscence|glans dehiscence
1106188|NCT02512861|Bupivacaine|bupivacaine
1106189|NCT02512861|Cardiac Surgery|cardiac surgery
1106190|NCT02512861|Pediatrics|pediatrics
1106191|NCT02512861|Nerve Block|nerve block
1106192|NCT02512848|postmenopause|postmenopause
1106193|NCT02512848|endometrial sampling|endometrial sampling
1106194|NCT02512848|vaginal bleeding|vaginal bleeding
1106195|NCT02512835|Primary health care|primary health care
1106196|NCT02512835|Public health|public health
1106197|NCT02512835|Medical Informatics|medical informatics
1106198|NCT02512835|Social Determinants of Health|social determinants of health
1106199|NCT02512822|radiofrequency|radiofrequency
1106200|NCT02512822|submental fat|submental fat
1106201|NCT02512822|fat reduction|fat reduction
1106202|NCT02512822|body contouring|body contouring
1106203|NCT02512796|Liver transplantation|liver transplantation
1106204|NCT02512796|Renal transplantation|renal transplantation
1106205|NCT02512796|Pancreas transplantation|pancreas transplantation
1106206|NCT02512783|Propofol|propofol
1106207|NCT02512783|Lidocaine|lidocaine
1106208|NCT02512783|Intravenous propofol|intravenous propofol
1106209|NCT02512757|Neoplasms, Lung|neoplasms, lung
1106210|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
1106211|NCT02512757|Pulmonary Cancer|pulmonary cancer
1106212|NCT02512744|Tracheostomy|tracheostomy
1106213|NCT02512744|Decannulation|decannulation
1106214|NCT02512744|Adult airway management|adult airway management
1106215|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
1106216|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
1106217|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1106218|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
1106219|NCT02512692|90Y TARE|90y tare
1106220|NCT02512692|radioembolization|radioembolization
1106221|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
1106222|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
1106223|NCT02512679|stem cell transplantation|stem cell transplantation
1106224|NCT02512679|bone marrow transplantation|bone marrow transplantation
1106225|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1106933|NCT02508532|BLU 285|blu 285
1106226|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
1106227|NCT02512679|pediatrics|pediatrics
1106228|NCT02512679|Combined Immune Deficiency|combined immune deficiency
1106229|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
1106230|NCT02512666|Hematologic malignancy|hematologic malignancy
1106231|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
1106232|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
1106233|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
1106234|NCT02512640|Laparoscopy|laparoscopy
1106235|NCT02512640|Oxidative stress|oxidative stress
1106236|NCT02512627|mild cognitive impairment|mild cognitive impairment
1106237|NCT02512627|exercise|exercise
1106238|NCT02512627|cognitive training|cognitive training
1106240|NCT02512575|Healthy subjects|healthy subjects
1106241|NCT02512575|Phase 1|phase 1
1106242|NCT02512575|placebo controlled|placebo controlled
1106243|NCT02512575|single ascending dose|single ascending dose
1106244|NCT02512575|Pharmacokinetics|pharmacokinetics
1106245|NCT02512575|Pharmacodynamics|pharmacodynamics
1106246|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
1106247|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1106248|NCT02512549|rehabiltation|rehabiltation
1106249|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
1106250|NCT02512523|CGMS|cgms
1106251|NCT02512523|Teneligliptin|teneligliptin
1106252|NCT02512523|Sitagliptin|sitagliptin
1106253|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
1106254|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1106255|NCT02512497|CTCL|ctcl
1106256|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
1106257|NCT02512497|T-PLL|t-pll
1106258|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
1106259|NCT02512497|T-LGL|t-lgl
1106260|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
1106261|NCT02512497|T-ALL|t-all
1106262|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1106263|NCT02512497|PTCL|ptcl
1106264|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1106265|NCT02512497|Romidepsin|romidepsin
1106266|NCT02512497|Istodax|istodax
1106267|NCT02512497|Depsipeptide|depsipeptide
1106268|NCT02512497|FK228|fk228
1106269|NCT02512497|Busulfan|busulfan
1106270|NCT02512497|Busulfex|busulfex
1106271|NCT02512497|Myleran|myleran
1106272|NCT02512497|Fludarabine|fludarabine
1106273|NCT02512497|Fludarabine phosphate|fludarabine phosphate
1106274|NCT02512497|Fludara|fludara
1106275|NCT02512484|tuberculosis|tuberculosis
1106276|NCT02512484|accident and emergency|accident and emergency
1106277|NCT02512471|minimum effective volume|minimum effective volume
1106278|NCT02512471|ropivacaine|ropivacaine
1106279|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
1106280|NCT02512419|Physical Activity|physical activity
1106281|NCT02512419|Latinos|latinos
1106282|NCT02512419|Mexican American Men|mexican american men
1106283|NCT02512419|Spanish-Language|spanish-language
1106284|NCT02512419|Text-Message|text-message
1106285|NCT02512406|Tourette Syndrome|tourette syndrome
1106286|NCT02512406|Tics|tics
1106287|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
1106288|NCT02512341|Electronic Stethoscope|electronic stethoscope
1106289|NCT02512341|Phonocardiography|phonocardiography
1106290|NCT02512341|Heart Auscultation|heart auscultation
1106291|NCT02512328|Colonoscopy|colonoscopy
1106292|NCT02512328|new media|new media
1106294|NCT02512328|colonoscopy preparation|colonoscopy preparation
1106295|NCT02512328|SPA|spa
1106296|NCT02512328|smartphone application|smartphone application
1106297|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1106298|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1106299|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
1106300|NCT02512315|Distant metastasis|distant metastasis
1106301|NCT02512315|Survival|survival
1106302|NCT02512302|COPD|copd
1106303|NCT02512276|Medication Non-adherence|medication non-adherence
1106304|NCT02512276|Hyperlipidemia|hyperlipidemia
1106305|NCT02512276|Diabetes|diabetes
1106306|NCT02512276|Hypertension|hypertension
1106307|NCT02512237|HER2|her2
1106308|NCT02512237|breast cancer|breast cancer
1106309|NCT02512237|ADC|adc
1106310|NCT02512237|antibody drug conjugate|antibody drug conjugate
1106311|NCT02512237|elevated HER2 expression|elevated her2 expression
1106312|NCT02512224|parenteral nutrition|parenteral nutrition
1106313|NCT02512224|enteral nutrition|enteral nutrition
1106314|NCT02512211|Hemophilia|hemophilia
1106315|NCT02512211|Validation|validation
1106316|NCT02512211|Questionnaires|questionnaires
1106317|NCT02512211|Activities|activities
1106318|NCT02512211|Sport|sport
1106319|NCT02512211|Patients|patients
1106320|NCT02512198|Professional Practice|professional practice
1106321|NCT02512198|General Practitioners|general practitioners
1106322|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
1106323|NCT02512198|Persuasive Communication|persuasive communication
1106324|NCT02512198|Information Theory|information theory
1106325|NCT02512198|Feedback|feedback
1106326|NCT02512185|Prostate cancer|prostate cancer
1106327|NCT02512185|Chemotherapy|chemotherapy
1106328|NCT02512185|mCRPC|mcrpc
1106329|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
1106330|NCT02512159|Foot care|foot care
1106331|NCT02512159|Wound management|wound management
1106332|NCT02512146|IBS|ibs
1106333|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
1106334|NCT02512133|MIGS|migs
1106335|NCT02512133|SLT|slt
1106336|NCT02512094|Barthel index|barthel index
1106337|NCT02512094|Hip fracture|hip fracture
1106338|NCT02512094|Validity|validity
1106339|NCT02512094|Reliability|reliability
1106340|NCT02512081|Sciatica|sciatica
1106341|NCT02512081|Patient Experience|patient experience
1106342|NCT02512081|Investigations|investigations
1106343|NCT02512081|Qualitative Research|qualitative research
1106344|NCT02512016|Pelvic floor|pelvic floor
1106345|NCT02511990|HIV|hiv
1106346|NCT02511990|10-1074|10-1074
1106347|NCT02511990|Monoclonal Antibody|monoclonal antibody
1106348|NCT02511977|Dental Prosthesis|dental prosthesis
1106349|NCT02511977|Implant-Supported|implant-supported
1106350|NCT02511964|Aerobic Exercise|aerobic exercise
1106351|NCT02511964|HIT,|hit,
1106352|NCT02511964|VO2Max|vo2max
1106353|NCT02511964|Performance|performance
1106354|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
1106355|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
1106356|NCT02511951|anastomosis time|anastomosis time
1106357|NCT02511951|reoperation rate|reoperation rate
1106358|NCT02511951|morbidity|morbidity
1106359|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
1106360|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
1106361|NCT02511938|childhood obesity|childhood obesity
1106362|NCT02511938|restaurant|restaurant
1106363|NCT02511938|away from home foods|away from home foods
1106364|NCT02511925|Critical care|critical care
1106365|NCT02511925|Feedback|feedback
1106366|NCT02511899|Microcirculation|microcirculation
1106367|NCT02511899|Endothelial function|endothelial function
1106368|NCT02511899|Metabolism|metabolism
1106369|NCT02511899|Cardiovascular Disease|cardiovascular disease
1106370|NCT02511899|human study|human study
1106371|NCT02511899|healthy subjects|healthy subjects
1106372|NCT02511899|Mangifera indica|mangifera indica
1106373|NCT02511899|Careless|careless
1106374|NCT02511886|Alcoholism|alcoholism
1106375|NCT02511886|Alcohol Abuse|alcohol abuse
1106376|NCT02511886|Alcohol Addiction|alcohol addiction
1106377|NCT02511886|Alcohol Dependence|alcohol dependence
1106378|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
1106379|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
1106380|NCT02511873|Fycompa|fycompa
1106381|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
1106382|NCT02511873|SFN|sfn
1106383|NCT02511873|Neuropathy|neuropathy
1106384|NCT02511873|Pain|pain
1106385|NCT02511847|Breast Cancer|breast cancer
1106386|NCT02511847|EGFR|egfr
1106387|NCT02511847|Afatinib|afatinib
1106388|NCT02511847|Paclitaxel|paclitaxel
1106389|NCT02511847|Pathologic complete remission|pathologic complete remission
1106390|NCT02511808|Drinking|drinking
1106391|NCT02511808|Alcohol Problems|alcohol problems
1106392|NCT02511808|Alcoholism|alcoholism
1106393|NCT02511808|Reduced Drinking|reduced drinking
1106394|NCT02511808|Problematic Drinking|problematic drinking
1106395|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
1106396|NCT02511808|Controlled Drinking|controlled drinking
1106397|NCT02511808|Heavy Drinking|heavy drinking
1106398|NCT02511795|AZD1775|azd1775
1106399|NCT02511795|Olaparib|olaparib
1106400|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
1106401|NCT02511795|Refractory Solid Tumours|refractory solid tumours
1106402|NCT02511795|Relapsed Small Cell Lung Cancer (SCLC)|relapsed small cell lung cancer (sclc)
1106403|NCT02511782|children|children
1106404|NCT02511782|bone marrow transplant|bone marrow transplant
1106405|NCT02511782|GVHD|gvhd
1106406|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
1106407|NCT02511730|Mammography|mammography
1106408|NCT02511704|Nicotine|nicotine
1106409|NCT02511704|Electronic cigarette|electronic cigarette
1106410|NCT02511704|Cigarette|cigarette
1106411|NCT02511639|Hormone receptor positive|hormone receptor positive
1106412|NCT02511639|HER2 negative|her2 negative
1106413|NCT02511626|endometriosis|endometriosis
1106414|NCT02511626|quality of life|quality of life
1106415|NCT02511626|professional activity|professional activity
1106416|NCT02511626|pain|pain
1106417|NCT02511626|infertility|infertility
1106418|NCT02511626|sexuality|sexuality
1106419|NCT02511626|partnership|partnership
1106420|NCT02511626|anxiety|anxiety
1106421|NCT02511626|depression|depression
1106422|NCT02511626|stress|stress
1106423|NCT02511626|childhood trauma|childhood trauma
1106424|NCT02511626|medical support|medical support
1106425|NCT02511626|dyspareunia|dyspareunia
1106426|NCT02511600|Lung Diseases|lung diseases
1106427|NCT02511600|Mesothelioma|mesothelioma
1106428|NCT02511600|Pleurectomy decortication|pleurectomy decortication
1106429|NCT02511600|Progel|progel
1106430|NCT02511600|Talcum powder|talcum powder
1106431|NCT02511600|Pain questionnaires|pain questionnaires
1106432|NCT02511600|Surveys|surveys
1106433|NCT02511600|Intraoperative air leaks|intraoperative air leaks
1106434|NCT02511600|IAL|ial
1106435|NCT02511574|progesterone|progesterone
1106436|NCT02511574|uterine cervix|uterine cervix
1106437|NCT02511574|cervical pessary|cervical pessary
1106438|NCT02511561|Otitis externa|otitis externa
1106439|NCT02511561|Swimmer's ear|swimmer's ear
1106440|NCT02511561|Ear infection|ear infection
1106441|NCT02511509|Schizophrenia|schizophrenia
1106442|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
1106443|NCT02511509|Bifrontal ECT|bifrontal ect
1106444|NCT02511509|Bitemporal ECT|bitemporal ect
1106445|NCT02511509|Cognitive functions|cognitive functions
1106446|NCT02511509|Postictal delirium|postictal delirium
1106447|NCT02511483|COMT|comt
1106448|NCT02511483|Beta-blocker|beta-blocker
1106449|NCT02511483|Hemicolectomy|hemicolectomy
1106450|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1106451|NCT02511470|Pediatric simulation study|pediatric simulation study
1106452|NCT02511470|Metronome|metronome
1106453|NCT02511444|GBS|gbs
1106454|NCT02511444|GBS culture|gbs culture
1106455|NCT02511444|GBS PCR|gbs pcr
1106456|NCT02511444|GBS colonization|gbs colonization
1106457|NCT02511431|Delta Hepatitis|delta hepatitis
1106458|NCT02511431|Hepatitis D|hepatitis d
1106459|NCT02511431|Liver Disease|liver disease
1106460|NCT02511431|Hepatitis D Virus|hepatitis d virus
1106461|NCT02511431|Chronic Hepatitis|chronic hepatitis
1106462|NCT02511405|rGBM|rgbm
1106463|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
1106464|NCT02511405|Recurrent GBM|recurrent gbm
1106465|NCT02511366|ileal brake|ileal brake
1106466|NCT02511353|malaria|malaria
1106467|NCT02511353|plasmodium|plasmodium
1106468|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1106469|NCT02511353|ivermectin|ivermectin
1106470|NCT02511327|Pertussis|pertussis
1106471|NCT02511327|Pregnancy|pregnancy
1106472|NCT02511327|Vaccination|vaccination
1106473|NCT02511327|Preterm|preterm
1106474|NCT02511327|Breast milk|breast milk
1106475|NCT02511327|Humoral immune response|humoral immune response
1106476|NCT02511327|Cellular immune response|cellular immune response
1106477|NCT02511327|Maternal antibodies|maternal antibodies
1106478|NCT02511314|Nursing homes|nursing homes
1106479|NCT02511314|quasi-experimental|quasi-experimental
1106480|NCT02511314|mixed methods|mixed methods
1106481|NCT02511314|parallel study|parallel study
1106482|NCT02511314|urinary incontinence|urinary incontinence
1106483|NCT02511288|hematologic test|hematologic test
1106484|NCT02511275|parenchymal clamping|parenchymal clamping
1106485|NCT02511275|microdialysis technique|microdialysis technique
1106486|NCT02511275|partial nephrectomy|partial nephrectomy
1106487|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
1106488|NCT02511249|language development|language development
1106489|NCT02511249|global intellectual functioning|global intellectual functioning
1106490|NCT02511249|motor abilities|motor abilities
1106491|NCT02511197|PET|pet
1106492|NCT02511197|lung injury|lung injury
1106493|NCT02511197|integrin receptor|integrin receptor
1106494|NCT02511184|crizotinib|crizotinib
1106495|NCT02511184|pembrolizumab|pembrolizumab
1106496|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
1106497|NCT02511184|Lung Cancer|lung cancer
1106498|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
1106499|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
1106500|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
1106501|NCT02511145|volunteers|volunteers
1106502|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
1106503|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
1106504|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
1106505|NCT02511093|Hypertension|hypertension
1106506|NCT02511093|Team-based care|team-based care
1106507|NCT02511093|Collaboration|collaboration
1106508|NCT02511093|Healthcare professionals|healthcare professionals
1106509|NCT02511093|Healthcare services|healthcare services
1106510|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
1106511|NCT02511054|Immunogenicity|immunogenicity
1106512|NCT02511054|Liver Stage|liver stage
1106513|NCT02511054|Parasites|parasites
1106514|NCT02511054|Blood|blood
1106515|NCT02511054|Infection|infection
1106516|NCT02511041|CDG|cdg
1106517|NCT02511041|PGM3|pgm3
1106518|NCT02511041|Immune|immune
1106519|NCT02511028|MRI|mri
1106520|NCT02511028|Multiple Sclerosis|multiple sclerosis
1106521|NCT02511028|Healthy Volunteer|healthy volunteer
1106522|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
1106523|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
1106524|NCT02511015|Mitochondria|mitochondria
1106525|NCT02511015|Neuroinflammation|neuroinflammation
1106526|NCT02511015|Immunology|immunology
1106527|NCT02511002|Influenza|influenza
1106528|NCT02511002|Hemagglutinin (HA)|hemagglutinin (ha)
1106529|NCT02511002|Post Influenza Challenge|post influenza challenge
1106530|NCT02511002|Neuranimidase (NA)|neuranimidase (na)
1106531|NCT02511002|Influenza Illness|influenza illness
1106532|NCT02510989|Syndromic obesity|syndromic obesity
1106534|NCT02510989|Exome|exome
1106535|NCT02510963|Vertical infection transmission|vertical infection transmission
1106536|NCT02510963|Tenofovir|tenofovir
1106537|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
1106538|NCT02510937|pharmacokinetic|pharmacokinetic
1106539|NCT02510937|pharmacodynamics|pharmacodynamics
1106540|NCT02510937|CC-90001|cc-90001
1106541|NCT02510937|Safety|safety
1106542|NCT02510924|Intubation|intubation
1106543|NCT02510924|Airtraq|airtraq
1106544|NCT02510924|General anesthesia|general anesthesia
1106545|NCT02510924|Difficult airway|difficult airway
1106546|NCT02510911|colectomy|colectomy
1106547|NCT02510911|laparoscopy|laparoscopy
1106548|NCT02510911|caffeine|caffeine
1106549|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1106550|NCT02510885|age-related macular degeneration|age-related macular degeneration
1106551|NCT02510885|diabetic retinopathy|diabetic retinopathy
1106552|NCT02510885|SD-OCT|sd-oct
1106553|NCT02510885|Angiography|angiography
1106554|NCT02510885|diabetic macular edema|diabetic macular edema
1106555|NCT02510846|Polyhandicap|polyhandicap
1106556|NCT02510846|Behavior disorders|behavior disorders
1106557|NCT02510846|Educative program|educative program
1106558|NCT02510846|Caregivers|caregivers
1106559|NCT02510846|Quality of life.|quality of life.
1106560|NCT02510833|Parkinson Disease|parkinson disease
1106561|NCT02510833|Physical Therapy Modalities|physical therapy modalities
1106562|NCT02510833|Quality of Life|quality of life
1106563|NCT02510833|Self Care|self care
1106564|NCT02510768|alba|alba
1106565|NCT02510664|Adolescence|adolescence
1106566|NCT02510664|Adherence|adherence
1106567|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
1106568|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
1106569|NCT02510651|cryoblebbing|cryoblebbing
1106570|NCT02510651|CO2 laser|co2 laser
1106571|NCT02510612|Dexmedetomidine|dexmedetomidine
1106572|NCT02510612|Diabetic|diabetic
1106573|NCT02510612|glycometabolism|glycometabolism
1106574|NCT02510612|sedation|sedation
1106575|NCT02510599|NASH|nash
1106576|NCT02510599|Liver disease|liver disease
1106577|NCT02510508|addiction|addiction
1106578|NCT02510508|substance abuse|substance abuse
1106579|NCT02510508|alcohol|alcohol
1106580|NCT02510508|drugs|drugs
1106581|NCT02510508|community reinforcement|community reinforcement
1106582|NCT02510508|family treatment|family treatment
1106583|NCT02510508|randomized control trial|randomized control trial
1106584|NCT02510495|Sphincterotomy|sphincterotomy
1106585|NCT02510495|Dilatation|dilatation
1106586|NCT02510495|Common bile duct|common bile duct
1106587|NCT02510495|Pancreatitis|pancreatitis
1106588|NCT02510482|cardiac biomarkers|cardiac biomarkers
1106589|NCT02510443|Permanent contraception method|permanent contraception method
1106590|NCT02510443|Contraceptive device|contraceptive device
1106591|NCT02510391|modular|modular
1106592|NCT02510391|anxiety|anxiety
1106593|NCT02510391|preschool|preschool
1106594|NCT02510391|exposure and response prevention|exposure and response prevention
1106595|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
1106596|NCT02510352|Rotator cuff tear|rotator cuff tear
1106597|NCT02510352|MRI|mri
1106598|NCT02510287|analgesia, epidural|analgesia, epidural
1106599|NCT02510287|labor pain|labor pain
1106600|NCT02510287|patient satisfaction|patient satisfaction
1106601|NCT02510274|ASP3325|asp3325
1106602|NCT02510274|pharmacokinetics|pharmacokinetics
1106603|NCT02510274|pharmacodynamics|pharmacodynamics
1106604|NCT02510274|Chronic Kidney Disease|chronic kidney disease
1106605|NCT02510274|Hyperphosphatemia|hyperphosphatemia
1106606|NCT02510261|RNAi therapeutic|rnai therapeutic
1106608|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
1106609|NCT02510261|TTR|ttr
1106610|NCT02510261|Transthyretin|transthyretin
1106611|NCT02510261|Amyloidosis|amyloidosis
1106612|NCT02510235|Dry Eye|dry eye
1106613|NCT02510222|child|child
1106614|NCT02510209|Teen pregnancy|teen pregnancy
1106615|NCT02510183|Acupressure|acupressure
1106616|NCT02510183|Perioperative Care|perioperative care
1106617|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1106618|NCT02510183|Nursing Care Management|nursing care management
1106619|NCT02510170|Fetus|fetus
1106620|NCT02510170|Skull|skull
1106621|NCT02510170|ultrasonography|ultrasonography
1106622|NCT02510157|sugammadex|sugammadex
1106623|NCT02510157|dexamethasone|dexamethasone
1106624|NCT02510157|neuromuscular blockade|neuromuscular blockade
1106625|NCT02510118|ChangTai Keli|changtai keli
1106626|NCT02510118|Colon cancer|colon cancer
1106627|NCT02510105|Critical Care|critical care
1106628|NCT02510105|ARDS|ards
1106629|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
1106630|NCT02510105|VDR4|vdr4
1106631|NCT02510105|Lung aeration|lung aeration
1106632|NCT02510105|CT scan|ct scan
1106633|NCT02510066|Pancreatic Cancer|pancreatic cancer
1106634|NCT02510066|Pain|pain
1106635|NCT02510066|Acupuncture|acupuncture
1106636|NCT02510040|Convergence Insufficiency|convergence insufficiency
1106637|NCT02510040|Divergence Insufficiency|divergence insufficiency
1106638|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
1106639|NCT02510040|Strabismus|strabismus
1106640|NCT02510027|HPV testing|hpv testing
1106641|NCT02510027|Triage|triage
1106642|NCT02510027|Mexico|mexico
1106643|NCT02510027|Cervical cancer screening|cervical cancer screening
1106644|NCT02510001|RASMT CRC|rasmt crc
1106645|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
1106646|NCT02510001|Dose Escalation|dose escalation
1106647|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
1106648|NCT02510001|Dose Expansion|dose expansion
1106649|NCT02509988|Nutrition|nutrition
1106650|NCT02509988|Glucose metabolism|glucose metabolism
1106651|NCT02509988|Body composition|body composition
1106652|NCT02509975|embolization|embolization
1106653|NCT02509975|prostate|prostate
1106654|NCT02509962|Energy metabolism|energy metabolism
1106655|NCT02509962|Glucose tolerance|glucose tolerance
1106656|NCT02509962|Blood pressure|blood pressure
1106657|NCT02509962|Immunoregulation|immunoregulation
1106658|NCT02509923|Male Subjects|male subjects
1106659|NCT02509910|Major abdominal surgery|major abdominal surgery
1106660|NCT02509910|Goal directed therapy|goal directed therapy
1106661|NCT02509897|Hypoxia training|hypoxia training
1106662|NCT02509897|Activity energy expenditure|activity energy expenditure
1106663|NCT02509897|Immunoregulation|immunoregulation
1106664|NCT02509897|Energy Metabolism|energy metabolism
1106665|NCT02509897|Exercise|exercise
1106666|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
1106667|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
1106668|NCT02509884|antiparasitic treatment|antiparasitic treatment
1106669|NCT02509884|surgery|surgery
1106670|NCT02509884|classification|classification
1106671|NCT02509884|staging|staging
1106672|NCT02509884|prospective cohort study|prospective cohort study
1106673|NCT02509871|Body composition|body composition
1106674|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
1106675|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
1106676|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1106677|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1106678|NCT02509819|rehabilitation|rehabilitation
1106679|NCT02509819|IDEO|ideo
1106680|NCT02509780|Vichy|vichy
1106681|NCT02509780|urine alkalization|urine alkalization
1106682|NCT02509767|Contraceptive Methods|contraceptive methods
1106683|NCT02509767|Female Contraception|female contraception
1106684|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
1106685|NCT02509767|Injectable contraception|injectable contraception
1106686|NCT02509767|Birth control|birth control
1106687|NCT02509754|atrial fibrillation|atrial fibrillation
1106688|NCT02509754|congestive heart failure|congestive heart failure
1106689|NCT02509754|catheter ablation|catheter ablation
1106690|NCT02509754|rate control|rate control
1106691|NCT02509754|left ventricular function|left ventricular function
1106692|NCT02509741|obesity|obesity
1106693|NCT02509741|nutrition|nutrition
1106694|NCT02509741|intervention|intervention
1106695|NCT02509741|food replacement|food replacement
1106696|NCT02509741|IOT|iot
1106697|NCT02509728|choline|choline
1106698|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
1106699|NCT02509715|thyroidectomy|thyroidectomy
1106700|NCT02509715|nerve monitoring|nerve monitoring
1106701|NCT02509702|Mobile health|mobile health
1106702|NCT02509702|Screening|screening
1106703|NCT02509702|Early detection of cancer|early detection of cancer
1106704|NCT02509702|HPV|hpv
1106705|NCT02509702|SMS intervention|sms intervention
1106706|NCT02509702|RCT|rct
1106707|NCT02509702|Tanzania|tanzania
1106708|NCT02509689|mTBI|mtbi
1106709|NCT02509689|cognition disorders|cognition disorders
1106710|NCT02509689|post-concussive syndrome|post-concussive syndrome
1106711|NCT02509689|neuroplasticity|neuroplasticity
1106712|NCT02509689|EEG|eeg
1106713|NCT02509689|biofeedback|biofeedback
1106714|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
1106715|NCT02509689|depression|depression
1106716|NCT02509676|dynamic stretching training|dynamic stretching training
1106717|NCT02509676|muscle tendon unit|muscle tendon unit
1106718|NCT02509676|ultrasound|ultrasound
1106719|NCT02509650|Exome sequencing|exome sequencing
1106720|NCT02509650|Skin disease|skin disease
1106721|NCT02509650|Familial lipomatosis|familial lipomatosis
1106722|NCT02509637|Respiratory System|respiratory system
1106723|NCT02509637|Physical Therapy Modalities|physical therapy modalities
1106724|NCT02509611|Yoga|yoga
1106725|NCT02509611|Parkinson's disease|parkinson's disease
1106726|NCT02509611|redox status|redox status
1106727|NCT02509611|motor function|motor function
1106728|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
1106729|NCT02509559|Propranolol|propranolol
1106730|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
1106731|NCT02509520|Nutritional supplementation|nutritional supplementation
1106732|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
1106733|NCT02509520|ICU acquired weakness|icu acquired weakness
1106734|NCT02509520|Post ICU Syndrome|post icu syndrome
1106735|NCT02509520|sarcopenia|sarcopenia
1106736|NCT02509507|Liver tumours|liver tumours
1106737|NCT02509494|Vaccine|vaccine
1106738|NCT02509494|Ebola|ebola
1106739|NCT02509494|Ebola virus disease|ebola virus disease
1106740|NCT02509494|EVD|evd
1106741|NCT02509494|Hemorrhagic fever|hemorrhagic fever
1106742|NCT02509494|Sierra Leone|sierra leone
1106743|NCT02509494|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1106744|NCT02509494|Safety|safety
1106745|NCT02509494|Immunogenicity|immunogenicity
1106746|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
1106747|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
1106748|NCT02509481|malaria|malaria
1106749|NCT02509481|lymphatic filariasis|lymphatic filariasis
1106750|NCT02509481|mosquito|mosquito
1106751|NCT02509481|ivermectin|ivermectin
1106752|NCT02509481|mass drug administration|mass drug administration
1106753|NCT02509455|Balance control|balance control
1106754|NCT02509455|Body-mounted sensors|body-mounted sensors
1106755|NCT02509455|Balance Measures|balance measures
1106756|NCT02509442|mapping brain functions|mapping brain functions
1106757|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
1106758|NCT02509442|potential evoked|potential evoked
1106759|NCT02509429|T1DM|t1dm
1106760|NCT02509429|Type 1 Diabetes|type 1 diabetes
1106761|NCT02509429|Artificial Pancreas|artificial pancreas
1106762|NCT02509429|DiAs platform|dias platform
1106763|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
1106764|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1106765|NCT02509416|competency|competency
1106766|NCT02509403|Perineal hygiene|perineal hygiene
1106767|NCT02509403|Hygiene wipes|hygiene wipes
1106768|NCT02509403|Hygiene Towels|hygiene towels
1106769|NCT02509403|Safety|safety
1106770|NCT02509403|Essential oils|essential oils
1106771|NCT02509403|Natural Health Product|natural health product
1106772|NCT02509390|Fibrinogen level|fibrinogen level
1106773|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
1106774|NCT02509390|Trauma|trauma
1106775|NCT02509390|Thrombosis risk|thrombosis risk
1106776|NCT02509377|Fetal Surgery|fetal surgery
1106777|NCT02509377|Open Fetal Surgery|open fetal surgery
1106778|NCT02509377|Elevated BMI|elevated bmi
1106779|NCT02509377|Body Mass Index|body mass index
1106780|NCT02509377|Spina Bifida|spina bifida
1106781|NCT02509364|AE-IPF|ae-ipf
1106782|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
1106783|NCT02509312|Blood Loss, Surgical|blood loss, surgical
1106784|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
1106785|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
1106786|NCT02509312|Cesarean Section|cesarean section
1106787|NCT02509312|Female|female
1106788|NCT02509312|Humans|humans
1106789|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
1106790|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
1106791|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
1106792|NCT02509312|Pregnancy|pregnancy
1106793|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
1106794|NCT02509299|COPD|copd
1106795|NCT02509299|Quality of life|quality of life
1106796|NCT02509299|Perceived health status|perceived health status
1106797|NCT02509286|Esophageal neoplasms|esophageal neoplasms
1106798|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
1106799|NCT02509286|adenocarcinoma|adenocarcinoma
1106800|NCT02509286|esophagectomy|esophagectomy
1106801|NCT02509286|surgery|surgery
1106802|NCT02509286|radiotherapy|radiotherapy
1106803|NCT02509286|chemotherapy|chemotherapy
1106804|NCT02509260|colorectal surgery|colorectal surgery
1106805|NCT02509247|sleep apnea|sleep apnea
1106806|NCT02509247|CPAP|cpap
1106807|NCT02509247|telemonitoring|telemonitoring
1106808|NCT02509247|telecare|telecare
1106809|NCT02509234|pediatric sarcomas|pediatric sarcomas
1106810|NCT02509234|Ewing sarcoma|ewing sarcoma
1106811|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
1106812|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
1106813|NCT02509208|iliac crest bone graft|iliac crest bone graft
1106814|NCT02509208|ICBG|icbg
1106815|NCT02509208|pelvic osteotomy|pelvic osteotomy
1106816|NCT02509208|spinal fusion|spinal fusion
1106817|NCT02509208|hemostasis|hemostasis
1106818|NCT02509208|haemostasis|haemostasis
1106819|NCT02509208|hemostatic|hemostatic
1106820|NCT02509208|haemostatic|haemostatic
1106821|NCT02509208|dextran|dextran
1106822|NCT02509208|SurgiClot|surgiclot
1106823|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
1106824|NCT02509182|Hyperoxia|hyperoxia
1106825|NCT02509182|One-Lung Ventilation|one-lung ventilation
1106826|NCT02509182|Thoracic Surgery|thoracic surgery
1106827|NCT02509182|Anesthesiology|anesthesiology
1106828|NCT02509156|Cardiomyopathy|cardiomyopathy
1106830|NCT02509156|Anthracyclines|anthracyclines
1106831|NCT02509156|Chemotherapy|chemotherapy
1106832|NCT02509156|Allogeneic|allogeneic
1106833|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
1106834|NCT02509156|MSCs|mscs
1106835|NCT02509156|Cancer survivors|cancer survivors
1106836|NCT02509156|Breast Cancer|breast cancer
1106837|NCT02509156|Leukemia|leukemia
1106838|NCT02509156|Lymphoma|lymphoma
1106839|NCT02509156|Sarcoma|sarcoma
1106840|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1106841|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
1106842|NCT02509130|Severe Asthma|severe asthma
1106843|NCT02509130|Asthma|asthma
1106844|NCT02509130|Specialised Asthma Care|specialised asthma care
1106845|NCT02509130|Asthma Care|asthma care
1106846|NCT02509117|Alzheimer's disease|alzheimer's disease
1106847|NCT02509104|Bioavailability|bioavailability
1106848|NCT02509104|Dutasteride|dutasteride
1106849|NCT02509104|Healthy Male Subjects|healthy male subjects
1106850|NCT02509104|Fixed Dose Combination|fixed dose combination
1106851|NCT02509078|ARDS|ards
1106852|NCT02509078|neuromuscular blocker|neuromuscular blocker
1106853|NCT02509078|cisatracurium|cisatracurium
1106854|NCT02509065|bionic pancreas|bionic pancreas
1106855|NCT02509065|artificial pancreas|artificial pancreas
1106856|NCT02509065|insulin|insulin
1106857|NCT02509065|glucagon|glucagon
1106858|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
1106859|NCT02509065|insulin pump|insulin pump
1106860|NCT02509065|outpatient|outpatient
1106861|NCT02509039|CC-122|cc-122
1106862|NCT02509039|Phase1|phase1
1106863|NCT02509039|solid tumor|solid tumor
1106864|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
1106865|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
1106866|NCT02509013|chronic kidney disease|chronic kidney disease
1106867|NCT02509013|stable coronary heart disease|stable coronary heart disease
1106868|NCT02509013|prevalence|prevalence
1106869|NCT02508987|Obesity|obesity
1106870|NCT02508987|oxidative stress|oxidative stress
1106871|NCT02508987|antioxidants|antioxidants
1106872|NCT02508987|periodontal disease|periodontal disease
1106873|NCT02508961|Physical Activity|physical activity
1106874|NCT02508961|Exercise|exercise
1106875|NCT02508961|Physiotherapy|physiotherapy
1106876|NCT02508948|airway management|airway management
1106877|NCT02508948|critically ill|critically ill
1106878|NCT02508948|hemodynamic management|hemodynamic management
1106879|NCT02508948|intubation|intubation
1106880|NCT02508948|prospective study|prospective study
1106881|NCT02508948|risk factors|risk factors
1106882|NCT02508909|Videoassisted surgery|videoassisted surgery
1106883|NCT02508883|Cancer|cancer
1106884|NCT02508883|hemorrhage|hemorrhage
1106885|NCT02508883|endoscopy|endoscopy
1106886|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1106887|NCT02508857|pain, postoperative|pain, postoperative
1106888|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
1106889|NCT02508857|magnesium sulfate|magnesium sulfate
1106890|NCT02508844|Probiotics|probiotics
1106891|NCT02508844|Vivomixx®|vivomixx®
1106892|NCT02508844|Microbiota|microbiota
1106893|NCT02508831|Bilateral amputation|bilateral amputation
1106894|NCT02508831|upper limb|upper limb
1106895|NCT02508831|allograft|allograft
1106896|NCT02508779|Diabetes|diabetes
1106897|NCT02508779|Blood Glucose Management|blood glucose management
1106898|NCT02508779|Preconception|preconception
1106899|NCT02508779|Hypoglycemia|hypoglycemia
1106900|NCT02508779|Women with diabetes|women with diabetes
1106901|NCT02508766|Postural Control|postural control
1106902|NCT02508766|Plantar Stimulation|plantar stimulation
1106903|NCT02508766|Volunteers|volunteers
1106904|NCT02508753|QT/QTc Intervals|qt/qtc intervals
1106905|NCT02508701|HPV|hpv
1106906|NCT02508701|Message Design|message design
1106907|NCT02508701|Adolescent Males|adolescent males
1106908|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
1106909|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
1106910|NCT02508688|diaphragmatic defect|diaphragmatic defect
1106911|NCT02508675|injury|injury
1106912|NCT02508675|risk factors|risk factors
1106913|NCT02508675|outcome|outcome
1106914|NCT02508675|costs|costs
1106915|NCT02508662|Advanced Cancers|advanced cancers
1106916|NCT02508662|Solid Tumors|solid tumors
1106917|NCT02508662|Genomic Mutations|genomic mutations
1106918|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
1106919|NCT02508662|Refractory|refractory
1106920|NCT02508623|Portal hypertension|portal hypertension
1106921|NCT02508623|liver cirrhosis|liver cirrhosis
1106922|NCT02508623|Rifaximin|rifaximin
1106923|NCT02508597|Smoking cessation intervention|smoking cessation intervention
1106924|NCT02508571|Infant, Premature|infant, premature
1106925|NCT02508571|Intervention Studies|intervention studies
1106926|NCT02508571|Bottle feeding|bottle feeding
1106927|NCT02508532|2L GIST|2l gist
1106928|NCT02508532|GIST second line|gist second line
1106929|NCT02508532|GIST gleevec|gist gleevec
1106930|NCT02508532|GIST imatinib|gist imatinib
1106931|NCT02508532|Second-line GIST clinical trial|second-line gist clinical trial
1106932|NCT02508532|BLU-285|blu-285
1106937|NCT02508532|GIST imatinib relapse|gist imatinib relapse
1106938|NCT02508532|GIST gleevec relapse|gist gleevec relapse
1106939|NCT02508532|GIST KIT|gist kit
1106940|NCT02508532|GIST relapse|gist relapse
1106941|NCT02508532|GIST refractory|gist refractory
1106942|NCT02508532|GIST imatinib intolerance|gist imatinib intolerance
1106943|NCT02508532|GIST TKI treatment|gist tki treatment
1106944|NCT02508532|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
1106945|NCT02508532|GIST TKI|gist tki
1106946|NCT02508532|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
1106947|NCT02508532|Advanced GIST|advanced gist
1106948|NCT02508532|GIST mutations|gist mutations
1106949|NCT02508532|GIST treatments|gist treatments
1106950|NCT02508532|Blueprint GIST|blueprint gist
1106951|NCT02508532|Relapsed GIST clinical trial|relapsed gist clinical trial
1106952|NCT02508532|Refractory GIST clinical trial|refractory gist clinical trial
1106953|NCT02508532|KIT-mutant GIST|kit-mutant gist
1106954|NCT02508532|cancer gist|cancer gist
1106955|NCT02508532|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1106956|NCT02508532|gist cancer|gist cancer
1106957|NCT02508532|PDGFRA|pdgfra
1106958|NCT02508506|ALKS 5461|alks 5461
1106959|NCT02508506|Alkermes|alkermes
1106960|NCT02508506|Samidorphan|samidorphan
1106961|NCT02508506|Renal Impairment|renal impairment
1106962|NCT02508506|Pharmacokinetics|pharmacokinetics
1106963|NCT02508506|Buprenorphine|buprenorphine
1106964|NCT02508480|Stigma|stigma
1106965|NCT02508480|Community Integration|community integration
1106966|NCT02508467|Liver cancer|liver cancer
1106967|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
1106968|NCT02508467|FGF19 overexpression|fgf19 overexpression
1106969|NCT02508467|FGF19 upregulation|fgf19 upregulation
1106970|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
1106971|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
1106972|NCT02508467|BLU-554|blu-554
1106973|NCT02508467|FGFR4|fgfr4
1106974|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
1106975|NCT02508467|Liver Disease|liver disease
1106976|NCT02508467|Liver Neoplasms|liver neoplasms
1106977|NCT02508454|Prevention|prevention
1106978|NCT02508454|Screening|screening
1106979|NCT02508454|Biobanking|biobanking
1106980|NCT02508441|Neoplasms|neoplasms
1106981|NCT02508441|Solid Tumors|solid tumors
1106982|NCT02508441|Advanced Malignancy|advanced malignancy
1106983|NCT02508441|Cancer|cancer
1106984|NCT02508428|Osteolysis|osteolysis
1106985|NCT02508428|Polyethylene|polyethylene
1106986|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
1106987|NCT02508428|Total Hip Replacement|total hip replacement
1106988|NCT02508428|Marathon|marathon
1106989|NCT02508415|obesity|obesity
1106990|NCT02508415|periodontal disease|periodontal disease
1106991|NCT02508415|intervention|intervention
1106992|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1106993|NCT02508389|oral cavity|oral cavity
1106994|NCT02508389|oropharynx|oropharynx
1106995|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1106996|NCT02508389|chemotherapy|chemotherapy
1106997|NCT02508389|oral mucositis|oral mucositis
1106998|NCT02508389|superoxide dismutase|superoxide dismutase
1106999|NCT02508389|radioprotection|radioprotection
1107000|NCT02508376|adjuvants|adjuvants
1107001|NCT02508376|AP10-602|ap10-602
1107003|NCT02508376|ID93|id93
1107004|NCT02508376|Tuberculosis|tuberculosis
1107005|NCT02508376|vaccine|vaccine
1107006|NCT02508363|Taxi drivers|taxi drivers
1107007|NCT02508363|Health care access|health care access
1107008|NCT02508363|15-163|15-163
1107009|NCT02508311|Tetraplegia|tetraplegia
1107010|NCT02508311|High Paraplegia|high paraplegia
1107011|NCT02508298|ICG|icg
1107012|NCT02508298|ARFI|arfi
1107013|NCT02508298|portal hypertension|portal hypertension
1107014|NCT02508298|cirrhosis|cirrhosis
1107015|NCT02508298|diagnostic study|diagnostic study
1107016|NCT02508272|Transcriptome profiling|transcriptome profiling
1107017|NCT02508259|mitochondria|mitochondria
1107018|NCT02508259|purinergic signaling|purinergic signaling
1107019|NCT02508259|cell danger response|cell danger response
1107020|NCT02508194|RSV|rsv
1107021|NCT02508194|Older adults|older adults
1107022|NCT02508194|MEDI7510|medi7510
1107023|NCT02508194|Vaccine|vaccine
1107024|NCT02508194|Efficacy|efficacy
1107025|NCT02508181|intra ocular pressure|intra ocular pressure
1107026|NCT02508181|I-gel|i-gel
1107027|NCT02508181|LMA Supreme|lma supreme
1107028|NCT02508181|strabismus surgery|strabismus surgery
1107029|NCT02508168|Drug therapy|drug therapy
1107030|NCT02508129|Insomnia|insomnia
1107031|NCT02508129|hypertension|hypertension
1107032|NCT02508129|blood pressure|blood pressure
1107033|NCT02508129|sleep|sleep
1107034|NCT02508129|behavioral treatment|behavioral treatment
1107035|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
1107036|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
1107037|NCT02508129|pragmatic trial|pragmatic trial
1107038|NCT02508129|internet|internet
1107336|NCT02506140|ticagrelor|ticagrelor
1107039|NCT02508116|pharmacogenetics|pharmacogenetics
1107040|NCT02508116|clopidogrel|clopidogrel
1107041|NCT02508116|genotype|genotype
1107042|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
1107043|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
1107044|NCT02508103|PMS|pms
1107045|NCT02508103|PMDD|pmdd
1107046|NCT02508038|alpha beta depleted|alpha beta depleted
1107047|NCT02508038|alphabeta|alphabeta
1107048|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
1107049|NCT02508038|alpha beta|alpha beta
1107050|NCT02508038|haploidentical|haploidentical
1107051|NCT02508038|Zoledronate|zoledronate
1107052|NCT02508038|Zoledronic acid|zoledronic acid
1107053|NCT02508038|Pediatric cancers|pediatric cancers
1107054|NCT02508038|alfa beta|alfa beta
1107055|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
1107056|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
1107057|NCT02508038|haploidentical HSCT|haploidentical hsct
1107058|NCT02508025|disability evaluation|disability evaluation
1107059|NCT02508025|psychosocial factors|psychosocial factors
1107060|NCT02508012|anti-TNF|anti-tnf
1107061|NCT02508012|Immuno-monitoring|immuno-monitoring
1107062|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
1107063|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1107064|NCT02508012|Crohn's disease|crohn's disease
1107065|NCT02508012|Ulcerative colitis|ulcerative colitis
1107066|NCT02507973|Mechanical Ventilation|mechanical ventilation
1107067|NCT02507973|Intracranial Pressure|intracranial pressure
1107068|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
1107069|NCT02507934|Dry Eye|dry eye
1107070|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
1107071|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
1107072|NCT02507908|serotonin|serotonin
1107073|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
1107074|NCT02507895|Stroke|stroke
1107075|NCT02507895|lower extremeties|lower extremeties
1107076|NCT02507895|Brain-computer interface|brain-computer interface
1107077|NCT02507895|Motor imagery|motor imagery
1107078|NCT02507895|Rehabilitation|rehabilitation
1107079|NCT02507895|TMS|tms
1107080|NCT02507843|Vitamin D|vitamin d
1107081|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
1107082|NCT02507791|Fitbit|fitbit
1107083|NCT02507791|Obesity|obesity
1107084|NCT02507791|Pediatrics|pediatrics
1107085|NCT02507778|Lung|lung
1107086|NCT02507778|Cancer|cancer
1107087|NCT02507778|Biomarkers|biomarkers
1107088|NCT02507778|Early detection|early detection
1107089|NCT02507778|Circulating tumor cell|circulating tumor cell
1107090|NCT02507765|SBRT|sbrt
1107091|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1107092|NCT02507713|Ultrasonography|ultrasonography
1107093|NCT02507713|Motor neurons|motor neurons
1107094|NCT02507713|Neuromuscular diseases|neuromuscular diseases
1107095|NCT02507713|Fasciculation|fasciculation
1107096|NCT02507700|nerve block|nerve block
1107097|NCT02507674|appendicitis|appendicitis
1107098|NCT02507674|pediatric|pediatric
1107099|NCT02507674|ultrasound|ultrasound
1107100|NCT02507635|cytokines|cytokines
1107101|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
1107102|NCT02507635|H1 antihistamines|h1 antihistamines
1107103|NCT02507583|Brain Tumor|brain tumor
1107104|NCT02507583|Glioma|glioma
1107105|NCT02507583|Newly Diagnosed|newly diagnosed
1107106|NCT02507557|Therapy, Fluid|therapy, fluid
1107107|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
1107108|NCT02507557|Postoperative Complications|postoperative complications
1107109|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
1107110|NCT02507544|Safety and Tolerability|safety and tolerability
1107111|NCT02507544|Tumor Response|tumor response
1107112|NCT02507544|Hematology|hematology
1107113|NCT02507544|Oncology|oncology
1107114|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
1107115|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
1107116|NCT02507466|locomotion|locomotion
1107117|NCT02507453|volunteers|volunteers
1107118|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
1107119|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
1107120|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
1107121|NCT02507388|AMD|amd
1107122|NCT02507388|nAMD|namd
1107123|NCT02507388|wetAMD|wetamd
1107124|NCT02507388|Age-Related Macular Degeneration|age-related macular degeneration
1107125|NCT02507375|Non-Squamous|non-squamous
1107126|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
1107127|NCT02507349|serious mental illness|serious mental illness
1107128|NCT02507349|mental health services research|mental health services research
1107129|NCT02507349|measurement-based care|measurement-based care
1107130|NCT02507349|shared decision making|shared decision making
1107131|NCT02507349|psychiatric medication management|psychiatric medication management
1107132|NCT02507349|community psychiatry|community psychiatry
1107133|NCT02507349|comparative effectiveness research|comparative effectiveness research
1107134|NCT02507349|mixed methods research|mixed methods research
1107135|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
1107136|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1107137|NCT02507258|osteoarthritis|osteoarthritis
1107138|NCT02507258|avascular necrosis|avascular necrosis
1107139|NCT02507258|correction of functional deformity|correction of functional deformity
1107140|NCT02507258|painful hip dysplasia|painful hip dysplasia
1107141|NCT02507258|protrusio acetabuli|protrusio acetabuli
1107142|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
1107143|NCT02507258|ankylosis|ankylosis
1107144|NCT02507245|GHD|ghd
1107145|NCT02507232|glioma|glioma
1107146|NCT02507232|temozolomide|temozolomide
1107147|NCT02507232|brain|brain
1107148|NCT02507232|NovoTTF-200A|novottf-200a
1107149|NCT02507232|cancer|cancer
1107150|NCT02507232|low-grade glioma|low-grade glioma
1107151|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
1107152|NCT02507206|cognitive impairment|cognitive impairment
1107153|NCT02507206|working memory|working memory
1107154|NCT02507206|Dopamine Agonists|dopamine agonists
1107155|NCT02507206|Cognition Disorders|cognition disorders
1107156|NCT02507206|Personality Disorders|personality disorders
1107157|NCT02507206|Delirium|delirium
1107158|NCT02507206|Dementia|dementia
1107159|NCT02507206|Amnestic|amnestic
1107160|NCT02507206|Cognitive Disorders|cognitive disorders
1107161|NCT02507206|Mental Disorders|mental disorders
1107162|NCT02507206|Dihydrexidine|dihydrexidine
1107163|NCT02507206|Dopamine A|dopamine a
1107164|NCT02507180|Clinical Decision Rule|clinical decision rule
1107165|NCT02507180|Ultrasound|ultrasound
1107166|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
1107167|NCT02507180|D-Dimer|d-dimer
1107168|NCT02507154|cetuximab|cetuximab
1107169|NCT02507154|NK cells|nk cells
1107170|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
1107171|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
1107172|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
1107173|NCT02507141|15-128|15-128
1107174|NCT02507050|Ivabradine|ivabradine
1107175|NCT02507050|Microvascular dysfunction|microvascular dysfunction
1107176|NCT02507050|PCI|pci
1107177|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
1107178|NCT02507050|IMR|imr
1107179|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
1107180|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1107181|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
1107182|NCT02506985|Rivaroxaban|rivaroxaban
1107183|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
1107184|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
1107185|NCT02506985|NETs|nets
1107186|NCT02506985|factor Xa|factor xa
1107187|NCT02506972|Blood glucose|blood glucose
1107188|NCT02506972|Humans|humans
1107189|NCT02506972|Postprandial|postprandial
1107190|NCT02506972|Sugar|sugar
1107191|NCT02506972|Carbohydrate|carbohydrate
1107192|NCT02506972|Oat beta-glucan|oat beta-glucan
1107193|NCT02506959|Multiple myeloma (MM)|multiple myeloma (mm)
1107194|NCT02506959|MM|mm
1107195|NCT02506959|Refractory|refractory
1107196|NCT02506959|Relapsed|relapsed
1107197|NCT02506959|Stem Cell Transplant|stem cell transplant
1107198|NCT02506959|Busulfan|busulfan
1107199|NCT02506959|Busulfex|busulfex
1107200|NCT02506959|Myleran|myleran
1107201|NCT02506959|Palifermin|palifermin
1107202|NCT02506959|Kepivance|kepivance
1107203|NCT02506959|Panobinostat|panobinostat
1107205|NCT02506959|Gemcitabine|gemcitabine
1107206|NCT02506959|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1107207|NCT02506959|Gemzar|gemzar
1107208|NCT02506959|Melphalan|melphalan
1107209|NCT02506959|Alkeran|alkeran
1107210|NCT02506959|Dexamethasone|dexamethasone
1107211|NCT02506959|Decadron|decadron
1107212|NCT02506959|Pyridoxine|pyridoxine
1107213|NCT02506959|Caphosol|caphosol
1107214|NCT02506959|Glutamine|glutamine
1107215|NCT02506959|Enterex|enterex
1107216|NCT02506959|Glutapak|glutapak
1107217|NCT02506959|NutreStore|nutrestore
1107218|NCT02506959|Resource|resource
1107219|NCT02506959|GlutaSolve|glutasolve
1107220|NCT02506959|Sympt-X|sympt-x
1107221|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
1107222|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1107223|NCT02506946|Adolescents|adolescents
1107224|NCT02506946|Young Women|young women
1107225|NCT02506946|MRI|mri
1107226|NCT02506946|MRS|mrs
1107227|NCT02506946|DXA|dxa
1107228|NCT02506946|Hirsutism|hirsutism
1107229|NCT02506946|Amenorrhea|amenorrhea
1107230|NCT02506946|Metabolic syndrome|metabolic syndrome
1107231|NCT02506946|Dyslipidemia|dyslipidemia
1107232|NCT02506946|Percentage liver fat|percentage liver fat
1107233|NCT02506920|Postprandial lipemia|postprandial lipemia
1107234|NCT02506920|glycemic response|glycemic response
1107235|NCT02506881|darbepoetin alfa|darbepoetin alfa
1107236|NCT02506881|pharmacokinetics|pharmacokinetics
1107237|NCT02506881|pharmacodynamics|pharmacodynamics
1107238|NCT02506881|healthy volunteers|healthy volunteers
1107239|NCT02506868|darbepoetin alfa|darbepoetin alfa
1107240|NCT02506842|Pancreatic Cancer|pancreatic cancer
1107241|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1107242|NCT02506842|AG|ag
1107243|NCT02506842|OFF|off
1107244|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
1107245|NCT02506829|Inpatients|inpatients
1107246|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
1107247|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
1107248|NCT02506738|telemonitoring|telemonitoring
1107249|NCT02506738|mHealth|mhealth
1107250|NCT02506738|functional status|functional status
1107251|NCT02506738|older people|older people
1107252|NCT02506725|prenatal care|prenatal care
1107253|NCT02506725|pregnancy|pregnancy
1107254|NCT02506725|prematurity|prematurity
1107255|NCT02506673|Audiovisual Aids|audiovisual aids
1107256|NCT02506673|Perioperative Period|perioperative period
1107257|NCT02506673|Anxiety|anxiety
1107258|NCT02506634|symptom|symptom
1107259|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
1107260|NCT02506556|Pi3K pathway|pi3k pathway
1107261|NCT02506543|Adolescent Health|adolescent health
1107262|NCT02506543|Ethiopia|ethiopia
1107263|NCT02506543|Sexual Violence|sexual violence
1107264|NCT02506530|lymphedema|lymphedema
1107265|NCT02506530|breast cancer|breast cancer
1107266|NCT02506517|HER pathway aberrations|her pathway aberrations
1107267|NCT02506439|Vitamin D|vitamin d
1107268|NCT02506439|Cholecalciferol|cholecalciferol
1107269|NCT02506439|Dose-response|dose-response
1107270|NCT02506439|Randomized Controlled Trial|randomized controlled trial
1107271|NCT02506439|Pregnancy|pregnancy
1107272|NCT02506439|Cord blood|cord blood
1107273|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
1107274|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
1107275|NCT02506439|Nutrition|nutrition
1107276|NCT02506439|Dietary intervention study|dietary intervention study
1107277|NCT02506426|Chronic Sinusitis|chronic sinusitis
1107278|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
1107279|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
1107280|NCT02506426|Septoplasty|septoplasty
1107281|NCT02506413|Maternal and Newborn Health|maternal and newborn health
1107282|NCT02506361|TOP2α|top2α
1107283|NCT02506361|anthracyclines|anthracyclines
1107284|NCT02506361|taxanes|taxanes
1107285|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
1107286|NCT02506335|Liver disease|liver disease
1107287|NCT02506335|cardiomyopathy|cardiomyopathy
1107288|NCT02506335|congenital heart disease|congenital heart disease
1107289|NCT02506322|Bipolar I Disorder|bipolar i disorder
1107290|NCT02506322|Bipolar II Disorder|bipolar ii disorder
1107291|NCT02506322|Relapse Prevention|relapse prevention
1107292|NCT02506296|type 2 diabetes|type 2 diabetes
1107293|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
1107294|NCT02506283|cryotherapy|cryotherapy
1107295|NCT02506283|recovery|recovery
1107296|NCT02506283|athletic performance|athletic performance
1107297|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
1107298|NCT02506283|rated perceived exertion|rated perceived exertion
1107299|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
1107300|NCT02506283|jump performance|jump performance
1107301|NCT02506244|Atrial Fibrillation|atrial fibrillation
1107302|NCT02506244|Wearable device|wearable device
1107303|NCT02506244|Wristband|wristband
1107304|NCT02506244|ECG Patch|ecg patch
1107305|NCT02506244|Strokes|strokes
1107306|NCT02506244|Asymptomatic|asymptomatic
1107307|NCT02506244|Heart Rhythm|heart rhythm
1107308|NCT02506244|Home Monitoring|home monitoring
1107309|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1107310|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
1107311|NCT02506231|Methotrexate|methotrexate
1107312|NCT02506231|Folinic acid|folinic acid
1107313|NCT02506231|Leucovorin|leucovorin
1107314|NCT02506231|Mucositis|mucositis
1107315|NCT02506192|Gulf War Illness|gulf war illness
1107316|NCT02506192|Chronic Inflammation|chronic inflammation
1107317|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
1107318|NCT02506192|Health-Related Quality of Life|health-related quality of life
1107319|NCT02506179|Real-life effect|real-life effect
1107320|NCT02506179|Adalimumab|adalimumab
1107321|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
1107322|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
1107323|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
1107324|NCT02506166|sleep apnea|sleep apnea
1107325|NCT02506166|sleep disordered breathing|sleep disordered breathing
1107326|NCT02506166|sudden cardiac death|sudden cardiac death
1107327|NCT02506166|heart failure|heart failure
1107328|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
1107329|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
1107330|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1107331|NCT02506166|risk stratification|risk stratification
1107332|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
1107333|NCT02506166|SERVE-HF|serve-hf
1107334|NCT02506140|minor stroke|minor stroke
1107335|NCT02506140|transient ischemic attack|transient ischemic attack
1107338|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
1107339|NCT02506140|platelet reactivity|platelet reactivity
1107340|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
1107341|NCT02506114|prostate|prostate
1107342|NCT02506062|ischemic preconditioning|ischemic preconditioning
1107343|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
1107345|NCT02506036|Treatment|treatment
1107346|NCT02506036|Social-Cognitive Training|social-cognitive training
1107347|NCT02506036|Web-based|web-based
1107348|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
1107349|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
1107350|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
1107351|NCT02506023|Factor VIII antigen|factor viii antigen
1107352|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
1107353|NCT02506023|Mutation type|mutation type
1107354|NCT02506010|Hypoxia|hypoxia
1107355|NCT02505984|oxytocin, bonding|oxytocin, bonding
1107356|NCT02505984|child development|child development
1107357|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
1107358|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
1107359|NCT02505945|Esophageal Reflux|esophageal reflux
1107360|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
1107361|NCT02505945|Heartburn|heartburn
1107362|NCT02505932|Shoulder instability|shoulder instability
1107363|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1107364|NCT02505906|Late toxicity|late toxicity
1107365|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
1107366|NCT02505906|Radiotherapy|radiotherapy
1107367|NCT02505880|Hypnosis|hypnosis
1107368|NCT02505880|Pediatric surgery|pediatric surgery
1107369|NCT02505880|Anesthesia|anesthesia
1107370|NCT02505854|Obesity|obesity
1107371|NCT02505854|Probiotic|probiotic
1107372|NCT02505854|Symbiotic|symbiotic
1107373|NCT02505854|Weight loss|weight loss
1107374|NCT02505854|Gut microbiota|gut microbiota
1107375|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
1107376|NCT02505854|Fructooligosaccharide|fructooligosaccharide
1107377|NCT02505854|Blood sugar|blood sugar
1107378|NCT02505854|Lipemia|lipemia
1107379|NCT02505841|Appendectomy|appendectomy
1107380|NCT02505841|Laparoscopy|laparoscopy
1107381|NCT02505841|pediatric surgery|pediatric surgery
1107382|NCT02505828|Arthritis|arthritis
1107383|NCT02505828|septic|septic
1107384|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
1107385|NCT02505828|diagnosis|diagnosis
1107386|NCT02505828|proteomic|proteomic
1107387|NCT02505828|cytokine|cytokine
1107388|NCT02505828|monocytes|monocytes
1107389|NCT02505802|Stroke|stroke
1107390|NCT02505802|Botulinum Toxins|botulinum toxins
1107391|NCT02505802|Muscle Spasticity|muscle spasticity
1107392|NCT02505802|Gait|gait
1107393|NCT02505789|Epstein-Barr Virus|epstein-barr virus
1107394|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
1107395|NCT02505789|Infection|infection
1107396|NCT02505789|Cell Transplants|cell transplants
1107397|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
1107398|NCT02505711|Agriculture|agriculture
1107399|NCT02505711|Food|food
1107400|NCT02505711|Micronutrients|micronutrients
1107401|NCT02505711|Pregnancy|pregnancy
1107402|NCT02505711|Infants|infants
1107403|NCT02505711|Women's groups|women's groups
1107404|NCT02505711|Bangladesh|bangladesh
1107405|NCT02505698|Breast Imaging|breast imaging
1107406|NCT02505698|Mammography|mammography
1107407|NCT02505698|Anatomical Imaging|anatomical imaging
1107408|NCT02505685|Lung|lung
1107409|NCT02505685|Cancer|cancer
1107410|NCT02505685|Biomarkers|biomarkers
1107411|NCT02505685|PET-CT|pet-ct
1107412|NCT02505685|Early detection|early detection
1107413|NCT02505672|Vestibular function|vestibular function
1107414|NCT02505672|chemoradiotherapy|chemoradiotherapy
1107415|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
1107416|NCT02505659|Preoperative re-education|preoperative re-education
1107417|NCT02505659|Knee functional performance|knee functional performance
1107418|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
1107419|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
1107420|NCT02505646|circulatory failure|circulatory failure
1107421|NCT02505646|fluid responsiveness|fluid responsiveness
1107422|NCT02505646|abdominal compression|abdominal compression
1107423|NCT02505633|brachial plexus block|brachial plexus block
1107424|NCT02505633|nerve stimulator|nerve stimulator
1107425|NCT02505633|ultrasound|ultrasound
1107426|NCT02505620|Neurocognitive function|neurocognitive function
1107427|NCT02505620|OSAS|osas
1107428|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
1107429|NCT02505594|Vasoreactivity|vasoreactivity
1107430|NCT02505594|Endothelial function|endothelial function
1107431|NCT02505594|Exercise|exercise
1107432|NCT02505581|Postoperative Wound Infection|postoperative wound infection
1107433|NCT02505581|Surgical Wound Infection|surgical wound infection
1107434|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
1107435|NCT02505568|Behcet Disease|behcet disease
1107436|NCT02505568|Infliximab|infliximab
1107437|NCT02505568|Adult participants|adult participants
1107438|NCT02505555|feasibility|feasibility
1107439|NCT02505555|accuracy|accuracy
1107440|NCT02505555|tolerability|tolerability
1107441|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
1107442|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
1107443|NCT02505542|axSpA|axspa
1107444|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
1107445|NCT02505542|Anti TNF-alpha|anti tnf-alpha
1107446|NCT02505542|Certolizumab Pegol|certolizumab pegol
1107447|NCT02505542|Remission|remission
1107448|NCT02505542|Spondylarthropathies|spondylarthropathies
1107449|NCT02505542|Arthritis|arthritis
1107450|NCT02505542|Spinal Diseases|spinal diseases
1107451|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
1107452|NCT02505529|Aging|aging
1107453|NCT02505529|Muscle|muscle
1107454|NCT02505529|Weakness|weakness
1107455|NCT02505529|Sarcopenia|sarcopenia
1107456|NCT02505529|Dynapenia|dynapenia
1107457|NCT02505516|pathology|pathology
1107458|NCT02505503|Claudication|claudication
1107459|NCT02505503|Footwear|footwear
1107460|NCT02505503|Shoes|shoes
1107461|NCT02505503|Walking capacity|walking capacity
1107462|NCT02505503|Walking distance|walking distance
1107463|NCT02505490|Lunch|lunch
1107464|NCT02505490|Television|television
1107465|NCT02505490|Macaroni and Cheese|macaroni and cheese
1107466|NCT02505490|Salad tossed in dressing|salad tossed in dressing
1107467|NCT02505477|schiozphrenia|schiozphrenia
1107468|NCT02505477|cognition|cognition
1107469|NCT02505477|negative symptoms|negative symptoms
1107470|NCT02505477|glutamate|glutamate
1107471|NCT02505477|glutathione|glutathione
1107472|NCT02505477|N-acetylcysteine|n-acetylcysteine
1107473|NCT02505451|Metabolic syndrome|metabolic syndrome
1107474|NCT02505451|diabetes|diabetes
1107475|NCT02505451|myocardial function|myocardial function
1107476|NCT02505451|dobutamine|dobutamine
1107477|NCT02505399|Rotational Atherectomy|rotational atherectomy
1107478|NCT02505399|clopidogrel|clopidogrel
1107479|NCT02505399|thrombosis|thrombosis
1107480|NCT02505399|ticagrelor|ticagrelor
1107481|NCT02505386|Ertapenem|ertapenem
1107482|NCT02505386|Subcutaneously|subcutaneously
1107483|NCT02505386|Aged|aged
1107484|NCT02505386|Elderly|elderly
1107485|NCT02505386|Pharmacokinetics|pharmacokinetics
1107486|NCT02505373|Brief Therapy|brief therapy
1107487|NCT02505373|Attempted Suicide|attempted suicide
1107488|NCT02505373|Therapeutic Alliance|therapeutic alliance
1107489|NCT02505373|Suicidal Ideation|suicidal ideation
1107490|NCT02505373|Suicide|suicide
1107491|NCT02505373|ASSIP|assip
1107492|NCT02505321|insulin resistance|insulin resistance
1107493|NCT02505321|physiology|physiology
1107494|NCT02505321|genetics|genetics
1107495|NCT02505321|gene variants|gene variants
1107496|NCT02505321|pathogenesis|pathogenesis
1107497|NCT02505321|type 2 diabetes|type 2 diabetes
1107498|NCT02505321|fat|fat
1107499|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
1107500|NCT02505308|insulin|insulin
1107501|NCT02505308|proinsulin|proinsulin
1107502|NCT02505308|genotype|genotype
1107503|NCT02505308|beta cells|beta cells
1107504|NCT02505308|physiology|physiology
1107505|NCT02505308|genetics|genetics
1107506|NCT02505308|pathogenesis|pathogenesis
1107507|NCT02505308|rare variants|rare variants
1107508|NCT02505308|type 2 diabetes|type 2 diabetes
1107509|NCT02505282|Orthostatic hypotension|orthostatic hypotension
1107510|NCT02505282|Vitamin K|vitamin k
1107511|NCT02505269|limited stage|limited stage
1107512|NCT02505269|Hodgkin's disease|hodgkin's disease
1107513|NCT02505269|non-bulky|non-bulky
1107514|NCT02505243|ribavirin|ribavirin
1107515|NCT02505243|direct-acting antivirals|direct-acting antivirals
1107516|NCT02505243|pharmacokinetics|pharmacokinetics
1107517|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
1107518|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
1107519|NCT02505204|clonidine|clonidine
1107520|NCT02505204|paravertebral block|paravertebral block
1107521|NCT02505204|hemodynamic stability|hemodynamic stability
1107522|NCT02505191|Pharmacokinetics|pharmacokinetics
1107523|NCT02505178|Depression|depression
1107524|NCT02505178|Depressive Disorder|depressive disorder
1107525|NCT02505178|Depressive Disorder, Major|depressive disorder, major
1107526|NCT02505178|Mental Disorders|mental disorders
1107527|NCT02505178|Mood Disorders|mood disorders
1107528|NCT02505178|Behavioural Symptoms|behavioural symptoms
1107529|NCT02505178|Problem Solving Therapy|problem solving therapy
1107530|NCT02505165|Intervention|intervention
1107531|NCT02505165|Illness Uncertainty|illness uncertainty
1107532|NCT02505165|Childhood Cancer|childhood cancer
1107533|NCT02505165|Solid Tumor|solid tumor
1107534|NCT02505165|Leukemia|leukemia
1107535|NCT02505165|Lymphoma|lymphoma
1107536|NCT02505165|Brain Tumor|brain tumor
1107537|NCT02505165|Randomized clinical trial|randomized clinical trial
1107538|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
1107539|NCT02505165|Parent|parent
1107542|NCT02505152|Hypertension, Portal|hypertension, portal
1107543|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
1107544|NCT02505152|Portosystemic shunt|portosystemic shunt
1107545|NCT02505152|Radiology, Interventional|radiology, interventional
1107546|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1107547|NCT02505139|distant metastasis|distant metastasis
1107548|NCT02505139|circulating tumor cells|circulating tumor cells
1107549|NCT02505139|outcome prediction|outcome prediction
1107550|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
1107551|NCT02505113|Hypertension, Portal|hypertension, portal
1107552|NCT02505100|threat of premature birth|threat of premature birth
1107553|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
1107554|NCT02505087|biomarkers|biomarkers
1107555|NCT02505087|washout|washout
1107556|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
1107557|NCT02505074|mitral valve|mitral valve
1107558|NCT02505074|tricuspid valve|tricuspid valve
1107559|NCT02505074|Melody valve|melody valve
1107560|NCT02505035|Palliative care|palliative care
1107561|NCT02505035|Pragmatic trial|pragmatic trial
1107562|NCT02505022|Cognition|cognition
1107563|NCT02505022|Early mental illness|early mental illness
1107564|NCT02505022|Role functioning|role functioning
1107565|NCT02505009|Therapeutic Uses|therapeutic uses
1107566|NCT02505009|Entecavir|entecavir
1107567|NCT02505009|Tenofovir|tenofovir
1107568|NCT02505009|Engerix-B|engerix-b
1107569|NCT02505009|DNA Virus Infections|dna virus infections
1107570|NCT02505009|Antiviral Agents|antiviral agents
1107571|NCT02505009|Vaccination|vaccination
1107572|NCT02504996|sciatalgia|sciatalgia
1107573|NCT02504996|emergency department|emergency department
1107574|NCT02504996|paracetamol|paracetamol
1107575|NCT02504996|morphine|morphine
1107576|NCT02504983|SNPs|snps
1107577|NCT02504970|Anesthesia|anesthesia
1107578|NCT02504970|Quality Improvement|quality improvement
1107579|NCT02504957|Photodynamic therapy|photodynamic therapy
1107580|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
1107581|NCT02504944|Propranolol|propranolol
1107582|NCT02504944|Newborn|newborn
1158393|NCT02223650|IXT|ixt
1107583|NCT02504944|Eye Drops|eye drops
1107584|NCT02504944|Retinal angiogenesis|retinal angiogenesis
1107585|NCT02504944|Retinal neovascularization|retinal neovascularization
1107586|NCT02504931|PTSD|ptsd
1107587|NCT02504931|Alcohol|alcohol
1107588|NCT02504931|Dual Diagnosis|dual diagnosis
1107589|NCT02504931|Sertraline|sertraline
1107590|NCT02504931|SSRI|ssri
1107591|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
1107592|NCT02504918|Regulatory|regulatory
1107593|NCT02504918|Chemoprevention|chemoprevention
1107594|NCT02504918|Coartem|coartem
1107595|NCT02504918|Parasitemia|parasitemia
1107596|NCT02504905|Parietal Lobe|parietal lobe
1107597|NCT02504905|Plasticity|plasticity
1107598|NCT02504905|Cerebellum|cerebellum
1107599|NCT02504905|Dystonia|dystonia
1107600|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1107601|NCT02504892|Overall Response Rate|overall response rate
1107602|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
1107603|NCT02504892|mTOR Therapy Naive|mtor therapy naive
1107608|NCT02504866|TBI|tbi
1107609|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
1107610|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
1107611|NCT02504853|TGFbeta|tgfbeta
1107612|NCT02504840|Multiple Sclerosis|multiple sclerosis
1107613|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
1107614|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
1107615|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
1107616|NCT02504827|pharmacokinetics|pharmacokinetics
1107617|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
1107618|NCT02504814|nasal high flow|nasal high flow
1107619|NCT02504801|primary lung cancer patients|primary lung cancer patients
1107620|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
1107621|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
1107622|NCT02504788|Hippocampus|hippocampus
1107623|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
1107624|NCT02504749|GIT motility|git motility
1107625|NCT02504749|General anaesthesia|general anaesthesia
1107626|NCT02504749|spinal anaesthesia|spinal anaesthesia
1107627|NCT02504736|LDL cholesterol|ldl cholesterol
1107628|NCT02504736|A1c|a1c
1107629|NCT02504736|High risk South Asians|high risk south asians
1107630|NCT02504736|Colesevelam|colesevelam
1107631|NCT02504723|Gastric varices|gastric varices
1107632|NCT02504723|cyanoacrylate|cyanoacrylate
1107633|NCT02504723|carvedilol|carvedilol
1107634|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
1107635|NCT02504710|Learning|learning
1107636|NCT02504710|Feedback|feedback
1107637|NCT02504710|Kinematics|kinematics
1107638|NCT02504710|Inertial Sensor|inertial sensor
1107639|NCT02504684|varicose veins|varicose veins
1107640|NCT02504684|endovenous laser treatment|endovenous laser treatment
1107641|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
1107642|NCT02504684|saphenous vein|saphenous vein
1107645|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
1107646|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
1107647|NCT02504632|platelet activation|platelet activation
1107648|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1107649|NCT02504593|Quality Assurance|quality assurance
1107650|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
1107651|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
1107652|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
1107653|NCT02504593|Community health workers|community health workers
1107654|NCT02504567|Catheter Ablation|catheter ablation
1107655|NCT02504567|Radiofrequency|radiofrequency
1107656|NCT02504567|Laser|laser
1107657|NCT02504567|Atrial Fibrillation|atrial fibrillation
1107658|NCT02504554|children|children
1107659|NCT02504541|Hypogonadism|hypogonadism
1107660|NCT02504541|Testosterone enanthate|testosterone enanthate
1107661|NCT02504528|asthma|asthma
1107662|NCT02504528|allergy|allergy
1107663|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1107664|NCT02504528|provocation|provocation
1107665|NCT02504502|Whole Genome Sequencing|whole genome sequencing
1107666|NCT02504502|Laboratory Report|laboratory report
1107667|NCT02504502|Patient Centered|patient centered
1107668|NCT02504502|Communication of Results|communication of results
1107669|NCT02504502|Patient Provider Communication|patient provider communication
1107670|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
1107671|NCT02504463|Alkermes|alkermes
1107672|NCT02504463|Samidorphan|samidorphan
1107673|NCT02504463|ALKS 33|alks 33
1107674|NCT02504463|Healthy Volunteer|healthy volunteer
1107675|NCT02504463|Pharmacokinetics|pharmacokinetics
1107676|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
1107677|NCT02504450|schizophrenia|schizophrenia
1107678|NCT02504424|Tissue Expansion|tissue expansion
1107679|NCT02504424|Tissue Expander|tissue expander
1107680|NCT02504424|Breast Tissue Expansion|breast tissue expansion
1107681|NCT02504424|Breast Tissue Expander|breast tissue expander
1107682|NCT02504424|Breast Reconstruction|breast reconstruction
1107683|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
1107684|NCT02504372|NSCLC|nsclc
1107685|NCT02504372|PDL1|pdl1
1107686|NCT02504372|PD-L1|pd-l1
1107687|NCT02504372|PDL|pdl
1107688|NCT02504359|BEAM|beam
1107689|NCT02504359|allogeneic|allogeneic
1107690|NCT02504359|myeloma|myeloma
1107691|NCT02504359|ixazomib|ixazomib
1107692|NCT02504359|transplant|transplant
1107693|NCT02504359|plasma cell leukemia|plasma cell leukemia
1107694|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
1107695|NCT02504333|Nab-paclitaxel|nab-paclitaxel
1107696|NCT02504333|Gemcitabine|gemcitabine
1107697|NCT02504333|modified FOLFOX|modified folfox
1107698|NCT02504320|Drug therapy|drug therapy
1107699|NCT02504255|Crohn disease|crohn disease
1107700|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
1107701|NCT02504255|immunologic markers|immunologic markers
1107702|NCT02504255|calprotectin|calprotectin
1107703|NCT02504216|Rivaroxaban|rivaroxaban
1107704|NCT02504216|Xarelto|xarelto
1107705|NCT02504216|Aspirin|aspirin
1107706|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
1107707|NCT02504216|Anticoagulant|anticoagulant
1107708|NCT02504216|Peripheral artery disease|peripheral artery disease
1107709|NCT02504216|Peripheral arterial disease|peripheral arterial disease
1107710|NCT02504216|Revascularization|revascularization
1107711|NCT02504216|Acute limb ischemia|acute limb ischemia
1107712|NCT02504216|Amputation|amputation
1107713|NCT02504216|Cardiovascular events|cardiovascular events
1107714|NCT02504190|Lymphoma|lymphoma
1107715|NCT02504190|TEAM conditioning|team conditioning
1107716|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
1107717|NCT02504164|midazolam|midazolam
1107718|NCT02504164|satisfaction|satisfaction
1107719|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
1107720|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
1107721|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
1107722|NCT02504073|Clinical Reasoning|clinical reasoning
1107723|NCT02504073|Physiotherapists|physiotherapists
1107724|NCT02504060|diarrhea|diarrhea
1107725|NCT02504060|abdominal pain|abdominal pain
1107726|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1107727|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
1107728|NCT02504034|Hypertension, Portal|hypertension, portal
1107729|NCT02504034|Radiology, Interventional|radiology, interventional
1107730|NCT02504034|Portalsystemic shunt|portalsystemic shunt
1107731|NCT02504008|bisphosphonate|bisphosphonate
1107732|NCT02504008|CRPS|crps
1107733|NCT02504008|RSD|rsd
1107734|NCT02504008|non-opioid|non-opioid
1107735|NCT02504008|CRPS-1|crps-1
1107736|NCT02504008|acute on chronic pain|acute on chronic pain
1107737|NCT02504008|chronic pain|chronic pain
1107738|NCT02504008|zoledronic acid|zoledronic acid
1107739|NCT02503969|Colorectal Cancer|colorectal cancer
1107740|NCT02503969|Mass Screening|mass screening
1107743|NCT02503969|Mental Health|mental health
1107744|NCT02503943|GLP-1|glp-1
1107745|NCT02503943|Masked hypertension|masked hypertension
1107746|NCT02503943|Lipid metabolism|lipid metabolism
1107747|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
1107748|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
1107749|NCT02503917|Cancer|cancer
1107750|NCT02503904|Pharmacology|pharmacology
1107751|NCT02503904|Lidocaine|lidocaine
1107752|NCT02503904|Epinephrine|epinephrine
1107753|NCT02503904|Cefazolin|cefazolin
1107754|NCT02503904|Metronidazole|metronidazole
1107755|NCT02503904|Infection|infection
1107756|NCT02503904|prevention|prevention
1107757|NCT02503904|prophylaxis|prophylaxis
1107758|NCT02503904|SSI|ssi
1107759|NCT02503904|Surgery|surgery
1107760|NCT02503904|Complications|complications
1107761|NCT02503865|Metabolic syndrome|metabolic syndrome
1107762|NCT02503865|Diabetes mellitus,|diabetes mellitus,
1107763|NCT02503865|Hypertension|hypertension
1107764|NCT02503865|Overweight|overweight
1107765|NCT02503865|analimentary detoxication|analimentary detoxication
1107766|NCT02503852|Female Pattern Baldness|female pattern baldness
1107767|NCT02503852|Male Pattern Baldness|male pattern baldness
1107768|NCT02503852|Genetic Alopecia|genetic alopecia
1107769|NCT02503852|Androgenic Alopecia|androgenic alopecia
1107770|NCT02503852|Hair Loss|hair loss
1107771|NCT02503839|Host-modulating therapy|host-modulating therapy
1107772|NCT02503839|Vaccine|vaccine
1107773|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
1107774|NCT02503813|brain death|brain death
1107775|NCT02503813|apnea challenge test|apnea challenge test
1107776|NCT02503787|chronic pain|chronic pain
1107777|NCT02503787|intractable pain|intractable pain
1107778|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
1568535|NCT00505505|Neurologic outcome|neurologic outcome
1107779|NCT02503774|Solid Tumors, MEDI9447, oleclumab, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC, immunotherapy, pancreatic, colorectal|solid tumors, medi9447, oleclumab, medi4736, durvalumab, cd73, pd-l1, egfrm nsclc, immunotherapy, pancreatic, colorectal
1107780|NCT02503761|meropenem|meropenem
1107781|NCT02503761|infusion|infusion
1107782|NCT02503761|late-onset sepsis|late-onset sepsis
1107783|NCT02503761|newborn|newborn
1107784|NCT02503761|management|management
1107785|NCT02503735|CKD|ckd
1107786|NCT02503735|HCV|hcv
1107787|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
1107789|NCT02503696|Colorectal Cancer|colorectal cancer
1107790|NCT02503696|Neoplasm|neoplasm
1107791|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
1107792|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
1107793|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1107794|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
1107795|NCT02503696|Neoplasms by Site|neoplasms by site
1107796|NCT02503696|Neoplasms|neoplasms
1107797|NCT02503696|Digestive System Diseases|digestive system diseases
1107798|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
1107799|NCT02503696|Colonic Diseases|colonic diseases
1107800|NCT02503696|Intestinal Diseases|intestinal diseases
1107801|NCT02503696|Rectal Diseases|rectal diseases
1107802|NCT02503683|RNAi therapeutic|rnai therapeutic
1107804|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1107805|NCT02503657|tipelukast|tipelukast
1107806|NCT02503657|IPF|ipf
1107807|NCT02503657|fibrosis|fibrosis
1107808|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1107809|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
1107810|NCT02503644|scleroderma|scleroderma
1107811|NCT02503644|IVA337|iva337
1107812|NCT02503644|dcSSc|dcssc
1107813|NCT02503631|Cancer|cancer
1107814|NCT02503631|Colorectal Cancer|colorectal cancer
1107815|NCT02503631|Neoplasm|neoplasm
1107816|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
1107817|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
1107818|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1107819|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
1107820|NCT02503631|Neoplasms by Site|neoplasms by site
1107821|NCT02503631|Neoplasms|neoplasms
1107822|NCT02503631|Digestive System Diseases|digestive system diseases
1107823|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
1107824|NCT02503631|Colonic Diseases|colonic diseases
1107825|NCT02503631|Intestinal Diseases|intestinal diseases
1107826|NCT02503631|Rectal Diseases|rectal diseases
1107827|NCT02503605|Biosimilar|biosimilar
1107828|NCT02503605|ovarian stimulation|ovarian stimulation
1107829|NCT02503605|oocyte donor|oocyte donor
1107830|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
1107831|NCT02503579|Executive function|executive function
1107832|NCT02503566|CAV|cav
1107833|NCT02503566|OCT|oct
1107834|NCT02503566|heart rate|heart rate
1107835|NCT02503566|antibodies|antibodies
1107836|NCT02503553|option grid|option grid
1107837|NCT02503553|neurosurgery|neurosurgery
1107838|NCT02503553|cerebral aneurysm|cerebral aneurysm
1107839|NCT02503540|macular edema|macular edema
1107840|NCT02503540|rvo|rvo
1107841|NCT02503540|diabetic macular edema|diabetic macular edema
1107842|NCT02503527|Enteral nutrition|enteral nutrition
1107843|NCT02503527|Tube feeding|tube feeding
1107844|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
1107845|NCT02503527|Diabetes|diabetes
1107846|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
1107847|NCT02503527|Blood glucose|blood glucose
1107848|NCT02503527|Insulin|insulin
1107849|NCT02503501|Memory|memory
1107850|NCT02503501|Insulin glulisine|insulin glulisine
1107851|NCT02503501|Alzheimer's disease|alzheimer's disease
1107852|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
1107853|NCT02503501|Intranasal insulin|intranasal insulin
1107854|NCT02503501|Cognition Disorders|cognition disorders
1107855|NCT02503488|Appetitive Aggression|appetitive aggression
1107856|NCT02503462|HIV|hiv
1107857|NCT02503462|darunavir|darunavir
1107858|NCT02503462|ritonavir|ritonavir
1107859|NCT02503462|cobicistat|cobicistat
1107860|NCT02503462|CSF|csf
1107861|NCT02503462|pharmacokinetics|pharmacokinetics
1107862|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
1107863|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
1107864|NCT02503423|cervical cancer|cervical cancer
1107865|NCT02503423|HNSCC|hnscc
1107866|NCT02503423|CTCL|ctcl
1107867|NCT02503423|PTCL|ptcl
1107868|NCT02503423|DLBCL|dlbcl
1107869|NCT02503410|back|back
1107870|NCT02503410|pain|pain
1107871|NCT02503345|Kidney Stones|kidney stones
1107872|NCT02503345|Nephrolithiasis|nephrolithiasis
1107873|NCT02503345|Urine Oxalate|urine oxalate
1107874|NCT02503345|Hyperoxaluria|hyperoxaluria
1107875|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
1107876|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
1107877|NCT02503345|Urological Diseases|urological diseases
1107878|NCT02503345|Kidney Diseases|kidney diseases
1107879|NCT02503345|Dietary Oxalate|dietary oxalate
1107880|NCT02503280|Cardiovascular|cardiovascular
1107881|NCT02503280|Secondary|secondary
1107882|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
1107883|NCT02503267|congenital heart diseases|congenital heart diseases
1107884|NCT02503254|Smoking|smoking
1107885|NCT02503254|Modified risk tobacco product|modified risk tobacco product
1107886|NCT02503254|Conventional cigarette|conventional cigarette
1107887|NCT02503254|Reduced exposure|reduced exposure
1107888|NCT02503254|Confinement|confinement
1107889|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
1107890|NCT02503215|Hemodialysis|hemodialysis
1107891|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
1107892|NCT02503215|Compression stockings|compression stockings
1107893|NCT02503189|Dry eye syndromes|dry eye syndromes
1107894|NCT02503189|Corneal diseases|corneal diseases
1107895|NCT02503189|Conjunctival diseases|conjunctival diseases
1107896|NCT02503176|Dry eye syndromes|dry eye syndromes
1107897|NCT02503176|Corneal diseases|corneal diseases
1107898|NCT02503176|Conjunctival diseases|conjunctival diseases
1107899|NCT02503163|Dry eye syndromes|dry eye syndromes
1107900|NCT02503163|Corneal diseases|corneal diseases
1107901|NCT02503163|Conjunctival diseases|conjunctival diseases
1107902|NCT02503150|Colorectal Cancer|colorectal cancer
1107903|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
1107904|NCT02503150|Dendritic Cell|dendritic cell
1107905|NCT02503137|male pattern baldness|male pattern baldness
1107906|NCT02503137|SM04554|sm04554
1107907|NCT02503137|AGA|aga
1107908|NCT02503111|Men who have sex with men|men who have sex with men
1107909|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
1107910|NCT02503111|Human papillomavirus|human papillomavirus
1107911|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
1107912|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
1107913|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
1107914|NCT02503111|Anal cancer|anal cancer
1107915|NCT02503111|High-risk oncogenic|high-risk oncogenic
1107916|NCT02503111|Intraepithelial lesion|intraepithelial lesion
1107917|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
1107918|NCT02503111|Dysplasia|dysplasia
1107919|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1107920|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1107921|NCT02503111|Ablative therapy|ablative therapy
1107922|NCT02503111|Electrocautery|electrocautery
1107923|NCT02503111|Infrared coagulation|infrared coagulation
1107924|NCT02503111|Active surveillance|active surveillance
1107925|NCT02503098|Eating Disorders|eating disorders
1107926|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
1107927|NCT02503098|Mobile Phone|mobile phone
1107928|NCT02503098|Smartphone|smartphone
1107929|NCT02503098|App|app
1107930|NCT02503098|Binge Eating Disorder|binge eating disorder
1107931|NCT02503098|Bulimia Nervosa|bulimia nervosa
1107932|NCT02503098|Signal Detection Analysis|signal detection analysis
1107933|NCT02503085|Ibuprofen|ibuprofen
1107934|NCT02503072|ARV adherence|arv adherence
1107935|NCT02503020|Arachidonic acid|arachidonic acid
1107936|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
1107937|NCT02503020|Preterm infants nutrition|preterm infants nutrition
1107938|NCT02502981|CKD|ckd
1107939|NCT02502981|left ventricle|left ventricle
1107940|NCT02502981|aldosterone|aldosterone
1107941|NCT02502981|spironolactone|spironolactone
1107942|NCT02502955|Quality Control|quality control
1107943|NCT02502955|Cardiosurgery|cardiosurgery
1107944|NCT02502955|Cardiology|cardiology
1107945|NCT02502955|Vascular Surgery|vascular surgery
1107946|NCT02502955|ICU|icu
1107947|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
1107948|NCT02502942|Exercise|exercise
1107949|NCT02502942|Upper airway muscle|upper airway muscle
1107950|NCT02502929|Diabetes|diabetes
1107951|NCT02502929|Depression|depression
1107952|NCT02502929|Medication therapy management|medication therapy management
1107953|NCT02502929|Community health workers|community health workers
1107954|NCT02502929|Cambodian|cambodian
1107955|NCT02502929|Refugee|refugee
1107956|NCT02502929|Prevention|prevention
1107957|NCT02502890|asthma|asthma
1107958|NCT02502890|nested case-control study|nested case-control study
1107959|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
1107960|NCT02502890|asthma exacerbations|asthma exacerbations
1107961|NCT02502890|cold symptoms|cold symptoms
1107962|NCT02502890|gene expression|gene expression
1107963|NCT02502838|overactive bladder|overactive bladder
1107964|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
1107965|NCT02502838|TVT|tvt
1107966|NCT02502812|bioequivalence|bioequivalence
1107967|NCT02502812|SB224326|sb224326
1107968|NCT02502812|clopidogrel|clopidogrel
1107969|NCT02502812|Relative bioavailability|relative bioavailability
1107970|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
1107971|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
1107972|NCT02502786|15-096|15-096
1107973|NCT02502773|Goal-directed therapy|goal-directed therapy
1107974|NCT02502773|Fluid loading|fluid loading
1107975|NCT02502773|Abdominal surgery|abdominal surgery
1107976|NCT02502773|Postoperative morbidity|postoperative morbidity
1107977|NCT02502773|Postoperative mortality|postoperative mortality
1107978|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
1107979|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
1107980|NCT02502773|General Anesthesia|general anesthesia
1107981|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
1107982|NCT02502760|Postoperative Complications|postoperative complications
1107983|NCT02502760|Perioperative Care|perioperative care
1107984|NCT02502760|Colorectal Surgery|colorectal surgery
1107985|NCT02502760|Frail Elderly|frail elderly
1107986|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
1107987|NCT02502734|pediatric subjects|pediatric subjects
1107989|NCT02502734|fluticasone furoate|fluticasone furoate
1107990|NCT02502721|Male|male
1107991|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
1107992|NCT02502708|glioma|glioma
1107993|NCT02502708|gliosarcoma|gliosarcoma
1107994|NCT02502708|malignant brain tumor|malignant brain tumor
1107995|NCT02502708|ependymoma|ependymoma
1107996|NCT02502708|medulloblastoma|medulloblastoma
1107997|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
1107998|NCT02502695|Lung Cancer|lung cancer
1107999|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
1108000|NCT02502669|acne|acne
1108001|NCT02502669|nodulocystic|nodulocystic
1108002|NCT02502669|finasteride|finasteride
1108003|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
1108004|NCT02502656|RAS mutation|ras mutation
1108005|NCT02502656|DNA|dna
1108006|NCT02502656|Colorectal Cancer|colorectal cancer
1108007|NCT02502643|Safety and Efficacy|safety and efficacy
1108008|NCT02502643|Thoracic Surgery|thoracic surgery
1108009|NCT02502617|Psychopathology|psychopathology
1108010|NCT02502617|Cognition|cognition
1108011|NCT02502617|Depression|depression
1108012|NCT02502617|Nutrition|nutrition
1108013|NCT02502617|Cortisol|cortisol
1108014|NCT02502617|Anorexia nervosa|anorexia nervosa
1108015|NCT02502604|Cognitive Remediation|cognitive remediation
1108016|NCT02502604|Goal Management Training|goal management training
1108017|NCT02502604|Major Depressive Disorder|major depressive disorder
1108018|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
1108019|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
1108020|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
1108021|NCT02502552|Crohn's Disease|crohn's disease
1108022|NCT02502552|Ulcerative Colitis|ulcerative colitis
1108023|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
1108024|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
1108025|NCT02502552|antibodies stability|antibodies stability
1108026|NCT02502552|mucosal healing|mucosal healing
1108027|NCT02502552|predictive markers|predictive markers
1108028|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
1108029|NCT02502539|Physical exercise|physical exercise
1108030|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
1108031|NCT02502539|Interleukins|interleukins
1108032|NCT02502539|miRNA|mirna
1108033|NCT02502539|Calgranulins|calgranulins
1108034|NCT02502487|Analgesia|analgesia
1108035|NCT02502487|Cystoscopy|cystoscopy
1108036|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
1108037|NCT02502487|Nerve block|nerve block
1108039|NCT02502474|staphylococcus aureus|staphylococcus aureus
1108040|NCT02502474|digestive carriage|digestive carriage
1108041|NCT02502474|mucosal colonization|mucosal colonization
1108042|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
1108043|NCT02502448|cardiac surgery|cardiac surgery
1108044|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
1108045|NCT02502422|Laryngeal mask airway|laryngeal mask airway
1108046|NCT02502409|Hemophilia B|hemophilia b
1108047|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
1108048|NCT02502396|Cancer|cancer
1108049|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
1108050|NCT02502396|Pulmonary embolism|pulmonary embolism
1108051|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1108052|NCT02502396|Chart review|chart review
1108053|NCT02502396|VTE|vte
1108054|NCT02502396|NVAF|nvaf
1108055|NCT02502396|Rivaroxaban|rivaroxaban
1108056|NCT02502383|Adolescent|adolescent
1108057|NCT02502383|Overweight|overweight
1108058|NCT02502383|Obesity|obesity
1108059|NCT02502383|Weight loss|weight loss
1108060|NCT02502383|Nutrition|nutrition
1108061|NCT02502383|Physical Activity|physical activity
1108062|NCT02502383|School-based|school-based
1108063|NCT02502383|Primary care|primary care
1108064|NCT02502383|Motivational Interviewing|motivational interviewing
1108065|NCT02502357|pain control|pain control
1108066|NCT02502357|healing statements|healing statements
1108067|NCT02502357|pelvic prolapse|pelvic prolapse
1108068|NCT02502344|insulin resistance|insulin resistance
1108069|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
1108070|NCT02502344|DM prevention|dm prevention
1108071|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
1108072|NCT02502331|immunogenicity|immunogenicity
1108073|NCT02502331|safety|safety
1108074|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
1108075|NCT02502305|health literacy|health literacy
1108076|NCT02502305|attitude|attitude
1108077|NCT02502305|motivation|motivation
1108078|NCT02502292|Health Literacy|health literacy
1108079|NCT02502292|Health Ageing|health ageing
1108080|NCT02502292|Health Literacy Interventions|health literacy interventions
1108081|NCT02502292|IROHLA|irohla
1108082|NCT02502292|Photo Novel Study|photo novel study
1108083|NCT02502240|ALK|alk
1108084|NCT02502240|Latin American|latin american
1108085|NCT02502227|mindfulness|mindfulness
1108086|NCT02502227|psychological stress|psychological stress
1108087|NCT02502227|wellness programs|wellness programs
1108088|NCT02502227|cortisol|cortisol
1108089|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
1108090|NCT02502214|PGD|pgd
1108091|NCT02502214|Next-Generation Sequencing|next-generation sequencing
1108092|NCT02502214|NGS|ngs
1108093|NCT02502214|Single-Gene disorders|single-gene disorders
1108094|NCT02502214|Cystic Fibrosis|cystic fibrosis
1108095|NCT02502214|CFTR|cftr
1108096|NCT02502214|Single-cell analysis|single-cell analysis
1108097|NCT02502214|PCR|pcr
1108098|NCT02502214|SNP|snp
1108099|NCT02502214|Whole Genome Amplification|whole genome amplification
1108100|NCT02502201|six-minute walk|six-minute walk
1108101|NCT02502188|Healthy Subjects|healthy subjects
1108102|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
1108103|NCT02502188|Moderate|moderate
1108104|NCT02502188|Phase 1|phase 1
1108105|NCT02502188|Safety|safety
1108106|NCT02502188|Tolerability|tolerability
1108107|NCT02502188|CC-90005|cc-90005
1108108|NCT02502175|Opium tincture|opium tincture
1108109|NCT02502175|opium|opium
1108110|NCT02502175|methadone|methadone
1108111|NCT02502175|opioid dependence|opioid dependence
1108112|NCT02502175|opiate dependence|opiate dependence
1108113|NCT02502175|clinical trial|clinical trial
1108114|NCT02502175|Iran|iran
1108115|NCT02502149|rFVIIIFc|rfviiifc
1108116|NCT02502149|Eloctate|eloctate
1108117|NCT02502149|Hemophilia|hemophilia
1108118|NCT02502136|CO2 insufflation|co2 insufflation
1108119|NCT02502110|Atrial Fibrillation|atrial fibrillation
1108120|NCT02502110|statin|statin
1108121|NCT02502110|radiofrequency ablation|radiofrequency ablation
1108122|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
1108123|NCT02502006|Healthy volunteers|healthy volunteers
1108124|NCT02502006|Celecoxib|celecoxib
1108125|NCT02502006|Naproxen|naproxen
1108126|NCT02502006|Prostaglandin|prostaglandin
1108127|NCT02502006|Cyclooxygenase|cyclooxygenase
1108128|NCT02501980|Screening|screening
1108129|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
1108130|NCT02501980|Biomarker|biomarker
1108131|NCT02501980|Mortality rate|mortality rate
1108132|NCT02501967|multiple chronic conditions|multiple chronic conditions
1108133|NCT02501941|Ketamine|ketamine
1108134|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
1108135|NCT02501941|Cortical Spreading Depression|cortical spreading depression
1108136|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1108137|NCT02501928|fesoterodine|fesoterodine
1108138|NCT02501928|Japan|japan
1108139|NCT02501915|Muscle|muscle
1108749|NCT02498496|ED|ed
1108140|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
1108141|NCT02501889|obesity|obesity
1108142|NCT02501889|overweight|overweight
1108143|NCT02501889|weight loss|weight loss
1108144|NCT02501889|satiety|satiety
1108145|NCT02501889|walnuts|walnuts
1108146|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
1108147|NCT02501876|The risk of progession|the risk of progession
1108148|NCT02501876|patients|patients
1108149|NCT02501850|Lipoprotein (a)|lipoprotein (a)
1108150|NCT02501837|Healthy women|healthy women
1108151|NCT02501811|Heart Failure|heart failure
1108152|NCT02501811|Ischemia|ischemia
1108153|NCT02501811|Autologous Stem Cells|autologous stem cells
1108154|NCT02501811|LV dysfunction|lv dysfunction
1108155|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
1108156|NCT02501811|ckit Cardiac Stem Cells|ckit cardiac stem cells
1108157|NCT02501811|Combination Cell Therapy|combination cell therapy
1108158|NCT02501811|LV function|lv function
1108159|NCT02501811|Functional status|functional status
1108160|NCT02501798|ADHD|adhd
1108161|NCT02501798|Methylphenidate|methylphenidate
1108162|NCT02501798|Academic|academic
1108163|NCT02501798|Motivation|motivation
1108164|NCT02501785|Quality of Life|quality of life
1108165|NCT02501785|Patient care givers|patient care givers
1108166|NCT02501785|15-145|15-145
1108167|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
1108168|NCT02501746|Group medical care|group medical care
1108169|NCT02501746|Microfinance|microfinance
1108170|NCT02501746|Hypertension|hypertension
1108171|NCT02501746|Community-based intervention|community-based intervention
1108172|NCT02501746|Global health|global health
1108173|NCT02501733|Total Knee Replacement|total knee replacement
1108174|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
1108176|NCT02501720|hand|hand
1108177|NCT02501720|flexion contracture|flexion contracture
1108178|NCT02501720|tourniquet|tourniquet
1108179|NCT02501720|tumescent technique|tumescent technique
1108180|NCT02501720|children|children
1108181|NCT02501707|echocardiography|echocardiography
1108182|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
1108183|NCT02501707|prognostic|prognostic
1108184|NCT02501707|chemo radiotherapy|chemo radiotherapy
1108185|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
1108186|NCT02501707|NSCLC|nsclc
1108187|NCT02501681|sublingual microcirculation|sublingual microcirculation
1108188|NCT02501681|cardiovascular surgery|cardiovascular surgery
1108189|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
1108190|NCT02501564|Osteoarthritis|osteoarthritis
1108191|NCT02501564|NAPROXEN SODIUM|naproxen sodium
1108192|NCT02501551|Malignant melanoma|malignant melanoma
1108193|NCT02501551|C-KIT mutation|c-kit mutation
1108194|NCT02501525|renal stone|renal stone
1108394|NCT02500628|complex 1|complex 1
1108195|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
1108196|NCT02501525|ureteral access sheath|ureteral access sheath
1108197|NCT02501525|pain|pain
1108198|NCT02501512|transesophageal signal|transesophageal signal
1108199|NCT02501512|swallowing|swallowing
1108200|NCT02501512|newborn|newborn
1108201|NCT02501486|adrenal insufficiency|adrenal insufficiency
1108202|NCT02501486|adverse drug reaction|adverse drug reaction
1108203|NCT02501486|corticosteroid|corticosteroid
1108204|NCT02501473|follicular lymphoma|follicular lymphoma
1108205|NCT02501473|fNHL|fnhl
1108206|NCT02501473|low-grade lymphoma|low-grade lymphoma
1108207|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1108208|NCT02501473|follicular NHL|follicular nhl
1108209|NCT02501473|Marginal Zone|marginal zone
1108210|NCT02501460|Adult cancer survivors|adult cancer survivors
1108211|NCT02501460|Exercise|exercise
1108212|NCT02501460|Dietary supplementation|dietary supplementation
1108213|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1108214|NCT02501434|unfractionated heparin|unfractionated heparin
1108215|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
1108216|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
1108217|NCT02501434|cerebral aneurysm|cerebral aneurysm
1108218|NCT02501434|coil embolization|coil embolization
1108219|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
1108220|NCT02501421|vaccine|vaccine
1108221|NCT02501421|influenza vector|influenza vector
1108222|NCT02501421|tuberculosis|tuberculosis
1108223|NCT02501382|Fasciitis|fasciitis
1108224|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
1108225|NCT02501382|Soft tissue infections|soft tissue infections
1108226|NCT02501382|Fournier's gangrene|fournier's gangrene
1108227|NCT02501382|Immunopathogenesis|immunopathogenesis
1108228|NCT02501356|prebiotic|prebiotic
1108229|NCT02501356|dietary supplement|dietary supplement
1108230|NCT02501343|Glucose metabolism|glucose metabolism
1108231|NCT02501343|Potential renal acid load|potential renal acid load
1108232|NCT02501343|Postprandial glycemia|postprandial glycemia
1108233|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
1108234|NCT02501343|Sodium bicarbonate|sodium bicarbonate
1108235|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
1108236|NCT02501317|urinary incontinence|urinary incontinence
1108237|NCT02501317|physical therapy|physical therapy
1108238|NCT02501317|rehabilitation|rehabilitation
1108239|NCT02501317|pelvic floor|pelvic floor
1108240|NCT02501317|perineum|perineum
1108241|NCT02501317|conservative treatment|conservative treatment
1108242|NCT02501265|Nicotine addiction|nicotine addiction
1108243|NCT02501265|Cigarette smoking|cigarette smoking
1108244|NCT02501265|Bupropion|bupropion
1108245|NCT02501265|Varenicline|varenicline
1108246|NCT02501265|Adaptive Approach|adaptive approach
1108247|NCT02501265|Nicotine Patch|nicotine patch
1108248|NCT02501265|Chantix|chantix
1108249|NCT02501252|Community|community
1108250|NCT02501252|Skilled birth attendance|skilled birth attendance
1108251|NCT02501252|Rural|rural
1108252|NCT02501252|Ethiopia|ethiopia
1108253|NCT02501226|Psychiatry|psychiatry
1108254|NCT02501226|Depression|depression
1108255|NCT02501226|Psychoeducation|psychoeducation
1108256|NCT02501226|Randomized controlled trial|randomized controlled trial
1108257|NCT02501226|Treatment adherence|treatment adherence
1108258|NCT02501226|Remission|remission
1108259|NCT02501213|Diuretic|diuretic
1108260|NCT02501213|Malignant ascites|malignant ascites
1108261|NCT02501200|Dyslipidemia|dyslipidemia
1108262|NCT02501200|CKD-391|ckd-391
1108263|NCT02501200|Atorvastatin|atorvastatin
1108264|NCT02501200|Ezetimibe|ezetimibe
1108265|NCT02501174|Geriatric oncology|geriatric oncology
1108266|NCT02501148|Embolic protection|embolic protection
1108267|NCT02501148|Carotid artery stenting|carotid artery stenting
1108268|NCT02501135|Femoral nerve blocks|femoral nerve blocks
1108269|NCT02501135|children|children
1108270|NCT02501135|knee and thigh surgery|knee and thigh surgery
1108271|NCT02501122|Quality|quality
1108272|NCT02501122|hospital care|hospital care
1108273|NCT02501122|adenotonsillectomy|adenotonsillectomy
1108274|NCT02501109|Aripiprazole|aripiprazole
1108275|NCT02501109|Oral Soluble Film|oral soluble film
1108276|NCT02501109|Schizophrenia|schizophrenia
1108277|NCT02501096|Lenvatinib|lenvatinib
1108278|NCT02501096|Lenvima|lenvima
1108279|NCT02501096|E7080|e7080
1108280|NCT02501096|Phase 1b/2|phase 1b/2
1108281|NCT02501096|Pembrolizumab|pembrolizumab
1108282|NCT02501096|Solid tumors|solid tumors
1108283|NCT02501083|cardiomyopathy|cardiomyopathy
1108284|NCT02501083|echocardiography|echocardiography
1108285|NCT02501083|prognosis|prognosis
1108286|NCT02501083|respiratory|respiratory
1108287|NCT02501083|home mechanical ventilation|home mechanical ventilation
1108288|NCT02501083|vital capacity|vital capacity
1108289|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
1108290|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
1108291|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
1108292|NCT02501070|Angioplasty|angioplasty
1108293|NCT02501070|Stent|stent
1108294|NCT02501070|Community Networks|community networks
1108295|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
1108296|NCT02501057|Unsafe Drinking|unsafe drinking
1108297|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
1108298|NCT02501031|Flaxseed|flaxseed
1108299|NCT02501031|Postmenopause|postmenopause
1108300|NCT02501031|Hormones|hormones
1108301|NCT02501031|Lignans|lignans
1108302|NCT02501031|No Evidence of Disease|no evidence of disease
1108303|NCT02501018|CLI|cli
1108304|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
1108305|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1108306|NCT02500966|stenosis|stenosis
1108307|NCT02500966|cervix|cervix
1108308|NCT02500966|medical device|medical device
1108309|NCT02500966|inventories|inventories
1108310|NCT02500966|Uterine Cervix|uterine cervix
1108311|NCT02500966|Intrauterine Devices|intrauterine devices
1108312|NCT02500966|intrauterine|intrauterine
1108313|NCT02500966|conization|conization
1108314|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
1108315|NCT02500953|ASP3325|asp3325
1108316|NCT02500953|pharmacokinetics|pharmacokinetics
1108317|NCT02500953|pharmacodynamics|pharmacodynamics
1108318|NCT02500927|ASP8273|asp8273
1108319|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
1108320|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
1108321|NCT02500927|EGFR Mutation|egfr mutation
1108322|NCT02500914|small cell lung cancer|small cell lung cancer
1108323|NCT02500901|Enzalutamide|enzalutamide
1108324|NCT02500901|Niraparib|niraparib
1108325|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
1108326|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
1108327|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
1108328|NCT02500888|OCD|ocd
1108329|NCT02500888|Neurosurgery|neurosurgery
1108330|NCT02500888|Radiosurgery|radiosurgery
1108331|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
1108332|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
1108333|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
1108334|NCT02500862|Eye|eye
1108335|NCT02500862|Imaging|imaging
1108336|NCT02500849|Gene therapy|gene therapy
1108337|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1108338|NCT02500849|HIV Infections|hiv infections
1108339|NCT02500849|Retroviridae Infections|retroviridae infections
1108340|NCT02500849|RNA Virus Infections|rna virus infections
1108341|NCT02500849|Virus Diseases|virus diseases
1108342|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1108343|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
1108344|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1108345|NCT02500849|Immune System Diseases|immune system diseases
1108346|NCT02500849|Busulfan|busulfan
1108347|NCT02500849|Pharmacologic Actions|pharmacologic actions
1108348|NCT02500836|Ear|ear
1108349|NCT02500836|Nose|nose
1108350|NCT02500836|Throat|throat
1108351|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
1108352|NCT02500823|Peripheral blood cells|peripheral blood cells
1108353|NCT02500810|neurotoxicity|neurotoxicity
1108354|NCT02500810|chemotherapy|chemotherapy
1108355|NCT02500810|monosialoganglioside|monosialoganglioside
1108356|NCT02500810|prevention|prevention
1108357|NCT02500758|Surgical scrubbing|surgical scrubbing
1108358|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
1108359|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
1108360|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
1108361|NCT02500719|Neurofeedback|neurofeedback
1108362|NCT02500719|fMRI|fmri
1108363|NCT02500719|Skin Conductance Response|skin conductance response
1108364|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
1108365|NCT02500680|Influenza|influenza
1108366|NCT02500680|Adjuvant|adjuvant
1108367|NCT02500667|N91115|n91115
1108368|NCT02500667|Rifampin|rifampin
1108369|NCT02500667|drug interaction|drug interaction
1108370|NCT02500667|Cavosonstat|cavosonstat
1108371|NCT02500654|Peri-implantitis|peri-implantitis
1108372|NCT02500654|Regenerative therapy|regenerative therapy
1108373|NCT02500654|Surgical therapy|surgical therapy
1108374|NCT02500654|Enamel matrix derivative|enamel matrix derivative
1108375|NCT02500654|Peri-implant microflora|peri-implant microflora
1108376|NCT02500654|Peri-implant fluid|peri-implant fluid
1108377|NCT02500641|Biological Markers|biological markers
1108378|NCT02500641|Cardiovascular disease|cardiovascular disease
1108379|NCT02500641|Humans|humans
1108380|NCT02500641|Pulse Wave Velocity|pulse wave velocity
1108381|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
1108382|NCT02500641|Allopurinol|allopurinol
1108383|NCT02500641|Pulse Wave Analysis|pulse wave analysis
1108384|NCT02500641|Thiazoles|thiazoles
1108385|NCT02500641|Inflammation|inflammation
1108386|NCT02500641|Uric acid|uric acid
1108387|NCT02500641|Febuxostat|febuxostat
1108388|NCT02500641|Oxidative stress|oxidative stress
1108389|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
1108390|NCT02500641|Arthritis|arthritis
1108391|NCT02500641|Hyperuricemia|hyperuricemia
1108392|NCT02500628|metformin|metformin
1108393|NCT02500628|mitochondria|mitochondria
1108395|NCT02500628|fibromyalgia|fibromyalgia
1108396|NCT02500628|neurogenic pain|neurogenic pain
1108397|NCT02500628|diabetes|diabetes
1108398|NCT02500628|tardive dyskinesia|tardive dyskinesia
1108399|NCT02500628|heart rate variability|heart rate variability
1108400|NCT02500602|PTSD|ptsd
1108401|NCT02500602|alcohol use disorders|alcohol use disorders
1108402|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
1108404|NCT02500602|Veteran|veteran
1108405|NCT02500602|substance use disorders|substance use disorders
1108406|NCT02500602|SUD|sud
1108407|NCT02500589|smoking|smoking
1108408|NCT02500589|tobacco|tobacco
1108409|NCT02500576|Melanoma|melanoma
1108410|NCT02500576|Metastatic|metastatic
1108411|NCT02500576|Cyclophosphamide|cyclophosphamide
1108412|NCT02500576|Cytoxan|cytoxan
1108413|NCT02500576|Neosar|neosar
1108414|NCT02500576|Mesna|mesna
1108415|NCT02500576|Mesnex|mesnex
1108416|NCT02500576|Fludarabine|fludarabine
1108417|NCT02500576|Fludarabine phosphate|fludarabine phosphate
1108418|NCT02500576|MK-3475|mk-3475
1108419|NCT02500576|Keytruda|keytruda
1108420|NCT02500576|Pembrolizumab|pembrolizumab
1108421|NCT02500576|SCH-900475|sch-900475
1108422|NCT02500576|IL-2|il-2
1108423|NCT02500576|Aldesleukin|aldesleukin
1108424|NCT02500576|Interleukin-2|interleukin-2
1108425|NCT02500576|Proleukin|proleukin
1108426|NCT02500576|TIL|til
1108427|NCT02500576|T-cells|t-cells
1108428|NCT02500576|Questionnaires|questionnaires
1108429|NCT02500576|Surveys|surveys
1108430|NCT02500576|Phone calls|phone calls
1108431|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1108432|NCT02500550|Graft versus host disease|graft versus host disease
1108433|NCT02500550|Immune reconstitution|immune reconstitution
1108434|NCT02500550|Alloreactive T-cells|alloreactive t-cells
1108435|NCT02500550|Photodynamic treatment|photodynamic treatment
1108436|NCT02500550|Hematologic malignancy|hematologic malignancy
1108437|NCT02500550|Transplant-related mortality|transplant-related mortality
1108438|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
1108439|NCT02500472|Tobacco|tobacco
1108440|NCT02500472|Smoking|smoking
1108441|NCT02500459|Topotecan|topotecan
1108442|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
1108443|NCT02500459|Cancer|cancer
1108750|NCT02498496|ER|er
1108444|NCT02500433|Cerebral palsy|cerebral palsy
1108445|NCT02500433|child|child
1108446|NCT02500433|rehabilitation|rehabilitation
1108447|NCT02500433|video games|video games
1108448|NCT02500433|virtual reality.|virtual reality.
1108449|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1108450|NCT02500420|Stress MRI|stress mri
1108451|NCT02500420|Cardiac MRI|cardiac mri
1108452|NCT02500420|Stress echocardiography|stress echocardiography
1108453|NCT02500420|T1 mapping|t1 mapping
1108454|NCT02500420|2D strain|2d strain
1108455|NCT02500394|renal replacement therapy|renal replacement therapy
1108456|NCT02500381|Duchenne muscular dystrophy|duchenne muscular dystrophy
1108457|NCT02500381|Exon Skipping|exon skipping
1108458|NCT02500381|DMD|dmd
1108459|NCT02500381|Exon 53|exon 53
1108460|NCT02500381|Exon 45|exon 45
1108461|NCT02500381|Ambulatory|ambulatory
1108462|NCT02500381|Pediatric|pediatric
1108463|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
1108464|NCT02500342|Fatigue|fatigue
1108465|NCT02500342|Randomized Controlled Trial|randomized controlled trial
1108466|NCT02500342|Thyroxine|thyroxine
1108467|NCT02500342|Hypothyroidism|hypothyroidism
1108468|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
1108470|NCT02500316|Long-acting|long-acting
1108471|NCT02500303|Amputation|amputation
1108472|NCT02500290|ACS|acs
1108473|NCT02500277|thoracoscopy|thoracoscopy
1108474|NCT02500277|pleuroscopy|pleuroscopy
1108475|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
1108476|NCT02500277|flexible cryoprobe|flexible cryoprobe
1108477|NCT02500277|cryobiopsy|cryobiopsy
1108478|NCT02500277|pleural biopsy|pleural biopsy
1108479|NCT02500251|Transplantation|transplantation
1108480|NCT02500251|belimumab|belimumab
1108481|NCT02500251|Velcade|velcade
1108482|NCT02500225|Etomidate|etomidate
1108483|NCT02500225|Sevoflurane|sevoflurane
1108484|NCT02500199|HER2 positive|her2 positive
1108485|NCT02500173|radiotherapy|radiotherapy
1108486|NCT02500173|side effects|side effects
1108487|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
1108488|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1108489|NCT02500147|Adolescents|adolescents
1108490|NCT02500147|Young Women|young women
1108491|NCT02500147|MRI|mri
1108492|NCT02500147|MRS|mrs
1108493|NCT02500147|DXA|dxa
1108494|NCT02500147|PNPLA3|pnpla3
1108495|NCT02500147|Metformin|metformin
1108496|NCT02500147|Randomized Clinical Trial|randomized clinical trial
1108497|NCT02500147|Placebo|placebo
1108498|NCT02500147|Hirsutism|hirsutism
1108499|NCT02500147|Acne|acne
1108500|NCT02500147|Amenorrhea|amenorrhea
1108501|NCT02500147|Metabolic Syndrome|metabolic syndrome
1108502|NCT02500147|Dyslipidemia|dyslipidemia
1108503|NCT02500147|Percentage liver fat|percentage liver fat
1108504|NCT02500121|Pembrolizumab|pembrolizumab
1108505|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
1108506|NCT02500108|Domperidone|domperidone
1108507|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
1108508|NCT02500108|Sudden cardiac death|sudden cardiac death
1108509|NCT02500108|Pharmacotherapy|pharmacotherapy
1108510|NCT02500108|Adverse events|adverse events
1108511|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
1108512|NCT02500082|SLC13A5 gene|slc13a5 gene
1108513|NCT02500082|citric acid cycle|citric acid cycle
1108514|NCT02500082|energy metabolism|energy metabolism
1108515|NCT02500056|Inguinal hernia|inguinal hernia
1108516|NCT02500056|Chronic pain|chronic pain
1108517|NCT02500056|Mesh|mesh
1108518|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
1108519|NCT02500043|Gastric Cancer|gastric cancer
1108520|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
1108521|NCT02499965|Topical Anesthetic|topical anesthetic
1108522|NCT02499965|Ethyl Chloride|ethyl chloride
1108523|NCT02499965|Pain Reduction|pain reduction
1108524|NCT02499965|IV cannulation|iv cannulation
1108525|NCT02499952|Pembrolizumab|pembrolizumab
1108526|NCT02499952|MK-3475|mk-3475
1108527|NCT02499952|PMNSGCT|pmnsgct
1108528|NCT02499952|PD-L1|pd-l1
1108529|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
1108530|NCT02499848|MRI Lesion|mri lesion
1108531|NCT02499848|transperineal injection|transperineal injection
1108532|NCT02499848|prostate biopsies|prostate biopsies
1108533|NCT02499822|Hypertension|hypertension
1108534|NCT02499822|Blood pressure variability|blood pressure variability
1108535|NCT02499822|Home systolic blood pressure|home systolic blood pressure
1108536|NCT02499822|Organ damage|organ damage
1108537|NCT02499822|Nifedipine GITS|nifedipine gits
1108538|NCT02499822|Ramipril|ramipril
1108539|NCT02499809|Vibration therapy|vibration therapy
1108540|NCT02499809|Recovery from exercise|recovery from exercise
1108541|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
1108542|NCT02499796|Humidifying devices|humidifying devices
1108543|NCT02499796|Respiratory mechanics|respiratory mechanics
1108544|NCT02499783|China|china
1108545|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
1108546|NCT02499783|Biologic|biologic
1108547|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
1108548|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
1108549|NCT02499757|Perception|perception
1108550|NCT02499757|brain response|brain response
1108551|NCT02499757|nicotine|nicotine
1108552|NCT02499757|taste|taste
1108553|NCT02499744|NIPPV|nippv
1108554|NCT02499744|HHFNC|hhfnc
1108556|NCT02499744|neonate|neonate
1108557|NCT02499731|physical activity|physical activity
1108558|NCT02499731|nutrition|nutrition
1108559|NCT02499731|social network|social network
1108560|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1108561|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
1108562|NCT02499718|quality of life|quality of life
1108563|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
1108564|NCT02499666|Exercise Capacity|exercise capacity
1108565|NCT02499666|Chronic Total Occlusion|chronic total occlusion
1108566|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1108567|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
1108568|NCT02499653|Acceptance|acceptance
1108569|NCT02499653|Adherence|adherence
1108570|NCT02499653|Clinical Psychology|clinical psychology
1108571|NCT02499640|Recovery of function|recovery of function
1108572|NCT02499640|Autonomic nervous system|autonomic nervous system
1108573|NCT02499640|Heart rate variability|heart rate variability
1108574|NCT02499640|Cryotherapy|cryotherapy
1108575|NCT02499640|Immersion|immersion
1108576|NCT02499627|Lymphoma|lymphoma
1108577|NCT02499627|Hodgkin|hodgkin
1108578|NCT02499627|PTCL|ptcl
1108579|NCT02499627|CD30+|cd30+
1108580|NCT02499614|MET amplification|met amplification
1108581|NCT02499614|ROS1 translocation|ros1 translocation
1108582|NCT02499614|Crizotinib|crizotinib
1108583|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1108584|NCT02499601|Heart Failure (HF)|heart failure (hf)
1108585|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
1108586|NCT02499575|Exparel|exparel
1108587|NCT02499575|bupivacaine|bupivacaine
1108588|NCT02499575|Hallux valgus deformity|hallux valgus deformity
1108589|NCT02499575|bunionectomy|bunionectomy
1108590|NCT02499536|Atelectasis|atelectasis
1108591|NCT02499536|Postoperative|postoperative
1108592|NCT02499536|Lung ultrasound|lung ultrasound
1108593|NCT02499510|femoropopliteal disease|femoropopliteal disease
1108594|NCT02499510|restenosis|restenosis
1108595|NCT02499497|Prostate Cancer|prostate cancer
1108596|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
1108597|NCT02499432|Implementation|implementation
1108598|NCT02499432|PTSD|ptsd
1108599|NCT02499393|newborn|newborn
1108600|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
1108601|NCT02499393|magnesium sulphate|magnesium sulphate
1108602|NCT02499380|RePneu|repneu
1108603|NCT02499380|Coil|coil
1108605|NCT02499380|PneumRx|pneumrx
1108606|NCT02499367|triple negative|triple negative
1108607|NCT02499367|metastatic|metastatic
1108608|NCT02499341|Tramadol|tramadol
1108609|NCT02499341|Ketamine|ketamine
1108610|NCT02499341|Morphine|morphine
1108611|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
1108612|NCT02499276|mechanical ventilation|mechanical ventilation
1108613|NCT02499276|pressure support ventilation|pressure support ventilation
1108614|NCT02499276|NAVA|nava
1108615|NCT02499276|PAV|pav
1108616|NCT02499276|variable ventilation|variable ventilation
1108617|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
1108618|NCT02499263|Adalimumab trough level|adalimumab trough level
1108619|NCT02499263|Fecal Calprotectin|fecal calprotectin
1108620|NCT02499263|Fecal microbiota|fecal microbiota
1108621|NCT02499250|refractory angina pectoris|refractory angina pectoris
1108622|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
1108623|NCT02499250|life quality|life quality
1108624|NCT02499250|anxiety|anxiety
1108625|NCT02499250|depression|depression
1108626|NCT02499250|inflammation|inflammation
1108627|NCT02499237|osteoporosis|osteoporosis
1108628|NCT02499237|denosumab|denosumab
1108629|NCT02499237|zoledronic acid|zoledronic acid
1108630|NCT02499237|bone mineral density|bone mineral density
1108631|NCT02499237|bone markers|bone markers
1108632|NCT02499211|obesity|obesity
1108633|NCT02499211|health disparities|health disparities
1108634|NCT02499211|healthy food marketing|healthy food marketing
1108635|NCT02499211|food environments|food environments
1108636|NCT02499211|marketing environments|marketing environments
1108637|NCT02499211|food access|food access
1108638|NCT02499211|food purchase decision making|food purchase decision making
1108639|NCT02499198|Nornicotine|nornicotine
1108640|NCT02499198|Tobacco|tobacco
1108641|NCT02499198|N'-nitrosonornicotine|n'-nitrosonornicotine
1108642|NCT02499198|NNN|nnn
1108643|NCT02499185|Biomarker|biomarker
1108644|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
1108645|NCT02499185|AKI|aki
1108646|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
1108647|NCT02499159|Exparel|exparel
1108648|NCT02499159|Thoracoscopy|thoracoscopy
1108649|NCT02499159|Bupivicaine|bupivicaine
1108650|NCT02499159|Liposomal|liposomal
1108651|NCT02499146|Palbociclib|palbociclib
1108652|NCT02499146|PD-0332991|pd-0332991
1109053|NCT02496728|Facebook|facebook
1108653|NCT02499146|pharmacokinetics|pharmacokinetics
1108654|NCT02499146|breast cancer patients|breast cancer patients
1108655|NCT02499146|Chinese|chinese
1108656|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
1108657|NCT02499107|food intake|food intake
1108658|NCT02499107|satiety|satiety
1108659|NCT02499107|blood glucose|blood glucose
1108660|NCT02499107|potato|potato
1108661|NCT02499107|insulin|insulin
1108662|NCT02499081|Relapsed|relapsed
1108663|NCT02499081|Refractory|refractory
1108664|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
1108665|NCT02499055|anxiety|anxiety
1108666|NCT02499055|behaviour therapy|behaviour therapy
1108667|NCT02499055|computer assisted therapy|computer assisted therapy
1108668|NCT02499055|psychotherapy|psychotherapy
1108669|NCT02499042|post-resuscitation|post-resuscitation
1108670|NCT02499042|oxygen therapy|oxygen therapy
1108671|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1108672|NCT02499016|Appendicitis|appendicitis
1108673|NCT02499016|Appendectomy|appendectomy
1108674|NCT02499016|Single-incision|single-incision
1108675|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1108676|NCT02499003|Follicular lymphoma|follicular lymphoma
1108677|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
1108678|NCT02498977|Liver|liver
1108679|NCT02498977|Transplant|transplant
1108680|NCT02498977|Immunosuppression|immunosuppression
1108681|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
1108682|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
1108683|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
1108684|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
1108685|NCT02498912|T Cells|t cells
1108686|NCT02498912|Cyclophosphamide|cyclophosphamide
1108687|NCT02498912|MUC16ecto antigen|muc16ecto antigen
1108688|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
1108689|NCT02498912|15-014|15-014
1108690|NCT02498899|Advanced Cancers|advanced cancers
1108691|NCT02498899|Video|video
1108692|NCT02498899|Questionnaires|questionnaires
1108693|NCT02498899|Surveys|surveys
1108694|NCT02498873|VO2Max|vo2max
1108695|NCT02498873|Physical Conditioning|physical conditioning
1108696|NCT02498873|Aerobic Exercise|aerobic exercise
1108697|NCT02498873|Performance|performance
1108698|NCT02498860|adenocarcinoma|adenocarcinoma
1108699|NCT02498860|lung|lung
1108700|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
1108701|NCT02498860|pemetrexed|pemetrexed
1108702|NCT02498860|cisplatin|cisplatin
1108703|NCT02498860|surgery|surgery
1108704|NCT02498834|Communication|communication
1108705|NCT02498834|provider|provider
1108706|NCT02498834|caregiver|caregiver
1108707|NCT02498834|adolescent|adolescent
1108708|NCT02498821|PICC|picc
1108709|NCT02498821|central catheter|central catheter
1108710|NCT02498821|vascular access|vascular access
1108711|NCT02498808|Interferon lambda|interferon lambda
1108712|NCT02498808|Interleukin-29|interleukin-29
1108713|NCT02498808|Neutrophil|neutrophil
1108714|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
1108715|NCT02498795|Dry needling|dry needling
1108716|NCT02498795|Eccentric exercise|eccentric exercise
1108717|NCT02498795|Patella|patella
1108718|NCT02498782|Chagas Disease|chagas disease
1108719|NCT02498782|Dosage forms|dosage forms
1108720|NCT02498782|Regimens|regimens
1108721|NCT02498769|Cardiac Surgery|cardiac surgery
1108722|NCT02498769|Postoperative Complications|postoperative complications
1108723|NCT02498769|Autonomic Nerve Block|autonomic nerve block
1108724|NCT02498730|bipolar disorder|bipolar disorder
1108725|NCT02498730|VO2max|vo2max
1108726|NCT02498730|aerobic exercise|aerobic exercise
1108727|NCT02498691|endometriosis|endometriosis
1108728|NCT02498691|preterm delivery|preterm delivery
1108729|NCT02498691|caesarean|caesarean
1108730|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
1108731|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
1108732|NCT02498665|Vaccine|vaccine
1108733|NCT02498665|Neoplasms|neoplasms
1108734|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
1108735|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
1108736|NCT02498639|outcome|outcome
1108737|NCT02498626|mixed venous saturation|mixed venous saturation
1108738|NCT02498626|open heart surgery|open heart surgery
1108739|NCT02498626|children|children
1108740|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
1108741|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
1108742|NCT02498600|Tube Cancer|tube cancer
1108743|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
1108744|NCT02498496|COPD|copd
1108745|NCT02498496|AECOPD|aecopd
1108746|NCT02498496|Magnesium Sulfate|magnesium sulfate
1108747|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
1108748|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1108751|NCT02498496|Emergency Department|emergency department
1108752|NCT02498483|Infant|infant
1108753|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
1108754|NCT02498457|coronary artery calcification|coronary artery calcification
1108755|NCT02498457|low calcium dialysate|low calcium dialysate
1108756|NCT02498457|effects|effects
1108757|NCT02498457|safety|safety
1108758|NCT02498444|Fontan|fontan
1108759|NCT02498444|Treprostinil|treprostinil
1108760|NCT02498444|Remodulin|remodulin
1108761|NCT02498444|Single ventricle|single ventricle
1108762|NCT02498431|irisin|irisin
1108763|NCT02498431|myocardial infarction|myocardial infarction
1108764|NCT02498431|coronary|coronary
1108765|NCT02498392|Major Depressive Disorder|major depressive disorder
1108766|NCT02498392|Depression|depression
1108767|NCT02498392|Anxiety symptoms|anxiety symptoms
1108768|NCT02498392|JNJ-42165279|jnj-42165279
1108769|NCT02498379|novel radiotracer|novel radiotracer
1108770|NCT02498379|biodistribution|biodistribution
1108771|NCT02498379|safety|safety
1108772|NCT02498340|G6PD|g6pd
1108773|NCT02498340|genotype|genotype
1108774|NCT02498340|phenotype|phenotype
1108775|NCT02498340|diet restriction|diet restriction
1108776|NCT02498327|Chronic|chronic
1108777|NCT02498314|Manual therapy|manual therapy
1108778|NCT02498314|Hip osteoarthritis|hip osteoarthritis
1108779|NCT02498314|Mobilization|mobilization
1108780|NCT02498301|travelers' diarrhea|travelers' diarrhea
1108781|NCT02498301|military|military
1108782|NCT02498301|enteric illness|enteric illness
1108783|NCT02498301|gastrointestinal|gastrointestinal
1108784|NCT02498288|capsule|capsule
1108785|NCT02498288|Isotretinoin|isotretinoin
1108786|NCT02498288|Bioequivalence|bioequivalence
1108787|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
1108788|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
1108789|NCT02498249|trapezius muscle|trapezius muscle
1108790|NCT02498249|neck pain|neck pain
1108791|NCT02498236|Psychosis|psychosis
1108792|NCT02498236|Schizophrenia|schizophrenia
1108793|NCT02498236|Oxytocin|oxytocin
1108794|NCT02498210|IVM|ivm
1108795|NCT02498210|HIPPO signaling|hippo signaling
1108796|NCT02498171|Labour analgesia|labour analgesia
1108797|NCT02498171|Intrathecal morphine|intrathecal morphine
1108798|NCT02498171|Bupivacaine|bupivacaine
1108799|NCT02498171|Fentanyl|fentanyl
1108800|NCT02498132|Mobile Technologies|mobile technologies
1108801|NCT02498119|Type 2 DM|type 2 dm
1108802|NCT02498119|lipid bodies|lipid bodies
1108803|NCT02498106|nutrition|nutrition
1108804|NCT02498106|aggression|aggression
1108805|NCT02498106|n-3 fatty acids|n-3 fatty acids
1108806|NCT02498106|psychiatry|psychiatry
1108807|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
1108808|NCT02498093|Resistance training|resistance training
1108809|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1108810|NCT02498093|Professional-Patient Relations|professional-patient relations
1108811|NCT02498093|Evidence-based practice|evidence-based practice
1108812|NCT02498080|Drug eluting balloons|drug eluting balloons
1108813|NCT02498080|Critical limb ischemia|critical limb ischemia
1108814|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
1108815|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1108816|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
1108817|NCT02498041|Barrett's Esophagus|barrett's esophagus
1108818|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
1108819|NCT02498028|cervical fusion|cervical fusion
1108820|NCT02498028|cervical arthroplasty|cervical arthroplasty
1108821|NCT02498028|cervicobrachial pain|cervicobrachial pain
1108822|NCT02498002|Diet|diet
1108823|NCT02498002|Fasting|fasting
1108824|NCT02498002|Intermittent Fasting|intermittent fasting
1108825|NCT02498002|Alternate-day Fasting|alternate-day fasting
1108826|NCT02498002|Physical Activity|physical activity
1108827|NCT02498002|Glucose|glucose
1108828|NCT02498002|Insulin|insulin
1108829|NCT02498002|Appetite|appetite
1108830|NCT02497989|Male circumcision|male circumcision
1108831|NCT02497989|Demand creation|demand creation
1108832|NCT02497976|Interstitial|interstitial
1108833|NCT02497976|Cystitis|cystitis
1108834|NCT02497976|Bladder|bladder
1108835|NCT02497976|Pain|pain
1108836|NCT02497950|HeartMate 3|heartmate 3
1108837|NCT02497950|LVAS|lvas
1108838|NCT02497950|LVAD|lvad
1108839|NCT02497950|Heart-assist devices|heart-assist devices
1108840|NCT02497950|Thoratec Corporation|thoratec corporation
1108841|NCT02497937|GSK2798745|gsk2798745
1108842|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
1108843|NCT02497937|Pharmacodynamics|pharmacodynamics
1108844|NCT02497937|Adults|adults
1108845|NCT02497937|Congestive Heart Failure|congestive heart failure
1108846|NCT02497911|Adductor Canal Catheter|adductor canal catheter
1108847|NCT02497911|Intraarticular Catheter|intraarticular catheter
1108848|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1108849|NCT02497885|MERS|mers
1108850|NCT02497885|healthcare personnel|healthcare personnel
1108851|NCT02497859|Weight Reduction|weight reduction
1108852|NCT02497859|Weight Loss Diet|weight loss diet
1108853|NCT02497859|Satiety Response|satiety response
1108854|NCT02497859|Insulin|insulin
1108855|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
1108856|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
1108857|NCT02497859|Ghrelin|ghrelin
1108858|NCT02497859|Glucose|glucose
1108859|NCT02497859|Eggs|eggs
1108860|NCT02497859|Protein|protein
1108861|NCT02497859|Energy Intake|energy intake
1108862|NCT02497859|Breakfast|breakfast
1108863|NCT02497846|Hyaluronic acid|hyaluronic acid
1108864|NCT02497846|MiconJet needle|miconjet needle
1108865|NCT02497807|Tourette syndrome|tourette syndrome
1108866|NCT02497807|Iron deficiency|iron deficiency
1108867|NCT02497794|chew gum|chew gum
1108868|NCT02497794|bowel movements|bowel movements
1108869|NCT02497794|cesarean section|cesarean section
1108870|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
1108871|NCT02497768|mastication|mastication
1108872|NCT02497768|pistachios|pistachios
1108873|NCT02497768|brazils|brazils
1108874|NCT02497768|participants|participants
1108875|NCT02497729|Endotracheal Intubation|endotracheal intubation
1108876|NCT02497729|Checklist|checklist
1108877|NCT02497729|Positioning|positioning
1108878|NCT02497690|Cochlear Implant|cochlear implant
1108879|NCT02497690|Hearing Aid|hearing aid
1108880|NCT02497690|Telemedicine|telemedicine
1108881|NCT02497677|parental sensitivity|parental sensitivity
1108882|NCT02497677|child attachment|child attachment
1108883|NCT02497664|Radiotherapy|radiotherapy
1108884|NCT02497664|Active Breathing Control Technique|active breathing control technique
1108885|NCT02497651|Smoking|smoking
1108886|NCT02497651|Diabetes|diabetes
1108887|NCT02497651|Incretin hormones|incretin hormones
1108888|NCT02497651|Glucose tolerance|glucose tolerance
1108889|NCT02497638|metformin|metformin
1108890|NCT02497638|atorvastatin|atorvastatin
1108891|NCT02497638|prostate-specific antigen|prostate-specific antigen
1108892|NCT02497638|biochemical recurrence|biochemical recurrence
1108893|NCT02497625|Low back pain|low back pain
1108894|NCT02497625|Empathy|empathy
1108895|NCT02497625|Subgroups|subgroups
1108896|NCT02497625|Minimal intervention|minimal intervention
1108897|NCT02497547|Atrophy|atrophy
1108898|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
1108899|NCT02497547|Oxytocin|oxytocin
1108900|NCT02497547|Oxytocics|oxytocics
1108901|NCT02497534|ataxia|ataxia
1108902|NCT02497534|neuromuscular|neuromuscular
1108903|NCT02497521|polycystic kidney disease|polycystic kidney disease
1108904|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1108905|NCT02497521|ADPKD|adpkd
1108906|NCT02497521|Tolvaptan|tolvaptan
1108907|NCT02497521|Jinarc|jinarc
1108908|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
1108909|NCT02497495|Immersion|immersion
1108910|NCT02497495|Recovery of Function|recovery of function
1108911|NCT02497495|Lactate|lactate
1108912|NCT02497495|Creatine Kinase|creatine kinase
1108913|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
1108914|NCT02497469|Drug Therapy|drug therapy
1108916|NCT02497456|Counselling|counselling
1108917|NCT02497456|Care|care
1108918|NCT02497456|antiretroviral therapy|antiretroviral therapy
1108919|NCT02497456|linkage|linkage
1108920|NCT02497456|Uganda|uganda
1108921|NCT02497456|Africa|africa
1108922|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
1108923|NCT02497443|seizure|seizure
1108924|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
1108925|NCT02497443|safety|safety
1108926|NCT02497443|remission|remission
1108927|NCT02497443|electroencephalography|electroencephalography
1108928|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
1108929|NCT02497443|autologous MSC|autologous msc
1108930|NCT02497443|efficacy|efficacy
1108931|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
1108932|NCT02497378|Multiple Myeloma|multiple myeloma
1108933|NCT02497378|Daratumumab|daratumumab
1108934|NCT02497378|JNJ-54767414|jnj-54767414
1108935|NCT02497378|Bortezomib|bortezomib
1108936|NCT02497378|Dexamethasone|dexamethasone
1108937|NCT02497365|keratits|keratits
1108938|NCT02497365|besifloxacin|besifloxacin
1108939|NCT02497339|Smoking cessation interventions|smoking cessation interventions
1108940|NCT02497339|mindfulness training|mindfulness training
1108941|NCT02497326|second degree burns|second degree burns
1108942|NCT02497326|heparin|heparin
1108943|NCT02497326|topical|topical
1108944|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
1108945|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
1108946|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
1108947|NCT02497287|Esketamine|esketamine
1108948|NCT02497287|Oral Antidepressant|oral antidepressant
1108949|NCT02497274|bariatric surgery|bariatric surgery
1108950|NCT02497274|taste perception|taste perception
1108951|NCT02497274|lipid receptors|lipid receptors
1108952|NCT02497261|Food Allergy|food allergy
1108953|NCT02497261|Peanut|peanut
1108954|NCT02497261|Sensitization|sensitization
1108955|NCT02497261|Child|child
1109054|NCT02496728|Instagram|instagram
1108956|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
1108957|NCT02497261|Prospective cohort|prospective cohort
1108958|NCT02497248|Atrial Fibrillation|atrial fibrillation
1108959|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
1108960|NCT02497248|Mitral stenosis|mitral stenosis
1108961|NCT02497248|Body surface mapping|body surface mapping
1108962|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
1108963|NCT02497196|TPCS|tpcs
1108964|NCT02497196|tDCS|tdcs
1160211|NCT02215525|HCV|hcv
1108965|NCT02497196|visceral pain|visceral pain
1108966|NCT02497196|pancreatitis|pancreatitis
1108967|NCT02497196|healthy subjects|healthy subjects
1108968|NCT02497196|pelvic pain|pelvic pain
1108969|NCT02497196|neuromodulation|neuromodulation
1108970|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
1108971|NCT02497157|bevacizumab|bevacizumab
1108972|NCT02497157|oxaliplatin|oxaliplatin
1108973|NCT02497157|irinotecan|irinotecan
1108974|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
1108975|NCT02497157|fluorouracil|fluorouracil
1108976|NCT02497157|levofolinate calcium|levofolinate calcium
1108977|NCT02497144|interstitial lung disease|interstitial lung disease
1108978|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1108979|NCT02497144|exercise capacity|exercise capacity
1108980|NCT02497144|quality of life|quality of life
1108981|NCT02497131|PTCL|ptcl
1108982|NCT02497131|CD30+|cd30+
1108983|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
1108984|NCT02497105|Epilepsy|epilepsy
1108985|NCT02497105|Intractable Seizures|intractable seizures
1108986|NCT02497105|Ketogenic Diet|ketogenic diet
1108987|NCT02497105|Biochemical Profiles|biochemical profiles
1108988|NCT02497079|Bronchoscopy|bronchoscopy
1108989|NCT02497079|Ultrasonography|ultrasonography
1108990|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
1108991|NCT02497079|Polymerase chain reaction|polymerase chain reaction
1108992|NCT02497079|Sensitivity and specificity|sensitivity and specificity
1108993|NCT02497066|topical|topical
1108994|NCT02497066|compound|compound
1108995|NCT02497066|pain|pain
1108996|NCT02497053|MPM|mpm
1108997|NCT02497040|anaesthesia|anaesthesia
1108998|NCT02497040|local anaesthesia|local anaesthesia
1108999|NCT02497040|hemodynamics|hemodynamics
1109000|NCT02497040|bupivacaine|bupivacaine
1109001|NCT02497040|levobupivacaine|levobupivacaine
1109002|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
1109003|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
1109004|NCT02496988|Milignant Gliomas|milignant gliomas
1109005|NCT02496988|Temozolomide|temozolomide
1109006|NCT02496962|sleep deprivation|sleep deprivation
1109007|NCT02496936|Energy Expenditure|energy expenditure
1109008|NCT02496936|Appetite|appetite
1109009|NCT02496936|Satiety|satiety
1109010|NCT02496923|prophylactic NHFO|prophylactic nhfo
1109011|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
1109012|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
1109013|NCT02496884|chronic kidney disease|chronic kidney disease
1109014|NCT02496884|. α2δ ligands|. α2δ ligands
1109015|NCT02496884|mirogabalin|mirogabalin
1109016|NCT02496884|pain relief|pain relief
1109017|NCT02496884|kidney metabolism|kidney metabolism
1109018|NCT02496858|Young Patient|young patient
1109019|NCT02496858|Genetic Characteristics|genetic characteristics
1109020|NCT02496832|Hypoxia|hypoxia
1109021|NCT02496832|18F-FAZA|18f-faza
1109022|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
1109023|NCT02496832|Positron emission tomography|positron emission tomography
1109024|NCT02496832|PET|pet
1109025|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
1109026|NCT02496819|Children|children
1109027|NCT02496806|Polyphenols|polyphenols
1109028|NCT02496806|Absorption|absorption
1109029|NCT02496806|Metabolism|metabolism
1109030|NCT02496806|Phlorotannins|phlorotannins
1109031|NCT02496806|Seaweeds|seaweeds
1109032|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
1109033|NCT02496767|tirasemtiv|tirasemtiv
1109034|NCT02496767|CK-2017357|ck-2017357
1109035|NCT02496767|double-blind|double-blind
1109036|NCT02496767|randomized|randomized
1109037|NCT02496767|placebo-controlled|placebo-controlled
1109038|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
1109039|NCT02496741|metformin|metformin
1109040|NCT02496741|chloroquine|chloroquine
1109041|NCT02496728|Mobile Health|mobile health
1109042|NCT02496728|Smartphone|smartphone
1109043|NCT02496728|Cardiovascular health|cardiovascular health
1109044|NCT02496728|College students|college students
1109045|NCT02496728|Smoking|smoking
1109046|NCT02496728|Physical activity|physical activity
1109047|NCT02496728|Diet|diet
1109048|NCT02496728|BMI|bmi
1109049|NCT02496728|Blood pressure|blood pressure
1109050|NCT02496728|Cholesterol|cholesterol
1109051|NCT02496728|Glucose|glucose
1109052|NCT02496728|Text|text
1109055|NCT02496728|Push Notifications|push notifications
1109056|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
1109057|NCT02496702|exergaming|exergaming
1109058|NCT02496702|Senior Fitness Test|senior fitness test
1109059|NCT02496689|HPP|hpp
1109060|NCT02496689|Bone Disease|bone disease
1109061|NCT02496689|Soft Bones|soft bones
1109062|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
1109063|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
1109064|NCT02496689|alkaline phosphatase|alkaline phosphatase
1109065|NCT02496689|rickets|rickets
1109066|NCT02496689|osteomalacia|osteomalacia
1109067|NCT02496676|Lymphoma|lymphoma
1109068|NCT02496676|Epstein-Barr Virus|epstein-barr virus
1109069|NCT02496676|Immunodeficiency|immunodeficiency
1109070|NCT02496676|MAGT1 Gene|magt1 gene
1109071|NCT02496676|Intracellular Magnesium|intracellular magnesium
1109072|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
1109073|NCT02496650|dexmedetomidine|dexmedetomidine
1109074|NCT02496650|benzodiasepines|benzodiasepines
1109075|NCT02496650|intensive care|intensive care
1109076|NCT02496637|Obesity|obesity
1109077|NCT02496637|Eating Disorders|eating disorders
1109078|NCT02496637|Appetite regulation|appetite regulation
1109079|NCT02496637|Eating Regulation|eating regulation
1109080|NCT02496611|Obesity|obesity
1109081|NCT02496611|Pharmacotherapy|pharmacotherapy
1109082|NCT02496611|GLP-1|glp-1
1109083|NCT02496611|Children|children
1109084|NCT02496611|Exenatide|exenatide
1109085|NCT02496611|BYDUREON|bydureon
1109086|NCT02496611|Weight Loss|weight loss
1109087|NCT02496611|Maintenance|maintenance
1109088|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
1109089|NCT02496598|Ovarian Follicle|ovarian follicle
1109090|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
1109091|NCT02496585|Prednisone|prednisone
1109092|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
1109093|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
1109094|NCT02496572|Short-course regimen|short-course regimen
1109095|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
1109096|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
1109097|NCT02496559|C-reactive Protein|c-reactive protein
1109098|NCT02496559|Primary Health Care|primary health care
1109099|NCT02496559|Child Welfare|child welfare
1109100|NCT02496559|After-Hours Care|after-hours care
1109101|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
1109102|NCT02496559|Drug Prescriptions|drug prescriptions
1109103|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
1109104|NCT02496520|sarcoma|sarcoma
1109408|NCT02494921|Metastatic|metastatic
1109105|NCT02496520|central nervous system tumor|central nervous system tumor
1109106|NCT02496520|childhood|childhood
1109107|NCT02496520|adolescent|adolescent
1109108|NCT02496520|immunotherapy|immunotherapy
1109109|NCT02496507|sitting|sitting
1109110|NCT02496507|intervention|intervention
1109111|NCT02496507|desks|desks
1109112|NCT02496507|workplace|workplace
1109113|NCT02496507|cardiovascular|cardiovascular
1109114|NCT02496507|metabolic|metabolic
1109115|NCT02496507|qualitative|qualitative
1109116|NCT02496507|randomised controlled trial|randomised controlled trial
1109117|NCT02496468|childhood asthma|childhood asthma
1109118|NCT02496468|preschool wheeze|preschool wheeze
1109119|NCT02496468|adult asthma|adult asthma
1109120|NCT02496468|transition|transition
1109121|NCT02496468|phenotype|phenotype
1109122|NCT02496468|endotype|endotype
1109123|NCT02496468|trajectory|trajectory
1109124|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
1109125|NCT02496455|pain, postoperative|pain, postoperative
1109126|NCT02496455|cesarean section|cesarean section
1109127|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
1109128|NCT02496442|Cystoscopy|cystoscopy
1109129|NCT02496442|PCNL|pcnl
1109130|NCT02496442|RERAS|reras
1109131|NCT02496442|Urethroscopy|urethroscopy
1109132|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
1109133|NCT02496403|Suboxone|suboxone
1109134|NCT02496403|Buprenorphine|buprenorphine
1109135|NCT02496403|Substance Use|substance use
1109136|NCT02496403|Behavioral intervention|behavioral intervention
1109137|NCT02496403|Opioid partial agonist|opioid partial agonist
1109138|NCT02496403|medication assisted therapy|medication assisted therapy
1109139|NCT02496403|opioid addiction|opioid addiction
1109140|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
1109141|NCT02496390|Gut microbiome|gut microbiome
1109142|NCT02496390|Metabolic disorders|metabolic disorders
1109143|NCT02496390|Obesity|obesity
1109144|NCT02496377|Anaemia|anaemia
1109145|NCT02496377|Iron deficiency|iron deficiency
1109146|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
1109147|NCT02496377|Patient blood management|patient blood management
1109148|NCT02496377|Hip arthroplasty|hip arthroplasty
1109149|NCT02496377|Knee arthroplasty|knee arthroplasty
1109150|NCT02496364|Tranexamic Acid|tranexamic acid
1109151|NCT02496364|Scoliosis|scoliosis
1109152|NCT02496364|bleeding control|bleeding control
1109153|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1109155|NCT02496338|Quality of Life|quality of life
1109156|NCT02496338|Marital Satisfaction|marital satisfaction
1109157|NCT02496338|training|training
1109158|NCT02496325|Pudendal nerve block|pudendal nerve block
1109159|NCT02496325|Ultrasound guided|ultrasound guided
1109160|NCT02496325|Transperineal puncture|transperineal puncture
1109161|NCT02496325|Perineal surgery|perineal surgery
1109162|NCT02496325|children|children
1109163|NCT02496312|Apathy|apathy
1109164|NCT02496312|Goal-directed behavior|goal-directed behavior
1109165|NCT02496312|Quantitative evaluation|quantitative evaluation
1109166|NCT02496312|Sensor|sensor
1109167|NCT02496312|Ethogram|ethogram
1109168|NCT02496299|COMPARISSON|comparisson
1109169|NCT02496299|CAUDAL BLOCK|caudal block
1109170|NCT02496299|BUPIVACAINE|bupivacaine
1109171|NCT02496299|DEXAMETHASONE|dexamethasone
1109172|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
1109173|NCT02496273|Dendritic Cells|dendritic cells
1109174|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
1109175|NCT02496273|Adeno-Associated Virus|adeno-associated virus
1109176|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
1109177|NCT02496260|Cardiac function|cardiac function
1109178|NCT02496260|Breast Cancer|breast cancer
1109179|NCT02496247|malnutrition|malnutrition
1109180|NCT02496247|undernutrition|undernutrition
1109181|NCT02496247|Z-score|z-score
1109182|NCT02496247|Guinea-Bissau|guinea-bissau
1109183|NCT02496247|food aid|food aid
1109184|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1109185|NCT02496234|Acute kidney injury|acute kidney injury
1109186|NCT02496234|Renal failure|renal failure
1109187|NCT02496234|Biomarker|biomarker
1109188|NCT02496221|Cholecystokinin|cholecystokinin
1109189|NCT02496221|ultrasonography|ultrasonography
1109190|NCT02496221|Albiglutide|albiglutide
1109191|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
1109192|NCT02496169|PTCA|ptca
1109193|NCT02496169|stenosis|stenosis
1109194|NCT02496169|sirolimus|sirolimus
1109195|NCT02496169|stent|stent
1109196|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
1109197|NCT02496156|adolescence|adolescence
1109198|NCT02496156|adherence|adherence
1109199|NCT02496156|insulin pump|insulin pump
1109200|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1109201|NCT02496156|continuous glucose monitor|continuous glucose monitor
1109202|NCT02496156|shared medical decision making|shared medical decision making
1109203|NCT02496143|Healthy Volunteers|healthy volunteers
1109204|NCT02496143|Phase I|phase i
1109510|NCT02494479|Psoriasis|psoriasis
1109205|NCT02496143|Placebo controlled|placebo controlled
1109206|NCT02496143|Single Ascending Dose|single ascending dose
1109207|NCT02496143|PK|pk
1109208|NCT02496143|Oral administration|oral administration
1109209|NCT02496143|Softgel|softgel
1109210|NCT02496130|minilaparotomy|minilaparotomy
1109211|NCT02496130|morcellation|morcellation
1109212|NCT02496130|laparoscopy|laparoscopy
1109213|NCT02496104|Preterm|preterm
1109214|NCT02496104|Infant|infant
1109215|NCT02496104|Habituation|habituation
1109216|NCT02496104|APIB|apib
1109217|NCT02496065|breast cancer|breast cancer
1109218|NCT02496065|BLZ-100|blz-100
1109219|NCT02496065|Tumor Paint|tumor paint
1109220|NCT02496065|breast tumors|breast tumors
1109221|NCT02496052|amnion graft|amnion graft
1109222|NCT02496052|New biological barrier system|new biological barrier system
1109223|NCT02496039|PBA|pba
1109224|NCT02496039|involuntary crying|involuntary crying
1109225|NCT02496039|involuntary laughing|involuntary laughing
1109226|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
1109227|NCT02496000|Metformin|metformin
1109228|NCT02496000|oral insulin|oral insulin
1109229|NCT02495974|Xtandi|xtandi
1109230|NCT02495974|Enzalutamide|enzalutamide
1109231|NCT02495974|Prostate cancer|prostate cancer
1109232|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
1109233|NCT02495961|hyperlipidemias|hyperlipidemias
1109234|NCT02495961|hyperglycemia|hyperglycemia
1109235|NCT02495961|hypertension|hypertension
1109236|NCT02495961|leptin|leptin
1109237|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
1109238|NCT02495935|TES|tes
1109239|NCT02495935|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
1109240|NCT02495935|Amblyopia|amblyopia
1109241|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
1109242|NCT02495909|morbidity|morbidity
1109243|NCT02495909|immunology|immunology
1109244|NCT02495883|Essential Tremor|essential tremor
1109245|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
1109246|NCT02495883|Therapy|therapy
1109247|NCT02495883|Alcohol|alcohol
1109248|NCT02495883|Propranolol|propranolol
1109249|NCT02495844|UCB0942|ucb0942
1109250|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
1109251|NCT02495844|Partial seizures|partial seizures
1109252|NCT02495844|Seizure therapy|seizure therapy
1109253|NCT02495831|PK study|pk study
1109254|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
1109255|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
1109957|NCT02491814|Dairy|dairy
1109256|NCT02495818|suprascapular nerve block|suprascapular nerve block
1109257|NCT02495818|ultrasound guided|ultrasound guided
1109258|NCT02495818|supraspinatus|supraspinatus
1109259|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
1109260|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
1109261|NCT02495779|PrEP|prep
1109262|NCT02495779|HIV|hiv
1109263|NCT02495779|MSM|msm
1109264|NCT02495779|Men Having Sex With Men|men having sex with men
1109265|NCT02495779|Episodic PrEP|episodic prep
1109266|NCT02495779|Adherence|adherence
1109267|NCT02495779|Episodic HIV Risk|episodic hiv risk
1109268|NCT02495766|Multiple sclerosis|multiple sclerosis
1109269|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
1109270|NCT02495766|Stem cells|stem cells
1109271|NCT02495766|Nervous System Diseases|nervous system diseases
1109272|NCT02495766|Demyelinating Diseases|demyelinating diseases
1109273|NCT02495766|Autoimmune Diseases|autoimmune diseases
1109274|NCT02495753|cesarean section|cesarean section
1109275|NCT02495753|wound infection|wound infection
1109276|NCT02495753|vaginal cleansing|vaginal cleansing
1109277|NCT02495753|endometritis|endometritis
1109278|NCT02495727|Step-reduction model|step-reduction model
1109279|NCT02495727|Reduced activity|reduced activity
1109280|NCT02495727|Atrophy|atrophy
1109281|NCT02495727|Skeletal Muscle|skeletal muscle
1109282|NCT02495727|Sarcopenia|sarcopenia
1109283|NCT02495727|Dynapenia|dynapenia
1109284|NCT02495714|Exercise|exercise
1109285|NCT02495714|Diet|diet
1109286|NCT02495714|Learning|learning
1109287|NCT02495688|General Anesthesia|general anesthesia
1109288|NCT02495688|Regional Anesthesia|regional anesthesia
1109289|NCT02495662|Vascular access|vascular access
1109290|NCT02495662|Hemodialysis|hemodialysis
1109291|NCT02495662|Arteriovenous shunt|arteriovenous shunt
1109292|NCT02495662|Arteriovenous fistula|arteriovenous fistula
1109293|NCT02495662|Maturation|maturation
1109294|NCT02495662|Liposomal prednisolone|liposomal prednisolone
1109295|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
1109296|NCT02495662|Radio-cephalic|radio-cephalic
1109297|NCT02495662|Shunt|shunt
1109298|NCT02495610|NPH|nph
1109299|NCT02495610|Gait analysis|gait analysis
1109300|NCT02495610|neuropsychology|neuropsychology
1109301|NCT02495610|micturition diary|micturition diary
1109302|NCT02495610|MRI|mri
1109303|NCT02495597|bronchial inflammation|bronchial inflammation
1109304|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
1109305|NCT02495597|Sputum|sputum
1109306|NCT02495597|Blood|blood
1109307|NCT02495597|Inflammation|inflammation
1109308|NCT02495597|adaptive immune system|adaptive immune system
1109309|NCT02495597|innate immune system|innate immune system
1109310|NCT02495584|Vitamin D|vitamin d
1109311|NCT02495584|Fortified milk|fortified milk
1109312|NCT02495584|Supplementation|supplementation
1109313|NCT02495584|UV exposure|uv exposure
1109314|NCT02495584|Winter|winter
1109315|NCT02495584|Healthy adults|healthy adults
1109316|NCT02495584|Body Composition|body composition
1109317|NCT02495584|Muscle function|muscle function
1109318|NCT02495584|Blood pressure|blood pressure
1109319|NCT02495571|ALS and Dysphagia|als and dysphagia
1109320|NCT02495571|ALS and cough|als and cough
1109321|NCT02495571|cough reflex test|cough reflex test
1109322|NCT02495558|Cough Reflex test|cough reflex test
1109323|NCT02495558|Decannulation|decannulation
1109324|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
1109325|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
1109326|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
1109327|NCT02495532|Lymph Nodes|lymph nodes
1109328|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
1109329|NCT02495506|Cardiac surgery|cardiac surgery
1109330|NCT02495506|bleeding|bleeding
1109331|NCT02495506|platelet transfusion|platelet transfusion
1109332|NCT02495480|disposable sheath|disposable sheath
1109333|NCT02495480|intubation|intubation
1109334|NCT02495480|colonoscopy|colonoscopy
1109335|NCT02495428|Bandage|bandage
1109336|NCT02495428|Treadmill|treadmill
1109337|NCT02495428|Lactate Acid|lactate acid
1109338|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
1109339|NCT02495376|YACS|yacs
1109340|NCT02495376|cancer|cancer
1109341|NCT02495376|MBSR|mbsr
1109342|NCT02495311|adenomyosis|adenomyosis
1109343|NCT02495311|uterine myoma|uterine myoma
1109344|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
1109345|NCT02495311|sexual dysfunction|sexual dysfunction
1109346|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
1109347|NCT02495298|Fascial manipulation|fascial manipulation
1109348|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
1109349|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
1109350|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
1109351|NCT02495272|Third stage of labour|third stage of labour
1109352|NCT02495272|Oxytocin|oxytocin
1109353|NCT02495272|Uterotonics|uterotonics
1109354|NCT02495272|Active management of third stage of labour|active management of third stage of labour
1109355|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
1109356|NCT02495259|Laryngoscopy|laryngoscopy
1109357|NCT02495259|intubating stylet|intubating stylet
1109358|NCT02495233|Erlotinib|erlotinib
1109359|NCT02495233|ASP2215|asp2215
1109360|NCT02495233|NSCLC|nsclc
1109361|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1109362|NCT02495220|dexmedetomidine|dexmedetomidine
1109363|NCT02495220|subtenon anesthesia|subtenon anesthesia
1109364|NCT02495220|postoperative pain|postoperative pain
1109366|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
1109367|NCT02495194|Horticultural therapy|horticultural therapy
1109368|NCT02495194|Randomized Controlled Trial|randomized controlled trial
1109369|NCT02495194|Gardening|gardening
1109370|NCT02495194|Elderly|elderly
1109371|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
1109372|NCT02495129|Sicca syndrome|sicca syndrome
1109373|NCT02495129|Salivary glands|salivary glands
1109374|NCT02495129|Positron Emission Tomography|positron emission tomography
1109375|NCT02495129|B cell depletion|b cell depletion
1109376|NCT02495103|Dose-Escalation|dose-escalation
1109377|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
1109378|NCT02495103|Safety|safety
1109379|NCT02495103|Overall Response|overall response
1109380|NCT02495090|Hypospadias|hypospadias
1109381|NCT02495090|exome sequencing|exome sequencing
1109382|NCT02495090|genital malformation|genital malformation
1109383|NCT02495077|Kidney Transplantation|kidney transplantation
1109384|NCT02495077|infliximab|infliximab
1109385|NCT02495077|Tissue Donors|tissue donors
1109386|NCT02495077|Remicade|remicade
1109387|NCT02495077|Induction Therapy|induction therapy
1109388|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
1109389|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
1109390|NCT02495051|barrett esophagus|barrett esophagus
1109391|NCT02495038|combination|combination
1109392|NCT02495038|rocuronium|rocuronium
1109393|NCT02495038|cisatracurium|cisatracurium
1109394|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
1109395|NCT02495038|drug synergism|drug synergism
1109396|NCT02495012|efficacy|efficacy
1109397|NCT02495012|safety|safety
1109398|NCT02495012|STEMI|stemi
1109399|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1109400|NCT02494999|immunogenicity|immunogenicity
1109401|NCT02494999|safety|safety
1109402|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
1109403|NCT02494986|Rilpivirine|rilpivirine
1109404|NCT02494986|Roll-over study|roll-over study
1109405|NCT02494960|smoking cessation intervention|smoking cessation intervention
1109406|NCT02494947|Coronary Angiography|coronary angiography
1109407|NCT02494947|Exercise|exercise
1109409|NCT02494921|Castration-Resistant|castration-resistant
1109410|NCT02494908|Parkinson Disease|parkinson disease
1109412|NCT02494882|Ruxolitinib|ruxolitinib
1109413|NCT02494882|Dasatinib|dasatinib
1109414|NCT02494882|Dexamethasone|dexamethasone
1109415|NCT02494882|14-272|14-272
1109416|NCT02494869|Aerobic Training|aerobic training
1109417|NCT02494869|Exercise|exercise
1109418|NCT02494869|Gene Expression|gene expression
1109419|NCT02494869|15-093|15-093
1109420|NCT02494856|Naproxen|naproxen
1109421|NCT02494856|Lower third molar|lower third molar
1109422|NCT02494856|Oral Surgery|oral surgery
1109423|NCT02494856|Esomeprazole|esomeprazole
1109424|NCT02494830|Anesthetic Drugs|anesthetic drugs
1109425|NCT02494817|HIV prevention|hiv prevention
1109426|NCT02494817|Toolkit|toolkit
1109427|NCT02494817|Male couples|male couples
1109428|NCT02494817|Sexual agreements|sexual agreements
1109429|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
1109430|NCT02494804|Milignant Gliomas|milignant gliomas
1109431|NCT02494804|Temozolomide|temozolomide
1109432|NCT02494778|Huntington's disease, pridopidine|huntington's disease, pridopidine
1109433|NCT02494765|I-gelTM|i-geltm
1109434|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
1109435|NCT02494765|supraglottic devices|supraglottic devices
1109436|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
1109437|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
1109438|NCT02494752|Contour deformities of face|contour deformities of face
1109439|NCT02494752|autologous fat grafting|autologous fat grafting
1109440|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
1109441|NCT02494739|antioxidant|antioxidant
1109442|NCT02494739|oxidative stress|oxidative stress
1109443|NCT02494739|inflammation|inflammation
1109444|NCT02494739|polyphenols|polyphenols
1109445|NCT02494739|yogurt|yogurt
1109446|NCT02494726|Ischemic stroke|ischemic stroke
1109447|NCT02494726|ICH stroke|ich stroke
1109448|NCT02494726|TEG|teg
1109449|NCT02494726|Thromboelastography|thromboelastography
1109450|NCT02494726|Stroke|stroke
1109451|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
1109452|NCT02494713|Neoadjuvant|neoadjuvant
1109453|NCT02494713|Hormone therapy|hormone therapy
1109454|NCT02494713|ADT|adt
1109455|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
1109456|NCT02494713|Chemotherapy|chemotherapy
1109457|NCT02494713|Radical Prostatectomy|radical prostatectomy
1109458|NCT02494700|Lymphoma|lymphoma
1109459|NCT02494700|Low grade B lymphocyte (B cell) lymphoma|low grade b lymphocyte (b cell) lymphoma
1568635|NCT00505180|Hemodialysis|hemodialysis
1109460|NCT02494700|Mantle cell lymphoma involving the ocular adnexa|mantle cell lymphoma involving the ocular adnexa
1109461|NCT02494700|Limited and advanced stage|limited and advanced stage
1109462|NCT02494700|Ocular adnexa|ocular adnexa
1109463|NCT02494700|Radiation therapy|radiation therapy
1109464|NCT02494700|XRT|xrt
1109465|NCT02494661|Public Health|public health
1109466|NCT02494661|Community|community
1109467|NCT02494661|Obesity|obesity
1109468|NCT02494661|Hispanic|hispanic
1109469|NCT02494661|Women|women
1109470|NCT02494661|Nutrition|nutrition
1109471|NCT02494661|Mindfulness and stress|mindfulness and stress
1109472|NCT02494661|Food shopping|food shopping
1109473|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
1109474|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
1109475|NCT02494648|Coronary artery disease|coronary artery disease
1109476|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
1109477|NCT02494583|Gastric carcinoma|gastric carcinoma
1109478|NCT02494583|Gastric cancer|gastric cancer
1109479|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
1109480|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
1109481|NCT02494583|PD1|pd1
1109482|NCT02494583|PD-1|pd-1
1109483|NCT02494583|PDL1|pdl1
1109484|NCT02494583|PD-L1|pd-l1
1109485|NCT02494544|knee implant|knee implant
1109486|NCT02494544|knee replacement|knee replacement
1109487|NCT02494544|total knee replacement|total knee replacement
1109488|NCT02494531|Alzheimer Disease|alzheimer disease
1109489|NCT02494531|PET|pet
1109490|NCT02494531|diagnosis|diagnosis
1109491|NCT02494531|MCI|mci
1109492|NCT02494531|illiterate|illiterate
1109493|NCT02494518|stroke|stroke
1109494|NCT02494518|aerobic exercise|aerobic exercise
1109495|NCT02494518|forced exercise|forced exercise
1109496|NCT02494518|repetitive task practice|repetitive task practice
1109497|NCT02494518|arm function|arm function
1109498|NCT02494518|upper extremity|upper extremity
1109499|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
1109500|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
1109501|NCT02494505|withdrawal|withdrawal
1109502|NCT02494505|quality of life|quality of life
1109503|NCT02494505|Clinical trial|clinical trial
1109504|NCT02494505|cost|cost
1109505|NCT02494492|Uveitis|uveitis
1109506|NCT02494492|Lymphocyte cells|lymphocyte cells
1109507|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
1109508|NCT02494492|vitreous haze|vitreous haze
1109509|NCT02494492|intravitreal injection|intravitreal injection
1109511|NCT02494479|Topical Psoriasis|topical psoriasis
1109512|NCT02494479|Mild Psoriasis|mild psoriasis
1109513|NCT02494479|Moderate Psoriasis|moderate psoriasis
1109514|NCT02494479|Active Psoriasis|active psoriasis
1109515|NCT02494479|Plaque Psoriasis|plaque psoriasis
1109516|NCT02494479|Skin Diseases|skin diseases
1109517|NCT02494466|Airway Resistance|airway resistance
1109518|NCT02494466|montelukast sodium|montelukast sodium
1109519|NCT02494466|laryngeal mask airway|laryngeal mask airway
1109520|NCT02494427|Crowns|crowns
1109521|NCT02494427|Inlays|inlays
1109522|NCT02494427|Onlays|onlays
1109523|NCT02494414|Cardiac arrest|cardiac arrest
1109524|NCT02494414|outcome|outcome
1109525|NCT02494414|neurological status|neurological status
1109526|NCT02494401|systemic sclerosis|systemic sclerosis
1109528|NCT02494375|Sleep|sleep
1109529|NCT02494375|glycemic control|glycemic control
1109530|NCT02494375|type 1 diabetes|type 1 diabetes
1109531|NCT02494375|amylase|amylase
1109532|NCT02494375|body composition|body composition
1109533|NCT02494375|lean|lean
1109534|NCT02494375|overweight|overweight
1109535|NCT02494375|obese|obese
1109536|NCT02494362|Hand exercises|hand exercises
1109537|NCT02494362|Hand function|hand function
1109538|NCT02494362|Computer based exercises|computer based exercises
1109539|NCT02494362|Therapeutic gaming|therapeutic gaming
1109540|NCT02494349|α1-blockers|α1-blockers
1109541|NCT02494349|antimuscarinic agent|antimuscarinic agent
1109542|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
1109543|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
1109544|NCT02494284|Coronary artery disease|coronary artery disease
1109545|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
1109546|NCT02494284|Drug eluting stent|drug eluting stent
1109547|NCT02494258|CC-486|cc-486
1109548|NCT02494258|Oral Azacitidine|oral azacitidine
1109549|NCT02494258|Solid tumors|solid tumors
1109550|NCT02494258|hematological disorders|hematological disorders
1109551|NCT02494258|rollover study|rollover study
1109552|NCT02494245|Rehabilitation|rehabilitation
1109553|NCT02494245|Intervention|intervention
1109554|NCT02494245|Walking|walking
1109555|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
1109556|NCT02494232|physical examination|physical examination
1109557|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
1109558|NCT02494219|Rapid streptococcal test|rapid streptococcal test
1110157|NCT02490527|cramping|cramping
1109559|NCT02494219|Throat swab culture|throat swab culture
1109560|NCT02494206|QBX258|qbx258
1160896|NCT02212483|Asthma|asthma
1109561|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
1109562|NCT02494206|VAK694|vak694
1109563|NCT02494206|QAX576|qax576
1109564|NCT02494206|15-085|15-085
1109565|NCT02494180|fentanyl|fentanyl
1109566|NCT02494180|midazolam|midazolam
1109567|NCT02494180|pethidine|pethidine
1109568|NCT02494180|diazepam|diazepam
1109569|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
1109570|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
1109571|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
1109572|NCT02494128|Child health service|child health service
1109573|NCT02494128|Family health|family health
1109574|NCT02494128|Nurse|nurse
1109575|NCT02494128|Education|education
1109576|NCT02494128|Parental group|parental group
1109577|NCT02494128|Group leadership|group leadership
1109578|NCT02494128|Health promotion|health promotion
1109579|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
1109580|NCT02494102|General Anesthesia|general anesthesia
1109581|NCT02494102|Modafinil|modafinil
1109582|NCT02494089|in situ simulation|in situ simulation
1109583|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
1109584|NCT02494089|clinical audit|clinical audit
1109585|NCT02494089|education|education
1109586|NCT02494089|patient simulation|patient simulation
1109587|NCT02494063|cervical cancer|cervical cancer
1109588|NCT02494063|sentinel lymph node|sentinel lymph node
1109589|NCT02494063|lymphadenectomy|lymphadenectomy
1109590|NCT02494050|Depression|depression
1109591|NCT02494050|Bipolar Disorder|bipolar disorder
1109592|NCT02494050|Anhedonia|anhedonia
1109593|NCT02494050|Women|women
1109594|NCT02494024|PSP|psp
1109595|NCT02494024|C2N-8E12|c2n-8e12
1109596|NCT02494024|tauopathy|tauopathy
1109597|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
1109598|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
1109599|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
1109600|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
1109601|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
1109602|NCT02493985|Brain physiology|brain physiology
1109603|NCT02493985|Intracranial pressure|intracranial pressure
1109604|NCT02493985|Cognition|cognition
1109605|NCT02493985|Cerebrovascular|cerebrovascular
1109606|NCT02493985|Head down tilt|head down tilt
1109607|NCT02493985|Space flight|space flight
1109608|NCT02493972|ovarian cancer|ovarian cancer
1109609|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
1109610|NCT02493972|manual exploration|manual exploration
1109611|NCT02493972|surgery|surgery
1109612|NCT02493972|GelPort|gelport
1109613|NCT02493959|PYY|pyy
1109614|NCT02493959|Degradation|degradation
1109615|NCT02493959|kinetics|kinetics
1109616|NCT02493959|men|men
1109617|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
1109618|NCT02493920|Delivery Room|delivery room
1109619|NCT02493920|Resuscitation|resuscitation
1109620|NCT02493920|Premature birth|premature birth
1109621|NCT02493920|Infant, Newborn|infant, newborn
1109622|NCT02493920|Respiration Artificial|respiration artificial
1109623|NCT02493894|Bowel preparation|bowel preparation
1109624|NCT02493894|perioperative bleeding|perioperative bleeding
1109625|NCT02493894|lumbar fusion|lumbar fusion
1109626|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
1109627|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
1109628|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
1109629|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
1109630|NCT02493868|Esketamine|esketamine
1109631|NCT02493868|Placebo|placebo
1109632|NCT02493868|Oral Antidepressant|oral antidepressant
1109633|NCT02493868|Relapse prevention|relapse prevention
1109634|NCT02493855|Treatment naive|treatment naive
1109635|NCT02493855|HCV|hcv
1109636|NCT02493855|Interferon free|interferon free
1109637|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
1109638|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
1109639|NCT02493855|Hepatitis C|hepatitis c
1109640|NCT02493842|Nerve Stimulation|nerve stimulation
1109641|NCT02493842|Neuroplasticity|neuroplasticity
1109642|NCT02493842|Sensory Feedback|sensory feedback
1109643|NCT02493790|cognitive dysfunction|cognitive dysfunction
1109644|NCT02493790|Activity of Daily Living|activity of daily living
1109645|NCT02493790|interference|interference
1109646|NCT02493790|rehabilitation|rehabilitation
1109647|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
1109648|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
1109649|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
1109650|NCT02493673|Stroke|stroke
1109651|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
1109652|NCT02493673|Brain oxygenation|brain oxygenation
1109653|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
1109654|NCT02493660|Arthroscopy|arthroscopy
1109655|NCT02493660|Shoulder Joint|shoulder joint
1568636|NCT00505180|Mortality|mortality
1109656|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
1109657|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
1109658|NCT02493634|Aortic Arch|aortic arch
1109659|NCT02493621|Pain, Postoperative|pain, postoperative
1109660|NCT02493621|Nerve Block|nerve block
1109661|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
1109663|NCT02493582|Apatinib|apatinib
1109664|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
1109665|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
1109666|NCT02493556|Phototherapy|phototherapy
1109667|NCT02493556|Plyometric exercise|plyometric exercise
1109668|NCT02493556|Muscle recovery|muscle recovery
1109669|NCT02493543|autoantibodies|autoantibodies
1109670|NCT02493530|MDS/MPN|mds/mpn
1109671|NCT02493504|Heparin|heparin
1109672|NCT02493491|dysphonia|dysphonia
1109673|NCT02493491|dysphagia|dysphagia
1109674|NCT02493491|neurogenic|neurogenic
1109675|NCT02493491|vocal fold augmentation|vocal fold augmentation
1109676|NCT02493491|VFA|vfa
1109677|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
1109678|NCT02493491|Prolaryn|prolaryn
1109679|NCT02493491|Radiesse|radiesse
1109680|NCT02493491|Coaptite|coaptite
1109681|NCT02493491|voice|voice
1109682|NCT02493491|Parkinson's Disease|parkinson's disease
1109683|NCT02493491|Multiple Sclerosis|multiple sclerosis
1109684|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1109685|NCT02493491|ALS|als
1109686|NCT02493491|MS|ms
1109687|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
1109688|NCT02493491|hyaluronic acid|hyaluronic acid
1109689|NCT02493478|Intubation|intubation
1109690|NCT02493478|Advanced airway intervention|advanced airway intervention
1109691|NCT02493478|Intensive care unit|intensive care unit
1109692|NCT02493465|everolimus|everolimus
1109693|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
1109694|NCT02493439|Best Possible Self|best possible self
1109695|NCT02493439|Positive Psychology|positive psychology
1109696|NCT02493439|Romanian Immigrants|romanian immigrants
1109697|NCT02493439|Optimism|optimism
1109698|NCT02493439|Future Thinking|future thinking
1109699|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
1109700|NCT02493413|stress|stress
1109701|NCT02493413|lymphocyte population|lymphocyte population
1109702|NCT02493413|personality type|personality type
1109703|NCT02493413|obesity|obesity
1109704|NCT02493413|heart rate variability|heart rate variability
1109705|NCT02493413|awareness|awareness
1109706|NCT02493400|Follow up|follow up
1109707|NCT02493400|Exercise|exercise
1109708|NCT02493400|Rehabilitation|rehabilitation
1109709|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
1109710|NCT02493387|Physical activity|physical activity
1109711|NCT02493387|Atrial fibrillation|atrial fibrillation
1109712|NCT02493348|Fibromyalgia|fibromyalgia
1109713|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
1109714|NCT02493348|Gamma Stimulation|gamma stimulation
1109715|NCT02493283|dapsone|dapsone
1109716|NCT02493283|blood leucocytes|blood leucocytes
1109717|NCT02493283|pharmacokinetics|pharmacokinetics
1109718|NCT02493283|metabolism|metabolism
1109719|NCT02493270|smoking cessation|smoking cessation
1109720|NCT02493270|tobacco|tobacco
1109721|NCT02493270|dental|dental
1109722|NCT02493270|periodontal|periodontal
1109723|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
1109724|NCT02493257|nasal congestion|nasal congestion
1109725|NCT02493257|rhinorrhea|rhinorrhea
1109726|NCT02493218|mindfulness|mindfulness
1109727|NCT02493218|intervention|intervention
1109728|NCT02493218|african american|african american
1109729|NCT02493218|youth|youth
1109730|NCT02493218|stress|stress
1109731|NCT02493218|poverty|poverty
1109732|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
1109733|NCT02493205|Stent|stent
1109734|NCT02493192|Parturition|parturition
1109735|NCT02493192|Humanizing Deliver|humanizing deliver
1109736|NCT02493192|Labor Pain|labor pain
1109737|NCT02493192|Natural Childbirth|natural childbirth
1109738|NCT02493192|Labor Onset|labor onset
1109739|NCT02493192|First Labor Stage|first labor stage
1109740|NCT02493192|Birth ball|birth ball
1109741|NCT02493192|meperidine|meperidine
1109742|NCT02493192|pethidine|pethidine
1109743|NCT02493140|Weight management|weight management
1109744|NCT02493140|cashew apple extract|cashew apple extract
1109745|NCT02493140|overweight|overweight
1109746|NCT02493101|Periostin staining|periostin staining
1109747|NCT02493101|Urine periostin level|urine periostin level
1109748|NCT02493101|Lupus nephritis|lupus nephritis
1109749|NCT02493101|IgA nephropathy|iga nephropathy
1109750|NCT02493075|atrial fibrillation|atrial fibrillation
1109751|NCT02493075|Catheter Ablation|catheter ablation
1109752|NCT02493075|contact force|contact force
1109753|NCT02493075|Chinese-specific|chinese-specific
1109754|NCT02493062|Hysterotomy|hysterotomy
1109755|NCT02493062|Myelomeningocele|myelomeningocele
1109756|NCT02493062|Open fetal surgery|open fetal surgery
1109757|NCT02493062|Sonohysterogram|sonohysterogram
1109758|NCT02493049|Multiple Sclerosis|multiple sclerosis
1109759|NCT02493049|Domperidone|domperidone
1109760|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
1109761|NCT02493049|Demyelinating disease|demyelinating disease
1109762|NCT02493049|Remyelination|remyelination
1109763|NCT02493023|Bronchoscopy|bronchoscopy
1109764|NCT02493023|Bronchoscopes|bronchoscopes
1109765|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1109766|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
1109767|NCT02493010|Public Speaking|public speaking
1109768|NCT02493010|Social Phobia|social phobia
1109769|NCT02493010|Biofeedback|biofeedback
1109770|NCT02492997|body fat|body fat
1109771|NCT02492984|FVIII inhibitor|fviii inhibitor
1109772|NCT02492971|Assistive technology|assistive technology
1109773|NCT02492971|functional needs|functional needs
1109774|NCT02492971|system usability|system usability
1109775|NCT02492945|Tennis elbow|tennis elbow
1109776|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
1109777|NCT02492945|Prolotherapy|prolotherapy
1109778|NCT02492945|Randomized controlled trial|randomized controlled trial
1109779|NCT02492945|Visual analogue scale|visual analogue scale
1109780|NCT02492945|disability|disability
1109781|NCT02492945|ultrasonography|ultrasonography
1109782|NCT02492919|cardiac surgery|cardiac surgery
1109783|NCT02492919|risk factors|risk factors
1109784|NCT02492919|infection|infection
1109785|NCT02492880|stimulation|stimulation
1109786|NCT02492880|implantable|implantable
1109787|NCT02492880|pulse generator|pulse generator
1109788|NCT02492880|back pain|back pain
1109789|NCT02492880|chronic pain|chronic pain
1109790|NCT02492880|leg pain|leg pain
1109791|NCT02492854|Lower Extremity Bypass|lower extremity bypass
1109792|NCT02492854|Surgical Site Infection|surgical site infection
1109793|NCT02492854|Wound Dressing|wound dressing
1109794|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
1109795|NCT02492841|dentin substitute|dentin substitute
1109796|NCT02492841|vital pulp therapy|vital pulp therapy
1109797|NCT02492841|Biodentine|biodentine
1109798|NCT02492841|caries|caries
1109799|NCT02492789|immunotherapy|immunotherapy
1109800|NCT02492789|solid tumor|solid tumor
1109801|NCT02492789|PD-1 blockade|pd-1 blockade
1109802|NCT02492776|Volunteers|volunteers
1109803|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
1109804|NCT02492737|AML|aml
1109805|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
1109806|NCT02492737|MDS|mds
1109807|NCT02492737|dual mutation|dual mutation
1109808|NCT02492737|MPN|mpn
1109809|NCT02492737|AITL|aitl
1109810|NCT02492737|hematologic malignancies|hematologic malignancies
1109811|NCT02492737|IDH1|idh1
1109812|NCT02492737|IDH2|idh2
1109813|NCT02492737|AG-881|ag-881
1109814|NCT02492724|cervical spine|cervical spine
1110210|NCT02489903|lung cancer|lung cancer
1109815|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
1109816|NCT02492724|degenerative disc disease|degenerative disc disease
1109817|NCT02492724|activ® C|activ® c
1109818|NCT02492724|clinical outcome|clinical outcome
1109819|NCT02492724|long-term results|long-term results
1109821|NCT02492724|VAS|vas
1109822|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
1109823|NCT02492724|range of motion (ROM)|range of motion (rom)
1109824|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
1109825|NCT02492698|Probiotic|probiotic
1109826|NCT02492698|Weight loss|weight loss
1109827|NCT02492698|Lp-PLA2|lp-pla2
1109828|NCT02492685|Quantitative analysis|quantitative analysis
1109829|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
1109830|NCT02492659|femtosecond laser|femtosecond laser
1109831|NCT02492633|Smoking cessation|smoking cessation
1109832|NCT02492633|Smoke-free housing|smoke-free housing
1109833|NCT02492633|Affordable housing|affordable housing
1109834|NCT02492633|Second-hand smoke|second-hand smoke
1109835|NCT02492633|Tobacco control|tobacco control
1109836|NCT02492620|ferric citrate|ferric citrate
1109837|NCT02492620|phosphate|phosphate
1109838|NCT02492620|kidney|kidney
1109839|NCT02492607|Women|women
1109840|NCT02492607|DCIS|dcis
1109841|NCT02492607|Active surveillance|active surveillance
1109842|NCT02492607|Standard treatment|standard treatment
1109843|NCT02492581|Selincro|selincro
1109844|NCT02492581|cohort|cohort
1109845|NCT02492581|real-life|real-life
1109846|NCT02492581|total alcohol consumption|total alcohol consumption
1109847|NCT02492581|heavy drinking days|heavy drinking days
1109848|NCT02492581|clinical global impression-severity|clinical global impression-severity
1109849|NCT02492581|EQ5D|eq5d
1109850|NCT02492581|AQoLS|aqols
1109851|NCT02492581|Sheehan disability scale|sheehan disability scale
1109852|NCT02492568|recurrent|recurrent
1109853|NCT02492568|NSCLC|nsclc
1109854|NCT02492568|pembrolizumab|pembrolizumab
1109855|NCT02492568|SBRT|sbrt
1109856|NCT02492555|IBD|ibd
1109857|NCT02492555|Telemedicine|telemedicine
1109858|NCT02492555|At-home monitoring|at-home monitoring
1109859|NCT02492555|Disease activity|disease activity
1161278|NCT02210481|OCT|oct
1109860|NCT02492555|fecal calprotectin|fecal calprotectin
1109861|NCT02492542|electrical stimulation|electrical stimulation
1109862|NCT02492542|urinary incontinence|urinary incontinence
1109863|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
1109864|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
1109865|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
1109866|NCT02492490|Kidney transplantation|kidney transplantation
1109867|NCT02492490|DCD|dcd
1109868|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
1109869|NCT02492490|MSC|msc
1109870|NCT02492451|intrauterine insemination|intrauterine insemination
1109871|NCT02492451|pregnancy rate|pregnancy rate
1109872|NCT02492451|endometrial injury|endometrial injury
1109873|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
1109874|NCT02492438|dialysis|dialysis
1109875|NCT02492438|immune response|immune response
1109876|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
1109877|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
1109878|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1109879|NCT02492399|mitral valve|mitral valve
1109880|NCT02492399|SAM syndrome|sam syndrome
1109881|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
1109882|NCT02492386|erectile dysfunction|erectile dysfunction
1109883|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
1109884|NCT02492373|topical high potency steroid|topical high potency steroid
1109885|NCT02492373|Qs NdYAG laser|qs ndyag laser
1109886|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
1109887|NCT02492360|Testicular Cancer|testicular cancer
1109888|NCT02492360|Cisplatin|cisplatin
1109889|NCT02492360|Pharmacogenomics|pharmacogenomics
1109890|NCT02492308|kidney|kidney
1109891|NCT02492308|transplantation|transplantation
1109892|NCT02492308|MSC|msc
1109893|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
1109894|NCT02492217|adalimumab|adalimumab
1109895|NCT02492217|TNF-alpha agents|tnf-alpha agents
1109896|NCT02492217|spondyloarthritis|spondyloarthritis
1109897|NCT02492217|biologic therapies|biologic therapies
1109898|NCT02492217|AS|as
1109899|NCT02492217|biomarkers|biomarkers
1109900|NCT02492217|efficacy prediction|efficacy prediction
1109901|NCT02492191|Smart Phones|smart phones
1109902|NCT02492191|Ambulatory Care|ambulatory care
1109903|NCT02492191|Outcome and Process Assessment|outcome and process assessment
1109904|NCT02492165|Japanese Encephalitis|japanese encephalitis
1109905|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1109906|NCT02492165|IMOJEV®|imojev®
1109907|NCT02492165|Live attenuated vaccine|live attenuated vaccine
1109908|NCT02492152|women|women
1109909|NCT02492152|active labor|active labor
1109910|NCT02492126|Chronic Cough|chronic cough
1109911|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
1109912|NCT02492126|Esophageal Motility|esophageal motility
1109913|NCT02492126|Cough Sensitivity|cough sensitivity
1109914|NCT02492113|Mechanical ventilation|mechanical ventilation
1109915|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
1109916|NCT02492113|Work of breathing|work of breathing
1109917|NCT02492113|Morbidly obese|morbidly obese
1109918|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
1109919|NCT02492087|topical|topical
1109920|NCT02492087|tranexamic acid|tranexamic acid
1109921|NCT02492087|haemostasis|haemostasis
1109922|NCT02492087|caesarean section|caesarean section
1109923|NCT02492087|bleeding|bleeding
1109924|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
1109925|NCT02492087|prophylactic|prophylactic
1109926|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
1109927|NCT02492074|cannabidiol|cannabidiol
1109928|NCT02492074|COMT|comt
1109929|NCT02492061|couples' HCT married couples|couples' hct married couples
1109930|NCT02492061|Rakai|rakai
1109931|NCT02492061|Uganda|uganda
1109932|NCT02492035|Hypertension|hypertension
1109933|NCT02492035|lifestyle|lifestyle
1109934|NCT02492035|clinical trials|clinical trials
1109935|NCT02492035|primary care setting|primary care setting
1109936|NCT02491996|desire model|desire model
1109937|NCT02491983|metastatic breast cancer|metastatic breast cancer
1109938|NCT02491983|Endocrine receptors positive|endocrine receptors positive
1109939|NCT02491983|HER-2 negative|her-2 negative
1109940|NCT02491957|Energy Expenditure|energy expenditure
1109941|NCT02491957|Physical Endurance|physical endurance
1109942|NCT02491957|Muscle Stength|muscle stength
1109943|NCT02491957|Metabolism|metabolism
1109944|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
1109945|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
1109946|NCT02491931|Dietary Supplements|dietary supplements
1109947|NCT02491931|Glutamine|glutamine
1109948|NCT02491931|TROPONIN I|troponin i
1109949|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
1109950|NCT02491879|mechanical low back pain|mechanical low back pain
1109951|NCT02491879|emergency department|emergency department
1109952|NCT02491879|ketoprofen|ketoprofen
1109954|NCT02491840|gastric cancer|gastric cancer
1109955|NCT02491840|cardia cancer|cardia cancer
1109956|NCT02491827|optical biopsy|optical biopsy
1109958|NCT02491814|Breakfast cereal|breakfast cereal
1109959|NCT02491814|Postprandial Glycemia|postprandial glycemia
1109960|NCT02491814|Satiety|satiety
1109961|NCT02491814|Food Intake|food intake
1109962|NCT02491814|Milk|milk
1109963|NCT02491814|Yogurt|yogurt
1109964|NCT02491814|Soy|soy
1109965|NCT02491814|Almond|almond
1109966|NCT02491801|Dairy|dairy
1109967|NCT02491801|Milk|milk
1109968|NCT02491801|Yogurt|yogurt
1109969|NCT02491801|Cheese|cheese
1109970|NCT02491801|Postprandial glycaemia|postprandial glycaemia
1109971|NCT02491801|Satiety|satiety
1109972|NCT02491801|Food Intake|food intake
1109973|NCT02491801|Elderly|elderly
1109974|NCT02491801|Prevention and Treatment|prevention and treatment
1109975|NCT02491762|Serratus Anterior|serratus anterior
1109976|NCT02491762|Accessory Respiratory|accessory respiratory
1109977|NCT02491762|Tissue Expander|tissue expander
1109978|NCT02491762|Respiratory Function Tests|respiratory function tests
1109979|NCT02491749|Cardiac anesthesia|cardiac anesthesia
1109980|NCT02491749|ultra fast track|ultra fast track
1109981|NCT02491749|ICU stay|icu stay
1109982|NCT02491710|Surgical education|surgical education
1109983|NCT02491710|Laparoscopy|laparoscopy
1109984|NCT02491710|Laparoscopic suturing|laparoscopic suturing
1109985|NCT02491697|DC-CIK|dc-cik
1109986|NCT02491697|Breast cancer|breast cancer
1109987|NCT02491697|Capecitabine|capecitabine
1109988|NCT02491684|asthma|asthma
1109989|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
1109990|NCT02491684|exacerbation|exacerbation
1109991|NCT02491684|Interferon|interferon
1109992|NCT02491684|efficacy|efficacy
1109993|NCT02491684|safety|safety
1109994|NCT02491684|prevention|prevention
1109995|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
1109996|NCT02491671|Lung Resection|lung resection
1109997|NCT02491671|Thoracic Surgery|thoracic surgery
1109998|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
1109999|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
1110000|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
1110001|NCT02491645|Sensory interventions|sensory interventions
1110002|NCT02491645|occupational therapy|occupational therapy
1110003|NCT02491632|Advanced Cancers|advanced cancers
1110004|NCT02491632|Dexamethasone|dexamethasone
1110005|NCT02491632|Decadron|decadron
1110006|NCT02491632|Exercise|exercise
1110007|NCT02491632|Physical activity|physical activity
1110008|NCT02491632|Questionnaires|questionnaires
1110009|NCT02491632|Surveys|surveys
1110010|NCT02491632|Physical activity tests|physical activity tests
1110011|NCT02491632|Phone calls|phone calls
1110012|NCT02491619|Angle class III|angle class iii
1110013|NCT02491619|tomography|tomography
1110014|NCT02491619|tooth inclination|tooth inclination
1110015|NCT02491619|bone thickness|bone thickness
1110016|NCT02491593|fecal occult blood|fecal occult blood
1110017|NCT02491554|Deep Brain Stimulation|deep brain stimulation
1110018|NCT02491554|Essential tremor|essential tremor
1110019|NCT02491554|DISTINCT|distinct
1110020|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
1110021|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
1110022|NCT02491515|Osteoporosis|osteoporosis
1110024|NCT02491515|denosumab|denosumab
1110025|NCT02491515|previous therapy|previous therapy
1110026|NCT02491489|Manual therapy|manual therapy
1110027|NCT02491476|Safety|safety
1110028|NCT02491476|Electrodes|electrodes
1110029|NCT02491476|Device|device
1110030|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
1110031|NCT02491476|Epileptogenic zone|epileptogenic zone
1110032|NCT02491476|Fast ripples|fast ripples
1110033|NCT02491463|Reactogenicity|reactogenicity
1110034|NCT02491463|Safety|safety
1110035|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
1110036|NCT02491463|Vaccine|vaccine
1110037|NCT02491463|Immunogenicity|immunogenicity
1110038|NCT02491424|Osseointegration|osseointegration
1110039|NCT02491424|Direct skeletal attachment|direct skeletal attachment
1110040|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
1110041|NCT02491385|bowel function recovery|bowel function recovery
1110042|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
1110043|NCT02491333|acupuncture|acupuncture
1110044|NCT02491333|insulin resistance|insulin resistance
1110045|NCT02491333|HOMA-IR|homa-ir
1110046|NCT02491333|metformin|metformin
1110047|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
1110048|NCT02491320|acupuncture|acupuncture
1110049|NCT02491320|pre-treatment|pre-treatment
1110050|NCT02491320|Letrozole|letrozole
1110051|NCT02491320|Live Birth|live birth
1110052|NCT02491294|School|school
1110053|NCT02491294|Family|family
1110054|NCT02491294|Fruit and Vegetables|fruit and vegetables
1110055|NCT02491294|Cooking|cooking
1110056|NCT02491294|Physical Activity|physical activity
1110057|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
1110058|NCT02491242|HIV|hiv
1110059|NCT02491242|dolutegravir|dolutegravir
1110060|NCT02491242|intolerance|intolerance
1110061|NCT02491242|dual therapies|dual therapies
1110187|NCT02490085|Type 2 diabetes|type 2 diabetes
1110062|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1110063|NCT02491229|Obesity|obesity
1110064|NCT02491229|Hepafast|hepafast
1110065|NCT02491216|Frailty|frailty
1110066|NCT02491216|Frail elderly|frail elderly
1110067|NCT02491216|Acupressure|acupressure
1110068|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
1110069|NCT02491203|Virtual reality|virtual reality
1110070|NCT02491203|telerehabilitation|telerehabilitation
1110071|NCT02491203|Stroke rehabilitation|stroke rehabilitation
1110072|NCT02491177|HIV Transmission|hiv transmission
1110073|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1110074|NCT02491177|Linkage to care|linkage to care
1110075|NCT02491177|Retention in care|retention in care
1110076|NCT02491177|Community Mentor Mothers|community mentor mothers
1110077|NCT02491177|Mobile phone text messaging|mobile phone text messaging
1110078|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
1110079|NCT02491177|Infant Health|infant health
1110080|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
1110081|NCT02491177|Early infant diagnosis|early infant diagnosis
1110082|NCT02491177|Acceptability of interventions|acceptability of interventions
1110083|NCT02491177|Vertical transmission|vertical transmission
1110084|NCT02491138|participants|participants
1110085|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
1110086|NCT02491034|Depression|depression
1110087|NCT02491034|Hispanics|hispanics
1110088|NCT02491034|Stigma|stigma
1110089|NCT02491034|Barriers to Treatment|barriers to treatment
1110090|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
1110091|NCT02491008|Bone mineral density|bone mineral density
1110092|NCT02491008|Osteoporosis|osteoporosis
1110093|NCT02491008|Fractures, Bone|fractures, bone
1110094|NCT02491008|Randomized Controlled Trial|randomized controlled trial
1110095|NCT02490995|children|children
1110096|NCT02490969|copeptin|copeptin
1110097|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
1110098|NCT02490969|emergency department|emergency department
1110099|NCT02490969|chest pain unit|chest pain unit
1110100|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
1110101|NCT02490956|Primary immunodeficiency|primary immunodeficiency
1110102|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
1110103|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
1110104|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
1110105|NCT02490930|lymphopenia|lymphopenia
1110106|NCT02490917|Female urinary incontinence|female urinary incontinence
1110107|NCT02490917|Sphincter deficiency|sphincter deficiency
1110108|NCT02490904|Kidney transplantation|kidney transplantation
1110109|NCT02490904|Eplerenone|eplerenone
1110110|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
1110111|NCT02490839|Helicobacter pylori|helicobacter pylori
1110112|NCT02490839|high dose dual therapy|high dose dual therapy
1110113|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
1110114|NCT02490839|antibiotic resistance|antibiotic resistance
1110115|NCT02490826|Speech Sound Disorders|speech sound disorders
1110116|NCT02490826|Tabletop|tabletop
1110117|NCT02490826|Digital|digital
1110118|NCT02490813|Fish allergy|fish allergy
1110119|NCT02490813|shrimp allergy|shrimp allergy
1110120|NCT02490813|crab allergy|crab allergy
1110121|NCT02490813|traditional Chinese medicine|traditional chinese medicine
1110122|NCT02490761|Geriatrics|geriatrics
1110123|NCT02490761|Nutritional Status|nutritional status
1110124|NCT02490761|Hospitalisation|hospitalisation
1110125|NCT02490722|Patient education|patient education
1110126|NCT02490722|Empowerment|empowerment
1110127|NCT02490709|Rectal neoplasms|rectal neoplasms
1110128|NCT02490709|Colorectal neoplasms|colorectal neoplasms
1110129|NCT02490709|Local excision|local excision
1110130|NCT02490696|PET scan|pet scan
1110131|NCT02490696|FAZA|faza
1110132|NCT02490696|F-Miso|f-miso
1110133|NCT02490696|hypoxia|hypoxia
1110134|NCT02490696|lung cancer|lung cancer
1110135|NCT02490631|skin flora|skin flora
1110136|NCT02490605|Postural balance|postural balance
1110137|NCT02490605|Temporomandibular disorders|temporomandibular disorders
1110138|NCT02490605|Splints|splints
1110139|NCT02490579|video messaging|video messaging
1110140|NCT02490579|exercise|exercise
1110141|NCT02490579|diet|diet
1110142|NCT02490579|weight gain|weight gain
1110143|NCT02490579|pregnancy|pregnancy
1110144|NCT02490566|chronic condition|chronic condition
1110145|NCT02490566|telehealth|telehealth
1110146|NCT02490566|nutrition|nutrition
1110147|NCT02490566|exercise|exercise
1110148|NCT02490553|air pollution|air pollution
1110149|NCT02490553|epidemiological survey|epidemiological survey
1110150|NCT02490553|representative sample|representative sample
1110151|NCT02490540|opioids|opioids
1110152|NCT02490540|analgesia|analgesia
1110153|NCT02490540|pain|pain
1110154|NCT02490540|anesthesia|anesthesia
1110155|NCT02490527|myopathy|myopathy
1110156|NCT02490527|muscular weakness|muscular weakness
1110159|NCT02490488|ovarian cancer|ovarian cancer
1110160|NCT02490462|Cerebral Palsy|cerebral palsy
1110161|NCT02490462|Physical Therapy|physical therapy
1110162|NCT02490462|Family-centered Care|family-centered care
1110163|NCT02490384|Cervical cerclage|cervical cerclage
1110164|NCT02490345|gabapentin|gabapentin
1110165|NCT02490319|radiation pneumonitis|radiation pneumonitis
1110166|NCT02490319|lung cancer|lung cancer
1110167|NCT02490319|prediction models|prediction models
1110168|NCT02490319|genetic variants|genetic variants
1110169|NCT02490241|pregnant|pregnant
1110170|NCT02490241|female|female
1110171|NCT02490241|women|women
1110172|NCT02490241|lithium|lithium
1110173|NCT02490241|bipolar|bipolar
1110174|NCT02490228|female|female
1110175|NCT02490228|minimally invasive surgery|minimally invasive surgery
1110176|NCT02490150|Corifollitropin alfa|corifollitropin alfa
1110177|NCT02490150|Stimulation protocol|stimulation protocol
1110178|NCT02490124|Diabetes Type 1|diabetes type 1
1110179|NCT02490124|Vascular Function|vascular function
1110180|NCT02490098|Type 1 diabetes|type 1 diabetes
1110181|NCT02490098|Closed-loop system|closed-loop system
1110182|NCT02490098|Artificial pancreas|artificial pancreas
1110183|NCT02490098|Insulin|insulin
1110184|NCT02490098|Glucagon|glucagon
1110185|NCT02490098|Hypoglycemia|hypoglycemia
1110186|NCT02490098|Postprandial glucose|postprandial glucose
1110188|NCT02490085|Closed-loop strategy|closed-loop strategy
1110189|NCT02490085|Artificial pancreas|artificial pancreas
1110190|NCT02490085|Insulin|insulin
1110191|NCT02490085|Elderly|elderly
1110192|NCT02490085|Multiple daily injections|multiple daily injections
1110193|NCT02490085|Hypoglycemia|hypoglycemia
1110194|NCT02490046|D mannose|d mannose
1110195|NCT02490046|multiple sclerosis|multiple sclerosis
1110196|NCT02490046|recurrent urinary infections|recurrent urinary infections
1110197|NCT02490020|Renal transplantation|renal transplantation
1110198|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
1110199|NCT02490020|Transplantation Rejection|transplantation rejection
1110200|NCT02490020|donation after cardiac death|donation after cardiac death
1110201|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
1110202|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
1110203|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
1110204|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
1110205|NCT02489916|CM4307|cm4307
1110206|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
1110207|NCT02489903|Epigenetics|epigenetics
1110208|NCT02489903|resensitization|resensitization
1110209|NCT02489903|Platinum doublets|platinum doublets
1110211|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
1110212|NCT02489877|multiple sclerosis|multiple sclerosis
1110213|NCT02489877|HERV-W virus|herv-w virus
1110214|NCT02489877|Herpesviridae family|herpesviridae family
1110215|NCT02489864|Terlipressin|terlipressin
1110216|NCT02489864|mean arterial pressure|mean arterial pressure
1110217|NCT02489864|type 2 HRS|type 2 hrs
1110218|NCT02489838|Liver Neoplasma|liver neoplasma
1110219|NCT02489838|Lung Radiation dose|lung radiation dose
1110220|NCT02489825|randomized controlled trial|randomized controlled trial
1110221|NCT02489825|vertebral fracture|vertebral fracture
1110222|NCT02489825|osteoporosis|osteoporosis
1110223|NCT02489825|vertebroplasty|vertebroplasty
1110224|NCT02489825|augmentation|augmentation
1110225|NCT02489812|children|children
1110226|NCT02489812|behavior|behavior
1110227|NCT02489812|anxiety|anxiety
1110228|NCT02489812|dentistry|dentistry
1110229|NCT02489799|advance care planning|advance care planning
1110230|NCT02489773|Lucica|lucica
1110231|NCT02489773|glycated albumin|glycated albumin
1110232|NCT02489773|GA|ga
1110233|NCT02489773|fructosamine|fructosamine
1110234|NCT02489760|Etanercept|etanercept
1110235|NCT02489760|Adalimumab|adalimumab
1110236|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
1110237|NCT02489760|Switch Study|switch study
1110238|NCT02489747|cognitive function|cognitive function
1110239|NCT02489747|CNT|cnt
1110240|NCT02489747|memory function|memory function
1110241|NCT02489747|Triticum aestivum L|triticum aestivum l
1110242|NCT02489747|wheat bran|wheat bran
1110243|NCT02489734|sevoflurane|sevoflurane
1110244|NCT02489734|emergence delirium|emergence delirium
1110245|NCT02489734|preschool|preschool
1110246|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
1110247|NCT02489721|depp vein thrombosis|depp vein thrombosis
1110248|NCT02489721|related blood stream infections|related blood stream infections
1110249|NCT02489721|midline|midline
1110250|NCT02489708|Bronchiolitis|bronchiolitis
1110251|NCT02489708|Cough|cough
1110252|NCT02489708|Ear Infection|ear infection
1110253|NCT02489708|Respiratory Infection|respiratory infection
1110254|NCT02489708|Wheezing|wheezing
1110255|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
1110256|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
1110257|NCT02489656|Double loop ureteral stent|double loop ureteral stent
1110258|NCT02489656|USSQ|ussq
1110259|NCT02489656|Quality of life|quality of life
1110260|NCT02489656|Pain|pain
1110363|NCT02488915|Ischemia|ischemia
1110261|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
1110262|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
1110263|NCT02489578|health care associated pneumonia|health care associated pneumonia
1110264|NCT02489565|Coronary Artery Disease|coronary artery disease
1110265|NCT02489565|stable|stable
1110266|NCT02489565|Telemedicine|telemedicine
1110267|NCT02489565|Patient Discharge|patient discharge
1110268|NCT02489539|Aortic aneurysm|aortic aneurysm
1110269|NCT02489539|Abdominal aorta|abdominal aorta
1110270|NCT02489539|Stent graft|stent graft
1110271|NCT02489539|Aneurysm|aneurysm
1110272|NCT02489539|Vascular Diseases|vascular diseases
1110273|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
1110274|NCT02489500|AL Amyloidosis|al amyloidosis
1110275|NCT02489500|Stem Cell Transplantation|stem cell transplantation
1110276|NCT02489448|Breast Cancer|breast cancer
1110277|NCT02489383|Asthma|asthma
1110278|NCT02489383|Continuous Exercise Training|continuous exercise training
1110279|NCT02489383|interval Exercise Training|interval exercise training
1110280|NCT02489383|Clinical Control|clinical control
1110281|NCT02489383|Inflammation|inflammation
1110282|NCT02489370|home care|home care
1110283|NCT02489370|telecare|telecare
1110284|NCT02489370|telehealth|telehealth
1110285|NCT02489370|telemonitoring|telemonitoring
1110286|NCT02489370|chronic heart failure|chronic heart failure
1110287|NCT02489370|randomized controlled trial|randomized controlled trial
1110288|NCT02489370|Congestive Heart Failure|congestive heart failure
1110289|NCT02489370|telemedicine|telemedicine
1110290|NCT02489331|Dyslipidemias|dyslipidemias
1110291|NCT02489318|Prostate Cancer|prostate cancer
1110292|NCT02489318|JNJ-56021927|jnj-56021927
1110293|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
1110294|NCT02489318|ARN-509|arn-509
1110295|NCT02489318|Apalutamide|apalutamide
1110296|NCT02489318|TITAN|titan
1110297|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
1110298|NCT02489305|Depressive Disorder, Major|depressive disorder, major
1110299|NCT02489305|Depression|depression
1110300|NCT02489305|Anti-Depressant|anti-depressant
1110301|NCT02489305|Observational|observational
1110302|NCT02489292|Urea Cycle Disorder|urea cycle disorder
1110303|NCT02489292|UCD|ucd
1110304|NCT02489292|cell therapy|cell therapy
1110305|NCT02489292|stem cell|stem cell
1110306|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
1110307|NCT02489279|Attention training|attention training
1110308|NCT02489279|Mobile devices|mobile devices
1110309|NCT02489279|Brain training|brain training
1110310|NCT02489266|Melanoma|melanoma
1110311|NCT02489266|Immunotherapy|immunotherapy
1110312|NCT02489227|PsO|pso
1110313|NCT02489214|donafenib|donafenib
1110314|NCT02489201|donafenib|donafenib
1110315|NCT02489188|gait asymmetry|gait asymmetry
1110316|NCT02489188|joint angles|joint angles
1110317|NCT02489175|Parastomal hernia|parastomal hernia
1110318|NCT02489175|prevention|prevention
1110319|NCT02489175|stomaplasty|stomaplasty
1110320|NCT02489175|ring|ring
1110321|NCT02489149|food insecurity|food insecurity
1110322|NCT02489136|spiritist passe|spiritist passe
1110323|NCT02489136|laying of hands|laying of hands
1110324|NCT02489136|newborn|newborn
1110325|NCT02489136|adult|adult
1110326|NCT02489136|conditions|conditions
1110327|NCT02489110|Alzheimer's Disease|alzheimer's disease
1110328|NCT02489110|Dementia|dementia
1110329|NCT02489110|caregiving|caregiving
1110330|NCT02489110|caregiver|caregiver
1110331|NCT02489110|coping|coping
1110332|NCT02489110|coping with caregiving|coping with caregiving
1110333|NCT02489110|stress|stress
1110334|NCT02489110|Hispanic caregiver|hispanic caregiver
1110335|NCT02489110|Latino caregiver|latino caregiver
1110336|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
1110337|NCT02489084|Genome-wide association study|genome-wide association study
1110338|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
1110339|NCT02489084|Toxicity|toxicity
1110340|NCT02489019|Anesthesia|anesthesia
1110341|NCT02489019|Fentanyl|fentanyl
1110342|NCT02489019|Elderly|elderly
1110343|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
1110344|NCT02488954|Ulcerative colitis|ulcerative colitis
1110345|NCT02488954|Probiotics|probiotics
1110346|NCT02488954|treatments|treatments
1110347|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
1110348|NCT02488941|Liver Function Tests|liver function tests
1110349|NCT02488941|Blood Coagulation|blood coagulation
1110350|NCT02488928|NSCLC|nsclc
1110351|NCT02488928|EBUS|ebus
1161900|NCT02207725|PRT4445|prt4445
1110352|NCT02488928|elastography|elastography
1110353|NCT02488928|predictive value|predictive value
1110354|NCT02488928|strain|strain
1110355|NCT02488915|Brain|brain
1110356|NCT02488915|Brain Clot|brain clot
1110357|NCT02488915|Brain Diseases|brain diseases
1110358|NCT02488915|Brain Infarction|brain infarction
1110359|NCT02488915|Cerebral Ischemia|cerebral ischemia
1110360|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
1110361|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
1110362|NCT02488915|EmboTrap|embotrap
1110365|NCT02488915|Ischemic Stroke|ischemic stroke
1110366|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
1110367|NCT02488915|Neurovascular Intervention|neurovascular intervention
1110368|NCT02488915|Revascularization|revascularization
1110369|NCT02488915|Stent Retriever|stent retriever
1110370|NCT02488915|Stroke|stroke
1110371|NCT02488915|Vascular Diseases|vascular diseases
1110372|NCT02488915|Neuravi|neuravi
1110373|NCT02488889|Chantix|chantix
1110374|NCT02488876|Cardiac surgery|cardiac surgery
1110375|NCT02488876|Tissue sample database|tissue sample database
1110376|NCT02488876|Inflammatory responds|inflammatory responds
1110377|NCT02488863|Older adults|older adults
1110378|NCT02488863|Chronic Pain|chronic pain
1110379|NCT02488863|Musculoskeletal|musculoskeletal
1110380|NCT02488850|immune monitoring|immune monitoring
1110381|NCT02488850|T cell activation|t cell activation
1110382|NCT02488850|early stage|early stage
1110383|NCT02488837|Deep Brain Stimulation|deep brain stimulation
1110384|NCT02488824|Quadriplegia|quadriplegia
1110385|NCT02488824|Paraplegia|paraplegia
1110386|NCT02488824|Spinal Cord Injury|spinal cord injury
1110387|NCT02488824|Body Temperature Regulation|body temperature regulation
1110388|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
1110389|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1110390|NCT02488785|Telehealth|telehealth
1110391|NCT02488785|Hispanics|hispanics
1110392|NCT02488785|Latinos|latinos
1110393|NCT02488785|Self-Care|self-care
1110394|NCT02488785|Mobile Health|mobile health
1110395|NCT02488785|mHealth|mhealth
1110396|NCT02488772|sleep quality|sleep quality
1110397|NCT02488772|emergency department|emergency department
1110398|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
1110399|NCT02488733|obesity|obesity
1110400|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
1110401|NCT02488733|bariatric surgery|bariatric surgery
1110402|NCT02488733|metabolic surgery|metabolic surgery
1110403|NCT02488720|amyloid imaging|amyloid imaging
1110404|NCT02488720|biomarkers|biomarkers
1110405|NCT02488720|cognition|cognition
1110406|NCT02488720|longitudinal|longitudinal
1110407|NCT02488720|cognitive decline|cognitive decline
1110408|NCT02488720|observational|observational
1110409|NCT02488707|low rectal cancer|low rectal cancer
1110410|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
1110411|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
1110412|NCT02488707|TEM|tem
1110413|NCT02488707|intersphincteric resection|intersphincteric resection
1110414|NCT02488707|ISR|isr
1110415|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
1110416|NCT02488707|total intersphincteric resection|total intersphincteric resection
1110417|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
1110418|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
1110419|NCT02488707|anal sphincter preservation|anal sphincter preservation
1110420|NCT02488707|total mesorectal excision|total mesorectal excision
1110421|NCT02488707|TME|tme
1110422|NCT02488707|TATA|tata
1110423|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
1110424|NCT02488707|external sphincter preservation|external sphincter preservation
1110425|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
1110426|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
1110427|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
1110428|NCT02488668|Neuroplasticity|neuroplasticity
1110429|NCT02488668|Sensory Feedback|sensory feedback
1110430|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
1110431|NCT02488642|late intrauterine death|late intrauterine death
1110432|NCT02488642|nitric oxide donors|nitric oxide donors
1110433|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1110434|NCT02488616|Closed-loop system|closed-loop system
1110435|NCT02488616|Artificial pancreas|artificial pancreas
1110436|NCT02488616|Type 1 diabetes|type 1 diabetes
1110437|NCT02488616|Hypoglycemia|hypoglycemia
1110438|NCT02488616|Insulin|insulin
1110439|NCT02488603|Breast Neoplasms|breast neoplasms
1110440|NCT02488603|Tamoxifen|tamoxifen
1110441|NCT02488603|Decision Aids|decision aids
1110442|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1110443|NCT02488564|operable breast cancer|operable breast cancer
1110444|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
1110445|NCT02488564|no prior therapy|no prior therapy
1110446|NCT02488564|pCR|pcr
1110447|NCT02488525|Acquired Von Willebrand|acquired von willebrand
1110448|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
1110449|NCT02488525|LVAD|lvad
1110450|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
1110451|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
1110452|NCT02488512|DLBCL|dlbcl
1110453|NCT02488512|MCL|mcl
1110454|NCT02488512|90Y-DOTATOC|90y-dotatoc
1110455|NCT02488512|SSR-positive tumour|ssr-positive tumour
1110456|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
1110457|NCT02488499|Psychosocial|psychosocial
1110458|NCT02488499|Group Treatment|group treatment
1110460|NCT02488460|Motor Activity|motor activity
1110461|NCT02488460|Cognition|cognition
1110462|NCT02488460|Academic Acheivement|academic acheivement
1110463|NCT02488460|Preadolescent Children|preadolescent children
1110464|NCT02488447|Allergy|allergy
1110465|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1110466|NCT02488447|Immunotherapy|immunotherapy
1110467|NCT02488447|Life Quality|life quality
1110468|NCT02488447|Adherence|adherence
1110469|NCT02488434|ICSI|icsi
1110470|NCT02488434|sperm selection|sperm selection
1110471|NCT02488434|fertile chip|fertile chip
1110472|NCT02488434|ıcsı outcomes|ıcsı outcomes
1110473|NCT02488395|Parkinson's disease|parkinson's disease
1110474|NCT02488395|Non-motor symptoms|non-motor symptoms
1110475|NCT02488395|Visual deficits|visual deficits
1110476|NCT02488395|Superior colliculus|superior colliculus
1110477|NCT02488395|fMRI|fmri
1110478|NCT02488382|lymphoma|lymphoma
1110479|NCT02488382|multiple myeloma|multiple myeloma
1110480|NCT02488382|stem cell mobilization|stem cell mobilization
1110481|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
1110482|NCT02488369|Children and adolescents|children and adolescents
1110483|NCT02488343|Multiple Sclerosis|multiple sclerosis
1110484|NCT02488343|Adherence|adherence
1110485|NCT02488343|Therapies|therapies
1110486|NCT02488343|Psychological Intervention|psychological intervention
1110487|NCT02488317|Chronic Kidney Disease|chronic kidney disease
1110488|NCT02488317|Hemodialysis|hemodialysis
1110489|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
1110490|NCT02488304|HRCT|hrct
1110491|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
1110492|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
1110493|NCT02488304|FRI|fri
1110494|NCT02488304|Computed Tomography|computed tomography
1110495|NCT02488304|CT|ct
1110496|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1110497|NCT02488304|BOS|bos
1110498|NCT02488304|Lung Transplant|lung transplant
1110499|NCT02488291|Epidural|epidural
1110500|NCT02488291|Analgesia labor|analgesia labor
1110501|NCT02488291|Perinatal|perinatal
1110502|NCT02488291|anesthesia|anesthesia
1110503|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
1110504|NCT02488265|Parkinson´s disease|parkinson´s disease
1110505|NCT02488265|Physicaltherapy|physicaltherapy
1110506|NCT02488265|Postural Balance|postural balance
1110507|NCT02488265|Gait|gait
1110508|NCT02488265|Rehabilitation|rehabilitation
1110509|NCT02488252|Chinese Medicine|chinese medicine
1110510|NCT02488252|ACEI|acei
1110511|NCT02488252|ARB|arb
1110512|NCT02488252|Pragmatic trial|pragmatic trial
1110513|NCT02488213|Nutritional Counseling|nutritional counseling
1110514|NCT02488213|Diet|diet
1110515|NCT02488187|Breast Cancer|breast cancer
1110516|NCT02488187|MRI|mri
1110517|NCT02488187|Mammogram|mammogram
1110518|NCT02488187|Whole Breast Sonogram|whole breast sonogram
1110519|NCT02488187|ABUS|abus
1110520|NCT02488161|Colorectal cancer|colorectal cancer
1110521|NCT02488161|Risk factors|risk factors
1110522|NCT02488161|Adverse events|adverse events
1110523|NCT02488161|Predictive models|predictive models
1110524|NCT02488122|Bone Mineral Density|bone mineral density
1110525|NCT02488122|Isometric Exercise|isometric exercise
1110526|NCT02488122|Bone Growth|bone growth
1110527|NCT02488109|anorexia nervosa|anorexia nervosa
1110528|NCT02488109|eating disorders|eating disorders
1110529|NCT02488109|refeeding|refeeding
1110530|NCT02488109|adolescent medicine|adolescent medicine
1110531|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
1110532|NCT02488083|non-invasive|non-invasive
1110533|NCT02488031|SCA, dysmetria|sca, dysmetria
1110534|NCT02488018|Glycemic index|glycemic index
1110535|NCT02488018|honey|honey
1110536|NCT02488018|reference glucose|reference glucose
1110537|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
1110538|NCT02488005|Small Bowel|small bowel
1110539|NCT02488005|Crohn's Disease|crohn's disease
1110540|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
1110541|NCT02487966|tDCS|tdcs
1110542|NCT02487966|Mirror Therapy|mirror therapy
1110543|NCT02487966|Phantom Limb Pain|phantom limb pain
1110544|NCT02487966|Traumatic amputation|traumatic amputation
1110545|NCT02487953|Nicotine addiction|nicotine addiction
1110546|NCT02487953|Cigarette smoking|cigarette smoking
1110547|NCT02487953|Smoking cessation|smoking cessation
1110548|NCT02487953|Nicotine patches|nicotine patches
1110549|NCT02487953|E-cigarettes|e-cigarettes
1110550|NCT02487940|Recurrent implantation failure|recurrent implantation failure
1110551|NCT02487940|IVF|ivf
1110552|NCT02487940|ICSI|icsi
1110553|NCT02487940|Intralipid|intralipid
1110554|NCT02487914|Drug Delivery|drug delivery
1110555|NCT02487914|Iontophoresis|iontophoresis
1110556|NCT02487914|Lidocaine|lidocaine
1110557|NCT02487914|Pressure|pressure
1110558|NCT02487914|Tactile perception|tactile perception
1110559|NCT02487901|arthrodesiss|arthrodesiss
1110560|NCT02487901|cervical vertebra|cervical vertebra
1110561|NCT02487901|laminoplasty|laminoplasty
1110659|NCT02487290|Endoleak|endoleak
1110562|NCT02487888|Genetic Variation|genetic variation
1110563|NCT02487888|Genetic Polymorphism|genetic polymorphism
1110564|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1110565|NCT02487888|Genetic Association Studies|genetic association studies
1110566|NCT02487888|Healthcare Utilization|healthcare utilization
1110567|NCT02487875|Sit-to-stand test|sit-to-stand test
1110568|NCT02487875|Muscle strength|muscle strength
1110569|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
1110570|NCT02487836|Laying of the biliary stent|laying of the biliary stent
1110572|NCT02487771|childhood development|childhood development
1110573|NCT02487745|Cocaine|cocaine
1110574|NCT02487745|Methadone|methadone
1110575|NCT02487745|Employment|employment
1110576|NCT02487745|Opioids|opioids
1110577|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
1110578|NCT02487719|Iron deficiecy|iron deficiecy
1110579|NCT02487719|pregnancy|pregnancy
1110580|NCT02487719|prenatal care|prenatal care
1110581|NCT02487706|Hemodialysis|hemodialysis
1110582|NCT02487706|HIV-infection|hiv-infection
1110583|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1110584|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
1110585|NCT02487654|Ganglionic plexi|ganglionic plexi
1110586|NCT02487654|Radiofrequency|radiofrequency
1110587|NCT02487654|late gadolinium enhancement cardiac MR imaging|late gadolinium enhancement cardiac mr imaging
1110588|NCT02487654|High Frequency Stimulation|high frequency stimulation
1110589|NCT02487641|Ultrasound|ultrasound
1110590|NCT02487641|mid-trimester|mid-trimester
1110591|NCT02487641|Obesity|obesity
1110592|NCT02487641|pregnancy|pregnancy
1110593|NCT02487615|Glycaemia|glycaemia
1110594|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
1110595|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
1110596|NCT02487615|Carotid Plaque|carotid plaque
1110597|NCT02487615|Intima Media Thickness|intima media thickness
1110598|NCT02487615|Ankle Brachial Index|ankle brachial index
1110599|NCT02487615|Exercise Stress Test|exercise stress test
1110600|NCT02487615|Coronary Calcium Score|coronary calcium score
1110601|NCT02487615|Insulinemia|insulinemia
1110602|NCT02487615|Leptin|leptin
1110603|NCT02487615|Inflammation|inflammation
1110604|NCT02487615|Resistin|resistin
1110605|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
1110606|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
1110607|NCT02487615|Body Mass Index|body mass index
1110608|NCT02487615|Adipose Tissue Function|adipose tissue function
1110609|NCT02487615|Single Gene Polymorphism|single gene polymorphism
1110610|NCT02487589|Falls|falls
1110611|NCT02487589|Elderly|elderly
1110612|NCT02487589|e-Health|e-health
1110613|NCT02487589|Telemedicine|telemedicine
1110614|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
1110615|NCT02487563|decitabine|decitabine
1110616|NCT02487563|rhTPO|rhtpo
1110617|NCT02487550|Renal neoplasma|renal neoplasma
1110618|NCT02487550|CIK cells|cik cells
1110619|NCT02487537|incretin release|incretin release
1110620|NCT02487524|Neuropathic Pain|neuropathic pain
1110621|NCT02487524|Breast Cancer|breast cancer
1110622|NCT02487524|Post surgical|post surgical
1110623|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1110624|NCT02487472|France|france
1110625|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
1110626|NCT02487472|Herpes zoster|herpes zoster
1110627|NCT02487472|Economic burden of disease|economic burden of disease
1110628|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1110629|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
1110630|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
1110631|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
1110632|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
1110633|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
1110634|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1110635|NCT02487433|food effect|food effect
1110636|NCT02487433|pharmacokinetics|pharmacokinetics
1110637|NCT02487433|healthy volunteers|healthy volunteers
1110638|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
1110639|NCT02487381|cannabidiol|cannabidiol
1110640|NCT02487381|COMT|comt
1162278|NCT02205814|WOMAC|womac
1110641|NCT02487381|Volunteers|volunteers
1110642|NCT02487355|dexmedetomidine|dexmedetomidine
1110643|NCT02487355|magnesium sulphate|magnesium sulphate
1110644|NCT02487342|Dairy|dairy
1110645|NCT02487342|appetite|appetite
1110646|NCT02487342|feeding behaviour|feeding behaviour
1110647|NCT02487329|Direct pulp capping|direct pulp capping
1110648|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
1110649|NCT02487329|Tricalcium silicate|tricalcium silicate
1110650|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1110651|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
1110652|NCT02487316|crizotinib|crizotinib
1110653|NCT02487316|CHOP chemotherapy|chop chemotherapy
1110654|NCT02487303|Acetaminophen|acetaminophen
1110655|NCT02487303|Pain, Postoperative|pain, postoperative
1110656|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
1110657|NCT02487303|Cesarean Section|cesarean section
1110662|NCT02487251|Family Mealtimes|family mealtimes
1110663|NCT02487251|Prevention|prevention
1110664|NCT02487238|Microbiome|microbiome
1110665|NCT02487238|Microbiota|microbiota
1110666|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
1110667|NCT02487238|Fecal Microbiota Transplant|fecal microbiota transplant
1110668|NCT02487238|FMT|fmt
1110669|NCT02487238|Gastroenterology|gastroenterology
1110670|NCT02487238|IBD|ibd
1110671|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
1110672|NCT02487238|Ulcerative Colitis|ulcerative colitis
1110673|NCT02487238|UC|uc
1110674|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
1110675|NCT02487238|IBD-U|ibd-u
1110676|NCT02487238|Rebiotix|rebiotix
1110677|NCT02487238|RBX2660|rbx2660
1110678|NCT02487238|Pediatrics|pediatrics
1110679|NCT02487238|McMaster Children's Hospital|mcmaster children's hospital
1110680|NCT02487238|Centre Hospitalier Universitaire Sainte-Justine|centre hospitalier universitaire sainte-justine
1110681|NCT02487238|Children's Hospital at London Health Sciences Centre|children's hospital at london health sciences centre
1110682|NCT02487212|fractional laser|fractional laser
1110683|NCT02487212|hypertrophic scar|hypertrophic scar
1110684|NCT02487212|topical corticosteroid|topical corticosteroid
1110685|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
1110686|NCT02487199|hepatitis C infection|hepatitis c infection
1110687|NCT02487199|hepatitis C|hepatitis c
1110688|NCT02487199|severe kidney disease|severe kidney disease
1110689|NCT02487199|chronic kidney disease|chronic kidney disease
1110690|NCT02487199|Genotype 1a|genotype 1a
1110691|NCT02487199|Genotype 4|genotype 4
1110692|NCT02487199|treatment experienced|treatment experienced
1110693|NCT02487199|interferon|interferon
1110694|NCT02487199|IFN|ifn
1110695|NCT02487199|pegIFN|pegifn
1110696|NCT02487186|Chronic periodontitis|chronic periodontitis
1110697|NCT02487186|Local doxycycline|local doxycycline
1110698|NCT02487186|Ultrasonic debridement|ultrasonic debridement
1110699|NCT02487186|PLGA microspheres|plga microspheres
1110700|NCT02487186|Microbiologic assessment|microbiologic assessment
1110701|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
1110702|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
1110703|NCT02487147|N95 Respirator|n95 respirator
1110704|NCT02487147|Personal Protective Equipment|personal protective equipment
1110705|NCT02487147|Viral Transmission|viral transmission
1110706|NCT02487121|weight loss|weight loss
1110707|NCT02487095|RB1 Inactivation|rb1 inactivation
1110708|NCT02487095|Kinase Inhibitor|kinase inhibitor
1110709|NCT02487095|DNA Damage Response Network|dna damage response network
1110710|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
1110711|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
1110712|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
1110713|NCT02487082|Children|children
1110714|NCT02487082|Melatonin|melatonin
1110715|NCT02487082|Donepezil|donepezil
1110716|NCT02487082|Sleep disorder|sleep disorder
1110717|NCT02487056|Heart Failure|heart failure
1110718|NCT02487056|Diagnosis|diagnosis
1110719|NCT02487056|Management|management
1110720|NCT02487043|Caries prevention|caries prevention
1110721|NCT02487043|Early Childhood Caries|early childhood caries
1110722|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
1110724|NCT02487030|Sustained Virologic Response|sustained virologic response
1110725|NCT02487030|Direct Acting Antiviral|direct acting antiviral
1110726|NCT02487030|Combination Therapy|combination therapy
1110727|NCT02487030|GS-7977|gs-7977
1110728|NCT02487030|GS-5885|gs-5885
1110729|NCT02487030|Ribavirin|ribavirin
1110730|NCT02487030|Sofosbuvir|sofosbuvir
1110731|NCT02487030|ledipasvir|ledipasvir
1110732|NCT02487030|Hepatitis C|hepatitis c
1110733|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
1110734|NCT02487030|Liver Diseases|liver diseases
1110735|NCT02487030|Virus Diseases|virus diseases
1110736|NCT02487030|Antiviral Agents|antiviral agents
1110737|NCT02486965|VAS|vas
1110738|NCT02486965|thermode test|thermode test
1110739|NCT02486965|training program|training program
1110740|NCT02486965|6MWT|6mwt
1110741|NCT02486913|Primary prevention|primary prevention
1110742|NCT02486913|National Health Service Health Check|national health service health check
1110743|NCT02486900|Craving|craving
1110744|NCT02486900|Cue Reactivity|cue reactivity
1110745|NCT02486900|Neurofeedback|neurofeedback
1110746|NCT02486887|telemonitoring|telemonitoring
1110747|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
1110748|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
1110749|NCT02486848|Hairloss|hairloss
1110750|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
1110751|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
1110752|NCT02486848|Minoxidil|minoxidil
1110753|NCT02486822|Labor scale|labor scale
1110754|NCT02486822|Partograph|partograph
1110755|NCT02486822|Spontaneous labor|spontaneous labor
1110756|NCT02486822|Primigravida|primigravida
1110757|NCT02486744|Acthar|acthar
1110758|NCT02486744|Dialysis|dialysis
1110759|NCT02486744|Kidney|kidney
1110760|NCT02486744|Non-Diabetic|non-diabetic
1110761|NCT02486731|Hormonal sensitivity|hormonal sensitivity
1110762|NCT02486731|bone growth|bone growth
1110763|NCT02486705|ptsd|ptsd
1110764|NCT02486705|family|family
1110765|NCT02486705|caregiver|caregiver
1110766|NCT02486705|burden|burden
1110767|NCT02486692|Mental Health|mental health
1110768|NCT02486692|PTSD|ptsd
1110769|NCT02486692|Stigma|stigma
1110770|NCT02486692|Peer Education|peer education
1110771|NCT02486692|Web Education|web education
1110772|NCT02486692|Self Help|self help
1110773|NCT02486653|tamsulosin|tamsulosin
1110774|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
1110775|NCT02486653|double-blind method|double-blind method
1110776|NCT02486653|random allocation|random allocation
1110777|NCT02486653|placebos|placebos
1110778|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
1110779|NCT02486653|urinary retention|urinary retention
1110780|NCT02486653|urinary tract infections|urinary tract infections
1110781|NCT02486653|urinary catheters|urinary catheters
1110782|NCT02486653|catheter-related infections|catheter-related infections
1110783|NCT02486653|postoperative complications|postoperative complications
1110784|NCT02486640|RRMS, CIS|rrms, cis
1110785|NCT02486627|cUTI|cuti
1110786|NCT02486627|AP|ap
1110787|NCT02486627|ACHN-490|achn-490
1110788|NCT02486627|anti-infective|anti-infective
1110789|NCT02486627|anti-bacterial|anti-bacterial
1110790|NCT02486627|antibiotic|antibiotic
1110791|NCT02486627|anti-microbial|anti-microbial
1110792|NCT02486627|UTI|uti
1110793|NCT02486627|bacterial infection|bacterial infection
1110794|NCT02486627|Gram-negative|gram-negative
1110795|NCT02486588|Financial incentives|financial incentives
1110796|NCT02486588|Messaging|messaging
1110797|NCT02486575|Residents|residents
1110798|NCT02486575|Training|training
1110799|NCT02486575|simulation|simulation
1110800|NCT02486575|mentoring|mentoring
1110801|NCT02486575|proctor|proctor
1110802|NCT02486562|Multiple Sclerosis|multiple sclerosis
1110803|NCT02486562|MS|ms
1110804|NCT02486549|Pain|pain
1110805|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
1110806|NCT02486549|Brachial Plexus|brachial plexus
1110807|NCT02486536|capsule endoscopy|capsule endoscopy
1110808|NCT02486536|polyethylene glycol|polyethylene glycol
1110809|NCT02486536|bowel preparation solutions|bowel preparation solutions
1110810|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
1110811|NCT02486510|HIV-1|hiv-1
1110812|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
1110813|NCT02486510|Maraviroc|maraviroc
1110814|NCT02486497|Pancreatic cancer|pancreatic cancer
1110815|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
1110816|NCT02486497|hENT1|hent1
1110817|NCT02486497|Gemcitabine|gemcitabine
1110818|NCT02486484|macular degeneration|macular degeneration
1110819|NCT02486484|diabetic retinopathy|diabetic retinopathy
1110820|NCT02486484|macular edema|macular edema
1110821|NCT02486484|retinal vein occlusion|retinal vein occlusion
1110822|NCT02486484|choroidal neovascularization|choroidal neovascularization
1110823|NCT02486471|cervical dysplasia|cervical dysplasia
1110824|NCT02486471|colposcopy|colposcopy
1110825|NCT02486471|haemostatic procedure|haemostatic procedure
1110826|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
1110827|NCT02486458|Fluoride|fluoride
1110828|NCT02486458|Biofilm fluid|biofilm fluid
1110829|NCT02486458|Calcium fluoride|calcium fluoride
1110830|NCT02486458|Topical|topical
1110831|NCT02486445|Deep venous thrombosis|deep venous thrombosis
1110832|NCT02486445|Rivaroxaban|rivaroxaban
1110833|NCT02486406|Hepatitis C Virus|hepatitis c virus
1110834|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
1110835|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
1110836|NCT02486406|Pediatric|pediatric
1110837|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
1110838|NCT02486341|basal insulin|basal insulin
1110839|NCT02486341|diabetes mellitus|diabetes mellitus
1110840|NCT02486341|elderly|elderly
1110841|NCT02486328|Cognitive dysfunction|cognitive dysfunction
1110842|NCT02486328|Colonoscopy|colonoscopy
1110843|NCT02486328|Sedation|sedation
1110844|NCT02486315|coronary bifurcation|coronary bifurcation
1110845|NCT02486315|coronary stent|coronary stent
1110846|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
1110847|NCT02486263|infant|infant
1110848|NCT02486263|esophagitis|esophagitis
1110849|NCT02486263|neonate|neonate
1110850|NCT02486263|GERD|gerd
1110851|NCT02486237|diabetes mellitus|diabetes mellitus
1110852|NCT02486237|complications|complications
1110853|NCT02486237|prevalence|prevalence
1110854|NCT02486224|deep sea mineral water|deep sea mineral water
1110855|NCT02486224|exercise recovery|exercise recovery
1110856|NCT02486224|hydration|hydration
1110857|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
1110858|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
1110859|NCT02486211|heart arrest|heart arrest
1110860|NCT02486211|resuscitation|resuscitation
1110861|NCT02486211|seizures|seizures
1110862|NCT02486211|hypothermia, induced|hypothermia, induced
1110863|NCT02486211|Amantadine|amantadine
1111568|NCT02482298|Hestia2|hestia2
1110864|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
1110865|NCT02486198|oxaliplatin|oxaliplatin
1110866|NCT02486198|neurotoxicity|neurotoxicity
1110867|NCT02486120|Genetic Counseling|genetic counseling
1110868|NCT02486120|Clinical Decision-Making|clinical decision-making
1110869|NCT02486107|cervical vertebra|cervical vertebra
1110870|NCT02486107|surgery|surgery
1110871|NCT02486107|tubular retractor|tubular retractor
1110872|NCT02486107|endoscope|endoscope
1110873|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
1110874|NCT02486094|Rectal Cancer|rectal cancer
1110875|NCT02486094|Apoptosis|apoptosis
1110876|NCT02486094|Proliferation|proliferation
1110877|NCT02486094|Cancer|cancer
1110878|NCT02486094|Tissue Study|tissue study
1110879|NCT02486081|Assistive device|assistive device
1110880|NCT02486081|the disabled|the disabled
1110881|NCT02486081|special education|special education
1110882|NCT02486081|movement analysis|movement analysis
1110883|NCT02486081|system development|system development
1110884|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
1110885|NCT02486042|ROP|rop
1110886|NCT02486042|Premature infant|premature infant
1110887|NCT02486016|Bioequivalence|bioequivalence
1110888|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
1110889|NCT02485990|Fallopian Tube|fallopian tube
1110890|NCT02485990|Epithelial Ovarian|epithelial ovarian
1110891|NCT02485990|EOC|eoc
1110892|NCT02485977|Pulmonary hypertension|pulmonary hypertension
1110893|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
1110894|NCT02485964|Vaccine|vaccine
1110895|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
1110896|NCT02485951|big-bubble technique|big-bubble technique
1110897|NCT02485951|peripheral air injection|peripheral air injection
1110898|NCT02485951|keratoconus|keratoconus
1110899|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1110900|NCT02485938|Cardiomyopathy|cardiomyopathy
1110901|NCT02485925|Interventional|interventional
1110902|NCT02485925|Radiofrequency ablation|radiofrequency ablation
1110903|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1110904|NCT02485925|Catheter ablation|catheter ablation
1110905|NCT02485912|Ebola|ebola
1110906|NCT02485912|vaccine|vaccine
1110907|NCT02485912|safety|safety
1110908|NCT02485912|immunogenicity|immunogenicity
1110909|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
1110910|NCT02485899|LINCL|lincl
1110911|NCT02485899|NCL2|ncl2
1110912|NCT02485899|CLN2|cln2
1110913|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
1110914|NCT02485886|PET|pet
1110915|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
1110916|NCT02485886|cysteine cathepsins|cysteine cathepsins
1110917|NCT02485886|macrophage|macrophage
1110918|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
1110919|NCT02485873|Pevention|pevention
1110920|NCT02485873|Stroke|stroke
1110921|NCT02485860|pilonidal cysts|pilonidal cysts
1110922|NCT02485860|Cavity wound|cavity wound
1110923|NCT02485860|long healing|long healing
1110924|NCT02485860|honey|honey
1110925|NCT02485847|Eye Diseases|eye diseases
1110926|NCT02485821|Estradiol|estradiol
1110927|NCT02485821|Misoprostol|misoprostol
1110928|NCT02485821|Induction of labor|induction of labor
1110929|NCT02485821|Cervical ripening|cervical ripening
1110930|NCT02485821|Bishop score|bishop score
1110931|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1110932|NCT02485808|Bladder Symptoms|bladder symptoms
1110933|NCT02485808|Overactive Bladder|overactive bladder
1110934|NCT02485808|Urinary Urgency|urinary urgency
1110935|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
1110936|NCT02485795|Pain Management|pain management
1110937|NCT02485795|Genetic Variation|genetic variation
1110938|NCT02485795|Genetic Polymorphism|genetic polymorphism
1110939|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
1110940|NCT02485795|Healthcare Utilization|healthcare utilization
1110941|NCT02485756|Drug interactions|drug interactions
1110942|NCT02485743|satiation|satiation
1110943|NCT02485743|satiety|satiety
1110944|NCT02485743|weight loss|weight loss
1110945|NCT02485743|maintained weight loss|maintained weight loss
1110946|NCT02485730|Prevention|prevention
1110947|NCT02485730|Cohort Analysis|cohort analysis
1110948|NCT02485730|Healthy Participants|healthy participants
1110949|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
1110950|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
1110951|NCT02485665|Prostate cancer|prostate cancer
1110952|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
1110953|NCT02485665|Radical prostatectomy|radical prostatectomy
1110954|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
1110955|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
1110956|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
1110957|NCT02485652|NSCLC|nsclc
1110958|NCT02485652|EGFR-TKI|egfr-tki
1110959|NCT02485652|non small cell lung cancer|non small cell lung cancer
1110960|NCT02485652|HM61713|hm61713
1110961|NCT02485652|T790M-positive|t790m-positive
1110962|NCT02485652|lung cancer|lung cancer
1110963|NCT02485652|Phase II|phase ii
1110964|NCT02485652|Olmutinib|olmutinib
1110965|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
1110966|NCT02485639|humoral immunity|humoral immunity
1110967|NCT02485639|influenza|influenza
1110968|NCT02485639|memory B cells|memory b cells
1110969|NCT02485626|Anthracyclines|anthracyclines
1110970|NCT02485600|Cadence|cadence
1110971|NCT02485600|Duodopa|duodopa
1110972|NCT02485600|Advanced Parkinson's disease|advanced parkinson's disease
1110973|NCT02485600|LCIG|lcig
1110974|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1110975|NCT02485600|Observational|observational
1110976|NCT02485587|Arousal Biofeedback|arousal biofeedback
1110977|NCT02485587|Electrodermal activity|electrodermal activity
1110978|NCT02485574|Bone bridging|bone bridging
1110979|NCT02485574|Arthrodesis|arthrodesis
1110980|NCT02485574|Lumbar|lumbar
1110981|NCT02485574|Cage|cage
1110982|NCT02485561|Colon cancer screening|colon cancer screening
1110983|NCT02485561|Colorectal cancer screening|colorectal cancer screening
1110984|NCT02485561|Colonoscopy|colonoscopy
1110985|NCT02485561|Sigmoidoscopy|sigmoidoscopy
1110986|NCT02485561|Stool blood test|stool blood test
1110987|NCT02485561|Narrative|narrative
1110988|NCT02485522|fecal incontinence|fecal incontinence
1110989|NCT02485522|diet|diet
1110990|NCT02485522|nutrition|nutrition
1110991|NCT02485522|metabolites|metabolites
1110992|NCT02485522|stool|stool
1110994|NCT02485379|Prostate cancer|prostate cancer
1110995|NCT02485379|Multiparametric MRI|multiparametric mri
1110996|NCT02485379|Prostate biopsy|prostate biopsy
1110997|NCT02485379|Targeted biopsy|targeted biopsy
1110998|NCT02485379|Comparative study|comparative study
1110999|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
1111000|NCT02485353|Vosaroxin|vosaroxin
1111001|NCT02485353|Cytarabine|cytarabine
1111002|NCT02485353|Remission Induction|remission induction
1111003|NCT02485353|Safety|safety
1111004|NCT02485353|Progression-Free Survival|progression-free survival
1111005|NCT02485353|Mortality Rate|mortality rate
1111006|NCT02485353|Length of Stay|length of stay
1111007|NCT02485314|children|children
1111008|NCT02485314|disability|disability
1111009|NCT02485314|family|family
1111010|NCT02485314|participation|participation
1111011|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
1111012|NCT02485275|AIS|ais
1111013|NCT02485275|ICAS|icas
1111014|NCT02485275|CSVD|csvd
1111015|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
1111016|NCT02485249|Iontophoresis|iontophoresis
1111017|NCT02485249|Macular Edema|macular edema
1111018|NCT02485249|Ophthalmology|ophthalmology
1111019|NCT02485223|Multiple Sclerosis|multiple sclerosis
1111020|NCT02485223|MS|ms
1111021|NCT02485223|Diagnostic test|diagnostic test
1111022|NCT02485223|Central veins|central veins
1111023|NCT02485223|MRI|mri
1111024|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
1111025|NCT02485197|Muscle Metabolic Function|muscle metabolic function
1111026|NCT02485197|Vitamin D Status|vitamin d status
1111027|NCT02485197|25(OH)D|25(oh)d
1111028|NCT02485197|Older Adults|older adults
1111029|NCT02485158|Subjective Effects|subjective effects
1111030|NCT02485158|Alcohol|alcohol
1111031|NCT02485158|Amphetamine|amphetamine
1111032|NCT02485158|THC|thc
1111033|NCT02485158|Personality|personality
1111034|NCT02485145|Topical|topical
1111035|NCT02485145|Hand osteoarthritis|hand osteoarthritis
1111036|NCT02485132|Type 2 diabetes|type 2 diabetes
1111037|NCT02485132|Sulfonylurea|sulfonylurea
1111038|NCT02485132|Hypoglycemia|hypoglycemia
1111039|NCT02485132|Quality of life|quality of life
1111040|NCT02485119|BAY 94-9343|bay 94-9343
1111041|NCT02485119|Anetumab ravtansine|anetumab ravtansine
1111042|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
1111043|NCT02485119|Phase I|phase i
1111044|NCT02485119|Japan|japan
1111045|NCT02485119|solid cancers|solid cancers
1111046|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
1111047|NCT02485119|mesothelin|mesothelin
1111048|NCT02485119|endometrial|endometrial
1111049|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
1111050|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
1111051|NCT02485080|hepatitis C|hepatitis c
1111052|NCT02485080|liver transplantation|liver transplantation
1111053|NCT02485080|genotype 1|genotype 1
1111054|NCT02485067|Overactive Bladder|overactive bladder
1111055|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
1111056|NCT02485067|Pilocarpine|pilocarpine
1111057|NCT02485041|Dapoxetine|dapoxetine
1111058|NCT02485041|Mirodenafil|mirodenafil
1111059|NCT02485041|DDI study|ddi study
1111060|NCT02485028|Dapoxetine|dapoxetine
1111061|NCT02485028|Mirodenafil|mirodenafil
1111062|NCT02485028|DDI study|ddi study
1111063|NCT02485015|CIK|cik
1111064|NCT02485015|gastric cancer|gastric cancer
1111065|NCT02485015|Apatinib|apatinib
1111066|NCT02485002|kidney|kidney
1111067|NCT02485002|kidney stone|kidney stone
1111068|NCT02485002|NGAL|ngal
1111069|NCT02485002|ureterorenoscopy|ureterorenoscopy
1111070|NCT02485002|intrarenal surgery|intrarenal surgery
1111071|NCT02485002|kidney function|kidney function
1111072|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
1111073|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1111074|NCT02484976|Childhood Obesity|childhood obesity
1111075|NCT02484976|Satiety|satiety
1111076|NCT02484976|BMI z-score|bmi z-score
1111077|NCT02484976|Impulsive|impulsive
1111078|NCT02484976|Non-obese controls|non-obese controls
1111079|NCT02484976|Visual food cues|visual food cues
1111080|NCT02484976|Leptin|leptin
1111081|NCT02484976|Hormones|hormones
1111082|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
1111083|NCT02484937|Pain management|pain management
1111084|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
1111085|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
1111086|NCT02484885|Pulmonary Function|pulmonary function
1111087|NCT02484872|Inflammation|inflammation
1111088|NCT02484872|Glasgow score|glasgow score
1111089|NCT02484872|Intensive Care Unit|intensive care unit
1111090|NCT02484872|Emergency|emergency
1111091|NCT02484859|Drug: remifentanil|drug: remifentanil
1111092|NCT02484859|Drug: tramadol|drug: tramadol
1111093|NCT02484859|Drug: metoprolol|drug: metoprolol
1111094|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
1111095|NCT02484859|Controlled hypotension|controlled hypotension
1111096|NCT02484833|First line|first line
1111097|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
1111098|NCT02484833|Cetuximab|cetuximab
1111099|NCT02484833|strategy study|strategy study
1111100|NCT02484820|Preterm Birth|preterm birth
1111101|NCT02484820|pessary|pessary
1111102|NCT02484820|threatened preterm labor|threatened preterm labor
1111103|NCT02484794|Eating Disorders|eating disorders
1111104|NCT02484794|Smartphone|smartphone
1111105|NCT02484794|App|app
1111106|NCT02484794|Mobile Health|mobile health
1111107|NCT02484794|Recovery Record|recovery record
1111108|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
1111109|NCT02484794|Outpatient Program|outpatient program
1111110|NCT02484794|Self Monitoring|self monitoring
1111111|NCT02484781|Gait disorder|gait disorder
1111112|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
1111113|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
1111114|NCT02484729|AZD9977|azd9977
1111115|NCT02484729|Safety|safety
1111116|NCT02484729|Tolerability|tolerability
1111117|NCT02484729|Pharmacokinetics|pharmacokinetics
1111118|NCT02484729|First-in-human|first-in-human
1111119|NCT02484729|Single Ascending Dose|single ascending dose
1111120|NCT02484729|Regional absorption|regional absorption
1111121|NCT02484729|Healthy male subjects|healthy male subjects
1111122|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
1111123|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
1111124|NCT02484716|Timolol|timolol
1111125|NCT02484651|deep neuromuscular block|deep neuromuscular block
1111126|NCT02484651|sugammadex|sugammadex
1111127|NCT02484651|stability of anesthesia|stability of anesthesia
1111128|NCT02484651|suppression of EMG activity|suppression of emg activity
1111129|NCT02484651|PQRS|pqrs
1111130|NCT02484651|General Anesthesia|general anesthesia
1111131|NCT02484651|Quality of Recovery|quality of recovery
1111132|NCT02484625|snacking|snacking
1111133|NCT02484625|food intake|food intake
1111134|NCT02484625|satiety|satiety
1111135|NCT02484625|obesity|obesity
1111136|NCT02484625|type-2 diabetes|type-2 diabetes
1111137|NCT02484599|Eating Disorders|eating disorders
1111138|NCT02484599|Anorexia Nervosa|anorexia nervosa
1111139|NCT02484599|Attention bias|attention bias
1111140|NCT02484599|Attention bias modification|attention bias modification
1111141|NCT02484586|Presbyopia|presbyopia
1111142|NCT02484586|Refractive error|refractive error
1111143|NCT02484586|Contact lens|contact lens
1111144|NCT02484573|Cirrhosis|cirrhosis
1111145|NCT02484573|Variceal Bleeding|variceal bleeding
1111146|NCT02484573|Non-selective beta blocker|non-selective beta blocker
1111147|NCT02484573|Intestinal Permeability|intestinal permeability
1111148|NCT02484573|Gene expression|gene expression
1111149|NCT02484573|Bacterial translocation|bacterial translocation
1111150|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1111151|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
1111152|NCT02484560|Muscular Dystrophy|muscular dystrophy
1111153|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
1111154|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
1111155|NCT02484560|Nervous System Diseases|nervous system diseases
1111156|NCT02484547|Aducanumab|aducanumab
1111157|NCT02484547|BIIB037|biib037
1111158|NCT02484534|Coagulation Factor|coagulation factor
1111159|NCT02484534|cirrhosis|cirrhosis
1111160|NCT02484508|Guli capsule|guli capsule
1111161|NCT02484508|knee osteoarthritis|knee osteoarthritis
1111162|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
1111163|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
1111164|NCT02484495|Program evaluation|program evaluation
1111165|NCT02484495|Process and impact evaluation|process and impact evaluation
1111166|NCT02484456|Major Depression|major depression
1111167|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
1111168|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
1111169|NCT02484456|Treatment Resistant|treatment resistant
1111170|NCT02484456|Glutamatergic System|glutamatergic system
1111171|NCT02484417|Neutralizing Antibody|neutralizing antibody
1111172|NCT02484417|Viral Shedding|viral shedding
1111173|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
1111174|NCT02484417|Upper Respiratory Infection|upper respiratory infection
1111175|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
1111176|NCT02484404|PARP Inhibitor|parp inhibitor
1111177|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
1111178|NCT02484378|ACS|acs
1111179|NCT02484378|IVUS|ivus
1111180|NCT02484378|HDL|hdl
1111181|NCT02484365|Hemoglobins|hemoglobins
1111182|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
1111183|NCT02484365|Preoperative Period|preoperative period
1111184|NCT02484365|Pediatrics|pediatrics
1111185|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
1111186|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
1111187|NCT02484326|Cardiac rupture|cardiac rupture
1111188|NCT02484326|Risk assessment|risk assessment
1111189|NCT02484300|loop gain|loop gain
1111190|NCT02484300|chemoreflex control|chemoreflex control
1111191|NCT02484300|melatonin|melatonin
1111192|NCT02484300|antioxidant|antioxidant
1111193|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
1111194|NCT02484300|ventilatory control|ventilatory control
1111195|NCT02484274|iron-deficiency|iron-deficiency
1111196|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
1111197|NCT02484274|infants and toddlers|infants and toddlers
1111198|NCT02484274|industrialised countries|industrialised countries
1111199|NCT02484274|population-based study|population-based study
1111200|NCT02484274|prevalence and risk factors|prevalence and risk factors
1111201|NCT02484274|screening strategies|screening strategies
1111202|NCT02484274|diagnosis markers|diagnosis markers
1111203|NCT02484274|primary prevention|primary prevention
1111204|NCT02484261|childhood leukemia|childhood leukemia
1111205|NCT02484261|relapsed leukemia|relapsed leukemia
1111206|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1111207|NCT02484235|obesity|obesity
1111208|NCT02484235|exercise|exercise
1111209|NCT02484235|HIIT|hiit
1111210|NCT02484235|Vo2|vo2
1111211|NCT02484235|kinetics|kinetics
1111212|NCT02484222|adenotonsillectomy|adenotonsillectomy
1111213|NCT02484222|fentanyl|fentanyl
1111214|NCT02484209|diabetes|diabetes
1111215|NCT02484209|frailty|frailty
1111216|NCT02484209|aged|aged
1111217|NCT02484209|metformin|metformin
1111218|NCT02484209|sulphonylurea|sulphonylurea
1111219|NCT02484209|hypoglycaemia|hypoglycaemia
1111220|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
1111221|NCT02484183|pneumonia|pneumonia
1111222|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1111223|NCT02484183|malnutrition|malnutrition
1111224|NCT02484183|Malawi|malawi
1111225|NCT02484183|Africa|africa
1111226|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
1111227|NCT02484183|child|child
1111228|NCT02484183|pediatric|pediatric
1111229|NCT02484183|hypoxemia|hypoxemia
1111230|NCT02484170|Mannitol|mannitol
1111231|NCT02484170|cream|cream
1111232|NCT02484170|neuropathic pain|neuropathic pain
1111233|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
1111234|NCT02484157|cardiac surgery|cardiac surgery
1111235|NCT02484144|information|information
1111236|NCT02484144|coronarography|coronarography
1111237|NCT02484144|understanding|understanding
1111238|NCT02484131|Osteoporosis|osteoporosis
1111239|NCT02484131|DXA Screening|dxa screening
1111240|NCT02484131|Women|women
1111241|NCT02484131|Breast Cancer|breast cancer
1111242|NCT02484131|Survivors|survivors
1111243|NCT02484131|Educational materials|educational materials
1111244|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
1111245|NCT02484092|Hemophilia B|hemophilia b
1111246|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
1111247|NCT02484092|Gene Therapy|gene therapy
1111248|NCT02484092|Gene Transfer|gene transfer
1111249|NCT02484092|Factor IX Deficiency|factor ix deficiency
1111250|NCT02484092|Factor IX Gene|factor ix gene
1111251|NCT02484092|Factor IX Protein|factor ix protein
1111252|NCT02484092|Vector|vector
1111253|NCT02484092|AAV|aav
1111254|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
1111255|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
1111256|NCT02484066|Guide Sheath|guide sheath
1111257|NCT02484066|Transbronchial biopsy|transbronchial biopsy
1111258|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
1111259|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
1111260|NCT02484053|blood disorders|blood disorders
1111261|NCT02484053|lymphoma|lymphoma
1111262|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
1111263|NCT02484053|diseases of the immune system|diseases of the immune system
1111264|NCT02484040|tumor response|tumor response
1111265|NCT02484040|toxicity|toxicity
1111266|NCT02484040|recurrence|recurrence
1111267|NCT02484040|chemoradiotherpy|chemoradiotherpy
1111268|NCT02484040|rectum|rectum
1111269|NCT02484027|acute ischemic stroke|acute ischemic stroke
1111270|NCT02484027|mRS|mrs
1111271|NCT02484027|rosuvastatin|rosuvastatin
1111272|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
1111273|NCT02484001|BIA 2-093|bia 2-093
1111274|NCT02484001|Epilepsy|epilepsy
1111275|NCT02483975|Fluticasone Furoate|fluticasone furoate
1111276|NCT02483975|Asthma|asthma
1111277|NCT02483975|HPA axis|hpa axis
1111278|NCT02483975|Children|children
1111279|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
1111280|NCT02483962|Chronic|chronic
1111281|NCT02483923|serratus anterior block|serratus anterior block
1111282|NCT02483923|ultrasound|ultrasound
1111283|NCT02483923|breast cancer|breast cancer
1111284|NCT02483923|postoperative pain|postoperative pain
1111285|NCT02483910|School-age children|school-age children
1111286|NCT02483910|Pediatrics|pediatrics
1111287|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
1111288|NCT02483884|Bombesin|bombesin
1111289|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
1111290|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
1111291|NCT02483884|Genital Diseases, Male|genital diseases, male
1111292|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
1111293|NCT02483884|Neoplasms|neoplasms
1111294|NCT02483884|Neoplasms by Site|neoplasms by site
1111295|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
1111296|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
1111297|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1111298|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
1111299|NCT02483884|Pharmacologic Actions|pharmacologic actions
1111300|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
1111301|NCT02483884|Therapeutic Uses|therapeutic uses
1111302|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
1111303|NCT02483858|oncology, solid tumors|oncology, solid tumors
1111304|NCT02483819|Elderly patient|elderly patient
1111305|NCT02483819|NICOM|nicom
1111306|NCT02483819|TURP|turp
1111307|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
1111308|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
1111309|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
1111310|NCT02483728|Metal Allergy|metal allergy
1111311|NCT02483715|Helicobacter pylori|helicobacter pylori
1111312|NCT02483715|high dose dual therapy|high dose dual therapy
1111313|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
1111314|NCT02483715|antibiotic resistance|antibiotic resistance
1111315|NCT02483702|Irradiated Blood|irradiated blood
1111316|NCT02483702|Non-Irradiated Blood|non-irradiated blood
1111445|NCT02482987|socket preservation|socket preservation
1111317|NCT02483702|graft versus host disease|graft versus host disease
1111318|NCT02483702|TA-GVHD|ta-gvhd
1111319|NCT02483702|potassium|potassium
1111320|NCT02483702|Blood transfusion|blood transfusion
1111321|NCT02483689|Post Operative Pain|post operative pain
1111322|NCT02483689|Appendicitis|appendicitis
1111323|NCT02483689|Appendectomy|appendectomy
1111324|NCT02483689|Local Anesthetic|local anesthetic
1111325|NCT02483689|Saline|saline
1111326|NCT02483689|Pain Management|pain management
1111327|NCT02483689|Surgery|surgery
1111328|NCT02483689|Recovery|recovery
1111329|NCT02483676|Rehabilitation|rehabilitation
1163157|NCT02201940|HCV|hcv
1111330|NCT02483676|Robotics|robotics
1111331|NCT02483676|Gait|gait
1111332|NCT02483663|Twins|twins
1111333|NCT02483663|Obesity|obesity
1111334|NCT02483663|Appetite|appetite
1111335|NCT02483637|spray cryotherapy|spray cryotherapy
1111336|NCT02483637|cryotherapy|cryotherapy
1111337|NCT02483637|chronic bronchitis|chronic bronchitis
1111338|NCT02483637|airflow restrictions|airflow restrictions
1111339|NCT02483611|Onset|onset
1111340|NCT02483611|Recovery|recovery
1111341|NCT02483611|Lidocaine|lidocaine
1111342|NCT02483611|Cisatracurium|cisatracurium
1111343|NCT02483611|Magnesium sulfate|magnesium sulfate
1111344|NCT02483611|Isotonic solution|isotonic solution
1111345|NCT02483598|buspirone|buspirone
1111346|NCT02483598|pharmacokinetics|pharmacokinetics
1111347|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
1111348|NCT02483585|Migraine|migraine
1111349|NCT02483585|Headache|headache
1111350|NCT02483585|Episodic|episodic
1111351|NCT02483585|Prevention|prevention
1111352|NCT02483585|Prophylaxis|prophylaxis
1111353|NCT02483559|Sleep|sleep
1111354|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
1111355|NCT02483559|Melatonin|melatonin
1111356|NCT02483546|Medical education|medical education
1111357|NCT02483546|simulation|simulation
1111358|NCT02483546|ACLS|acls
1111359|NCT02483520|Family caregiver|family caregiver
1111360|NCT02483507|Ultrasound guidance|ultrasound guidance
1111361|NCT02483507|Vascular access|vascular access
1111362|NCT02483507|Pediatric anesthesia|pediatric anesthesia
1111363|NCT02483494|Telemedicine|telemedicine
1111364|NCT02483494|Advanced Practice Nurse|advanced practice nurse
1111365|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
1111366|NCT02483481|ultrasound elastography|ultrasound elastography
1111367|NCT02483481|bone marrow transplant|bone marrow transplant
1111368|NCT02483429|Vertigo|vertigo
1111369|NCT02483429|Dizziness|dizziness
1111370|NCT02483429|Unsteadiness|unsteadiness
1111371|NCT02483429|Stroke|stroke
1111372|NCT02483429|Vestibular neuritis|vestibular neuritis
1111373|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
1111374|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
1111375|NCT02483429|Video-oculography|video-oculography
1111376|NCT02483429|Emergency department|emergency department
1111377|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
1111378|NCT02483403|Pulmonary Function|pulmonary function
1111379|NCT02483403|Volunteers|volunteers
1111380|NCT02483390|palliative care|palliative care
1111381|NCT02483390|e-health|e-health
1111382|NCT02483390|e-therapy|e-therapy
1111383|NCT02483390|psychosocial services|psychosocial services
1111384|NCT02483377|Sign or Symptom|sign or symptom
1111385|NCT02483351|Blood Transfusion|blood transfusion
1111386|NCT02483338|Psychometric validity|psychometric validity
1111387|NCT02483338|Pain scale|pain scale
1111388|NCT02483338|Postoperative|postoperative
1111389|NCT02483338|Children|children
1111390|NCT02483312|Recurrent|recurrent
1111391|NCT02483299|response to therapy|response to therapy
1111392|NCT02483286|Osteoporosis|osteoporosis
1111393|NCT02483286|Fall|fall
1111394|NCT02483286|Fracture|fracture
1111395|NCT02483286|sarcopenia|sarcopenia
1111396|NCT02483286|Exercise|exercise
1111397|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
1111398|NCT02483273|Sublingual microcirculation|sublingual microcirculation
1111399|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
1111400|NCT02483247|Neoplasms|neoplasms
1111401|NCT02483195|Hair loss|hair loss
1111402|NCT02483195|Post Menopausal|post menopausal
1111403|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
1111404|NCT02483169|ischemic stroke|ischemic stroke
1111405|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
1111406|NCT02483169|cilostazol|cilostazol
1111407|NCT02483169|probucol|probucol
1111408|NCT02483169|intima media thickness|intima media thickness
1111410|NCT02483156|Sofosbuvir|sofosbuvir
1111411|NCT02483156|Ribavirin|ribavirin
1111412|NCT02483143|contrast media|contrast media
1111413|NCT02483143|pulmonary embolism|pulmonary embolism
1111414|NCT02483143|N-acetylcysteine|n-acetylcysteine
1111415|NCT02483104|ABT-888|abt-888
1111416|NCT02483104|BRCA|brca
1111417|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
1111418|NCT02483104|carboplatin|carboplatin
1111419|NCT02483104|Fallopian tube|fallopian tube
1111420|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
1111421|NCT02483104|paclitaxel|paclitaxel
1111422|NCT02483104|Ovarian cancer|ovarian cancer
1111423|NCT02483104|veliparib|veliparib
1111424|NCT02483091|Knowledge translation|knowledge translation
1111425|NCT02483091|Clinical practice guidelines|clinical practice guidelines
1111426|NCT02483091|Multimodal care|multimodal care
1111427|NCT02483091|Brief Action Planning|brief action planning
1111428|NCT02483091|Feasibility outcomes|feasibility outcomes
1111429|NCT02483065|dementia|dementia
1111430|NCT02483065|hospital admission|hospital admission
1111431|NCT02483065|mortality|mortality
1111432|NCT02483065|health-related quality of life|health-related quality of life
1111433|NCT02483065|activities of daily living|activities of daily living
1111434|NCT02483052|lobectomy|lobectomy
1111435|NCT02483052|spray cryotherapy|spray cryotherapy
1111436|NCT02483052|lung cancer|lung cancer
1111437|NCT02483039|Acute kidney injury|acute kidney injury
1111438|NCT02483039|Chronic kidney disease|chronic kidney disease
1111439|NCT02483039|Quality improvement|quality improvement
1111440|NCT02483013|whitening dentifrices|whitening dentifrices
1111441|NCT02483013|color alteration|color alteration
1111442|NCT02483013|tooth sensitivity|tooth sensitivity
1111443|NCT02482987|dental|dental
1111444|NCT02482987|extraction|extraction
1111446|NCT02482987|ridge preservation|ridge preservation
1111447|NCT02482987|implant site preparation|implant site preparation
1111448|NCT02482974|Liver transplantation|liver transplantation
1111449|NCT02482974|Everolimus|everolimus
1111450|NCT02482974|Sirolimus|sirolimus
1111451|NCT02482974|Treatment outcome|treatment outcome
1111452|NCT02482974|Safety|safety
1111453|NCT02482948|Debridement|debridement
1111454|NCT02482948|collagenase|collagenase
1111455|NCT02482948|leptospermum honey|leptospermum honey
1111456|NCT02482922|feasibility studies|feasibility studies
1111457|NCT02482922|intervention|intervention
1111458|NCT02482922|Pre-Hypertensive|pre-hypertensive
1111459|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
1111460|NCT02482844|TAVI|tavi
1111461|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
1111462|NCT02482844|electrophysiology|electrophysiology
1111463|NCT02482844|Holter|holter
1111464|NCT02482844|pacemaker|pacemaker
1111465|NCT02482831|Sciatic nerve block|sciatic nerve block
1111569|NCT02482298|Ticagrelor|ticagrelor
1111466|NCT02482831|block duration|block duration
1111467|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
1111468|NCT02482831|fasting blood glucose|fasting blood glucose
1111469|NCT02482831|nerve block|nerve block
1111470|NCT02482831|sensory block duration|sensory block duration
1111471|NCT02482831|motor block duration|motor block duration
1111472|NCT02482818|chronic cough|chronic cough
1111473|NCT02482818|cough hypersensitivity|cough hypersensitivity
1111474|NCT02482818|Lyrica|lyrica
1111475|NCT02482818|Pregabalin|pregabalin
1111476|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
1111477|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
1111478|NCT02482792|Psychosomatic|psychosomatic
1111479|NCT02482792|Pain|pain
1111480|NCT02482753|Chidamide|chidamide
1111481|NCT02482753|breast cancer|breast cancer
1111482|NCT02482753|exemestane|exemestane
1111483|NCT02482753|Estrogen Receptor|estrogen receptor
1111484|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
1111485|NCT02482740|antiestrogens|antiestrogens
1111486|NCT02482727|Blood Flow Restriction|blood flow restriction
1111487|NCT02482727|Occlusion training|occlusion training
1111488|NCT02482727|Distal radius fracture|distal radius fracture
1111489|NCT02482714|Quality of Life|quality of life
1111490|NCT02482714|Physical Activity|physical activity
1111491|NCT02482701|EMR|emr
1111492|NCT02482701|EAC|eac
1111493|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
1111494|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
1111495|NCT02482675|Dairy|dairy
1111496|NCT02482675|Milk|milk
1111497|NCT02482675|Glucose|glucose
1111498|NCT02482675|Postprandial|postprandial
1111499|NCT02482675|Hyperglycemia|hyperglycemia
1111500|NCT02482675|Prediabetes|prediabetes
1111501|NCT02482675|Blood glucose|blood glucose
1111502|NCT02482675|Oxidative stress|oxidative stress
1111503|NCT02482675|Vascular health|vascular health
1111504|NCT02482675|Vascular function|vascular function
1111505|NCT02482662|Diagnosis|diagnosis
1111506|NCT02482636|infant immunisations|infant immunisations
1111507|NCT02482636|vaccines|vaccines
1111508|NCT02482636|paediatric|paediatric
1111509|NCT02482636|pneumococcal|pneumococcal
1111510|NCT02482636|meningococcal|meningococcal
1111511|NCT02482623|Dementia|dementia
1111512|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
1111513|NCT02482623|implementation science|implementation science
1111514|NCT02482623|depression|depression
1111515|NCT02482623|pain|pain
1111516|NCT02482610|Dairy|dairy
1111517|NCT02482610|Milk|milk
1111518|NCT02482610|Glucose|glucose
1111519|NCT02482610|Postprandial|postprandial
1111520|NCT02482610|Hyperglycemia|hyperglycemia
1111521|NCT02482610|Prediabetes|prediabetes
1111522|NCT02482610|Blood glucose|blood glucose
1111523|NCT02482610|Oxidative stress|oxidative stress
1111524|NCT02482610|Vascular health|vascular health
1111525|NCT02482610|Vascular function|vascular function
1111526|NCT02482571|Functional MRS|functional mrs
1111527|NCT02482571|Glutamate|glutamate
1111528|NCT02482558|Glycaemic Index|glycaemic index
1111529|NCT02482558|NAFLD|nafld
1111530|NCT02482558|Glycogen|glycogen
1111531|NCT02482558|Liver|liver
1111532|NCT02482558|Diet|diet
1111533|NCT02482532|Melanoma|melanoma
1111534|NCT02482532|metastatic|metastatic
1111535|NCT02482532|relapsed|relapsed
1111536|NCT02482532|refractory|refractory
1111537|NCT02482506|African American|african american
1111538|NCT02482506|Overweight|overweight
1111540|NCT02482480|SLEEP|sleep
1111541|NCT02482480|APNEA|apnea
1111542|NCT02482480|EXERCISE|exercise
1111543|NCT02482467|ovarian cyst|ovarian cyst
1111544|NCT02482467|prenatal diagnosis|prenatal diagnosis
1111545|NCT02482467|puberty|puberty
1111546|NCT02482454|radiofrequency ablation|radiofrequency ablation
1111547|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
1111548|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
1111549|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
1111550|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
1111551|NCT02482441|Colorectal Cancer|colorectal cancer
1111552|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
1111553|NCT02482415|Palliative Care|palliative care
1111554|NCT02482415|Randomized controlled trial|randomized controlled trial
1111555|NCT02482415|Family caregivers|family caregivers
1111556|NCT02482415|Intervention|intervention
1111557|NCT02482415|Family|family
1111558|NCT02482415|Intervention studies|intervention studies
1111559|NCT02482415|Home Care|home care
1111560|NCT02482311|AZD1775|azd1775
1111561|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
1111562|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
1111563|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1111564|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
1111565|NCT02482311|Solid tumours|solid tumours
1111566|NCT02482298|Sickle cell disease|sickle cell disease
1111567|NCT02482298|Young adults|young adults
1111570|NCT02482233|electronic cigarette|electronic cigarette
1111571|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
1111572|NCT02482233|smoking cessation|smoking cessation
1111573|NCT02482233|perioperative|perioperative
1111574|NCT02482194|Spinal cord injury|spinal cord injury
1111575|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
1111576|NCT02482194|transplantation|transplantation
1111577|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
1111578|NCT02482168|immunotherapy|immunotherapy
1111579|NCT02482168|CD40|cd40
1111580|NCT02482155|pharmacokinetics|pharmacokinetics
1111581|NCT02482155|MOMENTACT|momentact
1111582|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
1111583|NCT02482155|oral|oral
1111584|NCT02482155|granules|granules
1111585|NCT02482142|phosphorus|phosphorus
1111586|NCT02482142|lean|lean
1111587|NCT02482142|obese|obese
1111588|NCT02482142|energy expenditure|energy expenditure
1111589|NCT02482129|Acute anterior uveitis|acute anterior uveitis
1111590|NCT02482129|LME636|lme636
1111591|NCT02482116|malaria|malaria
1111592|NCT02482116|pneumonia|pneumonia
1111593|NCT02482116|Nigeria|nigeria
1111594|NCT02482116|IMCI|imci
1111595|NCT02482116|diagnosis|diagnosis
1111596|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
1111597|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
1111598|NCT02482051|Accelerate ID/AST|accelerate id/ast
1111599|NCT02482025|Medications|medications
1111600|NCT02482025|Hospitalization|hospitalization
1111601|NCT02482025|Electronic medical records|electronic medical records
1111602|NCT02482012|research|research
1111603|NCT02482012|vulnerable population|vulnerable population
1111604|NCT02482012|45 CFR 46.406|45 cfr 46.406
1111605|NCT02481999|Depth of anesthesia|depth of anesthesia
1111606|NCT02481973|PMS|pms
1111607|NCT02481973|Homoeopathy|homoeopathy
1111608|NCT02481973|Grant Bentley Method|grant bentley method
1111609|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
1111610|NCT02481934|NK cells|nk cells
1111611|NCT02481934|cell therapy|cell therapy
1111612|NCT02481934|NKAE|nkae
1111613|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
1111614|NCT02481921|heart failure|heart failure
1111615|NCT02481921|self-management|self-management
1111616|NCT02481921|group intervention|group intervention
1111617|NCT02481908|AECOPD|aecopd
1111618|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
1111622|NCT02481895|psychosocial functioning|psychosocial functioning
1111624|NCT02481869|unilateral|unilateral
1111625|NCT02481869|pilon|pilon
1111626|NCT02481843|Hyperoxia|hyperoxia
1111627|NCT02481843|Microcirculation|microcirculation
1111628|NCT02481843|Erythropoietin|erythropoietin
1111629|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
1111630|NCT02481804|diet|diet
1111631|NCT02481804|vitamin|vitamin
1111632|NCT02481778|Radiotherapy|radiotherapy
1111633|NCT02481778|Cardiac|cardiac
1111634|NCT02481778|Toxicity|toxicity
1111635|NCT02481752|Tobacco Use|tobacco use
1111636|NCT02481752|Nicotine Dependence|nicotine dependence
1111637|NCT02481739|endometriosis|endometriosis
1111638|NCT02481739|fertility|fertility
1163575|NCT02200159|ICU|icu
1111639|NCT02481739|endometriosis surgery|endometriosis surgery
1111640|NCT02481726|68Ga|68ga
1111641|NCT02481726|Alfatide II|alfatide ii
1111642|NCT02481726|RGD|rgd
1111643|NCT02481726|αvβ3|αvβ3
1111644|NCT02481726|PET/CT|pet/ct
1111645|NCT02481713|psychosis|psychosis
1111646|NCT02481713|adherence|adherence
1111647|NCT02481713|motivation|motivation
1111648|NCT02481674|Prodromal Stage|prodromal stage
1111649|NCT02481674|Early Manifest Stage|early manifest stage
1111650|NCT02481635|Blood Vessels|blood vessels
1111651|NCT02481635|Reconstructive Surgery|reconstructive surgery
1111652|NCT02481622|HIV infection|hiv infection
1111653|NCT02481622|vaginal tissues|vaginal tissues
1111654|NCT02481622|uterine tissues|uterine tissues
1111655|NCT02481609|Loss of Smell|loss of smell
1111656|NCT02481609|Olfaction|olfaction
1111657|NCT02481609|Hyposmia|hyposmia
1111658|NCT02481596|family|family
1111659|NCT02481596|support|support
1111660|NCT02481596|diet|diet
1111661|NCT02481596|exercise|exercise
1111662|NCT02481596|social|social
1111663|NCT02481583|levosulpiride|levosulpiride
1111664|NCT02481583|pharmacokinetics|pharmacokinetics
1111665|NCT02481583|adverse effects|adverse effects
1111666|NCT02481583|bioavailability|bioavailability
1111670|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
1111671|NCT02481518|Acute kidney injury|acute kidney injury
1111672|NCT02481492|Circumcision, Male|circumcision, male
1111673|NCT02481492|Shang Ring|shang ring
1111674|NCT02481492|Children|children
1111675|NCT02481492|Foreskin|foreskin
1111676|NCT02481466|Arterial plaque|arterial plaque
1111677|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1111678|NCT02481466|Portfolio diet|portfolio diet
1111679|NCT02481466|Dietary modification|dietary modification
1111680|NCT02481466|Dietary trials|dietary trials
1111681|NCT02481466|hypercholesterolemia|hypercholesterolemia
1111684|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
1111685|NCT02481466|glycemic index (GI)|glycemic index (gi)
1111686|NCT02481466|Carotid Ultrasound|carotid ultrasound
1111687|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
1111688|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
1111689|NCT02481440|spinal cord injury|spinal cord injury
1111690|NCT02481427|Total|total
1111691|NCT02481427|Unicondylar|unicondylar
1111692|NCT02481427|Osteoarthritis|osteoarthritis
1111693|NCT02481427|Arthroplasty|arthroplasty
1111694|NCT02481427|Replacement|replacement
1111695|NCT02481427|Knee|knee
1111696|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
1111697|NCT02481401|cardiovascular health|cardiovascular health
1111698|NCT02481401|behavior change|behavior change
1111699|NCT02481401|community-based|community-based
1111700|NCT02481401|family-based|family-based
1111701|NCT02481401|prevention|prevention
1111702|NCT02481375|iron|iron
1111703|NCT02481375|ferritin|ferritin
1111704|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
1111705|NCT02481375|hepcidin|hepcidin
1111706|NCT02481375|reticulocyte count|reticulocyte count
1111707|NCT02481375|hemoglobin|hemoglobin
1111708|NCT02481375|supplementation|supplementation
1111709|NCT02481349|Glioma|glioma
1111710|NCT02481349|Hatha yoga|hatha yoga
1111711|NCT02481349|Questionnaires|questionnaires
1111712|NCT02481349|Surveys|surveys
1111713|NCT02481336|Chemotherapy|chemotherapy
1111714|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
1111715|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
1111716|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
1111717|NCT02481323|cilostazol|cilostazol
1111718|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
1111719|NCT02481297|Leukemia|leukemia
1111720|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1111721|NCT02481297|CLL|cll
1111722|NCT02481297|Refractory/Relapsed|refractory/relapsed
1111826|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
1111723|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
1111724|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
1111725|NCT02481297|SLL|sll
1111726|NCT02481297|Lirilumab|lirilumab
1111727|NCT02481297|Rituximab|rituximab
1111728|NCT02481297|Rituxan|rituxan
1111729|NCT02481284|Breast reconstruction|breast reconstruction
1111730|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
1111731|NCT02481284|Skin perfusion|skin perfusion
1111732|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
1111733|NCT02481271|cholecystectomy|cholecystectomy
1111734|NCT02481258|Stenosis|stenosis
1111735|NCT02481258|Aortic Valve|aortic valve
1111736|NCT02481258|Aorta|aorta
1111737|NCT02481258|Calcified|calcified
1111738|NCT02481258|Calcific|calcific
1111739|NCT02481258|Calcification|calcification
1111740|NCT02481245|Bipolar Disorder|bipolar disorder
1111741|NCT02481245|Bezafibrate|bezafibrate
1111742|NCT02481245|Depressive Episode|depressive episode
1111743|NCT02481219|Polyps|polyps
1111744|NCT02481219|Capsule endoscopy|capsule endoscopy
1111745|NCT02481219|Bowel preparation regimen|bowel preparation regimen
1111746|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
1111747|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
1111748|NCT02481193|Cisatracurium|cisatracurium
1111749|NCT02481193|Myalgia|myalgia
1111750|NCT02481193|Fasciculation|fasciculation
1111751|NCT02481193|Succinylcholine|succinylcholine
1111752|NCT02481167|Aged|aged
1111753|NCT02481167|Meibomian Glands|meibomian glands
1111754|NCT02481167|dry eye|dry eye
1111755|NCT02481167|Elderly|elderly
1111756|NCT02481154|Glioma|glioma
1111757|NCT02481154|IDH1|idh1
1111758|NCT02481154|IDH2|idh2
1111759|NCT02481154|Dual Mutation|dual mutation
1111760|NCT02481154|AG-881|ag-881
1111761|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
1111762|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
1111763|NCT02481076|malleolar fractures|malleolar fractures
1111764|NCT02481076|ORIF|orif
1111765|NCT02481076|compression|compression
1111766|NCT02481076|infection|infection
1111767|NCT02481076|wound dehisence|wound dehisence
1111768|NCT02481063|Eccentric|eccentric
1111769|NCT02481063|Running|running
1111770|NCT02481063|Muscle|muscle
1111771|NCT02481063|Tendon|tendon
1111772|NCT02481063|Ultrasound|ultrasound
1111773|NCT02481063|Thermography|thermography
1111774|NCT02481050|Eribulin Mesylate|eribulin mesylate
1111775|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
1111776|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
1111777|NCT02481050|HER2-Negative|her2-negative
1111778|NCT02481024|Qualitative|qualitative
1111779|NCT02481024|Care transition|care transition
1111780|NCT02481024|Medication|medication
1111781|NCT02481011|Fibrinolytic agents|fibrinolytic agents
1111782|NCT02481011|Adverse effects|adverse effects
1111783|NCT02481011|Registries|registries
1111784|NCT02481011|Incidence|incidence
1111785|NCT02481011|Risk assessment|risk assessment
1111786|NCT02480985|Pituitary Disorders|pituitary disorders
1111787|NCT02480985|Traumatic Brain Injury|traumatic brain injury
1111788|NCT02480985|Critical Care|critical care
1111789|NCT02480985|Outcome Research|outcome research
1111790|NCT02480985|Risk Factors|risk factors
1111791|NCT02480985|Patient Oriented Research|patient oriented research
1111792|NCT02480972|fibrosis|fibrosis
1111793|NCT02480972|cirrhosis|cirrhosis
1111794|NCT02480972|MRI|mri
1111795|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
1111796|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
1111797|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
1111798|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
1111799|NCT02480946|Joint Diseases|joint diseases
1111800|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
1111801|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
1111802|NCT02480920|Drug Adherence|drug adherence
1111803|NCT02480907|eating disorders|eating disorders
1111804|NCT02480907|caregivers|caregivers
1111805|NCT02480907|parents|parents
1111806|NCT02480907|skills training|skills training
1111807|NCT02480907|workshops|workshops
1111808|NCT02480907|support|support
1111809|NCT02480907|internet|internet
1111810|NCT02480907|online|online
1111811|NCT02480907|family|family
1111812|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
1111813|NCT02480868|fusion of the ankle|fusion of the ankle
1111814|NCT02480855|work related stress|work related stress
1111815|NCT02480855|questionnaire|questionnaire
1111816|NCT02480855|early identification|early identification
1111817|NCT02480842|Breast Neoplasms|breast neoplasms
1111818|NCT02480842|Mammaplasty|mammaplasty
1111819|NCT02480842|Breast Implantation|breast implantation
1111820|NCT02480842|Range of Motion, Articular|range of motion, articular
1111821|NCT02480842|Shoulder Joint|shoulder joint
1111822|NCT02480842|Physical Therapy Modalities|physical therapy modalities
1111823|NCT02480803|Parkinson|parkinson
1111824|NCT02480803|Parkinson's Disease|parkinson's disease
1111825|NCT02480803|Deep Brain Stimulation|deep brain stimulation
1111827|NCT02480803|Duodopa|duodopa
1111828|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
1111829|NCT02480764|Drug therapy|drug therapy
1111830|NCT02480751|Chronic Renal Failure|chronic renal failure
1111831|NCT02480751|Prostaglandin|prostaglandin
1111832|NCT02480751|Prostacyclin|prostacyclin
1111833|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
1111834|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
1111836|NCT02480725|CSF|csf
1111837|NCT02480725|prion|prion
1111838|NCT02480725|thrombin|thrombin
1111839|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
1111840|NCT02480673|Chia|chia
1111841|NCT02480673|Dyslipidemia|dyslipidemia
1111842|NCT02480660|Hospitalized|hospitalized
1111843|NCT02480660|adolescents|adolescents
1111844|NCT02480660|knowledge|knowledge
1111845|NCT02480660|transition|transition
1111846|NCT02480660|educational intervention|educational intervention
1111847|NCT02480634|zoledronic acid|zoledronic acid
1111848|NCT02480634|radiotherapy|radiotherapy
1111849|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1111850|NCT02480595|AAA|aaa
1111851|NCT02480595|Endovascular|endovascular
1111852|NCT02480595|EVAR|evar
1111853|NCT02480595|Stent|stent
1111854|NCT02480595|Stent Graft|stent graft
1111855|NCT02480595|High Angle|high angle
1111856|NCT02480595|Tortuous|tortuous
1111857|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
1111858|NCT02480530|Medication Adherence|medication adherence
1111859|NCT02480530|Reciprocal Peer|reciprocal peer
1111860|NCT02480530|Telemonitoring|telemonitoring
1111861|NCT02480517|Hypertension|hypertension
1111862|NCT02480517|Renal Denervation|renal denervation
1111863|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
1111864|NCT02480439|Drug Therapy|drug therapy
1111865|NCT02480413|Broselow Tape|broselow tape
1111866|NCT02480413|Weight estimation|weight estimation
1111867|NCT02480413|Patient safety|patient safety
1111868|NCT02480400|MDD|mdd
1111869|NCT02480400|Escitalopram|escitalopram
1111870|NCT02480400|Placebo|placebo
1111871|NCT02480361|Acupuncture|acupuncture
1111872|NCT02480361|Gastric cancer|gastric cancer
1111873|NCT02480322|metabolic alterations|metabolic alterations
1111874|NCT02480257|intervention|intervention
1111875|NCT02480257|emotion regulation|emotion regulation
1111876|NCT02480257|fMRI|fmri
1111877|NCT02480257|mindfulness|mindfulness
1111878|NCT02480257|yoga-based movement|yoga-based movement
1111879|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
1111880|NCT02480231|Suburethral Slings|suburethral slings
1111881|NCT02480231|Midurethral Slings|midurethral slings
1111882|NCT02480231|Mid-urethral sling|mid-urethral sling
1111883|NCT02480231|urinary retention|urinary retention
1111884|NCT02480218|cognition|cognition
1111885|NCT02480218|tamoxifen|tamoxifen
1111886|NCT02480218|aromatase inhibitors|aromatase inhibitors
1111887|NCT02480205|CPAP|cpap
1111888|NCT02480205|NIV|niv
1111889|NCT02480205|NIPPV|nippv
1111890|NCT02480205|Edi|edi
1111893|NCT02480179|functional MRI|functional mri
1111894|NCT02480179|appetite|appetite
1111895|NCT02480179|neurofeedback|neurofeedback
1111896|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
1111897|NCT02480153|Phase 3|phase 3
1111898|NCT02480153|adalimumab|adalimumab
1111899|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
1111900|NCT02480140|Self-regulation|self-regulation
1111901|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
1111902|NCT02480140|Stroke|stroke
1111903|NCT02480140|Functional recovery|functional recovery
1111904|NCT02480140|Randomized controlled trial|randomized controlled trial
1111905|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
1111906|NCT02480075|Genetic Variation|genetic variation
1111907|NCT02480075|Genetic Polymorphism|genetic polymorphism
1111908|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1111909|NCT02480075|Genetic Association Studies|genetic association studies
1111910|NCT02480062|Decision Support System|decision support system
1111911|NCT02480062|mHealth|mhealth
1111912|NCT02480062|Primary Health Care|primary health care
1111913|NCT02480062|Non-communicable diseases|non-communicable diseases
1111914|NCT02480036|IORT|iort
1111915|NCT02480036|Kyphoplasty|kyphoplasty
1111916|NCT02480036|Spine|spine
1111917|NCT02480036|Cancer|cancer
1111918|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1111919|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
1111920|NCT02479997|Radioisotope (RI)|radioisotope (ri)
1111921|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
1111922|NCT02479984|staging laparoscopy|staging laparoscopy
1111923|NCT02479984|pancreatic cancer|pancreatic cancer
1111924|NCT02479984|biliary cancer|biliary cancer
1111925|NCT02479958|Photochemotherapy|photochemotherapy
1111926|NCT02479958|Bacteria|bacteria
1111927|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
1111928|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
1111929|NCT02479919|theta burst stimulation|theta burst stimulation
1111930|NCT02479919|Social Cognition|social cognition
1111931|NCT02479919|Schizophrenia|schizophrenia
1111932|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
1111933|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1111934|NCT02479906|PTSD|ptsd
1111935|NCT02479906|dTMS|dtms
1111936|NCT02479893|cold snare polypectomy|cold snare polypectomy
1111938|NCT02479893|hot snare polypectomy|hot snare polypectomy
1111939|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
1111940|NCT02479815|Program evaluation|program evaluation
1111941|NCT02479815|Process and impact evaluation|process and impact evaluation
1111942|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
1111943|NCT02479802|plasma exchange|plasma exchange
1163920|NCT02198573|K13|k13
1111944|NCT02479802|albumin|albumin
1111945|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
1111946|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
1111947|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
1111948|NCT02479789|Thyroidectomy|thyroidectomy
1111949|NCT02479763|Epidural waveform analysis|epidural waveform analysis
1111950|NCT02479763|Loss of resistance|loss of resistance
1111951|NCT02479737|Chest tube|chest tube
1111952|NCT02479737|chest drainage|chest drainage
1111953|NCT02479737|retained blood complications|retained blood complications
1111954|NCT02479737|chest tube clogging|chest tube clogging
1111955|NCT02479737|hemothorax|hemothorax
1111956|NCT02479737|tamponade|tamponade
1111957|NCT02479737|heart surgery|heart surgery
1111958|NCT02479737|pleural effusion|pleural effusion
1111959|NCT02479737|intensive care|intensive care
1111960|NCT02479724|continuous, non-invasive|continuous, non-invasive
1111961|NCT02479711|glass ionomer|glass ionomer
1111962|NCT02479711|bulk fill composite|bulk fill composite
1111963|NCT02479698|Stem cell transplant|stem cell transplant
1111964|NCT02479698|Human Leukocyte Antigen|human leukocyte antigen
1111966|NCT02479698|BK specific CTL lines|bk specific ctl lines
1111967|NCT02479698|BK-CTLs|bk-ctls
1111968|NCT02479698|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1111969|NCT02479698|HSCT|hsct
1111970|NCT02479698|BK Infection|bk infection
1111971|NCT02479698|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
1111972|NCT02479698|CTLs|ctls
1111973|NCT02479698|Myeloablative|myeloablative
1111974|NCT02479698|Non-myeloablative|non-myeloablative
1111975|NCT02479698|Graft Versus Host Disease|graft versus host disease
1111976|NCT02479698|GVHD|gvhd
1111977|NCT02479672|breathing tube placement|breathing tube placement
1111978|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
1111979|NCT02479672|direct laryngoscopy|direct laryngoscopy
1111980|NCT02479659|Immunizations|immunizations
1111981|NCT02479646|Pegfilgrastim|pegfilgrastim
1111982|NCT02479646|G-CSF|g-csf
1111983|NCT02479646|Pharmacokinetics|pharmacokinetics
1111984|NCT02479646|Pharmacodynamics|pharmacodynamics
1111985|NCT02479633|prognostic factors|prognostic factors
1111986|NCT02479607|Breast Cancer|breast cancer
1111987|NCT02479607|Cytostatic Agents|cytostatic agents
1111988|NCT02479607|Nursing|nursing
1111989|NCT02479607|Health Literacy|health literacy
1111990|NCT02479607|Quality of Life|quality of life
1111991|NCT02479607|Oncology Nursing|oncology nursing
1111992|NCT02479607|Self Care|self care
1111993|NCT02479607|Symptom Management|symptom management
1111994|NCT02479607|Participatory Care|participatory care
1111995|NCT02479607|Person-centered Care|person-centered care
1111996|NCT02479607|Information and Communication Technology|information and communication technology
1111997|NCT02479607|Patient-reported symptoms|patient-reported symptoms
1111998|NCT02479607|Mobile device|mobile device
1111999|NCT02479594|competence-feedback|competence-feedback
1112000|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
1112001|NCT02479568|Cardiovascular disease|cardiovascular disease
1112002|NCT02479568|biomarkers|biomarkers
1112003|NCT02479568|transcriptomics|transcriptomics
1112004|NCT02479568|orange juice|orange juice
1112005|NCT02479568|hesperidin|hesperidin
1112006|NCT02479568|systolic blood pressure|systolic blood pressure
1112007|NCT02479568|metabolomics|metabolomics
1112008|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
1112009|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
1112010|NCT02479542|Wound Healing|wound healing
1112011|NCT02479542|Global Health|global health
1112012|NCT02479542|Cameroon|cameroon
1112013|NCT02479516|Diabetes screening|diabetes screening
1112014|NCT02479516|Health Promotion|health promotion
1112015|NCT02479516|Low and Middle Income Countries|low and middle income countries
1112016|NCT02479516|CHAP|chap
1112017|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
1112018|NCT02479490|metastatic renal cancer|metastatic renal cancer
1112019|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
1112020|NCT02479490|prednisone|prednisone
1112021|NCT02479490|everolimus|everolimus
1112022|NCT02479477|Public Health|public health
1112023|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
1112024|NCT02479464|AssureRx|assurerx
1112025|NCT02479464|Algorithm|algorithm
1112032|NCT02479425|pressure ulcer|pressure ulcer
1112033|NCT02479425|Positioning|positioning
1112034|NCT02479412|Mild to moderate asthma|mild to moderate asthma
1112035|NCT02479412|FEV1|fev1
1112036|NCT02479412|efficacy|efficacy
1112037|NCT02479412|safety|safety
1112038|NCT02479399|Suglat|suglat
1112039|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
1112040|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
1112041|NCT02479399|ASP1941 long-term use|asp1941 long-term use
1112042|NCT02479347|General surgery|general surgery
1112043|NCT02479347|Postoperative|postoperative
1112044|NCT02479334|Spices|spices
1112045|NCT02479334|Functional food|functional food
1112046|NCT02479334|Cardiometabolic risk|cardiometabolic risk
1164045|NCT02197884|Healthy|healthy
1112047|NCT02479334|Metabolic syndrome|metabolic syndrome
1112048|NCT02479334|Inflammation|inflammation
1112049|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
1112050|NCT02479334|Acute|acute
1112056|NCT02479308|Alkermes|alkermes
1112057|NCT02479308|Samidorphan|samidorphan
1112058|NCT02479308|ALKS 5461|alks 5461
1112059|NCT02479308|QT/QTc|qt/qtc
1112060|NCT02479308|Buprenorphine|buprenorphine
1112061|NCT02479308|Pharmacodynamics|pharmacodynamics
1112062|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
1112063|NCT02479269|aerobic execise|aerobic execise
1112064|NCT02479269|C- Reactive Protein|c- reactive protein
1112065|NCT02479256|PCOS|pcos
1112066|NCT02479256|Induction of ovulation|induction of ovulation
1112067|NCT02479256|Clomiphene citrate|clomiphene citrate
1112068|NCT02479256|Tamoxifen|tamoxifen
1112069|NCT02479243|Arterial Spin Labeling|arterial spin labeling
1112070|NCT02479243|MRI|mri
1112071|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
1112072|NCT02479243|Collateral Circulation|collateral circulation
1112073|NCT02479243|Ischemic stroke|ischemic stroke
1112074|NCT02479230|vaccine|vaccine
1112075|NCT02479230|breast cancer|breast cancer
1112076|NCT02479230|metastatic|metastatic
1112077|NCT02479204|safety|safety
1112078|NCT02479204|heart rate|heart rate
1112079|NCT02479204|pharmacokinetics|pharmacokinetics
1112080|NCT02479191|Abdominal|abdominal
1112081|NCT02479191|Aortic|aortic
1112082|NCT02479191|Aneurysm|aneurysm
1112083|NCT02479152|Mechanical CPR|mechanical cpr
1112084|NCT02479152|Hemodynamics|hemodynamics
1112085|NCT02479126|Interstitial Lung Disease|interstitial lung disease
1112086|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1112087|NCT02479126|Electronic Health Records|electronic health records
1112088|NCT02479126|Computed Tomography|computed tomography
1112089|NCT02479126|Mortality|mortality
1112090|NCT02479126|Hospitalization|hospitalization
1112091|NCT02479126|Acute care visits|acute care visits
1112092|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
1112093|NCT02479113|GDM|gdm
1112094|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
1112095|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
1112096|NCT02479100|Breast|breast
1112097|NCT02479100|Cancer|cancer
1112098|NCT02479100|Diagnosis|diagnosis
1112099|NCT02479100|Patient management|patient management
1112100|NCT02479087|von Willebrand Factor|von willebrand factor
1112101|NCT02479087|Factor VIII|factor viii
1112103|NCT02479087|Immune Tolerance|immune tolerance
1112104|NCT02479087|Hemophilia A|hemophilia a
1112105|NCT02479074|Chronic|chronic
1112106|NCT02479061|Observationnal study|observationnal study
1112107|NCT02479061|Prevalence|prevalence
1112108|NCT02479061|Palliative care|palliative care
1112109|NCT02479061|Anti cancer center|anti cancer center
1112110|NCT02479048|satiety/appetite|satiety/appetite
1112111|NCT02479048|glycemic response|glycemic response
1112112|NCT02479048|cardiometabolic risk|cardiometabolic risk
1112113|NCT02479035|insulin sensitive|insulin sensitive
1112114|NCT02479035|insulin resistant|insulin resistant
1112115|NCT02479035|red raspberry|red raspberry
1112116|NCT02479035|polyphenols|polyphenols
1112117|NCT02479035|bioavailability|bioavailability
1112118|NCT02478996|perioperative|perioperative
1112119|NCT02478996|internet-based|internet-based
1112120|NCT02478996|exercise program|exercise program
1112121|NCT02478957|mastocytosis|mastocytosis
1112122|NCT02478957|cromolyn sodium|cromolyn sodium
1112123|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
1112124|NCT02478944|Manometry|manometry
1112125|NCT02478892|high risk|high risk
1112126|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
1112127|NCT02478827|Cognitive Training|cognitive training
1112128|NCT02478827|Working Memory|working memory
1112129|NCT02478827|Processing Speed|processing speed
1112130|NCT02478788|ADHD|adhd
1112131|NCT02478775|obesity|obesity
1112132|NCT02478775|fertility|fertility
1112133|NCT02478775|infertility|infertility
1112134|NCT02478775|reproductive hormones|reproductive hormones
1112135|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
1112136|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
1112137|NCT02478736|postoperative delirium|postoperative delirium
1112138|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
1112139|NCT02478736|cerebral oximetry|cerebral oximetry
1112140|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
1112141|NCT02478723|requiring therapy|requiring therapy
1112142|NCT02478723|Teeth|teeth
1112143|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
1112144|NCT02478697|employment|employment
1112145|NCT02478697|job-seeking|job-seeking
1112146|NCT02478697|tobacco cessation|tobacco cessation
1112147|NCT02478697|transtheoretical model|transtheoretical model
1112148|NCT02478697|behavior change|behavior change
1112149|NCT02478684|delayed cord clamping|delayed cord clamping
1112150|NCT02478684|premature infants|premature infants
1112151|NCT02478684|randomized study|randomized study
1112152|NCT02478684|hematocrit|hematocrit
1112153|NCT02478658|irisin|irisin
1112154|NCT02478658|resistance training|resistance training
1112155|NCT02478658|physical fitness|physical fitness
1112156|NCT02478658|Volunteers|volunteers
1112157|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1112158|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
1112159|NCT02478632|two-drug regimen|two-drug regimen
1112160|NCT02478632|bone mineral density|bone mineral density
1112161|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
1112162|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
1112163|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
1112164|NCT02478632|integrase inhibitor|integrase inhibitor
1112165|NCT02478619|Obesity|obesity
1112166|NCT02478619|Respiratory Muscle Training|respiratory muscle training
1112167|NCT02478619|Bariatric Surgery|bariatric surgery
1112168|NCT02478619|Breathing exercises|breathing exercises
1112169|NCT02478619|Gastroplasty|gastroplasty
1112170|NCT02478606|Lower Extremity|lower extremity
1112171|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
1112172|NCT02478606|Muscle Strength|muscle strength
1112173|NCT02478606|Static Stretching|static stretching
1112174|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
1112175|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
1112176|NCT02478593|Education|education
1112177|NCT02478593|Geriatric|geriatric
1112178|NCT02478593|Benzodiazepine|benzodiazepine
1112179|NCT02478593|Prevalence|prevalence
1112180|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
1112181|NCT02478580|Anesthesia Recovery Period|anesthesia recovery period
1112182|NCT02478554|Fetal growth restriction|fetal growth restriction
1112183|NCT02478554|macrosomia|macrosomia
1112184|NCT02478541|triglycerides|triglycerides
1112185|NCT02478541|glucose|glucose
1112186|NCT02478541|fructose|fructose
1112187|NCT02478541|fatty acids|fatty acids
1112188|NCT02478515|ranibizumab|ranibizumab
1112189|NCT02478515|PRN regimen|prn regimen
1112190|NCT02478515|macular edema|macular edema
1112191|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
1112192|NCT02478502|testicular cancer|testicular cancer
1112193|NCT02478502|cisplatin resistancy|cisplatin resistancy
1112194|NCT02478489|alcohol|alcohol
1112195|NCT02478489|heavy drinking|heavy drinking
1112196|NCT02478489|naltrexone|naltrexone
1112197|NCT02478489|hospital|hospital
1112198|NCT02478489|alcohol use disorder|alcohol use disorder
1112199|NCT02478489|alcohol dependence|alcohol dependence
1112200|NCT02478489|comparative effectiveness|comparative effectiveness
1112201|NCT02478463|Cabotegravir|cabotegravir
1112202|NCT02478463|Pharmacokinetic|pharmacokinetic
1112203|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
1112204|NCT02478463|GSK1265744|gsk1265744
1112205|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
1112206|NCT02478411|muscle weakness|muscle weakness
1112207|NCT02478411|rehabilitation|rehabilitation
1112208|NCT02478411|intensive care|intensive care
1112209|NCT02478411|mechanical ventilation|mechanical ventilation
1112210|NCT02478411|cyclo ergometer|cyclo ergometer
1112211|NCT02478411|physiotherapy|physiotherapy
1112212|NCT02478385|Birth environment|birth environment
1112213|NCT02478385|oxytocin|oxytocin
1112214|NCT02478385|epidural|epidural
1112215|NCT02478385|analgesia|analgesia
1112216|NCT02478385|home-like|home-like
1112217|NCT02478372|local infiltration analgesia|local infiltration analgesia
1112218|NCT02478372|Epidural|epidural
1112219|NCT02478372|Enhanced Recovery|enhanced recovery
1112220|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
1112221|NCT02478333|Healthy|healthy
1112222|NCT02478333|ALS-008176|als-008176
1112223|NCT02478333|Japanese adult participants|japanese adult participants
1112224|NCT02478320|Advanced Cancers|advanced cancers
1112418|NCT02477085|oxytocin|oxytocin
1112225|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
1112226|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
1112227|NCT02478320|Ilorasertib|ilorasertib
1112228|NCT02478320|ABT-348|abt-348
1112229|NCT02478307|chronic low back pain|chronic low back pain
1112230|NCT02478307|mindfulness meditation|mindfulness meditation
1112231|NCT02478307|cognitive therapy|cognitive therapy
1112232|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1112233|NCT02478307|efficacy|efficacy
1112234|NCT02478307|mechanisms|mechanisms
1112235|NCT02478307|coping|coping
1112236|NCT02478294|Atrial Fibrillation|atrial fibrillation
1112237|NCT02478294|Stroke|stroke
1112238|NCT02478294|Systemic embolism|systemic embolism
1112239|NCT02478294|Left atrial appendage excision|left atrial appendage excision
1112240|NCT02478294|Warfarin|warfarin
1112241|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1112242|NCT02478268|xenon gas|xenon gas
1112243|NCT02478255|Radiation induced lung injury|radiation induced lung injury
1112244|NCT02478255|Xenon gas|xenon gas
1112245|NCT02478255|hyperpolarized|hyperpolarized
1112246|NCT02478229|Liver transplant|liver transplant
1112247|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
1112248|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
1112249|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
1112250|NCT02478203|Airtraq|airtraq
1112251|NCT02478203|Glidescope|glidescope
1112252|NCT02478203|pediatric|pediatric
1112253|NCT02478203|face-to-face|face-to-face
1112254|NCT02478177|Anticoagulant|anticoagulant
1112255|NCT02478177|Stroke|stroke
1112256|NCT02478177|Ischemic Stroke|ischemic stroke
1112257|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
1112258|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
1112259|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
1112260|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
1112261|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1112262|NCT02478112|Balloon implant|balloon implant
1112263|NCT02478099|MPDL3280A|mpdl3280a
1112264|NCT02478099|cancer of the urinary tract|cancer of the urinary tract
1112265|NCT02478099|non small cell lung cancer|non small cell lung cancer
1112266|NCT02478099|triple negative breast cancer|triple negative breast cancer
1112267|NCT02478086|amino acids|amino acids
1112268|NCT02478086|renal function|renal function
1112269|NCT02478086|extreme premature|extreme premature
1112270|NCT02478060|Allergy|allergy
1112271|NCT02478060|Birch|birch
1112272|NCT02478060|Rhinitis|rhinitis
1112273|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
1112274|NCT02478060|SPIRE|spire
1112275|NCT02478060|Toleromune|toleromune
1112276|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
1112277|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
1112278|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
1112279|NCT02478008|Mitral Regurgitation|mitral regurgitation
1112280|NCT02478008|Mitral Insufficiency|mitral insufficiency
1112281|NCT02478008|Transapical|transapical
1112282|NCT02477995|Immunogenicity|immunogenicity
1112283|NCT02477995|Safety|safety
1112284|NCT02477995|DTaP Vaccine|dtap vaccine
1112285|NCT02477982|Propofol|propofol
1112286|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
1112287|NCT02477982|Pharmacokinetics|pharmacokinetics
1112288|NCT02477982|Obesity|obesity
1112289|NCT02477956|vitamin D|vitamin d
1112290|NCT02477956|obesity|obesity
1112291|NCT02477956|bariatric surgery|bariatric surgery
1112292|NCT02477917|allergy|allergy
1112293|NCT02477917|SCIT|scit
1112294|NCT02477904|Autism|autism
1112295|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
1112296|NCT02477904|Ketogenic Diet|ketogenic diet
1112297|NCT02477904|Biochemical Profiles|biochemical profiles
1112298|NCT02477891|Multiple myeloma|multiple myeloma
1112299|NCT02477891|Daratumumab|daratumumab
1112300|NCT02477891|Early access|early access
1112301|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
1112302|NCT02477878|Adult lymphomas|adult lymphomas
1112303|NCT02477878|Adult multiple myeloma|adult multiple myeloma
1112304|NCT02477852|tuberculosis|tuberculosis
1112305|NCT02477852|spinal|spinal
1112306|NCT02477852|general|general
1112307|NCT02477852|operation|operation
1112308|NCT02477852|drug|drug
1112309|NCT02477852|therapy|therapy
1112310|NCT02477839|epilepsy, children, partial-onset seizures, Lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
1112311|NCT02477800|BIIB037|biib037
1112312|NCT02477800|Aducanumab|aducanumab
1112313|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
1112314|NCT02477787|natural killer cells|natural killer cells
1112315|NCT02477774|Anterolateral Thigh|anterolateral thigh
1112316|NCT02477670|Negative Symptoms|negative symptoms
1112317|NCT02477670|Schizophrenia|schizophrenia
1112318|NCT02477670|AVP-786|avp-786
1112419|NCT02477085|amniotomy|amniotomy
1112715|NCT02475421|Glucagon|glucagon
1112319|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
1112320|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
1112321|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
1112322|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
1112323|NCT02477644|standard first-line treatment|standard first-line treatment
1112324|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
1112325|NCT02477644|bevacizumab|bevacizumab
1112326|NCT02477644|olaparib|olaparib
1112328|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
1112329|NCT02477631|oxidative stress|oxidative stress
1112330|NCT02477631|labile plasma iron|labile plasma iron
1112331|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
1112332|NCT02477592|novel approach|novel approach
1112333|NCT02477592|ablation|ablation
1112334|NCT02477566|pcos|pcos
1112335|NCT02477566|Long acting Triptorelin|long acting triptorelin
1112336|NCT02477566|Short acting Triptorelin|short acting triptorelin
1112337|NCT02477566|In Vitro Fertilization|in vitro fertilization
1112338|NCT02477553|decision aid|decision aid
1112339|NCT02477553|cancer screening|cancer screening
1112340|NCT02477553|colorectal neoplasm|colorectal neoplasm
1112341|NCT02477553|decision making|decision making
1112342|NCT02477553|risk communication|risk communication
1112343|NCT02477553|numeracy|numeracy
1112344|NCT02477553|health literacy|health literacy
1112345|NCT02477527|atripla|atripla
1112346|NCT02477527|stribild|stribild
1112347|NCT02477527|dreams|dreams
1112348|NCT02477501|Spinal anesthesia|spinal anesthesia
1112349|NCT02477501|cesarean|cesarean
1112350|NCT02477501|blood pressure|blood pressure
1112351|NCT02477501|Norepinephrine|norepinephrine
1112352|NCT02477501|Ephedrine|ephedrine
1112353|NCT02477488|Allopurinol|allopurinol
1112354|NCT02477488|Renal Dialysis|renal dialysis
1112355|NCT02477475|reflux esophagitis|reflux esophagitis
1112356|NCT02477475|Nexium|nexium
1112357|NCT02477449|safety|safety
1112358|NCT02477449|istaroxime|istaroxime
1112359|NCT02477423|Microbiome|microbiome
1112360|NCT02477423|Antibiotics|antibiotics
1112361|NCT02477410|porcine protein|porcine protein
1112362|NCT02477410|appetite|appetite
1112363|NCT02477410|muscle protein synthesis|muscle protein synthesis
1112364|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
1112365|NCT02477397|Spiromax|spiromax
1112366|NCT02477397|Budesonide/formoterol|budesonide/formoterol
1112367|NCT02477397|COPD|copd
1112368|NCT02477397|exacerbations|exacerbations
1112369|NCT02477397|SMART|smart
1112370|NCT02477345|Cholestasis|cholestasis
1112371|NCT02477345|Parenteral Nutrition|parenteral nutrition
1112372|NCT02477345|Liver disease|liver disease
1112373|NCT02477332|QGE031|qge031
1112374|NCT02477332|omalizumab|omalizumab
1112375|NCT02477332|chronic|chronic
1112376|NCT02477332|spontaneous|spontaneous
1112377|NCT02477332|urticaria|urticaria
1112378|NCT02477332|adults|adults
1112379|NCT02477332|CSU|csu
1112380|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
1112381|NCT02477293|Chronic rhinitis|chronic rhinitis
1112382|NCT02477293|Pattern identification|pattern identification
1112383|NCT02477293|Korean medicine|korean medicine
1112384|NCT02477254|lupus|lupus
1112385|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
1112386|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
1112387|NCT02477241|fMRI|fmri
1112388|NCT02477241|urodynamics|urodynamics
1112389|NCT02477215|Multiple Myeloma|multiple myeloma
1112390|NCT02477202|Mirena® IUD's|mirena® iud's
1112391|NCT02477202|Women|women
1112392|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
1112393|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
1112492|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
1112394|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
1112395|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
1112396|NCT02477150|lupus|lupus
1112397|NCT02477137|Prostate Cancer|prostate cancer
1112398|NCT02477137|Nursing|nursing
1112399|NCT02477137|Health Literacy|health literacy
1112400|NCT02477137|Quality of Life|quality of life
1112401|NCT02477137|Radiotherapy|radiotherapy
1112402|NCT02477137|Oncology Nursing|oncology nursing
1112403|NCT02477137|Self Care|self care
1112404|NCT02477137|Symptom Management|symptom management
1112405|NCT02477137|Participatory Care|participatory care
1112406|NCT02477137|Person-centered Care|person-centered care
1112407|NCT02477137|Information and Communication Technology|information and communication technology
1112408|NCT02477137|Patient-reported symptoms|patient-reported symptoms
1112409|NCT02477137|Mobile device|mobile device
1112410|NCT02477111|Endovascular repair|endovascular repair
1112411|NCT02477098|rectus sheath block|rectus sheath block
1112412|NCT02477098|cytokines|cytokines
1112413|NCT02477098|sleep|sleep
1112414|NCT02477085|Labor|labor
1112415|NCT02477085|induction|induction
1112416|NCT02477085|delivery|delivery
1112417|NCT02477085|prostaglandins|prostaglandins
1112420|NCT02477085|balloon catheter|balloon catheter
1112421|NCT02477059|Hand OA|hand oa
1112422|NCT02477059|Tocilizumab|tocilizumab
1112423|NCT02477059|Osteoarthritis|osteoarthritis
1112424|NCT02477059|Interleukin-6|interleukin-6
1112425|NCT02477020|Drug Therapy|drug therapy
1112426|NCT02477007|Paediatric emergency|paediatric emergency
1112427|NCT02477007|pain|pain
1112428|NCT02477007|long-bones fractures|long-bones fractures
1112429|NCT02477007|morphine|morphine
1112430|NCT02477007|ibuprofen|ibuprofen
1112431|NCT02477007|paracetamol|paracetamol
1112432|NCT02477007|children|children
1112433|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
1112434|NCT02476994|Parenteral Nutrition|parenteral nutrition
1112435|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
1112436|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
1112437|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
1164589|NCT02195284|MDI|mdi
1112438|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
1112439|NCT02476994|Phytosterols|phytosterols
1112440|NCT02476994|Intralipid|intralipid
1112441|NCT02476994|Infants/Preterm Infants|infants/preterm infants
1112442|NCT02476994|FADS1 and FADS2|fads1 and fads2
1112443|NCT02476994|Short Bowel Syndrome|short bowel syndrome
1112444|NCT02476994|Cancer Nutrition|cancer nutrition
1112445|NCT02476994|Olive Oil Emulsion|olive oil emulsion
1112446|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
1112447|NCT02476955|ARQ 092|arq 092
1112448|NCT02476955|Carboplatin|carboplatin
1112449|NCT02476955|Paclitaxel|paclitaxel
1112450|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
1112451|NCT02476955|Targeted therapy|targeted therapy
1112452|NCT02476955|Molecular therapy|molecular therapy
1112453|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
1112454|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
1112455|NCT02476955|Biomarkers|biomarkers
1112456|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
1112457|NCT02476955|Solid tumors|solid tumors
1112458|NCT02476955|Metastatic solid tumors|metastatic solid tumors
1112459|NCT02476955|Recurrent solid tumors|recurrent solid tumors
1112460|NCT02476955|Ovarian cancer|ovarian cancer
1112461|NCT02476955|Endometrial cancer|endometrial cancer
1112462|NCT02476955|Cervical cancer|cervical cancer
1112463|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
1112464|NCT02476955|AKT kinases|akt kinases
1112465|NCT02476955|AKT pathway|akt pathway
1112466|NCT02476955|AKT signaling|akt signaling
1112467|NCT02476955|AKT inhibitor|akt inhibitor
1112468|NCT02476955|AKT pan inhibitor|akt pan inhibitor
1112469|NCT02476955|Chemotherapy|chemotherapy
1112470|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
1112471|NCT02476955|AKT1|akt1
1112472|NCT02476955|AKT2|akt2
1112473|NCT02476955|AKT3|akt3
1112474|NCT02476955|Phase I Clinical Trial|phase i clinical trial
1112475|NCT02476955|Clinical oncology|clinical oncology
1112476|NCT02476955|Tumor|tumor
1112477|NCT02476955|AKT1 inhibitor|akt1 inhibitor
1112478|NCT02476955|AKT2 inhibitor|akt2 inhibitor
1112479|NCT02476955|AKT3 inhibitor|akt3 inhibitor
1112480|NCT02476955|AKT1 mutation|akt1 mutation
1112481|NCT02476955|AKT2 mutation|akt2 mutation
1112482|NCT02476955|AKT3 mutation|akt3 mutation
1112483|NCT02476955|AKT1 amplification|akt1 amplification
1112484|NCT02476955|AKT2 amplification|akt2 amplification
1112485|NCT02476955|AKT3 amplification|akt3 amplification
1112486|NCT02476955|Anastrozole|anastrozole
1112487|NCT02476955|Estrogen receptor positive|estrogen receptor positive
1112488|NCT02476955|PIK3CA mutation|pik3ca mutation
1112489|NCT02476929|Electronic nose|electronic nose
1112490|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
1112491|NCT02476929|Allergic Rhinitis|allergic rhinitis
1112493|NCT02476929|Nasal polyps|nasal polyps
1112494|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
1112495|NCT02476916|Hemolytic anemia|hemolytic anemia
1112496|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
1112497|NCT02476916|Drive PK|drive pk
1112498|NCT02476877|comorbidity|comorbidity
1112499|NCT02476877|epidemiology|epidemiology
1112500|NCT02476877|mental illness|mental illness
1112501|NCT02476877|drug abuse|drug abuse
1112502|NCT02476864|macitentan|macitentan
1112503|NCT02476864|biocomparison|biocomparison
1112504|NCT02476864|safety|safety
1112505|NCT02476851|Blood Donation|blood donation
1112506|NCT02476851|Whole Blood|whole blood
1112507|NCT02476838|hand injury|hand injury
1112508|NCT02476838|hand amputation|hand amputation
1112509|NCT02476838|hand amputee|hand amputee
1112510|NCT02476838|hand surgery|hand surgery
1112511|NCT02476825|volunteers|volunteers
1112512|NCT02476773|Hookworm Vaccine|hookworm vaccine
1112513|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
1112514|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
1112515|NCT02476760|Incretins|incretins
1112516|NCT02476760|Antidiabetic agents|antidiabetic agents
1112517|NCT02476760|Pancreatitis|pancreatitis
1112518|NCT02476747|Colonic polyp|colonic polyp
1112519|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
1112520|NCT02476721|pulmonary embolism|pulmonary embolism
1112521|NCT02476721|emergency department|emergency department
1112522|NCT02476708|schizophrenia|schizophrenia
1112523|NCT02476708|schizoaffective disorder|schizoaffective disorder
1112524|NCT02476708|cognition|cognition
1112525|NCT02476708|curcumin|curcumin
1112526|NCT02476695|CHB|chb
1112527|NCT02476682|Sessile serrated polyps|sessile serrated polyps
1112528|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
1112529|NCT02476669|plasma EBV DNA|plasma ebv dna
1112530|NCT02476669|biomarker|biomarker
1112531|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1112532|NCT02476617|Treatment naive|treatment naive
1112533|NCT02476617|Interferon free|interferon free
1112534|NCT02476617|HCV|hcv
1112535|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
1112536|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
1112537|NCT02476617|Hepatitis C|hepatitis c
1112538|NCT02476617|pegylated-interferon (pegIFN)/ribavirin (RBV) experienced|pegylated-interferon (pegifn)/ribavirin (rbv) experienced
1112539|NCT02476604|prevention|prevention
1112540|NCT02476604|adult|adult
1112541|NCT02476604|student|student
1112542|NCT02476591|Resource utilization|resource utilization
1112543|NCT02476591|intensive care unit|intensive care unit
1112544|NCT02476578|Hypocholesterolemia|hypocholesterolemia
1112545|NCT02476578|Frail Elderly|frail elderly
1112546|NCT02476578|Aged|aged
1112547|NCT02476578|Aged, 80 and over|aged, 80 and over
1112548|NCT02476578|Cholesterol|cholesterol
1112549|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
1112550|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1112551|NCT02476578|diet therapy|diet therapy
1112552|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
1112553|NCT02476578|Health Services for the Aged|health services for the aged
1112554|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
1112555|NCT02476578|Hypoglycemia|hypoglycemia
1112556|NCT02476565|Intubation|intubation
1112557|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
1112558|NCT02476461|xiapex|xiapex
1112559|NCT02476461|clostridium histolyticum|clostridium histolyticum
1112560|NCT02476448|ureteral jet|ureteral jet
1112561|NCT02476448|pelvic surgery|pelvic surgery
1112562|NCT02476448|cystoscopy|cystoscopy
1112563|NCT02476435|Depersonalization|depersonalization
1112564|NCT02476435|Derealization|derealization
1112565|NCT02476435|Embodiment|embodiment
1112566|NCT02476435|Emotional numbing|emotional numbing
1112567|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
1112568|NCT02476435|Angular gyrus|angular gyrus
1112569|NCT02476435|Temporo-parietal junction|temporo-parietal junction
1112570|NCT02476422|Diclofenac potassium|diclofenac potassium
1112571|NCT02476422|Post-operative dental pain|post-operative dental pain
1112572|NCT02476422|Moderate to severe pain|moderate to severe pain
1112573|NCT02476409|congestive heart failure|congestive heart failure
1112574|NCT02476409|tolvaptan|tolvaptan
1112575|NCT02476409|copeptin|copeptin
1112576|NCT02476331|Cognitive training|cognitive training
1112577|NCT02476331|Working memory|working memory
1112578|NCT02476331|Emotion regulation|emotion regulation
1112579|NCT02476266|resistance training|resistance training
1112580|NCT02476266|strength training|strength training
1112581|NCT02476266|balance|balance
1112582|NCT02476266|muscle strength|muscle strength
1112583|NCT02476253|acidosis|acidosis
1112584|NCT02476253|shock|shock
1112585|NCT02476253|sodium bicarbonate|sodium bicarbonate
1112586|NCT02476253|renal replacement therapy|renal replacement therapy
1112587|NCT02476240|Exercise|exercise
1112588|NCT02476240|Attention|attention
1112589|NCT02476227|atrial fibrillation|atrial fibrillation
1112590|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
1112591|NCT02476227|RF ablation|rf ablation
1112592|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
1112593|NCT02476201|Heart Failure|heart failure
1112594|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1112595|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
1112596|NCT02476201|Multipoint Pacing|multipoint pacing
1112597|NCT02476201|Hemodynamic Response|hemodynamic response
1112598|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
1112599|NCT02476175|mirabegron|mirabegron
1112600|NCT02476175|antimuscarinics|antimuscarinics
1112601|NCT02476175|beta 3 agonist|beta 3 agonist
1112602|NCT02476175|overactive bladder|overactive bladder
1112603|NCT02476175|children|children
1112604|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
1112605|NCT02476162|Cancer Prevention and Control|cancer prevention and control
1112606|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
1112607|NCT02476162|Pre-Hypertension|pre-hypertension
1112608|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
1112609|NCT02476136|anxiety disorder|anxiety disorder
1112610|NCT02476136|antidepressants|antidepressants
1112611|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
1112612|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
1112613|NCT02476110|Oral nutritive supplements|oral nutritive supplements
1112614|NCT02476110|Nutritional risk screening|nutritional risk screening
1112615|NCT02476110|Homecare|homecare
1112616|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
1112617|NCT02476097|proton pump inhibitor|proton pump inhibitor
1112618|NCT02476097|gastric acid rebound|gastric acid rebound
1112619|NCT02476097|randomized study|randomized study
1112620|NCT02476097|esomeprazole|esomeprazole
1112621|NCT02476071|HIV prevention|hiv prevention
1112622|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
1112623|NCT02476058|Major Depressive Disorder|major depressive disorder
1112624|NCT02476058|JNJ-42847922|jnj-42847922
1112625|NCT02476058|Diphenhydramine|diphenhydramine
1112627|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
1112628|NCT02476045|RAS wild-type|ras wild-type
1112629|NCT02476045|maintenance therapy|maintenance therapy
1112630|NCT02476045|panitumumab|panitumumab
1112631|NCT02476019|Obesity|obesity
1112632|NCT02476019|Energy Expenditure|energy expenditure
1112633|NCT02475993|Sickle Cell Disease|sickle cell disease
1112634|NCT02475980|Adolescent|adolescent
1112635|NCT02475980|Contraception|contraception
1112636|NCT02475980|Counseling|counseling
1112637|NCT02475967|E-Learning|e-learning
1112638|NCT02475967|coronary artery disease|coronary artery disease
1112639|NCT02475967|telerehabilitation|telerehabilitation
1112640|NCT02475967|e-health|e-health
1112641|NCT02475954|Depression|depression
1112642|NCT02475954|Telehealth|telehealth
1112643|NCT02475954|Parkinson's Disease|parkinson's disease
1112644|NCT02475954|Veterans|veterans
1112645|NCT02475954|Care-partners|care-partners
1112646|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1112647|NCT02475954|Caregiver|caregiver
1112648|NCT02475941|geriatric fractures|geriatric fractures
1112649|NCT02475915|Treatment interruption|treatment interruption
1112650|NCT02475915|Controlling HIV|controlling hiv
1112651|NCT02475902|prevention and control|prevention and control
1112652|NCT02475824|ERCP|ercp
1112653|NCT02475824|Sedation|sedation
1112654|NCT02475824|safety|safety
1112655|NCT02475811|3D ultrasonography|3d ultrasonography
1112656|NCT02475811|fetal Lung Volume|fetal lung volume
1112657|NCT02475811|neonatal respiratory function|neonatal respiratory function
1112658|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
1112659|NCT02475798|Iliac aneurysm|iliac aneurysm
1112660|NCT02475798|Branch|branch
1112661|NCT02475798|Connections|connections
1112662|NCT02475798|Endovascular graft|endovascular graft
1112663|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
1112664|NCT02475798|Aneurysm|aneurysm
1112665|NCT02475798|Vascular Diseases|vascular diseases
1112666|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
1112667|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
1112668|NCT02475785|Class II|class ii
1112669|NCT02475785|anchorage|anchorage
1112670|NCT02475785|FFRD|ffrd
1112671|NCT02475785|mini plates|mini plates
1112672|NCT02475785|fixed functional appliance|fixed functional appliance
1112673|NCT02475772|ovarian cancer|ovarian cancer
1112674|NCT02475772|recurrent|recurrent
1112675|NCT02475772|chemotherapy|chemotherapy
1112676|NCT02475772|intraperitoneal|intraperitoneal
1112677|NCT02475772|cisplatin|cisplatin
1112678|NCT02475772|doxorubicin|doxorubicin
1112679|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
1112680|NCT02475707|leukemia|leukemia
1112681|NCT02475707|lymphoblastic|lymphoblastic
1112682|NCT02475707|ALL|all
1112683|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
1112684|NCT02475707|HSCT|hsct
1112685|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
1112686|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1112687|NCT02475590|Excess weight loss|excess weight loss
1112688|NCT02475590|Quality of life|quality of life
1112689|NCT02475577|telemedicine|telemedicine
1112690|NCT02475577|heart failure|heart failure
1112691|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
1112692|NCT02475564|resveratrol|resveratrol
1112693|NCT02475512|elderly|elderly
1112694|NCT02475512|long-term care|long-term care
1112695|NCT02475499|Incretins|incretins
1112696|NCT02475499|Antidiabetic agents|antidiabetic agents
1112697|NCT02475499|Pancreatic Cancer|pancreatic cancer
1112698|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
1112699|NCT02475486|sympathetic nervous system|sympathetic nervous system
1112700|NCT02475486|SNA|sna
1112701|NCT02475486|fatigue|fatigue
1112702|NCT02475473|Volunteers|volunteers
1112703|NCT02475460|HeartMate 3|heartmate 3
1112704|NCT02475460|LVAS|lvas
1112705|NCT02475460|LVAD|lvad
1112706|NCT02475460|Heart-assist Devices|heart-assist devices
1112707|NCT02475460|Advanced|advanced
1112708|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
1112709|NCT02475460|refractory left ventricular|refractory left ventricular
1112710|NCT02475460|Thoratec Corporation|thoratec corporation
1112711|NCT02475434|Human Milk|human milk
1112712|NCT02475434|Prematurity|prematurity
1112713|NCT02475434|Nutrition|nutrition
1112714|NCT02475421|Diabetes|diabetes
1112716|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
1112717|NCT02475408|Circulation, Collateral|circulation, collateral
1112718|NCT02475408|Coronary Artery Disease|coronary artery disease
1112719|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
1112720|NCT02475408|Ischemia|ischemia
1112721|NCT02475395|Male Fertility|male fertility
1112722|NCT02475395|Male Infertility|male infertility
1112723|NCT02475395|Fertility|fertility
1112725|NCT02475395|Sperm Concentration|sperm concentration
1112726|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
1112727|NCT02475356|Mirena|mirena
1112728|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
1112729|NCT02475356|Dysmenorrhea|dysmenorrhea
1165011|NCT02193646|ADR|adr
1112730|NCT02475356|Japan|japan
1112731|NCT02475356|Post-marketing surveillance|post-marketing surveillance
1112732|NCT02475317|Volunteer|volunteer
1112733|NCT02475278|Drug therapy|drug therapy
1112734|NCT02475265|Anorexia Nervosa|anorexia nervosa
1112735|NCT02475265|Osteoporosis|osteoporosis
1112736|NCT02475265|Eating Disorder|eating disorder
1112737|NCT02475265|Disordered Eating|disordered eating
1112738|NCT02475265|Estrogen|estrogen
1112739|NCT02475265|Bone|bone
1112740|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
1112741|NCT02475226|Traumatic Brain Injury|traumatic brain injury
1112742|NCT02475226|Brain Damage|brain damage
1112743|NCT02475226|Mortality|mortality
1112744|NCT02475226|C10.228.140.199|c10.228.140.199
1112745|NCT02475213|Malanoma, Non small cell lung cancer, SCCHN|malanoma, non small cell lung cancer, scchn
1112746|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
1112748|NCT02475187|MEA|mea
1112749|NCT02475187|Thrombotic events|thrombotic events
1112750|NCT02475187|VTE|vte
1112751|NCT02475187|LMWH|lmwh
1112752|NCT02475187|Hip fractures|hip fractures
1112753|NCT02475161|Healthy|healthy
1112754|NCT02475161|Rabeprazole|rabeprazole
1112755|NCT02475161|JNJ-42847922|jnj-42847922
1112756|NCT02475148|JNJ-54175446|jnj-54175446
1112757|NCT02475148|Healthy|healthy
1112758|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
1112759|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
1112760|NCT02475135|Darunavir|darunavir
1112761|NCT02475135|Cobicistat|cobicistat
1112762|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
1112763|NCT02475135|Emtricitabine|emtricitabine
1112764|NCT02475135|Elvitegravir|elvitegravir
1112765|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
1112766|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1112767|NCT02475083|Stroke|stroke
1112768|NCT02475083|Virtual reality|virtual reality
1112769|NCT02475083|Balance|balance
1112770|NCT02475083|Falls|falls
1112771|NCT02475057|Prostate Cancer|prostate cancer
1112772|NCT02475057|Cardiovascular disease|cardiovascular disease
1112773|NCT02475057|Degarelix|degarelix
1112774|NCT02475044|post-concussion|post-concussion
1112775|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
1112776|NCT02475044|parenting|parenting
1112777|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
1112778|NCT02475018|Shuhua Milk|shuhua milk
1112779|NCT02475018|plant sterol esters|plant sterol esters
1112780|NCT02475018|serum cholesterol|serum cholesterol
1112781|NCT02475018|human|human
1112782|NCT02475005|self management app|self management app
1112783|NCT02475005|headache|headache
1112784|NCT02475005|adolescent|adolescent
1112785|NCT02474992|HIV|hiv
1112786|NCT02474992|Social network|social network
1112787|NCT02474992|Social support|social support
1112788|NCT02474992|Disclosure|disclosure
1112789|NCT02474992|Stigma|stigma
1112790|NCT02474992|Kenya|kenya
1112791|NCT02474979|Pressure ulcer|pressure ulcer
1112792|NCT02474979|Prevention|prevention
1112793|NCT02474979|Pressure mapping|pressure mapping
1112794|NCT02474953|Curcumin|curcumin
1112795|NCT02474953|Pharmacokinetic|pharmacokinetic
1112796|NCT02474940|Multiple Sclerosis|multiple sclerosis
1112797|NCT02474940|Chronic Pain|chronic pain
1112798|NCT02474940|Chronic Fatigue|chronic fatigue
1112799|NCT02474940|Autoimmune Diseases|autoimmune diseases
1112800|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
1112801|NCT02474940|Central Nervous System Diseases|central nervous system diseases
1112802|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
1112803|NCT02474940|Demyelinating Diseases|demyelinating diseases
1112804|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
1112805|NCT02474927|lung transplant|lung transplant
1112806|NCT02474927|Carfilzomib|carfilzomib
1112807|NCT02474901|Shedding|shedding
1112808|NCT02474901|Immunogenicity|immunogenicity
1112809|NCT02474901|Safety|safety
1112810|NCT02474901|HIV infected|hiv infected
1112811|NCT02474901|Children|children
1112812|NCT02474901|Young adults|young adults
1112813|NCT02474875|Fibromyalgia|fibromyalgia
1112814|NCT02474875|Patient education|patient education
1112815|NCT02474875|Central sensitization|central sensitization
1112816|NCT02474836|Allergy|allergy
1112817|NCT02474810|central venous catheters|central venous catheters
1112818|NCT02474810|hemodialysis|hemodialysis
1112819|NCT02474810|thrombosis|thrombosis
1112820|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
1112821|NCT02474797|Ultrasonography|ultrasonography
1112822|NCT02474797|Diaphragm|diaphragm
1112823|NCT02474797|Lung ultrasound|lung ultrasound
1112824|NCT02474797|Sepsis|sepsis
1112825|NCT02474797|Critical care|critical care
1112826|NCT02474797|Chest physiotherapy|chest physiotherapy
1112827|NCT02474745|second stage of labor|second stage of labor
1112828|NCT02474745|pushing techniques|pushing techniques
1112829|NCT02474719|nephrology|nephrology
1112830|NCT02474719|extra-renal purification|extra-renal purification
1112831|NCT02474719|peritoneal dialysis|peritoneal dialysis
1112832|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
1112833|NCT02474706|Infectious diseases|infectious diseases
1112834|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
1112835|NCT02474706|Antibiotics|antibiotics
1112836|NCT02474680|depression|depression
1112837|NCT02474680|Major Depressive Disorder|major depressive disorder
1112838|NCT02474680|MDD|mdd
1112839|NCT02474680|mental health|mental health
1112840|NCT02474680|pharmacogenomics|pharmacogenomics
1112841|NCT02474680|personalized medicine|personalized medicine
1112842|NCT02474680|precision medicine|precision medicine
1112843|NCT02474680|anti-depressants|anti-depressants
1112844|NCT02474667|DGF|dgf
1112845|NCT02474667|Delayed Graft Function|delayed graft function
1112846|NCT02474667|Renal Transplantation|renal transplantation
1112847|NCT02474667|Deseased Donor Kidney|deseased donor kidney
1112848|NCT02474667|BB3|bb3
1112849|NCT02474667|Kidney Transplantation|kidney transplantation
1112850|NCT02474667|Acute Kidney Injury|acute kidney injury
1112851|NCT02474641|Breast cancer|breast cancer
1112852|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
1112853|NCT02474641|Non-inferiority|non-inferiority
1112854|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
1112855|NCT02474628|Physiological Phenomena|physiological phenomena
1112856|NCT02474615|Apicoectomy|apicoectomy
1112857|NCT02474615|Oral surgery|oral surgery
1112858|NCT02474615|Biocompatible materials|biocompatible materials
1112859|NCT02474615|Dental Cements|dental cements
1112860|NCT02474615|Translational Medical Research|translational medical research
1112861|NCT02474602|phototherapy|phototherapy
1112862|NCT02474602|strength training|strength training
1112863|NCT02474602|photobiostimulation|photobiostimulation
1112864|NCT02474602|muscle development|muscle development
1112865|NCT02474589|Treatment|treatment
1112866|NCT02474589|orthopoxvirus|orthopoxvirus
1112867|NCT02474589|smallpox|smallpox
1112868|NCT02474563|Multiple Myeloma|multiple myeloma
1112869|NCT02474563|Bortezomib|bortezomib
1112870|NCT02474563|Melphalan|melphalan
1112871|NCT02474563|Prednisone|prednisone
1112872|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
1112873|NCT02474550|peg-filgrastim|peg-filgrastim
1112874|NCT02474550|febrile neutropenia|febrile neutropenia
1112875|NCT02474537|hepatic impairment,|hepatic impairment,
1112876|NCT02474537|INC280,|inc280,
1112877|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
1112878|NCT02474537|Non-Cancer|non-cancer
1112879|NCT02474524|Psychosis|psychosis
1112880|NCT02474524|Schizophrenia|schizophrenia
1112881|NCT02474524|Self-management|self-management
1112882|NCT02474524|Recovery|recovery
1112883|NCT02474524|Tablet computer|tablet computer
1112884|NCT02474524|Digital health|digital health
1112885|NCT02474524|Internet|internet
1112886|NCT02474524|Online|online
1112887|NCT02474524|Peer support|peer support
1112888|NCT02474498|Regenerative therapy|regenerative therapy
1112889|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
1112890|NCT02474498|Enamel matrix derivative|enamel matrix derivative
1112990|NCT02473822|Tape Locking Screw|tape locking screw
1112891|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
1112892|NCT02474498|Buccal furcation|buccal furcation
1112893|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1112894|NCT02474485|Absorb|absorb
1112895|NCT02474485|drug eluting balloon|drug eluting balloon
1112896|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
1112897|NCT02474472|Midline Laparotomy|midline laparotomy
1112898|NCT02474472|Sternotomy|sternotomy
1112899|NCT02474472|Thoracotomy|thoracotomy
1112900|NCT02474472|Thoracoabdominal Incision|thoracoabdominal incision
1112901|NCT02474459|Deep Brain Stimulation|deep brain stimulation
1112902|NCT02474459|DBS|dbs
1112903|NCT02474459|STN|stn
1112904|NCT02474459|GPi|gpi
1112905|NCT02474459|Globus pallidus|globus pallidus
1112906|NCT02474459|Subthalamic nucleus|subthalamic nucleus
1112907|NCT02474459|Neuromodulation|neuromodulation
1112908|NCT02474407|Seizures|seizures
1112909|NCT02474407|Epilepsy|epilepsy
1112910|NCT02474355|NSCLC|nsclc
1112911|NCT02474355|EGFRm|egfrm
1112912|NCT02474355|T790M|t790m
1112913|NCT02474329|Parkinson's disease|parkinson's disease
1112914|NCT02474329|Ambulatory monitoring|ambulatory monitoring
1112915|NCT02474329|Disease progression|disease progression
1112916|NCT02474303|Truvada|truvada
1113712|NCT02469935|Gallstones|gallstones
1112917|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
1112918|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
1112919|NCT02474303|Female Sex Workers|female sex workers
1112920|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
1112921|NCT02474290|FLT3-ITD|flt3-itd
1112922|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1112923|NCT02474238|Iridotomy|iridotomy
1112924|NCT02474225|intraocular pressure|intraocular pressure
1112925|NCT02474225|intravitreal|intravitreal
1112926|NCT02474212|Venous thromboembolism|venous thromboembolism
1112927|NCT02474212|pulmonary embolism|pulmonary embolism
1112928|NCT02474212|thromboprophylaxis|thromboprophylaxis
1112929|NCT02474212|anticoagulant|anticoagulant
1112930|NCT02474212|anti-FXa|anti-fxa
1112931|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
1112932|NCT02474212|enoxaparin|enoxaparin
1112933|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
1112934|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
1112935|NCT02474199|Liver Transplant|liver transplant
1112936|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
1112937|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
1112938|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
1112939|NCT02474186|breast|breast
1112940|NCT02474186|cancer|cancer
1112941|NCT02474186|metastatic|metastatic
1112942|NCT02474186|breast cancer|breast cancer
1112943|NCT02474186|metastatic breast cancer|metastatic breast cancer
1112944|NCT02474186|radiation|radiation
1112945|NCT02474186|radiotherapy|radiotherapy
1112946|NCT02474186|radiation therapy|radiation therapy
1112947|NCT02474186|abscopal|abscopal
1112948|NCT02474186|abscopal effect|abscopal effect
1112949|NCT02474186|T-cell|t-cell
1112950|NCT02474186|GM-CSF|gm-csf
1112951|NCT02474186|anti-tumor|anti-tumor
1112952|NCT02474186|immune|immune
1112953|NCT02474186|immune response|immune response
1112954|NCT02474186|capecitabine|capecitabine
1112955|NCT02474186|xeloda|xeloda
1112956|NCT02474186|taxol|taxol
1112957|NCT02474186|paclitaxel|paclitaxel
1112958|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
1112959|NCT02474108|atrial fibrillation|atrial fibrillation
1112960|NCT02474108|radiofrequency ablation|radiofrequency ablation
1112961|NCT02474108|prevention of AF|prevention of af
1112962|NCT02474108|mitral valve|mitral valve
1112963|NCT02474108|left atrium enlargement|left atrium enlargement
1112964|NCT02474108|cryoablation|cryoablation
1112965|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
1112966|NCT02474043|Injection drug use|injection drug use
1112967|NCT02474017|Inhaler|inhaler
1112968|NCT02474017|Adolescent|adolescent
1112969|NCT02473978|During Labor|during labor
1112970|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
1112971|NCT02473978|Cerebral|cerebral
1112972|NCT02473926|Physical Activity|physical activity
1112973|NCT02473926|Physical Function|physical function
1112974|NCT02473926|Physical Impairment|physical impairment
1112975|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
1112976|NCT02473887|ondansetron|ondansetron
1112977|NCT02473887|palatability|palatability
1112978|NCT02473887|vomiting|vomiting
1112979|NCT02473861|exercise training|exercise training
1112980|NCT02473861|breast cancer|breast cancer
1112981|NCT02473861|taxane chemotherapy|taxane chemotherapy
1112982|NCT02473861|peripheral neuropathy|peripheral neuropathy
1112983|NCT02473861|fatigue|fatigue
1112984|NCT02473861|autonomic function|autonomic function
1112985|NCT02473835|T-lymphocyte|t-lymphocyte
1112986|NCT02473835|Adipose tissue|adipose tissue
1112987|NCT02473835|Inflammation|inflammation
1112988|NCT02473835|Calorie restriction|calorie restriction
1112989|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
1112992|NCT02473822|joint trauma|joint trauma
1112993|NCT02473796|home based child care|home based child care
1112994|NCT02473770|Registry|registry
1112995|NCT02473770|Exposures|exposures
1112996|NCT02473770|Biological Specimens|biological specimens
1112997|NCT02473770|Occupational Health|occupational health
1112998|NCT02473757|Recombinant DNA Product|recombinant dna product
1112999|NCT02473757|Laboratory Evaluation|laboratory evaluation
1113000|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
1113001|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
1113002|NCT02473744|lower limb edema|lower limb edema
1113003|NCT02473744|subcutaneous drainage|subcutaneous drainage
1113004|NCT02473744|bioelectrical impedance|bioelectrical impedance
1113005|NCT02473744|quality of life|quality of life
1113006|NCT02473731|CDX3379|cdx3379
1113007|NCT02473705|Geriatric|geriatric
1113008|NCT02473705|bicarbonate|bicarbonate
1113009|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
1113010|NCT02473705|exercise capacity|exercise capacity
1113011|NCT02473679|First Responder|first responder
1113012|NCT02473679|BLS|bls
1113013|NCT02473679|AED|aed
1113014|NCT02473679|Resuscitation|resuscitation
1113808|NCT02469415|Lower-risk|lower-risk
1113015|NCT02473666|Patient Blood Management|patient blood management
1113016|NCT02473666|Red Blood Cells|red blood cells
1113017|NCT02473666|Platelet|platelet
1113018|NCT02473627|Pharmacokinetics|pharmacokinetics
1113019|NCT02473601|mivacurium chloramine|mivacurium chloramine
1113020|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
1113021|NCT02473601|muscle relaxation effect|muscle relaxation effect
1113022|NCT02473575|Caffeine, running, performance|caffeine, running, performance
1113023|NCT02473562|Parkinson's disease|parkinson's disease
1113024|NCT02473562|Varenicline|varenicline
1113025|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
1113026|NCT02473549|motor|motor
1113027|NCT02473549|rehabilitation|rehabilitation
1113028|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
1113029|NCT02473523|Fatigue|fatigue
1113030|NCT02473523|Pain Alleviation|pain alleviation
1113031|NCT02473523|Emotional Wellbeing|emotional wellbeing
1113032|NCT02473523|Physical Wellbeing|physical wellbeing
1113033|NCT02473523|Yoga|yoga
1113034|NCT02473510|Trivalent|trivalent
1113035|NCT02473510|Influenza|influenza
1113036|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
1113037|NCT02473510|Vaccine|vaccine
1113038|NCT02473510|Prevention|prevention
1113039|NCT02473510|Healthy|healthy
1113040|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
1113041|NCT02473497|activating mutation|activating mutation
1113042|NCT02473497|activating genetic alteration|activating genetic alteration
1113043|NCT02473497|genetic aberration|genetic aberration
1113045|NCT02473497|ROS1|ros1
1113046|NCT02473497|cMET|cmet
1113047|NCT02473497|crizotinib|crizotinib
1113048|NCT02473497|oral formulation|oral formulation
1113049|NCT02473484|High Grade Glioma|high grade glioma
1113050|NCT02473484|Proteomics|proteomics
1113051|NCT02473484|MALDI-MSI|maldi-msi
1113052|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
1113053|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
1113054|NCT02473471|Malocculsion|malocculsion
1113055|NCT02473458|Licorice|licorice
1113056|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
1113057|NCT02473458|Ischemic Stroke|ischemic stroke
1113058|NCT02473458|Acute|acute
1113059|NCT02473445|Inherited mitochondrial disease|inherited mitochondrial disease
1113060|NCT02473445|Leigh Syndrome|leigh syndrome
1113061|NCT02473445|Leber's Hereditary Optic Neuropathy (LHON)|leber's hereditary optic neuropathy (lhon)
1113062|NCT02473445|Myoclonic epilepsy and ragged-red fibers (MERFF)|myoclonic epilepsy and ragged-red fibers (merff)
1113063|NCT02473445|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (MELAS)|mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (melas)
1113064|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
1113065|NCT02473445|Polymerase gamma (POLG) -related disorders|polymerase gamma (polg) -related disorders
1113066|NCT02473445|Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)|mitochondrial neurogastrointestinal encephalopathy syndrome (mngie)
1113067|NCT02473432|respiratory muscle training|respiratory muscle training
1113068|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1113069|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
1113070|NCT02473432|stroke|stroke
1113071|NCT02473432|rehabilitation|rehabilitation
1113072|NCT02473419|Medical food|medical food
1113073|NCT02473419|ADHD|adhd
1113074|NCT02473419|Vayarin|vayarin
1113075|NCT02473419|Fish Oil|fish oil
1113076|NCT02473406|Acute Pancreatitis, prevent,Necrotizing|acute pancreatitis, prevent,necrotizing
1113077|NCT02473380|glioma|glioma
1113078|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
1113079|NCT02473341|Bovine Colostrum|bovine colostrum
1113080|NCT02473341|Corticosteriods|corticosteriods
1113081|NCT02473341|Endotoxin|endotoxin
1113082|NCT02473341|MELD|meld
1113083|NCT02473341|mDF|mdf
1113084|NCT02473328|dose reduction study|dose reduction study
1113085|NCT02473289|Depressive disorder, major|depressive disorder, major
1113086|NCT02473289|Sirukumab|sirukumab
1113087|NCT02473263|Severe septic syndrome|severe septic syndrome
1113088|NCT02473263|mobile intensive care unit|mobile intensive care unit
1113089|NCT02473263|strategy|strategy
1113090|NCT02473263|antibiotics|antibiotics
1113091|NCT02473263|hemodynamic optimization|hemodynamic optimization
1113092|NCT02473237|COPD|copd
1113093|NCT02473237|biomass|biomass
1113094|NCT02473224|challenge|challenge
1113095|NCT02473224|GII.2|gii.2
1113096|NCT02473224|HID50|hid50
1113097|NCT02473224|Norovirus|norovirus
1113098|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
1113099|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
1113100|NCT02473198|Amide Local Anesthetic|amide local anesthetic
1113101|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
1113102|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
1113103|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
1113104|NCT02473159|breast cancer|breast cancer
1113105|NCT02473146|AML|aml
1113106|NCT02473146|untreated|untreated
1113107|NCT02473146|60-80 years old|60-80 years old
1113108|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
1113109|NCT02473133|radiotherapy|radiotherapy
1113809|NCT02469415|Pacritinib|pacritinib
1113110|NCT02473133|dose redistribution|dose redistribution
1113111|NCT02473133|boost|boost
1113112|NCT02473120|metastatic|metastatic
1113113|NCT02473120|ESR1|esr1
1113114|NCT02473120|aromatase inhibitor|aromatase inhibitor
1113115|NCT02473120|breast cancer|breast cancer
1113116|NCT02473107|Dental caries|dental caries
1113117|NCT02473107|Primary tooth|primary tooth
1113118|NCT02473107|Caries Detection|caries detection
1113119|NCT02473094|Metformin|metformin
1113120|NCT02473094|Rectal Cancer|rectal cancer
1113121|NCT02473094|Rectum|rectum
1113122|NCT02473094|Radiotherapy|radiotherapy
1113123|NCT02473094|Capecitabine|capecitabine
1113124|NCT02473094|Neoadjuvant|neoadjuvant
1113125|NCT02473094|Adenocarcinoma|adenocarcinoma
1113126|NCT02473094|Carcinoma|carcinoma
1113127|NCT02473081|Type 2 diabetes|type 2 diabetes
1113128|NCT02473081|Minimal psychological intervention|minimal psychological intervention
1113129|NCT02473081|Glycemic control|glycemic control
1113130|NCT02473081|Depressive symptoms|depressive symptoms
1113131|NCT02473081|Problem Area in Diabetes|problem area in diabetes
1113132|NCT02473081|Middle-aged and older adults|middle-aged and older adults
1113133|NCT02473081|HbA1c protein, human|hba1c protein, human
1113134|NCT02473068|CPAP|cpap
1113135|NCT02473055|kangaroo care|kangaroo care
1113136|NCT02473055|sleep|sleep
1113137|NCT02473055|heart rate|heart rate
1113138|NCT02473055|respiratory rate|respiratory rate
1113139|NCT02473055|preterm infant|preterm infant
1113140|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
1113141|NCT02473042|PONV|ponv
1113142|NCT02473042|Breast cancer|breast cancer
1113143|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
1113144|NCT02473042|NMBM|nmbm
1113145|NCT02473042|Breast cancer surgery|breast cancer surgery
1113146|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
1113147|NCT02473042|Electrical stimulation|electrical stimulation
1113148|NCT02473042|Zofran|zofran
1113149|NCT02473042|Ondansetron|ondansetron
1113150|NCT02473042|Dexamethasone|dexamethasone
1113151|NCT02473042|Decadron|decadron
1113152|NCT02473042|Phenergan|phenergan
1113153|NCT02473042|Promethazine|promethazine
1113154|NCT02473042|Phenazine|phenazine
1113155|NCT02473042|Phencen|phencen
1113156|NCT02473042|Prometh|prometh
1113157|NCT02473042|Prorex|prorex
1113158|NCT02473042|V-Gan|v-gan
1113159|NCT02473042|Pepcid|pepcid
1113160|NCT02473042|Famotidine|famotidine
1113161|NCT02473042|Questionnaire|questionnaire
1113162|NCT02473042|Survey|survey
1113163|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
1113164|NCT02473003|Breast cancer|breast cancer
1113165|NCT02473003|prostate cancer|prostate cancer
1113166|NCT02473003|colorectal cancer|colorectal cancer
1113167|NCT02473003|fatigue|fatigue
1113168|NCT02473003|physical exercise|physical exercise
1113169|NCT02473003|randomised trial|randomised trial
1113170|NCT02473003|intervention|intervention
1113171|NCT02472990|DMD|dmd
1113172|NCT02472990|morphological predictive factors|morphological predictive factors
1113173|NCT02472990|Mechanical|mechanical
1113174|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1113175|NCT02472912|Pharmacokinetics|pharmacokinetics
1113176|NCT02472912|Adalimumab|adalimumab
1113177|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
1113178|NCT02472899|Geriatrics|geriatrics
1113179|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
1113180|NCT02472899|Biomarkers|biomarkers
1113181|NCT02472899|Immunology|immunology
1113182|NCT02472886|HCV genotype 1|hcv genotype 1
1113183|NCT02472886|HCV|hcv
1113184|NCT02472886|Sustained Virologic Response|sustained virologic response
1113185|NCT02472886|Direct Acting Antiviral|direct acting antiviral
1113186|NCT02472886|Combination Therapy|combination therapy
1113187|NCT02472886|GS-7977|gs-7977
1113188|NCT02472886|GS-5885|gs-5885
1113189|NCT02472886|Ribavirin|ribavirin
1113190|NCT02472886|Sofosbuvir|sofosbuvir
1113193|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
1113194|NCT02472886|Liver Diseases|liver diseases
1113195|NCT02472886|Virus Diseases|virus diseases
1113196|NCT02472886|Antiviral Agents|antiviral agents
1113197|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
1113198|NCT02472873|endometrioma|endometrioma
1113199|NCT02472873|endometriosis|endometriosis
1113200|NCT02472873|sclerotherapy|sclerotherapy
1113201|NCT02472873|ethanol|ethanol
1113202|NCT02472873|aspiration|aspiration
1113203|NCT02472873|laparoscopy|laparoscopy
1113204|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
1113205|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
1113206|NCT02472847|Marinol|marinol
1113207|NCT02472847|Dronabinol|dronabinol
1113208|NCT02472847|Fear extinction|fear extinction
1113209|NCT02472847|Healthy volunteers|healthy volunteers
1113210|NCT02472834|Carbamylation|carbamylation
1113211|NCT02472834|Albumin|albumin
1113212|NCT02472834|Protein structure|protein structure
1113213|NCT02472834|Kidney disease|kidney disease
1113214|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
1113215|NCT02472782|osteoporosis|osteoporosis
1113216|NCT02472782|quality of life|quality of life
1113217|NCT02472782|adherence|adherence
1113218|NCT02472782|treatment|treatment
1113219|NCT02472743|Phototherapy|phototherapy
1113220|NCT02472730|Colonoscopy|colonoscopy
1113221|NCT02472730|Training Techniques|training techniques
1113222|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1113223|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
1113224|NCT02472704|celiac disease|celiac disease
1113225|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
1113226|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
1113227|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
1113228|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
1113230|NCT02472691|AML|aml
1113231|NCT02472691|CMML|cmml
1113232|NCT02472691|DLI|dli
1113233|NCT02472691|Azacitidine|azacitidine
1113234|NCT02472691|Lenalidomide|lenalidomide
1113235|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
1113236|NCT02472691|C15.378.190.625|c15.378.190.625
1113237|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
1113238|NCT02472665|pediatric|pediatric
1113239|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
1113240|NCT02472613|Post－Stroke Depression|post－stroke depression
1113241|NCT02472613|Acupunture|acupunture
1113242|NCT02472613|Fluoxetine|fluoxetine
1113243|NCT02472613|RCT|rct
1113244|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
1113245|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
1113246|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
1113247|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
1113248|NCT02472574|minimally invasive surgery|minimally invasive surgery
1113249|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1113250|NCT02472574|Dose-effect Relationship|dose-effect relationship
1113251|NCT02472561|Cardiology|cardiology
1113252|NCT02472561|Vascular|vascular
1113253|NCT02472561|Peripheral Artery Disease|peripheral artery disease
1113254|NCT02472561|Artery|artery
1113255|NCT02472561|Mobile Health|mobile health
1113256|NCT02472561|Exercise|exercise
1113257|NCT02472561|PAD|pad
1113258|NCT02472535|HoFH|hofh
1113259|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
1113260|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
1113261|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
1113262|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
1113263|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
1113264|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
1113265|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
1113266|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
1113267|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
1113268|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
1113269|NCT02472509|Ultrasound (US)|ultrasound (us)
1113270|NCT02472470|rTMS|rtms
1113271|NCT02472470|Depression|depression
1113272|NCT02472470|Youth|youth
1113273|NCT02472470|TBS|tbs
1113274|NCT02472470|Brain Stimulation|brain stimulation
1113275|NCT02472470|Electrophysiology|electrophysiology
1113276|NCT02472470|Imaging|imaging
1113277|NCT02472431|ADRC|adrc
1113278|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
1113279|NCT02472431|Fat Tissue|fat tissue
1113280|NCT02472431|Stem Cells|stem cells
1113281|NCT02472431|Erectile Dysfunction|erectile dysfunction
1113282|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
1113283|NCT02472431|Venogenic Impotence|venogenic impotence
1113284|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
1113285|NCT02472431|Male Impotence|male impotence
1113286|NCT02472431|Male Sexual Impotence|male sexual impotence
1113287|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
1113288|NCT02472379|Immune System|immune system
1113289|NCT02472379|Behavioral Sciences|behavioral sciences
1113290|NCT02472379|Women's Health|women's health
1113291|NCT02472379|Health Psychology|health psychology
1113292|NCT02472379|Writing|writing
1113293|NCT02472353|breast|breast
1113294|NCT02472353|cancer|cancer
1113295|NCT02472353|doxorubicin|doxorubicin
1113296|NCT02472353|metformin|metformin
1113297|NCT02472353|cardiotoxicity|cardiotoxicity
1113298|NCT02472353|ejection fraction|ejection fraction
1113299|NCT02472353|LVEF|lvef
1113300|NCT02472288|urinary retention|urinary retention
1113301|NCT02472288|poststroke|poststroke
1113302|NCT02472288|electroacupuncture|electroacupuncture
1113303|NCT02472288|randomized controlled trial|randomized controlled trial
1113304|NCT02472288|effectiveness|effectiveness
1113305|NCT02472288|safety|safety
1113306|NCT02472262|Environmental|environmental
1113307|NCT02472262|Enteric|enteric
1113308|NCT02472249|TACE|tace
1113309|NCT02472249|CT perfusion|ct perfusion
1113310|NCT02472249|Liver blood flow|liver blood flow
1113311|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1113312|NCT02472223|"Pink Eye"|"pink eye"
1113313|NCT02472197|Endometrial polyp|endometrial polyp
1113314|NCT02472197|Hysteroscopic resection|hysteroscopic resection
1113315|NCT02472197|Morcellation|morcellation
1165663|NCT02190747|FOP|fop
1113316|NCT02472184|Office hysteroscopy|office hysteroscopy
1113317|NCT02472184|Endometrial biopsy|endometrial biopsy
1113318|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
1113319|NCT02472184|Uterine fibroids|uterine fibroids
1113320|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1113321|NCT02472171|blueberries|blueberries
1113322|NCT02472158|Bandages|bandages
1113323|NCT02472158|Central Venous Catheters|central venous catheters
1113324|NCT02472158|Catheter-Related Infections|catheter-related infections
1113325|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
1113326|NCT02472145|DACOGEN|dacogen
1113327|NCT02472145|Decitabine|decitabine
1113328|NCT02472145|JNJ-56022473|jnj-56022473
1113329|NCT02472145|CLS362|cls362
1113330|NCT02472132|Central Venous Catheter|central venous catheter
1113331|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
1113332|NCT02472132|Sub Clavian Vein|sub clavian vein
1113333|NCT02472132|Internal Jugular Vein|internal jugular vein
1113334|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
1113335|NCT02472119|Celiac disease|celiac disease
1113336|NCT02472119|Gluten-free diet|gluten-free diet
1113337|NCT02472119|Wheat flour treatment|wheat flour treatment
1113338|NCT02472119|Microbial transglutaminase|microbial transglutaminase
1113339|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
1113340|NCT02472119|Celiac Disease Treatment|celiac disease treatment
1113341|NCT02472106|Aortic Valve|aortic valve
1113342|NCT02472106|TAVI|tavi
1113343|NCT02472106|Stenosis|stenosis
1113344|NCT02472093|Postural exercise|postural exercise
1113345|NCT02472093|Back pain|back pain
1113346|NCT02472093|Tender points|tender points
1113347|NCT02472093|Fibromyalgia|fibromyalgia
1113348|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
1113349|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
1113350|NCT02472067|physical therapy|physical therapy
1113351|NCT02472067|psychological intervention|psychological intervention
1113352|NCT02472067|risk factors|risk factors
1113353|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
1113354|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
1113355|NCT02472041|chest drain|chest drain
1113356|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
1113357|NCT02472028|Stroke|stroke
1113358|NCT02472028|Antihypertensive Agents|antihypertensive agents
1113359|NCT02472028|Arterial Pressure|arterial pressure
1113360|NCT02472028|Memory Disorders|memory disorders
1113361|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
1113362|NCT02472015|dementia|dementia
1113363|NCT02472015|telemedicine|telemedicine
1113364|NCT02472015|long-term care facilities|long-term care facilities
1113365|NCT02472002|Transplant coronary diseases|transplant coronary diseases
1113366|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
1113367|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
1113368|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
1113369|NCT02471989|FODMAP|fodmap
1113370|NCT02471989|Diet|diet
1113371|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
1113372|NCT02471976|Leonetti law|leonetti law
1113373|NCT02471976|palliative care|palliative care
1113374|NCT02471963|Empagliflozin|empagliflozin
1113375|NCT02471963|Diabetes mellitus|diabetes mellitus
1113376|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
1113377|NCT02471963|Vascular Improvement|vascular improvement
1113378|NCT02471963|Endothelium function|endothelium function
1113379|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
1113380|NCT02471937|Group B Streptococcus|group b streptococcus
1113381|NCT02471937|Neonates|neonates
1113382|NCT02471937|colonization|colonization
1113383|NCT02471937|meningitis|meningitis
1113384|NCT02471937|Clonal Complex CC17|clonal complex cc17
1113385|NCT02471937|microbiota|microbiota
1113386|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
1113387|NCT02471924|Pregnant women|pregnant women
1113388|NCT02471911|DLBCL|dlbcl
1113389|NCT02471911|Aggressive|aggressive
1113390|NCT02471911|Diffuse|diffuse
1113391|NCT02471911|Large|large
1113392|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
1113393|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
1113394|NCT02471885|cardio-oncology|cardio-oncology
1113395|NCT02471885|anthracycline|anthracycline
1113396|NCT02471885|troponin|troponin
1113397|NCT02471885|chemotherapy|chemotherapy
1113398|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
1113399|NCT02471833|Hypertension|hypertension
1113400|NCT02471833|Prevention|prevention
1113401|NCT02471833|Family History|family history
1113402|NCT02471833|inflammation|inflammation
1113403|NCT02471833|blood brain barrier|blood brain barrier
1113404|NCT02471833|amyloid|amyloid
1113405|NCT02471820|Multiple Myeloma|multiple myeloma
1113406|NCT02471794|Type II Diabetes|type ii diabetes
1113407|NCT02471794|Personalized Health Planning|personalized health planning
1113408|NCT02471794|Shared Medical Appointments|shared medical appointments
1113409|NCT02471781|Aortic Aneurysm|aortic aneurysm
1113410|NCT02471781|Aneurysm|aneurysm
1113411|NCT02471781|Vascular Prosthesis|vascular prosthesis
1113412|NCT02471781|Vascular Disease|vascular disease
1113413|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
1113414|NCT02471768|central pressure|central pressure
1113415|NCT02471768|Gensini score|gensini score
1113416|NCT02471768|pulsatility|pulsatility
1113417|NCT02471768|coronary artery disease|coronary artery disease
1113418|NCT02471755|electro-acupuncture|electro-acupuncture
1113419|NCT02471755|menopause|menopause
1113420|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
1113421|NCT02471755|efficacy|efficacy
1113422|NCT02471755|RCT|rct
1113423|NCT02471755|placebo control|placebo control
1113424|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
1113425|NCT02471729|Chronic Heart Failure|chronic heart failure
1113426|NCT02471729|Renal Denervation|renal denervation
1113427|NCT02471729|Sympathetic activation|sympathetic activation
1113428|NCT02471729|Heart Failure|heart failure
1113429|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
1113430|NCT02471729|Heart Diseases|heart diseases
1113431|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
1113432|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
1113433|NCT02471703|Total Hip Replacement|total hip replacement
1113434|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
1113435|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
1113436|NCT02471690|Volunteers|volunteers
1113437|NCT02471677|Ovarian stimulation|ovarian stimulation
1113438|NCT02471677|corifollitropin alfa|corifollitropin alfa
1113439|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
1113440|NCT02471677|high responders|high responders
1113441|NCT02471677|follitropin beta|follitropin beta
1113442|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
1113443|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
1113444|NCT02471664|Mitral loop cerclage|mitral loop cerclage
1113445|NCT02471625|Controls|controls
1113446|NCT02471599|IgA nephropathy|iga nephropathy
1113447|NCT02471599|tonsillitis|tonsillitis
1113448|NCT02471599|tonsil provocation test|tonsil provocation test
1113449|NCT02471599|Tonsillectomy|tonsillectomy
1113450|NCT02471573|IVF|ivf
1113451|NCT02471573|Freeze-all|freeze-all
1113452|NCT02471573|frozen embryo transfer|frozen embryo transfer
1113453|NCT02471573|fresh transfer|fresh transfer
1113454|NCT02471560|Microbiota|microbiota
1113455|NCT02471560|DMF|dmf
1113456|NCT02471560|Gastro intestinal|gastro intestinal
1113457|NCT02471560|MS|ms
1113458|NCT02471547|Recurrence|recurrence
1113459|NCT02471495|NMIBC|nmibc
1113460|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
1113461|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
1113462|NCT02471495|BCG refractory|bcg refractory
1113463|NCT02471495|BCG failure|bcg failure
1113464|NCT02471495|Carcinoma in situ|carcinoma in situ
1113465|NCT02471495|CIS|cis
1113466|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
1113467|NCT02471482|Cerebral oxygenation|cerebral oxygenation
1113468|NCT02471482|Mozart music|mozart music
1113469|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
1113470|NCT02471404|metformin,|metformin,
1113471|NCT02471404|saxagliptin,|saxagliptin,
1113472|NCT02471404|dapagliflozin,|dapagliflozin,
1113473|NCT02471404|glimepiride,|glimepiride,
1113474|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
1113475|NCT02471378|Assay|assay
1113476|NCT02471378|Women|women
1113477|NCT02471378|Infected|infected
1113478|NCT02471378|Antibodies|antibodies
1113479|NCT02471365|Exposure Assessment|exposure assessment
1113480|NCT02471365|Questionnaire|questionnaire
1113481|NCT02471365|Product Use|product use
1113482|NCT02471365|Biomonitoring|biomonitoring
1113483|NCT02471352|Dermatologic Condition|dermatologic condition
1113484|NCT02471352|Skin Disease|skin disease
1113485|NCT02471352|Biospecimen|biospecimen
1113486|NCT02471352|Healthy Volunteers|healthy volunteers
1113487|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
1113488|NCT02471339|Psychological Intervention|psychological intervention
1113489|NCT02471339|Coping|coping
1113490|NCT02471339|Mindfulness|mindfulness
1113491|NCT02471339|Randomized|randomized
1113492|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
1113493|NCT02471326|HIV Therapy|hiv therapy
1113494|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
1113495|NCT02471313|Chemoembolization|chemoembolization
1113496|NCT02471313|Radiation Therapy|radiation therapy
1113497|NCT02471313|Tumor Hypoxia|tumor hypoxia
1113498|NCT02471313|PET Imaging|pet imaging
1113499|NCT02471300|Asthma|asthma
1113500|NCT02471300|Inflammasome|inflammasome
1113501|NCT02471300|Fasting|fasting
1113502|NCT02471300|Airflow Obstruction|airflow obstruction
1113503|NCT02471287|Ocular Genetic Diseases|ocular genetic diseases
1113504|NCT02471287|GENETIC DISEASE|genetic disease
1113505|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
1113506|NCT02471131|WATCHMAN|watchman
1113507|NCT02471131|Atrial Fibrillation|atrial fibrillation
1113508|NCT02471131|Hybrid Ablation|hybrid ablation
1113510|NCT02471131|Feasibility|feasibility
1113511|NCT02471131|Stroke Prevention|stroke prevention
1113512|NCT02471118|Inflammatory Type|inflammatory type
1113514|NCT02471092|glycemia|glycemia
1113515|NCT02471092|milk protein|milk protein
1113516|NCT02471079|Radiation-induced health problems|radiation-induced health problems
1113517|NCT02471079|Cardiovascular events|cardiovascular events
1113518|NCT02471079|Lung toxicity|lung toxicity
1113519|NCT02471053|Exercise|exercise
1113520|NCT02471053|Quality of Life|quality of life
1113521|NCT02471053|Complementary Therapies|complementary therapies
1113522|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
1113523|NCT02471053|Feasibility Studies|feasibility studies
1113524|NCT02471040|brain metabolism|brain metabolism
1113525|NCT02471040|cognitive function|cognitive function
1113526|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
1113527|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1113528|NCT02471027|Disease-free survival|disease-free survival
1113529|NCT02471027|Overall survival|overall survival
1113530|NCT02471014|Pneumovax23|pneumovax23
1113531|NCT02471014|Obesity|obesity
1113532|NCT02471001|concentration|concentration
1113533|NCT02471001|Isoflurane|isoflurane
1113534|NCT02471001|cardioprotective|cardioprotective
1113535|NCT02471001|cardioplegia|cardioplegia
1113536|NCT02471001|heart surgery|heart surgery
1113537|NCT02471001|Disorder|disorder
1113538|NCT02471001|Heart|heart
1113539|NCT02471001|Functional|functional
1113540|NCT02471001|Postoperative|postoperative
1113541|NCT02470949|body weight|body weight
1113542|NCT02470949|Hispanics|hispanics
1113543|NCT02470949|Energy Intake|energy intake
1113544|NCT02470949|Social Status|social status
1113545|NCT02470923|Smoking cessation|smoking cessation
1113546|NCT02470923|Nicotine|nicotine
1113547|NCT02470923|Spirometry|spirometry
1113548|NCT02470923|Internal medicine|internal medicine
1113549|NCT02470910|Prostate Cancer|prostate cancer
1113550|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
1113551|NCT02470806|Venous leg ulcer|venous leg ulcer
1113552|NCT02470806|ulcer|ulcer
1113553|NCT02470806|venous stasis|venous stasis
1113554|NCT02470806|compression|compression
1113555|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
1113556|NCT02470806|dfu|dfu
1113557|NCT02470806|vlu|vlu
1113558|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
1113559|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
1113560|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
1113561|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
1113562|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
1113563|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
1113564|NCT02470728|patient readmission|patient readmission
1113565|NCT02470728|pain relief units|pain relief units
1113566|NCT02470728|pain centers|pain centers
1113567|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
1113568|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
1113569|NCT02470728|pain clinics|pain clinics
1113570|NCT02470728|hospital readmission|hospital readmission
1113571|NCT02470728|emergencies|emergencies
1113572|NCT02470728|emergency medicine|emergency medicine
1113573|NCT02470728|critical care|critical care
1113574|NCT02470728|emergency treatment|emergency treatment
1113575|NCT02470728|opioid|opioid
1113576|NCT02470728|acute pain service|acute pain service
1113577|NCT02470715|genetic sequencing|genetic sequencing
1113578|NCT02470715|genome|genome
1113579|NCT02470715|cancer|cancer
1113580|NCT02470715|DNA|dna
1113581|NCT02470715|RNA|rna
1113582|NCT02470715|protein|protein
1113583|NCT02470715|metabolite|metabolite
1113584|NCT02470702|Volunteers|volunteers
1113585|NCT02470650|comparative effectiveness|comparative effectiveness
1113586|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
1113587|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
1113588|NCT02470598|Hydration status|hydration status
1113589|NCT02470598|Residual Renal Function|residual renal function
1113590|NCT02470598|Ultrafiltration|ultrafiltration
1113591|NCT02470585|Veliparib|veliparib
1113592|NCT02470585|Carboplatin|carboplatin
1113593|NCT02470585|Paclitaxel|paclitaxel
1113594|NCT02470585|Overall Survival|overall survival
1113595|NCT02470585|ABT-888|abt-888
1113596|NCT02470585|Randomized|randomized
1113597|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
1113598|NCT02470585|Ovarian|ovarian
1113599|NCT02470585|BRCA|brca
1113600|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
1113601|NCT02470546|Metformin|metformin
1113602|NCT02470546|Liver cirrhosis|liver cirrhosis
1113603|NCT02470481|Psoriatic arthritis|psoriatic arthritis
1113604|NCT02470468|Immunotherapy|immunotherapy
1113605|NCT02470468|Metastatic|metastatic
1113606|NCT02470468|NSCLC|nsclc
1113607|NCT02470468|Biological|biological
1166079|NCT02189161|AIN|ain
1113608|NCT02470468|Lung Cancer|lung cancer
1113609|NCT02470468|Vaccine|vaccine
1113610|NCT02470455|Atorvastatin|atorvastatin
1113611|NCT02470455|Prediabetics|prediabetics
1113612|NCT02470455|HbA1c|hba1c
1113613|NCT02470416|duodenal|duodenal
1113614|NCT02470416|ampulla|ampulla
1113615|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
1113616|NCT02470390|Volunteer|volunteer
1113617|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
1113618|NCT02470377|MdDS|mdds
1113620|NCT02470377|fMRI|fmri
1113621|NCT02470377|EEG|eeg
1113622|NCT02470364|Myasthenia gravis|myasthenia gravis
1113623|NCT02470364|Quality of life|quality of life
1113624|NCT02470325|Cerebral palsy|cerebral palsy
1113625|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
1113626|NCT02470312|utility of MediGuide system|utility of mediguide system
1113627|NCT02470312|CRT|crt
1113628|NCT02470312|EP|ep
1113629|NCT02470299|ketorolac|ketorolac
1113630|NCT02470299|GTPase|gtpase
1113631|NCT02470299|cancer|cancer
1113632|NCT02470299|peritoneal|peritoneal
1113633|NCT02470299|fallopian|fallopian
1113634|NCT02470299|ovarian|ovarian
1113635|NCT02470273|Melanoma|melanoma
1113636|NCT02470260|Diabetes|diabetes
1113637|NCT02470260|Pre-diabetes|pre-diabetes
1113638|NCT02470260|Cognition|cognition
1113639|NCT02470260|Depressive symptoms|depressive symptoms
1113640|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
1113641|NCT02470234|ADHD|adhd
1113642|NCT02470234|Children|children
1113643|NCT02470234|Pharmacokinetics|pharmacokinetics
1113644|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
1113645|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
1113646|NCT02470221|postoperative complications|postoperative complications
1113647|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
1113648|NCT02470182|sleep apnea|sleep apnea
1113649|NCT02470182|snoring|snoring
1113650|NCT02470156|community based participatory research|community based participatory research
1113651|NCT02470156|healthy eating|healthy eating
1113652|NCT02470156|physical activity|physical activity
1113653|NCT02470156|obesity|obesity
1113654|NCT02470143|Human-computer interaction|human-computer interaction
1113655|NCT02470143|Fear|fear
1113656|NCT02470143|Motivation|motivation
1113657|NCT02470143|Usability|usability
1113658|NCT02470130|simulation|simulation
1113659|NCT02470130|anxiety|anxiety
1113660|NCT02470130|debriefing|debriefing
1113661|NCT02470130|memorization|memorization
1113662|NCT02470104|children|children
1113663|NCT02470104|bone marrow transplant|bone marrow transplant
1113664|NCT02470104|autologous|autologous
1113665|NCT02470104|allogeneic|allogeneic
1113666|NCT02470104|breastmilk|breastmilk
1113667|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1113668|NCT02470078|extubation|extubation
1113669|NCT02470065|NSCLC|nsclc
1113670|NCT02470065|Early stage|early stage
1113671|NCT02470065|Phase II|phase ii
1113672|NCT02470065|Randomized|randomized
1113673|NCT02470065|EGFR mutated|egfr mutated
1113674|NCT02470052|Endobronchial Valves|endobronchial valves
1113675|NCT02470052|Intrabronchial Valves|intrabronchial valves
1113676|NCT02470052|Bronchial Valve|bronchial valve
1113677|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1113678|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1113679|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1113680|NCT02470052|Emphysema|emphysema
1113681|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
1113682|NCT02470052|Lung Diseases|lung diseases
1113683|NCT02470052|Respiratory Tract Disease|respiratory tract disease
1113684|NCT02470013|Malnutrition|malnutrition
1113685|NCT02470013|Geriatrics|geriatrics
1113686|NCT02470013|Enteral Nutrition|enteral nutrition
1113687|NCT02470000|myofascial pain|myofascial pain
1113688|NCT02470000|neck|neck
1113689|NCT02470000|laser|laser
1113690|NCT02470000|elastography|elastography
1113691|NCT02470000|shear wave velocity|shear wave velocity
1113692|NCT02470000|randomized control trial|randomized control trial
1113693|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
1113694|NCT02469987|safety|safety
1113695|NCT02469987|tolerability|tolerability
1113696|NCT02469987|immunogenicity|immunogenicity
1113697|NCT02469987|MYL-1402O|myl-1402o
1113698|NCT02469987|PK|pk
1113699|NCT02469987|Avastin®|avastin®
1113700|NCT02469987|biosimilarity|biosimilarity
1113701|NCT02469987|male|male
1113702|NCT02469974|Myelofibrosis|myelofibrosis
1113703|NCT02469974|RUXOLITINIB|ruxolitinib
1113704|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
1113705|NCT02469948|spasticity|spasticity
1113706|NCT02469948|botulinum toxin|botulinum toxin
1113707|NCT02469948|ultrasonography guidance|ultrasonography guidance
1113708|NCT02469948|electric stimulation guidance|electric stimulation guidance
1113709|NCT02469948|stroke|stroke
1113710|NCT02469935|Validation|validation
1113711|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
1113713|NCT02469909|Decannulation|decannulation
1113714|NCT02469909|tracheostomy|tracheostomy
1113715|NCT02469896|ALS|als
1113716|NCT02469896|tocilizumab|tocilizumab
1113717|NCT02469896|biomarker|biomarker
1113718|NCT02469870|Parents of children who have autism|parents of children who have autism
1113719|NCT02469870|video-conferencing|video-conferencing
1113720|NCT02469870|Applied Behavior Analysis|applied behavior analysis
1113721|NCT02469870|Acceptance Commitment Training|acceptance commitment training
1113722|NCT02469870|optimism training|optimism training
1113723|NCT02469870|Positive Behavior Support|positive behavior support
1113724|NCT02469857|AB103|ab103
1113725|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
1113726|NCT02469818|pocus|pocus
1113727|NCT02469818|ultrasonography|ultrasonography
1113728|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
1113729|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
1113730|NCT02469792|Ligament rupture|ligament rupture
1113731|NCT02469792|Intraarticular injection|intraarticular injection
1113732|NCT02469792|ADRC|adrc
1113733|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
1113734|NCT02469792|Adipose tissue|adipose tissue
1113735|NCT02469792|Stem cells|stem cells
1113736|NCT02469779|Tobacco Prevention|tobacco prevention
1113737|NCT02469779|ASPIRE Website|aspire website
1113738|NCT02469779|Surveys|surveys
1113739|NCT02469779|Questionnaires|questionnaires
1113740|NCT02469779|Focus Groups|focus groups
1113741|NCT02469779|Health Interactive Website|health interactive website
1113742|NCT02469766|ureteral stones|ureteral stones
1113743|NCT02469766|ureter|ureter
1113744|NCT02469766|ureteroscopy|ureteroscopy
1113745|NCT02469766|flexible|flexible
1113746|NCT02469766|SWL|swl
1113747|NCT02469753|NSAIDs|nsaids
1113748|NCT02469753|Anti-TNF|anti-tnf
1113749|NCT02469753|syndesmophytes|syndesmophytes
1113750|NCT02469753|mSASSS|msasss
1113751|NCT02469740|Ticagrelor|ticagrelor
1113752|NCT02469740|Clopidogrel|clopidogrel
1113753|NCT02469740|Coronary Artery Disease|coronary artery disease
1113754|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
1113755|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
1113756|NCT02469714|Patient Navigator|patient navigator
1113757|NCT02469714|Integrated Care|integrated care
1113758|NCT02469714|Latino|latino
1113759|NCT02469714|Mental health and wellness|mental health and wellness
1113760|NCT02469714|Physical health and wellness|physical health and wellness
1113761|NCT02469688|cedar pollinosis|cedar pollinosis
1113762|NCT02469688|immunological response,|immunological response,
1113763|NCT02469688|ASP4070|asp4070
1113764|NCT02469688|vaccine|vaccine
1113765|NCT02469675|Spinal Cord Injuries|spinal cord injuries
1113766|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1113767|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
1113768|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
1113769|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
1113770|NCT02469662|TEA|tea
1113771|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
1113772|NCT02469662|Elbow Replacement|elbow replacement
1113773|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
1113774|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
1113775|NCT02469662|Degenerative Arthritis|degenerative arthritis
1113776|NCT02469662|Elbow Joint Destruction|elbow joint destruction
1113777|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
1113778|NCT02469662|Ankylosed Joints|ankylosed joints
1113779|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
1113780|NCT02469662|significantly compromises daily living activities|significantly compromises daily living activities
1113781|NCT02469662|degree of joint or soft tissue damage precludes reliable osteosynthesis|degree of joint or soft tissue damage precludes reliable osteosynthesis
1113782|NCT02469662|precludes less radical procedures, including 13-C3 fractures of the distal humerus|precludes less radical procedures, including 13-c3 fractures of the distal humerus
1113783|NCT02469610|Post surgical pain|post surgical pain
1113784|NCT02469584|prolapse|prolapse
1113785|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
1113786|NCT02469545|depression|depression
1113895|NCT02468934|TKA pain|tka pain
1113787|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
1113788|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
1113789|NCT02469545|probiotic|probiotic
1113790|NCT02469480|MCRC|mcrc
1113791|NCT02469480|iron substitution|iron substitution
1113792|NCT02469480|iron deficiency anemia|iron deficiency anemia
1113793|NCT02469467|phosphate binder|phosphate binder
1113794|NCT02469467|dialysis|dialysis
1113795|NCT02469454|etonogestrel-implant|etonogestrel-implant
1113796|NCT02469454|newborn|newborn
1113797|NCT02469454|growth|growth
1113798|NCT02469454|Child Development|child development
1113799|NCT02469441|coffee|coffee
1113800|NCT02469441|postoperative ileus|postoperative ileus
1113801|NCT02469441|colorectal surgery|colorectal surgery
1113802|NCT02469428|Controlled human exposure study|controlled human exposure study
1113803|NCT02469428|Ozone|ozone
1113804|NCT02469428|Inflammation|inflammation
1113805|NCT02469415|Leukemia|leukemia
1113806|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
1113807|NCT02469415|MDS|mds
1113813|NCT02469415|Vidaza|vidaza
1113814|NCT02469415|5-AZC|5-azc
1113815|NCT02469415|AZA-CR|aza-cr
1113816|NCT02469415|Ladakamycin|ladakamycin
1113817|NCT02469415|NSC-102816|nsc-102816
1113818|NCT02469415|Azacytidine|azacytidine
1113819|NCT02469415|Decitabine|decitabine
1113820|NCT02469415|Dacogen|dacogen
1113821|NCT02469402|reduced|reduced
1113822|NCT02469402|protein|protein
1113823|NCT02469402|formula|formula
1113824|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
1113825|NCT02469402|infant|infant
1113826|NCT02469389|Schizophrenia|schizophrenia
1113827|NCT02469389|Negative Symptoms|negative symptoms
1113828|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
1113829|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
1113830|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
1113831|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
1113832|NCT02469363|Hemodynamic parameters|hemodynamic parameters
1113833|NCT02469350|Gait and balance disorders|gait and balance disorders
1113834|NCT02469350|serious game|serious game
1113835|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
1113836|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
1113837|NCT02469298|Danirixin|danirixin
1113838|NCT02469298|oseltamivir|oseltamivir
1113839|NCT02469285|Fatty acids|fatty acids
1113840|NCT02469285|Lipids|lipids
1113841|NCT02469285|Nitroso compounds|nitroso compounds
1113842|NCT02469285|Lipid metabolism|lipid metabolism
1113843|NCT02469285|Gut metabolism|gut metabolism
1113844|NCT02469259|oxytocin|oxytocin
1113845|NCT02469259|PTSD|ptsd
1113846|NCT02469259|Alcohol Use Disorder|alcohol use disorder
1113847|NCT02469259|social cognition|social cognition
1113848|NCT02469259|craving|craving
1113849|NCT02469259|fear-potentiated startle|fear-potentiated startle
1113850|NCT02469246|HIV|hiv
1113851|NCT02469246|HIV-1 Positive|hiv-1 positive
1113852|NCT02469246|Virologically-Suppressed|virologically-suppressed
1113853|NCT02469220|Diet|diet
1113854|NCT02469220|low FODMAP|low fodmap
1113855|NCT02469220|UC|uc
1113856|NCT02469220|IBS|ibs
1113857|NCT02469207|regenerative medicine|regenerative medicine
1113858|NCT02469207|stem cells|stem cells
1113859|NCT02469207|immunomodulatory|immunomodulatory
1113860|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
1113861|NCT02469207|gut physiology|gut physiology
1113862|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
1113863|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
1113864|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
1113865|NCT02469129|PARP1 inhibitors|parp1 inhibitors
1113866|NCT02469129|cancer treatments|cancer treatments
1113867|NCT02469103|capsule colonoscopy|capsule colonoscopy
1113868|NCT02469103|ulcerative colitis|ulcerative colitis
1113869|NCT02469077|Chronic Low Back Pain|chronic low back pain
1113870|NCT02469064|mechanical ventilation|mechanical ventilation
1113871|NCT02469064|respiratory muscle|respiratory muscle
1113872|NCT02469064|weaning|weaning
1113873|NCT02469064|training|training
1113874|NCT02469064|Intensive care|intensive care
1113875|NCT02469012|chronic hepatitis C|chronic hepatitis c
1113876|NCT02469012|antiviral treatment|antiviral treatment
1113877|NCT02469012|interferon-free|interferon-free
1113878|NCT02469012|neurocognitive performance|neurocognitive performance
1113879|NCT02469012|emotional state|emotional state
1113880|NCT02469012|quality of life|quality of life
1113881|NCT02468999|Intranasal insulin|intranasal insulin
1113882|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
1113883|NCT02468973|health behavior|health behavior
1113884|NCT02468973|consultation|consultation
1113885|NCT02468973|undergraduate|undergraduate
1113886|NCT02468960|Coronary Artery Disease|coronary artery disease
1113887|NCT02468960|OPN NC|opn nc
1113888|NCT02468960|Angina|angina
1113889|NCT02468960|Stable|stable
1113890|NCT02468960|Unstable|unstable
1113891|NCT02468947|Neonatal sepsis|neonatal sepsis
1113892|NCT02468934|electrical stimulation|electrical stimulation
1113893|NCT02468934|neurostimulation|neurostimulation
1113894|NCT02468934|neuromodulation|neuromodulation
1113896|NCT02468934|pain following total knee replacement|pain following total knee replacement
1113897|NCT02468934|total knee arthroplasty|total knee arthroplasty
1113898|NCT02468921|Goitre|goitre
1113899|NCT02468921|thyroid disease|thyroid disease
1113900|NCT02468921|struma|struma
1113901|NCT02468895|Myositis|myositis
1113902|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
1113903|NCT02468895|Antibodies|antibodies
1113904|NCT02468895|Genetics|genetics
1113905|NCT02468895|Biomarkers|biomarkers
1113906|NCT02468882|Breast cancer|breast cancer
1113907|NCT02468882|Radiotherapy|radiotherapy
1113908|NCT02468882|Toxicity|toxicity
1113909|NCT02468882|Outcomes|outcomes
1113910|NCT02468882|Watercress|watercress
1113920|NCT02468843|DYT1|dyt1
1113921|NCT02468830|mirabegron|mirabegron
1113922|NCT02468830|antimuscarinics|antimuscarinics
1113923|NCT02468830|beta 3 agonist|beta 3 agonist
1113924|NCT02468830|overactive bladder|overactive bladder
1113925|NCT02468830|children|children
1113926|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
1113927|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
1113928|NCT02468804|Parkinson's|parkinson's
1113929|NCT02468804|Non-parkinsons|non-parkinsons
1113930|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
1113931|NCT02468791|Autoimmune Diseases|autoimmune diseases
1113932|NCT02468791|Rituximab|rituximab
1113933|NCT02468791|Immune System Diseases|immune system diseases
1113934|NCT02468791|Joint Diseases|joint diseases
1113935|NCT02468791|Rheumatic Diseases|rheumatic diseases
1113936|NCT02468778|HeartMate PHP|heartmate php
1113937|NCT02468778|High Risk PCI|high risk pci
1113938|NCT02468778|Left Ventricular Dysfunction|left ventricular dysfunction
1113939|NCT02468778|Thoratec Corporation|thoratec corporation
1113940|NCT02468713|Omega-3|omega-3
1113941|NCT02468713|Blood lipid profiles|blood lipid profiles
1113942|NCT02468713|DHA|dha
1113943|NCT02468713|EPA|epa
1113944|NCT02468713|Triglyceride|triglyceride
1113945|NCT02468713|Glucose|glucose
1113946|NCT02468713|Insulin|insulin
1113947|NCT02468713|LDL|ldl
1113948|NCT02468713|TPN|tpn
1113949|NCT02468687|Relapsed/Refractory|relapsed/refractory
1113950|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical|sarcopenia, muscle wasting, elderly, strength, physical
1113951|NCT02468674|function, lean body mass, gait speed|function, lean body mass, gait speed
1113952|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
1113953|NCT02468648|Oral Therapy|oral therapy
1113954|NCT02468648|Liver Biopsy|liver biopsy
1113955|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
1113956|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
1113957|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1113958|NCT02468635|physical ability|physical ability
1113959|NCT02468635|pulmonary function|pulmonary function
1113960|NCT02468635|quality of daily life|quality of daily life
1113961|NCT02468596|Axonal excitability|axonal excitability
1113962|NCT02468596|Neuropathy|neuropathy
1113963|NCT02468596|QTRAC|qtrac
1113964|NCT02468596|anti-MAG|anti-mag
1113965|NCT02468596|Electrophysiology|electrophysiology
1113966|NCT02468583|Osteoarthritis|osteoarthritis
1113967|NCT02468583|Post-traumatic|post-traumatic
1113968|NCT02468583|Knee|knee
1113969|NCT02468583|Pain|pain
1113970|NCT02468583|Corticosteroid|corticosteroid
1113971|NCT02468583|Intra-articular|intra-articular
1113972|NCT02468583|Injection|injection
1113973|NCT02468570|PKU|pku
1113974|NCT02468570|PEG-PAL|peg-pal
1113975|NCT02468570|Pegvaliase|pegvaliase
1113976|NCT02468570|BMN 165|bmn 165
1113977|NCT02468570|rAv-PAL PEG|rav-pal peg
1113978|NCT02468570|PRISM 302|prism 302
1113979|NCT02468570|PRISM 303|prism 303
1113980|NCT02468570|BioMarin|biomarin
1113981|NCT02468570|165-302|165-302
1113982|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
1113983|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
1113984|NCT02468544|Engagement in care|engagement in care
1113985|NCT02468544|mHealth|mhealth
1113986|NCT02468531|Xenon|xenon
1113987|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
1113988|NCT02468505|Structured transition support program|structured transition support program
1113989|NCT02468505|Transition 'as usual'|transition 'as usual'
1113990|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
1113991|NCT02468492|Platelet Rich Plasma|platelet rich plasma
1113992|NCT02468492|Mechanism of Action|mechanism of action
1113993|NCT02468492|Stem Cells|stem cells
1113994|NCT02468492|Synovial Fluid|synovial fluid
1113995|NCT02468479|Liver cirrhosis|liver cirrhosis
1113996|NCT02468466|suicide|suicide
1113997|NCT02468466|prevention|prevention
1113998|NCT02468453|velos|velos
1113999|NCT02468453|Vascular|vascular
1114000|NCT02468453|Rejuvenation|rejuvenation
1114001|NCT02468440|renal insufficiency|renal insufficiency
1114002|NCT02468440|kidney transplant|kidney transplant
1114003|NCT02468440|educational therapy|educational therapy
1114004|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
1114005|NCT02468414|End Stage Renal Disease|end stage renal disease
1114006|NCT02468414|Anemia|anemia
1114007|NCT02468388|maltitol|maltitol
1114009|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
1114010|NCT02468388|saliva pH|saliva ph
1114011|NCT02468388|re-mineralization|re-mineralization
1114012|NCT02468388|dental caries|dental caries
1114013|NCT02468362|Intersphincteric resection|intersphincteric resection
1114014|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
1114015|NCT02468362|total mesorectal excsison|total mesorectal excsison
1114016|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
1114017|NCT02468349|Telemedicine|telemedicine
1114018|NCT02468349|Readmissions|readmissions
1114019|NCT02468336|Physiology|physiology
1114021|NCT02468323|Palonosetron|palonosetron
1114022|NCT02468323|Ondansetron|ondansetron
1114023|NCT02468323|Cesarean section|cesarean section
1114024|NCT02468310|Maternal mortality|maternal mortality
1114025|NCT02468310|Neonatal mortality|neonatal mortality
1114026|NCT02468310|Neonatal morbidity|neonatal morbidity
1114027|NCT02468310|Text messaging|text messaging
1114028|NCT02468310|Clinical decision making|clinical decision making
1114029|NCT02468310|Maternal Morbidity|maternal morbidity
1114030|NCT02468271|Clinimetrics|clinimetrics
1114031|NCT02468271|Lung function|lung function
1114032|NCT02468271|Lung clearance index|lung clearance index
1114033|NCT02468258|Assisted Reproduction|assisted reproduction
1114034|NCT02468245|Nursing intervention|nursing intervention
1114035|NCT02468245|compliance|compliance
1114036|NCT02468232|chronic heart failure|chronic heart failure
1114037|NCT02468232|cardiovascular death|cardiovascular death
1114038|NCT02468232|hospitalization|hospitalization
1114039|NCT02468232|outcome study|outcome study
1114040|NCT02468232|worsening heart failure|worsening heart failure
1114041|NCT02468232|NT-proBNP|nt-probnp
1114042|NCT02468232|NYHA|nyha
1114043|NCT02468232|KCCQ|kccq
1114044|NCT02468232|HF-rEF|hf-ref
1114045|NCT02468219|aortic stenosis|aortic stenosis
1114046|NCT02468219|aortic valve replacement|aortic valve replacement
1114047|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1114048|NCT02468219|frailty|frailty
1114049|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
1114050|NCT02468193|Cushing's syndrome|cushing's syndrome
1114051|NCT02468193|osilodrostat|osilodrostat
1114052|NCT02468193|LCI699|lci699
1114053|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
1114054|NCT02468193|adrenal adenoma|adrenal adenoma
1114055|NCT02468193|adrenal carcinoma|adrenal carcinoma
1114056|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
1114057|NCT02468193|AIMAH|aimah
1114058|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
1114059|NCT02468193|PPNAD|ppnad
1114060|NCT02468128|Analgesic|analgesic
1114061|NCT02468128|Opioids|opioids
1114062|NCT02468128|Pain relief after surgery|pain relief after surgery
1114063|NCT02468128|Dinalbuphine|dinalbuphine
1114064|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
1114065|NCT02468128|SDE|sde
1114066|NCT02468128|SDN|sdn
1114067|NCT02468128|LT1001|lt1001
1114068|NCT02468102|Rivaroxaban|rivaroxaban
1114069|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
1114070|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
1114071|NCT02468102|Anticoagulants|anticoagulants
1114072|NCT02468102|Hematologic Agents|hematologic agents
1114073|NCT02468102|Therapeutic Uses|therapeutic uses
1114074|NCT02468102|Observational|observational
1114075|NCT02468102|Pulmonary Embolism|pulmonary embolism
1114076|NCT02468102|Venous Thrombosis|venous thrombosis
1114077|NCT02468102|Venous Thromboembolism|venous thromboembolism
1114078|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
1114079|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1114080|NCT02468076|ERCP|ercp
1114081|NCT02468076|radiofrequency ablation|radiofrequency ablation
1114082|NCT02468076|obstructive jaundice|obstructive jaundice
1114083|NCT02468050|Anxiety|anxiety
1114084|NCT02468050|Depression|depression
1114085|NCT02468050|Exercise|exercise
1114086|NCT02468050|Breast Cancer|breast cancer
1114087|NCT02468050|Biopsy|biopsy
1114088|NCT02468050|Screening|screening
1114089|NCT02468050|Diagnosis|diagnosis
1114090|NCT02468037|iron|iron
1114091|NCT02468037|diabetes|diabetes
1114092|NCT02468037|phlebotomy|phlebotomy
1114093|NCT02467998|meaningful use|meaningful use
1114094|NCT02467998|electronic health records|electronic health records
1114095|NCT02467998|structured language|structured language
1114096|NCT02467998|NPWT|npwt
1114097|NCT02467998|PQRS|pqrs
1114098|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
1114099|NCT02467972|Hunger and satiety|hunger and satiety
1114100|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
1114101|NCT02467972|Bowel movements|bowel movements
1114102|NCT02467959|emergency ultrasound|emergency ultrasound
1114103|NCT02467959|acute appendicitis|acute appendicitis
1114104|NCT02467959|bedside ultrasound|bedside ultrasound
1114105|NCT02467920|exenatide|exenatide
1114106|NCT02467920|glargine|glargine
1114107|NCT02467920|aspart 30|aspart 30
1114108|NCT02467894|Adherence|adherence
1114109|NCT02467894|Exercise|exercise
1114110|NCT02467881|Physical Activity|physical activity
1114111|NCT02467881|Sedentary|sedentary
1114112|NCT02467881|Lifestyle Intervention|lifestyle intervention
1114113|NCT02467868|Pegfilgrastim|pegfilgrastim
1114114|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
1114115|NCT02467868|Breast Cancer|breast cancer
1114116|NCT02467868|Neutropenia|neutropenia
1114117|NCT02467855|Drug therapy|drug therapy
1114118|NCT02467842|Influenza vaccine|influenza vaccine
1114119|NCT02467842|Quadrivalent|quadrivalent
1114120|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
1114121|NCT02467829|Cerebral Palsy|cerebral palsy
1114122|NCT02467829|Walking Aids|walking aids
1114123|NCT02467816|Secondary schools|secondary schools
1114124|NCT02467816|School lunch|school lunch
1114125|NCT02467816|Plate waste|plate waste
1114126|NCT02467803|humeral fracture|humeral fracture
1114127|NCT02467803|exercise|exercise
1114128|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
1114129|NCT02467777|orthopaedics|orthopaedics
1114130|NCT02467777|post-operative warming|post-operative warming
1114131|NCT02467764|Knee|knee
1114132|NCT02467764|Knee osteoarthritis|knee osteoarthritis
1114133|NCT02467764|Knee replacement|knee replacement
1114134|NCT02467764|Hip|hip
1114135|NCT02467764|Hip osteoarthritis|hip osteoarthritis
1114136|NCT02467764|Hip replacement|hip replacement
1114137|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
1114138|NCT02467712|Fongal infection|fongal infection
1114139|NCT02467712|joint prosthesis|joint prosthesis
1114140|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
1114141|NCT02467699|Knee|knee
1114142|NCT02467699|Knee osteoarthritis|knee osteoarthritis
1114143|NCT02467699|Knee replacement|knee replacement
1114144|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
1114145|NCT02467621|Proton pump inhibitor|proton pump inhibitor
1114146|NCT02467621|Pneumonia|pneumonia
1114147|NCT02467621|Clostridium difficile infection|clostridium difficile infection
1114148|NCT02467608|HUEXC030|huexc030
1114149|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
1114150|NCT02467595|no muscle relaxant|no muscle relaxant
1114151|NCT02467595|rocuronium|rocuronium
1114152|NCT02467595|intubation condition|intubation condition
1114153|NCT02467595|tracheal intubation|tracheal intubation
1114154|NCT02467595|operating room time|operating room time
1114155|NCT02467595|low-dose rocuronium|low-dose rocuronium
1114156|NCT02467582|Aspirin|aspirin
1114157|NCT02467582|colon cancer|colon cancer
1114158|NCT02467582|stage II|stage ii
1114159|NCT02467582|stage III|stage iii
1114160|NCT02467582|PIK3CA|pik3ca
1114161|NCT02467582|double-blind|double-blind
1114162|NCT02467582|placebo|placebo
1114163|NCT02467582|Adjuvant Treatment|adjuvant treatment
1114164|NCT02467556|CRPS|crps
1114165|NCT02467556|intervention|intervention
1114166|NCT02467556|multimodal|multimodal
1114167|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
1114168|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
1114169|NCT02467543|Homoeopathic|homoeopathic
1114170|NCT02467530|end stage renal disease|end stage renal disease
1114171|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
1114172|NCT02467530|advanced glycation end products|advanced glycation end products
1114173|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
1114174|NCT02467517|Neuropathic pain|neuropathic pain
1114175|NCT02467517|Ketamine|ketamine
1114176|NCT02467517|Magnesium sulfate|magnesium sulfate
1114177|NCT02467517|Quality of life|quality of life
1114178|NCT02467517|Anxiety and depression|anxiety and depression
1114179|NCT02467517|Mood and sleep|mood and sleep
1114180|NCT02467491|Exercise|exercise
1114181|NCT02467491|Technology|technology
1114182|NCT02467491|Aging|aging
1114183|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1114184|NCT02467478|Endothelial cells|endothelial cells
1114185|NCT02467478|Cellular biomarker|cellular biomarker
1114186|NCT02467478|endothelial dysfunction|endothelial dysfunction
1114187|NCT02467478|CD34+|cd34+
1114188|NCT02467478|Impaired renal function|impaired renal function
1114189|NCT02467465|Fasciosis plantar|fasciosis plantar
1114190|NCT02467465|physiotherapy|physiotherapy
1114191|NCT02467465|fascitis plantar|fascitis plantar
1114192|NCT02467465|dry needling|dry needling
1114193|NCT02467439|unaware intervention;|unaware intervention;
1114194|NCT02467439|contract sexual partner referral|contract sexual partner referral
1114195|NCT02467439|peer referral|peer referral
1114196|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
1114197|NCT02467426|Chemotherapy|chemotherapy
1114198|NCT02467413|Alzheimer's Disease|alzheimer's disease
1114199|NCT02467413|Vascular Dementia|vascular dementia
1114200|NCT02467400|bone formation|bone formation
1114201|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
1114202|NCT02467387|Stem Cells|stem cells
1114203|NCT02467374|OCD|ocd
1114204|NCT02467374|Neuroimaging|neuroimaging
1114205|NCT02467374|Fear Extinction|fear extinction
1114206|NCT02467374|Behavior Therapy|behavior therapy
1114207|NCT02467361|Neoplasms|neoplasms
1114208|NCT02467296|Sodium|sodium
1114209|NCT02467296|outcomes|outcomes
1114210|NCT02467283|chronic periodontitis|chronic periodontitis
1114211|NCT02467283|genetics|genetics
1114212|NCT02467283|microarray analysis|microarray analysis
1114213|NCT02467283|gingiva|gingiva
1114214|NCT02467283|genes|genes
1114215|NCT02467283|inflammation|inflammation
1114216|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
1114217|NCT02467270|Molecular Response|molecular response
1114218|NCT02467270|CML|cml
1114219|NCT02467270|Leukemia|leukemia
1114220|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
1114221|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1114222|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
1114223|NCT02467270|Neoplasms|neoplasms
1114224|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
1114225|NCT02467270|Bone Marrow Diseases|bone marrow diseases
1114226|NCT02467270|Hematologic Diseases|hematologic diseases
1114227|NCT02467270|CP-CML|cp-cml
1114228|NCT02467244|Hypothyroidism|hypothyroidism
1114229|NCT02467244|Serum adiponectin|serum adiponectin
1114230|NCT02467244|hsCRP|hscrp
1114231|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
1114232|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
1114233|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
1114234|NCT02467244|Levothyroxin|levothyroxin
1114235|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
1114236|NCT02467231|chemotherapy|chemotherapy
1114237|NCT02467231|oncofertility|oncofertility
1114238|NCT02467231|alkylating agent|alkylating agent
1114239|NCT02467231|fertility preservation|fertility preservation
1114240|NCT02467231|fertility after cancer|fertility after cancer
1114241|NCT02467231|late effects|late effects
1114242|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
1114243|NCT02467218|Fibromyalgia|fibromyalgia
1114244|NCT02467218|Global Function|global function
1114245|NCT02467218|Sleep|sleep
1114246|NCT02467218|Chronic Pain|chronic pain
1114247|NCT02467218|Depression|depression
1114248|NCT02467218|Anxiety|anxiety
1114249|NCT02467205|Physical Activity|physical activity
1114250|NCT02467179|Arrhythmia|arrhythmia
1114251|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
1114252|NCT02467179|atrial fibrillation|atrial fibrillation
1114253|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
1114254|NCT02467166|esophagoscopy|esophagoscopy
1114255|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
1114256|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
1114257|NCT02467166|esophageal lesion|esophageal lesion
1114258|NCT02467166|arrhythmia|arrhythmia
1114259|NCT02467166|atrial fibrillation|atrial fibrillation
1114260|NCT02467166|AF|af
1114261|NCT02467166|esophageal damage|esophageal damage
1114262|NCT02467153|Sarcopenia|sarcopenia
1114263|NCT02467153|Older adult|older adult
1114264|NCT02467153|Vitamin D|vitamin d
1114265|NCT02467153|Physical activity|physical activity
1114266|NCT02467153|Muscle atrophy|muscle atrophy
1114267|NCT02467153|Muscle strength|muscle strength
1114268|NCT02467153|Physical function|physical function
1114269|NCT02467153|Frailty|frailty
1114270|NCT02467153|Osteoporosis|osteoporosis
1114271|NCT02467140|Inguinal hernia repair|inguinal hernia repair
1114272|NCT02467140|Hernia|hernia
1114273|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
1114274|NCT02467140|Biological mesh|biological mesh
1114275|NCT02467140|Tack fixation|tack fixation
1114276|NCT02467101|cicatricial alopecia|cicatricial alopecia
1114277|NCT02467101|treatment|treatment
1114278|NCT02467101|placebo|placebo
1114279|NCT02467101|double-blind|double-blind
1114280|NCT02467088|PMS|pms
1114281|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
1114282|NCT02467088|Indian females|indian females
1114283|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
1114284|NCT02467062|4D flow|4d flow
1114285|NCT02467049|ECG|ecg
1114286|NCT02467049|Ultrasound|ultrasound
1114287|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
1114288|NCT02467049|PICC|picc
1114289|NCT02467036|overweight children|overweight children
1114290|NCT02467036|overweight parents|overweight parents
1114291|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
1114292|NCT02467036|families with overweight child|families with overweight child
1114293|NCT02467036|bmi|bmi
1114294|NCT02467036|body mass index|body mass index
1114295|NCT02467036|treatment|treatment
1114296|NCT02467036|behavioral treatment|behavioral treatment
1114297|NCT02467036|family based treatment|family based treatment
1114298|NCT02467036|experiments|experiments
1114299|NCT02467036|intervention|intervention
1114300|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
1114301|NCT02467023|chronic critical illness|chronic critical illness
1114302|NCT02467023|strength training|strength training
1114303|NCT02467023|exercise|exercise
1114304|NCT02467023|sepsis|sepsis
1114305|NCT02467023|mechanical ventilation|mechanical ventilation
1114306|NCT02467010|Bortezomib|bortezomib
1114307|NCT02467010|cyclophosphamide|cyclophosphamide
1114308|NCT02467010|dexamethason|dexamethason
1114309|NCT02467010|multiple myeloma|multiple myeloma
1114310|NCT02466997|Vitiligo|vitiligo
1114311|NCT02466997|Tacrolimus|tacrolimus
1114312|NCT02466997|Face|face
1114313|NCT02466984|metoclopramide|metoclopramide
1114314|NCT02466984|subcutaneous route|subcutaneous route
1114315|NCT02466984|palliative care|palliative care
1114316|NCT02466984|pharmacology|pharmacology
1114317|NCT02466984|bioavailability|bioavailability
1114318|NCT02466984|nausea|nausea
1114319|NCT02466984|vomiting|vomiting
1114320|NCT02466958|depressed|depressed
1114321|NCT02466958|older adults|older adults
1114322|NCT02466958|antidepressants|antidepressants
1114323|NCT02466958|depression|depression
1114325|NCT02466919|Helicobacter pylori|helicobacter pylori
1114326|NCT02466906|Stage III colon cancer|stage iii colon cancer
1114327|NCT02466906|rhGM-CSF|rhgm-csf
1114328|NCT02466906|Immunotherapy|immunotherapy
1114329|NCT02466906|Surgery|surgery
1114330|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
1114331|NCT02466880|Type 2|type 2
1114332|NCT02466880|NIDDM|niddm
1114333|NCT02466867|Ringworm|ringworm
1114334|NCT02466854|Bleeding|bleeding
1114335|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
1114336|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
1114337|NCT02466854|1 year follow up|1 year follow up
1114338|NCT02466815|Healthy|healthy
1114339|NCT02466815|JNJ-42756493|jnj-42756493
1114340|NCT02466802|Advanced|advanced
1114341|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
1114342|NCT02466789|Von Willebrands Disease|von willebrands disease
1114343|NCT02466789|Hematologic Test|hematologic test
1114344|NCT02466789|VWF|vwf
1114345|NCT02466789|VWD|vwd
1114346|NCT02466763|round window|round window
1114347|NCT02466763|cochlear implants|cochlear implants
1114348|NCT02466763|cochleostomy|cochleostomy
1114349|NCT02466737|axillary surgery|axillary surgery
1114350|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
1114351|NCT02466711|gastric motility|gastric motility
1114352|NCT02466698|Colectomy|colectomy
1114353|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
1114354|NCT02466685|Bipolar|bipolar
1114355|NCT02466685|Depression|depression
1114356|NCT02466685|Cognition|cognition
1114357|NCT02466685|Cognitive|cognitive
1114358|NCT02466659|IXT|ixt
1114359|NCT02466646|Periodontal Debridement|periodontal debridement
1114360|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
1114361|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
1114362|NCT02466646|Interleukin-1beta|interleukin-1beta
1114363|NCT02466646|Interleukin-17|interleukin-17
1114364|NCT02466620|Body Weight|body weight
1114365|NCT02466620|Resuscitation|resuscitation
1114366|NCT02466620|Pediatric weight estimation|pediatric weight estimation
1114367|NCT02466607|Retinal function|retinal function
1114368|NCT02466568|advanced|advanced
1114369|NCT02466568|metastatic|metastatic
1114370|NCT02466568|lung disease|lung disease
1114371|NCT02466568|adenocarcinoma|adenocarcinoma
1114372|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1114373|NCT02466542|Esmolol|esmolol
1114374|NCT02466542|Pain|pain
1114375|NCT02466542|Anesthesia|anesthesia
1114376|NCT02466542|Analgesia|analgesia
1114377|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
1114378|NCT02466516|GS-4997|gs-4997
1114379|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1114380|NCT02466516|Fibrosis|fibrosis
1114381|NCT02466516|Simtuzumab|simtuzumab
1114382|NCT02466477|Pharmacogenomic|pharmacogenomic
1114383|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
1114384|NCT02466477|Pharmacogenomics|pharmacogenomics
1114385|NCT02466477|Genetic Testing|genetic testing
1114386|NCT02466477|Genetics|genetics
1114387|NCT02466477|Major Depressive Disorder|major depressive disorder
1114388|NCT02466477|GeneSight|genesight
1114389|NCT02466477|Enhanced GeneSight|enhanced genesight
1114390|NCT02466477|Psychotropic|psychotropic
1114391|NCT02466438|Antibiotics|antibiotics
1114392|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
1114393|NCT02466438|Resistant bacteria|resistant bacteria
1114394|NCT02466412|smoking|smoking
1114395|NCT02466412|nicotine absorption|nicotine absorption
1114396|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
1114397|NCT02466412|cigarette|cigarette
1114398|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
1114399|NCT02466373|clonidine|clonidine
1114400|NCT02466373|pharmacodynamics|pharmacodynamics
1114401|NCT02466373|pharmacokinetics|pharmacokinetics
1114402|NCT02466373|intensive care|intensive care
1114403|NCT02466373|delirium|delirium
1114404|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
1114405|NCT02466360|Physical activity|physical activity
1114406|NCT02466360|Self-exercises|self-exercises
1114407|NCT02466360|Brakes|brakes
1114408|NCT02466360|Levers|levers
1114409|NCT02466360|Adhesion|adhesion
1114410|NCT02466360|Self-care|self-care
1114826|NCT02464033|GAD65|gad65
1114411|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
1114412|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
1114413|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
1114414|NCT02466308|SAM|sam
1114415|NCT02466308|LITUS|litus
1114416|NCT02466269|Facial Nerve Injuries|facial nerve injuries
1114417|NCT02466256|Intraocular lens implantation|intraocular lens implantation
1114423|NCT02466217|Omics|omics
1114424|NCT02466217|System biology|system biology
1114425|NCT02466191|nystagmus|nystagmus
1114426|NCT02466191|pharmacological trial|pharmacological trial
1114427|NCT02466191|multiple sclerosis|multiple sclerosis
1114428|NCT02466191|oscillopsia|oscillopsia
1114429|NCT02466165|cardiometabolic risk|cardiometabolic risk
1114430|NCT02466165|physical exercise|physical exercise
1114431|NCT02466152|PK|pk
1114432|NCT02466152|GSK2894512|gsk2894512
1114433|NCT02466152|Atopic Dermatitis|atopic dermatitis
1114434|NCT02466139|microbiology|microbiology
1114435|NCT02466139|c reactive protein|c reactive protein
1114436|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
1114437|NCT02466126|Depression|depression
1114438|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
1114439|NCT02466126|Randomized Controlled Trial|randomized controlled trial
1114440|NCT02466074|Acetazolamide|acetazolamide
1114441|NCT02466074|Lesions|lesions
1114442|NCT02466074|Neurodegeneration|neurodegeneration
1114443|NCT02466074|Repair|repair
1114444|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
1114445|NCT02466048|spinal fusion|spinal fusion
1114446|NCT02466048|bone graft|bone graft
1114447|NCT02466048|collagen|collagen
1114448|NCT02466009|Colorectal cancer|colorectal cancer
1114449|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
1114450|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
1114451|NCT02465996|barrier dysfunction|barrier dysfunction
1114452|NCT02465996|functional dyspepsia|functional dyspepsia
1114453|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
1114454|NCT02465996|therapeutic response|therapeutic response
1114462|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1114463|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
1114464|NCT02465957|Neukoplast|neukoplast
1114465|NCT02465957|NK-92|nk-92
1114466|NCT02465957|Natural Killer Cell|natural killer cell
1114467|NCT02465957|MCC|mcc
1114468|NCT02465957|aNK|ank
1114469|NCT02465944|inflammation|inflammation
1114470|NCT02465931|Informed Consent|informed consent
1114471|NCT02465931|Fragile X Syndrome|fragile x syndrome
1114472|NCT02465931|Tablets|tablets
1114473|NCT02465931|Decisional Capacity|decisional capacity
1114474|NCT02465892|cancer|cancer
1114475|NCT02465892|stress|stress
1114476|NCT02465892|chronic pain|chronic pain
1114477|NCT02465892|anxiety|anxiety
1114478|NCT02465892|coping|coping
1114479|NCT02465892|balance|balance
1114480|NCT02465892|online course|online course
1114481|NCT02465892|psychosocial|psychosocial
1114482|NCT02465892|support|support
1114483|NCT02465892|tools|tools
1114484|NCT02465879|Psoriatic arthritis|psoriatic arthritis
1114485|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
1114486|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
1114487|NCT02465879|Seronegative|seronegative
1114488|NCT02465866|Plasma concentration|plasma concentration
1114489|NCT02465866|Time to plasma concentration|time to plasma concentration
1114490|NCT02465866|Elimination rate constant|elimination rate constant
1114491|NCT02465866|Elimination half life|elimination half life
1114492|NCT02465866|Area under the curve|area under the curve
1114493|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
1114494|NCT02465853|quality of Life|quality of life
1114495|NCT02465853|stroke|stroke
1114496|NCT02465840|rehabilitation|rehabilitation
1114497|NCT02465840|functional MRI|functional mri
1114498|NCT02465814|Uterine fibroids|uterine fibroids
1114499|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
1114500|NCT02465788|Helos|helos
1114501|NCT02465788|Hair Removal|hair removal
1114502|NCT02465788|Hair Reduction|hair reduction
1114503|NCT02465775|non-invasive|non-invasive
1114504|NCT02465762|non-invasive|non-invasive
1114505|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
1114506|NCT02465749|oxygen|oxygen
1114507|NCT02465749|blue light|blue light
1114508|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
1114509|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
1114510|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
1114511|NCT02465723|15-104|15-104
1114512|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
1114513|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
1114514|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
1114515|NCT02465710|Women|women
1114516|NCT02465710|Surgical treatment|surgical treatment
1114517|NCT02465697|Borderline Personality Disorder|borderline personality disorder
1114518|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
1114519|NCT02465697|Brain Imaging|brain imaging
1114520|NCT02465658|uterine prolapse|uterine prolapse
1114521|NCT02465658|cervical elongation|cervical elongation
1114522|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
1114523|NCT02465541|Cancer Survivors|cancer survivors
1114524|NCT02465541|Yoga|yoga
1114525|NCT02465541|Endometrial Cancer|endometrial cancer
1114526|NCT02465528|ALK|alk
1114527|NCT02465528|NSCLC|nsclc
1114528|NCT02465528|hematological malignancy|hematological malignancy
1114529|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
1114530|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
1114531|NCT02465515|albiglutide|albiglutide
1114532|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
1114533|NCT02465502|Colorectal cancer|colorectal cancer
1114534|NCT02465502|Regorafenib|regorafenib
1114535|NCT02465489|deferiprone|deferiprone
1114536|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
1114537|NCT02465489|pharmacokinetics|pharmacokinetics
1114538|NCT02465476|skin disease|skin disease
1114539|NCT02465476|telemedicine|telemedicine
1114540|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
1114541|NCT02465463|probiotic|probiotic
1114542|NCT02465450|JBT-101, Lenabasum, Cystic Fibrosis|jbt-101, lenabasum, cystic fibrosis
1114543|NCT02465424|quality of life questionnaires|quality of life questionnaires
1114544|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
1114545|NCT02465398|Three or four part fracture|three or four part fracture
1114546|NCT02465398|Hemiarthroplasty|hemiarthroplasty
1114547|NCT02465398|Multi-center|multi-center
1114548|NCT02465398|Europe|europe
1114549|NCT02465398|Non-controlled|non-controlled
1114550|NCT02465398|Anatomical reconstruction|anatomical reconstruction
1114551|NCT02465398|Proximal|proximal
1114552|NCT02465372|Physical Activity|physical activity
1114553|NCT02465372|Youth|youth
1114554|NCT02465372|School Health|school health
1114555|NCT02465346|acute stroke|acute stroke
1114556|NCT02465346|prehospital|prehospital
1114557|NCT02465346|treatment|treatment
1114558|NCT02465333|heel|heel
1114559|NCT02465333|atrophy|atrophy
1114560|NCT02465333|fat|fat
1114561|NCT02465333|adipose tissue|adipose tissue
1114562|NCT02465333|fat pad|fat pad
1114563|NCT02465307|Consciousness|consciousness
1114564|NCT02465307|Alertness|alertness
1114565|NCT02465307|Cognition|cognition
1114566|NCT02465307|Activity level|activity level
1114567|NCT02465307|Delirium|delirium
1114568|NCT02465307|Hyperactive delirium|hyperactive delirium
1114569|NCT02465307|Hypoactive delirium|hypoactive delirium
1114570|NCT02465307|Facial expression|facial expression
1114571|NCT02465307|Posture|posture
1114572|NCT02465307|Intensive care unit|intensive care unit
1114573|NCT02465294|Probiotics|probiotics
1114574|NCT02465294|Weight loss|weight loss
1114575|NCT02465294|Body composition|body composition
1114576|NCT02465255|Acute Abdominal Pain|acute abdominal pain
1114577|NCT02465255|Sublingual Analgesia|sublingual analgesia
1114578|NCT02465255|Children|children
1114579|NCT02465255|Ketorolac|ketorolac
1114580|NCT02465255|Tramadol|tramadol
1114581|NCT02465255|Paracetamol|paracetamol
1114582|NCT02465255|Analgesia|analgesia
1114583|NCT02465216|Tuberculosis|tuberculosis
1114584|NCT02465216|TB|tb
1114585|NCT02465216|Pulmonary|pulmonary
1114586|NCT02465216|Vaccine|vaccine
1114587|NCT02465216|Adjuvant|adjuvant
1114588|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
1114589|NCT02465190|Vaccine|vaccine
1114590|NCT02465190|Effectiveness|effectiveness
1114591|NCT02465190|Influenza|influenza
1114592|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
1114593|NCT02465177|ICU survivors|icu survivors
1114594|NCT02465177|Alcohol use disorder|alcohol use disorder
1114595|NCT02465177|SBIRT|sbirt
1114596|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
1114597|NCT02465034|Neural plasticity|neural plasticity
1114598|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
1114599|NCT02465034|Motor cortex|motor cortex
1114600|NCT02465021|Satiety|satiety
1114601|NCT02465021|Food intake|food intake
1114602|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
1114603|NCT02465021|Postprandial glycemia|postprandial glycemia
1114604|NCT02465008|postoperative|postoperative
1114605|NCT02465008|Patient-reported|patient-reported
1114606|NCT02464995|Asthma,|asthma,
1114607|NCT02464995|Asthma exacerbation|asthma exacerbation
1114608|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
1114609|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
1114610|NCT02464943|Aorta|aorta
1114611|NCT02464943|Thoracic|thoracic
1114612|NCT02464943|Aortic dissection|aortic dissection
1114613|NCT02464943|Type B|type b
1114614|NCT02464943|DeBakey type III|debakey type iii
1114615|NCT02464943|Endovascular|endovascular
1114616|NCT02464930|Blood|blood
1114617|NCT02464930|Cytology|cytology
1114618|NCT02464930|Esophagus|esophagus
1114619|NCT02464930|microRNA|microrna
1114620|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
1114621|NCT02464891|CCX168|ccx168
1114622|NCT02464891|dialysis|dialysis
1114623|NCT02464891|C5aR antagonist|c5ar antagonist
1114624|NCT02464865|thiamine deficiency|thiamine deficiency
1114625|NCT02464865|obese children|obese children
1167288|NCT02184221|Safety|safety
1114626|NCT02464865|Thai|thai
1114627|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
1114628|NCT02464839|Onychomycosis|onychomycosis
1114629|NCT02464839|Hallux valgus|hallux valgus
1114630|NCT02464826|Onychomycosis|onychomycosis
1114631|NCT02464826|Chronic paronychia|chronic paronychia
1114632|NCT02464826|Treatment|treatment
1114633|NCT02464813|pregabalin|pregabalin
1114634|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
1114635|NCT02464800|diabetic retinopathy|diabetic retinopathy
1114636|NCT02464787|antioxidants|antioxidants
1114637|NCT02464787|carotenoids|carotenoids
1114638|NCT02464787|diet|diet
1114639|NCT02464774|Breast Cancer|breast cancer
1114640|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
1114641|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
1114642|NCT02464774|Mastectomy|mastectomy
1114643|NCT02464774|Recurrence|recurrence
1114644|NCT02464735|Sleep disruption|sleep disruption
1114645|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
1114646|NCT02464735|Weaning|weaning
1114647|NCT02464722|Remifentanil|remifentanil
1114648|NCT02464722|Dexmedetomidine|dexmedetomidine
1114649|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
1114650|NCT02464709|Actinic Keratosis|actinic keratosis
1114651|NCT02464709|Photodynamic Therapy|photodynamic therapy
1114652|NCT02464709|Natural Daylight|natural daylight
1114653|NCT02464696|Hematological Malignancies|hematological malignancies
1114654|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
1114655|NCT02464696|Blood cancer|blood cancer
1114656|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
1114657|NCT02464696|NIPPV|nippv
1114658|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
1114659|NCT02464670|Ebola|ebola
1114660|NCT02464670|Vaccine|vaccine
1114661|NCT02464657|Leukemia|leukemia
1114662|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
1114663|NCT02464657|AML|aml
1114664|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
1114665|NCT02464657|MDS|mds
1114666|NCT02464657|High-risk|high-risk
1114667|NCT02464657|Nivolumab|nivolumab
1114668|NCT02464657|BMS-936558|bms-936558
1114669|NCT02464657|Opdivo|opdivo
1114670|NCT02464657|Idarubicin|idarubicin
1114671|NCT02464657|Idamycin|idamycin
1114672|NCT02464657|Cytarabine|cytarabine
1114673|NCT02464657|Ara-C|ara-c
1114674|NCT02464657|Cytosar|cytosar
1114675|NCT02464657|DepoCyt|depocyt
1114676|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1114677|NCT02464657|Solu-Medrol|solu-medrol
1114678|NCT02464657|Methylprednisolone|methylprednisolone
1114679|NCT02464657|Depo-Medrol|depo-medrol
1114680|NCT02464657|Medrol|medrol
1114681|NCT02464657|Dexamethasone|dexamethasone
1114682|NCT02464657|Decadron|decadron
1114683|NCT02464644|On-line Questionnaire|on-line questionnaire
1114684|NCT02464644|No travel|no travel
1114685|NCT02464644|Health|health
1114686|NCT02464644|Medicines|medicines
1114687|NCT02464644|Drugs|drugs
1114688|NCT02464644|Lifestyle|lifestyle
1114689|NCT02464644|Family|family
1114690|NCT02464644|Help for others|help for others
1114691|NCT02464644|Rare condition|rare condition
1114692|NCT02464644|General population|general population
1114693|NCT02464618|Colonoscopy|colonoscopy
1114694|NCT02464618|Upper endoscopy|upper endoscopy
1114695|NCT02464618|Adherence|adherence
1114696|NCT02464618|Disparities|disparities
1114697|NCT02464592|Cryoprobes|cryoprobes
1114698|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
1114699|NCT02464592|Cryobiopsy|cryobiopsy
1114700|NCT02464579|breastfeeding rate|breastfeeding rate
1114701|NCT02464579|preterm infant|preterm infant
1114702|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
1114703|NCT02464553|Low Back Pain Pain|low back pain pain
1114704|NCT02464553|Periradicular therapy|periradicular therapy
1114705|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
1114706|NCT02464540|laminate veneers|laminate veneers
1114707|NCT02464540|luting agent|luting agent
1114708|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
1114709|NCT02464514|Obesity|obesity
1114710|NCT02464514|Orexigen|orexigen
1114711|NCT02464514|Insulin|insulin
1114712|NCT02464514|Leptin|leptin
1114713|NCT02464514|Adiponectin|adiponectin
1114714|NCT02464514|Growth hormone replacement|growth hormone replacement
1114715|NCT02464501|PAD|pad
1114716|NCT02464501|COPPER-A|copper-a
1114717|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
1114718|NCT02464501|OPC|opc
1114719|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
1114720|NCT02464501|Paclitaxel|paclitaxel
1114721|NCT02464501|Pressana|pressana
1114722|NCT02464501|Precision Delivery System|precision delivery system
1114723|NCT02464488|Anticoagulants|anticoagulants
1114724|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
1114725|NCT02464488|Antithrombins|antithrombins
1114726|NCT02464488|Pharmacokinetics|pharmacokinetics
1167430|NCT02182947|MRI|mri
1114727|NCT02464488|Aged, 80 years and older|aged, 80 years and older
1114728|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
1114729|NCT02464475|interoception|interoception
1114730|NCT02464462|serum calcidiol|serum calcidiol
1114731|NCT02464462|T2DM|t2dm
1114732|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
1114733|NCT02464462|post-menopausal women|post-menopausal women
1114734|NCT02464462|ethnic diverse|ethnic diverse
1114735|NCT02464462|calcium supplementation|calcium supplementation
1114736|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
1114737|NCT02464449|Mobile Health Technology|mobile health technology
1114738|NCT02464449|Patient Care Management|patient care management
1114739|NCT02464436|RP|rp
1114740|NCT02464410|Opioid analgesics|opioid analgesics
1114741|NCT02464410|Primary care|primary care
1114742|NCT02464410|Veterans|veterans
1114743|NCT02464410|Motivational interviewing|motivational interviewing
1114744|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
1114745|NCT02464410|Self-efficacy|self-efficacy
1114746|NCT02464410|Behavioral symptoms|behavioral symptoms
1114747|NCT02464410|Injuries|injuries
1114748|NCT02464410|Opioid Safety|opioid safety
1114749|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
1114750|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
1114751|NCT02464371|muscle weakness|muscle weakness
1114752|NCT02464371|microRNAs|micrornas
1114753|NCT02464371|septic shock|septic shock
1114754|NCT02464358|HPV|hpv
1114755|NCT02464345|BED|bed
1114756|NCT02464345|Binge Eating Disorer|binge eating disorer
1114757|NCT02464345|BN|bn
1114758|NCT02464345|Bulimia Nervosa|bulimia nervosa
1114759|NCT02464345|Obesity|obesity
1114760|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
1114761|NCT02464332|BLZ-100|blz-100
1114762|NCT02464332|Tumor Paint|tumor paint
1114763|NCT02464306|recipients|recipients
1114764|NCT02464293|depression|depression
1114765|NCT02464293|anxiety|anxiety
1114766|NCT02464293|stress|stress
1114767|NCT02464280|Tomosynthesis|tomosynthesis
1114768|NCT02464280|osteosynthetic implant|osteosynthetic implant
1114769|NCT02464280|CT|ct
1114770|NCT02464280|monitoring|monitoring
1114771|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
1114772|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
1114773|NCT02464228|PTCL|ptcl
1114774|NCT02464228|Lymphoma|lymphoma
1114775|NCT02464228|AITL|aitl
1114776|NCT02464215|gastric cancer|gastric cancer
1114777|NCT02464215|D2|d2
1114778|NCT02464215|laparoscopic|laparoscopic
1114779|NCT02464215|open|open
1114780|NCT02464215|surgery|surgery
1114781|NCT02464202|Tooth autotransplantation|tooth autotransplantation
1114782|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
1114783|NCT02464202|CBCT|cbct
1114784|NCT02464202|Outcome|outcome
1114785|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
1114786|NCT02464176|Anesthesia, Local|anesthesia, local
1114787|NCT02464176|Anesthesia Conduction|anesthesia conduction
1114788|NCT02464176|Bupivacaine|bupivacaine
1114789|NCT02464176|Dexamethasone|dexamethasone
1114790|NCT02464176|Preanesthetic Medications|preanesthetic medications
1114791|NCT02464176|Nerve Block|nerve block
1114792|NCT02464176|Lumbar Plexus Block|lumbar plexus block
1114793|NCT02464176|Analgesia|analgesia
1114794|NCT02464176|Glucocorticoids|glucocorticoids
1114795|NCT02464176|Local Anesthetics|local anesthetics
1114796|NCT02464163|Influenza|influenza
1114797|NCT02464150|gluten|gluten
1114798|NCT02464150|antigen-specific T cells|antigen-specific t cells
1114799|NCT02464150|transcriptome|transcriptome
1114800|NCT02464098|Hematological Malignancies|hematological malignancies
1114801|NCT02464098|Solid Tumors|solid tumors
1114802|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1114803|NCT02464098|Childhood Cancer|childhood cancer
1114804|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
1114805|NCT02464085|Stroke|stroke
1114806|NCT02464085|Upper limb|upper limb
1114807|NCT02464085|Neuroplastic change|neuroplastic change
1114808|NCT02464085|Longitudinal|longitudinal
1114809|NCT02464085|Function|function
1114810|NCT02464072|Parathyroidectomy|parathyroidectomy
1114811|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
1114812|NCT02464059|cathelicidin|cathelicidin
1114813|NCT02464059|vitamin D|vitamin d
1114814|NCT02464046|Insomnia|insomnia
1114815|NCT02464046|JNJ-42847922|jnj-42847922
1114816|NCT02464046|Placebo|placebo
1114817|NCT02464033|Diamyd|diamyd
1114818|NCT02464033|Diabetes|diabetes
1114819|NCT02464033|Juvenile Diabetes|juvenile diabetes
1114820|NCT02464033|Diabetes Type 1|diabetes type 1
1114821|NCT02464033|Type 1 Diabetes|type 1 diabetes
1114822|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
1115427|NCT02460458|Hemorrhage|hemorrhage
1114823|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
1114824|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
1114825|NCT02464033|rhGAD65|rhgad65
1114828|NCT02464033|Diabetes Mellitus|diabetes mellitus
1114829|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
1114830|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
1114831|NCT02464033|Metabolic Diseases|metabolic diseases
1114832|NCT02464033|Vitamin D|vitamin d
1114833|NCT02464033|Etanercept|etanercept
1114834|NCT02463955|flexible endoscopy|flexible endoscopy
1114835|NCT02463929|Diphenhydramine|diphenhydramine
1114836|NCT02463929|emergence agitation|emergence agitation
1114837|NCT02463929|pediatric anesthesia|pediatric anesthesia
1114838|NCT02463929|PAEDS|paeds
1114839|NCT02463929|Withdrawal|withdrawal
1114840|NCT02463903|Adaptation, Psychological|adaptation, psychological
1114841|NCT02463903|Heart Failure|heart failure
1114842|NCT02463903|Intervention Studies|intervention studies
1114843|NCT02463903|Quality of Life|quality of life
1114844|NCT02463903|Hospital Readmission|hospital readmission
1114845|NCT02463903|Depression|depression
1114846|NCT02463903|Anxiety|anxiety
1114847|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
1114848|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
1114849|NCT02463890|Training|training
1114850|NCT02463864|frailty|frailty
1114851|NCT02463864|older adult|older adult
1114852|NCT02463864|hospital|hospital
1114853|NCT02463864|exercise|exercise
1114854|NCT02463864|randomised control trial|randomised control trial
1114855|NCT02463864|functional decline|functional decline
1114856|NCT02463851|Ablation|ablation
1114857|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
1114858|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
1114859|NCT02463851|Holter|holter
1114860|NCT02463838|Medi-Cal|medi-cal
1114861|NCT02463838|Health Plan|health plan
1114862|NCT02463838|Frequent Users|frequent users
1114863|NCT02463838|Heavy users|heavy users
1114864|NCT02463838|Care Coordination|care coordination
1114865|NCT02463838|Managed Care|managed care
1114866|NCT02463838|Case Management|case management
1114867|NCT02463838|Mental Health|mental health
1114868|NCT02463838|Substance Use|substance use
1114869|NCT02463838|Emergency Department|emergency department
1114870|NCT02463799|prostatic neoplasms|prostatic neoplasms
1114871|NCT02463799|castration-resistant|castration-resistant
1114872|NCT02463799|bone metastasis|bone metastasis
1114873|NCT02463799|radium-223|radium-223
1114874|NCT02463799|sipuleucel-T|sipuleucel-t
1114875|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
1114876|NCT02463747|Neutropenic fever|neutropenic fever
1114877|NCT02463747|extended infusion|extended infusion
1114878|NCT02463747|beta-lactam|beta-lactam
1114879|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
1114880|NCT02463721|sbp|sbp
1114881|NCT02463721|culture|culture
1114882|NCT02463708|Care Giver|care giver
1114883|NCT02463708|Dementia|dementia
1114884|NCT02463695|partial vestibular deficit|partial vestibular deficit
1114885|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
1114886|NCT02463682|Artificial Pancreas|artificial pancreas
1114887|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1114888|NCT02463682|Autoimmune Diseases|autoimmune diseases
1114889|NCT02463682|Diabetes Mellitus|diabetes mellitus
1114890|NCT02463682|Endocrine System Diseases|endocrine system diseases
1114891|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
1114892|NCT02463682|Immune System Diseases|immune system diseases
1114893|NCT02463682|Metabolic Diseases|metabolic diseases
1114894|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
1114895|NCT02463630|basilar invagination|basilar invagination
1114896|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
1114897|NCT02463630|surgery|surgery
1114898|NCT02463630|restoration technique|restoration technique
1114899|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
1114900|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
1114901|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
1114902|NCT02463591|Beriplex|beriplex
1114903|NCT02463591|Shed Blood|shed blood
1114904|NCT02463591|Washed Blood|washed blood
1114905|NCT02463591|Fibrinopeptide A|fibrinopeptide a
1114906|NCT02463578|Pneumococcal infection|pneumococcal infection
1114907|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
1114908|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
1114909|NCT02463578|Vaccinology|vaccinology
1114910|NCT02463578|Immunocompromised|immunocompromised
1114911|NCT02463578|Auto-immune diseases|auto-immune diseases
1114912|NCT02463578|Systemic vasculitis|systemic vasculitis
1114913|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
1114914|NCT02463565|nutritional assessment|nutritional assessment
1114915|NCT02463565|food survey|food survey
1114916|NCT02463565|hospitalized patients|hospitalized patients
1114917|NCT02463565|hospital food|hospital food
1114918|NCT02463539|Pneumococcal infection|pneumococcal infection
1115023|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1114919|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
1114920|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
1114921|NCT02463539|Systemic vasculitis|systemic vasculitis
1114922|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
1114924|NCT02463539|Immunocompromised|immunocompromised
1114925|NCT02463539|Auto-immune disease|auto-immune disease
1114926|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
1114927|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
1114928|NCT02463526|Physical Therapy|physical therapy
1114929|NCT02463513|Riboflavin|riboflavin
1114930|NCT02463513|Blood pressure|blood pressure
1114931|NCT02463513|MTHFR|mthfr
1114932|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
1114933|NCT02463448|Underactive Bladder|underactive bladder
1114934|NCT02463435|nutritional management|nutritional management
1114935|NCT02463435|olive oil|olive oil
1114936|NCT02463435|weight loss|weight loss
1114937|NCT02463435|body composition|body composition
1114938|NCT02463435|nutrigenomics|nutrigenomics
1114939|NCT02463435|polymorphisms|polymorphisms
1114940|NCT02463435|cardiovascular risk|cardiovascular risk
1114941|NCT02463435|sarcopenia|sarcopenia
1114942|NCT02463435|inflammation|inflammation
1114943|NCT02463435|food intake|food intake
1114944|NCT02463435|sedentary lifestyle|sedentary lifestyle
1114945|NCT02463435|patient adherence|patient adherence
1114946|NCT02463435|bone density|bone density
1114947|NCT02463396|MBCT|mbct
1114948|NCT02463396|Mindfulness|mindfulness
1114949|NCT02463396|ADHD|adhd
1114950|NCT02463383|PPAR-gamma|ppar-gamma
1114951|NCT02463383|estrogens|estrogens
1114952|NCT02463383|NSAIDS|nsaids
1114953|NCT02463383|polymorphism|polymorphism
1114954|NCT02463383|metabolomics|metabolomics
1114955|NCT02463357|Exercise, Aerobic|exercise, aerobic
1114956|NCT02463357|Cognitive Function|cognitive function
1114957|NCT02463344|Dry AMD|dry amd
1114958|NCT02463344|Geographic atrophy|geographic atrophy
1114959|NCT02463344|ASP7316|asp7316
1114960|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
1114961|NCT02463331|chloroquine|chloroquine
1114962|NCT02463331|treatment|treatment
1114963|NCT02463318|Multiple sclerosis|multiple sclerosis
1114964|NCT02463318|SIRT1|sirt1
1114965|NCT02463318|MnSOD|mnsod
1114966|NCT02463318|Catalase|catalase
1114967|NCT02463318|Oxidative stress|oxidative stress
1114968|NCT02463318|Antioxidant enzyme|antioxidant enzyme
1114969|NCT02463305|Colitis, ulcerative|colitis, ulcerative
1114970|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
1114971|NCT02463292|quality of life|quality of life
1114972|NCT02463292|young adults|young adults
1114973|NCT02463292|congenital heart disease|congenital heart disease
1114974|NCT02463266|Primary Care|primary care
1114975|NCT02463266|Elderly|elderly
1114976|NCT02463266|Depression|depression
1114977|NCT02463253|Renal Biopsy|renal biopsy
1114978|NCT02463253|elevated serum creatinine|elevated serum creatinine
1114979|NCT02463253|proteinuria|proteinuria
1114980|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
1114981|NCT02463201|Pediatric Obesity|pediatric obesity
1114982|NCT02463188|Sleep|sleep
1114983|NCT02463188|Substance Use|substance use
1114984|NCT02463188|Adolescents|adolescents
1114985|NCT02463175|Fluid Therapy;|fluid therapy;
1114986|NCT02463175|Transesophageal Doppler|transesophageal doppler
1114987|NCT02463149|School health|school health
1114988|NCT02463136|Adolescence|adolescence
1114989|NCT02463136|Brain Development|brain development
1114990|NCT02463136|Neuroimaging|neuroimaging
1114991|NCT02463136|Neurofeedback|neurofeedback
1114992|NCT02463136|Anxiety|anxiety
1114993|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
1114994|NCT02463110|Depression|depression
1114995|NCT02463110|Coronary Artery Disease|coronary artery disease
1114996|NCT02463110|Myocardial Infarction|myocardial infarction
1114997|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
1114998|NCT02463019|hepatitis B virus|hepatitis b virus
1114999|NCT02463019|tenofovir|tenofovir
1115000|NCT02462967|Liver Cirrhosis|liver cirrhosis
1115001|NCT02462954|Contraception|contraception
1115002|NCT02462954|Vaginal Gel|vaginal gel
1115003|NCT02462954|Diaphragm|diaphragm
1115004|NCT02462941|Heart transplant|heart transplant
1115005|NCT02462941|Adenosine|adenosine
1115006|NCT02462941|Pediatrics|pediatrics
1115007|NCT02462863|Diabetes|diabetes
1115008|NCT02462863|fish oil|fish oil
1115009|NCT02462863|arginine|arginine
1115010|NCT02462863|hyperglycemia|hyperglycemia
1115011|NCT02462850|Pain|pain
1115012|NCT02462850|Nausea|nausea
1115013|NCT02462850|Vomiting|vomiting
1115014|NCT02462837|Ureteral Stents|ureteral stents
1115015|NCT02462837|Pain and Discomfort|pain and discomfort
1115016|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
1115017|NCT02462824|Peripheral Artery Disease|peripheral artery disease
1115018|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
1115020|NCT02462811|Pain|pain
1115021|NCT02462811|Nausea|nausea
1115022|NCT02462811|Vomiting|vomiting
1115024|NCT02462785|Adolescents|adolescents
1115025|NCT02462785|Carbohydrate Counting|carbohydrate counting
1115026|NCT02462785|Glycemic Control|glycemic control
1115027|NCT02462785|Self-Management|self-management
1115029|NCT02462772|Cabotegravir|cabotegravir
1115030|NCT02462772|safety|safety
1115031|NCT02462772|long-acting injectable|long-acting injectable
1115032|NCT02462772|HIV prevention|hiv prevention
1115033|NCT02462772|acceptability|acceptability
1115034|NCT02462759|EMBRACE|embrace
1115035|NCT02462759|Spinal Muscular Atrophy|spinal muscular atrophy
1115036|NCT02462759|SMA|sma
1115037|NCT02462746|Postpartum|postpartum
1115038|NCT02462746|Dietary Supplements|dietary supplements
1115039|NCT02462746|Breastfeeding Women|breastfeeding women
1115040|NCT02462733|Self-control|self-control
1115041|NCT02462733|Preschoolers|preschoolers
1115042|NCT02462733|Tools of the Mind|tools of the mind
1115043|NCT02462733|Playing to Learn|playing to learn
1115044|NCT02462681|ketamine|ketamine
1115045|NCT02462681|adjuvant|adjuvant
1115046|NCT02462681|paravertebral block|paravertebral block
1115047|NCT02462668|Bronchoscopy|bronchoscopy
1115048|NCT02462668|Intubation|intubation
1115049|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
1115050|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
1115051|NCT02462629|central nervous system tumor|central nervous system tumor
1115052|NCT02462629|BLZ-100|blz-100
1115053|NCT02462629|pediatrics|pediatrics
1115054|NCT02462629|Tumor Paint|tumor paint
1115055|NCT02462629|brain cancer|brain cancer
1115056|NCT02462629|tozuleristide|tozuleristide
1115057|NCT02462616|risk analysis|risk analysis
1115058|NCT02462616|general Chinese population|general chinese population
1115059|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
1115060|NCT02462603|Parkinson's Disease|parkinson's disease
1115061|NCT02462603|PD|pd
1115062|NCT02462603|EPI-589|epi-589
1115063|NCT02462603|EPI589|epi589
1115064|NCT02462590|Probiotics|probiotics
1115065|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
1115066|NCT02462590|Infections|infections
1115067|NCT02462590|C-Difficile|c-difficile
1115068|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
1115069|NCT02462590|Diarrhea|diarrhea
1115070|NCT02462577|Local morphine|local morphine
1115071|NCT02462577|Postmastectomy pain|postmastectomy pain
1115072|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
1115073|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
1115074|NCT02462551|Depression|depression
1115075|NCT02462551|Treatment Resistant Depression|treatment resistant depression
1115076|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
1115077|NCT02462525|antibody drug conjugate|antibody drug conjugate
1115078|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
1115079|NCT02462512|Elastography|elastography
1115080|NCT02462512|Thyroid nodule|thyroid nodule
1115081|NCT02462473|Schizophrenia|schizophrenia
1115082|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
1115083|NCT02462473|Aripiprazole|aripiprazole
1115084|NCT02462473|Olanzapine|olanzapine
1115085|NCT02462473|Paliperidone|paliperidone
1115086|NCT02462473|Quetiapine|quetiapine
1115087|NCT02462473|Risperidone|risperidone
1115088|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
1115089|NCT02462460|Breast MRI|breast mri
1115090|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
1115091|NCT02462460|screening pancreatic|screening pancreatic
1115092|NCT02462460|screening ovarian|screening ovarian
1115093|NCT02462460|15-120|15-120
1115094|NCT02462447|prostate|prostate
1115095|NCT02462447|cancer|cancer
1115096|NCT02462447|biopsy|biopsy
1115097|NCT02462447|PET|pet
1115098|NCT02462434|Pediatric palliative care|pediatric palliative care
1115099|NCT02462421|SGLT2|sglt2
1115100|NCT02462421|SLC5A2|slc5a2
1115101|NCT02462421|SLC5A4|slc5a4
1115102|NCT02462421|SLC5A9|slc5a9
1115103|NCT02462421|SLC2A9|slc2a9
1115104|NCT02462421|GLUT9|glut9
1115105|NCT02462421|SGLT3|sglt3
1115106|NCT02462421|SGLT4|sglt4
1115107|NCT02462421|pharmacogenomics|pharmacogenomics
1115108|NCT02462356|CVATS|cvats
1115109|NCT02462356|UVATS|uvats
1115110|NCT02462356|perioperative effect|perioperative effect
1115111|NCT02462356|ergonomic influence|ergonomic influence
1115112|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
1115113|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
1115114|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
1115115|NCT02462317|Spasticity|spasticity
1115116|NCT02462317|Post stroke motor recovery|post stroke motor recovery
1115117|NCT02462317|Botulinum toxin|botulinum toxin
1115118|NCT02462317|Baclofen|baclofen
1115119|NCT02462317|Pharmacological modulation|pharmacological modulation
1115120|NCT02462304|Diabetic Macula Edema|diabetic macula edema
1115121|NCT02462304|End-Point-Management|end-point-management
1115122|NCT02462304|ranibizumab|ranibizumab
1115123|NCT02462304|bevacizumab|bevacizumab
1115124|NCT02462291|Neurological Disorders|neurological disorders
1115125|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
1115126|NCT02462291|Ecological Therapy|ecological therapy
1115127|NCT02462278|Fertility|fertility
1115128|NCT02462278|Continuous temperature monitor|continuous temperature monitor
1115129|NCT02462278|Basal Body Temperature|basal body temperature
1115130|NCT02462278|Natural family planning|natural family planning
1115131|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
1115132|NCT02462239|Bladder cancer|bladder cancer
1115133|NCT02462239|PET imaging|pet imaging
1115135|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
1115136|NCT02462213|Cardiac MRI|cardiac mri
1115137|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
1115138|NCT02462187|genital warts|genital warts
1115139|NCT02462187|perianal warts|perianal warts
1115140|NCT02462174|anesthesia|anesthesia
1115141|NCT02462174|analgesia|analgesia
1115143|NCT02462174|ketamine|ketamine
1115144|NCT02462174|bupivacaine|bupivacaine
1115145|NCT02462148|Anesthesia|anesthesia
1115146|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
1115147|NCT02462148|Anesthesia, Local|anesthesia, local
1115148|NCT02462148|Bupivacaine|bupivacaine
1115149|NCT02462148|Dexamethasone|dexamethasone
1115150|NCT02462148|Saphenous|saphenous
1115151|NCT02462148|Adductor Canal|adductor canal
1115152|NCT02462148|Nerve Block|nerve block
1115153|NCT02462148|Analgesia|analgesia
1115154|NCT02462148|Preanesthetic Medication|preanesthetic medication
1115155|NCT02462148|Perioperative Period|perioperative period
1115156|NCT02462148|Peripheral Nerve Block|peripheral nerve block
1115157|NCT02462135|Mild cognitive impairment|mild cognitive impairment
1115158|NCT02462135|Memory training|memory training
1115159|NCT02462135|Randomized controlled study|randomized controlled study
1115160|NCT02462044|Computed tomography|computed tomography
1115161|NCT02462044|Coronary CTA|coronary cta
1115162|NCT02462044|Contrast media|contrast media
1115163|NCT02462018|Cerebral Palsy|cerebral palsy
1115164|NCT02462018|Muscle Spasticity|muscle spasticity
1115165|NCT02462018|Orthoses|orthoses
1115166|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
1115167|NCT02462018|Prospective|prospective
1115168|NCT02461992|FVIII activity|fviii activity
1115169|NCT02461953|hemodialysis|hemodialysis
1115170|NCT02461953|hemoperfusion|hemoperfusion
1115171|NCT02461953|quality of life|quality of life
1115172|NCT02461940|Sexual behavior|sexual behavior
1115173|NCT02461940|condom use|condom use
1115174|NCT02461940|secondary abstinence|secondary abstinence
1115175|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
1115176|NCT02461901|clostridium difficile|clostridium difficile
1115177|NCT02461901|environment|environment
1115178|NCT02461901|contamination|contamination
1115179|NCT02461901|fidaxomicin|fidaxomicin
1115180|NCT02461888|Relapsed|relapsed
1115181|NCT02461888|Refractory|refractory
1115182|NCT02461888|Cyclophosphamide|cyclophosphamide
1115183|NCT02461888|Dexamethasone|dexamethasone
1115184|NCT02461875|OHSS|ohss
1115185|NCT02461875|Infertility|infertility
1115186|NCT02461875|Cabergoline|cabergoline
1115187|NCT02461875|GnRH antagonist|gnrh antagonist
1115188|NCT02461875|IVF-ET|ivf-et
1115189|NCT02461862|Contraception|contraception
1115190|NCT02461862|Contraception Behavior|contraception behavior
1115191|NCT02461862|Intra uterine device|intra uterine device
1115192|NCT02461862|Intra uterine System|intra uterine system
1115193|NCT02461862|IUD|iud
1115194|NCT02461862|IUS|ius
1115195|NCT02461862|Acute Pain|acute pain
1115196|NCT02461771|AMD|amd
1115197|NCT02461771|Wet AMD|wet amd
1115198|NCT02461771|Neovascular AMD|neovascular amd
1115199|NCT02461745|VIEKIRA PAK|viekira pak
1115200|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
1115201|NCT02461732|PTSD|ptsd
1115202|NCT02461732|substance dependence|substance dependence
1115203|NCT02461732|substance use|substance use
1115204|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
1115205|NCT02461693|Vigilance|vigilance
1115206|NCT02461693|Mood|mood
1115207|NCT02461693|Randomized Controlled Trial|randomized controlled trial
1115208|NCT02461693|Probability|probability
1115209|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
1115210|NCT02461667|alendronate, metformin|alendronate, metformin
1115211|NCT02461641|amniotic tissue|amniotic tissue
1115212|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
1115213|NCT02461641|Affinity|affinity
1115214|NCT02461641|NuShield|nushield
1115215|NCT02461628|Malaria|malaria
1115216|NCT02461628|Antimalarial subsidy|antimalarial subsidy
1115217|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
1115218|NCT02461628|Public-private partnership|public-private partnership
1115219|NCT02461628|Community health workers|community health workers
1115220|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
1115221|NCT02461615|Rare Lung Disease|rare lung disease
1115222|NCT02461615|Registry|registry
1115223|NCT02461602|Warfarin|warfarin
1115224|NCT02461576|HIV-1|hiv-1
1115225|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
1115226|NCT02461550|15-001|15-001
1115227|NCT02461498|Warfarin|warfarin
1115228|NCT02461485|adults|adults
1115229|NCT02461485|moderate constipation|moderate constipation
1115230|NCT02461472|risk factors|risk factors
1115231|NCT02461472|risk analysis|risk analysis
1115232|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
1115233|NCT02461472|general Chinese population|general chinese population
1115234|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
1115235|NCT02461459|TSC|tsc
1115236|NCT02461459|Autism|autism
1115238|NCT02461459|Intellectual Disability|intellectual disability
1115239|NCT02461459|ID|id
1115240|NCT02461459|MRI|mri
1115241|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
1115242|NCT02461446|MRI|mri
1115243|NCT02461446|10q23.3|10q23.3
1115244|NCT02461446|ASD|asd
1115245|NCT02461446|Autism|autism
1115246|NCT02461446|Macrocephaly|macrocephaly
1115247|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
1115248|NCT02461446|PTEN|pten
1115249|NCT02461433|Obesity|obesity
1115250|NCT02461433|Obese|obese
1115251|NCT02461433|surgical site infection|surgical site infection
1115252|NCT02461433|closed incisions|closed incisions
1115253|NCT02461433|negative pressure therapy|negative pressure therapy
1115254|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
1115255|NCT02461420|PMS|pms
1115256|NCT02461420|Genotype|genotype
1115257|NCT02461420|Phenotype|phenotype
1115258|NCT02461420|Natural History|natural history
1115259|NCT02461420|Mapping|mapping
1115260|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
1115261|NCT02461420|SHANK3|shank3
1115262|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
1115263|NCT02461420|ASD|asd
1115264|NCT02461420|Intellectual Disability|intellectual disability
1115265|NCT02461420|ID|id
1115266|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
1115267|NCT02461381|Diagnostic performance|diagnostic performance
1115268|NCT02461381|short-term heart rate variability|short-term heart rate variability
1115269|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
1115270|NCT02461381|DCAN|dcan
1115271|NCT02461342|Genetic|genetic
1115272|NCT02461342|environment|environment
1115273|NCT02461342|interaction analysis|interaction analysis
1115274|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
1115275|NCT02461342|CAN|can
1115276|NCT02461329|Hip Replacement, Total|hip replacement, total
1115277|NCT02461329|Gelatine solution|gelatine solution
1115278|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
1115279|NCT02461329|Volume therapy|volume therapy
1115280|NCT02461329|Platelet aggregation|platelet aggregation
1115281|NCT02461303|Klinefelter|klinefelter
1115282|NCT02461303|Spermatogenesis|spermatogenesis
1115283|NCT02461303|Puberty|puberty
1115284|NCT02461303|Fertility|fertility
1115285|NCT02461277|postoperative care|postoperative care
1115286|NCT02461277|exercise test|exercise test
1115287|NCT02461277|early ambulation|early ambulation
1115288|NCT02461277|Fast-track|fast-track
1115289|NCT02461251|Thromboelastometry|thromboelastometry
1115290|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
1115291|NCT02461251|Blood Component Transfusion|blood component transfusion
1115292|NCT02461212|HepaFat-Scan|hepafat-scan
1115293|NCT02461212|Liver Disease|liver disease
1115294|NCT02461212|Pediatrics|pediatrics
1115295|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
1115296|NCT02461199|Gut colonization|gut colonization
1115297|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
1115298|NCT02461199|Blood disorders|blood disorders
1115299|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
1115300|NCT02461199|Disease Eradication|disease eradication
1115301|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
1115302|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
1115303|NCT02461186|therapeutic efficacy|therapeutic efficacy
1115304|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
1115305|NCT02461186|Artemisinin-resistant|artemisinin-resistant
1115306|NCT02461160|Drug therapy|drug therapy
1115307|NCT02461134|GVHD|gvhd
1115308|NCT02461134|ponesimod|ponesimod
1115309|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
1115310|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
1115311|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
1115312|NCT02461121|graft-versus-host disease|graft-versus-host disease
1115313|NCT02461108|Public policy|public policy
1115314|NCT02461108|Food choice|food choice
1115315|NCT02461108|Nutrition labeling|nutrition labeling
1115316|NCT02461108|Fat tax|fat tax
1115317|NCT02461108|Vegetable subsidy|vegetable subsidy
1115318|NCT02461108|Behavioral economics|behavioral economics
1115319|NCT02461108|Health behavior|health behavior
1115320|NCT02461069|dimethyl fumarate|dimethyl fumarate
1115321|NCT02461056|ibuprofen|ibuprofen
1115322|NCT02461056|hydromorphone|hydromorphone
1115323|NCT02461056|drug interactions|drug interactions
1115324|NCT02461043|esophageal cancer|esophageal cancer
1115325|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
1115326|NCT02461043|esophageal surgery|esophageal surgery
1115327|NCT02461043|paclitaxel|paclitaxel
1115328|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
1115329|NCT02461030|Periodontal disease|periodontal disease
1115330|NCT02461030|Arginine|arginine
1115331|NCT02461017|intubation|intubation
1115332|NCT02461017|ventilation|ventilation
1115334|NCT02461017|airleak|airleak
1115335|NCT02461004|Dyslipidemia|dyslipidemia
1115337|NCT02461004|Atorvastatin|atorvastatin
1115338|NCT02461004|Ezetimibe|ezetimibe
1115339|NCT02460978|Dapagliflozin|dapagliflozin
1115340|NCT02460978|Efficacy|efficacy
1115341|NCT02460978|Safety|safety
1115342|NCT02460978|Add on to insulin|add on to insulin
1115343|NCT02460978|Oral Antidiabetic|oral antidiabetic
1115344|NCT02460978|Type 1 diabetes|type 1 diabetes
1115345|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
1115346|NCT02460952|perioperative period;|perioperative period;
1115347|NCT02460952|general anesthesia|general anesthesia
1115348|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
1115349|NCT02460939|metabolism of small molecules|metabolism of small molecules
1115350|NCT02460926|Scaling and root planning|scaling and root planning
1115351|NCT02460926|C-reactive protein|c-reactive protein
1115352|NCT02460913|acupuncture|acupuncture
1115353|NCT02460913|morphine|morphine
1115354|NCT02460913|acute pain|acute pain
1115355|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1115356|NCT02460887|induction chemotherapy|induction chemotherapy
1115357|NCT02460874|Brain Metastases|brain metastases
1115358|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
1115359|NCT02460874|Glyburide|glyburide
1115360|NCT02460861|Prostate Cancer|prostate cancer
1115361|NCT02460861|Molecular staging|molecular staging
1115362|NCT02460861|GSTP1|gstp1
1115363|NCT02460861|Surgical margins|surgical margins
1115364|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
1115365|NCT02460848|Malnutrition|malnutrition
1115366|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
1115367|NCT02460848|Cash Transfer|cash transfer
1115368|NCT02460848|Democratic Republic of Congo|democratic republic of congo
1115369|NCT02460848|Cluster randomize trial|cluster randomize trial
1115370|NCT02460796|Parkinson's disease|parkinson's disease
1115371|NCT02460796|Quality of life|quality of life
1115372|NCT02460796|Gait velocity|gait velocity
1115373|NCT02460796|Capacity|capacity
1115374|NCT02460783|Biomarkers|biomarkers
1115375|NCT02460783|Diabetes|diabetes
1115376|NCT02460783|Obesity|obesity
1115377|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
1115378|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1115379|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
1115380|NCT02460770|stem cell therapy|stem cell therapy
1115381|NCT02460770|ischemic heart failure|ischemic heart failure
1115382|NCT02460757|glottic movement|glottic movement
1115383|NCT02460757|emphysema|emphysema
1115384|NCT02460757|copd|copd
1115385|NCT02460757|vocal cord|vocal cord
1115386|NCT02460744|Breast cancer|breast cancer
1115387|NCT02460744|hypofractionation|hypofractionation
1115388|NCT02460744|radiotherapy|radiotherapy
1115390|NCT02460731|Young Plasma|young plasma
1115391|NCT02460718|diabetes mellitus|diabetes mellitus
1115392|NCT02460718|peer support|peer support
1115393|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
1115394|NCT02460666|depressed|depressed
1115395|NCT02460666|older adults|older adults
1115396|NCT02460666|Major Depressive Disorder|major depressive disorder
1115397|NCT02460666|Tai-Chi|tai-chi
1115398|NCT02460666|geriatric|geriatric
1115399|NCT02460653|High flow nasal cannula|high flow nasal cannula
1115400|NCT02460653|Oxygen therapy|oxygen therapy
1115401|NCT02460653|Ventilation|ventilation
1115402|NCT02460640|Minimally invasive surgery|minimally invasive surgery
1115403|NCT02460640|Partial nephrectomy|partial nephrectomy
1115404|NCT02460627|Arthroscopy|arthroscopy
1115405|NCT02460627|Meniscus|meniscus
1115406|NCT02460627|Lidocaine|lidocaine
1115407|NCT02460614|bronchiolitis|bronchiolitis
1115408|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
1115409|NCT02460614|pediatrics|pediatrics
1115410|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
1115411|NCT02460575|Safety|safety
1115412|NCT02460562|resin denture base|resin denture base
1115413|NCT02460549|therapeutic patient education|therapeutic patient education
1115414|NCT02460549|insulinoresistance|insulinoresistance
1115415|NCT02460549|empowerment|empowerment
1115416|NCT02460549|prostate cancer|prostate cancer
1115417|NCT02460549|oral endocrine therapy|oral endocrine therapy
1115418|NCT02460549|side effects|side effects
1115419|NCT02460536|attention bias modification treatment|attention bias modification treatment
1115420|NCT02460536|attention training|attention training
1115421|NCT02460536|anxiety disorders|anxiety disorders
1115422|NCT02460536|clinical trials|clinical trials
1115423|NCT02460471|Radiotherapy|radiotherapy
1115424|NCT02460471|Palliative Care|palliative care
1115426|NCT02460458|Factor VIII|factor viii
1115428|NCT02460458|von Willebrand Diseases|von willebrand diseases
1115429|NCT02460458|von Willebrand Factor|von willebrand factor
1115430|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
1115431|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
1115432|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
1115433|NCT02460445|Iron tissue depots|iron tissue depots
1115434|NCT02460445|Phlebotomy|phlebotomy
1115435|NCT02460445|Insulin resistance|insulin resistance
1115436|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
1115437|NCT02460445|Blood pressure|blood pressure
1115647|NCT02459327|Depression|depression
1115438|NCT02460445|Autonomic dysfunction|autonomic dysfunction
1115439|NCT02460445|Oxidative stress|oxidative stress
1115440|NCT02460445|Blood clotting tests|blood clotting tests
1115441|NCT02460445|Efficacy|efficacy
1115442|NCT02460445|Side effects|side effects
1115443|NCT02460445|Randomized clinical trial|randomized clinical trial
1115444|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
1115445|NCT02460432|Covered metalic stent|covered metalic stent
1115446|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1115447|NCT02460419|metastasis|metastasis
1115448|NCT02460419|capecitabine|capecitabine
1115449|NCT02460406|strength training|strength training
1115450|NCT02460406|virtual reality|virtual reality
1115451|NCT02460406|plyometric exercises|plyometric exercises
1115452|NCT02460406|cerebral palsy|cerebral palsy
1115453|NCT02460406|hemiplegic|hemiplegic
1115454|NCT02460393|tolerance|tolerance
1115455|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
1115456|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
1115457|NCT02460367|Vaccine Therapy|vaccine therapy
1115458|NCT02460367|Immunotherapy|immunotherapy
1115459|NCT02460367|Second line therapy|second line therapy
1115460|NCT02460367|Progressive|progressive
1115461|NCT02460367|Relapsed|relapsed
1115463|NCT02460367|IDO Inhibitor|ido inhibitor
1115464|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
1115465|NCT02460341|fMRI|fmri
1115466|NCT02460341|Brain function|brain function
1115467|NCT02460341|Sensory processing|sensory processing
1115468|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
1115469|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
1115470|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
1115471|NCT02460276|Lenalidomide|lenalidomide
1115472|NCT02460276|Rituximab|rituximab
1115473|NCT02460276|Ibrutinib|ibrutinib
1115474|NCT02460276|Response duration|response duration
1115475|NCT02460276|Complete remission rate|complete remission rate
1115476|NCT02460276|Quality of life|quality of life
1115477|NCT02460276|Overall survival|overall survival
1115478|NCT02460276|Safety|safety
1115479|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
1115480|NCT02460250|Liver graft|liver graft
1115481|NCT02460250|Brain Death|brain death
1115482|NCT02460250|FibroScan®|fibroscan®
1115483|NCT02460237|HPV|hpv
1115484|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
1115485|NCT02460224|Melanoma|melanoma
1115486|NCT02460224|Renal cancer|renal cancer
1115487|NCT02460224|Mesothelioma|mesothelioma
1115488|NCT02460224|Triple Negative Breast|triple negative breast
1115489|NCT02460224|TNBC|tnbc
1115490|NCT02460224|Renal|renal
1115491|NCT02460211|Cardiovascular Disease|cardiovascular disease
1115492|NCT02460211|Vitamin D|vitamin d
1115493|NCT02460211|Open Heart Surgery|open heart surgery
1115494|NCT02460198|PD1|pd1
1115495|NCT02460198|PD-1|pd-1
1115496|NCT02460198|PDL1|pdl1
1115497|NCT02460198|PD-L1|pd-l1
1115498|NCT02460198|MSI-H|msi-h
1115499|NCT02460198|MSI|msi
1115500|NCT02460172|bi lateral|bi lateral
1115501|NCT02460172|knee surgery|knee surgery
1115502|NCT02460172|arthroplasty|arthroplasty
1115503|NCT02460172|orthopedics|orthopedics
1115504|NCT02460081|PDA-002|pda-002
1115505|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
1115506|NCT02460081|Peripheral arterial disease|peripheral arterial disease
1115507|NCT02460081|Phase 2|phase 2
1115508|NCT02460081|Randomized|randomized
1115509|NCT02460068|melanoma brain metastases|melanoma brain metastases
1115510|NCT02460068|nivolumab|nivolumab
1115511|NCT02460068|ipilimumab|ipilimumab
1115512|NCT02460055|EGD Dysphagia|egd dysphagia
1115513|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
1115514|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
1115515|NCT02459964|Advanced Cancers|advanced cancers
1115516|NCT02459964|Pain|pain
1115517|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
1115518|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
1115519|NCT02459964|Phone call|phone call
1115520|NCT02459964|Numeric Rating Scale|numeric rating scale
1115521|NCT02459964|NRS|nrs
1168422|NCT02177526|CT|ct
1115522|NCT02459951|Muscle Spasticity|muscle spasticity
1115523|NCT02459951|Botox A|botox a
1115524|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
1115525|NCT02459912|Prostate|prostate
1115526|NCT02459912|Minimally|minimally
1115527|NCT02459912|Low-Risk|low-risk
1115528|NCT02459912|Invasive|invasive
1115529|NCT02459912|Cancer|cancer
1115532|NCT02459860|depression|depression
1115533|NCT02459860|randomized behavioral trial|randomized behavioral trial
1115534|NCT02459860|aged|aged
1115535|NCT02459860|Latinos|latinos
1115536|NCT02459860|Spanish-speaking|spanish-speaking
1115537|NCT02459860|chronic medical conditions|chronic medical conditions
1115538|NCT02459834|Allulose|allulose
1115539|NCT02459834|Fructose|fructose
1115540|NCT02459834|Dose Response|dose response
1115541|NCT02459834|Catalytic Dose|catalytic dose
1115542|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
1115543|NCT02459834|Randomized clinical trials|randomized clinical trials
1115544|NCT02459821|Multiple sclerosis|multiple sclerosis
1115545|NCT02459821|Gait rehabilitation|gait rehabilitation
1115546|NCT02459821|Quality of life|quality of life
1115547|NCT02459821|Stair climbing|stair climbing
1115548|NCT02459821|Robotic|robotic
1115549|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
1115550|NCT02459756|anthocyanins|anthocyanins
1115551|NCT02459756|bioavailability|bioavailability
1115552|NCT02459743|Hematological malignancies|hematological malignancies
1115553|NCT02459743|Next Generation Sequencing|next generation sequencing
1115554|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
1115555|NCT02459743|Prognosis|prognosis
1115556|NCT02459743|Diagnosis|diagnosis
1115557|NCT02459730|Dental caries|dental caries
1115558|NCT02459730|glass ionomer cement|glass ionomer cement
1115559|NCT02459730|ART|art
1115560|NCT02459704|Gingival Recession|gingival recession
1115561|NCT02459704|Semilunar flap|semilunar flap
1115562|NCT02459704|Enamel matrix derivative|enamel matrix derivative
1115563|NCT02459704|Periodontal regeneration|periodontal regeneration
1115564|NCT02459691|prediabetes|prediabetes
1115565|NCT02459691|metabolic syndrome|metabolic syndrome
1115566|NCT02459691|lifestyle|lifestyle
1115567|NCT02459691|behavior change|behavior change
1115568|NCT02459691|primary care|primary care
1115569|NCT02459691|latinos|latinos
1115570|NCT02459691|diet|diet
1115571|NCT02459691|physical activity|physical activity
1115572|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
1115573|NCT02459639|Chronic Widespread Pain|chronic widespread pain
1115574|NCT02459639|Telomere length|telomere length
1115575|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
1115576|NCT02459639|Integrative care|integrative care
1115577|NCT02459639|Existential aspects|existential aspects
1115578|NCT02459613|Radionuclide imaging|radionuclide imaging
1115579|NCT02459613|Annexin|annexin
1115580|NCT02459600|Eye surgery|eye surgery
1115581|NCT02459600|Children|children
1115582|NCT02459587|Self-Injurious Behavior|self-injurious behavior
1115583|NCT02459587|suicide prevention|suicide prevention
1115584|NCT02459574|Heart Failure|heart failure
1115585|NCT02459561|Obesity|obesity
1115586|NCT02459561|Diabetes|diabetes
1115587|NCT02459561|Overweight|overweight
1115588|NCT02459561|Medical device|medical device
1115589|NCT02459561|Endobarrier|endobarrier
1115590|NCT02459561|Clinical trial|clinical trial
1115591|NCT02459561|Diet|diet
1115592|NCT02459561|Exercise|exercise
1115593|NCT02459561|Body weight|body weight
1115594|NCT02459561|Medical therapy|medical therapy
1115595|NCT02459561|Medicine|medicine
1115596|NCT02459561|Device|device
1115597|NCT02459561|Randomised|randomised
1115598|NCT02459561|Control|control
1115599|NCT02459561|Intervention|intervention
1115600|NCT02459561|EndoBarrier Medical device|endobarrier medical device
1115601|NCT02459548|OSA|osa
1115602|NCT02459548|CPAP treatment|cpap treatment
1115603|NCT02459548|Primary care|primary care
1115604|NCT02459548|Efficacy|efficacy
1115605|NCT02459535|incretin release|incretin release
1115606|NCT02459522|Bayesian estimation|bayesian estimation
1115607|NCT02459522|short-term heart rate variability|short-term heart rate variability
1115608|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
1115609|NCT02459522|diagnostic performance|diagnostic performance
1115610|NCT02459509|Sedation|sedation
1115611|NCT02459509|dexmedetomidine|dexmedetomidine
1115612|NCT02459509|pediatric|pediatric
1115613|NCT02459509|preoperative period|preoperative period
1115614|NCT02459470|Fluid Responsiveness|fluid responsiveness
1115615|NCT02459470|Pulse Pressure Variation|pulse pressure variation
1115616|NCT02459470|Stroke Volume Variation|stroke volume variation
1115617|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1115618|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1115619|NCT02459457|paclitaxel|paclitaxel
1115620|NCT02459457|cisplatin|cisplatin
1115621|NCT02459457|carboplatin|carboplatin
1115622|NCT02459457|fluorouracil|fluorouracil
1115623|NCT02459444|Respiratory Muscles|respiratory muscles
1115624|NCT02459444|Muscle Weakness|muscle weakness
1115625|NCT02459444|Hospitalization|hospitalization
1115626|NCT02459444|Length of Stay|length of stay
1115627|NCT02459444|Mortality|mortality
1115630|NCT02459405|Colorectal surgery|colorectal surgery
1115631|NCT02459405|Near infrared|near infrared
1115632|NCT02459405|Indocyanine green|indocyanine green
1115633|NCT02459405|anastomotic leak|anastomotic leak
1115634|NCT02459405|Prevention of leak|prevention of leak
1115635|NCT02459392|Epiduroscopy,|epiduroscopy,
1115636|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
1115637|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
1115638|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
1115639|NCT02459366|Mechanical properties|mechanical properties
1115640|NCT02459366|Low back pain|low back pain
1115641|NCT02459353|dapagliflozin|dapagliflozin
1115642|NCT02459353|glucose variability|glucose variability
1115643|NCT02459327|Infant behavior|infant behavior
1115644|NCT02459327|Child behavior|child behavior
1115645|NCT02459327|Parenting|parenting
1115646|NCT02459327|Child rearing|child rearing
1115648|NCT02459327|Personal satisfaction|personal satisfaction
1115649|NCT02459327|Randomized controlled trials|randomized controlled trials
1115650|NCT02459327|Intervention studies|intervention studies
1115651|NCT02459327|Behavioral symptoms|behavioral symptoms
1115652|NCT02459327|Social behavior|social behavior
1115653|NCT02459288|Acute coronary syndrome|acute coronary syndrome
1115654|NCT02459288|Chronic kidney disease|chronic kidney disease
1115655|NCT02459288|End-Stage Renal Disease|end-stage renal disease
1115656|NCT02459288|eGFR|egfr
1115657|NCT02459288|Ticagrelor|ticagrelor
1115658|NCT02459288|Clopidogrel|clopidogrel
1115659|NCT02459275|feeding protocol|feeding protocol
1115660|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
1115661|NCT02459275|critically ill|critically ill
1115662|NCT02459275|surgical ICU|surgical icu
1115663|NCT02459275|enteral nutrition|enteral nutrition
1115664|NCT02459275|nutrition therapy|nutrition therapy
1115665|NCT02459223|Nutritional intervention|nutritional intervention
1115666|NCT02459223|iron deficiency anemia|iron deficiency anemia
1115667|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
1115668|NCT02459210|psychosis prodrome|psychosis prodrome
1115669|NCT02459210|cognitive remediation|cognitive remediation
1115670|NCT02459210|psychosis prevention|psychosis prevention
1115671|NCT02459197|Pain|pain
1115672|NCT02459184|preventive medicine|preventive medicine
1115673|NCT02459184|social determinants of health|social determinants of health
1115674|NCT02459184|primary health care|primary health care
1115675|NCT02459184|poverty|poverty
1115676|NCT02459184|income|income
1115677|NCT02459184|health promotion|health promotion
1115678|NCT02459132|High-intensity interval training|high-intensity interval training
1115679|NCT02459132|VO2peak|vo2peak
1115680|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
1115681|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
1115682|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
1115683|NCT02459132|Carotid distensibility|carotid distensibility
1115684|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
1115685|NCT02459119|urothelial cancer|urothelial cancer
1115686|NCT02459119|Regorafenib|regorafenib
1115687|NCT02459106|micro-RNA|micro-rna
1115688|NCT02459106|insulin resistance|insulin resistance
1115689|NCT02459093|wound complications|wound complications
1115690|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
1115691|NCT02459054|Artificial Heart|artificial heart
1115692|NCT02459054|Biventricular Heart Failure|biventricular heart failure
1115693|NCT02459054|SynCardia|syncardia
1115694|NCT02459002|Advanced lung cancer|advanced lung cancer
1115695|NCT02459002|NSCLC|nsclc
1115696|NCT02459002|palliative care|palliative care
1115697|NCT02458989|Thyroidectomy|thyroidectomy
1115698|NCT02458989|Thyroid surgery|thyroid surgery
1115699|NCT02458989|Scalpel|scalpel
1115700|NCT02458989|Electrocautery|electrocautery
1115701|NCT02458976|Scar|scar
1115702|NCT02458976|Pulsed-dye laser|pulsed-dye laser
1115703|NCT02458976|PDL|pdl
1115704|NCT02458963|PCOS|pcos
1115705|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
1115706|NCT02458963|Gonadotropin|gonadotropin
1115707|NCT02458963|IVF|ivf
1115708|NCT02458950|Anorexia nervosa|anorexia nervosa
1115709|NCT02458950|Siriraj Hospital|siriraj hospital
1115710|NCT02458950|Thai|thai
1115711|NCT02458937|Leukemia|leukemia
1115712|NCT02458937|Hodgkin Disease|hodgkin disease
1115713|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1115714|NCT02458937|Sickle Cell Disease|sickle cell disease
1115715|NCT02458937|Hip Core Decompression|hip core decompression
1115716|NCT02458937|Function Outcomes|function outcomes
1115717|NCT02458885|myocardial infarction|myocardial infarction
1115718|NCT02458885|observational registry|observational registry
1115719|NCT02458885|mortality|mortality
1115720|NCT02458872|Clinical Alarms|clinical alarms
1115721|NCT02458872|Patient Safety|patient safety
1115722|NCT02458859|Chronic|chronic
1115723|NCT02458859|Subacute|subacute
1115724|NCT02458833|Obesity|obesity
1115725|NCT02458833|Nutrition|nutrition
1115726|NCT02458833|Home Food Preparation|home food preparation
1115727|NCT02458833|Home Food Environment|home food environment
1115728|NCT02458833|Peer Mentoring|peer mentoring
1115729|NCT02458833|Early Head Start|early head start
1115730|NCT02458833|Cooking|cooking
1115731|NCT02458833|Diet|diet
1115732|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1115733|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
1115734|NCT02458820|ROSC|rosc
1115735|NCT02458820|Electroencephalogram|electroencephalogram
1115736|NCT02458742|spinal anesthesia|spinal anesthesia
1115737|NCT02458742|intrathecal morphine|intrathecal morphine
1115738|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
1115739|NCT02458742|postoperative pain|postoperative pain
1115740|NCT02458729|Tranexamic Acid|tranexamic acid
1115741|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
1115742|NCT02458729|Rivaroxaban|rivaroxaban
1115743|NCT02458703|workload|workload
1115744|NCT02458703|oxygen level|oxygen level
1115745|NCT02458703|oxygen consumption|oxygen consumption
1115846|NCT02457884|Hong Kong|hong kong
1115746|NCT02458703|breathing reserve|breathing reserve
1115747|NCT02458703|ventilatory efficiency|ventilatory efficiency
1115748|NCT02458690|Primary Care|primary care
1115749|NCT02458690|Older Adults|older adults
1115750|NCT02458690|Antidepressant Medications|antidepressant medications
1115751|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1115752|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
1115753|NCT02458612|cerebral palsy|cerebral palsy
1115754|NCT02458612|mirror therapy|mirror therapy
1115755|NCT02458612|strength training|strength training
1115756|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1115757|NCT02458560|Aortic Stenosis|aortic stenosis
1115758|NCT02458534|Simulated manikin|simulated manikin
1115759|NCT02458508|MC4R|mc4r
1115760|NCT02458508|chemotherapy|chemotherapy
1115761|NCT02458508|radiotherapy|radiotherapy
1115762|NCT02458495|Internet|internet
1115763|NCT02458495|Mobile Health|mobile health
1115764|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1115765|NCT02458495|Medication Adherence|medication adherence
1115766|NCT02458495|Psychological Theory|psychological theory
1115767|NCT02458482|Children|children
1115768|NCT02458482|Positive Airway Pressure|positive airway pressure
1115769|NCT02458482|Nebulizer|nebulizer
1115770|NCT02458482|Moderate|moderate
1115771|NCT02458482|Acute|acute
1115772|NCT02458482|AccuPAP|accupap
1115773|NCT02458417|Ablative laser|ablative laser
1115774|NCT02458417|Fractional laser|fractional laser
1115775|NCT02458417|Vitiligo|vitiligo
1115776|NCT02458417|Piebaldism|piebaldism
1115777|NCT02458417|Cell suspension grafting|cell suspension grafting
1115778|NCT02458391|Breast Cancer|breast cancer
1115779|NCT02458391|Lymphedema|lymphedema
1115780|NCT02458365|Violence|violence
1115781|NCT02458365|Bullying|bullying
1115782|NCT02458365|Social skills|social skills
1115783|NCT02458365|Prevention & control|prevention & control
1115784|NCT02458365|Adolescent|adolescent
1115785|NCT02458339|Brain tumor|brain tumor
1115786|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
1115787|NCT02458326|Migraine|migraine
1115788|NCT02458326|Fibromyalgia|fibromyalgia
1115789|NCT02458326|Aerobic exercise|aerobic exercise
1115790|NCT02458300|Bronchiolitis|bronchiolitis
1115791|NCT02458300|Chest|chest
1115792|NCT02458300|Physical therapy|physical therapy
1115793|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
1115794|NCT02458248|Chronic Kidney Disease|chronic kidney disease
1115795|NCT02458248|Sodium Reduction|sodium reduction
1115796|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
1115797|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
1115798|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
1115799|NCT02458196|IgG4 related disease|igg4 related disease
1115800|NCT02458196|IgG4-RD|igg4-rd
1115801|NCT02458196|Response rate|response rate
1115802|NCT02458196|Relapse|relapse
1115803|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
1115804|NCT02458170|Synovial tissue|synovial tissue
1115805|NCT02458170|Joint destruction|joint destruction
1115806|NCT02458170|Inflammation|inflammation
1115807|NCT02458157|ICU|icu
1115808|NCT02458157|Intensive|intensive
1115809|NCT02458157|CRRT|crrt
1115810|NCT02458157|Fluid Removal|fluid removal
1115811|NCT02458157|AKI|aki
1115812|NCT02458157|Critical Care|critical care
1115813|NCT02458131|community-based participatory research|community-based participatory research
1115814|NCT02458131|adolescents|adolescents
1115815|NCT02458118|chronic|chronic
1115816|NCT02458118|pancreatitis|pancreatitis
1115817|NCT02458118|secretin|secretin
1115818|NCT02458118|Blood flow|blood flow
1115819|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
1115820|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
1115821|NCT02458053|African American|african american
1115822|NCT02458053|male|male
1115823|NCT02458053|couples|couples
1115824|NCT02458053|randomized control trial|randomized control trial
1115825|NCT02458014|Leukemia|leukemia
1115826|NCT02458014|B-cell Lineage Acute Lymphocytic Leukemia|b-cell lineage acute lymphocytic leukemia
1115827|NCT02458014|Positive minimal residual disease|positive minimal residual disease
1115828|NCT02458014|MRD|mrd
1115829|NCT02458014|Acute lymphocytic leukemia|acute lymphocytic leukemia
1115830|NCT02458014|ALL|all
1115831|NCT02458014|Blinatumomab|blinatumomab
1115832|NCT02458014|Blinacyto|blinacyto
1115833|NCT02458014|Phone calls|phone calls
1115834|NCT02457949|Social Assistance|social assistance
1115835|NCT02457949|Drug Use|drug use
1115836|NCT02457949|Drug-Related harm|drug-related harm
1115837|NCT02457923|mobile phone counselling|mobile phone counselling
1115838|NCT02457923|infant feeding|infant feeding
1115839|NCT02457923|nutrition|nutrition
1115840|NCT02457897|Brown Adipose Tissue|brown adipose tissue
1115841|NCT02457897|Liothyronine|liothyronine
1115842|NCT02457897|Insulin Receptors|insulin receptors
1115843|NCT02457884|Diabetic macular oedema|diabetic macular oedema
1115844|NCT02457884|Perceptual learning|perceptual learning
1115845|NCT02457884|Chinese|chinese
1115847|NCT02457858|Type 1 Diabetes|type 1 diabetes
1115848|NCT02457858|Islet Transplant|islet transplant
1115849|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
1115850|NCT02457845|Glioma|glioma
1115851|NCT02457845|Glioblastoma|glioblastoma
1115852|NCT02457845|Gliosarcoma|gliosarcoma
1115853|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
1115854|NCT02457845|Oligodendroglioma|oligodendroglioma
1115855|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
1115856|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
1115857|NCT02457845|PNET|pnet
1115858|NCT02457845|Ependymoma|ependymoma
1115859|NCT02457845|Germ Cell Tumor|germ cell tumor
1115860|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
1115861|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
1115862|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
1115863|NCT02457845|Immunotherapy|immunotherapy
1115864|NCT02457845|Central Nervous System Agents|central nervous system agents
1115865|NCT02457845|Antineoplastic Agents|antineoplastic agents
1115866|NCT02457845|Neoplasms|neoplasms
1115867|NCT02457845|Pediatric|pediatric
1115868|NCT02457845|Pediatrics|pediatrics
1115869|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
1115870|NCT02457832|Neurology|neurology
1115871|NCT02457832|Neurosciences|neurosciences
1115872|NCT02457832|Physical Medicine|physical medicine
1115873|NCT02457832|Parkinson Disease|parkinson disease
1115874|NCT02457832|Rehabilitation|rehabilitation
1115875|NCT02457806|Dental Anesthesia|dental anesthesia
1115876|NCT02457780|PTSD|ptsd
1115877|NCT02457780|Trauma|trauma
1115878|NCT02457780|World Trade Center|world trade center
1115879|NCT02457780|Respiratory|respiratory
1115880|NCT02457780|Mind-Body|mind-body
1115881|NCT02457741|Mechanical ventilation|mechanical ventilation
1115882|NCT02457741|PEEP|peep
1115883|NCT02457741|Respiratory mechanics|respiratory mechanics
1115884|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
1115885|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
1115886|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
1115887|NCT02457676|Self-Regulation Training|self-regulation training
1115888|NCT02457676|Neuroimaging|neuroimaging
1115889|NCT02457676|Response Inhibition|response inhibition
1115890|NCT02457676|Behavioral Regulation|behavioral regulation
1115891|NCT02457676|Emotional Regulation|emotional regulation
1115892|NCT02457663|Burns|burns
1115893|NCT02457637|chronic liver disease|chronic liver disease
1115894|NCT02457637|acute liver injury|acute liver injury
1115895|NCT02457637|acute decompensation|acute decompensation
1115896|NCT02457637|multiple organ failures|multiple organ failures
1115897|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
1115898|NCT02457624|gastric cancer|gastric cancer
1115899|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
1115900|NCT02457624|intestinal metaplasia|intestinal metaplasia
1115901|NCT02457546|Fibrin sealant|fibrin sealant
1115902|NCT02457546|CSF leak|csf leak
1115903|NCT02457494|CALVIH|calvih
1115904|NCT02457494|Renal stone|renal stone
1115905|NCT02457494|HIV1|hiv1
1115906|NCT02457494|Renal colic|renal colic
1115907|NCT02457494|Atazanavir|atazanavir
1115908|NCT02457494|Crystalluria|crystalluria
1115909|NCT02457494|Chronic Kidney Disease|chronic kidney disease
1115910|NCT02457494|Calcium Oxalate|calcium oxalate
1115911|NCT02457481|Embryo Culture Techniques|embryo culture techniques
1115912|NCT02457481|Embryonic Development|embryonic development
1115913|NCT02457468|coflex|coflex
1115914|NCT02457468|interlaminar stabilization|interlaminar stabilization
1115915|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
1115916|NCT02457468|neurogenic claudication|neurogenic claudication
1115917|NCT02457468|decompression|decompression
1115918|NCT02457455|inflight emergencies|inflight emergencies
1115919|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
1115920|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
1115921|NCT02457442|Analgesics, Opioid|analgesics, opioid
1115922|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
1115923|NCT02457429|Children|children
1115924|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
1115925|NCT02457429|GORD|gord
1115926|NCT02457429|Trans-nasal catheter|trans-nasal catheter
1115927|NCT02457416|Peanut allergy|peanut allergy
1115928|NCT02457416|Oral immunotherapy|oral immunotherapy
1115929|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
1115930|NCT02457390|CE-LUS|ce-lus
1115931|NCT02457390|LUS|lus
1115932|NCT02457390|robot assisted CRC resection|robot assisted crc resection
1115933|NCT02457377|recurrent abortion|recurrent abortion
1115934|NCT02457377|cerclage|cerclage
1115935|NCT02457377|laparoscopy|laparoscopy
1115936|NCT02457377|cervical imcompetence|cervical imcompetence
1115937|NCT02457364|non-operative management|non-operative management
1115938|NCT02457351|Phase 1|phase 1
1115939|NCT02457351|Advanced solid tumor|advanced solid tumor
1115940|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
1115941|NCT02457351|Drug-drug Interaction|drug-drug interaction
1115942|NCT02457338|C-section|c-section
1115943|NCT02457338|Infants|infants
1115944|NCT02457338|Probiotic|probiotic
1115945|NCT02457338|B. infantis|b. infantis
1115951|NCT02457325|Lower third molar|lower third molar
1115952|NCT02457325|Oral Surgery|oral surgery
1115953|NCT02457299|Esophagectomy|esophagectomy
1115954|NCT02457299|Gastric Conduit|gastric conduit
1115955|NCT02457299|Esophageal Cancer|esophageal cancer
1115956|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
1115957|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
1115958|NCT02457247|Drug therapy|drug therapy
1115959|NCT02457234|fruits and vegetables|fruits and vegetables
1115960|NCT02457234|cultural immersion|cultural immersion
1115961|NCT02457221|Tacrolimus|tacrolimus
1115962|NCT02457221|Cyclophosphamide|cyclophosphamide
1115963|NCT02457221|Prograf|prograf
1115964|NCT02457221|lupus nephritis|lupus nephritis
1115965|NCT02457208|pharmacokinetics|pharmacokinetics
1115966|NCT02457195|PONV|ponv
1115967|NCT02457195|anesthesia|anesthesia
1115968|NCT02457195|granisetron|granisetron
1115969|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
1115970|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
1115971|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
1115972|NCT02457156|Blumgart anastomosis|blumgart anastomosis
1115973|NCT02457143|recall|recall
1115974|NCT02457143|income-related disparities|income-related disparities
1115975|NCT02457143|cancer screening|cancer screening
1115976|NCT02457117|CyberKnife|cyberknife
1115977|NCT02457117|Partial breast irradiation|partial breast irradiation
1115978|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
1115979|NCT02457117|breast sbrt|breast sbrt
1115980|NCT02457091|multiple sclerosis|multiple sclerosis
1115981|NCT02457091|exercise|exercise
1115982|NCT02457091|home-based|home-based
1115983|NCT02457091|training|training
1115984|NCT02457091|fitness|fitness
1115985|NCT02457078|nutritional supplements|nutritional supplements
1115986|NCT02457078|lutein|lutein
1115987|NCT02457078|DHA|dha
1115988|NCT02457078|vitamin E|vitamin e
1115989|NCT02457078|infant brain development|infant brain development
1115990|NCT02457065|survivors|survivors
1115991|NCT02457065|family|family
1115992|NCT02457052|Medical device|medical device
1115993|NCT02457039|Chemo-brain|chemo-brain
1115994|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
1115995|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
1115996|NCT02457039|Breast cancer|breast cancer
1115997|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1115998|NCT02457026|age-related macular degeneration|age-related macular degeneration
1115999|NCT02457026|verteporfin|verteporfin
1116000|NCT02457026|persistent disease activity|persistent disease activity
1116001|NCT02457026|photodynamic therapy|photodynamic therapy
1116002|NCT02457026|Aflibercept|aflibercept
1116003|NCT02457000|Sleep|sleep
1116004|NCT02457000|Skin|skin
1116005|NCT02457000|Circadian Rhythm|circadian rhythm
1116006|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
1116007|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
1116008|NCT02456961|Transepithelial CXL|transepithelial cxl
1116009|NCT02456961|Iontophoresis|iontophoresis
1116010|NCT02456961|Riboflavin|riboflavin
1116011|NCT02456948|treatment resistant depression|treatment resistant depression
1116012|NCT02456948|inflammation|inflammation
1116013|NCT02456948|microglia|microglia
1116014|NCT02456948|minocycline|minocycline
1116015|NCT02456922|Type 1 Diabetes|type 1 diabetes
1116016|NCT02456922|Type 2 Diabetes|type 2 diabetes
1116017|NCT02456922|Harmony 1|harmony 1
1116018|NCT02456896|Oxcarbazepine|oxcarbazepine
1116019|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
1116020|NCT02456896|Bipolar disorder|bipolar disorder
1116021|NCT02456896|Neuroprotection|neuroprotection
1116022|NCT02456883|ASP2215|asp2215
1116023|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
1116024|NCT02456883|Advanced Solid Tumors|advanced solid tumors
1116025|NCT02456883|Pharmacokinetics|pharmacokinetics
1116026|NCT02456883|gilteritinib|gilteritinib
1116027|NCT02456870|Adipose tissue|adipose tissue
1116028|NCT02456870|Overfeeding|overfeeding
1116029|NCT02456857|Breast cancer|breast cancer
1116030|NCT02456857|Triple-Negative Breast Cancer|triple-negative breast cancer
1116031|NCT02456857|TNBC|tnbc
1116032|NCT02456857|Tumors insensitive to standard neoadjuvant chemotherapy|tumors insensitive to standard neoadjuvant chemotherapy
1116033|NCT02456857|Temsirolimus|temsirolimus
1116034|NCT02456857|CCI-779|cci-779
1116035|NCT02456857|Torisel|torisel
1116036|NCT02456857|Liposomal Doxorubicin|liposomal doxorubicin
1116037|NCT02456857|Doxil|doxil
1116038|NCT02456857|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
1116039|NCT02456857|Bevacizumab|bevacizumab
1116040|NCT02456857|Avastin|avastin
1116041|NCT02456857|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
1116042|NCT02456857|rhuMAb-VEGF|rhumab-vegf
1116043|NCT02456818|Colonization|colonization
1116044|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
1116045|NCT02456818|Infection control measures|infection control measures
1116046|NCT02456818|Hand hygiene program|hand hygiene program
1116047|NCT02456818|Contact precautions|contact precautions
1116949|NCT02450994|emphysema|emphysema
1116048|NCT02456818|Immunocompromised host|immunocompromised host
1116049|NCT02456792|PCOS|pcos
1116050|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
1116051|NCT02456792|LOD|lod
1116052|NCT02456792|IVF|ivf
1116053|NCT02456779|pepsin|pepsin
1116054|NCT02456779|peptest|peptest
1116055|NCT02456779|GERD|gerd
1116056|NCT02456779|NERD|nerd
1116057|NCT02456779|diagnostic|diagnostic
1116058|NCT02456766|FibroTouch|fibrotouch
1116059|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
1116060|NCT02456766|liver biopsy|liver biopsy
1116061|NCT02456766|hepatic steatosis|hepatic steatosis
1116062|NCT02456753|in labor|in labor
1116063|NCT02456753|Ultrasonography|ultrasonography
1116064|NCT02456753|clinical examination|clinical examination
1116065|NCT02456753|Prenatal|prenatal
1116066|NCT02456740|Migraine|migraine
1116067|NCT02456740|Headache|headache
1116068|NCT02456740|Prevention|prevention
1116069|NCT02456740|Prophylaxis|prophylaxis
1116070|NCT02456727|Acupuncture|acupuncture
1116071|NCT02456727|Group/Community Acupuncture|group/community acupuncture
1116072|NCT02456727|Individual Acupuncture|individual acupuncture
1116073|NCT02456727|Chronic Pain|chronic pain
1116074|NCT02456727|Underserved|underserved
1116075|NCT02456727|Urban Primary Care|urban primary care
1116076|NCT02456727|Osteoarthritis|osteoarthritis
1116077|NCT02456727|Back Pain|back pain
1116078|NCT02456727|Neck Pain|neck pain
1116079|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
1116080|NCT02456714|FOLFIRINOX|folfirinox
1116081|NCT02456714|Phase II study|phase ii study
1116082|NCT02456701|CDX3379|cdx3379
1116083|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
1116084|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
1116085|NCT02456649|lumpectomy margins|lumpectomy margins
1116086|NCT02456636|Weight loss|weight loss
1116087|NCT02456636|Weight management|weight management
1116088|NCT02456636|Diabetes|diabetes
1116089|NCT02456636|Heart disease|heart disease
1116090|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
1116091|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
1116092|NCT02456584|confidence interval (CI)|confidence interval (ci)
1116093|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
1116094|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
1116095|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
1116096|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
1116097|NCT02456558|HIV infection|hiv infection
1116098|NCT02456558|antiretroviral drugs|antiretroviral drugs
1116099|NCT02456558|deferiprone|deferiprone
1116100|NCT02456558|pharmacokinetics|pharmacokinetics
1116101|NCT02456519|children|children
1116102|NCT02456519|surgery|surgery
1116103|NCT02456428|Incretins|incretins
1116104|NCT02456428|Antidiabetic Agents|antidiabetic agents
1116105|NCT02456428|Heart Failure|heart failure
1116106|NCT02456389|Probable cancer|probable cancer
1116107|NCT02456389|Proven cancer|proven cancer
1116108|NCT02456389|Elective cancer surgery|elective cancer surgery
1116109|NCT02456389|Postoperative death|postoperative death
1116110|NCT02456389|Postoperative complications|postoperative complications
1116111|NCT02456389|Healthcare utilization|healthcare utilization
1116112|NCT02456389|Quality of life|quality of life
1116113|NCT02456389|Adjuvant therapy|adjuvant therapy
1116114|NCT02456389|Disease-free survival|disease-free survival
1116115|NCT02456389|Overall survival|overall survival
1116116|NCT02456376|Sensor Fusion|sensor fusion
1116117|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
1116118|NCT02456376|Sensory deficits|sensory deficits
1116119|NCT02456376|Postural Control|postural control
1116120|NCT02456363|Adalimumab|adalimumab
1116122|NCT02456363|safety|safety
1116123|NCT02456363|efficacy|efficacy
1116124|NCT02456337|Gingival Recession|gingival recession
1116125|NCT02456337|Coronally advanced flap|coronally advanced flap
1116126|NCT02456337|Periodontal regeneration|periodontal regeneration
1116127|NCT02456324|Fistula, Anorectal|fistula, anorectal
1116128|NCT02456311|VATS|vats
1116129|NCT02456311|Energy sealing|energy sealing
1116130|NCT02456298|Telehealth|telehealth
1116131|NCT02456298|Applied behavior analysis|applied behavior analysis
1116132|NCT02456272|Otosclerosis|otosclerosis
1116133|NCT02456272|Surgical treatment|surgical treatment
1116134|NCT02456272|Hearing aids|hearing aids
1116135|NCT02456259|internal jugular vein patency|internal jugular vein patency
1116136|NCT02456259|MICS|mics
1116137|NCT02456259|neck cannula|neck cannula
1116138|NCT02456259|Jugular veins|jugular veins
1116139|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
1116140|NCT02456246|Lung Fibrosis|lung fibrosis
1116141|NCT02456246|FLT-PET|flt-pet
1116142|NCT02456246|NSCLC|nsclc
1116143|NCT02456233|rotor|rotor
1116144|NCT02456233|FIRM|firm
1116145|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1116146|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
1116147|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
1116148|NCT02456233|ablation|ablation
1116149|NCT02456233|contact mapping|contact mapping
1116150|NCT02456233|clinical trial|clinical trial
1116151|NCT02456233|signal processing|signal processing
1116152|NCT02456220|Herbst appliance|herbst appliance
1116153|NCT02456220|Computed tomography|computed tomography
1116154|NCT02456220|3D imaging|3d imaging
1116155|NCT02456220|Growth and development|growth and development
1116156|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
1116157|NCT02456168|Lupus|lupus
1116158|NCT02456168|SLE|sle
1116159|NCT02456155|bedside placement|bedside placement
1116160|NCT02456155|nasal jejunal tube|nasal jejunal tube
1116161|NCT02456155|ultrasound|ultrasound
1116162|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
1116163|NCT02456155|endoscope|endoscope
1116164|NCT02456155|efficacy|efficacy
1116165|NCT02456155|safety|safety
1116166|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
1116167|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
1116168|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
1116169|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
1116170|NCT02456051|New-Onset Diabetes|new-onset diabetes
1116171|NCT02456051|Adrenomedullin|adrenomedullin
1116172|NCT02456051|Early Diagnosis|early diagnosis
1116173|NCT02456051|Biological Markers|biological markers
1116174|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
1116175|NCT02456012|comorbidity|comorbidity
1116176|NCT02456012|clinical trial|clinical trial
1116177|NCT02455973|obesity|obesity
1116178|NCT02455973|overweight|overweight
1116179|NCT02455947|Burnout|burnout
1116180|NCT02455947|Teachers|teachers
1116181|NCT02455947|Meditation|meditation
1116182|NCT02455947|IBSR|ibsr
1116183|NCT02455947|"The Work"|"the work"
1116184|NCT02455947|Byron Katie|byron katie
1116185|NCT02455895|Blepharitis|blepharitis
1116186|NCT02455856|Healthy|healthy
1116187|NCT02455856|Itraconazole|itraconazole
1116188|NCT02455856|JNJ-42847922|jnj-42847922
1116189|NCT02455843|microwave ablation|microwave ablation
1116190|NCT02455843|chemotherapy|chemotherapy
1116191|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
1116192|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1116193|NCT02455830|Newborn infants|newborn infants
1116194|NCT02455830|Cytokines|cytokines
1116195|NCT02455830|Trophic factors|trophic factors
1116196|NCT02455791|Breast Cancer|breast cancer
1116197|NCT02455791|Triple negative breast cancer|triple negative breast cancer
1116198|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
1116199|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
1116200|NCT02455791|Fine needle aspirate|fine needle aspirate
1116201|NCT02455791|FNA|fna
1116202|NCT02455791|Core biopsy|core biopsy
1116203|NCT02455752|LE-TME|le-tme
1116204|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
1116205|NCT02455752|Retroperitoneal resection|retroperitoneal resection
1116206|NCT02455739|intestinal function|intestinal function
1116207|NCT02455739|chewing gum|chewing gum
1116208|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
1116209|NCT02455726|Magnesium Oxide|magnesium oxide
1116210|NCT02455726|Pain|pain
1116211|NCT02455687|Bronchial asthma|bronchial asthma
1116212|NCT02455687|Magnesium Sulfate|magnesium sulfate
1116213|NCT02455687|Inhaled budesonide|inhaled budesonide
1116214|NCT02455674|weight estimation|weight estimation
1116215|NCT02455674|emergency|emergency
1116216|NCT02455674|child|child
1116217|NCT02455635|Office Hysteroscopy|office hysteroscopy
1116218|NCT02455635|tubal patency|tubal patency
1116219|NCT02455635|infertility|infertility
1116220|NCT02455635|Lower Abdominal Pain|lower abdominal pain
1116221|NCT02455609|dexmedetomidine|dexmedetomidine
1116222|NCT02455609|ketamine|ketamine
1116223|NCT02455609|postoperative pain|postoperative pain
1116224|NCT02455596|Novaferon|novaferon
1116225|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
1116226|NCT02455596|Carcinoid Tumor|carcinoid tumor
1116227|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
1116228|NCT02455583|HIV prevention|hiv prevention
1116229|NCT02455583|Sexual activity biomarker|sexual activity biomarker
1116230|NCT02455583|Youth|youth
1116231|NCT02455583|Adolescents|adolescents
1116232|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
1116233|NCT02455570|Quality Management|quality management
1116234|NCT02455570|Education and training|education and training
1116235|NCT02455570|Safety|safety
1116236|NCT02455570|Learning curve|learning curve
1116237|NCT02455544|Urine congophilia|urine congophilia
1116238|NCT02455518|pain|pain
1116239|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
1116240|NCT02455505|Supportive Care|supportive care
1116241|NCT02455505|15-095|15-095
1116242|NCT02455492|Mortality|mortality
1116243|NCT02455492|Perioperative period|perioperative period
1116244|NCT02455492|Elective surgical procedures|elective surgical procedures
1116245|NCT02455479|cocaine vaccine|cocaine vaccine
1116246|NCT02455479|cocaine dependence|cocaine dependence
1116247|NCT02455479|Cocaine|cocaine
1116248|NCT02455440|esmolol|esmolol
1116249|NCT02455440|anesthetics|anesthetics
1116250|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
1116251|NCT02455427|conventional physical therapy|conventional physical therapy
1116252|NCT02455401|Postoperative Vomiting|postoperative vomiting
1116253|NCT02455388|Nutrition|nutrition
1116254|NCT02455388|Obesity|obesity
1116255|NCT02455388|Pediatric|pediatric
1116256|NCT02455375|Puumala virus|puumala virus
1116257|NCT02455375|diagnostic|diagnostic
1116258|NCT02455375|France|france
1116259|NCT02455336|tetraplegia|tetraplegia
1116260|NCT02455336|paraplegia|paraplegia
1116261|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
1116262|NCT02455336|hyperlipidemia|hyperlipidemia
1116263|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
1116264|NCT02455323|Efficacy|efficacy
1116265|NCT02455323|Tension-type headache|tension-type headache
1116266|NCT02455323|Manual therapy|manual therapy
1116267|NCT02455284|MRI|mri
1116268|NCT02455284|Tractography|tractography
1116269|NCT02455284|white|white
1116270|NCT02455284|physiology|physiology
1116271|NCT02455284|analysis|analysis
1116272|NCT02455284|matter|matter
1116273|NCT02455284|tracts|tracts
1116274|NCT02455271|Insomnia|insomnia
1116275|NCT02455258|Inactivity|inactivity
1116276|NCT02455180|Critical Care|critical care
1116277|NCT02455167|HCV|hcv
1116278|NCT02455167|Hepatitis C|hepatitis c
1116279|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
1116280|NCT02455154|Osteoporosis|osteoporosis
1116281|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
1116282|NCT02455154|early breast cancer|early breast cancer
1116283|NCT02455141|chemptherapy|chemptherapy
1116284|NCT02455141|triple negative|triple negative
1116285|NCT02455141|taxanes|taxanes
1116286|NCT02455141|carboplatin|carboplatin
1116287|NCT02455128|Anxiety|anxiety
1116288|NCT02455128|Fear|fear
1116289|NCT02455128|Colorectal Surgery|colorectal surgery
1116290|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
1116291|NCT02455115|Acute kidney injury|acute kidney injury
1116292|NCT02455115|Liver transplantation|liver transplantation
1116293|NCT02455115|Postoperative care|postoperative care
1116294|NCT02455115|Glomerular filtration rate|glomerular filtration rate
1116295|NCT02455115|Renal blood flow|renal blood flow
1116296|NCT02455115|Vasopressor|vasopressor
1116297|NCT02455115|Norepinephrine|norepinephrine
1116298|NCT02455102|Prevention|prevention
1116299|NCT02455102|Anticoagulation|anticoagulation
1116300|NCT02455102|Electronic warning system|electronic warning system
1116301|NCT02455089|Flare|flare
1116302|NCT02455089|Therapeutic adjustments|therapeutic adjustments
1116303|NCT02455089|Biological Marker|biological marker
1116304|NCT02455089|Immunologic Marker|immunologic marker
1116305|NCT02455089|Prognosis|prognosis
1116306|NCT02455076|Hypoglycemia|hypoglycemia
1116307|NCT02455037|Concussion|concussion
1116308|NCT02455037|Contact sport|contact sport
1116309|NCT02455037|Collision sport|collision sport
1116310|NCT02455037|Neck strengthening|neck strengthening
1116311|NCT02455024|Leukemia|leukemia
1116312|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
1116313|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1116314|NCT02455024|ponatinib|ponatinib
1116315|NCT02455024|Pharmacologic Actions|pharmacologic actions
1116316|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
1116317|NCT02455024|Risk factor|risk factor
1116318|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
1116319|NCT02455024|CML|cml
1116320|NCT02455024|CP-CML|cp-cml
1169413|NCT02171182|Qutenza|qutenza
1116321|NCT02455024|Iclusig|iclusig
1116322|NCT02455024|AP24534|ap24534
1116323|NCT02455024|AP-CML|ap-cml
1116324|NCT02455024|BP-CML|bp-cml
1116325|NCT02455024|Ph+ALL|ph+all
1116326|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
1116327|NCT02454998|Alveolar bone graft|alveolar bone graft
1116328|NCT02454946|Blood Group Antigens|blood group antigens
1116329|NCT02454946|erectile dysfunction|erectile dysfunction
1116330|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
1116331|NCT02454920|Strabismus|strabismus
1116332|NCT02454920|Optical Coherence Tomography|optical coherence tomography
1116429|NCT02454361|Safety|safety
1116333|NCT02454920|Extraocular muscles|extraocular muscles
1116334|NCT02454868|Remifentanil|remifentanil
1116335|NCT02454868|Intubation|intubation
1116336|NCT02454868|Children|children
1116337|NCT02454855|quality of life|quality of life
1116338|NCT02454855|melatonin|melatonin
1116339|NCT02454855|Elderly patient|elderly patient
1116340|NCT02454842|TH-4000|th-4000
1116341|NCT02454842|low-oxygen conditions|low-oxygen conditions
1116342|NCT02454842|hypoxia|hypoxia
1116343|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
1116344|NCT02454842|NSCLC|nsclc
1116345|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
1116346|NCT02454842|Tarloxotinib|tarloxotinib
1116347|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
1116348|NCT02454829|ovarian function|ovarian function
1116349|NCT02454790|Acute toxicity|acute toxicity
1116350|NCT02454790|Late toxicity|late toxicity
1116351|NCT02454790|Prediction models|prediction models
1116352|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
1116353|NCT02454738|chest|chest
1116354|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
1116355|NCT02454725|HIV Testing|hiv testing
1116356|NCT02454725|Latino|latino
1116357|NCT02454712|Prodrug|prodrug
1116358|NCT02454712|PF614|pf614
1116359|NCT02454712|oxycodone extended-release|oxycodone extended-release
1116360|NCT02454712|oral|oral
1116361|NCT02454699|antiviral|antiviral
1116362|NCT02454699|ascending dose|ascending dose
1116363|NCT02454699|Cytomegalovirus|cytomegalovirus
1116364|NCT02454699|food effect|food effect
1116365|NCT02454699|Herpesviridae|herpesviridae
1116366|NCT02454699|MBX-400|mbx-400
1116367|NCT02454686|Complications after hepatectomy|complications after hepatectomy
1116368|NCT02454673|Radiotherapy|radiotherapy
1116369|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
1116370|NCT02454673|Pharmacodynamics|pharmacodynamics
1116371|NCT02454673|Pharmacokinetics|pharmacokinetics
1116372|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
1116373|NCT02454660|adherence|adherence
1116374|NCT02454660|hypertension|hypertension
1116375|NCT02454660|mobile technology|mobile technology
1116376|NCT02454660|intervention|intervention
1116377|NCT02454647|Radiotherapy|radiotherapy
1116378|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
1116379|NCT02454647|Induction chemotherapy|induction chemotherapy
1116380|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1116381|NCT02454647|Preoperative factors|preoperative factors
1116382|NCT02454647|Dynamic factors|dynamic factors
1116383|NCT02454647|Prognostic Factor|prognostic factor
1116384|NCT02454634|IDH1R132H|idh1r132h
1116385|NCT02454634|peptide vaccine|peptide vaccine
1116386|NCT02454634|immunotherapy|immunotherapy
1116387|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
1116388|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
1116389|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
1116390|NCT02454543|metastatic|metastatic
1116391|NCT02454543|prostatectomy|prostatectomy
1116392|NCT02454543|androgen deprivation|androgen deprivation
1116393|NCT02454543|best systemic therapy|best systemic therapy
1116394|NCT02454504|Sugammadex|sugammadex
1116395|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
1116396|NCT02454504|Curare|curare
1116397|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
1116398|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
1116399|NCT02454491|radial artery access|radial artery access
1116400|NCT02454491|access site complications|access site complications
1116401|NCT02454491|verapamil|verapamil
1116402|NCT02454491|heparin|heparin
1116403|NCT02454478|lenvatinib|lenvatinib
1116404|NCT02454478|Everolimus|everolimus
1116405|NCT02454478|Carcinoma|carcinoma
1116406|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
1116407|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1116408|NCT02454452|Varicose Veins|varicose veins
1116409|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
1116410|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1116411|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
1116412|NCT02454439|Efficacy|efficacy
1116413|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
1116414|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
1116415|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
1116416|NCT02454426|Depression|depression
1116417|NCT02454426|Heart disease|heart disease
1116418|NCT02454413|dentures hygiene|dentures hygiene
1116419|NCT02454413|biofilm formation|biofilm formation
1116420|NCT02454413|oral health|oral health
1116421|NCT02454400|physical therapy|physical therapy
1116422|NCT02454400|lumbar spine surgery|lumbar spine surgery
1116423|NCT02454400|pre-surgical intervention|pre-surgical intervention
1116425|NCT02454374|Physiotherapy|physiotherapy
1116426|NCT02454374|Knee Loading|knee loading
1116427|NCT02454374|Randomised Controlled Trial|randomised controlled trial
1116428|NCT02454374|Pain|pain
1116430|NCT02454361|tolerability|tolerability
1116431|NCT02454361|pharmacokinetics|pharmacokinetics
1116432|NCT02454361|KBP-7072|kbp-7072
1116433|NCT02454348|septic shock|septic shock
1116434|NCT02454348|vasopressin|vasopressin
1116435|NCT02454348|norepinephrine|norepinephrine
1116436|NCT02454296|Laminaria|laminaria
1116437|NCT02454270|First-in-Human|first-in-human
1116438|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1116439|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
1116440|NCT02454270|Follicular Lymphoma|follicular lymphoma
1116441|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
1116442|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
1116443|NCT02454270|Dose Escalation Study|dose escalation study
1116444|NCT02454270|Duvortuxizumab|duvortuxizumab
1116445|NCT02454231|EPC|epc
1116446|NCT02454231|CD34+|cd34+
1116447|NCT02454231|CD14+CD34low|cd14+cd34low
1116448|NCT02454218|Fibromyalgia|fibromyalgia
1116449|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
1116450|NCT02454192|Evidence-based intervention|evidence-based intervention
1116451|NCT02454192|Implementation|implementation
1116452|NCT02454192|Underserved communities|underserved communities
1116453|NCT02454127|nutrition|nutrition
1116454|NCT02454127|popular diets|popular diets
1116455|NCT02454127|weight loss|weight loss
1116456|NCT02454127|lifestyle|lifestyle
1116457|NCT02454127|counseling|counseling
1116458|NCT02454114|Pneumonia|pneumonia
1116459|NCT02454114|Community|community
1116460|NCT02454114|Hospital|hospital
1116461|NCT02454114|Respiratory|respiratory
1116462|NCT02454114|Infection|infection
1116463|NCT02454088|Volume|volume
1116464|NCT02454088|Hands|hands
1116465|NCT02454088|Filler|filler
1116466|NCT02454088|Radiesse|radiesse
1116467|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
1116468|NCT02454075|YF476|yf476
1116469|NCT02454075|netazepide|netazepide
1116470|NCT02454075|gastric carcinoids|gastric carcinoids
1116471|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
1116472|NCT02454062|Phase I|phase i
1116473|NCT02454062|Solid Tumors|solid tumors
1116474|NCT02454062|Pharmacokinetics|pharmacokinetics
1116475|NCT02454062|Pharmacodynamics|pharmacodynamics
1116476|NCT02454062|MTD|mtd
1116477|NCT02454023|Stroke|stroke
1116478|NCT02454023|Transient ischemic attack|transient ischemic attack
1116479|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
1116480|NCT02454023|Portable sleep monitor|portable sleep monitor
1116481|NCT02454023|Screening|screening
1116482|NCT02453997|lupus nephritis|lupus nephritis
1116483|NCT02453997|mycophenolic acid|mycophenolic acid
1116484|NCT02453997|pharmacokinetics|pharmacokinetics
1116485|NCT02453997|pharmacogenomics|pharmacogenomics
1116486|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
1116487|NCT02453984|triple-negative breast cancer|triple-negative breast cancer
1116488|NCT02453984|non small cell lung cancer|non small cell lung cancer
1116489|NCT02453984|cancer of the urinary tract|cancer of the urinary tract
1116490|NCT02453971|alcohol consumption|alcohol consumption
1116491|NCT02453971|binge drinking|binge drinking
1116492|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
1116493|NCT02453971|students|students
1116494|NCT02453958|Injury|injury
1116495|NCT02453958|Brain|brain
1116496|NCT02453958|Traumatic Mild|traumatic mild
1116497|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
1116498|NCT02453945|pain|pain
1116499|NCT02453945|comfort|comfort
1116500|NCT02453945|healing|healing
1116501|NCT02453945|quality of life|quality of life
1116502|NCT02453932|Vascular dementia|vascular dementia
1116503|NCT02453932|Tianzhi granule|tianzhi granule
1116504|NCT02453932|Herbal medicine|herbal medicine
1116505|NCT02453932|Randomized controlled trial|randomized controlled trial
1116506|NCT02453932|Three arms|three arms
1116507|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
1116508|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
1116509|NCT02453919|blood pressure abnormality|blood pressure abnormality
1116510|NCT02453893|Iloperidone|iloperidone
1116511|NCT02453893|Risperidone|risperidone
1116512|NCT02453893|PANSS|panss
1116513|NCT02453880|anxiety|anxiety
1116514|NCT02453880|depression|depression
1116515|NCT02453880|chronic illness|chronic illness
1116516|NCT02453880|teen|teen
1116517|NCT02453880|young adult|young adult
1116518|NCT02453867|kidney transplantation|kidney transplantation
1116519|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
1116520|NCT02453867|tacrolimus once daily|tacrolimus once daily
1116521|NCT02453867|reduced immunosuppression|reduced immunosuppression
1116522|NCT02453867|recipients >65 years|recipients >65 years
1116523|NCT02453867|Senior|senior
1116524|NCT02453802|Tranexamic Acid|tranexamic acid
1116525|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
1116526|NCT02453802|Rivaroxaban|rivaroxaban
1116527|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
1116528|NCT02453789|cystic fibrosis|cystic fibrosis
1116529|NCT02453789|Burkholderia|burkholderia
1116530|NCT02453789|aztreonam|aztreonam
1116531|NCT02453776|Crohns Disease|crohns disease
1116532|NCT02453776|Ulcerative Colitis|ulcerative colitis
1116533|NCT02453776|Infliximab|infliximab
1116534|NCT02453776|Sustained|sustained
1116535|NCT02453776|Remission|remission
1116536|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
1116538|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
1116539|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
1116540|NCT02453763|Brain|brain
1116541|NCT02453763|Central Nervous System Diseases|central nervous system diseases
1116542|NCT02453763|Nervous System Diseases|nervous system diseases
1116543|NCT02453763|Parkinson disease|parkinson disease
1116544|NCT02453763|Stroke|stroke
1116545|NCT02453763|Epilepsy|epilepsy
1116546|NCT02453763|Depression|depression
1116547|NCT02453763|Schizophrenia|schizophrenia
1116548|NCT02453763|Brain imaging|brain imaging
1116549|NCT02453763|Electrical impedance tomography|electrical impedance tomography
1116650|NCT02453048|respiratory Tract Infection|respiratory tract infection
1116550|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
1116551|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
1116552|NCT02453763|Functional magnetic imaging|functional magnetic imaging
1116553|NCT02453763|Rehabilitation|rehabilitation
1116554|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
1116555|NCT02453750|Airway Inflammation|airway inflammation
1116556|NCT02453750|Asthma|asthma
1116557|NCT02453750|Hypersaline|hypersaline
1116558|NCT02453750|Pediatrics|pediatrics
1116559|NCT02453737|Proton|proton
1116560|NCT02453737|Brachytherapy|brachytherapy
1116561|NCT02453737|Partial Breast Irradiation|partial breast irradiation
1116562|NCT02453737|3D Conformal Photon|3d conformal photon
1116563|NCT02453724|Ultrasonography|ultrasonography
1116564|NCT02453724|Lung|lung
1116565|NCT02453724|Hemorrhage|hemorrhage
1116566|NCT02453724|Point of care ultrasound|point of care ultrasound
1116567|NCT02453698|Stop task|stop task
1116568|NCT02453698|modulatory effect of MPH|modulatory effect of mph
1116569|NCT02453698|bottom-up and top-down|bottom-up and top-down
1116570|NCT02453698|cognitive processes|cognitive processes
1116571|NCT02453633|Appointment reminder|appointment reminder
1116572|NCT02453633|Attendance|attendance
1116573|NCT02453633|No-show|no-show
1116574|NCT02453594|PD1|pd1
1116575|NCT02453594|PD-1|pd-1
1116576|NCT02453594|PDL1|pdl1
1116577|NCT02453594|PD-L1|pd-l1
1116578|NCT02453542|hemophilia|hemophilia
1116579|NCT02453542|inhibitors|inhibitors
1116580|NCT02453542|thrombin|thrombin
1116581|NCT02453529|plasma concentration|plasma concentration
1116582|NCT02453529|pulmonary concentration|pulmonary concentration
1116583|NCT02453516|Serratus Block|serratus block
1116584|NCT02453516|Breast Surgery|breast surgery
1116585|NCT02453503|Lichen planus|lichen planus
1116586|NCT02453503|Mucoadhesive film|mucoadhesive film
1116587|NCT02453503|licorice|licorice
1116588|NCT02453490|Colorectal Cancer|colorectal cancer
1116589|NCT02453490|liver metastasis|liver metastasis
1116590|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1116591|NCT02453477|Beta thalassemia|beta thalassemia
1116592|NCT02453477|Gene therapy|gene therapy
1116593|NCT02453477|Lentiviral vector|lentiviral vector
1116594|NCT02453451|MitraClip|mitraclip
1116595|NCT02453451|atrial septal defect|atrial septal defect
1116596|NCT02453451|iatrogenic|iatrogenic
1116597|NCT02453425|renal blood flow|renal blood flow
1116598|NCT02453425|renal oxygenation|renal oxygenation
1116599|NCT02453425|glomerular filtration rate|glomerular filtration rate
1116600|NCT02453425|filtration fraction|filtration fraction
1116601|NCT02453425|blood pressure|blood pressure
1116602|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
1116603|NCT02453412|Non-maturation|non-maturation
1116604|NCT02453412|Computational simulation|computational simulation
1116605|NCT02453386|Motor fluctuations|motor fluctuations
1116606|NCT02453386|Off time|off time
1116607|NCT02453386|On time|on time
1116608|NCT02453386|Dyskinesia|dyskinesia
1116609|NCT02453360|Anesthesia|anesthesia
1116610|NCT02453360|Analgesia|analgesia
1116611|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
1116612|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
1116613|NCT02453347|Alpha Stim|alpha stim
1116614|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
1116615|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
1116616|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
1116617|NCT02453295|Lymphedema|lymphedema
1116618|NCT02453295|Arm Disability|arm disability
1116619|NCT02453295|Cancer Survivorship|cancer survivorship
1116620|NCT02453295|Intervention|intervention
1116621|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
1116622|NCT02453269|Obesity|obesity
1116623|NCT02453269|Children|children
1116624|NCT02453269|Health Colective|health colective
1116625|NCT02453243|Suicide screening in the ED|suicide screening in the ed
1116626|NCT02453243|Safety Planning|safety planning
1116627|NCT02453217|severe mental illness|severe mental illness
1116628|NCT02453217|physical health screening|physical health screening
1116629|NCT02453217|randomised controlled trial|randomised controlled trial
1116630|NCT02453217|health behaviour change|health behaviour change
1116631|NCT02453178|physical activity|physical activity
1116632|NCT02453178|aging|aging
1116633|NCT02453178|cognition|cognition
1116634|NCT02453178|brain|brain
1116635|NCT02453178|exercise|exercise
1116636|NCT02453165|vaginal dehiscence|vaginal dehiscence
1116637|NCT02453152|myotubular myopathy|myotubular myopathy
1116638|NCT02453152|respiratory muscles|respiratory muscles
1116639|NCT02453152|natural history|natural history
1116640|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
1116641|NCT02453126|Esophageal Stricture|esophageal stricture
1116642|NCT02453048|Pertussis|pertussis
1116643|NCT02453048|Colonization|colonization
1116644|NCT02453048|Vaccine|vaccine
1116645|NCT02453048|Immune response|immune response
1116646|NCT02453048|BPZE1|bpze1
1116647|NCT02453048|Infection|infection
1116648|NCT02453048|Bordetella pertussis|bordetella pertussis
1116649|NCT02453048|B. pertussis|b. pertussis
1116651|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
1116652|NCT02453035|CAD|cad
1116653|NCT02453022|Bioavailability|bioavailability
1116654|NCT02453022|Omeprazole|omeprazole
1116655|NCT02453022|Danirixin|danirixin
1116656|NCT02453022|Food Effect|food effect
1116657|NCT02453022|Pharmacokinetics|pharmacokinetics
1116658|NCT02452996|GNbAC1|gnbac1
1116659|NCT02452996|Multiple Sclerosis|multiple sclerosis
1116660|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
1116661|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
1116662|NCT02452996|Monoclonal antibody|monoclonal antibody
1116663|NCT02452983|Anemia|anemia
1116664|NCT02452983|Leukemia|leukemia
1116665|NCT02452983|Hematologic diseases|hematologic diseases
1116666|NCT02452983|Cytopenias|cytopenias
1116667|NCT02452983|Bone marrow diseases|bone marrow diseases
1116668|NCT02452983|Preleukemia|preleukemia
1116669|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
1116670|NCT02452918|skin infection|skin infection
1116671|NCT02452892|Depression|depression
1116672|NCT02452892|Major depression|major depression
1116673|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
1116674|NCT02452892|LFMS|lfms
1116675|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1116676|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1116677|NCT02452840|verteporfin|verteporfin
1116678|NCT02452840|photodynamic therapy|photodynamic therapy
1116679|NCT02452840|persistent disease activity|persistent disease activity
1116680|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
1116681|NCT02452697|Nonmyeloablative|nonmyeloablative
1116682|NCT02452697|Stem Cell|stem cell
1116683|NCT02452697|Transplant|transplant
1116684|NCT02452684|Insomnia|insomnia
1116685|NCT02452658|Fast food literacy|fast food literacy
1116686|NCT02452645|Food|food
1116687|NCT02452645|Nutrition|nutrition
1116688|NCT02452645|Physical Activity|physical activity
1116689|NCT02452645|Family|family
1116690|NCT02452645|Child Care|child care
1116691|NCT02452645|Home|home
1116692|NCT02452645|Environment|environment
1116693|NCT02452632|ASP1941|asp1941
1116694|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
1116695|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1116696|NCT02452619|brain trauma|brain trauma
1116697|NCT02452619|cognitive impairment|cognitive impairment
1116698|NCT02452606|Stalevo|stalevo
1116699|NCT02452606|sleep disturbance|sleep disturbance
1116700|NCT02452606|central circadian clock|central circadian clock
1116701|NCT02452606|narcolepsy|narcolepsy
1116702|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
1116703|NCT02452580|Kangaroo Mother Care|kangaroo mother care
1116704|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
1116705|NCT02452580|Postnatal growth|postnatal growth
1116706|NCT02452541|Traumatic Brain Injury|traumatic brain injury
1116707|NCT02452541|Critically ill Patients|critically ill patients
1116708|NCT02452541|Death|death
1116709|NCT02452541|Head Injury|head injury
1116710|NCT02452541|TBI-Prognosis|tbi-prognosis
1116711|NCT02452541|Critical Care Medicine|critical care medicine
1116712|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
1116713|NCT02452541|Prognosis|prognosis
1116714|NCT02452541|Prognostic Evaluation|prognostic evaluation
1116715|NCT02452541|Outcome Research|outcome research
1116716|NCT02452541|Mortality|mortality
1116717|NCT02452541|Decision-making|decision-making
1116718|NCT02452528|Hepatitis B Virus|hepatitis b virus
1116719|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
1116720|NCT02452528|HBV|hbv
1116721|NCT02452502|stroke|stroke
1116722|NCT02452502|thrombolytic therapy|thrombolytic therapy
1116723|NCT02452502|atorvastatin|atorvastatin
1116724|NCT02452489|Different acupoints compatibility|different acupoints compatibility
1116725|NCT02452437|oxycodone|oxycodone
1116726|NCT02452437|hemodialysis|hemodialysis
1116727|NCT02452411|Internet|internet
1116728|NCT02452411|Adjustment disorders|adjustment disorders
1116729|NCT02452411|Homework assignments|homework assignments
1117417|NCT02448212|PET|pet
1116730|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
1116731|NCT02452411|Online therapy|online therapy
1116732|NCT02452411|Emotional Regulation|emotional regulation
1116733|NCT02452411|ICT's|ict's
1116734|NCT02452398|Hair removal|hair removal
1116735|NCT02452398|depilation|depilation
1116736|NCT02452398|epilation|epilation
1116737|NCT02452372|RNAi therapeutic|rnai therapeutic
1116738|NCT02452372|Porphyria|porphyria
1116739|NCT02452372|AIP|aip
1116740|NCT02452359|stretch marks|stretch marks
1116741|NCT02452346|MDS|mds
1116742|NCT02452333|Excisional breast biopsy|excisional breast biopsy
1116743|NCT02452333|Oncoplastic surgery|oncoplastic surgery
1116744|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
1116745|NCT02452333|Breast conserving surgery|breast conserving surgery
1116746|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
1116747|NCT02452320|bariatric|bariatric
1116843|NCT02451592|Hematologic malignancies|hematologic malignancies
1116748|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
1116749|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
1116750|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
1116751|NCT02452294|Brain|brain
1116752|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
1116753|NCT02452281|Stage III or Stage IV|stage iii or stage iv
1116754|NCT02452281|Malignant Melanoma|malignant melanoma
1116755|NCT02452281|Advanced Melanoma|advanced melanoma
1116756|NCT02452203|floating|floating
1116757|NCT02452203|interoception|interoception
1116758|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1116759|NCT02452177|vitamin D|vitamin d
1116760|NCT02452177|short bowel syndrome|short bowel syndrome
1116761|NCT02452177|farnesoid X receptor|farnesoid x receptor
1116762|NCT02452177|cholestasis|cholestasis
1116763|NCT02452164|otoscopy|otoscopy
1116764|NCT02452164|otitis media|otitis media
1116765|NCT02452164|cellphone|cellphone
1116766|NCT02452164|family|family
1116767|NCT02452151|Inflectra|inflectra
1116768|NCT02452151|Infliximab|infliximab
1116769|NCT02452151|Biosimilar|biosimilar
1116770|NCT02452099|DMSO|dmso
1116771|NCT02452099|cryopreservation|cryopreservation
1116772|NCT02452099|autologous transplantation|autologous transplantation
1116773|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
1116774|NCT02452099|hematological malignancies|hematological malignancies
1116775|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
1116776|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
1116777|NCT02452073|triiodothyronine|triiodothyronine
1116778|NCT02452073|thyroxine|thyroxine
1116779|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
1116780|NCT02452060|perioperative period|perioperative period
1116781|NCT02452060|pain|pain
1116782|NCT02452060|gastric bypass|gastric bypass
1116783|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1116784|NCT02452008|enzalutamide|enzalutamide
1116785|NCT02452008|LY2157299|ly2157299
1116786|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
1116787|NCT02451943|leiomyosarcoma|leiomyosarcoma
1116788|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
1116789|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
1116790|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
1116791|NCT02451943|liposarcoma|liposarcoma
1116792|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
1116793|NCT02451943|doxorubicin|doxorubicin
1116794|NCT02451917|Glargine insulin|glargine insulin
1116795|NCT02451917|Chronic Kidney Disease|chronic kidney disease
1116796|NCT02451917|CGMS|cgms
1116797|NCT02451904|Pathogenesis|pathogenesis
1116798|NCT02451904|Microvascular function|microvascular function
1116799|NCT02451904|Metabolic dysregulation|metabolic dysregulation
1116800|NCT02451904|Metabolomics|metabolomics
1116801|NCT02451878|shyness|shyness
1116802|NCT02451878|internet|internet
1116803|NCT02451878|self-help|self-help
1116804|NCT02451878|psychology|psychology
1116805|NCT02451878|wellbeing|wellbeing
1116806|NCT02451839|Crohn Disease|crohn disease
1116807|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
1116808|NCT02451839|Psoriasis|psoriasis
1116809|NCT02451839|Patient Outcome Assessment|patient outcome assessment
1116810|NCT02451839|Adalimumab|adalimumab
1116811|NCT02451839|Global Health|global health
1116812|NCT02451839|Quality of Life|quality of life
1116813|NCT02451826|ovulation inhibition|ovulation inhibition
1116814|NCT02451826|endometrial changes|endometrial changes
1116815|NCT02451826|bleeding patterns|bleeding patterns
1116816|NCT02451813|opening injection pressure|opening injection pressure
1116817|NCT02451813|femoral nerve block|femoral nerve block
1116818|NCT02451813|fascia iliaca|fascia iliaca
1116819|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
1116820|NCT02451774|pediatric|pediatric
1116821|NCT02451774|apoptosis|apoptosis
1116822|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
1116823|NCT02451761|next generation sequencing|next generation sequencing
1116824|NCT02451761|intellectual disability|intellectual disability
1116825|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
1116826|NCT02451761|gene disruption|gene disruption
1116827|NCT02451735|female breast cancer|female breast cancer
1116828|NCT02451735|bilateral breast cancer|bilateral breast cancer
1116829|NCT02451735|triple negative breast cancer|triple negative breast cancer
1116830|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
1116831|NCT02451735|BRCA 1|brca 1
1116832|NCT02451735|BRCA 2|brca 2
1116833|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
1116834|NCT02451735|genetic counseling|genetic counseling
1116835|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
1116836|NCT02451735|cancer education materials|cancer education materials
1116837|NCT02451683|SCI|sci
1116838|NCT02451631|Mobile Application|mobile application
1116839|NCT02451631|Diabetes management|diabetes management
1116840|NCT02451618|Perinatal Depression|perinatal depression
1116841|NCT02451605|surgery|surgery
1116842|NCT02451592|Fungemia|fungemia
1116948|NCT02450994|bronchitis|bronchitis
1116844|NCT02451579|Actinic Keratoses|actinic keratoses
1116845|NCT02451579|Photodynamic Therapy|photodynamic therapy
1116846|NCT02451579|PDT|pdt
1116847|NCT02451579|Blue Light|blue light
1116848|NCT02451566|Abdominal|abdominal
1116849|NCT02451566|Aortic|aortic
1116850|NCT02451566|Aneurysm|aneurysm
1116851|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1116852|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
1116853|NCT02451540|Computed Tomography scan|computed tomography scan
1116854|NCT02451540|CT scan|ct scan
1116855|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
1116856|NCT02451540|FRI|fri
1116857|NCT02451540|Roflumilast|roflumilast
1116858|NCT02451540|PRO|pro
1116859|NCT02451514|Antibody persistence|antibody persistence
1116860|NCT02451514|Young Adults|young adults
1116861|NCT02451514|Healthy Adolescents|healthy adolescents
1116862|NCT02451514|MenABCWY vaccine|menabcwy vaccine
1116863|NCT02451514|Booster response|booster response
1116864|NCT02451514|MenABCWY+OMV|menabcwy+omv
1116865|NCT02451475|Pregabalin|pregabalin
1116866|NCT02451475|Fibromyalgia|fibromyalgia
1116867|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1116868|NCT02451462|bone marrow transplant|bone marrow transplant
1116869|NCT02451449|Celiac disease|celiac disease
1116870|NCT02451449|Infertility|infertility
1116871|NCT02451449|Prevalence study|prevalence study
1116872|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
1116873|NCT02451423|Non-metastatic|non-metastatic
1116874|NCT02451423|Bladder|bladder
1116875|NCT02451410|Nutrition|nutrition
1116876|NCT02451410|Physical activity|physical activity
1116877|NCT02451410|Overweight|overweight
1116878|NCT02451410|Obesity|obesity
1116879|NCT02451410|Malnutrition|malnutrition
1116880|NCT02451371|Schizophrenia|schizophrenia
1116881|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
1116882|NCT02451371|tDCS|tdcs
1116883|NCT02451358|Influenza|influenza
1116884|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
1116885|NCT02451345|Prostate cancer|prostate cancer
1116886|NCT02451345|Tranformative Impact Award|tranformative impact award
1116887|NCT02451345|Early stage|early stage
1116888|NCT02451345|Active Surveillance|active surveillance
1116889|NCT02451345|Decision aid|decision aid
1116890|NCT02451345|Coaching session|coaching session
1116891|NCT02451345|Personalized|personalized
1116892|NCT02451345|UCSF|ucsf
1116893|NCT02451345|validation|validation
1116894|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
1116895|NCT02451293|Depression|depression
1116896|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
1116897|NCT02451293|Anxiety|anxiety
1116898|NCT02451293|Sleep|sleep
1116899|NCT02451293|Circadian|circadian
1116900|NCT02451280|stroke rehabilitation|stroke rehabilitation
1116901|NCT02451280|robot-assisted therapy|robot-assisted therapy
1116902|NCT02451280|hybrid therapy|hybrid therapy
1116903|NCT02451267|neck pain|neck pain
1116904|NCT02451267|aerobic exercise|aerobic exercise
1116905|NCT02451267|cervical pain|cervical pain
1116906|NCT02451241|Acupuncture|acupuncture
1116907|NCT02451228|Pharmacokinetics|pharmacokinetics
1116908|NCT02451228|Pharmacodynamics|pharmacodynamics
1116909|NCT02451228|Preterm labor|preterm labor
1116910|NCT02451228|Preterm birth|preterm birth
1116911|NCT02451228|Estradiol|estradiol
1116912|NCT02451228|Indomethacin|indomethacin
1116913|NCT02451228|Pregnancy|pregnancy
1116914|NCT02451228|Short Cervix|short cervix
1116915|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
1116916|NCT02451202|"surgical conditions"|"surgical conditions"
1116917|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
1116918|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
1116919|NCT02451189|Obesity|obesity
1116920|NCT02451189|Weight maintenance|weight maintenance
1116921|NCT02451189|Appetite|appetite
1116922|NCT02451189|Energy intake|energy intake
1116923|NCT02451189|Dietary fibre|dietary fibre
1116924|NCT02451189|Short-chain fatty acids|short-chain fatty acids
1116925|NCT02451189|Fermentation|fermentation
1116926|NCT02451189|Overweight|overweight
1116927|NCT02451150|Drug therapy|drug therapy
1116929|NCT02451124|Cancer|cancer
1116930|NCT02451124|Screening|screening
1116931|NCT02451111|Rituximab|rituximab
1116932|NCT02451111|Ibrutinib|ibrutinib
1116933|NCT02451111|Follicular Lymphoma|follicular lymphoma
1116934|NCT02451085|hip|hip
1116935|NCT02451085|surgery|surgery
1116936|NCT02451085|Replacement|replacement
1116937|NCT02451059|community resource|community resource
1116938|NCT02451059|well-child care visit|well-child care visit
1116939|NCT02451059|low-income|low-income
1116940|NCT02451046|Liver transplantation|liver transplantation
1116941|NCT02451046|Primary dysfunction|primary dysfunction
1116942|NCT02451033|Regenerative medicine|regenerative medicine
1116943|NCT02451020|healthy volunteers|healthy volunteers
1116944|NCT02451020|acclimatization|acclimatization
1116945|NCT02451020|sleep|sleep
1116946|NCT02451020|hypoxia|hypoxia
1116947|NCT02450994|airway disease|airway disease
1116953|NCT02450968|airway disease|airway disease
1116954|NCT02450968|bronchitis|bronchitis
1116955|NCT02450968|emphysema|emphysema
1116956|NCT02450968|lung|lung
1116957|NCT02450968|treatment|treatment
1116958|NCT02450955|Tension-type headache|tension-type headache
1116959|NCT02450955|manual therapy|manual therapy
1116960|NCT02450955|disability|disability
1116961|NCT02450955|spinal manipulation|spinal manipulation
1116962|NCT02450929|post operative|post operative
1116963|NCT02450929|pneumonia|pneumonia
1116964|NCT02450929|vascular|vascular
1116965|NCT02450929|orthopedic|orthopedic
1116966|NCT02450929|urologic|urologic
1116967|NCT02450929|neurologic|neurologic
1116968|NCT02450916|work-related injury|work-related injury
1116969|NCT02450916|occupational disease|occupational disease
1116970|NCT02450916|workers' compensation|workers' compensation
1116971|NCT02450916|psychological|psychological
1116972|NCT02450916|policy|policy
1116973|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
1116974|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
1116975|NCT02450877|Children|children
1116976|NCT02450877|Young Adults|young adults
1116977|NCT02450877|Azacitidine|azacitidine
1116978|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
1116979|NCT02450877|Molecular Relapse|molecular relapse
1116980|NCT02450877|Vidaza|vidaza
1116981|NCT02450877|AZA-AML-004|aza-aml-004
1116982|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
1116983|NCT02450851|Rare Diseases|rare diseases
1116984|NCT02450851|Undiagnosed Disease|undiagnosed disease
1116985|NCT02450838|Dengue Vaccine|dengue vaccine
1116986|NCT02450812|mCRPC|mcrpc
1116987|NCT02450773|postpartum|postpartum
1116988|NCT02450773|preeclampsia|preeclampsia
1116989|NCT02450773|gestational hypertension|gestational hypertension
1116990|NCT02450747|Visual Acuity|visual acuity
1116991|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
1116992|NCT02450721|atherosclerosis|atherosclerosis
1116993|NCT02450721|biomarkers|biomarkers
1116994|NCT02450721|carotid artery stenosis|carotid artery stenosis
1116995|NCT02450721|ischemic stroke.|ischemic stroke.
1116996|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
1116997|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
1116998|NCT02450708|15-059|15-059
1116999|NCT02450695|rTMS|rtms
1117000|NCT02450695|treatment refractory|treatment refractory
1117001|NCT02450695|treatment resistant|treatment resistant
1117002|NCT02450695|SSRI|ssri
1117003|NCT02450695|clomipramine|clomipramine
1117004|NCT02450669|Intubation|intubation
1117005|NCT02450669|Extubation|extubation
1117006|NCT02450669|Weaning|weaning
1117007|NCT02450669|Mechanical ventilation|mechanical ventilation
1117008|NCT02450617|Complex PTSD|complex ptsd
1117009|NCT02450604|Prevalence Study|prevalence study
1117010|NCT02450604|Fabry's disease|fabry's disease
1117011|NCT02450604|Chronic pain|chronic pain
1117012|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
1117013|NCT02450591|Erlotinib|erlotinib
1117014|NCT02450591|Surgery|surgery
1117015|NCT02450591|Radiation Therapy|radiation therapy
1117016|NCT02450591|15-067|15-067
1117017|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1117018|NCT02450552|ALS|als
1117019|NCT02450552|Lou Gehrig|lou gehrig
1117020|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
1117021|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
1117022|NCT02450539|biomarkers|biomarkers
1117023|NCT02450539|CDK 4 and 6|cdk 4 and 6
1117024|NCT02450513|adalimumab|adalimumab
1117025|NCT02450513|anti-TNF|anti-tnf
1117026|NCT02450513|pharmacokinetics|pharmacokinetics
1117027|NCT02450513|trough level|trough level
1117028|NCT02450513|immunogenicity|immunogenicity
1117029|NCT02450487|Piroxicam|piroxicam
1117030|NCT02450487|Pharmacogenetic|pharmacogenetic
1117031|NCT02450487|Lower Third molar|lower third molar
1117032|NCT02450448|Renal Neoplasms|renal neoplasms
1117033|NCT02450448|Circulating Tumor Cells|circulating tumor cells
1117034|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
1117035|NCT02450435|Circulating TUmor Cells|circulating tumor cells
1117036|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
1117037|NCT02450422|Circulating Tumor Cells|circulating tumor cells
1117038|NCT02450409|Total knee arthroplasty|total knee arthroplasty
1117039|NCT02450409|Midflexion instability|midflexion instability
1117040|NCT02450409|Gap technique|gap technique
1117041|NCT02450409|Anatomical alignment|anatomical alignment
1117042|NCT02450396|Rare diseases|rare diseases
1117043|NCT02450396|pregnancy|pregnancy
1117044|NCT02450396|pregnancy,|pregnancy,
1117045|NCT02450357|Breast Neoplasms|breast neoplasms
1117046|NCT02450357|Circulating Tumor Cells|circulating tumor cells
1117047|NCT02450279|Aerosol delivery|aerosol delivery
1117048|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
1117049|NCT02450279|Jet Nebulizer|jet nebulizer
1117050|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
1117051|NCT02450266|Primary disease|primary disease
1117052|NCT02450266|multiparametric MRI|multiparametric mri
1117053|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
1117054|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
1117055|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
1117056|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
1117057|NCT02450240|Depression|depression
1117058|NCT02450240|Anxiety|anxiety
1117059|NCT02450240|Eating Disorders|eating disorders
1117060|NCT02450240|Substance Use|substance use
1117061|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1117062|NCT02450240|Genetics|genetics
1117063|NCT02450240|Behavior|behavior
1117064|NCT02450240|Mental Health|mental health
1117065|NCT02450214|Ketamine|ketamine
1117066|NCT02450214|Magnesium|magnesium
1117067|NCT02450214|Analgesia|analgesia
1117068|NCT02450214|Liposuction|liposuction
1117069|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
1117070|NCT02450214|Preemptive analgesia|preemptive analgesia
1117071|NCT02450188|Erectile Dysfunction|erectile dysfunction
1117072|NCT02450188|PDE5 inhibitors|pde5 inhibitors
1117073|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
1117074|NCT02450175|Platelet Activation|platelet activation
1117075|NCT02450175|metastasis|metastasis
1117076|NCT02450110|spinal cord stimulation|spinal cord stimulation
1117077|NCT02450110|heart failure|heart failure
1117078|NCT02450110|autonomic regulation|autonomic regulation
1117079|NCT02450110|BNP|bnp
1117080|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
1117081|NCT02450071|Pre-hospital|pre-hospital
1117082|NCT02450071|Out-of-hospital|out-of-hospital
1117083|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
1117084|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
1117085|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
1117086|NCT02450071|Critical care (MeSH)|critical care (mesh)
1117087|NCT02450071|Airway management (MeSH)|airway management (mesh)
1117088|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
1117089|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
1117090|NCT02450071|Complications (MeSH)|complications (mesh)
1117091|NCT02450071|Patient safety|patient safety
1117092|NCT02450058|early breast cancer|early breast cancer
1117093|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
1117094|NCT02450058|FEC|fec
1117095|NCT02450058|paclitaxel|paclitaxel
1117096|NCT02449993|diagnostic study|diagnostic study
1117097|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
1117098|NCT02449993|progesterone receptor|progesterone receptor
1117099|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
1117100|NCT02449993|Ki-67|ki-67
1117101|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
1117102|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
1117103|NCT02449980|Tube Thoracostomy|tube thoracostomy
1117104|NCT02449980|Pediatric Surgery|pediatric surgery
1117105|NCT02449967|Pancreatic Cancer|pancreatic cancer
1117106|NCT02449967|HepaSphere|hepasphere
1117107|NCT02449954|Stress and Immune Responses|stress and immune responses
1117108|NCT02449954|morphine|morphine
1117109|NCT02449954|tramadol|tramadol
1117110|NCT02449954|ketorolac|ketorolac
1117111|NCT02449941|Stomach Neoplasms|stomach neoplasms
1117112|NCT02449941|proton pump inhibitor|proton pump inhibitor
1117113|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
1117114|NCT02449941|Helicobacter pylori|helicobacter pylori
1117115|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
1117116|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
1117117|NCT02449915|sacrocolpopexy|sacrocolpopexy
1117118|NCT02449915|rectocele repair|rectocele repair
1117119|NCT02449902|VVA|vva
1117120|NCT02449902|Postmenopausal|postmenopausal
1117121|NCT02449902|Painful Sex|painful sex
1117122|NCT02449863|Lung ultrasound|lung ultrasound
1117123|NCT02449863|Mechanical ventilation|mechanical ventilation
1117419|NCT02448199|pain|pain
1117124|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
1117125|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
1117126|NCT02449850|In-utero environment|in-utero environment
1117127|NCT02449850|Asthma|asthma
1117128|NCT02449850|Allergic diseases|allergic diseases
1117129|NCT02449850|Food allergy|food allergy
1117130|NCT02449850|Birth cohort study|birth cohort study
1117131|NCT02449850|Primary prevention|primary prevention
1117132|NCT02449850|Intervention study|intervention study
1117133|NCT02449850|Atopic dermatitis|atopic dermatitis
1117134|NCT02449850|Rhinitis|rhinitis
1117135|NCT02449850|Allergy|allergy
1117136|NCT02449850|Lung function|lung function
1117137|NCT02449850|Non-communicable diseases|non-communicable diseases
1117138|NCT02449850|Foetal growth|foetal growth
1117139|NCT02449850|Obesity|obesity
1117140|NCT02449850|Cardiovascular disease|cardiovascular disease
1117141|NCT02449850|Diabetes|diabetes
1117142|NCT02449850|Blood pressure|blood pressure
1117143|NCT02449850|Anthropometric|anthropometric
1117144|NCT02449850|Trans epidermic water loss|trans epidermic water loss
1117145|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1117146|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
1117147|NCT02449798|Difficult IV access|difficult iv access
1117148|NCT02449798|AccuCath|accucath
1117149|NCT02449798|IV outcomes|iv outcomes
1117150|NCT02449798|patient satisfaction|patient satisfaction
1117151|NCT02449785|Cystic fibrosis|cystic fibrosis
1117152|NCT02449785|MRI|mri
1117153|NCT02449785|UTE|ute
1117154|NCT02449785|CT|ct
1117155|NCT02449785|Exacerbation|exacerbation
1117156|NCT02449785|Quality of life|quality of life
1117157|NCT02449785|Pulmonary function|pulmonary function
1117158|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
1117159|NCT02449746|Schizophrenia|schizophrenia
1117160|NCT02449746|Psychosis|psychosis
1117161|NCT02449746|Mental Health|mental health
1117162|NCT02449746|Autoimmunity|autoimmunity
1117163|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
1117164|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
1117165|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
1117166|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1117167|NCT02449733|homosexuality|homosexuality
1117168|NCT02449733|male|male
1117169|NCT02449733|South Africa|south africa
1117170|NCT02449720|intraperitoneal|intraperitoneal
1117171|NCT02449720|ropivacaine|ropivacaine
1117172|NCT02449720|bowel resection|bowel resection
1117173|NCT02449720|local anaesthetic|local anaesthetic
1117174|NCT02449720|recovery|recovery
1117175|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
1117176|NCT02449681|the head and neck|the head and neck
1117177|NCT02449681|skin|skin
1117178|NCT02449681|TH-4000|th-4000
1117179|NCT02449681|Hypoxia|hypoxia
1117180|NCT02449681|Tarloxotinib|tarloxotinib
1117181|NCT02449668|Acupuncture|acupuncture
1117182|NCT02449668|Shoulder pain|shoulder pain
1117183|NCT02449668|Impingement syndrome|impingement syndrome
1117184|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
1117185|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
1117186|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
1117187|NCT02449642|estradiol level|estradiol level
1117188|NCT02449642|progesterone level|progesterone level
1117189|NCT02449629|HIV|hiv
1117190|NCT02449629|Transgender|transgender
1117191|NCT02449629|HIV Continuum of Care|hiv continuum of care
1117192|NCT02449616|Sickle cell|sickle cell
1117193|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
1117194|NCT02449603|Chinese population|chinese population
1117195|NCT02449590|Onion|onion
1117196|NCT02449590|Cardiovascular disease|cardiovascular disease
1117197|NCT02449590|metabolomics|metabolomics
1117198|NCT02449590|Gene expression|gene expression
1117199|NCT02449590|Biomarker|biomarker
1117200|NCT02449577|Metabolomics|metabolomics
1117201|NCT02449577|Beer|beer
1117202|NCT02449577|Biomarker|biomarker
1117203|NCT02449577|Glucose response|glucose response
1117204|NCT02449577|Insulin response|insulin response
1117205|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
1117206|NCT02449473|Asthma|asthma
1117207|NCT02449473|Reactive Airways|reactive airways
1117208|NCT02449473|Respiratory Tract Disease|respiratory tract disease
1117209|NCT02449473|Obstructive Tract Disease|obstructive tract disease
1117210|NCT02449473|Lung Diseases|lung diseases
1117211|NCT02449460|hypertension|hypertension
1117212|NCT02449460|epidemiology|epidemiology
1117213|NCT02449460|glucose|glucose
1117214|NCT02449460|body mass index|body mass index
1117215|NCT02449460|lipids|lipids
1117216|NCT02449460|smoking|smoking
1117217|NCT02449460|coronary artery disease|coronary artery disease
1117218|NCT02449460|arterial stiffness|arterial stiffness
1117219|NCT02449460|carotid ultrasound|carotid ultrasound
1117220|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1117221|NCT02449447|Blended treatment|blended treatment
1117222|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
1117223|NCT02449447|Face-to-face|face-to-face
1117420|NCT02448199|Knee|knee
1117224|NCT02449447|internet-based treatment|internet-based treatment
1117225|NCT02449421|trauma|trauma
1117226|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
1117227|NCT02449382|conventional treatment|conventional treatment
1117228|NCT02449382|mortality|mortality
1117229|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
1117230|NCT02449356|Prone position ventilation|prone position ventilation
1117231|NCT02449356|Endotracheal intubation|endotracheal intubation
1117232|NCT02449356|Displacement|displacement
1117233|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
1117234|NCT02449317|bioimpedance|bioimpedance
1117235|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
1117236|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
1117237|NCT02449278|ISRT|isrt
1117238|NCT02449278|chemotherapy|chemotherapy
1117239|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
1117240|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
1117241|NCT02449265|Chemotherapy|chemotherapy
1117242|NCT02449252|limited stage FL|limited stage fl
1117243|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
1117244|NCT02449252|Chemotherapy|chemotherapy
1117245|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
1117246|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1117247|NCT02449239|Bladder Neoplasm|bladder neoplasm
1117248|NCT02449239|Bladder Tumor|bladder tumor
1117249|NCT02449239|CIS|cis
1117250|NCT02449239|Papillary bladder cancer|papillary bladder cancer
1117251|NCT02449239|High grade bladder cancer|high grade bladder cancer
1117252|NCT02449200|cervical radiculopathy|cervical radiculopathy
1117253|NCT02449200|exercise|exercise
1117254|NCT02449200|manual therapy|manual therapy
1117255|NCT02449200|tape|tape
1117256|NCT02449174|C. difficile|c. difficile
1117257|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
1117258|NCT02449161|endometrial ablation|endometrial ablation
1117259|NCT02449148|energy restriction|energy restriction
1117260|NCT02449148|fasting|fasting
1117261|NCT02449148|intermittent fast|intermittent fast
1117262|NCT02449148|cancer prevention|cancer prevention
1117263|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
1117264|NCT02449135|Pancreatic Cancer|pancreatic cancer
1117265|NCT02449135|Nano drug|nano drug
1117266|NCT02449122|Lung Cancer|lung cancer
1117267|NCT02449122|Nano drug|nano drug
1117268|NCT02449109|Liver Cancer|liver cancer
1117269|NCT02449109|Nano drug|nano drug
1117270|NCT02449083|MRI|mri
1117271|NCT02449083|Shunt|shunt
1117272|NCT02449083|COPD|copd
1117273|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
1117274|NCT02449083|new sequences|new sequences
1117275|NCT02449083|magnet resonance imaging|magnet resonance imaging
1117276|NCT02449083|ventricular septal defect|ventricular septal defect
1117277|NCT02449083|Atrial septal defect|atrial septal defect
1117278|NCT02449070|Nicorandil|nicorandil
1117279|NCT02449070|Cardiac MRI|cardiac mri
1117280|NCT02449044|Hyponatremia|hyponatremia
1117281|NCT02449018|COPD,|copd,
1117282|NCT02449018|chronic bronchitis,|chronic bronchitis,
1117283|NCT02449018|inflammation,|inflammation,
1117284|NCT02449018|airway,|airway,
1117285|NCT02449018|LCI,|lci,
1117286|NCT02449018|pulmonary function test,|pulmonary function test,
1117287|NCT02449018|lung function,|lung function,
1117288|NCT02449018|controlled clinical trial,|controlled clinical trial,
1117289|NCT02449018|randomized,|randomized,
1117290|NCT02449018|airflow,|airflow,
1117291|NCT02449018|smoker|smoker
1117292|NCT02449005|regeneration|regeneration
1117293|NCT02449005|stem cells|stem cells
1117294|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
1117295|NCT02449005|fibrin glue|fibrin glue
1117296|NCT02449005|collagen fleece|collagen fleece
1117297|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
1117298|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
1117299|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
1117300|NCT02448992|Hippocampus|hippocampus
1117301|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
1117302|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
1117303|NCT02448940|probiotics|probiotics
1117304|NCT02448940|Lactobacillus|lactobacillus
1117305|NCT02448940|obesity|obesity
1117306|NCT02448940|body composition|body composition
1117307|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1117308|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
1117309|NCT02448927|Aortic stenosis|aortic stenosis
1117310|NCT02448927|TAVI|tavi
1117311|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
1117312|NCT02448927|CoreValve|corevalve
1117313|NCT02448927|BAV|bav
1117314|NCT02448927|Evolut R|evolut r
1117315|NCT02448862|IV-PCA|iv-pca
1117316|NCT02448862|Elderly patients|elderly patients
1117317|NCT02448862|Yound adults|yound adults
1117318|NCT02448862|Side effect|side effect
1117319|NCT02448862|Postoperative pain|postoperative pain
1117418|NCT02448212|Receptor Occupancy|receptor occupancy
1117320|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
1117321|NCT02448849|Autologous|autologous
1117322|NCT02448849|nonunion fracture|nonunion fracture
1117323|NCT02448849|bone marrow|bone marrow
1117324|NCT02448849|mesenchymal|mesenchymal
1117325|NCT02448849|stromal cell|stromal cell
1117326|NCT02448849|platelet lysate product|platelet lysate product
1117327|NCT02448823|HIV|hiv
1117328|NCT02448823|combined prevention|combined prevention
1117329|NCT02448823|demand generation|demand generation
1117330|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
1117331|NCT02448784|ARICEPT|aricept
1117332|NCT02448784|Dementia|dementia
1117333|NCT02448784|Lewy bodies|lewy bodies
1117334|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
1117335|NCT02448784|Post-marketing surveillance|post-marketing surveillance
1117336|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
1117337|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
1117338|NCT02448758|mutation|mutation
1117339|NCT02448732|ACM-1|acm-1
1117340|NCT02448732|intravitreal injection|intravitreal injection
1117341|NCT02448732|neovascularization|neovascularization
1117343|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
1117344|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
1117345|NCT02448693|colorectal neoplasms|colorectal neoplasms
1117346|NCT02448693|Narrow Band Imaging|narrow band imaging
1117347|NCT02448693|chromoendoscopy|chromoendoscopy
1117348|NCT02448641|ischemic stroke|ischemic stroke
1117349|NCT02448641|chronic stroke|chronic stroke
1117350|NCT02448641|fixed motor deficits|fixed motor deficits
1117351|NCT02448628|Hypertension|hypertension
1117352|NCT02448628|moderate renal impairment|moderate renal impairment
1117353|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1117354|NCT02448628|CS-3150|cs-3150
1117355|NCT02448628|Japanese|japanese
1117356|NCT02448615|Kenya|kenya
1117357|NCT02448615|Cohort|cohort
1117358|NCT02448602|Different acupoints compatibility|different acupoints compatibility
1117359|NCT02448589|Advanced Solid Tumors|advanced solid tumors
1117360|NCT02448589|Dose Escalation|dose escalation
1117361|NCT02448589|Dose Expansion|dose expansion
1117362|NCT02448589|MTD|mtd
1117363|NCT02448589|TAS-119|tas-119
1117364|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
1117365|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
1117366|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
1117367|NCT02448576|triple negative breast cancer|triple negative breast cancer
1117368|NCT02448576|brain metastasis|brain metastasis
1117369|NCT02448576|advanced breast cancer|advanced breast cancer
1117370|NCT02448563|Pregnancy|pregnancy
1117371|NCT02448563|African American|african american
1117372|NCT02448563|Weight Management Program|weight management program
1117373|NCT02448563|Behavioral Modifications|behavioral modifications
1117374|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
1117375|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
1117376|NCT02448537|PM01183|pm01183
1117377|NCT02448524|Treatment|treatment
1117378|NCT02448524|patients|patients
1117379|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
1117380|NCT02448511|ozone gas|ozone gas
1117381|NCT02448511|ulcer|ulcer
1117382|NCT02448511|infected ulcer|infected ulcer
1117383|NCT02448433|Phototherapy|phototherapy
1117384|NCT02448433|Light|light
1117385|NCT02448433|Depression|depression
1117386|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
1117387|NCT02448433|Youth|youth
1117388|NCT02448407|Knee osteoarthritis|knee osteoarthritis
1117389|NCT02448407|Platelet-rich plasma|platelet-rich plasma
1117390|NCT02448407|Pain's treatment|pain's treatment
1117391|NCT02448394|community support workers|community support workers
1117392|NCT02448394|retention in care|retention in care
1117393|NCT02448381|CTCL|ctcl
1117394|NCT02448381|Mycosis fungoides|mycosis fungoides
1117395|NCT02448381|Hypericin|hypericin
1117396|NCT02448381|SGX301|sgx301
1117397|NCT02448381|MF|mf
1117398|NCT02448355|OCT|oct
1117399|NCT02448342|Heart Failure|heart failure
1117400|NCT02448342|Remote Patient Monitoring|remote patient monitoring
1117401|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
1117402|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
1117403|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
1117404|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
1117405|NCT02448264|oral prophylaxis|oral prophylaxis
1117406|NCT02448264|BioCryst|biocryst
1117407|NCT02448264|first-in-human|first-in-human
1117408|NCT02448264|hereditary angioedema|hereditary angioedema
1117409|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
1117410|NCT02448238|probiotic|probiotic
1117411|NCT02448238|microbial translocation|microbial translocation
1117412|NCT02448238|immune activation|immune activation
1117413|NCT02448238|inflammation|inflammation
1117414|NCT02448238|VSL#3|vsl#3
1117415|NCT02448238|Mali|mali
1117416|NCT02448238|Africa|africa
1117421|NCT02448147|Heart failure|heart failure
1117422|NCT02448147|Exercise|exercise
1117423|NCT02448147|Biomarkers|biomarkers
1117424|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
1117425|NCT02448147|MicroRNA|microrna
1117426|NCT02448121|Cell therapy|cell therapy
1117427|NCT02448121|Sickle cell disease|sickle cell disease
1117428|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
1117429|NCT02448121|Autologous implantation|autologous implantation
1117430|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
1117431|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
1117432|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
1117433|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
1117434|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
1117435|NCT02448095|Philadelphia positive|philadelphia positive
1117436|NCT02448095|Compassionate use|compassionate use
1117437|NCT02448082|Dandruff|dandruff
1117438|NCT02448082|Pityriasis capitis|pityriasis capitis
1117439|NCT02448082|Ichthyol® Pale|ichthyol® pale
1117440|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
1117441|NCT02448043|brittleness|brittleness
1117442|NCT02448030|Metaboreflex|metaboreflex
1117443|NCT02448030|Variation of blood flow|variation of blood flow
1117444|NCT02448030|Functional electrical stimulation|functional electrical stimulation
1117445|NCT02448030|Isometric exercise.|isometric exercise.
1117446|NCT02448004|Healthy|healthy
1117447|NCT02448004|JNJ-63623872|jnj-63623872
1117448|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
1117449|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
1117450|NCT02447965|Abdominal Surgery|abdominal surgery
1117451|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1117452|NCT02447952|Biotelemetry|biotelemetry
1117453|NCT02447939|pharmacokinetics|pharmacokinetics
1117454|NCT02447939|trametinib|trametinib
1117455|NCT02447939|cutaneous melanoma|cutaneous melanoma
1117456|NCT02447939|dabrafenib|dabrafenib
1117457|NCT02447939|safety|safety
1117458|NCT02447926|leukapheresis|leukapheresis
1117459|NCT02447926|regulatory T cells|regulatory t cells
1117460|NCT02447926|liver transplantation|liver transplantation
1117461|NCT02447913|Family planning|family planning
1117462|NCT02447913|Voucher|voucher
1117463|NCT02447913|Immunisations|immunisations
1117464|NCT02447835|Metabolic Disorders|metabolic disorders
1117465|NCT02447809|microRNA|microrna
1117466|NCT02447809|Platelet|platelet
1117467|NCT02447809|Clopidogrel low response|clopidogrel low response
1117468|NCT02447796|(AVF)|(avf)
1117469|NCT02447796|surgery|surgery
1117470|NCT02447783|Flavanols|flavanols
1117471|NCT02447783|Cocoa flavanols|cocoa flavanols
1117472|NCT02447783|Blood pressure|blood pressure
1117473|NCT02447783|Platelet Function|platelet function
1117474|NCT02447770|Flavanols|flavanols
1117475|NCT02447770|Cocoa flavanols|cocoa flavanols
1117476|NCT02447770|Blood pressure|blood pressure
1117477|NCT02447770|Platelet Function|platelet function
1117478|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
1117479|NCT02447744|depression|depression
1117480|NCT02447744|anxiety|anxiety
1117481|NCT02447744|early life stress|early life stress
1117482|NCT02447731|respiratory insufficiency|respiratory insufficiency
1117483|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
1117484|NCT02447692|Pressure Support Ventilation|pressure support ventilation
1117485|NCT02447692|Weaning|weaning
1117486|NCT02447666|Azacitidine|azacitidine
1117487|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
1117488|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1117489|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1117490|NCT02447666|Vidaza|vidaza
1117491|NCT02447666|Hypomethylating agent|hypomethylating agent
1117492|NCT02447640|Volunteers|volunteers
1117493|NCT02447614|follow up|follow up
1117494|NCT02447614|Primary Snoring|primary snoring
1117495|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1117496|NCT02447588|intrauterine insemination|intrauterine insemination
1117497|NCT02447588|progesterone|progesterone
1117498|NCT02447549|IMRT|imrt
1117499|NCT02447549|IGRT|igrt
1117500|NCT02447549|Muscle invasive|muscle invasive
1117501|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
1117502|NCT02447536|Immunization|immunization
1117503|NCT02447536|Morbidity|morbidity
1117504|NCT02447536|Mortality|mortality
1117505|NCT02447536|BCG|bcg
1117506|NCT02447484|female sex workers|female sex workers
1117507|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
1117508|NCT02447484|behavior maintenance|behavior maintenance
1117509|NCT02447484|text messaging|text messaging
1117510|NCT02447458|Drug therapy|drug therapy
1117511|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
1117512|NCT02447432|Infants|infants
1117513|NCT02447432|Multidose|multidose
1117514|NCT02447432|Haemophilus influenzae|haemophilus influenzae
1117515|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
1117516|NCT02447432|Preservative|preservative
1117517|NCT02447432|Safety|safety
1117518|NCT02447432|Pneumonia|pneumonia
1117519|NCT02447432|Immunogenicity|immunogenicity
1117520|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1117521|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
1117522|NCT02447432|Respiratory tract infections|respiratory tract infections
1117523|NCT02447367|α1-blockers|α1-blockers
1117524|NCT02447367|antimuscarinic agent|antimuscarinic agent
1117525|NCT02447315|Pilocarpine|pilocarpine
1117526|NCT02447289|Dental caries|dental caries
1117527|NCT02447289|Moderate sedation|moderate sedation
1117528|NCT02447263|Liver Cancer|liver cancer
1117529|NCT02447263|HepaSphere|hepasphere
1117530|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1117531|NCT02447250|very low birth weight|very low birth weight
1117532|NCT02447250|albuterol|albuterol
1117533|NCT02447250|pulmonary function test|pulmonary function test
1117534|NCT02447237|liquid diet|liquid diet
1117535|NCT02447237|solid diet|solid diet
1117536|NCT02447224|appendicitis|appendicitis
1117537|NCT02447224|non operative management|non operative management
1117538|NCT02447224|appendectomy|appendectomy
1117539|NCT02447185|Lucentis|lucentis
1117541|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
1117542|NCT02447185|Vitrectomy|vitrectomy
1117543|NCT02447185|PDR|pdr
1117544|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
1117545|NCT02447159|Nigeria|nigeria
1117546|NCT02447159|Developing Countries|developing countries
1117547|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
1117548|NCT02447159|Hospitals/Economics|hospitals/economics
1117549|NCT02447159|HIV|hiv
1117550|NCT02447133|no known ocular pathology|no known ocular pathology
1117551|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
1117552|NCT02447107|Chronic Pain|chronic pain
1117553|NCT02447107|Technology|technology
1117554|NCT02447107|Mobile Phone Applications|mobile phone applications
1117555|NCT02447094|ischemic|ischemic
1117556|NCT02447094|tPA|tpa
1117557|NCT02447094|tele-medicine|tele-medicine
1117558|NCT02447094|robot|robot
1117559|NCT02447094|tele-stroke|tele-stroke
1117560|NCT02447042|sepsis|sepsis
1117561|NCT02447042|Fluids|fluids
1117562|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
1117563|NCT02447029|abortion|abortion
1117564|NCT02447029|pain management|pain management
1117565|NCT02447003|PD1|pd1
1117566|NCT02447003|PD-1|pd-1
1117567|NCT02447003|PDL1|pdl1
1117568|NCT02447003|PD-L1|pd-l1
1117569|NCT02446977|ischemic|ischemic
1117570|NCT02446977|stroke|stroke
1117571|NCT02446977|vitamin B2|vitamin b2
1117572|NCT02446938|mechanical ventilation|mechanical ventilation
1117573|NCT02446938|esophageal pressure|esophageal pressure
1117574|NCT02446938|catheter position|catheter position
1117575|NCT02446938|validation|validation
1117576|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
1117577|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
1117578|NCT02446886|Multiple Sclerosis|multiple sclerosis
1117579|NCT02446886|MS|ms
1117580|NCT02446886|RRMS|rrms
1117581|NCT02446886|SPMS|spms
1117582|NCT02446886|ACTH|acth
1117583|NCT02446873|children|children
1117584|NCT02446873|Ecuador|ecuador
1117585|NCT02446873|rural|rural
1117586|NCT02446873|poor|poor
1117587|NCT02446847|HIV|hiv
1117588|NCT02446847|3BNC117|3bnc117
1117589|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
1117590|NCT02446834|PCOS|pcos
1117591|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
1117592|NCT02446834|IGT|igt
1117593|NCT02446834|drugs treatment|drugs treatment
1117594|NCT02446795|Renal cell carcinoma|renal cell carcinoma
1117595|NCT02446795|Isoquercetin|isoquercetin
1117596|NCT02446795|kidney cancer|kidney cancer
1117597|NCT02446795|sunitinib|sunitinib
1117598|NCT02446795|fatigue|fatigue
1117599|NCT02446782|thoracoscopy|thoracoscopy
1117600|NCT02446782|pleuroscopy|pleuroscopy
1117601|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
1117602|NCT02446782|pleural effusion|pleural effusion
1117603|NCT02446756|Osteoarthritis|osteoarthritis
1117604|NCT02446756|MRI|mri
1117605|NCT02446756|Cartilage|cartilage
1117606|NCT02446756|Acupuncture|acupuncture
1117607|NCT02446743|Nervous System Diseases|nervous system diseases
1117608|NCT02446743|Meningitis|meningitis
1117609|NCT02446743|Central Nervous System Diseases|central nervous system diseases
1117610|NCT02446717|Hepatitis C|hepatitis c
1117611|NCT02446717|HCV Genotype 6|hcv genotype 6
1117612|NCT02446717|HCV GT1|hcv gt1
1117613|NCT02446717|Interferon (IFN) free|interferon (ifn) free
1117614|NCT02446717|HCV Genotype 5|hcv genotype 5
1117615|NCT02446717|HCV|hcv
1117616|NCT02446717|HCV GT4|hcv gt4
1117617|NCT02446717|HCV Genotype 4|hcv genotype 4
1117618|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
1117619|NCT02446717|Chronic HCV|chronic hcv
1117620|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
1117621|NCT02446717|HCV GT5|hcv gt5
1117622|NCT02446717|HCV Genotype 1|hcv genotype 1
1117627|NCT02446678|PillCam ESO2|pillcam eso2
1117628|NCT02446652|Advanced cervical cancer|advanced cervical cancer
1117629|NCT02446652|Epigenetic therapy|epigenetic therapy
1117630|NCT02446652|Randomized phase III|randomized phase iii
1117636|NCT02446613|Allergic Rhinitis|allergic rhinitis
1117637|NCT02446613|Nasal allergen challenge|nasal allergen challenge
1117638|NCT02446613|Allergic Asthma|allergic asthma
1117639|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
1117640|NCT02446587|endovascular therapy|endovascular therapy
1117641|NCT02446587|thrombectomy|thrombectomy
1117642|NCT02446587|selection|selection
1117643|NCT02446587|imaging|imaging
1117644|NCT02446587|perfusion|perfusion
1117645|NCT02446587|collaterals|collaterals
1117646|NCT02446587|ASPECTS|aspects
1117647|NCT02446574|chemoradiation|chemoradiation
1117648|NCT02446574|dose escalation|dose escalation
1117649|NCT02446561|Healthy Volunteer|healthy volunteer
1117650|NCT02446561|Pharmacokinetics|pharmacokinetics
1117651|NCT02446548|direct renin inhibitor|direct renin inhibitor
1117652|NCT02446548|kidney transplantation|kidney transplantation
1117653|NCT02446548|albuminuria|albuminuria
1117654|NCT02446496|Bioequivalence|bioequivalence
1117655|NCT02446496|film coated tablets|film coated tablets
1117656|NCT02446496|cefadroxil|cefadroxil
1117956|NCT02444897|PCA|pca
1117657|NCT02446483|Idiazole 20mg|idiazole 20mg
1117658|NCT02446483|PARIET 20 mg|pariet 20 mg
1117659|NCT02446483|Rabeprazole|rabeprazole
1117660|NCT02446483|bioequivalence|bioequivalence
1117661|NCT02446470|calcaneus|calcaneus
1117662|NCT02446470|fracture fixation, internal|fracture fixation, internal
1117663|NCT02446457|Lymphoma|lymphoma
1117664|NCT02446457|Follicular lymphoma|follicular lymphoma
1117666|NCT02446457|Relapsed|relapsed
1117667|NCT02446457|Rituximab|rituximab
1117668|NCT02446457|Rituxan|rituxan
1117669|NCT02446457|Pembrolizumab|pembrolizumab
1117670|NCT02446457|Keytruda|keytruda
1117671|NCT02446457|MK-3475|mk-3475
1117672|NCT02446457|SCH-900475|sch-900475
1117673|NCT02446457|Lenalidomide|lenalidomide
1117674|NCT02446457|CC-5013|cc-5013
1117675|NCT02446457|Revlimid|revlimid
1117676|NCT02446457|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1117677|NCT02446457|DLBCL|dlbcl
1117678|NCT02446444|High risk|high risk
1117679|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
1117680|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
1117681|NCT02446418|dry powder inahler|dry powder inahler
1117682|NCT02446418|vilanerol|vilanerol
1117683|NCT02446418|efficacy|efficacy
1117684|NCT02446418|safety|safety
1117685|NCT02446418|fluticasone furoate|fluticasone furoate
1117686|NCT02446418|quality of life|quality of life
1117687|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
1117688|NCT02446405|prostate cancer|prostate cancer
1117689|NCT02446405|prostate cancer treatment|prostate cancer treatment
1117690|NCT02446405|enzalutamide|enzalutamide
1117691|NCT02446353|Male Volunteers|male volunteers
1117692|NCT02446340|ShK-186|shk-186
1117693|NCT02446340|dalazatide|dalazatide
1117694|NCT02446340|Kv1.3|kv1.3
1117695|NCT02446340|SHK|shk
1117696|NCT02446301|Nalbuphine|nalbuphine
1117697|NCT02446301|SDE|sde
1117698|NCT02446301|dinalbuphine|dinalbuphine
1117699|NCT02446301|SDN|sdn
1117700|NCT02446301|pain|pain
1117701|NCT02446301|LT1001|lt1001
1117702|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
1117703|NCT02446262|Pain|pain
1117704|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
1117705|NCT02446262|Placebo|placebo
1117706|NCT02446262|Affective Neuroscience|affective neuroscience
1117707|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1117708|NCT02446249|Gene Therapy|gene therapy
1117709|NCT02446249|Xerostomia|xerostomia
1117710|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
1117711|NCT02446210|SCI|sci
1117712|NCT02446210|Neural Control|neural control
1117713|NCT02446210|Bilateral Movement|bilateral movement
1117714|NCT02446210|TMS|tms
1117715|NCT02446184|urethral obstruction|urethral obstruction
1117716|NCT02446184|posterior urethral valves|posterior urethral valves
1117717|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
1117718|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
1117719|NCT02446171|naloxegol oral solution|naloxegol oral solution
1117720|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
1117721|NCT02446171|relative bioavailability|relative bioavailability
1117722|NCT02446171|Phase I|phase i
1117723|NCT02446171|healthy subjects|healthy subjects
1117724|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
1117725|NCT02446106|Satiety|satiety
1117726|NCT02446106|Soups|soups
1117727|NCT02446106|Energy Intake|energy intake
1117728|NCT02446106|Snack Intake|snack intake
1117729|NCT02446093|pancreas|pancreas
1117730|NCT02446093|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1117731|NCT02446093|GMCI|gmci
1117732|NCT02446093|AdV-tk|adv-tk
1117733|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
1117734|NCT02446080|Constipation|constipation
1117735|NCT02446080|Probiotics|probiotics
1117736|NCT02446080|Women|women
1117737|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
1117738|NCT02446067|rTMS|rtms
1117739|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
1117740|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
1117741|NCT02446041|COPD|copd
1117742|NCT02446041|Chronic Bronchitis|chronic bronchitis
1117743|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
1117744|NCT02446002|Volunteer|volunteer
1117745|NCT02445989|HIV|hiv
1117746|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
1117747|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
1117748|NCT02445976|mCRPC|mcrpc
1117749|NCT02445976|metastatic|metastatic
1117750|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
1117751|NCT02445950|Coaching|coaching
1117752|NCT02445950|Well-being|well-being
1117753|NCT02445950|Digital Health|digital health
1117754|NCT02445950|Profiling|profiling
1117755|NCT02445950|Customer Satisfaction|customer satisfaction
1117756|NCT02445950|User Experience|user experience
1117757|NCT02445950|Occupational Health|occupational health
1117758|NCT02445950|Lifestyle|lifestyle
1117759|NCT02445950|Psychological Stress|psychological stress
1117760|NCT02445950|Cost-Effectiveness|cost-effectiveness
1117761|NCT02445950|Guideline Adherence|guideline adherence
1117762|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
1117763|NCT02445937|intensive care|intensive care
1117764|NCT02445937|surrogate decision making|surrogate decision making
1117765|NCT02445937|patient centered care|patient centered care
1117766|NCT02445937|palliative care|palliative care
1117767|NCT02445924|genetic signature|genetic signature
1117768|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
1117769|NCT02445924|micro RNA|micro rna
1117770|NCT02445898|Glucocorticoid|glucocorticoid
1117771|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
1117772|NCT02445898|Heart Rate Variability|heart rate variability
1117773|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
1117774|NCT02445885|Myocardial infarction|myocardial infarction
1117775|NCT02445885|Late presenters|late presenters
1117776|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1117777|NCT02445885|Reperfusion|reperfusion
1117778|NCT02445885|Angioplasty|angioplasty
1117779|NCT02445885|Duration of ischemia|duration of ischemia
1117780|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
1117781|NCT02445872|Nausea|nausea
1117782|NCT02445872|Vomiting|vomiting
1117783|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1117784|NCT02445872|CINV|cinv
1117785|NCT02445872|Aprepitant|aprepitant
1117786|NCT02445872|Lung cancer|lung cancer
1117787|NCT02445859|Antibiotic|antibiotic
1117788|NCT02445859|prophylaxis|prophylaxis
1117789|NCT02445859|surgical site infection|surgical site infection
1117790|NCT02445833|Obesity|obesity
1117791|NCT02445833|Internet intervention|internet intervention
1117792|NCT02445833|Cardiovascular disease|cardiovascular disease
1171294|NCT02162329|EEG|eeg
1117793|NCT02445833|Hypertension|hypertension
1117794|NCT02445833|Lifestyle intervention|lifestyle intervention
1117795|NCT02445833|Weight loss treatment|weight loss treatment
1117796|NCT02445755|Neonates|neonates
1117797|NCT02445755|Bilicare System|bilicare system
1117798|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
1117799|NCT02445729|Cesarean Section|cesarean section
1117800|NCT02445729|Wound Healing|wound healing
1117801|NCT02445677|TENS|tens
1117802|NCT02445677|chronic pain|chronic pain
1117803|NCT02445677|rehabilitation|rehabilitation
1117804|NCT02445664|Patient education|patient education
1117805|NCT02445664|Video intervention|video intervention
1117806|NCT02445651|Integrative Medicine|integrative medicine
1117807|NCT02445651|Alternative Medicine|alternative medicine
1117808|NCT02445651|Complementary Medicine|complementary medicine
1117809|NCT02445651|Parkinson's disease|parkinson's disease
1117810|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
1117811|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1117812|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
1117813|NCT02445651|Central Nervous System Diseases|central nervous system diseases
1117814|NCT02445651|Movement Disorders|movement disorders
1117815|NCT02445651|Nervous System Diseases|nervous system diseases
1117816|NCT02445651|Brain Diseases|brain diseases
1117817|NCT02445651|Oral supplements|oral supplements
1117818|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
1117819|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
1117820|NCT02445612|ASP7316|asp7316
1117821|NCT02445612|SMD|smd
1117822|NCT02445612|long term follow-up|long term follow-up
1118021|NCT02444598|civilian|civilian
1117823|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
1117824|NCT02445599|thoracotomy|thoracotomy
1117825|NCT02445599|pain management|pain management
1117826|NCT02445599|analgesia|analgesia
1117827|NCT02445599|postoperative care|postoperative care
1117828|NCT02445599|premedication|premedication
1117829|NCT02445599|preventive|preventive
1117830|NCT02445573|stress urinary incontinence|stress urinary incontinence
1117831|NCT02445573|electroacupuncture|electroacupuncture
1117832|NCT02445573|efficacy|efficacy
1117833|NCT02445560|probiotics|probiotics
1117834|NCT02445560|prebiotics|prebiotics
1117835|NCT02445560|high protein diet|high protein diet
1117836|NCT02445560|microbiota|microbiota
1117837|NCT02445534|Cell Therapy|cell therapy
1117838|NCT02445456|Rectal cancer|rectal cancer
1117839|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1117840|NCT02445417|Perinatal depression|perinatal depression
1117841|NCT02445378|Aromatherapy|aromatherapy
1117842|NCT02445378|essential oils|essential oils
1117843|NCT02445378|Acute Leukemia|acute leukemia
1117844|NCT02445365|Ulcerative colitis|ulcerative colitis
1117845|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
1117846|NCT02445339|Alcohol Dependence|alcohol dependence
1117847|NCT02445339|Alcohol Use Disorder|alcohol use disorder
1117848|NCT02445339|Care Management|care management
1117849|NCT02445339|Case Management|case management
1117850|NCT02445339|Emergency Care Services|emergency care services
1117851|NCT02445339|Emergency Department|emergency department
1117852|NCT02445339|Emergency Room|emergency room
1117853|NCT02445339|Extended-release naltrexone|extended-release naltrexone
1117854|NCT02445339|Frequent Users|frequent users
1117855|NCT02445339|Health Care Utilization|health care utilization
1117856|NCT02445339|Medical Management|medical management
1117857|NCT02445339|Naltrexone|naltrexone
1117858|NCT02445339|Population Health|population health
1117859|NCT02445339|Public Health|public health
1117860|NCT02445339|Vivitrol|vivitrol
1117861|NCT02445339|XR-NTX|xr-ntx
1117862|NCT02445339|XR-NTX+CM|xr-ntx+cm
1117863|NCT02445339|Alcoholism|alcoholism
1117864|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
1117865|NCT02445339|Central Nervous System Agents|central nervous system agents
1117866|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
1117867|NCT02445339|Clinical Trial|clinical trial
1117868|NCT02445339|Emergency Medicine|emergency medicine
1117869|NCT02445339|Mental Disorders|mental disorders
1117870|NCT02445339|Narcotic Antagonists|narcotic antagonists
1117871|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
1117872|NCT02445339|Pharmacologic Actions|pharmacologic actions
1117873|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
1117874|NCT02445339|Sensory System Agents|sensory system agents
1117875|NCT02445339|Substance-Related Disorders|substance-related disorders
1117876|NCT02445300|dressing|dressing
1117878|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
1117879|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
1117880|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
1117881|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
1117882|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
1117883|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
1117884|NCT02445248|DLBCL,|dlbcl,
1117885|NCT02445248|Relapsed/refractory,|relapsed/refractory,
1117886|NCT02445248|CTL019|ctl019
1117887|NCT02445248|CART19|cart19
1117888|NCT02445248|CART|cart
1117889|NCT02445248|CAR T cells|car t cells
1117890|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
1117891|NCT02445235|pain|pain
1117892|NCT02445235|wound care|wound care
1117893|NCT02445235|fungal infections|fungal infections
1117894|NCT02445235|scars|scars
1117895|NCT02445235|chronic pain|chronic pain
1117896|NCT02445235|outcomes|outcomes
1117897|NCT02445235|PRO|pro
1117898|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
1117899|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
1117900|NCT02445209|EOX|eox
1117901|NCT02445209|mDCF|mdcf
1117902|NCT02445209|efficacy|efficacy
1117903|NCT02445209|safety|safety
1117904|NCT02445170|Diabetes|diabetes
1117905|NCT02445170|amputation|amputation
1117906|NCT02445170|below-knee|below-knee
1117907|NCT02445170|transmetatarsal|transmetatarsal
1117908|NCT02445170|[M01.150.100]|[m01.150.100]
1117909|NCT02445170|[C19.246.099]|[c19.246.099]
1117910|NCT02445157|Gait speed|gait speed
1117911|NCT02445157|Functional outcome measure|functional outcome measure
1117912|NCT02445144|Inflammation|inflammation
1117913|NCT02445144|Blood Flow|blood flow
1117914|NCT02445144|Cognition|cognition
1117915|NCT02445131|CLL|cll
1117916|NCT02445118|adipose, allograft|adipose, allograft
1117917|NCT02445092|Intrauterine insemination|intrauterine insemination
1117918|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
1117919|NCT02445092|Pregnancy outcome|pregnancy outcome
1117920|NCT02445066|Vitamin D|vitamin d
1117921|NCT02445053|Cystic Fibrosis|cystic fibrosis
1117922|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
1117923|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
1117924|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
1117925|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
1117926|NCT02445040|multi-center study|multi-center study
1117927|NCT02445027|Primary Care|primary care
1117928|NCT02445027|Healthy|healthy
1117929|NCT02445014|Barrett's|barrett's
1117930|NCT02445014|GERD|gerd
1117931|NCT02445014|Capsule|capsule
1117932|NCT02445014|SECM|secm
1117933|NCT02444988|crystalloid|crystalloid
1117934|NCT02444988|acute kidney injury|acute kidney injury
1117935|NCT02444975|Urinary Tract Infections|urinary tract infections
1117936|NCT02444975|Water intake|water intake
1117937|NCT02444936|solid tumor|solid tumor
1117938|NCT02444936|chemotherapy|chemotherapy
1117939|NCT02444936|vaccine|vaccine
1117940|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
1117941|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
1117942|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
1117943|NCT02444923|Irregular cornea|irregular cornea
1117944|NCT02444923|Keratoconus|keratoconus
1117945|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
1117946|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
1117947|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
1117948|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
1117949|NCT02444910|KDT501|kdt501
1117950|NCT02444910|Diabetes|diabetes
1117951|NCT02444910|Diabetes Mellitus|diabetes mellitus
1117952|NCT02444910|Type 2|type 2
1117953|NCT02444910|KinDex|kindex
1117954|NCT02444897|Gastric cancer|gastric cancer
1117955|NCT02444897|epidural|epidural
1117958|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
1117959|NCT02444871|endotoxin activity assay|endotoxin activity assay
1117960|NCT02444871|thrombelastometry|thrombelastometry
1117961|NCT02444871|aggregometry|aggregometry
1117962|NCT02444858|paraquat poisoning|paraquat poisoning
1117963|NCT02444858|lung injury|lung injury
1117964|NCT02444858|stem cell therapy|stem cell therapy
1117965|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
1117966|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
1117967|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1117968|NCT02444819|HM61713|hm61713
1117969|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
1117970|NCT02444819|olmutinib|olmutinib
1117971|NCT02444806|Sleep disordered breathing|sleep disordered breathing
1117972|NCT02444806|Domiciliary NIV|domiciliary niv
1117973|NCT02444741|Lung Cancer|lung cancer
1117974|NCT02444741|Non-small cell lung cancer|non-small cell lung cancer
1117975|NCT02444741|NSCLC|nsclc
1117976|NCT02444741|Metastatic|metastatic
1117977|NCT02444741|Pembrolizumab|pembrolizumab
1117978|NCT02444741|Keytruda|keytruda
1117979|NCT02444741|MK-3475|mk-3475
1117980|NCT02444741|SCH-900475|sch-900475
1117981|NCT02444741|Stereotactic body radiation therapy|stereotactic body radiation therapy
1117982|NCT02444741|SBRT|sbrt
1117983|NCT02444741|Wide-field radiation therapy|wide-field radiation therapy
1117984|NCT02444741|WFRT|wfrt
1171610|NCT02160938|CNV|cnv
1117985|NCT02444741|Radiation therapy|radiation therapy
1117986|NCT02444741|XRT|xrt
1117987|NCT02444728|thrombocytopenia|thrombocytopenia
1117988|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
1117989|NCT02444728|hydroxychloroquine|hydroxychloroquine
1117990|NCT02444728|cyclophosphamide|cyclophosphamide
1117991|NCT02444728|remission|remission
1117992|NCT02444715|Lifestyle coaching|lifestyle coaching
1117993|NCT02444715|Phone-based system|phone-based system
1117994|NCT02444715|CVD prevention|cvd prevention
1117995|NCT02444715|Patient-centered decision support|patient-centered decision support
1117996|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
1117997|NCT02444689|Blood pressure|blood pressure
1117998|NCT02444689|Cardiovascular disease|cardiovascular disease
1117999|NCT02444689|Children|children
1118000|NCT02444689|Adolescent|adolescent
1118001|NCT02444689|Pediatrics|pediatrics
1118002|NCT02444689|End-organ damage|end-organ damage
1118003|NCT02444650|Correlation|correlation
1118004|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
1118005|NCT02444650|tonometry|tonometry
1118006|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
1118007|NCT02444624|Clostridium|clostridium
1118008|NCT02444624|premature birth|premature birth
1118009|NCT02444611|neonates|neonates
1118011|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
1118012|NCT02444611|vaccines|vaccines
1118013|NCT02444611|immunity|immunity
1118014|NCT02444611|immune response|immune response
1118015|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
1118016|NCT02444598|wounds|wounds
1118017|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
1118018|NCT02444598|conflict|conflict
1118019|NCT02444598|gunshot wound|gunshot wound
1118020|NCT02444598|blast injuries|blast injuries
1118022|NCT02444598|war|war
1118023|NCT02444559|Volunteers|volunteers
1118024|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
1118025|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
1118026|NCT02444455|cellular therapy|cellular therapy
1118027|NCT02444455|acute lung injury|acute lung injury
1118028|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
1118029|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
1118030|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
1118031|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1118032|NCT02444455|ALI|ali
1118033|NCT02444455|ARDS|ards
1118034|NCT02444442|Renal denervation|renal denervation
1118035|NCT02444442|Blood pressure|blood pressure
1118036|NCT02444442|Cardiovascular risk|cardiovascular risk
1118037|NCT02444442|Target organ damage|target organ damage
1118038|NCT02444442|Sympathetic activity|sympathetic activity
1118039|NCT02444442|Non-compliance|non-compliance
1118040|NCT02444429|Screening renal biopsy|screening renal biopsy
1118041|NCT02444429|Immunosuppression|immunosuppression
1118042|NCT02444403|HIV|hiv
1118043|NCT02444403|Viral hepatitis|viral hepatitis
1118044|NCT02444403|HCV|hcv
1118045|NCT02444403|Needle-stick injury|needle-stick injury
1118046|NCT02444403|Needle/syringes|needle/syringes
1118047|NCT02444403|Structural intervention|structural intervention
1118048|NCT02444403|Stepped wedge|stepped wedge
1118049|NCT02444403|Police|police
1118050|NCT02444403|Occupational safety|occupational safety
1118051|NCT02444403|Police Training|police training
1118052|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
1118053|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
1118054|NCT02444364|diabetes|diabetes
1118055|NCT02444364|bone loss|bone loss
1118056|NCT02444364|Bone Density|bone density
1118057|NCT02444325|group prenatal care|group prenatal care
1118058|NCT02444325|CenteringPregnancy|centeringpregnancy
1118059|NCT02444325|diabetes|diabetes
1118060|NCT02444312|Caregiving|caregiving
1118061|NCT02444312|Benefit Finding|benefit finding
1118062|NCT02444312|Writing Intervention|writing intervention
1118063|NCT02444273|liver diseases|liver diseases
1118064|NCT02444273|liver transplantation|liver transplantation
1118065|NCT02444273|preoperative care|preoperative care
1118066|NCT02444273|physical therapy|physical therapy
1118067|NCT02444260|Inguinal Hernia,|inguinal hernia,
1118068|NCT02444260|Local Anesthesia|local anesthesia
1118069|NCT02444260|Randomized Clinical trial|randomized clinical trial
1118070|NCT02444260|HERNIOPLASTY|hernioplasty
1118071|NCT02444221|Atrial Fibrillation|atrial fibrillation
1118072|NCT02444221|Rivaroxaban|rivaroxaban
1118073|NCT02444221|Stroke|stroke
1118074|NCT02444195|gynecologic cancer|gynecologic cancer
1118075|NCT02444195|guided imagery|guided imagery
1118076|NCT02444195|postoperative distress|postoperative distress
1118077|NCT02444195|perioperative distress|perioperative distress
1118078|NCT02444143|Kidney|kidney
1118079|NCT02444143|Immunosuppression|immunosuppression
1118080|NCT02444143|Transplant|transplant
1118081|NCT02444130|multifocality|multifocality
1118082|NCT02444130|monovision|monovision
1118083|NCT02444117|neurophysiology|neurophysiology
1118084|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
1118085|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
1118086|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
1118087|NCT02444091|Cyclophosphamide|cyclophosphamide
1118088|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
1118089|NCT02444091|CFS|cfs
1118090|NCT02444078|Alzheimer Disease|alzheimer disease
1118091|NCT02444078|Dementia|dementia
1118092|NCT02444078|Physical activity|physical activity
1118093|NCT02444078|Functional ability|functional ability
1118094|NCT02444078|Disability|disability
1118095|NCT02444078|Functional limitation|functional limitation
1118096|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
1118097|NCT02444065|Motivational interviewing|motivational interviewing
1118098|NCT02444065|Bulimia nervosa|bulimia nervosa
1118099|NCT02444065|Rapid response|rapid response
1118100|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
1118101|NCT02444000|chemotherapy|chemotherapy
1118102|NCT02444000|PCV|pcv
1118103|NCT02444000|radiotherapy|radiotherapy
1118104|NCT02444000|post operative treatment|post operative treatment
1118105|NCT02444000|anaplastic gliomas|anaplastic gliomas
1118106|NCT02444000|1p/19q codeletion|1p/19q codeletion
1118107|NCT02444000|cognition|cognition
1118108|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
1118109|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1118110|NCT02443961|pulmonary hypertension|pulmonary hypertension
1118111|NCT02443961|stem cell therapy|stem cell therapy
1118112|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
1118113|NCT02443961|very low weight preterm babies|very low weight preterm babies
1118114|NCT02443922|type 2 diabetes|type 2 diabetes
1118115|NCT02443922|beta cell function|beta cell function
1118116|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
1118117|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
1118118|NCT02443922|method standardization|method standardization
1118119|NCT02443922|insulin secretion|insulin secretion
1118120|NCT02443922|prediabetes|prediabetes
1118121|NCT02443922|insulin sensitivity|insulin sensitivity
1118122|NCT02443922|glimepiride|glimepiride
1118123|NCT02443922|sitagliptin|sitagliptin
1118124|NCT02443922|metformin|metformin
1118125|NCT02443909|Holmium Laser|holmium laser
1118126|NCT02443909|Kidney Stones|kidney stones
1118127|NCT02443909|RIRS|rirs
1118128|NCT02443883|stomach cancer|stomach cancer
1118129|NCT02443844|BPH|bph
1118130|NCT02443844|bladder cancer|bladder cancer
1118131|NCT02443844|treatment|treatment
1118132|NCT02443844|recurrence|recurrence
1118133|NCT02443844|progression|progression
1118134|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
1118135|NCT02443766|Integrative Medicine|integrative medicine
1118136|NCT02443766|Alternative Medicine|alternative medicine
1118137|NCT02443766|Complementary Medicine|complementary medicine
1118138|NCT02443766|Meditation Retreat|meditation retreat
1118139|NCT02443766|Ignatian Retreat|ignatian retreat
1118140|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
1118141|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1118142|NCT02443766|Wellbeing|wellbeing
1118143|NCT02443766|General Health|general health
1118144|NCT02443740|First in human|first in human
1118145|NCT02443740|Single Ascending Dose Study|single ascending dose study
1118146|NCT02443740|Safety and Tolerability|safety and tolerability
1118147|NCT02443740|Pharmacokinetics|pharmacokinetics
1118148|NCT02443740|Plasma|plasma
1118149|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
1118150|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
1118151|NCT02443714|Insulin Lispro|insulin lispro
1118152|NCT02443714|pharmacokinetics|pharmacokinetics
1118153|NCT02443714|pharmacodynamics|pharmacodynamics
1118154|NCT02443636|Depression|depression
1118155|NCT02443636|Mental Health|mental health
1118156|NCT02443636|Registry|registry
1118157|NCT02443636|Reliability|reliability
1118158|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
1118159|NCT02443636|Bipolar Disorder|bipolar disorder
1118160|NCT02443636|Mood disorder|mood disorder
1118161|NCT02443636|Suicide|suicide
1118162|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
1118163|NCT02443610|Venous Thromboembolism|venous thromboembolism
1118164|NCT02443610|Pregnancy|pregnancy
1118165|NCT02443597|ultrasound|ultrasound
1118166|NCT02443597|trisomy screening|trisomy screening
1118167|NCT02443597|obesity|obesity
1118168|NCT02443584|depression|depression
1118169|NCT02443584|pharmacogenetics|pharmacogenetics
1118170|NCT02443584|pharmacogenomics|pharmacogenomics
1118171|NCT02443584|major depressive disorder|major depressive disorder
1118172|NCT02443584|genetics|genetics
1118173|NCT02443584|anti-depressants|anti-depressants
1118174|NCT02443571|observational study|observational study
1118175|NCT02443558|Robotics|robotics
1118176|NCT02443558|Cerebral cortex|cerebral cortex
1118177|NCT02443558|Brain waves|brain waves
1118178|NCT02443558|Electroencephalography|electroencephalography
1118179|NCT02443558|Rehabilitation|rehabilitation
1118180|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
1118181|NCT02443545|Iron overload|iron overload
1118182|NCT02443545|Sickle cell disease|sickle cell disease
1118183|NCT02443545|Deferiprone|deferiprone
1118184|NCT02443545|Ferriprox|ferriprox
1118185|NCT02443545|Iron chelation|iron chelation
1118186|NCT02443519|Mindfulness|mindfulness
1118187|NCT02443519|MBCT|mbct
1118188|NCT02443519|Cognitive Therapy|cognitive therapy
1118189|NCT02443519|Disability|disability
1118190|NCT02443428|Breast Cancer|breast cancer
1118191|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
1118192|NCT02443389|nephrotoxic|nephrotoxic
1118193|NCT02443389|Fluid overload|fluid overload
1118194|NCT02443389|Acute renal failure|acute renal failure
1118195|NCT02443389|Prematurity|prematurity
1118196|NCT02443389|Risk factors|risk factors
1118197|NCT02443389|Epidemiology|epidemiology
1118198|NCT02443324|immuno-oncology|immuno-oncology
1118199|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
1118200|NCT02443324|angiogenesis|angiogenesis
1118201|NCT02443324|PD-1|pd-1
1118202|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
1118203|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
1118204|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
1118205|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
1118206|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
1118207|NCT02443298|ABBV-066|abbv-066
1118208|NCT02443298|BI 655066|bi 655066
1118209|NCT02443298|risankizumab|risankizumab
1118210|NCT02443259|NAPI|napi
1118211|NCT02443259|late preterm|late preterm
1118212|NCT02443207|Toothache|toothache
1118213|NCT02443207|Quality of life|quality of life
1118214|NCT02443207|Oral Health|oral health
1118215|NCT02443207|Children|children
1118216|NCT02443194|depression|depression
1118217|NCT02443194|glioblastoma|glioblastoma
1118218|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
1118219|NCT02443168|Pharmacokinetic|pharmacokinetic
1118221|NCT02443168|Male|male
1118222|NCT02443168|AG-221|ag-221
1118223|NCT02443168|[14C]|[14c]
1118224|NCT02443168|Single dose|single dose
1118225|NCT02443168|Oral|oral
1118226|NCT02443168|Intravenous|intravenous
1118227|NCT02443142|mild TBI|mild tbi
1118228|NCT02443142|concussion|concussion
1118229|NCT02443142|post-concussion syndrome|post-concussion syndrome
1118230|NCT02443103|pilot study|pilot study
1118231|NCT02443103|guanabenz acetate|guanabenz acetate
1118232|NCT02443090|secondary hypogonadism|secondary hypogonadism
1118233|NCT02443090|sexual dysfunction|sexual dysfunction
1118234|NCT02443090|erectile dysfunction|erectile dysfunction
1118235|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
1118236|NCT02443064|vancomycin|vancomycin
1118237|NCT02443064|blood stream infections|blood stream infections
1118238|NCT02443064|Chinese patients|chinese patients
1118239|NCT02443064|MRSA|mrsa
1118240|NCT02443038|patient fall|patient fall
1118241|NCT02443038|yoga|yoga
1118242|NCT02443038|balance|balance
1118243|NCT02443012|Diabetic Macular Edema|diabetic macular edema
1118244|NCT02443012|Nepafenac|nepafenac
1118245|NCT02443012|Laser therapy|laser therapy
1118246|NCT02443012|Clinically significant macular edema|clinically significant macular edema
1118247|NCT02443012|Adjunct Treatment|adjunct treatment
1118248|NCT02443012|Topical Nepafenac|topical nepafenac
1118249|NCT02442986|weaning failure|weaning failure
1118250|NCT02442986|polyneuropathy|polyneuropathy
1118251|NCT02442986|encephalopathy|encephalopathy
1118252|NCT02442986|sepsis|sepsis
1118253|NCT02442947|stress when dressed|stress when dressed
1118254|NCT02442947|protective garment|protective garment
1118255|NCT02442947|work clothes|work clothes
1118256|NCT02442934|Critical Care|critical care
1118362|NCT02442414|HER3|her3
1118257|NCT02442934|Critical Care Nursing|critical care nursing
1118258|NCT02442934|Discomfort|discomfort
1118259|NCT02442934|Sleep deprivation|sleep deprivation
1118260|NCT02442934|Noise|noise
1118261|NCT02442934|Thirst|thirst
1118262|NCT02442934|Pain|pain
1118263|NCT02442895|mature oocytes|mature oocytes
1118264|NCT02442895|antral follicles count|antral follicles count
1118265|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
1118266|NCT02442895|antimullerian hormone|antimullerian hormone
1118267|NCT02442882|Brain Concussion|brain concussion
1118268|NCT02442882|Balance|balance
1118269|NCT02442882|Locomotion|locomotion
1118270|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
1118271|NCT02442869|Suicide|suicide
1118272|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
1118273|NCT02442817|Linagliptin|linagliptin
1118274|NCT02442817|SDF1-α|sdf1-α
1118275|NCT02442804|Pomegranate|pomegranate
1118276|NCT02442804|Stroke|stroke
1118277|NCT02442804|Neuropsychology|neuropsychology
1118278|NCT02442791|Cardiac arrest|cardiac arrest
1118279|NCT02442791|GLP-1|glp-1
1118280|NCT02442791|Neuroprotection|neuroprotection
1118281|NCT02442752|Drug therapy|drug therapy
1118282|NCT02442739|Ketamine|ketamine
1118283|NCT02442739|Prevention of depression|prevention of depression
1118284|NCT02442726|Heat Injury|heat injury
1118285|NCT02442726|Humans|humans
1118286|NCT02442726|Laser Stimulation|laser stimulation
1118287|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
1118288|NCT02442726|Reaction Time|reaction time
1118289|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
1118290|NCT02442726|Thermal Thresholds|thermal thresholds
1118291|NCT02442713|Polysomnograph|polysomnograph
1118292|NCT02442713|fluvoxamine|fluvoxamine
1118293|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
1118294|NCT02442674|Hyponatremia|hyponatremia
1118295|NCT02442674|Euvolemic|euvolemic
1118296|NCT02442674|Hypervolemic|hypervolemic
1118297|NCT02442674|Serum sodium|serum sodium
1118298|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
1118299|NCT02442674|Electrolyte abnormality|electrolyte abnormality
1118300|NCT02442674|Electrolyte imbalance|electrolyte imbalance
1118301|NCT02442674|Metabolic disease|metabolic disease
1118302|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
1118303|NCT02442648|Renal Transplantation|renal transplantation
1118304|NCT02442648|Carfilzomib|carfilzomib
1118305|NCT02442648|Kyprolis|kyprolis
1118306|NCT02442648|Desensitization|desensitization
1118307|NCT02442622|de Quervain's disease|de quervain's disease
1118308|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
1118309|NCT02442622|ASTYM|astym
1118310|NCT02442622|de Quervain's treatment|de quervain's treatment
1118311|NCT02442609|internet|internet
1118312|NCT02442609|anesthesia|anesthesia
1118313|NCT02442609|information|information
1118314|NCT02442609|surgery|surgery
1118315|NCT02442609|question|question
1118316|NCT02442596|Abdominal sepsis|abdominal sepsis
1118317|NCT02442596|Sepsis|sepsis
1118318|NCT02442596|Septic shock|septic shock
1118319|NCT02442596|Epidemiology|epidemiology
1118320|NCT02442596|Etiology|etiology
1118321|NCT02442596|Microbiology|microbiology
1118322|NCT02442596|Abdomen|abdomen
1118323|NCT02442596|Intra-abdominal|intra-abdominal
1118324|NCT02442596|Infection|infection
1118325|NCT02442596|Gastrointestinal tract|gastrointestinal tract
1118326|NCT02442596|Perforation|perforation
1118327|NCT02442596|Peritonitis|peritonitis
1118328|NCT02442596|Pancreas|pancreas
1118329|NCT02442596|Biliary tract|biliary tract
1118330|NCT02442596|Megacolon|megacolon
1118331|NCT02442583|colorectal cancer|colorectal cancer
1118332|NCT02442583|survivor|survivor
1118333|NCT02442583|exercise|exercise
1118334|NCT02442583|physical activity|physical activity
1118335|NCT02442583|sedentary|sedentary
1118336|NCT02442570|alpha B-crystallin|alpha b-crystallin
1118337|NCT02442570|immune tolerance|immune tolerance
1118338|NCT02442557|alpha B-crystallin|alpha b-crystallin
1118339|NCT02442557|immune tolerance|immune tolerance
1118340|NCT02442518|placenta accreta|placenta accreta
1118341|NCT02442518|placenta previa|placenta previa
1118342|NCT02442518|ultrasound|ultrasound
1118343|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected|atrial fibrillation; pacemaker; device-detected
1118344|NCT02442492|sildenafil|sildenafil
1118345|NCT02442492|IUGR|iugr
1118346|NCT02442492|FGR|fgr
1118347|NCT02442492|STRIDER|strider
1118348|NCT02442479|exercise|exercise
1118349|NCT02442479|resistance training|resistance training
1118350|NCT02442479|muscle strength|muscle strength
1118351|NCT02442479|muscle hypertrophy|muscle hypertrophy
1118352|NCT02442440|anisodamine|anisodamine
1118353|NCT02442440|septic shock|septic shock
1118354|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
1118355|NCT02442427|Palivizumab|palivizumab
1118356|NCT02442427|Bronchiolitis|bronchiolitis
1118357|NCT02442427|Treatment|treatment
1118358|NCT02442414|Cancer|cancer
1118359|NCT02442414|Advanced Solid Tumors|advanced solid tumors
1118360|NCT02442414|EGFR|egfr
1118361|NCT02442414|HER2|her2
1118364|NCT02442414|ALK mutations|alk mutations
1118365|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
1118366|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
1118367|NCT02442414|Gastric Cancer|gastric cancer
1118368|NCT02442414|Colorectal Cancer|colorectal cancer
1118369|NCT02442388|pain|pain
1118370|NCT02442388|root canal therapy|root canal therapy
1118371|NCT02442388|endodontics|endodontics
1118372|NCT02442388|file|file
1118373|NCT02442375|head and neck cancer|head and neck cancer
1118374|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
1118375|NCT02442375|dose reduction|dose reduction
1118376|NCT02442375|dose de-escalation|dose de-escalation
1118377|NCT02442375|elective lymph nodes|elective lymph nodes
1118378|NCT02442375|FDG-PET|fdg-pet
1118379|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
1118380|NCT02442310|deferiprone|deferiprone
1118381|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
1118382|NCT02442310|pharmacokinetics|pharmacokinetics
1118383|NCT02442297|Glioblastoma|glioblastoma
1118384|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
1118385|NCT02442297|HER2-specific T cells|her2-specific t cells
1118386|NCT02442297|intracranial injection|intracranial injection
1118387|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
1118388|NCT02442284|Interferon-Free|interferon-free
1118389|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
1118390|NCT02442284|Hepatitis C Virus|hepatitis c virus
1118391|NCT02442284|Hepatitis C|hepatitis c
1118392|NCT02442284|Cirrhosis|cirrhosis
1118393|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
1118394|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
1118395|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
1118396|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
1118397|NCT02442271|Hepatitis C Virus|hepatitis c virus
1118398|NCT02442258|Renal Impairment|renal impairment
1118399|NCT02442219|gluten|gluten
1118400|NCT02442219|Tetramer|tetramer
1118401|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
1118402|NCT02442154|early tracheostomy|early tracheostomy
1118403|NCT02442154|severe head injury|severe head injury
1118404|NCT02442154|endotracheal intubation|endotracheal intubation
1118405|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
1118406|NCT02442141|Cerebral|cerebral
1118407|NCT02442141|Infants|infants
1118408|NCT02442141|Anesthesia|anesthesia
1118409|NCT02442141|Neurodevelopmental|neurodevelopmental
1118410|NCT02442128|Fentany|fentany
1118411|NCT02442128|intubation|intubation
1118412|NCT02442128|sevoflurane|sevoflurane
1118413|NCT02442128|children|children
1118414|NCT02442128|Propofol|propofol
1118415|NCT02442115|Autism|autism
1118416|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1118417|NCT02442115|Tummy Troubles|tummy troubles
1118418|NCT02442115|Constipation|constipation
1118419|NCT02442115|GI Disorders|gi disorders
1118420|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
1118421|NCT02442115|Gastrointestinal|gastrointestinal
1118422|NCT02442115|Oxidative Stress|oxidative stress
1118423|NCT02442115|Stomach problems|stomach problems
1118424|NCT02442115|Behaviors|behaviors
1118425|NCT02442115|Autistic|autistic
1118426|NCT02442115|ASD|asd
1118427|NCT02442115|MET gene|met gene
1118428|NCT02442115|GID|gid
1118429|NCT02442115|Pediatric|pediatric
1118430|NCT02442115|Pediatric GI disorders|pediatric gi disorders
1118431|NCT02442115|Children with Autism|children with autism
1118432|NCT02442115|functional constipation|functional constipation
1118433|NCT02442102|deglutition disorders|deglutition disorders
1118434|NCT02442102|therapeutics|therapeutics
1118435|NCT02442102|rehabilitation|rehabilitation
1118436|NCT02442102|outcome assessment|outcome assessment
1118437|NCT02442102|intubation|intubation
1118438|NCT02442102|critical care|critical care
1118439|NCT02442102|larynx|larynx
1118440|NCT02442102|voice|voice
1118441|NCT02442089|mHealth|mhealth
1118442|NCT02442089|eHealth|ehealth
1118443|NCT02442089|Health Systems|health systems
1118444|NCT02442089|Health Technology|health technology
1118445|NCT02442089|No Show|no show
1118446|NCT02442089|Non-attendance|non-attendance
1118447|NCT02442089|Chile|chile
1118448|NCT02442089|Randomized controlled trial|randomized controlled trial
1118449|NCT02442089|Efficiency, Organizational|efficiency, organizational
1118450|NCT02442089|Pediatric Hospitals|pediatric hospitals
1118451|NCT02442089|Global Health|global health
1118452|NCT02442089|Referral and Consultation|referral and consultation
1118453|NCT02442089|Health Care Systems|health care systems
1118454|NCT02442089|Community Health Systems|community health systems
1118455|NCT02442089|Health Information Systems|health information systems
1118456|NCT02442089|Integrated Health Care Systems|integrated health care systems
1118457|NCT02442089|Community Medicine|community medicine
1118458|NCT02442076|Skin vibration|skin vibration
1118459|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
1118460|NCT02442050|CABG|cabg
1118461|NCT02442050|valve surgery|valve surgery
1118462|NCT02442050|cardioplegia|cardioplegia
1118463|NCT02442050|heart surgery|heart surgery
1118464|NCT02442050|cardiac surgery|cardiac surgery
1118465|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
1118466|NCT02442050|myocardial arrest|myocardial arrest
1118467|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
1118468|NCT02442050|CPB|cpb
1118469|NCT02442037|cellular therapy|cellular therapy
1118470|NCT02442037|active ulcerative colitis|active ulcerative colitis
1118471|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
1118472|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
1118473|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1118474|NCT02442037|UC|uc
1118475|NCT02442024|diabetes mellitus|diabetes mellitus
1118476|NCT02442024|diet|diet
1118477|NCT02442024|nutrient sensing|nutrient sensing
1118478|NCT02442011|Hematology Biobank|hematology biobank
1118479|NCT02441998|Colorectal Cancer|colorectal cancer
1118480|NCT02441998|Diminutive Polyps|diminutive polyps
1118481|NCT02441998|Narrow Band Imaging|narrow band imaging
1118482|NCT02441998|Colonic Polyps|colonic polyps
1118483|NCT02441998|colonoscopy|colonoscopy
1118484|NCT02441998|diagnostic imaging|diagnostic imaging
1118485|NCT02441998|optical diagnosis|optical diagnosis
1118486|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
1118487|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
1118488|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
1118489|NCT02441907|Diabetic Macular Edema|diabetic macular edema
1118490|NCT02441907|Ocular Cytokines|ocular cytokines
1118491|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
1118492|NCT02441881|Radiofrequency ablation|radiofrequency ablation
1118493|NCT02441881|varicose veins|varicose veins
1118494|NCT02441881|endothermal ablation|endothermal ablation
1118495|NCT02441881|RFITT|rfitt
1118496|NCT02441881|Venefit|venefit
1118497|NCT02441842|β-blocker|β-blocker
1118498|NCT02441842|ACE inhibitor|ace inhibitor
1118499|NCT02441842|Stress|stress
1118500|NCT02441842|Craniotomy|craniotomy
1118501|NCT02441842|Postop hypertension|postop hypertension
1118502|NCT02441842|neurosurgical patients|neurosurgical patients
1118503|NCT02441829|Renal Impairment|renal impairment
1118504|NCT02441816|wet AMD|wet amd
1118505|NCT02441816|neovascular AMD|neovascular amd
1118506|NCT02441803|Leukemia|leukemia
1118507|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
1118509|NCT02441803|Refractory|refractory
1118510|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1118511|NCT02441803|AHSCT|ahsct
1118512|NCT02441803|Busulfan|busulfan
1118513|NCT02441803|Busulfex|busulfex
1118514|NCT02441803|Myleran|myleran
1118515|NCT02441803|Fludarabine|fludarabine
1118516|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
1118517|NCT02441803|Fludara|fludara
1118518|NCT02441803|Clofarabine|clofarabine
1118519|NCT02441803|Clofarex|clofarex
1118520|NCT02441803|Clolar|clolar
1118521|NCT02441803|Total body irradiation|total body irradiation
1118522|NCT02441803|TBI|tbi
1118523|NCT02441803|XRT|xrt
1118524|NCT02441803|Thymoglobulin|thymoglobulin
1118525|NCT02441803|ATG (Rabbit)|atg (rabbit)
1118526|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
1118527|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
1118528|NCT02441803|Rabbit ATG|rabbit atg
1118529|NCT02441803|rATG|ratg
1118530|NCT02441803|Stem cell infusion|stem cell infusion
1118531|NCT02441803|Cyclophosphamide|cyclophosphamide
1118532|NCT02441803|Cytoxan|cytoxan
1118533|NCT02441803|Neosar|neosar
1118534|NCT02441803|Tacrolimus|tacrolimus
1118535|NCT02441803|Prograf|prograf
1118536|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
1118537|NCT02441803|MMF|mmf
1118538|NCT02441803|CellCept|cellcept
1118539|NCT02441803|Decitabine|decitabine
1118540|NCT02441803|Dacogen|dacogen
1118541|NCT02441803|Cytarabine|cytarabine
1118542|NCT02441803|Ara-C|ara-c
1118543|NCT02441803|Cytosar|cytosar
1118544|NCT02441803|DepoCyt|depocyt
1118545|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1118546|NCT02441803|Idarubicin|idarubicin
1118547|NCT02441803|Idamycin|idamycin
1118548|NCT02441790|5th metacarpal|5th metacarpal
1118549|NCT02441790|EAROM|earom
1118550|NCT02441790|standard immobilization|standard immobilization
1118551|NCT02441790|Boxer's Fracture|boxer's fracture
1118552|NCT02441790|hand function|hand function
1118553|NCT02441790|DASH|dash
1118554|NCT02441790|trauma|trauma
1118555|NCT02441777|retinal imaging|retinal imaging
1118556|NCT02441777|optical imaging|optical imaging
1118557|NCT02441777|optical coherence tomography|optical coherence tomography
1118558|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
1118559|NCT02441764|Halaven|halaven
1118560|NCT02441764|Eribulin Mesylate|eribulin mesylate
1118561|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
1118959|NCT02439593|Pancreas|pancreas
1118562|NCT02441751|Electrocardiography|electrocardiography
1118563|NCT02441751|Hemorrhage|hemorrhage
1118564|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
1118565|NCT02441738|Atrial Fibrillation|atrial fibrillation
1118566|NCT02441738|Hybrid Ablation|hybrid ablation
1118567|NCT02441738|Catheter Ablation|catheter ablation
1118568|NCT02441686|Multiple Myeloma|multiple myeloma
1118569|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
1118570|NCT02441673|Subarachnoid block|subarachnoid block
1118571|NCT02441673|Tramadol|tramadol
1118572|NCT02441673|Nefopam|nefopam
1118573|NCT02441621|fluid responsiveness|fluid responsiveness
1118574|NCT02441621|diastolic dysfunction|diastolic dysfunction
1118575|NCT02441621|left ventricular|left ventricular
1118576|NCT02441556|thrombectomy|thrombectomy
1118577|NCT02441556|rt-PA|rt-pa
1118578|NCT02441556|stroke|stroke
1118579|NCT02441556|endovascular treatment|endovascular treatment
1118580|NCT02441556|randomized|randomized
1118581|NCT02441530|vitamin D|vitamin d
1118582|NCT02441517|Xtandi|xtandi
1118583|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1118584|NCT02441517|Metastatic|metastatic
1118585|NCT02441517|Prostate Cancer|prostate cancer
1118586|NCT02441517|Chemotherapy|chemotherapy
1118587|NCT02441517|Castration-resistant|castration-resistant
1118588|NCT02441517|Enzalutamide|enzalutamide
1118589|NCT02441504|Exercise training|exercise training
1118590|NCT02441504|microvascular rarefaction|microvascular rarefaction
1118591|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
1118592|NCT02441452|Nuss procedure|nuss procedure
1118593|NCT02441452|postoperative care|postoperative care
1118594|NCT02441452|early ambulation|early ambulation
1118595|NCT02441426|Cognitive development|cognitive development
1118596|NCT02441426|Diarrheal disease|diarrheal disease
1118597|NCT02441426|Enteric infections|enteric infections
1118598|NCT02441426|Malnutrition|malnutrition
1118599|NCT02441426|Vaccine Response|vaccine response
1118600|NCT02441426|Enteropathy|enteropathy
1118601|NCT02441426|Antibiotic use|antibiotic use
1118602|NCT02441426|Micronutrients|micronutrients
1118603|NCT02441426|Breast feeding|breast feeding
1118604|NCT02441426|Gut inflammation|gut inflammation
1118605|NCT02441413|HRCT|hrct
1118606|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
1118607|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
1118608|NCT02441413|FRI|fri
1118609|NCT02441413|Computed Tomography|computed tomography
1118610|NCT02441413|CT|ct
1118611|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1118612|NCT02441413|BOS|bos
1118613|NCT02441413|Lung Transplant|lung transplant
1118614|NCT02441400|GERD|gerd
1118615|NCT02441400|LES Pressure|les pressure
1118616|NCT02441400|Electrical Stimulation|electrical stimulation
1118617|NCT02441387|depression|depression
1118618|NCT02441387|elderly|elderly
1118619|NCT02441387|remission|remission
1118620|NCT02441387|treatment response|treatment response
1118621|NCT02441387|predictors of response|predictors of response
1118622|NCT02441387|cognitive decline|cognitive decline
1118623|NCT02441387|structural neuroimage|structural neuroimage
1118624|NCT02441387|genetic polymorphism|genetic polymorphism
1118625|NCT02441387|psychoeducation|psychoeducation
1118626|NCT02441374|Stroke|stroke
1118627|NCT02441374|Hemiparesis|hemiparesis
1118628|NCT02441374|Upper limb|upper limb
1118629|NCT02441348|Voice Therapy|voice therapy
1118630|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
1118631|NCT02441348|Lesions|lesions
1118632|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
1118633|NCT02441283|Chronic hepatitis C|chronic hepatitis c
1118634|NCT02441283|Hepatitis C virus|hepatitis c virus
1118635|NCT02441283|Sustained virologic response|sustained virologic response
1118636|NCT02441283|Hepatitis C|hepatitis c
1118637|NCT02441283|Direct Acting Antiviral|direct acting antiviral
1118638|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
1118639|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
1118640|NCT02441257|Control Ventilation|control ventilation
1118641|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
1118642|NCT02441205|High Intensity Interval Training|high intensity interval training
1118643|NCT02441192|physical training|physical training
1118644|NCT02441192|aerobic training|aerobic training
1118645|NCT02441192|resistance training|resistance training
1118646|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
1118647|NCT02441179|rehabilitation|rehabilitation
1118648|NCT02441179|spinal cord injury|spinal cord injury
1118649|NCT02441166|Bone marrow tryptase|bone marrow tryptase
1118650|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
1118651|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
1118652|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
1118653|NCT02441127|free gingival graft|free gingival graft
1118654|NCT02441127|diode laser|diode laser
1118655|NCT02441127|donor site|donor site
1118656|NCT02441127|mucogingival surgery|mucogingival surgery
1118657|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
1118658|NCT02441075|patients|patients
1118659|NCT02441075|BMT|bmt
1118660|NCT02441075|cyclosporine|cyclosporine
1118661|NCT02441075|tacrolimus|tacrolimus
1118662|NCT02441075|HSCT|hsct
1118663|NCT02441049|Latino|latino
1118664|NCT02441049|Hispanic|hispanic
1118665|NCT02441049|Diet|diet
1118666|NCT02441049|Family health|family health
1118667|NCT02441049|Promotora|promotora
1118668|NCT02441049|Intervention|intervention
1118669|NCT02441036|Gene expression and protein production|gene expression and protein production
1118670|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
1118671|NCT02441023|nutritional therapy|nutritional therapy
1118672|NCT02441023|health education|health education
1118673|NCT02441023|self-management|self-management
1118674|NCT02441023|multimedia|multimedia
1118675|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
1118676|NCT02440984|enteric nervous system|enteric nervous system
1118677|NCT02440984|anorectal disorder|anorectal disorder
1118678|NCT02440984|barostat anorectal|barostat anorectal
1118679|NCT02440984|physiology|physiology
1118680|NCT02440984|spina bifida|spina bifida
1118681|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
1118682|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
1118683|NCT02440971|SleepMinder|sleepminder
1118684|NCT02440971|ApneaLink Plus|apnealink plus
1118685|NCT02440971|Sleep disordered breathing|sleep disordered breathing
1118686|NCT02440971|Natriuretic peptide|natriuretic peptide
1118687|NCT02440932|low Phenylalanine diet|low phenylalanine diet
1118688|NCT02440932|PKU supplements|pku supplements
1118689|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
1118690|NCT02440932|appetite|appetite
1118691|NCT02440932|body weight|body weight
1118692|NCT02440919|Respiratory mechanics|respiratory mechanics
1118693|NCT02440919|Oxygenation|oxygenation
1118694|NCT02440919|Suction|suction
1118695|NCT02440919|Mechanical ventilation|mechanical ventilation
1118696|NCT02440919|Respiratory therapy|respiratory therapy
1118697|NCT02440919|Capnography|capnography
1118698|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
1118699|NCT02440906|Asthma|asthma
1118700|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
1118701|NCT02440906|Intracranial Injury|intracranial injury
1118702|NCT02440906|Neoplasms|neoplasms
1118703|NCT02440906|Heart Failure|heart failure
1118704|NCT02440906|HIV/AIDs|hiv/aids
1118705|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
1118706|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
1118707|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
1118708|NCT02440906|History of hepatitis C|history of hepatitis c
1118709|NCT02440906|Schizophrenia|schizophrenia
1118710|NCT02440906|Episodic Mood Disorders|episodic mood disorders
1118711|NCT02440906|Delusional Disorders|delusional disorders
1118712|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
1118713|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
1118714|NCT02440906|Neurotic Disorders|neurotic disorders
1118715|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
1118716|NCT02440893|Corus CAD|corus cad
1118717|NCT02440893|ASGES|asges
1118718|NCT02440893|Age/Sex/Gene Expression Score|age/sex/gene expression score
1118719|NCT02440893|Gene Expression|gene expression
1118720|NCT02440893|GES|ges
1118721|NCT02440893|CAD|cad
1118722|NCT02440893|CVD|cvd
1118723|NCT02440893|CHD|chd
1118724|NCT02440893|Precision Medicine|precision medicine
1118725|NCT02440893|Coronary Artery Disease|coronary artery disease
1118726|NCT02440893|Angina Pectoris|angina pectoris
1118727|NCT02440893|Chest Pain|chest pain
1118728|NCT02440893|Cardiovascular Disease|cardiovascular disease
1118729|NCT02440893|Coronary Heart Disease|coronary heart disease
1118730|NCT02440893|Metformin|metformin
1118731|NCT02440867|theta burst stimulation|theta burst stimulation
1118732|NCT02440867|Social Cognition|social cognition
1118733|NCT02440867|MRSI|mrsi
1118734|NCT02440867|Schizophrenia|schizophrenia
1118735|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
1118736|NCT02440841|VA106483|va106483
1118737|NCT02440841|fedovapagon|fedovapagon
1118738|NCT02440841|drug-drug interaction|drug-drug interaction
1118739|NCT02440841|DDI|ddi
1118740|NCT02440841|males|males
1118741|NCT02440841|rifampicin|rifampicin
1118742|NCT02440841|rifampin|rifampin
1118743|NCT02440841|itraconazole|itraconazole
1118744|NCT02440841|CYP3A4|cyp3a4
1118745|NCT02440841|pharmacokinetics|pharmacokinetics
1118746|NCT02440841|PK|pk
1118747|NCT02440815|Psychotherapy|psychotherapy
1118748|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
1118749|NCT02440815|Depression|depression
1118750|NCT02440815|Major Depression|major depression
1118751|NCT02440815|Major Depressive Disorder|major depressive disorder
1118752|NCT02440815|Late Life Depression|late life depression
1118753|NCT02440815|Multimodal imaging|multimodal imaging
1118754|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1118755|NCT02440815|Cerebral blood flow|cerebral blood flow
1118756|NCT02440815|Cortical atrophy|cortical atrophy
1118757|NCT02440815|White matter lesion|white matter lesion
1118758|NCT02440763|Natural History|natural history
1118759|NCT02440737|Newly diagnosed|newly diagnosed
1118760|NCT02440737|Cancer patient|cancer patient
1118761|NCT02440737|Caregiver|caregiver
1118762|NCT02440737|Support person|support person
1118763|NCT02440724|winged stents|winged stents
1118764|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
1118765|NCT02440724|partial covered|partial covered
1118766|NCT02440724|uncovered|uncovered
1118767|NCT02440724|endoscopic insertion|endoscopic insertion
1118768|NCT02440685|DLBCL|dlbcl
1118769|NCT02440685|FL|fl
1118770|NCT02440685|MCL|mcl
1118771|NCT02440685|PTCL|ptcl
1118772|NCT02440685|MF|mf
1118773|NCT02440685|CLL|cll
1118774|NCT02440672|Osteoarthritis|osteoarthritis
1118775|NCT02440672|TKA|tka
1118776|NCT02440672|Degenerative Knee Disease|degenerative knee disease
1118777|NCT02440659|Chronic Kidney Disease|chronic kidney disease
1118778|NCT02440659|Hemodialysis|hemodialysis
1118779|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
1118780|NCT02440646|Computed tomography angiography|computed tomography angiography
1118781|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
1118782|NCT02440646|Coronary artery disease|coronary artery disease
1118783|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
1118784|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
1118785|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
1118786|NCT02440646|Plaque burden|plaque burden
1118787|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
1118788|NCT02440646|Radiation dose|radiation dose
1118789|NCT02440646|SYNTAX score|syntax score
1118790|NCT02440646|Fractional flow reserve|fractional flow reserve
1118791|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
1118792|NCT02440607|Randomization|randomization
1118793|NCT02440607|cognitive aids types|cognitive aids types
1118794|NCT02440607|aids|aids
1118795|NCT02440594|Primary Care|primary care
1118796|NCT02440594|Depression|depression
1118797|NCT02440594|Elderly|elderly
1118798|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
1118799|NCT02440542|Nerve block|nerve block
1118800|NCT02440542|Ankle|ankle
1118801|NCT02440542|Talus|talus
1118802|NCT02440542|Pain, Postoperative|pain, postoperative
1118803|NCT02440516|Standardized|standardized
1118804|NCT02440516|Physical therapy|physical therapy
1118805|NCT02440516|occupational therapy|occupational therapy
1118806|NCT02440516|quality of life|quality of life
1118807|NCT02440516|disability|disability
1118808|NCT02440516|activities of daily living|activities of daily living
1118809|NCT02440516|ambulatory therapy|ambulatory therapy
1118810|NCT02440516|multiple sclerosis|multiple sclerosis
1118811|NCT02440464|Multiple Myeloma|multiple myeloma
1118812|NCT02440464|Allogeneic Transplant|allogeneic transplant
1118813|NCT02440464|Maintenance Therapy|maintenance therapy
1118814|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
1118815|NCT02440464|Hematologic Disorders|hematologic disorders
1118816|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
1118817|NCT02440425|platinum resistant|platinum resistant
1118818|NCT02440425|recurrent|recurrent
1118819|NCT02440425|persistent|persistent
1118820|NCT02440425|epithelial|epithelial
1118821|NCT02440425|ovarian|ovarian
1118822|NCT02440425|fallopian tube|fallopian tube
1118823|NCT02440425|primary peritoneal|primary peritoneal
1118824|NCT02440425|carcinoma|carcinoma
1118825|NCT02440412|Massage|massage
1118826|NCT02440412|Stress|stress
1118827|NCT02440412|salivary cortisol|salivary cortisol
1118828|NCT02440360|chronic homelessness|chronic homelessness
1118829|NCT02440347|local anesthesia|local anesthesia
1118830|NCT02440347|articaine|articaine
1118831|NCT02440347|AMSA|amsa
1118832|NCT02440334|cryosurgery|cryosurgery
1118833|NCT02440334|ultrasonography|ultrasonography
1118834|NCT02440282|patients|patients
1118835|NCT02440256|Cost-effectiveness|cost-effectiveness
1118836|NCT02440256|Opioid substitution treatment|opioid substitution treatment
1118837|NCT02440256|Integrated care|integrated care
1118839|NCT02440256|HAART|haart
1118840|NCT02440256|Testing|testing
1118841|NCT02440256|Linkage to care|linkage to care
1118842|NCT02440256|Treatment adherence|treatment adherence
1118843|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
1118844|NCT02440230|safety|safety
1118845|NCT02440230|Exemestane|exemestane
1118846|NCT02440230|ovarian function suppression|ovarian function suppression
1118847|NCT02440230|anastrozole|anastrozole
1118848|NCT02440204|sevoflurane|sevoflurane
1118849|NCT02440204|remifentanil|remifentanil
1118850|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
1118851|NCT02440178|leukemia|leukemia
1118852|NCT02440178|induction|induction
1118853|NCT02440178|prophylaxis|prophylaxis
1118854|NCT02440178|antifungal|antifungal
1118855|NCT02440178|micafungin|micafungin
1118856|NCT02440178|phase II|phase ii
1118857|NCT02440165|nutrition|nutrition
1118858|NCT02440165|nurse|nurse
1118859|NCT02440165|intervention|intervention
1118860|NCT02440165|malnutrition|malnutrition
1118861|NCT02440126|Multiple Sclerosis|multiple sclerosis
1118862|NCT02440126|immunological|immunological
1118863|NCT02440126|biomarkers|biomarkers
1118864|NCT02440126|observational|observational
1118865|NCT02440126|Relapsing|relapsing
1118866|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
1118867|NCT02440100|Phase 1|phase 1
1118868|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
1118869|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
1118870|NCT02440100|plasma and CSF abeta|plasma and csf abeta
1118871|NCT02440100|drug interaction|drug interaction
1118872|NCT02440074|Lumbar pain|lumbar pain
1118873|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
1118874|NCT02440061|Ghrelin|ghrelin
1118875|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
1118876|NCT02440048|extraction|extraction
1118877|NCT02440048|Bond Apatite|bond apatite
1118878|NCT02440035|Healthy Participants|healthy participants
1118879|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
1118880|NCT02440035|JNJ-61187191|jnj-61187191
1118881|NCT02439996|Kawasaki disease IVIG|kawasaki disease ivig
1118882|NCT02439970|kidney transplant allograft|kidney transplant allograft
1118883|NCT02439970|recipients|recipients
1118884|NCT02439944|Nicotine Patch|nicotine patch
1118885|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
1118886|NCT02439944|Smoking Cessation|smoking cessation
1118887|NCT02439944|Quit Smoking|quit smoking
1118888|NCT02439944|Abstinence|abstinence
1118889|NCT02439944|Dependence|dependence
1118890|NCT02439944|Nicotine|nicotine
1118891|NCT02439944|Tobacco|tobacco
1118892|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
1118893|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1118894|NCT02439944|Neuroimaging|neuroimaging
1118895|NCT02439944|Cue Reactivity|cue reactivity
1118896|NCT02439944|Resting State|resting state
1118897|NCT02439944|BOLD fMRI|bold fmri
1118898|NCT02439905|inflammatory cytokine|inflammatory cytokine
1118899|NCT02439905|protective effect|protective effect
1118900|NCT02439905|Dexmedetomidine|dexmedetomidine
1118901|NCT02439905|Precedex|precedex
1118902|NCT02439905|one lung ventilation|one lung ventilation
1118903|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
1118904|NCT02439892|Radiotherapy|radiotherapy
1118905|NCT02439892|Exercise|exercise
1118906|NCT02439892|Diet therapy|diet therapy
1118907|NCT02439892|Rehabilitation|rehabilitation
1118908|NCT02439892|Patient Compliance|patient compliance
1118909|NCT02439892|Feasibility Studies|feasibility studies
1118910|NCT02439892|Sample Size|sample size
1118911|NCT02439892|Patient satisfaction|patient satisfaction
1118912|NCT02439853|primary progressive aphasia|primary progressive aphasia
1118913|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
1118914|NCT02439853|progressive aphasia|progressive aphasia
1118915|NCT02439853|frontotemporal dementia|frontotemporal dementia
1118916|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
1118917|NCT02439827|Lifestyle|lifestyle
1118918|NCT02439827|Intervention|intervention
1118919|NCT02439827|Motor Activity|motor activity
1118920|NCT02439827|Mediating Variables|mediating variables
1118921|NCT02439827|Mental Health|mental health
1118923|NCT02439827|Adolescent Health|adolescent health
1118924|NCT02439827|School|school
1118925|NCT02439827|Health Promotion|health promotion
1118926|NCT02439827|Brazil|brazil
1118927|NCT02439801|PEEP|peep
1118928|NCT02439801|compliance|compliance
1118929|NCT02439801|peak airway pressures|peak airway pressures
1118930|NCT02439788|Neuroblastoma|neuroblastoma
1118931|NCT02439788|Natural Killer T Cells|natural killer t cells
1118932|NCT02439788|Gene Therapy|gene therapy
1118933|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
1118934|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
1118935|NCT02439775|Renal denervation|renal denervation
1118936|NCT02439762|Veterans|veterans
1118937|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
1118938|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
1118939|NCT02439749|Renal denervation|renal denervation
1118940|NCT02439736|Traumatic Brain Injury|traumatic brain injury
1118941|NCT02439736|Head Injury|head injury
1118942|NCT02439723|Regorafenib|regorafenib
1118943|NCT02439723|Lean body mass|lean body mass
1118944|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
1118945|NCT02439684|HbA1c|hba1c
1118946|NCT02439684|Diagnostic accuracy|diagnostic accuracy
1118947|NCT02439684|Diabetes Mellitus|diabetes mellitus
1118948|NCT02439684|Chinese|chinese
1118949|NCT02439684|Impaired fasting glucose|impaired fasting glucose
1118950|NCT02439671|Transition Support Program for young adults|transition support program for young adults
1118951|NCT02439658|genetic research|genetic research
1118952|NCT02439645|genetic research|genetic research
1118953|NCT02439606|GlideRite|gliderite
1118954|NCT02439606|Stylet|stylet
1118955|NCT02439606|Parker|parker
1118956|NCT02439606|orotracheal|orotracheal
1118957|NCT02439606|intubation|intubation
1118958|NCT02439606|GlideScope|glidescope
1118960|NCT02439593|chemoradiotherapy|chemoradiotherapy
1118961|NCT02439593|hyperthermia|hyperthermia
1118962|NCT02439580|Patients|patients
1118963|NCT02439580|After Surgery|after surgery
1118964|NCT02439567|Cirrhosis|cirrhosis
1118965|NCT02439567|Chronic hepatitis C|chronic hepatitis c
1118966|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
1118967|NCT02439567|Portal hypertension|portal hypertension
1118968|NCT02439567|Elastography|elastography
1118969|NCT02439567|Antiviral therapy|antiviral therapy
1118970|NCT02439541|cellular therapy|cellular therapy
1118971|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
1118972|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
1118973|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
1118974|NCT02439541|ischemic heart disease|ischemic heart disease
1118975|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1118976|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
1118977|NCT02439528|syndrome|syndrome
1118978|NCT02439528|genetic|genetic
1118979|NCT02439528|emphysema|emphysema
1118980|NCT02439515|post-acute stroke|post-acute stroke
1118981|NCT02439515|functional electrical stimulation|functional electrical stimulation
1118982|NCT02439515|biofeedback|biofeedback
1118983|NCT02439515|balance|balance
1118984|NCT02439515|cycling|cycling
1118985|NCT02439515|rehabilitation|rehabilitation
1118986|NCT02439515|gait|gait
1118987|NCT02439476|Multiple myeloma|multiple myeloma
1118988|NCT02439476|ASCT|asct
1118989|NCT02439476|plerixafor|plerixafor
1118990|NCT02439476|stem cell mobilization|stem cell mobilization
1118991|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
1118992|NCT02439450|lung|lung
1118993|NCT02439450|cancer|cancer
1118994|NCT02439450|gp96|gp96
1118995|NCT02439450|vaccine|vaccine
1118996|NCT02439450|immunotherapy|immunotherapy
1118997|NCT02439450|Heat Biologics|heat biologics
1118998|NCT02439450|Nivolumab|nivolumab
1118999|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
1119000|NCT02439385|Curcumin|curcumin
1119001|NCT02439385|Avastin|avastin
1119002|NCT02439385|FOLFIRI|folfiri
1119003|NCT02439385|Colorectal cancer|colorectal cancer
1119004|NCT02439385|Unresectable metastasis|unresectable metastasis
1119005|NCT02439346|Advanced solid tumors|advanced solid tumors
1119006|NCT02439346|Docetaxel|docetaxel
1119007|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
1119008|NCT02439346|Taxanes|taxanes
1119009|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
1119010|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
1119011|NCT02439333|Nasal high flow therapy|nasal high flow therapy
1119012|NCT02439333|Oxygen therapy|oxygen therapy
1119013|NCT02439307|Rifaximin|rifaximin
1119014|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1119015|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
1119016|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
1119017|NCT02439294|Ventricular remodeling|ventricular remodeling
1119018|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
1119019|NCT02439281|Ropivacaine|ropivacaine
1119020|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
1119021|NCT02439281|clonidine|clonidine
1119022|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
1119023|NCT02439281|rectus sheath block|rectus sheath block
1119024|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
1119025|NCT02439216|Muscular Dystrophies|muscular dystrophies
1119026|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
1119027|NCT02439216|Nervous System Diseases|nervous system diseases
1119028|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
1119029|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
1119030|NCT02439216|DMD|dmd
1119031|NCT02439216|dystrophin|dystrophin
1119032|NCT02439216|dystrophy|dystrophy
1119033|NCT02439216|Duchenne|duchenne
1119034|NCT02439203|Parkinson Disease|parkinson disease
1119035|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
1119036|NCT02439203|Dyskinesia|dyskinesia
1119037|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
1119038|NCT02439177|System Accuracy|system accuracy
1119039|NCT02439164|sedation|sedation
1119040|NCT02439164|eloquent area glioma|eloquent area glioma
1119041|NCT02439164|neurologic function|neurologic function
1119042|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1119043|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1119044|NCT02439125|levodopa|levodopa
1119045|NCT02439125|dyskinesia|dyskinesia
1119046|NCT02439125|parkinsons disease|parkinsons disease
1119047|NCT02439125|PD|pd
1119048|NCT02439112|Exercise|exercise
1119049|NCT02439112|Physical Function|physical function
1119050|NCT02439112|Physical Activity|physical activity
1119051|NCT02439112|Quality of Life|quality of life
1119052|NCT02439112|Pain|pain
1119053|NCT02439112|Bone Disease|bone disease
1119054|NCT02439086|rectal cancer|rectal cancer
1119055|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1119056|NCT02439086|long course radiotherapy|long course radiotherapy
1119057|NCT02439086|response|response
1119058|NCT02439047|reconstructive surgery|reconstructive surgery
1119059|NCT02439047|abdominal surgery|abdominal surgery
1119060|NCT02439034|pain management|pain management
1119061|NCT02439034|brachytherapy|brachytherapy
1119062|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
1119063|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
1119064|NCT02438969|Alcohol|alcohol
1119065|NCT02438969|Alcohol Dependence|alcohol dependence
1119066|NCT02438969|Stress|stress
1119067|NCT02438969|Fear Conditioning|fear conditioning
1119068|NCT02438917|Hepatitis C|hepatitis c
1119069|NCT02438917|Cirrhosis|cirrhosis
1119070|NCT02438917|Biomarkers|biomarkers
1119071|NCT02438917|Fibrosis|fibrosis
1119072|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
1119073|NCT02438904|Stem cell transplantation|stem cell transplantation
1119074|NCT02438904|SCT|sct
1119075|NCT02438904|Poor graft function|poor graft function
1119076|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
1119077|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
1119078|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
1119079|NCT02438865|Epirubicin|epirubicin
1119080|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
1119081|NCT02438800|Postpartum Period|postpartum period
1119082|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
1119083|NCT02438787|Ustekinumab|ustekinumab
1119084|NCT02438787|Golimumab|golimumab
1119085|NCT02438787|STELARA|stelara
1119086|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
1119087|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
1119088|NCT02438774|Maize, breast milk|maize, breast milk
1119089|NCT02438774|child growth, Tanzania|child growth, tanzania
1119090|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
1119091|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
1119092|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
1119093|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
1119094|NCT02438735|ovarian endometriomas|ovarian endometriomas
1119095|NCT02438735|AMH|amh
1119096|NCT02438735|ovarian reserve|ovarian reserve
1119097|NCT02438670|Artificial Pancreas|artificial pancreas
1119098|NCT02438670|Type 1 Diabetes|type 1 diabetes
1119099|NCT02438670|MPC|mpc
1119100|NCT02438670|PID|pid
1119101|NCT02438631|placenta|placenta
1119102|NCT02438631|placental passage|placental passage
1119103|NCT02438605|Nellix|nellix
1119104|NCT02438605|EVAS|evas
1119105|NCT02438605|EVAR|evar
1119106|NCT02438605|Dynamic CT|dynamic ct
1119107|NCT02438605|Dyna CT|dyna ct
1119108|NCT02438592|Continuum of care|continuum of care
1119109|NCT02438579|Hypertonic saline|hypertonic saline
1119110|NCT02438579|nasal irrigation|nasal irrigation
1119111|NCT02438579|gargling|gargling
1119112|NCT02438579|URTI|urti
1119113|NCT02438566|Tranexamic Acid|tranexamic acid
1119114|NCT02438566|Blood Loss|blood loss
1119115|NCT02438566|Total Hip Replacement|total hip replacement
1119116|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
1119117|NCT02438540|acupuncture|acupuncture
1119119|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
1119120|NCT02438540|insulin sensitivity|insulin sensitivity
1119121|NCT02438540|metformin|metformin
1119122|NCT02438540|inflammatory factor|inflammatory factor
1119123|NCT02438540|adipokines|adipokines
1119124|NCT02438540|lipid profile|lipid profile
1119125|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
1119126|NCT02438501|recurrent|recurrent
1119127|NCT02438501|advanced|advanced
1119128|NCT02438501|follicular lymphoma|follicular lymphoma
1119129|NCT02438462|Pulmonary Embolism|pulmonary embolism
1119130|NCT02438462|Soluble Fibrin|soluble fibrin
1119131|NCT02438462|D-Dimers|d-dimers
1119132|NCT02438462|Clinical Probability Score|clinical probability score
1119134|NCT02438449|breast reconstruction|breast reconstruction
1119135|NCT02438449|mastectomy|mastectomy
1119136|NCT02438449|health-related quality of life|health-related quality of life
1119137|NCT02438449|Health Utilities Index|health utilities index
1119138|NCT02438449|HUI|hui
1119139|NCT02438449|prospective|prospective
1119140|NCT02438449|quality-adjusted life years|quality-adjusted life years
1119141|NCT02438449|QALY|qaly
1119142|NCT02438410|infliximab|infliximab
1119143|NCT02438410|remicade|remicade
1119144|NCT02438410|IBD|ibd
1119145|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
1119146|NCT02438371|pregnancy|pregnancy
1119147|NCT02438371|preterm labor|preterm labor
1119148|NCT02438371|tocolysis|tocolysis
1119149|NCT02438293|rhinovirus|rhinovirus
1119150|NCT02438293|cardiac surgery|cardiac surgery
1119151|NCT02438293|paediatric|paediatric
1119152|NCT02438293|respiratory infection|respiratory infection
1119153|NCT02438293|children|children
1119154|NCT02438280|Orthodontic|orthodontic
1119155|NCT02438280|Orthodontic treatment|orthodontic treatment
1119757|NCT02434601|Dentin|dentin
1119156|NCT02438280|Accelerated orthodontics|accelerated orthodontics
1119157|NCT02438280|Vibration|vibration
1119158|NCT02438241|Pain Measurement|pain measurement
1119159|NCT02438241|Electric Stimulation|electric stimulation
1119160|NCT02438241|Spirometry|spirometry
1119161|NCT02438241|Manometry|manometry
1119162|NCT02438228|cardiac output|cardiac output
1119163|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
1119164|NCT02438228|pulse contour analysis|pulse contour analysis
1119165|NCT02438228|G09.330.380.124|g09.330.380.124
1119166|NCT02438215|PD|pd
1119167|NCT02438215|Parkinson's Disease|parkinson's disease
1119168|NCT02438189|Type 1 Diabetes|type 1 diabetes
1119169|NCT02438189|Hypoglycemia|hypoglycemia
1119170|NCT02438189|Hyperglycemia|hyperglycemia
1119171|NCT02438189|Artificial Pancreas|artificial pancreas
1119172|NCT02438163|Theta Burst Stimulation|theta burst stimulation
1119173|NCT02438150|Disaster|disaster
1119174|NCT02438150|Training|training
1119175|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
1119176|NCT02438137|OSA|osa
1119177|NCT02438137|sleep apnea|sleep apnea
1119178|NCT02438137|snoring|snoring
1119179|NCT02438137|dimethyl fumarate|dimethyl fumarate
1119180|NCT02438137|CPAP|cpap
1119181|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
1119182|NCT02438124|Parkinson's disease|parkinson's disease
1119183|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
1119184|NCT02438124|Gait|gait
1119185|NCT02438098|Rivaroxaban|rivaroxaban
1119186|NCT02438098|Obesity|obesity
1119187|NCT02438098|Bariatric surgery|bariatric surgery
1119188|NCT02438098|Pharmacokinetics|pharmacokinetics
1119189|NCT02438098|Pharmacodynamics|pharmacodynamics
1119190|NCT02438085|acute coronary syndromes|acute coronary syndromes
1119191|NCT02438085|outcome|outcome
1119192|NCT02438085|medical management|medical management
1119193|NCT02438085|comorbidities|comorbidities
1119194|NCT02438085|registry|registry
1119195|NCT02438072|antidepressive agent|antidepressive agent
1119196|NCT02438072|drug metabolism|drug metabolism
1119197|NCT02438072|CYP450|cyp450
1119198|NCT02438072|P-glycoprotein|p-glycoprotein
1119199|NCT02438072|Phenotypic study|phenotypic study
1119200|NCT02438059|Inequality in health|inequality in health
1119201|NCT02438059|workplace health promotion|workplace health promotion
1119202|NCT02438059|internet|internet
1119203|NCT02438059|mobile app|mobile app
1119204|NCT02438059|weight loss|weight loss
1119205|NCT02438059|intervention|intervention
1119206|NCT02438059|randomized controlled trial|randomized controlled trial
1119207|NCT02438046|Connective Tissue Grafts|connective tissue grafts
1119208|NCT02438046|Wound healing|wound healing
1119209|NCT02438046|Biomaterials|biomaterials
1119210|NCT02438046|Pain|pain
1119211|NCT02438046|Clinical Trials|clinical trials
1119212|NCT02438046|Mucogingival Surgery|mucogingival surgery
1119213|NCT02438033|Deep Brain Stimulation|deep brain stimulation
1119214|NCT02438033|Globus Pallidus|globus pallidus
1119215|NCT02438033|GPi|gpi
1119216|NCT02438033|PC+S|pc+s
1119217|NCT02438020|Acanthosis nigricans|acanthosis nigricans
1119218|NCT02438020|obesity|obesity
1119219|NCT02438020|children|children
1119220|NCT02438020|metformin|metformin
1119221|NCT02437942|Athletic injuries|athletic injuries
1119222|NCT02437942|chronic|chronic
1119223|NCT02437942|rehabilitation|rehabilitation
1119224|NCT02437942|diagnosis|diagnosis
1119225|NCT02437942|biomechanics|biomechanics
1119226|NCT02437916|Melanoma|melanoma
1119227|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1119228|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
1119229|NCT02437916|Carcinoma|carcinoma
1119230|NCT02437916|Head and Neck|head and neck
1119231|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
1119232|NCT02437916|Bladder|bladder
1119233|NCT02437916|Colorectal|colorectal
1119234|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
1119235|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
1119236|NCT02437877|Respiration|respiration
1119237|NCT02437877|Learning|learning
1119238|NCT02437877|Speech|speech
1119239|NCT02437877|Language and Hearing Sciences|language and hearing sciences
1119240|NCT02437799|Pulse oximeter|pulse oximeter
1119241|NCT02437799|Caesarean section|caesarean section
1119242|NCT02437799|hypotension|hypotension
1119243|NCT02437799|Spinal anaesthesia|spinal anaesthesia
1119245|NCT02437747|clinical trial|clinical trial
1119246|NCT02437708|regenerative endodontics|regenerative endodontics
1119247|NCT02437708|platelet rich fibrin|platelet rich fibrin
1119248|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
1119249|NCT02437695|Trendelenburg Position|trendelenburg position
1119250|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
1119251|NCT02437682|Proton pump inhibitor|proton pump inhibitor
1119252|NCT02437669|Intranasal|intranasal
1119253|NCT02437669|Hydromorphone|hydromorphone
1119254|NCT02437669|Pediatric|pediatric
1119255|NCT02437669|Emergency department|emergency department
1119256|NCT02437656|Radiochemotherapy|radiochemotherapy
1119257|NCT02437656|Metformin|metformin
1119258|NCT02437656|Rectal cancer|rectal cancer
1119259|NCT02437617|Advanced cancers|advanced cancers
1119260|NCT02437617|Tumor tissue|tumor tissue
1119261|NCT02437617|Genomic profile test|genomic profile test
1119262|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
1119263|NCT02437617|Molecular profiling|molecular profiling
1119264|NCT02437617|Molecular alteration|molecular alteration
1119265|NCT02437591|ASP2819|asp2819
1119266|NCT02437591|PAR-101|par-101
1119267|NCT02437591|OPT-80|opt-80
1119268|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1119269|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
1119270|NCT02437591|fidaxomicin|fidaxomicin
1119271|NCT02437591|Dificlir|dificlir
1119272|NCT02437578|vitamin d|vitamin d
1119273|NCT02437578|fertility|fertility
1119274|NCT02437578|markers|markers
1119275|NCT02437578|endocrine disruption|endocrine disruption
1119276|NCT02437578|reproduction|reproduction
1119277|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
1119278|NCT02437526|Cure|cure
1119279|NCT02437526|Analytic treatment interruption|analytic treatment interruption
1119280|NCT02437513|Dysphagia|dysphagia
1119281|NCT02437513|Aspiration|aspiration
1119282|NCT02437513|Laryngeal cancer|laryngeal cancer
1119283|NCT02437474|vegan diet|vegan diet
1119284|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
1119285|NCT02437474|cancer|cancer
1119286|NCT02437474|tumor remission|tumor remission
1119287|NCT02437461|knee synovitis|knee synovitis
1119288|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
1119289|NCT02437461|treatment response|treatment response
1119290|NCT02437448|Mass spectrometry|mass spectrometry
1119291|NCT02437448|Exhaled breath analysis|exhaled breath analysis
1119292|NCT02437435|assisted reproduction|assisted reproduction
1119293|NCT02437435|physical therapy|physical therapy
1119294|NCT02437435|manual therapy|manual therapy
1119295|NCT02437435|uterine artery|uterine artery
1119296|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
1119297|NCT02437435|Doppler ultrasonography|doppler ultrasonography
1119298|NCT02437435|vocal|vocal
1119299|NCT02437409|Ischemic, Acute|ischemic, acute
1119300|NCT02437357|Psychotherapy, Group|psychotherapy, group
1119301|NCT02437357|Metacognition|metacognition
1119302|NCT02437357|Cognitive Bias|cognitive bias
1119303|NCT02437331|Advanced heart failure|advanced heart failure
1119304|NCT02437331|diseased experience|diseased experience
1119305|NCT02437318|HR+|hr+
1119306|NCT02437318|HER2-negative|her2-negative
1119307|NCT02437318|advanced breast cancer|advanced breast cancer
1119308|NCT02437318|alpelisib|alpelisib
1119309|NCT02437318|fulvestrant|fulvestrant
1119310|NCT02437318|PI3K|pi3k
1119311|NCT02437318|Phase III|phase iii
1119312|NCT02437318|ER+|er+
1119313|NCT02437318|PgR+|pgr+
1119314|NCT02437318|men|men
1119315|NCT02437318|postmenopausal|postmenopausal
1119316|NCT02437318|aromatase inhibitor|aromatase inhibitor
1119317|NCT02437318|neoplasms|neoplasms
1119318|NCT02437305|Melanoma|melanoma
1119319|NCT02437305|People of Color|people of color
1119320|NCT02437279|Palpable|palpable
1119321|NCT02437279|Stage III|stage iii
1119322|NCT02437279|Skin melanoma|skin melanoma
1119323|NCT02437279|Ipilimumab|ipilimumab
1119324|NCT02437279|Nivolumab|nivolumab
1119325|NCT02437279|Surgery|surgery
1119326|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
1119327|NCT02437253|Inflammation|inflammation
1119328|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
1119329|NCT02437240|Pilates-based exercise|pilates-based exercise
1119330|NCT02437240|respiratory mechanics|respiratory mechanics
1119331|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
1119332|NCT02437240|sternotomy|sternotomy
1119333|NCT02437175|pelvic pain|pelvic pain
1119334|NCT02437175|quality of life|quality of life
1119335|NCT02437175|adenomyosis|adenomyosis
1119336|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
1119337|NCT02437162|Ustekinumab|ustekinumab
1119338|NCT02437162|Golimumab|golimumab
1119339|NCT02437162|Stelara|stelara
1119340|NCT02437149|Texting and driving|texting and driving
1119341|NCT02437149|Teenager and driving|teenager and driving
1119342|NCT02437149|Distracted Driving Campaign|distracted driving campaign
1119343|NCT02437123|mHealth|mhealth
1119344|NCT02437123|Indigenous|indigenous
1119345|NCT02437123|HIV prevention|hiv prevention
1119346|NCT02437123|substance use|substance use
1119347|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1119348|NCT02437110|Virus|virus
1119349|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
1119350|NCT02437071|Radiotherapy|radiotherapy
1119351|NCT02437071|Ablation|ablation
1119352|NCT02437071|Pembrolizumab|pembrolizumab
1119353|NCT02437071|15-069|15-069
1119354|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
1119355|NCT02437032|GDF-9|gdf-9
1119356|NCT02437032|BMP-15|bmp-15
1119357|NCT02437032|Steroids|steroids
1119358|NCT02437032|Apoptosis rate|apoptosis rate
1119359|NCT02437032|Endocrinology|endocrinology
1119360|NCT02437019|PCI-32765|pci-32765
1119361|NCT02437019|Ibrutinib|ibrutinib
1119362|NCT02437019|Early access program|early access program
1119363|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1119364|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
1119365|NCT02437006|stroke|stroke
1119366|NCT02437006|exercise capacity|exercise capacity
1119367|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
1119368|NCT02436993|Carboplatin|carboplatin
1119369|NCT02436993|Paclitaxel|paclitaxel
1119370|NCT02436993|Pertuzumab|pertuzumab
1119371|NCT02436993|Trastuzumab|trastuzumab
1119372|NCT02436993|Bevacizumab|bevacizumab
1119373|NCT02436980|premedication|premedication
1119374|NCT02436980|ERCP|ercp
1119375|NCT02436980|midazolam|midazolam
1119376|NCT02436980|tramadol|tramadol
1119377|NCT02436980|cognitive|cognitive
1119378|NCT02436928|H7N9 Influenza|h7n9 influenza
1119379|NCT02436928|Avian influenza A|avian influenza a
1119380|NCT02436928|cell culture derived|cell culture derived
1119381|NCT02436915|Slow gait|slow gait
1119382|NCT02436915|Executive function|executive function
1119383|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
1119384|NCT02436876|Osteosynthesis|osteosynthesis
1119385|NCT02436876|Complications|complications
1119386|NCT02436876|Infection or Inflammation|infection or inflammation
1119387|NCT02436876|Orthopedic|orthopedic
1119388|NCT02436876|Device|device
1119389|NCT02436876|Fracture|fracture
1119390|NCT02436876|Osteomyelitis|osteomyelitis
1119391|NCT02436863|Laminectomy|laminectomy
1119392|NCT02436863|Laminoplasty|laminoplasty
1119393|NCT02436863|Internal fixation|internal fixation
1119394|NCT02436863|deformity|deformity
1119395|NCT02436850|Thoracentesis|thoracentesis
1119396|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
1119397|NCT02436850|Ultrasound|ultrasound
1119398|NCT02436850|Soroka University Medical Center|soroka university medical center
1119399|NCT02436850|Physical Examination|physical examination
1119400|NCT02436850|Ethical Committee|ethical committee
1119401|NCT02436824|topical patch|topical patch
1119402|NCT02436824|chronic low back pain|chronic low back pain
1119403|NCT02436811|Health literacy|health literacy
1119404|NCT02436811|Pregnant women|pregnant women
1119405|NCT02436811|Feeding behaviour|feeding behaviour
1119406|NCT02436811|Oral health|oral health
1119407|NCT02436811|Child|child
1119408|NCT02436798|QT prolongation|qt prolongation
1119409|NCT02436798|Genomic biomarkers|genomic biomarkers
1119410|NCT02436785|music therapy|music therapy
1119411|NCT02436785|pain management|pain management
1119412|NCT02436785|self efficacy|self efficacy
1119413|NCT02436785|patient education|patient education
1119414|NCT02436785|relaxation|relaxation
1119415|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
1119416|NCT02436746|Bourneville's disease|bourneville's disease
1119417|NCT02436746|Cognitive variability|cognitive variability
1119418|NCT02436746|Loss of heterozygosity|loss of heterozygosity
1119419|NCT02436733|pleural mesothelioma|pleural mesothelioma
1119420|NCT02436733|phase II|phase ii
1119421|NCT02436733|randomized|randomized
1119422|NCT02436733|surgery|surgery
1119423|NCT02436733|chemotherapy|chemotherapy
1119424|NCT02436733|feasibility|feasibility
1119425|NCT02436694|Dexamethasone|dexamethasone
1119426|NCT02436694|Perineural|perineural
1119427|NCT02436655|aortic stenosis|aortic stenosis
1119428|NCT02436655|normal ejection fraction|normal ejection fraction
1119429|NCT02436655|asymptomatic|asymptomatic
1119430|NCT02436629|Red beetroot juice|red beetroot juice
1119431|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
1119432|NCT02436629|Nitrite|nitrite
1119433|NCT02436629|Soccer|soccer
1119434|NCT02436616|EEG|eeg
1119435|NCT02436616|Preterm Infants|preterm infants
1119436|NCT02436616|Neonate|neonate
1119437|NCT02436616|wireless|wireless
1119438|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
1119439|NCT02436603|IBS|ibs
1119440|NCT02436603|Mind-Body Training|mind-body training
1119441|NCT02436603|Integrative Medicine|integrative medicine
1119442|NCT02436603|FODMAP|fodmap
1119443|NCT02436590|osteoarthritis|osteoarthritis
1119444|NCT02436590|knee|knee
1119445|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
1119446|NCT02436590|PEMF|pemf
1119447|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
1119448|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
1119449|NCT02436577|bioequivalence|bioequivalence
1119450|NCT02436577|Phase I|phase i
1119451|NCT02436577|healthy Japanese subjects|healthy japanese subjects
1119452|NCT02436564|pancreas|pancreas
1119453|NCT02436564|stem cells|stem cells
1119454|NCT02436564|tumours|tumours
1119455|NCT02436564|in vitro models|in vitro models
1119456|NCT02436564|organoids|organoids
1119457|NCT02436564|cancer,|cancer,
1119458|NCT02436564|bile duct|bile duct
1119459|NCT02436564|liver|liver
1119460|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
1119461|NCT02436538|Mullerian anomalies|mullerian anomalies
1119462|NCT02436538|ICSI|icsi
1119463|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
1119464|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
1119465|NCT02436395|gastric cancer|gastric cancer
1119466|NCT02436395|gastrectomy|gastrectomy
1119467|NCT02436395|laparotomy|laparotomy
1119468|NCT02436395|SSIs|ssis
1119469|NCT02436395|povidone-iodine|povidone-iodine
1119470|NCT02436395|normal saline|normal saline
1119471|NCT02436369|diabetic patients|diabetic patients
1119472|NCT02436369|flaxseed|flaxseed
1119473|NCT02436369|lipid profile|lipid profile
1119474|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
1119475|NCT02436343|left ventricular functions|left ventricular functions
1119476|NCT02436343|pregnancy|pregnancy
1119477|NCT02436343|obesity|obesity
1119478|NCT02436330|Exergaming, Weight management|exergaming, weight management
1119479|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
1119480|NCT02436317|Soroka University Medical Center|soroka university medical center
1119481|NCT02436317|Heart Failure|heart failure
1119482|NCT02436317|cardiovascular|cardiovascular
1119483|NCT02436278|Gait speed|gait speed
1119484|NCT02436278|Mortality|mortality
1119485|NCT02436278|Morbidity|morbidity
1119486|NCT02436265|Neuraxial|neuraxial
1119487|NCT02436265|Caudal|caudal
1119488|NCT02436265|Block|block
1119489|NCT02436265|Anesthesia|anesthesia
1119490|NCT02436265|Dexamethasone|dexamethasone
1119491|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
1119492|NCT02436252|MDS|mds
1119493|NCT02436226|PCOS|pcos
1119494|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
1119495|NCT02436226|HCG|hcg
1119496|NCT02436213|workload|workload
1119497|NCT02436213|oxygen level|oxygen level
1119498|NCT02436213|oxygen consumption|oxygen consumption
1119499|NCT02436213|breathing reserve|breathing reserve
1119500|NCT02436213|ventilatory efficiency|ventilatory efficiency
1119501|NCT02436200|Intermittent Claudication|intermittent claudication
1119502|NCT02436200|IC|ic
1119503|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
1119504|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
1119505|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1119506|NCT02436187|NSTEMI|nstemi
1119507|NCT02436187|excess mortality|excess mortality
1119508|NCT02436187|evidence-based care|evidence-based care
1119509|NCT02436187|MINAP|minap
1119510|NCT02436161|Heart Failure|heart failure
1119511|NCT02436161|Comorbidity|comorbidity
1119512|NCT02436161|Patient Care Management|patient care management
1119513|NCT02436161|Primary Health Care|primary health care
1119514|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
1119515|NCT02436148|PEQ validation study, Finland|peq validation study, finland
1119516|NCT02436122|Prostate cancer|prostate cancer
1119517|NCT02436122|Preoperative|preoperative
1119518|NCT02436122|Glycemic control|glycemic control
1119519|NCT02436122|Hemoglobin A1c|hemoglobin a1c
1119520|NCT02436122|Pathologic outcomes|pathologic outcomes
1119521|NCT02436122|Oncological outcomes|oncological outcomes
1119522|NCT02436122|Treatment Outcome|treatment outcome
1119523|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
1119524|NCT02436096|Pain|pain
1119525|NCT02436096|Sleep|sleep
1119526|NCT02436070|Pediatrics|pediatrics
1119527|NCT02436070|Emergency Medicine|emergency medicine
1119528|NCT02436070|Text messaging|text messaging
1119529|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
1119530|NCT02436044|Locally advanced stge|locally advanced stge
1119531|NCT02436044|HAIC|haic
1119532|NCT02436044|FOLFOX4|folfox4
1119533|NCT02436044|Locally advanced|locally advanced
1119534|NCT02436018|Sedation|sedation
1119535|NCT02436018|Low pulse oximetry|low pulse oximetry
1119536|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1119537|NCT02436018|WEI NASAL JET|wei nasal jet
1119538|NCT02435979|wrist|wrist
1119539|NCT02435979|proximal strengthening|proximal strengthening
1119540|NCT02435979|hand therapy|hand therapy
1119541|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
1119542|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
1119543|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
1119544|NCT02435940|Usher|usher
1119545|NCT02435940|Leber|leber
1119546|NCT02435940|Bardet-Biedl|bardet-biedl
1119547|NCT02435940|Batten|batten
1119548|NCT02435940|Best|best
1119549|NCT02435940|cone dystrophy|cone dystrophy
1119550|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
1119551|NCT02435940|choroideremia|choroideremia
1119552|NCT02435940|congenital night blindness|congenital night blindness
1119553|NCT02435940|enhanced s-cone|enhanced s-cone
1119554|NCT02435940|cone monochromacy|cone monochromacy
1119555|NCT02435940|Goldmann-Favre|goldmann-favre
1119556|NCT02435940|Kearns-Sayre|kearns-sayre
1119557|NCT02435940|Refsum|refsum
1119558|NCT02435940|retinoschisis|retinoschisis
1119559|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
1119560|NCT02435940|rod dystrophy|rod dystrophy
1119561|NCT02435940|rod monochromacy|rod monochromacy
1119562|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
1119563|NCT02435940|stargardt|stargardt
1119564|NCT02435940|achromatopsia|achromatopsia
1119565|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
1119566|NCT02435940|cone dichromacy|cone dichromacy
1119567|NCT02435940|cone trichromacy|cone trichromacy
1119568|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
1119569|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
1119570|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
1119571|NCT02435888|Resting energy expenditure|resting energy expenditure
1119572|NCT02435888|Predictive equations|predictive equations
1119573|NCT02435888|Overweight|overweight
1119574|NCT02435875|hypertension|hypertension
1119575|NCT02435875|perioperative|perioperative
1119576|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
1119577|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
1119578|NCT02435849|Pediatric|pediatric
1119579|NCT02435849|ALL|all
1119580|NCT02435849|Cell therapy|cell therapy
1119581|NCT02435810|Neuroinflammation|neuroinflammation
1119582|NCT02435810|Infections|infections
1119583|NCT02435797|nicorandil|nicorandil
1119584|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1119585|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
1119586|NCT02435797|thrombus aspiration|thrombus aspiration
1119587|NCT02435784|2-COM|2-com
1119588|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1119589|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
1119590|NCT02435745|Prevalence|prevalence
1119591|NCT02435745|Aortic Aneurysm|aortic aneurysm
1119592|NCT02435719|HCAIs|hcais
1119593|NCT02435719|Handgel|handgel
1119594|NCT02435719|Hospital|hospital
1119595|NCT02435719|Effectiveness|effectiveness
1119596|NCT02435706|Dental implants|dental implants
1119597|NCT02435706|surgical flap|surgical flap
1119598|NCT02435706|esthetics|esthetics
1119599|NCT02435706|alveolar process|alveolar process
1119600|NCT02435693|pharmaceutical care|pharmaceutical care
1119601|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
1119602|NCT02435667|Resistance Training|resistance training
1119603|NCT02435667|Exercise|exercise
1119604|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
1119605|NCT02435654|Genes Polymorphisms|genes polymorphisms
1119606|NCT02435654|Plasma Concentration|plasma concentration
1119607|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
1119608|NCT02435602|cancer screening|cancer screening
1119609|NCT02435576|Acute toxicity|acute toxicity
1119610|NCT02435576|Late toxicity|late toxicity
1119611|NCT02435576|NTCP models|ntcp models
1119612|NCT02435563|Anti-HIV Agents|anti-hiv agents
1119613|NCT02435563|cardiovascular agents|cardiovascular agents
1119614|NCT02435563|drug interactions|drug interactions
1119615|NCT02435537|analgesia|analgesia
1119616|NCT02435537|intrathecal|intrathecal
1119617|NCT02435537|opioids|opioids
1119618|NCT02435537|morphine|morphine
1119619|NCT02435537|dexmedetomidine|dexmedetomidine
1119620|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
1119621|NCT02435524|Infant Nutrition|infant nutrition
1119622|NCT02435524|Burkina Faso|burkina faso
1119623|NCT02435511|agent-based modeling|agent-based modeling
1120016|NCT02433132|Adults|adults
1119624|NCT02435511|community resources|community resources
1119625|NCT02435511|simulation modeling|simulation modeling
1119626|NCT02435511|information intervention|information intervention
1119627|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
1119628|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
1119629|NCT02435485|rehabilitation|rehabilitation
1119630|NCT02435485|balance|balance
1119631|NCT02435472|Active Surveillance|active surveillance
1119632|NCT02435472|Exercise|exercise
1119633|NCT02435472|Prostate cancer|prostate cancer
1119634|NCT02435472|Life style|life style
1119635|NCT02435472|Survey|survey
1119636|NCT02435472|Personalized exercise|personalized exercise
1119637|NCT02435472|Exercise trainer|exercise trainer
1119638|NCT02435433|liver cancer|liver cancer
1119639|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
1119640|NCT02435420|EMPERION Modular Stem|emperion modular stem
1119641|NCT02435420|Survivorship|survivorship
1119642|NCT02435355|Sleep apnea|sleep apnea
1119643|NCT02435355|education|education
1119644|NCT02435355|compliance|compliance
1119645|NCT02435355|CPAP|cpap
1119646|NCT02435342|ShK-186|shk-186
1119647|NCT02435342|dalazatide|dalazatide
1119648|NCT02435342|psoriasis|psoriasis
1119649|NCT02435342|Kv1.3,|kv1.3,
1119650|NCT02435342|autoimmune|autoimmune
1119651|NCT02435316|Education|education
1119652|NCT02435290|prediction|prediction
1119653|NCT02435290|prescribing error|prescribing error
1119654|NCT02435290|risk factors|risk factors
1119655|NCT02435277|Diabetes|diabetes
1119656|NCT02435212|New formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, PRO, PK, safety, PK/PD, ICL670|new formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, pro, pk, safety, pk/pd, icl670
1119657|NCT02435186|p53 gene|p53 gene
1119658|NCT02435186|chemotherapy|chemotherapy
1119659|NCT02435186|recurrent|recurrent
1119660|NCT02435186|epithelial|epithelial
1119661|NCT02435186|ovarian cancer|ovarian cancer
1119662|NCT02435186|fallopian tube cancer|fallopian tube cancer
1119663|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
1119664|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
1119665|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
1119666|NCT02435095|Schizophrenia|schizophrenia
1119667|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
1119668|NCT02435095|Brain volume|brain volume
1119669|NCT02435095|Antipsychotics|antipsychotics
1119670|NCT02435082|Concussion|concussion
1119671|NCT02435082|Vascular Assessment|vascular assessment
1119672|NCT02435082|Vascular Regulation|vascular regulation
1119673|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
1119674|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
1119675|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
1119676|NCT02435082|Cerebral Blood Flow|cerebral blood flow
1119677|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
1119678|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
1119679|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
1119680|NCT02435069|cecostomy|cecostomy
1119681|NCT02435069|appendicostomy|appendicostomy
1119682|NCT02435056|medication overuse headache|medication overuse headache
1119683|NCT02435056|health care system|health care system
1119684|NCT02435030|NP-C|np-c
1119685|NCT02435030|LSD|lsd
1119686|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
1119687|NCT02435030|lysosomal storage disease|lysosomal storage disease
1119688|NCT02435030|NPC2|npc2
1119689|NCT02435030|NPC1|npc1
1119690|NCT02435030|Niemann-Pick Type C|niemann-pick type c
1119691|NCT02435030|Niemann-Pick,|niemann-pick,
1119692|NCT02435030|Arimoclomol|arimoclomol
1119693|NCT02435017|kidney disease|kidney disease
1119694|NCT02435017|recommended dietary allowances|recommended dietary allowances
1119695|NCT02435017|nutrition assessment|nutrition assessment
1119696|NCT02435017|food|food
1119697|NCT02435017|dietary proteins|dietary proteins
1119698|NCT02435017|Vitamin D|vitamin d
1119699|NCT02435017|dietary fats|dietary fats
1119700|NCT02435017|ethnology|ethnology
1119701|NCT02435017|Continental Population Groups|continental population groups
1119702|NCT02435017|Phosphorus, dietary|phosphorus, dietary
1119703|NCT02435017|Phosphorus/analysis|phosphorus/analysis
1119704|NCT02434991|trouble swallowing|trouble swallowing
1119705|NCT02434991|food sticking|food sticking
1119706|NCT02434991|Achalasia|achalasia
1119707|NCT02434965|Neonates|neonates
1119708|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1119709|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
1119710|NCT02434965|autologous|autologous
1119711|NCT02434952|Malaria, Falciparum|malaria, falciparum
1119712|NCT02434952|G6PD deficiency|g6pd deficiency
1119713|NCT02434952|Primaquine|primaquine
1119714|NCT02434952|Asia|asia
1119715|NCT02434926|fetoscopy|fetoscopy
1119716|NCT02434926|fetal surgery|fetal surgery
1119717|NCT02434926|anesthetic complications|anesthetic complications
1119718|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
1119719|NCT02434913|Arthroplasty|arthroplasty
1119720|NCT02434822|Cholera|cholera
1119721|NCT02434822|Shanchol™|shanchol™
1119722|NCT02434822|Cholera Vaccine|cholera vaccine
1119723|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
1119724|NCT02434809|Radiation|radiation
1119725|NCT02434809|14-225|14-225
1119726|NCT02434796|Intimate Partner Violence|intimate partner violence
1119727|NCT02434796|Gender-Based Violence|gender-based violence
1119728|NCT02434796|Gender|gender
1119729|NCT02434796|HIV|hiv
1119730|NCT02434783|Blood circulation|blood circulation
1119731|NCT02434783|Blood vessels|blood vessels
1119732|NCT02434783|Mitochondria|mitochondria
1119733|NCT02434783|Muscle, skeletal|muscle, skeletal
1119734|NCT02434783|Legs|legs
1119735|NCT02434783|Energy metabolism|energy metabolism
1119736|NCT02434731|Procedural pain|procedural pain
1119737|NCT02434731|Phlebotomy|phlebotomy
1119738|NCT02434731|Intellectual Disability|intellectual disability
1119739|NCT02434731|Child|child
1119740|NCT02434731|Buzzy|buzzy
1119741|NCT02434705|Eosinophilic|eosinophilic
1119742|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
1119743|NCT02434692|POAG|poag
1119744|NCT02434692|Glaucoma|glaucoma
1119745|NCT02434692|Cataract|cataract
1119746|NCT02434692|Surgery|surgery
1119747|NCT02434692|Ocular Pressure|ocular pressure
1119748|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
1119749|NCT02434679|neonatology newborns|neonatology newborns
1119750|NCT02434679|digestive acquisition|digestive acquisition
1119751|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
1119752|NCT02434627|Becker|becker
1119753|NCT02434627|Dystrophy|dystrophy
1119754|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
1119755|NCT02434601|Randomized clinical trial|randomized clinical trial
1119756|NCT02434601|Permanent dental restoration|permanent dental restoration
1119763|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1119764|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
1119765|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
1119766|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
1119767|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
1119768|NCT02434549|Randomized Controlled Trial|randomized controlled trial
1119769|NCT02434549|Placebo Controlled|placebo controlled
1119770|NCT02434549|Double Blinded|double blinded
1119771|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
1119773|NCT02434549|Pain|pain
1119774|NCT02434549|Spasticity|spasticity
1119775|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
1119776|NCT02434549|Dysport|dysport
1119777|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1119778|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
1119779|NCT02434536|Decision Analysis|decision analysis
1119780|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
1119781|NCT02434510|Infection|infection
1119782|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
1119783|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
1119784|NCT02434510|Splash Basins|splash basins
1119785|NCT02434497|LDL-C|ldl-c
1119786|NCT02434497|HoFH|hofh
1119787|NCT02434497|Hyperlipidemia|hyperlipidemia
1119788|NCT02434484|Symbenda|symbenda
1119789|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
1119790|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1119791|NCT02434484|Multiple myeloma|multiple myeloma
1119792|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
1119793|NCT02434458|fibromyalgia,|fibromyalgia,
1119794|NCT02434458|polyneuropathy|polyneuropathy
1119795|NCT02434458|small fiber neuropathy|small fiber neuropathy
1119796|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
1119797|NCT02434458|sudomotor|sudomotor
1119798|NCT02434406|Anxiety|anxiety
1119799|NCT02434406|Anxiety disorders|anxiety disorders
1119800|NCT02434406|Mental health|mental health
1119801|NCT02434406|Postpartum period|postpartum period
1119802|NCT02434406|maternal welfare|maternal welfare
1119803|NCT02434406|internet|internet
1119804|NCT02434406|intervention studies|intervention studies
1119805|NCT02434406|feasibility studies|feasibility studies
1119806|NCT02434406|randomized controlled trial|randomized controlled trial
1119807|NCT02434406|patient acceptance of health care|patient acceptance of health care
1119808|NCT02434393|Depression|depression
1119809|NCT02434393|Late Life Depression|late life depression
1119810|NCT02434393|LLD|lld
1119811|NCT02434393|amyloid imaging|amyloid imaging
1119812|NCT02434393|biomarkers|biomarkers
1119813|NCT02434380|Vitamin D|vitamin d
1119814|NCT02434380|Bone mineral content|bone mineral content
1119815|NCT02434380|Knee-heel length|knee-heel length
1119816|NCT02434380|Middle East|middle east
1119817|NCT02434367|Cancer|cancer
1120122|NCT02432482|Smartphone|smartphone
1119818|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
1119820|NCT02434328|CNV|cnv
1119821|NCT02434328|IVT|ivt
1119822|NCT02434315|Diabetes Mellitus|diabetes mellitus
1119823|NCT02434315|Sensing Technology|sensing technology
1119824|NCT02434289|Older adults|older adults
1119825|NCT02434289|Dietary protein|dietary protein
1119826|NCT02434289|Resistance exercise|resistance exercise
1119827|NCT02434289|Feasibility study|feasibility study
1119828|NCT02434289|Physical functioning|physical functioning
1119829|NCT02434289|Real-life setting|real-life setting
1119830|NCT02434250|Open angle glaucoma|open angle glaucoma
1119831|NCT02434250|Ocular hypertension|ocular hypertension
1119832|NCT02434250|Cataract|cataract
1119833|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
1119834|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
1119835|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
1119836|NCT02434224|Music therapy|music therapy
1119837|NCT02434224|premature infant|premature infant
1119838|NCT02434224|brain development|brain development
1119839|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
1119840|NCT02434198|balance assessment|balance assessment
1119841|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1119842|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
1119843|NCT02434185|Postmenopause|postmenopause
1119844|NCT02434185|Muscle Strength|muscle strength
1119845|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
1119846|NCT02434172|HIV|hiv
1119847|NCT02434172|Cryptococcus|cryptococcus
1119848|NCT02434172|Lateral Flow Assay|lateral flow assay
1119849|NCT02434172|sub-Saharan Africa|sub-saharan africa
1119850|NCT02434172|Screening|screening
1119851|NCT02434172|treatment|treatment
1119852|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
1119853|NCT02434120|MRI|mri
1119854|NCT02434120|Orbital neoplasm|orbital neoplasm
1119855|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1119856|NCT02434107|Lymph Node Excision|lymph node excision
1119857|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1119858|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1119859|NCT02434094|Insulin Pump|insulin pump
1119860|NCT02434094|Human Factors|human factors
1119861|NCT02434094|Focus Group|focus group
1119862|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
1119863|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
1119864|NCT02434081|NSCLC|nsclc
1119865|NCT02434081|IIIA/B|iiia/b
1119866|NCT02434068|kidney calculi|kidney calculi
1119867|NCT02434068|followup studies|followup studies
1119868|NCT02434042|probiotic|probiotic
1119869|NCT02434042|children|children
1119870|NCT02434042|gastrointestinal|gastrointestinal
1119871|NCT02434042|upper respiratory|upper respiratory
1119872|NCT02434016|Diaphragm|diaphragm
1119873|NCT02434016|Mechanical ventilation|mechanical ventilation
1119874|NCT02434003|3D reconstruction|3d reconstruction
1119875|NCT02434003|AIS|ais
1119876|NCT02434003|Computer models|computer models
1119877|NCT02434003|Spinal Deformity|spinal deformity
1119878|NCT02433990|Congenital Heart Disease|congenital heart disease
1119879|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
1119880|NCT02433977|Asthma|asthma
1119881|NCT02433977|Obesity|obesity
1119882|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
1119883|NCT02433977|nitrate|nitrate
1119884|NCT02433977|nitrite|nitrite
1119885|NCT02433977|nutritional supplements|nutritional supplements
1119886|NCT02433964|laser|laser
1119887|NCT02433964|LED|led
1119888|NCT02433964|PRICE|price
1119889|NCT02433964|pain|pain
1119890|NCT02433964|edema|edema
1119891|NCT02433951|exercise tolerance|exercise tolerance
1119892|NCT02433925|resveratrol|resveratrol
1119893|NCT02433925|oxidative stress|oxidative stress
1119894|NCT02433925|inflammation|inflammation
1119895|NCT02433873|Microbiota|microbiota
1119896|NCT02433873|Body weight|body weight
1119897|NCT02433873|Digestive system|digestive system
1119898|NCT02433847|mosapride|mosapride
1119899|NCT02433821|Mechanical Neck Pain|mechanical neck pain
1119900|NCT02433821|Pain|pain
1119901|NCT02433821|Function|function
1119902|NCT02433821|Quality of life|quality of life
1119903|NCT02433821|Pilates|pilates
1119904|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
1119905|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
1119906|NCT02433782|Haemophilia|haemophilia
1119907|NCT02433782|Arthropathy|arthropathy
1119908|NCT02433782|Pain|pain
1119909|NCT02433782|Range of motion|range of motion
1119910|NCT02433782|Miofascial techniques|miofascial techniques
1119911|NCT02433743|HIV/AIDS|hiv/aids
1119912|NCT02433743|RUTF|rutf
1119913|NCT02433743|fat free mass|fat free mass
1119914|NCT02433743|anemia|anemia
1119915|NCT02433743|zinc|zinc
1119916|NCT02433743|Senegal|senegal
1119917|NCT02433717|schizophrenia|schizophrenia
1119918|NCT02433717|schizoaffective disorder|schizoaffective disorder
1119919|NCT02433717|pharmacogenetics|pharmacogenetics
1119920|NCT02433717|pharmacokinetics|pharmacokinetics
1119921|NCT02433717|event-related potentials|event-related potentials
1119922|NCT02433717|paliperidone|paliperidone
1119923|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
1119924|NCT02433691|memory training|memory training
1119925|NCT02433691|cognitive benefits|cognitive benefits
1119926|NCT02433652|Dengue Vaccine|dengue vaccine
1119927|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
1119928|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
1119929|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
1119930|NCT02433574|radiosurgery|radiosurgery
1119931|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
1119932|NCT02433548|Analgesia|analgesia
1119933|NCT02433548|Emergency medicine|emergency medicine
1119934|NCT02433548|Anesthesia, Regional|anesthesia, regional
1119935|NCT02433535|severe asthma|severe asthma
1119936|NCT02433535|simvastatin|simvastatin
1119937|NCT02433535|allergic airway inflammation|allergic airway inflammation
1119938|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
1119939|NCT02433522|Maintenance treatment|maintenance treatment
1119940|NCT02433522|Rituximab|rituximab
1119941|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1119942|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
1119943|NCT02433509|acute ischemic stroke|acute ischemic stroke
1119944|NCT02433509|umbilical cord blood|umbilical cord blood
1119945|NCT02433496|Opioid|opioid
1119946|NCT02433483|Adolescent|adolescent
1119947|NCT02433483|Children|children
1119948|NCT02433483|Microtransplant|microtransplant
1119949|NCT02433483|Leukemia|leukemia
1119950|NCT02433457|Healthy Volunteers|healthy volunteers
1119951|NCT02433457|CC-292|cc-292
1119952|NCT02433457|Open-Label|open-label
1119953|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
1119954|NCT02433457|Phase I|phase i
1119955|NCT02433444|Biosensing Techniques|biosensing techniques
1119956|NCT02433431|mindfulness|mindfulness
1119957|NCT02433431|psychological stress|psychological stress
1119958|NCT02433431|immune marker|immune marker
1119959|NCT02433431|wellness programs|wellness programs
1119960|NCT02433431|mobile applications|mobile applications
1119961|NCT02433431|cortisol|cortisol
1119962|NCT02433405|Serum Amyloid A|serum amyloid a
1119963|NCT02433405|Fetuin-A|fetuin-a
1119964|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
1119965|NCT02433405|serum|serum
1119966|NCT02433405|periodontal diseases|periodontal diseases
1119967|NCT02433392|drug-eluting beads|drug-eluting beads
1119968|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
1119969|NCT02433353|PTSD|ptsd
1119970|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
1119971|NCT02433353|venlafaxine|venlafaxine
1119972|NCT02433353|EMDR|emdr
1119973|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
1119974|NCT02433353|antidepressant|antidepressant
1119975|NCT02433353|psychotherapy|psychotherapy
1119976|NCT02433340|Tolerability|tolerability
1119977|NCT02433340|Methotrexate|methotrexate
1119978|NCT02433340|Safety|safety
1119979|NCT02433327|Paediatric Early Warning System|paediatric early warning system
1119980|NCT02433327|trigger tool|trigger tool
1119981|NCT02433327|screening tool|screening tool
1119982|NCT02433327|risk assessment|risk assessment
1119983|NCT02433327|early recognition|early recognition
1119984|NCT02433301|chemotherapy|chemotherapy
1119985|NCT02433301|GEJ cancer|gej cancer
1119986|NCT02433301|PET/MR-imaging|pet/mr-imaging
1119987|NCT02433288|smart phone-based|smart phone-based
1119988|NCT02433288|rosuvastatin|rosuvastatin
1119989|NCT02433288|duration of treatment|duration of treatment
1119990|NCT02433288|Treatment adherence|treatment adherence
1119991|NCT02433223|outreach nursing|outreach nursing
1119992|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
1119993|NCT02433197|Testicular cancer|testicular cancer
1119994|NCT02433197|Germ cell cancer|germ cell cancer
1119995|NCT02433197|Physical exercise|physical exercise
1119996|NCT02433197|Cancer-related fatigue|cancer-related fatigue
1119997|NCT02433197|Chemotherapy|chemotherapy
1119998|NCT02433197|Clinical rules|clinical rules
1119999|NCT02433197|Metabolomics|metabolomics
1120000|NCT02433184|Etanercept|etanercept
1120001|NCT02433184|treat to target|treat to target
1120002|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
1120003|NCT02433171|regrowth|regrowth
1120004|NCT02433171|radiosurgery|radiosurgery
1120005|NCT02433171|radiation necrosis|radiation necrosis
1120006|NCT02433158|Rivipansel|rivipansel
1120007|NCT02433158|GMI-1070|gmi-1070
1120008|NCT02433158|Selectin Inhibitor|selectin inhibitor
1120009|NCT02433158|SCD|scd
1120010|NCT02433158|VOC|voc
1120011|NCT02433145|ADHD in preschoolers|adhd in preschoolers
1120012|NCT02433145|neuropsychological functions|neuropsychological functions
1120013|NCT02433145|behavior inhibition|behavior inhibition
1120014|NCT02433145|family function and parenting|family function and parenting
1120015|NCT02433132|Cystic fibrosis|cystic fibrosis
1120017|NCT02433132|Atypical form|atypical form
1120018|NCT02433132|Nasal brushing|nasal brushing
1120019|NCT02433132|Epithelial cells|epithelial cells
1120020|NCT02433132|Ion transport|ion transport
1120021|NCT02433106|Balance|balance
1120022|NCT02433106|Exercise|exercise
1120023|NCT02433054|deep vein thrombosis|deep vein thrombosis
1120024|NCT02433054|chronic venous disease|chronic venous disease
1120025|NCT02433054|May-Thurner syndrome|may-thurner syndrome
1120026|NCT02433054|venous stent|venous stent
1120027|NCT02433041|Postoperative delirium|postoperative delirium
1120028|NCT02433041|Cortisol|cortisol
1120029|NCT02433041|NSE|nse
1120030|NCT02433041|S-100beta|s-100beta
1120031|NCT02433041|MMSE|mmse
1120032|NCT02433041|Nu-DESC|nu-desc
1120033|NCT02433041|ICDSC|icdsc
1120034|NCT02433041|DOS|dos
1120035|NCT02433041|Haloperidol|haloperidol
1120036|NCT02433041|Ketamine|ketamine
1120037|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
1120038|NCT02433041|Placebo|placebo
1120039|NCT02433041|Prevention of|prevention of
1120040|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
1120041|NCT02433028|MS New Treatment Options|ms new treatment options
1120042|NCT02433015|Electronic Cigarette|electronic cigarette
1120043|NCT02433002|eGFR|egfr
1120044|NCT02433002|CKD|ckd
1120045|NCT02433002|Cystatin|cystatin
1120046|NCT02433002|Creatinine|creatinine
1120047|NCT02433002|Albuminuria|albuminuria
1120048|NCT02432989|Exercise Therapy|exercise therapy
1120049|NCT02432989|Concussion Management|concussion management
1120050|NCT02432989|Concussion Recovery|concussion recovery
1120051|NCT02432976|Quality of Life|quality of life
1120052|NCT02432976|Cardiac Surgery|cardiac surgery
1120053|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1120054|NCT02432976|Incretin mimetic|incretin mimetic
1120055|NCT02432976|Exenatide|exenatide
1120056|NCT02432937|Corever|corever
1120057|NCT02432937|hypertension|hypertension
1120058|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
1120059|NCT02432885|myocardial fibrosis|myocardial fibrosis
1120060|NCT02432885|muscular dystrophies|muscular dystrophies
1120061|NCT02432820|Prostate Cancer|prostate cancer
1120062|NCT02432768|Anaplerotic diet|anaplerotic diet
1120063|NCT02432768|McArdle Disease|mcardle disease
1120064|NCT02432768|Glycogen Storage Disease|glycogen storage disease
1120065|NCT02432768|Triheptanoin|triheptanoin
1120066|NCT02432755|home-based rehabilitation|home-based rehabilitation
1120067|NCT02432755|stroke|stroke
1120068|NCT02432755|combination therapy|combination therapy
1120069|NCT02432755|client-centered approach|client-centered approach
1120070|NCT02432755|post-acute|post-acute
1120071|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
1120072|NCT02432729|smoking cessation|smoking cessation
1120073|NCT02432729|smoking abstinence|smoking abstinence
1120074|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
1120075|NCT02432729|one year|one year
1120076|NCT02432729|healthy smokers|healthy smokers
1120077|NCT02432729|quit smoking|quit smoking
1120078|NCT02432703|Social Anxiety Disorder|social anxiety disorder
1120079|NCT02432703|JNJ-42165279|jnj-42165279
1120080|NCT02432690|Neoplasms|neoplasms
1120081|NCT02432677|tDCS|tdcs
1120082|NCT02432677|Opioid|opioid
1120083|NCT02432677|Pain|pain
1120084|NCT02432677|Pain threshold|pain threshold
1120085|NCT02432651|oxidative stress|oxidative stress
1120086|NCT02432651|hops|hops
1120087|NCT02432651|xanthohumol|xanthohumol
1120088|NCT02432651|DNA damage|dna damage
1120089|NCT02432651|cancer|cancer
1120090|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
1120091|NCT02432625|Collagen|collagen
1120092|NCT02432625|Brittle Bone Disorder|brittle bone disorder
1120093|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
1120094|NCT02432625|COL1A2|col1a2
1120095|NCT02432599|F18-choline|f18-choline
1120096|NCT02432586|T1DM|t1dm
1120097|NCT02432586|Diabetes|diabetes
1120098|NCT02432586|Child|child
1120099|NCT02432586|Toddler|toddler
1120100|NCT02432573|timing|timing
1120101|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1120103|NCT02432560|rare lung|rare lung
1120104|NCT02432560|Rare Lung Disease|rare lung disease
1120105|NCT02432547|Diabetic|diabetic
1120106|NCT02432547|Macular Oedema|macular oedema
1120107|NCT02432547|Retinopathy|retinopathy
1120108|NCT02432521|stroke|stroke
1120109|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1120110|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
1120111|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
1120112|NCT02432521|Brain Vascular Accident|brain vascular accident
1120113|NCT02432508|acupuncture|acupuncture
1120114|NCT02432508|laser|laser
1120115|NCT02432508|uremic pruritus|uremic pruritus
1120116|NCT02432508|randomized clinical trial|randomized clinical trial
1120117|NCT02432482|Tobacco|tobacco
1120118|NCT02432482|Cigarette|cigarette
1120119|NCT02432482|HIV|hiv
1120120|NCT02432482|Treatment|treatment
1120121|NCT02432482|Mobile|mobile
1120123|NCT02432469|coronary artery bypass|coronary artery bypass
1120124|NCT02432469|medication adherence|medication adherence
1120125|NCT02432469|secondary prevention|secondary prevention
1120126|NCT02432469|mobile applications|mobile applications
1120127|NCT02432443|Motor Skills|motor skills
1120128|NCT02432443|Pre-literacy Skills|pre-literacy skills
1120129|NCT02432443|Early Intervention|early intervention
1120130|NCT02432430|N05.300.150.410|n05.300.150.410
1120131|NCT02432430|practice guideline|practice guideline
1120132|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
1120133|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1120134|NCT02432417|Glioblastoma|glioblastoma
1120135|NCT02432417|Autophagy|autophagy
1120136|NCT02432417|EGFR|egfr
1120137|NCT02432417|EGFRvIII|egfrviii
1120138|NCT02432417|Chloroquine|chloroquine
1120139|NCT02432417|Radiotherapy|radiotherapy
1120140|NCT02432417|Temozolomide|temozolomide
1120141|NCT02432404|HSV-2|hsv-2
1120142|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
1120143|NCT02432365|Paclitaxel|paclitaxel
1120144|NCT02432365|Cisplatin|cisplatin
1120145|NCT02432365|Cervical cancer|cervical cancer
1120146|NCT02432365|Radical hysterectomy|radical hysterectomy
1120147|NCT02432365|Neoadjuvant|neoadjuvant
1120148|NCT02432339|immune system|immune system
1120149|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
1120150|NCT02432326|Neoplasms|neoplasms
1120151|NCT02432300|Traumatic Brain Injury|traumatic brain injury
1120152|NCT02432300|Alexithymia|alexithymia
1120153|NCT02432300|Emotions|emotions
1120154|NCT02432287|aging|aging
1120155|NCT02432287|metformin|metformin
1120156|NCT02432287|prediabetes|prediabetes
1120157|NCT02432274|E7080|e7080
1120158|NCT02432274|Lenvatinib|lenvatinib
1120159|NCT02432274|Solid malignancies|solid malignancies
1120160|NCT02432274|Osteosarcoma|osteosarcoma
1120161|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
1120162|NCT02432261|spermatogenesis|spermatogenesis
1120163|NCT02432261|androgen|androgen
1120164|NCT02432261|male contraception|male contraception
1120165|NCT02432248|DHEA|dhea
1120166|NCT02432248|live birth rate|live birth rate
1120167|NCT02432248|poor ovarian responder|poor ovarian responder
1120168|NCT02432235|Camidanlumab tesirine|camidanlumab tesirine
1120169|NCT02432196|Mitral Valve Repair|mitral valve repair
1120170|NCT02432196|Transapical|transapical
1120171|NCT02432196|artificial chordae|artificial chordae
1120172|NCT02432183|individual|individual
1120173|NCT02432144|MPS 7|mps 7
1120174|NCT02432144|Sly Syndrome|sly syndrome
1120175|NCT02432144|MPS VII|mps vii
1120176|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
1120177|NCT02432144|Rare Disease|rare disease
1120178|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
1120179|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
1120180|NCT02432144|Metabolic Disorder|metabolic disorder
1120181|NCT02432092|Cardiomegaly|cardiomegaly
1120182|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
1120183|NCT02432092|Heart Diseases|heart diseases
1120184|NCT02432092|Systolic dysfunction|systolic dysfunction
1120185|NCT02432092|Diastolic dysfunction|diastolic dysfunction
1120186|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
1120187|NCT02432092|Heart failure|heart failure
1120188|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
1120189|NCT02432079|Asplenia|asplenia
1120190|NCT02432079|Bilary Atresia|bilary atresia
1120191|NCT02432079|Birth Defect|birth defect
1120192|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
1120193|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
1120194|NCT02432079|Congenital Abnormalities|congenital abnormalities
1120195|NCT02432079|Congenital Heart Disease|congenital heart disease
1120196|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
1120197|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
1120198|NCT02432079|Genetics|genetics
1120199|NCT02432079|Genetic Testing|genetic testing
1120200|NCT02432079|Heart Defects, Congenital|heart defects, congenital
1120201|NCT02432079|Heart Diseases|heart diseases
1120202|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
1120203|NCT02432079|Intestinal malrotation|intestinal malrotation
1120204|NCT02432079|Laterality|laterality
1120205|NCT02432079|Left Atrial Isomerism|left atrial isomerism
1120206|NCT02432079|Pediatrics|pediatrics
1120207|NCT02432079|Polysplenia|polysplenia
1120208|NCT02432079|Right Atrial Isomerism|right atrial isomerism
1120209|NCT02432079|Splenic Diseases|splenic diseases
1120210|NCT02432079|Cilia|cilia
1120211|NCT02432079|Situs inversus|situs inversus
1120212|NCT02432079|Dextrocardia|dextrocardia
1120213|NCT02432066|Smoking|smoking
1120214|NCT02432066|Smoking Cessation|smoking cessation
1120215|NCT02432053|FK506|fk506
1120216|NCT02432053|Advagraf|advagraf
1120217|NCT02432053|Tacrolimus|tacrolimus
1120218|NCT02432053|Transplantation|transplantation
1120219|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
1120220|NCT02432040|psoriasis|psoriasis
1120221|NCT02432040|atorvastatin|atorvastatin
1120222|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
1120223|NCT02432040|betamethasone valerate|betamethasone valerate
1120224|NCT02431988|Relapsed|relapsed
1120225|NCT02431988|refractory|refractory
1120226|NCT02431988|DLBCL|dlbcl
1120227|NCT02431975|HIV|hiv
1120228|NCT02431975|infant|infant
1120229|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
1120230|NCT02431975|antiretroviral agents|antiretroviral agents
1120231|NCT02431962|Lung Cancer|lung cancer
1120232|NCT02431962|Screening|screening
1120233|NCT02431962|Computed Tomography|computed tomography
1120234|NCT02431949|Music|music
1120235|NCT02431949|Amusia|amusia
1120236|NCT02431936|Stress|stress
1120237|NCT02431936|Blood Pressure|blood pressure
1120238|NCT02431936|Salt Sensitivity|salt sensitivity
1120239|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
1120240|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
1120241|NCT02431923|Sequelae|sequelae
1120242|NCT02431923|Seroprevalence|seroprevalence
1120243|NCT02431923|Household Contacts|household contacts
1120244|NCT02431910|Electromyography|electromyography
1120245|NCT02431910|Baropodometry|baropodometry
1120246|NCT02431910|Torque|torque
1120247|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
1120248|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
1120249|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
1120250|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
1120251|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
1120252|NCT02431871|Hip dysplasia|hip dysplasia
1120253|NCT02431871|Occlusal defect|occlusal defect
1120254|NCT02431858|Nerve block|nerve block
1120255|NCT02431858|Catheter|catheter
1120256|NCT02431858|Catheter over needle|catheter over needle
1120257|NCT02431858|Femoral Nerve|femoral nerve
1120258|NCT02431858|Anaesthesia|anaesthesia
1120259|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
1120260|NCT02431858|[E02.148]|[e02.148]
1120261|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1120262|NCT02431845|Pharmacogenetics|pharmacogenetics
1120263|NCT02431832|Elderly|elderly
1120264|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
1120265|NCT02431819|Progressive compressive stockings|progressive compressive stockings
1120266|NCT02431793|Opioids|opioids
1120267|NCT02431780|Neonatal Seizures|neonatal seizures
1120962|NCT02428257|elderly|elderly
1120268|NCT02431780|Decision Support Algorithm|decision support algorithm
1120269|NCT02431780|EEG|eeg
1120270|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
1120271|NCT02431728|Melatonin|melatonin
1120272|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
1120273|NCT02431728|Anxiety|anxiety
1120274|NCT02431728|Depression|depression
1120275|NCT02431728|Insomnia|insomnia
1120276|NCT02431728|Stress|stress
1120277|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
1120278|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
1120279|NCT02431702|Oral Antipsychotics|oral antipsychotics
1120280|NCT02431702|Schizophrenia|schizophrenia
1120281|NCT02431702|Psychotic Disorders|psychotic disorders
1120282|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
1120283|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
1120284|NCT02431702|Personal and Social Performance|personal and social performance
1120285|NCT02431702|Disease Modification|disease modification
1120286|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
1120287|NCT02431663|ketamine|ketamine
1120288|NCT02431663|conventional anesthetics|conventional anesthetics
1120289|NCT02431663|children|children
1120290|NCT02431650|Induced blood stage malaria|induced blood stage malaria
1120291|NCT02431650|Transmission|transmission
1120292|NCT02431650|Mosquito feeding|mosquito feeding
1120293|NCT02431650|OZ439|oz439
1120294|NCT02431650|Primaquine|primaquine
1120295|NCT02431650|Piperaquine|piperaquine
1120296|NCT02431650|Artefonomel|artefonomel
1120297|NCT02431637|Induced blood stage malaria|induced blood stage malaria
1120298|NCT02431637|Transmission|transmission
1120299|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
1120300|NCT02431624|Healthy Volunteer|healthy volunteer
1120301|NCT02431585|abdominal pain|abdominal pain
1120302|NCT02431585|gluten free diet|gluten free diet
1120303|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
1120304|NCT02431572|Intracranial Tumors|intracranial tumors
1120305|NCT02431572|Glioblastoma|glioblastoma
1120306|NCT02431572|Melanoma|melanoma
1120307|NCT02431559|Ovarian Cancer|ovarian cancer
1120308|NCT02431559|Motolimod|motolimod
1120309|NCT02431559|Immunotherapy|immunotherapy
1120310|NCT02431559|PD-L1|pd-l1
1120311|NCT02431559|MEDI4736|medi4736
1120312|NCT02431559|Pegylated|pegylated
1120313|NCT02431559|Liposomal|liposomal
1120314|NCT02431559|Doxorubicin|doxorubicin
1120315|NCT02431559|PLD|pld
1120316|NCT02431559|TLR-8|tlr-8
1120317|NCT02431559|Durvalumab|durvalumab
1120318|NCT02431546|Cardiology|cardiology
1120319|NCT02431546|Vascular|vascular
1120320|NCT02431546|CAD|cad
1120321|NCT02431546|Duke|duke
1120322|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
1120323|NCT02431546|Prevention|prevention
1120325|NCT02431546|Mobile Health|mobile health
1120326|NCT02431546|Exercise|exercise
1120327|NCT02431533|IBS-D|ibs-d
1120328|NCT02431533|diarrhea predominant|diarrhea predominant
1120329|NCT02431520|Patient Compliance|patient compliance
1120330|NCT02431520|HPV-DNA probes|hpv-dna probes
1120331|NCT02431520|Papanicolaou test|papanicolaou test
1120332|NCT02431520|Cervical cancer|cervical cancer
1120333|NCT02431507|apnea|apnea
1120334|NCT02431507|sleep apnea|sleep apnea
1120335|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
1120336|NCT02431507|hyoid bone|hyoid bone
1120337|NCT02431455|Bariatric Surgery|bariatric surgery
1120338|NCT02431455|obesity, morbid|obesity, morbid
1120339|NCT02431455|incentive spirometry|incentive spirometry
1120340|NCT02431442|Heterozygous|heterozygous
1120341|NCT02431442|MC4R deficiency|mc4r deficiency
1120342|NCT02431442|associated|associated
1120343|NCT02431429|leishmaniasis|leishmaniasis
1120344|NCT02431429|miltefosine|miltefosine
1120345|NCT02431429|spermiogram|spermiogram
1120346|NCT02431416|females|females
1120347|NCT02431416|ghrelin|ghrelin
1120348|NCT02431416|GnRH|gnrh
1120349|NCT02431416|randomized, controlled study|randomized, controlled study
1120350|NCT02431416|children|children
1120351|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
1120352|NCT02431390|Rehabilitation|rehabilitation
1120353|NCT02431390|Stroke|stroke
1120354|NCT02431390|Upper limbs|upper limbs
1120355|NCT02431377|infant formula|infant formula
1120356|NCT02431364|KPT-335|kpt-335
1120357|NCT02431364|Verdinexor|verdinexor
1120358|NCT02431364|Karyopharm|karyopharm
1120359|NCT02431364|First-in-Human|first-in-human
1120360|NCT02431364|Adult Subjects|adult subjects
1120362|NCT02431351|Karyopharm|karyopharm
1120363|NCT02431351|Selinexor|selinexor
1120364|NCT02431351|SIER|sier
1120365|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1120366|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
1120367|NCT02431351|Refractory|refractory
1120368|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
1120369|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
1120370|NCT02431325|HIV|hiv
1120371|NCT02431325|Atherosclerosis|atherosclerosis
1120372|NCT02431325|Microbial Translocation|microbial translocation
1120373|NCT02431325|Teduglutide|teduglutide
1120374|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
1120375|NCT02431325|Inflammation|inflammation
1120376|NCT02431312|Chronic HBV|chronic hbv
1120377|NCT02431312|immunotherapy|immunotherapy
1120378|NCT02431312|DNA vaccine|dna vaccine
1120379|NCT02431312|electroporation|electroporation
1120380|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
1120381|NCT02431286|emesis, postoperative|emesis, postoperative
1120382|NCT02431273|TDF|tdf
1120383|NCT02431273|FTC|ftc
1120384|NCT02431273|MVC|mvc
1120385|NCT02431273|TDF-FTC|tdf-ftc
1120386|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
1120388|NCT02431273|ARV|arv
1120389|NCT02431260|solid tumor|solid tumor
1120390|NCT02431260|lymphoma|lymphoma
1120391|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
1120392|NCT02431260|BRD|brd
1120393|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1120394|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
1120395|NCT02431260|c-MYC|c-myc
1120396|NCT02431260|colorectal cancer|colorectal cancer
1120397|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
1120398|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1120399|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
1120400|NCT02431260|breast cancer|breast cancer
1120401|NCT02431260|NUT midline carcinoma|nut midline carcinoma
1120402|NCT02431260|leukemia|leukemia
1120403|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1120404|NCT02431260|atypical chronic myeloid leukemia (aCML)|atypical chronic myeloid leukemia (acml)
1120405|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1120406|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
1120407|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
1120408|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
1120409|NCT02431260|CMML|cmml
1120410|NCT02431260|MDS/MPN-U|mds/mpn-u
1120411|NCT02431260|RARS-T|rars-t
1120412|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
1120413|NCT02431247|Darunavir|darunavir
1120414|NCT02431247|Cobicistat|cobicistat
1120415|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
1120416|NCT02431247|Emtricitabine|emtricitabine
1120417|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1120418|NCT02431234|Type 2 diabetes|type 2 diabetes
1120419|NCT02431234|Arterial calcification|arterial calcification
1120420|NCT02431234|Mediacalcosis|mediacalcosis
1120421|NCT02431234|Calcium score|calcium score
1120422|NCT02431221|perhexiline|perhexiline
1120423|NCT02431221|HCM|hcm
1120424|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1120425|NCT02431221|CPEX|cpex
1120426|NCT02431195|obesity|obesity
1120427|NCT02431195|bariatric surgery|bariatric surgery
1120428|NCT02431195|physical activity|physical activity
1120429|NCT02431195|eating habits|eating habits
1120430|NCT02431156|presbyopia|presbyopia
1120431|NCT02431156|monovision|monovision
1120432|NCT02431156|activities of daily living,|activities of daily living,
1120433|NCT02431156|pseudophakic|pseudophakic
1120434|NCT02431130|Training Program|training program
1120435|NCT02431091|Optical Coherence Tomography|optical coherence tomography
1120436|NCT02431078|CTCs|ctcs
1120437|NCT02431078|ZEB1|zeb1
1120438|NCT02431078|gastric cancer|gastric cancer
1120439|NCT02431065|Rectus sheath block|rectus sheath block
1120440|NCT02431065|Single port laparoscopy|single port laparoscopy
1120441|NCT02431026|induced mild hypothermia|induced mild hypothermia
1120442|NCT02431026|cervical cooling collar|cervical cooling collar
1120443|NCT02431026|mri brain thermometry|mri brain thermometry
1120444|NCT02431026|MRI thermometry|mri thermometry
1120445|NCT02431026|rate-of-cooling|rate-of-cooling
1120446|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
1120447|NCT02431013|Drug-drug interaction|drug-drug interaction
1120448|NCT02431013|Pharmacokinetics|pharmacokinetics
1120449|NCT02430961|Critical Care|critical care
1120450|NCT02430961|Palliative Care|palliative care
1120451|NCT02430948|Screening|screening
1120452|NCT02430948|Shared Decision Making|shared decision making
1120453|NCT02430935|Psychosis|psychosis
1120454|NCT02430935|Psychosis NOS|psychosis nos
1120455|NCT02430935|Schizophrenia|schizophrenia
1120456|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
1120457|NCT02430935|Early Intervention|early intervention
1120458|NCT02430896|Neuropsychological|neuropsychological
1120459|NCT02430896|neuroimaging|neuroimaging
1120460|NCT02430896|genetic markers|genetic markers
1120461|NCT02430896|treatment response predictor|treatment response predictor
1120462|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
1120463|NCT02430870|Drug therapy|drug therapy
1120464|NCT02430844|acute kidney injury|acute kidney injury
1120465|NCT02430844|radiographic contrast|radiographic contrast
1120466|NCT02430844|critically ill|critically ill
1120467|NCT02430844|biomarker|biomarker
1120468|NCT02430818|ketamine|ketamine
1120469|NCT02430818|emergency medicine|emergency medicine
1120470|NCT02430818|orthopedics|orthopedics
1120471|NCT02430805|hypertension|hypertension
1120567|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
1120472|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
1120473|NCT02430805|renal disease|renal disease
1120474|NCT02430805|heart failure|heart failure
1120475|NCT02430805|genetics markers|genetics markers
1120476|NCT02430805|genomics markers|genomics markers
1120477|NCT02430805|proteomics markers|proteomics markers
1120478|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
1120479|NCT02430792|Exercise|exercise
1120480|NCT02430792|Football|football
1120481|NCT02430792|Quality of Life|quality of life
1120482|NCT02430779|irreversible electroporation|irreversible electroporation
1120483|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
1120484|NCT02430766|irreversible electroporation|irreversible electroporation
1120485|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
1120486|NCT02430753|irreversible electroporation|irreversible electroporation
1120487|NCT02430753|Lung Neoplasms|lung neoplasms
1120488|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
1120489|NCT02430740|Fertilization in Vitro|fertilization in vitro
1120490|NCT02430740|antagonist protocol|antagonist protocol
1120491|NCT02430740|antral follicle count|antral follicle count
1120492|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
1120493|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
1120494|NCT02430714|Thyroid Cancer|thyroid cancer
1120495|NCT02430714|Lenvima|lenvima
1120496|NCT02430714|Post-marketing surveillance|post-marketing surveillance
1120497|NCT02430714|LEN01T|len01t
1120498|NCT02430714|All-Patient Investigation|all-patient investigation
1120499|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
1120500|NCT02430701|irreversible electroporation|irreversible electroporation
1120501|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
1120502|NCT02430688|irreversible electroporation|irreversible electroporation
1120503|NCT02430688|Unresectable Extremities|unresectable extremities
1120504|NCT02430675|irreversible electroporation|irreversible electroporation
1120505|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
1120506|NCT02430662|irreversible electroporation|irreversible electroporation
1120507|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
1120508|NCT02430649|irreversible electroporation|irreversible electroporation
1120509|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
1120510|NCT02430636|irreversible electroporation|irreversible electroporation
1120511|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
1120512|NCT02430623|irreversible electroporation|irreversible electroporation
1120513|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
1120514|NCT02430610|irreversible electroporation|irreversible electroporation
1120515|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
1120516|NCT02430597|irreversible electroporation|irreversible electroporation
1120517|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
1120518|NCT02430545|Glasdegib|glasdegib
1120519|NCT02430545|PF-04449913|pf-04449913
1120520|NCT02430545|Drug-drug interaction|drug-drug interaction
1120521|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
1120522|NCT02430545|Pharmacokinetics|pharmacokinetics
1120523|NCT02430532|INSPIRE|inspire
1120524|NCT02430532|SPMS|spms
1120525|NCT02430532|Tecfidera|tecfidera
1120526|NCT02430532|BG00012|bg00012
1120527|NCT02430519|Chronic Periodontitis|chronic periodontitis
1120528|NCT02430519|Clinical Parameters|clinical parameters
1120529|NCT02430519|Furcation defects|furcation defects
1120530|NCT02430519|Radiographic bone fill|radiographic bone fill
1120532|NCT02430480|Multiparametric MRI|multiparametric mri
1120533|NCT02430480|Prostatectomy|prostatectomy
1120534|NCT02430480|Focal Prostate Cancer|focal prostate cancer
1120535|NCT02430480|Normal Testosterone|normal testosterone
1120536|NCT02430480|Non Metastatic|non metastatic
1120537|NCT02430454|ICU|icu
1120538|NCT02430454|decision making|decision making
1120539|NCT02430402|Climatotherapy|climatotherapy
1120540|NCT02430389|hemodynamic stability|hemodynamic stability
1120541|NCT02430389|remifentanil|remifentanil
1120542|NCT02430376|Non-Muscle Myosin|non-muscle myosin
1120543|NCT02430363|pembrolizumab|pembrolizumab
1120544|NCT02430363|MK-3475|mk-3475
1120545|NCT02430363|Glioblastoma|glioblastoma
1120546|NCT02430363|Gliosarcoma|gliosarcoma
1120547|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
1174792|NCT02146040|TIA|tia
1120548|NCT02430363|Pictilisib|pictilisib
1120549|NCT02430363|GDC-0941|gdc-0941
1120550|NCT02430363|BEZ235|bez235
1120551|NCT02430363|NVP-BEZ235|nvp-bez235
1120552|NCT02430363|Ipatasertib|ipatasertib
1120553|NCT02430363|GDC-0068|gdc-0068
1120554|NCT02430311|Chinese Patients|chinese patients
1120555|NCT02430285|biliary stone|biliary stone
1120556|NCT02430285|cholelithiasis|cholelithiasis
1120557|NCT02430285|pancreatitis|pancreatitis
1120558|NCT02430285|EUS|eus
1120559|NCT02430285|ERCP|ercp
1120560|NCT02430285|early|early
1120561|NCT02430285|choledocholithiasis|choledocholithiasis
1120562|NCT02430272|Child|child
1120563|NCT02430272|outpatient|outpatient
1120564|NCT02430272|premedication|premedication
1120565|NCT02430259|rifapentine|rifapentine
1120566|NCT02430259|isoniazid|isoniazid
1120568|NCT02430259|tuberculin skin test|tuberculin skin test
1120569|NCT02430207|Pulmonary Embolism|pulmonary embolism
1120570|NCT02430207|Temporary Pacing|temporary pacing
1120571|NCT02430207|Femoral Vein|femoral vein
1120572|NCT02430207|Subclavian Vein|subclavian vein
1120573|NCT02430168|Stone|stone
1120574|NCT02430168|RIRs|rirs
1120575|NCT02430168|PCNL|pcnl
1120576|NCT02430168|Pain|pain
1120577|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
1120578|NCT02430155|Bakri balloon|bakri balloon
1120579|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
1120580|NCT02430142|microcirculation|microcirculation
1120581|NCT02430142|oxygen uptake|oxygen uptake
1120582|NCT02430142|hypoxia|hypoxia
1120583|NCT02430142|adenosine|adenosine
1120584|NCT02430142|central venous saturation|central venous saturation
1120585|NCT02430142|hypoxanthine|hypoxanthine
1120586|NCT02430142|laserdoppler|laserdoppler
1120587|NCT02430103|Breast Cancer|breast cancer
1120588|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
1120589|NCT02430090|regionel anesthesia|regionel anesthesia
1120590|NCT02430090|levobupivacaine|levobupivacaine
1120591|NCT02430090|ceserean section|ceserean section
1120592|NCT02430077|Hepatic Steatosis|hepatic steatosis
1120593|NCT02430051|sensory processing|sensory processing
1120594|NCT02430051|oral care|oral care
1120595|NCT02430051|electrodermal activity|electrodermal activity
1120596|NCT02430051|cooperation|cooperation
1120597|NCT02430051|anxiety|anxiety
1120598|NCT02430051|distress|distress
1120599|NCT02430051|stress|stress
1120600|NCT02430051|behavior|behavior
1120601|NCT02430051|occupational therapy|occupational therapy
1120602|NCT02430038|transperineal ultrasound|transperineal ultrasound
1120603|NCT02430038|labour|labour
1120604|NCT02430038|sonopartogram|sonopartogram
1120605|NCT02430038|prediction model|prediction model
1120606|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
1120607|NCT02430025|Vascular Diseases|vascular diseases
1120608|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
1120609|NCT02430025|Chest Pain|chest pain
1120610|NCT02430025|Heart Diseases|heart diseases
1120611|NCT02430025|Myocardial Ischemia|myocardial ischemia
1120612|NCT02430025|Pathologic Processes|pathologic processes
1120613|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
1120614|NCT02430012|quality improvement|quality improvement
1120615|NCT02430012|secondary preventions|secondary preventions
1120616|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
1120617|NCT02429986|Chronic Heart Failure|chronic heart failure
1120618|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
1120619|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
1120620|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
1121415|NCT02425657|Education|education
1120621|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
1120622|NCT02429986|Periodic Breathing|periodic breathing
1120623|NCT02429973|Osteosarcoma|osteosarcoma
1120624|NCT02429960|Nociception|nociception
1120625|NCT02429960|Analgesia|analgesia
1120626|NCT02429960|Intraoperative|intraoperative
1120627|NCT02429960|Monitoring|monitoring
1120628|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
1120629|NCT02429947|CMT|cmt
1120630|NCT02429947|HMSN|hmsn
1120631|NCT02429947|HMN|hmn
1120632|NCT02429947|HSN|hsn
1120633|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1120634|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
1120635|NCT02429934|Arthritis|arthritis
1120636|NCT02429921|dietary intervention|dietary intervention
1120637|NCT02429921|arsenic poisoning|arsenic poisoning
1120638|NCT02429921|high-Se lentils|high-se lentils
1120639|NCT02429895|Methotrexate|methotrexate
1120640|NCT02429895|Efficacy|efficacy
1120641|NCT02429895|Safety|safety
1120642|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
1120643|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
1120644|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
1174916|NCT02145481|survey|survey
1120645|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1120646|NCT02429843|TRC105|trc105
1120647|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
1120648|NCT02429830|GERD|gerd
1120649|NCT02429830|obesity|obesity
1120650|NCT02429830|LSG|lsg
1120651|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1120652|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
1120653|NCT02429817|SPECT-CT analysis|spect-ct analysis
1120654|NCT02429817|High flow nasal cannula|high flow nasal cannula
1120655|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
1120656|NCT02429817|Jet nebulizer|jet nebulizer
1120657|NCT02429791|two-drug regimen|two-drug regimen
1120658|NCT02429791|virologically-suppressed|virologically-suppressed
1120659|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
1120660|NCT02429791|integrase inhibitor|integrase inhibitor
1120661|NCT02429791|protease inhibitor|protease inhibitor
1120662|NCT02429791|NNRTI-sparing|nnrti-sparing
1120663|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1120664|NCT02429791|HIV|hiv
1120665|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
1120666|NCT02429752|inspiratory muscle training|inspiratory muscle training
1120667|NCT02429752|low back pain|low back pain
1120668|NCT02429752|respiration|respiration
1120669|NCT02429752|breathing|breathing
1120670|NCT02429739|Working Memory Training, computerized|working memory training, computerized
1120671|NCT02429739|Dyslexia|dyslexia
1120672|NCT02429739|Reading fluency|reading fluency
1120673|NCT02429739|Reading comprehension|reading comprehension
1120674|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
1120675|NCT02429713|tourniquet|tourniquet
1120676|NCT02429713|total knee arthroplasty|total knee arthroplasty
1120677|NCT02429713|blood loss|blood loss
1120678|NCT02429674|Depression|depression
1120679|NCT02429674|Adolescence|adolescence
1120680|NCT02429648|AF|af
1120681|NCT02429635|Exercise|exercise
1120682|NCT02429635|lifestyle diseases|lifestyle diseases
1120683|NCT02429635|well-being|well-being
1120684|NCT02429596|antiepileptic drugs|antiepileptic drugs
1120685|NCT02429596|generic substitution|generic substitution
1120686|NCT02429570|meclofenamate|meclofenamate
1120687|NCT02429570|15-068|15-068
1120688|NCT02429557|autonomic failure|autonomic failure
1120689|NCT02429557|orthostatic hypotension|orthostatic hypotension
1120690|NCT02429557|compression garments|compression garments
1120691|NCT02429557|treatment|treatment
1120692|NCT02429544|Breast cancer|breast cancer
1120693|NCT02429544|Stage IV breast cancer|stage iv breast cancer
1120694|NCT02429544|Metastatic|metastatic
1120695|NCT02429544|Residential group programs|residential group programs
1120696|NCT02429544|Questionnaires|questionnaires
1120697|NCT02429544|Surveys|surveys
1120698|NCT02429544|EEG|eeg
1120699|NCT02429544|Computer testing|computer testing
1120700|NCT02429544|Saliva test|saliva test
1120701|NCT02429544|Study diary|study diary
1120702|NCT02429544|Actigraph|actigraph
1120703|NCT02429531|Pneumovax 23|pneumovax 23
1120704|NCT02429531|Typhim Vi|typhim vi
1120705|NCT02429531|allohemagglutinins|allohemagglutinins
1120706|NCT02429518|leishmaniasis|leishmaniasis
1120707|NCT02429518|miltefosine|miltefosine
1120708|NCT02429518|EKG|ekg
1120709|NCT02429492|Pathophysiology|pathophysiology
1120710|NCT02429492|Spinal interneurons|spinal interneurons
1120711|NCT02429492|Electrophysiology|electrophysiology
1120712|NCT02429492|EMG|emg
1120713|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1120714|NCT02429479|Advance Care Planning|advance care planning
1120715|NCT02429479|Living Will|living will
1120716|NCT02429479|Family Caregiver|family caregiver
1120717|NCT02429479|Advance Directive|advance directive
1120718|NCT02429479|Surrogate Decision Maker|surrogate decision maker
1120719|NCT02429479|Proxy|proxy
1120720|NCT02429479|Self-Efficacy|self-efficacy
1120721|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
1120722|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
1120723|NCT02429466|platinum refractory|platinum refractory
1120724|NCT02429466|cisplatin|cisplatin
1120725|NCT02429466|SGI110|sgi110
1120726|NCT02429466|Guadecitabine|guadecitabine
1120727|NCT02429453|Warfarin|warfarin
1120728|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
1120729|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
1120730|NCT02429453|fresh frozen plasma|fresh frozen plasma
1120731|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
1120732|NCT02429427|Primary Breast Cancer|primary breast cancer
1120733|NCT02429427|Celecoxib|celecoxib
1120734|NCT02429414|Surgical Procedure|surgical procedure
1120735|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
1120736|NCT02429414|FOB|fob
1120737|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
1120738|NCT02429414|DLT|dlt
1120739|NCT02429414|Video Double Lumen Tube|video double lumen tube
1120740|NCT02429414|VDLT|vdlt
1120741|NCT02429401|binge drinking|binge drinking
1120742|NCT02429401|heavy drinking|heavy drinking
1120743|NCT02429388|Heart failure|heart failure
1120744|NCT02429388|Spironolactone|spironolactone
1120745|NCT02429388|Diuretics|diuretics
1120746|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
1120747|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
1120748|NCT02429375|Relapsed|relapsed
1120749|NCT02429375|Refractory|refractory
1120750|NCT02429323|induction|induction
1120751|NCT02429323|pediatrics|pediatrics
1120752|NCT02429323|sevoflurane|sevoflurane
1120753|NCT02429323|intubation time|intubation time
1120754|NCT02429310|Intermittent Claudication|intermittent claudication
1120756|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
1120757|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
1120758|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1120759|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
1120760|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
1120761|NCT02429310|Supervised Exercise Programme|supervised exercise programme
1120762|NCT02429310|Exercise Therapy|exercise therapy
1120763|NCT02429297|Hypertension|hypertension
1120764|NCT02429297|Diabetes|diabetes
1120765|NCT02429297|mHealth|mhealth
1120766|NCT02429297|Interactive Voice Response|interactive voice response
1120767|NCT02429297|Bolivia|bolivia
1120768|NCT02429297|Chronic disease|chronic disease
1120769|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1120770|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
1120771|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
1120772|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
1120773|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
1120774|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
1120775|NCT02429245|Knee|knee
1120776|NCT02429245|Knee osteoarthritis|knee osteoarthritis
1120777|NCT02429245|Knee replacement|knee replacement
1120778|NCT02429232|Pioglitazone|pioglitazone
1120779|NCT02429232|Linagliptin|linagliptin
1120780|NCT02429232|Diabetes mellitus|diabetes mellitus
1120781|NCT02429232|Diabetic macular edema|diabetic macular edema
1120782|NCT02429232|Kidney|kidney
1120783|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
1120784|NCT02429154|Infant|infant
1120785|NCT02429154|Anesthesia, general|anesthesia, general
1120786|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1120787|NCT02429115|peer mentoring|peer mentoring
1120788|NCT02429115|chronic kidney disease|chronic kidney disease
1120789|NCT02429115|quality of life|quality of life
1120790|NCT02429115|pcori|pcori
1120791|NCT02429115|caregiver burden|caregiver burden
1120792|NCT02429102|Phase 1|phase 1
1120793|NCT02429102|Healthy subjects|healthy subjects
1120794|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
1120795|NCT02429089|recurrent|recurrent
1120796|NCT02429089|metastatic|metastatic
1120797|NCT02429063|Solid Tumors|solid tumors
1120798|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1120799|NCT02429050|Dyspnea|dyspnea
1120800|NCT02429050|Breathlessness|breathlessness
1120801|NCT02429050|Morphine|morphine
1120802|NCT02429050|Opioid|opioid
1120803|NCT02429050|Symptom Management|symptom management
1120804|NCT02429037|p53|p53
1120805|NCT02429037|gene therapy|gene therapy
1120806|NCT02429037|head and neck cancer|head and neck cancer
1120807|NCT02429024|Diabetes Mellitus|diabetes mellitus
1120808|NCT02429024|A1c|a1c
1120809|NCT02429011|depression|depression
1120810|NCT02429011|MRI|mri
1120811|NCT02429011|treatment-resistant|treatment-resistant
1120812|NCT02429011|imaging|imaging
1120813|NCT02429011|ketamine|ketamine
1120814|NCT02428985|Riociguat|riociguat
1120815|NCT02428985|Adempas|adempas
1120816|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
1120817|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
1120818|NCT02428985|Japan|japan
1120819|NCT02428985|Post-marketing surveillance|post-marketing surveillance
1120820|NCT02428972|brain tumor|brain tumor
1120821|NCT02428972|quality of life|quality of life
1120822|NCT02428972|cognition|cognition
1120823|NCT02428972|anesthetic technique|anesthetic technique
1120824|NCT02428959|Amyl Nitrite|amyl nitrite
1120825|NCT02428959|High Resolution Manometry|high resolution manometry
1120826|NCT02428946|Insulin Sensitivity|insulin sensitivity
1120827|NCT02428946|obesity|obesity
1120828|NCT02428946|dopamine|dopamine
1120829|NCT02428933|Brown Adipose Tissue|brown adipose tissue
1120830|NCT02428933|Obesity|obesity
1120831|NCT02428933|Insulin Sensitivity|insulin sensitivity
1120832|NCT02428933|Dopamine|dopamine
1120833|NCT02428920|cardiovascular health|cardiovascular health
1120834|NCT02428920|behavior change|behavior change
1120835|NCT02428920|community-based|community-based
1120836|NCT02428920|prevention|prevention
1120837|NCT02428907|simulation training|simulation training
1120838|NCT02428907|minimal sedation|minimal sedation
1120839|NCT02428907|colonoscopy|colonoscopy
1120840|NCT02428907|patient satisfaction|patient satisfaction
1120841|NCT02428907|teamwork|teamwork
1120842|NCT02428907|team training|team training
1120843|NCT02428907|patient safety|patient safety
1120844|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
1120845|NCT02428868|hip fracture|hip fracture
1120846|NCT02428868|anemia|anemia
1120847|NCT02428868|blood transfusion|blood transfusion
1120848|NCT02428868|tranexamic acid|tranexamic acid
1120849|NCT02428868|intravenous iron|intravenous iron
1120850|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
1120851|NCT02428842|Cervical cancer|cervical cancer
1120852|NCT02428842|Tumor biopsies|tumor biopsies
1120853|NCT02428842|Standard treatment|standard treatment
1120854|NCT02428842|Molecular profile|molecular profile
1120855|NCT02428842|Next Generation Sequencing|next generation sequencing
1120856|NCT02428829|hip|hip
1120857|NCT02428829|replacement|replacement
1120858|NCT02428829|arthroplasty|arthroplasty
1120859|NCT02428829|total|total
1120860|NCT02428829|orthopaedic|orthopaedic
1120861|NCT02428829|rehabiliation|rehabiliation
1120862|NCT02428829|physiotherapy|physiotherapy
1120863|NCT02428829|therapy|therapy
1120864|NCT02428816|differential diagnosis|differential diagnosis
1120865|NCT02428816|multimodal MRI|multimodal mri
1120866|NCT02428816|Parkinson's Disease|parkinson's disease
1120867|NCT02428816|Multiple System Atrophy|multiple system atrophy
1120868|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
1120869|NCT02428777|Hysteroscopy|hysteroscopy
1120870|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1120871|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
1120872|NCT02428751|doxorubicin|doxorubicin
1120873|NCT02428751|event-free survival|event-free survival
1120874|NCT02428738|Influenza Vaccine|influenza vaccine
1120875|NCT02428738|Text Message|text message
1120876|NCT02428673|Osteopenia|osteopenia
1120877|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
1120878|NCT02428673|cerebral palsy|cerebral palsy
1120879|NCT02428673|muscular dystrophy|muscular dystrophy
1120880|NCT02428673|spina bifida|spina bifida
1120881|NCT02428673|Rett Syndrome|rett syndrome
1120882|NCT02428660|Polypharmacy|polypharmacy
1120883|NCT02428660|Chronic conditions|chronic conditions
1120884|NCT02428660|Drug Therapy Problems|drug therapy problems
1120885|NCT02428660|Medication Therapy Management|medication therapy management
1120886|NCT02428660|Medication-Related Problems|medication-related problems
1120887|NCT02428660|CYP3A4|cyp3a4
1120888|NCT02428660|CYP3A5|cyp3a5
1120889|NCT02428660|Drug-drug interactions|drug-drug interactions
1120890|NCT02428660|Drug-gene interactions|drug-gene interactions
1120891|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
1120892|NCT02428660|Adverse Drug Reactions|adverse drug reactions
1120893|NCT02428660|Activities of Daily Living|activities of daily living
1120894|NCT02428647|growth|growth
1120895|NCT02428647|plasma zinc concentration|plasma zinc concentration
1120896|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
1120897|NCT02428634|Children|children
1120898|NCT02428634|School intervention|school intervention
1120899|NCT02428621|early orthodontic treatment|early orthodontic treatment
1120900|NCT02428621|activator|activator
1120901|NCT02428621|removable appliance|removable appliance
1120902|NCT02428621|Twicare®|twicare®
1120903|NCT02428621|Herbst appliance|herbst appliance
1120904|NCT02428608|Glabellar Lines|glabellar lines
1120905|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
1120906|NCT02428582|endovascular treatment|endovascular treatment
1120907|NCT02428582|arterial occlusive disease|arterial occlusive disease
1120908|NCT02428582|bare metal stent|bare metal stent
1120909|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
1120910|NCT02428569|shared decision making|shared decision making
1120911|NCT02428569|patient education|patient education
1120912|NCT02428569|decision aids|decision aids
1120913|NCT02428556|Decision making|decision making
1120914|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
1120915|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1120916|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1120917|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
1120918|NCT02428517|busulfan|busulfan
1120919|NCT02428517|antithymocyte globulin|antithymocyte globulin
1120920|NCT02428504|Questionnaire|questionnaire
1120921|NCT02428491|Diphtheria|diphtheria
1120922|NCT02428491|Tetanus|tetanus
1120923|NCT02428491|Pertussis|pertussis
1120924|NCT02428491|Poliomyelitis|poliomyelitis
1120925|NCT02428491|Hepatitis B|hepatitis b
1120926|NCT02428491|Haemophilus Influenzae Type b|haemophilus influenzae type b
1120927|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim®)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim®)
1120928|NCT02428452|autism|autism
1120929|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
1120930|NCT02428452|early intervention|early intervention
1120931|NCT02428452|infant|infant
1120932|NCT02428452|toddler|toddler
1120933|NCT02428452|early identification|early identification
1120934|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
1120935|NCT02428452|control group|control group
1120936|NCT02428452|treatment group|treatment group
1120937|NCT02428452|at risk|at risk
1120938|NCT02428452|social communication|social communication
1120939|NCT02428452|positive affect|positive affect
1120940|NCT02428452|smiling|smiling
1120941|NCT02428439|genetic markers|genetic markers
1120942|NCT02428439|predictors|predictors
1120943|NCT02428439|Antidepressive Agents|antidepressive agents
1120944|NCT02428439|Suicidal Ideation|suicidal ideation
1120945|NCT02428439|Adolescent|adolescent
1120946|NCT02428426|Mucosal Microbiome|mucosal microbiome
1120947|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
1120948|NCT02428426|duodenum|duodenum
1120949|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
1120950|NCT02428387|caregivers|caregivers
1120951|NCT02428387|intervention|intervention
1120952|NCT02428387|health related quality of life|health related quality of life
1120953|NCT02428387|dementia|dementia
1120954|NCT02428374|MRI|mri
1120955|NCT02428374|Ventricular function, left|ventricular function, left
1120956|NCT02428309|Tregs|tregs
1120957|NCT02428296|Clinical Trial|clinical trial
1120958|NCT02428296|Congenital Malformations|congenital malformations
1120959|NCT02428296|Overgrowth|overgrowth
1120960|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
1120961|NCT02428257|hip fracture|hip fracture
1120963|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
1120964|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
1120965|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
1120966|NCT02428257|hypotension|hypotension
1120967|NCT02428244|Smoking|smoking
1120968|NCT02428244|Cessation|cessation
1120969|NCT02428244|Trauma|trauma
1120970|NCT02428244|Fracture|fracture
1120971|NCT02428244|Complications|complications
1120972|NCT02428218|Randomized|randomized
1120973|NCT02428218|Ages 10-17|ages 10-17
1120974|NCT02428218|Pediatrics|pediatrics
1120975|NCT02428218|Placebo controlled|placebo controlled
1120976|NCT02428218|Relapse-Remitting|relapse-remitting
1120977|NCT02428218|Multiple Sclerosis|multiple sclerosis
1120978|NCT02428218|Safety|safety
1120979|NCT02428218|Efficacy|efficacy
1120980|NCT02428218|BG00012|bg00012
1120981|NCT02428179|Surgical site infection|surgical site infection
1120982|NCT02428179|Intraoperative briefings|intraoperative briefings
1120983|NCT02428179|Mortality|mortality
1120984|NCT02428179|Wound closure|wound closure
1120985|NCT02428179|Surgical procedure|surgical procedure
1120986|NCT02428166|crosslinking|crosslinking
1120987|NCT02428166|keratoconus|keratoconus
1120988|NCT02428166|keratometry|keratometry
1120989|NCT02428166|pachymetry|pachymetry
1120990|NCT02428166|pentacam|pentacam
1120991|NCT02428153|static stretching|static stretching
1120992|NCT02428153|dynamic stretching|dynamic stretching
1120993|NCT02428153|muscle-tendon unit|muscle-tendon unit
1120994|NCT02428153|ultrasound|ultrasound
1120995|NCT02428153|Subjects|subjects
1120996|NCT02428140|ischemic stroke|ischemic stroke
1120997|NCT02428140|atrial fibrillation|atrial fibrillation
1120998|NCT02428140|etiologic investigations|etiologic investigations
1120999|NCT02428140|secondary prevention|secondary prevention
1121000|NCT02428140|anticoagulation|anticoagulation
1121001|NCT02428140|arrhythmias|arrhythmias
1121002|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
1121003|NCT02428140|implantable loop recorder|implantable loop recorder
1121004|NCT02428140|external loop recorder|external loop recorder
1121005|NCT02428062|Post-operative complications|post-operative complications
1121006|NCT02428062|Mild cognitive impairment|mild cognitive impairment
1121007|NCT02428062|Delirium|delirium
1121008|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
1121009|NCT02428036|HF10|hf10
1121010|NCT02428036|HSV-1|hsv-1
1121011|NCT02428036|Oncolytic virus|oncolytic virus
1121012|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
1121013|NCT02428036|Phase I|phase i
1121014|NCT02428036|Melanoma|melanoma
1121015|NCT02428036|Intratumoral administration|intratumoral administration
1121016|NCT02428023|Thalassemia|thalassemia
1121017|NCT02428023|trait|trait
1121018|NCT02428023|coronary|coronary
1121019|NCT02428023|stroke|stroke
1121020|NCT02427997|Virtual Reality|virtual reality
1121021|NCT02427997|Treadmill|treadmill
1121022|NCT02427997|Multiple Sclerosis|multiple sclerosis
1121023|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
1121024|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
1121025|NCT02427958|Drug Therapy|drug therapy
1121026|NCT02427945|Information provision|information provision
1121027|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
1121028|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
1121030|NCT02427919|G-CSF receptor|g-csf receptor
1121031|NCT02427919|AML|aml
1121032|NCT02427919|refractory AML|refractory aml
1121033|NCT02427919|Neutropenic fever|neutropenic fever
1121034|NCT02427919|salvage chemotherapy|salvage chemotherapy
1121035|NCT02427906|cirrhosis|cirrhosis
1121036|NCT02427906|gut microbiota|gut microbiota
1121037|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
1121038|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
1121039|NCT02427893|immunotherapy|immunotherapy
1121040|NCT02427893|Vemurafenib|vemurafenib
1121041|NCT02427893|Cobimetinib|cobimetinib
1121043|NCT02427880|Nephrotic syndrome|nephrotic syndrome
1121044|NCT02427880|Acetazolamide|acetazolamide
1121045|NCT02427880|Furosemide|furosemide
1121046|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
1121047|NCT02427867|non cardiac surgery|non cardiac surgery
1121048|NCT02427867|myocardial ischemia|myocardial ischemia
1121049|NCT02427854|Major delivery complications|major delivery complications
1121050|NCT02427854|Perineal injuries|perineal injuries
1121051|NCT02427854|episiotomy|episiotomy
1121052|NCT02427789|Physical exercise|physical exercise
1121053|NCT02427789|Biomarkers|biomarkers
1121054|NCT02427789|Neuroprotection|neuroprotection
1121055|NCT02427789|ergospirometry|ergospirometry
1121056|NCT02427789|Major Depressive Disorder|major depressive disorder
1121057|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
1121058|NCT02427763|malocclusion|malocclusion
1121059|NCT02427763|Streptococcus mutans|streptococcus mutans
1121060|NCT02427763|Lactobacillus|lactobacillus
1121061|NCT02427763|Epithelium|epithelium
1121062|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
1121063|NCT02427737|Patient satisfaction|patient satisfaction
1121064|NCT02427737|Diagnostic Imaging|diagnostic imaging
1121169|NCT02427321|Cystoscopy|cystoscopy
1121366|NCT02426034|Advanced|advanced
1121065|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
1121066|NCT02427711|blood transfusions|blood transfusions
1121067|NCT02427711|Readmission|readmission
1121068|NCT02427711|Bipolar sealer|bipolar sealer
1121069|NCT02427672|antisocial behavior|antisocial behavior
1121070|NCT02427672|aggression|aggression
1121071|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
1121072|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1121073|NCT02427672|associated risk factors|associated risk factors
1121074|NCT02427659|VRD|vrd
1121075|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
1121076|NCT02427659|Burn Wound Care|burn wound care
1121077|NCT02427646|Kinematics|kinematics
1121078|NCT02427646|Botulinum toxin type A|botulinum toxin type a
1121079|NCT02427633|recovery position|recovery position
1121080|NCT02427633|comatose|comatose
1121081|NCT02427633|resource limited|resource limited
1121082|NCT02427620|Lymphoma|lymphoma
1121083|NCT02427620|Mantle cell lymphoma|mantle cell lymphoma
1121084|NCT02427620|MCL|mcl
1121085|NCT02427620|B-lymphocyte antigen|b-lymphocyte antigen
1121086|NCT02427620|CD20|cd20
1121087|NCT02427620|Ibrutinib|ibrutinib
1121088|NCT02427620|PCI-32765|pci-32765
1121089|NCT02427620|Imbruvica|imbruvica
1121090|NCT02427620|Rituximab|rituximab
1121091|NCT02427620|Rituxan|rituxan
1121092|NCT02427620|Cyclophosphamide|cyclophosphamide
1121093|NCT02427620|Cytoxan|cytoxan
1121094|NCT02427620|Neosar|neosar
1121095|NCT02427620|Vincristine|vincristine
1121096|NCT02427620|Mesna|mesna
1121097|NCT02427620|Mesnex|mesnex
1121098|NCT02427620|Dexamethasone|dexamethasone
1121099|NCT02427620|Decadron|decadron
1121100|NCT02427620|Doxorubicin|doxorubicin
1121101|NCT02427620|Doxorubicin hydrochloride|doxorubicin hydrochloride
1121102|NCT02427620|Adriamycin PFS|adriamycin pfs
1121103|NCT02427620|Adriamycin RDF|adriamycin rdf
1121104|NCT02427620|Adriamycin|adriamycin
1121105|NCT02427620|Rubex|rubex
1121106|NCT02427620|G-CSF|g-csf
1121107|NCT02427620|Filgrastim|filgrastim
1121108|NCT02427620|Neupogen|neupogen
1121109|NCT02427620|Methotrexate|methotrexate
1121110|NCT02427620|Cytarabine|cytarabine
1121111|NCT02427620|Ara-C|ara-c
1121112|NCT02427620|Cytosar|cytosar
1121113|NCT02427620|DepoCyt|depocyt
1121114|NCT02427620|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1121115|NCT02427620|Citrovorum|citrovorum
1121116|NCT02427620|Leucovorin|leucovorin
1121117|NCT02427620|Wellcovorin|wellcovorin
1121118|NCT02427607|Epilepsy|epilepsy
1121119|NCT02427607|Perampanel|perampanel
1121120|NCT02427594|Kidney Diseases|kidney diseases
1121121|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
1121122|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
1121123|NCT02427594|Blood pressure|blood pressure
1121124|NCT02427594|Urine net acid excretion|urine net acid excretion
1121125|NCT02427568|Anxiety|anxiety
1121126|NCT02427568|MDMA|mdma
1121127|NCT02427568|Life-threatening illness|life-threatening illness
1121128|NCT02427568|psychotherapy|psychotherapy
1121129|NCT02427542|Randomized Controlled Trial|randomized controlled trial
1121130|NCT02427529|hcg|hcg
1121131|NCT02427503|asthma|asthma
1121132|NCT02427503|sinonasal polyposis|sinonasal polyposis
1121133|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
1121134|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
1121135|NCT02427490|Palliative Care|palliative care
1121136|NCT02427490|Caregivers|caregivers
1121137|NCT02427490|Medical Oncology|medical oncology
1121138|NCT02427464|diabetic|diabetic
1121139|NCT02427464|neuropathy|neuropathy
1121140|NCT02427464|shooting pain|shooting pain
1121141|NCT02427464|burning pain|burning pain
1121142|NCT02427464|pins and needles pain|pins and needles pain
1121143|NCT02427464|foot pain|foot pain
1121144|NCT02427464|ViroMed|viromed
1121145|NCT02427438|video|video
1121146|NCT02427438|handout|handout
1121147|NCT02427438|home program|home program
1121148|NCT02427438|stabilization|stabilization
1121149|NCT02427438|strengthening|strengthening
1121150|NCT02427438|core|core
1121151|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1121152|NCT02427425|Pain|pain
1121153|NCT02427412|Tranexamic Acid|tranexamic acid
1121154|NCT02427412|Knee Arthroplasty|knee arthroplasty
1121155|NCT02427412|Blood loss|blood loss
1121156|NCT02427412|Blood transfusion|blood transfusion
1121157|NCT02427412|Thrombolic complication|thrombolic complication
1121158|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
1121159|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
1121160|NCT02427386|Endometriosis|endometriosis
1121161|NCT02427386|Pelvic pain|pelvic pain
1121162|NCT02427386|Homeopathy|homeopathy
1121163|NCT02427386|RCT|rct
1121164|NCT02427373|bioavailability|bioavailability
1121165|NCT02427373|fish oil|fish oil
1121166|NCT02427373|krill oil|krill oil
1121167|NCT02427360|Retrospective Studies|retrospective studies
1121168|NCT02427360|Clinical Efficacy|clinical efficacy
1121170|NCT02427321|Bladder cancer|bladder cancer
1121171|NCT02427321|Bladder imaging|bladder imaging
1121172|NCT02427308|leishmaniasis|leishmaniasis
1121173|NCT02427308|miltefosine|miltefosine
1121174|NCT02427308|pregnancy|pregnancy
1121175|NCT02427269|Barrett's Esophagus|barrett's esophagus
1121176|NCT02427269|Esophageal Cancer|esophageal cancer
1121177|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
1121178|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
1121179|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1121180|NCT02427230|Urinary Incontinence|urinary incontinence
1121181|NCT02427230|Spinal Cord Injury|spinal cord injury
1121182|NCT02427204|Hepatitis C infection|hepatitis c infection
1121183|NCT02427204|Hepatitis C treatment|hepatitis c treatment
1121184|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
1121185|NCT02427191|Heel pain|heel pain
1121186|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1121187|NCT02427178|MNGIE|mngie
1121188|NCT02427178|Stem Cell transplant|stem cell transplant
1121189|NCT02427113|TMD|tmd
1121190|NCT02427113|Music Medicine|music medicine
1121191|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
1121192|NCT02427100|Homeless|homeless
1121193|NCT02427100|Randomized Controlled Trial|randomized controlled trial
1121194|NCT02427100|Diet|diet
1121195|NCT02427100|Physical Activity|physical activity
1121196|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
1121197|NCT02427087|Physical activity|physical activity
1121198|NCT02427087|NAFLD|nafld
1121199|NCT02427087|Anthropometry|anthropometry
1121200|NCT02427087|Body Composition|body composition
1121201|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
1121202|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
1121203|NCT02426944|atrial fibrillation|atrial fibrillation
1121204|NCT02426944|cardioembolic event|cardioembolic event
1121205|NCT02426944|stroke|stroke
1121206|NCT02426944|left atrial appendage closure|left atrial appendage closure
1121207|NCT02426944|novel anticoagulants|novel anticoagulants
1121208|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
1121209|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
1121210|NCT02426931|renal calculi|renal calculi
1121211|NCT02426892|Solid Tumors|solid tumors
1121212|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
1121213|NCT02426892|ISA101|isa101
1121214|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
1121215|NCT02426892|Nivolumab|nivolumab
1121216|NCT02426892|BMS-936558|bms-936558
1121217|NCT02426892|Opdivo|opdivo
1121218|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
1121219|NCT02426879|cervical metastases|cervical metastases
1121220|NCT02426879|esophagectomy|esophagectomy
1121221|NCT02426853|Cancer Prevention|cancer prevention
1121222|NCT02426853|Sun protection|sun protection
1121223|NCT02426853|Photograph|photograph
1121224|NCT02426853|UV photograph|uv photograph
1121225|NCT02426853|Ultraviolet|ultraviolet
1121226|NCT02426853|Pamphlets|pamphlets
1121227|NCT02426853|Handouts|handouts
1121228|NCT02426853|Questionnaires|questionnaires
1121229|NCT02426853|Surveys|surveys
1121230|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
1121231|NCT02426840|Adverse bone health|adverse bone health
1121232|NCT02426840|Bone demineralization|bone demineralization
1121233|NCT02426840|HIV-infection|hiv-infection
1121234|NCT02426840|Children|children
1121235|NCT02426840|Adolescents|adolescents
1121236|NCT02426840|Calcium|calcium
1121237|NCT02426840|Vitamin D|vitamin d
1121238|NCT02426840|Supplementation|supplementation
1121239|NCT02426814|Patient Compliance|patient compliance
1121240|NCT02426814|Mobile Applications|mobile applications
1121241|NCT02426801|Patient Compliance|patient compliance
1121242|NCT02426801|Mobile Applications|mobile applications
1121243|NCT02426801|Medication Adherence|medication adherence
1121244|NCT02426788|medically unexplained|medically unexplained
1121245|NCT02426788|fibromyalgia|fibromyalgia
1121246|NCT02426788|PoTS|pots
1121247|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
1121248|NCT02426788|CFS|cfs
1121249|NCT02426788|IBS|ibs
1121250|NCT02426788|functional neurological|functional neurological
1121251|NCT02426788|chronic pain|chronic pain
1121252|NCT02426788|hyperventilation|hyperventilation
1121253|NCT02426788|unexplained cough|unexplained cough
1121254|NCT02426762|skin sealant|skin sealant
1121255|NCT02426762|laparoscopic surgery|laparoscopic surgery
1121256|NCT02426762|surgical site infection|surgical site infection
1121257|NCT02426762|wound healing|wound healing
1121258|NCT02426736|Shoulder Joint|shoulder joint
1121259|NCT02426736|Arthroscopy|arthroscopy
1121260|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
1121261|NCT02426736|Pain, Postoperative|pain, postoperative
1121262|NCT02426736|Brachial Plexus Block|brachial plexus block
1121263|NCT02426736|Corticosteroid|corticosteroid
1121264|NCT02426736|Dexamethasone|dexamethasone
1121265|NCT02426736|Bupivacaine|bupivacaine
1121266|NCT02426736|Perineural|perineural
1121267|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
1121268|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
1121269|NCT02426684|End Stage Renal Disease|end stage renal disease
1121270|NCT02426684|Kidney Transplant|kidney transplant
1121271|NCT02426684|Desensitization|desensitization
1121272|NCT02426684|Highly Sensitized|highly sensitized
1121273|NCT02426684|Antibodies|antibodies
1121274|NCT02426671|neuromodulation|neuromodulation
1121275|NCT02426671|Minimum Masking Level|minimum masking level
1121276|NCT02426645|Biomarkers|biomarkers
1121277|NCT02426645|Sepsis|sepsis
1121278|NCT02426645|Multi organ dysfunction|multi organ dysfunction
1121279|NCT02426645|Immunomonitoring|immunomonitoring
1121280|NCT02426645|CEUS|ceus
1121281|NCT02426632|Healthy|healthy
1121282|NCT02426632|JNJ-53718678|jnj-53718678
1121283|NCT02426606|Lentils|lentils
1121284|NCT02426606|Post-prandial|post-prandial
1121285|NCT02426606|Glycemic response|glycemic response
1121286|NCT02426606|Insulin response|insulin response
1121287|NCT02426606|Diabetes|diabetes
1121288|NCT02426606|Mixed meal|mixed meal
1121289|NCT02426606|Glycemia|glycemia
1121290|NCT02426606|Slowly digestible starch|slowly digestible starch
1121291|NCT02426606|Post-prandial glycemia|post-prandial glycemia
1121292|NCT02426593|CHF|chf
1121293|NCT02426593|Heart Failure|heart failure
1121294|NCT02426567|Crohn's Disease|crohn's disease
1121295|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
1121296|NCT02426567|Dietary Treatment|dietary treatment
1121297|NCT02426567|Gut microbiota|gut microbiota
1121298|NCT02426541|Diabetes Mellitus|diabetes mellitus
1121299|NCT02426541|Dapagliflozin|dapagliflozin
1121300|NCT02426541|Placebo|placebo
1121301|NCT02426541|Insulin resistance|insulin resistance
1121302|NCT02426541|Insulin sensitivity|insulin sensitivity
1121303|NCT02426476|heart rate variability|heart rate variability
1121304|NCT02426476|biofeedback|biofeedback
1121305|NCT02426476|chronic pain|chronic pain
1121306|NCT02426476|Veterans|veterans
1121307|NCT02426463|Neonatal intensive care|neonatal intensive care
1121308|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
1121309|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
1121310|NCT02426437|COPD|copd
1121311|NCT02426437|Emphysema|emphysema
1121312|NCT02426437|Chronic Bronchitis|chronic bronchitis
1121313|NCT02426424|c-PAP|c-pap
1121314|NCT02426398|EEG|eeg
1121315|NCT02426372|Ulcerative Colitis|ulcerative colitis
1121316|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
1121317|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
1121318|NCT02426307|Thrombosis|thrombosis
1121319|NCT02426307|Cardiovascular disease|cardiovascular disease
1121320|NCT02426307|Oral anticoagulation|oral anticoagulation
1121321|NCT02426307|bioprosthesis|bioprosthesis
1121322|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
1121323|NCT02426268|cardiac surgery|cardiac surgery
1121324|NCT02426268|cerebral oximetry|cerebral oximetry
1121325|NCT02426268|lower extremity oximetry|lower extremity oximetry
1121326|NCT02426255|Severe trauma|severe trauma
1121327|NCT02426255|traumatic Brain injury|traumatic brain injury
1121328|NCT02426255|Hemorrhage|hemorrhage
1121329|NCT02426242|brain-injury|brain-injury
1121330|NCT02426242|extubation|extubation
1121331|NCT02426229|SSc|ssc
1121332|NCT02426229|systemic sclerosis|systemic sclerosis
1121333|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
1121334|NCT02426216|prostate cancer|prostate cancer
1121335|NCT02426216|chemoprevention|chemoprevention
1121336|NCT02426216|biomarker|biomarker
1121337|NCT02426203|Echocardiography|echocardiography
1121338|NCT02426177|postpartum hypertension|postpartum hypertension
1121339|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
1121340|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
1121341|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
1121342|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
1121343|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
1121344|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
1121345|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
1121346|NCT02426125|transitional cell tumor|transitional cell tumor
1121347|NCT02426125|RANGE|range
1121348|NCT02426125|bladder cancer|bladder cancer
1121349|NCT02426099|Resistant hypertension|resistant hypertension
1121350|NCT02426099|diabetes mellitus|diabetes mellitus
1121351|NCT02426099|Spironolactone|spironolactone
1121352|NCT02426099|African|african
1121353|NCT02426086|Myelofibrosis|myelofibrosis
1121354|NCT02426086|JNJ-63935937|jnj-63935937
1121355|NCT02426086|Imetelstat|imetelstat
1121356|NCT02426073|Inflammaging|inflammaging
1121357|NCT02426047|seizures|seizures
1121358|NCT02426047|epilepsy|epilepsy
1121359|NCT02426047|catamenial|catamenial
1121360|NCT02426047|ketogenic diet|ketogenic diet
1121361|NCT02426047|modified Atkins diet|modified atkins diet
1121362|NCT02426047|intractable epilepsy|intractable epilepsy
1121363|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
1121364|NCT02426047|adult|adult
1121365|NCT02426047|medium chain triglyceride|medium chain triglyceride
1121369|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
1121370|NCT02425995|Chronic knee instability|chronic knee instability
1121371|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
1121372|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
1121373|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
1121374|NCT02425982|Tennis Elbow|tennis elbow
1121375|NCT02425982|Lateral elbow pain|lateral elbow pain
1121376|NCT02425982|Latera epicondylitis|latera epicondylitis
1121377|NCT02425930|gastric cancer|gastric cancer
1121378|NCT02425930|complement system|complement system
1121379|NCT02425930|overal survival|overal survival
1121380|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
1121381|NCT02425865|UC, IBD|uc, ibd
1121382|NCT02425839|shear wave elastography|shear wave elastography
1121383|NCT02425839|surface electromyogram|surface electromyogram
1121384|NCT02425839|masseter|masseter
1121385|NCT02425826|Parapsoriasis|parapsoriasis
1121386|NCT02425826|Plaque Psoriasis|plaque psoriasis
1121387|NCT02425826|CC-10004|cc-10004
1121388|NCT02425826|Apremilast|apremilast
1121389|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
1121390|NCT02425826|Safety|safety
1121391|NCT02425787|Loss of a child|loss of a child
1121392|NCT02425787|Grief|grief
1121393|NCT02425774|Prucalopride|prucalopride
1121394|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
1121395|NCT02425774|Postoperative Ileus|postoperative ileus
1121396|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
1121397|NCT02425761|Randomized Controlled Trial|randomized controlled trial
1121398|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
1121399|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
1121400|NCT02425722|ASP0456|asp0456
1121401|NCT02425722|linaclotide|linaclotide
1121402|NCT02425722|chronic constipation|chronic constipation
1121403|NCT02425696|right-to-left shunt|right-to-left shunt
1121404|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
1121405|NCT02425696|migraine|migraine
1121406|NCT02425696|silent cerebral infarction|silent cerebral infarction
1121407|NCT02425683|Colon Cancer|colon cancer
1121408|NCT02425683|Rectal Cancer|rectal cancer
1121409|NCT02425683|Colorectal Cancer|colorectal cancer
1121410|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
1121411|NCT02425670|Brain attack|brain attack
1121412|NCT02425670|stroke|stroke
1121413|NCT02425670|Ischemic stroke|ischemic stroke
1121414|NCT02425670|stem cell therapy|stem cell therapy
1121416|NCT02425657|Training|training
1121417|NCT02425657|Fast track|fast track
1121418|NCT02425657|Colonoscopy|colonoscopy
1121419|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
1121420|NCT02425631|SI joint fusion|si joint fusion
1121421|NCT02425631|SI joint pain|si joint pain
1121422|NCT02425631|SI joint|si joint
1121423|NCT02425631|SI joint treatment|si joint treatment
1121424|NCT02425631|SI joint disease|si joint disease
1121425|NCT02425631|Sacroiliac joint|sacroiliac joint
1121426|NCT02425631|Simmetry|simmetry
1121427|NCT02425566|autonomic nervous system|autonomic nervous system
1121428|NCT02425566|hypertension|hypertension
1121429|NCT02425566|ganglionic blocker|ganglionic blocker
1121430|NCT02425566|trimethaphan|trimethaphan
1121431|NCT02425566|splanchnic circulation|splanchnic circulation
1121432|NCT02425566|capacitance|capacitance
1121433|NCT02425553|Diet|diet
1121434|NCT02425553|Reflux|reflux
1121435|NCT02425553|Dyspepsia|dyspepsia
1121436|NCT02425553|Symptoms|symptoms
1121437|NCT02425553|Alcohol|alcohol
1121438|NCT02425540|Pelvic MRI|pelvic mri
1121439|NCT02425527|Brain Injuries|brain injuries
1121440|NCT02425527|Traumatic Brain Injury|traumatic brain injury
1121441|NCT02425527|Video Games|video games
1121442|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
1121443|NCT02425514|NovoMax|novomax
1121444|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
1121445|NCT02425501|Aflibercept|aflibercept
1121446|NCT02425501|anti-VEGF|anti-vegf
1121447|NCT02425488|Nursing|nursing
1121448|NCT02425488|Outcome and Process Assessment|outcome and process assessment
1121449|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
1121450|NCT02425488|Heart Failure|heart failure
1121451|NCT02425488|Education|education
1121452|NCT02425475|Dermoscopy|dermoscopy
1121453|NCT02425449|succinylcholine|succinylcholine
1121454|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
1121455|NCT02425449|pharmacologic effects|pharmacologic effects
1121456|NCT02425410|Diabetes Mellitus|diabetes mellitus
1121457|NCT02425410|Insulin-Dependent|insulin-dependent
1121458|NCT02425410|Virus Diseases|virus diseases
1121459|NCT02425410|Questionnaires|questionnaires
1121460|NCT02425410|Risk assessment|risk assessment
1121461|NCT02425410|Genome-Wide Association Study|genome-wide association study
1121462|NCT02425397|Ototoxicity|ototoxicity
1121463|NCT02425397|platinum derivatives|platinum derivatives
1121464|NCT02425397|paediatrics|paediatrics
1121466|NCT02425397|clinical research|clinical research
1121467|NCT02425384|adolescent|adolescent
1121468|NCT02425384|physical activity|physical activity
1121469|NCT02425384|accelerometer|accelerometer
1121470|NCT02425358|cell therapy|cell therapy
1121472|NCT02425358|timing|timing
1121473|NCT02425345|Physical Activity|physical activity
1121474|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
1121475|NCT02425345|Postmenopausal Women|postmenopausal women
1121476|NCT02425345|Balance|balance
1121477|NCT02425345|Strength|strength
1121478|NCT02425345|Exercise|exercise
1121479|NCT02425345|Cardiovascular Disease|cardiovascular disease
1121480|NCT02425345|Stroke|stroke
1121481|NCT02425345|Mortality|mortality
1121482|NCT02425345|Myocardial Infarction|myocardial infarction
1121483|NCT02425345|Falls|falls
1121484|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
1121485|NCT02425345|Peripheral Artery Disease|peripheral artery disease
1121486|NCT02425345|Physical Function|physical function
1121487|NCT02425345|Mobility|mobility
1121488|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
1121489|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1121490|NCT02425345|Hip Fractures|hip fractures
1121491|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
1121492|NCT02425332|Spinal Cord Injury|spinal cord injury
1121493|NCT02425332|adaptive control|adaptive control
1121494|NCT02425332|assessment|assessment
1121495|NCT02425332|assist-as-needed|assist-as-needed
1121496|NCT02425332|walking ability|walking ability
1121497|NCT02425332|Lokomat|lokomat
1121498|NCT02425306|peptide|peptide
1121499|NCT02425306|vaccine|vaccine
1121500|NCT02425306|adjuvant|adjuvant
1121501|NCT02425306|polyICLC|polyiclc
1121502|NCT02425306|cyclophosphamide|cyclophosphamide
1121503|NCT02425306|Montanide ISA-51|montanide isa-51
1121504|NCT02425267|Telerehabilitation|telerehabilitation
1121505|NCT02425241|Vaccine|vaccine
1121506|NCT02425241|DNA|dna
1121507|NCT02425241|HIV-1|hiv-1
1121508|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
1121509|NCT02425241|Clinical trial|clinical trial
1121510|NCT02425241|Vaccination|vaccination
1121511|NCT02425241|Prophylaxis|prophylaxis
1121512|NCT02425241|Adult male|adult male
1121513|NCT02425228|targeted biopsy|targeted biopsy
1121514|NCT02425228|conventional biopsy|conventional biopsy
1121515|NCT02425228|cognitive biopsy|cognitive biopsy
1121516|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
1121517|NCT02425215|Late radiation injury|late radiation injury
1121518|NCT02425215|Adult|adult
1121519|NCT02425215|Malignancy|malignancy
1121520|NCT02425215|Quality of Life|quality of life
1121521|NCT02425215|Chronic Pain|chronic pain
1121522|NCT02425202|pediatric|pediatric
1121523|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
1121524|NCT02425202|tonsillectomy|tonsillectomy
1121525|NCT02425202|analgesia|analgesia
1121526|NCT02425176|botulinum toxin|botulinum toxin
1121527|NCT02425176|sialorrhoea|sialorrhoea
1121528|NCT02425176|drooling|drooling
1121529|NCT02425163|Prostate Cancer|prostate cancer
1121530|NCT02425163|Shear Wave Elastography|shear wave elastography
1121531|NCT02425163|Prostate|prostate
1121532|NCT02425163|Prostate Biopsy|prostate biopsy
1121533|NCT02425150|Keratoconus|keratoconus
1121534|NCT02425150|Corneal crosslinking|corneal crosslinking
1121535|NCT02425150|Corneal biomechanics|corneal biomechanics
1121536|NCT02425150|Corneal densitometry|corneal densitometry
1121537|NCT02425150|Scheimpflug photography|scheimpflug photography
1121538|NCT02425111|Drug therapy|drug therapy
1121539|NCT02425098|Drug therapy|drug therapy
1121540|NCT02425085|retinectomy|retinectomy
1121541|NCT02425085|endodiathermy|endodiathermy
1121542|NCT02425085|inferior|inferior
1121543|NCT02425085|retinal redetachment|retinal redetachment
1121544|NCT02425072|Cancer|cancer
1121545|NCT02425072|Brain|brain
1121546|NCT02425072|Lung|lung
1121547|NCT02425072|Small-cell|small-cell
1121548|NCT02425059|irreversible electroporation|irreversible electroporation
1121549|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
1121550|NCT02425046|family|family
1121551|NCT02425033|POEM|poem
1121552|NCT02425033|Minimally invasive surgery|minimally invasive surgery
1121553|NCT02425033|Achalasia|achalasia
1121554|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
1121555|NCT02425020|Supplement|supplement
1121556|NCT02425020|performance|performance
1121557|NCT02425020|whey|whey
1121558|NCT02425020|meat|meat
1121559|NCT02425020|protein|protein
1121560|NCT02424994|Morbidity|morbidity
1121561|NCT02424994|Mortality|mortality
1121562|NCT02424994|Health care utilization|health care utilization
1121563|NCT02424994|Cohort|cohort
1121564|NCT02424994|Epidemiology|epidemiology
1121565|NCT02424994|Cardiovascular diseases|cardiovascular diseases
1121566|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
1121567|NCT02424955|Liver cancer|liver cancer
1121568|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
1121569|NCT02424955|Liver imaging|liver imaging
1121570|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
1121572|NCT02424929|Deep Brain Stimulation|deep brain stimulation
1121573|NCT02424916|Onco-dermatology|onco-dermatology
1121574|NCT02424916|Adoptive transfer|adoptive transfer
1121575|NCT02424916|Immunotherapy|immunotherapy
1121576|NCT02424903|infection|infection
1121577|NCT02424903|prosthesis|prosthesis
1121578|NCT02424903|hip|hip
1121579|NCT02424903|knee|knee
1121580|NCT02424903|shoulder|shoulder
1121581|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
1121582|NCT02424877|drug treatment|drug treatment
1121583|NCT02424877|compliance|compliance
1121584|NCT02424877|outcome|outcome
1121585|NCT02424864|4D PET-CT|4d pet-ct
1121586|NCT02424851|myeloma|myeloma
1121587|NCT02424851|multiple myeloma|multiple myeloma
1121588|NCT02424851|chronic kidney disease|chronic kidney disease
1121589|NCT02424851|renal failure|renal failure
1121590|NCT02424851|bortezomib|bortezomib
1121591|NCT02424851|Velcade|velcade
1121592|NCT02424851|thalidomide|thalidomide
1121593|NCT02424851|bendamustine|bendamustine
1121594|NCT02424851|dexamethasone|dexamethasone
1121595|NCT02424851|serum free light chains|serum free light chains
1121596|NCT02424851|proteosomal inhibition|proteosomal inhibition
1121597|NCT02424851|immunomodulatory|immunomodulatory
1121598|NCT02424825|diet|diet
1121599|NCT02424825|cooking|cooking
1121600|NCT02424825|multiple sclerosis|multiple sclerosis
1121601|NCT02424825|fatigue|fatigue
1121602|NCT02424812|handwashing|handwashing
1121603|NCT02424812|behavior|behavior
1121604|NCT02424799|Urticaria|urticaria
1121605|NCT02424799|SYK Inhibitor|syk inhibitor
1121606|NCT02424786|Adherence|adherence
1121607|NCT02424786|Polypharmacy|polypharmacy
1121608|NCT02424786|Elderly|elderly
1121609|NCT02424786|Chronic kidney disease|chronic kidney disease
1121610|NCT02424734|Late-onset Sepsis|late-onset sepsis
1121611|NCT02424708|Reduced Glutathione|reduced glutathione
1121612|NCT02424708|Intranasal|intranasal
1121613|NCT02424708|(in)GSH|(in)gsh
1121614|NCT02424708|Parkinson's Disease|parkinson's disease
1121615|NCT02424708|Glutathione|glutathione
1121616|NCT02424708|Uptake|uptake
1121617|NCT02424708|central nervous system|central nervous system
1121618|NCT02424695|Cortical arousal intensity|cortical arousal intensity
1121619|NCT02424695|RLS|rls
1121620|NCT02424695|Heart rate|heart rate
1121621|NCT02424695|Blood pressure|blood pressure
1121622|NCT02424695|PLMs|plms
1121623|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
1121827|NCT02423499|Emotions|emotions
1122133|NCT02422017|Leg ulcer|leg ulcer
1121624|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
1121625|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1121626|NCT02424630|postoperative pain|postoperative pain
1121627|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
1121628|NCT02424591|Spinal Fusion|spinal fusion
1121629|NCT02424552|severe asthma|severe asthma
1121630|NCT02424552|vitamin D|vitamin d
1121631|NCT02424552|treatment|treatment
1121632|NCT02424539|Seasonal|seasonal
1121633|NCT02424539|Fluticasone Furoate|fluticasone furoate
1121634|NCT02424539|Perennial|perennial
1121635|NCT02424539|Allergic Rhinitis|allergic rhinitis
1121636|NCT02424539|Nasal Spray|nasal spray
1121637|NCT02424526|cerebral palsy|cerebral palsy
1121638|NCT02424526|treadmill training|treadmill training
1121639|NCT02424526|walking|walking
1121640|NCT02424487|Initial pressure|initial pressure
1121641|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
1121642|NCT02424487|infants and children|infants and children
1121643|NCT02424474|cell free fetal DNA|cell free fetal dna
1121644|NCT02424474|general population|general population
1121645|NCT02424474|screening|screening
1121646|NCT02424474|trisomy 21|trisomy 21
1121647|NCT02424474|IVF|ivf
1121648|NCT02424435|Friedreich Ataxia|friedreich ataxia
1121649|NCT02424435|FRDA|frda
1121650|NCT02424422|Corrective Orthodontics|corrective orthodontics
1121651|NCT02424422|CBCT|cbct
1121652|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
1121653|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
1121654|NCT02424422|Hyrax Expansion|hyrax expansion
1121655|NCT02424422|Craniofacial Sutures|craniofacial sutures
1121656|NCT02424409|Asthma|asthma
1121657|NCT02424409|Relapse|relapse
1121658|NCT02424409|Therapeutic counselling|therapeutic counselling
1121659|NCT02424409|Protocol of care|protocol of care
1121660|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
1121661|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1121662|NCT02424396|Autoimmune diseases|autoimmune diseases
1121663|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
1121664|NCT02424370|Aortic stenosis|aortic stenosis
1121665|NCT02424370|TAVR|tavr
1121666|NCT02424370|Frailty|frailty
1121667|NCT02424370|Elderly|elderly
1121668|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
1121669|NCT02424357|suture contamination|suture contamination
1121670|NCT02424357|5%povidone iodine|5%povidone iodine
1121671|NCT02424344|COPD|copd
1121672|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1121673|NCT02424331|Respiratory mechanics|respiratory mechanics
1121674|NCT02424331|Plethysmography|plethysmography
1121675|NCT02424331|Diaphragm|diaphragm
1121676|NCT02424331|Respiratory muscles|respiratory muscles
1121677|NCT02424331|Breathing exercises|breathing exercises
1121678|NCT02424292|Breast cancer|breast cancer
1121679|NCT02424292|Physcial activity/exercise|physcial activity/exercise
1121680|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
1121681|NCT02424279|pancreatic cancer|pancreatic cancer
1121682|NCT02424279|pain|pain
1121683|NCT02424279|splanchnicectomy|splanchnicectomy
1121684|NCT02424266|Tear film|tear film
1121685|NCT02424266|Imaging|imaging
1121686|NCT02424266|Tomogrophy|tomogrophy
1121687|NCT02424266|dry eye|dry eye
1121688|NCT02424201|uterine atony|uterine atony
1121689|NCT02424175|Fecal Transplant|fecal transplant
1121690|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1121691|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
1121692|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
1121693|NCT02424110|argon beam coagulator|argon beam coagulator
1121694|NCT02424097|Prevention|prevention
1121695|NCT02424071|melatonin's|melatonin's
1121696|NCT02424071|quality of recovery|quality of recovery
1121697|NCT02424032|Neck pain|neck pain
1121698|NCT02424032|stabilization exercise|stabilization exercise
1121699|NCT02424032|connective tissue massage|connective tissue massage
1121700|NCT02424006|keratoplasty|keratoplasty
1121701|NCT02424006|bioengineered cornea|bioengineered cornea
1121702|NCT02424006|donor cornea|donor cornea
1121703|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
1121704|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1121705|NCT02423993|Quality of life|quality of life
1121706|NCT02423993|Therapeutic education|therapeutic education
1121707|NCT02423993|Insulin pump|insulin pump
1121708|NCT02423941|Liver Transplantation|liver transplantation
1121709|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
1121710|NCT02423941|Graft dysfunction|graft dysfunction
1121711|NCT02423941|Randomized study|randomized study
1121712|NCT02423928|immunotherapy|immunotherapy
1121713|NCT02423928|cryoablation|cryoablation
1121714|NCT02423928|prostate cancer|prostate cancer
1121715|NCT02423928|dendritic cell|dendritic cell
1121716|NCT02423915|Leukemia|leukemia
1121717|NCT02423915|Lymphoma|lymphoma
1121718|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
1121719|NCT02423915|Graft versus host disease|graft versus host disease
1121720|NCT02423915|GVHD|gvhd
1121828|NCT02423460|Ulcerative Colitis|ulcerative colitis
1121721|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
1121722|NCT02423915|CB|cb
1121723|NCT02423915|Tregs|tregs
1121724|NCT02423915|T cells|t cells
1121725|NCT02423915|Cord blood transplant|cord blood transplant
1121726|NCT02423915|Total body radiation|total body radiation
1121727|NCT02423915|TBI|tbi
1121728|NCT02423915|Radiation therapy|radiation therapy
1121729|NCT02423915|XRT|xrt
1121730|NCT02423915|Rituximab|rituximab
1121731|NCT02423915|Rituxan|rituxan
1121732|NCT02423915|Fludarabine|fludarabine
1121733|NCT02423915|Fludarabine phosphate|fludarabine phosphate
1121734|NCT02423915|Fludara|fludara
1121735|NCT02423915|Cyclophosphamide|cyclophosphamide
1121736|NCT02423915|Cytoxan|cytoxan
1121737|NCT02423915|Neosar|neosar
1121738|NCT02423915|Mycophenolate|mycophenolate
1121739|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
1121740|NCT02423915|MMF|mmf
1121741|NCT02423915|CellCept|cellcept
1121742|NCT02423915|Sirolimus|sirolimus
1121743|NCT02423915|Rapamune|rapamune
1121744|NCT02423915|G-CSF|g-csf
1121745|NCT02423915|Filgrastim|filgrastim
1121746|NCT02423915|Neupogen|neupogen
1121747|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
1121748|NCT02423889|SBRT|sbrt
1121749|NCT02423863|Cancer|cancer
1121750|NCT02423863|Immunotherapy|immunotherapy
1121751|NCT02423863|Intratumoral Injection|intratumoral injection
1121752|NCT02423863|Multicenter Study|multicenter study
1121753|NCT02423863|Autovaccination|autovaccination
1121754|NCT02423863|Solid Tumors|solid tumors
1121755|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
1121756|NCT02423850|Leg ulcers|leg ulcers
1121757|NCT02423850|Ulcer healing|ulcer healing
1121758|NCT02423850|Ulcer measurement|ulcer measurement
1121759|NCT02423850|Ulcer area|ulcer area
1121760|NCT02423850|Ulcer volume|ulcer volume
1121761|NCT02423850|3D measurement|3d measurement
1121762|NCT02423837|follicular lymphoma|follicular lymphoma
1121763|NCT02423837|bendamustine|bendamustine
1121764|NCT02423837|rituximab|rituximab
1121765|NCT02423798|Diabetes|diabetes
1121766|NCT02423798|Glucose sensor|glucose sensor
1121767|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
1121768|NCT02423798|CGM|cgm
1121769|NCT02423759|Chemoprevention|chemoprevention
1121770|NCT02423733|depression|depression
1121771|NCT02423733|dysthymia|dysthymia
1121772|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
1121773|NCT02423733|CBT|cbt
1121774|NCT02423733|problem-solving therapy|problem-solving therapy
1121775|NCT02423733|PST|pst
1121776|NCT02423733|waitlist|waitlist
1121777|NCT02423733|secondary mental health care|secondary mental health care
1121778|NCT02423733|mental health|mental health
1121779|NCT02423733|e-therapy|e-therapy
1121780|NCT02423733|computerized therapy|computerized therapy
1121781|NCT02423668|cataract surgery|cataract surgery
1121782|NCT02423668|biometry|biometry
1121783|NCT02423668|second eye refinement|second eye refinement
1121784|NCT02423668|effective lens position|effective lens position
1121785|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
1121786|NCT02423616|MIP|mip
1121787|NCT02423616|Hand Grip|hand grip
1121788|NCT02423616|Correlation|correlation
1121789|NCT02423616|Inspiratory Pressure|inspiratory pressure
1121790|NCT02423616|Hand Grip Force|hand grip force
1121791|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
1121792|NCT02423603|Metastatic|metastatic
1121793|NCT02423603|AKT Inhibitor|akt inhibitor
1121794|NCT02423603|Advanced|advanced
1121795|NCT02423603|AZD5363|azd5363
1121796|NCT02423603|Paclitaxel|paclitaxel
1121797|NCT02423603|PAKT|pakt
1121798|NCT02423590|Squamous|squamous
1121799|NCT02423590|Lung|lung
1121800|NCT02423590|Apatorsen|apatorsen
1121801|NCT02423577|antiviral|antiviral
1121802|NCT02423577|influenza|influenza
1121803|NCT02423577|challenge|challenge
1121804|NCT02423564|Probiotic|probiotic
1121805|NCT02423564|Digesta-Lac|digesta-lac
1121806|NCT02423564|Occasional Constipation|occasional constipation
1121807|NCT02423564|Constipation|constipation
1121808|NCT02423551|Gut microbiota|gut microbiota
1121809|NCT02423551|Intestinal permeability|intestinal permeability
1121810|NCT02423551|Gut barrier integrity|gut barrier integrity
1121811|NCT02423525|glioblastoma|glioblastoma
1121812|NCT02423525|astrocytoma|astrocytoma
1121813|NCT02423525|oligodendroglioma|oligodendroglioma
1121814|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
1121815|NCT02423525|low grade gliomas|low grade gliomas
1121816|NCT02423525|brain metastases|brain metastases
1121817|NCT02423525|meningiomas|meningiomas
1121818|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
1121819|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
1121820|NCT02423512|Vedolizumab|vedolizumab
1121821|NCT02423512|Ulcerative Colitis|ulcerative colitis
1121822|NCT02423512|Crohn's Disease|crohn's disease
1121823|NCT02423512|MADCAM1|madcam1
1121824|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
1121825|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
1121826|NCT02423499|Bipolar Disorder|bipolar disorder
1121833|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1121834|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1121835|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
1121836|NCT02423434|Diabetes Complications|diabetes complications
1121837|NCT02423382|silicone oil|silicone oil
1121838|NCT02423382|retinal saturation|retinal saturation
1121839|NCT02423382|retinal blood flow|retinal blood flow
1121840|NCT02423382|retinal detachment|retinal detachment
1121841|NCT02423369|S-100B protein|s-100b protein
1121842|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
1121843|NCT02423356|breast cancer|breast cancer
1121844|NCT02423356|sarcoma|sarcoma
1121845|NCT02423356|lymphoma|lymphoma
1121846|NCT02423356|echocardiography|echocardiography
1121847|NCT02423356|cardiotoxicity|cardiotoxicity
1121848|NCT02423356|pharmacogenetics|pharmacogenetics
1121849|NCT02423356|doxorubicin|doxorubicin
1121850|NCT02423356|chemotherapy|chemotherapy
1121851|NCT02423291|PMLBCL|pmlbcl
1121852|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
1121853|NCT02423291|CD30-positive|cd30-positive
1121854|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
1121855|NCT02423278|gastrectomy|gastrectomy
1121856|NCT02423278|lymphadenectomy|lymphadenectomy
1121857|NCT02423278|gastric cancer|gastric cancer
1121858|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
1121859|NCT02423278|overall survival|overall survival
1121860|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
1121861|NCT02423265|Ranolazine|ranolazine
1121862|NCT02423252|Critical illness|critical illness
1121863|NCT02423252|Intervention|intervention
1121864|NCT02423252|RCT|rct
1121865|NCT02423252|Relaxation|relaxation
1121866|NCT02423252|Guided imagery|guided imagery
1121867|NCT02423252|Touch/Massage|touch/massage
1121868|NCT02423252|Music listening|music listening
1121869|NCT02423252|Neuropeptides|neuropeptides
1121870|NCT02423252|Inflammatory molecules|inflammatory molecules
1121871|NCT02423252|Post-traumatic stress|post-traumatic stress
1121872|NCT02423252|Critical care nurse|critical care nurse
1121873|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
1121874|NCT02423252|Interpersonal support|interpersonal support
1121875|NCT02423213|OCT|oct
1121876|NCT02423213|image-guided surgery|image-guided surgery
1121877|NCT02423213|ophthalmic surgery|ophthalmic surgery
1121878|NCT02423187|Stomach ulcer|stomach ulcer
1121879|NCT02423187|Duodenal ulcer|duodenal ulcer
1121880|NCT02423187|Rabeprazole|rabeprazole
1121881|NCT02423187|Recurrence|recurrence
1121882|NCT02423161|OCT|oct
1121883|NCT02423161|image-guided surgery|image-guided surgery
1122398|NCT02420860|Ranitidine|ranitidine
1121884|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
1121885|NCT02423161|corneal surgery|corneal surgery
1121886|NCT02423148|Lung Cancer|lung cancer
1121887|NCT02423096|biomarker|biomarker
1121888|NCT02423096|neuroendocrine|neuroendocrine
1121889|NCT02423096|metabolite|metabolite
1121890|NCT02423096|cognitive functioning|cognitive functioning
1121891|NCT02423096|clinical symptoms|clinical symptoms
1121892|NCT02423096|schizophrenia|schizophrenia
1121897|NCT02423070|Cell-free DNA|cell-free dna
1121898|NCT02423070|Acute Rejection|acute rejection
1121899|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
1121900|NCT02423070|Non-Invasive Testing|non-invasive testing
1121901|NCT02423070|Chronic Rejection|chronic rejection
1121902|NCT02423057|Pharmacodynamics|pharmacodynamics
1121903|NCT02423057|DNA Methylation|dna methylation
1121904|NCT02423057|Pharmacokinetics|pharmacokinetics
1121905|NCT02423057|Nucleoside Analogue|nucleoside analogue
1121906|NCT02423057|Epigenetics|epigenetics
1121907|NCT02423044|Anxiety|anxiety
1121908|NCT02423044|fMRI|fmri
1121909|NCT02423044|Virtual Reality|virtual reality
1121910|NCT02423044|Shock Threat|shock threat
1121911|NCT02423044|Healthy Volunteer|healthy volunteer
1121912|NCT02423031|Physiological Measures|physiological measures
1121913|NCT02423031|Emotional Context|emotional context
1121914|NCT02423031|Pediatric|pediatric
1121915|NCT02423031|Distresss Screening|distresss screening
1121916|NCT02423005|Stress urinary incontinence|stress urinary incontinence
1121917|NCT02423005|Neurotech Vital Compact|neurotech vital compact
1121918|NCT02423005|1h Provacative Pad Test|1h provacative pad test
1121919|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
1121920|NCT02422992|Iron metabolism|iron metabolism
1121921|NCT02422992|MRI|mri
1121922|NCT02422992|risk factors|risk factors
1121923|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
1121924|NCT02422953|Stunting|stunting
1121925|NCT02422953|Wasting|wasting
1121926|NCT02422953|Underweight|underweight
1121927|NCT02422927|C-Reactive Protein|c-reactive protein
1121928|NCT02422927|Endothelial Microparticles|endothelial microparticles
1121929|NCT02422927|Endothelium|endothelium
1121930|NCT02422927|Nutraceutical|nutraceutical
1121931|NCT02422927|Cholesterol|cholesterol
1121932|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
1121933|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
1121934|NCT02422888|Endothelial function|endothelial function
1121935|NCT02422888|Ticagrelor|ticagrelor
1121936|NCT02422888|Prasugrel|prasugrel
1121937|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
1121938|NCT02422875|Scleroderma|scleroderma
1121939|NCT02422875|Myositis|myositis
1121940|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1121941|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
1121942|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
1121943|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
1121944|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1121945|NCT02422875|Graft vs Host Disease|graft vs host disease
1121946|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
1121947|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
1121948|NCT02422875|Hepatitis C|hepatitis c
1121949|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
1121950|NCT02422875|Sepsis|sepsis
1121951|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
1121952|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
1121953|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
1121954|NCT02422862|Physiotherapy|physiotherapy
1121955|NCT02422862|Manual Therapy|manual therapy
1121956|NCT02422849|Patient admission|patient admission
1121957|NCT02422836|photodamage|photodamage
1121958|NCT02422836|fine lines|fine lines
1121959|NCT02422836|wrinkles|wrinkles
1121960|NCT02422836|dyschromia|dyschromia
1121961|NCT02422823|anesthesia|anesthesia
1121962|NCT02422823|volumes|volumes
1121963|NCT02422823|articaine|articaine
1121964|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
1121965|NCT02422797|HIV|hiv
1121966|NCT02422797|NNRTI-sparing|nnrti-sparing
1121967|NCT02422797|two-drug regimen|two-drug regimen
1121968|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
1121969|NCT02422797|protease inhibitor|protease inhibitor
1121970|NCT02422797|integrase inhibitor|integrase inhibitor
1121971|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1121972|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
1121973|NCT02422797|virologically-suppressed|virologically-suppressed
1121974|NCT02422784|Vitamin D insufficient|vitamin d insufficient
1121975|NCT02422784|rooibos tea|rooibos tea
1121976|NCT02422784|calcium|calcium
1121977|NCT02422758|hypothermia|hypothermia
1121978|NCT02422758|perioperative nursing|perioperative nursing
1121979|NCT02422758|prewarming|prewarming
1121980|NCT02422758|prevention and control|prevention and control
1121981|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
1121982|NCT02422732|NF1|nf1
1121983|NCT02422732|Children|children
1121984|NCT02422732|Reading disability|reading disability
1121985|NCT02422732|Morphological and functional MRI|morphological and functional mri
1121986|NCT02422732|Genetic analysis|genetic analysis
1121987|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
1121988|NCT02422719|Intolerance|intolerance
1121989|NCT02422719|Resitance|resitance
1121990|NCT02422719|Radotinib|radotinib
1121991|NCT02422693|hydrotherapy|hydrotherapy
1121992|NCT02422693|aquatic|aquatic
1121993|NCT02422680|Quality assurance|quality assurance
1121994|NCT02422680|Caecum intubation rate|caecum intubation rate
1121995|NCT02422680|Patient satisfaction|patient satisfaction
1121996|NCT02422667|Orthopedics|orthopedics
1121997|NCT02422667|Outcome Assessment|outcome assessment
1121998|NCT02422628|EGFR inhibitor|egfr inhibitor
1121999|NCT02422628|EGFR mutation|egfr mutation
1122000|NCT02422628|EGFR|egfr
1122001|NCT02422628|adenocarcinoma|adenocarcinoma
1122002|NCT02422628|EGFR TKI|egfr tki
1122003|NCT02422628|treatment|treatment
1122004|NCT02422628|Non small cell|non small cell
1122005|NCT02422615|HR-positive|hr-positive
1122006|NCT02422615|HER2-negative|her2-negative
1122007|NCT02422615|Advanced breast cancer|advanced breast cancer
1122008|NCT02422615|LEE011|lee011
1122009|NCT02422615|ribociclib|ribociclib
1122010|NCT02422615|fulvestrant|fulvestrant
1122011|NCT02422615|faslodex|faslodex
1122012|NCT02422615|CDK|cdk
1122013|NCT02422615|CDK4|cdk4
1122014|NCT02422615|CDK6|cdk6
1122015|NCT02422615|CDK4/6|cdk4/6
1122016|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
1122017|NCT02422615|Phase III|phase iii
1122018|NCT02422615|ER-positive|er-positive
1122019|NCT02422615|PR-positive|pr-positive
1122020|NCT02422615|Postmenopausal|postmenopausal
1122021|NCT02422615|Men|men
1122022|NCT02422602|Patients|patients
1122023|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
1122024|NCT02422589|ALK-positive advanced tumors,|alk-positive advanced tumors,
1122025|NCT02422589|midazolam,|midazolam,
1122026|NCT02422589|warfarin,|warfarin,
1122027|NCT02422589|ceritinib,|ceritinib,
1122028|NCT02422589|ALK,|alk,
1122029|NCT02422589|CYP3A-4,|cyp3a-4,
1122030|NCT02422589|Drug drug intereaction|drug drug intereaction
1122031|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1122032|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
1122033|NCT02422563|chemo-radiation|chemo-radiation
1122034|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
1122035|NCT02422563|cisplatin|cisplatin
1122036|NCT02422563|paclitaxel|paclitaxel
1122037|NCT02422563|carboplatin|carboplatin
1122038|NCT02422563|ifosfamide|ifosfamide
1122039|NCT02422550|MRI|mri
1122040|NCT02422550|15-073|15-073
1122041|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
1122042|NCT02422524|Hepatic|hepatic
1122043|NCT02422524|impairment|impairment
1122044|NCT02422524|PA-824|pa-824
1122045|NCT02422524|Pharmacokinetics|pharmacokinetics
1122046|NCT02422524|Safety|safety
1122047|NCT02422524|Tuberculosis|tuberculosis
1122048|NCT02422511|Genome Sequencing|genome sequencing
1122049|NCT02422511|Exome Sequencing|exome sequencing
1122050|NCT02422511|Newborn Screening|newborn screening
1122051|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
1122052|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
1122053|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
1122054|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
1122055|NCT02422498|Biomarker of Response|biomarker of response
1122056|NCT02422498|15-032|15-032
1122057|NCT02422498|Patients|patients
1122058|NCT02422485|Salsalate|salsalate
1122059|NCT02422446|Endothelial function|endothelial function
1122060|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
1122061|NCT02422446|Triglycerides|triglycerides
1122062|NCT02422433|EGD|egd
1122063|NCT02422433|OFDI|ofdi
1122064|NCT02422433|Barrett's Esophagus|barrett's esophagus
1122065|NCT02422433|Imaging|imaging
1122066|NCT02422420|Diabetes Prevention|diabetes prevention
1122067|NCT02422420|Financial Incentives|financial incentives
1122068|NCT02422420|Medicaid|medicaid
1122069|NCT02422420|Motivation|motivation
1122070|NCT02422381|NSCLC|nsclc
1122071|NCT02422381|lung cancer|lung cancer
1122072|NCT02422381|Gemzar|gemzar
1122073|NCT02422381|Pembrolizumab|pembrolizumab
1122074|NCT02422381|Anti-PD-1|anti-pd-1
1122075|NCT02422381|Immunotherapy|immunotherapy
1122076|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
1122077|NCT02422368|Antioxidant|antioxidant
1122078|NCT02422368|Activity|activity
1122079|NCT02422368|Severity|severity
1122080|NCT02422355|hip|hip
1122081|NCT02422355|femoral neck|femoral neck
1122082|NCT02422355|Garden classification|garden classification
1122083|NCT02422355|healing|healing
1122084|NCT02422355|cut-out|cut-out
1122085|NCT02422355|iatrogenic fracture|iatrogenic fracture
1122086|NCT02422355|implant|implant
1122087|NCT02422355|rotational stability|rotational stability
1122088|NCT02422355|minimal invasive|minimal invasive
1122089|NCT02422329|Advanced Cancers|advanced cancers
1122090|NCT02422329|Constipation|constipation
1122091|NCT02422329|Recurrent cancer|recurrent cancer
1122092|NCT02422329|Locally advanced cancer|locally advanced cancer
1122093|NCT02422329|Metastatic cancer|metastatic cancer
1122094|NCT02422329|Video|video
1122095|NCT02422329|Fact sheet|fact sheet
1122096|NCT02422329|Questionnaires|questionnaires
1122097|NCT02422329|Surveys|surveys
1122098|NCT02422303|Depression|depression
1122099|NCT02422303|Gynecoligical surgery|gynecoligical surgery
1122100|NCT02422303|Ketamine|ketamine
1122101|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
1122102|NCT02422290|Ketamine|ketamine
1122103|NCT02422290|Glutamate|glutamate
1122104|NCT02422290|OCD treatment|ocd treatment
1122105|NCT02422290|OCD medication|ocd medication
1122106|NCT02422277|Cystoprostatectomy|cystoprostatectomy
1122107|NCT02422277|Sexual function|sexual function
1122108|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
1122109|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
1122110|NCT02422277|Erectile dysfunction|erectile dysfunction
1122111|NCT02422277|Penile rehabilitation|penile rehabilitation
1122112|NCT02422212|metabolism|metabolism
1122113|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
1122114|NCT02422212|weight regain|weight regain
1122115|NCT02422212|energy expenditure|energy expenditure
1122116|NCT02422212|bariatric|bariatric
1122117|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
1122118|NCT02422186|Esketamine|esketamine
1122119|NCT02422186|Oral Antidepressant|oral antidepressant
1122120|NCT02422186|Elderly Participants|elderly participants
1122121|NCT02422134|Pregnancy|pregnancy
1122122|NCT02422134|implantation|implantation
1122123|NCT02422134|Cytokine|cytokine
1122124|NCT02422108|RANKL|rankl
1122125|NCT02422082|Osteopenia|osteopenia
1122126|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
1122127|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
1122128|NCT02422056|Cleft Palate|cleft palate
1122129|NCT02422056|Hemorrhage|hemorrhage
1122130|NCT02422056|Palatoplasty|palatoplasty
1122131|NCT02422043|adolescence|adolescence
1122132|NCT02422030|Male Volunteers|male volunteers
1122135|NCT02422017|topical timolol|topical timolol
1122136|NCT02422004|Rehabilitation|rehabilitation
1122137|NCT02422004|Weight-bearing|weight-bearing
1122138|NCT02422004|Range of motion|range of motion
1122139|NCT02421978|Cognitive dysfunction|cognitive dysfunction
1122140|NCT02421978|Inflammation|inflammation
1122141|NCT02421978|Fatigue|fatigue
1122142|NCT02421978|Decreased motivation|decreased motivation
1122143|NCT02421965|Schizophrenia|schizophrenia
1122144|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
1122145|NCT02421965|Bipolar Disorder|bipolar disorder
1122146|NCT02421965|Major Depressive Disorder|major depressive disorder
1122147|NCT02421965|Mobile Application|mobile application
1122148|NCT02421965|Smartphone|smartphone
1122149|NCT02421965|SMI|smi
1122150|NCT02421965|Illness Self-Management|illness self-management
1122151|NCT02421965|EHealth|ehealth
1122152|NCT02421965|E-Health|e-health
1122153|NCT02421965|Health Technology|health technology
1122154|NCT02421965|mHealth|mhealth
1122155|NCT02421965|m-Health|m-health
1122156|NCT02421939|ASP2215|asp2215
1122157|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
1122158|NCT02421939|FLT3 Mutation|flt3 mutation
1122159|NCT02421939|gilteritinib|gilteritinib
1122160|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
1122161|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1122162|NCT02421874|Patient care team|patient care team
1122163|NCT02421874|Care management|care management
1122164|NCT02421874|Electronic health records|electronic health records
1122165|NCT02421861|anxiety|anxiety
1122166|NCT02421861|intensive care unit|intensive care unit
1122167|NCT02421861|critical care|critical care
1122168|NCT02421848|Body composition|body composition
1122169|NCT02421848|Sarcopenia|sarcopenia
1122170|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
1122171|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
1122172|NCT02421796|Malnutrition|malnutrition
1122173|NCT02421796|Celiac disease|celiac disease
1122174|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
1122175|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
1122176|NCT02421783|Multiple food allergy|multiple food allergy
1122177|NCT02421783|Body mass index|body mass index
1122178|NCT02421783|Osteoporosis|osteoporosis
1122179|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
1122180|NCT02421757|placebo|placebo
1122181|NCT02421744|rehabilitation|rehabilitation
1122182|NCT02421744|Multiple Sclerosis|multiple sclerosis
1122183|NCT02421744|mobility|mobility
1122184|NCT02421744|gait|gait
1122185|NCT02421744|task-oriented training|task-oriented training
1122186|NCT02421731|Rehabilitation|rehabilitation
1122187|NCT02421731|Gait|gait
1122188|NCT02421718|Acute toxicity|acute toxicity
1122189|NCT02421718|Late toxicity|late toxicity
1122190|NCT02421718|Prediction models|prediction models
1122191|NCT02421679|PTSD|ptsd
1122192|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
1122193|NCT02421679|open-label extension|open-label extension
1122194|NCT02421653|Micronutrient powders|micronutrient powders
1122195|NCT02421653|MNP|mnp
1122196|NCT02421653|Weaning|weaning
1122197|NCT02421653|Home fortification|home fortification
1122198|NCT02421653|Iodine|iodine
1122199|NCT02421653|Iodine deficiency|iodine deficiency
1122200|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
1122201|NCT02421653|IDD|idd
1122202|NCT02421653|Infant|infant
1122203|NCT02421653|Growth|growth
1122204|NCT02421653|Iodised oil|iodised oil
1122205|NCT02421627|moxibustion|moxibustion
1122206|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
1122207|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
1122208|NCT02421614|acute respiratory failure|acute respiratory failure
1122209|NCT02421614|lung|lung
1122210|NCT02421614|enteral feeding|enteral feeding
1122211|NCT02421614|feeding composition|feeding composition
1122212|NCT02421614|olive|olive
1122213|NCT02421614|high fat|high fat
1122214|NCT02421549|Remote Monitoring|remote monitoring
1122215|NCT02421549|Remote Care|remote care
1122216|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1122217|NCT02421549|Pacemaker|pacemaker
1122218|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1122219|NCT02421523|Exercise|exercise
1122220|NCT02421523|Strength training|strength training
1122221|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
1122222|NCT02421484|Phase I clinical trial|phase i clinical trial
1122223|NCT02421484|stem cell|stem cell
1122224|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
1122225|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
1122226|NCT02421471|Actinic Keratosis|actinic keratosis
1122227|NCT02421471|topical treatment|topical treatment
1122228|NCT02421471|ingenol mebutate|ingenol mebutate
1122229|NCT02421432|trananal TME|trananal tme
1122230|NCT02421432|safety|safety
1122231|NCT02421432|efficacy|efficacy
1122232|NCT02421432|difficult cases|difficult cases
1122233|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
1122234|NCT02421419|snapping finger|snapping finger
1122235|NCT02421419|trigger digits|trigger digits
1122236|NCT02421419|trigger thumb|trigger thumb
1122237|NCT02421393|Bone quality|bone quality
1122238|NCT02421393|Bone strength|bone strength
1122239|NCT02421393|Fractures|fractures
1122240|NCT02421393|Muscle strength|muscle strength
1122241|NCT02421393|Gait and balance|gait and balance
1122242|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
1122243|NCT02421393|Falls|falls
1122244|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
1122245|NCT02421380|MRI|mri
1122246|NCT02421380|14-205|14-205
1122247|NCT02421354|Myeloproliferative Diseases|myeloproliferative diseases
1122248|NCT02421354|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1122249|NCT02421354|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1122250|NCT02421354|MF|mf
1122251|NCT02421354|Nivolumab|nivolumab
1122252|NCT02421354|BMS-936558|bms-936558
1122253|NCT02421354|Questionnaire|questionnaire
1122254|NCT02421354|Survey|survey
1122255|NCT02421354|Phone call|phone call
1122256|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
1122257|NCT02421341|Pulmonary|pulmonary
1122258|NCT02421341|Skeletal Muscle|skeletal muscle
1122259|NCT02421341|Exercise|exercise
1122260|NCT02421315|OCD|ocd
1122261|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1122262|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1122263|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
1122264|NCT02421289|efavirenz|efavirenz
1122265|NCT02421289|Thai|thai
1122266|NCT02421289|HIV-infected patient|hiv-infected patient
1122267|NCT02421289|pharmacogenomic|pharmacogenomic
1122268|NCT02421263|Psilocybin|psilocybin
1122269|NCT02421263|Pharmacologic Actions|pharmacologic actions
1122270|NCT02421263|Psychotropic Drugs|psychotropic drugs
1122271|NCT02421224|Smoking Cessation|smoking cessation
1122272|NCT02421224|Incentives|incentives
1122273|NCT02421224|Health Behavior|health behavior
1122274|NCT02421224|Smoking|smoking
1122275|NCT02421224|Work-site|work-site
1122276|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
1122277|NCT02421211|Simeprevir|simeprevir
1122278|NCT02421211|Ledipasvir|ledipasvir
1122279|NCT02421211|Sofosbuvir|sofosbuvir
1122280|NCT02421198|Intervention Studies|intervention studies
1122281|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1122282|NCT02421185|JNJ 42756493|jnj 42756493
1122283|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
1122284|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
1122285|NCT02421159|HIV/AIDS|hiv/aids
1122286|NCT02421159|vulnerable populations|vulnerable populations
1122287|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
1122288|NCT02421159|peer-driven intervention|peer-driven intervention
1122289|NCT02421159|tailored intervention|tailored intervention
1122290|NCT02421159|African-American|african-american
1122291|NCT02421159|Latino/Hispanic|latino/hispanic
1122511|NCT02420691|Thymic|thymic
1122292|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
1122293|NCT02421159|Brooklyn|brooklyn
1122294|NCT02421133|Care transition program|care transition program
1122295|NCT02421133|Patient readmission|patient readmission
1122296|NCT02421133|Transition Nurse|transition nurse
1122297|NCT02421133|Stepped wedge|stepped wedge
1122299|NCT02421081|CD34|cd34
1122300|NCT02421081|CD133|cd133
1122301|NCT02421081|CD309|cd309
1122302|NCT02421081|Radial Artery|radial artery
1122303|NCT02421081|Ulnar Artery|ulnar artery
1122304|NCT02421081|Lymphoid Cell|lymphoid cell
1122305|NCT02421081|blood levels|blood levels
1122306|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
1122307|NCT02421081|stem cells|stem cells
1122308|NCT02421068|Paracetamol|paracetamol
1122309|NCT02421068|Fentanyl|fentanyl
1122310|NCT02421068|Phenobarbital|phenobarbital
1122311|NCT02421068|Doxapram|doxapram
1122312|NCT02421068|Midazolam|midazolam
1122313|NCT02421068|Sildenafil|sildenafil
1122314|NCT02421068|Levetiracetam|levetiracetam
1122315|NCT02421068|Pharmacokinetics|pharmacokinetics
1122316|NCT02421068|Pharmacology|pharmacology
1122317|NCT02421068|Fluconazole|fluconazole
1122318|NCT02421068|Ibuprofen|ibuprofen
1122319|NCT02421055|Bariatric Surgery|bariatric surgery
1122320|NCT02421055|Gastric Bypass|gastric bypass
1122321|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
1122322|NCT02421055|Gastroplasty|gastroplasty
1122323|NCT02421042|Hepatic Impairment|hepatic impairment
1122324|NCT02421042|Hepatic Function|hepatic function
1122325|NCT02421029|gadolinium|gadolinium
1122326|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
1122327|NCT02421029|heavy metal toxicity|heavy metal toxicity
1122328|NCT02421016|De novo stenosis|de novo stenosis
1122329|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
1122330|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
1122331|NCT02421003|heart surgery blood|heart surgery blood
1122332|NCT02420990|ADHD|adhd
1122333|NCT02420990|Adolescents|adolescents
1122334|NCT02420990|Substance Use Disorders|substance use disorders
1122335|NCT02420977|radiotracer|radiotracer
1122336|NCT02420964|injectable|injectable
1122337|NCT02420964|teaching methods|teaching methods
1122338|NCT02420951|Knee|knee
1122339|NCT02420951|Arthroplasty|arthroplasty
1122340|NCT02420951|Bupivacaine|bupivacaine
1122341|NCT02420951|Anesthetics, Local|anesthetics, local
1122342|NCT02420938|Leukemia|leukemia
1122343|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1122344|NCT02420938|CLL|cll
1122345|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1122346|NCT02420938|SLL|sll
1122347|NCT02420938|Refractory/relapsed|refractory/relapsed
1122348|NCT02420938|High-risk molecular features|high-risk molecular features
1122349|NCT02420938|Rituximab|rituximab
1122350|NCT02420938|Rituxan|rituxan
1122351|NCT02420938|Urelumab|urelumab
1122352|NCT02420925|Gastroparesis|gastroparesis
1122353|NCT02420925|Celiac Plexus Block|celiac plexus block
1122354|NCT02420912|Leukemia|leukemia
1122355|NCT02420912|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1122356|NCT02420912|CLL|cll
1122357|NCT02420912|Relapsed|relapsed
1122358|NCT02420912|Refractory|refractory
1122359|NCT02420912|High-risk|high-risk
1122360|NCT02420912|Untreated|untreated
1122361|NCT02420912|Nivolumab|nivolumab
1122362|NCT02420912|BMS-936558|bms-936558
1122363|NCT02420912|Opdivo|opdivo
1122364|NCT02420912|Ibrutinib|ibrutinib
1122365|NCT02420912|PCI-32765|pci-32765
1122366|NCT02420912|Imbruvica|imbruvica
1122367|NCT02420899|IVUS|ivus
1122368|NCT02420899|ACS|acs
1122369|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
1122370|NCT02420873|Leukemia|leukemia
1122371|NCT02420873|Hematological malignancy|hematological malignancy
1122372|NCT02420873|Myelofibrosis|myelofibrosis
1122373|NCT02420873|MF|mf
1122374|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
1122375|NCT02420873|BPDCN|bpdcn
1122376|NCT02420873|CD56 tumor marker|cd56 tumor marker
1122377|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
1122378|NCT02420873|AML|aml
1122379|NCT02420873|Natural-killer leukemia|natural-killer leukemia
1122380|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1122381|NCT02420873|ALL|all
1122382|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
1122383|NCT02420873|IMGN901|imgn901
1122384|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
1122385|NCT02420860|Myeloma|myeloma
1122386|NCT02420860|Multiple myeloma|multiple myeloma
1122387|NCT02420860|MM|mm
1122388|NCT02420860|Post autologous stem cell transplantation|post autologous stem cell transplantation
1122389|NCT02420860|ASCT|asct
1122390|NCT02420860|Elotuzumab|elotuzumab
1122391|NCT02420860|Lenalidomide|lenalidomide
1122392|NCT02420860|CC-5013|cc-5013
1122393|NCT02420860|Revlimid|revlimid
1122394|NCT02420860|Dexamethasone|dexamethasone
1122395|NCT02420860|Decadron|decadron
1122396|NCT02420860|Diphenhydramine|diphenhydramine
1122397|NCT02420860|Benadryl|benadryl
1122399|NCT02420860|Ranitidine hydrochloride|ranitidine hydrochloride
1122400|NCT02420860|Zantac|zantac
1122401|NCT02420860|Symptom questionnaire|symptom questionnaire
1122402|NCT02420860|Survey|survey
1122403|NCT02420847|Bladder cancer|bladder cancer
1122404|NCT02420847|Urothelial cancer|urothelial cancer
1122405|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
1122406|NCT02420847|Metastatic|metastatic
1122407|NCT02420847|Locally unresectable|locally unresectable
1122408|NCT02420847|Ixazomib|ixazomib
1122409|NCT02420847|Gemcitabine|gemcitabine
1122410|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
1122411|NCT02420847|Gemzar|gemzar
1122412|NCT02420847|Doxorubicin|doxorubicin
1122413|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
1122414|NCT02420847|Adriamycin PFS|adriamycin pfs
1122415|NCT02420847|Adriamycin RDF|adriamycin rdf
1122416|NCT02420847|Adriamycin|adriamycin
1122417|NCT02420847|Rubex|rubex
1122418|NCT02420808|CAD|cad
1122419|NCT02420808|STEMI|stemi
1122420|NCT02420808|non STEMI|non stemi
1122421|NCT02420808|Unstable angina|unstable angina
1122422|NCT02420808|Greece|greece
1122423|NCT02420795|Lymphoma|lymphoma
1122424|NCT02420795|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1122425|NCT02420795|Relapsed/Refractory|relapsed/refractory
1122426|NCT02420795|NHL|nhl
1122427|NCT02420795|Mantle cell lymphoma|mantle cell lymphoma
1122428|NCT02420795|MCL|mcl
1122429|NCT02420795|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1122430|NCT02420795|DLBCL|dlbcl
1122431|NCT02420795|Transformed large cell lymphoma|transformed large cell lymphoma
1122432|NCT02420795|TLCL|tlcl
1122433|NCT02420795|ONC201|onc201
1122434|NCT02420795|Phone call|phone call
1122435|NCT02420782|Pharmacokinetics|pharmacokinetics
1122436|NCT02420782|ASP6282|asp6282
1122437|NCT02420782|Pharmacodynamics|pharmacodynamics
1122438|NCT02420782|Drug-drug interaction|drug-drug interaction
1122439|NCT02420782|Midazolam|midazolam
1122440|NCT02420782|Safety and tolerability|safety and tolerability
1122441|NCT02420782|Healthy volunteers|healthy volunteers
1122442|NCT02420782|Itraconazole|itraconazole
1122444|NCT02420769|Progesterone|progesterone
1122445|NCT02420769|Doppler|doppler
1122446|NCT02420769|Corpus Luteum|corpus luteum
1122447|NCT02420743|PTD|ptd
1122448|NCT02420717|Leukemia|leukemia
1122449|NCT02420717|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1122450|NCT02420717|ALL|all
1122451|NCT02420717|Philadelphia Chromosome (Ph)-Like|philadelphia chromosome (ph)-like
1122452|NCT02420717|Relapsed|relapsed
1122453|NCT02420717|Refractory|refractory
1122454|NCT02420717|6-mercaptopurine|6-mercaptopurine
1122455|NCT02420717|Mercaptopurine|mercaptopurine
1122456|NCT02420717|6-MP|6-mp
1122457|NCT02420717|Purinethol|purinethol
1122458|NCT02420717|Ruxolitinib|ruxolitinib
1122459|NCT02420717|Jakafi|jakafi
1122460|NCT02420717|INCB018424|incb018424
1122461|NCT02420717|INC424|inc424
1122462|NCT02420717|Dasatinib|dasatinib
1122463|NCT02420717|BMS-354825|bms-354825
1122464|NCT02420717|Sprycel|sprycel
1122465|NCT02420717|Rituximab|rituximab
1122466|NCT02420717|Rituxan|rituxan
1122467|NCT02420717|G-CSF|g-csf
1122468|NCT02420717|Filgrastim|filgrastim
1122469|NCT02420717|Neupogen|neupogen
1122470|NCT02420717|Pegfilgrastim|pegfilgrastim
1122471|NCT02420717|Neulasta|neulasta
1122472|NCT02420717|PEG-G-CSF|peg-g-csf
1122473|NCT02420717|Methotrexate|methotrexate
1122474|NCT02420717|Cytarabine|cytarabine
1122475|NCT02420717|Ara-C|ara-c
1122476|NCT02420717|Cytosar|cytosar
1122477|NCT02420717|DepoCyt|depocyt
1122478|NCT02420717|Cytosine|cytosine
1122479|NCT02420717|Arabinosine Hydrochloride|arabinosine hydrochloride
1122480|NCT02420717|Cyclophosphamide|cyclophosphamide
1122481|NCT02420717|Cytoxan|cytoxan
1122482|NCT02420717|Neosar|neosar
1122483|NCT02420717|Mesna|mesna
1122484|NCT02420717|Mesnex|mesnex
1122485|NCT02420717|Doxorubicin|doxorubicin
1122486|NCT02420717|Doxorubucin hydrochloride|doxorubucin hydrochloride
1122487|NCT02420717|Adriamycin PFS|adriamycin pfs
1122488|NCT02420717|Adriamycin RDF|adriamycin rdf
1122489|NCT02420717|Adriamycin|adriamycin
1122490|NCT02420717|Rubex|rubex
1122491|NCT02420717|Vincristine|vincristine
1122492|NCT02420717|Dexamethasone|dexamethasone
1122493|NCT02420717|Decadron|decadron
1122494|NCT02420717|Solumedrol|solumedrol
1122495|NCT02420717|Methylprednisolone|methylprednisolone
1122496|NCT02420717|Depo-medrol|depo-medrol
1122497|NCT02420717|Medrol|medrol
1122498|NCT02420717|Solu-medrol|solu-medrol
1122499|NCT02420717|Prednisone|prednisone
1122500|NCT02420717|Leucovorin|leucovorin
1122501|NCT02420717|Citrovorum|citrovorum
1122502|NCT02420717|Wellcovorin|wellcovorin
1122503|NCT02420704|IVF|ivf
1122504|NCT02420704|endometrial thickness|endometrial thickness
1122505|NCT02420704|cleavage stage embryo|cleavage stage embryo
1122506|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
1122507|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
1122508|NCT02420691|Gastrointestinal cancer|gastrointestinal cancer
1122509|NCT02420691|Foregut neuroendocrine tumors|foregut neuroendocrine tumors
1122510|NCT02420691|NET|net
1122512|NCT02420691|Bronchopulmonary|bronchopulmonary
1122513|NCT02420691|Gastric|gastric
1122514|NCT02420691|Duodenal|duodenal
1122515|NCT02420691|Pancreatic|pancreatic
1122516|NCT02420691|LEE011|lee011
1122517|NCT02420665|Cervical Cancer|cervical cancer
1122518|NCT02420665|Cervical Dysplasia|cervical dysplasia
1122519|NCT02420665|Abnormal Pap test|abnormal pap test
1122520|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
1122521|NCT02420665|HPV|hpv
1122522|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
1122523|NCT02420665|VIA|via
1122524|NCT02420665|Colposcopy|colposcopy
1122525|NCT02420665|Proflavine|proflavine
1122526|NCT02420665|Acetic acid|acetic acid
1122527|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
1122528|NCT02420665|HRME|hrme
1122529|NCT02420665|Phone call|phone call
1122530|NCT02420613|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
1122531|NCT02420613|DIPG|dipg
1122532|NCT02420613|Newly Diagnosed|newly diagnosed
1122533|NCT02420613|Progressive|progressive
1122534|NCT02420613|Pediatrics|pediatrics
1122535|NCT02420613|Vorinostat|vorinostat
1122536|NCT02420613|SAHA|saha
1122537|NCT02420613|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1122538|NCT02420613|MSK-390|msk-390
1122539|NCT02420613|Zolinza|zolinza
1122540|NCT02420613|Temsirolimus|temsirolimus
1122541|NCT02420613|CCI-779|cci-779
1122542|NCT02420613|Torisel|torisel
1122543|NCT02420613|Radiation therapy|radiation therapy
1122544|NCT02420613|XRT|xrt
1122545|NCT02420600|Circulating tumor cells|circulating tumor cells
1122546|NCT02420600|Head and neck cancer|head and neck cancer
1122547|NCT02420600|PD-1|pd-1
1122548|NCT02420600|natural killer cells|natural killer cells
1122549|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1122550|NCT02420587|Prostate Cancer|prostate cancer
1122551|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1122653|NCT02419950|quality of life|quality of life
1122552|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
1122553|NCT02420587|mCRPC|mcrpc
1122554|NCT02420587|AMG 208|amg 208
1122555|NCT02420587|Questionnaire|questionnaire
1122556|NCT02420587|Survey|survey
1122557|NCT02420561|Depression|depression
1122558|NCT02420561|Substance-Related Disorders|substance-related disorders
1122559|NCT02420561|Mental Health|mental health
1122560|NCT02420535|Dementia|dementia
1122561|NCT02420535|Alzheimer's Disease|alzheimer's disease
1122562|NCT02420535|Caregivers|caregivers
1122563|NCT02420535|Behavioral|behavioral
1122564|NCT02420535|Caregiver burden|caregiver burden
1122565|NCT02420496|Parental nutrition|parental nutrition
1122566|NCT02420496|associated|associated
1122567|NCT02420470|diabetes|diabetes
1122568|NCT02420470|neural and vessel alteration|neural and vessel alteration
1122569|NCT02420470|prodromal stage|prodromal stage
1122570|NCT02420457|Fitness devices|fitness devices
1122571|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
1122572|NCT02420418|N-acetylcysteine|n-acetylcysteine
1122573|NCT02420418|Oxidative stress|oxidative stress
1122574|NCT02420418|inflammation|inflammation
1122575|NCT02420405|Gene testing|gene testing
1122576|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
1122577|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
1122578|NCT02420405|Small biopsies|small biopsies
1122579|NCT02420379|DMD|dmd
1122580|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
1122581|NCT02420379|eteplirsen|eteplirsen
1122582|NCT02420379|Dystrophin|dystrophin
1122583|NCT02420379|exon 51|exon 51
1122584|NCT02420353|muscle atrophy|muscle atrophy
1122585|NCT02420353|growth hormone|growth hormone
1122586|NCT02420353|ACL tear|acl tear
1122587|NCT02420340|Serious Mental Illness|serious mental illness
1122588|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
1122589|NCT02420327|nicotine|nicotine
1122590|NCT02420327|galantamine|galantamine
1122591|NCT02420327|attention|attention
1122592|NCT02420327|cognition|cognition
1122593|NCT02420327|non-smoker|non-smoker
1122594|NCT02420314|Ascorbate|ascorbate
1122595|NCT02420314|Ascorbic acid|ascorbic acid
1122596|NCT02420314|Vitamin C|vitamin c
1122597|NCT02420314|NSCLC|nsclc
1122598|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
1122599|NCT02420314|carboplatin|carboplatin
1122600|NCT02420314|paclitaxel|paclitaxel
1122601|NCT02420288|Pregnancy|pregnancy
1122602|NCT02420288|Fetoplacental growth|fetoplacental growth
1122603|NCT02420288|Physical exercise|physical exercise
1122604|NCT02420288|Pregnant|pregnant
1122605|NCT02420288|Placental development|placental development
1122606|NCT02420288|Active pregnancy|active pregnancy
1122607|NCT02420275|brain injury|brain injury
1122608|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
1122609|NCT02420275|sequel fatigue|sequel fatigue
1122610|NCT02420236|Exercise therapy|exercise therapy
1122611|NCT02420236|Resistance training|resistance training
1122612|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
1122613|NCT02420223|Recipients|recipients
1122923|NCT02418793|Inhibitors|inhibitors
1122614|NCT02420197|Exercise therapy|exercise therapy
1122615|NCT02420197|Resistance training|resistance training
1122616|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
1122617|NCT02420171|In Vitro|in vitro
1122618|NCT02420171|embryo quality|embryo quality
1122619|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1122620|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
1122621|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
1122622|NCT02420158|Quality of life|quality of life
1122623|NCT02420119|Iron Therapy|iron therapy
1122624|NCT02420119|serum phosphates|serum phosphates
1122625|NCT02420119|vitamin D|vitamin d
1122626|NCT02420106|cervical dystonia|cervical dystonia
1122627|NCT02420106|neck pain|neck pain
1122628|NCT02420106|OMM|omm
1122629|NCT02420106|spasmodic torticollis|spasmodic torticollis
1122630|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
1122631|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
1122632|NCT02420067|Audiological examination|audiological examination
1122633|NCT02420067|MRI|mri
1122634|NCT02420067|Surveillance|surveillance
1122635|NCT02420054|intermittent fasting|intermittent fasting
1122636|NCT02420054|alternate day fasting|alternate day fasting
1122637|NCT02420054|diabetes mellitus|diabetes mellitus
1122638|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1122639|NCT02420054|insulin sensitivity|insulin sensitivity
1122640|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
1122641|NCT02420041|Fluoroscopy|fluoroscopy
1122642|NCT02420041|Ultrasound|ultrasound
1122643|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
1122644|NCT02419963|microbiome|microbiome
1122645|NCT02419963|biomarkers|biomarkers
1122646|NCT02419963|Vitamin D|vitamin d
1122647|NCT02419963|Serotonin|serotonin
1122648|NCT02419950|inguinal hernia|inguinal hernia
1122649|NCT02419950|TEP|tep
1122650|NCT02419950|chronic pain|chronic pain
1122651|NCT02419950|male sex|male sex
1122652|NCT02419950|mesh fixation|mesh fixation
1122654|NCT02419950|national register|national register
1122655|NCT02419911|gastrointestinal|gastrointestinal
1122656|NCT02419911|gynecologic|gynecologic
1122657|NCT02419911|urologic|urologic
1122658|NCT02419911|bariatric|bariatric
1122659|NCT02419911|laparoscopic surgery|laparoscopic surgery
1122660|NCT02419898|Feasibility|feasibility
1122661|NCT02419885|finger amputation|finger amputation
1122662|NCT02419885|composite graft|composite graft
1122663|NCT02419885|adipo-fascia flap|adipo-fascia flap
1122664|NCT02419859|Diabetes Mellitus|diabetes mellitus
1122665|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1122666|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
1122667|NCT02419859|Metabolic Diseases|metabolic diseases
1122668|NCT02419859|Endocrine System Diseases|endocrine system diseases
1122669|NCT02419859|Insulin|insulin
1122670|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
1122671|NCT02419859|Insulin pumps|insulin pumps
1122672|NCT02419846|Informed Decision Making|informed decision making
1122673|NCT02419846|Prostate|prostate
1122674|NCT02419846|Cancer|cancer
1122675|NCT02419833|non-STEMI|non-stemi
1122676|NCT02419833|immediate|immediate
1122677|NCT02419833|delayed|delayed
1122678|NCT02419833|PCI|pci
1122679|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
1122680|NCT02419807|Indocyanine Green|indocyanine green
1122681|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
1122682|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
1122683|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1122684|NCT02419807|Lumpectomy|lumpectomy
1122685|NCT02419768|Long-range autocorrelations|long-range autocorrelations
1122686|NCT02419768|Variability|variability
1122687|NCT02419768|Physical Exercise|physical exercise
1122688|NCT02419768|Parkinson's Disease|parkinson's disease
1122689|NCT02419768|ICF|icf
1122690|NCT02419755|Infant leukemia|infant leukemia
1122691|NCT02419755|ALL|all
1122692|NCT02419755|AML|aml
1122693|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
1122694|NCT02419755|Pediatric|pediatric
1122695|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
1122696|NCT02419729|Menopause|menopause
1122697|NCT02419729|Fractional CO2 laser|fractional co2 laser
1122698|NCT02419729|Estrogen cream|estrogen cream
1122699|NCT02419716|colorectal cancer|colorectal cancer
1122700|NCT02419716|Colorectal cancer screening|colorectal cancer screening
1122701|NCT02419677|radiofrequency ablation|radiofrequency ablation
1122702|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
1122703|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
1122704|NCT02419664|pituitary|pituitary
1122705|NCT02419664|pituitary adenomas|pituitary adenomas
1122706|NCT02419664|Ga-PET|ga-pet
1122707|NCT02419664|Acromegaly|acromegaly
1122708|NCT02419664|TSHomas|tshomas
1122709|NCT02419664|Cushing|cushing
1122710|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
1122711|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
1122712|NCT02419638|lesions|lesions
1122713|NCT02419638|treatment|treatment
1122714|NCT02419573|cardiac arrest|cardiac arrest
1122924|NCT02418793|Long Acting|long acting
1122715|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1122716|NCT02419573|laryngeal tube|laryngeal tube
1122717|NCT02419573|endotracheal intubation|endotracheal intubation
1122718|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
1122719|NCT02419560|Relapsed|relapsed
1122720|NCT02419560|Laboratory biomarker research|laboratory biomarker research
1122721|NCT02419560|Pharmacologic study|pharmacologic study
1122722|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1122723|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
1122724|NCT02419547|Ventricular tachycardia|ventricular tachycardia
1122725|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
1122726|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
1122727|NCT02419547|programed stimulation|programed stimulation
1122728|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
1122729|NCT02419495|Advanced cancers|advanced cancers
1122730|NCT02419495|Malignant neoplasms|malignant neoplasms
1122731|NCT02419495|Paclitaxel|paclitaxel
1122732|NCT02419495|Taxol|taxol
1122733|NCT02419495|Eribulin|eribulin
1122734|NCT02419495|E7389|e7389
1122735|NCT02419495|Doxorubicin|doxorubicin
1122736|NCT02419495|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1122737|NCT02419495|Adriamycin PFS|adriamycin pfs
1122738|NCT02419495|Adriamycin RDF|adriamycin rdf
1122739|NCT02419495|Adriamycin|adriamycin
1122740|NCT02419495|Rubex|rubex
1122741|NCT02419495|Cyclophosphamide|cyclophosphamide
1122742|NCT02419495|Cytoxan|cytoxan
1122743|NCT02419495|Neosar|neosar
1122744|NCT02419495|Pemetrexed|pemetrexed
1122745|NCT02419495|LY231514|ly231514
1122746|NCT02419495|Alimta|alimta
1122747|NCT02419495|MTA|mta
1122748|NCT02419495|Multitargeted Antifolate|multitargeted antifolate
1122749|NCT02419495|NSC-698037|nsc-698037
1122750|NCT02419495|Topotecan|topotecan
1122751|NCT02419495|Hycamtin|hycamtin
1122752|NCT02419495|Selinexor|selinexor
1122753|NCT02419495|KPT-330|kpt-330
1122754|NCT02419495|Carboplatin|carboplatin
1122755|NCT02419495|Paraplatin|paraplatin
1122756|NCT02419495|Irinotecan|irinotecan
1122757|NCT02419495|CPT-11|cpt-11
1122758|NCT02419495|Camptosar|camptosar
1122759|NCT02419495|5-FU|5-fu
1122760|NCT02419495|Fluorouracil|fluorouracil
1122761|NCT02419495|5-Fluorouracil|5-fluorouracil
1122762|NCT02419495|Adrucil|adrucil
1122763|NCT02419495|Efudex|efudex
1122764|NCT02419495|Capecitabine|capecitabine
1122765|NCT02419495|Xeloda|xeloda
1122766|NCT02419495|Oxaliplatin|oxaliplatin
1122767|NCT02419495|Eloxatin|eloxatin
1122768|NCT02419495|Olaparib|olaparib
1122769|NCT02419495|Lynparza|lynparza
1122770|NCT02419495|Pembrolizumab|pembrolizumab
1122771|NCT02419495|Keytruda|keytruda
1122772|NCT02419495|MK-3475|mk-3475
1122773|NCT02419495|SCH-900475|sch-900475
1122774|NCT02419495|Nivolumab|nivolumab
1122775|NCT02419495|BMS-936558|bms-936558
1122776|NCT02419495|Opdivo|opdivo
1122777|NCT02419482|Exercise therapy|exercise therapy
1122778|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
1122779|NCT02419482|Fertility|fertility
1122780|NCT02419469|Leukemia|leukemia
1122781|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
1122782|NCT02419469|ALL|all
1122783|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
1122784|NCT02419469|LL|ll
1122785|NCT02419469|Lymphoma|lymphoma
1122786|NCT02419469|Cytarabine|cytarabine
1122787|NCT02419469|Ara-C|ara-c
1122788|NCT02419469|Cytosar|cytosar
1122789|NCT02419469|DepoCyt|depocyt
1122790|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1122791|NCT02419469|Daunorubicin|daunorubicin
1122792|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
1122793|NCT02419469|Cerubidine|cerubidine
1122794|NCT02419469|Daunomycin|daunomycin
1122795|NCT02419469|DNR|dnr
1122796|NCT02419469|Vincristine|vincristine
1122797|NCT02419469|Prednisone|prednisone
1122798|NCT02419469|PEG asparaginase|peg asparaginase
1122799|NCT02419469|Pegaspargase|pegaspargase
1122800|NCT02419469|Oncaspar|oncaspar
1122801|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
1122802|NCT02419469|Ofatumumab|ofatumumab
1122803|NCT02419469|Arzerra|arzerra
1122804|NCT02419469|Rituximab|rituximab
1122805|NCT02419469|Rituxan|rituxan
1122806|NCT02419469|Methotrexate|methotrexate
1122807|NCT02419469|Cyclophosphamide|cyclophosphamide
1122808|NCT02419469|Cytoxan|cytoxan
1122809|NCT02419469|Neosar|neosar
1122810|NCT02419469|Mercaptopurine|mercaptopurine
1122811|NCT02419469|6-mercaptopurine|6-mercaptopurine
1122812|NCT02419469|Purinethol|purinethol
1122813|NCT02419469|6-MP|6-mp
1122814|NCT02419469|Doxorubicin|doxorubicin
1122815|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
1122816|NCT02419469|Adriamycin PFS|adriamycin pfs
1122817|NCT02419469|Adriamycin RDF|adriamycin rdf
1122818|NCT02419469|Adriamycin|adriamycin
1122819|NCT02419469|Rubex|rubex
1122820|NCT02419469|Dexamethasone|dexamethasone
1122821|NCT02419469|Decadron|decadron
1122822|NCT02419469|Thioguanine|thioguanine
1122823|NCT02419469|6-thioguanine|6-thioguanine
1122824|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
1122825|NCT02419430|well-being|well-being
1122826|NCT02419430|stress|stress
1122827|NCT02419430|resilience|resilience
1122828|NCT02419430|self-compassion|self-compassion
1122829|NCT02419391|RSV Vaccines|rsv vaccines
1122830|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
1122831|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
1122832|NCT02419352|Cognitive function|cognitive function
1122833|NCT02419326|couples|couples
1122834|NCT02419326|relationships|relationships
1122835|NCT02419326|binge eating|binge eating
1122836|NCT02419326|eating disorder|eating disorder
1122837|NCT02419326|couple therapy|couple therapy
1122838|NCT02419313|Tremor|tremor
1122839|NCT02419313|Parkinson|parkinson
1122840|NCT02419313|botulinum|botulinum
1122841|NCT02419313|Xeomin|xeomin
1122842|NCT02419287|ALK|alk
1122843|NCT02419287|crizotinib|crizotinib
1122844|NCT02419274|asthma|asthma
1122845|NCT02419274|phenotype|phenotype
1122846|NCT02419274|childhood|childhood
1122847|NCT02419274|adulthood|adulthood
1122848|NCT02419261|knee surgery|knee surgery
1122849|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
1122850|NCT02419261|nerve block|nerve block
1122851|NCT02419235|Refractory hypertension|refractory hypertension
1122852|NCT02419235|Homoeopathy|homoeopathy
1122853|NCT02419235|Homoeopathic complex|homoeopathic complex
1122854|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
1122855|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
1122856|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
1122857|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
1122858|NCT02419209|Low sexual desire|low sexual desire
1122859|NCT02419209|Perimenopause|perimenopause
1122860|NCT02419209|Homeopathy|homeopathy
1122861|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1122862|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
1122863|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
1122864|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
1122865|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
1122866|NCT02419157|Cervical lesions|cervical lesions
1122867|NCT02419157|Clinical trial|clinical trial
1122868|NCT02419157|Self-etch adhesive|self-etch adhesive
1122869|NCT02419144|older adults;|older adults;
1122870|NCT02419144|oral hygiene;|oral hygiene;
1122871|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
1122872|NCT02419118|Myeloma|myeloma
1122873|NCT02419118|monoclonal antibody|monoclonal antibody
1122874|NCT02419118|Daratumumab|daratumumab
1122875|NCT02419105|Falls|falls
1122876|NCT02419105|hypogonadal men|hypogonadal men
1122877|NCT02419105|Seniors|seniors
1122878|NCT02419105|Testosterone|testosterone
1122879|NCT02419105|Colecalciferol|colecalciferol
1122880|NCT02419092|Inflammation|inflammation
1122881|NCT02419092|Insulin resistance|insulin resistance
1122882|NCT02419092|Bariatric surgery|bariatric surgery
1122883|NCT02419053|Surgical safety checklist|surgical safety checklist
1122884|NCT02419053|perioperative complications|perioperative complications
1122885|NCT02419053|pediatric|pediatric
1122886|NCT02419040|shoulder pain|shoulder pain
1122887|NCT02419040|rotator cuff|rotator cuff
1122888|NCT02419040|calcific tendonitis|calcific tendonitis
1122889|NCT02419040|barbotage|barbotage
1122890|NCT02419027|GI Flora|gi flora
1122891|NCT02419014|cranial electrotherapy|cranial electrotherapy
1122892|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
1122893|NCT02419014|restless legs syndrome|restless legs syndrome
1122894|NCT02418962|PfSPZ Vaccine|pfspz vaccine
1122895|NCT02418949|hand|hand
1122896|NCT02418949|rehabilitation|rehabilitation
1122897|NCT02418949|active movement training|active movement training
1122898|NCT02418949|passive cyclical stretching|passive cyclical stretching
1122899|NCT02418936|Waardenburg syndrome|waardenburg syndrome
1122900|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
1122901|NCT02418936|Diagnosis|diagnosis
1122902|NCT02418936|copy number variation|copy number variation
1122903|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
1122904|NCT02418910|bipolar|bipolar
1122905|NCT02418910|self assessment|self assessment
1122906|NCT02418910|prospective randomized trial|prospective randomized trial
1122907|NCT02418897|Fatigue|fatigue
1122908|NCT02418897|multiple sclerosis|multiple sclerosis
1122909|NCT02418897|neuromuscular junction|neuromuscular junction
1122910|NCT02418897|SFEMG|sfemg
1122911|NCT02418871|cataract|cataract
1122912|NCT02418871|presbyopia|presbyopia
1122913|NCT02418858|Essential tremor|essential tremor
1122914|NCT02418858|DBS|dbs
1122915|NCT02418832|Azoospermia|azoospermia
1122916|NCT02418832|Rete Testis|rete testis
1122917|NCT02418832|TEFNA|tefna
1122918|NCT02418806|Family Caregivers|family caregivers
1122919|NCT02418806|Psychotherapy Group|psychotherapy group
1122920|NCT02418793|Hemophilia|hemophilia
1122921|NCT02418793|Factor VII|factor vii
1122922|NCT02418793|Factor VIIa|factor viia
1122926|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
1122927|NCT02418728|lipolysis|lipolysis
1122928|NCT02418728|microdialysis|microdialysis
1122929|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
1122930|NCT02418702|depression|depression
1122931|NCT02418702|suicide|suicide
1122932|NCT02418702|ketamine|ketamine
1122933|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
1122934|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
1122935|NCT02418702|double-blind placebo control|double-blind placebo control
1122936|NCT02418676|Human insulin|human insulin
1122937|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
1122938|NCT02418676|Pressure Ulcer|pressure ulcer
1122939|NCT02418676|Wound Healing|wound healing
1122940|NCT02418676|Gel|gel
1122941|NCT02418663|fluid responsiveness|fluid responsiveness
1122942|NCT02418663|enhanced recovery program|enhanced recovery program
1122943|NCT02418650|volunteers|volunteers
1122944|NCT02418637|worksite|worksite
1122945|NCT02418637|screen|screen
1122946|NCT02418637|migrant|migrant
1122947|NCT02418637|agricultural|agricultural
1122948|NCT02418637|worker|worker
1122949|NCT02418637|hypertension|hypertension
1122950|NCT02418637|Hyperlipidemia|hyperlipidemia
1122951|NCT02418637|diabetes|diabetes
1122952|NCT02418637|feasibility|feasibility
1122953|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
1122954|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
1122955|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
1122956|NCT02418624|carboplatin|carboplatin
1122957|NCT02418624|olaparib|olaparib
1122958|NCT02418598|Adeno-associated virus|adeno-associated virus
1122959|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
1122960|NCT02418598|AAV-hAADC-2|aav-haadc-2
1122961|NCT02418598|AAV-2|aav-2
1122962|NCT02418598|Gene Therapy|gene therapy
1122963|NCT02418598|Gene Transfer|gene transfer
1177836|NCT02132052|PD|pd
1122964|NCT02418598|Parkinson Disease|parkinson disease
1122965|NCT02418598|Basal Ganglia Disease|basal ganglia disease
1122966|NCT02418598|Brain Disease|brain disease
1122967|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
1122968|NCT02418585|Esketamine|esketamine
1122969|NCT02418585|Placebo|placebo
1122970|NCT02418585|Oral Antidepressant|oral antidepressant
1122971|NCT02418559|Healthy|healthy
1122972|NCT02418559|JNJ-63623872|jnj-63623872
1122973|NCT02418559|Japanese Adult Participants|japanese adult participants
1122974|NCT02418533|infertility|infertility
1122975|NCT02418533|in vitro fertilization|in vitro fertilization
1122976|NCT02418533|fertility|fertility
1122977|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
1122978|NCT02418533|embryo|embryo
1122980|NCT02418533|Eeva|eeva
1122981|NCT02418533|IVF|ivf
1122982|NCT02418481|γδ T Cell|γδ t cell
1122983|NCT02418481|breast cancer|breast cancer
1122984|NCT02418481|her2-|her2-
1122985|NCT02418481|er-|er-
1122986|NCT02418481|pr-|pr-
1122987|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
1122988|NCT02418455|MPS 7|mps 7
1122989|NCT02418455|Sly Syndrome|sly syndrome
1122990|NCT02418455|MPS VII|mps vii
1122991|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
1122992|NCT02418455|Rare Disease|rare disease
1122993|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
1122994|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
1122995|NCT02418455|Metabolic Disorder|metabolic disorder
1122996|NCT02418442|Systemic Arthritis|systemic arthritis
1122997|NCT02418442|Oligoarthritis|oligoarthritis
1122998|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
1122999|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
1123000|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
1123001|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
1123002|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
1123003|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
1123004|NCT02418442|FROST|frost
1123005|NCT02418429|fat oxidation|fat oxidation
1123006|NCT02418429|hunger|hunger
1123007|NCT02418429|resistant starch|resistant starch
1123008|NCT02418429|whey protein|whey protein
1123009|NCT02418377|Obesity|obesity
1123010|NCT02418377|Genetics|genetics
1123011|NCT02418377|Whole exome sequencing|whole exome sequencing
1123012|NCT02418377|Children|children
1123013|NCT02418351|RRMS|rrms
1123014|NCT02418325|RRMS|rrms
1123015|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
1123016|NCT02418312|peptic ulcer|peptic ulcer
1123017|NCT02418312|thienopyridine|thienopyridine
1123018|NCT02418312|prevention|prevention
1123019|NCT02418299|urinary incontinence|urinary incontinence
1123020|NCT02418299|Er:YAG laser|er:yag laser
1123021|NCT02418286|Low Back Pain|low back pain
1123022|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
1123023|NCT02418286|Patient Registry|patient registry
1123024|NCT02418273|denosumab|denosumab
1123025|NCT02418273|pediatric|pediatric
1123026|NCT02418273|rheumatology|rheumatology
1123027|NCT02418273|osteoporosis|osteoporosis
1123028|NCT02418273|glucocorticoid|glucocorticoid
1123029|NCT02418260|Humerus|humerus
1123030|NCT02418260|shaft|shaft
1123031|NCT02418260|diaphyseal|diaphyseal
1123032|NCT02418260|fractures|fractures
1123033|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
1123034|NCT02418247|ablation|ablation
1123035|NCT02418247|thyroid cancer|thyroid cancer
1123036|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
1123037|NCT02418234|circulating tumor DNA|circulating tumor dna
1123038|NCT02418234|T790M|t790m
1123039|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
1123040|NCT02418234|digital droplet PCR|digital droplet pcr
1123041|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
1123042|NCT02418195|Depression|depression
1123043|NCT02418195|Ketamine|ketamine
1123044|NCT02418195|Suicide Attempt|suicide attempt
1123045|NCT02418195|Suicidal Ideation|suicidal ideation
1123046|NCT02418195|Suicidality|suicidality
1123047|NCT02418182|Analgesic|analgesic
1123048|NCT02418182|Pain Control|pain control
1123049|NCT02418182|IVF|ivf
1123050|NCT02418182|Tylenol|tylenol
1123051|NCT02418182|Acetaminophen|acetaminophen
1123052|NCT02418182|Egg Retrieval|egg retrieval
1123053|NCT02418182|iv vitro Fertilization|iv vitro fertilization
1123054|NCT02418117|Stereolitographic guide|stereolitographic guide
1123055|NCT02418117|flapless surgery|flapless surgery
1123056|NCT02418117|dental implants|dental implants
1123057|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
1123058|NCT02418065|Physical exercises|physical exercises
1123059|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
1123060|NCT02418065|Multimodal|multimodal
1123061|NCT02418065|Hemodialysis|hemodialysis
1123062|NCT02418065|Protein-Energy Wasting|protein-energy wasting
1123063|NCT02418052|esophageal cancer|esophageal cancer
1123064|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
1123065|NCT02418052|anastomotic leak|anastomotic leak
1123066|NCT02418052|neck flexion|neck flexion
1123067|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1123068|NCT02418039|Nutrition|nutrition
1123069|NCT02418013|Frailty|frailty
1123070|NCT02418013|Umbilical cord blood|umbilical cord blood
1123071|NCT02418013|Plasma|plasma
1123072|NCT02418013|Randomized trial|randomized trial
1123073|NCT02418013|Double-blinded trial|double-blinded trial
1123074|NCT02418013|Placebo-controlled trial|placebo-controlled trial
1123075|NCT02417974|Prevention|prevention
1123076|NCT02417974|Recurrence|recurrence
1123077|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
1123078|NCT02417961|Asthma,|asthma,
1123079|NCT02417961|Bronchial Diseases,|bronchial diseases,
1123080|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
1123081|NCT02417961|Lung Diseases,|lung diseases,
1123082|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
1123083|NCT02417961|Benralizumab|benralizumab
1123084|NCT02417909|Obesity|obesity
1123085|NCT02417909|quality of life|quality of life
1123086|NCT02417909|teenagers|teenagers
1123087|NCT02417909|psychological impact|psychological impact
1123088|NCT02417896|Acute kidney injury|acute kidney injury
1123089|NCT02417896|Spironolactone|spironolactone
1123090|NCT02417883|Furosemide|furosemide
1123091|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
1123092|NCT02417870|Transplantation|transplantation
1123093|NCT02417870|interleukin-2|interleukin-2
1123094|NCT02417870|IL-2|il-2
1123095|NCT02417870|Kidney|kidney
1123096|NCT02417870|Renal|renal
1123097|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
1123098|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
1123099|NCT02417792|psoriasis|psoriasis
1123100|NCT02417792|microbiota|microbiota
1123101|NCT02417766|Genetic Testing|genetic testing
1123102|NCT02417766|Secondary Findings|secondary findings
1123103|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
1123104|NCT02417766|Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal in|pediatric autoimmune neuropsychiatric disorders associated with streptococcal in
1123105|NCT02417766|Whole Exome Sequencing|whole exome sequencing
1123106|NCT02417753|PARACENTESIS|paracentesis
1123107|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
1123108|NCT02417753|Ascites|ascites
1123109|NCT02417753|AZD9150|azd9150
1123110|NCT02417753|Surgical Resection|surgical resection
1123111|NCT02417740|Portal Hypertension|portal hypertension
1123112|NCT02417740|Portal Fibrosis|portal fibrosis
1123113|NCT02417740|Liver Disease|liver disease
1123114|NCT02417740|Varices|varices
1123115|NCT02417740|Splenomegaly|splenomegaly
1123116|NCT02417727|MEMORY TESTING|memory testing
1123117|NCT02417727|Biomarkers|biomarkers
1123118|NCT02417727|Learning|learning
1123119|NCT02417714|Computed Tomography|computed tomography
1123120|NCT02417714|Radiation Reduction|radiation reduction
1123121|NCT02417714|Iterative Reconstruction|iterative reconstruction
1123122|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
1123123|NCT02417675|Option B+|option b+
1123124|NCT02417675|Adherence Club|adherence club
1123125|NCT02417675|Postpartum|postpartum
1123729|NCT02414620|Reduction|reduction
1123126|NCT02417675|Breastfeeding|breastfeeding
1123127|NCT02417675|Mother-to-child transmission|mother-to-child transmission
1123128|NCT02417662|NSCLC|nsclc
1123129|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
1123130|NCT02417662|Radiotherapy|radiotherapy
1123131|NCT02417662|Randomised|randomised
1123132|NCT02417662|Controlled|controlled
1123133|NCT02417662|Oligometastatic|oligometastatic
1123134|NCT02417610|Polynucleotide|polynucleotide
1123135|NCT02417610|Hyaluronic acid|hyaluronic acid
1123136|NCT02417610|Intra articular injection|intra articular injection
1123137|NCT02417597|hepatitis E|hepatitis e
1123138|NCT02417571|Chronic kidney disease|chronic kidney disease
1123139|NCT02417571|Blood pressure|blood pressure
1123140|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
1123141|NCT02417571|glomerular filtration rate|glomerular filtration rate
1123142|NCT02417519|Coffee|coffee
1123143|NCT02417519|Chlorogenic acid|chlorogenic acid
1123144|NCT02417519|Insulin|insulin
1123145|NCT02417519|Appetite|appetite
1123146|NCT02417519|Metabolomics|metabolomics
1123147|NCT02417506|Acute pain|acute pain
1123148|NCT02417506|Herbal|herbal
1123149|NCT02417506|VAS|vas
1123150|NCT02417506|Stop watch|stop watch
1123151|NCT02417493|Food allergy|food allergy
1123152|NCT02417493|self-management|self-management
1123153|NCT02417493|epinephrine self-injection|epinephrine self-injection
1123154|NCT02417493|ntervention|ntervention
1123155|NCT02417493|adolescents|adolescents
1123156|NCT02417467|Electronic cigarette|electronic cigarette
1123157|NCT02417467|E-cigarette|e-cigarette
1123158|NCT02417467|Smoking cessation|smoking cessation
1123159|NCT02417454|probiotic|probiotic
1123160|NCT02417454|stress|stress
1123161|NCT02417454|emotion psychophysiology|emotion psychophysiology
1123162|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
1123163|NCT02417441|TiLE|tile
1123364|NCT02416648|Attitudes|attitudes
1123164|NCT02417441|Embryo Assessment|embryo assessment
1123165|NCT02417441|Pregnancy|pregnancy
1123166|NCT02417441|Implantation|implantation
1123167|NCT02417441|Fertilization|fertilization
1123168|NCT02417428|Muscle function|muscle function
1123169|NCT02417428|Functional capacity|functional capacity
1123170|NCT02417415|Supine hypertension|supine hypertension
1123171|NCT02417415|Autonomic failure|autonomic failure
1123172|NCT02417415|Heat intolerance|heat intolerance
1123173|NCT02417415|Orthostatic hypotension|orthostatic hypotension
1123174|NCT02417415|Heat stress|heat stress
1123175|NCT02417402|back pain|back pain
1123176|NCT02417402|low back pain|low back pain
1123177|NCT02417402|chronic low back pain|chronic low back pain
1123178|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
1123179|NCT02417389|hypercalcemia|hypercalcemia
1123180|NCT02417389|osteoporosis|osteoporosis
1123181|NCT02417389|bone turnover|bone turnover
1123182|NCT02417389|bone mineral density|bone mineral density
1123183|NCT02417389|fractures|fractures
1123184|NCT02417376|Coronary heart disease|coronary heart disease
1123185|NCT02417376|Periodontitis|periodontitis
1123186|NCT02417376|C-reactive protein|c-reactive protein
1123187|NCT02417376|Blood pressure|blood pressure
1123188|NCT02417363|biomarkers|biomarkers
1123189|NCT02417363|renal disease|renal disease
1123190|NCT02417363|periodontitis|periodontitis
1123191|NCT02417324|medulloblastoma|medulloblastoma
1123192|NCT02417324|ependymoma|ependymoma
1123193|NCT02417324|pineoblastoma|pineoblastoma
1123194|NCT02417324|CNS-PNET|cns-pnet
1123195|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
1123196|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
1123197|NCT02417298|ketamine|ketamine
1123198|NCT02417298|pain|pain
1123199|NCT02417298|sickle cell disorder|sickle cell disorder
1123200|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1123201|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
1123202|NCT02417285|Phase 1B|phase 1b
1123203|NCT02417285|Open-Label|open-label
1123204|NCT02417285|Safety and Efficacy|safety and efficacy
1123205|NCT02417285|CC-122|cc-122
1123206|NCT02417285|Obinutuzumab|obinutuzumab
1123207|NCT02417285|GA101|ga101
1123208|NCT02417285|Relapsed|relapsed
1123209|NCT02417285|Refractory|refractory
1123210|NCT02417272|Total Disc Replacement|total disc replacement
1123211|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
1123212|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1123213|NCT02417246|pharmacokinetics|pharmacokinetics
1123214|NCT02417246|pharmacodynamics|pharmacodynamics
1123215|NCT02417246|pharmacogenetics|pharmacogenetics
1123216|NCT02417233|HIV-positive|hiv-positive
1123217|NCT02417233|adherence|adherence
1123218|NCT02417233|engagement to care|engagement to care
1123219|NCT02417233|mHealth|mhealth
1123220|NCT02417233|SMS|sms
1123221|NCT02417233|peer navigation|peer navigation
1123222|NCT02417233|retention|retention
1123223|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
1123224|NCT02417207|liver transplantation|liver transplantation
1123225|NCT02417207|hepatitis B|hepatitis b
1123226|NCT02417207|entecavir|entecavir
1123730|NCT02414620|Elimination|elimination
1123227|NCT02417194|Renal cell carcinoma|renal cell carcinoma
1123228|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
1123229|NCT02417194|Pathologic outcomes|pathologic outcomes
1123230|NCT02417194|Oncological outcomes|oncological outcomes
1123231|NCT02417194|Nephrectomy|nephrectomy
1123232|NCT02417181|Physician assistants|physician assistants
1123233|NCT02417181|Out-of-hours medical care|out-of-hours medical care
1123234|NCT02417181|Primary healthcare|primary healthcare
1123235|NCT02417181|Emergency Medical Services|emergency medical services
1123236|NCT02417155|Autonomic Nerve System|autonomic nerve system
1123237|NCT02417155|Epinephrin|epinephrin
1123238|NCT02417155|Hyperventilation|hyperventilation
1123239|NCT02417155|Hypoventilation|hypoventilation
1123240|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
1123241|NCT02417064|Esketamine|esketamine
1123242|NCT02417064|Placebo|placebo
1123243|NCT02417064|Oral Antidepressant|oral antidepressant
1123244|NCT02417051|Psychological Resilience|psychological resilience
1123245|NCT02417051|Perceived Stress|perceived stress
1123246|NCT02417051|Psychological Stress|psychological stress
1123247|NCT02417051|Disaster Worker|disaster worker
1123248|NCT02417051|Superstorm Sandy|superstorm sandy
1123249|NCT02417051|Mental Health|mental health
1123250|NCT02417051|Prevention|prevention
1123251|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
1123252|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
1123253|NCT02417025|Military|military
1123254|NCT02417025|Health Service Delivery|health service delivery
1123255|NCT02417025|Telepsychology|telepsychology
1123256|NCT02417025|Prolonged Exposure|prolonged exposure
1123257|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
1123258|NCT02417012|lifestyle|lifestyle
1123259|NCT02417012|exercise|exercise
1123260|NCT02417012|physical activity|physical activity
1123261|NCT02417012|diet|diet
1124256|NCT02411565|ovarian|ovarian
1123262|NCT02417012|glycemic control|glycemic control
1123263|NCT02417012|hba1c|hba1c
1123264|NCT02417012|glucose lowering drugs|glucose lowering drugs
1123265|NCT02416999|glioma|glioma
1123266|NCT02416999|high-grade glioma|high-grade glioma
1123267|NCT02416960|female infertility|female infertility
1123268|NCT02416960|glycemic index|glycemic index
1123269|NCT02416960|leptin|leptin
1123270|NCT02416960|ghrelin|ghrelin
1123271|NCT02416960|overweight|overweight
1123272|NCT02416960|obesity|obesity
1123273|NCT02416960|in vitro fertilization|in vitro fertilization
1123274|NCT02416947|Soluble Corn Fiber|soluble corn fiber
1123275|NCT02416947|Osteoporosis|osteoporosis
1123276|NCT02416947|Bone Loss|bone loss
1123277|NCT02416921|Facebook|facebook
1123278|NCT02416921|Weight Gain Prevention|weight gain prevention
1123279|NCT02416921|Women's Health|women's health
1123280|NCT02416921|Online|online
1123281|NCT02416921|Weight Gain|weight gain
1123282|NCT02416921|Weight Loss|weight loss
1123283|NCT02416921|Female Contraception|female contraception
1123284|NCT02416921|Obesity|obesity
1123285|NCT02416921|Body Weight|body weight
1123286|NCT02416921|Internet|internet
1123287|NCT02416882|active|active
1123288|NCT02416882|not active|not active
1123289|NCT02416882|normal body weight|normal body weight
1123290|NCT02416869|Dexamethasone|dexamethasone
1123291|NCT02416869|Lower third molar surgery|lower third molar surgery
1123292|NCT02416856|Aphasia|aphasia
1123293|NCT02416856|Brain|brain
1123294|NCT02416856|Stimulation|stimulation
1123295|NCT02416856|Communication|communication
1123296|NCT02416856|Stroke|stroke
1123297|NCT02416856|Speech Disorders|speech disorders
1123298|NCT02416856|Communications Disorders|communications disorders
1123299|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
1123300|NCT02416856|Neurologic Manifestations|neurologic manifestations
1123301|NCT02416856|Nervous System Diseases|nervous system diseases
1123302|NCT02416856|Signs and Symptoms|signs and symptoms
1123303|NCT02416843|Adipose tissue|adipose tissue
1123304|NCT02416843|metabolism|metabolism
1123305|NCT02416843|inflammation|inflammation
1123306|NCT02416843|post-prandial|post-prandial
1123307|NCT02416843|human|human
1123308|NCT02416830|embolization|embolization
1123309|NCT02416830|visceral Aneurysms|visceral aneurysms
1123310|NCT02416830|Prospective Registry|prospective registry
1123311|NCT02416817|Thrombelastography|thrombelastography
1123312|NCT02416817|Massive Transfusion|massive transfusion
1123313|NCT02416817|Major Trauma|major trauma
1123314|NCT02416817|Blood products|blood products
1123315|NCT02416817|Thromboelastometry|thromboelastometry
1123316|NCT02416804|buprenorphine|buprenorphine
1123317|NCT02416804|transdermal system|transdermal system
1123318|NCT02416804|Pain, postoperative|pain, postoperative
1123319|NCT02416804|Quality of life|quality of life
1123320|NCT02416804|Spinal stenosis|spinal stenosis
1123321|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
1123322|NCT02416791|robotic therapy|robotic therapy
1123323|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
1123324|NCT02416778|COPD|copd
1123325|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1123326|NCT02416778|Iron deficiency|iron deficiency
1123327|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
1123328|NCT02416765|Closed-loop strategy|closed-loop strategy
1123329|NCT02416765|Artificial pancreas|artificial pancreas
1123330|NCT02416765|Postprandial glucose|postprandial glucose
1123331|NCT02416765|Insulin|insulin
1123332|NCT02416765|Glucagon|glucagon
1123333|NCT02416765|Hypoglycemia|hypoglycemia
1123334|NCT02416765|Type 1 diabetes|type 1 diabetes
1123335|NCT02416752|remifentanil|remifentanil
1123336|NCT02416752|head and neck surgery|head and neck surgery
1123337|NCT02416752|recovery pofile|recovery pofile
1123338|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
1123339|NCT02416752|post operative pain|post operative pain
1123340|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
1123341|NCT02416726|Gene testing|gene testing
1123342|NCT02416726|Next-generation sequecing|next-generation sequecing
1123343|NCT02416726|Primary tumor|primary tumor
1123344|NCT02416726|Metastatic lymph node|metastatic lymph node
1123345|NCT02416726|Peripheral blood|peripheral blood
1123346|NCT02416713|Driving|driving
1123347|NCT02416713|Teens|teens
1123348|NCT02416713|Texting|texting
1123349|NCT02416713|Cellphone|cellphone
1123350|NCT02416713|DriveID|driveid
1123351|NCT02416713|Motor vehicle accident|motor vehicle accident
1123352|NCT02416700|Dental prosthesis|dental prosthesis
1123353|NCT02416700|Patients|patients
1123354|NCT02416700|Osseointegrated implants|osseointegrated implants
1123355|NCT02416674|abdominal wall|abdominal wall
1123356|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
1123357|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
1123358|NCT02416661|Lymphatic Diseases|lymphatic diseases
1123359|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1123360|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
1123361|NCT02416661|Lipidoses|lipidoses
1123362|NCT02416648|Adult HIV patients|adult hiv patients
1123363|NCT02416648|Knowledge|knowledge
1123365|NCT02416648|Sexual behaviors|sexual behaviors
1123366|NCT02416635|Liver Neoplasms|liver neoplasms
1123367|NCT02416635|Circulating Tumor Cells|circulating tumor cells
1123368|NCT02416622|XLRS|xlrs
1123369|NCT02416622|maculoschisis|maculoschisis
1123370|NCT02416622|retinal degeneration|retinal degeneration
1123371|NCT02416622|RS1|rs1
1123372|NCT02416622|adeno-associated virus|adeno-associated virus
1123373|NCT02416622|gene therapy|gene therapy
1123374|NCT02416622|AAV|aav
1123375|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
1123376|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1123377|NCT02416609|Chemopotentiator|chemopotentiator
1123378|NCT02416609|Low dose radiotherapy|low dose radiotherapy
1123379|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
1123380|NCT02416596|ICSI|icsi
1123381|NCT02416596|IVF|ivf
1123382|NCT02416596|hysteroscopy|hysteroscopy
1123383|NCT02416596|Supervision|supervision
1123384|NCT02416596|In-vitro Fertilization|in-vitro fertilization
1123385|NCT02416583|membrane sweeping|membrane sweeping
1123386|NCT02416583|dinoprostone|dinoprostone
1123387|NCT02416583|nulliparas|nulliparas
1123388|NCT02416583|labor induction|labor induction
1123389|NCT02416570|Clarithromycin|clarithromycin
1123390|NCT02416544|Overweight|overweight
1123391|NCT02416544|Obesity|obesity
1123392|NCT02416544|Caloric Restriction|caloric restriction
1123393|NCT02416544|Diet, Reducing|diet, reducing
1123394|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
1123395|NCT02416544|Body Weight Changes|body weight changes
1123396|NCT02416544|Energy intake|energy intake
1123397|NCT02416544|Feeding Behavior|feeding behavior
1123398|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
1123399|NCT02416531|Photodynamic therapy|photodynamic therapy
1123400|NCT02416531|Low-level laser therapy|low-level laser therapy
1123401|NCT02416531|Clobetasol propionate|clobetasol propionate
1123402|NCT02416518|Cancer|cancer
1123403|NCT02416518|Malignancy|malignancy
1123404|NCT02416518|Genomic|genomic
1123405|NCT02416518|Molecular|molecular
1123406|NCT02416479|medication adherence|medication adherence
1123407|NCT02416479|outcomes|outcomes
1123408|NCT02416479|intervention|intervention
1123409|NCT02416479|randomized controlled trial|randomized controlled trial
1123410|NCT02416466|Colorectal cancer|colorectal cancer
1123411|NCT02416466|Liver metastases|liver metastases
1123412|NCT02416466|Breast cancer|breast cancer
1123413|NCT02416466|Gastric cancer|gastric cancer
1123414|NCT02416466|Pancreas cancer|pancreas cancer
1123415|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
1123416|NCT02416466|CAR-T|car-t
1123417|NCT02416466|Immunotherapy|immunotherapy
1123418|NCT02416453|Healthy|healthy
1123419|NCT02416453|Ebola viruses|ebola viruses
1123420|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
1123421|NCT02416453|Filoviruses|filoviruses
1123422|NCT02416453|Monovalent vaccine|monovalent vaccine
1123423|NCT02416453|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1123424|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
1123425|NCT02416453|Safety|safety
1123426|NCT02416453|Immunogenicity|immunogenicity
1123427|NCT02416440|South African|south african
1123428|NCT02416440|urban African|urban african
1123429|NCT02416440|diabetes|diabetes
1123430|NCT02416440|prevalence|prevalence
1123431|NCT02416440|risk factors|risk factors
1123432|NCT02416440|genetics|genetics
1123433|NCT02416427|Atorvastatin|atorvastatin
1123434|NCT02416427|TAZ|taz
1123435|NCT02416427|Hippo pathway|hippo pathway
1123436|NCT02416427|ki67|ki67
1123437|NCT02416401|healthy|healthy
1123438|NCT02416401|aging|aging
1123439|NCT02416401|cognition|cognition
1123440|NCT02416401|age-related cognitive decline|age-related cognitive decline
1123441|NCT02416362|Postural Balance|postural balance
1123442|NCT02416362|Electromyography|electromyography
1123443|NCT02416362|Torque|torque
1123444|NCT02416349|Stroke|stroke
1123445|NCT02416349|Stretching|stretching
1123446|NCT02416349|Respiratory muscle|respiratory muscle
1123447|NCT02416349|Ventilatory pattern|ventilatory pattern
1123448|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
1123449|NCT02416336|sentinel lymph node|sentinel lymph node
1123450|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
1123451|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
1123452|NCT02416310|TEAS|teas
1123453|NCT02416310|cesarean section|cesarean section
1123454|NCT02416310|gastrointestinal function|gastrointestinal function
1123455|NCT02416297|malocclusion|malocclusion
1123456|NCT02416297|accelerated tooth movement|accelerated tooth movement
1123457|NCT02416297|Tomography|tomography
1123458|NCT02416297|Extraction|extraction
1123459|NCT02416258|Psoriasis|psoriasis
1123460|NCT02416232|melanoma|melanoma
1123461|NCT02416232|dabrafenib|dabrafenib
1123462|NCT02416232|trametinib|trametinib
1123463|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
1123464|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
1123470|NCT02416180|EVOHALER|evohaler
1123471|NCT02416180|Asthma|asthma
1123472|NCT02416180|SERETIDE|seretide
1123473|NCT02416180|DISKUS Inhaler|diskus inhaler
1123474|NCT02416180|MDI|mdi
1123475|NCT02416154|interferon-epsilon|interferon-epsilon
1123476|NCT02416154|female reproductive tract|female reproductive tract
1123477|NCT02416154|neopterin|neopterin
1123478|NCT02416154|menstrual cycle|menstrual cycle
1123479|NCT02416115|PONV|ponv
1123480|NCT02416115|ramosetron|ramosetron
1123481|NCT02416115|naloxone|naloxone
1123482|NCT02416089|Tampostat|tampostat
1123483|NCT02416089|Tamponade|tamponade
1123484|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
1123485|NCT02416076|Ulthera® System|ulthera® system
1123486|NCT02416076|Ultherapy®|ultherapy®
1123487|NCT02416076|Ulthera, Inc.|ulthera, inc.
1123488|NCT02416050|Cocaine|cocaine
1123489|NCT02416050|Dependence|dependence
1123490|NCT02416050|Abstinence|abstinence
1123491|NCT02416050|Prediction|prediction
1123492|NCT02416050|Model|model
1123493|NCT02416050|Humans|humans
1123494|NCT02416050|MRI|mri
1123495|NCT02416050|Cognitive|cognitive
1123496|NCT02416050|Impulsivity|impulsivity
1123497|NCT02416050|Craving|craving
1123498|NCT02416037|ARDS|ards
1123499|NCT02416037|prone position|prone position
1123500|NCT02416037|PEEP|peep
1123501|NCT02416037|mechanical ventilation|mechanical ventilation
1123502|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1123503|NCT02416024|anesthesia|anesthesia
1123504|NCT02416011|e-cigarette|e-cigarette
1123505|NCT02416011|nicotine dependence|nicotine dependence
1123506|NCT02415998|TEE|tee
1123507|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
1123508|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
1123509|NCT02415985|resource limited setting|resource limited setting
1123510|NCT02415985|AUC|auc
1123511|NCT02415985|Cmax|cmax
1123512|NCT02415985|Cmin|cmin
1123513|NCT02415985|Ctrough|ctrough
1123514|NCT02415972|ultrasound imaging|ultrasound imaging
1123515|NCT02415972|acute ischemic stroke|acute ischemic stroke
1123516|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
1123517|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1123518|NCT02415946|regenerative medicine|regenerative medicine
1123519|NCT02415946|bone substitutes|bone substitutes
1123520|NCT02415946|sinus floor augmentation|sinus floor augmentation
1123521|NCT02415933|Burkina Faso|burkina faso
1123522|NCT02415933|West Africa|west africa
1123523|NCT02415933|Children|children
1123524|NCT02415933|Child Abuse|child abuse
1123525|NCT02415933|Child Mental Health|child mental health
1123526|NCT02415933|Economic Empowerment|economic empowerment
1123527|NCT02415933|Women's Empowerment|women's empowerment
1123528|NCT02415933|Domestic Violence|domestic violence
1123529|NCT02415933|Child and Family Well-being|child and family well-being
1123530|NCT02415933|Child Separation|child separation
1123531|NCT02415933|Child Labor|child labor
1123532|NCT02415933|Child Maltreatment|child maltreatment
1123533|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
1123534|NCT02415920|human communication|human communication
1123535|NCT02415881|Panitumumab|panitumumab
1123536|NCT02415881|Optical Imaging|optical imaging
1123537|NCT02415868|Vaginal Microbiota|vaginal microbiota
1123538|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
1123539|NCT02415842|Pandemic|pandemic
1123540|NCT02415842|Exploratory|exploratory
1123541|NCT02415842|Protein epitopes|protein epitopes
1123542|NCT02415842|Laboratory evaluation|laboratory evaluation
1123543|NCT02415842|Retrospective|retrospective
1123544|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
1123545|NCT02415816|Pediatric|pediatric
1123546|NCT02415816|Whole body DWI MRI|whole body dwi mri
1123547|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
1123548|NCT02415803|clopidogrel|clopidogrel
1123549|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
1123550|NCT02415803|platelet reactivity|platelet reactivity
1123551|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
1123552|NCT02415790|E2027|e2027
1123675|NCT02414984|Golimumab|golimumab
1123553|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
1123554|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
1123555|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
1123556|NCT02415738|Cerebral oxygenation|cerebral oxygenation
1123557|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
1123558|NCT02415738|Prone positioning|prone positioning
1123559|NCT02415712|Pharmacotherapy|pharmacotherapy
1123560|NCT02415686|Dravet syndrome|dravet syndrome
1123561|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
1123562|NCT02415686|Arrhythmias|arrhythmias
1123563|NCT02415673|Orthodontics|orthodontics
1123564|NCT02415673|Nitinol|nitinol
1123565|NCT02415660|trigger point dry needling|trigger point dry needling
1123566|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
1123567|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
1123568|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
1123569|NCT02415660|shear wave elastography|shear wave elastography
1123570|NCT02415647|children|children
1123571|NCT02415647|mental health|mental health
1123572|NCT02415647|family genetic study|family genetic study
1123573|NCT02415621|metastatic|metastatic
1123574|NCT02415621|castration resistant|castration resistant
1123575|NCT02415621|abiraterone therapy|abiraterone therapy
1123576|NCT02415582|Hypertension|hypertension
1123577|NCT02415582|Bloodpressure|bloodpressure
1123578|NCT02415582|Post-exercise hypotension|post-exercise hypotension
1123579|NCT02415582|Combined exercise|combined exercise
1123580|NCT02415582|Aerobic exercise|aerobic exercise
1123581|NCT02415582|Resistance exercise|resistance exercise
1123582|NCT02415582|Aging|aging
1123583|NCT02415582|Elderly|elderly
1123584|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1123585|NCT02415569|bowel cleansing|bowel cleansing
1123586|NCT02415569|bisacodyl|bisacodyl
1123587|NCT02415569|polyethyleneglycol|polyethyleneglycol
1123588|NCT02415569|colonoscopy|colonoscopy
1123589|NCT02415569|the bristol stool form scale|the bristol stool form scale
1123590|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1123591|NCT02415556|Intranasal Insulin|intranasal insulin
1123592|NCT02415556|Placebo|placebo
1123593|NCT02415556|Memory|memory
1123594|NCT02415556|Gait|gait
1123595|NCT02415556|Non diabetic older controls|non diabetic older controls
1123596|NCT02415517|Cognitive training|cognitive training
1123597|NCT02415517|Cognitive impairment|cognitive impairment
1123598|NCT02415517|Heart failure|heart failure
1123599|NCT02415517|Cognition|cognition
1123600|NCT02415504|Care transition|care transition
1123601|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
1123602|NCT02415504|BPSD|bpsd
1123603|NCT02415504|Dementia|dementia
1123604|NCT02415504|Persons with dementia|persons with dementia
1123605|NCT02415504|Discharge processes|discharge processes
1123606|NCT02415491|TGA|tga
1123607|NCT02415491|ASO|aso
1123608|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1123609|NCT02415491|young adulthood|young adulthood
1123610|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1123611|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
1123612|NCT02415478|Endobronchial valve|endobronchial valve
1123613|NCT02415478|physical capacity|physical capacity
1123614|NCT02415478|quality of life|quality of life
1123615|NCT02415465|Knee|knee
1123616|NCT02415465|Replacement|replacement
1123617|NCT02415452|relationship|relationship
1123618|NCT02415452|retinal artery lesions|retinal artery lesions
1123619|NCT02415452|long-term outcomes|long-term outcomes
1123620|NCT02415439|Safety|safety
1123621|NCT02415439|tolerability|tolerability
1123622|NCT02415439|pharmacokinetics|pharmacokinetics
1123623|NCT02415439|adult|adult
1123624|NCT02415439|volunteers|volunteers
1123625|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
1123626|NCT02415413|Carfilzomib|carfilzomib
1123627|NCT02415413|Lenalidomide|lenalidomide
1123628|NCT02415413|Melphalan|melphalan
1123629|NCT02415413|Dexamethasone|dexamethasone
1123630|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
1123631|NCT02415361|Parents|parents
1123632|NCT02415361|Follow-Up Studies|follow-up studies
1123633|NCT02415309|Melatonin|melatonin
1123634|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
1123635|NCT02415309|Anxiety|anxiety
1123636|NCT02415309|Interventional Pain|interventional pain
1123637|NCT02415309|Pain Procedure|pain procedure
1123638|NCT02415296|gambling disorder|gambling disorder
1123639|NCT02415296|screening model|screening model
1123640|NCT02415296|online gambling|online gambling
1123641|NCT02415296|clinical validation|clinical validation
1123642|NCT02415257|Vestibular schwannoma|vestibular schwannoma
1123643|NCT02415257|acoustic neuroma|acoustic neuroma
1123644|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
1123645|NCT02415257|gentamicin|gentamicin
1123646|NCT02415257|rehabilitation|rehabilitation
1123647|NCT02415257|postural balance|postural balance
1123648|NCT02415244|ultrasound|ultrasound
1123649|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
1123650|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
1123651|NCT02415192|safety data|safety data
1123652|NCT02415192|hypertension therapy|hypertension therapy
1123653|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
1123654|NCT02415179|peripheral airway function|peripheral airway function
1123655|NCT02415127|Interferon gamma|interferon gamma
1123656|NCT02415114|Coenzyme Q10|coenzyme q10
1123657|NCT02415114|Resveratrol|resveratrol
1123658|NCT02415114|Statin|statin
1123659|NCT02415101|Adenocarcinoma|adenocarcinoma
1123660|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
1123661|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
1123662|NCT02415088|Nerve block|nerve block
1123663|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
1123664|NCT02415062|Parkinson's disease|parkinson's disease
1123665|NCT02415062|dementia|dementia
1123666|NCT02415036|HCC|hcc
1123667|NCT02415036|ICC|icc
1123668|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
1123669|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
1123670|NCT02414997|primary hypertension stage I|primary hypertension stage i
1123671|NCT02414997|vascular function|vascular function
1123672|NCT02414997|microRNA-126|microrna-126
1123673|NCT02414997|microRNA-34a|microrna-34a
1123674|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
1123676|NCT02414984|Observational|observational
1123677|NCT02414984|Compliance|compliance
1123678|NCT02414971|cancer related fatigue|cancer related fatigue
1123679|NCT02414971|prostate cancer|prostate cancer
1123680|NCT02414971|mitochondria|mitochondria
1123681|NCT02414932|ketamine|ketamine
1123682|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
1123683|NCT02414932|glutamate|glutamate
1123684|NCT02414906|Goal Directed Therapy|goal directed therapy
1123685|NCT02414906|Acute Kidney Injury|acute kidney injury
1123686|NCT02414880|Sugammadex|sugammadex
1123687|NCT02414880|Neostigmine|neostigmine
1123688|NCT02414880|Rocuronium|rocuronium
1123689|NCT02414880|Cirrhosis|cirrhosis
1123690|NCT02414880|Liver resection|liver resection
1123691|NCT02414880|Neuromuscular|neuromuscular
1123692|NCT02414841|radiocephalic|radiocephalic
1123693|NCT02414841|arteriovenous fistula|arteriovenous fistula
1123694|NCT02414841|AVF|avf
1123695|NCT02414841|hemodialysis|hemodialysis
1123696|NCT02414841|PRT-201|prt-201
1123697|NCT02414841|vonapanitase|vonapanitase
1123698|NCT02414841|vascular access|vascular access
1123699|NCT02414841|kidney|kidney
1123700|NCT02414841|renal|renal
1123701|NCT02414841|PATENCY-2|patency-2
1123702|NCT02414841|secondary patency|secondary patency
1123703|NCT02414841|fistula abandonment|fistula abandonment
1123704|NCT02414841|use for hemodialysis|use for hemodialysis
1123705|NCT02414789|erythema migrans|erythema migrans
1123706|NCT02414789|Lyme|lyme
1123707|NCT02414789|early diagnosis|early diagnosis
1123708|NCT02414789|skin biomarkers|skin biomarkers
1123709|NCT02414789|proteomics diagnostic|proteomics diagnostic
1123710|NCT02414789|mass spectrometry|mass spectrometry
1123711|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
1123712|NCT02414750|Melanoma|melanoma
1123713|NCT02414750|Positron Emission Tomography|positron emission tomography
1123714|NCT02414750|Tumor Characteristics|tumor characteristics
1123715|NCT02414750|Response monitoring|response monitoring
1123716|NCT02414750|Resistance prediction|resistance prediction
1123717|NCT02414750|molecular targeted therapy|molecular targeted therapy
1123718|NCT02414711|Depression|depression
1123719|NCT02414711|Primary care|primary care
1123720|NCT02414711|General Practitioners|general practitioners
1123721|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
1123722|NCT02414672|psychosocial intervention|psychosocial intervention
1123723|NCT02414672|advanced lung cancer|advanced lung cancer
1123724|NCT02414672|caregivers|caregivers
1123725|NCT02414672|self-care|self-care
1123726|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
1123727|NCT02414620|Efficacy|efficacy
1123728|NCT02414620|Dental Vibe Unit|dental vibe unit
1123731|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
1123732|NCT02414607|Elderberry juice|elderberry juice
1123733|NCT02414607|Alzheimer's|alzheimer's
1123734|NCT02414607|Inflammation|inflammation
1123735|NCT02414555|Fluid Management|fluid management
1123736|NCT02414516|HDAC|hdac
1123737|NCT02414516|Epigenetic|epigenetic
1123738|NCT02414516|Histone|histone
1123739|NCT02414516|Acetylation|acetylation
1123740|NCT02414503|oxytocin|oxytocin
1123741|NCT02414503|social cognition|social cognition
1123742|NCT02414490|CIDP|cidp
1123743|NCT02414477|tobacco toxicants|tobacco toxicants
1123744|NCT02414477|smokeless tobacco|smokeless tobacco
1123745|NCT02414477|nitrosamines|nitrosamines
1123746|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
1123747|NCT02414464|tooth bleaching|tooth bleaching
1123748|NCT02414464|adolescent|adolescent
1123749|NCT02414464|clinical trial|clinical trial
1123750|NCT02414451|Propranolol|propranolol
1123751|NCT02414425|Fecal Incontinence|fecal incontinence
1123752|NCT02414425|Botulinum Toxin A|botulinum toxin a
1123753|NCT02414425|Rectal injection|rectal injection
1123754|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
1123755|NCT02414412|immunity|immunity
1178787|NCT02128113|RTA 408|rta 408
1123756|NCT02414399|post-discharge mortality|post-discharge mortality
1123757|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
1123758|NCT02414399|azithromycin|azithromycin
1123759|NCT02414399|linear growth|linear growth
1123760|NCT02414386|Vitamin D|vitamin d
1123856|NCT02414061|metabolic health measures|metabolic health measures
1123761|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1123762|NCT02414386|Multi Organ Failure|multi organ failure
1123763|NCT02414386|Acute Kidney Injury|acute kidney injury
1123764|NCT02414386|Critical Care|critical care
1123765|NCT02414386|Citrate anticoagulation|citrate anticoagulation
1123766|NCT02414373|urination|urination
1123767|NCT02414373|analgesia, epidural|analgesia, epidural
1123768|NCT02414373|local anesthetics|local anesthetics
1123769|NCT02414360|Review Literature as Topic|review literature as topic
1123770|NCT02414347|Dementia|dementia
1123771|NCT02414347|Tauopathies|tauopathies
1123772|NCT02414347|Brain Diseases|brain diseases
1123773|NCT02414347|Central Nervous System Diseases|central nervous system diseases
1123774|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
1123775|NCT02414347|Nervous System Diseases|nervous system diseases
1123776|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
1123777|NCT02414334|Oligometastases|oligometastases
1123778|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
1123779|NCT02414334|Metastatic tumours|metastatic tumours
1123780|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
1123781|NCT02414295|Stem cell|stem cell
1123782|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
1123783|NCT02414295|Azoospermia|azoospermia
1123784|NCT02414295|Sterility|sterility
1123785|NCT02414295|Infertility|infertility
1123786|NCT02414282|Dementia|dementia
1123787|NCT02414282|Brain Diseases|brain diseases
1123788|NCT02414282|mild cognitive impairment|mild cognitive impairment
1123789|NCT02414282|Central Nervous System Diseases|central nervous system diseases
1123790|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
1123791|NCT02414269|modified T cells|modified t cells
1123792|NCT02414269|cyclophosphamide|cyclophosphamide
1123793|NCT02414269|CAR T cells|car t cells
1123794|NCT02414269|15-007|15-007
1123796|NCT02414269|immunotherapy|immunotherapy
1123797|NCT02414256|breast surgery|breast surgery
1123798|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
1123799|NCT02414230|Tauopathies|tauopathies
1123800|NCT02414230|Nervous System Diseases|nervous system diseases
1123801|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
1123802|NCT02414217|numeracy|numeracy
1123803|NCT02414217|health literacy|health literacy
1123804|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
1123805|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
1123806|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
1123807|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
1123808|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
1123809|NCT02414191|Feedback|feedback
1123810|NCT02414191|Temperature management|temperature management
1123811|NCT02414191|Anesthesia|anesthesia
1123812|NCT02414178|Dementia|dementia
1123813|NCT02414178|Brain Diseases|brain diseases
1123814|NCT02414178|Central Nervous System Diseases|central nervous system diseases
1123815|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
1123816|NCT02414178|nervous system diseases|nervous system diseases
1123817|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
1123818|NCT02414165|Recurrence|recurrence
1123819|NCT02414139|Non Small Cell Lung|non small cell lung
1123820|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
1123821|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
1123822|NCT02414139|NSCLC|nsclc
1123823|NCT02414139|INC280|inc280
1123824|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
1123825|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1123826|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
1123827|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1123828|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
1123829|NCT02414139|lung cancer|lung cancer
1123830|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
1123831|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
1123832|NCT02414139|MET exon 14 deletion|met exon 14 deletion
1123833|NCT02414139|MET exon 14 skipping|met exon 14 skipping
1123834|NCT02414139|MET exon 14 mutation|met exon 14 mutation
1123835|NCT02414139|MET mutation|met mutation
1123836|NCT02414139|MET amplification|met amplification
1123837|NCT02414139|MET inhibitor|met inhibitor
1123838|NCT02414139|MET dysregulation|met dysregulation
1123839|NCT02414139|MET activation|met activation
1123840|NCT02414139|MET signaling|met signaling
1123841|NCT02414139|MET pathway|met pathway
1123842|NCT02414139|met|met
1123843|NCT02414139|cMET|cmet
1123844|NCT02414126|Heart failure|heart failure
1123845|NCT02414126|child|child
1123846|NCT02414126|work of breathing|work of breathing
1123847|NCT02414126|cardiac function|cardiac function
1123848|NCT02414126|sleep|sleep
1123849|NCT02414126|polysomnography|polysomnography
1123850|NCT02414126|CPAP|cpap
1123851|NCT02414087|flat foot|flat foot
1123852|NCT02414087|therapeutic effect|therapeutic effect
1123853|NCT02414087|insoles|insoles
1123854|NCT02414087|children|children
1123855|NCT02414061|Postprandial glycemia|postprandial glycemia
1123857|NCT02414048|Hypoxia|hypoxia
1123858|NCT02414048|Head and neck cancer|head and neck cancer
1123859|NCT02414035|atrial fibrillation|atrial fibrillation
1123860|NCT02414035|anticoagulation|anticoagulation
1123861|NCT02414035|Dabigatran|dabigatran
1123862|NCT02413996|Virtual Reality Therapy|virtual reality therapy
1123863|NCT02413996|Rehabilitation|rehabilitation
1123864|NCT02413996|Total Knee Replacement|total knee replacement
1123865|NCT02413996|Knee Arthroplasty|knee arthroplasty
1123866|NCT02413996|Exercise|exercise
1123867|NCT02413996|Arthritis|arthritis
1123868|NCT02413996|Rheumatic Disease|rheumatic disease
1123870|NCT02413970|Neurostimulation|neurostimulation
1123871|NCT02413970|Hypoglossal nerve|hypoglossal nerve
1123872|NCT02413970|Tongue|tongue
1123873|NCT02413970|Upper airway stimulation|upper airway stimulation
1123874|NCT02413970|Surgery|surgery
1123875|NCT02413957|Elderly Patients|elderly patients
1123876|NCT02413957|Medication Safety|medication safety
1123877|NCT02413957|Pharmaceutical Care|pharmaceutical care
1123878|NCT02413957|Medication Reconciliation|medication reconciliation
1123879|NCT02413931|tuberculosis|tuberculosis
1123880|NCT02413931|MDR-TB|mdr-tb
1123881|NCT02413918|mixed episode|mixed episode
1123882|NCT02413866|body composition|body composition
1123883|NCT02413866|anthropometry|anthropometry
1123884|NCT02413840|COPD|copd
1123885|NCT02413840|Baduanjin qigong|baduanjin qigong
1123886|NCT02413840|depression|depression
1123887|NCT02413840|anxiety|anxiety
1123888|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
1123889|NCT02413801|Psoriasis|psoriasis
1123890|NCT02413801|PDUS|pdus
1123891|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1123892|NCT02413788|inflammatory markers|inflammatory markers
1123893|NCT02413788|exercise|exercise
1123894|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
1123895|NCT02413723|intubation|intubation
1123896|NCT02413723|critical care|critical care
1123897|NCT02413723|laryngoscope|laryngoscope
1123898|NCT02413723|videolaryngoscope|videolaryngoscope
1123899|NCT02413723|intratracheal|intratracheal
1123900|NCT02413658|Phenytoin|phenytoin
1123901|NCT02413658|Skin graft donor site|skin graft donor site
1123902|NCT02413658|Clean surgical site|clean surgical site
1123903|NCT02413658|Wound model|wound model
1123904|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
1123905|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
1123906|NCT02413632|screening|screening
1123907|NCT02413606|follow up care|follow up care
1123908|NCT02413606|satisfaction with care|satisfaction with care
1123909|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1123910|NCT02413593|HCV|hcv
1123911|NCT02413593|Sustained Virologic Response|sustained virologic response
1123912|NCT02413593|Direct Acting Antiviral|direct acting antiviral
1123913|NCT02413593|GS-7977|gs-7977
1123914|NCT02413593|GS-5885|gs-5885
1123915|NCT02413593|Ribavirin|ribavirin
1123916|NCT02413593|Sofosbuvir|sofosbuvir
1123917|NCT02413593|Ledipasvir|ledipasvir
1123918|NCT02413593|Hepatitis C|hepatitis c
1123919|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
1123920|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
1123921|NCT02413554|rivastigmine patch|rivastigmine patch
1123922|NCT02413554|post-operational delirium|post-operational delirium
1123923|NCT02413528|Patient Compliance|patient compliance
1123924|NCT02413528|Mobile Applications|mobile applications
1123925|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1123926|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1123927|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
1123929|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
1123930|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
1123931|NCT02413476|gastric cancer|gastric cancer
1123932|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
1123933|NCT02413450|Channelopathies|channelopathies
1123934|NCT02413450|Catecholaminergic|catecholaminergic
1123935|NCT02413450|Arrhythmogenic|arrhythmogenic
1123936|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1123937|NCT02413437|biopsy|biopsy
1123938|NCT02413424|sucralose|sucralose
1123939|NCT02413411|Arthroplasty|arthroplasty
1123940|NCT02413411|Osteoarthritis|osteoarthritis
1123941|NCT02413411|Replacement|replacement
1123942|NCT02413411|Intervention|intervention
1123943|NCT02413385|lifestyle intervention|lifestyle intervention
1123944|NCT02413385|physical activity|physical activity
1123945|NCT02413385|exercise|exercise
1123946|NCT02413385|eHealth|ehealth
1123947|NCT02413385|technology|technology
1123948|NCT02413385|coaching|coaching
1123949|NCT02413385|healthy eating|healthy eating
1123950|NCT02413372|First Line Therapy|first line therapy
1123952|NCT02413333|Contact lens solution|contact lens solution
1123953|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
1123954|NCT02413307|Compassion Focused Therapy|compassion focused therapy
1123955|NCT02413281|Healthy Volunteer|healthy volunteer
1123956|NCT02413281|Abuse Liability|abuse liability
1123957|NCT02413281|ALKS 5461|alks 5461
1123958|NCT02413281|Alkermes|alkermes
1123959|NCT02413255|Drug therapy|drug therapy
1123960|NCT02413242|S. aureus|s. aureus
1123961|NCT02413242|P. aeruginosa|p. aeruginosa
1123962|NCT02413242|Colonization|colonization
1123963|NCT02413242|Pneumonia|pneumonia
1123964|NCT02413242|ICU|icu
1123965|NCT02413216|Tic Disorder|tic disorder
1123966|NCT02413216|Tourette|tourette
1123967|NCT02413216|Motor tic|motor tic
1123968|NCT02413216|Vocal tic|vocal tic
1123969|NCT02413216|Habit reversal training|habit reversal training
1123970|NCT02413216|CBIT|cbit
1123971|NCT02413216|TicHelper|tichelper
1123972|NCT02413216|Behavior Therapy|behavior therapy
1123973|NCT02413203|lipidomics|lipidomics
1123974|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
1123975|NCT02413203|celecoxib|celecoxib
1123976|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
1123977|NCT02413164|Schizophrenia|schizophrenia
1123978|NCT02413164|Mental Health|mental health
1123979|NCT02413164|Physical Therapy|physical therapy
1123980|NCT02413164|Quality of life|quality of life
1123981|NCT02413164|Stigma|stigma
1123982|NCT02413164|Positive and negative symptoms|positive and negative symptoms
1123983|NCT02413164|Physical fitness|physical fitness
1123984|NCT02413164|Physical activity|physical activity
1123985|NCT02413151|Exercise training|exercise training
1123986|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
1123987|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
1123988|NCT02413151|Chronic Heart failure|chronic heart failure
1123989|NCT02413138|GHD|ghd
1123990|NCT02413112|Aging|aging
1123991|NCT02413112|Sarcopenia|sarcopenia
1123992|NCT02413112|Resistance training|resistance training
1123993|NCT02413112|Strength|strength
1123994|NCT02413112|Muscle mass|muscle mass
1123995|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
1123996|NCT02413086|early-stage amputation|early-stage amputation
1123997|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
1123998|NCT02413086|wound surface healing|wound surface healing
1123999|NCT02413073|whole body vibration|whole body vibration
1124000|NCT02413073|kidney disease|kidney disease
1124001|NCT02413034|antibiotic|antibiotic
1124002|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
1124003|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
1124004|NCT02413021|deferasirox|deferasirox
1124005|NCT02412995|sea buckthorn|sea buckthorn
1124006|NCT02412995|strawberry|strawberry
1124007|NCT02412995|glucose response|glucose response
1124008|NCT02412995|satiety|satiety
1124009|NCT02412995|metabolomics|metabolomics
1124010|NCT02412995|intake biomarker|intake biomarker
1124011|NCT02412956|mHealth|mhealth
1124012|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
1124013|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
1124014|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
1124015|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
1124016|NCT02412904|GnRH agonist|gnrh agonist
1124017|NCT02412904|in vitro fertilization|in vitro fertilization
1124018|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
1124019|NCT02412904|number of mature oocytes|number of mature oocytes
1124020|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
1124021|NCT02412865|mhealth|mhealth
1124022|NCT02412852|neuropathy|neuropathy
1124023|NCT02412826|pancreatitis|pancreatitis
1124024|NCT02412826|acoustic|acoustic
1124025|NCT02412826|sensor|sensor
1124026|NCT02412813|hypersensitivity|hypersensitivity
1124027|NCT02412813|metal sensitivity|metal sensitivity
1124028|NCT02412813|arthroplasty|arthroplasty
1124029|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
1124030|NCT02412813|metal-on-metal implants|metal-on-metal implants
1124031|NCT02412813|knee revision|knee revision
1124032|NCT02412800|Extravascular lung water|extravascular lung water
1124033|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
1124034|NCT02412800|Liver transplantation|liver transplantation
1124035|NCT02412774|diet beverages|diet beverages
1124036|NCT02412774|water|water
1124037|NCT02412774|diabetes|diabetes
1124038|NCT02412774|weight loss|weight loss
1124039|NCT02412774|insulin sensitivity|insulin sensitivity
1124040|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
1124041|NCT02412761|Pediatrics|pediatrics
1124042|NCT02412761|N-of-1 trial|n-of-1 trial
1124043|NCT02412748|Non-Resident|non-resident
1124044|NCT02412748|Fathers|fathers
1124045|NCT02412748|African American|african american
1124046|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
1124047|NCT02412735|Low back pain|low back pain
1124048|NCT02412735|Back pain|back pain
1124049|NCT02412735|Degenerative Disc Disease|degenerative disc disease
1124050|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
1124051|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
1124052|NCT02412735|Bone Diseases|bone diseases
1124053|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
1124054|NCT02412735|Nervous System Diseases|nervous system diseases
1124055|NCT02412735|Neurologic Manifestations|neurologic manifestations
1124056|NCT02412735|Pain|pain
1124057|NCT02412735|Spinal Diseases|spinal diseases
1124058|NCT02412735|Stem Cells|stem cells
1124059|NCT02412735|Adult Stem Cells|adult stem cells
1124060|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
1124061|NCT02412735|Mesoblast|mesoblast
1124062|NCT02412735|Hyaluronic Acid|hyaluronic acid
1124063|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
1124064|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
1124065|NCT02412735|Immunologic Factors|immunologic factors
1124066|NCT02412735|Pharmacologic Actions|pharmacologic actions
1124067|NCT02412735|Protective Agents|protective agents
1124068|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
1124069|NCT02412735|Viscosupplements|viscosupplements
1124070|NCT02412722|Drug therapy|drug therapy
1124071|NCT02412709|Long QT Syndrome|long qt syndrome
1124072|NCT02412709|LQTS|lqts
1124073|NCT02412709|genetic testing|genetic testing
1124074|NCT02412709|ECG|ecg
1124075|NCT02412709|saliva testing|saliva testing
1124076|NCT02412696|placental morphology|placental morphology
1124077|NCT02412696|CPAP|cpap
1124078|NCT02412696|placental secretory function|placental secretory function
1124079|NCT02412592|HBeAg positive|hbeag positive
1124080|NCT02412592|interferon|interferon
1124081|NCT02412592|peginterferon|peginterferon
1124082|NCT02412592|HBeAg seroconversion|hbeag seroconversion
1124083|NCT02412592|sustained viral response|sustained viral response
1124084|NCT02412592|relapse|relapse
1124085|NCT02412579|HCC|hcc
1124086|NCT02412579|Liver Cancer|liver cancer
1124087|NCT02412566|cholestasis|cholestasis
1124088|NCT02412566|growth failure|growth failure
1124089|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
1124090|NCT02412566|SMOF|smof
1124091|NCT02412514|polio|polio
1124092|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
1124093|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
1124094|NCT02412514|IPV|ipv
1124095|NCT02412514|OPV|opv
1124096|NCT02412462|Phase I|phase i
1124097|NCT02412462|Clusterin|clusterin
1124098|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
1124099|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
1124100|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
1124101|NCT02412462|Pharmacokinetics|pharmacokinetics
1124102|NCT02412449|Pharmacokinetics|pharmacokinetics
1124103|NCT02412449|Anemia|anemia
1124104|NCT02412449|Chronic kidney disease|chronic kidney disease
1124105|NCT02412449|CKD|ckd
1124106|NCT02412449|Renal impairment|renal impairment
1124107|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
1124108|NCT02412449|Ferrous sulfate|ferrous sulfate
1124109|NCT02412449|Iron|iron
1124110|NCT02412449|End stage renal disease|end stage renal disease
1124111|NCT02412449|Dialysis|dialysis
1124112|NCT02412449|Oral anemia treatment|oral anemia treatment
1124113|NCT02412449|Bioavailability|bioavailability
1124114|NCT02412449|Erythropoietin|erythropoietin
1124115|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
1124116|NCT02412449|Volunteers|volunteers
1124117|NCT02412410|laborist|laborist
1124118|NCT02412410|efficacy|efficacy
1124119|NCT02412410|sleep|sleep
1124120|NCT02412410|fatigue|fatigue
1124121|NCT02412410|SAFTE|safte
1124122|NCT02412410|cognition|cognition
1124123|NCT02412397|Shoulder|shoulder
1124124|NCT02412384|Lung Neoplasms|lung neoplasms
1124125|NCT02412384|Circulating Tumor Cells|circulating tumor cells
1124126|NCT02412371|veliparib|veliparib
1124127|NCT02412371|PARP inhibitor|parp inhibitor
1124128|NCT02412371|ABT-888|abt-888
1124129|NCT02412371|first line|first line
1124130|NCT02412371|previously untreated|previously untreated
1124131|NCT02412371|stage III|stage iii
1124132|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
1124133|NCT02412371|radiotherapy|radiotherapy
1124134|NCT02412371|paclitaxel|paclitaxel
1124135|NCT02412371|carboplatin|carboplatin
1124136|NCT02412358|toothbrushing|toothbrushing
1124137|NCT02412358|plaque control|plaque control
1124138|NCT02412358|gingivitis|gingivitis
1124139|NCT02412345|Erectile Dysfunction|erectile dysfunction
1124140|NCT02412345|Shockwave therapy|shockwave therapy
1124141|NCT02412345|Renal Transplant|renal transplant
1124142|NCT02412345|Male|male
1124143|NCT02412345|Renal Transplant Recipients|renal transplant recipients
1124144|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
1124145|NCT02412332|Adult stem cells|adult stem cells
1124146|NCT02412332|Cell therapy|cell therapy
1124147|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
1124148|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
1124149|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
1124150|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
1124151|NCT02412306|Amgen|amgen
1124152|NCT02412293|Perinatal|perinatal
1124153|NCT02412293|neonatal|neonatal
1124154|NCT02412293|newborn|newborn
1124155|NCT02412293|mortality|mortality
1124156|NCT02412189|Anesthesia|anesthesia
1124157|NCT02412189|Blood pressure|blood pressure
1124158|NCT02412189|Plasma volume|plasma volume
1124159|NCT02412189|Vasopressor agents|vasopressor agents
1124160|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
1124161|NCT02412189|Coronary artery bypass|coronary artery bypass
1124162|NCT02412176|pacemaker|pacemaker
1124163|NCT02412176|dyssynchrony|dyssynchrony
1124164|NCT02412176|apical pacing|apical pacing
1124165|NCT02412176|mid-septum|mid-septum
1124166|NCT02412098|Hepatic Impairment|hepatic impairment
1124167|NCT02412085|golimumab|golimumab
1124168|NCT02412085|ulcerative colitis|ulcerative colitis
1124169|NCT02412085|steroid-dependent|steroid-dependent
1124170|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
1124171|NCT02412072|Progesterone|progesterone
1124172|NCT02412072|LNG-IUS|lng-ius
1124173|NCT02412072|dilatation & curettage|dilatation & curettage
1124174|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
1124175|NCT02412046|Pressure ulcer|pressure ulcer
1124176|NCT02412046|Interface pressure|interface pressure
1124177|NCT02412046|Pressure mapping device|pressure mapping device
1124178|NCT02412046|Ischemia reperfusion|ischemia reperfusion
1124179|NCT02412046|Monitoring|monitoring
1124180|NCT02412046|Microvascularization|microvascularization
1124181|NCT02412033|vaginal misoprostol|vaginal misoprostol
1124182|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
1124183|NCT02411981|Lung Clearance Index|lung clearance index
1124184|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
1124185|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
1124186|NCT02411968|Cryosurgery|cryosurgery
1124187|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
1124188|NCT02411968|Diagnostic Imaging|diagnostic imaging
1124189|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
1124190|NCT02411968|Radionuclide imaging|radionuclide imaging
1124191|NCT02411968|Follow up|follow up
1124192|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
1124193|NCT02411890|postoperative pain|postoperative pain
1124194|NCT02411890|femoral nerve block|femoral nerve block
1124195|NCT02411890|adductor canal block|adductor canal block
1124196|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1124197|NCT02411877|Acute ischemic stroke|acute ischemic stroke
1124198|NCT02411877|Mild hypothermia|mild hypothermia
1124199|NCT02411877|Stroke|stroke
1124200|NCT02411877|Hypothermia|hypothermia
1124201|NCT02411877|Cerebral infarction|cerebral infarction
1124202|NCT02411877|Ischemia|ischemia
1124203|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
1124204|NCT02411877|Brain disease|brain disease
1124205|NCT02411877|Central nervous system disease|central nervous system disease
1124206|NCT02411877|Nervous system disease|nervous system disease
1124207|NCT02411877|Vascular disease|vascular disease
1124208|NCT02411877|Cardiovascular disease|cardiovascular disease
1124209|NCT02411877|Brain infarction|brain infarction
1124210|NCT02411877|Brain ischemia|brain ischemia
1124211|NCT02411877|Pathologic process|pathologic process
1124212|NCT02411877|Body temperature change|body temperature change
1124213|NCT02411877|Signs and symptoms|signs and symptoms
1124214|NCT02411864|IVIM|ivim
1124215|NCT02411864|brain|brain
1124216|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
1124217|NCT02411851|Actinic Keratoses|actinic keratoses
1124218|NCT02411838|Multiple sclerosis|multiple sclerosis
1124219|NCT02411838|calorie restriction|calorie restriction
1124220|NCT02411838|adipokines|adipokines
1124221|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
1124222|NCT02411812|Herbst Appliance|herbst appliance
1124223|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
1124224|NCT02411760|MRI|mri
1124225|NCT02411747|Medical|medical
1124226|NCT02411747|Urology|urology
1124227|NCT02411747|Randomized Controlled Trial|randomized controlled trial
1124228|NCT02411747|Endoscopy|endoscopy
1124229|NCT02411747|Cystoscopy|cystoscopy
1124230|NCT02411721|Anxiety|anxiety
1124231|NCT02411721|Dog Intervention|dog intervention
1124232|NCT02411721|MRI|mri
1124233|NCT02411721|Children|children
1124234|NCT02411695|Adolescent|adolescent
1124235|NCT02411695|Otsuka,|otsuka,
1124236|NCT02411695|Brexpiprazole|brexpiprazole
1124237|NCT02411669|Patient centred care|patient centred care
1124238|NCT02411656|Breast cancer|breast cancer
1124239|NCT02411656|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
1124240|NCT02411656|MIBC|mibc
1124241|NCT02411656|IBC|ibc
1124242|NCT02411656|Breast carcinoma|breast carcinoma
1124243|NCT02411656|Metastatic|metastatic
1124244|NCT02411656|MK-3475|mk-3475
1124245|NCT02411656|Keytruda|keytruda
1124246|NCT02411656|Pembrolizumab|pembrolizumab
1124247|NCT02411656|SCH-900475|sch-900475
1124248|NCT02411630|PrEP|prep
1124249|NCT02411630|HIV Prevention|hiv prevention
1124250|NCT02411578|T1D|t1d
1124251|NCT02411578|Type 1 diabetes|type 1 diabetes
1124252|NCT02411578|Mini-dose glucagon|mini-dose glucagon
1124253|NCT02411578|adults|adults
1124254|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
1124255|NCT02411565|epithelial|epithelial
1124257|NCT02411565|fallopian tube|fallopian tube
1124258|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
1124259|NCT02411565|peritoneal|peritoneal
1124260|NCT02411565|ovary|ovary
1124261|NCT02411539|HIV|hiv
1124262|NCT02411539|VRC01|vrc01
1124263|NCT02411500|Healthy|healthy
1124264|NCT02411500|Male|male
1124265|NCT02411500|Pharmacokinetics|pharmacokinetics
1124266|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
1124267|NCT02411461|Pediatric obesity|pediatric obesity
1124268|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
1124269|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
1124270|NCT02411435|rifampin|rifampin
1124271|NCT02411435|drug interaction|drug interaction
1124272|NCT02411435|pharmacokinetics|pharmacokinetics
1124273|NCT02411435|cabotegravir|cabotegravir
1124274|NCT02411422|intubation|intubation
1124275|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1124276|NCT02411422|manikins|manikins
1124277|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
1124278|NCT02411409|self-care|self-care
1124279|NCT02411383|Diaphragm pacing|diaphragm pacing
1124280|NCT02411383|Respiratory assistance|respiratory assistance
1124281|NCT02411383|Lung transplant|lung transplant
1124282|NCT02411357|Contraception|contraception
1124283|NCT02411357|Unintended pregnancy|unintended pregnancy
1124284|NCT02411357|HIV risk|hiv risk
1124285|NCT02411357|Sexually transmitted infections|sexually transmitted infections
1124286|NCT02411357|Women|women
1124287|NCT02411357|Pregnancy|pregnancy
1124288|NCT02411357|Neonatal health|neonatal health
1124289|NCT02411357|Drug use|drug use
1124290|NCT02411357|Drug treatment|drug treatment
1124291|NCT02411357|Opioids|opioids
1124292|NCT02411344|HER2+/HR+|her2+/hr+
1124293|NCT02411344|breast cancer|breast cancer
1124294|NCT02411331|Lock Solution|lock solution
1124295|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
1124296|NCT02411331|Central venous catheter infection|central venous catheter infection
1124297|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
1124298|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
1124299|NCT02411331|Ethanol lock solution|ethanol lock solution
1124424|NCT02410720|Adherence|adherence
1124300|NCT02411331|Vancomycin lock solution|vancomycin lock solution
1124301|NCT02411279|Heart failure|heart failure
1124302|NCT02411279|telemonitoring|telemonitoring
1124303|NCT02411279|intrusive sensors|intrusive sensors
1124304|NCT02411279|intrusive devices|intrusive devices
1124305|NCT02411279|Heart failure stage II|heart failure stage ii
1124306|NCT02411279|Heart failure stage III|heart failure stage iii
1124307|NCT02411279|heart disease|heart disease
1124308|NCT02411253|IL2|il2
1124309|NCT02411253|Interleukin 2|interleukin 2
1124310|NCT02411253|IL-2|il-2
1124311|NCT02411253|Auto-immune disease|auto-immune disease
1124312|NCT02411253|Insulin|insulin
1124313|NCT02411253|Diabetes|diabetes
1124314|NCT02411253|Regulatory T cells|regulatory t cells
1124315|NCT02411253|Treg|treg
1124316|NCT02411253|Immunoregulation|immunoregulation
1124317|NCT02411253|Immune tolerance|immune tolerance
1124318|NCT02411253|Immunotherapy|immunotherapy
1124319|NCT02411240|Air filtration|air filtration
1124320|NCT02411240|cardiovascular health|cardiovascular health
1124321|NCT02411240|cognition|cognition
1124322|NCT02411240|particulate matter|particulate matter
1124323|NCT02411240|mitochondrial DNA|mitochondrial dna
1124324|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
1124325|NCT02411227|Neurocognitive|neurocognitive
1124326|NCT02411227|Virtual Reality|virtual reality
1124327|NCT02411227|Rehabilitation|rehabilitation
1124328|NCT02411227|Driving|driving
1124329|NCT02411175|Constipation|constipation
1124330|NCT02411175|Homeopathy|homeopathy
1124331|NCT02411162|atopic dermatitis|atopic dermatitis
1124332|NCT02411162|FLIM|flim
1124333|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
1124334|NCT02411162|healthy volunteers|healthy volunteers
1124335|NCT02411162|GSK2894512|gsk2894512
1124336|NCT02411162|Skin residency|skin residency
1124337|NCT02411149|Adductor Canal Block|adductor canal block
1124338|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
1124339|NCT02411123|PGx|pgx
1124340|NCT02411123|pharmacogenetics|pharmacogenetics
1124341|NCT02411123|depression|depression
1124342|NCT02411123|anxiety|anxiety
1124343|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
1124344|NCT02411123|IDgenetix|idgenetix
1124345|NCT02411123|AltheaDx|altheadx
1124346|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
1124347|NCT02411097|Femoral nerve block|femoral nerve block
1124348|NCT02411097|Total knee arthroplasty|total knee arthroplasty
1124349|NCT02411084|Graft vs Host Disease|graft vs host disease
1124350|NCT02411084|Immune System Diseases|immune system diseases
1124351|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
1124352|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1124353|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1124354|NCT02411071|HIV-1|hiv-1
1124355|NCT02411071|antiretroviral treatment|antiretroviral treatment
1124356|NCT02411071|low viral load|low viral load
1124357|NCT02411071|low-level viremia|low-level viremia
1124358|NCT02411058|information|information
1124359|NCT02411058|incentives|incentives
1124360|NCT02411045|Indirect incentives|indirect incentives
1124361|NCT02411045|Exercise more|exercise more
1124362|NCT02411019|Phase 2 follow up|phase 2 follow up
1124363|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1124364|NCT02411019|Adult|adult
1124365|NCT02411019|Safety|safety
1124366|NCT02411019|Efficacy|efficacy
1124367|NCT02410941|Randomized controlled trial|randomized controlled trial
1124368|NCT02410941|Practice management|practice management
1124369|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
1124370|NCT02410941|Clinical decision support|clinical decision support
1124371|NCT02410941|Computerized clinical decision support|computerized clinical decision support
1124372|NCT02410941|Decision support systems, clinical|decision support systems, clinical
1124373|NCT02410941|Health Expenditures|health expenditures
1124374|NCT02410941|Physician's practice patterns|physician's practice patterns
1124375|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
1124376|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
1124377|NCT02410941|Diffusion of innovation|diffusion of innovation
1124378|NCT02410941|Decision Support Models|decision support models
1124379|NCT02410941|Clinical Prediction Rules|clinical prediction rules
1124380|NCT02410915|Rehabilitation|rehabilitation
1124381|NCT02410915|Robotics|robotics
1124382|NCT02410902|Autism|autism
1124383|NCT02410876|Bladder|bladder
1124384|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
1124385|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
1124386|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
1124387|NCT02410850|Oral Appliance|oral appliance
1124388|NCT02410850|objective adherence|objective adherence
1124389|NCT02410850|cardiovascular events|cardiovascular events
1124390|NCT02410850|cardiovascular mortality|cardiovascular mortality
1124391|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
1124392|NCT02410850|cost effectiveness|cost effectiveness
1124393|NCT02410837|lung lesion|lung lesion
1124394|NCT02410837|biopsy|biopsy
1124395|NCT02410837|bronchoscopy|bronchoscopy
1124396|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
1124397|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
1124398|NCT02410811|Cardiomyopathy|cardiomyopathy
1124399|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
1124400|NCT02410785|obesity,|obesity,
1124401|NCT02410785|body weight,|body weight,
1124402|NCT02410785|overweight,|overweight,
1124403|NCT02410785|weight loss,|weight loss,
1124404|NCT02410785|polyglucosamine,|polyglucosamine,
1124405|NCT02410785|L112|l112
1124406|NCT02410785|caloric restriction|caloric restriction
1124407|NCT02410785|physical activity|physical activity
1124408|NCT02410746|pain|pain
1124409|NCT02410746|surgery|surgery
1124410|NCT02410733|melanoma|melanoma
1124411|NCT02410733|Lipo-MERIT|lipo-merit
1124412|NCT02410733|cancer vaccine|cancer vaccine
1124413|NCT02410733|RB_0003-01|rb_0003-01
1124414|NCT02410733|BioNTech|biontech
1124415|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
1124416|NCT02410733|BioNTech RNA|biontech rna
1124418|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
1124419|NCT02410720|Polyethylene Glycols|polyethylene glycols
1124420|NCT02410720|Mobile application|mobile application
1124421|NCT02410720|Software|software
1124422|NCT02410720|Compliance|compliance
1124423|NCT02410720|Patient Compliance|patient compliance
1124425|NCT02410707|procedural sedation|procedural sedation
1124426|NCT02410707|procedural pain|procedural pain
1124427|NCT02410707|procedural anxiolysis|procedural anxiolysis
1124428|NCT02410655|Uterine atony|uterine atony
1124429|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
1124430|NCT02410655|Vaginal delivery|vaginal delivery
1124431|NCT02410655|Uterotonic|uterotonic
1124432|NCT02410655|Oxytocin|oxytocin
1124433|NCT02410655|Bolus|bolus
1124434|NCT02410655|Evidence-based|evidence-based
1124435|NCT02410655|Protocol|protocol
1124436|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
1124437|NCT02410629|Stroke|stroke
1124438|NCT02410616|Psychotherapy|psychotherapy
1124439|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
1124440|NCT02410616|Randomized Controlled Trial|randomized controlled trial
1124441|NCT02410616|Secondary Care|secondary care
1124442|NCT02410603|Chemotherapy|chemotherapy
1124443|NCT02410577|89Zr-J591|89zr-j591
1124444|NCT02410577|15-002|15-002
1124445|NCT02410564|insomnia|insomnia
1124446|NCT02410564|Sleep|sleep
1124447|NCT02410564|CBT-I intervention|cbt-i intervention
1124448|NCT02410564|SHUTi|shuti
1124449|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
1124450|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1124451|NCT02410551|MPN|mpn
1124452|NCT02410551|Myelofibrosis|myelofibrosis
1124453|NCT02410551|Polycythemia vera|polycythemia vera
1124454|NCT02410551|PV|pv
1124850|NCT02408185|Bacteriemia|bacteriemia
1124455|NCT02410551|Essential thrombocythemia|essential thrombocythemia
1124456|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1124457|NCT02410551|Allo TP|allo tp
1124458|NCT02410551|Pacritinib|pacritinib
1124459|NCT02410551|Busulfan|busulfan
1124460|NCT02410551|Busulfex|busulfex
1124461|NCT02410551|Myleran|myleran
1124462|NCT02410551|Questionnaires|questionnaires
1124463|NCT02410551|Surveys|surveys
1124464|NCT02410551|Phone calls|phone calls
1124465|NCT02410525|hyperlipidemia|hyperlipidemia
1124466|NCT02410525|positron emission tomography|positron emission tomography
1124467|NCT02410499|Drug therapy|drug therapy
1124468|NCT02410473|Congenital Heart Disease|congenital heart disease
1124469|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
1124470|NCT02410447|Shock waves|shock waves
1124471|NCT02410434|Stigma|stigma
1124472|NCT02410434|lesbian|lesbian
1124473|NCT02410434|gay|gay
1124474|NCT02410434|bisexual|bisexual
1124475|NCT02410434|transgender|transgender
1124476|NCT02410421|Individualized Medicine|individualized medicine
1124477|NCT02410421|Functional Neuroimaging|functional neuroimaging
1124478|NCT02410421|Robotic Proceedure|robotic proceedure
1124479|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1124480|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
1124481|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
1124482|NCT02410408|Patient Safety|patient safety
1124483|NCT02410408|App|app
1124484|NCT02410408|Root Cause Analysis|root cause analysis
1124485|NCT02410408|Patient Safety Certification|patient safety certification
1124486|NCT02410382|cancer|cancer
1124487|NCT02410382|radiation therapy|radiation therapy
1124488|NCT02410382|chemotherapy|chemotherapy
1124489|NCT02410382|dexamethasone|dexamethasone
1124490|NCT02410382|corticosteroids|corticosteroids
1124491|NCT02410343|long acting growth hormone|long acting growth hormone
1124492|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
1124493|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
1124494|NCT02410330|Salvagability index|salvagability index
1124495|NCT02410330|Sonothrombolysis|sonothrombolysis
1124496|NCT02410317|Postoperative pain|postoperative pain
1124497|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
1124498|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
1124499|NCT02410317|Ropivacaine|ropivacaine
1124500|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
1124501|NCT02410317|Emergency cesarean section|emergency cesarean section
1124502|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
1124503|NCT02410265|guided self-help|guided self-help
1124504|NCT02410265|student mental health|student mental health
1124505|NCT02410265|task shifting|task shifting
1124506|NCT02410265|prevention|prevention
1124507|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
1124508|NCT02410252|patient self-management|patient self-management
1124509|NCT02410252|iThermonitor|ithermonitor
1124510|NCT02410252|Home monitoring|home monitoring
1124511|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
1124512|NCT02410239|cALD|cald
1124513|NCT02410200|Pediatrics|pediatrics
1124514|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
1124515|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
1124516|NCT02410174|RCC|rcc
1124517|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1124518|NCT02410174|SBRT|sbrt
1124519|NCT02410161|ketone|ketone
1124520|NCT02410161|α-linolenic acid|α-linolenic acid
1124523|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
1124524|NCT02410161|acetoacetate|acetoacetate
1124525|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
1124526|NCT02410161|ketogenesis|ketogenesis
1124527|NCT02410148|open-angle glaucoma|open-angle glaucoma
1124528|NCT02410148|papilledema|papilledema
1124529|NCT02410148|non-invasive ICP|non-invasive icp
1124530|NCT02410148|Intracranial pressure|intracranial pressure
1124531|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1124532|NCT02410135|Sleep Disturbance|sleep disturbance
1124533|NCT02410096|exercise-induced asthma|exercise-induced asthma
1124534|NCT02410096|cold chamber|cold chamber
1124535|NCT02410096|exercise challenge|exercise challenge
1124536|NCT02410096|cold air challenge|cold air challenge
1124537|NCT02410096|oil supplementation|oil supplementation
1124538|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
1124539|NCT02410070|Distal radial fracture|distal radial fracture
1124540|NCT02410070|pronator quadratus|pronator quadratus
1124541|NCT02410070|mini-approach|mini-approach
1124542|NCT02410070|volar plating|volar plating
1124543|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
1124545|NCT02410057|formula|formula
1124546|NCT02410057|protein|protein
1124547|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
1124548|NCT02410057|amino acids|amino acids
1124549|NCT02410044|Patient Reported Outcomes|patient reported outcomes
1124550|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
1124551|NCT02409979|colonoscopy|colonoscopy
1124552|NCT02409979|carbon dioxide|carbon dioxide
1124553|NCT02409979|water exchange|water exchange
1124554|NCT02409979|discomfort|discomfort
1124555|NCT02409979|colonoscopy pain|colonoscopy pain
1124556|NCT02409966|periodontitis|periodontitis
1124557|NCT02409966|therapeutics|therapeutics
1124558|NCT02409966|quality of life|quality of life
1124559|NCT02409966|fear|fear
1124560|NCT02409966|anxiety|anxiety
1124561|NCT02409966|pain|pain
1124562|NCT02409953|volunteers|volunteers
1124563|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
1124564|NCT02409927|Metabolism|metabolism
1124565|NCT02409927|Ketones|ketones
1124566|NCT02409927|Lipids|lipids
1124567|NCT02409927|Emulsification|emulsification
1124568|NCT02409914|Insulin Resistance|insulin resistance
1124569|NCT02409914|Brain metabolism|brain metabolism
1124570|NCT02409914|PET|pet
1124571|NCT02409914|MRI|mri
1124572|NCT02409901|Physical Activity|physical activity
1124573|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
1124574|NCT02409901|Kidney Function|kidney function
1124575|NCT02409901|Employment|employment
1124576|NCT02409901|Kidney Transplant|kidney transplant
1124577|NCT02409875|early intervention|early intervention
1124578|NCT02409875|obesity|obesity
1124579|NCT02409875|body weight|body weight
1124580|NCT02409875|body mass index|body mass index
1124581|NCT02409875|overnutrition|overnutrition
1124582|NCT02409875|early promoters, genetic|early promoters, genetic
1124583|NCT02409862|oxytocin|oxytocin
1124584|NCT02409862|socioemotional functioning|socioemotional functioning
1124585|NCT02409862|aging|aging
1124586|NCT02409849|Octreotide LAR|octreotide lar
1124587|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
1124588|NCT02409849|unresectable or metastatic|unresectable or metastatic
1124589|NCT02409849|Disease-free survival|disease-free survival
1124590|NCT02409823|adverse drug reactions|adverse drug reactions
1124591|NCT02409823|adherence to treatment|adherence to treatment
1124592|NCT02409823|quality of life|quality of life
1124593|NCT02409823|clinical status|clinical status
1124594|NCT02409784|Brain metabolism|brain metabolism
1124595|NCT02409784|Ketones|ketones
1124596|NCT02409784|Ketogenic diet|ketogenic diet
1124597|NCT02409784|TEP scan|tep scan
1124598|NCT02409758|Voice disorders|voice disorders
1124599|NCT02409758|Hoarseness|hoarseness
1124600|NCT02409758|Therapy|therapy
1124601|NCT02409745|endometrial scratch|endometrial scratch
1124602|NCT02409745|IVF|ivf
1124603|NCT02409745|randomized controlled study|randomized controlled study
1124604|NCT02409745|Prospective controlled trial|prospective controlled trial
1124605|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
1124606|NCT02409745|In vitro fertilization|in vitro fertilization
1124607|NCT02409745|embryo transfer|embryo transfer
1124608|NCT02409732|Actinic cheilitis|actinic cheilitis
1124609|NCT02409732|Photodynamic therapy|photodynamic therapy
1124610|NCT02409732|Levulan|levulan
1124611|NCT02409732|Blue light|blue light
1124612|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
1124613|NCT02409719|Recovery of function|recovery of function
1124614|NCT02409706|Paediatric|paediatric
1124615|NCT02409706|Critical care|critical care
1124616|NCT02409706|Micronutrients|micronutrients
1124617|NCT02409680|Preterm birth|preterm birth
1124618|NCT02409680|Low dose aspirin|low dose aspirin
1124619|NCT02409667|plaque, psoriasis|plaque, psoriasis
1124620|NCT02409641|IOL|iol
1124621|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
1124622|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
1124623|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
1124624|NCT02409628|Surgical excision|surgical excision
1124626|NCT02409628|Secondary intention healing|secondary intention healing
1124627|NCT02409628|Acute wound repair|acute wound repair
1124628|NCT02409628|Tissue repair scaffold|tissue repair scaffold
1124629|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
1124630|NCT02409628|Electrospun scaffold|electrospun scaffold
1124631|NCT02409615|Complementary therapies|complementary therapies
1124632|NCT02409615|Hypnosis|hypnosis
1124633|NCT02409615|Healing Touch|healing touch
1124634|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
1124635|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
1124636|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
1124637|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
1124638|NCT02409576|EWS|ews
1124639|NCT02409576|OS|os
1124640|NCT02409576|RMS|rms
1124641|NCT02409550|Allergic Rhinitis|allergic rhinitis
1124642|NCT02409550|Asthma|asthma
1124643|NCT02409550|Children|children
1124644|NCT02409550|Control|control
1124645|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
1124646|NCT02409537|cardiovascular risk,|cardiovascular risk,
1124647|NCT02409537|total antioxidant capacity|total antioxidant capacity
1124648|NCT02409537|red wine polyphenol content|red wine polyphenol content
1124649|NCT02409537|vitamin E.|vitamin e.
1124650|NCT02409537|resveratrol|resveratrol
1124651|NCT02409511|Type 1 Diabetic|type 1 diabetic
1124652|NCT02409511|Type 2 Diabetic|type 2 diabetic
1124653|NCT02409511|Hypertension|hypertension
1124654|NCT02409511|Renal Injury|renal injury
1124655|NCT02409511|Diabetic retinopathy|diabetic retinopathy
1124656|NCT02409498|pudendal nerve block|pudendal nerve block
1124657|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
1124658|NCT02409485|self-management|self-management
1124659|NCT02409485|head and neck cancer|head and neck cancer
1124660|NCT02409485|psychosocial intervention|psychosocial intervention
1124661|NCT02409485|couples|couples
1124662|NCT02409472|randomized clinical trial|randomized clinical trial
1124663|NCT02409433|lacosamide|lacosamide
1124664|NCT02409433|phenytoin|phenytoin
1124665|NCT02409394|Subjects|subjects
1124666|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
1124667|NCT02409303|Screening|screening
1124668|NCT02409303|Preventive intervention|preventive intervention
1124669|NCT02409303|Risk|risk
1124670|NCT02409277|Self-Management|self-management
1124671|NCT02409277|Asthma|asthma
1124672|NCT02409264|Insomnia|insomnia
1124673|NCT02409264|Females|females
1124674|NCT02409264|Homeopathy|homeopathy
1124675|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
1124676|NCT02409251|Overuse|overuse
1124677|NCT02409251|Rheumatologists|rheumatologists
1124678|NCT02409251|Quality of care|quality of care
1124679|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
1124680|NCT02409238|Insulin Resistance|insulin resistance
1124681|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1124682|NCT02409225|remote monitoring|remote monitoring
1124683|NCT02409225|ICD|icd
1124684|NCT02409225|CRT-D|crt-d
1124685|NCT02409199|Gastric Carcinoma|gastric carcinoma
1124686|NCT02409199|apatinib|apatinib
1124687|NCT02409173|Metabolic syndrome|metabolic syndrome
1124688|NCT02409173|Sleep disorders|sleep disorders
1124689|NCT02409173|Bariatric Surgery|bariatric surgery
1124690|NCT02409173|Noninvasive ventilation|noninvasive ventilation
1124691|NCT02409173|Inflammation|inflammation
1124692|NCT02409173|Quality of life|quality of life
1124693|NCT02409160|Severe Obesity|severe obesity
1124694|NCT02409160|Sleep Disorders|sleep disorders
1124695|NCT02409160|Bariatric Surgery|bariatric surgery
1124696|NCT02409160|Inflammation|inflammation
1124697|NCT02409160|Quality of Life|quality of life
1124698|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
1124699|NCT02409134|Hematologic Malignancies|hematologic malignancies
1124700|NCT02409134|Adults|adults
1124701|NCT02409134|Cognition|cognition
1124702|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
1124703|NCT02409121|caregivers|caregivers
1124704|NCT02409121|health information technology|health information technology
1124705|NCT02409121|patient-centered care|patient-centered care
1124706|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
1124707|NCT02409069|P300|p300
1124708|NCT02409069|Memory task|memory task
1124709|NCT02409056|intervention|intervention
1124710|NCT02409056|translation|translation
1124711|NCT02409056|workplace|workplace
1124712|NCT02409056|CVD|cvd
1124713|NCT02409056|CDSMP|cdsmp
1124714|NCT02409043|Stroke|stroke
1124715|NCT02409043|Ischemic stroke|ischemic stroke
1124716|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
1124717|NCT02409043|Biomarkers|biomarkers
1124718|NCT02409043|Angiotensins|angiotensins
1124719|NCT02409017|insulin drip|insulin drip
1124720|NCT02409017|labor|labor
1124721|NCT02409004|Drug-drug interaction|drug-drug interaction
1124722|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
1124723|NCT02408991|Art-Assist Device|art-assist device
1124724|NCT02408991|Neupogen|neupogen
1124725|NCT02408926|Pertussis|pertussis
1124726|NCT02408926|Pregnancy|pregnancy
1124727|NCT02408926|Humoral immune response|humoral immune response
1124728|NCT02408926|Functionality|functionality
1124729|NCT02408926|Vaccination|vaccination
1124730|NCT02408913|Immunity|immunity
1124731|NCT02408913|Ebola Virus|ebola virus
1124732|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
1124733|NCT02408913|Healthy|healthy
1124734|NCT02408913|Filovirus|filovirus
1124735|NCT02408900|Spasticity|spasticity
1124736|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
1124737|NCT02408900|Elastography|elastography
1124738|NCT02408900|Ultrasound|ultrasound
1124739|NCT02408887|Thyroidectomy|thyroidectomy
1124740|NCT02408887|Serum Thyroglobulin|serum thyroglobulin
1124741|NCT02408887|Quality of Life|quality of life
1124742|NCT02408887|Central Neck Lymph Node Metastasis|central neck lymph node metastasis
1124743|NCT02408887|Central Neck Lymph Node Dissection|central neck lymph node dissection
1124744|NCT02408874|Nanoparticles|nanoparticles
1124745|NCT02408874|Inflammatory Response|inflammatory response
1124746|NCT02408874|Silver|silver
1124747|NCT02408874|Lung Function|lung function
1124748|NCT02408874|Lung Microbiome|lung microbiome
1124749|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
1124750|NCT02408835|lymphadenectomy|lymphadenectomy
1124751|NCT02408835|wound healing|wound healing
1124752|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
1124753|NCT02408809|Smoking Cessation|smoking cessation
1124754|NCT02408809|Randomized Controlled Trial|randomized controlled trial
1124755|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
1124756|NCT02408757|ultrasound|ultrasound
1124757|NCT02408757|cerebral perfusion|cerebral perfusion
1124758|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
1124759|NCT02408744|nephroprotection|nephroprotection
1124760|NCT02408744|pirfenidone|pirfenidone
1124761|NCT02408744|polymorphisms|polymorphisms
1124762|NCT02408718|Mobility|mobility
1124763|NCT02408718|walking aids|walking aids
1124764|NCT02408718|falls|falls
1124765|NCT02408718|gait and balance|gait and balance
1124766|NCT02408705|Endogenous Glucose Production|endogenous glucose production
1124767|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
1124768|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
1124769|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
1124770|NCT02408692|Emergency contraception|emergency contraception
1124771|NCT02408692|Obese BMI|obese bmi
1124772|NCT02408692|Normal BMI|normal bmi
1124773|NCT02408679|Vitamin D|vitamin d
1124774|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
1124775|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
1124776|NCT02408679|Healthy adults|healthy adults
1124777|NCT02408679|Predictive questionnaire|predictive questionnaire
1124778|NCT02408640|Internet-Based|internet-based
1124779|NCT02408640|Treatment|treatment
1124780|NCT02408549|Lacosamide|lacosamide
1124781|NCT02408549|Vimpat|vimpat
1124782|NCT02408549|Epilepsy|epilepsy
1124783|NCT02408549|Children|children
1124784|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
1124785|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
1124786|NCT02408549|Adults|adults
1124787|NCT02408536|chemotherapy|chemotherapy
1124788|NCT02408536|hormone therapy|hormone therapy
1124789|NCT02408536|borderline|borderline
1124790|NCT02408536|low-grade|low-grade
1124791|NCT02408536|serous ovarian cancer|serous ovarian cancer
1124792|NCT02408523|Lacosamide|lacosamide
1124793|NCT02408523|Vimpat|vimpat
1124794|NCT02408523|Epilepsy|epilepsy
1124795|NCT02408523|Children|children
1124796|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
1124797|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
1124798|NCT02408523|Adults|adults
1124799|NCT02408510|Volunteers|volunteers
1124800|NCT02408471|Arthritis|arthritis
1124801|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
1124802|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
1124803|NCT02408471|Osteoarthritis|osteoarthritis
1124804|NCT02408471|Autoimmune Diseases|autoimmune diseases
1124805|NCT02408471|Connective Tissue Diseases|connective tissue diseases
1124806|NCT02408471|Immune System Diseases|immune system diseases
1124807|NCT02408471|Joint Diseases|joint diseases
1124808|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
1124809|NCT02408471|Rheumatic Diseases|rheumatic diseases
1124810|NCT02408445|body composition|body composition
1124811|NCT02408445|Klinefelter syndrome|klinefelter syndrome
1124812|NCT02408445|XXY|xxy
1124813|NCT02408445|sex chromosome variation|sex chromosome variation
1124814|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
1124815|NCT02408432|Blood And Marrow Transplantation|blood and marrow transplantation
1124816|NCT02408432|Left ventricular dysfunction|left ventricular dysfunction
1124817|NCT02408432|LV|lv
1124818|NCT02408432|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
1124819|NCT02408432|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
1124820|NCT02408432|hMSCs|hmscs
1124821|NCT02408432|Standard of care drugs for heart failure|standard of care drugs for heart failure
1124822|NCT02408406|TNM Finding v7|tnm finding v7
1124823|NCT02408393|Surgery|surgery
1124824|NCT02408393|Paravertebral block|paravertebral block
1124825|NCT02408393|Chronic pain|chronic pain
1124826|NCT02408380|biomarker|biomarker
1124827|NCT02408380|disease progression|disease progression
1124828|NCT02408367|Training|training
1124829|NCT02408367|Cognition|cognition
1124830|NCT02408367|Multiple Sclerosis|multiple sclerosis
1124831|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
1124832|NCT02408315|induction of labor|induction of labor
1124833|NCT02408315|safety|safety
1124834|NCT02408315|pharmacokinetic|pharmacokinetic
1124835|NCT02408315|misoprostol|misoprostol
1124836|NCT02408250|algorithm|algorithm
1124837|NCT02408250|critical illness|critical illness
1124838|NCT02408250|early exercise|early exercise
1124839|NCT02408250|feasibility|feasibility
1124840|NCT02408250|intensive care unit|intensive care unit
1124841|NCT02408250|physical therapy|physical therapy
1124842|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1124843|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
1124844|NCT02408237|Healthy Participants|healthy participants
1124845|NCT02408224|ACS|acs
1124846|NCT02408185|infections|infections
1124847|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
1124848|NCT02408185|Skin infections|skin infections
1124849|NCT02408185|Pneumonia|pneumonia
1124851|NCT02408185|Nosocomial infections|nosocomial infections
1124852|NCT02408172|hypertension|hypertension
1124853|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
1124854|NCT02408172|Amlodipine|amlodipine
1124855|NCT02408172|metoprolol|metoprolol
1124856|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
1124857|NCT02408159|Zostavax|zostavax
1124858|NCT02408159|herpes zoster|herpes zoster
1124859|NCT02408159|shingles|shingles
1124860|NCT02408133|Breast Cancer|breast cancer
1124861|NCT02408133|elderly|elderly
1124862|NCT02408133|quality of life|quality of life
1124863|NCT02408133|exercise|exercise
1124864|NCT02408120|Hyperglycemia|hyperglycemia
1124865|NCT02408120|Hypoglycemia|hypoglycemia
1124866|NCT02408107|Physical activity|physical activity
1124867|NCT02408107|Randomized controlled trial|randomized controlled trial
1124868|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
1124869|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
1124870|NCT02408094|Protein markers|protein markers
1124871|NCT02408081|Depression|depression
1124872|NCT02408081|Family functioning|family functioning
1124873|NCT02408081|Family Focused Nursing|family focused nursing
1124874|NCT02408081|Quality of life|quality of life
1124875|NCT02408068|subjects|subjects
1124876|NCT02408029|Focus|focus
1124877|NCT02408029|Testing Performance|testing performance
1124878|NCT02408029|CORA Hemostasis System|cora hemostasis system
1124879|NCT02408003|Transesophageal|transesophageal
1124880|NCT02408003|Echocardiography|echocardiography
1124881|NCT02408003|Milrinone|milrinone
1124882|NCT02408003|Levosimendan|levosimendan
1124883|NCT02408003|Strain|strain
1124884|NCT02408003|Deformation|deformation
1124885|NCT02408003|Diastole|diastole
1124886|NCT02408003|Afterload|afterload
1124887|NCT02408003|Preload|preload
1124888|NCT02408003|Systole|systole
1124889|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
1124890|NCT02407964|DILI|dili
1124891|NCT02407938|dysphagia|dysphagia
1124892|NCT02407938|reflux symptoms|reflux symptoms
1124893|NCT02407938|retrosternal pain|retrosternal pain
1124894|NCT02407925|Optical diagnosis|optical diagnosis
1124895|NCT02407899|LADA|lada
1124896|NCT02407899|saxagliptin|saxagliptin
1124897|NCT02407899|vitamin D3|vitamin d3
1124898|NCT02407899|C-Peptide|c-peptide
1124899|NCT02407873|aged of 75 years or more|aged of 75 years or more
1124900|NCT02407860|breast feeding|breast feeding
1124901|NCT02407860|sucking|sucking
1124902|NCT02407860|dysfunction|dysfunction
1124903|NCT02407860|Latch assessment tool|latch assessment tool
1124904|NCT02407860|visual analogic scale|visual analogic scale
1124905|NCT02407860|infant physiology|infant physiology
1124906|NCT02407847|Nurse practitioners|nurse practitioners
1124907|NCT02407847|Primary healthcare|primary healthcare
1124908|NCT02407847|Emergency Medical Services|emergency medical services
1124909|NCT02407847|Substitution of care|substitution of care
1124910|NCT02407834|Biofilms|biofilms
1124911|NCT02407834|Dentures|dentures
1124912|NCT02407834|Denture Cleansers|denture cleansers
1124913|NCT02407834|Castor Oil|castor oil
1124914|NCT02407834|Stomatitis|stomatitis
1124915|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1124916|NCT02407821|Kidney Failure|kidney failure
1124917|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
1124918|NCT02407821|Dialysis, Renal|dialysis, renal
1124919|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
1124920|NCT02407821|Hemodialysis|hemodialysis
1124921|NCT02407821|Depressive Symptoms|depressive symptoms
1124922|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1124923|NCT02407821|Antidepressants|antidepressants
1124924|NCT02407821|Escitalopram|escitalopram
1125027|NCT02407197|CMR|cmr
1124925|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
1124926|NCT02407795|pain reduction|pain reduction
1124927|NCT02407795|quality of life|quality of life
1124928|NCT02407782|Scabies|scabies
1124929|NCT02407782|children|children
1124930|NCT02407782|cluster|cluster
1124931|NCT02407782|permethrin|permethrin
1124932|NCT02407782|Ivermectin|ivermectin
1124933|NCT02407769|Liver transplantation|liver transplantation
1124934|NCT02407769|Liver cirrhosis|liver cirrhosis
1124935|NCT02407769|Branched chain amino acids|branched chain amino acids
1124936|NCT02407769|Late evening supplementation|late evening supplementation
1124937|NCT02407769|Nutritional status|nutritional status
1124938|NCT02407756|Eczema|eczema
1124939|NCT02407743|postoperative pain|postoperative pain
1124940|NCT02407743|surgery|surgery
1124941|NCT02407743|pain resolution|pain resolution
1124942|NCT02407743|pain intensity|pain intensity
1124943|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
1124944|NCT02407743|pain-related genes|pain-related genes
1124945|NCT02407743|analgesic|analgesic
1124946|NCT02407704|Exercise|exercise
1124947|NCT02407704|Physical activity|physical activity
1124948|NCT02407704|GABA|gaba
1124949|NCT02407704|Venlafaxine|venlafaxine
1124950|NCT02407704|fMRI|fmri
1124951|NCT02407704|Spectroscopy|spectroscopy
1124952|NCT02407704|Reward system|reward system
1124953|NCT02407704|BDNF|bdnf
1124954|NCT02407704|Sleep|sleep
1124955|NCT02407704|Cognitive function|cognitive function
1124956|NCT02407704|Biomarkers|biomarkers
1124957|NCT02407704|Aerobic exercise|aerobic exercise
1124959|NCT02407665|fMRI|fmri
1124960|NCT02407639|insufflation|insufflation
1124961|NCT02407639|abdominal pain|abdominal pain
1124962|NCT02407626|ischemia|ischemia
1124963|NCT02407626|cardiac surgery|cardiac surgery
1124964|NCT02407626|volatile anesthetic|volatile anesthetic
1124965|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
1124966|NCT02407613|breast cancer|breast cancer
1124967|NCT02407613|MR-HIFU|mr-hifu
1124968|NCT02407613|ablation|ablation
1124969|NCT02407613|non-invasive treatment|non-invasive treatment
1124970|NCT02407600|EMEND for Injection|emend for injection
1124971|NCT02407600|5HT-3|5ht-3
1124972|NCT02407600|Fosaprepitant|fosaprepitant
1124973|NCT02407561|rectal|rectal
1124974|NCT02407561|adenocarcinoma|adenocarcinoma
1124975|NCT02407561|DecisionDx|decisiondx
1124976|NCT02407548|cholesterol efflux|cholesterol efflux
1124977|NCT02407548|dyslipidemia|dyslipidemia
1124978|NCT02407522|Metabolic Syndrome|metabolic syndrome
1124979|NCT02407522|black rice|black rice
1124980|NCT02407483|Laparoscopy|laparoscopy
1124981|NCT02407483|Training Programs|training programs
1124982|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
1124983|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
1124984|NCT02407444|Proximal hip fracture|proximal hip fracture
1124985|NCT02407444|Elderly patients|elderly patients
1124986|NCT02407444|Physiotherapy|physiotherapy
1124987|NCT02407444|Leg cycling ergometer|leg cycling ergometer
1124988|NCT02407418|spinal manipulation|spinal manipulation
1124989|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
1124990|NCT02407418|muscle strength|muscle strength
1124991|NCT02407379|Laser|laser
1124992|NCT02407379|periodontitis|periodontitis
1124993|NCT02407379|scaling root planing|scaling root planing
1124994|NCT02407379|bacteria|bacteria
1124996|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
1124997|NCT02407366|EGFR mutation|egfr mutation
1124998|NCT02407366|Icotinib|icotinib
1124999|NCT02407366|Radiotherapy|radiotherapy
1125000|NCT02407366|Chemoradiotherapy|chemoradiotherapy
1125001|NCT02407353|Phase 1|phase 1
1125002|NCT02407353|Double blind|double blind
1125003|NCT02407353|Placebo-Controlled|placebo-controlled
1125004|NCT02407353|Parallel Design|parallel design
1125005|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
1125006|NCT02407353|PF-06648671|pf-06648671
1125007|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
1125008|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
1125009|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
1125010|NCT02407314|Optical Coherence Tomography|optical coherence tomography
1125011|NCT02407314|Ticagrelor|ticagrelor
1125012|NCT02407314|Aspirin|aspirin
1125013|NCT02407314|Claudication|claudication
1125014|NCT02407314|Clopidogrel|clopidogrel
1125015|NCT02407288|OCD|ocd
1125016|NCT02407262|asthma|asthma
1125017|NCT02407262|black seed|black seed
1125018|NCT02407262|Nigella sativa|nigella sativa
1125019|NCT02407262|supplementation|supplementation
1125020|NCT02407236|Ustekinumab|ustekinumab
1125021|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
1125022|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
1125023|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
1125024|NCT02407223|Ustekinumab|ustekinumab
1125025|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
1125026|NCT02407197|T1 mapping|t1 mapping
1125033|NCT02407145|midurethral sling|midurethral sling
1125034|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
1125035|NCT02407119|H. pylori eradication|h. pylori eradication
1125036|NCT02407119|Atrophy|atrophy
1125037|NCT02407119|Intestinal metaplasia|intestinal metaplasia
1125038|NCT02407119|Endoscopic resection|endoscopic resection
1125039|NCT02407119|Stomach neoplasm|stomach neoplasm
1125040|NCT02407106|BLIS K12|blis k12
1125041|NCT02407106|streptococcus|streptococcus
1125042|NCT02407093|Body Composition|body composition
1125043|NCT02407093|Military|military
1125044|NCT02407093|High-Intensity Functional Training|high-intensity functional training
1125045|NCT02407093|Army Physical Fitness|army physical fitness
1125046|NCT02407093|CrossFit|crossfit
1125047|NCT02407002|Nitroglycerin|nitroglycerin
1125048|NCT02407002|Safety|safety
1125049|NCT02406976|Exercise|exercise
1125050|NCT02406976|Morbidity Obesity|morbidity obesity
1125051|NCT02406963|telemedicine|telemedicine
1125052|NCT02406950|Sitagliptin|sitagliptin
1125053|NCT02406950|Endothelium|endothelium
1125179|NCT02406027|Alzheimer's Disease|alzheimer's disease
1125054|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
1125055|NCT02406950|human|human
1125057|NCT02406924|particulated graft|particulated graft
1125058|NCT02406924|bone augmentation|bone augmentation
1125059|NCT02406924|vertical augmentation|vertical augmentation
1125060|NCT02406924|horizontal augmentation|horizontal augmentation
1125061|NCT02406911|platelet|platelet
1125062|NCT02406911|ticagrelor|ticagrelor
1125063|NCT02406911|clopidogrel|clopidogrel
1125064|NCT02406911|end stage renal disease|end stage renal disease
1125065|NCT02406911|hemodialysis|hemodialysis
1125066|NCT02406859|Spinal Cord Injury|spinal cord injury
1125067|NCT02406859|Constipation|constipation
1125068|NCT02406859|Fecal Incontinence|fecal incontinence
1125069|NCT02406859|Neurogenic Bowel|neurogenic bowel
1125070|NCT02406859|Bowel Biofeedback|bowel biofeedback
1125071|NCT02406859|Manometry|manometry
1125072|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
1125073|NCT02406846|Circulating Tumor Cells|circulating tumor cells
1125074|NCT02406833|glaucoma|glaucoma
1125075|NCT02406833|trabeculectomy|trabeculectomy
1125076|NCT02406807|chronic low back pain|chronic low back pain
1125077|NCT02406807|HVLA manipulation|hvla manipulation
1125078|NCT02406794|Breast cancer|breast cancer
1125079|NCT02406794|Hormonal therapy|hormonal therapy
1125080|NCT02406794|Aromatase inhibitors|aromatase inhibitors
1125081|NCT02406794|Estrogen deprivation|estrogen deprivation
1125082|NCT02406794|Myalgia|myalgia
1125083|NCT02406794|Arthralgia|arthralgia
1125084|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
1125085|NCT02406794|Pressure pain threshold|pressure pain threshold
1125086|NCT02406794|Neuromuscular taping|neuromuscular taping
1125087|NCT02406794|Kinesio taping|kinesio taping
1125088|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
1125089|NCT02406781|Advanced Sarcomas|advanced sarcomas
1125090|NCT02406781|Leiomyosarcoma|leiomyosarcoma
1125091|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
1125092|NCT02406781|Other Sarcoma|other sarcoma
1125093|NCT02406781|GIST|gist
1125094|NCT02406781|Osteosarcoma|osteosarcoma
1125095|NCT02406768|normal controls|normal controls
1125096|NCT02406742|CC-122|cc-122
1125097|NCT02406742|Pharmacokinetics|pharmacokinetics
1125098|NCT02406742|Safety|safety
1125099|NCT02406742|Ibrutinib|ibrutinib
1125100|NCT02406742|Obinutuzumab|obinutuzumab
1125101|NCT02406742|GA101|ga101
1125102|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1125103|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1125104|NCT02406703|local anesthesia|local anesthesia
1125105|NCT02406703|regional anesthetic|regional anesthetic
1125106|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
1125107|NCT02406690|Endometrial Receptivity|endometrial receptivity
1125108|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
1125109|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
1125110|NCT02406638|Mid-Urethral Sling|mid-urethral sling
1125111|NCT02406638|TVT|tvt
1125112|NCT02406638|TVT-O|tvt-o
1125113|NCT02406638|TVT-S|tvt-s
1125114|NCT02406612|Vascular Closure Device|vascular closure device
1125115|NCT02406612|Femoral Artery Closure|femoral artery closure
1125116|NCT02406573|Sensitivity|sensitivity
1125117|NCT02406547|Serrated lesion|serrated lesion
1125118|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
1125119|NCT02406547|Narrow Band Imaging|narrow band imaging
1125120|NCT02406547|Colonoscopy|colonoscopy
1125121|NCT02406547|colorectal neoplasms|colorectal neoplasms
1125122|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1125123|NCT02406521|mRCC|mrcc
1125124|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
1125125|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
1125126|NCT02406339|Physical Therapy|physical therapy
1125127|NCT02406339|Rehabilitation|rehabilitation
1125128|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1125129|NCT02406339|Muscle Strength|muscle strength
1125130|NCT02406300|Hip Fracture|hip fracture
1125131|NCT02406300|Regional Anesthesia|regional anesthesia
1125132|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
1125133|NCT02406300|Post-operative Mortality|post-operative mortality
1125134|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
1125135|NCT02406300|Quality of Life|quality of life
1125136|NCT02406274|Mammography|mammography
1125137|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
1125138|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
1125139|NCT02406274|15-053|15-053
1125140|NCT02406248|NSTEMI|nstemi
1125141|NCT02406222|Relapsed|relapsed
1125142|NCT02406222|Refractory|refractory
1125143|NCT02406222|Pomalidomide|pomalidomide
1125144|NCT02406222|Dexamethasone|dexamethasone
1125145|NCT02406222|Cyclophosphamide|cyclophosphamide
1125146|NCT02406209|uveitis|uveitis
1125147|NCT02406209|acute uveitis|acute uveitis
1125148|NCT02406209|anterior uveitis|anterior uveitis
1125149|NCT02406209|NS2|ns2
1125150|NCT02406209|Aldeyra|aldeyra
1125151|NCT02406209|prednisolone acetate|prednisolone acetate
1125152|NCT02406157|diabetic macular edema|diabetic macular edema
1125153|NCT02406157|micropulse|micropulse
1125154|NCT02406157|laser|laser
1125155|NCT02406157|subthreshold|subthreshold
1125156|NCT02406144|Multiple Myeloma|multiple myeloma
1125157|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
1125158|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
1125159|NCT02406131|Inflammation|inflammation
1125160|NCT02406131|Angioplasty|angioplasty
1125161|NCT02406131|Restenosis|restenosis
1125163|NCT02406118|transanal TME quality|transanal tme quality
1125164|NCT02406118|CRM|crm
1125165|NCT02406105|tremor|tremor
1125166|NCT02406105|Parkinson disease|parkinson disease
1125167|NCT02406105|functional radioablation|functional radioablation
1125168|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
1125169|NCT02406079|tracheotomy|tracheotomy
1125170|NCT02406079|procalcitonin|procalcitonin
1125171|NCT02406079|sepsis|sepsis
1125172|NCT02406053|lung cancer|lung cancer
1125173|NCT02406053|antioxidants|antioxidants
1125174|NCT02406053|oxidative damage|oxidative damage
1125175|NCT02406040|Protein synthesis|protein synthesis
1125176|NCT02406040|Protein breakdown|protein breakdown
1125177|NCT02406040|Muscle|muscle
1125178|NCT02406040|Energy restriction|energy restriction
1125180|NCT02406027|JNJ-54861911|jnj-54861911
1125181|NCT02406027|Placebo|placebo
1125182|NCT02406001|peri-implantitis|peri-implantitis
1125183|NCT02406001|osseous defects|osseous defects
1125184|NCT02406001|implant surface decontamination|implant surface decontamination
1125185|NCT02406001|bone grafting|bone grafting
1125186|NCT02406001|surgical therapy|surgical therapy
1125187|NCT02406001|porous titanium granules|porous titanium granules
1125188|NCT02406001|reconstruction|reconstruction
1125189|NCT02405988|Emergency Treatment|emergency treatment
1125190|NCT02405988|Morphine Derivates|morphine derivates
1125191|NCT02405988|Heroin|heroin
1125192|NCT02405988|Antidotes|antidotes
1125193|NCT02405988|Administration, Intravenous|administration, intravenous
1125194|NCT02405988|Pharmacology|pharmacology
1125195|NCT02405988|Naloxone|naloxone
1125196|NCT02405988|Healthy volunteers|healthy volunteers
1125197|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
1125198|NCT02405962|Childhood asthma|childhood asthma
1125199|NCT02405962|Randomized controlled trial|randomized controlled trial
1125200|NCT02405962|Training parents|training parents
1125201|NCT02405910|advanced|advanced
1125202|NCT02405910|non-squamous|non-squamous
1125203|NCT02405910|first line therapy|first line therapy
1125204|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
1125205|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
1125206|NCT02405897|forceps|forceps
1125207|NCT02405884|Glaucoma|glaucoma
1125208|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
1125209|NCT02405884|Low Tension Glaucoma|low tension glaucoma
1125210|NCT02405884|Ocular Hypertension|ocular hypertension
1125211|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1125212|NCT02405858|Abiraterone Acetate|abiraterone acetate
1125213|NCT02405858|ZYTIGA|zytiga
1125214|NCT02405858|Prednisolone|prednisolone
1125215|NCT02405845|Atherosclerosis|atherosclerosis
1125216|NCT02405845|Internal Carotid Artery|internal carotid artery
1125217|NCT02405845|Free-floating thrombus|free-floating thrombus
1125218|NCT02405845|Ulcerated plaque|ulcerated plaque
1125219|NCT02405845|FFT|fft
1125220|NCT02405819|Cancer|cancer
1125221|NCT02405819|Oncology|oncology
1125222|NCT02405819|Survivorship|survivorship
1125223|NCT02405819|Care|care
1125224|NCT02405819|Plan|plan
1125225|NCT02405780|Rheumatoid|rheumatoid
1125226|NCT02405780|Arthritis|arthritis
1125227|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
1125228|NCT02405754|Corus CAD|corus cad
1125229|NCT02405754|Personalized Medicine|personalized medicine
1125230|NCT02405754|CAD|cad
1125231|NCT02405754|ASGES|asges
1125232|NCT02405754|Age/Sex/Gene Expression Score|age/sex/gene expression score
1125233|NCT02405754|GES|ges
1125236|NCT02405754|Precision Medicine|precision medicine
1125237|NCT02405754|Clinical Utility|clinical utility
1125238|NCT02405754|Gene Expression|gene expression
1125239|NCT02405754|Coronary Heart Disease|coronary heart disease
1125240|NCT02405754|Cardiovascular Disease|cardiovascular disease
1125241|NCT02405754|Chest Pain|chest pain
1125242|NCT02405754|Coronary Artery Disease|coronary artery disease
1125243|NCT02405754|Angina Pectoris|angina pectoris
1125244|NCT02405754|exercise stress testing|exercise stress testing
1125245|NCT02405754|CT angiography|ct angiography
1125246|NCT02405754|invasive cardiac angiography|invasive cardiac angiography
1125247|NCT02405754|African-American patient|african-american patient
1125248|NCT02405754|ICA|ica
1125249|NCT02405754|CTA|cta
1125250|NCT02405728|PICC|picc
1125251|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
1125252|NCT02405728|VASCULAR ACCESS|vascular access
1125253|NCT02405728|DEEP VEIN THROMBOSIS|deep vein thrombosis
1125254|NCT02405728|CICC|cicc
1125255|NCT02405702|Infection|infection
1125256|NCT02405702|Knee|knee
1125257|NCT02405702|knee replacement|knee replacement
1125258|NCT02405676|Lymphoma|lymphoma
1125259|NCT02405676|non-Hodgkin|non-hodgkin
1125260|NCT02405676|B-lymphocytes|b-lymphocytes
1125261|NCT02405676|Child|child
1125262|NCT02405676|Multicenter study|multicenter study
1125263|NCT02405663|blood loss|blood loss
1125264|NCT02405663|caesarean section|caesarean section
1125265|NCT02405663|placental delivery|placental delivery
1125266|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
1125267|NCT02405637|Feeding intolerance|feeding intolerance
1125268|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
1125269|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
1125270|NCT02405585|Pancreatic Cancer|pancreatic cancer
1125271|NCT02405585|Immunotherapy|immunotherapy
1125272|NCT02405585|Vaccine Therapy|vaccine therapy
1125273|NCT02405572|formula-fed|formula-fed
1125274|NCT02405572|infants|infants
1125275|NCT02405546|Nasal intubation|nasal intubation
1125276|NCT02405546|Counterclockwise rotation|counterclockwise rotation
1125277|NCT02405533|AHCC|ahcc
1125278|NCT02405533|nutritional supplement|nutritional supplement
1125279|NCT02405533|HPV|hpv
1125280|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
1125281|NCT02405520|condylomata acuminata|condylomata acuminata
1125282|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
1125283|NCT02405507|Wheat germ|wheat germ
1125284|NCT02405507|Constipation|constipation
1125285|NCT02405507|Glycaemic Index|glycaemic index
1125286|NCT02405507|Blood Cholesterol Level|blood cholesterol level
1125287|NCT02405507|Glycaemic Response|glycaemic response
1125288|NCT02405507|Cholesterol|cholesterol
1125289|NCT02405507|PAC-SYM|pac-sym
1125290|NCT02405507|Gut Microbiota|gut microbiota
1125291|NCT02405468|blood microbiota|blood microbiota
1125292|NCT02405468|coronary disease|coronary disease
1125293|NCT02405468|myocardial infarction|myocardial infarction
1125294|NCT02405455|cervical insufficiency|cervical insufficiency
1125295|NCT02405455|cervical cerclage|cervical cerclage
1125296|NCT02405455|cervical pessary|cervical pessary
1125297|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
1125298|NCT02405416|Blood Loss|blood loss
1125299|NCT02405416|Haemorrhage|haemorrhage
1125300|NCT02405416|Vascular Control|vascular control
1125301|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
1125302|NCT02405403|PET|pet
1125303|NCT02405403|microglial activation|microglial activation
1125304|NCT02405390|Storz C-Mac®|storz c-mac®
1125305|NCT02405390|Pediatric Airway|pediatric airway
1125306|NCT02405390|Cervical Spine Injury|cervical spine injury
1125307|NCT02405390|Trauma Airway Management|trauma airway management
1125308|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
1125309|NCT02405377|hydration|hydration
1125310|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
1125311|NCT02405364|Multiple Myeloma|multiple myeloma
1125312|NCT02405364|Carfilzomib|carfilzomib
1125313|NCT02405364|Lenalidomide|lenalidomide
1125314|NCT02405364|Dexamethasone|dexamethasone
1125315|NCT02405364|Patient up to 65 years|patient up to 65 years
1125316|NCT02405364|initial management|initial management
1125317|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
1125318|NCT02405338|AML|aml
1125319|NCT02405325|physical activity|physical activity
1125320|NCT02405325|multilevel|multilevel
1125321|NCT02405325|cost-effectiveness|cost-effectiveness
1125322|NCT02405325|older adults|older adults
1125323|NCT02405312|communication|communication
1125324|NCT02405312|palliative care|palliative care
1125325|NCT02405312|death|death
1125326|NCT02405299|child|child
1125327|NCT02405299|disorders inhibition|disorders inhibition
1125328|NCT02405299|neuropsychology|neuropsychology
1125329|NCT02405299|rehabilitation|rehabilitation
1125330|NCT02405299|ADHD|adhd
1125331|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
1125332|NCT02405273|Lung Cancer|lung cancer
1125333|NCT02405273|Surgery|surgery
1125334|NCT02405273|COPD|copd
1125335|NCT02405273|Rehabilitation|rehabilitation
1125341|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
1125342|NCT02405247|AZD9291|azd9291
1125343|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
1125344|NCT02405221|HPV|hpv
1125345|NCT02405221|HPV16|hpv16
1125346|NCT02405221|Cervical Cancer|cervical cancer
1125347|NCT02405221|TA-CIN|ta-cin
1125348|NCT02405221|Vaccine|vaccine
1125349|NCT02405221|Adjuvant|adjuvant
1125350|NCT02405221|Nickles FaderPI|nickles faderpi
1125351|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
1125352|NCT02405182|MRI|mri
1125353|NCT02405182|Biomarker|biomarker
1125354|NCT02405169|Implantology|implantology
1125355|NCT02405169|oral surgery|oral surgery
1125356|NCT02405169|bone level changes|bone level changes
1125357|NCT02405169|marginal bone level|marginal bone level
1125358|NCT02405156|Letrozole|letrozole
1125359|NCT02405156|misoprostol|misoprostol
1125360|NCT02405156|second trimester miscarriage|second trimester miscarriage
1125361|NCT02405143|Controlled clinical trial|controlled clinical trial
1125362|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
1125363|NCT02405117|Bipolar Disorder|bipolar disorder
1125364|NCT02405117|Behavior Therapy|behavior therapy
1125365|NCT02405117|Technology Assisted|technology assisted
1125366|NCT02405117|Mobile Phone|mobile phone
1125367|NCT02405117|Smartphone|smartphone
1125368|NCT02405104|osteoarthritis|osteoarthritis
1125369|NCT02405104|hip|hip
1125370|NCT02405104|knee|knee
1125371|NCT02405104|total hip arthroplasty|total hip arthroplasty
1125372|NCT02405104|total knee arthroplasty|total knee arthroplasty
1125373|NCT02405104|post operative pain management|post operative pain management
1125374|NCT02405078|Lymphoma|lymphoma
1125375|NCT02405078|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1125376|NCT02405078|DLBCL|dlbcl
1125377|NCT02405078|Relapsed/Refractory|relapsed/refractory
1125378|NCT02405078|Fluorodeoxyglucose-positron emission tomography/computed tomography|fluorodeoxyglucose-positron emission tomography/computed tomography
1125379|NCT02405078|FDG-PET/CT|fdg-pet/ct
1125380|NCT02405078|18F-Fluorodeoxyglucose|18f-fluorodeoxyglucose
1125381|NCT02405078|Blood draws|blood draws
1125382|NCT02405078|Chemotherapy|chemotherapy
1125383|NCT02405039|DED|ded
1125384|NCT02405039|Disease|disease
1125385|NCT02405013|Africa|africa
1125386|NCT02405013|Hepatitis C|hepatitis c
1125387|NCT02405013|HIV|hiv
1125388|NCT02405013|Antiviral treatment|antiviral treatment
1125389|NCT02405013|Adults|adults
1125390|NCT02405013|HCV genotype 1|hcv genotype 1
1125391|NCT02405013|HCV genotype 2|hcv genotype 2
1125392|NCT02405013|HCV genotype 4|hcv genotype 4
1125393|NCT02404974|physical activity|physical activity
1125394|NCT02404948|coronary artery disease|coronary artery disease
1125395|NCT02404948|diagnosis|diagnosis
1125396|NCT02404948|non-invasive|non-invasive
1125397|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
1125398|NCT02404935|cetuximab|cetuximab
1125399|NCT02404935|maintenance|maintenance
1125400|NCT02404922|Safety/Efficacy Study|safety/efficacy study
1125401|NCT02404922|Randomized|randomized
1125402|NCT02404922|Double Blind|double blind
1125403|NCT02404883|Cancer|cancer
1125404|NCT02404883|decisional conflict|decisional conflict
1125405|NCT02404883|online|online
1125406|NCT02404883|decision-aid tool|decision-aid tool
1125407|NCT02404870|Diabetes|diabetes
1125408|NCT02404870|Phosphate|phosphate
1125409|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
1125410|NCT02404870|Vitamin D|vitamin d
1125411|NCT02404870|PTH|pth
1125412|NCT02404857|Post stroke|post stroke
1125413|NCT02404857|BCI|bci
1125414|NCT02404857|Reeducation|reeducation
1125415|NCT02404857|Hand movement|hand movement
1125416|NCT02404831|Physiotherapy|physiotherapy
1125417|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
1125418|NCT02404831|Exercise|exercise
1125419|NCT02404831|Telerehab|telerehab
1125420|NCT02404818|Radiation|radiation
1125421|NCT02404818|Cardiac|cardiac
1125422|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
1125423|NCT02404805|dolutegravir|dolutegravir
1125424|NCT02404805|simeprevir|simeprevir
1125425|NCT02404805|HIV|hiv
1125426|NCT02404805|HCV|hcv
1125427|NCT02404792|Frail Elderly|frail elderly
1125428|NCT02404792|IGF-1|igf-1
1125429|NCT02404779|ICU|icu
1125430|NCT02404779|Deep sedation|deep sedation
1125431|NCT02404779|Mechanical ventilation|mechanical ventilation
1125432|NCT02404779|Traumatic brain injury|traumatic brain injury
1125433|NCT02404779|Intracranial hypertension|intracranial hypertension
1125434|NCT02404779|Cisatracurium|cisatracurium
1125435|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
1125559|NCT02404142|NMBA|nmba
1125436|NCT02404779|Randomization versus placebo|randomization versus placebo
1125437|NCT02404766|manual therapy|manual therapy
1125438|NCT02404766|cervical|cervical
1125439|NCT02404766|range of movement|range of movement
1125440|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
1125441|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
1125442|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1125443|NCT02404740|VP shunted|vp shunted
1125645|NCT02403609|computerized assessment|computerized assessment
1125444|NCT02404740|Normal intracranial pathology|normal intracranial pathology
1125445|NCT02404740|patients|patients
1125446|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
1125447|NCT02404727|acetabular fixation|acetabular fixation
1125448|NCT02404727|dual mobility cup|dual mobility cup
1125449|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
1125450|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
1125451|NCT02404727|Accelerometry|accelerometry
1125452|NCT02404727|total hip arthroplasty|total hip arthroplasty
1125453|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
1125454|NCT02404662|Alcohol use disorder|alcohol use disorder
1125455|NCT02404662|Depression|depression
1125456|NCT02404662|Mood disorders|mood disorders
1125457|NCT02404662|Bipolar disorder|bipolar disorder
1125458|NCT02404662|Supportive text messages|supportive text messages
1125459|NCT02404623|Vitamin D|vitamin d
1125460|NCT02404623|Respiratory Morbidity|respiratory morbidity
1125461|NCT02404623|prematurity|prematurity
1125462|NCT02404610|propofol|propofol
1125463|NCT02404610|moderate procedural sedation|moderate procedural sedation
1125464|NCT02404610|deep procedural sedation|deep procedural sedation
1125465|NCT02404610|memory|memory
1125466|NCT02404610|emergency department|emergency department
1125467|NCT02404597|Cardiac output|cardiac output
1125468|NCT02404597|Low blood pressure|low blood pressure
1125469|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
1125470|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
1125471|NCT02404545|Hernia|hernia
1125472|NCT02404545|Mesh|mesh
1125473|NCT02404545|Ileal conduit|ileal conduit
1125474|NCT02404532|OPC-14597 Digital|opc-14597 digital
1125475|NCT02404532|Aripiprazole|aripiprazole
1125476|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
1125477|NCT02404532|Ingestible Event Marker|ingestible event marker
1125478|NCT02404519|Vitamin K|vitamin k
1125479|NCT02404519|Menaquinone-7|menaquinone-7
1125480|NCT02404519|Matrix Gla Protein|matrix gla protein
1125481|NCT02404519|Vascular stiffness|vascular stiffness
1125482|NCT02404506|Eribulin|eribulin
1125483|NCT02404506|Breast Cancer|breast cancer
1125484|NCT02404506|Elderly Patient|elderly patient
1125485|NCT02404506|Phase II Trial|phase ii trial
1125486|NCT02404506|HER2-neg|her2-neg
1125487|NCT02404506|adenocarcinoma|adenocarcinoma
1125488|NCT02404493|Atopic Dermatitis|atopic dermatitis
1125489|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
1125490|NCT02404428|active surveillance|active surveillance
1125491|NCT02404428|MRI|mri
1125492|NCT02404428|diet|diet
1125493|NCT02404415|catheter ablation|catheter ablation
1125494|NCT02404415|genomics|genomics
1125495|NCT02404402|Traumatic Brain Injury|traumatic brain injury
1125496|NCT02404402|Light Emitting Diodes|light emitting diodes
1125497|NCT02404402|Cognition|cognition
1125498|NCT02404402|Neuromodulation|neuromodulation
1125499|NCT02404402|PTSD|ptsd
1125500|NCT02404402|Neurorehabilitation|neurorehabilitation
1125501|NCT02404402|Veterans|veterans
1125502|NCT02404402|Sleep|sleep
1125503|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
1125504|NCT02404376|STEMI|stemi
1125505|NCT02404376|Reperfusion Injury|reperfusion injury
1125506|NCT02404376|Myocardial Infarction|myocardial infarction
1125507|NCT02404376|Myocardial Ischemia|myocardial ischemia
1125508|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
1125509|NCT02404376|Exenatide|exenatide
1125510|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
1125511|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
1125512|NCT02404376|Cardioprotection|cardioprotection
1125513|NCT02404363|Clopidogrel|clopidogrel
1125514|NCT02404363|Pancreatic Cancer|pancreatic cancer
1125515|NCT02404363|Efficacy|efficacy
1125516|NCT02404363|Chemotherapy|chemotherapy
1125517|NCT02404363|Microparticles|microparticles
1125518|NCT02404363|Disease free survival|disease free survival
1125519|NCT02404363|First line chemotherapy|first line chemotherapy
1125520|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
1125521|NCT02404311|HIV|hiv
1125522|NCT02404311|AIDS|aids
1125523|NCT02404311|Vaccine|vaccine
1125524|NCT02404298|Transcriptome analysis|transcriptome analysis
1125525|NCT02404298|peripheral blood|peripheral blood
1125526|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
1125527|NCT02404298|auto immune diseases|auto immune diseases
1125528|NCT02404298|IVIg|ivig
1125529|NCT02404272|Neonate|neonate
1125530|NCT02404272|oral feeding disorder|oral feeding disorder
1125531|NCT02404272|full oral feeding|full oral feeding
1125532|NCT02404272|training|training
1125533|NCT02404272|quality of health care|quality of health care
1125534|NCT02404259|pharmacokinetics|pharmacokinetics
1125535|NCT02404259|TDF|tdf
1125536|NCT02404259|HIV-infected children|hiv-infected children
1125537|NCT02404259|Thai|thai
1125538|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
1126039|NCT02401607|biomarkers|biomarkers
1125539|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
1125540|NCT02404259|less than eighteen years old|less than eighteen years old
1125541|NCT02404246|Bipolar|bipolar
1125542|NCT02404246|Peers|peers
1125543|NCT02404246|DBSA|dbsa
1125544|NCT02404220|Syk inhibitor|syk inhibitor
1125545|NCT02404220|Blood malignancy|blood malignancy
1125546|NCT02404220|Leukemia|leukemia
1125547|NCT02404207|Prevention|prevention
1125548|NCT02404194|schizophrenia|schizophrenia
1125549|NCT02404194|psychosis|psychosis
1125550|NCT02404194|at risk|at risk
1125551|NCT02404194|prodrome|prodrome
1125552|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
1125553|NCT02404181|Validation Studies|validation studies
1125554|NCT02404181|EEG|eeg
1125555|NCT02404142|Trachel intubation|trachel intubation
1125556|NCT02404142|IDS score|ids score
1125557|NCT02404142|Videoaryngoscopy|videoaryngoscopy
1125558|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
1125560|NCT02404142|Curare (Atracurium)|curare (atracurium)
1125561|NCT02404129|Fall|fall
1125562|NCT02404129|Turn 180 test|turn 180 test
1125563|NCT02404129|elderly|elderly
1125564|NCT02404129|balance|balance
1125565|NCT02404090|Obesity|obesity
1125566|NCT02404090|Weight Loss|weight loss
1125567|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
1125568|NCT02404090|Subchondral Mineralization|subchondral mineralization
1125569|NCT02404077|Patients|patients
1125570|NCT02404077|undergoing|undergoing
1125571|NCT02404077|ICU|icu
1125572|NCT02404051|Breast cancer|breast cancer
1125573|NCT02404051|HER2Negative|her2negative
1125574|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
1125575|NCT02404051|Metastatic|metastatic
1125576|NCT02404051|Locally Advanced|locally advanced
1125577|NCT02404051|fulvestrant|fulvestrant
1125578|NCT02404051|everolimus|everolimus
1125579|NCT02404051|exemestane|exemestane
1125580|NCT02404038|choice|choice
1125581|NCT02404038|young women|young women
1125582|NCT02404038|adolescent girls|adolescent girls
1125583|NCT02404038|preference|preference
1125584|NCT02404025|Eltrombopag|eltrombopag
1125585|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
1125586|NCT02404025|additive effect|additive effect
1125587|NCT02404025|cyclosporine A|cyclosporine a
1125588|NCT02404012|iron deficiency|iron deficiency
1125589|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
1125590|NCT02404012|gastric bypass|gastric bypass
1125591|NCT02404012|bariatric surgery|bariatric surgery
1125592|NCT02403973|Patient hotel|patient hotel
1125593|NCT02403973|Patient Satisfaction|patient satisfaction
1125594|NCT02403973|Perioperative care|perioperative care
1125595|NCT02403973|IN2005E|in2005e
1125596|NCT02403947|Multiple Sclerosis|multiple sclerosis
1125597|NCT02403947|Bone-marrow|bone-marrow
1125598|NCT02403947|Stem cells|stem cells
1125599|NCT02403947|Cell therapy|cell therapy
1125600|NCT02403934|Airway Management|airway management
1125601|NCT02403934|deep sedation|deep sedation
1125602|NCT02403934|Jaw elevation device|jaw elevation device
1125603|NCT02403921|biomarker|biomarker
1125604|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
1125605|NCT02403882|behavioral economics|behavioral economics
1125606|NCT02403882|food pantry|food pantry
1125607|NCT02403882|food choice|food choice
1125608|NCT02403869|Metastatic breast cancer|metastatic breast cancer
1125609|NCT02403869|Monotherapy|monotherapy
1125610|NCT02403869|chemotherapy|chemotherapy
1125611|NCT02403869|second line|second line
1125612|NCT02403869|treatment|treatment
1125613|NCT02403869|Her 2 negative|her 2 negative
1125614|NCT02403856|calcifying tendinitis|calcifying tendinitis
1125615|NCT02403856|Needle lavage|needle lavage
1125616|NCT02403856|Shoulder|shoulder
1125617|NCT02403856|Corticosteroid injection|corticosteroid injection
1125618|NCT02403856|Ultrasound-guided|ultrasound-guided
1125619|NCT02403817|Video Games|video games
1125620|NCT02403804|Dietary supplements|dietary supplements
1125621|NCT02403804|serum choline|serum choline
1125622|NCT02403804|women|women
1125623|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1125624|NCT02403778|Melanoma|melanoma
1125625|NCT02403778|Malignant Melanoma|malignant melanoma
1125626|NCT02403752|dementia|dementia
1125627|NCT02403752|Alzheimer's disease|alzheimer's disease
1125628|NCT02403752|exercise|exercise
1125629|NCT02403739|Growth|growth
1125630|NCT02403700|bone remodeling|bone remodeling
1125631|NCT02403700|bone resorption|bone resorption
1125632|NCT02403700|three-dimensional imaging|three-dimensional imaging
1125633|NCT02403700|clinical trial|clinical trial
1125634|NCT02403700|dental implant|dental implant
1125635|NCT02403700|maxilla|maxilla
1125636|NCT02403700|bone healing|bone healing
1125637|NCT02403635|HSV|hsv
1125638|NCT02403635|Herpes|herpes
1125639|NCT02403635|volunteers|volunteers
1125640|NCT02403635|drug-drug interaction|drug-drug interaction
1125641|NCT02403609|cognitive assessment|cognitive assessment
1125642|NCT02403609|Brain Performance Test|brain performance test
1125643|NCT02403609|Lumosity|lumosity
1125644|NCT02403609|test-retest reliability|test-retest reliability
1125646|NCT02403596|Hip replacement|hip replacement
1125647|NCT02403596|rivaroxaban|rivaroxaban
1125648|NCT02403596|exacyl|exacyl
1125649|NCT02403596|blood loss|blood loss
1125650|NCT02403583|HIV Transmission|hiv transmission
1125651|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1125652|NCT02403583|Serodiscordancy|serodiscordancy
1125653|NCT02403583|Home-based testing|home-based testing
1125654|NCT02403583|Home-based counseling|home-based counseling
1125655|NCT02403583|Linkage to care|linkage to care
1125656|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
1125657|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
1125658|NCT02403583|Retention in care|retention in care
1125859|NCT02402647|Hoarding|hoarding
1125659|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
1125660|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
1125661|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
1125662|NCT02403544|Oxaliplatin|oxaliplatin
1125663|NCT02403544|Capecitabine|capecitabine
1125664|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1125665|NCT02403531|Esophageal cancer|esophageal cancer
1125666|NCT02403531|Chemoradiotherapy|chemoradiotherapy
1125667|NCT02403531|induction chemotherapy|induction chemotherapy
1125668|NCT02403505|Prostate Cancer|prostate cancer
1125669|NCT02403505|SNP|snp
1125670|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
1125671|NCT02403505|Genetics|genetics
1125672|NCT02403505|Pharmacogenomic|pharmacogenomic
1125673|NCT02403505|Pharmacogenetic|pharmacogenetic
1125674|NCT02403505|gene|gene
1125675|NCT02403505|genome|genome
1125676|NCT02403505|genotype|genotype
1125677|NCT02403505|genotyping|genotyping
1125678|NCT02403505|Oncology|oncology
1125679|NCT02403505|Chemotherapy|chemotherapy
1125680|NCT02403505|Personalize|personalize
1125681|NCT02403505|Individualize|individualize
1125682|NCT02403492|Children|children
1125683|NCT02403492|Obesity|obesity
1125684|NCT02403492|Cardiovascular|cardiovascular
1125685|NCT02403492|Sleep|sleep
1125686|NCT02403492|Apnea|apnea
1125687|NCT02403492|Obstructive|obstructive
1125688|NCT02403466|Medical errors|medical errors
1125689|NCT02403466|Communication|communication
1125690|NCT02403466|Resident sign-out|resident sign-out
1125691|NCT02403453|Radiculopathy|radiculopathy
1125692|NCT02403453|Myelopathy|myelopathy
1125693|NCT02403453|Spondylosis|spondylosis
1125694|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
1125695|NCT02403453|C3-C7|c3-c7
1125696|NCT02403453|Osteophytes|osteophytes
1125697|NCT02403453|Neurological deficit|neurological deficit
1125698|NCT02403427|Bolus calculator|bolus calculator
1125699|NCT02403427|Insulin pump|insulin pump
1125700|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
1125701|NCT02403401|Pregnancy prevention|pregnancy prevention
1125702|NCT02403388|Patient safety|patient safety
1125703|NCT02403388|Primary care|primary care
1125704|NCT02403388|Incident reporting|incident reporting
1125705|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
1125706|NCT02403388|Risk management|risk management
1125707|NCT02403388|Assessment|assessment
1125708|NCT02403310|adverse-risk AML|adverse-risk aml
1125709|NCT02403310|poor-risk karyotype|poor-risk karyotype
1125710|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
1125711|NCT02403310|poor-risk mutations|poor-risk mutations
1125712|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
1125713|NCT02403310|treatment related AML|treatment related aml
1125714|NCT02403297|Bleeding gums|bleeding gums
1125715|NCT02403297|Gum inflammation|gum inflammation
1125716|NCT02403297|Saliva|saliva
1125717|NCT02403284|insulin resistance|insulin resistance
1125718|NCT02403284|lipid metabolism|lipid metabolism
1125719|NCT02403284|glucose metabolism|glucose metabolism
1125720|NCT02403284|high fat diets|high fat diets
1125721|NCT02403271|Pharmacyclics|pharmacyclics
1125722|NCT02403271|PCYC|pcyc
1125723|NCT02403271|Ibrutinib|ibrutinib
1125724|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
1125725|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
1125726|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
1125728|NCT02403271|Squamous|squamous
1125729|NCT02403271|Squamous NSCLC|squamous nsclc
1125730|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
1125731|NCT02403271|Immunotherapy|immunotherapy
1125732|NCT02403271|IMBRUVICA®|imbruvica®
1125733|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
1125734|NCT02403271|Anti-PD-L1|anti-pd-l1
1125735|NCT02403271|Lung Cancer|lung cancer
1125736|NCT02403271|Breast Cancer|breast cancer
1125737|NCT02403271|Triple Negative|triple negative
1125738|NCT02403271|HER2 Positive|her2 positive
1125739|NCT02403271|HER2 + Breast Cancer|her2 + breast cancer
1125740|NCT02403271|Pancreatic Cancer|pancreatic cancer
1125741|NCT02403258|acupuncture|acupuncture
1125742|NCT02403258|plum-blossom needle|plum-blossom needle
1125743|NCT02403258|tourette syndrome|tourette syndrome
1125744|NCT02403258|randomized controlled trial|randomized controlled trial
1125745|NCT02403245|Social interactions|social interactions
1125746|NCT02403245|Dementia|dementia
1125747|NCT02403245|Social stimulation|social stimulation
1125748|NCT02403245|Direct observation|direct observation
1125749|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
1125750|NCT02403219|Dry eye|dry eye
1125751|NCT02403219|Botulinum toxin A|botulinum toxin a
1125752|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
1125753|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
1125754|NCT02403193|NSCLC|nsclc
1125755|NCT02403193|PBF-509|pbf-509
1125756|NCT02403193|Immunotherapy|immunotherapy
1125757|NCT02403193|adenosine|adenosine
1125758|NCT02403193|PDR001|pdr001
1125759|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
1125954|NCT02402088|food cues|food cues
1125760|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
1125761|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
1125762|NCT02403180|Visual Performance|visual performance
1125763|NCT02403154|Anterior pelvic ring|anterior pelvic ring
1125764|NCT02403154|Internal fixation|internal fixation
1125765|NCT02403154|External fixation|external fixation
1125766|NCT02403154|Orthopaedic|orthopaedic
1125767|NCT02403154|Orthopedic|orthopedic
1125768|NCT02403154|pubic rami|pubic rami
1125769|NCT02403128|362.17|362.17
1125770|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
1125771|NCT02403102|Myeloma|myeloma
1125772|NCT02403102|Autograft|autograft
1125773|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
1125774|NCT02403089|Gut microbiota|gut microbiota
1125775|NCT02403089|Preterm birth|preterm birth
1125776|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1125777|NCT02403089|Microbial infections|microbial infections
1125778|NCT02403050|Neoplasm Staging|neoplasm staging
1125779|NCT02403050|Radiotherapy|radiotherapy
1125780|NCT02403050|Fiducial Markers|fiducial markers
1125781|NCT02403037|Breast Neoplasms|breast neoplasms
1125782|NCT02403037|Auricular Therapy|auricular therapy
1125783|NCT02403037|Acupressure|acupressure
1125784|NCT02403037|Chemotherapy|chemotherapy
1125785|NCT02403037|Nausea|nausea
1125786|NCT02403037|Vomiting|vomiting
1125787|NCT02403024|Colon cancer|colon cancer
1125788|NCT02403024|rectal cancer|rectal cancer
1125789|NCT02403024|exercise|exercise
1125790|NCT02403024|physical activity|physical activity
1125791|NCT02403024|metabolic health|metabolic health
1125792|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
1125793|NCT02403011|Manual Therapy|manual therapy
1125794|NCT02403011|Infant|infant
1125795|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
1125796|NCT02402998|Adults|adults
1125797|NCT02402998|Eltrombopag|eltrombopag
1125798|NCT02402998|Long-term remission|long-term remission
1125799|NCT02402985|nutritional support|nutritional support
1125800|NCT02402985|diet therapy|diet therapy
1125801|NCT02402985|protein diet|protein diet
1125802|NCT02402985|isocaloric diet|isocaloric diet
1125803|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
1125804|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
1125805|NCT02402972|prevention|prevention
1125806|NCT02402959|Insomnia|insomnia
1125807|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
1125808|NCT02402959|herbal medicine|herbal medicine
1125809|NCT02402959|cohort study|cohort study
1125810|NCT02402959|individualized treatment|individualized treatment
1125811|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
1125812|NCT02402920|Lung Cancer|lung cancer
1125813|NCT02402920|Small Cell Lung Cancer|small cell lung cancer
1125814|NCT02402920|SCLC|sclc
1125815|NCT02402920|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
1125816|NCT02402920|LS-SCLC|ls-sclc
1125817|NCT02402920|Extensive-Stage Small-Cell Lung Cancer|extensive-stage small-cell lung cancer
1125818|NCT02402920|ES-SCLC|es-sclc
1125819|NCT02402920|MK-3475|mk-3475
1125820|NCT02402920|Keytruda|keytruda
1125821|NCT02402920|Pembrolizumab|pembrolizumab
1125822|NCT02402920|SCH-900475|sch-900475
1125823|NCT02402920|Etoposide|etoposide
1125824|NCT02402920|VePesid|vepesid
1125825|NCT02402920|Cisplatin|cisplatin
1125826|NCT02402920|Platinol-AQ|platinol-aq
1125827|NCT02402920|Platinol|platinol
1125828|NCT02402920|CDDP|cddp
1125829|NCT02402920|Carboplatin|carboplatin
1125830|NCT02402920|Radiation therapy|radiation therapy
1125831|NCT02402920|XRT|xrt
1125832|NCT02402907|cesarean section|cesarean section
1125833|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
1125834|NCT02402907|CHG|chg
1125835|NCT02402907|surgical site infection|surgical site infection
1125836|NCT02402907|obstetrics|obstetrics
1125837|NCT02402907|infection prevention|infection prevention
1125838|NCT02402907|pregnancy|pregnancy
1125839|NCT02402881|venous thromboembolism|venous thromboembolism
1125840|NCT02402881|deep venous thrombosis|deep venous thrombosis
1125841|NCT02402881|pulmonary embolism|pulmonary embolism
1125842|NCT02402881|blood clots|blood clots
1125843|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
1125844|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
1125845|NCT02402855|free health care|free health care
1125846|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
1125847|NCT02402842|immunology|immunology
1125848|NCT02402842|taxane|taxane
1125849|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
1125850|NCT02402764|Breast - Female|breast - female
1125851|NCT02402764|Breast - Male|breast - male
1125852|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
1125853|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
1125854|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
1125855|NCT02402751|Volunteers|volunteers
1125856|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
1125857|NCT02402699|HBV|hbv
1125858|NCT02402699|HBC|hbc
1125860|NCT02402647|Compulsive Hoarding|compulsive hoarding
1125861|NCT02402595|Drug-drug interaction|drug-drug interaction
1125862|NCT02402595|Healthy Volunteers|healthy volunteers
1125863|NCT02402595|Pharmacokinetics|pharmacokinetics
1125864|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
1125865|NCT02402595|dextromethorphan|dextromethorphan
1125866|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
1125867|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
1125868|NCT02402595|itraconazole|itraconazole
1125869|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
1125870|NCT02402582|Quality of life|quality of life
1125871|NCT02402582|Perceived stress|perceived stress
1125872|NCT02402582|Anxiety|anxiety
1125873|NCT02402582|Myocardial infarction|myocardial infarction
1125874|NCT02402582|Clinical trial|clinical trial
1125875|NCT02402582|Iran|iran
1125876|NCT02402543|preemptive analgesia|preemptive analgesia
1125877|NCT02402543|anorectal surgery|anorectal surgery
1125878|NCT02402543|gabapentin|gabapentin
1125879|NCT02402543|neurontin|neurontin
1125880|NCT02402543|ketamine|ketamine
1125881|NCT02402543|acetaminophen|acetaminophen
1125882|NCT02402543|tylenol|tylenol
1125883|NCT02402543|postoperative pain|postoperative pain
1125884|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
1125885|NCT02402543|dexamethasone|dexamethasone
1125886|NCT02402543|decadron|decadron
1125887|NCT02402530|Neridronic Acid|neridronic acid
1125888|NCT02402530|Neridronate|neridronate
1125889|NCT02402530|CRPS|crps
1125890|NCT02402530|RSD|rsd
1125891|NCT02402517|Diabetes Prevention|diabetes prevention
1125892|NCT02402517|Obesity Prevention|obesity prevention
1125893|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
1125894|NCT02402491|In-Stent Restenosis|in-stent restenosis
1125895|NCT02402478|Clinical Cohort|clinical cohort
1125896|NCT02402478|Electronic Health Records|electronic health records
1125897|NCT02402478|Prognosis|prognosis
1125898|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
1125899|NCT02402439|Type 1 diabetes|type 1 diabetes
1125900|NCT02402439|diabetes mellitus|diabetes mellitus
1125901|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
1125902|NCT02402439|beta cell replacement|beta cell replacement
1125903|NCT02402426|Brain Health|brain health
1125904|NCT02402426|Brain Research|brain research
1125905|NCT02402426|Alzheimer's Disease|alzheimer's disease
1125906|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
1125907|NCT02402426|Parkinson's Disease|parkinson's disease
1125908|NCT02402426|Dementia|dementia
1125909|NCT02402426|Stroke|stroke
1125910|NCT02402426|PTSD|ptsd
1125911|NCT02402426|Multiple Sclerosis|multiple sclerosis
1125912|NCT02402400|NSTEMI|nstemi
1125913|NCT02402361|Neuropathic pain|neuropathic pain
1125914|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
1125915|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1125916|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
1125917|NCT02402309|SLS|sls
1125918|NCT02402309|Ichthyosis|ichthyosis
1181540|NCT02115750|RA|ra
1125919|NCT02402309|FALDH Deficiency|faldh deficiency
1125920|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
1125921|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
1125922|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
1125923|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
1125924|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
1125925|NCT02402309|Oligophrenia|oligophrenia
1125926|NCT02402283|Bioequivalency|bioequivalency
1125927|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
1125928|NCT02402270|Colonoscopy|colonoscopy
1125929|NCT02402270|Preparation|preparation
1125930|NCT02402257|Central Venous Catheter|central venous catheter
1125931|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
1125932|NCT02402257|Medical Education|medical education
1125933|NCT02402257|Patient Outcomes|patient outcomes
1125934|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
1125935|NCT02402257|Pneumothorax|pneumothorax
1125936|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
1125937|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
1126236|NCT02400359|weight loss|weight loss
1125938|NCT02402192|corifollitropin alfa|corifollitropin alfa
1125939|NCT02402192|recombinant FSH|recombinant fsh
1125940|NCT02402192|HP-hMG|hp-hmg
1125941|NCT02402192|time-lapse|time-lapse
1125942|NCT02402192|kinetics of development|kinetics of development
1125943|NCT02402179|protein quality|protein quality
1125944|NCT02402153|evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
1125945|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
1125946|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
1125947|NCT02402140|intrasubject variability|intrasubject variability
1125948|NCT02402127|Contact lenses|contact lenses
1125949|NCT02402127|Lubricity|lubricity
1125950|NCT02402101|tDCS|tdcs
1125951|NCT02402101|Dopamine|dopamine
1125952|NCT02402101|PET|pet
1125953|NCT02402088|stress|stress
1125955|NCT02402088|obesity|obesity
1125956|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
1125957|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
1125958|NCT02402075|D-wave|d-wave
1125959|NCT02402075|brain tumor surgery|brain tumor surgery
1125960|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
1125961|NCT02402062|pNET|pnet
1125962|NCT02401997|sperm|sperm
1125963|NCT02401997|oxidative stress|oxidative stress
1125964|NCT02401997|sexual abstinence|sexual abstinence
1125965|NCT02401971|Thalidomide|thalidomide
1125966|NCT02401971|Irinotecan|irinotecan
1125967|NCT02401971|Second Line|second line
1125968|NCT02401945|Macular Degeneration|macular degeneration
1125969|NCT02401919|Nursing|nursing
1125970|NCT02401919|Hospital|hospital
1125971|NCT02401919|Communication|communication
1125972|NCT02401919|Patient Participation|patient participation
1125973|NCT02401919|Individualised Care|individualised care
1125974|NCT02401893|aging|aging
1125975|NCT02401893|influenza vaccine|influenza vaccine
1125976|NCT02401893|immune responses|immune responses
1125977|NCT02401867|transgender|transgender
1125978|NCT02401867|female-to-male|female-to-male
1125979|NCT02401867|cervical cancer|cervical cancer
1125980|NCT02401867|HPV|hpv
1125981|NCT02401867|sexual health|sexual health
1125982|NCT02401854|atrial fibrillation|atrial fibrillation
1125983|NCT02401854|hypertension|hypertension
1125984|NCT02401854|risk factors|risk factors
1125985|NCT02401854|primary care|primary care
1125986|NCT02401854|elderly|elderly
1125987|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1125988|NCT02401815|KIT|kit
1125989|NCT02401815|Biomarkers|biomarkers
1125990|NCT02401815|PLX9486|plx9486
1125991|NCT02401815|PLX3397|plx3397
1125992|NCT02401815|Sunitinib|sunitinib
1125993|NCT02401802|Colonoscopy|colonoscopy
1125994|NCT02401802|Diet|diet
1125995|NCT02401802|Polyethylene glycols|polyethylene glycols
1125996|NCT02401802|Efficacy|efficacy
1125997|NCT02401802|Personal satisfaction|personal satisfaction
1125998|NCT02401802|Colorectal cancer screening|colorectal cancer screening
1125999|NCT02401789|oral surgery|oral surgery
1126000|NCT02401789|Implantology|implantology
1126001|NCT02401776|heart rate|heart rate
1126002|NCT02401776|blood pressure|blood pressure
1126003|NCT02401776|caffeine|caffeine
1126004|NCT02401776|energy drink|energy drink
1126005|NCT02401763|biomarker|biomarker
1126006|NCT02401737|Hepatitis B|hepatitis b
1126007|NCT02401724|Hemispatial neglect|hemispatial neglect
1126008|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
1126009|NCT02401724|Rehabilitation|rehabilitation
1126010|NCT02401698|Stroke|stroke
1126011|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1126012|NCT02401698|Neuronal Plasticity|neuronal plasticity
1126013|NCT02401698|Rehabilitation|rehabilitation
1126014|NCT02401685|breast cancer|breast cancer
1126015|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
1126016|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
1126017|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
1126018|NCT02401685|macrometastases|macrometastases
1126019|NCT02401685|axillary radiotherapy|axillary radiotherapy
1126020|NCT02401685|POSNOC|posnoc
1126021|NCT02401672|TMS|tms
1126022|NCT02401672|nicotine dependence|nicotine dependence
1126023|NCT02401672|smoking cessation|smoking cessation
1126024|NCT02401659|remote monitoring|remote monitoring
1126025|NCT02401659|satisfaction|satisfaction
1126026|NCT02401659|telemonitoring|telemonitoring
1126027|NCT02401659|quality of life|quality of life
1126028|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
1126029|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
1126030|NCT02401633|Compression-Only CPR|compression-only cpr
1126031|NCT02401633|Chest compression CPR|chest compression cpr
1126032|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
1126033|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
1126034|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
1126035|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
1126036|NCT02401607|stress|stress
1126037|NCT02401607|emergency physicians|emergency physicians
1126038|NCT02401607|health care workers|health care workers
1126040|NCT02401607|questionnaires|questionnaires
1126041|NCT02401607|anxiety|anxiety
1126042|NCT02401607|depression|depression
1126043|NCT02401607|burn-out|burn-out
1126044|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
1126045|NCT02401594|deep vein thrombosis|deep vein thrombosis
1126046|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
1126047|NCT02401542|UCC|ucc
1126048|NCT02401542|bladder cancer|bladder cancer
1126049|NCT02401542|B-701|b-701
1126050|NCT02401542|FGFR3|fgfr3
1126051|NCT02401542|invasive bladder cancer|invasive bladder cancer
1126052|NCT02401542|targeted therapy|targeted therapy
1126053|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
1126054|NCT02401542|TCC|tcc
1126055|NCT02401542|Phase 2|phase 2
1126251|NCT02400268|Bacteremia|bacteremia
1126056|NCT02401542|second line therapy|second line therapy
1126057|NCT02401542|monoclonal antibody|monoclonal antibody
1126058|NCT02401542|docetaxel|docetaxel
1126059|NCT02401542|combination therapy|combination therapy
1126060|NCT02401542|Phase 1|phase 1
1126061|NCT02401529|Dexamethasone|dexamethasone
1126062|NCT02401529|Prednisolone|prednisolone
1126063|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
1126064|NCT02401529|Pain, Postoperative|pain, postoperative
1126065|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1126066|NCT02401529|Randomized controlled trial|randomized controlled trial
1126067|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
1126068|NCT02401529|delayed feeding|delayed feeding
1126069|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
1126070|NCT02401516|Blood Pressure|blood pressure
1126071|NCT02401516|Posture|posture
1126072|NCT02401516|Quality Of Life|quality of life
1126073|NCT02401516|General Functional Capacity|general functional capacity
1126074|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
1126075|NCT02401516|Flexibility|flexibility
1126076|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
1126078|NCT02401477|helicobacter pylori|helicobacter pylori
1126079|NCT02401477|ilaprazole|ilaprazole
1126080|NCT02401477|eradication|eradication
1126081|NCT02401477|dual therapy|dual therapy
1126082|NCT02401477|high dose therapy|high dose therapy
1126083|NCT02401425|Letrozole|letrozole
1126084|NCT02401425|Misoprostol|misoprostol
1126085|NCT02401425|First-Trimester|first-trimester
1126086|NCT02401425|Pretreatment|pretreatment
1126087|NCT02401386|Fibromyalgia; Eight Brocades; Baduanjin; Qigong; Pain severity|fibromyalgia; eight brocades; baduanjin; qigong; pain severity
1126088|NCT02401373|Vaccines|vaccines
1126089|NCT02401373|Ebola Virus Disease|ebola virus disease
1126090|NCT02401347|PALB2 mutation|palb2 mutation
1126091|NCT02401347|BRIP1 mutation|brip1 mutation
1126092|NCT02401347|BARD1 mutation|bard1 mutation
1126093|NCT02401347|Rad51c mutation|rad51c mutation
1126094|NCT02401347|PTEN mutation|pten mutation
1126095|NCT02401347|CHEK2 mutation|chek2 mutation
1126096|NCT02401347|ATM mutation|atm mutation
1126097|NCT02401347|NBN mutation|nbn mutation
1126098|NCT02401347|Rad51d mutation|rad51d mutation
1126099|NCT02401347|Rad50 mutation|rad50 mutation
1126100|NCT02401347|MRE11 mutation|mre11 mutation
1126101|NCT02401347|FANC mutation|fanc mutation
1126102|NCT02401347|HRD assay score|hrd assay score
1126103|NCT02401347|ATR mutation|atr mutation
1126104|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
1126105|NCT02401256|Efavirenz|efavirenz
1126106|NCT02401256|metabolism|metabolism
1126107|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
1126108|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
1126109|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1126110|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
1126111|NCT02401204|Bacterial transmission|bacterial transmission
1126112|NCT02401204|Surveillance|surveillance
1126113|NCT02401204|Neonatal|neonatal
1126114|NCT02401204|Drug Resistance|drug resistance
1126115|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
1126116|NCT02401165|GADD34|gadd34
1126117|NCT02401165|Unfolded Protein Response|unfolded protein response
1126118|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
1126119|NCT02401100|Rectal Neoplasms|rectal neoplasms
1126120|NCT02401061|ITP|itp
1126121|NCT02401061|Thrombocytopenia|thrombocytopenia
1126122|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
1126123|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
1126124|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
1126125|NCT02401035|symptomatic GERD|symptomatic gerd
1126126|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
1126127|NCT02401022|smoking|smoking
1126128|NCT02401022|smoking cessation|smoking cessation
1126129|NCT02401022|cigarette|cigarette
1126130|NCT02400996|Endocrine Pancreas|endocrine pancreas
1126131|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
1126132|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
1126133|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
1126134|NCT02400970|fertility preservation|fertility preservation
1126135|NCT02400957|silver nanoparticles|silver nanoparticles
1126237|NCT02400359|lorcaserin|lorcaserin
1126136|NCT02400957|demineralization|demineralization
1126137|NCT02400957|brackets|brackets
1126138|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
1126139|NCT02400944|smoking exposure|smoking exposure
1126140|NCT02400944|15-047|15-047
1126141|NCT02400905|PAD|pad
1126142|NCT02400905|PVD|pvd
1126143|NCT02400905|SFA stent|sfa stent
1126144|NCT02400879|bispectral index|bispectral index
1126145|NCT02400879|cardiac surgery|cardiac surgery
1126146|NCT02400879|recovery|recovery
1126147|NCT02400879|remifentanil|remifentanil
1126148|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
1126149|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
1126150|NCT02400827|fertility preservation|fertility preservation
1126151|NCT02400801|endometriosis|endometriosis
1126152|NCT02400801|infertility|infertility
1126153|NCT02400801|assisted reproductive technology|assisted reproductive technology
1126154|NCT02400775|Pharmacotherapy|pharmacotherapy
1126155|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
1126156|NCT02400736|Individual Placement and Support|individual placement and support
1126157|NCT02400736|Supported Employment|supported employment
1126158|NCT02400736|Employment|employment
1126159|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
1126160|NCT02400736|Veterans|veterans
1126161|NCT02400736|Patient Aligned Care Team|patient aligned care team
1126162|NCT02400723|behavioral intervention|behavioral intervention
1126163|NCT02400723|relaxation|relaxation
1126164|NCT02400723|Veterans|veterans
1126165|NCT02400723|geriatric|geriatric
1126166|NCT02400684|AFSr classification|afsr classification
1126167|NCT02400684|laparoscopy|laparoscopy
1126168|NCT02400658|breast cancer|breast cancer
1126169|NCT02400658|early-stage|early-stage
1126170|NCT02400658|IORT|iort
1126171|NCT02400658|brachytherapy|brachytherapy
1126172|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
1126173|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
1126174|NCT02400632|drug-eluting balloon|drug-eluting balloon
1126175|NCT02400632|in-stent restenosis|in-stent restenosis
1126176|NCT02400619|shockwaves|shockwaves
1126177|NCT02400619|Physiotherapy|physiotherapy
1126178|NCT02400619|Botulinum toxin|botulinum toxin
1126179|NCT02400606|constructing VPs|constructing vps
1126180|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
1126181|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
1126182|NCT02400580|IV acetaminophen|iv acetaminophen
1126183|NCT02400580|Postoperative pain control|postoperative pain control
1126184|NCT02400580|Surgery|surgery
1126185|NCT02400567|Luminal|luminal
1126186|NCT02400567|Post menopausal|post menopausal
1126187|NCT02400567|Breast conservation|breast conservation
1126188|NCT02400567|Neoadjuvant|neoadjuvant
1126189|NCT02400554|Indian, North American|indian, north american
1126190|NCT02400554|Oklahoma|oklahoma
1126191|NCT02400554|Female|female
1126192|NCT02400554|health promotion|health promotion
1126193|NCT02400541|Anorexia nervosa|anorexia nervosa
1126194|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
1126195|NCT02400515|Exercise|exercise
1126196|NCT02400515|Exercise Therapy|exercise therapy
1126197|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1126198|NCT02400502|Schizophrenia|schizophrenia
1126199|NCT02400502|Treatment|treatment
1126200|NCT02400502|Meditation|meditation
1126201|NCT02400502|Mindfulness|mindfulness
1126202|NCT02400502|Stress reactivity|stress reactivity
1126203|NCT02400502|First Episode Psychosis|first episode psychosis
1126204|NCT02400502|Coping|coping
1126205|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
1126206|NCT02400489|Perimount|perimount
1126207|NCT02400489|Edwards|edwards
1126208|NCT02400476|HER2 +|her2 +
1126209|NCT02400476|Breast Cancer|breast cancer
1126210|NCT02400476|Neratinib|neratinib
1126211|NCT02400476|Nerlynx|nerlynx
1126212|NCT02400450|Pre-diabetes|pre-diabetes
1126213|NCT02400450|prediabetes|prediabetes
1126214|NCT02400450|glycated hemoglobin|glycated hemoglobin
1126215|NCT02400450|hemoglobin A1c|hemoglobin a1c
1126216|NCT02400450|LDL cholesterol|ldl cholesterol
1126217|NCT02400450|Cholesterol|cholesterol
1126218|NCT02400450|metabolic function|metabolic function
1126219|NCT02400450|vascular function|vascular function
1126220|NCT02400450|functional food|functional food
1126221|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1126222|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
1126223|NCT02400424|Radiochemotherapy|radiochemotherapy
1126224|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
1126225|NCT02400424|Peripheral primary tumor|peripheral primary tumor
1126226|NCT02400411|Carbohydrate|carbohydrate
1126227|NCT02400411|Glycemic response|glycemic response
1126228|NCT02400411|insulin|insulin
1126229|NCT02400411|whole grain|whole grain
1126230|NCT02400411|meal|meal
1126231|NCT02400359|fMRI|fmri
1126232|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
1126233|NCT02400359|endocrinology|endocrinology
1126234|NCT02400359|MRI|mri
1126235|NCT02400359|obesity|obesity
1126238|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
1126239|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
1126240|NCT02400333|relative bioavailability|relative bioavailability
1126241|NCT02400333|Phase I|phase i
1126242|NCT02400333|healthy subjects|healthy subjects
1126243|NCT02400307|Phase 1|phase 1
1126244|NCT02400307|Renally Impaired|renally impaired
1126245|NCT02400294|Critical care|critical care
1126246|NCT02400294|Mechanical ventilation|mechanical ventilation
1126247|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
1126248|NCT02400294|Oral care|oral care
1126249|NCT02400268|Enterobacteriaceae|enterobacteriaceae
1126250|NCT02400268|Bloodstream|bloodstream
1126252|NCT02400268|Recurrence|recurrence
1126253|NCT02400268|Reinfection|reinfection
1126254|NCT02400229|coronary artery disease|coronary artery disease
1126255|NCT02400229|stable chest pain|stable chest pain
1126256|NCT02400229|intermediate pretest probability|intermediate pretest probability
1126257|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
1126258|NCT02400229|coronary computed tomography|coronary computed tomography
1126259|NCT02400229|angiography|angiography
1126260|NCT02400229|invasive coronary angiography|invasive coronary angiography
1126261|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
1126262|NCT02400216|Cirrhosis|cirrhosis
1126263|NCT02400216|Liver Biopsy|liver biopsy
1126264|NCT02400216|Microbiome|microbiome
1126265|NCT02400203|hemp oil,|hemp oil,
1126267|NCT02400203|fatty acids|fatty acids
1126268|NCT02400203|omega-6|omega-6
1126269|NCT02400203|omega-3|omega-3
1126270|NCT02400203|blood pressure|blood pressure
1126271|NCT02400203|blood lipids|blood lipids
1126272|NCT02400190|radiation|radiation
1126273|NCT02400190|lumpectomy|lumpectomy
1126274|NCT02400190|favorable biology|favorable biology
1126275|NCT02400190|omission|omission
1126276|NCT02400125|Patient Registry|patient registry
1126277|NCT02400125|Coronary Artery Bypass|coronary artery bypass
1126278|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
1126279|NCT02400112|Vancomycin|vancomycin
1126280|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
1126281|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
1126282|NCT02400086|long term tracheostomy|long term tracheostomy
1126283|NCT02400047|Paediatric surgery|paediatric surgery
1126284|NCT02400034|midurethral sling|midurethral sling
1126285|NCT02400034|Voiding trial|voiding trial
1126286|NCT02400034|stress urinary incontinence|stress urinary incontinence
1126287|NCT02399995|Quality of Life|quality of life
1126288|NCT02399995|Hepatectomy|hepatectomy
1126289|NCT02399995|15-057|15-057
1126290|NCT02399982|Smartphone Application|smartphone application
1126291|NCT02399982|mobile mental health|mobile mental health
1126292|NCT02399982|Binge Eating|binge eating
1126293|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
1126294|NCT02399982|Eating Disorder treatment|eating disorder treatment
1126295|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
1126296|NCT02399982|self-monitoring|self-monitoring
1126297|NCT02399982|eating disorders|eating disorders
1126298|NCT02399982|ecological momentary intervention|ecological momentary intervention
1126299|NCT02399969|Low back pain|low back pain
1126300|NCT02399969|Acupuncture therapy|acupuncture therapy
1126301|NCT02399969|Acupuncture, ear|acupuncture, ear
1126302|NCT02399956|Lactation|lactation
1126303|NCT02399956|Pediatric malignancies|pediatric malignancies
1126304|NCT02399956|Cancer survivor|cancer survivor
1126305|NCT02399917|Leukemia|leukemia
1126306|NCT02399917|Acute Myeloid Leukemia|acute myeloid leukemia
1126307|NCT02399917|Refractory|refractory
1126308|NCT02399917|Relapsed|relapsed
1126309|NCT02399917|AML|aml
1126310|NCT02399917|Myelodysplastic Syndrome (MDS).|myelodysplastic syndrome (mds).
1126312|NCT02399917|High-risk|high-risk
1126313|NCT02399917|5-azacytidine|5-azacytidine
1126314|NCT02399917|Azacitidine|azacitidine
1126315|NCT02399917|5-aza|5-aza
1126316|NCT02399917|Vidaza|vidaza
1126317|NCT02399917|5-AZC|5-azc
1126318|NCT02399917|AZA-CR|aza-cr
1126319|NCT02399917|Ladakamycin|ladakamycin
1126320|NCT02399917|NSC-102816|nsc-102816
1126321|NCT02399917|Azacytidine|azacytidine
1126322|NCT02399917|Lirilumab|lirilumab
1126323|NCT02399917|Phone call|phone call
1126324|NCT02399891|Remodeling|remodeling
1126325|NCT02399891|Prognosis|prognosis
1126326|NCT02399891|Incidence|incidence
1126327|NCT02399891|Quality Assurance|quality assurance
1126328|NCT02399891|Ejection Fraction|ejection fraction
1126329|NCT02399891|Sudden Death|sudden death
1126330|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
1126331|NCT02399800|endosonography|endosonography
1126332|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
1126333|NCT02399735|NK cells|nk cells
1126334|NCT02399735|Liver Transplantation|liver transplantation
1126335|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
1126336|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
1126337|NCT02399670|Total hip arthroplasty|total hip arthroplasty
1126338|NCT02399670|degenerative joint disease|degenerative joint disease
1126339|NCT02399670|Femoral offset|femoral offset
1126340|NCT02399670|Patient reported outcome|patient reported outcome
1126341|NCT02399657|diabetes mellitus|diabetes mellitus
1126342|NCT02399657|macular edema|macular edema
1126343|NCT02399657|hard exudate|hard exudate
1126344|NCT02399657|intravitreal injections|intravitreal injections
1126345|NCT02399657|dexamethasone|dexamethasone
1126346|NCT02399657|implant|implant
1126347|NCT02399644|pain|pain
1126348|NCT02399644|rehabilitation|rehabilitation
1126349|NCT02399644|exercise|exercise
1126350|NCT02399644|psychological|psychological
1126351|NCT02399644|intervention|intervention
1126352|NCT02399631|Perioperative treatment|perioperative treatment
1126353|NCT02399631|Laparoscopic surgery|laparoscopic surgery
1126354|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
1126355|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
1126356|NCT02399618|Freeze-dried|freeze-dried
1126357|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
1126358|NCT02399592|Platinum resistant|platinum resistant
1126359|NCT02399579|cat allergy|cat allergy
1126360|NCT02399579|symptom score|symptom score
1126361|NCT02399566|erlotinib|erlotinib
1126362|NCT02399566|pemetrexed|pemetrexed
1126363|NCT02399566|maintenance therapy|maintenance therapy
1126364|NCT02399527|Vascular Anomalies|vascular anomalies
1126365|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
1126366|NCT02399527|Lymphatic Malformation|lymphatic malformation
1126367|NCT02399514|Sleep|sleep
1126368|NCT02399514|emphysema|emphysema
1126369|NCT02399514|coils|coils
1126370|NCT02399514|lung volume reduction|lung volume reduction
1126371|NCT02399501|2D ultrasound|2d ultrasound
1126372|NCT02399501|3D ultrasound|3d ultrasound
1126373|NCT02399501|sonohysterography|sonohysterography
1126374|NCT02399501|hysteroscopy|hysteroscopy
1126375|NCT02399501|Uterine factor of infertility|uterine factor of infertility
1126376|NCT02399475|Levothyroxine|levothyroxine
1126377|NCT02399475|Liothyronine|liothyronine
1126378|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
1126379|NCT02399475|Aging|aging
1126380|NCT02399475|Hypothyroidism|hypothyroidism
1126381|NCT02399475|Thyroid diseases|thyroid diseases
1126382|NCT02399449|iron|iron
1126383|NCT02399449|pharmacokinetics|pharmacokinetics
1126384|NCT02399436|Community-Based Participatory Research|community-based participatory research
1126385|NCT02399436|Community-Institutional Relations|community-institutional relations
1126386|NCT02399423|diabetes|diabetes
1126387|NCT02399423|metabolism|metabolism
1126388|NCT02399423|cardiovascular disease|cardiovascular disease
1126389|NCT02399423|weight gain|weight gain
1126390|NCT02399423|weight loss|weight loss
1126391|NCT02399423|european|european
1126392|NCT02399423|south asian|south asian
1126393|NCT02399423|obesity|obesity
1126394|NCT02399410|cytoreductive surgery|cytoreductive surgery
1126395|NCT02399410|hipec|hipec
1126396|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
1126397|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
1126398|NCT02399410|bevacizumab|bevacizumab
1126399|NCT02399410|colorectal surgery|colorectal surgery
1126400|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
1126401|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
1126402|NCT02399358|Cyclophosphamide|cyclophosphamide
1126403|NCT02399358|Hyponatremia|hyponatremia
1126404|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
1126405|NCT02399345|Treatment naive|treatment naive
1126406|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
1126407|NCT02399319|anterior pelvic ring|anterior pelvic ring
1126408|NCT02399319|symphysis disruption|symphysis disruption
1126409|NCT02399293|Cognitive training|cognitive training
1126410|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
1126411|NCT02399293|Acquired brain injury|acquired brain injury
1126412|NCT02399293|N-back|n-back
1126413|NCT02399293|Visual Search|visual search
1126414|NCT02399293|Cognitive transfer|cognitive transfer
1126415|NCT02399280|Meal pattern|meal pattern
1126416|NCT02399280|weight loss|weight loss
1126417|NCT02399280|high caloric intake|high caloric intake
1126418|NCT02399280|Dinner|dinner
1126419|NCT02399280|Lunch|lunch
1126420|NCT02399267|mechanical ventilation|mechanical ventilation
1126421|NCT02399267|weaning|weaning
1126422|NCT02399267|critically ill|critically ill
1126423|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
1126424|NCT02399267|screening|screening
1126425|NCT02399267|invasive ventilation|invasive ventilation
1126426|NCT02399267|SBT technique|sbt technique
1126427|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
1126428|NCT02399228|radiation therapy|radiation therapy
1126429|NCT02399228|chemotherapy|chemotherapy
1126430|NCT02399228|head and neck cancer|head and neck cancer
1126431|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
1126432|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
1126433|NCT02399189|rituximab|rituximab
1126434|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
1126435|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
1126436|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
1126437|NCT02399176|Osteoporosis|osteoporosis
1126438|NCT02399176|Yoga|yoga
1126439|NCT02399150|acute abdomen|acute abdomen
1126440|NCT02399150|Pain|pain
1126441|NCT02399150|stress biomarker|stress biomarker
1126442|NCT02399137|Pancreatic Cancer|pancreatic cancer
1126443|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
1126444|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1126445|NCT02399137|Gemcitabine|gemcitabine
1126446|NCT02399137|Nab-paclitaxel|nab-paclitaxel
1126447|NCT02399137|Abraxane|abraxane
1126448|NCT02399137|Free IGF-1|free igf-1
1126449|NCT02399137|Heregulin|heregulin
1126450|NCT02399124|RCC|rcc
1126451|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
1126452|NCT02399124|Kidney tumors|kidney tumors
1126453|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
1126454|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
1126455|NCT02399085|DLBCL|dlbcl
1126456|NCT02399085|CD19|cd19
1126457|NCT02399085|monoclonal antibody|monoclonal antibody
1126458|NCT02399085|MOR00208|mor00208
1126459|NCT02399085|MOR208|mor208
1126460|NCT02399085|lenalidomide|lenalidomide
1126461|NCT02399059|recurrence|recurrence
1126462|NCT02399033|Xihuang Capsules|xihuang capsules
1126463|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
1126464|NCT02399033|Recurrence|recurrence
1126465|NCT02399033|hepatectomy|hepatectomy
1126466|NCT02398994|Clinical Trials Unit|clinical trials unit
1126467|NCT02398994|Pediatric|pediatric
1126468|NCT02398968|Iron|iron
1126469|NCT02398968|RURTIs|rurtis
1126470|NCT02398968|CARIFS|carifs
1126471|NCT02398968|children|children
1126472|NCT02398955|Drug-Eluting Stents|drug-eluting stents
1126473|NCT02398955|Coronary Artery Disease|coronary artery disease
1126474|NCT02398955|Sirolimus|sirolimus
1126475|NCT02398955|Absorbable Implants|absorbable implants
1126476|NCT02398903|Morbid obesity|morbid obesity
1126477|NCT02398903|bariatric surgery|bariatric surgery
1126478|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
1126479|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1126480|NCT02398903|hormonal contraception|hormonal contraception
1126481|NCT02398903|combined oral contraceptive|combined oral contraceptive
1126482|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
1126483|NCT02398903|pharmacokinetics|pharmacokinetics
1126484|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
1126485|NCT02398825|Chronic phase|chronic phase
1126486|NCT02398825|Adults|adults
1126487|NCT02398825|Ponatinib|ponatinib
1126488|NCT02398825|Imatinib resistant|imatinib resistant
1126489|NCT02398760|Low Back Pain|low back pain
1126490|NCT02398760|Clinical Instability|clinical instability
1126491|NCT02398760|Motor Control Exercises|motor control exercises
1126492|NCT02398760|Clinical Tests|clinical tests
1126493|NCT02398734|sonolysis|sonolysis
1126494|NCT02398734|carotid endarterectomy|carotid endarterectomy
1126495|NCT02398734|stroke prevention|stroke prevention
1126496|NCT02398734|brain infarction|brain infarction
1126497|NCT02398721|FNAC|fnac
1126498|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
1126499|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1126500|NCT02398708|Graft versus Host Disease|graft versus host disease
1126501|NCT02398695|Plaque|plaque
1126502|NCT02398695|Saliva|saliva
1126503|NCT02398695|Caries|caries
1126504|NCT02398682|electronic alerts|electronic alerts
1126505|NCT02398682|acute kidney injury|acute kidney injury
1126506|NCT02398682|NHS|nhs
1126507|NCT02398682|mortality|mortality
1126508|NCT02398669|Obesity|obesity
1126509|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
1126510|NCT02398669|APD356|apd356
1126511|NCT02398669|Pediatric|pediatric
1126512|NCT02398669|Pharmacokinetics|pharmacokinetics
1126513|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
1126514|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
1126515|NCT02398643|COPD|copd
1126516|NCT02398643|Emphysema|emphysema
1126517|NCT02398643|Chronic Bronchitis|chronic bronchitis
1126518|NCT02398630|Histerosalpingography|histerosalpingography
1126519|NCT02398630|MRI|mri
1126520|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
1126521|NCT02398630|HSG|hsg
1126522|NCT02398630|Diagnostico Maipu|diagnostico maipu
1126523|NCT02398630|Imaging|imaging
1126524|NCT02398630|Carrascosa Patricia|carrascosa patricia
1126525|NCT02398617|Heart Failure|heart failure
1126526|NCT02398617|End of Life Care|end of life care
1126527|NCT02398617|Decision Making|decision making
1126528|NCT02398604|Pediatrics|pediatrics
1126529|NCT02398604|HLHS|hlhs
1126530|NCT02398591|Healthy|healthy
1126531|NCT02398591|JNJ 53718678|jnj 53718678
1126532|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1126533|NCT02398552|sunitinib|sunitinib
1126534|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
1126535|NCT02398526|Observational study|observational study
1126536|NCT02398526|Bone metastases|bone metastases
1126537|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
1126538|NCT02398526|Xofigo|xofigo
1126539|NCT02398526|Radium-223|radium-223
1126540|NCT02398500|First-in-human|first-in-human
1126541|NCT02398500|anti-VEGF|anti-vegf
1126542|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
1126543|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
1126544|NCT02398435|Still's disease|still's disease
1126545|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
1126546|NCT02398435|IL-18|il-18
1126547|NCT02398435|interleukin-18|interleukin-18
1126548|NCT02398435|IL-18 binding protein|il-18 binding protein
1126549|NCT02398422|Autonomic nervous system|autonomic nervous system
1126550|NCT02398422|Auditory processing disorder|auditory processing disorder
1126551|NCT02398422|Social behavior|social behavior
1126552|NCT02398409|stroke|stroke
1126553|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
1126554|NCT02398409|Family Caregivers|family caregivers
1126555|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1126556|NCT02398409|Informal Caregivers|informal caregivers
1126557|NCT02398370|ED|ed
1126558|NCT02398357|anticoagulation|anticoagulation
1126559|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
1126560|NCT02398331|Spinal cord injuries|spinal cord injuries
1126561|NCT02398331|Sexual function|sexual function
1126562|NCT02398331|Sexual response|sexual response
1126563|NCT02398331|Sexuality|sexuality
1126564|NCT02398331|Women|women
1126565|NCT02398318|neurosurgery|neurosurgery
1126566|NCT02398318|deep brain stimulation|deep brain stimulation
1126567|NCT02398318|exposure response prevention|exposure response prevention
1126568|NCT02398305|Cardiac catheterisation|cardiac catheterisation
1126569|NCT02398305|Radial access|radial access
1126570|NCT02398305|Compression|compression
1126571|NCT02398305|Terumo TR Band|terumo tr band
1126572|NCT02398305|radial artery|radial artery
1126573|NCT02398305|diagnostic|diagnostic
1126574|NCT02398279|schizophrenia|schizophrenia
1126575|NCT02398279|L-Arginine|l-arginine
1126576|NCT02398279|nitric oxide|nitric oxide
1126577|NCT02398279|drug augmentation|drug augmentation
1126578|NCT02398253|weight maintenance|weight maintenance
1126579|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
1126580|NCT02398253|successful weight loss|successful weight loss
1126581|NCT02398227|Battered Women|battered women
1126582|NCT02398227|Trauma|trauma
1126583|NCT02398227|Domestic Violence|domestic violence
1126584|NCT02398214|Sleep|sleep
1126585|NCT02398214|Infants|infants
1126586|NCT02398214|Toddlers|toddlers
1126587|NCT02398214|Behavioral intervention|behavioral intervention
1126588|NCT02398175|Pediatric polytrauma|pediatric polytrauma
1126589|NCT02398175|thoracic injuries|thoracic injuries
1126590|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
1126591|NCT02398162|Immunology|immunology
1126592|NCT02398136|intervention|intervention
1126593|NCT02398136|ketamine|ketamine
1126594|NCT02398136|PTSD|ptsd
1126595|NCT02398136|treatment|treatment
1126596|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
1126597|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
1126598|NCT02398123|caudal block|caudal block
1126599|NCT02398123|postoperative pain|postoperative pain
1182403|NCT02112591|TOT|tot
1126600|NCT02398123|children|children
1126601|NCT02398084|mastication|mastication
1126602|NCT02398084|cashews|cashews
1126603|NCT02398084|walnuts|walnuts
1126604|NCT02398084|participants|participants
1126605|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
1126606|NCT02398071|Exercise Recovery|exercise recovery
1126607|NCT02398071|COPD|copd
1126608|NCT02398058|trabectedin|trabectedin
1126609|NCT02398058|olaparib|olaparib
1126610|NCT02398058|sarcoma|sarcoma
1126611|NCT02398058|bone tumor|bone tumor
1126612|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
1126613|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
1126614|NCT02398045|computerised|computerised
1126615|NCT02398032|sleep apnea|sleep apnea
1126616|NCT02398032|hypertension|hypertension
1126617|NCT02398032|mechanosensitivity|mechanosensitivity
1126618|NCT02398032|chemosensitivity|chemosensitivity
1126619|NCT02398032|adhesion factors|adhesion factors
1126620|NCT02398019|CPB|cpb
1126621|NCT02398019|OXIRIS®|oxiris®
1126622|NCT02398019|SIRS|sirs
1126623|NCT02398019|AKI|aki
1126624|NCT02398019|Cytokines|cytokines
1126625|NCT02398019|LPS|lps
1126626|NCT02398006|Clavicle [mh]|clavicle [mh]
1126627|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
1126628|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
1126629|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
1126630|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
1126631|NCT02397980|Caregivers|caregivers
1126632|NCT02397967|NF1|nf1
1126633|NCT02397967|children|children
1126634|NCT02397967|reading disabilities|reading disabilities
1126635|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
1126636|NCT02397954|IPCV|ipcv
1126637|NCT02397954|Zimura®|zimura®
1126638|NCT02397954|Avastin®|avastin®
1126639|NCT02397954|Eylea®|eylea®
1126640|NCT02397954|Lucentis®|lucentis®
1126641|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1126643|NCT02397928|Minimal toxicity|minimal toxicity
1126644|NCT02397928|TTFields|ttfields
1126645|NCT02397928|Tumor Treating Fields|tumor treating fields
1126646|NCT02397928|Novocure|novocure
1126647|NCT02397928|Pemetrexed|pemetrexed
1126648|NCT02397928|Carboplatin|carboplatin
1126649|NCT02397928|Cisplatin|cisplatin
1126650|NCT02397915|Nasal Spray|nasal spray
1126651|NCT02397915|Fluticasone Furoate|fluticasone furoate
1126652|NCT02397915|Attributes|attributes
1126653|NCT02397915|Single Dose|single dose
1126654|NCT02397915|Allergic Rhinitis|allergic rhinitis
1126655|NCT02397915|Mometasone Furoate|mometasone furoate
1126863|NCT02396537|Intranasal|intranasal
1126656|NCT02397915|Questionnaire|questionnaire
1126657|NCT02397915|Preference|preference
1126658|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
1126659|NCT02397889|PTSD|ptsd
1126660|NCT02397889|ketamine|ketamine
1126661|NCT02397889|trauma|trauma
1126662|NCT02397889|treatment|treatment
1126663|NCT02397889|New York|new york
1126664|NCT02397889|NYC|nyc
1126665|NCT02397876|Food Allergy|food allergy
1126666|NCT02397876|Cows Milk Allergy|cows milk allergy
1126667|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
1126668|NCT02397837|Bipolar Disorder|bipolar disorder
1126669|NCT02397837|Cognition|cognition
1126670|NCT02397785|chronic pelvic pain|chronic pelvic pain
1126671|NCT02397785|electrical stimulation|electrical stimulation
1126672|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
1126673|NCT02397785|neuromodulation|neuromodulation
1126674|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
1126675|NCT02397772|Intestinal Nematodes|intestinal nematodes
1126676|NCT02397772|Hookworm|hookworm
1126677|NCT02397772|Ascaris|ascaris
1126678|NCT02397772|Mass Treatment|mass treatment
1126679|NCT02397772|Kenya|kenya
1126680|NCT02397746|osteoarthritis|osteoarthritis
1126681|NCT02397746|avascular necrosis|avascular necrosis
1126682|NCT02397746|ankylosis|ankylosis
1126683|NCT02397746|protrusio acetabuli|protrusio acetabuli
1126684|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
1126685|NCT02397746|correction of functional deformity|correction of functional deformity
1126686|NCT02397746|revision procedures|revision procedures
1126687|NCT02397720|Leukemia|leukemia
1126688|NCT02397720|Acute myeloid leukemia|acute myeloid leukemia
1126689|NCT02397720|AML|aml
1126690|NCT02397720|Refractory/ relapsed|refractory/ relapsed
1126691|NCT02397720|5-azacytidine|5-azacytidine
1126692|NCT02397720|Azacitidine|azacitidine
1126693|NCT02397720|5-aza|5-aza
1126694|NCT02397720|Vidaza|vidaza
1126695|NCT02397720|5-AZC|5-azc
1126696|NCT02397720|AZA-CR|aza-cr
1126697|NCT02397720|Ladakamycin|ladakamycin
1126698|NCT02397720|NSC-102816|nsc-102816
1126699|NCT02397720|Azacytidine|azacytidine
1126700|NCT02397720|Nivolumab|nivolumab
1126701|NCT02397720|BMS-936558|bms-936558
1126702|NCT02397720|Phone calls|phone calls
1126703|NCT02397694|Adult|adult
1126704|NCT02397694|HIV|hiv
1126705|NCT02397694|naive|naive
1126706|NCT02397655|stroke|stroke
1126707|NCT02397655|ischemia|ischemia
1126708|NCT02397655|atherosclerosis|atherosclerosis
1126709|NCT02397655|ultrasonography|ultrasonography
1126710|NCT02397590|Fimasartan|fimasartan
1126711|NCT02397564|scar|scar
1126712|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
1126713|NCT02397538|Fimasartan|fimasartan
1126714|NCT02397447|Momordica Charantia|momordica charantia
1126715|NCT02397447|Insulin secretion|insulin secretion
1126716|NCT02397447|Insulin sensitivity|insulin sensitivity
1126717|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
1126718|NCT02397421|Heart failure|heart failure
1126719|NCT02397421|Diabetes|diabetes
1126720|NCT02397421|Left ventricular remodelling|left ventricular remodelling
1126721|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
1126722|NCT02397395|Renal Impairment|renal impairment
1126723|NCT02397395|End-stage Renal Disease|end-stage renal disease
1126724|NCT02397395|Simeprevir|simeprevir
1126725|NCT02397395|Daclatasvir|daclatasvir
1126726|NCT02397382|Psoriasis|psoriasis
1126727|NCT02397382|Guselkumab|guselkumab
1126728|NCT02397382|Cytochromes P450|cytochromes p450
1126729|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
1126730|NCT02397356|ketamine|ketamine
1126731|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
1126732|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
1126733|NCT02397291|Pregnancy|pregnancy
1126734|NCT02397291|IUGR|iugr
1126735|NCT02397265|Type 1 diabetes|type 1 diabetes
1126736|NCT02397265|Hypoglycaemia|hypoglycaemia
1126737|NCT02397265|Closed loop insulin pump|closed loop insulin pump
1126738|NCT02397265|Artificial pancreas|artificial pancreas
1126739|NCT02397265|Exercise|exercise
1126740|NCT02397265|Mixed meals|mixed meals
1126741|NCT02397265|Bihormonal pump|bihormonal pump
1126742|NCT02397252|Human Papillomavirus|human papillomavirus
1126743|NCT02397252|Screening|screening
1126744|NCT02397252|Self-collection test|self-collection test
1126745|NCT02397252|Pap test|pap test
1127747|NCT02391233|Probation|probation
1126746|NCT02397226|Radiofrequency ablation|radiofrequency ablation
1126747|NCT02397226|Plethysmography|plethysmography
1126748|NCT02397226|Duplex ultrasound|duplex ultrasound
1126749|NCT02397226|High ligation/stripping|high ligation/stripping
1126750|NCT02397213|Ciclosporin|ciclosporin
1126751|NCT02397213|Acute Kidney injury|acute kidney injury
1126752|NCT02397213|Cardiac surgery|cardiac surgery
1126753|NCT02397213|Ischemia|ischemia
1126754|NCT02397213|Safety|safety
1126755|NCT02397213|Cystatin C|cystatin c
1126756|NCT02397200|Growth|growth
1126757|NCT02397200|low weight|low weight
1126758|NCT02397200|low height|low height
1126759|NCT02397200|Nutritional Supplementation|nutritional supplementation
1126760|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
1126761|NCT02397174|hypocaloric diet|hypocaloric diet
1126762|NCT02397174|Ovarian Cysts|ovarian cysts
1126763|NCT02397174|Ovarian Diseases|ovarian diseases
1126764|NCT02397174|Obesity|obesity
1126765|NCT02397174|Mediterranean Diet|mediterranean diet
1126766|NCT02397135|genomic markers|genomic markers
1126767|NCT02397083|Endometrial Cancer|endometrial cancer
1126768|NCT02397083|Endometrial hyperplasia|endometrial hyperplasia
1126769|NCT02397083|Intrauterine device|intrauterine device
1126770|NCT02397083|IUD|iud
1126771|NCT02397083|Levonorgestrel intrauterine device|levonorgestrel intrauterine device
1126772|NCT02397083|LIUD|liud
1126773|NCT02397083|Mirena|mirena
1126774|NCT02397083|Everolimus|everolimus
1126775|NCT02397083|Afinitor|afinitor
1126776|NCT02397083|Zortress|zortress
1126777|NCT02397083|RAD001|rad001
1126778|NCT02397083|Questionnaires|questionnaires
1126779|NCT02397083|Survey|survey
1126780|NCT02397083|Quality of life|quality of life
1126781|NCT02397083|QOL|qol
1126782|NCT02397070|Jaw exercise|jaw exercise
1126783|NCT02397070|Occlusal splint|occlusal splint
1126784|NCT02397070|Treatment|treatment
1126785|NCT02397070|Muscular pain|muscular pain
1126786|NCT02397070|Mandibular movement|mandibular movement
1126787|NCT02397044|Implants, stability, loading|implants, stability, loading
1126788|NCT02397031|borderline personality disorder|borderline personality disorder
1126789|NCT02397031|mindfulness|mindfulness
1126790|NCT02397018|stroke|stroke
1126791|NCT02397018|cord blood|cord blood
1126792|NCT02397018|umbilical cord blood|umbilical cord blood
1126793|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
1126794|NCT02397018|acute ischemic stroke|acute ischemic stroke
1126795|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
1126796|NCT02396992|Aspiration pneumonia|aspiration pneumonia
1126797|NCT02396992|Malnutrition|malnutrition
1126798|NCT02396992|Oral Health|oral health
1126799|NCT02396992|Bacterial colonization|bacterial colonization
1126800|NCT02396992|Aging|aging
1126801|NCT02396940|3D|3d
1126802|NCT02396940|Three-dimensional|three-dimensional
1126803|NCT02396940|Laparoscopy|laparoscopy
1126804|NCT02396940|Inguinal hernia repair|inguinal hernia repair
1126805|NCT02396927|3D|3d
1126806|NCT02396927|Three-dimensional|three-dimensional
1126807|NCT02396927|laparoscopy|laparoscopy
1126808|NCT02396927|cholecystectomy|cholecystectomy
1126809|NCT02396901|early goal direct therapy|early goal direct therapy
1126810|NCT02396901|preventive strategies|preventive strategies
1126811|NCT02396901|cardiac surgery|cardiac surgery
1126812|NCT02396888|Blood vessel|blood vessel
1126813|NCT02396888|Fibroplasia|fibroplasia
1126814|NCT02396888|Wound healing|wound healing
1126815|NCT02396888|Insulin|insulin
1126816|NCT02396836|Hand hygiene|hand hygiene
1126817|NCT02396836|Hand decontamination|hand decontamination
1126818|NCT02396836|Microbial load|microbial load
1126819|NCT02396836|Hand coverage|hand coverage
1126820|NCT02396836|Glove juice technique|glove juice technique
1126821|NCT02396836|Ayliffe technique|ayliffe technique
1126822|NCT02396836|6 step technique|6 step technique
1126823|NCT02396823|Blood pressure regulation|blood pressure regulation
1126824|NCT02396823|Respiratory Muscle Training|respiratory muscle training
1126825|NCT02396797|Sick leave|sick leave
1126826|NCT02396797|Mental Health|mental health
1126827|NCT02396797|Coping|coping
1126828|NCT02396797|Social Support|social support
1126829|NCT02396797|Subjective Health Complaints|subjective health complaints
1126830|NCT02396784|child overweight|child overweight
1126831|NCT02396784|child obesity|child obesity
1126832|NCT02396784|prevention|prevention
1126833|NCT02396784|targeted intervention|targeted intervention
1126834|NCT02396784|development of overweight|development of overweight
1126835|NCT02396771|Uterine|uterine
1126836|NCT02396771|Massage|massage
1126837|NCT02396771|Compression|compression
1126838|NCT02396732|Aspirin|aspirin
1126839|NCT02396732|Enoxaparin|enoxaparin
1126840|NCT02396732|Thromboprophylaxis|thromboprophylaxis
1126841|NCT02396732|Trauma|trauma
1126842|NCT02396732|Venous thromboembolism|venous thromboembolism
1126843|NCT02396693|Newborn|newborn
1126844|NCT02396693|non invasive ventilation|non invasive ventilation
1126845|NCT02396680|Ragweed Allergy|ragweed allergy
1126846|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
1126847|NCT02396680|Immunotherapy|immunotherapy
1126848|NCT02396680|Ragweed-SPIRE|ragweed-spire
1126849|NCT02396641|Best Supportive Care|best supportive care
1127748|NCT02391233|HIV testing|hiv testing
1126850|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
1126851|NCT02396628|resistance to therapy|resistance to therapy
1126852|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1126853|NCT02396628|Ruxolitinib|ruxolitinib
1126854|NCT02396615|Ad libitum energy intake|ad libitum energy intake
1126855|NCT02396615|Appetite|appetite
1126856|NCT02396589|stroke rehabilitation|stroke rehabilitation
1126857|NCT02396589|barriers to independence|barriers to independence
1126858|NCT02396589|environmental support|environmental support
1126859|NCT02396550|Expectations|expectations
1126860|NCT02396537|Children|children
1126861|NCT02396537|Midazolam|midazolam
1126862|NCT02396537|Lidocaine|lidocaine
1126864|NCT02396524|Chronic Disease|chronic disease
1126865|NCT02396524|Lifestyle Intervention|lifestyle intervention
1126866|NCT02396524|Health Promotion|health promotion
1126867|NCT02396524|Sport Mentorship|sport mentorship
1126869|NCT02396524|Health Technology|health technology
1126870|NCT02396524|Prevention|prevention
1126871|NCT02396524|Exercise|exercise
1126872|NCT02396524|Diet|diet
1126873|NCT02396472|social support|social support
1126874|NCT02396459|Triac|triac
1126875|NCT02396459|MCT8|mct8
1126876|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
1126877|NCT02396433|Halaven|halaven
1126878|NCT02396433|BRCA|brca
1126879|NCT02396433|E7449|e7449
1126880|NCT02396420|BPH|bph
1126881|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
1126882|NCT02396420|enlarged prostate|enlarged prostate
1126883|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
1126884|NCT02396407|Chlorine water treatment|chlorine water treatment
1126885|NCT02396407|Point-of-use water treatment|point-of-use water treatment
1126886|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
1126887|NCT02396407|Handwashing with soap|handwashing with soap
1126888|NCT02396407|Hand hygiene|hand hygiene
1126889|NCT02396407|Latrines|latrines
1126890|NCT02396407|Child potties|child potties
1126891|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
1126892|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
1126893|NCT02396407|Water|water
1126894|NCT02396407|Sanitation|sanitation
1126895|NCT02396407|Handwashing|handwashing
1126896|NCT02396407|Diarrhea|diarrhea
1126897|NCT02396407|Herd immunity|herd immunity
1126898|NCT02396407|Helminths|helminths
1126899|NCT02396394|HIV|hiv
1126900|NCT02396394|ART Adherence|art adherence
1126901|NCT02396394|Retention in Care|retention in care
1126902|NCT02396394|Pregnant Women|pregnant women
1126903|NCT02396394|Postpartum Women|postpartum women
1126904|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
1126905|NCT02396381|Conventional cigarette|conventional cigarette
1126906|NCT02396381|Exposure response|exposure response
1126907|NCT02396381|Smoking|smoking
1126908|NCT02396381|Tobacco Heating System|tobacco heating system
1126909|NCT02396368|Prostate cancer|prostate cancer
1126910|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
1126911|NCT02396368|Radium 223|radium 223
1126912|NCT02396368|Tasquinimod|tasquinimod
1126913|NCT02396355|flow cytometry|flow cytometry
1126914|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
1126915|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
1126916|NCT02396290|acne scar|acne scar
1126917|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
1126918|NCT02396290|platelet rich plasma|platelet rich plasma
1126919|NCT02396264|Mediterranean Diet|mediterranean diet
1126920|NCT02396264|Ovarian Cysts|ovarian cysts
1126921|NCT02396264|Treatment|treatment
1126922|NCT02396264|Ovarian Diseases|ovarian diseases
1126923|NCT02396264|normocaloric diet|normocaloric diet
1126924|NCT02396225|voriconazole|voriconazole
1126925|NCT02396225|inhalation|inhalation
1126926|NCT02396225|aerosol|aerosol
1126927|NCT02396225|epithelial lining fluid|epithelial lining fluid
1126928|NCT02396225|concentration|concentration
1126929|NCT02396225|pharmacokinetic|pharmacokinetic
1126930|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
1126931|NCT02396199|Endovascular|endovascular
1126932|NCT02396199|Juxtarenal|juxtarenal
1126933|NCT02396199|Pararenal|pararenal
1126934|NCT02396199|Fenestrated|fenestrated
1126935|NCT02396173|disability|disability
1126936|NCT02396173|vocational|vocational
1126937|NCT02396173|rehabilitation|rehabilitation
1126938|NCT02396173|prediction|prediction
1126939|NCT02396160|overactive bladder|overactive bladder
1126940|NCT02396160|urinary incontinence|urinary incontinence
1126941|NCT02396160|nocturia|nocturia
1126942|NCT02396160|urinary frequency|urinary frequency
1126943|NCT02396147|Drug therapy|drug therapy
1126944|NCT02396095|female|female
1126945|NCT02396095|cancer|cancer
1126946|NCT02396082|care coordination|care coordination
1126947|NCT02396082|quality of life|quality of life
1126948|NCT02396082|community-based|community-based
1126949|NCT02396082|care quality|care quality
1126950|NCT02396082|Long term care placement|long term care placement
1126951|NCT02396082|memory care|memory care
1126952|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
1126953|NCT02396056|Guided Bone Regeneration|guided bone regeneration
1126954|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
1126955|NCT02395991|gadoxetic acid|gadoxetic acid
1126956|NCT02395991|transient dyspnea|transient dyspnea
1126957|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
1126958|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
1126959|NCT02395952|cornea|cornea
1126960|NCT02395952|epithelial defect|epithelial defect
1126961|NCT02395952|amniotic membrane|amniotic membrane
1126962|NCT02395939|Cryobiopsy|cryobiopsy
1126963|NCT02395939|Radial EBUS|radial ebus
1126964|NCT02395939|Guide Sheath|guide sheath
1126965|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
1126966|NCT02395887|Spinal stenosis|spinal stenosis
1126967|NCT02395887|Spinal decompression|spinal decompression
1126968|NCT02395887|Postural balance|postural balance
1126969|NCT02395887|Neurogenic claudication|neurogenic claudication
1126970|NCT02395848|recurrent|recurrent
1126971|NCT02395848|infection|infection
1126972|NCT02395835|body mass index|body mass index
1126973|NCT02395835|methylation|methylation
1126974|NCT02395835|PPAR gamma|ppar gamma
1126975|NCT02395835|pregnancy|pregnancy
1126976|NCT02395822|AML|aml
1126977|NCT02395822|Relapsed|relapsed
1126978|NCT02395822|Refractory|refractory
1126979|NCT02395796|epidural|epidural
1126980|NCT02395796|labor analgesia|labor analgesia
1126981|NCT02395796|pressure monitoring|pressure monitoring
1126982|NCT02395783|Preterm infants|preterm infants
1126983|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
1126984|NCT02395770|Shoulder|shoulder
1126985|NCT02395770|Rotator cuff|rotator cuff
1126986|NCT02395770|Rehabilitation|rehabilitation
1126987|NCT02395770|Motor control|motor control
1126988|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
1126989|NCT02395757|Microperimetry|microperimetry
1126990|NCT02395757|Diagnostic|diagnostic
1126991|NCT02395731|dual eligible|dual eligible
1126992|NCT02395731|care coordination|care coordination
1126993|NCT02395731|community-based|community-based
1126994|NCT02395731|care quality|care quality
1126995|NCT02395731|care needs|care needs
1126996|NCT02395731|health services|health services
1126997|NCT02395731|care management|care management
1126998|NCT02395731|low income|low income
1126999|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
1127000|NCT02395718|elderly|elderly
1127001|NCT02395718|quick diagnostic unit|quick diagnostic unit
1127002|NCT02395718|short stay unit|short stay unit
1127003|NCT02395718|randomised controlled trial|randomised controlled trial
1127004|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
1127005|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
1127006|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
1127007|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
1127008|NCT02395653|Pediatric|pediatric
1127009|NCT02395653|Postoperative|postoperative
1127010|NCT02395653|Pain Management|pain management
1127011|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
1127012|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
1127013|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
1127014|NCT02395614|tissue expander|tissue expander
1127015|NCT02395614|breast reconstruction|breast reconstruction
1127016|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
1127017|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
1127018|NCT02395601|Phase 1|phase 1
1127019|NCT02395497|Penile Transplant|penile transplant
1127020|NCT02395497|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
1127021|NCT02395497|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
1127022|NCT02395497|Penis|penis
1127023|NCT02395497|Amputation|amputation
1127024|NCT02395497|Immunosuppression|immunosuppression
1127025|NCT02395497|Composite Tissue|composite tissue
1127026|NCT02395497|Male|male
1127027|NCT02395497|Humans|humans
1127028|NCT02395497|Allotransplantation|allotransplantation
1127029|NCT02395458|Sequential therapy|sequential therapy
1127030|NCT02395458|Triple therapy|triple therapy
1127031|NCT02395458|Eradication|eradication
1127032|NCT02395393|Acute rejection|acute rejection
1127033|NCT02395393|Chronic rejection|chronic rejection
1127034|NCT02395393|Confocal microscopy|confocal microscopy
1127035|NCT02395380|CRP|crp
1127036|NCT02395380|Postoperative complication|postoperative complication
1127037|NCT02395380|Length of stay|length of stay
1127038|NCT02395367|Prognosis|prognosis
1127039|NCT02395367|Risk Factors|risk factors
1127040|NCT02395354|Endoscopic treatment|endoscopic treatment
1127041|NCT02395354|Stenosis|stenosis
1127042|NCT02395354|Crohn's Disease|crohn's disease
1127043|NCT02395354|balloon dilatation|balloon dilatation
1127044|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
1127045|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
1127046|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
1127047|NCT02395341|reproductive hormones|reproductive hormones
1127048|NCT02395341|cancer survivors|cancer survivors
1127049|NCT02395341|endocrine function|endocrine function
1127050|NCT02395341|antral follicle counts|antral follicle counts
1127051|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
1127052|NCT02395341|perimenopause|perimenopause
1127053|NCT02395341|premature menopause|premature menopause
1127054|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
1127055|NCT02395328|Home visiting intervention|home visiting intervention
1127056|NCT02395328|South Africa|south africa
1127057|NCT02395328|Program evaluation|program evaluation
1127058|NCT02395315|Diabetes Mellitus|diabetes mellitus
1127059|NCT02395315|Osseointegration|osseointegration
1127060|NCT02395315|Bone vascularity|bone vascularity
1128862|NCT02385110|Decadron|decadron
1127061|NCT02395315|Primary implant stability|primary implant stability
1127062|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
1127063|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
1127064|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
1127065|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
1127066|NCT02395276|Congenital Heart Defects|congenital heart defects
1127067|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
1127068|NCT02395276|Hypothermia Therapy|hypothermia therapy
1127069|NCT02395276|Pediatrics|pediatrics
1127070|NCT02395237|Fed Conditions|fed conditions
1127071|NCT02395224|Follow-up studies|follow-up studies
1127072|NCT02395224|Prognosis|prognosis
1127073|NCT02395224|Palliative care|palliative care
1127074|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
1127075|NCT02395224|Cost-benefit analysis|cost-benefit analysis
1127076|NCT02395224|Population|population
1127077|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
1127078|NCT02395224|Terminal care|terminal care
1127079|NCT02395224|Medical futility|medical futility
1127080|NCT02395224|Survival rate|survival rate
1127081|NCT02395224|Norway|norway
1127082|NCT02395198|hepatitis c virus|hepatitis c virus
1127083|NCT02395198|opioid substitution treatment|opioid substitution treatment
1127084|NCT02395172|avelumab|avelumab
1127085|NCT02395172|MSB0010718C|msb0010718c
1127086|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
1127087|NCT02395172|Anti-PD-L1|anti-pd-l1
1127088|NCT02395159|vascular surgery patients|vascular surgery patients
1127089|NCT02395159|wound management|wound management
1127090|NCT02395133|Eczema|eczema
1127091|NCT02395120|Dental Care|dental care
1127092|NCT02395120|Caregiver Illness Perception|caregiver illness perception
1127093|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
1127094|NCT02395120|Dental Access|dental access
1127095|NCT02395120|Referral letter|referral letter
1127096|NCT02395120|Dental Caries|dental caries
1127097|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
1127098|NCT02395107|Functional Capacity|functional capacity
1127099|NCT02395107|Cardiomyopathies|cardiomyopathies
1127100|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
1127101|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
1127102|NCT02395107|Heart Diseases|heart diseases
1127103|NCT02395107|Heart Valve Diseases|heart valve diseases
1127104|NCT02395107|Atrial Fibrillation|atrial fibrillation
1127105|NCT02395107|Hypertrophy|hypertrophy
1127106|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
1127107|NCT02395107|Diastology|diastology
1127108|NCT02395081|pregnancy|pregnancy
1127109|NCT02395081|Mongolia|mongolia
1127110|NCT02395081|Vitamin D|vitamin d
1127111|NCT02395081|preeclampsia|preeclampsia
1127112|NCT02395068|Pharmacokinetics|pharmacokinetics
1127113|NCT02395068|Nimotuzumab|nimotuzumab
1127114|NCT02395068|Safety|safety
1127115|NCT02395068|Effcacy|effcacy
1127116|NCT02395068|Irinotecan|irinotecan
1127117|NCT02395029|PD|pd
1127118|NCT02395003|Obesity|obesity
1127119|NCT02395003|Pediatric|pediatric
1127120|NCT02394977|CPR|cpr
1127121|NCT02394977|Cardio first angle|cardio first angle
1127122|NCT02394977|Clinical trial|clinical trial
1127123|NCT02394951|chemotherapy|chemotherapy
1127124|NCT02394938|Music therapy|music therapy
1127125|NCT02394912|vena cava filter|vena cava filter
1127126|NCT02394899|SCD|scd
1127127|NCT02394899|early childhood intervention|early childhood intervention
1127128|NCT02394899|parental stress|parental stress
1127129|NCT02394899|neurocognition|neurocognition
1127130|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
1127131|NCT02394847|propofol|propofol
1127132|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
1127133|NCT02394847|anesthesia|anesthesia
1127134|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
1127135|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
1127136|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
1127137|NCT02394782|Rebif|rebif
1127138|NCT02394782|Interferon beta-1a|interferon beta-1a
1127139|NCT02394782|RebiSmart®2.0|rebismart®2.0
1127140|NCT02394782|MSdialog™|msdialog™
1127141|NCT02394769|Colorectal Cancer|colorectal cancer
1127142|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
1127143|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
1127144|NCT02394704|Rumination|rumination
1127145|NCT02394704|Sensory processing|sensory processing
1127146|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
1127147|NCT02394704|Depression|depression
1127148|NCT02394704|Anxiety|anxiety
1127149|NCT02394704|PTSD|ptsd
1127150|NCT02394665|Glioblastoma|glioblastoma
1127151|NCT02394665|Gliosarcoma|gliosarcoma
1127152|NCT02394665|GBM|gbm
1127153|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
1127154|NCT02394626|Surgery|surgery
1127155|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
1127156|NCT02394626|Survival|survival
1127161|NCT02394600|rhinitis|rhinitis
1127162|NCT02394600|allergy|allergy
1127163|NCT02394587|mindfulness|mindfulness
1127164|NCT02394587|MBSR|mbsr
1127166|NCT02394587|experimental|experimental
1127167|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
1127168|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
1127169|NCT02394548|Acute esophagitis|acute esophagitis
1127170|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
1127171|NCT02394535|Pancreatic Cancer|pancreatic cancer
1127172|NCT02394535|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1127173|NCT02394535|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
1127174|NCT02394535|Abraxane|abraxane
1127175|NCT02394535|Nab-Paclitaxel|nab-paclitaxel
1127176|NCT02394535|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
1127177|NCT02394535|ABI-007|abi-007
1127178|NCT02394535|Radiation therapy|radiation therapy
1127179|NCT02394535|XRT|xrt
1127180|NCT02394535|Capecitabine|capecitabine
1127181|NCT02394535|Xeloda|xeloda
1127182|NCT02394535|Questionnaires|questionnaires
1127183|NCT02394535|Surveys|surveys
1127184|NCT02394522|Malaria|malaria
1127185|NCT02394522|Spatial Repellents|spatial repellents
1127186|NCT02394522|Plasmodium|plasmodium
1127187|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
1127188|NCT02394509|Self-Management|self-management
1127189|NCT02394496|Fulvestrant|fulvestrant
1127190|NCT02394496|Lapatinib|lapatinib
1127191|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
1127192|NCT02394496|metastatic breast cancer|metastatic breast cancer
1127193|NCT02394483|Single ascending dose|single ascending dose
1127194|NCT02394483|double blind|double blind
1127195|NCT02394470|congestion|congestion
1127196|NCT02394470|total body water|total body water
1127197|NCT02394470|bioimpedentiometry|bioimpedentiometry
1127198|NCT02394470|lung ultrasound|lung ultrasound
1127199|NCT02394470|diuretics|diuretics
1127200|NCT02394470|dyspnea|dyspnea
1127201|NCT02394470|pulmonary B lines|pulmonary b lines
1127202|NCT02394470|deuterium|deuterium
1127203|NCT02394457|Postdural puncture headache|postdural puncture headache
1127204|NCT02394457|Epidural Blood Patch|epidural blood patch
1127205|NCT02394457|Cosyntropin|cosyntropin
1127206|NCT02394457|PDPH|pdph
1127207|NCT02394457|Regional anesthesia|regional anesthesia
1127208|NCT02394457|Lumbar puncture|lumbar puncture
1127209|NCT02394457|ACTH|acth
1127210|NCT02394457|Tetracosactin|tetracosactin
1127211|NCT02394444|Intervention program|intervention program
1127212|NCT02394444|Parenting stress|parenting stress
1127213|NCT02394444|Parental mental health|parental mental health
1127214|NCT02394444|Preterm infant's development|preterm infant's development
1127215|NCT02394431|Sickle Cell Disease|sickle cell disease
1127216|NCT02394431|Echocardiography|echocardiography
1127217|NCT02394431|Speckle tracking|speckle tracking
1127218|NCT02394392|Medication satisfaction|medication satisfaction
1127219|NCT02394392|Quality of life|quality of life
1127220|NCT02394392|Drug compliance|drug compliance
1127221|NCT02394366|Skin oxygenation|skin oxygenation
1127222|NCT02394366|peripheral perfusion|peripheral perfusion
1127223|NCT02394353|bariatrics|bariatrics
1127224|NCT02394353|transient elastography|transient elastography
1127225|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
1127226|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
1127227|NCT02394288|Cardiac Troponin|cardiac troponin
1127228|NCT02394288|Perioperative Period|perioperative period
1127229|NCT02394288|surgery|surgery
1127230|NCT02394262|Biological Markers|biological markers
1127231|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
1127232|NCT02394249|Insulin Resistance|insulin resistance
1127233|NCT02394249|Cognition|cognition
1127234|NCT02394249|Affect|affect
1127235|NCT02394249|Insulin|insulin
1127236|NCT02394249|Lipids|lipids
1127237|NCT02394236|exercise training|exercise training
1127238|NCT02394223|Cancer|cancer
1127239|NCT02394223|Prostate|prostate
1127241|NCT02394223|Biopsies|biopsies
1127242|NCT02394223|FFOCT procedure|ffoct procedure
1127246|NCT02394197|Plasmodium vivax|plasmodium vivax
1127247|NCT02394197|Mexico|mexico
1127248|NCT02394197|treatment|treatment
1127249|NCT02394197|chloroquine|chloroquine
1127250|NCT02394197|primaquine|primaquine
1127251|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
1127749|NCT02391194|AVB-620|avb-620
1127252|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
1127253|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1127254|NCT02394171|Physical Activity|physical activity
1127255|NCT02394171|Social Cohesion|social cohesion
1127256|NCT02394171|Intervention Development|intervention development
1129481|NCT02381418|Vaccine|vaccine
1127257|NCT02394171|Ethnic Minorities|ethnic minorities
1127258|NCT02394171|Nutrition|nutrition
1127259|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
1127260|NCT02394158|Prevention|prevention
1127261|NCT02394158|Metformin|metformin
1127262|NCT02394145|platelet|platelet
1127263|NCT02394145|ticagrelor|ticagrelor
1127264|NCT02394145|clopidogrel|clopidogrel
1127265|NCT02394145|end stage renal disease|end stage renal disease
1127266|NCT02394145|hemodialysis|hemodialysis
1127267|NCT02394145|genetics|genetics
1127268|NCT02394132|Lentigo maligna|lentigo maligna
1127269|NCT02394132|Imiquimod|imiquimod
1127270|NCT02394132|Radiotherapy|radiotherapy
1127271|NCT02394054|vasopressin|vasopressin
1127272|NCT02394054|intranasal administration|intranasal administration
1127273|NCT02394054|healthy sample|healthy sample
1127274|NCT02394041|acupuncture|acupuncture
1127275|NCT02394041|cervical dystocia|cervical dystocia
1127276|NCT02394041|caesarean section|caesarean section
1127277|NCT02394041|obstetric labor|obstetric labor
1127278|NCT02394041|randomized controlled trial|randomized controlled trial
1127279|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
1127280|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
1127281|NCT02393911|vestibulitis|vestibulitis
1127282|NCT02393911|microbiome|microbiome
1127283|NCT02393872|Prevention|prevention
1127284|NCT02393859|ALL|all
1127285|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
1127286|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
1127287|NCT02393859|Neoplasms|neoplasms
1127288|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
1127289|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
1127290|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
1127291|NCT02393846|ankle sprain|ankle sprain
1127292|NCT02393846|topical ketoprofen|topical ketoprofen
1127293|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
1127294|NCT02393846|emergency department|emergency department
1127295|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1127296|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
1127297|NCT02393833|HER2-ECD|her2-ecd
1127298|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1127299|NCT02393794|BRCA1|brca1
1127300|NCT02393794|BRCA2|brca2
1127301|NCT02393794|TNBC|tnbc
1127302|NCT02393781|severe sepsis|severe sepsis
1127303|NCT02393781|septic shock|septic shock
1127304|NCT02393781|adrenomedullin|adrenomedullin
1127305|NCT02393781|organ dysfunction|organ dysfunction
1127306|NCT02393703|exosomes|exosomes
1127307|NCT02393703|15-015|15-015
1127308|NCT02393664|Thoracoscopy|thoracoscopy
1127309|NCT02393664|Recovery|recovery
1127310|NCT02393664|Tracheal intubation|tracheal intubation
1127311|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
1127312|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
1127313|NCT02393586|Tuberculosis|tuberculosis
1127314|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
1127315|NCT02393586|WBA|wba
1127316|NCT02393586|Faropenem|faropenem
1127317|NCT02393573|Insulin Resistance|insulin resistance
1127318|NCT02393573|Protein balance|protein balance
1127319|NCT02393573|Surgery|surgery
1127320|NCT02393573|Post operative complications|post operative complications
1127321|NCT02393573|metformin|metformin
1127322|NCT02393573|Pre-diabetes|pre-diabetes
1127323|NCT02393573|Fasting blood glucose|fasting blood glucose
1127324|NCT02393547|obesity|obesity
1127325|NCT02393534|Primary Care|primary care
1127326|NCT02393534|Health Services Research|health services research
1127327|NCT02393534|Telemedicine|telemedicine
1127328|NCT02393521|Vibration|vibration
1127329|NCT02393521|Pressure Pain Threshold|pressure pain threshold
1127330|NCT02393521|Trigger Points|trigger points
1127331|NCT02393521|Neck Pain|neck pain
1127332|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
1127333|NCT02393508|transfusion reaction|transfusion reaction
1127334|NCT02393508|quality of life|quality of life
1127335|NCT02393443|oxytocin|oxytocin
1127336|NCT02393443|healthy sample|healthy sample
1127337|NCT02393443|intranasal administration|intranasal administration
1127338|NCT02393443|learning|learning
1127339|NCT02393417|Verruca vulgaris|verruca vulgaris
1127340|NCT02393417|Common Warts|common warts
1127341|NCT02393378|Drug Therapy|drug therapy
1127342|NCT02393365|Hepatitis C|hepatitis c
1127343|NCT02393365|HCV|hcv
1127344|NCT02393365|screening|screening
1127345|NCT02393352|Body Composition|body composition
1127346|NCT02393352|Autonomic Nervous System|autonomic nervous system
1127347|NCT02393352|Oxygen|oxygen
1127750|NCT02391194|stage I|stage i
1127348|NCT02393352|Randomized Controlled Trial|randomized controlled trial
1127349|NCT02393300|tranexamic acid|tranexamic acid
1127350|NCT02393300|blood loss|blood loss
1127351|NCT02393300|topical administration|topical administration
1127352|NCT02393300|intravenous administration|intravenous administration
1127353|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
1127549|NCT02392351|Hypertension|hypertension
1127354|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
1127355|NCT02393248|gastric cancer|gastric cancer
1127356|NCT02393248|urothelial cancer|urothelial cancer
1127357|NCT02393248|endometrial cancer|endometrial cancer
1127358|NCT02393248|multiple myeloma|multiple myeloma
1127359|NCT02393248|MPN|mpn
1127360|NCT02393235|unexplained infertility|unexplained infertility
1127361|NCT02393235|tubal infertility|tubal infertility
1127362|NCT02393235|pulsatility index|pulsatility index
1127363|NCT02393235|resistance index|resistance index
1127364|NCT02393235|fertile women|fertile women
1127365|NCT02393222|Dialysis|dialysis
1127366|NCT02393222|Cerebrovascular disease|cerebrovascular disease
1127367|NCT02393222|ESRD|esrd
1127368|NCT02393209|Drug therapy|drug therapy
1127369|NCT02393196|colloid preloading|colloid preloading
1127370|NCT02393196|colloid coloading|colloid coloading
1127371|NCT02393183|Antioxidant|antioxidant
1127372|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
1127373|NCT02393183|Thyroid eye disease|thyroid eye disease
1127374|NCT02393183|Severity score|severity score
1127375|NCT02393183|Activity score|activity score
1127376|NCT02393183|Quality of life|quality of life
1127377|NCT02393144|Labor analysis|labor analysis
1127378|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
1127379|NCT02393144|Labor curve|labor curve
1127380|NCT02393131|Brain Metastases|brain metastases
1127381|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
1127382|NCT02393131|Neurocognitive function|neurocognitive function
1127383|NCT02393118|Assistive technology|assistive technology
1127384|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
1127385|NCT02393118|sensory substitution|sensory substitution
1127386|NCT02393118|BrainPort|brainport
1127387|NCT02393118|Blindness|blindness
1127388|NCT02393118|Assistive device|assistive device
1127389|NCT02393105|Breast Cancer|breast cancer
1127390|NCT02393079|Traumatic Brain Injury|traumatic brain injury
1127391|NCT02393079|Cognitive|cognitive
1127392|NCT02393053|Gingival Recession|gingival recession
1127393|NCT02393053|Case-Control Studies|case-control studies
1127394|NCT02393053|Adipose Tissue|adipose tissue
1127395|NCT02393040|Alopecia|alopecia
1127396|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
1127397|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
1127398|NCT02393040|Hair loss|hair loss
1127399|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
1127400|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
1127401|NCT02393040|placebo|placebo
1127402|NCT02393040|double-blind|double-blind
1127403|NCT02393014|65 years old or older|65 years old or older
1127404|NCT02393014|hospitalized in|hospitalized in
1127405|NCT02393014|geriatrics|geriatrics
1127406|NCT02393001|skin cancer|skin cancer
1127407|NCT02393001|suspicious lesion|suspicious lesion
1127408|NCT02393001|skin biopsy|skin biopsy
1127409|NCT02393001|noninvasive|noninvasive
1127410|NCT02393001|screening|screening
1127411|NCT02392962|proprioception|proprioception
1127412|NCT02392962|countermovement jump|countermovement jump
1127413|NCT02392962|postural balance|postural balance
1127414|NCT02392949|Spine|spine
1127415|NCT02392949|mobilization|mobilization
1127416|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
1127417|NCT02392923|health related quality of life|health related quality of life
1127418|NCT02392910|Iron Sucrose|iron sucrose
1127419|NCT02392910|Mortality|mortality
1127420|NCT02392910|Hospitalization|hospitalization
1127421|NCT02392897|meal frequency|meal frequency
1127422|NCT02392897|eating frequency|eating frequency
1127423|NCT02392897|ingestive frequency|ingestive frequency
1127424|NCT02392897|Positive energy balance|positive energy balance
1127425|NCT02392897|Satiation|satiation
1127426|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
1127427|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1127428|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
1127429|NCT02392884|Minority Health|minority health
1127430|NCT02392884|Vulnerable Populations|vulnerable populations
1127431|NCT02392884|Underserved, Patients|underserved, patients
1127432|NCT02392884|Medication Adherence|medication adherence
1127433|NCT02392884|Medication Compliance|medication compliance
1127434|NCT02392884|Medication Non-compliance|medication non-compliance
1127435|NCT02392884|Medication Persistence|medication persistence
1127436|NCT02392884|Medication Non-Adherence|medication non-adherence
1127437|NCT02392871|Metastatic melanoma|metastatic melanoma
1127438|NCT02392871|Palliative radiotherapy|palliative radiotherapy
1127439|NCT02392845|Drug combination|drug combination
1127440|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
1127441|NCT02392845|Mathematical model|mathematical model
1127442|NCT02392845|Hematotoxicity|hematotoxicity
1127443|NCT02392845|Individualized dosage|individualized dosage
1127444|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
1127445|NCT02392832|intervention|intervention
1127446|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
1127447|NCT02392832|Anopheles mosquito|anopheles mosquito
1128460|NCT02387216|docetaxel|docetaxel
1127448|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
1127449|NCT02392806|CPAP|cpap
1127450|NCT02392806|Bubble CPAP|bubble cpap
1127451|NCT02392806|Extubation failure|extubation failure
1127452|NCT02392806|Preterm infant|preterm infant
1127453|NCT02392767|L-Arginine|l-arginine
1127454|NCT02392767|Pycnogenol|pycnogenol
1127455|NCT02392767|vitamin K2|vitamin k2
1127456|NCT02392767|vitamin B|vitamin b
1127457|NCT02392767|endothelial function|endothelial function
1127458|NCT02392767|hypertension|hypertension
1127459|NCT02392767|Homocystein >10|homocystein >10
1127460|NCT02392754|Screening|screening
1127461|NCT02392754|Atrial Fibrillation|atrial fibrillation
1127463|NCT02392754|Primary care|primary care
1127464|NCT02392741|Physical Activity|physical activity
1127465|NCT02392741|Microcirculation|microcirculation
1127466|NCT02392741|Pregnancy Outcome|pregnancy outcome
1127467|NCT02392741|Obesity|obesity
1127468|NCT02392741|Pregnancy|pregnancy
1127469|NCT02392715|Inspiratory muscle training|inspiratory muscle training
1127470|NCT02392715|General exercise training|general exercise training
1127471|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
1127472|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1127473|NCT02392702|Subjects|subjects
1127474|NCT02392702|Safety/Efficacy Study|safety/efficacy study
1127475|NCT02392702|Randomized|randomized
1127476|NCT02392702|Open Label|open label
1127477|NCT02392689|procalcitonin|procalcitonin
1127478|NCT02392689|biomarker|biomarker
1127479|NCT02392689|antibiotic therapy|antibiotic therapy
1127480|NCT02392689|emergency department|emergency department
1127481|NCT02392689|cardiology|cardiology
1127482|NCT02392689|in vitro diagnostics|in vitro diagnostics
1127483|NCT02392676|Ovarian cancer|ovarian cancer
1127484|NCT02392676|Platinum|platinum
1127485|NCT02392676|Somatic BRCA mutation|somatic brca mutation
1127486|NCT02392676|Homologous recombination repair|homologous recombination repair
1127487|NCT02392663|Sputum clearance|sputum clearance
1127488|NCT02392663|Cough severity|cough severity
1127489|NCT02392663|Hypertonic saline|hypertonic saline
1127490|NCT02392663|Acid hyaluronic|acid hyaluronic
1183562|NCT02107547|RCT|rct
1127491|NCT02392663|Tolerability|tolerability
1127492|NCT02392637|Biliary Tract Cancer|biliary tract cancer
1127493|NCT02392637|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1127494|NCT02392637|Extrahepatic cholangiocarcinoma,|extrahepatic cholangiocarcinoma,
1127495|NCT02392637|Gallbladder cancer|gallbladder cancer
1127496|NCT02392637|Metastatic|metastatic
1127497|NCT02392637|Unresectable|unresectable
1127498|NCT02392637|Abraxane|abraxane
1127499|NCT02392637|Nab-Paclitaxel|nab-paclitaxel
1127500|NCT02392637|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
1127501|NCT02392637|ABI-007|abi-007
1127502|NCT02392637|Cisplatin|cisplatin
1127503|NCT02392637|Platinol-AQ|platinol-aq
1127504|NCT02392637|Platinol|platinol
1127505|NCT02392637|CDDP|cddp
1127506|NCT02392637|Gemcitabine|gemcitabine
1127507|NCT02392637|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1127508|NCT02392637|Gemzar|gemzar
1127509|NCT02392637|Phone calls|phone calls
1127510|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
1127511|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
1127512|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
1127513|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
1127514|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
1127515|NCT02392572|Leukemia|leukemia
1127516|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
1127517|NCT02392572|AML|aml
1127518|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
1127519|NCT02392572|MDS|mds
1127520|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1127521|NCT02392572|ALL|all
1127522|NCT02392572|Relapsed|relapsed
1127523|NCT02392572|Refractory|refractory
1127524|NCT02392572|ONC201|onc201
1127525|NCT02392572|Cytarabine|cytarabine
1127526|NCT02392572|Ara-C|ara-c
1127527|NCT02392572|Cytosar|cytosar
1127528|NCT02392572|DepoCyt|depocyt
1127529|NCT02392572|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1127530|NCT02392559|Hypercholesterolemia|hypercholesterolemia
1127531|NCT02392559|Elevated Cholesterol|elevated cholesterol
1127532|NCT02392559|High Cholesterol|high cholesterol
1127533|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1127534|NCT02392559|PCSK9 mutations|pcsk9 mutations
1127535|NCT02392559|Paediatric|paediatric
1127536|NCT02392559|pediatric|pediatric
1127537|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
1127538|NCT02392533|ultrasound|ultrasound
1127539|NCT02392520|severe OHSS|severe ohss
1127540|NCT02392520|antagonist administration|antagonist administration
1127541|NCT02392520|conventional treatment|conventional treatment
1127542|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
1127543|NCT02392442|Bronchoscopy|bronchoscopy
1127544|NCT02392442|Endotoxin Instillation|endotoxin instillation
1127545|NCT02392442|Immunophenotype|immunophenotype
1127546|NCT02392442|miRNA|mirna
1127547|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
1127548|NCT02392390|Microbiota|microbiota
1127550|NCT02392351|Renal Denervation|renal denervation
1127551|NCT02392338|Atrial fibrillation|atrial fibrillation
1127552|NCT02392338|Ablation|ablation
1127553|NCT02392338|Hybrid|hybrid
1127554|NCT02392312|kidney transplant|kidney transplant
1127555|NCT02392312|ATG-F|atg-f
1127556|NCT02392286|Corticosteroid|corticosteroid
1127557|NCT02392273|migraine|migraine
1127558|NCT02392273|cluster headache|cluster headache
1127559|NCT02392273|primary headache|primary headache
1127560|NCT02392273|Ausanil|ausanil
1127561|NCT02392273|capsicum annuum|capsicum annuum
1127562|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
1127563|NCT02392221|Pediatric|pediatric
1127564|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
1127565|NCT02392208|telavancin|telavancin
1127566|NCT02392208|end-stage renal disease|end-stage renal disease
1127567|NCT02392208|ESRD|esrd
1127568|NCT02392208|pharmacokinetics|pharmacokinetics
1127569|NCT02392208|hemodialysis|hemodialysis
1127570|NCT02392208|chronic kidney disease|chronic kidney disease
1127571|NCT02392208|CKD|ckd
1127572|NCT02392208|dialysis|dialysis
1127573|NCT02392208|Vibativ|vibativ
1127574|NCT02392195|Plagiocephaly|plagiocephaly
1127575|NCT02392182|lung|lung
1127576|NCT02392169|neuroendocrine|neuroendocrine
1127577|NCT02392169|ADHD|adhd
1127578|NCT02392169|heredity|heredity
1127579|NCT02392169|cognitive function|cognitive function
1127580|NCT02392143|colorectal cancer screening|colorectal cancer screening
1127581|NCT02392104|International Normalized Ratio|international normalized ratio
1127582|NCT02392104|Warfarin|warfarin
1127583|NCT02392078|Procedural Success|procedural success
1127584|NCT02392078|Progression|progression
1127585|NCT02392078|Quality of Life|quality of life
1127586|NCT02392052|caregivers|caregivers
1127587|NCT02392039|Lymphoma|lymphoma
1127588|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1127589|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
1127590|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
1127591|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
1127592|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
1127593|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
1127594|NCT02392039|Transformed Lymphoma|transformed lymphoma
1127595|NCT02392039|Aggressive lymphoma|aggressive lymphoma
1127596|NCT02392039|Bone pain|bone pain
1127597|NCT02392039|Pegfilgrastim|pegfilgrastim
1127598|NCT02392039|Neulasta|neulasta
1127599|NCT02392039|PEG-G-CSF|peg-g-csf
1127600|NCT02392039|Loratadine|loratadine
1127601|NCT02392039|Placebo|placebo
1127602|NCT02392039|Sugar pill|sugar pill
1127603|NCT02392039|Questionnaires|questionnaires
1127604|NCT02392039|Surveys|surveys
1127605|NCT02392013|older adult falls|older adult falls
1127606|NCT02392013|home hazards|home hazards
1127607|NCT02392013|home barriers|home barriers
1127608|NCT02392000|chronic insomnia|chronic insomnia
1127609|NCT02392000|Veterans Health|veterans health
1127610|NCT02391974|Hyaluronic acid|hyaluronic acid
1127611|NCT02391974|Periodontal pockets|periodontal pockets
1127612|NCT02391974|Periodontitis|periodontitis
1127613|NCT02391948|Cerebral palsy|cerebral palsy
1127614|NCT02391948|Gross motor delay|gross motor delay
1127615|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
1127616|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
1127617|NCT02391922|first aid|first aid
1127618|NCT02391909|Vaccine|vaccine
1127619|NCT02391883|clopidogrel therapy|clopidogrel therapy
1127620|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
1127621|NCT02391883|adverse event|adverse event
1127622|NCT02391870|depression|depression
1127623|NCT02391870|mindfulness|mindfulness
1127624|NCT02391870|pregnancy|pregnancy
1127625|NCT02391870|prevention|prevention
1127626|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
1127627|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1127628|NCT02391857|Gastric emptying|gastric emptying
1127629|NCT02391844|Knee|knee
1127630|NCT02391844|Post-Operative Pain|post-operative pain
1127631|NCT02391844|Xartemis|xartemis
1127633|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
1127634|NCT02391831|Neuromuscular disease|neuromuscular disease
1127635|NCT02391818|balance|balance
1127636|NCT02391818|quality of life|quality of life
1127637|NCT02391818|chemotherapy|chemotherapy
1127638|NCT02391818|neuropathy|neuropathy
1127639|NCT02391818|cancer|cancer
1127640|NCT02391779|High normal blood pressure|high normal blood pressure
1127641|NCT02391779|Stage I|stage i
1127642|NCT02391766|Self-management|self-management
1127643|NCT02391766|Caregiving|caregiving
1127644|NCT02391766|Quality of life|quality of life
1127645|NCT02391766|Empowerment|empowerment
1127646|NCT02391753|levator avulsion|levator avulsion
1127647|NCT02391753|transperineal ultrasound|transperineal ultrasound
1127648|NCT02391753|levator hiatus|levator hiatus
1127649|NCT02391727|SYN004|syn004
1127650|NCT02391727|cetuximab|cetuximab
1127651|NCT02391714|pain assessment|pain assessment
1127652|NCT02391714|patient satisfaction|patient satisfaction
1127653|NCT02391714|Visual Analog Scale|visual analog scale
1127654|NCT02391714|contraceptive devices|contraceptive devices
1127655|NCT02391714|nulliparity|nulliparity
1127656|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
1127657|NCT02391662|Elderly|elderly
1127658|NCT02391662|Nab-paclitaxel|nab-paclitaxel
1127659|NCT02391662|Gemcitabine|gemcitabine
1127660|NCT02391649|schizophrenia|schizophrenia
1127661|NCT02391649|bibliotherapy program|bibliotherapy program
1127662|NCT02391649|problem-solving|problem-solving
1127663|NCT02391649|family caregivers|family caregivers
1127664|NCT02391649|randomized controlled trial|randomized controlled trial
1127665|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
1127666|NCT02391636|carbetocin|carbetocin
1127667|NCT02391636|oxytocin|oxytocin
1127668|NCT02391623|Multiple Ascending Dose|multiple ascending dose
1127669|NCT02391623|Healthy Subjects|healthy subjects
1127670|NCT02391623|Hyperlipidemia|hyperlipidemia
1127671|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
1127672|NCT02391623|Metabolic Diseases|metabolic diseases
1127673|NCT02391610|birth cohort study|birth cohort study
1127674|NCT02391610|environmental exposures|environmental exposures
1127675|NCT02391610|birth defects|birth defects
1127676|NCT02391610|pregnant outcomes|pregnant outcomes
1127677|NCT02391610|children development|children development
1127678|NCT02391545|Follicular Lymphoma|follicular lymphoma
1127679|NCT02391545|Previously Untreated|previously untreated
1127680|NCT02391519|Pregnancy|pregnancy
1127681|NCT02391519|High altitude|high altitude
1127682|NCT02391519|vasoreactivity|vasoreactivity
1127683|NCT02391519|myometrial arteries|myometrial arteries
1127684|NCT02391506|First CMC joint|first cmc joint
1127685|NCT02391506|Osteoarthritis|osteoarthritis
1127686|NCT02391506|Cartilage Replacement|cartilage replacement
1127687|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
1127688|NCT02391506|Damaged Articular Surface|damaged articular surface
1127689|NCT02391493|bilinguals|bilinguals
1127690|NCT02391493|language control|language control
1127691|NCT02391493|executive functions|executive functions
1127692|NCT02391493|functional MRI|functional mri
1127693|NCT02391493|stimulation mapping|stimulation mapping
1127694|NCT02391493|brain tumors|brain tumors
1127695|NCT02391480|Cancer|cancer
1127696|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
1127697|NCT02391480|Advanced Cancer|advanced cancer
1127698|NCT02391454|Neoplasms|neoplasms
1127699|NCT02391454|Cell Phones|cell phones
1127700|NCT02391454|Motor Activity|motor activity
1127701|NCT02391454|Feasibility|feasibility
1127702|NCT02391441|Pulmonary|pulmonary
1127703|NCT02391441|Arterial|arterial
1127704|NCT02391441|Hypertension|hypertension
1127705|NCT02391441|Lung|lung
1127706|NCT02391441|Transplantation|transplantation
1127707|NCT02391441|MRI|mri
1127708|NCT02391428|ADHD|adhd
1127709|NCT02391428|omega3|omega3
1127710|NCT02391402|Brain injury|brain injury
1127711|NCT02391402|TBI|tbi
1127712|NCT02391402|PTSD|ptsd
1127713|NCT02391402|Polytrauma|polytrauma
1127714|NCT02391389|preterm infant|preterm infant
1127715|NCT02391376|superficial heat|superficial heat
1127716|NCT02391376|hot pack|hot pack
1127717|NCT02391376|thermotherapy|thermotherapy
1127718|NCT02391376|physiotherapy|physiotherapy
1127719|NCT02391376|Schober Test|schober test
1127720|NCT02391363|anxiety|anxiety
1127721|NCT02391363|worry|worry
1127722|NCT02391337|Atrial fibrillation|atrial fibrillation
1127723|NCT02391337|Quality of life|quality of life
1127724|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
1127725|NCT02391337|Diastolic function|diastolic function
1127726|NCT02391337|Echocardiography|echocardiography
1127727|NCT02391337|Beta-blockers|beta-blockers
1127728|NCT02391337|Digoxin|digoxin
1127729|NCT02391311|tDCS|tdcs
1127730|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
1127731|NCT02391298|Multiple Sclerosis|multiple sclerosis
1127732|NCT02391298|stress|stress
1127733|NCT02391298|meditation|meditation
1127734|NCT02391298|attention|attention
1127735|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
1127736|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
1127737|NCT02391272|pregnancy|pregnancy
1127738|NCT02391246|central nervous system tumours|central nervous system tumours
1127739|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
1127740|NCT02391233|Effectiveness intervention|effectiveness intervention
1127741|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
1127742|NCT02391233|HIV prevention|hiv prevention
1127743|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
1127744|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
1127745|NCT02391233|Drug-users|drug-users
1127746|NCT02391233|Black/African-American women|black/african-american women
1127751|NCT02391194|newly diagnosed|newly diagnosed
1127752|NCT02391194|breast cancer|breast cancer
1127753|NCT02391194|stage II|stage ii
1127754|NCT02391194|stage III|stage iii
1127755|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
1127761|NCT02391155|oocyte retrival|oocyte retrival
1127762|NCT02391142|heart failure|heart failure
1127763|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
1127764|NCT02391142|sympathetic nervous system|sympathetic nervous system
1127766|NCT02391090|hypoxia|hypoxia
1127767|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
1127768|NCT02391090|inflammation|inflammation
1127769|NCT02391077|PrePex|prepex
1127770|NCT02391077|Male Circumcision|male circumcision
1127771|NCT02391077|Bacterial Load|bacterial load
1127772|NCT02391064|cognition|cognition
1127773|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
1127774|NCT02391064|impairment prediction|impairment prediction
1127775|NCT02391051|prostate cancer|prostate cancer
1127776|NCT02391051|focal brachytherapy|focal brachytherapy
1127777|NCT02391051|PSA|psa
1127778|NCT02391051|Biological marker|biological marker
1127779|NCT02391038|MLN0264|mln0264
1127780|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
1127781|NCT02391025|Metastatic|metastatic
1127782|NCT02391025|Prostate Cancer|prostate cancer
1127783|NCT02391025|Castrate Resistant|castrate resistant
1127784|NCT02391012|Ulcerative colitis|ulcerative colitis
1127785|NCT02391012|Crohns disease|crohns disease
1127786|NCT02391012|Microbial transplantation|microbial transplantation
1127787|NCT02390986|Cancer|cancer
1127788|NCT02390986|Malignant Neoplasm|malignant neoplasm
1127789|NCT02390986|Anti-cancer drug|anti-cancer drug
1127790|NCT02390947|Colorectal Cancer|colorectal cancer
1127791|NCT02390947|Famitinib|famitinib
1127792|NCT02390934|Radium 223|radium 223
1127793|NCT02390934|bone metastases|bone metastases
1127794|NCT02390908|alcohol use|alcohol use
1127795|NCT02390908|hazardous drinking|hazardous drinking
1127796|NCT02390908|behavioral intervention|behavioral intervention
1127797|NCT02390908|ART adherence|art adherence
1127798|NCT02390908|viral load|viral load
1127799|NCT02390908|CD4|cd4
1127800|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
1127801|NCT02390895|fetal surgery|fetal surgery
1127802|NCT02390895|outcome|outcome
1127803|NCT02390895|Foetus|foetus
1127804|NCT02390869|relapse|relapse
1127805|NCT02390869|progression|progression
1127806|NCT02390804|postoperative pain|postoperative pain
1127807|NCT02390804|hysterectomy|hysterectomy
1127808|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
1127809|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
1127810|NCT02390804|TLH|tlh
1127811|NCT02390778|secondary traumatic stress|secondary traumatic stress
1127812|NCT02390778|vicarious trauma|vicarious trauma
1127813|NCT02390778|secondary distress|secondary distress
1127814|NCT02390765|Stress Response|stress response
1127815|NCT02390765|Binge Eating|binge eating
1127816|NCT02390765|Eating Behavior|eating behavior
1127817|NCT02390765|Obesity|obesity
1127818|NCT02390765|Disordered Eating|disordered eating
1127823|NCT02390739|Immunotherapy|immunotherapy
1127824|NCT02390739|Gene Therapy|gene therapy
1127825|NCT02390739|Metastatic Cancer|metastatic cancer
1127826|NCT02390713|hepatectomy|hepatectomy
1127827|NCT02390713|post-operative liver failure|post-operative liver failure
1127828|NCT02390713|portal vein|portal vein
1127829|NCT02390713|portal flow|portal flow
1127830|NCT02390713|portal pressure|portal pressure
1127831|NCT02390713|modulation|modulation
1127832|NCT02390713|surgical device|surgical device
1127833|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
1127834|NCT02390700|Observational|observational
1127835|NCT02390700|Golimumab|golimumab
1127836|NCT02390700|SIMPONI|simponi
1127837|NCT02390700|Intravenous Infusion|intravenous infusion
1127838|NCT02390661|seroma|seroma
1127839|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
1127840|NCT02390661|breast lumpectomy|breast lumpectomy
1127841|NCT02390661|breast cancer|breast cancer
1127842|NCT02390635|Leukemia|leukemia
1127843|NCT02390635|Acute myeloid leukemia|acute myeloid leukemia
1127844|NCT02390635|AML|aml
1127845|NCT02390635|Acute promyelocytic leukemia|acute promyelocytic leukemia
1127846|NCT02390635|APL|apl
1127847|NCT02390635|Extramedullary leukemia|extramedullary leukemia
1127848|NCT02390635|EML|eml
1127849|NCT02390635|Whole body magnetic resonance imaging|whole body magnetic resonance imaging
1127850|NCT02390635|MRI|mri
1127851|NCT02390635|Positron emission tomography/ computed tomography|positron emission tomography/ computed tomography
1127852|NCT02390635|PET/CT|pet/ct
1127853|NCT02390635|18F-FDG|18f-fdg
1127854|NCT02390635|Gadolinium contrast agent|gadolinium contrast agent
1127855|NCT02390609|Healthy|healthy
1127856|NCT02390609|Ibrutinib|ibrutinib
1127857|NCT02390609|Bioavailability|bioavailability
1127858|NCT02390596|Kawasaki disease|kawasaki disease
1127859|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
1127860|NCT02390596|anakinra|anakinra
1127861|NCT02390596|resistance to IVIg|resistance to ivig
1127862|NCT02390596|coronary aneurysms|coronary aneurysms
1127863|NCT02390596|phase II trial|phase ii trial
1127864|NCT02390583|Internet dependence|internet dependence
1127865|NCT02390583|Sleep disorders|sleep disorders
1127866|NCT02390583|pathological gambling|pathological gambling
1127867|NCT02390570|Patient Capacity|patient capacity
1127868|NCT02390544|children|children
1127869|NCT02390544|bone marrow transplant|bone marrow transplant
1127870|NCT02390544|pharmacokinetics|pharmacokinetics
1127871|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
1127872|NCT02390531|Bevacizumab|bevacizumab
1127874|NCT02390505|vitamin C|vitamin c
1127875|NCT02390505|CRPS|crps
1127876|NCT02390505|Upper limb surgery|upper limb surgery
1127877|NCT02390479|Sclerostin|sclerostin
1127878|NCT02390479|OPG|opg
1127879|NCT02390479|RANKL|rankl
1127880|NCT02390453|mild cognitive impairment|mild cognitive impairment
1127881|NCT02390453|randomized controlled trial|randomized controlled trial
1127882|NCT02390453|cognitive training|cognitive training
1127883|NCT02390453|exercise training|exercise training
1127884|NCT02390453|cognition|cognition
1127885|NCT02390453|physical performance|physical performance
1127886|NCT02390453|disability|disability
1127887|NCT02390453|mood|mood
1127888|NCT02390440|Pain management|pain management
1127889|NCT02390440|Exparel|exparel
1127890|NCT02390440|Rib fracture|rib fracture
1127891|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
1127892|NCT02390427|Advanced Breast Cancer|advanced breast cancer
1127893|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
1127894|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
1127895|NCT02390388|pudendal block|pudendal block
1127896|NCT02390388|Hypospadias|hypospadias
1127897|NCT02390388|caudal block|caudal block
1127898|NCT02390388|child|child
1127899|NCT02390388|analgesia|analgesia
1127900|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
1127901|NCT02390336|Pain|pain
1127902|NCT02390336|Range of Motion|range of motion
1127903|NCT02390336|Physical Function|physical function
1127904|NCT02390336|Manual Therapy|manual therapy
1127905|NCT02390310|male circumcision|male circumcision
1127906|NCT02390310|Shang Ring|shang ring
1127907|NCT02390310|male circumcision device|male circumcision device
1127908|NCT02390310|prevention|prevention
1127909|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
1127910|NCT02390284|RGCD|rgcd
1127911|NCT02390284|Glaucoma Suspect|glaucoma suspect
1127912|NCT02390232|gut microbiota|gut microbiota
1127913|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
1127914|NCT02390232|Steatohepatitis|steatohepatitis
1127915|NCT02390232|Escherichia coli|escherichia coli
1127916|NCT02390232|colibactin|colibactin
1127917|NCT02390206|Stroke|stroke
1127918|NCT02390206|Spasticity|spasticity
1127919|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
1127920|NCT02390206|Dysport|dysport
1127921|NCT02390193|Chronic kidney disease|chronic kidney disease
1127922|NCT02390193|Dialysis|dialysis
1127923|NCT02390193|Sleep|sleep
1127924|NCT02390193|Pulmonary function|pulmonary function
1127925|NCT02390193|Polysomnography|polysomnography
1127926|NCT02390193|Upper airway|upper airway
1127927|NCT02390128|iodine|iodine
1127928|NCT02390128|thyroid|thyroid
1127929|NCT02390128|TSH|tsh
1127930|NCT02390128|pregnancy|pregnancy
1127931|NCT02390128|nutrition|nutrition
1127932|NCT02390128|diet|diet
1127933|NCT02390102|Anemia|anemia
1127934|NCT02390102|Severe aortic stenosis|severe aortic stenosis
1127935|NCT02390102|Red blood cell transfusion|red blood cell transfusion
1127936|NCT02390102|Erythropoietin|erythropoietin
1127937|NCT02390089|Dysphagia|dysphagia
1127938|NCT02390089|Cough|cough
1127939|NCT02390089|Aspiration pneumonia|aspiration pneumonia
1127940|NCT02390024|Mechanical Ventilation|mechanical ventilation
1127941|NCT02390024|Asynchronies|asynchronies
1127942|NCT02390024|Cognition|cognition
1127943|NCT02390011|Advanced Solid Tumor|advanced solid tumor
1127944|NCT02389998|Functional Pain|functional pain
1127945|NCT02389998|Abdominal Pain|abdominal pain
1127946|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
1127947|NCT02389998|IBS|ibs
1127948|NCT02389998|Functional Dyspepsia|functional dyspepsia
1127949|NCT02389998|FGID|fgid
1127950|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
1127951|NCT02389959|HHT|hht
1127952|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1127953|NCT02389959|epistaxis|epistaxis
1127954|NCT02389959|nose bleeds|nose bleeds
1127955|NCT02389959|nasal bleeding|nasal bleeding
1127956|NCT02389959|Avastin|avastin
1127957|NCT02389959|bevacizumab|bevacizumab
1127958|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
1127959|NCT02389946|Sirolimus|sirolimus
1127960|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
1127961|NCT02389946|DES|des
1127962|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
1127965|NCT02389894|Brain Infarction|brain infarction
1127967|NCT02389894|Aortic Valve Replacement|aortic valve replacement
1127968|NCT02389881|Drug therapy|drug therapy
1127971|NCT02389868|Blood platelets|blood platelets
1127972|NCT02389855|Progression|progression
1127973|NCT02389855|Quality of Life|quality of life
1127974|NCT02389816|Drug therapy|drug therapy
1127975|NCT02389790|Crohn's Disease|crohn's disease
1127976|NCT02389764|Breast cancer|breast cancer
1127977|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
1127978|NCT02389764|MIBC|mibc
1127979|NCT02389764|HER2-negative|her2-negative
1127980|NCT02389764|Breast carcinoma|breast carcinoma
1127981|NCT02389764|BIBF 1120|bibf 1120
1127982|NCT02389764|Nintedanib|nintedanib
1127983|NCT02389764|Phone call|phone call
1127984|NCT02389751|Esophageal Cancer|esophageal cancer
1127985|NCT02389751|Esophageal carcinoma|esophageal carcinoma
1127986|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction|adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction
1127987|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the cervical esophagus|adenocarcinoma or squamous cell carcinoma of the cervical esophagus
1127988|NCT02389751|Adenocarcinoma or squamous cell carcinoma of thoracic esophagus|adenocarcinoma or squamous cell carcinoma of thoracic esophagus
1127989|NCT02389751|Ganetespib|ganetespib
1127990|NCT02389751|Carboplatin|carboplatin
1127991|NCT02389751|Paraplatin|paraplatin
1127992|NCT02389751|Paclitaxel|paclitaxel
1127993|NCT02389751|Taxol|taxol
1127994|NCT02389725|peripheral intravenous access|peripheral intravenous access
1127995|NCT02389725|tourniquet techniques|tourniquet techniques
1127996|NCT02389712|Bipolar Disorder|bipolar disorder
1127997|NCT02389712|Mayo Clinic|mayo clinic
1127998|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
1127999|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
1128000|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
1128001|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
1128002|NCT02389686|INTRABEAM|intrabeam
1128003|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
1128005|NCT02389621|Elective invasive procedures|elective invasive procedures
1128006|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
1128007|NCT02389608|functional electrical stimulation|functional electrical stimulation
1128008|NCT02389608|hemiparesis|hemiparesis
1128009|NCT02389608|electromyography|electromyography
1128010|NCT02389608|balance|balance
1128011|NCT02389595|HIV|hiv
1128012|NCT02389595|vaccine|vaccine
1128013|NCT02389595|T cell|t cell
1128014|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
1128015|NCT02389569|Biomaterial|biomaterial
1128016|NCT02389569|Dental caries|dental caries
1128017|NCT02389569|Composite|composite
1128018|NCT02389543|KPT-330|kpt-330
1128019|NCT02389543|Selinexor|selinexor
1128020|NCT02389543|Multiple Myeloma|multiple myeloma
1128021|NCT02389543|Relapsed/refractory|relapsed/refractory
1128022|NCT02389543|Lenalidomide|lenalidomide
1128023|NCT02389543|Dexamethasone|dexamethasone
1128024|NCT02389543|Karyopharm|karyopharm
1128025|NCT02389530|glioma|glioma
1128026|NCT02389530|neoplasms|neoplasms
1128027|NCT02389504|Exertion|exertion
1128028|NCT02389504|Efficacy of Treatment|efficacy of treatment
1128029|NCT02389491|high density formula|high density formula
1128030|NCT02389491|heart defects|heart defects
1128031|NCT02389491|infant|infant
1128032|NCT02389478|oropharyngeal|oropharyngeal
1128033|NCT02389478|breastmilk|breastmilk
1128034|NCT02389478|colostrum|colostrum
1128035|NCT02389478|human milk|human milk
1128036|NCT02389478|premature infant|premature infant
1128037|NCT02389465|Depression|depression
1128038|NCT02389465|Geriatric|geriatric
1128039|NCT02389465|Inflammation|inflammation
1128040|NCT02389426|Multiple Sclerosis|multiple sclerosis
1128041|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
1128042|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
1128043|NCT02389426|Cerebral circulation|cerebral circulation
1128044|NCT02389413|PQ912|pq912
1128045|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
1128046|NCT02389413|QC - Inhibitor|qc - inhibitor
1128047|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
1128048|NCT02389400|newly diagnosed|newly diagnosed
1128049|NCT02389400|methotrexate|methotrexate
1128050|NCT02389400|cytosine arabinoside|cytosine arabinoside
1128051|NCT02389387|Dialysis Facilities|dialysis facilities
1128052|NCT02389387|African Americans|african americans
1128053|NCT02389387|Racial Disparity|racial disparity
1128054|NCT02389387|Kidney Transplantation|kidney transplantation
1128055|NCT02389387|Community-based Participatory Research|community-based participatory research
1128056|NCT02389387|Coalition|coalition
1128057|NCT02389348|Induced blood stage malaria|induced blood stage malaria
1128058|NCT02389335|type 1diabetes|type 1diabetes
1128060|NCT02389335|IL-2|il-2
1128061|NCT02389335|TNF α|tnf α
1128062|NCT02389322|ESAT6|esat6
1128063|NCT02389322|CFP10|cfp10
1128064|NCT02389322|skin test|skin test
1128065|NCT02389322|diagnostic test|diagnostic test
1128066|NCT02389309|Solid tumors|solid tumors
1128067|NCT02389309|Advanced tumors|advanced tumors
1128068|NCT02389309|Temsirolimus|temsirolimus
1128074|NCT02389309|Cyclophosphamide|cyclophosphamide
1128075|NCT02389309|Cytoxan|cytoxan
1128076|NCT02389309|Neosar|neosar
1128077|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
1128078|NCT02389283|ultrasound joint count|ultrasound joint count
1128079|NCT02389270|Neurotrophins|neurotrophins
1128080|NCT02389270|Nerve Growth Factor|nerve growth factor
1128081|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1128082|NCT02389270|Urinary Biomarkers|urinary biomarkers
1128083|NCT02389270|Children|children
1128084|NCT02389257|volunteers|volunteers
1128085|NCT02389231|interleukine 2|interleukine 2
1128086|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
1128087|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
1128088|NCT02389218|atrial fibrillation|atrial fibrillation
1128089|NCT02389218|cryoablation|cryoablation
1128090|NCT02389218|catheter ablation|catheter ablation
1128091|NCT02389192|Ebola|ebola
1128092|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
1128093|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
1128094|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
1128095|NCT02389153|myocardial infarction|myocardial infarction
1128096|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
1128097|NCT02389153|collaborative care|collaborative care
1128098|NCT02389153|quality of life|quality of life
1128099|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
1128100|NCT02389140|Blood flow|blood flow
1128101|NCT02389140|Glucose|glucose
1128102|NCT02389140|lactic acid|lactic acid
1128103|NCT02389127|Cirrhosis|cirrhosis
1128104|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1128105|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
1128106|NCT02389127|Glucose|glucose
1128107|NCT02389101|Lymphoma|lymphoma
1128108|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
1128109|NCT02389101|Somatostatin receptor|somatostatin receptor
1128110|NCT02389101|MRI|mri
1128111|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
1128112|NCT02389101|Early treatment response|early treatment response
1128113|NCT02389088|Granulosa Cell|granulosa cell
1128114|NCT02389088|Androgens|androgens
1128115|NCT02389088|FSH|fsh
1128116|NCT02389088|Ovary|ovary
1128117|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
1128118|NCT02389075|microbiome|microbiome
1128119|NCT02389075|colon mucosa|colon mucosa
1128120|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1128121|NCT02389049|Kartagener Syndrome|kartagener syndrome
1128122|NCT02389023|surgical site infection|surgical site infection
1128123|NCT02389023|infrainguinal bypass|infrainguinal bypass
1128124|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
1128125|NCT02389023|Prevena|prevena
1128126|NCT02389010|Umbilical Cord Blood|umbilical cord blood
1128127|NCT02389010|Diabetic Foot|diabetic foot
1128128|NCT02389010|Ulcer|ulcer
1128129|NCT02389010|Cost|cost
1128130|NCT02389010|Effectiveness|effectiveness
1128131|NCT02389010|Safety|safety
1128132|NCT02389010|Platelet Gel|platelet gel
1128133|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
1128134|NCT02389010|Adverse Event|adverse event
1128135|NCT02388997|mild asthma|mild asthma
1128136|NCT02388997|young adults|young adults
1128137|NCT02388997|rhinovirus|rhinovirus
1128138|NCT02388971|Drug therapy|drug therapy
1128139|NCT02388919|anlotinib|anlotinib
1128140|NCT02388919|Cancer|cancer
1128141|NCT02388919|NSCLC|nsclc
1128142|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
1128143|NCT02388880|ITPR|itpr
1128144|NCT02388880|CPP|cpp
1128145|NCT02388880|TBI|tbi
1128146|NCT02388880|traumatic brain injury|traumatic brain injury
1128147|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
1128148|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
1128149|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
1128150|NCT02388815|Diabetes Mellitus|diabetes mellitus
1128151|NCT02388815|Sensing Technology|sensing technology
1128152|NCT02388802|Infertility|infertility
1128153|NCT02388802|Transplant|transplant
1128154|NCT02388802|IVF|ivf
1128155|NCT02388802|Hysterectomy|hysterectomy
1128156|NCT02388802|Absolute uterine infertility|absolute uterine infertility
1128157|NCT02388789|sensory receptors|sensory receptors
1128158|NCT02388789|balance control|balance control
1128159|NCT02388789|gait|gait
1128160|NCT02388789|temperature|temperature
1128161|NCT02388776|ROTEM|rotem
1128162|NCT02388776|Fibrinogen|fibrinogen
1128163|NCT02388763|Contact lenses|contact lenses
1128164|NCT02388750|nausea|nausea
1128165|NCT02388750|vomiting|vomiting
1128166|NCT02388750|radiation|radiation
1128167|NCT02388750|anti-emetic drug|anti-emetic drug
1128168|NCT02388737|Drug therapy|drug therapy
1128169|NCT02388724|Drug therapy|drug therapy
1128170|NCT02388711|Dementia|dementia
1128171|NCT02388711|Transitional Care|transitional care
1128172|NCT02388711|Caregiver|caregiver
1128173|NCT02388698|HPV DNA|hpv dna
1128174|NCT02388698|PET-CT|pet-ct
1128175|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
1128176|NCT02388698|chemoradiation|chemoradiation
1128177|NCT02388685|peripheral arterial disease|peripheral arterial disease
1128178|NCT02388685|exercise|exercise
1128179|NCT02388685|perfusion|perfusion
1128180|NCT02388685|energetics|energetics
1128181|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
1128182|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1128183|NCT02388659|MRS Biomarkers|mrs biomarkers
1128184|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
1128185|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
1128186|NCT02388542|cardiovascular disease|cardiovascular disease
1128187|NCT02388542|education|education
1128188|NCT02388542|peer mentor|peer mentor
1128189|NCT02388529|Heart Failure|heart failure
1128190|NCT02388529|Bendavia™|bendavia™
1128191|NCT02388529|MTP-131|mtp-131
1128192|NCT02388516|Bangladesh|bangladesh
1128193|NCT02388516|Vitamin D|vitamin d
1128194|NCT02388516|Acute Respiratory Infections|acute respiratory infections
1128195|NCT02388516|Infancy|infancy
1128196|NCT02388516|Pregnancy|pregnancy
1128197|NCT02388503|Blood glucose|blood glucose
1128198|NCT02388490|Brentuximabvedotin|brentuximabvedotin
1128199|NCT02388490|EBV|ebv
1128200|NCT02388490|Lymphoma|lymphoma
1128201|NCT02388477|rotator cuff repair|rotator cuff repair
1128202|NCT02388477|Doxycycline|doxycycline
1128203|NCT02388464|Congestive Heart Failure|congestive heart failure
1128204|NCT02388464|Bendavia™|bendavia™
1184477|NCT02103751|CVD|cvd
1128205|NCT02388464|MTP-131|mtp-131
1128206|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
1128207|NCT02388438|demineralized bone matrix|demineralized bone matrix
1128208|NCT02388412|Positron emission tomography|positron emission tomography
1128209|NCT02388412|Tissue background ratio|tissue background ratio
1128210|NCT02388412|Optical coherence tomography|optical coherence tomography
1128211|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
1128212|NCT02388412|Vulnerability|vulnerability
1128213|NCT02388412|Acute coronary syndrome|acute coronary syndrome
1128214|NCT02388399|Optical coherence tomography|optical coherence tomography
1128215|NCT02388399|Axial Plaque Stress|axial plaque stress
1128216|NCT02388399|Wall Shear Stress|wall shear stress
1128217|NCT02388399|Vulnerability|vulnerability
1128218|NCT02388386|Telemedicine|telemedicine
1128219|NCT02388386|Mobile Health|mobile health
1128220|NCT02388360|Prostaglandin analogs|prostaglandin analogs
1128221|NCT02388360|Corneal biomechanics|corneal biomechanics
1128222|NCT02388360|Corneal Hysteresis|corneal hysteresis
1128223|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
1128224|NCT02388334|Caregivers|caregivers
1128225|NCT02388334|Quality of life|quality of life
1128226|NCT02388334|Quality of care|quality of care
1128227|NCT02388321|Analgesia|analgesia
1128228|NCT02388321|pediatrics|pediatrics
1128229|NCT02388321|pain management|pain management
1128230|NCT02388308|Prostate cancer|prostate cancer
1128231|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
1128232|NCT02388308|Ultrasound guidance|ultrasound guidance
1128233|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
1128234|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
1128235|NCT02388282|diaphragm echography|diaphragm echography
1128236|NCT02388282|respiratory mechanics|respiratory mechanics
1128237|NCT02388256|colon|colon
1128238|NCT02388256|colorectal|colorectal
1128239|NCT02388256|cancer|cancer
1128240|NCT02388256|neoplasm|neoplasm
1128241|NCT02388243|Brief intervention|brief intervention
1128242|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
1128243|NCT02388243|eLearning|elearning
1128244|NCT02388243|Screening|screening
1128245|NCT02388243|Capacity Building|capacity building
1128246|NCT02388243|Primary Health Care|primary health care
1128247|NCT02388243|Education, Medical|education, medical
1128248|NCT02388243|Education, Nursing|education, nursing
1128249|NCT02388243|Education, Professional|education, professional
1128250|NCT02388243|Community Health Workers|community health workers
1128251|NCT02388230|Breast cancer|breast cancer
1128252|NCT02388230|Elastography|elastography
1128253|NCT02388230|Ultrasound imaging|ultrasound imaging
1128254|NCT02388230|Quantification of toxicity|quantification of toxicity
1128255|NCT02388230|Side-effects|side-effects
1128256|NCT02388217|chronic pain|chronic pain
1128257|NCT02388217|cannabis|cannabis
1128258|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
1128259|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
1128260|NCT02388204|Gait|gait
1128261|NCT02388204|Locomotion|locomotion
1128262|NCT02388204|Freezing|freezing
1128263|NCT02388191|Contraception|contraception
1128264|NCT02388191|Naproxen|naproxen
1128265|NCT02388191|Intrauterine devices|intrauterine devices
1128266|NCT02388191|Pain Control|pain control
1128267|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
1128268|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
1128269|NCT02388165|Spinal Surgery|spinal surgery
1128270|NCT02388165|MRSA|mrsa
1128271|NCT02388165|Staphylococcus aureus|staphylococcus aureus
1128272|NCT02388139|acute myocardial infarction|acute myocardial infarction
1128273|NCT02388139|renal artery stenosis|renal artery stenosis
1128274|NCT02388113|Exercise therapy|exercise therapy
1128275|NCT02388113|Time factors|time factors
1128276|NCT02388074|Lung Cancer|lung cancer
1128277|NCT02388074|Porphyrin|porphyrin
1128278|NCT02388074|Fluorescence|fluorescence
1128279|NCT02388074|Diagnostic|diagnostic
1128280|NCT02388074|Sputum Cytology|sputum cytology
1128281|NCT02388074|Early Detection|early detection
1128282|NCT02388048|Leukemia|leukemia
1128283|NCT02388048|Chronic|chronic
1128284|NCT02388048|High-risk|high-risk
1128285|NCT02388048|ofatumumab|ofatumumab
1128286|NCT02388048|ibrutinib|ibrutinib
1128287|NCT02388048|Lymphoblastic|lymphoblastic
1128288|NCT02388035|profiles changes|profiles changes
1128289|NCT02388035|microorganisms|microorganisms
1128290|NCT02388035|cefotaxime|cefotaxime
1128291|NCT02388035|SBP|sbp
1128292|NCT02388035|Egyptian|egyptian
1128293|NCT02388035|effective antibiotics|effective antibiotics
1128294|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
1128295|NCT02388009|safety|safety
1128296|NCT02388009|immunogenicity|immunogenicity
1128297|NCT02388009|shigellosis|shigellosis
1128298|NCT02387970|Dental implants|dental implants
1128299|NCT02387970|Partial edentulism|partial edentulism
1568637|NCT00505167|Alzheimer's disease|alzheimer's disease
1128300|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
1128301|NCT02387957|Wet AMD|wet amd
1128302|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
1128303|NCT02387957|Fovista®|fovista®
1128304|NCT02387957|Avastin®|avastin®
1128305|NCT02387957|Lucentis®|lucentis®
1128306|NCT02387957|Eylea®|eylea®
1128307|NCT02387944|Children|children
1128308|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
1128309|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
1128310|NCT02387944|Thromboelastometry|thromboelastometry
1128311|NCT02387944|Platelet Function Tests|platelet function tests
1128312|NCT02387931|Adolescent|adolescent
1128313|NCT02387931|Endometriosis|endometriosis
1128314|NCT02387931|Diet|diet
1128315|NCT02387931|Nutrition|nutrition
1128316|NCT02387931|Pain|pain
1128317|NCT02387918|Tonsillectomy|tonsillectomy
1128318|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
1128319|NCT02387918|Dexamethasone|dexamethasone
1128320|NCT02387918|Acupuncture|acupuncture
1128321|NCT02387905|Stereotactic spinal radiosurgery|stereotactic spinal radiosurgery
1128322|NCT02387905|Spinal Cord Diseases|spinal cord diseases
1128323|NCT02387905|Vertebral body compression fracture|vertebral body compression fracture
1128324|NCT02387905|SSRS|ssrs
1128325|NCT02387905|Brief Pain Inventory|brief pain inventory
1128326|NCT02387905|MD Anderson Symptom Inventory - Spine Tumor|md anderson symptom inventory - spine tumor
1128327|NCT02387905|MDASI-SP|mdasi-sp
1128328|NCT02387905|Questionnaires|questionnaires
1128329|NCT02387905|Survey|survey
1128330|NCT02387879|Multiple Myeloma|multiple myeloma
1128331|NCT02387879|PASS|pass
1128332|NCT02387879|Observational|observational
1128333|NCT02387879|Non-interventional|non-interventional
1128334|NCT02387879|Relapse|relapse
1128335|NCT02387879|Refractory|refractory
1128336|NCT02387879|CC-5013|cc-5013
1128337|NCT02387879|Lenalidomide|lenalidomide
1128338|NCT02387879|Turkey|turkey
1128339|NCT02387866|Pharmacokinetic|pharmacokinetic
1128340|NCT02387866|Healthy Volunteers|healthy volunteers
1128341|NCT02387866|Male|male
1128342|NCT02387866|Japanese|japanese
1128343|NCT02387866|Caucasian|caucasian
1128344|NCT02387866|AG-221|ag-221
1128345|NCT02387840|Brain|brain
1128346|NCT02387840|Cancer|cancer
1128347|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
1128348|NCT02387840|NF1|nf1
1128349|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
1128350|NCT02387840|MRF|mrf
1128351|NCT02387827|long bout physical activity|long bout physical activity
1128352|NCT02387827|short bout physical activity|short bout physical activity
1128353|NCT02387827|Caloric Restriction|caloric restriction
1128354|NCT02387775|esophageal cooling device|esophageal cooling device
1128355|NCT02387775|post cardiac arrest|post cardiac arrest
1128356|NCT02387775|targetted temperature management|targetted temperature management
1130480|NCT02376283|STEMI|stemi
1128357|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
1128358|NCT02387775|cooling|cooling
1128359|NCT02387775|rewarming|rewarming
1128360|NCT02387762|Acalabrutinib|acalabrutinib
1128361|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1128362|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
1128363|NCT02387736|BPD|bpd
1128364|NCT02387736|DBT|dbt
1128365|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
1128366|NCT02387736|Borderline Personality Disorder|borderline personality disorder
1128367|NCT02387736|Suicide|suicide
1128368|NCT02387736|Non-suicidal self injury|non-suicidal self injury
1128369|NCT02387736|NSSI|nssi
1128370|NCT02387736|Randomized Control trials|randomized control trials
1128371|NCT02387736|treatment|treatment
1128372|NCT02387710|arousal threshold|arousal threshold
1128373|NCT02387710|phenotype|phenotype
1128375|NCT02387710|slow wave sleep|slow wave sleep
1128376|NCT02387684|chronic hepatitis B|chronic hepatitis b
1128377|NCT02387684|interferon|interferon
1128378|NCT02387684|peginterferon|peginterferon
1128379|NCT02387684|HBsAg loss|hbsag loss
1128380|NCT02387658|peripheral arterial disease|peripheral arterial disease
1128381|NCT02387658|claudication|claudication
1128382|NCT02387658|translesional pressure gradient|translesional pressure gradient
1128383|NCT02387658|pressure wire|pressure wire
1128384|NCT02387658|six minute walk|six minute walk
1128385|NCT02387658|superficial femoral artery|superficial femoral artery
1128386|NCT02387658|pressure gradient|pressure gradient
1128387|NCT02387658|endovascular|endovascular
1128388|NCT02387645|Endometrium|endometrium
1128389|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
1128390|NCT02387645|Early detection|early detection
1128391|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
1128392|NCT02387645|Gynaecological Cancer|gynaecological cancer
1128393|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
1128394|NCT02387606|Placebo|placebo
1128395|NCT02387606|Antiviral activity|antiviral activity
1128396|NCT02387606|JNJ-53718678|jnj-53718678
1128397|NCT02387593|Adenoma|adenoma
1128398|NCT02387593|Colonoscopy|colonoscopy
1128399|NCT02387593|Screening|screening
1128400|NCT02387580|Malaria|malaria
1128401|NCT02387580|Bioavailability|bioavailability
1128402|NCT02387580|Formulation|formulation
1128403|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1128404|NCT02387528|MIndfulness|mindfulness
1128405|NCT02387528|Primary Health Care|primary health care
1128406|NCT02387463|chronic hepatitis B|chronic hepatitis b
1128407|NCT02387463|antiviral therapy|antiviral therapy
1128408|NCT02387463|peginterferon|peginterferon
1128409|NCT02387463|HBeAg seroconversion|hbeag seroconversion
1128410|NCT02387463|HBsAg loss|hbsag loss
1128411|NCT02387450|Claudication|claudication
1128412|NCT02387450|Maximal walking distance|maximal walking distance
1128413|NCT02387450|Morbi-mortality|morbi-mortality
1128414|NCT02387437|ARDS|ards
1128415|NCT02387437|EIT|eit
1128416|NCT02387437|recruitment maneuvers|recruitment maneuvers
1128417|NCT02387424|depression|depression
1128418|NCT02387424|mindfulness|mindfulness
1128419|NCT02387424|pregnancy|pregnancy
1128420|NCT02387424|prevention|prevention
1128421|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
1128422|NCT02387411|heart failure|heart failure
1128423|NCT02387411|aerobic exercise|aerobic exercise
1128424|NCT02387411|strength training|strength training
1128425|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
1128426|NCT02387411|high-intensity exercise training|high-intensity exercise training
1128427|NCT02387333|Radical cystectomy|radical cystectomy
1128428|NCT02387333|Urinary diversion|urinary diversion
1128429|NCT02387333|Ileal conduit|ileal conduit
1128430|NCT02387333|Parastomal hernia|parastomal hernia
1128431|NCT02387333|Prophylactic mesh|prophylactic mesh
1128432|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
1128433|NCT02387320|Anxiety|anxiety
1128434|NCT02387320|Pain|pain
1128435|NCT02387320|Nausea|nausea
1128436|NCT02387320|Fatigue|fatigue
1128437|NCT02387320|Sleep Disturbance|sleep disturbance
1128438|NCT02387320|Breast Cancer|breast cancer
1128439|NCT02387320|Surgery|surgery
1128440|NCT02387294|immunogenicity|immunogenicity
1128441|NCT02387294|reduced dos|reduced dos
1128442|NCT02387294|Phase III|phase iii
1128443|NCT02387294|tolerability|tolerability
1128444|NCT02387294|safety|safety
1128445|NCT02387281|Freezing of gait|freezing of gait
1128446|NCT02387242|Tuberculosis|tuberculosis
1128447|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
1128448|NCT02387242|WBA|wba
1128449|NCT02387242|Rifampicin|rifampicin
1128450|NCT02387229|Atrial Fibrillation|atrial fibrillation
1128451|NCT02387229|Stroke|stroke
1128452|NCT02387229|Neurocognitive decline|neurocognitive decline
1128453|NCT02387229|Rivaroxaban|rivaroxaban
1128454|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
1128455|NCT02387229|Anticoagulation|anticoagulation
1128456|NCT02387216|NSCLC|nsclc
1128457|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
1128458|NCT02387216|heregulin|heregulin
1128459|NCT02387216|ErbB3|erbb3
1128461|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
1128462|NCT02387203|Appendiceal cancer|appendiceal cancer
1128463|NCT02387203|CRS/HIPEC|crs/hipec
1128464|NCT02387203|PMP|pmp
1128465|NCT02387190|Heart Failure|heart failure
1128466|NCT02387190|Lung function test|lung function test
1128467|NCT02387190|Telenursing|telenursing
1128468|NCT02387190|Morbidity|morbidity
1128469|NCT02387190|Mortality|mortality
1128470|NCT02387190|Quality of life|quality of life
1128471|NCT02387164|Type 1 diabetes|type 1 diabetes
1128472|NCT02387164|Islet autoantibodies|islet autoantibodies
1128473|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
1128474|NCT02387164|Immune tolerance|immune tolerance
1128475|NCT02387164|Prediabetes|prediabetes
1128476|NCT02387164|Glucose tolerance|glucose tolerance
1128477|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
1128478|NCT02387164|Prevention|prevention
1128480|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
1128481|NCT02387151|Rejection|rejection
1128482|NCT02387112|End stage heart disease|end stage heart disease
1128483|NCT02387112|Ventricular assist device|ventricular assist device
1128484|NCT02387099|Stage IIIB|stage iiib
1128485|NCT02387099|Stage IV|stage iv
1128486|NCT02387099|Recurrent|recurrent
1128487|NCT02387099|Metastatic|metastatic
1128488|NCT02387086|gefitinib|gefitinib
1128489|NCT02387086|thalidomide|thalidomide
1128490|NCT02387086|NSCLC|nsclc
1128491|NCT02387086|EGFR mutation|egfr mutation
1128492|NCT02387073|outcome assessment|outcome assessment
1128493|NCT02387073|self-reported|self-reported
1128494|NCT02387073|patient|patient
1128495|NCT02387073|clinical outcome|clinical outcome
1128496|NCT02387060|Anesthesia|anesthesia
1128497|NCT02387060|Spinal and Epidural|spinal and epidural
1128498|NCT02387060|Adverse Effect|adverse effect
1128499|NCT02387060|Complications|complications
1128500|NCT02387034|Osteoarthritis|osteoarthritis
1128501|NCT02387034|Sedentary|sedentary
1128502|NCT02387034|Physical activity|physical activity
1568638|NCT00505167|Memantine|memantine
1128503|NCT02387034|Health related quality of life|health related quality of life
1128504|NCT02387021|analgesia|analgesia
1128505|NCT02387021|nerve block|nerve block
1128506|NCT02387021|Total knee replacement|total knee replacement
1128507|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
1128508|NCT02386995|deep brain stimulation|deep brain stimulation
1128509|NCT02386969|Neuropathic Pain|neuropathic pain
1128510|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1128511|NCT02386956|manual therapy|manual therapy
1128512|NCT02386956|muscle chains|muscle chains
1128513|NCT02386956|Dynamic stretching|dynamic stretching
1128514|NCT02386956|Active stretching|active stretching
1128515|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
1128516|NCT02386930|Lifestyle modification|lifestyle modification
1128517|NCT02386930|HbA1c|hba1c
1128518|NCT02386930|Carbohydrates|carbohydrates
1128519|NCT02386891|food intake|food intake
1128520|NCT02386891|indoor thermal environment|indoor thermal environment
1128521|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
1128522|NCT02386878|Program Evaluation|program evaluation
1128523|NCT02386878|HIV Prevention|hiv prevention
1128524|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
1128525|NCT02386878|Adolescents|adolescents
1128526|NCT02386852|Ginseng|ginseng
1128527|NCT02386852|Ginkgo Biloba|ginkgo biloba
1128528|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
1128529|NCT02386852|cognition|cognition
1128530|NCT02386826|INC280|inc280
1128531|NCT02386826|c-MET Inhibitors|c-met inhibitors
1128532|NCT02386826|bevacizumab|bevacizumab
1128533|NCT02386826|Avastin|avastin
1128534|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
1128535|NCT02386800|primary myelofibrosis|primary myelofibrosis
1128536|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
1128537|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
1128538|NCT02386800|post essential thrombocythaemia myelofibrosis.|post essential thrombocythaemia myelofibrosis.
1128539|NCT02386787|Ultrasonography|ultrasonography
1128540|NCT02386787|Non-elective surgery|non-elective surgery
1128541|NCT02386787|Anesthesia|anesthesia
1128542|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
1128543|NCT02386774|corneal disease|corneal disease
1128544|NCT02386774|Blepharitis|blepharitis
1128545|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
1128546|NCT02386774|Microscopy, Confocal|microscopy, confocal
1128547|NCT02386748|Cesarean section|cesarean section
1128548|NCT02386748|Chewing gums|chewing gums
1128549|NCT02386748|Intestinal motility|intestinal motility
1128550|NCT02386735|Corticosteroid treatment|corticosteroid treatment
1128551|NCT02386735|COPD|copd
1128552|NCT02386735|Primary Health Care|primary health care
1128553|NCT02386735|Randomized controlled trial|randomized controlled trial
1128554|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
1128555|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
1128556|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
1128557|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
1128558|NCT02386683|neurosurgery|neurosurgery
1128559|NCT02386657|Sickle Cell Disease|sickle cell disease
1128560|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
1128561|NCT02386657|Emergency management|emergency management
1128562|NCT02386631|gait|gait
1128563|NCT02386631|orthotics|orthotics
1128564|NCT02386631|kinetics|kinetics
1128565|NCT02386631|hallux valgus|hallux valgus
1128566|NCT02386631|bunions|bunions
1128567|NCT02386618|colorectal cancer|colorectal cancer
1128568|NCT02386618|laterally spreading tumors|laterally spreading tumors
1128569|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
1128570|NCT02386618|local residual neoplasia|local residual neoplasia
1128571|NCT02386605|recovery|recovery
1128572|NCT02386605|rehabilitation|rehabilitation
1128573|NCT02386553|NURTURE|nurture
1128574|NCT02386540|Community Health Workers|community health workers
1128677|NCT02385838|Nutritional quality|nutritional quality
1128575|NCT02386540|Community Health Workers: utilization|community health workers: utilization
1128576|NCT02386540|Emergency Service|emergency service
1128577|NCT02386540|Primary Health Care/utilization|primary health care/utilization
1128578|NCT02386540|Health Services Accessibility|health services accessibility
1128579|NCT02386514|sexually transmitted infection|sexually transmitted infection
1128580|NCT02386514|gonorrhea|gonorrhea
1128581|NCT02386514|chlamydia|chlamydia
1128582|NCT02386514|presumptive therapy|presumptive therapy
1128583|NCT02386462|laryngeal mask airway|laryngeal mask airway
1128584|NCT02386462|circulatory reflexes|circulatory reflexes
1128585|NCT02386436|GSK2330811|gsk2330811
1128586|NCT02386436|Dose Escalation|dose escalation
1128587|NCT02386436|Safety|safety
1128588|NCT02386436|First Time in Human|first time in human
1128589|NCT02386436|Pharmacodynamics|pharmacodynamics
1128590|NCT02386436|Pharmacokinetics|pharmacokinetics
1128591|NCT02386423|RLS|rls
1128592|NCT02386423|Willis-Ekbom|willis-ekbom
1128593|NCT02386384|pregnancy failure|pregnancy failure
1128594|NCT02386358|Chronic Chagas Disease|chronic chagas disease
1568639|NCT00505167|Donepezil|donepezil
1128595|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
1128596|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
1128597|NCT02386358|Adult patients|adult patients
1128598|NCT02386345|FIRM procedure|firm procedure
1128599|NCT02386319|Melatonin|melatonin
1128600|NCT02386319|Analgesic|analgesic
1128601|NCT02386319|Surgery|surgery
1128602|NCT02386319|Pharmacokinetic|pharmacokinetic
1128603|NCT02386280|Primary Prevention|primary prevention
1128604|NCT02386280|Substance-Related Disorders|substance-related disorders
1128605|NCT02386280|Family|family
1128606|NCT02386254|premorbid|premorbid
1128607|NCT02386254|scoring system|scoring system
1128608|NCT02386254|ECOG|ecog
1128609|NCT02386254|ICU|icu
1128610|NCT02386254|morbidity|morbidity
1128611|NCT02386254|mortality|mortality
1128612|NCT02386241|brain tumor|brain tumor
1128613|NCT02386228|miRNA|mirna
1128614|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
1128615|NCT02386215|HIV self-testing|hiv self-testing
1128616|NCT02386215|randomized controlled trial|randomized controlled trial
1128617|NCT02386215|Kenya|kenya
1128618|NCT02386189|Continuity of Patient Care|continuity of patient care
1128619|NCT02386189|Health Records, Personal|health records, personal
1128620|NCT02386189|Veterans|veterans
1128621|NCT02386189|Patient Participation|patient participation
1128622|NCT02386189|Chronic Disease|chronic disease
1128623|NCT02386137|MR-HIFU|mr-hifu
1128624|NCT02386137|HIFU|hifu
1128625|NCT02386137|Fibroid treatment|fibroid treatment
1128626|NCT02386137|MR Perfusion|mr perfusion
1128627|NCT02386137|CEUS perfusion|ceus perfusion
1128628|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
1128629|NCT02386137|ARFI|arfi
1128630|NCT02386137|Fibroid stiffness|fibroid stiffness
1128631|NCT02386124|frailty|frailty
1128632|NCT02386124|elderly|elderly
1128633|NCT02386124|acute coronary syndrome|acute coronary syndrome
1128634|NCT02386124|acute heart failure|acute heart failure
1128635|NCT02386124|arrhythmias|arrhythmias
1128636|NCT02386111|Sutent|sutent
1128637|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1128638|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
1128639|NCT02386085|adverse effects|adverse effects
1128640|NCT02386085|side effects|side effects
1128641|NCT02386085|undesirable effects|undesirable effects
1128642|NCT02386072|Betanis®|betanis®
1128643|NCT02386072|Myrbetriq®|myrbetriq®
1128644|NCT02386072|Quality of Life|quality of life
1128645|NCT02386072|Antimuscarinics|antimuscarinics
1128646|NCT02386072|Betmiga®|betmiga®
1128647|NCT02386072|Overactive Bladder|overactive bladder
1128648|NCT02386072|Observational|observational
1128649|NCT02386059|ondansetron|ondansetron
1128650|NCT02386059|dexamethasone|dexamethasone
1128651|NCT02386059|vitrectomy|vitrectomy
1128652|NCT02386059|local anesthesia|local anesthesia
1128653|NCT02386046|Caffeine use|caffeine use
1128654|NCT02386046|Normative data|normative data
1128655|NCT02385968|Modic|modic
1128656|NCT02385968|Microbiology|microbiology
1128657|NCT02385968|Immunology|immunology
1128658|NCT02385942|u-health|u-health
1128659|NCT02385942|chronic wound management|chronic wound management
1128660|NCT02385942|pressure ulcer|pressure ulcer
1128661|NCT02385929|Head and Neck Cancer|head and neck cancer
1128662|NCT02385929|Intervention|intervention
1128663|NCT02385929|Rehabilitation|rehabilitation
1128664|NCT02385929|Late Effects|late effects
1128665|NCT02385929|Dysphagia|dysphagia
1128666|NCT02385916|EstroSense|estrosense
1128667|NCT02385916|estrogen|estrogen
1128668|NCT02385903|Flammacerium|flammacerium
1128669|NCT02385903|Ischemic wound|ischemic wound
1128670|NCT02385903|Lower limb|lower limb
1128671|NCT02385903|Arteriopathy|arteriopathy
1128672|NCT02385903|Amputation|amputation
1128673|NCT02385903|Dressing|dressing
1128674|NCT02385838|Nutrition labelling|nutrition labelling
1128675|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
1128676|NCT02385838|Purchasing intentions|purchasing intentions
1128775|NCT02385487|Sepsis|sepsis
1128678|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
1128679|NCT02385812|Lung Cancer|lung cancer
1128680|NCT02385812|Mesothelioma|mesothelioma
1128681|NCT02385812|Asbestos|asbestos
1128682|NCT02385812|Screening|screening
1128683|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
1128684|NCT02385799|Behavior|behavior
1128685|NCT02385799|sertraline|sertraline
1128686|NCT02385799|treatment|treatment
1128687|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1128688|NCT02385786|depression|depression
1128689|NCT02385786|treatment|treatment
1128690|NCT02385786|mindfulness meditation|mindfulness meditation
1128691|NCT02385786|psychotherapy|psychotherapy
1128692|NCT02385773|colostrum|colostrum
1128693|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
1128694|NCT02385760|Facial Acne|facial acne
1128695|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
1128696|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
1128697|NCT02385747|hysteroscopy|hysteroscopy
1128698|NCT02385747|Steroid receptors|steroid receptors
1128699|NCT02385734|Multiple gingival recession|multiple gingival recession
1128700|NCT02385734|Concentrated growth factor|concentrated growth factor
1128701|NCT02385734|Coronally advanced flap|coronally advanced flap
1128702|NCT02385695|Disc Degeneration Disease|disc degeneration disease
1128703|NCT02385695|DDD|ddd
1128704|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
1128705|NCT02385669|vaccine|vaccine
1128706|NCT02385669|peptide|peptide
1128707|NCT02385669|ipilimumab|ipilimumab
1128708|NCT02385669|Yervoy|yervoy
1128709|NCT02385669|Montanide ISA-51|montanide isa-51
1128710|NCT02385643|alcohol dependence|alcohol dependence
1128711|NCT02385643|abstinence|abstinence
1128712|NCT02385643|relapse prevention|relapse prevention
1128713|NCT02385643|mobile support system|mobile support system
1128714|NCT02385630|Longitudinal Studies|longitudinal studies
1128715|NCT02385630|Esophagectomy|esophagectomy
1128716|NCT02385630|Gastrectomy|gastrectomy
1128717|NCT02385630|Hunger|hunger
1128718|NCT02385630|Appetite|appetite
1128719|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
1128720|NCT02385630|Peptide YY|peptide yy
1128721|NCT02385630|Ghrelin|ghrelin
1128722|NCT02385630|Satiety Response|satiety response
1128723|NCT02385630|Feeding Behavior|feeding behavior
1128724|NCT02385630|Meals|meals
1128725|NCT02385630|Postprandial Period|postprandial period
1128726|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
1128727|NCT02385617|Peptide YY|peptide yy
1128728|NCT02385617|Ghrelin|ghrelin
1128729|NCT02385617|Satiety Response|satiety response
1128730|NCT02385617|Appetite|appetite
1128731|NCT02385617|Hunger|hunger
1128732|NCT02385617|Somatostatin|somatostatin
1128733|NCT02385617|Octreotide|octreotide
1128734|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
1128735|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
1128736|NCT02385617|Pharmacologic Actions|pharmacologic actions
1128737|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
1128738|NCT02385617|Endocrine System Diseases|endocrine system diseases
1128739|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
1128740|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
1128741|NCT02385604|Positron-Emission Tomography|positron-emission tomography
1128742|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
1128743|NCT02385604|Chemoradiotherapy|chemoradiotherapy
1128744|NCT02385604|Esophagectomy|esophagectomy
1128745|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
1128746|NCT02385604|Treatment Outcome|treatment outcome
1128747|NCT02385604|Survival|survival
1128748|NCT02385604|Recurrence|recurrence
1128749|NCT02385604|Disease-Free Survival|disease-free survival
1128750|NCT02385604|Progression-Free Survival|progression-free survival
1128751|NCT02385604|Prognosis|prognosis
1128752|NCT02385604|Neoplasm Grading|neoplasm grading
1128753|NCT02385604|Adenocarcinoma|adenocarcinoma
1128754|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
1128755|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
1128756|NCT02385591|physical activity|physical activity
1128757|NCT02385591|Latinos|latinos
1128758|NCT02385591|overweight|overweight
1128759|NCT02385591|SMS|sms
1128760|NCT02385591|mHealth|mhealth
1128861|NCT02385110|Dexamethasone|dexamethasone
1128761|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
1128762|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
1128763|NCT02385578|the rate of detection|the rate of detection
1128764|NCT02385552|colonoscopy|colonoscopy
1128765|NCT02385552|quality improvement|quality improvement
1128766|NCT02385552|adenoma detection rate|adenoma detection rate
1128767|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
1128768|NCT02385526|ASCEND|ascend
1128769|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
1128770|NCT02385513|Immunogenicity|immunogenicity
1128771|NCT02385487|Myocardial Infarction|myocardial infarction
1128772|NCT02385487|Inflammation|inflammation
1128773|NCT02385487|Critical Illness|critical illness
1128774|NCT02385487|Necrosis|necrosis
1128776|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
1128777|NCT02385487|Myocardial Ischemia|myocardial ischemia
1128778|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
1128779|NCT02385487|Heart Diseases|heart diseases
1128780|NCT02385487|Vascular Diseases|vascular diseases
1128781|NCT02385474|silver diamine fluoride|silver diamine fluoride
1128782|NCT02385474|randomized clinical trial|randomized clinical trial
1128783|NCT02385474|caries|caries
1128784|NCT02385474|children|children
1128785|NCT02385474|fluoride|fluoride
1128786|NCT02385448|dienogest|dienogest
1128787|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
1128788|NCT02385448|endometriosis|endometriosis
1128789|NCT02385435|caudal block|caudal block
1128790|NCT02385422|secondary prophylaxis|secondary prophylaxis
1128791|NCT02385422|Propranolol|propranolol
1128792|NCT02385422|Carvedilol|carvedilol
1128793|NCT02385422|comparative effectiveness research|comparative effectiveness research
1128794|NCT02385409|Patient Blood Management|patient blood management
1128795|NCT02385409|Preoperative anemia|preoperative anemia
1128796|NCT02385409|Hip replacement|hip replacement
1128797|NCT02385409|Knee replacement|knee replacement
1128798|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
1128799|NCT02385396|Infertility|infertility
1128800|NCT02385396|Myo-inositol|myo-inositol
1128801|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1128802|NCT02385383|Patient Blood Management|patient blood management
1128803|NCT02385383|Preoperative anemia|preoperative anemia
1128804|NCT02385383|IV Iron|iv iron
1128805|NCT02385357|Muscle function|muscle function
1128806|NCT02385357|Anaerobic power|anaerobic power
1128807|NCT02385357|Muscle damage|muscle damage
1128808|NCT02385331|Neutrophils|neutrophils
1128809|NCT02385331|necroptosis|necroptosis
1128810|NCT02385331|apoptosis|apoptosis
1128811|NCT02385305|Pressure support ventilation|pressure support ventilation
1128812|NCT02385305|respiratory drive|respiratory drive
1128813|NCT02385305|Physiology|physiology
1128815|NCT02385279|ACS|acs
1128816|NCT02385279|All comers|all comers
1128817|NCT02385279|PCI|pci
1128818|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
1128819|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
1128820|NCT02385253|Training|training
1128821|NCT02385253|Primary Health Care|primary health care
1128822|NCT02385253|Skin Cancer|skin cancer
1128823|NCT02385253|Primary Care Physicians|primary care physicians
1128824|NCT02385253|Surveillance|surveillance
1128825|NCT02385253|Education|education
1128826|NCT02385214|Malignant|malignant
1128827|NCT02385214|Melanoma|melanoma
1128828|NCT02385214|Cancer|cancer
1128829|NCT02385214|Surgery|surgery
1128830|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
1128831|NCT02385188|Vulva|vulva
1128832|NCT02385188|Genital, female|genital, female
1128833|NCT02385188|imiquimod|imiquimod
1128834|NCT02385175|Eustachian tube|eustachian tube
1128835|NCT02385175|test accuracy|test accuracy
1128836|NCT02385175|clinical test|clinical test
1128837|NCT02385175|questionnaire|questionnaire
1128838|NCT02385162|Mucolipidoses|mucolipidoses
1128839|NCT02385162|Metabolic Diseases|metabolic diseases
1128840|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
1128841|NCT02385149|resilience|resilience
1128842|NCT02385149|challenge test|challenge test
1128843|NCT02385149|whole grain wheat|whole grain wheat
1128844|NCT02385149|metabolic flexibility|metabolic flexibility
1128845|NCT02385149|cardio-metabolic|cardio-metabolic
1128846|NCT02385149|liver and adipose tissue|liver and adipose tissue
1128847|NCT02385136|NSCLC|nsclc
1128848|NCT02385136|Radiotherpy|radiotherpy
1128849|NCT02385136|Temozolomide|temozolomide
1128850|NCT02385123|ex-vivo|ex-vivo
1128851|NCT02385123|Influenza|influenza
1128852|NCT02385123|plasmablasts|plasmablasts
1128853|NCT02385110|Leukemia|leukemia
1128854|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1128855|NCT02385110|HLH|hlh
1128856|NCT02385110|Alemtuzumab|alemtuzumab
1128857|NCT02385110|CAMPATH-1H|campath-1h
1128858|NCT02385110|Campath|campath
1128859|NCT02385110|Etoposide|etoposide
1128860|NCT02385110|VePesid|vepesid
1128863|NCT02385110|Methotrexate|methotrexate
1128864|NCT02385110|Phone call|phone call
1128865|NCT02385071|Healthy|healthy
1128866|NCT02385071|Simeprevir|simeprevir
1128867|NCT02385071|Bioavailability|bioavailability
1128868|NCT02385058|Helminthiasis|helminthiasis
1128869|NCT02385058|Amoebiasis|amoebiasis
1128870|NCT02385058|Mebendazole|mebendazole
1128871|NCT02385058|Quinfamide|quinfamide
1128872|NCT02385058|Mexican population|mexican population
1128873|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1128874|NCT02385019|Graft vs host disease|graft vs host disease
1128875|NCT02385019|Regulatory T cells|regulatory t cells
1128876|NCT02385006|Thromboelastography|thromboelastography
1128877|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
1128878|NCT02384993|Alzheimer's Disease|alzheimer's disease
1128879|NCT02384993|Dementia|dementia
1128880|NCT02384993|aerobic exercise|aerobic exercise
1128881|NCT02384993|physical activity|physical activity
1128882|NCT02384993|exercise|exercise
1128883|NCT02384993|neuroimaging|neuroimaging
1128884|NCT02384980|Intermittent Claudication|intermittent claudication
1128885|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
1128886|NCT02384954|Lymphoma|lymphoma
1128887|NCT02384954|indolent B Cell|indolent b cell
1128888|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
1128889|NCT02384954|Cancer|cancer
1128890|NCT02384954|Immunotherapy|immunotherapy
1128891|NCT02384954|Relapsed|relapsed
1128892|NCT02384954|Refractory|refractory
1128893|NCT02384954|Rituximab|rituximab
1128894|NCT02384954|Interleukin-15|interleukin-15
1128895|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
1128896|NCT02384954|White Blood Cell|white blood cell
1128897|NCT02384954|Follicular Lymphoma|follicular lymphoma
1128898|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
1128899|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1128900|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1128901|NCT02384954|anti-CD20|anti-cd20
1128902|NCT02384928|Acupuncture|acupuncture
1128903|NCT02384928|Pharmacopuncture|pharmacopuncture
1128904|NCT02384928|Usual Care|usual care
1128905|NCT02384902|glycemic index|glycemic index
1128906|NCT02384902|diabetic nephropathy|diabetic nephropathy
1128907|NCT02384902|low glycemic load|low glycemic load
1128908|NCT02384902|inflammation|inflammation
1128909|NCT02384876|pediatric|pediatric
1128910|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
1128911|NCT02384876|ephedrine|ephedrine
1128912|NCT02384876|general anesthesia|general anesthesia
1128913|NCT02384863|Chest Pain|chest pain
1128914|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
1128915|NCT02384863|Cardiac|cardiac
1128916|NCT02384863|Emergency Department|emergency department
1128917|NCT02384863|Cardiac Testing|cardiac testing
1128918|NCT02384863|Healthcare Utilization|healthcare utilization
1128919|NCT02384863|Patient Centered Outcomes|patient centered outcomes
1128920|NCT02384863|Shared Decision Making|shared decision making
1128921|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
1128922|NCT02384863|Decision Aid|decision aid
1128923|NCT02384850|metastatic|metastatic
1128924|NCT02384837|national Cather Lad|national cather lad
1128925|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
1128926|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1128927|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
1128928|NCT02384759|cancer, colorectal,|cancer, colorectal,
1128929|NCT02384746|metastatic breast cancer|metastatic breast cancer
1128930|NCT02384746|ER-positive|er-positive
1128931|NCT02384746|HER2-negative|her2-negative
1128932|NCT02384746|Fulvestrant|fulvestrant
1128933|NCT02384746|MLN9708|mln9708
1128934|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
1128935|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
1128936|NCT02384694|weight|weight
1128937|NCT02384694|quality of life|quality of life
1128938|NCT02384694|depression|depression
1128939|NCT02384694|menopausal symptoms|menopausal symptoms
1128940|NCT02384694|exercise barriers|exercise barriers
1128941|NCT02384694|executive functions|executive functions
1128942|NCT02384681|Speech intelligibility|speech intelligibility
1128943|NCT02384681|Short-term memory|short-term memory
1128944|NCT02384681|Working memory|working memory
1128945|NCT02384681|Perceived mental task load|perceived mental task load
1128946|NCT02384668|Cholecalciferol|cholecalciferol
1128947|NCT02384668|Vitamin D3|vitamin d3
1128948|NCT02384668|Arterial stiffness|arterial stiffness
1128949|NCT02384668|Quality of Life|quality of life
1128950|NCT02384668|Bone density and geometry|bone density and geometry
1128951|NCT02384668|Muscle strength and balance|muscle strength and balance
1128952|NCT02384655|Preterms|preterms
1128953|NCT02384655|Breastfeeding|breastfeeding
1128954|NCT02384655|Lactation|lactation
1128955|NCT02384655|Macronutrients|macronutrients
1128956|NCT02384642|Adolescent Health|adolescent health
1128957|NCT02384642|Democratic Republic of Congo|democratic republic of congo
1128958|NCT02384642|Sexual Violence|sexual violence
1128959|NCT02384616|Lung Volume Measurements|lung volume measurements
1130481|NCT02376283|NSTEMI|nstemi
1128960|NCT02384616|airway resistance|airway resistance
1128961|NCT02384616|general anesthesia|general anesthesia
1128962|NCT02384564|Laryngoscopy|laryngoscopy
1128963|NCT02384564|Video Laryngoscopy|video laryngoscopy
1128964|NCT02384564|Tracheal intubation|tracheal intubation
1128965|NCT02384551|GERD|gerd
1128966|NCT02384551|diet|diet
1128967|NCT02384551|carbohydrate|carbohydrate
1128968|NCT02384551|obesity|obesity
1128969|NCT02384538|Osteoarthritis|osteoarthritis
1128970|NCT02384538|Joint diseases|joint diseases
1128971|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
1128972|NCT02384538|Rheumatic diseases|rheumatic diseases
1128973|NCT02384538|Arthritis|arthritis
1128974|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
1128975|NCT02384525|Septic AKI|septic aki
1128976|NCT02384525|CRRT|crrt
1128977|NCT02384525|BIA|bia
1128978|NCT02384512|Parkinson's disease|parkinson's disease
1128979|NCT02384512|akinesia|akinesia
1128982|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
1128983|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
1128984|NCT02384512|Quality of life|quality of life
1128985|NCT02384512|Daily practice|daily practice
1128986|NCT02384460|Simplex|simplex
1128987|NCT02384460|Recessive Dystrophic|recessive dystrophic
1128988|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
1128989|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
1128990|NCT02384447|above knee amputation|above knee amputation
1128991|NCT02384447|sciatic nerve|sciatic nerve
1128992|NCT02384447|ultrasonography|ultrasonography
1128993|NCT02384447|histology|histology
1128994|NCT02384408|menopause|menopause
1128995|NCT02384408|drospirenone|drospirenone
1128996|NCT02384408|tibolone|tibolone
1128997|NCT02384408|Bcl-2|bcl-2
1128998|NCT02384408|steroid receptors|steroid receptors
1128999|NCT02384395|Dolutegravir|dolutegravir
1129000|NCT02384395|Abacavir|abacavir
1129001|NCT02384395|Lamivudine|lamivudine
1129002|NCT02384395|acute HIV infection|acute hiv infection
1129003|NCT02384395|human leukocyte antigen|human leukocyte antigen
1129004|NCT02384395|latent HIV reservoir|latent hiv reservoir
1129005|NCT02384395|integrase-based regimen|integrase-based regimen
1129006|NCT02384395|viremia|viremia
1129007|NCT02384395|antiretroviral therapy|antiretroviral therapy
1129008|NCT02384395|fixed dose combination|fixed dose combination
1129009|NCT02384382|Cancer of the Prostate|cancer of the prostate
1129010|NCT02384356|Non-communicable diseases|non-communicable diseases
1129011|NCT02384356|Chronic disease|chronic disease
1129012|NCT02384356|Mobile health|mobile health
1129013|NCT02384356|Diabetes Mellitus|diabetes mellitus
1129014|NCT02384356|Hypertension|hypertension
1129015|NCT02384356|Bolivia|bolivia
1129016|NCT02384356|Longitudinal survey|longitudinal survey
1129017|NCT02384356|Health indicators|health indicators
1129018|NCT02384356|Primary care|primary care
1129019|NCT02384356|Ambulatory care|ambulatory care
1129020|NCT02384343|Dexmedetomidine|dexmedetomidine
1129021|NCT02384343|Cesarean section|cesarean section
1129022|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
1129023|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
1129024|NCT02384304|randomized controlled trial|randomized controlled trial
1129025|NCT02384304|alcohol|alcohol
1129026|NCT02384304|internet|internet
1129027|NCT02384304|internet based therapy|internet based therapy
1129028|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
1129029|NCT02384278|alcohol use disorder|alcohol use disorder
1129030|NCT02384278|internet|internet
1129031|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
1129032|NCT02384278|relapse prevention|relapse prevention
1129033|NCT02384265|Diabetes|diabetes
1129034|NCT02384265|Disparities|disparities
1129035|NCT02384265|Behavioral|behavioral
1129036|NCT02384265|Text messaging|text messaging
1129037|NCT02384265|Social networks|social networks
1129038|NCT02384265|African American|african american
1129039|NCT02384265|Female|female
1129040|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
1129041|NCT02384252|mitochondria|mitochondria
1129042|NCT02384252|contractile dysfunction|contractile dysfunction
1129043|NCT02384226|mobile application|mobile application
1129044|NCT02384226|postpartum|postpartum
1129045|NCT02384226|weight loss|weight loss
1129046|NCT02384187|Gabapentin|gabapentin
1129047|NCT02384187|PONV|ponv
1129048|NCT02384187|Adenotonsillectomy|adenotonsillectomy
1129049|NCT02384187|Pediatrics|pediatrics
1129050|NCT02384174|Aging|aging
1129051|NCT02384174|Resistant starch|resistant starch
1129052|NCT02384174|Dietary fibre|dietary fibre
1129053|NCT02384174|Immune system|immune system
1129054|NCT02384174|Bacteria|bacteria
1129055|NCT02384174|older subjects|older subjects
1129056|NCT02384122|Angiodysplasias|angiodysplasias
1129057|NCT02384122|Sandostatin LAR|sandostatin lar
1129058|NCT02384122|Gastrointestinal|gastrointestinal
1129059|NCT02384122|Somatostatin|somatostatin
1129060|NCT02384122|Octreotide|octreotide
1129061|NCT02384096|stimulation|stimulation
1129062|NCT02384096|implantable|implantable
1129063|NCT02384096|pulse generator|pulse generator
1129064|NCT02384096|back pain|back pain
1129072|NCT02383979|Phantom limb pain|phantom limb pain
1129073|NCT02383979|Mirror therapy|mirror therapy
1129074|NCT02383979|Elective amputation|elective amputation
1129075|NCT02383979|Residual limb pain|residual limb pain
1129076|NCT02383979|Functional MRI|functional mri
1129077|NCT02383953|twins|twins
1129078|NCT02383953|IBD|ibd
1129079|NCT02383953|UC|uc
1129080|NCT02383953|CD|cd
1129081|NCT02383875|nutrition economics|nutrition economics
1129082|NCT02383875|food expenditure|food expenditure
1129083|NCT02383875|nutritional quality|nutritional quality
1129084|NCT02383875|low income|low income
1129085|NCT02383862|Sleep|sleep
1129086|NCT02383862|Pain|pain
1129087|NCT02383862|Anxiety|anxiety
1129088|NCT02383862|Depression|depression
1129089|NCT02383862|Fatigue|fatigue
1129090|NCT02383862|PROMIS|promis
1129091|NCT02383862|primary care|primary care
1129092|NCT02383836|Patent Foramen Ovale|patent foramen ovale
1129093|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
1129094|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
1129095|NCT02383771|Ticagrelor|ticagrelor
1129096|NCT02383771|Aspirin|aspirin
1129097|NCT02383771|Peri-operative treatment|peri-operative treatment
1129098|NCT02383758|Behavioral Symptoms|behavioral symptoms
1129099|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
1129100|NCT02383758|Bowel Incontinence|bowel incontinence
1129101|NCT02383758|Constipation|constipation
1129102|NCT02383745|Acute EEG|acute eeg
1129103|NCT02383745|status epilepticus|status epilepticus
1129104|NCT02383745|seizure|seizure
1129105|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
1129106|NCT02383706|Pregnancy|pregnancy
1129107|NCT02383706|Obesity, Morbid|obesity, morbid
1129108|NCT02383706|Complications, pregnancy|complications, pregnancy
1129109|NCT02383693|depression|depression
1129110|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1129111|NCT02383693|tolerability|tolerability
1129112|NCT02383693|efficiency|efficiency
1129113|NCT02383693|TMS|tms
1129114|NCT02383693|refractory|refractory
1129115|NCT02383680|Methotrexate therapy|methotrexate therapy
1129116|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1129117|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
1129118|NCT02383641|Lipid Metabolism|lipid metabolism
1129119|NCT02383641|Inborn Errors|inborn errors
1129120|NCT02383641|Cholesterol Ester Storage Disease|cholesterol ester storage disease
1129121|NCT02383628|ICG Dye|icg dye
1129122|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
1129123|NCT02383628|tissue perfusion|tissue perfusion
1129124|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
1129125|NCT02383550|Multiple Sclerosis|multiple sclerosis
1129126|NCT02383550|Cognition|cognition
1129127|NCT02383498|Overall Response Rate|overall response rate
1129128|NCT02383498|Immune Activation|immune activation
1129129|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1129130|NCT02383498|T Cell Response|t cell response
1129131|NCT02383498|Cross-Over|cross-over
1129132|NCT02383485|arterial stiffness|arterial stiffness
1129140|NCT02383446|Echeclon|echeclon
1129141|NCT02383446|Elan|elan
1129142|NCT02383446|TTA|tta
1129143|NCT02383446|Transtibial Amputee|transtibial amputee
1129144|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
1129145|NCT02383368|Pharmacokinetics|pharmacokinetics
1129146|NCT02383368|ASP4132|asp4132
1129147|NCT02383368|Lymphoma|lymphoma
1129148|NCT02383368|Refractory Solid Tumors|refractory solid tumors
1129149|NCT02383355|Persistent immune activation|persistent immune activation
1129150|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
1129151|NCT02383342|Pain Processing|pain processing
1129152|NCT02383342|Genetic Factors|genetic factors
1129153|NCT02383342|Biomarkers|biomarkers
1129154|NCT02383329|malnutrition|malnutrition
1129155|NCT02383329|Underweight|underweight
1129156|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
1129157|NCT02383329|Children|children
1129158|NCT02383316|Insulin sensitivity|insulin sensitivity
1129159|NCT02383316|Metabolism|metabolism
1129160|NCT02383316|Noonan syndrome|noonan syndrome
1129161|NCT02383316|Shp2|shp2
1129162|NCT02383303|savings|savings
1129163|NCT02383303|assets|assets
1129164|NCT02383303|material hardship|material hardship
1129165|NCT02383303|poverty|poverty
1130482|NCT02376283|PPCI|ppci
1129166|NCT02383303|Individual Development Account|individual development account
1129167|NCT02383264|feeding intolerance|feeding intolerance
1129168|NCT02383264|preterm infants|preterm infants
1129169|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
1129170|NCT02383238|Dapagliflozin|dapagliflozin
1129171|NCT02383238|diabetes mellitus|diabetes mellitus
1129172|NCT02383238|vascular|vascular
1129173|NCT02383225|American Indian|american indian
1129174|NCT02383225|Adolescent|adolescent
1129175|NCT02383225|Prevention|prevention
1129176|NCT02383212|Advanced cancerous growth|advanced cancerous growth
1129177|NCT02383173|end of life|end of life
1129178|NCT02383173|palliative care|palliative care
1129179|NCT02383173|implementation|implementation
1129180|NCT02383160|low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
1129181|NCT02383160|nonunion|nonunion
1129182|NCT02383160|scaphoid|scaphoid
1129183|NCT02383147|Adult|adult
1129184|NCT02383147|Aged|aged
1129185|NCT02383147|Alpha Rhythm|alpha rhythm
1129186|NCT02383147|Auditory Cortex|auditory cortex
1129187|NCT02383147|Chronic|chronic
1129188|NCT02383147|Electroencephalography|electroencephalography
1129189|NCT02383147|Female|female
1129190|NCT02383147|Humans|humans
1129191|NCT02383147|Male|male
1129192|NCT02383147|Neurofeedback|neurofeedback
1129193|NCT02383147|Prospective Studies|prospective studies
1129194|NCT02383147|Questionnaires|questionnaires
1129195|NCT02383147|Tinnitus|tinnitus
1129196|NCT02383147|Treatment Outcome|treatment outcome
1129197|NCT02383095|Schizophrenia|schizophrenia
1129198|NCT02383095|Art-therapy|art-therapy
1129199|NCT02383095|Visual organization|visual organization
1129200|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
1129201|NCT02383069|Asthma|asthma
1129202|NCT02383069|Children|children
1129203|NCT02383069|Teenager|teenager
1129204|NCT02383069|Physical capacity|physical capacity
1129205|NCT02383056|wound|wound
1129206|NCT02383056|secondary intention healing|secondary intention healing
1129207|NCT02383056|lower extremity|lower extremity
1129208|NCT02383030|Breast cancer|breast cancer
1129209|NCT02383030|Metastatic|metastatic
1129210|NCT02383030|HER2 negative|her2 negative
1129211|NCT02383030|postmenopausal|postmenopausal
1129212|NCT02383030|maintenance therapy|maintenance therapy
1129213|NCT02383030|fulvestrant|fulvestrant
1129214|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
1129215|NCT02383004|myringotomy tubes|myringotomy tubes
1129216|NCT02383004|acupuncture|acupuncture
1129217|NCT02383004|emergence delirium|emergence delirium
1129218|NCT02383004|pediatrics|pediatrics
1129219|NCT02383004|general anesthesia|general anesthesia
1129220|NCT02382991|Moderately active amputees|moderately active amputees
1129221|NCT02382991|C-leg Compact|c-leg compact
1129222|NCT02382991|Knee prosthesis|knee prosthesis
1129224|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
1129225|NCT02382991|Amputation|amputation
1129226|NCT02382991|3C60|3c60
1129227|NCT02382991|TGUG|tgug
1129228|NCT02382991|LCI|lci
1129229|NCT02382991|QUEST|quest
1129230|NCT02382991|SF-36|sf-36
1129231|NCT02382952|Abdominal surgery|abdominal surgery
1129232|NCT02382952|Pelvic surgery|pelvic surgery
1129233|NCT02382952|Stoma takedown|stoma takedown
1129234|NCT02382952|Bowel resection|bowel resection
1129235|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
1129236|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
1129237|NCT02382926|Eulerian Magnification Method|eulerian magnification method
1129238|NCT02382900|quadrivalent|quadrivalent
1129239|NCT02382900|vaccine|vaccine
1129240|NCT02382887|intubation|intubation
1129241|NCT02382887|difficult airway|difficult airway
1129242|NCT02382887|fiberscopy|fiberscopy
1129243|NCT02382887|Airtraq|airtraq
1129244|NCT02382887|general anesthesia|general anesthesia
1129245|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
1129246|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
1129247|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1129248|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1129249|NCT02382861|Weaning|weaning
1129250|NCT02382861|Mechanical ventilation|mechanical ventilation
1129251|NCT02382861|Extubation|extubation
1129252|NCT02382848|Eating Disorders|eating disorders
1129253|NCT02382848|Bulimia Nervosa|bulimia nervosa
1129254|NCT02382848|Nightmares|nightmares
1129255|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
1129256|NCT02382835|metal-on-metal|metal-on-metal
1129257|NCT02382809|Alveolar osteitis|alveolar osteitis
1129258|NCT02382809|Third molar|third molar
1129259|NCT02382809|Dry socket|dry socket
1129260|NCT02382809|Mouthwash|mouthwash
1129261|NCT02382809|third molar extraction|third molar extraction
1129262|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
1129263|NCT02382783|Disease Activity|disease activity
1129264|NCT02382783|Flare|flare
1129265|NCT02382783|Management of Flares|management of flares
1129266|NCT02382783|Pfizer|pfizer
1129267|NCT02382744|Saphenous Nerve|saphenous nerve
1129268|NCT02382744|Nerve Block|nerve block
1129269|NCT02382744|Ultrasound guided|ultrasound guided
1129270|NCT02382744|Neurostimulation|neurostimulation
1129271|NCT02382744|Regional Anesthesia|regional anesthesia
1129272|NCT02382744|Ropivacaine|ropivacaine
1129273|NCT02382744|Foot Surgery|foot surgery
1129274|NCT02382744|Nerve Stimulation|nerve stimulation
1129275|NCT02382744|Ankle Surgery|ankle surgery
1129276|NCT02382718|fish allergy|fish allergy
1129277|NCT02382718|parvalbumin|parvalbumin
1129278|NCT02382718|immunotherapy|immunotherapy
1129279|NCT02382718|mCyp c 1|mcyp c 1
1129280|NCT02382705|capsule endoscopy|capsule endoscopy
1129281|NCT02382705|battery life|battery life
1129282|NCT02382705|completion rate|completion rate
1129283|NCT02382705|diagnostic yield|diagnostic yield
1129284|NCT02382640|Drug therapy|drug therapy
1129285|NCT02382614|Endobronchial Valve|endobronchial valve
1129286|NCT02382614|Minimally Invasive|minimally invasive
1129287|NCT02382614|Intrabronchial Valves|intrabronchial valves
1129288|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
1129289|NCT02382614|Spiration Valve System|spiration valve system
1129290|NCT02382614|Prolonged Air Leak|prolonged air leak
1129291|NCT02382614|Persistent Air Leak|persistent air leak
1129292|NCT02382601|Pregnancy|pregnancy
1129293|NCT02382601|IUGR|iugr
1129294|NCT02382601|Small for gestational age|small for gestational age
1129295|NCT02382562|Depression|depression
1129296|NCT02382562|Asthma|asthma
1129297|NCT02382562|Urticaria|urticaria
1129298|NCT02382549|vaccine|vaccine
1129299|NCT02382549|peptide|peptide
1129300|NCT02382549|dabrafenib|dabrafenib
1129301|NCT02382549|trametinib|trametinib
1129302|NCT02382549|Montanide ISA-51|montanide isa-51
1129303|NCT02382549|MEKINIST|mekinist
1129304|NCT02382549|Tafinlar|tafinlar
1129305|NCT02382536|Diabetes|diabetes
1129306|NCT02382536|Insulin therapy|insulin therapy
1129307|NCT02382536|insulin pump|insulin pump
1129308|NCT02382536|Infusion sets|infusion sets
1129309|NCT02382523|acthar|acthar
1129310|NCT02382523|proteinuria|proteinuria
1129311|NCT02382523|IgA nephropathy|iga nephropathy
1129312|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
1129313|NCT02382471|atherosclerotic|atherosclerotic
1129314|NCT02382471|BDNF|bdnf
1129315|NCT02382471|Follistatin|follistatin
1129316|NCT02382471|Irisin|irisin
1129317|NCT02382432|Anesthesia|anesthesia
1129318|NCT02382432|dexmedetomidine|dexmedetomidine
1129319|NCT02382432|pethidine|pethidine
1129320|NCT02382432|shivering|shivering
1129321|NCT02382432|spinal|spinal
1129322|NCT02382406|MK-3475|mk-3475
1129323|NCT02382406|Pembrolizumab|pembrolizumab
1129324|NCT02382406|Carboplatin|carboplatin
1129325|NCT02382406|Nab-paclitaxel|nab-paclitaxel
1129326|NCT02382393|cognitive assessment|cognitive assessment
1129327|NCT02382393|Brain Performance Test|brain performance test
1129328|NCT02382393|Lumosity|lumosity
1129329|NCT02382393|concurrent validity|concurrent validity
1129330|NCT02382393|computerized assessment|computerized assessment
1129331|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
1129332|NCT02382380|Contrast Agent|contrast agent
1129333|NCT02382380|Gadoterate|gadoterate
1129334|NCT02382341|ACL|acl
1129335|NCT02382341|BIOSURE|biosure
1129336|NCT02382341|HEALICOIL|healicoil
1129337|NCT02382341|PEEK|peek
1129338|NCT02382341|In-Growth|in-growth
1129339|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
1129340|NCT02382315|psychosocial intervention|psychosocial intervention
1129341|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
1129342|NCT02382302|U-health|u-health
1129343|NCT02382302|chronic wound management|chronic wound management
1129344|NCT02382289|Radiofrequency|radiofrequency
1129345|NCT02382289|monopolar|monopolar
1129346|NCT02382289|bipolar|bipolar
1129347|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
1129348|NCT02382289|three different modalities|three different modalities
1129349|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
1129350|NCT02382263|Fragile|fragile
1129351|NCT02382263|Nab-paclitaxel|nab-paclitaxel
1129352|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
1129353|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
1129354|NCT02382224|anxiety|anxiety
1129355|NCT02382224|worry exposure|worry exposure
1129356|NCT02382224|treatment|treatment
1129357|NCT02382211|CMV|cmv
1129358|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
1129359|NCT02382185|Cardiac output|cardiac output
1129360|NCT02382120|carbon dioxide|carbon dioxide
1129361|NCT02382120|cardiac output|cardiac output
1129362|NCT02382120|ventilation|ventilation
1129363|NCT02382120|thermodilution|thermodilution
1129364|NCT02382107|TB|tb
1129365|NCT02382107|Tuberculosis|tuberculosis
1129366|NCT02382107|Diagnostic study|diagnostic study
1129367|NCT02382094|curative intention|curative intention
1129368|NCT02382094|radiation Therapy|radiation therapy
1129369|NCT02382094|health related quality of life|health related quality of life
1129370|NCT02382055|Eating Disorders|eating disorders
1129371|NCT02382055|Psychotherapy|psychotherapy
1129372|NCT02382055|Anorexia Nervosa|anorexia nervosa
1129373|NCT02382055|Treatment|treatment
1129374|NCT02382042|Rural Health|rural health
1129375|NCT02382042|Veterans|veterans
1129376|NCT02382042|Substance Abuse|substance abuse
1129377|NCT02382003|Anxiety|anxiety
1129378|NCT02382003|Cognitive bias|cognitive bias
1129379|NCT02382003|Telemedicine|telemedicine
1129380|NCT02381990|Prostate|prostate
1129381|NCT02381990|PSA|psa
1129382|NCT02381990|FUSION|fusion
1129383|NCT02381990|Ultrasound|ultrasound
1129384|NCT02381990|MRI|mri
1129385|NCT02381990|Cancer|cancer
1129386|NCT02381990|Cryotherapy|cryotherapy
1129387|NCT02381990|Outcomes|outcomes
1129388|NCT02381990|Recurrence|recurrence
1129389|NCT02381990|QOL, Quality of Life|qol, quality of life
1129390|NCT02381990|Urinary function|urinary function
1129391|NCT02381990|Sexual Function|sexual function
1129392|NCT02381964|cerebral blood flow|cerebral blood flow
1129393|NCT02381964|cognitive function|cognitive function
1129394|NCT02381964|vitamins|vitamins
1129395|NCT02381964|energy expenditure|energy expenditure
1129396|NCT02381964|NIRS|nirs
1129397|NCT02381964|Indirect calorimetry|indirect calorimetry
1129398|NCT02381938|inactivity|inactivity
1129399|NCT02381938|behavior change|behavior change
1129400|NCT02381938|worksite wellness|worksite wellness
1129401|NCT02381938|child care|child care
1129402|NCT02381925|CT|ct
1129403|NCT02381925|Scintigraphy|scintigraphy
1129404|NCT02381925|Ultrasound|ultrasound
1129405|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1129406|NCT02381899|bendamustine|bendamustine
1129408|NCT02381886|IDHR132 mutations|idhr132 mutations
1129409|NCT02381886|IDH305|idh305
1129410|NCT02381886|IDH|idh
1129411|NCT02381886|IDH1|idh1
1129412|NCT02381886|AML|aml
1129413|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
1129414|NCT02381886|Leukemia|leukemia
1129415|NCT02381886|Myeloid|myeloid
1129416|NCT02381886|Acute|acute
1129417|NCT02381886|MDS|mds
1129418|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
1129419|NCT02381886|Glioma|glioma
1129420|NCT02381886|Oligodendroglioma|oligodendroglioma
1129421|NCT02381886|Astrocytoma|astrocytoma
1129422|NCT02381886|Glioblastoma|glioblastoma
1129423|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
1129424|NCT02381886|Solid Tumors|solid tumors
1129425|NCT02381873|Arthroplasty|arthroplasty
1129426|NCT02381873|Replacement|replacement
1129427|NCT02381873|Knee|knee
1129428|NCT02381873|Osteoarthritis|osteoarthritis
1129429|NCT02381847|gastric cancer|gastric cancer
1129430|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
1129431|NCT02381834|Urine Specimen Collection|urine specimen collection
1129432|NCT02381834|Infant|infant
1129433|NCT02381834|Neonate|neonate
1129434|NCT02381834|Bacterial Infection|bacterial infection
1129435|NCT02381821|junctional zone|junctional zone
1129436|NCT02381821|Implantation|implantation
1129437|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1129438|NCT02381717|ultrasound|ultrasound
1129439|NCT02381717|bupivacaine|bupivacaine
1129440|NCT02381717|femoral nerve block|femoral nerve block
1129441|NCT02381717|pain reduction|pain reduction
1129442|NCT02381678|Heart Valve Replacement|heart valve replacement
1129443|NCT02381678|Perimount 2900|perimount 2900
1129444|NCT02381678|China|china
1129445|NCT02381678|Perimount 6900P|perimount 6900p
1129446|NCT02381626|HEPA filter|hepa filter
1129447|NCT02381626|14-247|14-247
1129448|NCT02381613|Fish|fish
1129449|NCT02381613|Herring|herring
1129450|NCT02381613|Meat|meat
1129451|NCT02381613|Beef|beef
1129452|NCT02381600|vitamin D|vitamin d
1129453|NCT02381600|aging|aging
1129454|NCT02381600|cognitive function|cognitive function
1129455|NCT02381600|depression|depression
1129456|NCT02381600|executive function|executive function
1129457|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
1129458|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
1129459|NCT02381509|inferior vena cava filters|inferior vena cava filters
1129460|NCT02381496|ACT-453859|act-453859
1129461|NCT02381496|ACT-463036|act-463036
1129462|NCT02381496|Setipiprant|setipiprant
1129463|NCT02381496|Tolerability|tolerability
1129464|NCT02381496|safety|safety
1129465|NCT02381496|pharmacodynamics|pharmacodynamics
1129466|NCT02381496|pharmacokinetics|pharmacokinetics
1129467|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
1129468|NCT02381457|Aneuploidy|aneuploidy
1129470|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
1129471|NCT02381457|DiGeorge Syndrome|digeorge syndrome
1129472|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
1129473|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
1129474|NCT02381444|Observational Study|observational study
1129475|NCT02381444|Quality of life|quality of life
1129476|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
1129477|NCT02381431|imaging|imaging
1129478|NCT02381431|diagnostic|diagnostic
1129479|NCT02381431|pediatrics|pediatrics
1129480|NCT02381418|Influenza|influenza
1129482|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
1129483|NCT02381392|emergency medicine|emergency medicine
1129484|NCT02381392|infrared|infrared
1129485|NCT02381392|intravenous|intravenous
1129486|NCT02381379|CML|cml
1129487|NCT02381379|peginterferon|peginterferon
1129488|NCT02381379|stop|stop
1129489|NCT02381379|BCR-ABL|bcr-abl
1129490|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
1129491|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
1129492|NCT02381366|Premature Infants|premature infants
1129493|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1129494|NCT02381366|Chronic Lung Disease|chronic lung disease
1129495|NCT02381366|Cell Therapy|cell therapy
1129496|NCT02381353|Enucleation|enucleation
1129497|NCT02381353|Evisceration|evisceration
1129498|NCT02381353|Exparel|exparel
1129499|NCT02381353|bupivacaine|bupivacaine
1129500|NCT02381340|Obesity|obesity
1129501|NCT02381340|Bariatric surgery|bariatric surgery
1129502|NCT02381340|Gastric plication|gastric plication
1129503|NCT02381340|Minimal invasive surgery|minimal invasive surgery
1129504|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
1129505|NCT02381340|food-reward|food-reward
1129506|NCT02381340|satiety|satiety
1129507|NCT02381340|microbiota|microbiota
1129508|NCT02381327|Speed of eating|speed of eating
1129509|NCT02381327|body weight|body weight
1129510|NCT02381327|food intake|food intake
1129511|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
1129512|NCT02381301|Biological Markers|biological markers
1129513|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
1129514|NCT02381288|Drug therapy|drug therapy
1129515|NCT02381262|Fitbit|fitbit
1129516|NCT02381249|Esophagectomy|esophagectomy
1129517|NCT02381249|Gastrectomy|gastrectomy
1129518|NCT02381249|Octreotide|octreotide
1129519|NCT02381249|Somatostatin|somatostatin
1129520|NCT02381249|Appetite|appetite
1129521|NCT02381249|Hunger|hunger
1129522|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
1129523|NCT02381249|Peptide YY|peptide yy
1129524|NCT02381249|Reinforcement|reinforcement
1129525|NCT02381249|Reward|reward
1129526|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
1129527|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
1129528|NCT02381249|Nutritional Status|nutritional status
1129529|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
1129530|NCT02381249|Whipple Procedure|whipple procedure
1129531|NCT02381210|Congo Red Dot Test|congo red dot test
1129532|NCT02381197|Congo Red Dot Test|congo red dot test
1129533|NCT02381171|myofacial pain|myofacial pain
1129534|NCT02381171|neuromodulation|neuromodulation
1129535|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1129536|NCT02381171|electroacupuncture|electroacupuncture
1129537|NCT02381158|Wheezing|wheezing
1129538|NCT02381158|Children|children
1129539|NCT02381145|Polyphenols|polyphenols
1129540|NCT02381145|Resveratrol|resveratrol
1129541|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
1129542|NCT02381145|Insulin sensitivity|insulin sensitivity
1129543|NCT02381145|mitochondrial function|mitochondrial function
1129544|NCT02381145|lipid oxidation|lipid oxidation
1129545|NCT02381145|tissue lipolysis|tissue lipolysis
1129546|NCT02381119|dietary services|dietary services
1129547|NCT02381119|personalized advice|personalized advice
1129548|NCT02381119|biological markers|biological markers
1129549|NCT02381106|arterial contractility|arterial contractility
1129550|NCT02381106|Uterine contractility|uterine contractility
1129551|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1129552|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1129553|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1129554|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
1129555|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
1129556|NCT02381080|Follicular Lymphoma|follicular lymphoma
1129557|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1129558|NCT02381080|Ibrutinib|ibrutinib
1129559|NCT02381080|IMBRUVICA|imbruvica
1129560|NCT02381080|PCI-32765|pci-32765
1129561|NCT02381080|JNJ-54179060|jnj-54179060
1129562|NCT02381067|Cervical Fusion|cervical fusion
1129563|NCT02381067|NuCel|nucel
1129564|NCT02381067|Amniotic Allograft|amniotic allograft
1129565|NCT02381067|Prospective|prospective
1129566|NCT02381054|Patient reported outcomes|patient reported outcomes
1129567|NCT02381041|Rhinoplasty|rhinoplasty
1129568|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
1129569|NCT02381041|Cocaine|cocaine
1129570|NCT02381041|Adrenaline|adrenaline
1129571|NCT02381028|Atopic eczema|atopic eczema
1129572|NCT02381028|Human milk|human milk
1129573|NCT02381028|Topical treatment|topical treatment
1129574|NCT02381028|Children|children
1129575|NCT02381015|Genetic testing|genetic testing
1129576|NCT02381015|Genomic testing|genomic testing
1129577|NCT02381015|Chemoprevention|chemoprevention
1129578|NCT02381015|Prostate Specific Antigen|prostate specific antigen
1129579|NCT02381015|Prostate Cancer|prostate cancer
1129580|NCT02381015|Predictive Genetic Testing|predictive genetic testing
1129581|NCT02381015|Genetic Counseling|genetic counseling
1129582|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
1129583|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
1129584|NCT02380989|Ayurveda|ayurveda
1129585|NCT02380989|Acute pain|acute pain
1129586|NCT02380989|Sports Injury|sports injury
1129588|NCT02380963|Obesity|obesity
1129589|NCT02380963|Weight Loss|weight loss
1129590|NCT02380963|Muscle|muscle
1129591|NCT02380963|Cardiovascular Disease|cardiovascular disease
1129592|NCT02380963|Colorado Diet|colorado diet
1129593|NCT02380937|real-time MRI|real-time mri
1129594|NCT02380937|electrophysiology study|electrophysiology study
1129595|NCT02380937|atrial flutter|atrial flutter
1129596|NCT02380937|ablation|ablation
1129597|NCT02380937|active tracking|active tracking
1129598|NCT02380924|subjects|subjects
1129599|NCT02380911|Dyslipidemia|dyslipidemia
1129600|NCT02380911|Global cardiovascular risk|global cardiovascular risk
1129601|NCT02380911|Statins|statins
1129602|NCT02380911|Educational interventions|educational interventions
1129603|NCT02380885|severe mental illness|severe mental illness
1129604|NCT02380885|social cognition|social cognition
1129605|NCT02380885|intervention|intervention
1129606|NCT02380872|Gingival recession|gingival recession
1129607|NCT02380872|fibrin|fibrin
1129608|NCT02380872|connective tissue|connective tissue
1129609|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
1129610|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
1129611|NCT02380872|cytokine|cytokine
1129612|NCT02380859|problems of gait and balance|problems of gait and balance
1129613|NCT02380820|Mattress|mattress
1129614|NCT02380820|Preventing bed sores|preventing bed sores
1129615|NCT02380820|Skin pressure|skin pressure
1129616|NCT02380807|Paraspinal Muscles|paraspinal muscles
1129617|NCT02380807|Trigger Points|trigger points
1129618|NCT02380807|Randomized Controlled Trial|randomized controlled trial
1129619|NCT02380807|Mobility Limitation|mobility limitation
1129620|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
1129621|NCT02380768|Supraglottic airway|supraglottic airway
1129622|NCT02380768|Laryngeal mask airway|laryngeal mask airway
1129623|NCT02380768|Children|children
1129624|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
1129625|NCT02380755|Clomiphene citrate|clomiphene citrate
1129626|NCT02380755|sICAM-1|sicam-1
1129627|NCT02380755|sVCAM-1|svcam-1
1129628|NCT02380755|sE- Selectin|se- selectin
1129629|NCT02380755|Endothelial function|endothelial function
1129630|NCT02380755|Cardiovascular risk|cardiovascular risk
1129631|NCT02380755|Endocrine System Diseases|endocrine system diseases
1129632|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
1129633|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
1129634|NCT02380755|Infertility, Male|infertility, male
1129635|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
1129636|NCT02380755|Obesity|obesity
1129637|NCT02380755|Testosterone|testosterone
1129638|NCT02380742|Pessary|pessary
1129639|NCT02380742|Pain|pain
1129640|NCT02380742|EMLA|emla
1129641|NCT02380742|lidocaine|lidocaine
1129642|NCT02380742|prilocaine|prilocaine
1129643|NCT02380729|Health care delivery|health care delivery
1129644|NCT02380729|Human Phenotype Ontology|human phenotype ontology
1129645|NCT02380729|Mutation prioritization|mutation prioritization
1129646|NCT02380729|Next Generation Sequencing|next generation sequencing
1129647|NCT02380729|Mutation detection|mutation detection
1129648|NCT02380729|Bioinformatic analysis|bioinformatic analysis
1129649|NCT02380729|Quality of life|quality of life
1129650|NCT02380703|aggression|aggression
1129651|NCT02380703|dementia|dementia
1129652|NCT02380703|Alzheimer's disease|alzheimer's disease
1129653|NCT02380703|pain|pain
1129654|NCT02380703|depression|depression
1129655|NCT02380703|caregiver|caregiver
1129656|NCT02380703|behavioral health|behavioral health
1129657|NCT02380703|counseling|counseling
1129658|NCT02380690|self-management|self-management
1129659|NCT02380690|peer support|peer support
1129660|NCT02380690|social support|social support
1129661|NCT02380664|swimmers|swimmers
1129662|NCT02380664|adolescent swimmers|adolescent swimmers
1129663|NCT02380664|whole-body vibration|whole-body vibration
1129664|NCT02380664|bone and bones|bone and bones
1129665|NCT02380664|body composition|body composition
1129666|NCT02380625|Ebola|ebola
1129667|NCT02380625|EVD|evd
1129668|NCT02380625|Adaptive design|adaptive design
1129669|NCT02380625|therapeutics|therapeutics
1129670|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
1129671|NCT02380599|Spinal Manipulation|spinal manipulation
1129672|NCT02380599|Mobilization|mobilization
1129673|NCT02380599|Autonomic Nervous System|autonomic nervous system
1129674|NCT02380573|methylene blue|methylene blue
1129675|NCT02380573|fMRI|fmri
1129676|NCT02380560|myometrial thickness|myometrial thickness
1129677|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
1129678|NCT02380560|Preterm Labour|preterm labour
1129679|NCT02380547|Sonography|sonography
1129680|NCT02380547|Diaphragmatic function|diaphragmatic function
1129681|NCT02380547|Non invasive ventilation|non invasive ventilation
1130682|NCT02374866|Obesity|obesity
1129682|NCT02380547|Critical care patients|critical care patients
1129683|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
1129684|NCT02380534|High level of Lp(a)|high level of lp(a)
1129685|NCT02380521|Exenatide once weekly|exenatide once weekly
1129686|NCT02380521|T2DM|t2dm
1129687|NCT02380521|IMT|imt
1129688|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
1129689|NCT02380508|BCG study|bcg study
1129690|NCT02380495|Adolescents|adolescents
1129691|NCT02380495|Respiratory Pathology|respiratory pathology
1129692|NCT02380482|Traumatic brain injury|traumatic brain injury
1129693|NCT02380482|Myocardial dysfunction|myocardial dysfunction
1129694|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
1129695|NCT02380482|Speckle tracking|speckle tracking
1129696|NCT02380469|Caregivers|caregivers
1129697|NCT02380469|Cancer|cancer
1129698|NCT02380469|Information|information
1129699|NCT02380469|Intervention|intervention
1129700|NCT02380469|Randomised trial|randomised trial
1129701|NCT02380443|colorectal cancer|colorectal cancer
1129702|NCT02380443|KRAS mutant|kras mutant
1129703|NCT02380443|BRAF mutant|braf mutant
1129704|NCT02380443|metastatic|metastatic
1129705|NCT02380443|liver metastasis|liver metastasis
1129706|NCT02380443|AlloStim®|allostim®
1129707|NCT02380443|cryoablation|cryoablation
1129708|NCT02380443|cancer vaccine|cancer vaccine
1129709|NCT02380443|immunotherapy|immunotherapy
1129710|NCT02380430|Ambulatory surgery|ambulatory surgery
1129711|NCT02380430|Pain management|pain management
1129712|NCT02380430|Nausea and vomiting management|nausea and vomiting management
1129713|NCT02380430|Questionnaire|questionnaire
1129714|NCT02380430|Survey|survey
1129716|NCT02380404|Edentulous maxilla|edentulous maxilla
1129717|NCT02380391|Platelet reactivity|platelet reactivity
1129718|NCT02380391|Acute coronary syndrome|acute coronary syndrome
1129719|NCT02380391|Antiplatelet treatment|antiplatelet treatment
1129720|NCT02380391|Antiretroviral treatment|antiretroviral treatment
1129722|NCT02380365|lung transplantation|lung transplantation
1129723|NCT02380365|electrocardiography|electrocardiography
1129724|NCT02380365|macrolides|macrolides
1129725|NCT02380365|QTc interval|qtc interval
1129726|NCT02380365|arrhythmia|arrhythmia
1129727|NCT02380352|antibiotic stewardship|antibiotic stewardship
1129728|NCT02380352|non-inferiority|non-inferiority
1129729|NCT02380352|randomized controlled trial|randomized controlled trial
1129730|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1129731|NCT02380313|Enzalutamide|enzalutamide
1129732|NCT02380313|Abiraterone|abiraterone
1129733|NCT02380313|Dose-Finding|dose-finding
1129734|NCT02380313|Afuresertib|afuresertib
1129735|NCT02380287|interleukin-17|interleukin-17
1129736|NCT02380287|maximum tolerated dose|maximum tolerated dose
1129737|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
1129738|NCT02380274|Prostate Cancer|prostate cancer
1129739|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
1129740|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
1129741|NCT02380222|Systemic mastocytosis|systemic mastocytosis
1129742|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
1129743|NCT02380209|breast cancer|breast cancer
1129744|NCT02380209|CEST MRI|cest mri
1129745|NCT02380183|anesthesia|anesthesia
1129746|NCT02380183|nerve block|nerve block
1129747|NCT02380183|needle guidance|needle guidance
1129748|NCT02380170|sepsis|sepsis
1129749|NCT02380170|urinary tract infection|urinary tract infection
1129750|NCT02380170|resistance|resistance
1129751|NCT02380170|pathogens|pathogens
1129752|NCT02380170|mortality|mortality
1129753|NCT02380170|health economics|health economics
1129754|NCT02380157|Blood pressure|blood pressure
1129755|NCT02380157|Potassium, Dietary|potassium, dietary
1129756|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1129757|NCT02380157|Sympathetic nervous system|sympathetic nervous system
1129758|NCT02380144|carotenoid|carotenoid
1129759|NCT02380144|bioavailability|bioavailability
1129760|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
1129761|NCT02380144|flavonoid|flavonoid
1129762|NCT02380144|hesperidin|hesperidin
1129763|NCT02380144|narirutin|narirutin
1129764|NCT02380144|randomized cross-over|randomized cross-over
1129765|NCT02380144|Pharmacokinetics|pharmacokinetics
1129766|NCT02380144|micronutrients|micronutrients
1129767|NCT02380144|Oranges/Orange Juice|oranges/orange juice
1129768|NCT02380131|XELOX|xelox
1129769|NCT02380131|Herceptin|herceptin
1129770|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
1129771|NCT02380118|emergency|emergency
1129772|NCT02380118|emergency medicine|emergency medicine
1129773|NCT02380118|sedation|sedation
1129774|NCT02380118|acute agitation|acute agitation
1129775|NCT02380092|Knee|knee
1129776|NCT02380092|Post-Market Surveillance|post-market surveillance
1129777|NCT02380092|Legion|legion
1129778|NCT02380092|Verilast|verilast
1129779|NCT02380092|Degenerative Joint Disease|degenerative joint disease
1129780|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
1129783|NCT02380027|Prostate biopsy|prostate biopsy
1129784|NCT02380027|MRI|mri
1129785|NCT02380027|transrectal|transrectal
1129786|NCT02380027|Detection|detection
1129787|NCT02380001|Postoperative pain|postoperative pain
1129788|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
1129789|NCT02380001|third molar surgery|third molar surgery
1129790|NCT02379962|biobanking|biobanking
1129791|NCT02379962|research participation|research participation
1129792|NCT02379962|China|china
1129793|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
1129794|NCT02379949|social phobia|social phobia
1129795|NCT02379949|social anxiety disorder|social anxiety disorder
1129796|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
1129797|NCT02379936|Classification|classification
1129798|NCT02379936|HIE|hie
1129799|NCT02379936|Infections|infections
1129800|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
1129801|NCT02379936|Intensive Care|intensive care
1129802|NCT02379884|Mechanical ventilation|mechanical ventilation
1129803|NCT02379884|Elderly|elderly
1129804|NCT02379884|Mortality|mortality
1129805|NCT02379884|Health services|health services
1129806|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
1129807|NCT02379858|GI Tract Recovery|gi tract recovery
1129808|NCT02379858|Hospital Discharge|hospital discharge
1129809|NCT02379832|preeclampsia|preeclampsia
1129810|NCT02379832|preterm birth|preterm birth
1129811|NCT02379832|pregnancy|pregnancy
1129812|NCT02379832|placenta|placenta
1129813|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
1129814|NCT02379832|fetal growth restriction|fetal growth restriction
1129815|NCT02379832|ultrasound|ultrasound
1129816|NCT02379832|doppler|doppler
1129823|NCT02379793|LEO 80185 gel|leo 80185 gel
1129824|NCT02379793|calcipotriol|calcipotriol
1129825|NCT02379793|betamethasone|betamethasone
1129826|NCT02379754|vestibular schwannoma|vestibular schwannoma
1129827|NCT02379754|acoustic neuroma|acoustic neuroma
1129828|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
1129829|NCT02379754|gentamicin|gentamicin
1129830|NCT02379754|rehabilitation|rehabilitation
1129831|NCT02379754|postural balance|postural balance
1129832|NCT02379741|Antibodies|antibodies
1129833|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
1129834|NCT02379741|Antineoplastic agent|antineoplastic agent
1129835|NCT02379741|Physiological effects of drugs|physiological effects of drugs
1129836|NCT02379741|Therapeutic uses|therapeutic uses
1129837|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
1129838|NCT02379741|Immunotherapy, Active|immunotherapy, active
1129839|NCT02379741|CD40 Antigen|cd40 antigen
1129840|NCT02379741|Immunologic Factors|immunologic factors
1129841|NCT02379741|Injections, Intralesional|injections, intralesional
1129842|NCT02379728|positional therapy|positional therapy
1129843|NCT02379728|tennis ball technique|tennis ball technique
1129844|NCT02379728|sleep pregnancy|sleep pregnancy
1129845|NCT02379728|supine position|supine position
1129846|NCT02379728|supine|supine
1129847|NCT02379728|sleep position|sleep position
1129848|NCT02379728|low birth weight|low birth weight
1129849|NCT02379728|stillbirth|stillbirth
1129850|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
1129851|NCT02379715|Remifentanil|remifentanil
1129852|NCT02379715|smooth induction|smooth induction
1129853|NCT02379715|desflurane|desflurane
1129854|NCT02379689|psychosocial state|psychosocial state
1129855|NCT02379637|N-acetylcysteine|n-acetylcysteine
1129856|NCT02379637|adults|adults
1129857|NCT02379637|cough and cold|cough and cold
1129858|NCT02379572|5-ALA|5-ala
1129859|NCT02379572|Intraoperative MRI|intraoperative mri
1129860|NCT02379572|Extent of resection|extent of resection
1129861|NCT02379559|prostate cancer|prostate cancer
1129862|NCT02379559|African-American|african-american
1129863|NCT02379559|Metabolic Syndrome|metabolic syndrome
1129864|NCT02379559|Exercise|exercise
1129865|NCT02379559|Men's Health|men's health
1129866|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
1129867|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
1129868|NCT02379520|recurrent cancer|recurrent cancer
1129869|NCT02379520|refractory cancer|refractory cancer
1129870|NCT02379520|virus specific T-cells|virus specific t-cells
1129871|NCT02379520|gene therapy|gene therapy
1129872|NCT02379520|HPV|hpv
1129873|NCT02379507|mild to moderate|mild to moderate
1129874|NCT02379468|Diabetic|diabetic
1129875|NCT02379468|Foot|foot
1129876|NCT02379468|Ulcer|ulcer
1129877|NCT02379455|Polypharmacy|polypharmacy
1129878|NCT02379455|Geriatrics|geriatrics
1129879|NCT02379455|Elderly|elderly
1129880|NCT02379455|Drug review|drug review
1129888|NCT02379429|Saliva|saliva
1129889|NCT02379416|Drug Efflux|drug efflux
1129890|NCT02379416|Taxanes|taxanes
1129891|NCT02379416|Combination|combination
1129892|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
1129893|NCT02379416|Neoplasms|neoplasms
1129894|NCT02379403|Flavonoid|flavonoid
1129895|NCT02379403|Vascular|vascular
1129896|NCT02379403|Biomarkers|biomarkers
1129897|NCT02379403|Arterial Stiffness|arterial stiffness
1129898|NCT02379403|Nutrigenomics|nutrigenomics
1129899|NCT02379364|Physiotherapy|physiotherapy
1129900|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
1129901|NCT02379364|Manual therapy|manual therapy
1129902|NCT02379351|Non-stress Test|non-stress test
1129903|NCT02379351|Fetal Monitoring|fetal monitoring
1129904|NCT02379351|Telemedicine|telemedicine
1129905|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
1129906|NCT02379312|Foams|foams
1129907|NCT02379312|Satiety|satiety
1129908|NCT02379312|Appetite|appetite
1129909|NCT02379247|HER-2 Negative|her-2 negative
1129910|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
1129911|NCT02379234|CVVH|cvvh
1129912|NCT02379234|Renal replacement therapy|renal replacement therapy
1129913|NCT02379234|High fidelity simulation|high fidelity simulation
1129914|NCT02379234|Nurse training|nurse training
1129915|NCT02379208|Visual Field Tests|visual field tests
1129916|NCT02379208|Ocular Hypertension|ocular hypertension
1129917|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
1129918|NCT02379208|Quality of Life|quality of life
1129919|NCT02379208|Glaucoma progression|glaucoma progression
1129920|NCT02379208|Early glaucoma|early glaucoma
1129921|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
1129922|NCT02379208|RareBit|rarebit
1129923|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
1129924|NCT02379182|dysphagia|dysphagia
1129925|NCT02379182|VitalStim|vitalstim
1129926|NCT02379182|electrical stimulation|electrical stimulation
1129927|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
1129928|NCT02379156|Quadriplegia|quadriplegia
1129929|NCT02379156|Spinal Cord Injury|spinal cord injury
1130727|NCT02374671|Reading|reading
1129930|NCT02379156|Body Temperature Regulation|body temperature regulation
1129931|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
1129932|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
1129933|NCT02379130|Premature|premature
1129934|NCT02379130|Family Nurture Intervention|family nurture intervention
1129935|NCT02379091|Drug therapy|drug therapy
1129936|NCT02379078|Shared decision-making|shared decision-making
1129937|NCT02379078|Priority setting|priority setting
1129938|NCT02379078|Patient decision aid|patient decision aid
1129939|NCT02379078|Interprofessional care|interprofessional care
1129940|NCT02379078|Diabetes mellitus|diabetes mellitus
1129941|NCT02379078|Patient education|patient education
1129942|NCT02379078|Medical informatics|medical informatics
1129943|NCT02379078|Toolkit development|toolkit development
1129944|NCT02379078|Study protocol|study protocol
1129945|NCT02379078|User-centred design|user-centred design
1129946|NCT02379078|Qualitative methods|qualitative methods
1129947|NCT02379013|Fatigue|fatigue
1129948|NCT02379013|functional MRI|functional mri
1129949|NCT02378987|cerebral palsy|cerebral palsy
1129950|NCT02378987|language|language
1129951|NCT02378987|acoustic|acoustic
1129952|NCT02378987|motor speech|motor speech
1129953|NCT02378987|follow-up|follow-up
1129954|NCT02378974|Cerebral Infarction|cerebral infarction
1129955|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
1129956|NCT02378974|Stroke|stroke
1129957|NCT02378948|Esophagectomy|esophagectomy
1129958|NCT02378948|Nutrition|nutrition
1129959|NCT02378948|Oral feeding|oral feeding
1129960|NCT02378948|Enteral feeding|enteral feeding
1129961|NCT02378948|Pulmonary complications|pulmonary complications
1129962|NCT02378948|Anastomotic leakage|anastomotic leakage
1129963|NCT02378948|Quality of life|quality of life
1129964|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
1129965|NCT02378883|Apollo|apollo
1129966|NCT02378883|Onyx|onyx
1129967|NCT02378883|arteriovenous malformation|arteriovenous malformation
1129968|NCT02378883|AVM|avm
1129969|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
1129970|NCT02378883|Apollo™ Onyx™ Delivery Micro Catheter|apollo™ onyx™ delivery micro catheter
1129971|NCT02378883|Brain Diseases|brain diseases
1129972|NCT02378870|CRPC|crpc
1129973|NCT02378857|Univentricular heart defect|univentricular heart defect
1129974|NCT02378857|Fontan circulation|fontan circulation
1129975|NCT02378831|diagnosing sleep|diagnosing sleep
1129976|NCT02378818|Schizophrenia|schizophrenia
1129977|NCT02378818|Negative symptoms|negative symptoms
1129978|NCT02378818|Lack of motivation|lack of motivation
1129979|NCT02378818|Cognitive characterization|cognitive characterization
1129980|NCT02378818|Computational psychiatry|computational psychiatry
1129981|NCT02378818|Depression|depression
1129982|NCT02378805|Alport syndrome|alport syndrome
1129983|NCT02378805|thin basement membrane disease|thin basement membrane disease
1129984|NCT02378805|familial benign hematuria|familial benign hematuria
1129985|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
1129986|NCT02378779|Premature ejaculation|premature ejaculation
1129987|NCT02378779|general practice|general practice
1129988|NCT02378779|sexual dysfunction|sexual dysfunction
1129989|NCT02378766|tailored web-based intervention|tailored web-based intervention
1129990|NCT02378766|health behavior|health behavior
1129991|NCT02378766|hiv comorbidities|hiv comorbidities
1129992|NCT02378766|online trial|online trial
1129993|NCT02378753|Ebola|ebola
1129994|NCT02378753|Sierra Leone|sierra leone
1129995|NCT02378753|vaccine|vaccine
1129996|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
1129997|NCT02378740|Anesthesia|anesthesia
1129998|NCT02378740|Cervical Fusion|cervical fusion
1129999|NCT02378740|Quality of Recovery|quality of recovery
1130000|NCT02378740|Ketamine Infusion|ketamine infusion
1130001|NCT02378714|Smoking Cessation|smoking cessation
1130002|NCT02378714|Major Depressive Disorder|major depressive disorder
1130003|NCT02378714|Nicotine Dependence|nicotine dependence
1130004|NCT02378714|Varenicline|varenicline
1130005|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
1130006|NCT02378714|Cigarette Smoking|cigarette smoking
1130007|NCT02378701|Leukemia|leukemia
1130008|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
1130010|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
1130011|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
1130012|NCT02378701|CMML-1|cmml-1
1130013|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
1130014|NCT02378701|QUALMS-1|qualms-1
1130015|NCT02378701|Anemia Subset of FACT|anemia subset of fact
1130016|NCT02378701|FACT-An|fact-an
1130017|NCT02378701|Questionnaires|questionnaires
1130018|NCT02378701|Surveys|surveys
1130019|NCT02378688|Crohn's Disease|crohn's disease
1130020|NCT02378675|Adipocytokines|adipocytokines
1130021|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
1130022|NCT02378662|End Stage Renal Disease|end stage renal disease
1130023|NCT02378662|Anemia|anemia
1130024|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
1130025|NCT02378623|paradoxical embolism|paradoxical embolism
1130026|NCT02378623|lead thrombus|lead thrombus
1130027|NCT02378623|ICD|icd
1130028|NCT02378623|Pacemaker|pacemaker
1130728|NCT02374671|Readers|readers
1130029|NCT02378623|Cognitive decline|cognitive decline
1130030|NCT02378623|Stroke|stroke
1130031|NCT02378623|TIA|tia
1130032|NCT02378597|Resiliency burnout stress|resiliency burnout stress
1130033|NCT02378571|Medication adherence|medication adherence
1130034|NCT02378571|Hospital readmissions|hospital readmissions
1130035|NCT02378558|Breast Surgery|breast surgery
1130036|NCT02378545|Sepsis|sepsis
1130037|NCT02378545|Hyperoxia|hyperoxia
1130038|NCT02378545|Sepsis Six|sepsis six
1130039|NCT02378545|Oxygen delivery|oxygen delivery
1130040|NCT02378532|Glioblastoma|glioblastoma
1130041|NCT02378532|Chloroquine|chloroquine
1130042|NCT02378532|Autophagy|autophagy
1130043|NCT02378532|EGFRvIII|egfrviii
1130044|NCT02378532|Radiotherapy|radiotherapy
1130045|NCT02378532|Temozolomide|temozolomide
1130046|NCT02378519|Low back pain,|low back pain,
1130047|NCT02378519|neck pain,|neck pain,
1130048|NCT02378519|chronic pain|chronic pain
1130049|NCT02378519|SSED|ssed
1130050|NCT02378519|Pilot project|pilot project
1130051|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
1130052|NCT02378519|CBT-coaching|cbt-coaching
1130053|NCT02378519|physiotherapy|physiotherapy
1130054|NCT02378493|Antibiogramme|antibiogramme
1130055|NCT02378493|Antibiofilmogramme|antibiofilmogramme
1130056|NCT02378467|Cystic Fibrosis|cystic fibrosis
1130057|NCT02378467|Hypertonic Saline|hypertonic saline
1130058|NCT02378467|Inhaled Saline|inhaled saline
1130059|NCT02378467|Digestive System Diseases|digestive system diseases
1130060|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
1130061|NCT02378467|Lung Diseases|lung diseases
1130062|NCT02378467|Pancreatic Diseases|pancreatic diseases
1130063|NCT02378467|Pathologic Processes|pathologic processes
1130064|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
1130065|NCT02378454|Lung Clearance Index|lung clearance index
1130066|NCT02378454|Cystic Fibrosis|cystic fibrosis
1130067|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
1130068|NCT02378441|volunteers|volunteers
1130069|NCT02378428|Neuroblastoma|neuroblastoma
1130070|NCT02378415|Depression|depression
1130071|NCT02378402|Creatine|creatine
1130072|NCT02378402|heart failure|heart failure
1130073|NCT02378402|lipid|lipid
1130074|NCT02378402|MRS|mrs
1130075|NCT02378402|myocardium|myocardium
1130076|NCT02378324|Attendance|attendance
1130077|NCT02378324|Screening without fee|screening without fee
1130078|NCT02378311|Bike|bike
1130079|NCT02378311|Bicycle|bicycle
1130080|NCT02378311|Scooter|scooter
1130081|NCT02378311|Handlebar|handlebar
1130082|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
1130083|NCT02378285|platelet-rich plasma|platelet-rich plasma
1130084|NCT02378285|infiltration|infiltration
1130085|NCT02378285|tennis elbow|tennis elbow
1130086|NCT02378285|ultrasonography|ultrasonography
1130087|NCT02378272|Care Manager|care manager
1130088|NCT02378272|Primary Care|primary care
1130089|NCT02378272|Depressive symptoms|depressive symptoms
1130090|NCT02378272|quality of life|quality of life
1130091|NCT02378272|return to work|return to work
1130092|NCT02378246|Iodine|iodine
1130093|NCT02378246|Double-Blind Method|double-blind method
1130094|NCT02378246|Randomized Controlled Tria|randomized controlled tria
1130095|NCT02378246|Cognitive Development|cognitive development
1130096|NCT02378233|Iodine|iodine
1130097|NCT02378233|Double-Blind Method|double-blind method
1130098|NCT02378233|Randomized Controlled Trial|randomized controlled trial
1130099|NCT02378220|Home Care Agencies|home care agencies
1130100|NCT02378220|Home Health Care Agencies|home health care agencies
1130101|NCT02378220|Home Health Care Nursing|home health care nursing
1130102|NCT02378220|Home Health Nurses|home health nurses
1130103|NCT02378220|CYP 2D6|cyp 2d6
1130104|NCT02378220|CYP 2C9|cyp 2c9
1130105|NCT02378220|CYP 2C19|cyp 2c19
1130106|NCT02378220|CYP 3A4|cyp 3a4
1130107|NCT02378220|CYP 3A5|cyp 3a5
1130108|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
1130109|NCT02378168|postconditioning|postconditioning
1130110|NCT02378168|six month follow up|six month follow up
1130111|NCT02378168|cardiac event|cardiac event
1130112|NCT02378168|non-cardiac event|non-cardiac event
1130113|NCT02378155|cardioversion|cardioversion
1130114|NCT02378155|atrial fibrillation|atrial fibrillation
1130115|NCT02378129|Dentin Sensitivity|dentin sensitivity
1130116|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
1130117|NCT02378129|Glass Ionomer Cements|glass ionomer cements
1130118|NCT02378129|Randomized Controlled Trial|randomized controlled trial
1130119|NCT02378103|Aortic Dissection|aortic dissection
1130120|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
1130121|NCT02378077|Obesity|obesity
1130122|NCT02378077|Insulin Resistance|insulin resistance
1130123|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1568845|NCT00504452|HAART|haart
1130124|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
1130125|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
1130126|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
1130127|NCT02378038|PNT2258|pnt2258
1130128|NCT02378038|Richter's Transformation|richter's transformation
1130129|NCT02378038|NHL|nhl
1130130|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1130131|NCT02378038|Lymphoma|lymphoma
1130132|NCT02378038|DLBCL|dlbcl
1130133|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1130134|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
1130135|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1130136|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
1130137|NCT02378025|Chronic Pain|chronic pain
1130138|NCT02378025|Veterans|veterans
1130139|NCT02378025|Gulf War Illness|gulf war illness
1130140|NCT02377973|growth,|growth,
1130141|NCT02377973|infancy,|infancy,
1130142|NCT02377973|children,|children,
1130143|NCT02377973|diet,|diet,
1130144|NCT02377973|breastfeeding|breastfeeding
1130145|NCT02377973|complementary feeding|complementary feeding
1130146|NCT02377973|early life programming|early life programming
1130147|NCT02377973|tracking|tracking
1130148|NCT02377973|physical activity|physical activity
1130149|NCT02377960|SMS|sms
1130150|NCT02377960|text message|text message
1130151|NCT02377960|mHealth|mhealth
1130152|NCT02377960|IMB|imb
1130153|NCT02377947|Lactulose Retention Enema|lactulose retention enema
1130154|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
1130155|NCT02377947|The Retro Study|the retro study
1130156|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
1130157|NCT02377934|Cardiac MRT|cardiac mrt
1130158|NCT02377934|Radiotherapy|radiotherapy
1130159|NCT02377921|GNE Myopathy|gne myopathy
1130160|NCT02377921|GNEM|gnem
1130161|NCT02377921|HIBM|hibm
1130162|NCT02377921|Nonaka|nonaka
1130163|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1130164|NCT02377921|DMRV|dmrv
1130165|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
1130166|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
1130167|NCT02377882|Rocuronium|rocuronium
1130168|NCT02377882|Thyroid surgery|thyroid surgery
1130169|NCT02377856|acute hepatitis C|acute hepatitis c
1130170|NCT02377856|treatment|treatment
1130171|NCT02377856|SVR|svr
1130172|NCT02377843|vaccine|vaccine
1130173|NCT02377843|physician training|physician training
1130174|NCT02377843|adolescent health|adolescent health
1130175|NCT02377817|positional therapy|positional therapy
1130176|NCT02377817|tennis ball technique|tennis ball technique
1130177|NCT02377817|sleep in pregnancy|sleep in pregnancy
1130178|NCT02377817|supine|supine
1130179|NCT02377817|polysomnography|polysomnography
1130180|NCT02377817|sleep position|sleep position
1130181|NCT02377817|supine position|supine position
1130182|NCT02377804|dry needling|dry needling
1130183|NCT02377804|spasticity|spasticity
1130184|NCT02377804|pain|pain
1130185|NCT02377791|tacrolimus|tacrolimus
1130982|NCT02372942|prevention|prevention
1130186|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
1130187|NCT02377791|Kidney transplant|kidney transplant
1130188|NCT02377791|FK506|fk506
1130189|NCT02377791|Prograf|prograf
1130190|NCT02377791|Rejection|rejection
1130191|NCT02377791|Gene Polymorphism|gene polymorphism
1130192|NCT02377765|Neuromodulation|neuromodulation
1130193|NCT02377765|Detrusor overactivity|detrusor overactivity
1130194|NCT02377765|Urinary urgency|urinary urgency
1130195|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
1130196|NCT02377726|Randomized Controlled Trial|randomized controlled trial
1130197|NCT02377726|Alcohol|alcohol
1130198|NCT02377726|Internet|internet
1130199|NCT02377726|Internet based therapy|internet based therapy
1130200|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
1130201|NCT02377713|KHK6640|khk6640
1130202|NCT02377713|Phase 1|phase 1
1130203|NCT02377713|Japanese|japanese
1130204|NCT02377713|single dose|single dose
1130205|NCT02377713|Alzheimer's disease|alzheimer's disease
1130206|NCT02377687|Emergency surgery|emergency surgery
1130207|NCT02377687|HRQoL|hrqol
1130208|NCT02377687|Elderly|elderly
1130209|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
1130210|NCT02377648|Heart Transplant|heart transplant
1130211|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1130212|NCT02377635|Arsenic|arsenic
1130213|NCT02377635|Arsenicosis|arsenicosis
1130214|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
1130215|NCT02377609|Validation|validation
1130216|NCT02377609|Tacrolimus|tacrolimus
1130217|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
1130218|NCT02377596|Feeding|feeding
1130219|NCT02377596|difficulties|difficulties
1130220|NCT02377596|disorders|disorders
1130221|NCT02377596|childhood|childhood
1130222|NCT02377596|eating|eating
1130223|NCT02377557|Dermatologic Agent|dermatologic agent
1568846|NCT00504452|Treatment Experienced|treatment experienced
1130224|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
1130225|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
1130226|NCT02377505|Deep Brain Stimulation|deep brain stimulation
1130227|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
1130228|NCT02377466|GSK221149|gsk221149
1130229|NCT02377466|Retosiban|retosiban
1130230|NCT02377453|stroke|stroke
1130231|NCT02377453|participation|participation
1130232|NCT02377453|brain imaging|brain imaging
1130233|NCT02377453|biomechanical|biomechanical
1130234|NCT02377440|ACE inhibitor|ace inhibitor
1130235|NCT02377427|pharmacokinetics|pharmacokinetics
1130236|NCT02377427|pediatric|pediatric
1130237|NCT02377427|Mepolizumab|mepolizumab
1130238|NCT02377427|subcutaneous|subcutaneous
1130239|NCT02377427|eosinophilic asthma|eosinophilic asthma
1130240|NCT02377427|pharmacodynamics|pharmacodynamics
1130241|NCT02377414|Preterm labor|preterm labor
1130242|NCT02377414|Retosiban|retosiban
1130243|NCT02377414|Pharmacokinetics|pharmacokinetics
1130244|NCT02377414|Safety|safety
1130245|NCT02377414|Infusion|infusion
1130246|NCT02377414|GSK2847065|gsk2847065
1130247|NCT02377401|healthy volunteer|healthy volunteer
1130248|NCT02377401|Zanamivir|zanamivir
1130249|NCT02377401|pharmacokinetics|pharmacokinetics
1130250|NCT02377401|intravenous|intravenous
1130251|NCT02377388|diabetes mellitus|diabetes mellitus
1130252|NCT02377388|platelet function testing|platelet function testing
1130253|NCT02377388|acute coronary syndromes|acute coronary syndromes
1130254|NCT02377388|saxagliptin|saxagliptin
1130255|NCT02377388|sitagliptin|sitagliptin
1130256|NCT02377388|dpp-4 inhibitors|dpp-4 inhibitors
1130257|NCT02377375|Deep Brain Stimulation|deep brain stimulation
1130258|NCT02377375|OCD|ocd
1130259|NCT02377336|GS-6615|gs-6615
1130260|NCT02377336|coronary heart disease|coronary heart disease
1130261|NCT02377336|angina pectoris|angina pectoris
1130262|NCT02377336|late sodium current|late sodium current
1130263|NCT02377336|myocardial ischemia|myocardial ischemia
1130264|NCT02377336|coronary artery disease|coronary artery disease
1130265|NCT02377336|chronic stable angina|chronic stable angina
1130266|NCT02377323|Multiple Sclerosis|multiple sclerosis
1130267|NCT02377323|Patient-reported outcomes|patient-reported outcomes
1130268|NCT02377323|Employment status|employment status
1130269|NCT02377323|Quality of Life|quality of life
1130270|NCT02377323|Cognition|cognition
1130271|NCT02377323|Rebif|rebif
1130272|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
1130273|NCT02377297|primary tooth|primary tooth
1130274|NCT02377297|occlusal restoration|occlusal restoration
1130275|NCT02377297|glass-ionomer cement|glass-ionomer cement
1130276|NCT02377271|Bosentan|bosentan
1130277|NCT02377245|Juvenile|juvenile
1130278|NCT02377245|Inflammatory|inflammatory
1130279|NCT02377245|Rheumatism|rheumatism
1130280|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
1130281|NCT02377206|PET|pet
1130282|NCT02377206|[18F]DPA-714|[18f]dpa-714
1130283|NCT02377206|cognitive decline|cognitive decline
1130284|NCT02377193|kidney transplant|kidney transplant
1130285|NCT02377193|luminex method|luminex method
1130286|NCT02377193|simulect ATG|simulect atg
1130287|NCT02377193|immunosuppression|immunosuppression
1130288|NCT02377180|musculoskeletal pain|musculoskeletal pain
1130289|NCT02377180|regional anesthesia|regional anesthesia
1130290|NCT02377180|diagnostic nerve block|diagnostic nerve block
1130291|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
1130292|NCT02377180|referred pain|referred pain
1130293|NCT02377180|hyperalgesia|hyperalgesia
1130294|NCT02377180|experimental pain|experimental pain
1130295|NCT02377180|central hypersensitivity|central hypersensitivity
1130296|NCT02377180|human experimental pain|human experimental pain
1130297|NCT02377154|keratometry|keratometry
1130298|NCT02377154|verion|verion
1130299|NCT02377154|iol|iol
1130300|NCT02377154|intraocular lens|intraocular lens
1130301|NCT02377154|iolmaster|iolmaster
1130302|NCT02377154|lenstar|lenstar
1130303|NCT02377154|pentacam|pentacam
1130304|NCT02377154|IOL calculation|iol calculation
1130305|NCT02377154|VERION Image Guided System|verion image guided system
1130306|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
1130307|NCT02377141|TIPSS|tipss
1130308|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
1130309|NCT02377141|Decompensated Liver Disease|decompensated liver disease
1130310|NCT02377128|Study|study
1130311|NCT02377128|focus|focus
1130312|NCT02377128|ovarian|ovarian
1130313|NCT02377128|reserve|reserve
1130314|NCT02377115|Postoperative delirium|postoperative delirium
1130315|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
1130316|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1130317|NCT02377115|Risk assessment|risk assessment
1130318|NCT02377115|Tablet computer|tablet computer
1130319|NCT02377115|Clinical screening tool|clinical screening tool
1130320|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
1130321|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1130322|NCT02377063|colonic flora|colonic flora
1130323|NCT02377063|microbiomes|microbiomes
1130324|NCT02377050|Nutritional support|nutritional support
1130325|NCT02377037|Sitting|sitting
1130326|NCT02377037|Standing|standing
1130327|NCT02377037|Transitions|transitions
1130328|NCT02376998|Thoracic Aorta|thoracic aorta
1130329|NCT02376998|Trauma|trauma
1130330|NCT02376998|Endovascular|endovascular
1130331|NCT02376959|Anxiety|anxiety
1130332|NCT02376959|Complementary Therapies|complementary therapies
1130333|NCT02376959|energy therapies|energy therapies
1130334|NCT02376933|vertebral bodies|vertebral bodies
1130335|NCT02376933|vertebral fracture|vertebral fracture
1130336|NCT02376933|vertebral augmentation|vertebral augmentation
1130337|NCT02376933|radiotherapy|radiotherapy
1130338|NCT02376933|vertebroplasty|vertebroplasty
1130339|NCT02376933|kyphoplasty|kyphoplasty
1130340|NCT02376920|occular melanoma|occular melanoma
1130341|NCT02376920|melanoma of eye|melanoma of eye
1130342|NCT02376920|DecisionDx-UM|decisiondx-um
1130343|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
1130344|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1130345|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
1130346|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
1130347|NCT02376907|stent|stent
1130348|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
1130349|NCT02376855|Health Services Accessibility|health services accessibility
1130350|NCT02376842|severe sepsis infection|severe sepsis infection
1130351|NCT02376829|Orthodontic|orthodontic
1130352|NCT02376829|Orthodontic Treatment|orthodontic treatment
1130353|NCT02376829|Clear Aligners|clear aligners
1130354|NCT02376829|Malocclusion|malocclusion
1130355|NCT02376816|DMD|dmd
1130356|NCT02376816|muscular dystrophy|muscular dystrophy
1130357|NCT02376816|dystrophin|dystrophin
1130358|NCT02376803|Randomized controlled trial|randomized controlled trial
1130359|NCT02376803|Warfarin|warfarin
1130360|NCT02376803|Time in therapeutic range|time in therapeutic range
1130361|NCT02376803|Bleeding|bleeding
1130362|NCT02376803|Thromboembolic|thromboembolic
1130363|NCT02376803|Hemorrhage|hemorrhage
1130364|NCT02376803|Anticoagulant|anticoagulant
1130365|NCT02376803|TTR|ttr
1130366|NCT02376803|Chronobiology|chronobiology
1130367|NCT02376803|Chronotherapeutic|chronotherapeutic
1130368|NCT02376803|Coumadin|coumadin
1130369|NCT02376803|INR|inr
1130370|NCT02376803|International normalized ratio|international normalized ratio
1130371|NCT02376803|RCT|rct
1130372|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
1130373|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
1130374|NCT02376790|Etanercept|etanercept
1130375|NCT02376790|Enbrel|enbrel
1130376|NCT02376790|Methotrexate|methotrexate
1130377|NCT02376790|Minimal Disease Activity|minimal disease activity
1130378|NCT02376777|Anticoagulants|anticoagulants
1130379|NCT02376777|Antithrombins|antithrombins
1130380|NCT02376777|Atrial Fibrillation|atrial fibrillation
1130381|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
1130382|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
1130383|NCT02376777|Myocardial infarction|myocardial infarction
1130384|NCT02376777|Stroke|stroke
1130385|NCT02376777|Venous thrombosis|venous thrombosis
1130386|NCT02376777|Primary care|primary care
1130387|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
1130388|NCT02376751|Acid lipase disease|acid lipase disease
1130389|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1130390|NCT02376751|LIPA Deficiency|lipa deficiency
1130391|NCT02376751|Wolman disease|wolman disease
1130392|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
1130393|NCT02376725|Goniosynechialysis|goniosynechialysis
1130394|NCT02376712|Acute Kidney Injury|acute kidney injury
1130395|NCT02376712|Differential diagnosis|differential diagnosis
1130396|NCT02376712|Urinary indices|urinary indices
1130397|NCT02376712|Renal Blood Flow|renal blood flow
1130398|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
1130399|NCT02376699|CD40 Antigen|cd40 antigen
1130400|NCT02376699|Drug Therapy|drug therapy
1130401|NCT02376699|Follicular Lymphoma|follicular lymphoma
1130402|NCT02376699|Hodgkin Disease|hodgkin disease
1130403|NCT02376699|Immunotherapy|immunotherapy
1130404|NCT02376699|Indolent Lymphoma|indolent lymphoma
1130405|NCT02376699|Lymphoma|lymphoma
1130406|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
1130407|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1130408|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1130409|NCT02376699|Monoclonal Antibody|monoclonal antibody
1130410|NCT02376699|Neoplasms|neoplasms
1130411|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
1130412|NCT02376699|Solid tumor|solid tumor
1130413|NCT02376686|sleep Quality|sleep quality
1130414|NCT02376686|Depression|depression
1130415|NCT02376686|Music|music
1130416|NCT02376686|quality of life|quality of life
1130417|NCT02376673|Pediatric Health Literacy|pediatric health literacy
1130418|NCT02376673|Home Literacy Orientation|home literacy orientation
1130419|NCT02376673|safe sleep|safe sleep
1130420|NCT02376647|Patients|patients
1130421|NCT02376647|ARDS diagnosis|ards diagnosis
1130422|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
1130423|NCT02376621|Bioavailability|bioavailability
1130424|NCT02376595|Rocuronium|rocuronium
1130425|NCT02376595|Pharmacokinetics|pharmacokinetics
1130426|NCT02376595|Pharmacodynamics|pharmacodynamics
1130427|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
1130428|NCT02376582|helminth infection|helminth infection
1130429|NCT02376582|Impact of co-infection|impact of co-infection
1130430|NCT02376556|Dry eye syndrome|dry eye syndrome
1130431|NCT02376556|Blepharoplasty|blepharoplasty
1130432|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
1130433|NCT02376517|Health Behavior|health behavior
1130434|NCT02376517|Melanin Index|melanin index
1130435|NCT02376517|Spectrophotometry|spectrophotometry
1130436|NCT02376517|Sun Protective Clothing|sun protective clothing
1130437|NCT02376517|Education|education
1130438|NCT02376517|Primary Prevention|primary prevention
1130439|NCT02376439|siblings|siblings
1130440|NCT02376439|overweight|overweight
1130441|NCT02376439|adolescent|adolescent
1130442|NCT02376426|Healthy|healthy
1130443|NCT02376426|Ebola viruses|ebola viruses
1130444|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
1130445|NCT02376426|Filoviruses|filoviruses
1130446|NCT02376426|Monovalent vaccine|monovalent vaccine
1130447|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1130448|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
1130449|NCT02376426|Safety|safety
1130450|NCT02376426|Immunogenicity|immunogenicity
1130451|NCT02376413|Morbidity|morbidity
1130452|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
1130453|NCT02376413|Disease free survival|disease free survival
1130454|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
1130455|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
1130456|NCT02376400|Healthy|healthy
1130457|NCT02376400|Ebola viruses|ebola viruses
1130458|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
1130459|NCT02376400|Filoviruses|filoviruses
1130460|NCT02376400|Monovalent vaccine|monovalent vaccine
1130461|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1130462|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
1130463|NCT02376400|Safety|safety
1130464|NCT02376400|Immunogenicity|immunogenicity
1130465|NCT02376374|transmission|transmission
1130466|NCT02376374|vaccine|vaccine
1130467|NCT02376361|Surveillance|surveillance
1130468|NCT02376348|VMMC|vmmc
1130469|NCT02376348|Adult males|adult males
1130470|NCT02376348|HIV Prevention|hiv prevention
1130471|NCT02376348|Africa|africa
1130472|NCT02376335|Fatigue|fatigue
1130473|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
1130474|NCT02376335|Rituximab|rituximab
1130475|NCT02376335|PBC-40|pbc-40
1130476|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
1130477|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
1130478|NCT02376296|CRPC|crpc
1130479|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
1130483|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
1130484|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
1130485|NCT02376244|cardiac revascularisation|cardiac revascularisation
1130486|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
1130487|NCT02376244|Cardiac surgery|cardiac surgery
1130488|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
1130490|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
1130491|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
1130492|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
1130493|NCT02376205|Dysphagia|dysphagia
1130494|NCT02376192|Microcirculation|microcirculation
1130495|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
1130496|NCT02376192|Spinal Anesthesia|spinal anesthesia
1130497|NCT02376192|Phenylephrine|phenylephrine
1130498|NCT02376166|Prostate Cancer|prostate cancer
1130499|NCT02376140|micronutrient deficiency|micronutrient deficiency
1130500|NCT02376140|24-H recall|24-h recall
1130501|NCT02376140|West Africa|west africa
1130502|NCT02376140|Food consumption|food consumption
1130503|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
1130504|NCT02376127|14-203|14-203
1130505|NCT02376114|ocular blood flow|ocular blood flow
1130506|NCT02376114|ginkgo biloba|ginkgo biloba
1130507|NCT02376114|glaucoma|glaucoma
1130508|NCT02376114|vasospasm|vasospasm
1130509|NCT02376062|Continuing Medical Education|continuing medical education
1130510|NCT02376062|Chronic Diseases|chronic diseases
1130511|NCT02376062|Nepal|nepal
1130512|NCT02376062|Implementation Research|implementation research
1130513|NCT02376049|Atopic Dermatitis|atopic dermatitis
1130515|NCT02376049|AD|ad
1130516|NCT02376036|Normal healthy volunteer|normal healthy volunteer
1130517|NCT02376023|Cervical Cancer|cervical cancer
1130518|NCT02376023|Women|women
1130519|NCT02376023|Latina|latina
1130520|NCT02376023|Chile|chile
1130521|NCT02376023|Text Message|text message
1130522|NCT02376023|Technology|technology
1130523|NCT02376023|Screening|screening
1130524|NCT02376023|Cancer Prevention|cancer prevention
1130525|NCT02376023|Health Disparities|health disparities
1130526|NCT02376023|Mobile Health|mobile health
1130527|NCT02376010|atherosclerosis|atherosclerosis
1130528|NCT02376010|coronary artery disease|coronary artery disease
1130529|NCT02376010|cardiac CT|cardiac ct
1130530|NCT02376010|computed tomographic angiography|computed tomographic angiography
1130531|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
1130532|NCT02375971|laser ablation therapy|laser ablation therapy
1130533|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
1130534|NCT02375971|preterm infants|preterm infants
1130535|NCT02375971|RAINBOW|rainbow
1130536|NCT02375958|PCA062, Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer, pCAD, pcadherin, solid-tumors|pca062, triple negative breast cancer, head & neck cancer, esophageal cancer, pcad, pcadherin, solid-tumors
1130537|NCT02375945|lymphedema|lymphedema
1130538|NCT02375945|post operative compression treatment|post operative compression treatment
1130539|NCT02375945|compression therapy|compression therapy
1130540|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
1130541|NCT02375945|edema|edema
1130542|NCT02375932|Electronic Medical Records|electronic medical records
1130543|NCT02375932|Primary Health Care|primary health care
1130544|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1130545|NCT02375919|PERC rule|perc rule
1130546|NCT02375919|emergency department|emergency department
1130547|NCT02375919|pulmonary embolism|pulmonary embolism
1130548|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
1130549|NCT02375893|Coronary disease|coronary disease
1130550|NCT02375893|Bile acids|bile acids
1130551|NCT02375893|Gut microbiota|gut microbiota
1130552|NCT02375893|Risk factors|risk factors
1130553|NCT02375893|Atherosclerosis|atherosclerosis
1130554|NCT02375854|preterm|preterm
1130555|NCT02375854|acute kidney injury|acute kidney injury
1130556|NCT02375854|biomarkers|biomarkers
1130557|NCT02375854|chronic kidney disease|chronic kidney disease
1130558|NCT02375841|Communication|communication
1130559|NCT02375841|Physicians|physicians
1130560|NCT02375841|Patients|patients
1130561|NCT02375841|Caregivers|caregivers
1130562|NCT02375841|15-034|15-034
1130563|NCT02375828|Acceptability|acceptability
1130564|NCT02375828|Phase 3|phase 3
1130565|NCT02375828|Neonatal diabetes|neonatal diabetes
1130566|NCT02375815|statin|statin
1130567|NCT02375815|decision aid|decision aid
1130568|NCT02375802|Stem cells|stem cells
1130569|NCT02375789|Migraine Headache|migraine headache
1130570|NCT02375789|Cooling|cooling
1130571|NCT02375789|Intranasal|intranasal
1130572|NCT02375789|Rhinochill|rhinochill
1130573|NCT02375724|COPD|copd
1130574|NCT02375711|Chronic renal disease|chronic renal disease
1130575|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
1130576|NCT02375711|Biological Aging|biological aging
1130577|NCT02375685|Uveitis|uveitis
1130578|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
1130579|NCT02375685|Intermediate Uveitis|intermediate uveitis
1130580|NCT02375685|Posterior Uveitis|posterior uveitis
1130581|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
1130582|NCT02375672|Pembrolizumab|pembrolizumab
1130583|NCT02375672|MK-3475|mk-3475
1130584|NCT02375607|Pain management|pain management
1130585|NCT02375581|Radiotherapy|radiotherapy
1130586|NCT02375581|Icotinib|icotinib
1130587|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
1130588|NCT02375555|Multiple Myeloma|multiple myeloma
1130589|NCT02375516|Drug abuse|drug abuse
1130590|NCT02375503|Calcium|calcium
1130591|NCT02375503|Vitamin D|vitamin d
1130592|NCT02375503|Parathyroid Hormone|parathyroid hormone
1130593|NCT02375503|Bone|bone
1130594|NCT02375503|Microarchitecture|microarchitecture
1130595|NCT02375490|Exercise|exercise
1130596|NCT02375490|Eating Behavior|eating behavior
1130597|NCT02375490|Preschool Child|preschool child
1130598|NCT02375490|Early Childcare Center|early childcare center
1130599|NCT02375490|Obesity|obesity
1130600|NCT02375490|Physical Literacy|physical literacy
1130601|NCT02375477|Clostridium difficile|clostridium difficile
1130602|NCT02375477|C. difficile|c. difficile
1130603|NCT02375477|adherence|adherence
1130604|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
1130605|NCT02375464|carcinoid tumor|carcinoid tumor
1130606|NCT02375438|nutrition|nutrition
1130607|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
1130608|NCT02375438|malnutrition|malnutrition
1130609|NCT02375438|energy intake|energy intake
1130610|NCT02375438|nutritional risk|nutritional risk
1130611|NCT02375425|BV, HSV|bv, hsv
1130612|NCT02375425|contraceptive|contraceptive
1130613|NCT02375425|ex vivo challenge model|ex vivo challenge model
1130614|NCT02375412|heart rate variability|heart rate variability
1130615|NCT02375412|post-operative outcome|post-operative outcome
1130616|NCT02375373|Gut Microbiota|gut microbiota
1130617|NCT02375347|Gut Microbiota|gut microbiota
1130618|NCT02375321|OSA|osa
1130619|NCT02375321|Depression|depression
1130620|NCT02375321|Quality of Life|quality of life
1130621|NCT02375321|CPAP|cpap
1130622|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
1130623|NCT02375295|struvite|struvite
1130624|NCT02375295|infection|infection
1130625|NCT02375295|stones|stones
1130626|NCT02375295|calculi|calculi
1130627|NCT02375295|antibiotics|antibiotics
1130628|NCT02375282|ambulation|ambulation
1130629|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
1130630|NCT02375269|Visceral Surgery|visceral surgery
1130631|NCT02375269|Comprehensive Complication Index|comprehensive complication index
1130632|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
1130633|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
1130634|NCT02375230|Respiratory Function Tests|respiratory function tests
1130635|NCT02375230|Neonatal Simulation|neonatal simulation
1130636|NCT02375230|Resuscitation Teaching|resuscitation teaching
1130637|NCT02375178|anti-infective agents|anti-infective agents
1130638|NCT02375178|local/therapeutic use|local/therapeutic use
1130639|NCT02375178|chlorhexidine|chlorhexidine
1130640|NCT02375178|dental desinfectants|dental desinfectants
1130641|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
1130642|NCT02375178|mouthrinse|mouthrinse
1130643|NCT02375152|neurosurgery|neurosurgery
1130644|NCT02375152|capsulotomy|capsulotomy
1130645|NCT02375113|Obesity prevention|obesity prevention
1130646|NCT02375113|Soy supplementation|soy supplementation
1130647|NCT02375074|Supported Employment|supported employment
1130648|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
1130649|NCT02375074|Youth|youth
1130650|NCT02375074|Sick leave|sick leave
1130651|NCT02375074|Disability|disability
1130652|NCT02375074|Coping|coping
1130653|NCT02375074|Work|work
1130654|NCT02375074|Occupational|occupational
1130655|NCT02375074|Labor market participation|labor market participation
1130656|NCT02375074|Randomized Controlled Trial|randomized controlled trial
1130657|NCT02375061|Best Possible Self|best possible self
1130658|NCT02375061|Positive Psychology|positive psychology
1130659|NCT02375061|Optimism|optimism
1130660|NCT02375061|Positive Technologies|positive technologies
1130661|NCT02375061|Future thinking|future thinking
1130662|NCT02375061|Pain Catastrophizing|pain catastrophizing
1130663|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
1130664|NCT02374983|Radiation Dosimetry|radiation dosimetry
1130665|NCT02374957|leg pain|leg pain
1130666|NCT02374957|claudication|claudication
1130667|NCT02374931|desmoid|desmoid
1130668|NCT02374931|FES-PET|fes-pet
1130669|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
1130670|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
1130671|NCT02374918|Concussion|concussion
1130672|NCT02374918|Sleep problems|sleep problems
1130673|NCT02374918|Brain imaging|brain imaging
1130674|NCT02374918|fMRI|fmri
1130675|NCT02374905|drinksmeter|drinksmeter
1130676|NCT02374905|alcohol counselling|alcohol counselling
1130677|NCT02374892|Intervention|intervention
1130678|NCT02374892|Congenital Heart Disease|congenital heart disease
1130679|NCT02374892|Adolescent|adolescent
1130680|NCT02374892|Education|education
1130681|NCT02374892|Self-management|self-management
1130683|NCT02374866|Morbid Obesity|morbid obesity
1130684|NCT02374866|Therapeutic education|therapeutic education
1130685|NCT02374840|Pharmacogenomics|pharmacogenomics
1130686|NCT02374840|Adverse Drug Reactions|adverse drug reactions
1130687|NCT02374840|Pharmacogenetics|pharmacogenetics
1130688|NCT02374827|complete salpingectomy|complete salpingectomy
1130689|NCT02374827|standard tubal ligation|standard tubal ligation
1130690|NCT02374827|cesarean delivery|cesarean delivery
1130691|NCT02374827|feasibility|feasibility
1130692|NCT02374827|safety|safety
1130693|NCT02374827|partial salpingectomy|partial salpingectomy
1130694|NCT02374801|CRT-D device|crt-d device
1130695|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
1130696|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
1130697|NCT02374801|Sinus rhythm|sinus rhythm
1130698|NCT02374801|Heart Failure|heart failure
1130699|NCT02374775|axial plaque stress|axial plaque stress
1130700|NCT02374775|pressure|pressure
1130701|NCT02374775|pressure gradient|pressure gradient
1130702|NCT02374775|coronary plaque|coronary plaque
1130703|NCT02374775|plaque rupture|plaque rupture
1130704|NCT02374775|acute coronary syndrome|acute coronary syndrome
1130705|NCT02374775|acute myocardial infarction|acute myocardial infarction
1130706|NCT02374775|computational fluid dynamics|computational fluid dynamics
1130707|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
1130708|NCT02374775|wall shear stress|wall shear stress
1130709|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
1130710|NCT02374762|Hemodialysis|hemodialysis
1130711|NCT02374762|Vascular Access|vascular access
1130712|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
1130713|NCT02374749|Education|education
1130714|NCT02374749|Co-morbidities|co-morbidities
1130715|NCT02374749|Nurse|nurse
1130716|NCT02374736|recipients|recipients
1130717|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
1130718|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
1130719|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
1130720|NCT02374723|improve|improve
1130721|NCT02374723|vision|vision
1130722|NCT02374697|Second opinion|second opinion
1130723|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1130724|NCT02374671|Near Vision|near vision
1130725|NCT02374671|Reading Vision|reading vision
1130726|NCT02374671|Reading Glasses|reading glasses
1130730|NCT02374619|eccentric exercise|eccentric exercise
1130731|NCT02374619|pro-oxidants|pro-oxidants
1130732|NCT02374619|free radicals|free radicals
1130733|NCT02374619|adults|adults
1130734|NCT02374619|children|children
1130735|NCT02374606|outcomes measures|outcomes measures
1130736|NCT02374606|strength measurement|strength measurement
1130737|NCT02374606|disease progression|disease progression
1130738|NCT02374567|geriatric psychiatry|geriatric psychiatry
1130739|NCT02374567|pharmacovigilance|pharmacovigilance
1130740|NCT02374554|Respiratory Rate|respiratory rate
1130741|NCT02374554|Structured Light Plethysmography|structured light plethysmography
1130742|NCT02374554|Capnography|capnography
1130743|NCT02374541|Patient Navigation|patient navigation
1130744|NCT02374541|Health Disparities|health disparities
1130745|NCT02374541|Coordination of Services|coordination of services
1130746|NCT02374541|Early Intervention (Education)|early intervention (education)
1130747|NCT02374541|Health Services Accessibility|health services accessibility
1130748|NCT02374541|Patient Advocacy|patient advocacy
1130749|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
1130750|NCT02374528|wound|wound
1130751|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
1130752|NCT02374502|Spondylarthropathies|spondylarthropathies
1130753|NCT02374502|Motor Activity|motor activity
1130754|NCT02374502|Physical Therapists|physical therapists
1130755|NCT02374502|Accelerometry|accelerometry
1130756|NCT02374476|VT|vt
1130757|NCT02374476|Refractory VT|refractory vt
1130758|NCT02374476|VT Storm|vt storm
1130759|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
1130760|NCT02374476|V Fib|v fib
1130761|NCT02374476|VF|vf
1130762|NCT02374463|Balance|balance
1130763|NCT02374463|Fall Risk|fall risk
1130764|NCT02374463|Older Adults|older adults
1130765|NCT02374463|Tai Chi|tai chi
1130766|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
1130767|NCT02374450|Malaria|malaria
1130768|NCT02374450|Surveillance study|surveillance study
1130769|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
1130770|NCT02374450|Children|children
1130771|NCT02374450|Infants|infants
1130772|NCT02374450|Adverse events (AE) leading to hospitalisation or death|adverse events (ae) leading to hospitalisation or death
1130773|NCT02374450|Meningitis|meningitis
1130774|NCT02374450|Epidemiology|epidemiology
1130775|NCT02374450|Africa|africa
1130776|NCT02374398|Tranexamic Acid|tranexamic acid
1130777|NCT02374398|Blood Loss|blood loss
1130778|NCT02374398|Aquamantys System|aquamantys system
1130779|NCT02374398|TKA|tka
1130780|NCT02374372|hemodialysis|hemodialysis
1130781|NCT02374372|beta microglobulin|beta microglobulin
1130782|NCT02374372|amyloidosis|amyloidosis
1130783|NCT02374307|Falls|falls
1130784|NCT02374307|home-care services|home-care services
1130785|NCT02374307|older people|older people
1130786|NCT02374307|falls-prevention|falls-prevention
1130787|NCT02374281|Newborn|newborn
1130788|NCT02374281|Neonatal Screening|neonatal screening
1130789|NCT02374281|Autonomic Nervous System|autonomic nervous system
1130790|NCT02374281|Pain|pain
1130791|NCT02374281|non-nutritive sucking|non-nutritive sucking
1130792|NCT02374281|sucrose administration|sucrose administration
1130793|NCT02374281|nociceptive action|nociceptive action
1130794|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
1130795|NCT02374255|Advanced cancer|advanced cancer
1130796|NCT02374255|goals of care|goals of care
1130797|NCT02374255|quality of care|quality of care
1130798|NCT02374255|end of life discussions|end of life discussions
1130799|NCT02374242|Brain|brain
1130800|NCT02374242|Metastases|metastases
1130801|NCT02374242|Immunotherapy|immunotherapy
1130802|NCT02374242|Intracranial response|intracranial response
1130803|NCT02374242|Nivolumab|nivolumab
1130804|NCT02374242|Ipilimumab|ipilimumab
1130805|NCT02374242|Biomarkers|biomarkers
1130806|NCT02374242|Immune related response criteria|immune related response criteria
1130807|NCT02374229|pulmonary hypertension|pulmonary hypertension
1130808|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
1568847|NCT00504439|COPD,|copd,
1130809|NCT02374229|mitral valve disease|mitral valve disease
1130810|NCT02374216|Dental Implants|dental implants
1130811|NCT02374216|Periodontal Bone Loss|periodontal bone loss
1130812|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
1130813|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
1130814|NCT02374203|Critical Illness|critical illness
1130815|NCT02374203|Mechanical ventilator|mechanical ventilator
1130816|NCT02374203|Indirect Calorimetry|indirect calorimetry
1130817|NCT02374164|Drug therapy|drug therapy
1130818|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
1130819|NCT02374151|electrohysterography|electrohysterography
1130820|NCT02374138|psychosocial stress|psychosocial stress
1130821|NCT02374099|Breast Cancer|breast cancer
1130822|NCT02374099|Her2 -|her2 -
1130824|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
1130825|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
1130826|NCT02374099|Oralazacitidine|oralazacitidine
1130827|NCT02374099|Fulvestrant|fulvestrant
1130828|NCT02374099|Epigenetics|epigenetics
1130829|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
1130830|NCT02374008|Peripheral nerve block|peripheral nerve block
1130831|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
1130832|NCT02374008|Dexamethasone|dexamethasone
1130833|NCT02373995|Graves|graves
1130834|NCT02373995|Orbithopaty|orbithopaty
1130835|NCT02373995|euthyroidism|euthyroidism
1130836|NCT02373995|microbiome|microbiome
1130837|NCT02373943|vitamin A|vitamin a
1130838|NCT02373943|human|human
1130839|NCT02373943|bioavailability|bioavailability
1130840|NCT02373943|fortified maize|fortified maize
1130841|NCT02373943|cross-over|cross-over
1130842|NCT02373943|beta-carotene|beta-carotene
1130843|NCT02373930|Dolutegravir|dolutegravir
1130844|NCT02373930|safety|safety
1130845|NCT02373930|Rilpivirine|rilpivirine
1130846|NCT02373930|fixed dose combination|fixed dose combination
1130847|NCT02373930|relative bioavailability|relative bioavailability
1130848|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
1130849|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
1130850|NCT02373865|metformin monotherapy|metformin monotherapy
1130851|NCT02373800|Induced|induced
1130852|NCT02373800|pre-term labor|pre-term labor
1130853|NCT02373787|Resorbable|resorbable
1130854|NCT02373787|Collagen membrane|collagen membrane
1130855|NCT02373787|NobelReplace CC|nobelreplace cc
1130856|NCT02373774|infant|infant
1130857|NCT02373774|lumbar puncture|lumbar puncture
1130858|NCT02373774|patient safety|patient safety
1130859|NCT02373774|ultrasound|ultrasound
1130860|NCT02373735|stroke volume variation|stroke volume variation
1130861|NCT02373735|radical cystectomy|radical cystectomy
1130862|NCT02373735|blood loss|blood loss
1130863|NCT02373735|postoperative complications|postoperative complications
1130864|NCT02373696|Pain|pain
1130865|NCT02373696|Caesarean section|caesarean section
1130866|NCT02373670|Positive deviance|positive deviance
1130867|NCT02373670|Peer mentors|peer mentors
1130868|NCT02373657|trachoma|trachoma
1130869|NCT02373657|soil transmitted helminths|soil transmitted helminths
1130870|NCT02373657|water|water
1130871|NCT02373657|hand washing|hand washing
1130872|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
1130873|NCT02373592|Thermometry|thermometry
1130874|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1130875|NCT02373592|Foot Ulcer|foot ulcer
1130876|NCT02373592|Telemedicine|telemedicine
1130877|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
1130878|NCT02373579|methotrexate|methotrexate
1130879|NCT02373579|hepatotoxicity|hepatotoxicity
1130880|NCT02373566|burns|burns
1130881|NCT02373566|dermal substitute|dermal substitute
1130882|NCT02373566|scar quality|scar quality
1130883|NCT02373566|reconstruction|reconstruction
1130884|NCT02373566|wound healing|wound healing
1130885|NCT02373566|wound closure|wound closure
1130886|NCT02373553|posture|posture
1130887|NCT02373553|postural|postural
1130888|NCT02373553|kinetics|kinetics
1130889|NCT02373540|spinal cord stimulation|spinal cord stimulation
1130890|NCT02373540|chronic pain|chronic pain
1130891|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
1130892|NCT02373501|caesarean delivery|caesarean delivery
1130893|NCT02373501|uterine incision repair|uterine incision repair
1130894|NCT02373488|Constipation|constipation
1130895|NCT02373488|connective tissue manipulation|connective tissue manipulation
1130896|NCT02373488|abdominal massage|abdominal massage
1130897|NCT02373488|bowel movements|bowel movements
1130898|NCT02373488|quality of life|quality of life
1130899|NCT02373475|spine surgery|spine surgery
1130900|NCT02373475|prone position|prone position
1130901|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
1130902|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
1130903|NCT02373449|Ketamine|ketamine
1130904|NCT02373449|fMRI|fmri
1130905|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
1130906|NCT02373436|Upper Extremity|upper extremity
1130907|NCT02373436|Rehabilitation|rehabilitation
1130908|NCT02373397|Wound healing|wound healing
1568848|NCT00504439|CD11b,|cd11b,
1130909|NCT02373397|nerve regeneration|nerve regeneration
1130910|NCT02373397|re-epithelialization|re-epithelialization
1130911|NCT02373397|corneal epithelium|corneal epithelium
1130912|NCT02373397|laser corneal surgery|laser corneal surgery
1130913|NCT02373384|Radiolucent renal stones|radiolucent renal stones
1130914|NCT02373384|Oral dissolution therapy|oral dissolution therapy
1130915|NCT02373384|Systemic chemolysis|systemic chemolysis
1130916|NCT02373384|Renal uric acid stones|renal uric acid stones
1130917|NCT02373384|Alkalinization|alkalinization
1130918|NCT02373358|Complex trauma|complex trauma
1130919|NCT02373358|Yoga|yoga
1130920|NCT02373345|psychological factors|psychological factors
1130921|NCT02373345|functional disability|functional disability
1130922|NCT02373345|pain thresholds|pain thresholds
1130923|NCT02373345|tolerance thresholds|tolerance thresholds
1130924|NCT02373345|motor adaptations|motor adaptations
1130925|NCT02373345|natural course|natural course
1130926|NCT02373332|platelets|platelets
1130927|NCT02373332|12-lipoxygenase|12-lipoxygenase
1130928|NCT02373332|fatty acids|fatty acids
1130929|NCT02373332|DGLA|dgla
1130933|NCT02373319|Cardiovascular risk|cardiovascular risk
1130934|NCT02373319|Cholesterol|cholesterol
1130935|NCT02373319|Hypertension|hypertension
1130936|NCT02373319|Diabetes|diabetes
1130937|NCT02373319|Smoking|smoking
1130938|NCT02373319|Preventive Medicine|preventive medicine
1130939|NCT02373319|Epidemiology|epidemiology
1130940|NCT02373319|Public Health|public health
1130941|NCT02373319|Diet|diet
1130942|NCT02373319|Physical Activity|physical activity
1130943|NCT02373306|Risk stratification|risk stratification
1130944|NCT02373306|ICD intervention|icd intervention
1130945|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
1130946|NCT02373293|Acute pancreatitis|acute pancreatitis
1130947|NCT02373280|Helicobacter pylori|helicobacter pylori
1130948|NCT02373280|tailored therapy|tailored therapy
1130949|NCT02373280|eradication|eradication
1130950|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
1130951|NCT02373241|Sickle Cell Disease|sickle cell disease
1130952|NCT02373241|Kidney Disease|kidney disease
1130953|NCT02373241|Hypertension|hypertension
1130954|NCT02373241|Proteinuria|proteinuria
1130955|NCT02373241|Losartan|losartan
1130956|NCT02373241|Antihypertensive Agents|antihypertensive agents
1130957|NCT02373241|Blood Pressure|blood pressure
1130958|NCT02373111|Anti-aging|anti-aging
1130959|NCT02373111|Isoflavones|isoflavones
1130960|NCT02373111|Astaxanthine|astaxanthine
1130961|NCT02373111|Skin aging|skin aging
1130962|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
1130963|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
1130964|NCT02373085|Kidney transplant recipients|kidney transplant recipients
1130965|NCT02373085|Pyelonephritis|pyelonephritis
1130966|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
1130967|NCT02373033|Folate|folate
1130968|NCT02373033|folic acid|folic acid
1130969|NCT02373033|intervention trial|intervention trial
1130970|NCT02373033|folate status|folate status
1130971|NCT02373033|women in childbearing age|women in childbearing age
1130972|NCT02373033|food folate|food folate
1130973|NCT02372994|chronic disease|chronic disease
1130974|NCT02372994|continuity of patient care|continuity of patient care
1130975|NCT02372994|patient engagement|patient engagement
1130976|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
1130977|NCT02372994|user-centred design|user-centred design
1130978|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
1130979|NCT02372994|Medical Informatics|medical informatics
1130980|NCT02372994|Patient-centred care|patient-centred care
1130981|NCT02372942|efficacy|efficacy
1130983|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
1130984|NCT02372890|Cancer of Head and Neck|cancer of head and neck
1130985|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1130986|NCT02372890|Positron Emission Tomography|positron emission tomography
1130988|NCT02372890|FDG|fdg
1130989|NCT02372877|Sickle Cell Disease|sickle cell disease
1130990|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
1130991|NCT02372877|Hb S Disease|hb s disease
1130992|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
1130993|NCT02372864|Ovariectomy|ovariectomy
1130994|NCT02372864|Mindfulness|mindfulness
1130995|NCT02372864|Postmenopause|postmenopause
1130996|NCT02372864|Hot Flashes|hot flashes
1130997|NCT02372851|Arsenic|arsenic
1130998|NCT02372851|Household water treatment|household water treatment
1130999|NCT02372851|Point of use water treatment|point of use water treatment
1131000|NCT02372851|Water Quality|water quality
1131001|NCT02372851|Total Urinary Arsenic|total urinary arsenic
1131002|NCT02372851|West Bengal|west bengal
1131003|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
1131004|NCT02372851|Compliance|compliance
1131005|NCT02372851|Diarrhoea|diarrhoea
1131006|NCT02372825|Free iliac crest transfer|free iliac crest transfer
1131007|NCT02372825|Bone reconstruction|bone reconstruction
1568849|NCT00504439|CXCR2,|cxcr2,
1131008|NCT02372825|Ankle reconstruction|ankle reconstruction
1131009|NCT02372825|Heel reconstruction|heel reconstruction
1131010|NCT02372812|effect of dexamethasone|effect of dexamethasone
1131011|NCT02372812|general surgery|general surgery
1131012|NCT02372812|post operative|post operative
1131013|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
1131014|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
1131015|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
1131016|NCT02372773|MAPT|mapt
1131017|NCT02372773|PGRN|pgrn
1131018|NCT02372773|C9ORF72|c9orf72
1131019|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
1131020|NCT02372760|Spray Catheter|spray catheter
1131021|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
1131022|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
1131023|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
1131024|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
1131025|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
1131026|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
1131027|NCT02372747|Gastric cancer|gastric cancer
1131028|NCT02372721|acute kidney injury|acute kidney injury
1131127|NCT02372253|type 1 diabetes|type 1 diabetes
1131029|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
1131030|NCT02372643|clitoris|clitoris
1131031|NCT02372643|sexuality|sexuality
1131032|NCT02372643|vascularization|vascularization
1131033|NCT02372643|doppler|doppler
1131034|NCT02372643|ultrasound|ultrasound
1131035|NCT02372643|reference|reference
1131036|NCT02372643|female|female
1131037|NCT02372643|Pilot Projects|pilot projects
1131038|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
1131039|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
1131040|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
1131041|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
1131042|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
1131043|NCT02372643|Reference values|reference values
1131044|NCT02372643|Clitoris/blood supply|clitoris/blood supply
1131045|NCT02372617|cerebral palsy|cerebral palsy
1131046|NCT02372617|hip|hip
1131047|NCT02372617|luxation|luxation
1131048|NCT02372617|subluxation|subluxation
1131049|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
1131050|NCT02372604|Levocetirizine|levocetirizine
1131051|NCT02372604|H1-antihistamine|h1-antihistamine
1131052|NCT02372604|Fourfold dosage|fourfold dosage
1131053|NCT02372604|Efficacy|efficacy
1131054|NCT02372604|Tolerance|tolerance
1131055|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
1131056|NCT02372604|resistant|resistant
1131057|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
1131058|NCT02372591|Hydromorphone|hydromorphone
1131059|NCT02372591|Buprenorphine|buprenorphine
1131060|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
1131061|NCT02372578|ASP3662|asp3662
1131062|NCT02372565|African American|african american
1131063|NCT02372565|Women|women
1131064|NCT02372565|Physical Activity|physical activity
1131065|NCT02372565|Social Media|social media
1131066|NCT02372565|Exercise|exercise
1131067|NCT02372565|Facebook|facebook
1131068|NCT02372565|Text message|text message
1131069|NCT02372539|dexamethasone|dexamethasone
1131070|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
1131071|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
1131072|NCT02372526|Glucagon|glucagon
1131073|NCT02372526|Peptide YY 3-36|peptide yy 3-36
1131074|NCT02372526|Ghrelin|ghrelin
1131075|NCT02372526|Body Weight|body weight
1131076|NCT02372526|Obesity|obesity
1131077|NCT02372526|Overnutrition|overnutrition
1131078|NCT02372526|Overweight|overweight
1131079|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
1131080|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
1131081|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
1131082|NCT02372513|Children|children
1131083|NCT02372513|Liver disease|liver disease
1131084|NCT02372474|POF|pof
1131085|NCT02372474|ESS|ess
1131086|NCT02372474|stem cell therapy|stem cell therapy
1131087|NCT02372461|Amoxicillin|amoxicillin
1131088|NCT02372461|Placebo|placebo
1131089|NCT02372435|PJI|pji
1131090|NCT02372422|Twins|twins
1131091|NCT02372422|Twin gestation|twin gestation
1131092|NCT02372422|Preterm birth|preterm birth
1131093|NCT02372422|Prevention|prevention
1131094|NCT02372396|PTSD|ptsd
1131095|NCT02372396|Psychotherapy|psychotherapy
1131096|NCT02372396|OEF/OIF|oef/oif
1131097|NCT02372396|Veterans|veterans
1131098|NCT02372383|Cystic Fibrosis|cystic fibrosis
1131099|NCT02372383|Pharmacokinetics|pharmacokinetics
1131100|NCT02372383|Pharmacodynamics|pharmacodynamics
1131101|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
1131102|NCT02372383|Treatment|treatment
1131103|NCT02372357|chemotherapy|chemotherapy
1131104|NCT02372357|stem cell transplantation|stem cell transplantation
1131105|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
1568850|NCT00504439|safety,|safety,
1131106|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
1131107|NCT02372344|AZD0585|azd0585
1131108|NCT02372344|Japanese|japanese
1131109|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
1131110|NCT02372331|ERAS|eras
1131111|NCT02372331|Whipple's operation|whipple's operation
1131112|NCT02372331|Fast track|fast track
1131113|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
1131114|NCT02372318|cue-reactivity|cue-reactivity
1131115|NCT02372318|fMRI|fmri
1131116|NCT02372318|resting-state networks|resting-state networks
1131117|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
1131118|NCT02372279|Embryo development|embryo development
1131119|NCT02372279|Implantation|implantation
1131120|NCT02372279|In vitro fertilization|in vitro fertilization
1131121|NCT02372266|Infant, Newborn|infant, newborn
1131122|NCT02372266|hospital discharge|hospital discharge
1131123|NCT02372266|Early newborn discharge|early newborn discharge
1131124|NCT02372266|Newborn length of stay|newborn length of stay
1131125|NCT02372266|Maternity length of stay|maternity length of stay
1131126|NCT02372253|verapamil|verapamil
1131128|NCT02372253|diabetes|diabetes
1131130|NCT02372253|beta cell function|beta cell function
1131131|NCT02372253|insulin|insulin
1131132|NCT02372214|Endovascular Procedures|endovascular procedures
1131133|NCT02372214|3D printing|3d printing
1131134|NCT02372214|Simulation|simulation
1131135|NCT02372214|Training|training
1131136|NCT02372214|Learning curve|learning curve
1131137|NCT02372214|Education|education
1131138|NCT02372201|irritable bowel disease|irritable bowel disease
1131139|NCT02372201|microbiota|microbiota
1131140|NCT02372201|hydro colon therapy|hydro colon therapy
1131141|NCT02372201|food intolerance|food intolerance
1131142|NCT02372175|Dengue|dengue
1131143|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
1131144|NCT02372162|Molecular Diagnostics|molecular diagnostics
1131145|NCT02372162|Sorafenib|sorafenib
1131146|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
1131147|NCT02372162|Next-generation sequencing|next-generation sequencing
1131148|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
1131149|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
1131150|NCT02372162|Metabolomics|metabolomics
1131151|NCT02372123|Dysmenorrhea|dysmenorrhea
1131152|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
1131153|NCT02372123|physiotherapy|physiotherapy
1131154|NCT02372123|massage|massage
1131155|NCT02372123|connective tissue massage|connective tissue massage
1131156|NCT02372123|connective tissue manipulation|connective tissue manipulation
1131157|NCT02372084|Hepatic impairment,|hepatic impairment,
1131158|NCT02372084|osilodrostat,|osilodrostat,
1131159|NCT02372084|LCI699|lci699
1131160|NCT02372032|Herniation|herniation
1131161|NCT02372032|Discectomy|discectomy
1131162|NCT02372032|Ozone|ozone
1131163|NCT02372019|Social Anxiety Disorder|social anxiety disorder
1131164|NCT02372019|Social Phobia|social phobia
1131165|NCT02372019|Reconsolidation|reconsolidation
1131166|NCT02372019|Cognitive Bias Modification|cognitive bias modification
1131167|NCT02372019|Interpretation Bias|interpretation bias
1131168|NCT02371980|Drug therapy|drug therapy
1131169|NCT02371928|Shoulder|shoulder
1131170|NCT02371928|Instability|instability
1131171|NCT02371928|Neuromuscular|neuromuscular
1131172|NCT02371928|Physiotherapy|physiotherapy
1131173|NCT02371928|Exercise|exercise
1131174|NCT02371928|Dislocation|dislocation
1131175|NCT02371928|Recurrence|recurrence
1131176|NCT02371915|Rural access|rural access
1131177|NCT02371915|Telehealth|telehealth
1131178|NCT02371902|Elbow pain|elbow pain
1131179|NCT02371902|lateral epicondylitis|lateral epicondylitis
1131180|NCT02371902|conservative treatment|conservative treatment
1131181|NCT02371902|shock wave treatment|shock wave treatment
1131182|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
1131183|NCT02371850|Bioequivalence|bioequivalence
1131184|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
1131185|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
1131186|NCT02371824|Bone Marrow|bone marrow
1131188|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
1131189|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
1131190|NCT02371785|Critical Limb Ischemia|critical limb ischemia
1131191|NCT02371785|Claudication|claudication
1131192|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
1131193|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
1131194|NCT02371772|Warfarin|warfarin
1131195|NCT02371772|Self Care|self care
1131196|NCT02371772|Conventional care|conventional care
1131197|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
1131198|NCT02371733|aerobic exercise training|aerobic exercise training
1131199|NCT02371733|upper extremity|upper extremity
1131200|NCT02371733|exercise capacity|exercise capacity
1131201|NCT02371694|Lipid|lipid
1131202|NCT02371694|Carbohydrate counting|carbohydrate counting
1131203|NCT02371694|Adolescent|adolescent
1131204|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
1131205|NCT02371694|Insulin requirements|insulin requirements
1131206|NCT02371681|HR2E/RIPE|hr2e/ripe
1131207|NCT02371681|South Africa|south africa
1131208|NCT02371681|Time to Positivity/TTP|time to positivity/ttp
1131209|NCT02371681|FDG-PET/CT|fdg-pet/ct
1131210|NCT02371668|Influenza A|influenza a
1131211|NCT02371668|H1N1|h1n1
1131212|NCT02371668|Challenge Model|challenge model
1131213|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
1131214|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
1131215|NCT02371655|Bowel cleansing|bowel cleansing
1131216|NCT02371655|CTcolonography|ctcolonography
1131217|NCT02371655|Bowel preparation|bowel preparation
1131218|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
1131219|NCT02371642|Echocardiography|echocardiography
1131220|NCT02371629|Anticholinergic|anticholinergic
1131221|NCT02371629|Antimuscarinic|antimuscarinic
1131222|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1131223|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1131224|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1131225|NCT02371629|COPD|copd
1131226|NCT02371629|LAMA|lama
1131227|NCT02371629|Lung Disease|lung disease
1131228|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
1131229|NCT02371629|Lung Function|lung function
1131230|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
1131231|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1131232|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
1131233|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1131234|NCT02371603|GSK1278863|gsk1278863
1131235|NCT02371603|Anemia|anemia
1131236|NCT02371603|Drug interaction|drug interaction
1131237|NCT02371590|cancer|cancer
1131238|NCT02371590|lenalidomide|lenalidomide
1131239|NCT02371590|obinutuzumab|obinutuzumab
1131241|NCT02371577|Revlimid|revlimid
1131242|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1131243|NCT02371551|Medical Sonography|medical sonography
1131244|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
1131245|NCT02371538|stem cell transplant|stem cell transplant
1131246|NCT02371538|human breastmilk|human breastmilk
1131247|NCT02371525|adherence|adherence
1131248|NCT02371525|prevention|prevention
1131249|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
1131250|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
1131251|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
1131252|NCT02371499|microbiota|microbiota
1131253|NCT02371486|cesarean section defect|cesarean section defect
1131254|NCT02371486|implantation|implantation
1131255|NCT02371486|ivf|ivf
1131256|NCT02371473|Acetazolamide|acetazolamide
1131257|NCT02371473|Central Sleep Apnea|central sleep apnea
1131258|NCT02371473|Opium Abuse|opium abuse
1131259|NCT02371460|Neonatal Prematurity|neonatal prematurity
1131260|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
1131261|NCT02371460|Breastfeeding|breastfeeding
1131262|NCT02371447|bladder cancer|bladder cancer
1131263|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
1131264|NCT02371447|VPM1002BC|vpm1002bc
1131265|NCT02371447|BCG therapy|bcg therapy
1131266|NCT02371369|PLX3397|plx3397
1131267|NCT02371369|Pexidartinib|pexidartinib
1131268|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor|colony stimulating factor 1 receptor (csf-1r) inhibitor
1131269|NCT02371330|Thrombocytopenia|thrombocytopenia
1131270|NCT02371330|Neonate|neonate
1131271|NCT02371330|PFA-100|pfa-100
1131272|NCT02371330|Neo-BAT|neo-bat
1131273|NCT02371330|Hemorrhage|hemorrhage
1131274|NCT02371317|Randomized clinical trial|randomized clinical trial
1131275|NCT02371317|Early medical intervention|early medical intervention
1131276|NCT02371317|Intervention studies|intervention studies
1131277|NCT02371317|Blood pressure|blood pressure
1131278|NCT02371317|Stress Management|stress management
1131279|NCT02371304|local therapy|local therapy
1131280|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
1131281|NCT02371304|rectal preserving|rectal preserving
1131282|NCT02371291|Memory Flexibility|memory flexibility
1131283|NCT02371278|Leucine|leucine
1131284|NCT02371278|Protein|protein
1131285|NCT02371278|Diet|diet
1131286|NCT02371278|Muscle protein synthesis|muscle protein synthesis
1131287|NCT02371265|HIV|hiv
1131288|NCT02371265|Mozambique|mozambique
1131289|NCT02371265|antenatal care|antenatal care
1131290|NCT02371265|adherence|adherence
1131291|NCT02371265|retention|retention
1131292|NCT02371265|pregnancy|pregnancy
1131293|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
1131294|NCT02371252|Osteoporosis|osteoporosis
1131295|NCT02371252|Bisphosphonates|bisphosphonates
1131296|NCT02371252|Alendronate|alendronate
1131297|NCT02371252|Bone mineral density|bone mineral density
1131298|NCT02371252|Bone markers|bone markers
1131299|NCT02371239|Glucose regulation|glucose regulation
1131300|NCT02371239|Glucose|glucose
1131301|NCT02371239|Lipids|lipids
1131302|NCT02371226|MPS I|mps i
1131303|NCT02371213|Social Networking|social networking
1131304|NCT02371213|Mobile phone|mobile phone
1131305|NCT02371213|Antenatal Care|antenatal care
1131306|NCT02371213|Health education|health education
1131307|NCT02371213|Maternal outcome|maternal outcome
1131308|NCT02371213|Neonatal outcome|neonatal outcome
1131309|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
1131310|NCT02371174|Japan|japan
1131311|NCT02371174|Eribulin Mesylate|eribulin mesylate
1131312|NCT02371135|Gut Microbiome|gut microbiome
1131313|NCT02371135|15-016|15-016
1131314|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
1131315|NCT02370979|Dolutegravir|dolutegravir
1131316|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
1131317|NCT02370979|Reservoir|reservoir
1131318|NCT02370953|Toric IOL alignment|toric iol alignment
1131319|NCT02370953|VERION digital marker|verion digital marker
1131320|NCT02370953|Manual ink-marking|manual ink-marking
1131321|NCT02370953|Randomized controlled trial|randomized controlled trial
1131322|NCT02370940|Iron bioavailability|iron bioavailability
1131323|NCT02370940|phytate|phytate
1131324|NCT02370940|serum iron curve|serum iron curve
1131325|NCT02370940|hepcidin|hepcidin
1131326|NCT02370940|iron status|iron status
1131327|NCT02370914|Concussion|concussion
1131328|NCT02370888|Lenalidomide|lenalidomide
1131329|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1131330|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1131331|NCT02370862|Spinal Cord Injury|spinal cord injury
1131332|NCT02370862|Neurogenic Bowel|neurogenic bowel
1131333|NCT02370862|Bowel Evacuation|bowel evacuation
1131334|NCT02370862|Gut Motility|gut motility
1131335|NCT02370849|nimotuzumab|nimotuzumab
1131336|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
1131337|NCT02370849|Cisplatin|cisplatin
1131338|NCT02370849|S-1|s-1
1131339|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
1131340|NCT02370836|distress|distress
1131341|NCT02370823|Osteoarthritis|osteoarthritis
1131342|NCT02370823|Knee|knee
1131343|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
1131344|NCT02370797|IOERT|ioert
1131345|NCT02370797|Radiation|radiation
1131346|NCT02370797|Single fraction|single fraction
1131347|NCT02370797|Lumpectomy|lumpectomy
1131348|NCT02370797|Radiation therapy|radiation therapy
1131349|NCT02370797|Avera|avera
1131350|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
1131351|NCT02370784|Raynaud|raynaud
1131352|NCT02370758|Quantiferon-CMV|quantiferon-cmv
1131353|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
1131354|NCT02370758|Solid Organ Transplants|solid organ transplants
1131355|NCT02370758|CMV Disease|cmv disease
1131356|NCT02370745|Incretin|incretin
1131357|NCT02370745|GLP-1|glp-1
1131358|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
1131359|NCT02370745|Microvascular recruitment|microvascular recruitment
1131360|NCT02370745|Amino Acids|amino acids
1131361|NCT02370745|Microvascular blood flow|microvascular blood flow
1131362|NCT02370732|Alcohol|alcohol
1131363|NCT02370732|Bariatric Surgery|bariatric surgery
1131364|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
1131365|NCT02370732|Alcohol impairment|alcohol impairment
1131366|NCT02370732|Alcohol reinforcement|alcohol reinforcement
1131367|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
1131368|NCT02370719|Diabetes mellitus|diabetes mellitus
1131369|NCT02370719|Randomized controlled trial|randomized controlled trial
1131370|NCT02370719|Primary care|primary care
1131371|NCT02370719|Physical activity|physical activity
1131372|NCT02370719|Lifestyle|lifestyle
1131373|NCT02370719|Blood glucose|blood glucose
1131374|NCT02370719|Mobile health|mobile health
1131375|NCT02370719|Hb A1c|hb a1c
1131376|NCT02370719|Self-management|self-management
1131377|NCT02370706|PIM447|pim447
1131378|NCT02370706|LGH447|lgh447
1131379|NCT02370706|PIM inhibitor|pim inhibitor
1131380|NCT02370706|LEE011|lee011
1131381|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
1131382|NCT02370706|ruxolitinib|ruxolitinib
1131383|NCT02370706|INC424|inc424
1131384|NCT02370706|Jakavi®|jakavi®
1131385|NCT02370706|Jakafi®|jakafi®
1131386|NCT02370706|INCB18424|incb18424
1131387|NCT02370706|JAK inhibitor|jak inhibitor
1131388|NCT02370706|myelofibrosis|myelofibrosis
1131389|NCT02370706|PMF|pmf
1131390|NCT02370706|PPV-MF|ppv-mf
1131391|NCT02370706|PET-MF|pet-mf
1131392|NCT02370693|mycophenolate|mycophenolate
1131393|NCT02370693|lung scarring|lung scarring
1131394|NCT02370680|Antiplatelet|antiplatelet
1131395|NCT02370680|Antiplatelet therapy|antiplatelet therapy
1131396|NCT02370680|platelet turnover|platelet turnover
1131397|NCT02370680|high platelet turnover|high platelet turnover
1131398|NCT02370680|platelet aggregation|platelet aggregation
1131399|NCT02370680|cardiovascular disease|cardiovascular disease
1131400|NCT02370680|coronary artery disease|coronary artery disease
1131401|NCT02370680|diabetes mellitus|diabetes mellitus
1131402|NCT02370667|Exercise|exercise
1131403|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
1131404|NCT02370654|COPD|copd
1131405|NCT02370654|Tai chi|tai chi
1131406|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
1131407|NCT02370641|urolithin A|urolithin a
1131408|NCT02370641|microflora|microflora
1131409|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
1131410|NCT02370628|facet block|facet block
1131411|NCT02370602|Drug therapy|drug therapy
1131412|NCT02370589|Ebola|ebola
1131413|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
1131414|NCT02370498|Gastric cancer|gastric cancer
1131415|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
1131416|NCT02370498|PD1|pd1
1131417|NCT02370498|PD-1|pd-1
1131418|NCT02370498|PDL1|pdl1
1131419|NCT02370498|PD-L1|pd-l1
1131420|NCT02370472|Ultrasound|ultrasound
1131421|NCT02370472|Image|image
1131422|NCT02370472|Learning Tool|learning tool
1131423|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
1131424|NCT02370472|Simulated Setting|simulated setting
1131425|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
1131426|NCT02370459|Immunization|immunization
1131427|NCT02370459|Quality Improvement|quality improvement
1131428|NCT02370459|Adolescent Health Services|adolescent health services
1131429|NCT02370446|Medication Log|medication log
1131430|NCT02370446|15-008|15-008
1131431|NCT02370433|Spinal Cord Injury|spinal cord injury
1131432|NCT02370433|Neurogenic Bowel|neurogenic bowel
1131433|NCT02370433|Bowel Evacuation|bowel evacuation
1131434|NCT02370420|Platelet-rich plasma|platelet-rich plasma
1131435|NCT02370420|Osteoarthritis|osteoarthritis
1131436|NCT02370407|surgical education|surgical education
1131437|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
1131438|NCT02370407|laparoscopic simulation|laparoscopic simulation
1131439|NCT02370407|robotic simulation|robotic simulation
1131440|NCT02370407|medical education|medical education
1131441|NCT02370394|Intimate Partner Violence|intimate partner violence
1131442|NCT02370394|Perinatal Women|perinatal women
1131443|NCT02370394|Mental Health|mental health
1131444|NCT02370316|metacognition|metacognition
1131445|NCT02370316|MRI|mri
1131446|NCT02370316|Psychotherapy|psychotherapy
1131447|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
1131448|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
1131449|NCT02370251|Cholestasis|cholestasis
1131450|NCT02370251|Omegaven|omegaven
1131451|NCT02370251|Fish Oil|fish oil
1131452|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
1131453|NCT02370238|Cancer Stem Cells|cancer stem cells
1131454|NCT02370225|sjogren's syndrome|sjogren's syndrome
1131455|NCT02370225|aerobic exercise|aerobic exercise
1131456|NCT02370225|fatigue|fatigue
1131457|NCT02370212|Creatine|creatine
1131458|NCT02370212|interval training|interval training
1131459|NCT02370212|effects on performance|effects on performance
1131460|NCT02370173|PTSD|ptsd
1131461|NCT02370173|Stress|stress
1131462|NCT02370173|Sleep Problems|sleep problems
1131463|NCT02370173|Brain imaging|brain imaging
1131464|NCT02370173|fMRI|fmri
1131465|NCT02370147|smoking reduction intervention|smoking reduction intervention
1131466|NCT02370147|no intention to quit|no intention to quit
1131467|NCT02370147|randomized controlled trial|randomized controlled trial
1131468|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
1131469|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
1131470|NCT02370121|Insulin Secretion|insulin secretion
1131471|NCT02370121|Insulin Sensitivity|insulin sensitivity
1131472|NCT02370121|Central Obesity|central obesity
1131473|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
1131474|NCT02370108|parkinson's disease|parkinson's disease
1131475|NCT02370108|rest tremor|rest tremor
1131476|NCT02370108|tremor reduction|tremor reduction
1131477|NCT02370095|ARDS|ards
1131478|NCT02370095|Acute Lung Injury|acute lung injury
1131479|NCT02370095|Acute Respiratory Failure|acute respiratory failure
1131480|NCT02370082|lumpectomy|lumpectomy
1131481|NCT02370082|breast conserving surgery|breast conserving surgery
1131483|NCT02370030|citrulline|citrulline
1131484|NCT02370030|endothelial|endothelial
1131485|NCT02370030|toxemia|toxemia
1131486|NCT02370030|endothelial determination of progression|endothelial determination of progression
1131487|NCT02370030|with vs without citrulline|with vs without citrulline
1131488|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
1131489|NCT02370004|Asthma|asthma
1131490|NCT02370004|RFST|rfst
1131491|NCT02370004|Bronchial Diseases|bronchial diseases
1131492|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
1131493|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
1131494|NCT02370004|Lung Diseases|lung diseases
1131495|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
1131496|NCT02369991|bone transport|bone transport
1131497|NCT02369991|bone reconstruction|bone reconstruction
1188540|NCT02084576|OCT|oct
1131498|NCT02369991|tibia|tibia
1131499|NCT02369991|tibial fracture|tibial fracture
1131500|NCT02369978|Trypanocidal therapy|trypanocidal therapy
1131501|NCT02369978|Benznidazole|benznidazole
1131502|NCT02369978|Nifurtimox|nifurtimox
1131503|NCT02369978|Polymerase chain reaction|polymerase chain reaction
1131504|NCT02369978|Randomized trial|randomized trial
1131505|NCT02369965|HIV-1|hiv-1
1131506|NCT02369965|AIDS|aids
1131507|NCT02369965|Albuvirtide|albuvirtide
1131508|NCT02369965|Treatment-experienced|treatment-experienced
1131509|NCT02369965|Fusion inhibitor|fusion inhibitor
1131510|NCT02369939|anal carcinoma|anal carcinoma
1131511|NCT02369939|hyperthermia|hyperthermia
1131512|NCT02369939|radiotherapy|radiotherapy
1131513|NCT02369939|chemotherapy|chemotherapy
1131514|NCT02369939|radiochemotherapy|radiochemotherapy
1131515|NCT02369926|multiple sclerosis|multiple sclerosis
1131516|NCT02369926|telemedicine|telemedicine
1131517|NCT02369926|remote monitoring|remote monitoring
1131518|NCT02369926|lisinopril|lisinopril
1131519|NCT02369900|Esmolol|esmolol
1131520|NCT02369900|Septic Shock|septic shock
1131521|NCT02369900|Hypotension|hypotension
1131522|NCT02369900|Tachycardia|tachycardia
1131523|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
1131524|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
1131525|NCT02369822|Vitamin C|vitamin c
1131526|NCT02369822|convulsions status|convulsions status
1131527|NCT02369822|EEG|eeg
1131528|NCT02369822|children|children
1131529|NCT02369809|Ischemia|ischemia
1131530|NCT02369796|Drug therapy|drug therapy
1131531|NCT02369770|Acute Stroke|acute stroke
1131532|NCT02369770|Robotic therapy|robotic therapy
1131533|NCT02369770|Ankle impairment|ankle impairment
1131534|NCT02369744|Ureteral calculus|ureteral calculus
1131535|NCT02369744|Ureterolithiasis|ureterolithiasis
1131536|NCT02369744|Ureteral stone|ureteral stone
1131537|NCT02369744|Kidney stone|kidney stone
1131538|NCT02369744|Medical expulsive therapy|medical expulsive therapy
1131539|NCT02369744|tamsulosin|tamsulosin
1131540|NCT02369744|silodosin|silodosin
1131541|NCT02369744|rapaflo|rapaflo
1131542|NCT02369744|flomax|flomax
1131543|NCT02369679|upper limb|upper limb
1131544|NCT02369679|lymphedema|lymphedema
1131545|NCT02369666|Inflammation|inflammation
1131546|NCT02369666|Lycopene|lycopene
1131547|NCT02369666|Exercise|exercise
1131548|NCT02369653|Anticoagulation|anticoagulation
1131549|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
1131550|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
1131551|NCT02369601|amniorrhexis|amniorrhexis
1131552|NCT02369601|Ruptured membranes|ruptured membranes
1131553|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
1131554|NCT02369562|Dental implants|dental implants
1131555|NCT02369562|Periodontal Bone Loss|periodontal bone loss
1131556|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1131557|NCT02369549|Micro-particle curcumin|micro-particle curcumin
1131558|NCT02369549|Albuminuria|albuminuria
1131559|NCT02369536|NAFLD|nafld
1131560|NCT02369536|nutraceutical mixture|nutraceutical mixture
1131561|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
1131562|NCT02369510|spinal anesthesia|spinal anesthesia
1131563|NCT02369510|epinephrine|epinephrine
1131564|NCT02369510|bupivacaine|bupivacaine
1131565|NCT02369510|repeat cesarean|repeat cesarean
1131566|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
1131567|NCT02369471|Cannabidivarin|cannabidivarin
1131568|NCT02369471|CBDV|cbdv
1131569|NCT02369471|GWP42006|gwp42006
1131570|NCT02369432|Drug carriers|drug carriers
1131571|NCT02369432|Polymeric microparticles|polymeric microparticles
1131572|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
1131573|NCT02369432|Atopic dermatitis|atopic dermatitis
1131574|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
1131575|NCT02369432|Selective drug delivery|selective drug delivery
1131576|NCT02369432|Drug reservoir|drug reservoir
1131577|NCT02369419|frailty|frailty
1131578|NCT02369419|Heart failure|heart failure
1131579|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
1131580|NCT02369406|Botswana|botswana
1131581|NCT02369406|Immunology|immunology
1131582|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
1131583|NCT02369393|Internet based treatment|internet based treatment
1131584|NCT02369393|Depression|depression
1131585|NCT02369393|Efficacy|efficacy
1131586|NCT02369393|Cost-effectiveness|cost-effectiveness
1131587|NCT02369393|Behavioral Activation|behavioral activation
1131588|NCT02369393|Self-applied|self-applied
1131589|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
1131590|NCT02369393|Physical Activity|physical activity
1131591|NCT02369367|Malignant Gliomas|malignant gliomas
1131592|NCT02369367|Glioblastoma Multiforme|glioblastoma multiforme
1131593|NCT02369367|Gliosarcoma|gliosarcoma
1131594|NCT02369367|Anaplastic Astrocytoma|anaplastic astrocytoma
1188661|NCT02084030|POCD|pocd
1131595|NCT02369367|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
1131596|NCT02369367|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
1131597|NCT02369367|Camptosar|camptosar
1131598|NCT02369367|Irinotecan|irinotecan
1131599|NCT02369367|CPT-11|cpt-11
1131600|NCT02369367|Lenalidomide|lenalidomide
1131601|NCT02369367|Revlimid|revlimid
1131602|NCT02369367|CC-5013|cc-5013
1131603|NCT02369354|Kidney Transplant|kidney transplant
1131604|NCT02369354|African Americans|african americans
1131605|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
1131606|NCT02369341|Elderly|elderly
1131607|NCT02369341|Seasonal flu|seasonal flu
1131608|NCT02369341|Fluarix Tetra|fluarix tetra
1131609|NCT02369341|Adults|adults
1131610|NCT02369341|Immunogenicity|immunogenicity
1131611|NCT02369341|Reactogenicity|reactogenicity
1131612|NCT02369341|Influenza|influenza
1131613|NCT02369315|child development|child development
1131614|NCT02369315|music training|music training
1131615|NCT02369315|self-regulation|self-regulation
1131616|NCT02369315|exposure to violence|exposure to violence
1131617|NCT02369276|neck dissection surgery|neck dissection surgery
1131618|NCT02369276|shoulder disability|shoulder disability
1131619|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
1131620|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
1131622|NCT02369263|Leg Swelling|leg swelling
1131623|NCT02369263|Leg Pain|leg pain
1131624|NCT02369263|Blood Clot|blood clot
1131625|NCT02369250|regeneration|regeneration
1131626|NCT02369250|surgical therapy|surgical therapy
1131627|NCT02369250|furcation defect|furcation defect
1131628|NCT02369211|acetaminophen|acetaminophen
1131629|NCT02369172|Herpes|herpes
1131630|NCT02369172|volunteers|volunteers
1131631|NCT02369172|drug-drug interaction|drug-drug interaction
1131632|NCT02369120|patient education|patient education
1131633|NCT02369120|pain cognitions|pain cognitions
1131634|NCT02369107|acupuncture|acupuncture
1131635|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
1131636|NCT02369094|Frailty|frailty
1131637|NCT02369094|Frail elderly|frail elderly
1131638|NCT02369094|Acupressure|acupressure
1131639|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
1131640|NCT02369081|Hypertension|hypertension
1131641|NCT02369055|Rehabilitation|rehabilitation
1131642|NCT02369029|Phase I|phase i
1131643|NCT02369029|Dose escalation|dose escalation
1131644|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
1131645|NCT02369029|Acute Leucemia|acute leucemia
1131646|NCT02369029|Lymphoma|lymphoma
1131647|NCT02369029|Melanoma|melanoma
1131648|NCT02369029|Myeloma|myeloma
1131649|NCT02369029|HCC|hcc
1131650|NCT02369029|NSCLC|nsclc
1131651|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
1131652|NCT02369016|rituximab-refractory|rituximab-refractory
1131653|NCT02369003|Deep Brain Stimulation|deep brain stimulation
1131654|NCT02369003|Schwann Cells|schwann cells
1131655|NCT02368990|NSCLC|nsclc
1131656|NCT02368990|T790M|t790m
1131657|NCT02368990|EGFR|egfr
1131658|NCT02368990|TKI Resistance|tki resistance
1131659|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
1131660|NCT02368990|AZD9291|azd9291
1131661|NCT02368990|Clovis|clovis
1131662|NCT02368977|Colonoscopy|colonoscopy
1131663|NCT02368977|Polyps|polyps
1131664|NCT02368977|Adenomas|adenomas
1131665|NCT02368964|double triggering|double triggering
1131666|NCT02368964|Oocyte maturation|oocyte maturation
1131667|NCT02368964|GNRH Agonist|gnrh agonist
1131668|NCT02368964|hCG|hcg
1131669|NCT02368964|IVF treatment|ivf treatment
1131670|NCT02368964|immature oocytes|immature oocytes
1131671|NCT02368951|Phase 1|phase 1
1131672|NCT02368951|Solid Tumors|solid tumors
1131673|NCT02368951|FGFR2|fgfr2
1131674|NCT02368951|Antibody drug conjugate|antibody drug conjugate
1131675|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
1131676|NCT02368938|Prospective study|prospective study
1131677|NCT02368938|Mortality|mortality
1131678|NCT02368938|Cardiovascular events|cardiovascular events
1131679|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
1131680|NCT02368938|elderly Chinese|elderly chinese
1131681|NCT02368925|Rhytids|rhytids
1131682|NCT02368925|Skin Laxity|skin laxity
1131683|NCT02368912|Phase 1|phase 1
1131684|NCT02368912|ASP1707|asp1707
1131685|NCT02368912|Dose escalation|dose escalation
1131686|NCT02368912|Food effect|food effect
1131687|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
1131688|NCT02368912|Healthy subjects|healthy subjects
1131689|NCT02368912|Single ascending dose|single ascending dose
1131690|NCT02368912|Multiple ascending dose|multiple ascending dose
1131691|NCT02368899|technology|technology
1131692|NCT02368899|information science|information science
1131693|NCT02368899|health care|health care
1131694|NCT02368873|prevention|prevention
1131695|NCT02368847|Aged|aged
1131696|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
1131697|NCT02368821|cytotrophoblast|cytotrophoblast
1131698|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
1131699|NCT02368821|placentas|placentas
1131700|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
1131701|NCT02368821|preeclampsia|preeclampsia
1131702|NCT02368821|placenta accrete|placenta accrete
1131703|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
1131704|NCT02368808|South Africa|south africa
1131705|NCT02368808|peer support group|peer support group
1131706|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1131707|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
1131708|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
1131709|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
1131710|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
1131711|NCT02368782|ketamine|ketamine
1131712|NCT02368782|propofol|propofol
1131713|NCT02368782|child|child
1131715|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
1131716|NCT02368678|Halitosis|halitosis
1131717|NCT02368678|Sulfur compounds|sulfur compounds
1131718|NCT02368678|Periodontitis|periodontitis
1131719|NCT02368678|Periodontal treatment|periodontal treatment
1131720|NCT02368600|lifestyle intervention|lifestyle intervention
1131721|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
1131722|NCT02368600|Chinese|chinese
1131723|NCT02368600|prevention|prevention
1131724|NCT02368587|intracoronary infusion|intracoronary infusion
1131725|NCT02368587|intravenous infusion|intravenous infusion
1131726|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
1131727|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
1131728|NCT02368587|heart function|heart function
1131729|NCT02368548|Pharmaceutical care|pharmaceutical care
1131730|NCT02368548|Emergency Service|emergency service
1131731|NCT02368535|teamwork|teamwork
1131732|NCT02368509|sensory test|sensory test
1131733|NCT02368509|olfaction|olfaction
1131737|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
1131738|NCT02368496|HR-pQCT|hr-pqct
1131739|NCT02368496|DXA|dxa
1131740|NCT02368496|Bone trophicity|bone trophicity
1131741|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
1131742|NCT02368457|Tocopherol|tocopherol
1131743|NCT02368457|pentoxifylline|pentoxifylline
1131744|NCT02368457|vitamine E|vitamine e
1131745|NCT02368457|wounds and injuries|wounds and injuries
1131746|NCT02368457|antioxidants|antioxidants
1131747|NCT02368457|free radical scavengers|free radical scavengers
1131748|NCT02368457|radiation-protective agents|radiation-protective agents
1131749|NCT02368457|vasodilatadors agents|vasodilatadors agents
1131750|NCT02368457|osteonecrosis|osteonecrosis
1131751|NCT02368457|mandible|mandible
1131752|NCT02368457|extraoral fistula|extraoral fistula
1131753|NCT02368457|exposed bone|exposed bone
1131754|NCT02368457|necrotic bone|necrotic bone
1131755|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
1131756|NCT02368444|Posttraumatic Stress|posttraumatic stress
1131757|NCT02368444|Sleep|sleep
1131758|NCT02368431|Alcohol Use Disorder|alcohol use disorder
1131759|NCT02368431|Alcoholism|alcoholism
1131760|NCT02368431|Alcohol Dependence|alcohol dependence
1131761|NCT02368431|Zonisamide|zonisamide
1131762|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
1131763|NCT02368431|Drinking Behaviors|drinking behaviors
1131764|NCT02368431|Anticonvulsants|anticonvulsants
1131765|NCT02368418|Cardiovascular disease|cardiovascular disease
1131766|NCT02368418|Rural health|rural health
1131767|NCT02368418|China|china
1131768|NCT02368418|Cohort study|cohort study
1131769|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
1131770|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
1131771|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
1131772|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
1131773|NCT02368379|Metyrapone|metyrapone
1131774|NCT02368379|ACTH stimulation test|acth stimulation test
1131775|NCT02368314|Deep vein thrombosis|deep vein thrombosis
1131776|NCT02368314|Prophylaxis|prophylaxis
1131777|NCT02368314|Sodium enoxaparin|sodium enoxaparin
1131778|NCT02368288|chronic hepatitic B|chronic hepatitic b
1131779|NCT02368288|peginterferon|peginterferon
1131780|NCT02368288|HBsAg|hbsag
1131781|NCT02368288|entecavir|entecavir
1131782|NCT02368262|Cerebral Palsy|cerebral palsy
1131783|NCT02368262|Risk factors|risk factors
1131784|NCT02368262|Child|child
1131785|NCT02368262|urinary incontinence|urinary incontinence
1131786|NCT02368236|Early Detection of Cancer|early detection of cancer
1131787|NCT02368236|Intervention Studies|intervention studies
1131788|NCT02368236|Randomized Controlled Trial|randomized controlled trial
1131789|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
1131790|NCT02368236|Colonic Neoplasms|colonic neoplasms
1131791|NCT02368223|Children|children
1131792|NCT02368223|Rehabilitation|rehabilitation
1131793|NCT02368223|Telerehabilitation|telerehabilitation
1131794|NCT02368223|Upper limb therapy|upper limb therapy
1131795|NCT02368197|dialysis fistula|dialysis fistula
1131796|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
1131797|NCT02368197|balloon angioplasty|balloon angioplasty
1131798|NCT02368197|drug eluting balloon|drug eluting balloon
1131799|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
1131800|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
1131801|NCT02368158|myocard infarction|myocard infarction
1131802|NCT02368158|arrhythmia|arrhythmia
1131803|NCT02368158|fitness of driving|fitness of driving
1131805|NCT02368145|acute stroke|acute stroke
1131806|NCT02368145|post stroke depression|post stroke depression
1131807|NCT02368132|Caregivers|caregivers
1131808|NCT02368132|Dementia|dementia
1131809|NCT02368106|patient registry|patient registry
1131810|NCT02368106|radiation oncology|radiation oncology
1131811|NCT02368106|technology assessment|technology assessment
1131812|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
1131813|NCT02368080|Lung Clearance Index|lung clearance index
1131814|NCT02368080|Cystic Fibrosis|cystic fibrosis
1131815|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
1131816|NCT02368054|Epinephrine|epinephrine
1131817|NCT02368054|Bupivacaine|bupivacaine
1131818|NCT02368054|Stroke Volume|stroke volume
1131819|NCT02368054|Cardiac Output|cardiac output
1131820|NCT02368054|Heart Rate|heart rate
1131821|NCT02368054|Hemodynamics|hemodynamics
1131822|NCT02368054|Total Peripheral Resistance|total peripheral resistance
1131823|NCT02368054|Blood Pressure|blood pressure
1131824|NCT02368054|Paracervical block|paracervical block
1131825|NCT02368054|LiDCO|lidco
1131826|NCT02368054|Adrenaline|adrenaline
1131827|NCT02368054|Conization|conization
1131828|NCT02368054|PulsCO|pulsco
1131829|NCT02368028|Plaque|plaque
1131830|NCT02368028|Saliva|saliva
1131831|NCT02368028|Dental Caries|dental caries
1131832|NCT02368015|Penetration|penetration
1131833|NCT02368015|Cefazolin|cefazolin
1131834|NCT02368015|Hepatic cyst|hepatic cyst
1131835|NCT02368002|obesity|obesity
1131836|NCT02368002|diet, reducing|diet, reducing
1131837|NCT02367989|Glucose response|glucose response
1131838|NCT02367989|Insulin response|insulin response
1131839|NCT02367989|Satiety|satiety
1131840|NCT02367963|Peer education|peer education
1131841|NCT02367963|Comprehensive health intervention|comprehensive health intervention
1131842|NCT02367963|Lifestyle|lifestyle
1131843|NCT02367963|Adult|adult
1131844|NCT02367963|Mid age|mid age
1131845|NCT02367963|Male|male
1131846|NCT02367963|Female|female
1131847|NCT02367963|Human|human
1131848|NCT02367963|Clinical trial|clinical trial
1131849|NCT02367963|Prevention and control|prevention and control
1131850|NCT02367963|Cardiovascular Disease|cardiovascular disease
1131851|NCT02367963|Behavior|behavior
1131852|NCT02367963|Risk Factors|risk factors
1131853|NCT02367963|Healthy lifestyle|healthy lifestyle
1131854|NCT02367963|Healthy people program|healthy people program
1131855|NCT02367963|Peer-group|peer-group
1131856|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
1131857|NCT02367898|Cognitive Training|cognitive training
1131858|NCT02367898|Lumosity|lumosity
1131859|NCT02367898|Crossword Puzzles|crossword puzzles
1131860|NCT02367885|Prevention|prevention
1131861|NCT02367872|Drug therapy|drug therapy
1131862|NCT02367859|ameloblastoma|ameloblastoma
1131863|NCT02367859|BRAF|braf
1131864|NCT02367859|odontogenic cancer|odontogenic cancer
1131865|NCT02367859|adamantinoma|adamantinoma
1131866|NCT02367846|Calcium Tracer|calcium tracer
1131867|NCT02367846|Oral Contraceptives|oral contraceptives
1131868|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
1131869|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
1131870|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
1131871|NCT02367833|Combined oral contraceptive|combined oral contraceptive
1131872|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
1131873|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
1131874|NCT02367807|HIV prevention|hiv prevention
1131875|NCT02367807|PrEP|prep
1131876|NCT02367807|young men who have sex with men|young men who have sex with men
1131877|NCT02367807|Truvada|truvada
1131878|NCT02367768|trauma blue|trauma blue
1131879|NCT02367768|major trauma|major trauma
1131880|NCT02367768|cohort study|cohort study
1131881|NCT02367768|prognostic factor|prognostic factor
1131882|NCT02367768|Healing Time|healing time
1131883|NCT02367768|Post Operative|post operative
1131884|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1131885|NCT02367755|cardiac arrest|cardiac arrest
1131886|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
1131887|NCT02367755|propofol|propofol
1131888|NCT02367755|lorazepam|lorazepam
1131889|NCT02367755|cerebral perfusion|cerebral perfusion
1131890|NCT02367755|electroencephalography|electroencephalography
1131891|NCT02367742|Diet|diet
1131892|NCT02367742|Physical Activity|physical activity
1131893|NCT02367742|NAFLD|nafld
1131894|NCT02367703|Mini-laparoscopy|mini-laparoscopy
1131895|NCT02367703|hysterectomy|hysterectomy
1131896|NCT02367703|Benign uterine diseases|benign uterine diseases
1131897|NCT02367703|Operative time|operative time
1131898|NCT02367690|Diabetes|diabetes
1131899|NCT02367690|Foot Ulcers|foot ulcers
1131900|NCT02367690|DFU|dfu
1131901|NCT02367690|KPT-330|kpt-330
1131902|NCT02367690|Selinexor|selinexor
1131903|NCT02367690|Karyopharm|karyopharm
1131904|NCT02367677|Photo|photo
1131905|NCT02367664|Japanese encephalitis|japanese encephalitis
1131906|NCT02367664|immunogenicity|immunogenicity
1131907|NCT02367664|safety|safety
1131908|NCT02367664|vaccine|vaccine
1131909|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
1131910|NCT02367651|Pazopanib|pazopanib
1131911|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1131912|NCT02367599|PrEP|prep
1131913|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
1131914|NCT02367599|Truvada|truvada
1131915|NCT02367599|CCTG|cctg
1131916|NCT02367599|595|595
1131917|NCT02367599|Vitamin D|vitamin d
1131918|NCT02367599|Bone mineral density|bone mineral density
1131919|NCT02367521|TBI Depression|tbi depression
1131920|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
1131921|NCT02367508|advance care planning|advance care planning
1131922|NCT02367508|coping skills|coping skills
1131923|NCT02367508|mindfulness|mindfulness
1131924|NCT02367508|meditation|meditation
1131925|NCT02367508|cancer|cancer
1131926|NCT02367508|adult|adult
1131927|NCT02367508|caregivers|caregivers
1131928|NCT02367508|oncology providers|oncology providers
1131929|NCT02367508|advance directives|advance directives
1131930|NCT02367508|anxiety|anxiety
1131931|NCT02367508|depression|depression
1131932|NCT02367508|quality of life|quality of life
1131933|NCT02367508|pilot project|pilot project
1131934|NCT02367495|Coronary Restenosis|coronary restenosis
1131935|NCT02367495|restenosis|restenosis
1131936|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
1131937|NCT02367495|drug-eluting stent|drug-eluting stent
1131938|NCT02367495|drug-coated balloon|drug-coated balloon
1131939|NCT02367495|coronary angiography|coronary angiography
1131940|NCT02367482|rGBM|rgbm
1131941|NCT02367482|Recurrent GBM|recurrent gbm
1132143|NCT02366481|Prediabetes|prediabetes
1131942|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
1131943|NCT02367469|recurrent brain tumors|recurrent brain tumors
1131944|NCT02367469|brain tumors|brain tumors
1131945|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
1131946|NCT02367456|MDS|mds
1131947|NCT02367456|AML|aml
1131948|NCT02367443|radiotherapy|radiotherapy
1131949|NCT02367443|therapeutic use|therapeutic use
1131950|NCT02367443|Radiation|radiation
1131951|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
1131952|NCT02367443|chemotherapy|chemotherapy
1131953|NCT02367417|Revision|revision
1131954|NCT02367417|Knee Joint|knee joint
1131955|NCT02367417|PMCF|pmcf
1131956|NCT02367417|Endo-Modell SL|endo-modell sl
1131957|NCT02367378|Minimally invasive surgery|minimally invasive surgery
1131958|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1131959|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1131960|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
1131961|NCT02367365|indocyanine green angiography|indocyanine green angiography
1131962|NCT02367365|persistent disease activity|persistent disease activity
1131963|NCT02367352|Drug therapy|drug therapy
1131964|NCT02367352|dose escalation|dose escalation
1131965|NCT02367352|dose expansion|dose expansion
1131966|NCT02367339|Critical Care|critical care
1131967|NCT02367339|Nursing staff|nursing staff
1131968|NCT02367339|Medical staff|medical staff
1131969|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
1131970|NCT02367339|Digestive tract colonization|digestive tract colonization
1131971|NCT02367339|Cross-contamination|cross-contamination
1131972|NCT02367326|score|score
1131973|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
1131974|NCT02367326|crohn's disease|crohn's disease
1131975|NCT02367326|ulcerative colitis|ulcerative colitis
1131976|NCT02367326|clinical response|clinical response
1131977|NCT02367326|thiopurines|thiopurines
1131978|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
1131979|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
1131980|NCT02367313|Antiviral|antiviral
1131981|NCT02367313|Cold|cold
1131982|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1131983|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
1131984|NCT02367313|Aviragen|aviragen
1131985|NCT02367287|Diet|diet
1131986|NCT02367287|Phenotype|phenotype
1131987|NCT02367287|Immunology|immunology
1131988|NCT02367287|Microbiota|microbiota
1131989|NCT02367287|Metabolomics|metabolomics
1131990|NCT02367287|Physical activity|physical activity
1131991|NCT02367287|Neuroendocrine system|neuroendocrine system
1131992|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
1131993|NCT02367248|Brain hemorrhage|brain hemorrhage
1131994|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
1131995|NCT02367248|Deferoxamine|deferoxamine
1131996|NCT02367248|Xingnaojing injection|xingnaojing injection
1131997|NCT02367248|Hematoma edema|hematoma edema
1131999|NCT02367235|sacrocolpopexy|sacrocolpopexy
1132000|NCT02367235|Colpassist|colpassist
1132001|NCT02367235|vaginal positioning device|vaginal positioning device
1132002|NCT02367209|FD MRI|fd mri
1132003|NCT02367209|COPD|copd
1132004|NCT02367209|SPECT/CT|spect/ct
1132005|NCT02367209|DCE MRI|dce mri
1132006|NCT02367196|CC-90002|cc-90002
1132007|NCT02367196|Monoclonal|monoclonal
1132008|NCT02367196|Antibody|antibody
1132009|NCT02367196|CD47|cd47
1132010|NCT02367196|Advanced|advanced
1132011|NCT02367196|Solid Cancers|solid cancers
1132012|NCT02367196|Hematologic Cancers|hematologic cancers
1132013|NCT02367183|Crohn's Disease|crohn's disease
1132014|NCT02367183|Active Crohn's Disease|active crohn's disease
1132015|NCT02367183|GED-0301|ged-0301
1132016|NCT02367183|Endoscopic|endoscopic
1132017|NCT02367183|Double-Blind|double-blind
1132018|NCT02367183|IBD|ibd
1132019|NCT02367183|Mongersen|mongersen
1132020|NCT02367170|respiratory dysfunction|respiratory dysfunction
1132021|NCT02367170|chronic critical illness|chronic critical illness
1132022|NCT02367170|diaphragm weakness|diaphragm weakness
1132023|NCT02367170|sepsis|sepsis
1132024|NCT02367170|ventilator dependance|ventilator dependance
1132025|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
1132026|NCT02367105|Obesity|obesity
1132027|NCT02367105|Hypogonadism|hypogonadism
1132028|NCT02367105|Frailty|frailty
1132029|NCT02367092|Liver Transplantation|liver transplantation
1132030|NCT02367066|patients|patients
1132031|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
1132032|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
1132033|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
1132034|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1132035|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
1132036|NCT02367027|Biological Availability|biological availability
1132037|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
1132038|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
1132039|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
1132040|NCT02367014|Bendavia™|bendavia™
1132041|NCT02367014|elamipretide|elamipretide
1132042|NCT02367001|general practitioner|general practitioner
1132043|NCT02367001|screening|screening
1132044|NCT02367001|participation|participation
1132045|NCT02367001|organized screening|organized screening
1132046|NCT02366988|Chronic pancreatitis|chronic pancreatitis
1132047|NCT02366988|Clinical Trial|clinical trial
1132048|NCT02366988|Bile stricture|bile stricture
1132049|NCT02366988|Endoscopy|endoscopy
1132050|NCT02366988|Surgery|surgery
1132051|NCT02366975|BPH/LUTS|bph/luts
1132052|NCT02366975|TRT|trt
1132053|NCT02366975|Metabolic Syndrome|metabolic syndrome
1132054|NCT02366962|Influenza|influenza
1132055|NCT02366962|Vaccine|vaccine
1132056|NCT02366962|ASP7374|asp7374
1132057|NCT02366949|Phase 1|phase 1
1132058|NCT02366949|Solid tumors|solid tumors
1132059|NCT02366949|Breast cancer|breast cancer
1132060|NCT02366949|Paclitaxel|paclitaxel
1132061|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
1132062|NCT02366949|Oncology|oncology
1132063|NCT02366884|malignant|malignant
1132064|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
1132065|NCT02366884|cancer|cancer
1132066|NCT02366858|19 gauge|19 gauge
1132067|NCT02366858|22 gauge|22 gauge
1132068|NCT02366858|core tissue|core tissue
1132069|NCT02366806|Breast Cancer|breast cancer
1132070|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
1132071|NCT02366806|Educational Design|educational design
1132072|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
1132073|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
1132074|NCT02366780|Lactation|lactation
1132075|NCT02366780|Breastmilk|breastmilk
1132076|NCT02366780|Macronutrients|macronutrients
1132077|NCT02366767|Insulin Infusion Systems|insulin infusion systems
1132078|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
1132079|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1132080|NCT02366741|SCLC|sclc
1132081|NCT02366741|Neuro-cognitive function|neuro-cognitive function
1132082|NCT02366741|PCI|pci
1132083|NCT02366741|Hippocampal sparing|hippocampal sparing
1132084|NCT02366676|Recurrent cystitis|recurrent cystitis
1132085|NCT02366676|hyaluronic acid|hyaluronic acid
1132086|NCT02366676|chondroitin sulphate|chondroitin sulphate
1132087|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1132088|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
1132089|NCT02366663|radioimmunotherapy|radioimmunotherapy
1132090|NCT02366663|Zevalin|zevalin
1132091|NCT02366663|Lymphoma|lymphoma
1132092|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1132093|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1132094|NCT02366663|Immune System Diseases|immune system diseases
1132095|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
1132096|NCT02366663|Lymphatic Diseases|lymphatic diseases
1132097|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
1132098|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
1132099|NCT02366663|Neoplasms|neoplasms
1132100|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
1132101|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
1132102|NCT02366663|Immunologic Factors|immunologic factors
1132103|NCT02366663|Pharmacologic Actions|pharmacologic actions
1132104|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
1132105|NCT02366637|COPD|copd
1132106|NCT02366637|Sputum|sputum
1132107|NCT02366546|Adoptive cell transfer|adoptive cell transfer
1132108|NCT02366546|Cell therapy|cell therapy
1132109|NCT02366546|Immunotherapy|immunotherapy
1132110|NCT02366546|NY-ESO-1|ny-eso-1
1132111|NCT02366546|Esophageal cancer|esophageal cancer
1132112|NCT02366546|Melanoma|melanoma
1132113|NCT02366546|Head and neck cancer|head and neck cancer
1132114|NCT02366546|Ovarian cancer|ovarian cancer
1132115|NCT02366546|Synovial sarcoma|synovial sarcoma
1132116|NCT02366546|TCR gene therapy|tcr gene therapy
1132117|NCT02366533|Linkage to care|linkage to care
1132118|NCT02366533|HIV|hiv
1132119|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
1132120|NCT02366520|Child|child
1132121|NCT02366520|Child Behavior|child behavior
1132122|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
1132123|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
1132124|NCT02366520|Cooperative Behavior|cooperative behavior
1132125|NCT02366520|Dental Care/psychology*|dental care/psychology*
1132126|NCT02366520|Humans|humans
1132127|NCT02366520|Videotape Recording|videotape recording
1132128|NCT02366507|hypotension|hypotension
1132129|NCT02366507|doppler|doppler
1132130|NCT02366507|shock|shock
1132131|NCT02366494|prostate cancer|prostate cancer
1132132|NCT02366494|treatment response|treatment response
1132133|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
1132134|NCT02366481|Vitamin K|vitamin k
1132135|NCT02366481|Vitamin K2|vitamin k2
1132136|NCT02366481|Menaquinone-7|menaquinone-7
1132137|NCT02366481|Osteocalcin|osteocalcin
1132138|NCT02366481|Adults|adults
1132139|NCT02366481|Obesity|obesity
1132140|NCT02366481|Insulin resistance|insulin resistance
1132141|NCT02366481|Insulin sensitivity|insulin sensitivity
1132142|NCT02366481|Beta-cell function|beta-cell function
1132144|NCT02366468|Diabetic macular edema|diabetic macular edema
1132145|NCT02366468|Visual impairment|visual impairment
1132146|NCT02366442|dual/multitasking|dual/multitasking
1132147|NCT02366442|Executive function|executive function
1132148|NCT02366442|Affective function|affective function
1132149|NCT02366442|Balance|balance
1132150|NCT02366416|Exercise, Physical|exercise, physical
1132151|NCT02366403|PTSD|ptsd
1132152|NCT02366403|Meditation|meditation
1132153|NCT02366403|Yoga|yoga
1132154|NCT02366403|Cognitive Therapy|cognitive therapy
1132155|NCT02366390|Psychoeducative|psychoeducative
1132156|NCT02366390|HADS|hads
1132157|NCT02366390|COPD|copd
1132158|NCT02366390|dyspnea|dyspnea
1132159|NCT02366364|NRX-1074|nrx-1074
1132160|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
1132161|NCT02366364|Major Depressive Disorder|major depressive disorder
1132162|NCT02366364|Glycine Site Modulator|glycine site modulator
1132163|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
1132164|NCT02366312|KCOT|kcot
1132165|NCT02366273|Diabetes|diabetes
1132166|NCT02366273|Psoriasis|psoriasis
1132167|NCT02366273|Inflammation|inflammation
1132168|NCT02366273|Insulin-resistance|insulin-resistance
1132169|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
1132170|NCT02366247|Adefovir|adefovir
1132171|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
1132172|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
1132173|NCT02366208|Adefovir|adefovir
1132174|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
1132175|NCT02366195|T-VEC|t-vec
1132176|NCT02366195|CD8+ cell density|cd8+ cell density
1132177|NCT02366195|objective response rate|objective response rate
1132178|NCT02366195|unresected|unresected
1132179|NCT02366195|Melanoma|melanoma
1132180|NCT02366130|Breast cancer|breast cancer
1132181|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
1132182|NCT02366130|Ra-223 dichloride|ra-223 dichloride
1132183|NCT02366130|Xofigo|xofigo
1132184|NCT02366130|Radium-223 chloride|radium-223 chloride
1132185|NCT02366130|Radium-223 dichloride|radium-223 dichloride
1132186|NCT02366130|Alpharadin|alpharadin
1132187|NCT02366130|Denosumab|denosumab
1132188|NCT02366130|AMG 162|amg 162
1132189|NCT02366130|Prolia|prolia
1132190|NCT02366130|Hormone therapy|hormone therapy
1132191|NCT02366117|Quirc|quirc
1132192|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
1132193|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
1132194|NCT02366104|Aged|aged
1132195|NCT02366104|Primary Prevention|primary prevention
1132196|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
1132197|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
1132198|NCT02366026|HIV|hiv
1132199|NCT02366013|HIV|hiv
1132200|NCT02366013|HIV Prevention|hiv prevention
1132201|NCT02366013|HIV Vaccine|hiv vaccine
1132202|NCT02366013|Healthy|healthy
1132203|NCT02366000|Parent-child communication|parent-child communication
1132204|NCT02366000|Health risk behaviors|health risk behaviors
1132205|NCT02366000|Randomized controlled trial|randomized controlled trial
1132206|NCT02365987|interesterified|interesterified
1132207|NCT02365987|postprandial|postprandial
1132208|NCT02365974|arterial stiffness|arterial stiffness
1132209|NCT02365974|resistant hypertension|resistant hypertension
1132210|NCT02365974|sympathetic system|sympathetic system
1132211|NCT02365974|blood pressure|blood pressure
1132212|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1132213|NCT02365961|Hip Arthroscopy|hip arthroscopy
1132214|NCT02365948|Pharmacokinetics|pharmacokinetics
1132215|NCT02365948|Certolizumab Pegol|certolizumab pegol
1132216|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
1132217|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
1132218|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
1132219|NCT02365883|Prostate Cancer|prostate cancer
1132220|NCT02365883|Transrectal Imaging|transrectal imaging
1132221|NCT02365870|Anxiety Disorders|anxiety disorders
1132222|NCT02365870|Parkinson Disease|parkinson disease
1132223|NCT02365870|rotigotine|rotigotine
1132224|NCT02365857|spinal anesthesia|spinal anesthesia
1132225|NCT02365857|caesarian section|caesarian section
1132226|NCT02365857|Dexmedetomidine|dexmedetomidine
1132227|NCT02365844|Narrow Band Imaging|narrow band imaging
1132228|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
1132229|NCT02365831|MBC|mbc
1132230|NCT02365831|breast|breast
1132231|NCT02365831|metastatic|metastatic
1132232|NCT02365831|cancer|cancer
1132233|NCT02365831|HER2|her2
1132234|NCT02365818|Bladder Cancer|bladder cancer
1132235|NCT02365805|BRCA 1 levels|brca 1 levels
1132236|NCT02365805|HER2 Negative|her2 negative
1132237|NCT02365792|Clinical Decision Support|clinical decision support
1132238|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
1132239|NCT02365792|Emergency Medical Services|emergency medical services
1132240|NCT02365779|salpingectomy|salpingectomy
1132241|NCT02365779|optical biopsy|optical biopsy
1132242|NCT02365779|Cellvizio®|cellvizio®
1132246|NCT02365766|Pembrolizumab|pembrolizumab
1132247|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
1132248|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
1132249|NCT02365753|Pregnant women|pregnant women
1132250|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
1132251|NCT02365740|Gastric Emptying|gastric emptying
1132252|NCT02365740|Insulin Infusion Pump|insulin infusion pump
1132253|NCT02365701|Functional Dyspepsia|functional dyspepsia
1132254|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
1132255|NCT02365675|Pemphigus|pemphigus
1132256|NCT02365675|Pemphigoid|pemphigoid
1132257|NCT02365675|Wound Healing|wound healing
1132258|NCT02365675|Itch|itch
1132259|NCT02365675|Pain|pain
1132260|NCT02365675|Wound dressing|wound dressing
1132261|NCT02365675|Topical treatment|topical treatment
1132262|NCT02365662|Oncology|oncology
1132263|NCT02365662|Cancer|cancer
1132264|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
1132265|NCT02365662|Solid Tumors|solid tumors
1132266|NCT02365649|Crohn's Disease|crohn's disease
1132267|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
1132268|NCT02365623|TMC207|tmc207
1132269|NCT02365623|Bedaquiline|bedaquiline
1132270|NCT02365610|Cannabidivarin|cannabidivarin
1132271|NCT02365610|CBDV|cbdv
1132272|NCT02365610|GWP42006|gwp42006
1132273|NCT02365597|Urothelial Cancer|urothelial cancer
1132274|NCT02365597|JNJ-42756493|jnj-42756493
1132275|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1132276|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
1132277|NCT02365532|DILQTS|dilqts
1132278|NCT02365532|prolonged QT|prolonged qt
1132279|NCT02365519|LME636|lme636
1132280|NCT02365519|dry eye disease|dry eye disease
1132281|NCT02365519|efficacy|efficacy
1132282|NCT02365519|ocular discomfort|ocular discomfort
1132283|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
1132284|NCT02365506|LQTS|lqts
1132285|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
1132286|NCT02365506|LQT2|lqt2
1132287|NCT02365506|Sudden Cardiac Death|sudden cardiac death
1132288|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1132289|NCT02365467|TEVAR|tevar
1132290|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
1132291|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
1132292|NCT02365467|Type B Dissection|type b dissection
1132294|NCT02365441|GIST|gist
1132295|NCT02365441|Advanced|advanced
1132296|NCT02365428|Maternal welfare|maternal welfare
1132297|NCT02365402|chronic hepatitis B|chronic hepatitis b
1132298|NCT02365402|peginterferon|peginterferon
1132299|NCT02365402|sustained viral response|sustained viral response
1132300|NCT02365402|entecavir|entecavir
1132301|NCT02365402|HBeAg|hbeag
1132302|NCT02365337|Vitamin D|vitamin d
1132303|NCT02365337|time lapse monitoring|time lapse monitoring
1132304|NCT02365337|embryo|embryo
1132305|NCT02365324|culinary skills|culinary skills
1132306|NCT02365324|menu planning|menu planning
1132307|NCT02365324|grocery shopping|grocery shopping
1132308|NCT02365324|children|children
1132309|NCT02365324|healthy eating|healthy eating
1132310|NCT02365324|physical activity|physical activity
1132311|NCT02365272|pharmacokinetics|pharmacokinetics
1132312|NCT02365272|aminoglycosides|aminoglycosides
1132313|NCT02365246|atopic dermatitis|atopic dermatitis
1132314|NCT02365246|immunoadsorption|immunoadsorption
1132315|NCT02365233|Type II Diabetes|type ii diabetes
1132316|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
1132317|NCT02365194|Ventral Hernia|ventral hernia
1132318|NCT02365194|Prehabilitation|prehabilitation
1132319|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
1132320|NCT02365168|Fish allergy|fish allergy
1132321|NCT02365155|Frailty|frailty
1132322|NCT02365155|Heart failure|heart failure
1132323|NCT02365155|Physical activity|physical activity
1132324|NCT02365155|Cognitive state|cognitive state
1132325|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
1132326|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
1132327|NCT02365142|Osteoarthritis|osteoarthritis
1132328|NCT02365129|BRITE adipose tissue|brite adipose tissue
1132329|NCT02365129|physical activity|physical activity
1132330|NCT02365129|Thermogenesis|thermogenesis
1132331|NCT02365129|Body Temperature Regulation|body temperature regulation
1132332|NCT02365129|Energy Metabolism|energy metabolism
1132333|NCT02365116|Peer Mentorship|peer mentorship
1132334|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
1132335|NCT02365116|Suicide Risk|suicide risk
1132336|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
1132337|NCT02365103|Iron, Bioavailability|iron, bioavailability
1132338|NCT02365103|Hepcidins|hepcidins
1132339|NCT02365103|Intestinal, Absorption|intestinal, absorption
1132340|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
1132341|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
1132342|NCT02365077|Femur Head Necrosis|femur head necrosis
1132343|NCT02365077|Susceptibility|susceptibility
1132344|NCT02365077|GWAS|gwas
1132345|NCT02365025|Sleep patterns|sleep patterns
1132346|NCT02365025|Electronic Media Exposure|electronic media exposure
1132347|NCT02365025|Parental Intervention|parental intervention
1132348|NCT02364934|rocuronium|rocuronium
1132349|NCT02364934|sex|sex
1132350|NCT02364934|elderly|elderly
1132351|NCT02364934|Close-loop infusion system|close-loop infusion system
1132352|NCT02364921|venous ulcer|venous ulcer
1132353|NCT02364921|wound healing|wound healing
1132354|NCT02364921|compression bandages|compression bandages
1132355|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
1132356|NCT02364908|antimalarials|antimalarials
1132357|NCT02364908|therapeutic education|therapeutic education
1132358|NCT02364908|Coping questionnaire|coping questionnaire
1132359|NCT02364908|MASRI questionnaire|masri questionnaire
1132360|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
1132361|NCT02364908|lupus Quality Of Life|lupus quality of life
1132362|NCT02364908|internal medicine|internal medicine
1132363|NCT02364895|Mailed invitation|mailed invitation
1132364|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
1132365|NCT02364895|Screening|screening
1132366|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
1132367|NCT02364869|Indoxyl sulfate|indoxyl sulfate
1132368|NCT02364869|Intestine|intestine
1132369|NCT02364869|Endothelial function|endothelial function
1132370|NCT02364856|Autonomic Nervous System|autonomic nervous system
1132371|NCT02364856|Cerebral Palsy|cerebral palsy
1132372|NCT02364856|Pain|pain
1132373|NCT02364856|Children|children
1132374|NCT02364843|Threonine|threonine
1132375|NCT02364843|enteral feedings|enteral feedings
1132376|NCT02364843|infants|infants
1132377|NCT02364843|amino acid|amino acid
1132378|NCT02364843|requirements|requirements
1132379|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
1132380|NCT02364830|Peppermint oil|peppermint oil
1132381|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
1132382|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1132383|NCT02364817|Alcohol Dependence|alcohol dependence
1132384|NCT02364817|Adults|adults
1132385|NCT02364817|Treatment outcome|treatment outcome
1132386|NCT02364817|Mental Health|mental health
1132387|NCT02364791|pulmonary resection|pulmonary resection
1132388|NCT02364791|chest tube|chest tube
1132389|NCT02364791|segmentectomy|segmentectomy
1132390|NCT02364791|lobectomy|lobectomy
1132391|NCT02364778|CAD|cad
1132392|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
1132393|NCT02364765|Hemoglobin|hemoglobin
1132394|NCT02364765|Red Blood Cells|red blood cells
1132395|NCT02364765|Hematocrit|hematocrit
1132396|NCT02364765|Blood Platelets|blood platelets
1132397|NCT02364765|Body Weight|body weight
1132398|NCT02364765|Operative Time|operative time
1132399|NCT02364765|Age Groups|age groups
1132400|NCT02364765|Gender|gender
1132401|NCT02364726|Acupuncture|acupuncture
1132402|NCT02364726|Paclitaxel|paclitaxel
1132403|NCT02364726|15-011|15-011
1132404|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
1132405|NCT02364674|HRCT|hrct
1132406|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
1132407|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
1132408|NCT02364674|FRI|fri
1132409|NCT02364674|Computed Tomography|computed tomography
1132410|NCT02364674|CT|ct
1132411|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
1132412|NCT02364674|BOS|bos
1132413|NCT02364674|Lung Transplant|lung transplant
1132414|NCT02364661|Hepatitis B virus|hepatitis b virus
1132415|NCT02364661|Metabolovirus|metabolovirus
1132416|NCT02364648|Endothelium, vascular|endothelium, vascular
1132417|NCT02364648|MitoQ|mitoq
1132418|NCT02364648|Mitochondria|mitochondria
1132419|NCT02364648|Oxidative Stress|oxidative stress
1132420|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
1132421|NCT02364648|Cardiovascular Disease|cardiovascular disease
1132422|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
1132423|NCT02364622|flexible intubating stylet|flexible intubating stylet
1132424|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
1132425|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
1132426|NCT02364596|Staphylococcal infection|staphylococcal infection
1132427|NCT02364570|CVD|cvd
1132428|NCT02364570|Hyperglycemia|hyperglycemia
1132429|NCT02364570|Postprandial|postprandial
1132430|NCT02364570|Vascular Function|vascular function
1132431|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
1132432|NCT02364531|Prostate Cancer|prostate cancer
1132433|NCT02364531|Metastatic|metastatic
1132434|NCT02364531|Observational|observational
1132435|NCT02364531|Abiraterone Acetate|abiraterone acetate
1132436|NCT02364531|ZYTIGA|zytiga
1132437|NCT02364518|Snoring|snoring
1132438|NCT02364518|snoreplasy|snoreplasy
1132439|NCT02364518|Tranquill|tranquill
1132440|NCT02364518|Sutures|sutures
1132441|NCT02364505|caregivers|caregivers
1132442|NCT02364492|[C04.588.180]|[c04.588.180]
1132443|NCT02364440|skin laxity|skin laxity
1132444|NCT02364440|Ultherapy™ System|ultherapy™ system
1132445|NCT02364440|rhytids|rhytids
1133246|NCT02359812|Arm|arm
1132446|NCT02364427|Pulse wave velocity|pulse wave velocity
1132447|NCT02364427|Arterial stiffness|arterial stiffness
1132448|NCT02364427|AKI|aki
1132449|NCT02364401|Atrial Fibrillation|atrial fibrillation
1132450|NCT02364401|Catheter ablation|catheter ablation
1132451|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
1132452|NCT02364388|breast ultrasound|breast ultrasound
1132453|NCT02364388|Imagio|imagio
1132454|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
1132455|NCT02364388|Seno|seno
1132456|NCT02364388|opto-acoustics|opto-acoustics
1132457|NCT02364388|OA|oa
1132458|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
1132459|NCT02364310|Hypertension|hypertension
1132460|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
1132461|NCT02364310|Hypertension resistant|hypertension resistant
1132462|NCT02364297|Bleeding gastric varices|bleeding gastric varices
1132463|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
1132464|NCT02364297|Injection of adhesives|injection of adhesives
1132465|NCT02364271|High-sensitive troponin|high-sensitive troponin
1132466|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
1132467|NCT02364271|TIMI score|timi score
1132468|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
1132469|NCT02364271|Major adverse cardiac event|major adverse cardiac event
1132470|NCT02364271|HEART score|heart score
1132471|NCT02364245|Cerebral Palsy.|cerebral palsy.
1132472|NCT02364245|Upper Extremity|upper extremity
1132473|NCT02364245|Kinect|kinect
1132474|NCT02364245|Virtual reality|virtual reality
1132475|NCT02364219|prewarming|prewarming
1132476|NCT02364219|perioperative hypothermia|perioperative hypothermia
1132477|NCT02364219|microdialysis|microdialysis
1132478|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
1132479|NCT02364219|cytoreductive surgery|cytoreductive surgery
1132480|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
1132481|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
1132482|NCT02364206|temozolomide|temozolomide
1132483|NCT02364206|radiotherapy|radiotherapy
1132484|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
1132485|NCT02364193|Extravascular lung water|extravascular lung water
1132486|NCT02364154|biomarker|biomarker
1132487|NCT02364154|screening|screening
1132488|NCT02364154|coloscopy|coloscopy
1132489|NCT02364141|stroke|stroke
1132490|NCT02364141|upper extremity|upper extremity
1132491|NCT02364141|motor learning|motor learning
1132492|NCT02364141|rehabilitation|rehabilitation
1132493|NCT02364115|Spinal metastases|spinal metastases
1132494|NCT02364115|Spinal metastatic disease|spinal metastatic disease
1132495|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1132496|NCT02364115|Response|response
1132497|NCT02364115|Bone metastases|bone metastases
1132498|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
1132499|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
1132500|NCT02364089|Hypertension|hypertension
1132501|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
1132502|NCT02364089|Metabolic Syndrome|metabolic syndrome
1132503|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
1132504|NCT02364076|Pembrolizumab|pembrolizumab
1132505|NCT02364076|Epacadostat|epacadostat
1132506|NCT02364063|Urinary incontinence|urinary incontinence
1132507|NCT02364063|cerebral palsy|cerebral palsy
1132508|NCT02364063|urotherapy|urotherapy
1132510|NCT02364037|intrauterine device|intrauterine device
1132511|NCT02364037|subdermal implant|subdermal implant
1132512|NCT02364037|contraceptive counseling|contraceptive counseling
1132513|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
1132514|NCT02364024|Immune response|immune response
1132515|NCT02364024|Biomarker|biomarker
1132516|NCT02364024|Prognosis|prognosis
1132517|NCT02364011|Biomechanics|biomechanics
1132518|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
1132519|NCT02364011|TKA Bearings|tka bearings
1132520|NCT02364011|Osteoarthritis|osteoarthritis
1132521|NCT02364011|Total Knee Replacement|total knee replacement
1132522|NCT02363998|detoxification|detoxification
1132523|NCT02363998|agonist taper|agonist taper
1132524|NCT02363998|methadone step down|methadone step down
1132525|NCT02363998|buprenorphine step down|buprenorphine step down
1132526|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
1132527|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
1132528|NCT02363959|Lung Transplantation|lung transplantation
1132529|NCT02363959|Central Airway Stenosis|central airway stenosis
1132530|NCT02363959|Airway Exudative Plaques|airway exudative plaques
1132531|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
1132532|NCT02363959|Post-Lung Transplantation|post-lung transplantation
1132533|NCT02363959|Airway Ischemia|airway ischemia
1132534|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
1132535|NCT02363959|Bronchoscopy|bronchoscopy
1132536|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
1132537|NCT02363946|AATD|aatd
1132538|NCT02363933|Perampanel|perampanel
1132539|NCT02363933|Seizures|seizures
1132540|NCT02363920|COPD patients|copd patients
1132541|NCT02363907|diabetes mellitus|diabetes mellitus
1132542|NCT02363907|pediatric|pediatric
1133247|NCT02359812|Hand|hand
1132543|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
1132544|NCT02363907|CGM|cgm
1132545|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
1132546|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1132547|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
1132548|NCT02363842|Pressure Ulcer|pressure ulcer
1132549|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
1132550|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
1132551|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
1132552|NCT02363829|invasive carcinoma|invasive carcinoma
1132553|NCT02363829|uterine cervix|uterine cervix
1132554|NCT02363790|Ventral Hernia|ventral hernia
1132555|NCT02363790|Laparoscopic|laparoscopic
1132556|NCT02363764|respiratory sampling|respiratory sampling
1132557|NCT02363751|Bellini|bellini
1132558|NCT02363751|Metastatic|metastatic
1132559|NCT02363751|Chemotherapy|chemotherapy
1132560|NCT02363751|Bevacizumab|bevacizumab
1132561|NCT02363738|Bipolar Disorder|bipolar disorder
1132562|NCT02363738|Bipolar Depression|bipolar depression
1132563|NCT02363738|Inflammation|inflammation
1132564|NCT02363738|Bipolar|bipolar
1132565|NCT02363725|Acute myocardial infarction|acute myocardial infarction
1132566|NCT02363725|Inflammation|inflammation
1132567|NCT02363725|CRP|crp
1132568|NCT02363725|Colchicine|colchicine
1132569|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
1132570|NCT02363712|therapy|therapy
1132571|NCT02363712|shoe|shoe
1132572|NCT02363712|Randomized Controlled Trial|randomized controlled trial
1132573|NCT02363699|cholelithiasis|cholelithiasis
1132574|NCT02363699|Cytokines|cytokines
1132575|NCT02363699|under general anesthesia|under general anesthesia
1132576|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
1132577|NCT02363673|Children|children
1132578|NCT02363673|Homoeopathy|homoeopathy
1132579|NCT02363660|HIV-uninfected|hiv-uninfected
1132580|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
1132581|NCT02363647|thyroid cancer|thyroid cancer
1132582|NCT02363647|personalized therapy|personalized therapy
1132684|NCT02363049|Colectomy|colectomy
1189934|NCT02078479|VAS|vas
1132583|NCT02363647|personalized chemotherapy|personalized chemotherapy
1132584|NCT02363647|individualized treatment|individualized treatment
1132585|NCT02363647|colon cancer|colon cancer
1132586|NCT02363647|colorectal cancer|colorectal cancer
1132587|NCT02363634|magnesium status|magnesium status
1132588|NCT02363634|sleep quality|sleep quality
1132589|NCT02363608|Canine-Assisted|canine-assisted
1132590|NCT02363608|15-010|15-010
1132591|NCT02363608|post surgery patients|post surgery patients
1132592|NCT02363595|Genomic Predictors|genomic predictors
1132593|NCT02363595|14-277|14-277
1132594|NCT02363569|post coital bleeding|post coital bleeding
1132595|NCT02363569|vaginal bleeding|vaginal bleeding
1132596|NCT02363556|Cervical Dilation|cervical dilation
1132597|NCT02363556|Dilation and Evacuation|dilation and evacuation
1132598|NCT02363556|Misoprostol|misoprostol
1132599|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
1132600|NCT02363556|Abortion|abortion
1132601|NCT02363530|cataract surgery|cataract surgery
1132602|NCT02363530|cornea protect|cornea protect
1132603|NCT02363530|xerophthalmia|xerophthalmia
1132604|NCT02363530|Corneal clarity|corneal clarity
1132605|NCT02363517|Hepatitis|hepatitis
1132606|NCT02363517|Viral|viral
1132607|NCT02363517|Non-A|non-a
1132608|NCT02363517|Non-B|non-b
1132609|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
1132610|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
1132611|NCT02363504|Noradrenaline|noradrenaline
1132612|NCT02363504|locus coeruleus|locus coeruleus
1132613|NCT02363504|memory|memory
1132614|NCT02363465|skin thickness|skin thickness
1132615|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
1132616|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
1132617|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
1132618|NCT02363452|open single study|open single study
1132619|NCT02363452|interferon signature|interferon signature
1132620|NCT02363426|intravaginal culture|intravaginal culture
1132621|NCT02363426|in vitro fertilization|in vitro fertilization
1132622|NCT02363426|blastocyst|blastocyst
1132623|NCT02363426|pregnancy|pregnancy
1132625|NCT02363413|Overlap Syndrom|overlap syndrom
1132626|NCT02363413|home|home
1132627|NCT02363413|hospital|hospital
1132628|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
1132629|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
1132630|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
1132631|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
1132632|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
1132633|NCT02363387|HIV|hiv
1132634|NCT02363387|antiretroviral medications|antiretroviral medications
1132635|NCT02363387|incentives|incentives
1132636|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
1132637|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
1132638|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
1132639|NCT02363348|L arginine|l arginine
1132640|NCT02363348|Preeclampsia|preeclampsia
1132641|NCT02363335|GLP-1|glp-1
1132642|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
1132643|NCT02363335|GLP|glp
1132644|NCT02363322|Medical Countermeasures|medical countermeasures
1132645|NCT02363322|VHF|vhf
1132646|NCT02363322|EVD|evd
1132647|NCT02363309|13C|13c
1132648|NCT02363309|Stable Isotopes|stable isotopes
1132649|NCT02363309|Acetate|acetate
1132650|NCT02363309|Breath Tests|breath tests
1132651|NCT02363309|Palmitate|palmitate
1132652|NCT02363296|Brain Cooling - Selected|brain cooling - selected
1132653|NCT02363296|Brain Cooling Helmet|brain cooling helmet
1132654|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
1132655|NCT02363270|Analgesia|analgesia
1132656|NCT02363270|ketamine|ketamine
1132657|NCT02363257|Smoke free bus policy|smoke free bus policy
1132658|NCT02363257|BEST commuters|best commuters
1132659|NCT02363257|BEST employee|best employee
1132660|NCT02363244|Pap,HPVDNA|pap,hpvdna
1132661|NCT02363218|Liver Neoplasms|liver neoplasms
1132662|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1132663|NCT02363218|CyberKnife|cyberknife
1132664|NCT02363192|Pharmacy|pharmacy
1132665|NCT02363179|Emergency Service, Hospital|emergency service, hospital
1132666|NCT02363140|Musculoskeletal System|musculoskeletal system
1132667|NCT02363127|Reproductive Techniques|reproductive techniques
1132668|NCT02363127|Infertility|infertility
1132669|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
1132670|NCT02363088|cervical screening|cervical screening
1132671|NCT02363088|uptake|uptake
1132672|NCT02363088|SMS messages|sms messages
1132673|NCT02363088|text messages|text messages
1132674|NCT02363088|reminder|reminder
1132675|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
1132676|NCT02363075|severe asthenia|severe asthenia
1132677|NCT02363075|glioma|glioma
1132678|NCT02363075|MFI-20|mfi-20
1132679|NCT02363075|double-blind|double-blind
1132680|NCT02363075|stabilisation phase|stabilisation phase
1132681|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
1132682|NCT02363062|genes|genes
1132683|NCT02363062|whole exome sequencing|whole exome sequencing
1132685|NCT02363049|primary tumor resection|primary tumor resection
1132686|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
1132687|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
1132688|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
1132689|NCT02363049|Unresectable|unresectable
1132690|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
1132691|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
1132692|NCT02363010|Obesity|obesity
1132693|NCT02363010|Weight loss|weight loss
1132694|NCT02363010|Overweight|overweight
1132695|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
1132696|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
1132697|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
1132698|NCT02362984|DLBS1033|dlbs1033
1132699|NCT02362984|acute ischemic stroke|acute ischemic stroke
1132700|NCT02362984|MRS|mrs
1132701|NCT02362984|mNIHSS|mnihss
1132702|NCT02362919|Influenza vaccination|influenza vaccination
1132703|NCT02362919|Elderly individuals|elderly individuals
1132704|NCT02362919|Prospective cohort study|prospective cohort study
1132705|NCT02362919|response|response
1132706|NCT02362906|pneumonia|pneumonia
1132707|NCT02362906|pediatrics|pediatrics
1132708|NCT02362893|Hypertension|hypertension
1132709|NCT02362893|Adherence|adherence
1132710|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
1132711|NCT02362893|RCT|rct
1132712|NCT02362854|dental implant|dental implant
1132713|NCT02362854|laser|laser
1132714|NCT02362854|diode laser|diode laser
1132715|NCT02362854|peri-implantitis|peri-implantitis
1132716|NCT02362854|bacterial count|bacterial count
1132717|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
1132718|NCT02362828|Blood Patch, epidural|blood patch, epidural
1132719|NCT02362828|Obstetrics|obstetrics
1132720|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
1132721|NCT02362828|epidemiology|epidemiology
1132722|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
1132723|NCT02362828|Anaesthesia|anaesthesia
1132724|NCT02362828|childbirth complication|childbirth complication
1132725|NCT02362828|epidural analgesia|epidural analgesia
1132726|NCT02362828|postdural puncture headache|postdural puncture headache
1132727|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
1132728|NCT02362828|epidural|epidural
1132729|NCT02362776|NMR spectroscopy|nmr spectroscopy
1132730|NCT02362776|metabolic changes|metabolic changes
1132731|NCT02362776|blood plasma|blood plasma
1132732|NCT02362776|biomarker|biomarker
1132733|NCT02362776|cancer|cancer
1132734|NCT02362750|comparative effectiveness|comparative effectiveness
1132735|NCT02362750|survivorship|survivorship
1132736|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
1132737|NCT02362685|Metabolic myopathies|metabolic myopathies
1132738|NCT02362685|Exercise testing|exercise testing
1132739|NCT02362685|Blood sample|blood sample
1132740|NCT02362685|Muscle biopsy|muscle biopsy
1132741|NCT02362685|Genetic analysis|genetic analysis
1132742|NCT02362685|Cycloergometer|cycloergometer
1132743|NCT02362685|Grip-test|grip-test
1132744|NCT02362685|Exercise physiology|exercise physiology
1132745|NCT02362685|Muscle physiology|muscle physiology
1132746|NCT02362659|non-valvular|non-valvular
1132747|NCT02362659|atrial fibrillation|atrial fibrillation
1132748|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
1132749|NCT02362646|Heart Failure|heart failure
1132750|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
1132751|NCT02362646|Heart Transplantation|heart transplantation
1132752|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
1132753|NCT02362646|Cell Therapy|cell therapy
1132754|NCT02362646|Bridge to Transplant|bridge to transplant
1132755|NCT02362620|Castration Resistant Prostate Cancer, Biomarkers, Taxanes|castration resistant prostate cancer, biomarkers, taxanes
1132756|NCT02362594|PD-1|pd-1
1132757|NCT02362594|PD1|pd1
1132758|NCT02362594|Programmed Cell Death-1|programmed cell death-1
1132759|NCT02362594|Programmed Cell Death 1|programmed cell death 1
1132760|NCT02362594|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
1132761|NCT02362594|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
1132762|NCT02362594|PDL1|pdl1
1132763|NCT02362594|PDL2|pdl2
1132764|NCT02362581|Prophylaxis treatment|prophylaxis treatment
1132765|NCT02362581|On demand treatment|on demand treatment
1132766|NCT02362581|Severe hemophilia A|severe hemophilia a
1132767|NCT02362581|Moderate hemophilia A|moderate hemophilia a
1132768|NCT02362568|Intubation; Difficult|intubation; difficult
1132769|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
1132770|NCT02362490|chronic hepatitis B|chronic hepatitis b
1132771|NCT02362490|interferon|interferon
1132772|NCT02362490|Nucleotide analogues|nucleotide analogues
1132773|NCT02362490|HBsAg|hbsag
1132774|NCT02362464|Multi-epitope|multi-epitope
1132775|NCT02362464|Tarp Peptide|tarp peptide
1132776|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
1132777|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
1132778|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
1132779|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
1132780|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
1132781|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
1132782|NCT02362451|Vaccine Therapy|vaccine therapy
1132783|NCT02362438|Intrathecal|intrathecal
1132784|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
1132785|NCT02362438|Phase 1|phase 1
1132786|NCT02362438|Safety Study|safety study
1132787|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
1132788|NCT02362425|Neuromuscular Disease|neuromuscular disease
1132789|NCT02362425|Clinical Trial|clinical trial
1132790|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
1132791|NCT02362425|Myopathy|myopathy
1132792|NCT02362412|major depressive episodes|major depressive episodes
1132793|NCT02362412|FK949E|fk949e
1132794|NCT02362412|quetiapine|quetiapine
1132795|NCT02362412|bipolar depression|bipolar depression
1132796|NCT02362412|bipolar disorder|bipolar disorder
1132797|NCT02362373|epilepsy|epilepsy
1132798|NCT02362373|contraception|contraception
1132799|NCT02362373|drug interaction|drug interaction
1132800|NCT02362360|Ostomy|ostomy
1132801|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
1132802|NCT02362334|intraocular lens power|intraocular lens power
1132803|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
1132804|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
1132805|NCT02362295|palliative care|palliative care
1132806|NCT02362295|vulnerable population|vulnerable population
1132807|NCT02362295|qualitative research|qualitative research
1132808|NCT02362282|stroke|stroke
1132809|NCT02362282|walking|walking
1132810|NCT02362282|cognition|cognition
1132811|NCT02362282|rehabilitation|rehabilitation
1132812|NCT02362256|Opioid detoxification|opioid detoxification
1132813|NCT02362256|Opioid antagonist induction|opioid antagonist induction
1132814|NCT02362256|Conscious sedation|conscious sedation
1132815|NCT02362243|low back pain|low back pain
1132816|NCT02362243|low back injury|low back injury
1132817|NCT02362243|firefighter|firefighter
1132818|NCT02362243|prevention|prevention
1132819|NCT02362243|physical fitness|physical fitness
1132820|NCT02362243|exercise training|exercise training
1132821|NCT02362243|worksite|worksite
1132822|NCT02362243|web-based|web-based
1132823|NCT02362165|multiple myeloma|multiple myeloma
1132824|NCT02362165|cyclophosphamide|cyclophosphamide
1132825|NCT02362165|bortezomib|bortezomib
1132826|NCT02362165|doxorubicin|doxorubicin
1132827|NCT02362165|peripheral neuropathy|peripheral neuropathy
1132828|NCT02362152|Actinic keratosis|actinic keratosis
1132829|NCT02362152|Solar keratosis|solar keratosis
1132830|NCT02362152|Field treatment|field treatment
1132831|NCT02362152|Ingenol mebutate|ingenol mebutate
1132832|NCT02362152|Picato|picato
1132833|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
1132834|NCT02362126|EFTR|eftr
1132835|NCT02362126|FTRD|ftrd
1132836|NCT02362126|OTSC|otsc
1132837|NCT02362087|pain|pain
1132838|NCT02362061|junctional zone|junctional zone
1132839|NCT02362061|implantation|implantation
1132840|NCT02362061|three D ultraosund|three d ultraosund
1132841|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
1132842|NCT02362061|Pregnancy|pregnancy
1132843|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1132845|NCT02362035|B-Cell Malignancies|b-cell malignancies
1132846|NCT02362035|Mantle Cell|mantle cell
1132847|NCT02362035|Multiple Myeloma|multiple myeloma
1132848|NCT02362035|CLL|cll
1132849|NCT02362035|SLL|sll
1132850|NCT02362035|DLBCL|dlbcl
1132851|NCT02362035|Follicular|follicular
1132852|NCT02362035|Waldenstrom|waldenstrom
1132853|NCT02362035|Burkitt lymphoma|burkitt lymphoma
1132854|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
1132855|NCT02362035|hairy cell leukemia|hairy cell leukemia
1132856|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
1132857|NCT02362035|Acalabrutinib|acalabrutinib
1132858|NCT02362035|ACP-196|acp-196
1132859|NCT02362009|Myomas|myomas
1132860|NCT02362009|Leiomyomas|leiomyomas
1132861|NCT02362009|Fibromas|fibromas
1132862|NCT02361970|sepsis|sepsis
1132863|NCT02361970|gamma delta T cells|gamma delta t cells
1132864|NCT02361970|immunosuppression|immunosuppression
1132865|NCT02361944|oxygen|oxygen
1132866|NCT02361944|hyperoxia|hyperoxia
1132867|NCT02361944|reactive oxygen species|reactive oxygen species
1132868|NCT02361944|oxidative stress|oxidative stress
1132869|NCT02361944|oxidative damage|oxidative damage
1132870|NCT02361944|endothelial function|endothelial function
1132871|NCT02361944|vascular reactivity|vascular reactivity
1132872|NCT02361944|mitochondrial function|mitochondrial function
1132873|NCT02361944|surgery|surgery
1132874|NCT02361944|anesthesia|anesthesia
1132875|NCT02361944|kidney injury|kidney injury
1132876|NCT02361944|renal failure|renal failure
1132877|NCT02361944|delirium|delirium
1190280|NCT02076880|Obesity|obesity
1132878|NCT02361944|myocardial injury|myocardial injury
1132879|NCT02361944|arrythmia|arrythmia
1132880|NCT02361931|accelerating healing|accelerating healing
1132881|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
1132882|NCT02361931|diabetic patients|diabetic patients
1132883|NCT02361931|diabetic chronic ulcers|diabetic chronic ulcers
1132884|NCT02361931|Wagner grade II|wagner grade ii
1132885|NCT02361931|infection|infection
1132886|NCT02361931|necrosis|necrosis
1132887|NCT02361931|erythema|erythema
1132888|NCT02361931|mild drainage|mild drainage
1132890|NCT02361905|cellular leiomyomas|cellular leiomyomas
1132891|NCT02361905|GnRH analogue|gnrh analogue
1132892|NCT02361905|ulipristal acetate|ulipristal acetate
1132893|NCT02361892|ovarian reserve|ovarian reserve
1132894|NCT02361892|infertility|infertility
1132895|NCT02361892|leiomyomas|leiomyomas
1132896|NCT02361892|ulipristal acetate|ulipristal acetate
1132897|NCT02361879|fibroids|fibroids
1132898|NCT02361879|gnrh analogue|gnrh analogue
1132899|NCT02361879|ulipristal acetate|ulipristal acetate
1132900|NCT02361879|hysteroscopy|hysteroscopy
1132901|NCT02361840|Troponin I|troponin i
1132902|NCT02361840|Pediatric shock|pediatric shock
1132903|NCT02361827|Vitamin D|vitamin d
1132904|NCT02361827|IVF outcome|ivf outcome
1132905|NCT02361814|flexor tendon|flexor tendon
1132906|NCT02361814|finger|finger
1132907|NCT02361814|amniotic membrane|amniotic membrane
1132908|NCT02361814|allograft|allograft
1132909|NCT02361814|tendon injury|tendon injury
1132910|NCT02361801|cardiac surgery|cardiac surgery
1132911|NCT02361801|dobutamine|dobutamine
1132912|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
1132913|NCT02361788|etiology|etiology
1132914|NCT02361788|incidence|incidence
1132915|NCT02361788|risk factors|risk factors
1132916|NCT02361762|Executive Function|executive function
1132917|NCT02361762|Theory of Mind|theory of mind
1132918|NCT02361762|Individual Differences|individual differences
1132919|NCT02361762|Social Skills|social skills
1132920|NCT02361762|Executive Control|executive control
1132921|NCT02361710|Vitamin D|vitamin d
1132922|NCT02361710|pregnancy rate|pregnancy rate
1132923|NCT02361710|eFET|efet
1132924|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
1132925|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
1132926|NCT02361697|biomarker|biomarker
1132927|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
1132928|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
1132929|NCT02361684|cost-effectiveness|cost-effectiveness
1132930|NCT02361684|blended treatment|blended treatment
1132931|NCT02361684|Internet based treatment|internet based treatment
1132932|NCT02361684|Efficacy|efficacy
1132933|NCT02361684|Depression|depression
1132934|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
1132935|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
1132936|NCT02361645|prostaglandin E2|prostaglandin e2
1132937|NCT02361645|vitrectomy|vitrectomy
1132938|NCT02361606|adolescents|adolescents
1132939|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
1132940|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
1132941|NCT02361567|Post Operative Pain|post operative pain
1132942|NCT02361567|Addiction|addiction
1132943|NCT02361528|Septic shock|septic shock
1132944|NCT02361528|Severe sepsis|severe sepsis
1132945|NCT02361528|GM-CSF|gm-csf
1132946|NCT02361528|Immunosuppression|immunosuppression
1132947|NCT02361528|Hospital-acquired infections|hospital-acquired infections
1132948|NCT02361528|ICU-acquired infections|icu-acquired infections
1132949|NCT02361528|HLA-DR|hla-dr
1132950|NCT02361528|Monocytes|monocytes
1132951|NCT02361515|Prostate|prostate
1132952|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
1132953|NCT02361515|Stereotactic irradiation|stereotactic irradiation
1132954|NCT02361515|Spacer|spacer
1132955|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
1132956|NCT02361476|Anaesthesia|anaesthesia
1132957|NCT02361476|Children|children
1132958|NCT02361476|Clonidine|clonidine
1132959|NCT02361476|Sevoflurane|sevoflurane
1132960|NCT02361476|Postoperative agitation|postoperative agitation
1132961|NCT02361476|Prevention|prevention
1132962|NCT02361476|Pharmacokinetics|pharmacokinetics
1132963|NCT02361476|Safety|safety
1132964|NCT02361463|Laparoscopy;|laparoscopy;
1132965|NCT02361463|Training;|training;
1132966|NCT02361463|Three-Dimensional|three-dimensional
1132967|NCT02361450|Faecal incontinence|faecal incontinence
1132968|NCT02361450|Spina Bifida|spina bifida
1132969|NCT02361450|Enema|enema
1132970|NCT02361450|Constipation|constipation
1132971|NCT02361450|Myelomeningocele|myelomeningocele
1132972|NCT02361450|Human|human
1132973|NCT02361437|diabetes type II|diabetes type ii
1132974|NCT02361437|diabetic ulcers|diabetic ulcers
1132975|NCT02361424|PXT00864|pxt00864
1132976|NCT02361424|mild AD|mild ad
1132977|NCT02361424|phase 2a|phase 2a
1132978|NCT02361359|Arthroplasty|arthroplasty
1132979|NCT02361346|CD20|cd20
1132980|NCT02361346|immunotoxin|immunotoxin
1132981|NCT02361346|NHL|nhl
1132982|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1132983|NCT02361346|lymphoma|lymphoma
1132984|NCT02361346|cancer|cancer
1132985|NCT02361346|antibodies|antibodies
1132986|NCT02361346|immunotherapy|immunotherapy
1132987|NCT02361346|safety|safety
1132988|NCT02361346|pharmacokinetics|pharmacokinetics
1132989|NCT02361346|maximum tolerated dose|maximum tolerated dose
1132990|NCT02361346|MT-3724|mt-3724
1132991|NCT02361346|relapsed|relapsed
1132992|NCT02361346|refractory|refractory
1132993|NCT02361346|leukemia|leukemia
1132994|NCT02361346|CLL|cll
1132995|NCT02361346|SLL|sll
1132996|NCT02361320|Pancreatic cancer|pancreatic cancer
1132997|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1132998|NCT02361320|PDAC|pdac
1132999|NCT02361320|Computed tomography|computed tomography
1133000|NCT02361320|CT|ct
1133001|NCT02361320|Questionnaire|questionnaire
1133002|NCT02361320|Survey|survey
1133003|NCT02361268|end-stage renal disease|end-stage renal disease
1133004|NCT02361268|hemodialysis|hemodialysis
1133005|NCT02361268|yoga|yoga
1133006|NCT02361268|mind-body medicine|mind-body medicine
1133007|NCT02361268|meditation|meditation
1133008|NCT02361242|PXT00864|pxt00864
1133009|NCT02361242|mild AD|mild ad
1133010|NCT02361242|phase 2a|phase 2a
1133011|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
1133012|NCT02361125|Fatigue|fatigue
1133013|NCT02361125|Cancer related fatigue|cancer related fatigue
1133014|NCT02361125|Methylphenidate|methylphenidate
1133015|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
1133016|NCT02361125|Ritalin|ritalin
1133017|NCT02361125|Concerta|concerta
1133018|NCT02361125|Fatigue evaluations|fatigue evaluations
1133019|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
1133020|NCT02361086|CYP17|cyp17
1133021|NCT02361086|P450c17a|p450c17a
1133022|NCT02361086|lyase|lyase
1133023|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
1133024|NCT02361073|ERP|erp
1133025|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
1133026|NCT02361021|Critical Care|critical care
1133027|NCT02361021|Non invasive ventilation|non invasive ventilation
1133028|NCT02361021|Electrical impedance tomography|electrical impedance tomography
1133029|NCT02361021|End expiratory lung volume|end expiratory lung volume
1133030|NCT02361021|Lung ultrasound score|lung ultrasound score
1133031|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
1133032|NCT02361008|occlusion|occlusion
1133033|NCT02361008|TEE-guided|tee-guided
1133034|NCT02361008|asymmetric occluder|asymmetric occluder
1133035|NCT02361008|surgical repair|surgical repair
1133036|NCT02360982|Delirium|delirium
1133037|NCT02360982|regional anesthesia|regional anesthesia
1133038|NCT02360982|general anesthesia|general anesthesia
1133039|NCT02360969|strabismus|strabismus
1133040|NCT02360969|surgical procedure|surgical procedure
1133041|NCT02360969|anesthesia|anesthesia
1133042|NCT02360969|squint|squint
1133043|NCT02360969|child|child
1133044|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
1133045|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
1133046|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
1133047|NCT02360943|elderly patients|elderly patients
1133048|NCT02360943|Pulmonary embolism|pulmonary embolism
1133049|NCT02360943|Anticoagulant treatments|anticoagulant treatments
1133050|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1133051|NCT02360930|Pharmacokinetics|pharmacokinetics
1133052|NCT02360930|Vincristine|vincristine
1133053|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
1133054|NCT02360917|Cancer Survivorship|cancer survivorship
1133055|NCT02360891|multimodal biomarkers|multimodal biomarkers
1133056|NCT02360891|prognosis|prognosis
1133057|NCT02360891|endophenotypes|endophenotypes
1133058|NCT02360878|DJBS|djbs
1133059|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
1133060|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
1133061|NCT02360878|Endobarrier|endobarrier
1133062|NCT02360878|Obesity|obesity
1133063|NCT02360878|Type 2 diabetes|type 2 diabetes
1133064|NCT02360878|Incretin hormones|incretin hormones
1133065|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
1133066|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
1133067|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
1133068|NCT02360813|Forensic mental health|forensic mental health
1133069|NCT02360813|Forensic psychiatry|forensic psychiatry
1133070|NCT02360813|Clinical psychology|clinical psychology
1133071|NCT02360813|Randomized controlled trial|randomized controlled trial
1133072|NCT02360813|Principle driven intervention|principle driven intervention
1133073|NCT02360813|Psychological Intervention|psychological intervention
1133074|NCT02360813|Cognitive enhancement|cognitive enhancement
1133075|NCT02360800|Bleeding|bleeding
1133076|NCT02360800|Heart Surgery|heart surgery
1133077|NCT02360800|Reoperation|reoperation
1133078|NCT02360787|Almonds|almonds
1133079|NCT02360787|Energy restriction|energy restriction
1133080|NCT02360787|Obesity|obesity
1133081|NCT02360787|Body weight|body weight
1133082|NCT02360787|Body fat|body fat
1133083|NCT02360787|Blood pressure|blood pressure
1133084|NCT02360787|Cognitive function|cognitive function
1133085|NCT02360774|Canagliflozin|canagliflozin
1133086|NCT02360774|Obesity|obesity
1133087|NCT02360774|Weight Loss|weight loss
1133088|NCT02360774|Body Weight|body weight
1133089|NCT02360774|Body Weight Changes|body weight changes
1133090|NCT02360774|Overweight|overweight
1133091|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
1133092|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
1133093|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
1133094|NCT02360696|Functional Dyspepsia|functional dyspepsia
1133095|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
1133096|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
1133097|NCT02360657|Alzheimer's Disease|alzheimer's disease
1133098|NCT02360657|Alzheimer Dementia|alzheimer dementia
1133099|NCT02360657|JNJ-54861911|jnj-54861911
1133100|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
1133101|NCT02360631|smoking|smoking
1133102|NCT02360631|quit smoking|quit smoking
1133103|NCT02360631|smoking treatment|smoking treatment
1133104|NCT02360618|Bladder Cancer|bladder cancer
1133105|NCT02360618|Metformin|metformin
1133106|NCT02360618|Simvastatin|simvastatin
1133107|NCT02360618|Combination Therapy|combination therapy
1133108|NCT02360605|colorectal cancer screening|colorectal cancer screening
1133109|NCT02360605|low literacy|low literacy
1133110|NCT02360605|community clinics|community clinics
1133111|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
1133112|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
1133113|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
1133114|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
1133115|NCT02360579|Cell Therapy|cell therapy
1133116|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1133117|NCT02360579|TIL|til
1133118|NCT02360579|LN-144|ln-144
1133119|NCT02360579|IL-2|il-2
1133120|NCT02360579|Melanoma|melanoma
1133121|NCT02360566|Psychosis|psychosis
1133122|NCT02360566|Schizophrenia|schizophrenia
1133123|NCT02360566|Participatory Video|participatory video
1133124|NCT02360566|Narrative|narrative
1133125|NCT02360540|Pulmonary Embolism|pulmonary embolism
1133126|NCT02360540|Diagnostic strategy|diagnostic strategy
1133127|NCT02360540|Exclusion|exclusion
1133128|NCT02360540|Clinical probability|clinical probability
1133129|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
1133130|NCT02360540|PERC|perc
1133131|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1133132|NCT02360501|induction chemotherapy|induction chemotherapy
1133133|NCT02360501|docetaxel|docetaxel
1133134|NCT02360501|xeloda|xeloda
1133135|NCT02360475|Vaccine|vaccine
1133136|NCT02360475|Immunogenicity|immunogenicity
1133137|NCT02360475|Safety|safety
1133138|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
1133139|NCT02360475|Reactogenicity|reactogenicity
1133140|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1133141|NCT02360462|tDCS|tdcs
1133142|NCT02360462|Hallux Valgus|hallux valgus
1133143|NCT02360462|Chronic Pain|chronic pain
1133144|NCT02360449|Pivotal Response Treatment|pivotal response treatment
1133145|NCT02360449|Applied Behavior Analysis|applied behavior analysis
1133146|NCT02360449|Peer Initiation|peer initiation
1133147|NCT02360449|Social Skills Group|social skills group
1133148|NCT02360436|Rett|rett
1133149|NCT02360436|MeCP2|mecp2
1133150|NCT02360436|Glutathione|glutathione
1133151|NCT02360436|Cysteine|cysteine
1133152|NCT02360436|ROS|ros
1133153|NCT02360384|wireless motility capsule|wireless motility capsule
1133154|NCT02360332|Autism|autism
1133155|NCT02360332|transition to adulthood|transition to adulthood
1133156|NCT02360332|employment|employment
1133157|NCT02360332|High School Seniors|high school seniors
1133158|NCT02360319|First episode or recent onset|first episode or recent onset
1133159|NCT02360293|Exercise|exercise
1133160|NCT02360293|App-mediated|app-mediated
1133161|NCT02360293|Veterans|veterans
1133162|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
1133163|NCT02360267|Bipolar Disorder|bipolar disorder
1133164|NCT02360267|Pediatric|pediatric
1133165|NCT02360267|Offspring|offspring
1133166|NCT02360267|Depression|depression
1133167|NCT02360267|Mania|mania
1133168|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
1133169|NCT02360228|tACS|tacs
1133170|NCT02360228|tDCS|tdcs
1133171|NCT02360228|sham|sham
1133172|NCT02360228|auditory hallucinations|auditory hallucinations
1133173|NCT02360228|Schizophrenia|schizophrenia
1133174|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
1133175|NCT02360176|single port surgery|single port surgery
1133176|NCT02360176|bariatric surgery|bariatric surgery
1133177|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
1133178|NCT02360176|randomise prospective study|randomise prospective study
1133179|NCT02360176|complication rate|complication rate
1133180|NCT02360150|cardiac angiography|cardiac angiography
1133181|NCT02360150|cardiac MRI|cardiac mri
1133182|NCT02360137|carotids|carotids
1133183|NCT02360137|plaque|plaque
1133184|NCT02360137|characteristics|characteristics
1133185|NCT02360137|stroke|stroke
1133186|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
1133187|NCT02360111|Cyclophosphamide|cyclophosphamide
1133188|NCT02360111|Renal Insufficiency|renal insufficiency
1133189|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1133190|NCT02360111|14-273|14-273
1133191|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
1133192|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
1133193|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
1133194|NCT02360098|Anesthesia|anesthesia
1133195|NCT02360085|Cervical Myelopathy|cervical myelopathy
1133196|NCT02360085|Hypotension|hypotension
1133197|NCT02360072|child|child
1133198|NCT02360072|allergic rhinitis|allergic rhinitis
1133199|NCT02360072|asthma|asthma
1133200|NCT02360072|nitric oxide|nitric oxide
1133201|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
1133202|NCT02360059|Breast cancer|breast cancer
1133203|NCT02360059|Neuropathy|neuropathy
1133204|NCT02360059|Paclitaxel|paclitaxel
1133205|NCT02360059|Metformin|metformin
1133206|NCT02360059|Metformin ER|metformin er
1133207|NCT02360059|Placebo|placebo
1133208|NCT02360059|Sugar pill|sugar pill
1133209|NCT02360059|Questionnaires|questionnaires
1133210|NCT02360059|Sensory tests|sensory tests
1133211|NCT02360059|Fine-motor tests|fine-motor tests
1133212|NCT02360059|Surveys|surveys
1133213|NCT02360020|coronary stent|coronary stent
1133214|NCT02360020|outcome|outcome
1133215|NCT02360007|opioids|opioids
1133216|NCT02360007|buprenorphine|buprenorphine
1133217|NCT02360007|interim treatment|interim treatment
1133218|NCT02360007|opioid dependence|opioid dependence
1133219|NCT02359994|hemostasis|hemostasis
1133220|NCT02359981|Weight loss, Fitness|weight loss, fitness
1133221|NCT02359968|resectable esophageal|resectable esophageal
1133222|NCT02359968|junctional cancer|junctional cancer
1133223|NCT02359968|FOLFOX|folfox
1133224|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
1133225|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
1133226|NCT02359942|Eradication|eradication
1133227|NCT02359942|Urea breath test|urea breath test
1133228|NCT02359929|graft versus host disease|graft versus host disease
1133229|NCT02359929|GVHD|gvhd
1133230|NCT02359890|Interventional|interventional
1133231|NCT02359890|Radiofrequency ablation|radiofrequency ablation
1133232|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1133233|NCT02359877|pegylated interferon beta|pegylated interferon beta
1133234|NCT02359877|Volunteers|volunteers
1133235|NCT02359864|radiation treatment|radiation treatment
1133236|NCT02359838|Hematologic Malignancy|hematologic malignancy
1133237|NCT02359838|Geriatric Assessment|geriatric assessment
1133238|NCT02359838|Geriatric Oncology|geriatric oncology
1133239|NCT02359838|Frailty|frailty
1133240|NCT02359812|Stroke|stroke
1133241|NCT02359812|Upper extremity|upper extremity
1133242|NCT02359812|Rehabilitation|rehabilitation
1133243|NCT02359812|Robot|robot
1133244|NCT02359812|Hemiplegia|hemiplegia
1133245|NCT02359812|Spasticity|spasticity
1133248|NCT02359799|Cerebral palsy|cerebral palsy
1133249|NCT02359799|Ankle Impairments|ankle impairments
1133250|NCT02359799|Robotic rehabilitation|robotic rehabilitation
1133251|NCT02359773|Magnetocardiography|magnetocardiography
1133252|NCT02359773|Myocardial Infarction|myocardial infarction
1133253|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
1133254|NCT02359760|Rapid orthodontics|rapid orthodontics
1133255|NCT02359760|accelerated orthodontics|accelerated orthodontics
1133256|NCT02359760|Piezocision|piezocision
1133257|NCT02359760|flapless corticotomies|flapless corticotomies
1133258|NCT02359760|minimaly invasive|minimaly invasive
1133259|NCT02359747|free gDNA|free gdna
1133260|NCT02359747|culture media|culture media
1133261|NCT02359734|Patient safety|patient safety
1133262|NCT02359734|Medication errors|medication errors
1133263|NCT02359734|Smart infusion pump|smart infusion pump
1133264|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
1133265|NCT02359721|Microbial colonization|microbial colonization
1133266|NCT02359695|Poor ovarian response|poor ovarian response
1133267|NCT02359695|IVF|ivf
1133268|NCT02359695|Growth hormone|growth hormone
1133269|NCT02359643|Kawasaki disease|kawasaki disease
1133270|NCT02359617|continuous glucose sensor|continuous glucose sensor
1133271|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
1133272|NCT02359617|closed-loop glucose control|closed-loop glucose control
1133273|NCT02359617|type 1 diabetes|type 1 diabetes
1133274|NCT02359604|infant|infant
1133275|NCT02359604|ppi|ppi
1133276|NCT02359604|proton pump inhibitor|proton pump inhibitor
1133277|NCT02359604|microbiome|microbiome
1133278|NCT02359604|Microbiota|microbiota
1133279|NCT02359578|lymphatic system|lymphatic system
1133280|NCT02359578|occlusion pressure|occlusion pressure
1133281|NCT02359578|Indocyanine Green|indocyanine green
1133282|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
1133283|NCT02359526|Iluvien|iluvien
1133284|NCT02359526|Intra-vitreal injections|intra-vitreal injections
1133285|NCT02359526|Pilot study|pilot study
1133286|NCT02359513|bulimia|bulimia
1133287|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
1133288|NCT02359513|fluoxetine|fluoxetine
1133289|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
1133290|NCT02359513|brain serotonin profile|brain serotonin profile
1133291|NCT02359513|positon emission tomography|positon emission tomography
1133292|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
1133293|NCT02359500|Diagnosis|diagnosis
1133294|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
1133295|NCT02359487|Namibia|namibia
1133296|NCT02359487|Alcohol|alcohol
1133297|NCT02359487|HIV|hiv
1133298|NCT02359487|Sexual risk|sexual risk
1133299|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
1133300|NCT02359474|trabectedin|trabectedin
1133301|NCT02359461|Vascular function|vascular function
1133302|NCT02359461|Pulsatile cuts|pulsatile cuts
1133303|NCT02359461|Type 2 diabetes|type 2 diabetes
1133304|NCT02359461|Endothelium|endothelium
1133305|NCT02359461|Cardiovascular risk|cardiovascular risk
1133306|NCT02359461|Vasomotricity|vasomotricity
1133307|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
1133308|NCT02359435|Helicobacter pylori|helicobacter pylori
1133309|NCT02359435|Proton pump inhibitor|proton pump inhibitor
1133310|NCT02359435|Eradication|eradication
1133311|NCT02359396|Randomized open-label study|randomized open-label study
1133312|NCT02359396|Chinese Herbal|chinese herbal
1133313|NCT02359396|Constipation/drug therapy|constipation/drug therapy
1133314|NCT02359383|pleural disease|pleural disease
1133315|NCT02359383|infecTion|infection
1133316|NCT02359383|chest physiotherapy|chest physiotherapy
1133317|NCT02359370|Laryngoscopy|laryngoscopy
1133318|NCT02359370|Tracheal Intubation|tracheal intubation
1133319|NCT02359370|Lidocaine|lidocaine
1133320|NCT02359370|Magnesium Sulphate|magnesium sulphate
1133321|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
1133322|NCT02359331|Helicobacter pylori|helicobacter pylori
1133323|NCT02359331|resistance|resistance
1133324|NCT02359331|rescue therapy|rescue therapy
1133325|NCT02359318|White spot lesion|white spot lesion
1133326|NCT02359318|Resin Infiltration|resin infiltration
1133327|NCT02359318|Icon|icon
1133328|NCT02359318|Debonding|debonding
1133329|NCT02359318|Enamel damages|enamel damages
1133330|NCT02359318|Enamel|enamel
1133331|NCT02359318|Orthodontics|orthodontics
1133332|NCT02359266|Mood|mood
1133333|NCT02359266|Vitamin D deficiency|vitamin d deficiency
1133334|NCT02359266|Adjuvant treatment|adjuvant treatment
1133335|NCT02359253|Stroke|stroke
1133336|NCT02359253|Spasticity|spasticity
1133337|NCT02359253|Arm|arm
1133338|NCT02359253|Hand|hand
1133339|NCT02359253|Robotic therapy|robotic therapy
1133340|NCT02359227|Chronic Heart Failure|chronic heart failure
1133341|NCT02359227|Natriuretic Peptides|natriuretic peptides
1133342|NCT02359227|Cenderitide|cenderitide
1133343|NCT02359214|Vitamin D|vitamin d
1133344|NCT02359214|Cardiovascular disease|cardiovascular disease
1133345|NCT02359214|Diabetes|diabetes
1133346|NCT02359214|Obesity|obesity
1133347|NCT02359214|Cardiometabolic|cardiometabolic
1133745|NCT02357147|Amatuximab|amatuximab
1133348|NCT02359214|Bone disease|bone disease
1133349|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
1133350|NCT02359201|craving|craving
1133351|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
1133352|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
1133353|NCT02359175|Pain|pain
1133354|NCT02359175|Pain Measurement|pain measurement
1133355|NCT02359175|VAS|vas
1133356|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
1133357|NCT02359175|Analgesics|analgesics
1133358|NCT02359175|Opioid|opioid
1133359|NCT02359175|Epidural analgesia|epidural analgesia
1133360|NCT02359175|VATS|vats
1133361|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
1133362|NCT02359175|Lobectomy|lobectomy
1133363|NCT02359175|Wedge Resection|wedge resection
1133364|NCT02359175|Segmental Resection|segmental resection
1133365|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
1133366|NCT02359162|induction chemotherapy|induction chemotherapy
1133367|NCT02359162|survival|survival
1133368|NCT02359149|Intravitreal injections|intravitreal injections
1133369|NCT02359149|Nurses|nurses
1133370|NCT02359149|Physicians|physicians
1133371|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1133372|NCT02359136|Anesthesia, Local|anesthesia, local
1133373|NCT02359136|Ropivacaine|ropivacaine
1133374|NCT02359136|Randomized controlled trial|randomized controlled trial
1133375|NCT02359110|laparoscopy|laparoscopy
1133376|NCT02359110|postoperative pain|postoperative pain
1133377|NCT02359110|gynecology|gynecology
1133378|NCT02359110|gabapentin|gabapentin
1133380|NCT02359071|signoff|signoff
1133381|NCT02359071|handover|handover
1133382|NCT02359071|sign-out|sign-out
1133383|NCT02359071|shift change|shift change
1133384|NCT02359071|Emergency Department|emergency department
1133385|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
1133386|NCT02359045|Phase I,|phase i,
1133387|NCT02359045|Healthy Subjects,|healthy subjects,
1133388|NCT02359045|Pharmacokinetics,|pharmacokinetics,
1133979|NCT02355626|delirium|delirium
1133389|NCT02359045|Relative bioavailability|relative bioavailability
1133390|NCT02359032|Healthy subjects|healthy subjects
1133391|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
1133393|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
1133394|NCT02359006|Analgesia|analgesia
1133395|NCT02359006|pain analgesia|pain analgesia
1133396|NCT02359006|methadone|methadone
1133397|NCT02359006|opiates|opiates
1133398|NCT02358993|Urinary Tract Infections|urinary tract infections
1133399|NCT02358993|Catheter-Related Infections|catheter-related infections
1133400|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
1133401|NCT02358993|Urogynecology|urogynecology
1133402|NCT02358993|Urinary catheterization|urinary catheterization
1133403|NCT02358993|Post-operative Infections|post-operative infections
1133404|NCT02358993|Methenamine hippurate|methenamine hippurate
1133405|NCT02358980|Multiple Myeloma|multiple myeloma
1133406|NCT02358980|Cast Nephropathy|cast nephropathy
1133407|NCT02358980|Acute kidney injury|acute kidney injury
1133408|NCT02358980|KIDNEY THERAPY|kidney therapy
1133410|NCT02358967|ESRD|esrd
1133411|NCT02358967|dyslipidemia|dyslipidemia
1133412|NCT02358967|oxidative stress|oxidative stress
1133413|NCT02358967|inflammation|inflammation
1133414|NCT02358967|Hemodialysis|hemodialysis
1133415|NCT02358967|CKD|ckd
1133416|NCT02358954|quantitative sensory testing|quantitative sensory testing
1133417|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
1133418|NCT02358954|vection stimulation|vection stimulation
1133419|NCT02358954|3D-turntable|3d-turntable
1133420|NCT02358954|Volunteers|volunteers
1133421|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
1133422|NCT02358928|NAFLD|nafld
1133423|NCT02358928|Metabolic syndrome|metabolic syndrome
1133424|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
1133425|NCT02358928|Obesity|obesity
1133426|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1133427|NCT02358902|Exercise|exercise
1133428|NCT02358902|Fibromyalgia|fibromyalgia
1133429|NCT02358876|Parkinson's disease|parkinson's disease
1133430|NCT02358876|Deep brain stimulation|deep brain stimulation
1133431|NCT02358876|Bradykinesia|bradykinesia
1133432|NCT02358850|Tonsillectomy|tonsillectomy
1133433|NCT02358850|Adenoidectomy|adenoidectomy
1133434|NCT02358837|elastosonography|elastosonography
1133435|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
1133436|NCT02358824|Hypertension|hypertension
1133437|NCT02358824|CKD-828|ckd-828
1133438|NCT02358824|Telmisartan|telmisartan
1133439|NCT02358824|S-amlodipine|s-amlodipine
1133440|NCT02358824|Pharmacokinetic|pharmacokinetic
1133441|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
1133442|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
1133443|NCT02358811|Polysomnography|polysomnography
1133444|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
1133445|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
1133545|NCT02358317|Postural Stability|postural stability
1133546|NCT02358317|Exergaming|exergaming
1133446|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
1133447|NCT02358798|Preschool aged children|preschool aged children
1133448|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
1133449|NCT02358772|stroke|stroke
1133450|NCT02358772|thrombolysis|thrombolysis
1133451|NCT02358772|STEMO|stemo
1133452|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
1133453|NCT02358759|3PNs correction|3pns correction
1133454|NCT02358759|Giant oocyte management|giant oocyte management
1133455|NCT02358759|triploidy fertilization|triploidy fertilization
1133456|NCT02358759|Maternal nucleus removal|maternal nucleus removal
1133457|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
1133458|NCT02358733|POR|por
1133459|NCT02358733|IMSI|imsi
1133460|NCT02358720|bone metastases|bone metastases
1133461|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
1133462|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
1133463|NCT02358694|IBS|ibs
1133464|NCT02358694|IBS-D|ibs-d
1133465|NCT02358694|SBI|sbi
1133466|NCT02358681|Intranasal|intranasal
1133467|NCT02358681|Ketorolac|ketorolac
1133468|NCT02358681|Pediatric|pediatric
1133469|NCT02358681|Migraine|migraine
1133470|NCT02358681|Headache|headache
1133471|NCT02358655|Oral anticoagulant|oral anticoagulant
1133472|NCT02358655|Knowledge translation|knowledge translation
1133473|NCT02358655|Emergency department|emergency department
1191043|NCT02073656|HIV|hiv
1133474|NCT02358642|Rate of Pneumonia|rate of pneumonia
1133475|NCT02358642|Mortality rate|mortality rate
1133476|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
1133477|NCT02358603|Heart Failure|heart failure
1133478|NCT02358564|IBS|ibs
1133479|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
1133480|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
1133481|NCT02358564|Permeability|permeability
1133482|NCT02358564|Small Bowel|small bowel
1133483|NCT02358564|Lactulose|lactulose
1133484|NCT02358564|Mannitol|mannitol
1133485|NCT02358551|Pacemaker|pacemaker
1133486|NCT02358551|Axillary Vein|axillary vein
1133487|NCT02358551|Subclavian vein|subclavian vein
1133488|NCT02358551|Clinical Study|clinical study
1133489|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
1133490|NCT02358538|PCDH19|pcdh19
1133491|NCT02358538|ganaxolone|ganaxolone
1133492|NCT02358538|neurosteroid|neurosteroid
1133493|NCT02358538|CDKL5|cdkl5
1133494|NCT02358538|LGS|lgs
1133495|NCT02358538|CSWS|csws
1133496|NCT02358512|Intensive Care|intensive care
1133497|NCT02358512|Recovery of Function|recovery of function
1133498|NCT02358512|Survivors|survivors
1133499|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
1133500|NCT02358512|Medical Economics|medical economics
1133501|NCT02358499|triazoles|triazoles
1133502|NCT02358499|fungi|fungi
1133503|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
1133504|NCT02358499|leukemia|leukemia
1133505|NCT02358499|pediatrics|pediatrics
1133506|NCT02358499|pharmacokinetics|pharmacokinetics
1133507|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
1133508|NCT02358486|Functional Dyspepsia|functional dyspepsia
1133509|NCT02358486|Acupuncture|acupuncture
1133510|NCT02358486|Functional MRI|functional mri
1133511|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
1133512|NCT02358473|NSCLC|nsclc
1133513|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1133514|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
1133515|NCT02358473|KW-0761|kw-0761
1133516|NCT02358473|Mogamulizumab|mogamulizumab
1133517|NCT02358460|neonatal|neonatal
1133518|NCT02358460|respiratory|respiratory
1133519|NCT02358460|mechanical ventilation|mechanical ventilation
1133520|NCT02358447|total knee arthroplasty|total knee arthroplasty
1133521|NCT02358447|total knee prothesis|total knee prothesis
1133522|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
1133523|NCT02358447|SPECT/CT|spect/ct
1133524|NCT02358447|measurement of TKA component position|measurement of tka component position
1133525|NCT02358434|Implant|implant
1133526|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
1133527|NCT02358421|Risk of OHSS|risk of ohss
1133528|NCT02358356|midgut|midgut
1133529|NCT02358356|pancreatic|pancreatic
1133530|NCT02358356|neuroendocrine|neuroendocrine
1133531|NCT02358356|advanced|advanced
1133532|NCT02358356|unresectable low|unresectable low
1133533|NCT02358356|intermediate grade|intermediate grade
1133534|NCT02358356|mNETs|mnets
1133535|NCT02358356|pNETs|pnets
1133536|NCT02358343|Comorbid Depression|comorbid depression
1133537|NCT02358343|Major Depressive Disorder|major depressive disorder
1133538|NCT02358343|Dysthymia|dysthymia
1133539|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
1133540|NCT02358343|Sertraline|sertraline
1133541|NCT02358343|Engagement Interview|engagement interview
1133542|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1133543|NCT02358343|Hemodialysis|hemodialysis
1133544|NCT02358317|Autism|autism
1133547|NCT02358317|White Matter|white matter
1133548|NCT02358252|Heart Rate Variability|heart rate variability
1133549|NCT02358252|orthostatic hypotension|orthostatic hypotension
1133550|NCT02358252|stroke|stroke
1133551|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
1133552|NCT02358239|dizziness and vertigo|dizziness and vertigo
1133553|NCT02358239|emergency department (ED)|emergency department (ed)
1133554|NCT02358239|clinical trial|clinical trial
1133555|NCT02358239|acupuncture|acupuncture
1133556|NCT02358226|Substance-Related Disorders|substance-related disorders
1133557|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
1133558|NCT02358226|Alcoholism|alcoholism
1133559|NCT02358226|South Africa|south africa
1133560|NCT02358226|Men|men
1133561|NCT02358226|Soccer|soccer
1133562|NCT02358226|Vocational Training|vocational training
1133563|NCT02358213|reproductibility|reproductibility
1133564|NCT02358174|Hemorrhoids|hemorrhoids
1133565|NCT02358174|MMP|mmp
1133566|NCT02358174|NGAL|ngal
1133567|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
1133568|NCT02358161|Pancreatic cancer|pancreatic cancer
1133569|NCT02358161|LDE225|lde225
1133570|NCT02358161|Gemcitabine|gemcitabine
1133571|NCT02358161|nab paclitaxel|nab paclitaxel
1133572|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
1133573|NCT02358148|Chest Pain|chest pain
1133574|NCT02358148|ACS|acs
1133575|NCT02358148|Risk Stratification Score|risk stratification score
1133576|NCT02358148|HEART Score|heart score
1133577|NCT02358148|Modified TIMI|modified timi
1133578|NCT02358148|Coronary Artery Disease|coronary artery disease
1133579|NCT02358148|Risk Factors|risk factors
1133580|NCT02358148|Myocardial Infarction|myocardial infarction
1133581|NCT02358135|Pragmatic|pragmatic
1133582|NCT02358135|Equivalency|equivalency
1133583|NCT02358135|Teledermatology|teledermatology
1133584|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
1133585|NCT02358096|Chronic Kidney Disease|chronic kidney disease
1133586|NCT02358096|Type 2 Diabetes|type 2 diabetes
1133587|NCT02358096|ASP8232|asp8232
1133588|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
1133589|NCT02358057|Deep sedation|deep sedation
1133590|NCT02358057|Dexmedetomidine|dexmedetomidine
1133591|NCT02358057|Emergency Service, Hospital|emergency service, hospital
1133592|NCT02358031|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
1133593|NCT02358031|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
1133594|NCT02358031|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
1133595|NCT02358031|PD1|pd1
1133596|NCT02358031|PD-1|pd-1
1133597|NCT02358031|PDL1|pdl1
1133598|NCT02358031|PD-L1|pd-l1
1133599|NCT02358031|PDL2|pdl2
1133600|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
1133601|NCT02358018|PET/CT scan|pet/ct scan
1133602|NCT02358018|14-226|14-226
1133603|NCT02357992|Lung cancer|lung cancer
1133604|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
1133605|NCT02357992|NSCLC|nsclc
1133606|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
1133607|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
1133608|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
1133609|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
1133610|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
1133611|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
1133612|NCT02357992|SRT|srt
1133613|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1133614|NCT02357992|SABR|sabr
1133615|NCT02357992|Radiation therapy|radiation therapy
1133616|NCT02357992|XRT|xrt
1133617|NCT02357979|caries|caries
1133618|NCT02357979|prevention|prevention
1133619|NCT02357979|laser|laser
1133620|NCT02357979|fluoride|fluoride
1133621|NCT02357966|Staph|staph
1133622|NCT02357966|antibody|antibody
1133623|NCT02357940|Eczema|eczema
1133624|NCT02357940|Skin Irritation|skin irritation
1133625|NCT02357927|fears of recurrence|fears of recurrence
1133626|NCT02357927|cancer|cancer
1133627|NCT02357927|brief intervention|brief intervention
1133628|NCT02357927|telephone counseling|telephone counseling
1133629|NCT02357927|following primary cancer treatment|following primary cancer treatment
1133630|NCT02357914|Ultrasound|ultrasound
1133631|NCT02357914|Shoulder|shoulder
1133632|NCT02357914|Spinal Cord Injury|spinal cord injury
1133633|NCT02357914|Fluoroscopy|fluoroscopy
1133634|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
1133635|NCT02357888|craving|craving
1133636|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
1133637|NCT02357862|Heart Valve Diseases|heart valve diseases
1133638|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
1133639|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
1133640|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
1133641|NCT02357823|HIV infection|hiv infection
1133642|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
1133643|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
1133644|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
1133645|NCT02357784|SNM|snm
1133646|NCT02357784|Dual Incontinence|dual incontinence
1133647|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
1133648|NCT02357784|CPT Testing|cpt testing
1133649|NCT02357784|Fecal Incontinence|fecal incontinence
1133650|NCT02357784|Urinary Incontinence|urinary incontinence
1133651|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
1133652|NCT02357784|InterStim|interstim
1133653|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
1133654|NCT02357771|mal-align teeth|mal-align teeth
1133655|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
1133656|NCT02357758|Urinary Microbiota|urinary microbiota
1133657|NCT02357745|neopterin|neopterin
1133658|NCT02357745|plasma|plasma
1133659|NCT02357745|urine|urine
1133660|NCT02357745|saliva|saliva
1133661|NCT02357745|menopause|menopause
1133662|NCT02357745|periodontitis|periodontitis
1133663|NCT02357732|Metastatic Melanoma|metastatic melanoma
1133664|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
1133665|NCT02357719|Polysomnography|polysomnography
1133666|NCT02357719|Holter ECG|holter ecg
1133667|NCT02357719|Thoracic impedance|thoracic impedance
1133668|NCT02357719|Heart rate variability|heart rate variability
1133669|NCT02357719|Nasal flow|nasal flow
1133670|NCT02357693|nausea, postoperative|nausea, postoperative
1133671|NCT02357693|postoperative nausea|postoperative nausea
1133672|NCT02357693|postoperative vomiting|postoperative vomiting
1133673|NCT02357693|vomiting, postoperative|vomiting, postoperative
1133674|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
1133675|NCT02357602|Participants|participants
1133676|NCT02357602|HIV-1 negative|hiv-1 negative
1133677|NCT02357589|3D|3d
1133678|NCT02357589|laparoscopy|laparoscopy
1133679|NCT02357589|cholecystectomy|cholecystectomy
1133680|NCT02357563|fibroid|fibroid
1133681|NCT02357563|GnRH analogue|gnrh analogue
1133682|NCT02357563|ulipristal acetate|ulipristal acetate
1133683|NCT02357537|Telemedicine|telemedicine
1133684|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
1133685|NCT02357511|sensitivity|sensitivity
1133686|NCT02357511|specificity|specificity
1133687|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
1133688|NCT02357511|Saturation|saturation
1133689|NCT02357498|pituitary|pituitary
1133690|NCT02357498|adenoma|adenoma
1133691|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
1133692|NCT02357485|ADSC|adsc
1133693|NCT02357485|osteoarthritis|osteoarthritis
1133694|NCT02357485|knee|knee
1133695|NCT02357485|adipose|adipose
1133696|NCT02357472|Reproductive aging|reproductive aging
1133697|NCT02357472|DHEA|dhea
1133698|NCT02357472|poor ovarian responder|poor ovarian responder
1133699|NCT02357459|osteoarthritis|osteoarthritis
1133700|NCT02357459|knee|knee
1133701|NCT02357459|pain|pain
1133702|NCT02357459|corticosteroid|corticosteroid
1133703|NCT02357459|intra-articular|intra-articular
1133704|NCT02357459|injection|injection
1133705|NCT02357420|Diabetes Mellitus|diabetes mellitus
1133706|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
1133707|NCT02357420|Vomiting|vomiting
1133708|NCT02357420|Gastroparesis|gastroparesis
1133709|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
1133710|NCT02357407|fluoroquinolones|fluoroquinolones
1133711|NCT02357407|pharmacokinetic|pharmacokinetic
1133712|NCT02357407|infections|infections
1133713|NCT02357368|HIV-negative|hiv-negative
1133714|NCT02357329|fat taste|fat taste
1133715|NCT02357329|food preference|food preference
1133716|NCT02357329|consumption|consumption
1133717|NCT02357329|free fatty acids|free fatty acids
1133718|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
1133719|NCT02357303|Randomized controlled trial|randomized controlled trial
1133720|NCT02357303|Endoscopy|endoscopy
1133721|NCT02357303|Gastric mucosa|gastric mucosa
1133722|NCT02357303|Simethicone|simethicone
1133723|NCT02357303|Acetylcysteine|acetylcysteine
1133724|NCT02357290|mania|mania
1133725|NCT02357290|temper tantrum|temper tantrum
1133726|NCT02357290|irritability|irritability
1133727|NCT02357290|mood|mood
1133728|NCT02357290|bipolar|bipolar
1133729|NCT02357277|Osteoporosis|osteoporosis
1133730|NCT02357277|Glucocorticoids|glucocorticoids
1133731|NCT02357277|Postmenopausal|postmenopausal
1133732|NCT02357238|Uveitis|uveitis
1133733|NCT02357238|Infectious|infectious
1133734|NCT02357225|Pompe disease|pompe disease
1133735|NCT02357225|Pyridostigmine|pyridostigmine
1133736|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
1133737|NCT02357199|Mouth Diseases|mouth diseases
1133738|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
1133739|NCT02357199|Intervention Studies|intervention studies
1133740|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
1133741|NCT02357173|smoking|smoking
1133742|NCT02357173|nicotine|nicotine
1133743|NCT02357173|tobacco products|tobacco products
1133744|NCT02357173|electronic cigarette|electronic cigarette
1133748|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
1133749|NCT02357147|ARTEMIS|artemis
1133750|NCT02357134|Advanced cancers|advanced cancers
1133751|NCT02357134|Primary or secondary lung involvement|primary or secondary lung involvement
1133752|NCT02357134|Dyspnea|dyspnea
1133753|NCT02357134|Difficulty breathing|difficulty breathing
1133754|NCT02357134|Stationary cycle test|stationary cycle test
1133755|NCT02357134|Questionnaires|questionnaires
1133756|NCT02357134|Surveys|surveys
1133757|NCT02357134|High flow oxygen|high flow oxygen
1133758|NCT02357134|High flow air|high flow air
1133759|NCT02357134|Low flow oxygen|low flow oxygen
1133760|NCT02357134|Low flow air|low flow air
1133761|NCT02357108|Supportive Care|supportive care
1133762|NCT02357108|treatment options|treatment options
1133763|NCT02357108|doctor's compassion|doctor's compassion
1133764|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
1133765|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
1133766|NCT02357095|treatment|treatment
1133767|NCT02357030|Gulf War Illness|gulf war illness
1133768|NCT02357030|nutrients|nutrients
1133769|NCT02357030|methylphenidate|methylphenidate
1133770|NCT02357030|mitochondria|mitochondria
1133771|NCT02356991|Famitinib|famitinib
1133772|NCT02356991|Phase II|phase ii
1133773|NCT02356991|NSCLC|nsclc
1133774|NCT02356978|Rare disease|rare disease
1133775|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
1133776|NCT02356978|Paediatric|paediatric
1133777|NCT02356978|Experimental device|experimental device
1133778|NCT02356965|Third molar extraction|third molar extraction
1133779|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
1133780|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
1133781|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
1133782|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
1133783|NCT02356952|Randomized Clinical Trial|randomized clinical trial
1133784|NCT02356926|Adverse events|adverse events
1133785|NCT02356926|Medical errors|medical errors
1133786|NCT02356926|Emergency department|emergency department
1133787|NCT02356926|Cross checking|cross checking
1133788|NCT02356900|interval training|interval training
1133789|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
1133790|NCT02356900|VO2 max|vo2 max
1133791|NCT02356900|altitude|altitude
1133792|NCT02356900|exercise performance|exercise performance
1133793|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
1133794|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
1133795|NCT02356861|treatment|treatment
1133796|NCT02356861|photobiomodulation|photobiomodulation
1133797|NCT02356861|Veterans|veterans
1133798|NCT02356861|brain-injury|brain-injury
1133799|NCT02356861|TBI|tbi
1133800|NCT02356861|PTSD|ptsd
1133801|NCT02356848|self-care|self-care
1133802|NCT02356848|self-monitoring|self-monitoring
1133803|NCT02356848|secondary prevention|secondary prevention
1133804|NCT02356848|foot ulcer|foot ulcer
1133805|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
1133806|NCT02356757|self-care|self-care
1133807|NCT02356757|self-monitoring|self-monitoring
1133808|NCT02356757|medication adherence|medication adherence
1133809|NCT02356757|diet|diet
1133810|NCT02356757|physical activity|physical activity
1133811|NCT02356757|primary prevention|primary prevention
1133812|NCT02356744|Maternal outcome|maternal outcome
1133813|NCT02356744|Fetal outcome|fetal outcome
1133814|NCT02356744|bariatric surgery|bariatric surgery
1133815|NCT02356744|Third Trimester|third trimester
1133816|NCT02356731|seizures,|seizures,
1133817|NCT02356731|quality of life|quality of life
1133818|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
1133819|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
1133820|NCT02356640|Pancreatic cancer|pancreatic cancer
1133821|NCT02356627|Occupational therapy|occupational therapy
1133822|NCT02356627|Adaptive intervention|adaptive intervention
1133823|NCT02356627|Home-based|home-based
1133824|NCT02356627|Assistive Technology|assistive technology
1133825|NCT02356627|Home modification|home modification
1133826|NCT02356627|Clinical effectiveness|clinical effectiveness
1133827|NCT02356627|Cost-effectiveness|cost-effectiveness
1133828|NCT02356627|Cost-utility|cost-utility
1133829|NCT02356614|Lap Band|lap band
1133830|NCT02356601|MRI|mri
1133831|NCT02356601|Lumbar spine|lumbar spine
1133832|NCT02356601|Ultrasound|ultrasound
1133833|NCT02356575|surgery|surgery
1133834|NCT02356575|chemotherapy|chemotherapy
1133835|NCT02356575|radiation|radiation
1133836|NCT02356575|Acupuncture|acupuncture
1133837|NCT02356575|16-947|16-947
1133838|NCT02356562|Hepatitis C|hepatitis c
1133839|NCT02356562|Interferon-Free|interferon-free
1133840|NCT02356562|Treatment Experienced|treatment experienced
1133841|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
1133842|NCT02356562|Hepatitis C Virus|hepatitis c virus
1133843|NCT02356510|myocardial infarction|myocardial infarction
1133844|NCT02356510|TIMI flow|timi flow
1133845|NCT02356510|culprit lesion|culprit lesion
1133846|NCT02356510|culprit vessel|culprit vessel
1133847|NCT02356497|Bone metastases|bone metastases
1133848|NCT02356497|Metastatic bone disease|metastatic bone disease
1133849|NCT02356497|Multi-trial facility|multi-trial facility
1133850|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
1133851|NCT02356458|Relapsed|relapsed
1133852|NCT02356458|Refractory|refractory
1133853|NCT02356458|Cancer|cancer
1133854|NCT02356458|Lymphoma|lymphoma
1133855|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
1133856|NCT02356458|Bortezomib Velcade|bortezomib velcade
1133857|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
1133858|NCT02356432|cerebral microbleeds|cerebral microbleeds
1133859|NCT02356432|warfarin|warfarin
1133860|NCT02356432|NOACs|noacs
1133861|NCT02356432|acute ischemic stroke|acute ischemic stroke
1133862|NCT02356406|Radiosurgery|radiosurgery
1133863|NCT02356406|Celiac Plexus|celiac plexus
1133864|NCT02356406|Pain|pain
1133865|NCT02356406|Quality of Life|quality of life
1133866|NCT02356393|Desalinated Sea Water|desalinated sea water
1133867|NCT02356393|Magnesium|magnesium
1133868|NCT02356393|Drinking Water|drinking water
1133869|NCT02356367|telemonitoring|telemonitoring
1133870|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
1133871|NCT02356354|molecular factors|molecular factors
1133872|NCT02356354|cutaneous innervation|cutaneous innervation
1133873|NCT02356354|skin biopsy|skin biopsy
1133874|NCT02356354|post-burn scar|post-burn scar
1133875|NCT02356315|Brain|brain
1133876|NCT02356315|Brain Stem|brain stem
1133877|NCT02356315|Spinal Cord|spinal cord
1133878|NCT02356315|Neurophysiology|neurophysiology
1133879|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
1133880|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1133881|NCT02356276|locally advanced gastric cancer|locally advanced gastric cancer
1133882|NCT02356276|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
1133883|NCT02356276|radical gastrectomy with D2 lymphadenectomy|radical gastrectomy with d2 lymphadenectomy
1133884|NCT02356263|stressful events|stressful events
1133885|NCT02356263|psychological stress|psychological stress
1133886|NCT02356263|life experiences|life experiences
1133887|NCT02356250|liver biopsy f 4|liver biopsy f 4
1133888|NCT02356237|Episiotomy|episiotomy
1133889|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
1133890|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
1133891|NCT02356211|falls|falls
1133892|NCT02356185|Alcohol Drinking|alcohol drinking
1133893|NCT02356185|Injecting drug|injecting drug
1133894|NCT02356185|Antiretroviral therapy|antiretroviral therapy
1133895|NCT02356185|sub-Saharan Africa|sub-saharan africa
1133896|NCT02356172|Quality of Life|quality of life
1133897|NCT02356172|Depression|depression
1133898|NCT02356172|Kallmann Syndrome|kallmann syndrome
1133899|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1133900|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1133901|NCT02356159|Lymphoma|lymphoma
1133902|NCT02356159|Leukemia|leukemia
1133903|NCT02356159|Unrelated Donors|unrelated donors
1133904|NCT02356146|Kidney transplantation|kidney transplantation
1133905|NCT02356146|genotype|genotype
1133906|NCT02356146|tacrolimus|tacrolimus
1133907|NCT02356146|CYP3A5|cyp3a5
1133908|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
1133909|NCT02356094|glaucoma|glaucoma
1133910|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
1133911|NCT02356094|cornea|cornea
1133912|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
1133913|NCT02356055|activities of daily living|activities of daily living
1133914|NCT02356055|massed practice|massed practice
1133915|NCT02356055|occupational therapy|occupational therapy
1133916|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
1133917|NCT02356029|Emergency Medical Services|emergency medical services
1133918|NCT02356029|Medical Futility|medical futility
1133919|NCT02356029|Decision Making|decision making
1133920|NCT02356029|Emotional Stress|emotional stress
1133921|NCT02356029|Burnout, Professional|burnout, professional
1133922|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
1133923|NCT02356016|community dwelling elderly women|community dwelling elderly women
1133924|NCT02356016|electromyostimulation|electromyostimulation
1133925|NCT02356016|exercise|exercise
1133926|NCT02356016|dietary supplements|dietary supplements
1133927|NCT02356003|Tourette Syndrome|tourette syndrome
1133928|NCT02356003|Children|children
1133929|NCT02356003|Tics|tics
1133930|NCT02355977|Chronic periodontitis|chronic periodontitis
1133931|NCT02355977|Minocycline|minocycline
1133932|NCT02355977|Surface and root planning|surface and root planning
1133933|NCT02355977|Pocket depth|pocket depth
1133934|NCT02355977|Sulcus bleeding index|sulcus bleeding index
1133935|NCT02355977|Prevotella intermedia|prevotella intermedia
1133936|NCT02355912|Transfemoral|transfemoral
1133937|NCT02355873|heparin-coated|heparin-coated
1133938|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
1133939|NCT02355873|critical ill|critical ill
1133940|NCT02355873|acute kidney injury|acute kidney injury
1133941|NCT02355873|chronic kidney disease|chronic kidney disease
1133942|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
1133943|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
1133944|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1133945|NCT02355834|bowel control|bowel control
1133946|NCT02355834|Chronic diarrhoea|chronic diarrhoea
1133947|NCT02355834|rectal inflammation|rectal inflammation
1133948|NCT02355821|cellular aging|cellular aging
1133949|NCT02355821|vascular aging|vascular aging
1133950|NCT02355821|bone metabolism|bone metabolism
1133951|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
1133952|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
1133953|NCT02355821|pulse wave velocity|pulse wave velocity
1133954|NCT02355821|telomerase activity|telomerase activity
1133955|NCT02355795|weight change|weight change
1133956|NCT02355795|diet|diet
1133957|NCT02355795|dietary fat|dietary fat
1133958|NCT02355795|feeding design|feeding design
1133959|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
1133960|NCT02355769|heart failure|heart failure
1133961|NCT02355769|renal failure|renal failure
1133962|NCT02355769|prognosis|prognosis
1133963|NCT02355769|impedance cardiography|impedance cardiography
1133964|NCT02355717|children, bone|children, bone
1133965|NCT02355717|Simple obesity|simple obesity
1133966|NCT02355717|cardiovascular disease|cardiovascular disease
1133967|NCT02355717|osteoporosis|osteoporosis
1133968|NCT02355717|diabetes|diabetes
1133969|NCT02355704|Kidney Transplantation|kidney transplantation
1133970|NCT02355704|Atorvastatin|atorvastatin
1133971|NCT02355704|C-Reactive Protein|c-reactive protein
1133972|NCT02355704|Biopsy|biopsy
1133973|NCT02355704|Interleukin|interleukin
1133974|NCT02355652|Total knee arthroplasty|total knee arthroplasty
1133975|NCT02355652|IKS Score|iks score
1133976|NCT02355652|cemented, uncemented|cemented, uncemented
1133977|NCT02355626|Anxiety|anxiety
1133978|NCT02355626|level of anxiety|level of anxiety
1133980|NCT02355626|agitation|agitation
1133981|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
1133982|NCT02355626|neuroendocrine system|neuroendocrine system
1133983|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
1133984|NCT02355600|Oocyte|oocyte
1133985|NCT02355600|Tamoxifen|tamoxifen
1133986|NCT02355600|Fertility preservation|fertility preservation
1133987|NCT02355587|melanoma|melanoma
1133988|NCT02355587|cutaneous melanoma|cutaneous melanoma
1133989|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
1133990|NCT02355574|melanoma|melanoma
1133991|NCT02355574|cutaneous melanoma|cutaneous melanoma
1133992|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
1133993|NCT02355561|Bioavailability|bioavailability
1133994|NCT02355561|Healthy Participants|healthy participants
1133995|NCT02355561|JNJ-54861911|jnj-54861911
1133996|NCT02355561|Food Effect|food effect
1133997|NCT02355535|refractory|refractory
1133998|NCT02355535|intolerant|intolerant
1133999|NCT02355535|solid tumors|solid tumors
1134000|NCT02355535|lymphoma|lymphoma
1134001|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
1134002|NCT02355509|Acarbose|acarbose
1134003|NCT02355509|Postprandial lipemia|postprandial lipemia
1134004|NCT02355509|Cardiovascular risk|cardiovascular risk
1134005|NCT02355496|Cost Control|cost control
1134006|NCT02355496|Data Display|data display
1134007|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
1134008|NCT02355496|Physician's Practice Patterns|physician's practice patterns
1134009|NCT02355470|Sexual assault|sexual assault
1134010|NCT02355470|Alcohol consumption|alcohol consumption
1134011|NCT02355470|Intimate partner violence|intimate partner violence
1134012|NCT02355457|troponin|troponin
1134013|NCT02355457|myocardial infarction|myocardial infarction
1134014|NCT02355457|acs|acs
1134015|NCT02355457|AMI|ami
1134016|NCT02355457|biomarker|biomarker
1134017|NCT02355457|BACC|bacc
1134018|NCT02355457|high-sensitivity|high-sensitivity
1134019|NCT02355431|EGFR|egfr
1134020|NCT02355431|mutation|mutation
1134021|NCT02355405|lung ultrasound|lung ultrasound
1134022|NCT02355405|atelectasis|atelectasis
1134023|NCT02355405|thoracic computed Tomography|thoracic computed tomography
1134024|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
1134025|NCT02355366|Offspring|offspring
1134026|NCT02355366|significant mood symptoms|significant mood symptoms
1134027|NCT02355353|DWI-MRI|dwi-mri
1134028|NCT02355353|resectable liver metastases|resectable liver metastases
1134029|NCT02355340|Bone mineral density|bone mineral density
1134030|NCT02355340|Childhood cancer survivors|childhood cancer survivors
1134031|NCT02355314|ICU patients|icu patients
1134032|NCT02355314|Doppler-based renal|doppler-based renal
1134033|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
1134034|NCT02355288|Coronary Artery Disease|coronary artery disease
1134035|NCT02355288|Diabetes Mellitus|diabetes mellitus
1134036|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
1134037|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
1134038|NCT02355275|Home Exercise|home exercise
1134039|NCT02355275|Resistance Exercise|resistance exercise
1134040|NCT02355262|Insurance Coverage|insurance coverage
1134041|NCT02355262|Insurance Continuity|insurance continuity
1134042|NCT02355249|traditional three incisions|traditional three incisions
1134043|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
1134044|NCT02355249|MIE|mie
1134045|NCT02355249|esophageal cancer|esophageal cancer
1134046|NCT02355236|Naxozol|naxozol
1134047|NCT02355236|LDQ|ldq
1134048|NCT02355236|GSRS|gsrs
1134049|NCT02355236|Osteoarthritis|osteoarthritis
1134050|NCT02355236|Gastroprotective|gastroprotective
1134051|NCT02355223|Tuberculosis|tuberculosis
1134052|NCT02355223|Infection Control|infection control
1134053|NCT02355223|Transmission|transmission
1134054|NCT02355197|antioxidants|antioxidants
1191821|NCT02069847|EMR|emr
1134055|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
1134056|NCT02355197|oxidative stress|oxidative stress
1134057|NCT02355158|pain|pain
1134058|NCT02355158|diabetic neuropathy|diabetic neuropathy
1134059|NCT02355158|pain in feet|pain in feet
1134060|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
1134061|NCT02355132|Medicaid|medicaid
1134062|NCT02355132|public insurance|public insurance
1134063|NCT02355132|cardiovascular disease|cardiovascular disease
1134064|NCT02355132|prevention|prevention
1134065|NCT02355132|community health centers|community health centers
1134066|NCT02355132|electronic health records|electronic health records
1134067|NCT02355132|cancer prevention|cancer prevention
1134068|NCT02355080|HIV|hiv
1134069|NCT02355080|HCV|hcv
1134070|NCT02355067|parenting|parenting
1134071|NCT02355067|postpartum depression|postpartum depression
1134072|NCT02355067|mothers|mothers
1134073|NCT02355067|infants|infants
1134074|NCT02355067|depression|depression
1134075|NCT02355054|Recurrent|recurrent
1134076|NCT02355041|diet|diet
1134077|NCT02355041|body weight|body weight
1134078|NCT02355041|eating|eating
1134079|NCT02355041|meal replacement|meal replacement
1134080|NCT02355028|LHA510|lha510
1134081|NCT02355028|PoC|poc
1134082|NCT02355028|Age-related macular degeneration|age-related macular degeneration
1134083|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
1134084|NCT02354963|Poor ovarian response|poor ovarian response
1134085|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
1134086|NCT02354963|Follicular activation|follicular activation
1134087|NCT02354963|Poor ovarian reserve|poor ovarian reserve
1134088|NCT02354950|GSK1265744|gsk1265744
1134089|NCT02354950|healthy controls|healthy controls
1134090|NCT02354950|pharmacokinetic|pharmacokinetic
1134091|NCT02354950|Hepatic Impairment|hepatic impairment
1134092|NCT02354937|Pharmacokinetics|pharmacokinetics
1134093|NCT02354937|GSK1265744|gsk1265744
1134094|NCT02354937|Severe Renal Impairment|severe renal impairment
1134095|NCT02354911|Immunomodulation|immunomodulation
1134096|NCT02354872|Nicotine|nicotine
1134097|NCT02354859|Cystic Fibrosis|cystic fibrosis
1134098|NCT02354859|Gallium Nitrate|gallium nitrate
1134099|NCT02354859|IV Gallium|iv gallium
1134100|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
1134101|NCT02354833|Hypotension|hypotension
1134102|NCT02354833|Cesarean Delivery|cesarean delivery
1134103|NCT02354833|Phenylephrine|phenylephrine
1134104|NCT02354833|Spinal Anesthesia|spinal anesthesia
1134105|NCT02354833|Norepinephrine|norepinephrine
1134106|NCT02354807|BAT activation|bat activation
1134107|NCT02354807|quantitative PET imaging|quantitative pet imaging
1134108|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
1134109|NCT02354794|arginine|arginine
1134110|NCT02354794|supplementation|supplementation
1134111|NCT02354794|metabolic syndrome|metabolic syndrome
1134112|NCT02354794|endothelial function|endothelial function
1134113|NCT02354781|DMD|dmd
1134114|NCT02354781|muscular dystrophy|muscular dystrophy
1134115|NCT02354781|Follistatin|follistatin
1134116|NCT02354742|Echocardiography|echocardiography
1134117|NCT02354742|EGDT|egdt
1134118|NCT02354742|Sepsis|sepsis
1134119|NCT02354716|esophagus|esophagus
1134120|NCT02354716|upper GI|upper gi
1134121|NCT02354716|endoscopy|endoscopy
1134122|NCT02354716|endoFLIP|endoflip
1134123|NCT02354716|functional luminal imaging|functional luminal imaging
1134124|NCT02354716|esophageal stricture|esophageal stricture
1134125|NCT02354716|narrow esophagus|narrow esophagus
1134126|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
1134127|NCT02354716|esophageal narrowing|esophageal narrowing
1134128|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
1134129|NCT02354716|Zenkers diverticulum|zenkers diverticulum
1134130|NCT02354716|Schatzki ring|schatzki ring
1134131|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
1134132|NCT02354677|Bronchial epithelium|bronchial epithelium
1134133|NCT02354677|COPD|copd
1134134|NCT02354677|Repair|repair
1134135|NCT02354677|Remodelling|remodelling
1134136|NCT02354677|Club Cells|club cells
1134137|NCT02354664|respiratory test|respiratory test
1134138|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
1134139|NCT02354664|spirometry|spirometry
1134140|NCT02354651|Pompe disease|pompe disease
1134141|NCT02354651|mechanical ventilation|mechanical ventilation
1134142|NCT02354651|diaphragm pacing|diaphragm pacing
1134143|NCT02354638|Perceptions|perceptions
1134144|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
1134145|NCT02354625|Schwann cells|schwann cells
1134146|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
1134147|NCT02354586|gBRCAmut|gbrcamut
1134148|NCT02354586|BRCA|brca
1134149|NCT02354586|PARP inhibitor|parp inhibitor
1134150|NCT02354586|HRD|hrd
1134151|NCT02354586|Ovarian cancer|ovarian cancer
1134152|NCT02354586|Serous Epithelial|serous epithelial
1134153|NCT02354586|Fallopian Tube|fallopian tube
1134154|NCT02354586|Primary Peritoneal|primary peritoneal
1134155|NCT02354560|Erythromycin|erythromycin
1134156|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
1134157|NCT02354560|APC gene|apc gene
1134158|NCT02354560|nonsense mutations|nonsense mutations
1134159|NCT02354534|cervical dysplasia|cervical dysplasia
1134160|NCT02354534|HPV|hpv
1134161|NCT02354534|Treatment|treatment
1134162|NCT02354534|preinvasive|preinvasive
1134163|NCT02354534|cervix|cervix
1134164|NCT02354534|vaginal suppository|vaginal suppository
1134165|NCT02354534|Johns Hopkins|johns hopkins
1134166|NCT02354534|Cornelia Trimble|cornelia trimble
1134167|NCT02354534|abnormal pap|abnormal pap
1134168|NCT02354534|CIN|cin
1134169|NCT02354521|Protein|protein
1134170|NCT02354521|Mechanical ventilation|mechanical ventilation
1134171|NCT02354521|Children|children
1134172|NCT02354521|Outcomes|outcomes
1134173|NCT02354508|acromegaly|acromegaly
1134174|NCT02354508|GH|gh
1134175|NCT02354508|IGF-1|igf-1
1134176|NCT02354508|pasireotide LAR|pasireotide lar
1134177|NCT02354495|Indirect calorimetry|indirect calorimetry
1134178|NCT02354495|Protein|protein
1134179|NCT02354495|Mechanical ventilation|mechanical ventilation
1134180|NCT02354495|Respiratory failure|respiratory failure
1134181|NCT02354469|TBI|tbi
1134182|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
1134183|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
1134184|NCT02354469|Recovery of Function|recovery of function
1134185|NCT02354469|Motor Activity|motor activity
1134186|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
1134187|NCT02354469|Neural Injury|neural injury
1134188|NCT02354469|Biomarkers|biomarkers
1134189|NCT02354456|atrial fibrillation|atrial fibrillation
1134190|NCT02354456|epidemiology|epidemiology
1134191|NCT02354456|antiocaogulation|antiocaogulation
1134192|NCT02354430|pregnancy|pregnancy
1134193|NCT02354430|low back pain|low back pain
1134194|NCT02354430|sick leave,|sick leave,
1134195|NCT02354430|motor activity|motor activity
1134196|NCT02354404|Ebola virus|ebola virus
1134197|NCT02354404|Filoviridae Infections|filoviridae infections
1134198|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
1134199|NCT02354404|Viral Diseases|viral diseases
1134200|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
1134201|NCT02354365|PEEP adjustment|peep adjustment
1134202|NCT02354365|Tidal Volume|tidal volume
1134203|NCT02354365|Driving Pressure|driving pressure
1134204|NCT02354365|Compliance|compliance
1134205|NCT02354339|Metabolic Syndrome|metabolic syndrome
1134206|NCT02354339|Irvingia gabonensis|irvingia gabonensis
1134207|NCT02354339|African mango|african mango
1134208|NCT02354339|Insulin resistance|insulin resistance
1134209|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
1134210|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
1134211|NCT02354313|Rituximab|rituximab
1134212|NCT02354313|ASCT|asct
1134213|NCT02354313|Revlimid|revlimid
1134214|NCT02354313|High dose chemotherapy|high dose chemotherapy
1134215|NCT02354313|transplant|transplant
1134216|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
1134217|NCT02354261|BCCNS|bccns
1134218|NCT02354261|BCC|bcc
1134219|NCT02354261|itraconazole|itraconazole
1134220|NCT02354261|basal cell carcinoma|basal cell carcinoma
1134221|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
1134222|NCT02354248|TST|tst
1134223|NCT02354248|TMS|tms
1134224|NCT02354248|Stroke patients|stroke patients
1134225|NCT02354248|EMG|emg
1134226|NCT02354235|MT-2412|mt-2412
1134227|NCT02354235|MP-513|mp-513
1134228|NCT02354235|TA-7284|ta-7284
1134229|NCT02354235|Teneligliptin|teneligliptin
1134230|NCT02354235|Canagliflozin|canagliflozin
1134231|NCT02354222|MT-2412|mt-2412
1134232|NCT02354222|MP-513|mp-513
1134233|NCT02354222|TA-7284|ta-7284
1134234|NCT02354222|Teneligliptin|teneligliptin
1134235|NCT02354222|Canagliflozin|canagliflozin
1134236|NCT02354183|Commitment strategies|commitment strategies
1134237|NCT02354183|Motivation|motivation
1134238|NCT02354183|DBT skills|dbt skills
1134239|NCT02354183|Self-harm|self-harm
1134240|NCT02354183|Brief intervention|brief intervention
1134241|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
1134242|NCT02354157|children dietary pattern|children dietary pattern
1134243|NCT02354157|control rules|control rules
1134244|NCT02354157|instrumental learning|instrumental learning
1135141|NCT02348788|chloroquine|chloroquine
1134245|NCT02354157|food reinforcement|food reinforcement
1134246|NCT02354144|Human papillomavirus|human papillomavirus
1134247|NCT02354144|Carrageenan|carrageenan
1134248|NCT02354144|Microbicide|microbicide
1134249|NCT02354144|Anal HPV infection|anal hpv infection
1134250|NCT02354131|Ovarian cancer|ovarian cancer
1134251|NCT02354131|Niraparib|niraparib
1134252|NCT02354131|Bevacizumab|bevacizumab
1134253|NCT02354131|PARP|parp
1134254|NCT02354131|Phase 2 randomized|phase 2 randomized
1134255|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
1134256|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
1134257|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
1134258|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
1134259|NCT02354105|Diagnosis|diagnosis
1134260|NCT02354105|Cimzia|cimzia
1134261|NCT02354105|CZP|czp
1134262|NCT02354105|Certolizumab Pegol|certolizumab pegol
1134263|NCT02354105|CDP870|cdp870
1134264|NCT02354092|cervical dilation|cervical dilation
1134265|NCT02354092|pain|pain
1134266|NCT02354092|paracervical block|paracervical block
1134267|NCT02354092|osmotic dilators|osmotic dilators
1134268|NCT02354079|Low LDL-C|low ldl-c
1134269|NCT02354079|Target Identification|target identification
1134270|NCT02354079|Genetic|genetic
1134271|NCT02354079|Endocrinology|endocrinology
1134272|NCT02354079|Cardiovascular Disease|cardiovascular disease
1134273|NCT02354066|Hallux valgus surgery|hallux valgus surgery
1134274|NCT02354066|forefoot surgery|forefoot surgery
1134275|NCT02354066|brake response time|brake response time
1134276|NCT02354066|foot orthoses|foot orthoses
1134277|NCT02354053|HIV|hiv
1134278|NCT02354053|Triumeq|triumeq
1134279|NCT02354053|vulnerable populations|vulnerable populations
1134280|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
1134387|NCT02353364|Advanced maternal age|advanced maternal age
1134281|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
1134282|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
1134283|NCT02354014|Bedaquiline|bedaquiline
1134284|NCT02354014|TMC207|tmc207
1134285|NCT02354001|schizophrenia|schizophrenia
1134286|NCT02354001|mental illness|mental illness
1134287|NCT02354001|serm|serm
1134288|NCT02354001|raloxifene|raloxifene
1134289|NCT02354001|clinical trial|clinical trial
1134290|NCT02353988|AR-positive|ar-positive
1134291|NCT02353988|Androgen Antagonists|androgen antagonists
1134292|NCT02353988|Bicalutamide|bicalutamide
1134293|NCT02353988|TNBC|tnbc
1134294|NCT02353988|metastatic|metastatic
1134295|NCT02353975|SHR3824|shr3824
1134296|NCT02353975|food effect|food effect
1134297|NCT02353975|mass|mass
1134298|NCT02353975|balance|balance
1134299|NCT02353975|Phase I|phase i
1134300|NCT02353962|neglect|neglect
1134301|NCT02353962|exergames|exergames
1134302|NCT02353949|Mild cognitive impairment|mild cognitive impairment
1134303|NCT02353949|Alzheimer|alzheimer
1134305|NCT02353949|Amyloid|amyloid
1134306|NCT02353949|Frontotemporal|frontotemporal
1134307|NCT02353871|Moderate to Severe|moderate to severe
1134308|NCT02353858|Rectal Cancer|rectal cancer
1134309|NCT02353858|Hyperthermia|hyperthermia
1134310|NCT02353858|Radiochemotherapy|radiochemotherapy
1134311|NCT02353858|Chemoradiotherapy|chemoradiotherapy
1134312|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
1134313|NCT02353858|pathologic complete response|pathologic complete response
1134314|NCT02353858|Regression Grade|regression grade
1134315|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
1134316|NCT02353858|complete response|complete response
1134317|NCT02353806|Amlodipine besylate|amlodipine besylate
1134318|NCT02353806|Breast milk|breast milk
1134319|NCT02353806|Pharmacokinetics|pharmacokinetics
1134320|NCT02353806|Chronic hypertension|chronic hypertension
1134321|NCT02353806|Pregnancy|pregnancy
1134322|NCT02353793|Hypothermia|hypothermia
1134323|NCT02353793|(Poly) Trauma|(poly) trauma
1134324|NCT02353793|Emergency Room|emergency room
1134325|NCT02353793|Warming Blanket|warming blanket
1134326|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
1134327|NCT02353780|TNF inhibitors|tnf inhibitors
1134328|NCT02353702|Diaphragmatic function|diaphragmatic function
1134329|NCT02353702|sniff-test|sniff-test
1134330|NCT02353702|pulmonary complications|pulmonary complications
1134331|NCT02353702|upper abdominal surgery|upper abdominal surgery
1134332|NCT02353663|Rheumatic heart disease|rheumatic heart disease
1134333|NCT02353663|Rheumatic fever|rheumatic fever
1134334|NCT02353663|Mitral regurgitation|mitral regurgitation
1134335|NCT02353663|Aortic regurgitation|aortic regurgitation
1134336|NCT02353663|Mitral stenosis|mitral stenosis
1134337|NCT02353650|Q10|q10
1134338|NCT02353650|ubiquinol|ubiquinol
1134339|NCT02353611|tooth|tooth
1134340|NCT02353611|bleaching|bleaching
1134341|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
1134342|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
1134343|NCT02353585|apixaban|apixaban
1134344|NCT02353585|dabigatran|dabigatran
1134345|NCT02353585|rivaroxaban|rivaroxaban
1134346|NCT02353585|edoxaban|edoxaban
1134347|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
1134348|NCT02353559|acute leukemia|acute leukemia
1134349|NCT02353559|traumatic stress|traumatic stress
1134350|NCT02353559|quality of life|quality of life
1134351|NCT02353559|symptom burden|symptom burden
1134352|NCT02353559|psychosocial oncology|psychosocial oncology
1134353|NCT02353559|palliative care|palliative care
1134354|NCT02353559|intervention|intervention
1134355|NCT02353559|hematological malignancies|hematological malignancies
1134356|NCT02353559|supportive care|supportive care
1134357|NCT02353546|affective symptoms|affective symptoms
1134358|NCT02353546|cancer|cancer
1134359|NCT02353546|depression|depression
1134360|NCT02353546|palliative care|palliative care
1134361|NCT02353546|pilot trial|pilot trial
1134362|NCT02353546|psychotherapy|psychotherapy
1134363|NCT02353533|adenoma|adenoma
1134364|NCT02353533|EMR|emr
1134365|NCT02353533|FTRD|ftrd
1134366|NCT02353533|non- lifting|non- lifting
1134367|NCT02353533|colon|colon
1134368|NCT02353442|Pain|pain
1134369|NCT02353442|Rotator cuff|rotator cuff
1134370|NCT02353442|Stretching|stretching
1134371|NCT02353442|Mobilization|mobilization
1134372|NCT02353442|Scapula|scapula
1134373|NCT02353442|Posterior capsule|posterior capsule
1134374|NCT02353416|Mediterranean Diet|mediterranean diet
1134375|NCT02353416|Low-Glycemic Index|low-glycemic index
1134376|NCT02353416|AGEs|ages
1134377|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
1134378|NCT02353403|Sugar-reduced foods|sugar-reduced foods
1134379|NCT02353403|Postprandial glucose response|postprandial glucose response
1134380|NCT02353390|presyncope|presyncope
1134381|NCT02353390|syncope|syncope
1134382|NCT02353390|adolescent|adolescent
1134383|NCT02353390|young adult|young adult
1134384|NCT02353390|immunization|immunization
1134385|NCT02353390|vaccination|vaccination
1134386|NCT02353390|water consumption|water consumption
1134388|NCT02353364|Aneuploidy|aneuploidy
1134389|NCT02353325|Iron deficiency|iron deficiency
1134390|NCT02353325|Iron fortification|iron fortification
1134391|NCT02353325|Iron encapsulation|iron encapsulation
1134392|NCT02353312|Diastolic|diastolic
1134393|NCT02353312|Biopterin|biopterin
1134394|NCT02353312|Therapeutic Use|therapeutic use
1134395|NCT02353312|Drug Therapy|drug therapy
1134396|NCT02353312|Quality of Life|quality of life
1134397|NCT02353299|Cognition|cognition
1134398|NCT02353299|Balance|balance
1134399|NCT02353286|Biodegradable stents, ERCP|biodegradable stents, ercp
1134400|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
1134401|NCT02353234|Phenolics|phenolics
1134402|NCT02353234|Aleurone|aleurone
1134403|NCT02353234|Bioavailability|bioavailability
1134404|NCT02353234|Pharmacokinetics|pharmacokinetics
1134405|NCT02353221|Early arthritis|early arthritis
1134406|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
1134407|NCT02353182|abdominal|abdominal
1134408|NCT02353182|lower extremity|lower extremity
1134409|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
1134410|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
1134411|NCT02353156|postoperative pain|postoperative pain
1134412|NCT02353156|Sitz bath|sitz bath
1134413|NCT02353156|Electronic bidet|electronic bidet
1134414|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
1134416|NCT02353143|Relapsed|relapsed
1134417|NCT02353143|Refractory|refractory
1134418|NCT02353143|MEN1112|men1112
1134419|NCT02353143|Monoclonal antibody|monoclonal antibody
1134420|NCT02353130|autism spectrum disorders|autism spectrum disorders
1134421|NCT02353130|memantine|memantine
1134422|NCT02353130|cortical metrics|cortical metrics
1134423|NCT02353130|sensory testing|sensory testing
1134424|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
1134425|NCT02353065|Colles' Fracture|colles' fracture
1134426|NCT02353065|ultrasonography|ultrasonography
1134427|NCT02353052|morphology standards|morphology standards
1134428|NCT02353013|protein intake|protein intake
1134429|NCT02353013|body composition|body composition
1134430|NCT02352974|Diamyd|diamyd
1134431|NCT02352974|Diabetes|diabetes
1134432|NCT02352974|Juvenile Diabetes|juvenile diabetes
1134433|NCT02352974|Diabetes Type 1|diabetes type 1
1134434|NCT02352974|Type 1 Diabetes|type 1 diabetes
1134435|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
1134436|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
1134437|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1134438|NCT02352974|rhGAD65|rhgad65
1134439|NCT02352974|GAD65|gad65
1134440|NCT02352974|GAD-Alum|gad-alum
1134441|NCT02352974|Diabetes Mellitus|diabetes mellitus
1134442|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
1134443|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
1134444|NCT02352974|Metabolic Diseases|metabolic diseases
1134445|NCT02352974|Vitamin D|vitamin d
1134446|NCT02352961|Unrecognised condition|unrecognised condition
1134447|NCT02352922|Laparoscopy|laparoscopy
1134448|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
1134449|NCT02352922|Hysterectomy|hysterectomy
1134450|NCT02352922|Anesthetics, Local|anesthetics, local
1134451|NCT02352922|Bupivacaine|bupivacaine
1135142|NCT02348788|RCT|rct
1134452|NCT02352922|Pain, Postoperative|pain, postoperative
1134453|NCT02352896|Leigh syndrome|leigh syndrome
1134454|NCT02352896|Mitochondrial disorders|mitochondrial disorders
1134455|NCT02352896|EPI743|epi743
1134456|NCT02352896|Vincerinone|vincerinone
1134457|NCT02352870|Feasibility study|feasibility study
1134458|NCT02352870|Randomised controlled trial|randomised controlled trial
1134459|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
1134460|NCT02352870|Psychological distress|psychological distress
1134461|NCT02352870|Cognitive illness representations|cognitive illness representations
1134462|NCT02352870|Common sense model|common sense model
1134463|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
1134464|NCT02352857|Sugar-reduced foods|sugar-reduced foods
1134465|NCT02352857|Postprandial glucose response|postprandial glucose response
1134466|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
1134467|NCT02352792|Local control|local control
1134468|NCT02352779|Cancer Survivor|cancer survivor
1134469|NCT02352766|Thyroid cancer|thyroid cancer
1134470|NCT02352766|Thyroid nodules|thyroid nodules
1134471|NCT02352766|Palpable nodules|palpable nodules
1134472|NCT02352766|FNA|fna
1134473|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
1134474|NCT02352740|arginine|arginine
1134475|NCT02352740|supplementation|supplementation
1134476|NCT02352740|metabolic syndrome|metabolic syndrome
1134477|NCT02352740|nitric oxide|nitric oxide
1134478|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
1134479|NCT02352727|Accelerometers|accelerometers
1134480|NCT02352714|Adolescents|adolescents
1134481|NCT02352714|Women's Health|women's health
1134482|NCT02352714|Contraception|contraception
1134483|NCT02352714|Reproduction|reproduction
1134484|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
1134485|NCT02352714|Pregnancy Prevention|pregnancy prevention
1134486|NCT02352714|Intrauterine Device|intrauterine device
1134487|NCT02352701|helicobacter pylori|helicobacter pylori
1134488|NCT02352701|ilaprazole|ilaprazole
1134489|NCT02352701|eradication|eradication
1134490|NCT02352701|triple therapy|triple therapy
1134491|NCT02352688|elderly|elderly
1134492|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
1134493|NCT02352662|Congenital Heart Disease|congenital heart disease
1134494|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
1134495|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
1134496|NCT02352649|Peripheral nerve injury|peripheral nerve injury
1134497|NCT02352649|Neurotmesis|neurotmesis
1134498|NCT02352649|Gene therapy|gene therapy
1134499|NCT02352649|Plasmid|plasmid
1134500|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
1134501|NCT02352610|carpometacarpal joints|carpometacarpal joints
1134502|NCT02352597|PCOS|pcos
1134503|NCT02352597|Phytoestrogens|phytoestrogens
1134504|NCT02352597|ovulation induction|ovulation induction
1134505|NCT02352584|QIV|qiv
1134506|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
1134507|NCT02352584|Influenza vaccine|influenza vaccine
1134508|NCT02352584|Vaccination|vaccination
1134509|NCT02352558|Multiple Myeloma|multiple myeloma
1134510|NCT02352558|Lymphoma|lymphoma
1134511|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
1134512|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
1134513|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
1134514|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1134515|NCT02352532|Dry Needling|dry needling
1134516|NCT02352532|Shear Wave Elastography|shear wave elastography
1134517|NCT02352532|Ultrasound|ultrasound
1134518|NCT02352493|PNH|pnh
1134519|NCT02352493|RNAi therapeutic|rnai therapeutic
1134520|NCT02352480|Non Healing Wound|non healing wound
1134521|NCT02352467|Non Healing Wound|non healing wound
1134522|NCT02352454|Non Healing Wound|non healing wound
1134523|NCT02352428|Skin Cancer|skin cancer
1134524|NCT02352428|Secondary Prevention|secondary prevention
1134525|NCT02352428|Population Screening|population screening
1134526|NCT02352402|CABG|cabg
1134527|NCT02352402|Ticagrelor|ticagrelor
1134528|NCT02352402|Graft|graft
1134529|NCT02352402|Patency|patency
1134530|NCT02352389|Childhood|childhood
1134531|NCT02352389|Cancer|cancer
1134532|NCT02352389|Genetic mutations|genetic mutations
1134533|NCT02352376|Noninvasive ventilation|noninvasive ventilation
1134534|NCT02352376|Heart rate variability|heart rate variability
1134535|NCT02352376|Thoracic surgery|thoracic surgery
1134536|NCT02352363|Parkinson's Disease|parkinson's disease
1134537|NCT02352363|Motor fluctuations|motor fluctuations
1134538|NCT02352363|levodopa|levodopa
1134539|NCT02352363|inhaled drugs|inhaled drugs
1134540|NCT02352363|OFF episodes|off episodes
1134541|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
1134542|NCT02352350|Blood Lactate Level|blood lactate level
1134543|NCT02352350|Neurological Injury|neurological injury
1134544|NCT02352337|cancer|cancer
1134545|NCT02352337|pancreatic cancer|pancreatic cancer
1134546|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
1134547|NCT02352324|cardiac output|cardiac output
1134548|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
1134639|NCT02351778|Developing Countries|developing countries
1134549|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
1134550|NCT02352324|fluid responsiveness|fluid responsiveness
1134551|NCT02352272|sleep extension|sleep extension
1134552|NCT02352272|attention|attention
1134553|NCT02352272|physical performance|physical performance
1134554|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
1134555|NCT02352259|Bleomycin|bleomycin
1134556|NCT02352259|Electrochemotherapy|electrochemotherapy
1134557|NCT02352246|intermittent sprinting|intermittent sprinting
1134558|NCT02352246|abdominal fat mass|abdominal fat mass
1134559|NCT02352246|type 2 diabetes|type 2 diabetes
1134560|NCT02352246|postmenopausal women|postmenopausal women
1134561|NCT02352233|retroview colonoscope|retroview colonoscope
1134562|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
1134563|NCT02352233|colonoscopy|colonoscopy
1134564|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
1134565|NCT02352207|prenatal lung malformation|prenatal lung malformation
1134566|NCT02352207|KRAS mutation|kras mutation
1134567|NCT02352207|pregnant woman|pregnant woman
1134568|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
1134569|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
1134570|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
1134571|NCT02352155|haemostasis|haemostasis
1134572|NCT02352142|Separation stress|separation stress
1134573|NCT02352142|Family Nurture|family nurture
1134574|NCT02352142|Maternal Confidence|maternal confidence
1134575|NCT02352142|Maternal Competence|maternal competence
1134576|NCT02352142|Calming Cycle|calming cycle
1134577|NCT02352142|Kangaroo Care|kangaroo care
1134578|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
1134579|NCT02352142|Infant Psychological Development|infant psychological development
1134580|NCT02352142|Post-partum depression|post-partum depression
1134581|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
1134582|NCT02352116|Postoperative Experience|postoperative experience
1134583|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
1134584|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
1134585|NCT02352103|prostate cancer|prostate cancer
1134586|NCT02352103|Urinary continence|urinary continence
1134587|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
1134588|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
1134589|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
1134590|NCT02352090|Contraception, oral|contraception, oral
1134591|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
1134592|NCT02352090|Estradiol Valerate|estradiol valerate
1134593|NCT02352090|Dienogest|dienogest
1134594|NCT02352090|Insulin resistance|insulin resistance
1134595|NCT02352090|Chronic inflammation|chronic inflammation
1134596|NCT02352090|Coagulation|coagulation
1134597|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
1134598|NCT02352051|executive functions|executive functions
1134599|NCT02352038|malocclusion|malocclusion
1134600|NCT02352038|low-level laser therapy|low-level laser therapy
1134601|NCT02352025|S-equol|s-equol
1134602|NCT02352025|breast cancer|breast cancer
1134603|NCT02352025|triple negative|triple negative
1134604|NCT02352012|Interventional Treatment|interventional treatment
1134605|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
1134606|NCT02352012|Bronchoscope|bronchoscope
1134607|NCT02351999|Atrial fibrillation|atrial fibrillation
1134608|NCT02351999|Transseptal puncture|transseptal puncture
1134609|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
1134610|NCT02351986|subacromial impingement|subacromial impingement
1134611|NCT02351986|physical therapy|physical therapy
1134612|NCT02351986|cryotherapy|cryotherapy
1134613|NCT02351960|Drug therapy|drug therapy
1134614|NCT02351960|GERD|gerd
1134615|NCT02351960|Dexlansoprazole|dexlansoprazole
1134616|NCT02351947|stroke|stroke
1134617|NCT02351947|Cerebrovascular accident|cerebrovascular accident
1134618|NCT02351947|rehabilitation|rehabilitation
1134619|NCT02351947|motor learning|motor learning
1134620|NCT02351947|fMRI|fmri
1134621|NCT02351947|plasticity|plasticity
1134622|NCT02351934|colorectal surgery|colorectal surgery
1134623|NCT02351934|volume status|volume status
1134624|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
1134625|NCT02351921|spinal cord injury|spinal cord injury
1134626|NCT02351921|motor cortex|motor cortex
1134627|NCT02351921|somatosensory cortex|somatosensory cortex
1134628|NCT02351895|infection control|infection control
1134629|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
1134630|NCT02351856|laminopathy|laminopathy
1134631|NCT02351856|ARRY-797|arry-797
1134632|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
1134633|NCT02351804|Anesthetics, Local|anesthetics, local
1134634|NCT02351804|duration|duration
1134635|NCT02351804|Sensation|sensation
1134636|NCT02351804|adductor canal block|adductor canal block
1134637|NCT02351804|lower limb|lower limb
1134638|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
1134640|NCT02351778|Quality of Life|quality of life
1134641|NCT02351778|Mixed Methods|mixed methods
1134642|NCT02351778|Validation|validation
1134643|NCT02351778|Caregiver Burden|caregiver burden
1134644|NCT02351726|aortic valve replacement|aortic valve replacement
1134645|NCT02351726|aortic stenosis|aortic stenosis
1134646|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
1134647|NCT02351713|primary prevention|primary prevention
1134648|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
1134649|NCT02351674|Heart Rate|heart rate
1134650|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
1134651|NCT02351674|outcome|outcome
1134652|NCT02351648|readmission|readmission
1134653|NCT02351648|care transition|care transition
1134654|NCT02351635|Calprotectin|calprotectin
1134655|NCT02351635|Diagnosis|diagnosis
1134656|NCT02351609|smoking cessation|smoking cessation
1134657|NCT02351609|patient navigation|patient navigation
1134658|NCT02351609|financial incentives|financial incentives
1134659|NCT02351609|health disparities|health disparities
1134660|NCT02351596|Core Stability|core stability
1134661|NCT02351596|Balance|balance
1134662|NCT02351596|Core Control|core control
1134663|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
1134664|NCT02351492|Bile duct obstruction|bile duct obstruction
1134665|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
1134666|NCT02351492|MRCP|mrcp
1134667|NCT02351479|hula|hula
1134668|NCT02351479|breast cancer|breast cancer
1134669|NCT02351479|female|female
1134670|NCT02351479|hawaii|hawaii
1134671|NCT02351479|physical activity|physical activity
1134672|NCT02351479|cervical cancer|cervical cancer
1134673|NCT02351479|ovarian cancer|ovarian cancer
1134674|NCT02351479|endometrial cancer|endometrial cancer
1134675|NCT02351466|Brain Growth and Development|brain growth and development
1134676|NCT02351466|Cognition|cognition
1134677|NCT02351466|Children|children
1134976|NCT02349828|acyclovir|acyclovir
1134678|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
1134679|NCT02351466|MRI|mri
1134680|NCT02351466|Functional MRI|functional mri
1134681|NCT02351440|duloxetine|duloxetine
1134682|NCT02351414|Osteoarthritis|osteoarthritis
1134683|NCT02351414|Ankylosis|ankylosis
1134684|NCT02351414|Revision procedures|revision procedures
1134685|NCT02351414|Correction of functional deformity|correction of functional deformity
1134686|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
1134687|NCT02351414|Arthritis|arthritis
1134688|NCT02351388|Alzheimer's disease|alzheimer's disease
1134689|NCT02351388|Depressive symptoms|depressive symptoms
1134690|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
1134691|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
1134692|NCT02351388|Neuromodulation|neuromodulation
1134693|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1134694|NCT02351375|microbiota|microbiota
1134695|NCT02351375|small intestine|small intestine
1134696|NCT02351375|diet|diet
1134697|NCT02351375|feces|feces
1134698|NCT02351362|Retention|retention
1134699|NCT02351362|Attrition|attrition
1134700|NCT02351362|Incentive|incentive
1134701|NCT02351362|Pregnant women|pregnant women
1134702|NCT02351349|frailty|frailty
1134703|NCT02351349|CKD|ckd
1134704|NCT02351349|Physical Therapy Modalities|physical therapy modalities
1134705|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
1134706|NCT02351336|Threatened preterm birth|threatened preterm birth
1134707|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
1134708|NCT02351336|Fetal zone enlargement|fetal zone enlargement
1134709|NCT02351336|Prediction of preterm birth|prediction of preterm birth
1134710|NCT02351297|High protein diet|high protein diet
1134711|NCT02351297|Microbiota|microbiota
1134712|NCT02351297|Rectal biopsies|rectal biopsies
1134713|NCT02351297|Metabolomics|metabolomics
1134714|NCT02351297|Bacterial metabolites|bacterial metabolites
1134715|NCT02351297|volunteers|volunteers
1134716|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
1134717|NCT02351258|Pediatrics|pediatrics
1134718|NCT02351258|Medical Oncology|medical oncology
1134719|NCT02351258|Catheters|catheters
1134720|NCT02351258|Infection|infection
1134721|NCT02351206|X-Rays|x-rays
1134722|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
1134723|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
1134724|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
1134725|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
1134726|NCT02351167|Smoking cessation|smoking cessation
1134727|NCT02351167|Counseling|counseling
1134728|NCT02351167|Genetics and Genomics|genetics and genomics
1134729|NCT02351141|Noble Gas MRI|noble gas mri
1134730|NCT02351141|Pulmonary Function|pulmonary function
1134731|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
1134732|NCT02351128|lanreotide|lanreotide
1134733|NCT02351102|Congenital CMV|congenital cmv
1134734|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
1134735|NCT02351063|Heart failure|heart failure
1134736|NCT02351063|BNP|bnp
1134737|NCT02351063|home testing|home testing
1134738|NCT02351063|remote monitoring|remote monitoring
1134739|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
1134740|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
1134741|NCT02351037|AML|aml
1134742|NCT02351037|Ibrutinib|ibrutinib
1134743|NCT02351037|Cytarabine|cytarabine
1134744|NCT02351037|LD-AraC|ld-arac
1134745|NCT02351037|Azacitidine|azacitidine
1134746|NCT02350985|Migraine|migraine
1134747|NCT02350985|Migrainous Vertigo|migrainous vertigo
1134748|NCT02350985|Headache Disorders|headache disorders
1134749|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
1134750|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
1134751|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
1134752|NCT02350985|Vasodilator Agent|vasodilator agent
1134753|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
1134754|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
1134755|NCT02350985|Antidepressive Agent|antidepressive agent
1134756|NCT02350985|Propranolol|propranolol
1134757|NCT02350985|Venlafaxine|venlafaxine
1134758|NCT02350959|Plaque|plaque
1134759|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
1134760|NCT02350933|tracheal damages|tracheal damages
1134761|NCT02350920|IBD|ibd
1134762|NCT02350920|Crohn's disease|crohn's disease
1134763|NCT02350920|ulcerative colitis|ulcerative colitis
1134764|NCT02350920|ACT|act
1134765|NCT02350907|antimicrobial resistance|antimicrobial resistance
1134766|NCT02350907|point-of-care testing|point-of-care testing
1134767|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
1134768|NCT02350868|without Standard Treatment|without standard treatment
1134769|NCT02350855|Nutrition intervention|nutrition intervention
1134770|NCT02350855|Palliative care|palliative care
1134771|NCT02350855|Public Health|public health
1134772|NCT02350855|Quality of life|quality of life
1134773|NCT02350855|Tailored food formula|tailored food formula
1134774|NCT02350855|Body weight|body weight
1134775|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
1134776|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
1134777|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
1134778|NCT02350803|distraction osteogenesis|distraction osteogenesis
1134779|NCT02350803|mini plate|mini plate
1134780|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
1134781|NCT02350790|Robotics|robotics
1134782|NCT02350790|Laparoscopy|laparoscopy
1134783|NCT02350790|Endometriosis|endometriosis
1134784|NCT02350790|Argon|argon
1134785|NCT02350790|Gynecology|gynecology
1134786|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
1134787|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1134788|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
1134789|NCT02350777|14-228|14-228
1134790|NCT02350777|HSCT|hsct
1134791|NCT02350764|Nivolumab|nivolumab
1134792|NCT02350764|Lung|lung
1134793|NCT02350764|ipilimumab|ipilimumab
1134794|NCT02350764|NSCLC|nsclc
1134795|NCT02350764|14-137|14-137
1134796|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
1134797|NCT02350738|Mild cognitive impairment|mild cognitive impairment
1134798|NCT02350738|Dementia|dementia
1134799|NCT02350738|Cognitive training|cognitive training
1134800|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
1134801|NCT02350738|Cognitive therapy|cognitive therapy
1134802|NCT02350725|Chronic Fluid Overload|chronic fluid overload
1134803|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
1134804|NCT02350712|SCCHN|scchn
1134805|NCT02350647|Rotator cuff|rotator cuff
1134806|NCT02350647|Ossification|ossification
1134807|NCT02350647|Suture anchors|suture anchors
1134808|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
1134809|NCT02350582|breast cancer|breast cancer
1134810|NCT02350582|telerehabilitation|telerehabilitation
1134811|NCT02350582|strength|strength
1134812|NCT02350582|fatigue|fatigue
1134813|NCT02350582|quality of life|quality of life
1134814|NCT02350569|liver transplant|liver transplant
1134815|NCT02350569|hepatitis C|hepatitis c
1134816|NCT02350569|Gilead|gilead
1134817|NCT02350569|Communicable Diseases|communicable diseases
1134818|NCT02350569|Infection|infection
1134819|NCT02350569|Liver Diseases|liver diseases
1134820|NCT02350569|RNA Virus Infections|rna virus infections
1134821|NCT02350543|Aspirin usage|aspirin usage
1134822|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
1134823|NCT02350530|Colorectal cancer|colorectal cancer
1134824|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
1134825|NCT02350530|Liver metastases|liver metastases
1134826|NCT02350530|Liver resection|liver resection
1134827|NCT02350530|Liver ablation|liver ablation
1134828|NCT02350530|Conversion therapy|conversion therapy
1134829|NCT02350530|FOLFOXIRI|folfoxiri
1134830|NCT02350530|Oxaliplatin|oxaliplatin
1134831|NCT02350530|Irinotecan|irinotecan
1134832|NCT02350530|Fluorouracil|fluorouracil
1134833|NCT02350530|Bevacizumab|bevacizumab
1134834|NCT02350530|RAS mutation|ras mutation
1134835|NCT02350491|Pregnancy|pregnancy
1134836|NCT02350491|miRNA|mirna
1134837|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1134838|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1134839|NCT02350465|sarcopenia|sarcopenia
1134840|NCT02350465|aging|aging
1134841|NCT02350465|myosteatosis|myosteatosis
1134842|NCT02350465|exercise|exercise
1134843|NCT02350465|screening|screening
1134844|NCT02350452|laparoscopic surgery|laparoscopic surgery
1134845|NCT02350452|diode laser|diode laser
1134847|NCT02350452|AFC|afc
1134848|NCT02350439|Coronary artery disease|coronary artery disease
1134849|NCT02350439|Fractional floe reserve|fractional floe reserve
1134850|NCT02350400|Drug eluting beads|drug eluting beads
1134851|NCT02350400|Irinotecan|irinotecan
1134852|NCT02350400|Pharmacogenetics|pharmacogenetics
1134853|NCT02350400|Pharmacokinetics|pharmacokinetics
1134854|NCT02350374|diabetes|diabetes
1134855|NCT02350374|children|children
1134856|NCT02350361|endostar|endostar
1134857|NCT02350361|angiogenesis|angiogenesis
1134858|NCT02350361|EGFR-TKI|egfr-tki
1134859|NCT02350361|lung caner|lung caner
1134860|NCT02350348|neonates|neonates
1134861|NCT02350348|infants|infants
1134862|NCT02350348|anaesthesia|anaesthesia
1134863|NCT02350348|mortality|mortality
1134864|NCT02350348|adverse effects|adverse effects
1134865|NCT02350348|Epidemiological Study|epidemiological study
1134866|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
1134867|NCT02350335|aneurysm|aneurysm
1134868|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
1134869|NCT02350335|cerebral vasospasm|cerebral vasospasm
1134870|NCT02350335|outcome|outcome
1134871|NCT02350322|Diet|diet
1134872|NCT02350322|concentration|concentration
1134873|NCT02350322|seafood|seafood
1134874|NCT02350322|youths|youths
1134875|NCT02350322|Norway|norway
1134876|NCT02350322|Nutrient status in blood|nutrient status in blood
1134877|NCT02350322|Inflammatory markers|inflammatory markers
1134878|NCT02350309|Insomnia Disorder|insomnia disorder
1134879|NCT02350309|E2006|e2006
1134880|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
1134881|NCT02350296|headache|headache
1134882|NCT02350296|dental pain|dental pain
1134883|NCT02350296|neuralgia|neuralgia
1134884|NCT02350296|dysmenorrhoea|dysmenorrhoea
1134885|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
1134886|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
1134887|NCT02350283|Endovascular therapy|endovascular therapy
1134888|NCT02350283|Solitaire|solitaire
1134889|NCT02350283|Standard Medical Management|standard medical management
1134890|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
1134891|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
1134892|NCT02350257|child|child
1134893|NCT02350257|randomized controlled trial|randomized controlled trial
1134894|NCT02350257|internet|internet
1134895|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
1134896|NCT02350244|eyestrain|eyestrain
1134897|NCT02350244|occupational diseases|occupational diseases
1134898|NCT02350244|computer work|computer work
1134899|NCT02350244|muscle stretching exercise|muscle stretching exercise
1134900|NCT02350244|computer software application|computer software application
1134901|NCT02350244|MSDs|msds
1134902|NCT02350231|preterm birth|preterm birth
1134903|NCT02350231|Twin pregnancy|twin pregnancy
1134904|NCT02350231|progesterone|progesterone
1134905|NCT02350218|Transplantation|transplantation
1134906|NCT02350218|Living donor|living donor
1134907|NCT02350218|Eglandin|eglandin
1134908|NCT02350218|Alprostadil|alprostadil
1134909|NCT02350205|Burn wounds|burn wounds
1134910|NCT02350205|Burns|burns
1134911|NCT02350205|Skin substitute|skin substitute
1134912|NCT02350192|ehealth|ehealth
1134913|NCT02350192|intervention|intervention
1134914|NCT02350192|effectiveness|effectiveness
1134915|NCT02350192|randomized controlled trial|randomized controlled trial
1134916|NCT02350166|colorectal cancer|colorectal cancer
1134917|NCT02350166|hepatectomy|hepatectomy
1134918|NCT02350166|laparoscopic surgery|laparoscopic surgery
1134919|NCT02350166|laparotomy|laparotomy
1134920|NCT02350166|complications|complications
1134921|NCT02350153|Mortality|mortality
1134922|NCT02350153|Morbidity|morbidity
1134923|NCT02350153|Incidence|incidence
1134924|NCT02350153|Prevalence|prevalence
1134925|NCT02350140|HIV|hiv
1134926|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
1134927|NCT02350140|PMTCT|pmtct
1134928|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
1134929|NCT02350140|mobile phone|mobile phone
1134930|NCT02350140|text messaging|text messaging
1134931|NCT02350140|short message services (SMS)|short message services (sms)
1134932|NCT02350127|dementia|dementia
1134933|NCT02350127|clinical trial|clinical trial
1134934|NCT02350127|behavioral intervention|behavioral intervention
1134935|NCT02350127|exercise|exercise
1134936|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
1134937|NCT02350127|cognition|cognition
1134938|NCT02350127|function|function
1134939|NCT02350127|quality of life|quality of life
1134940|NCT02350114|Heart failure|heart failure
1134941|NCT02350114|6 Minute Walk Test|6 minute walk test
1134942|NCT02350088|fast-track surgery|fast-track surgery
1134943|NCT02350075|short implants|short implants
1134944|NCT02350075|sinus floor elevation|sinus floor elevation
1134945|NCT02350075|randomized controlled trial|randomized controlled trial
1134946|NCT02350036|Preeclampsia|preeclampsia
1134947|NCT02350036|placental protein 13|placental protein 13
1134948|NCT02350036|Uterine artery doppler|uterine artery doppler
1134949|NCT02350023|alopecia areata|alopecia areata
1134950|NCT02350023|betamethasone|betamethasone
1134951|NCT02350023|latanoprost|latanoprost
1134952|NCT02350023|topical steroid|topical steroid
1134953|NCT02350023|prostaglandin|prostaglandin
1134954|NCT02350010|Etiology|etiology
1134955|NCT02350010|Prognostic risk factors|prognostic risk factors
1134956|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
1134957|NCT02350010|non-invasive imaging|non-invasive imaging
1134958|NCT02350010|CT angiography|ct angiography
1134959|NCT02349997|central sleep apnea|central sleep apnea
1134960|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
1134961|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
1134962|NCT02349997|chronic heart failure|chronic heart failure
1134963|NCT02349997|fluid shift|fluid shift
1134964|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
1134965|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
1134966|NCT02349854|pruritus|pruritus
1134967|NCT02349854|itch|itch
1134968|NCT02349854|skin|skin
1134969|NCT02349854|scalp|scalp
1134970|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
1134971|NCT02349828|antiviral|antiviral
1134972|NCT02349828|herpes simplex virus|herpes simplex virus
1134973|NCT02349828|herpes|herpes
1134974|NCT02349828|burn patients|burn patients
1134975|NCT02349828|HSV|hsv
1134977|NCT02349815|Drug Utilization Study|drug utilization study
1134978|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
1134979|NCT02349789|Gait|gait
1134980|NCT02349789|Cerebellum|cerebellum
1134981|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
1134982|NCT02349789|tDCS|tdcs
1134983|NCT02349789|TMS|tms
1134984|NCT02349789|Balance|balance
1134985|NCT02349763|Dexamethasone|dexamethasone
1134986|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
1134987|NCT02349763|Paclitaxel|paclitaxel
1134988|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
1134989|NCT02349750|Unexplained infertility|unexplained infertility
1134990|NCT02349750|intrauterine insemenation|intrauterine insemenation
1134991|NCT02349750|ovulation induction|ovulation induction
1134992|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
1134993|NCT02349737|Body composition|body composition
1134994|NCT02349737|ICD|icd
1134995|NCT02349724|CEA|cea
1134996|NCT02349724|CAR T|car t
1134997|NCT02349711|probiotic|probiotic
1134998|NCT02349711|allergy|allergy
1134999|NCT02349711|immune|immune
1135000|NCT02349698|CAR T|car t
1135001|NCT02349698|Leukemia|leukemia
1135002|NCT02349698|Lymphoma|lymphoma
1135003|NCT02349685|Helicobacter pylori|helicobacter pylori
1135004|NCT02349685|Personalized therapy|personalized therapy
1135005|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
1135006|NCT02349685|rescue therapy|rescue therapy
1135007|NCT02349685|culture|culture
1135008|NCT02349672|HIE|hie
1135009|NCT02349672|Neonates|neonates
1135010|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
1135011|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
1135012|NCT02349581|Anesthetics, Local|anesthetics, local
1135013|NCT02349581|Mastectomy|mastectomy
1135014|NCT02349581|Neuralgia|neuralgia
1135015|NCT02349581|Nerve block|nerve block
1135016|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
1135017|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
1135018|NCT02349542|Safety|safety
1135019|NCT02349529|Epilepsy|epilepsy
1135020|NCT02349529|psychosocial|psychosocial
1135021|NCT02349503|Adrenocortical function|adrenocortical function
1135022|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
1135023|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
1135024|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
1135025|NCT02349503|Adolescents|adolescents
1135026|NCT02349503|Female|female
1135027|NCT02349503|Hyperplasia|hyperplasia
1135028|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
1135029|NCT02349503|Congenital Abnormalities|congenital abnormalities
1135030|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
1135031|NCT02349503|Disorders of Sex Development|disorders of sex development
1135032|NCT02349503|Endocrine System Diseases|endocrine system diseases
1135033|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
1135034|NCT02349503|Gonadal Disorders|gonadal disorders
1135035|NCT02349503|Metabolic Diseases|metabolic diseases
1135036|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
1135037|NCT02349503|Pathologic Processes|pathologic processes
1135038|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
1135039|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
1135040|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
1135041|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1135042|NCT02349490|endoscopy|endoscopy
1135043|NCT02349490|hemostasis|hemostasis
1135044|NCT02349451|Safety|safety
1135045|NCT02349451|Efficacy|efficacy
1135046|NCT02349451|Methotrexate|methotrexate
1135047|NCT02349373|Overuse injury|overuse injury
1135048|NCT02349373|Running related injury|running related injury
1135049|NCT02349373|Running pattern|running pattern
1135050|NCT02349360|safety|safety
1135051|NCT02349360|tolerability|tolerability
1135052|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
1135053|NCT02349321|adolescents|adolescents
1135054|NCT02349321|primary prevention|primary prevention
1135055|NCT02349321|randomised controlled trial|randomised controlled trial
1135056|NCT02349321|school|school
1135057|NCT02349321|South Africa|south africa
1135058|NCT02349321|parenting|parenting
1135059|NCT02349282|muscle strength|muscle strength
1135060|NCT02349282|physical performance|physical performance
1135061|NCT02349282|vitamin D3|vitamin d3
1135062|NCT02349282|Cholecalciferol|cholecalciferol
1135063|NCT02349282|Calcifediol|calcifediol
1135064|NCT02349269|Atrial fibrillation|atrial fibrillation
1135065|NCT02349269|CABG|cabg
1135066|NCT02349269|Stroke|stroke
1135067|NCT02349256|MUS|mus
1135068|NCT02349256|British South Asians|british south asians
1135069|NCT02349256|Somatic Symptoms|somatic symptoms
1135070|NCT02349256|Qualitative interviews|qualitative interviews
1135071|NCT02349243|obese|obese
1135072|NCT02349243|weight loss|weight loss
1135073|NCT02349243|entacapone|entacapone
1135074|NCT02349217|Breast cancer|breast cancer
1135075|NCT02349217|Breast cancer survivors|breast cancer survivors
1135076|NCT02349217|Breast cancer partners|breast cancer partners
1135077|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
1135078|NCT02349217|MBRE|mbre
1135079|NCT02349217|Standard of care|standard of care
1135080|NCT02349217|Pain Assessment|pain assessment
1135081|NCT02349217|Questionnaires|questionnaires
1135082|NCT02349217|Surveys|surveys
1135083|NCT02349217|Neurocognitive Tests|neurocognitive tests
1135084|NCT02349217|Cortisol Tests|cortisol tests
1135085|NCT02349217|Saliva tests|saliva tests
1135086|NCT02349217|Interviews|interviews
1135087|NCT02349217|Meditation|meditation
1135088|NCT02349217|Yoga|yoga
1135089|NCT02349217|Self-help materials|self-help materials
1135090|NCT02349204|Simulator|simulator
1135091|NCT02349204|Music|music
1135092|NCT02349204|Mozart Effect|mozart effect
1135093|NCT02349191|Alzheimers|alzheimers
1135094|NCT02349191|dementia|dementia
1135095|NCT02349191|omental transposition|omental transposition
1135096|NCT02349191|neurological|neurological
1135097|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
1135098|NCT02349152|Heart surgery|heart surgery
1135099|NCT02349126|Hepatitis B|hepatitis b
1135100|NCT02349126|HBV infection|hbv infection
1135101|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
1135102|NCT02349113|estrogen, aging|estrogen, aging
1135103|NCT02349087|EEG|eeg
1135104|NCT02349087|cardiac arrest|cardiac arrest
1135105|NCT02349087|resuscitation|resuscitation
1135106|NCT02349087|seizures|seizures
1135107|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
1135108|NCT02349061|Ustekinumab|ustekinumab
1135109|NCT02349048|Hepatitis C virus|hepatitis c virus
1135110|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
1135111|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
1135112|NCT02349048|Liver fibrosis|liver fibrosis
1135113|NCT02349048|Cirrhosis|cirrhosis
1135114|NCT02349048|Simeprevir|simeprevir
1135115|NCT02349048|Daclatasvir|daclatasvir
1135116|NCT02349048|Sofosbuvir|sofosbuvir
1135117|NCT02349035|Transradial amputee|transradial amputee
1135118|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
1135119|NCT02349022|Prostate cancer|prostate cancer
1135120|NCT02349022|PET scan|pet scan
1135121|NCT02349009|systemic sclerosis|systemic sclerosis
1135122|NCT02349009|scleroderma|scleroderma
1135123|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
1135124|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
1135125|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
1135126|NCT02348957|Dasatinib|dasatinib
1135127|NCT02348957|Any line|any line
1135128|NCT02348957|Chronic phase|chronic phase
1135129|NCT02348944|Biological markers|biological markers
1135130|NCT02348944|Cartilage|cartilage
1135131|NCT02348840|Midwives|midwives
1135132|NCT02348840|Pregnant Women|pregnant women
1135133|NCT02348827|Unipolar depression|unipolar depression
1135134|NCT02348827|Family Therapies|family therapies
1135135|NCT02348827|Psychoeducation|psychoeducation
1135136|NCT02348827|Family psychoeducation|family psychoeducation
1135137|NCT02348814|NAFLD, NASH|nafld, nash
1135140|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
1135143|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
1135144|NCT02348749|14-138|14-138
1135145|NCT02348749|PET/MR|pet/mr
1135146|NCT02348749|PET/CT scan|pet/ct scan
1135147|NCT02348736|airway|airway
1135148|NCT02348736|videolaryngoscope|videolaryngoscope
1135149|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
1135150|NCT02348697|MACT|mact
1135151|NCT02348684|Breast Cancer|breast cancer
1135152|NCT02348658|Pharmacological therapy|pharmacological therapy
1135153|NCT02348645|Pilot projects|pilot projects
1135154|NCT02348645|Feasibility studies|feasibility studies
1135155|NCT02348645|Intervention studies|intervention studies
1135156|NCT02348645|Orthopedics|orthopedics
1135157|NCT02348645|Orthopedic Procedures|orthopedic procedures
1135158|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
1135159|NCT02348645|Neurosurgery|neurosurgery
1135160|NCT02348645|Spine|spine
1135161|NCT02348645|Spinal Fusion|spinal fusion
1135162|NCT02348645|Spondylodesis|spondylodesis
1135163|NCT02348645|Spondylosyndesis|spondylosyndesis
1135164|NCT02348645|Laminectomy|laminectomy
1135165|NCT02348645|Foraminotomy|foraminotomy
1135166|NCT02348645|Decompression, surgical|decompression, surgical
1135167|NCT02348645|Low Back Pain|low back pain
1135168|NCT02348645|Quality of Life|quality of life
1135169|NCT02348580|teaching|teaching
1135170|NCT02348580|education|education
1135171|NCT02348580|active learning|active learning
1135172|NCT02348580|time on task|time on task
1135173|NCT02348580|financial education|financial education
1135174|NCT02348580|social education|social education
1135175|NCT02348580|rights based education|rights based education
1135176|NCT02348580|primary school|primary school
1135177|NCT02348580|life-skills|life-skills
1135276|NCT02347969|skin radiance|skin radiance
1135277|NCT02347969|skin elasticity|skin elasticity
1135278|NCT02347969|skin firmness|skin firmness
1135178|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
1135179|NCT02348554|obesity|obesity
1135180|NCT02348554|energy expenditure|energy expenditure
1135181|NCT02348554|daily living physical activity|daily living physical activity
1135182|NCT02348554|smartphone|smartphone
1135183|NCT02348554|accelerometry|accelerometry
1135184|NCT02348554|prediction algorithm|prediction algorithm
1135185|NCT02348528|Multiple Myeloma|multiple myeloma
1135186|NCT02348528|Relapsed|relapsed
1135187|NCT02348528|Refractory|refractory
1135188|NCT02348528|Lenalidomide|lenalidomide
1135189|NCT02348528|Dexamethasone|dexamethasone
1135190|NCT02348528|open-label|open-label
1135191|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
1135192|NCT02348502|HBsAg loss|hbsag loss
1135193|NCT02348502|interferon|interferon
1135194|NCT02348502|HBV reaction|hbv reaction
1135195|NCT02348502|Hepatitis B|hepatitis b
1135197|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
1135198|NCT02348489|SGI-110|sgi-110
1135199|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
1135200|NCT02348437|Pronator quadratus|pronator quadratus
1135201|NCT02348437|Distal radius fracture|distal radius fracture
1135202|NCT02348437|Repair|repair
1135203|NCT02348437|Volar plating|volar plating
1135204|NCT02348437|PRWE|prwe
1135205|NCT02348424|genitourinary|genitourinary
1135206|NCT02348424|Neisseriaceae|neisseriaceae
1135207|NCT02348424|pharyngeal|pharyngeal
1135208|NCT02348424|Solithromycin|solithromycin
1135209|NCT02348411|Medication-refractory|medication-refractory
1135210|NCT02348398|Cervical Cancer|cervical cancer
1135211|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
1135212|NCT02348398|Squamous cervical cancer|squamous cervical cancer
1135213|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
1135214|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
1135215|NCT02348398|Persistent cervical cancer|persistent cervical cancer
1135216|NCT02348398|Pazopanib|pazopanib
1135217|NCT02348398|GW786034|gw786034
1135218|NCT02348398|Topotecan|topotecan
1135219|NCT02348398|Hycamtin|hycamtin
1135220|NCT02348385|amphetamine|amphetamine
1135221|NCT02348385|cigarette smokers|cigarette smokers
1135222|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
1135223|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
1135224|NCT02348359|AMD|amd
1135225|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
1135226|NCT02348346|titanium dioxide|titanium dioxide
1135227|NCT02348281|triple negative breast cancer|triple negative breast cancer
1135228|NCT02348281|androgen receptor|androgen receptor
1135229|NCT02348281|bicalutamide|bicalutamide
1135230|NCT02348268|Neck Pain|neck pain
1135231|NCT02348268|Myofascial release|myofascial release
1135232|NCT02348268|Manual therapy|manual therapy
1135233|NCT02348242|Intensive care|intensive care
1135234|NCT02348242|corneal damage|corneal damage
1135235|NCT02348242|prevention|prevention
1135236|NCT02348242|nursing protocol|nursing protocol
1135237|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
1135238|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
1135239|NCT02348229|advanced gastric cancer|advanced gastric cancer
1135240|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
1135241|NCT02348177|Human immunideficiency virus|human immunideficiency virus
1135242|NCT02348177|Tuberculosis|tuberculosis
1135243|NCT02348177|superboosting|superboosting
1135244|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
1135245|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
1135246|NCT02348164|Carotenoids|carotenoids
1135247|NCT02348164|absorption|absorption
1135248|NCT02348164|citrus|citrus
1135249|NCT02348151|COPD|copd
1135250|NCT02348151|SWTi|swti
1135251|NCT02348151|Treadmill|treadmill
1135252|NCT02348138|Isometric Handgrip|isometric handgrip
1135253|NCT02348112|stress urinary incontinence|stress urinary incontinence
1135254|NCT02348112|Altis 522|altis 522
1135255|NCT02348112|urinary incontinence|urinary incontinence
1135256|NCT02348099|Diabetes|diabetes
1135257|NCT02348099|Lipohypertrophy|lipohypertrophy
1135258|NCT02348099|Ultrasound|ultrasound
1135259|NCT02348073|Epilepsy|epilepsy
1135260|NCT02348073|Attention Deficit Disorders|attention deficit disorders
1135261|NCT02348073|VAYARIN|vayarin
1135262|NCT02348073|Children|children
1135263|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
1135264|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
1135265|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
1135266|NCT02348008|MK-3475|mk-3475
1135267|NCT02348008|Pembrolizumab|pembrolizumab
1135268|NCT02348008|Bevacizumab|bevacizumab
1135269|NCT02347995|Exercise|exercise
1135270|NCT02347995|Protein|protein
1135271|NCT02347995|Nutrition|nutrition
1135272|NCT02347995|Stroke|stroke
1135273|NCT02347982|Turkey|turkey
1135274|NCT02347982|Epidemiologic|epidemiologic
1135275|NCT02347969|antioxidant|antioxidant
1135279|NCT02347969|skin hydration|skin hydration
1135280|NCT02347956|robot surgery|robot surgery
1135281|NCT02347956|reduced port|reduced port
1135282|NCT02347956|single-site|single-site
1135283|NCT02347956|safety|safety
1135284|NCT02347956|feasibility|feasibility
1135285|NCT02347930|acute kidney injury|acute kidney injury
1135286|NCT02347930|ultrasound technology|ultrasound technology
1135287|NCT02347904|Esophageal cancer|esophageal cancer
1135288|NCT02347904|Adjuvant treatment|adjuvant treatment
1135289|NCT02347904|S-1|s-1
1135290|NCT02347904|Oxaliplatin|oxaliplatin
1135291|NCT02347904|Feasibility|feasibility
1135292|NCT02347891|Inflammatory Myositis|inflammatory myositis
1135293|NCT02347891|Dermatomyositis|dermatomyositis
1135294|NCT02347891|Polymyositis|polymyositis
1135295|NCT02347891|Muscle Pain|muscle pain
1135296|NCT02347891|Myositis|myositis
1135297|NCT02347891|Refractory myositis|refractory myositis
1135298|NCT02347878|leukemia|leukemia
1135299|NCT02347878|lymphoma|lymphoma
1135300|NCT02347878|lumbar puncture|lumbar puncture
1135301|NCT02347878|intrathecal treatment|intrathecal treatment
1135302|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
1135303|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
1135304|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
1135305|NCT02347826|patient|patient
1135306|NCT02347826|discomfort|discomfort
1135307|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
1135308|NCT02347813|pioglitazone|pioglitazone
1135309|NCT02347813|PPARgamma|ppargamma
1135310|NCT02347813|skin cancer|skin cancer
1135311|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1135312|NCT02347774|COPD|copd
1135313|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1135314|NCT02347748|Pain|pain
1135315|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
1135316|NCT02347748|Postoperative Period|postoperative period
1135317|NCT02347748|Adaptation, Psychological|adaptation, psychological
1135318|NCT02347748|Relaxation|relaxation
1135319|NCT02347748|Stress, Psychological|stress, psychological
1135320|NCT02347735|Colorectal carcinoma|colorectal carcinoma
1135321|NCT02347735|Anastomotic leakage|anastomotic leakage
1135322|NCT02347735|Markers|markers
1135323|NCT02347735|Diagnosis|diagnosis
1135324|NCT02347722|biomarkers|biomarkers
1135325|NCT02347722|diagnosis|diagnosis
1135326|NCT02347722|etiology of heart failure|etiology of heart failure
1135327|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
1135328|NCT02347709|DFU|dfu
1135329|NCT02347709|Type 2 Diabetes|type 2 diabetes
1135330|NCT02347709|Neuropathy|neuropathy
1135331|NCT02347696|Diet|diet
1135332|NCT02347696|Physical Activity|physical activity
1135333|NCT02347696|Trial|trial
1135334|NCT02347696|Lipidomics|lipidomics
1135335|NCT02347696|Occidental Diseases|occidental diseases
1135336|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
1135337|NCT02347566|COPD|copd
1135338|NCT02347566|Physical Activity|physical activity
1135339|NCT02347566|Accelerometer|accelerometer
1135340|NCT02347540|Heart Failure|heart failure
1135341|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
1135342|NCT02347540|Pre-Eclampsia|pre-eclampsia
1135343|NCT02347540|Endothelial dysfunction|endothelial dysfunction
1135344|NCT02347540|Biological Markers|biological markers
1135345|NCT02347540|MicroRNAs|micrornas
1135346|NCT02347540|Circulating cells|circulating cells
1135347|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
1135348|NCT02347462|BiPAP|bipap
1135349|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
1135350|NCT02347449|Prognosis|prognosis
1135351|NCT02347449|Oncotype Dx|oncotype dx
1135352|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
1135353|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
1135354|NCT02347423|primary series|primary series
1135355|NCT02347371|Heart transplant|heart transplant
1135356|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
1135357|NCT02347371|Chronic rejection|chronic rejection
1135358|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
1135359|NCT02347345|HCV, injection drug use|hcv, injection drug use
1135360|NCT02347280|clostridium difficile|clostridium difficile
1135361|NCT02347280|colitis|colitis
1135362|NCT02347280|colon|colon
1135363|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
1135364|NCT02347267|Weight|weight
1135365|NCT02347267|Fat percentage|fat percentage
1135366|NCT02347267|Body Composition|body composition
1135367|NCT02347267|Blood pressure|blood pressure
1135368|NCT02347267|Sugar|sugar
1135369|NCT02347267|Sodium|sodium
1135370|NCT02347267|Dietary intake|dietary intake
1135371|NCT02347228|OB318|ob318
1135372|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
1135373|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
1135374|NCT02347228|Antrodia camphorata|antrodia camphorata
1135375|NCT02347202|Counseling|counseling
1135376|NCT02347163|triple neg|triple neg
1135377|NCT02347163|breast cancer|breast cancer
1135378|NCT02347163|zoledronate|zoledronate
1135379|NCT02347163|mevalonate pathway|mevalonate pathway
1135380|NCT02347124|smoking cessation|smoking cessation
1135381|NCT02347124|oral health care|oral health care
1135382|NCT02347124|tobacco quitlines|tobacco quitlines
1135383|NCT02347098|plaque|plaque
1135384|NCT02347098|LDL|ldl
1135385|NCT02347098|statin|statin
1135386|NCT02347098|endothelial|endothelial
1135387|NCT02347098|apheresis|apheresis
1135388|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
1135389|NCT02347033|Sertraline|sertraline
1135390|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
1135391|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
1135392|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
1135393|NCT02347020|Obesity|obesity
1135394|NCT02347020|Metabolic Disorders|metabolic disorders
1135395|NCT02347007|Obesity|obesity
1135396|NCT02347007|Overweight|overweight
1135397|NCT02347007|Body Weight|body weight
1135398|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
1135399|NCT02347007|Cholesterol|cholesterol
1135400|NCT02347007|Almonds|almonds
1135401|NCT02347007|Visceral Adiposity|visceral adiposity
1135402|NCT02347007|Quality of Life|quality of life
1135403|NCT02347007|Hispanic Americans|hispanic americans
1135404|NCT02347007|African Continental Ancestry Group|african continental ancestry group
1135405|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
1135406|NCT02346994|Body Weight|body weight
1135407|NCT02346994|Obesity in Adolescence|obesity in adolescence
1135408|NCT02346994|Obesity in Childhood|obesity in childhood
1135409|NCT02346994|Childhood Onset Obesity|childhood onset obesity
1135410|NCT02346994|Childhood Obesity|childhood obesity
1135411|NCT02346994|Child Obesity|child obesity
1135412|NCT02346994|Adolescent Obesity|adolescent obesity
1135413|NCT02346994|Teenagers|teenagers
1135414|NCT02346994|Teens|teens
1135415|NCT02346994|Youth|youth
1135416|NCT02346994|Adolescents|adolescents
1135417|NCT02346994|Adolescence|adolescence
1135418|NCT02346968|Kidney Transplantation|kidney transplantation
1135419|NCT02346968|Delayed Graft Function|delayed graft function
1135420|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
1135421|NCT02346968|Dialysis|dialysis
1135422|NCT02346955|Cancer|cancer
1135423|NCT02346955|Oncology|oncology
1135424|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
1135425|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
1135426|NCT02346955|CM-24|cm-24
1135427|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
1135428|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
1135429|NCT02346955|Uveal|uveal
1135430|NCT02346955|Acral|acral
1135431|NCT02346955|Mucosal|mucosal
1135432|NCT02346955|Cutaneous|cutaneous
1135433|NCT02346955|Colorectal|colorectal
1135434|NCT02346955|Gastric|gastric
1135435|NCT02346955|Ovarian|ovarian
1135436|NCT02346955|Bladder|bladder
1135437|NCT02346955|MK-6018-001|mk-6018-001
1135438|NCT02346929|Hematoma block|hematoma block
1135439|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
1135440|NCT02346929|ultrasound|ultrasound
1135441|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
1135442|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
1135443|NCT02346929|bupivacaine|bupivacaine
1135444|NCT02346929|pain reduction|pain reduction
1135445|NCT02346929|wrist fracture|wrist fracture
1135446|NCT02346890|Volunteer|volunteer
1135447|NCT02346877|Enbrel|enbrel
1135448|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
1135449|NCT02346864|head elevated position|head elevated position
1135450|NCT02346864|preterm|preterm
1135451|NCT02346864|three-stair-position|three-stair-position
1135452|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
1135453|NCT02346825|P-CIMT|p-cimt
1135454|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
1135455|NCT02346825|Hemiparesis|hemiparesis
1135456|NCT02346825|Cerebral Palsy|cerebral palsy
1135457|NCT02346825|Infants|infants
1135458|NCT02346825|Toddlers|toddlers
1135459|NCT02346825|Children|children
1135460|NCT02346786|Drinking Water|drinking water
1135461|NCT02346786|Mineral water|mineral water
1135462|NCT02346786|Sports|sports
1135463|NCT02346786|Accident prevention|accident prevention
1135464|NCT02346747|Stage III|stage iii
1135465|NCT02346747|Stage IV|stage iv
1135466|NCT02346747|Ovarian Cancer|ovarian cancer
1135467|NCT02346747|Maintenance|maintenance
1135468|NCT02346747|Immunotherapy|immunotherapy
1135469|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
1135470|NCT02346747|fallopian tube cancer|fallopian tube cancer
1135471|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
1135472|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
1135473|NCT02346734|Multiple Sclerosis|multiple sclerosis
1135474|NCT02346734|Telerehablitation|telerehablitation
1135475|NCT02346721|Sofosbuvir|sofosbuvir
1135476|NCT02346721|SOF/GS-5816|sof/gs-5816
1135477|NCT02346721|GS-5816|gs-5816
1135478|NCT02346721|Hepatitis C|hepatitis c
1135479|NCT02346721|HCV|hcv
1135480|NCT02346721|Cirrhosis|cirrhosis
1135481|NCT02346721|Velpatasvir|velpatasvir
1135482|NCT02346708|Parkinson's|parkinson's
1135484|NCT02346708|Kluger|kluger
1135485|NCT02346695|LV deformation|lv deformation
1135486|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
1135487|NCT02346695|Coronary flow reserve|coronary flow reserve
1135488|NCT02346682|major depression disorder|major depression disorder
1135489|NCT02346682|biochemistry|biochemistry
1135490|NCT02346682|TCM diagnosis|tcm diagnosis
1135491|NCT02346682|Neurological|neurological
1135492|NCT02346682|metabonomics|metabonomics
1135493|NCT02346682|neuroimaging|neuroimaging
1135494|NCT02346669|Microbiota|microbiota
1135495|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1135496|NCT02346669|Obesity|obesity
1135497|NCT02346617|CMV|cmv
1135498|NCT02346617|T cell therapy|t cell therapy
1135499|NCT02346604|exercise|exercise
1135500|NCT02346591|Positive psychology|positive psychology
1135501|NCT02346591|Wellbeing|wellbeing
1135502|NCT02346591|Stress reduction|stress reduction
1135503|NCT02346591|Relaxation|relaxation
1135504|NCT02346591|Gratitude|gratitude
1135505|NCT02346591|Mobile app|mobile app
1135506|NCT02346591|Intervention|intervention
1135507|NCT02346591|Altruism|altruism
1135508|NCT02346591|Psychological well-being|psychological well-being
1135509|NCT02346591|Social well-being|social well-being
1135510|NCT02346591|Physical well-being|physical well-being
1135511|NCT02346591|Workplace engagement|workplace engagement
1135512|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1135513|NCT02346552|laparoscope holder|laparoscope holder
1135514|NCT02346552|Nissen fundoplication|nissen fundoplication
1135515|NCT02346552|paraesophageal hernia|paraesophageal hernia
1135516|NCT02346552|sleeve surgery|sleeve surgery
1135517|NCT02346539|Nicotine|nicotine
1135518|NCT02346539|Depression|depression
1135519|NCT02346526|Prostate Cancer|prostate cancer
1135520|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
1135521|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
1135522|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
1135523|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
1135524|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
1135525|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1135526|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
1135527|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
1135528|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
1135529|NCT02346487|children|children
1135530|NCT02346474|Subcutaneous Fat|subcutaneous fat
1135531|NCT02346474|Visceral Fat|visceral fat
1135532|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
1135533|NCT02346461|Sialic Acid|sialic acid
1135534|NCT02346461|GNE Myopathy|gne myopathy
1135535|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
1135536|NCT02346461|GNE Gene|gne gene
1135537|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
1135538|NCT02346448|balloon dilation|balloon dilation
1135539|NCT02346448|adverse events|adverse events
1135540|NCT02346448|pancreatitis|pancreatitis
1135541|NCT02346448|bleeding|bleeding
1135542|NCT02346435|small renal mass|small renal mass
1135543|NCT02346435|active surveillance|active surveillance
1135544|NCT02346422|Heart Failure|heart failure
1135545|NCT02346422|Cardiomyopathies|cardiomyopathies
1135546|NCT02346422|Heart Diseases|heart diseases
1135547|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
1135548|NCT02346422|Cardiomegaly|cardiomegaly
1135549|NCT02346422|Gene Therapy|gene therapy
1135550|NCT02346396|neuropathic pain|neuropathic pain
1135551|NCT02346396|neurostimulation|neurostimulation
1135552|NCT02346396|ambulatory use|ambulatory use
1135553|NCT02346396|tDCS|tdcs
1135554|NCT02346383|back pain|back pain
1135555|NCT02346383|neuromodulation|neuromodulation
1135556|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
1135557|NCT02346383|spinal cord stimulation|spinal cord stimulation
1135558|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
1135559|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
1135560|NCT02346357|hip arthroscopy|hip arthroscopy
1135561|NCT02346357|analgesia|analgesia
1135562|NCT02346344|type 2 diabetes|type 2 diabetes
1135563|NCT02346344|beta cell function|beta cell function
1135564|NCT02346344|meal tolerance test|meal tolerance test
1135565|NCT02346344|maximum stimulation test|maximum stimulation test
1135566|NCT02346344|method standardization|method standardization
1135567|NCT02346344|insulin secretion|insulin secretion
1135568|NCT02346344|prediabetes|prediabetes
1135569|NCT02346344|insulin sensitivity|insulin sensitivity
1135570|NCT02346318|Radiotherapy|radiotherapy
1135571|NCT02346318|Adverse Effect|adverse effect
1135572|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
1135573|NCT02346292|COPD|copd
1135574|NCT02346292|Spirometry|spirometry
1135575|NCT02346292|severe and very severe COPD|severe and very severe copd
1135576|NCT02346292|COPD exacerbations|copd exacerbations
1135577|NCT02346292|therapy schemes|therapy schemes
1135578|NCT02346292|therapy changes|therapy changes
1135579|NCT02346279|Multiple Sclerosis|multiple sclerosis
1135580|NCT02346279|Rehabilitation|rehabilitation
1135581|NCT02346279|Questionnaire|questionnaire
1135582|NCT02346279|Patient-Reported Outcome|patient-reported outcome
1135583|NCT02346279|Responsiveness|responsiveness
1135584|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
1135585|NCT02346266|Stroke|stroke
1135586|NCT02346266|Stroke Prevention|stroke prevention
1135587|NCT02346266|Children|children
1135588|NCT02346266|Education|education
1135589|NCT02346240|Certolizumab Pegol|certolizumab pegol
1135590|NCT02346240|Cimzia|cimzia
1135591|NCT02346240|Psoriasis|psoriasis
1135592|NCT02346227|Human Papillomavirus|human papillomavirus
1135593|NCT02346227|Uterine cervix|uterine cervix
1135594|NCT02346227|Infection|infection
1135595|NCT02346227|Antiviral Drug|antiviral drug
1135596|NCT02346227|Therapeutic use|therapeutic use
1135597|NCT02346214|Gestational Age|gestational age
1135598|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
1135599|NCT02346214|Preterm|preterm
1135600|NCT02346214|Method-comparison|method-comparison
1135601|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
1135602|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
1135603|NCT02346162|Pre-pregnancy|pre-pregnancy
1135604|NCT02346162|Weight management|weight management
1135605|NCT02346136|Tai Chi|tai chi
1135606|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
1135607|NCT02346136|Intervention|intervention
1135608|NCT02346136|Elderly|elderly
1135609|NCT02346136|Mobility|mobility
1135610|NCT02346136|Health care utilization|health care utilization
1135611|NCT02346123|Chagas disease|chagas disease
1135612|NCT02346123|Polymorphisms|polymorphisms
1135613|NCT02346123|Biomarkers|biomarkers
1135614|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1135615|NCT02346097|Heart Failure|heart failure
1135616|NCT02346097|Ejection Fraction|ejection fraction
1135617|NCT02346097|Narrow|narrow
1135618|NCT02346097|Pacemaker|pacemaker
1135619|NCT02346097|Electrophysiology|electrophysiology
1135620|NCT02346097|Electrical activation mapping|electrical activation mapping
1135621|NCT02346097|Coronary Sinus|coronary sinus
1135622|NCT02346097|Mapping|mapping
1135623|NCT02346097|QRS|qrs
1135624|NCT02346097|QRS width|qrs width
1135625|NCT02346097|Pacing Interval|pacing interval
1135626|NCT02346097|Left Ventricular Lead|left ventricular lead
1135627|NCT02346097|Cardiac CT|cardiac ct
1135628|NCT02346097|Echocardiography|echocardiography
1135629|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
1135630|NCT02346097|6 Minutes Walk Test|6 minutes walk test
1135631|NCT02346097|Imaging|imaging
1135632|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
1135633|NCT02346097|Epicardial veins|epicardial veins
1135634|NCT02346097|Resynchronization|resynchronization
1135635|NCT02346097|ImagingCRT|imagingcrt
1135636|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
1135637|NCT02346097|Cardiac computed tomography|cardiac computed tomography
1135638|NCT02346071|Bodily distress syndrome|bodily distress syndrome
1135639|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
1136241|NCT02342561|Infection|infection
1135640|NCT02346071|Functional somatic symptoms|functional somatic symptoms
1135641|NCT02346071|Functional somatic syndromes|functional somatic syndromes
1135642|NCT02346071|Treatment|treatment
1135643|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
1135644|NCT02346045|hypertension|hypertension
1135645|NCT02346032|second line|second line
1135646|NCT02346006|Exercise|exercise
1135647|NCT02346006|Visual Acuity|visual acuity
1135648|NCT02346006|Blood Vessels|blood vessels
1135649|NCT02346006|Retina|retina
1135650|NCT02346006|Choroid|choroid
1135651|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
1135652|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
1135653|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
1135654|NCT02345954|Uterus Prolapse|uterus prolapse
1135655|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
1135656|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
1135657|NCT02345928|Safety|safety
1135658|NCT02345928|Efficacy|efficacy
1135659|NCT02345928|CNTO 7160|cnto 7160
1135660|NCT02345928|Healthy|healthy
1135661|NCT02345928|Asthma|asthma
1135662|NCT02345928|Atopic Dermatitis|atopic dermatitis
1135663|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
1135664|NCT02345863|CLL|cll
1135665|NCT02345850|Acute Leukemia|acute leukemia
1135666|NCT02345850|Myelodysplasia|myelodysplasia
1135667|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
1135668|NCT02345850|Chronic GVHD|chronic gvhd
1135669|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
1135670|NCT02345824|LEE011|lee011
1135671|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
1135672|NCT02345824|Anaplastic Glioma|anaplastic glioma
1135673|NCT02345824|Ribociclib|ribociclib
1135674|NCT02345759|CKD patients|ckd patients
1135675|NCT02345759|protein-restricted diets|protein-restricted diets
1135676|NCT02345759|compliance|compliance
1135677|NCT02345759|psychological aspects|psychological aspects
1135678|NCT02345707|Cabotegravir|cabotegravir
1135679|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
1135680|NCT02345707|Bioavailability|bioavailability
1135681|NCT02345707|Pharmacokinetics|pharmacokinetics
1135682|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1135683|NCT02345694|Gait|gait
1135684|NCT02345694|Posture|posture
1135685|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
1135686|NCT02345681|furosemide|furosemide
1135687|NCT02345681|under strict conditions|under strict conditions
1135688|NCT02345681|normalize|normalize
1135689|NCT02345681|ICU patients|icu patients
1135690|NCT02345681|fluid balance|fluid balance
1135691|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
1135692|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
1135693|NCT02345655|Substances consumption|substances consumption
1135694|NCT02345655|Opiate|opiate
1135695|NCT02345655|Family practice|family practice
1135696|NCT02345629|Refractory cancer pain|refractory cancer pain
1135697|NCT02345629|Cordotomy|cordotomy
1135698|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
1135699|NCT02345629|Heat pain sensory testing|heat pain sensory testing
1135700|NCT02345629|Symptom questionnaire|symptom questionnaire
1135701|NCT02345629|Advanced cancers|advanced cancers
1135702|NCT02345629|Pain|pain
1135703|NCT02345616|Cardiac surgery|cardiac surgery
1135704|NCT02345616|Pulmonary hypertension|pulmonary hypertension
1135705|NCT02345616|Nitric oxide|nitric oxide
1135706|NCT02345616|Induction anesthesia|induction anesthesia
1135707|NCT02345577|Kidney transplantation|kidney transplantation
1135708|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
1135709|NCT02345577|Muscle strength|muscle strength
1135710|NCT02345577|Intramuscular lipid content|intramuscular lipid content
1135711|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
1135712|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
1135713|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
1135714|NCT02345577|Physical Therapy Modalities|physical therapy modalities
1135715|NCT02345551|Exercise|exercise
1135716|NCT02345551|Sleep|sleep
1135717|NCT02345551|Telemedicine|telemedicine
1135718|NCT02345551|Behavior|behavior
1135719|NCT02345551|Shift work|shift work
1135720|NCT02345512|Falls|falls
1135721|NCT02345499|Radical cystectomy|radical cystectomy
1135722|NCT02345499|Laparoscopy|laparoscopy
1135723|NCT02345486|Pilot Projects|pilot projects
1135724|NCT02345486|Plasmalyte A|plasmalyte a
1135725|NCT02345486|Ringer's lactate|ringer's lactate
1135726|NCT02345486|Sodium Chloride|sodium chloride
1135727|NCT02345486|Critical Care|critical care
1135728|NCT02345486|"Resuscitation"|"resuscitation"
1135729|NCT02345473|Bladder cancer|bladder cancer
1135730|NCT02345473|Circulating cancer cells|circulating cancer cells
1135731|NCT02345421|LAL D|lal d
1135732|NCT02345421|CESD|cesd
1135733|NCT02345421|NASH|nash
1135734|NCT02345421|NAFLD|nafld
1135735|NCT02345421|Wilson's|wilson's
1135736|NCT02345421|Niemann Pick|niemann pick
1135737|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
1135738|NCT02345395|Brain Aneurysm|brain aneurysm
1135739|NCT02345395|Pterional Craniotomy|pterional craniotomy
1135740|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
1135741|NCT02345395|Transpalpebral Approach|transpalpebral approach
1135742|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
1135743|NCT02345382|Advanced acute leukemia|advanced acute leukemia
1135744|NCT02345356|Pharmacogenomics|pharmacogenomics
1135745|NCT02345356|Warfarin|warfarin
1135746|NCT02345356|Caribbean Hispanics|caribbean hispanics
1135747|NCT02345356|Polymorphisms|polymorphisms
1135748|NCT02345356|Dosing Algorithm|dosing algorithm
1135749|NCT02345278|Immunotherapy|immunotherapy
1135750|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
1135751|NCT02345252|HIV|hiv
1135752|NCT02345226|HIV|hiv
1135753|NCT02345213|DLB|dlb
1135754|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
1135755|NCT02345213|Lewy Body Disease|lewy body disease
1135756|NCT02345213|Dementia|dementia
1135757|NCT02345213|E2020|e2020
1135758|NCT02345213|Donepezil|donepezil
1135759|NCT02345213|Aricept|aricept
1135760|NCT02345200|dystrophy|dystrophy
1135761|NCT02345200|body composition|body composition
1135762|NCT02345200|malnutrition|malnutrition
1135763|NCT02345174|zirconium|zirconium
1135764|NCT02345174|oncology|oncology
1135765|NCT02345174|mAb|mab
1135766|NCT02345174|receptor occupancy|receptor occupancy
1135767|NCT02345174|dose|dose
1135768|NCT02345174|PET|pet
1135769|NCT02345174|HER3|her3
1135770|NCT02345174|89-Zr|89-zr
1135771|NCT02345174|biodistribution|biodistribution
1135772|NCT02345174|tumours|tumours
1135773|NCT02345161|Triple Therapy|triple therapy
1135774|NCT02345161|Formoterol|formoterol
1135775|NCT02345161|Respiratory|respiratory
1135776|NCT02345161|COPD|copd
1135777|NCT02345161|Budesonide|budesonide
1135778|NCT02345161|Vilanterol|vilanterol
1135779|NCT02345161|Fluticasone Furoate|fluticasone furoate
1135780|NCT02345161|Umeclidinium|umeclidinium
1135781|NCT02345161|Lung Function|lung function
1135782|NCT02345148|Healthy|healthy
1135783|NCT02345148|Esketamine|esketamine
1135784|NCT02345148|JNJ-54135419|jnj-54135419
1135785|NCT02345122|At-risk Drinking|at-risk drinking
1135786|NCT02345122|Depression|depression
1135787|NCT02345122|Anxiety|anxiety
1135788|NCT02345122|Alcohol Drinking|alcohol drinking
1135789|NCT02345109|weight|weight
1135790|NCT02345109|total body water|total body water
1135791|NCT02345109|body fat|body fat
1135792|NCT02345109|muscle mass|muscle mass
1135793|NCT02345109|bone mass|bone mass
1135795|NCT02345109|visceral fat|visceral fat
1135796|NCT02345109|calories|calories
1135797|NCT02345083|Frailty|frailty
1135798|NCT02345083|Pre-frailty|pre-frailty
1135799|NCT02345083|Fit|fit
1135800|NCT02345083|Robust|robust
1135801|NCT02345083|Elderly|elderly
1135802|NCT02345083|Sociodemography status|sociodemography status
1135803|NCT02345083|Functional status|functional status
1135804|NCT02345083|Cognitive status|cognitive status
1135805|NCT02345083|Nutrition status|nutrition status
1135806|NCT02345083|Comorbidity|comorbidity
1135807|NCT02345083|Polypharmacy|polypharmacy
1135808|NCT02345083|Mortality|mortality
1135809|NCT02345083|Depression status|depression status
1135810|NCT02345083|Health-related quality of life|health-related quality of life
1135811|NCT02345083|Fall incidence|fall incidence
1135812|NCT02345083|Hospitality|hospitality
1135813|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
1135814|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1135815|NCT02345057|CS-3150|cs-3150
1135816|NCT02345057|Japanese|japanese
1135817|NCT02345044|Essential hypertension|essential hypertension
1135818|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
1135819|NCT02345044|CS-3150|cs-3150
1135820|NCT02345044|Japanese|japanese
1135821|NCT02345031|hearing loss|hearing loss
1135822|NCT02345031|speech-in-noise|speech-in-noise
1135823|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
1135824|NCT02345018|Treatment large varicose veins|treatment large varicose veins
1135825|NCT02345018|Below-knee and branches|below-knee and branches
1135826|NCT02345018|Endovenous|endovenous
1135827|NCT02345005|Vascular diseases|vascular diseases
1135828|NCT02345005|Aneurysm|aneurysm
1135829|NCT02345005|Treatment Efficacy|treatment efficacy
1135830|NCT02345005|Medical device|medical device
1135831|NCT02345005|Population Register|population register
1135832|NCT02344979|NSCLC|nsclc
1135833|NCT02344979|Chemotherapy|chemotherapy
1135834|NCT02344979|thrombocytopenia|thrombocytopenia
1135835|NCT02344979|rhTPO|rhtpo
1135836|NCT02344940|operable|operable
1135837|NCT02344940|premenopausal|premenopausal
1135838|NCT02344940|endocrine therapy|endocrine therapy
1135839|NCT02344940|safety|safety
1135840|NCT02344940|tamoxifen|tamoxifen
1135841|NCT02344940|toremifene|toremifene
1135842|NCT02344927|Cancer|cancer
1135843|NCT02344927|End-of-life care|end-of-life care
1135844|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
1135845|NCT02344914|dental support|dental support
1135846|NCT02344914|second stage of labor|second stage of labor
1135847|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
1135848|NCT02344901|stroke prevention|stroke prevention
1135849|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
1135850|NCT02344901|warfarin|warfarin
1135851|NCT02344888|PCOS|pcos
1135852|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
1135853|NCT02344888|Prednisolone|prednisolone
1135854|NCT02344823|cirrhosis|cirrhosis
1135855|NCT02344823|erectile dysfunction|erectile dysfunction
1135856|NCT02344823|portal hypertension|portal hypertension
1135857|NCT02344797|Perioperative|perioperative
1135858|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
1135859|NCT02344784|ADD|add
1135860|NCT02344784|ADHD|adhd
1135861|NCT02344784|PPI|ppi
1135862|NCT02344771|Endothelial dysfunction|endothelial dysfunction
1135863|NCT02344771|General Surgery|general surgery
1135864|NCT02344771|Perioperative Care|perioperative care
1135865|NCT02344745|Lavender|lavender
1135866|NCT02344745|Aromatherapy|aromatherapy
1135867|NCT02344745|Urodynamics|urodynamics
1135868|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
1135869|NCT02344719|cirrhosis|cirrhosis
1135870|NCT02344719|portal hypertension|portal hypertension
1135871|NCT02344719|taurin|taurin
1135872|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
1135873|NCT02344706|Coma|coma
1135874|NCT02344706|Electroencephalography|electroencephalography
1135875|NCT02344693|Electroencephalography|electroencephalography
1135876|NCT02344654|Fluorescence|fluorescence
1135877|NCT02344654|Cholangiography|cholangiography
1135878|NCT02344654|Indocyanine Green|indocyanine green
1135879|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
1135880|NCT02344615|nerve stimulator|nerve stimulator
1135881|NCT02344615|ultrasound|ultrasound
1135882|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
1135883|NCT02344602|Diabetes Mellitus|diabetes mellitus
1135884|NCT02344602|Diabetes Complications|diabetes complications
1135885|NCT02344602|Uric Acid|uric acid
1135886|NCT02344602|Febuxostat|febuxostat
1135887|NCT02344602|Uloric|uloric
1135888|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
1135889|NCT02344602|Kidney Disease|kidney disease
1135890|NCT02344602|Vascular Disease|vascular disease
1135891|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
1135892|NCT02344602|Endothelial Function|endothelial function
1135893|NCT02344602|Arterial Stiffness|arterial stiffness
1135894|NCT02344602|Pharmacologic Actions|pharmacologic actions
1135895|NCT02344602|Gout Suppressants|gout suppressants
1135896|NCT02344602|Therapeutic Uses|therapeutic uses
1135897|NCT02344602|Free Radical Scavengers|free radical scavengers
1135898|NCT02344602|Antioxidants|antioxidants
1135899|NCT02344602|Protective Agents|protective agents
1135900|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
1135901|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
1135902|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
1135903|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
1135904|NCT02344602|Nitroglycerin|nitroglycerin
1135905|NCT02344602|Hyperglycemia|hyperglycemia
1135906|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
1135907|NCT02344602|Nitric Oxide|nitric oxide
1135908|NCT02344602|cGMP|cgmp
1135909|NCT02344602|Oxidative Stress|oxidative stress
1135910|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
1135911|NCT02344602|Inulin Clearance|inulin clearance
1135912|NCT02344602|PAH Clearance|pah clearance
1135913|NCT02344602|Skin Biopsy|skin biopsy
1135914|NCT02344602|T1R mRNA Expression|t1r mrna expression
1135915|NCT02344602|Cytokines|cytokines
1135916|NCT02344602|Chemokines|chemokines
1135917|NCT02344589|ACB|acb
1135918|NCT02344589|Adductor Canal Block|adductor canal block
1135919|NCT02344589|Peripheral Nerve Block|peripheral nerve block
1135920|NCT02344576|heart failure|heart failure
1135921|NCT02344576|heart-assist devices|heart-assist devices
1135922|NCT02344576|decision making|decision making
1135923|NCT02344576|decision support techniques|decision support techniques
1135924|NCT02344576|hospice care|hospice care
1135925|NCT02344576|palliative care|palliative care
1135926|NCT02344576|caregivers|caregivers
1135927|NCT02344563|volunteers|volunteers
1135928|NCT02344550|metastatic breast cancer|metastatic breast cancer
1135929|NCT02344550|HER2 negative|her2 negative
1135930|NCT02344550|hormone-receptor positive|hormone-receptor positive
1135931|NCT02344537|Lyme DIsease|lyme disease
1135932|NCT02344537|Kundalini Yoga|kundalini yoga
1135933|NCT02344498|Liver cirrhosis|liver cirrhosis
1135934|NCT02344498|Antiviral agents|antiviral agents
1135935|NCT02344498|Liver diseases|liver diseases
1135936|NCT02344472|MBC|mbc
1135937|NCT02344472|HER2|her2
1135938|NCT02344472|CTC|ctc
1135939|NCT02344472|endocrine therapy|endocrine therapy
1135940|NCT02344472|Pertuzumab|pertuzumab
1135941|NCT02344472|Trastuzumab|trastuzumab
1135942|NCT02344472|HER2 therapy|her2 therapy
1135943|NCT02344446|physical therapy intervention|physical therapy intervention
1135944|NCT02344433|Family health history|family health history
1135945|NCT02344433|Genetic literacy|genetic literacy
1135946|NCT02344433|Health literacy|health literacy
1135947|NCT02344433|Relational agent|relational agent
1135948|NCT02344433|Common chronic conditions|common chronic conditions
1135949|NCT02344420|Heart Failure|heart failure
1135950|NCT02344420|CRT|crt
1135951|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
1135952|NCT02344394|Atrial Fibrillation|atrial fibrillation
1135953|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
1135954|NCT02344394|Catheter Ablation|catheter ablation
1135955|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
1135956|NCT02344368|Sucrose|sucrose
1135957|NCT02344368|Anesthesia|anesthesia
1135958|NCT02344368|Blood specimen collection|blood specimen collection
1135959|NCT02344368|Injections, Intravenous|injections, intravenous
1135960|NCT02344355|Ascorbic Acid|ascorbic acid
1135961|NCT02344355|temozolomide|temozolomide
1135962|NCT02344355|radiation|radiation
1135963|NCT02344342|telemonitoring|telemonitoring
1135964|NCT02344290|HIV|hiv
1135965|NCT02344290|Cardiovascular Disease|cardiovascular disease
1135966|NCT02344290|Myocardial Infarction|myocardial infarction
1135967|NCT02344290|Inflammation|inflammation
1135968|NCT02344290|Statin|statin
1135969|NCT02344290|Computerized Tomography|computerized tomography
1135970|NCT02344290|Cholesterol|cholesterol
1135971|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
1135972|NCT02344277|Brugada syndrome|brugada syndrome
1135973|NCT02344277|Effectiveness|effectiveness
1135974|NCT02344277|Safety|safety
1135975|NCT02344264|US guided nerve block|us guided nerve block
1135976|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
1135977|NCT02344264|NCFL|ncfl
1136273|NCT02342392|pterygium|pterygium
1135978|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
1135979|NCT02344251|Drug study|drug study
1135980|NCT02344251|Medication compliance|medication compliance
1135981|NCT02344238|Medication compliance|medication compliance
1135982|NCT02344238|Technology|technology
1135983|NCT02344238|Drug study|drug study
1135984|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
1135985|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
1135986|NCT02344160|THA|tha
1135987|NCT02344095|recurrent, persistent|recurrent, persistent
1135988|NCT02344069|Fibrinogen|fibrinogen
1135989|NCT02344056|Having Lunch|having lunch
1135990|NCT02344056|Skipping Lunch|skipping lunch
1135991|NCT02344030|airway|airway
1135992|NCT02344030|videolaryngoscope|videolaryngoscope
1135993|NCT02343978|Chronic Constipation|chronic constipation
1135994|NCT02343978|CC|cc
1135995|NCT02343965|Touch-massage|touch-massage
1135996|NCT02343965|anxiety|anxiety
1135997|NCT02343965|leukemia|leukemia
1135998|NCT02343965|haematology|haematology
1135999|NCT02343965|cancerology|cancerology
1136000|NCT02343965|supportive care|supportive care
1136001|NCT02343965|complementary therapy|complementary therapy
1136002|NCT02343952|Pembrolizumab|pembrolizumab
1136003|NCT02343952|MK-3475|mk-3475
1136004|NCT02343874|Alcohol consumption|alcohol consumption
1136005|NCT02343874|Primary health care|primary health care
1136006|NCT02343874|health care costs|health care costs
1136007|NCT02343874|health service utilization|health service utilization
1136008|NCT02343861|Behavioral Research|behavioral research
1136009|NCT02343861|Emollients|emollients
1136010|NCT02343822|PRP|prp
1136011|NCT02343822|Platelet Rich Plasma|platelet rich plasma
1136012|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
1136013|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
1136014|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
1136015|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
1136016|NCT02343822|PRPLE|prple
1136017|NCT02343822|Multiple PRP Injections|multiple prp injections
1136018|NCT02343822|Multiple PRP|multiple prp
1136019|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
1136020|NCT02343822|Tennis Elbow|tennis elbow
1136021|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
1136022|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
1136023|NCT02343822|prp tennis elbow|prp tennis elbow
1136024|NCT02343809|Physiotherapy|physiotherapy
1136025|NCT02343809|Lateral epicondylitis|lateral epicondylitis
1136026|NCT02343809|Manual therapy|manual therapy
1136027|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
1136028|NCT02343783|Atopic Dermatitis|atopic dermatitis
1136029|NCT02343783|Asthma|asthma
1136030|NCT02343783|Healthy|healthy
1136031|NCT02343783|Skin Blisters|skin blisters
1136032|NCT02343783|Adult Participants|adult participants
1136033|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
1136034|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
1136035|NCT02343744|Guselkumab|guselkumab
1136036|NCT02343744|CNTO1959|cnto1959
1136037|NCT02343731|microbiome|microbiome
1136038|NCT02343731|hygiene hypothesis|hygiene hypothesis
1136039|NCT02343731|human-animal interaction|human-animal interaction
1136040|NCT02343731|microbiota|microbiota
1136137|NCT02343263|Tonsillectomy|tonsillectomy
1136041|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
1136042|NCT02343653|Malnutrition|malnutrition
1136043|NCT02343653|Muscle mass|muscle mass
1136044|NCT02343653|Nutrition|nutrition
1136045|NCT02343640|Baseball|baseball
1136046|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
1136047|NCT02343614|Intermediate risk|intermediate risk
1136048|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
1136049|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
1136050|NCT02343575|Hyperactive delirium|hyperactive delirium
1136051|NCT02343575|Mixed delirium|mixed delirium
1136052|NCT02343575|Anti-psychotic|anti-psychotic
1136053|NCT02343575|Haldol|haldol
1136054|NCT02343575|Valproic Acid|valproic acid
1136055|NCT02343536|Phase 1|phase 1
1136056|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
1136057|NCT02343536|R-CHOP|r-chop
1136058|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1136059|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
1136060|NCT02343536|Follicular Lymphoma|follicular lymphoma
1136061|NCT02343536|Transformed Lymphoma|transformed lymphoma
1136062|NCT02343523|Wearable device|wearable device
1136063|NCT02343523|Wrist-watch|wrist-watch
1136064|NCT02343523|Longitudinal monitoring|longitudinal monitoring
1136065|NCT02343523|Congestive Heart Failure|congestive heart failure
1136066|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
1136067|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
1136068|NCT02343484|gelified ethanol|gelified ethanol
1136069|NCT02343471|Whey proteins|whey proteins
1136070|NCT02343471|Postprandial lipemia|postprandial lipemia
1136071|NCT02343471|Pre-meal|pre-meal
1136072|NCT02343471|Type 2 diabetes|type 2 diabetes
1136073|NCT02343458|COPD|copd
1136074|NCT02343432|Anesthesia|anesthesia
1136075|NCT02343432|Adverse Effect|adverse effect
1136076|NCT02343432|Spinal|spinal
1136077|NCT02343432|Epidural|epidural
1136078|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
1136079|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
1136080|NCT02343419|Methacholine Chloride|methacholine chloride
1136081|NCT02343419|Respiratory Function Tests|respiratory function tests
1136082|NCT02343419|Spirometry|spirometry
1136083|NCT02343419|Airway Resistance|airway resistance
1136084|NCT02343419|Plethysmography|plethysmography
1136085|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
1136086|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
1136087|NCT02343406|Temozolomide|temozolomide
1136088|NCT02343406|Lomustine|lomustine
1136089|NCT02343406|ABT-414|abt-414
1136090|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
1136091|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
1136092|NCT02343406|Epithelial Growth Factor|epithelial growth factor
1136093|NCT02343406|Brain Tumor|brain tumor
1136094|NCT02343406|Brain Tumor Group|brain tumor group
1136095|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
1136096|NCT02343406|EORTC|eortc
1136097|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
1136098|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
1136099|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
1136100|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
1136101|NCT02343406|EGFR amplification|egfr amplification
1136102|NCT02343406|Children|children
1136103|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
1136104|NCT02343393|Biomarkers|biomarkers
1136105|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
1136106|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
1136107|NCT02343380|glucose|glucose
1136108|NCT02343380|respiratory quotient|respiratory quotient
1136109|NCT02343367|Hispanic|hispanic
1136110|NCT02343367|overweight|overweight
1136111|NCT02343367|families|families
1136112|NCT02343367|pediatric|pediatric
1136113|NCT02343367|primary care|primary care
1136114|NCT02343354|behavioural|behavioural
1136115|NCT02343354|diabetes prevention|diabetes prevention
1136116|NCT02343354|physical activity|physical activity
1136117|NCT02343354|healthy eating|healthy eating
1136118|NCT02343354|gestational diabetes|gestational diabetes
1136119|NCT02343341|early childhood education|early childhood education
1136120|NCT02343341|cardiovascular health|cardiovascular health
1136121|NCT02343341|behavior change|behavior change
1136122|NCT02343341|community-based|community-based
1136123|NCT02343341|family-based|family-based
1136124|NCT02343341|prevention|prevention
1136125|NCT02343315|low back pain|low back pain
1136126|NCT02343315|home exercises|home exercises
1136127|NCT02343315|chronic pain|chronic pain
1136128|NCT02343315|supervised exercise|supervised exercise
1136129|NCT02343315|core stability exercises|core stability exercises
1136130|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
1136131|NCT02343302|Pancreatic Fistula|pancreatic fistula
1136133|NCT02343289|Pharmacokinetics|pharmacokinetics
1136134|NCT02343289|Esketamine|esketamine
1136135|NCT02343289|JNJ-54135419|jnj-54135419
1136136|NCT02343276|Radial Spasm|radial spasm
1136138|NCT02343263|Adenotonsillectomy|adenotonsillectomy
1136139|NCT02343263|Pain|pain
1136140|NCT02343263|Hemorrhage|hemorrhage
1136141|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
1136142|NCT02343237|pain|pain
1136143|NCT02343237|quality of life|quality of life
1136144|NCT02343237|osteopathic treatment|osteopathic treatment
1136145|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
1136146|NCT02343211|Onconeural antibodies|onconeural antibodies
1136147|NCT02343211|Cancer|cancer
1136148|NCT02343185|diaphragm|diaphragm
1136149|NCT02343185|osteopathic treatment|osteopathic treatment
1136150|NCT02343185|myofascial release|myofascial release
1136151|NCT02343172|Liposarcoma,|liposarcoma,
1136152|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
1136153|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
1136154|NCT02343172|HDM201,|hdm201,
1136155|NCT02343172|LEE011|lee011
1136156|NCT02343133|Radiation countermeasure|radiation countermeasure
1136157|NCT02343133|radiomitigation|radiomitigation
1136158|NCT02343107|Obesity|obesity
1136159|NCT02343107|Type 2 diabetes|type 2 diabetes
1136160|NCT02343107|Metabolic syndrome|metabolic syndrome
1136161|NCT02343107|e-coaching|e-coaching
1136162|NCT02343107|Telehealth|telehealth
1136163|NCT02343094|Proteinuria|proteinuria
1136164|NCT02343094|Lipocalin 2|lipocalin 2
1136165|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
1136166|NCT02343094|ELISA|elisa
1136167|NCT02343081|brain neoplasm|brain neoplasm
1136168|NCT02343081|bioequivalence|bioequivalence
1136169|NCT02343081|temozolomide|temozolomide
1136170|NCT02343042|Selinexor|selinexor
1136171|NCT02343042|KCP-330|kcp-330
1136172|NCT02343042|STOMP|stomp
1136173|NCT02343042|Multiple Myeloma|multiple myeloma
1136274|NCT02342392|ranibizumab|ranibizumab
1136174|NCT02343042|Relapsed/Refractory|relapsed/refractory
1136175|NCT02343042|Dexamethasone|dexamethasone
1136176|NCT02343042|Pomalidomide|pomalidomide
1136177|NCT02343042|Bortezomib|bortezomib
1136178|NCT02343042|Karyopharm|karyopharm
1136179|NCT02343042|Lenalidomide|lenalidomide
1136180|NCT02343042|Daratumumab|daratumumab
1136181|NCT02343042|Newly Diagnosed|newly diagnosed
1136182|NCT02343042|Carfilzomib|carfilzomib
1136183|NCT02343029|Aerobic Exercise Training|aerobic exercise training
1136184|NCT02343029|prevention|prevention
1136185|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
1136186|NCT02343029|psychometric tests|psychometric tests
1136187|NCT02343029|cognition|cognition
1136188|NCT02343029|dementia|dementia
1136189|NCT02343029|cognitive impairment|cognitive impairment
1136190|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
1136191|NCT02343003|knee pain|knee pain
1136192|NCT02343003|osteoarthritis|osteoarthritis
1136193|NCT02343003|pain management|pain management
1136194|NCT02342990|working memory training|working memory training
1136195|NCT02342990|home-based training|home-based training
1136196|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
1136197|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
1136198|NCT02342990|neuropsychological profile|neuropsychological profile
1136199|NCT02342990|high density EEG|high density eeg
1136200|NCT02342990|slow waves activities|slow waves activities
1136201|NCT02342977|total hip arthroplasty|total hip arthroplasty
1136202|NCT02342964|Cystic fibrosis|cystic fibrosis
1136203|NCT02342964|hepatic fibrosis|hepatic fibrosis
1136204|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
1136205|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
1136206|NCT02342964|hepatic elasticity|hepatic elasticity
1136207|NCT02342951|Cystic fibrosis,|cystic fibrosis,
1136208|NCT02342951|lung clearance index,|lung clearance index,
1136209|NCT02342951|pulmonary function|pulmonary function
1136210|NCT02342938|Epilepsy surgery|epilepsy surgery
1136211|NCT02342938|High frequency activity|high frequency activity
1136213|NCT02342938|fMRI|fmri
1136214|NCT02342938|MEG|meg
1136215|NCT02342886|Tuberculosis|tuberculosis
1136216|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
1136217|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
1136218|NCT02342886|PA-824|pa-824
1136219|NCT02342886|Moxifloxacin|moxifloxacin
1136220|NCT02342886|Pyrazinamide|pyrazinamide
1136221|NCT02342886|Rifampicin|rifampicin
1136222|NCT02342886|Isoniazid|isoniazid
1136223|NCT02342886|Ethambutol|ethambutol
1136224|NCT02342886|HRZE|hrze
1136225|NCT02342886|HR|hr
1136226|NCT02342886|Pretomanid|pretomanid
1136227|NCT02342886|NC-006|nc-006
1136228|NCT02342886|STAND|stand
1136229|NCT02342873|ultrasound|ultrasound
1136230|NCT02342873|nerve stimulator|nerve stimulator
1136231|NCT02342860|Water|water
1136232|NCT02342860|sanitation|sanitation
1136233|NCT02342860|hygiene access in school|hygiene access in school
1136234|NCT02342756|ARDS, HFOV|ards, hfov
1136235|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
1136236|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
1136237|NCT02342626|Prostate|prostate
1136238|NCT02342626|Cancer|cancer
1136239|NCT02342626|Adenocarcinoma|adenocarcinoma
1136240|NCT02342587|Lapatinib|lapatinib
1136244|NCT02342561|Arthroplasty|arthroplasty
1136245|NCT02342561|Knee|knee
1136246|NCT02342561|Cylinder Sampling|cylinder sampling
1136247|NCT02342561|Bacteria|bacteria
1136248|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
1136249|NCT02342522|Cardioprotection|cardioprotection
1136250|NCT02342522|STEMI|stemi
1136251|NCT02342522|PPCI|ppci
1136252|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
1136253|NCT02342522|Myocardial infarct size|myocardial infarct size
1136254|NCT02342522|ST-elevation myocardial infarction|st-elevation myocardial infarction
1136255|NCT02342522|Remote Ischaemic Conditioning|remote ischaemic conditioning
1136256|NCT02342522|Cardiovascular mortality|cardiovascular mortality
1136257|NCT02342509|et Control|et control
1136258|NCT02342509|inhalational sedation|inhalational sedation
1136259|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
1136260|NCT02342470|prevention|prevention
1136261|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
1136262|NCT02342444|Trauma|trauma
1136263|NCT02342444|Surgery|surgery
1136264|NCT02342444|Enoxaparin|enoxaparin
1136265|NCT02342444|DVTs|dvts
1136266|NCT02342444|Thromboembolic events|thromboembolic events
1136267|NCT02342431|Thermoregulation|thermoregulation
1136268|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
1136269|NCT02342431|Cardiac Catheterization|cardiac catheterization
1136270|NCT02342405|Oxidative stress|oxidative stress
1136271|NCT02342405|Nitrogen oxide|nitrogen oxide
1136272|NCT02342405|Reactive oxygen species|reactive oxygen species
1136275|NCT02342392|anti-VEGF|anti-vegf
1136276|NCT02342392|recurrence|recurrence
1136277|NCT02342392|vascularity|vascularity
1136278|NCT02342392|size|size
1136279|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
1136280|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
1136281|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
1136282|NCT02342275|Infantile hemangioma|infantile hemangioma
1136283|NCT02342275|Propranolol|propranolol
1136284|NCT02342275|Atenolol|atenolol
1136285|NCT02342275|Efficacy|efficacy
1136286|NCT02342275|Safety|safety
1136287|NCT02342249|Influenza A|influenza a
1136288|NCT02342236|Biological Markers|biological markers
1136289|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
1136290|NCT02342223|facial lipoatrophy|facial lipoatrophy
1136291|NCT02342223|facial lipodystrophy|facial lipodystrophy
1136292|NCT02342223|hyaluronic acid|hyaluronic acid
1136293|NCT02342223|dermal filler|dermal filler
1136294|NCT02342223|filler agent|filler agent
1136295|NCT02342210|Mindfulness|mindfulness
1136296|NCT02342210|Group Therapy|group therapy
1136297|NCT02342197|Low responders|low responders
1136298|NCT02342197|Minidose long protocol|minidose long protocol
1136299|NCT02342197|Microdose flare protocol|microdose flare protocol
1136300|NCT02342197|Oocyte yield|oocyte yield
1136301|NCT02342171|Ebola Viral Disease|ebola viral disease
1136302|NCT02342171|Convalescent Plasma|convalescent plasma
1136303|NCT02342171|Developing Countries|developing countries
1136304|NCT02342145|beta-Thalassemia major|beta-thalassemia major
1136305|NCT02342119|kidney transplantation|kidney transplantation
1136306|NCT02342119|race disparities|race disparities
1136307|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
1136308|NCT02342119|transplant evaluation|transplant evaluation
1136309|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1136310|NCT02342093|Drospirenone|drospirenone
1136311|NCT02342093|Oral contraceptive|oral contraceptive
1136312|NCT02342080|Rehabilitation|rehabilitation
1136313|NCT02342080|Walking|walking
1136314|NCT02342080|Robotics|robotics
1136315|NCT02342080|Neuronal Plasticity|neuronal plasticity
1136316|NCT02342054|Cancer|cancer
1136317|NCT02342054|Prostate Cancer|prostate cancer
1136318|NCT02342054|Brachytherapy|brachytherapy
1136319|NCT02342054|Dose escalation|dose escalation
1136320|NCT02342054|High Dose Rate|high dose rate
1136321|NCT02342054|MRI-TRUS fusion|mri-trus fusion
1136322|NCT02342054|Detection of DILs by MRI|detection of dils by mri
1136323|NCT02342054|SINGLE FRACTION|single fraction
1136324|NCT02342041|SUVN-G3031|suvn-g3031
1136325|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
1136326|NCT02342041|first in human|first in human
1136327|NCT02342041|safety|safety
1136328|NCT02342041|pharmacokinetics|pharmacokinetics
1136329|NCT02342041|tolerability|tolerability
1136330|NCT02342041|single dose|single dose
1136331|NCT02342041|repeat dose|repeat dose
1136332|NCT02342028|sleep apnea|sleep apnea
1136333|NCT02342028|intermittent hypoxia|intermittent hypoxia
1136334|NCT02342028|regulatory T cell|regulatory t cell
1136335|NCT02342028|autoimmunity|autoimmunity
1136336|NCT02342002|mifepristone|mifepristone
1136337|NCT02342002|misoprostol|misoprostol
1136338|NCT02342002|obstetrics|obstetrics
1136339|NCT02342002|reproductive health|reproductive health
1136340|NCT02342002|pregnancy|pregnancy
1136341|NCT02342002|abortion|abortion
1136342|NCT02342002|missed abortion|missed abortion
1136343|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
1136344|NCT02341989|Recurrence|recurrence
1136345|NCT02341989|Carboplatin|carboplatin
1136346|NCT02341989|Bleomycin|bleomycin
1136347|NCT02341989|Etoposide|etoposide
1136348|NCT02341989|Cisplatin|cisplatin
1136349|NCT02341976|whole body vibration|whole body vibration
1136350|NCT02341976|pelvic floor muscle|pelvic floor muscle
1136351|NCT02341976|urinary incontinence|urinary incontinence
1136352|NCT02341976|Urinary sphincter|urinary sphincter
1136353|NCT02341950|videogame|videogame
1136354|NCT02341950|health|health
1136355|NCT02341950|behavior|behavior
1136356|NCT02341950|mobile|mobile
1136357|NCT02341950|spinal|spinal
1136358|NCT02341950|cord|cord
1136359|NCT02341950|dysfunction|dysfunction
1136360|NCT02341911|triple negative breast cancer|triple negative breast cancer
1136361|NCT02341911|fine line chemotherapy|fine line chemotherapy
1136362|NCT02341898|nursing home care|nursing home care
1136363|NCT02341898|physical restraints|physical restraints
1136364|NCT02341898|dementia|dementia
1136365|NCT02341898|implementation research|implementation research
1136366|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
1136367|NCT02341885|Kidney|kidney
1136368|NCT02341885|Renal replacement|renal replacement
1136369|NCT02341885|Acute kidney injury|acute kidney injury
1136370|NCT02341885|chronic kidney disease|chronic kidney disease
1136371|NCT02341885|Epidemiology|epidemiology
1136372|NCT02341885|Prevalence|prevalence
1136373|NCT02341872|White spot lesions|white spot lesions
1136374|NCT02341872|remineralization|remineralization
1136375|NCT02341872|QLF|qlf
1136376|NCT02341872|antibacterial|antibacterial
1136377|NCT02341846|cancer pain|cancer pain
1136378|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
1136379|NCT02341833|Sevoflurane|sevoflurane
1136380|NCT02341833|Liver transplantation|liver transplantation
1136381|NCT02341833|brain-death donors|brain-death donors
1136382|NCT02341820|breast cancer|breast cancer
1136383|NCT02341820|breast conserving surgery|breast conserving surgery
1136384|NCT02341820|cosmesis|cosmesis
1136385|NCT02341807|Choroideremia|choroideremia
1136386|NCT02341807|AAV|aav
1136387|NCT02341807|Gene therapy|gene therapy
1136389|NCT02341807|Adeno-associated virus|adeno-associated virus
1136390|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
1136391|NCT02341794|intracranial arterial disease|intracranial arterial disease
1136392|NCT02341794|dyslipidemia|dyslipidemia
1136393|NCT02341794|rosuvastatin|rosuvastatin
1136394|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
1136395|NCT02341781|Multicenter|multicenter
1136396|NCT02341781|Observational|observational
1136397|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
1136398|NCT02341781|Relapsed or progressed|relapsed or progressed
1136399|NCT02341781|Ibrutinib|ibrutinib
1136400|NCT02341768|clinical and device functional information|clinical and device functional information
1136401|NCT02341768|"real world ICD patient population"|"real world icd patient population"
1136402|NCT02341742|Physical activity|physical activity
1136403|NCT02341742|Bone health|bone health
1136404|NCT02341742|Pediatrics|pediatrics
1136405|NCT02341742|Bone|bone
1136406|NCT02341729|semi-urgent CABG|semi-urgent cabg
1136407|NCT02341729|reanimation|reanimation
1136408|NCT02341729|ticagrelor|ticagrelor
1136409|NCT02341729|crushed tablet|crushed tablet
1136410|NCT02341716|intermittent claudication|intermittent claudication
1136411|NCT02341716|exercise therapy|exercise therapy
1136412|NCT02341716|physiotherapy|physiotherapy
1136413|NCT02341690|Type 2 diabetes|type 2 diabetes
1136414|NCT02341690|Interval Walking Training|interval walking training
1136415|NCT02341690|Motivation|motivation
1136416|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
1136417|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1136418|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
1136419|NCT02341677|Ultrasonography|ultrasonography
1136420|NCT02341677|Biopsy|biopsy
1136421|NCT02341677|Image Fusion|image fusion
1136422|NCT02341664|Mobile Tablet Device|mobile tablet device
1136423|NCT02341664|Outpatient Clinic|outpatient clinic
1136424|NCT02341664|Tobacco|tobacco
1136425|NCT02341664|Health|health
1136426|NCT02341664|Barriers|barriers
1136427|NCT02341664|Prevention|prevention
1136428|NCT02341664|Prescribing Practices|prescribing practices
1136429|NCT02341664|Informed Consent|informed consent
1136430|NCT02341664|Statin|statin
1136431|NCT02341664|Lipid Panel|lipid panel
1136432|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
1136433|NCT02341664|Blood Draw|blood draw
1136434|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
1136435|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
1136436|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
1136437|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
1136438|NCT02341664|Cholesterol Management|cholesterol management
1136439|NCT02341664|Cardiovascular Risk|cardiovascular risk
1136440|NCT02341664|10-year CVD Risk|10-year cvd risk
1136441|NCT02341664|Labs|labs
1136442|NCT02341664|Coronary revascularization|coronary revascularization
1136443|NCT02341664|Arterial revascularization|arterial revascularization
1136444|NCT02341664|Imaging|imaging
1136445|NCT02341651|High blood pressure|high blood pressure
1136446|NCT02341651|Cardiovascular diseases|cardiovascular diseases
1136447|NCT02341651|Antihypertensive agents|antihypertensive agents
1136448|NCT02341651|Pharmacological treatment|pharmacological treatment
1136449|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
1136450|NCT02341651|Community health care workers|community health care workers
1136451|NCT02341651|Treatment algorithm|treatment algorithm
1136452|NCT02341651|Public and private healthcare providers|public and private healthcare providers
1136453|NCT02341651|Strategy|strategy
1136454|NCT02341651|Referral loops|referral loops
1136455|NCT02341651|Intervention|intervention
1136456|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
1136457|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
1136458|NCT02341612|cryotherapy|cryotherapy
1136459|NCT02341612|recovery of function|recovery of function
1136460|NCT02341612|rehabilitation|rehabilitation
1136461|NCT02341586|Malaria|malaria
1136462|NCT02341586|Cambodia|cambodia
1136463|NCT02341586|Iron|iron
1136464|NCT02341586|Childbearing Age|childbearing age
1136465|NCT02341586|Women|women
1136466|NCT02341586|Home Fortification|home fortification
1136467|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
1136468|NCT02341573|Randomized Controlled Trial|randomized controlled trial
1136469|NCT02341560|NAION|naion
1136470|NCT02341495|Azacitidine|azacitidine
1136471|NCT02341495|Vidaza|vidaza
1136472|NCT02341495|Deferasirox|deferasirox
1136473|NCT02341495|Exjade|exjade
1136474|NCT02341495|Cholecalciferol|cholecalciferol
1136475|NCT02341495|Vitamin D|vitamin d
1136476|NCT02341482|Itraconazole|itraconazole
1136477|NCT02341482|Healthy Volunteers|healthy volunteers
1136478|NCT02341482|Drug-drug interaction|drug-drug interaction
1136479|NCT02341482|PF-04958242|pf-04958242
1136480|NCT02341469|Burkina Faso|burkina faso
1136481|NCT02341469|cluster randomised|cluster randomised
1136482|NCT02341469|stepped-wedge|stepped-wedge
1136483|NCT02341469|IMCI|imci
1136484|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
1136485|NCT02341443|rigid fixation|rigid fixation
1136486|NCT02341443|no-rigid fixation|no-rigid fixation
1136487|NCT02341443|jaw|jaw
1136488|NCT02341430|hernia|hernia
1136489|NCT02341430|synthetic mesh|synthetic mesh
1136490|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
1136491|NCT02341391|chondrocyte cells|chondrocyte cells
1136492|NCT02341391|Osteoarthritis|osteoarthritis
1136493|NCT02341391|gene therapy|gene therapy
1136494|NCT02341378|chondrocyte cells|chondrocyte cells
1136495|NCT02341378|Osteoarthritis|osteoarthritis
1136496|NCT02341378|gene therapy|gene therapy
1136497|NCT02341365|Egg donation|egg donation
1136498|NCT02341365|vitaminD|vitamind
1136499|NCT02341365|ovarian reserve|ovarian reserve
1136500|NCT02341365|ovarian stimulation|ovarian stimulation
1136501|NCT02341326|Lung|lung
1136502|NCT02341326|COPD|copd
1136503|NCT02341326|smoking|smoking
1136504|NCT02341326|Non-smoker|non-smoker
1136505|NCT02341313|Hypoglycaemia|hypoglycaemia
1136506|NCT02341300|Pregnancy|pregnancy
1136507|NCT02341300|Cast-Iron pots|cast-iron pots
1136508|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
1136509|NCT02341274|Tacrolimus|tacrolimus
1136510|NCT02341274|Drug Formulation|drug formulation
1136511|NCT02341274|Absorption|absorption
1136512|NCT02341274|Bioavailability|bioavailability
1136513|NCT02341274|Healthy Volunteer|healthy volunteer
1136514|NCT02341248|Enteral Nutrition|enteral nutrition
1136515|NCT02341248|Pediatrics|pediatrics
1136516|NCT02341248|Microbiota|microbiota
1136517|NCT02341248|Metabolomics|metabolomics
1136518|NCT02341235|video game|video game
1136519|NCT02341235|narrative|narrative
1136521|NCT02341235|survivorship|survivorship
1136522|NCT02341235|cancer survivor|cancer survivor
1136523|NCT02341235|mhealth|mhealth
1136524|NCT02341235|physical activity|physical activity
1136525|NCT02341235|women|women
1136526|NCT02341235|women's health|women's health
1136527|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
1136528|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
1136529|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
1136530|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
1136531|NCT02341209|CTCL|ctcl
1136532|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
1136533|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
1136534|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1136535|NCT02341209|MF|mf
1136536|NCT02341209|SS|ss
1136537|NCT02341131|Schizophrenia|schizophrenia
1136538|NCT02341131|Cognitive Remediation|cognitive remediation
1136539|NCT02341131|BDNF|bdnf
1136540|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
1136541|NCT02341092|Traumatic brain injury|traumatic brain injury
1136542|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
1136543|NCT02341079|Osteoarthritis|osteoarthritis
1136544|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
1136545|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
1136546|NCT02341066|Cardiovascular risk score|cardiovascular risk score
1136547|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
1136548|NCT02341066|Endothelial dysfunction|endothelial dysfunction
1136549|NCT02341066|EndoPAT|endopat
1136550|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
1136551|NCT02341053|SMA|sma
1136552|NCT02341053|Neuromuscular disability|neuromuscular disability
1136553|NCT02341040|wheat allergy|wheat allergy
1136554|NCT02341040|food allergy|food allergy
1136555|NCT02341040|pediatric|pediatric
1136556|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
1136557|NCT02341027|Contraceptive implants|contraceptive implants
1136558|NCT02341027|Breastfeeding|breastfeeding
1136559|NCT02341027|Jadelle|jadelle
1136560|NCT02341027|Lactation|lactation
1136561|NCT02341027|Levonorgestrel|levonorgestrel
1136562|NCT02341014|Carfilzomib|carfilzomib
1136563|NCT02341014|Romidepsin|romidepsin
1136564|NCT02341014|Lenalidomide|lenalidomide
1136565|NCT02341014|Lymphomas|lymphomas
1136566|NCT02341014|14-179|14-179
1136567|NCT02341001|Bariatric surgery|bariatric surgery
1136568|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
1136569|NCT02341001|Text messaging|text messaging
1136570|NCT02341001|Weight loss|weight loss
1136571|NCT02341001|BAROS|baros
1136572|NCT02341001|Follow-up care|follow-up care
1136573|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
1136574|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1136575|NCT02340975|Immunotherapy|immunotherapy
1136576|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
1136577|NCT02340975|Tremelimumab|tremelimumab
1136578|NCT02340975|MEDI4736|medi4736
1136580|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1136581|NCT02340923|EIM|eim
1136582|NCT02340910|spasticity|spasticity
1136583|NCT02340910|whole body vibration|whole body vibration
1136584|NCT02340910|walking|walking
1136585|NCT02340871|Neurogenetics|neurogenetics
1136586|NCT02340871|genetic testing|genetic testing
1136587|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
1136588|NCT02340845|Treatments|treatments
1136589|NCT02340806|epidural bolus|epidural bolus
1136590|NCT02340806|pain management|pain management
1136591|NCT02340806|labor analgesia|labor analgesia
1136592|NCT02340793|Weight loss|weight loss
1136593|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
1136594|NCT02340754|mindfulness|mindfulness
1136595|NCT02340754|meditation|meditation
1136596|NCT02340754|stress, psychological|stress, psychological
1136597|NCT02340754|quality of life|quality of life
1136598|NCT02340754|randomized controlled trial|randomized controlled trial
1136599|NCT02340741|carbon dioxide|carbon dioxide
1136600|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
1136601|NCT02340741|air embolism|air embolism
1136602|NCT02340728|Stent Placement|stent placement
1136603|NCT02340728|Biliary Obstruction|biliary obstruction
1136604|NCT02340728|14-260|14-260
1136605|NCT02340715|Anal canal|anal canal
1136606|NCT02340715|Brain|brain
1136607|NCT02340715|Breast|breast
1136608|NCT02340715|Cervix|cervix
1136609|NCT02340715|Esophagus|esophagus
1136610|NCT02340715|Gynecology|gynecology
1136611|NCT02340715|Head and Neck|head and neck
1136612|NCT02340715|Lung|lung
1136613|NCT02340715|Pancreas|pancreas
1136614|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
1136615|NCT02340715|Prostate cancer|prostate cancer
1136616|NCT02340715|Sarcoma|sarcoma
1136617|NCT02340702|COPD and heart failure|copd and heart failure
1136618|NCT02340689|PH|ph
1195045|NCT02055326|men|men
1136619|NCT02340689|PH type 1|ph type 1
1136620|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
1136621|NCT02340689|Hyperoxaluria|hyperoxaluria
1136622|NCT02340689|Primary Oxalosis|primary oxalosis
1136623|NCT02340689|PH type 2|ph type 2
1136624|NCT02340689|PH type 3|ph type 3
1136625|NCT02340689|Genetic testing for PH|genetic testing for ph
1136626|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
1136627|NCT02340689|Hereditary study for PH|hereditary study for ph
1136628|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
1136629|NCT02340689|AGXT|agxt
1136630|NCT02340689|GRHPR|grhpr
1136631|NCT02340689|HOGA1|hoga1
1136632|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
1136633|NCT02340663|dental orthotic|dental orthotic
1136634|NCT02340663|bite splint|bite splint
1136635|NCT02340663|oral parafunction|oral parafunction
1136636|NCT02340663|clenching|clenching
1136637|NCT02340663|grinding|grinding
1136638|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
1136765|NCT02339714|moxibustion|moxibustion
1136639|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
1136640|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
1136641|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
1136642|NCT02340572|Healthy Subjects|healthy subjects
1136643|NCT02340559|meta-cognition|meta-cognition
1136644|NCT02340559|positive symptoms|positive symptoms
1136645|NCT02340559|early phases|early phases
1136646|NCT02340559|schizophrenia|schizophrenia
1136647|NCT02340533|adenomyosis|adenomyosis
1136648|NCT02340481|Diarrhea|diarrhea
1136649|NCT02340481|Flatulence|flatulence
1136650|NCT02340481|Abdominal discomfort|abdominal discomfort
1136651|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
1136652|NCT02340481|Simethicone|simethicone
1136653|NCT02340481|Placebo|placebo
1136654|NCT02340442|arteriovenous ratio|arteriovenous ratio
1136655|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
1136656|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
1136657|NCT02340416|orthopedic surgeries|orthopedic surgeries
1136658|NCT02340416|general anesthesia|general anesthesia
1136659|NCT02340403|Neuropathy|neuropathy
1136660|NCT02340403|Oxaliplatin|oxaliplatin
1136661|NCT02340403|Insula|insula
1136662|NCT02340403|choline|choline
1136663|NCT02340390|G7 Acetabular System|g7 acetabular system
1136664|NCT02340377|core body temperature|core body temperature
1136665|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
1136666|NCT02340377|rectal body temperature|rectal body temperature
1136667|NCT02340364|Hospital Readmissions|hospital readmissions
1136668|NCT02340364|Patient Navigation|patient navigation
1136669|NCT02340351|acupuncture|acupuncture
1136670|NCT02340351|auricular acupuncture|auricular acupuncture
1136671|NCT02340351|NADA|nada
1136672|NCT02340351|anxiety|anxiety
1136673|NCT02340351|depression|depression
1136674|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
1136675|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
1136676|NCT02340299|Airway Extubation|airway extubation
1136677|NCT02340299|Prematurity|prematurity
1136678|NCT02340273|tendinopathy|tendinopathy
1136679|NCT02340273|ultrasound|ultrasound
1136681|NCT02340273|heat|heat
1136682|NCT02340273|strength|strength
1136683|NCT02340273|LITUS|litus
1136684|NCT02340273|long duration|long duration
1136685|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
1136686|NCT02340273|tendonopathy|tendonopathy
1136687|NCT02340260|Exercise|exercise
1136688|NCT02340260|Risk factors|risk factors
1136689|NCT02340260|Exercise therapy|exercise therapy
1136690|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1136691|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
1136692|NCT02340208|Neoplasms|neoplasms
1136693|NCT02340208|Immunoconjugate|immunoconjugate
1136694|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
1136695|NCT02340195|Kidney impairment|kidney impairment
1136696|NCT02340182|gut flora|gut flora
1136697|NCT02340182|antibiotics|antibiotics
1136698|NCT02340182|systemic immune response|systemic immune response
1136699|NCT02340182|Volunteers|volunteers
1136700|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
1136701|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
1136702|NCT02340065|colonoscopy|colonoscopy
1136703|NCT02340065|adenoma detection rate|adenoma detection rate
1136704|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
1136705|NCT02340052|postoperative pain treatment|postoperative pain treatment
1136706|NCT02340039|Polyphenol|polyphenol
1136707|NCT02340039|Fruit|fruit
1136708|NCT02340039|Metabolic|metabolic
1136709|NCT02340026|Delay in motor skill development|delay in motor skill development
1136710|NCT02340000|acute sinusitis|acute sinusitis
1136711|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
1136712|NCT02340000|adults|adults
1136713|NCT02340000|outcomes|outcomes
1136714|NCT02339961|Systemic Sclerosis|systemic sclerosis
1136715|NCT02339961|Pulmonary hypertension|pulmonary hypertension
1136716|NCT02339961|Lung Doppler Signals|lung doppler signals
1136717|NCT02339948|Locally confined|locally confined
1136718|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
1136719|NCT02339935|Autism|autism
1136720|NCT02339909|Screening|screening
1136721|NCT02339909|Incentives|incentives
1136722|NCT02339896|rabies|rabies
1136723|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
1136724|NCT02339896|SPEEDA|speeda
1136725|NCT02339883|Physiological Measures|physiological measures
1136726|NCT02339883|MRI|mri
1136727|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1136728|NCT02339883|Cognitive Testing|cognitive testing
1136729|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
1136730|NCT02339857|saphenous vein|saphenous vein
1136731|NCT02339857|grafts|grafts
1136732|NCT02339844|glutamate|glutamate
1136733|NCT02339844|dopamine|dopamine
1136734|NCT02339844|cognition|cognition
1136735|NCT02339844|cortical thickness|cortical thickness
1136736|NCT02339844|ppi|ppi
1136737|NCT02339844|p50|p50
1136738|NCT02339831|Knee|knee
1136739|NCT02339831|Arthroplasty|arthroplasty
1136740|NCT02339831|CPM|cpm
1136741|NCT02339831|Camoped|camoped
1136742|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
1136743|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
1136744|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
1136745|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
1136746|NCT02339792|DRUG INTERACTIONS|drug interactions
1136747|NCT02339792|E-LEARNING|e-learning
1136748|NCT02339779|fat grafting|fat grafting
1136749|NCT02339779|fat injection|fat injection
1136750|NCT02339779|lipoaspirate|lipoaspirate
1136751|NCT02339779|fat transfer|fat transfer
1136752|NCT02339779|lipofilling|lipofilling
1136753|NCT02339779|liposculpturing|liposculpturing
1136754|NCT02339779|lipoinjection|lipoinjection
1136755|NCT02339779|lipotransfer|lipotransfer
1136756|NCT02339779|breast reconstruction|breast reconstruction
1136757|NCT02339766|Cesarean|cesarean
1136758|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
1136759|NCT02339766|Analgesia|analgesia
1136760|NCT02339766|Ultrasonography|ultrasonography
1136761|NCT02339727|Omega-3|omega-3
1136762|NCT02339727|Omega-6|omega-6
1136763|NCT02339714|allergic rhinitis|allergic rhinitis
1136764|NCT02339714|acupuncture|acupuncture
1136766|NCT02339714|efficacy|efficacy
1136767|NCT02339714|safety|safety
1136768|NCT02339649|sepsis|sepsis
1136769|NCT02339649|septic shock|septic shock
1136770|NCT02339649|ICU|icu
1136771|NCT02339649|long-term outcome|long-term outcome
1136772|NCT02339649|neurocognitive|neurocognitive
1136773|NCT02339649|inflammatory|inflammatory
1136774|NCT02339649|MRI|mri
1136775|NCT02339649|EEG|eeg
1136776|NCT02339649|brain imaging|brain imaging
1136777|NCT02339649|serum biomarkers|serum biomarkers
1136778|NCT02339649|CSF|csf
1136779|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
1136780|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
1136781|NCT02339610|Osteoarthritis|osteoarthritis
1136782|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
1136783|NCT02339584|OAG|oag
1136784|NCT02339584|OHT|oht
1136785|NCT02339532|HER2-positive|her2-positive
1136786|NCT02339532|non-metastatic|non-metastatic
1136787|NCT02339532|TOP2A|top2a
1136788|NCT02339519|Laryngeal Masks|laryngeal masks
1136789|NCT02339506|stress|stress
1136790|NCT02339506|ACTH|acth
1136791|NCT02339506|cosyntropin|cosyntropin
1136792|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
1136793|NCT02339506|cardiovagal|cardiovagal
1136794|NCT02339480|Massage therapy|massage therapy
1136795|NCT02339480|Simple obesity|simple obesity
1136796|NCT02339480|Energy metabolism|energy metabolism
1136797|NCT02339480|Mechanism|mechanism
1136798|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
1136799|NCT02339467|Older adult|older adult
1136800|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
1136801|NCT02339454|stable angina|stable angina
1136802|NCT02339454|exercise tolerance|exercise tolerance
1136803|NCT02339441|Systemic sclerosis|systemic sclerosis
1136804|NCT02339428|Colonoscopy|colonoscopy
1136805|NCT02339428|diagnostic|diagnostic
1136806|NCT02339428|diclophenac|diclophenac
1136807|NCT02339428|randomized controlled trial|randomized controlled trial
1136808|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
1136809|NCT02339363|mindfulness|mindfulness
1136810|NCT02339363|adolescents|adolescents
1136811|NCT02339363|working memory|working memory
1136812|NCT02339363|stress|stress
1136813|NCT02339363|anxiety|anxiety
1136814|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
1195281|NCT02054364|FBT|fbt
1136815|NCT02339298|Music Therapy|music therapy
1136816|NCT02339285|tACS|tacs
1136817|NCT02339285|Major Depressive Disorder|major depressive disorder
1136818|NCT02339285|MDD|mdd
1136819|NCT02339285|mood symptoms|mood symptoms
1136820|NCT02339285|sham|sham
1136821|NCT02339272|meiosis|meiosis
1136822|NCT02339272|synapsis|synapsis
1136823|NCT02339272|recombination|recombination
1136824|NCT02339272|sperm aneuploidy|sperm aneuploidy
1136825|NCT02339259|Rickettsial disease|rickettsial disease
1136826|NCT02339259|Febrile|febrile
1136827|NCT02339259|Murine typhus|murine typhus
1136828|NCT02339259|Scrub typhus|scrub typhus
1136829|NCT02339259|Diagnostic test|diagnostic test
1136830|NCT02339259|Clinical features|clinical features
1136831|NCT02339233|Epidural Stimulation|epidural stimulation
1136832|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
1136833|NCT02339220|Physical Therapy|physical therapy
1136834|NCT02339220|Rehabilitation|rehabilitation
1136835|NCT02339220|Occupational Therapy|occupational therapy
1136836|NCT02339220|Fitness Training|fitness training
1136837|NCT02339220|Recovery of Function|recovery of function
1136838|NCT02339220|Neuroplasticity|neuroplasticity
1136839|NCT02339220|Exercise Therapy|exercise therapy
1136840|NCT02339220|Brain Injuries|brain injuries
1136841|NCT02339220|Traumatic Brain Injury|traumatic brain injury
1136842|NCT02339220|Physical Therapy Modalities|physical therapy modalities
1136843|NCT02339220|Neuroimaging|neuroimaging
1136844|NCT02339194|complete denture|complete denture
1136845|NCT02339194|quality of life|quality of life
1136846|NCT02339194|patient satisfaction|patient satisfaction
1136847|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
1136849|NCT02339155|Immunogenicity|immunogenicity
1136850|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
1136851|NCT02339103|accidental hypothermia|accidental hypothermia
1136852|NCT02339103|rewarming|rewarming
1136853|NCT02339090|VRS-317|vrs-317
1136854|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
1136855|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
1136856|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
1136857|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
1136858|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
1136859|NCT02339090|Versartis|versartis
1136860|NCT02339090|Xten|xten
1136861|NCT02339090|Human Growth Hormone|human growth hormone
1136862|NCT02339090|somavaratan|somavaratan
1136863|NCT02339090|growth failure|growth failure
1136864|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
1136865|NCT02339064|Parkinson's disease,|parkinson's disease,
1136866|NCT02339064|apomorphine|apomorphine
1136867|NCT02339064|Apokyn|apokyn
1136868|NCT02339064|dopamine agonist|dopamine agonist
1136869|NCT02339064|levodopa|levodopa
1136870|NCT02339064|advanced|advanced
1136871|NCT02339064|PD|pd
1136872|NCT02339064|carbidopa|carbidopa
1136873|NCT02339064|pramipexole|pramipexole
1136874|NCT02339064|ropinirole|ropinirole
1136875|NCT02339064|rotigotine|rotigotine
1136876|NCT02339064|MAO-B inhibitors|mao-b inhibitors
1136877|NCT02339064|COMT inhibitors|comt inhibitors
1136878|NCT02339064|off|off
1136879|NCT02339064|dyskinesia|dyskinesia
1136880|NCT02339051|Basic Science|basic science
1136881|NCT02339038|Community Based Research|community based research
1136882|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
1136883|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
1136884|NCT02339038|Fixed Dose Combination|fixed dose combination
1136885|NCT02339038|Sustained Viral Response|sustained viral response
1136886|NCT02339025|Cohort|cohort
1136887|NCT02339025|Participation|participation
1136888|NCT02339025|Biobank|biobank
1136889|NCT02339012|Genome Wide Association|genome wide association
1136890|NCT02339012|Biomarkers|biomarkers
1136891|NCT02339012|Methylation|methylation
1136892|NCT02339012|Phenotype|phenotype
1136893|NCT02339012|Cytometry|cytometry
1136894|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
1136895|NCT02338999|Arteriosclerosis|arteriosclerosis
1136896|NCT02338999|Adult|adult
1136897|NCT02338986|High Titer Antibodies|high titer antibodies
1136898|NCT02338986|Convalescent Volunteers|convalescent volunteers
1136899|NCT02338986|Apheresis|apheresis
1136900|NCT02338986|Males|males
1136901|NCT02338986|Quantitative IgG|quantitative igg
1136902|NCT02338973|Macular Edema|macular edema
1136903|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
1136904|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
1136905|NCT02338973|Enhanced S-Cone Syndrom|enhanced s-cone syndrom
1136906|NCT02338973|Interferon Gamma|interferon gamma
1136907|NCT02338960|HSDD Female|hsdd female
1136908|NCT02338960|Sexual Desire Disorder|sexual desire disorder
1136909|NCT02338960|decreased desire|decreased desire
1136910|NCT02338960|female sexual dysfunction|female sexual dysfunction
1136911|NCT02338947|Frailty|frailty
1136912|NCT02338947|Cardiopulmonary Bypass|cardiopulmonary bypass
1136913|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
1136914|NCT02338947|Mortality|mortality
1136915|NCT02338947|Morbidity|morbidity
1136916|NCT02338921|triple combination therapy|triple combination therapy
1136917|NCT02338921|sitagliptin|sitagliptin
1136918|NCT02338921|dapagliflozin|dapagliflozin
1136919|NCT02338921|lobeglitazone|lobeglitazone
1136920|NCT02338908|dry needling|dry needling
1136921|NCT02338908|trigger point|trigger point
1136922|NCT02338908|eccentric exercise|eccentric exercise
1136923|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
1136924|NCT02338882|Lenses|lenses
1136925|NCT02338882|Intraocular|intraocular
1136926|NCT02338856|Obesity|obesity
1136927|NCT02338830|Twins|twins
1136928|NCT02338830|Preterm labor|preterm labor
1136929|NCT02338830|Progesterone|progesterone
1136930|NCT02338830|Short cervix|short cervix
1136931|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
1136932|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
1136933|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
1136934|NCT02338739|Retention|retention
1136935|NCT02338739|Lost to follow up|lost to follow up
1136936|NCT02338739|Adaptive strategies|adaptive strategies
1136937|NCT02338739|Dynamic regime|dynamic regime
1136938|NCT02338739|Sequentially randomized trial|sequentially randomized trial
1136939|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
1136940|NCT02338739|Engagement in care|engagement in care
1136941|NCT02338739|Kenya|kenya
1136942|NCT02338726|urinary incontinence|urinary incontinence
1136943|NCT02338726|pelvic floor|pelvic floor
1136944|NCT02338726|quality of life|quality of life
1136945|NCT02338726|elderly women|elderly women
1136946|NCT02338713|Drug therapy|drug therapy
1136947|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
1136948|NCT02338687|Calcium|calcium
1136949|NCT02338687|Dietary supplements|dietary supplements
1136950|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
1136951|NCT02338687|Pre-Eclampsia|pre-eclampsia
1136952|NCT02338687|Nutritional education|nutritional education
1136953|NCT02338687|Diet therapy|diet therapy
1136954|NCT02338687|Diet records|diet records
1136955|NCT02338687|Hospitalization|hospitalization
1136956|NCT02338687|Maternal mortality|maternal mortality
1136957|NCT02338635|ER stress|er stress
1136958|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
1136959|NCT02338622|olaparib|olaparib
1136960|NCT02338622|AZD5363|azd5363
1136961|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
1136962|NCT02338622|advanced solid tumours|advanced solid tumours
1136963|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
1136964|NCT02338609|height,|height,
1136965|NCT02338609|weight,|weight,
1136966|NCT02338609|Tanner Stage,|tanner stage,
1136967|NCT02338609|growth development,|growth development,
1136968|NCT02338609|everolimus,|everolimus,
1136969|NCT02338609|RAD001|rad001
1136970|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
1136971|NCT02338518|gastric cancer|gastric cancer
1136972|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1136973|NCT02338518|efficacy|efficacy
1136974|NCT02338518|safety|safety
1136975|NCT02338505|Robotic Surgery|robotic surgery
1136976|NCT02338505|Telelap-ALFX|telelap-alfx
1136977|NCT02338505|Gynecological disease|gynecological disease
1136978|NCT02338453|Social Anxiety|social anxiety
1136979|NCT02338453|Attention Modification|attention modification
1136980|NCT02338453|Dot-Probe|dot-probe
1136981|NCT02338453|GCBT|gcbt
1136982|NCT02338362|Corticosteroids|corticosteroids
1136983|NCT02338362|Bronchodilator Agents|bronchodilator agents
1136984|NCT02338362|Intraocular Pressure|intraocular pressure
1136985|NCT02338323|Hyperuricemia|hyperuricemia
1136986|NCT02338323|Renal Function|renal function
1136987|NCT02338323|Chronic kidney disease|chronic kidney disease
1136988|NCT02338323|Febuxostat|febuxostat
1136989|NCT02338323|Benzbromarone|benzbromarone
1136990|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
1136991|NCT02338297|Arterioportal shunts|arterioportal shunts
1136992|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
1136993|NCT02338297|Ethanol|ethanol
1136994|NCT02338297|Gelfoam|gelfoam
1136995|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
1136996|NCT02338284|increased intracranial pressure|increased intracranial pressure
1136997|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
1136998|NCT02338271|Low back pain|low back pain
1136999|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
1137000|NCT02338271|Hyaluronic acid|hyaluronic acid
1137001|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
1137002|NCT02338206|infertility|infertility
1137003|NCT02338193|GDM|gdm
1137004|NCT02338193|T2DM|t2dm
1137005|NCT02338193|prediabetes|prediabetes
1137006|NCT02338180|dental caries|dental caries
1137007|NCT02338180|risk assessment|risk assessment
1137008|NCT02338180|approximal sealant|approximal sealant
1137009|NCT02338180|permanent molar|permanent molar
1137010|NCT02338180|preventive dentistry|preventive dentistry
1137011|NCT02338180|adolescent|adolescent
1137012|NCT02338154|Aortic Valve Replacement|aortic valve replacement
1137013|NCT02338154|Aortic Stenosis|aortic stenosis
1137014|NCT02338154|EDWARDS INTUITY|edwards intuity
1137015|NCT02338141|cervical cancer|cervical cancer
1137016|NCT02338141|colposcopy|colposcopy
1137017|NCT02338141|human papillomavirus|human papillomavirus
1137018|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
1137019|NCT02338128|peritoneal dialysis|peritoneal dialysis
1137020|NCT02338128|hyperuricemia|hyperuricemia
1137021|NCT02338128|cardiovascular|cardiovascular
1137022|NCT02338128|Febuxostat|febuxostat
1137023|NCT02338089|Uterine contraction|uterine contraction
1137024|NCT02338089|Oxytocin desensitization|oxytocin desensitization
1137025|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
1137026|NCT02338063|Emotion Regulation|emotion regulation
1137027|NCT02338063|Health Promotion|health promotion
1137028|NCT02338063|Intervention|intervention
1137029|NCT02338063|Mental Health|mental health
1137030|NCT02338050|ALL|all
1137031|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
1137032|NCT02338050|Moxe|moxe
1137033|NCT02338050|CAT-8015, HA22|cat-8015, ha22
1137034|NCT02338024|Enrollment in HIV care|enrollment in hiv care
1137035|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
1137036|NCT02338024|specialized health care clinics|specialized health care clinics
1137037|NCT02338024|Ukraine|ukraine
1137038|NCT02337998|Neurology|neurology
1137039|NCT02337998|Sports Medicine|sports medicine
1137040|NCT02337972|diabetic macular edema|diabetic macular edema
1137041|NCT02337972|Intravitreal injection|intravitreal injection
1137042|NCT02337972|conjunctival flora|conjunctival flora
1137043|NCT02337959|Healthy Volunteers|healthy volunteers
1137044|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
1137045|NCT02337933|Metabolic Syndrome|metabolic syndrome
1137046|NCT02337933|Central Obesity|central obesity
1137047|NCT02337933|Insulin Sensitivity|insulin sensitivity
1137048|NCT02337933|Ursolic Acid|ursolic acid
1137049|NCT02337933|Triterpenoid|triterpenoid
1137050|NCT02337894|Protein kinetics|protein kinetics
1137051|NCT02337894|liver steatosis|liver steatosis
1137052|NCT02337868|dose-ranging,double blind,female,healthy,HydroVax,male,Placebo-Controlled,Vaccine,West Nile Virus|dose-ranging,double blind,female,healthy,hydrovax,male,placebo-controlled,vaccine,west nile virus
1137053|NCT02337855|Intestinal|intestinal
1137054|NCT02337855|Pichia pastoris|pichia pastoris
1137055|NCT02337855|S. mansoni|s. mansoni
1137056|NCT02337855|Schistosomiasis|schistosomiasis
1137057|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
1137058|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
1137059|NCT02337855|vaccine|vaccine
1137060|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
1137061|NCT02337829|CLL|cll
1137062|NCT02337829|SLL|sll
1137063|NCT02337829|Btk|btk
1137064|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1137065|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1137066|NCT02337829|Leukemia|leukemia
1137067|NCT02337829|Lymphoma|lymphoma
1137068|NCT02337829|Lymphocytic|lymphocytic
1137069|NCT02337829|ACP-196|acp-196
1137070|NCT02337829|acalabrutinib|acalabrutinib
1137071|NCT02337816|Endometriosis|endometriosis
1137072|NCT02337816|Metabolomics|metabolomics
1137073|NCT02337803|Physical Activity|physical activity
1137074|NCT02337790|Hypertension|hypertension
1137075|NCT02337790|Heart Failure|heart failure
1137077|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
1137078|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
1137079|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
1137080|NCT02337777|IDEAL|ideal
1137081|NCT02337777|T2* mapping|t2* mapping
1137082|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
1137083|NCT02337777|BOLD|bold
1137084|NCT02337777|phase contrast|phase contrast
1137085|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
1137086|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1137087|NCT02337712|Small cell lung cancer|small cell lung cancer
1137088|NCT02337712|Radiotherapy|radiotherapy
1137089|NCT02337712|Dose fractionation|dose fractionation
1137090|NCT02337686|Keytruda|keytruda
1137091|NCT02337686|pembrolizumab|pembrolizumab
1137092|NCT02337686|immune effector function|immune effector function
1137093|NCT02337686|pembrolizumab monotherapy|pembrolizumab monotherapy
1137094|NCT02337686|ex vivo T-cell-specific cytokines profiling|ex vivo t-cell-specific cytokines profiling
1137095|NCT02337686|immune effector Tcell:Treg ratio|immune effector tcell:treg ratio
1137096|NCT02337686|immunological changes|immunological changes
1137097|NCT02337686|immune response|immune response
1137098|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
1137099|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
1137100|NCT02337673|Splenectomy|splenectomy
1137101|NCT02337673|Gastric surgery|gastric surgery
1137102|NCT02337673|Gastrectomy|gastrectomy
1137103|NCT02337673|Pancreatic surgery|pancreatic surgery
1137104|NCT02337673|Pancreatectomy|pancreatectomy
1137105|NCT02337673|Liver surgery|liver surgery
1137106|NCT02337673|Hemihepatectomy|hemihepatectomy
1137107|NCT02337673|Cholecystectomy|cholecystectomy
1137108|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1137109|NCT02337673|Hypoxemia|hypoxemia
1137110|NCT02337673|Atelectasis|atelectasis
1137111|NCT02337673|Pulmonary obstruction|pulmonary obstruction
1137112|NCT02337673|Pneumonia|pneumonia
1137113|NCT02337673|Pneumothorax|pneumothorax
1137114|NCT02337673|Pleural effusion|pleural effusion
1137115|NCT02337673|Pulmonary edema|pulmonary edema
1137116|NCT02337621|sunken chest|sunken chest
1137117|NCT02337621|caved-in chest|caved-in chest
1137118|NCT02337621|chest deformity|chest deformity
1137119|NCT02337621|sunken sternum|sunken sternum
1137120|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
1137121|NCT02337608|GLPG1205|glpg1205
1137122|NCT02337595|CD45RA-depletion|cd45ra-depletion
1137123|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
1137124|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1137125|NCT02337595|immune reconstitution|immune reconstitution
1137126|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
1137127|NCT02337595|Immunocompromized Host|immunocompromized host
1137128|NCT02337491|Recurrent|recurrent
1137129|NCT02337452|Hereditary cancer-causing mutation|hereditary cancer-causing mutation
1137130|NCT02337452|Gene mutation|gene mutation
1137131|NCT02337452|Family member with genetic mutation|family member with genetic mutation
1137132|NCT02337452|Questionnaire|questionnaire
1137133|NCT02337452|Surveys|surveys
1137134|NCT02337452|Registry|registry
1137135|NCT02337452|Database|database
1137136|NCT02337452|Communication|communication
1137137|NCT02337413|Constipation|constipation
1137138|NCT02337374|Urodynamics|urodynamics
1137139|NCT02337374|Midurethral sling|midurethral sling
1137140|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
1137141|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
1137142|NCT02337361|risky alcohol use|risky alcohol use
1137143|NCT02337361|pregnancy|pregnancy
1137144|NCT02337348|coronary stents|coronary stents
1137145|NCT02337335|Hemodialyisis|hemodialyisis
1137146|NCT02337335|Predictive Model|predictive model
1137148|NCT02337335|patients|patients
1137149|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1137150|NCT02337322|HIV|hiv
1137151|NCT02337322|HIV-1|hiv-1
1137152|NCT02337322|Antiretroviral treatment|antiretroviral treatment
1137153|NCT02337322|HIV Advanced Disease|hiv advanced disease
1137154|NCT02337322|AIDS|aids
1137155|NCT02337322|Dolutegravir|dolutegravir
1137156|NCT02337322|Darunavir|darunavir
1137157|NCT02337296|Motivational Interviewing|motivational interviewing
1137158|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
1137159|NCT02337296|Cancer|cancer
1137160|NCT02337296|Oral Agents|oral agents
1137161|NCT02337296|Adherence|adherence
1137162|NCT02337270|Tuberculosis|tuberculosis
1137163|NCT02337270|Vaccine|vaccine
1137164|NCT02337270|Aerosol|aerosol
1137165|NCT02337270|Adenovirus|adenovirus
1137166|NCT02337270|Immunogenicity|immunogenicity
1137167|NCT02337244|Osteoarthritis|osteoarthritis
1137168|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
1137169|NCT02337244|Traumatic arthritis|traumatic arthritis
1137170|NCT02337244|Polyarthritis|polyarthritis
1137171|NCT02337244|Total knee arthroplasty|total knee arthroplasty
1137172|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
1137173|NCT02337166|alveolar bone loss|alveolar bone loss
1137174|NCT02337166|periodontal attachment loss|periodontal attachment loss
1137175|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
1137177|NCT02337140|complete AV-block|complete av-block
1137178|NCT02337140|HV-interval|hv-interval
1137179|NCT02337140|permanent pacemaker|permanent pacemaker
1137180|NCT02337140|valve implantation|valve implantation
1137181|NCT02337140|severe|severe
1137182|NCT02337140|conduction|conduction
1137183|NCT02337140|disorders|disorders
1137184|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
1137185|NCT02337101|Brain concussion|brain concussion
1137186|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
1137187|NCT02337101|Post-concussion symptoms|post-concussion symptoms
1137188|NCT02337101|Therapy|therapy
1137189|NCT02337101|Randomised controlled trial|randomised controlled trial
1137190|NCT02337101|Cognitive assessment|cognitive assessment
1137191|NCT02337088|delayed cord clamping|delayed cord clamping
1137192|NCT02337075|condition|condition
1137193|NCT02337075|preventing|preventing
1137194|NCT02337075|physical activity|physical activity
1137195|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
1137196|NCT02337036|Liver transplantation|liver transplantation
1137197|NCT02337036|Child|child
1137198|NCT02337036|Tacrolimus|tacrolimus
1137199|NCT02337036|Pharmacokinetic|pharmacokinetic
1137200|NCT02337023|Brain scintigraphy|brain scintigraphy
1137201|NCT02336997|skin regeneration|skin regeneration
1195784|NCT02052037|Egg|egg
1137202|NCT02336997|mechanical stretch|mechanical stretch
1137203|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
1137204|NCT02336958|cervical plexus|cervical plexus
1137205|NCT02336958|regional anesthesia|regional anesthesia
1137206|NCT02336958|ultrasound|ultrasound
1137207|NCT02336958|carotid surgery|carotid surgery
1137208|NCT02336932|vitamin d|vitamin d
1137209|NCT02336932|free hormone|free hormone
1137210|NCT02336932|surgical stress|surgical stress
1137211|NCT02336919|discharge|discharge
1137212|NCT02336919|mHealth|mhealth
1137213|NCT02336919|telehealth|telehealth
1137214|NCT02336919|text messaging|text messaging
1137215|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
1137216|NCT02336906|constipation|constipation
1137217|NCT02336893|Communication Barriers|communication barriers
1137218|NCT02336893|Total Communication Methods|total communication methods
1137219|NCT02336893|Quality Improvement|quality improvement
1137220|NCT02336893|Quality of Health Care|quality of health care
1137221|NCT02336893|Critical Care|critical care
1137222|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
1137223|NCT02336854|pharmacokinetics|pharmacokinetics
1137224|NCT02336841|Guided Self-Help|guided self-help
1137225|NCT02336841|Peer Mentoring|peer mentoring
1137226|NCT02336841|Anorexia Nervosa|anorexia nervosa
1137227|NCT02336841|Eating Disorders|eating disorders
1137228|NCT02336828|MEWS|mews
1137229|NCT02336828|deteriorate|deteriorate
1137230|NCT02336828|oncology|oncology
1137231|NCT02336828|ICU|icu
1137232|NCT02336828|predicting outcomes|predicting outcomes
1137233|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
1137234|NCT02336815|Multiple myeloma|multiple myeloma
1137235|NCT02336815|Karyopharm|karyopharm
1137236|NCT02336815|KPT-330|kpt-330
1137237|NCT02336815|Selinexor|selinexor
1137238|NCT02336815|Refractory|refractory
1137239|NCT02336815|Bortezomib|bortezomib
1137240|NCT02336815|Carfilzomib|carfilzomib
1137241|NCT02336815|Lenalidomide|lenalidomide
1137242|NCT02336815|Pomalidomide|pomalidomide
1137243|NCT02336815|Dexamethasone|dexamethasone
1137244|NCT02336815|STORM|storm
1137245|NCT02336815|Daratumumab|daratumumab
1137246|NCT02336802|Anxiety|anxiety
1137247|NCT02336802|Fear|fear
1137248|NCT02336802|Avoidance|avoidance
1137249|NCT02336776|Chronic Kidney Disease|chronic kidney disease
1137250|NCT02336776|Electrical Stimulation|electrical stimulation
1137251|NCT02336737|breast cancer|breast cancer
1137252|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
1137253|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1137254|NCT02336724|famitinib|famitinib
1137255|NCT02336698|Osteoarthritis|osteoarthritis
1137256|NCT02336698|Pain|pain
1137257|NCT02336698|Fulranumab|fulranumab
1137258|NCT02336698|JNJ-42160443|jnj-42160443
1137259|NCT02336698|Monotherapy|monotherapy
1137260|NCT02336698|Hip|hip
1137261|NCT02336698|Knee|knee
1137262|NCT02336698|Joint replacement surgery|joint replacement surgery
1137263|NCT02336685|Osteoarthritis|osteoarthritis
1137264|NCT02336685|Pain|pain
1137265|NCT02336685|Fulranumab|fulranumab
1137266|NCT02336685|JNJ-42160443|jnj-42160443
1137267|NCT02336685|Adjunctive therapy|adjunctive therapy
1137268|NCT02336685|Opioid|opioid
1137269|NCT02336685|Hip|hip
1137270|NCT02336685|Knee|knee
1137271|NCT02336685|Joint replacement surgery|joint replacement surgery
1137272|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1137273|NCT02336672|Cryothermoablation|cryothermoablation
1137274|NCT02336633|Huntington disease|huntington disease
1137275|NCT02336633|Neurodegenerative disease|neurodegenerative disease
1137276|NCT02336633|Volumetric MRI|volumetric mri
1137277|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
1137278|NCT02336633|metabolism|metabolism
1137279|NCT02336633|Caudate atrophy|caudate atrophy
1137280|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
1137281|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
1137282|NCT02336581|Mindfulness|mindfulness
1137283|NCT02336581|Inpatients|inpatients
1137284|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
1137285|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
1137286|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
1137287|NCT02336542|ESAT6|esat6
1137288|NCT02336542|CFP10|cfp10
1137289|NCT02336542|skin test|skin test
1137290|NCT02336542|diagnostic test|diagnostic test
1137291|NCT02336529|postoperative|postoperative
1137292|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
1137293|NCT02336477|paramyotonia congenita|paramyotonia congenita
1137294|NCT02336477|myotonia congenita|myotonia congenita
1137295|NCT02336477|Mexiletine|mexiletine
1137296|NCT02336477|Randomized clinical trial|randomized clinical trial
1137297|NCT02336451|ALK-positive|alk-positive
1137298|NCT02336451|NSCLC|nsclc
1137299|NCT02336451|brain metastasis|brain metastasis
1137300|NCT02336451|metastatic to the brain and/or to leptomeninges.|metastatic to the brain and/or to leptomeninges.
1137301|NCT02336425|Asthma|asthma
1137302|NCT02336412|Medication adherence|medication adherence
1137303|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
1137304|NCT02336386|Bortezomib|bortezomib
1137305|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
1137306|NCT02336373|hydroxyurea|hydroxyurea
1137307|NCT02336373|quality of life|quality of life
1137308|NCT02336373|viscosity|viscosity
1137309|NCT02336373|red cell density|red cell density
1137310|NCT02336347|Pharmacokinetics|pharmacokinetics
1137311|NCT02336347|Healthy Volunteers|healthy volunteers
1137312|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
1137313|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
1137314|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
1137315|NCT02336282|Executive dysfunction|executive dysfunction
1137316|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
1137317|NCT02336282|Cancer prevention and control|cancer prevention and control
1137318|NCT02336269|Pharmacogenomics|pharmacogenomics
1137319|NCT02336256|inguinal hernia repair|inguinal hernia repair
1137320|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
1137321|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
1137322|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
1137323|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
1137324|NCT02336243|premature birth|premature birth
1137325|NCT02336243|placentation disorders|placentation disorders
1137326|NCT02336243|preeclampsia|preeclampsia
1137327|NCT02336243|fetal growth|fetal growth
1137328|NCT02336230|GVHD|gvhd
1137329|NCT02336191|living donor liver transplantation|living donor liver transplantation
1137330|NCT02336191|graft function|graft function
1137331|NCT02336191|thromboelastometry|thromboelastometry
1137332|NCT02336165|Glioblastoma|glioblastoma
1137333|NCT02336165|Immunotherapy|immunotherapy
1137334|NCT02336165|T Cell|t cell
1137335|NCT02336165|PD-L1|pd-l1
1137336|NCT02336165|MEDI4736|medi4736
1137337|NCT02336165|Radiation|radiation
1137338|NCT02336165|Radiotherapy|radiotherapy
1137340|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
1137341|NCT02336074|HIV|hiv
1137344|NCT02336074|Early Intervention|early intervention
1137345|NCT02336074|Infection|infection
1137346|NCT02336074|Primary infection|primary infection
1137347|NCT02336074|Reservoir|reservoir
1137348|NCT02336074|Vorinostat|vorinostat
1137349|NCT02336074|HDAC|hdac
1137350|NCT02336022|general anesthesia|general anesthesia
1137351|NCT02336009|wrist arthritis|wrist arthritis
1137352|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
1137353|NCT02335970|Pain|pain
1137354|NCT02335970|Range of motion|range of motion
1137355|NCT02335970|Quality of life|quality of life
1137356|NCT02335944|non small cell lung cancer,|non small cell lung cancer,
1137357|NCT02335944|NSCLC,|nsclc,
1137358|NCT02335944|EGF816,|egf816,
1137359|NCT02335944|INC280,|inc280,
1137360|NCT02335944|tyrosine kinase inhibitor,|tyrosine kinase inhibitor,
1137361|NCT02335944|c-MET|c-met
1137362|NCT02335918|Opdivo®|opdivo®
1137363|NCT02335866|Platelet rich fibrin|platelet rich fibrin
1137364|NCT02335866|Gingival Recession|gingival recession
1137365|NCT02335853|urinary bladder|urinary bladder
1137366|NCT02335853|nerve growth factor|nerve growth factor
1137367|NCT02335853|overactive bladder|overactive bladder
1137368|NCT02335827|irreversible electroporation|irreversible electroporation
1137369|NCT02335827|renal tumor|renal tumor
1137370|NCT02335801|heart failure|heart failure
1137670|NCT02334059|obese|obese
1137371|NCT02335801|growth hormone|growth hormone
1137372|NCT02335801|testosterone|testosterone
1137373|NCT02335801|insulin resistance|insulin resistance
1137374|NCT02335801|thyroid hormones|thyroid hormones
1137375|NCT02335801|survival|survival
1137376|NCT02335788|Therapeutic|therapeutic
1137377|NCT02335788|Embolization|embolization
1137378|NCT02335736|infertility|infertility
1137379|NCT02335684|Heart-assist devices|heart-assist devices
1137380|NCT02335684|exercise capacity|exercise capacity
1137381|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
1137382|NCT02335671|Breast Conserving Surgery|breast conserving surgery
1137383|NCT02335671|Breast Cancer Stage I|breast cancer stage i
1137384|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
1137385|NCT02335645|ACL reconstruction|acl reconstruction
1137386|NCT02335645|Running Mechanics|running mechanics
1137387|NCT02335645|Physical Therapy|physical therapy
1137388|NCT02335645|Knee|knee
1137389|NCT02335645|Video Analysis|video analysis
1137390|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
1137391|NCT02335632|Hepatitis|hepatitis
1137392|NCT02335632|Probiotics|probiotics
1137393|NCT02335632|Lipopolysaccharides|lipopolysaccharides
1137394|NCT02335632|Cytokines|cytokines
1137395|NCT02335632|Alcoholics|alcoholics
1137396|NCT02335593|Hemodialysis patients|hemodialysis patients
1137397|NCT02335593|Zinc|zinc
1137398|NCT02335593|Anemia|anemia
1196029|NCT02050906|IDEA-P|idea-p
1137399|NCT02335593|Oxidative stress|oxidative stress
1137400|NCT02335580|Prognosis|prognosis
1137401|NCT02335554|Subthreshold|subthreshold
1137402|NCT02335554|Employees|employees
1137403|NCT02335554|Internet|internet
1137404|NCT02335554|Mobile|mobile
1137405|NCT02335554|cognitive-behavioral|cognitive-behavioral
1137406|NCT02335515|Gastroretentive System|gastroretentive system
1137407|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
1137408|NCT02335515|capsule|capsule
1137409|NCT02335515|Soctec|soctec
1137410|NCT02335515|Gastroenterology|gastroenterology
1137411|NCT02335476|optical coherence tomography|optical coherence tomography
1137412|NCT02335463|optical coherence tomography|optical coherence tomography
1137413|NCT02335450|exercise|exercise
1137414|NCT02335450|motivational interviewing|motivational interviewing
1137415|NCT02335424|P-D1|p-d1
1137416|NCT02335424|PD-1|pd-1
1137417|NCT02335424|PD1|pd1
1137418|NCT02335424|P-DL1|p-dl1
1137419|NCT02335424|PD-L1|pd-l1
1137420|NCT02335424|PDL-1|pdl-1
1137421|NCT02335424|PDL1|pdl1
1137422|NCT02335424|Bladder cancer|bladder cancer
1137423|NCT02335411|Gastric cancer|gastric cancer
1137424|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
1137425|NCT02335411|PD1|pd1
1137426|NCT02335411|PD-1|pd-1
1137427|NCT02335411|PDL1|pdl1
1137428|NCT02335411|PD-L1|pd-l1
1137429|NCT02335398|methadone|methadone
1137430|NCT02335398|chronic pain|chronic pain
1137431|NCT02335398|noncancer pain|noncancer pain
1137432|NCT02335398|cancer pain|cancer pain
1137433|NCT02335398|QTc prolongation|qtc prolongation
1137434|NCT02335372|Cervical cancer|cervical cancer
1137435|NCT02335372|Cervical neoplasia|cervical neoplasia
1137436|NCT02335372|Cervical cancer screening|cervical cancer screening
1137437|NCT02335372|Colposcopy|colposcopy
1137438|NCT02335372|Wide-field white light imaging|wide-field white light imaging
1137439|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
1137440|NCT02335372|Acetic acid|acetic acid
1137441|NCT02335372|Proflavine solution|proflavine solution
1137442|NCT02335333|Delayed Graft Function|delayed graft function
1137443|NCT02335333|Slow Graft Function|slow graft function
1137444|NCT02335333|Renal Transplant|renal transplant
1137445|NCT02335333|Extended Criteria Donor|extended criteria donor
1137446|NCT02335333|Biomarker of Aging|biomarker of aging
1137447|NCT02335333|Kidney Transplant|kidney transplant
1137448|NCT02335320|VHC|vhc
1137449|NCT02335320|IL28-B|il28-b
1137450|NCT02335320|point of care|point of care
1137451|NCT02335307|Pain|pain
1137452|NCT02335307|CYP2D6|cyp2d6
1137453|NCT02335294|Pain|pain
1137454|NCT02335294|abdominoplasty|abdominoplasty
1137455|NCT02335294|PCA|pca
1137456|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
1137457|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
1137458|NCT02335281|Ulcerative Colitis|ulcerative colitis
1137459|NCT02335281|Crohn's Disease|crohn's disease
1137460|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
1137461|NCT02335242|Sildenafil|sildenafil
1137462|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
1137463|NCT02335242|Dermatology|dermatology
1137464|NCT02335242|Pediatrics|pediatrics
1137465|NCT02335190|Sacroiliac joint|sacroiliac joint
1137466|NCT02335190|Radiofrequency ablation|radiofrequency ablation
1137467|NCT02335190|Ultrasound|ultrasound
1137468|NCT02335177|Falls|falls
1137469|NCT02335177|Elderly|elderly
1137470|NCT02335177|Physical activities|physical activities
1137471|NCT02335177|Technologies for autonomy|technologies for autonomy
1137472|NCT02335177|Impact of intervention|impact of intervention
1137473|NCT02335177|autonomy|autonomy
1137474|NCT02335177|physical activity program|physical activity program
1137475|NCT02335151|Circulating Tumor Cells|circulating tumor cells
1137476|NCT02335151|Anesthesia and immunity|anesthesia and immunity
1137477|NCT02335151|Cell Search System|cell search system
1137478|NCT02335138|HIV|hiv
1137479|NCT02335138|MSM|msm
1137480|NCT02335138|Couples|couples
1137481|NCT02335138|Home Testing|home testing
1137482|NCT02335138|Sexual Agreements|sexual agreements
1137483|NCT02335112|irreversible electroporation|irreversible electroporation
1137484|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
1137485|NCT02335099|hemodialysis|hemodialysis
1137486|NCT02335099|vascular access|vascular access
1137487|NCT02335099|vascular access patency|vascular access patency
1137488|NCT02335099|ticagrelor|ticagrelor
1137489|NCT02335099|brilinta|brilinta
1137490|NCT02335073|Prognosis|prognosis
1137491|NCT02335060|cannabis|cannabis
1137492|NCT02335060|Marijuana|marijuana
1137493|NCT02335060|THC|thc
1137494|NCT02335060|N-acetylcysteine|n-acetylcysteine
1137495|NCT02335060|Psychotic Disorders|psychotic disorders
1137496|NCT02335047|reliability|reliability
1137497|NCT02335047|clinical test|clinical test
1137498|NCT02335047|physical therapy|physical therapy
1137499|NCT02335034|Osteoarthritis|osteoarthritis
1137500|NCT02335034|Knee|knee
1196152|NCT02050386|MRI|mri
1137501|NCT02335034|Education|education
1137502|NCT02335034|Quality of life|quality of life
1137503|NCT02335034|Treatment outcome|treatment outcome
1137504|NCT02335034|Musculoskeletal pain|musculoskeletal pain
1137505|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
1137506|NCT02334995|biofeedback|biofeedback
1137507|NCT02334995|dissynergy|dissynergy
1137508|NCT02334982|Drug therapy|drug therapy
1137509|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
1137510|NCT02334956|MRI|mri
1137511|NCT02334956|Executive Deficits|executive deficits
1137512|NCT02334943|Immune Activation|immune activation
1137513|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
1137514|NCT02334943|Undetectable viral load|undetectable viral load
1137515|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
1137516|NCT02334943|Forms of Immune Activation|forms of immune activation
1137517|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
1137518|NCT02334930|propranolol|propranolol
1137519|NCT02334930|betablocker|betablocker
1137520|NCT02334930|angiogenesis|angiogenesis
1137521|NCT02334917|Suture Comparison|suture comparison
1137522|NCT02334891|congestive heart failure|congestive heart failure
1137523|NCT02334891|heart failure, diastolic|heart failure, diastolic
1137524|NCT02334891|heart failure, systolic|heart failure, systolic
1137525|NCT02334891|elderly frail|elderly frail
1137526|NCT02334891|guideline adherence|guideline adherence
1137527|NCT02334878|Stem Cells|stem cells
1137528|NCT02334878|Mesenchymal|mesenchymal
1137529|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
1137530|NCT02334826|revascularization|revascularization
1137531|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1137532|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
1137533|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
1137534|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
1137535|NCT02334761|Biopsy|biopsy
1137536|NCT02334748|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
1137537|NCT02334748|systemic inflammatory disorder|systemic inflammatory disorder
1137538|NCT02334748|painful joints|painful joints
1137539|NCT02334748|inflammation of the synovial membrane|inflammation of the synovial membrane
1137540|NCT02334748|auto-immune rheumatoid disease|auto-immune rheumatoid disease
1137541|NCT02334748|reactive rheumatoid arthritis|reactive rheumatoid arthritis
1137641|NCT02334202|Health Education|health education
1137542|NCT02334748|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
1137543|NCT02334748|Hereditary Periodic Fevers|hereditary periodic fevers
1137544|NCT02334748|Hereditary periodic fever syndrome(HPFS)|hereditary periodic fever syndrome(hpfs)
1137545|NCT02334748|Familial Mediterranean fever syndrome(FMFS)|familial mediterranean fever syndrome(fmfs)
1137546|NCT02334748|Hyperimmunoglobulinemia D|hyperimmunoglobulinemia d
1137547|NCT02334748|Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)|tumor necrosis factor (tnf) receptor-associated periodic syndrome (traps)
1137548|NCT02334748|Muckle-Wells syndrome (MWS)|muckle-wells syndrome (mws)
1137549|NCT02334748|Familial cold auto inflammatory syndrome|familial cold auto inflammatory syndrome
1137550|NCT02334735|Melanoma|melanoma
1137551|NCT02334735|Immunotherapy|immunotherapy
1137552|NCT02334735|DC Vaccine|dc vaccine
1137553|NCT02334735|Adjuvant Therapy|adjuvant therapy
1137554|NCT02334735|Immunogenicity|immunogenicity
1137555|NCT02334696|Vascular Access|vascular access
1137556|NCT02334683|Comparison|comparison
1137557|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
1137558|NCT02334683|Ultrasound|ultrasound
1137559|NCT02334683|Electrophysiologic|electrophysiologic
1137560|NCT02334683|Spasticity|spasticity
1137561|NCT02334683|Focal dystonia|focal dystonia
1137562|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
1137564|NCT02334670|AIDS|aids
1137565|NCT02334670|Fluconazole|fluconazole
1137566|NCT02334657|non-aneurysmal|non-aneurysmal
1137567|NCT02334644|Treatment|treatment
1137671|NCT02334059|magnesium|magnesium
1137568|NCT02334644|Natural Health Product|natural health product
1137569|NCT02334644|Anxiety|anxiety
1137570|NCT02334592|the effect of tanning|the effect of tanning
1137571|NCT02334592|vitamin D production|vitamin d production
1137572|NCT02334579|Radiation|radiation
1137573|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
1137574|NCT02334579|Radiotherapy|radiotherapy
1137575|NCT02334579|Prostate Tumor|prostate tumor
1137576|NCT02334579|Prostate Surgery|prostate surgery
1137577|NCT02334579|CyberKnife|cyberknife
1137578|NCT02334566|PTSD|ptsd
1137579|NCT02334566|Refugee children mental health|refugee children mental health
1137580|NCT02334566|community health care|community health care
1137581|NCT02334553|COPD|copd
1137582|NCT02334553|Chronic bronchitis|chronic bronchitis
1137583|NCT02334553|Cystic fibrosis|cystic fibrosis
1137584|NCT02334553|Bronchoconstriction|bronchoconstriction
1137585|NCT02334553|Perfluorocarbons|perfluorocarbons
1137586|NCT02334553|Carbon dioxide|carbon dioxide
1137587|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
1137588|NCT02334527|LCCC 1406|lccc 1406
1137589|NCT02334527|Lineberger|lineberger
1137590|NCT02334527|palbociclib|palbociclib
1137591|NCT02334514|Influenza|influenza
1137592|NCT02334514|Viral shedding|viral shedding
1137593|NCT02334514|oseltamivir|oseltamivir
1137594|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
1137595|NCT02334501|Healthy Volunteers|healthy volunteers
1137596|NCT02334462|Assays|assays
1137597|NCT02334462|Antibody|antibody
1137598|NCT02334462|Reactogenicity|reactogenicity
1137599|NCT02334462|Mosquito|mosquito
1137600|NCT02334462|Responses|responses
1137601|NCT02334449|healthy volunteers|healthy volunteers
1137602|NCT02334410|fractures|fractures
1137603|NCT02334410|immobilisation|immobilisation
1137604|NCT02334410|paraplegia|paraplegia
1137605|NCT02334410|tetraplegia|tetraplegia
1137606|NCT02334397|Prenatal Exercise|prenatal exercise
1137607|NCT02334397|Prenatal Education|prenatal education
1137608|NCT02334397|Pregnancy|pregnancy
1137609|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
1137610|NCT02334397|Education and Birth Outcomes|education and birth outcomes
1137611|NCT02334397|Maternal Quality of Life|maternal quality of life
1137612|NCT02334397|Birth Satisfaction|birth satisfaction
1137613|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
1137614|NCT02334371|Positron-Emission Tomography|positron-emission tomography
1137615|NCT02334332|Caregiver|caregiver
1137616|NCT02334293|Omegaven|omegaven
1137617|NCT02334293|parenteral nutrition|parenteral nutrition
1137618|NCT02334293|liver disease|liver disease
1137619|NCT02334293|liver injury|liver injury
1137620|NCT02334280|Community mental health|community mental health
1137621|NCT02334280|Health coach|health coach
1137622|NCT02334280|Weight loss|weight loss
1137623|NCT02334280|Fitness|fitness
1137624|NCT02334280|Serious mental illness|serious mental illness
1137625|NCT02334280|Health promotion|health promotion
1137626|NCT02334254|safety|safety
1137627|NCT02334254|rivaroxaban|rivaroxaban
1137628|NCT02334254|ticagrel|ticagrel
1137629|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
1137630|NCT02334254|undergoing PCI|undergoing pci
1137631|NCT02334241|Sorbact|sorbact
1137632|NCT02334241|Best local Cares|best local cares
1137633|NCT02334241|DFU|dfu
1137634|NCT02334202|Adolescent|adolescent
1137635|NCT02334202|Obesity/Psychology|obesity/psychology
1137636|NCT02334202|Loss of Control Eating|loss of control eating
1137637|NCT02334202|Child|child
1137638|NCT02334202|Female|female
1137639|NCT02334202|Follow-Up Studies|follow-up studies
1137640|NCT02334202|Health Behavior|health behavior
1137643|NCT02334202|Intervention Studies|intervention studies
1137644|NCT02334202|Prospective Studies|prospective studies
1137645|NCT02334202|Psychotherapy|psychotherapy
1137646|NCT02334202|Risk Factors|risk factors
1137647|NCT02334202|Weight Loss|weight loss
1137648|NCT02334202|Weight Gain|weight gain
1137649|NCT02334202|Military|military
1137650|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
1137651|NCT02334163|Nitazoxanide|nitazoxanide
1137652|NCT02334163|Serum ammonia|serum ammonia
1137653|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
1137654|NCT02334150|pelvic floor muscle|pelvic floor muscle
1137655|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
1137656|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
1137657|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1137658|NCT02334111|Social Determinants of Health|social determinants of health
1137659|NCT02334111|Child Development|child development
1137660|NCT02334111|Child Abuse|child abuse
1137661|NCT02334111|Child Neglect|child neglect
1137662|NCT02334111|Primary Care|primary care
1137663|NCT02334098|Aggression|aggression
1137664|NCT02334098|Omega-3 supplementation|omega-3 supplementation
1137665|NCT02334098|Neurocognition|neurocognition
1137666|NCT02334098|Attention|attention
1137667|NCT02334098|Antisocial|antisocial
1137668|NCT02334059|opioid sparing|opioid sparing
1137669|NCT02334059|ketamine|ketamine
1137672|NCT02334046|tracheal extubation|tracheal extubation
1137673|NCT02334046|remifentanil|remifentanil
1137674|NCT02334033|hypertension|hypertension
1137675|NCT02334033|blood pressure|blood pressure
1137676|NCT02334033|cystatin C|cystatin c
1137677|NCT02334033|real-life|real-life
1137678|NCT02334033|kidney|kidney
1137679|NCT02334020|Mental illness|mental illness
1137680|NCT02334020|training|training
1137681|NCT02334020|support|support
1137682|NCT02334020|Mental Health|mental health
1137683|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1137684|NCT02334007|deep vein thrombosis|deep vein thrombosis
1137685|NCT02334007|pulmonary embolism|pulmonary embolism
1137686|NCT02334007|lung resection|lung resection
1137687|NCT02334007|low molecular weight heparin|low molecular weight heparin
1137688|NCT02333968|Cancer pain|cancer pain
1137689|NCT02333968|Self-management|self-management
1137690|NCT02333968|Randomized controlled trial|randomized controlled trial
1137691|NCT02333942|Aging|aging
1137692|NCT02333942|Diagnostic Equipment|diagnostic equipment
1137693|NCT02333929|rivaroxaban|rivaroxaban
1137694|NCT02333929|NOAC|noac
1137695|NCT02333929|anti-Xa activity|anti-xa activity
1137696|NCT02333929|method comparison|method comparison
1137697|NCT02333929|LCMS|lcms
1137698|NCT02333903|Obesity|obesity
1137699|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
1137700|NCT02333903|Personalized physical activity program|personalized physical activity program
1137701|NCT02333903|Body Composition|body composition
1137702|NCT02333903|Fat mass|fat mass
1137703|NCT02333903|Lean mass|lean mass
1137704|NCT02333890|breast|breast
1137705|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
1137706|NCT02333851|Hospitalized patients|hospitalized patients
1137707|NCT02333838|Cord Cell Transplantation|cord cell transplantation
1137708|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
1137709|NCT02333799|Tuberculosis|tuberculosis
1137710|NCT02333799|MDR-TB|mdr-tb
1137711|NCT02333799|XDR-TB|xdr-tb
1137712|NCT02333799|Multi-drug resistant|multi-drug resistant
1137713|NCT02333799|Extensively drug resistant|extensively drug resistant
1137714|NCT02333799|Bedaquiline|bedaquiline
1137715|NCT02333799|PA-824|pa-824
1137716|NCT02333799|Linezolid|linezolid
1137717|NCT02333799|TB|tb
1137718|NCT02333799|Pretomanid|pretomanid
1137719|NCT02333799|TMC-207|tmc-207
1137720|NCT02333799|NiX-TB|nix-tb
1137721|NCT02333773|irreversible electroporation|irreversible electroporation
1137722|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
1137723|NCT02333734|Type 2 diabetes|type 2 diabetes
1137724|NCT02333734|Interval training|interval training
1137725|NCT02333734|Insulin resistance|insulin resistance
1137726|NCT02333734|fat metabolism|fat metabolism
1137727|NCT02333721|Stomach Neoplasms|stomach neoplasms
1137728|NCT02333721|Laparoscopy|laparoscopy
1137729|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
1137730|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
1137731|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
1137732|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
1137733|NCT02333669|SCNN1A|scnn1a
1137734|NCT02333630|asthma|asthma
1137735|NCT02333617|Manual Therapy|manual therapy
1137736|NCT02333617|Physical Therapy|physical therapy
1137737|NCT02333617|Dry Needling|dry needling
1137738|NCT02333617|Gluteus Medius|gluteus medius
1137739|NCT02333604|cancer|cancer
1137740|NCT02333604|cancer survivorship|cancer survivorship
1137741|NCT02333604|psychosocial needs|psychosocial needs
1137742|NCT02333604|cancer experience|cancer experience
1137743|NCT02333604|metastatic breast cancer|metastatic breast cancer
1137744|NCT02333604|multiple myeloma|multiple myeloma
1137745|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
1137746|NCT02333604|breast cancer|breast cancer
1137747|NCT02333604|Prostate|prostate
1137748|NCT02333604|Colon|colon
1137749|NCT02333604|Kidney|kidney
1137750|NCT02333604|Lung|lung
1137751|NCT02333604|Melanoma|melanoma
1137752|NCT02333604|Caregiver|caregiver
1137753|NCT02333604|gastric cancer|gastric cancer
1137754|NCT02333604|stomach cancer|stomach cancer
1137755|NCT02333604|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1137756|NCT02333552|Frailty|frailty
1137757|NCT02333552|Pre-frailty|pre-frailty
1137758|NCT02333552|Fit|fit
1137759|NCT02333552|Robust|robust
1137760|NCT02333552|Elderly|elderly
1137761|NCT02333552|Sociodemography status|sociodemography status
1137762|NCT02333552|Functional status|functional status
1137763|NCT02333552|Cognitive status|cognitive status
1137764|NCT02333552|Nutrition status|nutrition status
1137765|NCT02333552|Comorbidity|comorbidity
1137766|NCT02333552|Mortality|mortality
1137767|NCT02333552|Depression status|depression status
1137768|NCT02333526|ulcerative colitis|ulcerative colitis
1137769|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
1137770|NCT02333526|Syndecan-1|syndecan-1
1137771|NCT02333526|biomarker|biomarker
1137772|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
1137773|NCT02333435|Prostatectomy|prostatectomy
1137872|NCT02332798|safety|safety
1137774|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
1137775|NCT02333435|Quality of life|quality of life
1137776|NCT02333435|inflammation|inflammation
1137777|NCT02333435|cellular proliferation|cellular proliferation
1137778|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
1137779|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1137780|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
1137781|NCT02333422|ADHD|adhd
1137782|NCT02333409|Cancer of pancreas|cancer of pancreas
1137783|NCT02333409|Acupuncture|acupuncture
1137784|NCT02333409|Pain|pain
1137785|NCT02333396|Navigator|navigator
1137786|NCT02333396|Intervention Study|intervention study
1137787|NCT02333396|Randomized Controlled Trial|randomized controlled trial
1137788|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
1137789|NCT02333396|Decision Making|decision making
1568851|NCT00504439|repeat dose,|repeat dose,
1137790|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
1137791|NCT02333383|EAMs|eams
1137792|NCT02333383|Adalimumab|adalimumab
1137793|NCT02333370|Advanced breast cancer|advanced breast cancer
1137794|NCT02333370|Hormone receptor positive|hormone receptor positive
1137795|NCT02333370|HER2-negative|her2-negative
1137796|NCT02333370|LEE011,|lee011,
1137797|NCT02333370|Letrozole|letrozole
1137798|NCT02333370|Tamoxifen|tamoxifen
1137799|NCT02333370|Fulvestrant|fulvestrant
1137800|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
1137801|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
1137802|NCT02333344|prosthetic fixation|prosthetic fixation
1137803|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
1137804|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
1137805|NCT02333305|CoQ10|coq10
1137806|NCT02333305|hypoalbuminemia|hypoalbuminemia
1137807|NCT02333266|Candida bloodstream infection|candida bloodstream infection
1137808|NCT02333266|Detection fungal cells|detection fungal cells
1137809|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
1137810|NCT02333253|poor responders|poor responders
1137811|NCT02333253|GnRH antagonist|gnrh antagonist
1137812|NCT02333253|Conventional protocol|conventional protocol
1137813|NCT02333240|Pregnancy|pregnancy
1137814|NCT02333240|Postnatal Care|postnatal care
1137815|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
1137816|NCT02333240|Self Care|self care
1137817|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
1137818|NCT02333240|Qualitative Research|qualitative research
1137819|NCT02333240|Antihypertensive Agents|antihypertensive agents
1137820|NCT02333214|Virtual Reality Therapy|virtual reality therapy
1137821|NCT02333214|Video Game|video game
1137822|NCT02333214|Physical Exercise|physical exercise
1137823|NCT02333214|Aged|aged
1137824|NCT02333214|Frailty|frailty
1137825|NCT02333201|Deglutition Disorders|deglutition disorders
1137826|NCT02333201|Dysphagia|dysphagia
1137827|NCT02333201|Mechanical Ventilation|mechanical ventilation
1137828|NCT02333201|Sepsis|sepsis
1137829|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
1137830|NCT02333149|Melatonin|melatonin
1137831|NCT02333071|HSDD|hsdd
1137832|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
1137834|NCT02333058|AML|aml
1137835|NCT02333058|MDS|mds
1137836|NCT02333058|JMML|jmml
1137837|NCT02333045|HIV-negative|hiv-negative
1137838|NCT02333045|Women|women
1137839|NCT02333045|At-risk|at-risk
1137840|NCT02333019|risk|risk
1137841|NCT02333006|Anosognosia|anosognosia
1138546|NCT02328625|Scleroderma|scleroderma
1137842|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
1137843|NCT02332993|Negative Pressure Therapy|negative pressure therapy
1137844|NCT02332993|Wound Vac|wound vac
1137845|NCT02332993|Wound|wound
1137846|NCT02332993|Type II Diabetic|type ii diabetic
1137847|NCT02332954|Depression|depression
1137848|NCT02332954|Major Depressive Disorder|major depressive disorder
1137849|NCT02332954|Cognition|cognition
1137850|NCT02332954|Cognitive symptoms|cognitive symptoms
1137851|NCT02332954|vortioxetine|vortioxetine
1137852|NCT02332954|real life|real life
1137853|NCT02332954|naturalistic|naturalistic
1137854|NCT02332915|apraxia|apraxia
1137855|NCT02332915|aphasia|aphasia
1137856|NCT02332915|rehabilitation|rehabilitation
1137857|NCT02332915|efficacy|efficacy
1137858|NCT02332915|intensity|intensity
1137859|NCT02332902|Neurofibroma|neurofibroma
1137860|NCT02332902|NF-1|nf-1
1137861|NCT02332902|Everolimus|everolimus
1137862|NCT02332902|mTOR inhibitor|mtor inhibitor
1137863|NCT02332863|Pancreatic cancer|pancreatic cancer
1137864|NCT02332863|Image guided radiation therapy|image guided radiation therapy
1137865|NCT02332863|Fiducial marker placement|fiducial marker placement
1137866|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
1137867|NCT02332850|Relapsed|relapsed
1137868|NCT02332850|Refractory|refractory
1137869|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
1137870|NCT02332824|Pharmacological therapy|pharmacological therapy
1137871|NCT02332798|Multiple ascending doses|multiple ascending doses
1137873|NCT02332798|tolerability|tolerability
1137874|NCT02332798|pharmacokinetics|pharmacokinetics
1137875|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
1137876|NCT02332785|Colon Serrated Polyps|colon serrated polyps
1137877|NCT02332785|Serrated polyp|serrated polyp
1137878|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
1137879|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
1137880|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
1137881|NCT02332785|Colonoscopy|colonoscopy
1137882|NCT02332785|Endoscopy|endoscopy
1137883|NCT02332785|Data collection|data collection
1137884|NCT02332785|Data review|data review
1137885|NCT02332772|Colon Polyps|colon polyps
1137886|NCT02332772|Large polyps|large polyps
1137887|NCT02332772|Flat lesions|flat lesions
1137888|NCT02332772|Endoscopy|endoscopy
1137889|NCT02332772|Colonoscopic resection|colonoscopic resection
1137890|NCT02332772|Colonoscopy|colonoscopy
1137891|NCT02332772|Data review|data review
1137892|NCT02332772|Data collection|data collection
1137894|NCT02332668|PD-1|pd-1
1137895|NCT02332668|PDL1|pdl1
1137896|NCT02332668|PD-L1|pd-l1
1137897|NCT02332668|cHL|chl
1137898|NCT02332668|MSI-H|msi-h
1137899|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
1137900|NCT02332655|SWS|sws
1137901|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
1137902|NCT02332629|Glucocorticoid|glucocorticoid
1137903|NCT02332629|Endothelial barrier|endothelial barrier
1137904|NCT02332629|Glycocalyx|glycocalyx
1137905|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
1137906|NCT02332616|Glucocorticoid|glucocorticoid
1137907|NCT02332616|Complement activation|complement activation
1137908|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
1137909|NCT02332603|Glucocorticoid|glucocorticoid
1137910|NCT02332603|Glucose homeostasis|glucose homeostasis
1137911|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
1137912|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
1137913|NCT02332564|Circulation, Collateral|circulation, collateral
1137914|NCT02332564|Coronary Artery Disease|coronary artery disease
1137915|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
1137916|NCT02332564|Ischemia|ischemia
1137917|NCT02332538|LASER|laser
1137918|NCT02332538|PROSTATE|prostate
1137919|NCT02332538|BIPOLAR|bipolar
1137920|NCT02332538|HYPERPLASIA|hyperplasia
1137921|NCT02332538|VAPORIZATION|vaporization
1137922|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
1137923|NCT02332525|Cognitive Function|cognitive function
1137924|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
1137925|NCT02332525|cognitive normal elderly|cognitive normal elderly
1137926|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
1137927|NCT02332512|Wild-type EGFR|wild-type egfr
1137928|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
1137929|NCT02332512|apatinib|apatinib
1137930|NCT02332499|Anlotinib|anlotinib
1137931|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
1137932|NCT02332499|ALTER0703|alter0703
1137933|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
1137934|NCT02332447|Naloxone|naloxone
1137935|NCT02332447|SUDEP|sudep
1137936|NCT02332421|canine retraction|canine retraction
1137937|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
1137938|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
1137939|NCT02332408|vertebral hemangioma|vertebral hemangioma
1137940|NCT02332408|conventional radiotherapy|conventional radiotherapy
1137941|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
1137942|NCT02332408|randomized trial|randomized trial
1137943|NCT02332408|radioablation|radioablation
1137944|NCT02332395|pain|pain
1137945|NCT02332395|pain catastrophizing|pain catastrophizing
1137946|NCT02332395|cesarean section|cesarean section
1137947|NCT02332369|Cataract|cataract
1137948|NCT02332356|Crohn Disease|crohn disease
1137949|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
1137950|NCT02332356|Disease Attributes|disease attributes
1137951|NCT02332343|Retina|retina
1137952|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
1137953|NCT02332317|Advanced cancer|advanced cancer
1137954|NCT02332317|Early integration|early integration
1137955|NCT02332317|Palliative rehabilitation|palliative rehabilitation
1137956|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
1137957|NCT02332291|Depression|depression
1137958|NCT02332291|Geriatrics|geriatrics
1137959|NCT02332291|Elderly|elderly
1137960|NCT02332291|MRI|mri
1137961|NCT02332291|Antidepressants|antidepressants
1137962|NCT02332278|Cesarean section|cesarean section
1137963|NCT02332278|Early feeding|early feeding
1137964|NCT02332265|Food Security|food security
1137965|NCT02332265|Microfinance|microfinance
1137966|NCT02332265|Village Savings and Loans|village savings and loans
1137967|NCT02332265|HIV|hiv
1137968|NCT02332265|Quasi-experimental design|quasi-experimental design
1137969|NCT02332265|Malawi|malawi
1137970|NCT02332265|Structural intervention|structural intervention
1137971|NCT02332252|Surgical Wound Infection|surgical wound infection
1137972|NCT02332252|Electrocautery|electrocautery
1137973|NCT02332252|Scalpel|scalpel
1137974|NCT02332239|depression|depression
1137975|NCT02332239|violence|violence
1137976|NCT02332239|emergency department|emergency department
1137977|NCT02332239|mhealth|mhealth
1137978|NCT02332239|text message|text message
1137979|NCT02332213|Volatile organic compounds|volatile organic compounds
1137980|NCT02332213|Nanosensor technology|nanosensor technology
1137981|NCT02332213|GC-MS|gc-ms
1137982|NCT02332213|Breath-testing|breath-testing
1137983|NCT02332213|Digestive cancer|digestive cancer
1137984|NCT02332213|Precancerous lesions|precancerous lesions
1137985|NCT02332213|Colorectal cancer|colorectal cancer
1137986|NCT02332213|Adenoma|adenoma
1137987|NCT02332213|Gastric cancer|gastric cancer
1137988|NCT02332213|Atrophic gastritis|atrophic gastritis
1137989|NCT02332213|OLGIM|olgim
1137990|NCT02332200|Spondylolysis|spondylolysis
1137991|NCT02332200|Spondylolisthesis|spondylolisthesis
1137992|NCT02332200|Low Back Pain|low back pain
1137993|NCT02332174|pharmacokinetics|pharmacokinetics
1137994|NCT02332174|food effect|food effect
1137995|NCT02332174|sex effect|sex effect
1137996|NCT02332174|tolerability|tolerability
1137997|NCT02332135|microwave ablation|microwave ablation
1137998|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
1137999|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
1138000|NCT02332122|COPD|copd
1138001|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1138002|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
1138003|NCT02332122|Bronchiectasis|bronchiectasis
1138004|NCT02332122|Sensitization|sensitization
1138005|NCT02332122|Vitamin D|vitamin d
1138006|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
1138007|NCT02332109|oedema|oedema
1138008|NCT02332109|sodium chloride|sodium chloride
1138009|NCT02332109|hyaluronan|hyaluronan
1138010|NCT02332109|sodium hyaluronate|sodium hyaluronate
1138011|NCT02332070|acute kidney injury|acute kidney injury
1138012|NCT02332070|coronary angiography|coronary angiography
1138013|NCT02332070|cardiac surgery|cardiac surgery
1138014|NCT02332070|adverse events|adverse events
1138015|NCT02332070|iodinated contrast|iodinated contrast
1138016|NCT02332070|Thoracic Surgery|thoracic surgery
1138017|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
1138018|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
1138019|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
1138020|NCT02331966|FGF-23|fgf-23
1138021|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
1138022|NCT02331966|RECURRENCES|recurrences
1138023|NCT02331953|spine surgery|spine surgery
1138024|NCT02331953|cerebral oximetry|cerebral oximetry
1138025|NCT02331953|postoperative delirium|postoperative delirium
1138026|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1138027|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
1138028|NCT02331940|sleep quality|sleep quality
1138029|NCT02331927|colorectal cancer|colorectal cancer
1138030|NCT02331927|marker-driven|marker-driven
1138031|NCT02331927|bevacizumab|bevacizumab
1138032|NCT02331927|aflibercept|aflibercept
1138033|NCT02331927|cytokines|cytokines
1138034|NCT02331927|angiogenic factors|angiogenic factors
1138035|NCT02331927|CAF|caf
1138036|NCT02331914|GIST|gist
1138037|NCT02331914|Bio-databank|bio-databank
1138038|NCT02331862|urinary tract infection|urinary tract infection
1138039|NCT02331862|methylprednisolone|methylprednisolone
1138040|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
1138041|NCT02331849|GERD|gerd
1138042|NCT02331849|esophageal motility|esophageal motility
1138043|NCT02331836|adenoma detection rate|adenoma detection rate
1138044|NCT02331836|polyp detection rate|polyp detection rate
1138045|NCT02331836|withdrawal time|withdrawal time
1138046|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
1138047|NCT02331797|endoscope|endoscope
1138048|NCT02331797|microscope|microscope
1138049|NCT02331797|transcanal|transcanal
1138050|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
1138051|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
1138052|NCT02331719|ICH|ich
1138053|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
1138054|NCT02331693|EGFR|egfr
1138055|NCT02331693|CAR T cells|car t cells
1138056|NCT02331693|glioma|glioma
1138057|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
1138058|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
1138059|NCT02331667|Diet|diet
1138060|NCT02331667|Vitamin-D|vitamin-d
1138061|NCT02331667|Meat|meat
1138062|NCT02331667|Fatty fish|fatty fish
1138063|NCT02331667|Iodine|iodine
1138064|NCT02331667|fatty acid|fatty acid
1138065|NCT02331667|Intervention study|intervention study
1138066|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
1138067|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
1138068|NCT02331667|Nine hole peg test|nine hole peg test
1138069|NCT02331654|Chronic pain|chronic pain
1138070|NCT02331654|Direct Current Stimulation|direct current stimulation
1138071|NCT02331641|hepatectomy|hepatectomy
1138072|NCT02331641|hepatic resection|hepatic resection
1138073|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
1138074|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
1138075|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
1138076|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
1138077|NCT02331615|Traumatic Brain Injury|traumatic brain injury
1138078|NCT02331615|Executive function difficulties|executive function difficulties
1568852|NCT00504439|tolerability.|tolerability.
1138079|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
1138080|NCT02331602|atrial fibrillation|atrial fibrillation
1138081|NCT02331602|anticoagulation|anticoagulation
1138082|NCT02331602|inflammation|inflammation
1138083|NCT02331589|Fatigue|fatigue
1138084|NCT02331589|Panax ginseng|panax ginseng
1138085|NCT02331589|Chronic hepatitis|chronic hepatitis
1138086|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1138087|NCT02331589|Adiponectin|adiponectin
1138088|NCT02331563|dexmedetomidine|dexmedetomidine
1138089|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
1138090|NCT02331524|exercise|exercise
1138091|NCT02331524|daily activity|daily activity
1138092|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
1138093|NCT02331472|interstitial cystitis|interstitial cystitis
1138094|NCT02331472|biomarker|biomarker
1138095|NCT02331459|mood|mood
1138096|NCT02331459|cognitive state|cognitive state
1138097|NCT02331459|physical activity|physical activity
1138098|NCT02331459|frailty|frailty
1138099|NCT02331394|Chinese herbs|chinese herbs
1138100|NCT02331394|lung cancer|lung cancer
1138101|NCT02331394|quality of life|quality of life
1138102|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
1138103|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
1138104|NCT02331329|Accuracy of NICOM|accuracy of nicom
1138105|NCT02331329|precision of NICOM|precision of nicom
1138106|NCT02331316|obesity|obesity
1138107|NCT02331316|diet|diet
1138108|NCT02331316|weight|weight
1138109|NCT02331316|hunger|hunger
1138110|NCT02331316|public led trial|public led trial
1138111|NCT02331264|Cardiac Toxicity|cardiac toxicity
1138112|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
1138113|NCT02331186|Obesity|obesity
1138114|NCT02331186|Bariatric surgery|bariatric surgery
1138115|NCT02331186|Urinary incontinence|urinary incontinence
1138116|NCT02331186|Pelvic floor|pelvic floor
1138117|NCT02331173|XLRS|xlrs
1138118|NCT02331173|RS1|rs1
1138119|NCT02331173|maculoschisis|maculoschisis
1138120|NCT02331160|Pregnancy|pregnancy
1138121|NCT02331160|Breech Presentation|breech presentation
1138122|NCT02331160|Version, fetal|version, fetal
1138123|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
1138124|NCT02331160|Medicine, Traditional|medicine, traditional
1138125|NCT02331134|Tissue|tissue
1138126|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
1138127|NCT02331134|Melanoma|melanoma
1138128|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
1138129|NCT02331121|children|children
1138130|NCT02331121|parents|parents
1138131|NCT02331121|internet|internet
1138132|NCT02331121|video|video
1138133|NCT02331121|training|training
1138134|NCT02331121|interactive|interactive
1138135|NCT02331082|Infant Mortality|infant mortality
1138136|NCT02331082|Under-two mortality|under-two mortality
1138137|NCT02331082|Maternal Mortality|maternal mortality
1138138|NCT02331082|Implementation Research|implementation research
1138139|NCT02331082|Health Systems Strengthening|health systems strengthening
1138390|NCT02329704|Swimming down|swimming down
1138140|NCT02331082|Chronic Disease Management|chronic disease management
1138141|NCT02331082|Commuity Health Workers|commuity health workers
1138142|NCT02331069|radial neuropathy|radial neuropathy
1138143|NCT02331056|Stroke volume variation|stroke volume variation
1138144|NCT02331056|fluid responsiveness|fluid responsiveness
1138145|NCT02331056|One-lung ventilation|one-lung ventilation
1138146|NCT02331056|thoracotomy|thoracotomy
1138147|NCT02331030|brachio-axillary|brachio-axillary
1138148|NCT02331030|brachio-basilic|brachio-basilic
1138149|NCT02331030|interfascial plane block|interfascial plane block
1138150|NCT02331030|Pecs II block|pecs ii block
1138151|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
1138152|NCT02331017|Bimodal|bimodal
1138153|NCT02331017|Cochlear Implant|cochlear implant
1138154|NCT02331017|Hearing aid|hearing aid
1138155|NCT02331017|Auditory Perception|auditory perception
1138156|NCT02331004|Frail Elderly|frail elderly
1138157|NCT02331004|Motor Skills|motor skills
1138158|NCT02331004|Upper Extremity|upper extremity
1138159|NCT02330991|glioblastoma|glioblastoma
1138160|NCT02330991|relapse|relapse
1138161|NCT02330991|Temozolomide|temozolomide
1138162|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
1138163|NCT02330965|clinical research|clinical research
1138164|NCT02330965|mechanistic studies|mechanistic studies
1138165|NCT02330965|blood draw|blood draw
1138166|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
1138167|NCT02330952|Double-blind method|double-blind method
1138168|NCT02330952|Randomized Controlled trials|randomized controlled trials
1138169|NCT02330939|Postprandial glycemia|postprandial glycemia
1138170|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
1138171|NCT02330939|Saturated fatty acids|saturated fatty acids
1138172|NCT02330939|Glycemic index|glycemic index
1138173|NCT02330939|Glycemic load|glycemic load
1568853|NCT00504439|SB-656933,|sb-656933,
1138174|NCT02330939|Sensor augmented pump system|sensor augmented pump system
1138175|NCT02330926|Combined modality treatment|combined modality treatment
1138176|NCT02330926|Diet therapy|diet therapy
1138177|NCT02330926|Exercise therapy|exercise therapy
1138178|NCT02330926|Ibuprofen|ibuprofen
1138179|NCT02330926|Dietary supplements|dietary supplements
1138180|NCT02330913|total gastrectomy|total gastrectomy
1138181|NCT02330913|intracorporeal|intracorporeal
1138182|NCT02330913|totally laparoscopic|totally laparoscopic
1138183|NCT02330913|esophagojejunostomy|esophagojejunostomy
1138184|NCT02330913|anastomosis|anastomosis
1138185|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1138186|NCT02330900|Electromagnetic interference|electromagnetic interference
1138187|NCT02330900|Cell phone|cell phone
1138188|NCT02330887|Maternal Mortality|maternal mortality
1138189|NCT02330887|Institutional Birth Rate|institutional birth rate
1138190|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
1138191|NCT02330887|Preterm Birth|preterm birth
1138192|NCT02330887|Stillbirth|stillbirth
1138193|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
1138195|NCT02330887|Implementation Research|implementation research
1138196|NCT02330887|Global Health|global health
1138197|NCT02330874|Risk|risk
1138198|NCT02330874|score|score
1138199|NCT02330874|readmission|readmission
1138200|NCT02330874|ICU|icu
1138201|NCT02330861|Coronary Circulation|coronary circulation
1138202|NCT02330848|Obesity|obesity
1138203|NCT02330848|Walnuts|walnuts
1138204|NCT02330848|Endothelial Function|endothelial function
1138205|NCT02330848|Adults at risk|adults at risk
1138206|NCT02330835|school|school
1138207|NCT02330835|bus|bus
1138208|NCT02330835|school bus|school bus
1138209|NCT02330835|driver|driver
1138210|NCT02330835|training|training
1138211|NCT02330835|behavior|behavior
1138212|NCT02330835|management|management
1138213|NCT02330835|interactive|interactive
1138214|NCT02330835|computer|computer
1138215|NCT02330809|headache|headache
1138216|NCT02330809|hunger intensity|hunger intensity
1138217|NCT02330809|public led online trial|public led online trial
1138218|NCT02330809|water intake|water intake
1138219|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1138220|NCT02330783|Third-line treatment|third-line treatment
1138221|NCT02330783|Sorafenib|sorafenib
1138222|NCT02330783|Bevacizumab|bevacizumab
1138223|NCT02330770|GnRHa trigger|gnrha trigger
1138224|NCT02330770|Luteal phase support|luteal phase support
1138225|NCT02330770|OHSS|ohss
1138226|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
1138227|NCT02330757|FET protocols|fet protocols
1138228|NCT02330705|Intrauterine insemination|intrauterine insemination
1138229|NCT02330705|IUI|iui
1138230|NCT02330705|HCG|hcg
1138231|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
1138232|NCT02330653|Colitis|colitis
1138233|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
1138234|NCT02330653|Ulcerative colitis|ulcerative colitis
1138235|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
1138236|NCT02330640|CABG|cabg
1138237|NCT02330640|antiplatelet therapy|antiplatelet therapy
1138238|NCT02330640|ticagrelor|ticagrelor
1138239|NCT02330614|personality|personality
1138240|NCT02330614|bleaching|bleaching
1138241|NCT02330588|Obesity|obesity
1138242|NCT02330588|Prevention|prevention
1138243|NCT02330588|Pediatric|pediatric
1138244|NCT02330588|Parents|parents
1138245|NCT02330588|Primary Care|primary care
1138246|NCT02330588|eHealth|ehealth
1138247|NCT02330588|Internet|internet
1138248|NCT02330562|Marizomib|marizomib
1138249|NCT02330562|Bevacizumab|bevacizumab
1138250|NCT02330562|Avastin|avastin
1138251|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
1138252|NCT02330562|proteasome inhibitor|proteasome inhibitor
1138253|NCT02330562|glioblastoma|glioblastoma
1138254|NCT02330562|brain tumor|brain tumor
1138255|NCT02330562|malignant glioma|malignant glioma
1138256|NCT02330562|brain cancer|brain cancer
1138257|NCT02330562|gliosarcoma|gliosarcoma
1138258|NCT02330562|BEV|bev
1138259|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
1138260|NCT02330536|Thoracoscopy|thoracoscopy
1138261|NCT02330510|Alzheimer's Disease|alzheimer's disease
1138262|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
1138263|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
1138264|NCT02330510|Amyloid Imaging|amyloid imaging
1138267|NCT02330471|conization|conization
1138268|NCT02330471|LLETZ|lletz
1138269|NCT02330471|cervical dysplasia|cervical dysplasia
1138270|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1138271|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
1138272|NCT02330458|Crohn's disease|crohn's disease
1138273|NCT02330458|Pediatric IBD|pediatric ibd
1138274|NCT02330458|small bowel ultrasound|small bowel ultrasound
1138275|NCT02330458|infliximab|infliximab
1138276|NCT02330419|Naltrexone|naltrexone
1138277|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
1138278|NCT02330406|LDL Cholesterol|ldl cholesterol
1138279|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
1138280|NCT02330406|Diabetes Mellitus|diabetes mellitus
1138281|NCT02330406|Coronary Disease|coronary disease
1138282|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
1138283|NCT02330354|preschool|preschool
1138284|NCT02330354|behavior change|behavior change
1138285|NCT02330354|social marketing|social marketing
1138286|NCT02330354|child care providers|child care providers
1138287|NCT02330354|nutrition|nutrition
1138288|NCT02330354|child care centers|child care centers
1138289|NCT02330354|physical activity|physical activity
1138290|NCT02330341|Glucose Intolerance|glucose intolerance
1138291|NCT02330341|Artemisia dracunculus|artemisia dracunculus
1138292|NCT02330341|Insulin|insulin
1138293|NCT02330328|Chest Pain|chest pain
1138294|NCT02330328|Telemetry|telemetry
1138295|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
1138296|NCT02330315|transcranial ultrasound|transcranial ultrasound
1138297|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
1138298|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
1138299|NCT02330250|Pharmaceutical care|pharmaceutical care
1138300|NCT02330250|Pharmaceutical services|pharmaceutical services
1138301|NCT02330250|Medication adherence|medication adherence
1138302|NCT02330224|Blood pressure|blood pressure
1138303|NCT02330224|Lipids|lipids
1138304|NCT02330224|Cardiovascular|cardiovascular
1138305|NCT02330224|Health services|health services
1138306|NCT02330224|Hypertension|hypertension
1138311|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
1138312|NCT02330185|spinal anesthesia|spinal anesthesia
1138313|NCT02330185|ultrasonography|ultrasonography
1138314|NCT02330185|anatomical landmark|anatomical landmark
1138315|NCT02330159|Pilonidal|pilonidal
1138316|NCT02330159|Quality of Life|quality of life
1138317|NCT02330133|mid-life women|mid-life women
1138318|NCT02330133|unintended pregnancy|unintended pregnancy
1138319|NCT02330133|STI/HIV prevention|sti/hiv prevention
1138320|NCT02330133|intervention|intervention
1138321|NCT02330133|interactive|interactive
1138322|NCT02330133|CD-ROM|cd-rom
1138323|NCT02330133|multimedia|multimedia
1138324|NCT02330133|video|video
1138325|NCT02330120|peak airway pressure|peak airway pressure
1138326|NCT02330120|airway resistance|airway resistance
1138327|NCT02330120|sedation|sedation
1138328|NCT02330120|intensive care|intensive care
1138329|NCT02330094|aSAH|asah
1138331|NCT02330081|pathogen reduction technology|pathogen reduction technology
1138332|NCT02330081|whole blood|whole blood
1138333|NCT02330081|Platelets|platelets
1138334|NCT02330081|Mirasol|mirasol
1138335|NCT02330042|Diabetes|diabetes
1138337|NCT02330042|Angiography|angiography
1138338|NCT02330042|Diabetic retinopathy|diabetic retinopathy
1138339|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
1138340|NCT02330029|Pinaverium|pinaverium
1138341|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
1138547|NCT02328625|Device|device
1138342|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
1138343|NCT02330003|Influenza|influenza
1138344|NCT02330003|Influenza vaccine|influenza vaccine
1138345|NCT02330003|Split influenza vaccine|split influenza vaccine
1138346|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
1138347|NCT02329990|phosphorus intake|phosphorus intake
1138348|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
1138349|NCT02329964|Rocuronium|rocuronium
1138350|NCT02329964|Sugammadex|sugammadex
1138351|NCT02329964|Succinylcholine|succinylcholine
1138352|NCT02329964|Cisatracurium|cisatracurium
1138353|NCT02329964|Neostigmine|neostigmine
1138354|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
1138355|NCT02329912|postoperative ileus|postoperative ileus
1138356|NCT02329912|SmartPill|smartpill
1138357|NCT02329912|gastrointestinal transit|gastrointestinal transit
1138358|NCT02329912|prokinetic drugs|prokinetic drugs
1138359|NCT02329886|chronic diseases|chronic diseases
1138360|NCT02329886|risk factors|risk factors
1138361|NCT02329886|health outcomes|health outcomes
1138465|NCT02329054|Viral load|viral load
1138466|NCT02329054|Proof-of-concept|proof-of-concept
1138362|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
1138363|NCT02329873|Older adults|older adults
1138364|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
1138365|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
1138366|NCT02329847|JNJ54179060|jnj54179060
1138367|NCT02329847|Ibrutinib|ibrutinib
1138368|NCT02329847|Nivolumab|nivolumab
1138369|NCT02329821|lactate|lactate
1138370|NCT02329821|hartmann solution|hartmann solution
1138371|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
1138372|NCT02329808|TDM|tdm
1138373|NCT02329808|dried blood spot|dried blood spot
1138374|NCT02329808|immunosuppressive|immunosuppressive
1138375|NCT02329808|antifungal|antifungal
1138376|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
1138377|NCT02329769|DMD|dmd
1138378|NCT02329769|BioMarin|biomarin
1138379|NCT02329769|PRO044|pro044
1138380|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
1138381|NCT02329730|ESAT6|esat6
1138382|NCT02329730|CFP10|cfp10
1138383|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
1138384|NCT02329704|IUI/AIH|iui/aih
1138385|NCT02329704|Semen preparation|semen preparation
1138386|NCT02329704|Semen processing|semen processing
1138387|NCT02329704|ICSI/IVF|icsi/ivf
1138388|NCT02329704|ART|art
1138389|NCT02329704|Density Gradient|density gradient
1138391|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
1138392|NCT02329704|Sperm vitality testin|sperm vitality testin
1138393|NCT02329691|safety climate|safety climate
1138394|NCT02329691|surgery|surgery
1138395|NCT02329678|Apicomarginal defects|apicomarginal defects
1138396|NCT02329678|clinical study/trial|clinical study/trial
1138397|NCT02329678|collagen membrane|collagen membrane
1138398|NCT02329678|guided tissue regeneration|guided tissue regeneration
1138399|NCT02329678|endodontic microsurgery|endodontic microsurgery
1138400|NCT02329652|Neuroprosthesis|neuroprosthesis
1138401|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
1138402|NCT02329639|bevacizumab|bevacizumab
1138403|NCT02329639|paclitaxel|paclitaxel
1138404|NCT02329639|pharmacogenetics|pharmacogenetics
1138405|NCT02329639|breast cancer|breast cancer
1138406|NCT02329561|Pharmacokinetics|pharmacokinetics
1138407|NCT02329561|Opioid|opioid
1138408|NCT02329561|Geriatric|geriatric
1138409|NCT02329561|Pharmacodynamics|pharmacodynamics
1138410|NCT02329548|Alizarin|alizarin
1138411|NCT02329548|Orthostatic|orthostatic
1138412|NCT02329548|POTS|pots
1138413|NCT02329548|Tilt table testing|tilt table testing
1138414|NCT02329548|Syncope|syncope
1138415|NCT02329548|Anxiety|anxiety
1138416|NCT02329522|Haemodynamics|haemodynamics
1138417|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1138418|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
1138419|NCT02329522|severity|severity
1138420|NCT02329509|operative procedures|operative procedures
1138421|NCT02329483|Infertility|infertility
1138422|NCT02329483|Ovulation induction|ovulation induction
1138423|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
1138424|NCT02329483|Ovarian high responder|ovarian high responder
1138425|NCT02329483|Androgens|androgens
1138426|NCT02329483|Androstenedione|androstenedione
1138427|NCT02329483|Testosterone|testosterone
1138428|NCT02329483|rhFSH|rhfsh
1138429|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
1138430|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
1138431|NCT02329340|child safety|child safety
1138432|NCT02329340|injury|injury
1138433|NCT02329340|prevention|prevention
1138434|NCT02329340|computer|computer
1138435|NCT02329340|internet|internet
1138436|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
1138437|NCT02329327|Major|major
1138438|NCT02329327|Bleeding|bleeding
1138439|NCT02329327|Anticoagulant|anticoagulant
1138440|NCT02329301|malaria|malaria
1138441|NCT02329301|malaria, falciparum|malaria, falciparum
1138442|NCT02329301|antimalarials|antimalarials
1138443|NCT02329262|exercise|exercise
1138444|NCT02329262|mentors|mentors
1138445|NCT02329262|health education|health education
1138446|NCT02329262|obesity|obesity
1138447|NCT02329249|smoking cessation|smoking cessation
1138448|NCT02329249|coach-supported|coach-supported
1138449|NCT02329249|tobacco use cessation|tobacco use cessation
1138450|NCT02329249|online|online
1138451|NCT02329249|internet-based|internet-based
1138452|NCT02329249|tailored|tailored
1138453|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
1138454|NCT02329223|Omalizumab|omalizumab
1138455|NCT02329197|Infertility|infertility
1138456|NCT02329197|Invitro fertilization|invitro fertilization
1138457|NCT02329145|renal denervation|renal denervation
1138458|NCT02329132|diabetic macular edema|diabetic macular edema
1138459|NCT02329132|VEGF|vegf
1138460|NCT02329132|ranibizumab|ranibizumab
1138461|NCT02329132|oxygen consumption|oxygen consumption
1138462|NCT02329054|Ebola Virus Disease|ebola virus disease
1138463|NCT02329054|Antivirals|antivirals
1138464|NCT02329054|Mortality|mortality
1138467|NCT02329054|Phase II trial|phase ii trial
1138468|NCT02329054|Guinea|guinea
1138469|NCT02329054|Adults|adults
1138470|NCT02329054|Children|children
1138471|NCT02329041|videolaryngoscope|videolaryngoscope
1138472|NCT02329041|double-lumen tube|double-lumen tube
1138473|NCT02329041|intubation|intubation
1138474|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
1138475|NCT02329028|Electroencephalography|electroencephalography
1138476|NCT02329028|Coma|coma
1138477|NCT02329015|stress|stress
1138478|NCT02329015|alternative|alternative
1138479|NCT02329015|complementary|complementary
1138480|NCT02329015|self-regulation|self-regulation
1138481|NCT02329002|Retinoblastoma|retinoblastoma
1138482|NCT02329002|Second primary tumor|second primary tumor
1138483|NCT02329002|Screening|screening
1138484|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
1138485|NCT02328989|prematurity|prematurity
1138486|NCT02328989|short cervix|short cervix
1138487|NCT02328989|twin pregnancy|twin pregnancy
1138488|NCT02328989|pessary|pessary
1138489|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
1138490|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
1138491|NCT02328963|Everolimus|everolimus
1138492|NCT02328963|preemptive strategy|preemptive strategy
1138493|NCT02328963|mTOR inhibitor|mtor inhibitor
1138494|NCT02328898|Polymer free stent|polymer free stent
1138495|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
1138496|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
1138497|NCT02328885|graft versus leukemia|graft versus leukemia
1138499|NCT02328885|UCBT|ucbt
1138500|NCT02328872|screening|screening
1138501|NCT02328872|cervical screening|cervical screening
1138502|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1138503|NCT02328872|cancer prevention|cancer prevention
1138504|NCT02328859|Gait|gait
1138505|NCT02328859|Rehabilitation|rehabilitation
1138506|NCT02328859|Virtual Reality|virtual reality
1138507|NCT02328833|Depression|depression
1138508|NCT02328833|Clinical Practice Guideline|clinical practice guideline
1138509|NCT02328833|Implementation|implementation
1138510|NCT02328833|Primary Care|primary care
1138511|NCT02328833|Computerized Guideline|computerized guideline
1138512|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1138513|NCT02328820|Coronary Flow Reserve|coronary flow reserve
1138514|NCT02328807|adenocarcinoma|adenocarcinoma
1138515|NCT02328807|prostate|prostate
1138516|NCT02328807|ENCAGE™|encage™
1138517|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
1138518|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
1138519|NCT02328807|radiotherapy|radiotherapy
1138520|NCT02328794|smoking cessation|smoking cessation
1138521|NCT02328794|behavioral economics|behavioral economics
1138522|NCT02328794|e-cigarettes|e-cigarettes
1138523|NCT02328794|NRT|nrt
1138524|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
1138525|NCT02328781|drug-eluting stent|drug-eluting stent
1138526|NCT02328703|Reiki|reiki
1138527|NCT02328703|Neuropathic Pain|neuropathic pain
1138528|NCT02328703|Military Service Members|military service members
1138529|NCT02328703|Extermity Trauma|extermity trauma
1138530|NCT02328690|binaural beat technology|binaural beat technology
1138531|NCT02328690|sound technology|sound technology
1138532|NCT02328690|cardiovascular stress response|cardiovascular stress response
1138533|NCT02328690|military|military
1138534|NCT02328690|music|music
1138535|NCT02328690|anxiety|anxiety
1138536|NCT02328690|stress|stress
1138537|NCT02328677|Colorectal cancer|colorectal cancer
1138538|NCT02328677|rectosigmoid|rectosigmoid
1138539|NCT02328677|rectum|rectum
1138540|NCT02328677|colon|colon
1138541|NCT02328664|Endoscopic resection|endoscopic resection
1138542|NCT02328664|Pathology|pathology
1138543|NCT02328664|Rescue surgery|rescue surgery
1138544|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
1138545|NCT02328638|ASD|asd
1138549|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
1138550|NCT02328625|hand|hand
1138551|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
1138552|NCT02328547|diarrhea-predominant|diarrhea-predominant
1138553|NCT02328534|ICSI/IVF|icsi/ivf
1138554|NCT02328534|Semen processing|semen processing
1138555|NCT02328534|Semen preparation|semen preparation
1138556|NCT02328534|Swim down|swim down
1138557|NCT02328534|Density gradient|density gradient
1138558|NCT02328534|Silica solution|silica solution
1138559|NCT02328521|Neointima|neointima
1138560|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
1138561|NCT02328521|drug-eluting stents|drug-eluting stents
1138562|NCT02328521|Nicorandil|nicorandil
1138563|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1138564|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
1138565|NCT02328508|wound healing|wound healing
1138566|NCT02328508|inflammation|inflammation
1138665|NCT02328014|Folicular|folicular
1138567|NCT02328508|glycemic control|glycemic control
1138568|NCT02328508|amputation|amputation
1138569|NCT02328508|bacterial infection|bacterial infection
1138570|NCT02328508|quality of life|quality of life
1138571|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
1138572|NCT02328469|aseptic meningitis|aseptic meningitis
1138573|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
1138574|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
1138575|NCT02328469|inflammation|inflammation
1138576|NCT02328469|outcome|outcome
1138577|NCT02328443|CYP3A|cyp3a
1138578|NCT02328443|Metabolomics|metabolomics
1138579|NCT02328404|Vitamin D|vitamin d
1138580|NCT02328404|deficiency|deficiency
1138581|NCT02328404|hypovitaminosis D|hypovitaminosis d
1138582|NCT02328404|Biodal|biodal
1138583|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
1138584|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
1138585|NCT02328404|25(OH)D|25(oh)d
1138586|NCT02328404|PCOS|pcos
1138587|NCT02328404|insulin resistance|insulin resistance
1138588|NCT02328404|BMI|bmi
1138589|NCT02328404|chromium levels|chromium levels
1138590|NCT02328404|vitamin D 3|vitamin d 3
1138591|NCT02328404|cholecalciferol|cholecalciferol
1138592|NCT02328404|50,000 IU|50,000 iu
1138593|NCT02328365|Colorectal Cancer|colorectal cancer
1138594|NCT02328365|Comorbidity|comorbidity
1138595|NCT02328365|Perioperative Care|perioperative care
1138596|NCT02328365|Surgery|surgery
1138597|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
1138598|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
1138599|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
1138600|NCT02328352|prosthesis adhesion|prosthesis adhesion
1138601|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
1138602|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
1138603|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
1138604|NCT02328326|Diabetes|diabetes
1138605|NCT02328326|diabetes self-management|diabetes self-management
1138606|NCT02328326|patient activation|patient activation
1138607|NCT02328326|social support|social support
1138608|NCT02328313|Cancer|cancer
1138609|NCT02328313|Breast Cancer|breast cancer
1138610|NCT02328313|Geriatric|geriatric
1138611|NCT02328313|Advance Age|advance age
1138612|NCT02328313|Exercise|exercise
1138613|NCT02328313|Physical Activity|physical activity
1138614|NCT02328313|Genetic Marker|genetic marker
1138615|NCT02328313|p16|p16
1138616|NCT02328313|Chemotherapy|chemotherapy
1138617|NCT02328313|Breast Cancer Treatment|breast cancer treatment
1138618|NCT02328287|Spinal Fusion|spinal fusion
1138619|NCT02328287|Revision Surgery|revision surgery
1138620|NCT02328287|Pseudarthrosis|pseudarthrosis
1138621|NCT02328287|Cell Therapy|cell therapy
1138622|NCT02328287|Bone Graft|bone graft
1138623|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
1138624|NCT02328222|Early steroid withdrawal|early steroid withdrawal
1138625|NCT02328222|Acute allograft rejection|acute allograft rejection
1138626|NCT02328222|Mycophenolate|mycophenolate
1138627|NCT02328222|Tacrolimus|tacrolimus
1138628|NCT02328222|Basiliximab|basiliximab
1138629|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1138630|NCT02328196|Rasch analysis|rasch analysis
1138631|NCT02328196|Meal time performance|meal time performance
1138632|NCT02328183|polymyxin B|polymyxin b
1138633|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
1138634|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
1138635|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
1138636|NCT02328144|Postoperative pain|postoperative pain
1138637|NCT02328144|Metronidazole|metronidazole
1138638|NCT02328118|Lucentis|lucentis
1138639|NCT02328118|Ranibizumab|ranibizumab
1138640|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
1138641|NCT02328118|Vitrectomy|vitrectomy
1138642|NCT02328118|PDR|pdr
1138643|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
1138644|NCT02328066|NBI|nbi
1138745|NCT02327546|Anemia|anemia
1138645|NCT02328066|NICE classification|nice classification
1138646|NCT02328066|deep submucosal invasion|deep submucosal invasion
1138647|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
1138648|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
1138649|NCT02328053|fungal keratitis|fungal keratitis
1138650|NCT02328053|collagen cross linking|collagen cross linking
1138651|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1138652|NCT02328040|Closed loop|closed loop
1138653|NCT02328040|Artificial Pancreas|artificial pancreas
1138654|NCT02328040|Insulin|insulin
1138655|NCT02328040|Sitagliptin|sitagliptin
1138656|NCT02328040|Januvia|januvia
1138657|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1138658|NCT02328014|Btk|btk
1138659|NCT02328014|B-Cell Malignancies|b-cell malignancies
1138660|NCT02328014|Mantle Cell|mantle cell
1138661|NCT02328014|Multiple Myeloma|multiple myeloma
1138662|NCT02328014|CLL|cll
1138663|NCT02328014|SLL|sll
1138664|NCT02328014|DLBCL|dlbcl
1138666|NCT02328014|Waldenstrom|waldenstrom
1138667|NCT02328014|B-All|b-all
1138668|NCT02327988|cryotherapy|cryotherapy
1138669|NCT02327988|laser therapy|laser therapy
1138670|NCT02327988|eccentric exercise|eccentric exercise
1138671|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
1138672|NCT02327988|muscle damage|muscle damage
1138673|NCT02327988|dynamometry|dynamometry
1138674|NCT02327988|electromyography|electromyography
1138675|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1138676|NCT02327923|lidocaine infusion|lidocaine infusion
1197721|NCT02043639|ROM|rom
1138677|NCT02327923|Esmolol infusion|esmolol infusion
1138678|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
1138679|NCT02327923|Multimodal analgesia|multimodal analgesia
1138680|NCT02327910|Elderly patients，|elderly patients，
1138681|NCT02327910|General anesthesia，|general anesthesia，
1138682|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
1138683|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
1138684|NCT02327910|Extubation|extubation
1138685|NCT02327910|，Respiratory events|，respiratory events
1138686|NCT02327897|Atopic Asthma|atopic asthma
1138687|NCT02327897|Exposures|exposures
1138688|NCT02327897|Disease Progression|disease progression
1138689|NCT02327884|Genetics|genetics
1138690|NCT02327884|Dry Mouth|dry mouth
1138691|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
1138692|NCT02327884|Gland Dysfuntion|gland dysfuntion
1138693|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
1138694|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
1138695|NCT02327871|patients|patients
1138696|NCT02327871|Safety, Efficacy|safety, efficacy
1138697|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
1138698|NCT02327832|Confirmation|confirmation
1138699|NCT02327832|safety|safety
1138700|NCT02327793|Perfusion|perfusion
1138701|NCT02327793|Blood pressure|blood pressure
1138702|NCT02327767|Active Assistance|active assistance
1138703|NCT02327767|Resonance|resonance
1138704|NCT02327767|Stroke|stroke
1138705|NCT02327767|Arm Rehabilitation|arm rehabilitation
1138706|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
1138707|NCT02327741|clopidogrel|clopidogrel
1138708|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
1138709|NCT02327728|blepharospasm|blepharospasm
1138710|NCT02327728|botulinum A|botulinum a
1138711|NCT02327728|injection pattern|injection pattern
1138712|NCT02327728|tear|tear
1138713|NCT02327715|Hepatitis B virus|hepatitis b virus
1138714|NCT02327715|Emtricitabine|emtricitabine
1138715|NCT02327715|Pregnancy|pregnancy
1138716|NCT02327715|Vertical transmission|vertical transmission
1138717|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
1138718|NCT02327702|Emtricitabine|emtricitabine
1138719|NCT02327702|Pregnancy|pregnancy
1138720|NCT02327689|Hepatitis B virus|hepatitis b virus
1138721|NCT02327689|Cirrhosis|cirrhosis
1138722|NCT02327689|Emtricitabine|emtricitabine
1138723|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
1138724|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
1138725|NCT02327676|Emtricitabine|emtricitabine
1138726|NCT02327676|Child|child
1138727|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
1138728|NCT02327663|Emtricitabine|emtricitabine
1138729|NCT02327663|Adefovir dipivixil|adefovir dipivixil
1138730|NCT02327663|HBeAg|hbeag
1138731|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
1138732|NCT02327637|Bedrest|bedrest
1138733|NCT02327637|Physical Activity|physical activity
1138734|NCT02327585|Executive function training|executive function training
1138735|NCT02327585|child|child
1138736|NCT02327559|childbirth|childbirth
1138737|NCT02327559|mindfulness|mindfulness
1138738|NCT02327559|fear of labor|fear of labor
1138739|NCT02327559|labor pain|labor pain
1138740|NCT02327559|coping|coping
1138741|NCT02327559|self-efficacy|self-efficacy
1138742|NCT02327559|childbirth satisfaction|childbirth satisfaction
1138743|NCT02327559|depression|depression
1138744|NCT02327546|Pharmacokinetics|pharmacokinetics
1138746|NCT02327546|Chronic kidney disease|chronic kidney disease
1138747|NCT02327546|CKD|ckd
1138748|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
1138749|NCT02327546|Renal impairment|renal impairment
1138750|NCT02327546|Ferrous sulfate|ferrous sulfate
1138751|NCT02327546|Iron|iron
1138752|NCT02327546|Drug-drug interaction|drug-drug interaction
1138753|NCT02327546|End stage renal disease|end stage renal disease
1138754|NCT02327546|Dialysis|dialysis
1138755|NCT02327546|Erythropoietin|erythropoietin
1138756|NCT02327546|Oral anemia treatment|oral anemia treatment
1138757|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
1138758|NCT02327546|HIF|hif
1138759|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
1138760|NCT02327546|HIF-PHI|hif-phi
1138761|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
1138762|NCT02327533|microarray analysis|microarray analysis
1138763|NCT02327520|Clostridium difficile infection|clostridium difficile infection
1138764|NCT02327520|burden|burden
1138765|NCT02327520|nationwide study|nationwide study
1138766|NCT02327520|South East Asia|south east asia
1138767|NCT02327520|Thailand|thailand
1138768|NCT02327520|Epidemiology|epidemiology
1138769|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
1138770|NCT02327507|children|children
1138771|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
1138772|NCT02327507|health education|health education
1138773|NCT02327507|Medicaid|medicaid
1138774|NCT02327494|Neuromuscular blockade|neuromuscular blockade
1138775|NCT02327494|Laparoscopy|laparoscopy
1138776|NCT02327494|Oxygen measurements|oxygen measurements
1138777|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
1138778|NCT02327442|chemokine receptor|chemokine receptor
1138779|NCT02327442|galium|galium
1138780|NCT02327442|dosimetry|dosimetry
1138781|NCT02327442|glioma|glioma
1138782|NCT02327403|Proteinuria|proteinuria
1138783|NCT02327403|Kidney transplantation|kidney transplantation
1138784|NCT02327403|Allograft dysfunction|allograft dysfunction
1138785|NCT02327403|B7-1|b7-1
1138786|NCT02327403|Belatacept|belatacept
1138787|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
1138788|NCT02327377|Intervention studies|intervention studies
1138789|NCT02327377|Visceral pain|visceral pain
1138790|NCT02327377|Chronic pain|chronic pain
1138791|NCT02327377|Abdominal pain|abdominal pain
1138792|NCT02327377|Dyspepsia|dyspepsia
1138793|NCT02327377|Nausea|nausea
1138794|NCT02327377|Nociception|nociception
1138795|NCT02327377|Parents|parents
1138796|NCT02327377|Coping behavior|coping behavior
1138797|NCT02327377|Anxiety|anxiety
1138798|NCT02327377|Depression|depression
1138799|NCT02327377|Catastrophization|catastrophization
1138800|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
1138801|NCT02327377|Self efficacy|self efficacy
1138802|NCT02327377|Health services overutilization|health services overutilization
1138803|NCT02327377|Questionnaires|questionnaires
1138804|NCT02327377|Self report|self report
1138805|NCT02327377|Health surveys|health surveys
1138806|NCT02327377|Prospective studies|prospective studies
1138807|NCT02327377|Adolescent health|adolescent health
1138808|NCT02327377|Mental health services|mental health services
1138809|NCT02327377|Health services accessibility|health services accessibility
1138810|NCT02327377|Health diaries|health diaries
1138811|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
1138812|NCT02327377|Telemedicine|telemedicine
1138813|NCT02327377|E-Health|e-health
1138814|NCT02327377|Web-based intervention|web-based intervention
1138815|NCT02327377|Parenting education|parenting education
1138816|NCT02327325|Low Back Pain|low back pain
1138817|NCT02327325|Exercise|exercise
1138818|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
1138819|NCT02327325|Aged|aged
1138820|NCT02327299|Iron deficiency|iron deficiency
1138821|NCT02327299|Iron fortification|iron fortification
1138822|NCT02327286|Diabetes Mellitus|diabetes mellitus
1138823|NCT02327286|Gestational diabetes|gestational diabetes
1138824|NCT02327273|subjects|subjects
1138825|NCT02327221|Crohn Disease|crohn disease
1138826|NCT02327221|Cell therapy|cell therapy
1138827|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
1138828|NCT02327221|Treg|treg
1138829|NCT02327221|Autologous|autologous
1138830|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
1138831|NCT02327208|Military Training|military training
1138832|NCT02327208|Whey Protein|whey protein
1138833|NCT02327208|Body Composition|body composition
1138834|NCT02327182|MT-4666|mt-4666
1138835|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
1138836|NCT02327182|Alzheimer's Disease|alzheimer's disease
1138837|NCT02327182|Cognitive function|cognitive function
1138838|NCT02327182|Dementia|dementia
1138839|NCT02327182|Central Nervous System Agents|central nervous system agents
1138840|NCT02327169|Drug therapy|drug therapy
1138841|NCT02327156|Dexmedetomidine|dexmedetomidine
1138842|NCT02327104|mindfulness|mindfulness
1138843|NCT02327104|tobacco dependence|tobacco dependence
1138844|NCT02327104|relapse prevention|relapse prevention
1138845|NCT02327091|Alfacalcidol|alfacalcidol
1138846|NCT02327091|Falls|falls
1138847|NCT02327091|Handgrip|handgrip
1138848|NCT02327091|Muscle strength|muscle strength
1138849|NCT02327091|Sarcopenia|sarcopenia
1138851|NCT02327065|FNA|fna
1138852|NCT02327065|FNB|fnb
1138853|NCT02327052|Chagas disease|chagas disease
1138854|NCT02327052|longitudinal global strain|longitudinal global strain
1138855|NCT02327052|speckle tracking|speckle tracking
1138856|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1138857|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
1138858|NCT02327026|Tracheal intubation|tracheal intubation
1138859|NCT02326961|osteoarthritis|osteoarthritis
1138860|NCT02326961|knee|knee
1138861|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
1138862|NCT02326961|ADRC|adrc
1138863|NCT02326961|Celution|celution
1138864|NCT02326961|arthritis|arthritis
1138865|NCT02326948|Gallbladder cancer|gallbladder cancer
1138866|NCT02326948|Case-control study|case-control study
1138867|NCT02326948|Risk factor|risk factor
1138868|NCT02326948|Alcohol consumption|alcohol consumption
1138869|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
1138870|NCT02326948|Biliary stone|biliary stone
1138871|NCT02326935|MS|ms
1138872|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1138873|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
1138874|NCT02326935|Myelitis|myelitis
1138875|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
1138876|NCT02326922|Metraplant-E|metraplant-e
1138877|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
1138878|NCT02326922|Endometrial decidualization|endometrial decidualization
1138879|NCT02326909|Upper Urinary Tract|upper urinary tract
1138880|NCT02326909|Optical Coherence Tomography|optical coherence tomography
1138881|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
1138882|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
1138883|NCT02326909|Diagnostic accuracy|diagnostic accuracy
1138884|NCT02326896|intubation|intubation
1138885|NCT02326896|intensive care unit|intensive care unit
1138886|NCT02326896|MACOCHA Score|macocha score
1138887|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1138888|NCT02326870|laparoscope holder|laparoscope holder
1138889|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
1138890|NCT02326870|fundoplication surgery|fundoplication surgery
1138891|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
1138892|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
1138893|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
1138894|NCT02326870|right hemicolectomy|right hemicolectomy
1138895|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
1138896|NCT02326857|Distribution of Molecular Profiles in Latin American Women|distribution of molecular profiles in latin american women
1138897|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
1138898|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
1138899|NCT02326857|Prospective Cohort|prospective cohort
1138900|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
1138901|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
1138902|NCT02326844|DNA Damaging Agents|dna damaging agents
1138903|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
1138904|NCT02326818|Dystonia|dystonia
1138905|NCT02326818|Botulinum Toxin|botulinum toxin
1138906|NCT02326818|Musician's Dystonia|musician's dystonia
1138907|NCT02326818|Spasticity|spasticity
1138908|NCT02326792|Exercise|exercise
1138909|NCT02326792|Training|training
1138910|NCT02326792|Low back Pain|low back pain
1138911|NCT02326792|Physical Therapy|physical therapy
1138912|NCT02326779|esophageal cancer|esophageal cancer
1138913|NCT02326779|aspirin|aspirin
1138914|NCT02326779|survival|survival
1138915|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
1138916|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
1138917|NCT02326727|Epidural Analgesia|epidural analgesia
1138918|NCT02326727|Natural Killer Cells|natural killer cells
1138919|NCT02326675|Etoposide|etoposide
1138920|NCT02326675|Cryotherapy|cryotherapy
1138921|NCT02326662|spinal cord injury|spinal cord injury
1138922|NCT02326662|neural stem cells|neural stem cells
1138923|NCT02326662|paraplegia|paraplegia
1138924|NCT02326662|transplantation|transplantation
1138925|NCT02326649|cardiac output|cardiac output
1138926|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
1138927|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
1138928|NCT02326597|Hydroxyurea|hydroxyurea
1138929|NCT02326597|Bone marrow transplant|bone marrow transplant
1138930|NCT02326597|Chronic blood transfusion|chronic blood transfusion
1138931|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
1138932|NCT02326597|Decision making|decision making
1138933|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
1138934|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
1138935|NCT02326584|CD33 Antigen|cd33 antigen
1138936|NCT02326584|Drug Therapy|drug therapy
1139721|NCT02322385|PKD 2 gene|pkd 2 gene
1138937|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
1138938|NCT02326571|EEG|eeg
1138939|NCT02326571|Cortical Spreading Depression|cortical spreading depression
1138940|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
1138941|NCT02326571|miRNA|mirna
1138942|NCT02326571|Reactivity in EEG|reactivity in eeg
1138943|NCT02326571|Multimodal monitoring|multimodal monitoring
1138944|NCT02326558|zero ischemia|zero ischemia
1138945|NCT02326558|microwave|microwave
1138946|NCT02326558|ablation|ablation
1138947|NCT02326558|enucleation|enucleation
1138948|NCT02326558|renal cell carcinoma|renal cell carcinoma
1138949|NCT02326545|Video Games|video games
1138950|NCT02326545|Child|child
1138951|NCT02326545|Adolescent|adolescent
1138952|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
1138953|NCT02326532|Veterans|veterans
1138954|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1138955|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
1139057|NCT02325895|functional food|functional food
1138956|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1138957|NCT02326493|LV lead position|lv lead position
1138958|NCT02326493|Device programming|device programming
1138959|NCT02326493|Optimization|optimization
1138960|NCT02326493|Vectorcardiography|vectorcardiography
1138961|NCT02326480|Childhood Obesity|childhood obesity
1138962|NCT02326480|Genetics|genetics
1138963|NCT02326467|chlorhexidine|chlorhexidine
1138964|NCT02326467|safety|safety
1138965|NCT02326467|bath|bath
1138966|NCT02326467|rash|rash
1138967|NCT02326467|infant|infant
1138968|NCT02326441|advanced malignancies|advanced malignancies
1138969|NCT02326441|refractory therapies|refractory therapies
1138970|NCT02326441|phase 1|phase 1
1138971|NCT02326428|Stroke|stroke
1138972|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
1138973|NCT02326428|Brain ischemia|brain ischemia
1138974|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
1138975|NCT02326428|Stroke thrombectomy|stroke thrombectomy
1138976|NCT02326428|Stent-retriever|stent-retriever
1138977|NCT02326415|Acute Appendicitis|acute appendicitis
1138978|NCT02326415|Appendectomy|appendectomy
1138979|NCT02326415|Fast-Track|fast-track
1138980|NCT02326415|Clinical Pathway|clinical pathway
1138981|NCT02326402|Circulatory support|circulatory support
1138982|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
1138983|NCT02326402|Extracorporeal bypass|extracorporeal bypass
1138984|NCT02326389|Cognitive functioning|cognitive functioning
1138985|NCT02326363|substance abuse|substance abuse
1138986|NCT02326363|Mental Health Disorders|mental health disorders
1138987|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
1138988|NCT02326350|Aspirin|aspirin
1138989|NCT02326298|Certolizumab Pegol|certolizumab pegol
1138990|NCT02326298|Cimzia|cimzia
1138991|NCT02326298|Psoriasis|psoriasis
1138992|NCT02326285|induction therapy|induction therapy
1138993|NCT02326285|NSCLC|nsclc
1138994|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
1138995|NCT02326285|curative surgery|curative surgery
1138996|NCT02326272|Certolizumab Pegol|certolizumab pegol
1138997|NCT02326272|Cimzia|cimzia
1138998|NCT02326272|Psoriasis|psoriasis
1138999|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
1139000|NCT02326259|Disease Progression|disease progression
1139001|NCT02326246|MRI|mri
1139002|NCT02326246|active surveillance|active surveillance
1139003|NCT02326207|Infant, Newborn|infant, newborn
1139004|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
1139005|NCT02326207|Ventilator circuit|ventilator circuit
1139006|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
1139007|NCT02326181|respiratory muscle training|respiratory muscle training
1139008|NCT02326181|respiratory muscle strength|respiratory muscle strength
1139009|NCT02326181|respiratory endurance test|respiratory endurance test
1139010|NCT02326181|6-minute walking test|6-minute walking test
1139011|NCT02326142|Premature Obstetric Labor|premature obstetric labor
1139012|NCT02326142|Premature Birth|premature birth
1139013|NCT02326103|alcoholic|alcoholic
1139014|NCT02326103|hepatitis|hepatitis
1139015|NCT02326103|cirrhosis|cirrhosis
1139016|NCT02326103|cholesterol metabolites|cholesterol metabolites
1139017|NCT02326103|ciprofloxacin|ciprofloxacin
1139018|NCT02326077|sonopartogram|sonopartogram
1139019|NCT02326077|transperineal ultrasound|transperineal ultrasound
1139020|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
1139021|NCT02326077|labor|labor
1139022|NCT02326077|delivery|delivery
1139023|NCT02326077|partogram|partogram
1139024|NCT02326077|ultrasound|ultrasound
1139025|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
1139026|NCT02326051|APS|aps
1139027|NCT02326051|LMWH|lmwh
1139028|NCT02326038|Memory|memory
1139029|NCT02326038|Attention|attention
1139030|NCT02326038|MCI|mci
1139031|NCT02326038|Ritalin|ritalin
1139032|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
1139033|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
1139034|NCT02325999|early gastric cancer|early gastric cancer
1139035|NCT02325999|Disease-free survival|disease-free survival
1139036|NCT02325986|radiotherapy|radiotherapy
1139037|NCT02325986|esophageal carcinoma|esophageal carcinoma
1139038|NCT02325986|chemotherapy|chemotherapy
1139039|NCT02325973|STEMI|stemi
1139040|NCT02325973|IMR|imr
1139041|NCT02325973|FFR|ffr
1139042|NCT02325973|microcirculatory|microcirculatory
1139043|NCT02325960|exenatide|exenatide
1139044|NCT02325960|insulin glargine|insulin glargine
1139045|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
1139046|NCT02325934|Stribild|stribild
1139047|NCT02325934|pharmacokinetics|pharmacokinetics
1139048|NCT02325934|Crushing|crushing
1139049|NCT02325934|Drip feed|drip feed
1139050|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
1139051|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
1139052|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
1139053|NCT02325908|Hemodialysis|hemodialysis
1139054|NCT02325908|Estimated Dry Weight|estimated dry weight
1139055|NCT02325895|Osteoporosis|osteoporosis
1139056|NCT02325895|Dried plum|dried plum
1139058|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
1139059|NCT02325856|Hemodialysis|hemodialysis
1139060|NCT02325856|Body Composition Monitor|body composition monitor
1139061|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
1139062|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
1139063|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
1139064|NCT02325817|Bifurcation Lesions|bifurcation lesions
1139065|NCT02325817|drug eluting balloon|drug eluting balloon
1139066|NCT02325817|paclitaxel|paclitaxel
1139067|NCT02325817|drug coated balloon|drug coated balloon
1139068|NCT02325804|overweight and obesity|overweight and obesity
1139069|NCT02325804|adipose tissue|adipose tissue
1139070|NCT02325804|weight loss program|weight loss program
1139071|NCT02325804|low-calorie diet|low-calorie diet
1139072|NCT02325804|circuit-based exercise|circuit-based exercise
1139073|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
1139074|NCT02325765|congential cardiac surgery|congential cardiac surgery
1139075|NCT02325765|nuclearsome|nuclearsome
1139076|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
1139077|NCT02325752|readmission|readmission
1139078|NCT02325752|chronic diseases|chronic diseases
1139079|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
1139080|NCT02325726|Cardiac surgery|cardiac surgery
1139081|NCT02325726|Extracorporeal circulation|extracorporeal circulation
1139082|NCT02325726|Renal failure|renal failure
1139083|NCT02325713|ODT-PZQ|odt-pzq
1139084|NCT02325713|Bio-availability|bio-availability
1139085|NCT02325713|Praziquantel|praziquantel
1139086|NCT02325713|Cysticide|cysticide
1139087|NCT02325713|Pharmacokinetics|pharmacokinetics
1139088|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
1139089|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1139090|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
1139091|NCT02325687|Inflammation|inflammation
1139092|NCT02325687|TNF-alpha|tnf-alpha
1139093|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1139094|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
1139095|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
1139096|NCT02325687|Cytokines|cytokines
1139097|NCT02325687|Neurotrophins|neurotrophins
1139098|NCT02325687|BDNF|bdnf
1139099|NCT02325687|Beta-NGF|beta-ngf
1139100|NCT02325687|Proteomic Analysis|proteomic analysis
1139101|NCT02325674|Lipodystrophy|lipodystrophy
1139102|NCT02325674|Metreleptin Registry|metreleptin registry
1139103|NCT02325635|Adenoma Detection|adenoma detection
1139104|NCT02325635|Adenoma Prediction|adenoma prediction
1139105|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
1139106|NCT02325596|microRNA|microrna
1139107|NCT02325596|dendritic cell|dendritic cell
1139108|NCT02325596|helper T cell|helper t cell
1139109|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
1139110|NCT02325544|dissociative seizures,|dissociative seizures,
1139111|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
1139112|NCT02325531|implementation strategies|implementation strategies
1139113|NCT02325531|diabetes mellitus|diabetes mellitus
1139114|NCT02325531|cardiovascular disease|cardiovascular disease
1139115|NCT02325531|community health centers|community health centers
1139116|NCT02325531|quality improvement|quality improvement
1139117|NCT02325531|translational medical research|translational medical research
1139118|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
1139119|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
1139120|NCT02325518|AZORGA®|azorga®
1139121|NCT02325518|COSOPT®|cosopt®
1139122|NCT02325492|bariatric surgery|bariatric surgery
1139123|NCT02325492|NASH|nash
1139124|NCT02325492|ARAMCHOL|aramchol
1139125|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
1139126|NCT02325466|Peripheral Artery Disease|peripheral artery disease
1139127|NCT02325466|Type 2 Diabetes|type 2 diabetes
1139128|NCT02325466|Blood Viscosity|blood viscosity
1139129|NCT02325466|Ticagrelor|ticagrelor
1139130|NCT02325466|Aspirin|aspirin
1139131|NCT02325453|Robotic Surgery|robotic surgery
1139132|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
1139133|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
1139134|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
1139135|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
1139136|NCT02325453|Open Gastrectomy|open gastrectomy
1139137|NCT02325453|Gastric Surgery|gastric surgery
1139138|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
1139139|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
1139140|NCT02325440|immune function|immune function
1139141|NCT02325440|disease activity|disease activity
1139142|NCT02325427|stroke|stroke
1139143|NCT02325427|rehabilitation|rehabilitation
1139144|NCT02325427|upper limb|upper limb
1139145|NCT02325427|TMS|tms
1139146|NCT02325427|tDCS|tdcs
1139147|NCT02325414|Osteoporosis|osteoporosis
1139148|NCT02325414|Spinal Cord Injury|spinal cord injury
1139149|NCT02325414|Bone Diseases|bone diseases
1139150|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
1139247|NCT02325024|Sativex|sativex
1139151|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
1139152|NCT02325414|Spinal Cord Diseases|spinal cord diseases
1139153|NCT02325414|Central Nervous System Diseases|central nervous system diseases
1139154|NCT02325414|Nervous System Diseases|nervous system diseases
1139155|NCT02325414|Nervous System|nervous system
1139156|NCT02325414|Wounds and Injuries|wounds and injuries
1139157|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
1139158|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
1139159|NCT02325414|Pharmacologic Actions|pharmacologic actions
1139160|NCT02325414|Department of Defense|department of defense
1139161|NCT02325388|pressure ulcer|pressure ulcer
1139162|NCT02325388|decubitus ulcer|decubitus ulcer
1139163|NCT02325388|bed sore|bed sore
1139164|NCT02325388|continuous pressure mapping|continuous pressure mapping
1139165|NCT02325388|interface pressure imaging|interface pressure imaging
1139166|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1139167|NCT02325375|spinal fluid|spinal fluid
1139168|NCT02325375|CD163|cd163
1139169|NCT02325362|Cystic fibrosis|cystic fibrosis
1139170|NCT02325362|CFTR|cftr
1139171|NCT02325362|F508del mutation|f508del mutation
1139172|NCT02325362|Miglustat|miglustat
1139173|NCT02325362|Total Chloride Secretion|total chloride secretion
1139174|NCT02325362|Nasal Potential Difference|nasal potential difference
1139175|NCT02325349|Angiogenesis|angiogenesis
1139176|NCT02325349|Integrins|integrins
1139177|NCT02325349|RGD PET/CT|rgd pet/ct
1139178|NCT02325349|FDG PET/CT|fdg pet/ct
1139179|NCT02325349|Predictive value|predictive value
1139180|NCT02325349|Therapeutic response|therapeutic response
1139181|NCT02325349|Efficacy|efficacy
1139182|NCT02325349|Tolerability|tolerability
1139183|NCT02325336|Medication Errors|medication errors
1139184|NCT02325336|nurses|nurses
1139185|NCT02325336|hospital|hospital
1139186|NCT02325323|stomach cancer|stomach cancer
1139187|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
1139188|NCT02325323|prospective cohort|prospective cohort
1139189|NCT02325323|low grade dysplasia|low grade dysplasia
1139190|NCT02325323|high grade dysplasia|high grade dysplasia
1139191|NCT02325323|prognosis factor|prognosis factor
1139192|NCT02325323|gastric cancer risks|gastric cancer risks
1139193|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
1139194|NCT02325310|Postpartum vaccination|postpartum vaccination
1139195|NCT02325310|Breastfeeding women|breastfeeding women
1139196|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
1139197|NCT02325310|Breast milk|breast milk
1139198|NCT02325310|Vaccinology|vaccinology
1139199|NCT02325297|Intensive care unit|intensive care unit
1139200|NCT02325258|Sepsis diagnosis|sepsis diagnosis
1139201|NCT02325258|Sepsis drug therapy|sepsis drug therapy
1139202|NCT02325258|Sepsis outcome|sepsis outcome
1139203|NCT02325245|Frailty|frailty
1139204|NCT02325245|Pre-frailty|pre-frailty
1139205|NCT02325245|Metformin|metformin
1139206|NCT02325245|Elderly|elderly
1139207|NCT02325245|Quality of life|quality of life
1139208|NCT02325245|Handgrip|handgrip
1139209|NCT02325245|Gait speed|gait speed
1139210|NCT02325245|Myostatin|myostatin
1139211|NCT02325219|Psoriasis|psoriasis
1139212|NCT02325219|CNTO 1959|cnto 1959
1139213|NCT02325219|Guselkumab|guselkumab
1139214|NCT02325219|Placebo|placebo
1139216|NCT02325180|Plasmodium falciparum|plasmodium falciparum
1139217|NCT02325180|malaria|malaria
1139218|NCT02325180|efficacy|efficacy
1139219|NCT02325180|Indonesia|indonesia
1139220|NCT02325167|informal caregivers|informal caregivers
1139221|NCT02325167|mental stress|mental stress
1139222|NCT02325167|quality of life|quality of life
1139223|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
1139224|NCT02325128|social anxiety|social anxiety
1139225|NCT02325128|exposure therapy|exposure therapy
1139226|NCT02325128|extinction|extinction
1139227|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
1139228|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
1139229|NCT02325089|Elderly|elderly
1139230|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
1140042|NCT02321098|antifungal|antifungal
1139231|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
1139232|NCT02325089|Hypertension|hypertension
1139233|NCT02325089|Cardiovascular disease|cardiovascular disease
1139234|NCT02325089|Quality of life|quality of life
1139235|NCT02325076|Airway Management|airway management
1139236|NCT02325076|intubation|intubation
1139237|NCT02325076|pulmonary function test|pulmonary function test
1139238|NCT02325050|Healthy|healthy
1139239|NCT02325050|Ebola viruses|ebola viruses
1139240|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
1139241|NCT02325050|Filoviruses|filoviruses
1139242|NCT02325050|monovalent vaccine|monovalent vaccine
1139243|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1139244|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
1139245|NCT02325050|Safety|safety
1139246|NCT02325050|Immunogenicity|immunogenicity
1139248|NCT02325024|GW-1000-02|gw-1000-02
1139249|NCT02325024|Nabiximols|nabiximols
1139250|NCT02325024|Pharmacokinetics|pharmacokinetics
1139251|NCT02325024|Renal Insufficiency|renal insufficiency
1139252|NCT02325024|Chronic Kidney Failure|chronic kidney failure
1139254|NCT02325011|GW-1000-02|gw-1000-02
1139255|NCT02325011|Nabiximols|nabiximols
1139256|NCT02325011|Fluconazole|fluconazole
1139257|NCT02325011|Pharmacokinetics|pharmacokinetics
1139258|NCT02325011|Drug-drug interaction|drug-drug interaction
1139259|NCT02324998|Radical Prostatectomy|radical prostatectomy
1139260|NCT02324998|Prostate Cancer|prostate cancer
1139261|NCT02324998|PARP inhibition|parp inhibition
1139262|NCT02324998|Olaparib|olaparib
1139263|NCT02324998|Degarelix|degarelix
1139264|NCT02324998|Neoadjuvant|neoadjuvant
1139265|NCT02324998|Pharmacodynamics|pharmacodynamics
1139266|NCT02324998|Pharmacokinetics|pharmacokinetics
1139267|NCT02324998|Biomarkers|biomarkers
1139268|NCT02324985|muscle soreness|muscle soreness
1139269|NCT02324972|Atopic dermatitis|atopic dermatitis
1139270|NCT02324972|Eczema|eczema
1139271|NCT02324972|AD|ad
1139272|NCT02324972|AQX-1125|aqx-1125
1139273|NCT02324972|SHIP1|ship1
1139274|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
1139275|NCT02324946|Perioperative Period|perioperative period
1139276|NCT02324946|Mass Screening|mass screening
1139277|NCT02324920|Syncope|syncope
1139278|NCT02324920|Closed Loop Stimulation|closed loop stimulation
1139279|NCT02324920|CLS|cls
1139280|NCT02324894|screening|screening
1139281|NCT02324894|MRI|mri
1139282|NCT02324881|smartphone|smartphone
1139283|NCT02324881|application|application
1139284|NCT02324881|pain management|pain management
1139285|NCT02324868|Bandages|bandages
1139286|NCT02324868|Catheter|catheter
1139287|NCT02324855|Autogenic drainage|autogenic drainage
1139288|NCT02324855|Positive expiratory pressure|positive expiratory pressure
1139289|NCT02324855|Airway clearance technique|airway clearance technique
1139290|NCT02324855|Quality of life|quality of life
1139291|NCT02324855|Exacerbations|exacerbations
1139292|NCT02324855|Chest physiotherapy|chest physiotherapy
1139293|NCT02324829|Total joint replacement|total joint replacement
1139294|NCT02324829|Physiotherapy|physiotherapy
1139295|NCT02324829|Kalman filtering|kalman filtering
1139296|NCT02324829|Kinematic modeling|kinematic modeling
1139297|NCT02324829|Hidden Markov model|hidden markov model
1139298|NCT02324829|Motion segmentation|motion segmentation
1139299|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
1139300|NCT02324764|transradial coronary angiography|transradial coronary angiography
1139301|NCT02324764|radial artery occlusion|radial artery occlusion
1139302|NCT02324764|coronary heart disease|coronary heart disease
1139303|NCT02324764|Glidesheath Slender|glidesheath slender
1139304|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
1139305|NCT02324738|drug interaction|drug interaction
1139306|NCT02324725|naltrexone|naltrexone
1139307|NCT02324725|neuroimaging|neuroimaging
1139308|NCT02324725|heroin|heroin
1139309|NCT02324725|addiction|addiction
1139310|NCT02324725|dependence|dependence
1139311|NCT02324725|opioid|opioid
1139312|NCT02324725|Vivitrol®|vivitrol®
1139313|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
1139314|NCT02324699|Vedolizumab|vedolizumab
1139315|NCT02324699|Corticosteroids|corticosteroids
1139316|NCT02324699|Prednisone|prednisone
1139317|NCT02324699|Crohn's disease|crohn's disease
1139318|NCT02324686|Warfarin|warfarin
1139319|NCT02324686|International Normalized Ratio|international normalized ratio
1139320|NCT02324686|Vitamin K|vitamin k
1139321|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
1139322|NCT02324660|screening procedure|screening procedure
1139323|NCT02324660|peak expiratory flow|peak expiratory flow
1139324|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
1139325|NCT02324647|Urinary steroid profiling|urinary steroid profiling
1139326|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
1139327|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
1139328|NCT02324647|cost-effectiveness|cost-effectiveness
1139329|NCT02324621|protocol specific|protocol specific
1139330|NCT02324595|Ovarian Cancer|ovarian cancer
1139331|NCT02324595|Laparoscopy|laparoscopy
1139332|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1139333|NCT02324595|Robotic|robotic
1139334|NCT02324595|Interval Debulking Surgery|interval debulking surgery
1139335|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
1139336|NCT02324582|Mycobacterium bovis|mycobacterium bovis
1139337|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
1139338|NCT02324582|pembrolizumab|pembrolizumab
1139339|NCT02324569|Pharmacological therapy|pharmacological therapy
1139340|NCT02324556|Rectal Cancer|rectal cancer
1139341|NCT02324556|Surgery|surgery
1139342|NCT02324556|Laparoscopy|laparoscopy
1139343|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
1139344|NCT02324504|Peripherally Inserted Central Catheter (PICC)|peripherally inserted central catheter (picc)
1139345|NCT02324504|Electrocardiographic guidance|electrocardiographic guidance
1139346|NCT02324504|Reposition|reposition
1139347|NCT02324478|autonomic nervous system|autonomic nervous system
1139348|NCT02324478|heart rate variability|heart rate variability
1139349|NCT02324478|laparoscopic surgery|laparoscopic surgery
1139350|NCT02324478|general anesthesia|general anesthesia
1139351|NCT02324478|photoplethysmography|photoplethysmography
1139352|NCT02324439|ovarian cancer|ovarian cancer
1139353|NCT02324439|flaxseed|flaxseed
1139354|NCT02324439|dietary supplement|dietary supplement
1139355|NCT02324439|organic dietary supplement|organic dietary supplement
1139356|NCT02324439|recurrence|recurrence
1139357|NCT02324426|Parkinson's Disease|parkinson's disease
1139358|NCT02324426|Reduced Glutathione|reduced glutathione
1139359|NCT02324426|CNS|cns
1139360|NCT02324426|Glutathione|glutathione
1139361|NCT02324426|Uptake|uptake
1139362|NCT02324426|Intranasal|intranasal
1139363|NCT02324426|(in)GSH|(in)gsh
1139364|NCT02324387|Breast Cancer|breast cancer
1139365|NCT02324387|Molecular breast imaging|molecular breast imaging
1139366|NCT02324387|MBI|mbi
1139367|NCT02324387|Tc99m sestamibi|tc99m sestamibi
1139368|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1139369|NCT02324387|NAC|nac
1139370|NCT02324374|colon cancer|colon cancer
1139371|NCT02324361|Pediatric|pediatric
1139372|NCT02324361|Obesity|obesity
1139373|NCT02324361|Intervention|intervention
1139374|NCT02324361|Information and Communication Technologies|information and communication technologies
1139375|NCT02324361|Social Media|social media
1139376|NCT02324361|Text Messaging|text messaging
1139377|NCT02324361|Mobile Health|mobile health
1139378|NCT02324335|Oral Mucositis|oral mucositis
1139379|NCT02324335|Brilacidin|brilacidin
1139380|NCT02324335|Chemoradiation|chemoradiation
1139381|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
1139382|NCT02324296|small cell lung cancer|small cell lung cancer
1139383|NCT02324296|extended disease|extended disease
1139384|NCT02324296|limited disease|limited disease
1139385|NCT02324296|chemotherapy|chemotherapy
1139386|NCT02324296|cisplatin|cisplatin
1139387|NCT02324296|etoposide|etoposide
1139388|NCT02324296|ifosfamide|ifosfamide
1139389|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
1139390|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
1139391|NCT02324244|Cytomegalovirus|cytomegalovirus
1139392|NCT02324244|critical patient|critical patient
1139394|NCT02324244|immunocompetent|immunocompetent
1139395|NCT02324244|clinical suspicion|clinical suspicion
1139396|NCT02324244|risk factors|risk factors
1139397|NCT02324218|Diabetes mellitus|diabetes mellitus
1139398|NCT02324218|Hepatitis B|hepatitis b
1139399|NCT02324218|Incidence|incidence
1139400|NCT02324192|Ultrasonography|ultrasonography
1139401|NCT02324192|clinical|clinical
1139402|NCT02324192|hand|hand
1139403|NCT02324166|cefazolin|cefazolin
1139404|NCT02324166|lidocaine|lidocaine
1139405|NCT02324153|Post-operative Delirium|post-operative delirium
1139406|NCT02324114|Cancer|cancer
1139407|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
1139408|NCT02324062|Cancer Genetics|cancer genetics
1139409|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
1139410|NCT02324049|MPS IIIB|mps iiib
1139411|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
1139412|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
1139413|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
1139414|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
1139415|NCT02324049|Metabolic Diseases|metabolic diseases
1139416|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
1139417|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
1139418|NCT02324049|Connective Tissue Diseases|connective tissue diseases
1139419|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
1139420|NCT02324049|Mucinoses|mucinoses
1139421|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
1139422|NCT02324049|Pathologic Processes|pathologic processes
1139423|NCT02324023|ultrasound|ultrasound
1139424|NCT02324023|perfusion|perfusion
1139425|NCT02324023|endoscopic|endoscopic
1139426|NCT02324010|gastric emptying|gastric emptying
1139427|NCT02324010|glycemia|glycemia
1139428|NCT02324010|appetite|appetite
1139429|NCT02324010|incretin hormones|incretin hormones
1139430|NCT02323997|HPV|hpv
1139431|NCT02323997|cervical cancer|cervical cancer
1139432|NCT02323997|human papillomavirus|human papillomavirus
1139433|NCT02323997|cervical pre-cancer|cervical pre-cancer
1139434|NCT02323997|cervical neoplasia|cervical neoplasia
1139435|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
1139436|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
1139437|NCT02323945|strength|strength
1139438|NCT02323945|walking|walking
1139439|NCT02323945|breathing|breathing
1139440|NCT02323919|myocardial infarction|myocardial infarction
1139441|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
1139442|NCT02323919|angioplasty|angioplasty
1139443|NCT02323919|exercise|exercise
1139444|NCT02323919|cardiac patient|cardiac patient
1139445|NCT02323919|physical activity|physical activity
1139446|NCT02323906|Hepatocellular|hepatocellular
1139447|NCT02323906|Carcinoma|carcinoma
1139448|NCT02323906|Phase 1|phase 1
1139449|NCT02323906|CC-122|cc-122
1139450|NCT02323906|Sorafenib,|sorafenib,
1139451|NCT02323906|Nexavar|nexavar
1139452|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
1139453|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
1139454|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
1139455|NCT02323906|liver cancer|liver cancer
1139456|NCT02323893|Positron Emission Tomography|positron emission tomography
1139457|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
1139458|NCT02323867|Transplant|transplant
1139459|NCT02323867|Alternative Donor|alternative donor
1139460|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
1139461|NCT02323841|cervical cancer|cervical cancer
1139462|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1139463|NCT02323841|Adverse Effects|adverse effects
1139464|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
1139465|NCT02323815|behavior change communication|behavior change communication
1139466|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
1139467|NCT02323815|screening coverage|screening coverage
1139468|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
1139469|NCT02323763|Bipolar Disorder|bipolar disorder
1139470|NCT02323763|Suicidal Ideation|suicidal ideation
1139471|NCT02323698|acute intermittent hypoxia|acute intermittent hypoxia
1139472|NCT02323698|incomplete spinal cord injury|incomplete spinal cord injury
1139473|NCT02323685|DCI|dci
1139474|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
1139475|NCT02323685|SAH|sah
1139476|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1139477|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
1139478|NCT02323685|Cerebral Ischemia|cerebral ischemia
1139479|NCT02323685|Brain Ischemia|brain ischemia
1139480|NCT02323659|Mycosis Fungoides|mycosis fungoides
1139481|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1139482|NCT02323659|Interferon|interferon
1139483|NCT02323659|Methotrexate|methotrexate
1139484|NCT02323646|uterine fibroids|uterine fibroids
1139485|NCT02323646|leiomyoma|leiomyoma
1139486|NCT02323646|fibroid tumor|fibroid tumor
1139487|NCT02323646|fibroma|fibroma
1139488|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
1139489|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
1139490|NCT02323620|bone marrow|bone marrow
1139491|NCT02323620|stem cells|stem cells
1139492|NCT02323620|cardiovascular disease|cardiovascular disease
1139493|NCT02323620|mortality|mortality
1139494|NCT02323581|Thoracoabdominal|thoracoabdominal
1139495|NCT02323581|Aneurysm|aneurysm
1139496|NCT02323581|Endovascular|endovascular
1139497|NCT02323581|Stent-Graft|stent-graft
1139498|NCT02323568|ovarian cancer|ovarian cancer
1139499|NCT02323568|quality of life|quality of life
1139500|NCT02323568|remission more than 3 years|remission more than 3 years
1139501|NCT02323555|Cancer|cancer
1139502|NCT02323555|chemotherapy|chemotherapy
1139503|NCT02323555|Targeted therapy|targeted therapy
1139504|NCT02323555|Day Hospital|day hospital
1139505|NCT02323542|Starch|starch
1139506|NCT02323542|cereal products|cereal products
1139507|NCT02323542|glucose kinetics|glucose kinetics
1139508|NCT02323542|blood glucose|blood glucose
1139509|NCT02323542|blood insulin|blood insulin
1139510|NCT02323529|Orfadin|orfadin
1139511|NCT02323529|Nitisinone|nitisinone
1139512|NCT02323529|NTBC|ntbc
1139513|NCT02323503|CRT-D|crt-d
1139514|NCT02323503|replacement|replacement
1139515|NCT02323503|primary prevention|primary prevention
1139516|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
1139517|NCT02323490|meniscus repair|meniscus repair
1139518|NCT02323490|bone marrow stimulation|bone marrow stimulation
1139519|NCT02323477|cellular therapy|cellular therapy
1139520|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
1139521|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
1139522|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
1139523|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
1139524|NCT02323477|ischemic heart disease|ischemic heart disease
1140043|NCT02321072|oxygen|oxygen
1139525|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
1139526|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1139527|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
1139528|NCT02323438|exposure|exposure
1139529|NCT02323438|tobacco|tobacco
1139530|NCT02323438|nicotine|nicotine
1139531|NCT02323438|nicotine gum|nicotine gum
1139532|NCT02323438|electronic cigarette|electronic cigarette
1139533|NCT02323438|e-cig|e-cig
1139534|NCT02323425|stroke|stroke
1139535|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
1139536|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
1139537|NCT02323412|Low back pain|low back pain
1139538|NCT02323412|Chronic|chronic
1139539|NCT02323412|Modic Changes|modic changes
1139540|NCT02323412|MRI|mri
1139541|NCT02323412|epigenetics|epigenetics
1139542|NCT02323412|antibiotics|antibiotics
1139641|NCT02322853|tamoxifen|tamoxifen
1139543|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
1139544|NCT02323386|Dynamic RSA|dynamic rsa
1139545|NCT02323386|Knee|knee
1139546|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
1139547|NCT02323386|Kinematic Analysis|kinematic analysis
1139548|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1139549|NCT02323373|Tranexamic Acid|tranexamic acid
1139550|NCT02323373|Drug Administration Routes|drug administration routes
1139551|NCT02323360|SBRT|sbrt
1139552|NCT02323360|TACE|tace
1139553|NCT02323360|TAE|tae
1139554|NCT02323321|heart transplant|heart transplant
1139555|NCT02323321|heart preservation|heart preservation
1139556|NCT02323321|beating heart transplant|beating heart transplant
1139557|NCT02323295|Malignant bone tumors|malignant bone tumors
1139558|NCT02323282|Dose-response relationship|dose-response relationship
1139559|NCT02323282|Drug|drug
1139560|NCT02323256|cochlear implant|cochlear implant
1139561|NCT02323256|deafness|deafness
1139562|NCT02323256|audiometry|audiometry
1139563|NCT02323256|speech perception|speech perception
1139564|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
1139565|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
1139566|NCT02323243|Temporary urethral stent|temporary urethral stent
1139567|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
1139568|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
1139569|NCT02323217|BU99008|bu99008
1139570|NCT02323217|Radionuclide Imaging|radionuclide imaging
1139571|NCT02323217|Molecular Imaging|molecular imaging
1139572|NCT02323217|Healthy Volunteers|healthy volunteers
1139573|NCT02323217|Alzheimer Disease|alzheimer disease
1139574|NCT02323204|posttraumatic stress|posttraumatic stress
1139575|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1139576|NCT02323178|thrombocytopenia|thrombocytopenia
1139577|NCT02323178|eltrombopag|eltrombopag
1139578|NCT02323152|women|women
1139579|NCT02323152|high risk|high risk
1139580|NCT02323139|High risk MDS|high risk mds
1139581|NCT02323139|Azacitidine|azacitidine
1139582|NCT02323139|LDE255|lde255
1139583|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
1139584|NCT02323126|NSCLC,|nsclc,
1139585|NCT02323126|EGFR-mutated,|egfr-mutated,
1139586|NCT02323126|EGF816,|egf816,
1139587|NCT02323126|INC280,|inc280,
1139588|NCT02323126|Nivolumab,|nivolumab,
1139589|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
1139590|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
1139591|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
1139592|NCT02323126|cMET negative NSCLC|cmet negative nsclc
1139593|NCT02323113|Drug therapy|drug therapy
1139594|NCT02323100|cystic fibrosis|cystic fibrosis
1139595|NCT02323100|corrector|corrector
1139596|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
1139597|NCT02323100|nasal potential difference|nasal potential difference
1139598|NCT02323087|Antibiotic resistance|antibiotic resistance
1139599|NCT02323087|Point of care tests|point of care tests
1139600|NCT02323087|Primary Health Care|primary health care
1139601|NCT02323022|AML|aml
1139602|NCT02323022|cladribine|cladribine
1139603|NCT02323022|induction therapy|induction therapy
1139604|NCT02323009|Transpulmonary pressure|transpulmonary pressure
1139605|NCT02323009|Esophageal balloon|esophageal balloon
1139606|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
1139607|NCT02323009|Cstat|cstat
1139608|NCT02323009|Static effective compliance|static effective compliance
1139609|NCT02323009|Ventilator weaning|ventilator weaning
1139610|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
1139611|NCT02322983|Cerebral Palsy|cerebral palsy
1139612|NCT02322983|Dental Care|dental care
1139613|NCT02322983|Conscious Sedation|conscious sedation
1139614|NCT02322983|Autonomic Nervous System|autonomic nervous system
1139615|NCT02322983|Nitrous Oxide|nitrous oxide
1139616|NCT02322970|intracranial hypertension|intracranial hypertension
1139617|NCT02322970|tcd|tcd
1139618|NCT02322970|non invasive|non invasive
1139619|NCT02322970|ICP|icp
1139620|NCT02322944|acute myocardial infarction|acute myocardial infarction
1139621|NCT02322944|quality improvement|quality improvement
1139622|NCT02322944|reperfusion therapy|reperfusion therapy
1139623|NCT02322905|informal caregivers|informal caregivers
1139624|NCT02322905|caregiving|caregiving
1139625|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
1139626|NCT02322905|cancer|cancer
1139627|NCT02322905|emotion regulation|emotion regulation
1139628|NCT02322905|distress|distress
1139629|NCT02322905|inflammation|inflammation
1139630|NCT02322892|Thiamine|thiamine
1139631|NCT02322892|Vitamin B1|vitamin b1
1139632|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
1139633|NCT02322892|Cardiac surgery|cardiac surgery
1139634|NCT02322892|Lactate|lactate
1139635|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
1139636|NCT02322879|Acetaminophen|acetaminophen
1139637|NCT02322879|Propylene glycol|propylene glycol
1139638|NCT02322866|acne|acne
1139639|NCT02322853|Metastatic breast cancer|metastatic breast cancer
1139640|NCT02322853|p38 map kinase|p38 map kinase
1139642|NCT02322853|LY2228820|ly2228820
1139643|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
1139644|NCT02322827|hiv/aids|hiv/aids
1139645|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
1139646|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
1139647|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
1139648|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
1139649|NCT02322749|bioequivalence|bioequivalence
1139650|NCT02322749|bioavailability|bioavailability
1139651|NCT02322749|pharmacokinetics|pharmacokinetics
1139652|NCT02322749|Phase I|phase i
1139653|NCT02322749|AZD6244|azd6244
1139654|NCT02322749|cancer|cancer
1139655|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
1139656|NCT02322723|Adalimumab|adalimumab
1139657|NCT02322723|real life|real life
1139659|NCT02322723|Humira|humira
1139660|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
1139661|NCT02322723|effectiveness|effectiveness
1139662|NCT02322710|non-inferiority|non-inferiority
1139663|NCT02322710|randomized|randomized
1139664|NCT02322710|TulleGras|tullegras
1139665|NCT02322710|Urgotul|urgotul
1139666|NCT02322710|healing|healing
1139667|NCT02322710|surgical acute wounds|surgical acute wounds
1139668|NCT02322710|pain|pain
1139669|NCT02322697|Carnitine|carnitine
1139670|NCT02322697|hemodialysis|hemodialysis
1139671|NCT02322697|fatty acid|fatty acid
1139672|NCT02322697|imaging|imaging
1139673|NCT02322697|heart|heart
1139674|NCT02322684|Bougie|bougie
1139675|NCT02322684|Air-Q|air-q
1139676|NCT02322684|Insertion|insertion
1139677|NCT02322671|chewable tablet|chewable tablet
1139678|NCT02322671|montelukast sodium|montelukast sodium
1139679|NCT02322671|healthy adult subjects|healthy adult subjects
1139680|NCT02322671|relative bioavailability|relative bioavailability
1139681|NCT02322671|GW483100|gw483100
1139682|NCT02322593|Gastric Cancer|gastric cancer
1139683|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
1139684|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1139685|NCT02322593|First Line Treatment|first line treatment
1139686|NCT02322593|Antineoplastic Agents|antineoplastic agents
1139687|NCT02322580|anti-TNF|anti-tnf
1139688|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
1139689|NCT02322580|immunogenicity|immunogenicity
1139690|NCT02322554|electronic health records|electronic health records
1139691|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
1139692|NCT02322554|PQRS|pqrs
1139693|NCT02322554|quality reporting|quality reporting
1139694|NCT02322554|cellular based products|cellular based products
1139695|NCT02322554|bioengieered skin|bioengieered skin
1139696|NCT02322554|USWR|uswr
1139697|NCT02322528|Non-invasive instruments|non-invasive instruments
1139698|NCT02322528|Environment|environment
1139699|NCT02322528|Wavefront|wavefront
1139700|NCT02322528|Placido Disk|placido disk
1139701|NCT02322528|Ellipsometer|ellipsometer
1139702|NCT02322528|Thermal Imaging|thermal imaging
1139703|NCT02322515|Knee|knee
1139704|NCT02322515|Proprioception|proprioception
1139705|NCT02322515|Electromyography|electromyography
1139706|NCT02322515|Taping|taping
1139707|NCT02322502|laryngeal mask airway|laryngeal mask airway
1139708|NCT02322502|desflurane|desflurane
1139709|NCT02322502|sevoflurane|sevoflurane
1139710|NCT02322502|propofol|propofol
1139711|NCT02322489|microcurent|microcurent
1139712|NCT02322489|pain|pain
1139713|NCT02322489|flexibility|flexibility
1139714|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
1139715|NCT02322411|Stroke|stroke
1139716|NCT02322411|Deglutition|deglutition
1139717|NCT02322411|Deglutition disorders|deglutition disorders
1139718|NCT02322411|Resistance training|resistance training
1139719|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1139720|NCT02322385|PKD 1 gene|pkd 1 gene
1139722|NCT02322385|Truncational mutation|truncational mutation
1139723|NCT02322385|Hypomorphic mutation|hypomorphic mutation
1139724|NCT02322372|femoral blockade|femoral blockade
1139725|NCT02322372|bupivacaine|bupivacaine
1139726|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
1139727|NCT02322346|levobupivacaine|levobupivacaine
1139728|NCT02322320|Multiple Myeloma|multiple myeloma
1139729|NCT02322320|Lenalidomide|lenalidomide
1139730|NCT02322320|Maintenance Therapy|maintenance therapy
1139731|NCT02322320|Progression|progression
1139732|NCT02322320|Long-term|long-term
1139733|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
1139734|NCT02322320|Hematologic Disorders|hematologic disorders
1139735|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
1139736|NCT02322307|Crohn's Disease|crohn's disease
1139737|NCT02322307|Ulcerative Colitis|ulcerative colitis
1139738|NCT02322307|Colitis|colitis
1139746|NCT02322294|insulin|insulin
1139747|NCT02322294|body weight,|body weight,
1139748|NCT02322294|DXA scan|dxa scan
1139749|NCT02322281|cancer|cancer
1139750|NCT02322281|metastatic|metastatic
1139751|NCT02322281|locally advanced|locally advanced
1139752|NCT02322281|lung|lung
1139753|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
1139754|NCT02322281|NSCLC|nsclc
1139755|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
1139756|NCT02322281|EGFR|egfr
1139757|NCT02322281|T790M|t790m
1139758|NCT02322281|CO-1686|co-1686
1139759|NCT02322281|unresectable|unresectable
1139760|NCT02322281|recurrent|recurrent
1139761|NCT02322281|EGFR-directed therapy|egfr-directed therapy
1139762|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
1139763|NCT02322281|TIGER|tiger
1139764|NCT02322281|Rociletinib|rociletinib
1139765|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1139766|NCT02322268|Cosmos Caudatus|cosmos caudatus
1139767|NCT02322268|Ulam Raja|ulam raja
1139768|NCT02322268|Metabolomic profiling|metabolomic profiling
1139769|NCT02322268|antioxidant|antioxidant
1139770|NCT02322255|Natural History Study|natural history study
1139771|NCT02322255|Non-interventional Study|non-interventional study
1139772|NCT02322255|Observational Study|observational study
1139773|NCT02322255|Heterotopic ossification|heterotopic ossification
1139774|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
1139775|NCT02322255|FOP disease progression|fop disease progression
1139776|NCT02322255|FOP flare-up progression|fop flare-up progression
1139777|NCT02322255|Clementia|clementia
1139778|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
1139779|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
1139780|NCT02322255|FOP|fop
1139781|NCT02322255|Palovarotene|palovarotene
1139782|NCT02322229|VMT|vmt
1139783|NCT02322229|sVMA|svma
1139784|NCT02322229|vitrectomy|vitrectomy
1139785|NCT02322229|ocriplasmin|ocriplasmin
1139786|NCT02322216|Allergies|allergies
1139787|NCT02322216|Ocular|ocular
1139793|NCT02322190|Steroid Failure|steroid failure
1139794|NCT02322190|Immunomodulation|immunomodulation
1139795|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
1139796|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
1139797|NCT02322177|Pregnancy|pregnancy
1139798|NCT02322177|Methylmalonic Acidemia|methylmalonic acidemia
1139799|NCT02322177|Urea Cycle Disorder|urea cycle disorder
1139800|NCT02322164|Skin|skin
1139801|NCT02322164|TEMPERATURE|temperature
1139802|NCT02322164|Placebo|placebo
1139803|NCT02322151|Filgrastim|filgrastim
1139804|NCT02322151|Neupogen|neupogen
1139805|NCT02322151|Transplant|transplant
1139806|NCT02322151|Breast Feeding|breast feeding
1139807|NCT02322151|Concentration|concentration
1139808|NCT02322125|walking|walking
1139809|NCT02322125|locomotion|locomotion
1139810|NCT02322125|rehabilitation|rehabilitation
1139811|NCT02322112|Dietary Fiber|dietary fiber
1139812|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
1139813|NCT02322112|Overweight and Obesity|overweight and obesity
1139814|NCT02322112|Personalized Nutrition|personalized nutrition
1139815|NCT02322112|Inflammation|inflammation
1139816|NCT02322112|Metabolism|metabolism
1139817|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
1139818|NCT02322099|bone diseases|bone diseases
1139819|NCT02322099|osteopenia|osteopenia
1139820|NCT02322099|osteoporosis|osteoporosis
1139821|NCT02322099|fracture|fracture
1139822|NCT02322099|bone turnover|bone turnover
1139823|NCT02322099|alendronate|alendronate
1139824|NCT02322099|antiretroviral|antiretroviral
1139825|NCT02322060|IVA, ovary tissue grafting, POI|iva, ovary tissue grafting, poi
1139826|NCT02322034|chronic heart failure|chronic heart failure
1139827|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
1139828|NCT02322034|growth hormone deficiency|growth hormone deficiency
1139829|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
1139830|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
1139831|NCT02322034|interval training|interval training
1139832|NCT02322021|E2609|e2609
1139833|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
1139834|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
1139835|NCT02322021|Alzheimer's Disease|alzheimer's disease
1139836|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
1139837|NCT02321982|Mohs surgery|mohs surgery
1139838|NCT02321982|Preoperative consultation|preoperative consultation
1139839|NCT02321969|Chemoprevention|chemoprevention
1139840|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
1139841|NCT02321969|Green tea extract|green tea extract
1139842|NCT02321956|ASA class 1,2|asa class 1,2
1139843|NCT02321956|age 1-6 years|age 1-6 years
1139844|NCT02321956|General anesthesia with ETT|general anesthesia with ett
1139845|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
1139846|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
1139847|NCT02321930|Tofacitinib|tofacitinib
1139848|NCT02321930|biomarker|biomarker
1139849|NCT02321904|Confocal microscopy|confocal microscopy
1139850|NCT02321904|Cornea|cornea
1139851|NCT02321904|Neuropathy|neuropathy
1139852|NCT02321904|Detection|detection
1139853|NCT02321904|Diabetes|diabetes
1139854|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1139855|NCT02321839|Ranibizumab|ranibizumab
1139856|NCT02321839|Treat and extend|treat and extend
1139857|NCT02321813|quality of life|quality of life
1139858|NCT02321813|colorectal cancer|colorectal cancer
1139859|NCT02321813|definitive RCT|definitive rct
1139860|NCT02321813|complex intervention|complex intervention
1139861|NCT02321800|S-649266|s-649266
1139862|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
1139863|NCT02321800|cefiderocol|cefiderocol
1139864|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
1139865|NCT02321800|Gram-negative pathogens|gram-negative pathogens
1139866|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
1139867|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
1139868|NCT02321787|Ultrasonography|ultrasonography
1139869|NCT02321774|Stress|stress
1139870|NCT02321774|Virtual Reality|virtual reality
1139871|NCT02321774|Wearable Sensor|wearable sensor
1139872|NCT02321774|Wellness|wellness
1139873|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
1139874|NCT02321761|Rehabilitation|rehabilitation
1139875|NCT02321761|Acquired Brain Injury|acquired brain injury
1139877|NCT02321748|HSV|hsv
1139878|NCT02321748|Herpes|herpes
1139879|NCT02321748|volunteers|volunteers
1139880|NCT02321748|drug-drug interaction|drug-drug interaction
1139881|NCT02321735|Long-Term Survivor|long-term survivor
1139882|NCT02321735|Genomic|genomic
1139883|NCT02321735|Survivorship|survivorship
1139884|NCT02321735|Quality of Life|quality of life
1139885|NCT02321722|Colonoscopy|colonoscopy
1139886|NCT02321696|physiotherapy|physiotherapy
1139887|NCT02321696|manual therapy|manual therapy
1139888|NCT02321696|acupuncture|acupuncture
1139889|NCT02321696|eccentric exercise|eccentric exercise
1139890|NCT02321670|operative technique|operative technique
1139891|NCT02321644|CC-90001|cc-90001
1139892|NCT02321644|PHARMACOKINETICS|pharmacokinetics
1139893|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
1139894|NCT02321644|HEALTHY SUBJECTS|healthy subjects
1139895|NCT02321644|SINGLE DOSE|single dose
1139896|NCT02321644|MULTIPLE DOSE|multiple dose
1139897|NCT02321644|PUNCH BIOPSY|punch biopsy
1139898|NCT02321631|Malnourished|malnourished
1139899|NCT02321631|Head and Neck Cancer|head and neck cancer
1139900|NCT02321631|Surgery|surgery
1139901|NCT02321618|Hypertension|hypertension
1139902|NCT02321618|High Blood Pressure|high blood pressure
1139903|NCT02321618|African American men|african american men
1139904|NCT02321618|Black men|black men
1139905|NCT02321618|barbershop|barbershop
1139906|NCT02321605|Best Possible Self|best possible self
1139907|NCT02321605|Positive Psychology|positive psychology
1139908|NCT02321605|Optimism|optimism
1139909|NCT02321605|Positive Technology|positive technology
1139910|NCT02321605|Future Thinking|future thinking
1139911|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
1139912|NCT02321592|AFM13|afm13
1139913|NCT02321592|Natural Killer Cells|natural killer cells
1139914|NCT02321553|metabolic syndrome|metabolic syndrome
1139915|NCT02321553|glucose|glucose
1139916|NCT02321553|cholesterol|cholesterol
1139917|NCT02321553|brown rice|brown rice
1139918|NCT02321553|inflammation|inflammation
1139919|NCT02321553|oxidative stress|oxidative stress
1139920|NCT02321540|Lung Cancer|lung cancer
1139921|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
1139922|NCT02321540|NSCLC|nsclc
1139923|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
1139924|NCT02321540|EGFR|egfr
1139925|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1139926|NCT02321540|Ibrutinib|ibrutinib
1139927|NCT02321540|PCI-32765|pci-32765
1139928|NCT02321540|Imbruvica|imbruvica
1139929|NCT02321527|Breast Cancer|breast cancer
1139930|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
1139931|NCT02321527|CEUS|ceus
1139932|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
1139933|NCT02321527|SLN|sln
1139934|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
1139935|NCT02321527|OPTISON™|optison™
1139936|NCT02321527|Ultrasound|ultrasound
1139937|NCT02321527|Breast biopsy|breast biopsy
1139938|NCT02321527|Radioactive seed|radioactive seed
1139939|NCT02321527|Phone call|phone call
1139940|NCT02321527|Fine needle aspiration|fine needle aspiration
1139941|NCT02321527|FNA|fna
1139942|NCT02321501|Head and Neck Cancer|head and neck cancer
1139943|NCT02321501|Lung Cancer|lung cancer
1139944|NCT02321501|Non small cell lung|non small cell lung
1139945|NCT02321501|NSCLC|nsclc
1139946|NCT02321501|Metastatic|metastatic
1139947|NCT02321501|Locally advanced|locally advanced
1139948|NCT02321501|Metastatic solid tumors|metastatic solid tumors
1139949|NCT02321501|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
1139950|NCT02321501|ALK|alk
1139951|NCT02321501|Ceritinib|ceritinib
1139952|NCT02321501|LDK378|ldk378
1139953|NCT02321501|Zykadia|zykadia
1139954|NCT02321501|Everolimus|everolimus
1139955|NCT02321501|Afinitor|afinitor
1139956|NCT02321501|Zortress|zortress
1139957|NCT02321501|RAD001|rad001
1139958|NCT02321501|Pharmacokinetic|pharmacokinetic
1139959|NCT02321501|PK|pk
1139960|NCT02321501|Biomarker testing|biomarker testing
1139961|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
1139962|NCT02321462|preparation|preparation
1139963|NCT02321423|Nail Dystrophy|nail dystrophy
1139964|NCT02321423|Plantar Keratoderma|plantar keratoderma
1139965|NCT02321423|Palmar Keratoderma|palmar keratoderma
1139966|NCT02321423|Leukokeratosis|leukokeratosis
1139967|NCT02321423|Cysts|cysts
1139968|NCT02321423|Pain|pain
1139969|NCT02321423|KRT17|krt17
1139970|NCT02321423|KRT16|krt16
1139971|NCT02321423|KRT6A|krt6a
1139972|NCT02321423|KRT6B|krt6b
1139973|NCT02321423|KRT6C|krt6c
1139974|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
1139975|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
1139976|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
1139977|NCT02321358|Behavior Change|behavior change
1139978|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
1139979|NCT02321358|Survivorship|survivorship
1139980|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1139981|NCT02321345|Hematological Malignancies|hematological malignancies
1139982|NCT02321345|Palliative Care|palliative care
1139983|NCT02321345|Supportive care|supportive care
1139984|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
1139985|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
1139986|NCT02321319|chronic pain|chronic pain
1139987|NCT02321319|pediatric|pediatric
1139988|NCT02321293|curcumin|curcumin
1139989|NCT02321293|lung cancer|lung cancer
1139990|NCT02321293|TKI|tki
1139991|NCT02321267|AMD|amd
1139992|NCT02321267|PCV|pcv
1139993|NCT02321267|RAP|rap
1139994|NCT02321267|RVO|rvo
1139995|NCT02321267|DME|dme
1139996|NCT02321267|ERM|erm
1139997|NCT02321267|MH|mh
1139998|NCT02321267|mCNV|mcnv
1139999|NCT02321254|Stroke|stroke
1140000|NCT02321254|Upper limb|upper limb
1140001|NCT02321254|Robotics|robotics
1140002|NCT02321254|Electromyography|electromyography
1140003|NCT02321254|Rehabilitation|rehabilitation
1140004|NCT02321241|Wet-AMD|wet-amd
1140005|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
1140006|NCT02321241|Real life|real life
1140007|NCT02321241|Switch|switch
1140008|NCT02321241|Aflibercept|aflibercept
1140009|NCT02321228|Salpingectomy|salpingectomy
1140010|NCT02321228|Delayed oophorectomy|delayed oophorectomy
1140011|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
1140012|NCT02321228|Quality of life|quality of life
1140013|NCT02321228|Ovarian cancer|ovarian cancer
1140014|NCT02321228|BRCA|brca
1140015|NCT02321215|AECOPD|aecopd
1140016|NCT02321215|COPD|copd
1140017|NCT02321215|education|education
1140018|NCT02321202|omega-3|omega-3
1140019|NCT02321202|Progression|progression
1140020|NCT02321202|parenteral nutrition|parenteral nutrition
1140021|NCT02321150|Pterygium|pterygium
1140022|NCT02321150|Pterygiums|pterygiums
1140023|NCT02321150|Pterygia|pterygia
1140024|NCT02321150|Graft|graft
1140025|NCT02321150|Autograft|autograft
1140026|NCT02321150|Excision|excision
1140027|NCT02321150|Surgery|surgery
1140028|NCT02321150|Eye|eye
1140029|NCT02321150|electrocautery|electrocautery
1140030|NCT02321150|polyglactin|polyglactin
1140031|NCT02321124|Constipation|constipation
1140032|NCT02321124|connective tissue manipulation|connective tissue manipulation
1140033|NCT02321124|conservative therapy|conservative therapy
1140034|NCT02321124|massage|massage
1140035|NCT02321124|randomized controlled trial|randomized controlled trial
1140036|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
1140037|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
1140038|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
1140039|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
1140040|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
1140041|NCT02321098|Onychomycosis|onychomycosis
1140046|NCT02321072|critical care|critical care
1140047|NCT02321072|intensive care|intensive care
1140048|NCT02321059|incisional hernia|incisional hernia
1140050|NCT02321059|abdominal wall strength|abdominal wall strength
1140051|NCT02321059|validation|validation
1140052|NCT02321059|physical activity|physical activity
1140053|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
1140054|NCT02321033|glycemic index|glycemic index
1140055|NCT02321033|inactivity|inactivity
1140056|NCT02321033|insulin sensitivity|insulin sensitivity
1140057|NCT02321033|metabolic flexibility|metabolic flexibility
1140058|NCT02321033|arterial stiffness|arterial stiffness
1140059|NCT02321033|young men|young men
1140060|NCT02320994|stroke|stroke
1140061|NCT02320994|aftercare|aftercare
1140062|NCT02320981|GERD|gerd
1140063|NCT02320981|EGD|egd
1140064|NCT02320981|pH testing|ph testing
1140065|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
1140066|NCT02320981|impedance testing|impedance testing
1140067|NCT02320955|autologous bone flap|autologous bone flap
1140068|NCT02320955|decompressive craniectomy|decompressive craniectomy
1140069|NCT02320955|malignant brain swelling|malignant brain swelling
1140070|NCT02320955|patient specific implant|patient specific implant
1140071|NCT02320955|bone resorption|bone resorption
1140072|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
1140073|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
1140074|NCT02320942|Exercise|exercise
1140075|NCT02320942|Rehabilitation|rehabilitation
1140076|NCT02320942|Cancer|cancer
1140077|NCT02320929|irrigation|irrigation
1140078|NCT02320929|tenosynovitis|tenosynovitis
1140079|NCT02320929|purulent|purulent
1140080|NCT02320929|closed-catheter|closed-catheter
1140081|NCT02320929|flexor tendon|flexor tendon
1140082|NCT02320903|Criminal Justice|criminal justice
1140083|NCT02320903|Juvenile Delinquency|juvenile delinquency
1140084|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
1140085|NCT02320890|tDCS|tdcs
1140086|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
1140087|NCT02320890|MCI|mci
1140088|NCT02320864|muscle strength|muscle strength
1140089|NCT02320864|muscle weakness|muscle weakness
1140090|NCT02320864|hospitalization|hospitalization
1140091|NCT02320864|surgery|surgery
1140092|NCT02320864|total knee replacement|total knee replacement
1140093|NCT02320851|Somatoform disorder|somatoform disorder
1140094|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
1140095|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
1140096|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1140097|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
1140098|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
1140099|NCT02320838|Neural Conduction|neural conduction
1140100|NCT02320838|Pain Threshold|pain threshold
1140101|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
1140102|NCT02320825|Single-Fraction|single-fraction
1140103|NCT02320825|Hypofractionated|hypofractionated
1140104|NCT02320825|Spinal surgery|spinal surgery
1140105|NCT02320825|14-233|14-233
1140106|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
1140107|NCT02320799|HIV|hiv
1140108|NCT02320799|women|women
1140109|NCT02320799|gender based violence|gender based violence
1140110|NCT02320799|mental health|mental health
1140111|NCT02320799|africa|africa
1140112|NCT02320799|kenya|kenya
1140113|NCT02320799|global mental health|global mental health
1140114|NCT02320799|HIV treatment adherence|hiv treatment adherence
1140115|NCT02320786|Power mobility|power mobility
1140116|NCT02320786|Wheelchair skills training|wheelchair skills training
1140117|NCT02320786|Spinal Cord Injury|spinal cord injury
1140118|NCT02320773|Overactive Bladder|overactive bladder
1140119|NCT02320773|Quality of Life|quality of life
1140120|NCT02320773|Betanis®|betanis®
1140121|NCT02320773|Betmiga®|betmiga®
1140122|NCT02320773|Observational|observational
1140123|NCT02320773|Myrbetriq®|myrbetriq®
1140124|NCT02320747|Volunteers|volunteers
1140125|NCT02320734|surgical rating scale|surgical rating scale
1140126|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
1140127|NCT02320734|Anaesthesia|anaesthesia
1140128|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
1140129|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
1140130|NCT02320643|Partially absorbable mesh|partially absorbable mesh
1140131|NCT02320617|Lung Neoplasms|lung neoplasms
1140132|NCT02320617|diffusion weighted MRI|diffusion weighted mri
1140133|NCT02320617|ADC value|adc value
1140134|NCT02320617|treatment effect|treatment effect
1140135|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
1140136|NCT02320604|AmBisome|ambisome
1140137|NCT02320604|Pharmacokinetics|pharmacokinetics
1140138|NCT02320604|Obesity|obesity
1140139|NCT02320604|Bariatric surgery|bariatric surgery
1140140|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
1140141|NCT02320578|Laparoscopy 3D|laparoscopy 3d
1140142|NCT02320578|Cervical cancer|cervical cancer
1140246|NCT02319850|screening|screening
1140143|NCT02320565|Endometrial Cancer|endometrial cancer
1140144|NCT02320565|Laparoscopy 3D|laparoscopy 3d
1140250|NCT02319850|ultrasound|ultrasound
1140145|NCT02320552|Nutritional assessment|nutritional assessment
1140146|NCT02320539|MicroRNA|microrna
1140147|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
1140148|NCT02320526|Exercise|exercise
1140149|NCT02320526|Training|training
1140150|NCT02320526|Interval training|interval training
1140151|NCT02320526|Systemic inflammation|systemic inflammation
1140152|NCT02320526|Glucose disposal|glucose disposal
1140153|NCT02320526|Insulin sensitivity|insulin sensitivity
1140154|NCT02320526|Glucose effectiveness|glucose effectiveness
1140155|NCT02320513|Exercise|exercise
1140156|NCT02320461|diabetes mellitus|diabetes mellitus
1140157|NCT02320461|cardiovascular diseases|cardiovascular diseases
1140158|NCT02320461|cohort studies|cohort studies
1140159|NCT02320461|hypertension|hypertension
1140160|NCT02320461|obesity|obesity
1140161|NCT02320461|smoking|smoking
1140162|NCT02320461|social class|social class
1140163|NCT02320422|liver transplant|liver transplant
1140164|NCT02320422|medication adherence|medication adherence
1140165|NCT02320422|intervention|intervention
1140166|NCT02320409|Subjects|subjects
1140167|NCT02320383|CLL|cll
1140168|NCT02320357|Platelet activation|platelet activation
1140169|NCT02320357|CD40 ligand|cd40 ligand
1140170|NCT02320357|CD154|cd154
1140171|NCT02320357|Interferon alpha|interferon alpha
1140172|NCT02320357|clopidogrel|clopidogrel
1140173|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
1140174|NCT02320318|Colon, irritable|colon, irritable
1140175|NCT02320318|Bowel disease|bowel disease
1140176|NCT02320318|Diarrhea|diarrhea
1140177|NCT02320279|Fetal Heart Rate|fetal heart rate
1140178|NCT02320279|Fetal EKG|fetal ekg
1140179|NCT02320279|FHR tracing|fhr tracing
1140180|NCT02320279|fetal R-waves|fetal r-waves
1140181|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
1140182|NCT02320253|Diabetes|diabetes
1140183|NCT02320253|Obesity|obesity
1140184|NCT02320253|Primary Care|primary care
1140185|NCT02320253|Lifestyle Intervention|lifestyle intervention
1140186|NCT02320240|antidepressants|antidepressants
1140187|NCT02320240|acute kidney injury|acute kidney injury
1140188|NCT02320240|SNRI|snri
1140189|NCT02320240|renal failure|renal failure
1140190|NCT02320240|duloxetine|duloxetine
1140191|NCT02320240|CNODES|cnodes
1140192|NCT02320188|modification of treatment planned|modification of treatment planned
1140193|NCT02320188|Exercise|exercise
1140194|NCT02320175|family centered rounds|family centered rounds
1140195|NCT02320175|patient safety|patient safety
1140196|NCT02320175|errors|errors
1140197|NCT02320175|adverse events|adverse events
1140198|NCT02320175|concordance|concordance
1140199|NCT02320175|patient experience|patient experience
1140200|NCT02320149|acne|acne
1140201|NCT02320123|Terminal Care|terminal care
1140202|NCT02320123|Decision Making|decision making
1140203|NCT02320123|Communication|communication
1140204|NCT02320110|Irisin|irisin
1140205|NCT02320110|Adiponectin|adiponectin
1140206|NCT02320110|Leptin|leptin
1140207|NCT02320110|Insulin resistance|insulin resistance
1140208|NCT02320110|Body Mass Index|body mass index
1140209|NCT02320110|Obesity|obesity
1140210|NCT02320110|Metabolic Syndrome|metabolic syndrome
1140211|NCT02320110|Lipid Profile|lipid profile
1140212|NCT02320110|Diabetes Mellitus|diabetes mellitus
1140213|NCT02320084|HT-1|ht-1
1140214|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
1140215|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
1140216|NCT02320084|Orfadin|orfadin
1140217|NCT02320084|Long term safety|long term safety
1140218|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
1140219|NCT02320032|Alkermes|alkermes
1140220|NCT02320032|Schizophrenia|schizophrenia
1140221|NCT02320032|Aripiprazole|aripiprazole
1140222|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
1140223|NCT02320032|ALKS 9072|alks 9072
1140224|NCT02320006|hydrotubation|hydrotubation
1140225|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
1140226|NCT02320006|Acupuncture|acupuncture
1140227|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
1140228|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
1140229|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
1140230|NCT02319993|Herbs|herbs
1140231|NCT02319993|Quality of life|quality of life
1140232|NCT02319967|community health worker|community health worker
1140233|NCT02319967|emergency|emergency
1140234|NCT02319967|asthma|asthma
1140235|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
1140236|NCT02319941|ticagrelor|ticagrelor
1140237|NCT02319941|clopidogrel|clopidogrel
1140238|NCT02319941|Pharmacodynamics|pharmacodynamics
1140239|NCT02319941|Pharmacokinetics|pharmacokinetics
1140240|NCT02319915|tranexamic acid|tranexamic acid
1140241|NCT02319915|knee prosthesis|knee prosthesis
1140242|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
1140243|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
1140244|NCT02319863|prognosis|prognosis
1140245|NCT02319850|sarcopenia|sarcopenia
1140251|NCT02319798|Crohn's disease|crohn's disease
1140252|NCT02319798|ulcerative colitis|ulcerative colitis
1140253|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
1140255|NCT02319772|Healthy volunteers|healthy volunteers
1140256|NCT02319772|Ebola virus|ebola virus
1140257|NCT02319772|Filovirus|filovirus
1140258|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
1140259|NCT02319759|Guselkumab|guselkumab
1140260|NCT02319759|Ustekinumab|ustekinumab
1140261|NCT02319759|Placebo|placebo
1140262|NCT02319694|Basal Ganglia|basal ganglia
1140263|NCT02319694|Behavior|behavior
1140264|NCT02319694|Behavioral|behavioral
1140265|NCT02319694|Brain|brain
1140266|NCT02319694|Cognitive|cognitive
1140267|NCT02319694|Computer Simulation|computer simulation
1140268|NCT02319694|Cues|cues
1140269|NCT02319694|Data|data
1140270|NCT02319694|Deep Brain Stimulation|deep brain stimulation
1140271|NCT02319694|Disease|disease
1140272|NCT02319681|Caregivers|caregivers
1140273|NCT02319681|Anxiety|anxiety
1140274|NCT02319681|Depression|depression
1140275|NCT02319655|Epiretinal membrane|epiretinal membrane
1140276|NCT02319655|Macular pucker|macular pucker
1140277|NCT02319655|Membrane peeling|membrane peeling
1140278|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
1140279|NCT02319655|Air|air
1140280|NCT02319655|balanced salt solution|balanced salt solution
1140281|NCT02319655|Intraoperative OCT|intraoperative oct
1140282|NCT02319655|Hyporeflectivity|hyporeflectivity
1140283|NCT02319655|Retina|retina
1140284|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
1140285|NCT02319642|TNFα antagonist|tnfα antagonist
1140286|NCT02319642|Certolizumab pegol|certolizumab pegol
1140287|NCT02319642|Chinese patients|chinese patients
1140288|NCT02319642|Open-label|open-label
1140289|NCT02319629|Morbid obesity,|morbid obesity,
1140290|NCT02319629|Cholelithiasis|cholelithiasis
1140291|NCT02319629|Bariatric surgery|bariatric surgery
1140292|NCT02319629|Ursodiol|ursodiol
1140293|NCT02319577|NSCLC|nsclc
1140294|NCT02319577|EGFR|egfr
1140295|NCT02319577|vinorelbine|vinorelbine
1140296|NCT02319577|gefitinib|gefitinib
1140297|NCT02319564|Wheeze|wheeze
1140298|NCT02319564|Asthma|asthma
1140299|NCT02319564|Randomized Trial|randomized trial
1140300|NCT02319564|Pre-school aged children|pre-school aged children
1140301|NCT02319538|Chronic thyroiditis|chronic thyroiditis
1140302|NCT02319538|Total thyroidectomy|total thyroidectomy
1140303|NCT02319538|Anti-TPO|anti-tpo
1140304|NCT02319538|PROMs|proms
1140305|NCT02319538|SF36|sf36
1140306|NCT02319538|Fatigue questionnaire|fatigue questionnaire
1140307|NCT02319538|Fatigue|fatigue
1140308|NCT02319538|Autoimmune symptoms|autoimmune symptoms
1140309|NCT02319538|HADs|hads
1140310|NCT02319538|FSS|fss
1140311|NCT02319538|fVAS|fvas
1140312|NCT02319525|lupus nephritis|lupus nephritis
1140313|NCT02319525|lupus|lupus
1140314|NCT02319525|decision-making|decision-making
1140315|NCT02319525|minorities|minorities
1140316|NCT02319525|immunosuppressive medications|immunosuppressive medications
1140317|NCT02319525|decision-aid|decision-aid
1140318|NCT02319525|treatment|treatment
1140319|NCT02319525|Decision conflict|decision conflict
1140320|NCT02319525|SLE|sle
1140321|NCT02319486|Retinoblastoma|retinoblastoma
1140322|NCT02319486|carboplatin|carboplatin
1140323|NCT02319473|system of care|system of care
1140324|NCT02319473|acute myocardial infarction|acute myocardial infarction
1140325|NCT02319473|registry|registry
1140326|NCT02319473|Primary PCI|primary pci
1140327|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
1140328|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
1140329|NCT02319460|Warfarin Reversal|warfarin reversal
1140330|NCT02319447|Living Donation|living donation
1140331|NCT02319447|Kidney Transplantation|kidney transplantation
1140332|NCT02319421|Alarm fatigue|alarm fatigue
1140333|NCT02319395|Parkinson's Disease|parkinson's disease
1140334|NCT02319395|Behaviour addiction|behaviour addiction
1140335|NCT02319395|Dopamine agonist|dopamine agonist
1140336|NCT02319395|Genetic.|genetic.
1140337|NCT02319382|Parkinson Disease|parkinson disease
1140338|NCT02319382|[18F]DPA-714|[18f]dpa-714
1140339|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
1140340|NCT02319382|Neuroinflammation|neuroinflammation
1140341|NCT02319343|Glucocorticoid|glucocorticoid
1140342|NCT02319343|Quadriceps muscle function|quadriceps muscle function
1140343|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
1140344|NCT02319330|HIV|hiv
1140345|NCT02319330|Adherence|adherence
1140346|NCT02319330|Mental health|mental health
1140347|NCT02319330|Depression|depression
1140348|NCT02319330|Women|women
1140349|NCT02319330|Mobile phone technology|mobile phone technology
1140350|NCT02319330|eHealth|ehealth
1140351|NCT02319330|India|india
1140352|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
1140353|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
1140354|NCT02319265|sepsis|sepsis
1140355|NCT02319265|antioxidant|antioxidant
1140356|NCT02319265|melatonin|melatonin
1140357|NCT02319265|inflammation|inflammation
1140358|NCT02319239|Prostate neoplasms|prostate neoplasms
1140359|NCT02319239|Urogenital neoplasms|urogenital neoplasms
1140360|NCT02319239|Genital neoplasms, male|genital neoplasms, male
1140361|NCT02319239|Radiation therapy|radiation therapy
1140362|NCT02319239|PSA|psa
1140363|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
1140364|NCT02319239|Intra-fractional movement|intra-fractional movement
1140365|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
1140366|NCT02319239|Stereotactic|stereotactic
1140367|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
1140368|NCT02319239|Quality of life|quality of life
1140369|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
1140370|NCT02319213|intraocular pressure,|intraocular pressure,
1140371|NCT02319213|abdominal hypertension,|abdominal hypertension,
1140372|NCT02319213|laparoscopy,|laparoscopy,
1140373|NCT02319213|critical care|critical care
1140374|NCT02319200|Chemoprevention|chemoprevention
1140375|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
1140376|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
1140377|NCT02319200|Death|death
1140378|NCT02319200|Efficacy|efficacy
1140379|NCT02319200|Safety|safety
1140380|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
1140381|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
1140382|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
1140383|NCT02319122|Cerebral Palsy|cerebral palsy
1140384|NCT02319122|Muscle structure|muscle structure
1140385|NCT02319122|Strength training|strength training
1140386|NCT02319096|Whole body vibration therapy|whole body vibration therapy
1140387|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
1140388|NCT02319096|stress urinary incontinence|stress urinary incontinence
1140389|NCT02319083|CABG|cabg
1140390|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
1140391|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
1140392|NCT02319083|Coronary surgery|coronary surgery
1140393|NCT02319083|Myocardial infarction|myocardial infarction
1140394|NCT02319083|Coronary artery disease|coronary artery disease
1140395|NCT02319083|Off-pump|off-pump
1140396|NCT02319083|EuroSCORE|euroscore
1140397|NCT02319070|Cost|cost
1140398|NCT02319070|Clinical Outcomes|clinical outcomes
1140399|NCT02319070|Quality of Life|quality of life
1140400|NCT02319070|On Demand Treatment|on demand treatment
1140401|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
1140402|NCT02319057|Healthy volunteer study|healthy volunteer study
1140403|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
1140404|NCT02319005|Cardiomyopathy|cardiomyopathy
1140405|NCT02319005|Heart Failure|heart failure
1140407|NCT02319005|Amyloid|amyloid
1140408|NCT02319005|Transthyretin|transthyretin
1140409|NCT02319005|TTR|ttr
1140410|NCT02319005|RNAi therapeutic|rnai therapeutic
1140411|NCT02318953|Telemedicine|telemedicine
1140412|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
1140413|NCT02318953|Postoperative Care|postoperative care
1140414|NCT02318953|Cost Effectiveness|cost effectiveness
1140415|NCT02318953|Mobile Applications|mobile applications
1140416|NCT02318953|Health Services Research|health services research
1140417|NCT02318953|Breast Reconstruction|breast reconstruction
1140418|NCT02318940|ultrasound guided|ultrasound guided
1140419|NCT02318940|femoral vein|femoral vein
1140420|NCT02318940|central venous catheter|central venous catheter
1140421|NCT02318940|pediatric|pediatric
1140422|NCT02318927|Deep Brain Stimulation|deep brain stimulation
1140423|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
1140424|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
1140425|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
1140426|NCT02318875|Inflammation|inflammation
1140427|NCT02318875|swell|swell
1140428|NCT02318875|pain|pain
1140429|NCT02318875|functional impairment|functional impairment
1140430|NCT02318875|stiffness|stiffness
1140431|NCT02318862|reflux|reflux
1140432|NCT02318862|GERD|gerd
1140433|NCT02318862|EGD|egd
1140434|NCT02318862|pH testing|ph testing
1140435|NCT02318849|designated organ donor, college students|designated organ donor, college students
1140436|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
1140437|NCT02318823|social neuroscience|social neuroscience
1140438|NCT02318823|emotion|emotion
1140439|NCT02318823|face recognition|face recognition
1140440|NCT02318823|empathy|empathy
1140441|NCT02318823|beer|beer
1140442|NCT02318823|alcohol|alcohol
1140443|NCT02318823|social cognition|social cognition
1140444|NCT02318810|Muscle relaxants|muscle relaxants
1140445|NCT02318797|Chronic disease|chronic disease
1140446|NCT02318797|Mental Health|mental health
1140447|NCT02318797|Behavioral Health|behavioral health
1140448|NCT02318797|Community mental health centers|community mental health centers
1140449|NCT02318797|Intervention studies|intervention studies
1140450|NCT02318797|Mixed methods|mixed methods
1140451|NCT02318797|Qualitative research|qualitative research
1140452|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
1140453|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
1140760|NCT02317107|Gait|gait
1140454|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
1140457|NCT02318784|proteasome inhibitors|proteasome inhibitors
1140458|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
1140459|NCT02318745|Family Therapy|family therapy
1140460|NCT02318745|Substance abuse prevention|substance abuse prevention
1140461|NCT02318745|Minority|minority
1140462|NCT02318745|randomized trials|randomized trials
1140463|NCT02318745|outcome research|outcome research
1140464|NCT02318745|adolescent treatment|adolescent treatment
1140465|NCT02318732|violence|violence
1140466|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
1140467|NCT02318719|Developmental Phase III|developmental phase iii
1140468|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
1140469|NCT02318641|oxygen consumption|oxygen consumption
1140470|NCT02318641|retinal oximetry|retinal oximetry
1140471|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
1140472|NCT02318628|CAVI|cavi
1140473|NCT02318628|pulse wave velocity|pulse wave velocity
1140475|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
1140476|NCT02318615|Breast Neoplasm|breast neoplasm
1140477|NCT02318615|Lymphedema|lymphedema
1140478|NCT02318615|Autologous flap|autologous flap
1140479|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
1140480|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1140481|NCT02318602|Dravet syndrome|dravet syndrome
1140482|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
1140483|NCT02318576|Multiple Sclerosis|multiple sclerosis
1140484|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
1140485|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
1140486|NCT02318472|Microdialysis|microdialysis
1140487|NCT02318472|Patient related outcome|patient related outcome
1140488|NCT02318472|Heel rise test|heel rise test
1140489|NCT02318472|Immobilization|immobilization
1140490|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
1140491|NCT02318446|Folic acid|folic acid
1140492|NCT02318446|Homocysteine|homocysteine
1140493|NCT02318433|DRF|drf
1140494|NCT02318433|PTOA|ptoa
1140495|NCT02318433|dexamethasone|dexamethasone
1140496|NCT02318420|Obstetrics|obstetrics
1140497|NCT02318420|Partogram|partogram
1140498|NCT02318420|ePartogram|epartogram
1140499|NCT02318420|eHealth|ehealth
1140500|NCT02318420|Low-income|low-income
1140501|NCT02318420|Quality of care|quality of care
1140502|NCT02318420|Perinatal death|perinatal death
1140503|NCT02318420|Maternal death|maternal death
1140504|NCT02318420|Cesarean section|cesarean section
1140505|NCT02318420|Health information technology|health information technology
1140506|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
1140507|NCT02318381|suprascapular nerve|suprascapular nerve
1140508|NCT02318381|rotator cuff tear|rotator cuff tear
1140509|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
1140510|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
1140511|NCT02318355|hemodilution|hemodilution
1140512|NCT02318355|hemorrhage|hemorrhage
1140513|NCT02318355|trauma|trauma
1140514|NCT02318355|lactate|lactate
1140515|NCT02318355|base deficit|base deficit
1140516|NCT02318355|randomized control trial|randomized control trial
1140517|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
1140518|NCT02318316|Exhaled breath condensate|exhaled breath condensate
1140519|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1140520|NCT02318316|pulmonary complications|pulmonary complications
1140521|NCT02318290|Analgesia|analgesia
1140522|NCT02318290|Critical Care|critical care
1140523|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
1140524|NCT02318251|Power, rate of force development|power, rate of force development
1140525|NCT02318251|involuntary|involuntary
1140526|NCT02318251|reflexive|reflexive
1140527|NCT02318238|evaluation|evaluation
1140528|NCT02318238|exercise tolerance|exercise tolerance
1140529|NCT02318238|healthy children|healthy children
1140530|NCT02318238|6MWT|6mwt
1140531|NCT02318225|Misoprostol|misoprostol
1140532|NCT02318225|Office hysteroscopy|office hysteroscopy
1140533|NCT02318225|Pain|pain
1140534|NCT02318212|Cervical dilatation|cervical dilatation
1140535|NCT02318199|emergence agitation|emergence agitation
1140536|NCT02318199|intracranial surgery|intracranial surgery
1140537|NCT02318199|general anesthesia|general anesthesia
1140538|NCT02318199|incidence|incidence
1140539|NCT02318199|risk factor|risk factor
1140540|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
1140541|NCT02318186|remodulin|remodulin
1140542|NCT02318186|trepostinil|trepostinil
1140543|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
1140544|NCT02318173|Cervical dilatation|cervical dilatation
1140545|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
1140546|NCT02318160|Oxidative Status|oxidative status
1140547|NCT02318160|Children|children
1140548|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
1140549|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
1140550|NCT02318147|Bacterial Translocation|bacterial translocation
1140551|NCT02318147|Infectious Complications|infectious complications
1140552|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
1140553|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
1140554|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
1140555|NCT02318134|Intestinal flora|intestinal flora
1140556|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
1140557|NCT02318108|Organizational Innovation|organizational innovation
1140558|NCT02318108|Primary Health Care|primary health care
1140559|NCT02318095|Cancer of the pancreas|cancer of the pancreas
1140560|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
1140561|NCT02318069|immune response|immune response
1140562|NCT02318069|TBE-vaccine|tbe-vaccine
1140563|NCT02318069|elderly|elderly
1140564|NCT02318069|additional doses|additional doses
1140565|NCT02318056|hand|hand
1140566|NCT02318056|burns|burns
1140567|NCT02318056|thermal|thermal
1140568|NCT02318056|dressing|dressing
1140569|NCT02318056|Aquacel®|aquacel®
1140570|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
1140571|NCT02318056|Xeroform®|xeroform®
1140572|NCT02318056|Bacitracin®|bacitracin®
1140573|NCT02318056|partial thickness|partial thickness
1140574|NCT02318056|epithelialization|epithelialization
1140575|NCT02318056|wound healing|wound healing
1140576|NCT02318056|scar|scar
1140577|NCT02318056|scarring|scarring
1140578|NCT02318043|adenosine monophosphate|adenosine monophosphate
1140579|NCT02318043|histamine|histamine
1140580|NCT02318043|bronchial provocation test|bronchial provocation test
1140581|NCT02318043|asthma symptom score|asthma symptom score
1140582|NCT02318043|asthma control|asthma control
1140583|NCT02318030|Transplant|transplant
1140584|NCT02318030|Adaptive Immunity|adaptive immunity
1140586|NCT02318030|Medication Adherence|medication adherence
1140587|NCT02318030|Tacrolimus|tacrolimus
1140588|NCT02318030|PTLD|ptld
1140589|NCT02318017|adhd|adhd
1140590|NCT02318017|global network|global network
1140591|NCT02318017|eeg|eeg
1140592|NCT02318004|telemonitoring|telemonitoring
1140593|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
1140594|NCT02317991|nab-paclitaxel|nab-paclitaxel
1140595|NCT02317991|Abraxane|abraxane
1140596|NCT02317991|ramucirumab|ramucirumab
1140597|NCT02317991|Cyramza|cyramza
1140598|NCT02317991|GE junction|ge junction
1140599|NCT02317913|Kawasaki disease|kawasaki disease
1140600|NCT02317913|Epidemiology|epidemiology
1140601|NCT02317913|Incidence|incidence
1140602|NCT02317913|Coronary arterial lesions|coronary arterial lesions
1140603|NCT02317913|Shanghai|shanghai
1140604|NCT02317887|Gene Transfer|gene transfer
1140605|NCT02317887|X-Linked|x-linked
1140606|NCT02317887|Retinoschisis|retinoschisis
1140607|NCT02317887|AAV Vector|aav vector
1140608|NCT02317848|Diagnosis|diagnosis
1140609|NCT02317848|prognostic marker|prognostic marker
1140610|NCT02317848|polygraphy|polygraphy
1140611|NCT02317848|echocardiography|echocardiography
1140612|NCT02317848|ECG|ecg
1140613|NCT02317809|Healthy|healthy
1140614|NCT02317809|Pergoveris|pergoveris
1140615|NCT02317809|Bioequivalence|bioequivalence
1140616|NCT02317809|Infertility|infertility
1140617|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
1140618|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
1140619|NCT02317731|bowel preparation|bowel preparation
1140620|NCT02317718|serum vitamin D levels|serum vitamin d levels
1140621|NCT02317718|IVF|ivf
1140622|NCT02317718|ovarian reserve|ovarian reserve
1140623|NCT02317718|25 OHD3|25 ohd3
1140624|NCT02317718|pregnancy outcome|pregnancy outcome
1140625|NCT02317666|polypharmacy|polypharmacy
1140626|NCT02317666|drug burden index|drug burden index
1140627|NCT02317666|aged|aged
1140628|NCT02317666|medication review|medication review
1140629|NCT02317666|cholinergic agents|cholinergic agents
1140630|NCT02317640|Testosterone|testosterone
1140631|NCT02317640|Electrical Stimulation|electrical stimulation
1140632|NCT02317640|Stand Training|stand training
1140633|NCT02317614|Incentives|incentives
1140634|NCT02317614|Smartphone|smartphone
1140635|NCT02317614|Mobile intervention|mobile intervention
1140636|NCT02317614|eDOT|edot
1140637|NCT02317614|Adherence reinforcement|adherence reinforcement
1140638|NCT02317614|Drug users|drug users
1140639|NCT02317588|Oxylipins|oxylipins
1140640|NCT02317588|Flax oil|flax oil
1140641|NCT02317588|Fish oil|fish oil
1140642|NCT02317562|Peripheral neuropathy|peripheral neuropathy
1140643|NCT02317562|Disimmune disease|disimmune disease
1140644|NCT02317562|Neurology chronic disease|neurology chronic disease
1140645|NCT02317562|Rare disease|rare disease
1140647|NCT02317549|septic shock|septic shock
1140648|NCT02317549|vasodilatory shock|vasodilatory shock
1140649|NCT02317549|circulatory shock|circulatory shock
1140650|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1140651|NCT02317549|SIRS|sirs
1140652|NCT02317549|infection|infection
1140653|NCT02317549|toxemia|toxemia
1140655|NCT02317549|autodigestion|autodigestion
1140656|NCT02317549|multiorgan failure|multiorgan failure
1140658|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
1140659|NCT02317549|MODS|mods
1140660|NCT02317549|hyperlactatemia|hyperlactatemia
1140661|NCT02317549|tissue hypoxia|tissue hypoxia
1140662|NCT02317536|Muscle function|muscle function
1140663|NCT02317536|L-Carnitine|l-carnitine
1140664|NCT02317536|Carnipure|carnipure
1140666|NCT02317536|anabolism|anabolism
1140667|NCT02317536|6 minute walk|6 minute walk
1140668|NCT02317536|dynamometry|dynamometry
1140669|NCT02317536|muscle biopsy|muscle biopsy
1140670|NCT02317523|Dementia|dementia
1140671|NCT02317523|Caregiver|caregiver
1140672|NCT02317523|Cardiovascular Disease|cardiovascular disease
1140673|NCT02317523|Stress|stress
1140674|NCT02317523|Depression|depression
1140675|NCT02317523|Anxiety|anxiety
1140676|NCT02317523|Heart Disease|heart disease
1140677|NCT02317523|Carer|carer
1140678|NCT02317523|Care Giver|care giver
1140679|NCT02317523|Caregiving|caregiving
1140680|NCT02317523|Psychotherapy|psychotherapy
1140681|NCT02317523|Therapy|therapy
1140682|NCT02317523|Behavioral Activation|behavioral activation
1140683|NCT02317523|Education|education
1140684|NCT02317523|Intervention|intervention
1140685|NCT02317523|CBT|cbt
1140686|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
1140687|NCT02317510|Combined anesthesia|combined anesthesia
1140688|NCT02317510|General anesthesia|general anesthesia
1140689|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1140690|NCT02317497|Neurocritical care|neurocritical care
1140691|NCT02317497|Severe Stroke|severe stroke
1140692|NCT02317497|Ischemic stroke|ischemic stroke
1140693|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
1140694|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
1140695|NCT02317497|Sedation|sedation
1140696|NCT02317497|RASS|rass
1140697|NCT02317497|BIS|bis
1140698|NCT02317445|helicobacter pylori|helicobacter pylori
1140699|NCT02317445|eradication therapy|eradication therapy
1140700|NCT02317445|major adverse cardiac events|major adverse cardiac events
1140701|NCT02317445|long-term outcome|long-term outcome
1140702|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
1140703|NCT02317432|Depression|depression
1140704|NCT02317432|Anxiety|anxiety
1140705|NCT02317432|Disability|disability
1140706|NCT02317432|Ethnic Minority|ethnic minority
1140707|NCT02317432|Elders|elders
1140708|NCT02317419|Solid Cancers|solid cancers
1140709|NCT02317393|Nuclear medicine|nuclear medicine
1140710|NCT02317393|Positron emission tomography|positron emission tomography
1140711|NCT02317393|avb3 integrin expression|avb3 integrin expression
1140712|NCT02317380|Self-Affirmation|self-affirmation
1140713|NCT02317380|Weight Loss|weight loss
1140714|NCT02317380|Self vs. Other|self vs. other
1140715|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
1140716|NCT02317367|Construct Validity|construct validity
1140717|NCT02317367|Self-Affirmation|self-affirmation
1140718|NCT02317367|Alcohol Consumption|alcohol consumption
1140719|NCT02317367|Breast Cancer|breast cancer
1140722|NCT02317341|Fatigue|fatigue
1140723|NCT02317341|Ketamine|ketamine
1140724|NCT02317341|Cancer|cancer
1140725|NCT02317328|Retinal Images|retinal images
1140726|NCT02317328|Adaptive Optics|adaptive optics
1140727|NCT02317263|MS|ms
1140728|NCT02317250|Alzheimer's disease|alzheimer's disease
1140729|NCT02317250|Alzheimer disease|alzheimer disease
1140730|NCT02317250|MDC|mdc
1140731|NCT02317250|Mild Decline in Cognition|mild decline in cognition
1140732|NCT02317250|MCI|mci
1140733|NCT02317250|Dementia|dementia
1140734|NCT02317250|PET|pet
1140735|NCT02317250|FDG-PET|fdg-pet
1140736|NCT02317250|FDG|fdg
1140737|NCT02317250|amyloid|amyloid
1140738|NCT02317250|amyloid imaging|amyloid imaging
1140739|NCT02317250|CMS|cms
1140740|NCT02317250|Coverage with Evidence Development|coverage with evidence development
1140741|NCT02317250|CED|ced
1140742|NCT02317250|MCI-ID|mci-id
1140743|NCT02317224|3-Hole approach|3-hole approach
1140744|NCT02317224|extended thymectomy|extended thymectomy
1140745|NCT02317224|myasthenia gravis|myasthenia gravis
1140746|NCT02317224|safety|safety
1140747|NCT02317224|effectiveness|effectiveness
1140748|NCT02317198|Elderly|elderly
1140749|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
1140750|NCT02317198|clopidogrel|clopidogrel
1140751|NCT02317198|ticagrelor|ticagrelor
1140752|NCT02317172|Saliva substitute|saliva substitute
1140753|NCT02317172|Edible gel|edible gel
1140754|NCT02317172|Xerostomia|xerostomia
1140755|NCT02317172|Diabetes Mellitus|diabetes mellitus
1140756|NCT02317172|Hypertension|hypertension
1140757|NCT02317133|Tregs|tregs
1140758|NCT02317133|bacterial translocation|bacterial translocation
1140759|NCT02317133|cytokines|cytokines
1140761|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
1140762|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
1140763|NCT02317107|Recovery of Function|recovery of function
1140764|NCT02317107|Locomotion|locomotion
1140765|NCT02317107|Motor Activity|motor activity
1140766|NCT02317068|sick sinus syndrome|sick sinus syndrome
1140767|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1140768|NCT02317068|atrial pacing|atrial pacing
1140769|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
1140770|NCT02317055|MRI|mri
1140771|NCT02317055|Oxygenation|oxygenation
1140772|NCT02317055|nirs|nirs
1140773|NCT02317029|Cardioversion|cardioversion
1140774|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
1140775|NCT02317029|Myocardial Injury|myocardial injury
1140776|NCT02317029|Defibrillators|defibrillators
1140777|NCT02317029|Biomarkers|biomarkers
1140778|NCT02317016|oncology|oncology
1140779|NCT02317016|cancer|cancer
1140780|NCT02317016|non small cell lung cancer|non small cell lung cancer
1140781|NCT02317016|anticancer drug|anticancer drug
1140782|NCT02317016|pharmacokinetics|pharmacokinetics
1140783|NCT02317016|AZD9291|azd9291
1140784|NCT02317016|rosuvastatin|rosuvastatin
1140785|NCT02317016|EGFR genes|egfr genes
1140786|NCT02317003|physical exercise|physical exercise
1140787|NCT02317003|sedentarity|sedentarity
1140788|NCT02317003|general practice|general practice
1140789|NCT02317003|family medicine|family medicine
1140790|NCT02317003|pedometer|pedometer
1140791|NCT02316977|Reproducibility of Results|reproducibility of results
1140792|NCT02316964|AML|aml
1140793|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
1140794|NCT02316964|decitabine|decitabine
1140795|NCT02316951|Postoperative|postoperative
1140796|NCT02316951|Pain|pain
1140797|NCT02316951|Symptoms|symptoms
1140798|NCT02316951|Video recording|video recording
1140799|NCT02316951|Orthopedic surgery|orthopedic surgery
1140800|NCT02316938|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies
1140801|NCT02316912|allergy|allergy
1140802|NCT02316899|ASP0456|asp0456
1140803|NCT02316899|constipation|constipation
1140804|NCT02316899|linaclotide|linaclotide
1140805|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1140806|NCT02316886|coronary intervention|coronary intervention
1140807|NCT02316886|Vulnerable Plaque|vulnerable plaque
1140808|NCT02316886|Insignificant Stenosis|insignificant stenosis
1140809|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
1140810|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
1140811|NCT02316873|music training, rhythm|music training, rhythm
1140812|NCT02316847|Cluster Seizures|cluster seizures
1140813|NCT02316847|Seizures|seizures
1140814|NCT02316847|Clusters|clusters
1140815|NCT02316847|Acute repetitive seizures|acute repetitive seizures
1140816|NCT02316834|Fallopian Tube Cancer|fallopian tube cancer
1140817|NCT02316834|Ovarian Cancer|ovarian cancer
1140818|NCT02316834|Peritoneal Cancer|peritoneal cancer
1140819|NCT02316834|BMN 673|bmn 673
1140820|NCT02316834|Talazoparib tosylate|talazoparib tosylate
1140821|NCT02316821|Diabetes Mellitus|diabetes mellitus
1140822|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1140823|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
1140824|NCT02316821|Kidney Diseases|kidney diseases
1140825|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
1140826|NCT02316821|Diabetes Complications|diabetes complications
1140827|NCT02316821|Endocrine System Diseases|endocrine system diseases
1140828|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
1140829|NCT02316821|Metabolic Diseases|metabolic diseases
1140830|NCT02316821|Renal Insufficiency|renal insufficiency
1140831|NCT02316821|Urologic Diseases|urologic diseases
1140832|NCT02316821|bardoxolone methyl|bardoxolone methyl
1140833|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
1140834|NCT02316691|Graves Disease|graves disease
1140835|NCT02316691|Rituximab|rituximab
1140836|NCT02316678|Patient Preference|patient preference
1140837|NCT02316665|Type 1 diabetes|type 1 diabetes
1140838|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
1140839|NCT02316665|Nocturnal glycemia|nocturnal glycemia
1140840|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
1140841|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
1140842|NCT02316665|Sleep habits|sleep habits
1140843|NCT02316639|Neuromuscular Training|neuromuscular training
1140844|NCT02316639|Skeletally Immature|skeletally immature
1140845|NCT02316639|Knee Rehabilitation|knee rehabilitation
1140846|NCT02316600|elderly|elderly
1140847|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
1140848|NCT02316600|tele-monitoring|tele-monitoring
1140849|NCT02316600|self-management|self-management
1140850|NCT02316600|Patient 65 and over|patient 65 and over
1140851|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
1140852|NCT02316587|Computerized Tomography|computerized tomography
1141352|NCT02313909|Rivaroxaban|rivaroxaban
1140853|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
1140854|NCT02316587|Echocardiography|echocardiography
1140855|NCT02316587|Right Heart Catheterization|right heart catheterization
1140856|NCT02316574|Alcohol dependence|alcohol dependence
1140857|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
1140858|NCT02316574|Functional neuroimaging|functional neuroimaging
1140859|NCT02316535|colorectal cancer|colorectal cancer
1140860|NCT02316535|stage II/III|stage ii/iii
1140861|NCT02316535|elderly|elderly
1140862|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
1140863|NCT02316535|capecitabine|capecitabine
1140864|NCT02316535|non-inferiority|non-inferiority
1140865|NCT02316496|Cancer|cancer
1140866|NCT02316496|Colorectal|colorectal
1140867|NCT02316496|Metastatic|metastatic
1140868|NCT02316496|Thrid-line|thrid-line
1140869|NCT02316496|Irinotecan|irinotecan
1140870|NCT02316496|Cetuximab|cetuximab
1140871|NCT02316470|Clostridium difficile|clostridium difficile
1140872|NCT02316470|Valneva|valneva
1140873|NCT02316470|Phase 2|phase 2
1140874|NCT02316470|Healthy adults|healthy adults
1140875|NCT02316457|TNBC|tnbc
1140876|NCT02316457|Breast Cancer|breast cancer
1140877|NCT02316457|Warehouse|warehouse
1140878|NCT02316457|Mutanome|mutanome
1140879|NCT02316457|RNA|rna
1140880|NCT02316457|Vaccine|vaccine
1140881|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
1140882|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
1140883|NCT02316418|hair extensions|hair extensions
1140884|NCT02316392|Helium|helium
1140885|NCT02316392|MRI|mri
1140886|NCT02316392|Lung transplantation|lung transplantation
1140887|NCT02316379|Respiratory|respiratory
1140888|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
1140889|NCT02316314|Cardiomyopathy|cardiomyopathy
1140890|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
1140891|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
1140892|NCT02316249|Atrophy of Vagina|atrophy of vagina
1140893|NCT02316249|Gellhorn pessary|gellhorn pessary
1140894|NCT02316249|Ring with support pessary|ring with support pessary
1140895|NCT02316249|Estrace cream|estrace cream
1140896|NCT02316249|vaginitis with pessary|vaginitis with pessary
1140897|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
1140898|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
1140899|NCT02316249|pessary complications|pessary complications
1140900|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
1140901|NCT02316223|asthma|asthma
1140902|NCT02316223|high-risk|high-risk
1140903|NCT02316223|adult|adult
1140904|NCT02316223|elderly|elderly
1140905|NCT02316223|care coordination|care coordination
1140906|NCT02316223|community health worker|community health worker
1140907|NCT02316223|electronic medical record|electronic medical record
1140908|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
1140909|NCT02316197|Advanced solid tumors|advanced solid tumors
1140910|NCT02316197|Chronic lymphocytic Leukemia|chronic lymphocytic leukemia
1140911|NCT02316197|Phase I, first-in-human|phase i, first-in-human
1140912|NCT02316197|Dose escalation|dose escalation
1140913|NCT02316197|Dose expansion|dose expansion
1140914|NCT02316197|Safety profile|safety profile
1140915|NCT02316197|Tolerability|tolerability
1140916|NCT02316197|PK|pk
1140917|NCT02316197|Antitumor activity|antitumor activity
1140918|NCT02316197|Maximum tolerated dose|maximum tolerated dose
1140919|NCT02316197|M3814|m3814
1140920|NCT02316184|Alcohol|alcohol
1140921|NCT02316158|Burden|burden
1140922|NCT02316158|Mental illness|mental illness
1140923|NCT02316158|Stress|stress
1140924|NCT02316158|Social support|social support
1140925|NCT02316145|ADHD|adhd
1140926|NCT02316145|Autism spectrum condition|autism spectrum condition
1140927|NCT02316145|Tourette's disorder|tourette's disorder
1140928|NCT02316145|Internet-based|internet-based
1140929|NCT02316145|chat|chat
1140930|NCT02316145|coach|coach
1140931|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
1140932|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
1140933|NCT02316106|Daratumumab|daratumumab
1140934|NCT02316080|dental bleaching|dental bleaching
1140935|NCT02316080|dentin sensitivity|dentin sensitivity
1140936|NCT02316080|biomaterials|biomaterials
1140937|NCT02316067|Spinal cord|spinal cord
1140938|NCT02316067|Wounds and Injuries|wounds and injuries
1140939|NCT02316067|Rehabilitation|rehabilitation
1140940|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
1140941|NCT02316054|coronary microvascular disease|coronary microvascular disease
1140942|NCT02316054|coronary artery disease|coronary artery disease
1140943|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
1140944|NCT02316054|prognosis|prognosis
1140945|NCT02316054|atherosclerosis|atherosclerosis
1140946|NCT02316054|myocardial ischemia|myocardial ischemia
1140947|NCT02316054|coronary heart disease|coronary heart disease
1140948|NCT02316041|Femtosecond laser|femtosecond laser
1140949|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
1140950|NCT02316028|decitabine|decitabine
1140951|NCT02316028|colorectal cancer|colorectal cancer
1140952|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
1140953|NCT02316015|Child, Hospitalized|child, hospitalized
1140954|NCT02316015|Nutritional status|nutritional status
1140955|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
1140956|NCT02315976|propatyl nitrate|propatyl nitrate
1140957|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
1140958|NCT02315911|Tonsillectomy|tonsillectomy
1140959|NCT02315911|Adenoidectomy|adenoidectomy
1140960|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
1140961|NCT02315911|OSA|osa
1140962|NCT02315898|children, congenital heart disease, metabolomics|children, congenital heart disease, metabolomics
1140963|NCT02315885|healthy volunteers|healthy volunteers
1140964|NCT02315885|social drinkers|social drinkers
1140965|NCT02315885|alcohol|alcohol
1140966|NCT02315872|Multiple Sclerosis|multiple sclerosis
1140967|NCT02315872|Acthar Gel|acthar gel
1140968|NCT02315872|ACTH|acth
1140969|NCT02315872|Fatigue|fatigue
1140970|NCT02315859|suction work|suction work
1140971|NCT02315833|Migraine|migraine
1140972|NCT02315833|Aura|aura
1140973|NCT02315820|Macrosomia|macrosomia
1140974|NCT02315820|Induction of labor|induction of labor
1140975|NCT02315820|Expectant management|expectant management
1140976|NCT02315820|Shoulder dystocia|shoulder dystocia
1140977|NCT02315794|aesthetic outcome|aesthetic outcome
1140978|NCT02315794|titanium abutment|titanium abutment
1140979|NCT02315794|zirconia abutment|zirconia abutment
1140980|NCT02315768|CLL|cll
1140981|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1140982|NCT02315768|Ibrutinib|ibrutinib
1140983|NCT02315768|Obinutuzumab|obinutuzumab
1140984|NCT02315768|Cancer|cancer
1140985|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
1140986|NCT02315716|Multiple Myeloma|multiple myeloma
1140987|NCT02315716|Carfilzomib|carfilzomib
1140988|NCT02315703|Healthy|healthy
1140989|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
1140990|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
1140991|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
1140992|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
1140993|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
1140994|NCT02315703|Glycoprotein|glycoprotein
1140995|NCT02315703|Adjuvant|adjuvant
1140996|NCT02315703|Vaccine|vaccine
1140997|NCT02315703|Placebo|placebo
1140998|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
1140999|NCT02315677|Epistaxis|epistaxis
1141000|NCT02315677|Nasal Intubation|nasal intubation
1141001|NCT02315677|Maxillofacial surgery|maxillofacial surgery
1141002|NCT02315664|Physical activity|physical activity
1141003|NCT02315664|Exercise|exercise
1141004|NCT02315664|Osteoarthritis|osteoarthritis
1141005|NCT02315664|Knee|knee
1141006|NCT02315664|Arthritis|arthritis
1141007|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
1141008|NCT02315638|Adeno-associated virus|adeno-associated virus
1141009|NCT02315638|AAV|aav
1141010|NCT02315638|AAV8|aav8
1141011|NCT02315638|ddRNAi|ddrnai
1141012|NCT02315638|shRNA|shrna
1141013|NCT02315638|RNAi|rnai
1141014|NCT02315638|Hepatitis|hepatitis
1141015|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
1141016|NCT02315638|HCV|hcv
1141017|NCT02315638|CHC|chc
1141018|NCT02315638|Genotype 1|genotype 1
1141019|NCT02315625|MEN1|men1
1141020|NCT02315625|VHL|vhl
1141021|NCT02315625|Neoplasm|neoplasm
1141022|NCT02315625|NF1|nf1
1141023|NCT02315625|mTOR|mtor
1141024|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
1141025|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
1141026|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
1141027|NCT02315612|ALL|all
1141028|NCT02315612|Lymphoma|lymphoma
1141029|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
1141030|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
1141031|NCT02315599|T Cell Persistence|t cell persistence
1141032|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1141033|NCT02315586|Apoliprotein A-1|apoliprotein a-1
1141034|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
1141035|NCT02315573|Anesthetics, Local|anesthetics, local
1141036|NCT02315573|Pain Perception|pain perception
1141037|NCT02315573|Pain Measurement|pain measurement
1141038|NCT02315573|Analgesia|analgesia
1141039|NCT02315573|Lidocaine|lidocaine
1141040|NCT02315573|Bupivacaine|bupivacaine
1141041|NCT02315560|bedwetting|bedwetting
1141042|NCT02315547|Microbiota|microbiota
1141043|NCT02315547|Airway infection|airway infection
1141044|NCT02315547|Bronchiectasis|bronchiectasis
1141045|NCT02315547|Airway inflammation|airway inflammation
1141046|NCT02315547|Oxidative stress|oxidative stress
1141047|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
1141048|NCT02315534|GBM|gbm
1141049|NCT02315534|Malignant Glioma|malignant glioma
1141050|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
1141051|NCT02315521|posterior urethral valves|posterior urethral valves
1141354|NCT02313909|Aspirin|aspirin
1141052|NCT02315521|urethral atresia|urethral atresia
1141053|NCT02315521|Prune Belly Syndrome|prune belly syndrome
1141054|NCT02315521|Megalo-urethra|megalo-urethra
1141055|NCT02315521|Fetal renal function|fetal renal function
1141056|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
1141057|NCT02315521|Ultrasound|ultrasound
1141058|NCT02315482|autonomic nervous system|autonomic nervous system
1141059|NCT02315482|heart rate variability|heart rate variability
1141060|NCT02315482|prostatectomy|prostatectomy
1141061|NCT02315482|steep trendelenburg|steep trendelenburg
1141062|NCT02315482|pneumoperitoneum|pneumoperitoneum
1141063|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
1141064|NCT02315456|capsulorhexis|capsulorhexis
1141065|NCT02315456|IOL centration|iol centration
1141066|NCT02315443|Stroke|stroke
1141067|NCT02315443|Ischemia|ischemia
1141068|NCT02315443|Prehospital|prehospital
1141069|NCT02315443|NA-1|na-1
1141070|NCT02315443|Modified Rankin Scale|modified rankin scale
1141071|NCT02315443|Haemorrhagic stroke|haemorrhagic stroke
1141072|NCT02315443|Transient ischemic attack|transient ischemic attack
1141073|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
1141074|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
1141075|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
1141076|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
1141077|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
1141078|NCT02315404|Enteroscopy|enteroscopy
1141079|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
1141080|NCT02315352|Healthy|healthy
1141081|NCT02315352|L-PZQ|l-pzq
1141082|NCT02315352|PZQ|pzq
1141083|NCT02315352|MSC2499550A|msc2499550a
1141084|NCT02315352|Praziquantel|praziquantel
1141085|NCT02315326|Ibrutinib,|ibrutinib,
1141086|NCT02315326|Imbruvica™|imbruvica™
1141087|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
1141088|NCT02315326|HD-MTX|hd-mtx
1141089|NCT02315326|14-184|14-184
1141090|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
1141091|NCT02315287|Triple combination|triple combination
1141092|NCT02315287|Metformin|metformin
1141093|NCT02315287|Sitagliptin|sitagliptin
1141094|NCT02315287|Pioglitazone|pioglitazone
1141095|NCT02315287|Lobeglitazone|lobeglitazone
1141096|NCT02315274|Type 1 diabetes|type 1 diabetes
1141097|NCT02315274|Pregnancy|pregnancy
1141098|NCT02315274|Glycemic variability|glycemic variability
1141099|NCT02315274|Between visit contact|between visit contact
1141100|NCT02315261|Epidural analgesia|epidural analgesia
1141101|NCT02315261|Pain score|pain score
1141102|NCT02315248|bone density|bone density
1141103|NCT02315222|Nutriomics|nutriomics
1141104|NCT02315222|Dietary supplements|dietary supplements
1141105|NCT02315222|Scaling and root planing|scaling and root planing
1141106|NCT02315222|full mouth disinfection|full mouth disinfection
1141107|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
1141108|NCT02315183|Post cardiac surgery|post cardiac surgery
1141109|NCT02315170|diabetic retinopathy|diabetic retinopathy
1141110|NCT02315170|age-related macular edema|age-related macular edema
1141111|NCT02315157|Partial Response|partial response
1141112|NCT02315144|COPD|copd
1141113|NCT02315144|bronchodilation|bronchodilation
1141114|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
1141115|NCT02315092|Bacteria|bacteria
1141116|NCT02315092|Fluorescence|fluorescence
1141117|NCT02315079|Ocular Inflammation|ocular inflammation
1141118|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
1141119|NCT02315066|Immunotherapy|immunotherapy
1141120|NCT02315066|PF-04518600|pf-04518600
1141121|NCT02315066|PF-05082566|pf-05082566
1141122|NCT02315066|solid tumors|solid tumors
1141123|NCT02315066|tumors|tumors
1141124|NCT02315066|neoplasm metastasis|neoplasm metastasis
1141125|NCT02315066|Phase 1|phase 1
1141126|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
1141127|NCT02315066|HCC|hcc
1141128|NCT02315066|liver cancer|liver cancer
1141129|NCT02315066|ocular melanoma|ocular melanoma
1141130|NCT02315066|melanoma|melanoma
1141131|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1141132|NCT02315066|RCC|rcc
1141133|NCT02315066|kidney cancer|kidney cancer
1141134|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1141135|NCT02315066|HNSCC|hnscc
1141136|NCT02315066|head and neck cancer|head and neck cancer
1141137|NCT02315066|cervical cancer|cervical cancer
1141138|NCT02315066|cancer of the cervix|cancer of the cervix
1141139|NCT02315066|gastric cancer|gastric cancer
1141140|NCT02315066|stomach cancer|stomach cancer
1141141|NCT02315066|non small cell lung cancer|non small cell lung cancer
1141142|NCT02315066|NSCLC|nsclc
1141143|NCT02315066|lung cancer|lung cancer
1141144|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
1141145|NCT02315066|bladder cancer|bladder cancer
1141146|NCT02315066|OX40|ox40
1141147|NCT02315066|4-1BB|4-1bb
1141148|NCT02315053|NSCLC|nsclc
1141149|NCT02315053|CCRT|ccrt
1141150|NCT02315053|FDG PET/CT|fdg pet/ct
1141151|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
1141152|NCT02315040|Insemination method|insemination method
1141153|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
1141154|NCT02315040|EVIE|evie
1141155|NCT02315040|Pregnancy rate|pregnancy rate
1141156|NCT02315001|Liraglutide|liraglutide
1141157|NCT02315001|GLP-1|glp-1
1141158|NCT02315001|Ischaemic heart disease|ischaemic heart disease
1141159|NCT02315001|Coronary heart disease|coronary heart disease
1141160|NCT02315001|Chronic stable angina|chronic stable angina
1141161|NCT02314988|Tranexamic acid|tranexamic acid
1141162|NCT02314988|Antifibrinolytic|antifibrinolytic
1141163|NCT02314988|Perioperative blood loss|perioperative blood loss
1141164|NCT02314988|Postoperative drain output|postoperative drain output
1141165|NCT02314988|Allogenic transfusion|allogenic transfusion
1141166|NCT02314949|T-regulatory cells|t-regulatory cells
1141167|NCT02314949|Tolerogenic protocol|tolerogenic protocol
1141168|NCT02314949|immunomodulation|immunomodulation
1141169|NCT02314936|Constipation|constipation
1141170|NCT02314936|Polydextrose|polydextrose
1141171|NCT02314936|Dietary Fiber|dietary fiber
1141172|NCT02314936|Fiber|fiber
1141173|NCT02314936|Colonic Transit Time|colonic transit time
1141174|NCT02314936|PAC-SYM|pac-sym
1141175|NCT02314910|Innervation|innervation
1141176|NCT02314910|Jaw Bone|jaw bone
1141177|NCT02314910|Implants|implants
1141178|NCT02314910|Stereognostic|stereognostic
1141179|NCT02314910|Osseoperception|osseoperception
1141180|NCT02314871|perioperative analgesia|perioperative analgesia
1141181|NCT02314871|minimal residual disease|minimal residual disease
1141182|NCT02314871|cancer recurrence|cancer recurrence
1141183|NCT02314871|epidural|epidural
1141184|NCT02314871|morphine|morphine
1141185|NCT02314871|piritramide|piritramide
1141186|NCT02314871|colon|colon
1141187|NCT02314871|cancer|cancer
1141188|NCT02314871|circulating cancer cells|circulating cancer cells
1141189|NCT02314871|colon cancer surgery|colon cancer surgery
1141190|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
1141191|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
1141192|NCT02314845|Anesthesia, General|anesthesia, general
1141193|NCT02314845|Electric Impedance|electric impedance
1141194|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
1141195|NCT02314845|Intraoperative Period|intraoperative period
1141196|NCT02314832|femoral nerve block|femoral nerve block
1141197|NCT02314832|adductor canal block|adductor canal block
1141198|NCT02314832|tinetti score|tinetti score
1141199|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
1141200|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
1141201|NCT02314832|4- Ambulation distance|4- ambulation distance
1141202|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
1141203|NCT02314819|colorectal cancer|colorectal cancer
1141204|NCT02314793|Pharmacokinetics|pharmacokinetics
1141205|NCT02314793|ASP2205|asp2205
1141206|NCT02314741|poem|poem
1141207|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
1141208|NCT02314741|achalasia|achalasia
1141209|NCT02314728|Bishop Score|bishop score
1141210|NCT02314728|Induction of Labor|induction of labor
1141211|NCT02314728|Cervical Ripening|cervical ripening
1141212|NCT02314728|Unfavorable Cervix|unfavorable cervix
1141213|NCT02314728|Mode of Delivery|mode of delivery
1141214|NCT02314728|C-Section|c-section
1141215|NCT02314728|Cesarean Section|cesarean section
1141216|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
1141217|NCT02314702|Osteoarthritis|osteoarthritis
1141218|NCT02314702|Avascular necrosis|avascular necrosis
1141219|NCT02314702|Ankylosis|ankylosis
1141220|NCT02314702|Protrusio acetabuli|protrusio acetabuli
1141221|NCT02314702|Painful hip dysplasia|painful hip dysplasia
1141222|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
1141223|NCT02314702|Correction of functional deformity|correction of functional deformity
1141224|NCT02314702|Revision procedures|revision procedures
1141225|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
1141226|NCT02314663|medication adherence|medication adherence
1141227|NCT02314663|primary health care|primary health care
1141228|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
1141229|NCT02314611|osteoarthritis|osteoarthritis
1141230|NCT02314611|avascular necrosis|avascular necrosis
1141231|NCT02314611|ankylosis|ankylosis
1141232|NCT02314611|protrusio acetabuli|protrusio acetabuli
1141233|NCT02314611|painful hip dysplasia|painful hip dysplasia
1141234|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
1141235|NCT02314611|correction of functional deformity|correction of functional deformity
1141236|NCT02314611|revision procedures|revision procedures
1141237|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
1141238|NCT02314572|Binocular Trifocality|binocular trifocality
1141239|NCT02314572|Cataract Surgery|cataract surgery
1141240|NCT02314572|Spectacle Independence|spectacle independence
1141241|NCT02314572|Intermediate Vision|intermediate vision
1141242|NCT02314572|Photopic Vision|photopic vision
1141243|NCT02314572|Mesopic Vision|mesopic vision
1141244|NCT02314572|Scotopic Vision|scotopic vision
1141245|NCT02314572|Binocular Vision|binocular vision
1141246|NCT02314559|propofol|propofol
1141247|NCT02314559|colonoscopy|colonoscopy
1141248|NCT02314507|Gua sha|gua sha
1141249|NCT02314481|NSCLC|nsclc
1141250|NCT02314481|Clonal dominance|clonal dominance
1141251|NCT02314481|Clonal evolution|clonal evolution
1141252|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
1141253|NCT02314481|Genomic instability|genomic instability
1141254|NCT02314481|Drug resistance|drug resistance
1141255|NCT02314481|Immunotherapy|immunotherapy
1141256|NCT02314481|PDL1|pdl1
1141257|NCT02314481|BRAF V600|braf v600
1141260|NCT02314481|HER2 amplification|her2 amplification
1141261|NCT02314481|MPDL3280A|mpdl3280a
1141262|NCT02314481|Vemurafenib|vemurafenib
1141263|NCT02314481|Alectinib|alectinib
1141264|NCT02314481|T-DM1|t-dm1
1141265|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
1141266|NCT02314481|TRACERX|tracerx
1141267|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
1141268|NCT02314455|EoE|eoe
1141269|NCT02314455|dysphagia|dysphagia
1141270|NCT02314442|LDL-C|ldl-c
1141271|NCT02314442|RNAi therapeutic|rnai therapeutic
1141272|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
1141273|NCT02314403|ESRD|esrd
1141274|NCT02314390|Depression|depression
1141275|NCT02314390|Mindfulness|mindfulness
1141276|NCT02314390|MBCT|mbct
1141277|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
1141278|NCT02314364|Metastatic|metastatic
1141279|NCT02314364|EGFR|egfr
1141280|NCT02314364|ALK|alk
1141281|NCT02314364|ROS1|ros1
1141282|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1141283|NCT02314351|migraine disorders|migraine disorders
1141284|NCT02314351|migraine with aura|migraine with aura
1141285|NCT02314351|migraine without aura|migraine without aura
1141286|NCT02314351|pain management|pain management
1141287|NCT02314351|emergency department|emergency department
1141288|NCT02314325|Factor VIII deficiency|factor viii deficiency
1141289|NCT02314325|Arthropathy|arthropathy
1141290|NCT02314325|MRI|mri
1141291|NCT02314325|XRay|xray
1141292|NCT02314325|Joint|joint
1141293|NCT02314325|HJHS|hjhs
1141294|NCT02314312|Kidney transplantation|kidney transplantation
1141295|NCT02314312|ECD|ecd
1141296|NCT02314299|Macular edema|macular edema
1141297|NCT02314299|Macular degeneration|macular degeneration
1141298|NCT02314299|MTP-131|mtp-131
1141299|NCT02314299|Ocuvia™|ocuvia™
1141300|NCT02314286|Rosuvastatin|rosuvastatin
1141301|NCT02314286|severe preeclampsia|severe preeclampsia
1141302|NCT02314286|48 hours following delivery|48 hours following delivery
1141303|NCT02314260|labour induction|labour induction
1141304|NCT02314260|cervical length|cervical length
1141305|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
1141306|NCT02314260|Bishop score|bishop score
1141307|NCT02314247|PTCL|ptcl
1141308|NCT02314247|CTCL|ctcl
1141309|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1141310|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1141311|NCT02314247|Karyopharm|karyopharm
1141312|NCT02314247|KPT-330|kpt-330
1141313|NCT02314247|Selinexor|selinexor
1141314|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
1141315|NCT02314208|spastic paraplegia|spastic paraplegia
1141316|NCT02314208|metabolism|metabolism
1141317|NCT02314208|oxysterols|oxysterols
1141318|NCT02314208|neurogenetics|neurogenetics
1141319|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
1141320|NCT02314195|Music Therapy/methods|music therapy/methods
1141321|NCT02314195|Combined Modality Therapy|combined modality therapy
1141322|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
1141323|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
1141324|NCT02314182|unresectable|unresectable
1141325|NCT02314182|surgery|surgery
1141326|NCT02314182|chemotherapy|chemotherapy
1141327|NCT02314143|dabrafenib|dabrafenib
1141328|NCT02314143|MEK|mek
1141329|NCT02314143|trametinib|trametinib
1141330|NCT02314143|BRAF|braf
1141331|NCT02314143|melanoma|melanoma
1141332|NCT02314143|Oncology|oncology
1141333|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
1141334|NCT02314104|Nerve block|nerve block
1141335|NCT02314104|Anesthetics, Local|anesthetics, local
1141336|NCT02314078|Caesarean section|caesarean section
1141337|NCT02314078|Emergency|emergency
1141338|NCT02314078|Anaesthesia|anaesthesia
1141339|NCT02314065|Severe health anxiety|severe health anxiety
1141340|NCT02314065|Somatic symptom disorder|somatic symptom disorder
1141341|NCT02314065|Illness anxiety disorder|illness anxiety disorder
1141342|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
1141343|NCT02314065|Internet|internet
1141344|NCT02314065|Exposure|exposure
1141345|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
1141346|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
1141347|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
1141348|NCT02313974|Lupus Flare|lupus flare
1141349|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
1141350|NCT02313961|Reperfusion injury|reperfusion injury
1141351|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
1141355|NCT02313909|ASA|asa
1141356|NCT02313909|Oral Anticoagulant|oral anticoagulant
1141357|NCT02313909|Blood Thinner|blood thinner
1141358|NCT02313909|Stroke|stroke
1141359|NCT02313909|Ischemic Stroke|ischemic stroke
1141360|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
1141361|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
1141362|NCT02313909|ESUS|esus
1141363|NCT02313909|Transient Ischemic Attack|transient ischemic attack
1141364|NCT02313909|Thromboembolism|thromboembolism
1141365|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
1141366|NCT02313883|periodontitis|periodontitis
1141367|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
1141368|NCT02313883|scaling and root planing|scaling and root planing
1141369|NCT02313870|Bullous pemphigoid|bullous pemphigoid
1141370|NCT02313870|superpotent topical steroids|superpotent topical steroids
1141371|NCT02313870|methotrexate|methotrexate
1141372|NCT02313870|safety|safety
1141373|NCT02313857|Viralym-C|viralym-c
1141374|NCT02313857|Viral infections post HSCT|viral infections post hsct
1141375|NCT02313857|Virus-specific T cells|virus-specific t cells
1141376|NCT02313844|BK virus|bk virus
1141377|NCT02313844|Virus specific T cells|virus specific t cells
1141378|NCT02313844|Viral infections|viral infections
1141379|NCT02313831|autonomic nervous system|autonomic nervous system
1141380|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
1141381|NCT02313831|oxygen consumption|oxygen consumption
1141382|NCT02313831|metabolic profile|metabolic profile
1141383|NCT02313831|exercise training|exercise training
1141384|NCT02313831|expiratory flow limitation|expiratory flow limitation
1141385|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
1141386|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
1141387|NCT02313818|Active Duty Military|active duty military
1141388|NCT02313805|Insulin initiation|insulin initiation
1141389|NCT02313805|Insulin checklist|insulin checklist
1141390|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1141391|NCT02313792|Palifermin|palifermin
1141392|NCT02313740|Influenza|influenza
1141393|NCT02313740|Influenza Vaccines|influenza vaccines
1141394|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
1141395|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
1141396|NCT02313688|resection margin|resection margin
1141397|NCT02313688|length|length
1141398|NCT02313688|prognosis|prognosis
1141399|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
1141400|NCT02313675|opioid analgesics|opioid analgesics
1141401|NCT02313675|postoperative pain|postoperative pain
1141402|NCT02313675|IV tylenol|iv tylenol
1141403|NCT02313675|IV toradol|iv toradol
1141404|NCT02313649|liver|liver
1141405|NCT02313649|fibrosis|fibrosis
1141406|NCT02313649|elastography|elastography
1141407|NCT02313649|ShearWave Elastography|shearwave elastography
1141408|NCT02313649|ultrasound|ultrasound
1141409|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
1141410|NCT02313584|dabigatran|dabigatran
1141411|NCT02313571|Epidural Analgesia|epidural analgesia
1141412|NCT02313571|Pain|pain
1141413|NCT02313558|dentifrice|dentifrice
1141414|NCT02313558|gingivitis|gingivitis
1141415|NCT02313558|dental plaque|dental plaque
1141416|NCT02313519|Infections|infections
1141417|NCT02313519|anastomotic leakage|anastomotic leakage
1141418|NCT02313506|Physical activity|physical activity
1141419|NCT02313506|Exercise|exercise
1141420|NCT02313506|Osteoarthritis|osteoarthritis
1141421|NCT02313506|Knee|knee
1141422|NCT02313506|Arthritis|arthritis
1141423|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
1141424|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
1141425|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
1141426|NCT02313428|Medicaid Recipients|medicaid recipients
1141427|NCT02313428|Standard of Care|standard of care
1141428|NCT02313428|Diabetic Wounds|diabetic wounds
1141429|NCT02313363|Health care systems|health care systems
1141430|NCT02313363|Mobile applications|mobile applications
1141431|NCT02313363|Self-care|self-care
1141432|NCT02313363|Diabetes mellitus|diabetes mellitus
1141433|NCT02313363|Smartphone|smartphone
1141434|NCT02313350|Sciatica,|sciatica,
1141435|NCT02313350|herniated disc,|herniated disc,
1141436|NCT02313350|chemonucleolysis.|chemonucleolysis.
1141437|NCT02313337|Administration route|administration route
1141438|NCT02313337|Preanesthetic medication|preanesthetic medication
1141439|NCT02313337|Sedation|sedation
1141440|NCT02313324|Coccydynia|coccydynia
1141441|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
1141442|NCT02313324|Disability|disability
1141443|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
1141444|NCT02313272|neoplasms|neoplasms
1141445|NCT02313272|high-grade glioma|high-grade glioma
1141446|NCT02313272|recurrent glioma|recurrent glioma
1141447|NCT02313272|glioma|glioma
1141448|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
1141449|NCT02313272|Bevacizumab|bevacizumab
1141450|NCT02313272|Pembrolizumab|pembrolizumab
1142037|NCT02309996|Absenteeism|absenteeism
1141451|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
1141452|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
1141453|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
1141454|NCT02313272|brain and nervous system|brain and nervous system
1141455|NCT02313220|Obesity|obesity
1141456|NCT02313220|Dapagliflozin|dapagliflozin
1141457|NCT02313220|Exenatide|exenatide
1141458|NCT02313220|Combination treatment|combination treatment
1141459|NCT02313220|Type 2 diabetes|type 2 diabetes
1141460|NCT02313181|breastfeeding|breastfeeding
1141461|NCT02313181|lactation|lactation
1141462|NCT02313181|newborn|newborn
1141463|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
1141464|NCT02313155|Prevention|prevention
1141465|NCT02313129|Infertility|infertility
1141466|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
1141467|NCT02313116|Lumpectomy|lumpectomy
1141468|NCT02313116|Breast cancer|breast cancer
1141469|NCT02313116|Optical coherence tomography|optical coherence tomography
1141470|NCT02313116|Tumor margin|tumor margin
1141471|NCT02313116|Imaging|imaging
1141472|NCT02313103|ESRD|esrd
1141473|NCT02313103|End Stage Renal Disease|end stage renal disease
1141474|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
1141475|NCT02313103|Renally Impaired|renally impaired
1141476|NCT02313077|Healthy|healthy
1141477|NCT02313077|Ebola viruses|ebola viruses
1141478|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
1141479|NCT02313077|Filoviruses|filoviruses
1141480|NCT02313077|monovalent vaccine|monovalent vaccine
1141481|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
1141482|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
1141483|NCT02313077|Safety|safety
1141484|NCT02313077|Immunogenicity|immunogenicity
1141485|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
1141486|NCT02313038|Coronary heart disease|coronary heart disease
1141487|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
1141488|NCT02313038|Drug Eluting Stents|drug eluting stents
1141489|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
1141490|NCT02313012|Solid Tumors|solid tumors
1141491|NCT02313012|Locally Advanced Tumors|locally advanced tumors
1141492|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
1141493|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
1141494|NCT02313012|Melanoma|melanoma
1141495|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
1141496|NCT02313012|Thyroid carcinomas|thyroid carcinomas
1141497|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
1141498|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
1141499|NCT02312999|laparotomy|laparotomy
1141500|NCT02312999|plasma-Lyte|plasma-lyte
1141501|NCT02312999|volulyte|volulyte
1141502|NCT02312999|close loop|close loop
1141503|NCT02312999|abdominal surgery|abdominal surgery
1141504|NCT02312986|infection|infection
1141505|NCT02312986|colonization|colonization
1141506|NCT02312986|antibiotic resistance|antibiotic resistance
1141507|NCT02312973|Chronic kidney disease|chronic kidney disease
1141508|NCT02312973|Pharmacokinetics|pharmacokinetics
1141509|NCT02312973|Hemodialysis|hemodialysis
1141510|NCT02312973|Peritoneal dialysis|peritoneal dialysis
1141511|NCT02312973|Erythropoietin|erythropoietin
1141512|NCT02312934|Chemo brain|chemo brain
1141513|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
1141514|NCT02312934|CRCI|crci
1141515|NCT02312934|Breast cancer|breast cancer
1141516|NCT02312934|Chemo fog|chemo fog
1141517|NCT02312934|Nicotine|nicotine
1141518|NCT02312934|Transdermal nicotine|transdermal nicotine
1141519|NCT02312921|managed healthcare|managed healthcare
1141521|NCT02312921|dental care|dental care
1141522|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
1141523|NCT02312908|Parkinson Disease|parkinson disease
1141524|NCT02312908|Placebos|placebos
1141525|NCT02312908|Randomized Controlled Trial|randomized controlled trial
1141526|NCT02312908|Double-Blind Method|double-blind method
1141527|NCT02312908|Clinical Trial|clinical trial
1141528|NCT02312869|Mechanical Ventilation|mechanical ventilation
1141529|NCT02312869|Burn patients|burn patients
1141530|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
1141531|NCT02312843|Cognitive disorders|cognitive disorders
1141532|NCT02312843|Prediabetes|prediabetes
1141533|NCT02312843|Exercise|exercise
1141534|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1141535|NCT02312817|Liver Neoplasms|liver neoplasms
1141536|NCT02312817|Liver Disease|liver disease
1141537|NCT02312817|Early Detection of Cancer|early detection of cancer
1141538|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
1141539|NCT02312791|Radiation|radiation
1141540|NCT02312791|Prognosis|prognosis
1141541|NCT02312791|Palliative Care|palliative care
1141542|NCT02312778|non-specific low back pain|non-specific low back pain
1141543|NCT02312778|center of pressure|center of pressure
1141544|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
1141545|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
1141546|NCT02312778|postural control|postural control
1141547|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
1141548|NCT02312739|pain assessment|pain assessment
1141549|NCT02312739|pain measurement|pain measurement
1141550|NCT02312739|patient satisfaction|patient satisfaction
1141551|NCT02312739|anxiety|anxiety
1141552|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
1141553|NCT02312739|female sterilization|female sterilization
1141554|NCT02312726|mixed methods|mixed methods
1141555|NCT02312726|visual analog scale|visual analog scale
1141556|NCT02312726|verbal rating score|verbal rating score
1141557|NCT02312726|pain assessment|pain assessment
1141558|NCT02312726|patient satisfaction|patient satisfaction
1141559|NCT02312726|contraceptive devices|contraceptive devices
1141560|NCT02312726|postpartum|postpartum
1141561|NCT02312713|Osteoarthritis|osteoarthritis
1141562|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
1141563|NCT02312700|empowerment|empowerment
1141564|NCT02312700|communication|communication
1141565|NCT02312700|shared decision making|shared decision making
1141566|NCT02312687|XLH|xlh
1141567|NCT02312687|FGF23|fgf23
1141568|NCT02312687|KRN23|krn23
1141569|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
1141570|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
1141571|NCT02312674|palliative therapy|palliative therapy
1141572|NCT02312674|oral nutritional supplements|oral nutritional supplements
1141573|NCT02312674|quality of life|quality of life
1141574|NCT02312674|nutritional status|nutritional status
1141575|NCT02312661|ovarian cancer|ovarian cancer
1141576|NCT02312661|metformin|metformin
1141577|NCT02312661|carboplatin|carboplatin
1141578|NCT02312661|paclitaxel|paclitaxel
1141579|NCT02312648|Functional Capacity|functional capacity
1141580|NCT02312648|Physical Exertion|physical exertion
1141581|NCT02312648|Patient Care|patient care
1141582|NCT02312648|Early mobilization|early mobilization
1141583|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
1141584|NCT02312596|non-healing wound|non-healing wound
1141585|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
1141586|NCT02312596|platelet rich plasma|platelet rich plasma
1141587|NCT02312583|depression|depression
1141588|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
1141589|NCT02312570|non-healing wounds|non-healing wounds
1141590|NCT02312570|pressure ulcer|pressure ulcer
1141591|NCT02312570|platelet rich plasma|platelet rich plasma
1141592|NCT02312531|HBV|hbv
1141593|NCT02312531|Intrauterine infection|intrauterine infection
1141594|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
1141595|NCT02312531|immune barrier|immune barrier
1141596|NCT02312531|virus replication|virus replication
1141597|NCT02312531|placenta|placenta
1141598|NCT02312518|non-healing wounds|non-healing wounds
1141599|NCT02312518|venous stasis|venous stasis
1141600|NCT02312518|ulcer|ulcer
1141601|NCT02312518|platelet rich plasma|platelet rich plasma
1141602|NCT02312505|cardiac output monitoring|cardiac output monitoring
1141603|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
1141604|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
1141605|NCT02312492|fatty acid kinetics|fatty acid kinetics
1141606|NCT02312440|tranexamic acid|tranexamic acid
1141607|NCT02312440|blood loss|blood loss
1141608|NCT02312440|topical administration|topical administration
1141609|NCT02312440|intravenous administration|intravenous administration
1141610|NCT02312401|MRI|mri
1141611|NCT02312401|14-172|14-172
1141612|NCT02312388|central venous catheters|central venous catheters
1141613|NCT02312362|HFDS|hfds
1141614|NCT02312362|ab interno|ab interno
1141615|NCT02312362|MIGS|migs
1141616|NCT02312362|surgery|surgery
1141617|NCT02312349|Celiac Disease|celiac disease
1141618|NCT02312349|Gluten free elaborated food|gluten free elaborated food
1141619|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1141620|NCT02312336|Transcoronary Cooling|transcoronary cooling
1141621|NCT02312258|Ixazomib|ixazomib
1141622|NCT02312258|Newly diagnosed|newly diagnosed
1141623|NCT02312219|HIV|hiv
1141624|NCT02312219|Inflammation|inflammation
1141625|NCT02312219|Atherosclerosis|atherosclerosis
1141626|NCT02312219|Positron-Emission Tomography|positron-emission tomography
1141627|NCT02312219|Imaging|imaging
1141628|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
1141629|NCT02312193|hypertension|hypertension
1141630|NCT02312193|myogenic tone|myogenic tone
1141631|NCT02312167|endomicroscopy|endomicroscopy
1141632|NCT02312167|optical biopsy|optical biopsy
1141633|NCT02312167|exploratory surgery|exploratory surgery
1141634|NCT02312167|resection surgery|resection surgery
1141635|NCT02312167|robot-assisted|robot-assisted
1141636|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
1141637|NCT02312167|inflammatory|inflammatory
1141638|NCT02312167|rectum cancer|rectum cancer
1141639|NCT02312167|liver cancer|liver cancer
1141640|NCT02312167|ovarian cancer|ovarian cancer
1141641|NCT02312167|digestive cancer|digestive cancer
1141642|NCT02312167|pancreas cancer|pancreas cancer
1142140|NCT02309294|Patch Test|patch test
1141643|NCT02312167|duodenum cancer|duodenum cancer
1141644|NCT02312128|distal radius fractures|distal radius fractures
1141645|NCT02312128|early mobilization|early mobilization
1141646|NCT02312128|postoperative treatment|postoperative treatment
1141647|NCT02312128|outcome|outcome
1141648|NCT02312115|Renal transplant|renal transplant
1141649|NCT02312115|Kidney transplant|kidney transplant
1141650|NCT02312115|DGF|dgf
1141651|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
1141747|NCT02311569|JAK2|jak2
1141652|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
1141653|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1141654|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
1141655|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
1141656|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
1141657|NCT02312063|sulfonylurea|sulfonylurea
1141658|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
1141659|NCT02312037|Refractory CD33 AML|refractory cd33 aml
1141660|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
1141661|NCT02312037|Refractory CD33 APL|refractory cd33 apl
1141662|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
1141663|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
1141664|NCT02312024|CytoSorb adsorber|cytosorb adsorber
1141665|NCT02312024|sepsis|sepsis
1141666|NCT02312024|cytokines|cytokines
1141667|NCT02312024|hemofiltration|hemofiltration
1141668|NCT02312024|hemadsorption|hemadsorption
1141669|NCT02312024|inflammation|inflammation
1141670|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
1141671|NCT02312011|DM1|dm1
1141672|NCT02312011|Adult onset|adult onset
1141673|NCT02312011|Neuromuscular Disease|neuromuscular disease
1141674|NCT02312011|DMPKRx|dmpkrx
1141675|NCT02311998|Leukemia|leukemia
1141676|NCT02311998|CD22-positive Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia|cd22-positive philadelphia-chromosome positive acute lymphoblastic leukemia
1141677|NCT02311998|ALL|all
1141678|NCT02311998|Chronic Myeloid Leukemia Lymphoid Blast Phase|chronic myeloid leukemia lymphoid blast phase
1141679|NCT02311998|CML|cml
1141680|NCT02311998|Bosutinib|bosutinib
1141681|NCT02311998|SKI-606|ski-606
1141682|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin
1141683|NCT02311998|CMC-544|cmc-544
1141684|NCT02311998|Phone Call|phone call
1141685|NCT02311985|Liver cirrhosis|liver cirrhosis
1141686|NCT02311985|Blood coagulation|blood coagulation
1141687|NCT02311985|Thromboelastography|thromboelastography
1141688|NCT02311985|Blood transfusion|blood transfusion
1141689|NCT02311985|Catheterization, central venous|catheterization, central venous
1141690|NCT02311959|Breast|breast
1141691|NCT02311959|Invasive carcinoma|invasive carcinoma
1141692|NCT02311959|In situ carcinoma|in situ carcinoma
1141693|NCT02311959|Mastectomy|mastectomy
1141694|NCT02311959|Nipple areola|nipple areola
1141695|NCT02311959|Reconstruction|reconstruction
1141696|NCT02311959|Local recurrence|local recurrence
1141697|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
1141698|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
1141699|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
1141700|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
1141701|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
1141702|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
1141703|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
1141704|NCT02311751|Executive Function|executive function
1141705|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
1141706|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1141707|NCT02311751|Healthy Subjects|healthy subjects
1141708|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
1141709|NCT02311725|narrative communication|narrative communication
1141710|NCT02311725|depression|depression
1141711|NCT02311725|antidepressant augmentation|antidepressant augmentation
1141712|NCT02311725|primary care|primary care
1141713|NCT02311712|Esophageal cancer|esophageal cancer
1141714|NCT02311712|Early detection|early detection
1141715|NCT02311712|Cytological examination|cytological examination
1141717|NCT02311699|Physical Violence|physical violence
1141718|NCT02311699|Sexual Violence|sexual violence
1141719|NCT02311699|HIV|hiv
1141720|NCT02311699|AIDS|aids
1141721|NCT02311699|Prevention|prevention
1141722|NCT02311699|Community Intervention|community intervention
1141723|NCT02311699|Ethiopia|ethiopia
1141724|NCT02311699|Intimate Partner Violence|intimate partner violence
1141725|NCT02311686|Ethanol|ethanol
1141726|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
1141727|NCT02311686|Ethyl glucoronide|ethyl glucoronide
1141728|NCT02311686|Ethyl sulphate|ethyl sulphate
1141729|NCT02311686|Pharmacokinetics|pharmacokinetics
1141730|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
1141731|NCT02311673|obesity|obesity
1141732|NCT02311673|hyperphagia|hyperphagia
1141733|NCT02311647|Tamoxifen|tamoxifen
1141734|NCT02311647|Uterine cavity|uterine cavity
1141735|NCT02311647|endometrium|endometrium
1141736|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
1141737|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
1141738|NCT02311634|Urge urinary incontinence|urge urinary incontinence
1141739|NCT02311634|Comparative study|comparative study
1141740|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
1141741|NCT02311608|terlipressin|terlipressin
1141742|NCT02311608|somatostatin|somatostatin
1141743|NCT02311608|octreotide|octreotide
1141744|NCT02311608|comparative effectiveness research|comparative effectiveness research
1141745|NCT02311595|gastric cancer|gastric cancer
1141746|NCT02311595|laparoscope|laparoscope
1141749|NCT02311569|Primary myelofibrosis|primary myelofibrosis
1141750|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
1141751|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
1141752|NCT02311569|Essential thrombocythemia|essential thrombocythemia
1141753|NCT02311569|Polycythemia vera|polycythemia vera
1141754|NCT02311569|Betmiga|betmiga
1141755|NCT02311569|JAK2-V617F|jak2-v617f
1141756|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
1141757|NCT02311543|Breast Cancer|breast cancer
1141758|NCT02311543|TachoSil®|tachosil®
1141759|NCT02311543|Lymphatic Drainage|lymphatic drainage
1141760|NCT02311543|Surgical Sealing Patch|surgical sealing patch
1141761|NCT02311491|nano crystalline|nano crystalline
1141762|NCT02311491|archwire|archwire
1141763|NCT02311465|Palliative Care|palliative care
1141764|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
1141765|NCT02311439|Chemotherapy|chemotherapy
1141766|NCT02311439|Radiotherapy|radiotherapy
1141767|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
1141768|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1141769|NCT02311400|Emotion|emotion
1141770|NCT02311400|Self-Affirmation|self-affirmation
1141771|NCT02311400|Alcohol Consumption|alcohol consumption
1141772|NCT02311387|Incidence|incidence
1141773|NCT02311387|Prevalence|prevalence
1141774|NCT02311387|Human|human
1141775|NCT02311387|Mastomys|mastomys
1141776|NCT02311387|Serosurvey|serosurvey
1141777|NCT02311374|Human Brain|human brain
1141778|NCT02311374|Sleep|sleep
1141779|NCT02311374|EEG|eeg
1141780|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1141781|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
1141782|NCT02311361|Anti-PDL1|anti-pdl1
1141783|NCT02311361|Anti-CTLA4|anti-ctla4
1141784|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
1141785|NCT02311361|Monoclonal Antibody|monoclonal antibody
1141786|NCT02311361|Antitumor Immunity|antitumor immunity
1141787|NCT02311348|Biopsy|biopsy
1141788|NCT02311348|Pain|pain
1141789|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
1141790|NCT02311335|Atherosclerosis|atherosclerosis
1141791|NCT02311335|Genectic Variants|genectic variants
1141792|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
1141793|NCT02311335|Dyslipidemia|dyslipidemia
1141794|NCT02311322|Growth Disorder|growth disorder
1141795|NCT02311322|Growth|growth
1141796|NCT02311322|Exome Sequencing|exome sequencing
1141797|NCT02311244|All-cause mortality|all-cause mortality
1141798|NCT02311244|Cardiovascular mortality|cardiovascular mortality
1141799|NCT02311244|Myocardial infarction|myocardial infarction
1141800|NCT02311244|Stroke|stroke
1141801|NCT02311244|Dialysis|dialysis
1141802|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
1141803|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
1141804|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1141805|NCT02311205|Metastasis|metastasis
1141806|NCT02311205|Sorafenib|sorafenib
1141807|NCT02311192|Vitreous Haze|vitreous haze
1141808|NCT02311192|Ocular ultrasound|ocular ultrasound
1141809|NCT02311192|B scan|b scan
1141810|NCT02311192|Uveitis|uveitis
1141811|NCT02311179|Prosthesis fixation|prosthesis fixation
1141812|NCT02311179|hip arthroplasty|hip arthroplasty
1141813|NCT02311166|Hip dysplasia|hip dysplasia
1141814|NCT02311166|Soft tissue|soft tissue
1141816|NCT02311166|Self-report|self-report
1141817|NCT02311166|Physical activity|physical activity
1141818|NCT02311140|cystic fibrosis|cystic fibrosis
1141819|NCT02311140|nasal lavage|nasal lavage
1141820|NCT02311140|inflammation|inflammation
1141821|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
1141822|NCT02311140|IL-8|il-8
1141823|NCT02311140|pulmonary function|pulmonary function
1141824|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
1141825|NCT02311127|Securement device|securement device
1141826|NCT02311114|Program Evaluation|program evaluation
1141827|NCT02311114|Telehomecare|telehomecare
1141828|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1141829|NCT02311114|Heart Failure|heart failure
1141830|NCT02311114|LHINs|lhins
1141831|NCT02311114|Local Health Integrative Network|local health integrative network
1141832|NCT02311114|OTN|otn
1141833|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
1141834|NCT02311101|bladder cancer|bladder cancer
1141835|NCT02311101|mitomycin|mitomycin
1141836|NCT02311101|BCG|bcg
1141837|NCT02311101|intravesical|intravesical
1141838|NCT02311101|non-muscle invasive|non-muscle invasive
1141839|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
1141840|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
1141841|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
1141842|NCT02311010|transplant|transplant
1141843|NCT02311010|immunosuppressive drug|immunosuppressive drug
1141844|NCT02310984|Early breast cancer|early breast cancer
1141845|NCT02310984|Lumpectomy|lumpectomy
1141846|NCT02310984|Breast conserving surgery|breast conserving surgery
1141847|NCT02310984|Radiotherapy|radiotherapy
1141849|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
1141850|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
1141851|NCT02310958|infant|infant
1141852|NCT02310958|complications|complications
1141853|NCT02310958|inguinal hernia|inguinal hernia
1141854|NCT02310958|hernia recurrence|hernia recurrence
1141855|NCT02310945|pain|pain
1141856|NCT02310945|central nervous system sensitization|central nervous system sensitization
1141857|NCT02310945|physiotherapy|physiotherapy
1141858|NCT02310932|mental health|mental health
1141859|NCT02310932|cardiovascular disease|cardiovascular disease
1141860|NCT02310932|diabetes|diabetes
1141861|NCT02310932|hypertension|hypertension
1141862|NCT02310932|high blood pressure|high blood pressure
1141863|NCT02310919|Infertility|infertility
1141864|NCT02310919|In vitro fertilization|in vitro fertilization
1141865|NCT02310919|IVF|ivf
1141866|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
1141867|NCT02310906|Exon Skipping|exon skipping
1141868|NCT02310906|DMD|dmd
1141869|NCT02310906|Exon 53|exon 53
1141870|NCT02310906|Ambulatory|ambulatory
1141871|NCT02310906|Pediatric|pediatric
1141872|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
1141873|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
1141874|NCT02310854|autograft|autograft
1141875|NCT02310854|reconstruction|reconstruction
1141876|NCT02310854|orthopedic surgery|orthopedic surgery
1141877|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
1141878|NCT02310828|Cluster headache|cluster headache
1141879|NCT02310828|Migrainous neuralgia|migrainous neuralgia
1141880|NCT02310828|Horton's headache|horton's headache
1141881|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
1141882|NCT02310802|IVF|ivf
1141883|NCT02310802|ICSI|icsi
1141884|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
1141885|NCT02310737|cesarean section|cesarean section
1141886|NCT02310737|facial incision|facial incision
1141887|NCT02310737|postoperative pain|postoperative pain
1141888|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
1141889|NCT02310724|insulin sensitivity|insulin sensitivity
1141890|NCT02310724|beta cell function|beta cell function
1141891|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
1141892|NCT02310724|microvascular comorbidities|microvascular comorbidities
1141893|NCT02310711|Breast|breast
1141894|NCT02310711|Mastectomy|mastectomy
1141895|NCT02310711|Lumpectomy|lumpectomy
1141896|NCT02310711|Breast Therapy|breast therapy
1141897|NCT02310698|Ultrasound|ultrasound
1141898|NCT02310698|Enhanced Mammography|enhanced mammography
1141899|NCT02310698|14-240|14-240
1141900|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
1141901|NCT02310685|Cardiovascular age|cardiovascular age
1141902|NCT02310685|E-health wellness program|e-health wellness program
1141903|NCT02310685|Prevention|prevention
1141904|NCT02310685|Community pharmacists|community pharmacists
1141905|NCT02310685|Lifestyle change|lifestyle change
1141906|NCT02310685|Cardiometabolic age|cardiometabolic age
1141907|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1141908|NCT02310633|TBI|tbi
1141909|NCT02310633|memory disorder|memory disorder
1141910|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
1141911|NCT02310633|rehabilitation|rehabilitation
1141912|NCT02310607|Post-partum women|post-partum women
1141913|NCT02310581|Bunionectomy|bunionectomy
1141914|NCT02310568|PF 06372865|pf 06372865
1141915|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
1141916|NCT02310568|outpatient|outpatient
1141918|NCT02310568|efficacy|efficacy
1141919|NCT02310568|suboptimal response|suboptimal response
1141920|NCT02310555|Metabolic surgery|metabolic surgery
1141921|NCT02310529|Maternal depression|maternal depression
1141922|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
1141923|NCT02310503|Mohs Surgery|mohs surgery
1141924|NCT02310490|Nasolabial Folds|nasolabial folds
1141925|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
1141926|NCT02310438|Music therapy|music therapy
1141927|NCT02310438|stroke|stroke
1141928|NCT02310438|hemiparesis|hemiparesis
1141929|NCT02310438|neurologic music therapy|neurologic music therapy
1141930|NCT02310412|INTERCEPT|intercept
1141931|NCT02310412|platelet|platelet
1141932|NCT02310412|pathogen inactivation|pathogen inactivation
1141933|NCT02310412|platelet components stored|platelet components stored
1142141|NCT02309281|Eylea|eylea
1141934|NCT02310412|therapeutic efficacy|therapeutic efficacy
1141935|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
1141936|NCT02310399|Deafness|deafness
1141937|NCT02310399|Hearing Loss|hearing loss
1141939|NCT02310386|Fibromyalgia|fibromyalgia
1141940|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
1141941|NCT02310386|Randomized controlled trial|randomized controlled trial
1141942|NCT02310373|Nicotine-free hookah|nicotine-free hookah
1141943|NCT02310373|Waterpipe|waterpipe
1141944|NCT02310373|Smoking|smoking
1141945|NCT02310373|Sympathetic|sympathetic
1141946|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
1141947|NCT02310321|Cytarabine|cytarabine
1141953|NCT02310295|Diabetic retinopathy|diabetic retinopathy
1141954|NCT02310295|Macular edema|macular edema
1141955|NCT02310295|Anti-VEGF|anti-vegf
1141956|NCT02310295|Triamcinolone|triamcinolone
1141957|NCT02310282|Telemedicine|telemedicine
1141958|NCT02310282|Emergency medicine|emergency medicine
1141959|NCT02310282|Stroke|stroke
1141960|NCT02310282|Stroke syndromes|stroke syndromes
1141961|NCT02310269|Cushing's disease,|cushing's disease,
1141962|NCT02310269|pasireotide s.c.|pasireotide s.c.
1141963|NCT02310269|Signifor|signifor
1141964|NCT02310256|Mitochondria, muscle|mitochondria, muscle
1141965|NCT02310256|Exercise|exercise
1141966|NCT02310256|Blood Flow Velocity|blood flow velocity
1141967|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
1141968|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1141969|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
1141970|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
1141971|NCT02310230|Endoscopy, Upper|endoscopy, upper
1141972|NCT02310230|Minute Ventilation|minute ventilation
1141973|NCT02310230|Tidal Volume|tidal volume
1141974|NCT02310230|Respiratory Rate|respiratory rate
1141975|NCT02310217|Hypertension|hypertension
1141976|NCT02310217|Cognitive impairment|cognitive impairment
1141977|NCT02310217|Biomarkers|biomarkers
1141978|NCT02310191|ischemic stroke|ischemic stroke
1141979|NCT02310191|carotid stenting|carotid stenting
1141980|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
1141981|NCT02310191|Laboratory marker|laboratory marker
1141982|NCT02310178|weight loss|weight loss
1141983|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
1141984|NCT02310178|gastric bypass|gastric bypass
1141985|NCT02310178|gastric banding|gastric banding
1141986|NCT02310178|bariatric procedures|bariatric procedures
1141987|NCT02310178|cohort|cohort
1141988|NCT02310178|morbid obesity|morbid obesity
1141989|NCT02310178|medical and economical impact|medical and economical impact
1141990|NCT02310178|severe obesity|severe obesity
1141991|NCT02310165|Paracentesis|paracentesis
1141992|NCT02310165|Ascites|ascites
1141993|NCT02310152|Child|child
1141994|NCT02310152|Adolescent|adolescent
1141995|NCT02310152|Parents|parents
1141996|NCT02310152|Cognitive Therapy|cognitive therapy
1141997|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
1141998|NCT02310152|Anxiety|anxiety
1141999|NCT02310113|NIRS|nirs
1142000|NCT02310113|transfusion|transfusion
1142001|NCT02310113|RBC|rbc
1142002|NCT02310087|male infertility|male infertility
1142003|NCT02310087|spermatogenesis|spermatogenesis
1142004|NCT02310087|antioxidants|antioxidants
1142005|NCT02310087|DNA damage|dna damage
1142006|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
1142007|NCT02310087|apoptosis|apoptosis
1142008|NCT02310061|Dialysis|dialysis
1142009|NCT02310061|ESRD|esrd
1142010|NCT02310061|lung congestion|lung congestion
1142011|NCT02310061|heart failure|heart failure
1142012|NCT02310061|LW-US|lw-us
1142013|NCT02310009|Exercise|exercise
1142014|NCT02310009|IL-1RA|il-1ra
1142015|NCT02310009|Beta-cell function|beta-cell function
1142016|NCT02310009|Type 2 Diabetes|type 2 diabetes
1142017|NCT02309996|Randomized Controlled Trial|randomized controlled trial
1142018|NCT02309996|Intervention Studies|intervention studies
1142019|NCT02309996|Inservice Training|inservice training
1142020|NCT02309996|Personnel Management|personnel management
1142021|NCT02309996|Work place|work place
1142022|NCT02309996|Work accommodation|work accommodation
1142023|NCT02309996|Job modification|job modification
1142024|NCT02309996|Supervision|supervision
1142025|NCT02309996|Administration|administration
1142026|NCT02309996|Return to Work|return to work
1142027|NCT02309996|Industrial Psychology|industrial psychology
1142028|NCT02309996|Human Engineering|human engineering
1142029|NCT02309996|Risk Management|risk management
1142030|NCT02309996|Organization and Administration|organization and administration
1142031|NCT02309996|Work Disability|work disability
1142032|NCT02309996|Occupational Diseases|occupational diseases
1142033|NCT02309996|Occupational Injury|occupational injury
1142034|NCT02309996|Occupational Health|occupational health
1142035|NCT02309996|Occupational Exposure|occupational exposure
1142036|NCT02309996|Sick Leave|sick leave
1142038|NCT02309996|Employee Health|employee health
1142039|NCT02309983|bone turnover|bone turnover
1142040|NCT02309983|muscle atrophy|muscle atrophy
1142041|NCT02309983|fiber|fiber
1142042|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
1142043|NCT02309944|Wound Healing|wound healing
1142044|NCT02309944|Obesity|obesity
1142045|NCT02309944|Gynecologic Surgery|gynecologic surgery
1142046|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
1142047|NCT02309944|Surgical Complications|surgical complications
1142048|NCT02309931|Right hemicolectomy|right hemicolectomy
1142049|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
1142050|NCT02309931|Orocecal time|orocecal time
1142051|NCT02309931|Antipersitaltic|antipersitaltic
1142052|NCT02309931|Isoperistaltic|isoperistaltic
1142053|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
1142054|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
1142055|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
1142056|NCT02309918|HCV RNA|hcv rna
1142057|NCT02309918|LDV/SOF FDC|ldv/sof fdc
1142058|NCT02309905|inmates|inmates
1142059|NCT02309905|skin lesion|skin lesion
1142060|NCT02309905|telemedicine|telemedicine
1142061|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
1142062|NCT02309892|Neoplasms|neoplasms
1142063|NCT02309892|Immunoconjugate|immunoconjugate
1142064|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
1142065|NCT02309879|Intravenous lidocaine|intravenous lidocaine
1142066|NCT02309879|Magnesium sulphate|magnesium sulphate
1142067|NCT02309879|Mastectomy|mastectomy
1142068|NCT02309879|Pain|pain
1142069|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
1142070|NCT02309723|Alzheimer's Disease|alzheimer's disease
1142071|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
1142072|NCT02309723|Neuroimaging|neuroimaging
1142073|NCT02309723|Diagnostic Tool|diagnostic tool
1142074|NCT02309697|Development|development
1142075|NCT02309697|Assessments|assessments
1142076|NCT02309697|Premature birth|premature birth
1142077|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
1142078|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
1142079|NCT02309658|cervix neoplasm|cervix neoplasm
1142080|NCT02309658|hENT1 protein, human|hent1 protein, human
1142081|NCT02309658|Chemotherapy|chemotherapy
1142082|NCT02309645|fibrin sealant|fibrin sealant
1142083|NCT02309645|CSF leak|csf leak
1142084|NCT02309619|esophageal cancer|esophageal cancer
1142085|NCT02309619|esophagectomy|esophagectomy
1142086|NCT02309619|quality of life|quality of life
1142087|NCT02309593|osteoarthritis|osteoarthritis
1142088|NCT02309593|avascular necrosis|avascular necrosis
1142089|NCT02309593|ankylosis|ankylosis
1142090|NCT02309593|protrusio acetabuli|protrusio acetabuli
1142091|NCT02309593|painful hip dysplasia|painful hip dysplasia
1142092|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
1142093|NCT02309593|correction of functional deformity|correction of functional deformity
1142094|NCT02309593|revision procedures|revision procedures
1142095|NCT02309580|Ibrutinib|ibrutinib
1142096|NCT02309580|14-227|14-227
1142097|NCT02309567|Anti-p53 antibody|anti-p53 antibody
1142098|NCT02309567|PET/CT|pet/ct
1142099|NCT02309567|Lung Cancer|lung cancer
1142100|NCT02309567|FDG|fdg
1142101|NCT02309554|Contraception|contraception
1142102|NCT02309554|Post coital test|post coital test
1142103|NCT02309554|Vaginal|vaginal
1142104|NCT02309554|Diaphragm|diaphragm
1142105|NCT02309541|middle ear implant|middle ear implant
1142106|NCT02309541|feedback manager|feedback manager
1142107|NCT02309541|Sound quality|sound quality
1142108|NCT02309502|diabetic retinopathy|diabetic retinopathy
1142109|NCT02309502|retina|retina
1142110|NCT02309502|Laser|laser
1142111|NCT02309502|Pascal|pascal
1142112|NCT02309489|Family Planning Services|family planning services
1142113|NCT02309489|Maternal Health Services|maternal health services
1142114|NCT02309489|Breast Feeding|breast feeding
1142115|NCT02309489|Contraception|contraception
1142116|NCT02309489|Postnatal care|postnatal care
1142117|NCT02309489|Postpartum contraception|postpartum contraception
1142118|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
1142119|NCT02309489|Postpartum Period|postpartum period
1142120|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
1142121|NCT02309476|Pascal|pascal
1142122|NCT02309476|Laser|laser
1142123|NCT02309476|DMO|dmo
1142124|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1142125|NCT02309437|Pain|pain
1142126|NCT02309437|Oxycodone|oxycodone
1142127|NCT02309437|Opioids|opioids
1142128|NCT02309437|Oral Mucositis|oral mucositis
1142129|NCT02309411|Pediatric|pediatric
1142130|NCT02309385|uveitis|uveitis
1142131|NCT02309385|acute uveitis|acute uveitis
1142132|NCT02309385|anterior uveitis|anterior uveitis
1142133|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
1142134|NCT02309385|non-infectious uveitis|non-infectious uveitis
1142135|NCT02309385|DSP-Visulex|dsp-visulex
1142136|NCT02309385|Aciont|aciont
1142137|NCT02309346|clindamycin|clindamycin
1142138|NCT02309346|septic abortion|septic abortion
1142139|NCT02309307|safety and performance|safety and performance
1142142|NCT02309268|left atrial appendage closure|left atrial appendage closure
1142143|NCT02309255|Secondary coronary prevention|secondary coronary prevention
1142144|NCT02309255|Psychosocial factors|psychosocial factors
1142145|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
1142146|NCT02309229|sputum colour|sputum colour
1142147|NCT02309229|cystic fibrosis|cystic fibrosis
1142148|NCT02309229|pollution|pollution
1142149|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
1142150|NCT02309177|Pancreatic Cancer|pancreatic cancer
1142151|NCT02309177|Breast Cancer|breast cancer
1142152|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
1142153|NCT02309177|nab-Paclitaxel|nab-paclitaxel
1142154|NCT02309177|Gemcitabine|gemcitabine
1142155|NCT02309177|Carboplatin|carboplatin
1142156|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
1142157|NCT02309177|Lung Cancer|lung cancer
1142158|NCT02309177|mBC|mbc
1142160|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
1142161|NCT02309177|Hormone Receptor Positive|hormone receptor positive
1142162|NCT02309177|ER+|er+
1142163|NCT02309177|PR+|pr+
1142164|NCT02309177|TNBC|tnbc
1142165|NCT02309177|Nivolumab|nivolumab
1142166|NCT02309177|PD-1|pd-1
1142167|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
1142168|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
1142169|NCT02309177|Anti-PD-1|anti-pd-1
1142170|NCT02309177|BMS-936558|bms-936558
1142171|NCT02309125|immediate gradual loading|immediate gradual loading
1142172|NCT02309099|Acoustic Neuroma|acoustic neuroma
1142173|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
1142174|NCT02309099|Meniere's Disease|meniere's disease
1142175|NCT02309060|narrative communication|narrative communication
1142176|NCT02309060|depression|depression
1142177|NCT02309060|primary care|primary care
1142178|NCT02309060|treatment development|treatment development
1142179|NCT02309034|Overweight|overweight
1142180|NCT02309034|Obesity|obesity
1142181|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
1142182|NCT02309034|Adolescents|adolescents
1142183|NCT02309034|Exercise|exercise
1142184|NCT02309021|craving|craving
1142185|NCT02309008|Pharmacokinetics|pharmacokinetics
1142186|NCT02308995|Endometriosis|endometriosis
1142187|NCT02308995|Laparoscopy|laparoscopy
1142188|NCT02308995|Barbed sutures|barbed sutures
1142189|NCT02308982|encephalitis|encephalitis
1142190|NCT02308982|meningoencephalitis|meningoencephalitis
1142191|NCT02308982|encephalomyelitis|encephalomyelitis
1142192|NCT02308982|brain inflammation|brain inflammation
1142193|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
1142194|NCT02308982|randomised controlled trial|randomised controlled trial
1142195|NCT02308982|Central Nervous System Diseases|central nervous system diseases
1142196|NCT02308982|Central Nervous System Infection|central nervous system infection
1142197|NCT02308969|altered state of consciousness|altered state of consciousness
1142198|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1142199|NCT02308969|hallucination|hallucination
1142200|NCT02308969|model psychosis|model psychosis
1142201|NCT02308969|serotonin receptor|serotonin receptor
1142202|NCT02308969|LSD|lsd
1142203|NCT02308956|task sharing|task sharing
1142204|NCT02308956|task shifting|task shifting
1142205|NCT02308956|community mental health care|community mental health care
1142206|NCT02308956|primary care|primary care
1142207|NCT02308956|Developing country|developing country
1142208|NCT02308956|Sub-Saharan Africa|sub-saharan africa
1142209|NCT02308956|non-inferiority trial|non-inferiority trial
1142210|NCT02308917|IBD|ibd
1142211|NCT02308917|Crohn's|crohn's
1142212|NCT02308917|Ulcerative|ulcerative
1142213|NCT02308917|Colitis|colitis
1142214|NCT02308904|Infertility|infertility
1142215|NCT02308904|Thalassemia|thalassemia
1142216|NCT02308904|Iron overload|iron overload
1142217|NCT02308904|Pituitary Iron Load|pituitary iron load
1142218|NCT02308904|Oxidative Stress|oxidative stress
1142219|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
1142220|NCT02308891|pancreatitis|pancreatitis
1142221|NCT02308891|ERCP|ercp
1142222|NCT02308878|Opioid abuse|opioid abuse
1142223|NCT02308878|Cognitive Therapy|cognitive therapy
1142224|NCT02308878|Executive Function|executive function
1142225|NCT02308878|Mobile Health|mobile health
1142226|NCT02308878|Rehabilitation|rehabilitation
1142227|NCT02308865|Early palliative care|early palliative care
1142228|NCT02308865|Lung cancer|lung cancer
1142229|NCT02308865|Quality of life|quality of life
1142230|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
1142231|NCT02308839|Aneurysm|aneurysm
1142232|NCT02308839|Aorta|aorta
1142233|NCT02308839|Abdominal|abdominal
1142234|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
1142235|NCT02308787|platelet depletion|platelet depletion
1142236|NCT02308787|apheresis|apheresis
1142237|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
1142238|NCT02308735|gestation|gestation
1142239|NCT02308735|diabetes|diabetes
1142240|NCT02308735|ethanol|ethanol
1142241|NCT02308722|Borderline resectable|borderline resectable
1142242|NCT02308709|Radiotherapy|radiotherapy
1142243|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
1142244|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
1142245|NCT02308709|Image Registration|image registration
1142246|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
1142247|NCT02308696|Older Adults|older adults
1142248|NCT02308696|Aging in Place|aging in place
1142249|NCT02308683|hscrp|hscrp
1142250|NCT02308683|hgba1c|hgba1c
1142251|NCT02308683|diabetes mellitus|diabetes mellitus
1142252|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
1142253|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
1142254|NCT02308644|Contrast Sensitivity|contrast sensitivity
1142255|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
1142357|NCT02307994|infertility|infertility
1142256|NCT02308618|Achilles tendon rupture|achilles tendon rupture
1142257|NCT02308618|Rehabilitation|rehabilitation
1142258|NCT02308618|Immobilization|immobilization
1142259|NCT02308618|Muscle architecture|muscle architecture
1142260|NCT02308618|Functionality|functionality
1142261|NCT02308618|Neuromuscular parameters|neuromuscular parameters
1142262|NCT02308618|Weight-Bearing|weight-bearing
1142263|NCT02308605|SMARTCap|smartcap
1142264|NCT02308592|Pregnancy|pregnancy
1142265|NCT02308592|Depression|depression
1142266|NCT02308592|Antidepressant Use|antidepressant use
1142267|NCT02308592|Decision Aid|decision aid
1142268|NCT02308566|Intracranial Embolism|intracranial embolism
1142269|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
1142270|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
1142271|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
1142272|NCT02308553|nintedanib|nintedanib
1142273|NCT02308553|paclitaxel|paclitaxel
1142274|NCT02308553|kinase inhibitor|kinase inhibitor
1142275|NCT02308527|Children|children
1142276|NCT02308527|Young adults|young adults
1142277|NCT02308514|cryostimulation|cryostimulation
1142278|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
1142279|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
1142280|NCT02308462|children of mentally ill parents|children of mentally ill parents
1142281|NCT02308462|family intervention|family intervention
1142282|NCT02308462|randomized controlled trial|randomized controlled trial
1142283|NCT02308410|Tourniquet|tourniquet
1142284|NCT02308410|Postoperative outcome|postoperative outcome
1142285|NCT02308410|Total knee arthroplasty|total knee arthroplasty
1142286|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
1142287|NCT02308397|gluten|gluten
1142288|NCT02308397|bread|bread
1142289|NCT02308384|iFOBT|ifobt
1142290|NCT02308384|FIT|fit
1142291|NCT02308384|general practice|general practice
1142292|NCT02308384|early diagnosis|early diagnosis
1142293|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
1142294|NCT02308371|fluid resuscitation|fluid resuscitation
1142295|NCT02308358|Osteochondral Defect|osteochondral defect
1142296|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
1142297|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
1142298|NCT02308306|Chronic pain|chronic pain
1142299|NCT02308306|Opioid analgesics|opioid analgesics
1142300|NCT02308306|Prediction study|prediction study
1142301|NCT02308306|Pharmaco-EEG|pharmaco-eeg
1142302|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1142303|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
1142304|NCT02308293|Lactate|lactate
1142305|NCT02308293|high intensity interval exercise|high intensity interval exercise
1142306|NCT02308293|MRS|mrs
1142307|NCT02308280|High-risk myeloma|high-risk myeloma
1142308|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
1142309|NCT02308280|Bortezomib|bortezomib
1142310|NCT02308267|Cystic Fibrosis|cystic fibrosis
1142311|NCT02308267|Mucosal immunity|mucosal immunity
1142312|NCT02308254|Blood pressure|blood pressure
1142313|NCT02308254|Gastric emptying|gastric emptying
1142314|NCT02308254|Glycemia|glycemia
1142315|NCT02308254|Appetite|appetite
1142316|NCT02308254|Incretin Hormones|incretin hormones
1142317|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
1142318|NCT02308241|Ribavirin|ribavirin
1142319|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1142320|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
1142321|NCT02308241|14-211|14-211
1142322|NCT02308228|Aging|aging
1142323|NCT02308228|Hypertrophy|hypertrophy
1142324|NCT02308228|Metformin|metformin
1142325|NCT02308228|Strength|strength
1142326|NCT02308228|Muscle|muscle
1142327|NCT02308215|Retina|retina
1142328|NCT02308215|AMD|amd
1142329|NCT02308215|OCT|oct
1142330|NCT02308202|PTSD|ptsd
1142331|NCT02308202|treatment|treatment
1142332|NCT02308202|virtual reality|virtual reality
1142333|NCT02308202|doxazosin|doxazosin
1142334|NCT02308189|Exercise|exercise
1142335|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
1142336|NCT02308163|ASP015K|asp015k
1142337|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1142338|NCT02308150|asian pacific|asian pacific
1142339|NCT02308150|asian|asian
1142340|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
1142342|NCT02308111|Cirrhosis|cirrhosis
1142343|NCT02308111|Liver|liver
1142344|NCT02308085|Premenopausal|premenopausal
1142345|NCT02308085|endocrine responsive|endocrine responsive
1142346|NCT02308085|Breast|breast
1142347|NCT02308085|Pregnancy|pregnancy
1142348|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
1142349|NCT02308072|Head and Neck Cancer|head and neck cancer
1142350|NCT02308072|Locally Advanced|locally advanced
1142351|NCT02308072|Olaparib|olaparib
1142352|NCT02308072|Cisplatin|cisplatin
1142353|NCT02308072|IMRT|imrt
1142354|NCT02308072|Chemoradiotherapy|chemoradiotherapy
1142355|NCT02308072|PARP|parp
1142356|NCT02308072|HNSCC|hnscc
1142358|NCT02307942|Randomized Clinical Trials|randomized clinical trials
1142359|NCT02307942|gastric banding|gastric banding
1142360|NCT02307942|calorie restriction|calorie restriction
1142361|NCT02307942|SPPB|sppb
1142362|NCT02307942|physical performance|physical performance
1142363|NCT02307942|elderly|elderly
1142364|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
1142365|NCT02307916|ear drum|ear drum
1142366|NCT02307916|hole|hole
1142367|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
1142368|NCT02307890|Liver Transplantation|liver transplantation
1142369|NCT02307864|Healthy|healthy
1142370|NCT02307864|QT interval|qt interval
1142371|NCT02307864|QTc interval|qtc interval
1142372|NCT02307864|Electrocardiogram|electrocardiogram
1142373|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
1142374|NCT02307864|Moxifloxacin|moxifloxacin
1142375|NCT02307864|Placebo|placebo
1142376|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
1142377|NCT02307825|Azithromycin|azithromycin
1142378|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
1142379|NCT02307799|tobacco|tobacco
1142380|NCT02307799|spirometry|spirometry
1142381|NCT02307799|cohort study|cohort study
1142382|NCT02307799|case-control study|case-control study
1142383|NCT02307799|prevalence|prevalence
1142384|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
1142385|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
1142386|NCT02307773|Lidocaine|lidocaine
1142387|NCT02307773|Belching|belching
1142388|NCT02307773|Retching|retching
1142389|NCT02307773|Tolerance|tolerance
1142390|NCT02307747|infection in ICU|infection in icu
1142391|NCT02307734|Lay Health Workers|lay health workers
1142392|NCT02307734|Chinese|chinese
1142393|NCT02307734|Vietnamese|vietnamese
1142394|NCT02307734|Tobacco Use|tobacco use
1142395|NCT02307734|Intervention|intervention
1142396|NCT02307734|Behavior Change|behavior change
1142397|NCT02307734|Social Networks|social networks
1142398|NCT02307734|Asians|asians
1142399|NCT02307721|Emergency Treatment|emergency treatment
1142400|NCT02307721|Morphine Derivates|morphine derivates
1142401|NCT02307721|Heroin|heroin
1142402|NCT02307721|Antidotes|antidotes
1142403|NCT02307721|Administration, Intranasal|administration, intranasal
1142404|NCT02307721|Pharmacology|pharmacology
1142405|NCT02307721|Naloxone|naloxone
1142406|NCT02307721|Healthy volunteers|healthy volunteers
1142407|NCT02307695|Saxagliptin|saxagliptin
1142408|NCT02307695|Type 1 Diabetes|type 1 diabetes
1142409|NCT02307695|Glycemic variability|glycemic variability
1142410|NCT02307695|C-Peptide|c-peptide
1142412|NCT02307682|CNV|cnv
1142413|NCT02307682|IVT|ivt
1142414|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
1142415|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
1142416|NCT02307630|PET Imaging|pet imaging
1142417|NCT02307630|13-147|13-147
1142418|NCT02307617|Major depressive disorder|major depressive disorder
1142419|NCT02307617|MDD|mdd
1142420|NCT02307617|healthy control|healthy control
1142421|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1142422|NCT02307617|SSRI|ssri
1142423|NCT02307617|depression|depression
1142424|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
1142425|NCT02307617|TMS|tms
1142426|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1142427|NCT02307617|MRS|mrs
1142428|NCT02307617|adolescent|adolescent
1142429|NCT02307617|mild MDD|mild mdd
1142430|NCT02307617|mild depression|mild depression
1142431|NCT02307617|cortical excitability|cortical excitability
1142432|NCT02307617|cortical inhibition|cortical inhibition
1142433|NCT02307617|cortical silent period|cortical silent period
1142434|NCT02307617|motor threshold|motor threshold
1142435|NCT02307617|intracortical facilitation|intracortical facilitation
1142436|NCT02307617|intracortical inhibition|intracortical inhibition
1142437|NCT02307617|motor cortex|motor cortex
1142438|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1142439|NCT02307617|DLPFC|dlpfc
1142440|NCT02307617|thumb twitch|thumb twitch
1142441|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
1142442|NCT02307617|GABA|gaba
1142443|NCT02307617|glutamate|glutamate
1142444|NCT02307617|single pulse|single pulse
1142445|NCT02307617|paired pulse|paired pulse
1142446|NCT02307604|Brain tumor|brain tumor
1142447|NCT02307604|Biomarkers|biomarkers
1142448|NCT02307604|Screening|screening
1142449|NCT02307578|Perampanel|perampanel
1142450|NCT02307578|Fycompa|fycompa
1142451|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
1142452|NCT02307578|E2007-G000-332|e2007-g000-332
1142453|NCT02307578|E2007|e2007
1142454|NCT02307565|Midodrine|midodrine
1142455|NCT02307565|Blood pressure|blood pressure
1142456|NCT02307565|Orthostatic hypotension|orthostatic hypotension
1142457|NCT02307565|Spinal Cord Injury|spinal cord injury
1142458|NCT02307565|Sympathetic vascular control|sympathetic vascular control
1142459|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
1142559|NCT02307019|Apraxias|apraxias
1142460|NCT02307565|Cognition function tasks|cognition function tasks
1142461|NCT02307565|Quality of Life|quality of life
1142462|NCT02307565|MRI|mri
1142463|NCT02307565|fMRI|fmri
1142464|NCT02307552|Imaging|imaging
1142465|NCT02307552|ultrasound|ultrasound
1142466|NCT02307552|prostate|prostate
1142467|NCT02307552|cancer|cancer
1142468|NCT02307552|diagnostic tool|diagnostic tool
1142469|NCT02307552|catheter|catheter
1142470|NCT02307552|urethra|urethra
1142471|NCT02307552|digital rectal exam|digital rectal exam
1142472|NCT02307526|Hypotension, Postural|hypotension, postural
1142473|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
1142474|NCT02307513|CC-10004|cc-10004
1142475|NCT02307513|Efficacy|efficacy
1142476|NCT02307513|Safety|safety
1142477|NCT02307513|Phase 3|phase 3
1142478|NCT02307513|Behçet's Disease|behçet's disease
1142479|NCT02307487|TC-3 Gel|tc-3 gel
1142480|NCT02307487|MMC|mmc
1142481|NCT02307487|NMIBC|nmibc
1142482|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1142483|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
1142484|NCT02307487|Drug retention|drug retention
1142485|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
1142486|NCT02307487|Urologic Neoplasms|urologic neoplasms
1142487|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
1142488|NCT02307487|Urologic Diseases|urologic diseases
1142489|NCT02307474|Kidney|kidney
1142490|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
1142491|NCT02307474|Cancer|cancer
1142492|NCT02307474|Pilot|pilot
1142493|NCT02307474|Pazopanib|pazopanib
1142494|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
1142495|NCT02307474|SBRT|sbrt
1142496|NCT02307461|Phase 1|phase 1
1142497|NCT02307461|Bioequivalence|bioequivalence
1142498|NCT02307461|Pharmacokinetics|pharmacokinetics
1142499|NCT02307461|Food|food
1142500|NCT02307461|Healthy Adult|healthy adult
1142501|NCT02307435|non union fracture|non union fracture
1142502|NCT02307435|bone defect|bone defect
1142503|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
1142504|NCT02307435|cryopreservation|cryopreservation
1142505|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
1142506|NCT02307383|OXA 48|oxa 48
1142507|NCT02307383|carbapenemase|carbapenemase
1142508|NCT02307383|probiotics|probiotics
1142509|NCT02307331|Total Hip Replacement|total hip replacement
1142510|NCT02307318|Radial Artery|radial artery
1142511|NCT02307318|Hemostasis|hemostasis
1142512|NCT02307318|Angiography|angiography
1142513|NCT02307292|Superficial femoral artery|superficial femoral artery
1142514|NCT02307292|Self Expanding Stent System|self expanding stent system
1142515|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
1142516|NCT02307240|TNBC|tnbc
1142517|NCT02307240|HGSOC|hgsoc
1142518|NCT02307240|NMC|nmc
1142519|NCT02307188|Atrial Fibrillation|atrial fibrillation
1142520|NCT02307188|Atrial Flutter|atrial flutter
1142521|NCT02307188|Multipolar Catheter|multipolar catheter
1142522|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
1142523|NCT02307162|COPD|copd
1142524|NCT02307149|melanoma|melanoma
1142525|NCT02307149|ipilimumab|ipilimumab
1142526|NCT02307149|coxsackievirus A21|coxsackievirus a21
1142527|NCT02307149|CAVATAK|cavatak
1142528|NCT02307149|CVA21|cva21
1142529|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
1142530|NCT02307136|intensive care units|intensive care units
1142531|NCT02307136|emergency department|emergency department
1142532|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
1142533|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
1142534|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
1142535|NCT02307123|Airway management (MeSH)|airway management (mesh)
1142536|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
1142537|NCT02307123|Patient outcome|patient outcome
1142538|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
1142539|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
1142540|NCT02307110|diabetic retinopathy|diabetic retinopathy
1142840|NCT02305654|Phase III|phase iii
1142541|NCT02307110|diabetic macular edema|diabetic macular edema
1142542|NCT02307097|Randomised Controlled Trial|randomised controlled trial
1142543|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
1142544|NCT02307097|Social Anxiety Disorder|social anxiety disorder
1142545|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
1142547|NCT02307084|surgical site infection|surgical site infection
1142548|NCT02307084|long saphenous vein|long saphenous vein
1142549|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
1142550|NCT02307058|Prostate Cancer|prostate cancer
1142551|NCT02307045|Arterial stiffness|arterial stiffness
1142552|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
1142553|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
1142554|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
1142555|NCT02307032|P wave Wavelets|p wave wavelets
1142556|NCT02307032|Strain|strain
1142557|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
1142558|NCT02307019|Caregivers|caregivers
1142561|NCT02307019|Cerebral Stroke|cerebral stroke
1142562|NCT02307019|Rehabilitation|rehabilitation
1142563|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
1142564|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
1142565|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
1142566|NCT02306967|oral cancer|oral cancer
1142567|NCT02306967|oral dysplasia|oral dysplasia
1142568|NCT02306954|Kidney Cancer|kidney cancer
1142569|NCT02306954|High Dose IL-2|high dose il-2
1142570|NCT02306954|SBRT|sbrt
1142571|NCT02306928|Septic shock|septic shock
1142572|NCT02306928|Intensive care unit|intensive care unit
1142573|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
1142574|NCT02306928|Pharmacokinetics|pharmacokinetics
1142575|NCT02306928|Critically ill|critically ill
1142576|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
1142577|NCT02306863|Parkinson's Disease|parkinson's disease
1142578|NCT02306863|whole-body vibration|whole-body vibration
1142579|NCT02306863|WBV|wbv
1142580|NCT02306850|immunotherapy|immunotherapy
1142581|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
1142582|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
1142583|NCT02306850|neoadjuvant|neoadjuvant
1142584|NCT02306850|pembrolizumab|pembrolizumab
1142585|NCT02306850|MK-3475|mk-3475
1142586|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
1142587|NCT02306759|analgesia|analgesia
1142588|NCT02306759|ketamine|ketamine
1142589|NCT02306759|pain|pain
1142590|NCT02306746|Enteral nutrition|enteral nutrition
1142591|NCT02306746|randomised control trial|randomised control trial
1142592|NCT02306746|Critical care|critical care
1142593|NCT02306746|Outcome|outcome
1142594|NCT02306733|Post partum hemorrhage|post partum hemorrhage
1142595|NCT02306733|Ergometrine|ergometrine
1142596|NCT02306733|Oxytocin|oxytocin
1142597|NCT02306733|Obstetrics|obstetrics
1142598|NCT02306694|hemophilia|hemophilia
1142599|NCT02306694|bone disease|bone disease
1142600|NCT02306694|clinical study|clinical study
1142601|NCT02306694|biomarkers|biomarkers
1142602|NCT02306668|Dry eye|dry eye
1142603|NCT02306655|Coital incontinence|coital incontinence
1142604|NCT02306655|Incidence|incidence
1142605|NCT02306655|quality of life|quality of life
1142606|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
1142607|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1142608|NCT02306590|survival time|survival time
1142609|NCT02306590|ALS Functional Rating Scale|als functional rating scale
1142610|NCT02306590|quality of life|quality of life
1142611|NCT02306590|survival|survival
1142612|NCT02306577|STRIBILD|stribild
1142614|NCT02306577|Illicit dgug user|illicit dgug user
1142615|NCT02306564|ICSI|icsi
1142616|NCT02306564|cabergoline|cabergoline
1142617|NCT02306564|Subendometrial vascularity|subendometrial vascularity
1142618|NCT02306551|Offspring|offspring
1142619|NCT02306551|Attachment|attachment
1142620|NCT02306551|Risk development|risk development
1142621|NCT02306551|Resilience|resilience
1142622|NCT02306538|edema|edema
1142623|NCT02306538|inflammation|inflammation
1142624|NCT02306538|scar|scar
1142625|NCT02306538|ejection fraction|ejection fraction
1142626|NCT02306538|volumes|volumes
1142627|NCT02306512|Melanoma In Situ|melanoma in situ
1142628|NCT02306512|Lentigo Maligna|lentigo maligna
1142629|NCT02306512|Confocal Microscopy|confocal microscopy
1142630|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
1142631|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
1142632|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
1142633|NCT02306460|POCD|pocd
1142634|NCT02306460|Atrial Fibrillation|atrial fibrillation
1142635|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
1142636|NCT02306460|Atrial Appendage Closure|atrial appendage closure
1142637|NCT02306434|childbirth fear|childbirth fear
1142638|NCT02306434|Internet CBT|internet cbt
1142639|NCT02306434|counselling|counselling
1142640|NCT02306434|antenatal care|antenatal care
1142641|NCT02306434|postnatal care|postnatal care
1142642|NCT02306434|childbirth|childbirth
1142643|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
1142644|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
1142645|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
1142646|NCT02306421|the effectiveness and safety|the effectiveness and safety
1142647|NCT02306421|A multi center clinical trial|a multi center clinical trial
1142648|NCT02306395|endometrial local injury|endometrial local injury
1142649|NCT02306395|repeated implatation failure|repeated implatation failure
1142650|NCT02306395|embyo transfer|embyo transfer
1142651|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
1142652|NCT02306382|drainage|drainage
1142653|NCT02306382|perianal abscess|perianal abscess
1142654|NCT02306382|fistulas|fistulas
1142655|NCT02306382|incontience|incontience
1142658|NCT02306369|FGID|fgid
1142659|NCT02306369|functional abdominal pain|functional abdominal pain
1142660|NCT02306369|Adolescents|adolescents
1142661|NCT02306369|Children|children
1142662|NCT02306369|Treatment|treatment
1142663|NCT02306369|CBT|cbt
1142664|NCT02306369|Exposure|exposure
1142665|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
1142666|NCT02306369|Internet|internet
1142667|NCT02306369|Computerized|computerized
1142668|NCT02306369|Abdominal Pain|abdominal pain
1142669|NCT02306369|Functional Pain|functional pain
1142670|NCT02306369|Functional Disorders|functional disorders
1142671|NCT02306343|rapid acting insulin|rapid acting insulin
1142672|NCT02306343|insulin injection|insulin injection
1142673|NCT02306343|insulin delivery|insulin delivery
1142674|NCT02306343|local heating|local heating
1142675|NCT02306343|experimental device|experimental device
1142676|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
1142677|NCT02306330|Malditof|malditof
1142678|NCT02306330|Malditof MS|malditof ms
1142679|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
1142680|NCT02306330|identifying pathogens|identifying pathogens
1142681|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
1142682|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
1142683|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
1142684|NCT02306304|AAA|aaa
1142685|NCT02306304|Screening|screening
1142686|NCT02306304|duplex ultra sound|duplex ultra sound
1142687|NCT02306304|Israeli Arab men|israeli arab men
1142688|NCT02306304|family physician|family physician
1142689|NCT02306291|AML|aml
1142690|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
1142691|NCT02306291|E-selectin|e-selectin
1142692|NCT02306291|relapse refractory|relapse refractory
1142693|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
1142694|NCT02306291|induction|induction
1142695|NCT02306278|gabapentin|gabapentin
1142696|NCT02306278|postoperative pain|postoperative pain
1142697|NCT02306278|vomiting|vomiting
1142698|NCT02306278|nausea|nausea
1142699|NCT02306252|Cancer|cancer
1142700|NCT02306252|Older Adult|older adult
1142701|NCT02306252|Geriatric|geriatric
1142702|NCT02306252|Function|function
1142703|NCT02306252|Functional Deficit|functional deficit
1142704|NCT02306252|Occupational Therapy|occupational therapy
1142705|NCT02306252|Physical Therapy|physical therapy
1142706|NCT02306252|Supportive Care|supportive care
1142707|NCT02306252|Oncology|oncology
1142708|NCT02306252|physiology|physiology
1142709|NCT02306252|Geriatric Assessment|geriatric assessment
1142710|NCT02306252|Health Services for the Aged|health services for the aged
1142711|NCT02306252|Physical Therapy Specialty|physical therapy specialty
1142712|NCT02306226|TAVI|tavi
1142713|NCT02306226|Aortic stenosis|aortic stenosis
1142714|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1142715|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1142716|NCT02306226|Transfemoral access|transfemoral access
1142717|NCT02306200|Aorta|aorta
1142718|NCT02306200|Aortic Disease|aortic disease
1142719|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
1142720|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
1142721|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
1142722|NCT02306200|Aortic Dissection|aortic dissection
1142723|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
1142724|NCT02306174|Hoarding|hoarding
1142725|NCT02306135|Cancer|cancer
1142726|NCT02306135|Tumor|tumor
1142727|NCT02306135|Everolimus|everolimus
1142728|NCT02306135|mTOR|mtor
1142729|NCT02306135|Temsirolimus|temsirolimus
1142730|NCT02306135|Sirolimus|sirolimus
1142731|NCT02306135|Rapamycin|rapamycin
1142732|NCT02306122|medication adherence|medication adherence
1142733|NCT02306122|choice architecture|choice architecture
1142734|NCT02306122|pharmacy home|pharmacy home
1142735|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
1142736|NCT02306109|Intensive versus standard|intensive versus standard
1142737|NCT02306109|Motor Disability|motor disability
1142738|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
1142739|NCT02306096|RNA-sequencing|rna-sequencing
1142740|NCT02306096|pathological complete response|pathological complete response
1142741|NCT02306096|minimal residual disease|minimal residual disease
1142742|NCT02306096|molecular subtype|molecular subtype
1142743|NCT02306096|gene expression profiling|gene expression profiling
1142744|NCT02306096|mutation screening|mutation screening
1142745|NCT02306096|BRCA|brca
1142746|NCT02306096|translational research|translational research
1142747|NCT02306096|genomics|genomics
1142748|NCT02306096|transcriptomics|transcriptomics
1142749|NCT02306096|proteomics|proteomics
1142750|NCT02306096|metabolomics|metabolomics
1142751|NCT02306096|liquid biopsy|liquid biopsy
1142752|NCT02306096|circulating tumor cells|circulating tumor cells
1142753|NCT02306096|circulating tumor DNA|circulating tumor dna
1142754|NCT02306044|Bleeding|bleeding
1142755|NCT02306044|Platelet indices|platelet indices
1142756|NCT02306044|Platelet aggregometry|platelet aggregometry
1142757|NCT02306044|Bleeding questionnaire|bleeding questionnaire
1142758|NCT02306031|diclofenac|diclofenac
1142759|NCT02306031|macular thickness|macular thickness
1142760|NCT02306031|phacoemulsification|phacoemulsification
1142761|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
1142763|NCT02306018|liver transplantation|liver transplantation
1142764|NCT02306018|cardiac output|cardiac output
1142765|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
1142766|NCT02305966|advanced arthritis|advanced arthritis
1142767|NCT02305966|shoulder|shoulder
1142768|NCT02305953|Psoriasis|psoriasis
1142769|NCT02305953|Vascular Inflammation|vascular inflammation
1142770|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
1142771|NCT02305953|Ascending aorta|ascending aorta
1142772|NCT02305953|PET scan|pet scan
1142773|NCT02305953|Cytokine|cytokine
1142774|NCT02305953|Chemokine|chemokine
1142775|NCT02305927|Vitamin D|vitamin d
1142776|NCT02305927|Pregnant women|pregnant women
1142777|NCT02305914|acute pancreatitis|acute pancreatitis
1142778|NCT02305914|chronic pancreatitis|chronic pancreatitis
1142779|NCT02305914|pancreatic cancer|pancreatic cancer
1142780|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
1142781|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
1142782|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
1142783|NCT02305914|diabetes mellitus|diabetes mellitus
1142784|NCT02305914|blood lipid|blood lipid
1142785|NCT02305914|local complications|local complications
1142786|NCT02305914|quality of life|quality of life
1142787|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
1142788|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
1142789|NCT02305862|Rosuvastatin|rosuvastatin
1142790|NCT02305849|ASP015K|asp015k
1142791|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
1142792|NCT02305836|Electroacupuncture|electroacupuncture
1142793|NCT02305836|Donepezil|donepezil
1142794|NCT02305836|Alzheimer's disease|alzheimer's disease
1142795|NCT02305836|Randomized controlled trial|randomized controlled trial
1142796|NCT02305823|psychosis|psychosis
1142797|NCT02305823|antipsychotic agents|antipsychotic agents
1142798|NCT02305823|treatment|treatment
1142799|NCT02305823|effectiveness|effectiveness
1142800|NCT02305784|Cystic fibrosis|cystic fibrosis
1142801|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
1142802|NCT02305784|inflammation|inflammation
1142803|NCT02305784|Chitinase|chitinase
1142804|NCT02305784|cytokine|cytokine
1142805|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
1142806|NCT02305758|PARP inhibitor|parp inhibitor
1142807|NCT02305758|veliparib|veliparib
1142808|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
1142810|NCT02305758|first line|first line
1142811|NCT02305758|previously untreated|previously untreated
1142812|NCT02305758|colorectal cancer|colorectal cancer
1142813|NCT02305758|colon cancer|colon cancer
1142814|NCT02305758|rectal cancer|rectal cancer
1142815|NCT02305758|FOLFIRI|folfiri
1142816|NCT02305758|fluorouracil|fluorouracil
1142817|NCT02305758|5-FU|5-fu
1142818|NCT02305758|leucovorin|leucovorin
1142819|NCT02305758|irinotecan|irinotecan
1142820|NCT02305732|Chikungunya virus|chikungunya virus
1142821|NCT02305732|CHIKV|chikv
1142822|NCT02305732|Dengue virus|dengue virus
1142823|NCT02305732|DENV|denv
1142824|NCT02305732|pathogen inactivation|pathogen inactivation
1142825|NCT02305732|platelets|platelets
1142826|NCT02305732|Puerto Rico|puerto rico
1142827|NCT02305706|insertion|insertion
1142828|NCT02305706|patient comfort|patient comfort
1142829|NCT02305667|Laryngoscope|laryngoscope
1142830|NCT02305667|Macintosh|macintosh
1142831|NCT02305667|Glidescope®|glidescope®
1142832|NCT02305667|King Vision™|king vision™
1142833|NCT02305667|Airtraq®|airtraq®
1142834|NCT02305667|intubation|intubation
1142835|NCT02305667|double lumen tube|double lumen tube
1142836|NCT02305654|Penis cancer|penis cancer
1142837|NCT02305654|Chemotherapy|chemotherapy
1142838|NCT02305654|Chemoradiotherapy|chemoradiotherapy
1142839|NCT02305654|Surgery|surgery
1142841|NCT02305602|extracellular matrix|extracellular matrix
1142842|NCT02305589|postoperative delirium|postoperative delirium
1142843|NCT02305589|sugammadex|sugammadex
1142844|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
1142845|NCT02305589|hip fracture surgery|hip fracture surgery
1142846|NCT02305550|Nitric Oxide|nitric oxide
1142847|NCT02305524|endotracheal intubation|endotracheal intubation
1142848|NCT02305511|Catheterization|catheterization
1142849|NCT02305511|Peripheral|peripheral
1142850|NCT02305498|Yoga|yoga
1142851|NCT02305498|14-059|14-059
1142852|NCT02305485|NeoVas|neovas
1142853|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
1142854|NCT02305485|Sirolimus|sirolimus
1142855|NCT02305485|Randomized Controlled Trial|randomized controlled trial
1142856|NCT02305472|NeoVas|neovas
1142857|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
1142858|NCT02305472|Sirolimus|sirolimus
1142859|NCT02305472|Registry Trial|registry trial
1142860|NCT02305459|SIRT|sirt
1142861|NCT02305459|microcatheter|microcatheter
1142862|NCT02305459|primary liver tumor|primary liver tumor
1142863|NCT02305459|secondary liver tumor|secondary liver tumor
1142864|NCT02305459|radioembolisation|radioembolisation
1142865|NCT02305459|QLQ-C30|qlq-c30
1142866|NCT02305459|CIRSE|cirse
1142868|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
1142869|NCT02305433|frailty syndrome|frailty syndrome
1142870|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
1142871|NCT02305433|home-based physiotherapy|home-based physiotherapy
1142872|NCT02305433|home-dwelling|home-dwelling
1142873|NCT02305433|intervention|intervention
1142874|NCT02305433|randomised controlled trial|randomised controlled trial
1142875|NCT02305433|costs of social and health care|costs of social and health care
1142876|NCT02305433|quality of life|quality of life
1142877|NCT02305433|physical functioning|physical functioning
1142878|NCT02305433|mobility|mobility
1142879|NCT02305433|nutrition|nutrition
1142880|NCT02305394|ketamine|ketamine
1142881|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
1142882|NCT02305394|Cognitive Function|cognitive function
1142883|NCT02305342|Uncomplicated UTI|uncomplicated uti
1142884|NCT02305342|Enoxacin|enoxacin
1142885|NCT02305303|Quality of life|quality of life
1142886|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
1142887|NCT02305303|trauma|trauma
1142888|NCT02305238|Eylea,|eylea,
1142889|NCT02305238|Aflibercept|aflibercept
1142890|NCT02305238|Treat and Extend regimen|treat and extend regimen
1142891|NCT02305238|Age-related macular degeneration|age-related macular degeneration
1142892|NCT02305212|Working Memory|working memory
1142893|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1142894|NCT02305199|Hartmann's solution|hartmann's solution
1142895|NCT02305186|Immunotherapy|immunotherapy
1142896|NCT02305186|Neoadjuvant|neoadjuvant
1142897|NCT02305186|Resectable|resectable
1142898|NCT02305186|Borderline resectable|borderline resectable
1142899|NCT02305173|dexamethasone|dexamethasone
1142900|NCT02305173|pulmonary function|pulmonary function
1142901|NCT02305173|spirometry|spirometry
1142902|NCT02305173|mastectomy|mastectomy
1203056|NCT02019108|toeout|toeout
1142903|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
1142904|NCT02305160|Pulmonary surfactant|pulmonary surfactant
1142905|NCT02305160|Mortality|mortality
1142906|NCT02305160|Prematurity|prematurity
1142907|NCT02305147|Parkinson Disease|parkinson disease
1142908|NCT02305147|Biomarkers|biomarkers
1142909|NCT02305147|Prognostic factors|prognostic factors
1142910|NCT02305147|Prodromal features|prodromal features
1142911|NCT02305147|Disease progression|disease progression
1142912|NCT02305134|Tipepidine, GIRK|tipepidine, girk
1142913|NCT02305121|Trochanteric fracture|trochanteric fracture
1142915|NCT02305121|Fracture reduction|fracture reduction
1142916|NCT02305121|Antirotation|antirotation
1142917|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
1142918|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
1142919|NCT02305043|non-interventional|non-interventional
1142920|NCT02305043|advanced gastric cancer|advanced gastric cancer
1142921|NCT02305043|Trastuzumab|trastuzumab
1142922|NCT02305043|HER2|her2
1142923|NCT02304991|Peanut|peanut
1142924|NCT02304991|Food Allergy|food allergy
1142925|NCT02304978|colorectal cancer|colorectal cancer
1142926|NCT02304978|Tissular factor|tissular factor
1142927|NCT02304978|TF|tf
1142928|NCT02304965|LVAD|lvad
1142929|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
1142930|NCT02304952|Pain|pain
1142931|NCT02304952|Function|function
1142932|NCT02304952|Physiotherapy|physiotherapy
1142933|NCT02304952|Quality of Life|quality of life
1142934|NCT02304939|Norepinephrine|norepinephrine
1142935|NCT02304939|Intensive Care|intensive care
1142936|NCT02304939|Changeovers|changeovers
1142937|NCT02304939|Smart pumps|smart pumps
1142938|NCT02304939|Quick change|quick change
1142939|NCT02304939|Double pumping|double pumping
1142940|NCT02304939|Shock|shock
1142941|NCT02304926|Dyslipidemia|dyslipidemia
1142942|NCT02304926|Simvastatin|simvastatin
1142943|NCT02304926|Ezetimibe|ezetimibe
1142944|NCT02304926|Lipid profile|lipid profile
1142945|NCT02304926|Inflammation|inflammation
1142946|NCT02304926|Oxidative stress|oxidative stress
1142947|NCT02304926|Endothelial function|endothelial function
1142948|NCT02304900|cataract|cataract
1142949|NCT02304887|Osteoporosis|osteoporosis
1142950|NCT02304887|Bone mineral densisty|bone mineral densisty
1142951|NCT02304887|Renal function|renal function
1142952|NCT02304887|CKD-MBD|ckd-mbd
1142953|NCT02304874|Ferritins|ferritins
1142954|NCT02304874|Iron Overload|iron overload
1142955|NCT02304874|Metabolic Syndrome|metabolic syndrome
1142956|NCT02304874|Venesection therapy|venesection therapy
1142957|NCT02304874|Volunteers|volunteers
1142958|NCT02304861|cataract|cataract
1142959|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
1142960|NCT02304861|endothelial cell count|endothelial cell count
1142961|NCT02304861|endothelial cell pattern|endothelial cell pattern
1142962|NCT02304861|central corneal edema|central corneal edema
1142963|NCT02304848|Parkinson's Disease|parkinson's disease
1142965|NCT02304848|Deep Brain Stimulation|deep brain stimulation
1142966|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
1142967|NCT02304822|kidney stones|kidney stones
1142968|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
1142969|NCT02304822|ciprofloxacin|ciprofloxacin
1142971|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1142972|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
1142973|NCT02304809|genomic alterations|genomic alterations
1142974|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
1142975|NCT02304809|genomic.|genomic.
1142976|NCT02304796|Anxiety Disorders|anxiety disorders
1142977|NCT02304796|Group Psychotherapy|group psychotherapy
1142978|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1142979|NCT02304796|Dance/Movement Therapy|dance/movement therapy
1142980|NCT02304796|CBT|cbt
1142981|NCT02304796|DMT|dmt
1142982|NCT02304796|Unified Protocol|unified protocol
1142983|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
1142984|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
1142985|NCT02304757|bone mineral density|bone mineral density
1142986|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
1142987|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
1142988|NCT02304718|GDM|gdm
1142989|NCT02304718|pregnancy outcome|pregnancy outcome
1142990|NCT02304718|obesity|obesity
1142991|NCT02304718|exercise|exercise
1142992|NCT02304718|overweight|overweight
1142993|NCT02304640|fatigue|fatigue
1142994|NCT02304640|chemotherapy|chemotherapy
1142995|NCT02304640|breast cancer|breast cancer
1142996|NCT02304640|supportive care|supportive care
1142997|NCT02304640|Singapore|singapore
1142998|NCT02304523|Colonoscopy preparation|colonoscopy preparation
1142999|NCT02304523|Bowel cleansing|bowel cleansing
1143000|NCT02304523|Colon cleansing|colon cleansing
1203221|NCT02018315|G1D|g1d
1143001|NCT02304523|Colonoscopy|colonoscopy
1143002|NCT02304523|CDFR0612|cdfr0612
1143003|NCT02304523|CDFR0613|cdfr0613
1143004|NCT02304510|Prevalence|prevalence
1143005|NCT02304510|Menorrhagia|menorrhagia
1143006|NCT02304497|Diabetes mellitus|diabetes mellitus
1143007|NCT02304497|Platelet rich fibrin|platelet rich fibrin
1143008|NCT02304497|growth factor|growth factor
1143009|NCT02304445|Radiotherapy|radiotherapy
1143010|NCT02304445|Chemoembolization|chemoembolization
1143011|NCT02304432|D-cycloserine|d-cycloserine
1143012|NCT02304432|Glycine|glycine
1143013|NCT02304432|Psychosis|psychosis
1143014|NCT02304432|Mutation|mutation
1143015|NCT02304432|GABA|gaba
1143016|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
1143017|NCT02304367|TIO|tio
1143018|NCT02304367|ENS|ens
1143019|NCT02304367|FGF23|fgf23
1143020|NCT02304367|KRN23|krn23
1143021|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
1143022|NCT02304354|T lymphocytes|t lymphocytes
1143023|NCT02304354|rituximab|rituximab
1143024|NCT02304341|critical illness|critical illness
1143025|NCT02304341|disease progression|disease progression
1143026|NCT02304341|child|child
1143027|NCT02304341|severity of illness index|severity of illness index
1143028|NCT02304341|monitoring|monitoring
1143029|NCT02304328|SAH|sah
1143030|NCT02304328|WFNS|wfns
1143031|NCT02304328|hWFNS|hwfns
1143032|NCT02304328|grading|grading
1143033|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
1143034|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
1143035|NCT02304302|Memantine|memantine
1143036|NCT02304302|Episodic Memory|episodic memory
1143037|NCT02304302|CVLT|cvlt
1143038|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
1143039|NCT02304302|Short-term memory|short-term memory
1143040|NCT02304263|tenofovir|tenofovir
1143041|NCT02304263|aging|aging
1143042|NCT02304263|renal function|renal function
1143043|NCT02304263|HIV|hiv
1143044|NCT02304263|frailty|frailty
1143045|NCT02304237|Premature Birth|premature birth
1143046|NCT02304237|progesterone|progesterone
1143047|NCT02304224|sepsis|sepsis
1143048|NCT02304224|melatonin|melatonin
1143049|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
1143050|NCT02304224|outcome|outcome
1143051|NCT02304211|Microdosing|microdosing
1143052|NCT02304211|Phase 0|phase 0
1143053|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
1143054|NCT02304211|Intra-Arterial|intra-arterial
1143055|NCT02304211|PET Imaging|pet imaging
1143056|NCT02304185|Healthy|healthy
1143057|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
1143058|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
1143059|NCT02304185|Glycoprotein|glycoprotein
1143060|NCT02304185|Adjuvant|adjuvant
1143061|NCT02304185|Vaccine|vaccine
1143062|NCT02304185|Placebo|placebo
1143063|NCT02304172|Thyroidectomy|thyroidectomy
1143064|NCT02304172|Thunderbeat|thunderbeat
1143065|NCT02304159|HCV|hcv
1143066|NCT02304159|Genotype 3|genotype 3
1143067|NCT02304159|Treatment naive|treatment naive
1143068|NCT02304159|Treatment experienced|treatment experienced
1143069|NCT02304146|Foam|foam
1143070|NCT02304146|UGFS|ugfs
1143071|NCT02304146|Stripping|stripping
1143072|NCT02304146|Incompetence|incompetence
1143073|NCT02304120|proprioception|proprioception
1143363|NCT02302430|ROTC|rotc
1143074|NCT02304120|postural control|postural control
1143075|NCT02304120|sensorimotor training|sensorimotor training
1143076|NCT02304120|uncontrolled manifold|uncontrolled manifold
1143077|NCT02304029|epilepsy|epilepsy
1143078|NCT02304029|seizures|seizures
1143079|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
1143080|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
1143081|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
1143082|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
1143083|NCT02303964|Trauma|trauma
1143084|NCT02303964|Hemorrhage|hemorrhage
1143085|NCT02303964|Plasma|plasma
1143086|NCT02303964|Shock|shock
1143087|NCT02303964|Polytrauma|polytrauma
1143088|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
1143089|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
1143090|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
1143091|NCT02303860|Healthy volunteer study|healthy volunteer study
1143092|NCT02303808|Hyperosmolar agents|hyperosmolar agents
1143093|NCT02303808|Hypertonic saline|hypertonic saline
1143094|NCT02303808|Airway clearance techniques|airway clearance techniques
1143095|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
1143096|NCT02303808|Autogenic drainage|autogenic drainage
1143097|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
1143098|NCT02303795|valvular heart disease|valvular heart disease
1143099|NCT02303795|anticoagulant agents|anticoagulant agents
1143100|NCT02303795|NOACs|noacs
1143101|NCT02303795|rivaroxaban|rivaroxaban
1143102|NCT02303795|warfarin|warfarin
1143103|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
1143104|NCT02303769|Harnal|harnal
1143105|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
1143106|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
1143107|NCT02303730|Diabetes|diabetes
1143108|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1143109|NCT02303717|Left main|left main
1143110|NCT02303717|PCI|pci
1143111|NCT02303717|DES|des
1143112|NCT02303704|Multiperfusion set|multiperfusion set
1143113|NCT02303704|Myocardial protection|myocardial protection
1143114|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1143115|NCT02303691|anxiety|anxiety
1143116|NCT02303691|attention bias modification|attention bias modification
1143117|NCT02303691|computer|computer
1143118|NCT02303678|D2C7|d2c7
1143119|NCT02303678|Randazzo|randazzo
1143120|NCT02303678|Bigner|bigner
1143121|NCT02303678|Pro00053325|pro00053325
1143122|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
1143123|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
1143124|NCT02303665|ART failure|art failure
1143125|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1143126|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
1143127|NCT02303639|catheter ablation|catheter ablation
1143128|NCT02303626|BCX4161|bcx4161
1143129|NCT02303626|Prophylaxis|prophylaxis
1143130|NCT02303626|Prevention|prevention
1143131|NCT02303626|HAE|hae
1143132|NCT02303626|Hereditary Angioedema|hereditary angioedema
1143133|NCT02303600|Sub-acute cough|sub-acute cough
1143134|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
1143135|NCT02303587|pneumonia|pneumonia
1143136|NCT02303587|children|children
1143137|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
1143138|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
1143139|NCT02303535|Congenital heart disease|congenital heart disease
1143140|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
1143333|NCT02302573|sonovue|sonovue
1143141|NCT02303535|Specific Procedure Definitions|specific procedure definitions
1143143|NCT02303535|paediatric|paediatric
1143144|NCT02303535|pediatric|pediatric
1143145|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
1143146|NCT02303509|Healthy Subjects|healthy subjects
1143147|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
1143148|NCT02303509|Subjects|subjects
1143149|NCT02303496|platelet rich plasma|platelet rich plasma
1143150|NCT02303470|Exercise|exercise
1143151|NCT02303457|CO2 laser surgery|co2 laser surgery
1143152|NCT02303457|open surgery|open surgery
1143153|NCT02303457|multicenter prospective|multicenter prospective
1143154|NCT02303457|randomized|randomized
1143155|NCT02303457|controlled clinical studies|controlled clinical studies
1143156|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
1143157|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
1143158|NCT02303431|Pediatric|pediatric
1143159|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
1143160|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
1143161|NCT02303431|Anticoagulant|anticoagulant
1143162|NCT02303431|Safety|safety
1143163|NCT02303418|Obstetrics|obstetrics
1143164|NCT02303405|Glucose Control|glucose control
1143165|NCT02303405|Inflammation|inflammation
1143166|NCT02303379|Training Protocol|training protocol
1143167|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
1143168|NCT02303379|High-Intensity Interval Training|high-intensity interval training
1143169|NCT02303379|Continuous Training|continuous training
1143170|NCT02303379|Pyramid Training|pyramid training
1143171|NCT02303379|Physical Performance|physical performance
1143172|NCT02303353|Breast cancer|breast cancer
1143173|NCT02303353|Ovarian cancer|ovarian cancer
1143174|NCT02303353|Lung cancer|lung cancer
1143175|NCT02303353|Colon cancer|colon cancer
1143176|NCT02303353|Gastric cancer|gastric cancer
1143177|NCT02303353|Pancreatic cancer|pancreatic cancer
1143178|NCT02303353|Rectum cancer|rectum cancer
1143179|NCT02303353|Plasmacytoma|plasmacytoma
1143180|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
1143181|NCT02303340|Para Thyroid Hormone|para thyroid hormone
1143182|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
1143183|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
1143184|NCT02303275|Heart Failure|heart failure
1143185|NCT02303275|Congestive Heart Failure|congestive heart failure
1143186|NCT02303275|Lifestyle Change|lifestyle change
1143187|NCT02303236|Exercise|exercise
1143188|NCT02303197|head and neck cancer|head and neck cancer
1143189|NCT02303197|chemoradiotherapy|chemoradiotherapy
1143190|NCT02303197|radioactive stomatitis|radioactive stomatitis
1143191|NCT02303184|RVO|rvo
1143192|NCT02303184|ME|me
1143193|NCT02303184|Central Subfield Thickness|central subfield thickness
1143194|NCT02303184|OCT|oct
1143195|NCT02303184|optical coherence tomography|optical coherence tomography
1143196|NCT02303184|cystoid macular edema|cystoid macular edema
1143197|NCT02303184|subretinal fluid|subretinal fluid
1143198|NCT02303184|Eylea|eylea
1143199|NCT02303184|aflibercept|aflibercept
1143200|NCT02303184|anti-VEGF|anti-vegf
1143201|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
1143202|NCT02303171|APS|aps
1143203|NCT02303171|Warfarin|warfarin
1143204|NCT02303158|Alzheimer's Disease|alzheimer's disease
1143205|NCT02303158|Biomarkers|biomarkers
1143206|NCT02303158|Depression|depression
1143207|NCT02303158|dementia|dementia
1143208|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
1143209|NCT02303158|neuropsychological|neuropsychological
1143210|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
1143211|NCT02303119|LNH|lnh
1143212|NCT02303119|CD20+|cd20+
1143213|NCT02303119|follicular|follicular
1143214|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
1143215|NCT02303080|whey protein microgels|whey protein microgels
1143216|NCT02303080|thermogenesis|thermogenesis
1143217|NCT02303067|Cardiac|cardiac
1143218|NCT02303067|Computed Tomography|computed tomography
1143219|NCT02303067|Coronary Artery Disease|coronary artery disease
1143220|NCT02303054|Prostate Cancer|prostate cancer
1143221|NCT02303054|Focal Ablation|focal ablation
1143222|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
1143223|NCT02303054|Focal Therapy|focal therapy
1143224|NCT02303028|Pediatric|pediatric
1143225|NCT02303028|CNS Tumor|cns tumor
1143226|NCT02303028|Solid Tumour|solid tumour
1143227|NCT02303015|Germ cell cancer|germ cell cancer
1143228|NCT02303015|Late toxicity|late toxicity
1143229|NCT02303015|Renal impairment|renal impairment
1143230|NCT02303015|Cardiovascular disease|cardiovascular disease
1143231|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
1143232|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1143233|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
1143234|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
1143334|NCT02302547|HIV-DNA|hiv-dna
1143235|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
1143236|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
1143237|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
1143238|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1143239|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
1143240|NCT02302950|HIV infection|hiv infection
1143241|NCT02302950|raltegravir use|raltegravir use
1143242|NCT02302950|women|women
1143243|NCT02302937|Inguinal Hernia|inguinal hernia
1143244|NCT02302937|Primary|primary
1143245|NCT02302937|laparoscopic surgery|laparoscopic surgery
1143246|NCT02302937|single port surgery|single port surgery
1143247|NCT02302911|Early intervention|early intervention
1143248|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
1143249|NCT02302898|Weight Regain|weight regain
1143250|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
1143251|NCT02302859|Cancer Prevention|cancer prevention
1143252|NCT02302859|Tobacco Use Cessation|tobacco use cessation
1143253|NCT02302859|HIV-positive|hiv-positive
1143254|NCT02302859|Nicotine patch|nicotine patch
1143255|NCT02302859|NRT|nrt
1143256|NCT02302859|Questionnaire|questionnaire
1143257|NCT02302859|Survey|survey
1143258|NCT02302859|Smartphone|smartphone
1143259|NCT02302859|Counseling|counseling
1143260|NCT02302859|Saliva test|saliva test
1143261|NCT02302859|Saliva cotinine test|saliva cotinine test
1143262|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
1143263|NCT02302859|Smoking abstinence|smoking abstinence
1143264|NCT02302859|Aids|aids
1143265|NCT02302846|Leukemia|leukemia
1143266|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
1143267|NCT02302846|AML|aml
1143268|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
1143269|NCT02302846|MDS|mds
1143270|NCT02302846|Ixazomib|ixazomib
1143271|NCT02302846|MLN9708|mln9708
1143272|NCT02302833|Neuroendocrine tumors|neuroendocrine tumors
1143273|NCT02302833|Pheochromocytomas|pheochromocytomas
1143274|NCT02302833|Paragangliomas|paragangliomas
1143275|NCT02302833|Unresectable|unresectable
1143276|NCT02302833|Metastatic|metastatic
1143277|NCT02302833|Cabozantinib|cabozantinib
1143278|NCT02302833|XL-184|xl-184
1143279|NCT02302833|XL184|xl184
1143280|NCT02302833|Questionnaire|questionnaire
1143281|NCT02302833|Survey|survey
1143282|NCT02302820|Advance Care Planning|advance care planning
1143283|NCT02302820|Nurse Care Coordination|nurse care coordination
1143284|NCT02302820|Comparative Effectiveness|comparative effectiveness
1143285|NCT02302820|Advance Directive|advance directive
1143286|NCT02302820|Decision Aides|decision aides
1143287|NCT02302781|Reasons for Dropout|reasons for dropout
1143288|NCT02302781|Subfertility|subfertility
1143290|NCT02302781|NON IVF|non ivf
1143291|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
1143292|NCT02302742|TNBC|tnbc
1143293|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
1143294|NCT02302742|HBOC|hboc
1143295|NCT02302742|Prospective Registry|prospective registry
1143296|NCT02302729|Micronutrient intervention|micronutrient intervention
1143297|NCT02302729|Responsive feeding intervention|responsive feeding intervention
1143298|NCT02302729|School readiness intervention|school readiness intervention
1143299|NCT02302677|bile acids|bile acids
1143300|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
1143301|NCT02302677|obesity|obesity
1143302|NCT02302677|GLP-1|glp-1
1143303|NCT02302677|FGF-19|fgf-19
1143304|NCT02302664|Achilles|achilles
1143305|NCT02302664|Platelet Rich Plasma|platelet rich plasma
1143306|NCT02302664|Patient reported outcome measure|patient reported outcome measure
1143307|NCT02302664|Orthopaedic trauma|orthopaedic trauma
1143308|NCT02302664|Musculoskeletal|musculoskeletal
1143309|NCT02302664|Tendon|tendon
1143310|NCT02302664|Sports Injury|sports injury
1143311|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
1143312|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
1143313|NCT02302651|osteoid osteoma|osteoid osteoma
1143314|NCT02302651|bone tumor|bone tumor
1143315|NCT02302638|single-step media|single-step media
1143316|NCT02302638|embryo development|embryo development
1143317|NCT02302638|blastocyst formation|blastocyst formation
1143318|NCT02302638|embryo utilization|embryo utilization
1143319|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
1143320|NCT02302612|chronic conditions|chronic conditions
1143321|NCT02302612|complex patients|complex patients
1143322|NCT02302612|engagement|engagement
1143323|NCT02302612|activation|activation
1143324|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
1143325|NCT02302586|Patient controlled analgesia|patient controlled analgesia
1143326|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
1143327|NCT02302586|Postoperative acute pain|postoperative acute pain
1143328|NCT02302586|Chronic pain|chronic pain
1143329|NCT02302573|placenta accreta|placenta accreta
1143330|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
1143331|NCT02302573|pregnancy|pregnancy
1143332|NCT02302573|MRI|mri
1143335|NCT02302547|dual therapy|dual therapy
1143336|NCT02302547|NRTI|nrti
1143337|NCT02302547|virological control|virological control
1143338|NCT02302547|truvada®|truvada®
1143339|NCT02302534|scoliosis|scoliosis
1143340|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1143342|NCT02302508|pharmacokinetics|pharmacokinetics
1143343|NCT02302508|drug metabolism|drug metabolism
1143344|NCT02302508|platelet reactivity|platelet reactivity
1143345|NCT02302508|carboxylesterase|carboxylesterase
1143346|NCT02302508|cytochromes p450|cytochromes p450
1143347|NCT02302508|type 2 diabetes|type 2 diabetes
1143348|NCT02302508|active metabolite|active metabolite
1143349|NCT02302495|Carfilzomib weekly|carfilzomib weekly
1143350|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
1143351|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
1143352|NCT02302482|Functional autonomy level|functional autonomy level
1143353|NCT02302482|Cognitive function|cognitive function
1143354|NCT02302482|Predictive factors|predictive factors
1143355|NCT02302469|Lenalidomide|lenalidomide
1143356|NCT02302469|Hematology|hematology
1143357|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1143358|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
1143359|NCT02302456|tranexamic acid|tranexamic acid
1143360|NCT02302456|prevention|prevention
1143361|NCT02302430|Cohesion|cohesion
1143362|NCT02302430|Oxytocin|oxytocin
1143364|NCT02302430|Virtual-reality|virtual-reality
1143365|NCT02302417|Asthma|asthma
1143366|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
1143367|NCT02302417|Clinical Questionnaire|clinical questionnaire
1143368|NCT02302417|COPD|copd
1143369|NCT02302417|ACOS|acos
1143370|NCT02302404|FTIH|ftih
1143371|NCT02302404|pharmacodynamics|pharmacodynamics
1143372|NCT02302404|pharmacokinetics|pharmacokinetics
1143373|NCT02302404|GSK2982772|gsk2982772
1143374|NCT02302404|safety|safety
1143375|NCT02302404|Repeat dose|repeat dose
1143376|NCT02302404|tolerability|tolerability
1143377|NCT02302378|Hypotension|hypotension
1143378|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
1143379|NCT02302365|white blood cell depletion|white blood cell depletion
1143380|NCT02302365|apheresis|apheresis
1143381|NCT02302352|Probiotics|probiotics
1143382|NCT02302352|Immune system|immune system
1143383|NCT02302339|Advanced melanoma|advanced melanoma
1143384|NCT02302339|Unresectable melanoma|unresectable melanoma
1143385|NCT02302339|Metastatic melanoma|metastatic melanoma
1143386|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
1143387|NCT02302339|GPNMB|gpnmb
1143388|NCT02302339|CDX-011|cdx-011
1143389|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
1143390|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
1143391|NCT02302339|Skin neoplasm|skin neoplasm
1143392|NCT02302339|Varlilumab|varlilumab
1143393|NCT02302339|CDX-1127|cdx-1127
1143394|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
1143395|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
1143396|NCT02302326|mitochondrial function|mitochondrial function
1143397|NCT02302326|insulin resistance|insulin resistance
1143398|NCT02302326|inflammation|inflammation
1143399|NCT02302326|myoinositol|myoinositol
1143400|NCT02302326|metformin|metformin
1143401|NCT02302326|oxidative stress|oxidative stress
1143402|NCT02302313|healthy volunteers|healthy volunteers
1143403|NCT02302313|critical awareness|critical awareness
1143404|NCT02302313|hypnosis|hypnosis
1143405|NCT02302313|Analgesia Nociception Index|analgesia nociception index
1143406|NCT02302313|numerical verbal scale|numerical verbal scale
1143407|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
1143408|NCT02302313|nociception in critical awareness|nociception in critical awareness
1143409|NCT02302300|Cardiac surgery|cardiac surgery
1143410|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
1143411|NCT02302287|Chronic kidney disease|chronic kidney disease
1143412|NCT02302287|mediterranean diet|mediterranean diet
1143413|NCT02302287|low-protein diet|low-protein diet
1143414|NCT02302287|ketoacids|ketoacids
1143415|NCT02302287|intestinal microbiota|intestinal microbiota
1143416|NCT02302274|Brugada Syndrome|brugada syndrome
1143417|NCT02302274|ARVC|arvc
1143418|NCT02302274|flecainide|flecainide
1143419|NCT02302274|ST elevation|st elevation
1143420|NCT02302261|Pulsus paradoxus|pulsus paradoxus
1143421|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
1143422|NCT02302235|Ketogenic Diet|ketogenic diet
1143423|NCT02302235|radiotherapy|radiotherapy
1143424|NCT02302235|chemotherapy|chemotherapy
1143425|NCT02302235|safety|safety
1143426|NCT02302235|efficiency|efficiency
1143427|NCT02302209|oxytocin|oxytocin
1143428|NCT02302209|schizophrenia|schizophrenia
1143429|NCT02302209|autism spectrum disorder|autism spectrum disorder
1143430|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
1143431|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
1143432|NCT02302157|AST-OPC1|ast-opc1
1143433|NCT02302157|SCiStar|scistar
1143434|NCT02302157|OPC1|opc1
1143435|NCT02302157|Neural cell|neural cell
1143436|NCT02302157|Trauma spinal cord|trauma spinal cord
1143437|NCT02302157|stemcell transplant|stemcell transplant
1143438|NCT02302157|Cervical spine injury|cervical spine injury
1143439|NCT02302157|Paralysis|paralysis
1143440|NCT02302157|Quadriplegia|quadriplegia
1143441|NCT02302157|Tetraplegia|tetraplegia
1143442|NCT02302157|Spine injury|spine injury
1143443|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
1143444|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
1143445|NCT02302144|Postural Instability (falling)|postural instability (falling)
1143446|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
1143447|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
1143448|NCT02302118|esophageal carcinoma|esophageal carcinoma
1143449|NCT02302118|kardia carcinoma|kardia carcinoma
1143450|NCT02302092|Drug Therapy|drug therapy
1143451|NCT02302079|ASP8232|asp8232
1143452|NCT02302079|Diabetes Mellitus|diabetes mellitus
1143453|NCT02302079|ranibizumab|ranibizumab
1143454|NCT02302079|Diabetic Macular Edema|diabetic macular edema
1143455|NCT02302066|Drug therapy|drug therapy
1143456|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
1143457|NCT02302040|Adolescent|adolescent
1143458|NCT02302027|withdrawal therapy|withdrawal therapy
1143459|NCT02302027|oxygen therapy|oxygen therapy
1143460|NCT02302001|Breast augmentation|breast augmentation
1143461|NCT02302001|Breast implants|breast implants
1143462|NCT02302001|Silicone implants|silicone implants
1143463|NCT02302001|Breast surgery|breast surgery
1143464|NCT02301975|Adult|adult
1143465|NCT02301975|asthma|asthma
1143466|NCT02301975|Fluticasone Propionate|fluticasone propionate
1143467|NCT02301975|Adolescents|adolescents
1143468|NCT02301975|Salmeterol|salmeterol
1143469|NCT02301975|Vilanterol|vilanterol
1143470|NCT02301975|ELLIPTA|ellipta
1143471|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
1143472|NCT02301975|Non-inferior|non-inferior
1143473|NCT02301975|Fluticasone Furoate|fluticasone furoate
1143474|NCT02301962|panitumumab|panitumumab
1143475|NCT02301962|previously treated|previously treated
1143476|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
1143477|NCT02301962|fully human antibody|fully human antibody
1143478|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
1143479|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
1143480|NCT02301949|vascular malformation|vascular malformation
1143481|NCT02301949|thalidomide retreatment|thalidomide retreatment
1143482|NCT02301936|Sickle Cell Disease|sickle cell disease
1143483|NCT02301936|Gilead|gilead
1203810|NCT02015728|Brain|brain
1143484|NCT02301936|Hepatitis C|hepatitis c
1143485|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
1143486|NCT02301910|Myocardial Infarction|myocardial infarction
1143487|NCT02301910|Fibrinolysis|fibrinolysis
1143488|NCT02301910|Fortelyzin|fortelyzin
1143489|NCT02301871|MNP|mnp
1143490|NCT02301871|MET|met
1143491|NCT02301871|Soft tissue mobilization|soft tissue mobilization
1143492|NCT02301871|DNF|dnf
1143493|NCT02301871|Static Stretching|static stretching
1143494|NCT02301858|molecular pathology|molecular pathology
1143495|NCT02301858|functional genomics|functional genomics
1143496|NCT02301858|lung cancer|lung cancer
1143497|NCT02301858|primary tumor|primary tumor
1143498|NCT02301858|metastases|metastases
1143499|NCT02301845|Respiration, artificial|respiration, artificial
1143500|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
1143501|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1143502|NCT02301767|MRI|mri
1143503|NCT02301767|Risk Factor|risk factor
1143504|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
1143505|NCT02301767|(IMAGINE) Study|(imagine) study
1143506|NCT02301741|chronic low back pain|chronic low back pain
1143507|NCT02301728|breast milk|breast milk
1143508|NCT02301728|short chain fatty acids|short chain fatty acids
1143509|NCT02301728|maternal diet|maternal diet
1143510|NCT02301715|Intranasal oxytocin|intranasal oxytocin
1143511|NCT02301715|Emotion regulation|emotion regulation
1143512|NCT02301715|Attachment|attachment
1143513|NCT02301702|Maternal Immunization|maternal immunization
1143514|NCT02301702|Tdap|tdap
1143515|NCT02301702|Td|td
1143516|NCT02301702|Pertussis|pertussis
1143517|NCT02301689|Heart failure|heart failure
1143518|NCT02301689|Chronic heart failure|chronic heart failure
1143519|NCT02301689|Sleep disordered breathing|sleep disordered breathing
1143520|NCT02301689|Sleep apnea|sleep apnea
1143521|NCT02301689|Positive Airway Pressure|positive airway pressure
1143522|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
1143523|NCT02301650|Hepatitis B virus|hepatitis b virus
1143524|NCT02301650|pregnancy|pregnancy
1143525|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
1143526|NCT02301650|children|children
1143527|NCT02301650|safety|safety
1143528|NCT02301624|gMG|gmg
1143529|NCT02301624|Myasthenia Gravis|myasthenia gravis
1143530|NCT02301624|safety|safety
1143531|NCT02301624|efficacy|efficacy
1143532|NCT02301598|femtosecond laser|femtosecond laser
1143533|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
1143534|NCT02301598|atomic-force microscopy|atomic-force microscopy
1143535|NCT02301585|shock, septic|shock, septic
1143536|NCT02301585|hemodynamics|hemodynamics
1143537|NCT02301585|algorithms|algorithms
1143538|NCT02301533|HIV infection|hiv infection
1143539|NCT02301533|antiretroviral therapy|antiretroviral therapy
1143540|NCT02301533|adherence|adherence
1143541|NCT02301533|men who have sex with men|men who have sex with men
1143542|NCT02301520|Vitamin D|vitamin d
1143543|NCT02301520|Iodine|iodine
1143544|NCT02301520|Lead|lead
1143545|NCT02301520|Thyroid function|thyroid function
1143546|NCT02301520|point-of-care test|point-of-care test
1143547|NCT02301494|CTCL|ctcl
1143548|NCT02301494|Mycosis Fungoides|mycosis fungoides
1143549|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1143550|NCT02301494|MF|mf
1143551|NCT02301494|topical therapy|topical therapy
1143552|NCT02301494|early stage|early stage
1143553|NCT02301455|hypertension treatment|hypertension treatment
1143554|NCT02301455|stroke prevention|stroke prevention
1143555|NCT02301403|smoking|smoking
1143556|NCT02301403|cessation|cessation
1143557|NCT02301403|tobacco|tobacco
1143558|NCT02301390|INTERVENE|intervene
1143559|NCT02301390|Ventricular tachycardia|ventricular tachycardia
1143560|NCT02301390|India|india
1143561|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
1143562|NCT02301364|14-177|14-177
1143563|NCT02301338|Videoconferencing|videoconferencing
1143564|NCT02301338|Following Surgery|following surgery
1143565|NCT02301338|14-213|14-213
1143566|NCT02301299|stroke|stroke
1143567|NCT02301299|barriers|barriers
1143568|NCT02301299|community|community
1143569|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
1143570|NCT02301286|Colon cancer|colon cancer
1143571|NCT02301286|Survival|survival
1143572|NCT02301273|Intensive care unit|intensive care unit
1143573|NCT02301273|Physiotherapy|physiotherapy
1143574|NCT02301273|Upright position|upright position
1143575|NCT02301273|Exercise|exercise
1143576|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
1143577|NCT02301260|Processing Speed|processing speed
1143578|NCT02301260|Intervention|intervention
1143579|NCT02301260|Multiple Sclerosis|multiple sclerosis
1143580|NCT02301260|Cognition|cognition
1143581|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
1143582|NCT02301247|cognition|cognition
1143583|NCT02301247|memory|memory
1143584|NCT02301247|treatment|treatment
1143585|NCT02301234|Osteoarthritis|osteoarthritis
1143586|NCT02301234|Pain|pain
1143587|NCT02301234|Fulranumab|fulranumab
1143588|NCT02301234|JNJ-42160443|jnj-42160443
1143589|NCT02301234|Adjunctive therapy|adjunctive therapy
1143590|NCT02301234|Celecoxib|celecoxib
1143591|NCT02301234|Hip|hip
1143592|NCT02301234|Knee|knee
1143593|NCT02301234|Joint replacement surgery|joint replacement surgery
1143594|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
1143595|NCT02301221|Slow Transit Constipation|slow transit constipation
1143596|NCT02301221|Colonic motility|colonic motility
1143597|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
1143598|NCT02301169|Pain|pain
1143599|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
1143600|NCT02301143|Pancreatic Cancer|pancreatic cancer
1143601|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
1143602|NCT02301143|nab-Paclitaxel|nab-paclitaxel
1143603|NCT02301143|Abraxane|abraxane
1143604|NCT02301143|Gemcitabine|gemcitabine
1143605|NCT02301143|ABI-007|abi-007
1143606|NCT02301130|advanced solid tumors|advanced solid tumors
1143607|NCT02301130|solid tumors|solid tumors
1143608|NCT02301130|mogamulizumab|mogamulizumab
1143609|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
1143610|NCT02301130|Tremelimumab|tremelimumab
1143611|NCT02301130|POTELIGEO®|poteligeo®
1143612|NCT02301130|KW-0761|kw-0761
1143613|NCT02301117|Renal|renal
1143614|NCT02301117|Kidney Diseases|kidney diseases
1143615|NCT02301117|Urologic Diseases|urologic diseases
1143616|NCT02301117|Renal Insufficiency|renal insufficiency
1143617|NCT02301117|Renal Impairment|renal impairment
1143618|NCT02301117|Pharmacokinetics|pharmacokinetics
1143619|NCT02301117|Advance Solid Tumor|advance solid tumor
1143620|NCT02301117|Creatinine Clearance|creatinine clearance
1143621|NCT02301117|Kidney Neoplasms|kidney neoplasms
1143622|NCT02301117|Renal Tumor|renal tumor
1143623|NCT02301117|Kidney|kidney
1143624|NCT02301117|Urology|urology
1143625|NCT02301117|Pharmacologic Action|pharmacologic action
1143626|NCT02301104|Liver Neoplasms|liver neoplasms
1143627|NCT02301104|Hepatic|hepatic
1143628|NCT02301104|TAS-102|tas-102
1143629|NCT02301104|mCRC|mcrc
1143630|NCT02301104|Liver Impairment|liver impairment
1143631|NCT02301104|Pharmacologic Actions|pharmacologic actions
1143632|NCT02301104|Liver Diseases|liver diseases
1143633|NCT02301104|Liver|liver
1143634|NCT02301104|LFT|lft
1143635|NCT02301104|Advanced Solid Tumor|advanced solid tumor
1143636|NCT02301104|Pharmacokinetics|pharmacokinetics
1143637|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
1143835|NCT02299713|acupuncture|acupuncture
1143638|NCT02301078|Dupuytren disease|dupuytren disease
1143639|NCT02301078|needle aponeurotomy|needle aponeurotomy
1143640|NCT02301078|collagenase|collagenase
1143641|NCT02301065|Viral|viral
1143642|NCT02301065|Infection|infection
1143643|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1143644|NCT02301052|hemorrhoids|hemorrhoids
1143645|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
1143646|NCT02301052|herbal medicine|herbal medicine
1143647|NCT02301052|traditional persian medicine|traditional persian medicine
1143648|NCT02301000|Clostridium difficile|clostridium difficile
1143649|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
1143650|NCT02300987|Teratoma,|teratoma,
1143651|NCT02300987|Germ Cell tumor,|germ cell tumor,
1143652|NCT02300987|incurable teratoma,|incurable teratoma,
1143653|NCT02300987|CDK4/6,|cdk4/6,
1143654|NCT02300987|LEE011|lee011
1143655|NCT02300948|Pregnancy|pregnancy
1143656|NCT02300948|Perinatal Vitamins|perinatal vitamins
1143657|NCT02300948|folate|folate
1143658|NCT02300935|trametinib|trametinib
1143659|NCT02300935|nab-paclitaxel|nab-paclitaxel
1143660|NCT02300935|Mekinist|mekinist
1143661|NCT02300935|Abraxane|abraxane
1143662|NCT02300935|unresectable|unresectable
1143663|NCT02300935|metastatic|metastatic
1143664|NCT02300896|exercise|exercise
1143665|NCT02300896|physical fitness|physical fitness
1143666|NCT02300896|geriatrics|geriatrics
1143667|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
1143767|NCT02300207|Orthostatic tolerance|orthostatic tolerance
1143768|NCT02300207|Head-down bed rest|head-down bed rest
1143769|NCT02300194|Pain management|pain management
1143770|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
1143771|NCT02300155|Pregnancy|pregnancy
1143772|NCT02300155|Morning Sickness|morning sickness
1143773|NCT02300155|nausea and vomiting|nausea and vomiting
1143774|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
1143775|NCT02300155|perinatal vitamins|perinatal vitamins
1143776|NCT02300142|HSV|hsv
1143777|NCT02300142|Herpes|herpes
1143778|NCT02300142|genital infection|genital infection
1143779|NCT02300142|vaccine|vaccine
1143780|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
1143781|NCT02300077|fentanyl, morphine|fentanyl, morphine
1143782|NCT02300077|methadone|methadone
1143783|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
1143784|NCT02300051|Intervention|intervention
1143785|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
1143786|NCT02300051|Sexual addiction|sexual addiction
1143787|NCT02300051|Hypersexual behavior|hypersexual behavior
1143788|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
1143789|NCT02300012|Performance based investigations|performance based investigations
1143790|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
1143791|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
1143792|NCT02299973|bloating|bloating
1143793|NCT02299960|EndoPAT|endopat
1143794|NCT02299960|NICOM|nicom
1143795|NCT02299960|circulating endothelial cells|circulating endothelial cells
1143796|NCT02299908|Hernia, Inguinal|hernia, inguinal
1143797|NCT02299908|Herniorrhaphy|herniorrhaphy
1143798|NCT02299908|Abdominal Wall|abdominal wall
1143799|NCT02299908|Analgesia|analgesia
1143800|NCT02299908|Pain, Postoperative|pain, postoperative
1143801|NCT02299895|setting approach|setting approach
1143802|NCT02299895|health promotion|health promotion
1143803|NCT02299895|organization|organization
1143804|NCT02299895|implementation research|implementation research
1143805|NCT02299895|qualitative study|qualitative study
1143806|NCT02299895|comparison|comparison
1143807|NCT02299882|Posterior spine surgery|posterior spine surgery
1143808|NCT02299882|infection|infection
1143809|NCT02299882|vancomycin|vancomycin
1143810|NCT02299882|surgical wound infection|surgical wound infection
1143811|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
1143812|NCT02299856|Diagnostic Imaging|diagnostic imaging
1143813|NCT02299843|RFA|rfa
1143814|NCT02299843|ALPPS|alpps
1143815|NCT02299843|hepatectomy|hepatectomy
1143816|NCT02299843|morbidity and mortality|morbidity and mortality
1143817|NCT02299830|neoplasm|neoplasm
1143818|NCT02299830|central airway|central airway
1143819|NCT02299830|obstruction|obstruction
1143820|NCT02299791|clinic-level interventions|clinic-level interventions
1143821|NCT02299791|quality improvement|quality improvement
1143822|NCT02299791|translational medical research|translational medical research
1143823|NCT02299791|community health centers|community health centers
1143824|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
1143825|NCT02299765|EGFR Mutation|egfr mutation
1143826|NCT02299765|gefitinib|gefitinib
1143827|NCT02299765|chemotherapy|chemotherapy
1143828|NCT02299739|Herbal Medicine|herbal medicine
1143829|NCT02299739|Complementary Therapies|complementary therapies
1143830|NCT02299739|Liver Function Tests|liver function tests
1143831|NCT02299739|Risk Factors|risk factors
1143832|NCT02299726|acute heart failure|acute heart failure
1143833|NCT02299726|MRA|mra
1143834|NCT02299726|emergency department|emergency department
1143836|NCT02299713|knee pain|knee pain
1143837|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
1143838|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
1143839|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
1143840|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
1143841|NCT02299661|Chronic renal disease|chronic renal disease
1143842|NCT02299661|renal anemia|renal anemia
1143843|NCT02299635|PF-03084014|pf-03084014
1143844|NCT02299635|Notch Alterations|notch alterations
1143845|NCT02299609|C14.280.647.500|c14.280.647.500
1143846|NCT02299596|Colorectal neoplasm|colorectal neoplasm
1143847|NCT02299596|Physical activity|physical activity
1143848|NCT02299583|prevention|prevention
1143849|NCT02299583|early intervention|early intervention
1143850|NCT02299583|trauma-informed practice|trauma-informed practice
1143851|NCT02299570|Clostridium difficile|clostridium difficile
1143852|NCT02299570|C diff|c diff
1143853|NCT02299570|CDI|cdi
1143854|NCT02299570|CDAD|cdad
1143855|NCT02299570|Fecal transplant|fecal transplant
1143856|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
1143857|NCT02299570|Diarrhea|diarrhea
1143858|NCT02299570|FMT|fmt
1143859|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
1143860|NCT02299570|Microbiota suspension|microbiota suspension
1143861|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
1143862|NCT02299570|C diff diarrhea|c diff diarrhea
1143863|NCT02299505|LDK378|ldk378
1143864|NCT02299505|ceritinib|ceritinib
1143865|NCT02299505|Alk+|alk+
1143866|NCT02299505|Alk positive|alk positive
1143867|NCT02299505|NSCLC|nsclc
1143868|NCT02299505|lung Cancer|lung cancer
1143869|NCT02299492|Mental Health Services|mental health services
1143870|NCT02299479|insulin pump|insulin pump
1143871|NCT02299479|continuous glucose monitor|continuous glucose monitor
1143872|NCT02299479|activity monitor|activity monitor
1143873|NCT02299466|parenteral nutrition|parenteral nutrition
1143874|NCT02299466|complications|complications
1143875|NCT02299466|indications|indications
1143876|NCT02299466|long-term administration|long-term administration
1143877|NCT02299466|HTPN|htpn
1143878|NCT02299453|Telemedicine|telemedicine
1143879|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
1143880|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
1143881|NCT02299440|ketamine|ketamine
1143882|NCT02299440|low-dose ketamine|low-dose ketamine
1143883|NCT02299414|Pregnancy|pregnancy
1143884|NCT02299414|Chronic hypertension|chronic hypertension
1143885|NCT02299401|Medical abortion|medical abortion
1143886|NCT02299401|Induced abortion|induced abortion
1143887|NCT02299401|Pregnancy test|pregnancy test
1143888|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
1143889|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1143890|NCT02299388|Hypertension|hypertension
1143891|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1143892|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
1143893|NCT02299388|Pulse pressure|pulse pressure
1143894|NCT02299388|Renin-angiotensin system|renin-angiotensin system
1143895|NCT02299388|heart rate variability|heart rate variability
1143896|NCT02299375|Phase II clinical study|phase ii clinical study
1143897|NCT02299375|losmapimod|losmapimod
1143898|NCT02299375|exacerbations|exacerbations
1143899|NCT02299375|COPD|copd
1143900|NCT02299375|eosinophil sub-group|eosinophil sub-group
1143901|NCT02299362|Early Onset Scoliosis|early onset scoliosis
1143902|NCT02299362|EOS|eos
1143903|NCT02299362|Pulmonary function|pulmonary function
1143904|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
1143905|NCT02299362|MCGR|mcgr
1143906|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
1143907|NCT02299362|Growing rods|growing rods
1143908|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
1143909|NCT02299362|Cast|cast
1143910|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
1143911|NCT02299297|Alopecia Areata|alopecia areata
1143912|NCT02299284|Spastic|spastic
1143913|NCT02299284|Hemiplegia|hemiplegia
1143914|NCT02299245|telomere|telomere
1143915|NCT02299245|telomerase|telomerase
1143916|NCT02299245|statin|statin
1143917|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
1143918|NCT02299245|acute coronary syndrome|acute coronary syndrome
1143919|NCT02299232|dexmedetomidine|dexmedetomidine
1143920|NCT02299232|sedation|sedation
1143921|NCT02299232|MRI|mri
1143922|NCT02299219|Adolescent|adolescent
1143923|NCT02299219|Internet Self-Management|internet self-management
1143924|NCT02299219|Managing Cancer|managing cancer
1143925|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
1143926|NCT02299193|sleep hygiene|sleep hygiene
1143927|NCT02299180|Advanced care planning|advanced care planning
1143928|NCT02299180|End of life care|end of life care
1143929|NCT02299167|Perianal surgery|perianal surgery
1143930|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
1143931|NCT02299167|saddle block|saddle block
1143932|NCT02299115|Vigabatrin|vigabatrin
1143933|NCT02299115|Prednisolone|prednisolone
1143934|NCT02299102|Aspiration Procedures|aspiration procedures
1143935|NCT02299102|Bone Marrow|bone marrow
1143936|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
1143937|NCT02299089|acromegaly|acromegaly
1143938|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
1143939|NCT02299089|carcinoid syndrome|carcinoid syndrome
1143940|NCT02299089|octreotide|octreotide
1143941|NCT02299089|Sandostatin LAR|sandostatin lar
1143942|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
1143943|NCT02299076|Motivation|motivation
1143944|NCT02299063|Mitochondria|mitochondria
1143945|NCT02299063|Dexmedetomidine|dexmedetomidine
1143946|NCT02299063|Heart Defects, Congenital|heart defects, congenital
1143947|NCT02299050|Type 2 Diabetes|type 2 diabetes
1143948|NCT02299050|T2DM|t2dm
1143949|NCT02299050|Cycloset|cycloset
1143950|NCT02299050|Glycemic Control|glycemic control
1143951|NCT02299050|GLP-1|glp-1
1143952|NCT02299024|opioids|opioids
1143953|NCT02299024|health literacy|health literacy
1143954|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
1143955|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
1143956|NCT02299011|Coronary artery disease|coronary artery disease
1143957|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
1143958|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
1143959|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
1143960|NCT02298946|Liver Metastatic|liver metastatic
1143961|NCT02298946|B7-DC Fc Fushion Protein|b7-dc fc fushion protein
1143962|NCT02298933|Complement Inhibition|complement inhibition
1143963|NCT02298933|Platelet Refractoriness|platelet refractoriness
1143964|NCT02298933|Eculizumab|eculizumab
1143965|NCT02298907|colorectal cancer|colorectal cancer
1143966|NCT02298907|surgery|surgery
1143967|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1143968|NCT02298907|perioperative|perioperative
1143969|NCT02298907|fitness|fitness
1143970|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
1143971|NCT02298894|Lipoprotein|lipoprotein
1143972|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
1143973|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
1143974|NCT02298894|Ion mobility|ion mobility
1143975|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
1143976|NCT02298881|Dry Eye|dry eye
1143977|NCT02298881|Microbiome|microbiome
1143978|NCT02298855|Gynaecological cancer|gynaecological cancer
1143979|NCT02298855|Nurse-led care|nurse-led care
1143980|NCT02298855|Aftercare|aftercare
1143981|NCT02298855|Patient self-management|patient self-management
1143982|NCT02298855|Quality of life|quality of life
1143983|NCT02298855|Relapse free interval|relapse free interval
1143984|NCT02298855|Watch and wait|watch and wait
1143985|NCT02298842|Healthy Adults|healthy adults
1143986|NCT02298829|curvature|curvature
1143987|NCT02298829|bend|bend
1143988|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
1143989|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
1143990|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
1143991|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
1143992|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
1143993|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1143994|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
1143995|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
1143996|NCT02298816|immunization|immunization
1143997|NCT02298816|Vaccination|vaccination
1143998|NCT02298816|Influenza, Human|influenza, human
1143999|NCT02298816|Pneumonia|pneumonia
1144000|NCT02298790|Dietary Habits|dietary habits
1144001|NCT02298790|Circadian|circadian
1144002|NCT02298790|Metabolism|metabolism
1144003|NCT02298790|Feeding Behavior|feeding behavior
1144004|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
1144005|NCT02298725|Insulin Resistance|insulin resistance
1144006|NCT02298725|Obesity|obesity
1144007|NCT02298725|US Dietary Guidelines|us dietary guidelines
1144008|NCT02298712|Iduronidase|iduronidase
1144009|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
1144010|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
1144011|NCT02298712|Metabolism, Inborn Errors|metabolism, inborn errors
1144012|NCT02298699|Lysosomal Storage Diseases|lysosomal storage diseases
1144013|NCT02298699|Hereditary Diseases|hereditary diseases
1144014|NCT02298686|Inborn Errors of Metabolism|inborn errors of metabolism
1144015|NCT02298686|Lysosomal Storage Diseases|lysosomal storage diseases
1144016|NCT02298686|Metabolism Errors, Inborn|metabolism errors, inborn
1144017|NCT02298673|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1144018|NCT02298673|Hereditary Disease|hereditary disease
1144019|NCT02298673|Inborn Genetic Diseases|inborn genetic diseases
1144020|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
1144021|NCT02298660|Spinal Cord Injury|spinal cord injury
1144022|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
1144023|NCT02298660|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
1144024|NCT02298660|Urodynamics|urodynamics
1144025|NCT02298660|Cardiovascular|cardiovascular
1144026|NCT02298660|Quality of life|quality of life
1144027|NCT02298660|Blood pressure|blood pressure
1144028|NCT02298660|Twenty-four hour ambulatory blood pressure monitoring|twenty-four hour ambulatory blood pressure monitoring
1144029|NCT02298647|Lysosomal Storage Diseases|lysosomal storage diseases
1144030|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
1144031|NCT02298634|Lipogranulomatosis|lipogranulomatosis
1144032|NCT02298608|Renal mass|renal mass
1144033|NCT02298608|Kidney cancer|kidney cancer
1144034|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
1144035|NCT02298608|Ablation|ablation
1144036|NCT02298608|Safety|safety
1144037|NCT02298608|Efficacy|efficacy
1144038|NCT02298608|IRE|ire
1144039|NCT02298595|Carcinoma|carcinoma
1144040|NCT02298595|Squamous|squamous
1144041|NCT02298595|Oropharyngeal|oropharyngeal
1144042|NCT02298595|HPV|hpv
1144043|NCT02298595|Resectable|resectable
1144044|NCT02298582|safety|safety
1144045|NCT02298582|procedural pain|procedural pain
1144046|NCT02298582|intranasal fentanyl|intranasal fentanyl
1144047|NCT02298582|elderly|elderly
1144048|NCT02298569|patient discharge|patient discharge
1144049|NCT02298569|hospital readmission|hospital readmission
1144050|NCT02298569|postnatal care|postnatal care
1144051|NCT02298569|Home Care Services|home care services
1144052|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
1144146|NCT02298270|NF 2|nf 2
1144053|NCT02298569|Personal satisfaction|personal satisfaction
1144054|NCT02298569|Community Care Networks|community care networks
1144055|NCT02298556|Hypertension|hypertension
1144056|NCT02298556|Diabetes Mellitus|diabetes mellitus
1144057|NCT02298556|ACE Inhibitors|ace inhibitors
1144058|NCT02298556|Calcium Channel Blockers|calcium channel blockers
1144059|NCT02298517|Morbid obesity|morbid obesity
1144060|NCT02298517|bariatric surgery|bariatric surgery
1144061|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
1144062|NCT02298517|Respiratory muscle strength|respiratory muscle strength
1144063|NCT02298517|spirometry|spirometry
1144064|NCT02298517|physiotherapy|physiotherapy
1144065|NCT02298478|Self-help|self-help
1144066|NCT02298478|Computer-aided Treatment|computer-aided treatment
1144067|NCT02298478|Internet|internet
1144068|NCT02298478|Flying phobia|flying phobia
1144069|NCT02298478|minimal contact therapies|minimal contact therapies
1144070|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
1144071|NCT02298478|Waiting list control group|waiting list control group
1144072|NCT02298465|ESWL|eswl
1144073|NCT02298465|distal ureteric stone|distal ureteric stone
1144074|NCT02298465|transgluteal|transgluteal
1144075|NCT02298465|supine ESWL|supine eswl
1144076|NCT02298439|NAFLD|nafld
1144077|NCT02298426|Body Constitution Classification|body constitution classification
1144078|NCT02298426|Health Management|health management
1144079|NCT02298426|Obese Population|obese population
1144080|NCT02298374|Rehabilitation|rehabilitation
1144081|NCT02298374|Evaluation studies|evaluation studies
1144082|NCT02298374|Home care services|home care services
1144083|NCT02298361|Adolescent|adolescent
1144084|NCT02298361|Child|child
1144085|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
1144086|NCT02298361|Child, Preschool|child, preschool
1144087|NCT02298361|Cohort Studies|cohort studies
1144088|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
1144089|NCT02298361|Community Health Centers/standards|community health centers/standards
1144090|NCT02298361|Electronic Health Records|electronic health records
1144091|NCT02298361|Feasibility Studies|feasibility studies
1144092|NCT02298361|Female|female
1144093|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
1144094|NCT02298361|Humans|humans
1144095|NCT02298361|Infant|infant
1144096|NCT02298361|Infant, Newborn|infant, newborn
1144097|NCT02298361|Insurance Coverage|insurance coverage
1144098|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
1144099|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
1144100|NCT02298361|Insurance, Health|insurance, health
1144101|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
1144102|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
1144103|NCT02298361|Insurance, Health/trends|insurance, health/trends
1144104|NCT02298361|Logistic Models|logistic models
1144105|NCT02298361|Longitudinal Studies|longitudinal studies
1144106|NCT02298361|Male|male
1144107|NCT02298361|Medicaid|medicaid
1144108|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
1144109|NCT02298361|Medicaid/trends|medicaid/trends
1144110|NCT02298361|Medicaid/utilization|medicaid/utilization
1144111|NCT02298361|Medically Uninsured|medically uninsured
1144112|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
1144113|NCT02298361|Medicare/trends|medicare/trends
1144114|NCT02298361|Medicare/utilization|medicare/utilization
1144115|NCT02298361|Multivariate Analysis|multivariate analysis
1144116|NCT02298361|Oregon|oregon
1144117|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
1144118|NCT02298361|Patient-Centered Care|patient-centered care
1144119|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
1144120|NCT02298361|Pediatrics/standards|pediatrics/standards
1144121|NCT02298361|Population Surveillance/methods|population surveillance/methods
1144122|NCT02298361|Primary Health Care/economics|primary health care/economics
1144123|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
1144124|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
1144125|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
1144126|NCT02298361|Retrospective Studies|retrospective studies
1144127|NCT02298361|Socioeconomic Factors|socioeconomic factors
1144128|NCT02298361|United States|united states
1144129|NCT02298361|Young Adult|young adult
1144130|NCT02298348|Neuroblastoma|neuroblastoma
1144131|NCT02298348|NANT|nant
1144132|NCT02298348|Sorafenib|sorafenib
1144133|NCT02298348|Relapse|relapse
1144134|NCT02298335|Prednisone|prednisone
1144135|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
1144136|NCT02298335|prospective|prospective
1144138|NCT02298309|HIV|hiv
1144139|NCT02298309|Test and Treat|test and treat
1144140|NCT02298309|Linkage|linkage
1144141|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
1144142|NCT02298283|HL|hl
1144143|NCT02298283|brentuximab vedotin|brentuximab vedotin
1144144|NCT02298270|Neurofibromatosis|neurofibromatosis
1144145|NCT02298270|NF I|nf i
1144147|NCT02298270|Schwannomatosis|schwannomatosis
1144148|NCT02298270|Stress Management|stress management
1144149|NCT02298270|Resiliency|resiliency
1144150|NCT02298270|Skype|skype
1144151|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
1144152|NCT02298244|Atrial Fibrillation|atrial fibrillation
1144153|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
1144154|NCT02298244|Safety|safety
1144155|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
1144156|NCT02298231|Traumatic Brain Injury|traumatic brain injury
1144157|NCT02298231|Balance|balance
1144158|NCT02298231|TBI|tbi
1144159|NCT02298231|Veterans|veterans
1144160|NCT02298231|Virtual Reality|virtual reality
1144161|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
1144162|NCT02298166|FLT3 mutations|flt3 mutations
1144163|NCT02298166|Crenolanib|crenolanib
1144164|NCT02298166|Relapsed|relapsed
1144165|NCT02298166|Refractory|refractory
1144166|NCT02298140|SMS reminders|sms reminders
1144167|NCT02298140|Provider's compliance|provider's compliance
1144168|NCT02298140|malaria|malaria
1144169|NCT02298127|smoking cessation|smoking cessation
1144170|NCT02298127|auricular acupressure|auricular acupressure
1144171|NCT02298127|primary care settings|primary care settings
1144172|NCT02298127|randomized controlled trial|randomized controlled trial
1144173|NCT02298114|electrical stimulation|electrical stimulation
1144174|NCT02298114|intensive care unit|intensive care unit
1144175|NCT02298114|muscular atrophy|muscular atrophy
1144176|NCT02298101|Aerosol delivery|aerosol delivery
1144177|NCT02298101|Lung deposition|lung deposition
1144178|NCT02298101|SPECT|spect
1144179|NCT02298101|subjects|subjects
1144180|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
1144181|NCT02298075|Primary|primary
1144182|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
1144183|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
1144184|NCT02298049|fMRI|fmri
1144185|NCT02298049|reward|reward
1144186|NCT02298049|satiation|satiation
1144187|NCT02298036|Health Anxiety|health anxiety
1144188|NCT02298036|Urgent Care|urgent care
1144189|NCT02298036|Medically Unexplained|medically unexplained
1144190|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
1144191|NCT02298023|allogeneic stem cell|allogeneic stem cell
1144192|NCT02298023|Rotator cuff tear|rotator cuff tear
1144193|NCT02297997|sarcopenia|sarcopenia
1144194|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
1144195|NCT02297984|Neuroglobin|neuroglobin
1144196|NCT02297984|HIF-α|hif-α
1144197|NCT02297984|Acute ischemic stroke|acute ischemic stroke
1144198|NCT02297984|Prognosis|prognosis
1144199|NCT02297932|Exercise|exercise
1144200|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
1144201|NCT02297906|Intranasal|intranasal
1144202|NCT02297906|Ketorolac|ketorolac
1144203|NCT02297906|Pharmacokinetics|pharmacokinetics
1144204|NCT02297906|Pediatric|pediatric
1144205|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
1144206|NCT02297815|antibiotic use|antibiotic use
1144207|NCT02297815|effectiveness|effectiveness
1144208|NCT02297815|acute respiratory infections|acute respiratory infections
1144209|NCT02297815|pediatrics|pediatrics
1144210|NCT02297776|cardiac arrest|cardiac arrest
1144211|NCT02297776|biomarker|biomarker
1144212|NCT02297776|microRNA|microrna
1144213|NCT02297776|circRNA|circrna
1144214|NCT02297776|NSE|nse
1144215|NCT02297776|CPC|cpc
1144308|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
1144216|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
1144218|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
1144219|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
1144220|NCT02297685|Interferential currents therapy|interferential currents therapy
1144221|NCT02297685|Therapeutic exercises|therapeutic exercises
1144222|NCT02297685|Low back pain|low back pain
1144223|NCT02297685|Rehabilitation|rehabilitation
1144224|NCT02297672|breast cancer|breast cancer
1144225|NCT02297672|brachytherapy|brachytherapy
1144226|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
1144227|NCT02297672|palladium 103|palladium 103
1144228|NCT02297659|damage control|damage control
1144229|NCT02297659|resuscitation|resuscitation
1144230|NCT02297659|laparotomy|laparotomy
1144231|NCT02297646|Prevention|prevention
1144232|NCT02297646|Exercise|exercise
1144233|NCT02297646|Health|health
1144234|NCT02297646|Endurance|endurance
1144235|NCT02297633|COPD|copd
1144236|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
1144237|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
1144238|NCT02297620|Elderly patients|elderly patients
1144239|NCT02297620|ASP1941|asp1941
1144240|NCT02297607|Esophageal Cancer|esophageal cancer
1144241|NCT02297607|Esophagectomy|esophagectomy
1144242|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
1144941|NCT02293499|adolescent|adolescent
1144243|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
1144244|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
1144245|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
1144246|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
1144247|NCT02297581|Mortality [MeSH]|mortality [mesh]
1144248|NCT02297581|Complications|complications
1144249|NCT02297568|Breast-fed infant|breast-fed infant
1144250|NCT02297568|vitamin D supplementation|vitamin d supplementation
1144251|NCT02297568|Lactation|lactation
1144252|NCT02297555|Obesity|obesity
1144253|NCT02297555|Metabolic Syndrome|metabolic syndrome
1144254|NCT02297555|ENDOBARRIER®|endobarrier®
1144255|NCT02297542|Influenza Vaccine|influenza vaccine
1144256|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
1144257|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
1144258|NCT02297490|Specific Immunotherapy|specific immunotherapy
1144259|NCT02297490|SIT|sit
1144260|NCT02297490|SCIT|scit
1144261|NCT02297464|Risk|risk
1144262|NCT02297438|breast cancer|breast cancer
1144263|NCT02297438|postmenopausal women|postmenopausal women
1144264|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
1144265|NCT02297438|HER2 negative|her2 negative
1144266|NCT02297438|locoregionally recurrent|locoregionally recurrent
1144267|NCT02297438|metastatic|metastatic
1144268|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
1144269|NCT02297399|Colonoscopy|colonoscopy
1144270|NCT02297399|Diabetes Mellitus|diabetes mellitus
1144271|NCT02297399|Polyethylene glycols|polyethylene glycols
1144272|NCT02297399|Ascorbate|ascorbate
1144273|NCT02297399|Personal satisfaction|personal satisfaction
1144274|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
1144275|NCT02297386|PET Scan|pet scan
1144276|NCT02297386|MRI|mri
1144277|NCT02297386|14-185|14-185
1144278|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
1144279|NCT02297334|CytoSorb(TM)|cytosorb(tm)
1144280|NCT02297334|cytokines|cytokines
1144281|NCT02297334|inflammation|inflammation
1144282|NCT02297334|cardiac surgery|cardiac surgery
1144283|NCT02297334|extracorporeal bypass|extracorporeal bypass
1144284|NCT02297321|tattoos|tattoos
1144285|NCT02297321|laser|laser
1144286|NCT02297321|whitening|whitening
1144287|NCT02297321|patch|patch
1144288|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
1144289|NCT02297282|Depression|depression
1144290|NCT02297282|Behavioural Activation|behavioural activation
1144291|NCT02297269|Deep vein thrombosis|deep vein thrombosis
1144292|NCT02297269|Surgery|surgery
1144293|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
1144294|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
1144295|NCT02297191|volunteer|volunteer
1144296|NCT02297191|pilot study|pilot study
1144297|NCT02297191|adults|adults
1144298|NCT02297165|anorexic|anorexic
1144299|NCT02297165|olfactory stimulation|olfactory stimulation
1144300|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
1144301|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
1144302|NCT02297152|Sexual dysfunction|sexual dysfunction
1144303|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
1144304|NCT02297152|Masturbation aid|masturbation aid
1144305|NCT02297152|Ejaculatory disorders|ejaculatory disorders
1144306|NCT02297113|patients|patients
1144307|NCT02297113|departement|departement
1144309|NCT02297100|women|women
1144310|NCT02297100|interstitial cystitis|interstitial cystitis
1144311|NCT02297100|bladder pain syndrome|bladder pain syndrome
1144312|NCT02297100|botox|botox
1144313|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
1144314|NCT02297074|Bread|bread
1144315|NCT02297074|Glycemic index|glycemic index
1144316|NCT02297074|Glycemic load|glycemic load
1144317|NCT02297074|Insulinemic index|insulinemic index
1144318|NCT02297074|Satiety|satiety
1144319|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
1144320|NCT02297061|Hip fracture|hip fracture
1144321|NCT02297061|Thrombelastography|thrombelastography
1144322|NCT02297061|Blood loss|blood loss
1144323|NCT02297048|Potassium intake|potassium intake
1144324|NCT02297048|Progesterone|progesterone
1144325|NCT02297048|steroidogenesis|steroidogenesis
1144326|NCT02297048|RU486|ru486
1144327|NCT02297048|Synachtene test|synachtene test
1144328|NCT02297022|Deep Brain Stimulation|deep brain stimulation
1144329|NCT02297022|obesity|obesity
1144330|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
1144331|NCT02296996|BRAF V600|braf v600
1144332|NCT02296996|Rechallenge|rechallenge
1144333|NCT02296996|Combination|combination
1144334|NCT02296996|Dabrafenib|dabrafenib
1144335|NCT02296996|Trametinib|trametinib
1144336|NCT02296944|Childrens|childrens
1144337|NCT02296944|tempanoplasty|tempanoplasty
1144338|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
1144339|NCT02296944|retrospective|retrospective
1144340|NCT02296944|cohort|cohort
1144342|NCT02296918|SLL|sll
1144343|NCT02296918|PLL|pll
1144344|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1144345|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1144346|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
1144347|NCT02296918|ACP-196|acp-196
1144348|NCT02296918|acalabrutinib|acalabrutinib
1144349|NCT02296918|obinutuzumab|obinutuzumab
1144350|NCT02296918|rituximab|rituximab
1204942|NCT02010671|Survey|survey
1144351|NCT02296918|venetoclax|venetoclax
1144352|NCT02296905|Hepatic Impairment|hepatic impairment
1144353|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
1144354|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
1144355|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
1144356|NCT02296840|analgesia|analgesia
1144357|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1144358|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
1144359|NCT02296788|Gut Microbiota|gut microbiota
1144360|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
1144361|NCT02296775|Rituximab|rituximab
1144362|NCT02296775|Pharmacokinetics|pharmacokinetics
1144363|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
1144364|NCT02296736|diagnostic accuracy|diagnostic accuracy
1144365|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
1144366|NCT02296710|mitral valve|mitral valve
1144367|NCT02296710|valve surgery|valve surgery
1144368|NCT02296710|echocardiography|echocardiography
1144369|NCT02296697|Pressure Ulcer|pressure ulcer
1144370|NCT02296697|Low Level Laser Therapy|low level laser therapy
1144371|NCT02296697|Dressings|dressings
1144372|NCT02296632|Telemedicine|telemedicine
1144373|NCT02296632|Patient Reported Outcomes|patient reported outcomes
1144374|NCT02296593|lactate|lactate
1144375|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
1144376|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
1144377|NCT02296593|EIRUS|eirus
1144378|NCT02296593|blood glucose|blood glucose
1144379|NCT02296593|cardiac surgery|cardiac surgery
1144380|NCT02296593|central veinous catheter|central veinous catheter
1144381|NCT02296593|microdialysis|microdialysis
1144382|NCT02296554|SLAP Repair|slap repair
1144383|NCT02296554|Biceps Tenodesis|biceps tenodesis
1144384|NCT02296528|Feeding Tube Dependent|feeding tube dependent
1144385|NCT02296502|DSM Diagnosis|dsm diagnosis
1144386|NCT02296450|Quality of Life (QoL)|quality of life (qol)
1144387|NCT02296450|Assessment|assessment
1144388|NCT02296450|14-236|14-236
1144389|NCT02296450|Patients and Survivors|patients and survivors
1144390|NCT02296424|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
1144391|NCT02296424|systemic inflammatory disorder|systemic inflammatory disorder
1144392|NCT02296424|painful joints|painful joints
1144393|NCT02296424|inflammation of the synovial membrane|inflammation of the synovial membrane
1144394|NCT02296424|auto-immune rheumatoid disease|auto-immune rheumatoid disease
1144395|NCT02296424|reactive rheumatoid arthritis|reactive rheumatoid arthritis
1144396|NCT02296424|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
1144397|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
1144398|NCT02296385|volunteers|volunteers
1144399|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
1144400|NCT02296307|Aged|aged
1144401|NCT02296307|Algorithms|algorithms
1144402|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
1144403|NCT02296307|Chi-Square Distribution|chi-square distribution
1144404|NCT02296307|Early Detection of Cancer*|early detection of cancer*
1144405|NCT02296307|Feasibility Studies|feasibility studies
1144406|NCT02296307|Female|female
1144407|NCT02296307|Humans|humans
1144408|NCT02296307|Logistic Models|logistic models
1144409|NCT02296307|Mass Screening/methods*|mass screening/methods*
1144410|NCT02296307|Middle Aged|middle aged
1144411|NCT02296307|Neoplasm Grading|neoplasm grading
1144412|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
1144413|NCT02296307|Neoplasm Staging|neoplasm staging
1144414|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
1144415|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
1144416|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
1144417|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
1144418|NCT02296307|Pilot Projects|pilot projects
1144419|NCT02296307|Predictive Value of Tests|predictive value of tests
1144420|NCT02296307|Prevalence|prevalence
1144421|NCT02296307|Prognosis|prognosis
1144422|NCT02296307|Prospective Studies|prospective studies
1144423|NCT02296307|Quebec/epidemiology|quebec/epidemiology
1144424|NCT02296307|Tumor Burden|tumor burden
1144425|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
1144426|NCT02296268|stroke|stroke
1144427|NCT02296268|aerobic exercise|aerobic exercise
1144428|NCT02296268|screening|screening
1144429|NCT02296268|prescription|prescription
1144430|NCT02296255|cervical cancer screening|cervical cancer screening
1144431|NCT02296255|young women vaccination|young women vaccination
1144432|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
1144433|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
1144434|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
1144435|NCT02296177|evidence-based intervention|evidence-based intervention
1144436|NCT02296177|mammography|mammography
1144437|NCT02296177|underserved population|underserved population
1144438|NCT02296164|PROVe|prove
1144439|NCT02296164|CTCL|ctcl
1144440|NCT02296164|Mechlorethamine|mechlorethamine
1144441|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1144442|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
1144443|NCT02296164|Valchlor|valchlor
1144444|NCT02296164|Dermatology|dermatology
1144445|NCT02296164|MF-CTCL|mf-ctcl
1144446|NCT02296164|Mycosis Fungoides|mycosis fungoides
1144447|NCT02296164|Oncology|oncology
1144448|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
1144449|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
1144450|NCT02296099|stress urinary incontinence|stress urinary incontinence
1144451|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
1144452|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
1144453|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
1144454|NCT02296086|China [MeSH]|china [mesh]
1144455|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
1144456|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
1144457|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
1144458|NCT02296073|Sedation|sedation
1144459|NCT02296073|Dexmedetomidine|dexmedetomidine
1144460|NCT02296073|mechanical ventilation|mechanical ventilation
1144461|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
1144462|NCT02296021|helicobacter pylori|helicobacter pylori
1144463|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
1144464|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
1144465|NCT02296008|high resolution manometry|high resolution manometry
1144466|NCT02296008|children|children
1144467|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
1144468|NCT02296008|surgery|surgery
1144469|NCT02295995|Aged|aged
1144470|NCT02295995|Exercise|exercise
1144471|NCT02295995|Veterans|veterans
1144472|NCT02295995|Adherence|adherence
1144473|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
1144474|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
1144475|NCT02295982|one day surgery|one day surgery
1144476|NCT02295969|Rhinitis|rhinitis
1144477|NCT02295969|Conjunctivitis|conjunctivitis
1144478|NCT02295969|Grass pollen|grass pollen
1144479|NCT02295969|Sublingual tablet|sublingual tablet
1144480|NCT02295969|Allergen immunotherapy|allergen immunotherapy
1144481|NCT02295969|Safety|safety
1144482|NCT02295956|Pancreatic Cancer|pancreatic cancer
1144483|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1144484|NCT02295956|Preoperative therapy|preoperative therapy
1144485|NCT02295956|Questionnaires|questionnaires
1144486|NCT02295956|Surveys|surveys
1144487|NCT02295956|Exercises|exercises
1144488|NCT02295956|Stretching|stretching
1144489|NCT02295956|Walking|walking
1144490|NCT02295956|Nutrition counseling|nutrition counseling
1144491|NCT02295956|Resistance exercise bands|resistance exercise bands
1144492|NCT02295956|Phone calls|phone calls
1144493|NCT02295956|Booklet|booklet
1144494|NCT02295956|Pamphlet|pamphlet
1144495|NCT02295930|colorectal cancer,|colorectal cancer,
1144496|NCT02295930|bevacizumab|bevacizumab
1144497|NCT02295930|cetuximab|cetuximab
1144498|NCT02295930|folfoxiri|folfoxiri
1144499|NCT02295930|kras wild type|kras wild type
1144500|NCT02295904|perineum|perineum
1144501|NCT02295904|videoanalysis|videoanalysis
1144502|NCT02295865|Psoriasis|psoriasis
1144503|NCT02295865|Toreforant|toreforant
1144504|NCT02295865|JNJ-38518168|jnj-38518168
1144505|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
1144506|NCT02295852|Low-sodium diet|low-sodium diet
1144507|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
1144508|NCT02295839|Sleep|sleep
1144509|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1144510|NCT02295839|Fatigue|fatigue
1144511|NCT02295839|Sleep hygiene|sleep hygiene
1144512|NCT02295839|Relaxation|relaxation
1144513|NCT02295839|RCT|rct
1144514|NCT02295800|HIV|hiv
1144515|NCT02295800|PMTCT|pmtct
1144516|NCT02295800|Antenatal Care|antenatal care
1144517|NCT02295787|Depression|depression
1144518|NCT02295787|Suicide|suicide
1144519|NCT02295787|Suicidal Ideation|suicidal ideation
1144520|NCT02295787|Ketamine|ketamine
1144521|NCT02295787|Late-Life|late-life
1144522|NCT02295761|motor activity|motor activity
1144523|NCT02295761|obesity|obesity
1144524|NCT02295761|overweight|overweight
1144525|NCT02295761|intervention study|intervention study
1144526|NCT02295761|health promotion|health promotion
1144527|NCT02295761|lifestyle counseling|lifestyle counseling
1144528|NCT02295761|adherence|adherence
1144529|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
1144530|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
1144531|NCT02295709|ultrasound|ultrasound
1144630|NCT02295059|ERPR negative|erpr negative
1144532|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
1144533|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
1144534|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
1144535|NCT02295592|hemorrhoids|hemorrhoids
1144536|NCT02295592|The recurrence rate|the recurrence rate
1144538|NCT02295592|TSTstarr+|tststarr+
1144539|NCT02295566|Nitric Oxide|nitric oxide
1144540|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1144541|NCT02295566|Biofilm|biofilm
1144542|NCT02295553|Ketamine|ketamine
1144543|NCT02295553|Propofol|propofol
1144544|NCT02295553|Children|children
1144545|NCT02295553|Pediatrics|pediatrics
1144546|NCT02295553|Upper endoscopy|upper endoscopy
1144547|NCT02295514|Sepsis|sepsis
1144548|NCT02295514|Septic shock|septic shock
1144549|NCT02295501|Pathogen inactivation|pathogen inactivation
1144550|NCT02295501|ebola|ebola
1144551|NCT02295501|convalescent plasma|convalescent plasma
1144552|NCT02295501|EBOV|ebov
1144553|NCT02295501|amotosalen|amotosalen
1144554|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
1144555|NCT02295488|hymenoptera puncture|hymenoptera puncture
1144556|NCT02295462|nursing homes|nursing homes
1144557|NCT02295462|person-centered care|person-centered care
1144558|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
1144559|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
1144560|NCT02295462|antipsychotic drugs|antipsychotic drugs
1144561|NCT02295449|Prostate cancer|prostate cancer
1144562|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1144563|NCT02295436|minodronic acid|minodronic acid
1144564|NCT02295436|pharmacokinetics|pharmacokinetics
1144565|NCT02295436|tolerability|tolerability
1144566|NCT02295436|food|food
1144567|NCT02295436|age|age
1144568|NCT02295436|Chinese subjects|chinese subjects
1144569|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
1144570|NCT02295397|Food provocation|food provocation
1144571|NCT02295397|Matrix effect|matrix effect
1144572|NCT02295397|ED05|ed05
1144573|NCT02295397|Allergy|allergy
1144574|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
1144575|NCT02295384|Polypharmacy|polypharmacy
1144576|NCT02295384|Medication Therapy Management|medication therapy management
1144577|NCT02295371|Drug therapy|drug therapy
1144578|NCT02295371|Patient safety|patient safety
1144579|NCT02295371|Polydrug therapy|polydrug therapy
1144580|NCT02295319|Discharge|discharge
1144581|NCT02295319|Acute Admission Unit|acute admission unit
1144582|NCT02295319|Randomized Controlled Trial|randomized controlled trial
1144583|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
1144584|NCT02295293|Rhus|rhus
1144585|NCT02295293|Cholesterol|cholesterol
1144586|NCT02295293|Triglycerides|triglycerides
1144587|NCT02295293|Lipids|lipids
1144588|NCT02295293|Medicine, Traditional|medicine, traditional
1144589|NCT02295293|Herbal medicine|herbal medicine
1144590|NCT02295280|headache|headache
1144591|NCT02295267|Food allergy|food allergy
1144592|NCT02295267|Walnut|walnut
1144593|NCT02295267|Components|components
1144594|NCT02295267|Allergens|allergens
1144595|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
1144596|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
1144597|NCT02295215|chagas disease|chagas disease
1144598|NCT02295215|exercise|exercise
1144599|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
1144600|NCT02295163|Stellate ganglion block|stellate ganglion block
1144601|NCT02295163|hot flushes|hot flushes
1144602|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
1144603|NCT02295163|prostate cancer|prostate cancer
1144604|NCT02295150|Nadroparin|nadroparin
1144605|NCT02295150|Anti-Xa activity|anti-xa activity
1144606|NCT02295124|Nausea|nausea
1144607|NCT02295111|electro-acupuncture|electro-acupuncture
1144608|NCT02295111|chronic pelvic pain|chronic pelvic pain
1144609|NCT02295111|patient practitioner interactions|patient practitioner interactions
1144610|NCT02295111|TCM health consultation|tcm health consultation
1144611|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
1144612|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
1144613|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
1144614|NCT02295072|Brain structure|brain structure
1144615|NCT02295072|Brain function|brain function
1144616|NCT02295072|Cognitive function|cognitive function
1144617|NCT02295072|Physical fitness|physical fitness
1144618|NCT02295072|Body Mass Index|body mass index
1144619|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
1144620|NCT02295072|Mental health|mental health
1144621|NCT02295072|Stress|stress
1144622|NCT02295072|Neurology|neurology
1144623|NCT02295072|Obesity|obesity
1144624|NCT02295072|brain|brain
1144625|NCT02295072|risk factors|risk factors
1144626|NCT02295072|bone|bone
1144627|NCT02295072|bones|bones
1144628|NCT02295072|body composition|body composition
1144629|NCT02295059|Breast cancer|breast cancer
1144631|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
1144632|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
1144633|NCT02294955|catheter ablation|catheter ablation
1144634|NCT02294955|atrial fibrillation|atrial fibrillation
1144635|NCT02294942|RNTA06|rnta06
1144636|NCT02294942|RANCAD|rancad
1144637|NCT02294929|catheter ablation|catheter ablation
1144638|NCT02294929|cryoballoon|cryoballoon
1144639|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
1144640|NCT02294903|Prostate cancer|prostate cancer
1144641|NCT02294903|Encage|encage
1144642|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
1144643|NCT02294825|deep endometriosis;|deep endometriosis;
1144644|NCT02294825|colorectal endometriosis|colorectal endometriosis
1144645|NCT02294825|surgery|surgery
1144646|NCT02294825|medical treatment|medical treatment
1144647|NCT02294825|fertility|fertility
1144648|NCT02294812|Hearing Loss|hearing loss
1144649|NCT02294812|Speech Perception|speech perception
1144650|NCT02294812|Cognitive Training|cognitive training
1144651|NCT02294812|Cognitive Fitness|cognitive fitness
1144652|NCT02294812|Memory, Short-Term|memory, short-term
1144653|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
1144654|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
1144655|NCT02294799|Complementary Therapy|complementary therapy
1144656|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
1144657|NCT02294786|Randomised|randomised
1144658|NCT02294786|Octreotide|octreotide
1144659|NCT02294786|Diarrhoea|diarrhoea
1144660|NCT02294786|Phase II|phase ii
1144661|NCT02294786|Capecitabine|capecitabine
1144662|NCT02294786|Quality of life|quality of life
1144663|NCT02294786|Metastatic breast cancer|metastatic breast cancer
1144664|NCT02294786|HER2|her2
1144665|NCT02294786|Lapatinib|lapatinib
1144666|NCT02294786|Diarrhoea diary|diarrhoea diary
1144667|NCT02294773|Infertility|infertility
1144668|NCT02294773|Intrauterine insemination|intrauterine insemination
1144669|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
1144670|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
1144671|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
1144672|NCT02294760|Symptoms|symptoms
1144673|NCT02294760|Quality of Life|quality of life
1144674|NCT02294734|functional respiratory capacity|functional respiratory capacity
1144675|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
1144676|NCT02294734|GSK2269557|gsk2269557
1144677|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
1144678|NCT02294734|lung capacity|lung capacity
1144679|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
1144680|NCT02294708|scleral buckle|scleral buckle
1144681|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
1144682|NCT02294708|postoperative postures|postoperative postures
1144683|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
1144684|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
1144685|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
1144686|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
1144687|NCT02294682|antibiotics|antibiotics
1144688|NCT02294682|GSK2140944|gsk2140944
1144689|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
1144690|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
1144691|NCT02294643|sarpogrelate|sarpogrelate
1144692|NCT02294591|Bipolar Disorder|bipolar disorder
1144693|NCT02294591|Depression|depression
1144694|NCT02294591|Acetylcystein|acetylcystein
1144695|NCT02294591|Oxidative Stress|oxidative stress
1144696|NCT02294591|Urine|urine
1144697|NCT02294578|Biomarkers|biomarkers
1144698|NCT02294578|saliva|saliva
1144699|NCT02294578|mRNA|mrna
1144700|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1144701|NCT02294565|Breast Cancer|breast cancer
1144702|NCT02294565|Lymphatic Mapping|lymphatic mapping
1144703|NCT02294552|Cyclophosphamide|cyclophosphamide
1144704|NCT02294552|Leukemia|leukemia
1144705|NCT02294552|Lymphoma|lymphoma
1144706|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
1144707|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1144708|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
1144709|NCT02294552|Immune System Diseases|immune system diseases
1144710|NCT02294552|Busulfan|busulfan
1144711|NCT02294552|Fludarabine|fludarabine
1144712|NCT02294552|Tacrolimus|tacrolimus
1144713|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
1144714|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1144715|NCT02294552|Myeloablative Agonists|myeloablative agonists
1144716|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1144717|NCT02294552|Allogeneic|allogeneic
1144718|NCT02294526|Diet|diet
1144719|NCT02294526|Sardine|sardine
1144720|NCT02294526|Type 2 diabetes|type 2 diabetes
1144721|NCT02294513|Alzheimer disease|alzheimer disease
1144722|NCT02294513|Dementia|dementia
1144723|NCT02294513|Hearing loss|hearing loss
1144724|NCT02294513|Correction of hearing impairment|correction of hearing impairment
1144725|NCT02294513|Hearing aids|hearing aids
1144726|NCT02294513|Communication|communication
1144727|NCT02294513|Family caregivers|family caregivers
1144728|NCT02294513|Third-party disability|third-party disability
1144729|NCT02294500|ovarian function|ovarian function
1144730|NCT02294500|female|female
1144731|NCT02294500|Genital Function|genital function
1144732|NCT02294487|influenza|influenza
1144733|NCT02294487|pneumococcal|pneumococcal
1144734|NCT02294487|pneumonia|pneumonia
1144735|NCT02294487|vaccine|vaccine
1144736|NCT02294487|immunization|immunization
1144737|NCT02294487|#CAImmun|#caimmun
1144738|NCT02294487|Immuno-oncology|immuno-oncology
1144739|NCT02294487|supportive care|supportive care
1144740|NCT02294487|vaccination|vaccination
1144741|NCT02294487|meningococcal|meningococcal
1144742|NCT02294487|HIB|hib
1144743|NCT02294461|Enzalutamide|enzalutamide
1144744|NCT02294461|Androgen receptor|androgen receptor
1144745|NCT02294461|Prostate cancer|prostate cancer
1144746|NCT02294461|Xtandi|xtandi
1144747|NCT02294448|Cervical radiculopathy|cervical radiculopathy
1144748|NCT02294448|Neck pain|neck pain
1144749|NCT02294448|Qishe pill|qishe pill
1144750|NCT02294448|raditional Chinese medicine|raditional chinese medicine
1144751|NCT02294448|healthy Chinese subject|healthy chinese subject
1144752|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
1144753|NCT02294448|Personalized Medicine|personalized medicine
1144754|NCT02294448|Individualized Medicine|individualized medicine
1144755|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
1144756|NCT02294435|Endovascular|endovascular
1144757|NCT02294435|Ps-ide|ps-ide
1144758|NCT02294435|Early Feasibility|early feasibility
1144759|NCT02294435|Aneurysm|aneurysm
1144760|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
1144761|NCT02294435|Aortic Aneurysm|aortic aneurysm
1144762|NCT02294435|Aortic Diseases|aortic diseases
1144763|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
1144764|NCT02294435|Vascular Diseases|vascular diseases
1144765|NCT02294435|Pararenal aneurysm|pararenal aneurysm
1144766|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
1144767|NCT02294435|Aortic dissection|aortic dissection
1144768|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
1144769|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
1144770|NCT02294435|TAAA|taaa
1144771|NCT02294422|Loss of resistance|loss of resistance
1144772|NCT02294422|Pilot balloon|pilot balloon
1144773|NCT02294422|Cuff pressure|cuff pressure
1144774|NCT02294422|Endotracheal tube|endotracheal tube
1144775|NCT02294409|social anxiety|social anxiety
1144776|NCT02294409|psychosis|psychosis
1144777|NCT02294409|CBT|cbt
1144778|NCT02294409|randomized|randomized
1144779|NCT02294409|CRT|crt
1144780|NCT02294396|Anticholinergic|anticholinergic
1144781|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
1144782|NCT02294396|Mirabegron|mirabegron
1144783|NCT02294396|YM178|ym178
1144784|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
1144785|NCT02294383|Tissue Elasticity|tissue elasticity
1144786|NCT02294383|Tactile Imaging|tactile imaging
1144787|NCT02294370|type 2 diabetes|type 2 diabetes
1144788|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
1144789|NCT02294357|carfilzomib|carfilzomib
1144790|NCT02294357|proteasome inhibitor|proteasome inhibitor
1144791|NCT02294357|multiple myeloma|multiple myeloma
1144792|NCT02294357|relapsed/refractory|relapsed/refractory
1144793|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
1144794|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
1144795|NCT02294305|Depression|depression
1144801|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
1144809|NCT02294214|Spatial Repellents|spatial repellents
1144810|NCT02294214|Plasmodium|plasmodium
1144811|NCT02294201|Malaria|malaria
1144812|NCT02294201|Spatial Repellents|spatial repellents
1144813|NCT02294201|Plasmodium|plasmodium
1144814|NCT02294188|Malaria|malaria
1144815|NCT02294188|Spatial Repellents|spatial repellents
1144816|NCT02294188|Plasmodium|plasmodium
1144817|NCT02294175|larva|larva
1144818|NCT02294175|debridement|debridement
1144819|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
1144820|NCT02294175|biofilm|biofilm
1144821|NCT02294175|infection|infection
1144822|NCT02294175|chronic wound|chronic wound
1144823|NCT02294149|chemotherapy|chemotherapy
1144824|NCT02294149|Omega 3|omega 3
1144825|NCT02294136|HIV|hiv
1144826|NCT02294136|HCV|hcv
1144827|NCT02294136|Adherence|adherence
1144828|NCT02294136|Psychiatric|psychiatric
1144829|NCT02294136|Behavioral|behavioral
1144830|NCT02294136|Intervention|intervention
1144831|NCT02294110|failure|failure
1144832|NCT02294110|spinal anesthesia|spinal anesthesia
1144833|NCT02294071|acetaminophen|acetaminophen
1144834|NCT02294071|ibuprofen|ibuprofen
1144835|NCT02294058|MS|ms
1144836|NCT02294058|RMS|rms
1144837|NCT02294058|Multiple Sclerosis|multiple sclerosis
1144838|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1144839|NCT02294045|Knee|knee
1144840|NCT02294045|Healthy|healthy
1144841|NCT02294045|arthroscopy|arthroscopy
1144842|NCT02294045|MRI|mri
1144843|NCT02294045|amplification|amplification
1144844|NCT02294045|sounds|sounds
1144845|NCT02294045|pre-operative|pre-operative
1144846|NCT02294045|analyzing|analyzing
1144847|NCT02294032|Bcells|bcells
1144848|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
1144849|NCT02294032|antibody mediated rejection|antibody mediated rejection
1144850|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
1144851|NCT02294019|actual use|actual use
1144852|NCT02294019|compliance|compliance
1144853|NCT02294006|pancreatic|pancreatic
1144854|NCT02294006|neuroendocrine|neuroendocrine
1144855|NCT02294006|everolimus|everolimus
1144856|NCT02294006|metformin|metformin
1144857|NCT02294006|octreotide|octreotide
1144858|NCT02293941|liver inflammation|liver inflammation
1144859|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
1144860|NCT02293928|Antiplatelet therapy|antiplatelet therapy
1144861|NCT02293928|Aspirin|aspirin
1144862|NCT02293928|Clopidogrel|clopidogrel
1144863|NCT02293889|Knee osteoarthritis|knee osteoarthritis
1144864|NCT02293889|Pain|pain
1144865|NCT02293889|Vitamin D|vitamin d
1144866|NCT02293889|Physical activity|physical activity
1144867|NCT02293889|Pilot study|pilot study
1144868|NCT02293889|Qualitative Interview|qualitative interview
1144869|NCT02293889|Obesity|obesity
1144870|NCT02293889|Older adults|older adults
1144871|NCT02293876|Corneal Diseases|corneal diseases
1144872|NCT02293876|Corneal Ulcer|corneal ulcer
1144873|NCT02293876|Nursing Diagnosis|nursing diagnosis
1144874|NCT02293876|Intensive Care Units|intensive care units
1144875|NCT02293876|Nursing|nursing
1144876|NCT02293876|Randomized Clinical Trial|randomized clinical trial
1144877|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
1144878|NCT02293824|Infant, Premature|infant, premature
1144879|NCT02293824|Caffeine|caffeine
1144880|NCT02293824|Pharmacokinetics|pharmacokinetics
1144881|NCT02293824|Metabolism|metabolism
1144882|NCT02293772|Bedrest|bedrest
1144883|NCT02293772|Appetite|appetite
1144884|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
1144885|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
1144886|NCT02293746|OSA|osa
1144887|NCT02293746|neurostimulation|neurostimulation
1144888|NCT02293746|hypoglossal nerve|hypoglossal nerve
1144889|NCT02293746|tongue|tongue
1144890|NCT02293746|upper airway stimulation|upper airway stimulation
1144891|NCT02293746|surgery|surgery
1144892|NCT02293733|Retrospective|retrospective
1144893|NCT02293733|EGFR|egfr
1144894|NCT02293733|mutation|mutation
1144895|NCT02293733|TKI|tki
1144896|NCT02293733|NSCLC|nsclc
1144897|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
1144898|NCT02293707|Therapeutic vaccine|therapeutic vaccine
1144899|NCT02293707|Telomerase vaccine|telomerase vaccine
1144900|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
1146265|NCT02286245|Hotline|hotline
1144901|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
1144902|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
1144903|NCT02293681|Infliximab|infliximab
1144904|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1144905|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
1144906|NCT02293668|poor responders|poor responders
1144907|NCT02293655|ADHD|adhd
1144908|NCT02293655|inattention|inattention
1144909|NCT02293655|hyperactivity|hyperactivity
1144910|NCT02293655|methylphenidate|methylphenidate
1144911|NCT02293642|primary cancers of the breast|primary cancers of the breast
1144912|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
1144913|NCT02293642|primary cancers of the lung|primary cancers of the lung
1144914|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
1144915|NCT02293629|Subjects|subjects
1144916|NCT02293616|ICU|icu
1144917|NCT02293616|Respiratory Failure|respiratory failure
1144918|NCT02293616|Weakness|weakness
1144919|NCT02293616|Nitrate supplementation|nitrate supplementation
1144920|NCT02293603|cardiomyopathy|cardiomyopathy
1144921|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
1144922|NCT02293603|intracoronary infusion|intracoronary infusion
1144923|NCT02293603|adult stem cells|adult stem cells
1144924|NCT02293603|heart disease|heart disease
1144925|NCT02293603|ventricular dysfunction|ventricular dysfunction
1144926|NCT02293603|pathological processes|pathological processes
1144927|NCT02293603|cardiovascular diseases|cardiovascular diseases
1144928|NCT02293603|heart failure|heart failure
1144929|NCT02293590|Certolizumab pegol|certolizumab pegol
1144930|NCT02293590|DMARD|dmard
1144931|NCT02293590|Joint injection|joint injection
1144932|NCT02293590|Glucocorticoids|glucocorticoids
1144933|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
1144934|NCT02293564|Osteoarthritis|osteoarthritis
1144935|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
1144936|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
1144937|NCT02293512|Tinnitus|tinnitus
1144938|NCT02293512|Coping|coping
1144939|NCT02293512|Psychoeducational intervention|psychoeducational intervention
1144940|NCT02293499|asthma|asthma
1144942|NCT02293499|intervention|intervention
1144943|NCT02293486|Antioxidants|antioxidants
1144944|NCT02293486|Protein Carbonylation|protein carbonylation
1144945|NCT02293486|Malondialdehyde|malondialdehyde
1144946|NCT02293486|Punicaceae|punicaceae
1144947|NCT02293486|Athletic Performance|athletic performance
1144948|NCT02293460|Peripheral neuropathy|peripheral neuropathy
1144949|NCT02293460|Disimmune disease|disimmune disease
1144950|NCT02293460|Neurology Chronic disease|neurology chronic disease
1144951|NCT02293460|Rare disease|rare disease
1144952|NCT02293447|Uterine|uterine
1144953|NCT02293447|Fibroid|fibroid
1144954|NCT02293447|Embolization|embolization
1144955|NCT02293447|Leiomyoma|leiomyoma
1144956|NCT02293447|Lidocaine|lidocaine
1144957|NCT02293447|Pain|pain
1144958|NCT02293434|Malnutrition|malnutrition
1144959|NCT02293434|Status Nutritional Weight|status nutritional weight
1144960|NCT02293434|Pediatric intensive care|pediatric intensive care
1144961|NCT02293408|MPS IIIB|mps iiib
1144962|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
1144963|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
1144964|NCT02293408|Sanfilippo Syndrome|sanfilippo syndrome
1144965|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
1144966|NCT02293395|Myocardial infarction|myocardial infarction
1144967|NCT02293395|Unstable angina|unstable angina
1144968|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
1144969|NCT02293395|Rivaroxaban|rivaroxaban
1144970|NCT02293395|JNJ-39039039|jnj-39039039
1144971|NCT02293395|Bay 59-7939|bay 59-7939
1144972|NCT02293395|Xarelto|xarelto
1144973|NCT02293395|Clopidogrel|clopidogrel
1144974|NCT02293395|Ticagrelor|ticagrelor
1144975|NCT02293395|Plavix|plavix
1144976|NCT02293395|Brilinta|brilinta
1144977|NCT02293395|Effient|effient
1144978|NCT02293382|MPS IIIB|mps iiib
1144979|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
1144980|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
1144981|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
1144982|NCT02293343|histamine profile|histamine profile
1144983|NCT02293343|IgE Antibodies|ige antibodies
1144984|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
1144985|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
1144986|NCT02293291|Gulf war illness|gulf war illness
1144987|NCT02293278|MVPA|mvpa
1144988|NCT02293278|sedentary behaviour|sedentary behaviour
1144989|NCT02293278|PA intervention|pa intervention
1144990|NCT02293278|preschool|preschool
1144991|NCT02293278|gross motor|gross motor
1144992|NCT02293278|anthropometrics|anthropometrics
1144993|NCT02293278|day care|day care
1144994|NCT02293265|mepolizumab|mepolizumab
1144995|NCT02293265|omalizumab|omalizumab
1144996|NCT02293265|SB-240563|sb-240563
1144997|NCT02293265|Severe Asthma|severe asthma
1144998|NCT02293265|reslizumab|reslizumab
1144999|NCT02293252|Home Telemonitoring|home telemonitoring
1145000|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
1145001|NCT02293239|cachexia|cachexia
1145002|NCT02293239|cancer|cancer
1145003|NCT02293239|skeletal muscle mass|skeletal muscle mass
1145004|NCT02293239|nutrition|nutrition
1145005|NCT02293213|Category D|category d
1145006|NCT02293213|Category X|category x
1145007|NCT02293213|Electronic Medical Records|electronic medical records
1145008|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
1145009|NCT02293187|vitamin D|vitamin d
1145010|NCT02293187|muscle performance|muscle performance
1145011|NCT02293187|falls|falls
1145012|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
1145013|NCT02293161|monoclonal antibody|monoclonal antibody
1145014|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1145015|NCT02293148|GSK1278863|gsk1278863
1145016|NCT02293148|Anemia|anemia
1145017|NCT02293148|QTc|qtc
1145018|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1145019|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
1145020|NCT02293122|Agreement|agreement
1145021|NCT02293122|Repeatability|repeatability
1145022|NCT02293122|Reproducibility|reproducibility
1145023|NCT02293096|Genotype|genotype
1145024|NCT02293096|CYP2D6|cyp2d6
1145025|NCT02293096|ADRB1|adrb1
1145026|NCT02293057|Adolescent|adolescent
1145027|NCT02293057|Juvenile Justice|juvenile justice
1145028|NCT02293057|Drug Use|drug use
1145029|NCT02293057|Marijuana|marijuana
1145030|NCT02293057|Gender Responsive|gender responsive
1145031|NCT02293057|Girls|girls
1145032|NCT02293057|HIV|hiv
1145033|NCT02293057|Sexual Risk|sexual risk
1145034|NCT02293044|Sensitivity|sensitivity
1145035|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
1145036|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
1145037|NCT02293031|gene-activated matrix|gene-activated matrix
1145038|NCT02293031|VEGF gene|vegf gene
1145039|NCT02293031|DNA plasmid|dna plasmid
1145040|NCT02293031|bone gene therapy|bone gene therapy
1145041|NCT02293005|Lung Cancer|lung cancer
1145042|NCT02293005|Mesothelioma|mesothelioma
1145043|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
1145044|NCT02293005|MPM|mpm
1145045|NCT02293005|Alisertib|alisertib
1145046|NCT02293005|MLN8237|mln8237
1145047|NCT02292992|Electrical impedance tomography|electrical impedance tomography
1145048|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
1145049|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
1145050|NCT02292992|extubation|extubation
1145051|NCT02292979|HL|hl
1145052|NCT02292966|Hepatitis C|hepatitis c
1145053|NCT02292966|Hepatitis|hepatitis
1145054|NCT02292966|Asunaprevir|asunaprevir
1145055|NCT02292966|Daclatasvir|daclatasvir
1145056|NCT02292966|Beclabuvir|beclabuvir
1145057|NCT02292966|Neurocognitive function|neurocognitive function
1145058|NCT02292966|Brain metabolites|brain metabolites
1145059|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
1145060|NCT02292953|ICSI|icsi
1145061|NCT02292953|Ovum Pickup|ovum pickup
1145062|NCT02292953|Embryo Transfer|embryo transfer
1145063|NCT02292940|patient outcome assessment|patient outcome assessment
1145064|NCT02292940|electronic health records|electronic health records
1145065|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
1145066|NCT02292875|Grass Allergy|grass allergy
1145067|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
1145068|NCT02292875|Environmental Exposure Unit|environmental exposure unit
1145069|NCT02292875|Immunotherapy|immunotherapy
1145070|NCT02292875|ToleroMune Grass|toleromune grass
1145071|NCT02292849|Depression|depression
1145072|NCT02292823|STEMI|stemi
1145073|NCT02292823|heart attack|heart attack
1145074|NCT02292823|stent|stent
1145075|NCT02292823|Bare Metal Stent|bare metal stent
1145076|NCT02292823|myocardial infarction|myocardial infarction
1145077|NCT02292823|PCI|pci
1145078|NCT02292784|infants|infants
1145079|NCT02292784|retosiban|retosiban
1145080|NCT02292784|Preterm Labor|preterm labor
1145081|NCT02292784|long-term safety follow-up|long-term safety follow-up
1145082|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
1145083|NCT02292771|retosiban|retosiban
1145084|NCT02292771|GSK221149|gsk221149
1145085|NCT02292771|atosiban|atosiban
1145086|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
1145087|NCT02292745|chemotherapy|chemotherapy
1145088|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
1145089|NCT02292732|Pharmacokinetics|pharmacokinetics
1145090|NCT02292732|Solid Tumors|solid tumors
1145091|NCT02292732|Safety|safety
1145092|NCT02292732|Trametinib|trametinib
1145093|NCT02292732|MEK Inhibitor|mek inhibitor
1145094|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
1145095|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
1145096|NCT02292732|Norethindrone|norethindrone
1145097|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
1145098|NCT02292719|Hepatitis C Virus|hepatitis c virus
1145099|NCT02292719|Genotype 2|genotype 2
1146564|NCT02284191|Cardiology|cardiology
1145100|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
1145101|NCT02292719|Genotype 3|genotype 3
1145102|NCT02292719|Non-cirrhotic|non-cirrhotic
1145103|NCT02292719|Cirrhotic|cirrhotic
1145104|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
1145105|NCT02292706|Cirrhosis|cirrhosis
1145106|NCT02292706|Hepatitis C|hepatitis c
1145107|NCT02292693|intubation|intubation
1145108|NCT02292680|dentin|dentin
1145109|NCT02292680|environmental exposures|environmental exposures
1145110|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
1145111|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
1145112|NCT02292667|Postoperative Pain Management|postoperative pain management
1145113|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
1145114|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
1145115|NCT02292641|Rectum|rectum
1145116|NCT02292641|Diagnostic Imaging|diagnostic imaging
1145117|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
1145118|NCT02292641|Pelvic Exenteration|pelvic exenteration
1145119|NCT02292641|Neoplasms|neoplasms
1145120|NCT02292641|Adenocarcinoma|adenocarcinoma
1145121|NCT02292641|Carcinoma|carcinoma
1145122|NCT02292602|preschool|preschool
1145123|NCT02292602|obesity|obesity
1145124|NCT02292602|health disparities|health disparities
1145125|NCT02292602|intervention|intervention
1145126|NCT02292589|Traumatic Brain Injury|traumatic brain injury
1145127|NCT02292589|Post concussion syndrome|post concussion syndrome
1145128|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1145129|NCT02292589|Neuromodulation|neuromodulation
1145130|NCT02292576|volunteers|volunteers
1145131|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
1145132|NCT02292550|Non-small cell lung cancer,|non-small cell lung cancer,
1145133|NCT02292550|ALK translocation,|alk translocation,
1145134|NCT02292550|ALK-positive,|alk-positive,
1145135|NCT02292550|NSCLC,|nsclc,
1145136|NCT02292550|LEE011,|lee011,
1145137|NCT02292550|CDK4/6 inhibitor,|cdk4/6 inhibitor,
1145138|NCT02292550|EML4-ALK|eml4-alk
1145139|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
1145140|NCT02292537|SMA|sma
1145141|NCT02292537|SMN|smn
1145142|NCT02292537|SMNRx|smnrx
1145143|NCT02292537|ISIS-SMNRx|isis-smnrx
1145144|NCT02292537|ISIS-SMN Rx|isis-smn rx
1145145|NCT02292537|ISIS 396443|isis 396443
1145146|NCT02292537|CHERISH|cherish
1145147|NCT02292537|IONIS-SMNRx|ionis-smnrx
1145148|NCT02292537|IONIS-SMN Rx|ionis-smn rx
1145149|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
1145150|NCT02292511|mind-motor intervention|mind-motor intervention
1145151|NCT02292511|square-stepping exercise|square-stepping exercise
1145152|NCT02292511|older adults|older adults
1145153|NCT02292498|imaging, diagnostic|imaging, diagnostic
1145154|NCT02292498|feasibility|feasibility
1145155|NCT02292485|Lung Cancer Screening|lung cancer screening
1145156|NCT02292485|LCS|lcs
1145157|NCT02292485|Survey|survey
1145158|NCT02292485|Questionnaire|questionnaire
1145159|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
1145160|NCT02292472|masticatory muscles|masticatory muscles
1145161|NCT02292446|Polycythemia Vera|polycythemia vera
1145162|NCT02292446|Hematologic Diseases|hematologic diseases
1145163|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
1145164|NCT02292446|INC424|inc424
1145165|NCT02292446|Ruxolitinib|ruxolitinib
1145166|NCT02292433|Phase 1|phase 1
1145167|NCT02292433|type 2 diabetes|type 2 diabetes
1145168|NCT02292433|monotherapy|monotherapy
1145169|NCT02292433|PF-04937319|pf-04937319
1145170|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
1145171|NCT02292420|area under curve|area under curve
1145172|NCT02292420|amplitude|amplitude
1145173|NCT02292394|Depression|depression
1145174|NCT02292394|Depressive symptoms|depressive symptoms
1145175|NCT02292394|Prevention|prevention
1145176|NCT02292394|Caregivers|caregivers
1145177|NCT02292394|Telephone intervention|telephone intervention
1145178|NCT02292368|Head and Neck Cancer|head and neck cancer
1145179|NCT02292368|Xerostomia|xerostomia
1145180|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
1145181|NCT02292368|Acupuncture|acupuncture
1145182|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
1145183|NCT02292368|Radiation therapy|radiation therapy
1145184|NCT02292368|XRT|xrt
1145185|NCT02292368|Electroencephalogram|electroencephalogram
1145186|NCT02292368|EEG|eeg
1145187|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
1145188|NCT02292368|XQ|xq
1145189|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
1145190|NCT02292368|MDASI-HN|mdasi-hn
1145191|NCT02292368|Questionnaires|questionnaires
1145192|NCT02292368|Surveys|surveys
1145193|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
1145194|NCT02292355|posture|posture
1145195|NCT02292355|pain|pain
1145196|NCT02292355|clinical trial|clinical trial
1145197|NCT02292355|Pilates|pilates
1145198|NCT02292342|Flow mediated dilatation|flow mediated dilatation
1145199|NCT02292329|flow-mediated dilation|flow-mediated dilation
1145200|NCT02292329|Acai polyphenols|acai polyphenols
1147161|NCT02280772|adolescents|adolescents
1145201|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
1145202|NCT02292316|fall in the previous year|fall in the previous year
1145203|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
1145204|NCT02292290|Diabetes|diabetes
1145205|NCT02292290|Liraglutide|liraglutide
1145206|NCT02292290|Ramadan|ramadan
1145207|NCT02292290|fasting|fasting
1145208|NCT02292277|Ticagrelor|ticagrelor
1145209|NCT02292277|Pharmacokinetics|pharmacokinetics
1145210|NCT02292277|Platelet Aggregation|platelet aggregation
1145211|NCT02292277|Platelet Function Tests|platelet function tests
1145212|NCT02292251|Stroke|stroke
1145213|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
1145214|NCT02292238|Alzheimer's disease|alzheimer's disease
1145215|NCT02292238|benfotiamine|benfotiamine
1145216|NCT02292238|glucose|glucose
1145217|NCT02292238|Amyloid|amyloid
1145218|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
1145219|NCT02292199|Hypertension|hypertension
1145220|NCT02292199|TENS|tens
1145221|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
1145222|NCT02292186|Cardiomyopathy|cardiomyopathy
1145223|NCT02292186|Heart Failure|heart failure
1145225|NCT02292186|Amyloid|amyloid
1145226|NCT02292186|Transthyretin|transthyretin
1145227|NCT02292186|TTR|ttr
1145228|NCT02292186|RNAi therapeutic|rnai therapeutic
1145229|NCT02292173|Liver Neoplasms|liver neoplasms
1145230|NCT02292173|Liver Diseases|liver diseases
1145231|NCT02292173|Digestive System Diseases|digestive system diseases
1145232|NCT02292173|Advanced|advanced
1145233|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
1145234|NCT02292173|Kinase Inhibitor|kinase inhibitor
1145235|NCT02292147|Cerebral anoxia|cerebral anoxia
1145236|NCT02292147|Functional outcome|functional outcome
1145237|NCT02292134|Sleep quality|sleep quality
1145238|NCT02292134|Sleep architecture|sleep architecture
1145239|NCT02292134|Intensive care unit|intensive care unit
1145240|NCT02292134|Light|light
1145241|NCT02292134|Noise|noise
1145242|NCT02292134|Earplug|earplug
1145243|NCT02292134|Sleep mask|sleep mask
1145244|NCT02292121|Obesity|obesity
1145245|NCT02292121|Intestinal permeability|intestinal permeability
1145722|NCT02289482|Ritonavir|ritonavir
1145246|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
1145247|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
1145248|NCT02292121|Bariatric surgery|bariatric surgery
1145249|NCT02292108|Hypnosis|hypnosis
1145250|NCT02292108|self-hypnosis|self-hypnosis
1145251|NCT02292108|obesity|obesity
1145252|NCT02292108|high food impulsiveness|high food impulsiveness
1145253|NCT02292095|anesthesia|anesthesia
1145254|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
1145255|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
1145256|NCT02292082|Nerve Block|nerve block
1145257|NCT02292082|Rehabilitation|rehabilitation
1145258|NCT02292082|Knee Replacement, Total|knee replacement, total
1145259|NCT02291991|Safety|safety
1145260|NCT02291991|Tolerability|tolerability
1145261|NCT02291991|Pharmacokinetics|pharmacokinetics
1145262|NCT02291991|Pharmacodynamics|pharmacodynamics
1145263|NCT02291991|Immunogenecity|immunogenecity
1145264|NCT02291978|back pain|back pain
1145265|NCT02291978|facet joint|facet joint
1145266|NCT02291978|spine|spine
1145267|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
1145268|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
1145269|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
1145270|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
1145271|NCT02291926|Osteoarthritis|osteoarthritis
1145272|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
1145273|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
1145274|NCT02291913|everolimus|everolimus
1145275|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
1145276|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
1145277|NCT02291913|Afinitor|afinitor
1145278|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
1145279|NCT02291874|Diabetes|diabetes
1145280|NCT02291874|Ipragliflozin|ipragliflozin
1145281|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
1145282|NCT02291861|Dyskinesias|dyskinesias
1145283|NCT02291861|Movement Disorders|movement disorders
1145284|NCT02291861|Central Nervous System Diseases|central nervous system diseases
1145285|NCT02291861|Nervous System Diseases|nervous system diseases
1145286|NCT02291861|Neurologic Manifestations|neurologic manifestations
1145287|NCT02291861|Signs and Symptoms|signs and symptoms
1145288|NCT02291848|Multiple Myeloma|multiple myeloma
1145289|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
1145290|NCT02291809|HIV/AIDS|hiv/aids
1145291|NCT02291809|Pediatric|pediatric
1145292|NCT02291809|Vaccine|vaccine
1145293|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
1145294|NCT02291796|Bezafibrate|bezafibrate
1145295|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
1145296|NCT02291796|Inflammatory response|inflammatory response
1145297|NCT02291796|Acute myocardial infarction|acute myocardial infarction
1145298|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
1145299|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
1145300|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
1145301|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
1145302|NCT02291731|Autologous serum eye drops|autologous serum eye drops
1145303|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
1145304|NCT02291731|Persistent epithelial defects|persistent epithelial defects
1145305|NCT02291731|Corneal epithelial defects|corneal epithelial defects
1145306|NCT02291718|Suspected or confirmed|suspected or confirmed
1145307|NCT02291718|TAA|taa
1145308|NCT02291718|Computed tomography angiography|computed tomography angiography
1145309|NCT02291718|CTA|cta
1145310|NCT02291718|Contrast agent|contrast agent
1145311|NCT02291718|Radiation dose|radiation dose
1145312|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
1145313|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
1145314|NCT02291666|Cytochromes p450|cytochromes p450
1145315|NCT02291666|drug metabolism|drug metabolism
1145316|NCT02291666|pharmacokinetics|pharmacokinetics
1145317|NCT02291666|diabetes|diabetes
1145318|NCT02291666|probe markers|probe markers
1145319|NCT02291614|Amgen|amgen
1145320|NCT02291614|Phase 1|phase 1
1145321|NCT02291614|Clinical Trial|clinical trial
1145322|NCT02291614|Oncology|oncology
1145323|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
1145324|NCT02291614|Immunotherapy|immunotherapy
1145325|NCT02291536|THC and CBD|thc and cbd
1145326|NCT02291536|Attentional blink|attentional blink
1145327|NCT02291523|Fecal transplant|fecal transplant
1145328|NCT02291484|Computed tomography|computed tomography
1145329|NCT02291484|Coronary angiography|coronary angiography
1145330|NCT02291484|Coronary artery disease|coronary artery disease
1145331|NCT02291484|Perfusion imaging|perfusion imaging
1145332|NCT02291484|Comparative effectiveness|comparative effectiveness
1145333|NCT02291484|Randomized controlled trial|randomized controlled trial
1145334|NCT02291484|Cost-effectiveness|cost-effectiveness
1145335|NCT02291445|Peppermint oil|peppermint oil
1145336|NCT02291445|Menthol|menthol
1145337|NCT02291445|Volatile oil|volatile oil
1145338|NCT02291445|Plant oil|plant oil
1145339|NCT02291445|Visceral pain|visceral pain
1145340|NCT02291445|Abdominal pain|abdominal pain
1145341|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1145342|NCT02291445|Colonic disease|colonic disease
1145343|NCT02291419|ticagrelor|ticagrelor
1145344|NCT02291419|non-cardiac surgery|non-cardiac surgery
1145345|NCT02291419|elevated troponin|elevated troponin
1145346|NCT02291419|myocardial injury|myocardial injury
1145347|NCT02291406|Hysterectomy|hysterectomy
1145348|NCT02291406|Insulin resistance|insulin resistance
1145349|NCT02291406|Metabolism|metabolism
1145350|NCT02291380|Chronic Migraine|chronic migraine
1145351|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
1145352|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
1145353|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
1145354|NCT02291354|Slow Transit Constipation|slow transit constipation
1145355|NCT02291315|Triple Stable Isotope|triple stable isotope
1145356|NCT02291263|Polio|polio
1145357|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
1145358|NCT02291263|IPV|ipv
1145359|NCT02291263|oral polio vaccine|oral polio vaccine
1145360|NCT02291250|anthocyanin|anthocyanin
1145361|NCT02291250|blackcurrant|blackcurrant
1145362|NCT02291250|greencurrant|greencurrant
1145363|NCT02291250|glucose|glucose
1145364|NCT02291250|polyphenol|polyphenol
1145365|NCT02291250|post prandial glucose|post prandial glucose
1145366|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1145367|NCT02291237|hcm|hcm
1145368|NCT02291237|hocm|hocm
1145369|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
1145370|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
1145371|NCT02291237|cardiomyopathy|cardiomyopathy
1145372|NCT02291237|hypertrophic|hypertrophic
1145373|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
1145374|NCT02291237|genetic heart disease|genetic heart disease
1145375|NCT02291237|echocardiography|echocardiography
1145376|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1145377|NCT02291237|exercise Capacity|exercise capacity
1145378|NCT02291237|heart failure|heart failure
1145379|NCT02291237|angina|angina
1145380|NCT02291237|dyspnea|dyspnea
1145381|NCT02291237|diastolic dysfunction|diastolic dysfunction
1145382|NCT02291237|microvascular ischemia|microvascular ischemia
1145383|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
1145384|NCT02291237|GS-6615|gs-6615
1145385|NCT02291237|late INA|late ina
1145386|NCT02291224|dual protection|dual protection
1145387|NCT02291224|pregnancy|pregnancy
1145388|NCT02291224|reproductive health|reproductive health
1145389|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
1145391|NCT02291224|contraception|contraception
1145392|NCT02291224|adolescent health services|adolescent health services
1145393|NCT02291198|colorectal cancer|colorectal cancer
1147162|NCT02280772|treatment|treatment
1145394|NCT02291198|natural killer cell activity|natural killer cell activity
1145395|NCT02291198|screening|screening
1145396|NCT02291198|NK cells|nk cells
1145397|NCT02291159|stroke|stroke
1145398|NCT02291159|spasticity|spasticity
1145399|NCT02291159|dry needling|dry needling
1145400|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
1145401|NCT02291159|motor function|motor function
1145402|NCT02291146|gardening|gardening
1145403|NCT02291146|cooking|cooking
1145404|NCT02291146|nutrition education|nutrition education
1145405|NCT02291146|Hispanic Americans|hispanic americans
1145406|NCT02291133|Primary liver tumors|primary liver tumors
1145407|NCT02291133|Bleomycin|bleomycin
1145408|NCT02291133|Electrochemotherapy|electrochemotherapy
1145409|NCT02291107|Gait orthosis|gait orthosis
1145410|NCT02291107|Lokomat|lokomat
1145411|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
1145412|NCT02291094|Intravenous lidocaine|intravenous lidocaine
1145413|NCT02291094|Mastectomy|mastectomy
1145414|NCT02291094|Pain|pain
1145415|NCT02291081|HIV, AIDS|hiv, aids
1145416|NCT02291081|antiretroviral therapy|antiretroviral therapy
1145417|NCT02291081|aging|aging
1145418|NCT02291081|heart failure|heart failure
1145419|NCT02291081|coronary heart disease|coronary heart disease
1145420|NCT02291081|myocardial infarction|myocardial infarction
1145421|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
1145422|NCT02291042|Bladder|bladder
1145423|NCT02291042|Surgery|surgery
1145424|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
1145425|NCT02291016|COPD|copd
1145426|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1145427|NCT02291003|circadian|circadian
1145428|NCT02291003|sleep|sleep
1145429|NCT02290977|RT, TACE|rt, tace
1145430|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
1145431|NCT02290964|allogeneic transfusion|allogeneic transfusion
1145432|NCT02290938|adolescents|adolescents
1145433|NCT02290938|Native American|native american
1145434|NCT02290938|alcohol use|alcohol use
1145435|NCT02290938|drug use|drug use
1145436|NCT02290938|cultural|cultural
1145437|NCT02290938|traditional activities|traditional activities
1145438|NCT02290938|cultural identification|cultural identification
1145439|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
1145440|NCT02290925|randomised controlled trial|randomised controlled trial
1145441|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
1145442|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1145443|NCT02290886|safety evaluation|safety evaluation
1145444|NCT02290886|intravenous administration|intravenous administration
1145445|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
1145446|NCT02290886|ALS|als
1145447|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
1145448|NCT02290834|Chemo-brain|chemo-brain
1145449|NCT02290808|physical|physical
1145450|NCT02290808|activity|activity
1145451|NCT02290808|exercise|exercise
1145452|NCT02290808|new-parents|new-parents
1145453|NCT02290808|intervention|intervention
1145454|NCT02290808|theory-based|theory-based
1145455|NCT02290795|Vitreopapillary traction|vitreopapillary traction
1145456|NCT02290782|toxicity|toxicity
1145457|NCT02290782|outcome|outcome
1145458|NCT02290782|TARGIT|targit
1145459|NCT02290782|quality of life|quality of life
1145460|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
1145461|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
1145462|NCT02290769|Time of cannulation|time of cannulation
1145463|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
1145464|NCT02290769|Guide wire|guide wire
1145465|NCT02290756|Early child development|early child development
1145466|NCT02290756|Link Workers|link workers
1145467|NCT02290756|Community Birth attendants|community birth attendants
1145468|NCT02290756|Parenting Program|parenting program
1145469|NCT02290730|Lower trapezius|lower trapezius
1145470|NCT02290730|Kinesio taping|kinesio taping
1145471|NCT02290717|ultraviolet therapy|ultraviolet therapy
1145472|NCT02290717|non segmental|non segmental
1145473|NCT02290717|vitiligo|vitiligo
1145474|NCT02290717|topical corticosteroid|topical corticosteroid
1145475|NCT02290717|laser|laser
1145476|NCT02290717|fractional|fractional
1145477|NCT02290717|CO2|co2
1145478|NCT02290717|carbon dioxide|carbon dioxide
1145479|NCT02290717|UVB|uvb
1145480|NCT02290704|oxygen saturation|oxygen saturation
1145481|NCT02290704|retinal vessels|retinal vessels
1145482|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
1145483|NCT02290691|Needle Free, Influenza|needle free, influenza
1145484|NCT02290678|Pilot Study|pilot study
1145485|NCT02290678|Adventure-based Programming|adventure-based programming
1145486|NCT02290665|enema|enema
1145487|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
1145488|NCT02290639|Posttraumatic Stress|posttraumatic stress
1145489|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
1145490|NCT02290639|Military|military
1145491|NCT02290639|Primary Care|primary care
1147366|NCT02279875|Linezolid|linezolid
1145492|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
1145493|NCT02290639|Prolonged Exposure|prolonged exposure
1145494|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
1145495|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
1145496|NCT02290639|Behavioral Health Consultant|behavioral health consultant
1145497|NCT02290626|Elemental diet|elemental diet
1145498|NCT02290626|semi-solid diet|semi-solid diet
1145499|NCT02290626|gastric emptying|gastric emptying
1145501|NCT02290626|PEG|peg
1145502|NCT02290613|pulmonary hypertension|pulmonary hypertension
1145503|NCT02290613|systemic sclerosis|systemic sclerosis
1145504|NCT02290587|social cognitive|social cognitive
1145505|NCT02290587|theory of mind|theory of mind
1145506|NCT02290587|cognitive impairment|cognitive impairment
1145507|NCT02290587|functional MRI|functional mri
1145508|NCT02290587|brain activation network|brain activation network
1145509|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
1145510|NCT02290561|Therapeutics|therapeutics
1145511|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
1145512|NCT02290561|Ultrasonography|ultrasonography
1145513|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
1145514|NCT02290561|Image Fusion|image fusion
1145515|NCT02290548|high flow nasal cannula|high flow nasal cannula
1145516|NCT02290548|extubation failure|extubation failure
1145517|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
1145518|NCT02290535|children|children
1145519|NCT02290535|teenager|teenager
1145520|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
1145521|NCT02290496|Insomnia|insomnia
1145522|NCT02290496|Depression|depression
1145523|NCT02290496|Teen|teen
1145524|NCT02290496|SSRI|ssri
1145526|NCT02290496|Youth|youth
1145527|NCT02290470|Nausea|nausea
1145528|NCT02290470|Vomiting|vomiting
1145529|NCT02290457|resistance training|resistance training
1145530|NCT02290457|trunk muscle strength|trunk muscle strength
1145531|NCT02290457|physical fitness|physical fitness
1145532|NCT02290457|adolescent|adolescent
1145533|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
1145534|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1145723|NCT02289482|Safety|safety
1145535|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
1145536|NCT02290431|LBH589,|lbh589,
1145537|NCT02290431|panobinostat,|panobinostat,
1145538|NCT02290431|bortezomib,|bortezomib,
1145539|NCT02290431|dexamethasone,|dexamethasone,
1145540|NCT02290431|Phase II|phase ii
1145541|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1145542|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
1145543|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
1145544|NCT02290405|insomnia|insomnia
1145545|NCT02290405|primary insomnia|primary insomnia
1145546|NCT02290405|chronic insomnia|chronic insomnia
1145547|NCT02290392|African American|african american
1145548|NCT02290392|Environmental Factor|environmental factor
1145549|NCT02290392|Transcriptome|transcriptome
1145550|NCT02290392|Cardiovascular Disease|cardiovascular disease
1145551|NCT02290392|Hypertension|hypertension
1145552|NCT02290353|Engagement|engagement
1145553|NCT02290353|Motivation|motivation
1145554|NCT02290353|Exergaming|exergaming
1145555|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
1145556|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
1145557|NCT02290327|proton pump inhibitors|proton pump inhibitors
1145558|NCT02290327|pneumonia|pneumonia
1145559|NCT02290327|clostridium difficile infection|clostridium difficile infection
1145560|NCT02290262|Heart disease|heart disease
1145561|NCT02290262|Phase one rehabilitation|phase one rehabilitation
1145562|NCT02290223|Chronic pain|chronic pain
1145563|NCT02290223|Analgesics, Opioid|analgesics, opioid
1145564|NCT02290223|Cognitive Therapy|cognitive therapy
1145565|NCT02290223|Behavior Therapy|behavior therapy
1145566|NCT02290223|Mindfulness|mindfulness
1145567|NCT02290223|Psychophysiology|psychophysiology
1145568|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
1145569|NCT02290184|type 2 diabetes|type 2 diabetes
1145570|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
1145571|NCT02290184|lifestyle intervention|lifestyle intervention
1145572|NCT02290184|physical activity|physical activity
1145573|NCT02290184|weight loss|weight loss
1145574|NCT02290184|nutrition|nutrition
1145575|NCT02290184|Filipinos|filipinos
1145576|NCT02290184|culturally appropriate|culturally appropriate
1145577|NCT02290158|treatment outcomes|treatment outcomes
1145578|NCT02290158|Malocclusion/therapy|malocclusion/therapy
1145579|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
1145580|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1145581|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
1145582|NCT02290132|stem-cell transplant|stem-cell transplant
1145583|NCT02290132|T-cell lymphoma|t-cell lymphoma
1145584|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
1145585|NCT02290119|Intraoperative Sensors|intraoperative sensors
1145586|NCT02290119|Ligament Balancing|ligament balancing
1145587|NCT02290119|Clinical Outcomes|clinical outcomes
1145588|NCT02290106|obesity|obesity
1145589|NCT02290106|insulin sensitivity|insulin sensitivity
1145590|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
1145591|NCT02290106|fatty liver|fatty liver
1145592|NCT02290093|Cathartics|cathartics
1145593|NCT02290093|Colonoscopy|colonoscopy
1145594|NCT02290093|Polyethylene Glycols|polyethylene glycols
1145595|NCT02290093|Elderly|elderly
1145596|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
1145597|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
1145598|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
1145599|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
1145600|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
1145601|NCT02290080|Biomarkers|biomarkers
1145602|NCT02290080|Oxygen|oxygen
1145603|NCT02290080|Apoptosis|apoptosis
1145604|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
1145605|NCT02290080|Flow cytometry|flow cytometry
1145606|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
1145607|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
1145608|NCT02290067|system accuracy|system accuracy
1145609|NCT02290054|analgesia, epidural|analgesia, epidural
1145610|NCT02290054|urinary retention|urinary retention
1145611|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
1145612|NCT02290041|HIV Infection|hiv infection
1145613|NCT02290041|discordant immunological response|discordant immunological response
1145614|NCT02290028|CRT-D therapy|crt-d therapy
1145615|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
1145616|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
1145617|NCT02289989|Atopic dermatitis|atopic dermatitis
1145618|NCT02289989|Oregano|oregano
1145619|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
1145620|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
1145621|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
1145622|NCT02289976|talar avascular necrosis|talar avascular necrosis
1145623|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
1145624|NCT02289976|femoral condyle|femoral condyle
1145625|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
1145626|NCT02289950|Platinum-Sensitive|platinum-sensitive
1145627|NCT02289937|Postoperative pain|postoperative pain
1145628|NCT02289937|regional anaesthesia|regional anaesthesia
1145629|NCT02289937|total hip replacement|total hip replacement
1145630|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
1145631|NCT02289924|wet AMD|wet amd
1145632|NCT02289911|ultrasound|ultrasound
1145633|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
1145634|NCT02289885|trauma|trauma
1145635|NCT02289885|examination|examination
1145636|NCT02289885|knowledge|knowledge
1145637|NCT02289885|paramedic|paramedic
1145638|NCT02289820|RSV|rsv
1145639|NCT02289820|Older adults|older adults
1145640|NCT02289820|MEDI7510|medi7510
1145641|NCT02289820|Vaccine|vaccine
1145642|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1145643|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1145644|NCT02289807|intermediate risk|intermediate risk
1145645|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1145646|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
1145647|NCT02289794|Urinary tract infections|urinary tract infections
1145648|NCT02289755|Urine Oxalate|urine oxalate
1145649|NCT02289755|Nephrolithiasis|nephrolithiasis
1145650|NCT02289755|Kidney Stones|kidney stones
1145651|NCT02289755|Hyperoxaluria|hyperoxaluria
1145652|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
1145653|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
1145654|NCT02289755|Urological Diseases|urological diseases
1145655|NCT02289755|Kidney Diseases|kidney diseases
1145656|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
1145657|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
1145658|NCT02289742|tear film stability|tear film stability
1145659|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
1145660|NCT02289729|Duodopa|duodopa
1145661|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
1145662|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
1145663|NCT02289716|Osteoarthritis|osteoarthritis
1145664|NCT02289716|Pain|pain
1145665|NCT02289716|Fulranumab|fulranumab
1145666|NCT02289716|JNJ-42160443|jnj-42160443
1145667|NCT02289716|Monotherapy|monotherapy
1145668|NCT02289716|Hip|hip
1145669|NCT02289716|Knee|knee
1145670|NCT02289716|Joint replacement surgery|joint replacement surgery
1145671|NCT02289703|End-Stage Renal Disease|end-stage renal disease
1145672|NCT02289703|Healthy|healthy
1145673|NCT02289703|Rivaroxaban|rivaroxaban
1145674|NCT02289703|BAY 59-7939|bay 59-7939
1145675|NCT02289703|JNJ-39039039|jnj-39039039
1145676|NCT02289703|Xarelto|xarelto
1145677|NCT02289703|Hemodialysis|hemodialysis
1145678|NCT02289703|Blood Coagulation|blood coagulation
1145679|NCT02289703|Pharmacokinetics|pharmacokinetics
1145680|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
1145681|NCT02289690|ABT-888|abt-888
1145682|NCT02289690|Veliparib|veliparib
1145683|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
1145684|NCT02289677|intubation|intubation
1145685|NCT02289677|child|child
1145686|NCT02289677|resuscitation|resuscitation
1145687|NCT02289677|simulation|simulation
1145688|NCT02289677|Endotracheal|endotracheal
1145689|NCT02289664|intubation|intubation
1145690|NCT02289651|intubation|intubation
1145691|NCT02289638|intubation|intubation
1145692|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
1145693|NCT02289625|cognition|cognition
1145694|NCT02289625|neurovascular function|neurovascular function
1145695|NCT02289625|brain metabolism|brain metabolism
1145696|NCT02289625|exercise training|exercise training
1145697|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
1145698|NCT02289612|Fibre|fibre
1145699|NCT02289612|Postprandial Glucose|postprandial glucose
1145700|NCT02289612|Postprandial Insulin|postprandial insulin
1145701|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
1145702|NCT02289612|Satiety|satiety
1145703|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
1145704|NCT02289599|E2307|e2307
1145705|NCT02289599|Pharmacokinetics|pharmacokinetics
1145706|NCT02289547|chemotherapy|chemotherapy
1145707|NCT02289547|stomach neoplasms|stomach neoplasms
1145708|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
1145709|NCT02289521|Executive function|executive function
1145710|NCT02289521|Bilingualism|bilingualism
1145711|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1145712|NCT02289508|Heart Failure|heart failure
1145713|NCT02289508|Hemodynamics|hemodynamics
1145714|NCT02289508|Echocardiography|echocardiography
1145715|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
1145716|NCT02289508|Ultrasonography|ultrasonography
1145717|NCT02289508|USCOM|uscom
1145718|NCT02289495|Single Dose Escalation|single dose escalation
1145719|NCT02289495|Repeat Dose Escalation|repeat dose escalation
1145720|NCT02289495|GSK2838232|gsk2838232
1145721|NCT02289495|Ritonavir|ritonavir
1145724|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
1145725|NCT02289482|GSK2838232|gsk2838232
1145726|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
1145727|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
1145728|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
1145729|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
1145730|NCT02289456|(ABOUND.PS2)|(abound.ps2)
1145731|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
1145732|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
1145733|NCT02289443|complete dentures|complete dentures
1145734|NCT02289443|10-year follow-up|10-year follow-up
1145735|NCT02289443|patient report outcomes|patient report outcomes
1145736|NCT02289417|Ulcerative Colitis|ulcerative colitis
1145737|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
1145738|NCT02289391|Dexmedetomidine|dexmedetomidine
1145739|NCT02289391|Inflammatory factor|inflammatory factor
1145740|NCT02289391|Inflammatory mediator|inflammatory mediator
1145741|NCT02289391|Cytokines|cytokines
1145742|NCT02289391|Asthma|asthma
1145743|NCT02289365|Radiodermatitis|radiodermatitis
1145744|NCT02289365|Breast cancer|breast cancer
1145745|NCT02289365|Radiotherapy|radiotherapy
1145746|NCT02289313|obesity prevention|obesity prevention
1145747|NCT02289313|CBPR|cbpr
1145748|NCT02289313|high risk youth|high risk youth
1145749|NCT02289313|school health|school health
1145750|NCT02289287|Self-Management|self-management
1145751|NCT02289287|Stroke|stroke
1145752|NCT02289287|Intervention|intervention
1145753|NCT02289287|Group Processes|group processes
1145754|NCT02289261|Chronic pain|chronic pain
1145755|NCT02289261|Morphine|morphine
1145756|NCT02289261|Dexmedetomidine|dexmedetomidine
1145757|NCT02289235|Ginger|ginger
1145758|NCT02289235|Medicine, traditional|medicine, traditional
1145759|NCT02289235|Herbal medicine|herbal medicine
1145760|NCT02289222|Relapsed/Refractory|relapsed/refractory
1145761|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
1145762|NCT02289222|Immunotherapy|immunotherapy
1145763|NCT02289209|head and neck cancer|head and neck cancer
1145764|NCT02289209|reirradiation|reirradiation
1145765|NCT02289209|MK-3475|mk-3475
1145766|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
1145767|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
1145768|NCT02289209|Keytruda|keytruda
1145769|NCT02289209|pembrolizumab|pembrolizumab
1145770|NCT02289196|Vaccine|vaccine
1145771|NCT02289183|Stomach Neoplasms|stomach neoplasms
1145772|NCT02289183|Laparoscopy|laparoscopy
1145773|NCT02289183|Billroth I Operation|billroth i operation
1145774|NCT02289170|Chronic low back pain|chronic low back pain
1145775|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
1145776|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
1145777|NCT02289170|Contrast therapy|contrast therapy
1145778|NCT02289131|oral care|oral care
1145779|NCT02289105|Advance Directive|advance directive
1145780|NCT02289105|Active Choice|active choice
1145781|NCT02289105|Decision making|decision making
1145782|NCT02289053|Colorectal Cancer|colorectal cancer
1145783|NCT02289040|Acute Kidney Injury|acute kidney injury
1145784|NCT02289040|Microvesicles|microvesicles
1145785|NCT02289040|microRNA|microrna
1145786|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
1145787|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
1145788|NCT02289014|online intervention|online intervention
1145789|NCT02289014|stress management|stress management
1145790|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
1145791|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
1145792|NCT02289001|patient simulation|patient simulation
1145793|NCT02289001|simulation|simulation
1145794|NCT02289001|teamwork|teamwork
1145795|NCT02289001|interdisciplinary health team|interdisciplinary health team
1145796|NCT02289001|healthcare team|healthcare team
1145797|NCT02289001|nursing|nursing
1145798|NCT02289001|training programs|training programs
1145799|NCT02288988|GERD|gerd
1145800|NCT02288988|Short Esophagus|short esophagus
1145801|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
1145802|NCT02288988|Collis gastroplasty|collis gastroplasty
1145803|NCT02288975|hemoadsorption|hemoadsorption
1145804|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
1145805|NCT02288975|CytoSorb|cytosorb
1145806|NCT02288975|hemofiltration|hemofiltration
1145807|NCT02288975|SIRS|sirs
1145808|NCT02288975|sepsis|sepsis
1145809|NCT02288975|septic shock|septic shock
1145810|NCT02288975|membranes|membranes
1145811|NCT02288975|ICU|icu
1145812|NCT02288975|dialysis|dialysis
1145813|NCT02288975|adsorption|adsorption
1145814|NCT02288962|dopamine agonists|dopamine agonists
1145815|NCT02288962|cabergoline|cabergoline
1145816|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
1145817|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
1145818|NCT02288936|Enzalutamide|enzalutamide
1145819|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
1145820|NCT02288923|Total knee arthroplasty|total knee arthroplasty
1145821|NCT02288923|Femoral nerve block|femoral nerve block
1145822|NCT02288923|Local infiltration analgesia|local infiltration analgesia
1145823|NCT02288910|Liver Perfusion|liver perfusion
1145824|NCT02288910|DynaCT Perfusion|dynact perfusion
1145825|NCT02288910|Radioembolization|radioembolization
1145826|NCT02288910|Chemoembolization|chemoembolization
1145827|NCT02288897|Stage III|stage iii
1145828|NCT02288897|Stage IIIB|stage iiib
1145829|NCT02288897|Stage IIIC|stage iiic
1145830|NCT02288897|Stage IV (M1a)|stage iv (m1a)
1145831|NCT02288897|Stage 3|stage 3
1145832|NCT02288897|Stage 4|stage 4
1145833|NCT02288897|IVM1a|ivm1a
1145834|NCT02288897|IV(M1a)|iv(m1a)
1145835|NCT02288897|IV-M1a|iv-m1a
1145836|NCT02288897|in-transit|in-transit
1145837|NCT02288897|in transit|in transit
1145838|NCT02288897|intransit|intransit
1145839|NCT02288897|satellite|satellite
1145840|NCT02288897|recurrent|recurrent
1145841|NCT02288884|Complications|complications
1145842|NCT02288884|Cesarean Section|cesarean section
1145843|NCT02288884|Wound|wound
1145844|NCT02288884|Infection (Following Delivery)|infection (following delivery)
1145845|NCT02288871|aortic valve replacement|aortic valve replacement
1145846|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
1145847|NCT02288871|hemodynamics|hemodynamics
1145848|NCT02288858|Hair thinning|hair thinning
1145849|NCT02288819|loop diuretics|loop diuretics
1145850|NCT02288819|heart failure|heart failure
1145851|NCT02288819|natriuresis|natriuresis
1145852|NCT02288819|urinary analysis|urinary analysis
1145853|NCT02288793|attitudes|attitudes
1145854|NCT02288793|knowledge|knowledge
1145855|NCT02288793|examination|examination
1145856|NCT02288754|DNA in Tumors|dna in tumors
1145857|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
1145858|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
1145859|NCT02288741|induction chemotherapy|induction chemotherapy
1145860|NCT02288741|elderly patients|elderly patients
1145861|NCT02288728|Proximal gastrectomy|proximal gastrectomy
1145862|NCT02288728|quality of life|quality of life
1145863|NCT02288728|mortality|mortality
1145864|NCT02288728|morbidity|morbidity
1145865|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
1145866|NCT02288715|septic encephalopathy|septic encephalopathy
1145867|NCT02288676|genomics|genomics
1145868|NCT02288676|molecular markers|molecular markers
1145869|NCT02288676|genetic mutations|genetic mutations
1145870|NCT02288676|high-grade serous cancer|high-grade serous cancer
1145871|NCT02288676|ovarian cancer|ovarian cancer
1145872|NCT02288676|endometrial cancer|endometrial cancer
1145873|NCT02288676|driver mutations|driver mutations
1147463|NCT02279316|MCI|mci
1145874|NCT02288676|passenger mutations|passenger mutations
1145875|NCT02288676|molecular screening|molecular screening
1145876|NCT02288598|Stammering|stammering
1145877|NCT02288598|Brain stimulation|brain stimulation
1145878|NCT02288585|plant sterols|plant sterols
1145879|NCT02288585|blood lipids|blood lipids
1145880|NCT02288572|metabolic syndrome X|metabolic syndrome x
1145882|NCT02288572|insulin resistance|insulin resistance
1145883|NCT02288572|dyslipidemia|dyslipidemia
1145884|NCT02288572|probiotic bacteria|probiotic bacteria
1145885|NCT02288546|nutritional status|nutritional status
1145886|NCT02288546|pesticides|pesticides
1145887|NCT02288546|nitrate|nitrate
1145888|NCT02288533|Minimally Conscious State|minimally conscious state
1145889|NCT02288533|tDCS|tdcs
1145890|NCT02288520|Methotrexate|methotrexate
1145891|NCT02288520|Therapeutic strategy|therapeutic strategy
1145892|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
1145893|NCT02288494|hypoalbuminemia|hypoalbuminemia
1145894|NCT02288494|-acid base balance|-acid base balance
1145895|NCT02288494|acid base disorders|acid base disorders
1145896|NCT02288494|critical ill|critical ill
1145897|NCT02288494|Stewart approach|stewart approach
1145898|NCT02288494|human albumin infusion|human albumin infusion
1145899|NCT02288481|Tuberculosis|tuberculosis
1145900|NCT02288481|TBA-354|tba-354
1145901|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
1145902|NCT02288481|TB|tb
1145903|NCT02288468|Parkinson's Disease|parkinson's disease
1145904|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
1145905|NCT02288429|pharmacokinetics|pharmacokinetics
1145906|NCT02288429|cystic fibrosis|cystic fibrosis
1145907|NCT02288429|critical illness|critical illness
1145908|NCT02288403|Aerobic Exercise|aerobic exercise
1145909|NCT02288403|Oxygen Consumption|oxygen consumption
1145910|NCT02288403|Blood Pressure|blood pressure
1145911|NCT02288390|VAP|vap
1145912|NCT02288390|Oral care|oral care
1145913|NCT02288390|Chlorhexidine|chlorhexidine
1145914|NCT02288390|Miswak (Sewak)|miswak (sewak)
1145915|NCT02288377|Lanreotide|lanreotide
1145916|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
1145917|NCT02288377|Maintenance treatment|maintenance treatment
1145918|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1145919|NCT02288325|Fetzima|fetzima
1145920|NCT02288325|Relapse-prevention|relapse-prevention
1145921|NCT02288325|Placebo-controlled|placebo-controlled
1145922|NCT02288299|Instrumental cough assistance|instrumental cough assistance
1145923|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
1145924|NCT02288299|home mechanical ventilation|home mechanical ventilation
1145925|NCT02288299|prospective evaluation|prospective evaluation
1145926|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
1145927|NCT02288260|Russian ACS Registry|russian acs registry
1145928|NCT02288260|ticagrelor|ticagrelor
1145929|NCT02288247|Metastatic|metastatic
1145930|NCT02288247|Castration-resistant|castration-resistant
1145931|NCT02288247|Docetaxel|docetaxel
1145932|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
1145933|NCT02288247|Enzalutamide|enzalutamide
1145934|NCT02288247|Prostate Cancer|prostate cancer
1145935|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
1145936|NCT02288247|Prednisolone|prednisolone
1145937|NCT02288247|Xtandi|xtandi
1145938|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1145939|NCT02288234|Registry|registry
1145940|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1145941|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
1145942|NCT02288195|Chemoradiotherapy|chemoradiotherapy
1145943|NCT02288195|Capecitabine|capecitabine
1145944|NCT02288195|Oxaliplatin|oxaliplatin
1145945|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
1145946|NCT02288169|Symptom management|symptom management
1145947|NCT02288169|palliative care|palliative care
1145948|NCT02288117|PMCF|pmcf
1145949|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
1145950|NCT02288117|SP-CL|sp-cl
1145951|NCT02288117|anatomic stem|anatomic stem
1145952|NCT02288104|Interventional Radiology|interventional radiology
1145953|NCT02288104|Liver|liver
1145954|NCT02288104|Kidney|kidney
1145955|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
1145956|NCT02288104|Optical Biopsy|optical biopsy
1145957|NCT02288104|Scanner|scanner
1145958|NCT02288104|Fluoroscopy|fluoroscopy
1145959|NCT02288104|CT|ct
1145960|NCT02288104|Computed Tomography|computed tomography
1145961|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
1145962|NCT02288104|Fluorescein|fluorescein
1145963|NCT02288091|ALS|als
1145964|NCT02288091|Inosine|inosine
1145965|NCT02288091|Uric acid|uric acid
1145966|NCT02288091|Urate|urate
1145967|NCT02288091|Glutathione|glutathione
1145968|NCT02288091|Biomarker|biomarker
1145969|NCT02288091|Oxidative stress|oxidative stress
1145970|NCT02288091|Oxidative damage|oxidative damage
1145971|NCT02288091|proof-of-concept|proof-of-concept
1145972|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
1145973|NCT02288078|regorafenib|regorafenib
1145974|NCT02288078|Steroid|steroid
1145975|NCT02288078|fatigue and malaise|fatigue and malaise
1145976|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
1145977|NCT02288052|Handwriting|handwriting
1145978|NCT02288052|Motor learning|motor learning
1145979|NCT02288039|Pulmonary|pulmonary
1145980|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1145981|NCT02288026|Lung Neoplasms|lung neoplasms
1145982|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1145983|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
1145984|NCT02288013|Cesarean section|cesarean section
1145985|NCT02288013|uterine closure technique|uterine closure technique
1145986|NCT02288013|materials used|materials used
1145987|NCT02288000|Alzheimer|alzheimer
1145988|NCT02288000|Memantine|memantine
1145989|NCT02288000|biomarkers|biomarkers
1145990|NCT02288000|battery|battery
1145991|NCT02288000|cognition|cognition
1145992|NCT02288000|imaging|imaging
1145993|NCT02288000|neuropsychology|neuropsychology
1145994|NCT02287987|Renal function|renal function
1145995|NCT02287987|Off-clamp|off-clamp
1145996|NCT02287987|Partial nephrectomy|partial nephrectomy
1145997|NCT02287987|Robotic|robotic
1145998|NCT02287987|Hylar clamping|hylar clamping
1145999|NCT02287948|Balance|balance
1146000|NCT02287948|Multiple Sclerosis|multiple sclerosis
1146001|NCT02287948|Nintendo Wii Fit|nintendo wii fit
1146002|NCT02287935|Karydakis procedure|karydakis procedure
1146003|NCT02287935|Limberg flap|limberg flap
1146004|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
1146005|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
1146006|NCT02287896|anti-RhD antibody|anti-rhd antibody
1146007|NCT02287883|Patient activation and engagement|patient activation and engagement
1146008|NCT02287883|Patient reported outcomes|patient reported outcomes
1146009|NCT02287883|Accountable Care Organizations|accountable care organizations
1146010|NCT02287883|Chronic illness|chronic illness
1146011|NCT02287883|Vulnerable population|vulnerable population
1146012|NCT02287883|Comparison of approaches|comparison of approaches
1146013|NCT02287870|Epidural anesthesia|epidural anesthesia
1146014|NCT02287870|Chloroprocaine|chloroprocaine
1146015|NCT02287870|Lidocaine|lidocaine
1146016|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
1146017|NCT02287844|Immunonutrition|immunonutrition
1146018|NCT02287844|Prebiotics|prebiotics
1146019|NCT02287844|Lipopolysaccharides|lipopolysaccharides
1146020|NCT02287844|Cytokines|cytokines
1146021|NCT02287805|craniosynostosis|craniosynostosis
1146022|NCT02287805|simple form|simple form
1146023|NCT02287805|complex form|complex form
1146024|NCT02287805|diagnostic|diagnostic
1146025|NCT02287805|announcement|announcement
1146026|NCT02287805|impacts|impacts
1146027|NCT02287792|Infective endocarditis|infective endocarditis
1146028|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
1146029|NCT02287792|Impact|impact
1146030|NCT02287792|Patient's management|patient's management
1146031|NCT02287792|Diagnostic|diagnostic
1146032|NCT02287753|vascular occlusion test|vascular occlusion test
1146033|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
1146034|NCT02287740|Exercise|exercise
1146035|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
1146036|NCT02287701|bladder cancer|bladder cancer
1146037|NCT02287701|MRI|mri
1146038|NCT02287701|PET|pet
1146039|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
1146040|NCT02287688|Children 2-23 months of age|children 2-23 months of age
1146041|NCT02287675|Sentinel Node|sentinel node
1146042|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1146043|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
1146044|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
1146045|NCT02287649|Rituximab|rituximab
1146046|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
1146047|NCT02287649|ITP|itp
1146048|NCT02287610|RA|ra
1146049|NCT02287610|Delayed-release prednisone|delayed-release prednisone
1146050|NCT02287610|Immediate-release prednisone|immediate-release prednisone
1146051|NCT02287610|Non-interventional|non-interventional
1146052|NCT02287571|comfort|comfort
1146053|NCT02287571|satisfaction|satisfaction
1146054|NCT02287558|HHT|hht
1146055|NCT02287558|CASE4Z14|case4z14
1146056|NCT02287558|Pomalidomide|pomalidomide
1146057|NCT02287545|open angle glaucoma|open angle glaucoma
1146058|NCT02287545|corneal biomechanics|corneal biomechanics
1146059|NCT02287545|trabeculectomy|trabeculectomy
1146060|NCT02287506|diagnosis, strategy|diagnosis, strategy
1146061|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
1146062|NCT02287467|Antiviral|antiviral
1146063|NCT02287467|IVIG|ivig
1146064|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
1146065|NCT02287467|Antibody|antibody
1146066|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
1146067|NCT02287376|Migraine with and without aura|migraine with and without aura
1146068|NCT02287350|pain|pain
1146069|NCT02287350|moderate pain|moderate pain
1146070|NCT02287350|mild pain|mild pain
1146071|NCT02287350|acute pain|acute pain
1146072|NCT02287350|mild acute pain|mild acute pain
1146073|NCT02287350|moderate acute pain|moderate acute pain
1146074|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
1146075|NCT02287350|NSAID|nsaid
1146076|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
1146077|NCT02287337|Neck pain|neck pain
1146078|NCT02287324|Cervicalgia|cervicalgia
1146079|NCT02287311|EBV positive diseases|ebv positive diseases
1146080|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1146081|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1146082|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
1146083|NCT02287285|Exendin9|exendin9
1146084|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
1146085|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
1146086|NCT02287233|Treatment Naive AML|treatment naive aml
1146087|NCT02287233|Untreated AML|untreated aml
1146088|NCT02287220|Non-Contact Oximetry|non-contact oximetry
1146089|NCT02287220|video plethysmography|video plethysmography
1146090|NCT02287220|oxygen desaturation|oxygen desaturation
1146091|NCT02287168|Peritoneal lavage|peritoneal lavage
1207192|NCT02000622|BRCA|brca
1146092|NCT02287168|Dissemination|dissemination
1146093|NCT02287168|Gastrectomy|gastrectomy
1146094|NCT02287168|Cytology|cytology
1146095|NCT02287168|Lavage|lavage
1146096|NCT02287155|Health Promotion|health promotion
1146097|NCT02287155|Intervention Study|intervention study
1146098|NCT02287155|Occupational Therapy|occupational therapy
1146099|NCT02287155|Rural Population|rural population
1146100|NCT02287155|Quality of life|quality of life
1146101|NCT02287155|Sense of coherence|sense of coherence
1146102|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
1146103|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
1146104|NCT02287129|Functional operability|functional operability
1146105|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
1146106|NCT02287116|preterm infants|preterm infants
1146107|NCT02287116|CPAP|cpap
1146109|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
1146110|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
1146111|NCT02287103|Skipping Breakfast|skipping breakfast
1146112|NCT02287038|PTSD|ptsd
1146113|NCT02287038|ADHD|adhd
1146114|NCT02287038|Comorbidity|comorbidity
1146115|NCT02287038|Combat Trauma|combat trauma
1146116|NCT02287038|Cognitive Deficit|cognitive deficit
1146117|NCT02286986|Epilepsy|epilepsy
1146118|NCT02286986|Dravet syndrome|dravet syndrome
1146119|NCT02286986|Seizures|seizures
1146120|NCT02286986|Intractable Epilepsy|intractable epilepsy
1146121|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
1146122|NCT02286973|Tranexamic acid|tranexamic acid
1146123|NCT02286947|DMD|dmd
1146124|NCT02286947|exon 51|exon 51
1146125|NCT02286947|dystrophin|dystrophin
1146126|NCT02286947|dystrophy|dystrophy
1146127|NCT02286947|eteplirsen|eteplirsen
1146128|NCT02286947|Duchenne|duchenne
1146129|NCT02286934|Carvedilol|carvedilol
1146130|NCT02286934|CYP2D6|cyp2d6
1146131|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
1146132|NCT02286921|Testosterone|testosterone
1146133|NCT02286921|Enzalutamide|enzalutamide
1146134|NCT02286921|Abiraterone|abiraterone
1146135|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
1146136|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
1146137|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
1146138|NCT02286895|rotavirus|rotavirus
1146139|NCT02286895|rotavirus vaccine|rotavirus vaccine
1146140|NCT02286895|Mali|mali
1146141|NCT02286895|EPI vaccines|epi vaccines
1146142|NCT02286882|Single Ascending Dose|single ascending dose
1146143|NCT02286882|healthy subjects|healthy subjects
1146144|NCT02286869|mechanical ventilation|mechanical ventilation
1146145|NCT02286869|autonomic nervous system|autonomic nervous system
1146146|NCT02286869|heart rate variability|heart rate variability
1146147|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
1146148|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
1146149|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
1146150|NCT02286843|PET/CT|pet/ct
1146151|NCT02286843|14-156|14-156
1146152|NCT02286843|89Zr-pertuzumab|89zr-pertuzumab
1146153|NCT02286843|HER2-targeted|her2-targeted
1146154|NCT02286830|osteolysis|osteolysis
1146155|NCT02286830|zoledronic acid|zoledronic acid
1146156|NCT02286830|osteonecrosis|osteonecrosis
1146157|NCT02286830|bone markers|bone markers
1146158|NCT02286830|low-dose CT|low-dose ct
1146159|NCT02286791|Prevention of dementia|prevention of dementia
1146160|NCT02286791|Mindful awareness program|mindful awareness program
1146161|NCT02286791|Mild cognitive impairment|mild cognitive impairment
1146162|NCT02286791|Mindfulness|mindfulness
1146163|NCT02286791|Elderly|elderly
1146164|NCT02286791|Cognitive decline|cognitive decline
1146165|NCT02286765|Ulthera System|ulthera system
1146166|NCT02286765|Ultherapy|ultherapy
1146167|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
1146168|NCT02286739|Rotational Alignment|rotational alignment
1146169|NCT02286739|Intraoperative Sensors|intraoperative sensors
1146170|NCT02286739|Patient Outcomes|patient outcomes
1146171|NCT02286739|Soft Tissue Balance|soft tissue balance
1146172|NCT02286726|Leukemia|leukemia
1146173|NCT02286726|Acute myeloid leukemia|acute myeloid leukemia
1146174|NCT02286726|AML|aml
1146175|NCT02286726|CPX-351|cpx-351
1146176|NCT02286726|Phone call|phone call
1146177|NCT02286713|Lung Cancer Screening|lung cancer screening
1146178|NCT02286713|heavy smokers|heavy smokers
1146179|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
1146180|NCT02286713|patient decision aid|patient decision aid
1146181|NCT02286713|low-dose computed tomography|low-dose computed tomography
1146182|NCT02286713|LDCT|ldct
1146183|NCT02286713|standard educational information|standard educational information
1146184|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
1146185|NCT02286687|Advanced Cancers|advanced cancers
1146186|NCT02286687|Germline mutations|germline mutations
1146187|NCT02286687|Metastatic cancer|metastatic cancer
1146188|NCT02286687|Talazoparib Tosylate|talazoparib tosylate
1146189|NCT02286687|BMN 673|bmn 673
1146190|NCT02286687|Phone call|phone call
1146191|NCT02286674|mYpas|mypas
1146192|NCT02286674|anxiety|anxiety
1146193|NCT02286674|distraction|distraction
1146194|NCT02286674|inhalation induction|inhalation induction
1146195|NCT02286648|clinical signs|clinical signs
1146196|NCT02286648|child|child
1146197|NCT02286648|pulpotomy|pulpotomy
1146198|NCT02286583|RTM|rtm
1146199|NCT02286583|Female breast cancer|female breast cancer
1146200|NCT02286557|Methylphenidate|methylphenidate
1146201|NCT02286557|Multiple Sclerosis|multiple sclerosis
1146202|NCT02286557|Cognitive Fatigue|cognitive fatigue
1146203|NCT02286544|Myocardial Infarction|myocardial infarction
1146204|NCT02286544|Oxygen|oxygen
1146205|NCT02286544|Inflammation|inflammation
1146206|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
1146207|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
1146208|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
1146209|NCT02286544|Biomarkers|biomarkers
1146210|NCT02286544|Normoxemia|normoxemia
1146211|NCT02286544|Salmonella typhi|salmonella typhi
1146212|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
1146213|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
1146214|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
1146215|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
1146216|NCT02286544|Biological Markers|biological markers
1146217|NCT02286531|: Low grade glioma|: low grade glioma
1146218|NCT02286531|PET|pet
1146219|NCT02286531|FET|fet
1146220|NCT02286531|MRI|mri
1146221|NCT02286531|Standardized uptake value|standardized uptake value
1146222|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
1146223|NCT02286453|Benjakul|benjakul
1146224|NCT02286453|Alternative Medicine|alternative medicine
1146225|NCT02286440|Depression|depression
1146226|NCT02286440|Genotyping|genotyping
1146227|NCT02286440|Pharmacokinetic|pharmacokinetic
1146228|NCT02286440|Pharmacodynamic|pharmacodynamic
1146229|NCT02286414|oral anticoagulants|oral anticoagulants
1146230|NCT02286414|Geriatrics|geriatrics
1146231|NCT02286414|General Practitioner|general practitioner
1146232|NCT02286414|Safety|safety
1146233|NCT02286414|Misuse|misuse
1146234|NCT02286401|myocardial perfusion|myocardial perfusion
1146235|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
1146236|NCT02286401|coronary blood flow|coronary blood flow
1146237|NCT02286401|fractional flow reserve|fractional flow reserve
1146238|NCT02286401|coronary flow reserve|coronary flow reserve
1146239|NCT02286388|Deep carious lesion|deep carious lesion
1146240|NCT02286388|incomplete caries removal|incomplete caries removal
1146241|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
1146242|NCT02286388|dental composite resin|dental composite resin
1146243|NCT02286388|pulp vitality preservation|pulp vitality preservation
1146244|NCT02286388|randomized controlled trial|randomized controlled trial
1146245|NCT02286375|health-social partnership|health-social partnership
1146246|NCT02286375|self-efficacy|self-efficacy
1146247|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
1146248|NCT02286336|minimum effective concentration|minimum effective concentration
1146249|NCT02286336|ropivacaine|ropivacaine
1146250|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
1146251|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
1146252|NCT02286310|Exercise|exercise
1146253|NCT02286310|Kinematics|kinematics
1146254|NCT02286297|Intubation|intubation
1146255|NCT02286284|Early severe preeclampsia|early severe preeclampsia
1146256|NCT02286284|Angiogenic factor|angiogenic factor
1146257|NCT02286284|Apheresis|apheresis
1146258|NCT02286271|Seizure detection|seizure detection
1146259|NCT02286258|Inulin|inulin
1146260|NCT02286258|Ca-EDTA|ca-edta
1146261|NCT02286258|Gd-DOTA|gd-dota
1146262|NCT02286258|Chronic kidney disease|chronic kidney disease
1146263|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
1146264|NCT02286245|Triage|triage
1146266|NCT02286245|Primary Health Care|primary health care
1146267|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
1146268|NCT02286232|Chronic low back pain|chronic low back pain
1146269|NCT02286232|stretching exercises|stretching exercises
1146270|NCT02286206|Clozapine|clozapine
1146271|NCT02286206|Psychotropic Drugs|psychotropic drugs
1146272|NCT02286206|Antipsychotic Agents|antipsychotic agents
1146273|NCT02286206|Psychotic Disorders|psychotic disorders
1146274|NCT02286206|Schizophrenia|schizophrenia
1146275|NCT02286206|Adverse Effects|adverse effects
1146276|NCT02286206|Drug Monitoring|drug monitoring
1146277|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
1146278|NCT02286180|NIRS|nirs
1146279|NCT02286180|intern|intern
1146280|NCT02286167|modified-Atkins diet|modified-atkins diet
1146281|NCT02286167|ketogenic diet|ketogenic diet
1146282|NCT02286167|central nervous system malignancy|central nervous system malignancy
1146283|NCT02286167|glioma|glioma
1146284|NCT02286154|Hydroxyurea|hydroxyurea
1146285|NCT02286154|Sickle Cell|sickle cell
1146286|NCT02286154|Pharmacokinetics|pharmacokinetics
1146287|NCT02286154|dynamics|dynamics
1146288|NCT02286154|genomics|genomics
1146289|NCT02286128|Type 2 diabetes|type 2 diabetes
1146290|NCT02286128|RAGE|rage
1146291|NCT02286128|osteoblast|osteoblast
1146292|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
1146293|NCT02286115|Interstitial Cystitis|interstitial cystitis
1146294|NCT02286115|Vulvodynia|vulvodynia
1146295|NCT02286115|Dyspareunia|dyspareunia
1146296|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
1146297|NCT02286115|Emotional Processing|emotional processing
1146298|NCT02286089|dry-AMD|dry-amd
1146299|NCT02286089|Geographic Atrophy|geographic atrophy
1146300|NCT02286076|endometrioma|endometrioma
1146301|NCT02286076|laparoscopy|laparoscopy
1146302|NCT02286076|ovarian reserve|ovarian reserve
1146303|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
1146304|NCT02286037|Method|method
1146305|NCT02286037|Pin-prick|pin-prick
1146306|NCT02286037|Monofilament|monofilament
1146307|NCT02285998|Influenza|influenza
1146308|NCT02285985|Adipose tissue|adipose tissue
1146309|NCT02285985|Inflammation|inflammation
1146310|NCT02285985|.Obesity|.obesity
1146311|NCT02285933|stroke|stroke
1146312|NCT02285933|physical therapy specialty|physical therapy specialty
1146313|NCT02285933|exercise therapy|exercise therapy
1146314|NCT02285933|virtual reality|virtual reality
1146315|NCT02285933|man-machine systems|man-machine systems
1146316|NCT02285933|randomized control trial|randomized control trial
1146317|NCT02285933|inpatients|inpatients
1146318|NCT02285933|rehabilitation|rehabilitation
1146319|NCT02285920|hemodialysis|hemodialysis
1146320|NCT02285920|spironolactone|spironolactone
1146321|NCT02285920|cardiac fibrosis|cardiac fibrosis
1146322|NCT02285920|diastolic function|diastolic function
1146323|NCT02285881|diabetes treatment|diabetes treatment
1146324|NCT02285881|personalized medicine|personalized medicine
1146325|NCT02285881|shared decision making|shared decision making
1146326|NCT02285881|goal setting|goal setting
1146327|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
1146328|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
1146329|NCT02285868|Physical therapy|physical therapy
1146330|NCT02285868|Physical therapy outcomes|physical therapy outcomes
1146331|NCT02285855|Lung Cancer|lung cancer
1146332|NCT02285855|Non small cell lung cancer|non small cell lung cancer
1146333|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
1146334|NCT02285855|SBRT|sbrt
1146335|NCT02285855|XRT|xrt
1146336|NCT02285855|Radiation therapy|radiation therapy
1146337|NCT02285855|Metformin|metformin
1146338|NCT02285855|Metformin ER|metformin er
1146339|NCT02285855|Placebo|placebo
1146340|NCT02285855|Sugar pill|sugar pill
1146341|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
1146342|NCT02285855|Genotypes|genotypes
1146343|NCT02285855|Genetic mutations|genetic mutations
1146344|NCT02285842|osteoarthritis|osteoarthritis
1146345|NCT02285842|avascular necrosis|avascular necrosis
1146346|NCT02285842|ankylosis|ankylosis
1146347|NCT02285842|protrusio acetabuli|protrusio acetabuli
1146348|NCT02285842|painful hip dysplasia|painful hip dysplasia
1146349|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
1146350|NCT02285842|correction of functional deformity|correction of functional deformity
1146351|NCT02285842|revision procedures|revision procedures
1146352|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
1146353|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
1146354|NCT02285751|clopidogrel|clopidogrel
1146355|NCT02285751|prasugrel|prasugrel
1146356|NCT02285751|ticagrelor|ticagrelor
1146357|NCT02285751|critically ill|critically ill
1146358|NCT02285751|pharmacokinetic|pharmacokinetic
1146359|NCT02285751|pharmacodynamics|pharmacodynamics
1146360|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
1146361|NCT02285712|Peripheral venous catheter|peripheral venous catheter
1146362|NCT02285712|ultrasound|ultrasound
1146363|NCT02285712|nurse|nurse
1146364|NCT02285712|Intensive Care Units|intensive care units
1147778|NCT02277873|moon|moon
1146365|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1146366|NCT02285686|troponin|troponin
1146367|NCT02285686|biomarkers|biomarkers
1146368|NCT02285686|myocardial infarction|myocardial infarction
1146369|NCT02285686|critical illness|critical illness
1146370|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
1146371|NCT02285621|Scoliosis|scoliosis
1146372|NCT02285621|Spine deformity|spine deformity
1146373|NCT02285621|Brace|brace
1146374|NCT02285621|3D|3d
1146375|NCT02285608|Medication adherence|medication adherence
1207559|NCT01998958|SYNAPSE|synapse
1146376|NCT02285608|Patient education|patient education
1146377|NCT02285608|Mood disorders|mood disorders
1146378|NCT02285608|Economic assessment|economic assessment
1146379|NCT02285608|Mixed methods|mixed methods
1146380|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
1146381|NCT02285556|community|community
1146382|NCT02285556|DNA|dna
1146383|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
1146384|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
1146385|NCT02285504|Postpartum depression|postpartum depression
1146386|NCT02285465|Healthy volunteers|healthy volunteers
1146387|NCT02285465|Pharmacokinetics|pharmacokinetics
1146388|NCT02285465|Pharmacodynamics|pharmacodynamics
1146389|NCT02285465|ASP3700|asp3700
1146390|NCT02285452|physiologcal phenomena|physiologcal phenomena
1146391|NCT02285452|.HRV Parameters|.hrv parameters
1146392|NCT02285452|respiratory activity|respiratory activity
1146393|NCT02285452|thorax wraps|thorax wraps
1146394|NCT02285439|Pediatric Oncology|pediatric oncology
1146395|NCT02285439|Ras/Raf pathway|ras/raf pathway
1146396|NCT02285439|Low-Grade Glioma|low-grade glioma
1146397|NCT02285439|MEK inhibitor|mek inhibitor
1146398|NCT02285426|i-scan|i-scan
1146399|NCT02285426|histology|histology
1146400|NCT02285413|Melanoma|melanoma
1146401|NCT02285413|Dendritic cells|dendritic cells
1146402|NCT02285413|Cisplatin|cisplatin
1146403|NCT02285413|Vaccine|vaccine
1146404|NCT02285413|Immunotherapy|immunotherapy
1146405|NCT02285400|COPD|copd
1146406|NCT02285400|CPAP|cpap
1146407|NCT02285400|Central Drive|central drive
1146408|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
1146409|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
1146410|NCT02285348|inflammation|inflammation
1146411|NCT02285348|proteomic analysis|proteomic analysis
1146412|NCT02285309|Cardiac Surgery|cardiac surgery
1146413|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
1146414|NCT02285309|Enoximone|enoximone
1146415|NCT02285296|geriatric assessment|geriatric assessment
1146416|NCT02285296|Caregivers|caregivers
1146417|NCT02285296|Needs Assessment|needs assessment
1146418|NCT02285296|oncology nursing|oncology nursing
1146419|NCT02285296|frail elderly|frail elderly
1146420|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
1146421|NCT02285270|Circadian rhythm|circadian rhythm
1146422|NCT02285270|Adipose tissue, brown|adipose tissue, brown
1146423|NCT02285270|Metabolism|metabolism
1146424|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
1146425|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
1146426|NCT02285192|18F-FDG Injection|18f-fdg injection
1146427|NCT02285192|Positron Lymphography|positron lymphography
1146428|NCT02285192|Lymphatic Mapping|lymphatic mapping
1146429|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
1146430|NCT02285192|PET/CT|pet/ct
1146431|NCT02285192|14-222|14-222
1146432|NCT02285179|GDC-0032|gdc-0032
1146433|NCT02285179|Pi3K inhibitor|pi3k inhibitor
1146434|NCT02285179|tamoxifen|tamoxifen
1146435|NCT02285179|hormone receptor positive|hormone receptor positive
1146436|NCT02285179|RECIST|recist
1146437|NCT02285179|pharmacodynamic|pharmacodynamic
1146438|NCT02285166|Pharmaocological therapy|pharmaocological therapy
1146439|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
1146440|NCT02285153|intensive care unit|intensive care unit
1146441|NCT02285153|mortality|mortality
1146442|NCT02285153|Post mortem examination|post mortem examination
1146443|NCT02285153|bleeding|bleeding
1146444|NCT02285114|HIV|hiv
1146445|NCT02285114|emtricitabine|emtricitabine
1146446|NCT02285114|FTC|ftc
1146447|NCT02285114|tenofovir|tenofovir
1146448|NCT02285114|TDF|tdf
1146449|NCT02285114|TAF|taf
1146450|NCT02285114|antiretroviral|antiretroviral
1146451|NCT02285114|pharmacokinetic|pharmacokinetic
1146452|NCT02285114|PK|pk
1146453|NCT02285114|adolescents|adolescents
1146454|NCT02285114|children|children
1146455|NCT02285114|pediatric|pediatric
1146456|NCT02285114|Gilead|gilead
1146457|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
1146458|NCT02285101|PEG-BCT-100|peg-bct-100
1146459|NCT02285101|arginase|arginase
1146460|NCT02285075|temocillin|temocillin
1146461|NCT02285075|PD/PD|pd/pd
1146462|NCT02285075|T>MIC|t>mic
1146463|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
1146464|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
1146562|NCT02284191|Acute Medicine|acute medicine
1146563|NCT02284191|Emergency Medicine|emergency medicine
1146465|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
1146466|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
1146467|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
1146468|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
1146469|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
1146470|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
1146471|NCT02285049|Chronic urticaria|chronic urticaria
1146472|NCT02285049|Urticaria Control Test|urticaria control test
1146473|NCT02285023|Chronic urticaria|chronic urticaria
1146474|NCT02285023|CU-Q2oL|cu-q2ol
1146475|NCT02285010|pregabalin|pregabalin
1146476|NCT02285010|postoperative pain|postoperative pain
1146477|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
1146478|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
1146479|NCT02284984|mabthera|mabthera
1146480|NCT02284984|benlysta|benlysta
1146481|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
1146482|NCT02284958|walking|walking
1146483|NCT02284958|pedometer|pedometer
1146484|NCT02284932|COPD|copd
1146485|NCT02284932|atrophy|atrophy
1146486|NCT02284932|muscle|muscle
1146487|NCT02284906|Drug therapy|drug therapy
1146488|NCT02284867|uterine natural killer cells|uterine natural killer cells
1146489|NCT02284867|CD16|cd16
1146490|NCT02284867|CD56|cd56
1146491|NCT02284867|Preterm labour|preterm labour
1146492|NCT02284815|Gluten|gluten
1146494|NCT02284815|Remission|remission
1146495|NCT02284789|Hemophilia|hemophilia
1146496|NCT02284776|Therapeutic education|therapeutic education
1146497|NCT02284750|Bifurcation lesion|bifurcation lesion
1146498|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
1146499|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
1146500|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
1146501|NCT02284685|Mental Health Services|mental health services
1146502|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
1146503|NCT02284646|Physical training program|physical training program
1146504|NCT02284633|EGFR mutation|egfr mutation
1146505|NCT02284633|Liquid biopsies|liquid biopsies
1146506|NCT02284633|Lung cancer|lung cancer
1146507|NCT02284633|erlotinib|erlotinib
1146508|NCT02284620|anesthesia|anesthesia
1146509|NCT02284620|nerve block|nerve block
1146510|NCT02284620|infltration|infltration
1146512|NCT02284581|metastatic|metastatic
1146513|NCT02284581|breast|breast
1146514|NCT02284581|observational|observational
1146515|NCT02284581|disease management|disease management
1146516|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
1146517|NCT02284503|MI reduction|mi reduction
1146518|NCT02284503|intensive statin treatment|intensive statin treatment
1146519|NCT02284503|NSTE-ACS|nste-acs
1146520|NCT02284490|Brain Metastases|brain metastases
1146521|NCT02284477|Insulin resistance|insulin resistance
1146522|NCT02284477|Pulmonary function|pulmonary function
1146523|NCT02284477|Phthalates|phthalates
1146524|NCT02284464|Kidney transplant|kidney transplant
1146525|NCT02284464|Immunosuppression|immunosuppression
1146526|NCT02284464|Steroid withdrawal|steroid withdrawal
1146527|NCT02284464|Donor specific antibodies|donor specific antibodies
1146528|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
1146529|NCT02284438|ETT|ett
1146530|NCT02284438|Biofilm|biofilm
1146531|NCT02284438|Mechanical ventilation|mechanical ventilation
1146532|NCT02284438|Critical illness|critical illness
1146533|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
1146534|NCT02284412|Neostigmine|neostigmine
1146535|NCT02284412|Sugammadex|sugammadex
1146536|NCT02284399|aneuploidy|aneuploidy
1146537|NCT02284399|Trisomy 21|trisomy 21
1146538|NCT02284399|NIPT|nipt
1146539|NCT02284386|Total knee arthroplasty|total knee arthroplasty
1146540|NCT02284360|wound healing|wound healing
1146541|NCT02284360|APOSEC™|aposec™
1146542|NCT02284360|Safety|safety
1146543|NCT02284334|mitochondrial diseases|mitochondrial diseases
1146544|NCT02284334|nutrition|nutrition
1146545|NCT02284334|glycemic index|glycemic index
1146546|NCT02284308|NSCLC|nsclc
1146547|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1146548|NCT02284295|silica dust|silica dust
1146549|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
1146550|NCT02284295|genetic|genetic
1146551|NCT02284295|occupational|occupational
1146552|NCT02284282|Spinal Morphine|spinal morphine
1146553|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
1146554|NCT02284282|Post-operative pain|post-operative pain
1146555|NCT02284243|Bunion|bunion
1146556|NCT02284243|Bunionectomy|bunionectomy
1146557|NCT02284243|Pain|pain
1146558|NCT02284243|Analgesia|analgesia
1146559|NCT02284243|dexmedetomidine|dexmedetomidine
1146560|NCT02284243|intranasal|intranasal
1146561|NCT02284191|Radiology|radiology
1146565|NCT02284178|mechanical ventilation|mechanical ventilation
1146566|NCT02284178|aspiration|aspiration
1146567|NCT02284178|suctioning|suctioning
1146568|NCT02284178|secretions|secretions
1146569|NCT02284178|ventilator-associated events|ventilator-associated events
1146570|NCT02284152|bottle feeding|bottle feeding
1146571|NCT02284152|feeding behavior|feeding behavior
1146572|NCT02284152|infants|infants
1146573|NCT02284152|mothers|mothers
1146574|NCT02284152|responsive feeding|responsive feeding
1146575|NCT02284152|maternal feeding practices|maternal feeding practices
1146576|NCT02284152|maternal feeding styles|maternal feeding styles
1146577|NCT02284139|EGF ointment|egf ointment
1146578|NCT02284139|EGFR inhibitor|egfr inhibitor
1146579|NCT02284139|Skin side effect|skin side effect
1146580|NCT02284126|Vancomycin|vancomycin
1146581|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
1146582|NCT02284126|Craniotomy|craniotomy
1146583|NCT02284126|surgical site infection|surgical site infection
1146584|NCT02284126|wound prophylaxis|wound prophylaxis
1146585|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
1146586|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
1146587|NCT02284126|Administration, Topical|administration, topical
1146588|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
1146589|NCT02284126|antibiotics|antibiotics
1146590|NCT02284126|prophylaxis|prophylaxis
1146591|NCT02284126|neurosurgery|neurosurgery
1146592|NCT02284126|Bacterial Infections|bacterial infections
1146593|NCT02284126|Central Nervous System Infections|central nervous system infections
1146594|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
1146595|NCT02284087|movement disorders|movement disorders
1146596|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
1146597|NCT02284074|Biomarkers|biomarkers
1146598|NCT02284074|Chemokines|chemokines
1146599|NCT02284074|Cytokines|cytokines
1146600|NCT02284074|Gene Expression|gene expression
1146601|NCT02284074|Nasal Challenge|nasal challenge
1146602|NCT02284074|Inflammation|inflammation
1146603|NCT02284074|Nasal|nasal
1146604|NCT02284074|Nasosorption|nasosorption
1146605|NCT02284074|Respiratory|respiratory
1146606|NCT02284048|Ticagrelor|ticagrelor
1146607|NCT02284048|Coronary Flow Reserve|coronary flow reserve
1146608|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
1146609|NCT02284009|Albiglutide|albiglutide
1146610|NCT02283996|Adhesive Capsulitis|adhesive capsulitis
1146611|NCT02283996|Frozen Shoulder|frozen shoulder
1146612|NCT02283996|Shoulder Frozen|shoulder frozen
1146613|NCT02283996|Physical Therapy|physical therapy
1146614|NCT02283996|Corticosteroid Injections|corticosteroid injections
1146615|NCT02283996|Hydrodilation, Hydro-dilation|hydrodilation, hydro-dilation
1146616|NCT02283996|Watchful Waiting|watchful waiting
1146617|NCT02283996|Prospective|prospective
1146618|NCT02283996|Glenohumeral Ligament|glenohumeral ligament
1146619|NCT02283905|amphotericin-B|amphotericin-b
1146620|NCT02283905|continuously infused|continuously infused
1146621|NCT02283905|voriconazole|voriconazole
1146622|NCT02283892|respiratory complaints|respiratory complaints
1146623|NCT02283892|dyspnea|dyspnea
1146624|NCT02283892|cough|cough
1146625|NCT02283892|checklist|checklist
1146626|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
1146627|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
1146628|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
1146629|NCT02283853|Pediatrics|pediatrics
1146630|NCT02283749|NCSLC|ncslc
1146631|NCT02283749|lung cancer|lung cancer
1146632|NCT02283749|non small cell lung cancer|non small cell lung cancer
1146633|NCT02283749|bone metastases|bone metastases
1146634|NCT02283749|maintenance|maintenance
1146635|NCT02283736|Chronic periodontitis|chronic periodontitis
1146636|NCT02283736|Probiotics|probiotics
1146637|NCT02283736|Non- surgical treatment|non- surgical treatment
1146638|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
1146639|NCT02283710|Pentoxifylline|pentoxifylline
1146640|NCT02283710|Aminotransferase|aminotransferase
1146641|NCT02283710|Steatohepatitis|steatohepatitis
1146642|NCT02283697|hypertension|hypertension
1146643|NCT02283697|high blood pressure|high blood pressure
1146644|NCT02283697|sodium|sodium
1146645|NCT02283697|prevention|prevention
1146646|NCT02283697|dietary sodium|dietary sodium
1146647|NCT02283697|salt|salt
1146648|NCT02283684|LASER|laser
1146649|NCT02283684|PROSTATE|prostate
1146650|NCT02283684|BIPOLAR|bipolar
1146651|NCT02283684|HYPERPLASIA|hyperplasia
1146652|NCT02283684|VAPORIZATION|vaporization
1146653|NCT02283580|COPD|copd
1146654|NCT02283580|Healthy adults|healthy adults
1146655|NCT02283580|Resistance training|resistance training
1146656|NCT02283580|Elastic bands|elastic bands
1146657|NCT02283580|Limb muscle function|limb muscle function
1146658|NCT02283580|Volunteers|volunteers
1146659|NCT02283554|Periodontal Surgery|periodontal surgery
1146660|NCT02283554|Periodontal Regeneration|periodontal regeneration
1146661|NCT02283554|Growth factors|growth factors
1146662|NCT02283554|Clinical trials|clinical trials
1146663|NCT02283541|Gait|gait
1146664|NCT02283541|late life depression|late life depression
1146665|NCT02283541|mind-body therapies|mind-body therapies
1146666|NCT02283515|chronic periodontitis|chronic periodontitis
1146667|NCT02283515|local drug delivery|local drug delivery
1146668|NCT02283515|rosuvastatin|rosuvastatin
1146669|NCT02283515|osseo-differentiation|osseo-differentiation
1146670|NCT02283502|Uterine fibroid|uterine fibroid
1146671|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
1207936|NCT01997372|ATG|atg
1146672|NCT02283502|ultrasound|ultrasound
1146673|NCT02283502|non-invasive therapy|non-invasive therapy
1146674|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
1146675|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
1146676|NCT02283489|clinical trial|clinical trial
1146677|NCT02283489|randomized|randomized
1146678|NCT02283489|Endostatin|endostatin
1146679|NCT02283489|gene therapy|gene therapy
1146680|NCT02283476|efficacy and safety|efficacy and safety
1146681|NCT02283437|Bibliotherapy|bibliotherapy
1146682|NCT02283437|Problem-solving|problem-solving
1146683|NCT02283437|Randomized Controlled Trial|randomized controlled trial
1146684|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
1146685|NCT02283437|Family Caregivers|family caregivers
1146686|NCT02283385|Elder abuse|elder abuse
1146687|NCT02283385|Intervention|intervention
1146688|NCT02283385|Treatment|treatment
1146689|NCT02283385|Detection|detection
1146690|NCT02283359|Distal Esophagus|distal esophagus
1146691|NCT02283359|Esophageal|esophageal
1146692|NCT02283359|Gastric|gastric
1146693|NCT02283359|Carcinoma|carcinoma
1146694|NCT02283359|Adenocarcinoma|adenocarcinoma
1146695|NCT02283359|Stomach|stomach
1146696|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
1146697|NCT02283359|Recurrent|recurrent
1146698|NCT02283359|Metastatic|metastatic
1146699|NCT02283359|Unresectable|unresectable
1146700|NCT02283346|Prostate Cancer|prostate cancer
1146701|NCT02283346|HDR brachytherapy|hdr brachytherapy
1146702|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
1146703|NCT02283346|toxicity|toxicity
1146704|NCT02283346|biochemical control|biochemical control
1146705|NCT02283333|Behavioral Activation|behavioral activation
1146706|NCT02283333|Therapeutic Exposure|therapeutic exposure
1146707|NCT02283333|Mental Health|mental health
1146708|NCT02283333|Veterans|veterans
1146709|NCT02283333|Complicated Grief|complicated grief
1146710|NCT02283333|Military|military
1146711|NCT02283333|Treatment|treatment
1146712|NCT02283333|Cognitive Therapy|cognitive therapy
1146713|NCT02283333|Bereavement|bereavement
1146714|NCT02283333|Complicated Bereavement|complicated bereavement
1146715|NCT02283255|Fontan|fontan
1146716|NCT02283255|Exercise|exercise
1146717|NCT02283255|Pulmonary Function|pulmonary function
1146718|NCT02283255|Aerobic Capacity|aerobic capacity
1146719|NCT02283255|Skeletal Muscle|skeletal muscle
1146720|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
1146721|NCT02283242|Inflammation|inflammation
1146722|NCT02283242|Oxidative Stress|oxidative stress
1146723|NCT02283229|Plagiocephaly|plagiocephaly
1146724|NCT02283229|torticollis|torticollis
1146725|NCT02283229|occlusal defect|occlusal defect
1146726|NCT02283216|neuromodulation|neuromodulation
1146727|NCT02283216|noninvasive|noninvasive
1146728|NCT02283216|plasticity|plasticity
1146729|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
1146730|NCT02283216|hearing|hearing
1146731|NCT02283216|hyperacusis|hyperacusis
1146732|NCT02283203|Paracetamol|paracetamol
1146733|NCT02283203|Management of fever|management of fever
1146734|NCT02283203|Infections|infections
1146735|NCT02283190|Asparaginase|asparaginase
1146736|NCT02283190|Glutamine|glutamine
1146737|NCT02283164|Occupational health|occupational health
1146738|NCT02283164|Hazardous material handling|hazardous material handling
1146739|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
1146740|NCT02283151|Overweight/obese|overweight/obese
1146741|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
1146742|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
1146743|NCT02283086|Quality Improvement|quality improvement
1146744|NCT02283086|Physician Feedback|physician feedback
1146745|NCT02283073|Diagnosis|diagnosis
1146746|NCT02283060|Atripla|atripla
1146747|NCT02283060|Stribild|stribild
1146748|NCT02283060|HIV|hiv
1146749|NCT02283060|Sleep architecture|sleep architecture
1146750|NCT02283060|Neuropsychological performance|neuropsychological performance
1146751|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
1146752|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
1146753|NCT02282995|Functional dyspepsia|functional dyspepsia
1146754|NCT02282995|symptom response|symptom response
1146755|NCT02282982|Immunoprophylaxis|immunoprophylaxis
1146756|NCT02282982|Palivizumab|palivizumab
1146757|NCT02282969|Cancer Prevention|cancer prevention
1146758|NCT02282969|Smokers|smokers
1146759|NCT02282969|Quit smoking|quit smoking
1146760|NCT02282969|Interviews|interviews
1146761|NCT02282969|Questionnaires|questionnaires
1146762|NCT02282969|Surveys|surveys
1146763|NCT02282969|Lung cancer screening|lung cancer screening
1146764|NCT02282969|Patient decision aid|patient decision aid
1146765|NCT02282943|endometriosis|endometriosis
1146766|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
1146767|NCT02282943|Harmonic scalpel|harmonic scalpel
1146768|NCT02282943|AFS stage I-III|afs stage i-iii
1146769|NCT02282930|ACTH|acth
1146770|NCT02282930|Acthar|acthar
1146771|NCT02282930|IgA|iga
1146772|NCT02282930|Progressive|progressive
1146773|NCT02282930|Nephropathy|nephropathy
1146774|NCT02282930|renal function|renal function
1146775|NCT02282917|NF2|nf2
1146776|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
1146777|NCT02282917|Schwannoma|schwannoma
1146778|NCT02282917|Meningioma|meningioma
1146779|NCT02282904|Bone Marrow Transplant|bone marrow transplant
1146780|NCT02282904|Subablative Conditioning|subablative conditioning
1146781|NCT02282904|Graft Versus Host Disease|graft versus host disease
1146782|NCT02282904|Non-Myeloablative|non-myeloablative
1146783|NCT02282904|Reduced Intensity|reduced intensity
1146784|NCT02282891|propofol|propofol
1146785|NCT02282891|ketofol|ketofol
1146786|NCT02282878|High Sodium Diet|high sodium diet
1146787|NCT02282878|Low Sodium Diet|low sodium diet
1146788|NCT02282878|MS|ms
1146789|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
1146790|NCT02282839|Head and neck cancer|head and neck cancer
1146791|NCT02282839|Glutamine|glutamine
1146792|NCT02282839|Oral mucositis|oral mucositis
1146793|NCT02282839|Quality of life|quality of life
1146794|NCT02282813|Parathyroid Diseases|parathyroid diseases
1146795|NCT02282813|Renal Insufficiency|renal insufficiency
1146796|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
1146797|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1146798|NCT02282813|Vitamin D|vitamin d
1146799|NCT02282813|Hyperparathyroidism|hyperparathyroidism
1146800|NCT02282813|Kidney Diseases|kidney diseases
1146801|NCT02282813|Kidney Failure|kidney failure
1146802|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
1146803|NCT02282787|local anesthesia|local anesthesia
1146804|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
1146805|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
1146806|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
1146807|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
1146808|NCT02282735|neuroblastoma|neuroblastoma
1146809|NCT02282735|end-of-life|end-of-life
1146810|NCT02282735|decision-making|decision-making
1146811|NCT02282735|parent|parent
1146812|NCT02282735|child|child
1146813|NCT02282735|prognosis|prognosis
1146814|NCT02282735|preferences|preferences
1146815|NCT02282735|childhood cancer|childhood cancer
1146816|NCT02282735|oncology|oncology
1146817|NCT02282722|cancer|cancer
1146818|NCT02282722|palliative|palliative
1146819|NCT02282722|chemotherapy|chemotherapy
1146820|NCT02282722|metastatic|metastatic
1146821|NCT02282722|colorectal|colorectal
1146822|NCT02282722|communication|communication
1146823|NCT02282722|informed consent|informed consent
1146824|NCT02282722|video|video
1146825|NCT02282722|education|education
1146826|NCT02282722|oncology|oncology
1146827|NCT02282722|patient-centered|patient-centered
1146828|NCT02282722|outcomes research|outcomes research
1146829|NCT02282709|Immunity|immunity
1146830|NCT02282657|extracorporreal|extracorporreal
1146831|NCT02282657|CO2 removal|co2 removal
1146832|NCT02282657|ARDS|ards
1146833|NCT02282657|lung|lung
1146834|NCT02282657|Protective ventilation|protective ventilation
1146835|NCT02282631|active school travel|active school travel
1146836|NCT02282631|active travel|active travel
1146837|NCT02282631|incentive scheme|incentive scheme
1146838|NCT02282631|children|children
1146839|NCT02282631|school|school
1146840|NCT02282631|behaviour change|behaviour change
1146841|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
1146842|NCT02282592|Metabolic syndrome|metabolic syndrome
1146843|NCT02282592|case-control study|case-control study
1146844|NCT02282592|Breast cancer|breast cancer
1146845|NCT02282566|Muscle protein synthesis|muscle protein synthesis
1146846|NCT02282514|Autoimmune Diseases|autoimmune diseases
1146847|NCT02282514|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
1146848|NCT02282501|leptin levels|leptin levels
1146849|NCT02282501|ghrelin levels|ghrelin levels
1146850|NCT02282462|Chest tube|chest tube
1146851|NCT02282449|Venous access device|venous access device
1146852|NCT02282449|Port catheters|port catheters
1146853|NCT02282449|Chemotherapy|chemotherapy
1146854|NCT02282410|severe hemophilia A|severe hemophilia a
1146855|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
1146856|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
1146857|NCT02282410|standard prophylaxis|standard prophylaxis
1146858|NCT02282397|Diabetes Mellitus|diabetes mellitus
1146859|NCT02282371|Cetuximab|cetuximab
1146860|NCT02282371|BYL719|byl719
1146861|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
1146862|NCT02282371|14-116|14-116
1146863|NCT02282358|Mocetinostat|mocetinostat
1146864|NCT02282358|14-106|14-106
1146865|NCT02282345|Breast cancer|breast cancer
1146866|NCT02282345|BRCA deleterious mutation|brca deleterious mutation
1146868|NCT02282345|BMN 673|bmn 673
1146869|NCT02282345|Talazoparib tosylate|talazoparib tosylate
1569106|NCT00503854|Questionnaire|questionnaire
1146870|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
1146871|NCT02282293|Chemoprevention|chemoprevention
1146872|NCT02282293|Malaria|malaria
1146873|NCT02282293|Uganda|uganda
1146997|NCT02281682|cost-effectiveness|cost-effectiveness
1146874|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1146875|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1146876|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
1146877|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
1146878|NCT02282267|Droplet digital PCR|droplet digital pcr
1146879|NCT02282254|Type 1 diabetes|type 1 diabetes
1146880|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
1146881|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
1146882|NCT02282254|Closed-loop strategy|closed-loop strategy
1146883|NCT02282254|Artificial pancreas|artificial pancreas
1146884|NCT02282254|Glucagon|glucagon
1146885|NCT02282254|Hypoglycemia|hypoglycemia
1146886|NCT02282254|Insulin|insulin
1146887|NCT02282241|Melatonin|melatonin
1146888|NCT02282241|Sleep|sleep
1146889|NCT02282241|Delirium|delirium
1146890|NCT02282215|Fever|fever
1146891|NCT02282215|Induction chemotherapy|induction chemotherapy
1146892|NCT02282215|Infection|infection
1146893|NCT02282215|Leukemia|leukemia
1146894|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
1146895|NCT02282215|Neutropenia|neutropenia
1146896|NCT02282202|Sputum|sputum
1146897|NCT02282202|Bronchiectasis|bronchiectasis
1146898|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1146899|NCT02282202|Airway clearance therapy|airway clearance therapy
1146900|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
1146901|NCT02282189|Sputum|sputum
1146902|NCT02282189|Airway clearance therapy|airway clearance therapy
1146903|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
1146904|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1146905|NCT02282176|Neonates|neonates
1146906|NCT02282176|Preterm|preterm
1146907|NCT02282176|Azithromycin|azithromycin
1146908|NCT02282176|Ureaplasma|ureaplasma
1146909|NCT02282176|Chronic Lung disease|chronic lung disease
1146910|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1146911|NCT02282150|Fatigue|fatigue
1146912|NCT02282150|Quality of Life|quality of life
1146913|NCT02282150|Hydrocortisone|hydrocortisone
1146914|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
1146915|NCT02282124|weight|weight
1146916|NCT02282124|self-management|self-management
1146917|NCT02282124|exercise|exercise
1146918|NCT02282098|Atrial fibrillation|atrial fibrillation
1146919|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
1146920|NCT02282098|Stroke|stroke
1146921|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
1146922|NCT02282098|D-dimer|d-dimer
1146923|NCT02282098|C-reactive protein|c-reactive protein
1146924|NCT02282085|Medication Non-Adherence|medication non-adherence
1146925|NCT02282085|Antipsychotic|antipsychotic
1146926|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
1146927|NCT02282046|dental implant|dental implant
1146929|NCT02282007|Quality of life|quality of life
1146930|NCT02281994|PEMF|pemf
1146931|NCT02281994|odontoid fracture|odontoid fracture
1146932|NCT02281994|IDE|ide
1146933|NCT02281994|prospective|prospective
1146934|NCT02281955|Human Papillomavirus|human papillomavirus
1146935|NCT02281955|Oropharynx|oropharynx
1146936|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
1146937|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
1146938|NCT02281955|Radiation Therapy|radiation therapy
1146939|NCT02281955|Chemotherapy|chemotherapy
1146940|NCT02281955|p16|p16
1146941|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
1146942|NCT02281929|corticotherapy|corticotherapy
1146943|NCT02281929|antibiotherapy|antibiotherapy
1146944|NCT02281929|survival|survival
1146945|NCT02281929|infection|infection
1146946|NCT02281929|hepato renal syndrome|hepato renal syndrome
1146947|NCT02281916|Crohn disease|crohn disease
1146948|NCT02281916|Immunotherapy|immunotherapy
1146949|NCT02281916|Helminth antigen|helminth antigen
1146950|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
1146951|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1146952|NCT02281877|Gene Expression|gene expression
1146953|NCT02281851|Endogenous antioxidants|endogenous antioxidants
1146954|NCT02281851|Antioxidant supplements|antioxidant supplements
1146955|NCT02281851|Vitamin Supplements|vitamin supplements
1146956|NCT02281851|Exercise adaptations|exercise adaptations
1146957|NCT02281851|Oxidative stress|oxidative stress
1146958|NCT02281851|Redox regulation|redox regulation
1146959|NCT02281851|Cycling - exercise|cycling - exercise
1146960|NCT02281838|Stroke|stroke
1146961|NCT02281838|Hypertension|hypertension
1147060|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
1146962|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
1146963|NCT02281825|Anxiety|anxiety
1146964|NCT02281825|Impulsivity|impulsivity
1146965|NCT02281825|Computer Games|computer games
1146966|NCT02281825|Depression|depression
1146967|NCT02281812|Ablation Technique|ablation technique
1146968|NCT02281812|Breast cancer|breast cancer
1146969|NCT02281812|Stage 1|stage 1
1146970|NCT02281812|Lumpectomy|lumpectomy
1146971|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
1146972|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
1146973|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
1146974|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
1146975|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
1146976|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
1146977|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1146978|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
1146979|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
1146980|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1146981|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
1146982|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
1146983|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
1146984|NCT02281760|Histiocytosis|histiocytosis
1146985|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
1146986|NCT02281760|BRAF Inhibitor|braf inhibitor
1146987|NCT02281747|Biologic Therapy|biologic therapy
1146988|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
1146989|NCT02281747|Arthroplasty|arthroplasty
1146990|NCT02281708|normogram|normogram
1146991|NCT02281708|recurrence|recurrence
1146992|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
1146993|NCT02281708|disease free survival|disease free survival
1146994|NCT02281708|Quality of life|quality of life
1146995|NCT02281682|Keratosis, Actinic|keratosis, actinic
1146996|NCT02281682|Treatment Outcome|treatment outcome
1146998|NCT02281682|economic evaluation|economic evaluation
1146999|NCT02281682|imiquimod|imiquimod
1147000|NCT02281682|photodynamic therapy|photodynamic therapy
1147001|NCT02281682|topical fluorouracil|topical fluorouracil
1147002|NCT02281682|ingenol mebutate|ingenol mebutate
1147003|NCT02281643|Coinfection|coinfection
1147004|NCT02281643|Buruli ulcer|buruli ulcer
1147005|NCT02281643|Tuberculosis|tuberculosis
1147006|NCT02281643|Mansonella perstans|mansonella perstans
1147007|NCT02281630|Chronic Constipation|chronic constipation
1147008|NCT02281630|CC|cc
1147009|NCT02281578|Sex Workers|sex workers
1147010|NCT02281578|Prevention|prevention
1147011|NCT02281565|attitudes|attitudes
1147012|NCT02281565|blood donation|blood donation
1147013|NCT02281565|blood shortage|blood shortage
1147014|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
1147015|NCT02281539|Phantom Limb Pain|phantom limb pain
1147016|NCT02281539|Augmented Reality|augmented reality
1147017|NCT02281539|Myoelectric control|myoelectric control
1147018|NCT02281539|Virtual reality|virtual reality
1147019|NCT02281539|electromyography|electromyography
1147020|NCT02281539|pattern recognition|pattern recognition
1147021|NCT02281539|neurorehabilitation|neurorehabilitation
1147022|NCT02281513|Nutrition|nutrition
1147023|NCT02281487|tubal carcinoma|tubal carcinoma
1147024|NCT02281487|ovarian carcinoma|ovarian carcinoma
1147025|NCT02281487|tubectomy|tubectomy
1147026|NCT02281487|hysterectomy|hysterectomy
1147027|NCT02281487|dysplastic changes|dysplastic changes
1147028|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
1147029|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
1147030|NCT02281487|Salpingectomy|salpingectomy
1147031|NCT02281461|PrePex|prepex
1147032|NCT02281461|Infants|infants
1147033|NCT02281461|Early infants|early infants
1147034|NCT02281461|Children|children
1147035|NCT02281461|Circumcision|circumcision
1147036|NCT02281461|HIV|hiv
1147037|NCT02281461|AIDS|aids
1147038|NCT02281461|Non surgical|non surgical
1147039|NCT02281435|Male Circumcision|male circumcision
1147040|NCT02281435|HIV Prevention|hiv prevention
1147041|NCT02281435|Screen Failure Subjects|screen failure subjects
1147042|NCT02281435|PrePex with Incision|prepex with incision
1147043|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
1147044|NCT02281409|14-135|14-135
1147045|NCT02281396|safety|safety
1147046|NCT02281396|rabies vaccine|rabies vaccine
1147047|NCT02281396|MRC-5 cell|mrc-5 cell
1147048|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
1147049|NCT02281383|14-174|14-174
1147050|NCT02281370|cyclosporine|cyclosporine
1147051|NCT02281370|drug-drug interaction|drug-drug interaction
1147052|NCT02281370|pharmacokinetics|pharmacokinetics
1147053|NCT02281370|eltrombopag|eltrombopag
1147054|NCT02281370|SB-497115|sb-497115
1147055|NCT02281357|Asthma|asthma
1147056|NCT02281357|Reactive Airways|reactive airways
1147057|NCT02281357|Repiratory Tract Disease|repiratory tract disease
1147058|NCT02281357|Obstructive Lung Disease|obstructive lung disease
1147059|NCT02281357|Lung Diseases|lung diseases
1147160|NCT02280772|overweight|overweight
1147061|NCT02281318|Asthma control|asthma control
1147062|NCT02281318|Lung function|lung function
1147063|NCT02281318|Health-related quality of life|health-related quality of life
1147064|NCT02281318|Mepolizumab|mepolizumab
1147065|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
1147066|NCT02281292|Diabetic Macular Edema|diabetic macular edema
1147067|NCT02281292|Intravitreal|intravitreal
1147069|NCT02281292|Ophthalmology|ophthalmology
1147070|NCT02281292|Lucentis|lucentis
1147071|NCT02281292|OCT|oct
1147072|NCT02281253|L-carnitine|l-carnitine
1147073|NCT02281253|fibre|fibre
1147074|NCT02281253|bakery product|bakery product
1147075|NCT02281253|insulin resistance|insulin resistance
1147076|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1147077|NCT02281214|lung cancer, mutations|lung cancer, mutations
1147078|NCT02281214|patients|patients
1147079|NCT02281214|mutations|mutations
1147080|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
1147081|NCT02281175|PASSE-65+ program|passe-65+ program
1147082|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
1147083|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
1147084|NCT02281175|Older adults|older adults
1147085|NCT02281149|breast cancer|breast cancer
1147086|NCT02281149|radiotherapy|radiotherapy
1147087|NCT02281149|intensity modulation|intensity modulation
1147088|NCT02281149|toxicity|toxicity
1147089|NCT02281136|Actinic keratosis|actinic keratosis
1147090|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
1147091|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
1147092|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
1147093|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
1147094|NCT02281110|Fractional flow reserve|fractional flow reserve
1147095|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
1147096|NCT02281097|POTS|pots
1147097|NCT02281097|Vagal Stimulation|vagal stimulation
1147098|NCT02281084|Keywords provided by Celgene:|keywords provided by celgene:
1147099|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
1147100|NCT02281084|MDS|mds
1147101|NCT02281084|azacitidine|azacitidine
1147102|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
1147103|NCT02281084|decitabine|decitabine
1147104|NCT02281084|intermediate-1|intermediate-1
1147105|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
1147106|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
1147107|NCT02281084|Chronic|chronic
1147108|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
1147109|NCT02281084|PD-L1|pd-l1
1147110|NCT02281032|Palliative Care|palliative care
1147111|NCT02281032|Nursing Homes|nursing homes
1147112|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
1147113|NCT02281032|Older adults|older adults
1147114|NCT02280980|Stroke|stroke
1147115|NCT02280980|Postural Balance|postural balance
1147116|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
1147117|NCT02280980|Rehabilitation|rehabilitation
1147118|NCT02280980|Physical therapy|physical therapy
1147119|NCT02280980|Outpatient|outpatient
1147120|NCT02280967|Adolescent|adolescent
1147121|NCT02280967|Attitude|attitude
1147122|NCT02280967|Condom|condom
1147123|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
1147124|NCT02280967|Primary prevention|primary prevention
1147125|NCT02280967|School Health|school health
1147126|NCT02280954|Solid Tumor|solid tumor
1147127|NCT02280915|female|female
1147128|NCT02280915|subjects|subjects
1147129|NCT02280902|auto-immune diseases|auto-immune diseases
1147130|NCT02280902|inflammatory diseases|inflammatory diseases
1147131|NCT02280902|risk factors|risk factors
1147132|NCT02280902|infections|infections
1147133|NCT02280902|cohort study|cohort study
1147134|NCT02280889|quality of life|quality of life
1147135|NCT02280889|nevus or scar|nevus or scar
1147136|NCT02280889|stigmatization|stigmatization
1147137|NCT02280889|scar|scar
1147138|NCT02280876|MS|ms
1147139|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
1147140|NCT02280876|CNS|cns
1147141|NCT02280876|Nervous System Diseases|nervous system diseases
1147142|NCT02280850|Angina|angina
1147143|NCT02280837|GLP-1|glp-1
1147144|NCT02280824|Transcaval|transcaval
1147145|NCT02280824|TAVR|tavr
1147146|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
1147147|NCT02280811|HPV positive|hpv positive
1147148|NCT02280811|Metastatic|metastatic
1147149|NCT02280811|Diet|diet
1147150|NCT02280811|Screening|screening
1147151|NCT02280811|Risk Factors|risk factors
1147152|NCT02280811|Colorectal adenoma|colorectal adenoma
1147153|NCT02280811|Refractory|refractory
1147154|NCT02280811|Immunotherapy|immunotherapy
1147155|NCT02280811|Reproductive Cancers|reproductive cancers
1147156|NCT02280798|ERA|era
1147157|NCT02280772|glucomannan|glucomannan
1147158|NCT02280772|obesity|obesity
1147159|NCT02280772|children|children
1147163|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
1147164|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
1147165|NCT02280733|Quality Measures|quality measures
1147166|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
1147167|NCT02280733|Electronic Health Records|electronic health records
1147168|NCT02280733|Clinical Data Research Network|clinical data research network
1147169|NCT02280733|Real world data|real world data
1147170|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
1147171|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
1147172|NCT02280720|optical coherence tomography|optical coherence tomography
1147173|NCT02280720|strut coverage|strut coverage
1147174|NCT02280681|reproductive medicine|reproductive medicine
1147175|NCT02280681|artificial gametes|artificial gametes
1147176|NCT02280681|patient preference|patient preference
1147177|NCT02280681|decision making|decision making
1147178|NCT02280668|muscle|muscle
1147179|NCT02280668|muscle repair|muscle repair
1147180|NCT02280668|tissue repair|tissue repair
1147181|NCT02280668|eccentric exercise|eccentric exercise
1147182|NCT02280668|force loss|force loss
1147183|NCT02280668|icing|icing
1147184|NCT02280668|cold therapy|cold therapy
1147185|NCT02280668|DOMS|doms
1147186|NCT02280668|soreness|soreness
1147187|NCT02280668|recovery|recovery
1147188|NCT02280655|Blood Transfusions|blood transfusions
1147189|NCT02280642|Human papillomavirus|human papillomavirus
1147190|NCT02280642|Cervical cancer|cervical cancer
1147191|NCT02280642|Genital warts|genital warts
1147192|NCT02280642|Vaccine|vaccine
1147193|NCT02280642|Immunogenicity|immunogenicity
1147194|NCT02280564|motivational interviewing|motivational interviewing
1147195|NCT02280564|problem solving skills|problem solving skills
1147196|NCT02280564|family communication|family communication
1147197|NCT02280564|technology support|technology support
1147198|NCT02280564|cell phone system|cell phone system
1147199|NCT02280551|adolescent|adolescent
1147200|NCT02280551|alcohol|alcohol
1147201|NCT02280551|parent|parent
1147202|NCT02280551|epidemiology|epidemiology
1147203|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
1147204|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
1147205|NCT02280538|disease modifying|disease modifying
1147206|NCT02280525|Leukemia|leukemia
1147207|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1147209|NCT02280525|Natural Killer Cells|natural killer cells
1147210|NCT02280525|NK|nk
1147211|NCT02280525|Umbilical Cord Blood|umbilical cord blood
1147212|NCT02280525|UCB|ucb
1147213|NCT02280525|Lenalidomide|lenalidomide
1147214|NCT02280525|CC-5013|cc-5013
1147215|NCT02280525|Revlimid|revlimid
1147216|NCT02280525|Rituximab|rituximab
1147217|NCT02280525|Rituxan|rituxan
1147218|NCT02280525|Fludarabine|fludarabine
1147219|NCT02280525|Fludarabine phosphate|fludarabine phosphate
1147220|NCT02280525|Fludara|fludara
1147221|NCT02280525|Cyclophosphamide|cyclophosphamide
1147222|NCT02280525|Cytoxan|cytoxan
1147223|NCT02280525|Neosar|neosar
1147224|NCT02280525|Cytarabine|cytarabine
1147225|NCT02280525|Ara-C|ara-c
1147226|NCT02280525|Cytosar|cytosar
1147227|NCT02280525|DepoCyt|depocyt
1147228|NCT02280525|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1147229|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
1147230|NCT02280512|Leg fractures|leg fractures
1147231|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1147232|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
1147233|NCT02280486|saxagliptin|saxagliptin
1147234|NCT02280486|glimepiride|glimepiride
1147235|NCT02280486|metformin monotherapy|metformin monotherapy
1147236|NCT02280421|HSV|hsv
1147237|NCT02280421|Herpes|herpes
1147238|NCT02280421|volunteers|volunteers
1147239|NCT02280421|drug-drug interaction|drug-drug interaction
1147240|NCT02280421|transplant|transplant
1147241|NCT02280382|splinting|splinting
1147242|NCT02280369|posture detection|posture detection
1147243|NCT02280369|healthy subjects|healthy subjects
1147244|NCT02280356|Radiation Therapy|radiation therapy
1147245|NCT02280356|Brachytherapy|brachytherapy
1147246|NCT02280356|14-163|14-163
1147247|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
1147248|NCT02280343|lung function|lung function
1147249|NCT02280343|asbestosis|asbestosis
1147250|NCT02280330|Iodine Deficiency|iodine deficiency
1147251|NCT02280330|Micronutrient Powder|micronutrient powder
1147252|NCT02280330|Hypothyroidism|hypothyroidism
1147253|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1147254|NCT02280304|Concussion, Mild|concussion, mild
1147255|NCT02280304|Brain Injuries|brain injuries
1147256|NCT02280304|Community Integration|community integration
1147257|NCT02280304|Meditation|meditation
1147258|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
1147259|NCT02280278|colon cancer|colon cancer
1147260|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
1147261|NCT02280265|hemophilia A|hemophilia a
1147262|NCT02280265|standard prophylaxis|standard prophylaxis
1208743|NCT01993849|NAC|nac
1147263|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
1147264|NCT02280265|ADVATE|advate
1147265|NCT02280265|Pediatric|pediatric
1147266|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
1147267|NCT02280252|LABC|labc
1147268|NCT02280252|breast cancer|breast cancer
1147269|NCT02280252|breast|breast
1147270|NCT02280252|cancer|cancer
1147271|NCT02280252|metastasis|metastasis
1147272|NCT02280252|metastatic|metastatic
1147273|NCT02280252|tumor|tumor
1147274|NCT02280252|radiation|radiation
1147275|NCT02280252|radiation therapy|radiation therapy
1147276|NCT02280252|radiotherapy|radiotherapy
1147277|NCT02280252|paclitaxel|paclitaxel
1147278|NCT02280239|Fever|fever
1147279|NCT02280239|Acetaminophen|acetaminophen
1147280|NCT02280239|Body Temperature Regulation|body temperature regulation
1147281|NCT02280239|Critical Illness|critical illness
1147282|NCT02280239|Hypotension|hypotension
1147283|NCT02280200|claudication|claudication
1147284|NCT02280200|ankle foot orthoses|ankle foot orthoses
1147285|NCT02280200|community walking exercise|community walking exercise
1147286|NCT02280187|InductOs|inductos
1147287|NCT02280187|rhBMP-2|rhbmp-2
1147288|NCT02280187|Retrospective|retrospective
1147289|NCT02280187|France|france
1147290|NCT02280187|Fusion|fusion
1147291|NCT02280187|real world use|real world use
1147292|NCT02280174|Apo B-48|apo b-48
1147293|NCT02280174|TRL|trl
1147294|NCT02280174|Linagliptin|linagliptin
1147295|NCT02280148|Propofol|propofol
1147296|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
1147297|NCT02280148|driving simulator|driving simulator
1147298|NCT02280148|driving ability|driving ability
1147299|NCT02280148|cognitive function|cognitive function
1147300|NCT02280148|patients|patients
1147301|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
1147302|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
1147303|NCT02280122|saliva|saliva
1147304|NCT02280122|sensitivity/specificity|sensitivity/specificity
1147305|NCT02280109|Tenofovir|tenofovir
1147306|NCT02280109|Healthy Volunteers|healthy volunteers
1147307|NCT02280109|HIV|hiv
1147308|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
1147309|NCT02280096|Cognitive function|cognitive function
1147310|NCT02280096|Multiple sclerosis|multiple sclerosis
1147718|NCT02278133|KRAS|kras
1147311|NCT02280096|4-aminopyridine|4-aminopyridine
1147312|NCT02280096|Fatigue|fatigue
1147313|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
1147314|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
1147315|NCT02280083|upper limb spasticity|upper limb spasticity
1147316|NCT02280070|resectable rectal cancer|resectable rectal cancer
1147317|NCT02280070|SOX|sox
1147318|NCT02280070|mFOLFOX6|mfolfox6
1147319|NCT02280070|neoadjuvant|neoadjuvant
1147320|NCT02280057|PCOS|pcos
1147321|NCT02280057|metformin|metformin
1147322|NCT02280057|obesity|obesity
1147323|NCT02280057|randomized controlled trial|randomized controlled trial
1147324|NCT02280044|Campylobacter jejuni|campylobacter jejuni
1147325|NCT02280044|rifaximin|rifaximin
1147326|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
1147327|NCT02280044|dysentery|dysentery
1147328|NCT02280044|diarrhea|diarrhea
1147329|NCT02280031|Twin Pregnancy|twin pregnancy
1147330|NCT02280031|Pregnancy Complications|pregnancy complications
1147331|NCT02280018|Healthy|healthy
1147332|NCT02280018|JNJ-49122944|jnj-49122944
1147333|NCT02280018|Placebo|placebo
1147334|NCT02280005|Dialysis|dialysis
1147335|NCT02280005|Renal Failure|renal failure
1147336|NCT02280005|Wearable|wearable
1147337|NCT02280005|Artificial Kidney|artificial kidney
1147338|NCT02280005|Hemodialysis|hemodialysis
1147339|NCT02279992|Malignant Glioma|malignant glioma
1147340|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
1147341|NCT02279992|Brain metastasis|brain metastasis
1147342|NCT02279979|PHP|php
1147343|NCT02279979|Cardiogenic Shock|cardiogenic shock
1147344|NCT02279979|Percutaneous|percutaneous
1147345|NCT02279979|Ventricular Assist|ventricular assist
1147346|NCT02279979|Heart Pump|heart pump
1147347|NCT02279979|Catheter|catheter
1147348|NCT02279979|Thoratec Corporation|thoratec corporation
1147349|NCT02279940|rivaroxaban|rivaroxaban
1147350|NCT02279940|stroke|stroke
1147351|NCT02279940|transient ischemic attack|transient ischemic attack
1147352|NCT02279940|ischemia|ischemia
1147353|NCT02279927|Ureteroscopy|ureteroscopy
1147354|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
1147355|NCT02279901|CPAP|cpap
1147356|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
1147357|NCT02279901|CPAP compliance|cpap compliance
1147358|NCT02279901|Telemedicine|telemedicine
1147359|NCT02279901|Automated response mechanisms|automated response mechanisms
1147360|NCT02279901|Patient engagement|patient engagement
1147361|NCT02279901|OSA|osa
1147362|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
1569107|NCT00503854|Survey|survey
1147363|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
1147364|NCT02279875|Tuberculosis|tuberculosis
1147365|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
1147367|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
1147368|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
1147369|NCT02279875|TB|tb
1147370|NCT02279849|multi-level intervention|multi-level intervention
1147371|NCT02279849|price discounts|price discounts
1147372|NCT02279849|communication|communication
1147373|NCT02279849|low income population|low income population
1147374|NCT02279849|dietary intervention|dietary intervention
1147375|NCT02279849|obesity prevention|obesity prevention
1147376|NCT02279849|store-based intervention|store-based intervention
1147502|NCT02279108|sentinel lymph node|sentinel lymph node
1147377|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
1147378|NCT02279823|androgen|androgen
1147379|NCT02279823|alopecia|alopecia
1147380|NCT02279823|CB-03-01|cb-03-01
1147381|NCT02279823|solution|solution
1147383|NCT02279810|organ shortage|organ shortage
1147384|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
1147385|NCT02279797|bone marrow|bone marrow
1147386|NCT02279797|attitude|attitude
1147387|NCT02279771|colorectal anastomosis|colorectal anastomosis
1147388|NCT02279771|anastomotic leak|anastomotic leak
1147389|NCT02279771|ileostomy|ileostomy
1147390|NCT02279771|complications|complications
1147391|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
1147392|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
1147393|NCT02279758|metformin|metformin
1147394|NCT02279693|Raypilot dosimetry|raypilot dosimetry
1147395|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
1147396|NCT02279654|Lenalidomide|lenalidomide
1147397|NCT02279654|Revlimid|revlimid
1147398|NCT02279654|Transfusion-dependent|transfusion-dependent
1147399|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
1147400|NCT02279654|Intermediate-1-risk|intermediate-1-risk
1147401|NCT02279654|MDS|mds
1147402|NCT02279654|Isolated del(5q)|isolated del(5q)
1147403|NCT02279654|Prospective|prospective
1147404|NCT02279654|Non-interventional|non-interventional
1147405|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
1147406|NCT02279654|Disease registry|disease registry
1147407|NCT02279628|cesarean section|cesarean section
1147408|NCT02279628|spinal anesthesia|spinal anesthesia
1147409|NCT02279628|continuous wound infiltration|continuous wound infiltration
1147410|NCT02279628|intrathecal morphine|intrathecal morphine
1147411|NCT02279628|oral morphine|oral morphine
1147412|NCT02279615|Overactive Bladder|overactive bladder
1147413|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1147414|NCT02279615|Combination Therapy|combination therapy
1147415|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
1147416|NCT02279615|Mirabegron|mirabegron
1147417|NCT02279615|Myrbetriq|myrbetriq
1147418|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
1147419|NCT02279615|Tamsulosin|tamsulosin
1147420|NCT02279615|Flomax|flomax
1147421|NCT02279602|Pancreatic|pancreatic
1147422|NCT02279602|Gastrointestional|gastrointestional
1147423|NCT02279589|hyporesponsiveness|hyporesponsiveness
1147424|NCT02279589|vaccination|vaccination
1147425|NCT02279589|recommendations|recommendations
1147426|NCT02279589|improvement|improvement
1147427|NCT02279589|schedule|schedule
1147428|NCT02279589|fractional dose|fractional dose
1147429|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
1147430|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
1147431|NCT02279576|Pazopanib|pazopanib
1147432|NCT02279576|Weekly paclitaxel|weekly paclitaxel
1147433|NCT02279550|hip fracture, elderly|hip fracture, elderly
1147434|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
1147435|NCT02279537|Naïve patients|naïve patients
1147436|NCT02279537|Real life|real life
1147437|NCT02279537|Aflibercept|aflibercept
1147438|NCT02279524|NASH|nash
1147439|NCT02279511|Alzheimer|alzheimer
1147440|NCT02279485|Healthy Subjects|healthy subjects
1147441|NCT02279485|Bioequivalence|bioequivalence
1147442|NCT02279485|Fasted|fasted
1147443|NCT02279485|Fed|fed
1147444|NCT02279433|Neoplasms|neoplasms
1147445|NCT02279433|Lung Neoplasms|lung neoplasms
1147446|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
1147447|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
1147448|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
1147449|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
1147450|NCT02279394|Smoldering myeloma|smoldering myeloma
1147451|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
1147452|NCT02279381|Chlorhexidine|chlorhexidine
1147453|NCT02279381|Kangaroo mother care|kangaroo mother care
1147454|NCT02279381|RCT|rct
1147455|NCT02279342|Coronary artery disease|coronary artery disease
1147456|NCT02279342|hyperuricemia|hyperuricemia
1147457|NCT02279342|coronary plaque volume|coronary plaque volume
1147458|NCT02279342|IVUS|ivus
1147459|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
1147460|NCT02279316|home exercise|home exercise
1147461|NCT02279316|vitamin D|vitamin d
1147462|NCT02279316|mild cognitive impairment|mild cognitive impairment
1147464|NCT02279316|mild dementia|mild dementia
1147465|NCT02279290|Childhood trauma|childhood trauma
1147466|NCT02279264|ph|ph
1147467|NCT02279264|RightSpot Infant|rightspot infant
1147468|NCT02279264|Feeding Tube|feeding tube
1147469|NCT02279264|RightBio Metrics|rightbio metrics
1147470|NCT02279264|placement|placement
1147471|NCT02279264|Nasogastric Tube|nasogastric tube
1147472|NCT02279264|NG|ng
1147473|NCT02279264|infant|infant
1147474|NCT02279251|Anxiety|anxiety
1147475|NCT02279251|adolescents|adolescents
1147476|NCT02279251|school-based|school-based
1147477|NCT02279251|low-intensity CBT|low-intensity cbt
1147478|NCT02279225|Phototherapy|phototherapy
1147479|NCT02279225|Laser|laser
1147480|NCT02279225|Fibromyalgia|fibromyalgia
1147481|NCT02279225|DTM/ TMD|dtm/ tmd
1147482|NCT02279225|Pain|pain
1147483|NCT02279212|Critical illness|critical illness
1147484|NCT02279212|pain|pain
1147485|NCT02279212|quality of life|quality of life
1147486|NCT02279199|hemophilia|hemophilia
1147487|NCT02279199|joint health|joint health
1147488|NCT02279199|motor development|motor development
1147489|NCT02279199|motor proficiency|motor proficiency
1147490|NCT02279173|Pediatric|pediatric
1147491|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
1147492|NCT02279173|Amgen|amgen
1147493|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1147494|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
1147495|NCT02279147|anti-inflammatory|anti-inflammatory
1147496|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
1147497|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
1147498|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
1147499|NCT02279121|central venous catheter|central venous catheter
1147500|NCT02279121|Taurolidine|taurolidine
1147501|NCT02279121|lock-therapy|lock-therapy
1147503|NCT02279108|indocyanine green|indocyanine green
1147504|NCT02279108|fluorescence method|fluorescence method
1147505|NCT02279108|radioisotope conventional method|radioisotope conventional method
1147506|NCT02279108|breast cancer|breast cancer
1147507|NCT02279095|Open-label extension study|open-label extension study
1147508|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
1147509|NCT02279095|Efficacy and safety|efficacy and safety
1147510|NCT02279095|Heterotopic ossification|heterotopic ossification
1147719|NCT02278120|HR-positive|hr-positive
1147511|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
1147512|NCT02279095|Flare-up|flare-up
1147513|NCT02279095|Palovarotene|palovarotene
1147514|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
1147515|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
1147516|NCT02279095|Clementia|clementia
1147517|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
1147518|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
1147519|NCT02279095|FOP|fop
1147520|NCT02279069|stroke|stroke
1147521|NCT02279069|walking|walking
1147522|NCT02279069|rehabilitation|rehabilitation
1147523|NCT02279043|IUD|iud
1147524|NCT02279043|IUC|iuc
1147525|NCT02279043|birth control|birth control
1147526|NCT02279043|contraception|contraception
1147527|NCT02279043|online|online
1147528|NCT02279030|ablation|ablation
1147529|NCT02279017|Mobile Technology|mobile technology
1147530|NCT02279017|Diet and Fitness|diet and fitness
1147531|NCT02279004|Plasma Genotyping|plasma genotyping
1147532|NCT02279004|NSCLC|nsclc
1147533|NCT02279004|Melanoma|melanoma
1147534|NCT02278978|urothelial carcinoma|urothelial carcinoma
1147535|NCT02278978|BIBF1120|bibf1120
1147536|NCT02278965|Breast Cancer|breast cancer
1147537|NCT02278965|Early Stage|early stage
1147538|NCT02278939|diabetes prevention|diabetes prevention
1147539|NCT02278939|Filipinos|filipinos
1147540|NCT02278939|lifestyle intervention|lifestyle intervention
1147541|NCT02278926|Ultrasound|ultrasound
1147542|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
1147543|NCT02278913|inpatient|inpatient
1147544|NCT02278913|hospital|hospital
1147545|NCT02278913|randomized trial|randomized trial
1147546|NCT02278913|diabetes|diabetes
1147547|NCT02278913|analogs|analogs
1147548|NCT02278913|human insulin|human insulin
1147549|NCT02278900|communication|communication
1147550|NCT02278900|shared decision-making|shared decision-making
1147551|NCT02278887|melanoma|melanoma
1147552|NCT02278887|TIL treatment|til treatment
1147553|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
1147554|NCT02278887|ipilimumab|ipilimumab
1147555|NCT02278887|interleukin 2|interleukin 2
1147556|NCT02278887|non-myeloablative|non-myeloablative
1147557|NCT02278887|randomization|randomization
1147558|NCT02278874|Trisomy 13|trisomy 13
1147559|NCT02278874|Trisomy 18|trisomy 18
1147560|NCT02278874|Trisomy 21|trisomy 21
1147561|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
1147562|NCT02278874|Monosomy X|monosomy x
1147563|NCT02278874|XXX|xxx
1147564|NCT02278874|XXY|xxy
1147565|NCT02278874|XYY|xyy
1147566|NCT02278861|actinic keratosis|actinic keratosis
1147567|NCT02278861|tretinoin|tretinoin
1147568|NCT02278861|isotretinoin|isotretinoin
1147569|NCT02278861|cryotherapy|cryotherapy
1147570|NCT02278861|sun protection factor|sun protection factor
1147571|NCT02278861|clinical clearance|clinical clearance
1147572|NCT02278848|Computerised gait analysis|computerised gait analysis
1147573|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
1147574|NCT02278848|MRI flow|mri flow
1147575|NCT02278848|Urinary incontinence scale|urinary incontinence scale
1147576|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
1147577|NCT02278835|Cardiac valve|cardiac valve
1147578|NCT02278809|physical activity|physical activity
1147579|NCT02278809|screen time|screen time
1147580|NCT02278809|vegetables|vegetables
1147581|NCT02278809|fruit|fruit
1147582|NCT02278809|snacks|snacks
1147583|NCT02278809|softdrink|softdrink
1147584|NCT02278809|water|water
1147585|NCT02278809|fruit juice|fruit juice
1147586|NCT02278809|parenting practices|parenting practices
1147587|NCT02278809|online videos|online videos
1147588|NCT02278809|intervention mapping protocol|intervention mapping protocol
1147589|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
1147590|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
1147591|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
1147592|NCT02278770|diverticular disease|diverticular disease
1147593|NCT02278770|MRI|mri
1147594|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
1147595|NCT02278770|adipokines|adipokines
1147596|NCT02278757|Metabolic syndrome|metabolic syndrome
1147597|NCT02278757|Weight loss|weight loss
1147598|NCT02278757|Obesity|obesity
1147599|NCT02278757|Hypertension|hypertension
1147600|NCT02278757|Dyslipidemia|dyslipidemia
1147601|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
1147602|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
1147603|NCT02278744|14-054|14-054
1147604|NCT02278731|Physical activity|physical activity
1147605|NCT02278731|Rehabilitation|rehabilitation
1147606|NCT02278731|Older adults|older adults
1147607|NCT02278731|Pilates|pilates
1147608|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
1147609|NCT02278705|childhood obesity|childhood obesity
1147610|NCT02278705|childhood overweight|childhood overweight
1147611|NCT02278705|primary care|primary care
1147612|NCT02278705|weight management|weight management
1147613|NCT02278692|Vitamin K|vitamin k
1147614|NCT02278692|Calciphylaxis|calciphylaxis
1147615|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
1147616|NCT02278692|Dialysis|dialysis
1147617|NCT02278692|End-stage renal disease|end-stage renal disease
1147618|NCT02278653|Restaging|restaging
1147619|NCT02278653|Watchful Waiting|watchful waiting
1147620|NCT02278653|Quality of Life|quality of life
1147621|NCT02278653|Manometry|manometry
1147622|NCT02278601|Breakthrough pain|breakthrough pain
1147623|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
1147624|NCT02278549|Spinal kinematics|spinal kinematics
1147625|NCT02278536|Trisomy 13|trisomy 13
1147626|NCT02278536|Trisomy 18|trisomy 18
1147627|NCT02278536|Trisomy 21|trisomy 21
1147628|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
1147629|NCT02278536|Monosomy X|monosomy x
1147630|NCT02278536|XXX|xxx
1147631|NCT02278536|XXY|xxy
1147632|NCT02278536|XYY|xyy
1147633|NCT02278510|topotecan|topotecan
1147634|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
1147635|NCT02278510|CED|ced
1147636|NCT02278510|High Grade Glioma|high grade glioma
1147637|NCT02278484|sinus infections|sinus infections
1147638|NCT02278484|sinusitis|sinusitis
1147639|NCT02278484|chronic sinusitis|chronic sinusitis
1147640|NCT02278484|rhinosinusitis|rhinosinusitis
1147641|NCT02278484|allergic sinusitis|allergic sinusitis
1147642|NCT02278484|allergic rhinitis|allergic rhinitis
1147643|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
1147644|NCT02278484|sinus disease in children|sinus disease in children
1147645|NCT02278484|sinus balloon dilation|sinus balloon dilation
1147646|NCT02278484|balloon dilatation|balloon dilatation
1147647|NCT02278484|sinus disease|sinus disease
1147648|NCT02278484|pediatric|pediatric
1147649|NCT02278471|combination pill|combination pill
1147650|NCT02278471|polypill|polypill
1147651|NCT02278471|primary prevention|primary prevention
1147652|NCT02278445|Systemic Sclerosis|systemic sclerosis
1147653|NCT02278445|Pulmonary hypertension|pulmonary hypertension
1147654|NCT02278445|Lung Doppler Signals|lung doppler signals
1147655|NCT02278432|risk assessment|risk assessment
1147656|NCT02278432|pharmacovigilance|pharmacovigilance
1147657|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
1147658|NCT02278432|drug toxicity|drug toxicity
1147659|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
1147660|NCT02278432|omeprazole|omeprazole
1147661|NCT02278419|Hepatitis C|hepatitis c
1147662|NCT02278419|Simeprevir|simeprevir
1147663|NCT02278419|Sofosbuvir|sofosbuvir
1147664|NCT02278419|Healthy|healthy
1147665|NCT02278406|Parkinson's Disease|parkinson's disease
1147666|NCT02278406|Deep brain stimulator|deep brain stimulator
1147667|NCT02278406|dbs|dbs
1147668|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
1147669|NCT02278393|High LDL-C|high ldl-c
1147670|NCT02278393|dairy drinks|dairy drinks
1147671|NCT02278393|phytosterols|phytosterols
1147672|NCT02278341|ASP1517|asp1517
1147673|NCT02278341|FG-4592|fg-4592
1147674|NCT02278341|Anemia|anemia
1147675|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1147676|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
1147677|NCT02278341|Chronic Kidney Disease|chronic kidney disease
1147678|NCT02278341|Hematopoetic Agents|hematopoetic agents
1147679|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
1147680|NCT02278341|Hemoglobin|hemoglobin
1147681|NCT02278341|Dialysis|dialysis
1147682|NCT02278341|roxadustat|roxadustat
1147683|NCT02278328|dose titration study|dose titration study
1147684|NCT02278328|electrophysiology|electrophysiology
1147685|NCT02278315|Multiple Myeloma|multiple myeloma
1147686|NCT02278315|Radiopharmaceutical|radiopharmaceutical
1147687|NCT02278315|Therapy|therapy
1147688|NCT02278315|Phase 1|phase 1
1147689|NCT02278263|tranexamic acid|tranexamic acid
1147690|NCT02278263|enhanced recovery|enhanced recovery
1147691|NCT02278263|arthroplasty|arthroplasty
1147692|NCT02278263|perioperative care|perioperative care
1147693|NCT02278250|VX14-803-001|vx14-803-001
1147694|NCT02278250|VX-803|vx-803
1147695|NCT02278250|M4344|m4344
1147696|NCT02278250|Advanced Solid Tumor|advanced solid tumor
1147697|NCT02278250|Cytotoxic Chemotherapy|cytotoxic chemotherapy
1147698|NCT02278250|Gemcitabine|gemcitabine
1147699|NCT02278250|Cisplatin|cisplatin
1147700|NCT02278250|Carboplatin|carboplatin
1147701|NCT02278198|thyroid cancer|thyroid cancer
1147702|NCT02278172|vitamin D|vitamin d
1147703|NCT02278172|athletes|athletes
1147704|NCT02278172|fitness|fitness
1147705|NCT02278159|end-stage kidney disease|end-stage kidney disease
1147706|NCT02278159|peritoneal dialysis|peritoneal dialysis
1147707|NCT02278159|home hemodialysis|home hemodialysis
1147708|NCT02278159|technique survival|technique survival
1147709|NCT02278159|patient survival|patient survival
1147710|NCT02278133|metastatic,|metastatic,
1147711|NCT02278133|Colorectal cancer,|colorectal cancer,
1147712|NCT02278133|WNT974,|wnt974,
1147713|NCT02278133|LGX818,|lgx818,
1147714|NCT02278133|cetuximab,|cetuximab,
1147715|NCT02278133|BRAF-mutant,|braf-mutant,
1147716|NCT02278133|mCRC,|mcrc,
1147717|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
1147720|NCT02278120|HER2-negative|her2-negative
1147721|NCT02278120|Advanced breast cancer|advanced breast cancer
1147722|NCT02278120|Letrozole|letrozole
1147723|NCT02278120|Anastrozole|anastrozole
1147724|NCT02278120|Tamoxifen|tamoxifen
1147725|NCT02278120|Goserelin|goserelin
1147726|NCT02278120|CDK|cdk
1147727|NCT02278120|CDK4|cdk4
1147728|NCT02278120|CDK6|cdk6
1147729|NCT02278120|CDK4/6|cdk4/6
1147730|NCT02278120|Phase III|phase iii
1147731|NCT02278120|ER-positive|er-positive
1147732|NCT02278120|PR-positive|pr-positive
1147733|NCT02278120|Premenopausal|premenopausal
1147734|NCT02278094|OSAS|osas
1147735|NCT02278094|Adult|adult
1147736|NCT02278094|Home-based|home-based
1147737|NCT02278094|Genioglossus|genioglossus
1147738|NCT02278094|Inspiratory muscle|inspiratory muscle
1147739|NCT02278094|Exercise|exercise
1147740|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
1147741|NCT02278068|Type 2 diabetes|type 2 diabetes
1147742|NCT02278055|Radium-223|radium-223
1147743|NCT02278055|14-098|14-098
1147744|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
1147745|NCT02278016|procalcitonin|procalcitonin
1147746|NCT02278016|interleukin-6|interleukin-6
1147747|NCT02278016|agiotensininⅡ|agiotensininⅱ
1147748|NCT02278003|Amnesic|amnesic
1147749|NCT02278003|Propofol|propofol
1147750|NCT02278003|12-006|12-006
1147751|NCT02277977|sepsis|sepsis
1147752|NCT02277977|septic shock|septic shock
1147753|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1147754|NCT02277977|microcirculation|microcirculation
1147755|NCT02277964|RRMS|rrms
1147756|NCT02277964|Natalizumab|natalizumab
1147757|NCT02277964|Fingolimod|fingolimod
1147758|NCT02277964|Treatment Change|treatment change
1147759|NCT02277964|Disease Activity|disease activity
1147760|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
1147761|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
1147762|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
1147763|NCT02277912|ICH|ich
1147764|NCT02277912|Stroke|stroke
1147765|NCT02277912|Navigated|navigated
1147766|NCT02277912|Placebo|placebo
1147767|NCT02277912|TMS|tms
1147768|NCT02277899|childhood obesity|childhood obesity
1147769|NCT02277899|overweight|overweight
1147770|NCT02277899|communication|communication
1147771|NCT02277899|primary care|primary care
1147772|NCT02277899|weight management|weight management
1147773|NCT02277899|communication methods|communication methods
1147774|NCT02277899|patient-centered communication|patient-centered communication
1147775|NCT02277886|sodium alginate|sodium alginate
1147776|NCT02277886|esomeprazole|esomeprazole
1147777|NCT02277886|GERD|gerd
1147779|NCT02277873|parturition|parturition
1147780|NCT02277873|moon phases|moon phases
1147781|NCT02277860|Exercise|exercise
1147782|NCT02277847|Idarubicin|idarubicin
1147783|NCT02277847|Cytosine arabinoside|cytosine arabinoside
1147784|NCT02277847|Efficacy|efficacy
1147785|NCT02277847|Safety|safety
1147786|NCT02277821|Essential Hypertension|essential hypertension
1147787|NCT02277821|Central Blood Pressure|central blood pressure
1147788|NCT02277821|Microcirculation|microcirculation
1147789|NCT02277821|Endothelium Stimulation|endothelium stimulation
1147790|NCT02277808|Pneumocystis|pneumocystis
1147791|NCT02277808|Nebulizer|nebulizer
1147792|NCT02277808|Pentamidine|pentamidine
1147793|NCT02277795|Early infant male circumcision|early infant male circumcision
1147794|NCT02277795|HIV|hiv
1147795|NCT02277795|Prevention|prevention
1147796|NCT02277795|AccuCirc|accucirc
1147797|NCT02277795|Kenya|kenya
1147798|NCT02277795|Providers|providers
1147799|NCT02277795|Parents|parents
1147800|NCT02277782|Labor|labor
1147801|NCT02277782|Analgesia|analgesia
1147802|NCT02277756|high functioning autism|high functioning autism
1147803|NCT02277756|endogenous modulation systems|endogenous modulation systems
1147804|NCT02277730|Hypotension|hypotension
1147805|NCT02277717|cancer|cancer
1147806|NCT02277717|metastasis|metastasis
1147807|NCT02277717|HER2|her2
1147808|NCT02277717|trastuzumab|trastuzumab
1147809|NCT02277717|duocarmycin|duocarmycin
1147810|NCT02277717|SYD985|syd985
1147811|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
1147812|NCT02277717|ADC|adc
1147813|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
1147814|NCT02277704|PTSD|ptsd
1147815|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
1147816|NCT02277691|Pharmacological therapy|pharmacological therapy
1147817|NCT02277691|Drug Therapy|drug therapy
1147818|NCT02277678|Pruritus|pruritus
1147819|NCT02277665|Cannabis Use Disorder|cannabis use disorder
1147820|NCT02277665|Tobacco Use|tobacco use
1147821|NCT02277665|Treatment|treatment
1147822|NCT02277639|Transplant related mortality|transplant related mortality
1147823|NCT02277639|Graft versus host disease|graft versus host disease
1147824|NCT02277639|Bone marrow transplant|bone marrow transplant
1147825|NCT02277613|stem cells|stem cells
1147826|NCT02277587|Plenadren|plenadren
1147827|NCT02277587|Addison's disease|addison's disease
1147828|NCT02277587|Hydrocortisone|hydrocortisone
1147829|NCT02277587|Cortisone Acetate|cortisone acetate
1147830|NCT02277587|Monocytes|monocytes
1147831|NCT02277587|Natural Killer cells|natural killer cells
1147832|NCT02277587|Immunological profile|immunological profile
1147833|NCT02277587|Inflammation|inflammation
1147834|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
1147835|NCT02277574|Arthritis|arthritis
1147836|NCT02277574|Joint diseases|joint diseases
1147837|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
1147838|NCT02277548|chemotherapy|chemotherapy
1147839|NCT02277548|radiation therapy|radiation therapy
1147840|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
1147841|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
1147842|NCT02277444|Methotrexate|methotrexate
1147843|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
1147844|NCT02277444|Golimumab|golimumab
1147845|NCT02277444|Pediatric Participants|pediatric participants
1147846|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
1147847|NCT02277366|Lung Neoplasms|lung neoplasms
1147848|NCT02277366|Bronchoscopy|bronchoscopy
1147849|NCT02277366|Early Detection of Cancer|early detection of cancer
1147850|NCT02277353|Fluid responsiveness|fluid responsiveness
1147851|NCT02277353|NICOM|nicom
1147852|NCT02277353|Prone Position|prone position
1147853|NCT02277353|Stroke Volume Variation|stroke volume variation
1147854|NCT02277327|Hospitalization|hospitalization
1147855|NCT02277327|Readmissions|readmissions
1147856|NCT02277327|Medical complexity|medical complexity
1147857|NCT02277301|Pilot study|pilot study
1147858|NCT02277301|Randomised Controlled Trial|randomised controlled trial
1147859|NCT02277301|Parenting|parenting
1147860|NCT02277301|Paediatrics|paediatrics
1147861|NCT02277301|Mental Health|mental health
1147862|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
1147863|NCT02277262|peritonitis patients|peritonitis patients
1147864|NCT02277236|sarcopenia|sarcopenia
1147865|NCT02277236|aging|aging
1147866|NCT02277236|insulin resistance|insulin resistance
1147867|NCT02277236|screening|screening
1147868|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
1147869|NCT02277184|High Risk HNSCC|high risk hnscc
1147870|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
1147871|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
1147872|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
1147873|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
1148070|NCT02275897|Anesthesia|anesthesia
1147874|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
1147875|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
1147876|NCT02277158|Rectal cancer|rectal cancer
1147877|NCT02277158|S-1|s-1
1147878|NCT02277158|Chemoradiotherapy|chemoradiotherapy
1147879|NCT02277158|Phase I|phase i
1147880|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
1147881|NCT02277145|MSCs|mscs
1147882|NCT02277132|Fetal growth restriction|fetal growth restriction
1147883|NCT02277132|Sildenafil|sildenafil
1147884|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
1147885|NCT02277067|PPH|pph
1147886|NCT02277041|PPH|pph
1147887|NCT02277002|Cabin Air Filtration|cabin air filtration
1147888|NCT02277002|Particulate Matter|particulate matter
1147889|NCT02277002|Commuter Exposure|commuter exposure
1147890|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
1147891|NCT02276989|Chronic Pain|chronic pain
1147892|NCT02276989|Compliance Marker|compliance marker
1147893|NCT02276989|Narcotic Abuse|narcotic abuse
1147894|NCT02276989|Opioid related disorders|opioid related disorders
1147895|NCT02276989|Opiate substitution treatment|opiate substitution treatment
1147896|NCT02276989|Buprenorphrine|buprenorphrine
1147897|NCT02276989|Suboxone|suboxone
1147898|NCT02276989|Lyrica|lyrica
1147899|NCT02276989|Pregabalin|pregabalin
1147900|NCT02276989|Acetazolamide|acetazolamide
1147901|NCT02276989|Quinine|quinine
1147902|NCT02276989|Compliance|compliance
1147903|NCT02276976|crebral white matter lesions|crebral white matter lesions
1147904|NCT02276976|brain networks|brain networks
1147905|NCT02276976|MRI|mri
1147906|NCT02276976|DTI|dti
1147907|NCT02276976|fMRI|fmri
1147908|NCT02276976|cognitive impairment|cognitive impairment
1147909|NCT02276976|gene|gene
1147910|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
1147911|NCT02276950|Cardiac Surgery|cardiac surgery
1147912|NCT02276950|Epidemiologic Methods|epidemiologic methods
1147913|NCT02276950|Blood Transfusions|blood transfusions
1147914|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
1147915|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
1147916|NCT02276937|treadmill|treadmill
1147917|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
1148018|NCT02276287|HIV|hiv
1147918|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
1147919|NCT02276898|pediatric|pediatric
1147920|NCT02276898|lung clearance index|lung clearance index
1147921|NCT02276898|Multiple Breath Washout|multiple breath washout
1147922|NCT02276898|Hypertonic Saline|hypertonic saline
1147923|NCT02276885|breast|breast
1147924|NCT02276885|cancer|cancer
1147925|NCT02276885|breast cancer|breast cancer
1147926|NCT02276885|prone|prone
1147927|NCT02276885|partial breast irradiation|partial breast irradiation
1147928|NCT02276885|PBI|pbi
1147929|NCT02276872|pediatric|pediatric
1147930|NCT02276872|treprostinil|treprostinil
1147931|NCT02276872|transition|transition
1147932|NCT02276872|Remodulin|remodulin
1147933|NCT02276859|dual-wave bolus|dual-wave bolus
1147934|NCT02276859|square bolus|square bolus
1147935|NCT02276859|normal bolus|normal bolus
1147936|NCT02276859|standard bolus|standard bolus
1147937|NCT02276859|high-protein meal|high-protein meal
1147938|NCT02276859|prandial insulin requirement|prandial insulin requirement
1147939|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
1147940|NCT02276846|Bifurcation|bifurcation
1147941|NCT02276846|OCT|oct
1147942|NCT02276846|Transluminal|transluminal
1147943|NCT02276820|Adenovirus|adenovirus
1147944|NCT02276820|Virus specific T cells|virus specific t cells
1147945|NCT02276820|Viral infections|viral infections
1147946|NCT02276807|Depression|depression
1147947|NCT02276807|Behavioral Symptoms|behavioral symptoms
1147948|NCT02276807|Mental Disorders|mental disorders
1147949|NCT02276807|Depressive Disorder|depressive disorder
1147950|NCT02276807|suicidal ideation|suicidal ideation
1147951|NCT02276807|primary health care|primary health care
1147952|NCT02276807|Veterans|veterans
1147953|NCT02276794|Low back pain|low back pain
1147954|NCT02276794|Thrust manipulation|thrust manipulation
1147955|NCT02276794|Spinal manipulation|spinal manipulation
1147956|NCT02276794|Joint mobilization|joint mobilization
1147957|NCT02276794|Non-thrust manipulation|non-thrust manipulation
1147958|NCT02276794|proprioception|proprioception
1147959|NCT02276794|Postural stability|postural stability
1147960|NCT02276794|Baropodometry|baropodometry
1147961|NCT02276781|PAD|pad
1147962|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
1147963|NCT02276781|Biomarkers|biomarkers
1147964|NCT02276768|rectal distension|rectal distension
1147965|NCT02276768|rectal compliance|rectal compliance
1147966|NCT02276768|visceral pain|visceral pain
1147967|NCT02276768|pain intensity|pain intensity
1147968|NCT02276768|barostat|barostat
1147969|NCT02276768|distender|distender
1147970|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
1147971|NCT02276768|rectal sensory threshold|rectal sensory threshold
1147972|NCT02276768|analgesia|analgesia
1147973|NCT02276768|trimebutine|trimebutine
1147974|NCT02276768|pain management|pain management
1147975|NCT02276768|peripheral|peripheral
1147976|NCT02276768|colon cancer|colon cancer
1147977|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
1147978|NCT02276729|Upper limb|upper limb
1147979|NCT02276729|Rehabilitation|rehabilitation
1147980|NCT02276729|Occupational Therapy|occupational therapy
1147981|NCT02276729|Mirror Box Therapy|mirror box therapy
1147982|NCT02276690|iron deficiency|iron deficiency
1147983|NCT02276690|dosage of hepcidin|dosage of hepcidin
1147984|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
1147985|NCT02276690|mass spectrometry|mass spectrometry
1147986|NCT02276690|immuno-detection|immuno-detection
1147987|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
1147988|NCT02276664|lung cancer prevention|lung cancer prevention
1147989|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
1147990|NCT02276547|Mitral|mitral
1147991|NCT02276547|Regurgitation|regurgitation
1147992|NCT02276547|Heart valve|heart valve
1147993|NCT02276547|Transcatheter|transcatheter
1147994|NCT02276547|Transapical|transapical
1147995|NCT02276547|Functional|functional
1147996|NCT02276547|Degenerative|degenerative
1147997|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
1147998|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
1147999|NCT02276469|severe mental illness|severe mental illness
1148000|NCT02276443|Breast Cancer|breast cancer
1148001|NCT02276443|Triple-negative breast cancer|triple-negative breast cancer
1148002|NCT02276443|TNBC|tnbc
1148003|NCT02276443|Molecular testing|molecular testing
1148004|NCT02276443|Standard chemotherapy|standard chemotherapy
1148005|NCT02276443|Ultrasound|ultrasound
1148006|NCT02276430|Testicular cancer|testicular cancer
1148007|NCT02276430|Survivor|survivor
1148008|NCT02276430|Cardiovascular disease|cardiovascular disease
1148009|NCT02276430|Risk factors|risk factors
1148011|NCT02276417|Surgical ICU|surgical icu
1148012|NCT02276313|Peripheral|peripheral
1148013|NCT02276313|Infrainguinal|infrainguinal
1148014|NCT02276313|Drug Releasing Balloon|drug releasing balloon
1148015|NCT02276313|Drug Eluting Balloon|drug eluting balloon
1148016|NCT02276287|Adherence|adherence
1148017|NCT02276287|HAART|haart
1148019|NCT02276287|Illness Perception|illness perception
1148020|NCT02276287|IPQ-R|ipq-r
1148021|NCT02276235|catgut embedding|catgut embedding
1148022|NCT02276235|obese women|obese women
1148023|NCT02276235|obesity-related hormones|obesity-related hormones
1148024|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1148025|NCT02276222|COPD|copd
1148026|NCT02276157|cholangioscopy|cholangioscopy
1148027|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
1148028|NCT02276105|Quality of Life|quality of life
1148029|NCT02276105|EQ-5D|eq-5d
1148030|NCT02276105|SF-12|sf-12
1148031|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
1148032|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
1148033|NCT02276092|Pragmatic study|pragmatic study
1148034|NCT02276092|Multi-center|multi-center
1148035|NCT02276092|Time-dependent bias|time-dependent bias
1148036|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
1148037|NCT02276092|prospective audit and feedback|prospective audit and feedback
1148038|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
1148039|NCT02276079|Aerobic Exercise|aerobic exercise
1148040|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1148041|NCT02276066|kidney dysfunction|kidney dysfunction
1148042|NCT02276066|chronic critical illness|chronic critical illness
1148043|NCT02276066|sepsis|sepsis
1148044|NCT02276066|Glomerular filtration rate|glomerular filtration rate
1148045|NCT02276053|Epilepsy|epilepsy
1148046|NCT02276053|Brain tumor|brain tumor
1148047|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
1148048|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
1148049|NCT02276040|Arthroplasty|arthroplasty
1148050|NCT02276040|Knee Replacement|knee replacement
1148051|NCT02276040|Analgesia|analgesia
1148052|NCT02276040|pain|pain
1148053|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
1148054|NCT02276014|Beta carotene|beta carotene
1148055|NCT02276014|Retinol|retinol
1148056|NCT02276001|Adult Volunteers|adult volunteers
1148057|NCT02275988|Adult Volunteers|adult volunteers
1148058|NCT02275975|Adult Volunteers|adult volunteers
1148059|NCT02275962|Adult Volunteers|adult volunteers
1148060|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
1148061|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
1148062|NCT02275949|Acupuncture|acupuncture
1148063|NCT02275936|N91115|n91115
1148064|NCT02275936|Cavosonstat|cavosonstat
1148065|NCT02275910|Solid Tumors|solid tumors
1148066|NCT02275910|E7090|e7090
1148067|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
1148068|NCT02275897|Speed of Injection|speed of injection
1148069|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
1148071|NCT02275884|Parkinson Disease|parkinson disease
1148072|NCT02275884|Cacao|cacao
1148073|NCT02275884|Biogenic amines|biogenic amines
1148074|NCT02275884|Xanthines|xanthines
1148075|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
1148076|NCT02275871|Breast Cancer|breast cancer
1148077|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
1148078|NCT02275858|terminal ileum intubation|terminal ileum intubation
1148079|NCT02275845|metformin|metformin
1148080|NCT02275845|prevention|prevention
1148081|NCT02275819|Heart Failure|heart failure
1148082|NCT02275819|Exercise|exercise
1148083|NCT02275819|Echocardiography|echocardiography
1148084|NCT02275741|Vaccine|vaccine
1148085|NCT02275741|Antibody response|antibody response
1148086|NCT02275741|relaps rate|relaps rate
1148087|NCT02275741|expanded disability status scale|expanded disability status scale
1148088|NCT02275728|Menopause|menopause
1148089|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
1148090|NCT02275728|EMG Biofeedback|emg biofeedback
1148091|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
1148092|NCT02275728|Quality of life|quality of life
1148093|NCT02275728|Physical Therapie|physical therapie
1148094|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
1148095|NCT02275715|feeding problems|feeding problems
1148096|NCT02275702|Dexamethasone|dexamethasone
1148097|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
1148098|NCT02275702|QoR-40|qor-40
1148099|NCT02275702|Lung cancer|lung cancer
1148100|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
1148101|NCT02275689|Rotator cuff|rotator cuff
1148102|NCT02275689|Tendinosis|tendinosis
1148103|NCT02275689|Impingement|impingement
1148104|NCT02275689|radiofrequency|radiofrequency
1148105|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
1148106|NCT02275676|Nutritional Status|nutritional status
1148107|NCT02275676|Malnutrition|malnutrition
1148108|NCT02275676|Resting Energy Expenditure|resting energy expenditure
1148109|NCT02275663|relapsed AML|relapsed aml
1148110|NCT02275663|refractory AML|refractory aml
1148111|NCT02275663|azacytidine|azacytidine
1148112|NCT02275650|calcidiol|calcidiol
1148113|NCT02275650|25(oh)d|25(oh)d
1148114|NCT02275650|nbUVB|nbuvb
1148115|NCT02275650|cyp27A1|cyp27a1
1148116|NCT02275650|cyp27B1|cyp27b1
1148117|NCT02275650|vitamin D|vitamin d
1148208|NCT02275052|umeclidinium|umeclidinium
1148118|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
1148119|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
1148120|NCT02275637|ventricular Tachycardia|ventricular tachycardia
1148121|NCT02275611|oxytocin|oxytocin
1148122|NCT02275611|alcohol withdrawal|alcohol withdrawal
1148123|NCT02275611|alcohol dependence|alcohol dependence
1148124|NCT02275611|alcoholism|alcoholism
1148125|NCT02275585|Portal vein|portal vein
1148126|NCT02275585|Thrombosis|thrombosis
1148127|NCT02275585|Cirrhosis|cirrhosis
1148128|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1148129|NCT02275481|COPD|copd
1148130|NCT02275481|Emphysema|emphysema
1148131|NCT02275481|Chronic bronchitis|chronic bronchitis
1148132|NCT02275468|Chronic Kidney Disease|chronic kidney disease
1148133|NCT02275468|eGFR slope|egfr slope
1148134|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
1148135|NCT02275442|EPICES scale|epices scale
1148136|NCT02275442|Precarious situation|precarious situation
1148137|NCT02275442|Rural parturient women|rural parturient women
1148138|NCT02275442|Access to care|access to care
1148139|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
1148140|NCT02275442|General practice|general practice
1148141|NCT02275429|Metabolic Diseases|metabolic diseases
1148142|NCT02275429|Athletes|athletes
1148143|NCT02275429|Running|running
1148144|NCT02275429|Selenium|selenium
1148145|NCT02275429|Zinc|zinc
1148146|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
1148147|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
1148148|NCT02275429|Hyperkalemia|hyperkalemia
1148149|NCT02275429|Hypernatremia|hypernatremia
1148150|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
1148151|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
1148152|NCT02275390|mental illness|mental illness
1148153|NCT02275390|psychoeducation|psychoeducation
1148154|NCT02275390|nurse-led clinic|nurse-led clinic
1209910|NCT01988129|rls|rls
1148155|NCT02275390|randomized controlled trial|randomized controlled trial
1148156|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
1148157|NCT02275351|alopecia|alopecia
1148158|NCT02275351|topical|topical
1148159|NCT02275351|Samumed|samumed
1148160|NCT02275325|Posture|posture
1148161|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
1148162|NCT02275325|Medical management|medical management
1148163|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
1148164|NCT02275325|Neural plasticity|neural plasticity
1148165|NCT02275286|sarcoma|sarcoma
1148166|NCT02275273|Adnexal Masses|adnexal masses
1148167|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
1148168|NCT02275273|Anatomopathology|anatomopathology
1148169|NCT02275247|Stellate ganglion block|stellate ganglion block
1148170|NCT02275247|Aneurysm surgery|aneurysm surgery
1148171|NCT02275247|Cognitive recovery|cognitive recovery
1148172|NCT02275247|Cerebral vasospasm|cerebral vasospasm
1148173|NCT02275234|cardiac arrest|cardiac arrest
1148174|NCT02275234|psychological intervention|psychological intervention
1148175|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
1148176|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
1148177|NCT02275195|hepatitis|hepatitis
1148178|NCT02275195|alcohol|alcohol
1148179|NCT02275182|Dexmedetomidine|dexmedetomidine
1148180|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
1148181|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
1148182|NCT02275169|male infertility|male infertility
1148183|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
1148184|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
1148185|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
1148186|NCT02275143|cancer patients|cancer patients
1148187|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
1148188|NCT02275130|glottic insufficiency|glottic insufficiency
1148189|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
1148190|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
1148191|NCT02275117|Migraine Disorders|migraine disorders
1148192|NCT02275117|ALD403|ald403
1148193|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
1148194|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
1148195|NCT02275104|Ablation guidance|ablation guidance
1148196|NCT02275104|Software|software
1148197|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
1148198|NCT02275091|Children|children
1148199|NCT02275091|Cholesterol|cholesterol
1148200|NCT02275078|COPD|copd
1148201|NCT02275078|Action Plan|action plan
1148202|NCT02275078|Telesystem|telesystem
1148203|NCT02275078|New technology|new technology
1148204|NCT02275065|HIV-1 Infected|hiv-1 infected
1148205|NCT02275065|Adults|adults
1148206|NCT02275065|Treatment Naive|treatment naive
1148207|NCT02275052|shuttle walk test|shuttle walk test
1148209|NCT02275052|beta2-agonist|beta2-agonist
1148210|NCT02275052|exercise endurance time|exercise endurance time
1148211|NCT02275052|anticholinergic|anticholinergic
1148212|NCT02275052|combination product|combination product
1148213|NCT02275052|vilanterol|vilanterol
1148214|NCT02275052|exercise|exercise
1148215|NCT02275052|COPD|copd
1148216|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
1148217|NCT02274974|incisional|incisional
1148218|NCT02274974|infiltration|infiltration
1148219|NCT02274974|cs|cs
1148220|NCT02274974|lidocaine|lidocaine
1148221|NCT02274974|epinephrine|epinephrine
1148222|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
1148223|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
1148224|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
1148225|NCT02274922|ELISA,|elisa,
1148226|NCT02274922|PCR,|pcr,
1148227|NCT02274922|culture, stool|culture, stool
1148228|NCT02274909|electromyography|electromyography
1148229|NCT02274909|aged|aged
1148230|NCT02274909|muscle strength|muscle strength
1148231|NCT02274909|wavelet analysis|wavelet analysis
1148232|NCT02274909|pilates|pilates
1148233|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
1148234|NCT02274857|FIRMap|firmap
1148235|NCT02274857|Rotor|rotor
1148236|NCT02274857|FIRM-guided procedure|firm-guided procedure
1148237|NCT02274857|REAFFIRM|reaffirm
1148238|NCT02274805|Brown adipose tissue|brown adipose tissue
1148239|NCT02274805|Neck surgery|neck surgery
1148240|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
1148241|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
1148242|NCT02274766|LID|lid
1148243|NCT02274766|Parkinsonism|parkinsonism
1148244|NCT02274766|Parkinson's Disease|parkinson's disease
1148245|NCT02274727|Biomarker|biomarker
1148246|NCT02274727|Stroke|stroke
1148247|NCT02274727|Etiology|etiology
1148248|NCT02274727|Outcome|outcome
1148249|NCT02274675|Stroke|stroke
1148250|NCT02274675|Robot-assisted therapy|robot-assisted therapy
1148251|NCT02274675|Rehabilitation|rehabilitation
1148252|NCT02274623|Bone Neoplasms|bone neoplasms
1148253|NCT02274623|Hypocalcemia|hypocalcemia
1148254|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1148255|NCT02274610|docetaxel|docetaxel
1148256|NCT02274610|Pharmacokinetic|pharmacokinetic
1148257|NCT02274597|hypothermia|hypothermia
1148258|NCT02274597|pre-hospital|pre-hospital
1148259|NCT02274597|epitympanic|epitympanic
1148260|NCT02274597|temperature|temperature
1148261|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
1148262|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1148263|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
1148264|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
1148265|NCT02274519|multiple myeloma|multiple myeloma
1148266|NCT02274519|plasma cell disorder|plasma cell disorder
1148267|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
1148268|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
1148269|NCT02274506|Leukemia|leukemia
1148270|NCT02274506|Lymphoma|lymphoma
1148271|NCT02274506|CD19-specific T cells|cd19-specific t cells
1148272|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1148273|NCT02274506|ALL|all
1148274|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
1148275|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1148276|NCT02274506|NHL|nhl
1148277|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1148278|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
1148279|NCT02274506|Follicular lymphoma|follicular lymphoma
1148280|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
1148281|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1148282|NCT02274506|CLL|cll
1148283|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
1148284|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
1148285|NCT02274493|breast reconstruction|breast reconstruction
1148286|NCT02274493|scalp reconstruction|scalp reconstruction
1148287|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
1148288|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
1148289|NCT02274480|MRI|mri
1148290|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
1148291|NCT02274480|14-191|14-191
1148292|NCT02274467|Tsui Test|tsui test
1148293|NCT02274467|Labour|labour
1148294|NCT02274467|Epidural catheter|epidural catheter
1148295|NCT02274454|Uterine contraction|uterine contraction
1148296|NCT02274454|Oxytocin desensitization|oxytocin desensitization
1148297|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
1148298|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
1148299|NCT02274415|Sickle cell disease|sickle cell disease
1148300|NCT02274415|Immunogenicity|immunogenicity
1148301|NCT02274415|Antibody response|antibody response
1148302|NCT02274402|Prednisone|prednisone
1148303|NCT02274402|Glucocorticoids|glucocorticoids
1148304|NCT02274402|pharmacokinetics|pharmacokinetics
1148305|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
1148306|NCT02274389|Bedaquiline|bedaquiline
1148307|NCT02274389|Sirturo|sirturo
1148308|NCT02274389|Observational|observational
1148309|NCT02274389|Prospective|prospective
1148310|NCT02274363|Psoriasis|psoriasis
1148311|NCT02274363|Plaque|plaque
1148312|NCT02274363|Chronic|chronic
1148313|NCT02274350|prostate cancer|prostate cancer
1148314|NCT02274350|radiation therapy|radiation therapy
1148315|NCT02274350|sexual side effects|sexual side effects
1148316|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1148317|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1148318|NCT02274337|T790M mutation|t790m mutation
1148319|NCT02274324|parkinson|parkinson
1148320|NCT02274324|duodopa|duodopa
1148321|NCT02274324|diet|diet
1148322|NCT02274324|proteins|proteins
1148323|NCT02274324|amino acids|amino acids
1148324|NCT02274311|Acromegaly|acromegaly
1148325|NCT02274311|SERM|serm
1148326|NCT02274311|Clomiphene|clomiphene
1148327|NCT02274285|Tetanus|tetanus
1148328|NCT02274285|Diphtheria|diphtheria
1148329|NCT02274285|Pertussis|pertussis
1148330|NCT02274285|Poliomyelitis|poliomyelitis
1148331|NCT02274285|Bacterial meningitis|bacterial meningitis
1148332|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
1148333|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
1148334|NCT02274272|type 2 diabetes|type 2 diabetes
1148335|NCT02274246|Segmentation|segmentation
1148336|NCT02274246|GIMIAS® program|gimias® program
1148337|NCT02274246|Atrial fibrillation|atrial fibrillation
1148338|NCT02274246|Left atrial fibrosis|left atrial fibrosis
1148339|NCT02274246|Healthy volunteers|healthy volunteers
1148340|NCT02274233|Chelation|chelation
1148341|NCT02274233|Iron Overload|iron overload
1148342|NCT02274233|Thalassemia|thalassemia
1148343|NCT02274233|Transfusion|transfusion
1148344|NCT02274233|Iron Chelation|iron chelation
1148345|NCT02274220|systemic inflammation|systemic inflammation
1148346|NCT02274220|glucose metabolism|glucose metabolism
1148347|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
1148348|NCT02274207|Silver dressing|silver dressing
1148349|NCT02274207|NPWT|npwt
1148351|NCT02274207|foot|foot
1148352|NCT02274194|obstructive sleep apnoea|obstructive sleep apnoea
1148353|NCT02274194|nasal mask|nasal mask
1148354|NCT02274194|oronasal mask|oronasal mask
1148355|NCT02274194|breathing route|breathing route
1148356|NCT02274194|CPAP|cpap
1148357|NCT02274155|Head and Neck Cancer|head and neck cancer
1148358|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
1148359|NCT02274155|MEDI6469|medi6469
1148360|NCT02274155|Immunotherapy|immunotherapy
1148361|NCT02274142|dentinal caries|dentinal caries
1148362|NCT02274142|occlusal|occlusal
1148363|NCT02274142|occluso-proximal|occluso-proximal
1148364|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
1148366|NCT02274116|spasticity|spasticity
1148367|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
1148368|NCT02274116|breathing|breathing
1148369|NCT02274116|strength|strength
1148370|NCT02274090|Metformin|metformin
1148371|NCT02274090|Pocket depth|pocket depth
1148372|NCT02274090|moderate periodontitis|moderate periodontitis
1148373|NCT02274090|severe periodontitis|severe periodontitis
1148374|NCT02274077|length of stay|length of stay
1148375|NCT02274077|nausea|nausea
1148376|NCT02274077|emesis|emesis
1148377|NCT02274077|bowel function|bowel function
1148378|NCT02274077|pain scores|pain scores
1148379|NCT02274077|narcotic pain medication|narcotic pain medication
1148380|NCT02274077|post operative period|post operative period
1148381|NCT02274064|Retention|retention
1148382|NCT02274064|Blood Donor Motivation|blood donor motivation
1148383|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
1148384|NCT02274012|Gastric|gastric
1148385|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
1148386|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
1148387|NCT02274012|Esophageal Cancer|esophageal cancer
1148388|NCT02274012|Metastatic|metastatic
1148389|NCT02274012|HER2 amplified|her2 amplified
1148390|NCT02274012|Afatinib|afatinib
1148391|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
1148392|NCT02273999|post operative morbidity|post operative morbidity
1148393|NCT02273999|third molar|third molar
1148394|NCT02273999|extraction|extraction
1148395|NCT02273999|pain|pain
1148396|NCT02273986|Adult Volunteers|adult volunteers
1148397|NCT02273934|Home-based rehabilitation|home-based rehabilitation
1148398|NCT02273934|Activities of daily living|activities of daily living
1148399|NCT02273934|Restorative care|restorative care
1148400|NCT02273934|Reablement|reablement
1148401|NCT02273934|Everyday rehabilitation|everyday rehabilitation
1148402|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
1148403|NCT02273908|Low-Back Pain|low-back pain
1148404|NCT02273908|Neuropathic Pain|neuropathic pain
1148405|NCT02273908|Pregabalin|pregabalin
1148406|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
1148407|NCT02273882|RSV|rsv
1148408|NCT02273882|RSVH|rsvh
1148409|NCT02273882|Infant|infant
1148410|NCT02273882|Gestational Age|gestational age
1148411|NCT02273882|wGA|wga
1148412|NCT02273882|PRETERM|preterm
1148413|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
1148414|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
1148415|NCT02273843|Preterm|preterm
1148416|NCT02273843|late-onset sepsis|late-onset sepsis
1148417|NCT02273843|Vitamin D|vitamin d
1148418|NCT02273843|Dose|dose
1148419|NCT02273843|Interleukin-6|interleukin-6
1148420|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
1148421|NCT02273830|oxygen therapy|oxygen therapy
1148422|NCT02273830|COPD|copd
1148423|NCT02273830|exercise|exercise
1148424|NCT02273804|Topiramate|topiramate
1148425|NCT02273804|Obesity|obesity
1148426|NCT02273804|Children|children
1148427|NCT02273804|Adolescents|adolescents
1148428|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
1148429|NCT02273791|FET protocols|fet protocols
1148430|NCT02273739|solid tumor|solid tumor
1148431|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1148432|NCT02273739|ICC|icc
1148433|NCT02273739|chondrosarcoma|chondrosarcoma
1148434|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1148435|NCT02273739|AITL|aitl
1148436|NCT02273739|IDH|idh
1148437|NCT02273739|glioma|glioma
1148438|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
1148439|NCT02273726|Anemia|anemia
1148440|NCT02273726|Chronic Kidney Disease|chronic kidney disease
1148441|NCT02273726|Dialysis|dialysis
1148442|NCT02273726|hemodialysis|hemodialysis
1148443|NCT02273726|peritoneal dialysis|peritoneal dialysis
1148444|NCT02273726|hemoglobin|hemoglobin
1148445|NCT02273726|End stage renal disease|end stage renal disease
1148446|NCT02273726|Stable Dialysis|stable dialysis
1148447|NCT02273726|erythropoietins|erythropoietins
1148448|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1148449|NCT02273713|Esophageal cancer|esophageal cancer
1148450|NCT02273713|Metastasized|metastasized
1148451|NCT02273713|Nab-paclitaxel|nab-paclitaxel
1148452|NCT02273713|Toxicity|toxicity
1148453|NCT02273713|First line treatment|first line treatment
1148454|NCT02273713|Phase Ib/II|phase ib/ii
1148455|NCT02273700|Xarelto®|xarelto®
1148456|NCT02273700|protein/peptide profiles|protein/peptide profiles
1148457|NCT02273687|diaphragm movement|diaphragm movement
1148458|NCT02273687|ultrasound|ultrasound
1148459|NCT02273687|emergency room|emergency room
1148460|NCT02273674|Borderline Personality Disorder|borderline personality disorder
1148461|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1148462|NCT02273648|national|national
1148463|NCT02273648|multicenter|multicenter
1148464|NCT02273648|observational registry|observational registry
1148465|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
1148466|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
1148467|NCT02273648|coronary revascularization|coronary revascularization
1148468|NCT02273648|PCI|pci
1148469|NCT02273648|STEMI|stemi
1148470|NCT02273648|NSTEMI|nstemi
1148471|NCT02273648|Ischemia|ischemia
1148472|NCT02273648|Angina|angina
1148473|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
1148474|NCT02273648|Small Vessels|small vessels
1148475|NCT02273648|Chronic Total Occlusion|chronic total occlusion
1148476|NCT02273622|hydroxytyrosol|hydroxytyrosol
1148477|NCT02273622|dietary supplement|dietary supplement
1148478|NCT02273622|gene expression regulation|gene expression regulation
1148479|NCT02273609|Atrial fibrillation|atrial fibrillation
1148480|NCT02273609|Anticoagulation|anticoagulation
1148481|NCT02273609|Vitamin K antagonists|vitamin k antagonists
1148482|NCT02273609|INR control|inr control
1148483|NCT02273583|of the extremity|of the extremity
1148484|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1148485|NCT02273570|Anemia|anemia
1148486|NCT02273570|Vascular Stiffness|vascular stiffness
1148487|NCT02273570|Vascular Calcification|vascular calcification
1148488|NCT02273323|Flow mediated dilation|flow mediated dilation
1148489|NCT02273323|tea|tea
1148490|NCT02273323|blood pressure|blood pressure
1148491|NCT02273297|Body composition|body composition
1148492|NCT02273297|Body size|body size
1148493|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
1148494|NCT02273271|FLT-PET|flt-pet
1148495|NCT02273271|DWI-MRI|dwi-mri
1148496|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
1148497|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
1148498|NCT02273232|Claudication|claudication
1148499|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
1148500|NCT02273232|EQ-5D|eq-5d
1148501|NCT02273232|Symptoms free distance|symptoms free distance
1148502|NCT02273232|ABI|abi
1148503|NCT02273232|micro vessel formation|micro vessel formation
1148504|NCT02273219|Uveal|uveal
1148505|NCT02273219|Melanoma|melanoma
1148506|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
1148507|NCT02273206|Depression|depression
1148508|NCT02273206|Breast Cancer Screening|breast cancer screening
1148831|NCT02271607|moxibustion|moxibustion
1148509|NCT02273206|Cervical Cancer Screening|cervical cancer screening
1148510|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
1148511|NCT02273154|major depressive disorder|major depressive disorder
1148512|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
1148513|NCT02273154|buspirone|buspirone
1148514|NCT02273154|paroxetine|paroxetine
1148515|NCT02273154|anxiety|anxiety
1148516|NCT02273128|Osteoporosis|osteoporosis
1148517|NCT02273128|Chronic Periodontitis|chronic periodontitis
1148518|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
1148519|NCT02273115|induction|induction
1148520|NCT02273115|Foley catheter|foley catheter
1148521|NCT02273115|oxytocin|oxytocin
1148522|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
1148524|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
1148525|NCT02273102|MDS|mds
1148526|NCT02273102|Tranylcypromine|tranylcypromine
1148527|NCT02273102|TCP|tcp
1148528|NCT02273102|ATRA|atra
1148529|NCT02273102|Tretinoin|tretinoin
1148530|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
1148531|NCT02273089|arterial stiffness|arterial stiffness
1148532|NCT02273089|CPAP|cpap
1148533|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
1148534|NCT02273089|pulse wave velocity|pulse wave velocity
1148535|NCT02273063|PTSD|ptsd
1148536|NCT02273063|MDD|mdd
1148537|NCT02273063|TMS|tms
1148538|NCT02273063|5Hz|5hz
1148539|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
1148540|NCT02273037|Labour|labour
1148541|NCT02273037|Birth asphyxia|birth asphyxia
1148542|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
1148543|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
1148544|NCT02273037|Pinard Horn|pinard horn
1148545|NCT02273037|Pediatrics|pediatrics
1148546|NCT02273037|Uganda|uganda
1148547|NCT02273024|Exercise|exercise
1148548|NCT02273024|Quality of Life|quality of life
1148549|NCT02273024|Fatigue|fatigue
1148550|NCT02273024|Symptoms|symptoms
1148551|NCT02273024|Prehabilitation|prehabilitation
1148552|NCT02273024|Aerobic Capacity|aerobic capacity
1148553|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
1148554|NCT02272985|cerebral blood flow|cerebral blood flow
1148555|NCT02272985|hemodialysis|hemodialysis
1148556|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
1148557|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
1148558|NCT02272907|Bariatric Surgery|bariatric surgery
1148559|NCT02272907|Laparoscopy|laparoscopy
1148560|NCT02272907|Weight Loss Surgery|weight loss surgery
1148561|NCT02272907|Staple Line Reinforcement|staple line reinforcement
1148562|NCT02272894|Gastric Cancer|gastric cancer
1148563|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
1148564|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
1148565|NCT02272855|HF10|hf10
1148566|NCT02272855|HSV-1|hsv-1
1148567|NCT02272855|Ipilimumab|ipilimumab
1148568|NCT02272855|Oncolytic virus|oncolytic virus
1148569|NCT02272855|Phase II|phase ii
1148570|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
1148571|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
1148572|NCT02272855|Stage IV melanoma|stage iv melanoma
1148573|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
1148574|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
1148575|NCT02272855|Combination treatment|combination treatment
1148576|NCT02272855|Intratumoral injection|intratumoral injection
1148577|NCT02272842|Nepal|nepal
1148578|NCT02272842|Cobalamin|cobalamin
1148579|NCT02272842|Neurodevelopment|neurodevelopment
1148580|NCT02272842|Stunting|stunting
1148581|NCT02272842|Growth|growth
1148582|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
1148583|NCT02272777|Myelogenous|myelogenous
1148584|NCT02272777|Chronic|chronic
1148585|NCT02272777|BCR-ABL Positive|bcr-abl positive
1148586|NCT02272751|cancer survivorship|cancer survivorship
1148587|NCT02272751|exercise|exercise
1148588|NCT02272751|relaxation|relaxation
1148589|NCT02272751|mindfulness|mindfulness
1148590|NCT02272725|ultramarathon|ultramarathon
1148591|NCT02272725|ibuprofen|ibuprofen
1148592|NCT02272725|acute kidney injury|acute kidney injury
1148593|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
1148594|NCT02272725|exertion|exertion
1148595|NCT02272712|cancer survivor|cancer survivor
1148596|NCT02272712|computerized treatment|computerized treatment
1148597|NCT02272712|symptom management|symptom management
1148598|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1148599|NCT02272699|Nimotuzumab|nimotuzumab
1148600|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
1148601|NCT02272686|Lymphoma|lymphoma
1148602|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
1148603|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
1148604|NCT02272686|SCT|sct
1148605|NCT02272686|B-cell lymphoma|b-cell lymphoma
1148606|NCT02272686|Ibrutinib|ibrutinib
1148607|NCT02272686|PCI-32765|pci-32765
1148608|NCT02272686|Imbruvica|imbruvica
1148609|NCT02272660|preemptive analgesia|preemptive analgesia
1148610|NCT02272660|parecoxib sodium|parecoxib sodium
1148611|NCT02272660|total knee arthroplasty|total knee arthroplasty
1148612|NCT02272660|total hip arthroplasty|total hip arthroplasty
1148613|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
1148614|NCT02272634|COPD|copd
1148615|NCT02272595|Biologic Markers|biologic markers
1148616|NCT02272595|Molecular testing|molecular testing
1148617|NCT02272595|Advanced cancers|advanced cancers
1148618|NCT02272595|Molecular information|molecular information
1148619|NCT02272595|Molecular profiling|molecular profiling
1148620|NCT02272595|Genetic Mutation|genetic mutation
1148621|NCT02272569|glaucoma|glaucoma
1148622|NCT02272569|glaucoma drainage device|glaucoma drainage device
1148623|NCT02272569|glaucoma shunt|glaucoma shunt
1148624|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
1148625|NCT02272530|red blood cell|red blood cell
1148626|NCT02272530|erythrocytes|erythrocytes
1148627|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
1148628|NCT02272530|cardiovascular disease|cardiovascular disease
1148629|NCT02272517|Vortioxetine|vortioxetine
1148630|NCT02272517|Cognition|cognition
1148631|NCT02272504|HCC|hcc
1148632|NCT02272504|AFP|afp
1148633|NCT02272504|AFP-L3|afp-l3
1148634|NCT02272504|DCP|dcp
1148635|NCT02272504|Surveillance|surveillance
1148636|NCT02272504|biomarkers|biomarkers
1148637|NCT02272478|AML|aml
1148638|NCT02272478|MDS|mds
1148639|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
1148640|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
1148641|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
1148642|NCT02272452|Spectroscopy|spectroscopy
1148643|NCT02272452|Primary brain tumors|primary brain tumors
1148644|NCT02272452|Gliomas|gliomas
1148645|NCT02272452|extemporaneous analysis|extemporaneous analysis
1148646|NCT02272439|Bisphenol A|bisphenol a
1148647|NCT02272439|phthalates|phthalates
1148648|NCT02272439|infertility|infertility
1148649|NCT02272439|human|human
1148650|NCT02272426|Stroke|stroke
1148651|NCT02272426|Exercise Training|exercise training
1148652|NCT02272426|Cognitive Training|cognitive training
1148653|NCT02272426|Quality of Life|quality of life
1148654|NCT02272400|image guided radiation therapy|image guided radiation therapy
1148655|NCT02272400|partial breast irradiation|partial breast irradiation
1148656|NCT02272400|breast cancer|breast cancer
1148657|NCT02272400|breast|breast
1148658|NCT02272400|cancer|cancer
1148659|NCT02272400|breast preservation|breast preservation
1148661|NCT02272400|PBI|pbi
1148662|NCT02272374|Hemodialysis|hemodialysis
1148663|NCT02272374|Arteriovenous fistula|arteriovenous fistula
1148664|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
1148665|NCT02272374|Arteriovenous graft|arteriovenous graft
1148666|NCT02272374|Elderly|elderly
1148667|NCT02272374|Very elderly|very elderly
1148668|NCT02272348|Therapeutic education|therapeutic education
1148669|NCT02272348|Functional insulin therapy|functional insulin therapy
1148670|NCT02272335|Breast Cancer|breast cancer
1148671|NCT02272335|Health Disparities|health disparities
1148672|NCT02272335|Psychosocial Intervention|psychosocial intervention
1148673|NCT02272335|Cancer Survivors|cancer survivors
1148674|NCT02272322|Anterior prolapse|anterior prolapse
1148675|NCT02272296|Injections, Jet|injections, jet
1148676|NCT02272296|pharmacology|pharmacology
1148677|NCT02272296|Insulin Aspart|insulin aspart
1148678|NCT02272296|Equipment and Supplies|equipment and supplies
1148679|NCT02272283|PCI optimization|pci optimization
1148680|NCT02272283|Coronary Remodeling|coronary remodeling
1148681|NCT02272283|Drug-Eluting Stent|drug-eluting stent
1148682|NCT02272283|Optical Coherence Tomography|optical coherence tomography
1148683|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
1148684|NCT02272283|Strut Coverage|strut coverage
1148685|NCT02272283|Strut Apposition|strut apposition
1148686|NCT02272283|Vascular Healing Pattern|vascular healing pattern
1148687|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
1148688|NCT02272257|Physical Therapists|physical therapists
1148689|NCT02272257|Drug Prescriptions|drug prescriptions
1148690|NCT02272257|Humans|humans
1148691|NCT02272257|Physical Therapy Modalities|physical therapy modalities
1148692|NCT02272257|Referral and Consultation|referral and consultation
1148693|NCT02272257|Workers' Compensation|workers' compensation
1148694|NCT02272257|United States|united states
1148695|NCT02272257|Primary Care|primary care
1148696|NCT02272257|Health Services Research|health services research
1148697|NCT02272257|Triage|triage
1148698|NCT02272257|Acute|acute
1148699|NCT02272257|Cost|cost
1148700|NCT02272257|Occupational Health|occupational health
1148701|NCT02272244|Colorectal Cancer|colorectal cancer
1148702|NCT02272244|Cancer Screening|cancer screening
1148703|NCT02272244|Decision Support|decision support
1148704|NCT02272244|Navigation|navigation
1148705|NCT02272231|women's health|women's health
1148706|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
1148707|NCT02272231|african americans|african americans
1148708|NCT02272205|Hip replacement|hip replacement
1148709|NCT02272205|Knee replacement|knee replacement
1148710|NCT02272205|Knee infection|knee infection
1148711|NCT02272205|Hip infection|hip infection
1148712|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
1148713|NCT02272192|autism|autism
1148714|NCT02272192|autism spectrum disorder|autism spectrum disorder
1148715|NCT02272192|intensive intervention|intensive intervention
1148716|NCT02272192|early intervention|early intervention
1148717|NCT02272192|Early Start Denver Model|early start denver model
1148718|NCT02272179|adolescence|adolescence
1148719|NCT02272179|suicidality|suicidality
1148720|NCT02272179|depression|depression
1148721|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
1148722|NCT02272088|physical activity|physical activity
1148723|NCT02272088|energy expenditure|energy expenditure
1148724|NCT02272088|compensatory mechanisms|compensatory mechanisms
1148725|NCT02272088|adolescent|adolescent
1148726|NCT02272075|screeening|screeening
1148727|NCT02272062|Coronary artery disease|coronary artery disease
1148728|NCT02272062|Angina|angina
1148729|NCT02272062|Shared decision-making|shared decision-making
1148730|NCT02272062|Patient preferences|patient preferences
1148731|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
1148732|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
1148733|NCT02272049|Respiratory|respiratory
1148734|NCT02272036|Colonoscopy|colonoscopy
1148735|NCT02272036|Colonoscopy preparation|colonoscopy preparation
1148736|NCT02272036|screening|screening
1148737|NCT02272036|New media|new media
1148738|NCT02272036|SMS|sms
1148739|NCT02272036|Short message service|short message service
1148740|NCT02272023|alcohol|alcohol
1148741|NCT02272023|women|women
1148742|NCT02272023|motivational interviewing|motivational interviewing
1148743|NCT02271984|Healthy|healthy
1148744|NCT02271984|Praziquantel|praziquantel
1148745|NCT02271984|L-PZQ|l-pzq
1148746|NCT02271984|PZQ|pzq
1148747|NCT02271984|MSC2499550A|msc2499550a
1148748|NCT02271984|Bioavailability|bioavailability
1148749|NCT02271984|Pharmacokinetics|pharmacokinetics
1148750|NCT02271971|Psoriasis|psoriasis
1148751|NCT02271971|Vitamin D|vitamin d
1148752|NCT02271971|Metabolic syndrome|metabolic syndrome
1148753|NCT02271971|Insulin resistance|insulin resistance
1148754|NCT02271971|Cholesterol|cholesterol
1148755|NCT02271971|Methotrexate|methotrexate
1148756|NCT02271971|Dyslipidemia|dyslipidemia
1148757|NCT02271971|PASI|pasi
1148758|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
1148759|NCT02271958|Mifepristone|mifepristone
1148760|NCT02271958|Endometriosis|endometriosis
1148783|NCT02271906|BIBW 2992|bibw 2992
1148784|NCT02271906|Afatinib|afatinib
1148785|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1148786|NCT02271880|Medication nonadherence|medication nonadherence
1148787|NCT02271802|Butyrate|butyrate
1148788|NCT02271802|Interorgan metabolism|interorgan metabolism
1148789|NCT02271802|Short-chain fatty acids|short-chain fatty acids
1148790|NCT02271802|Gut production|gut production
1148791|NCT02271776|Insulin Sensitivity|insulin sensitivity
1148792|NCT02271763|cricothyroid membrane|cricothyroid membrane
1148793|NCT02271763|ultrasound|ultrasound
1148794|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
1148795|NCT02271737|Newborn|newborn
1148796|NCT02271737|infection|infection
1148797|NCT02271737|community health|community health
1148798|NCT02271724|CIDP|cidp
1148799|NCT02271724|MMN|mmn
1148800|NCT02271724|Spinal fluid|spinal fluid
1148801|NCT02271724|CD163|cd163
1148802|NCT02271724|CD19|cd19
1148803|NCT02271711|Brain Cancer|brain cancer
1148804|NCT02271711|Brain tumor|brain tumor
1148805|NCT02271711|Recurrent posterior fossa tumors|recurrent posterior fossa tumors
1148806|NCT02271711|Central nervous system|central nervous system
1148807|NCT02271711|CNS|cns
1148808|NCT02271711|Artificial antigen- presenting cells|artificial antigen- presenting cells
1148809|NCT02271711|aAPC|aapc
1148810|NCT02271711|Natural killer cells|natural killer cells
1148811|NCT02271711|NK|nk
1148812|NCT02271711|Ommaya reservoir|ommaya reservoir
1148813|NCT02271698|Knee arthroplasty|knee arthroplasty
1148814|NCT02271698|Dexamethasone|dexamethasone
1148815|NCT02271698|Acute pain|acute pain
1148816|NCT02271698|Chronic pain|chronic pain
1148817|NCT02271685|Diagnostic Information|diagnostic information
1148818|NCT02271685|Risk Perception|risk perception
1148819|NCT02271659|Prostate|prostate
1148820|NCT02271659|external beam radiotherapy|external beam radiotherapy
1148821|NCT02271659|brachytherapy boost|brachytherapy boost
1148822|NCT02271659|economical evaluation|economical evaluation
1148823|NCT02271646|paravertebral block|paravertebral block
1148824|NCT02271646|ultrasound guided|ultrasound guided
1148825|NCT02271633|Nitrate|nitrate
1148826|NCT02271633|Bioavailability|bioavailability
1148827|NCT02271633|Sports|sports
1148828|NCT02271620|1 prevalence|1 prevalence
1148829|NCT02271620|2 children|2 children
1148830|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
1148832|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
1148833|NCT02271555|sevoflurane|sevoflurane
1148834|NCT02271555|remifentanil|remifentanil
1148835|NCT02271542|Propofol|propofol
1148836|NCT02271542|Polymorphism|polymorphism
1148837|NCT02271542|UGT1A9|ugt1a9
1148838|NCT02271542|CYP2B6|cyp2b6
1148839|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
1148840|NCT02271529|Femoral Artery|femoral artery
1148841|NCT02271529|Drug-Eluting Stent|drug-eluting stent
1148842|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
1148843|NCT02271490|ICSI|icsi
1148844|NCT02271490|Acrosome Reaction|acrosome reaction
1148845|NCT02271490|Pregnancy outcome|pregnancy outcome
1148846|NCT02271477|Fluid replacement|fluid replacement
1148847|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
1148848|NCT02271477|Spinal Anesthesia|spinal anesthesia
1148849|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
1148850|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
1148851|NCT02271464|Ist line therapy|ist line therapy
1148852|NCT02271464|metronimic therapy|metronimic therapy
1148853|NCT02271464|bevacizumab|bevacizumab
1148854|NCT02271451|concussion|concussion
1148855|NCT02271438|Healthy|healthy
1148856|NCT02271438|Ibrutinib|ibrutinib
1148857|NCT02271438|Moxifloxacin|moxifloxacin
1148858|NCT02271438|Cardiac Repolarization|cardiac repolarization
1148859|NCT02271438|Electrocardiogram|electrocardiogram
1148860|NCT02271438|QTc interval|qtc interval
1148861|NCT02271399|venous thromboembolism|venous thromboembolism
1148862|NCT02271399|total knee arthroplasty|total knee arthroplasty
1148863|NCT02271386|Evidence-Based Practice|evidence-based practice
1148864|NCT02271386|Provider Education|provider education
1148865|NCT02271373|Vision, Ocular|vision, ocular
1148866|NCT02271373|Physical activity|physical activity
1148867|NCT02271373|Schoolchildren|schoolchildren
1148868|NCT02271373|Intervention Studies|intervention studies
1148869|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
1148870|NCT02271334|Asthma|asthma
1148871|NCT02271334|Albuterol|albuterol
1148872|NCT02271321|dementia|dementia
1148873|NCT02271321|white noise|white noise
1148874|NCT02271321|agitation|agitation
1148875|NCT02271321|saliva cortisol|saliva cortisol
1148876|NCT02271308|elastic band resistance training|elastic band resistance training
1148877|NCT02271308|nursing home residents|nursing home residents
1148878|NCT02271308|muscle strength|muscle strength
1148879|NCT02271308|flexibility|flexibility
1148880|NCT02271308|quality of life|quality of life
1148881|NCT02271308|ease of care|ease of care
1148882|NCT02271295|Cirrhosis|cirrhosis
1148883|NCT02271295|Child B|child b
1148884|NCT02271295|decompensation|decompensation
1148885|NCT02271295|mortality|mortality
1148886|NCT02271295|portal thrombosis|portal thrombosis
1148887|NCT02271295|anticoagulation|anticoagulation
1148888|NCT02271269|glaucoma|glaucoma
1148889|NCT02271269|medication adherence|medication adherence
1148890|NCT02271269|financial incentives|financial incentives
1148891|NCT02271269|behavioral economics|behavioral economics
1148892|NCT02271256|Functional intimate apparel|functional intimate apparel
1148893|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
1148894|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
1148895|NCT02271243|mucosal barrier injury|mucosal barrier injury
1148896|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
1148897|NCT02271217|Post stroke|post stroke
1148898|NCT02271217|Ischemic stroke|ischemic stroke
1148899|NCT02271126|ECMO|ecmo
1148900|NCT02271126|Heparin|heparin
1148901|NCT02271126|Thromboelastography|thromboelastography
1148902|NCT02271126|Bleeding complications|bleeding complications
1148904|NCT02271074|Care|care
1148905|NCT02271074|Treatment|treatment
1148906|NCT02271074|Retention|retention
1148907|NCT02271074|Implementation Science|implementation science
1148908|NCT02271048|telemedicine|telemedicine
1148909|NCT02271048|ultrasonography|ultrasonography
1148910|NCT02271048|echocardiography|echocardiography
1148911|NCT02271035|VUR|vur
1148912|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
1148913|NCT02271022|NSTEMI|nstemi
1148914|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
1148915|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
1148916|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
1148917|NCT02270983|Linaclotide|linaclotide
1148918|NCT02270983|Linzess|linzess
1148919|NCT02270944|GBS|gbs
1148920|NCT02270944|vaccine comparability|vaccine comparability
1148921|NCT02270944|Group B Strep|group b strep
1148922|NCT02270918|Xa inhibitor|xa inhibitor
1148923|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
1148924|NCT02270918|anticoagulation|anticoagulation
1148925|NCT02270905|meniscus|meniscus
1148926|NCT02270905|meniscectomy|meniscectomy
1148927|NCT02270905|decellularised|decellularised
1148928|NCT02270905|xenograft|xenograft
1148929|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
1148930|NCT02270866|aphasia|aphasia
1148931|NCT02270866|stroke|stroke
1148932|NCT02270853|ApneaLink|apnealink
1148933|NCT02270853|bronchial carcinoma|bronchial carcinoma
1148934|NCT02270853|sleep apnea screening|sleep apnea screening
1148935|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
1148936|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
1148937|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
1148938|NCT02270801|pregnancy|pregnancy
1148939|NCT02270775|Questionnaire|questionnaire
1148940|NCT02270775|Translation|translation
1148941|NCT02270762|Early Physical Exercise|early physical exercise
1148942|NCT02270762|Early Passive Exercise|early passive exercise
1148943|NCT02270762|Alveolar Recruitment|alveolar recruitment
1148944|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
1148945|NCT02270762|Oxygenation|oxygenation
1148946|NCT02270762|Ventilation|ventilation
1148947|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
1148948|NCT02270684|Home monitoring|home monitoring
1148949|NCT02270671|Social Anxiety|social anxiety
1148950|NCT02270671|Social Phobia|social phobia
1148951|NCT02270671|Depression|depression
1148952|NCT02270671|Attention Bias Modification Training|attention bias modification training
1148953|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
1148954|NCT02270658|hypertension|hypertension
1148955|NCT02270658|sleep apnea|sleep apnea
1148956|NCT02270606|Rectum|rectum
1148957|NCT02270541|Telemedicine|telemedicine
1148958|NCT02270541|Prehospital|prehospital
1148959|NCT02270541|Emergency Medicine|emergency medicine
1148960|NCT02270541|Stroke|stroke
1148961|NCT02270515|Patient-Centered Care|patient-centered care
1148962|NCT02270515|Medical Home|medical home
1148963|NCT02270502|critically illness|critically illness
1148964|NCT02270502|intensive care unit|intensive care unit
1148965|NCT02270502|outcome|outcome
1148966|NCT02270502|frailty|frailty
1148967|NCT02270476|Cystic Fibrosis|cystic fibrosis
1148968|NCT02270476|Infant|infant
1148969|NCT02270476|Toddler|toddler
1148970|NCT02270476|Children|children
1148971|NCT02270476|Newborn screening|newborn screening
1148972|NCT02270437|total knee arthroplasty|total knee arthroplasty
1148973|NCT02270437|cocktail analgesia|cocktail analgesia
1148974|NCT02270437|morphine consumption|morphine consumption
1148975|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1148976|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
1148977|NCT02270424|Humans|humans
1148978|NCT02270424|Treatment Outcome|treatment outcome
1148979|NCT02270398|Exercise|exercise
1148980|NCT02270398|Balance|balance
1148981|NCT02270398|Gait|gait
1148982|NCT02270398|Community|community
1148983|NCT02270398|Rehabilitation|rehabilitation
1148984|NCT02270398|Dual-task|dual-task
1148985|NCT02270385|pressure ulcer|pressure ulcer
1148986|NCT02270385|nursing home|nursing home
1148987|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
1148988|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
1148989|NCT02270372|MUC1|muc1
1148990|NCT02270372|vaccine|vaccine
1148991|NCT02270372|Phase 1b|phase 1b
1148992|NCT02270359|Myocardial Infarction|myocardial infarction
1148994|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
1148995|NCT02270333|sarcoidosis|sarcoidosis
1148996|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
1148997|NCT02270333|exercise capacity|exercise capacity
1148998|NCT02270333|quality of life|quality of life
1148999|NCT02270320|Tai Chi Chuan|tai chi chuan
1149000|NCT02270320|cognitive function|cognitive function
1149001|NCT02270320|motor function|motor function
1149002|NCT02270320|MRI|mri
1149003|NCT02270294|Ischemic stroke|ischemic stroke
1149004|NCT02270294|Thai traditional massage|thai traditional massage
1149005|NCT02270294|Vascular function|vascular function
1149006|NCT02270294|Cerebral blood flow|cerebral blood flow
1149007|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
1149008|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
1149009|NCT02270268|Gut microbiota|gut microbiota
1149010|NCT02270268|Soluble dietary fiber|soluble dietary fiber
1149011|NCT02270255|embolization|embolization
1149012|NCT02270255|analgesia|analgesia
1149014|NCT02270242|DAPT|dapt
1149015|NCT02270242|ticagrelor|ticagrelor
1149016|NCT02270242|aspirin|aspirin
1149017|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
1149018|NCT02270216|exercise pressor responses|exercise pressor responses
1149019|NCT02270203|si joint|si joint
1149020|NCT02270203|si joint injury|si joint injury
1149021|NCT02270203|si joint treatment|si joint treatment
1149022|NCT02270203|si joint inflammation|si joint inflammation
1149023|NCT02270203|si joint problems|si joint problems
1149024|NCT02270203|si joint symptoms|si joint symptoms
1149025|NCT02270203|hypermobile joint|hypermobile joint
1149026|NCT02270203|si joint arthritis|si joint arthritis
1149027|NCT02270203|si joint pain treatment|si joint pain treatment
1149028|NCT02270203|inflamed si joint|inflamed si joint
1149029|NCT02270203|si joint sclerosis|si joint sclerosis
1149030|NCT02270203|locked si joint|locked si joint
1149031|NCT02270203|si joint injuries|si joint injuries
1149032|NCT02270203|si joint disease|si joint disease
1149132|NCT02269839|Tinnitus|tinnitus
1149033|NCT02270203|si joint infection|si joint infection
1149034|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
1149035|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
1149036|NCT02270203|si joint pain|si joint pain
1149037|NCT02270203|si joint injections|si joint injections
1149038|NCT02270177|Headache|headache
1149039|NCT02270177|Telemedicine|telemedicine
1149040|NCT02270177|Videoconsultation|videoconsultation
1149041|NCT02270177|Headache-referrals|headache-referrals
1149042|NCT02270164|Lipids|lipids
1149043|NCT02270164|Cholesterol|cholesterol
1149044|NCT02270164|Dietary Supplements|dietary supplements
1149045|NCT02270164|Cynara scolymus|cynara scolymus
1149046|NCT02270164|Safety|safety
1149047|NCT02270151|Atrial fibrillation|atrial fibrillation
1149048|NCT02270151|Screening|screening
1149049|NCT02270151|Primary care|primary care
1149050|NCT02270151|Diagnostic|diagnostic
1149051|NCT02270138|physical activity|physical activity
1149052|NCT02270138|music|music
1149053|NCT02270138|sedentary lifestyle|sedentary lifestyle
1149054|NCT02270125|nasal mucosa|nasal mucosa
1149055|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
1149056|NCT02270125|mucotomy|mucotomy
1149057|NCT02270125|nanoparticles|nanoparticles
1149058|NCT02270125|scanning electron microscopy|scanning electron microscopy
1149059|NCT02270125|Raman microspectroscopy|raman microspectroscopy
1149060|NCT02270125|nasal polyposis|nasal polyposis
1149061|NCT02270112|atrial fibrillation|atrial fibrillation
1149062|NCT02270112|atrial electrophysiology|atrial electrophysiology
1149063|NCT02270112|stroke|stroke
1149064|NCT02270112|vascular stiffness|vascular stiffness
1149065|NCT02270073|Psychotherapy process|psychotherapy process
1149066|NCT02270073|Change mechanisms|change mechanisms
1149067|NCT02270073|Mindfulness|mindfulness
1149068|NCT02270073|Micro-interventions|micro-interventions
1149069|NCT02270073|Mindfulness interventions|mindfulness interventions
1149070|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
1149071|NCT02270060|Music Therapy|music therapy
1149072|NCT02270060|Sickle Cell Disease|sickle cell disease
1149073|NCT02270060|Pain|pain
1149074|NCT02270047|Ad libitum energy intake|ad libitum energy intake
1149075|NCT02270047|Appetite sensation|appetite sensation
1149076|NCT02270021|Pap smear|pap smear
1149077|NCT02270021|Screening|screening
1149078|NCT02270021|Women|women
1149079|NCT02270021|Human papillomavirus|human papillomavirus
1149080|NCT02270021|Cervical precancer|cervical precancer
1149081|NCT02270021|Guideline adherence|guideline adherence
1149082|NCT02270008|anal incontinence|anal incontinence
1149083|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
1149084|NCT02269995|Hepatocellular|hepatocellular
1149085|NCT02269995|Carcinoma|carcinoma
1149086|NCT02269969|Aminoglycoside|aminoglycoside
1149087|NCT02269969|Pharmacokinetics|pharmacokinetics
1149088|NCT02269969|Once daily dosing|once daily dosing
1149089|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
1149090|NCT02269943|oral azacitidine|oral azacitidine
1149091|NCT02269943|oral AZA|oral aza
1149092|NCT02269943|CC-486|cc-486
1149093|NCT02269943|metastatic|metastatic
1149094|NCT02269943|recurrent|recurrent
1149095|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1149096|NCT02269943|nasal|nasal
1149097|NCT02269943|solid tumors|solid tumors
1149098|NCT02269943|locally advanced|locally advanced
1149099|NCT02269943|rare head and neck cancer|rare head and neck cancer
1149100|NCT02269943|nasopharynx|nasopharynx
1149101|NCT02269943|single chemotherapy agent|single chemotherapy agent
1149102|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
1149103|NCT02269943|EBV-DN|ebv-dn
1149104|NCT02269943|Celgene|celgene
1149105|NCT02269943|Sponsor-study|sponsor-study
1149106|NCT02269943|oral chemotherapy|oral chemotherapy
1149107|NCT02269943|phase 2|phase 2
1149108|NCT02269943|oral Vidaza|oral vidaza
1149109|NCT02269943|EBV promoter methylation|ebv promoter methylation
1149110|NCT02269943|hypomethylation|hypomethylation
1149111|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
1149112|NCT02269943|EBV gene expression|ebv gene expression
1149113|NCT02269943|neoplasms|neoplasms
1149114|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
1149115|NCT02269917|Emerald|emerald
1149116|NCT02269917|Darunavir|darunavir
1149117|NCT02269917|Cobicistat|cobicistat
1149118|NCT02269917|Emtricitabine|emtricitabine
1149119|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
1149120|NCT02269891|Menopausal symptoms|menopausal symptoms
1149121|NCT02269891|Peri-menopause|peri-menopause
1149122|NCT02269891|Nu Femme|nu femme
1149123|NCT02269891|Labisia pumila|labisia pumila
1149124|NCT02269891|Eurycoma longifolia|eurycoma longifolia
1149125|NCT02269891|Hot flash|hot flash
1149126|NCT02269891|Joint pain|joint pain
1149127|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
1149128|NCT02269852|immunogenicity|immunogenicity
1149129|NCT02269852|safety|safety
1149130|NCT02269852|cross-reactivity|cross-reactivity
1149131|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
1149133|NCT02269839|rTMS|rtms
1149134|NCT02269813|MammaPrint|mammaprint
1149135|NCT02269813|BluePrint|blueprint
1149136|NCT02269813|TargetPrint|targetprint
1149137|NCT02269774|Atrial Fibrillation|atrial fibrillation
1149138|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
1149139|NCT02269774|Atrial Premature Complexes|atrial premature complexes
1149140|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
1149141|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
1149142|NCT02269761|Emergency Departments|emergency departments
1149143|NCT02269761|Chest|chest
1149144|NCT02269761|Lung|lung
1149145|NCT02269761|Cough|cough
1149146|NCT02269761|Dyspnea|dyspnea
1149147|NCT02269761|Wheezing|wheezing
1149148|NCT02269761|Ultrasound|ultrasound
1149149|NCT02269761|Ultrasonography|ultrasonography
1149150|NCT02269657|Scoliosis|scoliosis
1149151|NCT02269657|Postural balance|postural balance
1149152|NCT02269657|Lordosis|lordosis
1149153|NCT02269657|Kyphosis|kyphosis
1149154|NCT02269657|X-rays|x-rays
1149155|NCT02269631|Weight loss|weight loss
1149156|NCT02269631|Epidemiology|epidemiology
1149157|NCT02269631|Nutrition|nutrition
1149158|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
1149159|NCT02269605|HIV reservoir|hiv reservoir
1149160|NCT02269605|Bryostatin|bryostatin
1149161|NCT02269592|MGUS|mgus
1149162|NCT02269592|Smoldering Myeloma|smoldering myeloma
1149163|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
1149164|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
1149165|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
1149166|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1149167|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
1149168|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
1149169|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
1149170|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
1149171|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
1149172|NCT02269579|Secondary AML|secondary aml
1149173|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
1149174|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
1149175|NCT02269566|allergic rhinitis|allergic rhinitis
1149176|NCT02269566|immunotherapy|immunotherapy
1149177|NCT02269553|Migraine|migraine
1149178|NCT02269553|Headache|headache
1149179|NCT02269514|adoption|adoption
1149180|NCT02269514|electronic cigarettes|electronic cigarettes
1149181|NCT02269514|e-cigarettes|e-cigarettes
1149182|NCT02269514|combustible cigarettes|combustible cigarettes
1149183|NCT02269514|nicotine polacrilex|nicotine polacrilex
1149184|NCT02269514|own brand cigarette|own brand cigarette
1149185|NCT02269514|subjective measures|subjective measures
1149186|NCT02269514|pharmacokinetics|pharmacokinetics
1149187|NCT02269514|pharmacodynamics|pharmacodynamics
1149188|NCT02269488|Safety|safety
1149189|NCT02269488|Tolerability|tolerability
1149190|NCT02269488|MEDI3250|medi3250
1149191|NCT02269488|Japanese children|japanese children
1149192|NCT02269475|Efficacy|efficacy
1149193|NCT02269475|Safety|safety
1149194|NCT02269475|Tolerability|tolerability
1149195|NCT02269475|MEDI3250|medi3250
1149196|NCT02269475|Japanese children|japanese children
1149197|NCT02269449|transradial intervention|transradial intervention
1149198|NCT02269449|radial artery|radial artery
1149199|NCT02269410|Bariatric Surgery|bariatric surgery
1149200|NCT02269410|Nitrogen Balance|nitrogen balance
1149201|NCT02269410|Body composition|body composition
1149202|NCT02269410|Protein supplementation|protein supplementation
1149203|NCT02269410|Satiety|satiety
1149204|NCT02269410|Adherence|adherence
1149205|NCT02269397|Epilepsy|epilepsy
1149206|NCT02269397|Seizures|seizures
1149207|NCT02269397|Diagnosis|diagnosis
1149208|NCT02269397|Diagnostic|diagnostic
1149209|NCT02269397|Inflammation|inflammation
1149210|NCT02269384|Pain|pain
1149211|NCT02269384|Memory|memory
1149212|NCT02269384|Pressure Pain Threshold|pressure pain threshold
1149213|NCT02269384|Electromyography|electromyography
1149214|NCT02269384|Heart Rate Variability|heart rate variability
1149215|NCT02269319|ABSSSI|absssi
1149216|NCT02269319|MRX-I|mrx-i
1149217|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
1149218|NCT02269306|PCOS|pcos
1149219|NCT02269306|clomiphene citrate|clomiphene citrate
1149220|NCT02269306|AMH|amh
1149221|NCT02269306|visceral fat area|visceral fat area
1149222|NCT02269306|HOMA-IR|homa-ir
1149223|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
1149224|NCT02269293|Paclitaxel|paclitaxel
1149225|NCT02269293|Carboplatin|carboplatin
1149226|NCT02269293|14-110|14-110
1149227|NCT02269280|Leukemia|leukemia
1149228|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
1149229|NCT02269280|MDS|mds
1149230|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
1149231|NCT02269280|Transfusion-dependent|transfusion-dependent
1149232|NCT02269280|Transfusion-independent|transfusion-independent
1149233|NCT02269280|Best supportive care|best supportive care
1149234|NCT02269280|BSC|bsc
1149235|NCT02269280|Azacitidine|azacitidine
1149236|NCT02269280|5-Azacytidine|5-azacytidine
1149237|NCT02269280|5-AZA|5-aza
1149238|NCT02269280|Vidaza|vidaza
1149239|NCT02269280|5-AZC|5-azc
1149240|NCT02269280|AZA-CR|aza-cr
1149241|NCT02269280|Ladakamycin|ladakamycin
1149242|NCT02269280|NSC-102816|nsc-102816
1149243|NCT02269280|Azacytidine|azacytidine
1149244|NCT02269280|Decitabine|decitabine
1149245|NCT02269280|Dacogen|dacogen
1149246|NCT02269254|Comparative Study|comparative study
1149247|NCT02269254|Knee Prosthesis|knee prosthesis
1149248|NCT02269254|Prosthesis Design|prosthesis design
1149249|NCT02269254|Treatment Outcome|treatment outcome
1149250|NCT02269254|Follow-Up Studies|follow-up studies
1149251|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
1149252|NCT02269241|contraception|contraception
1149253|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
1149254|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
1149255|NCT02269241|oral contraceptive|oral contraceptive
1149256|NCT02269241|drospirenone|drospirenone
1149257|NCT02269241|LF111|lf111
1149258|NCT02269241|birth control|birth control
1149259|NCT02269150|Recipients|recipients
1149260|NCT02269150|Transplantation|transplantation
1149261|NCT02269137|status epileptics|status epileptics
1149262|NCT02269137|prognosis|prognosis
1149263|NCT02269137|risk factor|risk factor
1149264|NCT02269137|outcome|outcome
1149265|NCT02269098|type 2 diabetes|type 2 diabetes
1149266|NCT02269098|hyperglycemia|hyperglycemia
1149267|NCT02269098|Emergency Department|emergency department
1149268|NCT02269098|Patient Education as Topic|patient education as topic
1149269|NCT02269098|Drug Therapy|drug therapy
1149270|NCT02269085|Lymphoma|lymphoma
1149271|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
1149273|NCT02269085|Relapsed or refractory|relapsed or refractory
1149274|NCT02269085|Ibrutinib|ibrutinib
1149275|NCT02269085|PCI-32765|pci-32765
1149276|NCT02269085|Imbruvica|imbruvica
1149277|NCT02269085|Carfilzomib|carfilzomib
1149278|NCT02269072|Natriuretic Peptide|natriuretic peptide
1149279|NCT02269046|acupuncture|acupuncture
1149280|NCT02269046|moxibustion|moxibustion
1149281|NCT02269046|hyperlipidemias|hyperlipidemias
1149282|NCT02269046|effectiveness|effectiveness
1149283|NCT02269033|Breast cancer|breast cancer
1149284|NCT02269033|Patient Navigation|patient navigation
1149285|NCT02269033|Health Disparities|health disparities
1149286|NCT02269033|Latinas|latinas
1149287|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
1149288|NCT02269033|underserved|underserved
1149289|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
1149290|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
1149291|NCT02268994|ferric citrate|ferric citrate
1149292|NCT02268994|Chronic kidney disease|chronic kidney disease
1149293|NCT02268994|Anemia|anemia
1149294|NCT02268981|Oxymizer|oxymizer
1149295|NCT02268981|Oxygen conserving device|oxygen conserving device
1149296|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
1149297|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1149298|NCT02268968|Topical Lidocaine|topical lidocaine
1149299|NCT02268968|Nasal CPAP|nasal cpap
1149300|NCT02268968|Pain|pain
1149301|NCT02268968|Preterm Infants|preterm infants
1149302|NCT02268968|Salivary cortisol|salivary cortisol
1149303|NCT02268955|Biliary Colic|biliary colic
1149304|NCT02268955|Abdominal pain|abdominal pain
1149305|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
1149306|NCT02268916|diabetes|diabetes
1149307|NCT02268916|physical activity|physical activity
1149308|NCT02268916|participation|participation
1149309|NCT02268903|Pulmonary Embolism|pulmonary embolism
1149310|NCT02268903|Right Ventricle failure|right ventricle failure
1149311|NCT02268903|Diuretics|diuretics
1149312|NCT02268890|Multiple Myeloma|multiple myeloma
1149313|NCT02268890|Bortezomib|bortezomib
1149314|NCT02268890|Velcade|velcade
1149315|NCT02268877|ultrasonography|ultrasonography
1149316|NCT02268877|emergency department|emergency department
1149317|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
1149318|NCT02268864|Simeprevir|simeprevir
1149319|NCT02268864|Daclatasvir|daclatasvir
1149320|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
1149321|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
1149322|NCT02268838|E6007|e6007
1149323|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
1149324|NCT02268812|Pain Management|pain management
1149325|NCT02268812|Europe|europe
1149326|NCT02268812|Intrathecal|intrathecal
1149327|NCT02268799|Cardioversion|cardioversion
1149328|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
1149329|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
1149330|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
1149331|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
1149332|NCT02268786|Blastocyst|blastocyst
1149333|NCT02268786|Vitrification|vitrification
1149334|NCT02268786|In vitro fertilization|in vitro fertilization
1149335|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
1149336|NCT02268786|next generation sequencing|next generation sequencing
1149337|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
1149338|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
1149339|NCT02268721|Pilot study|pilot study
1149340|NCT02268721|Frail elderly|frail elderly
1149341|NCT02268721|Malnutrition|malnutrition
1149342|NCT02268721|Functionality|functionality
1149343|NCT02268721|Life quality|life quality
1149344|NCT02268721|Health care technology|health care technology
1149345|NCT02268708|COPD|copd
1149346|NCT02268708|Surgery, Thoracic|surgery, thoracic
1149347|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
1149348|NCT02268695|Taxanes|taxanes
1149349|NCT02268682|Educator-Guided|educator-guided
1149350|NCT02268682|Patient-Guided|patient-guided
1149351|NCT02268682|Standard of Care (Control)|standard of care (control)
1149352|NCT02268669|primary angioplasty|primary angioplasty
1149353|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
1149354|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
1149355|NCT02268643|breast cancer|breast cancer
1149356|NCT02268643|screening|screening
1149357|NCT02268643|ultrasound|ultrasound
1149358|NCT02268643|risk model|risk model
1149359|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
1149360|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1149361|NCT02268630|Anticoagulation|anticoagulation
1149362|NCT02268630|Rivaroxaban|rivaroxaban
1149363|NCT02268617|Treadmill|treadmill
1149364|NCT02268617|Walking|walking
1149365|NCT02268617|Gait|gait
1149366|NCT02268617|Exercise|exercise
1149367|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1149368|NCT02268578|TDCS|tdcs
1149369|NCT02268578|Memory Dysfunction|memory dysfunction
1149370|NCT02268578|Depression|depression
1149371|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
1149372|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
1149373|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
1149374|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
1149375|NCT02268539|pilot study|pilot study
1149376|NCT02268539|atrial fibrillation|atrial fibrillation
1149377|NCT02268539|ablation|ablation
1149378|NCT02268539|implanted loop recorder|implanted loop recorder
1149379|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
1149380|NCT02268526|immunogenicity|immunogenicity
1149381|NCT02268513|Cardiovascular Disease|cardiovascular disease
1149382|NCT02268513|Social network|social network
1149383|NCT02268513|South Asians|south asians
1149384|NCT02268487|Early Improvement|early improvement
1149385|NCT02268487|Depression|depression
1149386|NCT02268487|Antidepressant|antidepressant
1149387|NCT02268474|532nm|532nm
1149388|NCT02268474|Excel V|excel v
1149389|NCT02268474|Cutera|cutera
1149390|NCT02268474|Laser|laser
1149391|NCT02268474|Laser Light|laser light
1149392|NCT02268474|PDL|pdl
1149393|NCT02268474|595nm|595nm
1149394|NCT02268474|Flash Lamp|flash lamp
1149395|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
1149396|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
1149397|NCT02268422|Healthy volunteer|healthy volunteer
1149398|NCT02268422|crossover|crossover
1149399|NCT02268422|open-label|open-label
1149400|NCT02268422|randomised|randomised
1149401|NCT02268422|bioequivalence|bioequivalence
1149402|NCT02268422|pharmacokinetic study|pharmacokinetic study
1149403|NCT02268357|Dental Anxiety|dental anxiety
1149404|NCT02268357|Tooth Extraction|tooth extraction
1149405|NCT02268357|Propranolol|propranolol
1149406|NCT02268344|nerve regeneration|nerve regeneration
1149407|NCT02268344|spinal accessory nerve|spinal accessory nerve
1149408|NCT02268344|shoulder function|shoulder function
1149409|NCT02268344|head neck cancer|head neck cancer
1149410|NCT02268344|electrical stimulation|electrical stimulation
1149411|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
1149412|NCT02268292|Metabolic syndrome|metabolic syndrome
1149413|NCT02268292|Diabetes|diabetes
1149414|NCT02268292|Muscle strength|muscle strength
1149415|NCT02268292|Aerobic exercise|aerobic exercise
1149416|NCT02268292|Bicycle|bicycle
1149417|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
1149418|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
1149419|NCT02268214|Dapagliflozin|dapagliflozin
1149420|NCT02268214|Efficacy|efficacy
1149421|NCT02268214|Safety|safety
1149422|NCT02268214|Add on to insulin|add on to insulin
1149423|NCT02268214|Oral Antidiabetic|oral antidiabetic
1149424|NCT02268214|Type 1 diabetes|type 1 diabetes
1149425|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
1149426|NCT02268201|tacrolimus|tacrolimus
1149427|NCT02268188|Cancer Survivors|cancer survivors
1149428|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
1149429|NCT02268175|advanced prostate cancer|advanced prostate cancer
1149430|NCT02268175|high risk prostate cancer|high risk prostate cancer
1149996|NCT02264821|caesarean|caesarean
1149431|NCT02268162|Lung Neoplasms|lung neoplasms
1149432|NCT02268162|Bronchoscopy|bronchoscopy
1149433|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
1149434|NCT02268162|Fluoroscopy|fluoroscopy
1149435|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
1149436|NCT02268162|Diagnosis|diagnosis
1149437|NCT02268123|Male Infertility|male infertility
1149438|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
1149439|NCT02268123|Sperm Abnormality|sperm abnormality
1149440|NCT02268110|diastasis recti|diastasis recti
1149441|NCT02268110|physiotherapy|physiotherapy
1149442|NCT02268110|exercise therapy|exercise therapy
1149443|NCT02268110|abdominal binding|abdominal binding
1149444|NCT02268097|patella|patella
1149445|NCT02268097|total knee arthroplasty|total knee arthroplasty
1149446|NCT02268097|resection|resection
1149447|NCT02268084|PTSD|ptsd
1149448|NCT02268084|TMS|tms
1149449|NCT02268084|EEG|eeg
1149450|NCT02268071|Hypertension|hypertension
1149451|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
1149452|NCT02268071|Primary care|primary care
1149453|NCT02268071|White coat hypertension|white coat hypertension
1149454|NCT02268071|Masked Hypertension|masked hypertension
1149455|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1149456|NCT02268045|DLBCL|dlbcl
1149457|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1149458|NCT02268032|hormone replacement therapy|hormone replacement therapy
1149459|NCT02268019|hypospadias|hypospadias
1149460|NCT02268019|dehiscence|dehiscence
1149461|NCT02268019|urethral stricture|urethral stricture
1149462|NCT02268019|side effects|side effects
1149463|NCT02268006|rectal carcinoma|rectal carcinoma
1149464|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
1149465|NCT02268006|IMRT|imrt
1149466|NCT02268006|SIB|sib
1149467|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
1149468|NCT02267954|Calories|calories
1149469|NCT02267954|Fast Food Literacy|fast food literacy
1149470|NCT02267928|Symptom Assessment|symptom assessment
1149471|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
1149472|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
1149473|NCT02267902|Volunteers|volunteers
1149474|NCT02267889|Ganglionated plexi|ganglionated plexi
1149475|NCT02267850|Photobiomodulation|photobiomodulation
1149476|NCT02267850|Orthodontic treatment|orthodontic treatment
1149477|NCT02267850|Malocclusion|malocclusion
1149478|NCT02267850|OrthoPulse™|orthopulse™
1149479|NCT02267837|Alignment phase|alignment phase
1149480|NCT02267837|Photobiomodulation|photobiomodulation
1149481|NCT02267837|Orthodontic treatment|orthodontic treatment
1149482|NCT02267837|Malocclusion|malocclusion
1149483|NCT02267837|OrthoPulse™|orthopulse™
1149484|NCT02267824|Alignment phase|alignment phase
1149485|NCT02267824|Photobiomodulation|photobiomodulation
1149486|NCT02267824|Orthodontic treatment|orthodontic treatment
1149487|NCT02267824|Malocclusion|malocclusion
1149488|NCT02267824|OrthoPulse™|orthopulse™
1149489|NCT02267811|Photobiomodulation|photobiomodulation
1149490|NCT02267811|Orthodontic treatment|orthodontic treatment
1149491|NCT02267811|Malocclusion|malocclusion
1149492|NCT02267811|OrthoPulse™|orthopulse™
1149493|NCT02267798|Stroke|stroke
1149494|NCT02267798|Rehabilitation|rehabilitation
1149495|NCT02267798|Arm motor recovery|arm motor recovery
1149496|NCT02267798|biological biomarkers|biological biomarkers
1149497|NCT02267785|exercise|exercise
1149498|NCT02267785|mild cognitive impairment|mild cognitive impairment
1149499|NCT02267785|Parkinson's Disease|parkinson's disease
1149500|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
1149501|NCT02267720|Glass ionomer cement|glass ionomer cement
1149502|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
1149503|NCT02267720|Primary molars|primary molars
1149504|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
1149505|NCT02267707|ABI-007|abi-007
1149506|NCT02267707|Abraxane|abraxane
1149507|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
1149508|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
1149509|NCT02267707|Bile Duct Obstruction|bile duct obstruction
1149510|NCT02267707|Pancreatic Cancer|pancreatic cancer
1149511|NCT02267668|concussion|concussion
1149512|NCT02267668|sports concussion|sports concussion
1149513|NCT02267668|exercise therapy|exercise therapy
1149514|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
1149515|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
1149516|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1149517|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
1149518|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
1149519|NCT02267629|OCD|ocd
1149520|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
1149521|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
1149522|NCT02267616|Contraception|contraception
1149523|NCT02267564|patellar dislocation|patellar dislocation
1150098|NCT02263950|Sublingual|sublingual
1149524|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
1149525|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
1149526|NCT02267551|robotic surgery|robotic surgery
1149527|NCT02267551|simulation|simulation
1149528|NCT02267538|Delirium|delirium
1149529|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
1149530|NCT02267538|Postoperative Complications|postoperative complications
1149531|NCT02267538|Dexmedetomidine|dexmedetomidine
1149532|NCT02267538|Prevention|prevention
1149533|NCT02267525|Gastroparesis|gastroparesis
1149534|NCT02267525|Diabetic|diabetic
1149535|NCT02267525|Idiopathic|idiopathic
1149536|NCT02267512|Kidney Transplant Patients|kidney transplant patients
1211582|NCT01980654|Rituxan|rituxan
1149537|NCT02267512|ATG-F|atg-f
1149538|NCT02267499|cognitive training|cognitive training
1149539|NCT02267499|physical training|physical training
1149540|NCT02267499|exercise games|exercise games
1149541|NCT02267499|novelty serious games|novelty serious games
1149542|NCT02267499|computer training|computer training
1149543|NCT02267499|mild cognitive impairment|mild cognitive impairment
1149544|NCT02267499|mild dementia|mild dementia
1149545|NCT02267499|healthy elderly|healthy elderly
1149546|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
1149547|NCT02267486|patients|patients
1149548|NCT02267486|cognitive|cognitive
1149549|NCT02267460|Peyronie's disease|peyronie's disease
1149550|NCT02267460|penile plaque|penile plaque
1149551|NCT02267460|penile curvature|penile curvature
1149552|NCT02267447|Cardiovascular diseases|cardiovascular diseases
1149553|NCT02267447|Clinical prediction rule|clinical prediction rule
1149554|NCT02267447|Population projection|population projection
1149555|NCT02267447|Risk stratification|risk stratification
1149556|NCT02267447|Health behavior|health behavior
1149557|NCT02267408|Heart valve prosthesis|heart valve prosthesis
1149558|NCT02267408|Anticoagulation|anticoagulation
1149559|NCT02267408|Warfarin|warfarin
1149560|NCT02267395|Musicians, Injuries|musicians, injuries
1149561|NCT02267369|online|online
1149562|NCT02267369|social media|social media
1149563|NCT02267369|online social network|online social network
1149564|NCT02267369|physical activity|physical activity
1149565|NCT02267369|message|message
1149566|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
1149567|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
1149568|NCT02267330|Trauma Surgery|trauma surgery
1149569|NCT02267330|Pelvis fractures|pelvis fractures
1149570|NCT02267330|Femur fractures|femur fractures
1149571|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
1149572|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
1149573|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
1149574|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
1149575|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
1149576|NCT02267304|volunteers|volunteers
1149577|NCT02267291|Cardiac Catheterization|cardiac catheterization
1149578|NCT02267291|Echocardiography|echocardiography
1149579|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
1149580|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
1149581|NCT02267291|Ventricular Function|ventricular function
1149582|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
1149583|NCT02267278|Myelofibrosis|myelofibrosis
1149584|NCT02267278|MF|mf
1149585|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
1149586|NCT02267278|Ruxolitinib|ruxolitinib
1149587|NCT02267278|Jakafi|jakafi
1149588|NCT02267278|INCB018424|incb018424
1149589|NCT02267278|INC424|inc424
1149590|NCT02267278|Pracinostat|pracinostat
1149591|NCT02267278|Questionnaire|questionnaire
1149592|NCT02267278|Survey|survey
1149593|NCT02267265|educational intervention|educational intervention
1149594|NCT02267265|language development|language development
1149595|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
1149596|NCT02267265|postpartum|postpartum
1149597|NCT02267265|parental attachment|parental attachment
1149598|NCT02267265|loss to follow-up|loss to follow-up
1149599|NCT02267265|hearing loss|hearing loss
1149600|NCT02267265|achievement gap|achievement gap
1149601|NCT02267265|language gap|language gap
1149602|NCT02267265|school readiness|school readiness
1149603|NCT02267239|essential oils|essential oils
1149604|NCT02267239|chlorhexidine|chlorhexidine
1149605|NCT02267239|microscopy, confocal|microscopy, confocal
1149606|NCT02267239|immersion|immersion
1149607|NCT02267239|antiseptic|antiseptic
1149608|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
1149609|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
1149610|NCT02267187|Battle-injured (BI)|battle-injured (bi)
1149611|NCT02267187|Facial Trauma|facial trauma
1149612|NCT02267187|Fat Grafts|fat grafts
1149613|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1149614|NCT02267187|Wounded Warriors|wounded warriors
1149615|NCT02267174|Implementation|implementation
1149616|NCT02267174|quality improvement|quality improvement
1149617|NCT02267174|patient safety|patient safety
1149618|NCT02267174|handoffs|handoffs
1149619|NCT02267174|intensive care unit|intensive care unit
1149620|NCT02267174|postoperative care|postoperative care
1149621|NCT02267174|simulation|simulation
1149622|NCT02267161|agenesis|agenesis
1149623|NCT02267161|corpus callosum|corpus callosum
1149624|NCT02267161|prenatal diagnosis|prenatal diagnosis
1149625|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1149626|NCT02267148|Fatty liver|fatty liver
1149627|NCT02267148|Steatosis|steatosis
1149628|NCT02267148|Fibrosis|fibrosis
1149629|NCT02267148|Liver Stiffness|liver stiffness
1149630|NCT02267148|Cirrhosis|cirrhosis
1149631|NCT02267148|Genetics|genetics
1149632|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
1149633|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
1149634|NCT02267096|lung cancer screening|lung cancer screening
1149635|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
1149636|NCT02267070|cognitive training|cognitive training
1149637|NCT02267070|aerobic exercise|aerobic exercise
1149638|NCT02267070|neurotrophic factors|neurotrophic factors
1149639|NCT02267070|randomized controlled trial|randomized controlled trial
1149640|NCT02267057|Pain measurement|pain measurement
1149641|NCT02267057|Pain assessment|pain assessment
1149642|NCT02267057|Pain management|pain management
1149643|NCT02267057|Analgesia|analgesia
1149644|NCT02267057|Analgesics|analgesics
1149645|NCT02267057|Depressive symptoms|depressive symptoms
1149646|NCT02267057|Alzheimer disease|alzheimer disease
1149647|NCT02267057|Vascular dementia|vascular dementia
1149648|NCT02267057|Multi-infarct dementia|multi-infarct dementia
1149649|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
1149650|NCT02267057|Lewy body disease|lewy body disease
1149651|NCT02267031|cognitive dysfunction|cognitive dysfunction
1149652|NCT02267031|mechanical ventilation|mechanical ventilation
1149653|NCT02267031|hyperoxia|hyperoxia
1149654|NCT02267031|hypocapnia|hypocapnia
1149655|NCT02267018|nCPAP|ncpap
1149656|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
1149657|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
1149658|NCT02266979|peritoneal dialysis|peritoneal dialysis
1149659|NCT02266979|nursing staff|nursing staff
1149660|NCT02266979|nursing activities|nursing activities
1149661|NCT02266979|Personnel Downsizing|personnel downsizing
1149662|NCT02266953|Dietary services|dietary services
1149663|NCT02266953|Public Health Nursing|public health nursing
1149664|NCT02266953|Preschool child|preschool child
1149665|NCT02266940|pharmacokinetics|pharmacokinetics
1149666|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
1149667|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
1149668|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
1149669|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
1149670|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
1149671|NCT02266901|gastric bypass|gastric bypass
1149672|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
1149673|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
1149674|NCT02266888|B cells|b cells
1149675|NCT02266888|lung transplant recipient|lung transplant recipient
1149676|NCT02266888|rituximab|rituximab
1149677|NCT02266888|placebo|placebo
1149678|NCT02266888|standard of care|standard of care
1149679|NCT02266836|Stroke|stroke
1149680|NCT02266836|Cerebrovascular accident|cerebrovascular accident
1149681|NCT02266836|Upper Extremity|upper extremity
1149682|NCT02266836|Cerebral Infarction|cerebral infarction
1149683|NCT02266836|Brain Infarction|brain infarction
1149684|NCT02266836|Brain Ischemia|brain ischemia
1149685|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
1149686|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
1149687|NCT02266836|Nervous System Diseases|nervous system diseases
1149688|NCT02266836|Central Nervous System Diseases|central nervous system diseases
1149689|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
1149690|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
1149691|NCT02266758|Gestational Diabetes|gestational diabetes
1149692|NCT02266758|Obesity|obesity
1149693|NCT02266758|Pregnancy|pregnancy
1149694|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
1149695|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
1149696|NCT02266693|Internet Based|internet based
1149697|NCT02266693|CBT|cbt
1149698|NCT02266693|Transdiagnostic|transdiagnostic
1149699|NCT02266693|MDD|mdd
1149700|NCT02266693|PD|pd
1149701|NCT02266693|SAD|sad
1149702|NCT02266693|GAD|gad
1149703|NCT02266693|iCBT|icbt
1149704|NCT02266680|Social Anxiety|social anxiety
1149705|NCT02266680|Yoga|yoga
1149706|NCT02266667|NEMOT device|nemot device
1149707|NCT02266667|pediatrics|pediatrics
1149708|NCT02266667|surgery|surgery
1149709|NCT02266667|progressive scoliosis|progressive scoliosis
1149710|NCT02266654|Emergency Medical Services|emergency medical services
1149711|NCT02266654|Lactic Acid|lactic acid
1149712|NCT02266654|Sepsis|sepsis
1149713|NCT02266641|one-carbon metabolism|one-carbon metabolism
1149714|NCT02266641|folate|folate
1149715|NCT02266641|choline|choline
1149716|NCT02266641|DNA methylation|dna methylation
1149717|NCT02266641|imprint marker|imprint marker
1149718|NCT02266641|cancer risks|cancer risks
1149719|NCT02266602|IORT|iort
1149720|NCT02266602|Breast Cancer|breast cancer
1149721|NCT02266589|coagulopathy|coagulopathy
1149722|NCT02266589|hydrocortisone|hydrocortisone
1149723|NCT02266589|organ failure|organ failure
1149724|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
1149725|NCT02266563|Traumatic Brain Injury|traumatic brain injury
1149726|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
1149727|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
1149728|NCT02266563|PET imaging|pet imaging
1149729|NCT02266563|tauopathy|tauopathy
1149730|NCT02266563|amyloid|amyloid
1149731|NCT02266446|anxiety disorders|anxiety disorders
1149732|NCT02266446|cognitive bias modification|cognitive bias modification
1149733|NCT02266446|primary care|primary care
1149734|NCT02266446|attention|attention
1149735|NCT02266446|interpretation|interpretation
1149736|NCT02266446|computer|computer
1149737|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
1149738|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
1149739|NCT02266433|Tennis Elbow|tennis elbow
1149740|NCT02266433|Trigger Finger|trigger finger
1149741|NCT02266433|Tenosynovitis|tenosynovitis
1149742|NCT02266433|Inflammatory Disease|inflammatory disease
1149743|NCT02266433|Dexamethasone|dexamethasone
1149744|NCT02266433|Ketorolac|ketorolac
1149745|NCT02266433|Toradol|toradol
1149746|NCT02266420|Triple negative breast cancer|triple negative breast cancer
1149747|NCT02266420|immuno-histochemistery|immuno-histochemistery
1149748|NCT02266420|genomic profiles|genomic profiles
1149749|NCT02266407|Revision TKA|revision tka
1149750|NCT02266407|Septic|septic
1149751|NCT02266407|Aseptic|aseptic
1149752|NCT02266407|Transfusion|transfusion
1149753|NCT02266407|Blood Loss|blood loss
1149754|NCT02266381|PCNL|pcnl
1149755|NCT02266381|MPCNL|mpcnl
1149756|NCT02266381|guidance|guidance
1149757|NCT02266381|puncture|puncture
1149758|NCT02266368|Ureteral stents|ureteral stents
1149759|NCT02266368|Double J stent|double j stent
1149760|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
1149761|NCT02266368|USSQ|ussq
1149762|NCT02266368|UTI|uti
1149763|NCT02266355|Oxaliplatin|oxaliplatin
1149764|NCT02266355|Omalizumab|omalizumab
1149765|NCT02266329|controlled clinical trial|controlled clinical trial
1149766|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
1149767|NCT02266290|ADHESIVE TAPE|adhesive tape
1149768|NCT02266290|ANKLE INJURY|ankle injury
1149769|NCT02266290|POSTURAL BALANCE|postural balance
1149770|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
1149771|NCT02266277|electronic health record, utilization|electronic health record, utilization
1149772|NCT02266277|randomized controlled trial|randomized controlled trial
1149773|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
1149774|NCT02266277|influenza, prevention and control|influenza, prevention and control
1149775|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
1149776|NCT02266277|qualitative research|qualitative research
1149777|NCT02266225|Chronic disease management|chronic disease management
1149778|NCT02266225|Physical activity|physical activity
1149779|NCT02266225|Fall prevention|fall prevention
1149780|NCT02266225|Strength and balance exercise|strength and balance exercise
1149781|NCT02266199|questionnaire|questionnaire
1149782|NCT02266199|quality assurance|quality assurance
1149783|NCT02266199|qualitative Verification|qualitative verification
1149784|NCT02266199|conservative patients|conservative patients
1149785|NCT02266199|interview|interview
1149786|NCT02266160|tinnitus|tinnitus
1149787|NCT02266160|local anaesthetic|local anaesthetic
1149788|NCT02266160|EMLA cream 5%|emla cream 5%
1149789|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
1149790|NCT02266134|implementation|implementation
1149791|NCT02266134|measurement based care|measurement based care
1149792|NCT02266134|standardized|standardized
1149793|NCT02266134|tailored|tailored
1149794|NCT02266121|Multiple Sclerosis|multiple sclerosis
1149795|NCT02266121|MS|ms
1149796|NCT02266121|Cognitive deficits|cognitive deficits
1149797|NCT02266121|Motor deficits|motor deficits
1149798|NCT02266121|Fatigue|fatigue
1149799|NCT02266121|Nervous System Diseases|nervous system diseases
1149800|NCT02266121|Brain Diseases|brain diseases
1149801|NCT02266121|Brain stimulation|brain stimulation
1149802|NCT02266121|Working memory|working memory
1149803|NCT02266121|Motor learning|motor learning
1149804|NCT02266121|Central Nervous System Diseases|central nervous system diseases
1149805|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
1149806|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
1149807|NCT02266108|Female Sex Workers|female sex workers
1149808|NCT02266095|Osteoarthritis|osteoarthritis
1149809|NCT02266095|Thumb spica splint|thumb spica splint
1149810|NCT02266095|Oval-8 splint|oval-8 splint
1149811|NCT02266095|Tee-Pee splint|tee-pee splint
1149812|NCT02266069|implementation|implementation
1149813|NCT02266069|anticipatory care planning|anticipatory care planning
1149814|NCT02266069|symptom assessment|symptom assessment
1149815|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
1149816|NCT02266056|deep neuromuscular block|deep neuromuscular block
1149817|NCT02266056|sugammadex|sugammadex
1149818|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
1149819|NCT02266056|hemodynamic change|hemodynamic change
1149820|NCT02266043|Upper airway obstruction|upper airway obstruction
1149821|NCT02266017|pain|pain
1149822|NCT02266017|coping|coping
1149823|NCT02266017|mhealth|mhealth
1149824|NCT02266017|cancer|cancer
1149825|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
1149826|NCT02266004|neuromodulation|neuromodulation
1149827|NCT02265978|Emotional Self-Awareness|emotional self-awareness
1149828|NCT02265978|Positive Coping|positive coping
1149829|NCT02265978|Help-Seeking|help-seeking
1149830|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
1149831|NCT02265926|N95 masks|n95 masks
1149832|NCT02265926|pandemic response|pandemic response
1149833|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
1149834|NCT02265900|Positron Emission Tomography|positron emission tomography
1149835|NCT02265900|Dopamine|dopamine
1149836|NCT02265900|Parkinson's Disease|parkinson's disease
1149837|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
1149838|NCT02265887|Africa|africa
1149839|NCT02265887|Heart Disease|heart disease
1149840|NCT02265887|Echocardiography|echocardiography
1149932|NCT02265146|Vulnerable Plaque|vulnerable plaque
1149841|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
1149842|NCT02265848|Spinal cord stimulation|spinal cord stimulation
1149843|NCT02265848|Chronic pain|chronic pain
1149844|NCT02265848|Chronic low back pain|chronic low back pain
1149845|NCT02265848|Radiculopathy|radiculopathy
1149846|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
1149847|NCT02265848|High Frequency stimulation|high frequency stimulation
1149848|NCT02265822|melatonin|melatonin
1149849|NCT02265822|midazolam|midazolam
1149850|NCT02265822|children|children
1149851|NCT02265809|Interleukin 2|interleukin 2
1149852|NCT02265809|Type 1 diabetes|type 1 diabetes
1149853|NCT02265809|T regulatory cells|t regulatory cells
1149854|NCT02265809|Adaptive trial|adaptive trial
1149855|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
1149856|NCT02265796|fractional flow reserve|fractional flow reserve
1149857|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
1149858|NCT02265757|Behavioral Intervention|behavioral intervention
1149859|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
1149860|NCT02265757|HABIT|habit
1149861|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
1149862|NCT02265757|Multi-Component Intervention|multi-component intervention
1149863|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
1149864|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
1149865|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1149866|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
1149867|NCT02265731|Lymphatic Diseases|lymphatic diseases
1149868|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
1149869|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
1149870|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
1149871|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
1149872|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1149873|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
1149874|NCT02265718|Healthy|healthy
1149875|NCT02265718|elderly volunteers|elderly volunteers
1149876|NCT02265614|PGS|pgs
1149877|NCT02265614|blastocyst|blastocyst
1149878|NCT02265614|human|human
1149879|NCT02265614|IVF|ivf
1149880|NCT02265614|vitrification|vitrification
1149881|NCT02265614|single embryo transfer|single embryo transfer
1149882|NCT02265601|advance care planning|advance care planning
1149883|NCT02265601|living wills|living wills
1149884|NCT02265601|end of life|end of life
1149885|NCT02265601|cancer|cancer
1149886|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1149887|NCT02265588|Ulcerative colitis|ulcerative colitis
1149888|NCT02265588|Crohn's disease|crohn's disease
1149889|NCT02265588|Children|children
1149890|NCT02265588|Adolescents|adolescents
1149891|NCT02265588|Anxiety|anxiety
1149892|NCT02265588|Depression|depression
1149893|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
1149894|NCT02265562|Hysterectomy|hysterectomy
1149895|NCT02265562|Misoprostol|misoprostol
1149896|NCT02265562|Blood loss|blood loss
1149897|NCT02265549|Metastases,|metastases,
1149898|NCT02265549|Neoplasm|neoplasm
1149899|NCT02265549|Cerebral|cerebral
1149900|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
1149901|NCT02265458|Respiratory failure|respiratory failure
1149902|NCT02265458|NIV|niv
1149903|NCT02265458|Musical intervention|musical intervention
1151186|NCT02257463|COPD|copd
1149904|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
1149905|NCT02265445|due to ESBL-PE|due to esbl-pe
1149906|NCT02265432|Physical activity|physical activity
1149907|NCT02265432|Sedentary behavior|sedentary behavior
1149908|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
1149909|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
1149910|NCT02265354|Computer tailored health communication|computer tailored health communication
1149911|NCT02265354|messaging|messaging
1149912|NCT02265354|collective intelligence|collective intelligence
1149913|NCT02265354|recommender systems|recommender systems
1149914|NCT02265354|machine learning|machine learning
1149915|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
1149916|NCT02265328|Bovine Colostrum|bovine colostrum
1149917|NCT02265328|Glucocorticoids|glucocorticoids
1149918|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
1149919|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
1149920|NCT02265250|positron emission tomography|positron emission tomography
1149921|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
1149922|NCT02265237|Hepatitis C|hepatitis c
1149923|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
1149924|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
1149925|NCT02265198|Pulmonary Contusion|pulmonary contusion
1149927|NCT02265198|Respiratory Failure|respiratory failure
1149928|NCT02265172|Physiotherapy|physiotherapy
1149929|NCT02265172|Orthopaedic|orthopaedic
1149930|NCT02265172|Primary care|primary care
1149931|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
1150025|NCT02264626|sedation|sedation
1149933|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
1149934|NCT02265107|endothelial function|endothelial function
1149935|NCT02265107|physical training|physical training
1149936|NCT02265107|exercise|exercise
1149937|NCT02265107|coronary artery bypass|coronary artery bypass
1149938|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
1149939|NCT02265094|Development|development
1149941|NCT02265094|ERD|erd
1149942|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
1149943|NCT02265029|fibromyalgia|fibromyalgia
1149944|NCT02265029|rheumatism|rheumatism
1149945|NCT02265029|fatigue syndrom|fatigue syndrom
1149946|NCT02265029|pain|pain
1149947|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
1149948|NCT02265016|coronary artery disease|coronary artery disease
1149949|NCT02265016|acute coronary syndrome|acute coronary syndrome
1149950|NCT02265016|angina pectoris|angina pectoris
1149951|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
1149952|NCT02265016|red blood cells|red blood cells
1149953|NCT02265016|erythrocytes|erythrocytes
1149954|NCT02265003|red blood cells|red blood cells
1149955|NCT02265003|endothelial function|endothelial function
1149956|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
1149957|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
1149958|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
1149959|NCT02265003|oxidative status|oxidative status
1149960|NCT02265003|nitric oxide signalling|nitric oxide signalling
1149961|NCT02264990|veliparib|veliparib
1149962|NCT02264990|carboplatin|carboplatin
1149963|NCT02264990|paclitaxel|paclitaxel
1149964|NCT02264990|cisplatin|cisplatin
1149965|NCT02264990|pemetrexed|pemetrexed
1149966|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
1149967|NCT02264990|Metastatic|metastatic
1149968|NCT02264990|Non-squamous|non-squamous
1149969|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
1149970|NCT02264964|Hemodialysis|hemodialysis
1149971|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
1149972|NCT02264964|Central Venous Catheterization|central venous catheterization
1149973|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
1149974|NCT02264951|Short fatty acids|short fatty acids
1149975|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
1149976|NCT02264951|GLP-1 secretion|glp-1 secretion
1149977|NCT02264951|C8-diet oil|c8-diet oil
1149978|NCT02264951|GIP secretion|gip secretion
1149979|NCT02264925|Essential tremor|essential tremor
1149980|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
1149981|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
1149982|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
1149983|NCT02264925|Closed loop therapy|closed loop therapy
1149984|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
1149985|NCT02264899|Alzheimer's disease|alzheimer's disease
1149986|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
1149987|NCT02264873|Relapse|relapse
1149988|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
1149989|NCT02264847|Clomiphene Citrate|clomiphene citrate
1149990|NCT02264847|Ovulation trigger|ovulation trigger
1149991|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
1149992|NCT02264834|epidural|epidural
1149993|NCT02264834|primiparous patient|primiparous patient
1149994|NCT02264834|deambulation|deambulation
1149995|NCT02264821|analgesia|analgesia
1149997|NCT02264821|wound infiltration|wound infiltration
1149998|NCT02264821|intrathecal morphine.|intrathecal morphine.
1149999|NCT02264795|Cesarean section|cesarean section
1150000|NCT02264795|Lidocaine|lidocaine
1150001|NCT02264769|pregnancy|pregnancy
1150002|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
1150003|NCT02264769|Cesarean delivery|cesarean delivery
1150004|NCT02264769|carbetocin|carbetocin
1150005|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
1150006|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
1150007|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
1150008|NCT02264756|length of stay|length of stay
1150009|NCT02264756|stepped-wedge design|stepped-wedge design
1150010|NCT02264756|time-dependent bias|time-dependent bias
1150011|NCT02264704|MS|ms
1150012|NCT02264704|Exercise|exercise
1150013|NCT02264704|Training|training
1150014|NCT02264704|Multiple sclerosis|multiple sclerosis
1150015|NCT02264704|Immune response|immune response
1150016|NCT02264704|Neurotrophin|neurotrophin
1150017|NCT02264704|Cytokine|cytokine
1150018|NCT02264704|Fatigue|fatigue
1150019|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
1150020|NCT02264652|Refractory|refractory
1150021|NCT02264652|Partial|partial
1150022|NCT02264652|Epilepsy|epilepsy
1150023|NCT02264626|acute respiratory failure|acute respiratory failure
1150024|NCT02264626|noninvasive ventilation|noninvasive ventilation
1150026|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
1150027|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
1150028|NCT02264535|Allergy|allergy
1150029|NCT02264535|Skin test|skin test
1150030|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
1150031|NCT02264509|Arterial Insufficiency|arterial insufficiency
1150032|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
1150033|NCT02264509|Atherosclerosis|atherosclerosis
1150034|NCT02264509|Ankle-brachial index|ankle-brachial index
1150035|NCT02264509|HAART|haart
1150036|NCT02264496|Colorectal cancer|colorectal cancer
1150037|NCT02264496|Exercise|exercise
1150038|NCT02264496|CPEX|cpex
1150039|NCT02264496|Exercise, Physical|exercise, physical
1150040|NCT02264496|Exercise, Aerobic|exercise, aerobic
1150041|NCT02264496|Surgery|surgery
1150042|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
1150043|NCT02264470|Prediction|prediction
1150044|NCT02264470|Falls|falls
1150045|NCT02264470|Stroke|stroke
1150046|NCT02264457|Lenses, Intraocular|lenses, intraocular
1150047|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
1150048|NCT02264431|Obesity|obesity
1150049|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
1150050|NCT02264431|Sleep Habits|sleep habits
1150051|NCT02264431|Bariatric Surgery|bariatric surgery
1150052|NCT02264431|Cohort|cohort
1150053|NCT02264418|Solid tumours|solid tumours
1150054|NCT02264405|Autoimmune diseases|autoimmune diseases
1150055|NCT02264405|Systemic sclerosis|systemic sclerosis
1150056|NCT02264405|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
1150057|NCT02264379|Oligometastases|oligometastases
1150058|NCT02264379|Prostate Cancer|prostate cancer
1150059|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
1150060|NCT02264379|Hypo fractionation|hypo fractionation
1150061|NCT02264379|Normal fractionation|normal fractionation
1150062|NCT02264353|Obstructive|obstructive
1150063|NCT02264353|Sleep Apnea|sleep apnea
1150064|NCT02264353|Arousal threshold|arousal threshold
1150065|NCT02264353|Donepezil|donepezil
1150066|NCT02264340|Tension-type headache|tension-type headache
1150067|NCT02264340|relaxation techniques|relaxation techniques
1150068|NCT02264340|physiotherapy|physiotherapy
1150069|NCT02264327|Motivational Interviewing|motivational interviewing
1150070|NCT02264327|Evidence Based Practice|evidence based practice
1150071|NCT02264327|Online Simulation|online simulation
1150072|NCT02264327|Workforce development|workforce development
1150073|NCT02264327|Training|training
1150074|NCT02264314|Aged|aged
1150075|NCT02264314|Hearing Aids|hearing aids
1150076|NCT02264314|Rehabilitation|rehabilitation
1150077|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
1150078|NCT02264288|Diabetic Foot|diabetic foot
1150079|NCT02264275|Aerobic Exercise|aerobic exercise
1150080|NCT02264275|Exercise|exercise
1150081|NCT02264275|Exergame|exergame
1150082|NCT02264275|Behavior|behavior
1150083|NCT02264275|Video Game|video game
1150084|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
1150085|NCT02264275|Children|children
1150086|NCT02264275|Adolescents|adolescents
1150087|NCT02264275|Pediatric|pediatric
1150088|NCT02264275|Physical Fitness|physical fitness
1150089|NCT02264223|Bioavailability|bioavailability
1150090|NCT02264223|Isoflavones|isoflavones
1150091|NCT02264223|Plasma|plasma
1150092|NCT02264223|Human|human
1150093|NCT02264223|Processing|processing
1150094|NCT02264223|Cross-over|cross-over
1150095|NCT02263950|Cancer|cancer
1150096|NCT02263950|Malignant Neoplasm|malignant neoplasm
1150097|NCT02263950|Artemether|artemether
1150099|NCT02263950|Neoplastic disease|neoplastic disease
1150100|NCT02263950|Solid Tumour|solid tumour
1150101|NCT02263950|Anti-cancer drug|anti-cancer drug
1150102|NCT02263950|Chemotherapy|chemotherapy
1150104|NCT02263885|Parkinson's Disease|parkinson's disease
1150105|NCT02263885|ExAblate|exablate
1150106|NCT02263885|MRgFUS|mrgfus
1150107|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
1150108|NCT02263846|Breast cancer|breast cancer
1150109|NCT02263846|Menopause|menopause
1150110|NCT02263846|Estradiol|estradiol
1150111|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
1150112|NCT02263820|Acute Kidney Injury|acute kidney injury
1150113|NCT02263820|Acute Renal Failure|acute renal failure
1150114|NCT02263807|Patella luxation|patella luxation
1150115|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
1150116|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
1150117|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
1150118|NCT02263742|Peer-led whole health|peer-led whole health
1150119|NCT02263742|Mental Illness|mental illness
1150120|NCT02263742|Peer Health Navigation|peer health navigation
1150121|NCT02263742|Health care Coordination|health care coordination
1150122|NCT02263716|Physical Activity|physical activity
1150123|NCT02263716|Intensive Care|intensive care
1150124|NCT02263716|Activities of Daily Living|activities of daily living
1150125|NCT02263716|Delirium|delirium
1150920|NCT02258932|Liverpool|liverpool
1150127|NCT02263716|Mechanical Ventilation|mechanical ventilation
1150128|NCT02263716|Critical Care|critical care
1150129|NCT02263716|Critical Illness|critical illness
1150130|NCT02263716|Aging|aging
1150131|NCT02263716|Accelerometery|accelerometery
1150132|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
1150133|NCT02263677|diabetes|diabetes
1150134|NCT02263677|fatty liver|fatty liver
1150135|NCT02263664|microcirculation|microcirculation
1150136|NCT02263664|esophagectomy|esophagectomy
1150137|NCT02263664|side stream dark field|side stream dark field
1150138|NCT02263664|microcirculatory derangements|microcirculatory derangements
1150139|NCT02263651|Breast cancer|breast cancer
1150140|NCT02263651|Mastectomy|mastectomy
1150141|NCT02263651|Seroma|seroma
1150142|NCT02263651|Quilting suture|quilting suture
1150143|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
1150144|NCT02263638|rheumatism|rheumatism
1150145|NCT02263638|anakinra|anakinra
1150146|NCT02263625|Indication|indication
1150147|NCT02263625|Differences|differences
1150148|NCT02263612|Incisional Hernia|incisional hernia
1150149|NCT02263612|Complications|complications
1150150|NCT02263612|Long-term|long-term
1150151|NCT02263586|Ironman|ironman
1150152|NCT02263586|Triathlon|triathlon
1150153|NCT02263573|PEP'C-R|pep'c-r
1150154|NCT02263573|Endurance parameters|endurance parameters
1150155|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
1150156|NCT02263573|Older seniors|older seniors
1150157|NCT02263573|Over 70|over 70
1150158|NCT02263547|teriflunomide|teriflunomide
1150159|NCT02263547|colestipol hcl|colestipol hcl
1150160|NCT02263534|stress urinary incontinence|stress urinary incontinence
1150161|NCT02263534|tension free vaginal tape|tension free vaginal tape
1150162|NCT02263534|single incision minisling|single incision minisling
1150163|NCT02263534|midurethral sling|midurethral sling
1150164|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
1150165|NCT02263508|pembrolizumab|pembrolizumab
1150166|NCT02263508|KEYNOTE-034|keynote-034
1150167|NCT02263508|MASTERKEY-265|masterkey-265
1150168|NCT02263495|HER2-Negative|her2-negative
1150169|NCT02263482|muscle training|muscle training
1150170|NCT02263482|walking test|walking test
1150171|NCT02263482|chronic heart failure|chronic heart failure
1150172|NCT02263482|functional capacity|functional capacity
1150173|NCT02263443|bowel preparation|bowel preparation
1150174|NCT02263443|gynecologic surgery|gynecologic surgery
1150175|NCT02263443|laparotomy|laparotomy
1150176|NCT02263391|transmission|transmission
1150177|NCT02263391|prevention|prevention
1150178|NCT02263391|women|women
1150179|NCT02263391|childbearing age|childbearing age
1150180|NCT02263391|HIV testing|hiv testing
1150181|NCT02263391|testing strategy|testing strategy
1150182|NCT02263378|HPV, L-SIL|hpv, l-sil
1150183|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
1150184|NCT02263339|Exercise|exercise
1150185|NCT02263339|MRI|mri
1150186|NCT02263313|Safety and efficacy|safety and efficacy
1150187|NCT02263313|Combo stent|combo stent
1150188|NCT02263313|Late loss thrombosis|late loss thrombosis
1150189|NCT02263313|Late loss catch up|late loss catch up
1150190|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
1150191|NCT02263300|Medical student|medical student
1150192|NCT02263300|Virtual larynx|virtual larynx
1150193|NCT02263300|Didactic Training|didactic training
1150194|NCT02263300|Medical Education|medical education
1150195|NCT02263287|Alzheimer Disease|alzheimer disease
1150196|NCT02263287|Lewy Body Disease|lewy body disease
1150197|NCT02263261|dermal matrix|dermal matrix
1150198|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
1150199|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
1150200|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1150201|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
1150202|NCT02263235|mass spectrometry|mass spectrometry
1150203|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
1150204|NCT02263183|Metabolic risk|metabolic risk
1150205|NCT02263183|Abdominally overweight|abdominally overweight
1150206|NCT02263131|Influenza|influenza
1150207|NCT02263131|Influenza vaccine|influenza vaccine
1150208|NCT02263131|Split influenza vaccine|split influenza vaccine
1150209|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
1150210|NCT02263118|breastfeeding|breastfeeding
1150211|NCT02263118|rural|rural
1150212|NCT02263118|m-health|m-health
1150213|NCT02263118|mHealth|mhealth
1150214|NCT02263118|Patojitos|patojitos
1150215|NCT02263118|Guatemala|guatemala
1150216|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
1150217|NCT02263118|mobile|mobile
1150218|NCT02263118|eHealth|ehealth
1150219|NCT02263118|e-health|e-health
1150220|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
1150221|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
1150222|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
1150223|NCT02263092|Cortical excitability|cortical excitability
1150224|NCT02263092|Plasticity|plasticity
1150225|NCT02263092|Healthy subjects|healthy subjects
1150226|NCT02263040|influenza vaccine|influenza vaccine
1150227|NCT02263040|adult|adult
1150228|NCT02263040|immunogenicity|immunogenicity
1150229|NCT02263040|reactogenicity|reactogenicity
1150230|NCT02263027|influenza vaccine|influenza vaccine
1150231|NCT02263027|adult|adult
1150232|NCT02263027|safety|safety
1150233|NCT02263027|reactogenicity|reactogenicity
1150234|NCT02263014|Breast Cancer|breast cancer
1150235|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
1150236|NCT02263014|Questionnaires|questionnaires
1150237|NCT02263014|Surveys|surveys
1150238|NCT02263014|Psychosocial|psychosocial
1150239|NCT02263001|Auricular therapy|auricular therapy
1150240|NCT02263001|Acupuncture|acupuncture
1150241|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
1150242|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
1150244|NCT02262988|joint replacement|joint replacement
1150245|NCT02262988|total knee|total knee
1150246|NCT02262988|cell therapy|cell therapy
1150247|NCT02262975|Alzheimer's disease|alzheimer's disease
1150248|NCT02262936|Aged|aged
1150249|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
1150250|NCT02262936|Fesoterodine|fesoterodine
1150251|NCT02262936|Randomized Controlled Trial|randomized controlled trial
1150252|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1150253|NCT02262910|CRPC|crpc
1150254|NCT02262897|small cell lung cancer|small cell lung cancer
1150255|NCT02262897|chemotherapy|chemotherapy
1150256|NCT02262897|Nab-paclitaxel|nab-paclitaxel
1150257|NCT02262871|Cystic fibrosis|cystic fibrosis
1150258|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
1150259|NCT02262871|Non-invasive ventilation|non-invasive ventilation
1150260|NCT02262871|Respiratory distress|respiratory distress
1150261|NCT02262871|Oxygen therapy|oxygen therapy
1150262|NCT02262832|Diabetes|diabetes
1150263|NCT02262832|Leptin|leptin
1150264|NCT02262832|Lipodystrophy|lipodystrophy
1150265|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
1150266|NCT02262819|Skin Blister|skin blister
1150267|NCT02262819|Immune Response|immune response
1150268|NCT02262819|Suction Device|suction device
1150269|NCT02262819|Anti-Microbial|anti-microbial
1150270|NCT02262819|Killed Microbe|killed microbe
1150271|NCT02262806|Lipodystrophy|lipodystrophy
1150272|NCT02262806|Leptin|leptin
1150273|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
1150274|NCT02262806|Diabetes|diabetes
1150275|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
1150276|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
1150277|NCT02262728|Simeprevir|simeprevir
1150278|NCT02262728|Daclatasvir|daclatasvir
1150279|NCT02262728|Sofosbuvir|sofosbuvir
1150280|NCT02262728|Decompensated Liver Disease|decompensated liver disease
1150281|NCT02262715|Oseltamivir|oseltamivir
1150282|NCT02262715|VX-787|vx-787
1150283|NCT02262689|GSK2256294|gsk2256294
1150284|NCT02262689|normoxic|normoxic
1150285|NCT02262689|hypoxic|hypoxic
1150286|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
1150287|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
1150288|NCT02262676|Prevention and Control|prevention and control
1150289|NCT02262676|Stroke|stroke
1150290|NCT02262507|Brain|brain
1150291|NCT02262507|Hearing|hearing
1150292|NCT02262507|MTBI|mtbi
1150293|NCT02262468|retrospective analysis|retrospective analysis
1150294|NCT02262455|Serous tumor|serous tumor
1150295|NCT02262455|Granulosa tumor|granulosa tumor
1150296|NCT02262455|Clear Cell tumor|clear cell tumor
1150297|NCT02262455|Endometrial cancer|endometrial cancer
1150298|NCT02262455|Advanced solid tumors|advanced solid tumors
1150299|NCT02262455|Adenocarcinoma|adenocarcinoma
1150300|NCT02262455|Prostate cancer|prostate cancer
1150301|NCT02262455|Head and Neck cancer|head and neck cancer
1150302|NCT02262455|Lung cancer|lung cancer
1150303|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
1150304|NCT02262455|Small cell lung cancer|small cell lung cancer
1150305|NCT02262455|Gastric cancer|gastric cancer
1150306|NCT02262455|Kidney cancer|kidney cancer
1150307|NCT02262455|Pancreatic cancer|pancreatic cancer
1150308|NCT02262455|Breast cancer|breast cancer
1150309|NCT02262455|Colorectal cancer|colorectal cancer
1150310|NCT02262455|Bladder cancer|bladder cancer
1150311|NCT02262455|Esophagus cancer|esophagus cancer
1150312|NCT02262455|Liver cancer|liver cancer
1150313|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
1150314|NCT02262455|Skin cancer|skin cancer
1150315|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
1150316|NCT02262442|anaesthetics|anaesthetics
1150317|NCT02262442|transcutaneous pCO2|transcutaneous pco2
1150318|NCT02262442|capillary pCO2|capillary pco2
1150319|NCT02262442|special atomizing set|special atomizing set
1150320|NCT02262416|GnRH agonist|gnrh agonist
1150321|NCT02262416|IVF|ivf
1150322|NCT02262403|Hookworm|hookworm
1150323|NCT02262403|Helminths|helminths
1150324|NCT02262403|Treg|treg
1150325|NCT02262403|Immune regulation|immune regulation
1150326|NCT02262403|Vietnam|vietnam
1150327|NCT02262403|Allergic diseases|allergic diseases
1150328|NCT02262377|Group Medical Visits|group medical visits
1150329|NCT02262377|Integrative Medicine|integrative medicine
1150330|NCT02262377|Chronic Pain|chronic pain
1150331|NCT02262377|Depression|depression
1150333|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1150334|NCT02262377|Web based|web based
1150335|NCT02262377|Virtual Patient Advocate|virtual patient advocate
1150336|NCT02262377|Internet Based|internet based
1150337|NCT02262351|Atrial Fibrillation|atrial fibrillation
1150338|NCT02262351|Screening|screening
1150339|NCT02262351|Family Practice|family practice
1150340|NCT02262351|Novel screening technologies|novel screening technologies
1150341|NCT02262338|MPS II|mps ii
1150342|NCT02262338|Hunter Syndrome|hunter syndrome
1150343|NCT02262325|Non-small cell|non-small cell
1150344|NCT02262325|Lung Cancer|lung cancer
1150345|NCT02262325|Chemoradiation|chemoradiation
1150346|NCT02262286|Brain Injury|brain injury
1150347|NCT02262273|women|women
1150348|NCT02262273|platinum sensitive|platinum sensitive
1150349|NCT02262273|recurrent|recurrent
1150350|NCT02262273|serous|serous
1150351|NCT02262273|ovarian cancer|ovarian cancer
1150352|NCT02262273|BRCA|brca
1150353|NCT02262273|PARP|parp
1150354|NCT02262273|Olaparib|olaparib
1150355|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
1150356|NCT02262247|Transoral|transoral
1150357|NCT02262247|Oropharynx|oropharynx
1150358|NCT02262247|Hypopharynx|hypopharynx
1150359|NCT02262247|Endoscopic|endoscopic
1150360|NCT02262247|TORS|tors
1150361|NCT02262247|Endoscopic Transoral|endoscopic transoral
1150362|NCT02262247|Larynx|larynx
1150363|NCT02262234|Spinal cord injury|spinal cord injury
1150364|NCT02262234|Chronic pain|chronic pain
1150365|NCT02262234|Education|education
1150366|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
1150367|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
1150368|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
1150369|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
1150370|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1150371|NCT02262156|depression|depression
1150372|NCT02262156|epilepsy|epilepsy
1150373|NCT02262130|Omalizumab|omalizumab
1150374|NCT02262130|Efficacy|efficacy
1150375|NCT02262130|Safety|safety
1150376|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
1150377|NCT02262104|Exercise|exercise
1150378|NCT02262104|dementia|dementia
1150379|NCT02262104|nursing home|nursing home
1150380|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
1150381|NCT02262065|implant|implant
1150382|NCT02262065|allergy|allergy
1150383|NCT02262065|particle|particle
1150384|NCT02262065|cytokine|cytokine
1150385|NCT02262052|Deep vein thrombosis|deep vein thrombosis
1150386|NCT02262052|Diagnostic management|diagnostic management
1150387|NCT02262052|Recurrent|recurrent
1150388|NCT02262052|MRI|mri
1150389|NCT02262052|Ipsilateral|ipsilateral
1150390|NCT02262039|living|living
1150391|NCT02262039|kidney|kidney
1150392|NCT02262039|donors|donors
1150393|NCT02262013|Pediatric Obesity|pediatric obesity
1150394|NCT02262013|Lifestyle Intervention|lifestyle intervention
1150395|NCT02262013|Family-based Intervention|family-based intervention
1150396|NCT02262013|Motivational Interviewing|motivational interviewing
1150397|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
1150398|NCT02262000|Surgically inoperable|surgically inoperable
1151391|NCT02256163|gene|gene
1150399|NCT02262000|Radiation Therapy|radiation therapy
1150400|NCT02261987|Autogenic drainage|autogenic drainage
1150401|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
1150402|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
1150403|NCT02261987|Airway clearance techniques|airway clearance techniques
1150404|NCT02261987|Mucus clearances|mucus clearances
1150405|NCT02261974|Vaginal laxity|vaginal laxity
1150406|NCT02261974|Sexual Function|sexual function
1150407|NCT02261961|resistance exercise|resistance exercise
1150408|NCT02261961|Juven|juven
1150409|NCT02261961|exercise training|exercise training
1150410|NCT02261961|interleukin-1|interleukin-1
1150411|NCT02261961|insulin-like growth factor|insulin-like growth factor
1150412|NCT02261948|Cardiac Failure|cardiac failure
1150413|NCT02261948|Severe Heart Failure|severe heart failure
1150414|NCT02261935|Family caregiver|family caregiver
1150415|NCT02261935|Home care nursing practice|home care nursing practice
1150416|NCT02261935|Palliative care|palliative care
1150417|NCT02261935|End of life care|end of life care
1150418|NCT02261935|Family caregiver quality of life|family caregiver quality of life
1150419|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
1150420|NCT02261935|Family caregiver burden|family caregiver burden
1150421|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
1150422|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
1150423|NCT02261935|Family caregiver health status|family caregiver health status
1150424|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
1150425|NCT02261909|Emergency Medicine|emergency medicine
1150426|NCT02261909|diagnosis|diagnosis
1150427|NCT02261896|cyst|cyst
1150428|NCT02261896|pancreatic cyst|pancreatic cyst
1150429|NCT02261896|EUS-FNA|eus-fna
1150430|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
1150431|NCT02261883|PPHN|pphn
1150432|NCT02261870|MRI, T2 quantification|mri, t2 quantification
1150433|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
1150434|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
1150435|NCT02261857|Pediatrics|pediatrics
1150436|NCT02261857|Computer-Aided Design|computer-aided design
1150437|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
1150438|NCT02261857|Three-Dimensional Printing|three-dimensional printing
1150439|NCT02261857|Additive Manufacturing|additive manufacturing
1150440|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
1150441|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
1150442|NCT02261844|Metabolism|metabolism
1150443|NCT02261844|Hepatic function|hepatic function
1150444|NCT02261831|bacterial|bacterial
1150445|NCT02261831|gut|gut
1150446|NCT02261831|type 2 diabetes.|type 2 diabetes.
1150447|NCT02261831|16S rDNA gene|16s rdna gene
1150448|NCT02261831|intestinal crypt|intestinal crypt
1150449|NCT02261818|depression|depression
1150450|NCT02261818|aging|aging
1150451|NCT02261818|health services|health services
1150452|NCT02261792|Postural headache treatment|postural headache treatment
1150453|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
1150454|NCT02261792|Epidural blood patch|epidural blood patch
1150455|NCT02261792|Trendelenburg position|trendelenburg position
1150456|NCT02261792|Head-Down Tilt|head-down tilt
1150457|NCT02261792|Blood Patch, Epidural|blood patch, epidural
1150458|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
1150459|NCT02261740|Pelvic Pain|pelvic pain
1150460|NCT02261740|Genital Pain|genital pain
1150461|NCT02261727|COPD|copd
1150462|NCT02261727|Theophylline|theophylline
1150463|NCT02261727|Oral corticosteroids|oral corticosteroids
1150464|NCT02261727|COPD exacerbations|copd exacerbations
1150465|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
1150466|NCT02261714|Vaccine|vaccine
1150467|NCT02261714|KRAS|kras
1150468|NCT02261701|shoulder surgery|shoulder surgery
1150469|NCT02261701|rotator cuff injury|rotator cuff injury
1150470|NCT02261701|rehabilitation|rehabilitation
1150471|NCT02261701|function|function
1150472|NCT02261701|pain|pain
1150473|NCT02261701|quality of life|quality of life
1150474|NCT02261675|dexmedetomidine|dexmedetomidine
1150475|NCT02261675|sevoflurane|sevoflurane
1150476|NCT02261675|MAC bar|mac bar
1150477|NCT02261675|drug interaction|drug interaction
1150478|NCT02261675|anesthesia|anesthesia
1150479|NCT02261649|Cerebellar tumor|cerebellar tumor
1150480|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
1150481|NCT02261610|PCT algorithm|pct algorithm
1150482|NCT02261610|Antibiotic|antibiotic
1150483|NCT02261610|Pulmonary embolism|pulmonary embolism
1150484|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
1150485|NCT02261545|n-3 fatty acid|n-3 fatty acid
1150486|NCT02261545|Sirt-1|sirt-1
1150487|NCT02261545|AdipoR1|adipor1
1150488|NCT02261545|AdipoR2|adipor2
1150489|NCT02261545|MCP-1|mcp-1
1150490|NCT02261545|Adiponectin|adiponectin
1150491|NCT02261545|Resistin|resistin
1150492|NCT02261545|T2DM|t2dm
1150493|NCT02261506|Intensive care|intensive care
1150494|NCT02261506|bacteremia|bacteremia
1150495|NCT02261506|bloodstream infection|bloodstream infection
1150496|NCT02261506|antimicrobial|antimicrobial
1150497|NCT02261506|mortality|mortality
1150498|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
1150499|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
1150500|NCT02261454|postoperative ileus|postoperative ileus
1150501|NCT02261454|gum chewing|gum chewing
1150502|NCT02261454|postoperative care|postoperative care
1150503|NCT02261454|abdominal surgery|abdominal surgery
1150504|NCT02261454|child|child
1150505|NCT02261441|Cardiovascular disease|cardiovascular disease
1150506|NCT02261441|Hypertension|hypertension
1150507|NCT02261441|Diabetes|diabetes
1150508|NCT02261441|Smoking|smoking
1150509|NCT02261441|Hypercholesterolemia|hypercholesterolemia
1150510|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
1150511|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
1150512|NCT02261415|blood transfusion|blood transfusion
1150513|NCT02261415|blood loss|blood loss
1150514|NCT02261415|feasibility|feasibility
1150515|NCT02261415|outcome|outcome
1150516|NCT02261415|liver resection|liver resection
1150517|NCT02261402|Adherence|adherence
1150518|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
1150519|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
1150520|NCT02261402|Medication Possession Ratio|medication possession ratio
1150921|NCT02258932|NHS|nhs
1150521|NCT02261402|Medication-Related Problems|medication-related problems
1150522|NCT02261402|Pharmacist|pharmacist
1150523|NCT02261402|Pharmacist Intervention|pharmacist intervention
1150524|NCT02261402|Pharmacy|pharmacy
1150525|NCT02261402|Pharmacy Service|pharmacy service
1150526|NCT02261402|Pharmacy Practice|pharmacy practice
1150527|NCT02261402|Hypertension|hypertension
1150528|NCT02261402|Antihypertensive Agents|antihypertensive agents
1150529|NCT02261402|Anticoagulants|anticoagulants
1150530|NCT02261402|Statins|statins
1150531|NCT02261402|Dyslipidemia|dyslipidemia
1150532|NCT02261389|breast cancer|breast cancer
1150533|NCT02261389|follow-up|follow-up
1150534|NCT02261389|tumor markers|tumor markers
1150535|NCT02261376|pharmacokinetics|pharmacokinetics
1150536|NCT02261337|Sarcopenia|sarcopenia
1150537|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
1150538|NCT02261311|Breast|breast
1150539|NCT02261220|advanced solid tumors|advanced solid tumors
1150540|NCT02261220|durvalumab|durvalumab
1150541|NCT02261220|tremelimumab|tremelimumab
1150542|NCT02261194|depression|depression
1150543|NCT02261194|age-related macular degeneration|age-related macular degeneration
1150544|NCT02261194|self-care|self-care
1150545|NCT02261194|self-help|self-help
1150546|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
1150547|NCT02261168|Circadian Rhythm|circadian rhythm
1150548|NCT02261051|Palliative Care|palliative care
1150549|NCT02261051|Hospice|hospice
1150550|NCT02261051|End of Life|end of life
1150551|NCT02261051|Health Service Utilization|health service utilization
1150552|NCT02261051|Quality of Life|quality of life
1150553|NCT02261038|total knee arthroplasty|total knee arthroplasty
1150554|NCT02261038|total knee prothesis|total knee prothesis
1150555|NCT02261038|X-Ray|x-ray
1150556|NCT02261038|Kanekasu radiographs|kanekasu radiographs
1150557|NCT02261038|femoral component rotation|femoral component rotation
1150558|NCT02261038|effects|effects
1150559|NCT02261025|aspirin|aspirin
1150560|NCT02260908|Trauma|trauma
1150561|NCT02260908|Thromboprophylaxis|thromboprophylaxis
1150562|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
1150563|NCT02260908|Deep vein thrombosis|deep vein thrombosis
1150564|NCT02260856|RCT|rct
1150565|NCT02260856|Epiphysiodesis|epiphysiodesis
1150566|NCT02260856|Tantalum beads|tantalum beads
1150567|NCT02260856|Patient centered outcome data|patient centered outcome data
1150568|NCT02260856|Cost effective analysis|cost effective analysis
1150569|NCT02260843|Insomnia|insomnia
1150570|NCT02260843|Sleeping|sleeping
1150571|NCT02260843|Quality|quality
1150572|NCT02260817|Prostate Cancer|prostate cancer
1150573|NCT02260817|11C Choline|11c choline
1150574|NCT02260817|PET Imaging|pet imaging
1150575|NCT02260791|Rheumatoid|rheumatoid
1150576|NCT02260791|Arthritis|arthritis
1150577|NCT02260778|Learning Collaborative|learning collaborative
1150578|NCT02260778|Treat-to-Target|treat-to-target
1150579|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
1150580|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
1150581|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
1150582|NCT02260726|morphometry|morphometry
1150583|NCT02260726|dynamic|dynamic
1150584|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
1150585|NCT02260726|ultrasound|ultrasound
1150586|NCT02260726|screening|screening
1150587|NCT02260726|diagnosis|diagnosis
1150588|NCT02260700|Healthy|healthy
1150589|NCT02260700|Bioavailability|bioavailability
1150590|NCT02260700|Alzheimer's Disease|alzheimer's disease
1150591|NCT02260700|JNJ-54861911|jnj-54861911
1150592|NCT02260687|Aflibercept|aflibercept
1150593|NCT02260687|Anti-VEGF|anti-vegf
1150594|NCT02260674|Alzheimer's Disease|alzheimer's disease
1151970|NCT02253017|Pediatrics|pediatrics
1150595|NCT02260674|JNJ-54861911|jnj-54861911
1150596|NCT02260674|Placebo|placebo
1150597|NCT02260661|AZD8835|azd8835
1150598|NCT02260661|Fulvestrant|fulvestrant
1150599|NCT02260661|Breast Cancer|breast cancer
1150600|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
1150601|NCT02260622|Restenosis|restenosis
1150602|NCT02260622|Critical Limb Ischemia|critical limb ischemia
1150603|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
1150604|NCT02260622|Rivaroxaban|rivaroxaban
1150605|NCT02260622|Clopidogrel|clopidogrel
1150606|NCT02260609|Complex Wound|complex wound
1150607|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
1150608|NCT02260609|DFU|dfu
1150609|NCT02260609|GrafixCORE|grafixcore
1150610|NCT02260609|Exposed tendon|exposed tendon
1150611|NCT02260609|Exposed bone|exposed bone
1150612|NCT02260609|Allograft tissue|allograft tissue
1150613|NCT02260570|concussion|concussion
1150614|NCT02260570|traumatic brain injury|traumatic brain injury
1150615|NCT02260570|MRI|mri
1150616|NCT02260570|memory|memory
1150617|NCT02260570|tolcapone|tolcapone
1150618|NCT02260557|Systemic Sclerosis|systemic sclerosis
1150619|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
1150620|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
1150621|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1150622|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
1150623|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
1150624|NCT02260518|Gestational weight gain|gestational weight gain
1150625|NCT02260518|Lifestyle intervention|lifestyle intervention
1150626|NCT02260518|Pregnancy|pregnancy
1150627|NCT02260518|Postpartum|postpartum
1150628|NCT02260518|Physical activity|physical activity
1150629|NCT02260518|Nutrition|nutrition
1150630|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1150631|NCT02260505|Non-metastatic|non-metastatic
1150632|NCT02260505|KIT +|kit +
1150633|NCT02260505|Imatinib|imatinib
1150634|NCT02260505|Adjuvant treatment|adjuvant treatment
1150635|NCT02260505|High risk of recurrence|high risk of recurrence
1150636|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1150637|NCT02260505|Disease Free Survival|disease free survival
1150638|NCT02260505|Overall survival|overall survival
1150639|NCT02260505|Time To Secondary Resistance|time to secondary resistance
1150640|NCT02260505|Safety profile|safety profile
1150641|NCT02260505|Quality of Life during treatment|quality of life during treatment
1150642|NCT02260479|skin disinfection|skin disinfection
1150643|NCT02260479|bacterial colonization|bacterial colonization
1150644|NCT02260479|perioperative|perioperative
1150645|NCT02260479|chlorehexidine|chlorehexidine
1150646|NCT02260466|Amyloidosis|amyloidosis
1150647|NCT02260466|echocardiography|echocardiography
1150648|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
1150649|NCT02260466|radionuclide imaging|radionuclide imaging
1150650|NCT02260427|elective surgery|elective surgery
1150651|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
1150652|NCT02260427|elderly adult patients|elderly adult patients
1150653|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
1150654|NCT02260414|Lymphoma|lymphoma
1150655|NCT02260414|Multiple Myeloma|multiple myeloma
1150656|NCT02260414|tinzaparin|tinzaparin
1150657|NCT02260414|thrombin generation|thrombin generation
1150658|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
1150659|NCT02260388|CSPN|cspn
1150660|NCT02260388|neuropathy|neuropathy
1150661|NCT02260388|pain|pain
1150662|NCT02260388|pain management|pain management
1150663|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
1150664|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
1150665|NCT02260349|Prostate cancer|prostate cancer
1150666|NCT02260349|surgical margins|surgical margins
1150667|NCT02260349|indocyanine green|indocyanine green
1150668|NCT02260349|characterization|characterization
1150669|NCT02260349|prostatectomy|prostatectomy
1150670|NCT02260349|peroperative|peroperative
1150671|NCT02260349|detection|detection
1150672|NCT02260297|Actigraphy|actigraphy
1150673|NCT02260297|overweight and obese adults|overweight and obese adults
1150674|NCT02260297|sleep disorders|sleep disorders
1150675|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
1150676|NCT02260219|Ahmed implant|ahmed implant
1150677|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
1150678|NCT02260219|Intraocular pressure|intraocular pressure
1150679|NCT02260206|Pericardial Effusion|pericardial effusion
1150680|NCT02260206|Colchicine|colchicine
1150681|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
1150682|NCT02260206|pericardiocentesis|pericardiocentesis
1150683|NCT02260193|anemia|anemia
1150684|NCT02260193|end stage renal disease|end stage renal disease
1150685|NCT02260193|chronic kidney disease|chronic kidney disease
1150687|NCT02260193|dialysis|dialysis
1150688|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
1150689|NCT02260193|renal impairment|renal impairment
1150690|NCT02260193|erythropoietin|erythropoietin
1150691|NCT02260193|kidney|kidney
1150692|NCT02260193|oral anemia treatment|oral anemia treatment
1150693|NCT02260193|hemoglobin|hemoglobin
1150694|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
1150695|NCT02260193|HIF|hif
1150696|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
1150697|NCT02260193|HIF-PHI|hif-phi
1150698|NCT02260193|pharmacokinetics|pharmacokinetics
1150699|NCT02260154|Duspatalin|duspatalin
1150700|NCT02260154|mebeverine|mebeverine
1150701|NCT02260154|cholecystectomy|cholecystectomy
1150702|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
1150703|NCT02260154|abdominal pain|abdominal pain
1150704|NCT02260154|dyspepsia|dyspepsia
1150705|NCT02260154|antispasmodics|antispasmodics
1150706|NCT02260128|postoperative ileus|postoperative ileus
1150707|NCT02260128|chewing gum|chewing gum
1150708|NCT02259712|Women|women
1150709|NCT02259712|Pelvic floor disorders|pelvic floor disorders
1150710|NCT02259712|Urinary incontinence|urinary incontinence
1150711|NCT02259712|Fecal incontinence|fecal incontinence
1150712|NCT02259712|Physical Therapy Modalities|physical therapy modalities
1150713|NCT02259699|Ovarian Cancer|ovarian cancer
1150714|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1150715|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
1150716|NCT02259699|decision making|decision making
1150717|NCT02259686|Apelin|apelin
1150718|NCT02259686|volunteers|volunteers
1150719|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
1150721|NCT02259660|breathing|breathing
1150722|NCT02259660|snoring|snoring
1150723|NCT02259660|respiratory|respiratory
1150724|NCT02259660|exercise|exercise
1150725|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
1150726|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
1150727|NCT02259634|Patient Navigation|patient navigation
1150728|NCT02259634|Motivational Interviewing|motivational interviewing
1150729|NCT02259634|Formerly Incarcerated|formerly incarcerated
1150730|NCT02259634|Health Education|health education
1150731|NCT02259634|Quality of Life|quality of life
1150732|NCT02259634|Healthcare Utilization|healthcare utilization
1150733|NCT02259608|Trained innate immunity|trained innate immunity
1150734|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
1150735|NCT02259595|Hearing Loss|hearing loss
1150736|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
1150737|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
1150738|NCT02259595|Antioxidant|antioxidant
1150739|NCT02259595|NAC|nac
1150740|NCT02259595|N-acetylcysteine|n-acetylcysteine
1150741|NCT02259595|HPN-07|hpn-07
1150742|NCT02259582|Phase 2|phase 2
1150743|NCT02259582|histologically|histologically
1150744|NCT02259582|confirmed|confirmed
1150745|NCT02259582|malignancy|malignancy
1150746|NCT02259582|metastatic|metastatic
1150747|NCT02259582|pemetrexed|pemetrexed
1150748|NCT02259582|carboplatin|carboplatin
1150749|NCT02259582|carcinoma|carcinoma
1150750|NCT02259582|non small cell lung|non small cell lung
1150751|NCT02259582|lung neoplasms|lung neoplasms
1150752|NCT02259582|lung diseases|lung diseases
1150753|NCT02259569|Gastric insufflation|gastric insufflation
1150754|NCT02259569|I-gel|i-gel
1150755|NCT02259569|Peak airway pressure|peak airway pressure
1150756|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
1150757|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
1150758|NCT02259569|pediatric patient|pediatric patient
1150759|NCT02259543|gingival recession|gingival recession
1150760|NCT02259543|soft tissue|soft tissue
1150761|NCT02259543|root biomodification|root biomodification
1150762|NCT02259543|root coverage|root coverage
1150763|NCT02259543|citric acid|citric acid
1150764|NCT02259543|tetracycline|tetracycline
1150765|NCT02259517|ADHD|adhd
1150766|NCT02259517|Intuniv|intuniv
1150767|NCT02259517|Non-stimulant|non-stimulant
1150768|NCT02259517|Guanfacine extended-release|guanfacine extended-release
1150769|NCT02259517|Vyvanse|vyvanse
1150770|NCT02259517|Stimulant|stimulant
1150771|NCT02259517|Lisdexamfetamine|lisdexamfetamine
1150772|NCT02259504|aneurysms|aneurysms
1150773|NCT02259491|Wound Healing|wound healing
1150774|NCT02259491|Honey|honey
1150775|NCT02259491|Skin Grafts|skin grafts
1150776|NCT02259491|Free tissue transfer|free tissue transfer
1150777|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
1150778|NCT02259478|Hemolysis|hemolysis
1150779|NCT02259478|Transfusion Medicine|transfusion medicine
1150780|NCT02259478|Pharmacovigilance|pharmacovigilance
1150781|NCT02259465|microbiota|microbiota
1150782|NCT02259465|FODMAP|fodmap
1150783|NCT02259465|oligofructose|oligofructose
1150784|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
1150785|NCT02259465|Metabolomics|metabolomics
1150786|NCT02259465|Diet|diet
1150787|NCT02259452|Radiation Therapy|radiation therapy
1150788|NCT02259413|Hemodialysis|hemodialysis
1150789|NCT02259413|End-stage renal disease|end-stage renal disease
1150790|NCT02259413|Exercise|exercise
1150791|NCT02259413|Symptom Burden|symptom burden
1150792|NCT02259400|NIV|niv
1150793|NCT02259400|NSIPPV|nsippv
1150794|NCT02259400|BiPAP|bipap
1150795|NCT02259348|Hematological malignancies|hematological malignancies
1150796|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
1150797|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
1150798|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
1150799|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
1150800|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
1150801|NCT02259335|post-extubation failure|post-extubation failure
1150802|NCT02259322|Bariatric surgery|bariatric surgery
1150803|NCT02259322|Weight loss surgery|weight loss surgery
1150804|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
1150805|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
1150806|NCT02259322|Behavioral treatment|behavioral treatment
1150807|NCT02259322|Obesity|obesity
1150808|NCT02259322|Morbid obesity|morbid obesity
1150809|NCT02259322|Binge eating|binge eating
1150810|NCT02259322|Binge eating disorder|binge eating disorder
1150811|NCT02259322|Loss of control eating|loss of control eating
1150812|NCT02259322|Overeating|overeating
1150813|NCT02259309|misoprostol|misoprostol
1150814|NCT02259309|mucosal|mucosal
1150815|NCT02259309|cervical|cervical
1150816|NCT02259309|immune|immune
1150817|NCT02259309|buccal|buccal
1150818|NCT02259309|vaginal|vaginal
1150819|NCT02259283|achalasia|achalasia
1150820|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
1150821|NCT02259283|endoscopy|endoscopy
1150822|NCT02259270|Acid suppressive therapy|acid suppressive therapy
1150823|NCT02259270|Appropriateness|appropriateness
1150824|NCT02259270|Long term treatment|long term treatment
1150825|NCT02259270|Risk factors|risk factors
1150826|NCT02259270|Hospitalisation|hospitalisation
1150827|NCT02259270|Non-critically ill|non-critically ill
1150828|NCT02259270|Adult|adult
1150829|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
1150830|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1150831|NCT02259257|neovascularization|neovascularization
1150832|NCT02259257|quantitative analysis|quantitative analysis
1150833|NCT02259257|3D/4D imaging|3d/4d imaging
1150834|NCT02259257|CEUS|ceus
1150835|NCT02259257|Vasa vasorum|vasa vasorum
1150836|NCT02259231|RTA 408|rta 408
1150837|NCT02259231|RTA 408 Capsules|rta 408 capsules
1150838|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
1150839|NCT02259231|iNOS|inos
1150840|NCT02259231|Melanoma|melanoma
1150841|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
1150842|NCT02259231|omaveloxolone|omaveloxolone
1150843|NCT02259218|Biomarker|biomarker
1150844|NCT02259218|Radiation|radiation
1150845|NCT02259205|platelet activating factor|platelet activating factor
1150846|NCT02259205|inflammatory markers|inflammatory markers
1150847|NCT02259205|yogurt|yogurt
1150848|NCT02259205|olive oil|olive oil
1150849|NCT02259205|platelet aggregation|platelet aggregation
1150850|NCT02259205|oxidative stress|oxidative stress
1150851|NCT02259205|endothelial damage|endothelial damage
1150852|NCT02259205|bioactive lipids|bioactive lipids
1150853|NCT02259192|deaf adult|deaf adult
1150854|NCT02259192|single-sided|single-sided
1150855|NCT02259192|cochlear implant|cochlear implant
1150856|NCT02259179|Obesity|obesity
1150857|NCT02259179|Overweight|overweight
1150858|NCT02259179|Contrave|contrave
1150859|NCT02259179|Antiobesity agents|antiobesity agents
1150860|NCT02259179|Antiobesity drugs|antiobesity drugs
1150861|NCT02259179|Weight loss drug|weight loss drug
1150862|NCT02259179|Bioequivalence|bioequivalence
1150863|NCT02259179|Pharmacokinetic|pharmacokinetic
1150864|NCT02259153|Lipids|lipids
1150865|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
1150866|NCT02259153|Oxysterols|oxysterols
1150867|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
1150868|NCT02259140|cerebral palsy|cerebral palsy
1150869|NCT02259140|randomized controlled trial|randomized controlled trial
1150870|NCT02259140|hip dislocation|hip dislocation
1150871|NCT02259140|hip subluxation|hip subluxation
1150872|NCT02259140|patient centered outcomes|patient centered outcomes
1150873|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
1150874|NCT02259088|DME, macular edema, vision impairment, Chinese, diabetes|dme, macular edema, vision impairment, chinese, diabetes
1150875|NCT02259075|Migraine with aura|migraine with aura
1150876|NCT02259075|Migraine without aura|migraine without aura
1150877|NCT02259075|Headache disorders|headache disorders
1150878|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
1150879|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
1213344|NCT01972620|pain|pain
1150880|NCT02259075|Autonomic Nerve Block|autonomic nerve block
1150881|NCT02259036|child anxiety|child anxiety
1150882|NCT02259036|worries|worries
1150883|NCT02259036|fears|fears
1150884|NCT02259036|talk therapy|talk therapy
1150885|NCT02259023|Stress Perception|stress perception
1150886|NCT02259023|Discretionary Calories|discretionary calories
1150887|NCT02259023|Health|health
1150888|NCT02258997|sickle cell disease|sickle cell disease
1150889|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1150890|NCT02258958|deep venous thrombosis|deep venous thrombosis
1151971|NCT02253017|Cataract|cataract
1150891|NCT02258958|pulmonary embolus|pulmonary embolus
1150892|NCT02258958|thoracic surgery|thoracic surgery
1150893|NCT02258958|lung resection|lung resection
1150894|NCT02258958|incidence|incidence
1150895|NCT02258945|Type 1 diabetes|type 1 diabetes
1150896|NCT02258945|CSII|csii
1150897|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1150898|NCT02258945|Insulin pump|insulin pump
1150899|NCT02258945|Nutrition|nutrition
1150900|NCT02258945|Eating behaviours|eating behaviours
1150901|NCT02258945|Quality of life|quality of life
1150902|NCT02258945|Cardiometabolic risks|cardiometabolic risks
1150903|NCT02258945|Liverpool|liverpool
1150904|NCT02258945|NHS|nhs
1150905|NCT02258945|Metabolomics|metabolomics
1150906|NCT02258945|Observational|observational
1150907|NCT02258945|Lipoproteins|lipoproteins
1150908|NCT02258945|Lipids|lipids
1150909|NCT02258945|Food|food
1150910|NCT02258945|Food diary|food diary
1150911|NCT02258945|Cross-Sectional|cross-sectional
1150912|NCT02258932|Type 1 diabetes|type 1 diabetes
1150913|NCT02258932|CSII|csii
1150914|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1150915|NCT02258932|Insulin pump|insulin pump
1150916|NCT02258932|Nutrition|nutrition
1150917|NCT02258932|Eating behaviours|eating behaviours
1150918|NCT02258932|Quality of life|quality of life
1150919|NCT02258932|Cardiometabolic risks|cardiometabolic risks
1150922|NCT02258932|Metabolomics|metabolomics
1150923|NCT02258932|Observational|observational
1150924|NCT02258932|Lipoproteins|lipoproteins
1150925|NCT02258932|Lipids|lipids
1150926|NCT02258932|Food|food
1150927|NCT02258932|Food diary|food diary
1150928|NCT02258932|Longitudinal|longitudinal
1150929|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
1150930|NCT02258919|Decompressive craniectomy|decompressive craniectomy
1150931|NCT02258919|Randomized controlled trial|randomized controlled trial
1150932|NCT02258919|Acute stroke|acute stroke
1150933|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
1150934|NCT02258893|Parts per billion|parts per billion
1150935|NCT02258880|Acute Stroke|acute stroke
1150936|NCT02258880|Outcome Measures|outcome measures
1150937|NCT02258880|Physical Performance|physical performance
1150938|NCT02258867|Uveitis|uveitis
1150939|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
1150940|NCT02258867|Behcet's Disease|behcet's disease
1150941|NCT02258854|Uveitis|uveitis
1150942|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
1150943|NCT02258854|Intermediate Uveitis|intermediate uveitis
1150944|NCT02258854|Posterior Uveitis|posterior uveitis
1150945|NCT02258854|Panuveitis|panuveitis
1150946|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
1150947|NCT02258841|domestic violence|domestic violence
1150948|NCT02258841|mental health|mental health
1150949|NCT02258841|safety planning|safety planning
1150950|NCT02258815|pediatric|pediatric
1150951|NCT02258815|haploidentical|haploidentical
1150952|NCT02258815|stem cell transplantation|stem cell transplantation
1150953|NCT02258802|psychoeducational intervention|psychoeducational intervention
1150954|NCT02258802|nutrition intervention|nutrition intervention
1150955|NCT02258802|malnutrition|malnutrition
1150956|NCT02258802|micronutrient deficiency|micronutrient deficiency
1150957|NCT02258802|nutrition transition|nutrition transition
1150958|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
1150959|NCT02258763|Pneumonia|pneumonia
1150960|NCT02258763|Child|child
1150961|NCT02258763|Outcome|outcome
1150962|NCT02258763|Antibiotics|antibiotics
1150963|NCT02258763|Etiology|etiology
1150964|NCT02258737|Case management|case management
1150965|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
1150966|NCT02258737|discharge|discharge
1150967|NCT02258724|Adult|adult
1150968|NCT02258724|Registry|registry
1150969|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
1150970|NCT02258711|Bipolar disorder|bipolar disorder
1150971|NCT02258711|Psychoeducation|psychoeducation
1150972|NCT02258711|Smart-phone monitoring|smart-phone monitoring
1150973|NCT02258685|Gut microbiota composition|gut microbiota composition
1150974|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
1150975|NCT02258672|Minimally invasive surgery|minimally invasive surgery
1150976|NCT02258672|Functional capacity|functional capacity
1150977|NCT02258646|Exercise|exercise
1150978|NCT02258646|Rehabilitation|rehabilitation
1150979|NCT02258646|Telemedicine|telemedicine
1150980|NCT02258646|Treatment Outcome|treatment outcome
1150981|NCT02258646|Costs and Cost Analysis|costs and cost analysis
1150982|NCT02258646|Physical Therapists|physical therapists
1150983|NCT02258646|Adaptation, Psychological|adaptation, psychological
1150984|NCT02258568|Cigarette Smoking|cigarette smoking
1150985|NCT02258568|Pregnancy|pregnancy
1150986|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
1150987|NCT02258568|Romania|romania
1150988|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1150989|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
1151114|NCT02257801|Mood|mood
1150990|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1151972|NCT02253017|Surgery|surgery
1150991|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
1150992|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
1150993|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
1150994|NCT02258529|Cancer|cancer
1150995|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
1150996|NCT02258529|FL|fl
1150997|NCT02258529|SLL|sll
1150998|NCT02258503|Numerical scale|numerical scale
1150999|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
1151000|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
1151001|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
1151002|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
1151003|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
1151004|NCT02258490|graft versus host disease|graft versus host disease
1151005|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
1151006|NCT02258490|G-CSF|g-csf
1151007|NCT02258464|Breast Cancer|breast cancer
1151008|NCT02258451|Breast Cancer|breast cancer
1151009|NCT02258438|Sedentary Behavior|sedentary behavior
1151010|NCT02258425|Homeless Women|homeless women
1151011|NCT02258425|Parolees|parolees
1151012|NCT02258425|Probationers|probationers
1151013|NCT02258425|Community Drug Treatment|community drug treatment
1151014|NCT02258425|Recidivism|recidivism
1151015|NCT02258412|antimicrobial|antimicrobial
1151016|NCT02258412|efficacy|efficacy
1151017|NCT02258412|hand|hand
1151018|NCT02258412|hygiene|hygiene
1151019|NCT02258412|bacteria|bacteria
1151020|NCT02258373|Diabetes Mellitus|diabetes mellitus
1151021|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
1151022|NCT02258360|Thromboelastometry|thromboelastometry
1151023|NCT02258360|Haemostasis|haemostasis
1151024|NCT02258360|Hypothermia|hypothermia
1151025|NCT02258360|Heart Arrest|heart arrest
1151026|NCT02258334|Influenza|influenza
1151027|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
1151028|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
1151029|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
1151030|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
1151031|NCT02258295|Tendinitis|tendinitis
1151032|NCT02258295|Tendinosis|tendinosis
1151033|NCT02258295|Athletic Injuries|athletic injuries
1151034|NCT02258295|Elbow Joint|elbow joint
1151035|NCT02258295|Sports Medicine|sports medicine
1151036|NCT02258204|Cerebral Infarct|cerebral infarct
1151037|NCT02258204|Thrombolysis|thrombolysis
1151038|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
1151039|NCT02258204|Neuroprotection|neuroprotection
1151040|NCT02258204|Anesthetic agent|anesthetic agent
1151041|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
1151042|NCT02258191|NIV|niv
1151043|NCT02258191|COPD|copd
1151044|NCT02258191|telemonitoring|telemonitoring
1151045|NCT02258165|ovarian cancer|ovarian cancer
1151046|NCT02258165|imaging|imaging
1151047|NCT02258165|gated PET/CT scan|gated pet/ct scan
1151048|NCT02258152|PDD|pdd
1151049|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
1151050|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
1151051|NCT02258126|overweight children|overweight children
1151052|NCT02258126|hepatic fat|hepatic fat
1151053|NCT02258126|exercise|exercise
1151054|NCT02258126|nutritional education program|nutritional education program
1151055|NCT02258126|cardiometabolic risk|cardiometabolic risk
1151056|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
1151057|NCT02258048|Cirrhosis|cirrhosis
1151058|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
1151059|NCT02258022|Wounds and Injuries|wounds and injuries
1151060|NCT02258022|Sepsis|sepsis
1151061|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
1151062|NCT02257996|Telepsychology|telepsychology
1151063|NCT02257996|Online Therapy|online therapy
1151064|NCT02257996|Web conferencing|web conferencing
1151065|NCT02257996|RCT|rct
1151066|NCT02257996|HIPAA|hipaa
1151067|NCT02257983|hearing|hearing
1151068|NCT02257983|noise|noise
1151069|NCT02257983|oxidative stress|oxidative stress
1151070|NCT02257970|Lymphedema|lymphedema
1151071|NCT02257970|edema|edema
1213612|NCT01971437|OAB|oab
1151072|NCT02257970|swelling|swelling
1151073|NCT02257931|infection|infection
1151074|NCT02257931|bacteria|bacteria
1151075|NCT02257931|gram-negative|gram-negative
1151076|NCT02257931|HSCT|hsct
1151077|NCT02257931|allogeneic|allogeneic
1151078|NCT02257931|autologous|autologous
1151079|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
1151080|NCT02257918|antibiotic|antibiotic
1151081|NCT02257918|antimicrobial|antimicrobial
1151082|NCT02257918|AZD0914|azd0914
1151083|NCT02257918|Ceftriaxone|ceftriaxone
1151084|NCT02257918|drug-resistant|drug-resistant
1151085|NCT02257918|sexually transmitted infection|sexually transmitted infection
1152074|NCT02252471|prevention|prevention
1151086|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
1151087|NCT02257905|AL Amyloidosis|al amyloidosis
1151088|NCT02257905|Amyloidosis|amyloidosis
1151089|NCT02257905|allogeneic|allogeneic
1151090|NCT02257905|HSCT|hsct
1151091|NCT02257892|CTLA4|ctla4
1151092|NCT02257892|PI3KCD|pi3kcd
1151093|NCT02257892|MAG T1|mag t1
1151094|NCT02257892|Rare Immune Disorders|rare immune disorders
1151095|NCT02257892|Genetic Testing|genetic testing
1151096|NCT02257879|Midazolam|midazolam
1151097|NCT02257879|CYP3A|cyp3a
1151098|NCT02257879|Loperamide|loperamide
1151099|NCT02257866|Autoimmunity|autoimmunity
1151100|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
1151101|NCT02257866|Vasculitis|vasculitis
1151102|NCT02257866|Rheumatic Disease|rheumatic disease
1151103|NCT02257853|Caregiver Stress|caregiver stress
1151104|NCT02257853|Cancer Caregivers|cancer caregivers
1151105|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
1151106|NCT02257853|HSCT Caregivers|hsct caregivers
1151107|NCT02257827|Hypofractionated schedule|hypofractionated schedule
1151108|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1151109|NCT02257827|Conformal radiotherapy|conformal radiotherapy
1151110|NCT02257801|Memory|memory
1151111|NCT02257801|Cognition|cognition
1151112|NCT02257801|Execute Function|execute function
1151113|NCT02257801|Attention|attention
1151115|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
1151216|NCT02257385|umeclidinium bromide|umeclidinium bromide
1151116|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
1151117|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
1151118|NCT02257762|Complementary feeding|complementary feeding
1151119|NCT02257762|Home fortification|home fortification
1151120|NCT02257762|Efficacy/impact|efficacy/impact
1151121|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
1151122|NCT02257762|Cambodia|cambodia
1151123|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
1151124|NCT02257749|Concussion|concussion
1151125|NCT02257749|Persistent Symptoms|persistent symptoms
1151126|NCT02257749|Children|children
1151127|NCT02257749|Exercise|exercise
1151128|NCT02257749|Adolescents|adolescents
1151129|NCT02257749|Active Rehabilitation|active rehabilitation
1151130|NCT02257749|Education|education
1151131|NCT02257736|Prostatic neoplasms|prostatic neoplasms
1151132|NCT02257736|JN56021927|jn56021927
1151133|NCT02257736|ZYTIGA|zytiga
1151134|NCT02257736|Prednisone|prednisone
1151135|NCT02257736|Abiraterone acetate|abiraterone acetate
1151136|NCT02257736|Apalutamide|apalutamide
1151137|NCT02257723|Inpatient care|inpatient care
1151138|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
1151139|NCT02257723|Integrated medicine|integrated medicine
1151140|NCT02257710|national|national
1151141|NCT02257710|Multicenter|multicenter
1151142|NCT02257710|Observational registry|observational registry
1151143|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1151144|NCT02257710|Stenting|stenting
1151145|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
1151146|NCT02257710|Coronary revascularization|coronary revascularization
1151147|NCT02257710|Coronary Intervention|coronary intervention
1151148|NCT02257710|STEMI|stemi
1151149|NCT02257710|NSTEMI|nstemi
1151150|NCT02257710|Ischemia|ischemia
1151151|NCT02257710|Angina|angina
1151152|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1151153|NCT02257710|Small Vessels|small vessels
1151154|NCT02257710|Chronic Total Occlusion|chronic total occlusion
1151155|NCT02257684|ALL|all
1151156|NCT02257684|LBL|lbl
1151157|NCT02257658|Men who have Sex with Men|men who have sex with men
1151158|NCT02257658|HIV-positive|hiv-positive
1151159|NCT02257658|Syphilis|syphilis
1151160|NCT02257658|Contingency Management|contingency management
1151161|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
1151162|NCT02257593|macronutrient|macronutrient
1151163|NCT02257593|malnutrition|malnutrition
1151164|NCT02257593|birth weight|birth weight
1151165|NCT02257593|protein leverage|protein leverage
1151166|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
1151167|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
1151168|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
1151169|NCT02257580|Complications|complications
1151170|NCT02257580|Safety|safety
1151171|NCT02257554|expectations|expectations
1151172|NCT02257541|BGJ398|bgj398
1151173|NCT02257541|Imatinib Mesylate|imatinib mesylate
1151174|NCT02257541|14-140|14-140
1151175|NCT02257502|aflibercept|aflibercept
1151176|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
1151177|NCT02257502|young patient|young patient
1151178|NCT02257476|carfilzomib|carfilzomib
1151179|NCT02257476|advanced solid malignancies|advanced solid malignancies
1151180|NCT02257476|advanced solid cancers|advanced solid cancers
1151181|NCT02257476|prostate|prostate
1151182|NCT02257476|bladder|bladder
1151183|NCT02257476|colon|colon
1151184|NCT02257476|breast|breast
1151185|NCT02257476|lung|lung
1151187|NCT02257463|inspiratory muscle training|inspiratory muscle training
1151188|NCT02257463|dyspnea|dyspnea
1151189|NCT02257463|Quality of Life|quality of life
1151190|NCT02257450|Primary Aldosteronism|primary aldosteronism
1151191|NCT02257450|Hyperaldosteronism|hyperaldosteronism
1151192|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
1151193|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
1151194|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
1151195|NCT02257437|Complementary feeding|complementary feeding
1151196|NCT02257437|Home fortification|home fortification
1151197|NCT02257437|Acceptability|acceptability
1151198|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
1151199|NCT02257437|Cambodia|cambodia
1151200|NCT02257437|Cross-over studies|cross-over studies
1151201|NCT02257411|child|child
1151202|NCT02257411|ear based|ear based
1151203|NCT02257411|Proseal LMA|proseal lma
1151204|NCT02257398|TQTc|tqtc
1151205|NCT02257398|Moxifloxacin|moxifloxacin
1151206|NCT02257398|GSK2140944|gsk2140944
1151207|NCT02257385|indacaterol|indacaterol
1151208|NCT02257385|efficacy|efficacy
1151209|NCT02257385|FEV1|fev1
1151210|NCT02257385|ELLIPTA|ellipta
1151211|NCT02257385|non inferiority|non inferiority
1151212|NCT02257385|vilanterol|vilanterol
1151213|NCT02257385|COPD|copd
1151214|NCT02257385|safety|safety
1151215|NCT02257385|tiotropium|tiotropium
1151217|NCT02257385|GSK573719|gsk573719
1151218|NCT02257372|FEV1|fev1
1151219|NCT02257372|DPI|dpi
1151220|NCT02257372|ICS/LABA|ics/laba
1151221|NCT02257372|UMEC|umec
1151222|NCT02257372|COPD|copd
1151223|NCT02257359|Epelsiban|epelsiban
1151224|NCT02257359|Healthy Female Volunteers|healthy female volunteers
1151225|NCT02257359|Safety|safety
1151226|NCT02257359|Tolerability|tolerability
1151227|NCT02257359|Oxytocin|oxytocin
1151228|NCT02257359|Pharmacokinetics|pharmacokinetics
1151229|NCT02257346|Pregnancy|pregnancy
1151230|NCT02257346|Lidocaine|lidocaine
1151231|NCT02257346|Quality|quality
1151232|NCT02257346|Recovery|recovery
1151233|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
1151234|NCT02257333|Atherosclerosis|atherosclerosis
1151235|NCT02257333|Risk Factors|risk factors
1151236|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
1151237|NCT02257307|ROP|rop
1151238|NCT02257307|retinopathy|retinopathy
1151239|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
1151240|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
1151241|NCT02257281|Skin irritants|skin irritants
1151242|NCT02257281|inflammation|inflammation
1151243|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
1151244|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
1151245|NCT02257255|cesarean section|cesarean section
1151246|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
1151247|NCT02257255|pain measurement/methods|pain measurement/methods
1151248|NCT02257242|Bendamustine|bendamustine
1151249|NCT02257242|Rituximab|rituximab
1151250|NCT02257242|Vincristine sulfate|vincristine sulfate
1151251|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
1151253|NCT02257242|Escalation With Overdose Control|escalation with overdose control
1151254|NCT02257229|Feet, deformity, correction, management, gait|feet, deformity, correction, management, gait
1151255|NCT02257203|Dietary sucrose|dietary sucrose
1151256|NCT02257190|Glycemic control|glycemic control
1151257|NCT02257190|Exercise|exercise
1151258|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1151259|NCT02257164|femoral nerve block|femoral nerve block
1151260|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
1151261|NCT02257151|Volunteers|volunteers
1151262|NCT02257138|Leukemia|leukemia
1151263|NCT02257138|Myeloproliferative Diseases|myeloproliferative diseases
1151264|NCT02257138|Acute Myeloid Leukemia|acute myeloid leukemia
1151265|NCT02257138|AML|aml
1151266|NCT02257138|Ruxolitinib|ruxolitinib
1151267|NCT02257138|Jakafi|jakafi
1151268|NCT02257138|INCB018424|incb018424
1151269|NCT02257138|INC424|inc424
1151270|NCT02257138|Decitabine|decitabine
1151271|NCT02257138|Dacogen|dacogen
1151272|NCT02257138|Post myeloproliferative neoplasm|post myeloproliferative neoplasm
1151273|NCT02257138|Post MPN-AML|post mpn-aml
1151274|NCT02257125|rehabilitation|rehabilitation
1151275|NCT02257125|virtual reality|virtual reality
1151276|NCT02257125|stroke|stroke
1151277|NCT02257125|upper extremity|upper extremity
1151278|NCT02257125|arm|arm
1151279|NCT02257125|feedback|feedback
1151280|NCT02257125|reward|reward
1151281|NCT02257060|Endocardial Ablation|endocardial ablation
1151282|NCT02257060|Atrial Flutter|atrial flutter
1151283|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
1151284|NCT02256995|Pregnancy|pregnancy
1151285|NCT02256995|Preeclampsia|preeclampsia
1151286|NCT02256995|Eclampsia|eclampsia
1151287|NCT02256995|Proteinuria|proteinuria
1151288|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
1151289|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
1151290|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
1151291|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
1151292|NCT02256904|Alignment|alignment
1151293|NCT02256904|Kinematic|kinematic
1151294|NCT02256904|knee|knee
1151295|NCT02256904|satisfaction|satisfaction
1151296|NCT02256904|function|function
1151297|NCT02256904|survivorship|survivorship
1151298|NCT02256891|Rotator cuff tear|rotator cuff tear
1151299|NCT02256891|Rotator cuff injury|rotator cuff injury
1151300|NCT02256891|Shoulder pain|shoulder pain
1151301|NCT02256891|Shoulder injury|shoulder injury
1151302|NCT02256865|Sleep Restriction|sleep restriction
1151303|NCT02256865|Insulin Resistance|insulin resistance
1151304|NCT02256865|Testosterone|testosterone
1151305|NCT02256865|Cortisol|cortisol
1151306|NCT02256839|Tuberculosis|tuberculosis
1151307|NCT02256839|TB|tb
1151308|NCT02256683|atrial fibrillation|atrial fibrillation
1151309|NCT02256683|atrial flutter|atrial flutter
1151310|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
1151311|NCT02256683|Thrombus resolution|thrombus resolution
1151312|NCT02256683|Dabigatran|dabigatran
1151313|NCT02256683|Phenprocoumon|phenprocoumon
1151314|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
1151315|NCT02256670|Hormone Receptor Positive|hormone receptor positive
1151316|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
1151317|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1151318|NCT02256618|newborn infants|newborn infants
1151319|NCT02256618|neonates|neonates
1151320|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
1151321|NCT02256592|inflammation|inflammation
1151322|NCT02256592|microbiome|microbiome
1151323|NCT02256592|immune activation|immune activation
1151324|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
1151325|NCT02256592|dysbiosis|dysbiosis
1151326|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
1151327|NCT02256566|cognitive training|cognitive training
1151328|NCT02256566|depression|depression
1151329|NCT02256566|bipolar depression|bipolar depression
1151330|NCT02256566|anxiety|anxiety
1151331|NCT02256566|ptsd|ptsd
1151332|NCT02256566|generalized anxiety|generalized anxiety
1151333|NCT02256566|social phobia|social phobia
1151334|NCT02256514|therapeutic vaccine|therapeutic vaccine
1151335|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
1151336|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
1151337|NCT02256436|P-D1|p-d1
1151338|NCT02256436|PD-1|pd-1
1151339|NCT02256436|PD1|pd1
1151340|NCT02256436|P-DL1|p-dl1
1151341|NCT02256436|PD-L1|pd-l1
1151342|NCT02256436|PDL-1|pdl-1
1151343|NCT02256436|PDL1|pdl1
1151344|NCT02256436|Bladder cancer|bladder cancer
1151345|NCT02256423|Ibuprofen|ibuprofen
1151346|NCT02256423|healthy volunteer study|healthy volunteer study
1151347|NCT02256423|pharmacokinetics|pharmacokinetics
1151348|NCT02256410|low back pain|low back pain
1151349|NCT02256410|chronic pain|chronic pain
1151350|NCT02256410|sensitization|sensitization
1151351|NCT02256410|treatment|treatment
1151352|NCT02256410|trigger points|trigger points
1151353|NCT02256397|Asthma|asthma
1151354|NCT02256384|Respiration Rate|respiration rate
1151355|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
1151356|NCT02256384|postoperative|postoperative
1151357|NCT02256371|Neuropathic pain|neuropathic pain
1151358|NCT02256371|Hypnosis|hypnosis
1151359|NCT02256371|Relaxation|relaxation
1151360|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
1151361|NCT02256319|Deep brain stimulation|deep brain stimulation
1151362|NCT02256319|Dexmedetomidine|dexmedetomidine
1151363|NCT02256319|Propofol|propofol
1151364|NCT02256293|Type 1 Diabetes|type 1 diabetes
1151365|NCT02256280|Neuromuscular blockade|neuromuscular blockade
1151366|NCT02256280|Thoracic surgery|thoracic surgery
1151367|NCT02256254|Oxidative stress|oxidative stress
1151368|NCT02256254|Simvastatin|simvastatin
1151369|NCT02256228|Analgesia|analgesia
1151370|NCT02256228|Local infiltration analgesia|local infiltration analgesia
1151371|NCT02256228|Pain, relief|pain, relief
1151372|NCT02256228|Pain, Postoperative|pain, postoperative
1151373|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
1151374|NCT02256228|Ropivacaine|ropivacaine
1151375|NCT02256228|Saline|saline
1151376|NCT02256228|Therapeutic Uses|therapeutic uses
1151377|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
1151378|NCT02256228|Analgesics|analgesics
1151379|NCT02256228|Opioids|opioids
1151380|NCT02256228|Morphine|morphine
1151381|NCT02256228|Pain|pain
1151382|NCT02256228|Postoperative Complications|postoperative complications
1151383|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
1151384|NCT02256228|Anesthetics, Local|anesthetics, local
1151385|NCT02256228|Anesthetic|anesthetic
1151386|NCT02256228|Cytoreductive|cytoreductive
1151387|NCT02256228|Surgery|surgery
1151388|NCT02256228|Cancer|cancer
1151389|NCT02256215|Vitamin D|vitamin d
1151390|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
1151392|NCT02256163|familial TAA|familial taa
1151393|NCT02256163|blood collection|blood collection
1151394|NCT02256137|Frailty phenotype|frailty phenotype
1151395|NCT02256137|Physical fitness|physical fitness
1151396|NCT02256137|Childhood cancer|childhood cancer
1151397|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
1151398|NCT02256137|Physical frailty|physical frailty
1151399|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
1151400|NCT02256124|NF1|nf1
1151401|NCT02256124|Cognition|cognition
1151402|NCT02256124|Learning problems|learning problems
1151403|NCT02256124|Lamotrigine|lamotrigine
1151404|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
1151405|NCT02256124|TMS|tms
1151406|NCT02256098|Comparative Study|comparative study
1151407|NCT02256098|Knee Prosthesis|knee prosthesis
1151408|NCT02256098|Prosthesis Design|prosthesis design
1151409|NCT02256098|Treatment Outcome|treatment outcome
1151410|NCT02256098|Follow-Up Studies|follow-up studies
1151411|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
1151412|NCT02256085|Dissociative|dissociative
1151413|NCT02256085|Dissociation|dissociation
1151414|NCT02256085|Depersonalization|depersonalization
1151415|NCT02256085|Depersonalization Disorder|depersonalization disorder
1151416|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1151417|NCT02256085|TMS|tms
1151418|NCT02256085|DPD|dpd
1151419|NCT02256085|rTMS|rtms
1151420|NCT02256085|Behavioral Symptoms|behavioral symptoms
1151421|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
1151422|NCT02256033|Mild hepatic impairment|mild hepatic impairment
1151423|NCT02256033|Healthy volunteer|healthy volunteer
1151424|NCT02256033|Istradefylline|istradefylline
1151425|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
1151426|NCT02256007|Videogames; stroke|videogames; stroke
1151427|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
1151428|NCT02255968|Normal Volunteers|normal volunteers
1151429|NCT02255968|Safety|safety
1151430|NCT02255968|Pharmacokinetics|pharmacokinetics
1151431|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
1151432|NCT02255955|paracetamol codeine|paracetamol codeine
1151433|NCT02255955|disk surgery|disk surgery
1151434|NCT02255929|Benign Essential Tremor|benign essential tremor
1151435|NCT02255929|Tremor|tremor
1151436|NCT02255929|Neurologic Manifestations|neurologic manifestations
1151437|NCT02255929|Nervous System Diseases|nervous system diseases
1151438|NCT02255929|Movement Disorders|movement disorders
1151439|NCT02255929|Central Nervous System Diseases|central nervous system diseases
1151440|NCT02255916|oncology|oncology
1151441|NCT02255916|psychology|psychology
1151442|NCT02255916|cancer|cancer
1151443|NCT02255916|music|music
1151444|NCT02255916|sound-bed|sound-bed
1151445|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
1151446|NCT02255877|uni compartmental|uni compartmental
1151447|NCT02255864|Stents|stents
1151448|NCT02255864|Angioplasty|angioplasty
1151449|NCT02255864|Coronary Vessels|coronary vessels
1151450|NCT02255864|Coronary Artery Disease|coronary artery disease
1151451|NCT02255864|Angina Pectoris|angina pectoris
1151452|NCT02255864|Myocardial Ischemia|myocardial ischemia
1151453|NCT02255864|Myocardial Infarction|myocardial infarction
1151454|NCT02255864|Myocardial Revascularization|myocardial revascularization
1151455|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
1151456|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
1151457|NCT02255799|traumatic brain injury|traumatic brain injury
1151458|NCT02255799|TBI|tbi
1151459|NCT02255799|brain injury|brain injury
1151460|NCT02255799|memory|memory
1151461|NCT02255799|verbal memory deficits|verbal memory deficits
1151462|NCT02255799|memory problems|memory problems
1151463|NCT02255799|cognition|cognition
1151464|NCT02255799|cognitive impairment|cognitive impairment
1151465|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
1151466|NCT02255799|donepezil|donepezil
1151467|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1151468|NCT02255786|Group Therapy|group therapy
1151469|NCT02255786|Parents|parents
1151470|NCT02255786|Autism|autism
1151471|NCT02255786|Quality of Life|quality of life
1151472|NCT02255773|Head and Neck Cancer|head and neck cancer
1151473|NCT02255773|HNC|hnc
1151474|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
1151475|NCT02255773|Computerized tasks|computerized tasks
1151476|NCT02255773|Questionnaires|questionnaires
1151477|NCT02255773|Surveys|surveys
1151478|NCT02255773|Disease-free adult males|disease-free adult males
1151479|NCT02255773|Cancer survivors|cancer survivors
1151480|NCT02255760|MEDI3902, Safety, Pharmacokinetics|medi3902, safety, pharmacokinetics
1151481|NCT02255747|infants and children with constipation|infants and children with constipation
1151482|NCT02255734|Volunteers|volunteers
1151483|NCT02255695|posture|posture
1151484|NCT02255695|child|child
1151485|NCT02255695|prevention|prevention
1151486|NCT02255695|muscle strength|muscle strength
1151487|NCT02255695|muscle stretching exercises|muscle stretching exercises
1151488|NCT02255695|exercise therapy|exercise therapy
1151489|NCT02255695|disease management|disease management
1151490|NCT02255695|musculoskeletal pain|musculoskeletal pain
1151491|NCT02255695|adolescent|adolescent
1151492|NCT02255695|spinal curvatures|spinal curvatures
1151493|NCT02255682|physical activity|physical activity
1151494|NCT02255682|statin therapy|statin therapy
1151495|NCT02255682|diabetes mellitus|diabetes mellitus
1151496|NCT02255682|cardiovascular disease|cardiovascular disease
1151497|NCT02255682|Q10-supplementation|q10-supplementation
1151498|NCT02255643|motor cortex stimulation|motor cortex stimulation
1151499|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
1151500|NCT02255630|salbutamol|salbutamol
1151501|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1151502|NCT02255630|anaerobic power|anaerobic power
1151503|NCT02255604|Allergic Rhinitis|allergic rhinitis
1151504|NCT02255604|Allergen immunotherapy|allergen immunotherapy
1151505|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
1151506|NCT02255591|Perioperative analgesia|perioperative analgesia
1151507|NCT02255565|Quillivant|quillivant
1151508|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
1151509|NCT02255500|Total knee arthroplasty|total knee arthroplasty
1151510|NCT02255487|surgical device|surgical device
1151511|NCT02255487|surgical irrigation device|surgical irrigation device
1151512|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
1151513|NCT02255474|pediatrics|pediatrics
1151514|NCT02255474|refractive error - myopia|refractive error - myopia
1151515|NCT02255474|contact lenses|contact lenses
1151516|NCT02255474|intervention|intervention
1151517|NCT02255435|RTA 408|rta 408
1151518|NCT02255435|RTA 408 Capsules|rta 408 capsules
1151519|NCT02255435|Oxidative Stress|oxidative stress
1151520|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
1151521|NCT02255435|omaveloxolone|omaveloxolone
1151522|NCT02255422|omaveloxolone|omaveloxolone
1151523|NCT02255422|RTA 408 capsules|rta 408 capsules
1151524|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
1151525|NCT02255383|Osteoarthritis|osteoarthritis
1151526|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
1151527|NCT02255383|Traumatic Arthritis|traumatic arthritis
1151528|NCT02255383|Polyarthritis|polyarthritis
1151529|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
1151530|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
1151531|NCT02255357|Oxytocin|oxytocin
1151532|NCT02255357|Vasopressin|vasopressin
1151533|NCT02255357|Cocaine|cocaine
1151534|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
1151535|NCT02255344|Risk Model|risk model
1151536|NCT02255344|National Registry|national registry
1151537|NCT02255344|Comprehensive Care Program|comprehensive care program
1151538|NCT02255344|Major Cardiovascular Events|major cardiovascular events
1151539|NCT02255331|Arthroplasty|arthroplasty
1151540|NCT02255331|Replacement|replacement
1151541|NCT02255331|Hip|hip
1151542|NCT02255318|Taurolock®|taurolock®
1151543|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
1151544|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
1151545|NCT02255305|CDI|cdi
1151546|NCT02255305|C difficile|c difficile
1151547|NCT02255305|C diff|c diff
1151548|NCT02255305|Clostridium difficile|clostridium difficile
1151549|NCT02255253|Telmisartan|telmisartan
1151550|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
1151551|NCT02255253|Efficacy|efficacy
1151552|NCT02255253|hypertension|hypertension
1151553|NCT02255253|high sodium intake|high sodium intake
1151554|NCT02255240|breast cancer|breast cancer
1151555|NCT02255240|cancer|cancer
1151556|NCT02255240|survivorship|survivorship
1151557|NCT02255240|cancer survivor|cancer survivor
1151558|NCT02255240|physical activity|physical activity
1151559|NCT02255240|video game|video game
1151560|NCT02255240|women|women
1151561|NCT02255240|women's health|women's health
1151562|NCT02255227|vaccination|vaccination
1151563|NCT02255227|randomized|randomized
1151564|NCT02255227|anti-pneumococcal|anti-pneumococcal
1151565|NCT02255227|Pneumo 23|pneumo 23
1151566|NCT02255227|Prevenar 13|prevenar 13
1151567|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
1151568|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
1151569|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
1151570|NCT02255175|Depression|depression
1151571|NCT02255175|Perimenopause|perimenopause
1151572|NCT02255175|Estrogen|estrogen
1151573|NCT02255175|Estradiol treatment|estradiol treatment
1151574|NCT02255175|Mood Disorders|mood disorders
1151575|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
1151576|NCT02255175|Sex Steroids|sex steroids
1151577|NCT02255175|Depressive disorder|depressive disorder
1151578|NCT02255175|Mental Disorders|mental disorders
1151579|NCT02255175|Estradiol|estradiol
1151580|NCT02255175|Hormones|hormones
1151581|NCT02255175|Physiological effects of drugs|physiological effects of drugs
1151582|NCT02255175|Reproductive Control Agents|reproductive control agents
1152179|NCT02251951|Cancer|cancer
1151583|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1151584|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
1151585|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
1151586|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
1151587|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
1151588|NCT02255136|Interleukin|interleukin
1151589|NCT02255136|Immunoglobulin|immunoglobulin
1151590|NCT02255136|Homeopathy|homeopathy
1151591|NCT02255136|Allergic Rhinitis|allergic rhinitis
1151592|NCT02255136|Asthma|asthma
1151593|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
1151594|NCT02255110|TH-302|th-302
1151595|NCT02255110|Doxorubicin|doxorubicin
1151596|NCT02255110|Evofosfamide|evofosfamide
1151597|NCT02255097|PD-1|pd-1
1151598|NCT02255097|PD1|pd1
1151599|NCT02255097|PD-L1|pd-l1
1151600|NCT02255097|PDL1|pdl1
1151601|NCT02255084|Cervical cancer screening|cervical cancer screening
1151602|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
1151603|NCT02255084|vaginal self-sampling|vaginal self-sampling
1151604|NCT02255084|pap smear|pap smear
1151605|NCT02255084|general practitioner|general practitioner
1151606|NCT02255071|GERD|gerd
1151607|NCT02255071|Neiguan|neiguan
1151608|NCT02255071|Acupressure|acupressure
1151609|NCT02255071|P6|p6
1151610|NCT02255032|uveitis|uveitis
1151611|NCT02255032|macular edema|macular edema
1151612|NCT02255032|UME|ume
1151613|NCT02255032|posterior uveitis|posterior uveitis
1151614|NCT02255032|anterior uveitis|anterior uveitis
1151615|NCT02255032|panuveitis|panuveitis
1151616|NCT02255032|intermediate uveitis|intermediate uveitis
1151617|NCT02255032|noninfectious uveitis|noninfectious uveitis
1151618|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
1151619|NCT02255032|suprachoroidal space|suprachoroidal space
1151620|NCT02255032|injection|injection
1151621|NCT02255032|microneedle|microneedle
1151622|NCT02255032|intravitreal injection|intravitreal injection
1151623|NCT02255032|corticosteroid|corticosteroid
1151624|NCT02255032|CME|cme
1151625|NCT02255032|choroid|choroid
1151626|NCT02255032|retina|retina
1151627|NCT02255032|microinjection|microinjection
1151628|NCT02255032|SCS|scs
1151629|NCT02255006|volunteer|volunteer
1151630|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
1151631|NCT02254980|Total hip arthroplasty|total hip arthroplasty
1151632|NCT02254980|Cemented acetabular cup|cemented acetabular cup
1151633|NCT02254980|Vitamin-E|vitamin-e
1151634|NCT02254980|Radiostereometry|radiostereometry
1151635|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
1151636|NCT02254967|Aged|aged
1151637|NCT02254967|Fidaxomicin|fidaxomicin
1151638|NCT02254967|Clostridium Difficile|clostridium difficile
1151639|NCT02254967|Vancomycin|vancomycin
1151640|NCT02254954|glioblastoma|glioblastoma
1151641|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
1151642|NCT02254941|Monoclonal antibodies|monoclonal antibodies
1151643|NCT02254941|Chemotherapy|chemotherapy
1151644|NCT02254941|First line|first line
1151645|NCT02254928|poor ovarian response|poor ovarian response
1151646|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
1151647|NCT02254928|randomised clinical trial|randomised clinical trial
1151648|NCT02254928|corifollitropin alfa|corifollitropin alfa
1151649|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
1151650|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
1151651|NCT02254915|Synergo|synergo
1151652|NCT02254915|RITE|rite
1151653|NCT02254915|SHTC|shtc
1569108|NCT00503841|stage I breast cancer|stage i breast cancer
1151654|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1151655|NCT02254915|NMIBC|nmibc
1151656|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
1151657|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
1151658|NCT02254915|Transitional Cell Cancer|transitional cell cancer
1151659|NCT02254915|Mitomycin|mitomycin
1151660|NCT02254902|sedentary lifestyle|sedentary lifestyle
1151661|NCT02254902|physical activity|physical activity
1151662|NCT02254902|Somali women|somali women
1151663|NCT02254902|prevention|prevention
1151664|NCT02254876|Stroke|stroke
1151665|NCT02254876|Hemiplegia|hemiplegia
1151666|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
1151667|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
1151668|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
1151669|NCT02254863|Batten Disease|batten disease
1151670|NCT02254863|Hunter Syndrome|hunter syndrome
1151671|NCT02254863|Krabbe|krabbe
1151672|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1151673|NCT02254863|ALD|ald
1151674|NCT02254863|MLD|mld
1151675|NCT02254863|PMD|pmd
1151676|NCT02254850|Mesoglycan|mesoglycan
1151677|NCT02254850|Metabolic Syndrome|metabolic syndrome
1151678|NCT02254850|Flow Mediated Dilation|flow mediated dilation
1151679|NCT02254824|Xuezhikang|xuezhikang
1151680|NCT02254824|atorvastatin|atorvastatin
1151681|NCT02254785|poor prognosis|poor prognosis
1152180|NCT02251951|Stomach|stomach
1151682|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1151683|NCT02254785|cabazitaxel|cabazitaxel
1151684|NCT02254785|abiraterone|abiraterone
1151685|NCT02254785|enzalutamide|enzalutamide
1151686|NCT02254733|CBSST|cbsst
1151687|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
1151688|NCT02254733|Psychotic Disorder|psychotic disorder
1151689|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
1151690|NCT02254733|Social Skills Training|social skills training
1151691|NCT02254733|Assertive Community Treatment|assertive community treatment
1151692|NCT02254694|sagittal balance|sagittal balance
1151693|NCT02254694|posture|posture
1151694|NCT02254694|lumbar lordosis|lumbar lordosis
1151695|NCT02254694|high heeled shoes|high heeled shoes
1151696|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
1151697|NCT02254681|gemcitabine|gemcitabine
1151698|NCT02254681|cisplatin|cisplatin
1151699|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
1151700|NCT02254668|intima|intima
1151701|NCT02254668|thickness|thickness
1151702|NCT02254668|transplantation|transplantation
1151703|NCT02254668|cardiology|cardiology
1151704|NCT02254668|immunosuppression|immunosuppression
1151705|NCT02254655|puerarin|puerarin
1151706|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
1151707|NCT02254655|atherosclerosis|atherosclerosis
1151708|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
1151709|NCT02254629|Fecal microflora|fecal microflora
1151710|NCT02254629|IBS|ibs
1151711|NCT02254629|Sequential treatment|sequential treatment
1151712|NCT02254629|Probiotic|probiotic
1151713|NCT02254629|Laxative|laxative
1151714|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
1151715|NCT02254616|Hybrid therapy|hybrid therapy
1151716|NCT02254616|Mirror Therapy|mirror therapy
1151717|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1151718|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
1151719|NCT02254590|IEDL|iedl
1151720|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
1151721|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
1151722|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
1151723|NCT02254590|endoscopic decompression|endoscopic decompression
1151724|NCT02254590|spinal stenosis|spinal stenosis
1151725|NCT02254577|Infertility|infertility
1151726|NCT02254577|Progesterone|progesterone
1151728|NCT02254577|IVF|ivf
1151729|NCT02254577|FET|fet
1151730|NCT02254577|FBT|fbt
1151731|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
1151732|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
1151733|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
1151734|NCT02254551|LDE225|lde225
1151735|NCT02254551|Sonidegib|sonidegib
1151736|NCT02254551|bortezomib|bortezomib
1151737|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
1151738|NCT02254551|Velcade|velcade
1151739|NCT02254473|Knee|knee
1151740|NCT02254473|Osteoarthritis|osteoarthritis
1151741|NCT02254447|relative bio-availability|relative bio-availability
1151742|NCT02254447|fasting|fasting
1151743|NCT02254447|GW615775|gw615775
1151744|NCT02254447|Candesartan cilexetil|candesartan cilexetil
1151745|NCT02254447|ATACAND|atacand
1151746|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
1151747|NCT02254434|healthy volunteers|healthy volunteers
1151748|NCT02254434|pharmacokinetic|pharmacokinetic
1151749|NCT02254434|single-dose|single-dose
1151750|NCT02254434|Open-label|open-label
1151751|NCT02254434|fasting|fasting
1151752|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1151753|NCT02254421|Antiviral|antiviral
1569279|NCT00503230|tobacco|tobacco
1214471|NCT01967537|MEN1|men1
1151754|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
1151755|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
1151756|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1151757|NCT02254408|Antiviral|antiviral
1151758|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
1151759|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
1151760|NCT02254382|diastolic heart failure|diastolic heart failure
1151761|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
1151762|NCT02254343|stroke rehabilitation|stroke rehabilitation
1151763|NCT02254343|robot-assisted therapy|robot-assisted therapy
1151764|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
1151765|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
1151766|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
1151767|NCT02254317|Grape Seed Extract|grape seed extract
1151768|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
1151769|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
1151770|NCT02254304|RMS|rms
1151771|NCT02254304|CIS|cis
1151772|NCT02254304|RebiSmart™|rebismart™
1151773|NCT02254304|Rebif®|rebif®
1151774|NCT02254304|Interferon beta-1a|interferon beta-1a
1151775|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
1151776|NCT02254252|Angina pectoris|angina pectoris
1151777|NCT02254252|chest pain|chest pain
1151778|NCT02254252|nicroandil|nicroandil
1151779|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
1151780|NCT02254200|exercise|exercise
1151781|NCT02254200|fat oxidation|fat oxidation
1151782|NCT02254200|indirect calorimetry|indirect calorimetry
1151783|NCT02254200|insulin sensitivity|insulin sensitivity
1151784|NCT02254200|weight management|weight management
1151785|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
1151786|NCT02253810|Osteotomy|osteotomy
1151787|NCT02253810|Blood Transfusion|blood transfusion
1151788|NCT02253810|Tranexamic Acid|tranexamic acid
1151789|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
1151790|NCT02253758|Electroencephalography|electroencephalography
1151791|NCT02253758|Conscious Sedation|conscious sedation
1151792|NCT02253758|Deep Sedation|deep sedation
1151793|NCT02253758|Arousal|arousal
1151794|NCT02253758|Consciousness|consciousness
1151795|NCT02253745|ADHD|adhd
1151796|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
1151797|NCT02253732|MicroRNAs|micrornas
1151798|NCT02253732|exercise|exercise
1151799|NCT02253732|skeletal muscle|skeletal muscle
1151800|NCT02253732|metabolism|metabolism
1151801|NCT02253719|cervical neoplasia|cervical neoplasia
1151802|NCT02253719|cervical cancer'|cervical cancer'
1151803|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
1151804|NCT02253719|cryotherapy|cryotherapy
1151805|NCT02253706|bronchoscopy|bronchoscopy
1151806|NCT02253706|hypoxia|hypoxia
1151807|NCT02253706|oxygen supplementation|oxygen supplementation
1151809|NCT02253693|Hemophilia A|hemophilia a
1151810|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
1151811|NCT02253693|Accelerometry|accelerometry
1151812|NCT02253680|Osteoarthritis|osteoarthritis
1151813|NCT02253680|Total knee replacement|total knee replacement
1151814|NCT02253680|Enhanced recovery|enhanced recovery
1151815|NCT02253680|Compression bandages|compression bandages
1151816|NCT02253667|Palliative care|palliative care
1151817|NCT02253667|Lung disease|lung disease
1151818|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1151819|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
1151820|NCT02253667|Dyspnoea|dyspnoea
1151821|NCT02253667|Opioids|opioids
1151822|NCT02253654|Chronic Kidney Disease|chronic kidney disease
1151823|NCT02253654|Anemia|anemia
1151824|NCT02253654|Hemodialysis|hemodialysis
1151825|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
1151826|NCT02253641|African American, Women|african american, women
1151827|NCT02253641|Weight Loss|weight loss
1151828|NCT02253628|Coffee|coffee
1151829|NCT02253628|Gastrin|gastrin
1151830|NCT02253628|Alpha-amylase|alpha-amylase
1151831|NCT02253628|Cortisol|cortisol
1151832|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
1151833|NCT02253628|Self-reported stress|self-reported stress
1151834|NCT02253628|Blood pressure|blood pressure
1151835|NCT02253615|Aging|aging
1151836|NCT02253615|Resistance training|resistance training
1151837|NCT02253615|Muscle strength|muscle strength
1151838|NCT02253615|Functional performance|functional performance
1151839|NCT02253615|Postural balance|postural balance
1151840|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
1151841|NCT02253602|Lymph Nodes|lymph nodes
1151842|NCT02253602|USPIO|uspio
1151843|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
1151844|NCT02253576|infant|infant
1151845|NCT02253576|bronchiolitis|bronchiolitis
1151846|NCT02253576|hypertonic saline|hypertonic saline
1151847|NCT02253537|Tuberculosis|tuberculosis
1151848|NCT02253537|TB|tb
1151849|NCT02253524|Metoclopramide|metoclopramide
1151850|NCT02253524|Dimenhydrinate|dimenhydrinate
1151851|NCT02253524|emergency medicine|emergency medicine
1151852|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
1151853|NCT02253511|Hepotectomy|hepotectomy
1151854|NCT02253511|Recurrence-free survival|recurrence-free survival
1151855|NCT02253511|Overall survival|overall survival
1151856|NCT02253485|Mother-to-child transmission|mother-to-child transmission
1151857|NCT02253446|Dysmenorrhea|dysmenorrhea
1151858|NCT02253446|Piroxicam|piroxicam
1151859|NCT02253446|Diclofenac Sodium|diclofenac sodium
1151860|NCT02253446|Emergency department|emergency department
1151861|NCT02253433|asthma|asthma
1151862|NCT02253433|environmental triggers|environmental triggers
1151863|NCT02253433|home-based intervention|home-based intervention
1151864|NCT02253433|asthma home visits|asthma home visits
1151865|NCT02253420|Phase 1|phase 1
1151866|NCT02253420|Advanced solid tumor|advanced solid tumor
1151867|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1151868|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
1151869|NCT02253420|Drug-drug Interaction|drug-drug interaction
1151870|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1151871|NCT02253394|Ambrisentan|ambrisentan
1151872|NCT02253394|Spironolactone|spironolactone
1151873|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
1151874|NCT02253394|Aldosterone antagonism|aldosterone antagonism
1151875|NCT02253394|Cardiac output (CO)|cardiac output (co)
1151876|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
1151877|NCT02253394|Heart failure|heart failure
1151878|NCT02253394|Quality of life|quality of life
1151879|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
1151880|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1151881|NCT02253394|Troponin-I|troponin-i
1151882|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
1151883|NCT02253394|Collagen metabolism|collagen metabolism
1151884|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
1151885|NCT02253394|Collagen III|collagen iii
1151886|NCT02253394|Echocardiography|echocardiography
1151887|NCT02253394|WHO Functional Class|who functional class
1151888|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
1151889|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
1151890|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
1151891|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
1151892|NCT02253381|lateral decubitus position|lateral decubitus position
1151893|NCT02253381|hypotension|hypotension
1151894|NCT02253381|cesarean section|cesarean section
1151895|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
1151896|NCT02253329|Ageing|ageing
1151897|NCT02253329|Protein ingestion|protein ingestion
1151898|NCT02253316|Multiple Myeloma|multiple myeloma
1151899|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1151900|NCT02253316|Ixazomib|ixazomib
1151901|NCT02253316|Lenalidomide|lenalidomide
1151902|NCT02253316|Dexamethasone|dexamethasone
1151903|NCT02253277|CML, Ph+ ALL|cml, ph+ all
1151904|NCT02253251|Breast Cancer|breast cancer
1151905|NCT02253251|Cancer Risk|cancer risk
1151906|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
1151907|NCT02253251|Genetic Cancer Risk|genetic cancer risk
1151908|NCT02253251|Cancer Treatment|cancer treatment
1151909|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
1151910|NCT02253251|Autoimmunity|autoimmunity
1151911|NCT02253251|Endometriosis|endometriosis
1151912|NCT02253238|Head and Neck Cancer|head and neck cancer
1151913|NCT02253238|Dehydration|dehydration
1151914|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
1151915|NCT02253238|Radiation therapy|radiation therapy
1151916|NCT02253238|RT|rt
1151917|NCT02253238|XRT|xrt
1151918|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
1151919|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
1151920|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
1151921|NCT02253238|Salivary gland cancer|salivary gland cancer
1151922|NCT02253238|Oral cavity cancer|oral cavity cancer
1151923|NCT02253238|Questionnaires|questionnaires
1151924|NCT02253238|Surveys|surveys
1151925|NCT02253238|Quality of life|quality of life
1151926|NCT02253238|QOL|qol
1151927|NCT02253238|Phone calls|phone calls
1151928|NCT02253238|Self-monitoring devices|self-monitoring devices
1151929|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
1151930|NCT02253238|CYCORE|cycore
1151931|NCT02253238|Emergency room visits|emergency room visits
1151932|NCT02253238|ER|er
1151933|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
1151934|NCT02253238|ERHV|erhv
1151935|NCT02253225|Bipolar Disorder|bipolar disorder
1569280|NCT00503230|smoking|smoking
1151936|NCT02253225|Major Depression|major depression
1151937|NCT02253225|Rumination|rumination
1151938|NCT02253225|Self Processing|self processing
1151939|NCT02253173|VVA|vva
1151940|NCT02253173|Painful Sex|painful sex
1151941|NCT02253173|Postmenopausal|postmenopausal
1151942|NCT02253160|MNCs|mncs
1151943|NCT02253160|Mononuclear Cells|mononuclear cells
1151944|NCT02253160|Apheresis|apheresis
1151945|NCT02253160|Spectra Optia|spectra optia
1151946|NCT02253147|Nasolabial folds|nasolabial folds
1151947|NCT02253147|Dermal filler|dermal filler
1151948|NCT02253147|Hyaluronic acid (HA)|hyaluronic acid (ha)
1151949|NCT02253147|Wrinkles|wrinkles
1151950|NCT02253134|Syncopal events|syncopal events
1151951|NCT02253134|Palpitation events|palpitation events
1151952|NCT02253121|COPD|copd
1151953|NCT02253121|acute exacerbation|acute exacerbation
1151954|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
1151955|NCT02253121|hyperglycemia|hyperglycemia
1151956|NCT02253108|DES|des
1151957|NCT02253108|Angina pectoris|angina pectoris
1151958|NCT02253108|Stent|stent
1151959|NCT02253108|Optical coherence tomography|optical coherence tomography
1151960|NCT02253108|Stent thrombosis|stent thrombosis
1151961|NCT02253056|Fasting|fasting
1151962|NCT02253056|Caloric Restriction|caloric restriction
1151963|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
1151964|NCT02253043|Alzheimer's Disease|alzheimer's disease
1151965|NCT02253030|AMD|amd
1151966|NCT02253030|OCT|oct
1151967|NCT02253030|Angiography|angiography
1151968|NCT02253030|Macular degeneration|macular degeneration
1151969|NCT02253017|Therapeutic strategies|therapeutic strategies
1151973|NCT02253017|Intra-ocular lens|intra-ocular lens
1151974|NCT02252991|Breast cancer|breast cancer
1151975|NCT02252991|Fatigue|fatigue
1151976|NCT02252991|Physical activity|physical activity
1151977|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1151978|NCT02252965|Metformin XR|metformin xr
1151979|NCT02252965|Metformin IR|metformin ir
1151980|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
1151981|NCT02252926|Anesthetics, Local|anesthetics, local
1151982|NCT02252926|Bupivacaine|bupivacaine
1151983|NCT02252926|Lozenge|lozenge
1151984|NCT02252926|Administration, Topical|administration, topical
1151985|NCT02252900|Brain damages|brain damages
1151987|NCT02252900|infectious endocarditis|infectious endocarditis
1151988|NCT02252887|Gemcitabine,|gemcitabine,
1151989|NCT02252887|Trastuzumab|trastuzumab
1151990|NCT02252887|Pertuzumab|pertuzumab
1151991|NCT02252887|14-124|14-124
1151992|NCT02252874|balance|balance
1151993|NCT02252874|visual function|visual function
1151994|NCT02252874|community-dwelling older adults|community-dwelling older adults
1151995|NCT02252874|action video-game|action video-game
1151996|NCT02252822|Eating Disorders|eating disorders
1151997|NCT02252822|Self Help|self help
1151998|NCT02252822|Anonymous CBT|anonymous cbt
1151999|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
1152000|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
1152001|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
1152002|NCT02252783|Coronary Artery Disease|coronary artery disease
1152003|NCT02252783|Myocardial Ischemia|myocardial ischemia
1152004|NCT02252783|Coronary Disease|coronary disease
1152005|NCT02252783|Heart Diseases|heart diseases
1152006|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
1152007|NCT02252783|Arteriosclerosis|arteriosclerosis
1152008|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
1152009|NCT02252783|Vascular Diseases|vascular diseases
1152011|NCT02252770|ASLD|asld
1152012|NCT02252770|UCD|ucd
1152013|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
1152014|NCT02252744|dry eye disease|dry eye disease
1152015|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
1152016|NCT02252731|Phase I|phase i
1152017|NCT02252731|FG-4592|fg-4592
1152018|NCT02252731|Warfarin|warfarin
1152019|NCT02252731|Pharmacokinetics|pharmacokinetics
1152020|NCT02252731|Pharmacodynamics|pharmacodynamics
1152021|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
1152022|NCT02252705|Mortality|mortality
1152023|NCT02252705|Survival|survival
1152024|NCT02252692|Bioavailability|bioavailability
1152025|NCT02252692|pharmacokinetics|pharmacokinetics
1152026|NCT02252692|enalapril|enalapril
1152027|NCT02252692|enalaprilat|enalaprilat
1152028|NCT02252679|Bone Turnover Markers|bone turnover markers
1152029|NCT02252679|Calcium Isotopes|calcium isotopes
1152030|NCT02252666|MS|ms
1152031|NCT02252666|balance|balance
1152032|NCT02252666|standing|standing
1152033|NCT02252666|control|control
1152034|NCT02252666|movement|movement
1152035|NCT02252653|Cardiomyopathy|cardiomyopathy
1152036|NCT02252653|Heart Failure|heart failure
1152037|NCT02252653|FAC|fac
1152038|NCT02252653|Amyloid|amyloid
1152039|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
1152040|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
1152041|NCT02252640|Malaria|malaria
1152042|NCT02252640|Vaccine|vaccine
1152043|NCT02252640|Plasmodium|plasmodium
1152044|NCT02252640|Falciparum|falciparum
1152045|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
1152046|NCT02252601|Cystic Fibrosis|cystic fibrosis
1152047|NCT02252601|Hearing Loss|hearing loss
1152048|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
1152049|NCT02252588|COPD|copd
1152050|NCT02252588|Bacteria|bacteria
1152051|NCT02252562|Hand hygiene|hand hygiene
1152052|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
1152053|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
1152054|NCT02252536|alcohol use disorder|alcohol use disorder
1152055|NCT02252536|alcoholism|alcoholism
1152056|NCT02252536|alcohol dependence|alcohol dependence
1152057|NCT02252536|drinking alcohol|drinking alcohol
1152058|NCT02252523|Feasibility study|feasibility study
1152059|NCT02252497|hip arthroplasty|hip arthroplasty
1152060|NCT02252497|Tranexamic acid|tranexamic acid
1152061|NCT02252497|randomized control trial|randomized control trial
1152062|NCT02252484|prostate cancer|prostate cancer
1152063|NCT02252484|prostatectomy|prostatectomy
1152064|NCT02252484|weight loss|weight loss
1152065|NCT02252484|prevent weight gain|prevent weight gain
1152066|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
1152067|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
1152068|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
1152069|NCT02252471|alcohol|alcohol
1152070|NCT02252471|contraception|contraception
1152071|NCT02252471|smoking|smoking
1152072|NCT02252471|pregnancy|pregnancy
1152075|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
1152076|NCT02252458|Fentanyl|fentanyl
1152077|NCT02252432|KETAMINE|ketamine
1152078|NCT02252432|METHADONE|methadone
1152079|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
1152080|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
1152081|NCT02252432|Length of hospital stay|length of hospital stay
1152082|NCT02252432|Perioperative outcomes|perioperative outcomes
1152083|NCT02252419|Postoperative Period|postoperative period
1152084|NCT02252419|Anesthesia, General|anesthesia, general
1152085|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
1152086|NCT02252419|Dexamethasone|dexamethasone
1152087|NCT02252419|Acetaminophen|acetaminophen
1152088|NCT02252406|Stable Angina|stable angina
1152089|NCT02252406|Metabolic Syndrome|metabolic syndrome
1152090|NCT02252406|Women|women
1152091|NCT02252406|Biomarkers|biomarkers
1152092|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
1152093|NCT02252367|BPH/LUTS|bph/luts
1152094|NCT02252354|Drug therapy|drug therapy
1152095|NCT02252341|smoking|smoking
1152096|NCT02252341|inflammation|inflammation
1152097|NCT02252341|oxidative stress|oxidative stress
1152098|NCT02252341|NAC|nac
1152099|NCT02252341|treatment|treatment
1152100|NCT02252328|Uveitis|uveitis
1152101|NCT02252328|Simvastatin|simvastatin
1152102|NCT02252328|Visual acuity|visual acuity
1152103|NCT02252328|Corticosteroids|corticosteroids
1152104|NCT02252328|Immunosuppression|immunosuppression
1152105|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1152106|NCT02252302|Air pollution|air pollution
1152107|NCT02252302|Exercise|exercise
1152108|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
1152109|NCT02252302|Cognitive Function|cognitive function
1152110|NCT02252289|Asthma|asthma
1152111|NCT02252289|children|children
1152112|NCT02252289|fluctuation analysis|fluctuation analysis
1152113|NCT02252289|exacerbations|exacerbations
1152114|NCT02252276|Manual therapy|manual therapy
1152115|NCT02252276|proprioception|proprioception
1152116|NCT02252276|exercises|exercises
1152117|NCT02252276|ankle sprain|ankle sprain
1152118|NCT02252250|rectal cancer|rectal cancer
1152119|NCT02252250|laparoscopic|laparoscopic
1152120|NCT02252250|NOTES|notes
1152121|NCT02252237|Prednisone|prednisone
1152122|NCT02252237|Prednisolone|prednisolone
1152123|NCT02252237|Methylprednisolone|methylprednisolone
1152124|NCT02252237|Glucocorticoids|glucocorticoids
1152125|NCT02252237|pharmacokinetics|pharmacokinetics
1152126|NCT02252211|EphA2 positive cancer|epha2 positive cancer
1152127|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
1152128|NCT02252172|Multiple Myeloma|multiple myeloma
1152129|NCT02252172|Daratumumab|daratumumab
1152130|NCT02252172|JNJ-54767414|jnj-54767414
1152131|NCT02252172|Lenalidomide|lenalidomide
1152132|NCT02252172|Dexamethasone|dexamethasone
1152133|NCT02252159|Polycythemia|polycythemia
1152134|NCT02252159|Polycythemia Vera|polycythemia vera
1152135|NCT02252159|Hematologic Diseases|hematologic diseases
1152136|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
1152137|NCT02252159|Bone Marrow Diseases|bone marrow diseases
1152138|NCT02252159|Hydroxyurea|hydroxyurea
1152139|NCT02252159|Antineoplastic Agents|antineoplastic agents
1152140|NCT02252159|Therapeutic Uses|therapeutic uses
1152141|NCT02252159|Pharmacologic Actions|pharmacologic actions
1152142|NCT02252159|Antisickling Agents|antisickling agents
1152143|NCT02252159|Hematologic Agents|hematologic agents
1152144|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
1152145|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1152146|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
1152147|NCT02252146|DLBCL|dlbcl
1152148|NCT02252146|MYD88 L265P|myd88 l265p
1152149|NCT02252146|Lymphoma|lymphoma
1152150|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1152151|NCT02252146|Idera|idera
1152152|NCT02252146|IMO 8400|imo 8400
1152153|NCT02252133|Contact lenses|contact lenses
1152154|NCT02252133|Myopia|myopia
1152155|NCT02252107|Decitabine|decitabine
1152156|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1152157|NCT02252107|Conditioning|conditioning
1152159|NCT02252081|metformin|metformin
1152160|NCT02252081|cardiovascular disease|cardiovascular disease
1152161|NCT02252081|Chronic Kidney Disease|chronic kidney disease
1152162|NCT02252081|Metabolic Syndrome|metabolic syndrome
1152163|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
1152164|NCT02252042|Head and neck carcinoma|head and neck carcinoma
1152165|NCT02252042|PD1|pd1
1152166|NCT02252042|PD-1|pd-1
1152167|NCT02252042|PDL1|pdl1
1152168|NCT02252042|PD-L1|pd-l1
1152169|NCT02252029|Rotavirus|rotavirus
1152170|NCT02252029|Vaccine|vaccine
1152171|NCT02252003|Children|children
1152172|NCT02252003|Pain|pain
1152173|NCT02252003|Pain scale evaluation|pain scale evaluation
1152174|NCT02251964|IMID|imid
1152175|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
1152176|NCT02251964|rituximab|rituximab
1152177|NCT02251964|Immuno PET|immuno pet
1152178|NCT02251964|PET/CT|pet/ct
1152181|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
1152182|NCT02251951|Salvage treatment|salvage treatment
1152183|NCT02251951|Nab-paclitaxel|nab-paclitaxel
1152184|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
1152185|NCT02251912|Alcohol dependence|alcohol dependence
1152186|NCT02251912|Alcohol|alcohol
1152187|NCT02251912|Oxytocin|oxytocin
1152188|NCT02251912|Intranasal administration|intranasal administration
1152189|NCT02251847|cholesterol|cholesterol
1152190|NCT02251834|Healthcare Disparities|healthcare disparities
1152191|NCT02251834|stroke|stroke
1152192|NCT02251834|Hispanic Americans|hispanic americans
1152193|NCT02251834|community health worker|community health worker
1152194|NCT02251834|Mobile Health|mobile health
1152195|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
1152196|NCT02251834|hypertension|hypertension
1152197|NCT02251834|Randomized Controlled Trial|randomized controlled trial
1152198|NCT02251834|high cholesterol|high cholesterol
1152199|NCT02251834|behavioral|behavioral
1152200|NCT02251834|exercise|exercise
1152201|NCT02251834|diabetes|diabetes
1152202|NCT02251834|diet|diet
1152203|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
1152204|NCT02251743|ADHD|adhd
1152205|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1152206|NCT02251743|neurofeedback|neurofeedback
1152207|NCT02251743|EEG|eeg
1152208|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
1152209|NCT02251717|renal transplant|renal transplant
1152210|NCT02251704|Malaria|malaria
1152211|NCT02251704|MTI|mti
1152212|NCT02251704|Surveillance study|surveillance study
1152213|NCT02251704|Africa|africa
1152214|NCT02251704|RTSS, adjuvant|rtss, adjuvant
1152215|NCT02251704|Epidemiology|epidemiology
1152216|NCT02251691|Compliance|compliance
1152217|NCT02251678|Plaque|plaque
1152218|NCT02251678|Psoriasis|psoriasis
1152219|NCT02251678|Biomarkers|biomarkers
1152220|NCT02251678|CRP|crp
1152221|NCT02251678|αTNF|αtnf
1152222|NCT02251678|Interleuken|interleuken
1152223|NCT02251665|Acute ischemic stroke|acute ischemic stroke
1152224|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
1152225|NCT02251665|Transient ischemic attack|transient ischemic attack
1152226|NCT02251652|Actinic|actinic
1152227|NCT02251639|Oral cancer|oral cancer
1152228|NCT02251639|Pre-cancer|pre-cancer
1152229|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
1152230|NCT02251639|VELScope|velscope
1152231|NCT02251639|Point Spectroscopy System|point spectroscopy system
1152232|NCT02251639|Oral brush biopsy|oral brush biopsy
1152233|NCT02251639|Questionnaire|questionnaire
1152234|NCT02251639|Survey|survey
1152235|NCT02251639|Diagnostic aid|diagnostic aid
1152236|NCT02251639|Screening|screening
1152237|NCT02251626|MGH|mgh
1152238|NCT02251626|Burn patient|burn patient
1152239|NCT02251626|Adult|adult
1152240|NCT02251626|CoQ10|coq10
1152241|NCT02251626|Ubiquinol|ubiquinol
1152242|NCT02251600|Pediatric|pediatric
1152243|NCT02251600|Adolescent|adolescent
1152244|NCT02251600|Deflazacort|deflazacort
1152245|NCT02251561|contact lenses|contact lenses
1152246|NCT02251561|contact lens solution|contact lens solution
1152247|NCT02251561|corneal staining|corneal staining
1152248|NCT02251561|fluorescein|fluorescein
1152249|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1152250|NCT02251548|Leukemia|leukemia
1152251|NCT02251535|kinematic analysis|kinematic analysis
1152252|NCT02251535|femoral rollback|femoral rollback
1152253|NCT02251535|mobile bearing|mobile bearing
1152254|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
1152255|NCT02251496|Malnutrition|malnutrition
1152256|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1152257|NCT02251496|Nutrition Therapy|nutrition therapy
1152258|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
1152259|NCT02251496|Food|food
1152260|NCT02251483|DIBS|dibs
1152261|NCT02251483|SIBO|sibo
1152262|NCT02251470|stroke|stroke
1152263|NCT02251470|balance|balance
1152264|NCT02251470|exer-gaming|exer-gaming
1152265|NCT02251470|home-based exercises|home-based exercises
1152266|NCT02251470|Wii|wii
1152267|NCT02251470|postural balance|postural balance
1152268|NCT02251470|Nintendo|nintendo
1152269|NCT02251470|balance board|balance board
1152270|NCT02251470|Wii-Fit|wii-fit
1152271|NCT02251470|home|home
1152272|NCT02251470|feasibility|feasibility
1152273|NCT02251457|Myotonia Congenita|myotonia congenita
1152274|NCT02251457|ranolazine|ranolazine
1152275|NCT02251457|Ohio State|ohio state
1152276|NCT02251457|Open Label|open label
1152277|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
1152278|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
1152279|NCT02251431|diabetes mellitus|diabetes mellitus
1152280|NCT02251431|chronic kidney disease|chronic kidney disease
1152281|NCT02251431|diastolic function|diastolic function
1152282|NCT02251431|cardiac fibrosis|cardiac fibrosis
1152283|NCT02251431|cardiac strain|cardiac strain
1152284|NCT02251431|cardiac biomarker|cardiac biomarker
1152285|NCT02251431|renal biomarker|renal biomarker
1152286|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
1152287|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
1152288|NCT02251418|Endocrinology|endocrinology
1152289|NCT02251418|Dermatology|dermatology
1152290|NCT02251418|Wound healing|wound healing
1152291|NCT02251418|Ischemia|ischemia
1152292|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
1152293|NCT02251418|Pain management|pain management
1152294|NCT02251405|Melamine|melamine
1152295|NCT02251405|Melamine tableware|melamine tableware
1152296|NCT02251392|chamomilla|chamomilla
1152297|NCT02251392|matricaria|matricaria
1152298|NCT02251392|chamomile|chamomile
1152299|NCT02251392|chamomila|chamomila
1152300|NCT02251392|recutita|recutita
1152301|NCT02251392|Breast Neoplasms|breast neoplasms
1152302|NCT02251392|head and neck neoplasms|head and neck neoplasms
1152303|NCT02251392|radiotherapy|radiotherapy
1152304|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
1152305|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
1152306|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
1152406|NCT02250820|TTE|tte
1152307|NCT02251314|circulation tumour DNA|circulation tumour dna
1152308|NCT02251314|tumour heterogeneity|tumour heterogeneity
1152309|NCT02251314|liquid biopsy|liquid biopsy
1152310|NCT02251288|H7N9 pandemic|h7n9 pandemic
1152311|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
1152312|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
1152313|NCT02251288|MF59 adjuvant|mf59 adjuvant
1152314|NCT02251275|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1152315|NCT02251262|Pacemaker|pacemaker
1152316|NCT02251262|Endocarditis|endocarditis
1152317|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
1152318|NCT02251262|Diagnostic accuracy|diagnostic accuracy
1152319|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
1152320|NCT02251236|Stribild|stribild
1152321|NCT02251236|Genvoya|genvoya
1152322|NCT02251236|elvitegravir|elvitegravir
1152323|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
1152324|NCT02251236|HIV|hiv
1152325|NCT02251093|mycosis|mycosis
1152326|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
1152327|NCT02251093|lcr35|lcr35
1152328|NCT02251093|Lcr Regenerans®|lcr regenerans®
1152329|NCT02251080|adherence|adherence
1152330|NCT02251080|internet-based|internet-based
1152331|NCT02251054|Overactive Bladder|overactive bladder
1152332|NCT02251054|Multimedia|multimedia
1152333|NCT02251054|Behavioral Therapy|behavioral therapy
1152334|NCT02251041|Liver|liver
1152335|NCT02251041|Transplantation|transplantation
1152336|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
1152337|NCT02251041|Effectiveness|effectiveness
1333237|NCT01443910|Immersive Virtual Enviroment Technology|immersive virtual enviroment technology
1152338|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
1152339|NCT02251015|Postural balance|postural balance
1152340|NCT02251015|Temporomandibular disorders|temporomandibular disorders
1152342|NCT02250989|Endothelial disfunction|endothelial disfunction
1152343|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
1152344|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
1152345|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
1152346|NCT02250989|Nitric Oxide|nitric oxide
1152347|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
1152348|NCT02250989|Endothelin-1|endothelin-1
1152349|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
1152350|NCT02250989|Glucose|glucose
1152351|NCT02250989|Insulin|insulin
1152352|NCT02250989|C-peptide|c-peptide
1152353|NCT02250989|C-reactive protein|c-reactive protein
1152354|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
1152355|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
1152356|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
1152357|NCT02250950|self-determination theory|self-determination theory
1152358|NCT02250950|motivational interviewing|motivational interviewing
1152359|NCT02250950|exercise|exercise
1152360|NCT02250950|physical activity|physical activity
1152361|NCT02250937|Acute Myeloid Leukemia|acute myeloid leukemia
1152362|NCT02250937|AML|aml
1152363|NCT02250937|Myelodysplastic Syndrome|myelodysplastic syndrome
1152364|NCT02250937|MDS|mds
1152365|NCT02250937|Stem Cell Transplantation|stem cell transplantation
1152366|NCT02250937|Busulfan|busulfan
1152367|NCT02250937|Busulfex|busulfex
1152368|NCT02250937|Myleran|myleran
1152369|NCT02250937|Fludarabine|fludarabine
1152370|NCT02250937|Fludarabine Phosphate|fludarabine phosphate
1152371|NCT02250937|Fludara|fludara
1152372|NCT02250937|Cladribine|cladribine
1152373|NCT02250937|Leustatin|leustatin
1152374|NCT02250937|2-CdA|2-cda
1152375|NCT02250937|G-CSF|g-csf
1152376|NCT02250937|Filgrastim|filgrastim
1152377|NCT02250937|Neupogen|neupogen
1152378|NCT02250937|Methotrexate|methotrexate
1152379|NCT02250911|Caregivers of patients|caregivers of patients
1152380|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
1152381|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
1152382|NCT02250911|14-208|14-208
1152383|NCT02250898|Post Breast Surgery|post breast surgery
1152384|NCT02250898|Myofascial Massage|myofascial massage
1152385|NCT02250898|Pain|pain
1152386|NCT02250898|Mobility Limitations|mobility limitations
1152387|NCT02250885|Selinexor|selinexor
1152388|NCT02250885|phase 2|phase 2
1152389|NCT02250885|Gabrail|gabrail
1152390|NCT02250872|Cisplatin|cisplatin
1152391|NCT02250872|Nephrotoxicity|nephrotoxicity
1152392|NCT02250872|Gemigliptin|gemigliptin
1152393|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
1152394|NCT02250846|EGFR mutations|egfr mutations
1152395|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
1152396|NCT02250846|EGFR-TKI|egfr-tki
1152397|NCT02250846|Erlotinib|erlotinib
1152398|NCT02250833|Hypertension|hypertension
1152399|NCT02250833|CKD-828|ckd-828
1152400|NCT02250833|Telmisartan|telmisartan
1152401|NCT02250833|S-amlodipine|s-amlodipine
1152402|NCT02250833|Pharmacokinetic|pharmacokinetic
1152403|NCT02250820|Pediatric|pediatric
1152404|NCT02250820|Sedation|sedation
1152405|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
1152422|NCT02250742|ultrasound imaging|ultrasound imaging
1152423|NCT02250742|acupuncture|acupuncture
1152424|NCT02250742|back muscles|back muscles
1152425|NCT02250742|spine|spine
1152426|NCT02250742|muscle strength|muscle strength
1152427|NCT02250729|anaphylaxis|anaphylaxis
1152428|NCT02250729|pholcodine|pholcodine
1152429|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
1152430|NCT02250716|CIN1|cin1
1152431|NCT02250716|HIV seropositive women|hiv seropositive women
1152432|NCT02250716|Cryotherapy|cryotherapy
1152433|NCT02250703|Premedication|premedication
1152434|NCT02250690|idiopathic PD|idiopathic pd
1152435|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
1152436|NCT02250690|stable medication usage|stable medication usage
1152437|NCT02250690|age 40 to 80 years|age 40 to 80 years
1152438|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
1152439|NCT02250677|physical activity|physical activity
1152440|NCT02250677|Statin therapy|statin therapy
1152441|NCT02250677|cardiovascular disease|cardiovascular disease
1152442|NCT02250677|diabetes mellitus|diabetes mellitus
1152443|NCT02250664|Biomarkers of exposure|biomarkers of exposure
1152444|NCT02250664|Compensatory smoking|compensatory smoking
1152445|NCT02250664|Nicotine dependence|nicotine dependence
1152446|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
1152447|NCT02250664|Tobacco withdrawal|tobacco withdrawal
1152448|NCT02250664|Women|women
1152449|NCT02250664|Health disparities|health disparities
1152450|NCT02250664|Vulnerable populations|vulnerable populations
1215352|NCT01964014|once|once
1152451|NCT02250612|SYL040012|syl040012
1152452|NCT02250612|bamosiran|bamosiran
1152453|NCT02250612|siRNA|sirna
1152454|NCT02250612|RNAi|rnai
1152455|NCT02250612|Glaucoma|glaucoma
1152456|NCT02250612|Ocular hypertension|ocular hypertension
1152457|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
1152458|NCT02250599|treatment|treatment
1152459|NCT02250586|concerned significant other|concerned significant other
1152460|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
1152461|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
1152462|NCT02250534|Biomarkers of exposure|biomarkers of exposure
1152463|NCT02250534|Compensatory smoking|compensatory smoking
1152464|NCT02250534|Nicotine dependence|nicotine dependence
1152465|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
1152466|NCT02250534|Tobacco withdrawal|tobacco withdrawal
1152467|NCT02250534|Women|women
1152468|NCT02250534|Health disparities|health disparities
1152469|NCT02250534|Vulnerable populations|vulnerable populations
1152470|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
1152471|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
1152472|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
1152473|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
1152474|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
1152475|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
1152476|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
1152477|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
1152478|NCT02250430|acne|acne
1152479|NCT02250365|stroke, acute|stroke, acute
1152480|NCT02250365|upper extremity|upper extremity
1152481|NCT02250365|rehabilitation|rehabilitation
1152482|NCT02250365|electric stimulation therapy|electric stimulation therapy
1152483|NCT02250339|Child Mental Health|child mental health
1152484|NCT02250339|Parenting|parenting
1152485|NCT02250339|Family Issues|family issues
1152523|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
1152524|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
1152526|NCT02250261|cycling|cycling
1152527|NCT02250261|intervention|intervention
1153303|NCT02246686|efficacy|efficacy
1152528|NCT02250261|physical activity|physical activity
1152529|NCT02250261|environment|environment
1152530|NCT02250261|promotion|promotion
1152531|NCT02250248|Degenerative disc disease|degenerative disc disease
1152532|NCT02250248|Lumbar spine|lumbar spine
1152533|NCT02250209|Gastric Cancer|gastric cancer
1152534|NCT02250209|HER2-positive|her2-positive
1152535|NCT02250209|Trastuzumab|trastuzumab
1152536|NCT02250209|XELOX|xelox
1152537|NCT02250209|Stage III|stage iii
1152538|NCT02250209|D2 Gastrectomy|d2 gastrectomy
1152539|NCT02250196|Bowel preparation|bowel preparation
1152540|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
1152541|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
1152542|NCT02250183|Medihoney|medihoney
1152543|NCT02250183|Santyl|santyl
1152544|NCT02250183|Burns|burns
1152545|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
1152546|NCT02250144|Feet orthoses|feet orthoses
1152547|NCT02250144|KOOS|koos
1152548|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
1152549|NCT02250118|pleural|pleural
1152550|NCT02250118|effusion|effusion
1152551|NCT02250118|breast|breast
1152552|NCT02250118|cancer|cancer
1152553|NCT02250092|Cerebral Palsy|cerebral palsy
1152554|NCT02250092|Hemiparesis|hemiparesis
1152555|NCT02250092|Stroke|stroke
1152556|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
1152557|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1152558|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
1152559|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
1152560|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
1152561|NCT02250092|Bimanual Therapy|bimanual therapy
1152562|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
1152563|NCT02250040|Stroke|stroke
1152564|NCT02250040|Rehabilitation|rehabilitation
1152565|NCT02250040|Physiotherapy|physiotherapy
1152566|NCT02250040|Functional Recovery|functional recovery
1152567|NCT02250027|acute bronchitis|acute bronchitis
1152568|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
1152569|NCT02250001|HCV|hcv
1152570|NCT02249962|prospective|prospective
1152571|NCT02249962|cohort|cohort
1152572|NCT02249936|Volunteers|volunteers
1152573|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1152574|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
1152575|NCT02249923|Registry|registry
1152576|NCT02249923|Pediatric|pediatric
1152577|NCT02249884|radiodermatitis|radiodermatitis
1152578|NCT02249884|head and neck neoplasms|head and neck neoplasms
1152579|NCT02249884|Breast Neoplasms|breast neoplasms
1152580|NCT02249884|Urea|urea
1152581|NCT02249884|Matricaria|matricaria
1152582|NCT02249884|chamomilla|chamomilla
1152583|NCT02249884|chamomile|chamomile
1152584|NCT02249858|cervical spine|cervical spine
1152585|NCT02249858|OMT|omt
1152586|NCT02249858|HVLA|hvla
1152587|NCT02249858|ultrasound|ultrasound
1152588|NCT02249845|dehydration|dehydration
1152589|NCT02249845|children|children
1152590|NCT02249845|gastroenteritis|gastroenteritis
1152591|NCT02249832|stroke|stroke
1152592|NCT02249832|CVA|cva
1152593|NCT02249832|cerebrovascular accident|cerebrovascular accident
1152594|NCT02249832|cerebral stroke|cerebral stroke
1152595|NCT02249832|robotic therapy|robotic therapy
1152596|NCT02249832|anklebot|anklebot
1152597|NCT02249832|physical therapy|physical therapy
1152598|NCT02249819|stroke|stroke
1152599|NCT02249819|aphasia|aphasia
1152600|NCT02249819|CVA|cva
1152601|NCT02249819|apraxia|apraxia
1152602|NCT02249819|cerebrovascular accident|cerebrovascular accident
1152603|NCT02249819|cerebral stroke|cerebral stroke
1152604|NCT02249819|speech therapy|speech therapy
1152605|NCT02249819|aphasia therapy|aphasia therapy
1152606|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
1152607|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
1152608|NCT02249819|tDCS|tdcs
1152609|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
1152610|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1152611|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
1152612|NCT02249806|Outcome|outcome
1152613|NCT02249793|circadian|circadian
1152614|NCT02249793|oscillation|oscillation
1152615|NCT02249793|clock|clock
1152616|NCT02249793|human|human
1152617|NCT02249793|social behavior|social behavior
1152618|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
1152619|NCT02249793|social sensing|social sensing
1152620|NCT02249793|behavioral feature|behavioral feature
1152621|NCT02249793|Ginger.io|ginger.io
1152622|NCT02249793|blood pressure|blood pressure
1152623|NCT02249793|metabolism|metabolism
1152624|NCT02249793|metabolomics|metabolomics
1152625|NCT02249793|gut bacteria|gut bacteria
1152626|NCT02249793|microbiome|microbiome
1153505|NCT02245776|Stem cells|stem cells
1152627|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
1152628|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
1152629|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
1152630|NCT02249754|Nutrition education|nutrition education
1152631|NCT02249754|Maternal counselling|maternal counselling
1152632|NCT02249754|Complementary feeding|complementary feeding
1152633|NCT02249754|Infant growth|infant growth
1152634|NCT02249754|Micronutrients|micronutrients
1152635|NCT02249754|Tanzania|tanzania
1152636|NCT02249715|Parkinson|parkinson
1152638|NCT02249715|BNA|bna
1152639|NCT02249702|trabectedin|trabectedin
1152640|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
1152641|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
1152642|NCT02249676|neuromyelitis optica|neuromyelitis optica
1152643|NCT02249676|treatment|treatment
1152644|NCT02249663|Bioequivalence|bioequivalence
1152645|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
1152646|NCT02249650|TSB-9-W1|tsb-9-w1
1152647|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
1152648|NCT02249624|Developmental disabilities|developmental disabilities
1152649|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
1152650|NCT02249611|Physical activity|physical activity
1152651|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
1152652|NCT02249611|self-management of health|self-management of health
1152653|NCT02249572|Vestibular schwannoma|vestibular schwannoma
1152654|NCT02249572|Radiosurgery|radiosurgery
1152655|NCT02249572|Neurosurgery|neurosurgery
1152656|NCT02249572|Randomized|randomized
1152657|NCT02249533|Spot Light|spot light
1152658|NCT02249533|High School RIO|high school rio
1152659|NCT02249533|Concussion|concussion
1152660|NCT02249533|Injury Prevention|injury prevention
1152661|NCT02249533|Football|football
1152662|NCT02249533|Pop Warner|pop warner
1152663|NCT02249533|High School|high school
1152664|NCT02249533|Middle School|middle school
1152665|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
1152666|NCT02249520|MRI|mri
1152667|NCT02249520|Positron Emission Tomography|positron emission tomography
1152668|NCT02249520|PET|pet
1152669|NCT02249520|PET-MR|pet-mr
1152670|NCT02249520|mMR|mmr
1152671|NCT02249507|Resistant Hypertension|resistant hypertension
1152672|NCT02249507|Aerobic Exercise|aerobic exercise
1152673|NCT02249494|Nutritional Knowledge|nutritional knowledge
1152674|NCT02249494|Nutritional Counseling|nutritional counseling
1152675|NCT02249481|Anaesthetic|anaesthetic
1152676|NCT02249481|total knee replacement|total knee replacement
1152677|NCT02249481|Femoral nerve catheter|femoral nerve catheter
1333238|NCT01443897|Vitamin D|vitamin d
1215604|NCT01962831|obesity|obesity
1152678|NCT02249481|Adductor canal catheter|adductor canal catheter
1152679|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
1152680|NCT02249377|Baker's Cyst|baker's cyst
1152681|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
1152682|NCT02249325|Probiotic|probiotic
1152683|NCT02249325|Pregnancy|pregnancy
1152684|NCT02249299|ADHD,|adhd,
1152685|NCT02249299|Cannabis,|cannabis,
1152686|NCT02249299|Sativex,|sativex,
1152687|NCT02249299|Endocannabinoid,|endocannabinoid,
1152688|NCT02249299|Cognition|cognition
1152689|NCT02249286|Child Centered Counseling|child centered counseling
1152690|NCT02249286|Home based food production|home based food production
1152691|NCT02249286|Nutrition|nutrition
1152692|NCT02249286|Health|health
1152693|NCT02249286|IYCF|iycf
1152694|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
1152695|NCT02249234|Scrotal pain|scrotal pain
1152696|NCT02249234|Botox|botox
1152697|NCT02249221|Influenza vaccine|influenza vaccine
1152698|NCT02249221|Vaccination|vaccination
1152699|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
1152700|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
1152701|NCT02249221|CCIV|cciv
1152702|NCT02249208|Breast Cancer|breast cancer
1152703|NCT02249208|Sentinel Lymph Node|sentinel lymph node
1152704|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1152705|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
1152706|NCT02249208|False-negative Rate|false-negative rate
1152707|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
1152708|NCT02249169|IBS|ibs
1152709|NCT02249156|Health economics|health economics
1152710|NCT02249156|Financial incentives|financial incentives
1152711|NCT02249156|Health care spending|health care spending
1152712|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
1152713|NCT02249143|Prematurity|prematurity
1152714|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
1152715|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1152716|NCT02249078|Crohn's Disease|crohn's disease
1152717|NCT02249013|Ovarian Cancer|ovarian cancer
1152718|NCT02248974|End-Stage Heart Failure|end-stage heart failure
1152719|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
1152720|NCT02248974|Decision Aid|decision aid
1152721|NCT02248974|Medical Decision-Making|medical decision-making
1152722|NCT02248948|Omega-3|omega-3
1152723|NCT02248948|ADHD|adhd
1152724|NCT02248948|Quality of Life|quality of life
1152725|NCT02248948|Inattention|inattention
1152726|NCT02248948|Hyperactivity|hyperactivity
1152727|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
1152728|NCT02248935|Y Mesh|y mesh
1152729|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
1152730|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
1152731|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
1152732|NCT02248870|femoral neck|femoral neck
1152733|NCT02248857|UMS|ums
1152734|NCT02248857|medication schedule|medication schedule
1152735|NCT02248857|diabetes|diabetes
1152736|NCT02248857|drug labeling|drug labeling
1152737|NCT02248831|Dyspnea|dyspnea
1152738|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
1152739|NCT02248831|Doppler ultrasound|doppler ultrasound
1152740|NCT02248831|Lung Doppler signals|lung doppler signals
1152741|NCT02248805|colon cancer|colon cancer
1152742|NCT02248805|colorectal carcinoma|colorectal carcinoma
1152743|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
1152744|NCT02248779|Diabetes Risk|diabetes risk
1152745|NCT02248779|14-202|14-202
1152746|NCT02248753|Atrial fibrillation|atrial fibrillation
1152747|NCT02248753|Electrical cardioversion|electrical cardioversion
1152748|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
1152749|NCT02248753|Rhythm control|rhythm control
1152750|NCT02248753|Rate control|rate control
1152751|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
1152752|NCT02248740|varicose vein|varicose vein
1152753|NCT02248740|small saphenous vein|small saphenous vein
1152754|NCT02248701|Testosterone|testosterone
1152755|NCT02248701|Testosterone enanthate|testosterone enanthate
1152756|NCT02248701|Testosterone undecanoate|testosterone undecanoate
1152757|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
1152758|NCT02248701|Methyltestosterone|methyltestosterone
1152759|NCT02248701|Androgens|androgens
1152760|NCT02248701|Hormones|hormones
1152761|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
1152762|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
1152763|NCT02248701|Pharmacologic Actions|pharmacologic actions
1152764|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
1152765|NCT02248701|Antineoplastic Agents|antineoplastic agents
1152766|NCT02248701|Therapeutic Uses|therapeutic uses
1152767|NCT02248701|Anabolic Agents|anabolic agents
1152768|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
1152769|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
1152770|NCT02248701|Lean Tissue Mass|lean tissue mass
1152771|NCT02248701|Body Composition|body composition
1152772|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
1152773|NCT02248701|Muscle Strength|muscle strength
1152774|NCT02248701|5-alpha Reductase|5-alpha reductase
1152775|NCT02248701|Muscle Mass|muscle mass
1152776|NCT02248701|Bone Mineral Density|bone mineral density
1152777|NCT02248701|Adipose Tissue|adipose tissue
1152778|NCT02248701|Body Fat|body fat
1152779|NCT02248701|Density, Bone|density, bone
1152780|NCT02248701|Bone Formation|bone formation
1152781|NCT02248701|Bone Resorption|bone resorption
1152782|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
1152783|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
1152784|NCT02248701|Muscle, Skeletal|muscle, skeletal
1152785|NCT02248701|Bone and Bones|bone and bones
1152786|NCT02248701|Gait|gait
1152787|NCT02248701|Walking|walking
1152788|NCT02248701|Locomotion|locomotion
1152789|NCT02248701|Motor Activity|motor activity
1152790|NCT02248688|Bariatric Embolization|bariatric embolization
1152791|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
1152792|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
1152793|NCT02248688|Morbid Obesity|morbid obesity
1152794|NCT02248688|Obesity|obesity
1152795|NCT02248688|Weight Loss|weight loss
1152796|NCT02248688|Ghrelin|ghrelin
1152797|NCT02248688|Embolization|embolization
1152798|NCT02248675|sleep disorders|sleep disorders
1152799|NCT02248675|insomnia|insomnia
1152800|NCT02248675|suicidal ideation|suicidal ideation
1152801|NCT02248675|Depression|depression
1152802|NCT02248675|Depressive disorders|depressive disorders
1152803|NCT02248675|PTSD|ptsd
1152804|NCT02248675|anxiety disorders|anxiety disorders
1152805|NCT02248675|suicide|suicide
1152806|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
1152807|NCT02248662|DCIS|dcis
1152808|NCT02248662|PCORI|pcori
1152809|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
1152810|NCT02248662|radiation|radiation
1152811|NCT02248662|oncology|oncology
1152812|NCT02248662|patient-centered|patient-centered
1152813|NCT02248662|decision aid|decision aid
1152814|NCT02248662|decision-making|decision-making
1152815|NCT02248649|Parkinson's disease|parkinson's disease
1152816|NCT02248649|Exercise therapy|exercise therapy
1152817|NCT02248649|Mild cognitive impairment|mild cognitive impairment
1152818|NCT02248636|Alzheimer's disease|alzheimer's disease
1152819|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
1152820|NCT02248636|Discontinuation|discontinuation
1152821|NCT02248623|Anaesthesia|anaesthesia
1152822|NCT02248623|Isolated forearm test|isolated forearm test
1152823|NCT02248623|Responsiveness|responsiveness
1152824|NCT02248623|Laryngoscopy|laryngoscopy
1152825|NCT02248623|Intubation|intubation
1152826|NCT02248610|Pulmonary embolism|pulmonary embolism
1152827|NCT02248610|PE|pe
1152828|NCT02248610|Deep vein thrombosis|deep vein thrombosis
1152829|NCT02248610|DVT|dvt
1152830|NCT02248610|Rivaroxaban|rivaroxaban
1152831|NCT02248610|Venous thromboembolism|venous thromboembolism
1152832|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1152833|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
1152834|NCT02248610|Root cause analysis|root cause analysis
1152835|NCT02248571|breast cancer|breast cancer
1152836|NCT02248571|advanced|advanced
1152837|NCT02248571|inoperable|inoperable
1152838|NCT02248571|metastatic|metastatic
1152839|NCT02248571|HER2/neu-negative|her2/neu-negative
1152840|NCT02248571|hormone receptor positive|hormone receptor positive
1152841|NCT02248571|HR+|hr+
1152842|NCT02248571|female|female
1152843|NCT02248571|postmenopausal|postmenopausal
1152844|NCT02248558|Contest|contest
1152845|NCT02248558|Crowdsourcing|crowdsourcing
1152846|NCT02248558|Innovation|innovation
1152847|NCT02248558|Randomized controlled trial|randomized controlled trial
1152848|NCT02248558|China|china
1152849|NCT02248558|Social entrepreneurship|social entrepreneurship
1152850|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
1152851|NCT02248545|Autoimmune diseases|autoimmune diseases
1152852|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
1152853|NCT02248545|Celiac disease|celiac disease
1152854|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
1152855|NCT02248519|Gastric cancer|gastric cancer
1152856|NCT02248519|Gastrectomy|gastrectomy
1152857|NCT02248519|Laparoscopy|laparoscopy
1152858|NCT02248506|Candidiasis|candidiasis
1152859|NCT02248493|Pain, Postoperative|pain, postoperative
1152860|NCT02248493|Paracetamol|paracetamol
1152861|NCT02248493|Administration, Intravenous|administration, intravenous
1152862|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1152863|NCT02248493|Child|child
1152864|NCT02248493|Adolescent|adolescent
1152865|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
1152866|NCT02248428|multiple myeloma|multiple myeloma
1152867|NCT02248428|Clarithromycin|clarithromycin
1152868|NCT02248428|CTd|ctd
1152869|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
1152870|NCT02248415|Myocardial Ischemia|myocardial ischemia
1152871|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
1152872|NCT02248389|ablation|ablation
1152873|NCT02248389|laparoscopic surgery|laparoscopic surgery
1152874|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
1152875|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
1152876|NCT02248363|Rehabilitation|rehabilitation
1152877|NCT02248363|Effectiveness|effectiveness
1152878|NCT02248363|Determinants|determinants
1152879|NCT02248363|Prediction|prediction
1152880|NCT02248350|prostate cancer|prostate cancer
1152881|NCT02248350|physical activity|physical activity
1152882|NCT02248350|exercise|exercise
1152883|NCT02248350|intervention|intervention
1152884|NCT02248350|side effects|side effects
1152885|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
1152886|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
1153085|NCT02247440|HIV|hiv
1152887|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
1152888|NCT02248298|Ablative fractional laser|ablative fractional laser
1152889|NCT02248298|Actinic keratosis|actinic keratosis
1152890|NCT02248298|Efficacy|efficacy
1152891|NCT02248298|Photodynamic therapy|photodynamic therapy
1152892|NCT02248298|Short incubation time|short incubation time
1152893|NCT02248285|multiplex|multiplex
1152894|NCT02248285|polymerase chain reaction|polymerase chain reaction
1152896|NCT02248285|BioFire Diagnostics|biofire diagnostics
1152897|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
1152898|NCT02248285|Diarrheal disease|diarrheal disease
1152899|NCT02248285|Emergency department|emergency department
1152900|NCT02248285|rapid diagnostics|rapid diagnostics
1152901|NCT02248285|FilmArray|filmarray
1152902|NCT02248285|FilmArray GI Panel|filmarray gi panel
1152903|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
1152904|NCT02248272|Type 2 Diabetes|type 2 diabetes
1152905|NCT02248272|Hyperinsulinemia|hyperinsulinemia
1152906|NCT02248272|Meal frequency|meal frequency
1152907|NCT02248246|Hemostasis|hemostasis
1152908|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
1152909|NCT02248246|Laparoscopic|laparoscopic
1152910|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
1152911|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
1152912|NCT02248246|Observational|observational
1152913|NCT02248233|nimodipine|nimodipine
1152914|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
1152915|NCT02248233|Cerebral Infarction|cerebral infarction
1152916|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
1152917|NCT02248233|optimal dose|optimal dose
1152918|NCT02248233|multi-center|multi-center
1152919|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
1152920|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
1152921|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
1152922|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
1152923|NCT02248194|Quality of life|quality of life
1152924|NCT02248194|Satisfaction|satisfaction
1152925|NCT02248090|Phase 1|phase 1
1152926|NCT02248090|Safety|safety
1152927|NCT02248090|Tolerability|tolerability
1152928|NCT02248090|Pharmacokinetics|pharmacokinetics
1152929|NCT02248090|Ascending Doses|ascending doses
1152930|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
1152931|NCT02248090|Her2 Negative|her2 negative
1152932|NCT02248090|Advanced Breast Cancer|advanced breast cancer
1152933|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1152934|NCT02248064|Long term oxygen therapy|long term oxygen therapy
1152935|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
1152936|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
1152937|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1152938|NCT02248025|Fluid responsiveness|fluid responsiveness
1152939|NCT02248025|capillary refill time|capillary refill time
1152940|NCT02248025|microcirculation|microcirculation
1152941|NCT02248025|circulatory failure|circulatory failure
1152942|NCT02248025|passive leg raising|passive leg raising
1152943|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
1152944|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
1152945|NCT02248012|Chemotherapy|chemotherapy
1152946|NCT02247999|Cervical Cancer|cervical cancer
1152947|NCT02247999|HIV/AIDS|hiv/aids
1152948|NCT02247999|HPV|hpv
1152949|NCT02247999|Biomarkers|biomarkers
1152950|NCT02247999|Screening|screening
1152951|NCT02247986|Conduct Disorder|conduct disorder
1152952|NCT02247986|Methylphenidate|methylphenidate
1152953|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
1152954|NCT02247947|CPR|cpr
1152955|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
1152956|NCT02247934|PSC|psc
1152957|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
1152958|NCT02247921|nurse-organized service|nurse-organized service
1152959|NCT02247921|disabled stroke patients|disabled stroke patients
1152960|NCT02247908|Cigarette smoking|cigarette smoking
1152961|NCT02247908|Smoke|smoke
1152962|NCT02247908|Smoking|smoking
1152963|NCT02247908|Tobacco Use|tobacco use
1152964|NCT02247895|ICU Acquired weakness|icu acquired weakness
1152965|NCT02247895|Critical illness|critical illness
1152966|NCT02247895|Mechanical ventilation|mechanical ventilation
1152967|NCT02247882|Osteoarthritis|osteoarthritis
1152968|NCT02247882|Patient Education|patient education
1152969|NCT02247882|Aquatic Exercise|aquatic exercise
1152970|NCT02247882|kinetic|kinetic
1152972|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
1152973|NCT02247869|First line therapy|first line therapy
1152974|NCT02247856|nebulizers,|nebulizers,
1152975|NCT02247856|noninvasive ventilation|noninvasive ventilation
1152976|NCT02247856|COPD|copd
1152977|NCT02247856|scintigraphy,|scintigraphy,
1152978|NCT02247856|aerosol|aerosol
1152979|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
1152980|NCT02247843|Gene Therapy|gene therapy
1152981|NCT02247843|Lentiviral Vector|lentiviral vector
1152982|NCT02247843|Beta Globin|beta globin
1152983|NCT02247830|Radiodermatitis|radiodermatitis
1152984|NCT02247830|Head and neck neoplasms|head and neck neoplasms
1152985|NCT02247830|Radiotherapy|radiotherapy
1152986|NCT02247830|Urea|urea
1152987|NCT02247830|Matricaria|matricaria
1152988|NCT02247830|Breast Neoplasms|breast neoplasms
1152989|NCT02247830|chamomilla|chamomilla
1152990|NCT02247830|chamomile|chamomile
1152991|NCT02247778|clavicle|clavicle
1152992|NCT02247778|surgical intervention|surgical intervention
1152993|NCT02247778|mini-incision|mini-incision
1152994|NCT02247778|plate osteosynthesis|plate osteosynthesis
1152995|NCT02247752|hepatitis|hepatitis
1152996|NCT02247752|HBV|hbv
1152997|NCT02247752|chronic hepatitis|chronic hepatitis
1152998|NCT02247752|HCC|hcc
1152999|NCT02247752|cirrhosis|cirrhosis
1153000|NCT02247752|quantitative HBsAg|quantitative hbsag
1153001|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
1153002|NCT02247739|HAE|hae
1153003|NCT02247739|Hereditary Angioedema|hereditary angioedema
1153004|NCT02247739|Prophylaxis|prophylaxis
1153005|NCT02247726|RSV|rsv
1153006|NCT02247726|Third Trimester|third trimester
1153007|NCT02247726|Maternal Immunization|maternal immunization
1153008|NCT02247713|PET|pet
1153009|NCT02247713|radiotherapy|radiotherapy
1153010|NCT02247713|international|international
1153011|NCT02247713|NSCLC|nsclc
1153012|NCT02247713|overall survival|overall survival
1154890|NCT02238873|neutropenia|neutropenia
1153013|NCT02247713|low and middle income countries|low and middle income countries
1153014|NCT02247700|Pediatrics|pediatrics
1153015|NCT02247700|ARDS|ards
1153016|NCT02247700|ARF|arf
1153017|NCT02247700|ALI|ali
1153018|NCT02247700|Respiratory|respiratory
1153019|NCT02247700|Mechanical ventilation|mechanical ventilation
1153020|NCT02247700|Ventilation|ventilation
1153021|NCT02247700|Noninvasive monitoring|noninvasive monitoring
1153022|NCT02247700|electrical impedance tomography|electrical impedance tomography
1153023|NCT02247700|EIT|eit
1153024|NCT02247687|HIV-1|hiv-1
1153025|NCT02247687|antiretroviral treatment|antiretroviral treatment
1153026|NCT02247687|viral load|viral load
1153027|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
1153028|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
1153029|NCT02247648|tramadol|tramadol
1153030|NCT02247648|shoulder surgery|shoulder surgery
1153031|NCT02247648|pain|pain
1153032|NCT02247648|interscalen block|interscalen block
1153033|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
1153034|NCT02247635|Treatment adherence|treatment adherence
1153035|NCT02247635|Behavioral model of health care|behavioral model of health care
1153036|NCT02247635|Healthy lifestyle|healthy lifestyle
1153037|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
1153038|NCT02247635|Metabolic syndrome|metabolic syndrome
1153039|NCT02247635|Obesity|obesity
1153040|NCT02247622|telomeres|telomeres
1153041|NCT02247622|PSC|psc
1153042|NCT02247609|B cell lymphoma|b cell lymphoma
1153043|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1153044|NCT02247609|Burkitt lymphoma|burkitt lymphoma
1153045|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
1153046|NCT02247609|B cell malignancy|b cell malignancy
1153047|NCT02247596|Resveratrol|resveratrol
1153048|NCT02247596|obesity|obesity
1153049|NCT02247596|insulin resistance|insulin resistance
1153050|NCT02247596|energy expenditure|energy expenditure
1153051|NCT02247596|diabetes|diabetes
1153052|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
1153053|NCT02247570|PTSD|ptsd
1153054|NCT02247570|DSM-IV|dsm-iv
1153055|NCT02247557|IC/PBS|ic/pbs
1153056|NCT02247557|VAS|vas
1153057|NCT02247557|Botulinum Toxin A|botulinum toxin a
1153058|NCT02247557|Lipotoxin|lipotoxin
1333239|NCT01443871|Volunteer|volunteer
1216086|NCT01960907|COPD|copd
1153059|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
1153060|NCT02247518|Male|male
1153061|NCT02247518|Volunteers|volunteers
1153062|NCT02247492|International|international
1153063|NCT02247492|Multicenter|multicenter
1153064|NCT02247492|Observational registry|observational registry
1153065|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1153066|NCT02247492|Stenting|stenting
1153067|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
1153068|NCT02247492|Coronary revascularization|coronary revascularization
1153069|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1153070|NCT02247492|STEMI|stemi
1153071|NCT02247492|NSTEMI|nstemi
1153072|NCT02247492|Ischemia|ischemia
1153073|NCT02247492|Angina|angina
1153074|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1153075|NCT02247492|Small Vessels|small vessels
1153076|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
1153077|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
1153078|NCT02247466|Laparoscopy|laparoscopy
1153079|NCT02247453|lung cancer|lung cancer
1153080|NCT02247453|clinical trial|clinical trial
1153081|NCT02247453|screening|screening
1153082|NCT02247453|microRNA|microrna
1153083|NCT02247453|biomarkers|biomarkers
1153084|NCT02247440|HCV|hcv
1153086|NCT02247440|Thailand|thailand
1153087|NCT02247440|pegylated interferon|pegylated interferon
1153088|NCT02247440|ribavirin|ribavirin
1153089|NCT02247427|Heart failure|heart failure
1153090|NCT02247427|Super responder|super responder
1153091|NCT02247414|Cirrhosis|cirrhosis
1153092|NCT02247414|Hypertension|hypertension
1153093|NCT02247414|venous thrombosis|venous thrombosis
1153094|NCT02247414|Warfarin|warfarin
1153095|NCT02247414|Splenectomy|splenectomy
1153096|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
1153097|NCT02247414|Laparoscopy|laparoscopy
1153098|NCT02247401|Genotype 4|genotype 4
1153099|NCT02247401|non-responder|non-responder
1153100|NCT02247401|treatment experienced|treatment experienced
1153101|NCT02247401|HCV|hcv
1153102|NCT02247401|naive|naive
1153103|NCT02247401|relapser|relapser
1153104|NCT02247401|hepatitis infection|hepatitis infection
1153105|NCT02247401|compensated cirrhosis|compensated cirrhosis
1153106|NCT02247401|hepatitis c|hepatitis c
1153107|NCT02247401|Cirrhosis|cirrhosis
1153108|NCT02247401|Egypt|egypt
1153109|NCT02247401|null responder|null responder
1153110|NCT02247401|partial responder|partial responder
1153111|NCT02247388|Alcohol Dependence|alcohol dependence
1153112|NCT02247388|Alcoholism|alcoholism
1153113|NCT02247388|AB-CASI|ab-casi
1153114|NCT02247388|Emergency Department|emergency department
1153115|NCT02247362|Safety|safety
1153116|NCT02247362|Immunogenicity|immunogenicity
1153117|NCT02247336|colorectal cancer|colorectal cancer
1153118|NCT02247336|early detection of cancer|early detection of cancer
1153119|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
1153120|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
1153121|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
1153122|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
1153123|NCT02247297|preeclampsia|preeclampsia
1153124|NCT02247297|pregnancy|pregnancy
1153125|NCT02247271|peer coaches|peer coaches
1153126|NCT02247245|CHF|chf
1153127|NCT02247245|AF|af
1153128|NCT02247245|SR|sr
1153129|NCT02247245|HFREF|hfref
1153130|NCT02247245|CRT|crt
1153131|NCT02247219|Health education|health education
1153132|NCT02247219|Health services research|health services research
1153133|NCT02247206|Tourette Syndrome|tourette syndrome
1153134|NCT02247206|tic disorders|tic disorders
1153135|NCT02247206|behavior therapy|behavior therapy
1153136|NCT02247206|web-based videoconferencing|web-based videoconferencing
1153137|NCT02247206|VoIP|voip
1153138|NCT02247193|Botulinum Toxin|botulinum toxin
1153139|NCT02247193|Botox|botox
1153140|NCT02247193|Craniofacial deformity|craniofacial deformity
1153141|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
1153142|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
1153143|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
1153144|NCT02247128|Aortic Valve Disease|aortic valve disease
1153145|NCT02247128|Aortic Stenosis|aortic stenosis
1153146|NCT02247128|Myocardial Infarction|myocardial infarction
1153147|NCT02247128|Ischemic stroke|ischemic stroke
1153148|NCT02247128|Bleeding|bleeding
1153149|NCT02247128|Thrombosis|thrombosis
1153150|NCT02247128|Myocardial Ischemia|myocardial ischemia
1153151|NCT02247128|Heart Diseases|heart diseases
1153152|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
1153153|NCT02247128|Vascular Diseases|vascular diseases
1153154|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
1153155|NCT02247128|Aspirin|aspirin
1153156|NCT02247128|Clopidogrel|clopidogrel
1153157|NCT02247128|Prasugrel|prasugrel
1153158|NCT02247128|Ticagrelor|ticagrelor
1153159|NCT02247128|Antithrombotic treatment|antithrombotic treatment
1153160|NCT02247128|Oral anticoagulation|oral anticoagulation
1153161|NCT02247128|Warfarin|warfarin
1153162|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1153163|NCT02247128|Genetic Testing|genetic testing
1153164|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
1153165|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
1153166|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
1153167|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1153168|NCT02247115|competency|competency
1153169|NCT02247089|Night Shift work|night shift work
1153170|NCT02247089|Stress|stress
1153171|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
1153172|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
1153173|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
1153174|NCT02247089|Inflammation|inflammation
1153175|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
1153176|NCT02247089|Massage Therapy|massage therapy
1153177|NCT02247050|Costs and Cost Analysis|costs and cost analysis
1153178|NCT02247050|Professional Practice|professional practice
1153179|NCT02247050|Attitude of Health Personnel|attitude of health personnel
1153180|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
1153181|NCT02247050|Decision Making|decision making
1153772|NCT02244502|Paclitaxel|paclitaxel
1153182|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
1153183|NCT02247050|Physician-Patient Relations|physician-patient relations
1153184|NCT02247050|Physician's Role|physician's role
1153185|NCT02247050|Health Care|health care
1153186|NCT02247050|Quality of Health Care|quality of health care
1153187|NCT02247050|Quality Assurance|quality assurance
1153188|NCT02247050|Physicians, Primary Care|physicians, primary care
1153189|NCT02247050|Evidence-Based Medicine|evidence-based medicine
1153190|NCT02247050|Evidence-Based Practice|evidence-based practice
1153191|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
1153192|NCT02247050|Reminder Systems|reminder systems
1153193|NCT02247050|Judgment|judgment
1153194|NCT02247050|Cognition|cognition
1153195|NCT02247050|Patient Care|patient care
1153196|NCT02247050|Health Services Misuse|health services misuse
1153197|NCT02247050|Unnecessary Procedures|unnecessary procedures
1153198|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
1153199|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
1153200|NCT02247050|Over Prescribing|over prescribing
1153201|NCT02247050|Low Back Pain|low back pain
1153202|NCT02247050|Sinusitis|sinusitis
1153203|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
1153204|NCT02247050|Generalized Headache|generalized headache
1153205|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
1153206|NCT02247050|Antibiotics|antibiotics
1153207|NCT02247050|Humans|humans
1153208|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
1153209|NCT02247050|Pragmatic Trial|pragmatic trial
1153210|NCT02247050|Stepped Wedge Design|stepped wedge design
1153211|NCT02247050|Cluster Randomized Trial|cluster randomized trial
1153212|NCT02247050|Choosing Wisely|choosing wisely
1153213|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
1153214|NCT02247037|Patient Derived Xenograft|patient derived xenograft
1153215|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1153216|NCT02247037|Therapeutic Resistance|therapeutic resistance
1153217|NCT02247011|bone mineral density|bone mineral density
1153218|NCT02247011|25(OH)D|25(oh)d
1153219|NCT02246985|Processed foods|processed foods
1153220|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
1153221|NCT02246985|alpha-carotene|alpha-carotene
1153222|NCT02246985|beta-carotene|beta-carotene
1153223|NCT02246985|Vitamin A|vitamin a
1153224|NCT02246985|Lycopene|lycopene
1153225|NCT02246985|Gut absorption|gut absorption
1153226|NCT02246985|Bread|bread
1153227|NCT02246985|Mayonnaise|mayonnaise
1153228|NCT02246985|Bioavailability|bioavailability
1153229|NCT02246985|Fruits and Vegetables|fruits and vegetables
1153230|NCT02246985|Inflammation|inflammation
1153231|NCT02246985|Oxidative Stress|oxidative stress
1153232|NCT02246972|PTSD|ptsd
1153233|NCT02246972|Military sexual trauma|military sexual trauma
1153234|NCT02246972|Veterans|veterans
1153235|NCT02246972|Women in the military|women in the military
1153236|NCT02246972|Sexual assault|sexual assault
1153237|NCT02246946|pleural effusion|pleural effusion
1153238|NCT02246946|chest tube|chest tube
1153239|NCT02246946|respiratory therapy|respiratory therapy
1153240|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
1153241|NCT02246946|lung function|lung function
1153242|NCT02246946|pulmonary complications|pulmonary complications
1153243|NCT02246920|Bioequivalence|bioequivalence
1153244|NCT02246920|Allergic Rhinitis|allergic rhinitis
1153245|NCT02246907|Health related quality of life|health related quality of life
1153246|NCT02246855|Subjects|subjects
1153247|NCT02246842|Volunteers|volunteers
1153248|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
1153249|NCT02246816|Short Bowel Syndrome|short bowel syndrome
1153250|NCT02246816|SBS|sbs
1153251|NCT02246816|Chronic Diarrhea|chronic diarrhea
1153252|NCT02246816|Short Bowel|short bowel
1153253|NCT02246816|Short Gut|short gut
1153254|NCT02246816|Short Gut Syndrome|short gut syndrome
1153255|NCT02246816|Anti-Diarrheal|anti-diarrheal
1153256|NCT02246816|Opium Tincture|opium tincture
1153257|NCT02246816|loperamide|loperamide
1153258|NCT02246816|diphenoxylate|diphenoxylate
1153259|NCT02246816|ileostomies|ileostomies
1153260|NCT02246816|tincture of opium|tincture of opium
1153261|NCT02246816|DTO|dto
1153262|NCT02246816|codeine|codeine
1153263|NCT02246816|morphine|morphine
1153264|NCT02246816|opiate|opiate
1153265|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
1153266|NCT02246790|ablation, CABG|ablation, cabg
1153267|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
1153268|NCT02246777|Glaucoma|glaucoma
1153269|NCT02246764|Ocular hypertension.|ocular hypertension.
1153270|NCT02246764|Glaucoma|glaucoma
1153271|NCT02246751|postural control|postural control
1153272|NCT02246751|Targeted Training|targeted training
1153273|NCT02246751|cerebral palsy|cerebral palsy
1153274|NCT02246751|sensorimotor control|sensorimotor control
1153275|NCT02246751|trunk segments|trunk segments
1153276|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
1153277|NCT02246725|Depression|depression
1153278|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
1153279|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1153280|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
1153281|NCT02246725|Digestive System Diseases|digestive system diseases
1153282|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
1153283|NCT02246725|Intestinal Diseases|intestinal diseases
1153284|NCT02246725|Palliative chemotherapy|palliative chemotherapy
1153285|NCT02246725|Palliative care|palliative care
1153286|NCT02246725|Palliative treatment|palliative treatment
1153287|NCT02246725|Quality of life|quality of life
1153288|NCT02246725|Quality of life for relatives|quality of life for relatives
1153289|NCT02246725|Survival|survival
1153290|NCT02246712|tramadol|tramadol
1153291|NCT02246712|pharmacokinetics|pharmacokinetics
1153292|NCT02246712|enantiomers|enantiomers
1153293|NCT02246712|metabolism|metabolism
1153294|NCT02246712|diabetes|diabetes
1153295|NCT02246699|obesity|obesity
1153296|NCT02246699|overweight|overweight
1153297|NCT02246699|chitosan|chitosan
1153298|NCT02246699|fungal chitosan|fungal chitosan
1153299|NCT02246699|weight management|weight management
1153300|NCT02246686|Iberogast N|iberogast n
1153301|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
1153302|NCT02246686|add-on therapy|add-on therapy
1153304|NCT02246660|Peripheral Artery Disease|peripheral artery disease
1153305|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
1153306|NCT02246660|PAD|pad
1153307|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
1153308|NCT02246634|Neoplasm Metastases|neoplasm metastases
1153309|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
1153310|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
1153311|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
1153312|NCT02246634|Tumors|tumors
1153313|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
1153314|NCT02246621|MONARCH 3|monarch 3
1153315|NCT02246595|Sepsis|sepsis
1153316|NCT02246595|Severe Sepsis|severe sepsis
1153317|NCT02246595|Septic Shock|septic shock
1153318|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1153319|NCT02246595|Organ Dysfunction|organ dysfunction
1153320|NCT02246582|Type 1 Diabetes|type 1 diabetes
1153321|NCT02246582|Type 2 Diabetes|type 2 diabetes
1153322|NCT02246582|Enlite 3|enlite 3
1153323|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1153324|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
1153325|NCT02246569|RePneu®Coils|repneu®coils
1153326|NCT02246569|physical capacity|physical capacity
1153327|NCT02246569|quality of life|quality of life
1153328|NCT02246556|Amblyopia|amblyopia
1153329|NCT02246556|Dichoptic|dichoptic
1153330|NCT02246556|Virtual reality|virtual reality
1153331|NCT02246556|Stereopsis|stereopsis
1153332|NCT02246556|Stereo vision|stereo vision
1153333|NCT02246556|Visual acuity|visual acuity
1153334|NCT02246556|Binocular|binocular
1153335|NCT02246543|Appetite|appetite
1153336|NCT02246543|Gut Hormones|gut hormones
1153337|NCT02246543|Protein|protein
1153338|NCT02246543|Energy Density|energy density
1153339|NCT02246543|Gastric Emptying|gastric emptying
1153340|NCT02246465|Hypertrophic scar|hypertrophic scar
1153341|NCT02246465|Cicatrix|cicatrix
1153342|NCT02246465|Scar prevention|scar prevention
1153343|NCT02246465|Scar revision|scar revision
1153344|NCT02246452|Children and adolescents|children and adolescents
1153345|NCT02246452|Cancer|cancer
1569281|NCT00503230|HIV|hiv
1153346|NCT02246452|Malnutrition|malnutrition
1153347|NCT02246452|BMI percentile|bmi percentile
1153348|NCT02246452|BMI-SDS|bmi-sds
1153349|NCT02246439|Gastroenteritis|gastroenteritis
1153350|NCT02246439|Gastritis|gastritis
1153351|NCT02246439|Vomiting|vomiting
1153352|NCT02246439|Nausea|nausea
1153353|NCT02246439|Diarrhea|diarrhea
1153354|NCT02246413|BMI|bmi
1153355|NCT02246413|Depressive symptoms|depressive symptoms
1153356|NCT02246413|Integrated therapy|integrated therapy
1153357|NCT02246413|Cardiometabolic risk|cardiometabolic risk
1153358|NCT02246413|Self-regulation|self-regulation
1153359|NCT02246413|Behavior change|behavior change
1153360|NCT02246413|Precision medicine|precision medicine
1153361|NCT02246413|Lifestyle|lifestyle
1153362|NCT02246400|eCMP|ecmp
1153363|NCT02246400|eHealth|ehealth
1153364|NCT02246400|mHealth|mhealth
1153365|NCT02246400|Lifestyle intervention|lifestyle intervention
1153366|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
1153367|NCT02246400|PAMF|pamf
1153368|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
1153369|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
1153370|NCT02246387|Treatment Outcome|treatment outcome
1153371|NCT02246374|Parkinson's Disease|parkinson's disease
1153372|NCT02246374|ExAblate|exablate
1153373|NCT02246374|MRgFUS|mrgfus
1153374|NCT02246361|Ankle sprain|ankle sprain
1153375|NCT02246361|Infectious colitis|infectious colitis
1153376|NCT02246361|Diverticulitis|diverticulitis
1153377|NCT02246361|Pyelonephritis|pyelonephritis
1153378|NCT02246361|Prostatitis|prostatitis
1153379|NCT02246361|Pneumonitis|pneumonitis
1153674|NCT02244892|Disability glare|disability glare
1153380|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
1153381|NCT02246361|Doctor Patient Communication|doctor patient communication
1153382|NCT02246361|Adherence|adherence
1153383|NCT02246361|Satisfaction|satisfaction
1153384|NCT02246361|Scale|scale
1153385|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
1153386|NCT02246361|Adherence scale|adherence scale
1153387|NCT02246361|Satisfaction scale|satisfaction scale
1153388|NCT02246348|Systemic Sclerosis|systemic sclerosis
1153389|NCT02246348|Pulmonary hypertension|pulmonary hypertension
1153390|NCT02246348|Lung Doppler signals|lung doppler signals
1153391|NCT02246322|Pancreatic cancer|pancreatic cancer
1153392|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
1153393|NCT02246322|Lymphadenopathies|lymphadenopathies
1153394|NCT02246322|GIST|gist
1153395|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
1153396|NCT02246309|Infertility|infertility
1153397|NCT02246309|Embryo Culture|embryo culture
1153398|NCT02246309|Laboratory Technique|laboratory technique
1153399|NCT02246296|severe acute malnutrition|severe acute malnutrition
1153400|NCT02246296|wasting|wasting
1153401|NCT02246296|kwashiorkor|kwashiorkor
1153402|NCT02246296|nutrition|nutrition
1153403|NCT02246296|feeding|feeding
1153404|NCT02246296|milk|milk
1153405|NCT02246283|schizophrenia|schizophrenia
1153406|NCT02246283|elderly|elderly
1153407|NCT02246283|lifelong|lifelong
1153408|NCT02246283|quality of life|quality of life
1153409|NCT02246283|register|register
1153410|NCT02246283|questionaire|questionaire
1153411|NCT02246218|Urea Cycle Disorder|urea cycle disorder
1153412|NCT02246218|UCD|ucd
1153413|NCT02246218|Buphenyl|buphenyl
1153414|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
1153415|NCT02246218|Ravicti|ravicti
1153416|NCT02246218|Hyperammonemia|hyperammonemia
1153417|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
1153418|NCT02246218|GPB|gpb
1153419|NCT02246218|HPN-100|hpn-100
1153420|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
1153421|NCT02246205|delayed gastric emptying|delayed gastric emptying
1153422|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
1153423|NCT02246179|Fractional laser|fractional laser
1153424|NCT02246179|Topical anesthesia|topical anesthesia
1153425|NCT02246179|Drug delivery|drug delivery
1153426|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
1153427|NCT02246153|Advanced gastric cancer|advanced gastric cancer
1153428|NCT02246153|Elderly patients|elderly patients
1153429|NCT02246153|Morbidity|morbidity
1153430|NCT02246153|Mortality|mortality
1153431|NCT02246127|advanced pNET|advanced pnet
1153432|NCT02246127|everolimus|everolimus
1153433|NCT02246127|STZ-5FU|stz-5fu
1153434|NCT02246127|treatment sequence|treatment sequence
1153435|NCT02246114|Pregnancy|pregnancy
1153436|NCT02246114|Smoking|smoking
1153437|NCT02246114|Smoking cessation|smoking cessation
1153438|NCT02246101|cardiac disease|cardiac disease
1153439|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
1153440|NCT02246101|renal disease|renal disease
1153441|NCT02246101|albuminuria|albuminuria
1153442|NCT02246101|cardiovascular disease|cardiovascular disease
1153443|NCT02246101|CVD|cvd
1153444|NCT02246101|particulate matter|particulate matter
1153445|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
1153446|NCT02246075|Alzheimer's disease|alzheimer's disease
1153447|NCT02246075|Cognition|cognition
1153448|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
1153449|NCT02246062|Anxiety|anxiety
1153450|NCT02246062|Anesthesia|anesthesia
1153451|NCT02246062|Evaluation|evaluation
1153452|NCT02246062|Preoperative care|preoperative care
1153453|NCT02246062|Child|child
1153454|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
1153455|NCT02246010|diarrhea|diarrhea
1153456|NCT02246010|developing world|developing world
1153457|NCT02246010|lactose-free diet|lactose-free diet
1153458|NCT02246010|Clinical trial|clinical trial
1153459|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
1153460|NCT02245997|14-186|14-186
1153461|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
1153463|NCT02245945|prevention|prevention
1153464|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1153465|NCT02245932|Cardiovascular diseases|cardiovascular diseases
1153466|NCT02245932|Metabolism|metabolism
1153467|NCT02245932|Resveratrol|resveratrol
1153468|NCT02245919|Low Back Pain|low back pain
1153469|NCT02245919|Chronic Pain|chronic pain
1153470|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
1153471|NCT02245919|Primary Health Care|primary health care
1153472|NCT02245919|Physical Therapy|physical therapy
1153473|NCT02245906|Brazilian fruit peel|brazilian fruit peel
1153474|NCT02245906|Functional food|functional food
1153475|NCT02245906|Cardiometabolic risk|cardiometabolic risk
1153476|NCT02245906|Metabolic syndrome|metabolic syndrome
1153477|NCT02245906|Inflammation|inflammation
1153478|NCT02245906|Appetite|appetite
1153479|NCT02245906|Gut hormone|gut hormone
1153480|NCT02245880|cervical spine|cervical spine
1153481|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
1153482|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
1153483|NCT02245880|collar|collar
1153484|NCT02245867|Amyloidosis|amyloidosis
1153485|NCT02245867|Relapse|relapse
1153486|NCT02245867|Refractory|refractory
1153487|NCT02245854|diminutive polyps|diminutive polyps
1153488|NCT02245854|small polyps|small polyps
1153489|NCT02245854|cold snare polypectomy|cold snare polypectomy
1153490|NCT02245854|complications|complications
1153491|NCT02245854|bleeding|bleeding
1153492|NCT02245841|dermatomyositis|dermatomyositis
1153493|NCT02245841|Acthar gel|acthar gel
1153494|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
1153495|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
1153496|NCT02245815|Probiotics|probiotics
1153497|NCT02245815|Secreting IgA|secreting iga
1153498|NCT02245815|Preterm newborns|preterm newborns
1153499|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
1153500|NCT02245802|Prediction model|prediction model
1153501|NCT02245802|Mortality|mortality
1153502|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
1153503|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
1153504|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
1153506|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
1153507|NCT02245737|Alzheimer's disease|alzheimer's disease
1153508|NCT02245737|Dementia|dementia
1153509|NCT02245737|Brain Diseases|brain diseases
1153510|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
1153511|NCT02245737|Central Nervous System Diseases|central nervous system diseases
1153512|NCT02245737|Nervous System Diseases|nervous system diseases
1153513|NCT02245737|Mental Disorders|mental disorders
1153514|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1153515|NCT02245737|Tauopathies|tauopathies
1153516|NCT02245724|Mental retardation|mental retardation
1153517|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
1153518|NCT02245724|Stem cell|stem cell
1153519|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
1153520|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
1153521|NCT02245711|Stem Cell|stem cell
1153522|NCT02245698|Chronic Stroke|chronic stroke
1153523|NCT02245698|Subacute stroke|subacute stroke
1153524|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
1153525|NCT02245698|Stem cell|stem cell
1153526|NCT02245685|Substitution Therapy|substitution therapy
1153527|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
1153528|NCT02245672|Asthma|asthma
1153529|NCT02245672|fluticasone|fluticasone
1153530|NCT02245672|salmeterol|salmeterol
1153531|NCT02245672|CRC749|crc749
1153532|NCT02245672|Diskus|diskus
1153533|NCT02245672|Advair|advair
1153534|NCT02245672|FEV1|fev1
1153535|NCT02245672|MGR001|mgr001
1153536|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
1153537|NCT02245620|elamipretide|elamipretide
1153538|NCT02245607|Psychotic Disorders|psychotic disorders
1153539|NCT02245607|Cognitive Training|cognitive training
1153540|NCT02245607|Mental Disorders|mental disorders
1153541|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1153542|NCT02245594|Gastrointestinal motility|gastrointestinal motility
1153543|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
1153544|NCT02245594|Transit time|transit time
1153545|NCT02245594|Sleep pattern|sleep pattern
1153546|NCT02245568|Dementia|dementia
1153547|NCT02245568|Alzheimer Disease|alzheimer disease
1153548|NCT02245568|bvFTD|bvftd
1153549|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
1153550|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
1153551|NCT02245568|Brain Diseases|brain diseases
1153552|NCT02245568|Cognitive Disorders|cognitive disorders
1153553|NCT02245516|Intraretinal Fluid|intraretinal fluid
1153554|NCT02245516|Subretinal Fluid|subretinal fluid
1153555|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
1153556|NCT02245516|Diabetic Macular Edema|diabetic macular edema
1153557|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
1153558|NCT02245425|Neck pain|neck pain
1153559|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
1153560|NCT02245425|Range of Motion|range of motion
1153561|NCT02245425|Disability|disability
1153562|NCT02245412|GIGVHD|gigvhd
1153563|NCT02245399|Weight loss|weight loss
1153564|NCT02245399|Diabetes|diabetes
1153565|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
1153566|NCT02245399|Weight loss diet|weight loss diet
1153567|NCT02245399|mediterranean type diet|mediterranean type diet
1153568|NCT02245399|Canola oil|canola oil
1153569|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
1153570|NCT02245399|Glycemic index|glycemic index
1153571|NCT02245373|Depression|depression
1153572|NCT02245373|Primary Care|primary care
1153573|NCT02245373|Cost-effectiveness|cost-effectiveness
1153574|NCT02245373|Pharmacological treatment|pharmacological treatment
1153575|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
1153576|NCT02245360|GRAZAX|grazax
1153578|NCT02245347|Tuberculosis|tuberculosis
1153579|NCT02245347|MDR TB|mdr tb
1153580|NCT02245347|Drug resistant TB|drug resistant tb
1153581|NCT02245321|hemoglobin recovery|hemoglobin recovery
1153582|NCT02245321|iron recovery|iron recovery
1153583|NCT02245321|iron supplements|iron supplements
1153584|NCT02245308|Tobacco use cessation|tobacco use cessation
1153585|NCT02245308|Homelessness|homelessness
1153586|NCT02245308|Veterans|veterans
1153587|NCT02245295|Bronchial endoscopy|bronchial endoscopy
1153588|NCT02245295|ultrasound|ultrasound
1153589|NCT02245295|EBUS|ebus
1153590|NCT02245295|anesthesia|anesthesia
1153591|NCT02245295|lung cancer|lung cancer
1153592|NCT02245295|diagnosis including staging|diagnosis including staging
1153593|NCT02245256|delirium|delirium
1153594|NCT02245256|incidence|incidence
1153595|NCT02245256|dexmedetomidine|dexmedetomidine
1153596|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
1153597|NCT02245230|Hypertension|hypertension
1153598|NCT02245230|Autonomic Nervous System|autonomic nervous system
1153599|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
1153600|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
1153601|NCT02245230|Ganglionic Blockers|ganglionic blockers
1153602|NCT02245230|Trimethaphan|trimethaphan
1153603|NCT02245230|Blood Pressure|blood pressure
1153604|NCT02245230|Hemodynamics|hemodynamics
1153605|NCT02245191|Vasopressor|vasopressor
1153606|NCT02245191|Cesarian delivery|cesarian delivery
1153607|NCT02245191|Hypotension|hypotension
1153608|NCT02245191|Maternal cardiac output|maternal cardiac output
1153609|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
1153610|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
1153611|NCT02245191|Preeclampsia|preeclampsia
1153612|NCT02245165|Nitric oxide|nitric oxide
1153613|NCT02245165|Nitric oxide synthase|nitric oxide synthase
1153614|NCT02245165|Gastrointestinal motility|gastrointestinal motility
1153615|NCT02245165|Gut peptide hormones|gut peptide hormones
1153616|NCT02245152|child acute malnutrition|child acute malnutrition
1153617|NCT02245152|prevention|prevention
1153618|NCT02245152|behavior change communication|behavior change communication
1153619|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
1153620|NCT02245152|screening coverage|screening coverage
1153621|NCT02245139|diarrhea|diarrhea
1153622|NCT02245139|vomiting|vomiting
1153623|NCT02245139|fever|fever
1153624|NCT02245139|abdominal pain|abdominal pain
1153625|NCT02245139|oliguria|oliguria
1153626|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
1153627|NCT02245087|atorvastatin|atorvastatin
1153628|NCT02245087|coronary artery disease|coronary artery disease
1153629|NCT02245087|myocardial infarction|myocardial infarction
1153630|NCT02245087|stroke|stroke
1153631|NCT02245087|revascularization|revascularization
1153632|NCT02245074|Infantile asthma|infantile asthma
1153633|NCT02245074|Induced sputum|induced sputum
1153634|NCT02245074|Phenotypes|phenotypes
1153635|NCT02245074|Eosinophils|eosinophils
1153636|NCT02245074|Neutrophils|neutrophils
1153637|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
1153638|NCT02245061|cortical excitability|cortical excitability
1153639|NCT02245061|paired pulses|paired pulses
1153640|NCT02245061|TMS|tms
1153641|NCT02245061|SEEG|seeg
1153642|NCT02245061|DES|des
1153643|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
1153644|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
1153645|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
1153646|NCT02245035|Glutathione|glutathione
1153647|NCT02245035|Dairy consumption|dairy consumption
1153648|NCT02245035|Brain|brain
1153649|NCT02245035|Humans|humans
1153650|NCT02245022|HIV|hiv
1153651|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
1153652|NCT02245022|Africa|africa
1153653|NCT02245022|Uganda|uganda
1153654|NCT02245022|Pharmacokinetics|pharmacokinetics
1153655|NCT02245022|Pregnancy|pregnancy
1153656|NCT02245022|Breastfeeding|breastfeeding
1153657|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
1153658|NCT02244996|Lycium barbarum|lycium barbarum
1153659|NCT02244996|Antioxidation|antioxidation
1153660|NCT02244996|Visual field|visual field
1153661|NCT02244996|Electroretinogram|electroretinogram
1153662|NCT02244970|Mindfulness|mindfulness
1153663|NCT02244970|Depressive mood|depressive mood
1153664|NCT02244970|anxiety|anxiety
1153665|NCT02244970|early psychosis|early psychosis
1153666|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1153667|NCT02244944|NAFLD|nafld
1153668|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
1153669|NCT02244905|Positive Deviance|positive deviance
1153670|NCT02244905|Infection Control|infection control
1153671|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
1153672|NCT02244905|Staff Engagement|staff engagement
1153673|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1153675|NCT02244892|Corneal scar|corneal scar
1153676|NCT02244892|Corneal haze|corneal haze
1153677|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
1153678|NCT02244892|Contrast sensitivity|contrast sensitivity
1153679|NCT02244879|resveratrol|resveratrol
1153680|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
1153681|NCT02244879|inflammation|inflammation
1153682|NCT02244879|insulin resistance|insulin resistance
1153683|NCT02244879|body composition|body composition
1153684|NCT02244879|bone mass|bone mass
1153685|NCT02244866|IVF|ivf
1153686|NCT02244866|LH supplementation|lh supplementation
1153687|NCT02244866|ovarian stimulation|ovarian stimulation
1153688|NCT02244866|poor responder|poor responder
1153689|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
1153690|NCT02244814|glucose|glucose
1153691|NCT02244814|insulin resistance|insulin resistance
1153692|NCT02244814|dietary carbohydrate|dietary carbohydrate
1153693|NCT02244814|dietary fat|dietary fat
1153694|NCT02244814|adiposity|adiposity
1153695|NCT02244814|Air displacement plethysmography|air displacement plethysmography
1153696|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
1153697|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
1153698|NCT02244775|osteo-arthritis|osteo-arthritis
1153699|NCT02244775|post traumatic arthritis|post traumatic arthritis
1153700|NCT02244736|Arterial stiffness|arterial stiffness
1153701|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
1153702|NCT02244736|Coronary flow reserve|coronary flow reserve
1153703|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1153704|NCT02244723|diagnosis|diagnosis
1153705|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
1153706|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
1153707|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
1153708|NCT02244710|Ticagrelor|ticagrelor
1153709|NCT02244697|Stridor|stridor
1153710|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
1153711|NCT02244697|Ultrasound (US)|ultrasound (us)
1153712|NCT02244684|Folate|folate
1153713|NCT02244684|Folic Acid|folic acid
1153714|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
1153715|NCT02244684|Epigenetics|epigenetics
1153716|NCT02244684|Pregnancy|pregnancy
1153717|NCT02244684|Fetal Health|fetal health
1153718|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
1153719|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
1153720|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
1153721|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
1153722|NCT02244632|Colorectal cancer|colorectal cancer
1153723|NCT02244632|Colorectal carcinoma|colorectal carcinoma
1153724|NCT02244632|Colorectal tumors|colorectal tumors
1153725|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
1153726|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
1153727|NCT02244632|Gastrointestinal disease|gastrointestinal disease
1153728|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
1153729|NCT02244632|Tetrahydrofolates|tetrahydrofolates
1153730|NCT02244632|Therapeutic uses|therapeutic uses
1153731|NCT02244632|Pharmacokinetics|pharmacokinetics
1153732|NCT02244632|Pharmacodynamics|pharmacodynamics
1216960|NCT01956344|CBT|cbt
1153733|NCT02244632|Safety assessments|safety assessments
1153734|NCT02244619|Hip replacement|hip replacement
1153735|NCT02244619|Knee replacement|knee replacement
1153736|NCT02244619|randomized trial|randomized trial
1153737|NCT02244619|acetaminophen|acetaminophen
1153738|NCT02244619|post-op pain management|post-op pain management
1153739|NCT02244606|Invasive Candidiasis|invasive candidiasis
1153740|NCT02244606|Invasive Candida infections|invasive candida infections
1153741|NCT02244606|Candidemia|candidemia
1153742|NCT02244606|SCY-078|scy-078
1153743|NCT02244606|Micafungin|micafungin
1153744|NCT02244606|Fluconazole|fluconazole
1153745|NCT02244606|Echinocandin|echinocandin
1153746|NCT02244593|breast cancer survivors|breast cancer survivors
1153747|NCT02244593|FAST MRI|fast mri
1153748|NCT02244593|mammography screening|mammography screening
1153749|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
1153750|NCT02244567|PCOS|pcos
1153751|NCT02244554|tattoo removal|tattoo removal
1153752|NCT02244554|Q-switched laser|q-switched laser
1153753|NCT02244554|Nd:YAG laser|nd:yag laser
1153754|NCT02244554|nanosecond laser|nanosecond laser
1153755|NCT02244554|picosecond laser|picosecond laser
1153756|NCT02244554|laser therapy|laser therapy
1153757|NCT02244554|tattoo|tattoo
1153758|NCT02244554|pulsed-laser|pulsed-laser
1153759|NCT02244554|laser treatment|laser treatment
1153760|NCT02244554|remove tattoo|remove tattoo
1153761|NCT02244554|tattoo clearing|tattoo clearing
1153762|NCT02244554|tattoo lightening|tattoo lightening
1153763|NCT02244554|tattoo lighten|tattoo lighten
1153764|NCT02244554|resistant tattoo|resistant tattoo
1153765|NCT02244515|children|children
1153766|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
1153767|NCT02244502|Treatment|treatment
1153768|NCT02244502|Minimal toxicity|minimal toxicity
1153769|NCT02244502|TTFields|ttfields
1153770|NCT02244502|Tumor Treating Fields|tumor treating fields
1153771|NCT02244502|Novocure|novocure
1153773|NCT02244502|Weekly paclitaxel|weekly paclitaxel
1153774|NCT02244476|mouth feel|mouth feel
1153775|NCT02244476|acoustic tribology|acoustic tribology
1153776|NCT02244476|vibration spectrum|vibration spectrum
1153777|NCT02244476|sensory perception|sensory perception
1153778|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
1153779|NCT02244463|Thyroid Cancer|thyroid cancer
1153780|NCT02244450|Neonatal screening|neonatal screening
1153781|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
1153782|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
1153783|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
1153785|NCT02244424|Obesity|obesity
1153786|NCT02244424|Adolescent|adolescent
1153787|NCT02244424|Social media|social media
1153788|NCT02244424|Prevention|prevention
1153789|NCT02244411|EQUAL|equal
1153790|NCT02244411|Exercise|exercise
1153791|NCT02244411|Diet|diet
1153792|NCT02244411|Physical activity|physical activity
1153793|NCT02244411|14-164|14-164
1153794|NCT02244385|vascular disease|vascular disease
1153795|NCT02244385|pregnancy|pregnancy
1153796|NCT02244385|chronic hypertension|chronic hypertension
1153797|NCT02244385|diabetes|diabetes
1153798|NCT02244385|obesity|obesity
1153897|NCT02243774|Randomized Controlled Trial|randomized controlled trial
1155708|NCT02235350|Upper Limb|upper limb
1153799|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
1153800|NCT02244372|immunity|immunity
1153801|NCT02244359|Shared Decision making|shared decision making
1153802|NCT02244359|Patient Centred care|patient centred care
1153803|NCT02244359|Interprofessionalism|interprofessionalism
1153804|NCT02244359|Home care|home care
1153805|NCT02244359|Frail elderly|frail elderly
1153806|NCT02244164|Type 2 Diabetes|type 2 diabetes
1153807|NCT02244164|Incretinomimetics|incretinomimetics
1153808|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
1153809|NCT02244164|Pancreas|pancreas
1153810|NCT02244164|PanIN|panin
1153811|NCT02244164|RMN|rmn
1153812|NCT02244164|Lipasemia|lipasemia
1153813|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
1153814|NCT02244138|Adolescent|adolescent
1153815|NCT02244138|Screening|screening
1153816|NCT02244138|Primary Care|primary care
1153817|NCT02244138|Computer Decision Support Systems|computer decision support systems
1153818|NCT02244125|Myeloma|myeloma
1153819|NCT02244125|Multiple Myeloma|multiple myeloma
1153820|NCT02244125|Relapse|relapse
1153821|NCT02244125|Refractory|refractory
1153822|NCT02244125|PCD|pcd
1153823|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
1153824|NCT02244125|Transplantation|transplantation
1153825|NCT02244125|Autologous|autologous
1153826|NCT02244125|Pomalidomide|pomalidomide
1153827|NCT02244125|Immunoglobulin|immunoglobulin
1153828|NCT02244125|Ig|ig
1153829|NCT02244125|Free light Chain|free light chain
1153830|NCT02244099|Controlled substance prescribing|controlled substance prescribing
1153831|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
1153832|NCT02244099|Opioid use|opioid use
1569282|NCT00503230|Latino|latino
1153833|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
1153834|NCT02244073|blood glucose target|blood glucose target
1153836|NCT02244073|insulin|insulin
1153837|NCT02244073|hypoglycemia|hypoglycemia
1153838|NCT02244073|hyperglycemia|hyperglycemia
1153839|NCT02244073|glycated hemoglobin|glycated hemoglobin
1153840|NCT02244060|Vignette|vignette
1153841|NCT02244060|Priming effect|priming effect
1153842|NCT02244021|HD|hd
1153843|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
1153844|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
1153845|NCT02244008|Mobilization|mobilization
1153846|NCT02244008|Joint Range of Motion|joint range of motion
1153847|NCT02244008|Ankle|ankle
1153848|NCT02244008|Manual Therapy|manual therapy
1153849|NCT02243995|Training program|training program
1153850|NCT02243995|Resistance training|resistance training
1153851|NCT02243995|Endurance training|endurance training
1153852|NCT02243995|Muscle strength|muscle strength
1153853|NCT02243995|Exercise capacity|exercise capacity
1153854|NCT02243995|Fatigue|fatigue
1153855|NCT02243995|Quality of life|quality of life
1153856|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
1153857|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1153858|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
1153859|NCT02243969|Blood pressure|blood pressure
1153860|NCT02243969|Vascular function|vascular function
1153861|NCT02243943|Neuromuscular block|neuromuscular block
1153862|NCT02243943|neuromuscular reversal|neuromuscular reversal
1153863|NCT02243943|postoperative conditions|postoperative conditions
1153864|NCT02243943|respiratory failure|respiratory failure
1153865|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
1153866|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
1153867|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
1153868|NCT02243904|Autonomic nervous function|autonomic nervous function
1153869|NCT02243904|Blood pressure|blood pressure
1153870|NCT02243904|Cardiovascular regulation|cardiovascular regulation
1153872|NCT02243904|Occupational exposure|occupational exposure
1153873|NCT02243904|Renal function|renal function
1153874|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
1153875|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
1153876|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
1153877|NCT02243852|Visceral Fat|visceral fat
1153878|NCT02243852|Subcutaneous Fat|subcutaneous fat
1153879|NCT02243839|Prosthetic valve|prosthetic valve
1153880|NCT02243839|Thrombosis|thrombosis
1153881|NCT02243839|Surgery|surgery
1153882|NCT02243839|Thrombolytic therapy|thrombolytic therapy
1153883|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
1153884|NCT02243826|Lumbar puncture|lumbar puncture
1153885|NCT02243826|Adults|adults
1153886|NCT02243826|Nitrous oxide|nitrous oxide
1153887|NCT02243826|Procedural pain|procedural pain
1153888|NCT02243826|Procedural anxiety|procedural anxiety
1153889|NCT02243813|Psilocybin|psilocybin
1153890|NCT02243813|Pharmacologic Actions|pharmacologic actions
1153891|NCT02243813|Psychotropic Drugs|psychotropic drugs
1153892|NCT02243800|Vitamin D|vitamin d
1153893|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
1153894|NCT02243800|Cholecalciferol|cholecalciferol
1153895|NCT02243774|Vaccination|vaccination
1153896|NCT02243774|Immunization|immunization
1153898|NCT02243774|Prevention & Control|prevention & control
1153899|NCT02243774|Preventive Measures|preventive measures
1153900|NCT02243774|Health Promotion|health promotion
1153901|NCT02243774|Medicare|medicare
1153902|NCT02243774|Intention Prompts|intention prompts
1153903|NCT02243774|Letters|letters
1153904|NCT02243761|Concurrent Disorders|concurrent disorders
1153905|NCT02243761|Mental Health|mental health
1153906|NCT02243761|Addictions|addictions
1153907|NCT02243761|Caregiver Burden|caregiver burden
1153908|NCT02243722|laryngeal electromyography|laryngeal electromyography
1153909|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
1153910|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
1153911|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
1153912|NCT02243722|laryngeal sensation|laryngeal sensation
1153913|NCT02243722|tone language|tone language
1153914|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
1153915|NCT02243670|opioid addiction|opioid addiction
1153916|NCT02243670|opioid substitution therapy|opioid substitution therapy
1153917|NCT02243670|addiction|addiction
1153918|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
1153919|NCT02243670|opioid dependence|opioid dependence
1153920|NCT02243670|substitution treatment|substitution treatment
1153921|NCT02243670|noncompliance|noncompliance
1153922|NCT02243670|opiate addiction|opiate addiction
1153923|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
1153924|NCT02243670|adherence monitoring|adherence monitoring
1153925|NCT02243670|directly observed therapy|directly observed therapy
1153926|NCT02243670|medication adherence|medication adherence
1153927|NCT02243670|adherence|adherence
1153928|NCT02243670|mobile|mobile
1153929|NCT02243670|electronic monitoring|electronic monitoring
1153930|NCT02243670|wireless|wireless
1153931|NCT02243670|mobile device|mobile device
1153932|NCT02243670|artificial intelligence|artificial intelligence
1153933|NCT02243670|facial recognition|facial recognition
1153934|NCT02243670|computer vision|computer vision
1153935|NCT02243670|visual confirmation|visual confirmation
1153936|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
1153937|NCT02243670|nonadherence|nonadherence
1153938|NCT02243657|ASP3652|asp3652
1153939|NCT02243657|Age|age
1153940|NCT02243657|Gender|gender
1153941|NCT02243657|Pharmacokinetics|pharmacokinetics
1153942|NCT02243657|Pharmacodynamics|pharmacodynamics
1153943|NCT02243657|Phase 1|phase 1
1153944|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
1153945|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
1153946|NCT02243631|ATP|atp
1153947|NCT02243631|Probenecid|probenecid
1153948|NCT02243631|Chondrocalcinosis|chondrocalcinosis
1153949|NCT02243527|Exercise|exercise
1153950|NCT02243514|Hypertension|hypertension
1153951|NCT02243514|Heart failure|heart failure
1153952|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
1153953|NCT02243514|Renal nerve|renal nerve
1153954|NCT02243514|Remodeling|remodeling
1153955|NCT02243514|Nerve remodeling|nerve remodeling
1153956|NCT02243488|Menstruation|menstruation
1153957|NCT02243488|MHM|mhm
1153958|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
1153959|NCT02243488|Girls Education|girls education
1153960|NCT02243488|Absenteeism|absenteeism
1153961|NCT02243488|Access to Education|access to education
1153962|NCT02243488|Menstrual Health Education|menstrual health education
1153963|NCT02243488|Reusable Sanitary Product|reusable sanitary product
1153964|NCT02243462|Shivering|shivering
1153965|NCT02243462|Hypothermia|hypothermia
1153966|NCT02243462|Postoperative|postoperative
1153967|NCT02243462|Temperature|temperature
1153968|NCT02243462|Forced air warmer|forced air warmer
1153969|NCT02243449|mechanical ventilation|mechanical ventilation
1153970|NCT02243449|weaning|weaning
1153971|NCT02243449|elderly|elderly
1153972|NCT02243449|critically ill|critically ill
1153973|NCT02243449|screening|screening
1153974|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
1153975|NCT02243449|invasive ventilation|invasive ventilation
1153976|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
1153977|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
1153978|NCT02243436|LYMPHOMA|lymphoma
1153980|NCT02243423|Aortocaval compression|aortocaval compression
1153981|NCT02243423|Cesarean Section|cesarean section
1153982|NCT02243423|Spinal Anesthesia|spinal anesthesia
1153983|NCT02243423|Phenylephrine|phenylephrine
1153984|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
1153985|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
1153986|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
1153987|NCT02243384|Micrometastases|micrometastases
1153988|NCT02243358|Pancreatic, cancer|pancreatic, cancer
1153989|NCT02243345|decompression|decompression
1153990|NCT02243345|recompression|recompression
1153991|NCT02243345|delayed|delayed
1153992|NCT02243345|late|late
1153993|NCT02243332|Knee|knee
1153994|NCT02243332|Pain|pain
1153995|NCT02243332|Joint|joint
1153996|NCT02243332|Rehabilitation|rehabilitation
1153997|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
1153998|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
1153999|NCT02243332|Knee Pain|knee pain
1154000|NCT02243332|Quadriceps|quadriceps
1154001|NCT02243306|pharmacokinetics|pharmacokinetics
1154002|NCT02243306|Chronic kidney disease|chronic kidney disease
1154003|NCT02243306|peritoneal dialysis|peritoneal dialysis
1154004|NCT02243306|hemoglobin|hemoglobin
1154005|NCT02243306|Anemia|anemia
1154006|NCT02243306|GSK1278863|gsk1278863
1154007|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1154008|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1154009|NCT02243293|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1154010|NCT02243293|Hepatitis C|hepatitis c
1154011|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
1154012|NCT02243293|interferon free|interferon free
1154013|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
1154014|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
1154015|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
1154016|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
1154017|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
1154018|NCT02243280|HCV GT4|hcv gt4
1154019|NCT02243280|Hepatitis C virus|hepatitis c virus
1154020|NCT02243280|HCV GT1|hcv gt1
1154021|NCT02243280|HCV|hcv
1154022|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
1154023|NCT02243280|HCV GT6|hcv gt6
1154024|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
1154025|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
1154026|NCT02243280|RBV|rbv
1154027|NCT02243280|Cirrhotic|cirrhotic
1154028|NCT02243280|Hepatitis C|hepatitis c
1154029|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
1154030|NCT02243280|IFN free|ifn free
1154031|NCT02243280|HCV GT5|hcv gt5
1154032|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
1154033|NCT02243280|Ribavirin|ribavirin
1154034|NCT02243280|Child Pugh A|child pugh a
1154035|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
1154036|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
1154037|NCT02243280|ABT-493|abt-493
1154038|NCT02243280|ABT-530|abt-530
1154039|NCT02243280|glecaprevir|glecaprevir
1154040|NCT02243280|pibrentasvir|pibrentasvir
1154041|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
1154042|NCT02243241|Healthy volunteers|healthy volunteers
1154043|NCT02243241|Opioid|opioid
1154044|NCT02243241|ECG|ecg
1154045|NCT02243241|QTcI|qtci
1154046|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
1154047|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
1154048|NCT02243215|Laparoscopy|laparoscopy
1154049|NCT02243215|Training|training
1154050|NCT02243215|Off-site|off-site
1154051|NCT02243215|Box trainer|box trainer
1154052|NCT02243215|Virtual Reality Simulator|virtual reality simulator
1154053|NCT02243202|Obesity|obesity
1154054|NCT02243202|Overweight|overweight
1154055|NCT02243202|Canagliflozin|canagliflozin
1154056|NCT02243202|Phentermine|phentermine
1154057|NCT02243202|INVOKANA®|invokana®
1154058|NCT02243189|Healthy|healthy
1154059|NCT02243189|Asthma|asthma
1154060|NCT02243189|JNJ-43260295|jnj-43260295
1154061|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
1154062|NCT02243176|Saxagliptin|saxagliptin
1154063|NCT02243176|Acarbose|acarbose
1154064|NCT02243176|Type 2 Diabetes|type 2 diabetes
1154065|NCT02243176|Metformin|metformin
1154066|NCT02243124|Anemia|anemia
1154067|NCT02243124|Transfusion|transfusion
1154068|NCT02243124|AML|aml
1154069|NCT02243124|MDS|mds
1154070|NCT02243124|CLL|cll
1154071|NCT02243124|p53|p53
1154072|NCT02243124|erythropoiesis|erythropoiesis
1154073|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
1154667|NCT02239926|IBS-D|ibs-d
1154074|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
1154075|NCT02243072|family therapy|family therapy
1154076|NCT02243072|adolescents|adolescents
1154077|NCT02243072|regimen adherence|regimen adherence
1154078|NCT02243072|metabolic control|metabolic control
1154079|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
1154080|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
1154081|NCT02243059|Nodal imaging|nodal imaging
1154082|NCT02243033|Prostate cancer|prostate cancer
1154083|NCT02243033|Focal therapy|focal therapy
1154084|NCT02243033|Laser therapy|laser therapy
1154085|NCT02243033|Transrectal|transrectal
1154086|NCT02243033|MRI-guided|mri-guided
1154087|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
1154088|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
1154089|NCT02242968|Licensed Vaccines|licensed vaccines
1154090|NCT02242968|Blood Draw|blood draw
1154091|NCT02242968|Investigational Vaccines|investigational vaccines
1154092|NCT02242968|Healthy Volunteers|healthy volunteers
1154093|NCT02242968|Eligibility Screening|eligibility screening
1154094|NCT02242955|Alcohol-dependence|alcohol-dependence
1154096|NCT02242955|Detoxification|detoxification
1154097|NCT02242955|Diazepam|diazepam
1154098|NCT02242955|Benzodiazepines|benzodiazepines
1154099|NCT02242955|Anxiety|anxiety
1154396|NCT02241317|Education|education
1154100|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
1154101|NCT02242929|Treatment|treatment
1154102|NCT02242929|Imiquimod|imiquimod
1154103|NCT02242929|Curettage|curettage
1154104|NCT02242929|Surgery|surgery
1154105|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
1154106|NCT02242916|re-irradiation|re-irradiation
1154107|NCT02242916|photon|photon
1154108|NCT02242916|proton|proton
1154109|NCT02242916|carbon-ion|carbon-ion
1154110|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
1154111|NCT02242890|social networks|social networks
1154112|NCT02242890|social influence|social influence
1154113|NCT02242890|diffusion of innovation|diffusion of innovation
1154114|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
1154115|NCT02242890|LARC|larc
1154116|NCT02242799|Malaria|malaria
1154117|NCT02242799|HIV|hiv
1154118|NCT02242799|Dolutegravir|dolutegravir
1154119|NCT02242799|Artemisinin|artemisinin
1154120|NCT02242799|Pharmacokinetics|pharmacokinetics
1154121|NCT02242799|Interactions|interactions
1154122|NCT02242773|Prostate Cancer|prostate cancer
1154123|NCT02242773|Active Surveillance|active surveillance
1154124|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
1154125|NCT02242773|Multi-parametric MRI|multi-parametric mri
1154126|NCT02242773|MP-MRI|mp-mri
1154127|NCT02242760|acne|acne
1154128|NCT02242747|actinic keratosis|actinic keratosis
1154129|NCT02242747|field cancerization|field cancerization
1154130|NCT02242747|ingenol mebutate|ingenol mebutate
1154131|NCT02242747|5-fluorouracil|5-fluorouracil
1154132|NCT02242747|tolerability|tolerability
1154133|NCT02242747|safety|safety
1154134|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
1154135|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
1154136|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
1154137|NCT02242695|dequalinium chloride|dequalinium chloride
1154138|NCT02242695|Fluomizin|fluomizin
1154139|NCT02242695|clotrimazole|clotrimazole
1154140|NCT02242695|canesten|canesten
1154141|NCT02242656|Short Bowel Syndrome|short bowel syndrome
1154142|NCT02242656|SBS|sbs
1154143|NCT02242656|Chronic Diarrhea|chronic diarrhea
1154144|NCT02242656|Short Bowel|short bowel
1154145|NCT02242656|Short Gut|short gut
1154146|NCT02242656|Short Gut Syndrome|short gut syndrome
1154147|NCT02242656|Anti-Diarrheal|anti-diarrheal
1154148|NCT02242656|Opium Tincture|opium tincture
1154149|NCT02242656|loperamide|loperamide
1154150|NCT02242656|diphenoxylate|diphenoxylate
1154151|NCT02242656|ileostomies|ileostomies
1154152|NCT02242656|tincture of opium|tincture of opium
1154153|NCT02242656|DTO|dto
1154154|NCT02242656|codeine|codeine
1154155|NCT02242656|morphine|morphine
1154156|NCT02242656|opiate|opiate
1154157|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
1154158|NCT02242643|Comparator|comparator
1154159|NCT02242643|Children|children
1154160|NCT02242643|Seasonal influenza|seasonal influenza
1154161|NCT02242643|Safety|safety
1154162|NCT02242643|Immunogenicity|immunogenicity
1154163|NCT02242630|Subacromial bursitis|subacromial bursitis
1154164|NCT02242630|Triamcinolone|triamcinolone
1154165|NCT02242630|Methylprednisolone|methylprednisolone
1154166|NCT02242630|Shoulder pain|shoulder pain
1154167|NCT02242617|Adherence|adherence
1154168|NCT02242617|CPAP|cpap
1154169|NCT02242617|Oral Appliance|oral appliance
1154170|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
1154171|NCT02242617|Preference|preference
1154172|NCT02242591|Knee surgery|knee surgery
1154173|NCT02242591|Saphenous nerve|saphenous nerve
1154174|NCT02242591|Perineural block|perineural block
1154175|NCT02242591|Adductor Canal Block|adductor canal block
1154176|NCT02242591|Postoperative Pain|postoperative pain
1154177|NCT02242591|Mobilization|mobilization
1154178|NCT02242578|Negative symptoms|negative symptoms
1154179|NCT02242565|HIV prevention|hiv prevention
1154180|NCT02242565|ShangRing|shangring
1154181|NCT02242565|adverse events|adverse events
1154182|NCT02242565|wound healing|wound healing
1154183|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
1154184|NCT02242565|medical device|medical device
1154185|NCT02242565|Zambia|zambia
1154186|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
1154187|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
1154188|NCT02242513|Plantar Fasciitis|plantar fasciitis
1154189|NCT02242513|Ultrasound-guided|ultrasound-guided
1154190|NCT02242500|Gingival recession/surgery|gingival recession/surgery
1154191|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
1154192|NCT02242500|Root coverage|root coverage
1154193|NCT02242500|Treatment outcome|treatment outcome
1154194|NCT02242487|Parkinson's Disease|parkinson's disease
1154195|NCT02242487|Motor fluctuations|motor fluctuations
1154196|NCT02242487|levodopa|levodopa
1154197|NCT02242487|inhaled drugs|inhaled drugs
1154198|NCT02242487|OFF episodes|off episodes
1154199|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
1154200|NCT02242474|Surgical Wound Infection|surgical wound infection
1154201|NCT02242474|Surgical Site Infection|surgical site infection
1154598|NCT02240290|Dosimetry|dosimetry
1154202|NCT02242474|Antirheumatic Agents|antirheumatic agents
1154203|NCT02242474|Perioperative Care|perioperative care
1154204|NCT02242474|Anti-TNF|anti-tnf
1154205|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
1154206|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
1154207|NCT02242448|Healthy Volunteer|healthy volunteer
1154208|NCT02242448|Contrast|contrast
1154209|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
1154210|NCT02242409|Second Line treatment|second line treatment
1154211|NCT02242409|Gemcitabine|gemcitabine
1154212|NCT02242409|Nab-paclitaxel|nab-paclitaxel
1154213|NCT02242188|Breastfeeding|breastfeeding
1154214|NCT02242188|Iron supplementation|iron supplementation
1154215|NCT02242188|Psychomotor development|psychomotor development
1154216|NCT02242188|Safety|safety
1154217|NCT02242188|infants|infants
1154218|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
1154219|NCT02242149|Fat liver|fat liver
1154220|NCT02242149|Diabetes|diabetes
1154221|NCT02242149|Diacerein|diacerein
1154222|NCT02242149|Transient elastography|transient elastography
1154223|NCT02242149|Treatment|treatment
1154224|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
1154225|NCT02242136|Aggressive Behavior|aggressive behavior
1154226|NCT02242136|Appetitive Aggression|appetitive aggression
1154227|NCT02242136|Treatment|treatment
1154228|NCT02242136|FORNET|fornet
1154229|NCT02242123|Celiac Disease|celiac disease
1154230|NCT02242123|Gluten-free diet|gluten-free diet
1154231|NCT02242123|EmA assay|ema assay
1154232|NCT02242123|Duodenal culture medium|duodenal culture medium
1154233|NCT02242110|Nightmares|nightmares
1154234|NCT02242110|Sleep|sleep
1154235|NCT02242110|PTSD|ptsd
1154236|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
1154237|NCT02242071|Motor Neuron Disease|motor neuron disease
1154238|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1154239|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
1154240|NCT02242071|Stem cells|stem cells
1154241|NCT02242032|dry eye disease|dry eye disease
1154242|NCT02241993|glucose sensor|glucose sensor
1154243|NCT02241993|Inter-sensor distance|inter-sensor distance
1154244|NCT02241967|total knee arthroplasty|total knee arthroplasty
1154245|NCT02241967|pain|pain
1154246|NCT02241967|post-surgical pain|post-surgical pain
1154247|NCT02241967|opioid|opioid
1154248|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
1154249|NCT02241967|tDCS|tdcs
1154250|NCT02241967|brain stimulation|brain stimulation
1154251|NCT02241967|total hip arthroplasty|total hip arthroplasty
1154252|NCT02241967|TKA|tka
1154253|NCT02241967|THA|tha
1154254|NCT02241928|Muscular Dystrophy|muscular dystrophy
1154255|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
1154256|NCT02241928|Stem Cell|stem cell
1154257|NCT02241889|diabetes|diabetes
1154258|NCT02241889|closed-loop|closed-loop
1154259|NCT02241889|bi-hormonal|bi-hormonal
1154260|NCT02241889|exercise|exercise
1154261|NCT02241863|bipolar disorders|bipolar disorders
1154262|NCT02241863|medication adherence|medication adherence
1154263|NCT02241863|psychological intervention|psychological intervention
1154264|NCT02241863|multifaceted intervention|multifaceted intervention
1154265|NCT02241850|High Intensity Training|high intensity training
1154266|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
1154267|NCT02241850|Genome Wide association study|genome wide association study
1154268|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
1154269|NCT02241850|Subjects|subjects
1154270|NCT02241837|heart failure|heart failure
1154271|NCT02241837|percutaneous|percutaneous
1154272|NCT02241837|interventional cardiology|interventional cardiology
1154273|NCT02241837|apical remodeling|apical remodeling
1154274|NCT02241837|LV dilatation|lv dilatation
1154275|NCT02241837|akinesis|akinesis
1154276|NCT02241837|dyskinesis|dyskinesis
1154277|NCT02241837|myocardial infarction|myocardial infarction
1154278|NCT02241824|Lumbar Orthosis|lumbar orthosis
1154279|NCT02241824|Lumbar brace|lumbar brace
1154280|NCT02241811|Diabetic|diabetic
1154282|NCT02241811|Wound|wound
1154283|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
1154284|NCT02241811|Hydrogel|hydrogel
1154285|NCT02241798|epilepsy|epilepsy
1154286|NCT02241798|oxygen saturation|oxygen saturation
1154287|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
1154288|NCT02241798|sudep|sudep
1154289|NCT02241798|pre-oxygenation|pre-oxygenation
1154290|NCT02241733|exercise|exercise
1154291|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
1154292|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
1154293|NCT02241707|Varicose vein|varicose vein
1154294|NCT02241707|Endovenous ablation|endovenous ablation
1154295|NCT02241707|Compression|compression
1154296|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
1154297|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
1154298|NCT02241681|Peptamen 1.5|peptamen 1.5
1154299|NCT02241668|Brain tumor|brain tumor
1154300|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
1154301|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
1154302|NCT02241668|FLT PET|flt pet
1154303|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
1154304|NCT02241668|MRI|mri
1154305|NCT02241655|Anesthesia|anesthesia
1154306|NCT02241655|Electroencephalography|electroencephalography
1154307|NCT02241655|Burst suppression|burst suppression
1154308|NCT02241655|Surgery|surgery
1154309|NCT02241655|Delirium|delirium
1154310|NCT02241655|Falls|falls
1154311|NCT02241655|Health related quality of life|health related quality of life
1154312|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
1154313|NCT02241642|vascular closure device|vascular closure device
1154314|NCT02241642|Large hole closure device|large hole closure device
1154315|NCT02241629|motion sickness|motion sickness
1154316|NCT02241603|Insulin resistance|insulin resistance
1154317|NCT02241603|Consummatory Reward|consummatory reward
1154318|NCT02241577|peri-implantitis|peri-implantitis
1154319|NCT02241577|dental implants|dental implants
1154320|NCT02241577|randomized controlled trial|randomized controlled trial
1154321|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
1154322|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
1154323|NCT02241564|Immunosuppression|immunosuppression
1154324|NCT02241551|Borderline|borderline
1154325|NCT02241551|Resectable|resectable
1154326|NCT02241551|Pancreatic|pancreatic
1154327|NCT02241551|Cancer|cancer
1154328|NCT02241551|Neoadjuvant|neoadjuvant
1154329|NCT02241551|Chemotheraphy|chemotheraphy
1154330|NCT02241551|Gemcitabine|gemcitabine
1154331|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
1154332|NCT02241551|mFOFIRINOX|mfofirinox
1154333|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
1154334|NCT02241538|Pilates-based exercises|pilates-based exercises
1154335|NCT02241525|Pulmonary|pulmonary
1154336|NCT02241525|Thromboembolic|thromboembolic
1154337|NCT02241525|Lung|lung
1154338|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
1154339|NCT02241512|pediatric|pediatric
1154340|NCT02241512|ibuprofen|ibuprofen
1154341|NCT02241499|Digestive System Diseases|digestive system diseases
1154342|NCT02241499|Esophageal cancer|esophageal cancer
1154343|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
1154344|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1154345|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
1154346|NCT02241499|Endoscopic response|endoscopic response
1154347|NCT02241499|Fluorouracil|fluorouracil
1154348|NCT02241499|Metabolic response|metabolic response
1154349|NCT02241499|Oxaliplatin|oxaliplatin
1154350|NCT02241499|Radiotherapy|radiotherapy
1154351|NCT02241486|Burn pain|burn pain
1154352|NCT02241486|Procedural pain|procedural pain
1154353|NCT02241486|Sublingual fentanyl|sublingual fentanyl
1154354|NCT02241486|Morphine|morphine
1154355|NCT02241473|gait|gait
1154356|NCT02241473|physical activity|physical activity
1154357|NCT02241473|energy cost|energy cost
1154358|NCT02241473|efficiency|efficiency
1154359|NCT02241460|Premature Ejaculation|premature ejaculation
1154360|NCT02241460|Lidocaine|lidocaine
1154361|NCT02241447|aortic valve Stenosis|aortic valve stenosis
1154362|NCT02241447|Echo|echo
1154363|NCT02241447|TAVI|tavi
1154364|NCT02241447|SAVR|savr
1154365|NCT02241447|referral|referral
1154366|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
1154367|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
1154368|NCT02241434|Stem Cells|stem cells
1154369|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
1154370|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
1154371|NCT02241421|Metabolic Diseases|metabolic diseases
1154372|NCT02241421|Endocrine System Diseases|endocrine system diseases
1154373|NCT02241421|Hyperinsulinism|hyperinsulinism
1154374|NCT02241421|Lipid metabolism|lipid metabolism
1154375|NCT02241421|Anti Bacterial Agents|anti bacterial agents
1154376|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
1154377|NCT02241395|Cerebral Palsy|cerebral palsy
1154378|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
1154379|NCT02241395|stem cell|stem cell
1154380|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
1154381|NCT02241369|Human Papillomavirus|human papillomavirus
1154382|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
1154383|NCT02241356|Down syndrome|down syndrome
1154384|NCT02241356|visual functions|visual functions
1154385|NCT02241356|bifocals|bifocals
1154386|NCT02241356|children|children
1154387|NCT02241356|visual acuity at near|visual acuity at near
1154388|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
1154389|NCT02241330|Zinc|zinc
1154390|NCT02241330|deficiency|deficiency
1154391|NCT02241330|biofortification|biofortification
1154392|NCT02241330|wheat|wheat
1154393|NCT02241317|Diabetes mellitus|diabetes mellitus
1154394|NCT02241317|Hypoglycaemia|hypoglycaemia
1154395|NCT02241317|staff training|staff training
1154397|NCT02241317|blood glucose|blood glucose
1154398|NCT02241304|electromyography|electromyography
1154399|NCT02241304|neuromuscular blockade|neuromuscular blockade
1154400|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
1154401|NCT02241291|Registries|registries
1154402|NCT02241278|colon surgery|colon surgery
1154403|NCT02241278|ketamine|ketamine
1154404|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
1154405|NCT02241278|preemptive analgesia|preemptive analgesia
1154406|NCT02241265|asthma|asthma
1154407|NCT02241265|thermoplasty|thermoplasty
1154408|NCT02241252|ECG|ecg
1154409|NCT02241252|QT interval|qt interval
1154410|NCT02241252|Sotalol|sotalol
1154411|NCT02241252|Dofetilide|dofetilide
1154412|NCT02241252|iPhone|iphone
1154413|NCT02241226|wellbeing|wellbeing
1154414|NCT02241226|meditation|meditation
1154415|NCT02241226|Ayurveda|ayurveda
1154416|NCT02241226|yoga|yoga
1154417|NCT02241226|herbs|herbs
1154418|NCT02241226|health|health
1154419|NCT02241226|longevity|longevity
1154420|NCT02241226|individuals|individuals
1154421|NCT02241213|Stroke|stroke
1154422|NCT02241213|Aphasia|aphasia
1154423|NCT02241213|Broca|broca
1154424|NCT02241187|PEGPH20|pegph20
1154425|NCT02241187|Cetuximab|cetuximab
1154426|NCT02241187|14-039|14-039
1154427|NCT02241174|Atopic Dermatitis|atopic dermatitis
1154428|NCT02241161|skin eythema|skin eythema
1154429|NCT02241161|rejuvenating cream|rejuvenating cream
1154430|NCT02241161|rejuvenating serum|rejuvenating serum
1154431|NCT02241161|antioxidant serum|antioxidant serum
1154432|NCT02241135|Rav G protein|rav g protein
1154433|NCT02241135|rabies|rabies
1154435|NCT02241135|immunogenicity|immunogenicity
1154436|NCT02241135|PrEP vaccination|prep vaccination
1154437|NCT02241135|mRNA|mrna
1154438|NCT02241135|CV7201|cv7201
1154439|NCT02241122|prostate cancer|prostate cancer
1154440|NCT02241122|PSA|psa
1154441|NCT02241122|MRI|mri
1154442|NCT02241122|biopsy|biopsy
1154443|NCT02241122|biomarker|biomarker
1154444|NCT02241109|aortic stenosis progression|aortic stenosis progression
1154445|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
1154446|NCT02241109|calcification propensity|calcification propensity
1154447|NCT02241070|mindfulness meditation|mindfulness meditation
1154448|NCT02241070|mental health promotion|mental health promotion
1154449|NCT02241070|worker|worker
1154450|NCT02241057|temperature profile|temperature profile
1154451|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
1154452|NCT02241057|adhesion|adhesion
1154453|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
1154454|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
1154455|NCT02241031|Hematological Diseases|hematological diseases
1154456|NCT02241031|Thrombocytopenia|thrombocytopenia
1154457|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1154458|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
1154459|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
1154460|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
1154461|NCT02241005|Health-care associated infection|health-care associated infection
1154462|NCT02241005|Skin integrity|skin integrity
1154463|NCT02241005|Antimicrobial resistance|antimicrobial resistance
1154464|NCT02240992|Poor Graft Function|poor graft function
1154465|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
1154466|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
1154467|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
1154468|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1154469|NCT02240979|arterial waveform|arterial waveform
1154470|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1154471|NCT02240979|echocardiography|echocardiography
1154472|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
1154473|NCT02240966|Testicular Neoplasms|testicular neoplasms
1154474|NCT02240966|Hypogonadism|hypogonadism
1154475|NCT02240966|Metabolic Syndrome|metabolic syndrome
1154476|NCT02240966|Treatment related late effects|treatment related late effects
1154477|NCT02240953|Anticoagulation|anticoagulation
1154478|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
1154479|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
1154480|NCT02240953|Warfarin|warfarin
1154481|NCT02240953|Thrombosis|thrombosis
1154482|NCT02240940|Heart Failure|heart failure
1154483|NCT02240940|Volume Reduction|volume reduction
1154484|NCT02240940|Pressure Reduction|pressure reduction
1154485|NCT02240940|Ischemic Heart Failure|ischemic heart failure
1154486|NCT02240940|LAD Infarct|lad infarct
1154487|NCT02240927|Anticoagulation|anticoagulation
1154488|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
1154489|NCT02240927|Pregnancy|pregnancy
1154490|NCT02240927|Warfarin|warfarin
1154491|NCT02240927|Thrombosis|thrombosis
1154492|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
1154493|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
1154494|NCT02240914|Cockett Syndrome|cockett syndrome
1154495|NCT02240914|Vascular Ultrasound|vascular ultrasound
1154496|NCT02240914|IVUS|ivus
1154497|NCT02240901|Laryngeal mask airway|laryngeal mask airway
1154498|NCT02240901|endotracheal intubation|endotracheal intubation
1154499|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
1154500|NCT02240901|elderly patients|elderly patients
1154501|NCT02240888|pneumococcal|pneumococcal
1154502|NCT02240888|vaccination|vaccination
1154503|NCT02240888|antibody|antibody
1154504|NCT02240888|response|response
1154505|NCT02240888|immunosuppressive|immunosuppressive
1154506|NCT02240888|treatment|treatment
1154507|NCT02240888|inflammatory|inflammatory
1154508|NCT02240888|rheumatic|rheumatic
1154509|NCT02240888|disease|disease
1154510|NCT02240875|Ebola|ebola
1154511|NCT02240875|Zaire|zaire
1154512|NCT02240849|Neck pain|neck pain
1154513|NCT02240849|functional pillow|functional pillow
1154514|NCT02240849|sleep|sleep
1154515|NCT02240849|cervical lordosis|cervical lordosis
1154516|NCT02240823|Erectile Function|erectile function
1154517|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
1154518|NCT02240823|Stem Cell|stem cell
1154519|NCT02240797|Anorexia Nervosa|anorexia nervosa
1154520|NCT02240797|Neuroimaging|neuroimaging
1154521|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
1154522|NCT02240797|[11C]PKAB|[11c]pkab
1154523|NCT02240784|Porphyria|porphyria
1154525|NCT02240784|VP|vp
1154526|NCT02240784|HCP|hcp
1154527|NCT02240784|Variegate|variegate
1154528|NCT02240784|Coproporphyria|coproporphyria
1154529|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
1154530|NCT02240771|Thalidomide|thalidomide
1154531|NCT02240771|Capecitabine|capecitabine
1154532|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
1154533|NCT02240745|Echocardiography, Stress|echocardiography, stress
1154534|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
1154535|NCT02240745|Coronary Artery Disease|coronary artery disease
1154536|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1154537|NCT02240745|Coronary Circulation|coronary circulation
1154538|NCT02240615|Epiphora|epiphora
1154539|NCT02240615|Lacrimal Stent|lacrimal stent
1154540|NCT02240615|Lacrimal System|lacrimal system
1154541|NCT02240602|acute pain|acute pain
1154542|NCT02240602|postoperative|postoperative
1154543|NCT02240602|surgery|surgery
1154544|NCT02240589|Traumatic Brain Injury|traumatic brain injury
1154545|NCT02240589|Memantine|memantine
1154546|NCT02240589|Memory|memory
1154547|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
1154548|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
1154549|NCT02240563|LLLT|lllt
1154550|NCT02240563|safety|safety
1154551|NCT02240563|ultrasound|ultrasound
1154552|NCT02240550|Open Inguinal Hernia|open inguinal hernia
1154553|NCT02240537|AML|aml
1154554|NCT02240537|MM|mm
1154555|NCT02240537|MDS|mds
1154556|NCT02240537|sMM|smm
1154557|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
1154558|NCT02240524|HIPEC|hipec
1154559|NCT02240524|Paclitaxel|paclitaxel
1154560|NCT02240524|Oxaliplatin|oxaliplatin
1154561|NCT02240524|Capecitabine|capecitabine
1154562|NCT02240511|Body Composition|body composition
1154563|NCT02240511|Amino Acids Supplementation|amino acids supplementation
1154564|NCT02240511|Resistance Exercise|resistance exercise
1154565|NCT02240498|Abscess|abscess
1154566|NCT02240498|Drainage|drainage
1154567|NCT02240485|Pathological gambling|pathological gambling
1154568|NCT02240485|Treatment|treatment
1154569|NCT02240485|Marital relationship|marital relationship
1154570|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
1154571|NCT02240459|crossover study|crossover study
1154668|NCT02239913|Cocaine|cocaine
1154572|NCT02240459|placebo controlled|placebo controlled
1154573|NCT02240459|double blind|double blind
1154574|NCT02240459|overactive bladder|overactive bladder
1154575|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
1154576|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
1154577|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
1154578|NCT02240407|Pompe Disease|pompe disease
1154579|NCT02240407|Gene Therapy|gene therapy
1154580|NCT02240407|Repeated dosing|repeated dosing
1154581|NCT02240407|Immune modulation|immune modulation
1154582|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
1154583|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
1154584|NCT02240368|Children anesthesia|children anesthesia
1154585|NCT02240368|Bispectral monitor|bispectral monitor
1154586|NCT02240368|Entropy monitor|entropy monitor
1154587|NCT02240342|Ovarian reserve|ovarian reserve
1154588|NCT02240342|Poor response|poor response
1154589|NCT02240342|Follicle recruitment|follicle recruitment
1154590|NCT02240342|Bone marrow transplant|bone marrow transplant
1154591|NCT02240329|respiratory|respiratory
1154592|NCT02240329|cough|cough
1154593|NCT02240303|pain|pain
1154594|NCT02240303|mobility|mobility
1154595|NCT02240303|brain|brain
1154596|NCT02240303|cognition|cognition
1154597|NCT02240290|C14|c14
1154599|NCT02240290|Mass balance|mass balance
1154600|NCT02240290|ADME|adme
1154601|NCT02240277|Septic Shock|septic shock
1154602|NCT02240277|Meropenem|meropenem
1154603|NCT02240277|Ciprofloxacin|ciprofloxacin
1154604|NCT02240277|Pharmacokinetics|pharmacokinetics
1154605|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
1154606|NCT02240264|Cognitive function|cognitive function
1154607|NCT02240264|Academic performance|academic performance
1154608|NCT02240264|Mental health|mental health
1154609|NCT02240264|Eye tracking|eye tracking
1154610|NCT02240264|Krill oil|krill oil
1154611|NCT02240264|LCPUFA|lcpufa
1154612|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
1154613|NCT02240251|IVC Filter|ivc filter
1154614|NCT02240251|IVC filter removal|ivc filter removal
1154615|NCT02240251|Excimer Laser|excimer laser
1154616|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
1154617|NCT02240212|second line treatment|second line treatment
1154618|NCT02240212|oncology|oncology
1154619|NCT02240212|AKT inhibitor|akt inhibitor
1154620|NCT02240212|paclitaxel|paclitaxel
1154621|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
1154622|NCT02240212|Afuresertib|afuresertib
1154623|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
1154624|NCT02240186|prosthesis|prosthesis
1154625|NCT02240186|amputation|amputation
1154626|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
1154628|NCT02240160|Pharmacokinetics|pharmacokinetics
1154629|NCT02240160|Oral pH|oral ph
1154630|NCT02240147|adult congenital heart disease|adult congenital heart disease
1154631|NCT02240147|exercise capacity|exercise capacity
1154632|NCT02240147|exercise training|exercise training
1154633|NCT02240147|physical activity|physical activity
1154634|NCT02240121|Crohn's Disease|crohn's disease
1154635|NCT02240121|Rifaximin|rifaximin
1154636|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
1154637|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
1154638|NCT02240108|Crohn's Disease|crohn's disease
1154639|NCT02240108|Rifaximin|rifaximin
1154640|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
1154641|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
1154642|NCT02240082|Shiftwork|shiftwork
1154643|NCT02240082|Sleep disruption|sleep disruption
1154644|NCT02240082|Stress|stress
1154645|NCT02240030|Parkinson's Disease|parkinson's disease
1154646|NCT02240030|Motor fluctuations|motor fluctuations
1154647|NCT02240030|levodopa|levodopa
1154648|NCT02240030|inhaled drugs|inhaled drugs
1154649|NCT02240030|OFF episodes|off episodes
1154650|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
1154651|NCT02239991|Point of care|point of care
1154652|NCT02239991|perioperative hemostasis|perioperative hemostasis
1154653|NCT02239991|thromboelastometry|thromboelastometry
1154654|NCT02239991|bleeding risk|bleeding risk
1154655|NCT02239991|end-stage liver disease|end-stage liver disease
1154656|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
1154657|NCT02239991|whole blood coagulation|whole blood coagulation
1154658|NCT02239978|Parkinson Disease|parkinson disease
1154659|NCT02239978|Posture Balance|posture balance
1154660|NCT02239978|Learning|learning
1154661|NCT02239978|Dopamine|dopamine
1154662|NCT02239965|Neuromuscular blockade|neuromuscular blockade
1154663|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
1154664|NCT02239965|Focus group interview|focus group interview
1154665|NCT02239965|Clinical observation|clinical observation
1154666|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
1154669|NCT02239913|Pharmacotherapy|pharmacotherapy
1154670|NCT02239913|Phentermine|phentermine
1154671|NCT02239913|Topiramate|topiramate
1154672|NCT02239913|Self-Administration|self-administration
1154673|NCT02239900|Liver Cancer|liver cancer
1154674|NCT02239900|Lung Cancer|lung cancer
1154675|NCT02239900|Adrenal Gland|adrenal gland
1154676|NCT02239900|Metastasis|metastasis
1154677|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
1154678|NCT02239900|Ipilimumab|ipilimumab
1154679|NCT02239900|Yervoy|yervoy
1154680|NCT02239900|BMS-734016|bms-734016
1154681|NCT02239900|MDX010|mdx010
1154682|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1154683|NCT02239900|SBRT|sbrt
1154685|NCT02239887|LAA occlusion|laa occlusion
1154686|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
1154687|NCT02239887|Percutaneous|percutaneous
1154688|NCT02239887|Oral Anticoagulation|oral anticoagulation
1154689|NCT02239887|Occluder|occluder
1154690|NCT02239887|WAVECREST|wavecrest
1154691|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
1154692|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
1154693|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1154694|NCT02239822|Electrodes, Implanted|electrodes, implanted
1154695|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
1154696|NCT02239809|Electrodes, Implanted|electrodes, implanted
1154697|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
1154698|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
1154699|NCT02239796|Randomised controlled trial|randomised controlled trial
1154700|NCT02239796|Feasibility|feasibility
1154701|NCT02239783|osteoarthritis|osteoarthritis
1154702|NCT02239783|avascular necrosis|avascular necrosis
1154703|NCT02239783|ankylosis|ankylosis
1154704|NCT02239783|protrusio acetabuli|protrusio acetabuli
1154705|NCT02239783|painful hip dysplasia|painful hip dysplasia
1154706|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
1154707|NCT02239783|correction of functional deformity|correction of functional deformity
1154708|NCT02239783|revision procedures|revision procedures
1154709|NCT02239770|Nicotine|nicotine
1154710|NCT02239770|Random Delivery|random delivery
1154711|NCT02239770|Smoking Cessation|smoking cessation
1154712|NCT02239770|Plasma Nicotine|plasma nicotine
1154713|NCT02239770|Oral Film|oral film
1333135|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
1218216|NCT01950351|XRT|xrt
1154714|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
1154715|NCT02239744|air pollution|air pollution
1154716|NCT02239744|air purification|air purification
1154717|NCT02239744|intervention|intervention
1154718|NCT02239744|randomized controlled trial|randomized controlled trial
1154719|NCT02239744|cardiovascular health|cardiovascular health
1154720|NCT02239744|pulmonary health|pulmonary health
1154721|NCT02239731|EGFRI|egfri
1154722|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
1154723|NCT02239731|Skin toxicity|skin toxicity
1154724|NCT02239731|Topical|topical
1154725|NCT02239731|Doxycycline|doxycycline
1154726|NCT02239731|Foam|foam
1154727|NCT02239731|Phase II|phase ii
1154728|NCT02239731|Cetuximab|cetuximab
1154729|NCT02239731|Panitumumab|panitumumab
1154730|NCT02239731|Vectibix|vectibix
1154731|NCT02239731|Erbitux|erbitux
1154732|NCT02239731|Rash|rash
1154733|NCT02239718|Resin bonded bridges|resin bonded bridges
1154734|NCT02239718|Clinical trial|clinical trial
1154735|NCT02239718|Prospective|prospective
1154736|NCT02239718|Survival|survival
1154737|NCT02239718|Oral health related quality of life|oral health related quality of life
1154738|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
1154739|NCT02239705|Hemodynamic|hemodynamic
1154740|NCT02239679|Actinic Keratosis|actinic keratosis
1154741|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
1154742|NCT02239614|dengue fever|dengue fever
1154743|NCT02239614|dengue|dengue
1154744|NCT02239601|Physical Therapy|physical therapy
1154745|NCT02239601|Physiotherapy|physiotherapy
1154746|NCT02239601|Breast Cancer|breast cancer
1154747|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
1154748|NCT02239601|Nerve gliding exercises|nerve gliding exercises
1154749|NCT02239601|Nerve Entrapment|nerve entrapment
1154750|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
1154751|NCT02239562|sPIF|spif
1154752|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
1154753|NCT02239562|Autoimmune|autoimmune
1154754|NCT02239562|Liver|liver
1154755|NCT02239562|Hepatitis|hepatitis
1154756|NCT02239549|Colonic Polyps|colonic polyps
1154757|NCT02239549|Polypectomy|polypectomy
1154758|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
1154759|NCT02239536|hot snare polypectomy|hot snare polypectomy
1154760|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
1154761|NCT02239523|Pathologic fracture|pathologic fracture
1154762|NCT02239523|Insufficiency fracture|insufficiency fracture
1154763|NCT02239523|Secondary fracture|secondary fracture
1154764|NCT02239523|Fracture with bone fragility|fracture with bone fragility
1154765|NCT02239523|Osteoporosis|osteoporosis
1154766|NCT02239523|Bone loss|bone loss
1154767|NCT02239523|Osteopenia|osteopenia
1154768|NCT02239523|Metabolic Bone Disease|metabolic bone disease
1154769|NCT02239523|Fragility fracture|fragility fracture
1154770|NCT02239510|constipation|constipation
1154771|NCT02239510|bowel habits|bowel habits
1154772|NCT02239497|postoperatory pain|postoperatory pain
1154773|NCT02239497|orthopaedic surgery|orthopaedic surgery
1154774|NCT02239497|femoral block|femoral block
1154775|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
1154776|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
1154777|NCT02239419|Critical Limb Ischemia|critical limb ischemia
1154778|NCT02239419|Limb Ischemia|limb ischemia
1154779|NCT02239419|Wound Care|wound care
1154780|NCT02239419|Hemodialysis|hemodialysis
1154781|NCT02239419|Dialysis|dialysis
1154782|NCT02239419|Skin Ulceration|skin ulceration
1154783|NCT02239406|metal on metal total hip|metal on metal total hip
1154784|NCT02239406|avasuclar necrosis|avasuclar necrosis
1154785|NCT02239406|acetabular revision|acetabular revision
1154786|NCT02239406|bone vascularity|bone vascularity
1154787|NCT02239393|Multiple Sclerosis|multiple sclerosis
1154788|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
1154790|NCT02239380|Lorazepam|lorazepam
1154791|NCT02239380|Status Epilepticus|status epilepticus
1154792|NCT02239341|hospitalized|hospitalized
1154793|NCT02239341|activity restriction|activity restriction
1154794|NCT02239341|bed rest|bed rest
1154795|NCT02239341|antepartum|antepartum
1154796|NCT02239341|pregnant|pregnant
1154797|NCT02239341|high risk|high risk
1154798|NCT02239328|Lung cancer|lung cancer
1154799|NCT02239328|esophageal cancer|esophageal cancer
1154800|NCT02239315|Breast cancers|breast cancers
1154801|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1154802|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
1154803|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
1154804|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
1154805|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
1154806|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
1154807|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
1154808|NCT02239302|Evacuation Proctography|evacuation proctography
1154809|NCT02239289|Low back pain|low back pain
1154810|NCT02239289|Rehabilitation|rehabilitation
1154811|NCT02239289|Biofeedback|biofeedback
1154812|NCT02239289|Electromyography|electromyography
1154813|NCT02239289|Kinematic|kinematic
1154814|NCT02239276|Stiripentol|stiripentol
1154815|NCT02239276|Dravet syndrome|dravet syndrome
1154816|NCT02239276|Epilepsy|epilepsy
1154817|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
1154818|NCT02239250|Child health|child health
1154819|NCT02239250|Pneumonia|pneumonia
1154820|NCT02239250|Diarrhoea|diarrhoea
1154821|NCT02239250|Household air pollution|household air pollution
1154822|NCT02239250|PM2.5|pm2.5
1154823|NCT02239250|Stove intervention|stove intervention
1154824|NCT02239250|Biomass fuel|biomass fuel
1154825|NCT02239250|Monitoring and evaluation|monitoring and evaluation
1154826|NCT02239250|Water filter|water filter
1154827|NCT02239250|Compliance|compliance
1154828|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
1154829|NCT02239250|Rwanda|rwanda
1154830|NCT02239224|FSHD|fshd
1154831|NCT02239211|BUTEO|buteo
1154832|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
1154833|NCT02239211|PSC|psc
1154834|NCT02239211|VAP-1|vap-1
1154835|NCT02239211|BTT1023|btt1023
1154836|NCT02239211|Human monoclonal antibody|human monoclonal antibody
1154837|NCT02239198|HDL|hdl
1154838|NCT02239198|nutrition bar|nutrition bar
1154839|NCT02239185|Laparoscopy|laparoscopy
1154840|NCT02239185|purse string|purse string
1154841|NCT02239185|hernial sac|hernial sac
1154842|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
1154843|NCT02239159|elderly patients|elderly patients
1154844|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
1154845|NCT02239133|POP|pop
1154846|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
1154847|NCT02239107|laparoscopic drilling|laparoscopic drilling
1154848|NCT02239107|clomiphene citrate|clomiphene citrate
1154849|NCT02239107|n acetyl cysteine|n acetyl cysteine
1154850|NCT02239107|insulin resistance|insulin resistance
1154851|NCT02239094|Bipolar Disorder|bipolar disorder
1154852|NCT02239094|depression|depression
1154853|NCT02239094|Bipolar depression|bipolar depression
1154854|NCT02239081|Pharmacokinetics|pharmacokinetics
1154855|NCT02239081|Safety|safety
1154856|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
1154857|NCT02239055|Borderline Personality Disorder|borderline personality disorder
1154858|NCT02239055|Mentalization Based Treatment|mentalization based treatment
1154859|NCT02239055|MBT Skills Training|mbt skills training
1154860|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
1154861|NCT02239055|Acute Mental Health|acute mental health
1154862|NCT02239042|Gingival recessions|gingival recessions
1154863|NCT02239029|Platelet rich plasma|platelet rich plasma
1154864|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
1154865|NCT02239029|Balance|balance
1154866|NCT02239029|Strength|strength
1154867|NCT02239016|Sickle cell disease|sickle cell disease
1154868|NCT02239016|Hgb SS|hgb ss
1154869|NCT02239016|Hgb SC|hgb sc
1154870|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
1154871|NCT02238977|depression|depression
1154872|NCT02238977|ESRD|esrd
1154873|NCT02238977|hemodialysis|hemodialysis
1154874|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
1154875|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
1154876|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
1154877|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
1154878|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
1154879|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
1154880|NCT02238925|Secondary AML|secondary aml
1154881|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
1154882|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
1154883|NCT02238925|MDS|mds
1154884|NCT02238912|tinea|tinea
1154885|NCT02238886|Quality of Life|quality of life
1154886|NCT02238886|Enteral nutrition|enteral nutrition
1154887|NCT02238886|Nutrition Therapy|nutrition therapy
1154888|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
1154889|NCT02238873|lymphoma|lymphoma
1154891|NCT02238873|pegfilgrastim|pegfilgrastim
1154892|NCT02238860|Hepatitis B|hepatitis b
1154893|NCT02238860|cirrhosis|cirrhosis
1154894|NCT02238860|Entacavir|entacavir
1154895|NCT02238860|enofovir|enofovir
1154896|NCT02238847|Pancreatic|pancreatic
1154897|NCT02238847|Pancreatic Cancer|pancreatic cancer
1154898|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
1154899|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
1154900|NCT02238834|Phase I|phase i
1154901|NCT02238834|Safety and tolerability|safety and tolerability
1154902|NCT02238834|Pharmacokinetic|pharmacokinetic
1154903|NCT02238834|Randomized|randomized
1154904|NCT02238834|Double Blind|double blind
1154905|NCT02238834|Placebo-Controlled|placebo-controlled
1569392|NCT00502762|refractory|refractory
1154906|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
1154907|NCT02238834|FP-025|fp-025
1154908|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
1154909|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
1154910|NCT02238808|ER+ breast cancer|er+ breast cancer
1154911|NCT02238808|Luminal A|luminal a
1154912|NCT02238808|Estradiol|estradiol
1154913|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
1154914|NCT02238782|bioavailability|bioavailability
1154915|NCT02238782|pharmacokinetics|pharmacokinetics
1154916|NCT02238782|I phase|i phase
1154917|NCT02238782|AZD6244|azd6244
1154918|NCT02238782|cancer|cancer
1154919|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
1154920|NCT02238730|Depression|depression
1154921|NCT02238730|Depressive Disorder|depressive disorder
1154922|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
1154923|NCT02238730|Bipolar Disorder|bipolar disorder
1154924|NCT02238730|Major Depressive Disorder|major depressive disorder
1154925|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
1154926|NCT02238717|Pain|pain
1154927|NCT02238717|evoked pain|evoked pain
1154928|NCT02238717|healthy volunteer|healthy volunteer
1154929|NCT02238717|pharmacodynamics|pharmacodynamics
1154930|NCT02238704|Adherence|adherence
1154931|NCT02238704|Calcium supplementation|calcium supplementation
1154932|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
1154933|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
1154934|NCT02238691|PEEP|peep
1154935|NCT02238691|Air insufflation|air insufflation
1154936|NCT02238691|Mask ventilation|mask ventilation
1154937|NCT02238691|Esophageal manometry|esophageal manometry
1154938|NCT02238691|Esophageal impedance|esophageal impedance
1154939|NCT02238652|Nursing homes|nursing homes
1154940|NCT02238652|Dementia|dementia
1154941|NCT02238652|Quality of Life|quality of life
1154942|NCT02238652|Geriatrics|geriatrics
1154943|NCT02238652|Aged|aged
1154944|NCT02238652|Activities of Daily Living|activities of daily living
1154945|NCT02238652|Pain|pain
1154946|NCT02238652|Pain management|pain management
1154947|NCT02238652|Advance Care Planning|advance care planning
1154948|NCT02238652|Patient Safety|patient safety
1154949|NCT02238652|Costs and Cost Analysis|costs and cost analysis
1154950|NCT02238652|Medication Errors|medication errors
1154951|NCT02238652|Medical Order Entry Systems|medical order entry systems
1154952|NCT02238652|Medication Reconciliation|medication reconciliation
1154953|NCT02238652|Medication Therapy Management|medication therapy management
1154954|NCT02238652|Depression|depression
1154955|NCT02238652|Psychotropic Drugs|psychotropic drugs
1154956|NCT02238652|Informed Consent|informed consent
1154957|NCT02238652|Presumed Consent|presumed consent
1154958|NCT02238652|Anxiety|anxiety
1154959|NCT02238652|Apathy|apathy
1154960|NCT02238652|Hospitalization|hospitalization
1154961|NCT02238652|Mortality|mortality
1154962|NCT02238639|Venous thromboembolism|venous thromboembolism
1154963|NCT02238639|COPD exacerbations|copd exacerbations
1154964|NCT02238639|Anticoagulation|anticoagulation
1154965|NCT02238639|Mortality|mortality
1154966|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1154967|NCT02238626|pharmacotherapy|pharmacotherapy
1154968|NCT02238626|intervention|intervention
1154969|NCT02238626|prospective|prospective
1154970|NCT02238626|safety endpoint|safety endpoint
1154971|NCT02238626|preliminary efficacy|preliminary efficacy
1154972|NCT02238626|ibudilast|ibudilast
1154973|NCT02238613|Radioactive stents|radioactive stents
1154974|NCT02238613|Brachytherapy|brachytherapy
1154975|NCT02238613|Biliary obstruction|biliary obstruction
1154976|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
1154977|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
1154978|NCT02238613|ampullary carcinoma|ampullary carcinoma
1154979|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
1154980|NCT02238561|non-invasive|non-invasive
1154981|NCT02238561|measurement of oxygen|measurement of oxygen
1154982|NCT02238561|consumption|consumption
1154983|NCT02238561|delivery|delivery
1154984|NCT02238561|post-operative complications|post-operative complications
1154985|NCT02238548|immunity|immunity
1154986|NCT02238548|vaccination|vaccination
1154987|NCT02238548|milk|milk
1154988|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1154989|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
1154990|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1154991|NCT02238522|follicular lymphoma|follicular lymphoma
1154992|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
1154993|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
1154994|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
1154995|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1154996|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
1154997|NCT02238522|T-cell lymphoma|t-cell lymphoma
1154998|NCT02238522|Richter's syndrome|richter's syndrome
1154999|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
1155000|NCT02238509|Breast cancer|breast cancer
1155001|NCT02238509|HER2 Positive|her2 positive
1155002|NCT02238509|HER2+|her2+
1155003|NCT02238509|MBC|mbc
1155004|NCT02238509|Metastatic|metastatic
1155005|NCT02238509|Metastatic breast cancer|metastatic breast cancer
1155006|NCT02238509|Chemotherapy|chemotherapy
1155007|NCT02238509|Lapatinib|lapatinib
1155008|NCT02238509|Trastuzumab|trastuzumab
1155009|NCT02238509|anti HER2 therapies|anti her2 therapies
1155010|NCT02238496|Glioblastoma|glioblastoma
1155011|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
1155012|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
1155013|NCT02238496|Mixed Glioma|mixed glioma
1155014|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
1155015|NCT02238496|mTOR Protein|mtor protein
1155016|NCT02238496|Glioma|glioma
1155017|NCT02238496|Brain Neoplasms|brain neoplasms
1155018|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
1155019|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1155020|NCT02238483|COPD patients|copd patients
1155021|NCT02238483|Exacerbations|exacerbations
1155022|NCT02238483|ICS|ics
1155023|NCT02238483|LABA|laba
1155024|NCT02238470|Ischemic stroke|ischemic stroke
1155025|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
1155026|NCT02238470|Subdural hemorrhage|subdural hemorrhage
1155027|NCT02238470|Microbleed|microbleed
1155028|NCT02238470|Leukoaraiosis|leukoaraiosis
1155029|NCT02238470|Oral anticoagulants|oral anticoagulants
1155030|NCT02238457|Heart failure|heart failure
1155031|NCT02238457|Losartan|losartan
1155032|NCT02238444|Warfarin|warfarin
1155033|NCT02238444|Portal Vein|portal vein
1155034|NCT02238444|Anticoagulants|anticoagulants
1155035|NCT02238444|Cirrhosis|cirrhosis
1155036|NCT02238444|Hypertension|hypertension
1155037|NCT02238444|Venous Thrombosis|venous thrombosis
1155038|NCT02238444|Splenectomy|splenectomy
1155039|NCT02238431|Lucrin depot,|lucrin depot,
1155040|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
1155041|NCT02238431|artificial cycle,|artificial cycle,
1155042|NCT02238431|pregnancy,|pregnancy,
1155043|NCT02238431|cancellation|cancellation
1155044|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
1155045|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1155046|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
1155047|NCT02238392|adenosine|adenosine
1155048|NCT02238392|AF terminatin|af terminatin
1155049|NCT02238379|Intranasal oxytocin|intranasal oxytocin
1155050|NCT02238379|Social perception|social perception
1155051|NCT02238379|EEG/ERP|eeg/erp
1155052|NCT02238340|Postoperatory pain|postoperatory pain
1155053|NCT02238340|Oxycodone|oxycodone
1155054|NCT02238327|Antiretroviral therapy|antiretroviral therapy
1155055|NCT02238327|pulmonary function|pulmonary function
1155056|NCT02238327|biomarkers|biomarkers
1155057|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
1155058|NCT02238301|BOLD effect|bold effect
1155059|NCT02238288|anticoagulation|anticoagulation
1155060|NCT02238288|extraction|extraction
1155061|NCT02238288|epsilon amino caproic|epsilon amino caproic
1155062|NCT02238054|Cardiology|cardiology
1155063|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
1155064|NCT02238054|Bioresorbable stent|bioresorbable stent
1155065|NCT02238041|Glucose monitoring|glucose monitoring
1155066|NCT02238041|Intensive care unit|intensive care unit
1155067|NCT02238028|Heart rate variability|heart rate variability
1155068|NCT02238028|Blood pressure|blood pressure
1155069|NCT02238028|Circulating biomarkers|circulating biomarkers
1155070|NCT02238028|Respirator|respirator
1155071|NCT02238028|Fine particulate matter|fine particulate matter
1155072|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
1155073|NCT02238002|shallow anterior chamber|shallow anterior chamber
1155074|NCT02238002|narrow angle|narrow angle
1155075|NCT02238002|SS-OCT|ss-oct
1155076|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
1155077|NCT02237937|Depression, Affective Disorder|depression, affective disorder
1155078|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1155079|NCT02237924|endostar|endostar
1155080|NCT02237924|IMRT|imrt
1155081|NCT02237924|chemoradiation|chemoradiation
1155082|NCT02237911|total knee replacement|total knee replacement
1155083|NCT02237911|rehabilitation|rehabilitation
1155084|NCT02237911|exercise program|exercise program
1155085|NCT02237911|total knee arthroplasty|total knee arthroplasty
1155086|NCT02237898|Tobacco cessation|tobacco cessation
1155087|NCT02237885|Military Veterans|military veterans
1155088|NCT02237872|Brown Adipose Tissue|brown adipose tissue
1155089|NCT02237859|cdiff|cdiff
1155090|NCT02237859|vancomycin|vancomycin
1155091|NCT02237859|infection|infection
1155092|NCT02237859|clostridium difficile|clostridium difficile
1155093|NCT02237846|osteoarthritis|osteoarthritis
1155094|NCT02237846|knee|knee
1155095|NCT02237846|stem cells|stem cells
1155096|NCT02237846|mesenchymal|mesenchymal
1155097|NCT02237846|umbilical cord|umbilical cord
1155098|NCT02237833|septic shock|septic shock
1155099|NCT02237833|cerebral oximetry|cerebral oximetry
1155100|NCT02237833|vasopressor|vasopressor
1155101|NCT02237833|norepinephrine|norepinephrine
1155102|NCT02237807|Fed Conditions|fed conditions
1155104|NCT02237781|IVF|ivf
1155105|NCT02237781|ovarian stimulation|ovarian stimulation
1155106|NCT02237768|Fasting conditions|fasting conditions
1155107|NCT02237755|Clomiphene citrate|clomiphene citrate
1155108|NCT02237755|IVF|ivf
1155109|NCT02237755|Pregnancy Rates|pregnancy rates
1155110|NCT02237755|Ovarian Reserve|ovarian reserve
1155111|NCT02237729|healthy subjects|healthy subjects
1155112|NCT02237729|immunology|immunology
1155113|NCT02237729|PK|pk
1155114|NCT02237729|Phase 1|phase 1
1155115|NCT02237729|bioequivalence|bioequivalence
1155116|NCT02237729|biosimilarity|biosimilarity
1155117|NCT02237729|adalimumab|adalimumab
1155118|NCT02237729|single dose.|single dose.
1155119|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1155120|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
1155121|NCT02237703|Neuroimaging|neuroimaging
1155122|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
1155123|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1155124|NCT02237677|Trauma|trauma
1155125|NCT02237677|Neuroimaging|neuroimaging
1155126|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
1155127|NCT02237677|[11C]OMAR|[11c]omar
1155128|NCT02237677|Endocannabinoid|endocannabinoid
1155129|NCT02237664|Thoracoscopy|thoracoscopy
1155130|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
1155131|NCT02237664|Paravertebral analgesia|paravertebral analgesia
1155132|NCT02237651|anesthesia|anesthesia
1155133|NCT02237651|bronchosocopy|bronchosocopy
1155134|NCT02237651|lung transplantation|lung transplantation
1155135|NCT02237638|VEGF|vegf
1155136|NCT02237638|Vaccine|vaccine
1155137|NCT02237638|Angiogenesis|angiogenesis
1155138|NCT02237625|Hypophosphatasia|hypophosphatasia
1155139|NCT02237625|HPP|hpp
1155140|NCT02237599|SSEP|ssep
1155141|NCT02237599|neuropraxia|neuropraxia
1155142|NCT02237599|intraoperative|intraoperative
1155143|NCT02237599|automated|automated
1155144|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
1155145|NCT02237586|Malaria|malaria
1155146|NCT02237586|PfSPZ Challenge|pfspz challenge
1155147|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
1155148|NCT02237586|Sickle Cell Trait|sickle cell trait
1155149|NCT02237586|Sporozoites|sporozoites
1155150|NCT02237573|general practice|general practice
1155151|NCT02237573|viral infections|viral infections
1155152|NCT02237573|consultation reports|consultation reports
1155153|NCT02237573|drug prescription|drug prescription
1155154|NCT02237560|MCI|mci
1155155|NCT02237560|Exergaming|exergaming
1155156|NCT02237560|Cognition|cognition
1155157|NCT02237560|Exercise|exercise
1155158|NCT02237560|Older Adults|older adults
1155159|NCT02237547|spinal cord injury|spinal cord injury
1155160|NCT02237547|mesenchymal|mesenchymal
1155161|NCT02237547|bone marrow|bone marrow
1155162|NCT02237547|mononuclear cells|mononuclear cells
1155163|NCT02237547|stem cells|stem cells
1155164|NCT02237547|umbilical cord|umbilical cord
1155165|NCT02237534|Lanthanum|lanthanum
1155166|NCT02237534|Calcium Carbonate|calcium carbonate
1155167|NCT02237534|Vascular Calcification|vascular calcification
1155168|NCT02237521|Incretin hormones|incretin hormones
1155169|NCT02237521|End-stage renal disease|end-stage renal disease
1155170|NCT02237521|ESRD|esrd
1155171|NCT02237521|GLP-1|glp-1
1155172|NCT02237521|GIP|gip
1155173|NCT02237521|Insulin|insulin
1155174|NCT02237521|Glucagon|glucagon
1155175|NCT02237469|Breast cancer|breast cancer
1155176|NCT02237469|Breast conserving surgery.|breast conserving surgery.
1155177|NCT02237469|Radiotherapy.|radiotherapy.
1155178|NCT02237469|Treatment planning.|treatment planning.
1155179|NCT02237469|Prone.|prone.
1155180|NCT02237456|Myocardial infarction|myocardial infarction
1155181|NCT02237456|Atherosclerosis|atherosclerosis
1155182|NCT02237456|PCI|pci
1155183|NCT02237456|OCT|oct
1155184|NCT02237456|Optical coherence tomography|optical coherence tomography
1155185|NCT02237456|Stent|stent
1155186|NCT02237456|Bioresorbable stents|bioresorbable stents
1155187|NCT02237443|Patient Safety|patient safety
1155188|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
1155189|NCT02237417|MRI|mri
1155190|NCT02237417|Imaging|imaging
1155191|NCT02237417|Antipsychotic|antipsychotic
1155192|NCT02237404|Follow-Up studies|follow-up studies
1155193|NCT02237404|Biological Pacemakers|biological pacemakers
1155194|NCT02237404|Telemedicine|telemedicine
1155195|NCT02237404|Efficiency|efficiency
1155196|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
1155197|NCT02237391|Healthcare Utilization|healthcare utilization
1155198|NCT02237391|Chronic Pain|chronic pain
1155199|NCT02237391|Interdisciplinary|interdisciplinary
1155200|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
1155201|NCT02237365|neurological disability|neurological disability
1155202|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
1155203|NCT02237365|safety|safety
1155204|NCT02237365|aspirin|aspirin
1155205|NCT02237365|efficacy|efficacy
1155206|NCT02237352|Diabetes mellitus|diabetes mellitus
1155207|NCT02237352|Diabetic nephropathy|diabetic nephropathy
1155208|NCT02237352|Social Factors|social factors
1155209|NCT02237352|Biological Factors|biological factors
1155210|NCT02237352|VEGF-A|vegf-a
1155211|NCT02237352|Tenascin C|tenascin c
1155212|NCT02237352|Disease characterization|disease characterization
1155213|NCT02237352|Mechanisms|mechanisms
1155214|NCT02237352|Kidney|kidney
1155215|NCT02237352|Chronic kidney disease|chronic kidney disease
1155216|NCT02237352|Secondary nephropathy|secondary nephropathy
1155217|NCT02237352|South America|south america
1155218|NCT02237352|Hispanics|hispanics
1155219|NCT02237352|Ecuador|ecuador
1155220|NCT02237352|Biomarkers|biomarkers
1155221|NCT02237339|Allopurinol|allopurinol
1155222|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
1155223|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
1155224|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
1155225|NCT02237339|Endothelial function|endothelial function
1155226|NCT02237339|Scar|scar
1155227|NCT02237339|Hypertrophy|hypertrophy
1155228|NCT02237339|Hypertension|hypertension
1155229|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
1155230|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
1155231|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
1155232|NCT02237326|Cervical Cancer Screening|cervical cancer screening
1155233|NCT02237326|HIV infected women|hiv infected women
1155234|NCT02237313|psychological support|psychological support
1155235|NCT02237313|therapeutic education|therapeutic education
1155236|NCT02237313|vulnerability of patients|vulnerability of patients
1155237|NCT02237300|Bulimia nervosa|bulimia nervosa
1155238|NCT02237300|Binge eating disorder|binge eating disorder
1155239|NCT02237300|Food craving|food craving
1155240|NCT02237300|Anxiety|anxiety
1155241|NCT02237300|Bingeing|bingeing
1155242|NCT02237300|Cue Exposure Therapy|cue exposure therapy
1155243|NCT02237300|Virtual Reality|virtual reality
1155244|NCT02237274|Fontan circulation|fontan circulation
1155245|NCT02237274|High altitude exposure|high altitude exposure
1155246|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
1155247|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1155248|NCT02237248|Functional Movement Screen|functional movement screen
1155249|NCT02237248|Y Balance Test|y balance test
1155250|NCT02237235|Schizophrenia|schizophrenia
1155251|NCT02237235|Schizoaffective disorder|schizoaffective disorder
1155252|NCT02237235|Cognition|cognition
1155253|NCT02237235|Magnesium|magnesium
1155254|NCT02237235|Imaging|imaging
1155255|NCT02237235|Negative symptoms|negative symptoms
1155256|NCT02237222|Outcome Assessment|outcome assessment
1155257|NCT02237222|Gait|gait
1155258|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
1155259|NCT02237222|Psychometrics|psychometrics
1155260|NCT02237222|Clinical Assessment Tools|clinical assessment tools
1155261|NCT02237196|cat-allergic|cat-allergic
1155262|NCT02237196|cat immunotherapy|cat immunotherapy
1155263|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
1155264|NCT02237170|Sipuleucel-T|sipuleucel-t
1155265|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1155266|NCT02237170|Provenge|provenge
1155267|NCT02237157|pancreatic cancer|pancreatic cancer
1155268|NCT02237157|unresectable|unresectable
1155269|NCT02237157|gemcitabine|gemcitabine
1155270|NCT02237157|device|device
1155271|NCT02237157|local delivery|local delivery
1155272|NCT02237157|chemoembolization|chemoembolization
1155273|NCT02237131|Endometriosis|endometriosis
1155274|NCT02237131|Oral contraceptives|oral contraceptives
1155275|NCT02237131|Laparoscopy|laparoscopy
1155276|NCT02237118|Acute|acute
1155277|NCT02237118|wound|wound
1155278|NCT02237118|management|management
1155279|NCT02237118|measured|measured
1155280|NCT02237118|Visual analoge scale|visual analoge scale
1155281|NCT02237066|OCT|oct
1155282|NCT02237066|PTA|pta
1155283|NCT02237066|Balloon|balloon
1155284|NCT02237053|Energy expenditure|energy expenditure
1155285|NCT02237053|Glucagon|glucagon
1155286|NCT02237053|Octreotide|octreotide
1155287|NCT02237053|Weight loss|weight loss
1155288|NCT02237040|Children|children
1155289|NCT02237040|mandible|mandible
1155290|NCT02237040|condylar fracture|condylar fracture
1155291|NCT02237040|conservative treatment|conservative treatment
1155709|NCT02235337|Concussion|concussion
1155292|NCT02237040|functional treatment|functional treatment
1155293|NCT02237027|HIV|hiv
1155294|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
1155295|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1155296|NCT02237027|antiretroviral treatment|antiretroviral treatment
1155297|NCT02237027|prevention|prevention
1155298|NCT02237027|feasibility|feasibility
1155299|NCT02237027|female sex workers|female sex workers
1155300|NCT02237027|Benin|benin
1155301|NCT02237027|West Africa|west africa
1155302|NCT02237001|meniscal|meniscal
1155303|NCT02237001|meniscus|meniscus
1155304|NCT02237001|repair|repair
1155305|NCT02237001|knee|knee
1155306|NCT02237001|arthroscopy knee|arthroscopy knee
1155307|NCT02237001|horizontal|horizontal
1155308|NCT02236988|Apremilast|apremilast
1155309|NCT02236988|Healthy male subjects|healthy male subjects
1155310|NCT02236988|Pharmacokinetics|pharmacokinetics
1155311|NCT02236949|pediatric pain|pediatric pain
1155312|NCT02236949|intervention sustainability|intervention sustainability
1155313|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
1155314|NCT02236936|Head and neck|head and neck
1155315|NCT02236936|SCCHN|scchn
1155316|NCT02236936|Parenteral nutrition|parenteral nutrition
1155317|NCT02236936|Larynx|larynx
1155318|NCT02236936|Hypopharynx|hypopharynx
1155319|NCT02236936|Cavum oris|cavum oris
1155320|NCT02236936|Radiotherapy|radiotherapy
1155321|NCT02236936|Cetuximab|cetuximab
1155322|NCT02236936|Cisplatin|cisplatin
1155323|NCT02236923|cardiovascular|cardiovascular
1155324|NCT02236923|surgery|surgery
1155325|NCT02236923|ascending aorta|ascending aorta
1155326|NCT02236923|aortic dissection|aortic dissection
1155327|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
1155328|NCT02236884|rectal cancer|rectal cancer
1155329|NCT02236884|no scar|no scar
1155330|NCT02236884|NOTES|notes
1155331|NCT02236884|TaTME|tatme
1155332|NCT02236884|feasibility|feasibility
1155333|NCT02236884|safety|safety
1155334|NCT02236871|Adolescents|adolescents
1155335|NCT02236871|Dairy|dairy
1155336|NCT02236871|Bone|bone
1155337|NCT02236858|COPD|copd
1155338|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
1155339|NCT02236806|Breast cancer|breast cancer
1155340|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
1155341|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1155342|NCT02236806|Cardioprotection|cardioprotection
1155343|NCT02236806|Anthracyclines|anthracyclines
1155344|NCT02236780|in vitro fertilisation|in vitro fertilisation
1155345|NCT02236780|environmental conditions|environmental conditions
1155346|NCT02236780|pregnancy|pregnancy
1155347|NCT02236780|live birth rate|live birth rate
1155348|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
1155349|NCT02236754|beta cell mass|beta cell mass
1155350|NCT02236754|diabetes mellitus|diabetes mellitus
1155351|NCT02236702|Major Depressive Disorder|major depressive disorder
1155352|NCT02236702|Anhedonia|anhedonia
1155353|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
1155354|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
1155355|NCT02236676|motor learning TBI|motor learning tbi
1155356|NCT02236663|Intimate Partner Violence|intimate partner violence
1155357|NCT02236663|Dating Violence|dating violence
1155358|NCT02236663|Relationships|relationships
1155359|NCT02236663|Safety Planning|safety planning
1155360|NCT02236663|College|college
1155361|NCT02236663|Student|student
1155362|NCT02236663|App|app
1155363|NCT02236650|Parental Resilience|parental resilience
1155364|NCT02236650|Parental Stress|parental stress
1155365|NCT02236650|Family Adaptation|family adaptation
1155366|NCT02236650|Autistic Disorder|autistic disorder
1155370|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
1155372|NCT02236650|Parents|parents
1155373|NCT02236650|Parenting|parenting
1155374|NCT02236650|Primary Health Care|primary health care
1155378|NCT02236611|COPD|copd
1155379|NCT02236611|inhaler ease of use|inhaler ease of use
1155380|NCT02236611|glycopyrronium|glycopyrronium
1155381|NCT02236611|umeclidinium|umeclidinium
1155382|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
1155383|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1155384|NCT02236611|inhaler errors|inhaler errors
1155385|NCT02236598|borderline hypokalemia|borderline hypokalemia
1155386|NCT02236598|glucose tolerance|glucose tolerance
1155387|NCT02236598|insulin secretion|insulin secretion
1155388|NCT02236598|insulin sensitivity|insulin sensitivity
1155389|NCT02236598|fasting glucose|fasting glucose
1155390|NCT02236598|African American|african american
1155391|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
1155392|NCT02236572|Postmenopausal|postmenopausal
1155393|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
1155394|NCT02236572|Low and intermediate risk|low and intermediate risk
1155395|NCT02236559|high flow therapy|high flow therapy
1155396|NCT02236559|high flow nasal cannula|high flow nasal cannula
1155397|NCT02236559|acute respiratory failure|acute respiratory failure
1155398|NCT02236559|noninvasive ventilation|noninvasive ventilation
1155399|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
1155401|NCT02236546|PET/CT|pet/ct
1155402|NCT02236546|melanoma|melanoma
1155403|NCT02236546|imaging biomarkers|imaging biomarkers
1155404|NCT02236546|cancer imaging|cancer imaging
1155405|NCT02236520|Na+ MRI|na+ mri
1155406|NCT02236520|salt stores|salt stores
1155407|NCT02236494|alcoholism|alcoholism
1155408|NCT02236494|dangerous behavior|dangerous behavior
1155409|NCT02236494|aged|aged
1155410|NCT02236494|emergency medicine|emergency medicine
1155411|NCT02236455|complementary medicine|complementary medicine
1155412|NCT02236455|state anxiety|state anxiety
1155413|NCT02236455|acute pain|acute pain
1155414|NCT02236455|self-efficacy|self-efficacy
1155415|NCT02236455|surgery|surgery
1155416|NCT02236455|medical music intervention|medical music intervention
1155417|NCT02236455|nature therapy|nature therapy
1155418|NCT02236455|relaxation technique|relaxation technique
1155419|NCT02236442|Cephalalgia|cephalalgia
1155420|NCT02236442|Headache|headache
1155421|NCT02236442|Migraine|migraine
1155422|NCT02236442|Pain|pain
1155423|NCT02236442|Global|global
1155424|NCT02236442|Treatment|treatment
1155425|NCT02236442|Oxygen|oxygen
1155426|NCT02236442|Emergency|emergency
1155427|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
1155428|NCT02236429|bacterial vaginitis|bacterial vaginitis
1155429|NCT02236429|vaginal flora|vaginal flora
1155430|NCT02236429|microbiome|microbiome
1155431|NCT02236416|Dementia|dementia
1155432|NCT02236416|Prevention|prevention
1155433|NCT02236416|Physical Activity|physical activity
1155434|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
1155435|NCT02236390|Nightmare|nightmare
1155436|NCT02236390|PTSD|ptsd
1155437|NCT02236390|Sleep|sleep
1155438|NCT02236390|Emotion Regulation|emotion regulation
1155439|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
1155440|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
1155441|NCT02236377|ERRT|errt
1155442|NCT02236377|Nightmares|nightmares
1155443|NCT02236377|Sleep|sleep
1155444|NCT02236377|Trauma|trauma
1155445|NCT02236377|PTSD|ptsd
1155446|NCT02236351|patching|patching
1155447|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
1155448|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
1155449|NCT02236338|varicose vein|varicose vein
1155450|NCT02236338|greater saphenous vein|greater saphenous vein
1155451|NCT02236299|Right Coronary Artery|right coronary artery
1155452|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
1155453|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
1155454|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
1155455|NCT02236299|GLP-1|glp-1
1155456|NCT02236299|Stunning|stunning
1155457|NCT02236299|Cardioprotection|cardioprotection
1155458|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
1155459|NCT02236286|balance|balance
1155460|NCT02236286|gait|gait
1155461|NCT02236286|exercise|exercise
1155462|NCT02236273|Human papillomavirus|human papillomavirus
1155463|NCT02236273|vaccination|vaccination
1155464|NCT02236273|text message|text message
1155465|NCT02236273|reminder|reminder
1155466|NCT02236247|ivabradine|ivabradine
1155467|NCT02236247|heart rate|heart rate
1155468|NCT02236247|heart failure|heart failure
1155469|NCT02236234|HIV|hiv
1155470|NCT02236234|HPV|hpv
1155471|NCT02236234|Clinical trial|clinical trial
1155472|NCT02236234|outcome|outcome
1155473|NCT02236195|Urothelial|urothelial
1155474|NCT02236195|Bladder|bladder
1155475|NCT02236195|HDAC|hdac
1155476|NCT02236195|MGCD0103|mgcd0103
1155477|NCT02236195|Mocetinostat|mocetinostat
1155478|NCT02236195|CREBBP|crebbp
1155479|NCT02236195|EP300|ep300
1155480|NCT02236195|Mirati|mirati
1155481|NCT02236195|MethylGene|methylgene
1155482|NCT02236143|Healthy|healthy
1155483|NCT02236130|pediatric regional|pediatric regional
1155484|NCT02236117|heart rate variability|heart rate variability
1155485|NCT02236117|children|children
1155486|NCT02236117|progressive test|progressive test
1155487|NCT02236104|neuromuscular disorders|neuromuscular disorders
1155488|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
1155489|NCT02236104|respiratory parameters|respiratory parameters
1155490|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
1155491|NCT02236104|Vital capacity|vital capacity
1155492|NCT02236091|cerebral palsy|cerebral palsy
1155493|NCT02236091|stroke|stroke
1155494|NCT02236091|traumatic brain injury|traumatic brain injury
1155495|NCT02236065|Umbilical cord blood|umbilical cord blood
1155496|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
1155497|NCT02236065|Brain injury|brain injury
1155498|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
1155499|NCT02236065|Efficacy|efficacy
1155500|NCT02236065|Safety|safety
1155501|NCT02236052|Influenza|influenza
1155502|NCT02236052|Human|human
1155503|NCT02236052|RNA Virus Infections|rna virus infections
1155504|NCT02236052|Immunologic|immunologic
1155812|NCT02234739|efficacy|efficacy
1155505|NCT02236052|Immunogenic Factors|immunogenic factors
1155506|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
1155507|NCT02236052|Virus diseases|virus diseases
1155508|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
1155509|NCT02236052|Infection|infection
1155510|NCT02236039|Diesel exhaust|diesel exhaust
1155511|NCT02236039|Air pollution|air pollution
1155512|NCT02236039|Airway responsivness|airway responsivness
1155513|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
1155514|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
1155515|NCT02236013|ASP2215|asp2215
1155516|NCT02236013|Daunorubicin|daunorubicin
1155517|NCT02236013|Gilteritinib|gilteritinib
1155518|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
1155519|NCT02236013|Idarubicin|idarubicin
1155520|NCT02236013|Cytarabine|cytarabine
1155521|NCT02236000|NSABP|nsabp
1155522|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
1155523|NCT02236000|T DM1|t dm1
1155524|NCT02236000|Neratinib|neratinib
1155525|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
1155526|NCT02236000|HER2 positive|her2 positive
1155527|NCT02236000|Dose Escalation|dose escalation
1155528|NCT02235974|stroke|stroke
1155529|NCT02235974|critical periods|critical periods
1155530|NCT02235974|sensitive periods|sensitive periods
1155531|NCT02235974|hemiparesis|hemiparesis
1155532|NCT02235974|upper extremity|upper extremity
1155533|NCT02235974|physical rehabilitation|physical rehabilitation
1155534|NCT02235974|arm therapy|arm therapy
1155535|NCT02235974|occupational therapy|occupational therapy
1155536|NCT02235974|physical therapy|physical therapy
1155537|NCT02235974|task oriented training|task oriented training
1155538|NCT02235974|patient focused|patient focused
1155539|NCT02235974|arm function|arm function
1155540|NCT02235974|hand function|hand function
1155541|NCT02235974|neurorehabilitation|neurorehabilitation
1155542|NCT02235974|motor learning|motor learning
1155543|NCT02235974|motor control|motor control
1155544|NCT02235974|motor function|motor function
1155545|NCT02235974|motor recovery|motor recovery
1155546|NCT02235974|skill acquisition|skill acquisition
1155547|NCT02235974|skill training|skill training
1155548|NCT02235948|arsenic induced health problem|arsenic induced health problem
1155549|NCT02235948|modifying effects|modifying effects
1155550|NCT02235948|folic acid|folic acid
1155551|NCT02235948|oxidative damage|oxidative damage
1155552|NCT02235948|clinical trial|clinical trial
1155553|NCT02235922|Aged|aged
1155554|NCT02235922|Exercise|exercise
1155555|NCT02235922|Cognition|cognition
1155556|NCT02235922|Functional capacity|functional capacity
1155557|NCT02235909|Pediatric Hypertension|pediatric hypertension
1155558|NCT02235909|High Blood Pressure|high blood pressure
1155559|NCT02235909|Hypertension|hypertension
1155560|NCT02235909|Pediatric|pediatric
1155561|NCT02235909|Primary Hypertension|primary hypertension
1155562|NCT02235909|Secondary Hypertension|secondary hypertension
1155563|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
1155564|NCT02235883|Coronary artery disease|coronary artery disease
1155566|NCT02235883|diagnosis|diagnosis
1155567|NCT02235883|computational model|computational model
1155568|NCT02235883|non-invasive|non-invasive
1155569|NCT02235870|Weight Loss|weight loss
1155570|NCT02235870|Obesity|obesity
1155571|NCT02235870|BMI|bmi
1155572|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
1155573|NCT02235844|Mesenchymal|mesenchymal
1155574|NCT02235844|Stem Cells|stem cells
1155575|NCT02235844|Umbilical Cord|umbilical cord
1155576|NCT02235844|Duchenne's|duchenne's
1155577|NCT02235844|Muscular Dystrophy|muscular dystrophy
1155578|NCT02235831|DACP MF|dacp mf
1155579|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
1155580|NCT02235831|presbyopia|presbyopia
1155581|NCT02235831|visual performance|visual performance
1155582|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
1155583|NCT02235805|Metabolic Syndrome|metabolic syndrome
1155584|NCT02235805|Obesity|obesity
1155585|NCT02235805|Magnesium Supplementation|magnesium supplementation
1155586|NCT02235805|Vascular Stiffness|vascular stiffness
1155587|NCT02235805|Vascular Function|vascular function
1155588|NCT02235779|ILD|ild
1155589|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
1155590|NCT02235779|Cryobiopsy|cryobiopsy
1155591|NCT02235779|Transbronchial|transbronchial
1155592|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1155593|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
1155594|NCT02235740|Open label|open label
1155595|NCT02235740|carfilzomib|carfilzomib
1155596|NCT02235740|Phase I|phase i
1155597|NCT02235740|clinical activity|clinical activity
1155598|NCT02235740|pharmacokinetics|pharmacokinetics
1155599|NCT02235740|afuresertib|afuresertib
1155600|NCT02235740|relapsed|relapsed
1155601|NCT02235740|refractory|refractory
1155602|NCT02235740|safety|safety
1155603|NCT02235740|multiple myeloma|multiple myeloma
1155813|NCT02234739|safety|safety
1155604|NCT02235714|Airway inflammation|airway inflammation
1155605|NCT02235714|Tetraplegia|tetraplegia
1155606|NCT02235714|Asthma|asthma
1155607|NCT02235714|Exhaled breath condensate|exhaled breath condensate
1155608|NCT02235714|Spirometry|spirometry
1155609|NCT02235714|Pulmonary Function Testing|pulmonary function testing
1155610|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
1155611|NCT02235701|aldoxorubicin|aldoxorubicin
1155612|NCT02235701|ifosfamide|ifosfamide
1155614|NCT02235701|phase 1|phase 1
1155615|NCT02235701|INNO-206|inno-206
1155616|NCT02235688|aldoxorubicin|aldoxorubicin
1155617|NCT02235688|INNO-206|inno-206
1155618|NCT02235688|solid tumors|solid tumors
1155619|NCT02235688|gemcitabine|gemcitabine
1155620|NCT02235688|phase 1|phase 1
1155621|NCT02235675|Angioplasty|angioplasty
1155622|NCT02235675|Peripheral Artery Disease|peripheral artery disease
1155623|NCT02235675|Critical Limb Ischemia|critical limb ischemia
1155625|NCT02235675|PAD|pad
1155626|NCT02235662|HIV|hiv
1155627|NCT02235662|LNG|lng
1155628|NCT02235662|IVR|ivr
1155629|NCT02235662|Contraception|contraception
1155630|NCT02235662|Prevention|prevention
1155631|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
1155632|NCT02235623|Orchiopexy|orchiopexy
1155633|NCT02235610|Lung Transplantation|lung transplantation
1155634|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
1155635|NCT02235610|EVLP|evlp
1155636|NCT02235597|patient access|patient access
1155637|NCT02235597|patient centered care|patient centered care
1155638|NCT02235597|scheduling|scheduling
1155639|NCT02235597|access barriers|access barriers
1155640|NCT02235597|improve efficiency|improve efficiency
1155641|NCT02235597|decision making tools|decision making tools
1155642|NCT02235597|underserved|underserved
1155643|NCT02235584|Incretin hormones|incretin hormones
1155644|NCT02235584|GLP-1|glp-1
1155645|NCT02235584|GIP|gip
1155646|NCT02235584|Dexamethasone|dexamethasone
1155647|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
1155648|NCT02235558|Thrombectomy|thrombectomy
1155649|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
1155650|NCT02235558|Neuroprotection|neuroprotection
1155651|NCT02235545|HV Lead|hv lead
1155652|NCT02235545|ICD|icd
1155653|NCT02235545|CRT-D System|crt-d system
1155654|NCT02235545|Treatment of Heart Failure|treatment of heart failure
1155655|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
1155656|NCT02235545|Optisure|optisure
1155657|NCT02235532|clinical trial|clinical trial
1155658|NCT02235532|oral hygiene|oral hygiene
1155659|NCT02235532|Gingivitis|gingivitis
1155660|NCT02235532|Aloevera|aloevera
1155661|NCT02235532|Toothpaste|toothpaste
1155662|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
1155663|NCT02235493|HPP|hpp
1155664|NCT02235493|Soft Bones|soft bones
1155665|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
1155666|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
1155667|NCT02235493|alkaline phosphatase|alkaline phosphatase
1155668|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1155669|NCT02235493|rickets|rickets
1155670|NCT02235493|osteomalacia|osteomalacia
1155671|NCT02235467|autism|autism
1155672|NCT02235467|videomodeling|videomodeling
1155673|NCT02235467|behavioral therapy|behavioral therapy
1155674|NCT02235467|parental training|parental training
1155675|NCT02235454|glaucoma|glaucoma
1155676|NCT02235454|OCT|oct
1155677|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
1155678|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
1155679|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
1155680|NCT02235441|Chemoradiation therapy|chemoradiation therapy
1155681|NCT02235376|Critical Care|critical care
1155682|NCT02235376|Brain injured patients|brain injured patients
1155683|NCT02235376|Mechanical Ventilation|mechanical ventilation
1155684|NCT02235376|Weaning|weaning
1155685|NCT02235376|Extubation|extubation
1155686|NCT02235376|Prognostic score|prognostic score
1155687|NCT02235376|Clinical examination|clinical examination
1155688|NCT02235363|face lift|face lift
1155689|NCT02235363|thread lift|thread lift
1155690|NCT02235363|retaining ligament|retaining ligament
1155691|NCT02235363|V-Loc sutures|v-loc sutures
1155692|NCT02235363|tensiometer|tensiometer
1155693|NCT02235363|FACE-Q|face-q
1155694|NCT02235350|Adult|adult
1155695|NCT02235350|Male|male
1155696|NCT02235350|Female|female
1155697|NCT02235350|Neuronal Plasticity|neuronal plasticity
1155698|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
1155699|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
1155700|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
1155701|NCT02235350|Follow-up Studies|follow-up studies
1155702|NCT02235350|Video Recording|video recording
1155703|NCT02235350|Physical Therapy Modalities|physical therapy modalities
1155704|NCT02235350|Recovery of Function|recovery of function
1155705|NCT02235350|Action Observation Treatment|action observation treatment
1155706|NCT02235350|Mirror Neuron System|mirror neuron system
1155707|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
1155710|NCT02235337|Sports related concussion|sports related concussion
1155711|NCT02235337|mTBI|mtbi
1155712|NCT02235337|Vitamin B|vitamin b
1155713|NCT02235337|Riboflavin|riboflavin
1155714|NCT02235311|Proton pump inhibitor|proton pump inhibitor
1155715|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
1155716|NCT02235311|Ulcer healing|ulcer healing
1155717|NCT02235298|epicardial fat|epicardial fat
1155718|NCT02235298|diabetes|diabetes
1155719|NCT02235298|dapagliflozin|dapagliflozin
1155720|NCT02235285|capsular contracture|capsular contracture
1155721|NCT02235285|reoperation|reoperation
1155722|NCT02235285|breast augmentation|breast augmentation
1155723|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
1155724|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
1155725|NCT02235220|Bruxism|bruxism
1155726|NCT02235207|sedentary work|sedentary work
1155727|NCT02235207|musculoskeletal pain|musculoskeletal pain
1155728|NCT02235207|neuromuscular exercise|neuromuscular exercise
1155729|NCT02235207|physical fitness|physical fitness
1155730|NCT02235207|quality of life|quality of life
1155731|NCT02235207|work ability|work ability
1155732|NCT02235181|Twin Pregnancy|twin pregnancy
1155733|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
1155734|NCT02235181|Short Cervix|short cervix
1155735|NCT02235181|Arabin cervical pessary|arabin cervical pessary
1155736|NCT02235116|Number of patients|number of patients
1155737|NCT02235116|full body skin exam|full body skin exam
1155738|NCT02235116|Survey|survey
1155739|NCT02235116|preferences|preferences
1155740|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
1155741|NCT02235090|Neuromuscular disorders|neuromuscular disorders
1155742|NCT02235090|Outcome measures|outcome measures
1155743|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
1155744|NCT02235077|Heart Failure|heart failure
1155745|NCT02235077|Heart Diseases|heart diseases
1155746|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
1155747|NCT02235077|Spironolactone|spironolactone
1155748|NCT02235077|Aldactone|aldactone
1155749|NCT02235025|mild COPD|mild copd
1155750|NCT02235025|dyspnea|dyspnea
1155751|NCT02235025|exercise|exercise
1155752|NCT02235025|respiratory mechanics|respiratory mechanics
1155753|NCT02235012|Schizophrenia|schizophrenia
1155754|NCT02235012|Ketamine|ketamine
1155755|NCT02235012|Cognitive biases|cognitive biases
1155756|NCT02235012|Uncertainty|uncertainty
1155757|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
1155758|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
1155759|NCT02234947|type 1 diabetes|type 1 diabetes
1155760|NCT02234947|pancreas volume|pancreas volume
1155761|NCT02234934|Gene Therapy|gene therapy
1155762|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
1155763|NCT02234934|Lentiviral Vector|lentiviral vector
1155764|NCT02234921|Prostate|prostate
1155765|NCT02234921|Adenocarcinoma|adenocarcinoma
1155766|NCT02234921|Metastatic|metastatic
1155767|NCT02234921|DRibble|dribble
1155768|NCT02234921|Immunotherapy|immunotherapy
1155769|NCT02234921|Microbiome|microbiome
1155770|NCT02234908|Tuberculosis|tuberculosis
1156980|NCT02229513|uterotonics|uterotonics
1155771|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
1155772|NCT02234908|Incentives|incentives
1155773|NCT02234908|Symptom screening|symptom screening
1155774|NCT02234895|osteoarthritis|osteoarthritis
1155776|NCT02234895|biomechanics|biomechanics
1155777|NCT02234895|treatment|treatment
1155778|NCT02234895|symptoms|symptoms
1155779|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
1155780|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1155781|NCT02234869|RMS|rms
1155782|NCT02234869|flu-like symptoms|flu-like symptoms
1155783|NCT02234856|Hysterectomy|hysterectomy
1155784|NCT02234856|Laparoscopy|laparoscopy
1155785|NCT02234856|Surgical assessment|surgical assessment
1155786|NCT02234856|Education|education
1155787|NCT02234843|Pediatric|pediatric
1155788|NCT02234830|PCI|pci
1155789|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
1155790|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1155791|NCT02234804|OCT|oct
1155792|NCT02234804|Stent|stent
1155793|NCT02234778|critical limb ischemia|critical limb ischemia
1155794|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
1155795|NCT02234765|OSA|osa
1155796|NCT02234765|OSAS|osas
1155797|NCT02234765|Sleep apnea|sleep apnea
1155798|NCT02234765|Management|management
1155799|NCT02234765|Primary Care|primary care
1155800|NCT02234765|Sleep Unit|sleep unit
1155801|NCT02234765|Cost-Effectiveness|cost-effectiveness
1155802|NCT02234765|ESS|ess
1155803|NCT02234752|Schizophrenia|schizophrenia
1155804|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
1155805|NCT02234752|Cognition|cognition
1155806|NCT02234752|Cognitive Impairment|cognitive impairment
1155807|NCT02234752|Galantamine|galantamine
1155808|NCT02234752|Memantine|memantine
1155809|NCT02234739|voriconazole|voriconazole
1155810|NCT02234739|COPD|copd
1155811|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1155814|NCT02234726|child health|child health
1155815|NCT02234726|child development|child development
1155816|NCT02234726|malnutrition|malnutrition
1155817|NCT02234726|stunting|stunting
1155818|NCT02234726|community-based health services|community-based health services
1155819|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
1155820|NCT02234674|Pulsating suit|pulsating suit
1155821|NCT02234674|lymphedema|lymphedema
1155822|NCT02234674|leg volume|leg volume
1155823|NCT02234661|Low income|low income
1155824|NCT02234661|Education|education
1155825|NCT02234661|Poverty|poverty
1155826|NCT02234661|Children|children
1155827|NCT02234661|Parents|parents
1155828|NCT02234661|Head Start|head start
1155829|NCT02234648|Vascular Function|vascular function
1155830|NCT02234648|tart Montmorency cherries|tart montmorency cherries
1155831|NCT02234648|Arterial Stiffness|arterial stiffness
1155832|NCT02234648|Blood Flow|blood flow
1155833|NCT02234635|visual acuity|visual acuity
1155834|NCT02234635|objective visual quality|objective visual quality
1155835|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
1155836|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
1155837|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1155838|NCT02234622|Yoga|yoga
1155839|NCT02234622|Veterans|veterans
1155840|NCT02234609|dentistry|dentistry
1155841|NCT02234609|dental caries|dental caries
1155842|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
1155843|NCT02234609|effectiveness|effectiveness
1155844|NCT02234596|Nintedanib|nintedanib
1155845|NCT02234596|14-094|14-094
1155846|NCT02234583|pain|pain
1155847|NCT02234583|fibromyalgia|fibromyalgia
1155848|NCT02234570|neurocysticercosis|neurocysticercosis
1155849|NCT02234570|pork tapeworm|pork tapeworm
1155850|NCT02234570|Taenia solium|taenia solium
1155851|NCT02234557|Motor Control|motor control
1155852|NCT02234557|Attention|attention
1155853|NCT02234557|Cognitive Control|cognitive control
1155854|NCT02234544|vitamin D|vitamin d
1155855|NCT02234544|absorption|absorption
1155856|NCT02234544|ezetimibe|ezetimibe
1155857|NCT02234531|Virtual Reality,|virtual reality,
1155858|NCT02234531|Enhanced Feedback,|enhanced feedback,
1155859|NCT02234531|Stroke,|stroke,
1155860|NCT02234531|Rehabilitation,|rehabilitation,
1155861|NCT02234531|Motor Learning|motor learning
1155862|NCT02234505|prosthetics|prosthetics
1155863|NCT02234505|amputation|amputation
1155864|NCT02234505|gait stability|gait stability
1155865|NCT02234505|step variability|step variability
1155866|NCT02234505|load cell|load cell
1155867|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1155868|NCT02234492|Statin therapy|statin therapy
1155869|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
1155870|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
1155871|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
1155872|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
1155873|NCT02234479|Breast Cancer|breast cancer
1155874|NCT02234479|Radiation Dermatitis|radiation dermatitis
1155875|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
1155876|NCT02234466|Breast Surgery|breast surgery
1155877|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
1155878|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1155879|NCT02234453|cancer|cancer
1155880|NCT02234453|chemotherapy|chemotherapy
1155881|NCT02234453|home|home
1155882|NCT02234453|blood count|blood count
1155883|NCT02234453|remote|remote
1155884|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
1155885|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
1155886|NCT02234414|vitamin D|vitamin d
1155887|NCT02234401|Cystic Fibrosis|cystic fibrosis
1155888|NCT02234401|Noninvasive ventilation|noninvasive ventilation
1155889|NCT02234401|Non invasive ventilation|non invasive ventilation
1155890|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
1155891|NCT02234401|Bi level pressure support|bi level pressure support
1155892|NCT02234388|connective tissue disease|connective tissue disease
1155893|NCT02234388|registry|registry
1155894|NCT02234388|hospital for special surgery|hospital for special surgery
1155895|NCT02234375|Pulmonary embolism|pulmonary embolism
1155896|NCT02234375|Contrast|contrast
1155897|NCT02234375|Computed tomography|computed tomography
1155898|NCT02234375|Gadolinium|gadolinium
1155899|NCT02234349|bile acids|bile acids
1155900|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
1155901|NCT02234349|incretins|incretins
1155902|NCT02234349|intestinal flora|intestinal flora
1155903|NCT02234336|Echocardiography|echocardiography
1155904|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1155905|NCT02234336|cardiomyopathy|cardiomyopathy
1155906|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
1155907|NCT02234336|contrast|contrast
1155908|NCT02234323|prophylaxis treatment|prophylaxis treatment
1569393|NCT00502762|topotecan|topotecan
1155909|NCT02234323|Hemophilia A|hemophilia a
1155910|NCT02234323|Hemophilia|hemophilia
1155911|NCT02234323|episodic treatment|episodic treatment
1155912|NCT02234310|prophylaxis treatment|prophylaxis treatment
1155913|NCT02234310|episodic treatment|episodic treatment
1155914|NCT02234297|Glioma|glioma
1155915|NCT02234297|Tumor Paint|tumor paint
1155916|NCT02234297|BLZ100|blz100
1155917|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1155918|NCT02234284|Health Coaching|health coaching
1155919|NCT02234284|Health Disparities|health disparities
1155920|NCT02234284|Self-management|self-management
1155921|NCT02234284|Chronic Disease Model|chronic disease model
1155922|NCT02234245|Follow-Up studies|follow-up studies
1155923|NCT02234245|Biological Pacemakers|biological pacemakers
1155924|NCT02234245|Telemedicine|telemedicine
1155925|NCT02234245|Efficiency|efficiency
1155926|NCT02234232|Hemodialysis|hemodialysis
1155927|NCT02234232|Exercise, aerobic|exercise, aerobic
1155928|NCT02234232|Exercise, resistance|exercise, resistance
1155929|NCT02234232|Intradialytic|intradialytic
1155930|NCT02234232|Randomized Controlled Trial|randomized controlled trial
1155931|NCT02234232|Safety|safety
1155932|NCT02234232|Quality of life|quality of life
1155933|NCT02234232|Physical performance|physical performance
1155934|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
1155935|NCT02234193|wound healing|wound healing
1155936|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
1155937|NCT02234128|EVLP|evlp
1155938|NCT02234128|Lung Transplant|lung transplant
1155939|NCT02234128|Lung Transplantation|lung transplantation
1155940|NCT02234128|Toronto EVLP System™|toronto evlp system™
1155941|NCT02234128|PERFUSIX|perfusix
1155942|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
1155943|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
1155944|NCT02234076|Depression|depression
1155945|NCT02234076|Treatment|treatment
1155946|NCT02234076|VRET|vret
1155947|NCT02234063|Hypertension|hypertension
1155948|NCT02234063|Chronic Kidney Disease|chronic kidney disease
1155949|NCT02234063|End Stage Renal Disease|end stage renal disease
1155950|NCT02234063|APOL1|apol1
1155951|NCT02234063|Genomics|genomics
1155952|NCT02234063|Genetics|genetics
1155953|NCT02234063|Community-engaged|community-engaged
1155954|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
1155955|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
1155956|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
1155957|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
1155958|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
1155959|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
1155960|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
1155962|NCT02233998|Plaque|plaque
1155963|NCT02233998|Bleeding|bleeding
1155964|NCT02233998|Gums|gums
1155965|NCT02233998|Gingiva|gingiva
1155966|NCT02233998|Gingival Inflammation|gingival inflammation
1155967|NCT02233998|Gingival Bleeding|gingival bleeding
1155968|NCT02233985|bronchiolitis|bronchiolitis
1155969|NCT02233985|hypertonic|hypertonic
1155970|NCT02233985|saline|saline
1155971|NCT02233985|salbutamol|salbutamol
1155972|NCT02233972|Pharmacokinetics|pharmacokinetics
1155973|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
1155974|NCT02233946|Substance Abuse|substance abuse
1155975|NCT02233946|Prevention|prevention
1155976|NCT02233946|Youth|youth
1155977|NCT02233946|Alcohol|alcohol
1155978|NCT02233946|Drugs|drugs
1155979|NCT02233933|radiation proctitis|radiation proctitis
1155980|NCT02233933|bleeding|bleeding
1155981|NCT02233933|therapy|therapy
1155982|NCT02233868|Imaging Studies|imaging studies
1155983|NCT02233868|Alcoholism|alcoholism
1155984|NCT02233868|Inflammation|inflammation
1155985|NCT02233855|Seizures|seizures
1155986|NCT02233855|Cestode|cestode
1155987|NCT02233855|Hydrocephalus|hydrocephalus
1155988|NCT02233855|Taenia Solium|taenia solium
1155989|NCT02233855|Helminth|helminth
1155990|NCT02233842|Qualitative Data|qualitative data
1155991|NCT02233842|Questionnaire|questionnaire
1155992|NCT02233829|C-11 Raclopride|c-11 raclopride
1155993|NCT02233829|015 PET|015 pet
1155994|NCT02233829|Circadian Rhythm|circadian rhythm
1155995|NCT02233816|Influenza|influenza
1155996|NCT02233816|Human|human
1155997|NCT02233816|RNA Virus Infections|rna virus infections
1155998|NCT02233816|Immunologic|immunologic
1155999|NCT02233816|Immunogenic Factors|immunogenic factors
1156000|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
1156001|NCT02233816|Virus diseases|virus diseases
1156002|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
1156003|NCT02233816|Infection|infection
1156004|NCT02233803|tolerability|tolerability
1156005|NCT02233803|NEUMOTEROL|neumoterol
1156006|NCT02233803|efficacy|efficacy
1156007|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
1156008|NCT02233803|safety|safety
1156009|NCT02233803|Asthma|asthma
1156010|NCT02233803|pharmacodynamics|pharmacodynamics
1156011|NCT02233790|Myocardial infarction|myocardial infarction
1156012|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
1156013|NCT02233790|Ticagrelor|ticagrelor
1156014|NCT02233790|Clopidogrel|clopidogrel
1156015|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
1156016|NCT02233777|Pregabalin|pregabalin
1156017|NCT02233777|Bioequivalence|bioequivalence
1156018|NCT02233777|Bioavailability|bioavailability
1156019|NCT02233777|Pharmacokinetic|pharmacokinetic
1156020|NCT02233777|Antiepileptic|antiepileptic
1156021|NCT02233764|iron|iron
1156022|NCT02233764|zinc|zinc
1156023|NCT02233764|pearl millet|pearl millet
1156024|NCT02233764|India|india
1156025|NCT02233764|children|children
1156026|NCT02233764|trial|trial
1156027|NCT02233764|randomized|randomized
1156028|NCT02233751|Healthy Adult Males|healthy adult males
1156029|NCT02233738|Alcoholism|alcoholism
1156030|NCT02233738|Substance-related disorders|substance-related disorders
1156031|NCT02233738|Dual Diagnosis|dual diagnosis
1156032|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
1156033|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
1156034|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
1156035|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
1156036|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
1156037|NCT02233673|Obesity|obesity
1156038|NCT02233673|Pregnancy|pregnancy
1156039|NCT02233647|cocaine|cocaine
1156040|NCT02233647|phendimetrazine|phendimetrazine
1156041|NCT02233647|pharmacotherapy|pharmacotherapy
1156042|NCT02233634|Coronary Angiography|coronary angiography
1156043|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
1156044|NCT02233634|Oxygen|oxygen
1156045|NCT02233634|Hyperoxia|hyperoxia
1156046|NCT02233634|Carbon Dioxide|carbon dioxide
1156047|NCT02233634|Apnea|apnea
1156048|NCT02233634|Hyperventilation|hyperventilation
1156049|NCT02233608|Prostate cancer|prostate cancer
1156050|NCT02233608|Radical prostatectomy|radical prostatectomy
1156051|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
1156052|NCT02233608|Pfilates|pfilates
1156053|NCT02233608|Hypopressives|hypopressives
1156054|NCT02233608|Urinary Incontinence|urinary incontinence
1156055|NCT02233595|MRI|mri
1156056|NCT02233595|PET|pet
1156057|NCT02233595|rectal cancer|rectal cancer
1156058|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
1156059|NCT02233582|altitude|altitude
1156060|NCT02233582|mountain sickness|mountain sickness
1156061|NCT02233582|ibuprofen|ibuprofen
1156062|NCT02233582|hypoxia|hypoxia
1156063|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
1156064|NCT02233569|Ventral hernia|ventral hernia
1156065|NCT02233569|Incisional hernia|incisional hernia
1156066|NCT02233569|IPOM|ipom
1156067|NCT02233556|event-related potential|event-related potential
1156068|NCT02233556|mismatch negativity|mismatch negativity
1156069|NCT02233556|NMDA|nmda
1156070|NCT02233556|Glutamate|glutamate
1156071|NCT02233543|COPD|copd
1156072|NCT02233543|QVA149|qva149
1156073|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
1156074|NCT02233543|combination bronchodilator|combination bronchodilator
1156075|NCT02233530|Dementia|dementia
1156076|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
1156077|NCT02233530|Quality of life|quality of life
1156078|NCT02233530|Cognitive impairment|cognitive impairment
1156079|NCT02233530|Africa|africa
1156080|NCT02233530|Tanzania|tanzania
1156081|NCT02233530|Nigeria|nigeria
1156082|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
1156083|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
1156084|NCT02233530|Task-shifting|task-shifting
1156085|NCT02233530|Cognitive screening|cognitive screening
1156086|NCT02233517|Veterans|veterans
1156087|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1156088|NCT02233517|Aggression|aggression
1156089|NCT02233517|Anger|anger
1156090|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
1156091|NCT02233517|Combat Disorders|combat disorders
1156092|NCT02233491|PTDM|ptdm
1156093|NCT02233491|kidney transplant|kidney transplant
1156094|NCT02233491|lifestyle intervention|lifestyle intervention
1156095|NCT02233491|diet|diet
1156096|NCT02233491|exercise|exercise
1156097|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
1156098|NCT02233478|Soy Protein|soy protein
1156099|NCT02233478|Ellagitannins|ellagitannins
1156100|NCT02233465|parastomal|parastomal
1156101|NCT02233465|hernia|hernia
1156102|NCT02233465|mesh|mesh
1156103|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
1156104|NCT02233452|Neuropathic pain|neuropathic pain
1156105|NCT02233452|Methadone|methadone
1156106|NCT02233452|Ketamine|ketamine
1156107|NCT02233452|Multimodal analgesia|multimodal analgesia
1156108|NCT02233439|galactagogues|galactagogues
1156109|NCT02233439|herbs|herbs
1156110|NCT02233439|breastfeeding|breastfeeding
1156111|NCT02233439|supplements|supplements
1156112|NCT02233439|Silybum marianum|silybum marianum
1156113|NCT02233439|Galega officinalis|galega officinalis
1156114|NCT02233426|allergic rhinitis|allergic rhinitis
1156115|NCT02233426|nasal steroid|nasal steroid
1156116|NCT02233426|hypertonic saline|hypertonic saline
1156117|NCT02233426|eosinophil|eosinophil
1156118|NCT02233426|symptom score|symptom score
1156119|NCT02233413|Traumatic brain injury|traumatic brain injury
1156120|NCT02233413|TBI|tbi
1156121|NCT02233413|Low-level light therapy|low-level light therapy
1156122|NCT02233413|LLLT|lllt
1156123|NCT02233413|LLLT helmet|lllt helmet
1156124|NCT02233400|Acetaminophen|acetaminophen
1156125|NCT02233400|Gastric Bypass|gastric bypass
1156126|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
1156127|NCT02233400|Pain|pain
1156128|NCT02233400|Cost|cost
1156129|NCT02233387|cervix cancer|cervix cancer
1156130|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
1156131|NCT02233387|hypoxia|hypoxia
1156132|NCT02233387|phase II trial|phase ii trial
1156133|NCT02233374|Rectal Cancer|rectal cancer
1156134|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
1156135|NCT02233374|Positron Emission Tomography|positron emission tomography
1156136|NCT02233374|pathologic complete response|pathologic complete response
1156137|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
1156138|NCT02233374|Microstructural Imaging|microstructural imaging
1156139|NCT02233374|FDG PET|fdg pet
1156140|NCT02233361|Hearing rehabilitation|hearing rehabilitation
1156141|NCT02233361|Elderly|elderly
1156142|NCT02233361|Hearing aid use|hearing aid use
1156143|NCT02233322|ADHR|adhr
1156144|NCT02233322|Rickets|rickets
1156145|NCT02233322|Hypophosphatemia|hypophosphatemia
1156146|NCT02233283|LH pulsatility|lh pulsatility
1156147|NCT02233283|Insulin sensitivity|insulin sensitivity
1156148|NCT02233283|Metabolism|metabolism
1156149|NCT02233283|hypercaloric feeding|hypercaloric feeding
1156150|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
1156151|NCT02233257|Lorenzo's oil|lorenzo's oil
1156152|NCT02233257|erucic acid|erucic acid
1156153|NCT02233244|Drug Interaction|drug interaction
1156154|NCT02233205|microbubble|microbubble
1156155|NCT02233205|chemotherapy|chemotherapy
1156156|NCT02233205|alimentary|alimentary
1156157|NCT02233192|PrEP|prep
1156158|NCT02233192|conception|conception
1156159|NCT02233192|HIV|hiv
1156160|NCT02233192|serodiscordant|serodiscordant
1156161|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
1156162|NCT02233153|Senior|senior
1156163|NCT02233153|Elderly|elderly
1156164|NCT02233153|Acute Care|acute care
1156165|NCT02233153|Emergency Surgery|emergency surgery
1156166|NCT02233140|Diabetes|diabetes
1156167|NCT02233140|Ankle equinus|ankle equinus
1156168|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
1156169|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
1156170|NCT02233140|shockwave therapy|shockwave therapy
1156171|NCT02233127|Birth cohort|birth cohort
1156172|NCT02233127|Pakistan|pakistan
1156173|NCT02233127|Child mortality|child mortality
1156174|NCT02233088|Prediabetic State|prediabetic state
1156175|NCT02233088|Hypertension|hypertension
1156176|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
1156177|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
1156178|NCT02233062|Crohn's Disease|crohn's disease
1156179|NCT02233062|semen quality|semen quality
1156180|NCT02233062|enteral nutrition|enteral nutrition
1156181|NCT02233062|CDAI score higher than 150|cdai score higher than 150
1156182|NCT02233049|Children|children
1156183|NCT02233049|adolescents|adolescents
1156184|NCT02233049|young adults|young adults
1156185|NCT02233049|newly diagnosed|newly diagnosed
1156186|NCT02233036|Young Adults|young adults
1156187|NCT02233036|Transfer|transfer
1156188|NCT02233036|Chronic Disease|chronic disease
1156189|NCT02232997|Chronic kidney disease|chronic kidney disease
1156190|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
1156191|NCT02232997|diabetes mellitus|diabetes mellitus
1156192|NCT02232997|congestive heart failure|congestive heart failure
1156193|NCT02232997|hypertension|hypertension
1156194|NCT02232984|Heart Failure|heart failure
1156195|NCT02232984|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1156196|NCT02232984|CRT-D|crt-d
1156197|NCT02232984|Quadripolar pacing|quadripolar pacing
1156198|NCT02232971|glucagon|glucagon
1156199|NCT02232971|insulin pump|insulin pump
1156200|NCT02232971|artificial pancreas|artificial pancreas
1156201|NCT02232971|closed-loop|closed-loop
1156202|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
1156203|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
1156204|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
1156205|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
1156206|NCT02232945|influenza B virus|influenza b virus
1156207|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
1156208|NCT02232932|Liver transplantation|liver transplantation
1156209|NCT02232932|Radiochemotherapy|radiochemotherapy
1156210|NCT02232919|Deep Brain Stimulation|deep brain stimulation
1156211|NCT02232906|Chronic kidney disease|chronic kidney disease
1156212|NCT02232906|CKD|ckd
1156213|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
1156214|NCT02232906|ND-CKD|nd-ckd
1156215|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
1156216|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
1156217|NCT02232906|Iron|iron
1156218|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
1156219|NCT02232893|Abdominal Discomfort|abdominal discomfort
1156220|NCT02232893|Abdominal Bloating|abdominal bloating
1156221|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
1156222|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
1156223|NCT02232880|hypertension|hypertension
1156224|NCT02232880|inflammation|inflammation
1156225|NCT02232867|rehabilitation|rehabilitation
1156226|NCT02232867|stroke|stroke
1156227|NCT02232867|walking|walking
1156228|NCT02232867|interlimb connections|interlimb connections
1156229|NCT02232854|Depression|depression
1156230|NCT02232841|Electrical impedance tomography|electrical impedance tomography
1156231|NCT02232841|lung imaging|lung imaging
1156232|NCT02232789|Mephedrone|mephedrone
1156233|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
1156234|NCT02232789|Abuse liability|abuse liability
1156235|NCT02232789|Human Pharmacology|human pharmacology
1156236|NCT02232776|Losartan|losartan
1156237|NCT02232776|Ig A nephropathy|ig a nephropathy
1156238|NCT02232776|children|children
1156239|NCT02232776|proteinuria|proteinuria
1156240|NCT02232763|Losartan|losartan
1156241|NCT02232763|children|children
1156242|NCT02232763|proteinuria|proteinuria
1156243|NCT02232737|Biomarkers of exposure|biomarkers of exposure
1156244|NCT02232737|Compensatory smoking|compensatory smoking
1156245|NCT02232737|Nicotine dependence|nicotine dependence
1156246|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
1156247|NCT02232737|Tobacco withdrawal|tobacco withdrawal
1156248|NCT02232737|Women|women
1156249|NCT02232737|Health disparaties|health disparaties
1156250|NCT02232737|Vulnerable populations|vulnerable populations
1156251|NCT02232724|Prostate Cancer|prostate cancer
1156252|NCT02232724|Staging|staging
1156253|NCT02232724|PET/CT|pet/ct
1156254|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
1156255|NCT02232698|Sensing Technology|sensing technology
1156256|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
1156257|NCT02232685|Prostate cancer|prostate cancer
1156258|NCT02232685|Staging|staging
1156259|NCT02232685|PET/CT|pet/ct
1156260|NCT02232672|Prostate Cancer|prostate cancer
1156261|NCT02232672|Staging|staging
1156262|NCT02232672|PET/CT|pet/ct
1156263|NCT02232659|SynCardia|syncardia
1156264|NCT02232659|Total Artificial Heart|total artificial heart
1156265|NCT02232659|Biventricular heart failure|biventricular heart failure
1156266|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
1156267|NCT02232568|Patient blood management|patient blood management
1156268|NCT02232568|RBC transfusion|rbc transfusion
1156269|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
1156270|NCT02232529|modified release formulation|modified release formulation
1156271|NCT02232529|pharmacokinetics|pharmacokinetics
1156273|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
1156274|NCT02232490|cancer vaccine|cancer vaccine
1156275|NCT02232490|cirrhosis|cirrhosis
1156276|NCT02232490|hepatitis|hepatitis
1156277|NCT02232490|HCC|hcc
1156278|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
1156279|NCT02232490|immunotherapy|immunotherapy
1156280|NCT02232490|liver tumor|liver tumor
1156281|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
1156282|NCT02232464|Adult ADHD|adult adhd
1156283|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
1156284|NCT02232464|resting-state fMRI|resting-state fmri
1156285|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
1156286|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
1156287|NCT02232464|executive function|executive function
1156288|NCT02232451|loop|loop
1156289|NCT02232451|ERCP|ercp
1156290|NCT02232451|cannulation|cannulation
1156291|NCT02232451|biliary|biliary
1156292|NCT02232451|wire|wire
1156293|NCT02232438|Depression|depression
1156294|NCT02232438|Psychotherapy|psychotherapy
1156295|NCT02232438|Anxiety|anxiety
1156296|NCT02232438|Cancer|cancer
1156297|NCT02232412|Anemia|anemia
1156298|NCT02232412|NIRS|nirs
1156299|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
1156300|NCT02232412|RBC transfusion|rbc transfusion
1156301|NCT02232412|critical ill|critical ill
1156302|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
1156303|NCT02232412|tissue oxygenation|tissue oxygenation
1156304|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
1156305|NCT02232386|Adults|adults
1156306|NCT02232386|Ibrutinib|ibrutinib
1156307|NCT02232373|FODMAPs|fodmaps
1156308|NCT02232373|microbiota|microbiota
1156309|NCT02232373|oligofructose|oligofructose
1156310|NCT02232373|IBS|ibs
1156311|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
1156312|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
1156313|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
1156314|NCT02232360|Plaque composition|plaque composition
1156315|NCT02232360|Rosuvastatin|rosuvastatin
1156316|NCT02232360|Fenofibrate|fenofibrate
1156317|NCT02232360|Coronary artery disease|coronary artery disease
1156318|NCT02232347|traumatic brain injury|traumatic brain injury
1156319|NCT02232347|ketamine|ketamine
1156320|NCT02232347|microdialysis|microdialysis
1156321|NCT02232347|PtiO2|ptio2
1156322|NCT02232347|glutamate|glutamate
1156323|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
1156324|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
1156325|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
1156326|NCT02232282|Interstitial Cystitis|interstitial cystitis
1156327|NCT02232282|Suprapubic Pain|suprapubic pain
1156328|NCT02232282|Urinary Urgency|urinary urgency
1156329|NCT02232269|Coffee|coffee
1156330|NCT02232269|Grapefruit Juice|grapefruit juice
1156331|NCT02232269|Felodipine|felodipine
1156332|NCT02232269|Calcium Channel Blocker|calcium channel blocker
1156333|NCT02232269|Hemodynamics|hemodynamics
1156334|NCT02232269|CYP3A4|cyp3a4
1156335|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
1156336|NCT02232256|Insomnia|insomnia
1156337|NCT02232256|California poppy|california poppy
1156338|NCT02232256|Eschscholzia californica|eschscholzia californica
1156339|NCT02232256|Pain|pain
1156340|NCT02232256|Sleep quality|sleep quality
1156341|NCT02232243|Cancer|cancer
1156342|NCT02232243|Surgery|surgery
1156343|NCT02232243|Hydroxychloroquine|hydroxychloroquine
1156344|NCT02232217|Children|children
1156345|NCT02232217|Sleep|sleep
1156346|NCT02232217|Obesity|obesity
1156347|NCT02232204|insomnia|insomnia
1156348|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1156349|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
1156350|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
1156351|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
1156352|NCT02232165|acute spinal cord injury|acute spinal cord injury
1156353|NCT02232165|hemodynamic therapy|hemodynamic therapy
1156354|NCT02232165|functional outcome|functional outcome
1156355|NCT02232126|Hospital readmissions|hospital readmissions
1156356|NCT02232126|Randomized controlled trial|randomized controlled trial
1156357|NCT02232126|Older adults|older adults
1156358|NCT02232126|Care transitions|care transitions
1156359|NCT02232126|Social work|social work
1156360|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
1156361|NCT02232113|hemodialysis,|hemodialysis,
1156362|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
1156363|NCT02232113|cost-effectiveness,|cost-effectiveness,
1156364|NCT02232113|pharmacokinetics,|pharmacokinetics,
1156365|NCT02232113|endothelial dysfunction|endothelial dysfunction
1156366|NCT02232100|Attentional bias modification|attentional bias modification
1156367|NCT02232100|Chronic pain|chronic pain
1156368|NCT02232100|Visual-probe task|visual-probe task
1156369|NCT02232100|Internet-delivered therapy|internet-delivered therapy
1156370|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
1156371|NCT02232087|corticosteroid|corticosteroid
1156372|NCT02232087|pMDI|pmdi
1156373|NCT02232087|inhaler|inhaler
1156374|NCT02232074|Patient Navigation|patient navigation
1156375|NCT02232074|Medical Legal Partnership|medical legal partnership
1156376|NCT02232074|Healthcare Disparities|healthcare disparities
1156377|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
1156378|NCT02232035|diazepam|diazepam
1156379|NCT02232035|active phase|active phase
1156380|NCT02232022|Stroke|stroke
1156381|NCT02232022|Ischemic stroke|ischemic stroke
1156382|NCT02232022|Atrial fibrillation|atrial fibrillation
1156383|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
1156384|NCT02232022|Non-cryptogenic|non-cryptogenic
1156385|NCT02232009|Neonate|neonate
1156386|NCT02232009|Infant|infant
1156387|NCT02231983|Clinical Characteristics|clinical characteristics
1156388|NCT02231983|Genetic Profiles|genetic profiles
1156389|NCT02231970|Obesity|obesity
1156390|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
1156391|NCT02231970|Weight loss|weight loss
1156392|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
1156393|NCT02231892|Parameter Development|parameter development
1156394|NCT02231892|Cognitive Tasks|cognitive tasks
1156395|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1156396|NCT02231879|Infections|infections
1156397|NCT02231879|Hypogammaglobulinemia|hypogammaglobulinemia
1156398|NCT02231879|CXCR4|cxcr4
1156399|NCT02231879|Myelokathexis|myelokathexis
1156400|NCT02231879|Warts|warts
1156401|NCT02231866|Filovirus|filovirus
1156402|NCT02231866|Healthy|healthy
1156403|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
1156404|NCT02231866|Immunity|immunity
1156405|NCT02231866|Ebola Virus|ebola virus
1156406|NCT02231853|BK Virus|bk virus
1156407|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
1156409|NCT02231853|Adenovirus|adenovirus
1156410|NCT02231853|CMV|cmv
1156411|NCT02231840|Phenotypes|phenotypes
1156412|NCT02231840|Alcohol Use|alcohol use
1156413|NCT02231840|Alcohol|alcohol
1156414|NCT02231840|Alcohol Dependence|alcohol dependence
1156415|NCT02231840|Genetics|genetics
1156416|NCT02231827|subjects|subjects
1156417|NCT02231814|Crohn's disease|crohn's disease
1156418|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
1156419|NCT02231814|Diet|diet
1156420|NCT02231814|Enteral Nutrition|enteral nutrition
1156421|NCT02231801|Preterm|preterm
1156422|NCT02231801|Kangaroo Care|kangaroo care
1156423|NCT02231801|Skin-to-Skin|skin-to-skin
1156424|NCT02231801|Vital Sign|vital sign
1156425|NCT02231801|Heart Rate|heart rate
1156426|NCT02231801|Respiratory Rate|respiratory rate
1156427|NCT02231801|Oxygen Saturation|oxygen saturation
1156428|NCT02231788|Telminuvo|telminuvo
1156429|NCT02231788|Telmitrend|telmitrend
1156430|NCT02231788|Hypertension|hypertension
1156431|NCT02231788|24hr ABPM|24hr abpm
1156432|NCT02231788|Telmisartan|telmisartan
1156433|NCT02231788|S-amlodipine|s-amlodipine
1156434|NCT02231775|Neoadjuvant|neoadjuvant
1156435|NCT02231775|Dabrafenib|dabrafenib
1156436|NCT02231775|Tafinlar|tafinlar
1156437|NCT02231775|GSK2118436|gsk2118436
1156438|NCT02231775|Trametinib|trametinib
1156439|NCT02231775|GSK1120212|gsk1120212
1156440|NCT02231775|Combination therapy|combination therapy
1156441|NCT02231775|Surgery|surgery
1156442|NCT02231775|Adjuvant therapy|adjuvant therapy
1156443|NCT02231775|Melanoma|melanoma
1156444|NCT02231736|Type 2 Diabetes|type 2 diabetes
1156445|NCT02231736|Chromosomal damage|chromosomal damage
1156446|NCT02231736|Micronuclei|micronuclei
1156447|NCT02231736|DNA damage|dna damage
1156448|NCT02231736|HbA1c|hba1c
1156449|NCT02231736|Comet Assay|comet assay
1156450|NCT02231736|Glycemic control|glycemic control
1156451|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
1156452|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
1156453|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
1156454|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
1156455|NCT02231723|Pancreatic cancer|pancreatic cancer
1156456|NCT02231723|Pancreas cancer|pancreas cancer
1156457|NCT02231723|Pancreatic diseases|pancreatic diseases
1156458|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
1156459|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
1156460|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
1156461|NCT02231723|Gemcitabine|gemcitabine
1156462|NCT02231723|Gemzar|gemzar
1156463|NCT02231723|Nab-paclitaxel|nab-paclitaxel
1156464|NCT02231723|Paclitaxel|paclitaxel
1156465|NCT02231723|Abraxane|abraxane
1156466|NCT02231723|Oxaliplatin|oxaliplatin
1156467|NCT02231723|Leucovorin|leucovorin
1156468|NCT02231723|Irinotecan|irinotecan
1156469|NCT02231723|Fluorouracil|fluorouracil
1156470|NCT02231723|5-FU|5-fu
1156471|NCT02231723|MM-398|mm-398
1156472|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
1156473|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
1156474|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
1156475|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
1156476|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
1156477|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
1156478|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
1156479|NCT02231710|Fanconi Anemia|fanconi anemia
1156480|NCT02231710|Sickle Cell Disease|sickle cell disease
1156481|NCT02231710|Thalassemia|thalassemia
1156482|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
1156483|NCT02231710|Sphingolipidoses|sphingolipidoses
1156484|NCT02231697|XLMTM|xlmtm
1156485|NCT02231645|Parkinson's disease|parkinson's disease
1156486|NCT02231645|Deep brain stimulation|deep brain stimulation
1156487|NCT02231645|Subthalamic nucleus|subthalamic nucleus
1156488|NCT02231645|decision-making|decision-making
1156489|NCT02231645|cognition|cognition
1156490|NCT02231645|behavior|behavior
1156491|NCT02231632|Poliomyelitis|poliomyelitis
1156492|NCT02231632|Vaccine|vaccine
1156493|NCT02231632|Safety|safety
1156494|NCT02231632|efficacy|efficacy
1156495|NCT02231619|feasibility|feasibility
1156496|NCT02231619|self assessment|self assessment
1156497|NCT02231619|medical abortion|medical abortion
1156498|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
1156499|NCT02231619|South Africa|south africa
1156500|NCT02231606|Myopia Prevalence|myopia prevalence
1156501|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
1156502|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
1156503|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
1156504|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
1156505|NCT02231567|hip replacement|hip replacement
1156506|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
1156507|NCT02231567|WOMAC questionnaire|womac questionnaire
1156508|NCT02231554|low back pain|low back pain
1156509|NCT02231554|quality of life|quality of life
1156510|NCT02231554|rehabilitation|rehabilitation
1156511|NCT02231554|exercise|exercise
1156512|NCT02231541|Fibromylgia|fibromylgia
1156513|NCT02231541|Magnetic Fields|magnetic fields
1156514|NCT02231541|Pain|pain
1156515|NCT02231541|Visual Analogue scale|visual analogue scale
1156516|NCT02231528|anesthesia|anesthesia
1156517|NCT02231528|central venous catheter|central venous catheter
1156518|NCT02231528|jugular vein|jugular vein
1157132|NCT02229019|Volunteers|volunteers
1156519|NCT02231528|ultrasound guidance|ultrasound guidance
1156520|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
1156521|NCT02231489|Healthy|healthy
1156522|NCT02231489|JNJ-42756493|jnj-42756493
1156523|NCT02231489|JNJ-61818549|jnj-61818549
1156524|NCT02231463|ultrasound|ultrasound
1156525|NCT02231450|AE58054|ae58054
1156526|NCT02231450|Hepatic impairment|hepatic impairment
1156527|NCT02231411|Delayed Cord Clamping|delayed cord clamping
1156528|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
1156529|NCT02231398|Cardiovascular disease|cardiovascular disease
1156530|NCT02231398|Pregnant women|pregnant women
1156531|NCT02231398|Nulliparity|nulliparity
1156532|NCT02231398|Pregnancy outcomes|pregnancy outcomes
1156533|NCT02231398|Pregnancy complications|pregnancy complications
1156534|NCT02231398|Sleep disordered breathing|sleep disordered breathing
1156535|NCT02231385|Colorectal cancer|colorectal cancer
1156536|NCT02231385|Serrated adenomas|serrated adenomas
1156537|NCT02231385|Screening|screening
1156538|NCT02231385|Adenoma detection rate|adenoma detection rate
1156539|NCT02231385|Polypectomy|polypectomy
1156540|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
1156541|NCT02231307|birch pollen|birch pollen
1156542|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
1156543|NCT02231307|efficacy|efficacy
1156544|NCT02231281|HIV Infections|hiv infections
1156545|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1156546|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1156547|NCT02231281|Immune System Diseases|immune system diseases
1156548|NCT02231281|Lentivirus Infections|lentivirus infections
1156549|NCT02231281|Retroviridae Infections|retroviridae infections
1156550|NCT02231281|Virus Diseases|virus diseases
1156551|NCT02231281|RNA Virus Infections|rna virus infections
1156552|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1156553|NCT02231281|Slow Virus Diseases|slow virus diseases
1156554|NCT02231281|Therapeutic Uses|therapeutic uses
1156555|NCT02231281|Pharmacologic Actions|pharmacologic actions
1156556|NCT02231281|Antiretroviral therapy|antiretroviral therapy
1156557|NCT02231281|Early therapy|early therapy
1156558|NCT02231242|brain|brain
1156559|NCT02231242|children|children
1156560|NCT02231242|cerebral palsy|cerebral palsy
1156561|NCT02231242|bone marrow stem cells|bone marrow stem cells
1156562|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
1156563|NCT02231242|quadriparesis|quadriparesis
1156564|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
1156565|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
1156566|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
1156567|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
1156568|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
1156569|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
1156570|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
1156571|NCT02231229|Fast-TB|fast-tb
1156572|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
1156573|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
1156574|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
1156575|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
1156576|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
1156577|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
1156578|NCT02231203|fish oil|fish oil
1156579|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
1156580|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
1156581|NCT02231203|erythrocyte function|erythrocyte function
1156582|NCT02231190|muscle soreness|muscle soreness
1156583|NCT02231190|Muscle damage and recovery|muscle damage and recovery
1156584|NCT02231190|muscle function|muscle function
1156585|NCT02231190|eccentric exercise|eccentric exercise
1156586|NCT02231151|CPR quality assessment|cpr quality assessment
1156587|NCT02231151|Visual CPR assessment|visual cpr assessment
1156588|NCT02231151|Position relative to patient|position relative to patient
1156589|NCT02231138|Abelmoschus manihot|abelmoschus manihot
1156590|NCT02231138|Chronic Kidney Disease|chronic kidney disease
1156591|NCT02231138|proteinuria|proteinuria
1156592|NCT02231138|efficacy|efficacy
1156594|NCT02231125|Abelmoschus manihot|abelmoschus manihot
1156595|NCT02231125|IgA Nephropathy|iga nephropathy
1156596|NCT02231125|proteinuria|proteinuria
1156597|NCT02231125|efficacy|efficacy
1156598|NCT02231125|safety|safety
1156599|NCT02231112|Korean|korean
1156600|NCT02231112|Left side|left side
1569394|NCT00502749|Leukemia|leukemia
1156601|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
1156602|NCT02231099|mesh|mesh
1156603|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1156604|NCT02231086|Laparoscopy|laparoscopy
1156605|NCT02231086|Peritoneal Lavage|peritoneal lavage
1156606|NCT02231086|HIPEC|hipec
1156607|NCT02231073|Freezing of gait|freezing of gait
1156608|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1156609|NCT02231073|Exercise|exercise
1156610|NCT02231073|parkinsonism|parkinsonism
1156611|NCT02231060|Outcome Prediction|outcome prediction
1157233|NCT02228551|surgery|surgery
1156612|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
1156613|NCT02231060|Coma|coma
1156614|NCT02231060|Vegetative State|vegetative state
1156615|NCT02231060|Minimally Conscious State|minimally conscious state
1156616|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
1156617|NCT02231047|Diarrhea|diarrhea
1156618|NCT02231047|Pneumonia|pneumonia
1156619|NCT02231047|Child, Preschool|child, preschool
1156620|NCT02231047|Infant|infant
1156621|NCT02231047|Dietary Supplements|dietary supplements
1156622|NCT02231047|Colostrums|colostrums
1156623|NCT02231047|Developing Countries|developing countries
1156624|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1156625|NCT02231021|alogliptin|alogliptin
1156626|NCT02231021|pioglitazone|pioglitazone
1156627|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
1156628|NCT02231021|thiazolidinedione|thiazolidinedione
1156629|NCT02231008|SMS|sms
1156630|NCT02230969|peginterferon|peginterferon
1156631|NCT02230969|relapsing|relapsing
1156632|NCT02230969|pegylated|pegylated
1156633|NCT02230969|Subcutaneous|subcutaneous
1156634|NCT02230969|Injectable|injectable
1156635|NCT02230969|Multiple Sclerosis|multiple sclerosis
1156636|NCT02230943|rheumatoid|rheumatoid
1156637|NCT02230943|arthritis|arthritis
1156638|NCT02230943|osteoarthritis|osteoarthritis
1156639|NCT02230943|gout|gout
1156640|NCT02230930|Parkinson's disease|parkinson's disease
1156641|NCT02230930|Apomorphine|apomorphine
1156642|NCT02230930|Infusion|infusion
1156643|NCT02230930|Skin reactions|skin reactions
1156644|NCT02230930|Subcutaneous nodules|subcutaneous nodules
1156645|NCT02230930|Hydrocortisone|hydrocortisone
1156646|NCT02230930|Massage|massage
1156647|NCT02230930|Dilution|dilution
1156648|NCT02230904|Rotigotine patch|rotigotine patch
1156649|NCT02230904|Neupro|neupro
1156650|NCT02230904|Parkinson's Disease|parkinson's disease
1156651|NCT02230891|heart failure|heart failure
1156652|NCT02230891|biomarkers|biomarkers
1156653|NCT02230891|troponin|troponin
1156654|NCT02230891|BNP|bnp
1156655|NCT02230891|carvedilol|carvedilol
1156656|NCT02230891|spironolactone|spironolactone
1156657|NCT02230891|prevention|prevention
1156658|NCT02230878|JNJ-42847922|jnj-42847922
1156659|NCT02230878|Phase 1|phase 1
1156660|NCT02230878|Healthy|healthy
1156661|NCT02230878|Placebo|placebo
1156662|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
1156663|NCT02230852|Telemedicine|telemedicine
1156664|NCT02230852|Prehospital|prehospital
1156665|NCT02230852|Emergency Medicine|emergency medicine
1156666|NCT02230852|Stroke|stroke
1156667|NCT02230839|insulin resistance|insulin resistance
1156668|NCT02230839|muscle|muscle
1156669|NCT02230839|health education|health education
1156670|NCT02230839|exercise|exercise
1156671|NCT02230826|Arthroplasty|arthroplasty
1156672|NCT02230826|Hip Replacement|hip replacement
1156673|NCT02230826|Acetabular cup|acetabular cup
1156674|NCT02230826|Femoral stem|femoral stem
1156675|NCT02230813|Cohort Study,|cohort study,
1156676|NCT02230813|Cellulitis,|cellulitis,
1156677|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
1156678|NCT02230813|Emergency Department,|emergency department,
1156679|NCT02230813|Clinical Prediction Rule|clinical prediction rule
1156680|NCT02230787|Pilot study|pilot study
1156681|NCT02230787|randomized clinical trial|randomized clinical trial
1156682|NCT02230787|periodontal disease|periodontal disease
1156683|NCT02230787|gingival recession|gingival recession
1156684|NCT02230787|Emdogain|emdogain
1156685|NCT02230787|connective tissue|connective tissue
1156686|NCT02230787|wound healing|wound healing
1156687|NCT02230787|inflammation|inflammation
1156688|NCT02230774|hydration|hydration
1156689|NCT02230774|cognitive function|cognitive function
1156690|NCT02230774|doctors|doctors
1156691|NCT02230774|nurses|nurses
1156692|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
1156693|NCT02230761|steatoblepharon|steatoblepharon
1156694|NCT02230761|blepharoptosis|blepharoptosis
1156695|NCT02230761|dermatochalasis|dermatochalasis
1156696|NCT02230761|blepharoplasty|blepharoplasty
1156697|NCT02230761|periorbital|periorbital
1156698|NCT02230761|orbital|orbital
1156699|NCT02230761|eyelid|eyelid
1156700|NCT02230761|eyebags|eyebags
1156701|NCT02230761|eye bags|eye bags
1156702|NCT02230748|LAA|laa
1156703|NCT02230748|LAA-Occluder|laa-occluder
1156704|NCT02230748|Atrial Fibrillation|atrial fibrillation
1156705|NCT02230748|AF|af
1156706|NCT02230735|Robotic|robotic
1156707|NCT02230735|Hysterectomy|hysterectomy
1156708|NCT02230735|Uterosacral|uterosacral
1156709|NCT02230735|Bupivacaine|bupivacaine
1156710|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
1156711|NCT02230722|opioids|opioids
1156712|NCT02230722|chronic pain|chronic pain
1156713|NCT02230722|collaborative care|collaborative care
1156714|NCT02230709|Neck pain|neck pain
1156715|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
1156716|NCT02230709|Soreness|soreness
1156717|NCT02230683|Liver Cirrhosis|liver cirrhosis
1156718|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
1156719|NCT02230683|Portal Hypertension|portal hypertension
1156720|NCT02230670|Liver Cirrhosis|liver cirrhosis
1156721|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
1156722|NCT02230605|Delirium|delirium
1156723|NCT02230605|Post Operative Delirium|post operative delirium
1156724|NCT02230605|PD|pd
1156725|NCT02230605|POD|pod
1156726|NCT02230605|Anesthesia|anesthesia
1156727|NCT02230605|Anesthesiology|anesthesiology
1156728|NCT02230605|Post Operative Recovery|post operative recovery
1156729|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
1156730|NCT02230605|PACU|pacu
1156731|NCT02230605|Cognition|cognition
1156732|NCT02230605|Cognitive Impairment|cognitive impairment
1156733|NCT02230605|Memory|memory
1156734|NCT02230605|Thinking|thinking
1156735|NCT02230605|Confusion Assessment Method|confusion assessment method
1156736|NCT02230605|CAM|cam
1156737|NCT02230605|Neurobics|neurobics
1156738|NCT02230605|Neuroplasticity|neuroplasticity
1156739|NCT02230605|Lumosity|lumosity
1156740|NCT02230605|Brain Games|brain games
1156741|NCT02230605|Cognitive Exercise|cognitive exercise
1156742|NCT02230605|Cognitive Training|cognitive training
1156743|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
1156744|NCT02230605|Cognitive Reserve|cognitive reserve
1156745|NCT02230605|Neurobics Trial|neurobics trial
1156746|NCT02230605|Surgery|surgery
1156747|NCT02230605|Elderly Patients|elderly patients
1156748|NCT02230592|PET|pet
1156749|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
1156750|NCT02230592|Brain Imaging|brain imaging
1156751|NCT02230579|safety|safety
1156752|NCT02230579|tolerability|tolerability
1156753|NCT02230579|malaria|malaria
1156754|NCT02230566|MPS 7|mps 7
1156755|NCT02230566|Sly Syndrome|sly syndrome
1156756|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
1156757|NCT02230566|MPS VII|mps vii
1156758|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
1156759|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
1156760|NCT02230566|rare disease|rare disease
1156761|NCT02230566|lysosomal storage disease|lysosomal storage disease
1156762|NCT02230566|metabolic disorder|metabolic disorder
1156763|NCT02230514|Nonunion fracture|nonunion fracture
1156764|NCT02230514|Long bones|long bones
1156765|NCT02230514|Pseudoarthrosis|pseudoarthrosis
1156766|NCT02230514|Cell therapy|cell therapy
1156767|NCT02230514|Tissue engineering|tissue engineering
1156768|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
1156769|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
1156770|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
1156771|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
1156772|NCT02230475|Allergic Rhinitis|allergic rhinitis
1156773|NCT02230475|NMR|nmr
1156774|NCT02230462|patient satisfaction|patient satisfaction
1156775|NCT02230462|Mohs surgery|mohs surgery
1156776|NCT02230436|Pancreatectomy|pancreatectomy
1156777|NCT02230436|Time of drain removal|time of drain removal
1156778|NCT02230423|Functional nasal surgery|functional nasal surgery
1156779|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
1156780|NCT02230410|Barrett's|barrett's
1156781|NCT02230410|high grade dysplasia|high grade dysplasia
1156782|NCT02230410|ablation|ablation
1156783|NCT02230410|cyrotherapy|cyrotherapy
1156784|NCT02230397|skin aging|skin aging
1156785|NCT02230397|anti-aging cream|anti-aging cream
1156786|NCT02230397|wrinkles|wrinkles
1156787|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
1156788|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
1156789|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
1156790|NCT02230371|Myofascial pain|myofascial pain
1156791|NCT02230371|TMD|tmd
1156792|NCT02230371|5-HT3|5-ht3
1156793|NCT02230371|Granisetron|granisetron
1156794|NCT02230371|Placebo-controlled|placebo-controlled
1156795|NCT02230371|Patients|patients
1156796|NCT02230371|Randomized|randomized
1156797|NCT02230371|Double-blind|double-blind
1156798|NCT02230358|carotid endarterectomy|carotid endarterectomy
1156799|NCT02230358|cardiac output|cardiac output
1156800|NCT02230358|trans-cranial Doppler|trans-cranial doppler
1156801|NCT02230358|CEA|cea
1156802|NCT02230358|regional anesthesia|regional anesthesia
1156803|NCT02230358|general anesthesia|general anesthesia
1156804|NCT02230345|Probiotic|probiotic
1156805|NCT02230345|Yoghourt|yoghourt
1156806|NCT02230345|Inflammation|inflammation
1156807|NCT02230345|Metabolomics|metabolomics
1156808|NCT02230319|Cryotherapy|cryotherapy
1156809|NCT02230319|Cold therapy|cold therapy
1156810|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
1156811|NCT02230319|Paclitaxel|paclitaxel
1156812|NCT02230319|Breast Cancer|breast cancer
1156813|NCT02230319|Symptom management|symptom management
1156814|NCT02230319|Prevention|prevention
1156815|NCT02230293|ambulatory care,|ambulatory care,
1156816|NCT02230293|hypertension,|hypertension,
1156817|NCT02230293|health personnel,|health personnel,
1156818|NCT02230293|clinical trial|clinical trial
1156819|NCT02230280|Mobile health technology|mobile health technology
1156820|NCT02230280|Multiple chronic conditions|multiple chronic conditions
1156821|NCT02230280|Older adults|older adults
1156822|NCT02230280|Home and community care|home and community care
1156823|NCT02230280|Effectiveness|effectiveness
1156824|NCT02230280|Cost analysis|cost analysis
1156825|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
1156826|NCT02230267|boot camp|boot camp
1156827|NCT02230267|exercise|exercise
1156828|NCT02230267|balance training|balance training
1156829|NCT02230267|fall prevention|fall prevention
1156830|NCT02230267|falling|falling
1156831|NCT02230267|strength training|strength training
1156832|NCT02230254|Coronary Artery Disease|coronary artery disease
1156833|NCT02230241|Dyslipidaemia|dyslipidaemia
1156834|NCT02230241|LDL-C goals|ldl-c goals
1156835|NCT02230241|Guidelines|guidelines
1156836|NCT02230215|Total Knee Replacement|total knee replacement
1156837|NCT02230215|Visionaire|visionaire
1156838|NCT02230189|Asthma|asthma
1156839|NCT02230189|Allergen challenge|allergen challenge
1156840|NCT02230163|Chikungunya virus|chikungunya virus
1156841|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
1156842|NCT02230163|Neonates|neonates
1156843|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
1156844|NCT02230137|adolescents|adolescents
1156845|NCT02230137|type 1 diabetes|type 1 diabetes
1156846|NCT02230137|poorly controlled|poorly controlled
1156847|NCT02230137|SMS|sms
1156848|NCT02230137|Improve glycaemic control|improve glycaemic control
1156849|NCT02230137|HbA1c reduction|hba1c reduction
1156850|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
1156851|NCT02230124|Hydrocephalus|hydrocephalus
1156852|NCT02230111|Women|women
1156853|NCT02230111|Caloric restriction|caloric restriction
1156854|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
1156855|NCT02230111|Eating behaviours|eating behaviours
1156856|NCT02230111|Food habits|food habits
1156857|NCT02230111|Appetite sensations|appetite sensations
1156858|NCT02230111|Stress|stress
1156859|NCT02230111|Weight management|weight management
1156860|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
1156861|NCT02230098|ischemic heart disease|ischemic heart disease
1156862|NCT02230072|myelomeningocele|myelomeningocele
1156863|NCT02230072|MMC|mmc
1156864|NCT02230072|NTD|ntd
1156865|NCT02230072|neural|neural
1156866|NCT02230072|defect|defect
1156867|NCT02230072|Spina bifida|spina bifida
1156868|NCT02230072|Neural Tube Defect|neural tube defect
1156869|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
1156870|NCT02230059|observational Study|observational study
1156871|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1156872|NCT02230046|Healthy,|healthy,
1156873|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
1156874|NCT02230046|Bioequivalence.|bioequivalence.
1156875|NCT02230033|JNJ-56021927|jnj-56021927
1156876|NCT02230033|Itraconazole|itraconazole
1156877|NCT02230033|Gemfibrozil|gemfibrozil
1156878|NCT02229994|Dyspnea|dyspnea
1156879|NCT02229994|Self-administered questionnaire|self-administered questionnaire
1156880|NCT02229994|Chronic respiratory disease|chronic respiratory disease
1156881|NCT02229994|COPD|copd
1156882|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
1156883|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
1156884|NCT02229994|Cystic fibrosis|cystic fibrosis
1156885|NCT02229981|Lymphoma|lymphoma
1156886|NCT02229981|B-cell Lymphomas|b-cell lymphomas
1156887|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1156888|NCT02229981|Lymphosarcoma|lymphosarcoma
1156889|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
1156890|NCT02229981|KHSV|khsv
1156891|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
1156892|NCT02229981|HIV|hiv
1156893|NCT02229981|Epstein-Barr Virus|epstein-barr virus
1156894|NCT02229981|EBV|ebv
1156895|NCT02229981|Kaposi sarcoma|kaposi sarcoma
1156896|NCT02229968|craniosynostosis|craniosynostosis
1156897|NCT02229968|craniofacial|craniofacial
1156898|NCT02229968|amicar|amicar
1156899|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
1156900|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
1156901|NCT02229955|Dry Eye Syndromes|dry eye syndromes
1156902|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
1156903|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
1156904|NCT02229942|Rituximab|rituximab
1569395|NCT00502749|Lymphoma|lymphoma
1156905|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
1156906|NCT02229942|B-cell depletion|b-cell depletion
1156907|NCT02229929|Pruritus|pruritus
1156908|NCT02229929|uremic pruritus|uremic pruritus
1156909|NCT02229929|kappa opioid|kappa opioid
1156910|NCT02229929|CR845|cr845
1156911|NCT02229916|Testicular Neoplasms|testicular neoplasms
1156912|NCT02229916|Testicular Cancer|testicular cancer
1156913|NCT02229916|Cohort Study|cohort study
1156914|NCT02229903|OCD|ocd
1156915|NCT02229864|Absorb™ BVS|absorb™ bvs
1156916|NCT02229864|Angioplasty|angioplasty
1156917|NCT02229864|Bioabsorbable|bioabsorbable
1156918|NCT02229864|BVS|bvs
1156919|NCT02229864|Coronary Artery Disease|coronary artery disease
1156920|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1156921|NCT02229864|Coronary artery restenosis|coronary artery restenosis
1156922|NCT02229864|Coronary artery stenosis|coronary artery stenosis
1156923|NCT02229864|Coronary scaffold|coronary scaffold
1156924|NCT02229864|Coronary Stent|coronary stent
1156925|NCT02229864|Drug eluting stents|drug eluting stents
1156926|NCT02229864|Everolimus|everolimus
1156927|NCT02229864|Myocardial ischemia|myocardial ischemia
1156928|NCT02229864|Stent thrombosis|stent thrombosis
1156929|NCT02229864|Stents|stents
1156930|NCT02229708|Pregnancy|pregnancy
1156931|NCT02229708|Weight control|weight control
1156932|NCT02229708|Behavioral|behavioral
1156933|NCT02229708|technology-based intervention|technology-based intervention
1156934|NCT02229695|Trauma|trauma
1156935|NCT02229695|Sepsis|sepsis
1156936|NCT02229695|Temporary abdominal closure|temporary abdominal closure
1156937|NCT02229695|Bogota bag|bogota bag
1156938|NCT02229695|Vacuum assisted closure|vacuum assisted closure
1156939|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
1156940|NCT02229682|radiotherapy,|radiotherapy,
1156941|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
1156942|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
1156943|NCT02229682|loco-regional control,|loco-regional control,
1156944|NCT02229682|survival|survival
1156945|NCT02229656|olaparib|olaparib
1156946|NCT02229656|radiotherapy|radiotherapy
1156947|NCT02229656|Laryngeal SCC|laryngeal scc
1156948|NCT02229656|oropharyngeal SCC|oropharyngeal scc
1156949|NCT02229643|Traumatic brain injury|traumatic brain injury
1156950|NCT02229643|Neuroglobin|neuroglobin
1156951|NCT02229643|Nogo-A|nogo-a
1156952|NCT02229643|Prognosis|prognosis
1156953|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
1156954|NCT02229630|MRI|mri
1156955|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
1156956|NCT02229617|Intramuscular testosterone|intramuscular testosterone
1156957|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
1156958|NCT02229604|electroacupuncture|electroacupuncture
1156959|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
1156960|NCT02229604|cohort study|cohort study
1156961|NCT02229578|Burn pain|burn pain
1156962|NCT02229578|lidocaine|lidocaine
1156963|NCT02229578|donor site pain|donor site pain
1156964|NCT02229578|Narcotic use|narcotic use
1156965|NCT02229565|prostate cancer|prostate cancer
1156966|NCT02229565|prostate biopsy|prostate biopsy
1156967|NCT02229565|prostatectomy|prostatectomy
1156968|NCT02229526|Fish oil supplementation|fish oil supplementation
1156969|NCT02229526|RCT|rct
1156970|NCT02229526|High risk pregnancies|high risk pregnancies
1156971|NCT02229526|Twin pregnancy|twin pregnancy
1156972|NCT02229526|Preterm birth|preterm birth
1156973|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
1156974|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
1156975|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
1156976|NCT02229513|uterine atony|uterine atony
1156977|NCT02229513|cesarean section|cesarean section
1156978|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
1156979|NCT02229513|acute blood loss anemia|acute blood loss anemia
1156986|NCT02229513|massive hemorrhage|massive hemorrhage
1156987|NCT02229513|hemorrhage|hemorrhage
1156988|NCT02229513|uterine cooling|uterine cooling
1156989|NCT02229500|Propionate|propionate
1156990|NCT02229500|Microbiome|microbiome
1156991|NCT02229500|Dietary Fibre|dietary fibre
1156992|NCT02229500|Short chain fatty acids|short chain fatty acids
1156993|NCT02229487|Prediabetes|prediabetes
1156994|NCT02229487|Short sleepers|short sleepers
1156995|NCT02229487|GLP-1|glp-1
1156996|NCT02229474|Dementia|dementia
1156997|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
1156998|NCT02229474|Quality of life|quality of life
1156999|NCT02229474|Cognitive impairment|cognitive impairment
1157000|NCT02229474|Africa|africa
1157001|NCT02229474|Tanzania|tanzania
1157002|NCT02229474|Nigeria|nigeria
1157003|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
1157004|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
1157005|NCT02229474|Task-shifting|task-shifting
1157006|NCT02229474|Cognitive screening|cognitive screening
1157007|NCT02229448|Immunoglobulin G|immunoglobulin g
1157008|NCT02229448|focus|focus
1157009|NCT02229448|study|study
1157010|NCT02229448|detect|detect
1157011|NCT02229448|patients|patients
1157012|NCT02229435|Chronic kidney disease|chronic kidney disease
1157013|NCT02229435|Urological care|urological care
1157014|NCT02229435|Nephrological care|nephrological care
1157015|NCT02229409|adults|adults
1157016|NCT02229396|Diabetes Mellitus|diabetes mellitus
1157017|NCT02229396|Exenatide|exenatide
1157018|NCT02229396|Dapagliflozin|dapagliflozin
1157019|NCT02229396|Diabetes medication|diabetes medication
1157020|NCT02229396|Treatment efficacy|treatment efficacy
1157021|NCT02229396|Placebo|placebo
1157022|NCT02229396|Metabolism|metabolism
1157023|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
1157024|NCT02229383|Diabetes Mellitus|diabetes mellitus
1157025|NCT02229383|Exenatide|exenatide
1157026|NCT02229383|Diabetes drug|diabetes drug
1157027|NCT02229383|Treatment efficacy|treatment efficacy
1157028|NCT02229383|Placebo|placebo
1157029|NCT02229383|Metabolism|metabolism
1157030|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
1157031|NCT02229370|extracranial|extracranial
1157032|NCT02229370|carotid|carotid
1157033|NCT02229370|artery|artery
1157034|NCT02229370|aneurysm|aneurysm
1157035|NCT02229370|registry|registry
1157036|NCT02229370|CAR|car
1157037|NCT02229357|H5N2 Vaccine|h5n2 vaccine
1157038|NCT02229344|colitis, ulcerative|colitis, ulcerative
1157039|NCT02229344|MOSAIK|mosaik
1157040|NCT02229344|REMICADE|remicade
1157041|NCT02229344|Infliximab|infliximab
1157042|NCT02229331|haemophilia|haemophilia
1157043|NCT02229331|arthropathy|arthropathy
1157044|NCT02229331|pediatrics|pediatrics
1157045|NCT02229331|ankle|ankle
1157046|NCT02229331|biomechanics|biomechanics
1157047|NCT02229305|Anxiety|anxiety
1157048|NCT02229305|Trauma|trauma
1157049|NCT02229305|Depression|depression
1157050|NCT02229305|Problem Behavior|problem behavior
1157051|NCT02229305|evidence-based treatments|evidence-based treatments
1157052|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
1157053|NCT02229266|AML|aml
1157054|NCT02229266|high-risk AML|high-risk aml
1157055|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
1157056|NCT02229266|NK cells|nk cells
1157057|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
1157058|NCT02229266|immunotherapy|immunotherapy
1157059|NCT02229240|Albiglutide|albiglutide
1157060|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
1157061|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
1157062|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
1157068|NCT02229214|Renal function|renal function
1157069|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
1157070|NCT02229214|Kidney function|kidney function
1157071|NCT02229214|Qsymia|qsymia
1157072|NCT02229214|Iohexol|iohexol
1157073|NCT02229214|Serum Creatinine|serum creatinine
1157074|NCT02229214|Creatinine clearance|creatinine clearance
1157075|NCT02229214|Renal Clearance|renal clearance
1157076|NCT02229214|VI-0521|vi-0521
1157077|NCT02229214|Healthy volunteers|healthy volunteers
1157078|NCT02229201|propofol|propofol
1157079|NCT02229201|sevoflurane|sevoflurane
1157080|NCT02229201|Interleukin 6|interleukin 6
1157081|NCT02229201|Interleukin 10|interleukin 10
1157082|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
1157083|NCT02229175|Diabetic Macular Edema|diabetic macular edema
1157182|NCT02228798|NOAC|noac
1157084|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
1157085|NCT02229175|Type 1 Diabetes|type 1 diabetes
1157086|NCT02229175|Type 2 Diabetes|type 2 diabetes
1157087|NCT02229175|Macular Edema|macular edema
1157088|NCT02229175|bevacizumab|bevacizumab
1157089|NCT02229175|intravitreal injection|intravitreal injection
1157090|NCT02229175|Avastin|avastin
1157091|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
1157092|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
1157093|NCT02229162|umbilical cord|umbilical cord
1157094|NCT02229162|cesarean section|cesarean section
1157095|NCT02229162|Blood Loss, Surgical|blood loss, surgical
1157096|NCT02229149|breast cancer|breast cancer
1157097|NCT02229149|metastatic breast cancer|metastatic breast cancer
1157098|NCT02229149|HER2+ breast cancer|her2+ breast cancer
1157099|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
1157100|NCT02229136|mouth sores|mouth sores
1157101|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
1157102|NCT02229136|metastatic breast cancer|metastatic breast cancer
1157103|NCT02229123|seizures|seizures
1157104|NCT02229123|neonates|neonates
1157105|NCT02229123|anticonvulsant treatment|anticonvulsant treatment
1157106|NCT02229123|levetiracetam|levetiracetam
1157107|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1157108|NCT02229123|electroencephalography|electroencephalography
1157109|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
1157110|NCT02229110|e-Health|e-health
1157111|NCT02229110|allocation of care|allocation of care
1157112|NCT02229110|clinical inertia|clinical inertia
1157113|NCT02229110|quality of care|quality of care
1157114|NCT02229110|patient satisfaction|patient satisfaction
1157115|NCT02229097|type 1 diabetes|type 1 diabetes
1157116|NCT02229071|Donafenib|donafenib
1157117|NCT02229071|HCC|hcc
1157118|NCT02229071|Advanced|advanced
1157119|NCT02229071|inoperable|inoperable
1157120|NCT02229071|Phase 1B|phase 1b
1157121|NCT02229058|Gastric Cancer|gastric cancer
1157122|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
1157123|NCT02229058|S-1|s-1
1157124|NCT02229058|First Line|first line
1157125|NCT02229045|gastric caner|gastric caner
1157126|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
1157127|NCT02229045|5-FU/CF|5-fu/cf
1157128|NCT02229045|taxanes naive|taxanes naive
1157129|NCT02229032|Dravet Syndrome|dravet syndrome
1157130|NCT02229032|cannabidiol therapy|cannabidiol therapy
1157131|NCT02229032|Charlotte's Web|charlotte's web
1157133|NCT02229019|Mealtime assistance|mealtime assistance
1157134|NCT02229019|Older adults|older adults
1157135|NCT02229019|Nutrition|nutrition
1157136|NCT02229019|Nursing|nursing
1157137|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
1157138|NCT02229006|Sodium Fluoride|sodium fluoride
1157139|NCT02229006|Positron Emission Tomography|positron emission tomography
1157140|NCT02228980|Influenza|influenza
1157141|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
1157142|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
1157143|NCT02228967|Alcohol Use|alcohol use
1157144|NCT02228967|SBIRT|sbirt
1157145|NCT02228967|Military|military
1157146|NCT02228967|Health Behavior|health behavior
1157147|NCT02228967|Emergency Room|emergency room
1157148|NCT02228967|Health Promotion|health promotion
1157149|NCT02228967|Formative Research|formative research
1157150|NCT02228967|Randomized Trial|randomized trial
1157151|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
1157152|NCT02228954|Positron-Emission Tomography|positron-emission tomography
1157153|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
1157154|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
1157155|NCT02228889|Hernia|hernia
1157156|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
1157157|NCT02228889|Abdominal wall defect|abdominal wall defect
1157158|NCT02228889|Porcine mesh|porcine mesh
1157159|NCT02228889|Component separation|component separation
1157160|NCT02228889|Abdominal wall tumor|abdominal wall tumor
1157161|NCT02228889|Desmoid|desmoid
1157162|NCT02228863|Stroke|stroke
1157163|NCT02228863|Spasticity|spasticity
1157164|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
1157165|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
1157166|NCT02228850|Scleroderma|scleroderma
1157167|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
1157168|NCT02228850|CREST|crest
1157169|NCT02228850|Apricus Biosciences|apricus biosciences
1157170|NCT02228850|laser doppler|laser doppler
1157171|NCT02228850|thermography|thermography
1157172|NCT02228824|Smoking|smoking
1157173|NCT02228824|Non-daily smokers|non-daily smokers
1157174|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
1157175|NCT02228824|Biomarkers|biomarkers
1157176|NCT02228798|anticoagulant|anticoagulant
1157177|NCT02228798|atrial fibrillation|atrial fibrillation
1157178|NCT02228798|surgery|surgery
1157179|NCT02228798|oral anticoagulant|oral anticoagulant
1157180|NCT02228798|discontinue|discontinue
1157181|NCT02228798|DOAC|doac
1157183|NCT02228798|blood thinner|blood thinner
1157184|NCT02228798|interruption|interruption
1157185|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
1157186|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
1157187|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
1157188|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
1157189|NCT02228759|Ambulatory home regional|ambulatory home regional
1157190|NCT02228759|adductor canal block|adductor canal block
1157191|NCT02228759|Postoperative pain|postoperative pain
1157192|NCT02228759|total knee arthroplasty|total knee arthroplasty
1157193|NCT02228759|Home regional|home regional
1157194|NCT02228759|Fast track arthroplasty|fast track arthroplasty
1157195|NCT02228720|Chronic Sinusitis|chronic sinusitis
1157196|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
1157198|NCT02228694|Pre installation|pre installation
1157199|NCT02228694|Post installation|post installation
1157200|NCT02228694|Safety|safety
1157201|NCT02228694|Time|time
1157202|NCT02228668|AVANT|avant
1157203|NCT02228668|GERCOR|gercor
1157204|NCT02228668|Follow up|follow up
1157205|NCT02228668|Colon cancer|colon cancer
1157206|NCT02228668|Bevacizumab|bevacizumab
1157207|NCT02228668|Overall survival|overall survival
1157208|NCT02228655|Chronic Kidney Disease|chronic kidney disease
1157209|NCT02228655|CKD|ckd
1157210|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
1157211|NCT02228642|Type 1 diabetes|type 1 diabetes
1157212|NCT02228642|Type 2 diabetes|type 2 diabetes
1157213|NCT02228642|Hypoglycemia|hypoglycemia
1157214|NCT02228642|Cognition disorders|cognition disorders
1157215|NCT02228642|Inpatient|inpatient
1157216|NCT02228629|Diabetes|diabetes
1157217|NCT02228629|Foot complications|foot complications
1157218|NCT02228629|plantar keratoma|plantar keratoma
1157219|NCT02228629|plantar pressure|plantar pressure
1157220|NCT02228616|Constipation|constipation
1157221|NCT02228616|Chronic constipation|chronic constipation
1157222|NCT02228616|Prucalopride|prucalopride
1157223|NCT02228616|Women|women
1157224|NCT02228603|exercise therapy|exercise therapy
1157225|NCT02228603|rehabilitation|rehabilitation
1157226|NCT02228590|Parkinson's Disease|parkinson's disease
1157227|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
1157228|NCT02228564|Atherosclerosis|atherosclerosis
1157229|NCT02228564|Intermittent claudication|intermittent claudication
1157230|NCT02228564|BOLSTER|bolster
1157231|NCT02228551|Augmented renal clearance|augmented renal clearance
1157232|NCT02228551|non-critically ill|non-critically ill
1157234|NCT02228551|prevalence|prevalence
1157235|NCT02228551|risk factors|risk factors
1157236|NCT02228538|total knee arthroplasty|total knee arthroplasty
1157237|NCT02228538|osteoarthritis|osteoarthritis
1157238|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
1157239|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
1157240|NCT02228525|14-005|14-005
1157241|NCT02228512|HHV8|hhv8
1157242|NCT02228512|PEL|pel
1157243|NCT02228512|Immune Modulation|immune modulation
1157244|NCT02228512|CC-4047|cc-4047
1157245|NCT02228512|IMiD|imid
1157246|NCT02228499|asthma|asthma
1157247|NCT02228499|academics|academics
1157248|NCT02228499|GPA|gpa
1157249|NCT02228499|attendance|attendance
1157250|NCT02228447|Adolescent|adolescent
1157251|NCT02228447|Randomized controlled trial|randomized controlled trial
1157252|NCT02228447|Eating behavior|eating behavior
1157253|NCT02228447|Physical Activity|physical activity
1157254|NCT02228447|Sedentary lifestyle|sedentary lifestyle
1157255|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
1157256|NCT02228408|hemodialysis|hemodialysis
1157257|NCT02228408|ESRD|esrd
1157258|NCT02228408|Cardiovascular Disease|cardiovascular disease
1157259|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
1157260|NCT02228408|Hydralazine|hydralazine
1157261|NCT02228395|Single ascending doses|single ascending doses
1157262|NCT02228395|pharmacokinetics|pharmacokinetics
1157263|NCT02228395|safety|safety
1157264|NCT02228395|tolerability|tolerability
1157265|NCT02228395|healthy volunteers|healthy volunteers
1157266|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
1157267|NCT02228382|Bosutinib|bosutinib
1157268|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
1157269|NCT02228382|CML|cml
1157270|NCT02228382|Leukemia|leukemia
1157271|NCT02228382|Myelogenous|myelogenous
1157272|NCT02228382|Chronic|chronic
1157273|NCT02228382|BC-ABL Positive|bc-abl positive
1157274|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
1157275|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
1157276|NCT02228356|oligometastatic cancer|oligometastatic cancer
1157277|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1157278|NCT02228356|SBRT|sbrt
1157279|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
1157280|NCT02228356|ITV|itv
1157281|NCT02228356|Internal Target Volume|internal target volume
1157282|NCT02228356|Respiratory Motion Management|respiratory motion management
1157283|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
1157284|NCT02228356|IGRT|igrt
1157285|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
1157286|NCT02228330|Obturator nerve reflex|obturator nerve reflex
1157287|NCT02228330|Obturator nerve block|obturator nerve block
1157288|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
1157289|NCT02228317|Telemedicine|telemedicine
1157290|NCT02228317|Emergency Medical Services|emergency medical services
1157291|NCT02228317|Pre-hospital|pre-hospital
1157292|NCT02228304|Wet AMD|wet amd
1157293|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
1157294|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
1157295|NCT02228304|Active subfoveal CNV|active subfoveal cnv
1157296|NCT02228291|Polyphenols|polyphenols
1157297|NCT02228291|Endothelial function|endothelial function
1157298|NCT02228291|Gut barrier function|gut barrier function
1157299|NCT02228278|Pediatric|pediatric
1157300|NCT02228278|Obesity|obesity
1157301|NCT02228278|Overweight|overweight
1157302|NCT02228278|Texting|texting
1157303|NCT02228278|Text message|text message
1157304|NCT02228278|SMS|sms
1157305|NCT02228278|Diet|diet
1157306|NCT02228278|Weight Loss|weight loss
1157307|NCT02228278|Nutrition|nutrition
1157308|NCT02228278|Physical activity|physical activity
1157309|NCT02228278|BMI z-score|bmi z-score
1157310|NCT02228278|BMI|bmi
1157311|NCT02228252|Proteins|proteins
1157312|NCT02228252|Postprandial lipemia|postprandial lipemia
1157313|NCT02228252|Pre-meal|pre-meal
1157314|NCT02228252|Metabolic syndrome|metabolic syndrome
1157315|NCT02228239|Healthy|healthy
1157316|NCT02228239|Esketamine|esketamine
1157317|NCT02228239|Mirtazapine|mirtazapine
1157318|NCT02228239|Psychomotor.|psychomotor.
1157319|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
1157320|NCT02228226|Bone hole|bone hole
1157321|NCT02228226|Ossification|ossification
1157322|NCT02228226|Suture anchor|suture anchor
1157323|NCT02228226|Shoulder dislocation|shoulder dislocation
1157324|NCT02228213|multiple sclerosis|multiple sclerosis
1157325|NCT02228213|SPMS|spms
1157326|NCT02228200|Oncology Nursing|oncology nursing
1157327|NCT02228200|Advanced Practice Nursing|advanced practice nursing
1157328|NCT02228200|Nurse-led care|nurse-led care
1157329|NCT02228200|Chemotherapy|chemotherapy
1157330|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
1157331|NCT02228174|AUB-L|aub-l
1157332|NCT02228174|Fibroids|fibroids
1157333|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
1157334|NCT02228174|HMB|hmb
1157335|NCT02228174|Myoma|myoma
1157336|NCT02228174|Menorrhagia|menorrhagia
1157337|NCT02228161|Yoga|yoga
1157338|NCT02228161|Work-related Stress,|work-related stress,
1157339|NCT02228161|Stress Adaptation.|stress adaptation.
1157340|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
1157341|NCT02228122|Chronic wounds|chronic wounds
1157342|NCT02228122|Biofilms|biofilms
1157343|NCT02228122|Bacteria|bacteria
1157344|NCT02228096|relapsed/refractory|relapsed/refractory
1157345|NCT02228096|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
1157346|NCT02228096|Pharmaceuticals|pharmaceuticals
1157347|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
1157348|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
1157349|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1157350|NCT02228083|dental|dental
1157351|NCT02228083|epinephrine|epinephrine
1157352|NCT02228083|local anesthetic|local anesthetic
1157353|NCT02228083|lidocaine|lidocaine
1157354|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
1157355|NCT02228083|procedure|procedure
1157356|NCT02228070|strabismus|strabismus
1157357|NCT02228070|oculomotor palsy|oculomotor palsy
1157358|NCT02228070|abducens palsy|abducens palsy
1157359|NCT02228070|trochlear palsy|trochlear palsy
1157360|NCT02228057|arterial patency|arterial patency
1157361|NCT02228057|upper extremity|upper extremity
1157362|NCT02228057|anastomosis|anastomosis
1157363|NCT02228057|sensibility|sensibility
1157364|NCT02228057|pain|pain
1157365|NCT02228057|cold intolerance|cold intolerance
1157366|NCT02228044|suicide|suicide
1157367|NCT02228044|alcohol|alcohol
1157368|NCT02228044|marijuana|marijuana
1157369|NCT02228044|HIV|hiv
1157370|NCT02228044|prevention|prevention
1157371|NCT02228044|adolescent|adolescent
1157372|NCT02228031|Mirror neurons|mirror neurons
1157373|NCT02228031|Imitation|imitation
1157374|NCT02228031|Oxytocin|oxytocin
1157375|NCT02227992|Fibrin Sealant|fibrin sealant
1157376|NCT02227992|Hemostatics|hemostatics
1157377|NCT02227992|Coagulants|coagulants
1157378|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
1157379|NCT02227966|MCI|mci
1157380|NCT02227966|tDCS|tdcs
1157381|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
1157382|NCT02227953|Alzheimer's Disease|alzheimer's disease
1157383|NCT02227953|AD|ad
1157384|NCT02227953|tDCS|tdcs
1157385|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
1157386|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1157387|NCT02227927|GERD|gerd
1157388|NCT02227927|Gastroparesis|gastroparesis
1157389|NCT02227927|Domperidone|domperidone
1157390|NCT02227888|CF|cf
1157391|NCT02227888|F508Del|f508del
1157392|NCT02227888|Cavosonstat|cavosonstat
1157393|NCT02227888|N91115|n91115
1157394|NCT02227849|insulin resistance|insulin resistance
1157395|NCT02227836|Allergy Patch testing|allergy patch testing
1157396|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
1157397|NCT02227836|EoE|eoe
1157398|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
1157399|NCT02227823|electromyography|electromyography
1157400|NCT02227823|fatigability|fatigability
1157401|NCT02227823|decrement|decrement
1157402|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
1157403|NCT02227810|Electrical stimulation,|electrical stimulation,
1157404|NCT02227810|Activities of daily life,|activities of daily life,
1157405|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
1157406|NCT02227797|stem cell transplant|stem cell transplant
1157407|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1157408|NCT02227797|fungal infection|fungal infection
1157409|NCT02227797|voriconazole|voriconazole
1157410|NCT02227797|pediatric|pediatric
1157411|NCT02227719|after augmentation|after augmentation
1157412|NCT02227719|procedure|procedure
1157413|NCT02227706|Fibrin Sealant|fibrin sealant
1157414|NCT02227706|Hemostatics|hemostatics
1157415|NCT02227706|Coagulants|coagulants
1157416|NCT02227693|Thrombocytopenia|thrombocytopenia
1157417|NCT02227693|Chronic Liver Disease|chronic liver disease
1157418|NCT02227680|music therapy|music therapy
1157419|NCT02227680|massage therapy|massage therapy
1157420|NCT02227667|MEDI4736|medi4736
1157421|NCT02227667|14-109|14-109
1157422|NCT02227654|Ovary|ovary
1157423|NCT02227654|Cancer|cancer
1157424|NCT02227654|Morphology|morphology
1157425|NCT02227654|Surgery|surgery
1157426|NCT02227641|CMV|cmv
1157427|NCT02227641|Cytomegalovirus|cytomegalovirus
1157428|NCT02227641|EBV|ebv
1157429|NCT02227641|Epstein Barr Virus|epstein barr virus
1157430|NCT02227641|virus|virus
1157431|NCT02227641|T cell|t cell
1157432|NCT02227641|adoptive transfer|adoptive transfer
1157433|NCT02227641|transplantation|transplantation
1157434|NCT02227641|allogeneic|allogeneic
1157435|NCT02227589|adolescent,|adolescent,
1157436|NCT02227589|alcohol abuse|alcohol abuse
1157437|NCT02227589|depression,|depression,
1157438|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
1157439|NCT02227589|cannabis abuse|cannabis abuse
1157440|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
1157441|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1157442|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
1157443|NCT02227563|auditory hallucinations|auditory hallucinations
1157444|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1157445|NCT02227550|Atrilal fibrillation|atrilal fibrillation
1157446|NCT02227550|anticoagulation|anticoagulation
1157447|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
1157448|NCT02227550|catheter ablation|catheter ablation
1157449|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
1157450|NCT02227537|nighttime Bracing|nighttime bracing
1157451|NCT02227537|Providence|providence
1157452|NCT02227524|Multiple Sclerosis|multiple sclerosis
1157453|NCT02227524|Walking|walking
1157454|NCT02227524|Gait|gait
1157455|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
1157456|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
1157457|NCT02227485|Gingivitis|gingivitis
1157458|NCT02227485|Diabetes mellitus|diabetes mellitus
1157459|NCT02227485|Medicine, Traditional|medicine, traditional
1157460|NCT02227485|Herbal medicine|herbal medicine
1157461|NCT02227485|Punica granatum|punica granatum
1157462|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
1157463|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
1157464|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
1157465|NCT02227407|SCI|sci
1157466|NCT02227407|SMA|sma
1157467|NCT02227407|Paralysis|paralysis
1157468|NCT02227394|Asthma|asthma
1157469|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
1157470|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
1157471|NCT02227368|Myocardial Infarction|myocardial infarction
1157472|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
1157473|NCT02227368|Mycardial Ischemia|mycardial ischemia
1157474|NCT02227368|Heart Diseases|heart diseases
1157475|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
1157476|NCT02227368|Vascular Diseases|vascular diseases
1157477|NCT02227368|Altherosclerosis|altherosclerosis
1157478|NCT02227368|Arteriosclerosis|arteriosclerosis
1157479|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
1157480|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
1157481|NCT02227368|Ticagrelor|ticagrelor
1157482|NCT02227368|Ticlopidine|ticlopidine
1157483|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
1157484|NCT02227368|Hematologic Agents|hematologic agents
1157485|NCT02227368|Therapeutic Uses|therapeutic uses
1157486|NCT02227368|Pharmacologic Actions|pharmacologic actions
1157487|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
1157488|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
1157489|NCT02227368|Purinergic Antagonists|purinergic antagonists
1157490|NCT02227368|Purinergic Agents|purinergic agents
1157491|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
1157492|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
1157493|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
1157494|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
1157495|NCT02227368|Crardiovascular Agents|crardiovascular agents
1157496|NCT02227355|Parkinson's Disease|parkinson's disease
1157497|NCT02227355|Neupro®|neupro®
1157498|NCT02227355|Rotigotine|rotigotine
1157499|NCT02227355|Transdermal patch|transdermal patch
1157500|NCT02227355|NEUPART|neupart
1157501|NCT02227355|Levodopa|levodopa
1157502|NCT02227355|Noninterventional|noninterventional
1157503|NCT02227355|Combination therapy|combination therapy
1157504|NCT02227329|Home Parenteral Nutrition|home parenteral nutrition
1157505|NCT02227329|Infection Prevention|infection prevention
1157506|NCT02227329|CRBSI|crbsi
1157507|NCT02227329|Ethanol Lock Therapy|ethanol lock therapy
1157508|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
1157509|NCT02227316|Pain|pain
1157510|NCT02227316|UFE|ufe
1157511|NCT02227316|Fibroids|fibroids
1157512|NCT02227316|Adenomyosis|adenomyosis
1157513|NCT02227316|Bleeding|bleeding
1157514|NCT02227316|IV Acetaminophen|iv acetaminophen
1157515|NCT02227316|IV Ibuprofen|iv ibuprofen
1157516|NCT02227316|Menorrhagia|menorrhagia
1157517|NCT02227316|Leiomyoma|leiomyoma
1157518|NCT02227316|Patient Satisfaction|patient satisfaction
1157519|NCT02227290|Tinea Corporis|tinea corporis
1157520|NCT02227290|Ringworm|ringworm
1157521|NCT02227277|HIV|hiv
1157522|NCT02227277|HIV-1|hiv-1
1157523|NCT02227277|Pegintron|pegintron
1157524|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
1157525|NCT02227277|Viral suppression|viral suppression
1157526|NCT02227277|ART cessation|art cessation
1157527|NCT02227277|Immune function|immune function
1157528|NCT02227277|Innate immunity|innate immunity
1157529|NCT02227277|Toxicity|toxicity
1157530|NCT02227277|Immune-based therapy|immune-based therapy
1157531|NCT02227277|Treatment interruption|treatment interruption
1157532|NCT02227277|HIV Cure|hiv cure
1157533|NCT02227277|HIV Eradication|hiv eradication
1157534|NCT02227277|BEAT-HIV|beat-hiv
1157535|NCT02227277|HIV Cure Trial|hiv cure trial
1157536|NCT02227277|Cure Trial|cure trial
1157537|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
1157538|NCT02227264|Calcimimetic Agents|calcimimetic agents
1157539|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
1157540|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
1157541|NCT02227251|DLBCL|dlbcl
1157542|NCT02227251|Karyopharm|karyopharm
1157543|NCT02227251|KPT-330|kpt-330
1157544|NCT02227251|selinexor|selinexor
1157545|NCT02227238|integrase inhibitor|integrase inhibitor
1157546|NCT02227238|non-inferiority|non-inferiority
1157547|NCT02227238|dolutegravir|dolutegravir
1157548|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
1157549|NCT02227238|second-line treatment|second-line treatment
1157550|NCT02227238|HIV-1|hiv-1
1157551|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
1157552|NCT02227225|Postoperative Delirium|postoperative delirium
1157553|NCT02227186|Influenza vaccination rates|influenza vaccination rates
1157554|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
1157555|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
1157556|NCT02227082|radiotherapy|radiotherapy
1157557|NCT02227082|olaparib|olaparib
1157558|NCT02227082|breast cancer|breast cancer
1157559|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
1157560|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
1157561|NCT02227056|Methylphenidate|methylphenidate
1157562|NCT02227056|Traumatic brain injury|traumatic brain injury
1157563|NCT02227056|Cerebrovascular event|cerebrovascular event
1157564|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
1157565|NCT02227056|Function (ecologic)|function (ecologic)
1157566|NCT02227004|MRI|mri
1157567|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
1157568|NCT02227004|pacemakers|pacemakers
1157569|NCT02227004|ICD|icd
1157570|NCT02226965|PNT2258|pnt2258
1157571|NCT02226965|DLBCL|dlbcl
1157572|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1157573|NCT02226965|NHL|nhl
1157580|NCT02226913|sodium bicarbonate|sodium bicarbonate
1157581|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
1157582|NCT02226900|Hybrid Revascularization|hybrid revascularization
1157583|NCT02226887|Loop ileostomy|loop ileostomy
1157584|NCT02226887|Eventration|eventration
1157585|NCT02226874|Dose Estimation|dose estimation
1157586|NCT02226874|Dose Reconstruction|dose reconstruction
1157587|NCT02226874|Methods|methods
1157588|NCT02226874|Fallout|fallout
1157589|NCT02226874|Radiation Exposure|radiation exposure
1157595|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
1157596|NCT02226848|Angiogenesis|angiogenesis
1157597|NCT02226848|Traumatic Brain Injury|traumatic brain injury
1157598|NCT02226835|OCT|oct
1157599|NCT02226835|Alzheimer's Disease|alzheimer's disease
1157600|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1157601|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
1157602|NCT02226809|Muscle relaxants|muscle relaxants
1157603|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
1157604|NCT02226809|General anesthesia|general anesthesia
1157605|NCT02226809|Postanesthesia care unit|postanesthesia care unit
1157606|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
1157607|NCT02226796|Broca's Aphasia|broca's aphasia
1157608|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1157609|NCT02226783|Phase I|phase i
1157610|NCT02226783|Healthy subjects|healthy subjects
1157611|NCT02226783|PK|pk
1157612|NCT02226783|PD|pd
1157613|NCT02226757|NSCLC|nsclc
1157614|NCT02226757|HER2-expression|her2-expression
1157615|NCT02226757|EGFR-mutation|egfr-mutation
1157616|NCT02226757|Trastuzumab|trastuzumab
1157617|NCT02226757|Paclitaxel|paclitaxel
1157618|NCT02226744|breathing|breathing
1157619|NCT02226744|mind-body practices|mind-body practices
1157620|NCT02226744|yoga|yoga
1157621|NCT02226744|meditation|meditation
1157622|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
1157623|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
1157624|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
1157625|NCT02226705|Surgery|surgery
1157626|NCT02226705|Fungal Infection|fungal infection
1157627|NCT02226705|Survival|survival
1157628|NCT02226692|chronic low back pain|chronic low back pain
1157629|NCT02226692|prognostic factors|prognostic factors
1157630|NCT02226692|disabling low back pain|disabling low back pain
1157631|NCT02226692|lumbar muscle activity|lumbar muscle activity
1157632|NCT02226692|start back screening tool|start back screening tool
1157633|NCT02226692|physical evaluation|physical evaluation
1157634|NCT02226679|crossover|crossover
1157635|NCT02226679|rollover study|rollover study
1157636|NCT02226679|open label|open label
1157637|NCT02226666|MRI|mri
1157638|NCT02226666|Eovist|eovist
1157639|NCT02226666|MultiHance|multihance
1157640|NCT02226601|drowsiness|drowsiness
1157641|NCT02226601|loopiness|loopiness
1157642|NCT02226601|nausea|nausea
1157643|NCT02226575|Sense of coherence|sense of coherence
1157644|NCT02226549|hepatitis C|hepatitis c
1157645|NCT02226549|Gilead|gilead
1157646|NCT02226549|GS-9451|gs-9451
1157647|NCT02226536|Posture|posture
1157648|NCT02226536|Vertigo|vertigo
1157649|NCT02226536|glucose metabolism|glucose metabolism
1157650|NCT02226536|diet|diet
1157651|NCT02226536|scales|scales
1157652|NCT02226536|dinamic posturography|dinamic posturography
1157653|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
1157654|NCT02226523|acute coronary syndrome|acute coronary syndrome
1157655|NCT02226523|serum biomarkers|serum biomarkers
1157656|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
1157657|NCT02226484|GERD|gerd
1157658|NCT02226484|Acid reflux|acid reflux
1157659|NCT02226484|Reflux|reflux
1157660|NCT02226484|Quercetin|quercetin
1157661|NCT02226458|Autism|autism
1157662|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
1157663|NCT02226458|EPI-743|epi-743
1157664|NCT02226458|EPI743|epi743
1157665|NCT02226458|Rett syndrome|rett syndrome
1157666|NCT02226458|Angelman syndrome|angelman syndrome
1157667|NCT02226445|Adults|adults
1157668|NCT02226445|Outpatients|outpatients
1157669|NCT02226432|Barthel Scale|barthel scale
1157670|NCT02226432|Disability|disability
1157671|NCT02226432|Modified Ashworth Scale|modified ashworth scale
1157672|NCT02226432|Right Arm|right arm
1157673|NCT02226432|Neuromodulation|neuromodulation
1157674|NCT02226432|Spasticity|spasticity
1157675|NCT02226432|Stroke|stroke
1157676|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
1157677|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
1157678|NCT02226419|Exercise|exercise
1157679|NCT02226419|L-carnitine treatment|l-carnitine treatment
1157680|NCT02226419|Stable isotopes|stable isotopes
1157681|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
1157682|NCT02226406|Early Physical Exercise|early physical exercise
1157683|NCT02226406|Alveolar Recruitment|alveolar recruitment
1157684|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
1157685|NCT02226406|Oxygenation|oxygenation
1157686|NCT02226406|Ventilation|ventilation
1157687|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
1157688|NCT02226367|prazosin|prazosin
1157689|NCT02226367|alcohol use disorders|alcohol use disorders
1157690|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
1157691|NCT02226367|PTSD|ptsd
1157692|NCT02226367|combat trauma|combat trauma
1157693|NCT02226367|military|military
1157694|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
1157695|NCT02226354|Dietary vegetable oil|dietary vegetable oil
1157696|NCT02226354|Stearidonic acid|stearidonic acid
1157697|NCT02226354|Tissue|tissue
1157698|NCT02226354|Fatty Acid|fatty acid
1157699|NCT02226354|composition|composition
1157700|NCT02226341|Lupus|lupus
1157701|NCT02226341|Lupus Nephritis|lupus nephritis
1157702|NCT02226341|ACTHar|acthar
1157703|NCT02226341|Columbia|columbia
1157704|NCT02226341|Rheumatology|rheumatology
1157705|NCT02226341|CUMC|cumc
1157706|NCT02226341|Autoimmune|autoimmune
1157707|NCT02226341|SLE|sle
1157708|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
1157709|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
1157710|NCT02226302|Endometrial cancer|endometrial cancer
1157711|NCT02226302|Obesity|obesity
1157712|NCT02226289|bevacizumab|bevacizumab
1157713|NCT02226289|refractory|refractory
1157714|NCT02226289|colorectal cancer|colorectal cancer
1157715|NCT02226289|metastatic|metastatic
1157716|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
1157717|NCT02226263|Probiotics|probiotics
1157718|NCT02226263|Preterm newborns|preterm newborns
1157719|NCT02226250|sugar-based beverage|sugar-based beverage
1157720|NCT02226250|Time Influence|time influence
1157721|NCT02226237|urinary incontinence|urinary incontinence
1157722|NCT02226237|erectile dysfunction|erectile dysfunction
1157723|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
1157724|NCT02226237|Physiotherapy|physiotherapy
1157725|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
1157726|NCT02226224|endosonography|endosonography
1157727|NCT02226224|in vitro|in vitro
1157728|NCT02226224|Staging|staging
1157729|NCT02226198|LDL-C|ldl-c
1157730|NCT02226198|HoFH|hofh
1157731|NCT02226198|Hyperlipidemia|hyperlipidemia
1157732|NCT02226172|Primary myelofibrosis|primary myelofibrosis
1157733|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
1157734|NCT02226172|PMF|pmf
1157735|NCT02226172|PET-MF|pet-mf
1157736|NCT02226172|PPV-MF|ppv-mf
1157737|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
1157738|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
1157858|NCT02225574|Leukemia|leukemia
1157739|NCT02226172|smoothened inhibitor|smoothened inhibitor
1157740|NCT02226172|oral|oral
1157741|NCT02226172|single agent.|single agent.
1157742|NCT02226159|cervical|cervical
1157743|NCT02226159|radicular pain|radicular pain
1157744|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
1157745|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
1157746|NCT02226146|Bullous|bullous
1157747|NCT02226146|Blisters|blisters
1157748|NCT02226146|SKIN DISEASES|skin diseases
1157749|NCT02226146|BP|bp
1157750|NCT02226120|LCZ696, chronic heart failure, open-label study, ARNI|lcz696, chronic heart failure, open-label study, arni
1157751|NCT02226107|Lay health worker|lay health worker
1157752|NCT02226107|Patient navigation|patient navigation
1157753|NCT02226107|Screening colonoscopy|screening colonoscopy
1157754|NCT02226107|Colon cancer|colon cancer
1157755|NCT02226107|Training|training
1157756|NCT02226107|Hispanic|hispanic
1157757|NCT02226107|Latino|latino
1157758|NCT02226094|intra-ocular pressure|intra-ocular pressure
1157759|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
1157760|NCT02226094|intra ocular pressure|intra ocular pressure
1157761|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
1157762|NCT02226094|glaucoma|glaucoma
1157763|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
1157764|NCT02226094|ocular hypertension|ocular hypertension
1157765|NCT02226081|breast lesion|breast lesion
1157766|NCT02226081|ultrasound|ultrasound
1157767|NCT02226081|BI-RADS|bi-rads
1157768|NCT02226081|women|women
1157769|NCT02226081|malignancy|malignancy
1157770|NCT02226068|Atopic dermatitis|atopic dermatitis
1157771|NCT02226068|Ciclosporine|ciclosporine
1157772|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
1157773|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
1157774|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
1157784|NCT02225990|stroke|stroke
1157785|NCT02225990|stroke rehabilitation|stroke rehabilitation
1157786|NCT02225990|stroke therapy|stroke therapy
1157787|NCT02225964|APOEε4|apoeε4
1157788|NCT02225938|Intensive Care|intensive care
1157789|NCT02225938|Recovery|recovery
1157790|NCT02225938|Long term outcome|long term outcome
1157791|NCT02225938|Function|function
1157792|NCT02225925|brachytherapy|brachytherapy
1157793|NCT02225886|Renal anaemia|renal anaemia
1157794|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
1157795|NCT02225886|Intravenous iron administration|intravenous iron administration
1157796|NCT02225860|ADPKD|adpkd
1157797|NCT02225860|Copeptin|copeptin
1157798|NCT02225860|Vasopressin|vasopressin
1157799|NCT02225860|Diet|diet
1157800|NCT02225860|Water|water
1157810|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
1157811|NCT02225821|Implant Removal|implant removal
1157812|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
1157813|NCT02225821|Postoperative wound infection|postoperative wound infection
1157814|NCT02225821|Orthopedics|orthopedics
1157815|NCT02225808|CBT|cbt
1157816|NCT02225808|autism|autism
1157817|NCT02225808|anxiety|anxiety
1157818|NCT02225808|treatment|treatment
1157819|NCT02225808|fMRI|fmri
1157820|NCT02225795|Crohn's Disease|crohn's disease
1157821|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1157822|NCT02225795|Children|children
1157823|NCT02225795|Young Adults|young adults
1157824|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
1157825|NCT02225769|fever|fever
1157826|NCT02225769|point-of-care tests|point-of-care tests
1157827|NCT02225769|clinical algorithms|clinical algorithms
1157828|NCT02225769|electronic support|electronic support
1157829|NCT02225769|host biomarkers|host biomarkers
1157830|NCT02225756|Drug therapy|drug therapy
1157831|NCT02225756|Prevention and control|prevention and control
1157832|NCT02225756|Healing|healing
1157833|NCT02225756|Tissue regeneration|tissue regeneration
1157834|NCT02225756|Therapy|therapy
1157835|NCT02225743|Hypothermia|hypothermia
1157836|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
1157837|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
1157838|NCT02225717|Preterm labor|preterm labor
1157839|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
1157840|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
1157841|NCT02225717|Multiplex test|multiplex test
1157842|NCT02225691|type 1 diabetes|type 1 diabetes
1157843|NCT02225691|type 2 diabetes|type 2 diabetes
1157844|NCT02225691|paired testing|paired testing
1157845|NCT02225678|healthy volunteers|healthy volunteers
1157846|NCT02225678|asthma|asthma
1157847|NCT02225678|sputum eosinophils|sputum eosinophils
1157848|NCT02225639|ADHD|adhd
1157849|NCT02225639|Adult|adult
1157850|NCT02225613|Cruciate ligament injury|cruciate ligament injury
1157851|NCT02225613|Balance control|balance control
1157852|NCT02225613|Rehabilitation|rehabilitation
1157853|NCT02225613|Spa therapy|spa therapy
1157854|NCT02225613|Sport|sport
1157855|NCT02225600|Borderline Personality Disorder|borderline personality disorder
1157857|NCT02225600|Intranasal oxytocin|intranasal oxytocin
1157859|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
1157860|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
1157861|NCT02225574|CML|cml
1157862|NCT02225574|Accelerated phase|accelerated phase
1157863|NCT02225574|(AP)|(ap)
1157864|NCT02225574|Blast phase|blast phase
1157865|NCT02225574|(BP)|(bp)
1157866|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
1157867|NCT02225574|MEK-162|mek-162
1157868|NCT02225574|Nilotinib|nilotinib
1157869|NCT02225574|AMN107|amn107
1157870|NCT02225574|Tasigna|tasigna
1157871|NCT02225574|Questionnaires|questionnaires
1157872|NCT02225574|Surveys|surveys
1157873|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1157874|NCT02225561|Nitroprusside|nitroprusside
1157875|NCT02225561|Transthoracic|transthoracic
1157876|NCT02225561|Impedances|impedances
1157877|NCT02225535|low back pain|low back pain
1157878|NCT02225535|telehealth|telehealth
1157879|NCT02225535|videoconferencing|videoconferencing
1157880|NCT02225535|access to physical therapy|access to physical therapy
1157881|NCT02225535|interprofessional care|interprofessional care
1157882|NCT02225535|rural health|rural health
1157883|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
1157884|NCT02225522|Infant, Newborn|infant, newborn
1157885|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
1157886|NCT02225509|Thyroid cancer|thyroid cancer
1157887|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
1157888|NCT02225509|Thyroid nodule|thyroid nodule
1157889|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
1157890|NCT02225509|Indeterminate cytological result|indeterminate cytological result
1157891|NCT02225509|Molecular diagnostic|molecular diagnostic
1157892|NCT02225509|Transcriptomics|transcriptomics
1157893|NCT02225509|Molecular signature|molecular signature
1157894|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
1157895|NCT02225496|Oropharynx|oropharynx
1157896|NCT02225496|Human papilloma virus|human papilloma virus
1157897|NCT02225496|HPV positive|hpv positive
1157898|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
1157900|NCT02225496|Transoral robotic surgery|transoral robotic surgery
1157901|NCT02225496|TORS|tors
1157902|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
1157903|NCT02225496|Modified barium swallow|modified barium swallow
1157904|NCT02225496|MBS|mbs
1157905|NCT02225496|Questionnaires|questionnaires
1157906|NCT02225496|Surveys|surveys
1157907|NCT02225496|Speech and swallowing function|speech and swallowing function
1157908|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
1157909|NCT02225457|insulin resistance|insulin resistance
1157910|NCT02225457|type 2 diabetes|type 2 diabetes
1157911|NCT02225457|obesity|obesity
1157912|NCT02225457|polyphenols|polyphenols
1157913|NCT02225457|adipose tissue|adipose tissue
1157914|NCT02225457|overfeeding|overfeeding
1157915|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
1157916|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
1157917|NCT02225444|OsteoAMP growth factor|osteoamp growth factor
1157918|NCT02225444|autograft|autograft
1157919|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
1157920|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
1157921|NCT02225431|Contrast media|contrast media
1157922|NCT02225431|Angiography|angiography
1157923|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
1157924|NCT02225418|Laparoscopic|laparoscopic
1157925|NCT02225418|Cholecystectomy|cholecystectomy
1157926|NCT02225418|Postoperative|postoperative
1157927|NCT02225418|Pain|pain
1157928|NCT02225418|Quadratus lumborum|quadratus lumborum
1157929|NCT02225418|Ultrasound|ultrasound
1157930|NCT02225405|Lung Cancer|lung cancer
1157931|NCT02225405|Non-small Cell Lung Cancers|non-small cell lung cancers
1157932|NCT02225405|NCLC|nclc
1157933|NCT02225405|Chemotherapy|chemotherapy
1157934|NCT02225405|Nintedanib|nintedanib
1157935|NCT02225405|BIBF 1120|bibf 1120
1157936|NCT02225405|Cisplatin|cisplatin
1157937|NCT02225405|Platinol-AQ|platinol-aq
1157938|NCT02225405|Platinol|platinol
1157939|NCT02225405|CDDP|cddp
1157940|NCT02225405|Docetaxel|docetaxel
1157941|NCT02225405|Taxotere|taxotere
1157942|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
1157943|NCT02225392|Severe asthma|severe asthma
1157944|NCT02225379|Type 1 Diabetes|type 1 diabetes
1157945|NCT02225379|Hypoglycemia detection|hypoglycemia detection
1157946|NCT02225379|Non-invasive sensor|non-invasive sensor
1157947|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
1157948|NCT02225366|Melanoma|melanoma
1157949|NCT02225366|Metastatic|metastatic
1157950|NCT02225366|Antimicrobial peptide|antimicrobial peptide
1157951|NCT02225366|LL37|ll37
1157952|NCT02225366|Photographs|photographs
1157953|NCT02225353|Cervical Pessaries|cervical pessaries
1157954|NCT02225353|Progesterone|progesterone
1157955|NCT02225314|Parkinson's Disease|parkinson's disease
1157956|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
1157957|NCT02225301|Child maltreatment|child maltreatment
1157958|NCT02225301|Child Care|child care
1157959|NCT02225301|Knowledge|knowledge
1157960|NCT02225301|Attitude|attitude
1157961|NCT02225288|Healthy Subjects|healthy subjects
1157962|NCT02225288|Japanese|japanese
1157963|NCT02225288|Males|males
1157964|NCT02225275|Leukemia|leukemia
1157965|NCT02225275|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1157966|NCT02225275|CLL|cll
1157967|NCT02225275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1157968|NCT02225275|SLL|sll
1157969|NCT02225275|Recurrent|recurrent
1157970|NCT02225275|Lenalidomide|lenalidomide
1157971|NCT02225275|CC-5013|cc-5013
1157972|NCT02225275|Revlimid|revlimid
1157973|NCT02225275|Obinutuzumab|obinutuzumab
1157974|NCT02225275|GA101|ga101
1157975|NCT02225275|Gazyva|gazyva
1157976|NCT02225262|Prostate cancer|prostate cancer
1157977|NCT02225262|CyberKnife|cyberknife
1157978|NCT02225262|Stereotactic|stereotactic
1157979|NCT02225262|Radiation|radiation
1157980|NCT02225236|executive functioning|executive functioning
1157981|NCT02225236|metacognition|metacognition
1157982|NCT02225236|self-regulation|self-regulation
1157983|NCT02225236|preschoolers|preschoolers
1157984|NCT02225223|metastatic lesions|metastatic lesions
1157985|NCT02225223|vertebral body|vertebral body
1157986|NCT02225223|ablation|ablation
1157987|NCT02225223|radiation|radiation
1157988|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
1157989|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
1157990|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
1157991|NCT02225223|spine|spine
1157992|NCT02225223|vertebral augmentation|vertebral augmentation
1157993|NCT02225223|kyphoplasty|kyphoplasty
1157994|NCT02225223|spinal ablation|spinal ablation
1157995|NCT02225223|pain|pain
1157996|NCT02225223|quality of life|quality of life
1157997|NCT02225223|spinal tumors|spinal tumors
1157998|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
1157999|NCT02225197|Perioptic|perioptic
1158000|NCT02225197|Stereotactic|stereotactic
1158001|NCT02225197|Radiation|radiation
1158002|NCT02225197|Benign brain tumor|benign brain tumor
1158003|NCT02225197|Optic apparatus|optic apparatus
1158004|NCT02225184|Opioid Dependence|opioid dependence
1158005|NCT02225184|OPRM1|oprm1
1158006|NCT02225184|Outcome|outcome
1158007|NCT02225184|Treatment|treatment
1158008|NCT02225171|Genetic Knowledge|genetic knowledge
1158009|NCT02225171|Genetic Testing|genetic testing
1158010|NCT02225158|Immunity|immunity
1158011|NCT02225158|Co-Infection|co-infection
1158012|NCT02225158|Parasite|parasite
1158013|NCT02225158|Mycobacteria|mycobacteria
1158014|NCT02225145|Bone Marrow Transplant|bone marrow transplant
1158015|NCT02225145|Fertility|fertility
1158016|NCT02225145|Ovary|ovary
1158017|NCT02225132|Hydroxyurea|hydroxyurea
1158018|NCT02225132|Sickle Cell Disease|sickle cell disease
1158019|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
1158020|NCT02225119|Retinal Images|retinal images
1158021|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
1158022|NCT02225106|Dopamine Receptors|dopamine receptors
1158023|NCT02225106|Methylphenidate|methylphenidate
1158024|NCT02225106|Traumatic Brain Injury|traumatic brain injury
1158025|NCT02225106|C-11 Raclopride|c-11 raclopride
1158026|NCT02225106|Dopamine Release|dopamine release
1158027|NCT02225093|Safety|safety
1158028|NCT02225093|Dextromethorphan|dextromethorphan
1158029|NCT02225093|CYP2D6|cyp2d6
1158030|NCT02225093|Phase 1|phase 1
1158031|NCT02225093|Prostate cancer|prostate cancer
1222314|NCT01931345|MSM|msm
1158032|NCT02225093|CYP1A2|cyp1a2
1158033|NCT02225093|Pharmacokinetics|pharmacokinetics
1158034|NCT02225093|Drug-drug interactions|drug-drug interactions
1158035|NCT02225093|Caffeine|caffeine
1158036|NCT02225093|Enzalutamide|enzalutamide
1158037|NCT02225067|Patients|patients
1158038|NCT02225067|Volunteers|volunteers
1158039|NCT02225054|duration of analgesia|duration of analgesia
1158040|NCT02225041|intensive care|intensive care
1158041|NCT02225041|critical care|critical care
1158042|NCT02225041|child|child
1158043|NCT02225041|family|family
1158044|NCT02225041|survivors|survivors
1158045|NCT02225028|physical activity|physical activity
1158046|NCT02225028|physical fitness|physical fitness
1158047|NCT02225028|exercise program|exercise program
1158048|NCT02225028|telephone coaching|telephone coaching
1158049|NCT02225028|motivational counseling|motivational counseling
1158050|NCT02225028|stretching|stretching
1158051|NCT02225028|fitness improvement|fitness improvement
1158052|NCT02225028|exercise coaching|exercise coaching
1158053|NCT02225028|toning|toning
1158054|NCT02225028|SCI|sci
1158055|NCT02225028|spinal cord injury|spinal cord injury
1158056|NCT02225028|home-based|home-based
1158057|NCT02225028|home exercise|home exercise
1158058|NCT02225015|Cancer|cancer
1158059|NCT02225015|Breast cancer|breast cancer
1158060|NCT02225015|Ovarian cancer|ovarian cancer
1158061|NCT02225015|BRCA Mutation|brca mutation
1158062|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
1158063|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
1158361|NCT02223819|Crizotinib|crizotinib
1158064|NCT02225015|Telephone genetic counselling|telephone genetic counselling
1158065|NCT02225015|Cancer prevention|cancer prevention
1158066|NCT02225002|relapsed|relapsed
1158067|NCT02225002|refractory to standard therapy|refractory to standard therapy
1158068|NCT02225002|no effective therapy exists|no effective therapy exists
1158069|NCT02224976|exercise training|exercise training
1158070|NCT02224963|Aging,|aging,
1158071|NCT02224963|Macular Degeneration,|macular degeneration,
1158072|NCT02224963|Preparation for Future Care,|preparation for future care,
1158073|NCT02224963|Psychological Well-being,|psychological well-being,
1158074|NCT02224963|Problem Solving|problem solving
1158075|NCT02224963|Prevention|prevention
1158076|NCT02224963|Mental Health Promotion|mental health promotion
1158077|NCT02224950|Atopic dermatitis|atopic dermatitis
1158078|NCT02224950|eczema|eczema
1158079|NCT02224950|alternative therapy|alternative therapy
1158080|NCT02224950|complementary therapy|complementary therapy
1158081|NCT02224950|moisturizer|moisturizer
1158082|NCT02224937|Melatonin|melatonin
1158083|NCT02224937|Cognitive parameters|cognitive parameters
1158084|NCT02224937|pharmacodynamic|pharmacodynamic
1158085|NCT02224937|pharmacokinetics|pharmacokinetics
1158086|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
1158087|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
1158088|NCT02224924|14-141|14-141
1158089|NCT02224911|focal therapy|focal therapy
1158090|NCT02224911|prostate cancer treatment|prostate cancer treatment
1158091|NCT02224911|laser treatment|laser treatment
1158092|NCT02224885|Interventional radiology|interventional radiology
1158093|NCT02224885|Lung|lung
1158094|NCT02224885|Liver|liver
1158095|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
1158096|NCT02224885|Optical biopsy|optical biopsy
1158097|NCT02224885|Scanner|scanner
1158098|NCT02224885|Fluoroscopy|fluoroscopy
1158099|NCT02224885|CT|ct
1158100|NCT02224885|Computed Tomography|computed tomography
1158101|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
1158102|NCT02224885|Fluorescein|fluorescein
1158103|NCT02224872|bone marrow transplant|bone marrow transplant
1158104|NCT02224872|thymoglobulin|thymoglobulin
1158105|NCT02224872|cyclophosphamide|cyclophosphamide
1158106|NCT02224872|fludarabine|fludarabine
1158107|NCT02224872|tacrolimus|tacrolimus
1158108|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
1158109|NCT02224872|chemotherapy|chemotherapy
1158110|NCT02224872|GVHD|gvhd
1158111|NCT02224872|haploidentical|haploidentical
1158112|NCT02224833|appropriateness|appropriateness
1158113|NCT02224833|elderly|elderly
1158114|NCT02224833|polypharmacy|polypharmacy
1158115|NCT02224833|primary care|primary care
1158116|NCT02224820|transplantation|transplantation
1158117|NCT02224820|sensitised patients|sensitised patients
1158118|NCT02224820|HLA-antibodies|hla-antibodies
1158119|NCT02224807|breast cancer|breast cancer
1158120|NCT02224807|diet|diet
1158121|NCT02224807|exercise|exercise
1158122|NCT02224807|weight loss|weight loss
1158123|NCT02224794|abdominal|abdominal
1158124|NCT02224794|aortic|aortic
1158125|NCT02224794|aneurysm|aneurysm
1158126|NCT02224755|Heart Failure|heart failure
1158127|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
1158128|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
1158129|NCT02224755|Cardiomyopathy|cardiomyopathy
1158130|NCT02224755|Heart Disease|heart disease
1158131|NCT02224755|Cardiovascular Disease|cardiovascular disease
1158132|NCT02224755|Heart-assist devices|heart-assist devices
1158133|NCT02224755|Thoratec Corporation|thoratec corporation
1158134|NCT02224703|Cannabidiol|cannabidiol
1158135|NCT02224703|CBD|cbd
1158136|NCT02224703|GWP42003-P|gwp42003-p
1158137|NCT02224690|Cannabidiol|cannabidiol
1158138|NCT02224690|CBD|cbd
1158139|NCT02224690|Epidiolex|epidiolex
1158140|NCT02224690|GWP42003-P|gwp42003-p
1158141|NCT02224677|CFM|cfm
1158142|NCT02224677|facial asymmetry|facial asymmetry
1158143|NCT02224677|skin tag|skin tag
1158144|NCT02224677|facial tag|facial tag
1158145|NCT02224677|missing ear|missing ear
1158146|NCT02224677|small ear|small ear
1158147|NCT02224677|anotia|anotia
1158148|NCT02224677|microtia|microtia
1158149|NCT02224677|epibulbar dermoid|epibulbar dermoid
1158150|NCT02224677|coloboma|coloboma
1158151|NCT02224677|macrostomia|macrostomia
1158152|NCT02224677|lateral cleft|lateral cleft
1158153|NCT02224677|infant|infant
1158154|NCT02224677|toddler|toddler
1158155|NCT02224677|baby|baby
1158156|NCT02224677|neurodevelopment|neurodevelopment
1158157|NCT02224677|cognition|cognition
1158158|NCT02224677|socialization|socialization
1158159|NCT02224638|skin ulcers|skin ulcers
1158160|NCT02224612|Pediatric Face Masks|pediatric face masks
1158161|NCT02224612|children|children
1158162|NCT02224573|Cannabidiol|cannabidiol
1158163|NCT02224573|CBD|cbd
1158164|NCT02224573|GWP42003-P|gwp42003-p
1158165|NCT02224573|GWPCARE5|gwpcare5
1158166|NCT02224560|Cannabidiol|cannabidiol
1158167|NCT02224560|CBD|cbd
1158168|NCT02224560|Epidiolex|epidiolex
1158169|NCT02224560|GWP42003-P|gwp42003-p
1158170|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
1158171|NCT02224547|lung carcinoma|lung carcinoma
1158172|NCT02224547|NSCLC|nsclc
1158173|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
1158174|NCT02224534|Ticagrelor|ticagrelor
1158175|NCT02224534|Left ventricular remodeling|left ventricular remodeling
1158176|NCT02224534|Platelet reactivity|platelet reactivity
1158177|NCT02224521|FLAP inhibitor|flap inhibitor
1158178|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1158179|NCT02224521|COPD|copd
1158180|NCT02224521|Bioavailability|bioavailability
1158181|NCT02224469|Brain-Computer Interface|brain-computer interface
1158182|NCT02224469|Motor Cortex|motor cortex
1158183|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1158184|NCT02224469|Quality of Life|quality of life
1158185|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1158186|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
1158187|NCT02224456|chronic hepatitis B|chronic hepatitis b
1158188|NCT02224456|Cirrhosis|cirrhosis
1158189|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
1158190|NCT02224430|biomarker of relapse|biomarker of relapse
1158191|NCT02224430|schizophrenia|schizophrenia
1158192|NCT02224430|schizoaffective disorder|schizoaffective disorder
1158193|NCT02224430|on-body sensors|on-body sensors
1158194|NCT02224430|smartphone|smartphone
1158195|NCT02224430|observational|observational
1158196|NCT02224417|Diabetes|diabetes
1158197|NCT02224417|Treatment medication adherence|treatment medication adherence
1158198|NCT02224417|Physical activity|physical activity
1158199|NCT02224417|Financial incentives|financial incentives
1158200|NCT02224417|Outcome incentives|outcome incentives
1158201|NCT02224417|Process incentives|process incentives
1158202|NCT02224417|HbA1c|hba1c
1158203|NCT02224391|Smoking Cessation|smoking cessation
1158204|NCT02224391|Attentional bias modification|attentional bias modification
1158205|NCT02224391|ABM|abm
1158206|NCT02224391|Smartphone|smartphone
1158207|NCT02224391|Nicotine replacement therapy|nicotine replacement therapy
1158208|NCT02224391|Nicotine patch|nicotine patch
1158209|NCT02224391|NRT|nrt
1158210|NCT02224391|Questionnaires|questionnaires
1158211|NCT02224391|Surveys|surveys
1158212|NCT02224391|Saliva collection|saliva collection
1158213|NCT02224391|Cotinine level|cotinine level
1158214|NCT02224391|Counseling sessions|counseling sessions
1158215|NCT02224391|Electroencephalography|electroencephalography
1158216|NCT02224391|EEG|eeg
1158217|NCT02224378|fluid responsiveness|fluid responsiveness
1158218|NCT02224378|atrial fibrillation|atrial fibrillation
1158219|NCT02224378|passive leg raising|passive leg raising
1158220|NCT02224378|central venous pressure|central venous pressure
1158221|NCT02224378|valvular heart surgery|valvular heart surgery
1158222|NCT02224365|Diabetes|diabetes
1158223|NCT02224365|Arterial Stiffness|arterial stiffness
1158224|NCT02224365|Blood Pressure|blood pressure
1158225|NCT02224365|Endothelial Function|endothelial function
1158226|NCT02224365|Body Composition|body composition
1158227|NCT02224365|Glycemic Control|glycemic control
1158228|NCT02224365|Apples|apples
1158229|NCT02224365|Functional Foods|functional foods
1158230|NCT02224365|Polyphenols|polyphenols
1158231|NCT02224365|Fiber|fiber
1158232|NCT02224352|Electric Stimulation|electric stimulation
1158233|NCT02224352|Respiration|respiration
1158234|NCT02224352|Abdominal wall|abdominal wall
1158235|NCT02224352|Lung Diseases|lung diseases
1158236|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
1158237|NCT02224352|COPD|copd
1158238|NCT02224339|Atherosclerosis|atherosclerosis
1158239|NCT02224339|carotid plaque|carotid plaque
1158240|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1158241|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
1158242|NCT02224326|Alzheimer´s disease|alzheimer´s disease
1158243|NCT02224326|early diagnosis|early diagnosis
1158244|NCT02224326|evoked potentials|evoked potentials
1158245|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
1158246|NCT02224313|vaginal cytokine|vaginal cytokine
1158247|NCT02224287|Urolithiasis|urolithiasis
1158248|NCT02224287|Kidney Stones|kidney stones
1158249|NCT02224287|Ureteroscopy|ureteroscopy
1158250|NCT02224287|Fluoroscopy|fluoroscopy
1158251|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
1158252|NCT02224274|Cardiac Arrest|cardiac arrest
1158253|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
1158254|NCT02224274|Myocardial infarction (STEMI and NSTEMI)|myocardial infarction (stemi and nstemi)
1158255|NCT02224261|Axillary web syndrome|axillary web syndrome
1158256|NCT02224261|cording|cording
1158257|NCT02224261|physical therapy|physical therapy
1158258|NCT02224261|breast cancer|breast cancer
1158382|NCT02223741|PEDI|pedi
1158259|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
1158260|NCT02224248|exercise tolerance|exercise tolerance
1158261|NCT02224248|exercise test|exercise test
1158262|NCT02224248|health behavior|health behavior
1158263|NCT02224248|motor activity|motor activity
1158264|NCT02224248|motivation|motivation
1158265|NCT02224248|intention|intention
1158266|NCT02224248|self-rated health|self-rated health
1158267|NCT02224235|Stable angina|stable angina
1158268|NCT02224235|PCI|pci
1158269|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
1158270|NCT02224209|Carotid artery stenosis|carotid artery stenosis
1158271|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
1158272|NCT02224209|Staged angioplasty|staged angioplasty
1158273|NCT02224209|Routine single-stage stenting|routine single-stage stenting
1158274|NCT02224196|manual ventilation|manual ventilation
1158275|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
1158276|NCT02224196|peak airway pressure|peak airway pressure
1158277|NCT02224196|antral area|antral area
1158278|NCT02224183|low back pain|low back pain
1158279|NCT02224183|yoga|yoga
1158280|NCT02224183|education|education
1158281|NCT02224183|Veterans|veterans
1158282|NCT02224183|cost-effectiveness|cost-effectiveness
1158283|NCT02224183|military|military
1158284|NCT02224183|back pain|back pain
1158285|NCT02224170|Dexamethasone|dexamethasone
1158286|NCT02224170|Lidocaine|lidocaine
1158287|NCT02224170|Quality of Recovery|quality of recovery
1158288|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1158289|NCT02224144|Kidney Transplantation|kidney transplantation
1158290|NCT02224144|Calcitriol|calcitriol
1158291|NCT02224144|Bone Mineral Density|bone mineral density
1158292|NCT02224144|Bone Mass and Strength|bone mass and strength
1158293|NCT02224144|Vascular Calcifications|vascular calcifications
1158294|NCT02224144|Hyperparathyroidism|hyperparathyroidism
1158295|NCT02224144|Parathyroid Hormone|parathyroid hormone
1158296|NCT02224131|platelet function test|platelet function test
1158297|NCT02224131|stent;|stent;
1158298|NCT02224118|Healthy|healthy
1158299|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1158300|NCT02224118|CNTO 3649|cnto 3649
1158301|NCT02224092|heart health|heart health
1158302|NCT02224092|general well-being|general well-being
1158303|NCT02224066|Aortic stenosis|aortic stenosis
1158304|NCT02224066|TAVI|tavi
1158305|NCT02224066|TAVR|tavr
1158306|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1158307|NCT02224066|Ticagrelor|ticagrelor
1158308|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
1158309|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
1158310|NCT02224001|tip plasty|tip plasty
1158311|NCT02224001|septal cartilage|septal cartilage
1158312|NCT02223988|Patients|patients
1158313|NCT02223988|mechanical|mechanical
1158314|NCT02223988|ventilation|ventilation
1158315|NCT02223988|tracheostomy|tracheostomy
1158316|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
1158317|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
1158318|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
1158319|NCT02223975|Spectrum Analysis|spectrum analysis
1158320|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
1158321|NCT02223975|Raman probe|raman probe
1158322|NCT02223975|Optical|optical
1158323|NCT02223975|Diagnosis|diagnosis
1158324|NCT02223975|Cancer|cancer
1158325|NCT02223975|Multivariate analysis|multivariate analysis
1158326|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
1158327|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
1158328|NCT02223975|Vulva|vulva
1158329|NCT02223975|Vulvar Diseases|vulvar diseases
1569396|NCT00502749|Exercise|exercise
1222686|NCT01929369|CKD|ckd
1158330|NCT02223962|physical activity|physical activity
1158331|NCT02223962|COPD|copd
1158332|NCT02223962|activity monitors|activity monitors
1158333|NCT02223949|Obesity|obesity
1158334|NCT02223949|Labor complications|labor complications
1158335|NCT02223949|Induction of labor|induction of labor
1158336|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
1158337|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
1158338|NCT02223923|Phase 1|phase 1
1158339|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
1158340|NCT02223923|ATR Inhibitor|atr inhibitor
1158341|NCT02223923|Radiotherapy|radiotherapy
1158342|NCT02223910|brain computer interface|brain computer interface
1158343|NCT02223910|neurofeedback|neurofeedback
1158344|NCT02223910|functional connectivity|functional connectivity
1158345|NCT02223897|Liver transplantation|liver transplantation
1158346|NCT02223897|Biliary complication|biliary complication
1158347|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
1158348|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
1158349|NCT02223871|Malaria|malaria
1158350|NCT02223871|ACT-451840|act-451840
1158351|NCT02223858|Health Status Disparities|health status disparities
1158352|NCT02223858|Arthritis|arthritis
1158353|NCT02223858|Psychology|psychology
1158354|NCT02223858|Pain Management|pain management
1158355|NCT02223858|Affect|affect
1158356|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
1158357|NCT02223832|ACT-128800|act-128800
1158358|NCT02223832|Safety|safety
1158359|NCT02223832|Tolerability|tolerability
1158360|NCT02223832|Pharmacokinetics|pharmacokinetics
1158362|NCT02223819|14-063|14-063
1158363|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
1158364|NCT02223806|Uterine tonus assessment|uterine tonus assessment
1158365|NCT02223806|Active management of third stage of labor|active management of third stage of labor
1158366|NCT02223793|Vascular screening|vascular screening
1158367|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
1158368|NCT02223793|Blood pressure|blood pressure
1158369|NCT02223793|Lipids|lipids
1158370|NCT02223793|Lifestyle|lifestyle
1158371|NCT02223793|Identifying unknown risk|identifying unknown risk
1158372|NCT02223793|Low socioeconomic status|low socioeconomic status
1158373|NCT02223793|low threshold|low threshold
1158374|NCT02223780|COPD|copd
1158375|NCT02223780|palliative care|palliative care
1158377|NCT02223767|VR|vr
1158378|NCT02223767|Exposure therapy|exposure therapy
1158379|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
1158380|NCT02223741|Cerebral palsy|cerebral palsy
1158381|NCT02223741|GMFM-66|gmfm-66
1158383|NCT02223702|Aggressive periodontitis|aggressive periodontitis
1158384|NCT02223702|amoxicillin|amoxicillin
1158385|NCT02223702|metronidazole|metronidazole
1158386|NCT02223702|moxifloxacin|moxifloxacin
1158387|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
1158388|NCT02223689|SkinAffix|skinaffix
1158389|NCT02223676|Pharmacy|pharmacy
1158390|NCT02223676|Length-of-stay|length-of-stay
1158391|NCT02223676|Emergency Department|emergency department
1158392|NCT02223650|Intermittent Exotropia|intermittent exotropia
1158394|NCT02223650|overminus|overminus
1158395|NCT02223624|eccentric|eccentric
1158396|NCT02223624|exercise|exercise
1158397|NCT02223624|heart disease|heart disease
1158398|NCT02223624|chronic heart failure|chronic heart failure
1158399|NCT02223624|rehabilitation|rehabilitation
1158400|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
1158401|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
1158402|NCT02223585|Gut microbial|gut microbial
1158403|NCT02223585|response|response
1158404|NCT02223585|to protein-based|to protein-based
1158405|NCT02223585|diet|diet
1158406|NCT02223585|challenges|challenges
1158407|NCT02223585|population|population
1158408|NCT02223533|analgesia|analgesia
1158409|NCT02223533|post-operative|post-operative
1158410|NCT02223533|wound catheter infusion|wound catheter infusion
1158411|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
1158412|NCT02223520|Staphylococcus aureus|staphylococcus aureus
1158413|NCT02223520|Infection|infection
1158414|NCT02223520|Colonization|colonization
1158415|NCT02223520|Transmission|transmission
1158416|NCT02223520|Neonate|neonate
1158417|NCT02223468|Intestinal Microbiota|intestinal microbiota
1158418|NCT02223468|Liver Transplant|liver transplant
1158419|NCT02223468|Acute Rejection|acute rejection
1158420|NCT02223468|Infection|infection
1158421|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1158422|NCT02223455|Infection Control (IC)|infection control (ic)
1158423|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
1158424|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
1158425|NCT02223455|Compliance|compliance
1158426|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
1158427|NCT02223442|chronic pain|chronic pain
1158428|NCT02223442|central analgesic drugs|central analgesic drugs
1158429|NCT02223442|adherence to therapy|adherence to therapy
1158430|NCT02223442|side effects|side effects
1158431|NCT02223442|quality of life|quality of life
1158432|NCT02223442|MOR-NRI drugs|mor-nri drugs
1158433|NCT02223429|Paternal nurturance|paternal nurturance
1158434|NCT02223429|Oxytocin|oxytocin
1158435|NCT02223429|Vasopressin|vasopressin
1158436|NCT02223429|fMRI|fmri
1158437|NCT02223429|Neurobiology|neurobiology
1158438|NCT02223416|female|female
1158439|NCT02223416|volunteers|volunteers
1158440|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
1158441|NCT02223403|heart failure|heart failure
1158442|NCT02223403|exercise performance|exercise performance
1158443|NCT02223403|oxygen consumption|oxygen consumption
1158444|NCT02223390|South Africa|south africa
1158445|NCT02223390|HIV|hiv
1158446|NCT02223390|Mental health|mental health
1158447|NCT02223390|Trauma|trauma
1158448|NCT02223390|Women|women
1158449|NCT02223351|HSV|hsv
1158450|NCT02223351|HIV|hiv
1158451|NCT02223351|Herpes|herpes
1158452|NCT02223351|volunteers|volunteers
1158453|NCT02223351|drug-drug interaction|drug-drug interaction
1158454|NCT02223325|Elderly|elderly
1158455|NCT02223325|Prognosis|prognosis
1158456|NCT02223299|Depression|depression
1158457|NCT02223299|SSRI|ssri
1158458|NCT02223299|Nutritional Supplements|nutritional supplements
1158459|NCT02223299|Beck Depression Scale|beck depression scale
1158460|NCT02223299|L-tyrosine|l-tyrosine
1158461|NCT02223299|L-tryptophan|l-tryptophan
1158462|NCT02223286|Corus CAD|corus cad
1158463|NCT02223286|ASGES|asges
1158464|NCT02223286|Age/Sex/Gene Expression Score|age/sex/gene expression score
1158465|NCT02223286|Gene Expression|gene expression
1158466|NCT02223286|GES|ges
1158467|NCT02223286|CAD|cad
1158468|NCT02223286|CVD|cvd
1158469|NCT02223286|CHD|chd
1158470|NCT02223286|Precision Medicine|precision medicine
1158471|NCT02223286|Clinical Utility|clinical utility
1158472|NCT02223286|Coronary Artery Disease|coronary artery disease
1158473|NCT02223286|Angina Pectoris|angina pectoris
1158474|NCT02223286|Chest Pain|chest pain
1158475|NCT02223286|Cardiovascular Disease|cardiovascular disease
1158476|NCT02223286|Coronary Heart Disease|coronary heart disease
1158477|NCT02223286|UCU-CARD|ucu-card
1158478|NCT02223273|stroke,|stroke,
1158479|NCT02223273|quality improvement|quality improvement
1158480|NCT02223247|solid tumors|solid tumors
1158481|NCT02223247|cancer|cancer
1158482|NCT02223221|In Vitro Fertilization|in vitro fertilization
1158483|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
1158484|NCT02223221|Infertility, Female|infertility, female
1158485|NCT02223221|Abortion, Habitual|abortion, habitual
1158992|NCT02221024|Management|management
1158566|NCT02222922|ADC|adc
1158567|NCT02222922|PF-06647020|pf-06647020
1158568|NCT02222922|solid tumors|solid tumors
1158569|NCT02222922|tumors|tumors
1158570|NCT02222922|neoplasm metastasis|neoplasm metastasis
1158571|NCT02222922|TNBC|tnbc
1158572|NCT02222922|triple negative breast cancer|triple negative breast cancer
1158573|NCT02222922|NSCLC|nsclc
1158574|NCT02222922|non small cell lung cancer|non small cell lung cancer
1158575|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
1158576|NCT02222922|ovarian cancer|ovarian cancer
1158577|NCT02222922|OVCA|ovca
1158578|NCT02222909|Community Based Organization|community based organization
1158579|NCT02222909|Reverse Innovation|reverse innovation
1158580|NCT02222909|Social Services|social services
1158581|NCT02222909|Referral|referral
1158582|NCT02222909|Chronic disease|chronic disease
1158583|NCT02222870|Influenza|influenza
1158584|NCT02222870|Influenza virus vaccine|influenza virus vaccine
1158585|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
1158586|NCT02222870|Fluzone®|fluzone®
1158587|NCT02222857|Acute retinal necrosis|acute retinal necrosis
1158588|NCT02222857|Retinal detachment|retinal detachment
1159496|NCT02218840|smoking|smoking
1158589|NCT02222857|Laser photocoagulation|laser photocoagulation
1158590|NCT02222857|Vitrectomy|vitrectomy
1158591|NCT02222844|Cancer|cancer
1158592|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
1158593|NCT02222844|Colon, Sigmoid|colon, sigmoid
1158594|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
1158595|NCT02222844|General Surgery|general surgery
1158596|NCT02222844|Postoperative Complications|postoperative complications
1158597|NCT02222831|IVF|ivf
1158598|NCT02222831|Embryo Quality|embryo quality
1158599|NCT02222831|Time Lapse Culture|time lapse culture
1158600|NCT02222831|Preimplantation factor|preimplantation factor
1158601|NCT02222805|Cord clamping|cord clamping
1158602|NCT02222805|Iron deficiency|iron deficiency
1158603|NCT02222805|Anemia|anemia
1158604|NCT02222805|Iron|iron
1158605|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
1158606|NCT02222805|Jaundice|jaundice
1158607|NCT02222805|Neurodevelopment|neurodevelopment
1569502|NCT00502333|neck pain|neck pain
1158608|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
1158609|NCT02222740|Safety|safety
1158610|NCT02222740|Tolerability|tolerability
1158611|NCT02222740|Pharmacokinetics|pharmacokinetics
1158612|NCT02222714|ischemic stroke|ischemic stroke
1158613|NCT02222714|stroke|stroke
1158614|NCT02222714|APC|apc
1158615|NCT02222714|3K3A|3k3a
1158616|NCT02222714|3K3A-APC|3k3a-apc
1158617|NCT02222714|activated protein C|activated protein c
1158618|NCT02222714|RHAPSODY|rhapsody
1158619|NCT02222701|composite|composite
1158620|NCT02222701|dental|dental
1158621|NCT02222701|longevity|longevity
1158622|NCT02222688|cancer|cancer
1158623|NCT02222688|CLL|cll
1158624|NCT02222662|Massage|massage
1158625|NCT02222662|effectiveness|effectiveness
1158626|NCT02222662|autism|autism
1158627|NCT02222662|parent stress|parent stress
1158628|NCT02222649|Elderly|elderly
1158629|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
1158630|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
1158631|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
1158632|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
1158633|NCT02222623|insulin|insulin
1158634|NCT02222623|basal|basal
1158635|NCT02222623|diabetes|diabetes
1158636|NCT02222623|hospital|hospital
1158637|NCT02222623|glucose|glucose
1158638|NCT02222623|hypoglycemia|hypoglycemia
1158639|NCT02222623|glargine|glargine
1158640|NCT02222623|NPH|nph
1158889|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
1158641|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
1158642|NCT02222610|Radiation Retinopathy|radiation retinopathy
1158643|NCT02222597|head injury|head injury
1158644|NCT02222597|infrascanner|infrascanner
1158645|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
1158646|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
1158647|NCT02222584|physical activity|physical activity
1158648|NCT02222584|disease activity|disease activity
1158649|NCT02222584|quality of life|quality of life
1158650|NCT02222558|hypogonadism|hypogonadism
1158651|NCT02222558|Gonadal Disorders|gonadal disorders
1158652|NCT02222558|Endocrine System Diseases|endocrine system diseases
1158653|NCT02222558|Testosterone|testosterone
1158654|NCT02222558|Testosterone enanthate|testosterone enanthate
1158655|NCT02222558|Testosterone undecanoate|testosterone undecanoate
1158656|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
1158657|NCT02222558|Methyltestosterone|methyltestosterone
1158658|NCT02222558|Androgens|androgens
1158659|NCT02222558|Hormones|hormones
1158660|NCT02222558|Hormones,|hormones,
1158661|NCT02222558|Hormone Substitutes,|hormone substitutes,
1158662|NCT02222558|Hormone Antagonists|hormone antagonists
1158663|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
1158664|NCT02222558|Pharmacologic Actions|pharmacologic actions
1158665|NCT02222558|Therapeutic Uses|therapeutic uses
1158666|NCT02222558|Anabolic Agents|anabolic agents
1158667|NCT02222558|dihydrotestosterone|dihydrotestosterone
1158668|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
1158669|NCT02222532|tetronine|tetronine
1158670|NCT02222532|congenital heart disease|congenital heart disease
1158671|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
1158672|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
1158673|NCT02222519|statins|statins
1158674|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
1158675|NCT02222519|rocuronium|rocuronium
1158676|NCT02222519|myalgia|myalgia
1158677|NCT02222493|Phase 3|phase 3
1158678|NCT02222493|infliximab|infliximab
1158679|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
1158680|NCT02222480|Patients|patients
1158681|NCT02222480|with mild|with mild
1158682|NCT02222480|moderate|moderate
1158683|NCT02222480|essential|essential
1158684|NCT02222441|Palbociclib|palbociclib
1158685|NCT02222441|Modafinil|modafinil
1158686|NCT02222441|Pioglitazone|pioglitazone
1158687|NCT02222441|Pharmacokinetics|pharmacokinetics
1158688|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
1158689|NCT02222441|Healthy Volunteers|healthy volunteers
1158690|NCT02222441|CYP3A Inducers|cyp3a inducers
1158691|NCT02222415|Muscle mass|muscle mass
1158692|NCT02222415|Strength|strength
1158693|NCT02222415|Cross-sectional area|cross-sectional area
1158694|NCT02222415|Protein|protein
1158695|NCT02222402|Quality of Life|quality of life
1158696|NCT02222402|Exercise|exercise
1158697|NCT02222402|Functional Capacity|functional capacity
1158698|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
1158699|NCT02222363|Phase I|phase i
1158700|NCT02222363|Iron chelator|iron chelator
1158701|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
1158702|NCT02222363|Dose escalation study|dose escalation study
1158703|NCT02222363|Safety and tolerability|safety and tolerability
1158704|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
1158705|NCT02222363|Progression-free survival|progression-free survival
1569503|NCT00502333|prognosis|prognosis
1158706|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
1158707|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
1158708|NCT02222337|behavioral intervention|behavioral intervention
1158709|NCT02222337|quality of life|quality of life
1158710|NCT02222337|breast cancer|breast cancer
1158711|NCT02222337|Latina|latina
1158712|NCT02222337|caregiver|caregiver
1158713|NCT02222337|PCORI|pcori
1158714|NCT02222324|QTc Interval|qtc interval
1158715|NCT02222324|Healthy Subjects|healthy subjects
1158716|NCT02222272|cml|cml
1158717|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
1158718|NCT02222272|dasatinib|dasatinib
1158719|NCT02222272|nilotinib|nilotinib
1158720|NCT02222272|tki|tki
1158721|NCT02222272|second generation tki|second generation tki
1158722|NCT02222272|2nd generation tki|2nd generation tki
1158723|NCT02222259|Geriatric Oncology|geriatric oncology
1158724|NCT02222259|Quality of Life|quality of life
1158725|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
1158726|NCT02222259|Functional Status|functional status
1158727|NCT02222259|Chemotherapy|chemotherapy
1158728|NCT02222259|Older Adults|older adults
1158729|NCT02222246|Sickle Cell Disease|sickle cell disease
1158730|NCT02222246|Emergency Department|emergency department
1158731|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
1158732|NCT02222246|Pain Management|pain management
1158733|NCT02222246|Pilot Project|pilot project
1158734|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
1158735|NCT02222194|Lung cancer|lung cancer
1158736|NCT02222194|Surgery|surgery
1158737|NCT02222194|Videomediastinoscopy|videomediastinoscopy
1158738|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
1158739|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
1158740|NCT02222155|complement|complement
1158741|NCT02222155|vasculitis|vasculitis
1158742|NCT02222155|C5aR|c5ar
1158743|NCT02222142|Ischemic heart disease|ischemic heart disease
1158843|NCT02221674|Opioid|opioid
1158744|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
1158745|NCT02222142|Isoflurane|isoflurane
1158746|NCT02222142|Propofol|propofol
1158747|NCT02222129|Randomized controlled trial|randomized controlled trial
1158748|NCT02222129|anesthetics-local|anesthetics-local
1158749|NCT02222129|bupivacaine|bupivacaine
1158750|NCT02222129|analgesia|analgesia
1158751|NCT02222129|Pain, Postoperative|pain, postoperative
1158752|NCT02222116|STEMI|stemi
1158753|NCT02222116|BMS|bms
1158754|NCT02222116|DES|des
1158755|NCT02222116|mesh|mesh
1158756|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
1158757|NCT02222077|Central blood pressure|central blood pressure
1158758|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1158759|NCT02222077|Target-organ damage|target-organ damage
1158760|NCT02222077|Adolescents and young adults|adolescents and young adults
1158761|NCT02222051|neck pain|neck pain
1158762|NCT02222051|chronic pain|chronic pain
1158890|NCT02221427|First time mothers|first time mothers
1158763|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
1158764|NCT02221986|Neurooncology|neurooncology
1158765|NCT02221986|Physiotherapy|physiotherapy
1158766|NCT02221986|Occupational therapy|occupational therapy
1158767|NCT02221986|Neurorehabilitation|neurorehabilitation
1158768|NCT02221986|Glioma|glioma
1158769|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
1158770|NCT02221947|Alzheimer's|alzheimer's
1158771|NCT02221947|bryostatin|bryostatin
1158772|NCT02221947|PKC epsilon|pkc epsilon
1158773|NCT02221934|Pain|pain
1158774|NCT02221934|Chronic|chronic
1158775|NCT02221934|Amputation|amputation
1158776|NCT02221934|Phantom Pain|phantom pain
1158777|NCT02221934|Stump Pain|stump pain
1158778|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
1158779|NCT02221895|postpartum appointment|postpartum appointment
1158780|NCT02221895|breastfeeding|breastfeeding
1158781|NCT02221895|postpartum contraception|postpartum contraception
1158782|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
1158783|NCT02221895|postpartum depression screening|postpartum depression screening
1158784|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
1158785|NCT02221856|Motion View|motion view
1158786|NCT02221843|sun behavior|sun behavior
1158787|NCT02221843|immunosuppression|immunosuppression
1158788|NCT02221843|skin neoplasms|skin neoplasms
1158789|NCT02221843|sunbit|sunbit
1158790|NCT02221843|uv sensor|uv sensor
1158791|NCT02221843|uv dosimeter|uv dosimeter
1158792|NCT02221843|solar radiation|solar radiation
1158793|NCT02221843|uv exposition|uv exposition
1158794|NCT02221843|uv index|uv index
1158795|NCT02221804|Physical Inactivity|physical inactivity
1158796|NCT02221804|Skeletal Muscle|skeletal muscle
1158797|NCT02221804|Cachexia|cachexia
1158798|NCT02221791|Flavan-3-ol|flavan-3-ol
1158799|NCT02221791|Flavonoids|flavonoids
1158800|NCT02221791|Epicatechin|epicatechin
1158801|NCT02221791|Cocoa|cocoa
1158802|NCT02221791|Chocolate|chocolate
1158803|NCT02221791|Endothelial function|endothelial function
1158804|NCT02221791|Bioavailability|bioavailability
1158805|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1158806|NCT02221778|SBRT|sbrt
1158807|NCT02221765|Obesity|obesity
1158808|NCT02221765|Overnutrition|overnutrition
1158809|NCT02221765|Nutrition Disorders|nutrition disorders
1158810|NCT02221765|Overweight|overweight
1158811|NCT02221765|Body Weight|body weight
1158812|NCT02221765|Signs and Symptoms|signs and symptoms
1158813|NCT02221752|iron deficiency|iron deficiency
1158814|NCT02221752|iron deficiency anemia|iron deficiency anemia
1158815|NCT02221752|infant|infant
1158816|NCT02221752|pregnancy|pregnancy
1158817|NCT02221739|lung cancer|lung cancer
1158818|NCT02221739|NSCLC|nsclc
1158819|NCT02221739|lung|lung
1158820|NCT02221739|cancer|cancer
1158821|NCT02221739|radiation|radiation
1158822|NCT02221739|immunotherapy|immunotherapy
1158823|NCT02221739|metastatic|metastatic
1158824|NCT02221726|Healthy|healthy
1158825|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
1158826|NCT02221726|Placebo|placebo
1158827|NCT02221726|Transdermal delivery device system|transdermal delivery device system
1158828|NCT02221713|diverticulitis|diverticulitis
1158829|NCT02221713|diverticulosis|diverticulosis
1158830|NCT02221713|diverticular disease|diverticular disease
1158831|NCT02221700|Gastrointestinal cancer|gastrointestinal cancer
1158832|NCT02221700|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
1158833|NCT02221700|CIPN|cipn
1158834|NCT02221700|Symptom reduction|symptom reduction
1158835|NCT02221700|Massage|massage
1158836|NCT02221700|Symptom questionnaires|symptom questionnaires
1158837|NCT02221700|Surveys|surveys
1158838|NCT02221700|Leg function and balance tests|leg function and balance tests
1158839|NCT02221687|synbiotic formula|synbiotic formula
1158840|NCT02221687|infant formula|infant formula
1158841|NCT02221687|diarrhea|diarrhea
1158842|NCT02221674|Post-surgical pain|post-surgical pain
1158844|NCT02221661|Alzheimer|alzheimer
1158845|NCT02221661|cognitive impairment|cognitive impairment
1158846|NCT02221661|blood test|blood test
1158847|NCT02221648|Back|back
1158848|NCT02221648|Pain|pain
1158849|NCT02221648|Muscle|muscle
1158850|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
1158851|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1158852|NCT02221622|Alzheimer's disease|alzheimer's disease
1158853|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
1158854|NCT02221622|Dementia|dementia
1158855|NCT02221622|Regenerative therapeutic|regenerative therapeutic
1158856|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
1158857|NCT02221596|Vitamin D|vitamin d
1158858|NCT02221596|25(OH)D|25(oh)d
1158859|NCT02221596|Aerobic training|aerobic training
1158860|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
1158861|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
1158863|NCT02221583|End stage renal disease|end stage renal disease
1158864|NCT02221583|Renal transplant candidate|renal transplant candidate
1158865|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
1158866|NCT02221583|Immunosuppressants|immunosuppressants
1158867|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
1158868|NCT02221518|OCD|ocd
1158869|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1158870|NCT02221505|LOP628,|lop628,
1158871|NCT02221505|cKit,|ckit,
1158872|NCT02221505|ADC,|adc,
1158873|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
1158874|NCT02221505|maytansine|maytansine
1158875|NCT02221466|diabetes|diabetes
1158876|NCT02221466|foot|foot
1158877|NCT02221466|wounds|wounds
1158878|NCT02221466|nitric oxide|nitric oxide
1158879|NCT02221466|endothelium|endothelium
1158880|NCT02221466|infection|infection
1158881|NCT02221466|biological markers|biological markers
1158882|NCT02221466|observational study|observational study
1158883|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
1158884|NCT02221466|ulcers|ulcers
1158885|NCT02221466|cytokines|cytokines
1158886|NCT02221466|inflammation|inflammation
1158887|NCT02221453|Diabetic Macular Edema|diabetic macular edema
1158888|NCT02221453|Ocular Cytokines|ocular cytokines
1158891|NCT02221427|Labour progression|labour progression
1158892|NCT02221427|Prolonged labour|prolonged labour
1158893|NCT02221427|Oxytocin|oxytocin
1158894|NCT02221427|Mode of delivery|mode of delivery
1158895|NCT02221427|Maternal birth outcome|maternal birth outcome
1158896|NCT02221427|Neonatal birth outcome|neonatal birth outcome
1158897|NCT02221349|Sensitivity|sensitivity
1158898|NCT02221336|Bipolar disorder|bipolar disorder
1158899|NCT02221336|Daily electronic monitoring|daily electronic monitoring
1158900|NCT02221336|Smartphones|smartphones
1333240|NCT01443858|Smoking Cessation|smoking cessation
1158901|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
1158902|NCT02221336|Feedback loop|feedback loop
1158903|NCT02221310|targeted therapy|targeted therapy
1158904|NCT02221310|leukemia|leukemia
1158906|NCT02221310|immune therapy|immune therapy
1158907|NCT02221284|Pharmacological therapy|pharmacological therapy
1158908|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
1158909|NCT02221258|Rheumatic Disease|rheumatic disease
1158910|NCT02221258|RA|ra
1158911|NCT02221258|Stem cell|stem cell
1158912|NCT02221258|Cell therapy|cell therapy
1158913|NCT02221258|furestem|furestem
1158914|NCT02221258|Umbilical cord Blood|umbilical cord blood
1158915|NCT02221258|hUCB-MSC|hucb-msc
1158916|NCT02221258|UCB-MSC|ucb-msc
1158917|NCT02221245|Esophageal cancer|esophageal cancer
1158918|NCT02221245|Cancer Stem Cell|cancer stem cell
1158919|NCT02221245|CSC|csc
1158920|NCT02221245|Wnt|wnt
1158921|NCT02221245|Hegdehog|hegdehog
1158922|NCT02221245|Notch|notch
1158923|NCT02221245|Signaling|signaling
1158924|NCT02221245|Pathway|pathway
1158925|NCT02221245|Chemo-naive|chemo-naive
1158926|NCT02221232|ZuraPrep|zuraprep
1158927|NCT02221232|Antimicrobial|antimicrobial
1158928|NCT02221232|Bio-Science Laboratories|bio-science laboratories
1158929|NCT02221232|Zurex Pharma|zurex pharma
1158930|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
1158931|NCT02221219|infant|infant
1158932|NCT02221219|brain injury|brain injury
1158933|NCT02221219|renal|renal
1158934|NCT02221219|indomethacin|indomethacin
1158935|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
1158936|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
1158937|NCT02221180|Bioequivalence|bioequivalence
1158938|NCT02221180|Metformin|metformin
1158939|NCT02221180|Canagliflozin|canagliflozin
1158940|NCT02221180|Healthy|healthy
1158941|NCT02221167|breastfeeding|breastfeeding
1158942|NCT02221167|donor milk|donor milk
1158943|NCT02221167|formula|formula
1158944|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
1158945|NCT02221167|newborn|newborn
1158946|NCT02221154|in vitro fertilization|in vitro fertilization
1158947|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
1158948|NCT02221154|pregnancy|pregnancy
1158949|NCT02221115|Google Glass device|google glass device
1158950|NCT02221115|Evaluation|evaluation
1158951|NCT02221115|patient's|patient's
1158952|NCT02221115|response|response
1158953|NCT02221115|to new technology|to new technology
1158954|NCT02221115|clinical setting|clinical setting
1158955|NCT02221102|edoxaban|edoxaban
1158956|NCT02221102|aspirin|aspirin
1158957|NCT02221102|new oral anticoagulant|new oral anticoagulant
1158958|NCT02221102|TIA|tia
1158959|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
1158960|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
1158961|NCT02221076|Cellvizio|cellvizio
1158962|NCT02221076|Endomicroscopy|endomicroscopy
1158963|NCT02221076|Robot-assisted procedure|robot-assisted procedure
1158964|NCT02221076|Cervix cancer|cervix cancer
1158965|NCT02221076|Endocervix cancer|endocervix cancer
1158966|NCT02221076|Endometrium cancer|endometrium cancer
1158967|NCT02221076|Ovarian cancer|ovarian cancer
1158968|NCT02221076|Tubal cancer|tubal cancer
1158969|NCT02221076|Colposcopy|colposcopy
1158970|NCT02221076|Hysteroscopy|hysteroscopy
1158971|NCT02221063|thiamin|thiamin
1158972|NCT02221063|thiamin diphosphate|thiamin diphosphate
1158973|NCT02221063|beriberi|beriberi
1158974|NCT02221063|Cambodia|cambodia
1158975|NCT02221063|fish sauce|fish sauce
1158976|NCT02221063|fortification|fortification
1158977|NCT02221063|pregnancy|pregnancy
1158978|NCT02221063|breastfeeding|breastfeeding
1158979|NCT02221063|childbearing age|childbearing age
1158980|NCT02221037|PaO2/FiO2|pao2/fio2
1158981|NCT02221037|Peri-operative lung injury|peri-operative lung injury
1158982|NCT02221037|EVLWI|evlwi
1158983|NCT02221037|ARDS|ards
1158984|NCT02221037|PVPI|pvpi
1158985|NCT02221037|SOFA scores|sofa scores
1158986|NCT02221037|GSK2862277|gsk2862277
1158987|NCT02221037|Oesophagectomy|oesophagectomy
1158988|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
1158989|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
1158990|NCT02221024|Normal saline|normal saline
1158991|NCT02221024|Patency|patency
1158993|NCT02221024|of peripheral|of peripheral
1158994|NCT02221024|intravenous catheter|intravenous catheter
1158995|NCT02221011|Shock wave|shock wave
1158996|NCT02221011|Spasticity|spasticity
1158997|NCT02221011|Effect|effect
1158998|NCT02220998|Hepatitis C|hepatitis c
1158999|NCT02220998|HCV|hcv
1159000|NCT02220998|cirrhosis|cirrhosis
1159001|NCT02220998|Sofosbuvir|sofosbuvir
1159002|NCT02220998|Sovaldi|sovaldi
1159003|NCT02220998|SOF/VEL|sof/vel
1159004|NCT02220998|GS-5816|gs-5816
1159005|NCT02220998|GS-7977|gs-7977
1159006|NCT02220998|liver|liver
1159007|NCT02220998|Treatment naive|treatment naive
1159008|NCT02220998|Treatment Experience|treatment experience
1159009|NCT02220998|genotype 2|genotype 2
1159010|NCT02220972|Epilepsy|epilepsy
1159011|NCT02220972|Partial Onset Seizures|partial onset seizures
1159012|NCT02220972|Insomnia|insomnia
1159013|NCT02220959|morbid obesity surgery|morbid obesity surgery
1159014|NCT02220959|walk test|walk test
1159015|NCT02220959|exercise|exercise
1159016|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
1159017|NCT02220933|Multiple Sclerosis|multiple sclerosis
1159018|NCT02220933|MS|ms
1159019|NCT02220933|EDSS|edss
1159020|NCT02220920|insulin resistance|insulin resistance
1159021|NCT02220907|MT-2412|mt-2412
1159022|NCT02220907|MP-513|mp-513
1159023|NCT02220907|TA-7284|ta-7284
1159024|NCT02220907|Teneligliptin|teneligliptin
1159025|NCT02220907|Canagliflozin|canagliflozin
1159026|NCT02220894|PD-1|pd-1
1159027|NCT02220894|PD1|pd1
1159028|NCT02220894|PD-L1|pd-l1
1159029|NCT02220894|PDL1|pdl1
1159030|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
1159031|NCT02220868|HIV|hiv
1159032|NCT02220868|HCV|hcv
1159033|NCT02220868|DAA|daa
1159034|NCT02220829|alpha-blocker|alpha-blocker
1159035|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
1159036|NCT02220829|radiation therapy|radiation therapy
1159037|NCT02220829|prostate cancer|prostate cancer
1159038|NCT02220816|Attention|attention
1159039|NCT02220816|Competitive|competitive
1159040|NCT02220816|Training|training
1159041|NCT02220803|Acetazolamide|acetazolamide
1159042|NCT02220803|Zonegran|zonegran
1159043|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
1159044|NCT02220803|Apnea|apnea
1159045|NCT02220803|Respiration Disorders|respiration disorders
1159046|NCT02220803|Sleep Disorders|sleep disorders
1159047|NCT02220803|Cardiovascular|cardiovascular
1159048|NCT02220803|Hypertension|hypertension
1159049|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
1159050|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
1159051|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
1159052|NCT02220803|Sulfonamides|sulfonamides
1159053|NCT02220803|Therapeutic Uses|therapeutic uses
1159452|NCT02218996|Outpatient|outpatient
1159054|NCT02220803|Pharmacologic Actions|pharmacologic actions
1159055|NCT02220803|Vascular stifness|vascular stifness
1159056|NCT02220790|IPFN|ipfn
1159057|NCT02220790|Pediatric|pediatric
1159058|NCT02220790|Fungal|fungal
1159059|NCT02220790|Biomarker Assays|biomarker assays
1159060|NCT02220790|Candida|candida
1159061|NCT02220790|Pediatric ICU patient|pediatric icu patient
1159062|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
1159063|NCT02220777|Food effect|food effect
1159064|NCT02220777|Postmenopausal subjects|postmenopausal subjects
1159065|NCT02220777|Vasectomized subjects|vasectomized subjects
1159066|NCT02220777|FIH (First In Humans)|fih (first in humans)
1159067|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
1159068|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
1159069|NCT02220764|prospective study|prospective study
1159070|NCT02220764|chipping|chipping
1159071|NCT02220764|survival rate|survival rate
1159072|NCT02220764|fracture resistance|fracture resistance
1159073|NCT02220764|zirconia|zirconia
1159074|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
1159075|NCT02220751|Genes|genes
1159076|NCT02220751|Saliva|saliva
1159077|NCT02220751|Diagnosis|diagnosis
1159078|NCT02220738|Alzheimer's Disease|alzheimer's disease
1159079|NCT02220725|Andexanet alpha|andexanet alpha
1159080|NCT02220725|Anticoagulation|anticoagulation
1159081|NCT02220725|Antidote|antidote
1159082|NCT02220725|Rivaroxaban|rivaroxaban
1159083|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
1159084|NCT02220725|PRT4445|prt4445
1159085|NCT02220725|Xarelto|xarelto
1159086|NCT02220725|Reversal agent|reversal agent
1159087|NCT02220712|Aripiprazole|aripiprazole
1159088|NCT02220712|Deltoid|deltoid
1159089|NCT02220699|Ostoporosis|ostoporosis
1159090|NCT02220699|Primary Prevention|primary prevention
1159091|NCT02220699|Health Promotion|health promotion
1159092|NCT02220699|General Practice|general practice
1159093|NCT02220699|Secondary screening|secondary screening
1159094|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
1159095|NCT02220686|VAPOR|vapor
1159096|NCT02220686|smoking cessation|smoking cessation
1159097|NCT02220686|PAD|pad
1159098|NCT02220621|Intrauterine adhesion|intrauterine adhesion
1159099|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
1159100|NCT02220621|hysteroscopy|hysteroscopy
1159101|NCT02220621|clinical trial|clinical trial
1159102|NCT02220608|Multiple Myeloma|multiple myeloma
1159104|NCT02220608|Bortezomib|bortezomib
1159105|NCT02220595|Stenting|stenting
1159106|NCT02220595|Endarterectomy|endarterectomy
1159107|NCT02220595|Cognition|cognition
1159108|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
1159109|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
1159110|NCT02220582|socio-environmental factors|socio-environmental factors
1159111|NCT02220582|Contextual factors|contextual factors
1159112|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
1159113|NCT02220543|Primary health care|primary health care
1159114|NCT02220543|Physical Therapy|physical therapy
1159115|NCT02220530|Sedation.|sedation.
1159116|NCT02220530|Colonoscopy quality.|colonoscopy quality.
1159117|NCT02220530|Scientific and technical quality.|scientific and technical quality.
1159118|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
1159119|NCT02220530|Safety|safety
1159120|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
1159121|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
1159122|NCT02220517|prostate cancer|prostate cancer
1159123|NCT02220504|Treatment|treatment
1159124|NCT02220504|Maintenance|maintenance
1159125|NCT02220478|hip|hip
1159126|NCT02220478|Signature|signature
1159127|NCT02220465|sedentary|sedentary
1159128|NCT02220465|smoking|smoking
1159129|NCT02220465|cue reactivity|cue reactivity
1159130|NCT02220465|physical activity|physical activity
1159131|NCT02220439|rotavirus|rotavirus
1159132|NCT02220439|immunogenicity|immunogenicity
1159133|NCT02220439|enteric vaccine|enteric vaccine
1159134|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
1159135|NCT02220439|rotavirus vaccine|rotavirus vaccine
1159136|NCT02220439|gut microbiome|gut microbiome
1159137|NCT02220439|microbiome|microbiome
1159138|NCT02220426|Brown adipose tissue|brown adipose tissue
1159139|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
1159140|NCT02220413|Breastmilk|breastmilk
1159141|NCT02220413|Lactogenesis|lactogenesis
1159142|NCT02220413|Obesity|obesity
1159143|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1159144|NCT02220400|Ketamine|ketamine
1159145|NCT02220400|Surgery|surgery
1159146|NCT02220387|occupational COPD|occupational copd
1159147|NCT02220387|phenotype|phenotype
1159148|NCT02220387|genetic|genetic
1159149|NCT02220374|Osteoarthritis|osteoarthritis
1159150|NCT02220374|Finger|finger
1159151|NCT02220374|Supportive|supportive
1159152|NCT02220374|Tape|tape
1159153|NCT02220374|Pain|pain
1159154|NCT02220374|Function|function
1159155|NCT02220374|Trial|trial
1159156|NCT02220348|Linzess|linzess
1159157|NCT02220335|pulmonary hypertension|pulmonary hypertension
1159158|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
1159159|NCT02220335|left heart failure|left heart failure
1159160|NCT02220335|6-min walk distance|6-min walk distance
1159161|NCT02220322|cortical thickness|cortical thickness
1159162|NCT02220322|age|age
1159163|NCT02220309|Anxiety|anxiety
1159164|NCT02220309|Depression|depression
1159165|NCT02220309|Social Anxiety Disorder|social anxiety disorder
1159166|NCT02220309|Bipolar disorder II|bipolar disorder ii
1159167|NCT02220309|PTSD|ptsd
1159168|NCT02220309|GAD|gad
1159169|NCT02220309|Phobia|phobia
1159170|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
1159171|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
1159172|NCT02220257|remission, honeymoon|remission, honeymoon
1159173|NCT02220257|microangiopathy|microangiopathy
1159174|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
1159175|NCT02220244|optic neuritis|optic neuritis
1159176|NCT02220244|visual defect|visual defect
1159177|NCT02220244|visual loss|visual loss
1159178|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
1159179|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
1159180|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
1159181|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
1159182|NCT02220218|Healthy|healthy
1159183|NCT02220218|Metformin|metformin
1159184|NCT02220218|Canagliflozin|canagliflozin
1159185|NCT02220218|JNJ-28431754|jnj-28431754
1159186|NCT02220205|IUD|iud
1159187|NCT02220205|training|training
1159188|NCT02220205|simulation|simulation
1159189|NCT02220192|cervical neoplasia|cervical neoplasia
1159190|NCT02220192|cervix|cervix
1159191|NCT02220192|high-grade dysplasia|high-grade dysplasia
1159192|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
1159193|NCT02220192|precancerous cells|precancerous cells
1159194|NCT02220192|colposcopy|colposcopy
1159195|NCT02220166|Celiac Disease|celiac disease
1159196|NCT02220166|Gluten|gluten
1159197|NCT02220166|Gluten free diet|gluten free diet
1159198|NCT02220166|Triticum monococcum|triticum monococcum
1159199|NCT02220153|Monoclonal antibody|monoclonal antibody
1159200|NCT02220153|subjects|subjects
1159201|NCT02220153|First in human|first in human
1159202|NCT02220127|Brain|brain
1159203|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
1159204|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
1159205|NCT02220114|Infantile spasms|infantile spasms
1159206|NCT02220114|vigabatrin|vigabatrin
1159207|NCT02220114|soluble tablets|soluble tablets
1159208|NCT02220114|acceptability|acceptability
1159209|NCT02220114|adherence|adherence
1159210|NCT02220114|pharmacokinetics|pharmacokinetics
1159211|NCT02220101|hypothermia|hypothermia
1159212|NCT02220101|core temperature|core temperature
1159213|NCT02220101|temperature measurement methods|temperature measurement methods
1159214|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
1159216|NCT02220088|TACE failure|tace failure
1159217|NCT02220088|TACE refractoriness|tace refractoriness
1159218|NCT02220088|BCLC B|bclc b
1159219|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
1159220|NCT02220036|Diabetic nephropathy|diabetic nephropathy
1159221|NCT02220036|Renal function|renal function
1159222|NCT02220036|Insulin resistance|insulin resistance
1159223|NCT02220036|Metabolic profile|metabolic profile
1159224|NCT02220036|Serum magnesium level|serum magnesium level
1159225|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
1159226|NCT02220010|Pancreatic stenting|pancreatic stenting
1159227|NCT02219997|Cataract|cataract
1159228|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
1159229|NCT02219997|AcrySof|acrysof
1159230|NCT02219984|Anticoagulation|anticoagulation
1159231|NCT02219984|vitamin K antagonists|vitamin k antagonists
1159232|NCT02219984|Warfarin|warfarin
1159233|NCT02219984|low molecular weight heparin|low molecular weight heparin
1159234|NCT02219984|fondaparinux|fondaparinux
1159235|NCT02219984|antithrombotics|antithrombotics
1159236|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
1159237|NCT02219984|dabigatran|dabigatran
1159238|NCT02219984|rivaroxaban|rivaroxaban
1159239|NCT02219984|apixaban|apixaban
1159240|NCT02219984|edoxaban|edoxaban
1159241|NCT02219984|atrial fibrillation|atrial fibrillation
1159242|NCT02219984|venous thromboembolism|venous thromboembolism
1159243|NCT02219971|Healthy|healthy
1159244|NCT02219958|Hypertension|hypertension
1159245|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
1159246|NCT02219932|Fampridine|fampridine
1159247|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
1159248|NCT02219919|Pain|pain
1159249|NCT02219919|Sensitivity|sensitivity
1159250|NCT02219919|Pain Thresholds|pain thresholds
1159251|NCT02219919|Sensitization|sensitization
1159252|NCT02219919|Physical Therapy|physical therapy
1159253|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1159254|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
1159255|NCT02219893|Colorectal Cancer|colorectal cancer
1159256|NCT02219893|Cytoreductive surgery|cytoreductive surgery
1159257|NCT02219893|HIPEC|hipec
1159258|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
1159259|NCT02219893|Immunotoxin|immunotoxin
1159260|NCT02219893|MOC31PE|moc31pe
1159261|NCT02219880|Kava|kava
1159262|NCT02219880|Anxiety|anxiety
1159263|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
1159264|NCT02219880|Psychiatric|psychiatric
1159265|NCT02219880|Anxiolytic|anxiolytic
1159266|NCT02219880|GABA|gaba
1159267|NCT02219880|Kavalactones|kavalactones
1159268|NCT02219867|ketamine|ketamine
1159269|NCT02219867|MDD|mdd
1159270|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
1159271|NCT02219828|pericarditis|pericarditis
1159272|NCT02219828|recurrent pericarditis|recurrent pericarditis
1159273|NCT02219828|corticosteroids|corticosteroids
1159274|NCT02219828|anakinra|anakinra
1159275|NCT02219815|Preoperative Care|preoperative care
1159276|NCT02219815|Exercise Therapy|exercise therapy
1159277|NCT02219815|Cardiac Surgery|cardiac surgery
1159278|NCT02219815|Frailty|frailty
1159279|NCT02219802|Coronary artery disease|coronary artery disease
1159280|NCT02219802|Acute myocardial infarction|acute myocardial infarction
1159281|NCT02219802|Drug-coated balloon|drug-coated balloon
1159282|NCT02219802|Drug-eluting stent|drug-eluting stent
1159283|NCT02219776|Infection,|infection,
1159284|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
1159285|NCT02219776|Shoulder,|shoulder,
1159286|NCT02219776|skin preparation|skin preparation
1159287|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
1159288|NCT02219711|MGCD516|mgcd516
1159289|NCT02219711|MET|met
1159290|NCT02219711|AXL|axl
1159291|NCT02219711|RET|ret
1159292|NCT02219711|TRK|trk
1159293|NCT02219711|NTRK|ntrk
1159294|NCT02219711|DDR2|ddr2
1159295|NCT02219711|KDR|kdr
1159296|NCT02219711|VEGFR|vegfr
1159297|NCT02219711|PDGFRA|pdgfra
1159298|NCT02219711|KIT|kit
1159299|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1159300|NCT02219711|NSCLC|nsclc
1159301|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
1159302|NCT02219711|Head and neck cancer|head and neck cancer
1159303|NCT02219711|Renal cell carcinoma|renal cell carcinoma
1159304|NCT02219711|Prostate cancer|prostate cancer
1159305|NCT02219711|Phase 1|phase 1
1159306|NCT02219711|CBL|cbl
1159307|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
1159308|NCT02219659|sedation strategy|sedation strategy
1159309|NCT02219659|mechanical ventilation|mechanical ventilation
1159310|NCT02219659|ventilator weaning|ventilator weaning
1159311|NCT02219646|T2DM|t2dm
1159312|NCT02219646|ED|ed
1159313|NCT02219620|creative arts|creative arts
1159314|NCT02219620|older adults|older adults
1159315|NCT02219620|intervention study|intervention study
1159316|NCT02219594|gemstone CT|gemstone ct
1159317|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
1159318|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
1159319|NCT02219594|in-stent restenosis|in-stent restenosis
1159320|NCT02219594|coronary heart disease|coronary heart disease
1159321|NCT02219581|Osteoarthritis|osteoarthritis
1159322|NCT02219581|Postoperative pain|postoperative pain
1159323|NCT02219581|Total knee arthroplasty|total knee arthroplasty
1159324|NCT02219581|Orthopaedics|orthopaedics
1159325|NCT02219581|Inflammation|inflammation
1159326|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
1159327|NCT02219555|Carpal tunnel|carpal tunnel
1159328|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
1159329|NCT02219503|Hepatitis C|hepatitis c
1159330|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
1159331|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
1159332|NCT02219503|Cirrhotic|cirrhotic
1159333|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
1159334|NCT02219503|Hepatitis C Virus|hepatitis c virus
1159335|NCT02219503|Interferon-Free|interferon-free
1159336|NCT02219503|Child Pugh A|child pugh a
1159337|NCT02219503|Ribavirin-Free|ribavirin-free
1159338|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
1159339|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
1159340|NCT02219490|Cirrhosis|cirrhosis
1159341|NCT02219490|Naive|naive
1159342|NCT02219490|Treatment-Experienced|treatment-experienced
1159343|NCT02219490|Relapser|relapser
1159344|NCT02219490|Null responder|null responder
1159345|NCT02219490|Non responder|non responder
1159346|NCT02219477|Cirrhosis|cirrhosis
1159347|NCT02219477|Hepatitis C|hepatitis c
1159348|NCT02219477|Child-Pugh B|child-pugh b
1159349|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
1159350|NCT02219477|Interferon-Free|interferon-free
1159351|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
1159352|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
1159353|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
1159354|NCT02219477|Hepatitis C Virus|hepatitis c virus
1159355|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
1159356|NCT02219464|nasal cannula|nasal cannula
1159357|NCT02219451|Chronic heart failure|chronic heart failure
1159358|NCT02219451|exercise training|exercise training
1159359|NCT02219451|Sympathetic modulation|sympathetic modulation
1159360|NCT02219451|arterial baroreflex control|arterial baroreflex control
1159361|NCT02219425|Infertility|infertility
1159362|NCT02219425|Endometrium|endometrium
1159363|NCT02219425|Endometrial biopsy|endometrial biopsy
1159364|NCT02219425|Gene expression|gene expression
1159365|NCT02219412|ticagrelor|ticagrelor
1159366|NCT02219412|platelet aggregation rate|platelet aggregation rate
1159367|NCT02219412|ADP antagonist|adp antagonist
1159368|NCT02219412|antiplatelet therapy|antiplatelet therapy
1159369|NCT02219399|Pregnancy|pregnancy
1159370|NCT02219399|DHA|dha
1159371|NCT02219399|Gestational Length|gestational length
1159372|NCT02219399|Cognitive Development|cognitive development
1159373|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
1159374|NCT02219360|acute|acute
1159375|NCT02219360|exacerbation|exacerbation
1159376|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1159377|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
1159378|NCT02219347|biological markers|biological markers
1159379|NCT02219347|remission|remission
1159380|NCT02219347|ultrasonography|ultrasonography
1159381|NCT02219347|microarray|microarray
1159382|NCT02219347|survival analysis|survival analysis
1159383|NCT02219347|T cell|t cell
1159384|NCT02219334|Children|children
1159385|NCT02219334|Nasal suction devices|nasal suction devices
1159386|NCT02219334|Suctioning|suctioning
1159387|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
1159388|NCT02219308|Contraception|contraception
1159389|NCT02219308|Pain|pain
1159390|NCT02219308|Intrauterine Device|intrauterine device
1159391|NCT02219308|Paracervical Block|paracervical block
1159392|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
1159393|NCT02219295|Glut-transporters|glut-transporters
1159394|NCT02219295|taste receptors genes|taste receptors genes
1159395|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
1159396|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
1159397|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
1159398|NCT02219269|contraception|contraception
1159399|NCT02219269|family planning|family planning
1159400|NCT02219269|complex medical conditions|complex medical conditions
1159401|NCT02219256|Drug therapy|drug therapy
1159402|NCT02219243|Social Anxiety Disorder|social anxiety disorder
1159403|NCT02219243|Cognitive Training|cognitive training
1159404|NCT02219243|Interpretation Modification Program|interpretation modification program
1159405|NCT02219204|Acupuncture|acupuncture
1159406|NCT02219204|Herbal treatment|herbal treatment
1159407|NCT02219191|Puerarin tablet|puerarin tablet
1159408|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
1159409|NCT02219191|metabolism syndrome|metabolism syndrome
1159410|NCT02219165|Paediatrics|paediatrics
1159411|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
1159412|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
1159413|NCT02219165|feasibility|feasibility
1159414|NCT02219139|Edentulous|edentulous
1159415|NCT02219139|Roxolid|roxolid
1159416|NCT02219139|SLAclive surface|slaclive surface
1159417|NCT02219139|Titanium/zirconium|titanium/zirconium
1159418|NCT02219113|Damage of articular cartilage|damage of articular cartilage
1159419|NCT02219113|Cartilage degeneration|cartilage degeneration
1159420|NCT02219113|Intraarticular injection|intraarticular injection
1159421|NCT02219113|ADRC|adrc
1159422|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
1159423|NCT02219113|Adipose tissue|adipose tissue
1159424|NCT02219113|Stem cells|stem cells
1159425|NCT02219087|Total knee arthroplasty|total knee arthroplasty
1159426|NCT02219087|Total joint arthroplasty|total joint arthroplasty
1159427|NCT02219087|Knee replacement|knee replacement
1159428|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
1159429|NCT02219061|Measles|measles
1159430|NCT02219061|Meningitis C|meningitis c
1159431|NCT02219061|waning|waning
1159432|NCT02219061|Geometric Mean Titer|geometric mean titer
1159433|NCT02219061|China|china
1159434|NCT02219048|Asthma|asthma
1159435|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
1159436|NCT02219035|presentation with|presentation with
1159437|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
1159438|NCT02219022|Progressive resistance exercise|progressive resistance exercise
1159439|NCT02219022|Pain|pain
1159440|NCT02219022|Functional capacity|functional capacity
1159441|NCT02219022|Quality of life|quality of life
1159442|NCT02219022|Muscle strength|muscle strength
1159443|NCT02219009|OPC-14597 Digital|opc-14597 digital
1159444|NCT02219009|Aripiprazole|aripiprazole
1159445|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
1159446|NCT02219009|Treatment Adherence|treatment adherence
1159447|NCT02219009|Ingestible Event Marker|ingestible event marker
1159448|NCT02218996|Anxiety|anxiety
1159449|NCT02218996|Children|children
1159450|NCT02218996|Adolescent|adolescent
1159451|NCT02218996|Effectiveness|effectiveness
1159453|NCT02218983|trauma|trauma
1159454|NCT02218983|echo|echo
1159455|NCT02218983|echocardiogram|echocardiogram
1159456|NCT02218983|ultrasound|ultrasound
1159457|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
1159458|NCT02218970|rehabilitation|rehabilitation
1159459|NCT02218970|strength training|strength training
1159460|NCT02218970|muscle strength|muscle strength
1159461|NCT02218970|physical fitness|physical fitness
1159462|NCT02218957|Bariatric surgery|bariatric surgery
1159463|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1159464|NCT02218931|Pre-eclampsia|pre-eclampsia
1159465|NCT02218931|Gestational diabetes|gestational diabetes
1159466|NCT02218931|Stillbirth|stillbirth
1159467|NCT02218931|Small for gestational age|small for gestational age
1159468|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
1159469|NCT02218931|Obesity|obesity
1159470|NCT02218931|Raised Lipids|raised lipids
1159471|NCT02218931|High Blood Pressure|high blood pressure
1159472|NCT02218931|Cardiovascular risk|cardiovascular risk
1159473|NCT02218931|Insulin resistance|insulin resistance
1159474|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
1159475|NCT02218931|Dietary interventions|dietary interventions
1159476|NCT02218918|Ground walk|ground walk
1159477|NCT02218918|treadmill walk|treadmill walk
1159478|NCT02218918|Functional walk capacity|functional walk capacity
1159479|NCT02218918|COPD|copd
1159480|NCT02218918|Quality of Life|quality of life
1159481|NCT02218905|Correlation|correlation
1159482|NCT02218905|Sit to stand repetitions|sit to stand repetitions
1159483|NCT02218905|Anthropometric variables|anthropometric variables
1159484|NCT02218905|Age|age
1159485|NCT02218905|Height|height
1159486|NCT02218905|weight|weight
1159487|NCT02218905|Gender|gender
1159488|NCT02218905|Regression|regression
1159489|NCT02218866|Bariatric surgery|bariatric surgery
1159490|NCT02218866|Obesity|obesity
1159491|NCT02218866|Neuropathy|neuropathy
1159492|NCT02218853|Bipolar disorder|bipolar disorder
1159493|NCT02218853|Psychosis|psychosis
1159494|NCT02218853|Schizophrenia|schizophrenia
1159495|NCT02218840|cigar smoker|cigar smoker
1159497|NCT02218840|behavioral pharmacology|behavioral pharmacology
1159498|NCT02218840|smoking topography|smoking topography
1159499|NCT02218827|Dry Eye|dry eye
1159500|NCT02218827|Inflammatory reaction|inflammatory reaction
1159501|NCT02218827|steroids|steroids
1159502|NCT02218814|Femoral Nerve Block|femoral nerve block
1159503|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
1159504|NCT02218801|Liver metastasis|liver metastasis
1159505|NCT02218801|Colorectal carcinoma|colorectal carcinoma
1159506|NCT02218801|Unresectable|unresectable
1159507|NCT02218801|Borderline resectable|borderline resectable
1159508|NCT02218801|Initially unresectable|initially unresectable
1159509|NCT02218788|Nasolabial folds|nasolabial folds
1159510|NCT02218788|Marionette lines|marionette lines
1159511|NCT02218788|Cheek bones|cheek bones
1159512|NCT02218788|Jaw lines|jaw lines
1159513|NCT02218775|Kappa opioid receptor|kappa opioid receptor
1159514|NCT02218775|Mu opioid receptor|mu opioid receptor
1159515|NCT02218775|LY2456302|ly2456302
1159516|NCT02218775|Anhedonia|anhedonia
1159517|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
1159518|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
1159519|NCT02218762|replicated cross-over design|replicated cross-over design
1159520|NCT02218762|Respiratory|respiratory
1159522|NCT02218762|safety|safety
1159523|NCT02218762|pharmacokinetics|pharmacokinetics
1159524|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
1159525|NCT02218762|pharmacodynamics|pharmacodynamics
1159526|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
1159527|NCT02218736|Anhedonia|anhedonia
1159528|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
1159529|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
1159530|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
1159531|NCT02218723|healthy volunteer|healthy volunteer
1159532|NCT02218723|Asthma|asthma
1159533|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
1159534|NCT02218723|UD-DPI|ud-dpi
1159535|NCT02218723|ELLIPTA DPI|ellipta dpi
1159536|NCT02218723|Fluticasone furoate|fluticasone furoate
1159537|NCT02218697|Immunogenicity|immunogenicity
1159538|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
1159539|NCT02218697|Safety|safety
1159540|NCT02218697|Adults|adults
1159541|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
1159542|NCT02218697|Co-administration|co-administration
1159543|NCT02218697|Elderly|elderly
1159544|NCT02218697|Seasonal influenza|seasonal influenza
1159545|NCT02218697|Pneumococcal infection|pneumococcal infection
1159546|NCT02218632|Galactosaemia|galactosaemia
1159547|NCT02218632|Dysglycosylation|dysglycosylation
1159548|NCT02218632|Diet|diet
1159549|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
1159550|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
1159648|NCT02218203|combination therapy|combination therapy
1159551|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
1159552|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
1159553|NCT02218606|Abiraterone Acetate|abiraterone acetate
1159554|NCT02218606|CABAZITAXEL|cabazitaxel
1159555|NCT02218606|CASTRATION RESISTANT|castration resistant
1159556|NCT02218606|14-046|14-046
1159557|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
1159558|NCT02218580|massage therapy|massage therapy
1159559|NCT02218580|juvenile arthritis|juvenile arthritis
1159560|NCT02218580|pain|pain
1159561|NCT02218554|BRONJ|bronj
1159562|NCT02218528|subjects|subjects
1159563|NCT02218515|Autogenous bone graft|autogenous bone graft
1159564|NCT02218515|Chronic periodontitis|chronic periodontitis
1159565|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
1159566|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
1159567|NCT02218515|Periodontal flap surgery|periodontal flap surgery
1159568|NCT02218502|Ovarian cancer|ovarian cancer
1159569|NCT02218502|Diagnosis|diagnosis
1159570|NCT02218502|Risk of Malignancy Index|risk of malignancy index
1159571|NCT02218502|RMI|rmi
1159572|NCT02218502|Ultrasound|ultrasound
1159573|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
1159574|NCT02218502|DW-MRI|dw-mri
1159575|NCT02218502|Subjective assessment|subjective assessment
1159576|NCT02218489|Pain|pain
1159577|NCT02218489|Corticosteroid|corticosteroid
1159578|NCT02218489|Meibomian Gland Disease|meibomian gland disease
1159579|NCT02218489|Blepharitis|blepharitis
1159580|NCT02218489|Eyelid|eyelid
1159581|NCT02218489|Ocular Discomfort|ocular discomfort
1159582|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
1159583|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
1159584|NCT02218463|Labial agglutination|labial agglutination
1159585|NCT02218463|Labial fusion|labial fusion
1159586|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
1159587|NCT02218437|Umbilical Cord|umbilical cord
1159588|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
1159589|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
1159691|NCT02218073|Healthy|healthy
1159590|NCT02218398|airway resistance|airway resistance
1159591|NCT02218398|lung compliance|lung compliance
1159592|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
1159593|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
1159594|NCT02218385|Breast Health Screening|breast health screening
1159595|NCT02218385|Cytology|cytology
1159596|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
1159597|NCT02218372|vancomycin|vancomycin
1159598|NCT02218372|Clostridium difficile infection|clostridium difficile infection
1159599|NCT02218372|fidaxomicin|fidaxomicin
1159600|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
1159601|NCT02218359|Aerosol antibiotics|aerosol antibiotics
1159602|NCT02218359|Mechanical ventilation|mechanical ventilation
1159603|NCT02218359|Amikacin|amikacin
1159604|NCT02218359|Fosfomycin|fosfomycin
1159605|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
1159606|NCT02218359|Pneumonia|pneumonia
1159607|NCT02218359|Bacterial Infections|bacterial infections
1159608|NCT02218359|Lung Diseases|lung diseases
1159609|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
1159610|NCT02218359|Respiratory Tract Infections|respiratory tract infections
1159611|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
1159612|NCT02218359|Anti-Infective Agents|anti-infective agents
1159613|NCT02218359|Therapeutic Uses|therapeutic uses
1159614|NCT02218359|Pharmacologic Actions|pharmacologic actions
1159615|NCT02218359|MRSA|mrsa
1159616|NCT02218346|Healthy volunteers|healthy volunteers
1159617|NCT02218320|HIV|hiv
1159618|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
1159619|NCT02218320|raltegravir|raltegravir
1159620|NCT02218320|Isentress|isentress
1159621|NCT02218320|dolutegravir|dolutegravir
1159622|NCT02218320|Tivicay|tivicay
1159623|NCT02218320|pharmacodynamics|pharmacodynamics
1159624|NCT02218294|BCX4161|bcx4161
1159625|NCT02218294|BioCryst|biocryst
1159626|NCT02218294|hereditary angioedema|hereditary angioedema
1159627|NCT02218294|mass balance|mass balance
1159628|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
1159629|NCT02218294|ADME|adme
1159630|NCT02218268|type I diabetes|type i diabetes
1159631|NCT02218268|healthy|healthy
1159632|NCT02218268|children|children
1159633|NCT02218268|adolescents|adolescents
1159634|NCT02218268|young adults|young adults
1159635|NCT02218255|In Vitro Fertilization|in vitro fertilization
1159636|NCT02218242|Lung|lung
1159637|NCT02218242|Cancer|cancer
1159638|NCT02218242|Ultrasound|ultrasound
1159639|NCT02218242|Staging|staging
1159640|NCT02218229|shock wave|shock wave
1159641|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
1159642|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
1159643|NCT02218203|chronic pain|chronic pain
1159644|NCT02218203|central neuropathic pain|central neuropathic pain
1159645|NCT02218203|spinal cord injury|spinal cord injury
1159646|NCT02218203|dextromethorphan|dextromethorphan
1159647|NCT02218203|lidocaine|lidocaine
1159649|NCT02218203|analgesia|analgesia
1159650|NCT02218190|Alvimopan|alvimopan
1159651|NCT02218190|Ileus|ileus
1159652|NCT02218190|Posterior spinal fusion|posterior spinal fusion
1159653|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
1159654|NCT02218177|Ranibizumab|ranibizumab
1159655|NCT02218177|Aflibercept|aflibercept
1159656|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
1159657|NCT02218177|Cytokine analysis|cytokine analysis
1159658|NCT02218164|metastatic|metastatic
1159659|NCT02218164|cutaneous|cutaneous
1159660|NCT02218164|skin cancer|skin cancer
1159661|NCT02218151|Hematopoietic|hematopoietic
1159662|NCT02218151|Stem Cell|stem cell
1159663|NCT02218151|Transplant|transplant
1159664|NCT02218151|patient-centered|patient-centered
1159665|NCT02218151|Microbiota|microbiota
1159666|NCT02218151|GVHD|gvhd
1159667|NCT02218138|Adolescent|adolescent
1159668|NCT02218138|Diabetes|diabetes
1159669|NCT02218138|Depression|depression
1159670|NCT02218138|Obesity|obesity
1159671|NCT02218138|Stress|stress
1159672|NCT02218125|Healthy|healthy
1159673|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
1159674|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
1159675|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
1159676|NCT02218125|Vaccination|vaccination
1159677|NCT02218125|Ad26.ENVA.01|ad26.enva.01
1159678|NCT02218125|Recombinant|recombinant
1159679|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
1159680|NCT02218112|Blood pressure|blood pressure
1159681|NCT02218112|Obesity|obesity
1159682|NCT02218112|Glomerular filtration rate|glomerular filtration rate
1159683|NCT02218112|Renal Sodium handling|renal sodium handling
1159684|NCT02218099|Phase 1|phase 1
1159685|NCT02218099|ASP8232|asp8232
1159686|NCT02218099|Single dose|single dose
1159687|NCT02218099|Multiple doses|multiple doses
1159688|NCT02218086|postural control|postural control
1159689|NCT02218086|postural balance|postural balance
1159690|NCT02218086|slackline|slackline
1159692|NCT02218073|JNJ-42756493|jnj-42756493
1159693|NCT02218073|JNJ-61818549|jnj-61818549
1159694|NCT02218073|Isotope|isotope
1159695|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
1159696|NCT02218047|Polycythemia Vera|polycythemia vera
1159697|NCT02218047|PROUD-PV|proud-pv
1159698|NCT02218047|CONTINUATION-PV|continuation-pv
1159699|NCT02218047|AOP Orphan|aop orphan
1159700|NCT02218047|Polycythemia|polycythemia
1159701|NCT02218047|Hematologic Diseases|hematologic diseases
1159702|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
1159703|NCT02218047|Bone Marrow Diseases|bone marrow diseases
1159704|NCT02218047|Interferon-alpha|interferon-alpha
1159705|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
1159706|NCT02218021|Alkermes|alkermes
1159707|NCT02218021|ALKS 33|alks 33
1159708|NCT02218021|ALKS 5461|alks 5461
1159709|NCT02218021|Samidorphan|samidorphan
1159710|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
1159711|NCT02218008|depression|depression
1159712|NCT02218008|Alkermes|alkermes
1159713|NCT02218008|ALKS 5461|alks 5461
1159714|NCT02218008|samidorphan|samidorphan
1159715|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1159716|NCT02217995|Mindfulness|mindfulness
1159717|NCT02217969|Anesthesia|anesthesia
1159718|NCT02217969|Hypotension|hypotension
1159719|NCT02217930|TQT|tqt
1159720|NCT02217917|Healthy subjects|healthy subjects
1159721|NCT02217917|Randomized|randomized
1159722|NCT02217917|Double-blind|double-blind
1159723|NCT02217917|Single ascending dose|single ascending dose
1159724|NCT02217917|Multiple ascending dose|multiple ascending dose
1159725|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1159726|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
1159727|NCT02217878|ticagrelor|ticagrelor
1159728|NCT02217878|morphine|morphine
1159729|NCT02217878|pharmacokinetics|pharmacokinetics
1159730|NCT02217878|pharmacodynamics|pharmacodynamics
1159731|NCT02217878|drug interactions|drug interactions
1159732|NCT02217878|VASP assay|vasp assay
1159733|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
1159734|NCT02217878|VerifyNow|verifynow
1159735|NCT02217865|Colorectal Cancer|colorectal cancer
1159736|NCT02217865|CRC|crc
1159737|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
1159738|NCT02217865|Caregivers|caregivers
1159739|NCT02217865|Interviews|interviews
1159740|NCT02217865|Focus groups|focus groups
1159741|NCT02217865|Questionnaires|questionnaires
1159742|NCT02217865|Surveys|surveys
1159743|NCT02217852|hypertension|hypertension
1159744|NCT02217852|Tibetan|tibetan
1159745|NCT02217852|Nitrendipine|nitrendipine
1159746|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
1159747|NCT02217852|captopril|captopril
1159748|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
1159749|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
1159750|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
1159751|NCT02217774|Dental Implant|dental implant
1159752|NCT02217774|MGuide|mguide
1159753|NCT02217761|Pharmacokinetics|pharmacokinetics
1159754|NCT02217761|Antifungal Agents|antifungal agents
1159755|NCT02217735|Parkinson's Disease|parkinson's disease
1159756|NCT02217735|Caregivers|caregivers
1159757|NCT02217735|Expressive Writing|expressive writing
1159758|NCT02217735|Complementary Medicine|complementary medicine
1159759|NCT02217735|Cortisol|cortisol
1159760|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
1159761|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1159762|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
1159763|NCT02217696|Development|development
1159764|NCT02217696|Prediction|prediction
1159765|NCT02217696|Intervention|intervention
1159766|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
1159767|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
1159768|NCT02217683|Blood Transfusion|blood transfusion
1159769|NCT02217683|Nitric Oxide|nitric oxide
1159770|NCT02217657|Smart-Touch|smart-touch
1159771|NCT02217657|Contact force|contact force
1159772|NCT02217605|NAFLD|nafld
1159773|NCT02217605|Oral Fructose Challenge|oral fructose challenge
1159774|NCT02217605|31P MRS|31p mrs
1159775|NCT02217605|Liver|liver
1159776|NCT02217605|Subjects|subjects
1159777|NCT02217579|Weight loss|weight loss
1159778|NCT02217579|Appetite|appetite
1159779|NCT02217579|Overweight|overweight
1159780|NCT02217579|Obesity|obesity
1159781|NCT02217579|Dietary fiber|dietary fiber
1159782|NCT02217579|Dietary protein|dietary protein
1159783|NCT02217566|Prostatic neoplasms|prostatic neoplasms
1159784|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
1159785|NCT02217566|Abiraterone acetate|abiraterone acetate
1159786|NCT02217566|Prednisone|prednisone
1159787|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
1159788|NCT02217553|platelet|platelet
1159789|NCT02217553|P-selectin|p-selectin
1159790|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
1159791|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
1159792|NCT02217553|vitamin D|vitamin d
1159793|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
1159794|NCT02217527|crossover|crossover
1159795|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
1159796|NCT02217462|pregnancy|pregnancy
1159797|NCT02217462|gestational weight gain|gestational weight gain
1159798|NCT02217462|dietary intake|dietary intake
1159799|NCT02217462|food reward|food reward
1159800|NCT02217423|Physical Therapy Modalities|physical therapy modalities
1159801|NCT02217423|Respiration Disorders|respiration disorders
1159802|NCT02217423|Respiratory Therapy|respiratory therapy
1159803|NCT02217410|renal, de novo,|renal, de novo,
1159804|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
1159805|NCT02217384|Microbiome|microbiome
1159806|NCT02217384|DNA sequencing|dna sequencing
1159807|NCT02217384|Leptin|leptin
1159808|NCT02217384|Adiponectin|adiponectin
1159809|NCT02217384|Insulin|insulin
1159810|NCT02217384|IGF-I|igf-i
1159811|NCT02217371|ADHD Patient|adhd patient
1159812|NCT02217371|Healthy subjects|healthy subjects
1159813|NCT02217371|Sleepiness|sleepiness
1159815|NCT02217371|MWT|mwt
1159816|NCT02217371|EEG|eeg
1159817|NCT02217371|cognitive tests|cognitive tests
1159818|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1159819|NCT02217358|NBI endoscopy|nbi endoscopy
1159820|NCT02217358|videoendoscopy|videoendoscopy
1159821|NCT02217358|white light endoscopy|white light endoscopy
1159822|NCT02217358|magnifying endoscopy|magnifying endoscopy
1159823|NCT02217358|direct laryngoscopy|direct laryngoscopy
1159824|NCT02217332|Sinusitis|sinusitis
1159825|NCT02217332|Rhinosinusitis|rhinosinusitis
1159826|NCT02217332|CRS|crs
1159827|NCT02217332|CRSwNP|crswnp
1159828|NCT02217332|CSNP-E|csnp-e
1159829|NCT02217332|Nasal polyps|nasal polyps
1159830|NCT02217332|Nasal polyposis|nasal polyposis
1159831|NCT02217332|Eosinophilia|eosinophilia
1159832|NCT02217332|Asthma|asthma
1159833|NCT02217319|Volatile Anesthetic|volatile anesthetic
1159834|NCT02217319|Cardioprotection|cardioprotection
1159835|NCT02217319|Lung surgery|lung surgery
1159836|NCT02217319|non cardiac surgery|non cardiac surgery
1159837|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
1159838|NCT02217293|Ultrasound-guided|ultrasound-guided
1159839|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
1159840|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
1159841|NCT02217267|Peripheral neuropathy|peripheral neuropathy
1159842|NCT02217215|Spectroscopy|spectroscopy
1159843|NCT02217215|HPV|hpv
1159844|NCT02217202|knee replacement|knee replacement
1159845|NCT02217202|knee arthroplasty|knee arthroplasty
1159846|NCT02217202|revision|revision
1159847|NCT02217202|high risk|high risk
1159848|NCT02217189|Zinc supplementation.|zinc supplementation.
1159849|NCT02217189|Oxidative stress.|oxidative stress.
1159850|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
1159851|NCT02217189|Asthenospermia.|asthenospermia.
1159852|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
1159853|NCT02217137|Dry Eye|dry eye
1159854|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
1159855|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
1159856|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
1159857|NCT02217124|apple|apple
1159858|NCT02217124|high fiber|high fiber
1159859|NCT02217124|body composition|body composition
1159860|NCT02217124|children|children
1159861|NCT02217111|vocal fold nodules|vocal fold nodules
1159862|NCT02217111|pediatric|pediatric
1159863|NCT02217111|voice therapy|voice therapy
1159864|NCT02217111|acoustic|acoustic
1159865|NCT02217111|aerodynamic|aerodynamic
1159866|NCT02217111|quality of life|quality of life
1159867|NCT02217111|Adventures in Voice|adventures in voice
1159868|NCT02217098|ART|art
1159869|NCT02217098|Occlusal|occlusal
1159870|NCT02217098|Occlusoproximal|occlusoproximal
1159871|NCT02217098|Primary teeth|primary teeth
1159872|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
1159873|NCT02217085|Colon Cancer Screening|colon cancer screening
1159874|NCT02217085|Polyps|polyps
1159875|NCT02217085|Colonoscopy|colonoscopy
1159876|NCT02217072|academic performance|academic performance
1159877|NCT02217072|cognitive development|cognitive development
1159878|NCT02217072|children in care|children in care
1159879|NCT02217072|prevention of school failure|prevention of school failure
1159880|NCT02217059|Emergency Medical Services|emergency medical services
1159881|NCT02217059|Emergency Care|emergency care
1159882|NCT02217059|Hypertension|hypertension
1159883|NCT02217059|BpTRU|bptru
1159884|NCT02217059|Blood pressure|blood pressure
1159885|NCT02217046|Infection|infection
1159886|NCT02217046|prevention|prevention
1159887|NCT02217046|cardiac devices|cardiac devices
1159888|NCT02217033|Breast Cancer|breast cancer
1159889|NCT02217033|Stage I breast cancer|stage i breast cancer
1159890|NCT02217033|Stage II breast cancer|stage ii breast cancer
1159891|NCT02217033|Water study|water study
1159892|NCT02217033|'R'|'r'
1159893|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
1159894|NCT02217033|altered beverage|altered beverage
1159895|NCT02217033|Insomnia|insomnia
1159896|NCT02217033|Fatigue|fatigue
1159897|NCT02217033|Depression|depression
1159898|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
1159899|NCT02217020|Rectal Cancer|rectal cancer
1159900|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
1159901|NCT02217020|Neoadjuvant|neoadjuvant
1159902|NCT02217020|chemotherapy|chemotherapy
1159903|NCT02217020|FOLFOXIRI|folfoxiri
1159904|NCT02217007|Tourette|tourette
1159905|NCT02217007|Tourette's|tourette's
1159907|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
1159908|NCT02216994|Hirschsprung disease|hirschsprung disease
1159909|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
1159910|NCT02216994|diagnostic scoring system|diagnostic scoring system
1159911|NCT02216994|Prospective study|prospective study
1159912|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
1159913|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
1159914|NCT02216981|Intensive therapy|intensive therapy
1159915|NCT02216981|Intensive treatment|intensive treatment
1159916|NCT02216981|Treatment Resistant|treatment resistant
1159917|NCT02216968|vegetables|vegetables
1159918|NCT02216968|Head Start|head start
1159919|NCT02216968|preschool|preschool
1159920|NCT02216968|children|children
1159921|NCT02216968|theater|theater
1159922|NCT02216968|puppet|puppet
1159923|NCT02216942|Endodontics|endodontics
1159924|NCT02216942|Deciduous teeth|deciduous teeth
1159925|NCT02216942|Iodoform pastes|iodoform pastes
1159926|NCT02216942|Treatment Refusal|treatment refusal
1159927|NCT02216929|intubation|intubation
1159928|NCT02216929|intensive care|intensive care
1159929|NCT02216929|withholding treatment|withholding treatment
1159930|NCT02216929|cancer|cancer
1159931|NCT02216929|terminal care|terminal care
1159932|NCT02216929|APACHE|apache
1159933|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
1159934|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
1159935|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
1159936|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
1159937|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
1159938|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
1159939|NCT02216890|CD70 Antigen|cd70 antigen
1159940|NCT02216890|Drug Therapy|drug therapy
1159941|NCT02216877|Chronic Kidney Disease|chronic kidney disease
1159942|NCT02216877|Hypomagnesemia|hypomagnesemia
1159943|NCT02216851|hyaluronic acid|hyaluronic acid
1159944|NCT02216851|no-treatment control|no-treatment control
1159945|NCT02216851|enhancement|enhancement
1159946|NCT02216812|Finger stiffness|finger stiffness
1159947|NCT02216812|Range of motion|range of motion
1159948|NCT02216812|Distal radius fracture|distal radius fracture
1159949|NCT02216812|Vitamin C|vitamin c
1159950|NCT02216799|Parenteral nutrition|parenteral nutrition
1159951|NCT02216799|Hyperglycemia|hyperglycemia
1160353|NCT02214680|Timolol|timolol
1159952|NCT02216799|Glargine insulin|glargine insulin
1159953|NCT02216799|Regular insulin|regular insulin
1159954|NCT02216773|Liver hypertrophy|liver hypertrophy
1159955|NCT02216773|Liver resection|liver resection
1159956|NCT02216773|Liver metastases|liver metastases
1159957|NCT02216773|Portal vein ligation|portal vein ligation
1159958|NCT02216773|Portal vein embolization|portal vein embolization
1159959|NCT02216773|Radiofrequency splitting|radiofrequency splitting
1159960|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
1159961|NCT02216760|Myocardial infarction|myocardial infarction
1159962|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
1159963|NCT02216760|Catheter ablation|catheter ablation
1159964|NCT02216760|Substrate mapping|substrate mapping
1159965|NCT02216760|Ripple Conduction channels|ripple conduction channels
1159966|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
1159967|NCT02216734|HIV/AIDS|hiv/aids
1159968|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
1159969|NCT02216734|Mother support groups|mother support groups
1159970|NCT02216734|Retention-in-care|retention-in-care
1159971|NCT02216734|Male participation|male participation
1159972|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
1159973|NCT02216734|Infants|infants
1159974|NCT02216721|bone mineral density|bone mineral density
1159975|NCT02216721|bone turnover markers|bone turnover markers
1159976|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
1159977|NCT02216708|Severe malnutrition|severe malnutrition
1159978|NCT02216708|severe dehydration|severe dehydration
1159979|NCT02216708|cholera|cholera
1159980|NCT02216695|acute kidney injury|acute kidney injury
1159981|NCT02216695|epidemiology|epidemiology
1159982|NCT02216695|mortality|mortality
1159983|NCT02216682|Acetaminophen|acetaminophen
1159984|NCT02216682|Total knee replacement|total knee replacement
1159985|NCT02216682|Numeric rating scale|numeric rating scale
1159986|NCT02216669|Solid tumors|solid tumors
1159987|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
1159988|NCT02216643|Stroke|stroke
1159989|NCT02216643|Ischemic Stroke|ischemic stroke
1159990|NCT02216643|Thrombectomy|thrombectomy
1159991|NCT02216643|Reperfusion Therapy|reperfusion therapy
1159992|NCT02216643|Treatment|treatment
1159993|NCT02216630|COPD|copd
1159994|NCT02216604|Exercise|exercise
1159995|NCT02216604|Pediatric oncology|pediatric oncology
1159996|NCT02216604|Physical Performance|physical performance
1159997|NCT02216604|Quality of Life|quality of life
1159998|NCT02216604|Feasibility|feasibility
1159999|NCT02216604|during primary|during primary
1160000|NCT02216604|anticancer treatment|anticancer treatment
1160002|NCT02216591|Medication Adherence|medication adherence
1160003|NCT02216591|Working Memory|working memory
1160004|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1160005|NCT02216578|progressed|progressed
1160006|NCT02216578|(GIST)|(gist)
1160007|NCT02216565|Stroke|stroke
1160008|NCT02216565|Endovascular treatment|endovascular treatment
1160009|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
1160010|NCT02216565|Fibrinolysis|fibrinolysis
1160011|NCT02216552|Pediatrics|pediatrics
1160012|NCT02216552|Adolescents|adolescents
1160013|NCT02216552|NAFLD|nafld
1160014|NCT02216552|Spectroscopy|spectroscopy
1160015|NCT02216552|Type 2 diabetes|type 2 diabetes
1160016|NCT02216539|All terminal|all terminal
1160017|NCT02216539|leading|leading
1160018|NCT02216539|indication|indication
1160019|NCT02216539|lung transplantation|lung transplantation
1160020|NCT02216526|Skin health|skin health
1160021|NCT02216526|Nursing|nursing
1160022|NCT02216526|Long-term care|long-term care
1160023|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
1160024|NCT02216513|SAH|sah
1160025|NCT02216513|DFO|dfo
1160026|NCT02216513|cerebral autoregulation|cerebral autoregulation
1160027|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
1160028|NCT02216500|Ketogenic Therapy|ketogenic therapy
1160029|NCT02216500|Ketogenic Diet|ketogenic diet
1160030|NCT02216487|mCRC|mcrc
1160031|NCT02216487|colorectal cancer|colorectal cancer
1160032|NCT02216448|Arthroscopy skills|arthroscopy skills
1160033|NCT02216448|Knee|knee
1160034|NCT02216448|Virtual reality|virtual reality
1160035|NCT02216448|Simulator|simulator
1160036|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
1160037|NCT02216422|Hepatitis C|hepatitis c
1160038|NCT02216422|Hepatitis C Virus|hepatitis c virus
1160039|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
1160040|NCT02216422|Interferon-Free|interferon-free
1160041|NCT02216396|dementia|dementia
1160042|NCT02216396|care home|care home
1160043|NCT02216396|agitation|agitation
1160044|NCT02216396|coping|coping
1160045|NCT02216383|Post partum haemorrhage|post partum haemorrhage
1160046|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
1160047|NCT02216383|Carbetocin|carbetocin
1160048|NCT02216383|Syntocinon|syntocinon
1160049|NCT02216383|Syntometrine|syntometrine
1160050|NCT02216383|Birth experience|birth experience
1160051|NCT02216383|Labour|labour
1160052|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
1160053|NCT02216370|Atrial Fibrillation|atrial fibrillation
1160054|NCT02216370|Implantable Loop Recorder|implantable loop recorder
1160055|NCT02216370|Genetic Mutation|genetic mutation
1160056|NCT02216357|Samster's triad|samster's triad
1160057|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
1160058|NCT02216357|Widal's triad|widal's triad
1160059|NCT02216357|Francis' triad|francis' triad
1160060|NCT02216357|Aspirin triad|aspirin triad
1160061|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
1160062|NCT02216344|Patient safety monitors|patient safety monitors
1160063|NCT02216331|tuberculosis|tuberculosis
1160064|NCT02216331|PK|pk
1160065|NCT02216331|TMC207|tmc207
1160066|NCT02216331|bedaquiline|bedaquiline
1160067|NCT02216331|rifapentine|rifapentine
1160068|NCT02216331|rifampicin|rifampicin
1160069|NCT02216331|drug drug interaction|drug drug interaction
1160070|NCT02216318|sleep|sleep
1160071|NCT02216318|circadian|circadian
1160072|NCT02216318|melatonine|melatonine
1160073|NCT02216318|pupil response|pupil response
1160074|NCT02216305|HAL-RAR|hal-rar
1160075|NCT02216305|Hemorrhoids|hemorrhoids
1160076|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
1160077|NCT02216305|Anal repair|anal repair
1160078|NCT02216305|Quality of Life|quality of life
1160079|NCT02216305|Postoperative Complications|postoperative complications
1160080|NCT02216292|preterm single donor milk|preterm single donor milk
1160081|NCT02216292|human milk|human milk
1160082|NCT02216292|very lo birth weight infants|very lo birth weight infants
1160083|NCT02216292|enteral feedings|enteral feedings
1160084|NCT02216292|NEC|nec
1160085|NCT02216279|Pulmonary|pulmonary
1160086|NCT02216279|Hypertension|hypertension
1160087|NCT02216279|PH|ph
1160088|NCT02216279|PulmoBind|pulmobind
1160089|NCT02216279|Imaging|imaging
1160090|NCT02216266|Delirium|delirium
1160091|NCT02216266|CAM-ICU|cam-icu
1160092|NCT02216253|Urinary tract infection|urinary tract infection
1160093|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
1224863|NCT01919723|PCI|pci
1160094|NCT02216253|Urinary incontinence|urinary incontinence
1160095|NCT02216253|Stress urinary incontinence|stress urinary incontinence
1160385|NCT02214550|Pelvic Pain|pelvic pain
1160100|NCT02216227|surgical site infection|surgical site infection
1160101|NCT02216214|Urinary Incontinence|urinary incontinence
1160103|NCT02216214|Overactive Bladder|overactive bladder
1160104|NCT02216175|Cow's milk allergy|cow's milk allergy
1160105|NCT02216175|Desensitisation|desensitisation
1160106|NCT02216175|Safety|safety
1160107|NCT02216162|oncogeriatrics|oncogeriatrics
1160108|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
1160109|NCT02216162|compliance|compliance
1160110|NCT02216162|elderly|elderly
1160111|NCT02216162|Taï Chi|taï chi
1160112|NCT02216162|Physical training|physical training
1160113|NCT02216149|fluoropyrimidine|fluoropyrimidine
1160114|NCT02216149|S-1|s-1
1160115|NCT02216149|Teysuno|teysuno
1160116|NCT02216149|oxaliplatin|oxaliplatin
1160117|NCT02216149|coronary artery flow|coronary artery flow
1160118|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
1160119|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
1160120|NCT02216136|Mastectomy|mastectomy
1160121|NCT02216136|Breast Cancer|breast cancer
1160122|NCT02216136|Reconstruction|reconstruction
1160123|NCT02216136|Lumpectomy|lumpectomy
1160124|NCT02216136|Breast Conservation Therapy|breast conservation therapy
1160125|NCT02216123|Tafenoquine|tafenoquine
1160126|NCT02216123|Plasmodium vivax|plasmodium vivax
1160127|NCT02216123|Hemolysis|hemolysis
1160128|NCT02216123|Primaquine|primaquine
1160129|NCT02216123|Chloroquine|chloroquine
1160130|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
1160131|NCT02216123|Relapse|relapse
1160132|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
1160133|NCT02216110|Gastrectomy|gastrectomy
1160134|NCT02216110|Survival|survival
1160135|NCT02216110|Outcome|outcome
1160136|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
1160137|NCT02216019|cardiac surgery|cardiac surgery
1160138|NCT02216019|infectious complication|infectious complication
1160139|NCT02216006|Atelectasis|atelectasis
1160140|NCT02216006|Fresh gas flow|fresh gas flow
1160141|NCT02216006|Prevention|prevention
1160142|NCT02216006|Oxygenation|oxygenation
1160143|NCT02216006|Anaesthesia|anaesthesia
1160144|NCT02215993|Ticagrelor|ticagrelor
1160145|NCT02215993|Prasugrel|prasugrel
1160146|NCT02215993|VerifyNow|verifynow
1160147|NCT02215993|Acute coronary syndrome|acute coronary syndrome
1160148|NCT02215980|Multiple myeloma|multiple myeloma
1160149|NCT02215980|Diagnosis|diagnosis
1160150|NCT02215980|Elderly and unfit patients|elderly and unfit patients
1160151|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
1160152|NCT02215967|Immunotherapy|immunotherapy
1160153|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
1160154|NCT02215967|Gene Therapy|gene therapy
1160155|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
1160156|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
1160157|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
1160158|NCT02215915|Drug-eluting stent|drug-eluting stent
1160354|NCT02214680|Combigan|combigan
1160159|NCT02215915|Intravascular ultrasound|intravascular ultrasound
1160160|NCT02215902|ESRD|esrd
1160161|NCT02215902|Hepatitis C|hepatitis c
1160162|NCT02215889|Liver metastases|liver metastases
1160163|NCT02215889|Transplantation|transplantation
1160164|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
1160165|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
1160166|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
1160167|NCT02215837|Gastric cancer|gastric cancer
1160168|NCT02215837|D-CIK|d-cik
1160169|NCT02215837|Autologous tumor lysate|autologous tumor lysate
1160170|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1160171|NCT02215785|Funtional constipation|funtional constipation
1160172|NCT02215785|Kiwifruit|kiwifruit
1160173|NCT02215785|Health promotion|health promotion
1160178|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
1160179|NCT02215694|LDL particle size|ldl particle size
1160180|NCT02215694|probiotic|probiotic
1160181|NCT02215694|triglyceride|triglyceride
1160182|NCT02215681|otitis media with effusion|otitis media with effusion
1160183|NCT02215681|acupuncture|acupuncture
1160184|NCT02215681|inflammatory markers|inflammatory markers
1160185|NCT02215655|phosphate binder adherence|phosphate binder adherence
1160186|NCT02215655|autonomous motivation|autonomous motivation
1160187|NCT02215629|Leukemia|leukemia
1160188|NCT02215629|Acute Leukemia|acute leukemia
1160189|NCT02215629|Relapsed Leukemia|relapsed leukemia
1160190|NCT02215629|Refractory Leukemia|refractory leukemia
1160191|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
1160192|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
1160193|NCT02215590|Postural balance|postural balance
1160194|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
1160195|NCT02215590|Community integration|community integration
1160196|NCT02215590|Quality of life|quality of life
1160197|NCT02215590|Functional ambulation|functional ambulation
1160198|NCT02215577|cancer, colorectal|cancer, colorectal
1160199|NCT02215577|hepatectomy|hepatectomy
1160200|NCT02215577|portal vein|portal vein
1160201|NCT02215577|embolization|embolization
1160202|NCT02215577|two-stage|two-stage
1160203|NCT02215564|Bordetella pertussis|bordetella pertussis
1160204|NCT02215564|Carriage rates in young adults|carriage rates in young adults
1160207|NCT02215538|adult|adult
1160208|NCT02215538|WRAADDS|wraadds
1160209|NCT02215538|OROS MPH|oros mph
1160210|NCT02215538|emotional dysregulation|emotional dysregulation
1160212|NCT02215525|UVA|uva
1160213|NCT02215525|Herbal therapy|herbal therapy
1160214|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
1160215|NCT02215486|Head massage therapy|head massage therapy
1160216|NCT02215486|Massage therapy|massage therapy
1160217|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
1160218|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
1160219|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
1160220|NCT02215473|gingivitis|gingivitis
1160221|NCT02215473|periodontitis|periodontitis
1160222|NCT02215473|mouth rinse|mouth rinse
1160223|NCT02215473|bacteremia|bacteremia
1160224|NCT02215447|NAB-paclitaxel|nab-paclitaxel
1160225|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
1160226|NCT02215447|phase II|phase ii
1160227|NCT02215447|carboplatin|carboplatin
1160228|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
1160229|NCT02215421|vegetables|vegetables
1160230|NCT02215421|dietary intake|dietary intake
1160231|NCT02215421|preschoolers|preschoolers
1160232|NCT02215421|parents|parents
1160233|NCT02215421|video game|video game
1160234|NCT02215408|Diabetes|diabetes
1160235|NCT02215408|Hyperlipidemia|hyperlipidemia
1160236|NCT02215408|Hypertension|hypertension
1160237|NCT02215408|Cardiovascular Disease|cardiovascular disease
1160238|NCT02215395|Nestorone|nestorone
1160239|NCT02215395|miconazole nitrate|miconazole nitrate
1160240|NCT02215382|two reversal methods|two reversal methods
1160241|NCT02215382|changes in IOP|changes in iop
1160242|NCT02215382|heart rate|heart rate
1160243|NCT02215382|blood pressure|blood pressure
1160244|NCT02215382|tracheal extubation|tracheal extubation
1160245|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
1160246|NCT02215330|Eplerenone|eplerenone
1160247|NCT02215330|Photodynamic Therapy|photodynamic therapy
1160248|NCT02215330|Macula|macula
1160249|NCT02215330|Retina|retina
1160250|NCT02215317|Sleep Apnea|sleep apnea
1160251|NCT02215317|Stent|stent
1160252|NCT02215317|Coronary Artery Disease|coronary artery disease
1160253|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
1160254|NCT02215304|Dietary supplementation|dietary supplementation
1160255|NCT02215304|Probiotics|probiotics
1160256|NCT02215304|Safety/Efficiency|safety/efficiency
1160257|NCT02215304|Healthy infants|healthy infants
1160258|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
1160259|NCT02215278|iron biofortification|iron biofortification
1160260|NCT02215278|lpa bean|lpa bean
1160261|NCT02215278|stable iron isotope study|stable iron isotope study
1160262|NCT02215278|phytic acid|phytic acid
1160263|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
1160264|NCT02215239|health lifestyle|health lifestyle
1160265|NCT02215239|health promotion|health promotion
1160266|NCT02215239|occupational health|occupational health
1160267|NCT02215239|Work site health promotion|work site health promotion
1160268|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
1160269|NCT02215213|Vitamin D|vitamin d
1160270|NCT02215213|pregnancy|pregnancy
1160271|NCT02215213|Pakistan|pakistan
1160272|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
1160273|NCT02215174|Rosuvastatin|rosuvastatin
1160274|NCT02215174|PK|pk
1160275|NCT02215174|Interethnic|interethnic
1160276|NCT02215174|Morbid obese|morbid obese
1160277|NCT02215135|Corifollitropin alfa|corifollitropin alfa
1160278|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
1160279|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
1160280|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
1160281|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
1160282|NCT02215122|Fluticasone Propionate|fluticasone propionate
1160283|NCT02215122|Salmeterol|salmeterol
1160284|NCT02215122|Pharmacokinetics|pharmacokinetics
1160285|NCT02215122|Healthy Subjects|healthy subjects
1160286|NCT02215122|MGR001|mgr001
1160287|NCT02215122|CRC749|crc749
1160288|NCT02215122|Dry Powder Inhaler|dry powder inhaler
1160289|NCT02215122|generic|generic
1160290|NCT02215122|Advair Diskus|advair diskus
1160291|NCT02215122|Seretide Accuhaler|seretide accuhaler
1160292|NCT02215096|enzalutamide|enzalutamide
1160293|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1160294|NCT02215096|GSK2636771|gsk2636771
1160295|NCT02215096|PI3K-beta|pi3k-beta
1160296|NCT02215096|PTEN deficiency|pten deficiency
1160297|NCT02215083|peripheral neuropathy|peripheral neuropathy
1160298|NCT02215083|breast cancer|breast cancer
1160299|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
1160300|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
1160301|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1160302|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
1160303|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
1160304|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
1160305|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
1160306|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
1160307|NCT02215070|Lymphoma|lymphoma
1160308|NCT02215057|topical anesthesia|topical anesthesia
1160309|NCT02215057|intracameral lidocaine|intracameral lidocaine
1160310|NCT02215057|implantable collamer lens|implantable collamer lens
1160311|NCT02214875|Retention|retention
1160312|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
1160313|NCT02214849|Breastfeeding|breastfeeding
1160314|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
1160315|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
1160316|NCT02214849|Formula supplementation|formula supplementation
1160317|NCT02214849|Mobile health|mobile health
1160318|NCT02214849|WIC program|wic program
1160319|NCT02214836|kidney stones|kidney stones
1160320|NCT02214836|ultrasound imaging|ultrasound imaging
1160321|NCT02214836|ureter stones|ureter stones
1160322|NCT02214810|Bupivacaine|bupivacaine
1160323|NCT02214810|multimodal|multimodal
1160324|NCT02214810|exparel|exparel
1160325|NCT02214810|open reduction|open reduction
1160326|NCT02214810|internal fixation|internal fixation
1160327|NCT02214810|post-surgical pain control|post-surgical pain control
1160328|NCT02214797|Presbyopia|presbyopia
1160329|NCT02214797|Refractive Error|refractive error
1160330|NCT02214797|Contact Lenses|contact lenses
1160331|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
1160332|NCT02214784|SUI|sui
1160333|NCT02214784|Continence|continence
1160334|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
1160335|NCT02214771|Observational|observational
1160336|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
1160337|NCT02214771|France|france
1160338|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
1160339|NCT02214745|Israeli Arab population|israeli arab population
1160340|NCT02214745|Israeli/ethnology|israeli/ethnology
1160341|NCT02214732|Pregnancy|pregnancy
1160342|NCT02214732|Postpartum|postpartum
1160343|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1160344|NCT02214732|Depression|depression
1160345|NCT02214732|Anxiety|anxiety
1160346|NCT02214732|Stress|stress
1160347|NCT02214732|MBCT|mbct
1160348|NCT02214732|Actigraphy|actigraphy
1160349|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
1160350|NCT02214693|patients|patients
1160351|NCT02214680|Pupil diameter|pupil diameter
1160352|NCT02214680|Brimonidine|brimonidine
1160355|NCT02214667|Jail|jail
1160356|NCT02214667|co-occurring disorders|co-occurring disorders
1160357|NCT02214667|implementation|implementation
1160358|NCT02214667|acceptability|acceptability
1160359|NCT02214667|feasibility|feasibility
1160360|NCT02214667|fidelity|fidelity
1160361|NCT02214628|Wet AMD|wet amd
1160362|NCT02214628|Choroidal neovascularization|choroidal neovascularization
1160363|NCT02214628|Fovista®|fovista®
1160364|NCT02214628|E10030|e10030
1160365|NCT02214628|Avastin®|avastin®
1160366|NCT02214628|Eylea®|eylea®
1160367|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
1160368|NCT02214602|intermediate and high risk|intermediate and high risk
1160369|NCT02214602|immediate single instillation|immediate single instillation
1160370|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
1160371|NCT02214602|Disease prevention|disease prevention
1160372|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1160373|NCT02214576|intubation, intratracheal|intubation, intratracheal
1160374|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
1160375|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
1160376|NCT02214576|laryngoscopy|laryngoscopy
1160377|NCT02214563|Vitamin D|vitamin d
1160378|NCT02214563|Cholecalciferol|cholecalciferol
1160379|NCT02214563|Hepcidins|hepcidins
1160380|NCT02214563|Renal Dialysis|renal dialysis
1160381|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
1160382|NCT02214550|Dysmenorrhea|dysmenorrhea
1160383|NCT02214550|Migraine Disorders|migraine disorders
1160384|NCT02214550|Cross Organ Sensitization|cross organ sensitization
1160386|NCT02214550|Endometriosis|endometriosis
1160387|NCT02214550|Contraceptives, Oral|contraceptives, oral
1160388|NCT02214550|Birth Control Pills|birth control pills
1160389|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
1160390|NCT02214550|Visceral Pain|visceral pain
1160391|NCT02214550|Chronic Pain|chronic pain
1160392|NCT02214524|perioperative hypothermia|perioperative hypothermia
1160393|NCT02214524|Tympanic temperature|tympanic temperature
1160394|NCT02214524|Blood loss|blood loss
1160395|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
1160396|NCT02214524|Major surgery|major surgery
1160397|NCT02214511|major depressive disorder|major depressive disorder
1160398|NCT02214511|social rejection|social rejection
1160399|NCT02214511|rapid facial reaction|rapid facial reaction
1160400|NCT02214511|facial mimicry|facial mimicry
1160401|NCT02214511|prosocial behavior|prosocial behavior
1160402|NCT02214511|inflammation|inflammation
1160403|NCT02214511|self esteem|self esteem
1160404|NCT02214498|Dipper|dipper
1160405|NCT02214498|Non-dipper|non-dipper
1160406|NCT02214498|Chronopharmacology|chronopharmacology
1160407|NCT02214485|frailty|frailty
1160408|NCT02214485|exercise|exercise
1160409|NCT02214485|intervention|intervention
1160410|NCT02214472|Rumination síndrome|rumination síndrome
1160411|NCT02214472|Regurgitation|regurgitation
1160412|NCT02214472|Vomiting|vomiting
1160413|NCT02214472|Biofeedback|biofeedback
1160414|NCT02214472|Electromyography|electromyography
1160415|NCT02214472|Abdominal accommodation|abdominal accommodation
1160416|NCT02214459|mHealth|mhealth
1160417|NCT02214459|Hypertension|hypertension
1160418|NCT02214459|Mobile|mobile
1160419|NCT02214459|smartphone|smartphone
1160420|NCT02214459|diet|diet
1160421|NCT02214459|lifestyle|lifestyle
1160422|NCT02214459|bluetooth|bluetooth
1160423|NCT02214459|physical acitvity|physical acitvity
1160424|NCT02214459|behavior change|behavior change
1160425|NCT02214459|motivational interviewing|motivational interviewing
1160426|NCT02214446|truth telling|truth telling
1160427|NCT02214446|hope|hope
1160428|NCT02214446|quality of life|quality of life
1160429|NCT02214446|care burden|care burden
1160430|NCT02214446|children with cancer|children with cancer
1160431|NCT02214433|Antibiotic|antibiotic
1160432|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
1160433|NCT02214381|breast cancer|breast cancer
1160434|NCT02214381|elderly|elderly
1160435|NCT02214329|Postural Balance|postural balance
1160436|NCT02214329|Gait|gait
1160437|NCT02214329|Fall risk|fall risk
1160438|NCT02214303|Allergic asthma|allergic asthma
1160439|NCT02214303|Allergic rhinitis|allergic rhinitis
1160440|NCT02214303|Healthy subjects|healthy subjects
1160441|NCT02214290|Cardiovascular|cardiovascular
1160442|NCT02214290|Caffeine|caffeine
1160443|NCT02214290|L-citrulline|l-citrulline
1160444|NCT02214290|Arterial Function|arterial function
1160445|NCT02214290|Hemodynamics|hemodynamics
1160446|NCT02214290|Blood Pressure|blood pressure
1160447|NCT02214290|Pulse Wave Velocity|pulse wave velocity
1160448|NCT02214290|Pulse Wave Analysis|pulse wave analysis
1160449|NCT02214277|Embolic Protection|embolic protection
1160450|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
1160451|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
1160452|NCT02214277|TAVR|tavr
1160453|NCT02214277|Transfemoral|transfemoral
1160454|NCT02214277|Transapical|transapical
1160455|NCT02214277|Heart Valve Diseases|heart valve diseases
1160456|NCT02214277|Heart Diseases|heart diseases
1160457|NCT02214277|TAVI|tavi
1160458|NCT02214277|Aortic Stenosis|aortic stenosis
1160459|NCT02214277|Aortic Valve|aortic valve
1160460|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
1160461|NCT02214251|Parkinson's disease|parkinson's disease
1160462|NCT02214251|freezing of gait|freezing of gait
1160463|NCT02214251|movement disorders|movement disorders
1160464|NCT02214251|neuroscience|neuroscience
1160465|NCT02214251|neural|neural
1160466|NCT02214251|mechanism|mechanism
1160467|NCT02214212|traumatic brain injury|traumatic brain injury
1160469|NCT02214212|Sleep|sleep
1160470|NCT02214212|Bright White Light Therapy|bright white light therapy
1160471|NCT02214212|Red Light Therapy|red light therapy
1160472|NCT02214212|Recovery|recovery
1160473|NCT02214212|Central Nervous System Diseases|central nervous system diseases
1160474|NCT02214212|Brain Diseases|brain diseases
1160475|NCT02214212|Nervous System Diseases|nervous system diseases
1160476|NCT02214212|Signs and Symptoms|signs and symptoms
1160477|NCT02214212|Rehabilitation|rehabilitation
1160478|NCT02214212|Actigraphy|actigraphy
1160479|NCT02214199|Shoulder Pain|shoulder pain
1160480|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
1160481|NCT02214199|Exercise therapy|exercise therapy
1160482|NCT02214199|Randomized Controlled Trial|randomized controlled trial
1160483|NCT02214186|Pre-Eclampsia|pre-eclampsia
1160484|NCT02214186|Acute Kidney Injury|acute kidney injury
1160485|NCT02214186|Fluid Therapy|fluid therapy
1160486|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
1160487|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
1569604|NCT00502008|India|india
1160488|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
1160489|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
1160490|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
1160491|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
1160492|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
1160493|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
1160494|NCT02214160|Triheptanoin|triheptanoin
1160495|NCT02214160|UX007|ux007
1160497|NCT02214147|Alisertib|alisertib
1160498|NCT02214147|MLN8237|mln8237
1160499|NCT02214147|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
1160500|NCT02214134|Lung cancer|lung cancer
1160501|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
1160502|NCT02214134|Thymic malignancy|thymic malignancy
1160503|NCT02214134|Biomarkers|biomarkers
1160504|NCT02214134|Screening|screening
1160505|NCT02214121|sickle cell anemia|sickle cell anemia
1160506|NCT02214121|paediatric|paediatric
1160507|NCT02214108|BMI|bmi
1160508|NCT02214108|Obesity|obesity
1160509|NCT02214108|overweight|overweight
1160510|NCT02214108|child|child
1160511|NCT02214108|Physical activity|physical activity
1160512|NCT02214095|Cytokines|cytokines
1160513|NCT02214095|interleukin-1β|interleukin-1β
1160514|NCT02214095|chronic periodontitis|chronic periodontitis
1160515|NCT02214095|host modulation|host modulation
1160516|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
1160517|NCT02214056|mobile screening team|mobile screening team
1160518|NCT02214056|feasibility|feasibility
1160519|NCT02214030|Femoral compression device|femoral compression device
1160520|NCT02214030|manual compression|manual compression
1160521|NCT02214030|arterial hemostasis|arterial hemostasis
1160522|NCT02214030|coronary intervention|coronary intervention
1160523|NCT02214030|coronary artery disease|coronary artery disease
1160524|NCT02214017|diabetes|diabetes
1160525|NCT02214017|telemedicine|telemedicine
1160526|NCT02214017|glycemia|glycemia
1160527|NCT02214017|lipids|lipids
1160528|NCT02214017|blood pressure|blood pressure
1160529|NCT02214004|Breast cancer|breast cancer
1160530|NCT02214004|HER2|her2
1160531|NCT02214004|ER|er
1160532|NCT02214004|Postmenopausal|postmenopausal
1160533|NCT02214004|Trastuzumab|trastuzumab
1160534|NCT02214004|Letrozole|letrozole
1160535|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
1160536|NCT02213991|Breast Cancer|breast cancer
1160537|NCT02213991|Breast Conservative Surgery|breast conservative surgery
1160538|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
1160539|NCT02213991|Local Toxicity|local toxicity
1160540|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
1160541|NCT02213965|Intravenous Catheter|intravenous catheter
1160542|NCT02213965|Vasofix safety|vasofix safety
1160543|NCT02213965|Introcan safety|introcan safety
1160544|NCT02213952|Ulcer|ulcer
1160545|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
1160546|NCT02213939|Myocardial revascularization|myocardial revascularization
1160547|NCT02213939|Cytosorb|cytosorb
1160548|NCT02213939|Inflammatory response|inflammatory response
1160549|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
1160550|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1160551|NCT02213926|Btk|btk
1160552|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
1160553|NCT02213926|MCL|mcl
1160554|NCT02213926|ACP-196|acp-196
1160555|NCT02213926|Acalabrutinib|acalabrutinib
1160556|NCT02213926|ACE-LY-004|ace-ly-004
1160557|NCT02213900|delirium|delirium
1160558|NCT02213900|confusion|confusion
1160559|NCT02213900|surgery|surgery
1160560|NCT02213900|cognitive Impairment|cognitive impairment
1160561|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
1160562|NCT02213900|depression|depression
1160563|NCT02213900|anxiety|anxiety
1160564|NCT02213887|Drug Interactions|drug interactions
1160565|NCT02213887|Pantoprazole|pantoprazole
1160566|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
1160567|NCT02213887|Psychotropic Drugs|psychotropic drugs
1160568|NCT02213887|Antipsychotic Agents|antipsychotic agents
1160569|NCT02213887|Aripiprazole|aripiprazole
1160570|NCT02213887|Asenapine|asenapine
1160571|NCT02213887|Clozapine|clozapine
1160572|NCT02213887|Lurasidone|lurasidone
1160573|NCT02213887|Olanzapine|olanzapine
1160574|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
1160575|NCT02213887|Quetiapine|quetiapine
1160576|NCT02213887|Risperidone|risperidone
1160577|NCT02213887|Ziprasidone|ziprasidone
1160578|NCT02213887|Valproic Acid|valproic acid
1160579|NCT02213887|Lithium|lithium
1160580|NCT02213887|Gastrins|gastrins
1160581|NCT02213887|Psychotic Disorders|psychotic disorders
1160582|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
1160583|NCT02213874|Pregnant Women|pregnant women
1160584|NCT02213874|Women's Health|women's health
1570882|NCT00498680|PDE5i|pde5i
1160585|NCT02213874|Contraception|contraception
1160586|NCT02213874|Trust in Health Care|trust in health care
1160587|NCT02213861|CTCL|ctcl
1160588|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1160589|NCT02213861|Early-stage|early-stage
1160590|NCT02213861|SHAPE|shape
1160591|NCT02213861|SHP-141|shp-141
1160592|NCT02213861|topical|topical
1160593|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
1160594|NCT02213861|CAILS|cails
1160595|NCT02213861|mSWAT|mswat
1160596|NCT02213861|mycosis fungoides|mycosis fungoides
1160597|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
1160598|NCT02213848|TOF ratio|tof ratio
1160599|NCT02213848|Calcium chloride|calcium chloride
1160600|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
1160601|NCT02213822|genome|genome
1160602|NCT02213822|transcriptome|transcriptome
1160603|NCT02213822|molecular|molecular
1160604|NCT02213822|proteome|proteome
1160605|NCT02213822|oncogenic mutations|oncogenic mutations
1160606|NCT02213822|sequencing|sequencing
1160607|NCT02213822|solid tumor|solid tumor
1160608|NCT02213822|hematological malignancy|hematological malignancy
1160609|NCT02213822|cancer|cancer
1160610|NCT02213822|analysis|analysis
1160611|NCT02213822|genetic|genetic
1160612|NCT02213822|mutation|mutation
1160613|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
1160614|NCT02213783|Imipenem|imipenem
1160615|NCT02213783|Febrile neutropenia|febrile neutropenia
1160616|NCT02213783|Gram-negative infection|gram-negative infection
1160617|NCT02213783|Pharmacodynamic|pharmacodynamic
1160618|NCT02213783|Monte Carlo Simulation|monte carlo simulation
1160619|NCT02213757|Hematuria|hematuria
1160620|NCT02213757|Menopause|menopause
1160621|NCT02213757|Urinalysis|urinalysis
1160622|NCT02213744|HER2-positive|her2-positive
1160623|NCT02213744|HER2+|her2+
1160624|NCT02213744|HER2|her2
1160625|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
1160626|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
1160627|NCT02213744|trastuzumab|trastuzumab
1160628|NCT02213744|Herceptin|herceptin
1160629|NCT02213744|pertuzumab|pertuzumab
1160630|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
1160631|NCT02213744|TDM-1|tdm-1
1160632|NCT02213744|Perjeta|perjeta
1160633|NCT02213744|Kadcyla|kadcyla
1160634|NCT02213731|Atrial Fibrillation|atrial fibrillation
1160635|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
1160636|NCT02213731|Cryoablation|cryoablation
1160637|NCT02213731|Cryoballoon|cryoballoon
1160638|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
1160639|NCT02213718|Desflurane|desflurane
1160640|NCT02213718|myocardial function|myocardial function
1160641|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1160642|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
1160643|NCT02213705|TRANSPLANTATION|transplantation
1160644|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
1160645|NCT02213705|ADULT|adult
1160646|NCT02213692|Liver Resection|liver resection
1160647|NCT02213692|Harmonic Scalpel|harmonic scalpel
1160648|NCT02213692|Crush-clamping|crush-clamping
1160649|NCT02213692|A Prospective Randomized Study|a prospective randomized study
1160650|NCT02213679|Creatine|creatine
1160651|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
1160652|NCT02213679|Intervention|intervention
1160653|NCT02213679|Fatigue|fatigue
1160654|NCT02213679|Muscle strength|muscle strength
1160655|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
1160745|NCT02213185|Sterile water injections|sterile water injections
1160656|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
1160657|NCT02213666|Thrombus|thrombus
1160658|NCT02213666|Left atrial appendage|left atrial appendage
1160659|NCT02213666|Right atrial appendage|right atrial appendage
1160660|NCT02213653|Functional iron deficiency|functional iron deficiency
1160661|NCT02213653|Metastatic|metastatic
1160662|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
1160663|NCT02213640|post stroke|post stroke
1160664|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1160665|NCT02213640|prismatic adaptation|prismatic adaptation
1160666|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
1160667|NCT02213601|Yoga|yoga
1160668|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
1160669|NCT02213601|Treatment|treatment
1160670|NCT02213601|Postpartum Depression|postpartum depression
1160671|NCT02213588|Antioxidant|antioxidant
1160672|NCT02213575|Resistent Hypertension|resistent hypertension
1160673|NCT02213536|Metastatic brain cancer|metastatic brain cancer
1160674|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
1160675|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
1160676|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
1160677|NCT02213523|antioxidant|antioxidant
1160678|NCT02213510|pacemaker|pacemaker
1570883|NCT00498667|PET/CT|pet/ct
1160679|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1160680|NCT02213510|ICD|icd
1160681|NCT02213510|surgical wound closure|surgical wound closure
1160682|NCT02213510|sutures|sutures
1160683|NCT02213510|Zipline|zipline
1160684|NCT02213510|Zips|zips
1160685|NCT02213510|CIED|cied
1160686|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
1160687|NCT02213510|arrhythmia|arrhythmia
1160688|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
1160689|NCT02213484|aortopathy syndrome|aortopathy syndrome
1160690|NCT02213484|aortic aneurysm|aortic aneurysm
1160691|NCT02213484|aortic dissection|aortic dissection
1160692|NCT02213484|connective tissue disorder|connective tissue disorder
1160693|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
1160694|NCT02213458|Family Caregivers|family caregivers
1160695|NCT02213458|Patient Care Management|patient care management
1160696|NCT02213432|influenza vaccine|influenza vaccine
1160697|NCT02213432|cancer|cancer
1160698|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
1160699|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
1160700|NCT02213419|Ethanol|ethanol
1160701|NCT02213393|undernutrition|undernutrition
1160702|NCT02213393|nutritional status|nutritional status
1160703|NCT02213393|elderly patients|elderly patients
1160704|NCT02213393|protein|protein
1160705|NCT02213393|enriched products|enriched products
1160706|NCT02213393|recovery|recovery
1160707|NCT02213393|physical function|physical function
1160708|NCT02213393|quality of life|quality of life
1160709|NCT02213393|activities of daily living|activities of daily living
1160710|NCT02213380|delirium|delirium
1160711|NCT02213380|general anesthesia|general anesthesia
1160712|NCT02213380|regional anesthesia|regional anesthesia
1160713|NCT02213380|elderly patient|elderly patient
1160714|NCT02213380|hip fracture|hip fracture
1160715|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
1160716|NCT02213341|Milk Allergy|milk allergy
1160717|NCT02213341|Egg Allergy|egg allergy
1160718|NCT02213341|Peanut Allergy|peanut allergy
1160719|NCT02213341|Infant Vaccination|infant vaccination
1160720|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
1160721|NCT02213302|premedication|premedication
1160722|NCT02213302|preoperative anxiety|preoperative anxiety
1160723|NCT02213302|salivary cortisol level|salivary cortisol level
1160724|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
1160725|NCT02213289|Gastric|gastric
1160726|NCT02213289|Esophagogastric|esophagogastric
1160727|NCT02213276|Glucose infusion|glucose infusion
1160728|NCT02213276|Bone markers|bone markers
1160729|NCT02213276|Inflammatory markers|inflammatory markers
1160730|NCT02213263|rituximab|rituximab
1160731|NCT02213263|follicular lymphoma|follicular lymphoma
1160732|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1160733|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1160734|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
1160735|NCT02213211|Malawi|malawi
1160736|NCT02213211|Case management|case management
1160737|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
1160738|NCT02213211|Artemether lumefantrine|artemether lumefantrine
1160739|NCT02213211|School children|school children
1160740|NCT02213211|School health services|school health services
1160741|NCT02213211|Attendance|attendance
1160742|NCT02213211|Anaemia|anaemia
1160743|NCT02213211|Parasitic diseases|parasitic diseases
1160744|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
1160746|NCT02213185|Pain|pain
1160747|NCT02213185|VAS|vas
1160748|NCT02213185|Complementary method|complementary method
1160749|NCT02213172|IBS|ibs
1160750|NCT02213172|Probiotic|probiotic
1160751|NCT02213172|Constipation|constipation
1160752|NCT02213172|Bifidobacterium longum|bifidobacterium longum
1160753|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
1160754|NCT02213172|Lallemand Health Solutions|lallemand health solutions
1160755|NCT02213159|Dexmedetomidine|dexmedetomidine
1160756|NCT02213159|bariatric surgery|bariatric surgery
1160757|NCT02213159|postoperative pain|postoperative pain
1160758|NCT02213159|morphine consumption|morphine consumption
1160759|NCT02213159|Quality of recovery|quality of recovery
1160760|NCT02213133|Squamous|squamous
1160761|NCT02213133|SCC|scc
1160762|NCT02213133|Carcinoma|carcinoma
1160763|NCT02213133|KPT-330|kpt-330
1160764|NCT02213133|SINE|sine
1160765|NCT02213133|Selinexor|selinexor
1160766|NCT02213133|Karyopharm|karyopharm
1160767|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
1160768|NCT02213133|Lung|lung
1160769|NCT02213133|Head|head
1160770|NCT02213133|Neck|neck
1160771|NCT02213133|Esophageal|esophageal
1160772|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
1160773|NCT02213107|prostate|prostate
1160774|NCT02213094|preeclampsia|preeclampsia
1160775|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
1160776|NCT02213094|nicotinamide|nicotinamide
1160777|NCT02213081|Endometriosis|endometriosis
1160778|NCT02213081|chronic pelvic pain|chronic pelvic pain
1160779|NCT02213081|dysmenorrhea|dysmenorrhea
1160780|NCT02213081|dyschezia|dyschezia
1160781|NCT02213081|bleeding|bleeding
1160782|NCT02213081|ulipristal|ulipristal
1160783|NCT02213081|progesterone|progesterone
1160784|NCT02213068|Kidney|kidney
1160785|NCT02213068|Renal|renal
1160786|NCT02213068|Transplant|transplant
1160787|NCT02213068|EBV|ebv
1160788|NCT02213068|Immunosuppressants|immunosuppressants
1160789|NCT02213068|Belatacept|belatacept
1160790|NCT02213055|Lice|lice
1160791|NCT02213042|biomarker|biomarker
1160792|NCT02213042|Lapatinib|lapatinib
1160793|NCT02213042|Prosigna|prosigna
1160794|NCT02213042|ErbB2|erbb2
1160795|NCT02213042|PAM50|pam50
1160796|NCT02213042|HER2|her2
1160797|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
1160798|NCT02213042|HER2-enriched|her2-enriched
1160799|NCT02213042|Trastuzumab|trastuzumab
1160800|NCT02213029|epelsiban|epelsiban
1160801|NCT02213029|pharmacokinetics|pharmacokinetics
1160802|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
1160803|NCT02213029|pharmacodynamics|pharmacodynamics
1160804|NCT02213029|oxytocin infusions|oxytocin infusions
1160805|NCT02213029|Uterine contractions|uterine contractions
1160806|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
1160807|NCT02213003|islet transplantation|islet transplantation
1160808|NCT02212990|Fever|fever
1160809|NCT02212990|Antipyretics|antipyretics
1160810|NCT02212990|Acetaminophen|acetaminophen
1160811|NCT02212990|Ibuprofen|ibuprofen
1160812|NCT02212990|Influenza vaccine|influenza vaccine
1160813|NCT02212990|Influenza|influenza
1160814|NCT02212990|Body temperature changes|body temperature changes
1160815|NCT02212990|Signs and symptoms|signs and symptoms
1160816|NCT02212977|Port Catheter|port catheter
1160817|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
1160818|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
1160819|NCT02212964|Radiation Injury|radiation injury
1160820|NCT02212964|Radiation Necrosis|radiation necrosis
1160821|NCT02212964|Ultra-high field MRI|ultra-high field mri
1160822|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
1160823|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
1160824|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
1160825|NCT02212899|Spinal Surgery|spinal surgery
1160826|NCT02212899|Spinal Fusion|spinal fusion
1160827|NCT02212899|Deformity Correction|deformity correction
1160828|NCT02212899|Spinal Instrumentation|spinal instrumentation
1160829|NCT02212886|Glatiramer acetate|glatiramer acetate
1160830|NCT02212886|Copaxone|copaxone
1160831|NCT02212886|Multiple sclerosis|multiple sclerosis
1160832|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1160833|NCT02212886|RRMS|rrms
1160834|NCT02212886|GA Depot|ga depot
1160835|NCT02212886|Monthly injection|monthly injection
1160836|NCT02212873|school based intervention|school based intervention
1160837|NCT02212873|overweight|overweight
1160838|NCT02212873|obese|obese
1160839|NCT02212873|BMI z score|bmi z score
1160840|NCT02212873|fat mass|fat mass
1160841|NCT02212860|neoadjuvant|neoadjuvant
1160842|NCT02212860|radiation|radiation
1160843|NCT02212860|breast|breast
1160844|NCT02212860|cancer|cancer
1160845|NCT02212860|hypofractionation|hypofractionation
1160846|NCT02212860|stereotactic|stereotactic
1160847|NCT02212860|preoperative|preoperative
1160848|NCT02212834|Breast|breast
1160849|NCT02212834|Cancer|cancer
1160850|NCT02212834|Surveillance|surveillance
1160851|NCT02212834|Imaging|imaging
1160852|NCT02212834|Comparative|comparative
1160853|NCT02212834|Effectiveness|effectiveness
1160854|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
1160855|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
1160856|NCT02212808|Community hospitals|community hospitals
1160857|NCT02212808|Feasibility|feasibility
1160858|NCT02212795|healthy|healthy
1160859|NCT02212782|Healthy|healthy
1160860|NCT02212769|healthy|healthy
1160861|NCT02212756|healthy|healthy
1160862|NCT02212717|Acute cholecystitis|acute cholecystitis
1160863|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
1160864|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
1160865|NCT02212704|vestibular|vestibular
1160866|NCT02212704|proprioception|proprioception
1160867|NCT02212704|spatial orientation|spatial orientation
1160868|NCT02212704|bayesian|bayesian
1160869|NCT02212691|Sickle Cell|sickle cell
1160870|NCT02212652|Bariatric surgery|bariatric surgery
1160871|NCT02212652|Vitamin D deficiency|vitamin d deficiency
1160872|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
1160873|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
1160874|NCT02212652|Clinical outcomes|clinical outcomes
1160875|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
1160876|NCT02212639|Digoxin|digoxin
1160877|NCT02212613|Major Depressive Disorder|major depressive disorder
1160878|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
1160879|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
1160880|NCT02212587|inhaled antibiotics|inhaled antibiotics
1160881|NCT02212574|Wnt|wnt
1160882|NCT02212574|Medulloblastoma|medulloblastoma
1160883|NCT02212574|Chemotherapy|chemotherapy
1160884|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
1160885|NCT02212535|Sickle cell disease|sickle cell disease
1160886|NCT02212535|Open monocenter study|open monocenter study
1160887|NCT02212535|Phase I/II|phase i/ii
1160888|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
1160889|NCT02212535|Plerixafor|plerixafor
1160890|NCT02212522|Diabetes Mellitus|diabetes mellitus
1160891|NCT02212522|Insulin-Dependent|insulin-dependent
1160892|NCT02212522|Genome-Wide Association Study|genome-wide association study
1160893|NCT02212522|Environment-Wide Association Study|environment-wide association study
1160894|NCT02212522|Predisposition|predisposition
1160895|NCT02212522|Complications|complications
1160897|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
1160898|NCT02212483|Pediatric|pediatric
1160899|NCT02212483|Environment|environment
1160900|NCT02212483|Clinical effectiveness|clinical effectiveness
1160901|NCT02212483|Economical impact|economical impact
1160902|NCT02212444|plantar fasciitis|plantar fasciitis
1160903|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
1160904|NCT02212444|feasibility|feasibility
1160905|NCT02212444|Physiotherapy|physiotherapy
1160906|NCT02212444|Musculoskeletal|musculoskeletal
1160907|NCT02212431|Cystic Fibrosis|cystic fibrosis
1160908|NCT02212431|Cysteamine|cysteamine
1160909|NCT02212431|Pharmacokinetics|pharmacokinetics
1160910|NCT02212405|Deep rTMS|deep rtms
1160911|NCT02212405|Insular cortex|insular cortex
1160912|NCT02212405|PET|pet
1160913|NCT02212405|[11C]-PHNO|[11c]-phno
1160914|NCT02212392|acute pancreatitis|acute pancreatitis
1160915|NCT02212379|Raltegravir|raltegravir
1160916|NCT02212379|Etravirine|etravirine
1160917|NCT02212379|aged, 45 and over|aged, 45 and over
1160918|NCT02212379|Viral load|viral load
1160919|NCT02212379|Efficacy|efficacy
1160920|NCT02212379|Safety|safety
1160921|NCT02212366|TDCS|tdcs
1160922|NCT02212366|Depression|depression
1160923|NCT02212366|Brain Stimulation|brain stimulation
1160924|NCT02212366|Memory|memory
1160925|NCT02212366|Cognition|cognition
1160926|NCT02212366|EEG|eeg
1160927|NCT02212340|propofol|propofol
1160928|NCT02212340|desflurane|desflurane
1160929|NCT02212340|quality of recovery|quality of recovery
1160930|NCT02212340|vitrectomy|vitrectomy
1160931|NCT02212327|Na+ MRI|na+ mri
1160932|NCT02212327|salt stores|salt stores
1160933|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
1160934|NCT02212275|ASD|asd
1160935|NCT02212275|autism|autism
1160936|NCT02212275|typical development|typical development
1160937|NCT02212275|sensory testing|sensory testing
1160938|NCT02212275|the cortical metric|the cortical metric
1160939|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
1160940|NCT02212249|antibody|antibody
1160941|NCT02212249|systemic slerosis|systemic slerosis
1160942|NCT02212236|Distress|distress
1160943|NCT02212236|Depression|depression
1160944|NCT02212236|Anxiety|anxiety
1160945|NCT02212236|Stress|stress
1160946|NCT02212236|Coping|coping
1160947|NCT02212236|Illness perceptions|illness perceptions
1160948|NCT02212236|Stem cell transplantation|stem cell transplantation
1160949|NCT02212236|Bone marrow transplantation|bone marrow transplantation
1160950|NCT02212223|Vitamin D|vitamin d
1160951|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
1160952|NCT02212223|Dietary supplement|dietary supplement
1160953|NCT02212223|Ethnicity|ethnicity
1160954|NCT02212223|Immigrant|immigrant
1160955|NCT02212197|prostate cancer|prostate cancer
1160956|NCT02212197|leuprolide|leuprolide
1160957|NCT02212184|Diaphragm|diaphragm
1160958|NCT02212184|COPD|copd
1160959|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
1160960|NCT02212184|Ultrasonography|ultrasonography
1160961|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
1160962|NCT02212158|Type 1 diabetes|type 1 diabetes
1160963|NCT02212158|adolescents|adolescents
1160964|NCT02212158|HA1c|ha1c
1160965|NCT02212158|psychological intervention|psychological intervention
1160966|NCT02212145|prevention|prevention
1160967|NCT02212145|cardiovascular disease|cardiovascular disease
1160968|NCT02212145|risk factors|risk factors
1160969|NCT02212132|metamemory|metamemory
1160970|NCT02212132|memory complaints|memory complaints
1160971|NCT02212132|performance mnemonic|performance mnemonic
1160972|NCT02212132|cancer|cancer
1160973|NCT02212119|Dementia|dementia
1160974|NCT02212119|Paratonia|paratonia
1160975|NCT02212119|Caregiver Burden|caregiver burden
1160976|NCT02212119|Botulinum toxin|botulinum toxin
1571291|NCT00497068|pregnancy|pregnancy
1160977|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
1160978|NCT02212041|electronic cigarettes|electronic cigarettes
1160979|NCT02212041|smoking|smoking
1160980|NCT02212041|schizophrenia|schizophrenia
1160981|NCT02212041|serious mental illness|serious mental illness
1160982|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
1160983|NCT02212028|prasugrel|prasugrel
1160984|NCT02212028|pharmacodynamic|pharmacodynamic
1160985|NCT02212028|pharmacokinetic|pharmacokinetic
1160986|NCT02212002|Group B Streptococcus|group b streptococcus
1160987|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
1160988|NCT02212002|term infants|term infants
1160989|NCT02212002|vaginal delivery|vaginal delivery
1160990|NCT02212002|gut microbiota|gut microbiota
1160991|NCT02212002|feeding|feeding
1160992|NCT02212002|molecular analysis|molecular analysis
1160993|NCT02212002|real-time PCR|real-time pcr
1160994|NCT02211846|Pharmacokinetics|pharmacokinetics
1160995|NCT02211846|Mirabegron|mirabegron
1160996|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
1160997|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
1160998|NCT02211820|Encephalopathy|encephalopathy
1160999|NCT02211820|Imaging Studies|imaging studies
1161000|NCT02211820|Dementia|dementia
1161001|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
1161002|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
1161003|NCT02211794|degenerative joint disease|degenerative joint disease
1161004|NCT02211781|Tribal Communities|tribal communities
1161005|NCT02211781|Radiation|radiation
1161006|NCT02211781|Cancer|cancer
1161007|NCT02211768|Genetic Analysis|genetic analysis
1161008|NCT02211768|Biopsy|biopsy
1161009|NCT02211768|FDG-PET|fdg-pet
1161010|NCT02211768|FLT-PET|flt-pet
1161011|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
1161012|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
1161013|NCT02211755|Combination Treatment|combination treatment
1161014|NCT02211755|Solid Tumors|solid tumors
1161015|NCT02211755|Hematologic|hematologic
1161016|NCT02211742|dapagliflozin|dapagliflozin
1161017|NCT02211742|fasting glucose|fasting glucose
1161018|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
1161019|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
1161020|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
1161021|NCT02211703|perioperative hypothermia|perioperative hypothermia
1161022|NCT02211703|Epidemiology|epidemiology
1161023|NCT02211703|Tympanic temperature|tympanic temperature
1161024|NCT02211651|adipose tissue|adipose tissue
1161025|NCT02211651|placenta|placenta
1161026|NCT02211651|pregnancy|pregnancy
1161027|NCT02211651|umbilical cord|umbilical cord
1161028|NCT02211638|Drug Therapy|drug therapy
1161029|NCT02211625|Healthy|healthy
1161030|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
1161031|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
1161032|NCT02211612|Overfeeding|overfeeding
1161033|NCT02211612|Weight gain|weight gain
1161034|NCT02211612|Liver fat|liver fat
1161035|NCT02211612|Pancreatic fat|pancreatic fat
1161036|NCT02211612|Ectopic fat|ectopic fat
1161037|NCT02211612|Skeletal muscle|skeletal muscle
1161038|NCT02211612|Adipose tissue|adipose tissue
1161039|NCT02211612|Gene expression|gene expression
1161040|NCT02211612|DNA methylation|dna methylation
1161041|NCT02211612|Palmitate|palmitate
1161042|NCT02211612|Linoleic acid|linoleic acid
1161043|NCT02211612|Saturated fat|saturated fat
1161044|NCT02211612|Polyunsaturated fat|polyunsaturated fat
1161045|NCT02211612|Metabolism|metabolism
1161046|NCT02211612|Insulin sensitivity|insulin sensitivity
1161047|NCT02211599|protein|protein
1161048|NCT02211599|carbohydrate|carbohydrate
1161049|NCT02211599|lipid|lipid
1161050|NCT02211599|oxidation|oxidation
1161052|NCT02211599|sugar|sugar
1161053|NCT02211599|juice|juice
1161054|NCT02211599|obesity|obesity
1161055|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
1161056|NCT02211573|Water Based Physical Training.|water based physical training.
1161057|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
1161058|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
1161059|NCT02211534|Pain Intensity|pain intensity
1161060|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
1161061|NCT02211508|fibromyalgia|fibromyalgia
1161062|NCT02211508|pain|pain
1161063|NCT02211508|stimulation|stimulation
1161064|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
1161065|NCT02211482|dual therapy|dual therapy
1161066|NCT02211456|Endocardial pacing|endocardial pacing
1161067|NCT02211456|Multi site pacing|multi site pacing
1161068|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
1161069|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
1161070|NCT02211443|Escalating doses ;|escalating doses ;
1161071|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
1161072|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
1161073|NCT02211430|smoking cessation|smoking cessation
1161074|NCT02211430|pregnancy|pregnancy
1161075|NCT02211430|postpartum|postpartum
1161076|NCT02211430|intervention|intervention
1161077|NCT02211391|Nighttime Eating|nighttime eating
1161078|NCT02211391|Protein|protein
1161079|NCT02211391|Obesity|obesity
1161080|NCT02211391|Lipolysis|lipolysis
1161081|NCT02211391|Metabolism|metabolism
1161082|NCT02211378|stress|stress
1161083|NCT02211378|performance|performance
1161084|NCT02211378|cortisol|cortisol
1161085|NCT02211365|Hypertension|hypertension
1161086|NCT02211365|CVD|cvd
1161087|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
1161088|NCT02211339|Social skills|social skills
1161089|NCT02211339|Social communication|social communication
1161090|NCT02211339|Cognitive communication|cognitive communication
1161091|NCT02211339|Traumatic brain injury|traumatic brain injury
1161092|NCT02211339|Acquired brain injury|acquired brain injury
1161093|NCT02211339|Communication partner training|communication partner training
1161094|NCT02211339|Peer partner training|peer partner training
1161095|NCT02211339|Peer mentoring|peer mentoring
1161096|NCT02211339|Rating scales|rating scales
1161097|NCT02211339|Rehabilitation|rehabilitation
1161098|NCT02211326|AF or DVT|af or dvt
1161099|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
1161100|NCT02211300|glucose monitoring|glucose monitoring
1161101|NCT02211300|OptiScanner|optiscanner
1161102|NCT02211287|Dementia|dementia
1161103|NCT02211287|Decision-making|decision-making
1161104|NCT02211287|Communication|communication
1161105|NCT02211287|Advance Care Planning|advance care planning
1161106|NCT02211274|Quality of Life|quality of life
1161107|NCT02211274|Nursing Homes|nursing homes
1161108|NCT02211274|Housing for the Elderly|housing for the elderly
1161109|NCT02211274|Homes for the Aged|homes for the aged
1161110|NCT02211261|first in human|first in human
1161111|NCT02211261|single dose|single dose
1161112|NCT02211261|multiple dose|multiple dose
1161113|NCT02211261|escalation|escalation
1161114|NCT02211261|safety study|safety study
1161115|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1161116|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
1161117|NCT02211248|multidisciplinary care|multidisciplinary care
1161118|NCT02211248|clinical trial|clinical trial
1161119|NCT02211235|Cystic Fibrosis|cystic fibrosis
1161120|NCT02211235|Healthy Controls|healthy controls
1161121|NCT02211235|Diabetes|diabetes
1161122|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
1161123|NCT02211235|CFRD|cfrd
1161124|NCT02211222|Thyroid Cancer|thyroid cancer
1161125|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
1161126|NCT02211222|Differentiated|differentiated
1161127|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
1161128|NCT02211183|Sub-acromial spacer|sub-acromial spacer
1161129|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
1161130|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
1161131|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
1161132|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
1161133|NCT02211092|Family Caregivers|family caregivers
1161134|NCT02211092|Advanced Cancer|advanced cancer
1161135|NCT02211092|Palliative Care|palliative care
1161136|NCT02211092|Support|support
1161137|NCT02211092|Self Care|self care
1161138|NCT02211092|Physical Activity|physical activity
1161139|NCT02211079|Healthy|healthy
1161140|NCT02211079|JNJ-54861911|jnj-54861911
1161141|NCT02211079|Caffeine|caffeine
1161142|NCT02211079|Midazolam|midazolam
1161143|NCT02211079|Tolbutamide|tolbutamide
1161144|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
1161145|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
1161146|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
1161147|NCT02211079|Alzheimer's disease|alzheimer's disease
1161148|NCT02211053|Organ donation|organ donation
1161149|NCT02211053|Brain dead|brain dead
1161150|NCT02211053|Levothyroxine|levothyroxine
1161151|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
1161152|NCT02211040|physical activity|physical activity
1161153|NCT02211040|fruit intake|fruit intake
1161154|NCT02211040|vegetable intake|vegetable intake
1161155|NCT02211040|computer tailoring|computer tailoring
1161156|NCT02211040|eHealth|ehealth
1161157|NCT02211040|self-regulation|self-regulation
1161158|NCT02211040|goal setting|goal setting
1161159|NCT02211040|problem solving|problem solving
1161160|NCT02211040|general practice|general practice
1161161|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
1161162|NCT02211027|Head & Neck Cancer|head & neck cancer
1161163|NCT02211027|Vaccine|vaccine
1161164|NCT02211027|Carcinoma|carcinoma
1161165|NCT02211027|Immunization|immunization
1161166|NCT02211027|Autologous Tumor|autologous tumor
1161167|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1161168|NCT02211014|Btk|btk
1161169|NCT02211014|Multiple Myeloma|multiple myeloma
1161170|NCT02211014|MM|mm
1161171|NCT02211014|ACP-196|acp-196
1161172|NCT02211014|acalabrutinib|acalabrutinib
1161173|NCT02211001|Exercise Movement Techniques|exercise movement techniques
1161174|NCT02211001|Exercise Therapy|exercise therapy
1161175|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
1161176|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
1161177|NCT02210975|GERD|gerd
1161178|NCT02210975|LES|les
1161179|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
1161180|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
1161181|NCT02210962|early psychosis|early psychosis
1161182|NCT02210962|chronic schizophrenia|chronic schizophrenia
1161183|NCT02210962|first episode psychosis|first episode psychosis
1161184|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
1161185|NCT02210962|relapse prevention|relapse prevention
1161186|NCT02210962|efficacy|efficacy
1161187|NCT02210949|Blood transfusion|blood transfusion
1161188|NCT02210949|Erythropoietin|erythropoietin
1161189|NCT02210949|Iron suppletion|iron suppletion
1161190|NCT02210923|Baroreflex|baroreflex
1161191|NCT02210923|Electrical stimulation|electrical stimulation
1161192|NCT02210923|Carotid body|carotid body
1161193|NCT02210923|Chemoreceptors|chemoreceptors
1161194|NCT02210923|Resistant hypertension|resistant hypertension
1161195|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
1161196|NCT02210884|Vitamin D supplementation|vitamin d supplementation
1161197|NCT02210884|Lactation|lactation
1161198|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
1161199|NCT02210884|Breast feeding|breast feeding
1161200|NCT02210845|Diabetes|diabetes
1161201|NCT02210845|Supervised Exercise|supervised exercise
1161202|NCT02210845|Weight loss|weight loss
1161203|NCT02210832|smoking|smoking
1161204|NCT02210832|pregnancy|pregnancy
1161205|NCT02210832|cessation|cessation
1161206|NCT02210832|incentives|incentives
1161207|NCT02210819|Thromboembolism|thromboembolism
1161208|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
1161209|NCT02210819|Vascular Diseases|vascular diseases
1161210|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
1161211|NCT02210819|Thrombosis|thrombosis
1161212|NCT02210806|Asthma|asthma
1161213|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
1161214|NCT02210806|Mild asthma|mild asthma
1161215|NCT02210806|Moderate asthma|moderate asthma
1161216|NCT02210806|Persistent asthma|persistent asthma
1161217|NCT02210793|Transepithelial PRK|transepithelial prk
1161218|NCT02210793|Dry eye|dry eye
1161219|NCT02210793|Schirmer test|schirmer test
1161220|NCT02210793|Tear break up time|tear break up time
1161221|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
1161222|NCT02210754|Nicotine|nicotine
1161223|NCT02210754|Pharmacokinetics|pharmacokinetics
1161224|NCT02210754|Pharmacodynamics|pharmacodynamics
1161225|NCT02210754|blu e-cigs|blu e-cigs
1161226|NCT02210754|Tolerability|tolerability
1161227|NCT02210754|Safety|safety
1161228|NCT02210754|Smoke urge|smoke urge
1161229|NCT02210741|immune repertoire|immune repertoire
1161230|NCT02210741|Graves' disease|graves' disease
1161231|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
1161232|NCT02210728|stimulant medication|stimulant medication
1161233|NCT02210728|efficacy|efficacy
1161234|NCT02210728|symptoms|symptoms
1161235|NCT02210728|functional outcomes|functional outcomes
1161236|NCT02210663|Breast cancer|breast cancer
1161237|NCT02210663|PARP|parp
1161238|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
1161239|NCT02210663|Fallopian tube|fallopian tube
1161240|NCT02210663|Ovarian cancer|ovarian cancer
1161241|NCT02210663|veliparib|veliparib
1161242|NCT02210663|ABT-888|abt-888
1161243|NCT02210663|BRCA|brca
1161244|NCT02210650|kidney stone|kidney stone
1161245|NCT02210637|Appointments and Schedules|appointments and schedules
1161246|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
1161247|NCT02210637|Emergency Department|emergency department
1161248|NCT02210637|Hospitalization|hospitalization
1161249|NCT02210637|Mortality|mortality
1161250|NCT02210624|Anoxic Brain Injury|anoxic brain injury
1161251|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
1161252|NCT02210624|stoke|stoke
1161253|NCT02210598|labor, induced|labor, induced
1161254|NCT02210598|catheter|catheter
1161255|NCT02210598|oxytocin|oxytocin
1161256|NCT02210598|Cesarean section|cesarean section
1161257|NCT02210572|Intestinal microbiota|intestinal microbiota
1161258|NCT02210572|Intestinal gas|intestinal gas
1161259|NCT02210572|Dietary intervention|dietary intervention
1161260|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
1161261|NCT02210572|Prebiotics|prebiotics
1161262|NCT02210559|locally|locally
1161263|NCT02210559|advanced|advanced
1161264|NCT02210559|pancreatic|pancreatic
1161265|NCT02210559|cancer|cancer
1161266|NCT02210559|unresectable|unresectable
1161267|NCT02210559|pancreatic cancer|pancreatic cancer
1161268|NCT02210546|breast cancer|breast cancer
1571498|NCT00496444|5-AZC|5-azc
1161269|NCT02210546|intermediate risk|intermediate risk
1161270|NCT02210507|vitamin A|vitamin a
1161271|NCT02210507|retinol|retinol
1161272|NCT02210507|carotenoids|carotenoids
1161273|NCT02210481|vitrectomy,|vitrectomy,
1161274|NCT02210481|macular thinning,|macular thinning,
1161275|NCT02210481|retinal detachment,|retinal detachment,
1161276|NCT02210481|epimacular membrane,|epimacular membrane,
1161277|NCT02210481|intravitreal glucose,|intravitreal glucose,
1161279|NCT02210468|Osteoarthritis|osteoarthritis
1161280|NCT02210468|Protease Inhibitors|protease inhibitors
1161281|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
1161282|NCT02210468|Autologous treatment|autologous treatment
1161283|NCT02210468|APIC-CF|apic-cf
1161284|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
1161285|NCT02210455|FASD|fasd
1161286|NCT02210455|pFAS|pfas
1161287|NCT02210455|ARND|arnd
1161288|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
1161289|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
1161290|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
1161291|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
1161292|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
1161293|NCT02210442|educational games|educational games
1161294|NCT02210442|clinical practice guideline|clinical practice guideline
1161295|NCT02210442|family medicine|family medicine
1161296|NCT02210442|primary health care|primary health care
1161297|NCT02210442|cluster clinical trial|cluster clinical trial
1161298|NCT02210429|Supraclavicular Block|supraclavicular block
1161299|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
1161300|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
1161301|NCT02210429|Regional Anesthesia|regional anesthesia
1161302|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
1161303|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
1161304|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
1161305|NCT02210325|gonorrhea|gonorrhea
1161306|NCT02210325|chlamydia|chlamydia
1161307|NCT02210325|solithromycin|solithromycin
1161308|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
1161309|NCT02210286|dementia|dementia
1161310|NCT02210286|magnesium|magnesium
1161311|NCT02210286|learning|learning
1161312|NCT02210286|memory|memory
1161313|NCT02210286|Alzheimer's disease|alzheimer's disease
1161314|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
1161315|NCT02210273|SUI|sui
1161316|NCT02210260|Cancer|cancer
1161317|NCT02210260|Colorectal|colorectal
1161318|NCT02210260|Pain relief|pain relief
1161319|NCT02210234|wheat bran|wheat bran
1161320|NCT02210234|healthy immunity|healthy immunity
1161321|NCT02210234|T cells|t cells
1161322|NCT02210221|TBI|tbi
1161323|NCT02210195|Cannabis Treatment|cannabis treatment
1161324|NCT02210195|Alcohol Treatment|alcohol treatment
1161325|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
1161326|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
1161327|NCT02210195|Substance-Related Disorders|substance-related disorders
1161328|NCT02210195|Emend|emend
1161329|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
1161330|NCT02210195|Alcohol|alcohol
1161331|NCT02210195|Cannabis|cannabis
1161332|NCT02210195|aprepitant|aprepitant
1161333|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
1161334|NCT02210182|Oral Pentamidine|oral pentamidine
1161335|NCT02210182|Endo-exonuclease|endo-exonuclease
1161336|NCT02210156|Respiratory tract infection|respiratory tract infection
1161337|NCT02210156|Incidence|incidence
1161338|NCT02210156|Dietary supplements|dietary supplements
1161339|NCT02210156|Micronutrients|micronutrients
1161340|NCT02210156|Plant extracts|plant extracts
1161341|NCT02210117|Kidney Cancer|kidney cancer
1161342|NCT02210117|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1161343|NCT02210117|mRCC|mrcc
1161344|NCT02210117|Cytoreductive Nephrectomy|cytoreductive nephrectomy
1161345|NCT02210117|Presurgical therapy|presurgical therapy
1161346|NCT02210117|Nivolumab|nivolumab
1161347|NCT02210117|BMS-936558|bms-936558
1161348|NCT02210117|Bevacizumab|bevacizumab
1161349|NCT02210117|Avastin|avastin
1161350|NCT02210117|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1161351|NCT02210117|fhuMab-VEGF|fhumab-vegf
1161352|NCT02210117|Ipilimumab|ipilimumab
1161353|NCT02210117|Yervoy|yervoy
1161354|NCT02210117|BMS-734016|bms-734016
1161355|NCT02210117|MDX010|mdx010
1161356|NCT02210104|Melanoma|melanoma
1161357|NCT02210104|Sarcoma|sarcoma
1161358|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
1161359|NCT02210104|Advanced|advanced
1161360|NCT02210104|Metastatic|metastatic
1161361|NCT02210104|Immunotherapy|immunotherapy
1161362|NCT02210104|Ipilimumab|ipilimumab
1161363|NCT02210104|Yervoy|yervoy
1161364|NCT02210104|BMS-734016|bms-734016
1161365|NCT02210104|MDX010|mdx010
1161366|NCT02210104|Cyclophosphamide|cyclophosphamide
1161367|NCT02210104|Cytoxan|cytoxan
1161368|NCT02210104|Neosar|neosar
1161369|NCT02210104|CD4+T Cells|cd4+t cells
1161370|NCT02210078|Blood And Marrow Transplantation|blood and marrow transplantation
1161371|NCT02210078|Infection|infection
1161372|NCT02210078|Cytomegalovirus|cytomegalovirus
1161373|NCT02210078|CMV|cmv
1161374|NCT02210078|Stem cell transplant|stem cell transplant
1161375|NCT02210078|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1161376|NCT02210078|HSCT|hsct
1161377|NCT02210078|Human Leukocyte Antigen|human leukocyte antigen
1161378|NCT02210078|HLA|hla
1161379|NCT02210078|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
1161380|NCT02210078|CTL|ctl
1161381|NCT02210065|Leukemia|leukemia
1161382|NCT02210065|Lymphoma|lymphoma
1161482|NCT02209454|Comparative|comparative
1161383|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
1161384|NCT02210065|Hematological malignancies|hematological malignancies
1161385|NCT02210065|Cytotoxic T cells|cytotoxic t cells
1161386|NCT02210065|CTL|ctl
1161387|NCT02210065|Cytomegalovirus|cytomegalovirus
1161388|NCT02210065|CMV|cmv
1161389|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1161390|NCT02210065|HSCT|hsct
1161391|NCT02210052|radiofrequency ablation|radiofrequency ablation
1161392|NCT02210039|SECM|secm
1161393|NCT02210039|Esophagus|esophagus
1161394|NCT02210039|Imaging|imaging
1161395|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
1161396|NCT02210026|work of breathing|work of breathing
1161397|NCT02210026|pressure-rate products|pressure-rate products
1161398|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
1161399|NCT02210000|repeat dose|repeat dose
1161400|NCT02210000|phase II|phase ii
1161401|NCT02210000|GCSI-DD|gcsi-dd
1161402|NCT02210000|pharmacodynamics|pharmacodynamics
1161403|NCT02210000|gastroparesis|gastroparesis
1161404|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
1161405|NCT02210000|camicinal|camicinal
1161406|NCT02210000|GSK962040|gsk962040
1161407|NCT02210000|symptoms|symptoms
1161408|NCT02210000|gut motility|gut motility
1161409|NCT02209974|emphysema|emphysema
1161410|NCT02209974|CRP|crp
1161411|NCT02209974|interleukin-8|interleukin-8
1161412|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
1161413|NCT02209935|pediatric|pediatric
1161414|NCT02209935|acute neurologic disease|acute neurologic disease
1161415|NCT02209935|critical care|critical care
1161416|NCT02209935|rehabilitation|rehabilitation
1161417|NCT02209935|outcome|outcome
1161418|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
1161419|NCT02209909|preoperative aspirin use|preoperative aspirin use
1161420|NCT02209909|platelet activation|platelet activation
1161421|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
1161422|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
1161423|NCT02209896|PNP|pnp
1161424|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
1161425|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1161426|NCT02209870|Teamwork|teamwork
1161427|NCT02209870|electronic checklist|electronic checklist
1161428|NCT02209857|Breastcancer|breastcancer
1161429|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
1161430|NCT02209857|70-gene expression profile|70-gene expression profile
1161431|NCT02209857|MammaPrint|mammaprint
1161432|NCT02209818|Low level laser therapy|low level laser therapy
1161433|NCT02209818|Elastomeric separator|elastomeric separator
1161434|NCT02209818|Placebo|placebo
1161435|NCT02209818|Visual analog scale|visual analog scale
1161436|NCT02209818|Laser irradiation|laser irradiation
1161437|NCT02209766|Safety|safety
1161438|NCT02209766|Tolerability|tolerability
1161439|NCT02209766|Pharmacokinetics|pharmacokinetics
1161440|NCT02209766|Pharmacodynamics|pharmacodynamics
1161441|NCT02209766|D5884|d5884
1161442|NCT02209766|Japanese|japanese
1161443|NCT02209766|Caucasian|caucasian
1161444|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
1161445|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
1161446|NCT02209675|Rejection|rejection
1162336|NCT02205476|Phase 2|phase 2
1161447|NCT02209675|Liver Transplantation|liver transplantation
1161448|NCT02209675|Liver biopsy|liver biopsy
1161449|NCT02209662|APIC-PRP|apic-prp
1161450|NCT02209662|Chronic Wounds|chronic wounds
1161451|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
1161452|NCT02209636|hyperphosphatemia|hyperphosphatemia
1161453|NCT02209636|vascular dysfunction|vascular dysfunction
1161454|NCT02209636|chronic kidney disease|chronic kidney disease
1161455|NCT02209636|cardiovascular disease|cardiovascular disease
1161456|NCT02209636|endothelial dysfunction|endothelial dysfunction
1161457|NCT02209610|Heart Failure|heart failure
1161458|NCT02209597|Major Depressive Disorder|major depressive disorder
1161459|NCT02209597|MDD|mdd
1161460|NCT02209597|bupropion XL|bupropion xl
1161461|NCT02209597|Wellbutrin XL|wellbutrin xl
1161462|NCT02209571|Breath Tests|breath tests
1161463|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
1161464|NCT02209532|Lymph node mapping|lymph node mapping
1161465|NCT02209532|Endometrial cancer|endometrial cancer
1161466|NCT02209532|Uterine cancer|uterine cancer
1161467|NCT02209532|Cervical cancer|cervical cancer
1161468|NCT02209519|bacterial vaginosis|bacterial vaginosis
1161469|NCT02209519|recurrence|recurrence
1161470|NCT02209519|male partner|male partner
1161471|NCT02209506|MLN3126|mln3126
1161472|NCT02209493|Dietary intervention|dietary intervention
1161473|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
1161474|NCT02209493|Vegetable intake|vegetable intake
1161475|NCT02209493|Functional food|functional food
1161476|NCT02209493|Prevention|prevention
1161477|NCT02209467|walking|walking
1161478|NCT02209467|postural balance|postural balance
1161479|NCT02209467|falls|falls
1161480|NCT02209454|Dexketoprofen|dexketoprofen
1161481|NCT02209454|Bioavailability|bioavailability
1161483|NCT02209454|Pharmacokinetic|pharmacokinetic
1161484|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
1161485|NCT02209428|Temozolomide|temozolomide
1161486|NCT02209428|IDH mutation|idh mutation
1161487|NCT02209428|Low grade glioma|low grade glioma
1161488|NCT02209389|breast cancer|breast cancer
1161489|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
1161490|NCT02209389|breast cancer blood test|breast cancer blood test
1161491|NCT02209363|Parkinson's disease|parkinson's disease
1161492|NCT02209363|OSA|osa
1161493|NCT02209363|CPAP|cpap
1161494|NCT02209363|cognition|cognition
1161495|NCT02209311|Alveolar Bone Loss|alveolar bone loss
1161496|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
1161497|NCT02209311|Dental Implantation|dental implantation
1161498|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
1161499|NCT02209311|Sinus Lift|sinus lift
1161500|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
1161501|NCT02209311|Autologous MMSCs|autologous mmscs
1161502|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
1161503|NCT02209311|Tissue Engineered Construction|tissue engineered construction
1161504|NCT02209311|Oral Mucosa|oral mucosa
1161505|NCT02209285|Older adults|older adults
1161506|NCT02209285|Home and community care|home and community care
1161507|NCT02209285|Effectiveness|effectiveness
1161508|NCT02209285|Cost analysis|cost analysis
1161509|NCT02209285|Stroke|stroke
1161510|NCT02209285|TIA|tia
1161511|NCT02209285|Hypertension|hypertension
1161512|NCT02209285|Cardiovascular disease|cardiovascular disease
1161513|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
1161514|NCT02209220|Treatment compliance|treatment compliance
1161515|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
1161516|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
1161517|NCT02209220|Bariatric surgery|bariatric surgery
1161518|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1161519|NCT02209207|endurance training|endurance training
1161520|NCT02209207|interval training|interval training
1161521|NCT02209207|continuous training|continuous training
1161522|NCT02209207|walking training|walking training
1161523|NCT02209194|aneurysms|aneurysms
1161524|NCT02209194|vascular disease|vascular disease
1161525|NCT02209194|E-liac Stent Graft|e-liac stent graft
1161526|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
1161527|NCT02209194|iliac aneurysm|iliac aneurysm
1161528|NCT02209194|branched stent graft|branched stent graft
1161529|NCT02209194|self expanding stent graft|self expanding stent graft
1161530|NCT02209181|dental pain|dental pain
1161531|NCT02209181|post-surgical dental pain|post-surgical dental pain
1161532|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
1161533|NCT02209142|Major depression|major depression
1161534|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
1161535|NCT02209116|ADHD|adhd
1161536|NCT02209116|QB Test|qb test
1161537|NCT02209116|Activity|activity
1161538|NCT02209116|Attention|attention
1161539|NCT02209116|Children|children
1161540|NCT02209116|Clinical Decision Making|clinical decision making
1161541|NCT02209103|Polyphenols|polyphenols
1161542|NCT02209103|Orange|orange
1161543|NCT02209103|Sleep|sleep
1161544|NCT02209103|Fatigue|fatigue
1161545|NCT02209090|occiput-posterior|occiput-posterior
1161546|NCT02209090|occipitoposterior|occipitoposterior
1161547|NCT02209090|labour|labour
1161548|NCT02209064|Subxiphoid|subxiphoid
1161549|NCT02209064|Access|access
1161550|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
1161551|NCT02209051|AMNIOEXCEL|amnioexcel
1161552|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
1161553|NCT02209051|Wound|wound
1161554|NCT02209051|Foot health|foot health
1161555|NCT02209051|Ulcer|ulcer
1161556|NCT02209051|Foot Ulcer|foot ulcer
1161557|NCT02209051|Diabetic Foot|diabetic foot
1161558|NCT02209051|Foot Diseases|foot diseases
1161559|NCT02209051|Skin Diseases|skin diseases
1161560|NCT02209051|Leg Ulcer|leg ulcer
1161561|NCT02209051|Skin Ulcer|skin ulcer
1161562|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
1161563|NCT02209051|Vascular Diseases|vascular diseases
1161564|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
1161565|NCT02209051|Diabetes Complications|diabetes complications
1161566|NCT02209051|Diabetes Mellitus|diabetes mellitus
1161567|NCT02209051|Endocrine System Diseases|endocrine system diseases
1161568|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
1161569|NCT02209038|end stage renal disease|end stage renal disease
1161570|NCT02209038|hemodialysis|hemodialysis
1161571|NCT02209038|dialysis|dialysis
1161572|NCT02209025|Atherosclerosis|atherosclerosis
1161573|NCT02209025|Cholesterol|cholesterol
1161574|NCT02209025|Cholesterol, HDL|cholesterol, hdl
1161575|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
1161576|NCT02209025|Theobromine|theobromine
1161577|NCT02209012|Actinic Keratosis|actinic keratosis
1161578|NCT02208999|medullary neurostimulation|medullary neurostimulation
1161580|NCT02208999|Precision|precision
1161581|NCT02208999|rechargeable|rechargeable
1161582|NCT02208999|implantable|implantable
1161583|NCT02208986|GnRH antagonist|gnrh antagonist
1161584|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
1161585|NCT02208986|Oocyte donor|oocyte donor
1161586|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
1161587|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
1161588|NCT02208973|Asthma|asthma
1161589|NCT02208973|COPD|copd
1161590|NCT02208960|Neurodevelopment|neurodevelopment
1161591|NCT02208960|Neonatal kit|neonatal kit
1161592|NCT02208960|Kenya|kenya
1161593|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1161594|NCT02208960|Chlorhexidine|chlorhexidine
1161595|NCT02208960|ThermoSpot|thermospot
1161596|NCT02208947|advance care planning|advance care planning
1161597|NCT02208947|decision making|decision making
1161598|NCT02208947|patient engagement|patient engagement
1161599|NCT02208947|patient education|patient education
1161600|NCT02208947|financial incentives|financial incentives
1161601|NCT02208947|behavioral economics|behavioral economics
1161602|NCT02208934|PDE10 inhibitor|pde10 inhibitor
1161603|NCT02208934|Huntington's disease|huntington's disease
1161604|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
1161605|NCT02208934|psychiatric disorders|psychiatric disorders
1161606|NCT02208921|Type 2 Diabetes|type 2 diabetes
1161607|NCT02208908|Oral care|oral care
1161608|NCT02208908|cancer|cancer
1161609|NCT02208908|palliative|palliative
1161610|NCT02208908|training|training
1161611|NCT02208895|pleural|pleural
1161612|NCT02208895|glucose|glucose
1161613|NCT02208895|glucometer|glucometer
1161614|NCT02208895|i-STAT|i-stat
1161615|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
1161616|NCT02208869|cholesterol|cholesterol
1161617|NCT02208869|prevention|prevention
1161618|NCT02208869|registry|registry
1161619|NCT02208869|atherosclerosis|atherosclerosis
1161620|NCT02208869|treatment|treatment
1161621|NCT02208869|prevalence|prevalence
1161622|NCT02208830|bronchiectasis|bronchiectasis
1161623|NCT02208830|functional capacity|functional capacity
1161624|NCT02208830|lung functional|lung functional
1161625|NCT02208817|capillary refill|capillary refill
1161626|NCT02208817|paediatric early warning score|paediatric early warning score
1161627|NCT02208817|photoplethysmography|photoplethysmography
1161628|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
1161629|NCT02208791|Kidney Transplantation|kidney transplantation
1161630|NCT02208791|Graft Rejection|graft rejection
1161631|NCT02208791|Immunossupression|immunossupression
1161632|NCT02208778|Osteoarthritis|osteoarthritis
1161633|NCT02208778|Chronic Pain|chronic pain
1161634|NCT02208778|Pain relief|pain relief
1161635|NCT02208765|Coronary Circulation|coronary circulation
1161636|NCT02208765|Coronary Artery Disease|coronary artery disease
1161637|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
1161638|NCT02208765|Prognosis|prognosis
1161639|NCT02208752|rotator cuff tears|rotator cuff tears
1161640|NCT02208752|ultrasound measure|ultrasound measure
1161641|NCT02208752|pain|pain
1161642|NCT02208752|range of motion|range of motion
1161643|NCT02208752|muscle force|muscle force
1161644|NCT02208739|Chronic periodontitis|chronic periodontitis
1161645|NCT02208739|periodontal pathogens|periodontal pathogens
1161646|NCT02208739|inflammatory mediators|inflammatory mediators
1161647|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
1161648|NCT02208739|Oral hygiene instructions|oral hygiene instructions
1161649|NCT02208739|Polymerase chain reaction|polymerase chain reaction
1161650|NCT02208739|Elisa|elisa
1161651|NCT02208726|anxiety|anxiety
1161652|NCT02208726|students|students
1161653|NCT02208726|examinations|examinations
1161654|NCT02208726|Homeopathy|homeopathy
1161655|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
1161656|NCT02208687|Social Participation|social participation
1161657|NCT02208687|Fatigue|fatigue
1161658|NCT02208687|Self-Management|self-management
1161659|NCT02208687|Rehabilitation|rehabilitation
1161660|NCT02208687|Physical therapy|physical therapy
1226835|NCT01910363|A2|a2
1161661|NCT02208687|Occupational therapy|occupational therapy
1161662|NCT02208687|Group intervention|group intervention
1161663|NCT02208687|Exercise|exercise
1161664|NCT02208674|chronic kidney disease|chronic kidney disease
1161665|NCT02208674|albuminuria|albuminuria
1161666|NCT02208674|hypertension|hypertension
1161667|NCT02208674|dyslipidemia|dyslipidemia
1161668|NCT02208674|cardiovascular disease|cardiovascular disease
1161669|NCT02208674|pragmatic trial|pragmatic trial
1161670|NCT02208674|cluster randomized trial|cluster randomized trial
1161671|NCT02208661|Morquio A syndrome|morquio a syndrome
1161672|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
1161673|NCT02208661|Psychological health|psychological health
1161674|NCT02208648|coronary calcification|coronary calcification
1161675|NCT02208648|Computed Tomography|computed tomography
1161676|NCT02208648|Coronary artery calcium|coronary artery calcium
1161677|NCT02208648|calcium scores|calcium scores
1161678|NCT02208648|post-operative mortality|post-operative mortality
1161679|NCT02208635|Zinc Absorption|zinc absorption
1161680|NCT02208635|Biofortification|biofortification
1161681|NCT02208635|Maize|maize
1161682|NCT02208635|Zambia|zambia
1161683|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
1161684|NCT02208622|Zinc absorption|zinc absorption
1161685|NCT02208622|Iron Absorption|iron absorption
1161686|NCT02208622|Whey Protein|whey protein
1161687|NCT02208622|Mexico|mexico
1161688|NCT02208622|Stable isotopes|stable isotopes
1161689|NCT02208609|Zinc Absorption|zinc absorption
1161690|NCT02208609|Maize|maize
1161691|NCT02208609|Amaranth|amaranth
1161692|NCT02208609|Guatemala|guatemala
1161693|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
1161694|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
1161695|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
1161696|NCT02208557|Incisional hernia|incisional hernia
1161697|NCT02208557|prevention|prevention
1161698|NCT02208557|laparotomy closure|laparotomy closure
1161699|NCT02208557|absorbable mesh|absorbable mesh
1161700|NCT02208544|Thyroid Nodule|thyroid nodule
1161701|NCT02208544|Indeterminate Cytology|indeterminate cytology
1161702|NCT02208544|FDG-PET/CT|fdg-pet/ct
1161703|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
1161704|NCT02208544|Efficacy|efficacy
1161705|NCT02208544|Cost-Effectiveness|cost-effectiveness
1161706|NCT02208544|Quality-of-Life|quality-of-life
1161707|NCT02208544|Thyroidectomy|thyroidectomy
1161708|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
1161709|NCT02208531|Psychosocial stimulation|psychosocial stimulation
1161710|NCT02208531|Malnutrition|malnutrition
1161711|NCT02208531|Bangladesh|bangladesh
1161712|NCT02208531|Scaling up ECD|scaling up ecd
1161713|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
1161714|NCT02208518|Quantitative elastography|quantitative elastography
1161715|NCT02208518|Qualitative elastography|qualitative elastography
1161716|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
1161717|NCT02208518|Elastography|elastography
1161718|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
1161719|NCT02208479|cardiac surgery|cardiac surgery
1161720|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
1161721|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
1161722|NCT02208479|respiratory paralysis|respiratory paralysis
1161723|NCT02208479|muscle weakness|muscle weakness
1161724|NCT02208479|cardiac bypass|cardiac bypass
1161725|NCT02208479|valvular surgery|valvular surgery
1161726|NCT02208479|respiratory insufficiency|respiratory insufficiency
1161727|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1161728|NCT02208466|rTMS|rtms
1161729|NCT02208466|TMS|tms
1161730|NCT02208466|fluoxetine|fluoxetine
1161731|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
1161732|NCT02208453|Local anesthesia|local anesthesia
1161733|NCT02208453|Sub-acromial spacer|sub-acromial spacer
1161734|NCT02208440|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
1161735|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
1161736|NCT02208414|Food Allergies|food allergies
1161737|NCT02208388|Computed tomography perfusion|computed tomography perfusion
1161738|NCT02208388|Fractional flow reserve|fractional flow reserve
1161739|NCT02208375|Breast Cancer|breast cancer
1161835|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
1161740|NCT02208375|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
1161741|NCT02208375|Recurrent endometrial cancer|recurrent endometrial cancer
1161742|NCT02208375|Recurrent endometrial adenocarcinoma|recurrent endometrial adenocarcinoma
1161743|NCT02208375|Triple negative breast cancer|triple negative breast cancer
1161744|NCT02208375|Ovarian cancer|ovarian cancer
1161745|NCT02208375|Primary peritoneal cancer|primary peritoneal cancer
1161746|NCT02208375|Fallopian tube cancer|fallopian tube cancer
1161747|NCT02208375|Olaparib|olaparib
1161748|NCT02208375|AZD2014|azd2014
1161749|NCT02208375|AZD5363|azd5363
1161750|NCT02208362|chimeric antigen receptor|chimeric antigen receptor
1161751|NCT02208362|glioblastoma|glioblastoma
1161752|NCT02208349|intubation, laryngoscopy, prehospital, emergency medical services|intubation, laryngoscopy, prehospital, emergency medical services
1161753|NCT02208323|Hypoxia|hypoxia
1161754|NCT02208323|Respiratory Distress|respiratory distress
1161755|NCT02208310|Crohn's disease|crohn's disease
1161756|NCT02208310|Vitamin D deficiency|vitamin d deficiency
1161757|NCT02208284|Single Ascending Dose|single ascending dose
1161758|NCT02208284|healthy subjects|healthy subjects
1161759|NCT02208284|Hyperlipidemia|hyperlipidemia
1161760|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
1161761|NCT02208284|Metabolic Diseases|metabolic diseases
1161762|NCT02208271|tissue necrosis|tissue necrosis
1161763|NCT02208271|metal on metal total hip|metal on metal total hip
1161764|NCT02208271|biomarker|biomarker
1161765|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
1161766|NCT02208232|IOL rotation|iol rotation
1161767|NCT02208219|Stroke|stroke
1161768|NCT02208219|Paresis|paresis
1161769|NCT02208219|Upper extremity|upper extremity
1161770|NCT02208219|Motor deficits|motor deficits
1161771|NCT02208219|Music Therapy|music therapy
1161772|NCT02208219|Neurorehabilitation|neurorehabilitation
1161773|NCT02208206|Neuropathic pain|neuropathic pain
1161774|NCT02208206|Phenotype|phenotype
1161775|NCT02208206|Genotype|genotype
1161776|NCT02208206|Biomarkers|biomarkers
1161777|NCT02208206|HIV|hiv
1161778|NCT02208206|Diabetes mellitus|diabetes mellitus
1161779|NCT02208206|Breast cancer|breast cancer
1161780|NCT02208206|Genomics|genomics
1161781|NCT02208206|Quantitative sensory testing|quantitative sensory testing
1161782|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
1161783|NCT02208180|Return of results|return of results
1161784|NCT02208180|Genomics|genomics
1161785|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
1161786|NCT02208167|HXTC|hxtc
1161787|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
1161788|NCT02208167|Acute HIV infection|acute hiv infection
1161789|NCT02208167|Chronic HIV infection|chronic hiv infection
1161790|NCT02208167|Leukapheresis|leukapheresis
1161791|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
1161792|NCT02208154|colonization|colonization
1161793|NCT02208154|decolonization|decolonization
1161794|NCT02208154|selective decontamination|selective decontamination
1161795|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
1161796|NCT02208141|children|children
1161797|NCT02208141|obesity|obesity
1161798|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
1161799|NCT02208141|inflammation|inflammation
1161800|NCT02208141|macrophage infiltration|macrophage infiltration
1161801|NCT02208141|insulin resistance|insulin resistance
1161802|NCT02208141|dyslipidemia|dyslipidemia
1161803|NCT02208128|Renal cell carcinoma|renal cell carcinoma
1161804|NCT02208128|Biomarkers|biomarkers
1161805|NCT02208128|Molecular modifications|molecular modifications
1161806|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1161807|NCT02208115|Exercise|exercise
1161808|NCT02208115|Appetite|appetite
1161809|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
1161810|NCT02208089|Keratoconus|keratoconus
1161811|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
1161812|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
1161813|NCT02208076|Growth disorders|growth disorders
1161814|NCT02208076|Saizen|saizen
1161815|NCT02208076|Easypod|easypod
1161816|NCT02208076|Growth hormone|growth hormone
1161817|NCT02208076|Pediatric subject|pediatric subject
1161818|NCT02208063|Bacteremia|bacteremia
1161819|NCT02208063|Staphylococcus aureus|staphylococcus aureus
1161820|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1161821|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
1161822|NCT02208050|Multiple Sclerosis|multiple sclerosis
1161823|NCT02208050|Upper limb function|upper limb function
1161824|NCT02208050|Mobility|mobility
1161825|NCT02208050|Fampridine|fampridine
1161826|NCT02208050|DASH|dash
1161827|NCT02208050|AMSQ|amsq
1161828|NCT02208050|MSWS-12|msws-12
1161829|NCT02208050|MSIS-29|msis-29
1161830|NCT02208050|SF-36|sf-36
1161831|NCT02208050|9HPT|9hpt
1161832|NCT02208050|25FTW|25ftw
1161833|NCT02208050|JTT|jtt
1161834|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
1161836|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
1161837|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
1161838|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
1161839|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
1161840|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1161841|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1161842|NCT02207972|Pregnant|pregnant
1161843|NCT02207972|labor|labor
1161844|NCT02207972|Epidural|epidural
1161845|NCT02207959|Gastric cancer|gastric cancer
1161846|NCT02207959|Neoplasia|neoplasia
1161847|NCT02207959|Endoscopic imaging|endoscopic imaging
1161848|NCT02207959|In vivo imaging|in vivo imaging
1161849|NCT02207933|anterioposterior|anterioposterior
1161850|NCT02207933|weight|weight
1161851|NCT02207933|shifting|shifting
1161852|NCT02207933|training|training
1161853|NCT02207933|patient|patient
1161854|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
1161855|NCT02207881|herpes labialis|herpes labialis
1161856|NCT02207881|cold sore|cold sore
1161857|NCT02207829|COPD|copd
1161858|NCT02207829|inhaler critical errors|inhaler critical errors
1161859|NCT02207829|double-dummy|double-dummy
1161860|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
1161861|NCT02207829|inhaler preference|inhaler preference
1161862|NCT02207829|tiotropium|tiotropium
1161863|NCT02207829|umeclidinium|umeclidinium
1161864|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1161865|NCT02207816|Infants|infants
1161866|NCT02207816|Efficacy|efficacy
1161867|NCT02207816|Children|children
1161868|NCT02207816|Malaria|malaria
1161869|NCT02207816|Plasmodium falciparum|plasmodium falciparum
1161870|NCT02207816|Safety|safety
1161871|NCT02207816|Surveillance|surveillance
1161872|NCT02207816|Immunogenicity|immunogenicity
1161873|NCT02207816|RTS,S/AS01E|rts,s/as01e
1161874|NCT02207816|Africa|africa
1161875|NCT02207803|Brain Injuries|brain injuries
1161876|NCT02207803|Caregivers|caregivers
1161877|NCT02207803|Intervention Studies|intervention studies
1161878|NCT02207803|Latin America|latin america
1161879|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
1161880|NCT02207790|Healthy Volunteers|healthy volunteers
1161881|NCT02207777|Obesity|obesity
1161882|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
1161883|NCT02207777|Type 2 Diabetes|type 2 diabetes
1161884|NCT02207777|Sleeve Gastrectomy (SG)|sleeve gastrectomy (sg)
1161885|NCT02207777|Weight Loss|weight loss
1161886|NCT02207777|Low-Calorie Diet|low-calorie diet
1161887|NCT02207751|Chronic Kidney Disease|chronic kidney disease
1161888|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
1161889|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
1161890|NCT02207751|Catheter Function|catheter function
1161891|NCT02207738|acne|acne
1161892|NCT02207738|acne scar|acne scar
1161893|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
1161894|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
1161895|NCT02207725|Andexanet alpha|andexanet alpha
1161896|NCT02207725|Anticoagulation|anticoagulation
1161897|NCT02207725|Antidote|antidote
1161898|NCT02207725|Apixaban|apixaban
1161899|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
1161901|NCT02207725|Eliquis|eliquis
1161902|NCT02207725|Reversal agent|reversal agent
1161903|NCT02207712|Diabetes|diabetes
1161904|NCT02207712|Macular Oedema|macular oedema
1161905|NCT02207712|Diabetic retinopathy|diabetic retinopathy
1161906|NCT02207712|Noctura|noctura
1161907|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
1161908|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
1161909|NCT02207686|VHL germline mutation|vhl germline mutation
1161910|NCT02207686|VHL somatic mutation|vhl somatic mutation
1161911|NCT02207686|Tumor development|tumor development
1161912|NCT02207673|epilepsy surgery|epilepsy surgery
1161913|NCT02207673|biomarker|biomarker
1161914|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
1161915|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
1161916|NCT02207660|cisplatin|cisplatin
1161917|NCT02207660|Cervical cancer|cervical cancer
1161918|NCT02207660|metastasis|metastasis
1161919|NCT02207660|recurrence|recurrence
1161920|NCT02207634|High cholesterol|high cholesterol
1161921|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
1161922|NCT02207634|Lowering cholesterol|lowering cholesterol
1161923|NCT02207634|Lowering high cholesterol|lowering high cholesterol
1161924|NCT02207634|Hypercholesterolemia|hypercholesterolemia
1161925|NCT02207621|Glaucoma|glaucoma
1161926|NCT02207608|BCG|bcg
1161927|NCT02207608|hyaluronic acid|hyaluronic acid
1161928|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1161929|NCT02207608|non bacterial cystitis|non bacterial cystitis
1161930|NCT02207582|depression; trns|depression; trns
1161931|NCT02207556|AL amyloidosis|al amyloidosis
1161932|NCT02207556|amyloidosis|amyloidosis
1161933|NCT02207556|light chain amyloidosis|light chain amyloidosis
1161934|NCT02207543|Cancer|cancer
1161935|NCT02207543|Palliative care|palliative care
1161936|NCT02207543|home|home
1161937|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
1161938|NCT02207517|convergence insufficiency|convergence insufficiency
1161939|NCT02207517|vision therapy|vision therapy
1161940|NCT02207517|reading|reading
1161941|NCT02207517|attention|attention
1161942|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
1161943|NCT02207491|Glaucoma|glaucoma
1571499|NCT00496444|AZA-CR|aza-cr
1161944|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
1161945|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
1161946|NCT02207478|Peripheral lung lesions|peripheral lung lesions
1161947|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
1161948|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
1161949|NCT02207452|Lung Imaging|lung imaging
1161950|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
1161951|NCT02207426|Healthy volunteers|healthy volunteers
1161952|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
1161954|NCT02207413|Children|children
1161955|NCT02207413|Adults|adults
1161956|NCT02207413|Immunogenicity|immunogenicity
1161957|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1161958|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
1161959|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
1161960|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
1161961|NCT02207309|pazopanib|pazopanib
1161962|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
1161963|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
1161964|NCT02207309|votrient|votrient
1161965|NCT02207270|Coronary artery disease|coronary artery disease
1161966|NCT02207270|Costs|costs
1161967|NCT02207270|Cost minimization|cost minimization
1161968|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
1161969|NCT02207270|Risk score|risk score
1161970|NCT02207270|Same day discharge|same day discharge
1161971|NCT02207257|PER977|per977
1161972|NCT02207257|anticoagulation reversal|anticoagulation reversal
1161973|NCT02207257|pharmacokinetics|pharmacokinetics
1161974|NCT02207257|edoxaban|edoxaban
1161975|NCT02207257|whole blood clotting time|whole blood clotting time
1161976|NCT02207257|D-dimer|d-dimer
1161977|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
1161978|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
1161979|NCT02207257|prothrombin time|prothrombin time
1161980|NCT02207244|Psoriasis|psoriasis
1161981|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
1161982|NCT02207244|Guselkumab|guselkumab
1161983|NCT02207244|Adalimumab|adalimumab
1161984|NCT02207244|CNTO 1959|cnto 1959
1161985|NCT02207244|Monoclonal antibody|monoclonal antibody
1161986|NCT02207231|Psoriasis|psoriasis
1161987|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
1161988|NCT02207231|Guselkumab|guselkumab
1161989|NCT02207231|Adalimumab|adalimumab
1161990|NCT02207231|CNTO 1959|cnto 1959
1161991|NCT02207231|Monoclonal antibody|monoclonal antibody
1161992|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
1161993|NCT02207179|Intraoperative|intraoperative
1161994|NCT02207179|Cancer margin|cancer margin
1161995|NCT02207179|Spectroscopy|spectroscopy
1161996|NCT02207179|Polarization|polarization
1161997|NCT02207166|hypertension|hypertension
1161998|NCT02207166|device|device
1161999|NCT02207166|errors|errors
1162000|NCT02207166|human factor engineering|human factor engineering
1162001|NCT02207166|usability engineering|usability engineering
1162002|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
1162003|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
1162004|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
1162005|NCT02207127|sleep apnea|sleep apnea
1162006|NCT02207114|Sepsis|sepsis
1162007|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
1162008|NCT02207114|Antibiotic use|antibiotic use
1162009|NCT02207114|Intensive Care Unit|intensive care unit
1162010|NCT02207101|Young athletes|young athletes
1162011|NCT02207101|Cardiac endurance|cardiac endurance
1162012|NCT02207101|Herbal|herbal
1162013|NCT02207101|Ejection Fraction|ejection fraction
1162014|NCT02207101|Basic Research|basic research
1162015|NCT02207101|Cardiovascular Injury|cardiovascular injury
1162016|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
1162017|NCT02207088|Hepatitis C|hepatitis c
1162018|NCT02207088|End-stage renal disease|end-stage renal disease
1162019|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
1162020|NCT02207088|Severe Renal Impairment|severe renal impairment
1162021|NCT02207088|renal disease|renal disease
1162022|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
1162023|NCT02207088|Renal impairment|renal impairment
1162024|NCT02207088|dialysis|dialysis
1162025|NCT02207088|Hepatitis C Virus|hepatitis c virus
1162026|NCT02207088|cirrhosis|cirrhosis
1162027|NCT02207075|SPMS|spms
1162028|NCT02207075|Myelin Water Fraction|myelin water fraction
1162029|NCT02207075|activated microglia|activated microglia
1162030|NCT02207036|Tobacco|tobacco
1162031|NCT02207036|cigarettes|cigarettes
1162032|NCT02207036|cessation|cessation
1162033|NCT02207036|intervention|intervention
1162034|NCT02207036|young adults|young adults
1162035|NCT02207036|Internet|internet
1162036|NCT02207036|social media|social media
1162037|NCT02207036|mobile health|mobile health
1162038|NCT02207023|Stroke|stroke
1162039|NCT02207023|Telehealth|telehealth
1162040|NCT02207023|Rehabilitation|rehabilitation
1162041|NCT02207023|Stroke Coach|stroke coach
1162042|NCT02207023|Randomized controlled trial|randomized controlled trial
1162043|NCT02207023|Lifestyle behaviours|lifestyle behaviours
1162044|NCT02207023|Secondary prevention|secondary prevention
1162045|NCT02207023|Chronic disease self-management|chronic disease self-management
1162046|NCT02207010|Glioblastoma|glioblastoma
1162047|NCT02207010|GBM|gbm
1162048|NCT02207010|first recurrence|first recurrence
1162049|NCT02206997|perioperative hypothermia|perioperative hypothermia
1162050|NCT02206997|prewarming|prewarming
1162051|NCT02206997|treatment guideline|treatment guideline
1162052|NCT02206958|Toileting disability|toileting disability
1162053|NCT02206958|Functional urinary incontinence|functional urinary incontinence
1162054|NCT02206958|Urinary incontinence|urinary incontinence
1162055|NCT02206958|Frailty|frailty
1162056|NCT02206958|Physical activity|physical activity
1162057|NCT02206932|Hepatitis C|hepatitis c
1162058|NCT02206932|HIV|hiv
1162059|NCT02206932|Simeprevir|simeprevir
1162060|NCT02206932|Sofosbuvir|sofosbuvir
1162061|NCT02206919|Flow mediated dilation|flow mediated dilation
1162062|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
1162063|NCT02206919|Diabetes|diabetes
1162064|NCT02206919|Endothelial dysfunction|endothelial dysfunction
1162065|NCT02206919|Popliteal artery|popliteal artery
1162066|NCT02206919|Atherosclerosis|atherosclerosis
1162067|NCT02206919|Cardiovascular disease|cardiovascular disease
1162068|NCT02206919|Vascular disease|vascular disease
1162069|NCT02206906|Medication Adherence|medication adherence
1162070|NCT02206906|Incentives|incentives
1162071|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
1162072|NCT02206880|Thoracic Surgery|thoracic surgery
1162073|NCT02206880|Delirium|delirium
1162074|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
1162075|NCT02206880|Intensive Care|intensive care
1162076|NCT02206854|Pharmakokinetic|pharmakokinetic
1162077|NCT02206854|capsules|capsules
1162078|NCT02206854|R-Flurbiprofen|r-flurbiprofen
1162079|NCT02206841|fibrosis|fibrosis
1162080|NCT02206841|markers|markers
1162081|NCT02206828|HERNIA|hernia
1162082|NCT02206828|SYMCHRO|symchro
1162083|NCT02206828|SOFRADIM|sofradim
1162084|NCT02206828|REGISTRY|registry
1162085|NCT02206828|SYMBOTEX|symbotex
1162086|NCT02206802|Alopecia|alopecia
1162087|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
1162088|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
1162089|NCT02206802|Hair Loss|hair loss
1162090|NCT02206802|Minoxidil|minoxidil
1162091|NCT02206802|Hair Thinning|hair thinning
1162092|NCT02206776|OCD|ocd
1162093|NCT02206750|Controlled Human exposure study|controlled human exposure study
1162094|NCT02206750|Air Pollution|air pollution
1162095|NCT02206750|Cardiovascular|cardiovascular
1162096|NCT02206750|Social factors|social factors
1162097|NCT02206750|Cognitive function|cognitive function
1162098|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
1162099|NCT02206698|Intraabdominal Injury|intraabdominal injury
1162100|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
1162101|NCT02206698|Pediatric trauma|pediatric trauma
1162102|NCT02206698|blunt abdominal injury|blunt abdominal injury
1162103|NCT02206698|blunt trauma|blunt trauma
1162104|NCT02206698|clinical prediction model|clinical prediction model
1162105|NCT02206633|dehydration|dehydration
1162106|NCT02206607|Phase 1|phase 1
1162107|NCT02206607|bioavailability|bioavailability
1162108|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
1162109|NCT02206607|PF-04937319|pf-04937319
1162110|NCT02206581|dehydration|dehydration
1162111|NCT02206568|diabetes mellitus|diabetes mellitus
1162112|NCT02206568|phase 1|phase 1
1162113|NCT02206568|insulin lispro|insulin lispro
1162114|NCT02206568|male subjects|male subjects
1162115|NCT02206555|HIV|hiv
1162116|NCT02206555|prevention|prevention
1162117|NCT02206555|prophylaxis|prophylaxis
1162118|NCT02206555|antiretroviral|antiretroviral
1162119|NCT02206555|biomedical|biomedical
1162120|NCT02206555|bio-behavioural|bio-behavioural
1162121|NCT02206555|evaluation|evaluation
1162122|NCT02206555|demonstration study|demonstration study
1162123|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
1162124|NCT02206529|obesity|obesity
1162125|NCT02206529|child|child
1162126|NCT02206529|weight management|weight management
1162127|NCT02206529|behavioral|behavioral
1162128|NCT02206529|social networks|social networks
1162129|NCT02206529|social support|social support
1162130|NCT02206503|LENALIDOMIDE|lenalidomide
1162131|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
1162132|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
1162133|NCT02206503|WITHOUT CRAB|without crab
1162134|NCT02206490|Gulf War Illness|gulf war illness
1162135|NCT02206490|treatment|treatment
1162229|NCT02206048|Proflavine|proflavine
1162136|NCT02206490|dextromethorphan|dextromethorphan
1162137|NCT02206490|naltrexone|naltrexone
1162138|NCT02206477|breast capsular contructure|breast capsular contructure
1162139|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
1162140|NCT02206477|radiotherapy|radiotherapy
1571500|NCT00496444|Ladakamycin|ladakamycin
1162141|NCT02206477|breast reconstruction|breast reconstruction
1162142|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
1162143|NCT02206464|Antibody Response|antibody response
1162144|NCT02206464|Avian Influenza|avian influenza
1162145|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
1162146|NCT02206464|Immunogenicity|immunogenicity
1162147|NCT02206451|Assay|assay
1162148|NCT02206451|Infection|infection
1162149|NCT02206451|Direct Skin Feed|direct skin feed
1162150|NCT02206451|Midgut|midgut
1162151|NCT02206451|Parasite|parasite
1162152|NCT02206438|supraglottic airway devices|supraglottic airway devices
1162153|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
1162154|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
1162155|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
1162156|NCT02206425|multiple myeloma|multiple myeloma
1162157|NCT02206425|Relapsed/refractory|relapsed/refractory
1162158|NCT02206425|Ixazomib|ixazomib
1162159|NCT02206425|Proteasome inhibitor|proteasome inhibitor
1162160|NCT02206425|Oral|oral
1162161|NCT02206412|high mobility group box 1|high mobility group box 1
1162162|NCT02206412|prognostic biomarker|prognostic biomarker
1162163|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
1162164|NCT02206412|patients|patients
1162165|NCT02206373|creatinine|creatinine
1162166|NCT02206373|glomerular filtration rate|glomerular filtration rate
1162167|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
1162168|NCT02206360|Pancreatic Cancer|pancreatic cancer
1162169|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
1162170|NCT02206360|Pancreas Cancer|pancreas cancer
1162171|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1162172|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
1162173|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
1162174|NCT02206360|BRCA 1/2|brca 1/2
1162175|NCT02206360|HNPCC|hnpcc
1162176|NCT02206360|Lynch Syndrome|lynch syndrome
1162177|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
1162178|NCT02206360|FAMMM|fammm
1162179|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
1162180|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
1162181|NCT02206360|MRI|mri
1162182|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
1162183|NCT02206360|EUS|eus
1162184|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
1162185|NCT02206360|Early detection|early detection
1162186|NCT02206360|Screening|screening
1162187|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
1162188|NCT02206308|escalating doses|escalating doses
1162189|NCT02206308|safety|safety
1162190|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
1162191|NCT02206295|selexipag|selexipag
1162192|NCT02206295|ACT-333679|act-333679
1162193|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
1162194|NCT02206243|BPH|bph
1162195|NCT02206230|glioblastoma|glioblastoma
1162196|NCT02206230|radiotherapy|radiotherapy
1162197|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
1162198|NCT02206204|Selexipag|selexipag
1162199|NCT02206204|ACT-333679|act-333679
1162200|NCT02206152|Diabetes|diabetes
1162201|NCT02206152|Hypoglycemia|hypoglycemia
1162202|NCT02206152|Unawareness|unawareness
1162203|NCT02206152|HAAF|haaf
1162204|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
1162205|NCT02206126|Weight loss|weight loss
1162206|NCT02206126|Obesity|obesity
1162207|NCT02206126|Sympathetic activity|sympathetic activity
1162208|NCT02206126|Metabolic profile|metabolic profile
1162209|NCT02206126|Endothelial function|endothelial function
1162210|NCT02206113|Standing workstation|standing workstation
1162211|NCT02206100|PER977|per977
1162212|NCT02206100|enoxaparin|enoxaparin
1162213|NCT02206100|anticoagulation reversal|anticoagulation reversal
1162214|NCT02206100|whole blood clotting time|whole blood clotting time
1162215|NCT02206087|PER977|per977
1162216|NCT02206087|heparin|heparin
1162217|NCT02206087|anticoagulation reversal|anticoagulation reversal
1162218|NCT02206087|whole blood clotting time|whole blood clotting time
1162219|NCT02206048|Cervix Carcinoma|cervix carcinoma
1162220|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
1162221|NCT02206048|AIS|ais
1162222|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1162223|NCT02206048|CIN|cin
1162224|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
1162225|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
1162226|NCT02206048|CKC|ckc
1162227|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
1162228|NCT02206048|HRME|hrme
1162230|NCT02206022|Central Venous Catheter|central venous catheter
1162231|NCT02206022|Remifentanil|remifentanil
1162232|NCT02206022|local anesthesia|local anesthesia
1162233|NCT02206022|pain|pain
1162234|NCT02205996|Type 2 diabetes|type 2 diabetes
1162235|NCT02205996|Hypoglycaemia|hypoglycaemia
1162236|NCT02205996|Platelets|platelets
1162237|NCT02205996|Inflammation|inflammation
1162238|NCT02205983|enrolling|enrolling
1162239|NCT02205983|adult|adult
1162240|NCT02205983|volunteers|volunteers
1162241|NCT02205970|TENS|tens
1162242|NCT02205970|Dysmenorrhea|dysmenorrhea
1162243|NCT02205970|analgesia|analgesia
1162244|NCT02205970|interactive|interactive
1162245|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
1162246|NCT02205944|chronic kidney disease|chronic kidney disease
1162247|NCT02205944|hemodialysis|hemodialysis
1162248|NCT02205944|vascular access|vascular access
1162249|NCT02205944|arteriovenous fistula|arteriovenous fistula
1162250|NCT02205944|forearm exercise|forearm exercise
1162251|NCT02205931|Epilepsy|epilepsy
1162252|NCT02205931|Ketogenic diet|ketogenic diet
1162253|NCT02205931|Antiepileptic drugs|antiepileptic drugs
1162254|NCT02205931|Randomised controlled trial|randomised controlled trial
1162255|NCT02205905|PER977|per977
1162256|NCT02205905|metabolic disposition|metabolic disposition
1162257|NCT02205905|mass balance|mass balance
1162258|NCT02205905|metabolites|metabolites
1162259|NCT02205905|radiolabeled|radiolabeled
1162260|NCT02205892|natural product|natural product
1162261|NCT02205892|clinical trial|clinical trial
1162262|NCT02205879|pregabalin|pregabalin
1162263|NCT02205879|patients|patients
1162264|NCT02205879|treatment|treatment
1162265|NCT02205853|Oncology Service Hospital|oncology service hospital
1162266|NCT02205853|Patient-centred|patient-centred
1162267|NCT02205853|Exercise|exercise
1162268|NCT02205853|Neoplasms|neoplasms
1162269|NCT02205853|Rehabilitation|rehabilitation
1162270|NCT02205853|Qualitative Research|qualitative research
1162271|NCT02205853|Health Plan Implementation|health plan implementation
1162272|NCT02205853|Quality of Health Care|quality of health care
1162273|NCT02205853|Guidelines|guidelines
1162274|NCT02205853|Quality of Life|quality of life
1162275|NCT02205827|whole blood clotting time|whole blood clotting time
1162276|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
1162277|NCT02205814|Arthritis|arthritis
1162279|NCT02205814|Injections, intra-articular|injections, intra-articular
1162280|NCT02205814|Fasitibant|fasitibant
1162281|NCT02205814|MEN 16132|men 16132
1162282|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
1162283|NCT02205749|biobanks|biobanks
1162284|NCT02205749|informed consent|informed consent
1162285|NCT02205749|health literacy|health literacy
1162286|NCT02205736|Breast health education|breast health education
1162287|NCT02205736|Latino women|latino women
1162288|NCT02205736|Group education|group education
1162289|NCT02205736|Breast cancer|breast cancer
1162290|NCT02205723|Asthma|asthma
1162291|NCT02205723|Asthma exacerbations|asthma exacerbations
1162292|NCT02205723|Pediatric|pediatric
1162293|NCT02205697|Fruit|fruit
1162294|NCT02205697|Vegetable|vegetable
1162295|NCT02205684|Physical activity|physical activity
1162296|NCT02205684|Exercise|exercise
1162297|NCT02205684|High intensity training|high intensity training
1162298|NCT02205684|Schizophrenia|schizophrenia
1162299|NCT02205684|Symptoms|symptoms
1162300|NCT02205684|Well-being|well-being
1162301|NCT02205684|Cognition|cognition
1162302|NCT02205684|Hippocampal volume|hippocampal volume
1162303|NCT02205684|Neuroplasticity|neuroplasticity
1162304|NCT02205684|Smoking|smoking
1162305|NCT02205684|Substance use|substance use
1162306|NCT02205684|Metabolic indices|metabolic indices
1162307|NCT02205671|caregiving|caregiving
1162308|NCT02205671|chronic illness|chronic illness
1162309|NCT02205671|patient education|patient education
1162310|NCT02205671|self management|self management
1162311|NCT02205658|Sensory Processing|sensory processing
1162312|NCT02205658|Autism|autism
1162313|NCT02205645|medial|medial
1162314|NCT02205645|meniscus|meniscus
1162315|NCT02205645|scaffold|scaffold
1162316|NCT02205645|repair|repair
1162317|NCT02205645|tear|tear
1162318|NCT02205645|injury|injury
1162319|NCT02205619|Residual cementum|residual cementum
1162320|NCT02205619|root surface instrumentation|root surface instrumentation
1162321|NCT02205619|ultrasonic scaling|ultrasonic scaling
1162322|NCT02205619|air polishing with glycine|air polishing with glycine
1162323|NCT02205593|psoriasis|psoriasis
1162324|NCT02205593|atopic dermatitis|atopic dermatitis
1162325|NCT02205593|eczema|eczema
1162326|NCT02205593|patient education|patient education
1162327|NCT02205593|stress reduction|stress reduction
1162328|NCT02205593|quality of life|quality of life
1162329|NCT02205554|Analgesia|analgesia
1162330|NCT02205554|Pharmacokinetics|pharmacokinetics
1162331|NCT02205554|Treatment|treatment
1162332|NCT02205541|Eculizumab|eculizumab
1162333|NCT02205541|Shiga-toxin|shiga-toxin
1162334|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
1162335|NCT02205541|pediatric|pediatric
1162337|NCT02205476|open-label|open-label
1162338|NCT02205476|safety|safety
1162339|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
1162340|NCT02205463|Esophagus|esophagus
1162341|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
1162342|NCT02205463|Stomach|stomach
1162343|NCT02205463|Gastric|gastric
1162344|NCT02205463|Cancer|cancer
1162345|NCT02205463|HER2|her2
1162346|NCT02205463|Metastatic|metastatic
1162347|NCT02205463|Adenocarcinoma|adenocarcinoma
1162348|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
1162349|NCT02205450|Growth Hormone|growth hormone
1162350|NCT02205450|Children|children
1162351|NCT02205437|Schizophrenia|schizophrenia
1162352|NCT02205437|Psychosis|psychosis
1162353|NCT02205437|Antipsychotics|antipsychotics
1162354|NCT02205437|Treatment response|treatment response
1162355|NCT02205437|Metabolic side effects|metabolic side effects
1162356|NCT02205437|Gene expression|gene expression
1162358|NCT02205437|Genes|genes
1162359|NCT02205424|Ischaemic stroke|ischaemic stroke
1162360|NCT02205424|Alzheimer's disease|alzheimer's disease
1162361|NCT02205424|Brain volume|brain volume
1162362|NCT02205424|Cortical thickness|cortical thickness
1162363|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
1162364|NCT02205411|heart assist device|heart assist device
1162365|NCT02205411|ventricular assist device|ventricular assist device
1162366|NCT02205398|INC280|inc280
1162367|NCT02205398|c-MET inhibitor|c-met inhibitor
1162368|NCT02205398|cetuximab|cetuximab
1162369|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
1162370|NCT02205398|head and neck|head and neck
1162371|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
1162372|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
1162373|NCT02205398|SCCHN,|scchn,
1162374|NCT02205398|cancer|cancer
1162375|NCT02205398|oral and nasal cavity|oral and nasal cavity
1162376|NCT02205398|paranasal sinuses|paranasal sinuses
1162377|NCT02205398|pharynx|pharynx
1162378|NCT02205398|larynx|larynx
1162379|NCT02205398|parotid glands|parotid glands
1162380|NCT02205398|lympth nodes of neck|lympth nodes of neck
1162381|NCT02205398|mucosal lining|mucosal lining
1162382|NCT02205398|epithelium|epithelium
1162383|NCT02205398|colon|colon
1162384|NCT02205398|large intestine|large intestine
1162385|NCT02205398|rectal cancer|rectal cancer
1162386|NCT02205385|Neuroma|neuroma
1162387|NCT02205385|Amputee|amputee
1162388|NCT02205385|Amputation Stump|amputation stump
1162389|NCT02205385|Assessment, Pain|assessment, pain
1162390|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
1162391|NCT02205359|AdaptivCRT|adaptivcrt
1162392|NCT02205359|aCRT|acrt
1162393|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
1162394|NCT02205333|Advanced Solid tumors|advanced solid tumors
1162395|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1162396|NCT02205333|programmed death 1|programmed death 1
1162397|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
1162398|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
1162399|NCT02205333|OX40 ligand|ox40 ligand
1162400|NCT02205320|Pegfilgrastim|pegfilgrastim
1162401|NCT02205320|Pharmacokinetics|pharmacokinetics
1162402|NCT02205320|Pharmacodynamics|pharmacodynamics
1162403|NCT02205320|Healthy volunteers|healthy volunteers
1162404|NCT02205307|Rectal cancer|rectal cancer
1162405|NCT02205307|Rectal neoplasm|rectal neoplasm
1162406|NCT02205307|Colorectal surgery|colorectal surgery
1162407|NCT02205307|Anastomosis|anastomosis
1162408|NCT02205294|Osteopathic treatment|osteopathic treatment
1162409|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
1162410|NCT02205294|Proximal Leg DVT|proximal leg dvt
1162411|NCT02205281|Overweight|overweight
1162412|NCT02205281|Obese|obese
1162413|NCT02205281|Pregnancy|pregnancy
1162414|NCT02205281|Weight Gain|weight gain
1162415|NCT02205281|Weight Loss|weight loss
1162416|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1162417|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1162418|NCT02205268|Biofeedback|biofeedback
1162419|NCT02205268|Neurofeedback Training|neurofeedback training
1162420|NCT02205268|Prefrontal Cortex|prefrontal cortex
1162421|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
1162422|NCT02205255|AECOPD|aecopd
1162423|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1162424|NCT02205255|Acute exacerbation|acute exacerbation
1162425|NCT02205255|Hospitalization|hospitalization
1162426|NCT02205255|Azithromycin|azithromycin
1162427|NCT02205255|Macrolides|macrolides
1162428|NCT02205255|Randomized Controlled Trial|randomized controlled trial
1162429|NCT02205255|Placebo|placebo
1162430|NCT02205255|Economic Impact|economic impact
1162431|NCT02205255|Cost-effectiveness|cost-effectiveness
1162432|NCT02205255|EQ5D|eq5d
1162433|NCT02205242|AECOPD|aecopd
1162434|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1162435|NCT02205242|Acute exacerbation|acute exacerbation
1162436|NCT02205242|Hospitalization|hospitalization
1162437|NCT02205242|Azithromycin|azithromycin
1162438|NCT02205242|Macrolides|macrolides
1571501|NCT00496444|NSC-102816|nsc-102816
1162439|NCT02205242|Randomized Controlled Trial|randomized controlled trial
1162440|NCT02205242|Placebo|placebo
1162441|NCT02205242|Physical Activity|physical activity
1162442|NCT02205242|PRO-Active|pro-active
1162443|NCT02205242|Activity Monitor|activity monitor
1162444|NCT02205216|tDCS|tdcs
1162446|NCT02205216|Freezing of Gait|freezing of gait
1162447|NCT02205216|Parkinson|parkinson
1162448|NCT02205216|Rehabilitation|rehabilitation
1162449|NCT02205203|Anxiety|anxiety
1162450|NCT02205203|Social Anxiety|social anxiety
1162451|NCT02205203|Social Phobia|social phobia
1162452|NCT02205203|Separation Anxiety|separation anxiety
1162453|NCT02205203|Generalized Anxiety|generalized anxiety
1162454|NCT02205203|GAD|gad
1162455|NCT02205203|Phobia|phobia
1162456|NCT02205203|Panic|panic
1162457|NCT02205203|Agoraphobia|agoraphobia
1162458|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
1162459|NCT02205203|OCD|ocd
1162460|NCT02205203|Child|child
1162461|NCT02205203|Adolescent|adolescent
1162462|NCT02205203|Smartphone|smartphone
1162463|NCT02205203|Teen|teen
1162464|NCT02205203|Youth|youth
1162465|NCT02205190|Fimasartan|fimasartan
1162466|NCT02205177|Anxiety|anxiety
1162467|NCT02205177|Social Anxiety|social anxiety
1162468|NCT02205177|Social Phobia|social phobia
1162469|NCT02205177|Separation Anxiety|separation anxiety
1162470|NCT02205177|Generalized Anxiety|generalized anxiety
1162471|NCT02205177|GAD|gad
1162472|NCT02205177|Phobia|phobia
1162473|NCT02205177|Panic|panic
1162474|NCT02205177|Agoraphobia|agoraphobia
1162475|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
1162476|NCT02205177|OCD|ocd
1162477|NCT02205177|Child|child
1162478|NCT02205177|Adolescent|adolescent
1162479|NCT02205177|Smartphone|smartphone
1162481|NCT02205177|Youth|youth
1162482|NCT02205164|palonosetron|palonosetron
1162483|NCT02205164|aprepitant|aprepitant
1162484|NCT02205164|CINV|cinv
1162485|NCT02205164|AML|aml
1162486|NCT02205164|multiple-days|multiple-days
1162487|NCT02205151|Fimasartan|fimasartan
1162488|NCT02205138|Spinal Fusion|spinal fusion
1162489|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
1162490|NCT02205138|Degenerative Disc Disease|degenerative disc disease
1162491|NCT02205138|Cell Therapy|cell therapy
1162492|NCT02205138|Bone Graft|bone graft
1162493|NCT02205125|polyp|polyp
1162494|NCT02205125|colon|colon
1162495|NCT02205125|polypectomy|polypectomy
1162496|NCT02205125|snare|snare
1162497|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
1162498|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
1162499|NCT02205099|Schizophrenia|schizophrenia
1162500|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1162501|NCT02205034|Prader Willi|prader willi
1162502|NCT02205008|advanced gastric cancer|advanced gastric cancer
1162503|NCT02205008|serosal invasion|serosal invasion
1162504|NCT02205008|peritoneal recurrence|peritoneal recurrence
1162505|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1162506|NCT02204995|Osteoarthritis|osteoarthritis
1162507|NCT02204995|Thumb|thumb
1162508|NCT02204995|LRTI|lrti
1162509|NCT02204995|Trapeziectomy|trapeziectomy
1162510|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
1162511|NCT02204956|Smoking cessation|smoking cessation
1162512|NCT02204956|Tobacco use cessation|tobacco use cessation
1162513|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
1162514|NCT02204930|Haemostat|haemostat
1162515|NCT02204930|Liver surgery|liver surgery
1162516|NCT02204930|Primary liver cancer|primary liver cancer
1162517|NCT02204930|Metastatic liver cancer|metastatic liver cancer
1162518|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
1162519|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
1162520|NCT02204930|Living donation for liver transplant|living donation for liver transplant
1162521|NCT02204917|Ultrasound|ultrasound
1162522|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
1162523|NCT02204917|Optison|optison
1162524|NCT02204917|contrast enhanced Voiding Urosonography|contrast enhanced voiding urosonography
1162525|NCT02204917|ceVUS|cevus
1162526|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
1162527|NCT02204917|Children|children
1162528|NCT02204917|Kidney|kidney
1162529|NCT02204917|Bladder|bladder
1162530|NCT02204917|Urethra|urethra
1162531|NCT02204917|Voiding Cystourethrography|voiding cystourethrography
1162532|NCT02204917|VCUG|vcug
1162533|NCT02204917|Safety|safety
1162534|NCT02204917|Urinary tract|urinary tract
1162535|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
1162536|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
1162537|NCT02204891|Abdominal pain|abdominal pain
1162538|NCT02204891|Abdominal discomfort|abdominal discomfort
1162539|NCT02204891|Flatulence|flatulence
1162540|NCT02204891|Diarrhea|diarrhea
1162541|NCT02204891|Bacterial overgrowth|bacterial overgrowth
1162542|NCT02204891|Cytokines|cytokines
1162543|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
1162544|NCT02204865|Sleep Apnoea|sleep apnoea
1162545|NCT02204865|Heart failure|heart failure
1162546|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
1162547|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
1162548|NCT02204813|Gastric Bypass|gastric bypass
1162549|NCT02204813|RYGB|rygb
1162550|NCT02204813|GLP-1|glp-1
1162551|NCT02204813|Xenin|xenin
1162552|NCT02204813|Insulin Secretion|insulin secretion
1162553|NCT02204813|Glucose Homeostasis|glucose homeostasis
1162554|NCT02204813|Vertical Sleeve|vertical sleeve
1162555|NCT02204813|Lap Band|lap band
1162556|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
1162557|NCT02204774|aortic aneurysm|aortic aneurysm
1162558|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
1162559|NCT02204735|Meal Time|meal time
1162560|NCT02204735|Weight Loss|weight loss
1162561|NCT02204735|Circadian Rhythm|circadian rhythm
1162562|NCT02204709|obese|obese
1162563|NCT02204709|obesity|obesity
1162564|NCT02204709|metabolic syndrome|metabolic syndrome
1162565|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
1162566|NCT02204709|fish|fish
1162567|NCT02204696|sleep apnea|sleep apnea
1162568|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
1162569|NCT02204696|sleepiness|sleepiness
1162570|NCT02204696|quality of life|quality of life
1162572|NCT02204683|Neovascularization|neovascularization
1162573|NCT02204683|macular degeneration|macular degeneration
1162574|NCT02204683|wet macular degeneration|wet macular degeneration
1162575|NCT02204683|vitrectomy|vitrectomy
1162576|NCT02204670|Irisin|irisin
1162577|NCT02204670|Obesity|obesity
1162578|NCT02204670|Exercise|exercise
1162579|NCT02204670|Myokine|myokine
1162580|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
1162581|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
1162582|NCT02204631|Head and Neck Cancer|head and neck cancer
1162583|NCT02204618|single sided deafness|single sided deafness
1162584|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
1162585|NCT02204618|Cost-utility|cost-utility
1162586|NCT02204618|Tinnitus|tinnitus
1162587|NCT02204618|Cochlear implants|cochlear implants
1162588|NCT02204618|Bone conduction device|bone conduction device
1162589|NCT02204618|Dichotic hearing|dichotic hearing
1162590|NCT02204618|Squelch effect.|squelch effect.
1162591|NCT02204605|patients|patients
1162592|NCT02204605|puzzling|puzzling
1162593|NCT02204605|conditions|conditions
1162594|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
1162595|NCT02204579|Hypocalcemia|hypocalcemia
1162596|NCT02204579|ADH|adh
1162597|NCT02204579|Hypoparathyroidism|hypoparathyroidism
1162598|NCT02204566|OFDI|ofdi
1162599|NCT02204566|RF Ablation|rf ablation
1162600|NCT02204566|Atrial Fibrillation|atrial fibrillation
1162601|NCT02204566|Imaging|imaging
1162602|NCT02204566|Esophagus|esophagus
1162603|NCT02204553|Multiple Myeloma|multiple myeloma
1162604|NCT02204553|Panobinostat|panobinostat
1162605|NCT02204553|LBH589|lbh589
1162606|NCT02204553|Expanded Access|expanded access
1162607|NCT02204553|EAP, ETP|eap, etp
1162608|NCT02204553|Expanded Treatment|expanded treatment
1162609|NCT02204553|Bortezomib|bortezomib
1162610|NCT02204553|HDAC|hdac
1162611|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
1162612|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
1162613|NCT02204527|hypertension|hypertension
1162614|NCT02204527|diabetes mellitus|diabetes mellitus
1162615|NCT02204527|vitamin D|vitamin d
1162616|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1162617|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
1162618|NCT02204501|Aviragen|aviragen
1162619|NCT02204488|Osteoarthritis|osteoarthritis
1162620|NCT02204488|Thumb|thumb
1162621|NCT02204488|Total joint arthroplasty|total joint arthroplasty
1162622|NCT02204488|Trapeziectomy|trapeziectomy
1162623|NCT02204462|PET|pet
1162624|NCT02204462|Positron Emission Tomography|positron emission tomography
1162625|NCT02204462|Breast Cancer|breast cancer
1162626|NCT02204462|Imaging|imaging
1162627|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
1162628|NCT02204449|peer mentorship|peer mentorship
1162629|NCT02204449|healthcare utilization|healthcare utilization
1162630|NCT02204449|continuity of cardiac care|continuity of cardiac care
1162631|NCT02204436|hyperpigmentation|hyperpigmentation
1162632|NCT02204436|depigmenting treatment|depigmenting treatment
1162633|NCT02204436|hand|hand
1162634|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
1162635|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
1162636|NCT02204410|ADHD|adhd
1162637|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1162638|NCT02204410|DESR|desr
1162639|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
1162640|NCT02204410|Emotional Dysregulation|emotional dysregulation
1162641|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
1162642|NCT02204410|Fish Oil|fish oil
1162643|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
1162644|NCT02204397|INGAP|ingap
1162645|NCT02204397|Ustekinumab|ustekinumab
1162646|NCT02204384|Dietary fiber|dietary fiber
1162647|NCT02204384|Dietary Supplements|dietary supplements
1162648|NCT02204384|Type 2 diabetes|type 2 diabetes
1162649|NCT02204384|Postprandial Period|postprandial period
1162650|NCT02204384|Plasma insulin|plasma insulin
1162651|NCT02204384|Plasma glucose|plasma glucose
1162652|NCT02204384|Area Under Curve|area under curve
1162653|NCT02204384|Soluble fiber|soluble fiber
1162654|NCT02204371|Pazopanib|pazopanib
1162655|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
1162656|NCT02204371|bleeding|bleeding
1162657|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
1162658|NCT02204319|low level laser light device|low level laser light device
1162659|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
1162660|NCT02204293|Canakinumab|canakinumab
1162661|NCT02204293|Joint involvement|joint involvement
1162662|NCT02204293|AOSD|aosd
1162663|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
1162664|NCT02204267|Stroke|stroke
1162665|NCT02204267|atrial fibrillation|atrial fibrillation
1162666|NCT02204267|ECG|ecg
1162667|NCT02204241|Multiple myeloma|multiple myeloma
1162668|NCT02204241|Diagnosis|diagnosis
1162669|NCT02204241|CCyd|ccyd
1162670|NCT02204228|osteoarthritis|osteoarthritis
1162671|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
1162672|NCT02204228|post traumatic arthritis|post traumatic arthritis
1162673|NCT02204228|avascular necrosis|avascular necrosis
1162674|NCT02204228|severe fractures|severe fractures
1162675|NCT02204215|Weakness|weakness
1162676|NCT02204215|Mechanical Ventilation|mechanical ventilation
1162677|NCT02204215|Acupuncture Therapy|acupuncture therapy
1162678|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
1162679|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
1162680|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
1162681|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
1162682|NCT02204202|[18F] ISO-1|[18f] iso-1
1162683|NCT02204189|acute pancreatitis|acute pancreatitis
1162684|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
1162685|NCT02204189|TongFuSan|tongfusan
1162686|NCT02204189|ShenQue acupoint|shenque acupoint
1162687|NCT02204150|Optical Coherence Tomography|optical coherence tomography
1162688|NCT02204150|Barrett's Esophagus|barrett's esophagus
1162689|NCT02204150|Esophagus|esophagus
1162690|NCT02204150|Imaging|imaging
1162691|NCT02204124|Whipple procedure|whipple procedure
1162692|NCT02204111|Palliative Treatment|palliative treatment
1162693|NCT02204111|Trabectedin|trabectedin
1162694|NCT02204111|Patient Reported Outcome|patient reported outcome
1162695|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
1162696|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
1162697|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1162698|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1162699|NCT02204020|allogeneic|allogeneic
1162700|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
1162701|NCT02204020|hematopoietic|hematopoietic
1162702|NCT02204020|transplantation|transplantation
1162703|NCT02204020|transplant|transplant
1162704|NCT02204020|graft-versus-tumor|graft-versus-tumor
1162705|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
1162706|NCT02204020|epigenetic|epigenetic
1162707|NCT02204020|maintenance|maintenance
1162708|NCT02204020|hypomethylation|hypomethylation
1162709|NCT02204020|relapse|relapse
1162710|NCT02204007|Acetabular Shell|acetabular shell
1162711|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
1162712|NCT02204007|3D imaging|3d imaging
1162713|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
1162714|NCT02203994|spasticity|spasticity
1162715|NCT02203994|spinal cord injury|spinal cord injury
1162716|NCT02203981|normal Eyes|normal eyes
1162717|NCT02203968|Fibrinogen replacement|fibrinogen replacement
1162718|NCT02203968|Trauma coagulopathy|trauma coagulopathy
1162719|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
1162720|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
1162721|NCT02203968|Haemorrhage|haemorrhage
1162722|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
1162723|NCT02203968|Feasibility trial|feasibility trial
1162724|NCT02203968|Clinical trials|clinical trials
1162725|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
1162726|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
1162727|NCT02203942|Trichomoniasis|trichomoniasis
1162728|NCT02203929|Macular Holes|macular holes
1162729|NCT02203929|Progression|progression
1162730|NCT02203916|Drug therapy|drug therapy
1162731|NCT02203890|Growth|growth
1162732|NCT02203890|Hematology|hematology
1162733|NCT02203890|Hydration|hydration
1162734|NCT02203890|Oxidation|oxidation
1162735|NCT02203890|Infection|infection
1162736|NCT02203890|Inflammation|inflammation
1162737|NCT02203890|Guatemalan children|guatemalan children
1162738|NCT02203851|BI 655066|bi 655066
1162739|NCT02203851|risankizumab|risankizumab
1162936|NCT02203019|Propofol|propofol
1162740|NCT02203838|Schizophrenia|schizophrenia
1162741|NCT02203838|Schizophrenic|schizophrenic
1162742|NCT02203838|Schizophrenias|schizophrenias
1162743|NCT02203838|Risperidone|risperidone
1162744|NCT02203838|Long-acting Risperidone|long-acting risperidone
1162745|NCT02203838|Atrigel|atrigel
1162746|NCT02203838|Subcutaneous|subcutaneous
1162747|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
1162748|NCT02203825|NKG2D|nkg2d
1162749|NCT02203825|Multiple Myeloma|multiple myeloma
1162750|NCT02203825|Cell Therapy|cell therapy
1162751|NCT02203799|Peanut Allergy|peanut allergy
1162752|NCT02203799|Anaphylaxis|anaphylaxis
1162753|NCT02203799|Desensitization|desensitization
1162754|NCT02203799|Food Allergy|food allergy
1162755|NCT02203799|Oral Immunotherapy|oral immunotherapy
1162756|NCT02203786|amphetamine|amphetamine
1162757|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
1162758|NCT02203786|dopamine antagonists|dopamine antagonists
1162759|NCT02203786|pathological gambling|pathological gambling
1162760|NCT02203786|priming|priming
1162761|NCT02203786|reinforcement|reinforcement
1162762|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
1162764|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
1162765|NCT02203773|ABT-199|abt-199
1162766|NCT02203773|GDC-0199|gdc-0199
1162767|NCT02203773|Treatment Naive AML|treatment naive aml
1162768|NCT02203773|Untreated AML|untreated aml
1162769|NCT02203760|Relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas|relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas
1162770|NCT02203734|Pregnancy|pregnancy
1162771|NCT02203734|Depression|depression
1162772|NCT02203734|Massage|massage
1162773|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
1162774|NCT02203708|Mother/child|mother/child
1162775|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
1162776|NCT02203695|Enzalutamide|enzalutamide
1162777|NCT02203682|Graves' orbitopathy|graves' orbitopathy
1162778|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
1162779|NCT02203682|Thyroid eye disease|thyroid eye disease
1162780|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1162781|NCT02203682|Doxycycline|doxycycline
1162782|NCT02203682|EUGOGO|eugogo
1162783|NCT02203682|CAS|cas
1162784|NCT02203669|breast reconstruction|breast reconstruction
1162785|NCT02203669|occupational therapy|occupational therapy
1162786|NCT02203669|physical therapy|physical therapy
1162787|NCT02203669|upper extremity morbidity|upper extremity morbidity
1162788|NCT02203656|intervention studies|intervention studies
1162789|NCT02203656|nutrition|nutrition
1162790|NCT02203656|exercise|exercise
1162791|NCT02203656|testosterone|testosterone
1162792|NCT02203656|patient readmission|patient readmission
1162793|NCT02203630|Septic shock|septic shock
1162794|NCT02203630|Vasopressor Agents|vasopressor agents
1162795|NCT02203630|Phenylephrine|phenylephrine
1162796|NCT02203630|Norepinephrine|norepinephrine
1162797|NCT02203630|Tachycardia|tachycardia
1162798|NCT02203630|Heart Rate|heart rate
1162799|NCT02203630|Arrhythmia|arrhythmia
1162800|NCT02203630|Catecholamine|catecholamine
1162801|NCT02203617|anticipatory guidance|anticipatory guidance
1162802|NCT02203617|baby books|baby books
1162803|NCT02203617|safety|safety
1162804|NCT02203591|surgical skin prep|surgical skin prep
1162805|NCT02203591|CHG|chg
1162806|NCT02203591|IPA|ipa
1162807|NCT02203552|Breast Cancer|breast cancer
1162808|NCT02203539|circadian rhythm|circadian rhythm
1162809|NCT02203539|light exposure|light exposure
1162810|NCT02203539|exercise capacity|exercise capacity
1162811|NCT02203539|endurance|endurance
1162812|NCT02203539|strength|strength
1162813|NCT02203539|reaction|reaction
1162814|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1162815|NCT02203526|ABC DLBCL|abc dlbcl
1162816|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
1162817|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
1162818|NCT02203513|p53 Dysfunction|p53 dysfunction
1162819|NCT02203513|Cell Cycle Arrest|cell cycle arrest
1162820|NCT02203513|Checkpoint Kinases|checkpoint kinases
1162821|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
1162822|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
1162823|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
1162824|NCT02203435|code blue|code blue
1162825|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1162826|NCT02203435|APACHE|apache
1162827|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
1162828|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
1162829|NCT02203422|Cyclosporin A|cyclosporin a
1162830|NCT02203409|liver tumor|liver tumor
1162831|NCT02203409|Two stage hepatectomy|two stage hepatectomy
1162832|NCT02203409|Hypertrophy|hypertrophy
1162833|NCT02203409|laparoscopy|laparoscopy
1162834|NCT02203409|ALPPS|alpps
1162835|NCT02203396|SAA|saa
1162836|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
1162837|NCT02203396|ATG|atg
1162838|NCT02203396|Cyclosporine|cyclosporine
1162839|NCT02203396|Levamisole|levamisole
1162840|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1162937|NCT02203019|Sepsis|sepsis
1162841|NCT02203383|Central Sleep Apnoea|central sleep apnoea
1162842|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
1162843|NCT02203383|Heart Failure|heart failure
1162844|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
1162845|NCT02203357|hepatitis B|hepatitis b
1162846|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
1162847|NCT02203357|immunogenicity|immunogenicity
1162848|NCT02203357|adults|adults
1162849|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
1162850|NCT02203305|Unilateral hearing loss|unilateral hearing loss
1162851|NCT02203305|Single Sided Deafness|single sided deafness
1162852|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
1162853|NCT02203292|Traumatic Brain Injury|traumatic brain injury
1162854|NCT02203292|Blood Transfusion|blood transfusion
1162855|NCT02203279|Chair-side hard relining|chair-side hard relining
1162856|NCT02203279|complete denture|complete denture
1162857|NCT02203279|patients' satisfaction|patients' satisfaction
1162858|NCT02203279|supporting tissues|supporting tissues
1162859|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
1162860|NCT02203279|heat cured relining material|heat cured relining material
1162861|NCT02203266|Medication Adherence|medication adherence
1162862|NCT02203266|Patient Compliance|patient compliance
1162863|NCT02203253|solid tumor|solid tumor
1162864|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
1162865|NCT02203253|thalidomide|thalidomide
1162866|NCT02203253|prevention|prevention
1162867|NCT02203240|Cacao|cacao
1162868|NCT02203240|Polyphenols|polyphenols
1163275|NCT02201511|food effect|food effect
1162869|NCT02203240|Prediabetic State|prediabetic state
1162870|NCT02203240|Blood Glucose|blood glucose
1162871|NCT02203240|Glucose Intolerance|glucose intolerance
1162872|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1162873|NCT02203240|Obesity|obesity
1162874|NCT02203240|Muscle, Skeletal|muscle, skeletal
1162875|NCT02203240|Endotoxins|endotoxins
1162876|NCT02203240|Gut Permeability|gut permeability
1162877|NCT02203240|Incretins|incretins
1162878|NCT02203240|Metabolic Flexibility|metabolic flexibility
1162879|NCT02203227|Dietary supplements|dietary supplements
1162880|NCT02203227|Cotinine level|cotinine level
1162881|NCT02203227|Malondialdehyde|malondialdehyde
1162882|NCT02203227|Chronic smokers|chronic smokers
1162883|NCT02203227|Hyperlipidemia|hyperlipidemia
1162884|NCT02203214|Ligamys|ligamys
1162885|NCT02203214|ACL|acl
1162886|NCT02203214|healing|healing
1162887|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
1162888|NCT02203201|Celiac Disease|celiac disease
1162889|NCT02203201|Gluten-free diet|gluten-free diet
1162890|NCT02203201|EMA assay|ema assay
1162891|NCT02203201|Duodenal culture medium|duodenal culture medium
1162892|NCT02203175|propofol|propofol
1162893|NCT02203175|pretreatment|pretreatment
1162894|NCT02203175|mixture|mixture
1162895|NCT02203162|cough|cough
1162896|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
1162897|NCT02203162|electronic cigarette|electronic cigarette
1162898|NCT02203162|capsaicin|capsaicin
1162899|NCT02203136|Bladder cancer|bladder cancer
1162900|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
1162901|NCT02203136|MIBC|mibc
1162902|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
1162903|NCT02203136|Bladder surgery|bladder surgery
1162904|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
1162905|NCT02203136|MRI|mri
1162906|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
1162907|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
1162908|NCT02203097|Target controlled infusion|target controlled infusion
1162909|NCT02203097|propofol|propofol
1162910|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
1162911|NCT02203097|arterial stiffness|arterial stiffness
1162912|NCT02203097|Transcranial Doppler|transcranial doppler
1162913|NCT02203097|SphygmoCor|sphygmocor
1162914|NCT02203084|Cystic Fibrosis|cystic fibrosis
1162915|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
1162916|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
1162917|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
1162918|NCT02203071|sports|sports
1162919|NCT02203071|injury|injury
1162920|NCT02203071|knee|knee
1162921|NCT02203071|pain|pain
1162922|NCT02203071|cartilage|cartilage
1162923|NCT02203058|Inspiratory capacity|inspiratory capacity
1162924|NCT02203058|Positive-pressure respiration|positive-pressure respiration
1162925|NCT02203058|Exercise|exercise
1162926|NCT02203058|Activities of daily living|activities of daily living
1162927|NCT02203058|COPD.|copd.
1162928|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
1162929|NCT02203032|Psoriasis|psoriasis
1162930|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
1162931|NCT02203032|Guselkumab|guselkumab
1162932|NCT02203032|Ustekinumab|ustekinumab
1162933|NCT02203032|CNTO 1959|cnto 1959
1162934|NCT02203032|Monoclonal antibody|monoclonal antibody
1162935|NCT02203019|Dexmedetomidine|dexmedetomidine
1162938|NCT02203019|Mechanical Ventilation|mechanical ventilation
1162939|NCT02203019|Respiratory Failure|respiratory failure
1162940|NCT02203006|HIV,|hiv,
1162941|NCT02203006|infection,|infection,
1162942|NCT02203006|cohort|cohort
1162943|NCT02202967|Aspirin|aspirin
1162944|NCT02202967|Intestinal bleeding|intestinal bleeding
1162945|NCT02202967|Misoprostol|misoprostol
1162946|NCT02202967|NSAIDs|nsaids
1162947|NCT02202967|Small intestine|small intestine
1162948|NCT02202967|Video capsule endoscopy|video capsule endoscopy
1162949|NCT02202954|Stroke|stroke
1162950|NCT02202954|Muscle Spasticity|muscle spasticity
1162951|NCT02202954|Rehabilitation|rehabilitation
1162952|NCT02202928|Colorectal cancer|colorectal cancer
1162953|NCT02202928|DC-CIK|dc-cik
1162954|NCT02202928|Autologous tumor lysate|autologous tumor lysate
1162955|NCT02202902|Cushing's syndrome|cushing's syndrome
1162956|NCT02202902|cardiac steatosis|cardiac steatosis
1162957|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
1162958|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
1162959|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
1162960|NCT02202889|Adolescents|adolescents
1162961|NCT02202889|Bone mass|bone mass
1162962|NCT02202889|Calcium|calcium
1162963|NCT02202889|Perceived milk intolerance|perceived milk intolerance
1162964|NCT02202889|lactose maldigestion|lactose maldigestion
1162965|NCT02202863|Dietary intervention|dietary intervention
1162966|NCT02202863|Wine grape pomace flour|wine grape pomace flour
1163774|NCT02199184|Neulasta|neulasta
1162967|NCT02202863|Metabolic Syndrome|metabolic syndrome
1162968|NCT02202863|Oxidative stress|oxidative stress
1162969|NCT02202863|Antioxidants|antioxidants
1162970|NCT02202863|Fiber|fiber
1162971|NCT02202785|Drug therapy|drug therapy
1162972|NCT02202772|Urothelial|urothelial
1162973|NCT02202772|Cisplatin|cisplatin
1162974|NCT02202772|Gemcitabine|gemcitabine
1162975|NCT02202772|Cabazitaxel|cabazitaxel
1162976|NCT02202772|Bladder|bladder
1162977|NCT02202772|Carcinoma|carcinoma
1162978|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
1162979|NCT02202772|Intravesical|intravesical
1162980|NCT02202772|Recurrent|recurrent
1162981|NCT02202772|Non-muscle|non-muscle
1162982|NCT02202772|Invasive|invasive
1162983|NCT02202772|Cancer|cancer
1162984|NCT02202759|Drug therapy|drug therapy
1162985|NCT02202746|Breast cancer|breast cancer
1162986|NCT02202746|Metastatic breast cancer|metastatic breast cancer
1162987|NCT02202746|MBC|mbc
1162988|NCT02202746|HER2 positive|her2 positive
1162989|NCT02202746|HER2+|her2+
1162990|NCT02202746|Estrogen receptor positive|estrogen receptor positive
1162991|NCT02202746|ER+|er+
1162992|NCT02202746|Triple negative|triple negative
1162993|NCT02202746|FGFR1|fgfr1
1162994|NCT02202746|11q|11q
1162995|NCT02202746|FGF aberrant|fgf aberrant
1162996|NCT02202746|Biomarker negative|biomarker negative
1162997|NCT02202746|FGF non-aberrant|fgf non-aberrant
1162998|NCT02202733|cooking skills|cooking skills
1162999|NCT02202733|eating out|eating out
1163000|NCT02202733|foods prepared away from home|foods prepared away from home
1163001|NCT02202720|Sevoflurane|sevoflurane
1163002|NCT02202720|RASS score|rass score
1163003|NCT02202720|Sedation|sedation
1163004|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
1163005|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
1163006|NCT02202681|Duodenum|duodenum
1163007|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
1163008|NCT02202681|Optical Coherence Tomography|optical coherence tomography
1163009|NCT02202681|Imaging|imaging
1163010|NCT02202681|Celiac Disease|celiac disease
1163011|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
1163012|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
1163013|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
1163014|NCT02202655|lymphocyte subsets|lymphocyte subsets
1163015|NCT02202616|COPD,|copd,
1163016|NCT02202616|QVA149,|qva149,
1163017|NCT02202616|Tiotropium,|tiotropium,
1163018|NCT02202616|FDC,|fdc,
1163019|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
1163020|NCT02202616|POWER|power
1163021|NCT02202590|SECM|secm
1163022|NCT02202590|Esophagus|esophagus
1163023|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
1163024|NCT02202590|Allergy|allergy
1163025|NCT02202577|Surgical site infection|surgical site infection
1163026|NCT02202577|Surgical site antisepsis|surgical site antisepsis
1163027|NCT02202577|Cesarean Delivery|cesarean delivery
1163028|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
1163029|NCT02202564|liver transplantation|liver transplantation
1163030|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
1163031|NCT02202564|gene therapy|gene therapy
1163032|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
1163033|NCT02202551|LID|lid
1163034|NCT02202551|Parkinsonism|parkinsonism
1163035|NCT02202551|Parkinson's Disease|parkinson's disease
1163036|NCT02202538|SCI|sci
1163037|NCT02202538|Indego|indego
1163038|NCT02202538|Walking|walking
1163039|NCT02202499|pharmacotherapy|pharmacotherapy
1163040|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
1163041|NCT02202447|EC1169|ec1169
1163042|NCT02202447|prostate cancer|prostate cancer
1163043|NCT02202447|EC0652|ec0652
1163044|NCT02202421|Autism|autism
1163045|NCT02202421|Applied Behavior Analysis|applied behavior analysis
1163046|NCT02202395|Hydroxytriptolide|hydroxytriptolide
1163047|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
1163048|NCT02202395|Methotrexate|methotrexate
1163049|NCT02202395|T8|t8
1163050|NCT02202395|LTS|lts
1163051|NCT02202369|Multimodal Analgesia|multimodal analgesia
1163052|NCT02202369|Pain Management|pain management
1163053|NCT02202356|RSV|rsv
1163054|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
1163055|NCT02202343|Nutrition|nutrition
1163056|NCT02202343|Food|food
1163057|NCT02202343|Security|security
1163058|NCT02202343|School|school
1163059|NCT02202343|Health|health
1163060|NCT02202317|Liver Cancer|liver cancer
1163061|NCT02202317|Hepatic Tumors|hepatic tumors
1163062|NCT02202317|Primary Liver Tumors|primary liver tumors
1163063|NCT02202317|Metastatic Liver Tumors|metastatic liver tumors
1163064|NCT02202317|Yttrium-90|yttrium-90
1163065|NCT02202317|Y-90|y-90
1163066|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
1163067|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
1163068|NCT02202278|Oxidative Stress|oxidative stress
1163069|NCT02202278|IMA|ima
1163070|NCT02202278|OHSS|ohss
1163071|NCT02202278|ICSI|icsi
1163072|NCT02202278|long agonist protocol|long agonist protocol
1163073|NCT02202278|TAC|tac
1163074|NCT02202278|TOS|tos
1163075|NCT02202278|OSI|osi
1163076|NCT02202278|MDA|mda
1163077|NCT02202265|Heart Diseases|heart diseases
1163078|NCT02202252|Patient comfort|patient comfort
1163079|NCT02202252|Drains|drains
1163080|NCT02202252|Breast cancer|breast cancer
1163081|NCT02202252|Modified radical mastectomy|modified radical mastectomy
1163082|NCT02202252|Seroma|seroma
1163083|NCT02202200|Melanoma|melanoma
1163084|NCT02202200|BRAF mutated|braf mutated
1163085|NCT02202174|supraglottic airway|supraglottic airway
1163086|NCT02202174|children|children
1163087|NCT02202174|safety|safety
1163088|NCT02202174|efficacy|efficacy
1163089|NCT02202161|pharmacokinetic|pharmacokinetic
1163090|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
1163091|NCT02202161|metformin|metformin
1163092|NCT02202161|sitagliptin|sitagliptin
1163093|NCT02202161|GSK2330672|gsk2330672
1163094|NCT02202161|pharmacodynamic|pharmacodynamic
1163095|NCT02202148|Fibroscan|fibroscan
1163096|NCT02202148|alcohol dependence|alcohol dependence
1163097|NCT02202148|alcohol withdrawal|alcohol withdrawal
1163098|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
1163099|NCT02202148|BDNF|bdnf
1163100|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
1163101|NCT02202135|skin infection|skin infection
1163102|NCT02202135|ceftaroline|ceftaroline
1163103|NCT02202135|wound infection|wound infection
1163104|NCT02202135|cellulitis|cellulitis
1163105|NCT02202135|burn infection|burn infection
1163106|NCT02202135|bacterial infection|bacterial infection
1163107|NCT02202135|vancomycin|vancomycin
1163108|NCT02202122|Femoral Neck Fractures|femoral neck fractures
1163109|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
1163110|NCT02202122|Perioperative Complications|perioperative complications
1163111|NCT02202109|Screen|screen
1163112|NCT02202109|self-sampler|self-sampler
1163113|NCT02202109|cervical, cancer|cervical, cancer
1163114|NCT02202109|women|women
1163115|NCT02202109|community health workers|community health workers
1163116|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
1163117|NCT02202109|Haitian|haitian
1163118|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
1163119|NCT02202083|Oxytocin|oxytocin
1163120|NCT02202083|Cook Balloon|cook balloon
1163121|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
1163122|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
1163123|NCT02202070|Bruxism|bruxism
1163124|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
1163125|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
1163126|NCT02202057|respiratory sensation|respiratory sensation
1163127|NCT02202057|somatosensation|somatosensation
1163128|NCT02202057|resistive load|resistive load
1572110|NCT00494182|Carboplatin|carboplatin
1228803|NCT01901016|HIV|hiv
1163129|NCT02202057|magnitude estimation|magnitude estimation
1163130|NCT02202044|Bladder Cancer|bladder cancer
1163131|NCT02202018|Knowledge Translation|knowledge translation
1163132|NCT02202018|Chronic Kidney Disease|chronic kidney disease
1163133|NCT02202018|Dialysis|dialysis
1163134|NCT02202018|Home dialysis|home dialysis
1163135|NCT02202018|Cluster randomized trial|cluster randomized trial
1163136|NCT02202005|Bioequivalence|bioequivalence
1163137|NCT02201979|breast|breast
1163138|NCT02201979|ptosis|ptosis
1163139|NCT02201979|sagging|sagging
1163140|NCT02201979|implant|implant
1163141|NCT02201979|lift|lift
1163142|NCT02201966|low back pain|low back pain
1163143|NCT02201966|pediatric|pediatric
1163144|NCT02201966|gymnasts|gymnasts
1163145|NCT02201953|Sofosbuvir|sofosbuvir
1163146|NCT02201953|Velpatasvir|velpatasvir
1163147|NCT02201953|SOF/VEL|sof/vel
1163148|NCT02201953|GS-5816|gs-5816
1163149|NCT02201953|Hepatitis C|hepatitis c
1163150|NCT02201953|HCV|hcv
1163151|NCT02201953|Cirrhosis|cirrhosis
1163152|NCT02201953|Genotype 3|genotype 3
1163153|NCT02201940|Sofosbuvir|sofosbuvir
1163154|NCT02201940|SOF/VEL|sof/vel
1163155|NCT02201940|Velpatasvir|velpatasvir
1163156|NCT02201940|Hepatitis C|hepatitis c
1163158|NCT02201940|cirrhosis|cirrhosis
1163159|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
1163160|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
1163161|NCT02201927|egocentric space|egocentric space
1163162|NCT02201901|Sofosbuvir|sofosbuvir
1163163|NCT02201901|Velpatasvir|velpatasvir
1163164|NCT02201901|SOF/VEL|sof/vel
1163165|NCT02201901|GS-5816|gs-5816
1163166|NCT02201901|Hepatitis C|hepatitis c
1163167|NCT02201901|HCV|hcv
1163168|NCT02201901|Cirrhosis|cirrhosis
1163169|NCT02201901|CPT-B|cpt-b
1163170|NCT02201888|Schizophrenia|schizophrenia
1163171|NCT02201888|Rehabilitation|rehabilitation
1163172|NCT02201888|Cognition|cognition
1163173|NCT02201875|hypoxia|hypoxia
1163174|NCT02201875|exercise|exercise
1163175|NCT02201875|periodic breathing|periodic breathing
1163176|NCT02201875|hypercapnia|hypercapnia
1163177|NCT02201875|apneas|apneas
1163178|NCT02201875|cardiac failure|cardiac failure
1163179|NCT02201862|Aneuploidy|aneuploidy
1163180|NCT02201862|Down Syndrome|down syndrome
1163181|NCT02201862|amniocentesis|amniocentesis
1163182|NCT02201862|chronic villus sampling|chronic villus sampling
1163183|NCT02201862|Trisomy|trisomy
1163184|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
1163185|NCT02201862|Chromosome disorders|chromosome disorders
1163186|NCT02201849|Alkermes|alkermes
1163187|NCT02201849|ALKS 8700|alks 8700
1163188|NCT02201810|smoking cessation|smoking cessation
1163189|NCT02201810|quit line|quit line
1163190|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
1163191|NCT02201810|tobacco intervention|tobacco intervention
1163192|NCT02201797|Reproducibility of Results|reproducibility of results
1163193|NCT02201797|Liver neoplasm|liver neoplasm
1163194|NCT02201797|Neoplasm metastasis|neoplasm metastasis
1163195|NCT02201797|Regional Perfusion|regional perfusion
1163196|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
1163197|NCT02201784|Subarachnoid block|subarachnoid block
1163198|NCT02201784|intrathecal|intrathecal
1163199|NCT02201784|spinal anesthesia|spinal anesthesia
1163200|NCT02201784|isobaric|isobaric
1163201|NCT02201784|levobupivacaine|levobupivacaine
1163202|NCT02201784|ropivacaine|ropivacaine
1163203|NCT02201771|CABG|cabg
1163204|NCT02201771|Antiplatelet|antiplatelet
1163205|NCT02201771|Ticagrelor|ticagrelor
1163206|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
1163207|NCT02201732|Incomplete miscarriage|incomplete miscarriage
1163208|NCT02201732|Hysteroscopy|hysteroscopy
1163209|NCT02201732|curettage, pregnancy|curettage, pregnancy
1163210|NCT02201732|RCT|rct
1163211|NCT02201719|Adenomyosis|adenomyosis
1163212|NCT02201719|Dysmenorrhea|dysmenorrhea
1163213|NCT02201719|Chronic pelvic pain|chronic pelvic pain
1163214|NCT02201719|Infertility|infertility
1163215|NCT02201719|Sensitivity histology|sensitivity histology
1163216|NCT02201719|womens health|womens health
1163217|NCT02201719|junction zone|junction zone
1163218|NCT02201706|Retinal detachment|retinal detachment
1163219|NCT02201706|silicone oil|silicone oil
1163220|NCT02201706|retinectomy|retinectomy
1163221|NCT02201693|Crohn's disease,|crohn's disease,
1163222|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
1163223|NCT02201693|enteral nutrition,|enteral nutrition,
1163224|NCT02201693|randomized multicenter study|randomized multicenter study
1163225|NCT02201680|anxiety|anxiety
1163226|NCT02201680|preoperative|preoperative
1163227|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
1163228|NCT02201667|myocardial perfusion|myocardial perfusion
1163229|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
1163230|NCT02201667|antiplatelet|antiplatelet
1163231|NCT02201641|Indirect pulp capping|indirect pulp capping
1163232|NCT02201641|reversible pulpitis|reversible pulpitis
1163233|NCT02201641|periapical radiolucency|periapical radiolucency
1163234|NCT02201641|periapical radiographs|periapical radiographs
1163235|NCT02201641|cone beam computed tomography|cone beam computed tomography
1163236|NCT02201641|calcium silicate cements|calcium silicate cements
1163237|NCT02201641|glass ionomer cements|glass ionomer cements
1163238|NCT02201641|caries|caries
1163239|NCT02201628|Oesophageal|oesophageal
1163240|NCT02201628|Nasopharyngeal|nasopharyngeal
1163241|NCT02201628|temperature|temperature
1164226|NCT02196974|cryobiopsy|cryobiopsy
1163242|NCT02201628|Intubation, endotracheal|intubation, endotracheal
1163243|NCT02201628|Pediatric|pediatric
1163244|NCT02201628|Anesthesia|anesthesia
1163245|NCT02201628|Hypothermia|hypothermia
1163246|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
1163247|NCT02201602|sulphonylureas|sulphonylureas
1163248|NCT02201602|gliclazide|gliclazide
1163249|NCT02201602|glibenclamide|glibenclamide
1163250|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
1163251|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
1163252|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
1163253|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
1163254|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
1163255|NCT02201576|immunosuppressive agents|immunosuppressive agents
1163256|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
1163257|NCT02201563|Radiosurgery|radiosurgery
1163258|NCT02201563|Brain metastases|brain metastases
1163259|NCT02201563|Minocycline|minocycline
1163260|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
1163261|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
1163262|NCT02201524|Phase 2|phase 2
1163263|NCT02201524|randomized|randomized
1163264|NCT02201524|double-blind|double-blind
1163265|NCT02201524|placebo|placebo
1163266|NCT02201524|plaque|plaque
1163267|NCT02201524|psoriasis|psoriasis
1163268|NCT02201524|safety|safety
1163269|NCT02201524|efficacy|efficacy
1163270|NCT02201524|JAK|jak
1163271|NCT02201524|janus kinase|janus kinase
1163272|NCT02201524|moderate|moderate
1163273|NCT02201524|severe|severe
1163274|NCT02201511|relative bioavailbility|relative bioavailbility
1163276|NCT02201511|pharmacokinetics|pharmacokinetics
1163277|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
1163278|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
1163279|NCT02201485|percutaneous recanalization|percutaneous recanalization
1163280|NCT02201485|treatment|treatment
1163281|NCT02201485|reocclusion|reocclusion
1163282|NCT02201485|patency|patency
1163283|NCT02201472|liver|liver
1163284|NCT02201472|mre|mre
1163285|NCT02201472|mri|mri
1163286|NCT02201472|neonatal|neonatal
1163287|NCT02201472|mr touch|mr touch
1163288|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
1163289|NCT02201433|breastfeeding|breastfeeding
1163290|NCT02201433|fathers|fathers
1163291|NCT02201433|preterm newborns|preterm newborns
1163292|NCT02201433|partner influence|partner influence
1163293|NCT02201394|Antiplatelet|antiplatelet
1163294|NCT02201394|Ticagrelor|ticagrelor
1163295|NCT02201394|Platelets|platelets
1163296|NCT02201394|Thrombosis|thrombosis
1163297|NCT02201394|Coronary artery disease|coronary artery disease
1163298|NCT02201381|Cancer|cancer
1163299|NCT02201381|Cancer Treatments|cancer treatments
1163300|NCT02201381|Cancer Palliative Care|cancer palliative care
1163301|NCT02201381|Metabolic|metabolic
1163302|NCT02201381|Metabolism|metabolism
1163303|NCT02201381|Existing Medicines|existing medicines
1163304|NCT02201381|Licensed Medicines|licensed medicines
1163305|NCT02201381|Real World|real world
1163306|NCT02201381|Breast Cancer|breast cancer
1163307|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
1163308|NCT02201381|Colon Cancer|colon cancer
1163309|NCT02201381|Prostrate Cancer|prostrate cancer
1163310|NCT02201381|Brain Cancer|brain cancer
1163311|NCT02201381|Ovarian Cancer|ovarian cancer
1163312|NCT02201381|Pancreatic Cancer|pancreatic cancer
1163313|NCT02201381|AML|aml
1163314|NCT02201381|CML|cml
1163315|NCT02201381|Leukemea|leukemea
1163316|NCT02201381|Metformin|metformin
1163317|NCT02201381|Statins|statins
1163318|NCT02201381|Mebendazole|mebendazole
1163319|NCT02201381|Doxycycline|doxycycline
1163320|NCT02201381|Ibuprofen|ibuprofen
1163321|NCT02201381|Metastatic|metastatic
1163322|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
1163323|NCT02201355|Head and Neck cancer|head and neck cancer
1163324|NCT02201342|Fontan|fontan
1163325|NCT02201342|Pharmacokinetics|pharmacokinetics
1163326|NCT02201342|Pharmacodynamics|pharmacodynamics
1163327|NCT02201342|Exercise capacity|exercise capacity
1163328|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
1163329|NCT02201342|Vascular function|vascular function
1163330|NCT02201342|EndoPAT|endopat
1163331|NCT02201342|Myocardial performance|myocardial performance
1163332|NCT02201316|Healthy adult human subjects|healthy adult human subjects
1163333|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
1163334|NCT02201316|Bioequivalence|bioequivalence
1163335|NCT02201316|Dyspepsia|dyspepsia
1163336|NCT02201303|CD11b|cd11b
1163337|NCT02201303|Neutrophils|neutrophils
1163338|NCT02201303|CXCL1|cxcl1
1163339|NCT02201303|Danirixin|danirixin
1163340|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
1163341|NCT02201303|Children|children
1163342|NCT02201303|CXCR2|cxcr2
1163439|NCT02200783|Radial artery|radial artery
1163440|NCT02200783|Femoral artery|femoral artery
1163343|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
1163344|NCT02201277|IVC|ivc
1163345|NCT02201277|IVC Filter|ivc filter
1163346|NCT02201277|Filter|filter
1163347|NCT02201277|Option|option
1163348|NCT02201277|Denali|denali
1163349|NCT02201277|filter tilt|filter tilt
1163350|NCT02201277|filter migration|filter migration
1163351|NCT02201277|filter fracture|filter fracture
1163352|NCT02201277|filter thrombus|filter thrombus
1163353|NCT02201277|filter penetration|filter penetration
1163354|NCT02201264|myocardial infarction|myocardial infarction
1163355|NCT02201264|Angioplasty|angioplasty
1163356|NCT02201264|Stent|stent
1163357|NCT02201251|Epilepsy|epilepsy
1163358|NCT02201251|Topiramate|topiramate
1163359|NCT02201251|Levetiracetam|levetiracetam
1163360|NCT02201251|Pediatric|pediatric
1163361|NCT02201212|TSC1|tsc1
1163362|NCT02201212|TSC2|tsc2
1163363|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
1163364|NCT02201212|MTOR|mtor
1163365|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
1163366|NCT02201160|NAFLD|nafld
1163367|NCT02201160|Fatty acid composition|fatty acid composition
1163368|NCT02201160|Omega 3 supplementation|omega 3 supplementation
1163369|NCT02201160|Metabolism|metabolism
1163370|NCT02201134|Cardiac arrest|cardiac arrest
1163371|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
1163372|NCT02201134|Sevoflurane|sevoflurane
1163373|NCT02201134|Sedation|sedation
1163374|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
1163375|NCT02201134|Requiring sedation|requiring sedation
1163376|NCT02201134|Adult patients|adult patients
1163377|NCT02201134|Patient covered by french health care system|patient covered by french health care system
1163775|NCT02199184|PEG-G-CSF|peg-g-csf
1163378|NCT02201095|caesarean section|caesarean section
1163379|NCT02201095|perioperative hypothermia|perioperative hypothermia
1163380|NCT02201095|active warming|active warming
1163381|NCT02201095|forced air warming|forced air warming
1163382|NCT02201095|conduction mattress warming|conduction mattress warming
1163383|NCT02201095|thermal comfort|thermal comfort
1163384|NCT02201095|Prevention of|prevention of
1163385|NCT02201069|nutrition|nutrition
1163386|NCT02201069|physical activity|physical activity
1163387|NCT02201069|sleep|sleep
1163388|NCT02201069|weight loss|weight loss
1163389|NCT02201056|Drug Therapy|drug therapy
1163390|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
1163391|NCT02201043|thalidomide|thalidomide
1163392|NCT02200952|OHSS|ohss
1163393|NCT02200952|Oocytes triggering|oocytes triggering
1163394|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
1163395|NCT02200952|Luteal phase supplementation|luteal phase supplementation
1163396|NCT02200952|recombinant LH|recombinant lh
1163397|NCT02200900|High flow nasal cannula|high flow nasal cannula
1163398|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
1163399|NCT02200900|Respiratory physiology|respiratory physiology
1163400|NCT02200887|Dyskinesia|dyskinesia
1163401|NCT02200887|Slow Wave Sleep|slow wave sleep
1163402|NCT02200874|disease related malnutrition|disease related malnutrition
1163403|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
1163404|NCT02200874|length of hospital stay|length of hospital stay
1163405|NCT02200874|quality of life|quality of life
1163406|NCT02200874|body composition|body composition
1163407|NCT02200874|health care costs|health care costs
1163408|NCT02200861|sedation,|sedation,
1163409|NCT02200861|tooth extraction,|tooth extraction,
1163410|NCT02200848|Lenalidomide|lenalidomide
1163411|NCT02200848|Ibrutinib|ibrutinib
1163412|NCT02200848|Rituximab|rituximab
1163413|NCT02200848|CLL|cll
1163414|NCT02200848|SLL|sll
1163415|NCT02200835|aortic dissection|aortic dissection
1163416|NCT02200835|Chinese patients|chinese patients
1163417|NCT02200835|gender differences|gender differences
1163418|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
1163419|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
1163420|NCT02200822|RAAS-blocker|raas-blocker
1163421|NCT02200822|beta blocker|beta blocker
1163422|NCT02200822|spironolactone|spironolactone
1163423|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
1163424|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
1163425|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1163426|NCT02200822|heart failure|heart failure
1163427|NCT02200822|dyssynchrony|dyssynchrony
1163428|NCT02200822|left bundle branch block|left bundle branch block
1163429|NCT02200809|MR-guided therapy|mr-guided therapy
1163430|NCT02200809|Focal laser ablation|focal laser ablation
1163431|NCT02200809|Prostate cancer|prostate cancer
1163432|NCT02200796|Dietary Protein|dietary protein
1163433|NCT02200796|Satiety|satiety
1163434|NCT02200796|Food Intake|food intake
1163435|NCT02200796|Thermic Effect of Food|thermic effect of food
1163436|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
1163437|NCT02200783|Cardiac catheterization|cardiac catheterization
1163438|NCT02200783|Radiation Protection|radiation protection
1163441|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
1163442|NCT02200744|Procedural sedation|procedural sedation
1163443|NCT02200744|emergency department|emergency department
1163444|NCT02200744|adults|adults
1163445|NCT02200744|propofol|propofol
1163446|NCT02200744|recall assessment|recall assessment
1163447|NCT02200731|Childhood cancer|childhood cancer
1163448|NCT02200731|Psychosocial intervention|psychosocial intervention
1163449|NCT02200731|Family|family
1163450|NCT02200731|Siblings|siblings
1163451|NCT02200731|Childhood cancer survivors|childhood cancer survivors
1163452|NCT02200731|Cogntive Behavioural|cogntive behavioural
1163453|NCT02200731|Manualized|manualized
1163454|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
1163455|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
1163456|NCT02200692|plasma transfusion|plasma transfusion
1163457|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
1163458|NCT02200692|transfusion reaction|transfusion reaction
1163459|NCT02200692|blood transfusion|blood transfusion
1163460|NCT02200692|Solvent detergent plasma|solvent detergent plasma
1163461|NCT02200679|Autism spectrum disorders|autism spectrum disorders
1163462|NCT02200679|Prevalence|prevalence
1163463|NCT02200679|Diagnosis|diagnosis
1163464|NCT02200679|Screen|screen
1163465|NCT02200679|Risk Factor|risk factor
1163466|NCT02200679|SRS|srs
1163467|NCT02200679|ASRS|asrs
1163468|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
1163469|NCT02200666|Diabetes|diabetes
1163470|NCT02200666|Forxiga|forxiga
1163471|NCT02200666|Long-term use|long-term use
1163472|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
1163473|NCT02200627|Diabetes|diabetes
1163474|NCT02200627|Forxiga|forxiga
1163475|NCT02200627|Elderly|elderly
1163476|NCT02200601|Seipher Wellness|seipher wellness
1163477|NCT02200601|algorithm|algorithm
1163478|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
1163479|NCT02200601|volunteers|volunteers
1163480|NCT02200601|validation|validation
1163481|NCT02200601|heart health algorithm|heart health algorithm
1163482|NCT02200588|psychosis|psychosis
1163483|NCT02200588|schizophrenia|schizophrenia
1163484|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
1163485|NCT02200549|inspiratory muscle training|inspiratory muscle training
1163486|NCT02200549|exercise training|exercise training
1163487|NCT02200523|EEG|eeg
1163488|NCT02200523|electrode|electrode
1163489|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
1163490|NCT02200510|Transition to Adult Care|transition to adult care
1163491|NCT02200510|Self Care|self care
1163492|NCT02200510|Personal Electronic Health Records|personal electronic health records
1163493|NCT02200510|Adolescent|adolescent
1163494|NCT02200510|Young Adult|young adult
1163495|NCT02200510|Disease Management|disease management
1163496|NCT02200510|Physician-Patient Relations|physician-patient relations
1163497|NCT02200484|obesity|obesity
1163498|NCT02200484|adolescents, females|adolescents, females
1163499|NCT02200484|child development|child development
1163500|NCT02200484|weight loss programs|weight loss programs
1163501|NCT02200484|child rearing|child rearing
1163502|NCT02200484|parenting|parenting
1163503|NCT02200471|Cosmetic dermatology|cosmetic dermatology
1163504|NCT02200471|near-infrared|near-infrared
1163505|NCT02200471|patient preference|patient preference
1163506|NCT02200471|physician preference|physician preference
1163507|NCT02200445|Ulcerative colitis|ulcerative colitis
1163508|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
1163509|NCT02200445|Interleukin 2|interleukin 2
1163510|NCT02200445|Interleukin-2|interleukin-2
1163511|NCT02200445|IL-2|il-2
1163512|NCT02200445|Regulatory T Cells|regulatory t cells
1163513|NCT02200445|Tregs|tregs
1163514|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
1163515|NCT02200432|Smoking Cessation|smoking cessation
1163516|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
1163517|NCT02200432|Health Behavior Change|health behavior change
1163518|NCT02200432|Patient decision support|patient decision support
1163519|NCT02200419|Rotem|rotem
1572111|NCT00494182|Paclitaxel|paclitaxel
1163520|NCT02200419|Point of care coagulation tests|point of care coagulation tests
1163521|NCT02200419|Cardiac surgery|cardiac surgery
1163522|NCT02200419|Vascular surgery|vascular surgery
1163523|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
1163524|NCT02200419|Blood products|blood products
1163525|NCT02200419|Transfusion|transfusion
1163526|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
1163527|NCT02200406|Desvenlafaxine|desvenlafaxine
1163528|NCT02200406|Opioid-dependent|opioid-dependent
1163529|NCT02200406|Addiction|addiction
1163530|NCT02200406|Depression|depression
1163531|NCT02200406|Methadone|methadone
1163532|NCT02200406|Comorbidity|comorbidity
1163533|NCT02200393|Spinal cord injury|spinal cord injury
1163534|NCT02200393|Tetraplegia|tetraplegia
1163535|NCT02200393|Ventilator|ventilator
1163536|NCT02200367|Primary health care|primary health care
1163537|NCT02200367|Computer communication network|computer communication network
1163538|NCT02200367|Depression|depression
1163539|NCT02200328|Clostridium difficile infection|clostridium difficile infection
1163540|NCT02200328|Diarrhea|diarrhea
1163541|NCT02200328|Flagyl|flagyl
1163542|NCT02200328|Metronidazole|metronidazole
1163543|NCT02200315|Stomach neoplasms|stomach neoplasms
1163544|NCT02200315|Surgical site infection|surgical site infection
1163545|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
1163546|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
1163547|NCT02200289|Birth cohort|birth cohort
1163548|NCT02200289|Ghana|ghana
1163549|NCT02200289|Biomass|biomass
1163550|NCT02200289|Cook stove|cook stove
1163551|NCT02200289|Oxidative stress|oxidative stress
1163552|NCT02200289|Lung development|lung development
1163553|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
1163554|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
1163555|NCT02200263|macular pigment|macular pigment
1163556|NCT02200263|visual function|visual function
1163557|NCT02200237|EV71 Vaccine|ev71 vaccine
1163558|NCT02200211|Amblyopia|amblyopia
1163559|NCT02200198|undernutrition|undernutrition
1163560|NCT02200198|abdominal surgery|abdominal surgery
1163561|NCT02200198|respiratory muscles|respiratory muscles
1163562|NCT02200198|muscles strength|muscles strength
1163563|NCT02200198|pulmonary complication|pulmonary complication
1163564|NCT02200198|perioperative care|perioperative care
1163565|NCT02200185|post traumatic pain|post traumatic pain
1163566|NCT02200185|titrated morphine|titrated morphine
1163567|NCT02200185|nebulised morphine|nebulised morphine
1163568|NCT02200172|Cancer|cancer
1163569|NCT02200172|Melatonin|melatonin
1163570|NCT02200172|Delirium|delirium
1163571|NCT02200172|Feasibility Studies|feasibility studies
1163572|NCT02200172|Palliative Care|palliative care
1163573|NCT02200159|Sedation|sedation
1163574|NCT02200159|Dexmedetomidine|dexmedetomidine
1163576|NCT02200159|Delirium|delirium
1163577|NCT02200146|sarcoidosis|sarcoidosis
1163578|NCT02200146|treatment|treatment
1163579|NCT02200146|lung|lung
1163580|NCT02200146|glucocorticoids|glucocorticoids
1163581|NCT02200146|hydroxychloroquine|hydroxychloroquine
1163582|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
1163583|NCT02200133|Survivorship Care Plan|survivorship care plan
1163584|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
1163585|NCT02200107|Self Care|self care
1163586|NCT02200107|Treatment Outcome|treatment outcome
1163587|NCT02200107|Patient Education as Topic|patient education as topic
1163588|NCT02200107|Physical Therapy Modalities|physical therapy modalities
1163589|NCT02200081|Extensive disease|extensive disease
1163590|NCT02200081|After first line therapy|after first line therapy
1163591|NCT02200081|Immuno therapy|immuno therapy
1163592|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
1163593|NCT02200068|Patient Reported Outcomes|patient reported outcomes
1163594|NCT02200068|Personal Health Record|personal health record
1163595|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
1163596|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
1163597|NCT02200055|Total Body Volume|total body volume
1163598|NCT02200055|Fluid Resuscitation|fluid resuscitation
1163599|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
1163600|NCT02200016|Postoperative pain|postoperative pain
1163601|NCT02200016|Regional anesteshia|regional anesteshia
1163602|NCT02200016|Nerve catheters|nerve catheters
1163603|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
1163604|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
1163605|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
1163606|NCT02199977|Malaria|malaria
1163607|NCT02199977|Antimalarial subsidy|antimalarial subsidy
1163608|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
1163609|NCT02199977|public-private partnership|public-private partnership
1163610|NCT02199964|Dry eye|dry eye
1163611|NCT02199964|environmental stress|environmental stress
1163612|NCT02199964|artificial tears|artificial tears
1163613|NCT02199964|cyclosporin|cyclosporin
1163614|NCT02199964|Restasis|restasis
1572112|NCT00494182|SCCHN|scchn
1163615|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
1163616|NCT02199951|dihydroartemisinin|dihydroartemisinin
1163617|NCT02199951|piperaquine|piperaquine
1163618|NCT02199925|Autism|autism
1163619|NCT02199925|Autism spectrum|autism spectrum
1163620|NCT02199925|Autism children|autism children
1163621|NCT02199912|cachexia|cachexia
1163622|NCT02199912|nutrition|nutrition
1163623|NCT02199912|cancer|cancer
1163624|NCT02199912|colorectal tumor|colorectal tumor
1163625|NCT02199834|diabetes|diabetes
1163626|NCT02199834|peer support|peer support
1163627|NCT02199834|personalized feedback report|personalized feedback report
1163628|NCT02199795|stroke|stroke
1163629|NCT02199795|hemiplegia|hemiplegia
1163630|NCT02199795|footdrop|footdrop
1163631|NCT02199795|electrical stimulation|electrical stimulation
1163632|NCT02199769|Clinical decision support|clinical decision support
1163633|NCT02199769|Diabetes screening|diabetes screening
1163634|NCT02199756|Uterine contractions|uterine contractions
1163635|NCT02199756|Indomethacin|indomethacin
1163636|NCT02199756|Nanovectors|nanovectors
1163637|NCT02199743|schizophrenia|schizophrenia
1163638|NCT02199743|schizoaffective|schizoaffective
1163639|NCT02199743|cognition|cognition
1163640|NCT02199743|lurasidone|lurasidone
1163641|NCT02199743|Latuda|latuda
1163642|NCT02199717|Physical Activity|physical activity
1163643|NCT02199717|Accelerometer|accelerometer
1163644|NCT02199717|Exercise|exercise
1163645|NCT02199717|Obesity|obesity
1163647|NCT02199704|Parenting|parenting
1163648|NCT02199704|Psychosis|psychosis
1163649|NCT02199704|Schizophrenia|schizophrenia
1163650|NCT02199704|Delusions|delusions
1163651|NCT02199704|Hallucinations|hallucinations
1163652|NCT02199691|Meningitis|meningitis
1163653|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
1163654|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
1163655|NCT02199691|MENVEO vaccine|menveo vaccine
1163656|NCT02199691|Adacel®|adacel®
1163657|NCT02199691|GARDASIL®|gardasil®
1163658|NCT02199639|Haemophilia|haemophilia
1163659|NCT02199639|Arthropathy|arthropathy
1163660|NCT02199639|Range of Movement|range of movement
1163661|NCT02199639|Strength|strength
1163662|NCT02199639|Proprioception|proprioception
1163663|NCT02199639|Gait|gait
1163664|NCT02199639|Quality of Life|quality of life
1163665|NCT02199613|HIV|hiv
1163666|NCT02199613|antiretroviral therapy|antiretroviral therapy
1163667|NCT02199587|Medical clown|medical clown
1163668|NCT02199587|Growth hormone|growth hormone
1163669|NCT02199587|Precocious puberty|precocious puberty
1163670|NCT02199548|Adolescent|adolescent
1163671|NCT02199548|Decision-making|decision-making
1163672|NCT02199548|Social network|social network
1163673|NCT02199535|operating room,|operating room,
1163674|NCT02199535|risk factors|risk factors
1163675|NCT02199535|anesthesiologists|anesthesiologists
1163676|NCT02199509|Levetiracetam|levetiracetam
1163677|NCT02199509|Cranial Dystonia|cranial dystonia
1163678|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
1163679|NCT02199496|Malabsorption|malabsorption
1163680|NCT02199496|Enteropathy|enteropathy
1163681|NCT02199496|Diarrhea|diarrhea
1163682|NCT02199496|IL-23|il-23
1163683|NCT02199496|IL-12|il-12
1163684|NCT02199483|Energy Expenditure|energy expenditure
1163685|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
1163686|NCT02199483|Neurocognitive Function|neurocognitive function
1163687|NCT02199483|Weight Loss|weight loss
1163688|NCT02199470|β-CELLS,|β-cells,
1163689|NCT02199470|MIXED MEAL TEST,|mixed meal test,
1163690|NCT02199470|C-PEPTİDE|c-peptide
1163691|NCT02199431|Lu AF11167|lu af11167
1163692|NCT02199431|Interaction|interaction
1163693|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
1163694|NCT02199392|P-glycoprotein|p-glycoprotein
1163695|NCT02199392|Healthy Volunteers|healthy volunteers
1163696|NCT02199379|renal impairment|renal impairment
1163697|NCT02199379|disease severity|disease severity
1163698|NCT02199366|Cardiac MRI|cardiac mri
1163699|NCT02199366|Radiation|radiation
1163700|NCT02199366|Proton Radiation|proton radiation
1163701|NCT02199366|Breast Cancer|breast cancer
1163702|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
1163703|NCT02199340|Exercise testing|exercise testing
1163704|NCT02199340|Children|children
1163705|NCT02199340|Exercise capacity|exercise capacity
1163706|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
1163707|NCT02199327|Mitomycin C|mitomycin c
1163708|NCT02199327|Interferon alfa 2b|interferon alfa 2b
1163709|NCT02199314|intra|intra
1163710|NCT02199314|operative|operative
1163711|NCT02199314|neurophysiologic|neurophysiologic
1163712|NCT02199314|monitoring|monitoring
1163713|NCT02199314|transcranial|transcranial
1163714|NCT02199314|motor|motor
1163715|NCT02199314|evoked|evoked
1163716|NCT02199314|potential|potential
1163717|NCT02199314|anesthesia|anesthesia
1163718|NCT02199314|pulses|pulses
1163719|NCT02199301|Kidney transplantation|kidney transplantation
1163720|NCT02199301|Tolerance induction|tolerance induction
1163721|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
1163722|NCT02199301|Bone marrow transplantation|bone marrow transplantation
1163723|NCT02199301|Transplantation conditioning|transplantation conditioning
1163724|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1163725|NCT02199301|Living donor|living donor
1163726|NCT02199301|Haplotype|haplotype
1163727|NCT02199301|Immune tolerance|immune tolerance
1163728|NCT02199275|Non-urgent surgery|non-urgent surgery
1163729|NCT02199275|General anesthesia|general anesthesia
1163730|NCT02199275|Enterocyte damage|enterocyte damage
1163731|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
1163732|NCT02199262|Intensive care unit|intensive care unit
1163733|NCT02199262|Incidents|incidents
1163734|NCT02199262|prevention|prevention
1163735|NCT02199262|music|music
1163736|NCT02199262|reflexology|reflexology
1163737|NCT02199249|open anatomic reduction|open anatomic reduction
1163738|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
1163739|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
1163740|NCT02199236|oral capecitabine|oral capecitabine
1163741|NCT02199236|infusional 5-FU|infusional 5-fu
1163742|NCT02199236|Questionnaires|questionnaires
1163743|NCT02199236|14-104|14-104
1163744|NCT02199210|Massive transfusion protocols|massive transfusion protocols
1163745|NCT02199210|Self-regulatory learning|self-regulatory learning
1163746|NCT02199210|Forethought|forethought
1163747|NCT02199210|Clinical expertise|clinical expertise
1163748|NCT02199210|Simulation|simulation
1163749|NCT02199210|Education|education
1163750|NCT02199184|Leukemia|leukemia
1163751|NCT02199184|Burkitt leukemia|burkitt leukemia
1163752|NCT02199184|Burkitt-like leukemia/lymphoma|burkitt-like leukemia/lymphoma
1163753|NCT02199184|Newly diagnosed|newly diagnosed
1163754|NCT02199184|Relapsed/refractory|relapsed/refractory
1163755|NCT02199184|Ofatumumab|ofatumumab
1163756|NCT02199184|Arzerra|arzerra
1163757|NCT02199184|Etoposide|etoposide
1163758|NCT02199184|VePesid|vepesid
1163759|NCT02199184|Doxorubicin|doxorubicin
1163760|NCT02199184|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1163761|NCT02199184|Adriamycin PFS|adriamycin pfs
1163762|NCT02199184|Adriamycin RDF|adriamycin rdf
1163763|NCT02199184|Adriamycin|adriamycin
1163764|NCT02199184|Rubex|rubex
1163765|NCT02199184|Vincristine|vincristine
1163766|NCT02199184|Cyclophosphamide|cyclophosphamide
1163767|NCT02199184|Cytoxan|cytoxan
1163768|NCT02199184|Neosar|neosar
1163769|NCT02199184|Prednisone|prednisone
1163770|NCT02199184|Rituximab|rituximab
1163771|NCT02199184|Rituxan|rituxan
1163772|NCT02199184|DA-EPOCH|da-epoch
1163773|NCT02199184|Pegfilgrastim|pegfilgrastim
1163776|NCT02199184|G-CSF|g-csf
1163777|NCT02199184|Filgrastim|filgrastim
1163778|NCT02199184|Neupogen|neupogen
1163779|NCT02199184|Phone calls|phone calls
1163780|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
1163781|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
1163782|NCT02199171|cytoreductive surgery|cytoreductive surgery
1163783|NCT02199158|iridoplasty|iridoplasty
1163784|NCT02199158|angle|angle
1163785|NCT02199158|glaucoma|glaucoma
1163786|NCT02199158|anterior chamber|anterior chamber
1163787|NCT02199158|laser treatment|laser treatment
1163788|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1163789|NCT02199119|children|children
1163790|NCT02199119|television|television
1163791|NCT02199119|exercise|exercise
1163792|NCT02199119|food intake|food intake
1163793|NCT02199119|appetite|appetite
1163794|NCT02199119|satiation|satiation
1163795|NCT02199093|MeSH terms:|mesh terms:
1163796|NCT02199093|Apraxias|apraxias
1163797|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
1163798|NCT02199093|Stroke|stroke
1163799|NCT02199093|Cerebral Stroke|cerebral stroke
1163800|NCT02199093|Rehabilitation|rehabilitation
1163801|NCT02199093|Occupational therapy|occupational therapy
1163802|NCT02199093|Treatment Outcome|treatment outcome
1163803|NCT02199093|Activities of Daily Living|activities of daily living
1163804|NCT02199054|Snack Foods|snack foods
1163805|NCT02199054|Safflower Oil|safflower oil
1163807|NCT02199054|Postmenopausal women|postmenopausal women
1163808|NCT02199054|Metabolic Syndrome|metabolic syndrome
1163809|NCT02199041|Cord Blood|cord blood
1163810|NCT02199041|Haploidentical|haploidentical
1163811|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
1163812|NCT02199028|hyaluronidase|hyaluronidase
1163813|NCT02199028|infusion sets|infusion sets
1163814|NCT02199028|insulin pump|insulin pump
1163815|NCT02199028|Continuous glucose monitor|continuous glucose monitor
1163816|NCT02199015|Dysarthria|dysarthria
1163817|NCT02199015|Electrical Stimulation|electrical stimulation
1163818|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
1163819|NCT02199015|Spasticity|spasticity
1163820|NCT02199015|Treatment|treatment
1163821|NCT02199002|acid pocket|acid pocket
1163822|NCT02199002|GERD|gerd
1163823|NCT02199002|Barrett|barrett
1163824|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
1163825|NCT02198950|sepsis|sepsis
1163826|NCT02198950|diagnosis|diagnosis
1163827|NCT02198950|biomarker|biomarker
1163828|NCT02198937|smokers|smokers
1163829|NCT02198937|non-smokers|non-smokers
1163830|NCT02198924|sequential administration|sequential administration
1163831|NCT02198924|pain control|pain control
1163832|NCT02198924|inflammation control|inflammation control
1163833|NCT02198924|function recovery|function recovery
1163834|NCT02198911|Habituation|habituation
1163835|NCT02198911|Orosensory cues|orosensory cues
1163836|NCT02198911|Satiation|satiation
1163837|NCT02198885|FAST|fast
1163838|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
1163839|NCT02198885|Prehospital care|prehospital care
1163840|NCT02198885|ultrasound|ultrasound
1163841|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
1163842|NCT02198885|RP-Xpress|rp-xpress
1164225|NCT02196974|diagnosis|diagnosis
1163843|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
1163844|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
1163845|NCT02198859|Prostate Cancer|prostate cancer
1163846|NCT02198859|Lithium|lithium
1163847|NCT02198859|Androgen|androgen
1163849|NCT02198833|Urinary Tract Infection|urinary tract infection
1163850|NCT02198833|Bacteriuria|bacteriuria
1163851|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
1163852|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
1163853|NCT02198833|Spinal Cord injury|spinal cord injury
1163854|NCT02198820|Femoral Neck Fractures|femoral neck fractures
1163855|NCT02198820|Perioperative Care|perioperative care
1163856|NCT02198820|Perioperative Period|perioperative period
1163857|NCT02198820|Postoperative Complications|postoperative complications
1163858|NCT02198794|Dyskinesias|dyskinesias
1163859|NCT02198794|Movement Disorders|movement disorders
1163860|NCT02198794|Central Nervous System Diseases|central nervous system diseases
1163861|NCT02198794|Nervous System Diseases|nervous system diseases
1163862|NCT02198794|Neurologic Manifestations|neurologic manifestations
1163863|NCT02198794|Signs and Symptoms|signs and symptoms
1163864|NCT02198781|atrial fibrilation|atrial fibrilation
1163865|NCT02198781|atrial-ventricula|atrial-ventricula
1163866|NCT02198781|right ventricle|right ventricle
1163867|NCT02198781|left ventricle|left ventricle
1163868|NCT02198781|surrogate marker|surrogate marker
1163869|NCT02198781|ventricular dysfunction|ventricular dysfunction
1163870|NCT02198781|pacing|pacing
1163871|NCT02198768|ankle fracture|ankle fracture
1163872|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
1163873|NCT02198768|prospective|prospective
1163874|NCT02198768|observational|observational
1163875|NCT02198755|high resolution ultrasound|high resolution ultrasound
1163876|NCT02198755|osteomyelitis|osteomyelitis
1163877|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
1163878|NCT02198716|Elderly|elderly
1163879|NCT02198716|Angina|angina
1163880|NCT02198703|Probiotics|probiotics
1163881|NCT02198703|AB-Life|ab-life
1163882|NCT02198703|LDL-cholesterol|ldl-cholesterol
1163883|NCT02198703|Hypercholesterolemia|hypercholesterolemia
1163884|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
1163885|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
1163886|NCT02198664|Peanut|peanut
1163888|NCT02198664|Oral Desensitization|oral desensitization
1163889|NCT02198664|Peanut Allergen|peanut allergen
1163890|NCT02198664|Peanut-Allergic Children|peanut-allergic children
1163891|NCT02198664|Children|children
1163892|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
1163893|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
1163894|NCT02198651|Adalimumab|adalimumab
1163895|NCT02198651|Taper|taper
1163896|NCT02198651|Flare|flare
1163897|NCT02198651|Arthritis|arthritis
1163898|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
1163899|NCT02198651|Remission|remission
1163900|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
1163901|NCT02198651|Ultrasound|ultrasound
1163902|NCT02198651|Biomarker|biomarker
1163903|NCT02198651|Drug Level|drug level
1163904|NCT02198651|Reduced dose|reduced dose
1163905|NCT02198638|Influenza|influenza
1163906|NCT02198638|Vaccination rate|vaccination rate
1163907|NCT02198638|Hospital acquired infection|hospital acquired infection
1163908|NCT02198625|Moderate FiO2|moderate fio2
1163909|NCT02198625|Protective lung ventilation|protective lung ventilation
1163910|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
1163911|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
1163912|NCT02198625|recruitment maneuvers|recruitment maneuvers
1163913|NCT02198599|Multiple sclerosis|multiple sclerosis
1163914|NCT02198599|Stroke|stroke
1163915|NCT02198599|Nursing|nursing
1163916|NCT02198599|Mobility|mobility
1163917|NCT02198599|Rehabilitation|rehabilitation
1163918|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
1163919|NCT02198573|malaria|malaria
1163921|NCT02198573|pfmrp1|pfmrp1
1163922|NCT02198573|Myanmar|myanmar
1163923|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
1163924|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
1163925|NCT02198547|Magnesium solfatus,|magnesium solfatus,
1163926|NCT02198547|Sciatic block|sciatic block
1163927|NCT02198534|visual acuity|visual acuity
1163928|NCT02198534|Landolt C|landolt c
1163929|NCT02198534|ETDRS charts|etdrs charts
1163930|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
1163931|NCT02198534|FrACT|fract
1163932|NCT02198534|Comparison|comparison
1163933|NCT02198534|acceptance|acceptance
1163934|NCT02198534|Test retest reliability|test retest reliability
1163935|NCT02198534|duration|duration
1163936|NCT02198534|questionnaire|questionnaire
1163937|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
1163938|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1163939|NCT02198482|Volasertib|volasertib
1163940|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
1163941|NCT02198469|actinic cheilitis|actinic cheilitis
1163942|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
1163943|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
1163944|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
1163945|NCT02198430|Haemophilia|haemophilia
1163946|NCT02198430|Arthropathy|arthropathy
1163947|NCT02198430|Range of motion|range of motion
1163948|NCT02198430|Strength|strength
1163949|NCT02198430|Proprioception|proprioception
1163950|NCT02198430|Gait|gait
1163951|NCT02198430|Quality of Life.|quality of life.
1163952|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
1163953|NCT02198417|PCOS|pcos
1163954|NCT02198417|Acne|acne
1163955|NCT02198417|Infertility|infertility
1163956|NCT02198417|Irregular menses|irregular menses
1163957|NCT02198417|Irregular period|irregular period
1163958|NCT02198417|Mitochondria|mitochondria
1163959|NCT02198417|Metabolism|metabolism
1163960|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
1163961|NCT02198378|pain|pain
1163962|NCT02198378|prehospital setting|prehospital setting
1163963|NCT02198378|acute coronary syndrome|acute coronary syndrome
1163964|NCT02198365|mRNA,|mrna,
1163965|NCT02198365|DNA,|dna,
1163966|NCT02198365|integrated HPV DNA|integrated hpv dna
1163967|NCT02198365|human papillomavirus,|human papillomavirus,
1163968|NCT02198365|cervical neoplasia|cervical neoplasia
1163969|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
1163970|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
1163971|NCT02198261|alopecia|alopecia
1163972|NCT02198261|androgenetic alopecia|androgenetic alopecia
1163973|NCT02198261|hair loss|hair loss
1163974|NCT02198261|minoxidil|minoxidil
1163975|NCT02198261|5% minoxidil foam|5% minoxidil foam
1163976|NCT02198261|male pattern hair loss|male pattern hair loss
1163977|NCT02198209|liraglutide|liraglutide
1163978|NCT02198209|GLP-1|glp-1
1163979|NCT02198209|liver glucokinase|liver glucokinase
1163980|NCT02198170|Healthy Volunteers|healthy volunteers
1163981|NCT02198157|duration of second stage|duration of second stage
1163982|NCT02198157|urinary catheterization|urinary catheterization
1163983|NCT02198157|epidural anaesthesia|epidural anaesthesia
1163984|NCT02198144|Hypertension|hypertension
1163985|NCT02198144|High Blood Pressure|high blood pressure
1163986|NCT02198144|African American Men|african american men
1163987|NCT02198144|Black Men|black men
1163988|NCT02198118|breast cancer|breast cancer
1163989|NCT02198118|physiotherapy|physiotherapy
1163990|NCT02198118|radiotherapy|radiotherapy
1163991|NCT02198105|PAD|pad
1163992|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
1163993|NCT02198105|cutting-balloon|cutting-balloon
1163994|NCT02198105|drug-coated-balloon|drug-coated-balloon
1163995|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
1163996|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
1163997|NCT02198092|lynch syndrome|lynch syndrome
1163998|NCT02198092|hnpcc|hnpcc
1163999|NCT02198092|colorectal cancer|colorectal cancer
1164000|NCT02198092|genetic syndrome|genetic syndrome
1164001|NCT02198092|epigenomics|epigenomics
1164002|NCT02198092|septin9|septin9
1164003|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
1164004|NCT02198079|Pediatrics|pediatrics
1164005|NCT02198079|Cystic Fibrosis|cystic fibrosis
1164006|NCT02198066|Sternotomy incision|sternotomy incision
1164007|NCT02198066|Silver dressing|silver dressing
1164008|NCT02198066|Sternal wound infection|sternal wound infection
1164009|NCT02198040|Elbow|elbow
1164010|NCT02198040|Joint disease|joint disease
1164011|NCT02198040|Hemophilia|hemophilia
1164012|NCT02198040|Physiotherapy modalities|physiotherapy modalities
1164013|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
1164014|NCT02198027|postoperative analgesia|postoperative analgesia
1164015|NCT02198027|peritubal block|peritubal block
1164016|NCT02198027|pain|pain
1572218|NCT00493727|Isoprostane|isoprostane
1164017|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
1164018|NCT02198014|Knee|knee
1164019|NCT02198014|Joint disease|joint disease
1164020|NCT02198014|Haemophilia|haemophilia
1164021|NCT02198014|Physiotherapy modalities|physiotherapy modalities
1164022|NCT02198001|Platelets|platelets
1164023|NCT02198001|fibrin|fibrin
1164024|NCT02198001|growth factors|growth factors
1164025|NCT02198001|bisphosphonates|bisphosphonates
1164026|NCT02198001|tooth extraction|tooth extraction
1164027|NCT02197988|Surgery|surgery
1164028|NCT02197988|Abdominal|abdominal
1164029|NCT02197988|Epidural Anesthesia|epidural anesthesia
1164030|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
1164031|NCT02197988|TAP block|tap block
1164032|NCT02197975|Healthy Volunteers|healthy volunteers
1164033|NCT02197962|Osteoarthritis|osteoarthritis
1164034|NCT02197962|Radial shockwaves|radial shockwaves
1164035|NCT02197936|Peristalsis|peristalsis
1164036|NCT02197936|ultrasound|ultrasound
1164037|NCT02197923|Menorrhagia|menorrhagia
1164038|NCT02197923|Dysmenorrhea|dysmenorrhea
1164039|NCT02197923|Pelvic pain|pelvic pain
1164040|NCT02197923|expression profiling|expression profiling
1164041|NCT02197923|uterine biopsies|uterine biopsies
1164042|NCT02197923|serum hormones|serum hormones
1164043|NCT02197897|Tamoxifen citrate|tamoxifen citrate
1164044|NCT02197897|Bladder Cancer|bladder cancer
1164046|NCT02197884|JNJ-54861911|jnj-54861911
1164047|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
1164048|NCT02197884|Itraconazole|itraconazole
1164049|NCT02197884|Clarithromycin|clarithromycin
1164050|NCT02197884|Alzheimer's disease|alzheimer's disease
1164051|NCT02197871|COPD|copd
1164052|NCT02197871|malnutrition|malnutrition
1164053|NCT02197871|nutrition supplementation|nutrition supplementation
1164054|NCT02197858|invasive arterial pressure|invasive arterial pressure
1164055|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
1164056|NCT02197858|propofol|propofol
1164057|NCT02197858|remifentanil|remifentanil
1164058|NCT02197845|sickle cell disease|sickle cell disease
1164059|NCT02197845|hydroxyurea|hydroxyurea
1164060|NCT02197845|patient navigator|patient navigator
1164061|NCT02197845|community health worker|community health worker
1164062|NCT02197845|public health worker|public health worker
1164063|NCT02197845|fetal hemoglobin|fetal hemoglobin
1164064|NCT02197845|health services research|health services research
1164065|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
1164066|NCT02197832|Endometrial injury|endometrial injury
1164067|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
1164068|NCT02197780|Diagnostic accuracy|diagnostic accuracy
1164069|NCT02197780|Fecal biomarker|fecal biomarker
1164070|NCT02197780|Clinical Decision Rule|clinical decision rule
1164071|NCT02197780|Cohort Study|cohort study
1164072|NCT02197767|fibrillary GN|fibrillary gn
1164073|NCT02197767|rituximab|rituximab
1164074|NCT02197767|Rituxan|rituxan
1164075|NCT02197767|MabThera|mabthera
1164076|NCT02197767|Zytux|zytux
1164077|NCT02197754|pharmacokinetics|pharmacokinetics
1164078|NCT02197754|polyphenol metabolites|polyphenol metabolites
1164079|NCT02197754|lean individuals|lean individuals
1164080|NCT02197754|obese individuals|obese individuals
1164081|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
1164082|NCT02197715|Pregnancy|pregnancy
1164083|NCT02197715|Contraceptive Methods|contraceptive methods
1164084|NCT02197715|Family Planning Services|family planning services
1164086|NCT02197702|asthma|asthma
1164087|NCT02197702|pediatric|pediatric
1164088|NCT02197702|virus|virus
1164089|NCT02197702|corticosteroid|corticosteroid
1164090|NCT02197689|Personalized Medication Management|personalized medication management
1164091|NCT02197689|Medication Adherence|medication adherence
1164092|NCT02197689|SMS Medication Reminder|sms medication reminder
1164093|NCT02197663|acupuncture|acupuncture
1164094|NCT02197663|stroke|stroke
1164095|NCT02197663|Randomized Controlled Trial|randomized controlled trial
1164096|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
1164097|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
1164098|NCT02197611|Haemophilia|haemophilia
1164099|NCT02197611|Adherence of Treatment|adherence of treatment
1164100|NCT02197611|Knowledge of Illness|knowledge of illness
1164101|NCT02197611|Medical-patient Relationship|medical-patient relationship
1164102|NCT02197611|Illness Behavior|illness behavior
1164103|NCT02197611|Treatment Difficulties.|treatment difficulties.
1164104|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
1164105|NCT02197585|Male patients|male patients
1164106|NCT02197585|Age > 18 year|age > 18 year
1164107|NCT02197585|Primary hernia|primary hernia
1164108|NCT02197585|glue|glue
1164109|NCT02197572|Drug therapy|drug therapy
1164110|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
1164111|NCT02197546|Injection pain|injection pain
1164112|NCT02197546|local anesthesia|local anesthesia
1164113|NCT02197546|acupuncture|acupuncture
1164114|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
1164115|NCT02197481|Clamp crushing technique|clamp crushing technique
1164116|NCT02197481|Liver parenchyma transection|liver parenchyma transection
1164117|NCT02197481|Randomized controlled trial|randomized controlled trial
1164118|NCT02197468|Gut microbiome|gut microbiome
1164119|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
1164120|NCT02197468|Antibiotics|antibiotics
1164121|NCT02197429|Vulvodynia|vulvodynia
1164122|NCT02197429|Acupuncture|acupuncture
1164123|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
1164124|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
1164125|NCT02197429|Vulvar Pain|vulvar pain
1164126|NCT02197429|Dyspareunia|dyspareunia
1164127|NCT02197429|Female Sexual Function|female sexual function
1164128|NCT02197403|Dexmedetomidine|dexmedetomidine
1164129|NCT02197403|Sedation|sedation
1164130|NCT02197403|Paradoxical excitement response|paradoxical excitement response
1164131|NCT02197403|Alcohol drinkers|alcohol drinkers
1164132|NCT02197390|Childhood obesity|childhood obesity
1164133|NCT02197390|Latino|latino
1164134|NCT02197390|Hispanic|hispanic
1164135|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
1164136|NCT02197364|Interstitial Lung Disease|interstitial lung disease
1164137|NCT02197364|Diagnosis|diagnosis
1164138|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
1164139|NCT02197351|stomach neoplasms|stomach neoplasms
1164140|NCT02197351|narrow band imaging|narrow band imaging
1164141|NCT02197351|gastroscopy|gastroscopy
1164142|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
1164143|NCT02197325|NSTEMI and STEMI|nstemi and stemi
1164144|NCT02197312|yttrium-oxide|yttrium-oxide
1164145|NCT02197312|Y-TZP|y-tzp
1164146|NCT02197312|bridge|bridge
1164147|NCT02197312|NobelProcera|nobelprocera
1164148|NCT02197312|Shaded Zirconia|shaded zirconia
1164149|NCT02197273|Total knee arthroplasty|total knee arthroplasty
1164150|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
1164151|NCT02197273|Total hip arthroplasty|total hip arthroplasty
1164152|NCT02197273|Total joint arthroplasty|total joint arthroplasty
1164153|NCT02197273|Hip replacement|hip replacement
1164154|NCT02197273|Knee replacement|knee replacement
1164155|NCT02197273|Shoulder replacement|shoulder replacement
1164156|NCT02197260|Periodontitis|periodontitis
1164157|NCT02197260|amoxicillin|amoxicillin
1164158|NCT02197260|metronidazole|metronidazole
1164159|NCT02197260|case management|case management
1164160|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
1164161|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
1164162|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
1164163|NCT02197208|natural cycle|natural cycle
1164164|NCT02197208|spontaneous ovulation|spontaneous ovulation
1164165|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
1164166|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
1164167|NCT02197182|Amsel's criteria|amsel's criteria
1164168|NCT02197182|Pap smear|pap smear
1164170|NCT02197169|Brain Cancer|brain cancer
1164171|NCT02197169|Brain Neoplasms|brain neoplasms
1164172|NCT02197169|Central Nervous System Diseases|central nervous system diseases
1164173|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
1164174|NCT02197169|CNS|cns
1164175|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
1164176|NCT02197169|DNX-2401|dnx-2401
1164177|NCT02197169|Delta-24-RGD|delta-24-rgd
1164178|NCT02197169|Glioma|glioma
1164179|NCT02197169|Glioblastoma|glioblastoma
1164180|NCT02197169|Gliosarcoma|gliosarcoma
1164181|NCT02197169|Interferon gamma|interferon gamma
1164182|NCT02197169|Malignant brain tumor|malignant brain tumor
1164183|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
1164184|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
1164185|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
1164186|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
1164187|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1164188|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
1164189|NCT02197169|Nervous System Diseases|nervous system diseases
1164190|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
1164191|NCT02197169|AMC™|amc™
1164192|NCT02197169|Cannula|cannula
1164193|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
1164194|NCT02197143|esomeprazole|esomeprazole
1164195|NCT02197143|ranitidine|ranitidine
1164196|NCT02197143|hydrotalcid|hydrotalcid
1164197|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
1164198|NCT02197143|emergancy medicine|emergancy medicine
1164199|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
1164200|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
1164201|NCT02197065|hip fracture|hip fracture
1164202|NCT02197065|myocardial ischemia|myocardial ischemia
1164203|NCT02197065|statin|statin
1164204|NCT02197065|surgery|surgery
1164205|NCT02197065|troponin|troponin
1164206|NCT02197065|complication|complication
1164207|NCT02197065|arthroplasty|arthroplasty
1164208|NCT02197065|hip|hip
1164209|NCT02197065|knee|knee
1164210|NCT02197065|orthopedic|orthopedic
1164211|NCT02197065|atorvastatin|atorvastatin
1164212|NCT02197065|cardiovascular|cardiovascular
1164213|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
1164214|NCT02197000|BRCA mutation|brca mutation
1164215|NCT02197000|Breast cancer|breast cancer
1164216|NCT02197000|Estrogen metabolism|estrogen metabolism
1164217|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
1164218|NCT02197000|Breast density|breast density
1164219|NCT02196987|Pain|pain
1164220|NCT02196987|Catheter|catheter
1164221|NCT02196987|Urethra|urethra
1164222|NCT02196987|Urination|urination
1164223|NCT02196974|bronchoscopy|bronchoscopy
1164224|NCT02196974|lung nodule|lung nodule
1164227|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
1164228|NCT02196961|Adjuvant|adjuvant
1164229|NCT02196961|Nivolumab|nivolumab
1164230|NCT02196961|Ipilimumab|ipilimumab
1164231|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
1164232|NCT02196935|Cholangitis|cholangitis
1164233|NCT02196935|Choledocholithiasis|choledocholithiasis
1164234|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1164235|NCT02196935|Medically underserved area|medically underserved area
1164236|NCT02196935|Anesthesia|anesthesia
1164237|NCT02196922|Chronic Heart Failure|chronic heart failure
1164238|NCT02196922|Telehealth|telehealth
1164239|NCT02196922|Self Management|self management
1164240|NCT02196909|HIBM|hibm
1164241|NCT02196909|GNE|gne
1164242|NCT02196870|Airway pressure stress index|airway pressure stress index
1164243|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
1164244|NCT02196870|Acute Respiratory Failure|acute respiratory failure
1164245|NCT02196870|Chest wall elastance|chest wall elastance
1164246|NCT02196870|Lung stress|lung stress
1164247|NCT02196857|Leukemia|leukemia
1164248|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
1164249|NCT02196857|AML|aml
1164250|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
1164251|NCT02196857|MDS|mds
1164252|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
1164253|NCT02196857|Azacytidine|azacytidine
1164254|NCT02196857|5-Azacytidine|5-azacytidine
1164255|NCT02196857|5-AZA|5-aza
1164256|NCT02196857|Vidaza|vidaza
1164257|NCT02196857|5-AZC|5-azc
1164258|NCT02196857|AZA-CR|aza-cr
1164259|NCT02196857|Ladakamycin|ladakamycin
1164260|NCT02196857|NSC-102816|nsc-102816
1164261|NCT02196857|Sorafenib|sorafenib
1164262|NCT02196857|Nexavar|nexavar
1164263|NCT02196857|BAY 43-9006|bay 43-9006
1164264|NCT02196844|Lung cancer|lung cancer
1164265|NCT02196844|Hatha Yoga|hatha yoga
1164266|NCT02196844|Questionnaires|questionnaires
1164267|NCT02196844|Surveys|surveys
1164268|NCT02196844|Walk Test|walk test
1164269|NCT02196844|Caregiver|caregiver
1164270|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1164271|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
1164272|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
1164273|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
1164274|NCT02196831|tesamorelin|tesamorelin
1164275|NCT02196805|bioequivalence|bioequivalence
1164276|NCT02196805|imported PROBUCOL table|imported probucol table
1164277|NCT02196805|Lorelco|lorelco
1164278|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
1164279|NCT02196805|Chang Tai|chang tai
1164280|NCT02196792|Joint Diseases|joint diseases
1164281|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
1164282|NCT02196792|radiostereometric analysis|radiostereometric analysis
1164283|NCT02196792|Total hip arthroplasty|total hip arthroplasty
1164284|NCT02196779|Abdominoplasty|abdominoplasty
1164285|NCT02196779|circulation|circulation
1164286|NCT02196779|skin|skin
1164287|NCT02196779|dissection|dissection
1164288|NCT02196779|laser|laser
1164289|NCT02196779|fluorescence|fluorescence
1164290|NCT02196779|imaging|imaging
1164291|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
1164292|NCT02196753|PET CT|pet ct
1164293|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
1164294|NCT02196753|Infective endocarditis|infective endocarditis
1164295|NCT02196753|Generator pocket infection|generator pocket infection
1164296|NCT02196753|Fever of unknown origin|fever of unknown origin
1572219|NCT00493727|Proteinuria|proteinuria
1164297|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
1164298|NCT02196727|Postoperative pain|postoperative pain
1164299|NCT02196727|Multimodal analgesia|multimodal analgesia
1164300|NCT02196727|Bascom Cleft Lift|bascom cleft lift
1164301|NCT02196727|Day-case.|day-case.
1164302|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
1164303|NCT02196701|methotrexate|methotrexate
1164304|NCT02196701|adalimumab|adalimumab
1164305|NCT02196701|biologic|biologic
1164306|NCT02196701|psoriasis|psoriasis
1164307|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
1164308|NCT02196688|subjects with mCRC who failed at least 2nd line therapy|subjects with mcrc who failed at least 2nd line therapy
1164309|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
1164310|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
1164311|NCT02196610|hemodialysis,|hemodialysis,
1164312|NCT02196610|Pulse wave velocity|pulse wave velocity
1164313|NCT02196610|Renal insufficiency,|renal insufficiency,
1164314|NCT02196610|tonometry|tonometry
1164315|NCT02196597|anorectal manometry|anorectal manometry
1164316|NCT02196571|GDM|gdm
1164317|NCT02196571|Exercise|exercise
1164318|NCT02196571|Diabetes|diabetes
1164319|NCT02196571|Pregnancy|pregnancy
1164320|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
1164321|NCT02196558|Japanese subjects|japanese subjects
1164322|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
1164421|NCT02196012|obesity|obesity
1164323|NCT02196532|optical coherence tomography|optical coherence tomography
1164324|NCT02196532|migraine|migraine
1164325|NCT02196506|OPC-34712|opc-34712
1164326|NCT02196506|brexpiprazole|brexpiprazole
1164327|NCT02196506|Major Depressive Disorder|major depressive disorder
1164328|NCT02196506|Adjunctive Treatment|adjunctive treatment
1164329|NCT02196506|Anxious Distress|anxious distress
1164330|NCT02196493|Productive|productive
1164331|NCT02196493|Cough|cough
1164332|NCT02196493|Bronchitis|bronchitis
1164333|NCT02196493|Azithromycin|azithromycin
1164334|NCT02196467|myoblast|myoblast
1164335|NCT02196467|transplantation|transplantation
1164336|NCT02196467|strength|strength
1164337|NCT02196467|tacrolimus|tacrolimus
1164338|NCT02196467|immunosuppression|immunosuppression
1164339|NCT02196454|HPV vaccine|hpv vaccine
1164340|NCT02196454|vaccination|vaccination
1164341|NCT02196454|immunization|immunization
1164342|NCT02196454|video|video
1164343|NCT02196454|health education|health education
1164344|NCT02196454|communication|communication
1164345|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
1164346|NCT02196441|topical anesthesia|topical anesthesia
1164347|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
1164348|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
1164349|NCT02196428|Telemonitoring|telemonitoring
1164350|NCT02196428|Teleconsultation|teleconsultation
1164351|NCT02196415|Hindfoot Alignment|hindfoot alignment
1164352|NCT02196415|Rearfoot|rearfoot
1164353|NCT02196415|Malalignment|malalignment
1164354|NCT02196415|biplanar radiography|biplanar radiography
1164355|NCT02196415|3D measurement|3d measurement
1164356|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
1164357|NCT02196376|orthostatic intolerance|orthostatic intolerance
1165145|NCT02193061|Rotarix|rotarix
1164358|NCT02196376|autonomic dysfunction|autonomic dysfunction
1164359|NCT02196350|personalized treatment|personalized treatment
1164360|NCT02196350|prevention|prevention
1164361|NCT02196350|improved diagnosis|improved diagnosis
1164362|NCT02196337|Iodine deficiency|iodine deficiency
1164363|NCT02196324|Prurigo Nodularis|prurigo nodularis
1164364|NCT02196324|Atopic Dermatitis|atopic dermatitis
1164365|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
1164366|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
1164367|NCT02196298|physical therapy|physical therapy
1164368|NCT02196298|gait|gait
1164369|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
1164370|NCT02196298|gross motor function|gross motor function
1164371|NCT02196298|participation|participation
1164372|NCT02196285|Double|double
1164373|NCT02196285|Viral|viral
1164374|NCT02196285|Vaccine|vaccine
1164375|NCT02196285|Measles|measles
1164376|NCT02196285|Rubella|rubella
1164377|NCT02196285|Safety|safety
1164378|NCT02196285|Efficacy|efficacy
1164379|NCT02196285|Imunogenicity|imunogenicity
1164380|NCT02196259|Pre-Post|pre-post
1164381|NCT02196233|Trigger Finger|trigger finger
1164382|NCT02196233|Prospective Clinical Research|prospective clinical research
1164383|NCT02196233|Randomized|randomized
1164384|NCT02196233|Questionnaires|questionnaires
1164385|NCT02196233|Transverse|transverse
1164386|NCT02196233|Longitudinal|longitudinal
1164387|NCT02196207|Severe Hemophilia A|severe hemophilia a
1164388|NCT02196207|Previously Untreated Patients|previously untreated patients
1164389|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
1164390|NCT02196207|Long-Acting Factor VIII|long-acting factor viii
1164391|NCT02196207|Prophylaxis|prophylaxis
1164392|NCT02196155|plantar fasciitis|plantar fasciitis
1164393|NCT02196155|Botulinum toxin A|botulinum toxin a
1164394|NCT02196155|Cortisone|cortisone
1164395|NCT02196155|RCT|rct
1164396|NCT02196142|Cortisol|cortisol
1164397|NCT02196142|Alcohol Craving|alcohol craving
1164398|NCT02196142|Alcohol Dependence|alcohol dependence
1164399|NCT02196129|low back pain|low back pain
1164400|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
1164401|NCT02196129|sinbaro-3|sinbaro-3
1164402|NCT02196116|Alzheimer disease|alzheimer disease
1164403|NCT02196116|amyloid load|amyloid load
1164404|NCT02196116|educational level|educational level
1164405|NCT02196116|cognitive performances|cognitive performances
1164406|NCT02196103|TOLAC|tolac
1164407|NCT02196103|PROM|prom
1164408|NCT02196103|Previous Cesarian section|previous cesarian section
1164409|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
1164410|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
1164411|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
1164412|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
1164413|NCT02196051|Insulin resistance|insulin resistance
1164414|NCT02196051|Exercise|exercise
1164415|NCT02196051|de novo lipogenesis|de novo lipogenesis
1164416|NCT02196051|NAFLD|nafld
1164417|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1164418|NCT02196038|heart failure|heart failure
1164419|NCT02196025|Insomnia|insomnia
1164420|NCT02196012|overweight|overweight
1164422|NCT02196012|Technology|technology
1164423|NCT02196012|College Students|college students
1164424|NCT02195986|vaginal dryness|vaginal dryness
1164425|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
1164426|NCT02195986|dysuria|dysuria
1164427|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
1164428|NCT02195986|vaginal atrophy|vaginal atrophy
1164429|NCT02195973|ovarian cancer|ovarian cancer
1164430|NCT02195973|platinum resistant|platinum resistant
1164431|NCT02195973|LED225|led225
1164432|NCT02195973|Sonidegib|sonidegib
1164433|NCT02195973|Paclitaxel|paclitaxel
1164434|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
1164435|NCT02195947|Growth hormone|growth hormone
1164436|NCT02195947|IVF/ICSI|ivf/icsi
1164437|NCT02195947|Poor responder|poor responder
1164438|NCT02195947|Antagonist protocol|antagonist protocol
1164439|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
1164440|NCT02195895|Teriparatide|teriparatide
1164441|NCT02195895|Alendronate|alendronate
1164442|NCT02195895|Alendronic Acid|alendronic acid
1164443|NCT02195895|Osteoporosis|osteoporosis
1164444|NCT02195895|Bone Fracture|bone fracture
1164445|NCT02195895|Bone Loss|bone loss
1164446|NCT02195895|Spinal Cord Injury|spinal cord injury
1164447|NCT02195895|Bone Diseases|bone diseases
1164448|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
1164449|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
1164450|NCT02195895|Spinal Cord Diseases|spinal cord diseases
1164451|NCT02195895|Central Nervous System Diseases|central nervous system diseases
1164452|NCT02195895|Nervous System Diseases|nervous system diseases
1164453|NCT02195895|Nervous System|nervous system
1165146|NCT02193061|RotaTeq|rotateq
1164454|NCT02195895|Wounds and Injuries|wounds and injuries
1164455|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
1164456|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
1164457|NCT02195895|Pharmacologic Actions|pharmacologic actions
1164458|NCT02195882|strength training|strength training
1164459|NCT02195882|scapular stabilization|scapular stabilization
1164460|NCT02195882|kayakers.|kayakers.
1164461|NCT02195869|PCYC1129|pcyc1129
1164462|NCT02195869|PCYC1129CA|pcyc1129ca
1164463|NCT02195869|1129|1129
1164464|NCT02195869|Ibrutinib|ibrutinib
1164465|NCT02195869|PCI32765|pci32765
1164466|NCT02195869|IMBRUVICA|imbruvica
1164467|NCT02195869|Pharmacyclics|pharmacyclics
1164468|NCT02195869|PCYC|pcyc
1164469|NCT02195869|GVHD|gvhd
1164470|NCT02195869|Steroid dependent|steroid dependent
1164471|NCT02195869|refractory|refractory
1164472|NCT02195869|chronic|chronic
1164473|NCT02195869|graft versus host disease|graft versus host disease
1164474|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
1164475|NCT02195869|immunology|immunology
1164476|NCT02195856|Diabetes|diabetes
1164477|NCT02195856|Nitrate|nitrate
1164478|NCT02195856|Nitrite|nitrite
1164479|NCT02195856|Hepatic|hepatic
1164480|NCT02195856|MRI|mri
1164481|NCT02195856|Incretin|incretin
1164482|NCT02195856|Insulin|insulin
1164483|NCT02195856|Glucose|glucose
1164484|NCT02195843|CRT-D|crt-d
1164485|NCT02195843|Heart Failure|heart failure
1164486|NCT02195843|Middle East|middle east
1164487|NCT02195843|Quadripolar|quadripolar
1164488|NCT02195830|Sepsis|sepsis
1164489|NCT02195830|ultrasound|ultrasound
1333241|NCT01443858|Cigarette Smoking|cigarette smoking
1164490|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
1164491|NCT02195778|Health Literacy|health literacy
1164492|NCT02195778|Adult|adult
1164493|NCT02195778|UAE|uae
1164494|NCT02195778|Disease|disease
1164495|NCT02195778|Age|age
1164496|NCT02195765|Chronic Periodontitis|chronic periodontitis
1164497|NCT02195765|Periodontal disease|periodontal disease
1164498|NCT02195752|Compounded pain cream|compounded pain cream
1164499|NCT02195752|Ordinary care|ordinary care
1164500|NCT02195752|Compounding|compounding
1164501|NCT02195752|Topical treatment|topical treatment
1164502|NCT02195752|Analgesia|analgesia
1164503|NCT02195739|smoking|smoking
1164504|NCT02195739|smoking cessation|smoking cessation
1164505|NCT02195739|cardiovascular disease|cardiovascular disease
1164506|NCT02195739|pharmacological intervention|pharmacological intervention
1164507|NCT02195739|UK primary care population|uk primary care population
1164508|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
1164509|NCT02195700|Dyskinesias|dyskinesias
1164510|NCT02195700|Movement Disorders|movement disorders
1164511|NCT02195700|Central Nervous System Diseases|central nervous system diseases
1164512|NCT02195700|Nervous System Diseases|nervous system diseases
1164513|NCT02195700|Neurologic Manifestations|neurologic manifestations
1164514|NCT02195700|Signs and Symptoms|signs and symptoms
1164515|NCT02195661|Epilepsy|epilepsy
1164516|NCT02195661|Electroencephalogram|electroencephalogram
1164517|NCT02195661|children|children
1164518|NCT02195661|sedation|sedation
1164519|NCT02195648|Tension-Type Headache|tension-type headache
1164520|NCT02195648|Physical Therapy Modalities|physical therapy modalities
1164919|NCT02193932|intractable|intractable
1164521|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
1164522|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
1164523|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
1164524|NCT02195609|Menopause|menopause
1164525|NCT02195609|Hot Flashes|hot flashes
1164526|NCT02195609|Postmenopausal Women|postmenopausal women
1164527|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
1164528|NCT02195570|contingency management|contingency management
1164529|NCT02195570|smoking cessation|smoking cessation
1164530|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
1164531|NCT02195570|maternal smoking|maternal smoking
1164532|NCT02195531|Adherence|adherence
1164533|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
1164534|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1164535|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
1164536|NCT02195479|Multiple Myeloma|multiple myeloma
1164537|NCT02195479|Bortezomib|bortezomib
1164538|NCT02195479|Velcade|velcade
1164539|NCT02195479|Melphalan|melphalan
1164540|NCT02195479|Prednisone|prednisone
1164541|NCT02195479|Daratumumab|daratumumab
1164542|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
1164543|NCT02195453|FACT-L scale|fact-l scale
1164544|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
1164545|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
1164546|NCT02195427|Nasolabial folds|nasolabial folds
1164547|NCT02195427|Dermal filler|dermal filler
1164548|NCT02195427|Hyaluronic acid (HA)|hyaluronic acid (ha)
1164549|NCT02195427|Wrinkles|wrinkles
1164550|NCT02195414|NeoVas|neovas
1164551|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
1164552|NCT02195414|Sirolimus|sirolimus
1164553|NCT02195414|First-in-Man|first-in-man
1164648|NCT02195037|Delayed Cord Clamping|delayed cord clamping
1164554|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
1164555|NCT02195388|Arterial stiffness,|arterial stiffness,
1164556|NCT02195388|endothelial function,|endothelial function,
1164557|NCT02195388|autonomic nervous system,|autonomic nervous system,
1164558|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
1164559|NCT02195388|arterial hypertension,|arterial hypertension,
1164560|NCT02195388|pulse wave velocity,|pulse wave velocity,
1164561|NCT02195388|augmentation index,|augmentation index,
1164562|NCT02195388|arterial stiffness index,|arterial stiffness index,
1164563|NCT02195388|heart rate variability,|heart rate variability,
1164564|NCT02195388|heart rate turbulence,|heart rate turbulence,
1164565|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
1164566|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
1164567|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1164568|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
1164569|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
1164570|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
1164571|NCT02195349|Biopsy|biopsy
1164572|NCT02195349|Induration|induration
1164573|NCT02195349|First time in human|first time in human
1164574|NCT02195349|T-cells|t-cells
1164575|NCT02195349|LAG-3|lag-3
1164576|NCT02195349|safety|safety
1164577|NCT02195349|GSK2831781|gsk2831781
1164578|NCT02195349|psoriasis|psoriasis
1164579|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
1164580|NCT02195310|Sternotomy|sternotomy
1164581|NCT02195310|Surgical site Occurences|surgical site occurences
1164582|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
1164583|NCT02195310|Surgical Site Infection|surgical site infection
1164584|NCT02195297|cellulitis|cellulitis
1164585|NCT02195297|anticellulitis|anticellulitis
1164586|NCT02195284|Inhaler preference|inhaler preference
1164587|NCT02195284|Overall inhaler error|overall inhaler error
1164588|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
1164590|NCT02195284|TURBUHALER|turbuhaler
1164591|NCT02195284|ELLIPTA|ellipta
1164592|NCT02195284|Ease of use|ease of use
1164593|NCT02195284|Critical inhaler error|critical inhaler error
1164594|NCT02195271|Melatonin|melatonin
1164595|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1164596|NCT02195271|Neuroplasticity|neuroplasticity
1164597|NCT02195271|Analgesia|analgesia
1164598|NCT02195271|Pain|pain
1164599|NCT02195245|CO2 filter|co2 filter
1164600|NCT02195245|anesthesia|anesthesia
1164601|NCT02195245|device|device
1164602|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
1164603|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
1164604|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
1164605|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
1164606|NCT02195219|conservative|conservative
1164607|NCT02195219|treatment|treatment
1164608|NCT02195219|surgical|surgical
1164609|NCT02195219|Acromioclavicular|acromioclavicular
1164610|NCT02195219|Joint|joint
1164611|NCT02195219|dislocation|dislocation
1164710|NCT02194686|cardiovascular disease|cardiovascular disease
1164612|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
1164613|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
1164614|NCT02195206|Lung Imaging|lung imaging
1164615|NCT02195206|Healthy Adults|healthy adults
1164616|NCT02195193|Health Services Research|health services research
1164617|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
1164618|NCT02195193|Depression|depression
1164619|NCT02195193|Integrated care|integrated care
1164620|NCT02195180|Pancreas|pancreas
1164621|NCT02195180|adenocarcinoma|adenocarcinoma
1164622|NCT02195180|cancer|cancer
1164623|NCT02195180|asparaginase|asparaginase
1164624|NCT02195180|erythrocytes|erythrocytes
1164625|NCT02195180|red blood cell|red blood cell
1164626|NCT02195180|Encapsulation|encapsulation
1164627|NCT02195180|folfox|folfox
1164628|NCT02195180|gemcitabine|gemcitabine
1164629|NCT02195154|18F-DTBZ|18f-dtbz
1164630|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
1164631|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
1164632|NCT02195141|boost|boost
1164633|NCT02195141|IMRT|imrt
1164634|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
1164635|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
1164636|NCT02195076|Lung cancer|lung cancer
1164637|NCT02195076|Breast Cancer|breast cancer
1164638|NCT02195076|Biosensors|biosensors
1164639|NCT02195076|Volatile Organic Compounds|volatile organic compounds
1164640|NCT02195076|Odor|odor
1164641|NCT02195076|Urine Sample|urine sample
1164642|NCT02195076|Exhaled Breath Samples|exhaled breath samples
1164643|NCT02195063|Pain management|pain management
1164644|NCT02195063|Scar care|scar care
1164645|NCT02195063|Wound care|wound care
1164646|NCT02195063|UDT|udt
1164647|NCT02195063|Urinary drug testing|urinary drug testing
1164649|NCT02195024|pacemaker|pacemaker
1164650|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
1164651|NCT02195024|MRI conditional|mri conditional
1164652|NCT02195024|pacemaker leads|pacemaker leads
1164653|NCT02195011|Regorafenib|regorafenib
1164655|NCT02195011|Radioembolization|radioembolization
1164656|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
1164657|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
1164658|NCT02195011|Liver Metastases|liver metastases
1164659|NCT02195011|SIRT|sirt
1164660|NCT02195011|Refractory|refractory
1164661|NCT02194985|Fabry disease|fabry disease
1164662|NCT02194985|Lysosomal storage disease|lysosomal storage disease
1164663|NCT02194985|migalastat HCl|migalastat hcl
1164664|NCT02194985|AT1001|at1001
1164665|NCT02194972|constipation|constipation
1164666|NCT02194972|colon transit time|colon transit time
1164667|NCT02194972|gut microbiota|gut microbiota
1164668|NCT02194972|soluble dietary fiber|soluble dietary fiber
1164669|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
1164670|NCT02194959|Patient Navigation|patient navigation
1164671|NCT02194959|Screening Colonoscopy|screening colonoscopy
1164672|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
1164673|NCT02194959|African Americans|african americans
1164674|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
1164675|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
1164676|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
1164677|NCT02194946|dialysis initiation.|dialysis initiation.
1164678|NCT02194933|Schizophrenia|schizophrenia
1164679|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
1164680|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
1164681|NCT02194907|Emotional Aging|emotional aging
1164682|NCT02194907|Neurofeedback|neurofeedback
1164683|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
1164684|NCT02194881|Cystic fibrosis|cystic fibrosis
1164686|NCT02194881|G551D mutation|g551d mutation
1164687|NCT02194881|Novel treatments|novel treatments
1164688|NCT02194881|Potentiator|potentiator
1164689|NCT02194881|Ivacaftor|ivacaftor
1164690|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
1164691|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
1164692|NCT02194868|acute graft versus host disease|acute graft versus host disease
1164693|NCT02194855|rocuronium|rocuronium
1164694|NCT02194855|cisatracurium|cisatracurium
1164695|NCT02194855|pharmacokinetic|pharmacokinetic
1164696|NCT02194842|metastatic|metastatic
1164697|NCT02194842|prostate cancer|prostate cancer
1164698|NCT02194816|Parkinson's Disease|parkinson's disease
1164699|NCT02194816|PD|pd
1164700|NCT02194816|Complementary and Alternative|complementary and alternative
1164701|NCT02194816|CAM|cam
1164702|NCT02194790|Chronic Kidney Disease|chronic kidney disease
1164703|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
1164704|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
1164705|NCT02194725|Stress and Coping Model|stress and coping model
1164706|NCT02194725|Coping|coping
1164707|NCT02194712|circulating anodic antigen|circulating anodic antigen
1164708|NCT02194686|cilostazol|cilostazol
1164709|NCT02194686|progenitor cells|progenitor cells
1164711|NCT02194686|risk factors|risk factors
1164712|NCT02194686|angiogenesis|angiogenesis
1164713|NCT02194686|biological markers|biological markers
1164714|NCT02194686|endothelial function|endothelial function
1164715|NCT02194660|Fractures Liaison Service|fractures liaison service
1164716|NCT02194660|Osteoporosis|osteoporosis
1164717|NCT02194660|Fracture|fracture
1164718|NCT02194660|Medication adherence|medication adherence
1164719|NCT02194647|Osteoporosis|osteoporosis
1164720|NCT02194647|Medication Monitoring|medication monitoring
1164721|NCT02194647|Education|education
1164722|NCT02194647|Adherence|adherence
1164723|NCT02194647|Management|management
1164724|NCT02194595|type 2 diabetes|type 2 diabetes
1164725|NCT02194595|beta-cell function|beta-cell function
1164726|NCT02194595|GLP-1|glp-1
1164727|NCT02194595|insulin|insulin
1164728|NCT02194582|FSGS|fsgs
1164729|NCT02194582|NS|ns
1164730|NCT02194582|Kidney disease|kidney disease
1164731|NCT02194582|Kidney failure|kidney failure
1164732|NCT02194582|Renal disease|renal disease
1164733|NCT02194582|nephrotic syndrome|nephrotic syndrome
1164734|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1164735|NCT02194582|familial kidney disease|familial kidney disease
1164736|NCT02194582|minimal change disease|minimal change disease
1164737|NCT02194582|proteinuria|proteinuria
1164738|NCT02194543|Cataract|cataract
1164739|NCT02194543|HD 3D|hd 3d
1164740|NCT02194543|Microscope|microscope
1164741|NCT02194530|Peanut allergic individuals|peanut allergic individuals
1164742|NCT02194530|Allergic/atopic individuals (not allergic to peanut)|allergic/atopic individuals (not allergic to peanut)
1164743|NCT02194530|Non-allergic individuals|non-allergic individuals
1164744|NCT02194517|diabetes|diabetes
1164745|NCT02194517|diet control toolset|diet control toolset
1164746|NCT02194517|food exchanges|food exchanges
1164747|NCT02194517|CHO|cho
1164748|NCT02194517|FP|fp
1164749|NCT02194504|Metabolic health|metabolic health
1164750|NCT02194504|Phenotyping|phenotyping
1164751|NCT02194504|Abdominal obesity|abdominal obesity
1164752|NCT02194504|Abdominal adiposity|abdominal adiposity
1164753|NCT02194504|Liver fat|liver fat
1164754|NCT02194504|Belly fat|belly fat
1164755|NCT02194491|[11C]AS2471907|[11c]as2471907
1164756|NCT02194491|ASP3662|asp3662
1164757|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
1164758|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
1164759|NCT02194478|Stress|stress
1164760|NCT02194478|Meditation|meditation
1164761|NCT02194478|Mind body|mind body
1164762|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
1164763|NCT02194439|Affect|affect
1164764|NCT02194439|Anti-inflammatory|anti-inflammatory
1164765|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
1164766|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
1164767|NCT02194439|Alloantigen|alloantigen
1164768|NCT02194439|Allogeneic|allogeneic
1164769|NCT02194439|Allograft rejection|allograft rejection
1164770|NCT02194439|Allograft Tolerance|allograft tolerance
1164771|NCT02194439|Antigens|antigens
1164772|NCT02194439|Autoimmunity|autoimmunity
1164773|NCT02194439|Biomarkers|biomarkers
1164774|NCT02194439|Biospecimen Repository|biospecimen repository
1164775|NCT02194439|BMT|bmt
1164776|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
1164777|NCT02194439|Cell Transplantation|cell transplantation
1164778|NCT02194439|Cells|cells
1164779|NCT02194439|Clonal Expansion|clonal expansion
1164780|NCT02194439|Complex|complex
1164781|NCT02194439|Cytokine|cytokine
1164782|NCT02194439|Data|data
1164783|NCT02194439|Development|development
1164784|NCT02194439|Environment|environment
1164785|NCT02194439|Failure (biologic function)|failure (biologic function)
1164786|NCT02194439|Genomics|genomics
1164787|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
1164788|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
1164789|NCT02194439|GVHD|gvhd
1164790|NCT02194439|GVL|gvl
1164791|NCT02194439|Hematopoietic|hematopoietic
1164792|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1164793|NCT02194439|HCT|hct
1164794|NCT02194439|HSCT|hsct
1164795|NCT02194439|IL-33 Receptor|il-33 receptor
1164796|NCT02194439|Immune Reconstitution|immune reconstitution
1164797|NCT02194439|Immune Response|immune response
1164798|NCT02194439|Inflammatory|inflammatory
1164799|NCT02194439|Modeling|modeling
1164800|NCT02194439|Novel|novel
1164801|NCT02194439|Novel therapeutics|novel therapeutics
1164802|NCT02194439|Outcome|outcome
1164803|NCT02194439|Pathway interactions|pathway interactions
1164804|NCT02194439|Peptides|peptides
1164805|NCT02194439|Prevent|prevent
1164806|NCT02194439|Process|process
1164807|NCT02194439|Production|production
1164808|NCT02194439|Proteomics|proteomics
1164809|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
1164810|NCT02194439|Response|response
1164811|NCT02194439|Role|role
1164812|NCT02194439|Signal|signal
1164813|NCT02194439|ST2|st2
1164814|NCT02194439|Transduction|transduction
1164815|NCT02194439|T-cell response|t-cell response
1164816|NCT02194439|T-cell Activation|t-cell activation
1164817|NCT02194439|T-Lymphocytes|t-lymphocytes
1164818|NCT02194439|Tissues|tissues
1164819|NCT02194400|RSLV-132|rslv-132
1164820|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
1164821|NCT02194400|Lupus|lupus
1164822|NCT02194400|SLE|sle
1164823|NCT02194400|Resolve|resolve
1164824|NCT02194387|Breast Cancer|breast cancer
1164825|NCT02194387|Ovarian Cancer|ovarian cancer
1164826|NCT02194387|Triple negative breast cancer|triple negative breast cancer
1164827|NCT02194387|TNBC|tnbc
1164828|NCT02194387|BRCA-positive survivor|brca-positive survivor
1164829|NCT02194387|High-grade serous ovarian cancer|high-grade serous ovarian cancer
1164830|NCT02194387|HGSOC|hgsoc
1164831|NCT02194387|Female biological relative of a BRCA positive TNBC or HGSOC survivor|female biological relative of a brca positive tnbc or hgsoc survivor
1164832|NCT02194387|Cancer survivors|cancer survivors
1164833|NCT02194387|Employees at MD Anderson|employees at md anderson
1164834|NCT02194387|Multi-phase Optimization Strategy|multi-phase optimization strategy
1164835|NCT02194387|MOST|most
1164836|NCT02194387|Energy balance interventions|energy balance interventions
1164837|NCT02194387|EB|eb
1164838|NCT02194387|Telephone Coaching|telephone coaching
1164839|NCT02194387|Text Messaging|text messaging
1164840|NCT02194387|Resistance Training|resistance training
1164841|NCT02194387|Daily Self-Monitoring|daily self-monitoring
1164842|NCT02194387|Weekly Self-Monitoring|weekly self-monitoring
1164843|NCT02194387|Email Coaching|email coaching
1164844|NCT02194387|Questionnaires|questionnaires
1164845|NCT02194387|Surveys|surveys
1164846|NCT02194374|Leukemia|leukemia
1164847|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1164848|NCT02194374|CLL|cll
1164849|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
1164850|NCT02194374|SLL|sll
1164851|NCT02194374|B cell|b cell
1164852|NCT02194374|ROR1-specific T cells|ror1-specific t cells
1164853|NCT02194374|Fludarabine|fludarabine
1164854|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
1164855|NCT02194374|Fludara|fludara
1164856|NCT02194374|Cyclophosphamide|cyclophosphamide
1164857|NCT02194374|Cytoxan|cytoxan
1164858|NCT02194374|Neosar|neosar
1164859|NCT02194374|Rituximab|rituximab
1164860|NCT02194374|Rituxan|rituxan
1164861|NCT02194374|Bendamustine|bendamustine
1164862|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
1164863|NCT02194374|Bendamustine HCL|bendamustine hcl
1164864|NCT02194374|CEP-18083|cep-18083
1164865|NCT02194374|SDX-105|sdx-105
1164866|NCT02194374|Treanda|treanda
1164867|NCT02194231|Mesothelioma|mesothelioma
1164868|NCT02194231|MPM|mpm
1164869|NCT02194231|Trabectedin|trabectedin
1164870|NCT02194192|prevention of hypotension|prevention of hypotension
1164871|NCT02194192|spinal anesthesia|spinal anesthesia
1164872|NCT02194192|cesarean section|cesarean section
1164873|NCT02194192|ephedrine|ephedrine
1164874|NCT02194192|ondansetron|ondansetron
1164875|NCT02194140|ultrasound|ultrasound
1164876|NCT02194140|iodinated contrast material|iodinated contrast material
1164877|NCT02194140|computed tomography|computed tomography
1164878|NCT02194114|Chronic Renal Failure|chronic renal failure
1164879|NCT02194114|End-Stage Renal Disease|end-stage renal disease
1164880|NCT02194114|Nitrogen Balance|nitrogen balance
1164881|NCT02194114|Dietary Protein Intake|dietary protein intake
1164882|NCT02194101|oxygen delivery|oxygen delivery
1164883|NCT02194101|proximal femoral fracture|proximal femoral fracture
1164884|NCT02194101|goal-directed therapy|goal-directed therapy
1164885|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
1164886|NCT02194062|Nasal steroids|nasal steroids
1164887|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
1164888|NCT02194062|SNOT-22|snot-22
1164889|NCT02194062|Lund-Kennedy|lund-kennedy
1164890|NCT02194036|Ownership of body|ownership of body
1164891|NCT02194036|Bodily and mental balance|bodily and mental balance
1164892|NCT02194036|Learning|learning
1164893|NCT02194036|Body image|body image
1164894|NCT02194036|Sensations|sensations
1164895|NCT02194036|Expectations|expectations
1164896|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
1164897|NCT02194023|gingivitis|gingivitis
1164898|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
1164899|NCT02194023|mouthrinse|mouthrinse
1164900|NCT02194023|dental plaque|dental plaque
1164901|NCT02194023|de novo|de novo
1164902|NCT02194023|in vivo|in vivo
1164903|NCT02194010|Outcome Measure|outcome measure
1164904|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
1164905|NCT02193984|Diabetes|diabetes
1164906|NCT02193984|Peer support|peer support
1164907|NCT02193984|Hispanic|hispanic
1164908|NCT02193984|Latino|latino
1164909|NCT02193971|Acute coronary syndrome|acute coronary syndrome
1164910|NCT02193971|Drug eluting stent|drug eluting stent
1164911|NCT02193971|Everolimus|everolimus
1164912|NCT02193971|Prasugrel|prasugrel
1164913|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
1164914|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1164915|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
1164916|NCT02193932|EEG triggered|eeg triggered
1164917|NCT02193932|fMRI|fmri
1164918|NCT02193932|epilepsy|epilepsy
1164920|NCT02193919|psoriasis|psoriasis
1164921|NCT02193906|Cognitive training|cognitive training
1164922|NCT02193906|Multiple sclerosis|multiple sclerosis
1164923|NCT02193906|Cognitive deficits|cognitive deficits
1164924|NCT02193893|cell-based therapy|cell-based therapy
1164925|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
1164926|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
1164927|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
1164928|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
1164929|NCT02193880|stem cell transplant|stem cell transplant
1164930|NCT02193867|LIPA|lipa
1164931|NCT02193867|Wolman Disease|wolman disease
1164932|NCT02193867|Wolman Phenotype|wolman phenotype
1164933|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
1164934|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
1164935|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
1164936|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
1164937|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
1164938|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
1164939|NCT02193867|LAL Deficiency|lal deficiency
1164940|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
1164941|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
1164942|NCT02193867|Related Disorders:|related disorders:
1164943|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1164944|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1164945|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
1164946|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
1164947|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
1164948|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
1164949|NCT02193854|Telemedicine|telemedicine
1164950|NCT02193854|Mobile phone|mobile phone
1164951|NCT02193854|Rural physicians|rural physicians
1164952|NCT02193854|Mongolia|mongolia
1164953|NCT02193841|Simple bone cyst|simple bone cyst
1164954|NCT02193841|Unicameral bone cyst|unicameral bone cyst
1164955|NCT02193828|Dupuytren's nodules|dupuytren's nodules
1164956|NCT02193815|psoriasis|psoriasis
1164957|NCT02193815|plaque|plaque
1164958|NCT02193815|vulgaris|vulgaris
1164959|NCT02193815|phase 1|phase 1
1164960|NCT02193815|randomized|randomized
1164961|NCT02193815|double-blind|double-blind
1164962|NCT02193815|topical|topical
1164963|NCT02193815|safety|safety
1164964|NCT02193802|Crohn's disease|crohn's disease
1164965|NCT02193802|small bowel (SB)|small bowel (sb)
1164966|NCT02193802|capsule endoscopy|capsule endoscopy
1164967|NCT02193802|ileocolonoscopy|ileocolonoscopy
1164968|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
1164969|NCT02193789|Anastomosis site structure|anastomosis site structure
1164970|NCT02193789|Stent insertion|stent insertion
1164971|NCT02193789|Stent migration|stent migration
1164972|NCT02193776|Tuberculosis|tuberculosis
1164973|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
1164974|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
1164975|NCT02193776|Pa-824|pa-824
1164976|NCT02193776|Bedaquiline|bedaquiline
1164977|NCT02193776|Moxifloxacin|moxifloxacin
1164978|NCT02193776|Pyrazinamide|pyrazinamide
1164979|NCT02193776|Nitroimidazole|nitroimidazole
1164980|NCT02193776|Quinolone|quinolone
1164981|NCT02193776|Pretomanid|pretomanid
1164982|NCT02193776|NC-005|nc-005
1164983|NCT02193763|pediatric|pediatric
1164984|NCT02193763|lumbar puncture|lumbar puncture
1164985|NCT02193763|ultrasonography|ultrasonography
1164986|NCT02193763|efficacy|efficacy
1164987|NCT02193750|Crohn's Disease|crohn's disease
1164988|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
1164989|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
1164990|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
1164991|NCT02193698|POEMS syndrome|poems syndrome
1164992|NCT02193698|lenalidomide|lenalidomide
1164993|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
1164994|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
1164995|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
1164996|NCT02193685|Children|children
1164997|NCT02193672|Advanced cancers|advanced cancers
1164998|NCT02193672|PET/CT|pet/ct
1164999|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
1165000|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
1165001|NCT02193672|Chemotherapy|chemotherapy
1165002|NCT02193672|Phone calls|phone calls
1165003|NCT02193659|breakfast cereal|breakfast cereal
1165004|NCT02193659|omega-3|omega-3
1165005|NCT02193659|cholesterol|cholesterol
1165006|NCT02193659|lipidic profile|lipidic profile
1165007|NCT02193659|consumption|consumption
1165008|NCT02193659|acceptability|acceptability
1165009|NCT02193646|Colonoscopy|colonoscopy
1165010|NCT02193646|Adenoma|adenoma
1165012|NCT02193646|Screening Colon Cancer|screening colon cancer
1165013|NCT02193620|Analgesic|analgesic
1165014|NCT02193620|Narcotics|narcotics
1165015|NCT02193620|Opioids|opioids
1165016|NCT02193620|Pain relief after surgery|pain relief after surgery
1165017|NCT02193607|Occult stress incontinence|occult stress incontinence
1165018|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
1165019|NCT02193607|Surgical Intervention|surgical intervention
1165020|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
1165021|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
1165022|NCT02193607|Combined Surgery|combined surgery
1165023|NCT02193607|Two-step Approach|two-step approach
1165024|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
1165025|NCT02193607|Randomized Controlled Trial|randomized controlled trial
1165026|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
1165027|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1165028|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
1165029|NCT02193568|Supratentorial Glioma|supratentorial glioma
1165030|NCT02193568|Craniotomy|craniotomy
1165031|NCT02193555|Presbyopia|presbyopia
1165032|NCT02193555|Refractive error correction|refractive error correction
1165033|NCT02193555|Contact lenses|contact lenses
1165034|NCT02193542|regional anesthesia|regional anesthesia
1165035|NCT02193542|general anesthesia|general anesthesia
1165036|NCT02193542|obstetric|obstetric
1165037|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
1165038|NCT02193503|cancer|cancer
1165039|NCT02193503|solid tumors|solid tumors
1165040|NCT02193503|gene therapy|gene therapy
1165041|NCT02193503|cell therapy|cell therapy
1165042|NCT02193503|encapsulation|encapsulation
1165144|NCT02193061|immunological behavior|immunological behavior
1165043|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
1165044|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
1165045|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
1165046|NCT02193451|Male LUTS|male luts
1165047|NCT02193451|Voiding dysfunction|voiding dysfunction
1165048|NCT02193451|Benign prostate obstruction|benign prostate obstruction
1165049|NCT02193451|Detrusor underactivity|detrusor underactivity
1165050|NCT02193438|Heart rate variability|heart rate variability
1165051|NCT02193438|Resting energy expenditure|resting energy expenditure
1165052|NCT02193438|Facial thermography|facial thermography
1165053|NCT02193438|Blood pressure|blood pressure
1165054|NCT02193438|Spices ingestion|spices ingestion
1165055|NCT02193425|Brain|brain
1165056|NCT02193425|Connectivity|connectivity
1165058|NCT02193425|fcMRI|fcmri
1165059|NCT02193425|18FDG|18fdg
1165060|NCT02193412|analgesia nociception index|analgesia nociception index
1165061|NCT02193412|heart rate variability|heart rate variability
1165062|NCT02193412|autonomic nervous system|autonomic nervous system
1165063|NCT02193412|specificity|specificity
1333242|NCT01443858|Meclizine|meclizine
1165064|NCT02193412|systemic venous return|systemic venous return
1165065|NCT02193412|pulse pressure variation|pulse pressure variation
1165066|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
1165067|NCT02193399|Stem cell transplantation|stem cell transplantation
1165068|NCT02193399|Fatigue|fatigue
1165069|NCT02193399|Physiotherapy|physiotherapy
1165070|NCT02193399|Quality of Life|quality of life
1165071|NCT02193399|Cancer|cancer
1165072|NCT02193399|Psychosocial aspects|psychosocial aspects
1165073|NCT02193386|Cerebral Palsy|cerebral palsy
1165074|NCT02193386|Physical Therapy|physical therapy
1165075|NCT02193386|gait analysis|gait analysis
1165076|NCT02193386|gross motor function|gross motor function
1165077|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1165078|NCT02193373|Autonomic Nervous System|autonomic nervous system
1165079|NCT02193373|Heart Rate Variability|heart rate variability
1165080|NCT02193373|Sub-Occipital Release|sub-occipital release
1165081|NCT02193373|Rib-Raising|rib-raising
1165082|NCT02193373|Stellate Ganglion Release|stellate ganglion release
1165083|NCT02193360|Inflammation|inflammation
1165084|NCT02193360|PBC|pbc
1165085|NCT02193347|Immunotherapy|immunotherapy
1165086|NCT02193347|Adult|adult
1165087|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
1165088|NCT02193334|HGF|hgf
1165089|NCT02193334|KP-100IT|kp-100it
1165090|NCT02193334|Intrathecal injection|intrathecal injection
1165091|NCT02193321|Atrial Fibrillation|atrial fibrillation
1165092|NCT02193321|Amniotic Membrane|amniotic membrane
1165093|NCT02193295|Weight Reduction|weight reduction
1165094|NCT02193295|Caloric Restriction|caloric restriction
1165095|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
1165096|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1165097|NCT02193269|Abstinent cocaine users|abstinent cocaine users
1165098|NCT02193269|minocycline|minocycline
1165099|NCT02193269|antibiotic|antibiotic
1165100|NCT02193256|varenicline|varenicline
1165101|NCT02193256|prazosin|prazosin
1165102|NCT02193256|cigarette smoking|cigarette smoking
1165103|NCT02193256|alcohol drinking|alcohol drinking
1165104|NCT02193256|sleep|sleep
1165105|NCT02193256|dreams|dreams
1165419|NCT02191683|Tanzania|tanzania
1165106|NCT02193243|Congenital Heart Disease|congenital heart disease
1165107|NCT02193243|Six Minute Walk Test|six minute walk test
1165108|NCT02193243|Exercise Testing|exercise testing
1165109|NCT02193243|Peak oxygen uptake|peak oxygen uptake
1165110|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
1165111|NCT02193204|Alcohol dependence|alcohol dependence
1165112|NCT02193204|Stress|stress
1165113|NCT02193204|Cytokines|cytokines
1165114|NCT02193204|Depressive Symptomatology|depressive symptomatology
1165115|NCT02193191|Plerixafor|plerixafor
1165116|NCT02193191|13-229|13-229
1165117|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1165118|NCT02193152|NSCLC|nsclc
1165119|NCT02193152|Pazopanib|pazopanib
1165120|NCT02193126|Long term foster care|long term foster care
1165121|NCT02193126|child abuse and neglect|child abuse and neglect
1165122|NCT02193126|trauma|trauma
1165123|NCT02193113|Diabetic Macular Edema|diabetic macular edema
1165124|NCT02193113|DME|dme
1165125|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
1165126|NCT02193113|KVD001|kvd001
1165127|NCT02193113|KVD001-001|kvd001-001
1165128|NCT02193113|Intravitreal|intravitreal
1165129|NCT02193113|IVT|ivt
1165130|NCT02193113|Diabetes mellitus|diabetes mellitus
1165131|NCT02193087|Drug therapy|drug therapy
1165132|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
1165133|NCT02193074|SMA|sma
1165134|NCT02193074|SMN|smn
1165135|NCT02193074|SMNRx|smnrx
1165136|NCT02193074|ISIS-SMNRx|isis-smnrx
1165137|NCT02193074|ISIS-SMN Rx|isis-smn rx
1165138|NCT02193074|ISIS 396443|isis 396443
1165139|NCT02193074|IONIS-SMNRx|ionis-smnrx
1165140|NCT02193074|IONIS-SMN Rx|ionis-smn rx
1165141|NCT02193074|Spinraza|spinraza
1165142|NCT02193074|ENDEAR|endear
1165143|NCT02193061|Rotavirus|rotavirus
1165147|NCT02193061|vaccine interchangeability|vaccine interchangeability
1165148|NCT02193035|Microparticles|microparticles
1165149|NCT02193035|Severe aortic stenosis|severe aortic stenosis
1165150|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
1165151|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
1165152|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
1165153|NCT02192996|VLBW preterm|vlbw preterm
1165154|NCT02192996|GUT microbiota|gut microbiota
1165155|NCT02192996|probiotics supplementation|probiotics supplementation
1165156|NCT02192996|immune compounds|immune compounds
1165157|NCT02192970|Retinal detachment|retinal detachment
1165158|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
1165159|NCT02192957|cardioversion|cardioversion
1165160|NCT02192957|electrical cardioversion|electrical cardioversion
1165161|NCT02192957|atrial fibrillation|atrial fibrillation
1165162|NCT02192957|cardioversion protocol|cardioversion protocol
1165163|NCT02192944|ECG|ecg
1165164|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
1165165|NCT02192892|Young children|young children
1165166|NCT02192892|Acceptability|acceptability
1165167|NCT02192892|Food intake|food intake
1165168|NCT02192892|Energy dense porridge|energy dense porridge
1165169|NCT02192879|thoracic epidural|thoracic epidural
1165170|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
1165172|NCT02192879|liver resection|liver resection
1165173|NCT02192879|pain management|pain management
1165174|NCT02192853|Diabetes Mellitus|diabetes mellitus
1165175|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
1165176|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
1165177|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
1165178|NCT02192853|sitagliptin|sitagliptin
1165179|NCT02192853|Enzyme activity|enzyme activity
1165180|NCT02192840|provisional T stenting|provisional t stenting
1165181|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
1165182|NCT02192827|Pediatric|pediatric
1165183|NCT02192827|Asthma|asthma
1165184|NCT02192827|Exacerbation|exacerbation
1165185|NCT02192827|Dexamethasone|dexamethasone
1165186|NCT02192827|Peak flow|peak flow
1165187|NCT02192814|Lacosamide|lacosamide
1165188|NCT02192814|LCM|lcm
1165189|NCT02192814|Epilepsy|epilepsy
1165190|NCT02192814|Partial-onset seizures|partial-onset seizures
1165191|NCT02192814|iv|iv
1165192|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
1165193|NCT02192801|Renal function|renal function
1165194|NCT02192801|GFR|gfr
1165195|NCT02192801|Proteinuria|proteinuria
1165196|NCT02192788|SBRT|sbrt
1165197|NCT02192788|Oligometastases|oligometastases
1165198|NCT02192788|Prostate Cancer|prostate cancer
1165199|NCT02192775|Measles virus|measles virus
1165200|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
1165201|NCT02192775|Cyclophosphamide|cyclophosphamide
1165202|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
1165203|NCT02192749|autism|autism
1165204|NCT02192749|umbilical cord|umbilical cord
1165205|NCT02192749|mesenchymal|mesenchymal
1165206|NCT02192749|stem cells|stem cells
1165207|NCT02192736|asthma|asthma
1165208|NCT02192736|umbilical cord|umbilical cord
1165209|NCT02192736|mesenchymal|mesenchymal
1165210|NCT02192736|stem cells|stem cells
1165211|NCT02192736|trophic factors|trophic factors
1165212|NCT02192710|outpatient surgery|outpatient surgery
1165213|NCT02192710|anaesthesia|anaesthesia
1165214|NCT02192710|midazolam|midazolam
1165215|NCT02192710|electronic tab|electronic tab
1165216|NCT02192697|safety|safety
1165217|NCT02192697|pharmacokinetics|pharmacokinetics
1165218|NCT02192697|tolerability|tolerability
1165219|NCT02192697|ASP8273|asp8273
1165220|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
1165221|NCT02192697|T790M resistance mutation|t790m resistance mutation
1165222|NCT02192697|NSCLC|nsclc
1165223|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
1165224|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
1165225|NCT02192697|antitumor activity|antitumor activity
1165226|NCT02192697|EGFR|egfr
1165227|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
1165228|NCT02192684|insulin sensitivity|insulin sensitivity
1165229|NCT02192684|cardiovascular risk|cardiovascular risk
1165230|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
1165231|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
1165232|NCT02192671|radiofrequency ablation|radiofrequency ablation
1165233|NCT02192671|hepatic resection|hepatic resection
1165234|NCT02192671|portal hypertension|portal hypertension
1165235|NCT02192671|Milan criteria|milan criteria
1165236|NCT02192671|randomized critical trial|randomized critical trial
1165237|NCT02192619|APL|apl
1165238|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
1165239|NCT02192619|AML M3|aml m3
1165240|NCT02192606|Laparoscopy|laparoscopy
1165241|NCT02192606|3D Visual System|3d visual system
1165242|NCT02192606|Total Hysterectomy|total hysterectomy
1165243|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
1165244|NCT02192567|phase 1|phase 1
1165245|NCT02192567|oncology|oncology
1165246|NCT02192554|OPC-34712|opc-34712
1165247|NCT02192554|brexpiprazole|brexpiprazole
1165248|NCT02192554|Dementia|dementia
1165249|NCT02192554|Alzheimer's Disease|alzheimer's disease
1165250|NCT02192554|Cognitive Disorders|cognitive disorders
1165251|NCT02192554|Memory|memory
1165252|NCT02192554|Agitation|agitation
1165253|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
1165254|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
1165255|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
1165256|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
1165257|NCT02192541|Sarcomas|sarcomas
1165258|NCT02192528|vitamin D|vitamin d
1165259|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
1165260|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
1165261|NCT02192528|MACCE|macce
1165262|NCT02192528|mortality|mortality
1165263|NCT02192528|cardiac|cardiac
1165264|NCT02192528|cerebrovascular|cerebrovascular
1165265|NCT02192515|Healthy Subjects|healthy subjects
1165266|NCT02192515|Japanese Adult|japanese adult
1165267|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
1165268|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
1165269|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
1165270|NCT02192489|Sarcoidosis|sarcoidosis
1165271|NCT02192476|Stroke, subluxation|stroke, subluxation
1165272|NCT02192450|Diabetes Mellitus|diabetes mellitus
1165273|NCT02192450|Hypoglycaemia|hypoglycaemia
1165274|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
1165275|NCT02192450|Metabolic Diseases|metabolic diseases
1165276|NCT02192450|Endocrine System Diseases|endocrine system diseases
1165277|NCT02192450|Autoimmune Diseases|autoimmune diseases
1165278|NCT02192450|Insulin|insulin
1165279|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
1165280|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
1165281|NCT02192437|methionine|methionine
1165282|NCT02192437|cysteine|cysteine
1165283|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
1165284|NCT02192424|beta-cell function,|beta-cell function,
1165285|NCT02192424|type 2 diabetes,|type 2 diabetes,
1165286|NCT02192424|intermittent insulin|intermittent insulin
1165287|NCT02192411|lidocaine|lidocaine
1165288|NCT02192411|tumescent|tumescent
1165289|NCT02192411|endovenous|endovenous
1165290|NCT02192411|laser|laser
1165291|NCT02192411|pain|pain
1165292|NCT02192398|Pain|pain
1165293|NCT02192398|Pain management|pain management
1165294|NCT02192398|Neck|neck
1165295|NCT02192398|Back|back
1165296|NCT02192372|creatinine|creatinine
1165297|NCT02192372|glomerular filtration rate|glomerular filtration rate
1165298|NCT02192372|metabolic syndrome|metabolic syndrome
1165299|NCT02192346|metastatic|metastatic
1165300|NCT02192346|refractory|refractory
1165301|NCT02192346|progressive|progressive
1165302|NCT02192320|Atorvastatin|atorvastatin
1165303|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
1165304|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
1165305|NCT02192320|conservative treatment|conservative treatment
1165306|NCT02192307|Sensitivity|sensitivity
1165307|NCT02192294|Bosutinib|bosutinib
1165308|NCT02192294|absolute bioavailability|absolute bioavailability
1165309|NCT02192281|Physical activity|physical activity
1165310|NCT02192281|Recess|recess
1165311|NCT02192281|Accelerometer|accelerometer
1165312|NCT02192281|Play|play
1165313|NCT02192255|diabetes type 2|diabetes type 2
1165314|NCT02192255|primary care|primary care
1165315|NCT02192255|chronic disease care improvement|chronic disease care improvement
1165316|NCT02192255|adherence, randomized trial|adherence, randomized trial
1165317|NCT02192255|BP control|bp control
1165318|NCT02192255|lipid control|lipid control
1165319|NCT02192255|glucose control|glucose control
1165320|NCT02192255|natural language processing.|natural language processing.
1165321|NCT02192242|acute ischemic pain|acute ischemic pain
1165322|NCT02192242|model|model
1165323|NCT02192242|S100|s100
1165324|NCT02192242|interleukine 6|interleukine 6
1165325|NCT02192216|Body composition|body composition
1165326|NCT02192216|Chemotherapy|chemotherapy
1165327|NCT02192216|Muscle mass|muscle mass
1165328|NCT02192216|Muscle function|muscle function
1165329|NCT02192216|Exercise|exercise
1165330|NCT02192177|Apoptosis|apoptosis
1165331|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
1165332|NCT02192177|obstetric outcomes|obstetric outcomes
1165333|NCT02192164|plaque psoriasis|plaque psoriasis
1165334|NCT02192164|smoking|smoking
1165335|NCT02192164|etanercept|etanercept
1165336|NCT02192151|Analgesic|analgesic
1165337|NCT02192151|Narcotics|narcotics
1165338|NCT02192151|Opioids|opioids
1165339|NCT02192151|Non-scheduled substanse|non-scheduled substanse
1165340|NCT02192138|Pleural effusion|pleural effusion
1165341|NCT02192138|Pleural fluid|pleural fluid
1165342|NCT02192138|Thoracentesis|thoracentesis
1165343|NCT02192138|Intrapleural pressure|intrapleural pressure
1165344|NCT02192138|Pleural manometry|pleural manometry
1165345|NCT02192125|stroke|stroke
1165346|NCT02192125|rehabilitation|rehabilitation
1165347|NCT02192125|balance|balance
1165348|NCT02192125|training|training
1165349|NCT02192125|posture|posture
1165565|NCT02191358|Piroxicam|piroxicam
1165350|NCT02192086|Kidney transplantation|kidney transplantation
1165351|NCT02192060|Biofilm|biofilm
1165352|NCT02192060|Triclosan|triclosan
1165353|NCT02192060|Crossover|crossover
1165354|NCT02192060|Clinical trial|clinical trial
1165355|NCT02192034|Colonoscopy|colonoscopy
1165356|NCT02192034|Colon cancer|colon cancer
1165357|NCT02192034|screening|screening
1165358|NCT02192034|navigation|navigation
1165359|NCT02192021|CTCL|ctcl
1165360|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1165361|NCT02192021|Mycosis Fungoides|mycosis fungoides
1165362|NCT02192008|Challenge|challenge
1165363|NCT02192008|Re-challenge|re-challenge
1165364|NCT02192008|Controlled Infection|controlled infection
1165365|NCT02192008|Enteric fever|enteric fever
1165366|NCT02191982|Cancer|cancer
1165367|NCT02191982|Chemotherapy|chemotherapy
1165368|NCT02191982|Fatigue|fatigue
1165369|NCT02191982|Elderly|elderly
1165370|NCT02191982|Geriatric|geriatric
1165371|NCT02191982|Any Cancer|any cancer
1165372|NCT02191982|Cancer Treatment|cancer treatment
1165373|NCT02191982|Weakness|weakness
1165374|NCT02191982|Tiredness|tiredness
1165375|NCT02191969|Chemotherapy|chemotherapy
1165376|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
1165377|NCT02191969|Cancer Therapy|cancer therapy
1165378|NCT02191969|Fatigue|fatigue
1165379|NCT02191969|Physical Activity|physical activity
1165380|NCT02191969|Physical Function|physical function
1165381|NCT02191969|Tiredness|tiredness
1165382|NCT02191969|Colon Cancer|colon cancer
1165383|NCT02191969|Rectal Cancer|rectal cancer
1165384|NCT02191969|Walk With Ease|walk with ease
1165385|NCT02191969|Colorectal Cancer|colorectal cancer
1165386|NCT02191969|Geriatric Assessment|geriatric assessment
1165387|NCT02191969|Geriatric|geriatric
1165388|NCT02191969|Elderly|elderly
1165389|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
1165390|NCT02191956|Early Onset|early onset
1165391|NCT02191956|Young Children|young children
1165392|NCT02191956|Parenting|parenting
1165393|NCT02191956|Behavioral Parent Training|behavioral parent training
1165394|NCT02191943|caries|caries
1165395|NCT02191943|proximal|proximal
1165396|NCT02191943|non-cavitated|non-cavitated
1165397|NCT02191943|fluoridation|fluoridation
1165398|NCT02191878|Liver Cancer|liver cancer
1165399|NCT02191878|Liver Neoplasms|liver neoplasms
1165400|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
1165401|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
1165402|NCT02191839|cardiac surgery|cardiac surgery
1165403|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
1165404|NCT02191839|inflammation|inflammation
1165405|NCT02191839|post operative bleeding|post operative bleeding
1165406|NCT02191839|organ function|organ function
1165407|NCT02191826|Transthyretin|transthyretin
1165408|NCT02191826|TTR|ttr
1165409|NCT02191826|Amyloidosis|amyloidosis
1165410|NCT02191826|SOM0226|som0226
1165411|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
1165412|NCT02191774|Medical abortion|medical abortion
1165413|NCT02191774|Home abortion|home abortion
1165414|NCT02191683|Anaemia|anaemia
1165415|NCT02191683|Pregnancy|pregnancy
1165416|NCT02191683|Foetal programming|foetal programming
1165417|NCT02191683|Epigenetics|epigenetics
1165418|NCT02191683|Non-communicable diseases|non-communicable diseases
1165420|NCT02191657|HIV|hiv
1165421|NCT02191657|deferiprone|deferiprone
1165422|NCT02191657|iron chelation|iron chelation
1165423|NCT02191631|OCD|ocd
1165424|NCT02191631|adolescents|adolescents
1165425|NCT02191631|pediatric|pediatric
1165426|NCT02191631|internet|internet
1165427|NCT02191631|online|online
1165428|NCT02191631|CBT|cbt
1165429|NCT02191618|Aneurysm|aneurysm
1165430|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
1165431|NCT02191618|Vascular Diseases|vascular diseases
1165432|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
1165433|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
1165434|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
1165435|NCT02191618|Brain Diseases|brain diseases
1165436|NCT02191618|Central Nervous System Diseases|central nervous system diseases
1165437|NCT02191618|Nervous System Diseases|nervous system diseases
1165438|NCT02191605|Computerized Brief Intervention|computerized brief intervention
1165439|NCT02191592|Tinnitus|tinnitus
1165440|NCT02191592|EMA|ema
1165441|NCT02191592|Bothersome|bothersome
1165442|NCT02191566|Stomach Cancer|stomach cancer
1165443|NCT02191553|mindfulness meditation|mindfulness meditation
1165444|NCT02191553|alpha rhythm|alpha rhythm
1165445|NCT02191553|EEG|eeg
1165446|NCT02191553|brain mapping|brain mapping
1165447|NCT02191553|emotion|emotion
1165448|NCT02191553|attention|attention
1165449|NCT02191527|PMTCT|pmtct
1165450|NCT02191527|HIV|hiv
1165451|NCT02191527|Syphilis|syphilis
1165452|NCT02191527|Anemia during pregnancy|anemia during pregnancy
1165453|NCT02191527|Point of care diagnostics|point of care diagnostics
1165454|NCT02191514|Prehospital|prehospital
1165455|NCT02191514|EMS|ems
1165456|NCT02191514|EMD|emd
1165457|NCT02191514|Stroke|stroke
1165458|NCT02191514|Dispatch|dispatch
1165459|NCT02191501|Obesity Treatment|obesity treatment
1165460|NCT02191501|Endoscopy|endoscopy
1165461|NCT02191501|Pyloric Suturing|pyloric suturing
1165462|NCT02191501|Pyloric restriction|pyloric restriction
1165463|NCT02191488|Fluorescence|fluorescence
1165464|NCT02191488|Brain Tumors|brain tumors
1165465|NCT02191488|Brain Metastases|brain metastases
1165466|NCT02191488|Malignant Glioma|malignant glioma
1165467|NCT02191488|Brain Lesions|brain lesions
1165468|NCT02191475|sepsis shock|sepsis shock
1165469|NCT02191475|Tigecycline|tigecycline
1165470|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
1165471|NCT02191475|Abdominal infection|abdominal infection
1165472|NCT02191462|Pharmacokinetics|pharmacokinetics
1165473|NCT02191462|Niagen|niagen
1165474|NCT02191462|Nicotinamide riboside|nicotinamide riboside
1165475|NCT02191436|Haemophilia|haemophilia
1165476|NCT02191436|Adherence|adherence
1165477|NCT02191436|Family Functioning|family functioning
1165478|NCT02191436|Quality of Life|quality of life
1165480|NCT02191436|Illness Behavior|illness behavior
1165481|NCT02191436|Coping Strategies|coping strategies
1165482|NCT02191423|postpartum Depression|postpartum depression
1165483|NCT02191423|Diadic psychotherapy|diadic psychotherapy
1165484|NCT02191423|Oxytocin|oxytocin
1165485|NCT02191423|fMRI|fmri
1165486|NCT02191423|attachment|attachment
1165487|NCT02191423|empathy|empathy
1165488|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
1165489|NCT02191410|one-lung ventilation|one-lung ventilation
1165490|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
1165491|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
1165492|NCT02191410|stroke volume variation|stroke volume variation
1165493|NCT02191410|fluid responsiveness|fluid responsiveness
1165494|NCT02191397|Escitalopram|escitalopram
1165495|NCT02191397|Major depressive disorder|major depressive disorder
1165496|NCT02191397|Non-inferiority|non-inferiority
1165497|NCT02191397|Bupropion|bupropion
1165498|NCT02191371|oxygenation|oxygenation
1165499|NCT02191371|microcirculation|microcirculation
1165500|NCT02191371|one-lung ventilation|one-lung ventilation
1165501|NCT02191371|thoracic surgery|thoracic surgery
1165502|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
1165503|NCT02191358|Drug-drug interaction|drug-drug interaction
1165504|NCT02191358|Drug-gene interaction|drug-gene interaction
1165505|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
1165506|NCT02191358|Drug Metabolism|drug metabolism
1165507|NCT02191358|Elderly|elderly
1165508|NCT02191358|Geriatric medicine|geriatric medicine
1165509|NCT02191358|Geriatrics|geriatrics
1165510|NCT02191358|Personalized medicine|personalized medicine
1165511|NCT02191358|Pharmacist|pharmacist
1165512|NCT02191358|Pharmacogenetics|pharmacogenetics
1165513|NCT02191358|Pharmacogenomics|pharmacogenomics
1165514|NCT02191358|Pharmacokinetics|pharmacokinetics
1165515|NCT02191358|Polymorphism|polymorphism
1165516|NCT02191358|Polypharmacy|polypharmacy
1165517|NCT02191358|Precision medicine|precision medicine
1165518|NCT02191358|Seniors|seniors
1165519|NCT02191358|YouScript|youscript
1165520|NCT02191358|CYP2C9|cyp2c9
1165521|NCT02191358|CYP2C19|cyp2c19
1165522|NCT02191358|CYP2D6|cyp2d6
1165523|NCT02191358|CYP3A4|cyp3a4
1165524|NCT02191358|CYP3A5|cyp3a5
1165525|NCT02191358|VKORC1|vkorc1
1165526|NCT02191358|Amitriptyline|amitriptyline
1165527|NCT02191358|Aripiprazole|aripiprazole
1165528|NCT02191358|Atomoxetine|atomoxetine
1165529|NCT02191358|Carvedilol|carvedilol
1165530|NCT02191358|Celecoxib|celecoxib
1165531|NCT02191358|Citalopram|citalopram
1165532|NCT02191358|Clobazam|clobazam
1165533|NCT02191358|Clomipramine|clomipramine
1165534|NCT02191358|Clopidogrel|clopidogrel
1165535|NCT02191358|Clozapine|clozapine
1165536|NCT02191358|Codeine|codeine
1165537|NCT02191358|Desipramine|desipramine
1165538|NCT02191358|Dextromethorphan|dextromethorphan
1165539|NCT02191358|Diazepam|diazepam
1165540|NCT02191358|Doxepin|doxepin
1165541|NCT02191358|Escitalopram|escitalopram
1165542|NCT02191358|Esomeprazole|esomeprazole
1165543|NCT02191358|Fesoterodine|fesoterodine
1165544|NCT02191358|Flecainide|flecainide
1165545|NCT02191358|Fluoxetine|fluoxetine
1165546|NCT02191358|Flurbiprofen|flurbiprofen
1165547|NCT02191358|Fluvoxamine|fluvoxamine
1165548|NCT02191358|Haloperidol|haloperidol
1165549|NCT02191358|Hydrocodone|hydrocodone
1165550|NCT02191358|Ibuprofen|ibuprofen
1165551|NCT02191358|Iloperidone|iloperidone
1165552|NCT02191358|Imipramine|imipramine
1165553|NCT02191358|Indomethacin|indomethacin
1165554|NCT02191358|Meloxicam|meloxicam
1165555|NCT02191358|Metoprolol|metoprolol
1165556|NCT02191358|Mexiletine|mexiletine
1165557|NCT02191358|Nortriptyline|nortriptyline
1165558|NCT02191358|Omeprazole|omeprazole
1165559|NCT02191358|Oxycodone|oxycodone
1165560|NCT02191358|Paroxetine|paroxetine
1165561|NCT02191358|Perphenazine|perphenazine
1165562|NCT02191358|Phenobarbital|phenobarbital
1165563|NCT02191358|Phenytoin|phenytoin
1165564|NCT02191358|Pimozide|pimozide
1165566|NCT02191358|Proguanil|proguanil
1165567|NCT02191358|Propafenone|propafenone
1165568|NCT02191358|Propranolol|propranolol
1165569|NCT02191358|Risperidone|risperidone
1165570|NCT02191358|Sertraline|sertraline
1165571|NCT02191358|Tetrabenazine|tetrabenazine
1165572|NCT02191358|Thioridazine|thioridazine
1165573|NCT02191358|Timolol|timolol
1165574|NCT02191358|Tolterodine|tolterodine
1165575|NCT02191358|Torsemide|torsemide
1165576|NCT02191358|Tramadol|tramadol
1165577|NCT02191358|Trimipramine|trimipramine
1165578|NCT02191358|Venlafaxine|venlafaxine
1165579|NCT02191358|Voriconazole|voriconazole
1165580|NCT02191358|Vortioxetine|vortioxetine
1165581|NCT02191345|guided imagery|guided imagery
1165582|NCT02191345|burnout|burnout
1165583|NCT02191345|compassion fatigue|compassion fatigue
1165584|NCT02191345|state anxiety|state anxiety
1165585|NCT02191267|CTE|cte
1165586|NCT02191267|Positron Emission Topography|positron emission topography
1165587|NCT02191267|Tau|tau
1165588|NCT02191267|Beta-amyloid|beta-amyloid
1165589|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
1165590|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1165591|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
1165592|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
1165593|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
1165594|NCT02191124|Measurement-based care|measurement-based care
1165595|NCT02191124|Unipolar depression|unipolar depression
1165596|NCT02191124|Outpatients|outpatients
1165597|NCT02191111|Pharmacist|pharmacist
1165598|NCT02191111|Pharmacy practice|pharmacy practice
1165599|NCT02191111|Patient care|patient care
1165600|NCT02191111|Community pharmacy|community pharmacy
1165601|NCT02191111|Hypertension|hypertension
1165602|NCT02191111|Diabetes|diabetes
1165603|NCT02191111|Dyslipidemia|dyslipidemia
1165604|NCT02191111|Pharmaceutical care|pharmaceutical care
1165605|NCT02191098|HIV|hiv
1165606|NCT02191098|ART|art
1165607|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
1165608|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
1165609|NCT02191059|Wild Type EGFR|wild type egfr
1165610|NCT02191059|Icotinib|icotinib
1165611|NCT02191059|Second-line Treatment|second-line treatment
1165612|NCT02191046|nasal irrigation|nasal irrigation
1165613|NCT02191046|sinusitis|sinusitis
1165614|NCT02191046|children|children
1165615|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
1165616|NCT02191046|nasal irrigation device|nasal irrigation device
1165617|NCT02191033|cigarette smoking|cigarette smoking
1165618|NCT02191033|tobacco use cessation products|tobacco use cessation products
1165619|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
1165620|NCT02191020|Acitretin Capsules|acitretin capsules
1165621|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
1165622|NCT02190994|Hydrocortisone|hydrocortisone
1165623|NCT02190994|Pituitary adenomas|pituitary adenomas
1165624|NCT02190994|Replacement therapy|replacement therapy
1165625|NCT02190981|Small bowel obstruction|small bowel obstruction
1165626|NCT02190981|Ultrasound|ultrasound
1165627|NCT02190981|Emergency department|emergency department
1165628|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1165629|NCT02190968|Internet interventions|internet interventions
1165630|NCT02190968|Residual depressive symptoms|residual depressive symptoms
1165631|NCT02190968|Depressive relapse prevention|depressive relapse prevention
1165632|NCT02190903|delirium|delirium
1165633|NCT02190903|hip fracture|hip fracture
1165634|NCT02190903|general anesthesia|general anesthesia
1165635|NCT02190903|spinal anesthesia|spinal anesthesia
1165636|NCT02190903|postoperative complications|postoperative complications
1165637|NCT02190877|Heart Failure|heart failure
1165638|NCT02190877|Impedance|impedance
1165639|NCT02190877|Fluids|fluids
1165640|NCT02190851|urinary disorders|urinary disorders
1165641|NCT02190851|Parkinson's disease|parkinson's disease
1165642|NCT02190838|Melanoma|melanoma
1165643|NCT02190838|Melatonin|melatonin
1165644|NCT02190838|Metformin|metformin
1165645|NCT02190838|Dacarbazine|dacarbazine
1165646|NCT02190812|wrist muscle strength|wrist muscle strength
1165647|NCT02190799|Corona Virus|corona virus
1165648|NCT02190799|Convalescent plasma|convalescent plasma
1165649|NCT02190799|Serology|serology
1165650|NCT02190786|Hyperuricemia|hyperuricemia
1165651|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
1165652|NCT02190747|Intervention study|intervention study
1165653|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
1165654|NCT02190747|Efficacy and safety|efficacy and safety
1165655|NCT02190747|Heterotopic ossification|heterotopic ossification
1165656|NCT02190747|Flare-up|flare-up
1165657|NCT02190747|Palovarotene|palovarotene
1165658|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
1165659|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
1165660|NCT02190747|Clementia|clementia
1165761|NCT02190344|Eight|eight
1165661|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
1165662|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
1165664|NCT02190734|Stroke|stroke
1165665|NCT02190734|Pusher Syndrome|pusher syndrome
1165666|NCT02190734|Lateropulsion|lateropulsion
1165667|NCT02190734|Pushing Behaviors|pushing behaviors
1165668|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
1165669|NCT02190721|Neutropenia|neutropenia
1165670|NCT02190708|PQ912|pq912
1165671|NCT02190708|Midazolam|midazolam
1165672|NCT02190708|Omeprazole|omeprazole
1165673|NCT02190708|Pharmacokinetics|pharmacokinetics
1165674|NCT02190708|Drug Interaction|drug interaction
1165675|NCT02190682|postoperative|postoperative
1165676|NCT02190682|chronic|chronic
1165677|NCT02190682|pain|pain
1165678|NCT02190682|software|software
1165679|NCT02190656|Rectal cancer|rectal cancer
1165680|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
1165681|NCT02190656|Functional outcomes|functional outcomes
1165682|NCT02190643|Smoking|smoking
1165683|NCT02190643|HIV|hiv
1165684|NCT02190643|Latino|latino
1165685|NCT02190643|Cessation|cessation
1165686|NCT02190643|Nicotine patch|nicotine patch
1165687|NCT02190617|Asthma|asthma
1165688|NCT02190617|Guidelines|guidelines
1165689|NCT02190617|Community Health Worker|community health worker
1165690|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
1165691|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
1165692|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
1165693|NCT02190604|cystic fibrosis|cystic fibrosis
1165694|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
1165695|NCT02190591|epidural|epidural
1165696|NCT02190591|pregnant|pregnant
1165697|NCT02190591|Cesarean Section|cesarean section
1165698|NCT02190591|forceps|forceps
1165699|NCT02190591|vaginal|vaginal
1165700|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
1165701|NCT02190552|Brain|brain
1165702|NCT02190552|Brain Clot|brain clot
1165703|NCT02190552|Brain Diseases|brain diseases
1165704|NCT02190552|Brain Infarction|brain infarction
1165705|NCT02190552|Cerebral Ischemia|cerebral ischemia
1165706|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
1165707|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
1165708|NCT02190552|EmboTrap|embotrap
1165709|NCT02190552|Ischemia|ischemia
1165710|NCT02190552|Ischemic|ischemic
1165711|NCT02190552|Ischemic Stroke|ischemic stroke
1165712|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
1165713|NCT02190552|Neurovascular Intervention|neurovascular intervention
1165714|NCT02190552|Revascularization|revascularization
1165715|NCT02190552|Stent Retriever|stent retriever
1165716|NCT02190552|Stroke|stroke
1165717|NCT02190552|Vascular Diseases|vascular diseases
1165718|NCT02190539|Breast cancer|breast cancer
1165719|NCT02190539|complementary medicine|complementary medicine
1165720|NCT02190539|homeopathy|homeopathy
1165721|NCT02190539|quality of life|quality of life
1165722|NCT02190526|mesalamine|mesalamine
1165723|NCT02190526|amitriptyline|amitriptyline
1165724|NCT02190526|Severity of Illness Index|severity of illness index
1165725|NCT02190500|stroke|stroke
1165726|NCT02190500|tpa|tpa
1165727|NCT02190500|emergency medical service|emergency medical service
1165728|NCT02190500|ems|ems
1165729|NCT02190500|mobile|mobile
1165730|NCT02190500|ct scan|ct scan
1165731|NCT02190474|fibromyalgia|fibromyalgia
1165732|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
1165733|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
1165734|NCT02190474|adolescent pain|adolescent pain
1165735|NCT02190474|mindfulness|mindfulness
1165736|NCT02190474|MBSR|mbsr
1165737|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
1165738|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1165739|NCT02190461|Re-admitted patients|re-admitted patients
1165740|NCT02190461|Open clinical trial|open clinical trial
1165741|NCT02190461|Exacerbations|exacerbations
1165742|NCT02190448|galactogogue|galactogogue
1165743|NCT02190448|lactation|lactation
1165744|NCT02190448|milk production|milk production
1165745|NCT02190448|breastfeeding|breastfeeding
1165746|NCT02190435|Computer-assisted navigation|computer-assisted navigation
1165747|NCT02190435|ADAPT|adapt
1165748|NCT02190435|Intramedullary nail|intramedullary nail
1165749|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
1165750|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
1165751|NCT02190422|echocardiography|echocardiography
1165752|NCT02190422|cardiology|cardiology
1165753|NCT02190422|pediatrics|pediatrics
1165754|NCT02190409|Dental Implant,|dental implant,
1165755|NCT02190396|Calcium|calcium
1165756|NCT02190396|Vitamin D|vitamin d
1165757|NCT02190396|Placental calcification.|placental calcification.
1165758|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
1165759|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
1165760|NCT02190357|Cirrhosis|cirrhosis
1165762|NCT02190344|Channel|channel
1165763|NCT02190344|Paddle|paddle
1165764|NCT02190344|Coil|coil
1165765|NCT02190344|MRI|mri
1165766|NCT02190344|Prostate|prostate
1165767|NCT02190344|Healthy Male|healthy male
1165768|NCT02190331|Detraining|detraining
1165769|NCT02190331|Neck|neck
1165770|NCT02190331|Exercise|exercise
1165771|NCT02190331|Posture|posture
1165772|NCT02190331|Rehabilitation|rehabilitation
1165773|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
1165774|NCT02190318|residual renal function；|residual renal function；
1165775|NCT02190318|RAAS|raas
1165776|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
1165777|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
1165778|NCT02190279|Imaging|imaging
1165779|NCT02190279|NaF|naf
1165780|NCT02190266|Extrapulmonary|extrapulmonary
1165781|NCT02190266|Immunodeficiency|immunodeficiency
1165782|NCT02190266|Genetics|genetics
1165783|NCT02190266|Infection|infection
1165784|NCT02190266|Fungal|fungal
1165785|NCT02190253|Renal Threshold|renal threshold
1165786|NCT02190253|Liver Transplant|liver transplant
1165787|NCT02190253|Transplantation|transplantation
1165788|NCT02190253|Hepatitis E|hepatitis e
1165789|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
1165790|NCT02190240|Integrative Medicine|integrative medicine
1165791|NCT02190240|Pain Management|pain management
1165792|NCT02190227|Breast Cancer|breast cancer
1165793|NCT02190227|Chemotherapy|chemotherapy
1165794|NCT02190227|Neoadjuvant|neoadjuvant
1165795|NCT02190227|RNA Disruption Assay|rna disruption assay
1165796|NCT02190227|Biopsies|biopsies
1165797|NCT02190227|Response|response
1165798|NCT02190214|Hyperthyroidism|hyperthyroidism
1165799|NCT02190214|Hypothyroidism|hypothyroidism
1165800|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
1165801|NCT02190214|Iodine deficiency|iodine deficiency
1165802|NCT02190214|Genetic susceptibility|genetic susceptibility
1165803|NCT02190201|videolaryngoscope|videolaryngoscope
1165804|NCT02190201|double lumen intubation|double lumen intubation
1165805|NCT02190188|wedge insoles,|wedge insoles,
1165806|NCT02190188|knee brace,|knee brace,
1165807|NCT02190188|orthotic device|orthotic device
1165808|NCT02190188|goal|goal
1165809|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
1165810|NCT02190149|Factor VIII Deficiency|factor viii deficiency
1165811|NCT02190149|Factor FIX Deficiency|factor fix deficiency
1165812|NCT02190136|obesity|obesity
1165813|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
1165814|NCT02190136|aerobic fitness|aerobic fitness
1165815|NCT02190136|resistance training|resistance training
1165816|NCT02190136|stretching/yoga training|stretching/yoga training
1165817|NCT02190136|glycemia|glycemia
1165818|NCT02190136|mood state|mood state
1165819|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1165820|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
1165821|NCT02190123|Treatment persistence.|treatment persistence.
1165822|NCT02190110|Pulmonary embolism|pulmonary embolism
1165823|NCT02190110|diagnosis|diagnosis
1165824|NCT02190110|emergency medicine|emergency medicine
1165825|NCT02190110|ultrasonography|ultrasonography
1165826|NCT02190097|PCOS|pcos
1165827|NCT02190097|insulin sensitivity|insulin sensitivity
1165828|NCT02190097|paleolithic diet|paleolithic diet
1165829|NCT02190084|apathy|apathy
1165830|NCT02190084|Alzheimer's|alzheimer's
1165831|NCT02190084|executive function|executive function
1165832|NCT02190071|EUS-FNA|eus-fna
1165833|NCT02190071|cytopathology|cytopathology
1165834|NCT02190071|slide smear|slide smear
1165835|NCT02190058|safety|safety
1165836|NCT02190058|pharmacokinetics|pharmacokinetics
1165837|NCT02190058|DS-1971a|ds-1971a
1165838|NCT02190045|Balance|balance
1165839|NCT02190045|gait|gait
1165840|NCT02190045|Wii-Fit|wii-fit
1165841|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
1165842|NCT02190019|apathy|apathy
1165843|NCT02190019|executive function|executive function
1165844|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
1165845|NCT02190006|Follicle output rate|follicle output rate
1165846|NCT02190006|preovulatory count|preovulatory count
1165847|NCT02190006|ICSI|icsi
1165848|NCT02189993|Mortality|mortality
1165849|NCT02189993|Long term follow-up|long term follow-up
1165850|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
1165851|NCT02189980|Nausea|nausea
1165852|NCT02189980|Post-operative|post-operative
1165853|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
1165854|NCT02189967|radiotherapy|radiotherapy
1165855|NCT02189967|accelerated fractionation|accelerated fractionation
1165856|NCT02189967|conventional fractionation|conventional fractionation
1165857|NCT02189967|postoperative|postoperative
1165858|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
1165859|NCT02189941|Deferiprone|deferiprone
1165860|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
1165861|NCT02189941|Pharmacokinetics|pharmacokinetics
1165862|NCT02189902|Vitamin D|vitamin d
1165863|NCT02189889|Active preoperative anemia management|active preoperative anemia management
1165864|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
1165865|NCT02189889|RBC transfusion|rbc transfusion
1165866|NCT02189889|Red cell transfusion|red cell transfusion
1165867|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
1165868|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
1165869|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
1165870|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
1165871|NCT02189889|Iron deficiency anemia|iron deficiency anemia
1165872|NCT02189889|EPO|epo
1165873|NCT02189889|Feraheme|feraheme
1165874|NCT02189876|HIV Prevention|hiv prevention
1165875|NCT02189876|Behavioral Intervention|behavioral intervention
1165876|NCT02189876|Condom Use|condom use
1165877|NCT02189876|African American|african american
1165878|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
1165879|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
1165880|NCT02189876|Internet|internet
1165881|NCT02189863|Driving Simulator|driving simulator
1165882|NCT02189863|Air Optix Aqua|air optix aqua
1165883|NCT02189863|AOAMF|aoamf
1165884|NCT02189850|colonoscopy|colonoscopy
1165885|NCT02189850|pediatric|pediatric
1165886|NCT02189837|Raised cholesterol|raised cholesterol
1165887|NCT02189837|Cholesterol|cholesterol
1165888|NCT02189837|Elevated Cholesterol|elevated cholesterol
1165889|NCT02189837|Hyperlipidemias|hyperlipidemias
1165890|NCT02189837|Dyslipidemias|dyslipidemias
1165891|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
1165892|NCT02189837|Metabolic Diseases|metabolic diseases
1165893|NCT02189811|IPV|ipv
1165894|NCT02189811|OPV|opv
1165895|NCT02189811|tOPV|topv
1165896|NCT02189811|bOPV|bopv
1165897|NCT02189811|Polio|polio
1165898|NCT02189811|Endgame|endgame
1165899|NCT02189811|Pakistan|pakistan
1165900|NCT02189798|Cochlear Implant|cochlear implant
1165901|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
1165902|NCT02189798|Cochlear Implantation|cochlear implantation
1165903|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
1165904|NCT02189798|Listening Benefits|listening benefits
1165905|NCT02189798|Adults|adults
1165906|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
1165907|NCT02189798|Electrical Stimulation|electrical stimulation
1165908|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
1165909|NCT02189785|social|social
1165910|NCT02189785|rejection|rejection
1165911|NCT02189785|acceptance|acceptance
1165912|NCT02189785|PET|pet
1165913|NCT02189785|opioid|opioid
1165914|NCT02189785|fMRI|fmri
1165915|NCT02189785|reward|reward
1165916|NCT02189785|exclusion|exclusion
1165917|NCT02189772|ADHD|adhd
1165918|NCT02189772|Inattention|inattention
1165919|NCT02189772|MDX|mdx
1165920|NCT02189759|Hypothermia|hypothermia
1165921|NCT02189759|Hyperthermia|hyperthermia
1165922|NCT02189759|Kangaroo Mother Care|kangaroo mother care
1165923|NCT02189759|Newborn|newborn
1165924|NCT02189746|Hypothermia|hypothermia
1165925|NCT02189746|Newborn|newborn
1165926|NCT02189746|Hyperthermia|hyperthermia
1165927|NCT02189746|Kangaroo mother care|kangaroo mother care
1165928|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
1165929|NCT02189720|Amifampridine|amifampridine
1165930|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
1165931|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
1165932|NCT02189720|3,4-DAP|3,4-dap
1165933|NCT02189720|LEMS|lems
1165934|NCT02189720|CMS|cms
1165935|NCT02189720|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
1165936|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
1165937|NCT02189720|Neuromuscular disorders|neuromuscular disorders
1165938|NCT02189720|Neuromuscular|neuromuscular
1165939|NCT02189720|eye movement|eye movement
1165940|NCT02189720|electromyography|electromyography
1165941|NCT02189720|EMG|emg
1165942|NCT02189720|Expanded Access|expanded access
1165943|NCT02189720|Firdapse®|firdapse®
1165944|NCT02189720|Downbeat Nystagmus|downbeat nystagmus
1165945|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
1165946|NCT02189707|Constipation|constipation
1165947|NCT02189707|Probiotics|probiotics
1165948|NCT02189707|Dietary supplement|dietary supplement
1165949|NCT02189694|Type 1 diabetes|type 1 diabetes
1165950|NCT02189694|Hypoglycemia|hypoglycemia
1165951|NCT02189694|Insulin|insulin
1165952|NCT02189694|Glucagon|glucagon
1165953|NCT02189694|Closed-loop system|closed-loop system
1165954|NCT02189694|Artificial pancreas|artificial pancreas
1165955|NCT02189681|spinal anaesthesia|spinal anaesthesia
1165956|NCT02189681|ultrasound|ultrasound
1165957|NCT02189681|paramedian|paramedian
1165958|NCT02189668|Appendicitis|appendicitis
1165959|NCT02189668|Non-operative|non-operative
1165960|NCT02189668|Children|children
1165961|NCT02189668|Appendicolith|appendicolith
1165962|NCT02189668|fecalith|fecalith
1165963|NCT02189668|Pediatrics|pediatrics
1165964|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
1165965|NCT02189629|Acne vulgaris|acne vulgaris
1165966|NCT02189629|Safety|safety
1165967|NCT02189629|Face|face
1165968|NCT02189629|Trunk|trunk
1165969|NCT02189616|asthma management|asthma management
1165970|NCT02189616|SMS reminder|sms reminder
1165971|NCT02189616|SMS consultation|sms consultation
1165972|NCT02189603|hepatitis E|hepatitis e
1165973|NCT02189603|Immunogenicity|immunogenicity
1165974|NCT02189603|vaccine|vaccine
1165975|NCT02189603|safety|safety
1165976|NCT02189590|supraglottic airway|supraglottic airway
1165977|NCT02189590|children|children
1165978|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
1165979|NCT02189590|air-Q|air-q
1165980|NCT02189590|i-gel|i-gel
1165981|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
1165982|NCT02189577|COPD|copd
1165983|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
1165984|NCT02189525|traumatic brain injury|traumatic brain injury
1165985|NCT02189525|sports head injury|sports head injury
1165986|NCT02189525|sports concussion|sports concussion
1165987|NCT02189512|brain-death organ donors|brain-death organ donors
1165988|NCT02189512|intestinal manipulation|intestinal manipulation
1165989|NCT02189512|monocytes|monocytes
1165990|NCT02189499|Stents|stents
1165991|NCT02189499|Angioplasty|angioplasty
1165992|NCT02189499|Coronary Vessels|coronary vessels
1165993|NCT02189499|Coronary Artery Disease|coronary artery disease
1165994|NCT02189499|Angina Pectoris|angina pectoris
1165995|NCT02189499|Myocardial Ischemia|myocardial ischemia
1165996|NCT02189499|Myocardial Infarction|myocardial infarction
1165997|NCT02189499|Myocardial Revascularization|myocardial revascularization
1165998|NCT02189486|Prostate Cancer|prostate cancer
1165999|NCT02189486|Radical Prostatectomy|radical prostatectomy
1166000|NCT02189486|Prostate biopsy|prostate biopsy
1166001|NCT02189486|Upgrading|upgrading
1166002|NCT02189486|Upgrading Reference set|upgrading reference set
1166003|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
1166004|NCT02189473|motor function|motor function
1166005|NCT02189473|ambulatory status|ambulatory status
1166006|NCT02189473|pain|pain
1166007|NCT02189473|quality of life|quality of life
1166008|NCT02189473|overall survival|overall survival
1166009|NCT02189473|local control|local control
1166010|NCT02189473|toxicity|toxicity
1166011|NCT02189460|Cognition|cognition
1166012|NCT02189447|Keratoconus|keratoconus
1166013|NCT02189447|Ectasia|ectasia
1166014|NCT02189447|Corneal Cross-linking|corneal cross-linking
1166015|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
1166016|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
1166017|NCT02189421|multibending endoscope|multibending endoscope
1166018|NCT02189408|Platelet rich plasma|platelet rich plasma
1166019|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
1166020|NCT02189408|Outerbridge|outerbridge
1166021|NCT02189395|Type 2 diabetes|type 2 diabetes
1166022|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
1166023|NCT02189395|insulin|insulin
1166024|NCT02189395|glargine|glargine
1166026|NCT02189382|Sensitivity|sensitivity
1166027|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
1166028|NCT02189356|exercise program|exercise program
1166029|NCT02189356|nurse|nurse
1166030|NCT02189343|Multiple Myeloma|multiple myeloma
1166031|NCT02189343|Relapsed and Refractory|relapsed and refractory
1166032|NCT02189343|Refractory Disease|refractory disease
1166424|NCT02187796|Dementia|dementia
1166033|NCT02189343|Progressive Disease|progressive disease
1166034|NCT02189343|Pomalidomide|pomalidomide
1166035|NCT02189343|Dexamethasone|dexamethasone
1166036|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
1166037|NCT02189343|Ricolinostat|ricolinostat
1166038|NCT02189304|Healthy volunteers|healthy volunteers
1166039|NCT02189291|Indwelling catheter|indwelling catheter
1166040|NCT02189291|Hospital stay|hospital stay
1166041|NCT02189291|Urinary tract infection|urinary tract infection
1166042|NCT02189291|Sacrocolpopexy|sacrocolpopexy
1166043|NCT02189278|Breast Cancer|breast cancer
1166044|NCT02189278|Surveillance|surveillance
1166045|NCT02189278|Mammography|mammography
1166046|NCT02189278|Adherence|adherence
1166047|NCT02189265|Live birth [MeSH]|live birth [mesh]
1166048|NCT02189265|Infant [MeSH]|infant [mesh]
1166049|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
1166050|NCT02189265|Second-hand smoke|second-hand smoke
1166051|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
1166052|NCT02189265|Smoke-free|smoke-free
1166053|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
1166054|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
1166055|NCT02189213|anxiety|anxiety
1166056|NCT02189213|SSRI|ssri
1166057|NCT02189213|biomarker|biomarker
1166058|NCT02189213|sleep|sleep
1166059|NCT02189213|children|children
1166060|NCT02189213|adolescents|adolescents
1166061|NCT02189213|young adults|young adults
1166062|NCT02189200|nutritional counseling|nutritional counseling
1166063|NCT02189200|oat bran|oat bran
1166064|NCT02189200|dyslipidemia|dyslipidemia
1166065|NCT02189200|cardiovascular disease|cardiovascular disease
1166066|NCT02189187|Weight Loss|weight loss
1166067|NCT02189187|Body Weight Changes|body weight changes
1166068|NCT02189187|Body Weight|body weight
1166069|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
1166070|NCT02189187|Emotions|emotions
1166071|NCT02189187|Emotion regulation|emotion regulation
1166072|NCT02189187|Health Behavior|health behavior
1166073|NCT02189187|Eating behavior|eating behavior
1166074|NCT02189174|Solid tumor,|solid tumor,
1166075|NCT02189174|breast cancer,|breast cancer,
1166076|NCT02189174|lung cancer,|lung cancer,
1166077|NCT02189174|endometrial cancer|endometrial cancer
1166078|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
1166080|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
1166081|NCT02189161|RFA|rfa
1166082|NCT02189148|Prediction|prediction
1166083|NCT02189148|Preeclampsia|preeclampsia
1166084|NCT02189148|Preterm birth|preterm birth
1166085|NCT02189148|Pregnancy|pregnancy
1166086|NCT02189148|Placenta|placenta
1166087|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
1166088|NCT02189148|fetal growth restriction|fetal growth restriction
1166089|NCT02189148|Ultrasound|ultrasound
1166090|NCT02189148|Doppler|doppler
1166091|NCT02189148|Biomarkers|biomarkers
1166092|NCT02189148|PAPP-A|papp-a
1166093|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
1166094|NCT02189109|glioblastoma|glioblastoma
1166095|NCT02189109|multiforme|multiforme
1166096|NCT02189109|radiation|radiation
1166097|NCT02189109|radiation therapy|radiation therapy
1166098|NCT02189096|Sepsis|sepsis
1166099|NCT02189096|National Early Warning Score|national early warning score
1166100|NCT02189096|Lactate|lactate
1166101|NCT02189083|Leiomyoma|leiomyoma
1166102|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
1166103|NCT02189083|Randomized Controlled Trial|randomized controlled trial
1166104|NCT02189070|Follow-up|follow-up
1166105|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
1166106|NCT02189070|Patient preference|patient preference
1166107|NCT02189070|DUTCH PEERS|dutch peers
1166108|NCT02189070|TWENTE|twente
1166109|NCT02189057|Bipolar|bipolar
1166110|NCT02189057|Unipolar|unipolar
1166111|NCT02189057|Genotyping|genotyping
1166112|NCT02189057|Pharmacokinetic|pharmacokinetic
1166113|NCT02189057|Pharmacodynamic|pharmacodynamic
1166114|NCT02189044|aged;|aged;
1166115|NCT02189044|breathing exercises;|breathing exercises;
1166116|NCT02189044|muscle strength.|muscle strength.
1166117|NCT02189031|Upper limb Amputee|upper limb amputee
1166118|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
1166119|NCT02189031|Prosthetic|prosthetic
1166120|NCT02189018|Peripheral arterial disease|peripheral arterial disease
1166121|NCT02189018|Endovascular|endovascular
1166122|NCT02189018|Exercise|exercise
1166123|NCT02189018|Perfusion|perfusion
1166124|NCT02189018|Functional capacity|functional capacity
1166125|NCT02189005|High blood sugar|high blood sugar
1166126|NCT02189005|High HbA1C|high hba1c
1166127|NCT02189005|hyperglycemia|hyperglycemia
1166128|NCT02189005|Pre-Diabetes|pre-diabetes
1166129|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
1166130|NCT02188992|Sepsis|sepsis
1166131|NCT02188992|Immune activation|immune activation
1166132|NCT02188992|Systemic Inflammation|systemic inflammation
1166133|NCT02188992|Emergency Medicine|emergency medicine
1166425|NCT02187796|HAND|hand
1166134|NCT02188992|Critical Care|critical care
1166135|NCT02188979|airway|airway
1166136|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
1166137|NCT02188979|intubation - tracheal|intubation - tracheal
1166138|NCT02188979|obesity.|obesity.
1166139|NCT02188966|Geographic Information System|geographic information system
1166140|NCT02188966|Emergency Care Information Systems|emergency care information systems
1166141|NCT02188966|Telemedicine|telemedicine
1166142|NCT02188966|Emergency Hospital Service|emergency hospital service
1166143|NCT02188953|aflatoxin|aflatoxin
1166144|NCT02188953|Kenya|kenya
1166145|NCT02188940|Asthma|asthma
1166146|NCT02188940|Obesity|obesity
1166147|NCT02188940|Clinical control|clinical control
1166148|NCT02188940|Exercise|exercise
1166149|NCT02188940|Weight-loss|weight-loss
1166150|NCT02188927|Advanced notification letter|advanced notification letter
1166151|NCT02188927|Standard invitation|standard invitation
1166152|NCT02188927|Participation rate|participation rate
1166153|NCT02188927|Colonoscopy|colonoscopy
1166154|NCT02188927|Screening|screening
1166155|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
1166156|NCT02188927|Digestive System Diseases|digestive system diseases
1166157|NCT02188914|Inhalant use disorder|inhalant use disorder
1166158|NCT02188914|Positron emission tomography|positron emission tomography
1166159|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
1166160|NCT02188914|Executive functions assessment|executive functions assessment
1166161|NCT02188914|Transcriptome|transcriptome
1166162|NCT02188901|HCC|hcc
1166163|NCT02188901|Sonazoid|sonazoid
1166164|NCT02188901|Ultrasonography|ultrasonography
1166165|NCT02188901|Screening|screening
1166166|NCT02188888|septic shock|septic shock
1166167|NCT02188888|esmolol|esmolol
1166168|NCT02188888|tachycardia|tachycardia
1166169|NCT02188888|betablockers|betablockers
1166170|NCT02188875|Fitbit One|fitbit one
1166171|NCT02188875|wearable sensor|wearable sensor
1166172|NCT02188875|wearable device|wearable device
1166173|NCT02188875|web-based intervention|web-based intervention
1166174|NCT02188875|SMS text messages|sms text messages
1166175|NCT02188875|randomized controlled trial|randomized controlled trial
1166176|NCT02188875|physical activity|physical activity
1166177|NCT02188875|behavioral intervention|behavioral intervention
1166178|NCT02188875|text message prompts|text message prompts
1166179|NCT02188875|text messaging|text messaging
1166180|NCT02188875|technology|technology
1166181|NCT02188875|exercise|exercise
1166182|NCT02188862|Rheumatic heart disease|rheumatic heart disease
1166183|NCT02188862|Acute rheumatic fever|acute rheumatic fever
1166184|NCT02188862|Group A streptococcal disease|group a streptococcal disease
1166185|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
1166186|NCT02188862|Genetics|genetics
1166188|NCT02188849|creatine|creatine
1166189|NCT02188849|resistance training|resistance training
1166190|NCT02188849|older women|older women
1166191|NCT02188849|muscle strength|muscle strength
1166192|NCT02188823|prediabetes|prediabetes
1166193|NCT02188823|obesity|obesity
1166194|NCT02188823|mindful eating|mindful eating
1166195|NCT02188823|positive affect|positive affect
1166196|NCT02188823|low carbohydrate|low carbohydrate
1166197|NCT02188823|ketogenic|ketogenic
1166198|NCT02188823|diet|diet
1166200|NCT02188810|fluviral|fluviral
1166201|NCT02188810|healthy volunteer|healthy volunteer
1166202|NCT02188810|adjuvant|adjuvant
1166203|NCT02188810|TH1 immune response|th1 immune response
1166204|NCT02188797|homeless|homeless
1166205|NCT02188797|young adults|young adults
1166206|NCT02188797|substance use|substance use
1166207|NCT02188797|HIV risk|hiv risk
1166208|NCT02188797|sexual risk behavior|sexual risk behavior
1166209|NCT02188797|group motivational interviewing|group motivational interviewing
1166210|NCT02188771|Moderate to Severe OA|moderate to severe oa
1166211|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
1166212|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
1166213|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
1166214|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
1166215|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
1166216|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
1166217|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
1166218|NCT02188758|iron|iron
1166219|NCT02188758|hepcidin-25|hepcidin-25
1166220|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
1166221|NCT02188758|interleukin-6|interleukin-6
1166222|NCT02188745|metastatic|metastatic
1166223|NCT02188745|locally advanced|locally advanced
1166224|NCT02188745|ER+|er+
1166225|NCT02188745|Estrogen therapy|estrogen therapy
1166226|NCT02188745|Estradiol therapy|estradiol therapy
1166227|NCT02188732|Community Mental Health|community mental health
1166228|NCT02188732|Serious Mental Illness|serious mental illness
1166229|NCT02188732|Medical Comorbidity|medical comorbidity
1166230|NCT02188732|Self-Management|self-management
1166231|NCT02188732|Automated Telehealth|automated telehealth
1166232|NCT02188732|Early Mortality|early mortality
1166233|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
1166234|NCT02188719|Tregs|tregs
1166235|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
1166236|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
1166237|NCT02188719|Liver Transplantation|liver transplantation
1166238|NCT02188680|fructose test|fructose test
1166239|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
1166240|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
1166241|NCT02188667|Neuropathic Pain|neuropathic pain
1166242|NCT02188667|Headache Pain|headache pain
1166243|NCT02188654|psoriatic arthritis|psoriatic arthritis
1166244|NCT02188654|inflammation|inflammation
1166245|NCT02188654|metabolic syndrome|metabolic syndrome
1166246|NCT02188654|metformin|metformin
1166247|NCT02188641|Psoriatic arthritis|psoriatic arthritis
1166248|NCT02188641|inflammation|inflammation
1166249|NCT02188641|obesity|obesity
1166250|NCT02188641|diet|diet
1166251|NCT02188641|exercise|exercise
1166252|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
1166253|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
1166254|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
1166255|NCT02188615|laparoscopy|laparoscopy
1166256|NCT02188615|thoracoscopy|thoracoscopy
1166257|NCT02188576|Craniofacial Surgery|craniofacial surgery
1166258|NCT02188576|tranexamic acid|tranexamic acid
1166259|NCT02188576|Antifibrinolytic|antifibrinolytic
1166260|NCT02188563|Smoking cessation|smoking cessation
1166261|NCT02188563|Head and neck neoplasms|head and neck neoplasms
1166262|NCT02188563|Lung neoplasms|lung neoplasms
1166263|NCT02188563|Thoracic neoplasms|thoracic neoplasms
1166264|NCT02188563|Radiation|radiation
1166265|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
1166266|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
1166267|NCT02188537|Myeloma|myeloma
1166268|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
1166269|NCT02188537|Nelfinavir|nelfinavir
1166270|NCT02188537|bortezomib|bortezomib
1166271|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
1166272|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
1166273|NCT02188511|E-Cigarettes|e-cigarettes
1166274|NCT02188511|Lung|lung
1166275|NCT02188511|Non-Smokers|non-smokers
1166276|NCT02188511|Lung Biology|lung biology
1166277|NCT02188472|Oxidative Stress|oxidative stress
1166278|NCT02188472|antibiotics|antibiotics
1166279|NCT02188446|Radical cystectomy|radical cystectomy
1166280|NCT02188446|Bladder cancer|bladder cancer
1166281|NCT02188446|Smoking cessation|smoking cessation
1166282|NCT02188446|Alcohol cessation|alcohol cessation
1166283|NCT02188446|Postoperative complications|postoperative complications
1166284|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
1166286|NCT02188420|TMS|tms
1166287|NCT02188420|Stroke|stroke
1166288|NCT02188420|Paired Associative Stimulation|paired associative stimulation
1166289|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1166290|NCT02188407|thoracotomy|thoracotomy
1166291|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
1166292|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
1166293|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
1166294|NCT02188407|cytokines|cytokines
1166295|NCT02188407|interleukine (IL)|interleukine (il)
1166296|NCT02188394|migraine,|migraine,
1166297|NCT02188394|pressure pain,|pressure pain,
1166298|NCT02188394|anesthetic blocks|anesthetic blocks
1166299|NCT02188394|patients|patients
1166300|NCT02188381|Resistant Hypertension|resistant hypertension
1166301|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
1166302|NCT02188368|Pomalidomide|pomalidomide
1166303|NCT02188368|Lenalidomide refractory|lenalidomide refractory
1166304|NCT02188368|multiple myeloma|multiple myeloma
1166305|NCT02188355|Ultimaster|ultimaster
1166306|NCT02188355|registry|registry
1166307|NCT02188355|DES|des
1166308|NCT02188355|DAPT|dapt
1166309|NCT02188329|Early care and education|early care and education
1166310|NCT02188329|ECE|ece
1166311|NCT02188329|workforce|workforce
1166312|NCT02188329|child care|child care
1166313|NCT02188329|caregivers|caregivers
1166314|NCT02188329|home-based providers|home-based providers
1166315|NCT02188329|center-based providers|center-based providers
1166316|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
1166317|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
1166318|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
1166319|NCT02188316|Jumbo forceps.|jumbo forceps.
1166320|NCT02188290|Haploidentical donor|haploidentical donor
1166321|NCT02188290|Unrelated donor|unrelated donor
1166322|NCT02188290|Umbilical cord blood|umbilical cord blood
1166323|NCT02188290|Graft versus host disease|graft versus host disease
1166324|NCT02188290|Transplant-related mortality|transplant-related mortality
1166325|NCT02188290|Hematologic malignancy|hematologic malignancy
1166326|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1166327|NCT02188251|Activamp|activamp
1166328|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
1166329|NCT02188251|Body weight|body weight
1166330|NCT02188251|Fat Loss|fat loss
1166331|NCT02188251|Metabolic markers|metabolic markers
1166332|NCT02188251|Overweight participants|overweight participants
1166333|NCT02188251|DXA|dxa
1166334|NCT02188251|AMPK|ampk
1166335|NCT02188238|saliva|saliva
1166336|NCT02188238|protein|protein
1166337|NCT02188238|oral health|oral health
1166338|NCT02188238|film|film
1166339|NCT02188238|pellicle|pellicle
1166340|NCT02188225|Hot flash|hot flash
1166341|NCT02188225|Acupuncture|acupuncture
1166342|NCT02188225|Fluoxetine|fluoxetine
1166343|NCT02188225|Quality of life|quality of life
1166344|NCT02188199|Hip|hip
1166345|NCT02188199|Knee|knee
1166346|NCT02188199|Hip replacement|hip replacement
1166347|NCT02188199|Knee replacement|knee replacement
1166348|NCT02188199|Total Joint|total joint
1166349|NCT02188186|triple combination|triple combination
1166350|NCT02188186|metformin|metformin
1166351|NCT02188186|sitagliptin|sitagliptin
1166352|NCT02188186|thiazolidinedione|thiazolidinedione
1166353|NCT02188160|Pain|pain
1166354|NCT02188160|Corticosteroid|corticosteroid
1166355|NCT02188160|Dry Eye|dry eye
1166356|NCT02188160|Hyperemia|hyperemia
1166357|NCT02188160|Ocular Discomfort|ocular discomfort
1166358|NCT02188147|Syncope|syncope
1166359|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
1166360|NCT02188147|Sudden Cardiac Death|sudden cardiac death
1166361|NCT02188147|Cardiac Arrest|cardiac arrest
1166362|NCT02188147|Emergency Service|emergency service
1166363|NCT02188147|Emergency Department|emergency department
1166364|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
1166365|NCT02188147|Holter|holter
1166366|NCT02188147|Holter Electrocardiography|holter electrocardiography
1166367|NCT02188147|Holter Monitoring|holter monitoring
1166368|NCT02188134|Adverse events,|adverse events,
1166369|NCT02188134|adverse drug reactions,|adverse drug reactions,
1166370|NCT02188134|medication error,|medication error,
1166371|NCT02188134|noncompliance|noncompliance
1166372|NCT02188108|quality of life|quality of life
1166373|NCT02188108|QOL|qol
1166374|NCT02188108|urolithiasis|urolithiasis
1166375|NCT02188108|nephrolithiasis|nephrolithiasis
1166376|NCT02188108|kidney stones|kidney stones
1166377|NCT02188108|patient-reported outcomes|patient-reported outcomes
1166378|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
1166379|NCT02188056|Venous|venous
1166380|NCT02188056|Thromboembolic|thromboembolic
1166381|NCT02188056|Pulmonary embolism|pulmonary embolism
1166382|NCT02188043|Alcohol use disorder|alcohol use disorder
1166383|NCT02188043|Motivational Intervention|motivational intervention
1166384|NCT02188043|Health expenditures|health expenditures
1166385|NCT02188043|efficacy study|efficacy study
1166386|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
1166387|NCT02188030|industrial workers|industrial workers
1166388|NCT02188030|physical-activity program|physical-activity program
1166389|NCT02188030|resistance training|resistance training
1166390|NCT02188030|randomized controlled trial|randomized controlled trial
1166391|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
1166392|NCT02188004|HPV|hpv
1166393|NCT02188004|genital warts|genital warts
1166394|NCT02187991|metastatic breast cancer|metastatic breast cancer
1166395|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
1166396|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
1166397|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
1166398|NCT02187991|alisertib|alisertib
1166399|NCT02187991|paclitaxel|paclitaxel
1166400|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
1166401|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
1166402|NCT02187978|VLBW infants|vlbw infants
1166403|NCT02187978|NEC|nec
1166404|NCT02187978|Preterm infants|preterm infants
1166405|NCT02187926|Drug therapy|drug therapy
1166406|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
1166407|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
1166408|NCT02187887|alcohol|alcohol
1166409|NCT02187887|young adult veterans|young adult veterans
1166410|NCT02187887|brief intervention|brief intervention
1166411|NCT02187887|online|online
1166412|NCT02187887|perceived norms|perceived norms
1166413|NCT02187835|complexity|complexity
1166414|NCT02187835|electroencephalogram|electroencephalogram
1166415|NCT02187835|entropy|entropy
1166416|NCT02187835|negative symptoms|negative symptoms
1166417|NCT02187835|schizophrenia.|schizophrenia.
1166418|NCT02187822|Brain|brain
1166419|NCT02187822|Advanced solid tumors|advanced solid tumors
1166420|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
1166421|NCT02187822|Brain lesions|brain lesions
1166422|NCT02187822|Primary solid malignancy|primary solid malignancy
1166423|NCT02187796|HIV|hiv
1166426|NCT02187796|COGNISION System|cognision system
1166427|NCT02187796|ERP|erp
1166428|NCT02187796|event-related potentials|event-related potentials
1166429|NCT02187783|Solid malignancy,|solid malignancy,
1166430|NCT02187783|Hematologic malignancy,|hematologic malignancy,
1166431|NCT02187783|Mutations,|mutations,
1166432|NCT02187783|Amplifications,|amplifications,
1166433|NCT02187783|Signature,|signature,
1166434|NCT02187783|CDK4,|cdk4,
1166435|NCT02187783|CDK6,|cdk6,
1166436|NCT02187783|CDK4/6,|cdk4/6,
1166437|NCT02187783|Cyclin D1,|cyclin d1,
1166438|NCT02187783|CCND1,|ccnd1,
1166439|NCT02187783|Cyclin D3,|cyclin d3,
1166440|NCT02187783|CCND3,|ccnd3,
1166441|NCT02187783|p16 mutation,|p16 mutation,
1166442|NCT02187783|CDKN2A,|cdkn2a,
1166443|NCT02187783|LEE011,|lee011,
1166444|NCT02187783|Breast cancer,|breast cancer,
1166445|NCT02187783|Ovarian cancer,|ovarian cancer,
1166446|NCT02187783|Lymphoma,|lymphoma,
1166447|NCT02187783|Mesothelioma,|mesothelioma,
1166448|NCT02187783|Pancreatic neuroendocrine,|pancreatic neuroendocrine,
1166449|NCT02187783|Leukemia|leukemia
1166450|NCT02187783|Tumor|tumor
1166451|NCT02187757|Dyslipidemia|dyslipidemia
1166452|NCT02187757|High cholesterol|high cholesterol
1166453|NCT02187757|High LDL|high ldl
1166454|NCT02187757|Triglycerides|triglycerides
1166455|NCT02187744|Biosimilars|biosimilars
1166456|NCT02187744|Non-inferiority|non-inferiority
1166457|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
1166458|NCT02187744|Early Breast Cancer|early breast cancer
1166459|NCT02187744|PK|pk
1166460|NCT02187744|Phase 3|phase 3
1166461|NCT02187744|Trastuzumab|trastuzumab
1166462|NCT02187744|Herceptin|herceptin
1166463|NCT02187744|HER2 Positive|her2 positive
1166464|NCT02187731|Multiple Myeloma|multiple myeloma
1572220|NCT00493727|Diabetes|diabetes
1166465|NCT02187731|Functional Imaging|functional imaging
1166466|NCT02187731|PET/CT|pet/ct
1166467|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
1166468|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1166469|NCT02187718|Local Anaesthesia|local anaesthesia
1166470|NCT02187692|schizophrenia;|schizophrenia;
1166471|NCT02187692|meta-cognition;|meta-cognition;
1166472|NCT02187692|general functioning;|general functioning;
1166473|NCT02187692|positive symptoms;|positive symptoms;
1166474|NCT02187692|insight;|insight;
1166475|NCT02187679|Tourette Syndrome|tourette syndrome
1166476|NCT02187679|Tourette's Syndrome|tourette's syndrome
1166477|NCT02187679|Chronic Vocal Tic|chronic vocal tic
1166478|NCT02187679|Vocal Tic|vocal tic
1166479|NCT02187666|Cervical|cervical
1166480|NCT02187666|Lumbar|lumbar
1166481|NCT02187666|Spine|spine
1166482|NCT02187666|Spinal Disease|spinal disease
1166483|NCT02187653|IOM|iom
1166484|NCT02187653|IONM|ionm
1166485|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
1166486|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
1166487|NCT02187653|Spine|spine
1166488|NCT02187653|Lumbar|lumbar
1166489|NCT02187653|Cervical|cervical
1166490|NCT02187640|Acupressure|acupressure
1166491|NCT02187640|Self-administration|self-administration
1166492|NCT02187640|Psychiatric in-patients|psychiatric in-patients
1166493|NCT02187640|Constipation|constipation
1166494|NCT02187640|Self-administered acupressure program|self-administered acupressure program
1166495|NCT02187640|Sham control group|sham control group
1166496|NCT02187614|Acute Renal colic|acute renal colic
1166497|NCT02187614|Acute Ureteric Colic|acute ureteric colic
1166498|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
1166499|NCT02187614|Urolithiasis|urolithiasis
1166500|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
1166501|NCT02187601|CLD|cld
1166502|NCT02187549|Hyaluronic Acid|hyaluronic acid
1166503|NCT02187549|Osteoarthritis|osteoarthritis
1166504|NCT02187549|Knee|knee
1166505|NCT02187549|Hyaluronan|hyaluronan
1166506|NCT02187549|Viscoelastic|viscoelastic
1166507|NCT02187549|Hydrogel|hydrogel
1166508|NCT02187510|Hemodynamics|hemodynamics
1166509|NCT02187510|Premature Infant|premature infant
1166510|NCT02187510|Umbilical cord|umbilical cord
1166511|NCT02187510|Milking|milking
1166512|NCT02187510|Delayed clamping|delayed clamping
1166513|NCT02187471|pain|pain
1166514|NCT02187471|fibromyalgia|fibromyalgia
1166515|NCT02187445|Sickle Cell Disease|sickle cell disease
1166516|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
1166517|NCT02187445|Acute Chest Syndrome|acute chest syndrome
1166518|NCT02187419|Sleep|sleep
1166519|NCT02187419|Menopause|menopause
1166520|NCT02187419|Hypnosis|hypnosis
1166521|NCT02187419|Relaxation|relaxation
1166522|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
1166523|NCT02187419|Hot Flash|hot flash
1166524|NCT02187406|athletic tape|athletic tape
1166525|NCT02187406|tennis|tennis
1166526|NCT02187406|warm-up exercise|warm-up exercise
1166527|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
1166528|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
1166529|NCT02187289|NCSG|ncsg
1166530|NCT02187289|Compression bandages|compression bandages
1166531|NCT02187289|devices|devices
1166532|NCT02187289|Night time compression|night time compression
1166533|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
1166534|NCT02187289|Compression therapy|compression therapy
1166535|NCT02187289|Reid Sleeve|reid sleeve
1166536|NCT02187289|Comprefit|comprefit
1166537|NCT02187289|Medassist|medassist
1166538|NCT02187289|Tribute|tribute
1166539|NCT02187289|Comprilan|comprilan
1166540|NCT02187276|Predictive factors of response|predictive factors of response
1166541|NCT02187276|mild and moderate|mild and moderate
1166542|NCT02187276|Alzheimer disease|alzheimer disease
1166543|NCT02187276|mixed dementia|mixed dementia
1166544|NCT02187276|APOE|apoe
1166545|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
1166546|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
1166547|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
1166548|NCT02187263|registry,|registry,
1166549|NCT02187263|biomaterial,|biomaterial,
1166550|NCT02187263|clinical trial|clinical trial
1166551|NCT02187263|Patients|patients
1166552|NCT02187250|PCOS|pcos
1166553|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
1166554|NCT02187250|roflumilast|roflumilast
1166555|NCT02187250|liraglutide|liraglutide
1166556|NCT02187250|metformin|metformin
1166557|NCT02187250|obesity|obesity
1166558|NCT02187224|Alcohol Dependence|alcohol dependence
1166559|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1166560|NCT02187224|Progesterone|progesterone
1166561|NCT02187211|Alcohol Dependence|alcohol dependence
1166562|NCT02187211|Minocycline|minocycline
1166563|NCT02187198|Opioid Dependence|opioid dependence
1166564|NCT02187198|Buprenorphine|buprenorphine
1166565|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
1166566|NCT02187185|Periodontitis|periodontitis
1166567|NCT02187172|Psoriasis|psoriasis
1166568|NCT02187172|Cardiovascular Disease|cardiovascular disease
1166569|NCT02187172|Vascular Inflammation|vascular inflammation
1166570|NCT02187172|Lipid Biomarkers|lipid biomarkers
1166571|NCT02187172|FDG-PET/CT|fdg-pet/ct
1166572|NCT02187159|pain|pain
1166573|NCT02187159|fibromyalgia|fibromyalgia
1166574|NCT02187146|Vitamin D|vitamin d
1166575|NCT02187146|Infertility|infertility
1166576|NCT02187146|IVF|ivf
1166577|NCT02187146|ART|art
1166578|NCT02187133|Relapsed|relapsed
1166579|NCT02187133|Refractory|refractory
1166580|NCT02187120|Wounds and Injuries|wounds and injuries
1166581|NCT02187120|Acute Coagulopathy|acute coagulopathy
1166582|NCT02187120|Tranexamic Acid|tranexamic acid
1166583|NCT02187120|Emergency Medical Services|emergency medical services
1166584|NCT02187107|HIV|hiv
1166585|NCT02187107|AIDS|aids
1166586|NCT02187107|TMC114|tmc114
1166587|NCT02187107|Ritonavir|ritonavir
1166588|NCT02187107|Norvir|norvir
1166589|NCT02187107|Darunavir|darunavir
1166590|NCT02187081|HCC|hcc
1166591|NCT02187081|RFA|rfa
1166592|NCT02187081|Sorafenib|sorafenib
1166593|NCT02187081|Tumor recurrence|tumor recurrence
1166594|NCT02187081|Overall survival|overall survival
1166595|NCT02187068|Anaesthetics iv|anaesthetics iv
1166596|NCT02187068|Dexmedetomidine|dexmedetomidine
1166597|NCT02187068|Pharmacokinetic|pharmacokinetic
1166598|NCT02187042|sunitinib|sunitinib
1166599|NCT02187042|call center|call center
1166600|NCT02187042|management of patients|management of patients
1166601|NCT02187042|nurses|nurses
1166602|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
1166603|NCT02187029|Hyperuricemia|hyperuricemia
1166604|NCT02187029|gout|gout
1166605|NCT02187029|serum uric acid|serum uric acid
1166606|NCT02187016|Gingivitis|gingivitis
1166607|NCT02187016|plaque|plaque
1166608|NCT02187016|interproximal cleaning|interproximal cleaning
1166609|NCT02187016|dental floss|dental floss
1166610|NCT02187003|Sickle Cell Anemia|sickle cell anemia
1166611|NCT02187003|Sickle Cell Disease|sickle cell disease
1166612|NCT02187003|Sickle Cell Disorders|sickle cell disorders
1166613|NCT02187003|pain crisis|pain crisis
1166614|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
1166615|NCT02187003|rivipansel|rivipansel
1166616|NCT02187003|GMI-1070|gmi-1070
1166617|NCT02187003|selectin inhibitor|selectin inhibitor
1166618|NCT02187003|SCD|scd
1166619|NCT02187003|VOC|voc
1166620|NCT02186977|immunogenicity|immunogenicity
1166621|NCT02186977|safety|safety
1166622|NCT02186977|proof of concept|proof of concept
1166623|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
1166624|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
1166625|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
1166626|NCT02186951|preventive antibiotics|preventive antibiotics
1166627|NCT02186938|head and neck cancer|head and neck cancer
1166628|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
1166629|NCT02186925|Kidney Cancer|kidney cancer
1166630|NCT02186925|Prostate Cancer|prostate cancer
1166631|NCT02186925|Bladder Cancer|bladder cancer
1166632|NCT02186912|edentulous|edentulous
1166633|NCT02186912|Nobel Active|nobel active
1166634|NCT02186912|Nobel Procera|nobel procera
1166635|NCT02186912|IBO|ibo
1166636|NCT02186912|CAD/CAM|cad/cam
1166637|NCT02186886|Ulcerative Colitis|ulcerative colitis
1166638|NCT02186886|Golimumab|golimumab
1166639|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
1166640|NCT02186886|PIMS|pims
1166641|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
1166642|NCT02186873|Golimumab|golimumab
1166643|NCT02186873|SIMPONI|simponi
1166644|NCT02186834|Relapsed|relapsed
1166645|NCT02186834|Refractory|refractory
1166646|NCT02186834|Myeloma|myeloma
1166647|NCT02186821|hematological malignancy|hematological malignancy
1166648|NCT02186821|solid tumor malignancy|solid tumor malignancy
1166649|NCT02186821|mutation|mutation
1166650|NCT02186821|translocation|translocation
1166651|NCT02186821|rearrangement|rearrangement
1166652|NCT02186821|amplification|amplification
1166653|NCT02186821|ALK|alk
1166654|NCT02186821|ROS1|ros1
1166655|NCT02186821|NSCLC|nsclc
1166656|NCT02186821|B-cell lymphoma|b-cell lymphoma
1166657|NCT02186795|Arthroplasty|arthroplasty
1166658|NCT02186795|Replacement, Hip|replacement, hip
1166659|NCT02186782|Clomiphene citrate|clomiphene citrate
1166660|NCT02186782|Estradiol|estradiol
1166661|NCT02186782|Endometrial thickness|endometrial thickness
1166662|NCT02186756|Fibromyalgia|fibromyalgia
1166663|NCT02186756|Complementary Therapies|complementary therapies
1166664|NCT02186756|Biofeedback|biofeedback
1166665|NCT02186756|Randomized controlled trial|randomized controlled trial
1166666|NCT02186756|Relaxation Therapy|relaxation therapy
1166667|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
1166668|NCT02186743|IBS|ibs
1166669|NCT02186743|Diet|diet
1166670|NCT02186743|Food sensitivity|food sensitivity
1333243|NCT01443858|Nicotine Patch|nicotine patch
1233198|NCT01881334|ALL|all
1166671|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
1166672|NCT02186730|Adolescents|adolescents
1166673|NCT02186730|Depression|depression
1166674|NCT02186730|Low Mood|low mood
1166675|NCT02186704|Atrial Fibrillation|atrial fibrillation
1166676|NCT02186704|Implantable Defibrillators|implantable defibrillators
1166677|NCT02186704|Implanted Electrodes|implanted electrodes
1166678|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
1166679|NCT02186691|tetralogy of Fallot|tetralogy of fallot
1166680|NCT02186652|obese|obese
1166681|NCT02186652|children|children
1166682|NCT02186652|adolescents|adolescents
1166683|NCT02186652|GERD|gerd
1166684|NCT02186652|pharmacokinetic|pharmacokinetic
1166685|NCT02186639|exhaled breath|exhaled breath
1166686|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
1166687|NCT02186639|SESI-MS|sesi-ms
1166688|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
1166689|NCT02186613|Breast Feeding|breast feeding
1166690|NCT02186613|Telephone|telephone
1166691|NCT02186613|Education|education
1166692|NCT02186613|Primary Health Care|primary health care
1166693|NCT02186600|Low bone mass|low bone mass
1166694|NCT02186600|Post-menopausal women|post-menopausal women
1166695|NCT02186600|Bone mineral density|bone mineral density
1166696|NCT02186600|Bone structure|bone structure
1166697|NCT02186600|Bone turnover|bone turnover
1166698|NCT02186600|Bone-loading exercises|bone-loading exercises
1166699|NCT02186600|calcium and vitamin D|calcium and vitamin d
1166700|NCT02186600|risedronate|risedronate
1166701|NCT02186574|Non-Hodgkin|non-hodgkin
1166702|NCT02186574|Lymphoma|lymphoma
1166703|NCT02186574|Hepatitis B|hepatitis b
1166704|NCT02186574|Tenofovir|tenofovir
1166705|NCT02186574|Viread|viread
1166706|NCT02186561|intracranial aneurysm|intracranial aneurysm
1166707|NCT02186561|brain aneurysm|brain aneurysm
1166708|NCT02186522|Sepsis|sepsis
1166709|NCT02186522|Septic shock|septic shock
1166710|NCT02186522|Critical care|critical care
1166711|NCT02186522|Immune dysfunction|immune dysfunction
1166712|NCT02186522|Inflammatory markers|inflammatory markers
1166713|NCT02186522|Neutrophil|neutrophil
1166714|NCT02186522|Monocyte|monocyte
1166715|NCT02186522|Tregs|tregs
1166716|NCT02186470|Breast Cancer|breast cancer
1166717|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
1166718|NCT02186470|Hormone responsive breast cancer|hormone responsive breast cancer
1166719|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
1166720|NCT02186457|Whipple|whipple
1166721|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
1166722|NCT02186444|prostate|prostate
1166723|NCT02186431|Contact lenses|contact lenses
1166724|NCT02186418|sickle cell disease|sickle cell disease
1166725|NCT02186418|sickle cell anemia|sickle cell anemia
1166726|NCT02186418|hemoglobinopathies|hemoglobinopathies
1166727|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
1166728|NCT02186418|gene transfer|gene transfer
1166729|NCT02186418|gene therapy|gene therapy
1166730|NCT02186392|Depression|depression
1166731|NCT02186392|Anxiety|anxiety
1166732|NCT02186392|Stroke|stroke
1166733|NCT02186392|Cerebral Infarction|cerebral infarction
1166734|NCT02186392|Sleep disorders|sleep disorders
1166735|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
1166736|NCT02186392|Circadian Light|circadian light
1166737|NCT02186392|Light therapy|light therapy
1166738|NCT02186392|Melatonin|melatonin
1166739|NCT02186392|Sleep|sleep
1166740|NCT02186392|Sleep apnea|sleep apnea
1166741|NCT02186392|Coagulation disturbances|coagulation disturbances
1166742|NCT02186392|Bone metabolism|bone metabolism
1166743|NCT02186392|Rehabilitation|rehabilitation
1166744|NCT02186392|Mood disorders|mood disorders
1166745|NCT02186392|Mental disorders|mental disorders
1166746|NCT02186392|Neurologic Manifestations|neurologic manifestations
1166747|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
1166748|NCT02186392|Brain Diseases|brain diseases
1166749|NCT02186392|Vascular Disease|vascular disease
1166750|NCT02186392|Brain Infarction|brain infarction
1166751|NCT02186392|Brain Ischemia|brain ischemia
1166752|NCT02186379|Obesity|obesity
1166753|NCT02186379|Obesity Prevention|obesity prevention
1166754|NCT02186379|Childhood obesity prevention|childhood obesity prevention
1166755|NCT02186379|Rapid Eating Style|rapid eating style
1166756|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
1166757|NCT02186353|Whole grains|whole grains
1166758|NCT02186353|Food processing|food processing
1166759|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
1166760|NCT02186327|Integrative Health Coaching|integrative health coaching
1166761|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
1166762|NCT02186301|cancer|cancer
1166763|NCT02186301|metastatic|metastatic
1166764|NCT02186301|locally advanced|locally advanced
1166765|NCT02186301|lung|lung
1166766|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
1166767|NCT02186301|NSCLC|nsclc
1233333|NCT01880944|MRI|mri
1166768|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
1166769|NCT02186301|EGFR|egfr
1166770|NCT02186301|T790M|t790m
1166771|NCT02186301|CO-1686|co-1686
1166772|NCT02186301|unresectable|unresectable
1166773|NCT02186301|recurrent|recurrent
1166774|NCT02186301|EGFR-directed therapy|egfr-directed therapy
1166775|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
1166776|NCT02186301|TIGER|tiger
1166777|NCT02186301|rociletinib|rociletinib
1166778|NCT02186288|Critical Care|critical care
1166779|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
1166780|NCT02186288|Electrical impedance tomography|electrical impedance tomography
1166781|NCT02186288|End expiratory lung volume|end expiratory lung volume
1166782|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
1166783|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
1166784|NCT02186275|Crohn|crohn
1166785|NCT02186275|vitamin D|vitamin d
1166786|NCT02186275|remission|remission
1166787|NCT02186275|inflammation|inflammation
1166788|NCT02186275|tolerance|tolerance
1166789|NCT02186262|Glioma|glioma
1166790|NCT02186262|MRI|mri
1166791|NCT02186262|Rotating frame relaxation|rotating frame relaxation
1166792|NCT02186262|DWI|dwi
1166793|NCT02186262|treatment response|treatment response
1166794|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
1166795|NCT02186236|blood|blood
1166796|NCT02186236|urine|urine
1166797|NCT02186236|14-114|14-114
1166798|NCT02186223|Pulmonary Embolism|pulmonary embolism
1166799|NCT02186223|PE|pe
1166800|NCT02186223|DVT|dvt
1166801|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
1166802|NCT02186223|VTE|vte
1166803|NCT02186223|Venous Thromboembolism|venous thromboembolism
1166804|NCT02186223|prophylaxis|prophylaxis
1166805|NCT02186223|thromboprophylaxis|thromboprophylaxis
1166806|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
1166807|NCT02186223|prophylactic|prophylactic
1166808|NCT02186223|prevention|prevention
1166809|NCT02186223|Inferior vena cava filter|inferior vena cava filter
1166810|NCT02186223|IVC filter|ivc filter
1166811|NCT02186223|filter|filter
1166812|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
1166813|NCT02186223|trauma|trauma
1166814|NCT02186223|critically-ill|critically-ill
1166815|NCT02186210|microcirculation|microcirculation
1166816|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
1166817|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
1166818|NCT02186210|vascular occlusion test|vascular occlusion test
1166819|NCT02186210|recovery slope|recovery slope
1166820|NCT02186197|Volume Responsiveness|volume responsiveness
1166821|NCT02186184|Myopia progression|myopia progression
1166822|NCT02186184|Orthokeratology|orthokeratology
1166823|NCT02186171|Osteoporosis in men|osteoporosis in men
1166824|NCT02186158|Pneumonia|pneumonia
1166825|NCT02186158|Elderly|elderly
1166826|NCT02186158|Ascorbic acid|ascorbic acid
1166827|NCT02186158|Vitamin C|vitamin c
1166828|NCT02186158|Hospitalized patient|hospitalized patient
1166829|NCT02186132|heart rate|heart rate
1166830|NCT02186132|neostigmine|neostigmine
1166831|NCT02186132|atropine|atropine
1166832|NCT02186132|dosage|dosage
1166833|NCT02186093|Coronary Artery Disease|coronary artery disease
1166834|NCT02186093|Angina, Stable|angina, stable
1166835|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1166836|NCT02186093|Coronary Angiography|coronary angiography
1166837|NCT02186080|diabetes mellitus|diabetes mellitus
1166838|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
1166839|NCT02186080|gemigliptin|gemigliptin
1166840|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
1166841|NCT02186067|Hypertension|hypertension
1166842|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
1166843|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
1166844|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
1166845|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
1166846|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
1166847|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
1166848|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
1166849|NCT02186015|MBC|mbc
1166850|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
1166851|NCT02186015|Symptom Management|symptom management
1166852|NCT02186002|ACT-451840|act-451840
1166853|NCT02186002|Safety|safety
1166854|NCT02186002|Tolerability|tolerability
1166855|NCT02186002|Pharmacokinetics|pharmacokinetics
1166856|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
1166857|NCT02185989|Humans|humans
1166858|NCT02185989|*Intensive Care Units|*intensive care units
1166859|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
1166860|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
1166861|NCT02185976|preoperative anxiety|preoperative anxiety
1166862|NCT02185976|paediatric patients|paediatric patients
1166863|NCT02185976|Cartoon|cartoon
1166864|NCT02185963|Diabetes|diabetes
1166865|NCT02185963|Dyslipidemia|dyslipidemia
1166962|NCT02185690|carboplatin|carboplatin
1166866|NCT02185963|HDL function|hdl function
1166867|NCT02185963|Cholesterol efflux|cholesterol efflux
1166868|NCT02185963|MCA assay|mca assay
1166869|NCT02185963|MCP-1|mcp-1
1166870|NCT02185950|Burn|burn
1166871|NCT02185950|Skin graft|skin graft
1166872|NCT02185950|Elasticity|elasticity
1166873|NCT02185950|Skin|skin
1166874|NCT02185950|Physical therapy modalities|physical therapy modalities
1166875|NCT02185937|imatinib|imatinib
1166876|NCT02185937|gastrectomy|gastrectomy
1166877|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1166878|NCT02185937|pharmacokinetics|pharmacokinetics
1166879|NCT02185924|PARECOXIB|parecoxib
1166880|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
1166881|NCT02185911|chronic kidney disease,|chronic kidney disease,
1166882|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
1166883|NCT02185911|non dialysis,|non dialysis,
1166884|NCT02185898|electronic cigarettes|electronic cigarettes
1166885|NCT02185898|e-cigarettes|e-cigarettes
1166886|NCT02185898|combustible cigarettes|combustible cigarettes
1166887|NCT02185898|second-hand smoke|second-hand smoke
1166888|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
1166889|NCT02185898|tobacco-burning|tobacco-burning
1166890|NCT02185885|Ischemic stroke|ischemic stroke
1166891|NCT02185885|Embolic stroke|embolic stroke
1166892|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1166893|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
1166894|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
1166895|NCT02185872|Exercise|exercise
1166896|NCT02185872|Physical Fitness|physical fitness
1166897|NCT02185872|Body Composition, Beneficial|body composition, beneficial
1166898|NCT02185859|Lidocaine|lidocaine
1166899|NCT02185859|Magnesium|magnesium
1166900|NCT02185859|Mastectomy|mastectomy
1166901|NCT02185859|Functional Recovery|functional recovery
1166902|NCT02185846|Fed condition|fed condition
1166903|NCT02185833|Fasting condition|fasting condition
1166904|NCT02185820|Multiple myeloma|multiple myeloma
1166905|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
1166907|NCT02185807|cataract|cataract
1166908|NCT02185807|surgery|surgery
1166909|NCT02185807|consent process|consent process
1166910|NCT02185807|video-assisted|video-assisted
1166911|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1166912|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1166913|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1166914|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
1166915|NCT02185794|HCV|hcv
1166916|NCT02185794|Sustained Virologic Response|sustained virologic response
1166917|NCT02185794|Direct Acting Antiviral|direct acting antiviral
1166918|NCT02185794|Combination Therapy|combination therapy
1166919|NCT02185794|Open Label|open label
1166920|NCT02185794|Hepatitis|hepatitis
1166921|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
1166922|NCT02185794|Hepatitis C|hepatitis c
1166923|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
1166924|NCT02185794|Liver Diseases|liver diseases
1166925|NCT02185794|Digestive System Diseases|digestive system diseases
1166926|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
1166927|NCT02185794|Virus Diseases|virus diseases
1166928|NCT02185794|Enterovirus Infections|enterovirus infections
1166929|NCT02185794|Picornaviridae Infections|picornaviridae infections
1166930|NCT02185794|RNA Virus Infections|rna virus infections
1166931|NCT02185794|Flaviviridae Infections|flaviviridae infections
1166932|NCT02185794|Antiviral Agents|antiviral agents
1166933|NCT02185794|Anti-Infective Agents|anti-infective agents
1166934|NCT02185794|Therapeutic Uses|therapeutic uses
1166935|NCT02185794|Pharmacologic Actions|pharmacologic actions
1166936|NCT02185794|Antimetabolites|antimetabolites
1166937|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1166938|NCT02185781|Phase I|phase i
1166939|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
1166940|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
1166941|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
1166942|NCT02185781|≥60 years|≥60 years
1166943|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
1166944|NCT02185768|Liver cancer|liver cancer
1166945|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
1166946|NCT02185755|Type 2 Diabetes|type 2 diabetes
1166947|NCT02185742|HIV|hiv
1166948|NCT02185742|jail|jail
1166949|NCT02185742|detainee|detainee
1166950|NCT02185742|Linkage and Retention|linkage and retention
1166951|NCT02185742|Treatment as Prevention|treatment as prevention
1166952|NCT02185742|Strength Based Case Management|strength based case management
1166953|NCT02185742|releases|releases
1166954|NCT02185729|Intravenous Feeding|intravenous feeding
1166955|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
1166956|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
1166957|NCT02185716|levobupivacaine|levobupivacaine
1166958|NCT02185690|Lung cancer|lung cancer
1166959|NCT02185690|Non small cell lung cancer|non small cell lung cancer
1166960|NCT02185690|non squamous|non squamous
1166961|NCT02185690|pemetrexed|pemetrexed
1166963|NCT02185690|binimetinib|binimetinib
1166964|NCT02185690|chemotherapy|chemotherapy
1166965|NCT02185690|combination chemotherapy|combination chemotherapy
1166966|NCT02185690|Phase 1|phase 1
1166967|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
1166968|NCT02185690|carcinoma|carcinoma
1166969|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
1166970|NCT02185677|multiple system atrophy|multiple system atrophy
1166971|NCT02185677|imaging study|imaging study
1166972|NCT02185664|internal jugular vein|internal jugular vein
1166973|NCT02185664|landmark|landmark
1166974|NCT02185664|ultrasound|ultrasound
1166975|NCT02185664|static|static
1166976|NCT02185664|cardiac surgery|cardiac surgery
1166977|NCT02185651|Pompe Disease|pompe disease
1166978|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
1166979|NCT02185651|Infusion Associated Reaction|infusion associated reaction
1166980|NCT02185638|obesity|obesity
1166981|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
1166982|NCT02185638|appetite|appetite
1166983|NCT02185638|GLP-1|glp-1
1166984|NCT02185638|ghrelin|ghrelin
1166985|NCT02185638|CCK|cck
1166986|NCT02185599|colposcopy|colposcopy
1166987|NCT02185599|CIN|cin
1166988|NCT02185599|cervical neoplasia|cervical neoplasia
1166989|NCT02185599|cervical dysplasia|cervical dysplasia
1166990|NCT02185599|cervical cancer|cervical cancer
1166991|NCT02185599|CIN2+|cin2+
1166992|NCT02185573|Bulk fill|bulk fill
1166993|NCT02185573|SonicFill|sonicfill
1166994|NCT02185573|resin composite application|resin composite application
1166995|NCT02185573|class II restoration|class ii restoration
1166996|NCT02185560|Sorafenib|sorafenib
1166997|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
1166998|NCT02185560|Japan|japan
1166999|NCT02185560|Post Marketing Surveillance|post marketing surveillance
1167000|NCT02185560|Drug Use Investigation|drug use investigation
1167001|NCT02185547|women|women
1167002|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
1167003|NCT02185521|Hemodynamics|hemodynamics
1167004|NCT02185521|Medical Informatics|medical informatics
1167005|NCT02185508|IONM|ionm
1167006|NCT02185508|Lumbar Disk Disease|lumbar disk disease
1167007|NCT02185508|Degenerative Spine Disease|degenerative spine disease
1167008|NCT02185508|Radiculopathy|radiculopathy
1167009|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
1167010|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
1167011|NCT02185508|Electromyography|electromyography
1167012|NCT02185482|Psychological counselling|psychological counselling
1167013|NCT02185482|Randomized single blind study|randomized single blind study
1167014|NCT02185482|Depression|depression
1167015|NCT02185482|Diabetes|diabetes
1167016|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
1167017|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
1167018|NCT02185469|vitrectomy|vitrectomy
1167019|NCT02185443|SBRT|sbrt
1167020|NCT02185443|radiation|radiation
1167021|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
1167022|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
1167023|NCT02185443|Anal Canal|anal canal
1167024|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
1167025|NCT02185417|Hypertension|hypertension
1167026|NCT02185417|Diuretic|diuretic
1167027|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
1167028|NCT02185417|Point of Care Research|point of care research
1167029|NCT02185391|Coronary Disease|coronary disease
1167030|NCT02185391|Audience Response System|audience response system
1167031|NCT02185365|T1-rho MRI|t1-rho mri
1167032|NCT02185365|dGEMRIC MRI|dgemric mri
1167033|NCT02185365|DDH|ddh
1167034|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
1167035|NCT02185352|Bevacizumab|bevacizumab
1167036|NCT02185352|Brain Metastases|brain metastases
1167037|NCT02185352|Breast Cancer|breast cancer
1167038|NCT02185352|Chemotherapy|chemotherapy
1167039|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
1167040|NCT02185339|Respiratory mechanics|respiratory mechanics
1167041|NCT02185339|Respiratory function test|respiratory function test
1167042|NCT02185339|Hemodynamics|hemodynamics
1167043|NCT02185326|Poor responders|poor responders
1167044|NCT02185326|Poor ovarian response|poor ovarian response
1167045|NCT02185326|IVF/ICSI|ivf/icsi
1167046|NCT02185326|Microflare protocol|microflare protocol
1167047|NCT02185326|Growth hormone|growth hormone
1167048|NCT02185326|Oral contraceptive pills|oral contraceptive pills
1167049|NCT02185300|GSK1349572|gsk1349572
1167050|NCT02185300|granule|granule
1167051|NCT02185300|pediatric|pediatric
1333244|NCT01443845|COPD|copd
1233776|NCT01878942|LSD|lsd
1167052|NCT02185300|CONTREX mineral water|contrex mineral water
1167053|NCT02185300|free-acid|free-acid
1167054|NCT02185300|chelating|chelating
1167055|NCT02185300|cations|cations
1167056|NCT02185300|divalent|divalent
1167057|NCT02185300|dolutegravir|dolutegravir
1167058|NCT02185300|dispersible tablet|dispersible tablet
1167059|NCT02185300|relative bioavailability|relative bioavailability
1167060|NCT02185274|Transsexualism|transsexualism
1167061|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
1167062|NCT02185274|Sex hormones|sex hormones
1167063|NCT02185274|Mood|mood
1167064|NCT02185274|Stress|stress
1167065|NCT02185274|Cortisol|cortisol
1167066|NCT02185274|Cardiovascular|cardiovascular
1167067|NCT02185274|Metabolome|metabolome
1167068|NCT02185261|Relapse|relapse
1167069|NCT02185261|Minimal residual disease|minimal residual disease
1167070|NCT02185261|Graft-versus-host disease|graft-versus-host disease
1167071|NCT02185261|Acute leukemia|acute leukemia
1167072|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
1167073|NCT02185248|Pediatric Obesity|pediatric obesity
1167074|NCT02185248|Body Mass Index|body mass index
1167075|NCT02185248|Weight Perception|weight perception
1167076|NCT02185248|Counseling|counseling
1167077|NCT02185248|Health Behavior|health behavior
1167078|NCT02185235|Electrical stimulation|electrical stimulation
1167079|NCT02185235|Biofeedback|biofeedback
1167080|NCT02185222|Vitamin D|vitamin d
1167081|NCT02185222|Cholecalciferol|cholecalciferol
1167082|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
1167083|NCT02185222|Memory complaint|memory complaint
1167084|NCT02185222|Subjective memory complaint|subjective memory complaint
1167085|NCT02185222|Mild cognitive impairment|mild cognitive impairment
1167086|NCT02185222|Preventive therapy|preventive therapy
1167087|NCT02185222|Cognitive disorders|cognitive disorders
1167088|NCT02185196|Vitamin D,|vitamin d,
1167089|NCT02185196|Severe pneumonia,|severe pneumonia,
1167090|NCT02185196|Under-five children,|under-five children,
1167091|NCT02185196|Randomised|randomised
1167092|NCT02185196|Controlled|controlled
1167093|NCT02185196|Trial (RCT)|trial (rct)
1167094|NCT02185196|Morbidity|morbidity
1167095|NCT02185170|Prostate|prostate
1167096|NCT02185170|Cancer|cancer
1167097|NCT02185170|Medical Device|medical device
1167098|NCT02185170|Fluorescence|fluorescence
1167099|NCT02185157|elderly|elderly
1167100|NCT02185157|dual-task training|dual-task training
1167101|NCT02185157|aerobic training|aerobic training
1167102|NCT02185157|gait|gait
1167103|NCT02185157|cognition|cognition
1167104|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
1167105|NCT02185131|Major Depressive Disorder|major depressive disorder
1167106|NCT02185131|Alcohol Use Disorder|alcohol use disorder
1167107|NCT02185092|exacerbations|exacerbations
1167108|NCT02185092|COPD|copd
1167109|NCT02185092|pneumonia|pneumonia
1167110|NCT02185092|probiotic|probiotic
1167111|NCT02185079|labor|labor
1167112|NCT02185079|epidural|epidural
1167113|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
1167114|NCT02185027|Oral anticoagulants|oral anticoagulants
1167115|NCT02185027|Surgery|surgery
1167116|NCT02185027|Haemorrhage|haemorrhage
1167117|NCT02185027|Emergency|emergency
1167118|NCT02185014|Crohn's Disease|crohn's disease
1167119|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
1167120|NCT02185001|MPFL|mpfl
1167121|NCT02185001|Repair|repair
1167122|NCT02185001|Patellar dislocation|patellar dislocation
1167123|NCT02185001|Knee|knee
1167124|NCT02184988|Glabellar Lines|glabellar lines
1167125|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
1167126|NCT02184975|cold knife conization|cold knife conization
1167127|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
1167128|NCT02184975|cervix|cervix
1167130|NCT02184949|Coronary angioplasty|coronary angioplasty
1167131|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1167132|NCT02184949|PTCA|ptca
1167133|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
1167134|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
1167135|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
1167136|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1167137|NCT02184871|RNAseq|rnaseq
1167138|NCT02184871|risk factors|risk factors
1167139|NCT02184871|asbestos|asbestos
1167140|NCT02184845|single tooth implant|single tooth implant
1167141|NCT02184845|supported restoration(s)|supported restoration(s)
1167142|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
1167143|NCT02184845|mandibular central incisor|mandibular central incisor
1167144|NCT02184845|lateral incisor|lateral incisor
1167145|NCT02184845|areas of the mouth|areas of the mouth
1167146|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
1167147|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
1233855|NCT01878630|CHF|chf
1167148|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
1167149|NCT02184819|levosimendan|levosimendan
1167150|NCT02184819|mortality|mortality
1167151|NCT02184819|inotropic agents|inotropic agents
1167152|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
1167153|NCT02184819|renal replacement therapy|renal replacement therapy
1167154|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
1167155|NCT02184819|ICU stay|icu stay
1167156|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
1167157|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
1167158|NCT02184793|mechanical ventilation|mechanical ventilation
1167159|NCT02184793|semirecumbent position|semirecumbent position
1167160|NCT02184793|electronic monitoring device|electronic monitoring device
1167161|NCT02184780|Neurodevelopment|neurodevelopment
1167162|NCT02184780|General Anaesthesia|general anaesthesia
1167163|NCT02184780|Infants|infants
1167164|NCT02184780|Epidural|epidural
1167165|NCT02184780|Spinal|spinal
1167166|NCT02184780|Anxiety and depression|anxiety and depression
1167167|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
1167168|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
1167169|NCT02184741|IVIG|ivig
1167170|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
1167171|NCT02184741|Recurrent abortion|recurrent abortion
1167172|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
1167173|NCT02184728|end-tidal CO2|end-tidal co2
1167174|NCT02184728|capnometer|capnometer
1167175|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
1167176|NCT02184676|Type 1 diabetes|type 1 diabetes
1167177|NCT02184676|risk assessment|risk assessment
1167178|NCT02184676|immunological marker|immunological marker
1167179|NCT02184676|children|children
1167180|NCT02184676|relatives|relatives
1167181|NCT02184676|autoantibodies|autoantibodies
1167182|NCT02184676|lymphocytes|lymphocytes
1167183|NCT02184676|T cells|t cells
1167184|NCT02184676|epitopes|epitopes
1167185|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
1167186|NCT02184663|Unresectable|unresectable
1167187|NCT02184663|Pancreatic cancer|pancreatic cancer
1167188|NCT02184663|GERCOR|gercor
1167189|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
1167190|NCT02184663|Quality of life|quality of life
1167191|NCT02184663|Fatigue|fatigue
1167192|NCT02184650|Premature infants|premature infants
1167193|NCT02184650|Nutritional status|nutritional status
1167194|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
1167195|NCT02184637|Malaria|malaria
1167196|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
1167197|NCT02184624|BREEZHALER|breezhaler
1167198|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
1167199|NCT02184624|MDI|mdi
1167200|NCT02184624|Inhaler preference|inhaler preference
1167201|NCT02184624|Overall inhaler error|overall inhaler error
1167202|NCT02184624|HANDIHALER|handihaler
1167203|NCT02184624|Ease of use|ease of use
1167204|NCT02184624|TURBUHALER|turbuhaler
1167205|NCT02184624|ELLIPTA|ellipta
1167206|NCT02184624|Critical inhaler error|critical inhaler error
1167207|NCT02184611|lung function|lung function
1167208|NCT02184611|Umeclidinium|umeclidinium
1167209|NCT02184611|GSK573719|gsk573719
1167210|NCT02184611|anticholinergic|anticholinergic
1167211|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
1167212|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
1167213|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1167214|NCT02184598|ADHD|adhd
1167215|NCT02184598|Cognitive training|cognitive training
1167216|NCT02184598|fMRI|fmri
1167217|NCT02184598|Cognitive function|cognitive function
1167218|NCT02184585|bioavailability|bioavailability
1167219|NCT02184585|crossover design|crossover design
1167220|NCT02184585|healthy male volunteers|healthy male volunteers
1167221|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
1167222|NCT02184585|Dutasteride|dutasteride
1167223|NCT02184572|Rubella|rubella
1167224|NCT02184572|Healthy children|healthy children
1167225|NCT02184572|Measles|measles
1167226|NCT02184572|Safety|safety
1167227|NCT02184572|Mumps|mumps
1167228|NCT02184572|12 to 15 months|12 to 15 months
1167229|NCT02184572|Immunogenicity|immunogenicity
1167230|NCT02184507|insulin resistance|insulin resistance
1167231|NCT02184507|blood glucose|blood glucose
1167232|NCT02184507|CABG|cabg
1167233|NCT02184507|oxidative stress|oxidative stress
1167234|NCT02184494|Parkinson's Disease|parkinson's disease
1167235|NCT02184494|Multiple Sclerosis|multiple sclerosis
1167236|NCT02184494|Fatigue|fatigue
1167237|NCT02184494|Resting Energy Expenditure|resting energy expenditure
1167238|NCT02184494|Whole Body Vibration|whole body vibration
1167239|NCT02184494|Exercise|exercise
1167240|NCT02184494|Blood Lactate|blood lactate
1167241|NCT02184481|Depression|depression
1167242|NCT02184481|Anxiety|anxiety
1167243|NCT02184481|Working memory|working memory
1167244|NCT02184481|Rumination|rumination
1167245|NCT02184481|Cognitive training|cognitive training
1167246|NCT02184481|Executive functioning|executive functioning
1167247|NCT02184468|Cardiac Arrest|cardiac arrest
1167248|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
1167249|NCT02184468|Firefighters|firefighters
1167250|NCT02184468|Police|police
1167251|NCT02184468|Defibrillators|defibrillators
1167252|NCT02184468|Survival|survival
1167253|NCT02184455|Diabetic|diabetic
1167254|NCT02184455|Chronic Ulcer|chronic ulcer
1167255|NCT02184455|Wound Healing|wound healing
1167257|NCT02184442|SAPIEN|sapien
1167258|NCT02184442|TAVR|tavr
1167259|NCT02184442|THV|thv
1167260|NCT02184442|Aortic Stenosis|aortic stenosis
1167261|NCT02184442|Heart Valve Disease|heart valve disease
1167262|NCT02184442|Aortic Valve|aortic valve
1167263|NCT02184442|Retroflex|retroflex
1167264|NCT02184442|Ascendra|ascendra
1167265|NCT02184429|First in human|first in human
1167266|NCT02184429|single ascending dose study|single ascending dose study
1167267|NCT02184429|multiple ascending dose study|multiple ascending dose study
1167268|NCT02184429|safety and tolerability|safety and tolerability
1167269|NCT02184429|pharmacokinetics|pharmacokinetics
1167270|NCT02184429|food effect|food effect
1167271|NCT02184429|Parkinson's Disease|parkinson's disease
1167272|NCT02184416|Inlyta|inlyta
1167273|NCT02184416|axitinib|axitinib
1167274|NCT02184416|Sutent|sutent
1167275|NCT02184416|sunitinib|sunitinib
1167276|NCT02184416|renal|renal
1167277|NCT02184390|Internet|internet
1167278|NCT02184390|Education|education
1167279|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
1167280|NCT02184377|cricothyroid muscle|cricothyroid muscle
1167281|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
1167282|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
1167283|NCT02184377|lexical tone|lexical tone
1167284|NCT02184377|Mandarin|mandarin
1167285|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
1167286|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
1167287|NCT02184221|Effectiveness|effectiveness
1167289|NCT02184208|ARDS|ards
1167290|NCT02184208|ALI|ali
1167291|NCT02184208|mechanical ventilation|mechanical ventilation
1167292|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
1167293|NCT02184169|hemodynamics|hemodynamics
1167294|NCT02184169|neonatal|neonatal
1167295|NCT02184169|cardiac disease|cardiac disease
1167296|NCT02184169|congenital heart disease|congenital heart disease
1167297|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
1167298|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1167299|NCT02184117|Adenosine|adenosine
1167300|NCT02184117|Contrast Media|contrast media
1167301|NCT02184104|caffeine|caffeine
1167302|NCT02184104|pharmacokinetics|pharmacokinetics
1167303|NCT02184104|pharmacodynamics|pharmacodynamics
1167304|NCT02184026|nightmare|nightmare
1167305|NCT02184026|PTSD|ptsd
1167306|NCT02184026|trauma|trauma
1167307|NCT02184026|children|children
1167308|NCT02184026|Children Age 8 to 13|children age 8 to 13
1167309|NCT02184013|Atrial fibrillation|atrial fibrillation
1167310|NCT02184013|Catheter ablation|catheter ablation
1167311|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
1167312|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
1167313|NCT02184013|ECGI mapping|ecgi mapping
1167314|NCT02184013|Atrial Fibrosis|atrial fibrosis
1167315|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
1167316|NCT02184000|strain elastography|strain elastography
1167317|NCT02184000|hepatopathy|hepatopathy
1167318|NCT02184000|liver fibrosis|liver fibrosis
1167319|NCT02183987|Knowledge Translation|knowledge translation
1167320|NCT02183987|Chronic Kidney Disease|chronic kidney disease
1167321|NCT02183987|Dialysis|dialysis
1167322|NCT02183987|Intent-to-defer|intent-to-defer
1167323|NCT02183987|Early dialysis|early dialysis
1167324|NCT02183987|Cluster randomized trial|cluster randomized trial
1167325|NCT02183974|otitis media with effusion|otitis media with effusion
1167326|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
1167327|NCT02183961|otitis media with effusion|otitis media with effusion
1167328|NCT02183961|peptest|peptest
1167329|NCT02183961|restech|restech
1167330|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
1167331|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
1167332|NCT02183948|treatment|treatment
1167333|NCT02183948|mask face exoressions|mask face exoressions
1167334|NCT02183948|genier|genier
1167335|NCT02183935|Obesity|obesity
1167336|NCT02183935|Diabetes|diabetes
1167337|NCT02183935|Metabolic syndrome|metabolic syndrome
1167338|NCT02183935|Gut hormones|gut hormones
1167339|NCT02183935|Adipokines|adipokines
1167340|NCT02183935|Appetite|appetite
1167341|NCT02183935|Adolescent|adolescent
1167342|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
1167343|NCT02183896|Chondral lesions|chondral lesions
1167344|NCT02183896|Hip|hip
1167345|NCT02183896|Microfracture|microfracture
1167346|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
1167347|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
1167348|NCT02183883|NSCLC|nsclc
1167349|NCT02183883|Afatinib|afatinib
1167350|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
1167351|NCT02183883|Clonal dominance|clonal dominance
1167352|NCT02183883|Drug resistance|drug resistance
1167353|NCT02183883|EGFR|egfr
1167354|NCT02183883|HER2|her2
1167355|NCT02183883|Phase 2|phase 2
1167356|NCT02183870|lung cancer|lung cancer
1167357|NCT02183870|adenocarcinoma|adenocarcinoma
1167358|NCT02183870|NSCLC|nsclc
1167359|NCT02183870|ROS1|ros1
1167360|NCT02183870|ROS1 translocation|ros1 translocation
1167361|NCT02183870|crizotinib|crizotinib
1167362|NCT02183870|phase II|phase ii
1167363|NCT02183857|children|children
1167364|NCT02183857|congenital heart disease|congenital heart disease
1167365|NCT02183844|Medical Informatics|medical informatics
1167366|NCT02183844|Patient-Centered|patient-centered
1167367|NCT02183844|Healthcare Preferences|healthcare preferences
1167368|NCT02183844|Health Education|health education
1167369|NCT02183844|Quality Improvement|quality improvement
1167370|NCT02183844|Weight Loss|weight loss
1167371|NCT02183844|Personal Satisfaction|personal satisfaction
1167372|NCT02183844|Humans|humans
1167373|NCT02183844|Cognition|cognition
1167374|NCT02183844|Body Weight|body weight
1167375|NCT02183818|Smoking|smoking
1167376|NCT02183818|COPD|copd
1167377|NCT02183818|Non-Smokers|non-smokers
1167378|NCT02183818|Smokers|smokers
1167379|NCT02183805|triple negative breast cancer|triple negative breast cancer
1167380|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
1167381|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
1167382|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
1167383|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
1167384|NCT02183779|nitrous oxide|nitrous oxide
1167385|NCT02183753|LAIV|laiv
1167386|NCT02183753|Flumist|flumist
1167387|NCT02183753|wood smoke|wood smoke
1167388|NCT02183740|Education|education
1167389|NCT02183740|Nurses|nurses
1167390|NCT02183740|Nursing homes|nursing homes
1167391|NCT02183740|Fecal incontinence|fecal incontinence
1167392|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
1167393|NCT02183727|ACL|acl
1167394|NCT02183727|knee injury|knee injury
1167395|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
1167396|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
1167397|NCT02183597|Data Accuracy|data accuracy
1167398|NCT02183597|Reproducibility of Results|reproducibility of results
1167399|NCT02183597|Diagnosis|diagnosis
1167400|NCT02183558|PCOS|pcos
1167401|NCT02183558|GDM|gdm
1167402|NCT02183558|OGTT|ogtt
1167403|NCT02183558|Glucose metabolism|glucose metabolism
1167404|NCT02183519|Cough|cough
1167405|NCT02183519|Reflex|reflex
1167406|NCT02183519|Voluntary|voluntary
1167407|NCT02183519|Healthy older adults|healthy older adults
1167408|NCT02183519|Parkinson's disease|parkinson's disease
1167409|NCT02183519|Respiratory kinematics|respiratory kinematics
1167410|NCT02183519|Cueing|cueing
1167411|NCT02183454|intracoronary stent|intracoronary stent
1167412|NCT02183454|drug eluting stent|drug eluting stent
1167413|NCT02183454|sirolimus|sirolimus
1167414|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
1167415|NCT02183272|Depression|depression
1167416|NCT02183272|Suicidal Ideation|suicidal ideation
1167417|NCT02183272|Ketamine|ketamine
1167418|NCT02183272|Emergency Department|emergency department
1167419|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1167420|NCT02183207|Introducer method|introducer method
1167421|NCT02182999|Hallux valgus surgery|hallux valgus surgery
1167422|NCT02182999|wound infiltration|wound infiltration
1167423|NCT02182999|pain|pain
1167424|NCT02182986|Biomarkers|biomarkers
1167524|NCT02181608|Fear Conditioning|fear conditioning
1167525|NCT02181608|Stress|stress
1167425|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
1167426|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
1167427|NCT02182947|Pediatric|pediatric
1167428|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
1167429|NCT02182947|capsule endoscopy|capsule endoscopy
1167431|NCT02182947|Crohn's Disease|crohn's disease
1167432|NCT02182947|Indeterminant Colitis|indeterminant colitis
1167433|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
1167434|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
1167435|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
1167436|NCT02182843|Cellentra ACDF|cellentra acdf
1167437|NCT02182817|General Anaesthesia|general anaesthesia
1167438|NCT02182817|Neurocognitive Development|neurocognitive development
1167439|NCT02182817|Behaviour|behaviour
1167440|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
1167441|NCT02182804|Narrow Band Imaging|narrow band imaging
1167442|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
1167443|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
1167444|NCT02182804|Head and Neck Cancer|head and neck cancer
1167445|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1167446|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
1167447|NCT02182687|Bridge to transplant|bridge to transplant
1167448|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1167449|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
1167450|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
1167451|NCT02182596|First relapsing AML|first relapsing aml
1167452|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
1167453|NCT02182466|Colonoscopy|colonoscopy
1167454|NCT02182466|Screening colonoscopy|screening colonoscopy
1167455|NCT02182440|SA-AKI|sa-aki
1167456|NCT02182440|Sepsis|sepsis
1167457|NCT02182440|AKI|aki
1167458|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
1167459|NCT02182440|recAP|recap
1167460|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
1167461|NCT02182167|Toxic Liver|toxic liver
1167462|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
1167463|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
1167464|NCT02182115|Decolonization|decolonization
1167465|NCT02182115|Surgical site infection|surgical site infection
1167466|NCT02181894|Infant|infant
1167467|NCT02181894|Newborn|newborn
1167468|NCT02181894|Neonate|neonate
1167469|NCT02181894|Intubation|intubation
1167470|NCT02181894|Neonatal resuscitation|neonatal resuscitation
1167471|NCT02181842|Pharmacological therapy|pharmacological therapy
1167472|NCT02181829|Whole Lung IMRT|whole lung imrt
1167473|NCT02181829|14-075|14-075
1167474|NCT02181816|Pharmacological therapy|pharmacological therapy
1167475|NCT02181790|psoriasis|psoriasis
1167476|NCT02181790|palmoplantar|palmoplantar
1167477|NCT02181790|acitretin|acitretin
1167478|NCT02181790|retinoids|retinoids
1167479|NCT02181790|laser treatment|laser treatment
1167480|NCT02181777|Psychosis|psychosis
1167481|NCT02181777|Schizophrenia|schizophrenia
1167482|NCT02181777|Social Skills|social skills
1167483|NCT02181777|Therapy|therapy
1167484|NCT02181764|XLH|xlh
1167485|NCT02181751|Child Sexual Abuse|child sexual abuse
1167486|NCT02181751|CSA|csa
1167487|NCT02181751|Treatment|treatment
1167488|NCT02181751|Prevention|prevention
1167489|NCT02181751|PTSD|ptsd
1167490|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
1167491|NCT02181751|Depression|depression
1167492|NCT02181751|Anxiety|anxiety
1167493|NCT02181751|Quality of Life|quality of life
1167494|NCT02181751|Attachment|attachment
1167495|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
1167496|NCT02181751|Group Therapy|group therapy
1167497|NCT02181725|Chronic Pain|chronic pain
1167498|NCT02181725|Adolescent|adolescent
1167499|NCT02181725|Graded Exposure|graded exposure
1167500|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
1167501|NCT02181712|lung transplant|lung transplant
1167502|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
1167503|NCT02181712|cell therapy|cell therapy
1167504|NCT02181686|Heart Failure|heart failure
1167505|NCT02181686|Iperia ICD family|iperia icd family
1167506|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
1167507|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
1167508|NCT02181673|Psoriatic arthritis|psoriatic arthritis
1167509|NCT02181673|Golimumab|golimumab
1167510|NCT02181673|Simponi|simponi
1167511|NCT02181660|AML|aml
1167512|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
1167513|NCT02181660|Gilteritinib|gilteritinib
1167514|NCT02181660|ASP2215|asp2215
1167515|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
1167516|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
1167517|NCT02181634|CCA|cca
1167518|NCT02181634|Bile Duct Cancer|bile duct cancer
1167519|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
1167520|NCT02181634|Abraxane®|abraxane®
1167521|NCT02181634|Gemcitabine|gemcitabine
1167522|NCT02181634|Gemzar®|gemzar®
1167523|NCT02181608|Alcohol Dependence|alcohol dependence
1167526|NCT02181608|Alcohol|alcohol
1167527|NCT02181595|Reading|reading
1167528|NCT02181595|FACIT-SP|facit-sp
1167529|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
1167530|NCT02181582|Health Humans|health humans
1167531|NCT02181582|Receptor Occupancy|receptor occupancy
1167532|NCT02181569|Addiction Severity Index|addiction severity index
1167533|NCT02181569|Addiction|addiction
1167534|NCT02181569|Sleep Measures|sleep measures
1167535|NCT02181569|Sleep Disorders|sleep disorders
1167536|NCT02181556|colorectal cancer|colorectal cancer
1167537|NCT02181556|Metastatic|metastatic
1167538|NCT02181543|Clonidine|clonidine
1167539|NCT02181543|Psychomotor agitation|psychomotor agitation
1167540|NCT02181543|Anesthesia recovery period|anesthesia recovery period
1167541|NCT02181543|Tonsillectomy|tonsillectomy
1167542|NCT02181543|Child, preschool|child, preschool
1167543|NCT02181478|Total Body Irradiation|total body irradiation
1167544|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
1167545|NCT02181478|hMSC|hmsc
1167546|NCT02181478|Cyclophosphamide|cyclophosphamide
1167547|NCT02181478|Fludarabine|fludarabine
1167548|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
1167549|NCT02181478|DMSO|dmso
1167550|NCT02181478|Cyclosporine|cyclosporine
1167551|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
1167552|NCT02181478|MMF|mmf
1167553|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
1167554|NCT02181478|G-CSF|g-csf
1167555|NCT02181478|GVHD|gvhd
1167556|NCT02181478|Cancer|cancer
1167557|NCT02181478|feasibility|feasibility
1167558|NCT02181452|liver|liver
1167559|NCT02181452|fibrosis|fibrosis
1167560|NCT02181452|ShearWave Elastography|shearwave elastography
1167561|NCT02181452|ultrasound|ultrasound
1167562|NCT02181426|Knee Arthroscopy|knee arthroscopy
1167563|NCT02181413|Drug therapy|drug therapy
1167564|NCT02181413|TOURMALINE|tourmaline
1167565|NCT02181413|ixazomib|ixazomib
1167566|NCT02181400|diabetic retinopathy|diabetic retinopathy
1167567|NCT02181400|diabetic macular edema|diabetic macular edema
1167568|NCT02181400|diabetic macular oedema|diabetic macular oedema
1167569|NCT02181400|near infrared light therapy|near infrared light therapy
1167570|NCT02181387|labor pain|labor pain
1167571|NCT02181387|acetaminophen|acetaminophen
1167572|NCT02181374|atrial fibrillation|atrial fibrillation
1167573|NCT02181374|NT-proBNP|nt-probnp
1167574|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
1167575|NCT02181361|atrial fibrillation|atrial fibrillation
1167576|NCT02181361|cardioembolic stroke|cardioembolic stroke
1167577|NCT02181361|Hirudin|hirudin
1167578|NCT02181361|aspirin|aspirin
1167579|NCT02181361|warfarin|warfarin
1167580|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
1167581|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
1167582|NCT02181296|Interscalene block|interscalene block
1167583|NCT02181296|Drug concentration|drug concentration
1167584|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
1167585|NCT02181283|alcohol|alcohol
1167586|NCT02181283|prescribed drugs|prescribed drugs
1167587|NCT02181283|National Guard|national guard
1167588|NCT02181270|NAFLD|nafld
1167589|NCT02181270|obesity|obesity
1167590|NCT02181270|ck18|ck18
1167591|NCT02181270|blood lipids|blood lipids
1167592|NCT02181270|high intensity exercise training|high intensity exercise training
1167593|NCT02181270|individuals|individuals
1167594|NCT02181270|>5% liver fat|>5% liver fat
1167595|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1167596|NCT02181257|Lung Transplantation|lung transplantation
1167597|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
1167598|NCT02181257|Methoxsalen|methoxsalen
1167599|NCT02181244|egg|egg
1167600|NCT02181244|oatmeal|oatmeal
1167601|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
1167602|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
1167603|NCT02181244|inflammatory markers|inflammatory markers
1167604|NCT02181231|depression|depression
1167605|NCT02181231|older adult|older adult
1167606|NCT02181231|buprenorphine|buprenorphine
1167607|NCT02181231|Effexor XR|effexor xr
1167608|NCT02181231|treatment resistant|treatment resistant
1167609|NCT02181231|venlafaxine|venlafaxine
1167610|NCT02181231|Saint Louis|saint louis
1167611|NCT02181231|late life|late life
1167612|NCT02181231|major depression|major depression
1167613|NCT02181192|biochemical recurrence|biochemical recurrence
1167614|NCT02181192|prostate carcinoma|prostate carcinoma
1167615|NCT02181192|prostate cancer|prostate cancer
1167616|NCT02181192|PSA|psa
1167617|NCT02181192|postoperative|postoperative
1167618|NCT02181192|radiotherapy|radiotherapy
1167619|NCT02181192|imaging diagnostic|imaging diagnostic
1167620|NCT02181192|PET/CT|pet/ct
1167621|NCT02181192|social economic aspects|social economic aspects
1167622|NCT02181192|quality of life|quality of life
1167623|NCT02181179|yoga|yoga
1167624|NCT02181179|exercise intervention|exercise intervention
1167625|NCT02181179|smoking|smoking
1167626|NCT02181179|stress|stress
1167627|NCT02181179|mind-body|mind-body
1167628|NCT02181179|intervention|intervention
1167629|NCT02181166|Breast Neoplasms|breast neoplasms
1167630|NCT02181166|Mastectomy|mastectomy
1167631|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
1167632|NCT02181166|Physical Therapy Modalities|physical therapy modalities
1167633|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
1167634|NCT02181153|siblings|siblings
1167635|NCT02181140|fine needle aspiration|fine needle aspiration
1167636|NCT02181140|core biopsy|core biopsy
1167637|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
1167638|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
1167639|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
1167640|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
1234465|NCT01875874|ALF|alf
1167641|NCT02181127|bionic pancreas|bionic pancreas
1167642|NCT02181127|artificial pancreas|artificial pancreas
1167643|NCT02181127|insulin|insulin
1167644|NCT02181127|glucagon|glucagon
1167645|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
1167646|NCT02181127|outpatient|outpatient
1167647|NCT02181127|insulin pump|insulin pump
1167648|NCT02181127|glucagon pump|glucagon pump
1167649|NCT02181114|Coaching|coaching
1167650|NCT02181114|Educational Materials|educational materials
1167651|NCT02181114|Expert System|expert system
1167652|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
1167653|NCT02181088|Malaria|malaria
1167654|NCT02181088|Plasmodium falciparum|plasmodium falciparum
1167655|NCT02181088|RH5|rh5
1167656|NCT02181075|ThermoDox|thermodox
1167657|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
1167658|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
1167659|NCT02181075|Non invasive drug delivery|non invasive drug delivery
1168065|NCT02179437|Propofol|propofol
1167660|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
1167661|NCT02181075|Liver tumour(s)|liver tumour(s)
1167662|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
1167663|NCT02181062|Stroke|stroke
1167664|NCT02181062|Stroke prevention|stroke prevention
1167665|NCT02181062|older adults|older adults
1167666|NCT02181062|self efficacy|self efficacy
1167667|NCT02181062|walking|walking
1167668|NCT02181062|minorities|minorities
1167669|NCT02181062|minority older adults|minority older adults
1167670|NCT02181062|hypertension|hypertension
1167671|NCT02181062|high blood pressure|high blood pressure
1167672|NCT02181062|elderly|elderly
1167673|NCT02181062|sedentary lifestyle|sedentary lifestyle
1167674|NCT02181049|Childhood cancer survivors|childhood cancer survivors
1167675|NCT02181049|Cardiac|cardiac
1167676|NCT02181049|Vascular|vascular
1167677|NCT02181049|Cardiovascular|cardiovascular
1167678|NCT02181049|Late-sequelae|late-sequelae
1167679|NCT02181036|Family work shop|family work shop
1167680|NCT02181036|speech developmental delays|speech developmental delays
1167681|NCT02181036|children|children
1167682|NCT02181023|COPD|copd
1167683|NCT02181023|Hyperinflation|hyperinflation
1167684|NCT02181023|Aclidinium|aclidinium
1167685|NCT02181023|Glycopyrronium|glycopyrronium
1167686|NCT02181023|Volume distribution|volume distribution
1167687|NCT02181023|Anticholinergic|anticholinergic
1167688|NCT02181023|Pharmacokinetics|pharmacokinetics
1167689|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
1167690|NCT02181023|Phase III|phase iii
1167691|NCT02181010|African American|african american
1167692|NCT02181010|Adolescents|adolescents
1167693|NCT02181010|Urban|urban
1167694|NCT02181010|Food Desert|food desert
1167695|NCT02181010|Food Insecurity|food insecurity
1167696|NCT02181010|Obesity|obesity
1167697|NCT02181010|Baltimore City|baltimore city
1167698|NCT02181010|Peer mentors|peer mentors
1167699|NCT02181010|Multi level|multi level
1167700|NCT02181010|Policy|policy
1167701|NCT02181010|Caregivers|caregivers
1167702|NCT02181010|Systems|systems
1167703|NCT02181010|Agent Based Model|agent based model
1167704|NCT02181010|Systems Dynamic Model|systems dynamic model
1167705|NCT02181010|Corner Store|corner store
1167706|NCT02181010|Carryout|carryout
1167707|NCT02181010|Recreation Center|recreation center
1167708|NCT02181010|Text Messaging|text messaging
1167709|NCT02181010|Social Media|social media
1167710|NCT02181010|Mapping|mapping
1167711|NCT02180997|α1-blockers|α1-blockers
1167712|NCT02180997|antimuscarinic agent|antimuscarinic agent
1167713|NCT02180984|Binge Eating|binge eating
1167714|NCT02180984|Obesity|obesity
1167715|NCT02180984|TMS|tms
1167716|NCT02180984|Neuroimage|neuroimage
1167717|NCT02180984|Neuromodulation|neuromodulation
1167718|NCT02180984|Biomarkers|biomarkers
1167719|NCT02180984|Eating Disorders|eating disorders
1167720|NCT02180984|Cognition|cognition
1167721|NCT02180984|Endocrine|endocrine
1167722|NCT02180984|Hormones|hormones
1167723|NCT02180984|BDNF|bdnf
1167724|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
1167725|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
1167726|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
1167727|NCT02180971|Coronary spasm|coronary spasm
1167829|NCT02180607|fMRI|fmri
1167830|NCT02180607|reward|reward
1167728|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
1167729|NCT02180958|cAVM|cavm
1167730|NCT02180958|ONYX|onyx
1167731|NCT02180945|dAVF|davf
1167732|NCT02180945|Arteriovenous fistula|arteriovenous fistula
1167733|NCT02180945|ONYX|onyx
1167734|NCT02180919|Telemonitoring|telemonitoring
1167735|NCT02180919|COPD|copd
1167736|NCT02180919|Heart failure|heart failure
1167737|NCT02180919|Exacerbation|exacerbation
1167738|NCT02180919|Respiratory failure|respiratory failure
1167739|NCT02180919|Prevention|prevention
1167740|NCT02180919|Self monitoring|self monitoring
1167741|NCT02180906|Fasciitis|fasciitis
1167742|NCT02180906|Gangrene|gangrene
1167743|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
1167744|NCT02180906|Soft Tissue Infections|soft tissue infections
1167745|NCT02180906|Fournier's Gangrene|fournier's gangrene
1167746|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
1167747|NCT02180906|Flesh eating bacteria|flesh eating bacteria
1167748|NCT02180906|Meleneys ulcer|meleneys ulcer
1167749|NCT02180906|Wounds and Injuries|wounds and injuries
1167750|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
1167751|NCT02180906|Staphylococcus aureus|staphylococcus aureus
1167752|NCT02180906|Immunopathogenesis|immunopathogenesis
1167753|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
1167754|NCT02180906|Necrosis/blood|necrosis/blood
1167755|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
1167756|NCT02180906|Necrosis/mortality|necrosis/mortality
1167757|NCT02180906|Necrosis/surgery|necrosis/surgery
1167758|NCT02180906|Prognosis|prognosis
1167759|NCT02180906|Risk Factors|risk factors
1167760|NCT02180906|Bacterial Infections|bacterial infections
1167761|NCT02180906|Infection|infection
1167762|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
1167763|NCT02180906|Observational study|observational study
1167764|NCT02180906|Biological markers|biological markers
1167765|NCT02180880|Neuralgia|neuralgia
1167766|NCT02180880|Spinal cord|spinal cord
1167767|NCT02180880|Oxcarbazepine|oxcarbazepine
1167768|NCT02180880|Pregabalin|pregabalin
1167769|NCT02180880|Drug therapy|drug therapy
1167770|NCT02180880|Algorithms|algorithms
1167771|NCT02180854|Early warning score|early warning score
1167772|NCT02180854|Rapid response systems|rapid response systems
1167773|NCT02180854|Medical emergency team|medical emergency team
1167774|NCT02180841|soy|soy
1167775|NCT02180841|hypertension|hypertension
1167776|NCT02180841|HDL-C|hdl-c
1167777|NCT02180841|cholesterol efflux|cholesterol efflux
1167778|NCT02180841|cardiovascular disease|cardiovascular disease
1167779|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
1167780|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
1167781|NCT02180815|Minimally invasive surgery|minimally invasive surgery
1167782|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
1167783|NCT02180815|Tongue implants|tongue implants
1167784|NCT02180802|obese adolescents|obese adolescents
1167913|NCT02180113|Fibroscan|fibroscan
1167785|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
1167786|NCT02180789|tamsulosin,|tamsulosin,
1167787|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
1167788|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
1167789|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
1167790|NCT02180750|Children|children
1167791|NCT02180750|HIV|hiv
1167792|NCT02180750|orphans|orphans
1167793|NCT02180737|dexmedetomedine|dexmedetomedine
1167794|NCT02180737|sedation|sedation
1167795|NCT02180737|interventional radiology|interventional radiology
1167796|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1167797|NCT02180724|Btk|btk
1167798|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
1167799|NCT02180724|WM|wm
1167800|NCT02180724|Waldenström|waldenström
1167801|NCT02180724|Macroglobulinemia|macroglobulinemia
1167802|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1167803|NCT02180711|Btk|btk
1167804|NCT02180711|Follicular Lymphoma|follicular lymphoma
1167805|NCT02180711|FL|fl
1167806|NCT02180711|acalabrutinib|acalabrutinib
1167807|NCT02180711|ACP-196|acp-196
1167808|NCT02180711|MZL|mzl
1167809|NCT02180711|Marginal Zone Lymphoma|marginal zone lymphoma
1167810|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1167811|NCT02180672|OSA|osa
1167812|NCT02180672|sleep apnea|sleep apnea
1167813|NCT02180672|nasal steroids|nasal steroids
1167814|NCT02180672|corticosteroids|corticosteroids
1167815|NCT02180646|GLP-1|glp-1
1167816|NCT02180646|GIP|gip
1167817|NCT02180646|second meal phenomena|second meal phenomena
1167818|NCT02180646|type 2 diabetes|type 2 diabetes
1167819|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
1167820|NCT02180620|GIP|gip
1167821|NCT02180620|GLP-1|glp-1
1167822|NCT02180620|exercise timing|exercise timing
1167823|NCT02180620|resistance exercise|resistance exercise
1167824|NCT02180620|glucose concentrations|glucose concentrations
1167825|NCT02180607|depression|depression
1167826|NCT02180607|social|social
1167827|NCT02180607|rejection|rejection
1167828|NCT02180607|acceptance|acceptance
1167831|NCT02180607|exclusion|exclusion
1167832|NCT02180581|Infections|infections
1167833|NCT02180581|Allergy|allergy
1167834|NCT02180581|Immune function|immune function
1167835|NCT02180581|Microbiota|microbiota
1167836|NCT02180581|Infant|infant
1167837|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
1167838|NCT02180568|Lung localization|lung localization
1167839|NCT02180568|Lipiodol|lipiodol
1167840|NCT02180568|Hook wire|hook wire
1167841|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
1167842|NCT02180542|stroke|stroke
1167843|NCT02180542|Ischemic stroke|ischemic stroke
1167844|NCT02180542|Cerebral infarction|cerebral infarction
1167845|NCT02180542|recurrent stroke|recurrent stroke
1167846|NCT02180542|atrial fibrillation|atrial fibrillation
1167847|NCT02180542|premature atrial complexes|premature atrial complexes
1167848|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
1167849|NCT02180542|left atrial function|left atrial function
1167850|NCT02180542|carotid artery|carotid artery
1167851|NCT02180542|plaque morphology|plaque morphology
1167852|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
1167853|NCT02180464|psoriasis, topical|psoriasis, topical
1167854|NCT02180438|HIV-2|hiv-2
1167855|NCT02180425|acne|acne
1167856|NCT02180425|lipid|lipid
1167857|NCT02180425|tretinoin|tretinoin
1167858|NCT02180425|isotretinoin|isotretinoin
1167859|NCT02180412|Acute porphyria|acute porphyria
1167860|NCT02180412|Hemin|hemin
1167861|NCT02180399|Sepsis|sepsis
1167862|NCT02180399|Capillary blood lactate|capillary blood lactate
1167863|NCT02180399|Serial measurement of capillary|serial measurement of capillary
1167864|NCT02180386|Audiovisual distraction|audiovisual distraction
1167865|NCT02180386|Pediatric dentistry|pediatric dentistry
1167866|NCT02180360|Capoeira training|capoeira training
1167867|NCT02180360|Range of motion|range of motion
1167868|NCT02180360|Flexibility|flexibility
1167869|NCT02180360|beginners|beginners
1167870|NCT02180347|Pediatrics|pediatrics
1167871|NCT02180347|Contact lenses|contact lenses
1167872|NCT02180334|Gastric Emptying|gastric emptying
1167873|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
1167874|NCT02180334|Incretins|incretins
1167875|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
1167876|NCT02180334|Diabetes Mellitus|diabetes mellitus
1167877|NCT02180321|Tranexamic acid|tranexamic acid
1167878|NCT02180321|pharmacokinetics|pharmacokinetics
1167879|NCT02180321|craniosynostosis|craniosynostosis
1167880|NCT02180308|Head cancer|head cancer
1167881|NCT02180308|Neck cancer|neck cancer
1167882|NCT02180308|MRI|mri
1167883|NCT02180308|PET|pet
1167884|NCT02180282|Acne Treatment|acne treatment
1167885|NCT02180269|Healthy|healthy
1167886|NCT02180269|JNJ-54861911|jnj-54861911
1167887|NCT02180269|Alzheimer's disease|alzheimer's disease
1167888|NCT02180256|IVF|ivf
1167889|NCT02180256|ICSI|icsi
1167890|NCT02180256|Embryo transfer|embryo transfer
1167891|NCT02180256|Assisted reproduction|assisted reproduction
1167892|NCT02180256|Endometrial injury|endometrial injury
1167893|NCT02180256|Endometrial scratching|endometrial scratching
1167894|NCT02180243|meditation|meditation
1167895|NCT02180243|acupuncture|acupuncture
1167896|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
1167897|NCT02180243|Gulf War health education|gulf war health education
1167898|NCT02180243|iRest yoga|irest yoga
1167899|NCT02180230|Short implants|short implants
1167900|NCT02180230|prospective multicenter study|prospective multicenter study
1167901|NCT02180230|maxilla & mandible|maxilla & mandible
1167902|NCT02180217|LCI699|lci699
1167903|NCT02180217|Cushing's disease|cushing's disease
1167904|NCT02180204|Cerebral Infarction|cerebral infarction
1167905|NCT02180204|Ischemic Stroke|ischemic stroke
1167906|NCT02180204|Thrombolysis|thrombolysis
1167907|NCT02180191|Gut microbiota|gut microbiota
1167908|NCT02180178|microvascular disease|microvascular disease
1167909|NCT02180178|coronary artery disease|coronary artery disease
1167910|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
1167911|NCT02180152|Perinatal outcomes|perinatal outcomes
1167912|NCT02180113|Cirrhotic patients|cirrhotic patients
1167914|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
1167915|NCT02180113|Oesophageal Varices|oesophageal varices
1167916|NCT02180113|Portal Hypertension|portal hypertension
1167917|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
1167918|NCT02180087|Cardiac surgery|cardiac surgery
1167919|NCT02180087|Post-operative pain|post-operative pain
1167920|NCT02180087|Kétoprofène|kétoprofène
1167921|NCT02180087|Minimum analgesic dose|minimum analgesic dose
1167922|NCT02180087|Morphin consumption|morphin consumption
1167923|NCT02180087|Morphin secondary effects|morphin secondary effects
1167924|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
1167925|NCT02180087|Renal fonction|renal fonction
1167926|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
1167927|NCT02180061|PD1|pd1
1167928|NCT02180061|PD-1|pd-1
1167929|NCT02180061|PDL1|pdl1
1167930|NCT02180061|PD-L1|pd-l1
1167931|NCT02180035|diet therapy|diet therapy
1167932|NCT02180035|symbiotic|symbiotic
1167933|NCT02180035|dyslipidemia|dyslipidemia
1167934|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
1167935|NCT02180035|body composition|body composition
1167936|NCT02180035|adherence|adherence
1167937|NCT02180035|HIV|hiv
1167938|NCT02180035|HAART|haart
1167939|NCT02180022|Quercetin|quercetin
1167940|NCT02180022|Endothelial function|endothelial function
1167941|NCT02180022|Onion peel extract|onion peel extract
1167942|NCT02180022|volunteers|volunteers
1167943|NCT02179996|Vaccination|vaccination
1167944|NCT02179996|Very preterm-born infants|very preterm-born infants
1167945|NCT02179996|Hib immunisation|hib immunisation
1167946|NCT02179996|Pertussis immunisation|pertussis immunisation
1167947|NCT02179983|Bronchiectasis|bronchiectasis
1167948|NCT02179983|rehabilitation|rehabilitation
1167949|NCT02179983|exercise|exercise
1167950|NCT02179983|exacerbations|exacerbations
1167951|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
1167952|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
1167953|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
1167954|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
1167955|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
1167956|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
1167957|NCT02179957|Stenoses|stenoses
1167958|NCT02179957|Ischaemia|ischaemia
1167959|NCT02179957|haemodynamics|haemodynamics
1167960|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
1167961|NCT02179957|computed tomography (CT)|computed tomography (ct)
1167962|NCT02179957|cardiac|cardiac
1167963|NCT02179944|medication abortion|medication abortion
1167964|NCT02179944|serum hCG|serum hcg
1167965|NCT02179918|Advanced Solid Tumors|advanced solid tumors
1167966|NCT02179905|MRI|mri
1168167|NCT02178904|Ischemia|ischemia
1167967|NCT02179905|Heart rate variability|heart rate variability
1167968|NCT02179905|Fatty acid|fatty acid
1167969|NCT02179892|anesthesia|anesthesia
1167971|NCT02179892|pain|pain
1167972|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
1167973|NCT02179853|Kawasaki disease|kawasaki disease
1167974|NCT02179853|Anakinra|anakinra
1167975|NCT02179853|IL-1|il-1
1167976|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
1167977|NCT02179840|Cerebral autoregulation|cerebral autoregulation
1167978|NCT02179814|bulimia nervosa|bulimia nervosa
1167979|NCT02179814|dopamine|dopamine
1167980|NCT02179814|reward|reward
1167981|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
1167982|NCT02179814|gene|gene
1167983|NCT02179814|catecholamines|catecholamines
1167984|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
1167985|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
1167986|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
1167987|NCT02179801|AAA|aaa
1167988|NCT02179801|Screening|screening
1167989|NCT02179788|lactation|lactation
1167990|NCT02179788|breastfeeding|breastfeeding
1167991|NCT02179788|human milk|human milk
1167992|NCT02179788|insulin|insulin
1167993|NCT02179788|metformin|metformin
1167994|NCT02179788|prediabetes|prediabetes
1167995|NCT02179788|pre-diabetes|pre-diabetes
1167996|NCT02179788|insulin resistance|insulin resistance
1167997|NCT02179762|cancer survivor|cancer survivor
1167998|NCT02179762|prostate cancer|prostate cancer
1167999|NCT02179762|exercise|exercise
1168000|NCT02179762|Active surveillance|active surveillance
1168001|NCT02179762|EASE|ease
1168002|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
1168003|NCT02179749|Substance-Related Disorders|substance-related disorders
1168004|NCT02179749|Mental Disorders|mental disorders
1168005|NCT02179749|Mifepristone|mifepristone
1168006|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
1168007|NCT02179749|Alcohol Treatment|alcohol treatment
1168008|NCT02179749|Alcohol|alcohol
1168009|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
1168010|NCT02179723|wound healing|wound healing
1168011|NCT02179723|cosmetic results|cosmetic results
1168012|NCT02179723|trocar incision|trocar incision
1168013|NCT02179710|adherence|adherence
1168014|NCT02179710|cystic fibrosis|cystic fibrosis
1168015|NCT02179710|adolescents|adolescents
1168016|NCT02179710|adults|adults
1168017|NCT02179697|Groups:|groups:
1168018|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
1168019|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
1168020|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
1168021|NCT02179697|Group 2|group 2
1168022|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
1168023|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
1168024|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
1168025|NCT02179658|Clostridium|clostridium
1168026|NCT02179658|Infections|infections
1168027|NCT02179658|Difficile|difficile
1168028|NCT02179658|Vancomycin|vancomycin
1168029|NCT02179658|Fidaxomicin|fidaxomicin
1168030|NCT02179632|disclosure|disclosure
1168031|NCT02179632|conflicts of interest|conflicts of interest
1168032|NCT02179632|trust|trust
1168033|NCT02179632|patient doctor relationship|patient doctor relationship
1168034|NCT02179593|Maxillary expansion|maxillary expansion
1168035|NCT02179593|Orthognathic surgery|orthognathic surgery
1168036|NCT02179593|Symmetry|symmetry
1168037|NCT02179593|Palatal expansion technique|palatal expansion technique
1168038|NCT02179593|Maxilla abnormality|maxilla abnormality
1168039|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
1168040|NCT02179580|Clinical trial|clinical trial
1168041|NCT02179580|Good Clinical Practice|good clinical practice
1168042|NCT02179567|Metastatic NSCLC|metastatic nsclc
1168043|NCT02179567|Elderly|elderly
1168044|NCT02179567|1st Line|1st line
1168045|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
1168046|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
1168047|NCT02179515|Immune Response|immune response
1168048|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
1168049|NCT02179515|Vaccine Therapy|vaccine therapy
1168050|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
1168051|NCT02179515|Immunotherapy|immunotherapy
1168052|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
1168053|NCT02179489|HIPEC|hipec
1168054|NCT02179489|controlled clinical trial|controlled clinical trial
1168055|NCT02179489|colorectal cancer|colorectal cancer
1168056|NCT02179476|Facet joint|facet joint
1168057|NCT02179476|facet joint pain|facet joint pain
1168058|NCT02179476|facet joint disease|facet joint disease
1168059|NCT02179476|lumbar pain|lumbar pain
1168060|NCT02179476|back pain|back pain
1168061|NCT02179463|Gastric Cancer|gastric cancer
1168062|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1168063|NCT02179463|Response Evaluation|response evaluation
1168064|NCT02179437|TIVA|tiva
1168066|NCT02179437|Postoperative pain|postoperative pain
1168067|NCT02179437|Liver resection surgery|liver resection surgery
1168068|NCT02179437|Retrospective study|retrospective study
1168069|NCT02179424|smoking cessation interventions|smoking cessation interventions
1168070|NCT02179398|Fever without source|fever without source
1168071|NCT02179398|Antibiotic prescription|antibiotic prescription
1168072|NCT02179398|Serious bacterial infection|serious bacterial infection
1168073|NCT02179385|Type 2 diabetes|type 2 diabetes
1168074|NCT02179385|Type II diabetes|type ii diabetes
1168075|NCT02179359|Stem Cell Transplant|stem cell transplant
1168076|NCT02179346|cartilage defect|cartilage defect
1168077|NCT02179346|hip|hip
1168078|NCT02179346|impingement|impingement
1168079|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
1168080|NCT02179320|Dry needling|dry needling
1168081|NCT02179320|Clinical Trial|clinical trial
1168082|NCT02179307|muscle hypertrophy|muscle hypertrophy
1168083|NCT02179307|strength|strength
1168084|NCT02179307|resistance training|resistance training
1168085|NCT02179307|exercise|exercise
1168086|NCT02179307|physical fitness|physical fitness
1168087|NCT02179307|health|health
1168088|NCT02179307|physical conditioning|physical conditioning
1168089|NCT02179294|Pain relief|pain relief
1168090|NCT02179294|Labour|labour
1168091|NCT02179294|Child birth|child birth
1168092|NCT02179294|Anaesthetics|anaesthetics
1168093|NCT02179268|Antidepressants|antidepressants
1168094|NCT02179268|bone mineral density|bone mineral density
1168095|NCT02179268|bone turnover markers|bone turnover markers
1168096|NCT02179255|DOR|dor
1168097|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
1168098|NCT02179255|Ovarian Failure|ovarian failure
1168099|NCT02179255|Human Growth Hormone|human growth hormone
1168100|NCT02179242|cardiac rehab|cardiac rehab
1168101|NCT02179242|heart failure|heart failure
1168102|NCT02179242|KCCQ|kccq
1168103|NCT02179242|6 minute walk test|6 minute walk test
1168104|NCT02179242|readmission|readmission
1168105|NCT02179229|Kidney transplantation|kidney transplantation
1168106|NCT02179229|pCresol|pcresol
1168107|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
1168108|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
1168109|NCT02179216|Efficacity of Hydration|efficacity of hydration
1168110|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
1168111|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
1168112|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
1168113|NCT02179177|Sickle Cell Disease|sickle cell disease
1168114|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
1168115|NCT02179151|Obesity|obesity
1168116|NCT02179151|Hyperphagia|hyperphagia
1168117|NCT02179125|COPD|copd
1168118|NCT02179125|Endobronchial treatment|endobronchial treatment
1168119|NCT02179112|Surgery|surgery
1168120|NCT02179112|Specialties, Surgical|specialties, surgical
1168121|NCT02179112|Geography, Medical|geography, medical
1168122|NCT02179112|Developing Countries|developing countries
1168123|NCT02179112|Developed Countries|developed countries
1168124|NCT02179112|Laparotomy|laparotomy
1168125|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1168126|NCT02179112|Treatment Outcome|treatment outcome
1168127|NCT02179112|Quality of Health Care|quality of health care
1168128|NCT02179099|overactive bladder|overactive bladder
1168129|NCT02179099|OAB|oab
1168130|NCT02179099|urgency|urgency
1168131|NCT02179099|botulinum toxin|botulinum toxin
1168132|NCT02179099|BTX|btx
1168133|NCT02179099|botox|botox
1168134|NCT02179099|intravesical|intravesical
1168135|NCT02179099|TheraCoat|theracoat
1168136|NCT02179099|TCGel|tcgel
1168137|NCT02179099|TC-3 Gel|tc-3 gel
1572221|NCT00493727|Mucomyst|mucomyst
1168138|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
1168139|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
1168140|NCT02179034|tobacco|tobacco
1168141|NCT02179034|electronic cigarettes|electronic cigarettes
1168142|NCT02179034|menthol|menthol
1168143|NCT02179034|flavors|flavors
1168144|NCT02179021|Thromboelastometry|thromboelastometry
1168145|NCT02179021|Haemostasis|haemostasis
1168146|NCT02179021|Hypothermia|hypothermia
1168147|NCT02179021|Heart arrest|heart arrest
1168148|NCT02179008|Santen|santen
1168149|NCT02179008|Eye|eye
1168150|NCT02179008|Glaucoma|glaucoma
1168151|NCT02179008|Ocular hypertension|ocular hypertension
1168152|NCT02178982|mechanical ventilation|mechanical ventilation
1168153|NCT02178982|ARDS|ards
1168154|NCT02178982|Ventilator strategy|ventilator strategy
1168155|NCT02178982|outcome|outcome
1168156|NCT02178943|Molecular Diagnostics|molecular diagnostics
1168157|NCT02178943|Heart Transplantation|heart transplantation
1168158|NCT02178943|Risk Factors|risk factors
1168159|NCT02178943|Prognosis|prognosis
1168160|NCT02178930|HIV|hiv
1168161|NCT02178930|cardiovascular disease|cardiovascular disease
1168162|NCT02178930|self-management|self-management
1168163|NCT02178930|HIV co-morbidities|hiv co-morbidities
1168164|NCT02178930|self-efficacy|self-efficacy
1168165|NCT02178930|coronary heart disease risk|coronary heart disease risk
1168166|NCT02178930|quality of life|quality of life
1168168|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
1168169|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
1168170|NCT02178904|Fractional Flow Rate|fractional flow rate
1168171|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
1168172|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
1168173|NCT02178891|short implants|short implants
1168174|NCT02178891|Nobel Biocare|nobel biocare
1168175|NCT02178891|partially edentulous|partially edentulous
1168176|NCT02178891|maxilla or mandible|maxilla or mandible
1168177|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
1168178|NCT02178865|translocation|translocation
1168179|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
1168180|NCT02178839|β- glucan|β- glucan
1168181|NCT02178839|Appetite|appetite
1168182|NCT02178839|Insulin Resistance|insulin resistance
1168183|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
1168184|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
1168185|NCT02178826|Orthodontics|orthodontics
1168186|NCT02178826|Polysomnography|polysomnography
1168187|NCT02178826|Quality of life|quality of life
1168188|NCT02178813|Minocycline|minocycline
1168189|NCT02178813|Neuroprotection|neuroprotection
1168190|NCT02178813|Stroke|stroke
1168191|NCT02178787|cerebral blood flow|cerebral blood flow
1168192|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
1168193|NCT02178787|transcranial Doppler|transcranial doppler
1168194|NCT02178787|diabetes mellitus|diabetes mellitus
1168195|NCT02178787|cerebral autoregulation|cerebral autoregulation
1168196|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1168197|NCT02178774|spinal anesthesia|spinal anesthesia
1168198|NCT02178774|cesarean section|cesarean section
1168199|NCT02178761|Erectile dysfunction|erectile dysfunction
1168200|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1168201|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
1168202|NCT02178761|Angioplasty|angioplasty
1168203|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
1168204|NCT02178748|Tuberculosis|tuberculosis
1168205|NCT02178748|Phase II|phase ii
1168206|NCT02178748|MVA85A|mva85a
1168207|NCT02178748|Schistosoma mansoni|schistosoma mansoni
1168208|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
1168209|NCT02178709|Pancreatic|pancreatic
1168210|NCT02178709|Cancer|cancer
1168211|NCT02178709|Resectable|resectable
1168212|NCT02178683|TACROLIMUS|tacrolimus
1168213|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
1168214|NCT02178683|FLUDARABINE|fludarabine
1168215|NCT02178683|HLA-MATCHED|hla-matched
1168216|NCT02178683|MIS-MATCHED|mis-matched
1168217|NCT02178657|Stroke|stroke
1168218|NCT02178657|Cell therapy|cell therapy
1168219|NCT02178657|Bone marrow|bone marrow
1168220|NCT02178605|rhBMP-2|rhbmp-2
1168221|NCT02178605|arthrodesis|arthrodesis
1168222|NCT02178605|cervical|cervical
1168223|NCT02178592|integrase inhibitor|integrase inhibitor
1168224|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
1168225|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
1168226|NCT02178592|dolutegravir|dolutegravir
1168227|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
1168228|NCT02178592|HIV-1 infection|hiv-1 infection
1168229|NCT02178592|efavirenz|efavirenz
1168230|NCT02178592|co-infection|co-infection
1168231|NCT02178579|Heart Failure|heart failure
1168232|NCT02178579|Cardiac Toxicity|cardiac toxicity
1168233|NCT02178579|Multiple Myeloma|multiple myeloma
1168234|NCT02178579|Bortezomib|bortezomib
1168235|NCT02178579|Carfilzomib|carfilzomib
1168236|NCT02178566|COPD|copd
1168237|NCT02178566|Trepostinil|trepostinil
1168238|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
1168239|NCT02178553|Thoracotomy|thoracotomy
1168240|NCT02178553|Pain|pain
1168241|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
1168242|NCT02178527|Geriatrics|geriatrics
1168243|NCT02178527|Accidental Falls|accidental falls
1168244|NCT02178527|Podiatry|podiatry
1168245|NCT02178527|Exercise Therapy|exercise therapy
1168246|NCT02178527|Orthotic Devices|orthotic devices
1168247|NCT02178527|Foot|foot
1168248|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
1168249|NCT02178501|type 2 diabetes|type 2 diabetes
1168250|NCT02178501|cardiovascular diseases|cardiovascular diseases
1168251|NCT02178475|NHL|nhl
1168252|NCT02178475|Breast Cancer|breast cancer
1168253|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
1168254|NCT02178410|Atrial Fibrillation|atrial fibrillation
1168255|NCT02178410|Vitamin D3|vitamin d3
1168256|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
1168257|NCT02178410|Fish oil|fish oil
1168258|NCT02178397|erlotinib|erlotinib
1168259|NCT02178397|lung cancer|lung cancer
1168260|NCT02178397|EGFR mutation|egfr mutation
1168261|NCT02178384|Loading Forces|loading forces
1168262|NCT02178384|Removable partial dentures|removable partial dentures
1168263|NCT02178384|Bilateral distal extension|bilateral distal extension
1168264|NCT02178371|Upper extremity|upper extremity
1168265|NCT02178371|Physical therapy modalities|physical therapy modalities
1168266|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
1168267|NCT02178345|MRI|mri
1168268|NCT02178345|14-126|14-126
1168269|NCT02178332|Children|children
1168270|NCT02178332|socio-emotional|socio-emotional
1168271|NCT02178332|socio-emotional skills|socio-emotional skills
1168272|NCT02178332|psychiatric symptoms|psychiatric symptoms
1168273|NCT02178332|SDQ|sdq
1168274|NCT02178332|Finland|finland
1168275|NCT02178332|School|school
1168276|NCT02178332|School community|school community
1168277|NCT02178332|Teacher|teacher
1168278|NCT02178332|Whole school approach|whole school approach
1168279|NCT02178332|Intervention|intervention
1168280|NCT02178332|Effectiveness study|effectiveness study
1168281|NCT02178332|Cluster randomised trial|cluster randomised trial
1168282|NCT02178319|portal hypertension|portal hypertension
1168283|NCT02178319|Randomized clinical trial|randomized clinical trial
1168284|NCT02178319|laparoscopic|laparoscopic
1168285|NCT02178319|open|open
1168286|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
1168287|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
1168288|NCT02178228|Anastomotic Leaks|anastomotic leaks
1168289|NCT02178228|Bowel Resection|bowel resection
1168290|NCT02178228|Postoperative Complication|postoperative complication
1168291|NCT02178215|atopic dermatitis|atopic dermatitis
1168292|NCT02178215|skin barrier function|skin barrier function
1168293|NCT02178215|transepidermal water loss|transepidermal water loss
1168294|NCT02178215|skin pH|skin ph
1168295|NCT02178215|stratum corneum hydration|stratum corneum hydration
1168296|NCT02178215|sebum|sebum
1168297|NCT02178215|wrinkle|wrinkle
1168298|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
1168299|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
1168300|NCT02178189|infant|infant
1168301|NCT02178189|weight gain|weight gain
1168302|NCT02178189|infant formula|infant formula
1168303|NCT02178150|Magnesium|magnesium
1168304|NCT02178150|Insulin Resistance|insulin resistance
1168305|NCT02178150|Lipid profile|lipid profile
1168306|NCT02178150|Sex hormones|sex hormones
1168307|NCT02178150|Inflammatory factors|inflammatory factors
1168308|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
1168309|NCT02178098|LDL|ldl
1168310|NCT02178098|Cholesterol|cholesterol
1168311|NCT02178085|glaucoma|glaucoma
1168312|NCT02178085|phase-contrast MRI|phase-contrast mri
1168313|NCT02178085|blood flow|blood flow
1168314|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
1168315|NCT02178072|HNSCC|hnscc
1168316|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
1168317|NCT02178046|Gingivitis|gingivitis
1168318|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
1168319|NCT02178020|Knee Arthroplasty|knee arthroplasty
1168320|NCT02178020|Osteolysis|osteolysis
1168321|NCT02178020|Radiolucent Lines|radiolucent lines
1168322|NCT02177994|Elective Cesarean Section|elective cesarean section
1168323|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
1168324|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
1168325|NCT02177994|post cesarean section infection|post cesarean section infection
1168326|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
1168327|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1572222|NCT00493727|albuminuria|albuminuria
1168328|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
1168329|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
1168330|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1168331|NCT02177968|fall|fall
1168332|NCT02177968|elderly|elderly
1168333|NCT02177968|characteristics|characteristics
1168334|NCT02177955|Third Molar|third molar
1168335|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
1168336|NCT02177955|hemodynamic|hemodynamic
1168337|NCT02177955|Benzodiazepines|benzodiazepines
1168338|NCT02177929|Spinal cord injury,|spinal cord injury,
1168339|NCT02177929|adaptive sport,|adaptive sport,
1168340|NCT02177929|dynamometry,|dynamometry,
1168341|NCT02177929|electromyography,|electromyography,
1168342|NCT02177929|force platform.|force platform.
1168343|NCT02177916|lung transplantation|lung transplantation
1168344|NCT02177903|hypothermia|hypothermia
1168345|NCT02177903|surgical site infection|surgical site infection
1168346|NCT02177903|opioid usage|opioid usage
1168347|NCT02177903|blood loss|blood loss
1168348|NCT02177903|pain severity|pain severity
1168349|NCT02177903|anxiety|anxiety
1168350|NCT02177903|Length of Stay|length of stay
1168351|NCT02177877|Epilepsy|epilepsy
1168352|NCT02177877|Seizures|seizures
1168353|NCT02177877|Wrist accelerometer|wrist accelerometer
1168354|NCT02177877|Epilepsy diary|epilepsy diary
1168355|NCT02177877|Seizure detection|seizure detection
1168356|NCT02177877|Biosensor|biosensor
1168357|NCT02177851|Iron bio-availability|iron bio-availability
1168358|NCT02177851|Hepcidin|hepcidin
1168359|NCT02177851|Iron absorption|iron absorption
1168360|NCT02177812|Oncology|oncology
1168361|NCT02177812|LSD1|lsd1
1168362|NCT02177812|GSK2879552|gsk2879552
1168363|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
1168364|NCT02177799|Gastroenteritis|gastroenteritis
1168365|NCT02177799|Hospitalized|hospitalized
1168366|NCT02177799|Children|children
1168367|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
1168368|NCT02177786|Gilead|gilead
1168369|NCT02177760|SCID|scid
1168370|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
1168371|NCT02177760|maternal engraftment|maternal engraftment
1168372|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
1168373|NCT02177760|sirolimus|sirolimus
1168374|NCT02177734|Adjuvant|adjuvant
1168375|NCT02177734|Safety|safety
1168376|NCT02177734|Influenza|influenza
1168377|NCT02177734|H7N9|h7n9
1168378|NCT02177734|Immunogenicity|immunogenicity
1168379|NCT02177734|Adults|adults
1168380|NCT02177721|Raxibacumab|raxibacumab
1168381|NCT02177721|anthrax|anthrax
1168382|NCT02177721|anti-toxin|anti-toxin
1168383|NCT02177695|Bladder Cancer|bladder cancer
1168384|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1168385|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
1168386|NCT02177695|COXEN|coxen
1168387|NCT02177695|S1314|s1314
1168388|NCT02177695|SWOG|swog
1168389|NCT02177682|AKT inhibitor|akt inhibitor
1168390|NCT02177682|Afuresertib|afuresertib
1168391|NCT02177682|multiple myeloma|multiple myeloma
1168392|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
1168393|NCT02177669|Ages 20-89|ages 20-89
1168394|NCT02177669|English speaking|english speaking
1168395|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
1168396|NCT02177656|heart failure|heart failure
1168397|NCT02177656|self-care|self-care
1168398|NCT02177656|self-care maintenance|self-care maintenance
1168399|NCT02177656|self-care management|self-care management
1168400|NCT02177656|self-efficacy|self-efficacy
1168401|NCT02177656|quality of life|quality of life
1168402|NCT02177656|symptoms|symptoms
1168403|NCT02177643|Diabetes|diabetes
1168404|NCT02177643|Diacerein|diacerein
1168405|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
1168406|NCT02177617|Cervical Dystonia|cervical dystonia
1168407|NCT02177617|Botox|botox
1168408|NCT02177578|Subventricular Zone|subventricular zone
1168409|NCT02177578|progenitor cell|progenitor cell
1168410|NCT02177578|radiation therapy|radiation therapy
1168411|NCT02177578|temozolomide|temozolomide
1168412|NCT02177565|Non-union|non-union
1168413|NCT02177565|fracture|fracture
1168414|NCT02177565|bone marrow stem cells|bone marrow stem cells
1168415|NCT02177552|Esophageal cancer|esophageal cancer
1168416|NCT02177552|Gastric cancer|gastric cancer
1168417|NCT02177539|cycloplegia|cycloplegia
1168418|NCT02177539|refraction in children|refraction in children
1168419|NCT02177539|cycloplegic agents|cycloplegic agents
1168420|NCT02177539|cycloplegic schemes|cycloplegic schemes
1168421|NCT02177539|cyclopentolate|cyclopentolate
1168423|NCT02177526|MRI|mri
1168424|NCT02177513|Cannabis|cannabis
1168425|NCT02177513|Pharmacodynamics|pharmacodynamics
1168426|NCT02177513|Marijuana|marijuana
1168427|NCT02177513|Cannabinoids|cannabinoids
1168428|NCT02177513|Vaporized|vaporized
1168429|NCT02177474|depressive symptoms|depressive symptoms
1168430|NCT02177474|perceived social support|perceived social support
1168431|NCT02177474|coronary heart disease|coronary heart disease
1168432|NCT02177474|peer support|peer support
1168433|NCT02177474|women|women
1168434|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
1168435|NCT02177240|GlideScope®|glidescope®
1168436|NCT02177240|GlideRite®|gliderite®
1168437|NCT02177240|Flex-it®|flex-it®
1168438|NCT02177240|Difficult intubation|difficult intubation
1168439|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1168440|NCT02177227|Attune|attune
1168441|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
1168442|NCT02177227|TruMatch|trumatch
1168443|NCT02177188|Hypovolaemic shock|hypovolaemic shock
1168444|NCT02177188|Monitoring|monitoring
1168445|NCT02177188|Haemorrhage|haemorrhage
1168446|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
1168447|NCT02177175|Carvedilol|carvedilol
1168448|NCT02177175|Anthracycline|anthracycline
1168449|NCT02177175|HER2|her2
1168450|NCT02177175|14-099|14-099
1168451|NCT02177136|PSC|psc
1168452|NCT02177123|glaucoma shunt|glaucoma shunt
1168453|NCT02177123|glaucoma drainage device|glaucoma drainage device
1168454|NCT02177110|advanced melanoma|advanced melanoma
1168455|NCT02177110|metastatic melanoma|metastatic melanoma
1168456|NCT02177110|fresh frozen tissue|fresh frozen tissue
1168457|NCT02177110|FFPE tissue|ffpe tissue
1168458|NCT02177097|Pain|pain
1168459|NCT02177097|Infection|infection
1168460|NCT02177097|Inflammation|inflammation
1168461|NCT02177097|Prosthesis|prosthesis
1168462|NCT02177084|PTNS|ptns
1168463|NCT02177084|rectal cancer|rectal cancer
1168464|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
1168465|NCT02177071|CROHN DISEASE|crohn disease
1168466|NCT02177071|INFLIXIMAB|infliximab
1168467|NCT02177071|COMBINATION THERAPY|combination therapy
1168468|NCT02177071|steroid free remission|steroid free remission
1168469|NCT02177071|anti-metabolites|anti-metabolites
1168470|NCT02177058|Nursing homes|nursing homes
1168471|NCT02177058|Hospitalizations|hospitalizations
1168472|NCT02177032|Rabies vaccines|rabies vaccines
1168473|NCT02177032|intradermal|intradermal
1168474|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
1168475|NCT02177019|frequent headaches|frequent headaches
1168476|NCT02177019|personalized health plan|personalized health plan
1168477|NCT02176993|Acute stroke|acute stroke
1168478|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
1168480|NCT02176980|hepatitis C|hepatitis c
1168481|NCT02176980|alcohol|alcohol
1168482|NCT02176980|integrated care|integrated care
1168483|NCT02176941|Telomere Length|telomere length
1168484|NCT02176941|Arterial Aging|arterial aging
1168485|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
1168486|NCT02176941|Inflammation|inflammation
1168487|NCT02176941|Atherosclerosis|atherosclerosis
1168488|NCT02176889|Lactospore|lactospore
1168489|NCT02176889|Bacillus coagulans|bacillus coagulans
1168490|NCT02176889|Safety|safety
1168491|NCT02176889|Probiotic|probiotic
1168492|NCT02176889|Healthy Adults|healthy adults
1168493|NCT02176889|Tolerability|tolerability
1168494|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
1168495|NCT02176876|RA|ra
1168496|NCT02176876|GS-5745|gs-5745
1168497|NCT02176876|MMP9|mmp9
1168498|NCT02176876|phase 1|phase 1
1168499|NCT02176863|FORCE|force
1168500|NCT02176863|post-polio syndrome|post-polio syndrome
1168501|NCT02176863|Flebogamma|flebogamma
1168502|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
1168503|NCT02176863|IGIV|igiv
1168504|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
1168505|NCT02176837|vasospasm|vasospasm
1168506|NCT02176837|nitrite|nitrite
1168507|NCT02176837|sodium nitrite|sodium nitrite
1168508|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1168509|NCT02176811|Betatrophin|betatrophin
1168510|NCT02176785|Sleep|sleep
1168511|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
1168512|NCT02176720|Glioma|glioma
1168513|NCT02176720|Glioblastoma|glioblastoma
1168514|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
1168515|NCT02176720|GBM|gbm
1168516|NCT02176720|Recurrence|recurrence
1168517|NCT02176720|PET|pet
1168518|NCT02176720|FDOPA|fdopa
1168519|NCT02176707|Lung Function|lung function
1168520|NCT02176707|Exercise Capacity|exercise capacity
1168521|NCT02176694|persistent asthma|persistent asthma
1168522|NCT02176694|adherence|adherence
1168523|NCT02176694|text message reminders|text message reminders
1168524|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
1168525|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
1168526|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
1168527|NCT02176642|PTNS|ptns
1168528|NCT02176642|Neuromodulation|neuromodulation
1168529|NCT02176642|Oxybutynin|oxybutynin
1168530|NCT02176642|Anticholinergic Medication|anticholinergic medication
1168531|NCT02176629|Virtual Reality|virtual reality
1168532|NCT02176629|mild cognitive impairment|mild cognitive impairment
1168533|NCT02176629|Alzheimer's disease|alzheimer's disease
1168534|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
1168535|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
1168536|NCT02176590|Coping Power|coping power
1168537|NCT02176590|Power PATH|power path
1168538|NCT02176590|Head Start|head start
1168539|NCT02176486|Drug therapy|drug therapy
1168540|NCT02176473|Depression|depression
1168541|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
1168542|NCT02176460|Double-blind|double-blind
1168543|NCT02176460|placebo-controlled|placebo-controlled
1168544|NCT02176460|randomized|randomized
1168545|NCT02176460|colchicine|colchicine
1168546|NCT02176434|End stage renal disease|end stage renal disease
1168547|NCT02176434|Transplantation|transplantation
1168548|NCT02176434|Tolerance|tolerance
1168549|NCT02176408|Major Depressive Disorder|major depressive disorder
1168550|NCT02176408|Depression|depression
1168551|NCT02176408|MDD|mdd
1168552|NCT02176408|Exercise|exercise
1168553|NCT02176408|Physical Activity|physical activity
1168554|NCT02176408|Treatment|treatment
1168555|NCT02176408|Behavioral Activation|behavioral activation
1168556|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
1168557|NCT02176395|Randomized Controlled Trial|randomized controlled trial
1168558|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
1168559|NCT02176395|Proteomics|proteomics
1168560|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
1168561|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
1168562|NCT02176343|Cataract|cataract
1168563|NCT02176343|Intraocular lens|intraocular lens
1168564|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
1168565|NCT02176330|Randomised Controlled Trial|randomised controlled trial
1168566|NCT02176330|Virtual Clinic|virtual clinic
1168567|NCT02176330|ePAQ-PF|epaq-pf
1168568|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
1168569|NCT02176330|Economic Analysis|economic analysis
1168570|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
1168571|NCT02176317|ASD|asd
1168572|NCT02176317|Umbilical cord blood|umbilical cord blood
1168573|NCT02176317|Autologous cord blood|autologous cord blood
1168574|NCT02176317|cord blood|cord blood
1168575|NCT02176304|knee|knee
1168576|NCT02176304|arthritis|arthritis
1168577|NCT02176304|injections|injections
1168578|NCT02176304|corticosteroids|corticosteroids
1168579|NCT02176291|Buprenorphine|buprenorphine
1168580|NCT02176291|Receptors, opioid|receptors, opioid
1168581|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
1168582|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
1168583|NCT02176278|Diabetes|diabetes
1168584|NCT02176278|Asian|asian
1168585|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
1168586|NCT02176265|CAD|cad
1168587|NCT02176265|PCI|pci
1168588|NCT02176265|bioactive coronary stent|bioactive coronary stent
1168589|NCT02176265|OCT|oct
1168590|NCT02176226|Major Depressive Disorder|major depressive disorder
1168591|NCT02176226|Anxiety Disorders|anxiety disorders
1168592|NCT02176226|Behavior Therapy|behavior therapy
1168593|NCT02176226|Technology Assisted|technology assisted
1168594|NCT02176226|Mobile Phone|mobile phone
1168595|NCT02176226|Cellular Phone|cellular phone
1168596|NCT02176226|Smartphone|smartphone
1168597|NCT02176226|App|app
1168598|NCT02176213|Relapsed|relapsed
1168599|NCT02176213|Refractory|refractory
1168600|NCT02176213|Multiple Myeloma|multiple myeloma
1168601|NCT02176213|Pomalidomide|pomalidomide
1168602|NCT02176213|Cyclophosphamide|cyclophosphamide
1168603|NCT02176213|Dexamethasone|dexamethasone
1168604|NCT02176174|Ethnic group|ethnic group
1168605|NCT02176174|Cardiovascular disease|cardiovascular disease
1168606|NCT02176174|Atherosclerosis|atherosclerosis
1168607|NCT02176161|Prostate Cancer|prostate cancer
1168608|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
1168609|NCT02176148|cutaneous lupus|cutaneous lupus
1168610|NCT02176148|systemic lupus|systemic lupus
1168611|NCT02176148|systemic therapy|systemic therapy
1168612|NCT02176148|medication|medication
1168613|NCT02176135|HIV|hiv
1168614|NCT02176135|HAART suppressed|haart suppressed
1168615|NCT02176135|Auranofin|auranofin
1168616|NCT02176135|HIV latent reservoir|hiv latent reservoir
1168617|NCT02176057|trachoma|trachoma
1168618|NCT02176044|Nitric Oxide|nitric oxide
1168619|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
1168620|NCT02176044|Spatial Working Memory|spatial working memory
1168621|NCT02176044|Psychosis|psychosis
1168622|NCT02176044|Schizophrenia|schizophrenia
1168623|NCT02176031|Graft Versus Host Disease|graft versus host disease
1168624|NCT02176018|Episodic Migraine|episodic migraine
1168625|NCT02176018|Migraine|migraine
1168626|NCT02176018|Headache|headache
1168627|NCT02175979|postoperative ileus|postoperative ileus
1168628|NCT02175979|anastomotic leak|anastomotic leak
1168629|NCT02175979|colorectal surgery|colorectal surgery
1168630|NCT02175979|inflammation|inflammation
1168631|NCT02175953|caregiver burden|caregiver burden
1168632|NCT02175953|stress|stress
1168633|NCT02175953|depression|depression
1168634|NCT02175953|dementia|dementia
1168635|NCT02175927|Helicobacter pylori|helicobacter pylori
1168636|NCT02175927|Treatment Failure|treatment failure
1168637|NCT02175927|second-line therapy|second-line therapy
1168638|NCT02175914|Erythromycin|erythromycin
1168639|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
1168640|NCT02175914|APC gene|apc gene
1168641|NCT02175914|nonsense mutations|nonsense mutations
1168642|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
1168643|NCT02175901|antibiotic|antibiotic
1168644|NCT02175888|Iron bio availability|iron bio availability
1168645|NCT02175888|Hepcidin|hepcidin
1168646|NCT02175888|Iron absorption|iron absorption
1168647|NCT02175875|ticagrelor|ticagrelor
1168648|NCT02175875|platelet function test|platelet function test
1168649|NCT02175875|comatose|comatose
1168650|NCT02175875|PCI|pci
1168651|NCT02175875|naso-gastric tube|naso-gastric tube
1168652|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
1168653|NCT02175862|Trauma|trauma
1168654|NCT02175862|Early retirement|early retirement
1168655|NCT02175862|ISS|iss
1168656|NCT02175862|Quality of life|quality of life
1168657|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
1168658|NCT02175849|Social Network Analysis|social network analysis
1168659|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
1168660|NCT02175836|Heart Failure|heart failure
1168661|NCT02175836|Risk Stratification|risk stratification
1168662|NCT02175836|Autonomic Nervous System|autonomic nervous system
1168663|NCT02175836|Heart Rate|heart rate
1168664|NCT02175836|Repolarization|repolarization
1168665|NCT02175823|Cancer survivors|cancer survivors
1168666|NCT02175823|circadian rhythm|circadian rhythm
1168667|NCT02175823|Elderly Patients|elderly patients
1168668|NCT02175823|frailty|frailty
1168669|NCT02175810|Obesity|obesity
1168670|NCT02175810|Bariatric surgery|bariatric surgery
1168671|NCT02175810|physical activity|physical activity
1168672|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
1168673|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
1168674|NCT02175784|Blood glucose|blood glucose
1168675|NCT02175784|insulin|insulin
1168676|NCT02175784|ipragliflozin|ipragliflozin
1168677|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
1168678|NCT02175732|Type 1 Diabetes|type 1 diabetes
1168679|NCT02175732|Distress|distress
1168680|NCT02175719|Torticollis|torticollis
1168681|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
1168682|NCT02175693|Torticollis|torticollis
1168683|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
1168684|NCT02175680|HIV-1|hiv-1
1168685|NCT02175680|HIV|hiv
1168686|NCT02175680|Treatment Substitution|treatment substitution
1168687|NCT02175680|PRO 140|pro 140
1168688|NCT02175680|PRO140|pro140
1168689|NCT02175680|CytoDyn|cytodyn
1168690|NCT02175680|Amarex|amarex
1168691|NCT02175667|Global postural reeducation|global postural reeducation
1168692|NCT02175667|Stabilometry|stabilometry
1168693|NCT02175667|Postural Sway|postural sway
1168694|NCT02175667|Range of motion|range of motion
1168695|NCT02175667|Personality traits|personality traits
1168696|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
1168697|NCT02175654|RAS/BRAF mutation|ras/braf mutation
1168698|NCT02175654|Regorafenib|regorafenib
1168699|NCT02175654|FOLFOXIRI|folfoxiri
1168700|NCT02175654|Bevacizumab|bevacizumab
1168701|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
1168702|NCT02175641|Serious Mental Illness|serious mental illness
1168703|NCT02175641|Effectiveness trial|effectiveness trial
1168704|NCT02175641|Supportive housing|supportive housing
1168705|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
1168706|NCT02175628|Ultrasound|ultrasound
1168707|NCT02175628|Breast|breast
1168708|NCT02175628|Angiography|angiography
1168709|NCT02175615|CYCLOSPORINE|cyclosporine
1168710|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
1168711|NCT02175615|PROPHYLAXIS|prophylaxis
1168712|NCT02175615|CHILDREN|children
1168713|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
1168714|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
1168715|NCT02175589|Monozygous|monozygous
1168716|NCT02175589|MEFV|mefv
1168717|NCT02175589|Colchicine|colchicine
1168718|NCT02175589|Serum Amyloid A|serum amyloid a
1168719|NCT02175563|Chest|chest
1168720|NCT02175563|Compression|compression
1168721|NCT02175550|partially edentulous|partially edentulous
1168722|NCT02175550|maxilla|maxilla
1168723|NCT02175550|implants|implants
1168724|NCT02175550|Conical connection|conical connection
1168725|NCT02175550|Nobel Biocare|nobel biocare
1168726|NCT02175550|NobelReplace|nobelreplace
1168727|NCT02175550|Immediate loading|immediate loading
1168728|NCT02175550|One- stage surgery|one- stage surgery
1168729|NCT02175550|Two- stage surgery|two- stage surgery
1168730|NCT02175550|supported restoration|supported restoration
1168731|NCT02175550|patients|patients
1168732|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1168733|NCT02175537|Disease management|disease management
1168734|NCT02175537|Obesity|obesity
1168735|NCT02175537|Social Network|social network
1168736|NCT02175537|Chronic disease|chronic disease
1168737|NCT02175537|Prevention and control|prevention and control
1168738|NCT02175537|Education|education
1168739|NCT02175524|nut chewing|nut chewing
1168740|NCT02175511|Home Blood Pressure|home blood pressure
1168741|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
1168742|NCT02175511|Telemonitoring|telemonitoring
1168743|NCT02175511|Hypertension|hypertension
1168744|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
1168745|NCT02175472|Parkinson's disease|parkinson's disease
1168746|NCT02175472|Light therapy|light therapy
1168747|NCT02175472|Circadian rhythm|circadian rhythm
1168748|NCT02175446|Breast cancer|breast cancer
1168749|NCT02175446|HER2Negative|her2negative
1168750|NCT02175446|Second line treatment|second line treatment
1168751|NCT02175446|HER2-|her2-
1168752|NCT02175446|MBC|mbc
1168753|NCT02175446|Metastatic|metastatic
1168754|NCT02175446|Metastatic breast cancer|metastatic breast cancer
1168755|NCT02175446|bevacizumab|bevacizumab
1168756|NCT02175446|eribulin|eribulin
1168757|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
1168758|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
1168759|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
1168760|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
1168761|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
1168762|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
1168763|NCT02175433|AGS67C|ags67c
1168764|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1168765|NCT02175433|AGS67E|ags67e
1168766|NCT02175420|BCG|bcg
1168767|NCT02175420|Salmonella|salmonella
1168768|NCT02175420|Trained immunity|trained immunity
1168769|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
1168770|NCT02175407|Healthy subjects|healthy subjects
1168771|NCT02175407|ASP1707|asp1707
1168772|NCT02175407|Itraconazole|itraconazole
1168773|NCT02175381|Metastatic NSCLC|metastatic nsclc
1168774|NCT02175381|Elderly|elderly
1168775|NCT02175381|1st Line|1st line
1168776|NCT02175381|Platinum-based treatment|platinum-based treatment
1168777|NCT02175368|total etch protocol|total etch protocol
1168778|NCT02175368|direct filling therapy|direct filling therapy
1168779|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
1168780|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1168781|NCT02175277|Darbepoetin alfa|darbepoetin alfa
1168782|NCT02175277|low risk MDS|low risk mds
1168783|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
1168784|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
1168785|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
1168786|NCT02175251|rTMS|rtms
1168787|NCT02175251|Schizophrenia|schizophrenia
1168788|NCT02175251|high frequency rTMS|high frequency rtms
1168789|NCT02175251|low frequency rTMS|low frequency rtms
1168790|NCT02175251|AHRS|ahrs
1168791|NCT02175251|SAPS SANS PANSS|saps sans panss
1168792|NCT02175251|GAF|gaf
1168793|NCT02175251|UKU|uku
1168794|NCT02175225|Brain hemorrhage|brain hemorrhage
1168795|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
1168796|NCT02175225|Bleeding in the brain|bleeding in the brain
1168797|NCT02175225|Deferoxamine|deferoxamine
1168798|NCT02175225|iDEF trial|idef trial
1168799|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
1168800|NCT02175199|Contact lens|contact lens
1168801|NCT02175199|Vision care|vision care
1168802|NCT02175199|Daily wear|daily wear
1168803|NCT02175199|Color contact lens|color contact lens
1168804|NCT02175186|Gastritis|gastritis
1168805|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
1168806|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
1168807|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
1168808|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
1168809|NCT02175160|Driver reaction time|driver reaction time
1168810|NCT02175134|tuberculosis|tuberculosis
1168811|NCT02175134|peritonitis|peritonitis
1168812|NCT02175134|laparoscopy|laparoscopy
1168813|NCT02175108|Cerebral palsy|cerebral palsy
1168814|NCT02175108|Adolescents|adolescents
1168815|NCT02175108|Adults|adults
1168816|NCT02175108|Diet|diet
1168817|NCT02175108|Activity|activity
1168818|NCT02175108|Metabolic Syndrome|metabolic syndrome
1168819|NCT02175095|regorafenib|regorafenib
1168820|NCT02175095|fluorothymidine|fluorothymidine
1168821|NCT02175095|positron emission tomography|positron emission tomography
1168822|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
1168823|NCT02175082|Parkinson Disease|parkinson disease
1168824|NCT02175082|Exercise|exercise
1168825|NCT02175082|Rehabilitation|rehabilitation
1168826|NCT02175082|Physical Therapy|physical therapy
1168827|NCT02175082|Cycling|cycling
1168828|NCT02175069|Shoulder surgery|shoulder surgery
1168829|NCT02175056|First In Human|first in human
1168830|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
1168831|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
1168832|NCT02175030|Emergency contraception|emergency contraception
1168833|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
1168834|NCT02175030|Copper IUD|copper iud
1168835|NCT02175017|ONO-4538|ono-4538
1168836|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1168838|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
1168839|NCT02175004|TTR|ttr
1168840|NCT02175004|Transthyretin|transthyretin
1168841|NCT02175004|Amyloidosis|amyloidosis
1168842|NCT02174978|Malaria vaccine|malaria vaccine
1168843|NCT02174952|Parenting interventions|parenting interventions
1168844|NCT02174952|ADHD|adhd
1168845|NCT02174952|Family functioning|family functioning
1168846|NCT02174952|Parent Training|parent training
1168847|NCT02174939|cilostazol|cilostazol
1168848|NCT02174939|progenitor cells|progenitor cells
1168849|NCT02174939|coronary artery disease|coronary artery disease
1168850|NCT02174939|myocardial infarction|myocardial infarction
1168851|NCT02174939|angiogenesis|angiogenesis
1168852|NCT02174939|biological markers|biological markers
1168853|NCT02174939|endothelial function|endothelial function
1168854|NCT02174913|Awakening time|awakening time
1168855|NCT02174913|Bispectral index|bispectral index
1168856|NCT02174913|clinical signs|clinical signs
1168857|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
1168858|NCT02174913|spine surgery|spine surgery
1168859|NCT02174900|G6PD deficiency|g6pd deficiency
1168860|NCT02174900|safety|safety
1168861|NCT02174900|transmission|transmission
1168862|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1168863|NCT02174887|liver metastases|liver metastases
1168864|NCT02174861|Chronic Migraine|chronic migraine
1168865|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
1168867|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
1168868|NCT02174848|NBIA|nbia
1168869|NCT02174848|Deferiprone|deferiprone
1168870|NCT02174848|Ferriprox|ferriprox
1168871|NCT02174835|Pharmacokinetics|pharmacokinetics
1168872|NCT02174835|Healthy Volunteers|healthy volunteers
1168873|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
1168874|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
1168875|NCT02174822|Drug-drug interaction|drug-drug interaction
1168876|NCT02174822|Pharmacokinetics|pharmacokinetics
1168877|NCT02174822|Healthy Volunteers|healthy volunteers
1168878|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
1168879|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
1168880|NCT02174809|Pregnancy|pregnancy
1168881|NCT02174809|Gestational Weight Gain|gestational weight gain
1168882|NCT02174809|Primary Care|primary care
1168883|NCT02174809|Guidelines|guidelines
1168884|NCT02174796|Pectus excavatum|pectus excavatum
1168885|NCT02174796|cardiac output|cardiac output
1168886|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
1168887|NCT02174783|Weight Loss|weight loss
1168888|NCT02174783|Diet, Mediterranean|diet, mediterranean
1168889|NCT02174783|Diet, Reducing|diet, reducing
1168890|NCT02174783|protein sparing modified diet|protein sparing modified diet
1168891|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
1168892|NCT02174744|Numerical scale|numerical scale
1168893|NCT02174744|Algoplus® scale|algoplus® scale
1168894|NCT02174744|Doloplus® scale|doloplus® scale
1168895|NCT02174731|Renal,|renal,
1168896|NCT02174731|CKD,|ckd,
1168897|NCT02174731|Epoetin alfa,|epoetin alfa,
1168898|NCT02174731|Roxadustat,|roxadustat,
1168899|NCT02174731|dialysis,|dialysis,
1168900|NCT02174731|anemia|anemia
1168901|NCT02174718|Cholecalciferol|cholecalciferol
1168902|NCT02174718|Transdermal patch|transdermal patch
1168903|NCT02174705|vaccination|vaccination
1168904|NCT02174705|pain management|pain management
1168905|NCT02174705|sucrose|sucrose
1168906|NCT02174705|rotavirus|rotavirus
1168907|NCT02174666|Aglycones|aglycones
1168908|NCT02174666|Isoflavones|isoflavones
1168909|NCT02174666|Red clover|red clover
1168910|NCT02174666|Osteopenia|osteopenia
1168911|NCT02174666|Menopause|menopause
1168912|NCT02174666|Bone turnover|bone turnover
1168913|NCT02174666|Bone mineral density|bone mineral density
1168914|NCT02174640|Coffee|coffee
1168915|NCT02174640|Polyphenolics|polyphenolics
1168916|NCT02174627|Renal,|renal,
1168917|NCT02174627|CKD,|ckd,
1168918|NCT02174627|Roxadustat,|roxadustat,
1168919|NCT02174627|anemia,|anemia,
1168920|NCT02174627|non-dialysis|non-dialysis
1168921|NCT02174614|Cocaine use disorder|cocaine use disorder
1168922|NCT02174601|bowel preparation|bowel preparation
1168923|NCT02174601|coolprep|coolprep
1168924|NCT02174601|colonoscopy|colonoscopy
1168925|NCT02174601|prediction model|prediction model
1168926|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
1236088|NCT01868360|cornea|cornea
1168927|NCT02174575|Hepatectomy|hepatectomy
1168928|NCT02174562|Type 2 diabetes|type 2 diabetes
1168929|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
1168930|NCT02174549|Hypoxia|hypoxia
1168931|NCT02174549|Embolization|embolization
1168932|NCT02174549|Tirapazamine|tirapazamine
1168933|NCT02174523|pharmacokinetic|pharmacokinetic
1168934|NCT02174523|lurasidone|lurasidone
1168935|NCT02174523|multiple dose|multiple dose
1168936|NCT02174510|pharmacokinetic|pharmacokinetic
1168937|NCT02174510|lurasidone|lurasidone
1168938|NCT02174510|single dose|single dose
1168939|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
1168940|NCT02174497|Bowel Preparation|bowel preparation
1168941|NCT02174497|Safety|safety
1168942|NCT02174497|Tolerability|tolerability
1168943|NCT02174484|Pacemaker|pacemaker
1168944|NCT02174484|Remote monitoring|remote monitoring
1168945|NCT02174484|Remote follow-up|remote follow-up
1168946|NCT02174484|Home monitoring|home monitoring
1168947|NCT02174484|Periodic IEGM|periodic iegm
1168948|NCT02174484|Intracardiac electrogram|intracardiac electrogram
1168949|NCT02174471|Aortic Stenosis|aortic stenosis
1168950|NCT02174471|Aortic Valve Replacement|aortic valve replacement
1168951|NCT02174471|T1 Mapping|t1 mapping
1168952|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
1168953|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
1168954|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
1168955|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
1168956|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
1168957|NCT02174445|Imatinib|imatinib
1168958|NCT02174445|Nilotinib|nilotinib
1168959|NCT02174432|Itch|itch
1168960|NCT02174432|Chronic Itch|chronic itch
1168961|NCT02174432|Nalbupine|nalbupine
1168962|NCT02174419|Itch|itch
1168963|NCT02174419|Chronic Itch|chronic itch
1168964|NCT02174419|nalbuphine|nalbuphine
1168965|NCT02174406|Ultrasound|ultrasound
1168966|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
1168967|NCT02174406|14-119|14-119
1168968|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
1168969|NCT02174367|Liver fibrosis|liver fibrosis
1168970|NCT02174367|Fatty liver disease|fatty liver disease
1168971|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1168972|NCT02174367|Transient elastography|transient elastography
1168973|NCT02174367|Fibroscan|fibroscan
1168974|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
1168975|NCT02174367|Alanine aminotransferase|alanine aminotransferase
1168976|NCT02174367|Liver function tests|liver function tests
1168977|NCT02174354|Psoriasis|psoriasis
1168978|NCT02174354|Methotrexate|methotrexate
1168979|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
1168980|NCT02174354|Injury of Liver|injury of liver
1168981|NCT02174341|Chikungunya fever|chikungunya fever
1168982|NCT02174341|Chikungunya Virus|chikungunya virus
1168983|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
1168984|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
1168985|NCT02174289|Heart Failure|heart failure
1168986|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1168987|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
1168988|NCT02174250|PD|pd
1168989|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
1168990|NCT02174224|Violence|violence
1168991|NCT02174224|At-risk youth|at-risk youth
1168992|NCT02174224|Intentional Injury|intentional injury
1168993|NCT02174224|Violence Intervention|violence intervention
1168994|NCT02174224|Youth|youth
1168995|NCT02174224|recidivism|recidivism
1168996|NCT02174198|Immediate implant|immediate implant
1168997|NCT02174198|bone graft|bone graft
1168998|NCT02174198|immediate restoration|immediate restoration
1168999|NCT02174185|bladder cancer|bladder cancer
1169000|NCT02174185|conduit diversion|conduit diversion
1169001|NCT02174185|orthotopic neobladder|orthotopic neobladder
1169002|NCT02174185|health-related quality of life|health-related quality of life
1169003|NCT02174185|validated questionnaire|validated questionnaire
1169004|NCT02174146|leptin|leptin
1169005|NCT02174146|visfatin|visfatin
1169006|NCT02174146|chronic periodontitis|chronic periodontitis
1169007|NCT02174146|diabetes mellitus|diabetes mellitus
1169008|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
1169009|NCT02174133|left ventricular assist device|left ventricular assist device
1169010|NCT02174133|endothelial function|endothelial function
1169011|NCT02174133|microvascular perfusion|microvascular perfusion
1169012|NCT02174133|microparticles|microparticles
1169013|NCT02174107|Health economics|health economics
1169014|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
1169015|NCT02174107|Radiation therapy|radiation therapy
1169016|NCT02174107|Painful spine metastases|painful spine metastases
1333245|NCT01443845|Exacerbations|exacerbations
1333246|NCT01443845|Roflumilast|roflumilast
1236205|NCT01867801|PCI|pci
1169017|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
1169018|NCT02174068|Paracetamol|paracetamol
1169019|NCT02174068|Nefopam|nefopam
1169020|NCT02174068|Pharmacokinetic|pharmacokinetic
1169021|NCT02174068|Drug interaction|drug interaction
1169022|NCT02174055|Depression|depression
1169023|NCT02174055|14-101|14-101
1169024|NCT02174029|Atrophy|atrophy
1169025|NCT02174029|Ventilator|ventilator
1169026|NCT02174029|Induced|induced
1169027|NCT02174029|Diaphragm|diaphragm
1169028|NCT02174029|Dysfunction|dysfunction
1169029|NCT02174016|Intensive Care Units|intensive care units
1169030|NCT02174016|Pediatric|pediatric
1169031|NCT02174003|whole body hyperthermia|whole body hyperthermia
1169032|NCT02174003|depression|depression
1169033|NCT02174003|fibromyalgia|fibromyalgia
1169034|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
1169035|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
1169036|NCT02174003|open treatment|open treatment
1169037|NCT02173990|adenocarcinoma|adenocarcinoma
1169038|NCT02173990|colon and/or rectum|colon and/or rectum
1169039|NCT02173977|GnRH Agonist|gnrh agonist
1169040|NCT02173977|GnRH Antagonist|gnrh antagonist
1169041|NCT02173977|OHSS|ohss
1169042|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
1169043|NCT02173964|positron emission tomography|positron emission tomography
1169044|NCT02173964|computed tomography|computed tomography
1169045|NCT02173964|bowel|bowel
1169046|NCT02173964|pinaverium bromide|pinaverium bromide
1169047|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
1169048|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
1169049|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
1169050|NCT02173951|Deferiprone|deferiprone
1169051|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
1169052|NCT02173951|Transfusion units|transfusion units
1169053|NCT02173938|Smokers|smokers
1169054|NCT02173938|outpatient|outpatient
1169055|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
1169056|NCT02173873|Age related macular degeneration|age related macular degeneration
1169057|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
1169058|NCT02173860|Coronary artery disease|coronary artery disease
1169059|NCT02173860|Valvular heart disease|valvular heart disease
1169060|NCT02173860|Fractional flow reserve|fractional flow reserve
1169061|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
1169062|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
1169063|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
1169064|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
1169065|NCT02173847|femtosecond laser|femtosecond laser
1169066|NCT02173847|laser welding|laser welding
1169067|NCT02173834|Brown Adipose Tissue|brown adipose tissue
1169068|NCT02173834|Weight|weight
1169069|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
1169070|NCT02173756|chemotherapy|chemotherapy
1169071|NCT02173756|mucositis|mucositis
1169072|NCT02173756|systemic opioids|systemic opioids
1169073|NCT02173756|morphine|morphine
1169074|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
1169075|NCT02173704|Meningitis|meningitis
1169076|NCT02173704|Infants|infants
1169077|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
1169078|NCT02173626|Mindfulness|mindfulness
1169079|NCT02173613|infection lung elderly patients|infection lung elderly patients
1169080|NCT02173600|Cardiovascular risk|cardiovascular risk
1169081|NCT02173600|Primary prevention|primary prevention
1169082|NCT02173600|Intensive dietary counselling|intensive dietary counselling
1169083|NCT02173600|Physical exercise|physical exercise
1169084|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
1169085|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
1169086|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
1169087|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
1169088|NCT02173561|combat|combat
1169089|NCT02173561|military|military
1169090|NCT02173561|CPT|cpt
1169091|NCT02173561|group therapy|group therapy
1169092|NCT02173548|heart failure|heart failure
1169093|NCT02173548|HFpEF|hfpef
1169094|NCT02173548|diastole|diastole
1169095|NCT02173548|diastolic heart failure|diastolic heart failure
1169096|NCT02173548|inflammation|inflammation
1169097|NCT02173548|interleukin-1|interleukin-1
1169098|NCT02173548|C-reactive protein|c-reactive protein
1169099|NCT02173522|Prostate cancer|prostate cancer
1169100|NCT02173522|Prostate artery embolization|prostate artery embolization
1169101|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
1169102|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
1169103|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
1169104|NCT02173457|Chiglitazar|chiglitazar
1169105|NCT02173457|Sitagliptin|sitagliptin
1169106|NCT02173457|diabetes|diabetes
1169107|NCT02173457|type 2 diabetes|type 2 diabetes
1169108|NCT02173444|in-vitro fertilization|in-vitro fertilization
1169109|NCT02173444|ovarian stimulation|ovarian stimulation
1169110|NCT02173431|BMI|bmi
1169111|NCT02173431|Pressure|pressure
1169112|NCT02173431|Bedsore|bedsore
1169113|NCT02173418|Postoperative pain|postoperative pain
1169114|NCT02173418|Acute postoperative pain|acute postoperative pain
1169395|NCT02171273|Circadian|circadian
1169115|NCT02173418|Chronic postoperative pain|chronic postoperative pain
1169116|NCT02173418|Shoulder pain|shoulder pain
1169117|NCT02173418|Thoracotomy|thoracotomy
1169118|NCT02173418|Thoracoscopy|thoracoscopy
1169119|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
1169120|NCT02173405|Pelvic pain|pelvic pain
1169121|NCT02173405|Trigger points + injections|trigger points + injections
1169122|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
1169123|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
1169124|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
1169125|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
1169126|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
1169127|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
1169128|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
1169129|NCT02173405|Oculinum|oculinum
1169130|NCT02173379|Absorb™ BVS|absorb™ bvs
1169131|NCT02173379|Angioplasty|angioplasty
1169132|NCT02173379|Bioabsorbable|bioabsorbable
1169133|NCT02173379|BVS|bvs
1169134|NCT02173379|Coronary Artery Disease|coronary artery disease
1169135|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1169136|NCT02173379|Coronary artery restenosis|coronary artery restenosis
1169137|NCT02173379|Coronary artery stenosis|coronary artery stenosis
1169138|NCT02173379|Coronary scaffold|coronary scaffold
1169139|NCT02173379|Coronary Stent|coronary stent
1169140|NCT02173379|Drug eluting stents|drug eluting stents
1169141|NCT02173379|Everolimus|everolimus
1169142|NCT02173379|Myocardial ischemia|myocardial ischemia
1169143|NCT02173379|Stent thrombosis|stent thrombosis
1169144|NCT02173379|Stents|stents
1169145|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
1169146|NCT02173314|Long term foster care|long term foster care
1169241|NCT02172742|BIA 2-093|bia 2-093
1169147|NCT02173314|child abuse and neglect|child abuse and neglect
1169148|NCT02173262|Breast|breast
1169149|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
1169150|NCT02173236|Early Dental Implant Loading|early dental implant loading
1169151|NCT02173210|Premature birth|premature birth
1169152|NCT02173210|Premature delivery|premature delivery
1169153|NCT02173210|Metabolomics|metabolomics
1169154|NCT02173210|Microbiota|microbiota
1169155|NCT02173210|Genetics|genetics
1169156|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
1169157|NCT02173197|Occupational Therapy|occupational therapy
1169158|NCT02173197|Complex patients|complex patients
1169159|NCT02173197|Occupational performance problem|occupational performance problem
1169160|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
1169161|NCT02173184|bacterial vaginosis|bacterial vaginosis
1169162|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
1169163|NCT02173171|Melanoma|melanoma
1169164|NCT02173171|talimogene laherparepvec|talimogene laherparepvec
1169165|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1169166|NCT02173145|cough|cough
1169167|NCT02173145|immunomodulation|immunomodulation
1169168|NCT02173145|macrolide|macrolide
1169169|NCT02173119|Hepatocellular|hepatocellular
1169170|NCT02173119|Carcinoma|carcinoma
1169171|NCT02173119|HCC|hcc
1169172|NCT02173119|lipiodol|lipiodol
1169173|NCT02173093|Neuroblastoma|neuroblastoma
1169174|NCT02173093|Osteosarcoma|osteosarcoma
1169175|NCT02173093|Solid tumor|solid tumor
1169176|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
1169177|NCT02173093|Bispecific antibodies|bispecific antibodies
1169178|NCT02173093|Activated T cells|activated t cells
1169179|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
1169180|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1169181|NCT02173080|quality of life|quality of life
1169182|NCT02173080|patient reported outcome tool|patient reported outcome tool
1169183|NCT02173067|Diabetes mellitus|diabetes mellitus
1169184|NCT02173067|Epinephrine|epinephrine
1169185|NCT02173067|Anesthesia, Dental|anesthesia, dental
1169186|NCT02173067|lidocaine|lidocaine
1169187|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
1169188|NCT02173054|Acne|acne
1169189|NCT02173054|Moisturizer|moisturizer
1169190|NCT02173054|Efficacy|efficacy
1169191|NCT02173054|Irritation|irritation
1169192|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
1169193|NCT02173041|Substance Use Disorder,|substance use disorder,
1169194|NCT02173041|Community based intervention|community based intervention
1169195|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
1333247|NCT01443845|Daliresp|daliresp
1169196|NCT02173028|Remote Patient Management system;|remote patient management system;
1169197|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1169198|NCT02173015|accidental falls|accidental falls
1169199|NCT02173015|older adults|older adults
1169200|NCT02173015|long-term care|long-term care
1169201|NCT02173015|nursing home|nursing home
1169202|NCT02173015|postural balance|postural balance
1169203|NCT02173002|Telemedicine|telemedicine
1169204|NCT02173002|Patient empowerment|patient empowerment
1169205|NCT02173002|Integrated care|integrated care
1169206|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
1169207|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
1169208|NCT02172989|Radio-guided surgery|radio-guided surgery
1169209|NCT02172989|breast cancer|breast cancer
1169210|NCT02172976|pancreas cancer|pancreas cancer
1169211|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1169212|NCT02172976|Folfirinox|folfirinox
1169213|NCT02172976|gemcitabine|gemcitabine
1169214|NCT02172963|Stem Cell Transplantation|stem cell transplantation
1169215|NCT02172963|Decidual Stromal Cells|decidual stromal cells
1169216|NCT02172937|Stem Cell Transplantation|stem cell transplantation
1169217|NCT02172937|Decidual Stromal Cells|decidual stromal cells
1169218|NCT02172924|Stem Cell Transplantation|stem cell transplantation
1169219|NCT02172924|Decidual Stromal Cells|decidual stromal cells
1169220|NCT02172911|Cervical cancer|cervical cancer
1169221|NCT02172911|Papillomavirus|papillomavirus
1169222|NCT02172911|Chemoradiation|chemoradiation
1169223|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
1169224|NCT02172911|Persistent cervical cancer|persistent cervical cancer
1169225|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
1169226|NCT02172885|cell infusion|cell infusion
1169227|NCT02172872|Newly diagnosed|newly diagnosed
1169228|NCT02172872|AML|aml
1169229|NCT02172872|Elderly|elderly
1169230|NCT02172872|Decitabine|decitabine
1169231|NCT02172872|Transplant|transplant
1169232|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
1169233|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
1169234|NCT02172820|contingency management|contingency management
1169235|NCT02172768|pharmacokinetics|pharmacokinetics
1169236|NCT02172768|alternate dosing|alternate dosing
1169237|NCT02172768|micafungin|micafungin
1169238|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
1169239|NCT02172755|BIA 2-093|bia 2-093
1169240|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
1169242|NCT02172729|adductor canal block|adductor canal block
1169243|NCT02172729|healthy volunteers|healthy volunteers
1169244|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
1169245|NCT02172729|lower limb|lower limb
1169246|NCT02172729|duration|duration
1169247|NCT02172729|Muscle Strength|muscle strength
1169248|NCT02172729|Anesthetics, Local|anesthetics, local
1169249|NCT02172729|Sensation|sensation
1169250|NCT02172703|TBI|tbi
1169251|NCT02172703|SAH|sah
1169252|NCT02172703|ICP|icp
1169253|NCT02172703|non invasive measurement|non invasive measurement
1169254|NCT02172690|Gastric Cancer|gastric cancer
1169255|NCT02172690|Laparoscopic Staging|laparoscopic staging
1169256|NCT02172690|Cytology|cytology
1169257|NCT02172690|Peritoneal Metastases|peritoneal metastases
1169258|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
1169259|NCT02172664|dental adhesive|dental adhesive
1169260|NCT02172664|retention|retention
1169261|NCT02172664|enamel margin discoloration|enamel margin discoloration
1169262|NCT02172664|self etch|self etch
1169263|NCT02172664|selective etch procedures|selective etch procedures
1169264|NCT02172651|Vitamin D|vitamin d
1169265|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
1169266|NCT02172651|Stage IV colon cancer|stage iv colon cancer
1169267|NCT02172651|Resectable liver metastases|resectable liver metastases
1169268|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
1169269|NCT02172638|ERAS|eras
1169270|NCT02172638|Fast-Track|fast-track
1169271|NCT02172638|Ovarian cancer|ovarian cancer
1169272|NCT02172638|Gynecologic surgery|gynecologic surgery
1169273|NCT02172638|Gynecology oncology|gynecology oncology
1169274|NCT02172638|Median length of stay|median length of stay
1169275|NCT02172638|Readmission rate|readmission rate
1169276|NCT02172638|Surgery related complications|surgery related complications
1169277|NCT02172638|Cost|cost
1169278|NCT02172625|Athletic performance|athletic performance
1169279|NCT02172625|Running|running
1169280|NCT02172625|Dietary supplementation|dietary supplementation
1169281|NCT02172625|Quality of life|quality of life
1169282|NCT02172625|Running performance|running performance
1169283|NCT02172625|oxidative damage|oxidative damage
1169284|NCT02172612|Anticholinergic drugs|anticholinergic drugs
1169285|NCT02172599|sit-stand workstation|sit-stand workstation
1169286|NCT02172599|workplace|workplace
1169287|NCT02172599|multi-component intervention|multi-component intervention
1169288|NCT02172599|randomised control trial design|randomised control trial design
1169289|NCT02172599|physical activity|physical activity
1169290|NCT02172599|sitting|sitting
1169291|NCT02172599|sedentary behaviour|sedentary behaviour
1169292|NCT02172599|process evaluation|process evaluation
1169293|NCT02172599|health|health
1169294|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
1169295|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1169296|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1169297|NCT02172365|TKI failure|tki failure
1169298|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
1169299|NCT02172092|Diabetes|diabetes
1169300|NCT02172092|Ketoacidosis|ketoacidosis
1169301|NCT02172092|fluid shift|fluid shift
1169396|NCT02171273|Genetic|genetic
1169302|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
1169303|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
1169304|NCT02172066|Childhood maltreatment|childhood maltreatment
1169305|NCT02172053|Workplace|workplace
1169306|NCT02172053|Industrial workers|industrial workers
1169307|NCT02172053|Resistance exercise|resistance exercise
1169308|NCT02172053|Fatigue|fatigue
1169309|NCT02172053|Occupational risk|occupational risk
1169310|NCT02172053|Physical therapy|physical therapy
1169311|NCT02172040|High blood pressure|high blood pressure
1169312|NCT02172040|Systolic blood pressure|systolic blood pressure
1169313|NCT02172040|Diastolic blood pressure|diastolic blood pressure
1169314|NCT02172040|Antihypertensive|antihypertensive
1169315|NCT02172014|Mechanical Ventilation|mechanical ventilation
1169316|NCT02172014|Sedation|sedation
1169317|NCT02172014|Fentanyl|fentanyl
1169318|NCT02172014|Midazolam|midazolam
1169319|NCT02172014|Comfort behavior scale|comfort behavior scale
1169320|NCT02172001|IDA|ida
1169321|NCT02172001|Iron deficiency|iron deficiency
1169322|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
1169323|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
1169324|NCT02171988|propranolol|propranolol
1169325|NCT02171988|bisoprolol|bisoprolol
1169326|NCT02171988|pyridostigmine|pyridostigmine
1169327|NCT02171975|Spinal anaesthesia|spinal anaesthesia
1169328|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
1169329|NCT02171975|Paramedian spinal|paramedian spinal
1169330|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
1169331|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
1169332|NCT02171962|Chinese patient|chinese patient
1169333|NCT02171949|Chronic hepatitis|chronic hepatitis
1169334|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
1169335|NCT02171936|Pain|pain
1169336|NCT02171936|Precariousness|precariousness
1169337|NCT02171936|EPICES Score|epices score
1169338|NCT02171936|CETD|cetd
1169339|NCT02171923|depression|depression
1169340|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1169341|NCT02171910|Sedation|sedation
1169342|NCT02171871|EFFECTS,|effects,
1169343|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
1169344|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
1169345|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
1169346|NCT02171858|Stroke|stroke
1169347|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
1169348|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
1169349|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
1169350|NCT02171819|Influenza|influenza
1169351|NCT02171819|Avian|avian
1169352|NCT02171819|H5N1|h5n1
1169353|NCT02171819|Vaccine|vaccine
1169354|NCT02171390|Hypogonadism|hypogonadism
1169355|NCT02171390|Endothelial dysfunction|endothelial dysfunction
1169356|NCT02171390|Insulin resistance|insulin resistance
1169357|NCT02171390|Inflammation|inflammation
1169358|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
1169359|NCT02171377|COPD|copd
1169360|NCT02171377|electrical stimulation|electrical stimulation
1169361|NCT02171377|Rehabilitation|rehabilitation
1169362|NCT02171377|exercise test|exercise test
1169363|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
1169364|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
1169365|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
1169366|NCT02171338|Procalcitonin|procalcitonin
1169367|NCT02171338|Antibiotic therapy|antibiotic therapy
1169368|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
1169369|NCT02171325|irinotecan|irinotecan
1169370|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
1169371|NCT02171312|Dizziness|dizziness
1169372|NCT02171312|Imbalance|imbalance
1169373|NCT02171286|KRAS|kras
1169374|NCT02171286|EGFR|egfr
1169375|NCT02171286|BRAF|braf
1169376|NCT02171286|NRAS and HRAS|nras and hras
1169377|NCT02171286|PIK3CA|pik3ca
1169378|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
1169379|NCT02171286|HER2|her2
1169380|NCT02171286|IDH1 and IDH2|idh1 and idh2
1169382|NCT02171286|TP53|tp53
1169383|NCT02171286|c-KIT|c-kit
1169384|NCT02171286|STAT1&3|stat1&3
1169385|NCT02171286|PDGFRA|pdgfra
1169386|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
1169387|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1169388|NCT02171286|Advanced melanoma|advanced melanoma
1169389|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
1169390|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
1169391|NCT02171286|Circulating Tumor DNA|circulating tumor dna
1169392|NCT02171273|Sleep|sleep
1169393|NCT02171273|Aging|aging
1169394|NCT02171273|Metabolism|metabolism
1169397|NCT02171273|Alertness|alertness
1169398|NCT02171260|Tumors|tumors
1169399|NCT02171260|Lymphomas|lymphomas
1169400|NCT02171260|Solid Tumors|solid tumors
1169401|NCT02171260|Pediatric|pediatric
1169402|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
1169403|NCT02171247|contrast|contrast
1169404|NCT02171234|Epilepsy|epilepsy
1169405|NCT02171234|BIA 2-093|bia 2-093
1169406|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
1169407|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
1169408|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
1169409|NCT02171221|Fluorouracil|fluorouracil
1169410|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
1169411|NCT02171195|BIA 2-093|bia 2-093
1169412|NCT02171195|Epilepsy|epilepsy
1169414|NCT02171182|8% capsaicin patch|8% capsaicin patch
1169415|NCT02171182|Non-interventional|non-interventional
1169416|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
1169417|NCT02171182|Observational|observational
1169418|NCT02171182|Czech Republic|czech republic
1169419|NCT02171143|ASP2409|asp2409
1169420|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
1169421|NCT02171143|methotrexate|methotrexate
1169422|NCT02171130|Diabetes Mellitus|diabetes mellitus
1169423|NCT02171130|Hypoglycemia|hypoglycemia
1169424|NCT02171130|Glucagon|glucagon
1169425|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
1169426|NCT02171130|Immunogenicity|immunogenicity
1169427|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
1169428|NCT02171117|microtransplantation|microtransplantation
1169429|NCT02171117|elderly patients|elderly patients
1169430|NCT02171117|HLA-mismatched|hla-mismatched
1169431|NCT02171117|donor|donor
1169432|NCT02171117|Peripheral|peripheral
1169433|NCT02171117|stem cell|stem cell
1169434|NCT02171117|infusion|infusion
1169435|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1169436|NCT02171104|bone marrow transplantation|bone marrow transplantation
1169437|NCT02171104|IMD|imd
1169438|NCT02171104|AMACRD|amacrd
1169439|NCT02171104|MNGIE|mngie
1169440|NCT02171104|HDLS|hdls
1169441|NCT02171104|OP|op
1169442|NCT02171104|ALD|ald
1169443|NCT02171091|endotracheal|endotracheal
1169444|NCT02171091|intubation|intubation
1169445|NCT02171091|airway|airway
1169446|NCT02171091|inflammation|inflammation
1169447|NCT02171078|Breast Cancer|breast cancer
1169448|NCT02171078|Breast Neoplasms|breast neoplasms
1169449|NCT02171078|Health Services Research|health services research
1169450|NCT02171078|Surveillance|surveillance
1169451|NCT02171078|Diagnostic Imaging|diagnostic imaging
1169452|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
1169453|NCT02171078|Mammography|mammography
1169454|NCT02171078|Toxicity|toxicity
1169455|NCT02171078|Adverse Effects|adverse effects
1169456|NCT02171078|Side Effects|side effects
1169457|NCT02171078|Recurrence|recurrence
1169458|NCT02171065|NIRS/IVUS|nirs/ivus
1169459|NCT02171065|multimodality imaging|multimodality imaging
1169460|NCT02171065|PROSPECT|prospect
1169461|NCT02170961|Acute heart failure|acute heart failure
1169462|NCT02170961|RAAS|raas
1169463|NCT02170961|MMP3|mmp3
1169464|NCT02170961|MMP12|mmp12
1169465|NCT02170961|Polymorphysm|polymorphysm
1169466|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
1169467|NCT02170948|nerve block|nerve block
1169468|NCT02170948|ankle block|ankle block
1169469|NCT02170948|dexmedetomidine|dexmedetomidine
1169470|NCT02170948|Precedex|precedex
1169471|NCT02170948|ankle surgery|ankle surgery
1169472|NCT02170948|forefoot surgery|forefoot surgery
1169473|NCT02170948|duration|duration
1169474|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
1169475|NCT02170883|asthma|asthma
1169476|NCT02170883|mHealth|mhealth
1169477|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
1169478|NCT02170883|pharmacy practice|pharmacy practice
1169479|NCT02170883|pharmacist|pharmacist
1169480|NCT02170857|Hyaluronic acid|hyaluronic acid
1169481|NCT02170857|infra-bony defects|infra-bony defects
1169482|NCT02170857|chronic periodontitis|chronic periodontitis
1169483|NCT02170857|experimental|experimental
1169484|NCT02170857|radiographic|radiographic
1169485|NCT02170857|clinical|clinical
1169486|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
1169487|NCT02170857|open flap curettage|open flap curettage
1169488|NCT02170818|Education|education
1169489|NCT02170818|Curriculum|curriculum
1169490|NCT02170818|Anesthesiology|anesthesiology
1169491|NCT02170818|Operating Rooms|operating rooms
1169492|NCT02170779|multiple sclerosis|multiple sclerosis
1169493|NCT02170779|spasticity|spasticity
1169494|NCT02170779|stretching|stretching
1169495|NCT02170779|exercise|exercise
1169496|NCT02170779|rehabilitation|rehabilitation
1169497|NCT02170714|Acute severe colitis|acute severe colitis
1169498|NCT02170714|Children|children
1169499|NCT02170714|Infliximab|infliximab
1169500|NCT02170714|colectomy|colectomy
1169501|NCT02170688|IV contrast|iv contrast
1169502|NCT02170688|contrast dosing|contrast dosing
1169503|NCT02170662|male pattern hair loss|male pattern hair loss
1169504|NCT02170662|androgenetic alopecia|androgenetic alopecia
1169505|NCT02170662|bimatoprost|bimatoprost
1169506|NCT02170649|BIA 2-093|bia 2-093
1169507|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
1169508|NCT02170558|Trabecular Metal|trabecular metal
1169509|NCT02170558|Metal reduction CT|metal reduction ct
1169510|NCT02170558|TM- Ardis|tm- ardis
1169511|NCT02170545|avascular necrosis|avascular necrosis
1169512|NCT02170545|humeral head fracture|humeral head fracture
1169513|NCT02170545|proximal arm fracture|proximal arm fracture
1169514|NCT02170545|arthroplasty|arthroplasty
1169515|NCT02170532|asthma|asthma
1169516|NCT02170519|pulmonary hypertension|pulmonary hypertension
1169517|NCT02170493|Insole Sensor|insole sensor
1169518|NCT02170493|Optimial Limb Loading|optimial limb loading
1169519|NCT02170493|42IIIB|42iiib
1169520|NCT02170493|IIIC|iiic
1169521|NCT02170493|Lower Extremity Fractures|lower extremity fractures
1169522|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
1169523|NCT02170454|neuromodulation|neuromodulation
1169524|NCT02170454|swallowing|swallowing
1169525|NCT02170454|magnetic stimulation|magnetic stimulation
1169526|NCT02170454|healthy subjects|healthy subjects
1169527|NCT02170441|Tuberculosis|tuberculosis
1169528|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
1169529|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
1169530|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
1169531|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
1169532|NCT02170441|Line Probe Assay|line probe assay
1169630|NCT02170025|Tolerability|tolerability
1169533|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
1169534|NCT02170441|Pyrosequencing|pyrosequencing
1169535|NCT02170428|growth,|growth,
1169536|NCT02170428|infancy,|infancy,
1169537|NCT02170428|children,|children,
1169538|NCT02170428|diet,|diet,
1169539|NCT02170428|breastfeeding|breastfeeding
1169540|NCT02170428|complementary feeding|complementary feeding
1169541|NCT02170428|early life programming|early life programming
1169542|NCT02170428|tracking|tracking
1169543|NCT02170428|physical activity|physical activity
1169544|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
1169545|NCT02170415|Breast surgery|breast surgery
1169546|NCT02170415|Complex intervention|complex intervention
1169547|NCT02170415|Pain treatment|pain treatment
1169548|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
1169549|NCT02170376|BIA 9-1067|bia 9-1067
1169550|NCT02170376|Opicapone|opicapone
1169551|NCT02170363|Heart Failure|heart failure
1169552|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
1169553|NCT02170363|Cardiomyopathies|cardiomyopathies
1169554|NCT02170363|Heart Disease|heart disease
1169555|NCT02170363|Cardiovascular Disease|cardiovascular disease
1169556|NCT02170363|Heart-assist devices|heart-assist devices
1169557|NCT02170363|Thoratec Corporation|thoratec corporation
1169558|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
1169559|NCT02170298|ADHD|adhd
1169560|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1169561|NCT02170298|Vyvanse|vyvanse
1169562|NCT02170298|Lisdexamfetamine|lisdexamfetamine
1169563|NCT02170285|perinatal stroke|perinatal stroke
1169564|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
1169565|NCT02170285|brain stimulation|brain stimulation
1169566|NCT02170285|tDCS|tdcs
1169567|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
1169568|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
1169569|NCT02170259|Tension-type headache|tension-type headache
1169570|NCT02170259|Depression|depression
1169571|NCT02170259|Anxiety|anxiety
1169572|NCT02170259|Manual therapy|manual therapy
1169573|NCT02170259|Spinal manipulation|spinal manipulation
1169574|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
1169575|NCT02170246|Acute HIV infection|acute hiv infection
1169576|NCT02170246|Central nervous system|central nervous system
1236975|NCT01864356|IVF|ivf
1169577|NCT02170246|Antiretroviral therapy|antiretroviral therapy
1169578|NCT02170246|Telmisartan|telmisartan
1169579|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
1169580|NCT02170220|Drug therapy|drug therapy
1169581|NCT02170207|Pharmacological therapy|pharmacological therapy
1169582|NCT02170194|smart phone apps|smart phone apps
1169583|NCT02170194|subthreshold PTSD|subthreshold ptsd
1169584|NCT02170194|resilience enhancement|resilience enhancement
1169585|NCT02170194|military veterans|military veterans
1169586|NCT02170194|natural disasters|natural disasters
1169587|NCT02170194|terrorism|terrorism
1169588|NCT02170194|shootings|shootings
1169589|NCT02170194|fMRI|fmri
1169590|NCT02170194|physiology|physiology
1169591|NCT02170181|SBRT|sbrt
1169592|NCT02170181|prostate cancer|prostate cancer
1169593|NCT02170181|lung cancer|lung cancer
1169594|NCT02170181|bladder cancer|bladder cancer
1169595|NCT02170181|kidney cancer|kidney cancer
1169596|NCT02170181|oligometastatic disease|oligometastatic disease
1169597|NCT02170168|Community health services|community health services
1169598|NCT02170168|Models, organizational|models, organizational
1169599|NCT02170168|Referral and consultation|referral and consultation
1169600|NCT02170168|Palliative medicine|palliative medicine
1169601|NCT02170168|Terminal care|terminal care
1169602|NCT02170142|MRI|mri
1169603|NCT02170142|perinatal brain|perinatal brain
1169604|NCT02170142|development, neonates|development, neonates
1169605|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
1169606|NCT02170103|sonothrombolysis|sonothrombolysis
1169607|NCT02170103|reperfusion|reperfusion
1169608|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
1169609|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
1169610|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
1169611|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
1169612|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
1169613|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
1169614|NCT02170090|translational research|translational research
1169615|NCT02170090|multidisciplinary|multidisciplinary
1169616|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
1169617|NCT02170077|Epilepsy|epilepsy
1169618|NCT02170077|BIA 2-093|bia 2-093
1169619|NCT02170064|Epilepsy|epilepsy
1169620|NCT02170064|BIA 2-093|bia 2-093
1169621|NCT02170051|negative symptoms|negative symptoms
1169622|NCT02170051|cognition|cognition
1169623|NCT02170051|functioning|functioning
1169624|NCT02170051|defeatist attitudes|defeatist attitudes
1169625|NCT02170051|psychosocial treatment|psychosocial treatment
1169626|NCT02170038|Drug Kinetics|drug kinetics
1169627|NCT02170025|Cystic fibrosis|cystic fibrosis
1169628|NCT02170025|delta F508|delta f508
1169629|NCT02170025|Safety|safety
1169632|NCT02170025|Pharmacokinetics|pharmacokinetics
1169634|NCT02170012|safety|safety
1169635|NCT02170012|tolerability|tolerability
1169636|NCT02170012|PK|pk
1169637|NCT02169973|Healthy|healthy
1169638|NCT02169973|Positron Emission Tomography|positron emission tomography
1169639|NCT02169973|11C-MK-3168|11c-mk-3168
1169640|NCT02169973|JNJ-42165279|jnj-42165279
1169641|NCT02169973|Human Brain|human brain
1169642|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
1169643|NCT02169895|Opicapone|opicapone
1169644|NCT02169895|Bia 9-1067|bia 9-1067
1169645|NCT02169882|Tuberculous meningitis|tuberculous meningitis
1169646|NCT02169882|Rifampicin|rifampicin
1169647|NCT02169882|Dose finding study|dose finding study
1169648|NCT02169882|Pharmacokinetics|pharmacokinetics
1169649|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
1169650|NCT02169856|Cholecystectomy|cholecystectomy
1169651|NCT02169856|Laparoscopic|laparoscopic
1169652|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1169653|NCT02169843|Dexmedetomidine,|dexmedetomidine,
1169654|NCT02169843|agitation,|agitation,
1169655|NCT02169843|AFPS,|afps,
1169656|NCT02169843|NRS,|nrs,
1169657|NCT02169843|mean arterial pressure|mean arterial pressure
1169658|NCT02169843|heart rate(HR)|heart rate(hr)
1169659|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
1169661|NCT02169778|Weight loss|weight loss
1169662|NCT02169778|Intermittent energy restriction|intermittent energy restriction
1169663|NCT02169778|Metabolic compensation|metabolic compensation
1169664|NCT02169778|Diet therapy|diet therapy
1169665|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
1169666|NCT02169765|Liver Cancer|liver cancer
1169667|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
1169668|NCT02169739|ischemic preconditioning|ischemic preconditioning
1169669|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
1169670|NCT02169739|ischemic stroke|ischemic stroke
1169671|NCT02169739|white matter disease|white matter disease
1169672|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
1169673|NCT02169739|cognitive decline|cognitive decline
1169674|NCT02169739|leukoaraiosis|leukoaraiosis
1169675|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
1169676|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
1169677|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
1169678|NCT02169713|Healthy subjects|healthy subjects
1169679|NCT02169713|Mirabegron|mirabegron
1169680|NCT02169713|Solifenacin|solifenacin
1169681|NCT02169713|Tamsulosin HCl|tamsulosin hcl
1169682|NCT02169700|Ischemic compression|ischemic compression
1169683|NCT02169700|Myofascial trigger points|myofascial trigger points
1169684|NCT02169700|Post-needling soreness|post-needling soreness
1169685|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
1169686|NCT02169674|Hepatitis B|hepatitis b
1169687|NCT02169674|Vaccine|vaccine
1169688|NCT02169674|Immunogenicity|immunogenicity
1169689|NCT02169661|Oxidative stress|oxidative stress
1169690|NCT02169661|Lipid peroxides|lipid peroxides
1169691|NCT02169661|Phytochemicals|phytochemicals
1169692|NCT02169661|Ready meals|ready meals
1169693|NCT02169661|Beetroot|beetroot
1169694|NCT02169661|Blood pressure|blood pressure
1169695|NCT02169648|macular edema|macular edema
1169696|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
1169697|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
1169698|NCT02169648|ranibizumab|ranibizumab
1169699|NCT02169648|cytokines|cytokines
1169700|NCT02169648|visual acuity|visual acuity
1169701|NCT02169648|central macular thickness|central macular thickness
1169702|NCT02169635|macular buckle|macular buckle
1169703|NCT02169635|high myopia|high myopia
1169704|NCT02169635|posterior staphyloma|posterior staphyloma
1169705|NCT02169609|Neuroblastoma|neuroblastoma
1169706|NCT02169609|Immunotherapy|immunotherapy
1169707|NCT02169609|Dinutuximab|dinutuximab
1169708|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
1169709|NCT02169596|Nitric oxide|nitric oxide
1169710|NCT02169596|Ticagrelor|ticagrelor
1169711|NCT02169596|Antiplatelet agents|antiplatelet agents
1169712|NCT02169596|Endothelial function|endothelial function
1169713|NCT02169583|GSK1325756|gsk1325756
1169714|NCT02169583|Safety|safety
1169715|NCT02169583|Bioavailability|bioavailability
1169716|NCT02169583|Pharmacokinetics|pharmacokinetics
1169717|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1169718|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
1169719|NCT02169570|Vitamin D|vitamin d
1169720|NCT02169570|Calcium|calcium
1169721|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
1169722|NCT02169531|Hyperglycemia|hyperglycemia
1169723|NCT02169531|Immunotherapy|immunotherapy
1169724|NCT02169531|Autologous|autologous
1169725|NCT02169518|PON1 activity|pon1 activity
1169726|NCT02169518|HDL functionality|hdl functionality
1169727|NCT02169518|LDL oxidation|ldl oxidation
1169728|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
1169729|NCT02169518|Obesity|obesity
1169730|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
1169731|NCT02169518|Bariatric Surgery|bariatric surgery
1169732|NCT02169505|Lymphoma|lymphoma
1169733|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
1169734|NCT02169505|HL|hl
1169735|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
1169736|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1169737|NCT02169505|ALCL|alcl
1169738|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1169739|NCT02169505|ASCT|asct
1169740|NCT02169505|Graft-versus-host disease|graft-versus-host disease
1169741|NCT02169505|GVHD|gvhd
1169742|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
1169743|NCT02169505|SGN-35|sgn-35
1169744|NCT02169505|Adcetris|adcetris
1169745|NCT02169492|Thrombectomy|thrombectomy
1169746|NCT02169492|Stroke|stroke
1169747|NCT02169492|ReVive SE|revive se
1169748|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
1169749|NCT02169479|Opicapone|opicapone
1169750|NCT02169479|BIA 9-1067|bia 9-1067
1169751|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
1169752|NCT02169466|Opicapone|opicapone
1169753|NCT02169466|BIA 9-1067|bia 9-1067
1169754|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
1169755|NCT02169453|BIA 9-1067|bia 9-1067
1169756|NCT02169453|Opicapone|opicapone
1169757|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
1169758|NCT02169440|BIA 9-1067|bia 9-1067
1169759|NCT02169440|Opicapone|opicapone
1169760|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
1169761|NCT02169427|BIA 9-1067|bia 9-1067
1169762|NCT02169427|Opicapone|opicapone
1169763|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
1169764|NCT02169414|BIA 9-1067|bia 9-1067
1169765|NCT02169414|Opicapone|opicapone
1169766|NCT02169388|Gut microflora|gut microflora
1169767|NCT02169388|colorectal cancer|colorectal cancer
1169768|NCT02169388|Chemotherapy|chemotherapy
1169769|NCT02169388|Immunity|immunity
1169770|NCT02169388|Nutrition|nutrition
1169771|NCT02169362|Burns|burns
1169772|NCT02169362|Thermal burns|thermal burns
1169773|NCT02169362|Second degree burns|second degree burns
1169774|NCT02169362|Partial thickness burns|partial thickness burns
1169775|NCT02169362|Deep partial thickness burns|deep partial thickness burns
1169776|NCT02169362|Acute burns|acute burns
1169777|NCT02169362|Burn wounds|burn wounds
1169778|NCT02169336|Bunion|bunion
1169779|NCT02169336|Bunionectomy|bunionectomy
1169780|NCT02169336|Pain|pain
1169781|NCT02169336|Analgesia|analgesia
1169782|NCT02169336|dexmedetomidine|dexmedetomidine
1169783|NCT02169336|intranasal|intranasal
1169784|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
1169785|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
1169786|NCT02169323|Step-down|step-down
1169787|NCT02169310|Traumatic Brain Injury|traumatic brain injury
1169788|NCT02169310|Decision-Making|decision-making
1169789|NCT02169310|Dopaminergic Network|dopaminergic network
1169790|NCT02169310|Brain Imaging|brain imaging
1169791|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
1169792|NCT02169297|Pain Management|pain management
1169793|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
1169794|NCT02169258|coronary artery disease|coronary artery disease
1169795|NCT02169258|peripheral artery disease|peripheral artery disease
1169796|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1169797|NCT02169258|coronary angiography|coronary angiography
1169798|NCT02169258|revascularization|revascularization
1169799|NCT02169258|gene polymorphisms|gene polymorphisms
1169800|NCT02169258|microRNAs|micrornas
1169801|NCT02169232|Awake intubation|awake intubation
1169802|NCT02169232|Videolaryngoscope|videolaryngoscope
1169803|NCT02169232|Fiberoptic|fiberoptic
1169804|NCT02169206|Frozen shoulder|frozen shoulder
1169805|NCT02169206|scapulothoracic angle|scapulothoracic angle
1169806|NCT02169206|scapulohumeral angle|scapulohumeral angle
1169807|NCT02169206|acromiohumeral distance|acromiohumeral distance
1169808|NCT02169206|center equator distance|center equator distance
1169809|NCT02169206|shoulder radiography|shoulder radiography
1169810|NCT02169193|microaspiration|microaspiration
1169811|NCT02169193|mechanical ventilation|mechanical ventilation
1169812|NCT02169193|enteral feeding|enteral feeding
1169813|NCT02169193|99m technetium|99m technetium
1169814|NCT02169193|pepsin|pepsin
1169815|NCT02169180|Ibrutinib|ibrutinib
1169816|NCT02169180|IMBRUVICA|imbruvica
1169817|NCT02169180|PCI-32765|pci-32765
1169818|NCT02169180|JNJ-54179060|jnj-54179060
1169819|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
1169820|NCT02169167|Diabetes complications|diabetes complications
1169821|NCT02169167|Diabetic foot|diabetic foot
1169822|NCT02169167|Foot ulcer|foot ulcer
1169823|NCT02169167|Wound healing|wound healing
1169824|NCT02169167|Wound infection|wound infection
1169825|NCT02169141|pharmacokinetics|pharmacokinetics
1169826|NCT02169141|pharmacodynamics|pharmacodynamics
1169827|NCT02169141|MDR-TB|mdr-tb
1169828|NCT02169141|Levofloxacin|levofloxacin
1169829|NCT02169141|Capreomycin|capreomycin
1169830|NCT02169102|Low power laser|low power laser
1169831|NCT02169102|Pulpitis|pulpitis
1169832|NCT02169102|Pain|pain
1169833|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
1169834|NCT02169050|Vitamin D deficiency|vitamin d deficiency
1169835|NCT02169050|Inflammation|inflammation
1169836|NCT02169050|Obesity|obesity
1169837|NCT02169037|Rotor|rotor
1169838|NCT02169037|FIRM|firm
1169839|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1169840|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
1169841|NCT02169037|Ablation|ablation
1169842|NCT02169037|Contact mapping|contact mapping
1169843|NCT02169037|Clinical trial|clinical trial
1169844|NCT02169037|Signal processing.|signal processing.
1169845|NCT02169024|prenatal care|prenatal care
1169846|NCT02169024|group care|group care
1169847|NCT02169024|Expect With Me|expect with me
1169848|NCT02169024|evaluation studies|evaluation studies
1169849|NCT02169024|group prenatal care|group prenatal care
1169850|NCT02169011|Breast reconstruction|breast reconstruction
1169851|NCT02169011|Breast cancer|breast cancer
1169852|NCT02168998|Medical clown|medical clown
1169853|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
1169854|NCT02168985|Child violence|child violence
1169855|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
1169856|NCT02168985|Intimate partner violence|intimate partner violence
1169857|NCT02168985|Tanzania|tanzania
1169858|NCT02168985|Marriage counseling|marriage counseling
1169859|NCT02168985|Child maltreatment|child maltreatment
1169860|NCT02168985|Couples communication|couples communication
1169861|NCT02168972|atrial fibrillation|atrial fibrillation
1169862|NCT02168972|global|global
1169863|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
1169864|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
1169865|NCT02168959|Femoral Nerve Block|femoral nerve block
1169866|NCT02168959|Pain Control|pain control
1169867|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
1169868|NCT02168959|Prospective|prospective
1169869|NCT02168959|Randomized|randomized
1169870|NCT02168933|psoriasis|psoriasis
1169871|NCT02168933|nail|nail
1169873|NCT02168933|excimer|excimer
1169874|NCT02168933|treatment|treatment
1169875|NCT02168920|Alzeheimer|alzeheimer
1169876|NCT02168894|Peripheral neuropathy|peripheral neuropathy
1169877|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
1169878|NCT02168894|Cancer Survivors|cancer survivors
1169879|NCT02168894|Acupuncture|acupuncture
1169880|NCT02168894|Electrical stimulation|electrical stimulation
1169881|NCT02168894|Nerve function tests|nerve function tests
1169882|NCT02168894|Hand function tests|hand function tests
1169883|NCT02168894|Balance tests|balance tests
1169884|NCT02168894|Questionnaires|questionnaires
1169885|NCT02168894|Surveys|surveys
1169886|NCT02168881|labour|labour
1169887|NCT02168881|induction|induction
1169888|NCT02168881|misoprostol|misoprostol
1169889|NCT02168881|dinoprostone|dinoprostone
1169890|NCT02168868|Autoimmune Diseases|autoimmune diseases
1169891|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
1169892|NCT02168868|Inflammation|inflammation
1169893|NCT02168868|Risk Factors|risk factors
1169894|NCT02168855|Smoking cessation|smoking cessation
1169895|NCT02168855|Non-daily smokers|non-daily smokers
1170089|NCT02167932|Walking|walking
1169896|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
1169897|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
1169898|NCT02168842|Parkinson|parkinson
1169899|NCT02168842|Parkinson Disease|parkinson disease
1169900|NCT02168842|Parkinson's Disease|parkinson's disease
1169901|NCT02168829|AF ablation|af ablation
1169902|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
1169903|NCT02168829|Stroke prevention|stroke prevention
1169904|NCT02168816|Osteomyelitis|osteomyelitis
1169905|NCT02168816|Diabetes|diabetes
1169906|NCT02168816|Foot Infection|foot infection
1169907|NCT02168803|abnormal cholesterol|abnormal cholesterol
1169908|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
1169909|NCT02168777|Patients with Cancer|patients with cancer
1169910|NCT02168751|one lung ventilation|one lung ventilation
1169911|NCT02168751|inflammatory response|inflammatory response
1169912|NCT02168751|thoracic surgery|thoracic surgery
1169913|NCT02168738|nutrition|nutrition
1169914|NCT02168725|briciclib|briciclib
1169915|NCT02168725|Dose escalation|dose escalation
1169916|NCT02168725|Maximum tolerated dose|maximum tolerated dose
1169917|NCT02168712|Coronary Heart Disease|coronary heart disease
1169918|NCT02168712|Interval exercise training|interval exercise training
1169919|NCT02168712|Continuous exercise training|continuous exercise training
1169920|NCT02168712|Quality of life|quality of life
1169921|NCT02168712|Safety|safety
1169922|NCT02168699|children|children
1169923|NCT02168699|infants|infants
1169924|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
1169925|NCT02168699|ultrasonography|ultrasonography
1169926|NCT02168686|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1169927|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
1169928|NCT02168686|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
1169929|NCT02168686|alpha1AT|alpha1at
1169930|NCT02168686|A1AT|a1at
1169931|NCT02168686|ADVM-043|advm-043
1169932|NCT02168686|AAVrh.10halpha1AT|aavrh.10halpha1at
1169933|NCT02168686|AAVrh.10hA1AT|aavrh.10ha1at
1169934|NCT02168686|Gene transfer vector|gene transfer vector
1169935|NCT02168686|Gene therapy|gene therapy
1169936|NCT02168686|Lung disease|lung disease
1169937|NCT02168686|Emphysema|emphysema
1169938|NCT02168686|ANN001-01|ann001-01
1169939|NCT02168686|ADVANCE study|advance study
1169940|NCT02168673|COPD|copd
1169941|NCT02168673|Cigarette Smoke|cigarette smoke
1169942|NCT02168673|Smoker|smoker
1169943|NCT02168673|Nonsmoker|nonsmoker
1169944|NCT02168673|ODF2|odf2
1169945|NCT02168673|Cilia|cilia
1169946|NCT02168660|Obesity|obesity
1169947|NCT02168660|Insulin Resistance|insulin resistance
1169948|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
1169949|NCT02168660|Children|children
1169950|NCT02168660|Adolescents|adolescents
1169951|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
1169952|NCT02168647|Insulin resistance|insulin resistance
1169953|NCT02168647|Physical activity|physical activity
1169954|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
1169955|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
1169956|NCT02168647|Self-determination theory|self-determination theory
1169957|NCT02168647|Motivational interviewing|motivational interviewing
1169958|NCT02168621|Chronic periodontitis|chronic periodontitis
1169959|NCT02168621|Non-surgical therapy|non-surgical therapy
1169960|NCT02168621|Ultrasonic debridement|ultrasonic debridement
1169961|NCT02168621|Scaling and root planing|scaling and root planing
1169962|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
1169963|NCT02168608|ischemia precondition|ischemia precondition
1169964|NCT02168608|remote ischemia precondition|remote ischemia precondition
1169965|NCT02168608|anti-inflammation|anti-inflammation
1169966|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
1237458|NCT01862185|sepsis|sepsis
1169967|NCT02168582|Physical Therapy Modalities|physical therapy modalities
1169968|NCT02168582|Prognosis|prognosis
1169969|NCT02168582|Patient Selection|patient selection
1169970|NCT02168569|treatment|treatment
1169971|NCT02168569|artemisin-based combinations|artemisin-based combinations
1169972|NCT02168569|children|children
1169973|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
1169974|NCT02168517|Obesity|obesity
1169975|NCT02168517|Pain|pain
1169976|NCT02168517|Fertility|fertility
1169977|NCT02168478|Neo-Synalar|neo-synalar
1169978|NCT02168478|Patch Test|patch test
1169979|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
1169980|NCT02168478|Saline|saline
1169981|NCT02168478|Presensitization|presensitization
1169982|NCT02168465|self-efficacy|self-efficacy
1169983|NCT02168465|self-management|self-management
1169984|NCT02168465|web-based intervention research|web-based intervention research
1169985|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1169986|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
1169987|NCT02168452|Radioisotope (RI)|radioisotope (ri)
1169988|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
1169989|NCT02168439|Dexmedetomidine|dexmedetomidine
1169990|NCT02168439|Midazolam|midazolam
1170183|NCT02167425|HIV|hiv
1169991|NCT02168413|cortical excitability|cortical excitability
1169992|NCT02168413|robotized TMS|robotized tms
1169993|NCT02168413|EEG|eeg
1169994|NCT02168413|EMG|emg
1169995|NCT02168387|atelectasis|atelectasis
1169996|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
1169997|NCT02168387|acetylcysteine|acetylcysteine
1169998|NCT02168387|dornase alfa|dornase alfa
1169999|NCT02168374|Glass ionomer cement|glass ionomer cement
1170000|NCT02168374|Indirect pulp therapy|indirect pulp therapy
1170001|NCT02168361|cirrhosis|cirrhosis
1170002|NCT02168322|growth factors|growth factors
1170003|NCT02168322|periodontal regeneration|periodontal regeneration
1170004|NCT02168322|modefied perforated membranes|modefied perforated membranes
1170005|NCT02168296|Pharmacokinetics|pharmacokinetics
1170006|NCT02168296|Blood glucose|blood glucose
1170007|NCT02168296|subjects|subjects
1170008|NCT02168283|cardiovascular disease|cardiovascular disease
1170009|NCT02168283|hypertension|hypertension
1170010|NCT02168257|Nasal Cannula|nasal cannula
1170011|NCT02168244|psoriasis|psoriasis
1170012|NCT02168244|biologics|biologics
1170013|NCT02168244|subcutaneous|subcutaneous
1170014|NCT02168244|pain|pain
1170015|NCT02168244|heat|heat
1170016|NCT02168244|ice|ice
1170017|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
1170018|NCT02168231|Biologic mesh|biologic mesh
1170019|NCT02168231|Strattice|strattice
1170020|NCT02168218|protein synthesis|protein synthesis
1170021|NCT02168218|intrahepatic fat|intrahepatic fat
1170022|NCT02168218|lean body mass|lean body mass
1170023|NCT02168218|IGF1|igf1
1170024|NCT02168218|energy metabolism|energy metabolism
1170025|NCT02168205|Healthy volunteer|healthy volunteer
1170026|NCT02168205|Pharmacokinetics|pharmacokinetics
1170027|NCT02168205|Pomalyst|pomalyst
1170028|NCT02168205|Pomalidomide|pomalidomide
1170029|NCT02168205|Food effect|food effect
1170030|NCT02168205|smoker|smoker
1170031|NCT02168192|Breaking bad news skills|breaking bad news skills
1170032|NCT02168192|Communications skills|communications skills
1170033|NCT02168192|Medical education|medical education
1170034|NCT02168192|Obstetrics|obstetrics
1170035|NCT02168192|Simulation|simulation
1170036|NCT02168166|Neurological Disorders|neurological disorders
1170037|NCT02168166|Neuroscience|neuroscience
1170038|NCT02168166|Neuropsychology|neuropsychology
1170039|NCT02168166|EEG|eeg
1170040|NCT02168166|Cognitive remediation|cognitive remediation
1170041|NCT02168166|Cognitive Response|cognitive response
1170042|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
1170043|NCT02168153|Reaction Times|reaction times
1170044|NCT02168153|Response Times|response times
1170045|NCT02168153|Special Forces|special forces
1170046|NCT02168153|Biomechanical Assessments|biomechanical assessments
1170047|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1170048|NCT02168114|Exercise|exercise
1170049|NCT02168114|Optical Imaging|optical imaging
1170050|NCT02168114|Magnetic Resonance|magnetic resonance
1170051|NCT02168101|MLN9708|mln9708
1170052|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
1170053|NCT02168101|multiple myeloma|multiple myeloma
1170054|NCT02168101|ixazomib|ixazomib
1170055|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
1170056|NCT02168088|Sudden unexplained death|sudden unexplained death
1170057|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
1170058|NCT02168036|lung disease|lung disease
1170059|NCT02168036|mediastinal lymph node|mediastinal lymph node
1170060|NCT02168036|bronchoscopy|bronchoscopy
1170061|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
1170062|NCT02168023|surgical site infection|surgical site infection
1333248|NCT01443832|ferrous sulfate|ferrous sulfate
1170063|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
1170064|NCT02168023|caesarean section|caesarean section
1170065|NCT02168023|wound dehiscence|wound dehiscence
1170066|NCT02167984|esophageal swallow|esophageal swallow
1170067|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
1170068|NCT02167984|esophageal impedance|esophageal impedance
1170069|NCT02167984|newborn|newborn
1170070|NCT02167984|preterm|preterm
1170071|NCT02167971|traumatic brain injury|traumatic brain injury
1170072|NCT02167971|diffuse axonal injury|diffuse axonal injury
1170073|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1170074|NCT02167971|neuromodulation|neuromodulation
1170075|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
1170076|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
1170077|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
1170078|NCT02167945|Cirrhosis|cirrhosis
1170079|NCT02167945|Naïve|naïve
1170080|NCT02167945|Hepatitis C|hepatitis c
1170081|NCT02167945|Hepatitis C Virus|hepatitis c virus
1170082|NCT02167945|Treatment-Experienced|treatment-experienced
1170083|NCT02167945|Relapser|relapser
1170084|NCT02167945|Null responder|null responder
1170085|NCT02167945|Non responder|non responder
1170086|NCT02167932|Breast Cancer|breast cancer
1170087|NCT02167932|Walk With Ease|walk with ease
1170088|NCT02167932|Physical Activity|physical activity
1170090|NCT02167932|Younger Women|younger women
1170091|NCT02167932|Cancer|cancer
1170092|NCT02167932|p16|p16
1170093|NCT02167932|Aging|aging
1170094|NCT02167932|Biomarkers|biomarkers
1170095|NCT02167932|Biomarkers of Aging|biomarkers of aging
1170096|NCT02167932|Chemotherapy|chemotherapy
1170097|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
1170098|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
1170099|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1170100|NCT02167919|Prostate|prostate
1170101|NCT02167919|Men|men
1170102|NCT02167919|Hyperplasia|hyperplasia
1170103|NCT02167893|Pharmacological therapy|pharmacological therapy
1170104|NCT02167867|body contouring|body contouring
1170105|NCT02167867|circumference reduction|circumference reduction
1170106|NCT02167867|body shaping|body shaping
1170107|NCT02167867|low level laser|low level laser
1170108|NCT02167854|LJM716|ljm716
1170109|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
1170110|NCT02167854|TRASTUZUMAB|trastuzumab
1170111|NCT02167854|HER2+|her2+
1170112|NCT02167854|14-057|14-057
1170113|NCT02167841|Breech presentation,|breech presentation,
1170114|NCT02167841|External cephalic version,|external cephalic version,
1170115|NCT02167841|Maternal posture,|maternal posture,
1170116|NCT02167841|Pregnancy,|pregnancy,
1170117|NCT02167841|Caesarean section.|caesarean section.
1170118|NCT02167828|HIV|hiv
1170119|NCT02167828|AIDS|aids
1170120|NCT02167828|treatment adherence|treatment adherence
1170121|NCT02167828|social network|social network
1170122|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
1170123|NCT02167789|HF, diagnosis|hf, diagnosis
1170124|NCT02167763|contraception|contraception
1170125|NCT02167763|IUD|iud
1170126|NCT02167763|copper|copper
1170127|NCT02167750|cognitive|cognitive
1170128|NCT02167750|phytochmicals|phytochmicals
1170129|NCT02167750|caffeine|caffeine
1170130|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
1170131|NCT02167737|Accident Prevention|accident prevention
1170132|NCT02167737|Accidental Falls|accidental falls
1170133|NCT02167737|Geriatric Health Services|geriatric health services
1170134|NCT02167737|Gender Differences|gender differences
1170135|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
1170136|NCT02167698|Mechanical ventilation|mechanical ventilation
1170137|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
1170138|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
1170139|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
1170140|NCT02167659|Lymphedema|lymphedema
1170141|NCT02167659|Breast cancer|breast cancer
1170142|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
1170143|NCT02167659|L-Dex|l-dex
1170144|NCT02167646|Soft tissue defect|soft tissue defect
1170145|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
1170146|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
1170147|NCT02167646|dorsal digital flap|dorsal digital flap
1170148|NCT02167633|Radiosurgery|radiosurgery
1170149|NCT02167633|Laminectomy|laminectomy
1170150|NCT02167633|Radiotherapy|radiotherapy
1170151|NCT02167633|Spinal Cord Compression|spinal cord compression
1170152|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
1170153|NCT02167633|Randomized Controlled Trial|randomized controlled trial
1170154|NCT02167607|Purple Potatoes|purple potatoes
1170155|NCT02167607|Polyphenolics|polyphenolics
1170156|NCT02167581|Maxillofacial surgery|maxillofacial surgery
1170157|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
1170158|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
1170159|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
1170160|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
1170161|NCT02167555|Wild Blueberries|wild blueberries
1170162|NCT02167555|Polyphenolics|polyphenolics
1170163|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
1170164|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
1170165|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
1170166|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
1170167|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
1170168|NCT02167516|Xinfeng capsule|xinfeng capsule
1170169|NCT02167516|Knee osteoarthritis|knee osteoarthritis
1170170|NCT02167516|Randomized controlled trials|randomized controlled trials
1170171|NCT02167516|Double-blind|double-blind
1170172|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
1170173|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
1170174|NCT02167464|Hypertension|hypertension
1170175|NCT02167451|stem cell transplant|stem cell transplant
1170176|NCT02167451|GVHD prevention|gvhd prevention
1170177|NCT02167438|Cesarean|cesarean
1170178|NCT02167438|Section|section
1170179|NCT02167438|second|second
1170180|NCT02167438|stage|stage
1170181|NCT02167438|labor|labor
1170182|NCT02167425|People who Inject Drugs|people who inject drugs
1170184|NCT02167425|Methadone|methadone
1170185|NCT02167425|Sub Saharan Africa|sub saharan africa
1170186|NCT02167425|Tanzania|tanzania
1170187|NCT02167425|Implementation Science|implementation science
1170188|NCT02167412|POTS|pots
1170189|NCT02167412|Syncope|syncope
1170190|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
1170191|NCT02167386|Black/African-American|black/african-american
1170192|NCT02167360|adult patients|adult patients
1170193|NCT02167360|B-cell ALL|b-cell all
1170194|NCT02167360|chemo-refractory|chemo-refractory
1170195|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
1170196|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
1170197|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
1170198|NCT02167334|panendoscopy|panendoscopy
1170199|NCT02167334|preoxygenation|preoxygenation
1170200|NCT02167334|non invasive ventilation|non invasive ventilation
1170201|NCT02167295|betel nut|betel nut
1170202|NCT02167295|dependence|dependence
1170203|NCT02167295|withdraw|withdraw
1170204|NCT02167295|deprivation test|deprivation test
1170205|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
1170206|NCT02167269|Jackson Rees system|jackson rees system
1170207|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
1170208|NCT02167269|spontaneous breathing|spontaneous breathing
1170209|NCT02167269|pediatric anesthesia|pediatric anesthesia
1170210|NCT02167230|Coronary Artery Disease|coronary artery disease
1170211|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
1170212|NCT02167230|Bifurcation|bifurcation
1170213|NCT02167230|Jailed-balloon technique|jailed-balloon technique
1170214|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1170215|NCT02167217|Corticosteroids|corticosteroids
1170216|NCT02167217|Infants|infants
1170217|NCT02167217|Young Children|young children
1170218|NCT02167217|Toddlers|toddlers
1170219|NCT02167165|Atrial Fibrillation|atrial fibrillation
1170220|NCT02167165|Digoxin|digoxin
1170221|NCT02167165|SNP|snp
1170222|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
1170223|NCT02167126|Athletic Performance;|athletic performance;
1170224|NCT02167126|Muscle Strength;|muscle strength;
1170225|NCT02167126|Isometric Contraction;|isometric contraction;
1170226|NCT02167126|Kinesio Taping|kinesio taping
1170227|NCT02167100|HIV|hiv
1170228|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1170229|NCT02167100|Patient Care|patient care
1170230|NCT02167100|Patient Care Management|patient care management
1170231|NCT02167100|Lost to Follow-Up|lost to follow-up
1170232|NCT02167087|Sentinel node mapping|sentinel node mapping
1170233|NCT02167087|lymphatic mapping|lymphatic mapping
1170234|NCT02167087|lymphatic metastasis|lymphatic metastasis
1170235|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
1170236|NCT02167087|indocyanine green|indocyanine green
1170237|NCT02167087|ICG|icg
1170238|NCT02167087|near infrared|near infrared
1170239|NCT02167087|colon cancer|colon cancer
1170240|NCT02167087|laparoscopic surgery|laparoscopic surgery
1170241|NCT02167074|Diagnostic accuracy|diagnostic accuracy
1170242|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
1170243|NCT02167074|EUS-FNA|eus-fna
1170244|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
1170245|NCT02167074|EUS-FNB|eus-fnb
1170246|NCT02167074|Pancreatic mass|pancreatic mass
1170247|NCT02167074|Lymph node|lymph node
1170248|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
1170249|NCT02167048|Executive Function|executive function
1170250|NCT02167048|Methylphenidate|methylphenidate
1170251|NCT02167048|Psychostimulants|psychostimulants
1170252|NCT02167048|Adolescent|adolescent
1170253|NCT02167048|Child|child
1170254|NCT02167048|Working Memory|working memory
1170255|NCT02167048|Prefrontal Cortex|prefrontal cortex
1170256|NCT02167048|Attention|attention
1170257|NCT02167048|Cognitive Function|cognitive function
1170258|NCT02167048|Inhibition|inhibition
1170259|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
1170260|NCT02167035|Ocular Hypertension|ocular hypertension
1170261|NCT02167022|intense therapy|intense therapy
1170262|NCT02167022|brain plasticity|brain plasticity
1170263|NCT02167022|Perception-Action approach|perception-action approach
1170264|NCT02167009|ARTERY EMBOLIZATION|artery embolization
1170265|NCT02167009|BPH|bph
1170266|NCT02166970|Hilar tumor|hilar tumor
1170267|NCT02166970|Metal stent|metal stent
1170268|NCT02166970|Single|single
1170269|NCT02166970|Multiple|multiple
1170270|NCT02166957|Esophageal disruption|esophageal disruption
1170271|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
1170272|NCT02166957|rendez-vous technique|rendez-vous technique
1170273|NCT02166957|NOTES|notes
1170274|NCT02166957|recanalization|recanalization
1170275|NCT02166957|dilatations|dilatations
1170276|NCT02166957|Stenting|stenting
1170277|NCT02166957|radiation therapy|radiation therapy
1170278|NCT02166957|head and neck carcinoma|head and neck carcinoma
1170279|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1170280|NCT02166944|ALS functional ration scale|als functional ration scale
1170281|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
1170282|NCT02166944|tamoxifen|tamoxifen
1170283|NCT02166944|mTOR|mtor
1170284|NCT02166931|Essence of Chicken|essence of chicken
1170285|NCT02166931|stress|stress
1170286|NCT02166931|cognitive function|cognitive function
1170287|NCT02166918|Schizophrenia|schizophrenia
1170288|NCT02166918|Real-Life Functioning|real-life functioning
1170289|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
1170290|NCT02166892|Childhood obesity|childhood obesity
1170291|NCT02166892|Plate|plate
1170292|NCT02166892|Food consumption|food consumption
1170293|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
1170294|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
1170296|NCT02166879|Chart review|chart review
1170297|NCT02166879|Questionnaire|questionnaire
1170298|NCT02166879|Survey|survey
1170299|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1170300|NCT02166853|Sevoflurane|sevoflurane
1170301|NCT02166853|Mechanical ventilation|mechanical ventilation
1170302|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
1170303|NCT02166853|Prospective study|prospective study
1170304|NCT02166853|Lung injury|lung injury
1170305|NCT02166853|Gas exchange|gas exchange
1170306|NCT02166853|Inflammation|inflammation
1170307|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
1170308|NCT02166853|sRAGE|srage
1170309|NCT02166827|TMS|tms
1170310|NCT02166827|Cognitive Stimulation|cognitive stimulation
1170311|NCT02166827|NeuroAD|neuroad
1170312|NCT02166801|Cerebral palsy|cerebral palsy
1170313|NCT02166801|Children|children
1170314|NCT02166801|Early Intervention|early intervention
1170315|NCT02166801|Communication|communication
1170316|NCT02166801|Gross motor function|gross motor function
1170317|NCT02166801|Hand function|hand function
1170318|NCT02166788|metastatic melanoma|metastatic melanoma
1170319|NCT02166788|groin lymph nodes|groin lymph nodes
1170320|NCT02166788|surgery|surgery
1170321|NCT02166788|lymphadenectomy|lymphadenectomy
1170322|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1170323|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
1170324|NCT02166762|Heart failure|heart failure
1170325|NCT02166762|Cardiomyopathy|cardiomyopathy
1170326|NCT02166762|QLV|qlv
1170327|NCT02166762|LV lead placement|lv lead placement
1170328|NCT02166762|Arrhythmia|arrhythmia
1170329|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
1170330|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
1170331|NCT02166736|Fractional Flow Reserve|fractional flow reserve
1170332|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
1170333|NCT02166723|Cryoballoon ablation|cryoballoon ablation
1170334|NCT02166710|Knee arthroplasty|knee arthroplasty
1170335|NCT02166710|Adductor canal block|adductor canal block
1170336|NCT02166710|Quadriceps strength|quadriceps strength
1170337|NCT02166697|Pharmacological therapy|pharmacological therapy
1170338|NCT02166684|Do-it-yourself devices|do-it-yourself devices
1170339|NCT02166684|User-experiences|user-experiences
1170340|NCT02166684|Health behavior|health behavior
1170341|NCT02166684|Self-measurement|self-measurement
1170342|NCT02166684|Methodology, Evaluation|methodology, evaluation
1170343|NCT02166684|Personal health records|personal health records
1170344|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1170345|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
1170346|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
1170347|NCT02166658|metastases|metastases
1170348|NCT02166645|patient positioning|patient positioning
1170349|NCT02166645|premature infant|premature infant
1170350|NCT02166645|mechanical ventilation|mechanical ventilation
1170351|NCT02166645|airway extubation|airway extubation
1170352|NCT02166632|Knee arthroplasty|knee arthroplasty
1170353|NCT02166632|Exparel|exparel
1170354|NCT02166632|Bupivacaine liposome|bupivacaine liposome
1170355|NCT02166632|Total knee replacement|total knee replacement
1170356|NCT02166632|Pain control|pain control
1170357|NCT02166619|Stroke|stroke
1170358|NCT02166619|Rehabilitation|rehabilitation
1170359|NCT02166619|Electric stimulation therapy|electric stimulation therapy
1170360|NCT02166619|Neuroplasticity|neuroplasticity
1170361|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
1170362|NCT02166567|Male infertility|male infertility
1170363|NCT02166567|apoptosis|apoptosis
1170364|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
1170365|NCT02166567|DNA fragmentation|dna fragmentation
1170366|NCT02166554|Adhesions|adhesions
1170367|NCT02166554|Hyaluronan|hyaluronan
1170368|NCT02166554|Gynaecological surgery|gynaecological surgery
1170369|NCT02166554|Clinical outcomes|clinical outcomes
1170370|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
1170371|NCT02166541|children,|children,
1170372|NCT02166541|intervention study,|intervention study,
1170373|NCT02166541|manipulation, spinal|manipulation, spinal
1170374|NCT02166541|randomized controlled trial|randomized controlled trial
1170478|NCT02165969|tumor|tumor
1170375|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
1170376|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
1170377|NCT02166528|urinary incontinence|urinary incontinence
1170378|NCT02166528|massively parallel sequencing|massively parallel sequencing
1170379|NCT02166515|cervical cancer|cervical cancer
1170380|NCT02166515|ovarian cancer|ovarian cancer
1170381|NCT02166515|endometrial cancer|endometrial cancer
1170382|NCT02166515|high-throughput sequencing|high-throughput sequencing
1170383|NCT02166502|pediatric|pediatric
1170385|NCT02166502|prevention|prevention
1170386|NCT02166502|prophylaxis|prophylaxis
1170387|NCT02166502|nevirapine|nevirapine
1170388|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
1170389|NCT02166489|polycystic kidney disease|polycystic kidney disease
1170390|NCT02166489|intravenous injection|intravenous injection
1170391|NCT02166489|CRF|crf
1170392|NCT02166450|Denture stomatitis|denture stomatitis
1170393|NCT02166450|Dentures|dentures
1170394|NCT02166450|Denture wearers|denture wearers
1170395|NCT02166437|osteoporosis|osteoporosis
1170396|NCT02166437|BMD|bmd
1170397|NCT02166437|teriparatide|teriparatide
1170398|NCT02166437|bisphosphonate|bisphosphonate
1170399|NCT02166437|denosmab|denosmab
1170400|NCT02166424|Pregnancy|pregnancy
1170401|NCT02166424|Depression|depression
1170402|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
1170403|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
1170404|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
1170405|NCT02166359|Icodextrin|icodextrin
1170406|NCT02166359|Triglyceride|triglyceride
1170407|NCT02166346|Transverse myelitis|transverse myelitis
1170408|NCT02166333|vitamin D|vitamin d
1170409|NCT02166333|falls|falls
1170410|NCT02166333|high risk of falling|high risk of falling
1170411|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
1170412|NCT02166333|10-29 ng/ml|10-29 ng/ml
1170413|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
1170415|NCT02166294|Ulcer|ulcer
1170416|NCT02166294|Diabetes|diabetes
1170417|NCT02166294|Amputation|amputation
1170418|NCT02166294|Limb salvage|limb salvage
1170419|NCT02166281|Insomnia|insomnia
1170420|NCT02166281|Anxiety|anxiety
1170421|NCT02166281|Depression|depression
1170422|NCT02166281|Restless leg syndrome|restless leg syndrome
1170423|NCT02166281|Aromatase inhibitor|aromatase inhibitor
1170424|NCT02166281|Body composition|body composition
1170425|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1170426|NCT02166268|Allergic rhinitis|allergic rhinitis
1170427|NCT02166268|Allergy|allergy
1170428|NCT02166268|Grass pollen|grass pollen
1170429|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
1170430|NCT02166242|thioredoxin reductase|thioredoxin reductase
1170431|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
1170432|NCT02166216|Healthy subjects|healthy subjects
1170433|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
1170434|NCT02166216|Troponin|troponin
1170435|NCT02166216|Leisure sports athletes|leisure sports athletes
1170436|NCT02166216|Cycling|cycling
1170437|NCT02166216|CT coronary angiography|ct coronary angiography
1170438|NCT02166216|Outcomes|outcomes
1170439|NCT02166190|Pancreatic cancer|pancreatic cancer
1170440|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
1170441|NCT02166190|radiofrequency ablation|radiofrequency ablation
1170442|NCT02166164|Pain|pain
1170443|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
1170444|NCT02166164|thermal sensitization|thermal sensitization
1170445|NCT02166164|Catastrophization|catastrophization
1170446|NCT02166164|Anxiety|anxiety
1170447|NCT02166125|gastric bypass|gastric bypass
1170448|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
1170449|NCT02166125|esophageal stent|esophageal stent
1170450|NCT02166125|suturing|suturing
1170451|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
1170452|NCT02166112|Biologic implant|biologic implant
1170453|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
1170454|NCT02166047|Hepatitis B|hepatitis b
1170455|NCT02166047|HBV|hbv
1170456|NCT02166047|GS-9620|gs-9620
1170457|NCT02166047|TLR-7 Agonist|tlr-7 agonist
1170458|NCT02166034|children|children
1170459|NCT02166034|fruit|fruit
1170460|NCT02166034|vegetable|vegetable
1170461|NCT02166034|diet|diet
1170462|NCT02166034|school|school
1170463|NCT02166034|garden|garden
1170464|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
1170465|NCT02166021|Stem Cells|stem cells
1170466|NCT02166008|Repamipide|repamipide
1170467|NCT02166008|Dual antiplatelet|dual antiplatelet
1170468|NCT02166008|Peptic ulcer|peptic ulcer
1170469|NCT02165995|Brain Tumor|brain tumor
1170470|NCT02165995|Glioma|glioma
1170471|NCT02165995|Tumor resection|tumor resection
1170472|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
1170473|NCT02165995|nTMS|ntms
1170474|NCT02165995|Brain mapping|brain mapping
1170475|NCT02165995|Motor function|motor function
1170476|NCT02165995|Speech function|speech function
1170477|NCT02165995|Speech mapping|speech mapping
1170479|NCT02165969|inflammatory process|inflammatory process
1170480|NCT02165969|fracture|fracture
1170481|NCT02165969|defect|defect
1170482|NCT02165956|Cereals|cereals
1170483|NCT02165956|Obesity|obesity
1170484|NCT02165956|Complementary Feeding|complementary feeding
1170485|NCT02165930|Bioavailability|bioavailability
1170486|NCT02165930|oxycodone|oxycodone
1170487|NCT02165930|ethanol interaction|ethanol interaction
1170488|NCT02165930|healthy volunteers|healthy volunteers
1170489|NCT02165917|Endometriosis|endometriosis
1170490|NCT02165917|Adhesions|adhesions
1170491|NCT02165917|Hyalobarrier®|hyalobarrier®
1170492|NCT02165917|Hyaluronic acid|hyaluronic acid
1170493|NCT02165917|Antiadhesion agent|antiadhesion agent
1170494|NCT02165917|Adhesionbarrier|adhesionbarrier
1170495|NCT02165917|Pregnancy rate|pregnancy rate
1170496|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
1170497|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
1170498|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
1170499|NCT02165865|hand transplantation|hand transplantation
1170500|NCT02165865|hand allotransplantation|hand allotransplantation
1170501|NCT02165865|upper extremity transplantation|upper extremity transplantation
1170502|NCT02165865|upper extremity amputation|upper extremity amputation
1170503|NCT02165865|hand amputation|hand amputation
1170504|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
1170505|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
1170506|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
1170507|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
1170508|NCT02165852|ampulla of Vater|ampulla of vater
1170509|NCT02165852|adenoma|adenoma
1170510|NCT02165852|papillectomy|papillectomy
1170511|NCT02165852|injection|injection
1170512|NCT02165852|non-injection|non-injection
1170513|NCT02165826|Drug therapy|drug therapy
1170514|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
1170515|NCT02165761|Hemodialysis|hemodialysis
1170516|NCT02165761|End Stage Renal Disease|end stage renal disease
1170517|NCT02165761|Vascular Graft|vascular graft
1170518|NCT02165722|Influenza|influenza
1170519|NCT02165722|HPV|hpv
1170520|NCT02165722|Tdap|tdap
1170521|NCT02165722|MCV|mcv
1170522|NCT02165722|vaccination|vaccination
1170523|NCT02165722|adolescents|adolescents
1170524|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
1170525|NCT02165683|Cancer|cancer
1170526|NCT02165683|Pediatric|pediatric
1170527|NCT02165683|PET Scan|pet scan
1170528|NCT02165670|Ischemic heart disesase|ischemic heart disesase
1170529|NCT02165670|Myocardial infarction|myocardial infarction
1170530|NCT02165670|Angina pectoris|angina pectoris
1170531|NCT02165657|Excimer laser|excimer laser
1170532|NCT02165657|UVB|uvb
1170533|NCT02165657|Psoriasis|psoriasis
1170534|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1170535|NCT02165644|Vasospasm|vasospasm
1170536|NCT02165644|Acetazolamide|acetazolamide
1170537|NCT02165618|frailty|frailty
1170538|NCT02165618|geriatric, elderly|geriatric, elderly
1170539|NCT02165618|polypharmacy|polypharmacy
1170540|NCT02165605|external beam radiotherapy|external beam radiotherapy
1170541|NCT02165605|breast cancer|breast cancer
1170542|NCT02165592|Hemophilia|hemophilia
1170543|NCT02165592|Arthropathy|arthropathy
1170544|NCT02165592|Range of Motion|range of motion
1170545|NCT02165592|Strength|strength
1170546|NCT02165592|Proprioception|proprioception
1170547|NCT02165592|Gait|gait
1170548|NCT02165592|Quality of Life|quality of life
1170549|NCT02165579|procalcitonin|procalcitonin
1170550|NCT02165579|biomarkers|biomarkers
1170551|NCT02165579|Osteomyelitis|osteomyelitis
1170552|NCT02165579|diabetes|diabetes
1170553|NCT02165579|foot ulcer(s)|foot ulcer(s)
1170554|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
1170555|NCT02165566|intensive insulin therapy|intensive insulin therapy
1170556|NCT02165566|critical care patients|critical care patients
1170557|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
1170558|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
1170559|NCT02165553|Blood Pressure|blood pressure
1170560|NCT02165553|Vascular Function|vascular function
1170561|NCT02165553|Inflammation|inflammation
1170562|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
1170563|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
1170564|NCT02165540|Doula|doula
1170565|NCT02165540|Pain management|pain management
1170566|NCT02165540|Miscarriage|miscarriage
1170567|NCT02165540|Abortion|abortion
1170568|NCT02165514|spinal curvatures|spinal curvatures
1170569|NCT02165488|ketamine|ketamine
1170570|NCT02165488|abuse|abuse
1170571|NCT02165488|abdominal discomfort|abdominal discomfort
1170572|NCT02165488|cholangiopathy|cholangiopathy
1170573|NCT02165462|Haemophilia|haemophilia
1170574|NCT02165462|Arthropathy|arthropathy
1170575|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
1170576|NCT02165462|Proprioception|proprioception
1170577|NCT02165449|ketamine|ketamine
1170578|NCT02165449|major depression|major depression
1170579|NCT02165449|imaging|imaging
1170580|NCT02165449|gene expression|gene expression
1170581|NCT02165423|pediatric|pediatric
1170582|NCT02165423|solid organ transplant|solid organ transplant
1170583|NCT02165423|parents|parents
1170584|NCT02165423|heart|heart
1170585|NCT02165423|kidney|kidney
1170586|NCT02165423|liver|liver
1170587|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
1170588|NCT02165397|Ibrutinib|ibrutinib
1170589|NCT02165397|Pharmacyclics|pharmacyclics
1170590|NCT02165397|PCYC|pcyc
1170591|NCT02165397|Lymphoma|lymphoma
1170592|NCT02165397|Btk inhibitor|btk inhibitor
1170593|NCT02165397|WM|wm
1170594|NCT02165397|Rituximab|rituximab
1170595|NCT02165397|Rituxan|rituxan
1170596|NCT02165397|Waldenström's|waldenström's
1170597|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1170598|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
1170599|NCT02165397|NHL|nhl
1170600|NCT02165384|tympanostomy|tympanostomy
1170601|NCT02165384|myringotomy|myringotomy
1170602|NCT02165384|otitis media|otitis media
1170603|NCT02165384|ear tubes|ear tubes
1170604|NCT02165384|ear infection|ear infection
1170605|NCT02165358|BMD|bmd
1170606|NCT02165358|LGMD2I|lgmd2i
1170607|NCT02165358|Calf enlargement|calf enlargement
1170608|NCT02165358|Muscular dystrophy|muscular dystrophy
1170609|NCT02165358|MRI|mri
1170610|NCT02165306|epilepsy|epilepsy
1170611|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
1170612|NCT02165280|Surgery|surgery
1170613|NCT02165254|physical activity|physical activity
1170614|NCT02165254|coronary heart disease|coronary heart disease
1170615|NCT02165254|exercise|exercise
1170616|NCT02165254|affect|affect
1170617|NCT02165254|mind/body therapies|mind/body therapies
1170618|NCT02165254|stress, psychological|stress, psychological
1170619|NCT02165241|Hypertension|hypertension
1170620|NCT02165241|Cardiac remodeling|cardiac remodeling
1170621|NCT02165241|Immune system|immune system
1170622|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
1170623|NCT02165202|long-acting injectable;|long-acting injectable;
1170624|NCT02165202|HIV PrEP;|hiv prep;
1170625|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
1170626|NCT02165189|Simeprevir|simeprevir
1170627|NCT02165189|Sofosbuvir|sofosbuvir
1170628|NCT02165189|Ribavirin|ribavirin
1170629|NCT02165189|Hepatitits C|hepatitits c
1170630|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
1170631|NCT02165176|cannabis|cannabis
1170632|NCT02165176|toxicology|toxicology
1170633|NCT02165176|intoxication|intoxication
1170634|NCT02165150|Elastic Band|elastic band
1170635|NCT02165150|Institutional Elders|institutional elders
1170636|NCT02165150|Functional Fitness|functional fitness
1170637|NCT02165150|Sleep Quality|sleep quality
1170638|NCT02165150|Depression|depression
1170639|NCT02165137|trauma|trauma
1170640|NCT02165137|major trauma|major trauma
1170641|NCT02165137|multiple trauma|multiple trauma
1170642|NCT02165137|outcome|outcome
1170643|NCT02165137|quality|quality
1170644|NCT02165137|process Management|process management
1170645|NCT02165137|emergency room|emergency room
1170646|NCT02165137|trauma center|trauma center
1170647|NCT02165124|Obesity|obesity
1170648|NCT02165124|Morbid Obesity|morbid obesity
1170649|NCT02165124|Bariatric Surgery|bariatric surgery
1170650|NCT02165124|Embolization|embolization
1170651|NCT02165124|Minimally Invasive|minimally invasive
1170652|NCT02165124|Weight Loss|weight loss
1170653|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
1170654|NCT02165111|Raynaud Disease|raynaud disease
1170655|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
1170656|NCT02165085|Biomarkers|biomarkers
1170657|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
1170658|NCT02165085|Pathophysiology|pathophysiology
1170659|NCT02165072|Inferior vena cava|inferior vena cava
1170660|NCT02165072|Kidney injury|kidney injury
1170661|NCT02165072|Ultrasound|ultrasound
1170662|NCT02165059|Nausea|nausea
1170663|NCT02165059|Vomiting|vomiting
1170664|NCT02165059|Functional dyspepsia|functional dyspepsia
1170665|NCT02165059|Bloating|bloating
1170666|NCT02165059|Regurgitation|regurgitation
1170667|NCT02165059|Retching|retching
1170668|NCT02165020|Prostate|prostate
1170669|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
1170670|NCT02165020|Hyaluronic acid|hyaluronic acid
1170671|NCT02165020|Spacer|spacer
1170672|NCT02165020|Rectum toxicity|rectum toxicity
1170673|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
1170674|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
1170675|NCT02164968|Device investigation|device investigation
1170676|NCT02164955|Pomalidomide|pomalidomide
1170677|NCT02164955|Multiple Myeloma|multiple myeloma
1170678|NCT02164955|Relapsed, Refractory|relapsed, refractory
1170679|NCT02164955|Observational|observational
1170680|NCT02164955|Imnovid|imnovid
1170681|NCT02164955|Registry|registry
1170682|NCT02164955|Post-approval|post-approval
1170683|NCT02164955|Safety|safety
1170684|NCT02164929|TAP block|tap block
1170685|NCT02164929|Paravertebral block|paravertebral block
1170686|NCT02164929|Epidural|epidural
1170687|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
1170688|NCT02164916|BRAF Mutant|braf mutant
1170689|NCT02164916|Metastatic|metastatic
1170690|NCT02164903|Quality of Life|quality of life
1170691|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
1170692|NCT02164903|Imatinib|imatinib
1170693|NCT02164903|Dasatinib|dasatinib
1170694|NCT02164877|Dietary fiber|dietary fiber
1170695|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
1170696|NCT02164851|pathologic process|pathologic process
1170697|NCT02164799|Shock|shock
1170698|NCT02164799|Predicting diagnosis|predicting diagnosis
1170699|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
1170700|NCT02164786|Acute severe disease|acute severe disease
1170701|NCT02164786|Intensive care unit|intensive care unit
1170702|NCT02164786|adult|adult
1170703|NCT02164786|cohort study|cohort study
1170704|NCT02164786|metabolomics|metabolomics
1170706|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
1170707|NCT02164773|sevoflurane|sevoflurane
1170708|NCT02164773|pediatric|pediatric
1170709|NCT02164773|lower abdominal surgery|lower abdominal surgery
1170710|NCT02164773|caudal|caudal
1171007|NCT02163538|ligasure|ligasure
1170711|NCT02164773|magnesium sulfate|magnesium sulfate
1170712|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
1170713|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
1170714|NCT02164760|burns|burns
1170715|NCT02164760|dermal substitute|dermal substitute
1170716|NCT02164760|scar quality|scar quality
1170717|NCT02164760|reconstruction|reconstruction
1170718|NCT02164760|wound healing|wound healing
1170719|NCT02164760|wound closure|wound closure
1170720|NCT02164734|surfactant|surfactant
1170721|NCT02164721|Heart failure|heart failure
1170722|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
1170723|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
1170724|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
1170725|NCT02164695|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1170726|NCT02164695|Remote ischemic perconditioning|remote ischemic perconditioning
1170727|NCT02164695|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1170728|NCT02164695|Cardiac magnetic resonance|cardiac magnetic resonance
1170729|NCT02164682|Hypospadias repair|hypospadias repair
1170730|NCT02164682|Caudal block|caudal block
1170731|NCT02164682|Postoperative complications|postoperative complications
1170732|NCT02164669|Inflammation|inflammation
1170733|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
1170734|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
1170735|NCT02164643|Alzheimer's disease|alzheimer's disease
1170736|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
1170737|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
1170739|NCT02164630|Hope|hope
1170740|NCT02164630|Resilience|resilience
1170741|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
1170742|NCT02164617|Dementia|dementia
1170743|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
1170744|NCT02164617|Long-term care facilities|long-term care facilities
1170745|NCT02164617|Elastic band exercise|elastic band exercise
1170746|NCT02164617|Functional fitness|functional fitness
1170747|NCT02164617|Daily life function|daily life function
1170748|NCT02164617|Depression|depression
1170749|NCT02164617|Problem behaviors|problem behaviors
1170750|NCT02164604|ranibizumab|ranibizumab
1170751|NCT02164604|intravitreal therapy|intravitreal therapy
1170752|NCT02164604|ROP|rop
1170753|NCT02164604|Plus disease|plus disease
1170754|NCT02164604|stage 3 plus|stage 3 plus
1170755|NCT02164591|gastroparesis|gastroparesis
1170756|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
1170757|NCT02164591|GES|ges
1170758|NCT02164591|vomiting|vomiting
1170759|NCT02164591|nausea|nausea
1170760|NCT02164591|bloating|bloating
1170761|NCT02164591|postprandial fullness|postprandial fullness
1170762|NCT02164591|epigastric pain|epigastric pain
1170763|NCT02164552|PCOS|pcos
1170764|NCT02164552|vitamin D|vitamin d
1170765|NCT02164552|insulin resistance|insulin resistance
1170766|NCT02164552|glycemic control|glycemic control
1170767|NCT02164539|GSK573719|gsk573719
1170768|NCT02164539|asthma|asthma
1170769|NCT02164539|UMEC|umec
1170770|NCT02164539|FF|ff
1170771|NCT02164539|GSK2829332|gsk2829332
1170772|NCT02164539|persistent obstruction|persistent obstruction
1170773|NCT02164539|GW685698|gw685698
1170774|NCT02164539|Fluticasone Furoate|fluticasone furoate
1170775|NCT02164539|COPD|copd
1171081|NCT02163213|diarrhea|diarrhea
1170776|NCT02164539|umeclidinium bromide|umeclidinium bromide
1170777|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
1170778|NCT02164526|Left Heart Disease|left heart disease
1170779|NCT02164526|Heart failure|heart failure
1170780|NCT02164526|Registry|registry
1170781|NCT02164526|China|china
1170782|NCT02164513|COPD|copd
1170783|NCT02164513|umeclidinium|umeclidinium
1170784|NCT02164513|fluticasone furoate|fluticasone furoate
1170785|NCT02164513|vilanterol|vilanterol
1170786|NCT02164513|triple therapy|triple therapy
1170787|NCT02164513|exacerbation|exacerbation
1170788|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
1170789|NCT02164461|Adenocarcinoma|adenocarcinoma
1170790|NCT02164461|Carcinoma|carcinoma
1170791|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
1170792|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
1170793|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
1170794|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
1170795|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
1170796|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1170797|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
1170798|NCT02164461|Neoplasms|neoplasms
1170799|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
1170800|NCT02164461|Uterine Neoplasms|uterine neoplasms
1170801|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
1170802|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
1170803|NCT02164461|Neoplasms by Site|neoplasms by site
1170804|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
1170805|NCT02164461|Uterine Diseases|uterine diseases
1170806|NCT02164461|Genital Diseases, Female|genital diseases, female
1170807|NCT02164448|dexmedetomidine|dexmedetomidine
1170808|NCT02164448|postoperative bowel movement|postoperative bowel movement
1170809|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
1170810|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
1170811|NCT02164435|Renal denervation|renal denervation
1170812|NCT02164435|Renal artery|renal artery
1170814|NCT02164422|Drinkers|drinkers
1170815|NCT02164422|Guanfacine|guanfacine
1170816|NCT02164383|Smoking Cessation|smoking cessation
1170817|NCT02164383|Smoking|smoking
1170818|NCT02164383|Nicotine|nicotine
1170819|NCT02164357|Ischaemic Stroke|ischaemic stroke
1170820|NCT02164357|Main artery occlusion|main artery occlusion
1170821|NCT02164357|Endovascular treatment|endovascular treatment
1170822|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
1170823|NCT02164344|HIV|hiv
1170824|NCT02164344|Gut|gut
1170825|NCT02164344|probiotics|probiotics
1170826|NCT02164344|immune activation|immune activation
1170827|NCT02164305|Rotator cuff muscle|rotator cuff muscle
1170828|NCT02164305|Excitability|excitability
1170829|NCT02164305|Proprioception|proprioception
1170830|NCT02164305|Kinematics|kinematics
1170831|NCT02164305|Muscle activity|muscle activity
1170832|NCT02164305|Electromyography|electromyography
1170833|NCT02164292|Liver tumor|liver tumor
1170834|NCT02164292|ALPPS|alpps
1170835|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
1170836|NCT02164292|Morbidity|morbidity
1170837|NCT02164292|Hypertrophy|hypertrophy
1170838|NCT02164279|Microalbuminuria|microalbuminuria
1170839|NCT02164279|diabetic nephropathy|diabetic nephropathy
1170840|NCT02164279|type I diabetes|type i diabetes
1170841|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
1170842|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1170843|NCT02164227|anxiety|anxiety
1170844|NCT02164227|breathing exercise|breathing exercise
1170845|NCT02164227|labour|labour
1170846|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
1170847|NCT02164188|Stress|stress
1170848|NCT02164188|Well-being|well-being
1170849|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
1170850|NCT02164188|Positive psychology|positive psychology
1170851|NCT02164175|HeRO Graft|hero graft
1170852|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
1170853|NCT02164149|Colon cancer|colon cancer
1170854|NCT02164149|Quality of surgery|quality of surgery
1170855|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
1170856|NCT02164123|Autonomic effects|autonomic effects
1170857|NCT02164123|spinal mobilization|spinal mobilization
1170858|NCT02164123|clinical trial|clinical trial
1170859|NCT02164097|ICE|ice
1170860|NCT02164097|ODSH|odsh
1170861|NCT02164097|platelet recovery|platelet recovery
1170862|NCT02164097|recurrent solid tumor|recurrent solid tumor
1170863|NCT02164084|acne|acne
1170864|NCT02164071|Haematological malignancy|haematological malignancy
1170865|NCT02164071|Elderly|elderly
1170866|NCT02164071|Health Status|health status
1170867|NCT02164071|Scale validation|scale validation
1170868|NCT02164058|Myocardial infarction|myocardial infarction
1170869|NCT02164058|STEMI|stemi
1170870|NCT02164058|ST elevation MI|st elevation mi
1170871|NCT02164058|Acute MI|acute mi
1170872|NCT02164019|Pathologic Fractures|pathologic fractures
1170873|NCT02164019|hip replacements|hip replacements
1170874|NCT02164019|12-287|12-287
1170875|NCT02164006|Hodgkin's|hodgkin's
1170876|NCT02163980|dexmedetomidine|dexmedetomidine
1170877|NCT02163980|caudal block|caudal block
1170878|NCT02163980|children|children
1170879|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
1170880|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
1170881|NCT02163967|CES|ces
1170882|NCT02163967|heart rate variability|heart rate variability
1170883|NCT02163967|parasympathetic|parasympathetic
1170884|NCT02163967|Vagal|vagal
1170885|NCT02163954|platelet|platelet
1170886|NCT02163954|ticagrelor|ticagrelor
1170887|NCT02163954|clopidogrel|clopidogrel
1170888|NCT02163954|end stage renal disease|end stage renal disease
1170889|NCT02163954|hemodialysis|hemodialysis
1170890|NCT02163941|PTSD|ptsd
1170891|NCT02163941|empathy|empathy
1170892|NCT02163941|meditation|meditation
1170893|NCT02163941|compassion|compassion
1170894|NCT02163941|inflammation|inflammation
1170895|NCT02163941|oxytocin|oxytocin
1170896|NCT02163941|fMRI|fmri
1170897|NCT02163928|Antioxidants|antioxidants
1170898|NCT02163928|Carotenoids|carotenoids
1170899|NCT02163928|Diet|diet
1170900|NCT02163915|Drug therapy|drug therapy
1170901|NCT02163889|Candida|candida
1170902|NCT02163889|Blood culture|blood culture
1170903|NCT02163889|Antifungal therapy|antifungal therapy
1170904|NCT02163889|Sepsis|sepsis
1170905|NCT02163876|spine|spine
1170906|NCT02163876|injury|injury
1170907|NCT02163876|trauma|trauma
1170908|NCT02163876|spine injury|spine injury
1170909|NCT02163876|cervical spine injury|cervical spine injury
1170910|NCT02163876|cervical spine|cervical spine
1170911|NCT02163876|stemcells transplantation|stemcells transplantation
1170912|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
1170913|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
1170914|NCT02163863|Biomimetic stent|biomimetic stent
1170915|NCT02163863|Helical centerline|helical centerline
1170916|NCT02163837|sleep quality|sleep quality
1170917|NCT02163837|physical activity|physical activity
1170918|NCT02163837|daytime sleepiness|daytime sleepiness
1170919|NCT02163837|actigraphy|actigraphy
1170920|NCT02163837|quality of life|quality of life
1170921|NCT02163824|postsurgical|postsurgical
1170922|NCT02163824|postoperative|postoperative
1170923|NCT02163824|ocular|ocular
1170924|NCT02163824|cataract|cataract
1170925|NCT02163824|inflammation|inflammation
1170926|NCT02163824|pain|pain
1170927|NCT02163824|corticosteroid|corticosteroid
1170928|NCT02163811|Self-management|self-management
1170929|NCT02163811|Functional status|functional status
1170930|NCT02163811|Depression|depression
1170931|NCT02163798|Tai Chi|tai chi
1170932|NCT02163798|Walking|walking
1170933|NCT02163798|Physical activity|physical activity
1170934|NCT02163798|Randomized controlled trial|randomized controlled trial
1170935|NCT02163798|Chinese population|chinese population
1170936|NCT02163798|Exercise|exercise
1170937|NCT02163798|Body composition|body composition
1170938|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
1170939|NCT02163798|Energy expenditure|energy expenditure
1170940|NCT02163798|Fitness|fitness
1170941|NCT02163798|SF-12|sf-12
1170942|NCT02163785|Inferior rectal cancer|inferior rectal cancer
1170943|NCT02163785|Abdominoperineal resection|abdominoperineal resection
1170944|NCT02163785|Miles operation|miles operation
1170945|NCT02163785|Supine Miles operation|supine miles operation
1170946|NCT02163785|Prone Miles operation|prone miles operation
1170947|NCT02163785|Total mesorectal excision|total mesorectal excision
1170948|NCT02163785|Circumferential radial margin|circumferential radial margin
1170949|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
1170950|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
1170951|NCT02163720|ovarian cancer|ovarian cancer
1170952|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
1170953|NCT02163720|relapse|relapse
1170954|NCT02163720|platinum-sensitive|platinum-sensitive
1170955|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
1170956|NCT02163707|Psilocybin|psilocybin
1170957|NCT02163707|Pharmacokinetics|pharmacokinetics
1170958|NCT02163694|PARP Inhibitor|parp inhibitor
1170959|NCT02163694|Veliparib|veliparib
1170960|NCT02163694|BRCA1|brca1
1170961|NCT02163694|BRCA2|brca2
1170962|NCT02163694|HER2-negative|her2-negative
1170963|NCT02163694|Locally recurrent|locally recurrent
1170964|NCT02163694|Breast Cancer|breast cancer
1170965|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
1170966|NCT02163694|ABT-888|abt-888
1170967|NCT02163694|Genetic breast cancer|genetic breast cancer
1170968|NCT02163694|Paclitaxel|paclitaxel
1170969|NCT02163694|BRCA Mutation|brca mutation
1170970|NCT02163694|PARP|parp
1170971|NCT02163694|Carboplatin|carboplatin
1170972|NCT02163668|Yoga|yoga
1170973|NCT02163668|Bone turnover markers|bone turnover markers
1170974|NCT02163668|Bone strength|bone strength
1170975|NCT02163668|Bone mineral density|bone mineral density
1170976|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
1170977|NCT02163642|Bronchiectasis|bronchiectasis
1170978|NCT02163642|Immunity|immunity
1170979|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
1170980|NCT02163629|stress management|stress management
1170981|NCT02163629|cardiac transplantation|cardiac transplantation
1170982|NCT02163629|quality of life|quality of life
1170983|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
1170985|NCT02163616|uterine atony|uterine atony
1170986|NCT02163616|high fever|high fever
1170987|NCT02163616|hyperpyrexia|hyperpyrexia
1170988|NCT02163616|shock index|shock index
1170989|NCT02163590|Spinal mobilisation|spinal mobilisation
1170990|NCT02163590|Pressure pain threshold|pressure pain threshold
1170991|NCT02163590|Thoracic spine|thoracic spine
1170992|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
1170993|NCT02163577|XLH|xlh
1170994|NCT02163577|FGF23|fgf23
1170995|NCT02163577|KRN23|krn23
1170996|NCT02163564|Adolescent|adolescent
1170997|NCT02163564|Depression|depression
1170998|NCT02163564|Insomnia|insomnia
1170999|NCT02163551|dyspnea|dyspnea
1171000|NCT02163551|respiratory sensation|respiratory sensation
1171001|NCT02163551|event-related potentials|event-related potentials
1171002|NCT02163551|spinal cord injury|spinal cord injury
1171003|NCT02163538|energy device|energy device
1171004|NCT02163538|laparoscopic|laparoscopic
1171005|NCT02163538|hysterectomy|hysterectomy
1171006|NCT02163538|enseal|enseal
1171008|NCT02163538|raw tlx|raw tlx
1171009|NCT02163525|Fibroids|fibroids
1171010|NCT02163525|Myomas|myomas
1171011|NCT02163525|leiomyomata|leiomyomata
1171012|NCT02163525|menorrhagia|menorrhagia
1171013|NCT02163525|Acessa Procedure|acessa procedure
1171014|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
1171016|NCT02163525|Acessa|acessa
1171017|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
1171018|NCT02163512|Ascites|ascites
1171019|NCT02163512|Beta blockers treatment|beta blockers treatment
1171020|NCT02163486|I-gel|i-gel
1171021|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
1171022|NCT02163486|head position|head position
1171023|NCT02163460|ventral hernia|ventral hernia
1171024|NCT02163460|seroma|seroma
1171025|NCT02163460|drainage|drainage
1171026|NCT02163460|infection|infection
1171027|NCT02163447|Chemoprevention|chemoprevention
1171028|NCT02163447|Malaria|malaria
1171029|NCT02163447|Uganda|uganda
1171030|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1171031|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1238857|NCT01856257|NULOJIX|nulojix
1171032|NCT02163434|pregnancy|pregnancy
1171033|NCT02163434|nausea|nausea
1171034|NCT02163434|vomiting|vomiting
1171035|NCT02163434|hyperemesis|hyperemesis
1171036|NCT02163434|treatment|treatment
1171037|NCT02163434|gabapentin|gabapentin
1171038|NCT02163434|metoclopramide|metoclopramide
1171039|NCT02163434|safety|safety
1171040|NCT02163421|Drug therapy|drug therapy
1171041|NCT02163408|MRI|mri
1171042|NCT02163408|Plaque Characterization|plaque characterization
1171043|NCT02163395|Ceramic implant|ceramic implant
1171044|NCT02163382|Nava|nava
1171045|NCT02163382|Non Invasive Ventilation|non invasive ventilation
1171046|NCT02163356|neuroblastoma|neuroblastoma
1171047|NCT02163356|recurrent|recurrent
1171048|NCT02163356|resistant|resistant
1171049|NCT02163343|Serum metal ion levels|serum metal ion levels
1171050|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
1171051|NCT02163343|Hip replacement|hip replacement
1171052|NCT02163291|advanced gastric cancer|advanced gastric cancer
1171053|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1171054|NCT02163291|safety|safety
1171055|NCT02163291|feasibility|feasibility
1171056|NCT02163278|DBPR108|dbpr108
1171057|NCT02163278|DPP4|dpp4
1171058|NCT02163278|Diabetes|diabetes
1171059|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
1171060|NCT02163278|Incretins|incretins
1171061|NCT02163239|FloShield|floshield
1171062|NCT02163239|MID|mid
1171063|NCT02163239|Minimally invasive surgery|minimally invasive surgery
1171064|NCT02163239|Minimally Invasive devices|minimally invasive devices
1171065|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
1171066|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
1171067|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
1171068|NCT02163239|Cannula|cannula
1171069|NCT02163239|Blunt Obturator|blunt obturator
1171070|NCT02163239|Cholecystectomy|cholecystectomy
1171071|NCT02163239|Benign hysterectomy|benign hysterectomy
1171072|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
1171073|NCT02163226|Bone metastases|bone metastases
1171074|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
1171075|NCT02163226|Standard Radiation Therapy|standard radiation therapy
1171076|NCT02163226|XRT|xrt
1171077|NCT02163226|Pain control|pain control
1171078|NCT02163226|Palliation of symptoms|palliation of symptoms
1171079|NCT02163226|Questionnaire|questionnaire
1171080|NCT02163226|Survey|survey
1171082|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
1171083|NCT02163200|Bedsores|bedsores
1171084|NCT02163200|pressure|pressure
1171085|NCT02163200|hip|hip
1171086|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
1171087|NCT02163187|sphincter preservation|sphincter preservation
1171088|NCT02163187|rectal polyp|rectal polyp
1171089|NCT02163187|InterStimTM|interstimtm
1171090|NCT02163187|14-100|14-100
1171091|NCT02163174|neonatal|neonatal
1171092|NCT02163174|pentoxifylline|pentoxifylline
1171093|NCT02163174|randomized controlled trial|randomized controlled trial
1171094|NCT02163161|Phase I|phase i
1171095|NCT02163161|Open Label|open label
1171096|NCT02163161|Single dose|single dose
1171097|NCT02163161|Crossover|crossover
1171098|NCT02163161|Bioavailability|bioavailability
1171099|NCT02163161|Fasting|fasting
1171100|NCT02163161|Fed|fed
1171101|NCT02163161|PF-04965842|pf-04965842
1171102|NCT02163161|Healthy|healthy
1171103|NCT02163122|Cat Allergy|cat allergy
1171104|NCT02163122|Feld1|feld1
1171105|NCT02163109|Oxygen consumption|oxygen consumption
1171106|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
1171107|NCT02163109|Cardiac output|cardiac output
1171108|NCT02163070|whey protein|whey protein
1171109|NCT02163070|malnutrition|malnutrition
1171110|NCT02163070|oxidative stress|oxidative stress
1171111|NCT02163070|hemodialysis|hemodialysis
1171112|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
1171113|NCT02163057|Papillomavirus|papillomavirus
1171114|NCT02163031|heart transplant|heart transplant
1171115|NCT02163031|radial approach|radial approach
1171116|NCT02163031|catheterization|catheterization
1171117|NCT02163005|GDL contrast agent|gdl contrast agent
1171118|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
1171119|NCT02162992|SS-A antigen|ss-a antigen
1171120|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1171121|NCT02162992|Atrioventricular Block|atrioventricular block
1171122|NCT02162992|Sudden death|sudden death
1171123|NCT02162979|Parkinson's disease|parkinson's disease
1171124|NCT02162979|PD|pd
1171125|NCT02162979|dyskinesia|dyskinesia
1171126|NCT02162979|treatment|treatment
1171127|NCT02162979|motor complications|motor complications
1171128|NCT02162966|colistin|colistin
1171129|NCT02162966|ICU|icu
1171130|NCT02162966|critical care|critical care
1171131|NCT02162953|eye disease|eye disease
1171132|NCT02162953|retinal|retinal
1171133|NCT02162953|best1|best1
1171134|NCT02162940|low back pain|low back pain
1171135|NCT02162940|epidural steroid injection|epidural steroid injection
1171136|NCT02162940|statin|statin
1171137|NCT02162940|quality of life|quality of life
1171138|NCT02162927|muscular strength|muscular strength
1171139|NCT02162927|muscular endurance|muscular endurance
1171140|NCT02162927|muscular power|muscular power
1171141|NCT02162927|rowing|rowing
1171142|NCT02162927|CrossFit|crossfit
1171143|NCT02162927|dietary nitrate|dietary nitrate
1171144|NCT02162914|Intra-hepatic|intra-hepatic
1171145|NCT02162914|Hilar|hilar
1171146|NCT02162914|Locally Advanced|locally advanced
1171147|NCT02162914|Non Resectable|non resectable
1171148|NCT02162914|Metastatic|metastatic
1171149|NCT02162914|Regorafenib|regorafenib
1171150|NCT02162914|Placebo|placebo
1171151|NCT02162901|Diabetes prevention|diabetes prevention
1171152|NCT02162875|Schistosoma mansoni|schistosoma mansoni
1171153|NCT02162875|treatment|treatment
1171154|NCT02162875|school children|school children
1171155|NCT02162875|adults|adults
1171156|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
1171157|NCT02162862|Physical Illness|physical illness
1171158|NCT02162862|Wellbutrin|wellbutrin
1171159|NCT02162849|Tobacco Use Cessation|tobacco use cessation
1171160|NCT02162849|Smoking Cessation|smoking cessation
1171161|NCT02162849|Cancer Prevention|cancer prevention
1171162|NCT02162849|Behavioral Counseling|behavioral counseling
1171163|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
1171164|NCT02162849|NRT|nrt
1171165|NCT02162849|Nicotine patch|nicotine patch
1171166|NCT02162849|Placebo patch|placebo patch
1171167|NCT02162849|Placebo pill|placebo pill
1171168|NCT02162849|Sugar pill|sugar pill
1171169|NCT02162849|Varenicline|varenicline
1171170|NCT02162849|Chantix|chantix
1171171|NCT02162849|Questionnaires|questionnaires
1171172|NCT02162849|Surveys|surveys
1171173|NCT02162849|Saliva test|saliva test
1171174|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
1171175|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1171176|NCT02162836|Prostate Cancer|prostate cancer
1171177|NCT02162836|Androgen Receptor|androgen receptor
1171178|NCT02162836|JNJ-56021927|jnj-56021927
1171179|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
1171180|NCT02162810|hypospadias|hypospadias
1171181|NCT02162797|HIV|hiv
1171182|NCT02162797|AIDS|aids
1171183|NCT02162797|zinc|zinc
1171184|NCT02162797|zinc supplement|zinc supplement
1171185|NCT02162797|immunological deficiency|immunological deficiency
1171186|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
1171187|NCT02162758|Drug therapy|drug therapy
1171188|NCT02162745|Bronchiolitis|bronchiolitis
1171189|NCT02162745|Normal saline solution|normal saline solution
1171190|NCT02162745|Hypertonic solution|hypertonic solution
1171191|NCT02162745|Nasal irrigation|nasal irrigation
1171192|NCT02162680|local anesthesia|local anesthesia
1171193|NCT02162680|intravenous catheter|intravenous catheter
1171194|NCT02162654|neuroprotection|neuroprotection
1171195|NCT02162654|ischemic preconditioning|ischemic preconditioning
1171196|NCT02162654|cerebral aneurysm|cerebral aneurysm
1171197|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
1171198|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
1171199|NCT02162628|Sexual Dysfunction|sexual dysfunction
1171200|NCT02162628|Mesh|mesh
1171201|NCT02162628|POP|pop
1171202|NCT02162628|Transvaginal|transvaginal
1171203|NCT02162628|Total Repair|total repair
1171204|NCT02162628|Uterine Prolapse|uterine prolapse
1171205|NCT02162628|Cystocele|cystocele
1171206|NCT02162628|Rectocele|rectocele
1171207|NCT02162628|Enterocele|enterocele
1171208|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
1171209|NCT02162628|Native Tissue Repair|native tissue repair
1171210|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
1171211|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
1171212|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
1171213|NCT02162628|Vaginal Mesh|vaginal mesh
1171214|NCT02162628|Transvaginal Mesh|transvaginal mesh
1171215|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
1171216|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
1171217|NCT02162615|Sexual Dysfunction|sexual dysfunction
1171218|NCT02162615|Mesh|mesh
1171219|NCT02162615|POP|pop
1171220|NCT02162615|Transvaginal|transvaginal
1171221|NCT02162615|Anterior|anterior
1171222|NCT02162615|Posterior|posterior
1171223|NCT02162615|Apical|apical
1171224|NCT02162615|Uterine Prolapse|uterine prolapse
1171225|NCT02162615|Cystocele|cystocele
1171226|NCT02162615|Rectocele|rectocele
1171227|NCT02162615|Enterocele|enterocele
1171228|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
1171229|NCT02162615|Native Tissue Repair|native tissue repair
1171230|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
1171231|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
1171232|NCT02162615|Restorelle Direct Fix|restorelle direct fix
1171233|NCT02162615|Vaginal Mesh|vaginal mesh
1171234|NCT02162615|Transvaginal Mesh|transvaginal mesh
1171235|NCT02162576|asthma|asthma
1171236|NCT02162576|asthma control|asthma control
1171237|NCT02162576|healthcare utilization costs|healthcare utilization costs
1171238|NCT02162576|community hotspots|community hotspots
1171239|NCT02162576|public health research|public health research
1171240|NCT02162563|Colorectal cancer|colorectal cancer
1171241|NCT02162563|Chemotherapy|chemotherapy
1171242|NCT02162563|Anti-EGFR|anti-egfr
1171243|NCT02162563|Liver metastases|liver metastases
1171244|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
1171245|NCT02162563|Resectability of liver|resectability of liver
1171246|NCT02162563|Liver expert panel|liver expert panel
1171247|NCT02162550|Type 2 Diabetes|type 2 diabetes
1171248|NCT02162550|Cardiovascular Disease|cardiovascular disease
1171249|NCT02162550|Hyperglycemia|hyperglycemia
1171250|NCT02162550|Carotid Plaque|carotid plaque
1171251|NCT02162550|Endothelial function|endothelial function
1171252|NCT02162550|Incretins|incretins
1171253|NCT02162550|Atherosclerosis|atherosclerosis
1171254|NCT02162537|Strategy|strategy
1171255|NCT02162537|Radiotherapy|radiotherapy
1171256|NCT02162537|Chemotherapy|chemotherapy
1171257|NCT02162537|Cisplatin|cisplatin
1171258|NCT02162524|aerobic exercise|aerobic exercise
1171259|NCT02162524|obesity|obesity
1171260|NCT02162524|energy balance|energy balance
1171261|NCT02162511|Haplocompatible|haplocompatible
1171262|NCT02162511|Stem cell transplant|stem cell transplant
1171263|NCT02162511|Borderline organ function|borderline organ function
1171264|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
1171265|NCT02162498|Peer support|peer support
1171266|NCT02162498|Adherence|adherence
1171267|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
1171268|NCT02162498|Early infant diagnosis|early infant diagnosis
1171269|NCT02162498|Stigma and disclosure|stigma and disclosure
1171270|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
1171271|NCT02162459|Adolescent|adolescent
1171272|NCT02162459|supplements|supplements
1171273|NCT02162459|strength|strength
1171274|NCT02162459|whey protein|whey protein
1171275|NCT02162459|bench press strength|bench press strength
1171276|NCT02162459|squat strength|squat strength
1171277|NCT02162420|severe aplastic anemia|severe aplastic anemia
1171404|NCT02161861|tripeptide FEE|tripeptide fee
1171278|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1171279|NCT02162381|Humphrey visual fields|humphrey visual fields
1171280|NCT02162381|methylphenidate|methylphenidate
1171281|NCT02162381|attention deficit disorder|attention deficit disorder
1171282|NCT02162381|MoCa questionnaire|moca questionnaire
1171283|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
1171284|NCT02162342|upper extremity|upper extremity
1171285|NCT02162342|muscle activity|muscle activity
1171286|NCT02162342|kinematics|kinematics
1171287|NCT02162342|motion capture|motion capture
1171288|NCT02162342|Electromyography|electromyography
1171289|NCT02162329|Breast Cancer|breast cancer
1171290|NCT02162329|Cognitive function|cognitive function
1171291|NCT02162329|Questionnaires|questionnaires
1171292|NCT02162329|Surveys|surveys
1171293|NCT02162329|Electroencephalography|electroencephalography
1171295|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
1171296|NCT02162329|fMRI|fmri
1171297|NCT02162329|Tibetan meditation|tibetan meditation
1171298|NCT02162329|Quality of life|quality of life
1171299|NCT02162329|QOL|qol
1171300|NCT02162303|Atherosclerosis|atherosclerosis
1171301|NCT02162303|Vascular|vascular
1171302|NCT02162303|Cardiovascular|cardiovascular
1171303|NCT02162303|Coronary artery disease|coronary artery disease
1171304|NCT02162303|Imaging|imaging
1171305|NCT02162303|PET|pet
1171306|NCT02162303|Scan|scan
1171307|NCT02162303|anti-inflammatory|anti-inflammatory
1171308|NCT02162277|To decrease|to decrease
1171309|NCT02162277|number|number
1171310|NCT02162277|osteoporotic|osteoporotic
1171311|NCT02162277|patients in|patients in
1171312|NCT02162277|Kami-Ina area|kami-ina area
1171313|NCT02162277|Nagano prefecture|nagano prefecture
1171314|NCT02162264|Alzheimer's Disease|alzheimer's disease
1171315|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
1171316|NCT02162251|Alzheimer's Disease|alzheimer's disease
1171317|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
1171318|NCT02162238|zinc|zinc
1171319|NCT02162238|diet|diet
1171320|NCT02162238|water|water
1171321|NCT02162238|morbidity|morbidity
1171322|NCT02162238|growth|growth
1171323|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
1171324|NCT02162225|Platelet Activation|platelet activation
1171325|NCT02162225|Platelet Aggregation|platelet aggregation
1171326|NCT02162225|Nitrite|nitrite
1171327|NCT02162225|Sickle Cell Anemia|sickle cell anemia
1171328|NCT02162225|Diet Therapy|diet therapy
1171329|NCT02162199|Antibiotic|antibiotic
1171330|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
1171331|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
1171332|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
1239225|NCT01854632|Africa|africa
1171333|NCT02162186|Hip Joint/radiography|hip joint/radiography
1171334|NCT02162186|Hip Joint/surgery|hip joint/surgery
1171335|NCT02162186|Hip Prosthesis|hip prosthesis
1171336|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
1171337|NCT02162186|Female|female
1171338|NCT02162186|Male|male
1171339|NCT02162186|Adult|adult
1171340|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
1171341|NCT02162173|Non-ampullary polyp|non-ampullary polyp
1171342|NCT02162173|Ampullary polyp|ampullary polyp
1171343|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
1171344|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
1171345|NCT02162160|probiotic|probiotic
1171346|NCT02162160|post-menopausal|post-menopausal
1171347|NCT02162160|atrophic vaginitis|atrophic vaginitis
1171348|NCT02162147|patient safety|patient safety
1171349|NCT02162147|pediatrics|pediatrics
1171350|NCT02162147|emergency medicine|emergency medicine
1171351|NCT02162134|cholecystectomy|cholecystectomy
1171352|NCT02162134|laparoscopic|laparoscopic
1171353|NCT02162134|postoperative|postoperative
1171354|NCT02162134|ileus|ileus
1171355|NCT02162134|chewing gum|chewing gum
1171356|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1171357|NCT02162095|Coronary artery disease|coronary artery disease
1171358|NCT02162095|Coronary calcium score|coronary calcium score
1171359|NCT02162043|Glaucoma|glaucoma
1171360|NCT02162043|Perimetry|perimetry
1171361|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
1171362|NCT02162043|Screening|screening
1171363|NCT02162043|Visual fields|visual fields
1171364|NCT02162017|Acute ischemic stroke|acute ischemic stroke
1171365|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
1171366|NCT02162017|Head position|head position
1171367|NCT02162017|Lying flat head position|lying flat head position
1171368|NCT02162017|Sitting up head position|sitting up head position
1171369|NCT02162017|Death|death
1171370|NCT02162017|Disability|disability
1171371|NCT02162017|Clinical trial|clinical trial
1171372|NCT02162004|Type 1 diabetes|type 1 diabetes
1171373|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
1171374|NCT02162004|Insulin pump|insulin pump
1171375|NCT02162004|Sensor-augmented pump|sensor-augmented pump
1171376|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
1171377|NCT02161991|aprepitant|aprepitant
1171378|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
1171379|NCT02161978|antiangiogenic|antiangiogenic
1171380|NCT02161978|cancer|cancer
1171381|NCT02161978|vascular|vascular
1171382|NCT02161978|biomarker|biomarker
1171383|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1171384|NCT02161965|Anticoagulation|anticoagulation
1171385|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
1171386|NCT02161965|Arterial stiffness|arterial stiffness
1171387|NCT02161965|Biomarker|biomarker
1171388|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
1171389|NCT02161926|Obesity|obesity
1171390|NCT02161926|dietary restrictions|dietary restrictions
1171391|NCT02161926|metabolism|metabolism
1171392|NCT02161926|nutrition|nutrition
1171393|NCT02161926|elderly|elderly
1171394|NCT02161874|edentulism|edentulism
1171395|NCT02161874|dental implants|dental implants
1171396|NCT02161874|clinical study|clinical study
1171397|NCT02161874|endosseous|endosseous
1171398|NCT02161874|randomized|randomized
1171399|NCT02161874|crestal bone level|crestal bone level
1171401|NCT02161874|Nanotite Certain|nanotite certain
1171402|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
1171403|NCT02161874|Tapered|tapered
1171405|NCT02161861|fertilization rates|fertilization rates
1171406|NCT02161861|embryos|embryos
1171407|NCT02161861|oocytes|oocytes
1171408|NCT02161835|Congenital myotonia|congenital myotonia
1171409|NCT02161835|Myotonia congenita|myotonia congenita
1171410|NCT02161835|Thomsons disease|thomsons disease
1171411|NCT02161835|Becker type|becker type
1171412|NCT02161835|Training|training
1171413|NCT02161835|Exercise|exercise
1171414|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
1171415|NCT02161809|MVPA|mvpa
1171416|NCT02161809|Healthy Eating|healthy eating
1171417|NCT02161809|children|children
1171418|NCT02161809|childhood obesity|childhood obesity
1171419|NCT02161796|Phase 1|phase 1
1171420|NCT02161796|FG-4592|fg-4592
1171421|NCT02161796|Age/gender comparison|age/gender comparison
1171422|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1171423|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
1171424|NCT02161757|Asthma|asthma
1171425|NCT02161757|Reactive Airways|reactive airways
1171426|NCT02161757|Respiratory Tract Disease|respiratory tract disease
1572827|NCT00491335|Nicotine|nicotine
1171427|NCT02161757|Obstructive Lung Disease|obstructive lung disease
1171428|NCT02161757|Lung Diseases|lung diseases
1171429|NCT02161744|Adipose derived stem cells|adipose derived stem cells
1171430|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
1171431|NCT02161744|Pulmonary Function Tests|pulmonary function tests
1171432|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1171433|NCT02161718|Alkermes|alkermes
1171434|NCT02161718|Schizophrenia|schizophrenia
1171435|NCT02161718|Alcohol Use Disorder|alcohol use disorder
1171436|NCT02161718|ALKS 3831|alks 3831
1171437|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
1171438|NCT02161705|pain control|pain control
1171439|NCT02161705|post mastectomy pain control|post mastectomy pain control
1171440|NCT02161679|Antibody drug conjugate|antibody drug conjugate
1171441|NCT02161679|IMMU-132|immu-132
1171442|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
1171443|NCT02161679|Safety and tolerability|safety and tolerability
1171444|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
1171445|NCT02161666|Obesity|obesity
1171446|NCT02161666|Gastric Bypass|gastric bypass
1171447|NCT02161666|Bariatric Surgery|bariatric surgery
1171448|NCT02161666|Incretin Function|incretin function
1171449|NCT02161666|Islet Function|islet function
1171450|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
1171451|NCT02161653|survival|survival
1171452|NCT02161653|oxidative stress|oxidative stress
1171453|NCT02161627|spinal cord stimulation|spinal cord stimulation
1171454|NCT02161627|automatic control|automatic control
1171455|NCT02161614|hormone replacement therapy|hormone replacement therapy
1171456|NCT02161614|Dopplervelocimetry|dopplervelocimetry
1171457|NCT02161614|Flow-mediated dilation|flow-mediated dilation
1171458|NCT02161614|menopause|menopause
1171459|NCT02161614|Estradiol valerate|estradiol valerate
1171460|NCT02161601|Cricoid pressure|cricoid pressure
1171461|NCT02161601|Rapid Sequence Induction|rapid sequence induction
1171462|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
1171463|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
1171464|NCT02161497|Medical History Taking|medical history taking
1171465|NCT02161497|Electronic Health Records|electronic health records
1171466|NCT02161497|Pediatrics|pediatrics
1171467|NCT02161497|Parents|parents
1171468|NCT02161484|Peripheral Nerve Block|peripheral nerve block
1171469|NCT02161484|Total Hip Replacement|total hip replacement
1171470|NCT02161471|Atria, Heart|atria, heart
1171471|NCT02161471|Function, Atrial|function, atrial
1171472|NCT02161471|Heart Defects, Congenital|heart defects, congenital
1171473|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
1171474|NCT02161471|Congenital Abnormalities|congenital abnormalities
1171475|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
1171476|NCT02161471|Transposition of Great Arteries|transposition of great arteries
1171477|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
1171478|NCT02161458|Escitalopram|escitalopram
1171479|NCT02161458|Amyloid Beta|amyloid beta
1171480|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
1171481|NCT02161445|impedance|impedance
1171482|NCT02161445|pep|pep
1171483|NCT02161445|tevg|tevg
1171484|NCT02161445|dyspnea|dyspnea
1171485|NCT02161445|AHF|ahf
1171486|NCT02161445|BNP|bnp
1171487|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
1171488|NCT02161419|First line|first line
1171489|NCT02161419|Extensive disease|extensive disease
1171490|NCT02161419|Small cell lung cancer|small cell lung cancer
1171491|NCT02161406|Scleroderma|scleroderma
1171492|NCT02161393|Physical Activity|physical activity
1171493|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
1171494|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1171495|NCT02161380|Gene therapy|gene therapy
1171496|NCT02161380|Mitochondrial Genes|mitochondrial genes
1171497|NCT02161380|Leber's|leber's
1171498|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
1171499|NCT02161367|colorectal surgery|colorectal surgery
1171500|NCT02161367|postoperative ileus|postoperative ileus
1171501|NCT02161367|simethicone|simethicone
1171502|NCT02161367|randomized controlled trial|randomized controlled trial
1171503|NCT02161367|double blind|double blind
1171504|NCT02161367|pilot study|pilot study
1171505|NCT02161367|anti-foaming agent|anti-foaming agent
1171506|NCT02161367|abdominal pain|abdominal pain
1171607|NCT02160938|microarray|microarray
1171507|NCT02161367|abdominal distention|abdominal distention
1171508|NCT02161367|nausea vomiting|nausea vomiting
1171509|NCT02161367|flatus|flatus
1171510|NCT02161367|bowel movement|bowel movement
1171511|NCT02161367|placebo|placebo
1171512|NCT02161367|postoperative complications|postoperative complications
1171513|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
1171514|NCT02161367|hydrated silica gel|hydrated silica gel
1171515|NCT02161367|gas bubbles|gas bubbles
1171516|NCT02161367|intestinal tract|intestinal tract
1171517|NCT02161354|Dental Pain|dental pain
1171518|NCT02161354|Acute Pain|acute pain
1171519|NCT02161354|Mild Pain|mild pain
1171520|NCT02161354|Moderate Pain|moderate pain
1171521|NCT02161341|Bacterial microbiome|bacterial microbiome
1171522|NCT02161341|Gene expression|gene expression
1171523|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
1171524|NCT02161302|Endometriosis|endometriosis
1171525|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1171526|NCT02161302|tDCS|tdcs
1171527|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
1171528|NCT02161302|NIRS|nirs
1171529|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
1171530|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
1171531|NCT02161263|LASIK|lasik
1171532|NCT02161263|Satisfaction|satisfaction
1171533|NCT02161237|Acute rejection|acute rejection
1171534|NCT02161237|Advagraf|advagraf
1171535|NCT02161237|Renal function|renal function
1171536|NCT02161224|Phase 1|phase 1
1171537|NCT02161224|FG-4592|fg-4592
1171538|NCT02161224|Single dose|single dose
1171539|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
1171540|NCT02161211|alcohol|alcohol
1171541|NCT02161211|anxiety|anxiety
1171542|NCT02161198|Panax ginseng CA|panax ginseng ca
1171543|NCT02161198|ginsan|ginsan
1171544|NCT02161198|polysaccharide|polysaccharide
1171545|NCT02161198|immunity|immunity
1171546|NCT02161198|natural killer cell|natural killer cell
1171547|NCT02161185|Epilepsy|epilepsy
1171548|NCT02161185|seizure cluster|seizure cluster
1171549|NCT02161185|acute repetitive seizures|acute repetitive seizures
1171550|NCT02161185|open-label|open-label
1171551|NCT02161185|intranasal Midazolam|intranasal midazolam
1171552|NCT02161185|USL261|usl261
1171553|NCT02161185|Upsher-Smith|upsher-smith
1171554|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
1171555|NCT02161172|Cognitive outcome|cognitive outcome
1171556|NCT02161172|Psychological outcome|psychological outcome
1171557|NCT02161133|Veterans|veterans
1171558|NCT02161133|neuropsychology|neuropsychology
1171559|NCT02161133|fatigue|fatigue
1171560|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
1171561|NCT02161133|Gulf War Illness|gulf war illness
1171562|NCT02161133|behavioral treatment|behavioral treatment
1171563|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
1171564|NCT02161107|Grass|grass
1171565|NCT02161107|Allergy|allergy
1171566|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
1171567|NCT02161107|rhinitis|rhinitis
1171568|NCT02161107|asthma|asthma
1171569|NCT02161094|Community management incentives|community management incentives
1171570|NCT02161081|Myocardial ischemia|myocardial ischemia
1171571|NCT02161081|Coronary artery disease|coronary artery disease
1171572|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
1171573|NCT02161081|Modified scan protocol|modified scan protocol
1171574|NCT02161081|Diagnostic performance|diagnostic performance
1171575|NCT02161081|Radiation dose|radiation dose
1171576|NCT02161068|ADPKD|adpkd
1171577|NCT02161068|Chart Review|chart review
1171578|NCT02161068|PKD Genotyping|pkd genotyping
1171579|NCT02161055|Insulin|insulin
1171580|NCT02161055|Hyperglycemia|hyperglycemia
1171581|NCT02161055|Postoperative Mortality|postoperative mortality
1171582|NCT02161055|Intensive insulin therapy|intensive insulin therapy
1171583|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
1171584|NCT02161055|Brain Injuries|brain injuries
1171585|NCT02161055|Wounds and Injuries|wounds and injuries
1171586|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
1171587|NCT02161055|Trauma, Nervous System|trauma, nervous system
1171588|NCT02161042|Blood transfusion|blood transfusion
1171589|NCT02161042|Storage Lesion|storage lesion
1171590|NCT02161042|Endothelial dysfunction|endothelial dysfunction
1171591|NCT02161042|Nitric Oxide|nitric oxide
1171592|NCT02161029|Gastric tumor|gastric tumor
1171593|NCT02161003|Fecal Incontinence|fecal incontinence
1171594|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
1171595|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
1171596|NCT02160990|Obesity|obesity
1171597|NCT02160977|Surgical procedures|surgical procedures
1171598|NCT02160977|Minimally invasive|minimally invasive
1171599|NCT02160977|Arthroplasty|arthroplasty
1171600|NCT02160977|Knee|knee
1171601|NCT02160964|Inferior Vena Cava|inferior vena cava
1171602|NCT02160951|Multiple Myeloma,|multiple myeloma,
1171603|NCT02160951|Phase I,|phase i,
1171604|NCT02160951|PIM,|pim,
1171605|NCT02160951|Japanese patients,|japanese patients,
1171606|NCT02160951|LGH447|lgh447
1171608|NCT02160938|prenatal|prenatal
1171609|NCT02160938|copy number variant|copy number variant
1171611|NCT02160938|microdeletion|microdeletion
1171612|NCT02160938|microduplication|microduplication
1171613|NCT02160938|genetic|genetic
1171614|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
1171615|NCT02160847|children|children
1171616|NCT02160847|pediatric obesity|pediatric obesity
1171617|NCT02160847|parent training|parent training
1171618|NCT02160847|home-based|home-based
1171619|NCT02160847|nutrition|nutrition
1239684|NCT01853020|EBC|ebc
1171620|NCT02160847|physical activity|physical activity
1171621|NCT02160847|parent-child interaction|parent-child interaction
1171622|NCT02160847|parenting|parenting
1171623|NCT02160834|Sedentary behavior|sedentary behavior
1171624|NCT02160834|Physical activity|physical activity
1171625|NCT02160834|Obesity|obesity
1171626|NCT02160834|Mobile health|mobile health
1171627|NCT02160834|Smartphone|smartphone
1171628|NCT02160834|Time spent sedentary|time spent sedentary
1171629|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
1171630|NCT02160821|Caudal Epidural|caudal epidural
1171631|NCT02160821|Pediatric Pain control|pediatric pain control
1171632|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
1171633|NCT02160795|Periconceptional|periconceptional
1171634|NCT02160795|Folic Acid|folic acid
1171635|NCT02160795|Leukemia|leukemia
1171636|NCT02160795|Childhood Cancer|childhood cancer
1171637|NCT02160769|Tear Lipid Thickness|tear lipid thickness
1171638|NCT02160769|Pterygium surgery|pterygium surgery
1171639|NCT02160756|Healthy|healthy
1171640|NCT02160756|JNJ-56021927|jnj-56021927
1171641|NCT02160756|JNJ-56142060|jnj-56142060
1171642|NCT02160756|ARN-509|arn-509
1171643|NCT02160730|Cushings disease|cushings disease
1171644|NCT02160730|R-roscovitine|r-roscovitine
1171645|NCT02160717|Turner Syndrome|turner syndrome
1171646|NCT02160717|Diabetes|diabetes
1171647|NCT02160704|Sperm density|sperm density
1171648|NCT02160704|Testosterone|testosterone
1171649|NCT02160704|Hypogonadism|hypogonadism
1171650|NCT02160652|Ureteral Obstruction|ureteral obstruction
1171651|NCT02160652|HYDRONEPHROSIS|hydronephrosis
1171652|NCT02160652|nephrostomy tube|nephrostomy tube
1171653|NCT02160639|diabetes self management education|diabetes self management education
1171654|NCT02160639|diabetes self management support|diabetes self management support
1171655|NCT02160639|type 2 diabetes|type 2 diabetes
1171656|NCT02160626|Seborrheic keratosis|seborrheic keratosis
1171657|NCT02160626|A101|a101
1171658|NCT02160613|Osteoprotegerin|osteoprotegerin
1171659|NCT02160613|Biomarker|biomarker
1171660|NCT02160613|Chronic periodontitis|chronic periodontitis
1171661|NCT02160613|Open flap debridement|open flap debridement
1171662|NCT02160561|mechanical|mechanical
1171663|NCT02160561|ventilation|ventilation
1171664|NCT02160561|acute|acute
1171665|NCT02160561|respiratory|respiratory
1171666|NCT02160561|failure|failure
1171667|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
1171668|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
1171669|NCT02160535|Concussion|concussion
1171670|NCT02160535|Post Concussive Headache|post concussive headache
1171671|NCT02160522|Intubation|intubation
1171672|NCT02160522|cuff|cuff
1171673|NCT02160522|cuffed|cuffed
1171674|NCT02160522|endotracheal|endotracheal
1171675|NCT02160522|tube|tube
1171676|NCT02160522|pressure|pressure
1171677|NCT02160522|pediatric|pediatric
1171678|NCT02160522|child|child
1171679|NCT02160522|children|children
1171680|NCT02160522|emergency|emergency
1171681|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
1171682|NCT02160496|Weight Loss|weight loss
1171683|NCT02160496|Obesity|obesity
1171684|NCT02160496|Overweight|overweight
1171685|NCT02160496|Diet, Reducing|diet, reducing
1171686|NCT02160496|Lipids|lipids
1171687|NCT02160483|Chronic pelvic pain|chronic pelvic pain
1171688|NCT02160483|Endometriosis|endometriosis
1171689|NCT02160457|Cerebral palsy|cerebral palsy
1171690|NCT02160457|Instrumented gait analysis|instrumented gait analysis
1171691|NCT02160457|Gait Deviation Index|gait deviation index
1171692|NCT02160444|CBT|cbt
1171693|NCT02160444|Parent Training|parent training
1171694|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
1171695|NCT02160431|Children|children
1171696|NCT02160431|OCD|ocd
1171697|NCT02160431|CBT|cbt
1171698|NCT02160431|Neuropsychological profiles|neuropsychological profiles
1171699|NCT02160405|Iron levels|iron levels
1171700|NCT02160392|HIV|hiv
1171701|NCT02160392|female|female
1171702|NCT02160392|genital tract|genital tract
1171703|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
1171704|NCT02160379|brain responses to food|brain responses to food
1171705|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
1171706|NCT02160379|bile acids|bile acids
1171707|NCT02160366|Advanced Cancers|advanced cancers
1171708|NCT02160366|Molecular profiling|molecular profiling
1171709|NCT02160366|Biomarker data|biomarker data
1171710|NCT02160366|Data analysis|data analysis
1171711|NCT02160366|Tumor marker|tumor marker
1171814|NCT02159963|Training|training
1171712|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
1171713|NCT02160340|Vitreomacular Traction|vitreomacular traction
1171714|NCT02160340|Vitreous|vitreous
1171715|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
1171716|NCT02160301|pain|pain
1171717|NCT02160301|postoperative|postoperative
1171718|NCT02160301|multimodal|multimodal
1239735|NCT01852799|PAD|pad
1171719|NCT02160301|satisfaction|satisfaction
1171720|NCT02160301|narcotic|narcotic
1171721|NCT02160288|Botox|botox
1171722|NCT02160288|Obstructed Defecation Syndrome|obstructed defecation syndrome
1171723|NCT02160288|ODS|ods
1171724|NCT02160288|Outlet-Type Constipation|outlet-type constipation
1171725|NCT02160288|injection|injection
1171726|NCT02160275|Artificial pancreas|artificial pancreas
1171727|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
1171728|NCT02160275|Diabetes Type 1|diabetes type 1
1171729|NCT02160249|Schizophrenia|schizophrenia
1171730|NCT02160249|Psychotic disorders|psychotic disorders
1171731|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
1171732|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
1171733|NCT02160236|tenoxicam|tenoxicam
1171734|NCT02160236|postoperative pain|postoperative pain
1171735|NCT02160223|sugammadex|sugammadex
1171736|NCT02160223|neostigmine|neostigmine
1171737|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
1171738|NCT02160197|Ankle Fractures|ankle fractures
1171739|NCT02160197|Fracture Fixation|fracture fixation
1171740|NCT02160197|Early Ambulation|early ambulation
1171741|NCT02160197|Fracture Healing|fracture healing
1171742|NCT02160197|Return to Work|return to work
1171743|NCT02160171|Decision Support Algorithm|decision support algorithm
1171744|NCT02160171|Neonatal Seizures|neonatal seizures
1171745|NCT02160171|EEG|eeg
1171746|NCT02160158|Fesoterodine|fesoterodine
1171747|NCT02160158|SR3|sr3
1171748|NCT02160158|SR4|sr4
1171749|NCT02160158|bioavailability|bioavailability
1171750|NCT02160158|pharmacokinetics|pharmacokinetics
1171751|NCT02160158|sprinkle|sprinkle
1171752|NCT02160158|applesauce|applesauce
1171753|NCT02160145|Chronic Kidney Disease|chronic kidney disease
1171754|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1171755|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
1171756|NCT02160119|Emotion|emotion
1171757|NCT02160119|Attention|attention
1171758|NCT02160119|Event-related potential|event-related potential
1171759|NCT02160119|Functional neuroimaging|functional neuroimaging
1171760|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
1171761|NCT02160119|Development|development
1171762|NCT02160106|Cancer|cancer
1171763|NCT02160106|advanced solid tumors|advanced solid tumors
1171764|NCT02160106|metastatic|metastatic
1171765|NCT02160106|phase I|phase i
1171766|NCT02160106|transforming growth factor beta|transforming growth factor beta
1171767|NCT02160106|TGF-β|tgf-β
1171768|NCT02160106|first-in-human|first-in-human
1171769|NCT02160106|TEW-7197|tew-7197
1171770|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
1171771|NCT02160106|ALK5|alk5
1171772|NCT02160106|Smad2|smad2
1171773|NCT02160106|Smad3|smad3
1171774|NCT02160106|phospho-Smad|phospho-smad
1171775|NCT02160106|phospho Smad|phospho smad
1171776|NCT02160106|psmad|psmad
1171777|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
1171778|NCT02160106|pharmacokinetics|pharmacokinetics
1171779|NCT02160106|MedPacto|medpacto
1171780|NCT02160106|National OncoVenture|national oncoventure
1171781|NCT02160093|sarcopenia|sarcopenia
1171782|NCT02160093|frailty|frailty
1171783|NCT02160093|chronic disease control|chronic disease control
1171784|NCT02160093|aging psychology|aging psychology
1171785|NCT02160080|Boceprevir;|boceprevir;
1171786|NCT02160080|Liver pre-transplant|liver pre-transplant
1171787|NCT02160067|Healthy Volunteers|healthy volunteers
1171788|NCT02160067|Pharmacokinetics|pharmacokinetics
1171789|NCT02160054|tacrolimus|tacrolimus
1171790|NCT02160054|cyclosporine|cyclosporine
1171791|NCT02160054|Graceptor®|graceptor®
1171792|NCT02160054|kidney transplantation|kidney transplantation
1171793|NCT02160041|Solid tumor malignancy|solid tumor malignancy
1171794|NCT02160041|hematologic malignancy|hematologic malignancy
1171795|NCT02160041|mutation|mutation
1171796|NCT02160041|translocations|translocations
1171797|NCT02160041|amplifications,|amplifications,
1171798|NCT02160041|fusions|fusions
1171799|NCT02160041|signature|signature
1171800|NCT02160041|FGFR|fgfr
1171801|NCT02160041|ligand|ligand
1171802|NCT02160041|BGJ398|bgj398
1171803|NCT02160028|Information|information
1171804|NCT02160028|Pain|pain
1171805|NCT02160028|Stress|stress
1171806|NCT02160028|Fear|fear
1171807|NCT02160028|Placebo analgesia|placebo analgesia
1171808|NCT02160002|Incubator Weaning|incubator weaning
1171809|NCT02160002|Moderately Preterm Infants|moderately preterm infants
1171810|NCT02160002|Growth Velocity|growth velocity
1171811|NCT02159976|Helicobacter pylori|helicobacter pylori
1171812|NCT02159963|FSHD|fshd
1171813|NCT02159963|HIT|hit
1171815|NCT02159963|Exercise|exercise
1171816|NCT02159963|10-20-30 interval training|10-20-30 interval training
1171817|NCT02159937|cancer|cancer
1171818|NCT02159937|in vitro|in vitro
1171819|NCT02159937|peptides|peptides
1171820|NCT02159937|dendritic cells|dendritic cells
1171821|NCT02159924|Smartphone measurements|smartphone measurements
1171822|NCT02159924|Orientation|orientation
1171823|NCT02159924|Range of motion|range of motion
1171824|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
1171825|NCT02159924|Posture|posture
1171826|NCT02159924|Thoracic spine|thoracic spine
1171827|NCT02159924|Shoulder girdle|shoulder girdle
1171828|NCT02159911|Cervical|cervical
1171829|NCT02159911|Hysteroscopy|hysteroscopy
1171830|NCT02159911|Misoprostol|misoprostol
1171831|NCT02159911|Oral|oral
1171832|NCT02159898|Esophageal Cancer|esophageal cancer
1171833|NCT02159898|Dysphagia|dysphagia
1171834|NCT02159898|Regurgitation|regurgitation
1171835|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
1171836|NCT02159885|adherence|adherence
1171837|NCT02159885|telemedicine|telemedicine
1171838|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
1171839|NCT02159872|Leukemia|leukemia
1171840|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
1171842|NCT02159872|Omacetaxine|omacetaxine
1171843|NCT02159872|Synribo|synribo
1171844|NCT02159872|Homoharringtonine|homoharringtonine
1171845|NCT02159859|ertapenem|ertapenem
1171846|NCT02159859|pharmacokinetic|pharmacokinetic
1171847|NCT02159859|pharmacodynamics|pharmacodynamics
1171848|NCT02159859|hemodialysis|hemodialysis
1171849|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
1171850|NCT02159846|Herbs|herbs
1171851|NCT02159846|Diabetes Mellitus|diabetes mellitus
1171852|NCT02159846|HbA1c|hba1c
1171853|NCT02159846|Lipid Profile|lipid profile
1171854|NCT02159833|Food allergy|food allergy
1171855|NCT02159833|Diagnosis|diagnosis
1171856|NCT02159807|Pain control|pain control
1171857|NCT02159807|labor|labor
1171858|NCT02159807|epidural|epidural
1171859|NCT02159807|pregnant|pregnant
1171860|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1171861|NCT02159794|Aortic valve stenosis|aortic valve stenosis
1171862|NCT02159794|Severe aortic stenosis|severe aortic stenosis
1171863|NCT02159768|tracheal intubation|tracheal intubation
1171864|NCT02159742|Adult subjects|adult subjects
1171865|NCT02159742|history|history
1171866|NCT02159742|treatment|treatment
1171867|NCT02159742|photodynamic therapy|photodynamic therapy
1171868|NCT02159716|Subjects|subjects
1171869|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
1171870|NCT02159703|stage IVa SCCA|stage iva scca
1171871|NCT02159703|oropharynx|oropharynx
1171872|NCT02159703|negative for PNI,|negative for pni,
1171873|NCT02159703|negative surgical margins|negative surgical margins
1171874|NCT02159690|prostate cancer|prostate cancer
1171875|NCT02159690|prostatectomy|prostatectomy
1171876|NCT02159690|localized prostate cancer|localized prostate cancer
1171877|NCT02159677|EIM|eim
1171878|NCT02159664|didgeridoo|didgeridoo
1171879|NCT02159664|sleep apnea|sleep apnea
1171880|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
1171881|NCT02159651|tacrolimus|tacrolimus
1171882|NCT02159651|interstitial pneumonia|interstitial pneumonia
1171883|NCT02159651|prograf|prograf
1171884|NCT02159638|Diabetes Mellitus|diabetes mellitus
1171885|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1171886|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1171887|NCT02159638|Endocrine System Diseases|endocrine system diseases
1171888|NCT02159638|Blood glucose|blood glucose
1171889|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
1171890|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
1171891|NCT02159625|Hemodialysis|hemodialysis
1171892|NCT02159625|hypotension|hypotension
1171893|NCT02159625|occurrence rate|occurrence rate
1171894|NCT02159612|FSHD|fshd
1171895|NCT02159612|MRI|mri
1171896|NCT02159612|Disease progression|disease progression
1171897|NCT02159586|gastroparesis|gastroparesis
1171898|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
1171899|NCT02159586|GES|ges
1171900|NCT02159586|vomiting|vomiting
1171901|NCT02159586|nausea|nausea
1171902|NCT02159586|bloating|bloating
1171903|NCT02159586|postprandial fullness|postprandial fullness
1171904|NCT02159586|epigastric pain|epigastric pain
1171905|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
1171906|NCT02159521|deep vein thrombosis|deep vein thrombosis
1171907|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
1171908|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
1171909|NCT02159508|nutritional status|nutritional status
1171910|NCT02159508|nutritional intervention|nutritional intervention
1171911|NCT02159508|handgrip strength|handgrip strength
1171912|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
1171913|NCT02159508|chemoradiotherapy|chemoradiotherapy
1171914|NCT02159508|survival|survival
1171915|NCT02159469|Hypogonadism|hypogonadism
1171916|NCT02159469|Testosterone enanthate|testosterone enanthate
1171917|NCT02159443|Hu14.18K322A|hu14.18k322a
1333249|NCT01443832|iron absorption|iron absorption
1240017|NCT01851551|NHL|nhl
1171918|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
1171919|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
1171920|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
1171921|NCT02159391|Accident Prevention|accident prevention
1171922|NCT02159391|Alcohol Drinking|alcohol drinking
1171923|NCT02159391|Substance-Related Disorders|substance-related disorders
1171924|NCT02159391|Motivational Interviewing|motivational interviewing
1171926|NCT02159391|Humans|humans
1171927|NCT02159391|Intervention Studies|intervention studies
1171928|NCT02159391|Recurrence|recurrence
1171929|NCT02159391|Risk Factors|risk factors
1171930|NCT02159391|Trauma Centers|trauma centers
1171931|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
1171932|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
1171933|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
1171934|NCT02159378|Gestational Diabetes|gestational diabetes
1171935|NCT02159378|Fructosamines|fructosamines
1171936|NCT02159378|Insulin treatment|insulin treatment
1171937|NCT02159339|DNA methylation|dna methylation
1171938|NCT02159313|Biological Availability|biological availability
1171939|NCT02159300|Fibromyalgia|fibromyalgia
1171940|NCT02159300|Pain|pain
1171941|NCT02159287|ischemic stroke|ischemic stroke
1171942|NCT02159287|atrial fibrillation|atrial fibrillation
1171943|NCT02159287|bridging therapy|bridging therapy
1171944|NCT02159274|Late symptoms|late symptoms
1171945|NCT02159274|Shoulder function|shoulder function
1171946|NCT02159274|Cosmetic results|cosmetic results
1171947|NCT02159274|EORTC|eortc
1171948|NCT02159274|Lymphoedema|lymphoedema
1171949|NCT02159261|Personal Satisfaction|personal satisfaction
1171950|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
1171951|NCT02159235|cadmium|cadmium
1171952|NCT02159235|lead|lead
1171953|NCT02159235|mercury|mercury
1171954|NCT02159235|zinc|zinc
1171955|NCT02159235|endostatin|endostatin
1171956|NCT02159235|angiostatin|angiostatin
1171957|NCT02159235|VEGF|vegf
1171958|NCT02159235|CAD|cad
1171959|NCT02159235|osteopontin|osteopontin
1171960|NCT02159209|Acute Kidney Injury|acute kidney injury
1171961|NCT02159209|Adverse Drug Reaction|adverse drug reaction
1171962|NCT02159209|Acute Kidney Failure|acute kidney failure
1171963|NCT02159209|Kidney|kidney
1171964|NCT02159209|Kidneys|kidneys
1171965|NCT02159196|mechanical ventilation|mechanical ventilation
1171966|NCT02159196|nebulisation|nebulisation
1171967|NCT02159196|respiratory failure|respiratory failure
1171968|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
1171969|NCT02159157|breast cancer, exercise|breast cancer, exercise
1171970|NCT02159144|Brown adipose tissue|brown adipose tissue
1171971|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
1171972|NCT02159144|White adipose tissue|white adipose tissue
1171973|NCT02159131|ethinyl estradiol|ethinyl estradiol
1171974|NCT02159131|GSK1265744|gsk1265744
1171975|NCT02159131|pharmacokinetics|pharmacokinetics
1171976|NCT02159131|oral contraceptive|oral contraceptive
1171977|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
1171978|NCT02159131|levonorgestrel|levonorgestrel
1172459|NCT02157025|perimetry|perimetry
1171979|NCT02159118|bone marrow aspiration|bone marrow aspiration
1171980|NCT02159118|bone marrow biopsy|bone marrow biopsy
1171981|NCT02159118|OnControl|oncontrol
1171982|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
1171983|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
1171984|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
1171985|NCT02159105|postsurgical bleeding|postsurgical bleeding
1171986|NCT02159105|abdominal ultrasound|abdominal ultrasound
1171987|NCT02159105|FAST scan|fast scan
1171988|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
1171989|NCT02159092|Waterpipe|waterpipe
1171990|NCT02159092|Smoking cessation|smoking cessation
1171991|NCT02159092|Contingency management|contingency management
1171992|NCT02159092|Dependence|dependence
1171993|NCT02159079|Sepsis|sepsis
1171994|NCT02159079|Severe Sepsis|severe sepsis
1171995|NCT02159079|Septic Shock|septic shock
1171996|NCT02159079|Conservative Fluid Management|conservative fluid management
1171997|NCT02159079|Fluid Balance|fluid balance
1171998|NCT02159079|Fluid Restriction|fluid restriction
1171999|NCT02159066|Melanoma|melanoma
1172000|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
1172001|NCT02159040|Int-2 MDS|int-2 mds
1172002|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
1172003|NCT02159027|AIDS Dementia Complex|aids dementia complex
1172004|NCT02159014|Physical activity intervention|physical activity intervention
1172005|NCT02159014|Aerobic dance|aerobic dance
1172006|NCT02159014|Nutritional intervention|nutritional intervention
1172007|NCT02159014|Online participation|online participation
1172008|NCT02159014|Primary Care settings|primary care settings
1172009|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
1172010|NCT02159014|Qrisk2|qrisk2
1172011|NCT02159014|QDS Diabetes|qds diabetes
1172012|NCT02159001|clozapine|clozapine
1172013|NCT02159001|ECT|ect
1172014|NCT02159001|PANSS|panss
1172015|NCT02159001|schizoaffective disorder|schizoaffective disorder
1172016|NCT02159001|schizophrenia|schizophrenia
1172017|NCT02159001|treatment|treatment
1172018|NCT02158988|Gastric cancer|gastric cancer
1172019|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
1172020|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
1172021|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1172022|NCT02158988|HIPEC|hipec
1172023|NCT02158962|Partner abuse|partner abuse
1172024|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
1172025|NCT02158962|Intimate Partner Violence|intimate partner violence
1172026|NCT02158949|alcohol|alcohol
1172027|NCT02158949|mHealth|mhealth
1172028|NCT02158949|SBIRT|sbirt
1172029|NCT02158936|thrombocytopenia|thrombocytopenia
1172030|NCT02158936|myelodysplastic syndromes|myelodysplastic syndromes
1172031|NCT02158936|MDS|mds
1172032|NCT02158936|thrombopoietin|thrombopoietin
1172033|NCT02158936|azacitidine|azacitidine
1172034|NCT02158936|Eltrombopag|eltrombopag
1172035|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
1172036|NCT02158923|ventilation|ventilation
1172037|NCT02158923|lung|lung
1172038|NCT02158923|lung complications|lung complications
1172039|NCT02158923|postoperative complications|postoperative complications
1172040|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
1172041|NCT02158910|Alzheimer's disease|alzheimer's disease
1172042|NCT02158884|Major extremity trauma|major extremity trauma
1172043|NCT02158884|wounded warriors|wounded warriors
1172044|NCT02158884|IDEO|ideo
1172045|NCT02158884|return to run|return to run
1172046|NCT02158871|Education|education
1172047|NCT02158871|Early intervention|early intervention
1172048|NCT02158871|Workplace|workplace
1172049|NCT02158871|Stigma|stigma
1172050|NCT02158871|Mental Health Literacy|mental health literacy
1172051|NCT02158858|Phase 1/2|phase 1/2
1172052|NCT02158858|Oncology|oncology
1172053|NCT02158858|BET Inhibitor|bet inhibitor
1172054|NCT02158858|Ruxolitinib|ruxolitinib
1172055|NCT02158845|endometriosis|endometriosis
1172056|NCT02158845|blood coagulation|blood coagulation
1172057|NCT02158845|levonorgestrel|levonorgestrel
1172058|NCT02158845|GnRH agonist|gnrh agonist
1172059|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
1172060|NCT02158832|Lymphoedema|lymphoedema
1172061|NCT02158832|Edema|edema
1172062|NCT02158832|Oedema|oedema
1172063|NCT02158832|Cancer|cancer
1172064|NCT02158832|Breast Cancer|breast cancer
1172065|NCT02158819|Visionaire|visionaire
1172066|NCT02158819|Health Economics|health economics
1172067|NCT02158819|Degenerative arthritis|degenerative arthritis
1172068|NCT02158819|total knee arthroplasty|total knee arthroplasty
1172069|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
1172070|NCT02158793|face transplant|face transplant
1172071|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
1172072|NCT02158793|facial disfigurement|facial disfigurement
1172073|NCT02158793|facial trauma|facial trauma
1172074|NCT02158754|Corus CAD|corus cad
1172075|NCT02158754|ASGES|asges
1172076|NCT02158754|Coronary Artery Disease|coronary artery disease
1172077|NCT02158754|Gene Expression|gene expression
1172078|NCT02158754|Age/Sex/Gene Expression Score|age/sex/gene expression score
1172079|NCT02158754|GES|ges
1172080|NCT02158754|Angina Pectoris|angina pectoris
1172081|NCT02158754|Chest Pain|chest pain
1172082|NCT02158754|Cardiovascular Disease|cardiovascular disease
1172083|NCT02158754|CAD|cad
1172084|NCT02158754|CVD|cvd
1172085|NCT02158754|CHD|chd
1172086|NCT02158754|Coronary Heart Disease|coronary heart disease
1172087|NCT02158754|Precision Medicine|precision medicine
1172088|NCT02158754|Clinical Utility|clinical utility
1172089|NCT02158741|Self-Management|self-management
1172090|NCT02158741|Home Visits|home visits
1172091|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
1172092|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
1172093|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
1172094|NCT02158702|Efficacy and Safety|efficacy and safety
1172095|NCT02158689|Poor responders|poor responders
1172096|NCT02158689|letrozole|letrozole
1172097|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
1172098|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
1172099|NCT02158676|Inflammatory markers|inflammatory markers
1172100|NCT02158676|Nutritional status|nutritional status
1172101|NCT02158676|Fatty acids|fatty acids
1172102|NCT02158676|Glucose|glucose
1172103|NCT02158676|Prebiotic|prebiotic
1172104|NCT02158676|Synbiotic|synbiotic
1172105|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1172106|NCT02158663|TMS|tms
1172107|NCT02158663|PTSD|ptsd
1172108|NCT02158650|informed consent|informed consent
1172109|NCT02158650|video-based|video-based
1172110|NCT02158637|PRO-CTCAE|pro-ctcae
1172111|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
1172112|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
1172113|NCT02158637|Questionnaire|questionnaire
1172114|NCT02158637|Adverse Events|adverse events
1172115|NCT02158637|Symptoms|symptoms
1172116|NCT02158611|Individual Counseling service|individual counseling service
1172117|NCT02158611|Group Counseling service|group counseling service
1172118|NCT02158585|Lamotrigine|lamotrigine
1172119|NCT02158585|Lamictal|lamictal
1172120|NCT02158585|Anticonvulsant|anticonvulsant
1172121|NCT02158585|Ménière's disease|ménière's disease
1172122|NCT02158585|Vertigo attack|vertigo attack
1172123|NCT02158585|Dizziness|dizziness
1172124|NCT02158585|Vestibular disorder|vestibular disorder
1172125|NCT02158572|prevention of pregnancy|prevention of pregnancy
1172126|NCT02158546|Major Depressive Disorder|major depressive disorder
1172127|NCT02158546|Depression|depression
1172128|NCT02158546|Alkermes|alkermes
1172129|NCT02158546|ALKS 5461|alks 5461
1172130|NCT02158546|Samidorphan|samidorphan
1172131|NCT02158533|Major Depressive Disorder|major depressive disorder
1172132|NCT02158533|Depression|depression
1172133|NCT02158533|Alkermes|alkermes
1172134|NCT02158533|ALKS 5461|alks 5461
1172135|NCT02158533|Samidorphan|samidorphan
1172136|NCT02158507|metastatic|metastatic
1172137|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1172138|NCT02158507|Veliparib|veliparib
1172139|NCT02158507|Lapatinib|lapatinib
1172140|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
1172141|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
1172142|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
1172143|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
1172144|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
1172145|NCT02158494|Balance and Gait Training|balance and gait training
1172146|NCT02158494|Breathing Awareness Training|breathing awareness training
1172147|NCT02158481|Vascular function|vascular function
1172148|NCT02158481|Dietary ingredients|dietary ingredients
1172149|NCT02158481|Acute glucose load|acute glucose load
1172150|NCT02158481|Oxidative stress|oxidative stress
1172151|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
1172152|NCT02158455|CABG|cabg
1172153|NCT02158455|Saphenous vein|saphenous vein
1172154|NCT02158455|Radial artery|radial artery
1172155|NCT02158442|Diabetes|diabetes
1172156|NCT02158442|Lower limb infection|lower limb infection
1172157|NCT02158442|Significant wound infections|significant wound infections
1172158|NCT02158442|Intravenous antibiotics|intravenous antibiotics
1172159|NCT02158442|Timentin|timentin
1172160|NCT02158429|substance use disorders|substance use disorders
1172161|NCT02158429|pregnancy|pregnancy
1172162|NCT02158429|maternal attachment|maternal attachment
1172163|NCT02158429|paternal attachment|paternal attachment
1172164|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
1172165|NCT02158416|platelet|platelet
1172166|NCT02158416|transfusion|transfusion
1172167|NCT02158416|ThromboLUX|thrombolux
1172460|NCT02157025|pediatrics|pediatrics
1172168|NCT02158416|corrected count increment|corrected count increment
1172169|NCT02158416|thrombocytopenic|thrombocytopenic
1172170|NCT02158403|HeartMate II|heartmate ii
1172171|NCT02158403|heart assist device|heart assist device
1172172|NCT02158403|pump thrombosis|pump thrombosis
1172173|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
1172174|NCT02158403|thrombus|thrombus
1172175|NCT02158403|Thoratec Corporation|thoratec corporation
1172176|NCT02158390|Down syndrome|down syndrome
1172177|NCT02158390|Language intervention|language intervention
1172178|NCT02158390|Communication intervention|communication intervention
1172179|NCT02158377|Dental implants|dental implants
1172180|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
1172181|NCT02158377|TSV dental implants|tsv dental implants
1172182|NCT02158377|Zimmer Dental|zimmer dental
1172183|NCT02158377|Implant stability|implant stability
1172184|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
1172185|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
1172186|NCT02158364|Pharmacological therapy|pharmacological therapy
1172187|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
1172188|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1172189|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
1172190|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
1172191|NCT02158338|asthma|asthma
1172192|NCT02158338|maternal bonding|maternal bonding
1172193|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
1172194|NCT02158338|mother-infant interaction|mother-infant interaction
1172195|NCT02158312|neuroplasticity|neuroplasticity
1172196|NCT02158273|Alcohol|alcohol
1172197|NCT02158273|Relapse|relapse
1172198|NCT02158260|Capsule endoscopy|capsule endoscopy
1172199|NCT02158260|Patient position changing|patient position changing
1172200|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
1172201|NCT02158234|head and neck cancer|head and neck cancer
1172202|NCT02158234|paranasal sinuses|paranasal sinuses
1172203|NCT02158234|nasal cavity|nasal cavity
1172204|NCT02158234|nasopharynx|nasopharynx
1172205|NCT02158234|oropharynx|oropharynx
1172206|NCT02158234|oral cavity|oral cavity
1172207|NCT02158234|larynx|larynx
1172208|NCT02158234|hypopharynx|hypopharynx
1172209|NCT02158234|salivary glands|salivary glands
1172210|NCT02158234|cervical lymph nodes|cervical lymph nodes
1172211|NCT02158208|before any treatment|before any treatment
1172212|NCT02158208|at the diagnosis|at the diagnosis
1172213|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
1172214|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
1172215|NCT02158182|Cirrhosis|cirrhosis
1172216|NCT02158130|Physical Inactivity|physical inactivity
1172217|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
1172218|NCT02158130|Body Weight|body weight
1172219|NCT02158130|Energy Expenditure|energy expenditure
1172220|NCT02158130|Metabolic Syndrome|metabolic syndrome
1172221|NCT02158117|Emergency Treatment|emergency treatment
1172222|NCT02158117|Morphine Derivates|morphine derivates
1172223|NCT02158117|Heroin|heroin
1172224|NCT02158117|Antidotes|antidotes
1172225|NCT02158117|Administration, Intranasal|administration, intranasal
1172226|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1172227|NCT02158078|Diabetes Mellitus|diabetes mellitus
1172228|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1172229|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
1172230|NCT02158078|Metabolic Diseases|metabolic diseases
1172231|NCT02158078|Endocrine System Diseases|endocrine system diseases
1172232|NCT02158078|Insulin|insulin
1172233|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
1172234|NCT02158078|Insulin pumps|insulin pumps
1172235|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1172236|NCT02158065|physical activity|physical activity
1172237|NCT02158065|PROactive|proactive
1172238|NCT02158065|telecoaching|telecoaching
1172239|NCT02158052|HLA matched|hla matched
1172240|NCT02158052|bone marrow transplantation|bone marrow transplantation
1172241|NCT02158052|kidney transplantation|kidney transplantation
1172242|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
1172243|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
1172244|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
1172245|NCT02158039|Ethanol|ethanol
1172246|NCT02158026|Follicular sensitivity index|follicular sensitivity index
1172247|NCT02158026|ICSI|icsi
1172248|NCT02158026|IVF|ivf
1172249|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
1172250|NCT02157987|epistaxis|epistaxis
1172251|NCT02157987|safety|safety
1172252|NCT02157987|quality of life|quality of life
1172253|NCT02157987|bevacizumab|bevacizumab
1172254|NCT02157987|spray|spray
1172255|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
1172256|NCT02157948|osteoporosis|osteoporosis
1172257|NCT02157948|postmenopausal|postmenopausal
1172258|NCT02157948|denosumab|denosumab
1172259|NCT02157948|women|women
1172260|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
1172261|NCT02157922|Cystic fibrosis|cystic fibrosis
1172262|NCT02157922|mucolytic|mucolytic
1172263|NCT02157922|mucociliary clearance|mucociliary clearance
1172264|NCT02157922|lung clearance|lung clearance
1172265|NCT02157909|Lens fit|lens fit
1172266|NCT02157909|contact lenses|contact lenses
1172267|NCT02157909|myopia|myopia
1172268|NCT02157896|Acute ischemic stroke|acute ischemic stroke
1172269|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
1172270|NCT02157896|Endostatin|endostatin
1172395|NCT02157311|HIV-1|hiv-1
1172271|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
1172272|NCT02157870|Ovary|ovary
1172273|NCT02157870|ovarian cancer|ovarian cancer
1172274|NCT02157870|biologic therapy|biologic therapy
1172275|NCT02157870|platinum-resistant|platinum-resistant
1172276|NCT02157870|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
1172277|NCT02157870|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
1172278|NCT02157870|paclitaxel|paclitaxel
1172279|NCT02157870|tgDCC-E1A|tgdcc-e1a
1172280|NCT02157870|E1A|e1a
1172281|NCT02157870|Taxol|taxol
1172282|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
1172283|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
1172284|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1172285|NCT02157844|Obesity|obesity
1172286|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
1172287|NCT02157844|fat digestion|fat digestion
1172288|NCT02157844|whole body protein synthesis|whole body protein synthesis
1172289|NCT02157844|protein digestion|protein digestion
1172391|NCT02157337|statin|statin
1172290|NCT02157844|amino acid metabolism|amino acid metabolism
1172291|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
1172292|NCT02157844|lipolysis|lipolysis
1172293|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
1172294|NCT02157805|Meat processes|meat processes
1172295|NCT02157805|Amino acids bioavailability|amino acids bioavailability
1172296|NCT02157805|Digestion rate|digestion rate
1172297|NCT02157805|Protein synthesis|protein synthesis
1172298|NCT02157805|Aging|aging
1172299|NCT02157805|Sarcopenia|sarcopenia
1172300|NCT02157792|Solid Tumor|solid tumor
1172301|NCT02157792|Advanced Solid Tumor|advanced solid tumor
1172302|NCT02157792|VX12-970-001|vx12-970-001
1172303|NCT02157792|M6620|m6620
1172304|NCT02157792|VX-970|vx-970
1172305|NCT02157792|Gemcitabine|gemcitabine
1172306|NCT02157792|Cisplatin|cisplatin
1172307|NCT02157792|Etoposide|etoposide
1172308|NCT02157792|Carboplatin|carboplatin
1172309|NCT02157792|Irinotecan|irinotecan
1172310|NCT02157779|Veterans|veterans
1172311|NCT02157779|Anger|anger
1172312|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
1172313|NCT02157779|Treatment|treatment
1172314|NCT02157766|Mental Health|mental health
1172315|NCT02157766|Asthma|asthma
1172316|NCT02157766|Mindfulness|mindfulness
1172317|NCT02157766|Compassion|compassion
1172318|NCT02157766|Meditation|meditation
1172319|NCT02157753|Osteoporotic fracture|osteoporotic fracture
1172320|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
1172321|NCT02157753|adherence and compliance|adherence and compliance
1172322|NCT02157701|Dietary herbs|dietary herbs
1172323|NCT02157701|Polyherbal capsule|polyherbal capsule
1172324|NCT02157701|Functional exercise capacity|functional exercise capacity
1172325|NCT02157701|Joint health|joint health
1172326|NCT02157688|folliculitis decalvans|folliculitis decalvans
1172327|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
1172328|NCT02157688|antibiotics|antibiotics
1172329|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
1172330|NCT02157675|Muscle damage|muscle damage
1172331|NCT02157675|Eccentric exercise|eccentric exercise
1172332|NCT02157636|Phase 1|phase 1
1172333|NCT02157636|Oncology|oncology
1172334|NCT02157636|BET Inhibitor|bet inhibitor
1172335|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
1172336|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
1172337|NCT02157610|Cervical Cancer|cervical cancer
1172338|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
1172339|NCT02157610|Smoking Cessation|smoking cessation
1172340|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
1172341|NCT02157610|MAPS|maps
1172342|NCT02157610|Saliva test|saliva test
1172343|NCT02157610|Self help materials|self help materials
1172344|NCT02157610|Pamphlets|pamphlets
1172345|NCT02157610|Texas Quitline|texas quitline
1172346|NCT02157610|Nicotine patch|nicotine patch
1172347|NCT02157610|Questionnaires|questionnaires
1172348|NCT02157610|Surveys|surveys
1172349|NCT02157610|Telephone counseling sessions|telephone counseling sessions
1172350|NCT02157571|prulifloxacin|prulifloxacin
1172351|NCT02157571|AECB|aecb
1172352|NCT02157571|Levofloxacin|levofloxacin
1172353|NCT02157545|muscle relaxants|muscle relaxants
1172354|NCT02157545|pyridostigmine|pyridostigmine
1172355|NCT02157545|pharmacodynamics|pharmacodynamics
1172356|NCT02157545|potency|potency
1172357|NCT02157532|Severe stroke|severe stroke
1172358|NCT02157532|IV tPA|iv tpa
1172359|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
1172360|NCT02157519|Oral Chemotherapy|oral chemotherapy
1172361|NCT02157519|Cancer|cancer
1172362|NCT02157506|Acute Heart failure|acute heart failure
1172363|NCT02157506|Hemodynamics|hemodynamics
1172364|NCT02157506|Pharmacokinetics|pharmacokinetics
1172365|NCT02157506|Renal Function|renal function
1172366|NCT02157493|American Indian|american indian
1172367|NCT02157493|Adolescents|adolescents
1172368|NCT02157493|Entrepreneurship|entrepreneurship
1172369|NCT02157493|Paraprofessional|paraprofessional
1172370|NCT02157493|Life skills|life skills
1172371|NCT02157480|glucose profile|glucose profile
1172372|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
1172373|NCT02157480|electrostimulation|electrostimulation
1172374|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
1172375|NCT02157441|Placenta Previa|placenta previa
1172376|NCT02157441|uterine cavity|uterine cavity
1172377|NCT02157402|Adolescent|adolescent
1172379|NCT02157376|Upper GI bleeding|upper gi bleeding
1172380|NCT02157376|Seriously ill patients|seriously ill patients
1172381|NCT02157350|Eye Diseases|eye diseases
1172382|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1172383|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
1172384|NCT02157350|Retinal Oxymetry|retinal oxymetry
1172385|NCT02157350|Retina Ischemia|retina ischemia
1172386|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
1172387|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
1172388|NCT02157350|Fluorescein Angiography|fluorescein angiography
1172389|NCT02157337|aortic surgery|aortic surgery
1172390|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
1172392|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
1172393|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
1172394|NCT02157324|Btk|btk
1172396|NCT02157311|simplification,|simplification,
1172397|NCT02157311|treatment discontinuation|treatment discontinuation
1172398|NCT02157311|virological success|virological success
1172399|NCT02157311|four days a week|four days a week
1172400|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
1172401|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
1172402|NCT02157285|LARC|larc
1172403|NCT02157285|contraception|contraception
1172404|NCT02157272|Antiphospholipid|antiphospholipid
1172405|NCT02157272|Syndrome|syndrome
1172406|NCT02157272|Rivaroxaban|rivaroxaban
1172407|NCT02157272|Warfarin|warfarin
1172408|NCT02157272|Thrombosis|thrombosis
1172409|NCT02157272|Treatment|treatment
1172410|NCT02157246|hypoxia|hypoxia
1172411|NCT02157246|rectal cancer|rectal cancer
1172412|NCT02157207|antioxidants|antioxidants
1172413|NCT02157207|Caucasians|caucasians
1172414|NCT02157207|healthy|healthy
1172415|NCT02157207|African Americans|african americans
1172416|NCT02157207|vascular|vascular
1172417|NCT02157207|aging|aging
1172418|NCT02157207|racial differences|racial differences
1172419|NCT02157181|HCL variant|hcl variant
1172420|NCT02157181|HCL relapse|hcl relapse
1172421|NCT02157181|Risk stratified|risk stratified
1172422|NCT02157168|Affordable Care Act|affordable care act
1172423|NCT02157168|Medically underserved minorities|medically underserved minorities
1172424|NCT02157168|Community health workers|community health workers
1172425|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
1172426|NCT02157142|Severe aortic stenosis|severe aortic stenosis
1172427|NCT02157142|Aortic valve stenosis|aortic valve stenosis
1172428|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1172429|NCT02157129|Tracheostomy|tracheostomy
1172430|NCT02157129|inflammation|inflammation
1172431|NCT02157129|mucous congestion|mucous congestion
1172432|NCT02157129|inhalation therapy|inhalation therapy
1172433|NCT02157129|phospholipids|phospholipids
1172434|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
1172435|NCT02157103|GBM|gbm
1172436|NCT02157103|Glioblastoma|glioblastoma
1172437|NCT02157103|Bevacizumab|bevacizumab
1172438|NCT02157103|Avastin|avastin
1172439|NCT02157103|Subcutaneous|subcutaneous
1172440|NCT02157090|HSL of lips|hsl of lips
1172441|NCT02157090|perioral skin|perioral skin
1172442|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
1172443|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
1172444|NCT02157077|Eye diseases|eye diseases
1172445|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
1172446|NCT02157077|Eyes and Vision|eyes and vision
1172447|NCT02157077|Seniors|seniors
1172448|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
1172449|NCT02157077|Retinal Disease|retinal disease
1172450|NCT02157038|whiplash|whiplash
1172451|NCT02157038|neck pain|neck pain
1172452|NCT02157038|chronic pain|chronic pain
1172453|NCT02157038|motor vehicle accident|motor vehicle accident
1172454|NCT02157038|car accident|car accident
1172455|NCT02157038|MRI|mri
1172456|NCT02157038|DNA|dna
1172457|NCT02157038|RNA|rna
1172458|NCT02157025|Humphrey visual fields|humphrey visual fields
1172461|NCT02156973|cardiac computed tomography|cardiac computed tomography
1172462|NCT02156973|Image quality|image quality
1172463|NCT02156947|Power Doppler sonography|power doppler sonography
1172464|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
1172465|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
1172466|NCT02156908|cognitive remediation|cognitive remediation
1172467|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
1172468|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
1172469|NCT02156882|TB|tb
1172470|NCT02156882|Tuberculosis|tuberculosis
1172471|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
1172472|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
1172473|NCT02156869|Prostate cancer|prostate cancer
1172474|NCT02156869|Screening|screening
1172475|NCT02156869|Decision aids|decision aids
1172476|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
1172477|NCT02156856|cardiac output|cardiac output
1172478|NCT02156856|cardiac surgery|cardiac surgery
1172479|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
1172480|NCT02156843|Nephropathy|nephropathy
1573426|NCT00488956|edema|edema
1172481|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
1172482|NCT02156843|Kidney Disease|kidney disease
1172483|NCT02156843|Type 2 Diabetes|type 2 diabetes
1172484|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
1172485|NCT02156817|Heart rate variability|heart rate variability
1172486|NCT02156817|Respiratory rate variability|respiratory rate variability
1172487|NCT02156817|Preterm Infants|preterm infants
1172488|NCT02156817|Length of Hospital Stay|length of hospital stay
1172489|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
1172490|NCT02156791|Grass pollen|grass pollen
1172491|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
1172492|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
1172493|NCT02156778|Post-Stroke Complication|post-stroke complication
1172494|NCT02156778|Risk Factor Control|risk factor control
1172495|NCT02156778|Quality-of-Life|quality-of-life
1172496|NCT02156765|Atrial Fibrillation|atrial fibrillation
1172497|NCT02156765|Screening|screening
1172498|NCT02156765|Stroke patients|stroke patients
1172499|NCT02156739|Liver Neoplasms|liver neoplasms
1172500|NCT02156739|Liver lesions|liver lesions
1172501|NCT02156739|Benign liver lesions|benign liver lesions
1172502|NCT02156739|Malignant liver lesions|malignant liver lesions
1172503|NCT02156739|Contrast-Enhanced Magnetic Resonance Imaging|contrast-enhanced magnetic resonance imaging
1172504|NCT02156739|MRI|mri
1172505|NCT02156739|Gadoxetate|gadoxetate
1172506|NCT02156739|Eovist|eovist
1172507|NCT02156739|Gadopentetate Dimeglumine|gadopentetate dimeglumine
1172508|NCT02156739|Magnevist|magnevist
1172509|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1172510|NCT02156726|fludarabine|fludarabine
1172511|NCT02156726|rituximab|rituximab
1172512|NCT02156726|elderly|elderly
1172513|NCT02156726|comorbid|comorbid
1172514|NCT02156726|FCR|fcr
1172515|NCT02156726|CIRS|cirs
1172516|NCT02156713|Hemiparesis|hemiparesis
1172517|NCT02156713|Occupational Therapy|occupational therapy
1172518|NCT02156700|shear wave elastography|shear wave elastography
1172519|NCT02156700|haemangiomas|haemangiomas
1172520|NCT02156700|metastases|metastases
1172521|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
1172522|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
1172523|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
1172524|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
1172525|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
1172526|NCT02156674|MPS VI|mps vi
1172527|NCT02156648|Invasive ductal|invasive ductal
1172528|NCT02156648|HER2-neu positive|her2-neu positive
1172529|NCT02156635|Rehabilitation|rehabilitation
1172530|NCT02156635|Direct Current Stimulation|direct current stimulation
1172531|NCT02156635|Acute Stroke|acute stroke
1172532|NCT02156622|HIV|hiv
1172533|NCT02156622|Depression|depression
1172534|NCT02156622|Measurement-based care|measurement-based care
1172535|NCT02156622|Outcomes|outcomes
1172536|NCT02156622|Viral load|viral load
1172537|NCT02156609|HeartMate PHP|heartmate php
1172538|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
1172539|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
1172540|NCT02156609|PCI|pci
1172541|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
1172542|NCT02156609|Thoratec Corporation|thoratec corporation
1172543|NCT02156596|renal colic|renal colic
1172544|NCT02156596|nebulised morphine|nebulised morphine
1172545|NCT02156596|Intravenous NSAID|intravenous nsaid
1172546|NCT02156583|Ventricular Assist Device|ventricular assist device
1172547|NCT02156583|Skeletal Muscle|skeletal muscle
1172548|NCT02156583|Frailty|frailty
1172549|NCT02156583|Older adults|older adults
1172550|NCT02156570|Hepatitis C|hepatitis c
1172551|NCT02156570|Acute/early chronic|acute/early chronic
1172552|NCT02156570|Recently acquired|recently acquired
1172553|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
1172554|NCT02156570|Sofosbuvir|sofosbuvir
1172555|NCT02156570|Ribavirin|ribavirin
1172556|NCT02156531|Anxiety|anxiety
1172557|NCT02156531|Youth Anxiety|youth anxiety
1172558|NCT02156531|CBM|cbm
1172559|NCT02156531|Cognitive Bias Modification|cognitive bias modification
1172560|NCT02156531|Adolescents|adolescents
1172561|NCT02156518|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises
1172562|NCT02156505|stent|stent
1172563|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
1172564|NCT02156505|restenosis|restenosis
1172565|NCT02156479|CMV|cmv
1172566|NCT02156479|T-Track CMV|t-track cmv
1172567|NCT02156479|allo-HSCT|allo-hsct
1172568|NCT02156479|CMI|cmi
1172569|NCT02156466|Psoriasis|psoriasis
1172570|NCT02156466|MSB0010841|msb0010841
1172571|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
1172572|NCT02156466|M1095|m1095
1172573|NCT02156453|Functional recovery|functional recovery
1172574|NCT02156453|Total knee arthroplasty|total knee arthroplasty
1172575|NCT02156440|Ostearthritis|ostearthritis
1172576|NCT02156440|Knee|knee
1172577|NCT02156440|SierraSil|sierrasil
1172578|NCT02156414|Prostatectomy|prostatectomy
1172579|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
1172580|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
1172581|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
1172582|NCT02156414|Prospective Studies|prospective studies
1172583|NCT02156401|Venous thromboembolism|venous thromboembolism
1172584|NCT02156401|Deep vein thrombosis|deep vein thrombosis
1172585|NCT02156401|Pulmonary embolism|pulmonary embolism
1172586|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
1172587|NCT02156401|Outcome|outcome
1172588|NCT02156401|Prognosis|prognosis
1172589|NCT02156375|Healthy|healthy
1172590|NCT02156375|Ustekinumab|ustekinumab
1172591|NCT02156375|STELARA®|stelara®
1172592|NCT02156362|Thyroid carcinoma|thyroid carcinoma
1172593|NCT02156362|predictive factors|predictive factors
1172594|NCT02156362|refractory|refractory
1172595|NCT02156362|Differentiated|differentiated
1172596|NCT02156362|follicular origin|follicular origin
1172597|NCT02156349|Diabetes|diabetes
1172598|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
1172599|NCT02156336|Ranexa|ranexa
1172600|NCT02156336|Ranolazine|ranolazine
1172601|NCT02156336|Neurology|neurology
1172602|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
1172603|NCT02156271|Insomnia|insomnia
1172604|NCT02156258|Imaging|imaging
1172605|NCT02156258|Mammography|mammography
1172606|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
1172607|NCT02156232|vericeal bleeding|vericeal bleeding
1172608|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
1172609|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
1172610|NCT02156232|embolization|embolization
1172611|NCT02156180|exhaled breath|exhaled breath
1172612|NCT02156180|volatile organic compounds|volatile organic compounds
1172613|NCT02156180|surgery|surgery
1172614|NCT02156180|chemotherapy|chemotherapy
1172615|NCT02156180|radiotherapy|radiotherapy
1172616|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
1172617|NCT02156141|Kennedy's disease|kennedy's disease
1172618|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
1172619|NCT02156141|High Intensity Training|high intensity training
1172620|NCT02156141|High Intensity Interval Training|high intensity interval training
1172621|NCT02156141|HIT|hit
1172622|NCT02156141|HIIT|hiit
1172623|NCT02156141|Training|training
1172624|NCT02156141|Exercise|exercise
1172625|NCT02156141|10-20-30|10-20-30
1172626|NCT02156128|Cognitive therapy|cognitive therapy
1172627|NCT02156115|Lymphangiomatosis|lymphangiomatosis
1172628|NCT02156115|Lymphangiogenesis|lymphangiogenesis
1172629|NCT02156115|Smooth Muscle Cell|smooth muscle cell
1172630|NCT02156115|Vascular Anomalies|vascular anomalies
1172631|NCT02156102|Genetic Disorders|genetic disorders
1172632|NCT02156102|Sickle Cell Disease|sickle cell disease
1172633|NCT02156102|African American|african american
1172634|NCT02156102|Leg Ulcers|leg ulcers
1172635|NCT02156102|Skin|skin
1172636|NCT02156089|fMRI|fmri
1172637|NCT02156089|Reward Processing|reward processing
1172638|NCT02156089|Nutrition|nutrition
1172639|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
1172640|NCT02156089|ADHD|adhd
1172641|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
1172642|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
1172643|NCT02156063|Miscarriage|miscarriage
1172644|NCT02156063|Pregnancy Loss|pregnancy loss
1172645|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
1172646|NCT02156037|Hispanic|hispanic
1172647|NCT02156037|clinical decision support|clinical decision support
1172648|NCT02156037|diabetes|diabetes
1172649|NCT02156037|Hba1c|hba1c
1172650|NCT02156037|psychosocial|psychosocial
1172651|NCT02156024|clinical trials|clinical trials
1172652|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
1172653|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
1172654|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
1172655|NCT02156011|Video-fluoroscopy|video-fluoroscopy
1172656|NCT02156011|Instrumented implants|instrumented implants
1172657|NCT02156011|Optical motion capture|optical motion capture
1172658|NCT02156011|Ground reaction forces|ground reaction forces
1172659|NCT02156011|Electromyography|electromyography
1172660|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
1172661|NCT02155972|Bipolar|bipolar
1172662|NCT02155972|Depression|depression
1172663|NCT02155972|Probiotic|probiotic
1172664|NCT02155972|ALIGN|align
1172665|NCT02155972|HAMD|hamd
1172666|NCT02155972|STAI|stai
1172667|NCT02155972|YMRS|ymrs
1172668|NCT02155972|CGI|cgi
1172669|NCT02155972|SDS|sds
1172670|NCT02155972|WHOQOL-BREF|whoqol-bref
1172671|NCT02155972|C-SSRS|c-ssrs
1172672|NCT02155972|TSES|tses
1172673|NCT02155959|astigmatism|astigmatism
1172674|NCT02155959|cataract|cataract
1172675|NCT02155959|toric|toric
1172676|NCT02155959|lens|lens
1172677|NCT02155946|Aging|aging
1172678|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
1172679|NCT02155946|Cognitive Disorders|cognitive disorders
1172680|NCT02155946|Imaging|imaging
1172681|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1172682|NCT02155946|Neurology|neurology
1172683|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
1172684|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
1172685|NCT02155920|Ependymoma|ependymoma
1172686|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
1172687|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
1172688|NCT02155881|Drug therapy|drug therapy
1172689|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
1172690|NCT02155868|Postoperative complications|postoperative complications
1172691|NCT02155868|Cardiac surgery|cardiac surgery
1172692|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
1172693|NCT02155842|exercise therapy|exercise therapy
1172695|NCT02155829|TBI|tbi
1172696|NCT02155829|Riluzole|riluzole
1172697|NCT02155829|Rilutek|rilutek
1172698|NCT02155829|augmentation|augmentation
1172699|NCT02155829|supplement|supplement
1172700|NCT02155829|double blinded|double blinded
1172701|NCT02155829|clinical trial|clinical trial
1172702|NCT02155829|placebo|placebo
1172703|NCT02155829|RCT|rct
1172704|NCT02155829|Randomized Control Trial|randomized control trial
1172705|NCT02155816|inflammation|inflammation
1172706|NCT02155816|lipoproteins|lipoproteins
1172707|NCT02155816|omega 3|omega 3
1172708|NCT02155816|omega 7|omega 7
1172709|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
1172710|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
1172711|NCT02155803|hypercalcemia|hypercalcemia
1172712|NCT02155803|hypercalciuria|hypercalciuria
1172713|NCT02155803|nephrocalcinosis|nephrocalcinosis
1172714|NCT02155803|nephrolithiasis|nephrolithiasis
1172715|NCT02155803|interstitial nephritis|interstitial nephritis
1172716|NCT02155803|glomerulonephritis|glomerulonephritis
1172717|NCT02155803|acute kidney disease|acute kidney disease
1172718|NCT02155803|chronic kidney disease|chronic kidney disease
1172719|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
1172720|NCT02155777|BRCA1|brca1
1172721|NCT02155777|BRCA2|brca2
1172722|NCT02155777|Risk-reducing surgery|risk-reducing surgery
1172723|NCT02155777|Oral Contraceptives|oral contraceptives
1172724|NCT02155764|tooth|tooth
1172725|NCT02155764|extraction|extraction
1172726|NCT02155764|alveolar socket|alveolar socket
1172727|NCT02155764|socket preservation|socket preservation
1172728|NCT02155764|ridge preservation|ridge preservation
1172729|NCT02155764|bone graft|bone graft
1172730|NCT02155764|tricalcium phosphate|tricalcium phosphate
1172731|NCT02155764|octacalcium phosphate|octacalcium phosphate
1172732|NCT02155764|xenograft|xenograft
1172733|NCT02155764|bio oss|bio oss
1172734|NCT02155751|Obesity prevention|obesity prevention
1172735|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
1172736|NCT02155751|Postpartum|postpartum
1172737|NCT02155751|Maternal obesity risk|maternal obesity risk
1172738|NCT02155738|IV acetaminophen|iv acetaminophen
1172739|NCT02155738|Postoperative pain|postoperative pain
1172740|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
1172741|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
1172742|NCT02155725|PPH|pph
1172743|NCT02155725|fibrinogen|fibrinogen
1172744|NCT02155725|vaginal delivery|vaginal delivery
1172745|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
1172746|NCT02155686|Elderly|elderly
1172747|NCT02155686|Prevention|prevention
1172748|NCT02155686|Multiple chronic disease|multiple chronic disease
1172749|NCT02155686|Telemonitoring|telemonitoring
1172750|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
1172751|NCT02155686|Home heath care|home heath care
1172752|NCT02155686|Medico-economics|medico-economics
1172753|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
1172754|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1172755|NCT02155660|Lung Disease|lung disease
1172756|NCT02155660|Bronchial Diseases|bronchial diseases
1172757|NCT02155660|COPD Exacerbation|copd exacerbation
1172758|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
1172759|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
1172760|NCT02155647|MSB0010718C|msb0010718c
1172761|NCT02155647|avelumab|avelumab
1172762|NCT02155647|Bavencio|bavencio
1172763|NCT02155647|anti PD-L1|anti pd-l1
1172764|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
1172765|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
1172766|NCT02155634|Multiple Myeloma|multiple myeloma
1172767|NCT02155634|Lenalidomide|lenalidomide
1172768|NCT02155634|Revlimid|revlimid
1172769|NCT02155634|Phase III|phase iii
1172770|NCT02155634|Phase IIIb|phase iiib
1172771|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
1172772|NCT02155621|cancer genomics|cancer genomics
1172773|NCT02155621|precision medicine|precision medicine
1172774|NCT02155621|metastatic cancer|metastatic cancer
1172775|NCT02155621|clinical decision-making|clinical decision-making
1172776|NCT02155608|ADHD|adhd
1172777|NCT02155608|neuromodulation|neuromodulation
1172778|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
1172779|NCT02155608|cognition|cognition
1172780|NCT02155582|Solid tumors|solid tumors
1172781|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
1172782|NCT02155569|Cesarean|cesarean
1172784|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
1172785|NCT02155504|Healthy volunteers|healthy volunteers
1172786|NCT02155504|Pharmacokinetics|pharmacokinetics
1172787|NCT02155504|ASP3700|asp3700
1172788|NCT02155504|Itraconazole|itraconazole
1172789|NCT02155504|Drug-drug interaction|drug-drug interaction
1172790|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
1172791|NCT02155465|Ruxolitinib|ruxolitinib
1172792|NCT02155465|Erlotinib|erlotinib
1172793|NCT02155465|EGFR-mutant|egfr-mutant
1172794|NCT02155465|14-043|14-043
1172795|NCT02155452|ALA|ala
1172796|NCT02155452|Malignant gliomas|malignant gliomas
1172797|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
1172798|NCT02155413|Acute pain|acute pain
1172799|NCT02155413|Audit|audit
1172800|NCT02155413|Safety|safety
1172801|NCT02155413|Tolerability|tolerability
1172802|NCT02155400|perioperative hypothermia|perioperative hypothermia
1172803|NCT02155400|thermal compression|thermal compression
1172804|NCT02155400|forced air warming|forced air warming
1172805|NCT02155387|EVLW|evlw
1172806|NCT02155387|EVLWI|evlwi
1172807|NCT02155387|PVPI|pvpi
1172808|NCT02155387|MICS|mics
1172809|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
1172810|NCT02155361|Diabetes mellitus|diabetes mellitus
1172811|NCT02155361|Diabetes complications|diabetes complications
1172812|NCT02155361|Pain|pain
1172813|NCT02155309|scopolamine|scopolamine
1172814|NCT02155309|motion|motion
1172815|NCT02155309|sickness|sickness
1172816|NCT02155296|positive youth development|positive youth development
1172817|NCT02155296|restorative practices|restorative practices
1172818|NCT02155296|school climate|school climate
1172819|NCT02155296|social competency|social competency
1172820|NCT02155283|Chronic Low Back Pain|chronic low back pain
1172821|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
1172822|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
1172823|NCT02155270|Cataract|cataract
1172824|NCT02155270|Incision|incision
1172825|NCT02155270|Precut|precut
1172826|NCT02155270|Corneal|corneal
1172827|NCT02155270|OCT|oct
1172828|NCT02155270|Intraoperative OCT|intraoperative oct
1172829|NCT02155270|Imaging|imaging
1172830|NCT02155270|Astigmatism|astigmatism
1172831|NCT02155270|Clear corneal incision|clear corneal incision
1172832|NCT02155257|Osteoarthritis|osteoarthritis
1172833|NCT02155244|CBDS|cbds
1172834|NCT02155244|ERCP|ercp
1172835|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
1172836|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
1172837|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
1172838|NCT02155218|Contrast Media|contrast media
1172839|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
1172840|NCT02155192|C0743T08|c0743t08
1172841|NCT02155192|C0743T09|c0743t09
1172842|NCT02155192|C0743T12|c0743t12
1172843|NCT02155192|Psoriasis|psoriasis
1172844|NCT02155192|Pharmacogenomics|pharmacogenomics
1172845|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
1172846|NCT02155166|anesthesia|anesthesia
1172847|NCT02155166|pain|pain
1172848|NCT02155166|nulliparous|nulliparous
1172849|NCT02155140|enteral feeding|enteral feeding
1172850|NCT02155140|Discharged|discharged
1174051|NCT02149498|BNA|bna
1172851|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
1172852|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
1172853|NCT02155127|chronic kidney disease|chronic kidney disease
1172854|NCT02155127|physical function|physical function
1172855|NCT02155114|Hepcidins|hepcidins
1172856|NCT02155114|Homeostasis|homeostasis
1172857|NCT02155114|Iron/administration & dosage|iron/administration & dosage
1172858|NCT02155114|Biological Markers/blood|biological markers/blood
1172859|NCT02155101|Efficacy|efficacy
1172860|NCT02155101|Safety|safety
1172861|NCT02155101|Darunavir|darunavir
1172862|NCT02155101|HIV-1 RNA level|hiv-1 rna level
1172863|NCT02155101|Cameroon|cameroon
1172864|NCT02155088|Locally Advanced|locally advanced
1172865|NCT02155088|Metastatic|metastatic
1172866|NCT02155088|Recurrent|recurrent
1172867|NCT02155088|Pancreas|pancreas
1172868|NCT02155075|Breast neoplasm|breast neoplasm
1172869|NCT02155075|Breast implants|breast implants
1172870|NCT02155075|Mammography|mammography
1172871|NCT02155075|Breast imaging|breast imaging
1172872|NCT02155075|Imaging augmented breast|imaging augmented breast
1172873|NCT02155062|Nutritional biomarker|nutritional biomarker
1172874|NCT02155062|Dietary assessment|dietary assessment
1172875|NCT02155062|Whole grain|whole grain
1172877|NCT02155062|Rye|rye
1172878|NCT02155062|Alkylresorcinol|alkylresorcinol
1172879|NCT02155062|Urine|urine
1172880|NCT02155049|TED|ted
1172881|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
1172882|NCT02155036|exercise|exercise
1172883|NCT02155036|rehabilitation|rehabilitation
1172884|NCT02155036|kidney function|kidney function
1172885|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
1172886|NCT02155010|Dexmedetomidine|dexmedetomidine
1172887|NCT02155010|Spinal anesthesia|spinal anesthesia
1172888|NCT02154971|HIV Seropositivity|hiv seropositivity
1172889|NCT02154971|Audiometry|audiometry
1172890|NCT02154971|Hearing Loss|hearing loss
1172891|NCT02154958|Follicular output rate|follicular output rate
1172892|NCT02154958|IVF|ivf
1172893|NCT02154958|ICSI|icsi
1172894|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
1172895|NCT02154906|periodontal disease|periodontal disease
1172896|NCT02154906|periodontitis|periodontitis
1172897|NCT02154893|Ultrasound|ultrasound
1172898|NCT02154893|Laser|laser
1172899|NCT02154893|Therapeutic exercise|therapeutic exercise
1172900|NCT02154893|Rehabilitation|rehabilitation
1172901|NCT02154893|Osteoarthritis|osteoarthritis
1172902|NCT02154880|HIV|hiv
1172903|NCT02154880|lung|lung
1172904|NCT02154880|aging|aging
1172905|NCT02154867|IBS-D|ibs-d
1172906|NCT02154867|FMT|fmt
1172907|NCT02154867|metagenomics|metagenomics
1172908|NCT02154867|gut microbiome|gut microbiome
1172909|NCT02154854|Renal|renal
1172910|NCT02154854|Transplantation|transplantation
1172911|NCT02154854|Tacrolimus|tacrolimus
1172912|NCT02154854|Arterial stiffness|arterial stiffness
1172913|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
1172914|NCT02154841|Postoperative|postoperative
1172915|NCT02154841|nutrition|nutrition
1172916|NCT02154841|taste|taste
1172917|NCT02154841|perception|perception
1172918|NCT02154841|preference|preference
1172919|NCT02154841|choice|choice
1172920|NCT02154828|Children|children
1172921|NCT02154828|aged|aged
1172922|NCT02154828|3 to 6 years|3 to 6 years
1172923|NCT02154815|End Stage Renal Disease|end stage renal disease
1172924|NCT02154815|Renal transplantation|renal transplantation
1172925|NCT02154815|Dialysis|dialysis
1172926|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
1172927|NCT02154815|Psychological adjustment|psychological adjustment
1172928|NCT02154815|Quality of life.|quality of life.
1172929|NCT02154776|LEE011,|lee011,
1172930|NCT02154776|buparlisib,|buparlisib,
1172931|NCT02154776|letrozole,|letrozole,
1172932|NCT02154776|HR +,|hr +,
1172933|NCT02154776|HER2 - negative,|her2 - negative,
1172934|NCT02154776|post-menopausal,|post-menopausal,
1172935|NCT02154776|breast cancer,|breast cancer,
1172936|NCT02154776|CDK 4/6,|cdk 4/6,
1172937|NCT02154776|PI3K,|pi3k,
1172938|NCT02154776|MTD|mtd
1172939|NCT02154763|Bariatric surgery|bariatric surgery
1172940|NCT02154763|Bariatrics|bariatrics
1172941|NCT02154763|Local anesthetic|local anesthetic
1172942|NCT02154763|Ropivacaine|ropivacaine
1172943|NCT02154763|Intraperitoneal|intraperitoneal
1172944|NCT02154750|Atrioventricular delay|atrioventricular delay
1172945|NCT02154750|AV delay|av delay
1172946|NCT02154750|Pacemaker|pacemaker
1172947|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
1172948|NCT02154750|Bradycardia|bradycardia
1172949|NCT02154750|PR interval|pr interval
1172950|NCT02154750|Atrioventricular block|atrioventricular block
1172951|NCT02154750|AV block|av block
1172952|NCT02154750|Echocardiography|echocardiography
1172953|NCT02154750|Arrhythmia|arrhythmia
1172954|NCT02154750|AV optimization|av optimization
1172955|NCT02154737|Pancreatic|pancreatic
1172956|NCT02154737|Gemcitabine|gemcitabine
1172957|NCT02154737|Gemzar|gemzar
1172958|NCT02154737|erlotinib|erlotinib
1172959|NCT02154737|Tarceva|tarceva
1172960|NCT02154711|mitochondrial disease|mitochondrial disease
1172961|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
1172962|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1172963|NCT02154711|creatine|creatine
1172964|NCT02154711|phosphocreatine|phosphocreatine
1172965|NCT02154685|Smoking|smoking
1172966|NCT02154685|Nicotine|nicotine
1172967|NCT02154685|Addiction|addiction
1172968|NCT02154685|Cessation|cessation
1172969|NCT02154620|Distal radius fracture|distal radius fracture
1172970|NCT02154620|wrist fracture|wrist fracture
1172971|NCT02154620|volar plate|volar plate
1172972|NCT02154620|surgical treatment|surgical treatment
1172973|NCT02154620|plaster immobilisation|plaster immobilisation
1172974|NCT02154607|oral lichen planus|oral lichen planus
1172975|NCT02154607|recurrence|recurrence
1172976|NCT02154607|Treatment|treatment
1172977|NCT02154607|cancer|cancer
1172978|NCT02154607|Primary disease Management|primary disease management
1172979|NCT02154594|Acacia|acacia
1172980|NCT02154594|Chlorhexidine|chlorhexidine
1172981|NCT02154594|Gingivitis|gingivitis
1172982|NCT02154594|Orthodontic appliances.|orthodontic appliances.
1172983|NCT02154581|Dental implants|dental implants
1172984|NCT02154581|Esthetic score|esthetic score
1172985|NCT02154581|Immediate implants|immediate implants
1172986|NCT02154581|Gingival biotype|gingival biotype
1172987|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
1172988|NCT02154542|Nava|nava
1173289|NCT02153060|safety|safety
1172989|NCT02154542|Mechanical ventilation|mechanical ventilation
1172990|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1172991|NCT02154464|Morphine-sparing|morphine-sparing
1172992|NCT02154464|Paracetamol|paracetamol
1172993|NCT02154464|Obesity|obesity
1172994|NCT02154464|Gastric banding|gastric banding
1172995|NCT02154425|Cimzia®|cimzia®
1172997|NCT02154425|Breastfeeding|breastfeeding
1172998|NCT02154425|Nursing|nursing
1172999|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
1173000|NCT02154412|Respiration|respiration
1173001|NCT02154412|Motor control|motor control
1173002|NCT02154412|Blood Pressure|blood pressure
1173003|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
1173004|NCT02154386|bone augmentation|bone augmentation
1173005|NCT02154386|tooth extraction|tooth extraction
1173006|NCT02154386|dental implant|dental implant
1173007|NCT02154360|HIV infection|hiv infection
1173008|NCT02154360|NK-1R antagonists|nk-1r antagonists
1173009|NCT02154360|aprepitant|aprepitant
1173010|NCT02154360|ritonavir boosting|ritonavir boosting
1173011|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1173012|NCT02154347|HbA1c|hba1c
1173013|NCT02154334|Allergic Rhinitis|allergic rhinitis
1173014|NCT02154334|Healthy|healthy
1173015|NCT02154334|Esketamine|esketamine
1173016|NCT02154334|Mometasone|mometasone
1173017|NCT02154334|Oxymetazoline|oxymetazoline
1173018|NCT02154334|Phase 1|phase 1
1173019|NCT02154308|Influenza|influenza
1173020|NCT02154308|Influenza vaccine|influenza vaccine
1173021|NCT02154308|Split influenza vaccine|split influenza vaccine
1173022|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
1173023|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
1173024|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
1173025|NCT02154282|cirrhosis|cirrhosis
1173026|NCT02154269|Chagas disease|chagas disease
1173027|NCT02154269|G-CSF|g-csf
1173028|NCT02154269|Cell therapy|cell therapy
1173029|NCT02154256|walking|walking
1173030|NCT02154256|incentives|incentives
1173031|NCT02154256|exercise|exercise
1173032|NCT02154256|habits|habits
1173033|NCT02154230|weight loss|weight loss
1173034|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
1173035|NCT02154230|gut microbiota|gut microbiota
1173036|NCT02154230|body composition|body composition
1173037|NCT02154230|bile salts|bile salts
1173038|NCT02154191|Lumbosacral Region|lumbosacral region
1173039|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
1173040|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
1173041|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
1173042|NCT02154178|biomarkers|biomarkers
1173043|NCT02154178|invasive fungal infection|invasive fungal infection
1173044|NCT02154178|Candida|candida
1173045|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
1173046|NCT02154165|Phototherapy|phototherapy
1173047|NCT02154165|Light emitting diodes|light emitting diodes
1173048|NCT02154165|Blue light|blue light
1173049|NCT02154165|Turquoise light|turquoise light
1173050|NCT02154152|Bed wetting|bed wetting
1173051|NCT02154152|Primary Enuresis|primary enuresis
1173052|NCT02154152|Frequency|frequency
1173053|NCT02154152|Efficacy|efficacy
1173054|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
1173055|NCT02154152|Causticum 200c|causticum 200c
1173056|NCT02154139|Pharmacological therapy|pharmacological therapy
1173057|NCT02154113|Syneron|syneron
1173058|NCT02154113|Velashape|velashape
1173059|NCT02154113|ELOS|elos
1173060|NCT02154113|Ultrashape|ultrashape
1173061|NCT02154100|Metabolic Syndrome|metabolic syndrome
1173062|NCT02154100|Arterial Stiffness|arterial stiffness
1173063|NCT02154100|Blood Pressure|blood pressure
1173064|NCT02154100|Endothelial Function|endothelial function
1173065|NCT02154100|Tart Cherries|tart cherries
1173066|NCT02154087|Venous leg ulcer|venous leg ulcer
1173067|NCT02154087|Ulcer|ulcer
1173068|NCT02154087|Venous stasis|venous stasis
1173069|NCT02154087|Compression|compression
1173070|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
1173071|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
1173072|NCT02154035|Viral Suppression|viral suppression
1173073|NCT02154035|Functional Cure|functional cure
1173074|NCT02154022|PK|pk
1173075|NCT02154009|Autonomic Nervous System|autonomic nervous system
1573427|NCT00488943|Stent-Graft|stent-graft
1173076|NCT02154009|Catecholamines|catecholamines
1173077|NCT02154009|Dysautonomia|dysautonomia
1173078|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
1173079|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
1173080|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
1173081|NCT02153983|Obesity|obesity
1173082|NCT02153983|Colchicine|colchicine
1173083|NCT02153983|Inflammation|inflammation
1173084|NCT02153983|Metabolic Syndrome|metabolic syndrome
1173085|NCT02153983|Dyslipidemia|dyslipidemia
1173086|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
1173087|NCT02153970|Proxy Reported Outcome|proxy reported outcome
1173088|NCT02153970|Pediatric|pediatric
1173089|NCT02153970|Neuromuscular Disease|neuromuscular disease
1173090|NCT02153970|Cerebral Palsy|cerebral palsy
1173091|NCT02153957|Exercise|exercise
1173092|NCT02153957|Memory|memory
1173093|NCT02153957|BDNF|bdnf
1173094|NCT02153957|Zamzee|zamzee
1173095|NCT02153957|QOL|qol
1173096|NCT02153944|Startle|startle
1173097|NCT02153944|Induced-Threat|induced-threat
1173098|NCT02153944|Memory|memory
1173099|NCT02153944|Stimulant|stimulant
1173100|NCT02153944|Cognitive Interference|cognitive interference
1173101|NCT02153931|Children's Tumor Foundation|children's tumor foundation
1173102|NCT02153931|Social Support|social support
1173103|NCT02153931|Online|online
1173104|NCT02153931|Anxiety|anxiety
1173105|NCT02153931|Depression|depression
1173106|NCT02153918|Surgery|surgery
1173107|NCT02153918|Neoadjuvant|neoadjuvant
1173108|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
1173109|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
1173110|NCT02153918|Vaccine|vaccine
1173111|NCT02153905|Tumor Regression|tumor regression
1173112|NCT02153905|Immunotherapy|immunotherapy
1173113|NCT02153905|Metastatic Cancer|metastatic cancer
1173114|NCT02153905|Gene Therapy|gene therapy
1173115|NCT02153905|T Cells|t cells
1173116|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
1173117|NCT02153892|Heart Failure|heart failure
1173118|NCT02153892|Ventricular Reshaping|ventricular reshaping
1173119|NCT02153879|HDL|hdl
1173120|NCT02153879|Niacin|niacin
1173121|NCT02153879|Fenofibrate|fenofibrate
1173122|NCT02153879|Diabetes|diabetes
1173123|NCT02153879|Metabolomics|metabolomics
1173124|NCT02153866|rotavirus vaccine|rotavirus vaccine
1173125|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
1173126|NCT02153827|Shoulder|shoulder
1173127|NCT02153827|Eccentric Training|eccentric training
1173128|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
1173129|NCT02153814|Infertility|infertility
1173130|NCT02153814|In vitro fertilization|in vitro fertilization
1173131|NCT02153814|Endometrial injury|endometrial injury
1173132|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
1173133|NCT02153788|Insomnia|insomnia
1173134|NCT02153788|HIV|hiv
1173135|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
1173136|NCT02153775|Cigarette|cigarette
1173137|NCT02153775|Smoking|smoking
1173138|NCT02153775|Craving|craving
1173139|NCT02153762|Atopic Dermatitis|atopic dermatitis
1173140|NCT02153762|AD|ad
1173141|NCT02153723|Treatment trial|treatment trial
1173142|NCT02153710|Aphasia|aphasia
1173143|NCT02153710|Anomia|anomia
1173144|NCT02153697|solar lentigines|solar lentigines
1173145|NCT02153697|Q-switches Laser|q-switches laser
1173146|NCT02153697|bleaching cream|bleaching cream
1173147|NCT02153684|smoking|smoking
1173148|NCT02153684|small airway dysfunction|small airway dysfunction
1173149|NCT02153684|mild COPD|mild copd
1173150|NCT02153684|dyspnea|dyspnea
1173151|NCT02153684|exercise|exercise
1173152|NCT02153684|clinical outcomes|clinical outcomes
1173153|NCT02153671|LAIV H5N2|laiv h5n2
1173154|NCT02153671|Influenza vaccine|influenza vaccine
1173155|NCT02153671|Russia|russia
1173156|NCT02153658|PrePex|prepex
1173157|NCT02153658|Odor|odor
1173158|NCT02153658|Cleaning technique|cleaning technique
1173159|NCT02153658|Male Circumcision|male circumcision
1173160|NCT02153658|HIV|hiv
1173161|NCT02153658|AIDS|aids
1173162|NCT02153658|Chlorhexidine|chlorhexidine
1173163|NCT02153658|Soap|soap
1173164|NCT02153645|Parkinson's Disease|parkinson's disease
1173165|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
1173166|NCT02153645|Dyskinesias|dyskinesias
1173167|NCT02153645|Parkinsonism|parkinsonism
1173168|NCT02153632|Parkinson's Disease|parkinson's disease
1173169|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
1173170|NCT02153632|LID|lid
1173171|NCT02153632|Parkinsonism|parkinsonism
1173172|NCT02153632|Dyskinesia|dyskinesia
1173173|NCT02153619|Grief|grief
1173174|NCT02153619|bereavement|bereavement
1173175|NCT02153619|questionnaires|questionnaires
1173176|NCT02153619|therapy sessions|therapy sessions
1173177|NCT02153619|14-102|14-102
1173178|NCT02153606|Glycerin Suppositories|glycerin suppositories
1241629|NCT01844414|HIV|hiv
1173179|NCT02153606|Enteral Nutrition|enteral nutrition
1173180|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
1173181|NCT02153606|Infant, Premature|infant, premature
1173182|NCT02153606|Meconium|meconium
1173183|NCT02153593|Clinical trial|clinical trial
1173184|NCT02153593|Randomized|randomized
1173185|NCT02153593|Fibrin glue|fibrin glue
1173186|NCT02153593|Tranexamic acid|tranexamic acid
1173187|NCT02153593|Blood loss|blood loss
1173188|NCT02153567|Functional dyspepsia|functional dyspepsia
1173189|NCT02153567|symptom response|symptom response
1173190|NCT02153567|postprandial fullness|postprandial fullness
1173191|NCT02153567|Anxiety|anxiety
1173192|NCT02153567|Depression|depression
1173193|NCT02153528|Bangladesh|bangladesh
1173194|NCT02153528|Rimfapicin|rimfapicin
1173890|NCT02150096|disability|disability
1173195|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
1173196|NCT02153515|Fingerprick|fingerprick
1173197|NCT02153515|Fresh|fresh
1173198|NCT02153515|Your own blood|your own blood
1173199|NCT02153515|autologous blood|autologous blood
1173200|NCT02153515|Dry eyes|dry eyes
1173201|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
1173202|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
1173203|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
1173204|NCT02153463|Tourette Syndrome|tourette syndrome
1173205|NCT02153463|Persistent Tic Disorder|persistent tic disorder
1173206|NCT02153463|Physical Activity|physical activity
1173207|NCT02153463|Quality of Life|quality of life
1173208|NCT02153450|pancreatic cancer|pancreatic cancer
1173209|NCT02153450|Radiation|radiation
1173210|NCT02153450|Metformin|metformin
1173211|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
1173212|NCT02153411|Asthma control|asthma control
1173213|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
1173214|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
1173215|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
1173216|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
1173217|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
1173218|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
1173219|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
1173220|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
1173221|NCT02153359|asthma|asthma
1173222|NCT02153359|HEPA|hepa
1173223|NCT02153359|air pollutants|air pollutants
1173224|NCT02153359|lung function|lung function
1173225|NCT02153359|home environment|home environment
1173226|NCT02153359|respiratory symptoms|respiratory symptoms
1173227|NCT02153359|diet|diet
1173228|NCT02153346|indirect cost|indirect cost
1173229|NCT02153346|asthma|asthma
1173230|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
1173231|NCT02153333|Serologic response|serologic response
1173232|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
1173233|NCT02153333|Laboratory evaluations|laboratory evaluations
1173234|NCT02153320|HBsAg|hbsag
1173235|NCT02153320|Persistence of the immune response|persistence of the immune response
1173236|NCT02153320|Adjuvants|adjuvants
1173237|NCT02153294|low tidal volume|low tidal volume
1173238|NCT02153294|high tidal volume|high tidal volume
1173239|NCT02153294|protective ventilation|protective ventilation
1173240|NCT02153294|ARDS|ards
1173241|NCT02153281|Depression|depression
1173242|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
1173243|NCT02153281|MAO-B|mao-b
1173244|NCT02153268|Safety|safety
1173245|NCT02153268|efficacy|efficacy
1173246|NCT02153268|BonoFill|bonofill
1173247|NCT02153268|bone filler|bone filler
1173248|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
1173249|NCT02153268|Bone augmentation|bone augmentation
1173250|NCT02153268|sinus augmentation|sinus augmentation
1173251|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
1173252|NCT02153255|Morquio|morquio
1173253|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
1173254|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
1173255|NCT02153255|GALNS|galns
1173256|NCT02153242|Pacing|pacing
1173257|NCT02153242|Haemodynamics|haemodynamics
1173258|NCT02153242|Pilot|pilot
1173259|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
1173260|NCT02153229|epitheliod subtype|epitheliod subtype
1173261|NCT02153229|limited to the hemithorax|limited to the hemithorax
1173262|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
1173263|NCT02153203|Autism spectrum disorder|autism spectrum disorder
1173264|NCT02153203|Problem behavior|problem behavior
1173265|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
1173266|NCT02153190|T1DM,|t1dm,
1173267|NCT02153190|Artificial Pancreas|artificial pancreas
1173268|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
1173269|NCT02153177|RCT|rct
1173270|NCT02153177|rotator cuff tear|rotator cuff tear
1241752|NCT01843764|RDT|rdt
1173271|NCT02153177|NSAIDs|nsaids
1173272|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1173273|NCT02153177|rotator cuff repair|rotator cuff repair
1173274|NCT02153164|Enthalpy|enthalpy
1173275|NCT02153164|Trendelenberg position|trendelenberg position
1173276|NCT02153164|Mechanical ventilation|mechanical ventilation
1173277|NCT02153138|vegetarian diet|vegetarian diet
1173278|NCT02153138|vegan|vegan
1173279|NCT02153138|cardiovascular diseases|cardiovascular diseases
1173280|NCT02153138|endothelial function|endothelial function
1173281|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
1173282|NCT02153112|Drug therapy|drug therapy
1173283|NCT02153099|Drug therapy|drug therapy
1173284|NCT02153086|Pharmacological therapy|pharmacological therapy
1173285|NCT02153073|Pharmacological therapy|pharmacological therapy
1173286|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
1173287|NCT02153060|dexamethasone|dexamethasone
1173288|NCT02153060|efficacy|efficacy
1173290|NCT02153047|Smoking cessation|smoking cessation
1173291|NCT02153047|Spirometry|spirometry
1173292|NCT02153047|Primary health care|primary health care
1173293|NCT02153034|Buruli ulcer|buruli ulcer
1173294|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
1173295|NCT02153034|M. ulcerans disease|m. ulcerans disease
1173296|NCT02153021|anthropometric parameters;|anthropometric parameters;
1173297|NCT02153021|biochemical parameters;|biochemical parameters;
1173298|NCT02153021|inflammatory markers|inflammatory markers
1173299|NCT02153021|neuropeptide markers|neuropeptide markers
1173300|NCT02153021|phototherapy|phototherapy
1173301|NCT02153008|Strep throat|strep throat
1173302|NCT02152956|AML|aml
1173303|NCT02152956|leukemia|leukemia
1173304|NCT02152956|myelogenous|myelogenous
1173305|NCT02152956|myeloid|myeloid
1173306|NCT02152956|refractory|refractory
1173307|NCT02152956|MDS|mds
1173308|NCT02152956|Myelodysplastic|myelodysplastic
1173309|NCT02152943|Breast Cancer|breast cancer
1173310|NCT02152943|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
1173311|NCT02152943|Solid Tumors|solid tumors
1173312|NCT02152943|Advanced Solid Tumors|advanced solid tumors
1173313|NCT02152943|Everolimus|everolimus
1173314|NCT02152943|Afinitor|afinitor
1173315|NCT02152943|Zortress|zortress
1173316|NCT02152943|RAD001|rad001
1173317|NCT02152943|Trastuzumab|trastuzumab
1173318|NCT02152943|Herceptin|herceptin
1173319|NCT02152943|Letrozole|letrozole
1173320|NCT02152943|Femara|femara
1173321|NCT02152930|Fish oil supplements|fish oil supplements
1173322|NCT02152930|Supervised Exercise Training|supervised exercise training
1173323|NCT02152930|Walking distance|walking distance
1173324|NCT02152930|Hemorheological factors|hemorheological factors
1173325|NCT02152930|Cardiovascular risk|cardiovascular risk
1173326|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
1173327|NCT02152904|rebleeding|rebleeding
1173328|NCT02152904|mortality|mortality
1173329|NCT02152904|nationwide|nationwide
1173330|NCT02152891|Emergency Medical Services|emergency medical services
1173331|NCT02152891|Elderly|elderly
1173332|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
1173333|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
1173334|NCT02152878|bipolar disorder|bipolar disorder
1173335|NCT02152878|depression|depression
1173336|NCT02152865|medication|medication
1173337|NCT02152852|Type 2 Diabetes|type 2 diabetes
1173338|NCT02152826|Sensitivity|sensitivity
1173339|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
1173340|NCT02152787|emergence agitation|emergence agitation
1173341|NCT02152787|propofol|propofol
1173342|NCT02152787|strabismus surgery|strabismus surgery
1173343|NCT02152787|children|children
1173344|NCT02152787|elective strabismus surgery|elective strabismus surgery
1173345|NCT02152761|bimagrumab,|bimagrumab,
1173346|NCT02152761|BYM338,|bym338,
1173347|NCT02152761|hip fracture,|hip fracture,
1173348|NCT02152761|elderly,|elderly,
1173349|NCT02152761|controlled clinical trial,|controlled clinical trial,
1173350|NCT02152761|randomized,|randomized,
1173351|NCT02152761|muscle wasting (atrophy)|muscle wasting (atrophy)
1173352|NCT02152748|glioblastoma|glioblastoma
1173353|NCT02152748|morphological and molecular changes|morphological and molecular changes
1173354|NCT02152748|progression|progression
1173355|NCT02152748|therapy-resistance|therapy-resistance
1173356|NCT02152722|Breath test|breath test
1173357|NCT02152722|Volatile Organic Compounds|volatile organic compounds
1173358|NCT02152722|VOC|voc
1173359|NCT02152722|oxidative stress|oxidative stress
1173360|NCT02152722|radiation biodosimetry|radiation biodosimetry
1173361|NCT02152722|metabolomics|metabolomics
1173362|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
1173363|NCT02152709|Safety|safety
1173364|NCT02152709|Immunogenicity|immunogenicity
1173365|NCT02152709|Vaccine|vaccine
1173366|NCT02152709|Hepatitis B|hepatitis b
1173367|NCT02152657|Spinal cord injury|spinal cord injury
1173368|NCT02152657|Stem cell transplantation|stem cell transplantation
1173369|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
1173370|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
1173371|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
1173372|NCT02152618|Serious emotional disturbance|serious emotional disturbance
1173373|NCT02152618|foster care|foster care
1173374|NCT02152618|child protective services|child protective services
1173375|NCT02152605|SGRQ|sgrq
1173376|NCT02152605|vilanterol|vilanterol
1173377|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
1173378|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1173379|NCT02152605|COPD|copd
1173380|NCT02152605|umeclidinium|umeclidinium
1173381|NCT02152592|Postoperative pain|postoperative pain
1173382|NCT02152592|Ambulatory surgery|ambulatory surgery
1173383|NCT02152592|NSAIDS|nsaids
1173384|NCT02152592|CR Oxycodone|cr oxycodone
1173385|NCT02152592|Compliance to study medication|compliance to study medication
1173386|NCT02152579|Stable Angina|stable angina
1173387|NCT02152553|Biomarker|biomarker
1173388|NCT02152553|Glucocorticoids|glucocorticoids
1173389|NCT02152553|Metabolism|metabolism
1173390|NCT02152553|Pharmacology|pharmacology
1173391|NCT02152553|Metabolomics|metabolomics
1173392|NCT02152540|TBI|tbi
1173393|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1173394|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
1173395|NCT02152540|Quality of life|quality of life
1173396|NCT02152540|Executive Function|executive function
1173397|NCT02152540|Veterans|veterans
1173398|NCT02152501|obese|obese
1173399|NCT02152501|overweight|overweight
1173400|NCT02152501|exercise|exercise
1173401|NCT02152501|energy expenditure differences|energy expenditure differences
1173402|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
1173403|NCT02152501|food|food
1173404|NCT02152501|physical activity|physical activity
1173405|NCT02152501|biological|biological
1173406|NCT02152501|neurobehavioral|neurobehavioral
1173407|NCT02152501|behavioral|behavioral
1173408|NCT02152488|cerebral blood flow|cerebral blood flow
1173409|NCT02152488|position|position
1173410|NCT02152488|cervical spine|cervical spine
1173411|NCT02152475|Blue-LED|blue-led
1173412|NCT02152475|Curcumin|curcumin
1173413|NCT02152475|PDT|pdt
1173414|NCT02152475|Oral disinfection|oral disinfection
1173415|NCT02152462|exergaming|exergaming
1173416|NCT02152462|breast cancer|breast cancer
1173417|NCT02152462|African American women|african american women
1173418|NCT02152462|obesity|obesity
1173419|NCT02152423|enoxaparin|enoxaparin
1173420|NCT02152423|Enoxamed|enoxamed
1173421|NCT02152423|lovenox|lovenox
1173422|NCT02152423|anti Xa|anti xa
1173423|NCT02152423|acute coronary syndrome|acute coronary syndrome
1173424|NCT02152410|acupuncture|acupuncture
1173425|NCT02152410|renal colic|renal colic
1173426|NCT02152358|Cytomegalovirus|cytomegalovirus
1173427|NCT02152358|Herpes simplex virus|herpes simplex virus
1173428|NCT02152358|ICU|icu
1173429|NCT02152358|mechanical ventilation|mechanical ventilation
1173430|NCT02152358|mortality|mortality
1173431|NCT02152358|ventilator-free days|ventilator-free days
1173432|NCT02152358|PCR|pcr
1173433|NCT02152345|kidney|kidney
1173434|NCT02152345|renal|renal
1173435|NCT02152345|transplant|transplant
1173436|NCT02152345|belatacept|belatacept
1173437|NCT02152345|delayed graft function|delayed graft function
1173438|NCT02152345|thymoglobulin|thymoglobulin
1173439|NCT02152345|tacrolimus|tacrolimus
1173440|NCT02152345|kidney function|kidney function
1173441|NCT02152345|immunosuppression|immunosuppression
1173442|NCT02152345|NGAL|ngal
1173443|NCT02152332|JNJ-54861912|jnj-54861912
1173444|NCT02152332|RSC-385896|rsc-385896
1173445|NCT02152332|MTS-0385896A|mts-0385896a
1173446|NCT02152332|Phase 1|phase 1
1173447|NCT02152332|Moxifloxacin|moxifloxacin
1173448|NCT02152332|Placebo|placebo
1173449|NCT02152332|Healthy|healthy
1173450|NCT02152319|Parkinson's disease|parkinson's disease
1173451|NCT02152319|Telemedicine|telemedicine
1173452|NCT02152319|Telehealth|telehealth
1173453|NCT02152319|Kinesia|kinesia
1173454|NCT02152319|Tremor|tremor
1173455|NCT02152319|Bradykinesia|bradykinesia
1173456|NCT02152319|Dyskinesia|dyskinesia
1173457|NCT02152306|Fimasartan|fimasartan
1173458|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
1173459|NCT02152306|Antihypertension|antihypertension
1173460|NCT02152267|Temporomandibular|temporomandibular
1173461|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
1173462|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
1173463|NCT02152267|Prefrontal Cortex|prefrontal cortex
1173464|NCT02152254|Metastatic Cancer|metastatic cancer
1173465|NCT02152254|Molecular Profiling|molecular profiling
1173466|NCT02152254|Genomic alteration analysis of the tumor|genomic alteration analysis of the tumor
1173467|NCT02152254|Advanced Cancer Therapy|advanced cancer therapy
1173468|NCT02152254|Gene mutations|gene mutations
1173469|NCT02152254|Tumor biopsy|tumor biopsy
1173470|NCT02152254|Personalized medicine|personalized medicine
1173471|NCT02152241|IBD|ibd
1173472|NCT02152241|Crohn|crohn
1173473|NCT02152241|Colitis|colitis
1173474|NCT02152241|Function|function
1173475|NCT02152176|pain|pain
1173476|NCT02152176|analgesia|analgesia
1173477|NCT02152176|morphine|morphine
1173478|NCT02152176|PCA|pca
1173479|NCT02152176|Nurse|nurse
1173480|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
1173481|NCT02152150|iron|iron
1173482|NCT02152150|anemia|anemia
1173483|NCT02152150|bio-fortification|bio-fortification
1173484|NCT02152150|children|children
1173485|NCT02152150|India|india
1173486|NCT02152124|Acromegaly|acromegaly
1173487|NCT02152124|Acromegaly treatment|acromegaly treatment
1173488|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
1173489|NCT02152124|Pegvisomant|pegvisomant
1173490|NCT02152124|Insulin sensitivity|insulin sensitivity
1173491|NCT02152124|Gut hormones|gut hormones
1173492|NCT02152124|Lipid metabolism|lipid metabolism
1173493|NCT02152124|Adipokines|adipokines
1173494|NCT02152111|Obesity|obesity
1173495|NCT02152111|Coconut flour|coconut flour
1173496|NCT02152111|Diet quality|diet quality
1173497|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
1173499|NCT02152085|Mobility|mobility
1173500|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
1173501|NCT02152085|Multiple sclerosis|multiple sclerosis
1173502|NCT02152059|Small cell lung cancer|small cell lung cancer
1173503|NCT02152059|BIBF1120|bibf1120
1173504|NCT02152059|nintedanib|nintedanib
1173505|NCT02152059|platinum-sensitive|platinum-sensitive
1173506|NCT02152033|Substance Abuse|substance abuse
1173507|NCT02152033|Continuing Care|continuing care
1173508|NCT02152033|Recovery|recovery
1173509|NCT02152033|Substance Abuse Treatment|substance abuse treatment
1173510|NCT02152033|Parent|parent
1173511|NCT02152033|Family|family
1173512|NCT02152033|Young Adult|young adult
1173513|NCT02152007|pachyonychia congenita|pachyonychia congenita
1173514|NCT02151994|BIA 5-1058|bia 5-1058
1173515|NCT02151994|hypertension|hypertension
1173516|NCT02151994|chronic heart failure|chronic heart failure
1173517|NCT02151994|cardiovascular disorders|cardiovascular disorders
1173518|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
1173519|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
1173520|NCT02151929|myocardial infarction|myocardial infarction
1173521|NCT02151929|primary PCI|primary pci
1173522|NCT02151929|stent|stent
1173523|NCT02151916|dental caries|dental caries
1173524|NCT02151916|early childhood caries|early childhood caries
1173525|NCT02151916|topical fluorides|topical fluorides
1173526|NCT02151916|fluoride varnish|fluoride varnish
1173527|NCT02151903|NHL|nhl
1173528|NCT02151903|Immunocytokine|immunocytokine
1173529|NCT02151903|Lymphoma|lymphoma
1173530|NCT02151903|Non-Hodgkin|non-hodgkin
1173531|NCT02151903|B-cell|b-cell
1173532|NCT02151903|IL (interleukin)|il (interleukin)
1173533|NCT02151890|POF|pof
1173534|NCT02151890|ESS|ess
1173535|NCT02151890|stem cell|stem cell
1173536|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
1173537|NCT02151864|liver cancer|liver cancer
1173538|NCT02151864|cirrhosis|cirrhosis
1173539|NCT02151864|Child-Pugh A|child-pugh a
1173540|NCT02151864|Hedgehog|hedgehog
1173541|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
1173542|NCT02151851|TNFα antagonist|tnfα antagonist
1173543|NCT02151851|Certolizumab Pegol|certolizumab pegol
1173544|NCT02151851|Chinese patients|chinese patients
1173545|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
1173546|NCT02151825|Gut microbiota|gut microbiota
1173547|NCT02151825|Probiotics|probiotics
1173548|NCT02151825|Prebiotics|prebiotics
1173549|NCT02151825|Synbiotic|synbiotic
1173550|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
1173551|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
1173552|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
1173553|NCT02151825|Inulin|inulin
1173554|NCT02151825|GOS|gos
1173555|NCT02151825|Body Weight|body weight
1173556|NCT02151825|Overweight|overweight
1173557|NCT02151825|Adiposity|adiposity
1173558|NCT02151825|Obesity|obesity
1173559|NCT02151825|ANGPTL4|angptl4
1173560|NCT02151786|Pharmacological therapy|pharmacological therapy
1173561|NCT02151773|Pharmacological therapy|pharmacological therapy
1173562|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
1173563|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
1173564|NCT02151721|Vorinostat|vorinostat
1173565|NCT02151721|Gefitinib|gefitinib
1173566|NCT02151721|BIM polymorphism|bim polymorphism
1173567|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
1173568|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
1173569|NCT02151682|chronic pain|chronic pain
1173570|NCT02151682|opioid|opioid
1173571|NCT02151669|Mediterranean diet|mediterranean diet
1173572|NCT02151669|Smoking/tobacco|smoking/tobacco
1173573|NCT02151669|Spirometry|spirometry
1173574|NCT02151656|Schizophrenia|schizophrenia
1173575|NCT02151656|Mental disorders|mental disorders
1173576|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
1173577|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
1173578|NCT02151630|wart|wart
1173579|NCT02151630|verruca vulgaris|verruca vulgaris
1173580|NCT02151630|topical therapy|topical therapy
1173581|NCT02151630|pyruvic acid|pyruvic acid
1173582|NCT02151630|salicylic acid|salicylic acid
1173583|NCT02151617|Multiple dose|multiple dose
1173584|NCT02151617|safety|safety
1173585|NCT02151617|tolerability|tolerability
1173586|NCT02151617|PK|pk
1173587|NCT02151591|Quit smoking|quit smoking
1173588|NCT02151591|Quit drinking|quit drinking
1173589|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
1173590|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
1173591|NCT02151565|back pain|back pain
1173592|NCT02151565|sciatica|sciatica
1173593|NCT02151565|electrotherapy|electrotherapy
1173594|NCT02151565|HTEMS|htems
1173595|NCT02151565|TENS|tens
1173596|NCT02151552|lung inflammation|lung inflammation
1173597|NCT02151552|positron emission tomography|positron emission tomography
1173598|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
1173599|NCT02151513|Cancer-associated pain|cancer-associated pain
1173600|NCT02151513|Immune function|immune function
1173601|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
1173602|NCT02151500|Somatoform disorders|somatoform disorders
1173603|NCT02151500|Chronic pain|chronic pain
1173604|NCT02151500|Somatic symptoms|somatic symptoms
1173605|NCT02151500|Emotional processing|emotional processing
1173606|NCT02151500|Primary Care|primary care
1173607|NCT02151487|Supraclavicular block|supraclavicular block
1173608|NCT02151487|Ropivacaine|ropivacaine
1173609|NCT02151487|Dexamethasone|dexamethasone
1173610|NCT02151487|Clonidine|clonidine
1173611|NCT02151461|Diabetes|diabetes
1173612|NCT02151461|Type 2 Diabetes|type 2 diabetes
1173613|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1173614|NCT02151435|Biomarkers|biomarkers
1173615|NCT02151435|Forced Vital Capacity|forced vital capacity
1173616|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
1173617|NCT02151435|Prognosis|prognosis
1173618|NCT02151422|Adults|adults
1173619|NCT02151422|age 18-65|age 18-65
1173620|NCT02151422|physician-diagnosed|physician-diagnosed
1173621|NCT02151422|persistent asthma|persistent asthma
1173622|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
1173623|NCT02151383|Acute heart failure,|acute heart failure,
1173624|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
1173625|NCT02151357|first in man|first in man
1173626|NCT02151357|dose escalating|dose escalating
1173627|NCT02151357|MTD|mtd
1173628|NCT02151357|DLT|dlt
1173629|NCT02151331|Chronic care model|chronic care model
1173630|NCT02151331|Mood disorders|mood disorders
1173631|NCT02151331|Adaptive implementation|adaptive implementation
1173632|NCT02151279|Shrimp allergy|shrimp allergy
1173633|NCT02151279|Chitosan|chitosan
1173634|NCT02151279|fining agent|fining agent
1173635|NCT02151266|Heart failure|heart failure
1173636|NCT02151266|Exercise|exercise
1173637|NCT02151266|Cognitive training|cognitive training
1173638|NCT02151253|Nocturia|nocturia
1173639|NCT02151253|Daytime sleepiness|daytime sleepiness
1173640|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
1173641|NCT02151227|Meta-Analysis|meta-analysis
1173642|NCT02151227|Metabolic Syndrome|metabolic syndrome
1173643|NCT02151227|Magnesium|magnesium
1173644|NCT02151227|Dose Response Effect|dose response effect
1173645|NCT02151227|Systematic Review|systematic review
1173646|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
1173647|NCT02151214|Quality of life|quality of life
1173648|NCT02151214|Parenteral nutrition|parenteral nutrition
1173649|NCT02151214|Undernutrition|undernutrition
1173650|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
1173651|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
1173652|NCT02151136|Sucrose|sucrose
1173653|NCT02151136|Pain|pain
1173654|NCT02151123|Colonic Neoplasms|colonic neoplasms
1173655|NCT02151123|Colon Cancer|colon cancer
1173656|NCT02151123|Microbiome|microbiome
1173657|NCT02151110|Healthy Male|healthy male
1173658|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
1173659|NCT02151097|Prostatectomy|prostatectomy
1173660|NCT02151097|Prostate cancer|prostate cancer
1173661|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
1173662|NCT02151084|randomized|randomized
1173663|NCT02151084|selumetinib|selumetinib
1173664|NCT02151084|tablets|tablets
1173665|NCT02151084|cisplatin|cisplatin
1173666|NCT02151084|gemcitabine|gemcitabine
1173667|NCT02151084|non-resectable|non-resectable
1173668|NCT02151084|recurrent|recurrent
1173669|NCT02151084|metstatic|metstatic
1173670|NCT02151071|Breast Cancer|breast cancer
1173671|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
1173672|NCT02151071|Breast Conserving Surgery|breast conserving surgery
1173673|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
1173674|NCT02151071|Beta particle detection|beta particle detection
1173675|NCT02151058|Staining|staining
1173676|NCT02151058|Intensity|intensity
1173677|NCT02151058|Area|area
1173678|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
1173679|NCT02151045|L3-L4 stage|l3-l4 stage
1173680|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
1173681|NCT02151045|Scan control|scan control
1173682|NCT02151032|Colorectal Cancer|colorectal cancer
1173683|NCT02151032|Colorectal cancer screening|colorectal cancer screening
1173684|NCT02151032|Multimedia|multimedia
1173685|NCT02151032|Booklet|booklet
1173686|NCT02151032|Pamphlet|pamphlet
1173687|NCT02151032|Audio CD|audio cd
1173688|NCT02151032|Video with animated images|video with animated images
1173689|NCT02151032|Video with non-moving images|video with non-moving images
1173690|NCT02151032|Questionnaires|questionnaires
1173692|NCT02151006|DHEA|dhea
1173693|NCT02151006|IVF|ivf
1173694|NCT02151006|ICSI|icsi
1173695|NCT02150993|Africa|africa
1173696|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
1173697|NCT02150993|HIV-2|hiv-2
1173698|NCT02150993|firsts line ART|firsts line art
1173699|NCT02150993|Adults|adults
1173700|NCT02150980|Fractures|fractures
1173701|NCT02150980|burden of fractures|burden of fractures
1173702|NCT02150980|orthopaedic fractures|orthopaedic fractures
1173703|NCT02150980|orthopaedic injuries|orthopaedic injuries
1173704|NCT02150980|orthopaedic trauma|orthopaedic trauma
1173705|NCT02150980|observational study|observational study
1173706|NCT02150980|outcomes of fracture care|outcomes of fracture care
1173707|NCT02150980|epidemiology|epidemiology
1173708|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
1173709|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
1173710|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
1173711|NCT02150954|induction of labor|induction of labor
1173712|NCT02150954|pitocin|pitocin
1173713|NCT02150954|foley bulb|foley bulb
1173714|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
1173715|NCT02150941|Endoscopy|endoscopy
1173716|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
1173717|NCT02150915|Acupoints|acupoints
1173718|NCT02150915|Acupuncture therapy|acupuncture therapy
1173719|NCT02150915|Median nerve|median nerve
1173720|NCT02150915|Biomechanics|biomechanics
1173721|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
1173722|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
1173723|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
1173724|NCT02150889|insulin resistance|insulin resistance
1173725|NCT02150889|lipid metabolism|lipid metabolism
1173726|NCT02150889|diabetes|diabetes
1173727|NCT02150876|DES|des
1173728|NCT02150876|SDF|sdf
1173729|NCT02150876|MACE|mace
1173730|NCT02150876|SYNERGY|synergy
1173731|NCT02150863|actinic keratosis|actinic keratosis
1173732|NCT02150863|field cancerization|field cancerization
1173733|NCT02150863|organ transplant patients|organ transplant patients
1173734|NCT02150850|Femoral Fractures|femoral fractures
1173735|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
1173736|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
1173737|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
1173738|NCT02150850|Stress Fractures|stress fractures
1173739|NCT02150850|Bone Fractures|bone fractures
1173740|NCT02150850|Hip Fractures|hip fractures
1173741|NCT02150850|Osteoporosis|osteoporosis
1173742|NCT02150837|Obesity|obesity
1173743|NCT02150837|Weight Loss|weight loss
1173744|NCT02150837|Meal replacements|meal replacements
1173745|NCT02150837|Weight maintenance|weight maintenance
1173746|NCT02150798|Diet Therapy|diet therapy
1173747|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
1173748|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
1173749|NCT02150798|Oximetry|oximetry
1173750|NCT02150798|phase angle|phase angle
1173751|NCT02150798|Triglycerides, blood|triglycerides, blood
1173752|NCT02150798|Lipids, blood|lipids, blood
1173753|NCT02150798|Hand Strength|hand strength
1173754|NCT02150798|Body Composition|body composition
1173755|NCT02150798|Electric Impedance|electric impedance
1173756|NCT02150785|Thrombolysis|thrombolysis
1173757|NCT02150785|Safety of Streptokinase|safety of streptokinase
1173758|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
1173759|NCT02150785|Stroke treatment|stroke treatment
1173760|NCT02150759|Dexmedetomidine|dexmedetomidine
1173761|NCT02150759|Ketamine|ketamine
1173762|NCT02150759|Pain|pain
1173763|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1173764|NCT02150746|Pancreatic cancer|pancreatic cancer
1173765|NCT02150746|PDAC|pdac
1173766|NCT02150746|Circulating tumor cells|circulating tumor cells
1173767|NCT02150720|Hip fractures|hip fractures
1173768|NCT02150720|Clinical Trial|clinical trial
1173769|NCT02150720|Randomized|randomized
1173770|NCT02150720|Fibrin glue|fibrin glue
1173771|NCT02150720|Tranexamic acid|tranexamic acid
1173772|NCT02150720|Blood loss|blood loss
1173773|NCT02150681|preconception|preconception
1173774|NCT02150681|pregnancy|pregnancy
1173775|NCT02150681|postpartum|postpartum
1173776|NCT02150681|women|women
1173777|NCT02150668|ADHD|adhd
1173778|NCT02150668|Homework|homework
1173779|NCT02150668|School|school
1173780|NCT02150668|Organization|organization
1173781|NCT02150668|Time-management|time-management
1173782|NCT02150616|Pulmonary hypertension|pulmonary hypertension
1173783|NCT02150616|Interstitial lung disease|interstitial lung disease
1173784|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
1173785|NCT02150603|Heart defects, congenital|heart defects, congenital
1173786|NCT02150603|Patient-reported outcomes|patient-reported outcomes
1173787|NCT02150603|Health status|health status
1173788|NCT02150603|Factors, psychosocial|factors, psychosocial
1173789|NCT02150603|Health behavior|health behavior
1173790|NCT02150603|Quality of life|quality of life
1173791|NCT02150603|Sense of coherence|sense of coherence
1173792|NCT02150603|Illness perceptions|illness perceptions
1173793|NCT02150603|Depression|depression
1173794|NCT02150603|Anxiety|anxiety
1173795|NCT02150590|airway disease|airway disease
1173796|NCT02150590|bronchitis|bronchitis
1173797|NCT02150590|emphysema|emphysema
1173798|NCT02150590|lung|lung
1173799|NCT02150577|Screening|screening
1173800|NCT02150577|Mood Stabilizers|mood stabilizers
1173801|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
1173802|NCT02150577|Peer Support|peer support
1173803|NCT02150577|Telepsychiatry|telepsychiatry
1173804|NCT02150577|Implementation|implementation
1173805|NCT02150577|Rural|rural
1173806|NCT02150564|Malignant gliomas|malignant gliomas
1173807|NCT02150564|Sono RCT|sono rct
1173808|NCT02150551|Crohn disease|crohn disease
1173809|NCT02150551|ulcerative colitis|ulcerative colitis
1173810|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
1173811|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
1173812|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
1173813|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
1173814|NCT02150538|Prolonged AV conduction|prolonged av conduction
1173815|NCT02150525|breast cancer|breast cancer
1173816|NCT02150525|vaginal dryness|vaginal dryness
1173817|NCT02150525|dyspareunia|dyspareunia
1173818|NCT02150525|genital irritation|genital irritation
1173819|NCT02150512|Septic shock|septic shock
1173820|NCT02150512|Critically ill patients|critically ill patients
1173821|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
1173822|NCT02150512|Fluid resuscitation|fluid resuscitation
1173823|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
1173824|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
1173825|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
1173826|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
1173827|NCT02150447|Proton pump inhibitor|proton pump inhibitor
1173828|NCT02150434|Oxygen therapy|oxygen therapy
1173829|NCT02150434|Hypoxemia|hypoxemia
1173830|NCT02150434|COPD|copd
1173831|NCT02150434|Closed-loop|closed-loop
1173832|NCT02150434|Automated titration,|automated titration,
1173833|NCT02150382|hypertension|hypertension
1173834|NCT02150382|rural|rural
1173835|NCT02150382|China|china
1173836|NCT02150382|protocol-based treatment|protocol-based treatment
1173837|NCT02150343|Cat allergy|cat allergy
1173838|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
1173839|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
1173840|NCT02150330|DHEAS|dheas
1173841|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
1173842|NCT02150330|Folliculogenesis.|folliculogenesis.
1173843|NCT02150330|Oocyte maturation.|oocyte maturation.
1173844|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
1173845|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
1173846|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1173847|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1173848|NCT02150317|Sorafenib|sorafenib
1173849|NCT02150278|Driving|driving
1173850|NCT02150278|Alcohol consumption|alcohol consumption
1173851|NCT02150278|Risk perception|risk perception
1173852|NCT02150252|Clinical trial|clinical trial
1173853|NCT02150252|Ischemic stroke|ischemic stroke
1173854|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
1173855|NCT02150252|Gait parameter|gait parameter
1173856|NCT02150252|Quality of life|quality of life
1173857|NCT02150239|pain|pain
1173858|NCT02150239|postoperative|postoperative
1173859|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
1173860|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
1173861|NCT02150213|BGG492|bgg492
1173862|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
1173863|NCT02150187|Male|male
1173864|NCT02150187|Baldness|baldness
1173865|NCT02150187|hair loss pattern|hair loss pattern
1173866|NCT02150174|Schizophrenia|schizophrenia
1173867|NCT02150174|Episodic memory deficits|episodic memory deficits
1173868|NCT02150148|breast cancer|breast cancer
1173869|NCT02150148|prostate cancer|prostate cancer
1173870|NCT02150148|colorectal cancer|colorectal cancer
1173871|NCT02150148|small intestine cancer|small intestine cancer
1173872|NCT02150148|thyroid cancer|thyroid cancer
1173873|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
1173874|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
1173875|NCT02150148|endometrial cancer|endometrial cancer
1173876|NCT02150148|kidney cancer|kidney cancer
1173877|NCT02150148|cervical cancer|cervical cancer
1173878|NCT02150148|diet|diet
1173879|NCT02150148|exercise|exercise
1173880|NCT02150148|physical activity|physical activity
1173881|NCT02150148|garden|garden
1173882|NCT02150135|Pancreatic cancer|pancreatic cancer
1173883|NCT02150135|Quality of life|quality of life
1173884|NCT02150135|Pain|pain
1173885|NCT02150122|Vitamin D|vitamin d
1173886|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
1173887|NCT02150122|Adolescents|adolescents
1173888|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
1173889|NCT02150096|clinical trial|clinical trial
1173891|NCT02150096|women|women
1173892|NCT02150083|midurethral sling|midurethral sling
1173893|NCT02150083|voiding study|voiding study
1173894|NCT02150083|voiding trial|voiding trial
1173895|NCT02150083|retrograde voiding trial|retrograde voiding trial
1173896|NCT02150070|Healthy subjects|healthy subjects
1173897|NCT02150070|ASP2408|asp2408
1173898|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
1173899|NCT02150070|Safety and Tolerability|safety and tolerability
1173900|NCT02150070|Pharmacokinetics|pharmacokinetics
1173901|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
1173902|NCT02150031|prevention and control|prevention and control
1173903|NCT02150031|chlorhexidine|chlorhexidine
1173904|NCT02150031|therapeutic irrigation|therapeutic irrigation
1173905|NCT02150031|mouthwashes|mouthwashes
1173906|NCT02150031|culture|culture
1173907|NCT02150018|- Critical Care|- critical care
1173908|NCT02150018|Non invasive ventilation|non invasive ventilation
1173909|NCT02150018|Electrical impedance tomography|electrical impedance tomography
1173910|NCT02150018|End expiratory lung volume|end expiratory lung volume
1173911|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
1173912|NCT02150005|periodontal diseases|periodontal diseases
1173913|NCT02150005|cardiovascular diseases|cardiovascular diseases
1173914|NCT02150005|periodontitis treatment|periodontitis treatment
1173915|NCT02149992|gestational diabetes|gestational diabetes
1173916|NCT02149992|myoinositol|myoinositol
1173917|NCT02149979|Incision|incision
1173918|NCT02149979|Wound Closure|wound closure
1173919|NCT02149979|Laser Tissue Soldering|laser tissue soldering
1173920|NCT02149966|safety and tolerability|safety and tolerability
1173921|NCT02149966|pharmacokinetic study|pharmacokinetic study
1173922|NCT02149953|Pregnancy|pregnancy
1173923|NCT02149953|Glycine requirements|glycine requirements
1173924|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
1173925|NCT02149953|Stable isotopes|stable isotopes
1173926|NCT02149940|Elderly|elderly
1173927|NCT02149940|Frailty|frailty
1173928|NCT02149940|Polypharmacy|polypharmacy
1173929|NCT02149940|Medication review|medication review
1173930|NCT02149940|Clinical pharmacy services|clinical pharmacy services
1173931|NCT02149927|EEG|eeg
1173932|NCT02149927|fMRI|fmri
1173933|NCT02149927|connectivity|connectivity
1173934|NCT02149927|sevoflurane|sevoflurane
1173935|NCT02149914|Ryodoraku|ryodoraku
1173936|NCT02149914|Meridian energy|meridian energy
1173937|NCT02149914|Heart rate variability|heart rate variability
1173938|NCT02149914|Autonomic Nervous System|autonomic nervous system
1173939|NCT02149914|GERD|gerd
1173940|NCT02149901|Pure Autonomic Failure|pure autonomic failure
1173941|NCT02149901|Multiple System Atrophy|multiple system atrophy
1173942|NCT02149901|Pseudoephedrine|pseudoephedrine
1173943|NCT02149901|Water|water
1173944|NCT02149901|Osmopressor|osmopressor
1173945|NCT02149888|HIV|hiv
1173946|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1173947|NCT02149888|PrEP|prep
1173948|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
1173949|NCT02149875|Acute ischemic stroke|acute ischemic stroke
1173950|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
1173951|NCT02149875|Cerebrolysin|cerebrolysin
1173952|NCT02149862|Bladder cancer|bladder cancer
1173953|NCT02149862|Diagnostic|diagnostic
1173954|NCT02149862|Infrared|infrared
1173955|NCT02149862|Spectrum|spectrum
1173956|NCT02149862|Urina|urina
1173957|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
1173958|NCT02149862|or|or
1174052|NCT02149485|PGD,|pgd,
1173959|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
1173960|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
1173961|NCT02149849|Surgical positioning|surgical positioning
1173962|NCT02149849|Lung cancer|lung cancer
1173963|NCT02149849|Thoracotomy|thoracotomy
1173964|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
1173965|NCT02149836|major depressive disorder|major depressive disorder
1173966|NCT02149836|depression|depression
1173967|NCT02149836|treatment resistent depression|treatment resistent depression
1173968|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
1173969|NCT02149823|Borderline Personality Disorder|borderline personality disorder
1173970|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
1173971|NCT02149823|Social Cognition|social cognition
1173972|NCT02149823|BPD|bpd
1173973|NCT02149823|SPD|spd
1173974|NCT02149823|MASC|masc
1173975|NCT02149823|Autism Spectrum Disorder|autism spectrum disorder
1173976|NCT02149823|Schizophrenia|schizophrenia
1173977|NCT02149823|Schizoaffective Disorder|schizoaffective disorder
1173978|NCT02149823|Bipolar Disorder|bipolar disorder
1173979|NCT02149810|MDD|mdd
1173980|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
1173981|NCT02149784|Chemotherapy|chemotherapy
1173982|NCT02149784|Resection of primary tumor|resection of primary tumor
1173983|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
1173984|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
1173985|NCT02149771|stents|stents
1173986|NCT02149771|chemoembolization|chemoembolization
1173987|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
1173988|NCT02149758|Etoricoxib|etoricoxib
1173989|NCT02149758|Periodontitis|periodontitis
1173990|NCT02149758|Superoxide dismutase|superoxide dismutase
1173991|NCT02149758|Saliva|saliva
1173992|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
1173993|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
1173994|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
1173995|NCT02149719|Peanut allergy|peanut allergy
1173996|NCT02149719|Desensitisation|desensitisation
1173997|NCT02149719|Safety|safety
1173998|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
1173999|NCT02149706|SPMS|spms
1174000|NCT02149706|Multiple Sclerosis|multiple sclerosis
1174001|NCT02149706|NeuroVax|neurovax
1174002|NCT02149693|Flipped classroom|flipped classroom
1174003|NCT02149693|High-fidelity simulation|high-fidelity simulation
1174004|NCT02149693|Medical education reform|medical education reform
1174005|NCT02149693|Medical teamwork|medical teamwork
1174006|NCT02149693|Resuscitation training|resuscitation training
1174007|NCT02149680|Post-dural puncture headache|post-dural puncture headache
1174008|NCT02149680|epidural blood patch|epidural blood patch
1174009|NCT02149680|labour analgesia|labour analgesia
1174010|NCT02149680|epidural analgesia|epidural analgesia
1174011|NCT02149667|osteoarthritis|osteoarthritis
1174012|NCT02149667|avascular necrosis|avascular necrosis
1174013|NCT02149667|ankylosis|ankylosis
1174014|NCT02149667|protrusio acetabuli|protrusio acetabuli
1174015|NCT02149667|painful hip dysplasia|painful hip dysplasia
1174016|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
1174017|NCT02149667|correction of functional deformity|correction of functional deformity
1174018|NCT02149667|revision procedures|revision procedures
1174019|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1174020|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1174021|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
1174022|NCT02149654|Engager bioprosthesis|engager bioprosthesis
1174023|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
1174024|NCT02149615|optic disc swelling|optic disc swelling
1174025|NCT02149615|antiacne medication|antiacne medication
1174026|NCT02149615|isotretinoin|isotretinoin
1174027|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
1174028|NCT02149589|ARDS|ards
1174029|NCT02149589|PEEP|peep
1174030|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
1174031|NCT02149589|Lung Morphology|lung morphology
1174032|NCT02149576|Retrospective Review|retrospective review
1174033|NCT02149576|Pilot Study|pilot study
1174034|NCT02149576|Early Stage NSCLC|early stage nsclc
1174035|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
1174036|NCT02149576|Re-intervention Rates|re-intervention rates
1174037|NCT02149550|Plasmodium falciparum|plasmodium falciparum
1174038|NCT02149550|malaria|malaria
1174039|NCT02149537|sickle cell disease|sickle cell disease
1174040|NCT02149537|sickle cell anemia|sickle cell anemia
1174041|NCT02149537|hydroxyurea|hydroxyurea
1174042|NCT02149537|Nigeria|nigeria
1174043|NCT02149537|low income country|low income country
1174044|NCT02149537|middle income country|middle income country
1174045|NCT02149537|developing country|developing country
1174046|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
1174047|NCT02149524|Trastuzumab|trastuzumab
1174048|NCT02149524|Biosimilar|biosimilar
1174049|NCT02149498|Parkinson|parkinson
1174053|NCT02149485|follow up|follow up
1174054|NCT02149459|Radiotherapy|radiotherapy
1174055|NCT02149459|Ketosis|ketosis
1174056|NCT02149459|Metformin|metformin
1174057|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
1174058|NCT02149459|Metabolome|metabolome
1174059|NCT02149459|Insulin|insulin
1174060|NCT02149459|recurrent brain tumors|recurrent brain tumors
1174061|NCT02149459|gliomas|gliomas
1174062|NCT02149459|glioblastomas|glioblastomas
1174063|NCT02149459|astrocytomas|astrocytomas
1174064|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
1174065|NCT02149446|Distal pancreatic resections|distal pancreatic resections
1174066|NCT02149446|Reinforced staple line|reinforced staple line
1174067|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
1174068|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
1174069|NCT02149433|Steroids|steroids
1174070|NCT02149433|Infants|infants
1174071|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
1174072|NCT02149394|Thirst|thirst
1174074|NCT02149394|Water|water
1174075|NCT02149394|Perioperative Nursing|perioperative nursing
1174076|NCT02149394|Recovery Room|recovery room
1174077|NCT02149381|Depression|depression
1174078|NCT02149381|treatment as usual|treatment as usual
1174079|NCT02149381|CBASP|cbasp
1174080|NCT02149381|befriending|befriending
1174081|NCT02149355|teeth position|teeth position
1174082|NCT02149355|jaw alignment|jaw alignment
1174083|NCT02149342|Actinic keratoses|actinic keratoses
1174084|NCT02149342|Daylight-PDT|daylight-pdt
1174085|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
1174086|NCT02149342|HAL|hal
1174087|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
1174088|NCT02149342|MAL|mal
1174089|NCT02149342|Hyperspectral imaging|hyperspectral imaging
1174090|NCT02149329|fever|fever
1174091|NCT02149329|neutropenia|neutropenia
1174092|NCT02149329|febrile neutropenia|febrile neutropenia
1174093|NCT02149329|carbapenem|carbapenem
1174094|NCT02149329|imipenem|imipenem
1174095|NCT02149329|meropenem|meropenem
1174096|NCT02149329|antibiotic stewardship|antibiotic stewardship
1174097|NCT02149329|hematology|hematology
1174098|NCT02149329|oncology|oncology
1174099|NCT02149290|Heart Failure|heart failure
1174100|NCT02149290|Six minute walk test|six minute walk test
1174101|NCT02149277|Infertility|infertility
1174102|NCT02149277|IVF|ivf
1174103|NCT02149277|Embryo transfer|embryo transfer
1174104|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
1174105|NCT02149251|ICSI|icsi
1174106|NCT02149238|flavanols|flavanols
1174107|NCT02149238|cardiovascular effects|cardiovascular effects
1174108|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
1174109|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
1174110|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
1174111|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
1174112|NCT02149212|Iliac|iliac
1174113|NCT02149212|Vein|vein
1174114|NCT02149212|Stent|stent
1174115|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
1174116|NCT02149160|Frontotemporal dementia|frontotemporal dementia
1174117|NCT02149160|Granulin|granulin
1174118|NCT02149147|physical activity|physical activity
1174119|NCT02149147|environmental factors|environmental factors
1174120|NCT02149147|variety|variety
1174121|NCT02149147|MVPA|mvpa
1174122|NCT02149095|treprostinil|treprostinil
1174123|NCT02149082|Intracranial hematoma|intracranial hematoma
1174124|NCT02149082|traumatic brain injury|traumatic brain injury
1174125|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
1174126|NCT02149082|NIRS|nirs
1174127|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
1174128|NCT02149043|inflammatory bowel disease|inflammatory bowel disease
1174129|NCT02149043|ulcerative colitis|ulcerative colitis
1174130|NCT02149043|thermography|thermography
1174131|NCT02149043|endoscopy|endoscopy
1174132|NCT02149043|CRP|crp
1174133|NCT02149017|amyloid plaque|amyloid plaque
1174134|NCT02149017|Positron-Emission Tomography|positron-emission tomography
1174135|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
1174136|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1174137|NCT02149004|Prevention|prevention
1174138|NCT02149004|Long-term life|long-term life
1174139|NCT02149004|Cure|cure
1174140|NCT02149004|Cohort|cohort
1174141|NCT02148965|motor activity|motor activity
1174142|NCT02148965|clinical trials|clinical trials
1174143|NCT02148965|pregnancy|pregnancy
1174144|NCT02148965|hypertension|hypertension
1174145|NCT02148965|cohort studies|cohort studies
1174146|NCT02148952|Maternal Health|maternal health
1174147|NCT02148952|Maternal Death|maternal death
1174148|NCT02148952|Maternal Morbidity|maternal morbidity
1174149|NCT02148952|Stillbirth|stillbirth
1174150|NCT02148952|Neonatal Mortality|neonatal mortality
1174151|NCT02148952|Quality Improvement|quality improvement
1174152|NCT02148952|Resource Limited Settings|resource limited settings
1174153|NCT02148952|Checklist|checklist
1174154|NCT02148952|Safe Childbirth|safe childbirth
1174155|NCT02148939|ischemic stroke|ischemic stroke
1174156|NCT02148939|Antiplatelet Effects|antiplatelet effects
1174157|NCT02148939|aspirin|aspirin
1174158|NCT02148939|metamizole|metamizole
1174159|NCT02148939|dipyrone|dipyrone
1174160|NCT02148900|Marfan syndrome|marfan syndrome
1174161|NCT02148900|blood test|blood test
1174162|NCT02148900|aortic root size|aortic root size
1174163|NCT02148900|Marfan related disorders|marfan related disorders
1174164|NCT02148874|pregnant|pregnant
1174165|NCT02148874|flu shot|flu shot
1174166|NCT02148874|influenza|influenza
1174167|NCT02148874|vaccine|vaccine
1174168|NCT02148848|Osteoporosis|osteoporosis
1174169|NCT02148848|Femoral neck fracture|femoral neck fracture
1174170|NCT02148848|hemiarthroplasty|hemiarthroplasty
1174171|NCT02148835|Omega-3 Index|omega-3 index
1174172|NCT02148835|Bioavailability|bioavailability
1174173|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
1174174|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
1174175|NCT02148835|Fortified food|fortified food
1174176|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
1174177|NCT02148822|kala azar|kala azar
1174178|NCT02148822|malnutrition|malnutrition
1174179|NCT02148822|stunting|stunting
1174180|NCT02148822|thinness|thinness
1174181|NCT02148822|Leishmania donovani|leishmania donovani
1174182|NCT02148796|Wheezing|wheezing
1174183|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
1174184|NCT02148796|Asthma|asthma
1174185|NCT02148796|Atopy|atopy
1174186|NCT02148783|Traumatic brain injury|traumatic brain injury
1174187|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
1174188|NCT02148783|Methylphenidate|methylphenidate
1174189|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
1174190|NCT02148783|Motivation and reward|motivation and reward
1174191|NCT02148783|Positron emission tomography|positron emission tomography
1174192|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
1174193|NCT02148770|rt-fmri|rt-fmri
1174194|NCT02148770|self-control|self-control
1174195|NCT02148770|eating behaviour|eating behaviour
1174196|NCT02148770|overweight|overweight
1174197|NCT02148770|neurofeedback|neurofeedback
1174198|NCT02148757|DVT|dvt
1174199|NCT02148731|Colon cancer|colon cancer
1174200|NCT02148731|Elderly patients|elderly patients
1174201|NCT02148718|Crohn's Disease|crohn's disease
1174202|NCT02148705|fire/flame|fire/flame
1174203|NCT02148705|scalds|scalds
1174204|NCT02148705|contact|contact
1174205|NCT02148679|Heart Failure|heart failure
1174206|NCT02148679|Diet|diet
1174207|NCT02148653|Cardiometabolic risk|cardiometabolic risk
1174208|NCT02148653|Diet|diet
1174209|NCT02148653|Dietary prevention|dietary prevention
1174210|NCT02148653|Functional diet|functional diet
1174211|NCT02148653|Functional foods|functional foods
1174212|NCT02148653|Metabolic Syndrome|metabolic syndrome
1174213|NCT02148653|Overweight|overweight
1174214|NCT02148627|antibody|antibody
1174215|NCT02148627|autoimmune|autoimmune
1174216|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
1174217|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
1174218|NCT02148601|Colonoscopy|colonoscopy
1174219|NCT02148601|Randomized clinical trial|randomized clinical trial
1174220|NCT02148588|Central Post Stroke Pain|central post stroke pain
1174221|NCT02148588|Nerve block|nerve block
1174222|NCT02148575|Palliative Care|palliative care
1174223|NCT02148575|Self-management|self-management
1174224|NCT02148575|Breast Cancer|breast cancer
1174225|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
1174226|NCT02148549|R0 resection|r0 resection
1174227|NCT02148549|Resection rate|resection rate
1174228|NCT02148549|Optimal schedule|optimal schedule
1174229|NCT02148523|Medication Adherence|medication adherence
1174230|NCT02148523|High Blood Pressure|high blood pressure
1174231|NCT02148523|Diabetes|diabetes
1174232|NCT02148523|Statins|statins
1174233|NCT02148510|human|human
1174234|NCT02148510|sleep apnea|sleep apnea
1174235|NCT02148510|adults|adults
1174236|NCT02148510|oral appliance|oral appliance
1174237|NCT02148510|efficacy|efficacy
1174238|NCT02148510|safety|safety
1174239|NCT02148510|polygraphy|polygraphy
1174240|NCT02148510|bruxism|bruxism
1174241|NCT02148510|cost|cost
1174242|NCT02148497|volunteers|volunteers
1174243|NCT02148484|PTSD|ptsd
1174244|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
1174245|NCT02148484|Child Sexual Abuse|child sexual abuse
1174246|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1174247|NCT02148471|Steatosis|steatosis
1174248|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1174249|NCT02148458|Intermittent fasting|intermittent fasting
1174250|NCT02148458|Mediterranean diet|mediterranean diet
1174251|NCT02148458|overweight|overweight
1174252|NCT02148458|Calorie restriction|calorie restriction
1174253|NCT02148445|smoking cessation|smoking cessation
1174254|NCT02148445|tobacco use cessation products|tobacco use cessation products
1174255|NCT02148445|nicotine|nicotine
1174256|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
1174257|NCT02148419|quality of life|quality of life
1174258|NCT02148419|maltreatment|maltreatment
1174259|NCT02148419|neglect|neglect
1174260|NCT02148419|childhood|childhood
1174261|NCT02148406|Yoga|yoga
1174262|NCT02148406|Mind-body therapies|mind-body therapies
1174263|NCT02148406|Fatigue|fatigue
1174264|NCT02148406|Colorectal cancer|colorectal cancer
1174265|NCT02148406|Depressive symptoms|depressive symptoms
1174266|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
1174267|NCT02148367|Traumatic brain injury|traumatic brain injury
1174268|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
1174269|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
1174270|NCT02148367|Angiogenesis|angiogenesis
1174271|NCT02148354|Depression|depression
1174272|NCT02148354|Self-applied treatment|self-applied treatment
1174273|NCT02148354|Internet|internet
1174274|NCT02148354|Support by the therapist|support by the therapist
1174275|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
1174276|NCT02148354|Positive Psychology|positive psychology
1174277|NCT02148354|Behavioral Activation|behavioral activation
1174278|NCT02148328|Healthy participants|healthy participants
1174279|NCT02148328|Immunogenicity|immunogenicity
1174280|NCT02148328|Influenza|influenza
1174281|NCT02148328|Prevention|prevention
1174282|NCT02148328|Safety|safety
1174283|NCT02148315|physical activity|physical activity
1174284|NCT02148315|children|children
1174285|NCT02148315|school|school
1174286|NCT02148315|garden|garden
1174287|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
1174288|NCT02148302|Epidermal Grafts|epidermal grafts
1174289|NCT02148302|Chronic wounds|chronic wounds
1174290|NCT02148302|Clinical trial|clinical trial
1174291|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
1174292|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
1174293|NCT02148276|Social harm detection|social harm detection
1174294|NCT02148276|Instrument development|instrument development
1174295|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
1174296|NCT02148276|Substance abuse|substance abuse
1174297|NCT02148276|Research participation|research participation
1174298|NCT02148263|Contact Lenses|contact lenses
1174299|NCT02148263|Neophytes|neophytes
1174300|NCT02148263|Contact Lens Adaptation|contact lens adaptation
1174301|NCT02148263|Randomized|randomized
1174302|NCT02148250|Type 2 diabetes|type 2 diabetes
1174303|NCT02148250|Insulin resistance|insulin resistance
1174304|NCT02148250|High insulin requirements|high insulin requirements
1174305|NCT02148250|U 500|u 500
1174306|NCT02148237|Breastfeeding duration|breastfeeding duration
1174307|NCT02148237|Puerto Rican mothers|puerto rican mothers
1174308|NCT02148237|WIC program|wic program
1174309|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
1174310|NCT02148224|glycemic index|glycemic index
1174311|NCT02148224|body composition|body composition
1174312|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
1174313|NCT02148211|Fluarix|fluarix
1174314|NCT02148211|FluLaval|flulaval
1174315|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
1174316|NCT02148211|Pregnancy Registry|pregnancy registry
1174317|NCT02148211|Pregnancy outcome|pregnancy outcome
1174318|NCT02148185|Crohn's disease|crohn's disease
1174319|NCT02148172|Knee|knee
1174320|NCT02148172|plyometrics|plyometrics
1174321|NCT02148172|motor learning|motor learning
1174322|NCT02148172|psychological factors|psychological factors
1174323|NCT02148159|anorexia|anorexia
1174324|NCT02148159|cachexia|cachexia
1174325|NCT02148159|cancer|cancer
1174326|NCT02148159|unintentional weigh loss|unintentional weigh loss
1174327|NCT02148159|gastrointestinal tract|gastrointestinal tract
1174328|NCT02148159|adults|adults
1174329|NCT02148146|short bowel syndrome|short bowel syndrome
1174330|NCT02148146|intestinal failure|intestinal failure
1174331|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
1174332|NCT02148133|Thrombocytopenia|thrombocytopenia
1174333|NCT02148133|Eltrombopag|eltrombopag
1174334|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
1174335|NCT02148133|Thrombopoietin|thrombopoietin
1174336|NCT02148094|HIV|hiv
1174337|NCT02148094|AIDS|aids
1174338|NCT02148094|India|india
1174339|NCT02148094|Prevention|prevention
1174340|NCT02148094|Female sex workers|female sex workers
1174341|NCT02148094|PrEP|prep
1174342|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
1174343|NCT02148094|Truvada|truvada
1174344|NCT02148094|Tenofovir|tenofovir
1174345|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
1174346|NCT02148068|Obesity|obesity
1174347|NCT02148068|Bariatric Surgery|bariatric surgery
1174348|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
1174349|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
1174350|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
1174351|NCT02148055|fetal MRI|fetal mri
1174352|NCT02148055|autopsy|autopsy
1174353|NCT02148042|Anorexia|anorexia
1174354|NCT02148042|Generalized anxiety|generalized anxiety
1174355|NCT02148042|Fear|fear
1174356|NCT02148029|Deep vein thrombosis|deep vein thrombosis
1174357|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
1174358|NCT02148029|Thrombus resolution|thrombus resolution
1174359|NCT02148016|Corneal disorders|corneal disorders
1174360|NCT02148016|Chemical injury|chemical injury
1174361|NCT02148016|Pterygium|pterygium
1174362|NCT02148016|Refractive error|refractive error
1174363|NCT02148016|Myopia|myopia
1174364|NCT02148016|Hyperopia|hyperopia
1174365|NCT02148016|Cornea|cornea
1174366|NCT02148016|Monocular|monocular
1174367|NCT02148016|Transparent|transparent
1174368|NCT02148016|Transplantation|transplantation
1174369|NCT02148016|Visual function|visual function
1174370|NCT02147990|cancer|cancer
1174371|NCT02147990|metastatic|metastatic
1174372|NCT02147990|locally advanced|locally advanced
1174373|NCT02147990|lung|lung
1174374|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
1174375|NCT02147990|NSCLC|nsclc
1174376|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
1174377|NCT02147990|EGFR|egfr
1174378|NCT02147990|T790M|t790m
1174379|NCT02147990|CO-1686|co-1686
1174380|NCT02147990|unresectable|unresectable
1174381|NCT02147990|recurrent|recurrent
1174382|NCT02147990|EGFR-directed therapy|egfr-directed therapy
1174383|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
1174384|NCT02147990|TIGER|tiger
1174385|NCT02147990|Rociletinib|rociletinib
1174386|NCT02147977|Renal Dialysis|renal dialysis
1174387|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
1174388|NCT02147977|Death Sudden Cardiac|death sudden cardiac
1174389|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
1174390|NCT02147964|intratesticular androgens|intratesticular androgens
1174391|NCT02147964|testosterone|testosterone
1174392|NCT02147964|dutasteride|dutasteride
1174393|NCT02147964|gonadotropin suppression|gonadotropin suppression
1174394|NCT02147964|male contraception|male contraception
1174395|NCT02147964|spermatogenesis|spermatogenesis
1174396|NCT02147951|Melanoma|melanoma
1174397|NCT02147938|France|france
1174398|NCT02147938|Tacrolimus|tacrolimus
1174399|NCT02147938|Prograf|prograf
1174400|NCT02147938|Observational|observational
1174401|NCT02147938|Advagraf|advagraf
1174402|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1174403|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
1174404|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
1174405|NCT02147912|Depression|depression
1174406|NCT02147912|COPD|copd
1174407|NCT02147912|Aerobic Exercise|aerobic exercise
1174408|NCT02147912|Anxiety|anxiety
1174409|NCT02147912|Quality of life|quality of life
1174410|NCT02147912|neurocognitive functioning|neurocognitive functioning
1174411|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
1174412|NCT02147873|MDS|mds
1174413|NCT02147873|CMML|cmml
1174414|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
1174415|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1174416|NCT02147873|TL32711|tl32711
1174417|NCT02147873|TL32711-0094|tl32711-0094
1174418|NCT02147873|azacitidine|azacitidine
1174419|NCT02147873|birinapant|birinapant
1174420|NCT02147873|higher risk|higher risk
1174421|NCT02147873|naive|naive
1174422|NCT02147873|double blind|double blind
1174423|NCT02147873|placebo|placebo
1174424|NCT02147873|placebo controlled|placebo controlled
1174425|NCT02147873|randomized|randomized
1174426|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1174427|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
1174428|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1174429|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
1174430|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1174431|NCT02147860|Insulin Pump|insulin pump
1174432|NCT02147847|Presbycusis|presbycusis
1174433|NCT02147847|Hearing In Noise|hearing in noise
1174434|NCT02147847|Hearing Impairment|hearing impairment
1174435|NCT02147847|Hearing Loss|hearing loss
1174436|NCT02147847|Aging|aging
1174437|NCT02147847|Plasticity|plasticity
1174438|NCT02147847|Video Games|video games
1174439|NCT02147847|Perceptual Learning|perceptual learning
1174440|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
1174441|NCT02147834|fractional flow reserve|fractional flow reserve
1174442|NCT02147795|Patient Blood Management|patient blood management
1174443|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
1174444|NCT02147795|Patient Safety|patient safety
1174445|NCT02147795|Anemia|anemia
1174446|NCT02147795|Clinical Outcome|clinical outcome
1174447|NCT02147795|perioperative care|perioperative care
1174448|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
1243240|NCT01836900|OTSC|otsc
1174449|NCT02147769|cerebral autoregulation|cerebral autoregulation
1174450|NCT02147769|preterm|preterm
1174451|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
1174549|NCT02147249|erythema migrans|erythema migrans
1174550|NCT02147249|Lyme borreliosis|lyme borreliosis
1174452|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
1174453|NCT02147743|Adolescents|adolescents
1174454|NCT02147743|Family-Based treatment|family-based treatment
1174455|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
1174456|NCT02147730|chronic pain|chronic pain
1174457|NCT02147717|preterm newborns|preterm newborns
1174458|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
1174459|NCT02147717|Acupuncture|acupuncture
1174460|NCT02147717|perioperative pain|perioperative pain
1174461|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
1174462|NCT02147665|Hookah|hookah
1174463|NCT02147665|waterpipe|waterpipe
1174464|NCT02147665|smoking|smoking
1174465|NCT02147665|sympathetic|sympathetic
1174466|NCT02147652|moderate dementia|moderate dementia
1174467|NCT02147652|severe dementia|severe dementia
1174468|NCT02147652|Alzheimer's disease|alzheimer's disease
1174469|NCT02147652|Vascular dementia|vascular dementia
1174470|NCT02147652|agitation|agitation
1174471|NCT02147652|personalized music therapy|personalized music therapy
1174472|NCT02147626|preeclampsia|preeclampsia
1174473|NCT02147626|cardiovascular disease|cardiovascular disease
1174474|NCT02147626|health behaviors|health behaviors
1174475|NCT02147626|behavioral intervention|behavioral intervention
1174476|NCT02147626|web-based|web-based
1174477|NCT02147626|Hypertension|hypertension
1174478|NCT02147626|Post-partum Weight Retention|post-partum weight retention
1174479|NCT02147600|adalimumab|adalimumab
1174480|NCT02147600|biologicals|biologicals
1174481|NCT02147600|immunogenicity|immunogenicity
1174482|NCT02147574|slow-transit constipation|slow-transit constipation
1174483|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
1174484|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
1174485|NCT02147522|community health worker|community health worker
1174486|NCT02147522|promotoras|promotoras
1174487|NCT02147522|self-care behaviors activation|self-care behaviors activation
1174488|NCT02147522|depression|depression
1174489|NCT02147522|low-income patients|low-income patients
1174490|NCT02147522|safety-net care|safety-net care
1174491|NCT02147509|Dry eye|dry eye
1174492|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
1174493|NCT02147509|The quality of life|the quality of life
1174494|NCT02147496|Food intake|food intake
1174495|NCT02147496|Appetite|appetite
1174496|NCT02147496|Blood glucose|blood glucose
1174497|NCT02147496|Insulin|insulin
1174498|NCT02147496|Dairy|dairy
1174499|NCT02147496|Milk|milk
1174500|NCT02147483|Mindfulness|mindfulness
1174501|NCT02147483|Alcohol use disorders|alcohol use disorders
1174502|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
1174503|NCT02147470|Acute kidney injury|acute kidney injury
1174504|NCT02147457|Prematurity|prematurity
1174505|NCT02147457|Extremely low birth weight|extremely low birth weight
1174506|NCT02147457|Phenotyping|phenotyping
1174507|NCT02147444|Rivaroxaban|rivaroxaban
1174508|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1174509|NCT02147444|NOAC|noac
1174510|NCT02147444|Xa inhibitor|xa inhibitor
1174511|NCT02147418|Head and neck cancer|head and neck cancer
1174512|NCT02147418|Throat cancer|throat cancer
1174513|NCT02147418|Human papillomavirus|human papillomavirus
1174514|NCT02147418|HPV|hpv
1174515|NCT02147418|Exosome|exosome
1174516|NCT02147418|Diagnostic|diagnostic
1174517|NCT02147418|Early Detection|early detection
1174518|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
1174519|NCT02147405|Lymph Node Biopsy|lymph node biopsy
1174520|NCT02147405|Apheresis|apheresis
1174521|NCT02147392|PET Imaging|pet imaging
1174522|NCT02147379|Bipolar Disorder|bipolar disorder
1174523|NCT02147379|Cognition|cognition
1174524|NCT02147379|Euthymic|euthymic
1174525|NCT02147379|Lurasidone|lurasidone
1174526|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
1174527|NCT02147353|External Genital Warts|external genital warts
1174528|NCT02147353|Sinecatechins|sinecatechins
1174529|NCT02147353|Cryotherapy|cryotherapy
1174530|NCT02147340|Heart Failure patients|heart failure patients
1174531|NCT02147340|Remote Patient Management|remote patient management
1174532|NCT02147340|External Sensors|external sensors
1174533|NCT02147327|vitamin D|vitamin d
1174534|NCT02147327|cord blood|cord blood
1174535|NCT02147327|neonatal sepsis|neonatal sepsis
1174536|NCT02147327|neonatal morbidity|neonatal morbidity
1174537|NCT02147314|diabetes|diabetes
1174538|NCT02147314|glucometer|glucometer
1174539|NCT02147314|Yofimeter|yofimeter
1174540|NCT02147314|diabetes monitoring|diabetes monitoring
1174541|NCT02147275|hypertension|hypertension
1174542|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
1174543|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
1573428|NCT00488943|AAA|aaa
1174544|NCT02147275|cognitive function|cognitive function
1174545|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
1174546|NCT02147262|Lyme borreliosis|lyme borreliosis
1174547|NCT02147262|molecular characteristics|molecular characteristics
1174548|NCT02147262|outcome|outcome
1174850|NCT02145832|Fluconazole|fluconazole
1174551|NCT02147249|inflammation|inflammation
1174552|NCT02147249|outcome|outcome
1174553|NCT02147236|autism|autism
1174554|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
1174555|NCT02147236|social skills intervention|social skills intervention
1174556|NCT02147223|flavanols|flavanols
1174557|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
1174558|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
1174559|NCT02147210|antibody mediated rejection|antibody mediated rejection
1174560|NCT02147210|Ephrin-B1|ephrin-b1
1174561|NCT02147184|SSRI|ssri
1174562|NCT02147184|serotonin transporter|serotonin transporter
1174563|NCT02147184|DXA|dxa
1174564|NCT02147184|pQCT|pqct
1174565|NCT02147184|bone mass|bone mass
1174566|NCT02147184|adolescents|adolescents
1174567|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
1174568|NCT02147145|GIST|gist
1174569|NCT02147145|endoscopy|endoscopy
1174570|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
1174571|NCT02147132|Cigarette|cigarette
1174572|NCT02147132|Methadone|methadone
1174573|NCT02147132|Smoking|smoking
1174574|NCT02147132|Cessation|cessation
1174575|NCT02147132|Varenicline|varenicline
1174576|NCT02147132|Nicotine|nicotine
1174577|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
1174578|NCT02147106|Videoconsultation|videoconsultation
1174579|NCT02147106|Feasibility|feasibility
1174580|NCT02147080|prevention or control|prevention or control
1174581|NCT02147067|microvascular angina|microvascular angina
1174582|NCT02147067|coronary microvascular disease|coronary microvascular disease
1174583|NCT02147067|coronary physiology|coronary physiology
1174584|NCT02147067|ranolazine|ranolazine
1174585|NCT02147054|Organophosphate poisoning|organophosphate poisoning
1174586|NCT02147054|Intermediate syndrome|intermediate syndrome
1174587|NCT02147054|Rocuronium|rocuronium
1174588|NCT02147041|diabetes mellitus|diabetes mellitus
1174589|NCT02147041|hyperlipidemia|hyperlipidemia
1174590|NCT02147041|green tea|green tea
1174591|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
1174592|NCT02147028|whole brain RT|whole brain rt
1174593|NCT02147028|hippocampal sparing|hippocampal sparing
1174594|NCT02147028|neurocognitive function|neurocognitive function
1174595|NCT02147015|Acute Exacerbations|acute exacerbations
1174596|NCT02147015|Corticosteroids|corticosteroids
1174597|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1174598|NCT02147015|Doses|doses
1174599|NCT02147002|Chronic Kidney Disease|chronic kidney disease
1174600|NCT02147002|Cardiovascular Complications|cardiovascular complications
1174601|NCT02146989|Cerebral Palsy|cerebral palsy
1174602|NCT02146989|child|child
1174603|NCT02146989|upper extremity|upper extremity
1174604|NCT02146989|strength, reproducibility|strength, reproducibility
1174605|NCT02146976|postoperative|postoperative
1174606|NCT02146976|sleep quality|sleep quality
1174607|NCT02146976|propofol|propofol
1174608|NCT02146976|sevoflurane|sevoflurane
1174609|NCT02146950|LCS-12|lcs-12
1174610|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
1174611|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
1174612|NCT02146950|Levonorgestrel|levonorgestrel
1174613|NCT02146950|Pearl Index|pearl index
1174614|NCT02146950|Hormonal Contraception|hormonal contraception
1174615|NCT02146937|active surveillance|active surveillance
1174616|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
1174617|NCT02146937|biopsy|biopsy
1174618|NCT02146911|Smoking Cessation Medication|smoking cessation medication
1174619|NCT02146911|Smoking Treatment|smoking treatment
1174620|NCT02146911|Tobacco Treatment|tobacco treatment
1174621|NCT02146911|Quitting Smoking|quitting smoking
1174622|NCT02146911|Bupropion|bupropion
1174623|NCT02146911|Varenicline|varenicline
1174624|NCT02146911|Efficacy|efficacy
1174625|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
1174626|NCT02146911|Genetics analysis|genetics analysis
1174627|NCT02146911|Smoking Personality|smoking personality
1174628|NCT02146911|Dependence|dependence
1174629|NCT02146911|Addiction|addiction
1174630|NCT02146911|Cigarettes|cigarettes
1174631|NCT02146911|Primary Care Physicians|primary care physicians
1174632|NCT02146911|Biochemical Confirmation|biochemical confirmation
1174633|NCT02146898|spinal anesthesia|spinal anesthesia
1174634|NCT02146898|hypotension|hypotension
1174635|NCT02146898|pregnancy|pregnancy
1174636|NCT02146872|Coronary Artery Disease|coronary artery disease
1174637|NCT02146872|Myocardial Infarction|myocardial infarction
1174638|NCT02146872|Atherosclerosis|atherosclerosis
1174639|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
1174640|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
1174641|NCT02146872|Genetic Testing|genetic testing
1174642|NCT02146872|Genetic Linkage|genetic linkage
1174643|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
1174644|NCT02146846|cml|cml
1174645|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1174646|NCT02146833|prostate cancer|prostate cancer
1174647|NCT02146833|Karyopharm|karyopharm
1174648|NCT02146833|KPT-330|kpt-330
1174649|NCT02146833|selinexor|selinexor
1174650|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
1174651|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
1174652|NCT02146742|ASP1707|asp1707
1174653|NCT02146742|Japanese subjects|japanese subjects
1174654|NCT02146742|Safety|safety
1174655|NCT02146742|Pharmacokinetics|pharmacokinetics
1174656|NCT02146742|Pharmacodynamics|pharmacodynamics
1174657|NCT02146729|Randomized|randomized
1174658|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
1174659|NCT02146729|Spine Trauma|spine trauma
1174660|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
1174661|NCT02146729|Functional Outcome|functional outcome
1174662|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
1174663|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
1174664|NCT02146703|gemcitabine|gemcitabine
1174665|NCT02146703|S-1|s-1
1174666|NCT02146690|pathology|pathology
1174667|NCT02146690|newborn|newborn
1174668|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
1174669|NCT02146690|pain|pain
1174670|NCT02146677|prematurity|prematurity
1174671|NCT02146677|newborns|newborns
1174672|NCT02146677|pain|pain
1174673|NCT02146677|cost|cost
1174674|NCT02146664|Acute NSTEMI|acute nstemi
1174675|NCT02146664|DLBS1033|dlbs1033
1174676|NCT02146664|SPECT|spect
1174677|NCT02146664|Infarct size|infarct size
1174678|NCT02146664|Left ventricular function|left ventricular function
1174679|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
1174680|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
1174681|NCT02146573|Communication|communication
1174682|NCT02146573|Health personnel|health personnel
1174683|NCT02146573|Decision making|decision making
1174684|NCT02146573|Critical Care|critical care
1174685|NCT02146573|Length of Stay|length of stay
1174686|NCT02146573|Iatrogenic Disease|iatrogenic disease
1174688|NCT02146560|Non-cardiac|non-cardiac
1174689|NCT02146560|Elective|elective
1174690|NCT02146560|Adult|adult
1174691|NCT02146560|Patients|patients
1174692|NCT02146560|Troponin|troponin
1174693|NCT02146560|Myocardial|myocardial
1174694|NCT02146560|Injury|injury
1174695|NCT02146560|Postoperative|postoperative
1174696|NCT02146560|Recovery|recovery
1174697|NCT02146560|Outcome|outcome
1174698|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
1174699|NCT02146521|z-axis limited CT|z-axis limited ct
1174700|NCT02146521|computed tomography|computed tomography
1174701|NCT02146521|CT|ct
1174702|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
1174703|NCT02146521|emergency patients|emergency patients
1174704|NCT02146508|Esophageal cancer|esophageal cancer
1174705|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
1174706|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
1174707|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
1174708|NCT02146508|Cancer prevention|cancer prevention
1174709|NCT02146482|back pain|back pain
1174710|NCT02146482|low back pain|low back pain
1174711|NCT02146482|sit-stand workstation|sit-stand workstation
1174712|NCT02146482|standing desk|standing desk
1174713|NCT02146469|varicella vaccination|varicella vaccination
1174714|NCT02146443|Manual dexterity|manual dexterity
1174715|NCT02146443|hand to eye coordination|hand to eye coordination
1174716|NCT02146443|stress|stress
1174717|NCT02146443|fatigue|fatigue
1174718|NCT02146430|pain|pain
1174719|NCT02146430|fibromyalgia|fibromyalgia
1174720|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
1174721|NCT02146417|Deep neuromuscular block|deep neuromuscular block
1174722|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1174723|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
1174724|NCT02146404|1H MRS|1h mrs
1174725|NCT02146404|Lactate|lactate
1174726|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
1174727|NCT02146339|nutrition|nutrition
1174728|NCT02146339|milk|milk
1174729|NCT02146339|polar lipids|polar lipids
1174730|NCT02146339|cardiometabolic risk|cardiometabolic risk
1174731|NCT02146300|birch pollen|birch pollen
1174732|NCT02146300|allergy|allergy
1174733|NCT02146300|breathing|breathing
1174734|NCT02146300|pattern|pattern
1174735|NCT02146300|exposure|exposure
1174736|NCT02146287|cycled light|cycled light
1174737|NCT02146287|preterm infants|preterm infants
1174738|NCT02146287|infant neurodevelopment|infant neurodevelopment
1174739|NCT02146287|infant sleep|infant sleep
1174740|NCT02146274|PROSPER|prosper
1174741|NCT02146274|Stroke|stroke
1174742|NCT02146274|Ischemic Stroke|ischemic stroke
1174743|NCT02146261|Volunteers|volunteers
1174744|NCT02146261|Japanese|japanese
1174745|NCT02146261|Males|males
1174746|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
1174747|NCT02146235|Music Therapy|music therapy
1174748|NCT02146235|Pulmonary Disease|pulmonary disease
1174749|NCT02146235|COPD|copd
1174750|NCT02146235|Music Visualization|music visualization
1174751|NCT02146235|Therapeutic Singing|therapeutic singing
1174752|NCT02146235|Wind-playing|wind-playing
1174753|NCT02146235|Lung Condition|lung condition
1174754|NCT02146196|Heart failure|heart failure
1174755|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
1174756|NCT02146183|Stevio glycosides|stevio glycosides
1174757|NCT02146183|sport|sport
1174758|NCT02146183|glycogen|glycogen
1174759|NCT02146170|Sample Acquisition|sample acquisition
1174760|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
1174761|NCT02146170|Mig6 Expression|mig6 expression
1174762|NCT02146170|Proteomic Analysis|proteomic analysis
1174763|NCT02146170|Genomic Analysis|genomic analysis
1174764|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
1174765|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
1174766|NCT02146144|microscotomas|microscotomas
1174767|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
1174768|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
1174769|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
1174770|NCT02146118|Erlotinib|erlotinib
1174771|NCT02146118|Silybin-phytosome|silybin-phytosome
1174772|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
1174773|NCT02146092|lung resection|lung resection
1174774|NCT02146092|incentive spirometry|incentive spirometry
1174775|NCT02146092|physiotherapy|physiotherapy
1174776|NCT02146092|quality improvement|quality improvement
1174777|NCT02146092|outcomes|outcomes
1174778|NCT02146092|post operative complications|post operative complications
1174779|NCT02146066|GBM|gbm
1174780|NCT02146066|Brain tumor|brain tumor
1174781|NCT02146066|glioblastoma|glioblastoma
1174782|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
1174783|NCT02146053|healthy participants|healthy participants
1174784|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
1174785|NCT02146040|anticoagulation|anticoagulation
1174786|NCT02146040|atrial fibrillation|atrial fibrillation
1174787|NCT02146040|cardioversion|cardioversion
1174788|NCT02146040|complications|complications
1174789|NCT02146040|hemorrhage|hemorrhage
1174790|NCT02146040|medications|medications
1174791|NCT02146040|thromboembolism|thromboembolism
1174793|NCT02146040|stroke|stroke
1174794|NCT02146040|treatment|treatment
1174795|NCT02146027|HIV|hiv
1174796|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
1174797|NCT02146027|NK cell|nk cell
1174798|NCT02146027|CD4|cd4
1174799|NCT02146027|Lymphocyte|lymphocyte
1174800|NCT02146027|Cell activation|cell activation
1174801|NCT02146027|Antiretroviral therapy|antiretroviral therapy
1174802|NCT02146027|Immune discordants|immune discordants
1174803|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
1174804|NCT02146001|sedentary behavior|sedentary behavior
1174805|NCT02146001|physical activity|physical activity
1174806|NCT02146001|older adults|older adults
1174807|NCT02145988|DLBS1033|dlbs1033
1174808|NCT02145988|Peripheral arterial disease|peripheral arterial disease
1174809|NCT02145988|Ankle-brachial index|ankle-brachial index
1174810|NCT02145975|Severe postoperative pain|severe postoperative pain
1174811|NCT02145975|Morphine|morphine
1174812|NCT02145975|Fentanyl|fentanyl
1174813|NCT02145975|Time to titration of pain|time to titration of pain
1174814|NCT02145975|Pain and PACU|pain and pacu
1174815|NCT02145975|Anesthesiology|anesthesiology
1174816|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
1174817|NCT02145962|magnetic therapy|magnetic therapy
1174818|NCT02145962|safety and efficacy|safety and efficacy
1174819|NCT02145962|wound care|wound care
1174820|NCT02145949|aging|aging
1174821|NCT02145949|clinical|clinical
1174822|NCT02145949|translational|translational
1174823|NCT02145949|functional mobility|functional mobility
1174824|NCT02145949|total knee arthroplasty|total knee arthroplasty
1174825|NCT02145936|fatty acid|fatty acid
1174826|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
1174827|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
1174828|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
1174829|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
1174830|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
1174831|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
1174832|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
1174833|NCT02145897|CLI|cli
1174834|NCT02145884|hemangioma|hemangioma
1174835|NCT02145884|birthmark|birthmark
1174836|NCT02145884|strawberry hemangioma|strawberry hemangioma
1174838|NCT02145871|Radical Cystectomy|radical cystectomy
1174839|NCT02145871|Perioperative Fluid Management|perioperative fluid management
1174840|NCT02145871|EV1000|ev1000
1174841|NCT02145871|14-069|14-069
1174842|NCT02145858|atrial fibrillation, pericardial effusion, pleural effusion|atrial fibrillation, pericardial effusion, pleural effusion
1174843|NCT02145845|critical limb ischemia|critical limb ischemia
1174844|NCT02145845|wound healing|wound healing
1174845|NCT02145845|amputation|amputation
1174846|NCT02145832|TINN|tinn
1174847|NCT02145832|Pharmacokinetic|pharmacokinetic
1174848|NCT02145832|Neonates|neonates
1174849|NCT02145832|Antifungal|antifungal
1174851|NCT02145832|Micafungin|micafungin
1174852|NCT02145806|Urinary incontinence|urinary incontinence
1174853|NCT02145806|Validation study|validation study
1174854|NCT02145806|Pregnant women|pregnant women
1174855|NCT02145806|Postpartum period|postpartum period
1174856|NCT02145793|primary care|primary care
1174857|NCT02145793|pediatrics|pediatrics
1174858|NCT02145793|parenting|parenting
1174859|NCT02145793|education|education
1174860|NCT02145780|Overfeeding|overfeeding
1174861|NCT02145780|Fat distribution|fat distribution
1174862|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
1174863|NCT02145780|Insulin sensitivity|insulin sensitivity
1174864|NCT02145780|Insulin resistance|insulin resistance
1174865|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
1174866|NCT02145780|Stable isotopes|stable isotopes
1174867|NCT02145780|Lipid oxidation|lipid oxidation
1174868|NCT02145780|Energy expenditure|energy expenditure
1174869|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
1174870|NCT02145754|erythema migrans|erythema migrans
1174871|NCT02145754|Lyme borreliosis|lyme borreliosis
1174872|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
1174873|NCT02145754|skin culture|skin culture
1174874|NCT02145754|culture media|culture media
1174971|NCT02145351|Chronotropic incompetence|chronotropic incompetence
1174875|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
1174876|NCT02145728|Cognitive functional therapy|cognitive functional therapy
1174877|NCT02145728|Exercise classes|exercise classes
1174878|NCT02145702|ESRD|esrd
1174879|NCT02145702|Kidney Failure|kidney failure
1174880|NCT02145702|Exercise|exercise
1174881|NCT02145702|Cognitive impairment|cognitive impairment
1174882|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
1174883|NCT02145624|pertussis|pertussis
1174884|NCT02145624|maternal vaccination|maternal vaccination
1174885|NCT02145624|maternal immunisation|maternal immunisation
1174886|NCT02145624|immune response|immune response
1174887|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
1174888|NCT02145598|Multiple Myeloma|multiple myeloma
1174889|NCT02145598|Revlimid|revlimid
1174890|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
1174891|NCT02145585|Cardiac surgery|cardiac surgery
1174892|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
1174893|NCT02145585|Anesthesia|anesthesia
1174894|NCT02145546|Pacing dependent|pacing dependent
1174895|NCT02145546|Atrial Fibrillation|atrial fibrillation
1174896|NCT02145546|Amiodarone|amiodarone
1174897|NCT02145546|Propafenone|propafenone
1174898|NCT02145546|Sotalol|sotalol
1174899|NCT02145546|AF burden|af burden
1174900|NCT02145533|MMP|mmp
1174901|NCT02145533|NGAL|ngal
1174902|NCT02145533|Arterial Aneurysms|arterial aneurysms
1174903|NCT02145520|bronchiolitis|bronchiolitis
1174904|NCT02145507|Leukoreduction|leukoreduction
1174905|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
1174906|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
1174907|NCT02145507|Red blood cell recovery|red blood cell recovery
1174908|NCT02145507|Plasma clotting factors|plasma clotting factors
1174909|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
1174910|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
1174911|NCT02145494|Focal boost|focal boost
1174912|NCT02145494|Prostate|prostate
1174913|NCT02145481|coronary artery disease|coronary artery disease
1174914|NCT02145481|decision quality|decision quality
1174915|NCT02145481|decision making|decision making
1174917|NCT02145481|measure development|measure development
1174918|NCT02145481|patient-centered care|patient-centered care
1174919|NCT02145481|cardiology|cardiology
1174920|NCT02145481|heart disease|heart disease
1174921|NCT02145468|Myocardial infarction|myocardial infarction
1174922|NCT02145468|Acute coronary syndrome|acute coronary syndrome
1174923|NCT02145468|Cardiovascular disease|cardiovascular disease
1174924|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
1174925|NCT02145468|NSTEMI|nstemi
1174926|NCT02145468|Losmapimod|losmapimod
1174927|NCT02145468|STEMI|stemi
1174928|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
1174929|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
1174930|NCT02145455|Knee Joint/radiography|knee joint/radiography
1174931|NCT02145455|Knee Joint/surgery|knee joint/surgery
1174932|NCT02145455|Knee Prosthesis|knee prosthesis
1174933|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
1174934|NCT02145455|Female|female
1174935|NCT02145455|Male|male
1174936|NCT02145455|Adult|adult
1174937|NCT02145442|Impaired fasting glucose|impaired fasting glucose
1174938|NCT02145442|Prediabetes|prediabetes
1174939|NCT02145442|Obesity|obesity
1174940|NCT02145442|Overweight|overweight
1174941|NCT02145442|Insulin sensitivity|insulin sensitivity
1174942|NCT02145442|Weight loss|weight loss
1174943|NCT02145442|Nutritional supplement|nutritional supplement
1174944|NCT02145442|Waist|waist
1174945|NCT02145442|Body composition|body composition
1174946|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
1174947|NCT02145429|Depression Prevention|depression prevention
1174948|NCT02145416|Imaging|imaging
1174949|NCT02145416|Chemoradiotherapy|chemoradiotherapy
1174950|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
1174951|NCT02145403|Carfilzomib|carfilzomib
1174952|NCT02145403|Relapse|relapse
1174953|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
1174954|NCT02145403|Multiple Myeloma|multiple myeloma
1174955|NCT02145403|Lymphoma|lymphoma
1174956|NCT02145403|Leukemia|leukemia
1174957|NCT02145390|Bladder Cancer|bladder cancer
1174958|NCT02145390|Bladder Carcinoma|bladder carcinoma
1174959|NCT02145390|Transition Cell Cancer|transition cell cancer
1174960|NCT02145390|TCC|tcc
1174961|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
1174962|NCT02145377|Cholera|cholera
1174963|NCT02145377|Vaccine|vaccine
1174964|NCT02145377|Mali|mali
1174965|NCT02145364|Ulthera System®|ulthera system®
1174966|NCT02145364|Ultherapy®|ultherapy®
1174967|NCT02145364|Ulthera, Inc.|ulthera, inc.
1174968|NCT02145351|HFpEF|hfpef
1174969|NCT02145351|Heart failure|heart failure
1174970|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1175168|NCT02144389|Mansoni|mansoni
1174972|NCT02145338|Urinary tract infection|urinary tract infection
1174973|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
1174974|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
1174975|NCT02145325|Kidney transplant|kidney transplant
1174976|NCT02145325|Regulatory T cells|regulatory t cells
1174977|NCT02145325|Leukopheresis|leukopheresis
1174978|NCT02145325|Immune cells|immune cells
1174979|NCT02145325|Stem Cells|stem cells
1174980|NCT02145325|Tolerance|tolerance
1174981|NCT02145273|Maternal Depression|maternal depression
1174982|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
1174983|NCT02145273|School Readiness|school readiness
1174984|NCT02145260|Hemodialysis|hemodialysis
1174985|NCT02145260|Hypotension|hypotension
1174986|NCT02145260|Hospitalization|hospitalization
1174987|NCT02145208|BPH|bph
1174988|NCT02145195|Vitamin D|vitamin d
1174989|NCT02145195|Children|children
1174990|NCT02145195|Supplements|supplements
1174991|NCT02145195|Cardiometabolic markers|cardiometabolic markers
1174992|NCT02145195|Immune defense|immune defense
1174993|NCT02145195|Bone turnover|bone turnover
1174994|NCT02145195|Muscle strength|muscle strength
1174995|NCT02145182|DGF|dgf
1174996|NCT02145182|Dialysis|dialysis
1174997|NCT02145182|Kidney|kidney
1174998|NCT02145182|Kidney Transplantation|kidney transplantation
1174999|NCT02145182|eGFR|egfr
1175000|NCT02145182|Complement|complement
1175001|NCT02145182|Eculizumab|eculizumab
1175002|NCT02145169|procedural sedation|procedural sedation
1175003|NCT02145169|emergence reaction|emergence reaction
1175004|NCT02145169|nitrous oxide|nitrous oxide
1175005|NCT02145169|ketamine|ketamine
1175006|NCT02145156|HPV vaccination|hpv vaccination
1175007|NCT02145156|Tailored health messaging|tailored health messaging
1175008|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
1175009|NCT02145143|Vemurafenib|vemurafenib
1175010|NCT02145143|14-031|14-031
1175011|NCT02145130|Skin|skin
1175012|NCT02145130|Tissue-engineering|tissue-engineering
1175013|NCT02145130|Autologous|autologous
1175014|NCT02145130|Dermis|dermis
1175015|NCT02145130|Epidermis|epidermis
1175016|NCT02145117|MBSR|mbsr
1175017|NCT02145117|fMRI|fmri
1175018|NCT02145117|PTH|pth
1175019|NCT02145091|Psilocybin|psilocybin
1175020|NCT02145091|Hallucinogens|hallucinogens
1175021|NCT02145091|Pharmacologic Actions|pharmacologic actions
1175022|NCT02145091|Central Nervous System Agents|central nervous system agents
1175023|NCT02145091|Therapeutic Uses|therapeutic uses
1175024|NCT02145091|Psychotropic Drugs|psychotropic drugs
1175025|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
1175026|NCT02145065|restenosis|restenosis
1175027|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
1175028|NCT02145052|Fascial closure|fascial closure
1175029|NCT02145052|Interrupted suture|interrupted suture
1175030|NCT02145052|Running suture|running suture
1175031|NCT02145052|Continuous suture|continuous suture
1175032|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1175033|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1175034|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
1175035|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
1175036|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
1175037|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
1175038|NCT02145039|Large-cell lymphoma|large-cell lymphoma
1175039|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
1175040|NCT02145039|Multiple myeloma|multiple myeloma
1175041|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1175042|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
1175043|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
1175044|NCT02145039|Follicular lymphoma|follicular lymphoma
1175045|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1175046|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
1175047|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
1175048|NCT02145039|Refractory leukemia|refractory leukemia
1175049|NCT02145039|MDS|mds
1175050|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
1175051|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
1175052|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
1175053|NCT02145000|Rotavirus|rotavirus
1175054|NCT02145000|Gastroenteritis|gastroenteritis
1175055|NCT02145000|Diarrhea|diarrhea
1175056|NCT02145000|Vaccine|vaccine
1175057|NCT02145000|Niger|niger
1175058|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
1175059|NCT02144961|breast reconstruction|breast reconstruction
1175060|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
1175061|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
1175062|NCT02144961|autologous tissue transfer|autologous tissue transfer
1175063|NCT02144948|diabetes|diabetes
1175064|NCT02144935|pediatrics|pediatrics
1175065|NCT02144922|Hypertension|hypertension
1175066|NCT02144922|Statin|statin
1175067|NCT02144909|Diabetes self management|diabetes self management
1175068|NCT02144909|support group|support group
1175370|NCT02143648|pruritus|pruritus
1175069|NCT02144909|semi structured support group|semi structured support group
1175070|NCT02144883|telephone counseling|telephone counseling
1175071|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
1175072|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
1175073|NCT02144844|Antepartum depression|antepartum depression
1175074|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
1175075|NCT02144844|Feasibility|feasibility
1175076|NCT02144844|randomized clinical trial|randomized clinical trial
1175078|NCT02144831|stroke prevention|stroke prevention
1175079|NCT02144831|ASA|asa
1175080|NCT02144831|clopidogrel|clopidogrel
1175081|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
1175082|NCT02144753|IBS-C|ibs-c
1175083|NCT02144753|Constipation|constipation
1175084|NCT02144753|IBS|ibs
1175085|NCT02144740|Flow-mediated dilation|flow-mediated dilation
1175086|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
1175087|NCT02144688|HIV|hiv
1175088|NCT02144688|Cognitive symptoms|cognitive symptoms
1175089|NCT02144688|Cognitive evaluation|cognitive evaluation
1175090|NCT02144688|Neuropsychological testing|neuropsychological testing
1175091|NCT02144688|Quality of life|quality of life
1175092|NCT02144688|Anxiety|anxiety
1175093|NCT02144688|Viral load|viral load
1175094|NCT02144688|Antiretroviral|antiretroviral
1175095|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
1175096|NCT02144688|Lumbar puncture|lumbar puncture
1175097|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
1175098|NCT02144688|MRI|mri
1175099|NCT02144649|Prostate Cancer|prostate cancer
1175100|NCT02144649|Tangerine Juice|tangerine juice
1175101|NCT02144649|Tomato Juice|tomato juice
1175102|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1175103|NCT02144623|Valproate|valproate
1175104|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
1175105|NCT02144623|Lymphomas|lymphomas
1175106|NCT02144623|B-cell lymphomas|b-cell lymphomas
1175107|NCT02144623|Translational research|translational research
1175108|NCT02144623|Monoclonal antibodies|monoclonal antibodies
1175109|NCT02144610|CLI|cli
1175110|NCT02144597|morbid obesity|morbid obesity
1175111|NCT02144597|gastric bypass|gastric bypass
1175112|NCT02144597|bariatrics|bariatrics
1175113|NCT02144597|diet|diet
1175114|NCT02144597|caloric restriction|caloric restriction
1175115|NCT02144597|liver fat|liver fat
1175116|NCT02144597|appetite|appetite
1175117|NCT02144584|ischemic stroke|ischemic stroke
1175118|NCT02144584|memantine|memantine
1175119|NCT02144584|upper extremity weakness|upper extremity weakness
1175120|NCT02144584|motor recovery|motor recovery
1175121|NCT02144558|Sperm parameters|sperm parameters
1175122|NCT02144558|Spinal cord injuries|spinal cord injuries
1175123|NCT02144558|Oxidative stress|oxidative stress
1175124|NCT02144558|Inflammatory syndrome|inflammatory syndrome
1175125|NCT02144545|Surgery|surgery
1175126|NCT02144545|Morbid Obesity|morbid obesity
1175127|NCT02144545|Bariatric surgery|bariatric surgery
1175128|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
1175129|NCT02144545|Bougie Size|bougie size
1175130|NCT02144545|Distance from pylorus|distance from pylorus
1175131|NCT02144545|Hormones|hormones
1175132|NCT02144545|Gastric remanent|gastric remanent
1175133|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
1175134|NCT02144532|hypermobility|hypermobility
1175135|NCT02144532|Compression garment|compression garment
1175136|NCT02144532|pain|pain
1175137|NCT02144532|isokinetic evaluation|isokinetic evaluation
1175138|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
1175139|NCT02144493|common bile duct stones|common bile duct stones
1175140|NCT02144493|diverticulum|diverticulum
1175141|NCT02144480|coronary bypass surgery|coronary bypass surgery
1175142|NCT02144480|rehabilitation|rehabilitation
1175143|NCT02144480|exercise training|exercise training
1175144|NCT02144480|platelet activation|platelet activation
1175145|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
1175146|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
1175147|NCT02144454|Cardiovascular disease|cardiovascular disease
1175148|NCT02144454|Fatty acids|fatty acids
1175149|NCT02144454|Vascular function|vascular function
1175150|NCT02144454|Blood pressure|blood pressure
1175151|NCT02144454|Plasma lipids|plasma lipids
1175152|NCT02144454|Insulin resistance|insulin resistance
1175153|NCT02144454|Endothelial activation|endothelial activation
1175154|NCT02144441|Diabetes Mellitus|diabetes mellitus
1175155|NCT02144441|Insulin|insulin
1175156|NCT02144441|Self Administration|self administration
1175157|NCT02144441|Patient Satisfaction|patient satisfaction
1175158|NCT02144441|Glucose|glucose
1175159|NCT02144441|Hypoglycemia|hypoglycemia
1175160|NCT02144441|Hyperglycemia|hyperglycemia
1175161|NCT02144415|abuse liability|abuse liability
1175162|NCT02144415|recreational drug user|recreational drug user
1175163|NCT02144415|stimulant|stimulant
1175164|NCT02144415|d-amphetamine|d-amphetamine
1175165|NCT02144415|ADHD|adhd
1175166|NCT02144389|Arachidonic acid|arachidonic acid
1175167|NCT02144389|Bilharzia|bilharzia
1175179|NCT02144363|Mechanical Ventilation|mechanical ventilation
1175180|NCT02144363|Extubation failure|extubation failure
1175181|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
1175182|NCT02144337|Physical activity|physical activity
1175183|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1175184|NCT02144337|Children|children
1175185|NCT02144337|Intervention|intervention
1175186|NCT02144324|Maxillary protraction|maxillary protraction
1175187|NCT02144324|Modified Tandem Appliance|modified tandem appliance
1175188|NCT02144324|Face mask therapy|face mask therapy
1175189|NCT02144324|Class III malocclusion|class iii malocclusion
1175190|NCT02144324|Maxillary deficiency|maxillary deficiency
1175192|NCT02144311|FDG PET/CT|fdg pet/ct
1175193|NCT02144311|histologic heterogeneity|histologic heterogeneity
1175194|NCT02144311|14-061|14-061
1175195|NCT02144298|microcirculation|microcirculation
1175196|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
1175197|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
1175198|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
1175199|NCT02144285|Renal dialysis|renal dialysis
1175200|NCT02144272|Antibody|antibody
1175201|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
1175202|NCT02144272|Interleukin-17|interleukin-17
1175212|NCT02144220|Telemedicine|telemedicine
1175213|NCT02144220|Virtual care visit|virtual care visit
1175214|NCT02144220|Remote visit|remote visit
1175215|NCT02144220|Video-conferencing|video-conferencing
1175216|NCT02144194|Oral Vinorelbine|oral vinorelbine
1175217|NCT02144194|Oral Chemotherapy|oral chemotherapy
1175218|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
1175219|NCT02144194|Advanced Breast Cancer|advanced breast cancer
1175220|NCT02144194|Maintenance treatment|maintenance treatment
1175221|NCT02144181|Ulthera® System|ulthera® system
1175222|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
1175223|NCT02144181|Ulthera, Inc.|ulthera, inc.
1175224|NCT02144168|Prebiotics|prebiotics
1175225|NCT02144168|diarrhoea|diarrhoea
1175226|NCT02144168|Enteral nutrition|enteral nutrition
1175227|NCT02144168|Fibre|fibre
1175228|NCT02144168|Bifidobacteria|bifidobacteria
1175229|NCT02144168|SCFA|scfa
1175230|NCT02144155|Oxytocin|oxytocin
1175231|NCT02144142|Microbiome|microbiome
1175232|NCT02144142|Atopic dermatitis|atopic dermatitis
1175233|NCT02144142|Eczema|eczema
1175234|NCT02144142|Bacteriotherapy|bacteriotherapy
1175235|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
1175236|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
1175237|NCT02144129|Lean Body Mass|lean body mass
1175238|NCT02144129|Muscle Strength|muscle strength
1175239|NCT02144116|dance-movement therapy|dance-movement therapy
1175240|NCT02144116|balance|balance
1175241|NCT02144116|Fibromyalgia|fibromyalgia
1175242|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
1175243|NCT02144103|Retinal Degeneration|retinal degeneration
1175244|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
1175245|NCT02144103|Optic Neuropathy|optic neuropathy
1175246|NCT02144103|Intraocular pressure|intraocular pressure
1175247|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
1175248|NCT02144103|Optic nerve atrophy|optic nerve atrophy
1175249|NCT02144103|Subtenon injection|subtenon injection
1175250|NCT02144103|Glaucomatous damage|glaucomatous damage
1175251|NCT02144103|ADRC|adrc
1175252|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
1175253|NCT02144103|Fat tissue|fat tissue
1175254|NCT02144103|Stem cells|stem cells
1175255|NCT02144090|Angiography|angiography
1175256|NCT02144090|Angioplasty|angioplasty
1175257|NCT02144090|Coronary artery disease|coronary artery disease
1175258|NCT02144090|Diagnostic|diagnostic
1175259|NCT02144090|Fractional flow reserve|fractional flow reserve
1176559|NCT02138149|urodynamics|urodynamics
1175260|NCT02144077|Photodynamic Therapy|photodynamic therapy
1175261|NCT02144077|PDT|pdt
1175262|NCT02144077|non-aggressive BCC|non-aggressive bcc
1175263|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
1175264|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
1175265|NCT02144038|multiple myeloma,|multiple myeloma,
1175266|NCT02144038|relapsed and refractory,|relapsed and refractory,
1175267|NCT02144038|LGH447,|lgh447,
1175268|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
1175269|NCT02144038|PIM Kinase,|pim kinase,
1175270|NCT02144038|BYL719,|byl719,
1175271|NCT02144038|PI3K inhibitor|pi3k inhibitor
1175272|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
1175273|NCT02144025|Topical Cyclosporine|topical cyclosporine
1175274|NCT02143986|sepsis|sepsis
1175275|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
1175276|NCT02143986|Ferritin|ferritin
1175277|NCT02143986|Still's disease|still's disease
1175278|NCT02143973|Uremic|uremic
1175279|NCT02143973|Pruritus|pruritus
1175280|NCT02143973|Itch|itch
1175281|NCT02143973|Chronic Itch|chronic itch
1175282|NCT02143973|Nalbuphine|nalbuphine
1175283|NCT02143960|Syneron|syneron
1175284|NCT02143960|Velashape|velashape
1175285|NCT02143960|ELOS|elos
1175286|NCT02143960|Zeltiq|zeltiq
1175287|NCT02143960|Cryolipolysis|cryolipolysis
1175288|NCT02143947|Orthoses|orthoses
1175289|NCT02143947|Foot|foot
1175290|NCT02143947|Kinematics|kinematics
1175291|NCT02143947|EMG|emg
1175292|NCT02143947|Biomechanics|biomechanics
1175293|NCT02143934|Plasmodium vivax|plasmodium vivax
1175294|NCT02143934|Hypnozoites|hypnozoites
1175295|NCT02143934|Primaquine|primaquine
1175296|NCT02143934|Liver-stage|liver-stage
1175297|NCT02143934|Blood-stage|blood-stage
1175298|NCT02143934|Plasmodium falciparum|plasmodium falciparum
1175299|NCT02143921|NGO zinc scale|ngo zinc scale
1175300|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
1175301|NCT02143908|Diarrhea|diarrhea
1175302|NCT02143908|L-lysine supplementation|l-lysine supplementation
1175303|NCT02143908|immune status|immune status
1175304|NCT02143908|adults|adults
1175305|NCT02143908|Bangladesh|bangladesh
1175306|NCT02143908|aged 18-45 years|aged 18-45 years
1175307|NCT02143908|urban community|urban community
1175308|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
1175309|NCT02143882|fluenz|fluenz
1175310|NCT02143882|pandemrix|pandemrix
1175311|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
1175312|NCT02143882|immunogenicity|immunogenicity
1175313|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
1175314|NCT02143869|Lung cancer|lung cancer
1175315|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
1175316|NCT02143869|Body composition|body composition
1175317|NCT02143869|Perioperative|perioperative
1175318|NCT02143830|marrow aplasia|marrow aplasia
1175319|NCT02143830|cytopenia|cytopenia
1175320|NCT02143830|myelodysplasia|myelodysplasia
1175321|NCT02143830|AML|aml
1175322|NCT02143830|bone marrow transplant|bone marrow transplant
1175323|NCT02143830|cytoreductive regimen|cytoreductive regimen
1175324|NCT02143830|T-cell reduction|t-cell reduction
1175325|NCT02143817|whole body vibration training|whole body vibration training
1175326|NCT02143817|L-citrulline|l-citrulline
1175327|NCT02143817|hypertension|hypertension
1175328|NCT02143817|obesity|obesity
1175329|NCT02143817|arterial function|arterial function
1175330|NCT02143817|arterial stiffness|arterial stiffness
1175331|NCT02143817|autonomic function|autonomic function
1175332|NCT02143817|endothelial function|endothelial function
1175333|NCT02143804|Oncolytic virus|oncolytic virus
1175334|NCT02143804|GMCSF|gmcsf
1175335|NCT02143804|pRb|prb
1175336|NCT02143804|PDL1|pdl1
1175337|NCT02143804|Immunotherapy|immunotherapy
1175338|NCT02143804|Adenovirus|adenovirus
1175339|NCT02143791|SCS|scs
1175340|NCT02143791|Burst stimulation|burst stimulation
1175341|NCT02143778|MBT|mbt
1175342|NCT02143778|CSPH|csph
1175343|NCT02143778|HVPG|hvpg
1175344|NCT02143765|Mitiglinide|mitiglinide
1175345|NCT02143765|Acarbose|acarbose
1175346|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1175347|NCT02143752|Smoking|smoking
1175348|NCT02143752|Tobacco|tobacco
1175349|NCT02143752|Addiction|addiction
1175350|NCT02143752|Mindfulness|mindfulness
1175351|NCT02143752|Meditation|meditation
1175352|NCT02143739|asthma|asthma
1175353|NCT02143713|Dyspareunia|dyspareunia
1175354|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
1175355|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
1175356|NCT02143713|Elagolix|elagolix
1175357|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
1175358|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
1175359|NCT02143700|exacerbation|exacerbation
1175360|NCT02143700|cognitive|cognitive
1175361|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1175362|NCT02143687|Pulmonary hypertension|pulmonary hypertension
1175363|NCT02143687|Interstitial lung disease|interstitial lung disease
1175364|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
1175365|NCT02143674|Stretching exercise muscle|stretching exercise muscle
1175366|NCT02143674|Elderly|elderly
1175367|NCT02143674|Techniques and exercise|techniques and exercise
1175368|NCT02143674|Physiotherapy|physiotherapy
1175369|NCT02143648|uremic|uremic
1175371|NCT02143648|itch|itch
1175372|NCT02143648|chronic itch|chronic itch
1175373|NCT02143648|nalbuphine|nalbuphine
1175374|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
1175375|NCT02143622|Head and neck cancer|head and neck cancer
1175376|NCT02143609|airway disease|airway disease
1175377|NCT02143609|bronchitis|bronchitis
1175378|NCT02143609|emphysema|emphysema
1175379|NCT02143609|lung|lung
1175380|NCT02143596|stroke|stroke
1175381|NCT02143596|dehydration|dehydration
1175382|NCT02143596|prognosis|prognosis
1175383|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
1175384|NCT02143583|birch pollen|birch pollen
1175385|NCT02143583|desensitization|desensitization
1175386|NCT02143583|allergen immunotherapy|allergen immunotherapy
1175387|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
1175388|NCT02143570|Darifenacin|darifenacin
1175389|NCT02143570|Physiotherapy|physiotherapy
1175390|NCT02143570|Quality of Life|quality of life
1175391|NCT02143557|breast milk|breast milk
1175392|NCT02143557|infants|infants
1175393|NCT02143557|chylothorax|chylothorax
1175394|NCT02143557|cardiac surgery|cardiac surgery
1175395|NCT02143557|modified breast milk|modified breast milk
1175396|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
1175397|NCT02143544|Cardiac surgery|cardiac surgery
1175398|NCT02143544|High-risk patients|high-risk patients
1175399|NCT02143518|Human Hookworm|human hookworm
1175400|NCT02143518|Necator americanus|necator americanus
1175401|NCT02143518|Hookworm|hookworm
1175402|NCT02143518|Hookworm Disease|hookworm disease
1175403|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
1175404|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
1175405|NCT02143518|Neglected Tropical Disease|neglected tropical disease
1175406|NCT02143518|Na-GST-1|na-gst-1
1175407|NCT02143518|CpG|cpg
1175408|NCT02143479|France|france
1175409|NCT02143479|Prograf|prograf
1175410|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
1175411|NCT02143479|Tacrolimus|tacrolimus
1175412|NCT02143479|Observational|observational
1175413|NCT02143466|Phase I|phase i
1175414|NCT02143466|Safety|safety
1175415|NCT02143466|Tolerability|tolerability
1175416|NCT02143466|Efficacy|efficacy
1175417|NCT02143466|Anti-tumour|anti-tumour
1175418|NCT02143466|AZD9291|azd9291
1175419|NCT02143466|AZD6094|azd6094
1175420|NCT02143466|MEDI4736|medi4736
1175421|NCT02143466|Osimertinib|osimertinib
1175422|NCT02143466|Savolitinib|savolitinib
1175423|NCT02143466|Selumetinib|selumetinib
1175424|NCT02143466|Durvalumab|durvalumab
1175425|NCT02143466|Ascending Doses|ascending doses
1175426|NCT02143466|Expansion cohorts|expansion cohorts
1175427|NCT02143466|EGFR|egfr
1175428|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1175429|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
1175430|NCT02143453|exercise|exercise
1175431|NCT02143453|overweight|overweight
1175432|NCT02143453|children|children
1175433|NCT02143427|social skills training,|social skills training,
1175434|NCT02143427|computer based,|computer based,
1175435|NCT02143427|social competence training,|social competence training,
1175436|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
1175437|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
1175438|NCT02143427|randomized controlled trial|randomized controlled trial
1175439|NCT02143388|Local advanced|local advanced
1175440|NCT02143388|high risk|high risk
1175441|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1175442|NCT02143362|Intraoperative wake up|intraoperative wake up
1175443|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
1175444|NCT02143362|Dexmedetomidine|dexmedetomidine
1175445|NCT02143362|Propofol|propofol
1175446|NCT02143349|obesity|obesity
1175447|NCT02143349|herbal remedies|herbal remedies
1175448|NCT02143349|metabolic disorders|metabolic disorders
1175449|NCT02143336|Surgical site infections|surgical site infections
1175450|NCT02143336|Skin closure techniques|skin closure techniques
1175451|NCT02143336|Colorectal surgery|colorectal surgery
1175452|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
1175453|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
1175454|NCT02143297|Pulse Oximetry|pulse oximetry
1175455|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
1175456|NCT02143297|Fourier Analysis|fourier analysis
1175457|NCT02143297|Neural Networks (Computer)|neural networks (computer)
1175458|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
1175459|NCT02143258|stenting venous sinus|stenting venous sinus
1175460|NCT02143258|intracranial hypertension|intracranial hypertension
1175461|NCT02143258|quality of life|quality of life
1175462|NCT02143258|headache|headache
1175463|NCT02143258|visual impairment|visual impairment
1175464|NCT02143232|knee replacement|knee replacement
1175465|NCT02143232|hip replacement|hip replacement
1175466|NCT02143232|patient monitor|patient monitor
1175467|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
1175468|NCT02143219|FOLFIRINOX|folfirinox
1175469|NCT02143219|toxicity|toxicity
1175470|NCT02143219|efficacy|efficacy
1175471|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1175472|NCT02143206|Pain|pain
1175473|NCT02143206|Arthritis|arthritis
1175474|NCT02143206|Dyspnea|dyspnea
1175475|NCT02143206|Exercise|exercise
1175476|NCT02143206|Aerobic|aerobic
1175477|NCT02143193|Breastfeeding|breastfeeding
1175478|NCT02143193|Newborn|newborn
1175479|NCT02143193|Formula|formula
1175480|NCT02143193|Temperature|temperature
1175481|NCT02143193|Initial Bath|initial bath
1175482|NCT02143180|real-time tissue elastography|real-time tissue elastography
1175483|NCT02143180|hepatic fibrosis|hepatic fibrosis
1175484|NCT02143154|vancomycin, GBS|vancomycin, gbs
1175485|NCT02143141|postoperative pain|postoperative pain
1175486|NCT02143141|narcotic side effects|narcotic side effects
1175487|NCT02143128|score|score
1175488|NCT02143128|postoperative|postoperative
1175489|NCT02143128|pain|pain
1175490|NCT02143128|nausea|nausea
1175491|NCT02143128|mental status|mental status
1175492|NCT02143128|tool|tool
1175493|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
1175494|NCT02143089|CCSWI|ccswi
1175495|NCT02143076|Medication Adherence|medication adherence
1175496|NCT02143076|Hydroxyurea|hydroxyurea
1175497|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
1175498|NCT02143024|depression|depression
1175499|NCT02143024|family|family
1175500|NCT02143024|primary health care|primary health care
1175501|NCT02143011|sugar|sugar
1175502|NCT02143011|sucrose|sucrose
1175503|NCT02143011|fruit juice|fruit juice
1175504|NCT02143011|orange juice|orange juice
1175505|NCT02143011|metabolism|metabolism
1175506|NCT02143011|immune cell aging|immune cell aging
1175507|NCT02143011|lipids|lipids
1175508|NCT02142998|GERD|gerd
1175509|NCT02142998|Laparoscopic|laparoscopic
1175510|NCT02142998|sleeve|sleeve
1175511|NCT02142998|gastrectomy|gastrectomy
1175512|NCT02142972|Low back pain|low back pain
1175513|NCT02142972|Oswestry questionnaire|oswestry questionnaire
1175514|NCT02142972|Post-partum Depression|post-partum depression
1175515|NCT02142972|Pelvic pain|pelvic pain
1175516|NCT02142959|RTA 408|rta 408
1175517|NCT02142959|RTA 408 Lotion|rta 408 lotion
1175518|NCT02142959|Breast cancer|breast cancer
1175519|NCT02142959|Radiation therapy|radiation therapy
1175520|NCT02142959|Radiation dermatitis|radiation dermatitis
1175521|NCT02142959|Oxidative stress|oxidative stress
1175522|NCT02142959|Inflammation|inflammation
1175523|NCT02142959|omaveloxolone|omaveloxolone
1175524|NCT02142933|colonization|colonization
1175525|NCT02142933|screening|screening
1175526|NCT02142933|group B streptococci|group b streptococci
1175527|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
1175528|NCT02142933|enterobacteriaceae|enterobacteriaceae
1175529|NCT02142920|Healthy Volunteers|healthy volunteers
1175656|NCT02142179|Adolescents|adolescents
1175530|NCT02142907|Breast conservative surgery|breast conservative surgery
1175531|NCT02142907|boost radiation|boost radiation
1175532|NCT02142907|acute toxicity|acute toxicity
1175533|NCT02142907|cosmesis|cosmesis
1175534|NCT02142907|local control|local control
1175535|NCT02142894|Tuberculosis|tuberculosis
1175537|NCT02142868|Expanded Access|expanded access
1175538|NCT02142868|Advanced Breast Cancer|advanced breast cancer
1175539|NCT02142855|volunteers|volunteers
1175540|NCT02142855|young (18-30 y)|young (18-30 y)
1244635|NCT01830439|PK|pk
1175541|NCT02142855|older (65-75 y)|older (65-75 y)
1175542|NCT02142855|age groups|age groups
1175543|NCT02142842|Adipose stem cell|adipose stem cell
1175544|NCT02142842|Platelet rich plasma|platelet rich plasma
1175545|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
1175546|NCT02142842|Injured cartilage|injured cartilage
1175547|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
1175548|NCT02142777|S-equol|s-equol
1175549|NCT02142777|COX activity|cox activity
1175550|NCT02142764|Multiple Sclerosis|multiple sclerosis
1175551|NCT02142764|CD8+ T-cells|cd8+ t-cells
1175552|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
1175553|NCT02142764|pentamers|pentamers
1175554|NCT02142751|Escherichia coli|escherichia coli
1175555|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
1175556|NCT02142751|Bacteremia|bacteremia
1175557|NCT02142751|Urinary tract infection|urinary tract infection
1175558|NCT02142751|Bloodstream infection|bloodstream infection
1175559|NCT02142751|Fosfomycin|fosfomycin
1175560|NCT02142751|Meropenem|meropenem
1175561|NCT02142751|Pharmacokinetics|pharmacokinetics
1175562|NCT02142751|intestinal colonization|intestinal colonization
1175563|NCT02142751|Recurrence|recurrence
1175564|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
1175565|NCT02142751|Ceftriaxone|ceftriaxone
1175566|NCT02142738|PD-1|pd-1
1175567|NCT02142738|PD1|pd1
1175568|NCT02142738|PD-L1|pd-l1
1175569|NCT02142738|PDL1|pdl1
1175570|NCT02142712|Ischemic Stroke|ischemic stroke
1175571|NCT02142712|Brain Edema|brain edema
1175572|NCT02142712|Diphenhydramine|diphenhydramine
1175573|NCT02142712|Dextromethorphan|dextromethorphan
1175574|NCT02142712|Famotidine|famotidine
1175575|NCT02142699|Acute kidney injury|acute kidney injury
1175576|NCT02142699|Cardiac surgery|cardiac surgery
1175577|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
1175578|NCT02142699|hemearginate|hemearginate
1175579|NCT02142686|Hysteroscopy|hysteroscopy
1175580|NCT02142686|Filling pressures|filling pressures
1175581|NCT02142673|Operative hysteroscopy|operative hysteroscopy
1175582|NCT02142673|Filling pressure|filling pressure
1175583|NCT02142660|Adhesion barrier system|adhesion barrier system
1175584|NCT02142660|Bariatric surgery|bariatric surgery
1175585|NCT02142647|infant growth|infant growth
1175586|NCT02142647|dietary protein|dietary protein
1175587|NCT02142647|body composition|body composition
1175588|NCT02142647|gut microbiome|gut microbiome
1175589|NCT02142608|Prostate cancer|prostate cancer
1175590|NCT02142608|Ultrasound Imaging|ultrasound imaging
1175591|NCT02142595|dexmedetomidine|dexmedetomidine
1175592|NCT02142595|midazolam|midazolam
1175593|NCT02142595|sleep quality|sleep quality
1175594|NCT02142595|delirium|delirium
1175595|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
1175596|NCT02142582|Compliance|compliance
1175597|NCT02142582|Short Bowel Syndrome|short bowel syndrome
1175598|NCT02142582|Oral Rehydration Solution|oral rehydration solution
1175599|NCT02142569|Monacolin K|monacolin k
1175600|NCT02142569|Cholesterol|cholesterol
1175601|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
1175602|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
1175604|NCT02142530|DLBCL|dlbcl
1175605|NCT02142530|PTCL|ptcl
1175606|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
1175607|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1175608|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1175609|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
1175610|NCT02142504|Drug therapy|drug therapy
1175611|NCT02142491|Egg allergy|egg allergy
1175612|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
1175613|NCT02142478|physical activity|physical activity
1175614|NCT02142478|behaviour change|behaviour change
1175615|NCT02142478|exercise referral|exercise referral
1175616|NCT02142478|self-determination theory|self-determination theory
1175617|NCT02142478|mixed-method|mixed-method
1175618|NCT02142478|evaluation|evaluation
1175619|NCT02142478|qualitative|qualitative
1175620|NCT02142452|Pregnancy|pregnancy
1175621|NCT02142452|Obesity/Overweight|obesity/overweight
1175622|NCT02142452|postpartum|postpartum
1175623|NCT02142452|mobile health|mobile health
1175624|NCT02142452|cardiovascular disease|cardiovascular disease
1175625|NCT02142439|Anorexia|anorexia
1175626|NCT02142439|Bulimia|bulimia
1175627|NCT02142439|Physical activity|physical activity
1175628|NCT02142439|Treatment|treatment
1175629|NCT02142426|wound chronic|wound chronic
1175630|NCT02142413|Stroke|stroke
1175631|NCT02142413|Atrial fibrillation|atrial fibrillation
1175632|NCT02142413|Holter ECG|holter ecg
1175633|NCT02142413|cardiac MRI|cardiac mri
1175634|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
1175635|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
1175636|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
1175637|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
1175638|NCT02142283|Acute ischemic stroke|acute ischemic stroke
1175639|NCT02142283|Wake up stroke|wake up stroke
1175640|NCT02142283|Late presenting stroke|late presenting stroke
1175641|NCT02142257|Obesity|obesity
1175642|NCT02142257|Gastric Bypass|gastric bypass
1175643|NCT02142257|Aspiration Therapy|aspiration therapy
1175644|NCT02142257|AspireAssist|aspireassist
1175645|NCT02142244|Sentinel node biopsy|sentinel node biopsy
1175646|NCT02142244|Near infra red light|near infra red light
1175647|NCT02142244|Indocyanine green|indocyanine green
1175648|NCT02142244|micrometastasis|micrometastasis
1175649|NCT02142231|acupuncture|acupuncture
1175650|NCT02142231|test anxiety|test anxiety
1175651|NCT02142231|neuroenhancer|neuroenhancer
1175652|NCT02142231|placebo|placebo
1175653|NCT02142179|Asthma|asthma
1175654|NCT02142179|Knowledge|knowledge
1175655|NCT02142179|School-Based Service|school-based service
1175657|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
1175658|NCT02142166|biomarker|biomarker
1175659|NCT02142153|First in man|first in man
1175660|NCT02142153|Antifungal|antifungal
1175661|NCT02142153|Intravenous infusion|intravenous infusion
1175662|NCT02142153|Healthy volunteers|healthy volunteers
1175663|NCT02142140|Treatment of ADHD|treatment of adhd
1175664|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
1175666|NCT02142127|Mass balance|mass balance
1175667|NCT02142127|Pharmacokinetics|pharmacokinetics
1175668|NCT02142127|Metabolites|metabolites
1175669|NCT02142127|Healthy subjects|healthy subjects
1175670|NCT02142127|Healthy male volunteers|healthy male volunteers
1175671|NCT02142114|Intravitreal injection|intravitreal injection
1175672|NCT02142114|Needle size|needle size
1175673|NCT02142114|Pain|pain
1175674|NCT02142114|Intraocular pressure|intraocular pressure
1175675|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
1175676|NCT02142101|Gut Microbiota|gut microbiota
1175677|NCT02142101|Polycystic kidney disease|polycystic kidney disease
1175678|NCT02142101|Chronic kidney disease|chronic kidney disease
1175679|NCT02142101|Uremic metabolites|uremic metabolites
1175680|NCT02142088|Glycaemic Control|glycaemic control
1175681|NCT02142088|Glucose Monitoring|glucose monitoring
1175682|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
1175683|NCT02142075|Pharmacokinetics|pharmacokinetics
1175684|NCT02142062|Venous outflow obstruction|venous outflow obstruction
1175685|NCT02142062|Iliac Vein|iliac vein
1175686|NCT02142062|Common Femoral Vein|common femoral vein
1175687|NCT02142062|Iliac Compression|iliac compression
1175688|NCT02142049|DLBCL|dlbcl
1175689|NCT02142049|ABC|abc
1175690|NCT02142049|GCB|gcb
1175691|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
1175692|NCT02142049|Pharmacyclics|pharmacyclics
1175693|NCT02142049|Lenalidomide|lenalidomide
1175694|NCT02142049|lymphoma|lymphoma
1175695|NCT02142049|Rituximab|rituximab
1175696|NCT02142049|EPOCH|epoch
1175697|NCT02142036|Metastatic disease|metastatic disease
1175698|NCT02142036|Metastasis|metastasis
1175699|NCT02142036|Targeted therapy|targeted therapy
1175700|NCT02142036|Solid tumor|solid tumor
1175701|NCT02142036|Personalized medicine|personalized medicine
1175702|NCT02142036|N-of-1 trial|n-of-1 trial
1175703|NCT02141997|efficacy|efficacy
1175704|NCT02141997|Methotrexate|methotrexate
1175705|NCT02141997|safety|safety
1175706|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
1175707|NCT02141971|Down syndrome|down syndrome
1175708|NCT02141971|Alzheimer's disease|alzheimer's disease
1175709|NCT02141971|biomarkers|biomarkers
1175710|NCT02141971|amyloid|amyloid
1175711|NCT02141971|tau|tau
1175712|NCT02141945|Cancer|cancer
1175713|NCT02141945|Colon Cancer|colon cancer
1175714|NCT02141945|Colorectal Cancer|colorectal cancer
1175715|NCT02141945|Neoplasm|neoplasm
1175716|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
1175717|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
1175718|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1175719|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
1175720|NCT02141945|Neoplasms by Site|neoplasms by site
1175721|NCT02141945|Neoplasms|neoplasms
1175722|NCT02141945|Colonic Diseases|colonic diseases
1175723|NCT02141945|Digestive System Diseases|digestive system diseases
1175724|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
1175725|NCT02141945|Intestinal Diseases|intestinal diseases
1175726|NCT02141945|Rectal Diseases|rectal diseases
1175727|NCT02141932|Hand-held|hand-held
1175728|NCT02141932|Ultrasound|ultrasound
1175729|NCT02141932|Diagnosis|diagnosis
1175730|NCT02141932|Cardiovascular|cardiovascular
1175731|NCT02141932|Carotid artery stenosis|carotid artery stenosis
1175732|NCT02141919|renal cancer|renal cancer
1175733|NCT02141880|Obesity|obesity
1175734|NCT02141867|Surgery|surgery
1175735|NCT02141867|Mortality|mortality
1175736|NCT02141841|intrathecal;|intrathecal;
1175737|NCT02141841|bupivacaine;|bupivacaine;
1175738|NCT02141841|concentration;|concentration;
1175739|NCT02141828|Leukemia|leukemia
1175740|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
1175741|NCT02141828|Epizyme|epizyme
1175742|NCT02141828|Phase 1b|phase 1b
1175743|NCT02141828|MLL gene|mll gene
1175744|NCT02141828|11q23|11q23
1175745|NCT02141828|Ambiguous lineage|ambiguous lineage
1175746|NCT02141828|ALL|all
1175747|NCT02141828|AML|aml
1175748|NCT02141828|Acute leukemias|acute leukemias
1175749|NCT02141828|MLL-r|mll-r
1175750|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
1175751|NCT02141724|Neuromuscular|neuromuscular
1175752|NCT02141724|Wheelchair|wheelchair
1175753|NCT02141724|Pain|pain
1175754|NCT02141724|Bedsore|bedsore
1175755|NCT02141724|Trouble postural|trouble postural
1175756|NCT02141711|Drug therapy|drug therapy
1175757|NCT02141698|Drug therapy|drug therapy
1175758|NCT02141685|in vitro fertilization|in vitro fertilization
1175759|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
1175760|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
1175761|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
1175762|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
1175763|NCT02141685|prediction of blastocysts|prediction of blastocysts
1175764|NCT02141685|infertility|infertility
1175765|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
1175766|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
1175767|NCT02141672|lupus nephritis|lupus nephritis
1175768|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
1175769|NCT02141672|voclosporin|voclosporin
1175770|NCT02141646|HIV/AIDS, motivational interviewing, behavioral skills training, MRI|hiv/aids, motivational interviewing, behavioral skills training, mri
1175771|NCT02141633|smokers|smokers
1175772|NCT02141633|airway blood flow|airway blood flow
1175773|NCT02141633|fluticasone|fluticasone
1175774|NCT02141633|echocardiogram|echocardiogram
1175775|NCT02141607|shock|shock
1175776|NCT02141607|heart failure|heart failure
1175777|NCT02141607|inflammation|inflammation
1175778|NCT02141607|biomarkers|biomarkers
1175779|NCT02141607|cardiovascular instability|cardiovascular instability
1175780|NCT02141607|metabolic pathways|metabolic pathways
1175781|NCT02141607|proteolysis|proteolysis
1175782|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
1175783|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
1175784|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1175785|NCT02141581|Young adults|young adults
1175786|NCT02141568|Cost-effective|cost-effective
1175787|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
1175788|NCT02141568|Frequent Attenders|frequent attenders
1175789|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
1175790|NCT02141542|Metastatic Melanoma|metastatic melanoma
1175791|NCT02141529|Intraarticular|intraarticular
1175792|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
1175793|NCT02141529|osteoarthritis|osteoarthritis
1175794|NCT02141516|Meningitis|meningitis
1175795|NCT02141516|vaccination|vaccination
1175796|NCT02141516|complement deficiency|complement deficiency
1175797|NCT02141516|asplenia|asplenia
1175798|NCT02141516|splenic dysfunction|splenic dysfunction
1175799|NCT02141503|Biomarkers|biomarkers
1175800|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
1175801|NCT02141490|Lymph Node|lymph node
1175802|NCT02141490|Biopsy|biopsy
1175803|NCT02141490|Metastatic Nodes|metastatic nodes
1175804|NCT02141490|Imaging Agent|imaging agent
1175805|NCT02141477|Leukemia|leukemia
1175806|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
1175807|NCT02141477|AML|aml
1175808|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
1175809|NCT02141477|MDS|mds
1175810|NCT02141477|Omacetaxine|omacetaxine
1175811|NCT02141477|Synribo|synribo
1175812|NCT02141477|Homoharringtonine|homoharringtonine
1175813|NCT02141477|Decitabine|decitabine
1175814|NCT02141477|Dacogen|dacogen
1175815|NCT02141451|DLBCL|dlbcl
1175816|NCT02141438|Radium-223|radium-223
1175817|NCT02141438|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1175818|NCT02141438|CRPC|crpc
1175819|NCT02141438|Phase IV|phase iv
1175820|NCT02141438|Safety study|safety study
1175821|NCT02141425|Healthy volunteers|healthy volunteers
1175822|NCT02141425|ASP015K|asp015k
1175823|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
1175824|NCT02141412|prevent shivering|prevent shivering
1175825|NCT02141412|improve quality of emergence|improve quality of emergence
1175826|NCT02141412|anesthesia|anesthesia
1175827|NCT02141412|without delay|without delay
1175828|NCT02141412|recovery|recovery
1175829|NCT02141386|Multiple Sclerosis|multiple sclerosis
1175830|NCT02141386|Cognitive remediation|cognitive remediation
1175831|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
1175832|NCT02141386|Cognitive impairment|cognitive impairment
1175833|NCT02141373|seroma|seroma
1175834|NCT02141373|axillary|axillary
1175835|NCT02141373|dissection|dissection
1175836|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
1175837|NCT02141321|IUD|iud
1175838|NCT02141321|Misoprostol|misoprostol
1175839|NCT02141321|Rectal administration|rectal administration
1175840|NCT02141308|Retina|retina
1175841|NCT02141308|Optical coherence tomography|optical coherence tomography
1175842|NCT02141308|Imaging|imaging
1175843|NCT02141282|Oncology|oncology
1175844|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1175845|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
1175846|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
1175847|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
1175848|NCT02141256|elderly|elderly
1175849|NCT02141256|protein enrichment|protein enrichment
1175850|NCT02141256|undernutrition|undernutrition
1175851|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
1175852|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
1175853|NCT02141217|Bacterial infection|bacterial infection
1175854|NCT02141204|HRV|hrv
1175855|NCT02141204|Liquid vaccine|liquid vaccine
1175856|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
1175857|NCT02141191|cystic fibrosis|cystic fibrosis
1175858|NCT02141191|hypertonic saline|hypertonic saline
1175859|NCT02141191|nebulizer|nebulizer
1175860|NCT02141191|nasal cannula|nasal cannula
1175861|NCT02141165|sleep apnea|sleep apnea
1175862|NCT02141165|portable monitor|portable monitor
1175863|NCT02141165|primary care|primary care
1175864|NCT02141165|cost-effectiveness|cost-effectiveness
1175865|NCT02141165|OSAS|osas
1175866|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1175867|NCT02141139|Inflammation|inflammation
1175868|NCT02141139|Perioperative Period|perioperative period
1175869|NCT02141126|Older adults|older adults
1175870|NCT02141126|Strength training|strength training
1175871|NCT02141126|Muscle mass|muscle mass
1175872|NCT02141126|Function|function
1175873|NCT02141126|Inpatients|inpatients
1175874|NCT02141100|thioguanine|thioguanine
1175875|NCT02141100|mercaptopurine|mercaptopurine
1175876|NCT02141100|methotrexate|methotrexate
1175877|NCT02141048|Parenting programme|parenting programme
1175878|NCT02141048|Randomised controlled trial|randomised controlled trial
1175879|NCT02141048|South Africa|south africa
1175880|NCT02141048|Positive parenting|positive parenting
1175881|NCT02141048|Child behaviour problems|child behaviour problems
1175882|NCT02141048|Implementation fidelity|implementation fidelity
1175883|NCT02141048|Low- and middle-income country|low- and middle-income country
1175884|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
1175885|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
1175886|NCT02141035|Motor unit number estimation|motor unit number estimation
1175887|NCT02141035|Compression neuropathy|compression neuropathy
1175888|NCT02141022|Multiple Sclerosis|multiple sclerosis
1175889|NCT02141022|Cognition|cognition
1175890|NCT02141022|Cognitive Remediation|cognitive remediation
1175891|NCT02141022|Gilenya|gilenya
1175892|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
1175893|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
1175894|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
1175895|NCT02140983|Insulin Resistance|insulin resistance
1175896|NCT02140983|Family History of Dementia|family history of dementia
1175897|NCT02140983|Cognition|cognition
1175898|NCT02140970|ureteral stent|ureteral stent
1175899|NCT02140970|stent pain|stent pain
1175900|NCT02140970|ureteral spasm|ureteral spasm
1175901|NCT02140970|NSAID|nsaid
1175902|NCT02140970|ibuprofen|ibuprofen
1175903|NCT02140970|placebo|placebo
1175904|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
1175905|NCT02140970|urolithiasis|urolithiasis
1175906|NCT02140957|Toddler Bottle Use|toddler bottle use
1175907|NCT02140957|Educational Intervention|educational intervention
1175908|NCT02140957|Pediatrics|pediatrics
1175909|NCT02140957|Iron Deficiency|iron deficiency
1175910|NCT02140944|Cord blood transplantation|cord blood transplantation
1175911|NCT02140944|CCR5Δ32|ccr5δ32
1175912|NCT02140944|HIV cure|hiv cure
1175913|NCT02140931|Cell therapy|cell therapy
1175914|NCT02140931|Autologous|autologous
1175915|NCT02140918|Fludrocortisone|fludrocortisone
1175916|NCT02140918|Mineralocorticoids|mineralocorticoids
1175917|NCT02140918|Hemodynamics|hemodynamics
1175918|NCT02140918|Pharmacokinetics|pharmacokinetics
1175919|NCT02140905|Hemodialysis|hemodialysis
1175920|NCT02140905|Heart failure|heart failure
1175921|NCT02140905|Impedance|impedance
1175922|NCT02140905|Fluids|fluids
1175923|NCT02140879|pregnancy|pregnancy
1175924|NCT02140879|inflammation|inflammation
1175925|NCT02140879|infant assessment|infant assessment
1175926|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
1175927|NCT02140853|Mortality|mortality
1175928|NCT02140853|Therapy|therapy
1175929|NCT02140840|TMTB|tmtb
1175930|NCT02140840|Mekinist|mekinist
1175931|NCT02140840|Trametinib|trametinib
1175932|NCT02140840|relapse|relapse
1175933|NCT02140840|refractory|refractory
1175934|NCT02140840|response rate|response rate
1175935|NCT02140827|bowel preparation|bowel preparation
1175936|NCT02140827|instant messaging program|instant messaging program
1175938|NCT02140814|niacinamide|niacinamide
1175939|NCT02140814|Vitamin B3|vitamin b3
1175940|NCT02140814|Vitamin B|vitamin b
1175941|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
1175942|NCT02140801|Drug-eluting stent|drug-eluting stent
1175943|NCT02140801|Thrombosis|thrombosis
1175944|NCT02140788|schizophrenia|schizophrenia
1175945|NCT02140788|schizo-affective disorder|schizo-affective disorder
1175946|NCT02140775|HIV|hiv
1175947|NCT02140775|AIDS|aids
1175948|NCT02140775|Fatigue|fatigue
1175949|NCT02140775|armodafinil|armodafinil
1175950|NCT02140775|Unemployment|unemployment
1175951|NCT02140762|Meningitis ABCWY|meningitis abcwy
1175952|NCT02140762|Adolescents|adolescents
1175953|NCT02140762|Vaccination|vaccination
1175954|NCT02140762|Meningococcal disease|meningococcal disease
1175955|NCT02140749|Bifidobacteria|bifidobacteria
1175956|NCT02140749|Bristol Stool Scale|bristol stool scale
1175957|NCT02140749|Constipation|constipation
1175958|NCT02140749|Diet|diet
1175959|NCT02140749|Fructooligosacchardes|fructooligosacchardes
1175960|NCT02140749|Microbiota|microbiota
1175961|NCT02140749|Oligofructose|oligofructose
1175962|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
1175963|NCT02140736|Epoetin biosimilar|epoetin biosimilar
1175964|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
1175965|NCT02140723|delay of surgery|delay of surgery
1175966|NCT02140723|rectal cancer|rectal cancer
1175967|NCT02140723|TP53|tp53
1175968|NCT02140723|predictive marker|predictive marker
1175969|NCT02140723|MRT imaging|mrt imaging
1175970|NCT02140710|premature infant|premature infant
1175971|NCT02140710|visceral osteopathy|visceral osteopathy
1176172|NCT02139787|Immigrants|immigrants
1175972|NCT02140710|alternative medicine|alternative medicine
1175973|NCT02140710|meconium passage|meconium passage
1175974|NCT02140710|enteral feedings|enteral feedings
1175975|NCT02140710|hospital stay|hospital stay
1175976|NCT02140684|Real-world|real-world
1175977|NCT02140684|observational|observational
1175978|NCT02140684|Nitric oxide|nitric oxide
1175979|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
1175981|NCT02140671|asthma management|asthma management
1175982|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
1175983|NCT02140671|compliance|compliance
1175984|NCT02140671|hospital admission|hospital admission
1175985|NCT02140671|educations|educations
1175986|NCT02140671|self-management|self-management
1175987|NCT02140671|guidelines|guidelines
1175988|NCT02140671|exacerbations|exacerbations
1175989|NCT02140671|diagnostic accuracy|diagnostic accuracy
1175990|NCT02140671|symptom control|symptom control
1175991|NCT02140658|ischemic stroke|ischemic stroke
1175992|NCT02140658|Statins Medication Compliance|statins medication compliance
1175993|NCT02140658|outcome|outcome
1175994|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
1175995|NCT02140632|Local steroid injection|local steroid injection
1175996|NCT02140632|Wrist splinting|wrist splinting
1175997|NCT02140619|ischemic stroke|ischemic stroke
1175998|NCT02140619|Medication Compliance|medication compliance
1175999|NCT02140619|outcome|outcome
1176000|NCT02140606|AML|aml
1176001|NCT02140606|phase1|phase1
1176002|NCT02140606|MTD|mtd
1176003|NCT02140606|Cafusertib|cafusertib
1176004|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
1176005|NCT02140541|Asthma|asthma
1176006|NCT02140541|Blood eosinophils|blood eosinophils
1176007|NCT02140541|Sputum eosinophils|sputum eosinophils
1176008|NCT02140541|Clinical predictor|clinical predictor
1176009|NCT02140541|UK primary care|uk primary care
1176010|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
1176011|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
1176012|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
1176013|NCT02140502|Enterobacterial Infections|enterobacterial infections
1176014|NCT02140502|Prostate cancer|prostate cancer
1176015|NCT02140502|Biopsy|biopsy
1176016|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
1176017|NCT02140476|Thyroid goiter|thyroid goiter
1176018|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
1176019|NCT02140476|Bipolar device|bipolar device
1176020|NCT02140476|Sealing and cutting device|sealing and cutting device
1176021|NCT02140476|Thyroidectomy|thyroidectomy
1176022|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
1176023|NCT02140437|Fulvestrant|fulvestrant
1176024|NCT02140437|Anastrozole|anastrozole
1176025|NCT02140437|Luminal A-like|luminal a-like
1176026|NCT02140437|Postmenopausal|postmenopausal
1176027|NCT02140437|Advanced breast cancer|advanced breast cancer
1176028|NCT02140424|type 1 diabetes|type 1 diabetes
1176029|NCT02140424|osteoporosis|osteoporosis
1176030|NCT02140424|children|children
1176031|NCT02140398|infertility|infertility
1176032|NCT02140398|PCOS|pcos
1176033|NCT02140398|scratching|scratching
1176034|NCT02140398|endometrial receptivity|endometrial receptivity
1176035|NCT02140372|colchicine|colchicine
1176036|NCT02140372|platelet activity|platelet activity
1176037|NCT02140372|neutrophil|neutrophil
1176038|NCT02140359|homelessness|homelessness
1176039|NCT02140359|housing first|housing first
1176040|NCT02140359|social networks|social networks
1176041|NCT02140359|drug abuse|drug abuse
1176042|NCT02140359|alcohol use|alcohol use
1176043|NCT02140359|HIV|hiv
1176044|NCT02140333|erlotinib|erlotinib
1176045|NCT02140333|EGFR mutation|egfr mutation
1176046|NCT02140307|Health Promotion|health promotion
1176047|NCT02140307|Prevention|prevention
1176048|NCT02140307|Relaxation Response|relaxation response
1176049|NCT02140307|Meditation|meditation
1176050|NCT02140307|Cortisol|cortisol
1176051|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
1176052|NCT02140268|Phase I|phase i
1176053|NCT02140268|Healthy|healthy
1176054|NCT02140268|Pharmacokinetics|pharmacokinetics
1176055|NCT02140255|HIV Remission|hiv remission
1176056|NCT02140242|AML|aml
1176057|NCT02140242|leukemia|leukemia
1176058|NCT02140242|induction treatment|induction treatment
1176059|NCT02140242|daunorubicin|daunorubicin
1176060|NCT02140242|7+3|7+3
1176061|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
1176062|NCT02140229|Remission,|remission,
1176063|NCT02140229|DAS28,|das28,
1176064|NCT02140229|ACR/EULAR,|acr/eular,
1176065|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
1176066|NCT02140229|Longitudinal follow-up|longitudinal follow-up
1176067|NCT02140216|Blood transfusion|blood transfusion
1176068|NCT02140216|Immune|immune
1176069|NCT02140216|Surgery|surgery
1176070|NCT02140203|Metabolic Syndrome|metabolic syndrome
1176071|NCT02140203|Waist circumference|waist circumference
1176072|NCT02140203|blood pressure|blood pressure
1176073|NCT02140203|triglyceride|triglyceride
1176074|NCT02140203|HDL|hdl
1176075|NCT02140177|Screening|screening
1176076|NCT02140177|Adults|adults
1176077|NCT02140177|Medical Inpatients|medical inpatients
1176078|NCT02140177|Suicide|suicide
1176079|NCT02140164|Cystoid Macular Edema|cystoid macular edema
1176080|NCT02140164|Minocycline|minocycline
1176081|NCT02140164|Microglia|microglia
1176082|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
1176083|NCT02140151|amd|amd
1176084|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
1176085|NCT02140151|exudative macular degeneration|exudative macular degeneration
1176086|NCT02140151|age-related macular degeneration|age-related macular degeneration
1176087|NCT02140151|ranibizumab|ranibizumab
1176088|NCT02140151|anti-VEGF|anti-vegf
1176089|NCT02140125|ASP2408|asp2408
1176090|NCT02140112|T. suis ova|t. suis ova
1176091|NCT02140112|Trichuris suis ova|trichuris suis ova
1176092|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
1176093|NCT02140112|ASD|asd
1176094|NCT02140099|Mental health|mental health
1176095|NCT02140099|Violence|violence
1176096|NCT02140099|Substance use|substance use
1176097|NCT02140099|Adolescent|adolescent
1176098|NCT02140099|Prevention|prevention
1176099|NCT02140086|asthma|asthma
1176100|NCT02140086|Buteyko|buteyko
1176101|NCT02140086|remedial breathing|remedial breathing
1176102|NCT02140086|children|children
1176103|NCT02140073|GERD|gerd
1176104|NCT02140073|Omez|omez
1176105|NCT02140073|Omez DSR|omez dsr
1176106|NCT02140073|heartburn|heartburn
1176107|NCT02140073|esophagitis|esophagitis
1176108|NCT02140073|omeprazole|omeprazole
1176109|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
1176110|NCT02140060|Glaucoma|glaucoma
1176111|NCT02140060|Ocular|ocular
1176112|NCT02140060|Hypertension|hypertension
1176113|NCT02140060|OAG|oag
1176114|NCT02140060|POAG|poag
1176115|NCT02140060|OHT|oht
1176116|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
1176117|NCT02140047|Hib|hib
1176118|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
1176119|NCT02140034|Overall Survival|overall survival
1176120|NCT02140034|Disease Free Survival|disease free survival
1176121|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
1176122|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
1176123|NCT02140021|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
1176124|NCT02140021|Gynecological Cancer|gynecological cancer
1176125|NCT02140021|High-grade dysplasia|high-grade dysplasia
1176126|NCT02140021|Carcinoma of the cervix|carcinoma of the cervix
1176127|NCT02140021|Carcinoma of the vagina|carcinoma of the vagina
1176128|NCT02140021|Carcinoma of the vulva|carcinoma of the vulva
1176129|NCT02140021|Invasive squamous cell carcinoma|invasive squamous cell carcinoma
1176130|NCT02140021|Anal pap test|anal pap test
1176131|NCT02140021|Anoscopy|anoscopy
1176132|NCT02140008|supraglottic airway devices|supraglottic airway devices
1176133|NCT02140008|the i-gel|the i-gel
1245407|NCT01827163|HER2|her2
1176134|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
1176135|NCT02140008|children|children
1176136|NCT02139995|transfusion|transfusion
1176137|NCT02139995|trigger|trigger
1176138|NCT02139995|critically-ill|critically-ill
1176139|NCT02139982|hemodynamics|hemodynamics
1176140|NCT02139982|anaesthetics|anaesthetics
1176141|NCT02139982|brachial plexus|brachial plexus
1176142|NCT02139982|peripheral nerves|peripheral nerves
1176143|NCT02139982|skin temperature|skin temperature
1176144|NCT02139982|sympathetic nervous system|sympathetic nervous system
1176145|NCT02139982|dose-response relationship|dose-response relationship
1176146|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1176147|NCT02139943|Canagliflozin|canagliflozin
1176148|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
1176149|NCT02139930|smoking|smoking
1176150|NCT02139930|nicotine reduction|nicotine reduction
1176151|NCT02139917|transitional palliative care|transitional palliative care
1176152|NCT02139917|end stage renal failure|end stage renal failure
1176153|NCT02139904|Mesothelioma|mesothelioma
1176154|NCT02139904|Vinorelbine|vinorelbine
1176155|NCT02139904|BRCA1|brca1
1176156|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1176157|NCT02139891|non responders|non responders
1176158|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
1176159|NCT02139813|Obesity -|obesity -
1176160|NCT02139813|Bariatric surgery|bariatric surgery
1176161|NCT02139813|Gastric bypass|gastric bypass
1176162|NCT02139800|Neonatal resuscitation|neonatal resuscitation
1176163|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
1176164|NCT02139800|Delivery Room|delivery room
1176165|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1176166|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
1176167|NCT02139800|Sustained inflation|sustained inflation
1176168|NCT02139787|Hypertension, obesity|hypertension, obesity
1176169|NCT02139787|Dietary behaviors|dietary behaviors
1176170|NCT02139787|Physical activity behaviors|physical activity behaviors
1176171|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
1176173|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
1176174|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
1176175|NCT02139774|Prostate Cancer|prostate cancer
1176176|NCT02139774|Elderly|elderly
1176177|NCT02139774|Geriatric|geriatric
1176178|NCT02139774|Radiation|radiation
1176179|NCT02139774|Arthritis|arthritis
1176180|NCT02139774|Exercise|exercise
1176181|NCT02139774|Walking|walking
1176182|NCT02139774|Endocrine Therapy|endocrine therapy
1176183|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
1176184|NCT02139774|Active Surveillance|active surveillance
1176186|NCT02139761|Cocaine|cocaine
1176187|NCT02139761|Treatment|treatment
1176188|NCT02139748|Dental Implants|dental implants
1176189|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
1176190|NCT02139748|Acellular Dermis|acellular dermis
1176191|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
1176192|NCT02139735|Ultrasonics,|ultrasonics,
1176193|NCT02139735|Electromyography,|electromyography,
1176194|NCT02139735|Pain Measurement,|pain measurement,
1176195|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
1176196|NCT02139722|hepatitis B|hepatitis b
1176197|NCT02139722|hepatitis C|hepatitis c
1176198|NCT02139722|screening|screening
1176199|NCT02139722|Asian Americans|asian americans
1176200|NCT02139722|mobile technology|mobile technology
1176201|NCT02139657|Rabies|rabies
1176202|NCT02139657|Rabies virus|rabies virus
1176203|NCT02139657|Rhabdoviridae|rhabdoviridae
1176204|NCT02139657|Rabies immune globulin|rabies immune globulin
1176205|NCT02139657|Rabies antibodies|rabies antibodies
1176206|NCT02139657|Passive rabies immunization|passive rabies immunization
1176207|NCT02139644|fluticasone propionate|fluticasone propionate
1176208|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
1176209|NCT02139631|hemodynamic|hemodynamic
1176210|NCT02139631|mechanical ventilation|mechanical ventilation
1176211|NCT02139631|respiration with positive pressure|respiration with positive pressure
1176212|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
1176213|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
1176214|NCT02139618|Daylight|daylight
1176215|NCT02139618|Photodynamic-therapy|photodynamic-therapy
1176216|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
1176217|NCT02139592|Pharmacological therapy|pharmacological therapy
1176218|NCT02139579|chemotherapy|chemotherapy
1176219|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
1176220|NCT02139579|Bevacizumab|bevacizumab
1176221|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
1176222|NCT02139553|Rehabilitation|rehabilitation
1176223|NCT02139540|Treatment|treatment
1176224|NCT02139527|arthroplasty|arthroplasty
1176225|NCT02139527|spinal|spinal
1176226|NCT02139527|CHARITE|charite
1176227|NCT02139527|PRODISC-L|prodisc-l
1176228|NCT02139527|PRODISC|prodisc
1176229|NCT02139527|disc|disc
1176230|NCT02139527|replacement|replacement
1176231|NCT02139527|lumbar|lumbar
1176232|NCT02139514|Social Skills|social skills
1176233|NCT02139514|Adults|adults
1176234|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
1176235|NCT02139501|Dose and frequency|dose and frequency
1176236|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
1176237|NCT02139488|Esophageal cancer|esophageal cancer
1176238|NCT02139488|Chemoradiation|chemoradiation
1176239|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
1176240|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
1176241|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
1176242|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
1176243|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
1176244|NCT02139410|sarcopenia|sarcopenia
1176245|NCT02139410|mortality|mortality
1176246|NCT02139384|procalcitonin|procalcitonin
1176247|NCT02139384|community acquired pneumonia|community acquired pneumonia
1176248|NCT02139384|pneumonia score|pneumonia score
1176249|NCT02139371|Positron Emission Tomography|positron emission tomography
1176250|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
1176251|NCT02139371|Breast cancer|breast cancer
1176252|NCT02139371|Prostate cancer|prostate cancer
1176253|NCT02139371|Urinary bladder cancer|urinary bladder cancer
1176254|NCT02139371|Biodistribution|biodistribution
1176255|NCT02139371|Radiation exposure|radiation exposure
1176256|NCT02139358|Breast - Female|breast - female
1176257|NCT02139358|Metastatic|metastatic
1176258|NCT02139358|HER2+|her2+
1176259|NCT02139345|Osteoarthritis|osteoarthritis
1176260|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
1176261|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
1176262|NCT02139345|Avascular necrosis|avascular necrosis
1176263|NCT02139345|AVN|avn
1177055|NCT02135575|health|health
1176264|NCT02139332|Attachment theory|attachment theory
1176265|NCT02139332|Parent- child relationship|parent- child relationship
1176266|NCT02139332|Child mental health|child mental health
1176267|NCT02139332|Behavioral health|behavioral health
1176268|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
1176269|NCT02139280|Cyclophosphamide|cyclophosphamide
1176270|NCT02139280|Hematopoietic|hematopoietic
1176271|NCT02139280|Stem Cell|stem cell
1176272|NCT02139280|Mobilization|mobilization
1176273|NCT02139280|Hematologic Malignancy|hematologic malignancy
1176274|NCT02139267|CIN3|cin3
1176275|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1176276|NCT02139267|High-Risk HPV|high-risk hpv
1176277|NCT02139267|HPV Infection|hpv infection
1176278|NCT02139267|Neoplasm|neoplasm
1176279|NCT02139267|Precancerous Diseases|precancerous diseases
1176280|NCT02139267|Uterine Diseases|uterine diseases
1176281|NCT02139267|Genital Diseases, Female|genital diseases, female
1176282|NCT02139254|Gestational Diabetes|gestational diabetes
1176283|NCT02139254|HbA1c|hba1c
1176284|NCT02139254|Glucose|glucose
1176285|NCT02139254|First Trimenon|first trimenon
1176286|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
1176287|NCT02139228|persistency|persistency
1176288|NCT02139228|children|children
1176289|NCT02139228|CRM197|crm197
1176290|NCT02139228|anti-PRP antibody|anti-prp antibody
1176291|NCT02139202|Acute|acute
1176292|NCT02139202|Myocardial|myocardial
1176293|NCT02139202|Infarction|infarction
1176294|NCT02139202|AMI|ami
1176295|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
1176296|NCT02139176|disclosure|disclosure
1176297|NCT02139176|discordant|discordant
1176298|NCT02139176|HIV|hiv
1176299|NCT02139176|Malawi|malawi
1176300|NCT02139163|Community acquired pneumonia|community acquired pneumonia
1176301|NCT02139163|CAP|cap
1176302|NCT02139163|CAPNETZ|capnetz
1176303|NCT02139163|age ≥18|age ≥18
1176304|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
1176305|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
1176306|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
1176307|NCT02139163|fever|fever
1176308|NCT02139150|FLT PET Imaging|flt pet imaging
1176309|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
1176310|NCT02139150|CT|ct
1176311|NCT02139150|scans|scans
1176312|NCT02139150|14-050|14-050
1176313|NCT02139098|sleep architecture|sleep architecture
1176314|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
1176315|NCT02139098|insomnia|insomnia
1176316|NCT02139085|varicose veins|varicose veins
1176317|NCT02139085|catheter ablation|catheter ablation
1176318|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
1176319|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1176320|NCT02139072|Anticoagulation|anticoagulation
1176321|NCT02139072|International normalized ratio|international normalized ratio
1176322|NCT02139072|Warfarin|warfarin
1176323|NCT02139059|anuria|anuria
1176324|NCT02139059|children|children
1176325|NCT02139059|ureteroscopy|ureteroscopy
1176326|NCT02139059|initial urinary drainage|initial urinary drainage
1176327|NCT02139059|ureteric stones|ureteric stones
1176328|NCT02139046|Drug therapy|drug therapy
1176329|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
1176330|NCT02139020|Targeted therapies|targeted therapies
1176331|NCT02139020|Plasma samples|plasma samples
1176332|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
1176333|NCT02138981|Milan Criteria|milan criteria
1176334|NCT02138968|Pre-frailty|pre-frailty
1176335|NCT02138968|Frail|frail
1176336|NCT02138968|Exercise|exercise
1176337|NCT02138968|Nutritional assessment|nutritional assessment
1176338|NCT02138968|Functional capacity|functional capacity
1176339|NCT02138942|automated vascular filling|automated vascular filling
1176340|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
1176341|NCT02138942|General Surgery|general surgery
1176342|NCT02138942|Fluid Therapy|fluid therapy
1176343|NCT02138929|Esophageal Cancer|esophageal cancer
1176344|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
1176345|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
1176346|NCT02138929|GEJ|gej
1176347|NCT02138929|Metastatic|metastatic
1176348|NCT02138929|Everolimus|everolimus
1176349|NCT02138929|Afinitor|afinitor
1176350|NCT02138929|Zortress|zortress
1176351|NCT02138929|RAD001|rad001
1176352|NCT02138929|LDE 225|lde 225
1176353|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
1176354|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1176355|NCT02138916|Lung Disease|lung disease
1176356|NCT02138916|Bronchial Diseases|bronchial diseases
1176357|NCT02138916|COPD Exacerbation|copd exacerbation
1176358|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
1176359|NCT02138903|weaning|weaning
1176360|NCT02138903|Cardiac|cardiac
1176361|NCT02138903|Echocardiography|echocardiography
1176362|NCT02138903|Mechanical Ventilation|mechanical ventilation
1176363|NCT02138890|Autologous Protein Solution|autologous protein solution
1176364|NCT02138890|APS|aps
1176365|NCT02138890|Osteoarthritis|osteoarthritis
1176366|NCT02138890|Intra Articular Injection|intra articular injection
1176468|NCT02138539|sun spots|sun spots
1176367|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
1176368|NCT02138877|pyeloplasty|pyeloplasty
1176369|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
1176370|NCT02138877|obstructive uropathy|obstructive uropathy
1176371|NCT02138877|urinary stent|urinary stent
1176372|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
1176373|NCT02138864|Parkinsonism|parkinsonism
1176374|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
1176375|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
1176376|NCT02138812|Phase 1|phase 1
1176377|NCT02138812|Solid tumors|solid tumors
1176378|NCT02138812|Breast cancer|breast cancer
1176379|NCT02138812|Paclitaxel|paclitaxel
1176380|NCT02138812|MPS-1 inhibitor|mps-1 inhibitor
1176381|NCT02138812|Taxanes|taxanes
1176382|NCT02138799|Phase I|phase i
1176383|NCT02138799|Pharmacokinetics|pharmacokinetics
1176384|NCT02138799|Safety|safety
1176385|NCT02138799|Drug-drug interactions|drug-drug interactions
1176386|NCT02138799|Enzalutamide|enzalutamide
1176387|NCT02138799|Rifampin|rifampin
1176388|NCT02138799|CYP3A4|cyp3a4
1176389|NCT02138799|CYP2D8|cyp2d8
1176390|NCT02138799|Enzyme induction|enzyme induction
1176391|NCT02138786|Richter's Transformation|richter's transformation
1176392|NCT02138786|Richter's Syndrome|richter's syndrome
1176393|NCT02138786|Karyopharm|karyopharm
1176394|NCT02138786|selinexor|selinexor
1176395|NCT02138786|KPT-330|kpt-330
1176396|NCT02138786|SIRRT|sirrt
1176398|NCT02138773|prolonged release formulation|prolonged release formulation
1176399|NCT02138773|adrenergic blocker|adrenergic blocker
1176400|NCT02138773|Bioequivalence|bioequivalence
1176401|NCT02138760|prostate cancer|prostate cancer
1176402|NCT02138760|prostate biopsy|prostate biopsy
1176403|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
1176404|NCT02138760|detection rates|detection rates
1176405|NCT02138760|performance|performance
1176406|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
1176407|NCT02138747|tolterodine ER|tolterodine er
1176408|NCT02138747|mirabegron|mirabegron
1176409|NCT02138734|antitumor|antitumor
1176410|NCT02138734|BCG|bcg
1176411|NCT02138734|bladder cancer|bladder cancer
1176412|NCT02138734|cancer|cancer
1176413|NCT02138734|immunotherapy|immunotherapy
1176414|NCT02138734|instillation|instillation
1176415|NCT02138734|interleukin-15|interleukin-15
1176416|NCT02138734|intravesical|intravesical
1176417|NCT02138734|naive|naive
1176418|NCT02138734|non-muscle invasive|non-muscle invasive
1176419|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
1176420|NCT02138734|ALT-803|alt-803
1176421|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
1176422|NCT02138721|Prostatectomy|prostatectomy
1176423|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
1176424|NCT02138708|congenital heart disease,|congenital heart disease,
1176425|NCT02138708|heart shunt,|heart shunt,
1176426|NCT02138708|acetylcholine|acetylcholine
1176427|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
1176428|NCT02138695|atrial fibrillation|atrial fibrillation
1176429|NCT02138695|catheter ablation|catheter ablation
1176430|NCT02138695|recurrence|recurrence
1176431|NCT02138682|DaT-SPECT scan|dat-spect scan
1176432|NCT02138682|Parkinson's|parkinson's
1176433|NCT02138682|Diagnostic|diagnostic
1176434|NCT02138669|Cornea|cornea
1176435|NCT02138669|Keratoconus|keratoconus
1176436|NCT02138669|Steep cornea|steep cornea
1176437|NCT02138656|Crying|crying
1176438|NCT02138656|Chiropractic|chiropractic
1176439|NCT02138656|Infant|infant
1176440|NCT02138656|pediatric|pediatric
1176441|NCT02138656|Infantile colic|infantile colic
1176442|NCT02138656|Clinical Trial|clinical trial
1176443|NCT02138643|Achalasia|achalasia
1176444|NCT02138643|Megaesophagus|megaesophagus
1176445|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
1176446|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
1176447|NCT02138630|Exercise|exercise
1176448|NCT02138617|Colon Cancer|colon cancer
1176449|NCT02138617|Irinotecan|irinotecan
1176450|NCT02138617|FOLFIRI|folfiri
1176451|NCT02138617|Genotyping|genotyping
1176452|NCT02138617|UGT1A1|ugt1a1
1176453|NCT02138604|chest pain|chest pain
1176454|NCT02138604|myocardial ischemia|myocardial ischemia
1176455|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
1176456|NCT02138604|plethesmography|plethesmography
1176457|NCT02138604|non invasive dP/dt|non invasive dp/dt
1176458|NCT02138591|vitamin d deficiency|vitamin d deficiency
1176459|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
1176460|NCT02138591|resistin, human|resistin, human
1176461|NCT02138591|protein, human|protein, human
1176462|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
1176463|NCT02138591|Cholecalciferol|cholecalciferol
1176464|NCT02138591|Nutritional Status|nutritional status
1176465|NCT02138591|length of stay|length of stay
1176466|NCT02138539|hyperpigmentation|hyperpigmentation
1176467|NCT02138539|melasma|melasma
1176469|NCT02138539|dark spots|dark spots
1176470|NCT02138526|cancer|cancer
1176471|NCT02138526|pazopanib|pazopanib
1176472|NCT02138526|food|food
1176473|NCT02138526|pharmacokinetics|pharmacokinetics
1176474|NCT02138513|Mindfulness|mindfulness
1176475|NCT02138513|MBCT|mbct
1176476|NCT02138513|Cancer|cancer
1176477|NCT02138513|Oncology|oncology
1176478|NCT02138513|E-health|e-health
1176479|NCT02138513|Cost-effectiveness|cost-effectiveness
1176480|NCT02138500|PF-06372865|pf-06372865
1176481|NCT02138500|phase 1|phase 1
1176482|NCT02138500|open-label|open-label
1176483|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
1176484|NCT02138500|positron emission tomography|positron emission tomography
1176485|NCT02138500|healthy subjects|healthy subjects
1176486|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
1176487|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
1176488|NCT02138487|postoperative restrictions|postoperative restrictions
1176489|NCT02138487|patient satisfaction|patient satisfaction
1176490|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
1176491|NCT02138474|homeopathy|homeopathy
1176492|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
1176493|NCT02138461|glaucoma|glaucoma
1176494|NCT02138461|bimatoprost|bimatoprost
1176495|NCT02138461|latanoprost|latanoprost
1176496|NCT02138461|tolerability|tolerability
1176497|NCT02138448|Cancer Screenings|cancer screenings
1176498|NCT02138448|Health Information Technology|health information technology
1176499|NCT02138448|Patient Health Record|patient health record
1176500|NCT02138448|Preventive Services|preventive services
1176501|NCT02138422|colorectal cancer|colorectal cancer
1176502|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
1176503|NCT02138383|pancreas|pancreas
1176504|NCT02138383|malignant neoplasm|malignant neoplasm
1176505|NCT02138383|endocrine system|endocrine system
1176506|NCT02138357|Restless Legs Syndrome|restless legs syndrome
1176507|NCT02138357|Willis Ekbom Disease|willis ekbom disease
1176508|NCT02138357|Twitchy Legs|twitchy legs
1176509|NCT02138357|Periodic Limb Movements|periodic limb movements
1176510|NCT02138357|Leg Movements|leg movements
1176511|NCT02138357|Augmentation|augmentation
1176512|NCT02138357|Requip|requip
1176513|NCT02138357|ropinirole|ropinirole
1176514|NCT02138357|Mirapex|mirapex
1176515|NCT02138357|pramipexole|pramipexole
1176516|NCT02138357|gabapentin|gabapentin
1176517|NCT02138357|Horizant|horizant
1176518|NCT02138357|Neupro|neupro
1176519|NCT02138357|rotigotine|rotigotine
1176520|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
1176521|NCT02138331|Microvesicles|microvesicles
1176522|NCT02138331|Exosomes|exosomes
1176523|NCT02138331|Cord Blood|cord blood
1176524|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
1176525|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1176526|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
1176527|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
1176528|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
1176529|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
1176530|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
1176531|NCT02138305|Myocardial Perfusion|myocardial perfusion
1176532|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
1176533|NCT02138253|liver transplant|liver transplant
1176534|NCT02138253|hepatitis C|hepatitis c
1176535|NCT02138253|liver fibrosis|liver fibrosis
1176536|NCT02138253|hepatic fibrosis|hepatic fibrosis
1176537|NCT02138253|liver cirrhosis|liver cirrhosis
1176538|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
1176539|NCT02138227|Organ donation request|organ donation request
1176540|NCT02138227|Effective Communication|effective communication
1176541|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
1176542|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
1176543|NCT02138201|spinal cord injury|spinal cord injury
1176544|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
1176545|NCT02138175|bleeding|bleeding
1176546|NCT02138175|blood loss|blood loss
1176547|NCT02138175|hemoglobin|hemoglobin
1176548|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
1176549|NCT02138175|noninvasive monitoring|noninvasive monitoring
1176550|NCT02138162|Phase 1|phase 1
1176551|NCT02138162|Pharmacokinetics|pharmacokinetics
1176552|NCT02138162|Safety|safety
1176553|NCT02138162|Severe hepatic impairment|severe hepatic impairment
1176554|NCT02138162|Enzalutamide|enzalutamide
1176555|NCT02138149|spinal cord injury|spinal cord injury
1176556|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
1176557|NCT02138149|nerve growth factor|nerve growth factor
1176558|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1176560|NCT02138123|dense cataract|dense cataract
1176561|NCT02138123|phacoemulsification|phacoemulsification
1176562|NCT02138123|lens-shell technique|lens-shell technique
1176563|NCT02138123|intraocular lens|intraocular lens
1176564|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
1176565|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
1176566|NCT02138071|low back pain|low back pain
1176567|NCT02138071|lumbar pain|lumbar pain
1176568|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
1176569|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1176570|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
1176571|NCT02138045|Liraglutide|liraglutide
1176572|NCT02138032|message framing|message framing
1176573|NCT02138032|smoking cessation|smoking cessation
1176574|NCT02138032|peripheral artery disease|peripheral artery disease
1176575|NCT02138019|corneal ulcers|corneal ulcers
1176576|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
1176577|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
1176578|NCT02138019|cataract surgery|cataract surgery
1176579|NCT02138019|mucous membrane grafting|mucous membrane grafting
1176581|NCT02137954|pain|pain
1176582|NCT02137941|Stress|stress
1176583|NCT02137941|occupations|occupations
1176584|NCT02137941|biomarkers|biomarkers
1176585|NCT02137941|firefighters|firefighters
1176586|NCT02137928|Retinoblastoma|retinoblastoma
1176587|NCT02137928|carboplatin|carboplatin
1176589|NCT02137902|Tobacco dependence|tobacco dependence
1176590|NCT02137902|Cardiovascular disease|cardiovascular disease
1176591|NCT02137902|Risk behaviors|risk behaviors
1176592|NCT02137902|Smoking|smoking
1176593|NCT02137902|Physical activity|physical activity
1176594|NCT02137902|Alaska Native people|alaska native people
1176595|NCT02137889|CLL|cll
1176596|NCT02137876|B cells|b cells
1176597|NCT02137876|Thymoglubulin|thymoglubulin
1176598|NCT02137876|humoral rejections|humoral rejections
1176599|NCT02137876|transplant|transplant
1176600|NCT02137876|rATG|ratg
1176601|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
1176602|NCT02137863|Diabetes Mellitus|diabetes mellitus
1176603|NCT02137863|Dexmedetomidine|dexmedetomidine
1176604|NCT02137837|Metastatic breast cancer|metastatic breast cancer
1176605|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
1176606|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1176607|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
1176608|NCT02137837|Stage IV breast cancer|stage iv breast cancer
1176609|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1176610|NCT02137811|cancer|cancer
1176611|NCT02137811|CorrectChemo|correctchemo
1176612|NCT02137811|assay|assay
1176613|NCT02137811|lab test|lab test
1176614|NCT02137811|MICK assay|mick assay
1176615|NCT02137811|apoptosis|apoptosis
1573928|NCT00487305|K562|k562
1176616|NCT02137811|increase survival|increase survival
1176617|NCT02137811|increase response rates|increase response rates
1176618|NCT02137811|decrease time to progression|decrease time to progression
1176619|NCT02137811|chemotherapy|chemotherapy
1176620|NCT02137811|cancer treatment|cancer treatment
1176621|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
1176622|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
1176623|NCT02137798|fluoroscopy|fluoroscopy
1176624|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
1176625|NCT02137785|Actinic Keratosis|actinic keratosis
1176626|NCT02137759|Glioblastoma|glioblastoma
1176627|NCT02137746|Prostate Cancer|prostate cancer
1176628|NCT02137746|Radical Prostatectomy|radical prostatectomy
1176629|NCT02137720|Diabetes|diabetes
1176630|NCT02137720|Treatment Adherence|treatment adherence
1176631|NCT02137720|Self-management|self-management
1176632|NCT02137720|Emotional Distress|emotional distress
1176633|NCT02137720|Diabetes-related Distress|diabetes-related distress
1176634|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1176635|NCT02137707|Gilenya|gilenya
1176636|NCT02137707|Fingolimod|fingolimod
1176637|NCT02137694|Papillomavirus|papillomavirus
1176638|NCT02137694|Vaginal auto-takings|vaginal auto-takings
1176639|NCT02137694|Urinary test|urinary test
1176640|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
1176641|NCT02137681|rituximab|rituximab
1176642|NCT02137681|efficacy|efficacy
1176643|NCT02137681|safety|safety
1176644|NCT02137642|constipation|constipation
1176645|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
1176646|NCT02137629|Vidaza|vidaza
1176647|NCT02137629|Observational study|observational study
1176648|NCT02137629|Korea|korea
1176649|NCT02137616|psychosis|psychosis
1176650|NCT02137616|syndrome|syndrome
1176651|NCT02137616|risk|risk
1176652|NCT02137616|antipsychotic|antipsychotic
1176653|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
1176654|NCT02137590|Spanish Black Radish|spanish black radish
1176655|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
1176656|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
1176657|NCT02137590|Acetaminophen|acetaminophen
1176658|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
1176659|NCT02137551|adherence|adherence
1176660|NCT02137551|healthcare costs|healthcare costs
1176661|NCT02137551|appointment based model|appointment based model
1176662|NCT02137551|accountable care organization|accountable care organization
1176663|NCT02137512|Artificial Pancreas|artificial pancreas
1176664|NCT02137486|stable angina|stable angina
1176665|NCT02137486|high angulated bifurcation|high angulated bifurcation
1176666|NCT02137486|SYNTAX|syntax
1176667|NCT02137486|DES|des
1176668|NCT02137486|BMS|bms
1176669|NCT02137460|Alzheimer's disease|alzheimer's disease
1176670|NCT02137460|Early diagnosis|early diagnosis
1176671|NCT02137460|Prediction|prediction
1176672|NCT02137460|Biomarker|biomarker
1176673|NCT02137460|Imaging|imaging
1176674|NCT02137447|Prevena|prevena
1176675|NCT02137447|faster healing time|faster healing time
1176676|NCT02137447|surgical site infection|surgical site infection
1176677|NCT02137434|Acute calcium|acute calcium
1176678|NCT02137434|Dietary calcium|dietary calcium
1176679|NCT02137434|Supplementary calcium|supplementary calcium
1176680|NCT02137434|Postprandial metabolism|postprandial metabolism
1176681|NCT02137421|Coronary artery disease|coronary artery disease
1176682|NCT02137421|Metabolic syndrome|metabolic syndrome
1176683|NCT02137421|Resveratrol|resveratrol
1176684|NCT02137421|β-catenin|β-catenin
1176685|NCT02137421|Wnt signaling|wnt signaling
1176686|NCT02137421|FOXO|foxo
1176687|NCT02137421|MnSOD|mnsod
1176688|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
1176689|NCT02137408|Pre-term delivery|pre-term delivery
1176690|NCT02137408|Preeclampsia|preeclampsia
1176691|NCT02137408|Endothelial Health|endothelial health
1176692|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1176693|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
1176694|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
1176695|NCT02137369|MDD|mdd
1176696|NCT02137369|Major Depressive Disorder|major depressive disorder
1176697|NCT02137369|Treatment|treatment
1176698|NCT02137369|Antidepressants|antidepressants
1176699|NCT02137369|Lexapro|lexapro
1176700|NCT02137369|Talk therapy|talk therapy
1176701|NCT02137356|rectal cancer|rectal cancer
1176702|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
1176703|NCT02137356|Selinexor|selinexor
1176704|NCT02137356|capecitabine|capecitabine
1176705|NCT02137356|chemoradiation|chemoradiation
1176706|NCT02137356|radiation|radiation
1176707|NCT02137356|radiotherapy|radiotherapy
1176708|NCT02137356|neoadjuvant|neoadjuvant
1176709|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
1176710|NCT02137343|Gastric Cancer|gastric cancer
1176711|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
1176712|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
1176713|NCT02137343|GEJ Cancer|gej cancer
1176714|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
1176715|NCT02137330|Severe obesity|severe obesity
1176716|NCT02137330|Children|children
1176717|NCT02137317|Pesticides|pesticides
1176718|NCT02137317|Personal protective equipment|personal protective equipment
1176719|NCT02137317|Developing countries|developing countries
1176720|NCT02137317|Tropical Climate|tropical climate
1176721|NCT02137304|cough help|cough help
1176722|NCT02137304|in-exsufflation|in-exsufflation
1176723|NCT02137304|neuromuscular disease|neuromuscular disease
1176724|NCT02137304|cough assistance optimization|cough assistance optimization
1176725|NCT02137304|efficient cough flow|efficient cough flow
1176726|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
1176727|NCT02137291|Lung isolation device|lung isolation device
1176728|NCT02137291|One-lung ventilation|one-lung ventilation
1176729|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
1176730|NCT02137291|Bronchial blocker|bronchial blocker
1176731|NCT02137278|Syncope|syncope
1176732|NCT02137278|Presyncope|presyncope
1176733|NCT02137278|Vasoactive drugs|vasoactive drugs
1176734|NCT02137278|Hypotension|hypotension
1176735|NCT02137278|Carotid sinus massage|carotid sinus massage
1176736|NCT02137278|Tilt table test|tilt table test
1176737|NCT02137265|Azoospermia|azoospermia
1176738|NCT02137265|Hypogonadism|hypogonadism
1176739|NCT02137265|Clomiphene|clomiphene
1176740|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
1176741|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
1176742|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
1176743|NCT02137252|Lobular Carcinoma|lobular carcinoma
1176744|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
1176745|NCT02137213|Opioid-induced constipation|opioid-induced constipation
1176746|NCT02137213|Methadone|methadone
1176747|NCT02137213|Naloxone|naloxone
1176748|NCT02137187|Atrial fibrillation|atrial fibrillation
1176749|NCT02137187|Heart failure|heart failure
1176750|NCT02137187|Catheter ablation|catheter ablation
1176751|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
1176752|NCT02137187|Implantable defibrillator|implantable defibrillator
1176753|NCT02137148|Vascular Access|vascular access
1176754|NCT02137148|Sonic Window|sonic window
1176755|NCT02137148|Ultrasound|ultrasound
1176756|NCT02137135|chronic postoperative pain|chronic postoperative pain
1176757|NCT02137135|menstrual cycle|menstrual cycle
1176758|NCT02137122|Volunteers|volunteers
1176759|NCT02137109|Pediatric|pediatric
1176760|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
1176761|NCT02137083|Chemotherapy|chemotherapy
1176762|NCT02137083|Endocrine therapy|endocrine therapy
1176763|NCT02137083|Docetaxel|docetaxel
1176764|NCT02137083|Fulvestrant|fulvestrant
1176765|NCT02137070|Weightloss and brain function|weightloss and brain function
1176766|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
1176767|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
1176768|NCT02137057|Heart Rate Variability|heart rate variability
1176769|NCT02137057|spinal anesthesia|spinal anesthesia
1176771|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
1176772|NCT02137044|multiple sclerosis|multiple sclerosis
1176773|NCT02137044|pain|pain
1176774|NCT02137044|depression|depression
1176775|NCT02137018|hernia|hernia
1176776|NCT02137018|incisional hernia|incisional hernia
1176777|NCT02137018|device|device
1176778|NCT02137018|pig|pig
1176779|NCT02137005|walking|walking
1176780|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
1176781|NCT02137005|health status|health status
1176782|NCT02137005|cognition|cognition
1176783|NCT02137005|quality of life|quality of life
1176784|NCT02137005|Transition to Adult Care|transition to adult care
1176785|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1176786|NCT02136953|Exercise|exercise
1176787|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
1176788|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
1176789|NCT02136953|Treatment Efficacy|treatment efficacy
1176790|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1176791|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
1176792|NCT02136914|LID|lid
1176793|NCT02136914|Parkinsonism|parkinsonism
1176794|NCT02136901|NuSurface|nusurface
1176795|NCT02136901|Meniscus|meniscus
1176796|NCT02136901|Prosthesis|prosthesis
1176797|NCT02136901|KOOS|koos
1176798|NCT02136888|Ponesimod|ponesimod
1176799|NCT02136888|Safety|safety
1176800|NCT02136875|COPD|copd
1176801|NCT02136875|COPD exacerbation|copd exacerbation
1176802|NCT02136862|Alport syndrome|alport syndrome
1176803|NCT02136862|kidney disease|kidney disease
1333250|NCT01443832|Beninese women|beninese women
1176804|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
1176805|NCT02136836|Genes, erbB-2|genes, erbb-2
1176806|NCT02136836|Prognosis|prognosis
1176807|NCT02136823|Spinal Cord Injury|spinal cord injury
1176808|NCT02136810|Hypertension|hypertension
1176809|NCT02136810|Perioperative Care|perioperative care
1176810|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
1176811|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1176812|NCT02136797|14-070|14-070
1176813|NCT02136784|pain|pain
1176814|NCT02136784|cold presser test|cold presser test
1176815|NCT02136784|buprenorphine|buprenorphine
1176816|NCT02136784|opioids|opioids
1176817|NCT02136758|lifestyle modification|lifestyle modification
1176818|NCT02136758|diet|diet
1176819|NCT02136758|exercise|exercise
1176820|NCT02136758|cardiovascular disease|cardiovascular disease
1176821|NCT02136758|gene expression|gene expression
1176822|NCT02136758|obesity|obesity
1176823|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
1176824|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
1176825|NCT02136745|mind body|mind body
1176826|NCT02136745|intervention|intervention
1176827|NCT02136745|group|group
1176828|NCT02136745|Relaxation Response|relaxation response
1176829|NCT02136745|genomic effects|genomic effects
1176830|NCT02136732|chronic conditions|chronic conditions
1176831|NCT02136732|multimorbid|multimorbid
1176832|NCT02136719|Uterine massage|uterine massage
1176833|NCT02136719|vaginal birth|vaginal birth
1176834|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
1176835|NCT02136706|Stable coronary artery disease|stable coronary artery disease
1176836|NCT02136693|obstructed defecation|obstructed defecation
1176837|NCT02136693|STARR|starr
1176838|NCT02136693|constipation|constipation
1176839|NCT02136693|incontinence|incontinence
1176840|NCT02136693|psyllium|psyllium
1176841|NCT02136680|HIV disease|hiv disease
1176842|NCT02136680|palliative care|palliative care
1176843|NCT02136680|educational intervention|educational intervention
1176844|NCT02136667|Preeclampsia|preeclampsia
1176845|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
1176846|NCT02136654|diabetes|diabetes
1176847|NCT02136654|ethnicity|ethnicity
1176848|NCT02136654|South Asian|south asian
1176849|NCT02136654|diabetes management|diabetes management
1176850|NCT02136641|Anesthesia|anesthesia
1176851|NCT02136641|Spinal Anesthesia|spinal anesthesia
1176852|NCT02136641|Conscious Sedation|conscious sedation
1176853|NCT02136641|Operating Rooms.|operating rooms.
1176854|NCT02136628|RTL Technique|rtl technique
1176855|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
1176856|NCT02136615|insulin sensitivity|insulin sensitivity
1176857|NCT02136615|human|human
1176858|NCT02136615|inflammation|inflammation
1176859|NCT02136615|adipose tissue|adipose tissue
1176860|NCT02136563|Chronic kidney disease|chronic kidney disease
1176861|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
1176862|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
1176863|NCT02136563|Observational study|observational study
1176864|NCT02136550|smoking|smoking
1176865|NCT02136550|smoking cessation|smoking cessation
1176866|NCT02136550|mucociliary clearance|mucociliary clearance
1176867|NCT02136550|proteomics|proteomics
1176868|NCT02136550|miRNA|mirna
1176869|NCT02136498|smoking cessation|smoking cessation
1176870|NCT02136498|varenicline|varenicline
1176871|NCT02136498|adherence|adherence
1176872|NCT02136472|Subfertility|subfertility
1176873|NCT02136472|Metabolic syndrome|metabolic syndrome
1176874|NCT02136472|Plasma volume|plasma volume
1176875|NCT02136472|Intima media thickness|intima media thickness
1176876|NCT02136472|Flow mediated dilatation|flow mediated dilatation
1176877|NCT02136459|Thyroidectomy|thyroidectomy
1176878|NCT02136459|Endotracheal tube|endotracheal tube
1176879|NCT02136459|Voice|voice
1176880|NCT02136459|Complications|complications
1176881|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
1176882|NCT02136446|Paravertebral block|paravertebral block
1176883|NCT02136446|Mastectomy|mastectomy
1176884|NCT02136446|Post-operative pain|post-operative pain
1176885|NCT02136446|Echogenic|echogenic
1176886|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
1176887|NCT02136433|Hand|hand
1176888|NCT02136433|Rehabilitation|rehabilitation
1176889|NCT02136433|Stroke|stroke
1176890|NCT02136433|Brain-injury|brain-injury
1176891|NCT02136433|Tablet|tablet
1176892|NCT02136407|Vitamin D|vitamin d
1176893|NCT02136407|vitamin D deficiency|vitamin d deficiency
1176894|NCT02136407|parathyroid hormone|parathyroid hormone
1176895|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
1176896|NCT02136368|older adults|older adults
1176897|NCT02136368|multiple-modality exercise|multiple-modality exercise
1176898|NCT02136368|mind-motor exercise|mind-motor exercise
1176899|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
1176900|NCT02136368|global cognitive functioning|global cognitive functioning
1176901|NCT02136368|mobility|mobility
1176902|NCT02136368|vascular function|vascular function
1176903|NCT02136368|sensorimotor function|sensorimotor function
1176904|NCT02136368|brain imaging|brain imaging
1176905|NCT02136368|community-based research|community-based research
1176906|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
1176907|NCT02136342|no available effective treatment|no available effective treatment
1176908|NCT02136316|Healthy volunteers|healthy volunteers
1176909|NCT02136316|ASP7962|asp7962
1176910|NCT02136316|pharmacokinetics|pharmacokinetics
1176911|NCT02136290|Weight loss|weight loss
1176912|NCT02136277|colorectal surgery|colorectal surgery
1176913|NCT02136277|cardiac output|cardiac output
1176914|NCT02136264|hypertension|hypertension
1176915|NCT02136264|dietary intervention|dietary intervention
1176916|NCT02136264|personalized nutrition|personalized nutrition
1176917|NCT02136264|randomized controlled trial|randomized controlled trial
1176918|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
1176919|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
1176920|NCT02136251|Autologous bone grafting|autologous bone grafting
1176921|NCT02136238|amputation|amputation
1176922|NCT02136238|transradial|transradial
1176923|NCT02136238|prosthesis|prosthesis
1176924|NCT02136238|terminal device|terminal device
1176925|NCT02136225|youth|youth
1176926|NCT02136225|gun|gun
1176927|NCT02136225|access|access
1176928|NCT02136225|home|home
1176929|NCT02136186|home telemonitoring|home telemonitoring
1176930|NCT02136186|readmission|readmission
1176931|NCT02136186|high risk|high risk
1176932|NCT02136160|elementary school|elementary school
1176933|NCT02136160|children|children
1176934|NCT02136160|health promotion|health promotion
1176935|NCT02136160|teachers|teachers
1176936|NCT02136160|prevention|prevention
1176937|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1176938|NCT02136147|Neuropsychiatry|neuropsychiatry
1176939|NCT02136147|Drug therapy|drug therapy
1176940|NCT02136147|Pharmacogenetics|pharmacogenetics
1176941|NCT02136147|Child Psychiatry|child psychiatry
1176942|NCT02136134|Multiple Myeloma|multiple myeloma
1176943|NCT02136134|Plasmacytoma|plasmacytoma
1176944|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
1176945|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
1176946|NCT02136134|Daratumumab|daratumumab
1176947|NCT02136134|VELCADE|velcade
1176948|NCT02136108|Chronic pain|chronic pain
1176949|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
1176950|NCT02136108|Mobile health|mobile health
1176951|NCT02136108|Medicaid|medicaid
1176952|NCT02136108|Patient navigation|patient navigation
1177751|NCT02132429|Migraine|migraine
1176953|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
1176954|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1176955|NCT02136082|HIV|hiv
1176956|NCT02136082|Women|women
1176957|NCT02136082|Children|children
1176958|NCT02136082|Nutrition|nutrition
1176959|NCT02136056|Sick-leave|sick-leave
1176960|NCT02136056|Return to work|return to work
1176961|NCT02136056|Self-management|self-management
1176962|NCT02136056|Self-efficacy|self-efficacy
1176963|NCT02136056|Quality of Life and Well-being|quality of life and well-being
1176964|NCT02136056|Motivation|motivation
1176965|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
1176966|NCT02136017|AEFI|aefi
1176967|NCT02136017|influenza vaccine|influenza vaccine
1176968|NCT02136004|arteriotomy|arteriotomy
1176969|NCT02136004|vessel closure|vessel closure
1176970|NCT02136004|femoral access site|femoral access site
1176971|NCT02135978|Spinal Cord Injury|spinal cord injury
1176972|NCT02135978|Shoulder Pain|shoulder pain
1176973|NCT02135978|Exercise|exercise
1176974|NCT02135952|Periodontitis|periodontitis
1176975|NCT02135952|Diabetes|diabetes
1176976|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
1176977|NCT02135913|Obese|obese
1176978|NCT02135913|Children|children
1176979|NCT02135913|Vitamin D deficiency|vitamin d deficiency
1176980|NCT02135913|Low HDL|low hdl
1176981|NCT02135900|Heliox|heliox
1176982|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
1176983|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
1176984|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
1176985|NCT02135887|MB-6|mb-6
1176986|NCT02135874|Leukemia|leukemia
1176987|NCT02135874|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
1176988|NCT02135874|MPAL|mpal
1176989|NCT02135874|Newly Diagnosed|newly diagnosed
1176990|NCT02135874|Relapsed|relapsed
1176991|NCT02135874|Clofarabine|clofarabine
1176992|NCT02135874|Clofarex|clofarex
1176993|NCT02135874|Clolar|clolar
1176994|NCT02135874|Idarubicin|idarubicin
1176995|NCT02135874|Idamycin|idamycin
1176996|NCT02135874|Cytarabine|cytarabine
1176997|NCT02135874|Ara-C|ara-c
1176998|NCT02135874|Cytosar|cytosar
1176999|NCT02135874|DepoCyt|depocyt
1177000|NCT02135874|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1177001|NCT02135874|Vincristine|vincristine
1177002|NCT02135874|Rituximab|rituximab
1177003|NCT02135874|Rituxan|rituxan
1177004|NCT02135874|Dexamethasone|dexamethasone
1177005|NCT02135874|Decadron|decadron
1177006|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
1177007|NCT02135861|heart failure|heart failure
1177008|NCT02135861|MRI|mri
1177009|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
1177010|NCT02135861|pulmonary oedema|pulmonary oedema
1177011|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
1177012|NCT02135822|gemcitabine|gemcitabine
1177013|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
1177014|NCT02135796|Septic Shock|septic shock
1177015|NCT02135796|Severe Sepsis|severe sepsis
1177016|NCT02135796|ICU|icu
1177017|NCT02135770|heparin|heparin
1177018|NCT02135770|sepsis|sepsis
1177019|NCT02135770|inflammation|inflammation
1177020|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1177021|NCT02135744|COPD|copd
1177022|NCT02135744|Readmissions|readmissions
1177023|NCT02135718|ELLIPTA|ellipta
1177024|NCT02135718|Asthma|asthma
1177025|NCT02135718|Inhaler preference|inhaler preference
1177026|NCT02135718|Fluticasone furoate|fluticasone furoate
1177027|NCT02135718|ELLIPTA inhaler|ellipta inhaler
1177028|NCT02135718|Dry Powder Inhaler|dry powder inhaler
1177029|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
1177030|NCT02135692|Extension study|extension study
1177031|NCT02135692|Expanded access|expanded access
1177032|NCT02135692|Safety|safety
1177033|NCT02135692|Mepolizumab|mepolizumab
1177034|NCT02135692|Eosinophils|eosinophils
1177035|NCT02135666|Twinrix|twinrix
1177036|NCT02135666|Long-term follow-up|long-term follow-up
1177037|NCT02135666|Persistence|persistence
1177038|NCT02135666|Hepatitis A|hepatitis a
1177039|NCT02135666|Antibody|antibody
1177040|NCT02135666|Immunity|immunity
1177041|NCT02135666|Hepatitis B|hepatitis b
1177042|NCT02135666|Combination vaccine|combination vaccine
1177043|NCT02135666|Adult|adult
1177044|NCT02135601|colonoscopy|colonoscopy
1177045|NCT02135601|water|water
1177046|NCT02135601|adenoma|adenoma
1177047|NCT02135601|pain|pain
1177048|NCT02135575|premenopausal|premenopausal
1177049|NCT02135575|postmenopausal|postmenopausal
1177050|NCT02135575|cardiovascular|cardiovascular
1177051|NCT02135575|exercise training|exercise training
1177052|NCT02135575|vascular function|vascular function
1177053|NCT02135575|cardiac function|cardiac function
1177054|NCT02135575|cardiac morphology|cardiac morphology
1177056|NCT02135562|endometrial cancer|endometrial cancer
1177057|NCT02135562|survivor|survivor
1177058|NCT02135562|obesity|obesity
1177059|NCT02135562|diet|diet
1177060|NCT02135562|high protein|high protein
1177061|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
1177062|NCT02135562|PSMF|psmf
1177063|NCT02135523|ovarian cancer|ovarian cancer
1177064|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
1177065|NCT02135523|progression free survival|progression free survival
1177066|NCT02135484|Prostate Cancer|prostate cancer
1177067|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1177068|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
1177069|NCT02135484|CRPC|crpc
1177070|NCT02135484|Skeletal metastases|skeletal metastases
1177071|NCT02135484|Alpharadin|alpharadin
1177072|NCT02135484|Xofigo|xofigo
1177073|NCT02135484|Radium-223 chloride|radium-223 chloride
1177074|NCT02135484|Radium-223 dichloride|radium-223 dichloride
1177075|NCT02135471|gingival recession|gingival recession
1177076|NCT02135471|dental enamel proteins|dental enamel proteins
1177077|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
1177078|NCT02135471|tobacco|tobacco
1177079|NCT02135458|Heart failure|heart failure
1177080|NCT02135458|Telemonitoring|telemonitoring
1177081|NCT02135458|therapeutic education|therapeutic education
1177082|NCT02135458|care network|care network
1177083|NCT02135458|hospitalization|hospitalization
1177084|NCT02135445|Drug therapy|drug therapy
1177085|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
1177086|NCT02135406|Adult|adult
1177087|NCT02135406|18 years or older|18 years or older
1177088|NCT02135406|multiple myeloma|multiple myeloma
1177089|NCT02135406|poor prognosis|poor prognosis
1177090|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
1177091|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
1177092|NCT02135367|PRP|prp
1177093|NCT02135367|growth factors|growth factors
1177094|NCT02135367|Viscosupplementation|viscosupplementation
1177095|NCT02135367|injections|injections
1177096|NCT02135367|chondropathy|chondropathy
1177097|NCT02135367|randomized controlled trial|randomized controlled trial
1177098|NCT02135354|AECOPD|aecopd
1177099|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1177100|NCT02135354|Acute exacerbation|acute exacerbation
1177101|NCT02135354|Hospitalization|hospitalization
1333251|NCT01443832|fonio|fonio
1177102|NCT02135354|Azithromycin|azithromycin
1177103|NCT02135354|Macrolides|macrolides
1177104|NCT02135354|Randomized Controlled Trial|randomized controlled trial
1177105|NCT02135354|Placebo|placebo
1177106|NCT02135341|Detrusor Overactivity|detrusor overactivity
1177107|NCT02135341|Impaired Contractility|impaired contractility
1177108|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
1177109|NCT02135328|Type 2 diabetes|type 2 diabetes
1177110|NCT02135328|Dietary behaviors|dietary behaviors
1177111|NCT02135328|Physical activity behaviors|physical activity behaviors
1177112|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
1177113|NCT02135328|Immigrants|immigrants
1177114|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
1177115|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
1177116|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
1177117|NCT02135302|hepatic|hepatic
1177118|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
1177119|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1177120|NCT02135211|multiple risk factor|multiple risk factor
1177121|NCT02135211|lifestyle intervention|lifestyle intervention
1177122|NCT02135211|health behavior|health behavior
1177123|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
1177124|NCT02135211|health related quality of life|health related quality of life
1177125|NCT02135198|GABA modulator|gaba modulator
1177126|NCT02135198|AZD7325|azd7325
1177127|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
1177128|NCT02135198|volunteers|volunteers
1177129|NCT02135146|Hypotension|hypotension
1177130|NCT02135146|Kidney injury|kidney injury
1177131|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1177132|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1177133|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
1177134|NCT02135094|trapezius|trapezius
1177135|NCT02135094|upper back|upper back
1177136|NCT02135094|muscle pain|muscle pain
1177137|NCT02135094|pain relief|pain relief
1177138|NCT02135094|ultrasound|ultrasound
1177139|NCT02135094|double blind|double blind
1177140|NCT02135094|Sam|sam
1177141|NCT02135094|ZetrOZ|zetroz
1177142|NCT02135094|muscle|muscle
1177143|NCT02135094|LITUS|litus
1177144|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
1177145|NCT02135081|Single ventricle|single ventricle
1177146|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1177147|NCT02135081|Congenital heart lesion|congenital heart lesion
1177148|NCT02135081|Right or left ventricle|right or left ventricle
1177149|NCT02135081|Cerebral blood flow|cerebral blood flow
1177150|NCT02135081|Pulmonary blood flow|pulmonary blood flow
1177151|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
1177152|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
1177153|NCT02135068|type 1 diabetes|type 1 diabetes
1177154|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
1177155|NCT02135068|exercise|exercise
1177156|NCT02135068|hypoglycemia|hypoglycemia
1177157|NCT02135055|organ function|organ function
1177158|NCT02135055|sedation|sedation
1177159|NCT02135029|Hyperlipidemia|hyperlipidemia
1177160|NCT02135029|statin intolerance|statin intolerance
1177161|NCT02135016|effect-site concentration|effect-site concentration
1177162|NCT02135016|propofol|propofol
1177163|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
1177164|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1177165|NCT02134990|Docetaxel|docetaxel
1177166|NCT02134977|Pharmacological therapy|pharmacological therapy
1177167|NCT02134964|Safety|safety
1177168|NCT02134964|Tolerability|tolerability
1177169|NCT02134964|Pharmacokinetics|pharmacokinetics
1177170|NCT02134964|Dose escalation|dose escalation
1177171|NCT02134964|Randomized|randomized
1177172|NCT02134964|Healthy volunteers|healthy volunteers
1177173|NCT02134964|OLT1177|olt1177
1177174|NCT02134964|Olatec|olatec
1177175|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1177176|NCT02134899|cyst|cyst
1177177|NCT02134899|kidney|kidney
1177178|NCT02134899|liver|liver
1177179|NCT02134899|kidney transplantation|kidney transplantation
1177180|NCT02134899|IF/TA|if/ta
1177181|NCT02134899|fibrosis|fibrosis
1177182|NCT02134899|DSA|dsa
1177183|NCT02134899|mTOR inhibitors|mtor inhibitors
1177184|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
1177185|NCT02134873|Pain|pain
1177186|NCT02134873|Pain management|pain management
1177187|NCT02134873|Hospitalized|hospitalized
1177188|NCT02134873|Infants|infants
1177189|NCT02134873|Sucrose|sucrose
1177190|NCT02134847|Resident|resident
1177191|NCT02134847|Fatigue|fatigue
1177192|NCT02134847|Sleep deprivation|sleep deprivation
1177193|NCT02134847|medical errors|medical errors
1177194|NCT02134808|Major Depressive Disorder|major depressive disorder
1177195|NCT02134808|Creatine|creatine
1177196|NCT02134808|Brain Chemistry|brain chemistry
1177197|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1573929|NCT00487292|accidents|accidents
1177198|NCT02134808|Treatment Resistance|treatment resistance
1177199|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
1177200|NCT02134795|Parkinson's disease|parkinson's disease
1177201|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
1177202|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
1177203|NCT02134756|Supplement impact|supplement impact
1177204|NCT02134756|Performance|performance
1177205|NCT02134756|Fatigue|fatigue
1177206|NCT02134743|dental implant|dental implant
1177207|NCT02134743|Surface energy|surface energy
1177208|NCT02134743|Hydrophilicity|hydrophilicity
1177209|NCT02134743|Contact angle|contact angle
1177210|NCT02134743|Titanium implant roughness|titanium implant roughness
1177211|NCT02134743|Surface conditioning|surface conditioning
1177212|NCT02134730|FRIENDS for life|friends for life
1177213|NCT02134730|universal prevention|universal prevention
1177214|NCT02134730|school children|school children
1177215|NCT02134730|anxiety|anxiety
1177216|NCT02134717|sarcoidosis|sarcoidosis
1177217|NCT02134717|CCR5 inhibition|ccr5 inhibition
1177218|NCT02134717|maraviroc|maraviroc
1177219|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
1177220|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
1177221|NCT02134678|self-system therapy|self-system therapy
1177222|NCT02134678|cognitive therapy|cognitive therapy
1177223|NCT02134678|depression|depression
1177224|NCT02134678|psychotherapy|psychotherapy
1177225|NCT02134678|mechanisms of action|mechanisms of action
1177226|NCT02134665|Vancomycin|vancomycin
1177227|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
1177228|NCT02134665|Creatinine clearance|creatinine clearance
1177229|NCT02134652|Ultrasonography|ultrasonography
1177230|NCT02134652|World Health|world health
1177231|NCT02134626|Portal Hypertension|portal hypertension
1177232|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
1177233|NCT02134626|Esophageal Varices|esophageal varices
1177234|NCT02134626|Liver Cirrhosis|liver cirrhosis
1177235|NCT02134626|Simvastatin|simvastatin
1177236|NCT02134626|Nitric oxide|nitric oxide
1177237|NCT02134626|HVPG|hvpg
1177238|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
1177239|NCT02134613|Inflammation|inflammation
1177240|NCT02134613|Psoriatic arthritis|psoriatic arthritis
1177241|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
1177242|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
1177244|NCT02134600|EPA|epa
1177245|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
1177246|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
1177247|NCT02134600|Childhood cancer|childhood cancer
1177248|NCT02134600|Body composition|body composition
1177249|NCT02134600|Inflammation|inflammation
1177250|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
1177349|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
1177251|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
1177252|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
1177253|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
1177254|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
1177255|NCT02134574|Lymphoma,|lymphoma,
1177256|NCT02134574|leukemia,|leukemia,
1177257|NCT02134574|multiple myeloma,|multiple myeloma,
1177258|NCT02134574|hodgkin disease|hodgkin disease
1177259|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
1177260|NCT02134522|childhood obesity|childhood obesity
1177261|NCT02134522|Sleep Apnea|sleep apnea
1177262|NCT02134509|Cigarette smoking|cigarette smoking
1177263|NCT02134496|hip|hip
1177264|NCT02134496|knee|knee
1177265|NCT02134496|arthroplasty|arthroplasty
1177266|NCT02134496|spinal|spinal
1177267|NCT02134496|anesthesia|anesthesia
1177268|NCT02134483|Parathyroid|parathyroid
1177269|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
1177270|NCT02134483|Transplantation|transplantation
1177271|NCT02134470|saliva|saliva
1177272|NCT02134470|blood|blood
1177273|NCT02134470|urine|urine
1177274|NCT02134444|Dizziness|dizziness
1177275|NCT02134444|Vertigo|vertigo
1177276|NCT02134444|Vestibular Diseases|vestibular diseases
1177277|NCT02134444|Vestibular Neuritis|vestibular neuritis
1177278|NCT02134444|Labyrinth Diseases|labyrinth diseases
1177279|NCT02134444|Ear Diseases|ear diseases
1177280|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
1177281|NCT02134444|Telerehabilitation|telerehabilitation
1177282|NCT02134444|Gaze control|gaze control
1177283|NCT02134444|Balance|balance
1177284|NCT02134431|HIV|hiv
1177285|NCT02134431|tenofovir|tenofovir
1177286|NCT02134431|miocrobicide|miocrobicide
1177287|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
1177288|NCT02134431|adolescents|adolescents
1177289|NCT02134431|pediatrics|pediatrics
1177290|NCT02134418|Schizophrenia|schizophrenia
1246903|NCT01819987|mother|mother
1177291|NCT02134418|Irony|irony
1177292|NCT02134418|Hemispheric processing|hemispheric processing
1177293|NCT02134418|Theory of mind|theory of mind
1177294|NCT02134405|functional dyspepsia|functional dyspepsia
1177295|NCT02134405|symptoms|symptoms
1177296|NCT02134405|proton pump inhibitor|proton pump inhibitor
1177297|NCT02134405|gastritis|gastritis
1177298|NCT02134392|C-diff|c-diff
1177299|NCT02134392|Clostridium difficile|clostridium difficile
1177300|NCT02134392|Fecal Transplant|fecal transplant
1177301|NCT02134392|FMT|fmt
1177302|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
1177303|NCT02134379|Thoracic Impedance|thoracic impedance
1177304|NCT02134379|Diagnostic Marker|diagnostic marker
1177305|NCT02134379|Bed Rest Test|bed rest test
1177306|NCT02134379|Transthoracic Impedance|transthoracic impedance
1177307|NCT02134379|Heart Failure|heart failure
1177308|NCT02134379|HF|hf
1177309|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
1177310|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
1177311|NCT02134366|Epilepsy|epilepsy
1177312|NCT02134366|Clobazam|clobazam
1177313|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
1177314|NCT02134366|Partial Motor Seizure|partial motor seizure
1177315|NCT02134340|IGF1R|igf1r
1177316|NCT02134314|ESRD (End Stage Renal Disease)|esrd (end stage renal disease)
1177317|NCT02134314|CKD (Chronic Kidney Disease)|ckd (chronic kidney disease)
1177318|NCT02134314|Kidney Transplant|kidney transplant
1177319|NCT02134314|ECD|ecd
1177320|NCT02134314|delayed graft function|delayed graft function
1177321|NCT02134314|chronic kidney disease|chronic kidney disease
1177322|NCT02134314|expanded-criteria donor|expanded-criteria donor
1177323|NCT02134314|end stage renal disease|end stage renal disease
1177324|NCT02134301|oritavancin|oritavancin
1177325|NCT02134301|pediatrics|pediatrics
1177326|NCT02134301|gram positive|gram positive
1177327|NCT02134301|bacterial infection|bacterial infection
1177328|NCT02134301|Confirmed|confirmed
1177329|NCT02134301|Suspected|suspected
1177330|NCT02134288|Dialysis|dialysis
1177331|NCT02134288|Kidney Transplant|kidney transplant
1177332|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
1177333|NCT02134288|Delayed Graft Function|delayed graft function
1177334|NCT02134288|Belatacept|belatacept
1177335|NCT02134275|whole body vibration training|whole body vibration training
1177336|NCT02134275|young adult|young adult
1177337|NCT02134275|weight gain|weight gain
1177338|NCT02134275|obesity|obesity
1177339|NCT02134275|randomized clinical trial|randomized clinical trial
1177340|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
1177341|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
1177342|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
1177343|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
1177344|NCT02134262|Retroviral Vector|retroviral vector
1177345|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
1177346|NCT02134262|Lymphoma|lymphoma
1177347|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
1177348|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1177645|NCT02133053|bitop|bitop
1177350|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
1177351|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1177352|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
1177353|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
1177354|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
1177355|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1177356|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
1177357|NCT02134262|Neoplasms|neoplasms
1177358|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
1177359|NCT02134262|Immune System Diseases|immune system diseases
1177360|NCT02134249|infertility|infertility
1177361|NCT02134249|ICSI|icsi
1177362|NCT02134249|OHSS|ohss
1177363|NCT02134249|Diosmin|diosmin
1177364|NCT02134249|Cabergoline|cabergoline
1177365|NCT02134210|PsO|pso
1177366|NCT02134197|Oncology|oncology
1177367|NCT02134197|Solid tumors|solid tumors
1177368|NCT02134197|Antibody drug conjugate|antibody drug conjugate
1177369|NCT02134197|Maximum tolerated dose|maximum tolerated dose
1177370|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
1177371|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
1177372|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
1177373|NCT02134171|ADAMTS13,|adamts13,
1177374|NCT02134171|troponin,|troponin,
1177375|NCT02134171|plasma exchange.|plasma exchange.
1177376|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
1177377|NCT02134145|Mobile Health|mobile health
1177378|NCT02134145|mHealth|mhealth
1177379|NCT02134145|Technology|technology
1177380|NCT02134132|Platelet gel|platelet gel
1177381|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
1177382|NCT02134132|umbilical cord blood|umbilical cord blood
1177383|NCT02134119|dietary supplement|dietary supplement
1177384|NCT02134119|endurance athletes|endurance athletes
1177385|NCT02134119|VO2max|vo2max
1177386|NCT02134119|red blood cells|red blood cells
1177387|NCT02134106|Multicenter|multicenter
1177388|NCT02134106|Open-label|open-label
1177389|NCT02134106|Randomized|randomized
1177390|NCT02134106|Controlled|controlled
1177391|NCT02134106|RCT|rct
1177392|NCT02134106|antibiotic|antibiotic
1177393|NCT02134106|drug-resistant|drug-resistant
1177394|NCT02134106|Gram-negative|gram-negative
1177395|NCT02134106|bacteria|bacteria
1177396|NCT02134080|Tourette Syndrome|tourette syndrome
1177397|NCT02134080|FAAH-Inhibitor|faah-inhibitor
1177398|NCT02134080|Tics|tics
1177399|NCT02134080|Tic Disorders|tic disorders
1177400|NCT02134067|advanced solid tumors|advanced solid tumors
1177401|NCT02134067|tumor|tumor
1177402|NCT02134067|Dose Escalation|dose escalation
1177403|NCT02134067|TAS-119|tas-119
1177404|NCT02134067|Taxane|taxane
1177405|NCT02134067|Paclitaxel|paclitaxel
1177406|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
1177407|NCT02134067|AurA|aura
1177408|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
1177409|NCT02134054|Biological treatment|biological treatment
1177410|NCT02134054|IBD|ibd
1177411|NCT02134041|traumatic brain injury|traumatic brain injury
1177412|NCT02134041|Alzheimer disease|alzheimer disease
1177413|NCT02134015|Carcinoma|carcinoma
1177414|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
1177415|NCT02134015|Lung Neoplasms|lung neoplasms
1177416|NCT02134015|Bronchogenic|bronchogenic
1177417|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
1177418|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
1177419|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
1177420|NCT02134015|Neoplasms by Site|neoplasms by site
1177421|NCT02134015|Neoplasms|neoplasms
1177422|NCT02134015|Lung Diseases|lung diseases
1177423|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
1177424|NCT02134015|Erlotinib|erlotinib
1177425|NCT02134015|Therapeutic Uses|therapeutic uses
1177426|NCT02134015|Pharmacologic Actions|pharmacologic actions
1177427|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1177428|NCT02134002|cocaine|cocaine
1177429|NCT02134002|disulfiram|disulfiram
1177430|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
1177431|NCT02133989|Carotid stenosis|carotid stenosis
1177432|NCT02133989|Stenting|stenting
1177433|NCT02133989|Clopidogrel resistance|clopidogrel resistance
1177434|NCT02133989|Stroke, ischemic|stroke, ischemic
1177435|NCT02133976|chronic low back pain|chronic low back pain
1177436|NCT02133976|psychosocial interventions|psychosocial interventions
1177437|NCT02133976|mechanisms|mechanisms
1177438|NCT02133963|depression|depression
1177439|NCT02133963|postpartum depression|postpartum depression
1177440|NCT02133963|pregnancy|pregnancy
1177441|NCT02133963|perinatal depression|perinatal depression
1177442|NCT02133963|sleep|sleep
1177443|NCT02133963|life stress|life stress
1177539|NCT02133547|Kartagener Syndrome|kartagener syndrome
1177444|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
1177445|NCT02133950|cryopreservation|cryopreservation
1177446|NCT02133950|pregnancy|pregnancy
1177447|NCT02133924|Graft vs Host Disease|graft vs host disease
1177448|NCT02133924|Graft vs Host Reaction|graft vs host reaction
1177449|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1177450|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1177451|NCT02133924|adverse effects|adverse effects
1177452|NCT02133898|Depression|depression
1177453|NCT02133898|MTHFR|mthfr
1177454|NCT02133898|L-methylfolate|l-methylfolate
1177455|NCT02133885|Resistent Hypertension|resistent hypertension
1177456|NCT02133885|Systolic Blood Pressure|systolic blood pressure
1177457|NCT02133872|Resistent Hypertension|resistent hypertension
1177458|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
1177459|NCT02133820|Healthy Volunteer|healthy volunteer
1177460|NCT02133820|Pharmacokinetics|pharmacokinetics
1177461|NCT02133807|Lipoprotein(a);|lipoprotein(a);
1177462|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
1177463|NCT02133807|Apheresis;|apheresis;
1177464|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
1177465|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
1177466|NCT02133807|Intima-media thickness;|intima-media thickness;
1177467|NCT02133807|Regression;|regression;
1177468|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
1177469|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
1177470|NCT02133807|Virtual Histology;|virtual histology;
1177471|NCT02133807|Plaque;|plaque;
1177472|NCT02133807|Atorvastatin;|atorvastatin;
1177473|NCT02133794|Hip fracture|hip fracture
1177474|NCT02133794|Tomosynthesis|tomosynthesis
1177475|NCT02133794|X-ray|x-ray
1177476|NCT02133794|Emergency room|emergency room
1177477|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
1177478|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
1177479|NCT02133781|Child identical twins|child identical twins
1177480|NCT02133781|Young and elderly adults|young and elderly adults
1177481|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
1573930|NCT00487292|shift work|shift work
1247190|NCT01818596|HIV|hiv
1177482|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
1177483|NCT02133716|pain|pain
1177484|NCT02133716|premature infant|premature infant
1177485|NCT02133716|sucrose|sucrose
1177486|NCT02133716|breastfeeding|breastfeeding
1177487|NCT02133716|expressed breast milk|expressed breast milk
1177488|NCT02133716|PIPP|pipp
1177489|NCT02133703|Genetic counseling|genetic counseling
1177490|NCT02133703|genetic testing|genetic testing
1177491|NCT02133703|BRCA1|brca1
1177492|NCT02133703|BRCA2|brca2
1177493|NCT02133703|Hereditary breast cancer|hereditary breast cancer
1177494|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
1177495|NCT02133690|rotavirus|rotavirus
1177496|NCT02133690|rotavirus vaccine|rotavirus vaccine
1177497|NCT02133690|BRV-PV|brv-pv
1177498|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
1177499|NCT02133664|multiple sclerosis|multiple sclerosis
1177500|NCT02133664|cognition|cognition
1177501|NCT02133664|clinical trial|clinical trial
1177502|NCT02133664|thiotic acid|thiotic acid
1177503|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
1177504|NCT02133651|Clostridium difficile|clostridium difficile
1177505|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
1177506|NCT02133651|Diarrhea|diarrhea
1177507|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
1177508|NCT02133638|Delirium|delirium
1177509|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
1177510|NCT02133638|Propofol|propofol
1177511|NCT02133638|S100b protein|s100b protein
1177512|NCT02133638|Sevoflurane|sevoflurane
1177513|NCT02133625|Advanced solid tumor|advanced solid tumor
1177514|NCT02133625|Metastatic solid tumor|metastatic solid tumor
1177515|NCT02133612|esophageal cancer|esophageal cancer
1177516|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
1177517|NCT02133612|esophageal surgery|esophageal surgery
1177518|NCT02133612|paclitaxel|paclitaxel
1177519|NCT02133612|cisplatin|cisplatin
1177520|NCT02133586|Air pollution|air pollution
1177521|NCT02133586|Ozone|ozone
1177522|NCT02133586|Nitrogen dioxide|nitrogen dioxide
1177523|NCT02133586|Lung function|lung function
1177524|NCT02133586|Cytokines|cytokines
1177525|NCT02133573|progesterone|progesterone
1177526|NCT02133573|congenital heart disease|congenital heart disease
1177527|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
1177528|NCT02133573|brain development|brain development
1177529|NCT02133573|cardiac surgery|cardiac surgery
1177530|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
1177531|NCT02133573|fetus|fetus
1177532|NCT02133573|fetal neuroprotection|fetal neuroprotection
1177533|NCT02133560|Sickle cell|sickle cell
1177534|NCT02133560|Thalassemia|thalassemia
1177535|NCT02133560|Adherence|adherence
1177536|NCT02133547|Nitric Oxide|nitric oxide
1177537|NCT02133547|Nose|nose
1177538|NCT02133547|Healthy Volunteers|healthy volunteers
1177540|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1177541|NCT02133534|Chronic kidney disease|chronic kidney disease
1177542|NCT02133534|High cholesterol|high cholesterol
1177543|NCT02133521|DLBS1033|dlbs1033
1177544|NCT02133521|Acute ischemic stroke|acute ischemic stroke
1177545|NCT02133521|NIHSS|nihss
1177546|NCT02133521|Barthel Index|barthel index
1177646|NCT02133053|Ectoin|ectoin
1177547|NCT02133495|lower eyelid|lower eyelid
1177548|NCT02133495|retraction|retraction
1177549|NCT02133469|Effectiveness|effectiveness
1177550|NCT02133469|Prevenar|prevenar
1177551|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
1177552|NCT02133469|vaccine serotype|vaccine serotype
1177553|NCT02133456|safety|safety
1177554|NCT02133456|influenza vaccine|influenza vaccine
1177555|NCT02133456|post-marketing|post-marketing
1177556|NCT02133443|Mechanical ventilation|mechanical ventilation
1177557|NCT02133443|Acute respiratory failure|acute respiratory failure
1177558|NCT02133443|Weaning|weaning
1177559|NCT02133443|Pressure support ventilation|pressure support ventilation
1177560|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1177561|NCT02133430|Postoperative delirium|postoperative delirium
1177562|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
1177563|NCT02133417|QTUS|qtus
1177564|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
1177565|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
1177566|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
1177567|NCT02133391|Accountable Care Organization|accountable care organization
1177568|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
1177569|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
1177570|NCT02133391|Medicaid|medicaid
1177571|NCT02133391|Reminder Systems/economics|reminder systems/economics
1177572|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
1177573|NCT02133378|Bleeding|bleeding
1177574|NCT02133378|Hemostatic|hemostatic
1177575|NCT02133352|pulmonary hypertension|pulmonary hypertension
1177576|NCT02133352|diastolic dyfunction|diastolic dyfunction
1177577|NCT02133326|Analgesia|analgesia
1177578|NCT02133326|Third Molar Extraction|third molar extraction
1177579|NCT02133326|Ibuprofen|ibuprofen
1177580|NCT02133326|Acetaminophen|acetaminophen
1177581|NCT02133326|Pain Medicine|pain medicine
1177582|NCT02133326|Nonsteroidal|nonsteroidal
1177583|NCT02133326|Anti-inflammatory|anti-inflammatory
1177584|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
1177585|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
1177586|NCT02133313|Glucose Transporters|glucose transporters
1177587|NCT02133274|Neoplasms|neoplasms
1177588|NCT02133274|Early Palliative Care|early palliative care
1177589|NCT02133274|Psychosocial Intervention|psychosocial intervention
1177590|NCT02133274|Symptoms|symptoms
1177591|NCT02133274|Quality of life|quality of life
1177592|NCT02133274|Depression|depression
1177593|NCT02133248|donor specific antibodies|donor specific antibodies
1177594|NCT02133248|B cells|b cells
1177595|NCT02133248|antibody mediated rejection|antibody mediated rejection
1177596|NCT02133248|kidney transplant|kidney transplant
1177597|NCT02133248|desensitization|desensitization
1177598|NCT02133235|endobronchial blocker|endobronchial blocker
1177599|NCT02133235|lung separation|lung separation
1177600|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
1177601|NCT02133209|migraine|migraine
1177602|NCT02133209|headache|headache
1177603|NCT02133209|meditation|meditation
1177604|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
1177605|NCT02133209|MBSR|mbsr
1177606|NCT02133196|Metastatic|metastatic
1177607|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
1177608|NCT02133196|NSCLC|nsclc
1177609|NCT02133196|Lung Cancer|lung cancer
1177610|NCT02133170|BIPOLAR DISORDER|bipolar disorder
1177611|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
1177612|NCT02133170|MINDFULNESS|mindfulness
1177613|NCT02133170|PSYCHOEDUCATION|psychoeducation
1177614|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
1177615|NCT02133157|tumor|tumor
1177616|NCT02133144|NAFLD|nafld
1177617|NCT02133144|insulin resistance|insulin resistance
1177618|NCT02133144|metabolic syndrome|metabolic syndrome
1177619|NCT02133144|de novo lipogenesis|de novo lipogenesis
1177620|NCT02133144|overfeeding|overfeeding
1177621|NCT02133118|Type 2 diabetes|type 2 diabetes
1177622|NCT02133118|New-user design|new-user design
1177623|NCT02133118|Weight trajectory|weight trajectory
1177624|NCT02133118|Add-on therapy|add-on therapy
1177625|NCT02133118|Sulphonylureas.|sulphonylureas.
1177626|NCT02133105|Heart failure|heart failure
1177627|NCT02133105|Renal failure|renal failure
1177628|NCT02133105|Inotropic drugs|inotropic drugs
1177629|NCT02133105|Levosimendan|levosimendan
1177630|NCT02133105|Dobutamine|dobutamine
1177631|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
1177632|NCT02133092|RSV|rsv
1177633|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
1177634|NCT02133092|LRTI|lrti
1177635|NCT02133092|Acute respiratory infection|acute respiratory infection
1177940|NCT02131610|T cells|t cells
1177636|NCT02133092|Belgian children|belgian children
1177637|NCT02133066|Ultrasound|ultrasound
1177638|NCT02133066|Lumbar Puncture|lumbar puncture
1177639|NCT02133066|Spinal Tap|spinal tap
1177640|NCT02133066|Pediatric|pediatric
1177641|NCT02133066|Infant|infant
1177642|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
1177643|NCT02133053|Allergic Rhinitis|allergic rhinitis
1177644|NCT02133053|Ectoine|ectoine
1177647|NCT02133040|Brown Adipose Tissue|brown adipose tissue
1177648|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1177649|NCT02133014|pancreatitis|pancreatitis
1177650|NCT02133014|laparoscopic|laparoscopic
1177651|NCT02133014|drainage|drainage
1177652|NCT02133014|surgery|surgery
1177653|NCT02133001|Major Depressive Disorder|major depressive disorder
1177654|NCT02133001|Esketamine|esketamine
1177655|NCT02133001|Intranasal esketamine|intranasal esketamine
1177656|NCT02133001|Placebo|placebo
1177657|NCT02132975|prostate|prostate
1177658|NCT02132975|cancer|cancer
1177659|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
1177660|NCT02132923|RSV|rsv
1177661|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
1177662|NCT02132923|LRTI|lrti
1177663|NCT02132923|Acute respiratory infection|acute respiratory infection
1177664|NCT02132923|Japanese children|japanese children
1177665|NCT02132897|Antiepileptic|antiepileptic
1177666|NCT02132897|Carbamazepine|carbamazepine
1177667|NCT02132897|Bio-equivalence|bio-equivalence
1177668|NCT02132897|Fed|fed
1177669|NCT02132897|Crossover|crossover
1177670|NCT02132832|marijuana|marijuana
1177671|NCT02132832|attentional bias|attentional bias
1177672|NCT02132832|stress|stress
1177673|NCT02132832|buspirone|buspirone
1177674|NCT02132819|transfusion|transfusion
1177675|NCT02132819|feeding|feeding
1177676|NCT02132819|TRAGI|tragi
1177677|NCT02132819|NEC|nec
1177678|NCT02132806|class II furcation involvement|class ii furcation involvement
1177679|NCT02132806|piezoelectric surgery|piezoelectric surgery
1177680|NCT02132806|regeneration|regeneration
1177681|NCT02132806|biomaterial|biomaterial
1177682|NCT02132793|technology|technology
1177683|NCT02132793|mobile|mobile
1177684|NCT02132793|anger management|anger management
1177685|NCT02132793|anger|anger
1177686|NCT02132793|PTSD|ptsd
1177687|NCT02132793|veterans|veterans
1177688|NCT02132767|Heart surgery|heart surgery
1177689|NCT02132767|Cardiac surgery|cardiac surgery
1177690|NCT02132767|Coronary artery bypass|coronary artery bypass
1177691|NCT02132767|Mitral valve surgery|mitral valve surgery
1177692|NCT02132767|Aortic valve surgery|aortic valve surgery
1177693|NCT02132767|Atrial fibrillation|atrial fibrillation
1177694|NCT02132767|Atrial flutter|atrial flutter
1177695|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
1177696|NCT02132767|Valve surgery|valve surgery
1177697|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
1177698|NCT02132728|flaxseed|flaxseed
1177699|NCT02132728|lignans|lignans
1177700|NCT02132728|inflammation|inflammation
1177701|NCT02132728|Nutrition|nutrition
1177702|NCT02132728|enterolactone|enterolactone
1177703|NCT02132728|enterodiol|enterodiol
1177704|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
1177705|NCT02132676|Self-Management|self-management
1177706|NCT02132676|Patient Care Management|patient care management
1177707|NCT02132676|Peer Group|peer group
1177708|NCT02132676|Disease Management|disease management
1177709|NCT02132676|Health Plan Implementation|health plan implementation
1177710|NCT02132676|Diabetes Mellitus|diabetes mellitus
1177711|NCT02132650|Rehabilitation|rehabilitation
1177712|NCT02132650|Walking|walking
1177713|NCT02132650|Motor skills disorders|motor skills disorders
1177714|NCT02132650|Electromyography|electromyography
1177715|NCT02132598|Lung Cancer|lung cancer
1177716|NCT02132598|Non Small Cell|non small cell
1177717|NCT02132598|Brain metastases|brain metastases
1177718|NCT02132598|c-MET|c-met
1177719|NCT02132520|Hemiparesis|hemiparesis
1177720|NCT02132520|Stroke|stroke
1177721|NCT02132520|Rehabilitation|rehabilitation
1177722|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1177723|NCT02132520|Electroencephalography|electroencephalography
1177724|NCT02132520|Functional Neuroimaging|functional neuroimaging
1177725|NCT02132520|Brain-Computer Interface|brain-computer interface
1177726|NCT02132507|epilepsy|epilepsy
1177727|NCT02132507|fMRI|fmri
1177728|NCT02132507|EEG|eeg
1177729|NCT02132507|ICA|ica
1177730|NCT02132481|Smartphones|smartphones
1177731|NCT02132481|Mobile phones|mobile phones
1177732|NCT02132481|Substance use disorder|substance use disorder
1177733|NCT02132481|Recovery Support Services|recovery support services
1177734|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
1177735|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
1177736|NCT02132481|Randomized field experiment|randomized field experiment
1177737|NCT02132481|Effectiveness|effectiveness
1177738|NCT02132481|Post-Discharge|post-discharge
1177739|NCT02132468|PNET|pnet
1177740|NCT02132468|GI-NET|gi-net
1177741|NCT02132468|neuroendocrine|neuroendocrine
1177742|NCT02132468|carcinoid|carcinoid
1177743|NCT02132455|Screening colonoscopy|screening colonoscopy
1177744|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
1177745|NCT02132442|Children|children
1177746|NCT02132442|Adolescents|adolescents
1177747|NCT02132442|Adults|adults
1177748|NCT02132442|Type 2 diabetes|type 2 diabetes
1177749|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1177750|NCT02132442|Vitamin D deficiency|vitamin d deficiency
1177752|NCT02132416|Prospective study|prospective study
1177753|NCT02132416|Surgical management|surgical management
1177754|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
1177755|NCT02132416|Trauma|trauma
1177756|NCT02132416|Ventilator support|ventilator support
1177757|NCT02132403|pancreatic cancer|pancreatic cancer
1177758|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
1177759|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
1177760|NCT02132403|locally advanced|locally advanced
1177761|NCT02132403|recurrent|recurrent
1177762|NCT02132403|metastatic|metastatic
1177763|NCT02132390|Breast cancer|breast cancer
1177764|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
1177765|NCT02132390|Goserelin|goserelin
1177766|NCT02132364|stroke|stroke
1177767|NCT02132364|hypertension|hypertension
1177768|NCT02132364|secondary prevention|secondary prevention
1177769|NCT02132364|educational program|educational program
1177770|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1177771|NCT02132338|Prevention|prevention
1177772|NCT02132338|Health Education|health education
1177773|NCT02132325|Pancreatic Cancer|pancreatic cancer
1177774|NCT02132325|Dignity Therapy|dignity therapy
1177775|NCT02132325|Palliative Care|palliative care
1177776|NCT02132325|Advanced Lung Cancer|advanced lung cancer
1177777|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1177778|NCT02132312|Cataract|cataract
1177779|NCT02132312|Lens replacement|lens replacement
1177780|NCT02132312|pediatric|pediatric
1177781|NCT02132299|Malaria|malaria
1177782|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
1177783|NCT02132299|PfSPZ Vaccine|pfspz vaccine
1177784|NCT02132299|PfSPZ Challenge|pfspz challenge
1177785|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
1177786|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
1177787|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
1177788|NCT02132286|Amygdala|amygdala
1177789|NCT02132286|Antidepressant|antidepressant
1177790|NCT02132286|Quetiapine|quetiapine
1177791|NCT02132286|Citalopram|citalopram
1177792|NCT02132286|imaging biomarker|imaging biomarker
1177793|NCT02132260|Naftifine|naftifine
1177794|NCT02132260|Naftin®|naftin®
1177795|NCT02132260|Tinea pedis|tinea pedis
1177796|NCT02132247|Minor athletic injuries|minor athletic injuries
1177797|NCT02132247|Pain|pain
1177798|NCT02132247|Diclofenac|diclofenac
1177799|NCT02132247|Topical|topical
1177800|NCT02132221|Chronic non cancer pain|chronic non cancer pain
1177801|NCT02132221|Long term opioid therapy|long term opioid therapy
1177802|NCT02132221|Side effects|side effects
1177803|NCT02132221|risks|risks
1177804|NCT02132221|function|function
1177805|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
1177806|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
1177807|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1177808|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
1177809|NCT02132143|Progression-free survival|progression-free survival
1177810|NCT02132130|gene therapy|gene therapy
1177811|NCT02132130|unilateral hearing loss|unilateral hearing loss
1177812|NCT02132130|bilateral hearing loss|bilateral hearing loss
1177813|NCT02132130|balance|balance
1177814|NCT02132130|vestibular|vestibular
1177815|NCT02132130|cochlear implant|cochlear implant
1177816|NCT02132130|hearing restoration|hearing restoration
1177817|NCT02132104|Intrauterine adhesions|intrauterine adhesions
1177818|NCT02132104|Asherman Syndrome|asherman syndrome
1177819|NCT02132104|Amnion graft|amnion graft
1177820|NCT02132091|Sirtuins|sirtuins
1177821|NCT02132091|Calorie Restriction|calorie restriction
1177822|NCT02132091|Intermittent Fasting|intermittent fasting
1177823|NCT02132091|Antioxidant|antioxidant
1177824|NCT02132091|Aging|aging
1177825|NCT02132091|Metabolism|metabolism
1177826|NCT02132091|Mitochondria|mitochondria
1177827|NCT02132091|Oxidative Stress|oxidative stress
1177828|NCT02132078|Lung transplant recipients|lung transplant recipients
1177829|NCT02132078|diverticulitis|diverticulitis
1177830|NCT02132078|immunosuppression|immunosuppression
1177831|NCT02132052|Essential Tremor|essential tremor
1177832|NCT02132052|Multiple System Atrophy|multiple system atrophy
1177833|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
1177834|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
1177835|NCT02132052|Parkinson's Disease|parkinson's disease
1177837|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
1177838|NCT02132026|Aortic Stenosis|aortic stenosis
1177839|NCT02132026|Denosumab|denosumab
1177840|NCT02132026|Alendronic Acid|alendronic acid
1177841|NCT02132026|Osteoporosis|osteoporosis
1177842|NCT02131987|Dislocation|dislocation
1177843|NCT02131987|Hemiarthroplasty|hemiarthroplasty
1177844|NCT02131987|Femoral neck fracture|femoral neck fracture
1177845|NCT02131987|Femoral offset|femoral offset
1177846|NCT02131987|Leg length difference|leg length difference
1177847|NCT02131987|Wiberg angle|wiberg angle
1177848|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
1177849|NCT02131961|diabetic foot|diabetic foot
1177850|NCT02131961|foot ulcer|foot ulcer
1177851|NCT02131961|foot wound|foot wound
1177852|NCT02131961|plantar ulcer|plantar ulcer
1177853|NCT02131961|plantar wound|plantar wound
1177854|NCT02131961|contact cast|contact cast
1177855|NCT02131961|collagenase|collagenase
1177856|NCT02131948|Insulin resistance|insulin resistance
1177857|NCT02131948|Brain insulin action|brain insulin action
1177858|NCT02131948|Type 2 Diabetes|type 2 diabetes
1177859|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
1177860|NCT02131909|children|children
1177861|NCT02131909|upper-limb|upper-limb
1177862|NCT02131909|mirror therapy|mirror therapy
1177863|NCT02131909|bimanual coordination|bimanual coordination
1177864|NCT02131909|kinematics analysis|kinematics analysis
1177865|NCT02131896|Type 1 Diabetes|type 1 diabetes
1177866|NCT02131896|Newly diagnosed|newly diagnosed
1177867|NCT02131896|Lipid profile|lipid profile
1177868|NCT02131896|Mediterranean diet|mediterranean diet
1177869|NCT02131883|Health Anxiety|health anxiety
1177870|NCT02131883|Hypochondriasis|hypochondriasis
1177871|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
1177872|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
1177873|NCT02131883|Personality Disorders|personality disorders
1177874|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
1177875|NCT02131883|Group-CBT|group-cbt
1177876|NCT02131883|Illness Perception|illness perception
1177877|NCT02131883|Cost-effectiveness|cost-effectiveness
1177878|NCT02131870|iron absorption|iron absorption
1177879|NCT02131870|healthy females|healthy females
1177880|NCT02131870|child bearing age|child bearing age
1177881|NCT02131857|Mindfulness|mindfulness
1177882|NCT02131857|stress reduction|stress reduction
1177883|NCT02131844|colorectal surgery|colorectal surgery
1177884|NCT02131844|postoperative recovery|postoperative recovery
1177885|NCT02131844|early mobilization|early mobilization
1177886|NCT02131831|telomere|telomere
1177887|NCT02131831|telomerase|telomerase
1177888|NCT02131831|cirrhosis|cirrhosis
1177889|NCT02131818|amoxicillin|amoxicillin
1177890|NCT02131818|postpartum infections|postpartum infections
1177891|NCT02131818|puerperal infection|puerperal infection
1177892|NCT02131805|skin|skin
1177893|NCT02131805|Brachytherapy|brachytherapy
1177894|NCT02131805|14-001|14-001
1177895|NCT02131779|prostate cancer disparities|prostate cancer disparities
1177896|NCT02131779|African American|african american
1177897|NCT02131779|Spiritually based intervention|spiritually based intervention
1177898|NCT02131779|Men's Health|men's health
1177899|NCT02131779|Informed Decision Making|informed decision making
1177900|NCT02131779|Community Based Participatory Research|community based participatory research
1177901|NCT02131779|Health Communication|health communication
1177902|NCT02131779|Health Information Technology|health information technology
1177903|NCT02131779|Community Health Advisors|community health advisors
1177904|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1177905|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
1177906|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1177907|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
1177908|NCT02131753|hairy cell leukemia|hairy cell leukemia
1177909|NCT02131753|untreated|untreated
1177910|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
1177911|NCT02131740|corneal|corneal
1177912|NCT02131740|eye rubbing|eye rubbing
1177913|NCT02131727|hand hygiene|hand hygiene
1177914|NCT02131727|communicable diseases|communicable diseases
1177915|NCT02131727|respiratory tract infections|respiratory tract infections
1177916|NCT02131727|primary prevention|primary prevention
1177917|NCT02131727|employees|employees
1177918|NCT02131714|pressure pain threshold|pressure pain threshold
1177919|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
1177920|NCT02131714|therapeutic exercise|therapeutic exercise
1177921|NCT02131714|conservative treatment|conservative treatment
1177922|NCT02131714|facial pain|facial pain
1177923|NCT02131701|Physical fitness|physical fitness
1177924|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
1177925|NCT02131701|Prescription of exercise|prescription of exercise
1177926|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
1177927|NCT02131675|C-peptide|c-peptide
1177928|NCT02131675|type 1 diabetes|type 1 diabetes
1177929|NCT02131662|Uterine fibroids|uterine fibroids
1177930|NCT02131649|Prostate Cancer|prostate cancer
1177931|NCT02131649|PET|pet
1177932|NCT02131649|MRI|mri
1177933|NCT02131649|Fluorocholine|fluorocholine
1177934|NCT02131649|Radiotherapy|radiotherapy
1177935|NCT02131649|Prostatectomy|prostatectomy
1177936|NCT02131610|Sleep apnea|sleep apnea
1177937|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
1177938|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
1177939|NCT02131610|Epigenetics|epigenetics
1177941|NCT02131597|Leukemia|leukemia
1177942|NCT02131597|Myelodysplastic syndrome|myelodysplastic syndrome
1177943|NCT02131597|MDS|mds
1177944|NCT02131597|Higher risk|higher risk
1177945|NCT02131597|SGI-110|sgi-110
1177946|NCT02131584|Leukemia|leukemia
1177947|NCT02131584|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1177948|NCT02131584|CLL|cll
1177950|NCT02131584|Brief Fatigue Inventory|brief fatigue inventory
1177951|NCT02131584|BFI|bfi
1177952|NCT02131584|Questionnaires|questionnaires
1177953|NCT02131584|Surveys|surveys
1177954|NCT02131584|Ruxolitinib|ruxolitinib
1177955|NCT02131584|Jakafi|jakafi
1177956|NCT02131584|INCB018424|incb018424
1177957|NCT02131584|INC424|inc424
1177958|NCT02131571|HIV|hiv
1177959|NCT02131571|bone|bone
1177960|NCT02131571|fractures|fractures
1177961|NCT02131571|vitamin D|vitamin d
1177962|NCT02131571|biomarkers|biomarkers
1177963|NCT02131558|Endometrial cancer|endometrial cancer
1177964|NCT02131558|Sentinel lymph node|sentinel lymph node
1177965|NCT02131558|Indocyanine green|indocyanine green
1177966|NCT02131558|Near infrared imaging|near infrared imaging
1177967|NCT02131545|quetiapine|quetiapine
1177968|NCT02131545|pharmacokinetics|pharmacokinetics
1177969|NCT02131545|dementia|dementia
1177970|NCT02131545|delirium|delirium
1177971|NCT02131545|palliative care|palliative care
1177972|NCT02131532|Post-stroke fatigue|post-stroke fatigue
1177973|NCT02131532|Psychological intervention|psychological intervention
1177974|NCT02131532|Feasibility|feasibility
1177975|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
1177976|NCT02131506|pretreated breast cancer|pretreated breast cancer
1177977|NCT02131506|advanced disease|advanced disease
1573931|NCT00487292|sleepiness|sleepiness
1177978|NCT02131454|asthma and COPD treatment|asthma and copd treatment
1177979|NCT02131454|inhalation techniques|inhalation techniques
1177980|NCT02131454|training of inhalation|training of inhalation
1177981|NCT02131428|Heart Failure|heart failure
1177982|NCT02131428|Depression|depression
1177983|NCT02131428|BNP|bnp
1177984|NCT02131415|schizophrenia|schizophrenia
1177985|NCT02131415|real-life|real-life
1177986|NCT02131415|long-acting injectable|long-acting injectable
1177987|NCT02131415|Reliam|reliam
1177988|NCT02131389|Hip|hip
1177989|NCT02131389|Arthroplasty|arthroplasty
1177990|NCT02131389|Arthroplasties|arthroplasties
1177991|NCT02131389|Prosthesis|prosthesis
1177992|NCT02131389|Iconacy|iconacy
1177993|NCT02131389|Osteoarthritis|osteoarthritis
1177994|NCT02131389|Arthritis|arthritis
1177995|NCT02131389|THA|tha
1177996|NCT02131389|THR|thr
1177997|NCT02131389|DJD|djd
1177998|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
1177999|NCT02131376|partial nephrectomy|partial nephrectomy
1178000|NCT02131376|kidney function test|kidney function test
1178001|NCT02131376|robotics|robotics
1178002|NCT02131324|Psoriasis|psoriasis
1178003|NCT02131311|single use|single use
1178004|NCT02131311|disposable|disposable
1178005|NCT02131311|pessary|pessary
1178006|NCT02131311|stress urinary incontinence|stress urinary incontinence
1178007|NCT02131311|sui|sui
1178008|NCT02131298|Palbociclib|palbociclib
1178009|NCT02131298|Itraconazole|itraconazole
1178010|NCT02131298|Pharmacokinetics|pharmacokinetics
1178011|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
1178012|NCT02131298|Healthy Volunteers|healthy volunteers
1178013|NCT02131285|Rehabilitation,|rehabilitation,
1178014|NCT02131285|Balance,|balance,
1178015|NCT02131285|Sensory strategies,|sensory strategies,
1178016|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
1178017|NCT02131285|Postural control|postural control
1178018|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
1178019|NCT02131194|Cataract|cataract
1178020|NCT02131194|Nutritional Supplement|nutritional supplement
1178021|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
1178022|NCT02131142|ischemic heart disease|ischemic heart disease
1178023|NCT02131142|CAD|cad
1178024|NCT02131129|schizophrenia|schizophrenia
1178025|NCT02131129|schizophreniform disorder|schizophreniform disorder
1178026|NCT02131129|schizoaffective disorder|schizoaffective disorder
1178027|NCT02131129|first episode|first episode
1178028|NCT02131129|psychosis|psychosis
1178029|NCT02131129|cognition|cognition
1178030|NCT02131116|schizophrenia|schizophrenia
1178031|NCT02131116|schizophreniform disorder|schizophreniform disorder
1178032|NCT02131116|schizoaffective disorder|schizoaffective disorder
1178033|NCT02131116|cognition|cognition
1178034|NCT02131116|metacognition|metacognition
1178035|NCT02131116|insight|insight
1178036|NCT02131116|first episode psychosis|first episode psychosis
1178037|NCT02131116|psychosis|psychosis
1178038|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
1178039|NCT02131090|Epidural|epidural
1178040|NCT02131090|Catheter|catheter
1178041|NCT02131090|Fixation|fixation
1178042|NCT02131090|Device|device
1178043|NCT02131090|Intrapartum|intrapartum
1178044|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
1178045|NCT02131051|ectoine|ectoine
1178046|NCT02131051|allergic rhinitis|allergic rhinitis
1178047|NCT02131051|bitop|bitop
1178048|NCT02131038|Ectoine|ectoine
1178049|NCT02131038|bitop|bitop
1178050|NCT02131038|Allergic Rhinitis|allergic rhinitis
1178051|NCT02131012|Macular edema|macular edema
1178052|NCT02130999|Non-24|non-24
1178053|NCT02130999|absolute bioavailability|absolute bioavailability
1178054|NCT02130999|tasimelteon|tasimelteon
1178055|NCT02130999|Hetlioz™|hetlioz™
1178056|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
1178057|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
1178058|NCT02130986|antibiotic exposure|antibiotic exposure
1178059|NCT02130986|antibiotic decision making|antibiotic decision making
1178060|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
1178061|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
1178062|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
1178063|NCT02130986|acute bronchitis|acute bronchitis
1178064|NCT02130986|procalcitonin guideline|procalcitonin guideline
1178065|NCT02130973|teriparatide|teriparatide
1178066|NCT02130973|Forteo|forteo
1178067|NCT02130973|Denosumab|denosumab
1178068|NCT02130973|Prolia|prolia
1178069|NCT02130973|bone density|bone density
1178070|NCT02130973|treatment|treatment
1178072|NCT02130960|Reliability|reliability
1178073|NCT02130960|Obese|obese
1178074|NCT02130960|Energy Expenditure|energy expenditure
1178075|NCT02130960|Resting Energy Expenditure|resting energy expenditure
1178076|NCT02130960|Resting Metabolic Rate|resting metabolic rate
1178077|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1178078|NCT02130947|Prostate Cancer|prostate cancer
1178079|NCT02130947|mCRPC|mcrpc
1178080|NCT02130947|Pilot Study|pilot study
1178081|NCT02130947|UNC Lineberger|unc lineberger
1178082|NCT02130947|Exercise|exercise
1178083|NCT02130934|Childhood cancer|childhood cancer
1178084|NCT02130934|anthracyclines|anthracyclines
1178085|NCT02130934|cardiotoxicity|cardiotoxicity
1178086|NCT02130934|cardiac MRI|cardiac mri
1178087|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
1178088|NCT02130934|Ventricular function|ventricular function
1178089|NCT02130921|Stigma|stigma
1178090|NCT02130921|HIV|hiv
1178091|NCT02130921|CHWs|chws
1178092|NCT02130921|PLH|plh
1178093|NCT02130921|Injecting Drug Users|injecting drug users
1178094|NCT02130921|FM|fm
1178095|NCT02130895|prescribing|prescribing
1178096|NCT02130895|STOPP Criteria|stopp criteria
1178097|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
1178098|NCT02130895|clinical decision support|clinical decision support
1178099|NCT02130895|Electronic Medical Records|electronic medical records
1178100|NCT02130895|primary care|primary care
1178101|NCT02130882|Interleukin-5|interleukin-5
1178102|NCT02130882|Monoclonal Antibody|monoclonal antibody
1178103|NCT02130882|Treatment|treatment
1178104|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
1178105|NCT02130869|Natural killer cells|natural killer cells
1178106|NCT02130856|Neonatal mortality|neonatal mortality
1178107|NCT02130856|Neonatal kit|neonatal kit
1178108|NCT02130856|Pakistan|pakistan
1178109|NCT02130856|Randomized Control Trial|randomized control trial
1178110|NCT02130856|Chlorhexidine|chlorhexidine
1178111|NCT02130856|ThermoSpot|thermospot
1178112|NCT02130856|Birth|birth
1178113|NCT02130843|URINARY INCONTINENCE|urinary incontinence
1178114|NCT02130843|URODYNAMICS|urodynamics
1178115|NCT02130843|URINARY RETENTION|urinary retention
1178116|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
1178117|NCT02130830|hemorrhoids|hemorrhoids
1178118|NCT02130830|Rubber band ligation|rubber band ligation
1178119|NCT02130830|pain|pain
1178120|NCT02130817|Renal Transplant|renal transplant
1178121|NCT02130817|Kidney Transplant|kidney transplant
1178122|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
1178123|NCT02130817|Delayed Graft Function|delayed graft function
1178124|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
1178125|NCT02130804|Obesity|obesity
1178126|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
1178127|NCT02130804|Salsalate|salsalate
1178128|NCT02130804|Hispanics|hispanics
1178129|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
1178130|NCT02130765|Ischemic|ischemic
1178131|NCT02130765|Non-ischemic|non-ischemic
1178132|NCT02130765|Catheter Ablation|catheter ablation
1178133|NCT02130752|Stomach Neoplasms|stomach neoplasms
1178134|NCT02130752|Operative Time|operative time
1178135|NCT02130752|Gastrectomy|gastrectomy
1178136|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
1178137|NCT02130752|Mortality|mortality
1178138|NCT02130752|Morbidity|morbidity
1178139|NCT02130739|Anesthesia|anesthesia
1178140|NCT02130739|Epidural|epidural
1178141|NCT02130739|Thoracic Nerves|thoracic nerves
1178142|NCT02130739|Horner syndrome|horner syndrome
1178143|NCT02130726|Gastric cancer|gastric cancer
1178144|NCT02130726|Minimally-invasive|minimally-invasive
1178145|NCT02130726|Oncological quality of resection|oncological quality of resection
1178146|NCT02130700|mCRPC|mcrpc
1178147|NCT02130700|metastatic|metastatic
1178539|NCT02129296|Tolerance|tolerance
1178148|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
1178149|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1178150|NCT02130687|Hypertension|hypertension
1178151|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
1178152|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
1178153|NCT02130687|Sitagliptin|sitagliptin
1178154|NCT02130687|Aprepitant|aprepitant
1178155|NCT02130687|Ramipril|ramipril
1178156|NCT02130674|traumatic brain injury|traumatic brain injury
1178157|NCT02130674|glutamine|glutamine
1178158|NCT02130674|microdialysis|microdialysis
1178159|NCT02130674|metabolism|metabolism
1178160|NCT02130661|drug interaction|drug interaction
1178161|NCT02130661|healthy volunteer|healthy volunteer
1178162|NCT02130661|rilapladib|rilapladib
1178163|NCT02130661|SB-659032|sb-659032
1178164|NCT02130661|Alzheimer's disease|alzheimer's disease
1178165|NCT02130661|itraconazole|itraconazole
1178166|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
1178167|NCT02130648|Cystic Fibrosis|cystic fibrosis
1178168|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
1178170|NCT02130635|Pharmacodynamics|pharmacodynamics
1178171|NCT02130635|dry powder inhaler|dry powder inhaler
1178172|NCT02130635|GSK2269557|gsk2269557
1178173|NCT02130635|safety|safety
1178174|NCT02130635|COPD subjects|copd subjects
1178175|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
1178176|NCT02130622|Promethazine|promethazine
1178177|NCT02130570|Adverse events|adverse events
1178178|NCT02130570|Readmissions|readmissions
1178179|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
1178180|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
1178181|NCT02130570|Medication reconciliation|medication reconciliation
1178182|NCT02130570|Discharge Advocate|discharge advocate
1178183|NCT02130570|Patient engagement|patient engagement
1178184|NCT02130570|Transitions of care|transitions of care
1178185|NCT02130570|Transitions coach|transitions coach
1178186|NCT02130570|Pharmacist intervention|pharmacist intervention
1178187|NCT02130557|Leukemia|leukemia
1178188|NCT02130557|Myelogenous|myelogenous
1178189|NCT02130557|Chronic|chronic
1178190|NCT02130557|BCR-ABL Positive|bcr-abl positive
1178191|NCT02130557|Bosutinib|bosutinib
1178192|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
1178193|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1178194|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
1178195|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
1178196|NCT02130557|Bone Marrow Diseases|bone marrow diseases
1178197|NCT02130557|Hematologic Diseases|hematologic diseases
1178198|NCT02130557|Translocation, Genetic|translocation, genetic
1178199|NCT02130557|Pathologic Processes|pathologic processes
1178200|NCT02130557|Imatinib|imatinib
1178201|NCT02130557|Therapeutic Uses|therapeutic uses
1178202|NCT02130557|Pharmacologic Actions|pharmacologic actions
1178203|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1178204|NCT02130466|PD1|pd1
1178205|NCT02130466|PD-1|pd-1
1178206|NCT02130466|PDL1|pdl1
1178207|NCT02130466|PD-L1|pd-l1
1178208|NCT02130453|Ischemia|ischemia
1178209|NCT02130453|Coronary artery disease|coronary artery disease
1178210|NCT02130453|Nuclear stress test|nuclear stress test
1178211|NCT02130453|Stress Echocardiogram|stress echocardiogram
1178212|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
1178213|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
1178214|NCT02130453|ReSTE|reste
1178215|NCT02130453|SPECT|spect
1178216|NCT02130453|Regadenoson|regadenoson
1178217|NCT02130440|nasal obstruction|nasal obstruction
1178218|NCT02130440|sneezing|sneezing
1178219|NCT02130440|itching|itching
1178220|NCT02130440|rhinorrhea|rhinorrhea
1178221|NCT02130440|respiratory infections|respiratory infections
1178222|NCT02130440|wheezing|wheezing
1178223|NCT02130427|Adult subjects|adult subjects
1178224|NCT02130427|NSCLC|nsclc
1178225|NCT02130414|Cyclosporine|cyclosporine
1178226|NCT02130414|Healthy Volunteers|healthy volunteers
1178227|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
1178228|NCT02130414|CyCol|cycol
1178229|NCT02130414|Pharmacokinetics|pharmacokinetics
1178230|NCT02130401|neuromodulation|neuromodulation
1178231|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
1178232|NCT02130401|Type 2 Diabetes|type 2 diabetes
1178233|NCT02130362|Adalimumab|adalimumab
1178234|NCT02130362|Crohn's|crohn's
1178235|NCT02130362|Crohn's Disease|crohn's disease
1178236|NCT02130362|Registry|registry
1178237|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
1178238|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
1178239|NCT02130349|IBD|ibd
1178240|NCT02130349|Crohns Disease|crohns disease
1178241|NCT02130349|Ulcerative Colitis|ulcerative colitis
1178242|NCT02130349|Cohort|cohort
1178243|NCT02130349|Biobank|biobank
1178244|NCT02130349|Population based|population based
1178245|NCT02130349|IBDSL|ibdsl
1178246|NCT02130336|Metabolic syndrome|metabolic syndrome
1178247|NCT02130336|Metabolic risk factors|metabolic risk factors
1178248|NCT02130336|High-intensity interval training|high-intensity interval training
1178249|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
1178250|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
1178251|NCT02130310|Chronic ulcers|chronic ulcers
1178252|NCT02130310|Venous ulcers|venous ulcers
1178253|NCT02130297|Mohs|mohs
1178254|NCT02130297|scar|scar
1178255|NCT02130297|post excision|post excision
1178256|NCT02130297|CO2 laser|co2 laser
1178257|NCT02130297|laser|laser
1178258|NCT02130297|skin cancer|skin cancer
1178259|NCT02130297|resurfacing|resurfacing
1178260|NCT02130271|Sciatica|sciatica
1178261|NCT02130271|PET scan|pet scan
1178263|NCT02130271|Inflammation|inflammation
1178264|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
1178265|NCT02130258|Radicular|radicular
1178266|NCT02130258|Pain|pain
1178267|NCT02130258|Epidural Steroid Injection|epidural steroid injection
1178268|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1178269|NCT02130245|Acute cholecystitis|acute cholecystitis
1178270|NCT02130245|Early|early
1178271|NCT02130245|Delayed|delayed
1178272|NCT02130232|Gestational weight gain|gestational weight gain
1178273|NCT02130232|Lifestyle|lifestyle
1178274|NCT02130232|Intervention|intervention
1178275|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
1178276|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
1178277|NCT02130193|Efficacy|efficacy
1178278|NCT02130193|Danirixin|danirixin
1178279|NCT02130193|EXACT-PRO|exact-pro
1178280|NCT02130193|COPD|copd
1178281|NCT02130193|Safety|safety
1178282|NCT02130193|RD|rd
1178283|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
1178284|NCT02130193|EXACT-RS|exact-rs
1178286|NCT02130193|HCRU exacerbations|hcru exacerbations
1178287|NCT02130193|PD|pd
1178288|NCT02130167|Myopia progression|myopia progression
1178289|NCT02130167|Low concentration atropine|low concentration atropine
1178290|NCT02130154|Brown adipose Tissue|brown adipose tissue
1178291|NCT02130154|Ageing|ageing
1178292|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
1178293|NCT02130154|Obesity|obesity
1178294|NCT02130141|cocoa|cocoa
1178295|NCT02130141|dark chocolate|dark chocolate
1178296|NCT02130141|hypertension|hypertension
1178297|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
1178298|NCT02130141|flavanols|flavanols
1178299|NCT02130102|technology acceptance|technology acceptance
1178300|NCT02130102|ambient assisted living|ambient assisted living
1178301|NCT02130102|independent living|independent living
1178302|NCT02130102|quality of life|quality of life
1178303|NCT02130102|socioeconomic impact|socioeconomic impact
1178304|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
1178305|NCT02130063|IDA|ida
1178306|NCT02130063|Iron deficiency|iron deficiency
1178307|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
1178308|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
1178309|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
1178310|NCT02130050|Cardiovascular disease|cardiovascular disease
1178311|NCT02130050|Polysomnography|polysomnography
1178312|NCT02130050|Metabolomic|metabolomic
1178313|NCT02130037|APPLICATION|application
1178314|NCT02130037|SMARTPHONE|smartphone
1178315|NCT02130037|BULIMIA|bulimia
1178316|NCT02130037|B.E.D|b.e.d
1178317|NCT02130037|BINGE EATING DISORDER|binge eating disorder
1178318|NCT02130024|Age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend|age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend
1178319|NCT02129998|Infertility|infertility
1178320|NCT02129998|IVF/ICSI|ivf/icsi
1178321|NCT02129998|Progesterone|progesterone
1178322|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
1178323|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
1178324|NCT02129985|short-term insulin treatment|short-term insulin treatment
1178325|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
1178326|NCT02129985|beta cell function|beta cell function
1178327|NCT02129985|glycaemic remission|glycaemic remission
1178328|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
1178329|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
1178330|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
1178331|NCT02129946|Type 2 Diabetes|type 2 diabetes
1178332|NCT02129946|Resistant Starch|resistant starch
1178333|NCT02129946|Postprandial Glucose|postprandial glucose
1178334|NCT02129946|Postprandial Insulin|postprandial insulin
1178335|NCT02129946|Satiety|satiety
1178336|NCT02129933|EAC|eac
1178337|NCT02129933|HGD|hgd
1178338|NCT02129933|Esophagus|esophagus
1178339|NCT02129920|Stroke|stroke
1178340|NCT02129920|Cerebral Infarction|cerebral infarction
1178341|NCT02129920|Atrial Fibrillation|atrial fibrillation
1178342|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
1178343|NCT02129920|Heart Diseases|heart diseases
1178344|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
1178345|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
1178346|NCT02129920|Brain Diseases|brain diseases
1178347|NCT02129920|Central Nervous System Diseases|central nervous system diseases
1178348|NCT02129920|Nervous System Diseases|nervous system diseases
1178349|NCT02129920|Vascular Diseases|vascular diseases
1178350|NCT02129920|Brain Infarction|brain infarction
1178351|NCT02129920|Brain Ischemia|brain ischemia
1178352|NCT02129920|Anticoagulants|anticoagulants
1178353|NCT02129920|Hematologic Agents|hematologic agents
1178354|NCT02129920|Therapeutic Uses|therapeutic uses
1178355|NCT02129907|Anemias|anemias
1178356|NCT02129907|Iron-Deficiency|iron-deficiency
1178357|NCT02129907|thrombin|thrombin
1178358|NCT02129894|cesarean section|cesarean section
1178359|NCT02129894|postoperative pain|postoperative pain
1178360|NCT02129894|pregnancy|pregnancy
1178361|NCT02129894|abdominal binder|abdominal binder
1178362|NCT02129868|Type 1 diabetes|type 1 diabetes
1178363|NCT02129868|Closed-loop glucose control|closed-loop glucose control
1178364|NCT02129868|Artificial Pancreas|artificial pancreas
1178365|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1178366|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
1178367|NCT02129842|AFib|afib
1178368|NCT02129842|AF|af
1178369|NCT02129842|ablation|ablation
1178370|NCT02129842|EndoPAT|endopat
1178371|NCT02129842|Endothelial dysfunction|endothelial dysfunction
1178372|NCT02129842|PAT|pat
1178373|NCT02129829|Cirrhosis|cirrhosis
1178374|NCT02129829|HBV|hbv
1178375|NCT02129829|HIV|hiv
1178376|NCT02129829|HCV|hcv
1178377|NCT02129816|Female|female
1178378|NCT02129816|Postmenopause|postmenopause
1178379|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
1178380|NCT02129790|Bipolar Disorder|bipolar disorder
1178381|NCT02129790|Suicidal|suicidal
1178382|NCT02129790|Depression|depression
1178383|NCT02129790|Self-harm|self-harm
1178384|NCT02129790|Psychosocial intervention|psychosocial intervention
1178385|NCT02129777|Drug therapy|drug therapy
1178386|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
1178387|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
1178388|NCT02129699|NSCLC|nsclc
1178389|NCT02129699|stage IV|stage iv
1178390|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
1178391|NCT02129686|Acupuncture|acupuncture
1178392|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
1178393|NCT02129686|Stage I Breast Cancer|stage i breast cancer
1178394|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
1178395|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
1178396|NCT02129673|Glaucoma|glaucoma
1178397|NCT02129673|Intra-ocular pressure|intra-ocular pressure
1178398|NCT02129673|Slow Release|slow release
1178399|NCT02129673|Controlled release|controlled release
1178400|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
1178401|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
1178402|NCT02129647|Axitinib|axitinib
1178403|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1178404|NCT02129634|Limb-salvage|limb-salvage
1178405|NCT02129634|Randomized Controlled Trial|randomized controlled trial
1178406|NCT02129634|Paclitaxel|paclitaxel
1178407|NCT02129621|Lipocalin|lipocalin
1178408|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
1178409|NCT02129608|overweight|overweight
1178410|NCT02129608|obese|obese
1178411|NCT02129608|central adiposity|central adiposity
1178412|NCT02129608|Laser|laser
1178413|NCT02129608|lorcaserin|lorcaserin
1178414|NCT02129608|low level laser therapy|low level laser therapy
1178415|NCT02129608|belviq|belviq
1178416|NCT02129595|Resveratrol|resveratrol
1178417|NCT02129595|Diabetes Mellitus|diabetes mellitus
1178418|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1178419|NCT02129595|Insulin Resistance|insulin resistance
1178420|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
1178421|NCT02129595|Metabolic Diseases|metabolic diseases
1178422|NCT02129595|Endocrine System Diseases|endocrine system diseases
1178423|NCT02129595|Hyperinsulinism|hyperinsulinism
1178424|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1178425|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
1178426|NCT02129595|Analgesics|analgesics
1178427|NCT02129595|Sensory System Agents|sensory system agents
1178428|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
1178429|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
1178430|NCT02129595|Pharmacologic Actions|pharmacologic actions
1178431|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
1178432|NCT02129595|Therapeutic Uses|therapeutic uses
1178433|NCT02129595|Antirheumatic Agents|antirheumatic agents
1178434|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1178435|NCT02129595|Antineoplastic Agents|antineoplastic agents
1178436|NCT02129595|Antioxidants|antioxidants
1178540|NCT02129296|Safety|safety
1178437|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1178438|NCT02129595|Protective Agents|protective agents
1178439|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
1178440|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1178441|NCT02129595|Hematologic Agents|hematologic agents
1178442|NCT02129595|Antimutagenic Agents|antimutagenic agents
1178443|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
1178444|NCT02129595|Central Nervous System Agents|central nervous system agents
1178445|NCT02129595|Brown Adipose Tissue|brown adipose tissue
1178446|NCT02129556|Metastatic|metastatic
1178447|NCT02129556|Breast|breast
1178448|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
1178449|NCT02129556|PD-L1 expressing|pd-l1 expressing
1178450|NCT02129556|HER2-positive|her2-positive
1178451|NCT02129543|SCT|sct
1178452|NCT02129543|Stem Cell Transplantation|stem cell transplantation
1178453|NCT02129543|Stem Cell Transplant|stem cell transplant
1178454|NCT02129530|Community Mobilization|community mobilization
1178455|NCT02129530|HIV|hiv
1178456|NCT02129530|Intimate Partner Violence|intimate partner violence
1178457|NCT02129530|Gender Norms|gender norms
1178458|NCT02129504|root coverage|root coverage
1178459|NCT02129504|gingival recession|gingival recession
1178460|NCT02129504|periodontal surgery|periodontal surgery
1178461|NCT02129491|stroke|stroke
1178462|NCT02129491|Congenital stroke|congenital stroke
1178463|NCT02129491|neonatal|neonatal
1178464|NCT02129491|hemiplegia|hemiplegia
1178465|NCT02129478|olanzapine|olanzapine
1178466|NCT02129478|pediatrics|pediatrics
1178467|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
1178468|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
1178469|NCT02129465|Cytomegalovirus|cytomegalovirus
1178470|NCT02129465|CMV|cmv
1178471|NCT02129465|pregnancy|pregnancy
1178472|NCT02129465|transmission|transmission
1178473|NCT02129452|Alzheimer disease|alzheimer disease
1178474|NCT02129452|Dementia|dementia
1178475|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
1178476|NCT02129452|Tauopathies|tauopathies
1178477|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
1178478|NCT02129452|Amyloid Plaque|amyloid plaque
1178479|NCT02129452|MicroRNAs|micrornas
1178480|NCT02129452|Early Diagnosis|early diagnosis
1178481|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
1178482|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
1178483|NCT02129439|Ulcerative colitis|ulcerative colitis
1178484|NCT02129439|Phase II|phase ii
1178485|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
1178486|NCT02129439|intrarectal application|intrarectal application
1178487|NCT02129439|proof-of-concept|proof-of-concept
1178488|NCT02129426|Sedation|sedation
1178489|NCT02129426|MRI|mri
1178490|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1178491|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
1178492|NCT02129413|Cerebral vasospasm|cerebral vasospasm
1178493|NCT02129413|Ruptured aneurysm|ruptured aneurysm
1178494|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
1178495|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
1178496|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
1178497|NCT02129413|Neurostimulation|neurostimulation
1178498|NCT02129413|Carotid body|carotid body
1178499|NCT02129400|Xenon-inhalation|xenon-inhalation
1178500|NCT02129400|Erythropoetin|erythropoetin
1178501|NCT02129400|Pharmakokinetic|pharmakokinetic
1178502|NCT02129400|Pharmacodynamic|pharmacodynamic
1178503|NCT02129400|Hemodynamic parameters|hemodynamic parameters
1178504|NCT02129400|Inflammatory parameters|inflammatory parameters
1178505|NCT02129400|Growth factors|growth factors
1178506|NCT02129400|Oxidative stress parameters|oxidative stress parameters
1178507|NCT02129387|Nicotine|nicotine
1178508|NCT02129387|Smoking Progression|smoking progression
1178509|NCT02129387|EEG|eeg
1178510|NCT02129387|Young adults|young adults
1178511|NCT02129387|Light smokers|light smokers
1178512|NCT02129387|rs1051730 genotype|rs1051730 genotype
1178513|NCT02129374|Spondylolysis|spondylolysis
1178514|NCT02129374|Lumbar spine|lumbar spine
1178515|NCT02129374|Young population|young population
1178516|NCT02129374|Direct repair|direct repair
1178517|NCT02129374|Union rate|union rate
1178518|NCT02129374|Functional outcome|functional outcome
1178519|NCT02129361|traumatic brain injury|traumatic brain injury
1178520|NCT02129348|Alzheimer's disease|alzheimer's disease
1178521|NCT02129348|psychosis|psychosis
1178522|NCT02129348|agitation|agitation
1178523|NCT02129348|aggression|aggression
1178524|NCT02129348|Lithium|lithium
1178525|NCT02129348|delusions|delusions
1178526|NCT02129348|hallucinations|hallucinations
1178527|NCT02129335|glioblastoma|glioblastoma
1178528|NCT02129335|partner|partner
1178529|NCT02129335|stress|stress
1178530|NCT02129335|exercise|exercise
1178531|NCT02129335|outcome|outcome
1178532|NCT02129309|COPD|copd
1178533|NCT02129309|Apelin|apelin
1178534|NCT02129309|agonist|agonist
1178535|NCT02129309|antagonist|antagonist
1178536|NCT02129296|Morbid obesity|morbid obesity
1178537|NCT02129296|Gastric balloon|gastric balloon
1178538|NCT02129296|Weight loss|weight loss
1178541|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
1178542|NCT02129270|Fractures of the distal radius|fractures of the distal radius
1178543|NCT02129270|Hematoma block|hematoma block
1178544|NCT02129270|Lidocaine|lidocaine
1178545|NCT02129244|MDR-TB|mdr-tb
1178546|NCT02129244|HIV|hiv
1178547|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
1178548|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
1178549|NCT02129231|rosuvastatin|rosuvastatin
1178550|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
1178551|NCT02129231|oxidative stress|oxidative stress
1178552|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
1178553|NCT02129205|solid tumors|solid tumors
1178554|NCT02129205|triple negative breast cancer|triple negative breast cancer
1178555|NCT02129205|PF-06650808|pf-06650808
1178556|NCT02129205|Phase 1|phase 1
1178557|NCT02129153|Randomized controlled trial|randomized controlled trial
1178558|NCT02129153|Population, School Age|population, school age
1178559|NCT02129140|hernia repair|hernia repair
1178560|NCT02129140|ventral incisional hernia|ventral incisional hernia
1178561|NCT02129140|biologic mesh|biologic mesh
1178562|NCT02129140|hernia graft|hernia graft
1178563|NCT02129088|Healthy|healthy
1178564|NCT02129088|Esketamine|esketamine
1178565|NCT02129088|Phase 1|phase 1
1178566|NCT02129088|Placebo|placebo
1178567|NCT02129088|Elderly|elderly
1178568|NCT02129088|Adult|adult
1178569|NCT02129036|Ovarian cancer|ovarian cancer
1178570|NCT02129036|Clear cell carcinoma|clear cell carcinoma
1178571|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
1178572|NCT02129036|Chemotherapy|chemotherapy
1178573|NCT02129036|response to chemotherapy|response to chemotherapy
1178574|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
1178575|NCT02129036|Prognostic factors|prognostic factors
1178576|NCT02129023|Exergame|exergame
1178577|NCT02129023|user health|user health
1178578|NCT02129023|exercise|exercise
1178579|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
1178580|NCT02129010|terson syndrome|terson syndrome
1178581|NCT02129010|CSF-proteines|csf-proteines
1178582|NCT02129010|phospho-tau|phospho-tau
1178583|NCT02129010|beta-amyloid|beta-amyloid
1178584|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
1178585|NCT02128984|Malnutrition|malnutrition
1178586|NCT02128984|Dietary supplement|dietary supplement
1178587|NCT02128984|Nutritional supplement|nutritional supplement
1178588|NCT02128984|Symbiotic formula|symbiotic formula
1178589|NCT02128984|DHA|dha
1178590|NCT02128984|Cystic Fibrosis|cystic fibrosis
1178591|NCT02128984|Failure to Thrive|failure to thrive
1178592|NCT02128971|Iron supplement study|iron supplement study
1178593|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
1178594|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
1178595|NCT02128945|PET|pet
1178596|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1178597|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
1178598|NCT02128945|Fludarabine|fludarabine
1178599|NCT02128919|Schizophrenia|schizophrenia
1178600|NCT02128919|Cigarette smoking|cigarette smoking
1178601|NCT02128919|Cognition|cognition
1178602|NCT02128919|Craving|craving
1178603|NCT02128919|MATRICS|matrics
1178604|NCT02128906|ERCC1|ercc1
1178605|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
1178606|NCT02128906|oropharynx|oropharynx
1178607|NCT02128906|larynx|larynx
1178608|NCT02128906|hypopharynx|hypopharynx
1178609|NCT02128906|p16|p16
1178610|NCT02128906|radiotherapy|radiotherapy
1178611|NCT02128906|docetaxel|docetaxel
1178612|NCT02128906|cetuximab|cetuximab
1178613|NCT02128906|cisplatin|cisplatin
1178614|NCT02128906|EGFR|egfr
1178615|NCT02128906|Biomarker|biomarker
1178616|NCT02128906|efficacy|efficacy
1178617|NCT02128906|head and neck|head and neck
1178618|NCT02128906|tongue|tongue
1178619|NCT02128906|throat|throat
1178620|NCT02128893|Isavuconazole|isavuconazole
1178621|NCT02128893|Esomeprazole|esomeprazole
1178622|NCT02128893|BAL4815|bal4815
1178623|NCT02128893|BAL8728|bal8728
1178624|NCT02128893|Healthy Subjects|healthy subjects
1178625|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
1178626|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
1178627|NCT02128867|GOR|gor
1178628|NCT02128867|GER|ger
1178629|NCT02128867|airway clearance techniques|airway clearance techniques
1178630|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1178631|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
1178632|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1178633|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
1178634|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1178635|NCT02128854|African Americans|african americans
1178636|NCT02128854|Blacks|blacks
1178637|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
1178638|NCT02128854|Randomized Control Trial|randomized control trial
1178639|NCT02128854|Controlled Clinical Trial|controlled clinical trial
1178834|NCT02127905|PBSC|pbsc
1178640|NCT02128854|Behavioral Research|behavioral research
1178641|NCT02128854|Behavioral Medicine|behavioral medicine
1178642|NCT02128841|rivaroxaban|rivaroxaban
1178739|NCT02128334|Uro-Oncologists|uro-oncologists
1178643|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
1178644|NCT02128841|anticoagulants|anticoagulants
1178645|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
1178646|NCT02128828|AIDS Dementia Complex|aids dementia complex
1178647|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
1178648|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
1178649|NCT02128815|adults|adults
1178650|NCT02128815|coaching|coaching
1178651|NCT02128815|type 2 diabetes|type 2 diabetes
1178652|NCT02128802|Obesity|obesity
1178653|NCT02128802|Renal failure|renal failure
1178654|NCT02128802|Gastric bypass|gastric bypass
1178655|NCT02128789|Older Adults|older adults
1178656|NCT02128789|Caregivers|caregivers
1178657|NCT02128789|Aging|aging
1178658|NCT02128789|Support|support
1178659|NCT02128776|Children|children
1178660|NCT02128776|Chronic illnesses|chronic illnesses
1178661|NCT02128724|Lung cancer|lung cancer
1178662|NCT02128724|BKM120|bkm120
1178663|NCT02128724|Hypoxia|hypoxia
1248759|NCT01811459|ICU|icu
1178664|NCT02128724|Misonidazole|misonidazole
1178665|NCT02128724|Radiotherapy|radiotherapy
1178666|NCT02128711|lung|lung
1178667|NCT02128711|cystic fibrosis|cystic fibrosis
1178668|NCT02128711|bacteria|bacteria
1178669|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
1178670|NCT02128698|Bariatric surgery|bariatric surgery
1178671|NCT02128698|Protein supplementation|protein supplementation
1178672|NCT02128698|Physical activity|physical activity
1178673|NCT02128698|Muscle mass|muscle mass
1178674|NCT02128698|Weight loss|weight loss
1178675|NCT02128698|Physical fitness|physical fitness
1178676|NCT02128698|Muscle strength|muscle strength
1178677|NCT02128685|Threatened miscarriage|threatened miscarriage
1178678|NCT02128685|Dydrogesterone|dydrogesterone
1178679|NCT02128685|Randomized controlled trial|randomized controlled trial
1178680|NCT02128646|Pain Management|pain management
1178681|NCT02128646|Exparel|exparel
1178682|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
1178683|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
1178684|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
1178685|NCT02128633|Dentin Sensitivities|dentin sensitivities
1178686|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
1178687|NCT02128620|Internet|internet
1178688|NCT02128620|Education|education
1178689|NCT02128620|Appointments and Schedules|appointments and schedules
1178690|NCT02128607|low back pain|low back pain
1178691|NCT02128607|manual therapy|manual therapy
1178692|NCT02128607|Mulligan|mulligan
1178693|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
1178694|NCT02128607|Kinematic spine model|kinematic spine model
1178695|NCT02128568|Depression/therapy;|depression/therapy;
1178696|NCT02128568|Developing Countries;|developing countries;
1178697|NCT02128568|Interpersonal Relations;|interpersonal relations;
1178698|NCT02128568|Life Change Events;|life change events;
1178699|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
1178700|NCT02128568|Resilience, Psychological;|resilience, psychological;
1178701|NCT02128568|Sierra Leone;|sierra leone;
1178702|NCT02128568|Survivors/psychology;|survivors/psychology;
1178703|NCT02128568|Social Adjustment;|social adjustment;
1178704|NCT02128568|Social Behavior;|social behavior;
1178706|NCT02128555|ankle arthritis|ankle arthritis
1178707|NCT02128555|osteoarthritis|osteoarthritis
1178708|NCT02128555|total ankle replacement|total ankle replacement
1178709|NCT02128555|arthrodesis|arthrodesis
1178710|NCT02128555|quality of life|quality of life
1178711|NCT02128555|musculoskeletal|musculoskeletal
1178712|NCT02128542|Veterans HCV|veterans hcv
1178713|NCT02128529|COPD|copd
1178714|NCT02128490|Drug therapy|drug therapy
1178715|NCT02128477|Myocardial infarction|myocardial infarction
1178716|NCT02128477|Repolarization instability|repolarization instability
1178717|NCT02128477|Ventricular fibrillation|ventricular fibrillation
1178718|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
1178719|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
1178720|NCT02128464|Customized Cutting Block|customized cutting block
1178721|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
1178722|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
1178723|NCT02128425|Colorectal cancer|colorectal cancer
1178724|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
1178725|NCT02128425|FOLFOXIRI|folfoxiri
1178726|NCT02128425|FOLFOX|folfox
1178727|NCT02128425|Oxaliplatin|oxaliplatin
1178728|NCT02128425|irinotecan|irinotecan
1178729|NCT02128425|Leucovorin|leucovorin
1178730|NCT02128425|5-FU|5-fu
1178731|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
1178732|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
1178733|NCT02128360|Low ovarian reserve|low ovarian reserve
1178734|NCT02128360|Poor responder|poor responder
1178735|NCT02128360|Infertility|infertility
1178736|NCT02128347|Hemodialysis, Home|hemodialysis, home
1178737|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
1178738|NCT02128347|Telemedicine|telemedicine
1178741|NCT02128334|Eligard|eligard
1178742|NCT02128334|prostate carcinoma|prostate carcinoma
1178743|NCT02128321|Isavuconazole|isavuconazole
1178744|NCT02128321|Repaglinide|repaglinide
1178745|NCT02128321|Caffeine|caffeine
1178746|NCT02128321|BAL4815|bal4815
1178747|NCT02128321|BAL8728|bal8728
1178748|NCT02128321|Healthy Subjects|healthy subjects
1178749|NCT02128308|Antituberculosis agents|antituberculosis agents
1178750|NCT02128308|Pharmacokinetics|pharmacokinetics
1178751|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
1178752|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
1178753|NCT02128282|Bile duct cancer|bile duct cancer
1178754|NCT02128282|Biliary tract cancer|biliary tract cancer
1178755|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
1178756|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
1178757|NCT02128256|Osteomyelitis|osteomyelitis
1248790|NCT01811355|ALS|als
1178758|NCT02128256|Bone substitute|bone substitute
1178759|NCT02128256|Ceramic|ceramic
1178760|NCT02128256|Gentamicin|gentamicin
1178761|NCT02128230|High risk|high risk
1178762|NCT02128230|Carfilzomib|carfilzomib
1178763|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
1178764|NCT02128191|Ibuprofen|ibuprofen
1178765|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1178766|NCT02128178|Morbid obesity|morbid obesity
1178767|NCT02128178|Laparoscopic surgery|laparoscopic surgery
1178768|NCT02128178|Compression ultrasonography|compression ultrasonography
1178769|NCT02128178|Pulmonary embolism|pulmonary embolism
1178770|NCT02128178|Bleeding|bleeding
1178771|NCT02128165|gastric balloon|gastric balloon
1178772|NCT02128165|morbid obesity|morbid obesity
1178773|NCT02128152|stroke|stroke
1178774|NCT02128152|exoskeleton|exoskeleton
1178775|NCT02128152|Ekso|ekso
1178776|NCT02128152|ambulation|ambulation
1178777|NCT02128152|robotics|robotics
1178778|NCT02128139|Infective endocarditis|infective endocarditis
1178779|NCT02128139|Developing country|developing country
1178780|NCT02128139|Global health|global health
1178781|NCT02128139|Cardiac surgery|cardiac surgery
1178782|NCT02128139|Heart valve disease|heart valve disease
1178783|NCT02128139|Bacteremia|bacteremia
1178784|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
1178785|NCT02128126|HPV16 positive|hpv16 positive
1178786|NCT02128126|No curative treatment options|no curative treatment options
1178788|NCT02128113|Cataract surgery|cataract surgery
1178789|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
1178790|NCT02128113|omaveloxolone|omaveloxolone
1178791|NCT02128100|Pancreatic Cancer|pancreatic cancer
1178792|NCT02128087|HIV|hiv
1178793|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
1178794|NCT02128087|co-trimoxazole|co-trimoxazole
1178795|NCT02128087|SMS|sms
1178796|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
1178797|NCT02128087|Adolescents|adolescents
1178798|NCT02128087|Uganda|uganda
1178799|NCT02128087|Adherence|adherence
1178800|NCT02128035|radiation protection|radiation protection
1178801|NCT02128035|interventional cardiologist|interventional cardiologist
1178802|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1178803|NCT02128035|angiography|angiography
1178804|NCT02128035|lead shield|lead shield
1178805|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
1178806|NCT02128022|Angina Pectoris|angina pectoris
1178807|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
1178808|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
1178809|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
1178810|NCT02127996|Angina Pectoris|angina pectoris
1178811|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
1178812|NCT02127996|Myocardial Infarction|myocardial infarction
1178813|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
1178814|NCT02127996|Reperfusion Injury|reperfusion injury
1178815|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
1178816|NCT02127957|cystic fibrosis|cystic fibrosis
1178817|NCT02127957|exercise|exercise
1178818|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
1178819|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
1178820|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
1178821|NCT02127918|Children|children
1178822|NCT02127918|Electroencephalogram|electroencephalogram
1178823|NCT02127918|Neuropsychology|neuropsychology
1178824|NCT02127918|Development|development
1178825|NCT02127918|Antiepileptic drugs|antiepileptic drugs
1178826|NCT02127918|Clobazam|clobazam
1178827|NCT02127918|Seizures|seizures
1178828|NCT02127905|Fanconi Anemia|fanconi anemia
1178829|NCT02127905|compassionate treatment|compassionate treatment
1178830|NCT02127905|BMT|bmt
1178831|NCT02127905|HSCT|hsct
1178832|NCT02127905|unrelated|unrelated
1178833|NCT02127905|bone marrow transplantation|bone marrow transplantation
1178835|NCT02127905|peripheral blood|peripheral blood
1178836|NCT02127905|CD34+|cd34+
1178837|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
1178838|NCT02127892|SCID|scid
1178839|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
1178840|NCT02127892|unrelated|unrelated
1178841|NCT02127892|MUD|mud
1178842|NCT02127892|bone marrow|bone marrow
1178843|NCT02127892|cord blood|cord blood
1178844|NCT02127892|haplo-identical|haplo-identical
1178845|NCT02127892|peripheral blood|peripheral blood
1178846|NCT02127892|CD34+ selection|cd34+ selection
1178847|NCT02127892|T cell depletion|t cell depletion
1178848|NCT02127892|HSCT|hsct
1178849|NCT02127892|BMT|bmt
1178850|NCT02127892|CliniMACS|clinimacs
1178851|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1178852|NCT02127879|Schizophrenia|schizophrenia
1178853|NCT02127879|Negative symptoms|negative symptoms
1178854|NCT02127879|Intensive|intensive
1573932|NCT00487292|naps|naps
1178855|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1178856|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
1178857|NCT02127853|serial cataract surgery|serial cataract surgery
1178858|NCT02127853|hyperalgesia|hyperalgesia
1178859|NCT02127853|gabapentin|gabapentin
1178860|NCT02127853|central sensitization|central sensitization
1178861|NCT02127840|primary aldosteronism|primary aldosteronism
1178862|NCT02127840|adrenal adenoma|adrenal adenoma
1178863|NCT02127840|arterial hypertension|arterial hypertension
1178864|NCT02127814|induced diarrhea|induced diarrhea
1178865|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
1178866|NCT02127788|Haematology|haematology
1178867|NCT02127788|Micafungin|micafungin
1178868|NCT02127788|Observational study|observational study
1178869|NCT02127788|Prophylaxis|prophylaxis
1178870|NCT02127788|Invasive Fungal Infection|invasive fungal infection
1178871|NCT02127788|France|france
1178872|NCT02127762|Pain|pain
1178873|NCT02127762|Quality of Life|quality of life
1178874|NCT02127762|Glycemic Control|glycemic control
1178875|NCT02127762|diabetic neuropathy|diabetic neuropathy
1178876|NCT02127762|mindfulness|mindfulness
1178877|NCT02127762|stress reduction|stress reduction
1178878|NCT02127762|adult|adult
1178879|NCT02127762|chronic pain|chronic pain
1178880|NCT02127762|depression|depression
1178881|NCT02127762|cortisol|cortisol
1178882|NCT02127749|antibiotics|antibiotics
1178883|NCT02127749|gut microbiota|gut microbiota
1178884|NCT02127749|endotoxemia|endotoxemia
1178885|NCT02127749|innate immunity|innate immunity
1178886|NCT02127723|cellulite|cellulite
1178887|NCT02127710|AZD6094|azd6094
1178888|NCT02127710|Savolitinib|savolitinib
1178889|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
1178890|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
1178891|NCT02127684|diabetic macular edema|diabetic macular edema
1178892|NCT02127645|RADIOTHERAPY|radiotherapy
1178893|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
1178894|NCT02127645|LOCAL EXCISION|local excision
1178895|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
1178896|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1178897|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
1178898|NCT02127619|knee prosthesis|knee prosthesis
1178899|NCT02127619|total knee replacement|total knee replacement
1178900|NCT02127619|total knee arthroplasty|total knee arthroplasty
1178901|NCT02127619|prospective study|prospective study
1178902|NCT02127619|Therapeutic level IV|therapeutic level iv
1178903|NCT02127593|Norgestimate|norgestimate
1178904|NCT02127593|Ethinyl estradiol|ethinyl estradiol
1178905|NCT02127593|Norgestrel|norgestrel
1178906|NCT02127593|Norelgestromin|norelgestromin
1178907|NCT02127593|Ortho cyclen|ortho cyclen
1178908|NCT02127593|Phase 1|phase 1
1178909|NCT02127593|Healthy Women|healthy women
1178910|NCT02127580|THV|thv
1178911|NCT02127580|BAV|bav
1178912|NCT02127580|pre-dilation|pre-dilation
1178913|NCT02127580|Aortic valve stenosis|aortic valve stenosis
1178914|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
1178915|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
1178916|NCT02127541|beta-cell imaging|beta-cell imaging
1178917|NCT02127541|exendin-4|exendin-4
1178918|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
1178919|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
1178920|NCT02127515|Down, trisomy 21|down, trisomy 21
1178921|NCT02127515|NIPT|nipt
1178922|NCT02127515|Amniocentesis|amniocentesis
1178923|NCT02127515|miscarriage|miscarriage
1178924|NCT02127515|invasive|invasive
1178925|NCT02127515|prenatal|prenatal
1178926|NCT02127515|screening.|screening.
1178927|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
1178928|NCT02127463|AMD|amd
1178929|NCT02127463|Dry AMD|dry amd
1178930|NCT02127463|Non-Exudative AMD|non-exudative amd
1178931|NCT02127463|MC-1101|mc-1101
1178932|NCT02127450|Enterobacteriaceae|enterobacteriaceae
1178933|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
1178934|NCT02127450|carbapenemases|carbapenemases
1178935|NCT02127450|prevalence|prevalence
1178936|NCT02127450|screening algorithm|screening algorithm
1178937|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
1178938|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
1178939|NCT02127437|Somatostatin,|somatostatin,
1178940|NCT02127437|lanreotide|lanreotide
1178941|NCT02127424|Nurse|nurse
1178942|NCT02127424|Nursing|nursing
1178943|NCT02127424|Screening|screening
1178945|NCT02127424|Emergency Service Hospital|emergency service hospital
1178946|NCT02127411|Mindfulness|mindfulness
1178947|NCT02127411|Benzodiazepines|benzodiazepines
1178948|NCT02127411|Sleep|sleep
1178949|NCT02127411|Dependence|dependence
1178950|NCT02127411|Relapse Prevention|relapse prevention
1574326|NCT00485589|anti-CD20|anti-cd20
1178951|NCT02127398|C. difficile colitis|c. difficile colitis
1178952|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
1178953|NCT02127372|non-small cell|non-small cell
1178954|NCT02127372|lung cancer|lung cancer
1178955|NCT02127359|Metastatic|metastatic
1178956|NCT02127346|Chronic Periodontitis|chronic periodontitis
1178957|NCT02127346|Vitamin D concentration|vitamin d concentration
1178958|NCT02127346|Calcium concentration|calcium concentration
1178959|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1178960|NCT02127333|Coronary artery disease|coronary artery disease
1178961|NCT02127333|Endothelial function|endothelial function
1178962|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
1178963|NCT02127307|Heart failure (HF)|heart failure (hf)
1178964|NCT02127307|Nuclear imaging|nuclear imaging
1178965|NCT02127307|Radiopharmaceutical|radiopharmaceutical
1178966|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
1178967|NCT02127294|migraine|migraine
1178968|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
1178969|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
1178970|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
1178971|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
1178972|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
1178973|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
1178974|NCT02127281|Drainage|drainage
1178975|NCT02127255|chemotherapy|chemotherapy
1178976|NCT02127255|nausea|nausea
1178977|NCT02127255|vomiting|vomiting
1178978|NCT02127255|cancer|cancer
1178979|NCT02127242|hepatolithiasis|hepatolithiasis
1178980|NCT02127242|ureteroscope|ureteroscope
1178981|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
1178982|NCT02127242|hepatectomy|hepatectomy
1178983|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1178984|NCT02127229|disposable accessory cost|disposable accessory cost
1178985|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
1178986|NCT02127216|Mobile Health|mobile health
1178987|NCT02127216|Diabetes|diabetes
1178988|NCT02127216|Self-Care of Diabetes|self-care of diabetes
1178989|NCT02127203|oxidative stress|oxidative stress
1178990|NCT02127203|periodontal disease|periodontal disease
1178991|NCT02127203|nitric oxide|nitric oxide
1178992|NCT02127190|nitro-fatty acids|nitro-fatty acids
1178993|NCT02127190|anti-inflammatory|anti-inflammatory
1178994|NCT02127190|Nrf2 activation|nrf2 activation
1178995|NCT02127190|contrast induced AKI|contrast induced aki
1178996|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
1178997|NCT02127177|coronary heart disease|coronary heart disease
1178998|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
1178999|NCT02127177|lipid profiles|lipid profiles
1179000|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
1179001|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
1179002|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
1179003|NCT02127138|clinical study|clinical study
1179004|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
1179005|NCT02127138|Provisional T Stenting|provisional t stenting
1179006|NCT02127112|Ridge Augmentation|ridge augmentation
1179007|NCT02127112|Bone regeneration|bone regeneration
1179008|NCT02127112|Guided Bone Regeneration|guided bone regeneration
1179009|NCT02127112|Partially Edentulous|partially edentulous
1179010|NCT02127099|OSA|osa
1179011|NCT02127099|obstructive|obstructive
1179012|NCT02127099|sleep|sleep
1179013|NCT02127099|apnea|apnea
1179014|NCT02127099|operation|operation
1179015|NCT02127086|Acute pain severity|acute pain severity
1179016|NCT02127086|Non-communicative patients|non-communicative patients
1179017|NCT02127086|PAIN algorithm|pain algorithm
1179018|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
1179019|NCT02127073|Breast cancer|breast cancer
1179020|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
1179021|NCT02127073|Oxytocin|oxytocin
1179022|NCT02127060|vitamin C|vitamin c
1179023|NCT02127060|effectiveness|effectiveness
1179024|NCT02127060|pain management|pain management
1179025|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
1179026|NCT02127034|Healthy subjects|healthy subjects
1179027|NCT02127034|Mirabegron|mirabegron
1179028|NCT02127034|Solifenacin|solifenacin
1179029|NCT02127034|Digoxin|digoxin
1179030|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
1179031|NCT02127021|Nutritional Status|nutritional status
1179032|NCT02127021|Quality of Life|quality of life
1179033|NCT02127021|Biochemical Marker|biochemical marker
1179034|NCT02127008|epidural fat|epidural fat
1179035|NCT02127008|resection|resection
1179036|NCT02127008|spinal stenosis|spinal stenosis
1179037|NCT02127008|lumbar spine|lumbar spine
1179038|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
1179039|NCT02126982|clopidogrel besylate|clopidogrel besylate
1333252|NCT01443819|Radiculopathy|radiculopathy
1179040|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
1179041|NCT02126982|Generic clopidogrel|generic clopidogrel
1179042|NCT02126982|Coronary Artery Disease|coronary artery disease
1179043|NCT02126969|Cancer|cancer
1179044|NCT02126969|Low dose radiation|low dose radiation
1179045|NCT02126956|ACT-128800|act-128800
1179046|NCT02126943|PAH|pah
1179047|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
1179048|NCT02126930|anti-infectious treatment|anti-infectious treatment
1179049|NCT02126930|observance|observance
1179050|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
1179051|NCT02126917|Phase 1|phase 1
1179052|NCT02126917|Alcohol|alcohol
1179053|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
1179054|NCT02126917|Pharmacokinetics|pharmacokinetics
1179055|NCT02126891|Cardiac functions|cardiac functions
1179056|NCT02126891|Endurance training|endurance training
1179057|NCT02126891|Senior athletes|senior athletes
1179058|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
1179059|NCT02126813|Postoperative urinary retention|postoperative urinary retention
1179060|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
1179061|NCT02126813|Urinary bladder volume|urinary bladder volume
1179062|NCT02126800|breast cancer|breast cancer
1179063|NCT02126787|Anxiety disorders|anxiety disorders
1179064|NCT02126787|Depressive disorders|depressive disorders
1179065|NCT02126787|Personality disorders|personality disorders
1179066|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
1179067|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
1179068|NCT02126787|Group psychotherapy|group psychotherapy
1179069|NCT02126787|Day treatment|day treatment
1179070|NCT02126774|epilepsy|epilepsy
1179071|NCT02126774|focal epilepsy|focal epilepsy
1179072|NCT02126761|Influenza|influenza
1179073|NCT02126761|elderly|elderly
1179074|NCT02126761|adjuvant|adjuvant
1179075|NCT02126748|bronchiolitis|bronchiolitis
1179076|NCT02126748|Wang score|wang score
1179077|NCT02126748|Sa02|sa02
1179078|NCT02126748|airway clearance techniques|airway clearance techniques
1179079|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
1179080|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
1179081|NCT02126722|Helicobacter pylori|helicobacter pylori
1179082|NCT02126722|Gastritis|gastritis
1179083|NCT02126709|Povidone Iodine|povidone iodine
1179084|NCT02126709|Safety|safety
1179085|NCT02126709|Efficacy|efficacy
1179086|NCT02126709|Acne treatment|acne treatment
1179087|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
1179088|NCT02126696|Lesotho|lesotho
1179089|NCT02126696|Southern Africa|southern africa
1179090|NCT02126696|Comorbidity|comorbidity
1179091|NCT02126696|Virologic failure|virologic failure
1179092|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
1179093|NCT02126683|Plaquenil|plaquenil
1179094|NCT02126657|Acne scars|acne scars
1179095|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
1179096|NCT02126644|Photoaging|photoaging
1179097|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
1179098|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
1179099|NCT02126618|urodynamic studies|urodynamic studies
1179100|NCT02126618|diuresis|diuresis
1179101|NCT02126605|diabetes alert dogs|diabetes alert dogs
1179102|NCT02126605|hypoglycemia|hypoglycemia
1179103|NCT02126579|melanoma|melanoma
1179104|NCT02126579|neoplasms|neoplasms
1179105|NCT02126579|Poly ICLC|poly iclc
1179106|NCT02126579|Freund's Adjuvant|freund's adjuvant
1179107|NCT02126579|Metastatic melanoma|metastatic melanoma
1179108|NCT02126579|resiquimod|resiquimod
1179109|NCT02126579|adjuvants|adjuvants
1179110|NCT02126579|peptide vaccine|peptide vaccine
1179111|NCT02126566|striae distensiae|striae distensiae
1179112|NCT02126553|Leukemia|leukemia
1179113|NCT02126553|Acute myeloid leukemia|acute myeloid leukemia
1179114|NCT02126553|AML|aml
1179115|NCT02126553|Remission|remission
1179116|NCT02126553|Lenalidomide|lenalidomide
1179117|NCT02126553|CC-5013|cc-5013
1179118|NCT02126553|Revlimid|revlimid
1179119|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
1179120|NCT02126540|Atherectomy|atherectomy
1179121|NCT02126540|Optical Coherence Tomography|optical coherence tomography
1179995|NCT02122445|Thera-Band|thera-band
1179122|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
1179123|NCT02126514|Alzheimer disease|alzheimer disease
1179124|NCT02126501|weaning|weaning
1179125|NCT02126501|NCPAP|ncpap
1179126|NCT02126501|Preterm|preterm
1179127|NCT02126501|sudden wean|sudden wean
1179128|NCT02126501|gradual pressure off wean|gradual pressure off wean
1179129|NCT02126488|treadmill training|treadmill training
1179130|NCT02126488|generalization|generalization
1179131|NCT02126488|retention|retention
1179132|NCT02126475|"parkinson patients ON"|"parkinson patients on"
1179133|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
1179134|NCT02126475|time estimation|time estimation
1179135|NCT02126475|anticipation|anticipation
1179136|NCT02126462|Human Hookworm|human hookworm
1179137|NCT02126462|Necator americanus|necator americanus
1179138|NCT02126462|Hookworm|hookworm
1179139|NCT02126462|Hookworm Disease|hookworm disease
1179140|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
1179141|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
1179142|NCT02126462|Neglected Tropical Disease|neglected tropical disease
1179143|NCT02126462|Na-APR-1|na-apr-1
1179144|NCT02126462|Na-GST-1|na-gst-1
1179145|NCT02126436|phantom limb pain|phantom limb pain
1179146|NCT02126436|phantom limb sensation|phantom limb sensation
1179147|NCT02126436|acupuncture|acupuncture
1179148|NCT02126436|randomised controlled trial|randomised controlled trial
1179149|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
1179150|NCT02126410|sarcopenia|sarcopenia
1179151|NCT02126410|sleep duration|sleep duration
1179152|NCT02126410|body composition|body composition
1179153|NCT02126410|skeletal muscle|skeletal muscle
1179154|NCT02126397|endometrial polyp|endometrial polyp
1179155|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
1179156|NCT02126397|hysteroscopy|hysteroscopy
1179157|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
1179158|NCT02126397|Laser Diode|laser diode
1179159|NCT02126384|Immunology|immunology
1179160|NCT02126384|human|human
1179161|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
1179162|NCT02126384|Antibody-Producing Cells|antibody-producing cells
1179163|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
1179164|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
1179165|NCT02126332|Epidural analgesia|epidural analgesia
1179166|NCT02126332|Acute respiratory failure|acute respiratory failure
1179167|NCT02126332|Mechanical ventilation|mechanical ventilation
1179168|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
1179169|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
1179170|NCT02126319|prostate cancer counseling|prostate cancer counseling
1179171|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
1179172|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
1179173|NCT02126280|human monocytes|human monocytes
1179174|NCT02126280|activation|activation
1179175|NCT02126280|biomarkers|biomarkers
1179176|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
1179177|NCT02126267|periodontal disease|periodontal disease
1179178|NCT02126267|therapy|therapy
1179179|NCT02126267|anti-bacterial agents|anti-bacterial agents
1179180|NCT02126267|Randomized Controlled Trials|randomized controlled trials
1179181|NCT02126241|Heart Failure|heart failure
1179182|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
1179183|NCT02126241|Optimization|optimization
1179184|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
1179185|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
1179186|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
1179187|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
1179188|NCT02126215|carbon dioxide|carbon dioxide
1179189|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
1179190|NCT02126215|post-op delirium|post-op delirium
1179191|NCT02126202|Elderly|elderly
1179192|NCT02126202|Octogenarians|octogenarians
1179193|NCT02126202|PCI|pci
1179194|NCT02126202|Myocardial infarction|myocardial infarction
1179195|NCT02126202|NSTEMI|nstemi
1179196|NCT02126202|Unstable angina pectoris|unstable angina pectoris
1179197|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1179198|NCT02126189|Human Papillomavirus|human papillomavirus
1179199|NCT02126189|Aetiology|aetiology
1179200|NCT02126189|prevalence|prevalence
1179201|NCT02126189|risk factors|risk factors
1179202|NCT02126189|clinical outcome|clinical outcome
1179203|NCT02126163|Excessive Drinking|excessive drinking
1179204|NCT02126163|Hazardous Drinking|hazardous drinking
1179205|NCT02126137|HCV|hcv
1179206|NCT02126137|Ezetimibe|ezetimibe
1179207|NCT02126137|Cholesterol|cholesterol
1179208|NCT02126137|Host|host
1179209|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
1179210|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
1179211|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1179212|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
1179213|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
1179214|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
1179215|NCT02126085|ischemic stroke|ischemic stroke
1179216|NCT02126085|recanalisation|recanalisation
1179217|NCT02126085|sedation|sedation
1179218|NCT02126072|Ethanol|ethanol
1179219|NCT02126072|Alcohol|alcohol
1179220|NCT02126072|Consumption|consumption
1179221|NCT02126072|Gut wall integrity|gut wall integrity
1179222|NCT02126072|Endotoxemia|endotoxemia
1179223|NCT02126059|dementia|dementia
1179224|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
1179225|NCT02126059|quality of life|quality of life
1179226|NCT02126046|Cord Blood Transplant|cord blood transplant
1179227|NCT02126046|Haploidentical HSCT|haploidentical hsct
1179228|NCT02126046|Thalassemia major|thalassemia major
1179229|NCT02126033|celiac|celiac
1179230|NCT02126033|telomere|telomere
1179231|NCT02126033|telomerase|telomerase
1179232|NCT02126020|Keratoprosthesis|keratoprosthesis
1179233|NCT02126020|corneal melt|corneal melt
1179234|NCT02126020|keratolysis|keratolysis
1179235|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
1179236|NCT02126020|infliximab|infliximab
1179237|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
1179238|NCT02126007|fatigue|fatigue
1179240|NCT02126007|behavioral intervention|behavioral intervention
1179241|NCT02126007|sleep|sleep
1179242|NCT02125981|limaprost alfadex|limaprost alfadex
1179243|NCT02125981|cervical myelopathy|cervical myelopathy
1179244|NCT02125981|surgery|surgery
1179245|NCT02125968|chronic low back pain|chronic low back pain
1179246|NCT02125968|video game|video game
1179247|NCT02125968|therapeutic effects|therapeutic effects
1179248|NCT02125955|Pediatric|pediatric
1179249|NCT02125955|Overweight|overweight
1179250|NCT02125955|Obesity|obesity
1179251|NCT02125955|Gut microbiota|gut microbiota
1179252|NCT02125955|Adiposity|adiposity
1179253|NCT02125955|Prebiotic|prebiotic
1179254|NCT02125955|Dietary fiber|dietary fiber
1179255|NCT02125942|Borderline Personality Disorder|borderline personality disorder
1179256|NCT02125877|Iron overload|iron overload
1179257|NCT02125877|Chelation|chelation
1179258|NCT02125877|Thalassemia|thalassemia
1179259|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1179260|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
1179261|NCT02125877|Deferasirox|deferasirox
1179262|NCT02125877|ICL670|icl670
1179263|NCT02125877|Dispersible tablet|dispersible tablet
1179264|NCT02125877|Film-coated tablet|film-coated tablet
1179265|NCT02125864|AMD|amd
1179266|NCT02125864|VEGF|vegf
1179267|NCT02125864|Aflibercept|aflibercept
1179268|NCT02125851|slurry|slurry
1179269|NCT02125851|splenda|splenda
1179270|NCT02125851|sucralose|sucralose
1179271|NCT02125851|budesonide|budesonide
1179272|NCT02125851|mucosal contact time|mucosal contact time
1179273|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
1179274|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1179275|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
1179276|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
1179277|NCT02125812|antimicrobial(s)|antimicrobial(s)
1179278|NCT02125812|microbiology|microbiology
1179279|NCT02125773|PrEP|prep
1179280|NCT02125773|Risk score|risk score
1179281|NCT02125773|Self-perception|self-perception
1179282|NCT02125760|Respiratory muscle training|respiratory muscle training
1179283|NCT02125760|stroke|stroke
1179284|NCT02125760|rehabilitation|rehabilitation
1179285|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
1179286|NCT02125721|cystinuria|cystinuria
1179287|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
1179288|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
1179289|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
1179290|NCT02125708|Ovula Ring|ovula ring
1179291|NCT02125708|body-core-temperature|body-core-temperature
1179292|NCT02125708|biomarkers|biomarkers
1179293|NCT02125708|Single pregnancies|single pregnancies
1179294|NCT02125708|PPROM|pprom
1179295|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
1179296|NCT02125682|HDL|hdl
1179297|NCT02125682|Hyperlipidemia|hyperlipidemia
1179298|NCT02125682|Diabetes|diabetes
1179299|NCT02125682|Inflammation|inflammation
1179300|NCT02125669|basal cell carcinoma|basal cell carcinoma
1179301|NCT02125669|laser surgery|laser surgery
1179302|NCT02125669|pulsed dye laser|pulsed dye laser
1179303|NCT02125669|randomized controlled trial|randomized controlled trial
1179304|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
1179305|NCT02125643|Caffeine|caffeine
1179306|NCT02125643|Maximal voluntary strength|maximal voluntary strength
1179307|NCT02125630|Metastatic breast carcer|metastatic breast carcer
1179308|NCT02125630|Bone metastasis|bone metastasis
1179309|NCT02125630|surgery|surgery
1179310|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
1179311|NCT02125617|Abiraterone|abiraterone
1179312|NCT02125617|Biomarker|biomarker
1179313|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
1179314|NCT02125617|Plasma|plasma
1179315|NCT02125617|Predictive markers|predictive markers
1179316|NCT02125604|Gastrointestinal event|gastrointestinal event
1180201|NCT02121548|Haitian|haitian
1179317|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
1179318|NCT02125565|Arterial|arterial
1179319|NCT02125565|Blood|blood
1179320|NCT02125565|Gas|gas
1179321|NCT02125565|Needle|needle
1179322|NCT02125565|Pain|pain
1179323|NCT02125565|Local|local
1179324|NCT02125565|Anaesthesia|anaesthesia
1179325|NCT02125565|Anaesthetic|anaesthetic
1179326|NCT02125552|vascular access device|vascular access device
1179327|NCT02125552|ultrasonography|ultrasonography
1179328|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
1179329|NCT02125526|Acute myocardial infarction|acute myocardial infarction
1179330|NCT02125526|Persisting ischemia|persisting ischemia
1179331|NCT02125526|No reflow|no reflow
1179332|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
1179333|NCT02125526|Exhausted autoregulation|exhausted autoregulation
1179334|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1179335|NCT02125513|ovarian cancer|ovarian cancer
1179336|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
1179337|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
1179338|NCT02125513|randomized study|randomized study
1179339|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
1179340|NCT02125500|HCV genotype 1|hcv genotype 1
1179341|NCT02125487|Clinical Breast Examination|clinical breast examination
1179342|NCT02125487|Breast Cancer detection|breast cancer detection
1179343|NCT02125487|Breast Simulator|breast simulator
1179344|NCT02125487|Hybrid Simulation|hybrid simulation
1179345|NCT02125487|Patient Simulation|patient simulation
1179346|NCT02125487|Standardized Patient|standardized patient
1179347|NCT02125487|Medical student education|medical student education
1179348|NCT02125487|Health Communication|health communication
1179349|NCT02125487|Communication Barriers|communication barriers
1179350|NCT02125487|Cultural competency|cultural competency
1179351|NCT02125487|Cultural|cultural
1179352|NCT02125487|Middle East|middle east
1179353|NCT02125487|Lebanon|lebanon
1179354|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
1179355|NCT02125474|Lutetium|lutetium
1179356|NCT02125474|Treatment Outcome|treatment outcome
1179357|NCT02125461|Locally advanced|locally advanced
1179358|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
1179359|NCT02125461|MEDI4736|medi4736
1179360|NCT02125461|PD-L1|pd-l1
1179361|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
1179362|NCT02125461|Chemoradiation|chemoradiation
1179363|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
1179364|NCT02125448|Esophageal cancer|esophageal cancer
1179365|NCT02125448|MRI|mri
1179366|NCT02125448|PET-CT|pet-ct
1179367|NCT02125448|Response assessment|response assessment
1179368|NCT02125435|Healthy subjects|healthy subjects
1179369|NCT02125435|ASP2408|asp2408
1179370|NCT02125435|pharmacokinetics|pharmacokinetics
1179371|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
1179372|NCT02125396|liver cancer|liver cancer
1179373|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
1179374|NCT02125396|radiotherapy|radiotherapy
1179375|NCT02125396|adjuvant therapy|adjuvant therapy
1179376|NCT02125383|Parkinson's disease|parkinson's disease
1179377|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
1179378|NCT02125357|sequencing|sequencing
1179379|NCT02125357|abiraterone|abiraterone
1179380|NCT02125357|enzalutamide|enzalutamide
1179381|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1179382|NCT02125357|randomized|randomized
1179383|NCT02125331|Blood Pressure|blood pressure
1179384|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
1179385|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
1179386|NCT02125318|polycythemia vera|polycythemia vera
1179387|NCT02125318|primary myelofibrosis|primary myelofibrosis
1179388|NCT02125318|essential thrombocythemia|essential thrombocythemia
1179389|NCT02125318|anagrelide|anagrelide
1179390|NCT02125318|thrombocytosis|thrombocytosis
1179391|NCT02125318|GALE-401|gale-401
1179392|NCT02125305|Metformin|metformin
1179393|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
1179394|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
1179395|NCT02125201|intranasal fentanyl|intranasal fentanyl
1179396|NCT02125201|newborn|newborn
1179397|NCT02125162|BCX4161|bcx4161
1179398|NCT02125162|BioCryst|biocryst
1179399|NCT02125162|hereditary angioedema|hereditary angioedema
1179400|NCT02125162|relative bioavailability|relative bioavailability
1179401|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
1179402|NCT02125149|pregnancy|pregnancy
1179403|NCT02125149|obese|obese
1179404|NCT02125136|unresectable|unresectable
1179405|NCT02125136|borderline resectable|borderline resectable
1179406|NCT02125110|neurotoxicants|neurotoxicants
1179407|NCT02125110|MRI|mri
1179408|NCT02125110|developing brain|developing brain
1179409|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
1179410|NCT02125097|Endovascular Therapy|endovascular therapy
1179411|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
1180202|NCT02121496|Depression|depression
1179412|NCT02125084|Castrate-resistant|castrate-resistant
1179413|NCT02125084|Enzalutamide|enzalutamide
1179414|NCT02125084|Everolimus|everolimus
1179415|NCT02125058|intracutaneous sutures|intracutaneous sutures
1179416|NCT02125058|transcutaneous sutures|transcutaneous sutures
1179417|NCT02125058|dermatological surgery|dermatological surgery
1179418|NCT02125058|facial area|facial area
1179419|NCT02125045|GSH|gsh
1179420|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
1179421|NCT02125045|endothelial dysfunction|endothelial dysfunction
1179422|NCT02125045|oxidative stress|oxidative stress
1574327|NCT00485589|CD20|cd20
1179423|NCT02125019|Breast Cancer|breast cancer
1179424|NCT02125019|Taxane|taxane
1179425|NCT02125019|Gait|gait
1179426|NCT02125019|Men|men
1179427|NCT02125019|Women|women
1179428|NCT02125006|Mindfulness|mindfulness
1179429|NCT02125006|Breast Cancer|breast cancer
1179430|NCT02125006|Painful Neuropathy|painful neuropathy
1179431|NCT02125006|Chronic Pain|chronic pain
1179432|NCT02125006|fMRI|fmri
1179433|NCT02125006|Disability|disability
1179434|NCT02125006|Quality of Life|quality of life
1179435|NCT02125006|Cytokines|cytokines
1179436|NCT02125006|Cortisol|cortisol
1179437|NCT02124993|Gastrectomy|gastrectomy
1179438|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
1179439|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
1179440|NCT02124980|Mobile Health|mobile health
1179441|NCT02124928|stroke|stroke
1179442|NCT02124928|biomarkers|biomarkers
1179443|NCT02124928|vulnerable plaque|vulnerable plaque
1179444|NCT02124928|carotid endarterectomy|carotid endarterectomy
1179445|NCT02124928|carotid artery disease|carotid artery disease
1179446|NCT02124915|prosthetic socket|prosthetic socket
1179447|NCT02124915|amputee|amputee
1179448|NCT02124889|bariatric surgery|bariatric surgery
1179449|NCT02124889|multivitamin|multivitamin
1179450|NCT02124889|weight loss|weight loss
1179451|NCT02124889|adherence|adherence
1179452|NCT02124876|amputee|amputee
1179453|NCT02124876|prosthetics|prosthetics
1179454|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
1179455|NCT02124811|Schizophrenia|schizophrenia
1179456|NCT02124811|Clozapine|clozapine
1179457|NCT02124811|Minocycline|minocycline
1179458|NCT02124798|Subcutaneous|subcutaneous
1179459|NCT02124798|Autoinjector|autoinjector
1179460|NCT02124798|Belimumab|belimumab
1179461|NCT02124798|Real-Life Use Study|real-life use study
1179462|NCT02124798|Reliability|reliability
1179463|NCT02124785|Long-term persistence|long-term persistence
1179464|NCT02124785|Havrix|havrix
1179465|NCT02124785|Hepatitis A|hepatitis a
1179466|NCT02124772|v600-mutation|v600-mutation
1179467|NCT02124772|neuroblastoma|neuroblastoma
1179468|NCT02124772|Trametinib|trametinib
1179469|NCT02124772|pediatrics|pediatrics
1179470|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
1179471|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
1179472|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
1179473|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
1179474|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
1179475|NCT02124746|Polycythemia Vera|polycythemia vera
1179476|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
1179477|NCT02124746|blood disorders|blood disorders
1179478|NCT02124733|Actinic Keratosis|actinic keratosis
1179479|NCT02124733|Actinic Keratoses|actinic keratoses
1179480|NCT02124733|AK|ak
1179481|NCT02124733|PDT|pdt
1179482|NCT02124733|Photodynamic Therapy|photodynamic therapy
1179483|NCT02124733|Blue Light Therapy|blue light therapy
1179484|NCT02124733|ALA|ala
1179485|NCT02124733|aminolevulinic acid|aminolevulinic acid
1179486|NCT02124733|Levulan|levulan
1179487|NCT02124720|Autism spectrum disorders|autism spectrum disorders
1179488|NCT02124720|Stereotypy|stereotypy
1179489|NCT02124720|Repetitive behavior|repetitive behavior
1179490|NCT02124707|Head and neck cancer|head and neck cancer
1179491|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
1179492|NCT02124707|Metastatic|metastatic
1179493|NCT02124707|Recurrent|recurrent
1179494|NCT02124707|Phase II|phase ii
1179495|NCT02124707|Carboplatin|carboplatin
1179496|NCT02124707|Paclitaxel|paclitaxel
1179497|NCT02124707|Cetuximab|cetuximab
1179498|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
1179499|NCT02124694|complicated grief|complicated grief
1179500|NCT02124694|prolonged grief|prolonged grief
1179501|NCT02124694|interpersonal conflicts|interpersonal conflicts
1179502|NCT02124694|depression|depression
1179503|NCT02124694|American Indians|american indians
1179504|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
1179505|NCT02124694|traumatic grief|traumatic grief
1179506|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
1179507|NCT02124668|Xtandi|xtandi
1179508|NCT02124668|MDV3100|mdv3100
1179509|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
1179510|NCT02124668|Enzalutamide|enzalutamide
1179511|NCT02124655|Biofilms|biofilms
1179512|NCT02124655|Chlorhexidine|chlorhexidine
1179513|NCT02124655|Microscopy, confocal|microscopy, confocal
1179514|NCT02124655|Dental plaque|dental plaque
1179515|NCT02124655|Mouthwashes|mouthwashes
1179516|NCT02124642|Folate requirements|folate requirements
1179517|NCT02124642|Pregnancy|pregnancy
1179518|NCT02124642|Folic acid|folic acid
1179519|NCT02124642|DNA methylation|dna methylation
1179520|NCT02124642|Folate biomarkers|folate biomarkers
1179521|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
1179522|NCT02124616|Muscular dystrophy|muscular dystrophy
1179523|NCT02124616|Muscle diseases|muscle diseases
1179524|NCT02124616|myasthenic syndromes|myasthenic syndromes
1179525|NCT02124616|Polyneuropathies|polyneuropathies
1179526|NCT02124616|Myopathies|myopathies
1179527|NCT02124603|cataract|cataract
1179528|NCT02124603|prophylaxis|prophylaxis
1179529|NCT02124603|susceptibility|susceptibility
1179530|NCT02124590|Carnitine|carnitine
1179531|NCT02124590|Acylcarnitine|acylcarnitine
1179532|NCT02124590|Exercise|exercise
1179533|NCT02124590|Exercise Intensity|exercise intensity
1179534|NCT02124590|Insulin Sensitivity|insulin sensitivity
1179535|NCT02124564|Lacosamide|lacosamide
1179536|NCT02124564|Epilepsy|epilepsy
1179537|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
1179538|NCT02124564|Monotherapy|monotherapy
1179539|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
1179540|NCT02124512|obese|obese
1179541|NCT02124512|insulin resistance|insulin resistance
1179542|NCT02124512|metabolic syndrome|metabolic syndrome
1179543|NCT02124499|anesthesia recovery period|anesthesia recovery period
1179544|NCT02124499|postoperative complications|postoperative complications
1179545|NCT02124499|pain|pain
1179546|NCT02124499|pain measurement|pain measurement
1179547|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
1179548|NCT02124499|quality of life|quality of life
1179549|NCT02124499|genetic association study|genetic association study
1179550|NCT02124486|IIH|iih
1179551|NCT02124486|Weight loss|weight loss
1179552|NCT02124486|Bariatric surgery|bariatric surgery
1179553|NCT02124473|Resistant hypertension|resistant hypertension
1179554|NCT02124473|Homeopathy|homeopathy
1179555|NCT02124473|Blood pressure|blood pressure
1179556|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1179557|NCT02124460|Pediatric|pediatric
1179558|NCT02124460|Obesity|obesity
1179559|NCT02124460|Overweight|overweight
1179560|NCT02124460|Intervention|intervention
1179561|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
1179562|NCT02124421|Ovarian cancer|ovarian cancer
1179563|NCT02124421|Cytoreductive surgery|cytoreductive surgery
1179564|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1179565|NCT02124421|Systemic chemotherapy|systemic chemotherapy
1179566|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
1179567|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
1179568|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1179569|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
1179570|NCT02124421|IV chemotherapy|iv chemotherapy
1179571|NCT02124382|liver failure|liver failure
1179572|NCT02124382|liver malignancy|liver malignancy
1179573|NCT02124382|metabolic diseases|metabolic diseases
1179574|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
1179575|NCT02124369|Pancreatic cancer|pancreatic cancer
1179576|NCT02124369|locally advanced|locally advanced
1179577|NCT02124369|unresectable|unresectable
1179578|NCT02124343|Neutrophil|neutrophil
1179579|NCT02124343|Exercise|exercise
1179580|NCT02124343|COPD|copd
1179581|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
1179582|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
1179583|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
1179584|NCT02124317|S-1|s-1
1179585|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
1179586|NCT02124317|objective response rate|objective response rate
1179587|NCT02124304|Sternocleidomastoid|sternocleidomastoid
1179588|NCT02124304|Neck pain|neck pain
1179589|NCT02124304|EMG|emg
1179590|NCT02124304|Perceived Exertion|perceived exertion
1179591|NCT02124304|Thera-Band|thera-band
1179592|NCT02124304|Cervical Paraspinals|cervical paraspinals
1179593|NCT02124291|In Vitro Fertilization|in vitro fertilization
1179594|NCT02124291|Vitrification|vitrification
1179595|NCT02124291|Frozen Embryo|frozen embryo
1179596|NCT02124291|Assisted Hatching|assisted hatching
1179597|NCT02124291|Pregnancy Rate|pregnancy rate
1179598|NCT02124278|Single ascending dose|single ascending dose
1179599|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
1179600|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
1179601|NCT02124252|cervical cancer screening|cervical cancer screening
1179602|NCT02124252|human papillomavirus testing|human papillomavirus testing
1179603|NCT02124252|Kenya|kenya
1179604|NCT02124252|implementation science|implementation science
1179605|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
1179606|NCT02124213|Receptor Occupancy|receptor occupancy
1179607|NCT02124213|PET|pet
1179608|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
1179609|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1179610|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1179611|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
1179811|NCT02123212|Screening|screening
1179612|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
1179613|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
1179614|NCT02124161|flu vaccine|flu vaccine
1179615|NCT02124148|cancer|cancer
1179616|NCT02124135|Nutrition|nutrition
1179617|NCT02124122|Focus|focus
1179618|NCT02124122|safety|safety
1179619|NCT02124109|Rheumatic Fever|rheumatic fever
1179620|NCT02124109|Acquired Heart Disease|acquired heart disease
1179621|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
1179622|NCT02124109|Endomyocardial Fibrosis|endomyocardial fibrosis
1179623|NCT02124096|Zoonotic|zoonotic
1179624|NCT02124096|Influenza|influenza
1179625|NCT02124096|Infections|infections
1179626|NCT02124096|Ohio|ohio
1179627|NCT02124096|Fairs|fairs
1179628|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
1179629|NCT02124083|Phase I, Phase 2|phase i, phase 2
1179630|NCT02124083|Vorinostat|vorinostat
1179631|NCT02124070|Cystinosis|cystinosis
1179632|NCT02124070|Myopathy|myopathy
1179633|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
1179634|NCT02124057|Liver|liver
1179635|NCT02124057|Motor Neuron Disease|motor neuron disease
1179636|NCT02124044|Coinfection|coinfection
1179637|NCT02124044|HCV Genotype 1b|hcv genotype 1b
1179638|NCT02124044|Interferon Free therapy|interferon free therapy
1179639|NCT02124044|Liver Biopsy|liver biopsy
1179640|NCT02124044|Virological Response|virological response
1179641|NCT02124031|Osteoarthritis|osteoarthritis
1179642|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
1179643|NCT02124031|Disability|disability
1179644|NCT02124031|Joint function|joint function
1179645|NCT02124018|Myocardial infarction|myocardial infarction
1179646|NCT02124018|Risk stratification|risk stratification
1179647|NCT02124018|Sudden cardiac death|sudden cardiac death
1179648|NCT02124018|Preserved ejection fraction|preserved ejection fraction
1179649|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
1179650|NCT02124005|Knee surgery|knee surgery
1179651|NCT02124005|Femoral block|femoral block
1179652|NCT02124005|Bupivacaine|bupivacaine
1179653|NCT02124005|Ultrasound|ultrasound
1179654|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
1179655|NCT02123966|Oral mucosal disease|oral mucosal disease
1179656|NCT02123953|Drug therapy|drug therapy
1179657|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
1179658|NCT02123940|Lung ultrasound|lung ultrasound
1179659|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
1179660|NCT02123940|Weaning failure|weaning failure
1179661|NCT02123940|Postextubation distress|postextubation distress
1179662|NCT02123927|Drug therapy|drug therapy
1179663|NCT02123914|Exercise training|exercise training
1179664|NCT02123914|Allergic rhinitis|allergic rhinitis
1179665|NCT02123914|Vitamin C|vitamin c
1179666|NCT02123914|Cytokine|cytokine
1179667|NCT02123914|Rhinitis symptoms|rhinitis symptoms
1179668|NCT02123901|Mind and body Exercise|mind and body exercise
1179669|NCT02123901|Flow mediated dilation|flow mediated dilation
1179670|NCT02123901|Diabetes|diabetes
1179671|NCT02123888|Prostate|prostate
1179672|NCT02123888|Lung|lung
1179673|NCT02123862|Prostate Cancer|prostate cancer
1179674|NCT02123862|Breast Cancer|breast cancer
1179675|NCT02123862|Colorectal Cancer|colorectal cancer
1179676|NCT02123862|Colon Cancer|colon cancer
1179677|NCT02123862|Rectal Cancer|rectal cancer
1179678|NCT02123862|Cancer|cancer
1179679|NCT02123862|Solid Tumor|solid tumor
1179680|NCT02123862|Metastatic|metastatic
1179681|NCT02123862|Circulating Tumor Cells|circulating tumor cells
1179682|NCT02123810|fatigue|fatigue
1179683|NCT02123810|motor skills|motor skills
1179684|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1179685|NCT02123784|Rotator Cuff Tear|rotator cuff tear
1179686|NCT02123784|Rotator Cuff Repair|rotator cuff repair
1179687|NCT02123784|Biomarker|biomarker
1179688|NCT02123784|Predictive factors|predictive factors
1179689|NCT02123784|Skeletal Muscle|skeletal muscle
1179690|NCT02123784|Tendon|tendon
1179691|NCT02123784|Subacromial Bursa|subacromial bursa
1179692|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
1179693|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
1179694|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
1179695|NCT02123758|Prostate cancer|prostate cancer
1179696|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
1179697|NCT02123758|Prednisone|prednisone
1179698|NCT02123758|JNJ-56021927|jnj-56021927
1179699|NCT02123745|infiltration|infiltration
1179700|NCT02123745|extravasation|extravasation
1179701|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
1179702|NCT02123732|Diabetes|diabetes
1180203|NCT02121496|Development|development
1179703|NCT02123732|Diabetes Mellitus|diabetes mellitus
1179704|NCT02123732|Herbal|herbal
1179705|NCT02123732|food supplement|food supplement
1179706|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
1179707|NCT02123693|Low back pain|low back pain
1179708|NCT02123693|Dynamic MRI|dynamic mri
1179709|NCT02123680|expectation|expectation
1179710|NCT02123680|chronic illness|chronic illness
1179711|NCT02123680|trajectory|trajectory
1179712|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
1179713|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
1179714|NCT02123615|Subdermal bloodless space|subdermal bloodless space
1179715|NCT02123615|Subdermal injection|subdermal injection
1179716|NCT02123615|Subcutaneous injection|subcutaneous injection
1179717|NCT02123615|Injectable electromyography needle|injectable electromyography needle
1179718|NCT02123615|Electrical stimulation|electrical stimulation
1179719|NCT02123615|MRI with Gadolinium|mri with gadolinium
1179720|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
1179721|NCT02123602|abdominal muscles|abdominal muscles
1179722|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
1179723|NCT02123576|Renal failure|renal failure
1179724|NCT02123576|Pentoxyfylline|pentoxyfylline
1179725|NCT02123576|Liver transplantation|liver transplantation
1179726|NCT02123576|Cirrhosis|cirrhosis
1179727|NCT02123550|deep|deep
1179728|NCT02123550|venous|venous
1179729|NCT02123550|thrombosis|thrombosis
1179730|NCT02123550|Doppler|doppler
1179731|NCT02123550|ultrasound|ultrasound
1179732|NCT02123550|plastic|plastic
1179733|NCT02123550|surgery|surgery
1179734|NCT02123550|thromboembolism|thromboembolism
1179735|NCT02123550|prevention|prevention
1179736|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
1179737|NCT02123537|Functional electrical stimulation|functional electrical stimulation
1179738|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
1179739|NCT02123498|ear pressure|ear pressure
1179740|NCT02123498|ear fullness|ear fullness
1179741|NCT02123498|ear pain|ear pain
1179743|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
1179744|NCT02123498|LPR|lpr
1179745|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
1179746|NCT02123498|GERD|gerd
1179747|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
1179748|NCT02123498|acid reflux|acid reflux
1179749|NCT02123485|Depression,|depression,
1179750|NCT02123485|ECT,|ect,
1179751|NCT02123485|rTMS,|rtms,
1179752|NCT02123485|Right prefrontal,|right prefrontal,
1179753|NCT02123485|antidepressive efficacy|antidepressive efficacy
1179754|NCT02123485|Inflammation markers|inflammation markers
1179755|NCT02123433|HIV|hiv
1179756|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
1179757|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
1179758|NCT02123433|Vaccine|vaccine
1179759|NCT02123433|Immunological Response|immunological response
1179760|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
1179761|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
1179762|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
1179763|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
1179764|NCT02123407|Lymph Nodes|lymph nodes
1179765|NCT02123394|Low Back Pain|low back pain
1179766|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
1179767|NCT02123394|Low Back Ache|low back ache
1179768|NCT02123394|Low Backache|low backache
1179769|NCT02123394|Lower Back Pain|lower back pain
1179770|NCT02123394|Lumbago|lumbago
1179771|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
1179772|NCT02123381|cetuximab|cetuximab
1179773|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
1179774|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1179775|NCT02123368|Osteoarthritis|osteoarthritis
1179776|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
1179777|NCT02123368|Knee|knee
1179778|NCT02123342|health|health
1179779|NCT02123342|older adults|older adults
1179780|NCT02123342|mobile phone|mobile phone
1179781|NCT02123329|Qatar|qatar
1179782|NCT02123329|Pharmacy|pharmacy
1179783|NCT02123329|Pharmacist|pharmacist
1179784|NCT02123329|Smoking cessation|smoking cessation
1179785|NCT02123316|local allergic rhinitis|local allergic rhinitis
1179786|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
1179787|NCT02123316|house dust mite allergy|house dust mite allergy
1179788|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
1179789|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
1179790|NCT02123290|Plasmodium|plasmodium
1179791|NCT02123290|falciparum|falciparum
1179792|NCT02123290|malaria|malaria
1179793|NCT02123290|vivax|vivax
1179794|NCT02123290|DSM265|dsm265
1179795|NCT02123290|pharmacokinetics|pharmacokinetics
1179796|NCT02123290|adult|adult
1179797|NCT02123251|Incentives,|incentives,
1179798|NCT02123251|Diabetes,|diabetes,
1179799|NCT02123251|Medicaid,|medicaid,
1179800|NCT02123251|Health behavior,|health behavior,
1179801|NCT02123251|Cost effectiveness|cost effectiveness
1179802|NCT02123225|STOP-BANG|stop-bang
1180801|NCT02119117|IVF|ivf
1179803|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
1179804|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
1179805|NCT02123225|portable monitoring|portable monitoring
1179806|NCT02123225|sleep medicine|sleep medicine
1179807|NCT02123225|unattended sleep study|unattended sleep study
1179808|NCT02123225|postoperative sleep study|postoperative sleep study
1179809|NCT02123212|Hepatitis C|hepatitis c
1179810|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
1179812|NCT02123199|COPD|copd
1179813|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
1179814|NCT02123173|one lung ventilation,|one lung ventilation,
1179815|NCT02123173|cardiac output|cardiac output
1179816|NCT02123173|fluid responsiveness|fluid responsiveness
1179817|NCT02123160|Depression|depression
1179818|NCT02123160|Dyadic therapy|dyadic therapy
1179819|NCT02123160|Behavioral Problems|behavioral problems
1179820|NCT02123160|Child parent therapy|child parent therapy
1179821|NCT02123160|Affect regulation|affect regulation
1179822|NCT02123160|Immune markers|immune markers
1179823|NCT02123160|Cortisol|cortisol
1179824|NCT02123121|Aging|aging
1179825|NCT02123121|Biogenesis|biogenesis
1179826|NCT02123121|Cell Respiration|cell respiration
1179827|NCT02123121|Elderly|elderly
1179828|NCT02123121|Enzymes|enzymes
1179829|NCT02123121|Mitochondria|mitochondria
1179830|NCT02123121|Mitochondrial DNA|mitochondrial dna
1179831|NCT02123121|Muscle Fatigue|muscle fatigue
1179832|NCT02123121|Physical Function|physical function
1179833|NCT02123121|Resveratrol|resveratrol
1179834|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
1179835|NCT02123082|Urolithiasis|urolithiasis
1179836|NCT02123082|Kidney stones|kidney stones
1179837|NCT02123082|Ureteral Obstruction|ureteral obstruction
1179838|NCT02123082|Ureteroscopes|ureteroscopes
1179839|NCT02123082|Ureteroscopies|ureteroscopies
1179840|NCT02123069|Autonomic nervous system|autonomic nervous system
1179841|NCT02123069|Blood pressure|blood pressure
1179842|NCT02123069|Blood vessels|blood vessels
1179843|NCT02123069|Physiological effects of drugs|physiological effects of drugs
1179844|NCT02123069|Vascular stiffness|vascular stiffness
1179845|NCT02123056|reflex fainting|reflex fainting
1179846|NCT02123056|vasovagal syncope|vasovagal syncope
1179847|NCT02123056|metoprolol|metoprolol
1179848|NCT02123056|randomized clinical trial|randomized clinical trial
1179849|NCT02123056|quality of life|quality of life
1179850|NCT02123043|rehabilitation|rehabilitation
1179851|NCT02123043|wheelchair|wheelchair
1179852|NCT02123043|older adults|older adults
1179853|NCT02123043|manual wheelchair|manual wheelchair
1179854|NCT02123043|motor learning|motor learning
1179855|NCT02123043|biomechanics|biomechanics
1179856|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
1179857|NCT02123030|Lung cancer|lung cancer
1179858|NCT02123030|pulmonary disease|pulmonary disease
1179859|NCT02123017|Bowel Evacuation|bowel evacuation
1179860|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
1179861|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
1179862|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
1179863|NCT02122991|spinal cord injury|spinal cord injury
1179864|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
1179865|NCT02122991|baroreceptor integrity|baroreceptor integrity
1179866|NCT02122991|sympathetic integrity|sympathetic integrity
1179867|NCT02122991|vagal integrity|vagal integrity
1179868|NCT02122991|autonomic integrity|autonomic integrity
1179869|NCT02122991|arterial stiffness|arterial stiffness
1179870|NCT02122991|cognitive function|cognitive function
1179871|NCT02122991|traumatic brain injury|traumatic brain injury
1179872|NCT02122991|cerebral blood flow|cerebral blood flow
1179873|NCT02122978|psoriasis|psoriasis
1179874|NCT02122978|dermatology|dermatology
1179875|NCT02122978|mindfulness|mindfulness
1179876|NCT02122978|self-compassion|self-compassion
1179877|NCT02122952|Gene Transfer|gene transfer
1179878|NCT02122952|Gene Therapy|gene therapy
1179879|NCT02122952|Adeno-associated virus|adeno-associated virus
1179880|NCT02122952|Survival Motor Neuron|survival motor neuron
1179881|NCT02122952|SMN|smn
1179882|NCT02122952|AAV9|aav9
1179883|NCT02122926|Transitions in care|transitions in care
1179884|NCT02122926|discharge intervention|discharge intervention
1179885|NCT02122926|RCT|rct
1179886|NCT02122926|readmission rates|readmission rates
1179887|NCT02122926|medication adherence|medication adherence
1179888|NCT02122926|glycemic control|glycemic control
1179889|NCT02122926|ED visits|ed visits
1179890|NCT02122926|medication reconciliation|medication reconciliation
1179891|NCT02122926|Coleman Transitions Coach|coleman transitions coach
1179892|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
1179893|NCT02122913|TRK|trk
1179894|NCT02122913|TRKA|trka
1179895|NCT02122913|TRKB|trkb
1179896|NCT02122913|TRKC|trkc
1179897|NCT02122913|NTRK1|ntrk1
1179898|NCT02122913|NTRK2|ntrk2
1179899|NCT02122913|NTRK3|ntrk3
1179900|NCT02122913|larotrectinib|larotrectinib
1179901|NCT02122913|NTRK fusion positive|ntrk fusion positive
1180802|NCT02119117|blastocyst|blastocyst
1179902|NCT02122913|NTRK gene rearrangements|ntrk gene rearrangements
1179903|NCT02122913|NTRK1 fusion|ntrk1 fusion
1179904|NCT02122913|NTRK2 fusion|ntrk2 fusion
1179905|NCT02122913|NTRK3 fusion|ntrk3 fusion
1179906|NCT02122913|NTRK1 gene rearrangement|ntrk1 gene rearrangement
1179907|NCT02122913|NTRK2 gene rearrangement|ntrk2 gene rearrangement
1574328|NCT00485563|Cancer|cancer
1179908|NCT02122913|NTRK3 gene rearrangement|ntrk3 gene rearrangement
1179909|NCT02122913|ETV6-NTRK3|etv6-ntrk3
1179910|NCT02122913|fusion|fusion
1179911|NCT02122913|tumors|tumors
1179912|NCT02122913|solid tumors|solid tumors
1179913|NCT02122913|CNS tumors|cns tumors
1179914|NCT02122913|central nervous system tumors|central nervous system tumors
1179915|NCT02122913|TRK fusion|trk fusion
1179916|NCT02122913|ETV6|etv6
1179917|NCT02122913|ETV6 fusion|etv6 fusion
1179918|NCT02122913|ETV6 gene rearrangement|etv6 gene rearrangement
1179919|NCT02122913|solid CNS tumor|solid cns tumor
1179920|NCT02122913|Advanced CNS tumor|advanced cns tumor
1179921|NCT02122913|Primary CNS tumor|primary cns tumor
1179922|NCT02122913|Metastatic CNS tumor|metastatic cns tumor
1179923|NCT02122913|LOXO-101|loxo-101
1179924|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
1179925|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
1179926|NCT02122861|Melanoma|melanoma
1179927|NCT02122848|Heart failure|heart failure
1179928|NCT02122848|Exercise tolerance|exercise tolerance
1179929|NCT02122848|Noninvasive ventilation|noninvasive ventilation
1179930|NCT02122835|exercise|exercise
1179931|NCT02122835|aerobic exercise|aerobic exercise
1179932|NCT02122822|supratentoria glioma|supratentoria glioma
1179933|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
1179934|NCT02122796|Breast Cancer|breast cancer
1179935|NCT02122796|Mastectomy|mastectomy
1179936|NCT02122796|Acupuncture|acupuncture
1179937|NCT02122770|Drug Therapy|drug therapy
1179938|NCT02122731|antihypertensive therapy|antihypertensive therapy
1179939|NCT02122731|amiloride|amiloride
1179940|NCT02122731|add-on|add-on
1179941|NCT02122731|resistant hypertension|resistant hypertension
1179942|NCT02122731|blood pressure control|blood pressure control
1179943|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
1179944|NCT02122731|microalbuminuria.|microalbuminuria.
1179945|NCT02122705|Remifentanil|remifentanil
1179946|NCT02122705|Labour analgesia|labour analgesia
1179947|NCT02122666|Metabolic Syndrome|metabolic syndrome
1179948|NCT02122666|Pre-diabetes|pre-diabetes
1179949|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
1179950|NCT02122666|Phospholipids|phospholipids
1179951|NCT02122653|Fatigue|fatigue
1179952|NCT02122653|aging|aging
1179953|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
1179954|NCT02122653|interpolated|interpolated
1179955|NCT02122653|twitch technique|twitch technique
1179956|NCT02122627|Vitamin D, COPD, immunomodulation, pulmonary function|vitamin d, copd, immunomodulation, pulmonary function
1179957|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1179958|NCT02122614|COPD|copd
1179959|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
1179960|NCT02122614|Physical activity|physical activity
1179961|NCT02122614|Exercise|exercise
1179962|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
1179963|NCT02122575|Inflammasome|inflammasome
1179964|NCT02122575|Fasting|fasting
1179965|NCT02122575|Sirt3|sirt3
1179966|NCT02122562|Ketamine|ketamine
1179967|NCT02122562|Major Depression|major depression
1179968|NCT02122562|Alcohol|alcohol
1179969|NCT02122562|Alcohol Clamp|alcohol clamp
1179970|NCT02122562|NMDA Antagonist|nmda antagonist
1179971|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
1179972|NCT02122549|Telemetry|telemetry
1179973|NCT02122523|Image guided surgery|image guided surgery
1179974|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
1179975|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
1179976|NCT02122497|aortic occlusive disease|aortic occlusive disease
1179977|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
1179978|NCT02122497|open surgical repair|open surgical repair
1179979|NCT02122497|endovascular aortic repair|endovascular aortic repair
1179980|NCT02122484|reperfusion damage|reperfusion damage
1179981|NCT02122471|CIC|cic
1179982|NCT02122471|Constipation|constipation
1179983|NCT02122471|Chronic Constipation|chronic constipation
1179984|NCT02122471|Synergy|synergy
1179985|NCT02122471|Plecanatide|plecanatide
1179986|NCT02122458|hearing impairment|hearing impairment
1179987|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
1179988|NCT02122458|traumatic brain injury|traumatic brain injury
1179989|NCT02122458|auditory processing disorder|auditory processing disorder
1179990|NCT02122445|Gluteus Maximum|gluteus maximum
1179991|NCT02122445|Gluteus Medius|gluteus medius
1179992|NCT02122445|TFL|tfl
1179993|NCT02122445|EMG|emg
1179994|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
1179996|NCT02122445|kinesiology tape|kinesiology tape
1179997|NCT02122432|teledermatology|teledermatology
1179998|NCT02122432|dermatology|dermatology
1179999|NCT02122432|general practice|general practice
1180000|NCT02122432|organization of care|organization of care
1180001|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
1180002|NCT02122406|Depression|depression
1180003|NCT02122406|Anxiety|anxiety
1180004|NCT02122406|DAS28|das28
1180005|NCT02122406|HADS|hads
1180006|NCT02122380|Growth Hormone|growth hormone
1180007|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
1180008|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
1180009|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
1180136|NCT02121730|Cancer|cancer
1180010|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
1180011|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
1180012|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
1180013|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
1180014|NCT02122302|Patient self-assessment|patient self-assessment
1180015|NCT02122302|Online assessment|online assessment
1180016|NCT02122289|Exacerbation, QoL|exacerbation, qol
1180017|NCT02122276|Spinal cord injury|spinal cord injury
1180018|NCT02122276|Passive motion|passive motion
1180019|NCT02122276|Fatigue index|fatigue index
1180020|NCT02122276|Hypertonia|hypertonia
1180021|NCT02122250|Diabetes|diabetes
1180022|NCT02122250|Health literacy|health literacy
1180023|NCT02122250|web intervention|web intervention
1180024|NCT02122224|satiety|satiety
1180025|NCT02122224|satiation|satiation
1180026|NCT02122224|diet quality|diet quality
1180027|NCT02122224|memory|memory
1180028|NCT02122224|obesity|obesity
1180029|NCT02122224|protein|protein
1180030|NCT02122224|fiber|fiber
1180031|NCT02122211|Sperm motility|sperm motility
1180032|NCT02122198|Cognitive impairment|cognitive impairment
1180033|NCT02122198|Executive function|executive function
1180034|NCT02122198|Arterial stiffness|arterial stiffness
1180035|NCT02122198|Endothelial function|endothelial function
1180036|NCT02122198|Menopause|menopause
1180037|NCT02122198|Women's health|women's health
1180038|NCT02122198|Hormone therapy|hormone therapy
1180039|NCT02122198|functional MRI|functional mri
1180040|NCT02122159|safety|safety
1180041|NCT02122159|tolerability|tolerability
1180042|NCT02122159|RPE cellular therapy|rpe cellular therapy
1180043|NCT02122159|MMD|mmd
1180044|NCT02122146|ADC|adc
1180045|NCT02122146|PF-06664178|pf-06664178
1180046|NCT02122146|solid tumors|solid tumors
1180047|NCT02122146|tumors|tumors
1180048|NCT02122146|neoplasm metastasis|neoplasm metastasis
1180049|NCT02122146|NSCLC|nsclc
1180050|NCT02122146|non small cell lung cancer|non small cell lung cancer
1180051|NCT02122146|OVCA|ovca
1180052|NCT02122146|ovarian cancer|ovarian cancer
1180053|NCT02122146|Phase 1|phase 1
1180054|NCT02122146|breast cancer|breast cancer
1180055|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
1180056|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
1180057|NCT02122107|Treatment Exposure|treatment exposure
1180058|NCT02122107|Smoking History|smoking history
1180059|NCT02122107|14-071|14-071
1180060|NCT02122068|Meditation|meditation
1180061|NCT02122068|Mindfulness|mindfulness
1180062|NCT02122068|Caregiver|caregiver
1180063|NCT02122068|Dementia|dementia
1180064|NCT02122068|Depression|depression
1180065|NCT02122055|combined sedation|combined sedation
1180066|NCT02122029|Lifestyle intervention|lifestyle intervention
1180067|NCT02122029|Bariatric surgery|bariatric surgery
1180068|NCT02122029|Weight management|weight management
1180069|NCT02122029|Physical activity|physical activity
1180070|NCT02122016|Ventilator weaning|ventilator weaning
1180071|NCT02122016|Protocols|protocols
1180072|NCT02122016|Computer driven weaning|computer driven weaning
1180073|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
1180074|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
1180075|NCT02122016|Respiration, Artificial|respiration, artificial
1180076|NCT02122003|sorafenib|sorafenib
1180077|NCT02122003|pazopanib|pazopanib
1180078|NCT02122003|cross-resistance|cross-resistance
1180079|NCT02122003|TKI|tki
1180080|NCT02122003|mRCC|mrcc
1180081|NCT02121990|(IP) Cisplatin|(ip) cisplatin
1180082|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
1180083|NCT02121990|IV Bevacizumab|iv bevacizumab
1180084|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
1180085|NCT02121990|Optimally Debulked|optimally debulked
1180086|NCT02121990|Stage II/III|stage ii/iii
1180087|NCT02121990|Ovary|ovary
1180088|NCT02121990|Pertoneum|pertoneum
1180089|NCT02121990|10-220|10-220
1180090|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
1180091|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
1180092|NCT02121964|Arthritis|arthritis
1180093|NCT02121964|Orthopedic Disorders|orthopedic disorders
1180094|NCT02121964|Orthopedics|orthopedics
1180095|NCT02121964|Surgery,|surgery,
1180096|NCT02121964|Orthopedic|orthopedic
1180097|NCT02121964|arthroplasty|arthroplasty
1180098|NCT02121964|hip|hip
1180099|NCT02121964|osteoarthritis|osteoarthritis
1180100|NCT02121964|capsulectomy|capsulectomy
1180101|NCT02121964|capsulotomy|capsulotomy
1180102|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
1180103|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
1180105|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
1180106|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1180107|NCT02121938|Microbiome|microbiome
1180108|NCT02121925|Registry|registry
1180109|NCT02121899|Registry|registry
1180110|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
1180111|NCT02121860|Hepatic Impairment|hepatic impairment
1180112|NCT02121860|Pharmacokinetics|pharmacokinetics
1180113|NCT02121860|Pharmacodynamics|pharmacodynamics
1180114|NCT02121808|Morbid Obesity|morbid obesity
1180115|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
1180116|NCT02121808|Pre-Oxygenation|pre-oxygenation
1180117|NCT02121808|Functional Residual Capacity|functional residual capacity
1180119|NCT02121795|HIV-1 Positive|hiv-1 positive
1180120|NCT02121795|Virologically-suppressed|virologically-suppressed
1180121|NCT02121782|QIV|qiv
1180122|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
1180123|NCT02121782|Influenza vaccine|influenza vaccine
1180124|NCT02121782|Vaccination|vaccination
1180125|NCT02121769|cholestasis|cholestasis
1180126|NCT02121769|short bowel syndrome|short bowel syndrome
1180127|NCT02121756|Dipyridamole|dipyridamole
1180128|NCT02121756|HIV|hiv
1180129|NCT02121756|Immune Markers|immune markers
1180130|NCT02121756|Immune Activation|immune activation
1180131|NCT02121756|Inflammation|inflammation
1180132|NCT02121743|strattice|strattice
1180133|NCT02121743|colostomy|colostomy
1180134|NCT02121743|parastomal hernia|parastomal hernia
1180135|NCT02121730|grafting kidney|grafting kidney
1180137|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
1180138|NCT02121704|Sedation|sedation
1180139|NCT02121704|Colonoscopy|colonoscopy
1180140|NCT02121704|Propofol|propofol
1180141|NCT02121704|Scope guide|scope guide
1180142|NCT02121691|Cancer|cancer
1180143|NCT02121691|Obesity|obesity
1180144|NCT02121691|Body Mass Index|body mass index
1180145|NCT02121678|Resistance training|resistance training
1180146|NCT02121678|Aerobic exercise|aerobic exercise
1180147|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
1180148|NCT02121678|Bicycle ergometry test|bicycle ergometry test
1180149|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
1180150|NCT02121652|lung cancer survivors|lung cancer survivors
1180151|NCT02121652|insomnia treatment|insomnia treatment
1180152|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
1180153|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
1180154|NCT02121639|AZD5363|azd5363
1180155|NCT02121639|Docetaxel|docetaxel
1180156|NCT02121639|Prednisolone|prednisolone
1180157|NCT02121626|Cancer|cancer
1180158|NCT02121626|Chemotheraphy|chemotheraphy
1180159|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
1180160|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
1180161|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
1180162|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
1180163|NCT02121626|Anorexia|anorexia
1180164|NCT02121626|Borborygmi|borborygmi
1180165|NCT02121626|Bloating|bloating
1180166|NCT02121626|Constipation|constipation
1180167|NCT02121626|Diarrhoea|diarrhoea
1180168|NCT02121626|Mucositis|mucositis
1180169|NCT02121626|Dysphagia|dysphagia
1180170|NCT02121626|Early satiety|early satiety
1180171|NCT02121626|Frequency of defaecation|frequency of defaecation
1180172|NCT02121626|Incontinence|incontinence
1180173|NCT02121626|Mucus discharge|mucus discharge
1180174|NCT02121626|Nausea|nausea
1180175|NCT02121626|Nocturnal defaecation|nocturnal defaecation
1180176|NCT02121626|Pain|pain
1180177|NCT02121626|Reflux|reflux
1180178|NCT02121626|Regurgitation|regurgitation
1180179|NCT02121626|Steatorrhoea|steatorrhoea
1180180|NCT02121626|Tenesmus|tenesmus
1180181|NCT02121626|Urgency of defaecation|urgency of defaecation
1180182|NCT02121626|Vomiting|vomiting
1180183|NCT02121626|Weight loss|weight loss
1180184|NCT02121626|Wind.|wind.
1180185|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
1180186|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
1180187|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1180188|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
1180189|NCT02121574|Surgery|surgery
1180190|NCT02121574|thermometers|thermometers
1180191|NCT02121574|Hypothermia|hypothermia
1180192|NCT02121574|anesthesia|anesthesia
1180193|NCT02121574|temperature|temperature
1180194|NCT02121561|Shame|shame
1180195|NCT02121548|Screen|screen
1180196|NCT02121548|cervical, cancer|cervical, cancer
1180197|NCT02121548|HPV|hpv
1180198|NCT02121548|women|women
1180199|NCT02121548|community health workers|community health workers
1180200|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
1180204|NCT02121496|Infant sleep|infant sleep
1180205|NCT02121470|AKI|aki
1180206|NCT02121470|Acute Kidney Injury|acute kidney injury
1180207|NCT02121470|Renal failure|renal failure
1180208|NCT02121470|NGAL|ngal
1180209|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
1180210|NCT02121470|lipocalin-2|lipocalin-2
1180211|NCT02121470|siderocalin|siderocalin
1180212|NCT02121470|Intensive care|intensive care
1180213|NCT02121470|ICU|icu
1180214|NCT02121470|Critical care|critical care
1180215|NCT02121457|cognitive performance|cognitive performance
1180216|NCT02121457|selenium|selenium
1180217|NCT02121457|brazil nuts|brazil nuts
1180218|NCT02121457|oxidative stress|oxidative stress
1180219|NCT02121444|RRMS|rrms
1180220|NCT02121444|CIS|cis
1180221|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
1180222|NCT02121366|Insulinoma|insulinoma
1180223|NCT02121366|Ethanol|ethanol
1180224|NCT02121366|Ablation Techniques|ablation techniques
1180225|NCT02121353|Age related macular degeneration|age related macular degeneration
1180226|NCT02121353|AMD|amd
1180227|NCT02121353|Wet AMD|wet amd
1180228|NCT02121353|Eye conditions|eye conditions
1180229|NCT02121353|CFT|cft
1180230|NCT02121353|OCT|oct
1180231|NCT02121353|CNV|cnv
1180232|NCT02121353|FA|fa
1180233|NCT02121353|Ocular|ocular
1180234|NCT02121353|Eye|eye
1180235|NCT02121353|Disorder of the eye|disorder of the eye
1180236|NCT02121340|Depression|depression
1180237|NCT02121340|Health disparities|health disparities
1180238|NCT02121340|African American|african american
1180239|NCT02121340|Geriatric|geriatric
1180240|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
1180241|NCT02121314|TB|tb
1180242|NCT02121314|bioavailability|bioavailability
1180243|NCT02121314|HRZE|hrze
1180244|NCT02121314|fasting|fasting
1180245|NCT02121314|fed|fed
1180246|NCT02121301|Dry Eye|dry eye
1180247|NCT02121301|Dry Eye Syndrome|dry eye syndrome
1180248|NCT02121301|SkQ1|skq1
1180249|NCT02121301|KCS|kcs
1180250|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
1180251|NCT02121288|Peripheral Artery Disease|peripheral artery disease
1180252|NCT02121288|Myocardial Blood Flow|myocardial blood flow
1180253|NCT02121288|Cardiac Blood Flow|cardiac blood flow
1180254|NCT02121236|CBCT|cbct
1180255|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
1180256|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
1180257|NCT02121236|Histopathology|histopathology
1180258|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
1180259|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
1180260|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
1180261|NCT02121197|Macular Diabetic Edema|macular diabetic edema
1180262|NCT02121197|Ozurdex|ozurdex
1180263|NCT02121197|Retrospective|retrospective
1180264|NCT02121197|European|european
1180265|NCT02121197|Intra-vitreal injections|intra-vitreal injections
1180266|NCT02121184|Oxytocin|oxytocin
1180267|NCT02121184|Labor, Obstetric|labor, obstetric
1180268|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
1180269|NCT02121184|Epidural|epidural
1180270|NCT02121158|CSP 592|csp 592
1180271|NCT02121158|ICD|icd
1180272|NCT02121158|cardiovascular|cardiovascular
1180273|NCT02121158|heart|heart
1180274|NCT02121158|aging|aging
1180275|NCT02121158|chronic diseases|chronic diseases
1180276|NCT02121158|multi-site trial|multi-site trial
1180277|NCT02121158|investigational device|investigational device
1180278|NCT02121158|cardiomyopathy|cardiomyopathy
1180279|NCT02121158|coronary artery disease|coronary artery disease
1180280|NCT02121158|congestive heart failure|congestive heart failure
1180281|NCT02121158|myocardial infarction|myocardial infarction
1180282|NCT02121158|I-70|i-70
1180283|NCT02121158|I70|i70
1180284|NCT02121158|elderly|elderly
1180285|NCT02121158|defibrillator|defibrillator
1180286|NCT02121145|Vivotif|vivotif
1180287|NCT02121145|Typherix|typherix
1180288|NCT02121145|Salmonella Typhi|salmonella typhi
1180289|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
1180290|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
1180291|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
1180292|NCT02121145|Plasmablast|plasmablast
1180293|NCT02121132|Overweight|overweight
1180294|NCT02121132|Obesity|obesity
1180295|NCT02121119|Peripheral nerve block|peripheral nerve block
1180296|NCT02121119|Lidocaine|lidocaine
1180297|NCT02121119|Bupivacaine|bupivacaine
1180298|NCT02121093|vibration|vibration
1180299|NCT02121093|physiotherapy|physiotherapy
1180300|NCT02121093|cortex|cortex
1180301|NCT02121093|muscles|muscles
1180302|NCT02121067|postpartum|postpartum
1180303|NCT02121067|contraception|contraception
1180304|NCT02121067|intrauterine device|intrauterine device
1180305|NCT02121067|intrauterine system|intrauterine system
1180306|NCT02121067|mirena|mirena
1180307|NCT02121067|uterine involution|uterine involution
1180308|NCT02121054|Antiplatelet Agents|antiplatelet agents
1180309|NCT02121054|Drug Resistance|drug resistance
1180310|NCT02121041|Hypertension|hypertension
1180311|NCT02121041|Blood Pressure|blood pressure
1180312|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1180313|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
1180314|NCT02121028|Stroke|stroke
1180315|NCT02121028|Transient Ischemic Attack|transient ischemic attack
1180316|NCT02121028|Imaging|imaging
1180317|NCT02121015|Postpartum Depression|postpartum depression
1180318|NCT02121015|Depression Prevention|depression prevention
1180319|NCT02121015|Supportive Accountability|supportive accountability
1180320|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
1180321|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
1180322|NCT02121002|Knee|knee
1180323|NCT02120989|insomnia|insomnia
1180324|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
1180325|NCT02120989|partner-assisted|partner-assisted
1180326|NCT02120976|Safety|safety
1180327|NCT02120976|Tolerability|tolerability
1180328|NCT02120976|Pharmacokinetics|pharmacokinetics
1180329|NCT02120976|Food-effect|food-effect
1180330|NCT02120976|Diabetes|diabetes
1180331|NCT02120963|Fatigue|fatigue
1180332|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
1180333|NCT02120963|Physical Therapy|physical therapy
1180334|NCT02120963|Person-Centred Care|person-centred care
1180335|NCT02120950|PCV|pcv
1180336|NCT02120937|amygdala|amygdala
1180337|NCT02120937|mindfulness|mindfulness
1180338|NCT02120937|mood|mood
1180339|NCT02120937|emotion|emotion
1180340|NCT02120937|bipolar disorder|bipolar disorder
1180341|NCT02120937|parental bipolar disorder|parental bipolar disorder
1180342|NCT02120937|adolescence|adolescence
1180343|NCT02120924|Moderate facial rosacea|moderate facial rosacea
1180344|NCT02120924|Azelaic acid|azelaic acid
1180345|NCT02120924|Rosacea|rosacea
1180346|NCT02120911|Her2+|her2+
1180347|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
1180348|NCT02120911|Pertuzumab|pertuzumab
1180349|NCT02120911|Trastuzumab|trastuzumab
1180350|NCT02120898|Actinic Keratosis|actinic keratosis
1180351|NCT02120898|Imiquimod|imiquimod
1180352|NCT02120898|Zyclara|zyclara
1180353|NCT02120885|Gastric cancer|gastric cancer
1180354|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
1180355|NCT02120885|Physical activity intervention|physical activity intervention
1180356|NCT02120859|PCI|pci
1180357|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
1180358|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
1180359|NCT02120846|Stroke|stroke
1180360|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
1180361|NCT02120846|Muscle function|muscle function
1180362|NCT02120846|Cognitive function|cognitive function
1180363|NCT02120833|Atopic Dermatitis|atopic dermatitis
1180364|NCT02120820|massage|massage
1180365|NCT02120820|multisensory environment|multisensory environment
1180366|NCT02120820|challenging behaviours|challenging behaviours
1180367|NCT02120820|relaxation|relaxation
1180368|NCT02120807|Certolizumab|certolizumab
1180369|NCT02120807|Cisplatin|cisplatin
1180370|NCT02120807|Pemetrexed|pemetrexed
1180371|NCT02120807|thoracic|thoracic
1180372|NCT02120807|13-063|13-063
1180373|NCT02120794|Type 1 diabetes|type 1 diabetes
1180374|NCT02120794|Pediatric|pediatric
1180375|NCT02120794|Threshold Suspend|threshold suspend
1180376|NCT02120794|Sensor augmented pump|sensor augmented pump
1180377|NCT02120768|Barrier resection|barrier resection
1180378|NCT02120768|Local recurrence|local recurrence
1180379|NCT02120768|Complication|complication
1180380|NCT02120742|Road traffic injury prevention|road traffic injury prevention
1180381|NCT02120742|Helmet use|helmet use
1180382|NCT02120742|mHealth intervention|mhealth intervention
1180383|NCT02120729|Pharmacogenetics|pharmacogenetics
1180384|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
1180385|NCT02120729|Major Depressive Disorder|major depressive disorder
1180386|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
1180387|NCT02120729|Length of Stay|length of stay
1180388|NCT02120729|30 Day Readmission Rate|30 day readmission rate
1180389|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
1180390|NCT02120716|HIV|hiv
1180391|NCT02120716|STIs|stis
1180392|NCT02120716|Health Check Up|health check up
1180393|NCT02120716|Intervention|intervention
1180394|NCT02120703|Pregabalin|pregabalin
1180395|NCT02120703|gabapentin|gabapentin
1180396|NCT02120703|microdiscectomy|microdiscectomy
1180397|NCT02120703|pain|pain
1180398|NCT02120690|pain|pain
1180399|NCT02120690|fibromyagia|fibromyagia
1180400|NCT02120690|TNS|tns
1180401|NCT02120677|skin cancer|skin cancer
1180402|NCT02120677|basal cell carcinoma|basal cell carcinoma
1180403|NCT02120651|Fibrin monomer|fibrin monomer
1180404|NCT02120651|Tympanoplasty|tympanoplasty
1180405|NCT02120651|Hemostatic sponge|hemostatic sponge
1180406|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
1180407|NCT02120638|Pyrazinamide|pyrazinamide
1180408|NCT02120625|radiofrequency ablation|radiofrequency ablation
1180409|NCT02120625|neurotomy|neurotomy
1180410|NCT02120625|facet joint|facet joint
1180411|NCT02120625|medial branch|medial branch
1180412|NCT02120625|low back pain|low back pain
1180413|NCT02120612|Opioid Dependence|opioid dependence
1180414|NCT02120612|Addiction|addiction
1180415|NCT02120612|Naloxone|naloxone
1180416|NCT02120612|Naloxone Education|naloxone education
1180417|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
1180418|NCT02120612|OOKS|ooks
1180419|NCT02120586|Elderly|elderly
1180420|NCT02120586|Institutionalization|institutionalization
1180421|NCT02120586|Sarcopenia|sarcopenia
1180422|NCT02120586|Strength training|strength training
1180423|NCT02120586|Muscle mass|muscle mass
1180424|NCT02120586|Muscle strength|muscle strength
1180425|NCT02120586|Physical performance|physical performance
1180426|NCT02120573|Cardiac Arrest|cardiac arrest
1180427|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1180428|NCT02120573|Training|training
1180429|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
1180430|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
1180431|NCT02120560|Neurocognitive Function|neurocognitive function
1180432|NCT02120547|Liver Insufficiency|liver insufficiency
1180433|NCT02120547|Hepatic impairment|hepatic impairment
1180434|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
1180435|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
1180436|NCT02120508|stroke|stroke
1180437|NCT02120508|aphasia|aphasia
1180438|NCT02120508|rTMS|rtms
1180439|NCT02120508|Functional MRI|functional mri
1180440|NCT02120508|Speech training|speech training
1180441|NCT02120495|condylectomy|condylectomy
1180442|NCT02120495|TMJ function|tmj function
1180443|NCT02120495|intraoral approach|intraoral approach
1180444|NCT02120482|ABO isoagglutinins|abo isoagglutinins
1180445|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
1180446|NCT02120482|immunoadsorption|immunoadsorption
1180447|NCT02120482|membrane filtration|membrane filtration
1180448|NCT02120482|plasmapheresis|plasmapheresis
1180449|NCT02120443|infiltration|infiltration
1180450|NCT02120443|extravasation|extravasation
1180451|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
1180452|NCT02120430|Early childhood|early childhood
1180453|NCT02120430|Audiovisual materials|audiovisual materials
1180454|NCT02120430|Parent-child interaction|parent-child interaction
1180455|NCT02120430|Parenting programs|parenting programs
1180456|NCT02120430|Timing|timing
1180457|NCT02120417|Breast Cancer|breast cancer
1180458|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
1180459|NCT02120378|miscarriage|miscarriage
1180460|NCT02120378|fetal viability|fetal viability
1180461|NCT02120378|prematurity|prematurity
1180462|NCT02120365|Alcoholism|alcoholism
1180463|NCT02120365|Heavy Drinking|heavy drinking
1180464|NCT02120365|Perampanel|perampanel
1180465|NCT02120352|bi-monthly|bi-monthly
1180466|NCT02120352|GSK744|gsk744
1180467|NCT02120352|injectable|injectable
1180468|NCT02120352|long acting|long acting
1180469|NCT02120352|maintenance|maintenance
1180470|NCT02120352|abacavir|abacavir
1180471|NCT02120352|every other month|every other month
1180472|NCT02120352|rilpivirine|rilpivirine
1180473|NCT02120352|HIV-1 infection|hiv-1 infection
1180474|NCT02120352|integrase inhibitor|integrase inhibitor
1180475|NCT02120352|TMC278 LA|tmc278 la
1180477|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1180478|NCT02120352|LA|la
1180479|NCT02120352|once monthly|once monthly
1180480|NCT02120352|GSK1265744|gsk1265744
1180481|NCT02120352|induction|induction
1180482|NCT02120352|treatment satisfication|treatment satisfication
1180483|NCT02120352|once daily|once daily
1180484|NCT02120352|lamivudine|lamivudine
1180485|NCT02120352|adherence|adherence
1180486|NCT02120352|TMC278|tmc278
1180487|NCT02120352|therapy-naive|therapy-naive
1180488|NCT02120339|Hypertension|hypertension
1180489|NCT02120339|PAH|pah
1180490|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
1180491|NCT02120313|rehabilitation|rehabilitation
1180492|NCT02120313|total knee arthroplasty|total knee arthroplasty
1180493|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
1180494|NCT02120287|Bevacizumab|bevacizumab
1180495|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1180496|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
1180497|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1180498|NCT02120287|Glioblastoma|glioblastoma
1180499|NCT02120287|Brain Cancer|brain cancer
1180500|NCT02120287|Brain Tumor|brain tumor
1180501|NCT02120287|Radiosurgery|radiosurgery
1180502|NCT02120274|RNA Virus Infections|rna virus infections
1180503|NCT02120274|Flaviviridae Infections|flaviviridae infections
1180504|NCT02120274|Hepatitis C|hepatitis c
1180505|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
1180506|NCT02120274|Vitamin D|vitamin d
1180507|NCT02120274|Cholecalciferol|cholecalciferol
1180508|NCT02120274|Vitamin B 12|vitamin b 12
1180509|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
1180510|NCT02120261|trigger point injection|trigger point injection
1180511|NCT02120248|WIC|wic
1180512|NCT02120248|Oregon|oregon
1180513|NCT02120248|Breastfeeding|breastfeeding
1180514|NCT02120248|Peer Counseling|peer counseling
1180515|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
1180516|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
1180517|NCT02120235|LSD|lsd
1180518|NCT02120235|Gaucher disease|gaucher disease
1180519|NCT02120235|Fabry disease|fabry disease
1180520|NCT02120235|Pompe disease|pompe disease
1180521|NCT02120235|Niemann-Pick disease|niemann-pick disease
1180522|NCT02120222|melanoma|melanoma
1180523|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
1180524|NCT02120183|Caregivers|caregivers
1180525|NCT02120183|Quality of life|quality of life
1180526|NCT02120183|Neoplasms|neoplasms
1180527|NCT02120183|Psychotherapy, group|psychotherapy, group
1180528|NCT02120183|Family|family
1180529|NCT02120183|Adaptation, psychological|adaptation, psychological
1180530|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
1180531|NCT02120183|Cancer patients|cancer patients
1180532|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
1180533|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1180534|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
1180535|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1180536|NCT02120157|Treatment related leukemia|treatment related leukemia
1180537|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
1180538|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
1180539|NCT02120118|Treatment failure|treatment failure
1180540|NCT02120105|Renal aminoaciduria|renal aminoaciduria
1180541|NCT02120105|cystinuria|cystinuria
1180542|NCT02120105|D-penicillamine|d-penicillamine
1180543|NCT02120105|renal tubular transport|renal tubular transport
1180544|NCT02120105|inborn errors|inborn errors
1180545|NCT02120105|tiopronin|tiopronin
1180546|NCT02120105|urolithiasis|urolithiasis
1180547|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
1180548|NCT02120079|Dry Eye|dry eye
1180549|NCT02120066|Submacular hemorrhage|submacular hemorrhage
1180550|NCT02120066|Vitrectomy|vitrectomy
1180551|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
1180552|NCT02120053|Immediate complete denture|immediate complete denture
1180553|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
1180554|NCT02120053|Alveolar bone loss|alveolar bone loss
1180555|NCT02120053|Bone substitute material|bone substitute material
1180556|NCT02120053|Edentulism|edentulism
1180557|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
1180558|NCT02120027|Colon, irritable|colon, irritable
1180559|NCT02120027|Bowel disease|bowel disease
1180560|NCT02120027|Diarrhea|diarrhea
1180561|NCT02120014|Heart Failure|heart failure
1180562|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
1180563|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
1180564|NCT02120014|Venous Plethysmography|venous plethysmography
1180565|NCT02120014|Blood Volume Study|blood volume study
1180566|NCT02120001|Medical Devices|medical devices
1180567|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
1180568|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
1180569|NCT02120001|Endotracheal Tube|endotracheal tube
1180570|NCT02120001|Microbial Diversity|microbial diversity
1180571|NCT02120001|Drug-Resistance|drug-resistance
1180572|NCT02120001|biofilms|biofilms
1180573|NCT02120001|endotracheal intubation|endotracheal intubation
1180574|NCT02120001|mechanical ventilation|mechanical ventilation
1180575|NCT02119988|TIPS|tips
1180576|NCT02119988|Embolization|embolization
1180577|NCT02119988|Variceal rebleeding|variceal rebleeding
1180578|NCT02119975|Rumination|rumination
1180579|NCT02119975|Working memory|working memory
1180580|NCT02119975|Depression|depression
1180581|NCT02119975|Anxiety|anxiety
1180582|NCT02119975|Working memory training|working memory training
1180583|NCT02119975|Overgeneral memories|overgeneral memories
1180584|NCT02119962|burnout|burnout
1180585|NCT02119962|working memory|working memory
1180586|NCT02119962|working memory training|working memory training
1180587|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
1180588|NCT02119962|executive control|executive control
1180589|NCT02119949|Substance abuse|substance abuse
1180590|NCT02119949|Addiction|addiction
1180591|NCT02119949|Working memory|working memory
1180592|NCT02119949|Craving|craving
1180593|NCT02119949|Impulsivity|impulsivity
1180594|NCT02119949|Attention control|attention control
1180595|NCT02119936|Stress|stress
1180596|NCT02119936|Anxiety|anxiety
1180597|NCT02119936|Mental Health|mental health
1180598|NCT02119936|Mental Health Services|mental health services
1180599|NCT02119936|Maternal Mental Health|maternal mental health
1251190|NCT01800721|HIV|hiv
1180600|NCT02119923|Depression|depression
1180601|NCT02119923|Anxiety|anxiety
1180602|NCT02119923|Working memory|working memory
1180603|NCT02119923|Rumination|rumination
1180604|NCT02119923|Cognitive training|cognitive training
1180605|NCT02119923|Executive functioning|executive functioning
1180803|NCT02119117|COQ10|coq10
1180606|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
1180607|NCT02119910|behavioral intervention|behavioral intervention
1180608|NCT02119910|treatment manual|treatment manual
1180609|NCT02119910|feeding|feeding
1180610|NCT02119910|food refusal|food refusal
1180611|NCT02119910|diet|diet
1180612|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
1180613|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
1180614|NCT02119897|Low Level Light Therapy|low level light therapy
1180615|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
1180616|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
1180617|NCT02119884|Terlipressin|terlipressin
1180618|NCT02119884|Octreotide|octreotide
1180619|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
1180620|NCT02119845|Chronic kidney disease|chronic kidney disease
1180621|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
1180622|NCT02119845|Hemodialysis|hemodialysis
1180623|NCT02119845|Vascular access|vascular access
1180624|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
1180625|NCT02119832|Chronic kidney disease|chronic kidney disease
1180626|NCT02119832|Arteriovenous fistula|arteriovenous fistula
1180627|NCT02119832|Hemodialysis|hemodialysis
1180628|NCT02119832|Vascular access|vascular access
1180629|NCT02119819|Weight loss|weight loss
1180630|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
1180631|NCT02119767|Atherosclerosis|atherosclerosis
1180632|NCT02119754|Wound|wound
1180633|NCT02119754|Ulcer|ulcer
1180634|NCT02119754|Infected|infected
1180635|NCT02119754|Infection|infection
1180636|NCT02119741|Interdental papilla|interdental papilla
1180637|NCT02119741|hyaluronic acid|hyaluronic acid
1180638|NCT02119741|esthetic zone|esthetic zone
1180639|NCT02119741|black triangles|black triangles
1180640|NCT02119715|Breast Cancer|breast cancer
1180641|NCT02119715|Neutropenia|neutropenia
1180642|NCT02119715|Febrile Neutropenia|febrile neutropenia
1180769|NCT02119273|Endoscopic|endoscopic
1180643|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
1180644|NCT02119689|Diabetes|diabetes
1180645|NCT02119689|Retinopathy|retinopathy
1180646|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
1180647|NCT02119676|Colon Cancer|colon cancer
1180648|NCT02119676|Ruxolitinib|ruxolitinib
1180649|NCT02119676|adenocarcinoma|adenocarcinoma
1180650|NCT02119676|regorafenib|regorafenib
1180651|NCT02119676|Jakavi ®|jakavi ®
1180652|NCT02119676|Jakafi ®|jakafi ®
1180653|NCT02119676|Stivarga ®|stivarga ®
1180654|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
1180655|NCT02119650|Non small cell lung cancer|non small cell lung cancer
1180656|NCT02119637|Emotion|emotion
1180657|NCT02119637|Tactile Discrimination|tactile discrimination
1180658|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1180659|NCT02119637|Somatosensory|somatosensory
1180660|NCT02119637|Somatosensory Cortex|somatosensory cortex
1180661|NCT02119624|Neural Networks|neural networks
1180662|NCT02119624|Alcoholism|alcoholism
1180663|NCT02119624|fMRI|fmri
1180664|NCT02119624|Reward|reward
1180665|NCT02119624|Addiction|addiction
1180666|NCT02119611|Deep Brain Stimulation|deep brain stimulation
1180667|NCT02119611|Movement Disorders|movement disorders
1180668|NCT02119611|Parkinson's Disease|parkinson's disease
1180669|NCT02119611|Dystonia|dystonia
1180670|NCT02119611|Essential Tremor|essential tremor
1180671|NCT02119598|Prehospital care|prehospital care
1180672|NCT02119598|Telemedicine|telemedicine
1180673|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
1180674|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
1180675|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
1180676|NCT02119585|cytokines|cytokines
1180677|NCT02119585|respiratory system elastance|respiratory system elastance
1180678|NCT02119585|lung elastance|lung elastance
1180679|NCT02119585|chest wall elastance|chest wall elastance
1180680|NCT02119585|shunt|shunt
1180681|NCT02119585|dead space|dead space
1180682|NCT02119585|acute respiratory failure|acute respiratory failure
1180683|NCT02119585|atelectasis|atelectasis
1180684|NCT02119585|pleural effusion|pleural effusion
1180685|NCT02119572|diabetes,peer support|diabetes,peer support
1180686|NCT02119559|Circulating Tumor Cells|circulating tumor cells
1180687|NCT02119559|Treatment Efficiency|treatment efficiency
1180688|NCT02119559|Biomarker|biomarker
1180689|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
1180690|NCT02119546|Alzheimer's disease|alzheimer's disease
1180691|NCT02119546|Cognitive function|cognitive function
1180692|NCT02119546|Exercise training|exercise training
1180693|NCT02119533|brain injury|brain injury
1180694|NCT02119533|concussion|concussion
1180695|NCT02119533|post traumatic stress|post traumatic stress
1180696|NCT02119520|Periodontitis|periodontitis
1180697|NCT02119520|Surgery|surgery
1180698|NCT02119520|Growth Factors|growth factors
1180699|NCT02119520|Statins|statins
1180700|NCT02119507|Dental caries|dental caries
1180701|NCT02119507|Curodont Repair|curodont repair
1180702|NCT02119507|P11-4|p11-4
1181001|NCT02118168|HAART|haart
1180703|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1180704|NCT02119494|phenotypes|phenotypes
1180705|NCT02119494|categories|categories
1180706|NCT02119494|stage|stage
1180707|NCT02119494|GOLD|gold
1180708|NCT02119494|treatment|treatment
1180810|NCT02119078|Geriatric syndromes|geriatric syndromes
1180709|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
1180710|NCT02119481|Expressive writing condition|expressive writing condition
1180711|NCT02119481|Waiting list control condition|waiting list control condition
1180712|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
1180713|NCT02119429|Blood pressure|blood pressure
1180714|NCT02119429|Pre-menopausal|pre-menopausal
1180715|NCT02119429|Supplementation|supplementation
1180716|NCT02119416|Cardiovascular influences|cardiovascular influences
1180717|NCT02119416|caffeine|caffeine
1180718|NCT02119416|healthy children|healthy children
1180719|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
1180720|NCT02119390|adolescents|adolescents
1180721|NCT02119390|young adults|young adults
1180722|NCT02119390|medication adherence|medication adherence
1180723|NCT02119377|trans|trans
1180724|NCT02119377|transsexual|transsexual
1180725|NCT02119377|transgender|transgender
1180726|NCT02119377|sistergirl|sistergirl
1180727|NCT02119377|brotherboy|brotherboy
1180728|NCT02119377|androgynous|androgynous
1180729|NCT02119377|genderqueer|genderqueer
1180730|NCT02119364|cerebral palsy|cerebral palsy
1180731|NCT02119364|working memory|working memory
1180732|NCT02119364|cognitive training|cognitive training
1180733|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
1180734|NCT02119351|blood exposure|blood exposure
1180735|NCT02119351|blood control|blood control
1180736|NCT02119351|IV catheter insertion|iv catheter insertion
1180737|NCT02119338|5-ala|5-ala
1180738|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
1180739|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
1180740|NCT02119338|glioma|glioma
1180741|NCT02119338|astrocytoma|astrocytoma
1180742|NCT02119338|glioblastoma|glioblastoma
1180743|NCT02119338|oligodendroglioma|oligodendroglioma
1180744|NCT02119338|recurrence of glioma|recurrence of glioma
1180745|NCT02119325|fibre|fibre
1180746|NCT02119325|overweight|overweight
1180747|NCT02119325|impaired fasting glucose|impaired fasting glucose
1180748|NCT02119312|Malaria|malaria
1180749|NCT02119312|Plasmodium|plasmodium
1180750|NCT02119312|Plasmodium falciparum|plasmodium falciparum
1180751|NCT02119312|Clinical Trials|clinical trials
1180752|NCT02119312|Vaccine Study|vaccine study
1180753|NCT02119312|Drug Study|drug study
1180754|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
1180755|NCT02119312|Seattle BioMed|seattle biomed
1180756|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
1180757|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
1180758|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
1180759|NCT02119286|dry powder inhaler|dry powder inhaler
1180760|NCT02119286|safety|safety
1180761|NCT02119286|COPD|copd
1180762|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
1180763|NCT02119286|efficacy|efficacy
1180764|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
1180765|NCT02119286|umeclidinium bromide|umeclidinium bromide
1180766|NCT02119273|CRSsNP|crssnp
1180767|NCT02119273|Steroids|steroids
1180768|NCT02119273|Corticosteroids|corticosteroids
1180770|NCT02119273|Surgery|surgery
1180771|NCT02119273|Perioperative|perioperative
1180772|NCT02119260|First Time in Human|first time in human
1180773|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
1180774|NCT02119260|Heart failure|heart failure
1180775|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
1180776|NCT02119195|composite|composite
1180777|NCT02119195|sealant|sealant
1180778|NCT02119195|longevity|longevity
1180779|NCT02119182|Traumatic Brain Injury|traumatic brain injury
1180780|NCT02119182|Biomarkers|biomarkers
1180781|NCT02119182|Neuroimaging|neuroimaging
1180782|NCT02119182|Psychological Health|psychological health
1180783|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
1180784|NCT02119156|treatment holiday|treatment holiday
1180785|NCT02119156|PGA|pga
1180786|NCT02119156|belimumab|belimumab
1180787|NCT02119156|Lymphostat-B|lymphostat-b
1180788|NCT02119156|rebound|rebound
1180789|NCT02119156|SELENA SLEDAI|selena sledai
1180790|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
1180791|NCT02119156|immunogenicity|immunogenicity
1333253|NCT01443819|Transforaminal|transforaminal
1180792|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
1180793|NCT02119130|cluster randomized trial|cluster randomized trial
1180794|NCT02119130|interferon-gamma|interferon-gamma
1180795|NCT02119130|tuberculin test|tuberculin test
1180796|NCT02119130|operational comparison|operational comparison
1180797|NCT02119130|cost effectiveness|cost effectiveness
1180798|NCT02119130|qualitative evaluation|qualitative evaluation
1180799|NCT02119117|mtDNA|mtdna
1180800|NCT02119117|aneuploidy|aneuploidy
1180804|NCT02119091|QT prolongation|qt prolongation
1180805|NCT02119091|Chinese|chinese
1180806|NCT02119091|Caucasian|caucasian
1180807|NCT02119091|Moxifloxacin|moxifloxacin
1180808|NCT02119078|Geriatrics|geriatrics
1180809|NCT02119078|Acute Care for Elders|acute care for elders
1180811|NCT02119078|Delirium|delirium
1180812|NCT02119078|Falls|falls
1180813|NCT02119078|Polypharmacy|polypharmacy
1180814|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
1180815|NCT02119065|hepatic malignancy|hepatic malignancy
1180816|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
1180817|NCT02119039|Cross-linking|cross-linking
1180818|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
1180819|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
1180820|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
1180821|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
1180822|NCT02118987|Drug Desensitization|drug desensitization
1180823|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
1180824|NCT02118974|Hysterectomy|hysterectomy
1180825|NCT02118974|Robot-assisted|robot-assisted
1180826|NCT02118974|Laparoscopy|laparoscopy
1180827|NCT02118961|Diphtheria|diphtheria
1180828|NCT02118961|Tetanus|tetanus
1180829|NCT02118961|Pertussis|pertussis
1180830|NCT02118961|DTaP vaccine|dtap vaccine
1180831|NCT02118961|Adolescents|adolescents
1180832|NCT02118948|abuse|abuse
1180833|NCT02118948|sexual behavior|sexual behavior
1180834|NCT02118948|sexual risk reduction|sexual risk reduction
1180835|NCT02118948|behavioral intervention|behavioral intervention
1180836|NCT02118896|Tacrolimus|tacrolimus
1180837|NCT02118896|FK506E|fk506e
1180838|NCT02118896|MR4|mr4
1180839|NCT02118896|Advagraf|advagraf
1180840|NCT02118896|Kidney Transplantation|kidney transplantation
1180841|NCT02118896|Renal Transplantation|renal transplantation
1180842|NCT02118896|Heart Transplantation|heart transplantation
1180843|NCT02118883|exercise|exercise
1180844|NCT02118883|hydration|hydration
1180845|NCT02118883|dehydration|dehydration
1180846|NCT02118883|rehydration|rehydration
1180847|NCT02118883|alkaline water|alkaline water
1180848|NCT02118883|blood viscosity|blood viscosity
1180849|NCT02118883|plasma osmolality|plasma osmolality
1180850|NCT02118883|bioimpedance|bioimpedance
1180851|NCT02118870|ACS patients|acs patients
1180852|NCT02118870|Older than 18 years|older than 18 years
1180853|NCT02118870|PCI|pci
1180854|NCT02118870|Combo stent|combo stent
1180855|NCT02118857|Microorganisms and foods|microorganisms and foods
1180856|NCT02118857|Fecal microbiota|fecal microbiota
1180857|NCT02118857|Salivary microbiota|salivary microbiota
1180858|NCT02118844|bariatric surgery|bariatric surgery
1180859|NCT02118844|surgical conditions|surgical conditions
1180860|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
1180861|NCT02118831|macular degeneration|macular degeneration
1180862|NCT02118831|diabetic macular edema|diabetic macular edema
1180863|NCT02118831|vein occlusion|vein occlusion
1180864|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
1180865|NCT02118805|ALS|als
1180866|NCT02118805|Myasthenia Gravis|myasthenia gravis
1180867|NCT02118805|Myopathy|myopathy
1180868|NCT02118805|Stroke|stroke
1180869|NCT02118805|Parkinson's Disease|parkinson's disease
1180870|NCT02118805|Bulbar|bulbar
1180871|NCT02118805|Orofacial|orofacial
1180872|NCT02118805|Ultrasound|ultrasound
1180873|NCT02118805|Electrical Impedance Myography|electrical impedance myography
1180874|NCT02118792|atopic dermatitis|atopic dermatitis
1180875|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
1180876|NCT02118779|DM1|dm1
1180877|NCT02118779|Physical Exercise|physical exercise
1180878|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
1180879|NCT02118779|Biomarkers|biomarkers
1180880|NCT02118766|atopic dermatitis|atopic dermatitis
1180881|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
1180882|NCT02118740|Autologous Stem Cells|autologous stem cells
1180883|NCT02118740|Spinal Cord Injury|spinal cord injury
1180884|NCT02118740|Preclinical|preclinical
1180885|NCT02118727|ALS|als
1180886|NCT02118727|FTD|ftd
1180887|NCT02118727|Tau|tau
1180888|NCT02118727|pNF-H/C3|pnf-h/c3
1180889|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
1180890|NCT02118714|Kidney Diseases|kidney diseases
1180891|NCT02118714|Urologic Diseases|urologic diseases
1180892|NCT02118714|Diabetes Complications|diabetes complications
1180893|NCT02118714|Diabetes Mellitus|diabetes mellitus
1180894|NCT02118714|Endocrine System Diseases|endocrine system diseases
1180895|NCT02118701|Shared decision making|shared decision making
1180896|NCT02118701|Dementia|dementia
1180897|NCT02118701|Long-term care|long-term care
1180898|NCT02118701|Nursing home|nursing home
1180899|NCT02118701|Care plan|care plan
1180900|NCT02118636|Joint pain|joint pain
1180901|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
1180902|NCT02118636|Estrogen|estrogen
1180903|NCT02118636|Androgen|androgen
1180904|NCT02118623|Bipolar Disorder|bipolar disorder
1180905|NCT02118623|Bipolar|bipolar
1180906|NCT02118623|Online intervention|online intervention
1180907|NCT02118623|Internet intervention|internet intervention
1180908|NCT02118623|Self help|self help
1180910|NCT02118545|Liver Resection|liver resection
1180911|NCT02118545|Liver Dysfunction|liver dysfunction
1180912|NCT02118545|Liver Regeneration|liver regeneration
1180913|NCT02118545|Postoperative Outcome|postoperative outcome
1180914|NCT02118532|Atherosclerosis|atherosclerosis
1180915|NCT02118532|Superficial Femoral Artery|superficial femoral artery
1180916|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
1180917|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
1180918|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
1180919|NCT02118519|Chondrogenesis|chondrogenesis
1180920|NCT02118519|orthopedics|orthopedics
1180921|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
1180922|NCT02118506|Rehabilitation.|rehabilitation.
1180923|NCT02118506|Biomechanics.|biomechanics.
1180924|NCT02118506|Neurological gait disorders.|neurological gait disorders.
1180925|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
1180926|NCT02118493|Laser Excision|laser excision
1180927|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
1180928|NCT02118467|Shock|shock
1180929|NCT02118467|Vasopressor agents|vasopressor agents
1180930|NCT02118467|Norepinephrine|norepinephrine
1180931|NCT02118467|Epinephrine|epinephrine
1180932|NCT02118467|Phenylephrine|phenylephrine
1180933|NCT02118467|Vasopressin|vasopressin
1180934|NCT02118467|Atrial fibrillation|atrial fibrillation
1180935|NCT02118467|Tachyarrhythmia|tachyarrhythmia
1180936|NCT02118454|Medication adherence|medication adherence
1180937|NCT02118454|Self-management|self-management
1180938|NCT02118454|Depression|depression
1180939|NCT02118454|Coping|coping
1180940|NCT02118454|Social support|social support
1180941|NCT02118454|Mobile health|mobile health
1180942|NCT02118454|Antiretroviral treatment|antiretroviral treatment
1180943|NCT02118428|whole blood|whole blood
1180944|NCT02118428|transfusion|transfusion
1180945|NCT02118428|Plasmodium|plasmodium
1180946|NCT02118428|Malaria|malaria
1180947|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
1180948|NCT02118428|Whole blood transfusion|whole blood transfusion
1180949|NCT02118415|not eligible for surgery|not eligible for surgery
1180950|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
1180951|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
1180952|NCT02118363|upper limb|upper limb
1180953|NCT02118363|lower limb|lower limb
1180954|NCT02118363|monitoring|monitoring
1180955|NCT02118363|assessment|assessment
1180956|NCT02118363|sensor|sensor
1180957|NCT02118337|select advanced malignancies,|select advanced malignancies,
1180958|NCT02118337|kidney cancer,|kidney cancer,
1180959|NCT02118337|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1180960|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1180961|NCT02118324|ALL|all
1180962|NCT02118324|fitness intervention|fitness intervention
1180963|NCT02118311|Acute Leukemias|acute leukemias
1180964|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
1180965|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
1180966|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1180967|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
1180968|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
1180969|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
1180970|NCT02118311|Multiple Myeloma|multiple myeloma
1180971|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1180972|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1180973|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
1180974|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
1180975|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1180976|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
1180977|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
1180978|NCT02118285|Ovarian cancer|ovarian cancer
1180979|NCT02118285|Fallopian cancer|fallopian cancer
1180980|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
1180981|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
1180982|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
1180983|NCT02118259|Residence for dependent elderly|residence for dependent elderly
1333254|NCT01443819|Disc Protrusion|disc protrusion
1180984|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
1180985|NCT02118233|carotid|carotid
1180986|NCT02118233|stenosis|stenosis
1180987|NCT02118233|surgery|surgery
1180988|NCT02118233|cognitive|cognitive
1180989|NCT02118233|unilateral|unilateral
1180990|NCT02118207|SCUBA diving|scuba diving
1180991|NCT02118207|Exercise|exercise
1180992|NCT02118207|Microparticles|microparticles
1180993|NCT02118207|Repetitive diving|repetitive diving
1180994|NCT02118207|Endothelial function|endothelial function
1180995|NCT02118194|paraplegia|paraplegia
1180996|NCT02118194|paralysis|paralysis
1180997|NCT02118194|robotics|robotics
1180998|NCT02118194|walking|walking
1180999|NCT02118194|immobilization|immobilization
1181000|NCT02118168|HIV|hiv
1181002|NCT02118168|Tat Protein|tat protein
1181003|NCT02118129|Vitamin D|vitamin d
1181004|NCT02118129|Intervention|intervention
1181005|NCT02118129|Behaviour|behaviour
1181006|NCT02118129|Mobile app|mobile app
1181310|NCT02116803|cancer|cancer
1181007|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
1181008|NCT02118103|Lumbosacral Region|lumbosacral region
1181009|NCT02118103|Psychomotor Performance|psychomotor performance
1181010|NCT02118103|Manipulation, Spinal|manipulation, spinal
1181011|NCT02118090|malaria|malaria
1181012|NCT02118090|Plasmodium vivax|plasmodium vivax
1181013|NCT02118090|drug resistance|drug resistance
1181014|NCT02118090|chloroquine|chloroquine
1181015|NCT02118090|Cambodia|cambodia
1181016|NCT02118064|G17DT|g17dt
1181017|NCT02118064|irinotecan|irinotecan
1181018|NCT02118064|Colorectal Cancer|colorectal cancer
1181019|NCT02118051|Infertility|infertility
1181020|NCT02118051|IVF|ivf
1181021|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
1181022|NCT02118051|Ovarian stimulation|ovarian stimulation
1181023|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
1181024|NCT02118038|Sulprostone|sulprostone
1181025|NCT02118038|Cardiac impact|cardiac impact
1181026|NCT02118038|Emotional impact|emotional impact
1181027|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
1181028|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
1181029|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
1181030|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
1181031|NCT02118012|Direct Acting Antivirals|direct acting antivirals
1181032|NCT02118012|Ribavirin|ribavirin
1181033|NCT02118012|Hepatitis C|hepatitis c
1181034|NCT02117999|corneal cross-linking|corneal cross-linking
1181035|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
1181036|NCT02117999|iontophoresis|iontophoresis
1181037|NCT02117999|progressive keratoconus|progressive keratoconus
1181038|NCT02117986|critically ill patients|critically ill patients
1181039|NCT02117986|colistin dosing|colistin dosing
1181040|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
1181041|NCT02117960|atherosclerotic|atherosclerotic
1181042|NCT02117960|BMP-4|bmp-4
1181043|NCT02117960|YKL40|ykl40
1181044|NCT02117960|HSP70|hsp70
1181045|NCT02117960|HSP27|hsp27
1181046|NCT02117947|child secondhand smoke|child secondhand smoke
1181047|NCT02117947|maternal smoking|maternal smoking
1181048|NCT02117947|tobacco|tobacco
1181049|NCT02117947|nicotine|nicotine
1181050|NCT02117947|behavioral counseling|behavioral counseling
1181051|NCT02117947|low-income|low-income
1181052|NCT02117947|underserved|underserved
1181053|NCT02117934|HBV vaccine|hbv vaccine
1181054|NCT02117934|HEPLISAV-B|heplisav-b
1181055|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
1181056|NCT02117934|Hepatitis B|hepatitis b
1181057|NCT02117934|Hepatitis|hepatitis
1181058|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
1181059|NCT02117934|Prevention and Control|prevention and control
1181060|NCT02117934|Healthy|healthy
1181061|NCT02117934|Healthy volunteers|healthy volunteers
1181062|NCT02117921|Mind Body Syndrome|mind body syndrome
1181063|NCT02117921|MBS|mbs
1181064|NCT02117921|Chronic Pain|chronic pain
1181065|NCT02117908|prevention|prevention
1181066|NCT02117908|radiofrequency treatment|radiofrequency treatment
1181067|NCT02117908|lung cancer ablation|lung cancer ablation
1181068|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
1181069|NCT02117895|Celiac Plexus|celiac plexus
1181070|NCT02117895|Resection|resection
1181071|NCT02117895|Pancreatic Cancer|pancreatic cancer
1181072|NCT02117895|Body and Tail|body and tail
1181073|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
1181074|NCT02117869|Grapefruit juice|grapefruit juice
1181075|NCT02117856|Implant-Supported Denture|implant-supported denture
1181076|NCT02117856|Single-Implant Denture|single-implant denture
1181077|NCT02117856|Patient Satisfaction|patient satisfaction
1181078|NCT02117856|Edentulous Mandible|edentulous mandible
1181079|NCT02117856|Dental Implants|dental implants
1181080|NCT02117856|Standard of Care|standard of care
1574329|NCT00485563|Vaccine|vaccine
1181081|NCT02117856|Randomized Clinical Trial|randomized clinical trial
1181082|NCT02117830|To determine|to determine
1181083|NCT02117830|effects|effects
1181084|NCT02117830|once|once
1181085|NCT02117830|daily|daily
1181086|NCT02117830|oral doses|oral doses
1181087|NCT02117830|Androxal|androxal
1181088|NCT02117804|Discharge Planning|discharge planning
1181089|NCT02117804|Decision Support|decision support
1181090|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
1181091|NCT02117765|T1D|t1d
1181092|NCT02117765|ustekinumab|ustekinumab
1181093|NCT02117765|new-onset|new-onset
1181094|NCT02117765|diabetes|diabetes
1181095|NCT02117726|Sedation;|sedation;
1181096|NCT02117726|ARDS;|ards;
1181097|NCT02117726|Mechanical ventilation|mechanical ventilation
1181098|NCT02117726|Hypnotics|hypnotics
1181099|NCT02117726|Antianxiety Drugs|antianxiety drugs
1181100|NCT02117726|Causing|causing
1181101|NCT02117726|Adverse Effects|adverse effects
1181102|NCT02117726|Therapeutic Use|therapeutic use
1181103|NCT02117700|fatty liver|fatty liver
1181104|NCT02117700|obesity|obesity
1181105|NCT02117700|children|children
1181503|NCT02115919|HIV|hiv
1181106|NCT02117700|oxidative stress|oxidative stress
1181107|NCT02117700|antioxidants|antioxidants
1181108|NCT02117674|colonoscopy|colonoscopy
1181109|NCT02117674|adenoma detection rate|adenoma detection rate
1181110|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
1181111|NCT02117674|right colon retroflexion|right colon retroflexion
1181112|NCT02117674|feasibility|feasibility
1181113|NCT02117661|L-carnitine|l-carnitine
1181114|NCT02117661|Metabolic syndrome|metabolic syndrome
1181115|NCT02117661|Atherosclerosis|atherosclerosis
1181116|NCT02117661|Coronary artery disease|coronary artery disease
1181117|NCT02117661|Carotid|carotid
1181118|NCT02117661|Plaque|plaque
1181119|NCT02117661|Cardiovascular disease|cardiovascular disease
1181120|NCT02117661|Heart disease|heart disease
1181121|NCT02117661|Vascular disease|vascular disease
1181122|NCT02117648|advanced cancer|advanced cancer
1181123|NCT02117648|metastatic cancer|metastatic cancer
1181124|NCT02117635|Efficacy|efficacy
1181125|NCT02117635|Non comparative|non comparative
1181126|NCT02117635|Neural stem cells|neural stem cells
1181127|NCT02117635|Intracranial administration|intracranial administration
1181128|NCT02117609|Elderly|elderly
1181129|NCT02117609|Nursing home|nursing home
1181130|NCT02117609|Functional impairment|functional impairment
1181131|NCT02117609|High-protein oral supplement|high-protein oral supplement
1181132|NCT02117596|Pediatric|pediatric
1181133|NCT02117596|Renal|renal
1181134|NCT02117596|Transplant|transplant
1181135|NCT02117583|pharmacokinetics|pharmacokinetics
1181136|NCT02117583|relative bioavailability|relative bioavailability
1181137|NCT02117583|food effects|food effects
1181138|NCT02117583|oxycodone|oxycodone
1181139|NCT02117570|Clostridium difficile|clostridium difficile
1181140|NCT02117570|vaccine|vaccine
1181141|NCT02117557|Single-incision|single-incision
1181142|NCT02117557|Laparoscopy|laparoscopy
1181143|NCT02117557|Colorectal Cancer|colorectal cancer
1181144|NCT02117544|Contact lens|contact lens
1181145|NCT02117544|Presbyopia|presbyopia
1181146|NCT02117544|Multifocal|multifocal
1181147|NCT02117518|type 1 diabetes|type 1 diabetes
1181148|NCT02117518|autoreactive T cells|autoreactive t cells
1181149|NCT02117518|beta cell peptides|beta cell peptides
1181150|NCT02117518|genetically modified T cells|genetically modified t cells
1181151|NCT02117518|mRNA electroporation|mrna electroporation
1181152|NCT02117505|Biological Availability|biological availability
1181153|NCT02117505|JNJ-39220675|jnj-39220675
1181154|NCT02117505|Healthy|healthy
1181155|NCT02117505|Phase 1|phase 1
1181156|NCT02117492|hysterectomy|hysterectomy
1181157|NCT02117492|vaginal cuff|vaginal cuff
1181158|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
1181159|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
1181160|NCT02117466|cetuximab|cetuximab
1181161|NCT02117466|PET-imaging|pet-imaging
1181162|NCT02117453|ANCA vasculitis|anca vasculitis
1181163|NCT02117453|Statin|statin
1181164|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
1181165|NCT02117453|Cardiovascular events|cardiovascular events
1181166|NCT02117453|Myocardial infarction|myocardial infarction
1181167|NCT02117453|Stroke|stroke
1181168|NCT02117453|Arterial revascularization|arterial revascularization
1181169|NCT02117453|Unstable angina|unstable angina
1181170|NCT02117453|Death|death
1181171|NCT02117440|Lung Cancer|lung cancer
1181172|NCT02117440|Lung Neoplasms|lung neoplasms
1181173|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1181174|NCT02117388|Older adults|older adults
1181175|NCT02117388|insomnia|insomnia
1181176|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
1181177|NCT02117388|Behavioral Therapy|behavioral therapy
1181178|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
1181179|NCT02117388|Cognitive Therapy|cognitive therapy
1181180|NCT02117375|multiple sclerosis|multiple sclerosis
1181181|NCT02117375|spinal cord|spinal cord
1181183|NCT02117375|longitudinal study|longitudinal study
1181184|NCT02117375|disability|disability
1181185|NCT02117362|Melanoma|melanoma
1181186|NCT02117362|Ipilimumab|ipilimumab
1181187|NCT02117362|Yervoy|yervoy
1181188|NCT02117362|Galectin|galectin
1181189|NCT02117362|GR-MD-02|gr-md-02
1181190|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
1181191|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
1181192|NCT02117362|Providence Health & Services|providence health & services
1181193|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
1181194|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
1181195|NCT02117362|Immunotherapy|immunotherapy
1181196|NCT02117349|surgical hemostasis|surgical hemostasis
1181197|NCT02117349|bleeding|bleeding
1181198|NCT02117349|fibrin sealant|fibrin sealant
1181199|NCT02117349|fibrinogen|fibrinogen
1181200|NCT02117349|thrombin|thrombin
1181201|NCT02117349|spray dried|spray dried
1181202|NCT02117323|corneal opacities|corneal opacities
1181203|NCT02117323|Optical coherence tomography|optical coherence tomography
1181204|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
1181205|NCT02117284|Rubidium-82|rubidium-82
1181206|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
1181207|NCT02117284|automated elution system|automated elution system
1181208|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
1181209|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
1181210|NCT02117271|treatment|treatment
1181211|NCT02117271|placebo|placebo
1181212|NCT02117271|appearance|appearance
1181213|NCT02117271|skin quality|skin quality
1181214|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
1181215|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
1181216|NCT02117232|colonoscopy|colonoscopy
1181217|NCT02117232|cecal intubation|cecal intubation
1181218|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
1181219|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
1181220|NCT02117219|MDS|mds
1181221|NCT02117206|L-arginine|l-arginine
1181222|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
1181223|NCT02117180|FGID|fgid
1181224|NCT02117180|children|children
1181225|NCT02117180|FODMAP|fodmap
1181226|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
1181227|NCT02117154|HbA1c|hba1c
1181228|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1181229|NCT02117141|Food Effect|food effect
1181230|NCT02117141|Pharmacokinetics|pharmacokinetics
1181231|NCT02117128|Tranexamic Acid|tranexamic acid
1181232|NCT02117128|Antifibrinolytic|antifibrinolytic
1181233|NCT02117128|Blood transfusion|blood transfusion
1181234|NCT02117128|Total knee arthroplasty|total knee arthroplasty
1181235|NCT02117076|Restless leg syndrome|restless leg syndrome
1181236|NCT02117076|RLS|rls
1181237|NCT02117076|gabapentin|gabapentin
1181238|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
1181239|NCT02117076|Neurontin|neurontin
1181240|NCT02117076|Horizant|horizant
1181241|NCT02117050|Multiple Sclerosis|multiple sclerosis
1181242|NCT02117050|Rebif ®|rebif ®
1181243|NCT02117050|Tecfidera ™|tecfidera ™
1181244|NCT02117050|treatment change|treatment change
1181245|NCT02117024|lung|lung
1181246|NCT02117024|cancer|cancer
1181247|NCT02117024|gp96|gp96
1181248|NCT02117024|vaccine|vaccine
1181249|NCT02117024|immunotherapy|immunotherapy
1181250|NCT02117024|Heat Biologics|heat biologics
1181251|NCT02117024|cyclophosphamide|cyclophosphamide
1181252|NCT02117024|vinorelbine|vinorelbine
1181253|NCT02117024|erlotinib|erlotinib
1181254|NCT02117024|gemcitabine|gemcitabine
1181255|NCT02117024|paclitaxel|paclitaxel
1181256|NCT02117024|docetaxel|docetaxel
1181257|NCT02117024|pemetrexed|pemetrexed
1181258|NCT02116998|GEN-004|gen-004
1181259|NCT02116998|Aluminum hydroxide|aluminum hydroxide
1181260|NCT02116998|Vaccine|vaccine
1181261|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
1181262|NCT02116998|Pneumococcal Infections|pneumococcal infections
1181263|NCT02116998|Strep pneumoniae|strep pneumoniae
1181264|NCT02116998|Pneumonia|pneumonia
1181265|NCT02116985|Dual-Loop TCI|dual-loop tci
1181266|NCT02116985|NI|ni
1181267|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1181268|NCT02116972|osteoarthritis|osteoarthritis
1181269|NCT02116972|knee|knee
1181270|NCT02116972|pain|pain
1181271|NCT02116972|corticosteroid|corticosteroid
1181272|NCT02116972|intra-articular|intra-articular
1181273|NCT02116972|injection|injection
1181274|NCT02116959|Systemic|systemic
1181275|NCT02116959|Chemotherapy|chemotherapy
1181276|NCT02116959|Melphalan|melphalan
1181277|NCT02116933|Autologous Fat Grafting|autologous fat grafting
1181278|NCT02116933|Breast Augmentation|breast augmentation
1181279|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
1181280|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
1181281|NCT02116920|CIN|cin
1181282|NCT02116920|HPV DNA|hpv dna
1181283|NCT02116920|mRNA E6/E7|mrna e6/e7
1181284|NCT02116920|CIN triage|cin triage
1181285|NCT02116920|Cervix Biopsy|cervix biopsy
1181286|NCT02116920|VIA|via
1181287|NCT02116920|Cervix Cancer|cervix cancer
1181288|NCT02116907|Healthy|healthy
1181289|NCT02116907|Male Subjects|male subjects
1181290|NCT02116894|Colorectal cancer|colorectal cancer
1181291|NCT02116894|PF-03446962|pf-03446962
1181292|NCT02116894|regorafenib|regorafenib
1181293|NCT02116881|Incisional hernia|incisional hernia
1181294|NCT02116881|colorectal surgery|colorectal surgery
1181295|NCT02116881|bowel obstruction|bowel obstruction
1181296|NCT02116868|Pupillometry|pupillometry
1181297|NCT02116868|Pupillary reflex|pupillary reflex
1181298|NCT02116868|Analgesia|analgesia
1181299|NCT02116868|Laparoscopic surgery|laparoscopic surgery
1181300|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
1181301|NCT02116868|Target controlled infusion|target controlled infusion
1181302|NCT02116803|solid tumors|solid tumors
1181303|NCT02116803|TKI258|tki258
1181304|NCT02116803|Dovitinib|dovitinib
1181305|NCT02116803|fulvestrant|fulvestrant
1181306|NCT02116803|cancers with a mass|cancers with a mass
1181307|NCT02116803|bulky tumor|bulky tumor
1181308|NCT02116803|nodule|nodule
1181309|NCT02116803|lump|lump
1181311|NCT02116803|solid malignancies|solid malignancies
1181312|NCT02116790|acute|acute
1181313|NCT02116790|pain|pain
1181314|NCT02116764|Hematopoietic (Stem) Cell Transplantation|hematopoietic (stem) cell transplantation
1181315|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
1181316|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
1181317|NCT02116738|flap|flap
1181318|NCT02116738|pilonidal sinus|pilonidal sinus
1181319|NCT02116738|vas|vas
1181320|NCT02116738|recurrence|recurrence
1181321|NCT02116712|LAM|lam
1181322|NCT02116712|saracatinib|saracatinib
1181323|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1181324|NCT02116699|oropharyngeal|oropharyngeal
1181325|NCT02116699|colostrum|colostrum
1181326|NCT02116699|mother's milk|mother's milk
1181327|NCT02116699|premature|premature
1181328|NCT02116699|neonate|neonate
1181329|NCT02116699|infection|infection
1181330|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
1181331|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
1181332|NCT02116699|breastmilk|breastmilk
1181333|NCT02116699|human milk|human milk
1181334|NCT02116699|late-onset sepsis|late-onset sepsis
1181335|NCT02116699|microbiome|microbiome
1181336|NCT02116699|antioxidant|antioxidant
1181337|NCT02116699|enteral feeds|enteral feeds
1181338|NCT02116686|chronic heart failure|chronic heart failure
1181339|NCT02116686|Polysomnography|polysomnography
1181340|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
1181341|NCT02116686|Electrocardiogram|electrocardiogram
1181342|NCT02116673|Head injury|head injury
1181343|NCT02116673|Concussion|concussion
1181344|NCT02116673|Cognitive rest|cognitive rest
1181345|NCT02116673|Emergency department|emergency department
1181346|NCT02116647|Gender discrimination|gender discrimination
1181347|NCT02116647|Psychoanalysis|psychoanalysis
1181348|NCT02116647|Randomized controlled trial|randomized controlled trial
1181349|NCT02116621|Musculoskeletal pain|musculoskeletal pain
1181350|NCT02116621|Chronic pain|chronic pain
1181351|NCT02116621|Patient centered outcomes research|patient centered outcomes research
1181352|NCT02116621|Physician patient relationship|physician patient relationship
1181353|NCT02116621|Mobile applications|mobile applications
1181354|NCT02116595|volunteers|volunteers
1181355|NCT02116582|MDV3100|mdv3100
1181356|NCT02116582|Xtandi|xtandi
1181357|NCT02116582|Abiraterone|abiraterone
1181358|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1181359|NCT02116582|Enzalutamide|enzalutamide
1181360|NCT02116569|Multiple Myeloma|multiple myeloma
1181361|NCT02116569|Daratumumab|daratumumab
1181362|NCT02116569|JNJ-54767414|jnj-54767414
1181363|NCT02116569|Phase 1|phase 1
1181364|NCT02116569|Relapse|relapse
1181365|NCT02116569|Refractory|refractory
1181366|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
1181367|NCT02116556|Bacterial Infections|bacterial infections
1181368|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
1181369|NCT02116543|Hepatitis C|hepatitis c
1181370|NCT02116543|HCV|hcv
1181371|NCT02116517|obese women|obese women
1181372|NCT02116517|high LDL-C|high ldl-c
1181373|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
1181374|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1181375|NCT02116504|Biopharmaceutical|biopharmaceutical
1181376|NCT02116504|Immunogenicity|immunogenicity
1181377|NCT02116504|Anti-Drug Antibody|anti-drug antibody
1181378|NCT02116504|Prediction|prediction
1181379|NCT02116478|plantar fasciitis|plantar fasciitis
1181380|NCT02116478|gastrocnemius recession|gastrocnemius recession
1181381|NCT02116439|Violence|violence
1181382|NCT02116426|copeptin|copeptin
1181383|NCT02116426|troponin HS|troponin hs
1181384|NCT02116413|fluid challenge|fluid challenge
1181385|NCT02116413|fluid resuscitation|fluid resuscitation
1181386|NCT02116400|Suicidal ideation|suicidal ideation
1181387|NCT02116387|Proprioception|proprioception
1181388|NCT02116348|Cerebral palsy children|cerebral palsy children
1181389|NCT02116348|Cerebrolysin|cerebrolysin
1181390|NCT02116348|Sleep questionnaire|sleep questionnaire
1181391|NCT02116348|Quality of life|quality of life
1181392|NCT02116348|Bayley III scale|bayley iii scale
1181393|NCT02116335|arterial stiffness|arterial stiffness
1181394|NCT02116335|flow-mediated dilation|flow-mediated dilation
1181395|NCT02116335|endothelial function|endothelial function
1181396|NCT02116335|pulse wave velocity|pulse wave velocity
1181397|NCT02116335|inflammation|inflammation
1181398|NCT02116335|oxidative stress|oxidative stress
1181399|NCT02116335|Nitric Oxide|nitric oxide
1181400|NCT02116335|Cold Pressor Test|cold pressor test
1181401|NCT02116335|physio flow|physio flow
1181402|NCT02116335|Bosentan|bosentan
1181403|NCT02116335|Endothelin Receptor|endothelin receptor
1181404|NCT02116335|Endothelin-1|endothelin-1
1181405|NCT02116335|BMI|bmi
1181406|NCT02116335|stress|stress
1181407|NCT02116335|blood pressure|blood pressure
1181408|NCT02116283|smoking|smoking
1181409|NCT02116283|healthy|healthy
1181410|NCT02116283|smartphone|smartphone
1181411|NCT02116270|Renal Failure|renal failure
1181412|NCT02116270|Dialysis|dialysis
1181504|NCT02115893|Nitrate|nitrate
1181413|NCT02116270|Biological Aging|biological aging
1181414|NCT02116257|Nausea|nausea
1181415|NCT02116257|Vomiting|vomiting
1181416|NCT02116244|Dry Eye|dry eye
1181417|NCT02116244|Civamide|civamide
1181418|NCT02116244|Zucapsaicin|zucapsaicin
1181419|NCT02116244|Neuropeptides|neuropeptides
1181420|NCT02116244|TRPV-1|trpv-1
1181421|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
1181422|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
1181423|NCT02116218|acupuncture|acupuncture
1181424|NCT02116218|complementary alternative medicine|complementary alternative medicine
1181425|NCT02116218|cancer pain|cancer pain
1181426|NCT02116218|emergency department|emergency department
1181427|NCT02116205|Hantaan virus|hantaan virus
1181428|NCT02116205|Puumala virus|puumala virus
1181429|NCT02116205|HFRS|hfrs
1181430|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1181431|NCT02116192|Adolescent|adolescent
1181432|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
1181433|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1181434|NCT02116179|Hepatitis C|hepatitis c
1181435|NCT02116179|Hispanic|hispanic
1181436|NCT02116179|Criminal Justice|criminal justice
1181437|NCT02116166|aging|aging
1181438|NCT02116166|sarcopenia|sarcopenia
1181439|NCT02116166|mitochondria|mitochondria
1181440|NCT02116166|skeletal muscle|skeletal muscle
1181441|NCT02116166|inflammation|inflammation
1181442|NCT02116153|Cardiac Troponin T|cardiac troponin t
1181443|NCT02116153|Micro-RNA|micro-rna
1181444|NCT02116153|Sensitivity|sensitivity
1181445|NCT02116153|Specificity|specificity
1181446|NCT02116140|positron emission tomography|positron emission tomography
1181447|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
1181448|NCT02116140|[11C]acetate|[11c]acetate
1181449|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
1181450|NCT02116140|Myocardial Energetics|myocardial energetics
1181451|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
1181452|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
1181453|NCT02116140|heart rate variability|heart rate variability
1181454|NCT02116140|overnight polysomnogram|overnight polysomnogram
1181455|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
1181456|NCT02116140|Urine Normetanephrine|urine normetanephrine
1181457|NCT02116140|Quality of Life|quality of life
1181458|NCT02116127|Depression|depression
1181459|NCT02116127|Pregnancy|pregnancy
1181460|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1181461|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1181462|NCT02116101|Intestinal Health|intestinal health
1181463|NCT02116101|Prebiotics|prebiotics
1181464|NCT02116101|Blood Lipid|blood lipid
1181465|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
1181466|NCT02116049|Disclosure, intervention|disclosure, intervention
1181467|NCT02116049|HIV|hiv
1181468|NCT02116049|prevention|prevention
1181469|NCT02116049|Disclosure Intervention|disclosure intervention
1181470|NCT02116049|Attention Control Case Management|attention control case management
1181471|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
1181472|NCT02116036|Rivaroxaban|rivaroxaban
1181473|NCT02116036|Thromboembolism|thromboembolism
1181474|NCT02116036|Bleeding|bleeding
1181475|NCT02116036|Feasibility|feasibility
1181476|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
1181477|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
1181478|NCT02115971|chronic|chronic
1181479|NCT02115971|functional|functional
1181480|NCT02115971|instability|instability
1181481|NCT02115971|ankle|ankle
1181482|NCT02115945|chronic postoperative pain|chronic postoperative pain
1181483|NCT02115945|total knee arthroplasty|total knee arthroplasty
1181484|NCT02115945|femoral block|femoral block
1181485|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
1181486|NCT02115932|Diabetes Mellitus|diabetes mellitus
1181487|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1181488|NCT02115932|Diabetes Complications|diabetes complications
1181489|NCT02115932|Diabetic Foot|diabetic foot
1181490|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
1181491|NCT02115932|Gait|gait
1181492|NCT02115932|Balance, Postural|balance, postural
1181493|NCT02115932|Muscle Strength|muscle strength
1181494|NCT02115932|Exercise Therapy|exercise therapy
1181495|NCT02115932|Physical Therapy Modalities|physical therapy modalities
1181496|NCT02115932|Endocrine System Diseases|endocrine system diseases
1181497|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
1181498|NCT02115932|Metabolic Diseases|metabolic diseases
1181499|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
1181500|NCT02115932|Quality of Life|quality of life
1181501|NCT02115932|Training|training
1181502|NCT02115919|condyloma|condyloma
1181505|NCT02115893|Performance|performance
1181506|NCT02115893|Sports|sports
1181507|NCT02115880|Depression|depression
1181508|NCT02115880|Prevention|prevention
1181509|NCT02115880|Adolescent|adolescent
1181510|NCT02115880|Child|child
1181511|NCT02115880|Randomised Controlled Trial|randomised controlled trial
1181512|NCT02115880|Risk|risk
1181513|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
1181514|NCT02115880|Group-based therapy|group-based therapy
1181515|NCT02115867|diverticular disease|diverticular disease
1181516|NCT02115867|diverticulitis|diverticulitis
1181517|NCT02115867|diverticulosis|diverticulosis
1181518|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
1181519|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
1181520|NCT02115841|serial reaction time task|serial reaction time task
1181521|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
1181522|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
1181523|NCT02115828|Vismodegib|vismodegib
1181524|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1181525|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
1181526|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1181527|NCT02115815|MEDI7510|medi7510
1181528|NCT02115789|cicatrix|cicatrix
1181529|NCT02115789|Demonstrate|demonstrate
1181530|NCT02115789|that there|that there
1181531|NCT02115789|is no perception of superiority|is no perception of superiority
1181532|NCT02115776|bacteremia|bacteremia
1181533|NCT02115776|prophylaxis|prophylaxis
1181534|NCT02115776|antibiotics|antibiotics
1181535|NCT02115776|dentistry|dentistry
1181536|NCT02115763|physically active,|physically active,
1181537|NCT02115763|18-35 year old men|18-35 year old men
1181538|NCT02115750|CHS-0214|chs-0214
1181539|NCT02115750|Enbrel|enbrel
1181541|NCT02115750|Biosimilar|biosimilar
1181542|NCT02115750|Etanercept|etanercept
1181543|NCT02115724|Low childhood SES|low childhood ses
1181544|NCT02115724|Early Life Stress|early life stress
1181545|NCT02115724|Endothelial function|endothelial function
1181546|NCT02115724|Flow mediated dilation|flow mediated dilation
1181547|NCT02115724|Cardiovascular disease|cardiovascular disease
1181548|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
1181549|NCT02115711|India|india
1181550|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
1181551|NCT02115711|Community health workers|community health workers
1181552|NCT02115711|Hypertension|hypertension
1181553|NCT02115711|Diabetes|diabetes
1181554|NCT02115711|Smoking|smoking
1181555|NCT02115698|Sarcopenia|sarcopenia
1181556|NCT02115698|Frailty|frailty
1181557|NCT02115698|Ageing|ageing
1181558|NCT02115698|Protein supplementation|protein supplementation
1181559|NCT02115698|Protein quality|protein quality
1181560|NCT02115698|Exercise training|exercise training
1181561|NCT02115698|Muscle protein turnover|muscle protein turnover
1181562|NCT02115685|spinal cord injury|spinal cord injury
1181563|NCT02115685|sympathetic nervous system|sympathetic nervous system
1181564|NCT02115685|locomotor training|locomotor training
1181565|NCT02115685|exercise|exercise
1181566|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
1181567|NCT02115672|imatinib|imatinib
1181568|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
1181569|NCT02115672|BL-8040|bl-8040
1181570|NCT02115659|ADPKD|adpkd
1181571|NCT02115659|triptolide|triptolide
1181572|NCT02115646|burn|burn
1181573|NCT02115646|scar|scar
1181574|NCT02115620|Heart failure|heart failure
1181575|NCT02115620|Cardiac failure|cardiac failure
1181576|NCT02115620|Congestive Heart Failure|congestive heart failure
1181577|NCT02115620|Cardiomyopathy|cardiomyopathy
1181578|NCT02115620|Myocardial Failure|myocardial failure
1181579|NCT02115620|Telemedicine|telemedicine
1181580|NCT02115620|Telehealth|telehealth
1181581|NCT02115620|Remote Consultation|remote consultation
1181582|NCT02115607|Breast cancer|breast cancer
1181583|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
1181584|NCT02115607|Angiogenesis|angiogenesis
1181585|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
1181586|NCT02115607|Subharmonic imaging|subharmonic imaging
1181587|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
1181588|NCT02115594|metastatic breast cancer|metastatic breast cancer
1181589|NCT02115594|estrogen receptor|estrogen receptor
1181590|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1181591|NCT02115594|Histone Deacetylases|histone deacetylases
1181592|NCT02115594|HDAC inhibitors|hdac inhibitors
1181593|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
1181594|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
1181595|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
1181596|NCT02115581|Coenzyme O10|coenzyme o10
1181597|NCT02115581|Children|children
1181598|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
1181599|NCT02115555|type 1|type 1
1181600|NCT02115555|diabetes|diabetes
1181601|NCT02115555|adolescents|adolescents
1181602|NCT02115555|heath information technology|heath information technology
1181604|NCT02115542|liver|liver
1181605|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
1181606|NCT02115542|gallbladder cancer|gallbladder cancer
1181607|NCT02115542|carcinoma|carcinoma
1181608|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
1181609|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
1181610|NCT02115542|gall bladder|gall bladder
1181611|NCT02115542|unresectable|unresectable
1181612|NCT02115542|locally advanced|locally advanced
1181613|NCT02115542|metastatic disease|metastatic disease
1181614|NCT02115542|Bile Duct Diseases|bile duct diseases
1181615|NCT02115542|Gallbladder Diseases|gallbladder diseases
1181616|NCT02115542|regorafenib|regorafenib
1181617|NCT02115542|stivarga|stivarga
1181618|NCT02115542|Bay 73-4506|bay 73-4506
1181619|NCT02115542|multikinase inhibitor|multikinase inhibitor
1181620|NCT02115516|Malaria|malaria
1181621|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
1181622|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
1181623|NCT02115516|PfSPZ Challenge|pfspz challenge
1181624|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
1181625|NCT02115516|PfSPZ-CVac|pfspz-cvac
1181626|NCT02115490|Alveolar bone|alveolar bone
1181627|NCT02115490|Bisphosphonates|bisphosphonates
1181628|NCT02115490|Cone-beam CT|cone-beam ct
1181629|NCT02115490|Osteoporosis|osteoporosis
1181630|NCT02115477|Uterus cancer|uterus cancer
1181631|NCT02115477|Hysterectomy|hysterectomy
1181632|NCT02115477|Lymphadenectomy|lymphadenectomy
1181633|NCT02115477|Lymphedema|lymphedema
1181634|NCT02115464|Metformin|metformin
1181635|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
1181636|NCT02115464|Locally advanced|locally advanced
1181637|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
1181638|NCT02115464|Lung cancer treatment|lung cancer treatment
1181639|NCT02115399|Dermatitis|dermatitis
1181640|NCT02115399|Staphylococcus|staphylococcus
1181641|NCT02115399|Staphylococcus aureus|staphylococcus aureus
1181642|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
1181643|NCT02115399|Non-atopic controls|non-atopic controls
1181644|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
1181645|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
1181646|NCT02115373|c-Met inhibitor|c-met inhibitor
1181647|NCT02115373|Phase 1b|phase 1b
1181648|NCT02115373|Sorafenib|sorafenib
1181649|NCT02115373|MSC2156119J|msc2156119j
1181650|NCT02115360|epidural calcitonin|epidural calcitonin
1181651|NCT02115360|amputation|amputation
1181652|NCT02115360|postoperative pain|postoperative pain
1181653|NCT02115360|Later Complication|later complication
1181654|NCT02115334|Developmental delay|developmental delay
1181655|NCT02115334|Early Intervention|early intervention
1181656|NCT02115334|Home programs|home programs
1181657|NCT02115334|Preschool activities|preschool activities
1181658|NCT02115295|Leukemia|leukemia
1181659|NCT02115295|Acute Myeloid Leukemia|acute myeloid leukemia
1181660|NCT02115295|AML|aml
1181661|NCT02115295|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
1181662|NCT02115295|HR MDS|hr mds
1181663|NCT02115295|Myeloid Blast Phase of Chronic Myeloid Leukemia|myeloid blast phase of chronic myeloid leukemia
1181664|NCT02115295|CML|cml
1181665|NCT02115295|Acute Biphenotypic Leukemia|acute biphenotypic leukemia
1181666|NCT02115295|Cladribine|cladribine
1181667|NCT02115295|Leustatin|leustatin
1181668|NCT02115295|2-CdA|2-cda
1181669|NCT02115295|Cytarabine|cytarabine
1181670|NCT02115295|Ara-C|ara-c
1181671|NCT02115295|Cytosar|cytosar
1181672|NCT02115295|DepoCyt|depocyt
1181673|NCT02115295|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1181674|NCT02115295|Idarubicin|idarubicin
1181675|NCT02115295|Idamycin|idamycin
1181676|NCT02115295|Phone calls|phone calls
1181677|NCT02115269|Indoprocaf|indoprocaf
1181678|NCT02115269|Indomethacin|indomethacin
1181679|NCT02115269|Caffeine|caffeine
1181680|NCT02115269|Prochlorperazine|prochlorperazine
1181681|NCT02115269|Migraine with Aura|migraine with aura
1181682|NCT02115269|Migraine without Aura|migraine without aura
1181683|NCT02115269|Tension-Type Headache|tension-type headache
1181684|NCT02115256|External Cephalic Version|external cephalic version
1181685|NCT02115256|breech|breech
1181686|NCT02115230|Heart Failure|heart failure
1181687|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
1181688|NCT02115230|Hypertension|hypertension
1181689|NCT02115230|Renal Denervation|renal denervation
1181690|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
1181691|NCT02115217|Kinestiotaping|kinestiotaping
1181692|NCT02115217|Basketball players|basketball players
1181693|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
1181694|NCT02115217|on postural stability|on postural stability
1181695|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
1181696|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
1181697|NCT02115191|Closure.|closure.
1181698|NCT02115191|Recurrence.|recurrence.
1181699|NCT02115178|Hemodynamic changes|hemodynamic changes
1181700|NCT02115178|Spinal anesthesia|spinal anesthesia
1181701|NCT02115178|Patient position|patient position
1181702|NCT02115178|Impedance cardiography|impedance cardiography
1181703|NCT02115152|Capecitabine|capecitabine
1181704|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
1181705|NCT02115152|Early Breast Cancer|early breast cancer
1181706|NCT02115139|melanoma|melanoma
1181707|NCT02115139|brain|brain
1181708|NCT02115139|metastases|metastases
1181709|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
1181710|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
1181711|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1181712|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
1181713|NCT02115100|Out of range hypertension|out of range hypertension
1181714|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
1181715|NCT02115087|laparotomy|laparotomy
1181716|NCT02115087|levobupivacaine|levobupivacaine
1181717|NCT02115087|patient controlled analgesia|patient controlled analgesia
1181718|NCT02115074|Low-grade gliomas|low-grade gliomas
1181719|NCT02115074|high-grade gliomas|high-grade gliomas
1181720|NCT02115074|optico-chiasmatic|optico-chiasmatic
1181721|NCT02115074|relapsed|relapsed
1181722|NCT02115074|refractory|refractory
1181723|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
1181724|NCT02115035|Multiple Myeloma|multiple myeloma
1181725|NCT02115022|pancreatic cancer|pancreatic cancer
1181726|NCT02115022|resectability|resectability
1181727|NCT02115022|endosonography (EUS)|endosonography (eus)
1181728|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
1181729|NCT02115022|staging|staging
1181730|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
1181731|NCT02114996|mechanical ventilation|mechanical ventilation
1181732|NCT02114996|ischemic stroke|ischemic stroke
1181733|NCT02114983|deep vein thrombosis|deep vein thrombosis
1181734|NCT02114983|diagnostic accuracy|diagnostic accuracy
1181735|NCT02114983|general practitioner|general practitioner
1181736|NCT02114983|test|test
1181737|NCT02114983|compression ultrasonography|compression ultrasonography
1181738|NCT02114983|ultrasound|ultrasound
1181739|NCT02114970|Older Adults|older adults
1181740|NCT02114970|Informed Consent|informed consent
1181741|NCT02114970|Technology|technology
1181742|NCT02114970|Tablet-delivered|tablet-delivered
1181743|NCT02114957|bio-availability|bio-availability
1181744|NCT02114957|decursin|decursin
1181745|NCT02114957|decursinol angelate|decursinol angelate
1181746|NCT02114957|decursinol|decursinol
1181747|NCT02114957|subjects|subjects
1181748|NCT02114944|Do-not-intubate|do-not-intubate
1181749|NCT02114944|DNI|dni
1181750|NCT02114944|Palliative treatment|palliative treatment
1181751|NCT02114944|Acute respiratory failure|acute respiratory failure
1181752|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
1181753|NCT02114944|Hypoxia|hypoxia
1181754|NCT02114944|Respiratory acidosis|respiratory acidosis
1181755|NCT02114944|Hypercarbia|hypercarbia
1181756|NCT02114944|Non invasive ventilation|non invasive ventilation
1181757|NCT02114944|NIV|niv
1181758|NCT02114944|CPAP|cpap
1181759|NCT02114944|Oxygen-therapy|oxygen-therapy
1181760|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
1181761|NCT02114931|arthritis|arthritis
1181762|NCT02114931|rheumatoid|rheumatoid
1181763|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
1181764|NCT02114918|children|children
1181765|NCT02114918|adolescents|adolescents
1181766|NCT02114918|attention bias modification|attention bias modification
1181767|NCT02114905|Tourette's|tourette's
1181768|NCT02114905|Tic Disorder|tic disorder
1181769|NCT02114905|CBIT|cbit
1181770|NCT02114905|Dissemination|dissemination
1181771|NCT02114905|Occupational Therapist|occupational therapist
1181772|NCT02114892|metabolic syndrome|metabolic syndrome
1181773|NCT02114892|central obesity|central obesity
1181774|NCT02114892|resveratrol|resveratrol
1181775|NCT02114892|insulin secretion|insulin secretion
1181776|NCT02114892|insulin sensitivity|insulin sensitivity
1181777|NCT02114879|Physical Therapy|physical therapy
1181778|NCT02114879|Occupational Therapy|occupational therapy
1181779|NCT02114879|Rehabilitation|rehabilitation
1181780|NCT02114879|Older adults|older adults
1181781|NCT02114879|Depression|depression
1181782|NCT02114879|Physical Functioning|physical functioning
1181783|NCT02114827|Multiple Myeloma|multiple myeloma
1181784|NCT02114814|Diabetes|diabetes
1181785|NCT02114814|Hispanic|hispanic
1181786|NCT02114814|Adult|adult
1181787|NCT02114814|Family Member|family member
1181788|NCT02114801|Cerebral Palsy;|cerebral palsy;
1181789|NCT02114801|Toothbrushing;|toothbrushing;
1181790|NCT02114801|Dental Plaque|dental plaque
1181791|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
1181792|NCT02114775|growth hormone|growth hormone
1181793|NCT02114775|fatigue|fatigue
1181794|NCT02114775|sildenafil|sildenafil
1181795|NCT02114775|neurology|neurology
1181796|NCT02114762|otitis media|otitis media
1181797|NCT02114762|eustachian tube|eustachian tube
1181798|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
1181799|NCT02114762|eustachian tube function testing|eustachian tube function testing
1181800|NCT02114749|Healthy volunteers|healthy volunteers
1181801|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
1181802|NCT02114736|Stroke|stroke
1181803|NCT02114736|Muscle spasticity|muscle spasticity
1181804|NCT02114736|Stiff knee gait|stiff knee gait
1181805|NCT02114736|Botulinum toxin|botulinum toxin
1181806|NCT02114736|Tenotomy|tenotomy
1181807|NCT02114723|Mediacal Taping concept|mediacal taping concept
1181808|NCT02114723|Neuromuscular bandage|neuromuscular bandage
1181809|NCT02114723|Physiotherapy techniques|physiotherapy techniques
1181810|NCT02114723|Kinesio Tape|kinesio tape
1181811|NCT02114710|coagulopathy|coagulopathy
1181812|NCT02114710|hydrocortisone|hydrocortisone
1181813|NCT02114710|organ failure|organ failure
1181814|NCT02114697|Cancer survivorship, cardiovascular disease, stroke, TIA|cancer survivorship, cardiovascular disease, stroke, tia
1181815|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
1181816|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
1181817|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
1181818|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
1181819|NCT02114619|radioiodine therapy|radioiodine therapy
1181820|NCT02114619|Graves' disease|graves' disease
1181821|NCT02114619|Hyperthyroidism|hyperthyroidism
1181822|NCT02114619|calculated dose|calculated dose
1181823|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
1181824|NCT02114606|EoE|eoe
1181825|NCT02114606|Cytosponge|cytosponge
1181826|NCT02114593|Mental Health|mental health
1181827|NCT02114593|Children|children
1181828|NCT02114593|Parent support program|parent support program
1181829|NCT02114593|Somali families|somali families
1181830|NCT02114593|Sweden|sweden
1181831|NCT02114580|mild cognitive impairment|mild cognitive impairment
1181832|NCT02114580|exercise|exercise
1181833|NCT02114580|brain plasticity|brain plasticity
1181834|NCT02114580|FMRI|fmri
1181835|NCT02114567|AECOPD|aecopd
1181836|NCT02114567|work of breathing|work of breathing
1181837|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
1181838|NCT02114554|MELAS|melas
1181839|NCT02114554|MIDD|midd
1181840|NCT02114554|Heteroplasmy|heteroplasmy
1181841|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
1181842|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
1181843|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
1181844|NCT02114528|Catheter Ablation|catheter ablation
1181845|NCT02114528|ICD Shocks|icd shocks
1181846|NCT02114515|Patient Navigators|patient navigators
1181847|NCT02114515|Readmissions|readmissions
1181848|NCT02114515|Peer Coaching|peer coaching
1181849|NCT02114502|Myeloma|myeloma
1181850|NCT02114502|Multiple myeloma|multiple myeloma
1181851|NCT02114502|MM|mm
1181852|NCT02114502|Refractory|refractory
1181853|NCT02114502|Relapsed|relapsed
1181854|NCT02114502|Stem Cell Transplant|stem cell transplant
1181855|NCT02114502|SCT|sct
1181856|NCT02114502|Carfilzomib|carfilzomib
1181857|NCT02114502|SAHA|saha
1181858|NCT02114502|Vorinostat|vorinostat
1181859|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1181860|NCT02114502|MSK-390|msk-390
1181861|NCT02114502|Zolinza|zolinza
1181862|NCT02114502|Gemcitabine|gemcitabine
1181863|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1181864|NCT02114502|Gemzar|gemzar
1181865|NCT02114502|Busulfan|busulfan
1181866|NCT02114502|Busulfex|busulfex
1181867|NCT02114502|Myleran|myleran
1181868|NCT02114502|Palifermin|palifermin
1181869|NCT02114502|Kepivance|kepivance
1181870|NCT02114502|Dexamethasone|dexamethasone
1181871|NCT02114502|Decadron|decadron
1181872|NCT02114502|Melphalan|melphalan
1181873|NCT02114502|Alkeran|alkeran
1181874|NCT02114502|Caphosol|caphosol
1181875|NCT02114502|Glutamine|glutamine
1181876|NCT02114502|Enterex|enterex
1181877|NCT02114502|Glutapak-10|glutapak-10
1181878|NCT02114502|NutreStore|nutrestore
1181879|NCT02114502|Resource|resource
1181880|NCT02114502|GlutaSolve|glutasolve
1181881|NCT02114502|Sympt-X G.I.|sympt-x g.i.
1181882|NCT02114502|Sympt-X|sympt-x
1181883|NCT02114502|Pyridoxine|pyridoxine
1181884|NCT02114489|AOH|aoh
1181885|NCT02114489|ibandronate|ibandronate
1181886|NCT02114476|GDM|gdm
1181887|NCT02114476|implant|implant
1181888|NCT02114476|diabetes mellitus|diabetes mellitus
1181889|NCT02114476|metabolic syndrome|metabolic syndrome
1181890|NCT02114463|Local analgesia system|local analgesia system
1181891|NCT02114463|Ropivacaine|ropivacaine
1181892|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
1181893|NCT02114463|Postoperative|postoperative
1181894|NCT02114450|Stroke|stroke
1181895|NCT02114450|Paresis|paresis
1181896|NCT02114450|Gait rehabilitation|gait rehabilitation
1181897|NCT02114450|Human-Machine Interaction|human-machine interaction
1182580|NCT02111811|Depression|depression
1181898|NCT02114450|Wearable Robotic Devices|wearable robotic devices
1181899|NCT02114437|Closed-Loop TCI|closed-loop tci
1181901|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1181902|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
1181903|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
1181904|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
1181905|NCT02114424|Sleep questionnaire|sleep questionnaire
1181906|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
1181907|NCT02114424|Adverse events|adverse events
1181908|NCT02114424|Compliance|compliance
1181909|NCT02114385|Prevention|prevention
1181910|NCT02114372|Alzheimer's disease|alzheimer's disease
1181911|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
1181912|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
1181913|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
1181914|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
1181915|NCT02114346|Side Effects|side effects
1181916|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
1181917|NCT02114346|Prevention|prevention
1181918|NCT02114333|Shingles vaccine|shingles vaccine
1181919|NCT02114333|Immune response|immune response
1181920|NCT02114333|Zoster vaccine|zoster vaccine
1181921|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
1181922|NCT02114320|Biliary drainage|biliary drainage
1181923|NCT02114320|Metal stent|metal stent
1181924|NCT02114307|electrical stimulation|electrical stimulation
1181925|NCT02114307|venous insufficiency|venous insufficiency
1181926|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
1181927|NCT02114307|varicose veins|varicose veins
1181928|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
1181929|NCT02114294|Anterior knee pain|anterior knee pain
1181930|NCT02114294|Randomised controlled trial|randomised controlled trial
1181931|NCT02114294|Exercise intervention|exercise intervention
1181932|NCT02114294|Hip strengthening|hip strengthening
1181933|NCT02114294|Quadriceps based training|quadriceps based training
1181934|NCT02114294|Anterior knee pain score|anterior knee pain score
1181935|NCT02114281|Oral Health|oral health
1181936|NCT02114281|Periodontitis|periodontitis
1181937|NCT02114281|Tooth cavities|tooth cavities
1181938|NCT02114281|Saliva|saliva
1181939|NCT02114281|Halitosis|halitosis
1181940|NCT02114281|Mucosa|mucosa
1181941|NCT02114281|Chronic kidney disease|chronic kidney disease
1181942|NCT02114281|Inflammation|inflammation
1181943|NCT02114281|Nutrition|nutrition
1181944|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
1181945|NCT02114255|Influenza|influenza
1181946|NCT02114255|Trained immunity|trained immunity
1181947|NCT02114255|BCG|bcg
1181948|NCT02114242|Parkinson's disease|parkinson's disease
1181949|NCT02114242|multiple system atrophy|multiple system atrophy
1181950|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
1181951|NCT02114242|alpha-synuclein|alpha-synuclein
1181952|NCT02114229|Alisertib|alisertib
1181953|NCT02114229|MLN8237|mln8237
1181954|NCT02114229|AT/RT|at/rt
1181955|NCT02114229|MRT|mrt
1181956|NCT02114190|Overweight Adolescents|overweight adolescents
1181957|NCT02114190|Mindful Eating and Living|mindful eating and living
1181958|NCT02114190|Family Systems|family systems
1181959|NCT02114190|Body-Mass Index|body-mass index
1181960|NCT02114190|Mindfulness|mindfulness
1181961|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
1181962|NCT02114177|Simeprevir|simeprevir
1181963|NCT02114177|Sofosbuvir|sofosbuvir
1181964|NCT02114177|HCV|hcv
1181965|NCT02114177|Cirrhosis|cirrhosis
1181966|NCT02114164|AirSeal|airseal
1181967|NCT02114164|Trocar|trocar
1181968|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
1181969|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
1181970|NCT02114151|Simeprevir|simeprevir
1181971|NCT02114151|Sofosbuvir|sofosbuvir
1181972|NCT02114151|HCV|hcv
1181973|NCT02114151|Cirrhosis|cirrhosis
1181974|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
1181975|NCT02114138|pAKI|paki
1181976|NCT02114138|stress injury on the kidney|stress injury on the kidney
1181977|NCT02114138|chronic kidney disease|chronic kidney disease
1181978|NCT02114138|CKD|ckd
1181979|NCT02114125|Physical activity|physical activity
1181980|NCT02114125|Cognitive training|cognitive training
1181981|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1181982|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
1181983|NCT02114112|Preterms|preterms
1181984|NCT02114099|Kawasaki Disease|kawasaki disease
1181985|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
1181986|NCT02114086|Observational Study|observational study
1181987|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
1181988|NCT02114086|early and late effects of radiation|early and late effects of radiation
1181989|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
1181990|NCT02114073|glaucoma|glaucoma
1181991|NCT02114073|trabeculectomy|trabeculectomy
1181992|NCT02114073|cyclosporine|cyclosporine
1181993|NCT02114073|betamethasone|betamethasone
1181994|NCT02114060|HSV|hsv
1181995|NCT02114060|Herpes|herpes
1181996|NCT02114060|genital infection|genital infection
1181997|NCT02114060|vaccine|vaccine
1181998|NCT02114034|Severe asthma,|severe asthma,
1181999|NCT02114034|child,|child,
1182000|NCT02114034|outcome,|outcome,
1182001|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
1182002|NCT02114021|Betamethasone gel|betamethasone gel
1182003|NCT02114021|lidocaine jelly|lidocaine jelly
1182004|NCT02114021|sore throat|sore throat
1182005|NCT02114021|cough|cough
1182006|NCT02114021|hoarseness of voice|hoarseness of voice
1182007|NCT02114008|Gastric emptying.|gastric emptying.
1182008|NCT02114008|Residual gastric volume.|residual gastric volume.
1182009|NCT02114008|Preoperative fasting.|preoperative fasting.
1182010|NCT02114008|Morbid Obesity.|morbid obesity.
1182011|NCT02114008|Diabetes.|diabetes.
1182012|NCT02113995|Obesity, Morbid|obesity, morbid
1182013|NCT02113995|Insulin Resistance|insulin resistance
1182014|NCT02113995|Acute-Phase Reaction|acute-phase reaction
1182015|NCT02113995|Gastroplasty|gastroplasty
1182016|NCT02113995|Length of Stay|length of stay
1182017|NCT02113995|Protocols|protocols
1182018|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
1182019|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
1182020|NCT02113969|Quality of Life|quality of life
1182021|NCT02113969|Symptoms|symptoms
1182022|NCT02113969|Pessary|pessary
1182023|NCT02113969|Treatment|treatment
1182024|NCT02113956|HIV Prevention|hiv prevention
1182025|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
1182026|NCT02113956|Text-Messaging|text-messaging
1182027|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
1182028|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
1182029|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1182030|NCT02113904|Netherton syndrome|netherton syndrome
1182031|NCT02113904|Adalimumab|adalimumab
1182032|NCT02113904|TNF-alpha|tnf-alpha
1182033|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
1182034|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
1182035|NCT02113891|Complement blockade|complement blockade
1182036|NCT02113891|Eculizumab|eculizumab
1182037|NCT02113891|Kidney transplantation|kidney transplantation
1182038|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
1182039|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
1182040|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
1182041|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
1182042|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
1182043|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
1182044|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
1182045|NCT02113852|Heavy smokers|heavy smokers
1182046|NCT02113852|Treatment naive patients|treatment naive patients
1182047|NCT02113839|Dyspnea perception|dyspnea perception
1182048|NCT02113839|COPD|copd
1182049|NCT02113839|Exacerbations|exacerbations
1182050|NCT02113839|CO2 rebreathing test|co2 rebreathing test
1182051|NCT02113826|Pazopanib|pazopanib
1182052|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
1182053|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
1182054|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1182055|NCT02113813|Midazolam|midazolam
1182056|NCT02113813|T790M resistance mutation|t790m resistance mutation
1182057|NCT02113813|EGFR|egfr
1182058|NCT02113813|NSCLC|nsclc
1182059|NCT02113813|naquotinib|naquotinib
1182060|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
1182061|NCT02113813|ASP8273|asp8273
1182062|NCT02113787|epilepsy|epilepsy
1182063|NCT02113787|anticonvulsants|anticonvulsants
1182064|NCT02113787|generic drugs|generic drugs
1182065|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1182066|NCT02113748|Downhill walking|downhill walking
1182067|NCT02113748|exercise|exercise
1182068|NCT02113735|ARDS|ards
1182069|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1182070|NCT02113735|Acthar|acthar
1182071|NCT02113735|ACTH|acth
1182072|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
1182073|NCT02113722|Sudden cardiac death|sudden cardiac death
1182074|NCT02113722|Ganglionectomy|ganglionectomy
1182075|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
1182076|NCT02113722|Cardiac surgery|cardiac surgery
1182077|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
1182078|NCT02113709|Amblyopia|amblyopia
1182079|NCT02113709|Strabismus|strabismus
1182080|NCT02113709|Occlusion therapy|occlusion therapy
1182081|NCT02113709|Visual improvement|visual improvement
1182082|NCT02113696|morbid obesity|morbid obesity
1182083|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
1182084|NCT02113696|ingestion of omega 3|ingestion of omega 3
1182085|NCT02113696|inflammatory cytokines|inflammatory cytokines
1182086|NCT02113696|biochemical factors|biochemical factors
1182087|NCT02113696|anthropometric factors|anthropometric factors
1182883|NCT02110459|POL7080|pol7080
1182088|NCT02113683|colo-rectal cancer|colo-rectal cancer
1182089|NCT02113683|stomach cancer|stomach cancer
1182090|NCT02113683|melanoma|melanoma
1182091|NCT02113683|MMS test|mms test
1182092|NCT02113683|therapy monitoring|therapy monitoring
1182093|NCT02113683|Sarcoma|sarcoma
1182094|NCT02113670|stress urinary incontinence|stress urinary incontinence
1182095|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
1182096|NCT02113670|urodynamic study|urodynamic study
1182097|NCT02113657|Prostate cancer|prostate cancer
1182098|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
1182099|NCT02113657|CRPC|crpc
1182100|NCT02113657|Metastatic|metastatic
1182101|NCT02113657|Hormone therapy treatment|hormone therapy treatment
1182102|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
1182103|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
1182104|NCT02113657|GnRH|gnrh
1182105|NCT02113657|Ipilimumab|ipilimumab
1182106|NCT02113657|Yervoy|yervoy
1182107|NCT02113657|BMS-734016|bms-734016
1182108|NCT02113657|MDX010|mdx010
1182109|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
1182110|NCT02113631|Boceprevir,|boceprevir,
1182111|NCT02113631|Telaprevir,|telaprevir,
1182112|NCT02113631|Safety|safety
1182113|NCT02113631|Effectiveness|effectiveness
1182114|NCT02113631|Head-to-head trial|head-to-head trial
1182115|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
1182116|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
1182117|NCT02113605|FGID|fgid
1182118|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
1182119|NCT02113605|Abdominal pain|abdominal pain
1182120|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
1182121|NCT02113605|Pediatric pain|pediatric pain
1182122|NCT02113592|Pain management|pain management
1182123|NCT02113592|Opioid use|opioid use
1182124|NCT02113592|Pragmatic|pragmatic
1182125|NCT02113592|Collaborative care|collaborative care
1182126|NCT02113592|Primary care|primary care
1182127|NCT02113579|Tooth Sensitivity|tooth sensitivity
1182128|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
1182129|NCT02113566|DOMS|doms
1182130|NCT02113540|coronary angiography|coronary angiography
1182131|NCT02113540|chronic stable angina|chronic stable angina
1182132|NCT02113540|CIN|cin
1182133|NCT02113527|Electrogastrography|electrogastrography
1182134|NCT02113527|Functional dyspepsia|functional dyspepsia
1182135|NCT02113527|Gastric emptying|gastric emptying
1182136|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
1182137|NCT02113527|Rome III criteria|rome iii criteria
1182138|NCT02113514|Appalachian|appalachian
1182139|NCT02113514|abnormal pap test|abnormal pap test
1182140|NCT02113501|HGT1|hgt1
1182141|NCT02113501|high risk bladder cancer|high risk bladder cancer
1182142|NCT02113501|substaging|substaging
1182143|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
1182144|NCT02113501|lamina propria|lamina propria
1182145|NCT02113475|CDT|cdt
1182146|NCT02113475|PCDT|pcdt
1182147|NCT02113475|DVT|dvt
1182148|NCT02113475|PTS|pts
1182149|NCT02113475|Quality of Life|quality of life
1182150|NCT02113462|Chronic kidney disease|chronic kidney disease
1182151|NCT02113462|Endothelial dysfunction|endothelial dysfunction
1182152|NCT02113462|Inflammation|inflammation
1182153|NCT02113462|Insulin resistance|insulin resistance
1182154|NCT02113462|Tg/hdl ratio|tg/hdl ratio
1182155|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
1182156|NCT02113436|FP/SLM|fp/slm
1182157|NCT02113436|Asthma|asthma
1182158|NCT02113436|Infant|infant
1182159|NCT02113436|Efficacy|efficacy
1182160|NCT02113436|Safety|safety
1182161|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
1182162|NCT02113410|osteoarthritis|osteoarthritis
1182163|NCT02113410|Older adults|older adults
1182164|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
1182165|NCT02113410|Pain|pain
1182166|NCT02113410|Physical Function|physical function
1182167|NCT02113410|Balance|balance
1182168|NCT02113410|Fatigue|fatigue
1182169|NCT02113410|Depression|depression
1182170|NCT02113410|Life Satisfaction|life satisfaction
1182171|NCT02113397|Cystic fibrosis|cystic fibrosis
1182172|NCT02113397|Microbiome|microbiome
1182173|NCT02113397|Sputum|sputum
1182174|NCT02113397|Tobramycin|tobramycin
1182175|NCT02113397|Colistimethate|colistimethate
1182176|NCT02113384|Rectal cancer|rectal cancer
1182177|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
1182178|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
1182179|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
1182180|NCT02113384|Peritoneal lavage|peritoneal lavage
1182181|NCT02113371|Injury Prevention|injury prevention
1182182|NCT02113371|Health Promotion|health promotion
1182183|NCT02113371|Well being|well being
1182184|NCT02113371|Safety|safety
1182185|NCT02113371|Nutrition|nutrition
1182186|NCT02113371|Physical Activity|physical activity
1182187|NCT02113371|Sleep|sleep
1182188|NCT02113371|Stress|stress
1183587|NCT02107469|Crude Herb|crude herb
1182189|NCT02113358|fluid therapy|fluid therapy
1182190|NCT02113358|neurosurgery|neurosurgery
1182191|NCT02113345|metamemory|metamemory
1182192|NCT02113345|memory|memory
1182193|NCT02113345|mild cognitive impairment|mild cognitive impairment
1182194|NCT02113332|Insulin injections|insulin injections
1182195|NCT02113332|Overweight|overweight
1182196|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
1182197|NCT02113319|Core Binding Factors|core binding factors
1182198|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
1182199|NCT02113319|molecular relapse|molecular relapse
1182200|NCT02113293|phase I study|phase i study
1182201|NCT02113293|tolerability|tolerability
1182202|NCT02113293|safety|safety
1182203|NCT02113293|CyclASol®|cyclasol®
1182204|NCT02113293|eye drops|eye drops
1182205|NCT02113267|esophagitis|esophagitis
1182206|NCT02113267|eosinophils|eosinophils
1182207|NCT02113267|allergy|allergy
1182208|NCT02113267|inflammation|inflammation
1182209|NCT02113267|corticosteroids|corticosteroids
1182210|NCT02113254|corn|corn
1182211|NCT02113254|macular pigment|macular pigment
1182212|NCT02113254|lutein|lutein
1182213|NCT02113254|zeaxanthin|zeaxanthin
1182214|NCT02113254|Age Macular Degeneration|age macular degeneration
1182215|NCT02113254|AMD|amd
1182216|NCT02113241|metabolic syndrome|metabolic syndrome
1182217|NCT02113241|forxiga|forxiga
1182218|NCT02113241|dapagliflozin|dapagliflozin
1182219|NCT02113241|insulin secretion|insulin secretion
1182220|NCT02113241|insulin sensitivity|insulin sensitivity
1182221|NCT02113228|Energy metabolism|energy metabolism
1182222|NCT02113228|Stable isotopes|stable isotopes
1182223|NCT02113228|Short bowel syndrome|short bowel syndrome
1182224|NCT02113228|Doubly labeled water|doubly labeled water
1182225|NCT02113215|aging|aging
1182226|NCT02113215|lipid metabolism|lipid metabolism
1182227|NCT02113215|very low density lipoproteins|very low density lipoproteins
1182228|NCT02113202|Optical imaging|optical imaging
1182229|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
1182230|NCT02113202|Near infrared fluorescence|near infrared fluorescence
1182231|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
1182232|NCT02113202|IRDye800CW|irdye800cw
1182233|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1182234|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
1182235|NCT02113189|gait|gait
1182236|NCT02113189|Parkinson's disease|parkinson's disease
1182237|NCT02113176|SAH|sah
1182238|NCT02113163|Type 2 diabetes|type 2 diabetes
1182239|NCT02113163|T2DM|t2dm
1182240|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
1182241|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
1182242|NCT02113163|dyslipidemia|dyslipidemia
1182243|NCT02113163|triglycerides|triglycerides
1182244|NCT02113163|lipids|lipids
1182245|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
1182246|NCT02113163|EPA|epa
1182247|NCT02113163|ethyl-EPA|ethyl-epa
1182248|NCT02113163|Metformin|metformin
1182249|NCT02113163|Glucophage|glucophage
1182250|NCT02113163|Lovaza|lovaza
1182251|NCT02113163|Vascepa|vascepa
1182252|NCT02113163|Epanova|epanova
1182253|NCT02113163|Astra Zeneca|astra zeneca
1182254|NCT02113163|Amarin|amarin
1182255|NCT02113163|GSK|gsk
1182256|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
1182257|NCT02113137|halitosis|halitosis
1182258|NCT02113137|chlorine dioxide|chlorine dioxide
1182259|NCT02113137|tongue cleaning|tongue cleaning
1182260|NCT02113124|Chronic Brain Injury|chronic brain injury
1182261|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
1182262|NCT02113124|Amino Acids|amino acids
1182263|NCT02113124|Microbiome|microbiome
1182264|NCT02113098|Stroke|stroke
1182265|NCT02113098|Gait|gait
1182266|NCT02113098|Rehabilitation|rehabilitation
1182267|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
1182268|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
1182269|NCT02113059|Liver regeneration|liver regeneration
1182270|NCT02113059|liver dysfunction|liver dysfunction
1182271|NCT02113059|platelets|platelets
1182272|NCT02113059|plasma|plasma
1182273|NCT02113059|serum|serum
1182274|NCT02113059|platelet activation|platelet activation
1182275|NCT02113059|morbidity|morbidity
1182276|NCT02113059|mortality|mortality
1182277|NCT02113059|Growth factors|growth factors
1182278|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
1182279|NCT02113046|pancreas|pancreas
1182280|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
1182281|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
1182282|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
1182283|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
1182284|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
1182380|NCT02112656|Therapeutic Uses|therapeutic uses
1182285|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
1182286|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
1183588|NCT02107469|Crude|crude
1182287|NCT02112994|Acid lipase disease|acid lipase disease
1182288|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1182289|NCT02112994|LAL Deficiency|lal deficiency
1182290|NCT02112994|LIPA Deficiency|lipa deficiency
1182291|NCT02112994|Wolman disease|wolman disease
1182292|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
1182293|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
1182294|NCT02112994|Metabolic Diseases|metabolic diseases
1182295|NCT02112994|Lipidoses|lipidoses
1182296|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1182297|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
1182298|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
1182299|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
1182300|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
1182301|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
1182302|NCT02112981|Coronary Arteriosclerosis|coronary arteriosclerosis
1182303|NCT02112968|Myopia|myopia
1182304|NCT02112968|Hyperopia|hyperopia
1182305|NCT02112968|Presbyopia|presbyopia
1182306|NCT02112968|Supracor|supracor
1182307|NCT02112968|Zyoptix|zyoptix
1182308|NCT02112968|Proscan|proscan
1182309|NCT02112968|LASIK|lasik
1182310|NCT02112955|Stroke|stroke
1182311|NCT02112955|Disease management|disease management
1182312|NCT02112955|Self efficacy|self efficacy
1182313|NCT02112955|Quality of life|quality of life
1182314|NCT02112955|Community integration|community integration
1182315|NCT02112942|Hepatitis C virus|hepatitis c virus
1182316|NCT02112942|HCV|hcv
1182317|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
1182318|NCT02112929|Lung Diseases|lung diseases
1182319|NCT02112890|Mexico|mexico
1182320|NCT02112890|Adolescents|adolescents
1182321|NCT02112890|Hepatitis|hepatitis
1182322|NCT02112890|Seroprevalence|seroprevalence
1182323|NCT02112890|Pertussis|pertussis
1182324|NCT02112890|Young adults|young adults
1182325|NCT02112877|iliofemoral vein|iliofemoral vein
1182326|NCT02112877|venous|venous
1182327|NCT02112877|venous obstruction|venous obstruction
1182328|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
1182329|NCT02112838|Nephritis, IGA Type|nephritis, iga type
1182330|NCT02112825|Exercise|exercise
1182331|NCT02112825|blood pressure|blood pressure
1182332|NCT02112825|chronic kidney disease|chronic kidney disease
1182333|NCT02112812|Parkinsons disease|parkinsons disease
1182334|NCT02112812|Helicobacter pylori|helicobacter pylori
1182335|NCT02112812|Eradication|eradication
1182336|NCT02112812|Levodopa response|levodopa response
1182337|NCT02112812|Motor outcomes|motor outcomes
1182338|NCT02112812|Quality of Life|quality of life
1182339|NCT02112812|Open label|open label
1182340|NCT02112799|Hepatitis B|hepatitis b
1182341|NCT02112786|Overactive Bladder|overactive bladder
1182342|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
1182343|NCT02112760|specific stabilization exercise|specific stabilization exercise
1182344|NCT02112760|ultrasound|ultrasound
1182345|NCT02112760|low back pain|low back pain
1574330|NCT00485563|Phase 2|phase 2
1182346|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
1182347|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
1182348|NCT02112747|ACCS|accs
1182349|NCT02112747|Lynch Syndrome|lynch syndrome
1182350|NCT02112747|LS|ls
1182351|NCT02112734|vitamin D|vitamin d
1182352|NCT02112734|food allergy|food allergy
1182353|NCT02112734|eczema|eczema
1182354|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
1182355|NCT02112708|Depression|depression
1182356|NCT02112708|Social Work|social work
1182357|NCT02112708|Primary Health Care|primary health care
1182358|NCT02112695|endurance sportswomen|endurance sportswomen
1182359|NCT02112695|addiction|addiction
1182360|NCT02112695|undernutrition|undernutrition
1182361|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
1182362|NCT02112695|pituitary region|pituitary region
1182363|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
1182364|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
1182365|NCT02112682|Axillary radiotherapy|axillary radiotherapy
1182366|NCT02112656|Carcinoma|carcinoma
1182367|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1182368|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1182369|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
1182370|NCT02112656|Neoplasms|neoplasms
1182371|NCT02112656|Adenocarcinoma|adenocarcinoma
1182372|NCT02112656|Liver Neoplasms|liver neoplasms
1182373|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
1182374|NCT02112656|Neoplasms by Site|neoplasms by site
1182375|NCT02112656|Digestive System Diseases|digestive system diseases
1182376|NCT02112656|Liver Diseases|liver diseases
1182377|NCT02112656|Doxorubicin|doxorubicin
1182378|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
1182379|NCT02112656|Antineoplastic Agents|antineoplastic agents
1182381|NCT02112656|Pharmacologic Actions|pharmacologic actions
1182382|NCT02112643|Thyroid eye disease|thyroid eye disease
1182383|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
1182384|NCT02112643|Graves' orbitopathy|graves' orbitopathy
1182385|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
1182386|NCT02112630|Hepatitis C Infection|hepatitis c infection
1182387|NCT02112630|HCV, genotype 1|hcv, genotype 1
1182388|NCT02112630|End Stage Renal Disease|end stage renal disease
1182389|NCT02112630|ESRD|esrd
1182390|NCT02112630|Boceprevir|boceprevir
1182391|NCT02112630|Pegylated Interferon|pegylated interferon
1182392|NCT02112630|Ribavirin|ribavirin
1182393|NCT02112617|Neuroblastoma|neuroblastoma
1182394|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
1182395|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
1182396|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
1182397|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
1182398|NCT02112591|Stress urinary incontinence|stress urinary incontinence
1182399|NCT02112591|mesh|mesh
1182400|NCT02112591|tape|tape
1182401|NCT02112591|micturition dysfunction|micturition dysfunction
1182402|NCT02112591|urinary obstruction|urinary obstruction
1182404|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
1182405|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
1182406|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1182407|NCT02112526|Novo Activated B-cell (ABC)|novo activated b-cell (abc)
1182408|NCT02112526|Novo Activated B-cell|novo activated b-cell
1182409|NCT02112526|ABC DLBCL|abc dlbcl
1182410|NCT02112526|DLBCL|dlbcl
1182411|NCT02112526|Lymphoma|lymphoma
1182412|NCT02112526|B-Cell|b-cell
1182413|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
1182414|NCT02112526|Immune System Diseases|immune system diseases
1182415|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
1182416|NCT02112487|PAH-SYMPACT|pah-sympact
1182417|NCT02112487|PAH|pah
1182418|NCT02112487|psychometric instrument|psychometric instrument
1182419|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
1182420|NCT02112474|Neuropathic pain|neuropathic pain
1182421|NCT02112474|Leg Pain|leg pain
1182422|NCT02112474|Chronic Pain|chronic pain
1182423|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
1182424|NCT02112474|Neurostimulation|neurostimulation
1182425|NCT02112461|end of life care|end of life care
1182426|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
1182427|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
1182428|NCT02112435|mandibular advancement splint|mandibular advancement splint
1182429|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
1182430|NCT02112435|oral appliance|oral appliance
1182431|NCT02112422|Parturients|parturients
1182432|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1182433|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
1182434|NCT02112409|autologous blood transfusion|autologous blood transfusion
1182435|NCT02112409|cell salvage|cell salvage
1182436|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
1182437|NCT02112409|hemoglobin level|hemoglobin level
1182439|NCT02112396|Concerned Significant Others|concerned significant others
1182440|NCT02112396|Contingency management|contingency management
1182441|NCT02112396|Reinforcement|reinforcement
1182442|NCT02112396|Family Intervention|family intervention
1182443|NCT02112383|Procrastination|procrastination
1182444|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
1182445|NCT02112383|Internet interventions|internet interventions
1182446|NCT02112383|Group intervention|group intervention
1182447|NCT02112383|Students|students
1182448|NCT02112383|Randomized controlled trial|randomized controlled trial
1182449|NCT02112370|Ropivacaine|ropivacaine
1182450|NCT02112370|Epinephrine|epinephrine
1182451|NCT02112370|Endoscopy|endoscopy
1182452|NCT02112370|Robotics|robotics
1182453|NCT02112370|Thyroidectomy|thyroidectomy
1182454|NCT02112357|molecular profiling|molecular profiling
1182455|NCT02112357|genetic sequencing|genetic sequencing
1182456|NCT02112357|personalised medicine|personalised medicine
1182457|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
1182458|NCT02112331|Preterm newborns|preterm newborns
1182459|NCT02112331|Gastric lipolysis|gastric lipolysis
1182460|NCT02112331|Physical treatments|physical treatments
1182461|NCT02112331|Human milk|human milk
1182462|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
1182463|NCT02112279|Microbiota|microbiota
1182464|NCT02112279|c-difficile|c-difficile
1182465|NCT02112279|colonoscopy|colonoscopy
1182466|NCT02112279|stool transplant|stool transplant
1182467|NCT02112266|depression|depression
1182468|NCT02112266|online therapy|online therapy
1182469|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
1182470|NCT02112266|quality of life|quality of life
1182471|NCT02112266|alexithymia|alexithymia
1182472|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
1182473|NCT02112253|Tourette's syndrome|tourette's syndrome
1182474|NCT02112253|Deep brain stimulation|deep brain stimulation
1182676|NCT02111447|anesthesia|anesthesia
1182475|NCT02112253|Stereotactic surgery|stereotactic surgery
1182476|NCT02112253|Globus pallidus interna|globus pallidus interna
1182477|NCT02112253|Tics|tics
1182478|NCT02112240|sentinel lymph node|sentinel lymph node
1182479|NCT02112240|lymphatic mapping|lymphatic mapping
1182480|NCT02112240|rectal tumor|rectal tumor
1182481|NCT02112227|Heart Failure|heart failure
1182482|NCT02112227|Transitional Care|transitional care
1182483|NCT02112227|Knowledge Translation|knowledge translation
1182484|NCT02112227|Outcomes|outcomes
1182485|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
1182486|NCT02112214|Gastric cancer|gastric cancer
1182487|NCT02112214|Screening|screening
1182488|NCT02112175|Multiple Myeloma|multiple myeloma
1182489|NCT02112175|Lenalidomide|lenalidomide
1182490|NCT02112175|Revlimid|revlimid
1182491|NCT02112175|MPV|mpv
1182492|NCT02112175|Melphalan|melphalan
1182493|NCT02112175|Prednisone|prednisone
1182494|NCT02112175|Velcade|velcade
1182495|NCT02112175|Placebo|placebo
1182496|NCT02112149|Body Composition|body composition
1182497|NCT02112149|Exercise|exercise
1182498|NCT02112149|Survivorship|survivorship
1182499|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
1182500|NCT02112136|Renal cysts|renal cysts
1182501|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
1182502|NCT02112136|Genetic|genetic
1182503|NCT02112123|icariin|icariin
1182504|NCT02112123|pharmacokinetics|pharmacokinetics
1182505|NCT02112123|healthy participants|healthy participants
1182506|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
1182507|NCT02112097|Subdermal bloodless space|subdermal bloodless space
1182508|NCT02112097|Subdermal injection|subdermal injection
1182509|NCT02112097|Subcutaneous injection|subcutaneous injection
1182510|NCT02112097|Injectable electromyography needle|injectable electromyography needle
1182511|NCT02112097|Electrical stimulation|electrical stimulation
1182512|NCT02112097|MRI with Gadolinium|mri with gadolinium
1182513|NCT02112071|Exercise|exercise
1182514|NCT02112071|Diabetic kidney disease|diabetic kidney disease
1182515|NCT02112071|vascular function|vascular function
1182516|NCT02112071|physical function|physical function
1182517|NCT02112032|melanoma|melanoma
1182518|NCT02112032|advanced|advanced
1182519|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
1182520|NCT02112019|Sialoendoscopy|sialoendoscopy
1182521|NCT02112019|Saliva|saliva
1182522|NCT02112019|Dry Mouth|dry mouth
1182523|NCT02112006|hand surgery|hand surgery
1182524|NCT02112006|wrist surgery|wrist surgery
1182525|NCT02112006|finger surgery|finger surgery
1182526|NCT02112006|anesthesia|anesthesia
1182527|NCT02112006|regional anesthesia|regional anesthesia
1182528|NCT02112006|postoperative pain|postoperative pain
1182529|NCT02111993|Defibrillation testing|defibrillation testing
1182530|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
1182531|NCT02111993|ULV|ulv
1182532|NCT02111993|DFT|dft
1182533|NCT02111993|ICD|icd
1182534|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1182535|NCT02111993|cardiomyopathy|cardiomyopathy
1182536|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
1182537|NCT02111993|cardiac device testing|cardiac device testing
1182538|NCT02111980|CIED|cied
1182539|NCT02111980|pacemaker|pacemaker
1182540|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1182541|NCT02111980|ICD|icd
1182542|NCT02111980|radiofrequency|radiofrequency
1182543|NCT02111980|cardiac device programming|cardiac device programming
1182544|NCT02111980|RF sponge detection|rf sponge detection
1182545|NCT02111980|RF assure|rf assure
1182546|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
1182547|NCT02111980|temporary pacing|temporary pacing
1182548|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
1182549|NCT02111980|pacing interference|pacing interference
1182550|NCT02111980|Arrhythmia|arrhythmia
1182551|NCT02111954|prostate cancer|prostate cancer
1182552|NCT02111954|primary|primary
1182553|NCT02111954|recurrence|recurrence
1182554|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
1182555|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
1182556|NCT02111915|Maternal depression|maternal depression
1182557|NCT02111902|Cardiovascular Disease|cardiovascular disease
1182558|NCT02111902|Obesity|obesity
1182559|NCT02111902|Physical Activity|physical activity
1182560|NCT02111902|Vitamin D deficiency|vitamin d deficiency
1182561|NCT02111902|African Americans|african americans
1182562|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
1182563|NCT02111863|Skin Cancer|skin cancer
1182564|NCT02111863|Metastatic Melanoma|metastatic melanoma
1182565|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
1182566|NCT02111863|Immunotherapy|immunotherapy
1182567|NCT02111863|Clinical Response|clinical response
1182568|NCT02111850|Gene Therapy|gene therapy
1182569|NCT02111850|Tumor Regression|tumor regression
1182570|NCT02111850|Immunotherapy|immunotherapy
1182571|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
1182572|NCT02111824|Lung Cancer|lung cancer
1182573|NCT02111824|Peripheral lung lesions|peripheral lung lesions
1182574|NCT02111824|Lung biopsy|lung biopsy
1182575|NCT02111824|Minimally invasive|minimally invasive
1182576|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
1182577|NCT02111824|MIMIG|mimig
1182578|NCT02111824|Indocyanine green|indocyanine green
1182579|NCT02111824|ICG|icg
1182581|NCT02111811|Treatment Outcome|treatment outcome
1182582|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
1182583|NCT02111811|Employment|employment
1182584|NCT02111811|Rehabilitation|rehabilitation
1182585|NCT02111798|substance abuse treatment|substance abuse treatment
1182586|NCT02111798|cocaine dependence|cocaine dependence
1182587|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
1182588|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
1182589|NCT02111785|Dexamethasone|dexamethasone
1182590|NCT02111785|Burr hole craniostomy|burr hole craniostomy
1182591|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
1182592|NCT02111772|mild asthma, rhinovirus, young adults|mild asthma, rhinovirus, young adults
1182593|NCT02111746|Postoperative pain|postoperative pain
1182594|NCT02111746|sternotomy|sternotomy
1182595|NCT02111746|laparotomy|laparotomy
1182596|NCT02111746|thoracotomy|thoracotomy
1182597|NCT02111746|mini-thoracotomy|mini-thoracotomy
1182598|NCT02111746|truncal surgical incisions|truncal surgical incisions
1182599|NCT02111746|local anaesthetics|local anaesthetics
1182600|NCT02111746|bupivacaine|bupivacaine
1182601|NCT02111720|HIV|hiv
1182602|NCT02111720|Disclosure|disclosure
1182603|NCT02111720|Family|family
1182604|NCT02111720|Intervention|intervention
1182605|NCT02111694|infant|infant
1182606|NCT02111694|intake|intake
1182607|NCT02111694|satiation|satiation
1182608|NCT02111694|mother|mother
1182609|NCT02111694|feeding practices|feeding practices
1182610|NCT02111694|bottle feeding|bottle feeding
1182611|NCT02111694|formula feeding|formula feeding
1182612|NCT02111694|maternal responsiveness|maternal responsiveness
1182613|NCT02111694|infant cues|infant cues
1182614|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
1182615|NCT02111681|radiation treatments|radiation treatments
1182616|NCT02111681|13-174|13-174
1182617|NCT02111668|Aorta|aorta
1182618|NCT02111668|Dilatation|dilatation
1182619|NCT02111668|Marfan syndrome|marfan syndrome
1182620|NCT02111668|Genetic|genetic
1182621|NCT02111668|Fbn1|fbn1
1182622|NCT02111655|Thrombosis|thrombosis
1182623|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
1182624|NCT02111655|Hemodialysis|hemodialysis
1182625|NCT02111655|Doppler ultrasound|doppler ultrasound
1182626|NCT02111655|Vascular access blood flow|vascular access blood flow
1182627|NCT02111655|Surveillance|surveillance
1182628|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
1182629|NCT02111642|Stress urinary incontinence|stress urinary incontinence
1182630|NCT02111642|Midurethral sling|midurethral sling
1182631|NCT02111642|Patient satisfaction|patient satisfaction
1182632|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
1575918|NCT00479518|Cystatin C|cystatin c
1182633|NCT02111616|cancer survivorship care|cancer survivorship care
1182634|NCT02111616|provider communication|provider communication
1182635|NCT02111616|provider care coordination|provider care coordination
1182636|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1182637|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
1182638|NCT02111577|Immunotherapy|immunotherapy
1182639|NCT02111577|Metastatic|metastatic
1182640|NCT02111577|Castrate Resistant|castrate resistant
1182641|NCT02111577|Prostate Cancer|prostate cancer
1182642|NCT02111577|Biological|biological
1182643|NCT02111577|Vaccine|vaccine
1182644|NCT02111564|Heart Failure|heart failure
1182645|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
1182646|NCT02111564|Stroke Acute|stroke acute
1182647|NCT02111564|Infectious Diseases|infectious diseases
1182648|NCT02111564|Rheumatic Diseases|rheumatic diseases
1182649|NCT02111564|Medically ill Patient|medically ill patient
1182650|NCT02111564|Rivaroxaban|rivaroxaban
1182651|NCT02111564|Thromboembolism|thromboembolism
1182652|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
1182653|NCT02111551|Autism|autism
1182654|NCT02111551|Nicotinic agonist|nicotinic agonist
1182655|NCT02111551|Cognition|cognition
1182656|NCT02111551|P50|p50
1182657|NCT02111551|Alpha 7|alpha 7
1182658|NCT02111499|psoriasis plaque test|psoriasis plaque test
1182659|NCT02111499|topical application|topical application
1182660|NCT02111499|atrophy measure|atrophy measure
1182661|NCT02111486|Breakfast|breakfast
1182662|NCT02111486|Satiety|satiety
1182663|NCT02111486|Fibre|fibre
1182664|NCT02111486|Glucose|glucose
1182665|NCT02111486|Gastric emptying|gastric emptying
1182666|NCT02111473|endothelial dysfunction|endothelial dysfunction
1182667|NCT02111473|bone mineral metabolism|bone mineral metabolism
1182668|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
1182669|NCT02111460|Initially|initially
1182670|NCT02111460|Untreated|untreated
1182671|NCT02111460|Distant metastatic|distant metastatic
1182672|NCT02111447|children|children
1182673|NCT02111447|sevoflurane|sevoflurane
1182674|NCT02111447|isoflurane|isoflurane
1182675|NCT02111447|propofol|propofol
1182677|NCT02111447|MRI|mri
1182678|NCT02111447|delirium|delirium
1182679|NCT02111434|visceral adiposity index|visceral adiposity index
1182680|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
1182681|NCT02111434|testosterone|testosterone
1182682|NCT02111421|dexmedetomidine|dexmedetomidine
1182683|NCT02111421|parturient|parturient
1182684|NCT02111421|nonpregnant women|nonpregnant women
1182685|NCT02111421|sedation|sedation
1182686|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
1182687|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
1182688|NCT02111408|Depression|depression
1182689|NCT02111408|Peripheral arterial disease|peripheral arterial disease
1182690|NCT02111382|Low back pain|low back pain
1182691|NCT02111382|osteopathic manipulations|osteopathic manipulations
1182692|NCT02111382|electroencephalography|electroencephalography
1182693|NCT02111369|Essential Tremor|essential tremor
1182694|NCT02111369|Essential Vocal Tremor|essential vocal tremor
1182695|NCT02111369|Essential Voice Tremor|essential voice tremor
1182696|NCT02111343|auditory processing disorder|auditory processing disorder
1182697|NCT02111343|central auditory processing disorder|central auditory processing disorder
1182698|NCT02111343|auditory processing|auditory processing
1182699|NCT02111343|auditory training|auditory training
1182700|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
1182701|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
1182702|NCT02111330|Cancer|cancer
1182703|NCT02111317|ASP015K|asp015k
1182704|NCT02111317|Pharmacokinetics|pharmacokinetics
1182705|NCT02111317|Healthy Subjects|healthy subjects
1182706|NCT02111304|cholera|cholera
1182707|NCT02111304|diarrhea|diarrhea
1182708|NCT02111304|secretory diarrhea|secretory diarrhea
1182709|NCT02111304|ORS|ors
1182710|NCT02111304|V. cholerae O1|v. cholerae o1
1182711|NCT02111304|iOWH032|iowh032
1182712|NCT02111304|children|children
1182713|NCT02111304|pharmacokinetic|pharmacokinetic
1182714|NCT02111304|Bangladesh|bangladesh
1182715|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
1182716|NCT02111278|Manipulation|manipulation
1182717|NCT02111278|Lumbar|lumbar
1182718|NCT02111278|Low Back Pain|low back pain
1182719|NCT02111278|Manual Therapy|manual therapy
1182720|NCT02111278|Adolescents|adolescents
1182721|NCT02111252|Drug Therapy|drug therapy
1182722|NCT02111239|DIEP|diep
1182723|NCT02111239|DIEP flap|diep flap
1182724|NCT02111239|Breast reconstruction|breast reconstruction
1182725|NCT02111239|Breast Cancer|breast cancer
1182726|NCT02111239|CTA|cta
1182727|NCT02111239|MRA|mra
1182728|NCT02111226|hypertension|hypertension
1182729|NCT02111226|cardiovascular disease|cardiovascular disease
1182730|NCT02111226|diabetes|diabetes
1182731|NCT02111226|chronic disease management|chronic disease management
1182732|NCT02111213|physical activity|physical activity
1182733|NCT02111213|Intervention|intervention
1182734|NCT02111213|Attitude to Computers|attitude to computers
1182735|NCT02111200|urea cycle disorders|urea cycle disorders
1182736|NCT02111187|LDE225|lde225
1182737|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
1182738|NCT02111187|Pre-surgical|pre-surgical
1182739|NCT02111174|Neuropathy|neuropathy
1182740|NCT02111174|Peripheral neuropathy|peripheral neuropathy
1182741|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1182742|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
1182743|NCT02111161|Immunoglobulin|immunoglobulin
1182744|NCT02111161|Patient Reported Outcome|patient reported outcome
1182745|NCT02111161|Health-Related Quality of Life|health-related quality of life
1182746|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
1182747|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
1182748|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
1182749|NCT02111122|Parkinson`s Disease|parkinson`s disease
1182750|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
1182751|NCT02111122|Sodium Oxybate|sodium oxybate
1182752|NCT02111109|Microcirculation|microcirculation
1182753|NCT02111109|Trauma|trauma
1182754|NCT02111109|Haemorrhage|haemorrhage
1182755|NCT02111109|Shock|shock
1182756|NCT02111070|Influenza|influenza
1182757|NCT02111070|Influenza vaccine|influenza vaccine
1182758|NCT02111070|Split influenza vaccine|split influenza vaccine
1182759|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
1182760|NCT02111057|Total Hip Replacement|total hip replacement
1182761|NCT02111057|Flare|flare
1182762|NCT02111057|Perioperative Outcomes|perioperative outcomes
1182763|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
1182764|NCT02111031|CELLSEARCH|cellsearch
1182765|NCT02111031|CTC|ctc
1182766|NCT02111031|metastatic breast cancer|metastatic breast cancer
1182767|NCT02111031|Registry|registry
1182768|NCT02111031|mBC|mbc
1182769|NCT02111005|apoptosis|apoptosis
1182770|NCT02111005|periodontal disease|periodontal disease
1182771|NCT02111005|smoking|smoking
1182772|NCT02110979|Patient Decision Aid|patient decision aid
1182773|NCT02110979|Shared Decision Making|shared decision making
1182774|NCT02110966|Anaesthetic effect|anaesthetic effect
1182775|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
1182776|NCT02110966|Local tramadol|local tramadol
1182777|NCT02110966|Mepivacaine|mepivacaine
1182778|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
1182782|NCT02110927|Aerobic exercise|aerobic exercise
1182783|NCT02110927|Lipolysis|lipolysis
1182784|NCT02110914|Feasibility study|feasibility study
1182785|NCT02110914|Coaching|coaching
1182786|NCT02110914|Health related quality of life|health related quality of life
1182787|NCT02110914|Adherence|adherence
1182788|NCT02110901|radiocephalic|radiocephalic
1182789|NCT02110901|arteriovenous fistula|arteriovenous fistula
1182790|NCT02110901|AVF|avf
1182791|NCT02110901|hemodialysis|hemodialysis
1182792|NCT02110901|PRT-201|prt-201
1182793|NCT02110901|vascular access|vascular access
1182794|NCT02110901|kidney|kidney
1182795|NCT02110901|renal|renal
1182796|NCT02110901|vonapanitase|vonapanitase
1182797|NCT02110901|PATENCY-1|patency-1
1182798|NCT02110875|Healthy Volunteers|healthy volunteers
1182799|NCT02110849|Prostate|prostate
1182800|NCT02110849|Proton Therapy|proton therapy
1182801|NCT02110849|Cancer|cancer
1182802|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
1182803|NCT02110810|Indomethacin|indomethacin
1182804|NCT02110810|NSAIDs|nsaids
1182805|NCT02110797|RETT syndrome|rett syndrome
1182806|NCT02110797|MECP2|mecp2
1182807|NCT02110797|Osteoporosis|osteoporosis
1182808|NCT02110797|RANK-ligand|rank-ligand
1182809|NCT02110797|osteoprotegerin|osteoprotegerin
1182810|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
1182811|NCT02110784|eurartesim|eurartesim
1182812|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
1182813|NCT02110771|schizophrenia|schizophrenia
1182814|NCT02110771|social cognition|social cognition
1182815|NCT02110771|facial affects recognition|facial affects recognition
1182816|NCT02110771|cognitive remediation|cognitive remediation
1182817|NCT02110758|Patient Care Management|patient care management
1182818|NCT02110758|Patient Care Planning|patient care planning
1182819|NCT02110758|Patient-Centered Care|patient-centered care
1182820|NCT02110758|Patient Care Team|patient care team
1182821|NCT02110758|Advance Care Planning|advance care planning
1182822|NCT02110758|Delivery of Health Care|delivery of health care
1182823|NCT02110758|Evidence-based Practice|evidence-based practice
1182824|NCT02110758|Health Care Costs|health care costs
1182825|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1182826|NCT02110758|Quality of Health Care|quality of health care
1182827|NCT02110758|Neoplasms|neoplasms
1182828|NCT02110758|Medical Oncology|medical oncology
1182829|NCT02110719|narcotic use|narcotic use
1182830|NCT02110719|pain|pain
1182831|NCT02110719|constipation|constipation
1182832|NCT02110719|nausea|nausea
1182833|NCT02110706|Myasthenia Gravis|myasthenia gravis
1182834|NCT02110706|Rituximab|rituximab
1182835|NCT02110693|Substance Use|substance use
1182836|NCT02110693|Substance Use Disorder|substance use disorder
1182837|NCT02110693|Screening|screening
1182838|NCT02110693|Brief Assessment|brief assessment
1182839|NCT02110680|overactive bladder|overactive bladder
1182840|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
1182841|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
1182842|NCT02110667|Prostate cancer|prostate cancer
1182843|NCT02110667|Prostatectomy|prostatectomy
1182844|NCT02110667|Ultrasound|ultrasound
1182845|NCT02110667|TPUS|tpus
1182846|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
1182847|NCT02110654|asthma|asthma
1182848|NCT02110654|montelukast|montelukast
1182849|NCT02110654|surgery|surgery
1182850|NCT02110654|treatment outcomes|treatment outcomes
1182854|NCT02110628|total gastrectomy|total gastrectomy
1182855|NCT02110628|pouch|pouch
1182856|NCT02110628|roux-en-y|roux-en-y
1182857|NCT02110628|quality of life|quality of life
1182858|NCT02110602|Nutrition|nutrition
1182859|NCT02110589|seizures|seizures
1182860|NCT02110550|endocrown|endocrown
1182861|NCT02110550|marginal adaptation|marginal adaptation
1182862|NCT02110550|anatomic form|anatomic form
1182863|NCT02110550|retention loss|retention loss
1182864|NCT02110550|IPS.emmax crowns|ips.emmax crowns
1182865|NCT02110537|Atrial fibrillation|atrial fibrillation
1182866|NCT02110537|Acupuncture|acupuncture
1182867|NCT02110537|Recurrence|recurrence
1182868|NCT02110537|Electrical cardioversion|electrical cardioversion
1182869|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
1182870|NCT02110498|Pancreatic cyst|pancreatic cyst
1182871|NCT02110498|IPMN|ipmn
1182872|NCT02110498|SCA|sca
1182873|NCT02110498|SPN|spn
1182874|NCT02110498|MCN|mcn
1182875|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
1182876|NCT02110485|Appendicitis|appendicitis
1182877|NCT02110485|Pediatric|pediatric
1182878|NCT02110485|Children|children
1182879|NCT02110485|Non-operative|non-operative
1182880|NCT02110485|Antibiotics alone|antibiotics alone
1182881|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
1182882|NCT02110472|Presbyopic|presbyopic
1182884|NCT02110459|Pharmacokinetics|pharmacokinetics
1182885|NCT02110446|Sjögren's syndrome|sjögren's syndrome
1182886|NCT02110446|SS-1|ss-1
1182887|NCT02110446|Gan-Lu-Yin|gan-lu-yin
1182888|NCT02110446|Sang-Ju-Yin|sang-ju-yin
1182889|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
1182890|NCT02110433|chronic heart failure|chronic heart failure
1182891|NCT02110433|BNP|bnp
1182892|NCT02110433|telemedicine|telemedicine
1182893|NCT02110433|telemonitoring|telemonitoring
1182894|NCT02110433|weight|weight
1182895|NCT02110433|education|education
1182896|NCT02110433|self management|self management
1182897|NCT02110433|cost effectiveness|cost effectiveness
1182898|NCT02110420|Safety|safety
1182899|NCT02110420|Pharmacokinetics|pharmacokinetics
1182900|NCT02110420|Healthy Subjects|healthy subjects
1182901|NCT02110420|First-in-Human|first-in-human
1182902|NCT02110407|healthy young adults|healthy young adults
1182903|NCT02110407|tDCS|tdcs
1182904|NCT02110407|LOCATO task|locato task
1182905|NCT02110407|visual-spatial learning|visual-spatial learning
1182906|NCT02110394|observational|observational
1182907|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1182908|NCT02110394|bendamustine|bendamustine
1182909|NCT02110381|High blood pressure|high blood pressure
1182910|NCT02110355|Metastatic melanoma|metastatic melanoma
1182911|NCT02110342|PF-04449913|pf-04449913
1182912|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
1182913|NCT02110342|Human ADME|human adme
1182914|NCT02110342|Radiolabel|radiolabel
1182915|NCT02110342|Mass Balance|mass balance
1182916|NCT02110342|Pharmacokinetics|pharmacokinetics
1182917|NCT02110329|colorectal cancer|colorectal cancer
1182918|NCT02110329|stage II and III|stage ii and iii
1182919|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
1182920|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
1182921|NCT02110290|quality of life|quality of life
1182922|NCT02110290|adaptive sports|adaptive sports
1182923|NCT02110290|therapeutic recreation|therapeutic recreation
1182924|NCT02110290|mental health|mental health
1182925|NCT02110277|Ovarian Cancer|ovarian cancer
1182926|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
1182927|NCT02110264|Opioid Use|opioid use
1182928|NCT02110264|Incarceration|incarceration
1182929|NCT02110264|Vivitrol|vivitrol
1182930|NCT02110264|Patient Navigator|patient navigator
1182931|NCT02110264|Drug Education|drug education
1182932|NCT02110238|osteoarthritis|osteoarthritis
1182933|NCT02110238|knee pain|knee pain
1182934|NCT02110238|Supartz|supartz
1182935|NCT02110238|Euflexxa|euflexxa
1182936|NCT02110238|HA|ha
1182937|NCT02110238|hyaluronic acid|hyaluronic acid
1182938|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
1182939|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
1182940|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
1182941|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
1182942|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
1182943|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
1182944|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
1182945|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
1182946|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
1182947|NCT02110212|Cataract|cataract
1182948|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
1182949|NCT02110212|Optical devices, laser|optical devices, laser
1182950|NCT02110186|lumbar disc herniation|lumbar disc herniation
1182951|NCT02110186|dynamic stabilization|dynamic stabilization
1182952|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
1182953|NCT02110186|discectomy alone|discectomy alone
1182954|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
1182956|NCT02110069|Vascular anomaly|vascular anomaly
1182957|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
1182958|NCT02110069|Tufted angioma|tufted angioma
1182959|NCT02110069|hemangioendothelioma|hemangioendothelioma
1182960|NCT02110056|healthy older adults|healthy older adults
1182961|NCT02110056|tDCS|tdcs
1182962|NCT02110056|LOCATO task|locato task
1182963|NCT02110056|visual-spatial learning|visual-spatial learning
1182964|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
1182965|NCT02110043|tDCS|tdcs
1182966|NCT02110043|LOCATO task|locato task
1182967|NCT02110043|visual-spatial learning|visual-spatial learning
1182968|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
1182969|NCT02110030|Ultrasound|ultrasound
1182970|NCT02110030|Interferential current therapy|interferential current therapy
1182971|NCT02110030|Rehabilitation|rehabilitation
1182972|NCT02110030|Shoulder pain|shoulder pain
1182973|NCT02110017|Ecological task|ecological task
1182974|NCT02110017|fMRI|fmri
1182975|NCT02110017|Schizophrenia|schizophrenia
1182976|NCT02110017|Social Cognition|social cognition
1182977|NCT02109978|Diabetes|diabetes
1182978|NCT02109978|Type 2 diabetes|type 2 diabetes
1182979|NCT02109978|Diabetes therapy response|diabetes therapy response
1182980|NCT02109978|Diabetes progression|diabetes progression
1182981|NCT02109939|MDD|mdd
1182982|NCT02109939|Pharmacogenomic|pharmacogenomic
1183277|NCT02108769|Yoga|yoga
1182983|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
1182984|NCT02109939|Pharmacogenomics|pharmacogenomics
1182985|NCT02109939|Genetic Testing|genetic testing
1182986|NCT02109939|Genetics|genetics
1182987|NCT02109939|Major Depressive Disorder|major depressive disorder
1182988|NCT02109939|GeneSight|genesight
1182989|NCT02109939|Assurex|assurex
1182990|NCT02109939|AssureRx|assurerx
1182991|NCT02109939|Psychotropic|psychotropic
1182992|NCT02109939|Randomized|randomized
1182993|NCT02109939|Double Blind|double blind
1182994|NCT02109939|Placebo Controlled|placebo controlled
1182995|NCT02109913|Breast Cancer|breast cancer
1182996|NCT02109913|metastatic|metastatic
1182997|NCT02109913|hormone receptor positive|hormone receptor positive
1182998|NCT02109913|everolimus|everolimus
1182999|NCT02109913|biomarker|biomarker
1183000|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
1183001|NCT02109861|Multiple Myeloma|multiple myeloma
1183002|NCT02109861|Phase 0 study|phase 0 study
1183003|NCT02109861|Microdose study|microdose study
1183004|NCT02109861|Micro array|micro array
1183005|NCT02109861|Gene expression profiling|gene expression profiling
1183006|NCT02109848|keratoconus|keratoconus
1183007|NCT02109848|post-keratoplasty|post-keratoplasty
1183008|NCT02109835|Diabetes|diabetes
1183009|NCT02109835|coronary artery disease|coronary artery disease
1183010|NCT02109835|Cardiac computed tomography|cardiac computed tomography
1183011|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
1183012|NCT02109835|Plaque progression|plaque progression
1183013|NCT02109822|Cystic Fibrosis|cystic fibrosis
1183014|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
1183015|NCT02109822|Lung Infection|lung infection
1183016|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
1183017|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
1183018|NCT02109796|tDCS|tdcs
1183019|NCT02109796|Stroke|stroke
1183020|NCT02109796|Force|force
1183021|NCT02109796|Spasticity|spasticity
1183022|NCT02109796|Gait|gait
1183023|NCT02109796|EMG|emg
1183024|NCT02109796|Isokinetic|isokinetic
1183025|NCT02109783|Athletes|athletes
1183026|NCT02109783|Ergogenic aids|ergogenic aids
1183027|NCT02109783|Caffeine|caffeine
1183028|NCT02109783|Nutrigenomics|nutrigenomics
1183029|NCT02109783|Genotype|genotype
1183030|NCT02109770|22q|22q
1183031|NCT02109770|DiGeorge|digeorge
1183032|NCT02109770|Angelman|angelman
1183033|NCT02109770|Cri du chat|cri du chat
1183034|NCT02109770|Miller Dieker|miller dieker
1183035|NCT02109770|1p36|1p36
1183036|NCT02109770|Phelan McDermid|phelan mcdermid
1183037|NCT02109770|Prader Willi|prader willi
1183038|NCT02109770|Wolf Hirschorn|wolf hirschorn
1183039|NCT02109770|Smith Magenis|smith magenis
1183040|NCT02109770|Trisomy 21|trisomy 21
1183041|NCT02109770|Down syndrome|down syndrome
1183042|NCT02109770|Trisomy 18|trisomy 18
1183043|NCT02109770|Edwards syndrome|edwards syndrome
1183044|NCT02109770|Trisomy 13|trisomy 13
1183045|NCT02109770|Patau syndrome|patau syndrome
1183046|NCT02109770|Monosomy X|monosomy x
1183047|NCT02109770|Turner syndrome|turner syndrome
1183049|NCT02109770|Klinefelter syndrome|klinefelter syndrome
1183050|NCT02109770|XXX|xxx
1183051|NCT02109770|XYY|xyy
1183052|NCT02109757|Hearing conservation|hearing conservation
1183053|NCT02109757|Personal attenuation rating|personal attenuation rating
1183054|NCT02109757|earplug|earplug
1183055|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
1183056|NCT02109731|Sleep Apnea|sleep apnea
1183057|NCT02109718|Burns|burns
1183058|NCT02109718|Dressings|dressings
1183059|NCT02109718|Outpatient Management|outpatient management
1183060|NCT02109718|Petrolatum Jelly|petrolatum jelly
1183061|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
1183062|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
1183063|NCT02109692|muscle dystrophies|muscle dystrophies
1183064|NCT02109692|dystromirs|dystromirs
1183065|NCT02109692|longitudinal study|longitudinal study
1183066|NCT02109692|miRNA|mirna
1183067|NCT02109653|NSCLC,|nsclc,
1183068|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
1183069|NCT02109653|BRAF V600,|braf v600,
1183070|NCT02109653|LGX818|lgx818
1183071|NCT02109640|Colorectal|colorectal
1183072|NCT02109640|Surgery|surgery
1183073|NCT02109640|Laparoscopic|laparoscopic
1183074|NCT02109640|Analgesia|analgesia
1183075|NCT02109640|Enhanced Recovery|enhanced recovery
1183076|NCT02109640|Targinact|targinact
1183077|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
1183078|NCT02109627|Ficlatuzumab|ficlatuzumab
1183079|NCT02109627|High Dose Cytarabine|high dose cytarabine
1183080|NCT02109627|antibody|antibody
1183081|NCT02109614|lipoprotein(a)|lipoprotein(a)
1183082|NCT02109614|aortic stenosis|aortic stenosis
1183083|NCT02109601|Patient Portals|patient portals
1183084|NCT02109601|Personal Health Records|personal health records
1183085|NCT02109601|Patient Engagement|patient engagement
1183086|NCT02109601|Mobile Health|mobile health
1183087|NCT02109601|Tablet Computers|tablet computers
1183088|NCT02109575|Acute Rejection|acute rejection
1183089|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
1183090|NCT02109575|Cardiac Catheterization|cardiac catheterization
1183091|NCT02109575|Cardiomyopathy|cardiomyopathy
1183092|NCT02109575|Cell-Free DNA|cell-free dna
1183093|NCT02109575|Congenital Heart Defect|congenital heart defect
1183094|NCT02109575|Congenital Heart Disease|congenital heart disease
1183095|NCT02109575|Coronary Angiogram|coronary angiogram
1183096|NCT02109575|Donor Specific DNA|donor specific dna
1183097|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
1183098|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
1183099|NCT02109575|Heart Failure|heart failure
1183100|NCT02109575|Heart Transplant Failure|heart transplant failure
1183101|NCT02109575|Heart Transplant|heart transplant
1183102|NCT02109575|Heart Transplant Rejection|heart transplant rejection
1183103|NCT02109562|Schizophrenia|schizophrenia
1183104|NCT02109562|Schizophrenic|schizophrenic
1183105|NCT02109562|Schizophrenias|schizophrenias
1183106|NCT02109562|Risperidone|risperidone
1183107|NCT02109536|Colonoscopy|colonoscopy
1183108|NCT02109536|Looping|looping
1183109|NCT02109536|Loop recognition|loop recognition
1183110|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
1183111|NCT02109471|corneal opacities|corneal opacities
1183112|NCT02109471|Optical coherence tomography|optical coherence tomography
1183113|NCT02109458|Lung nodule biopsy|lung nodule biopsy
1183114|NCT02109432|Pedal Desk|pedal desk
1183115|NCT02109432|Physical Activity|physical activity
1183116|NCT02109432|Workplace|workplace
1183117|NCT02109432|Energy Expenditure|energy expenditure
1183118|NCT02109419|computerized assessments|computerized assessments
1183119|NCT02109419|mood|mood
1183120|NCT02109419|life space|life space
1183121|NCT02109419|cognition|cognition
1183122|NCT02109393|Rehabilitation|rehabilitation
1183123|NCT02109393|Robot-assisted walking training|robot-assisted walking training
1183124|NCT02109393|Treadmill|treadmill
1183125|NCT02109393|Lokomat|lokomat
1183126|NCT02109367|ovarian cancer|ovarian cancer
1183127|NCT02109367|ovarian mass|ovarian mass
1183128|NCT02109367|CA-125|ca-125
1183130|NCT02109367|culdocentesis|culdocentesis
1183131|NCT02109367|biomarker(s)|biomarker(s)
1183132|NCT02109354|HIV infection|hiv infection
1183133|NCT02109354|Vaccine|vaccine
1183134|NCT02109341|mPC|mpc
1183135|NCT02109328|Bladder cancer|bladder cancer
1183136|NCT02109328|Urothelial cancer|urothelial cancer
1183137|NCT02109328|Alisertib|alisertib
1183138|NCT02109328|Phase 2|phase 2
1183139|NCT02109328|Advanced disease|advanced disease
1183140|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
1183141|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
1183142|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
1183143|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
1183144|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
1183145|NCT02109276|Higher Order Aberrations|higher order aberrations
1183146|NCT02109276|Contrast Sensitivity|contrast sensitivity
1183147|NCT02109263|Breast-feeding|breast-feeding
1183148|NCT02109263|Saccharose|saccharose
1183149|NCT02109263|Breast-feeding newborn|breast-feeding newborn
1183150|NCT02109263|cortical pain responses|cortical pain responses
1183151|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
1183152|NCT02109263|Salivary rate cortisol|salivary rate cortisol
1183153|NCT02109263|heel lance|heel lance
1183154|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
1183155|NCT02109237|Lung transplantation|lung transplantation
1183156|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
1183157|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
1183158|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
1183159|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
1183160|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
1183161|NCT02109185|rhinnorea|rhinnorea
1183162|NCT02109185|nasal itching|nasal itching
1183163|NCT02109185|sneezing|sneezing
1183164|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1183165|NCT02109172|COPD|copd
1183166|NCT02109146|TACE|tace
1183167|NCT02109146|Postoperation|postoperation
1183168|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
1183169|NCT02109133|intraocular pressure|intraocular pressure
1183170|NCT02109107|body contouring|body contouring
1183171|NCT02109107|body shaping|body shaping
1183172|NCT02109107|circumference reduction|circumference reduction
1183173|NCT02109094|insulin|insulin
1183174|NCT02109094|metabolomics|metabolomics
1183175|NCT02109081|dexamethasone|dexamethasone
1183176|NCT02109081|delirium|delirium
1183177|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1183178|NCT02109081|postoperative|postoperative
1183179|NCT02109081|elderly|elderly
1183180|NCT02109068|Breast Cancer|breast cancer
1183181|NCT02109068|Survivorship|survivorship
1183182|NCT02109068|Weight Loss|weight loss
1183183|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
1183184|NCT02109055|Thoracic Surgery|thoracic surgery
1183185|NCT02109055|Exercise Therapy|exercise therapy
1183186|NCT02109016|FGFR1 amplification|fgfr1 amplification
1183187|NCT02109016|FGF alteration|fgf alteration
1183188|NCT02109016|VEGF alteration|vegf alteration
1183189|NCT02109016|PDGF alteration|pdgf alteration
1183190|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1183191|NCT02109016|VEGFR inhibitor|vegfr inhibitor
1183192|NCT02109016|FGFR inhibitor|fgfr inhibitor
1183193|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
1183194|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
1183195|NCT02109003|tracheal cuff|tracheal cuff
1183196|NCT02109003|cuff overinflation|cuff overinflation
1183197|NCT02109003|cuff underinflation|cuff underinflation
1183198|NCT02108990|borderline personality disorder|borderline personality disorder
1183199|NCT02108990|rejection|rejection
1183200|NCT02108990|social pain|social pain
1183201|NCT02108977|Remote Consultation|remote consultation
1183202|NCT02108977|Teleconsultation|teleconsultation
1183203|NCT02108977|Videoconferencing|videoconferencing
1183204|NCT02108977|Genetic Counseling|genetic counseling
1183205|NCT02108977|Costs and Cost Analysis|costs and cost analysis
1183206|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
1183207|NCT02108977|Telehealth|telehealth
1183208|NCT02108964|NSCLC|nsclc
1183209|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
1183210|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
1183211|NCT02108964|acquired T790M mutation|acquired t790m mutation
1183212|NCT02108964|de novo T790M mutation|de novo t790m mutation
1183213|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
1183214|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
1183215|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
1183216|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
1183217|NCT02108964|1st line|1st line
1183218|NCT02108951|CML|cml
1183219|NCT02108951|Ph-CML|ph-cml
1183220|NCT02108951|leukaemia|leukaemia
1183221|NCT02108951|leukemia|leukemia
1183222|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
1183223|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
1183224|NCT02108951|TKI intolerance|tki intolerance
1183225|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1183226|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
1183227|NCT02108912|stroke|stroke
1183228|NCT02108912|gait|gait
1183229|NCT02108912|cardiovascular|cardiovascular
1183230|NCT02108899|Schizophrenia|schizophrenia
1183231|NCT02108899|Episodic memory deficits|episodic memory deficits
1183232|NCT02108886|preterm labor|preterm labor
1183233|NCT02108886|montelukast|montelukast
1183234|NCT02108886|uterine contractions|uterine contractions
1183235|NCT02108873|Appointments and Schedules|appointments and schedules
1183236|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
1183237|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
1183238|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1183239|NCT02108860|GPA|gpa
1183240|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
1183241|NCT02108860|Wegener granulomatosis|wegener granulomatosis
1183242|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
1183243|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
1183244|NCT02108860|AAV|aav
1183245|NCT02108860|Vasculitis|vasculitis
1183246|NCT02108860|Systemic vasculitis|systemic vasculitis
1183247|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
1183248|NCT02108860|Lung Diseases|lung diseases
1183249|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
1183250|NCT02108860|Vascular Diseases|vascular diseases
1183251|NCT02108860|Abatacept|abatacept
1183252|NCT02108860|CTLA4-Ig|ctla4-ig
1183253|NCT02108860|Immunosuppressive agent|immunosuppressive agent
1183254|NCT02108860|Prednisone|prednisone
1183255|NCT02108860|Glucocorticoids|glucocorticoids
1183256|NCT02108860|Glucocorticoid|glucocorticoid
1183257|NCT02108860|Corticosteroid|corticosteroid
1183258|NCT02108860|Corticosteroids|corticosteroids
1183259|NCT02108860|Treatment|treatment
1183260|NCT02108860|Pharmacologic Actions|pharmacologic actions
1183261|NCT02108860|Therapeutic Uses|therapeutic uses
1183262|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
1183263|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1183264|NCT02108847|Pain, Postoperative|pain, postoperative
1183265|NCT02108847|Nerve Block|nerve block
1183266|NCT02108847|Anesthesia, Regional|anesthesia, regional
1183267|NCT02108847|Fascia Iliaca Block|fascia iliaca block
1183268|NCT02108847|Ultrasound Guided|ultrasound guided
1183269|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
1183270|NCT02108834|acute pain|acute pain
1183271|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
1183272|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
1183589|NCT02107469|Herb|herb
1183273|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
1183274|NCT02108808|FFR|ffr
1183275|NCT02108808|adenosine|adenosine
1183276|NCT02108808|Ticagrelor|ticagrelor
1183278|NCT02108769|Yogic breathing|yogic breathing
1183279|NCT02108769|Saliva|saliva
1183280|NCT02108769|Proteomics|proteomics
1183281|NCT02108769|Lipdomics|lipdomics
1183282|NCT02108769|Nerve growth factor|nerve growth factor
1183283|NCT02108769|Thirumanthiram|thirumanthiram
1183284|NCT02108717|Telemedicine|telemedicine
1183285|NCT02108717|appendicitis|appendicitis
1183286|NCT02108717|remote consultation|remote consultation
1183287|NCT02108704|Parkinson's Disease|parkinson's disease
1183288|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
1183289|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
1183290|NCT02108678|Depression|depression
1183291|NCT02108678|Illness Management|illness management
1183292|NCT02108678|Behavioral Treatment|behavioral treatment
1183293|NCT02108678|Impairment|impairment
1183294|NCT02108652|anti-PD-L1|anti-pd-l1
1183295|NCT02108652|PD-L1|pd-l1
1183296|NCT02108652|MPDL3280A|mpdl3280a
1183297|NCT02108652|PD-1|pd-1
1183298|NCT02108652|bladder cancer|bladder cancer
1183299|NCT02108652|atezolizumab|atezolizumab
1183300|NCT02108652|Tecentriq|tecentriq
1183301|NCT02108626|Electronic Cigarettes|electronic cigarettes
1183302|NCT02108626|Lozenge|lozenge
1183303|NCT02108626|Nicotine|nicotine
1183304|NCT02108626|Tobacco|tobacco
1183305|NCT02108626|Dependence|dependence
1183306|NCT02108626|Withdrawal|withdrawal
1183307|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
1183308|NCT02108613|Supportive care|supportive care
1183309|NCT02108613|Quality of life|quality of life
1183310|NCT02108600|Kidney transplantation|kidney transplantation
1183311|NCT02108600|Inflammation|inflammation
1183312|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
1183313|NCT02108548|ASP7657|asp7657
1183314|NCT02108548|Pharmacokinetics|pharmacokinetics
1183315|NCT02108548|Pharmacodynamics|pharmacodynamics
1183316|NCT02108548|Healthy Subjects|healthy subjects
1183317|NCT02108548|First in man|first in man
1183318|NCT02108548|Safety|safety
1183319|NCT02108535|burns|burns
1183320|NCT02108535|dressings|dressings
1183321|NCT02108535|silver sulfadiazine|silver sulfadiazine
1183322|NCT02108535|silver compounds|silver compounds
1183323|NCT02108535|cost|cost
1183324|NCT02108522|CMV infection|cmv infection
1183325|NCT02108522|EBV infection|ebv infection
1183326|NCT02108522|HHV6 virus infection|hhv6 virus infection
1183327|NCT02108522|BK virus infection|bk virus infection
1183328|NCT02108522|Adenovirus infection|adenovirus infection
1183329|NCT02108522|JC virus infection|jc virus infection
1183330|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
1183331|NCT02108522|Virus Specific T cells|virus specific t cells
1183332|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
1183333|NCT02108509|Osteopenia|osteopenia
1183334|NCT02108509|Osteoporosis|osteoporosis
1183335|NCT02108509|Hypogonadism|hypogonadism
1183336|NCT02108509|Opioid medications|opioid medications
1183337|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
1183338|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
1183339|NCT02108470|Dentist-Patient Relations|dentist-patient relations
1183340|NCT02108470|patients' participation.|patients' participation.
1183341|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
1183342|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
1183343|NCT02108444|hepatitis|hepatitis
1183344|NCT02108444|hepatitis B|hepatitis b
1183345|NCT02108444|lymphoma|lymphoma
1183346|NCT02108444|Hematologic Diseases|hematologic diseases
1183347|NCT02108431|urinary diversion|urinary diversion
1183348|NCT02108431|urethral catheter|urethral catheter
1183349|NCT02108431|suprapubic tube|suprapubic tube
1183350|NCT02108431|radical prostatectomy|radical prostatectomy
1183351|NCT02108431|robotic surgery|robotic surgery
1183352|NCT02108431|discomfort|discomfort
1183353|NCT02108431|pain|pain
1183354|NCT02108405|critically ill patient.|critically ill patient.
1183355|NCT02108392|PXE|pxe
1183356|NCT02108392|phenotype|phenotype
1183357|NCT02108392|eye|eye
1183358|NCT02108392|biomarkers|biomarkers
1183359|NCT02108366|severe|severe
1183360|NCT02108366|influenza A|influenza a
1183361|NCT02108366|celecoxib|celecoxib
1183362|NCT02108353|Type 2 Diabetes|type 2 diabetes
1183363|NCT02108353|metabolic control|metabolic control
1183364|NCT02108353|Metabolomics|metabolomics
1183365|NCT02108353|Circadian Rhythm|circadian rhythm
1183366|NCT02108353|Melatonin|melatonin
1183367|NCT02108353|Biomarker|biomarker
1183368|NCT02108353|Clock Gene|clock gene
1183369|NCT02108353|PBMC|pbmc
1183370|NCT02108353|Cardiovascular function|cardiovascular function
1183371|NCT02108353|Epigenetic modification|epigenetic modification
1183372|NCT02108353|Lifestyle Intervention|lifestyle intervention
1183373|NCT02108340|Appendicitis|appendicitis
1183374|NCT02108340|Diagnosis|diagnosis
1183375|NCT02108340|Microwave radiometry|microwave radiometry
1183376|NCT02108340|Ultrasonography|ultrasonography
1183377|NCT02108327|Blood loss|blood loss
1183378|NCT02108327|total knee arthroplasty|total knee arthroplasty
1183379|NCT02108327|hot knife|hot knife
1183380|NCT02108327|cold knife|cold knife
1183381|NCT02108327|unipolar electrocautery|unipolar electrocautery
1183382|NCT02108327|surgical blade|surgical blade
1183383|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
1183384|NCT02108301|renal transplantation|renal transplantation
1183385|NCT02108301|glucose tolerance|glucose tolerance
1183386|NCT02108301|immunosuppression|immunosuppression
1183387|NCT02108236|acupuncture|acupuncture
1183388|NCT02108236|chinese traditional medicine|chinese traditional medicine
1183389|NCT02108223|ICSI|icsi
1183390|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
1183391|NCT02108223|rLH|rlh
1183392|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
1183393|NCT02108210|Cytokines|cytokines
1183394|NCT02108210|Interleukin-1|interleukin-1
1183395|NCT02108210|Fatigue|fatigue
1183396|NCT02108210|Anakinra|anakinra
1183397|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
1183398|NCT02108171|intranasal|intranasal
1183399|NCT02108171|dexmedetomidine|dexmedetomidine
1183400|NCT02108171|early recovery|early recovery
1183401|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
1183402|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
1183403|NCT02108145|jaundice|jaundice
1183404|NCT02108145|metal stent|metal stent
1183405|NCT02108145|PTBS|ptbs
1183406|NCT02108132|hemophilia|hemophilia
1183407|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
1183408|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
1183409|NCT02108106|safety and tolerability|safety and tolerability
1183410|NCT02108106|pharmacokinetic study|pharmacokinetic study
1183411|NCT02108080|Alcohol|alcohol
1183412|NCT02108080|Adolescents|adolescents
1183413|NCT02108080|Adults|adults
1183414|NCT02108054|fMRI|fmri
1183415|NCT02108054|Alcoholism|alcoholism
1183416|NCT02108054|Phenotype|phenotype
1183417|NCT02108054|Imaging|imaging
1183418|NCT02108041|Physicians|physicians
1183419|NCT02108041|Pharmacogenetic Testing|pharmacogenetic testing
1183420|NCT02108041|Decision-Making|decision-making
1183421|NCT02108041|Communicative Behaviors|communicative behaviors
1183422|NCT02108028|Advance Care Planning Guide|advance care planning guide
1183423|NCT02108028|End-of-Life|end-of-life
1333255|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
1183424|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
1183425|NCT02108015|Glutamate Receptors|glutamate receptors
1183426|NCT02108015|Healthy Volunteers|healthy volunteers
1183427|NCT02108002|Missense Mutations|missense mutations
1183428|NCT02108002|Hemangioblastoma|hemangioblastoma
1183429|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
1183430|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
1183431|NCT02107989|Epilepsy|epilepsy
1183432|NCT02107989|MRI|mri
1183433|NCT02107989|fMRI|fmri
1183434|NCT02107989|MEG|meg
1183435|NCT02107976|Diabetes|diabetes
1183436|NCT02107976|Red Blood Cells|red blood cells
1183437|NCT02107976|Vitamin C|vitamin c
1183438|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
1183439|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
1183440|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
1183441|NCT02107963|Osteosarcoma|osteosarcoma
1183442|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
1183443|NCT02107963|Sarcomas|sarcomas
1183444|NCT02107950|Ovarian|ovarian
1183445|NCT02107950|Platinum Sensitive|platinum sensitive
1183446|NCT02107950|Epithelial|epithelial
1183447|NCT02107937|serous|serous
1183448|NCT02107937|endometrioid|endometrioid
1183449|NCT02107937|mucinous|mucinous
1183450|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
1183451|NCT02107924|Total|total
1183452|NCT02107924|Knee|knee
1183453|NCT02107924|Replacment|replacment
1183454|NCT02107924|Infection|infection
1183455|NCT02107924|Stimulan|stimulan
1183456|NCT02107911|men who have sex with men|men who have sex with men
1183457|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
1183458|NCT02107911|HIV infection|hiv infection
1183459|NCT02107859|Cystic fibrosis|cystic fibrosis
1183460|NCT02107859|Nonsense mutation|nonsense mutation
1183461|NCT02107859|Premature stop codon|premature stop codon
1183462|NCT02107859|PTC124|ptc124
1183463|NCT02107859|Ataluren|ataluren
1183464|NCT02107820|Bladder training|bladder training
1183465|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
1183466|NCT02107820|Overactive bladder|overactive bladder
1183467|NCT02107820|Randomised controlled study|randomised controlled study
1183468|NCT02107807|Influenza,|influenza,
1183469|NCT02107807|H5N1|h5n1
1183470|NCT02107807|aH5N1|ah5n1
1183471|NCT02107807|H5N1 vaccine|h5n1 vaccine
1183472|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
1183473|NCT02107807|MF59|mf59
1183474|NCT02107807|Adjuvant|adjuvant
1183475|NCT02107807|Avian flu|avian flu
1183476|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
1183477|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
1183478|NCT02107807|Pandemic vaccine|pandemic vaccine
1183479|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
1183480|NCT02107794|Grave's|grave's
1183481|NCT02107794|Disease|disease
1183482|NCT02107794|Thyroid|thyroid
1183483|NCT02107794|Hyperthyroidism|hyperthyroidism
1183484|NCT02107794|Thyroidectomy|thyroidectomy
1183485|NCT02107794|Radioactive|radioactive
1183486|NCT02107794|Iodine|iodine
1183487|NCT02107794|Antithyroid|antithyroid
1183488|NCT02107794|Shared|shared
1183489|NCT02107794|Decision|decision
1183490|NCT02107794|Making|making
1183491|NCT02107794|Aid|aid
1183492|NCT02107794|Evidence|evidence
1183493|NCT02107794|Based|based
1183494|NCT02107794|Endocrinology|endocrinology
1183495|NCT02107794|Mayo|mayo
1183496|NCT02107794|Clinic|clinic
1183497|NCT02107781|Open abdomen|open abdomen
1183498|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
1183499|NCT02107768|Stroke|stroke
1183500|NCT02107768|Exercise|exercise
1183501|NCT02107768|Randomized trial|randomized trial
1183502|NCT02107768|Quality of Life|quality of life
1183503|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
1183504|NCT02107755|melanoma|melanoma
1183505|NCT02107742|Injections|injections
1183506|NCT02107742|Time factors|time factors
1183507|NCT02107742|Pain|pain
1183508|NCT02107742|Healthy volunteers|healthy volunteers
1183509|NCT02107742|Lidocaine|lidocaine
1183510|NCT02107729|Injections|injections
1183511|NCT02107729|Pain|pain
1183512|NCT02107729|Healthy volunteers|healthy volunteers
1183513|NCT02107729|Lidocaine|lidocaine
1183514|NCT02107716|Pain|pain
1183515|NCT02107716|Injections|injections
1183516|NCT02107716|Lidocaine|lidocaine
1183517|NCT02107716|Healthy volunteers|healthy volunteers
1183518|NCT02107703|MONARCH 2|monarch 2
1183519|NCT02107690|Injections|injections
1183520|NCT02107690|Temperature|temperature
1183521|NCT02107690|Pain|pain
1183522|NCT02107690|Healthy volunteers|healthy volunteers
1183523|NCT02107690|Lidocaine|lidocaine
1183524|NCT02107664|Radiotherapy|radiotherapy
1183525|NCT02107664|Cachexia|cachexia
1183526|NCT02107664|Inflammation|inflammation
1183527|NCT02107664|Depression|depression
1183528|NCT02107651|Bleeding|bleeding
1183529|NCT02107651|Anticoagulation|anticoagulation
1576616|NCT00476944|Bivalirudin|bivalirudin
1183530|NCT02107638|Parkinson's Disease|parkinson's disease
1183531|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1183532|NCT02107638|Falls|falls
1183533|NCT02107638|Balance|balance
1183534|NCT02107638|Motor function|motor function
1183535|NCT02107625|Defecation|defecation
1183536|NCT02107625|Abdominal pain|abdominal pain
1183537|NCT02107612|Mini-Dental Implant|mini-dental implant
1183538|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
1183539|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
1183540|NCT02107612|Overdentures|overdentures
1183541|NCT02107612|Aged|aged
1183542|NCT02107586|biceps tenodesis|biceps tenodesis
1183543|NCT02107586|biceps tenotomy|biceps tenotomy
1183544|NCT02107586|biceps tendonitis|biceps tendonitis
1183545|NCT02107586|biceps inflammation|biceps inflammation
1183546|NCT02107586|shoulder surgery|shoulder surgery
1183547|NCT02107573|Randomized Controlled Trial|randomized controlled trial
1183548|NCT02107573|Rotator Cuff Tear|rotator cuff tear
1183549|NCT02107573|Suprascapular Nerve|suprascapular nerve
1183550|NCT02107573|Decompression|decompression
1183551|NCT02107573|Shoulder Surgery|shoulder surgery
1183552|NCT02107560|Cholangitis|cholangitis
1183553|NCT02107560|Bacteremia|bacteremia
1183554|NCT02107560|Endotoxemia|endotoxemia
1183555|NCT02107560|Blood|blood
1183556|NCT02107560|Bile|bile
1183557|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
1183558|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
1183559|NCT02107547|labral tear|labral tear
1183560|NCT02107547|biceps tenodesis|biceps tenodesis
1183561|NCT02107547|shoulder surgery|shoulder surgery
1183563|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
1183564|NCT02107534|parent training|parent training
1183565|NCT02107534|homework|homework
1183566|NCT02107534|parenting stress|parenting stress
1183567|NCT02107521|sperm morphology|sperm morphology
1183568|NCT02107521|ICSI|icsi
1183569|NCT02107521|IMSI|imsi
1183570|NCT02107521|implantation|implantation
1183571|NCT02107521|pregnancy|pregnancy
1183572|NCT02107508|activity energy expenditure|activity energy expenditure
1183573|NCT02107508|body composition|body composition
1183575|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
1183576|NCT02107469|Diabetic|diabetic
1183577|NCT02107469|Polyneuropathy|polyneuropathy
1183578|NCT02107469|Ayurvedic|ayurvedic
1183579|NCT02107469|Ayurveda|ayurveda
1183580|NCT02107469|Neuralgia|neuralgia
1183581|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
1183582|NCT02107469|Sida cordifolia|sida cordifolia
1183583|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
1183584|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
1183585|NCT02107469|Extracts|extracts
1183586|NCT02107469|Extract|extract
1183590|NCT02107469|Herbal|herbal
1183591|NCT02107469|Herbal Extract|herbal extract
1183592|NCT02107469|Decoction|decoction
1183593|NCT02107469|Churna|churna
1183594|NCT02107469|Powder|powder
1183595|NCT02107469|Bala|bala
1183596|NCT02107469|Bhumyamalaki|bhumyamalaki
1183597|NCT02107469|Tamalaki|tamalaki
1183598|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
1183599|NCT02107430|Immunotherapy|immunotherapy
1183600|NCT02107430|Prostate Cancer|prostate cancer
1183601|NCT02107430|Biological, Vaccine|biological, vaccine
1183602|NCT02107417|chemotherapy|chemotherapy
1183603|NCT02107417|pain|pain
1183604|NCT02107417|paresthesia|paresthesia
1183605|NCT02107417|Physiotherapy|physiotherapy
1183606|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
1183607|NCT02107404|Immunotherapy|immunotherapy
1183608|NCT02107404|Prostate Cancer|prostate cancer
1183609|NCT02107404|Biological|biological
1183610|NCT02107404|Vaccine|vaccine
1183611|NCT02107391|Immunotherapy|immunotherapy
1183612|NCT02107391|Prostate Cancer|prostate cancer
1183613|NCT02107391|Biological|biological
1183614|NCT02107391|Vaccine|vaccine
1183615|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
1183616|NCT02107378|Immunotherapy|immunotherapy
1183617|NCT02107378|Serous|serous
1183618|NCT02107378|Relapsed|relapsed
1183619|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
1183620|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
1183621|NCT02107378|Biological|biological
1183622|NCT02107378|Vaccine|vaccine
1183623|NCT02107365|Hepatitis C|hepatitis c
1183624|NCT02107365|HCV infection|hcv infection
1183625|NCT02107365|HCV genotype 4|hcv genotype 4
1183626|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
1183627|NCT02107365|Asunaprevir|asunaprevir
1183628|NCT02107365|Daclatasvir|daclatasvir
1183629|NCT02107365|Pegylated Interferon|pegylated interferon
1183630|NCT02107365|Ribavirin|ribavirin
1183631|NCT02107352|Anti-craving medication|anti-craving medication
1183632|NCT02107352|Inhibition|inhibition
1183633|NCT02107352|Attentional Bias|attentional bias
1183634|NCT02107352|Event-Related Potentials|event-related potentials
1183635|NCT02107352|Relapse|relapse
1183636|NCT02107339|methadone|methadone
1183637|NCT02107339|hydromorphone|hydromorphone
1183638|NCT02107339|acute postoperative pain|acute postoperative pain
1183639|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
1183640|NCT02107326|Type 1 diabetes|type 1 diabetes
1183641|NCT02107326|HbA1C|hba1c
1183642|NCT02107326|Quality of Life|quality of life
1183643|NCT02107326|Hypoglycaemia|hypoglycaemia
1183644|NCT02107326|Self-management|self-management
1183645|NCT02107326|Telemedicine|telemedicine
1183646|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1183647|NCT02107274|Azithromycin|azithromycin
1183648|NCT02107274|Bronchiectasis|bronchiectasis
1183649|NCT02107274|Macrolide|macrolide
1183650|NCT02107274|Inflammation|inflammation
1183651|NCT02107274|Pulmonary|pulmonary
1183652|NCT02107261|Musician's Dystonia|musician's dystonia
1183653|NCT02107248|Arthroplasty|arthroplasty
1183654|NCT02107248|Replacement|replacement
1183656|NCT02107248|Posterolateral surgery|posterolateral surgery
1183657|NCT02107248|Precautions|precautions
1183658|NCT02107235|Chemoradiotherapy|chemoradiotherapy
1183659|NCT02107235|cisplatin|cisplatin
1183660|NCT02107222|COPD|copd
1183661|NCT02107222|Exacerbation|exacerbation
1183662|NCT02107222|invasive ventilation|invasive ventilation
1183663|NCT02107222|CO2-Removal|co2-removal
1183664|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
1183665|NCT02107196|Colon, irritable|colon, irritable
1183666|NCT02107196|Bowel disease|bowel disease
1183667|NCT02107196|Diarrhea|diarrhea
1183668|NCT02107183|Oxygen therapy|oxygen therapy
1183669|NCT02107183|Extubation|extubation
1183670|NCT02107183|Weaning|weaning
1183671|NCT02107183|Reintubation|reintubation
1183672|NCT02107183|Acute respiratory failure|acute respiratory failure
1183673|NCT02107144|trimetazidine|trimetazidine
1183674|NCT02107144|microcirculation|microcirculation
1183675|NCT02107144|stenting|stenting
1183676|NCT02107144|pressure wire|pressure wire
1183677|NCT02107118|Stem cells|stem cells
1183678|NCT02107118|cardiovascular disease|cardiovascular disease
1183679|NCT02107118|erectile dysfunction|erectile dysfunction
1183680|NCT02107105|Rectal cancer|rectal cancer
1183681|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
1183682|NCT02107105|Quality of Life|quality of life
1183683|NCT02107105|QOL|qol
1183684|NCT02107105|Post surgery|post surgery
1183685|NCT02107105|Pre-surgery|pre-surgery
1183686|NCT02107105|Questionnaires|questionnaires
1183687|NCT02107105|Surveys|surveys
1183688|NCT02107079|melatonin|melatonin
1183689|NCT02107079|bioavailability|bioavailability
1183690|NCT02107079|pharmacokinetics|pharmacokinetics
1183691|NCT02107066|exercise|exercise
1183692|NCT02107066|physical activity|physical activity
1183693|NCT02107066|ovarian cancer|ovarian cancer
1183694|NCT02107066|quality of life|quality of life
1183695|NCT02107066|fatigue|fatigue
1183696|NCT02107066|weight|weight
1183697|NCT02107053|Oxidative stress,|oxidative stress,
1183698|NCT02107053|hemodialysis,|hemodialysis,
1183699|NCT02107053|pomegranate juice,|pomegranate juice,
1183700|NCT02107053|dietary supplement|dietary supplement
1183701|NCT02107053|patients|patients
1183702|NCT02107001|Lung ultrasound|lung ultrasound
1183703|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
1183704|NCT02107001|Pleuritis|pleuritis
1183705|NCT02107001|Pulmonary embolism|pulmonary embolism
1183706|NCT02107001|Lung Cancer|lung cancer
1183707|NCT02106988|Lymphoma|lymphoma
1183708|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
1183709|NCT02106988|Radiation therapy|radiation therapy
1183710|NCT02106988|XRT|xrt
1183711|NCT02106988|Dexamethasone|dexamethasone
1183712|NCT02106988|Decadron|decadron
1183713|NCT02106988|Etoposide|etoposide
1183714|NCT02106988|VePesid|vepesid
1183715|NCT02106988|Ifosfamide|ifosfamide
1183716|NCT02106988|Ifex|ifex
1183717|NCT02106988|Mesna|mesna
1183718|NCT02106988|Mesnex|mesnex
1183719|NCT02106988|Carboplatin|carboplatin
1183720|NCT02106988|Paraplatin|paraplatin
1183721|NCT02106962|hemodialysis|hemodialysis
1183722|NCT02106962|fistula|fistula
1183723|NCT02106962|clotting|clotting
1183724|NCT02106962|tranexamic acid|tranexamic acid
1183725|NCT02106962|bacitracin|bacitracin
1183726|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
1183727|NCT02106936|Focal Hand Dystonia|focal hand dystonia
1183728|NCT02106936|Depotentiation|depotentiation
1183729|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1183730|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
1183731|NCT02106936|Healthy Volunteer|healthy volunteer
1183732|NCT02106910|Barrett's Esophagus|barrett's esophagus
1183733|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
1183734|NCT02106884|Pancreatic cancer|pancreatic cancer
1183735|NCT02106884|Locally advanced|locally advanced
1183736|NCT02106884|Metastatic|metastatic
1183737|NCT02106871|cancer|cancer
1183738|NCT02106871|pancreas|pancreas
1576617|NCT00476944|PCI|pci
1183739|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
1183740|NCT02106871|fatigue|fatigue
1183741|NCT02106871|sildenafil|sildenafil
1183742|NCT02106871|lean mass|lean mass
1183743|NCT02106871|muscle|muscle
1183744|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
1183745|NCT02106845|Regorafenib|regorafenib
1183746|NCT02106845|Probe substrates|probe substrates
1183747|NCT02106845|Pharmacokinetics|pharmacokinetics
1183748|NCT02106845|Cancer|cancer
1183749|NCT02106845|Safety|safety
1183750|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
1183751|NCT02106832|Ciprofloxacin|ciprofloxacin
1183752|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
1183753|NCT02106832|Exacerbation|exacerbation
1183754|NCT02106832|Bronchiectasis|bronchiectasis
1183755|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
1183756|NCT02106819|Emotions|emotions
1183757|NCT02106819|Affective Prosody|affective prosody
1183758|NCT02106819|Facial Expression|facial expression
1183759|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
1183760|NCT02106806|Oxidative stress|oxidative stress
1183761|NCT02106806|Zinc|zinc
1183762|NCT02106806|Chemotherapy|chemotherapy
1183763|NCT02106806|Colorectal cancer|colorectal cancer
1183764|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
1183765|NCT02106793|Mitomicin C|mitomicin c
1183766|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
1183767|NCT02106780|Phase 1|phase 1
1183768|NCT02106780|Healthy subjects|healthy subjects
1183769|NCT02106780|Excretion|excretion
1183770|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
1183771|NCT02106767|rosuvastatin|rosuvastatin
1183772|NCT02106767|rifampin|rifampin
1183773|NCT02106767|pharmacokinetics|pharmacokinetics
1183774|NCT02106767|drug interaction|drug interaction
1183775|NCT02106767|healthy volunteer|healthy volunteer
1183776|NCT02106767|drug transporter|drug transporter
1183777|NCT02106767|Asian|asian
1183778|NCT02106767|White|white
1183779|NCT02106741|Pain|pain
1183780|NCT02106741|Acupressure|acupressure
1183781|NCT02106741|Symptoms|symptoms
1183782|NCT02106741|Fatigue|fatigue
1183783|NCT02106741|Self-administered|self-administered
1183784|NCT02106728|Eating Disorders|eating disorders
1183785|NCT02106728|Family Therapy|family therapy
1183786|NCT02106728|Multi-Family Therapy|multi-family therapy
1183787|NCT02106728|Bulimia Nervosa|bulimia nervosa
1183788|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
1183789|NCT02106702|HIV|hiv
1183790|NCT02106702|detention|detention
1183791|NCT02106702|substance abuse|substance abuse
1183792|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
1183793|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
1183794|NCT02106676|hyperandrogenism|hyperandrogenism
1183795|NCT02106676|cordblood|cordblood
1183796|NCT02106676|androgens|androgens
1183797|NCT02106663|atrial fibrillation|atrial fibrillation
1183798|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1183799|NCT02106663|PAF|paf
1183800|NCT02106663|arrhythmia|arrhythmia
1183801|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
1183802|NCT02106663|circumferential ablation|circumferential ablation
1183803|NCT02106663|CPVA|cpva
1183804|NCT02106663|segmental ablation|segmental ablation
1183805|NCT02106663|PVI|pvi
1183806|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
1183807|NCT02106650|Relapsed PTCL|relapsed ptcl
1183808|NCT02106650|Refractory PTCL|refractory ptcl
1183809|NCT02106637|ACS|acs
1183810|NCT02106637|Cessation|cessation
1183811|NCT02106624|mechanical ventilation|mechanical ventilation
1183812|NCT02106611|MRI|mri
1183813|NCT02106611|stress echo|stress echo
1183814|NCT02106611|Clinical Assessment|clinical assessment
1183815|NCT02106611|14-017|14-017
1183816|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
1183817|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
1183818|NCT02106598|Head and Neck Melanoma|head and neck melanoma
1183819|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
1183820|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
1183821|NCT02106598|13-249|13-249
1183822|NCT02106585|Safety|safety
1183823|NCT02106585|Tolerability|tolerability
1183824|NCT02106585|Pharmacokinetics|pharmacokinetics
1183825|NCT02106585|Food-effect|food-effect
1183826|NCT02106585|Diabetes|diabetes
1183827|NCT02106572|superficial bladder cancer|superficial bladder cancer
1183828|NCT02106572|viscum album extract|viscum album extract
1183829|NCT02106572|mistletoe extract|mistletoe extract
1183830|NCT02106572|abnobaVISCUM|abnobaviscum
1183831|NCT02106572|recurrence rate|recurrence rate
1183832|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
1183833|NCT02106559|Pleural Malignancy|pleural malignancy
1183834|NCT02106559|PDT|pdt
1183835|NCT02106546|veliparib|veliparib
1183836|NCT02106546|carboplatin|carboplatin
1183837|NCT02106546|paclitaxel|paclitaxel
1183838|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
1183839|NCT02106546|Overall Survival|overall survival
1183840|NCT02106546|Advanced|advanced
1183841|NCT02106546|Metastatic|metastatic
1183842|NCT02106546|ABT-888|abt-888
1183843|NCT02106546|Squamous|squamous
1183844|NCT02106546|Randomized|randomized
1183845|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
1183846|NCT02106546|placebo controlled|placebo controlled
1183847|NCT02106533|Coronary artery disease|coronary artery disease
1183848|NCT02106533|Exercise|exercise
1183849|NCT02106533|Ventilatory efficiency|ventilatory efficiency
1183850|NCT02106520|Epistaxis|epistaxis
1183851|NCT02106520|Bevacizumab|bevacizumab
1183852|NCT02106507|Apalutamide|apalutamide
1183853|NCT02106507|RAD001|rad001
1183854|NCT02106507|Everolimus|everolimus
1183855|NCT02106507|Castration-resistant|castration-resistant
1183856|NCT02106507|13-025|13-025
1183857|NCT02106507|ARN-509|arn-509
1183858|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
1183859|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
1183860|NCT02106481|TKA|tka
1183861|NCT02106481|TKR|tkr
1183862|NCT02106481|Knee OA|knee oa
1183863|NCT02106481|pain management|pain management
1183864|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
1183865|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
1183866|NCT02106468|Oral Lichen Planus|oral lichen planus
1183867|NCT02106468|Corticosteroid|corticosteroid
1183868|NCT02106468|Omega -3|omega -3
1183869|NCT02106455|Pharmacological theapy|pharmacological theapy
1183870|NCT02106442|Pharmacological therapy|pharmacological therapy
1183871|NCT02106429|Vascular Surgery|vascular surgery
1183872|NCT02106416|prostate cancer|prostate cancer
1183873|NCT02106416|bladder cancer|bladder cancer
1183874|NCT02106416|MRI|mri
1183875|NCT02106416|PET|pet
1183876|NCT02106416|perfusion|perfusion
1183877|NCT02106390|Central Nervous System Diseases|central nervous system diseases
1183878|NCT02106390|Nervous System Diseases|nervous system diseases
1183879|NCT02106390|Meningitis|meningitis
1183880|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
1183881|NCT02106325|Ketamine|ketamine
1183882|NCT02106325|Ketlar|ketlar
1183883|NCT02106325|Depression|depression
1183884|NCT02106325|Antidepressants|antidepressants
1183885|NCT02106325|Treatment|treatment
1183886|NCT02106325|Acute|acute
1183887|NCT02106312|Radiotherapy|radiotherapy
1183888|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
1183889|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
1183890|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
1183891|NCT02106286|surgery|surgery
1183892|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
1183893|NCT02106286|anaerobic threshold|anaerobic threshold
1183894|NCT02106286|fitness|fitness
1183895|NCT02106286|beta-blockers|beta-blockers
1183896|NCT02106273|LMA|lma
1183897|NCT02106273|Bronchial blocker|bronchial blocker
1183898|NCT02106260|safety|safety
1183899|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
1183900|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
1183901|NCT02106260|CLS003|cls003
1183902|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
1183903|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
1183904|NCT02106234|intravenous normal saline|intravenous normal saline
1183905|NCT02106234|acute kidney injury|acute kidney injury
1183906|NCT02106221|Care coordination|care coordination
1183907|NCT02106221|nurse care management|nurse care management
1183908|NCT02106221|practice facilitation|practice facilitation
1183909|NCT02106221|health information technology|health information technology
1183910|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
1183911|NCT02106182|Nocturia|nocturia
1183912|NCT02106182|Silodosin|silodosin
1183913|NCT02106182|Thrupas|thrupas
1183914|NCT02106169|Food allergy|food allergy
1183915|NCT02106169|Children and families|children and families
1183916|NCT02106169|Therapeutic education|therapeutic education
1183917|NCT02106169|Quality of life|quality of life
1183918|NCT02106130|Mosapride citrate|mosapride citrate
1183919|NCT02106130|Rebamipide|rebamipide
1183920|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
1183921|NCT02106130|oral administration|oral administration
1183922|NCT02106130|healthy male subjects|healthy male subjects
1183923|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
1183924|NCT02106104|Diabetic kidney disease|diabetic kidney disease
1183925|NCT02106104|Diabetic nephropathy|diabetic nephropathy
1183926|NCT02106104|Renoprotection|renoprotection
1183927|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
1183928|NCT02106104|Linagliptin|linagliptin
1183929|NCT02106104|SU derivatives|su derivatives
1183930|NCT02106104|Glimepiride|glimepiride
1183931|NCT02106078|Bipolar Disorder|bipolar disorder
1183932|NCT02106078|Bipolar|bipolar
1183933|NCT02106078|Online Intervention|online intervention
1183934|NCT02106078|Internet intervention|internet intervention
1183935|NCT02106078|Self-Help|self-help
1183936|NCT02106065|Dementia|dementia
1183937|NCT02106065|Caregivers|caregivers
1183938|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
1183939|NCT02106065|Brain Diseases|brain diseases
1183940|NCT02106065|Cost of Illness|cost of illness
1183941|NCT02106065|Stress, Psychological|stress, psychological
1183942|NCT02106065|Depression|depression
1183943|NCT02106065|Vital Statistics|vital statistics
1183944|NCT02106065|Mortality|mortality
1183945|NCT02106065|Behavioral Symptoms|behavioral symptoms
1183946|NCT02106065|Residential Facilities|residential facilities
1183947|NCT02106065|Emergency Medical Services|emergency medical services
1183948|NCT02106065|Long-Term Care|long-term care
1183949|NCT02106052|cognitive function|cognitive function
1183950|NCT02106052|cognitive impairment|cognitive impairment
1183951|NCT02106052|cognitive intervention|cognitive intervention
1183952|NCT02106052|cognitive improvement|cognitive improvement
1183953|NCT02106052|information processing speed|information processing speed
1183954|NCT02106052|exercise training program|exercise training program
1183955|NCT02106052|aerobic exercise|aerobic exercise
1183956|NCT02106052|stretching and toning|stretching and toning
1183957|NCT02106052|Multiple sclerosis|multiple sclerosis
1183958|NCT02106052|executive function|executive function
1183959|NCT02106039|diabetes mellitus|diabetes mellitus
1183960|NCT02106039|tuberculosis|tuberculosis
1183961|NCT02106039|management|management
1183962|NCT02106039|randomized controlled trial|randomized controlled trial
1183963|NCT02106026|Breastfeeding|breastfeeding
1183964|NCT02106026|Nursing|nursing
1183965|NCT02106026|Patient Education as Topic|patient education as topic
1183966|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1183967|NCT02106026|Hispanic Americans.|hispanic americans.
1183969|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
1183970|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
1183971|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
1183972|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
1183973|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
1183974|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
1183975|NCT02106000|Post Partum|post partum
1183976|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
1183977|NCT02106000|Inhalation Profiles|inhalation profiles
1183978|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
1183979|NCT02105987|Fixed-dose combination|fixed-dose combination
1183980|NCT02105987|Once daily|once daily
1183981|NCT02105987|Trii|trii
1183982|NCT02105987|Single-tablet regimen|single-tablet regimen
1183983|NCT02105974|COPD|copd
1183984|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
1183985|NCT02105974|Vilanterol (VI)|vilanterol (vi)
1183986|NCT02105974|Dry Powder Inhaler|dry powder inhaler
1183987|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1183988|NCT02105961|exacerbations|exacerbations
1183989|NCT02105961|SB240563|sb240563
1183990|NCT02105961|mepolizumab|mepolizumab
1183991|NCT02105961|eosinophils|eosinophils
1183992|NCT02105948|eosinophils|eosinophils
1183993|NCT02105948|SB240563|sb240563
1183994|NCT02105948|exacerbations|exacerbations
1184393|NCT02104115|Stomach|stomach
1183995|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1183996|NCT02105948|mepolizumab|mepolizumab
1183997|NCT02105922|Frailty|frailty
1183998|NCT02105922|Ageing|ageing
1183999|NCT02105922|Protein supplementation|protein supplementation
1184000|NCT02105922|Protein quality|protein quality
1184001|NCT02105922|Exercise training|exercise training
1184002|NCT02105922|Sarcopenia|sarcopenia
1184003|NCT02105896|dental bonding|dental bonding
1184004|NCT02105857|knee mobilazation|knee mobilazation
1184005|NCT02105857|TKA|tka
1184006|NCT02105857|joint replacement|joint replacement
1184007|NCT02105857|rehabilitation|rehabilitation
1184008|NCT02105844|atrial fibrillation|atrial fibrillation
1184009|NCT02105844|dementia|dementia
1184010|NCT02105844|cognitive dysfunction|cognitive dysfunction
1184011|NCT02105844|stroke|stroke
1184012|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
1184013|NCT02105831|left ventricular assist device|left ventricular assist device
1184014|NCT02105831|contrast ultrasound|contrast ultrasound
1184015|NCT02105831|perfusion imaging|perfusion imaging
1184016|NCT02105818|Self-reported questionnaire|self-reported questionnaire
1184017|NCT02105818|Swallowing disorders|swallowing disorders
1184018|NCT02105818|Systemic sclerosis|systemic sclerosis
1184019|NCT02105818|Drug therapy|drug therapy
1184020|NCT02105818|Adherence to medication regime|adherence to medication regime
1184021|NCT02105818|Coping strategy|coping strategy
1184022|NCT02105818|Pharmaceutical care|pharmaceutical care
1184023|NCT02105818|Patient safety|patient safety
1184024|NCT02105818|Patient oriented care|patient oriented care
1184025|NCT02105805|intention weight loss|intention weight loss
1184026|NCT02105805|heart failure|heart failure
1184027|NCT02105805|6-minute walk test|6-minute walk test
1184028|NCT02105792|Diabetes|diabetes
1184029|NCT02105792|Type 2 diabetes|type 2 diabetes
1576618|NCT00476944|MAVE|mave
1184030|NCT02105792|Diabetes therapy response|diabetes therapy response
1184031|NCT02105792|Diabetes progression|diabetes progression
1184032|NCT02105766|Sickle Cell Disease|sickle cell disease
1184033|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1184034|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
1184035|NCT02105766|Cyclophosphamide|cyclophosphamide
1184036|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
1184037|NCT02105740|BEHAVIORAL|behavioral
1184038|NCT02105740|HYPNOSIS|hypnosis
1184039|NCT02105740|ANXIETY|anxiety
1184040|NCT02105740|DEPRESSION|depression
1184041|NCT02105727|Dietary sodium|dietary sodium
1184042|NCT02105727|Urinary sodium excretion|urinary sodium excretion
1184043|NCT02105727|Urinary iodine excretion|urinary iodine excretion
1184044|NCT02105714|Diarrhoea|diarrhoea
1184045|NCT02105714|Abdominal pain|abdominal pain
1184046|NCT02105714|Bacterial|bacterial
1184047|NCT02105714|Protozoal|protozoal
1184048|NCT02105714|Helminth|helminth
1184049|NCT02105675|Immunotherapy|immunotherapy
1184050|NCT02105675|Metastatic|metastatic
1184051|NCT02105675|Castrate Resistant|castrate resistant
1184052|NCT02105675|Prostate Cancer|prostate cancer
1184053|NCT02105675|Biological|biological
1184054|NCT02105675|Vaccine|vaccine
1184055|NCT02105649|cerebral palsy|cerebral palsy
1184056|NCT02105649|standing|standing
1184057|NCT02105649|strengthening|strengthening
1184058|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
1184059|NCT02105623|rosuvastatin|rosuvastatin
1184060|NCT02105610|volatile anesthetics|volatile anesthetics
1184061|NCT02105610|desflurane|desflurane
1184062|NCT02105610|isoflurane|isoflurane
1184063|NCT02105610|sevoflurane|sevoflurane
1184064|NCT02105610|TIVA|tiva
1184065|NCT02105610|cardiac surgery|cardiac surgery
1184066|NCT02105610|mortality|mortality
1184067|NCT02105610|anesthesia|anesthesia
1184068|NCT02105610|intensive care|intensive care
1184069|NCT02105597|Diabetes mellitus|diabetes mellitus
1184070|NCT02105597|Medication adherence|medication adherence
1184071|NCT02105597|Compliance|compliance
1184072|NCT02105597|Mobile health|mobile health
1184073|NCT02105571|Body Weight|body weight
1184074|NCT02105571|Nutrition|nutrition
1184075|NCT02105571|Physical Activity|physical activity
1184076|NCT02105571|Sleep|sleep
1184077|NCT02105571|Health Promotion|health promotion
1184078|NCT02105571|Stress|stress
1184079|NCT02105571|Safety|safety
1184080|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
1184081|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
1184082|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
1184083|NCT02105545|cancer|cancer
1184084|NCT02105545|oncology|oncology
1184085|NCT02105545|malignant|malignant
1184086|NCT02105545|malignancy|malignancy
1184087|NCT02105545|genetics|genetics
1184088|NCT02105545|genomics|genomics
1184089|NCT02105545|exome|exome
1184090|NCT02105545|DNA|dna
1184091|NCT02105545|RNA|rna
1184092|NCT02105545|sequencing|sequencing
1184093|NCT02105545|epigenetic|epigenetic
1184094|NCT02105545|clinically actionable findings|clinically actionable findings
1184095|NCT02105545|CAF|caf
1184096|NCT02105545|secondary findings|secondary findings
1184097|NCT02105545|SF|sf
1184098|NCT02105545|single nucleotide variants|single nucleotide variants
1184099|NCT02105545|SNV|snv
1184100|NCT02105545|bioinformatics|bioinformatics
1184101|NCT02105545|genotype|genotype
1184102|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
1184103|NCT02105545|ACMG|acmg
1184104|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
1184105|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
1184106|NCT02105506|Esophagus|esophagus
1184107|NCT02105506|Stomach|stomach
1184108|NCT02105506|Resection|resection
1184109|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
1184110|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
1184111|NCT02105493|Nitroglycerin|nitroglycerin
1184112|NCT02105493|Radial Artery Occlusion|radial artery occlusion
1184113|NCT02105493|Transradial Catheterization|transradial catheterization
1184114|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
1184115|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
1184116|NCT02105480|Murmur detection|murmur detection
1184117|NCT02105480|Heart auscultation|heart auscultation
1184118|NCT02105441|cochlear implant|cochlear implant
1184119|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
1184120|NCT02105428|Insulin Resistance|insulin resistance
1184121|NCT02105428|Overweight, Obese Women|overweight, obese women
1184122|NCT02105428|Protein Metabolism|protein metabolism
1184123|NCT02105428|Post Translational Modifications|post translational modifications
1184124|NCT02105415|Critical care|critical care
1184125|NCT02105415|Emergent|emergent
1184126|NCT02105415|Etomidate|etomidate
1184127|NCT02105415|Hemodynamics|hemodynamics
1184128|NCT02105415|Intensive care unit|intensive care unit
1184129|NCT02105415|Intubation|intubation
1184130|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
1184131|NCT02105402|Speech sound disorders|speech sound disorders
1184132|NCT02105402|Randomized Controlled Trial|randomized controlled trial
1184133|NCT02105402|Speech intelligibility|speech intelligibility
1184134|NCT02105402|PROMPT treatment|prompt treatment
1184135|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
1184136|NCT02105402|Children|children
1184137|NCT02105402|Functional outcomes|functional outcomes
1184138|NCT02105402|Treatment efficacy|treatment efficacy
1184139|NCT02105389|fatigue|fatigue
1184140|NCT02105389|quality of life|quality of life
1184141|NCT02105389|chemotherapy|chemotherapy
1184142|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
1184143|NCT02105389|children|children
1184144|NCT02105389|pilot|pilot
1184145|NCT02105389|yoga|yoga
1184146|NCT02105376|depression|depression
1184147|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
1184148|NCT02105376|trigeminal stimulation|trigeminal stimulation
1184149|NCT02105350|MEK162|mek162
1184150|NCT02105350|Gemcitabine|gemcitabine
1184151|NCT02105350|Oxaliplatin|oxaliplatin
1184152|NCT02105350|Non-resectable|non-resectable
1184153|NCT02105350|Recurrent or metastatic|recurrent or metastatic
1184154|NCT02105324|bionic pancreas|bionic pancreas
1184155|NCT02105324|artificial pancreas|artificial pancreas
1184156|NCT02105324|insulin|insulin
1184157|NCT02105324|glucagon|glucagon
1184158|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
1184159|NCT02105324|outpatient|outpatient
1184160|NCT02105324|insulin pump|insulin pump
1184161|NCT02105324|pediatrics|pediatrics
1184162|NCT02105324|children|children
1184163|NCT02105324|camp|camp
1184164|NCT02105324|summer camp|summer camp
1184165|NCT02105311|Intraocular pressure|intraocular pressure
1184166|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
1184167|NCT02105311|Travoprost|travoprost
1184168|NCT02105311|Ocular surface disease|ocular surface disease
1184169|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
1184170|NCT02105298|Fluids|fluids
1184171|NCT02105298|Intraoperative|intraoperative
1184172|NCT02105298|Respiratory|respiratory
1184173|NCT02105298|Outcomes|outcomes
1184174|NCT02105298|Surgery|surgery
1184175|NCT02105298|Anesthesia|anesthesia
1184176|NCT02105259|Test|test
1184177|NCT02105259|psychodynamic|psychodynamic
1184178|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
1184179|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
1184180|NCT02105246|cardiovascular disease|cardiovascular disease
1184181|NCT02105246|cardiac rehabilitation|cardiac rehabilitation
1184182|NCT02105246|secondary prevention|secondary prevention
1184183|NCT02105246|comparative effectiveness|comparative effectiveness
1184184|NCT02105246|6 minute walk test|6 minute walk test
1184185|NCT02105233|ultrasonography|ultrasonography
1184186|NCT02105233|ultrasonics|ultrasonics
1184187|NCT02105233|brain|brain
1184188|NCT02105233|surgery|surgery
1184189|NCT02105220|Respiratory mechanics|respiratory mechanics
1184190|NCT02105220|Esophageal pressure|esophageal pressure
1184191|NCT02105220|Functional residual capacity|functional residual capacity
1184288|NCT02104583|VT|vt
1184192|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
1184193|NCT02105194|cerebral decompression illness|cerebral decompression illness
1184194|NCT02105181|benign biliary stricture|benign biliary stricture
1184195|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
1184196|NCT02105181|chronic pancreatitis|chronic pancreatitis
1184197|NCT02105181|biliary surgical procedure|biliary surgical procedure
1184198|NCT02105181|fully covered metal stent|fully covered metal stent
1184199|NCT02105155|Liver transplantation,|liver transplantation,
1184200|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
1184201|NCT02105155|Prograf® ,|prograf® ,
1184202|NCT02105155|Advagraf® ,|advagraf® ,
1184203|NCT02105155|acute rejection,|acute rejection,
1184204|NCT02105155|GFR|gfr
1184205|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1184206|NCT02105142|Interventions|interventions
1184207|NCT02105142|Primary care|primary care
1184208|NCT02105142|Pediatric|pediatric
1184209|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
1184210|NCT02105090|Endoscopy|endoscopy
1184211|NCT02105090|Lozenge|lozenge
1184212|NCT02105090|Articaine|articaine
1184213|NCT02105090|Dyspepsia|dyspepsia
1184214|NCT02105090|Hematemesis|hematemesis
1184215|NCT02105090|Abdominal pain|abdominal pain
1184216|NCT02105090|Heartburn|heartburn
1184217|NCT02105077|xenon|xenon
1184218|NCT02105077|doping|doping
1184219|NCT02105077|anesthesia|anesthesia
1184220|NCT02105077|mass spectrometry|mass spectrometry
1184221|NCT02105077|surgery|surgery
1184222|NCT02105038|distal radius fracture|distal radius fracture
1184223|NCT02105038|steering|steering
1184224|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
1184225|NCT02105025|insertion time|insertion time
1184227|NCT02105012|moderate persistent|moderate persistent
1184228|NCT02105012|Adult|adult
1184229|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
1184230|NCT02104986|Dose De-escalation|dose de-escalation
1184231|NCT02104986|Chemotherapy|chemotherapy
1184232|NCT02104960|Skin Surface Microscopy|skin surface microscopy
1184233|NCT02104960|Skin Aging|skin aging
1184234|NCT02104960|PROOF|proof
1184235|NCT02104895|Breast cancer|breast cancer
1184236|NCT02104895|Early breast cancer|early breast cancer
1184237|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
1184238|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
1184239|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
1184240|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
1184241|NCT02104882|High-Grade Glioma|high-grade glioma
1184242|NCT02104882|Malignant Glioma|malignant glioma
1184243|NCT02104882|IORT|iort
1184244|NCT02104869|Influenza vaccine|influenza vaccine
1184245|NCT02104856|Asthma|asthma
1184246|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
1184247|NCT02104856|Registry|registry
1184248|NCT02104856|Device|device
1184249|NCT02104856|Alair|alair
1184250|NCT02104830|empegfilgrastim|empegfilgrastim
1184251|NCT02104830|pegylated filgrastim|pegylated filgrastim
1184252|NCT02104830|neutropenia|neutropenia
1184253|NCT02104830|febrile neutropenia|febrile neutropenia
1184254|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
1184255|NCT02104830|breast cancer|breast cancer
1184256|NCT02104830|docetaxel|docetaxel
1184257|NCT02104830|doxorubicin|doxorubicin
1184258|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
1184259|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
1184260|NCT02104791|Procalcitonin|procalcitonin
1184261|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
1184262|NCT02104752|Curcumin|curcumin
1184263|NCT02104752|Turmeric|turmeric
1184264|NCT02104752|Schizophrenia|schizophrenia
1184265|NCT02104752|Cognition|cognition
1184266|NCT02104752|Psychosis|psychosis
1184267|NCT02104739|prediabetes|prediabetes
1184268|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
1184269|NCT02104739|exenatide|exenatide
1184270|NCT02104739|saxagliptin|saxagliptin
1184271|NCT02104739|exenatide ER|exenatide er
1184272|NCT02104713|Skin Burn Degree Second|skin burn degree second
1184273|NCT02104713|Second degree Burn|second degree burn
1184274|NCT02104713|Burn wound|burn wound
1184275|NCT02104700|HIV|hiv
1184276|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
1184277|NCT02104687|CI, cardiac index|ci, cardiac index
1184278|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
1184279|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
1184280|NCT02104622|spinal cord injury|spinal cord injury
1184281|NCT02104622|exoskeleton|exoskeleton
1184282|NCT02104622|ambulation|ambulation
1184283|NCT02104622|walking|walking
1184284|NCT02104622|robotics|robotics
1184285|NCT02104609|Obesity|obesity
1184286|NCT02104609|Emergency contraception|emergency contraception
1184287|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
1184289|NCT02104583|VF|vf
1184290|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
1184291|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
1184292|NCT02104583|shock|shock
1184293|NCT02104583|ATP|atp
1184294|NCT02104570|Fatigue|fatigue
1184295|NCT02104570|Proprioception|proprioception
1184296|NCT02104570|Shoulder|shoulder
1184297|NCT02104557|Sayana|sayana
1184298|NCT02104557|Pregnancy|pregnancy
1184299|NCT02104557|Contraception|contraception
1184300|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
1184301|NCT02104557|PMS|pms
1184302|NCT02104557|Post Marketing Surveillance|post marketing surveillance
1184303|NCT02104544|DHA intake;|dha intake;
1184304|NCT02104544|Plasma;|plasma;
1184305|NCT02104544|Erythrocyte;|erythrocyte;
1184306|NCT02104544|Breast milk.|breast milk.
1184307|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
1184308|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
1184309|NCT02104492|multiple sclerosis|multiple sclerosis
1184310|NCT02104492|respiratory muscle strength|respiratory muscle strength
1184311|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
1184312|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
1184313|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
1184314|NCT02104492|quality of life|quality of life
1184315|NCT02104492|qualitative research|qualitative research
1184316|NCT02104466|acupuncture|acupuncture
1184317|NCT02104466|pain|pain
1184318|NCT02104466|neuropathy|neuropathy
1184319|NCT02104453|airway maneuver|airway maneuver
1184320|NCT02104440|Cytopenia|cytopenia
1184321|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
1184322|NCT02104414|Exparel|exparel
1184323|NCT02104375|wave reflection|wave reflection
1184324|NCT02104375|augmentation Index|augmentation index
1184325|NCT02104375|heart rate variability|heart rate variability
1184326|NCT02104375|arterial stiffness|arterial stiffness
1184327|NCT02104349|spine surgery|spine surgery
1184328|NCT02104349|post op pain management|post op pain management
1184329|NCT02104336|Pearson|pearson
1184330|NCT02104336|EPI743|epi743
1184331|NCT02104336|EPI-743|epi-743
1184332|NCT02104336|Vincerinone|vincerinone
1184333|NCT02104336|Mitochondrial disorder|mitochondrial disorder
1184334|NCT02104336|Mitochondrial disease|mitochondrial disease
1184335|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
1184336|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
1184337|NCT02104323|Other NF2-related tumors|other nf2-related tumors
1184338|NCT02104310|malignant glioma|malignant glioma
1184339|NCT02104310|FDOPA|fdopa
1184340|NCT02104310|PET CT|pet ct
1184341|NCT02104310|radiation therapy|radiation therapy
1184342|NCT02104297|Nasal septum operation|nasal septum operation
1184343|NCT02104297|agitation|agitation
1184344|NCT02104284|Bronchial provocation test|bronchial provocation test
1184345|NCT02104284|Mannitol|mannitol
1184346|NCT02104284|Methacholine|methacholine
1184347|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
1184348|NCT02104284|Sensitivity and specificity|sensitivity and specificity
1184349|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
1184350|NCT02104271|argon plasma coagulation|argon plasma coagulation
1184351|NCT02104271|rectal bleeding|rectal bleeding
1184352|NCT02104258|Hamstring|hamstring
1184353|NCT02104258|Muscle|muscle
1184354|NCT02104258|Injury|injury
1184355|NCT02104258|Treatment|treatment
1184356|NCT02104258|Rehabilitation|rehabilitation
1184357|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
1184358|NCT02104232|Maternal depression|maternal depression
1184359|NCT02104219|Hypophosphatasia|hypophosphatasia
1184361|NCT02104219|bone disease|bone disease
1184362|NCT02104219|Soft Bones|soft bones
1184363|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
1184364|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
1184365|NCT02104219|alkaline phosphatase|alkaline phosphatase
1184366|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1184367|NCT02104219|rickets|rickets
1184368|NCT02104219|osteomalacia|osteomalacia
1184369|NCT02104193|brain metastases|brain metastases
1184370|NCT02104193|simvastatin|simvastatin
1184371|NCT02104193|radiation therapy|radiation therapy
1184372|NCT02104180|non-inferiority|non-inferiority
1184373|NCT02104180|randomized|randomized
1184374|NCT02104180|TulleGras|tullegras
1184375|NCT02104180|Urgotul|urgotul
1184376|NCT02104180|pain|pain
1184377|NCT02104180|venous leg ulcer|venous leg ulcer
1184378|NCT02104180|healing|healing
1184379|NCT02104167|DDD|ddd
1184380|NCT02104167|degenerative disc disease|degenerative disc disease
1184381|NCT02104167|cervical spine|cervical spine
1184382|NCT02104167|fusion rate|fusion rate
1184383|NCT02104141|DDD|ddd
1184384|NCT02104141|lumbar spine|lumbar spine
1184385|NCT02104141|fusion rate|fusion rate
1184386|NCT02104141|degenerative disc disease|degenerative disc disease
1184387|NCT02104128|Anhedonia|anhedonia
1184388|NCT02104128|Dopamine|dopamine
1184389|NCT02104128|Bupropion|bupropion
1184390|NCT02104128|fMRI|fmri
1184391|NCT02104128|emotional processing|emotional processing
1184392|NCT02104128|reward|reward
1184394|NCT02104115|Small bowel|small bowel
1184395|NCT02104115|Colon|colon
1184396|NCT02104115|MRI|mri
1184397|NCT02104115|Function|function
1184398|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
1184399|NCT02104102|Elderly|elderly
1184400|NCT02104102|mirror therapy|mirror therapy
1184401|NCT02104102|hands|hands
1184402|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
1184403|NCT02104089|Endovascular|endovascular
1184404|NCT02104089|Fenestration|fenestration
1184405|NCT02104089|Branch|branch
1184406|NCT02104089|Off-the-shelf|off-the-shelf
1184407|NCT02104076|Bile Duct Obstructions|bile duct obstructions
1184408|NCT02104076|Biliary Stases|biliary stases
1184409|NCT02104076|Biliary Tract|biliary tract
1184410|NCT02104076|Stents|stents
1184411|NCT02104024|Kidney|kidney
1184412|NCT02104024|Pancreas|pancreas
1184413|NCT02104024|Transplant|transplant
1184414|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
1184415|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
1184416|NCT02104011|Beta-blockers|beta-blockers
1184417|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
1184418|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
1184419|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
1184420|NCT02103998|brain development|brain development
1184421|NCT02103998|cerebral palsy|cerebral palsy
1184422|NCT02103998|cognitive dealy|cognitive dealy
1184423|NCT02103985|Healthy|healthy
1184424|NCT02103985|JNJ-39823277|jnj-39823277
1184425|NCT02103985|JNJ-40917006|jnj-40917006
1184426|NCT02103985|Pharmacokinetics|pharmacokinetics
1184427|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
1184428|NCT02103946|serratus|serratus
1184429|NCT02103946|paravertebral|paravertebral
1184430|NCT02103946|breast|breast
1184431|NCT02103946|cancer|cancer
1184432|NCT02103946|axilla|axilla
1184433|NCT02103907|balance|balance
1184434|NCT02103907|knee|knee
1184435|NCT02103907|osteoarthritis|osteoarthritis
1184436|NCT02103907|physical function|physical function
1184437|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
1184438|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
1184439|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
1184440|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
1184441|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
1184442|NCT02103894|Pick's disease|pick's disease
1184443|NCT02103894|tauopathies|tauopathies
1184444|NCT02103881|Agitation|agitation
1184445|NCT02103881|Ketamine|ketamine
1184446|NCT02103881|Haloperidol|haloperidol
1184447|NCT02103881|Emergency Medical Services|emergency medical services
1184448|NCT02103881|Feeling of restlessness|feeling of restlessness
1184449|NCT02103881|Increased motor activity|increased motor activity
1184450|NCT02103868|Tobacco cessation|tobacco cessation
1184451|NCT02103868|Zari worker|zari worker
1184452|NCT02103868|Behavior therapy|behavior therapy
1184453|NCT02103868|Qualitative Research|qualitative research
1184454|NCT02103868|Mumbai|mumbai
1184455|NCT02103855|pancreas transplantation|pancreas transplantation
1184456|NCT02103855|immunosuppression|immunosuppression
1184457|NCT02103855|belatacept|belatacept
1184458|NCT02103829|Cigarette smoking|cigarette smoking
1184459|NCT02103829|Tobacco smoking|tobacco smoking
1184460|NCT02103829|Smoking, Tobacco|smoking, tobacco
1184461|NCT02103803|concussion|concussion
1184462|NCT02103803|sports-related concussion|sports-related concussion
1184463|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
1184464|NCT02103803|eye tracking|eye tracking
1184465|NCT02103803|oculometrics|oculometrics
1184466|NCT02103777|high dose of caffeine|high dose of caffeine
1184467|NCT02103777|low dose of caffeine|low dose of caffeine
1184468|NCT02103777|prevention|prevention
1184469|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
1184470|NCT02103764|cyclic desogestrel|cyclic desogestrel
1184471|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
1184472|NCT02103764|lipid metabolism|lipid metabolism
1184473|NCT02103764|glucose metabolism|glucose metabolism
1184474|NCT02103764|endometrial histology changing|endometrial histology changing
1184475|NCT02103751|biomarkers|biomarkers
1184476|NCT02103751|HPHCs|hphcs
1184478|NCT02103751|smoking|smoking
1184479|NCT02103751|Smokers|smokers
1184480|NCT02103751|non-smokers|non-smokers
1184481|NCT02103738|Lucentis|lucentis
1184482|NCT02103738|Ranibizumab|ranibizumab
1184483|NCT02103738|Treat and Extend|treat and extend
1184484|NCT02103738|wetAMD|wetamd
1184485|NCT02103738|Age related macular degeneration|age related macular degeneration
1184486|NCT02103699|Hepatitis C virus|hepatitis c virus
1184487|NCT02103699|Simeprevir|simeprevir
1184488|NCT02103699|Ribonucleic acid|ribonucleic acid
1184489|NCT02103699|Sustained virologic response|sustained virologic response
1184490|NCT02103686|Neuropathic pain|neuropathic pain
1184491|NCT02103686|pregabalin|pregabalin
1185194|NCT02100384|Maintenance|maintenance
1184492|NCT02103660|contraceptive implant|contraceptive implant
1184493|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
1184494|NCT02103660|Hormonal Contraception|hormonal contraception
1184495|NCT02103660|progestin|progestin
1184496|NCT02103647|Neuropathic pain|neuropathic pain
1184497|NCT02103647|pregabalin|pregabalin
1184498|NCT02103634|breast cancer|breast cancer
1184499|NCT02103634|FDG PET/CT|fdg pet/ct
1184500|NCT02103634|MRI|mri
1184501|NCT02103634|NaF PET/MRI|naf pet/mri
1184502|NCT02103634|NaF PET/CT|naf pet/ct
1184503|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
1184504|NCT02103556|Constipation|constipation
1184505|NCT02103556|Rome III criteria|rome iii criteria
1184506|NCT02103556|Hemodialysis|hemodialysis
1184507|NCT02103491|Half-ironman|half-ironman
1184508|NCT02103491|Triathlon|triathlon
1184509|NCT02103491|Salt|salt
1184510|NCT02103491|Exercise|exercise
1184511|NCT02103491|Performance|performance
1184512|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
1184513|NCT02103478|MDS|mds
1184514|NCT02103465|Parkinson's Disease|parkinson's disease
1184515|NCT02103465|treatment|treatment
1184516|NCT02103465|old patients|old patients
1184517|NCT02103465|Rotigotine|rotigotine
1184518|NCT02103439|Hepatitis C|hepatitis c
1184519|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
1184520|NCT02103439|Peginterferon|peginterferon
1184521|NCT02103439|Treatment|treatment
1256182|NCT01778101|reflux|reflux
1184522|NCT02103426|Cytomegalovirus|cytomegalovirus
1184523|NCT02103426|ASP0113|asp0113
1184524|NCT02103426|CMV-seropositive|cmv-seropositive
1184525|NCT02103426|Healthy subjects|healthy subjects
1184526|NCT02103426|CMV-seronegative|cmv-seronegative
1184527|NCT02103426|Dialysis|dialysis
1184528|NCT02103374|weaned tobacco|weaned tobacco
1184529|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
1184530|NCT02103361|autoimmune disease|autoimmune disease
1184531|NCT02103361|pregnancy|pregnancy
1184532|NCT02103361|psoriasis|psoriasis
1184533|NCT02103361|Stelara|stelara
1184534|NCT02103361|ustekinumab|ustekinumab
1184535|NCT02103361|birth outcome|birth outcome
1184536|NCT02103361|malformation|malformation
1184537|NCT02103361|birth defect|birth defect
1184538|NCT02103361|psoriatic arthritis|psoriatic arthritis
1184539|NCT02103361|Crohn's Disease|crohn's disease
1184540|NCT02103348|Severe asthma|severe asthma
1184541|NCT02103348|Sputum|sputum
1184542|NCT02103348|Mucolysis|mucolysis
1184543|NCT02103335|Myeloma|myeloma
1184544|NCT02103335|Multiple Myeloma|multiple myeloma
1184545|NCT02103335|Pomalidomide|pomalidomide
1184546|NCT02103335|Marizomib|marizomib
1184547|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
1184548|NCT02103335|Relapsed|relapsed
1184549|NCT02103335|Refractory|refractory
1184550|NCT02103309|Soft contact lenses|soft contact lenses
1184551|NCT02103309|DACP|dacp
1184552|NCT02103283|Diabetic Macular Edema|diabetic macular edema
1184553|NCT02103244|pharmacokinetics|pharmacokinetics
1184554|NCT02103244|safety|safety
1184555|NCT02103231|Preterm birth|preterm birth
1184556|NCT02103231|Hypertension|hypertension
1184557|NCT02103231|Exercise capacity|exercise capacity
1184558|NCT02103231|Cardiovascular risk|cardiovascular risk
1184559|NCT02103218|HIV|hiv
1184560|NCT02103218|risky sex prevention|risky sex prevention
1184561|NCT02103218|intervention|intervention
1184562|NCT02103205|Lactoferrin|lactoferrin
1184563|NCT02103205|Infant formula|infant formula
1184564|NCT02103205|Iron|iron
1184565|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
1184566|NCT02103179|ECC|ecc
1184567|NCT02103179|VEGF signaling|vegf signaling
1184568|NCT02103140|Breast Cancer|breast cancer
1184569|NCT02103140|Obesity|obesity
1184570|NCT02103140|African American female|african american female
1184571|NCT02103140|exergaming|exergaming
1184572|NCT02103101|polymorphism|polymorphism
1184573|NCT02103101|ABCB1|abcb1
1184574|NCT02103101|P-glycoprotein|p-glycoprotein
1184575|NCT02103101|oral anticoagulant|oral anticoagulant
1184576|NCT02103101|dabigatran|dabigatran
1184577|NCT02103101|apixaban|apixaban
1184578|NCT02103101|rivaroxaban|rivaroxaban
1184579|NCT02103101|hemorrhagic complication|hemorrhagic complication
1184580|NCT02103101|thrombo-embolism|thrombo-embolism
1184581|NCT02103101|serious adverse event|serious adverse event
1184582|NCT02103088|Prostate cancer|prostate cancer
1184583|NCT02103088|Intervention|intervention
1184584|NCT02103088|Rehabilitation|rehabilitation
1184585|NCT02103088|Couple|couple
1184586|NCT02103088|Sexology|sexology
1184587|NCT02103088|Urology|urology
1184588|NCT02103088|Late effects|late effects
1184589|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
1184590|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
1184591|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
1184592|NCT02103075|silent period|silent period
1184593|NCT02103075|cerebellum|cerebellum
1184594|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
1184595|NCT02103062|nab®Paclitaxel|nab®paclitaxel
1184596|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
1184597|NCT02103062|Progression Free Survival|progression free survival
1184598|NCT02103062|Overall Survival|overall survival
1184599|NCT02103062|Duration of Response|duration of response
1184600|NCT02103062|RAS|ras
1184601|NCT02103036|Low Back Pain|low back pain
1184602|NCT02103036|Core stability exercise|core stability exercise
1184603|NCT02103036|Back school|back school
1184604|NCT02103036|TENS|tens
1184605|NCT02103036|Infra- red light|infra- red light
1184606|NCT02102997|DTS|dts
1184607|NCT02102997|Stents|stents
1184608|NCT02102997|Stent|stent
1184609|NCT02102997|DES|des
1184610|NCT02102997|Drug eluting|drug eluting
1184611|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
1184612|NCT02102997|Drug eluting stents|drug eluting stents
1184613|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
1184614|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
1184615|NCT02102997|Sirolimus|sirolimus
1184616|NCT02102997|Sirolimus eluting|sirolimus eluting
1184617|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1184618|NCT02102997|PCI|pci
1184619|NCT02102997|Registry|registry
1184620|NCT02102997|Registries|registries
1184621|NCT02102997|Multi center|multi center
1184622|NCT02102997|Multi centre|multi centre
1184623|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
1184624|NCT02102984|metallic biliary stents|metallic biliary stents
1184625|NCT02102984|covered biliary stents|covered biliary stents
1184626|NCT02102984|uncovered biliary stents|uncovered biliary stents
1184627|NCT02102971|liver|liver
1184628|NCT02102971|ischemia|ischemia
1184629|NCT02102971|reperfusion|reperfusion
1184630|NCT02102958|diabetes|diabetes
1184631|NCT02102958|visual impairment|visual impairment
1184632|NCT02102958|foot care|foot care
1184633|NCT02102958|diabetes self-management education|diabetes self-management education
1184634|NCT02102945|Computed tomography|computed tomography
1184635|NCT02102945|Perfusion imaging|perfusion imaging
1184636|NCT02102945|Coma|coma
1184637|NCT02102945|Heart arrest|heart arrest
1184638|NCT02102945|Brain death|brain death
1184639|NCT02102906|Adult|adult
1184640|NCT02102906|Humans|humans
1184641|NCT02102906|Conversion disorder|conversion disorder
1184642|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
1184643|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
1184644|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
1184645|NCT02102880|Genetic Association Studies|genetic association studies
1184646|NCT02102867|HIV|hiv
1184647|NCT02102867|STI|sti
1184648|NCT02102867|Primary Prevention|primary prevention
1184649|NCT02102867|Topical Microbicides|topical microbicides
1184650|NCT02102867|User Experience|user experience
1184651|NCT02102867|Drug Delivery Systems|drug delivery systems
1184652|NCT02102854|kidney transplantation|kidney transplantation
1184653|NCT02102854|acute rejection|acute rejection
1184654|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
1184655|NCT02102828|DVT|dvt
1184656|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
1184657|NCT02102815|total knee arthroplasty|total knee arthroplasty
1184658|NCT02102815|pain control|pain control
1184659|NCT02102815|dexamethasone|dexamethasone
1184660|NCT02102815|steroids|steroids
1184661|NCT02102802|PTSD|ptsd
1184662|NCT02102802|MDMA|mdma
1184663|NCT02102802|Brain activity|brain activity
1184664|NCT02102802|fMRI|fmri
1184665|NCT02102802|Heart rate variability|heart rate variability
1184666|NCT02102802|Physiological correlate|physiological correlate
1184667|NCT02102776|Primary Pterygium|primary pterygium
1184668|NCT02102776|Mitomycin C|mitomycin c
1184669|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
1184670|NCT02102776|Conjunctival autograft|conjunctival autograft
1184671|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
1184672|NCT02102763|Overweight|overweight
1184673|NCT02102763|Obesity|obesity
1184674|NCT02102763|Dietary intake|dietary intake
1184675|NCT02102763|Physical activity levels|physical activity levels
1184676|NCT02102763|Blood pressure levels|blood pressure levels
1184677|NCT02102763|Family perceptions|family perceptions
1184678|NCT02102737|insulin resistance|insulin resistance
1184679|NCT02102737|Scintigraphy|scintigraphy
1184680|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
1184681|NCT02102724|African Americans|african americans
1184682|NCT02102724|Older Adults|older adults
1184683|NCT02102711|VITAMIN A|vitamin a
1184684|NCT02102711|BLOOD CONCENTRATION|blood concentration
1184685|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
1184686|NCT02102698|Tourette's Syndrome|tourette's syndrome
1184687|NCT02102698|Ecopipam|ecopipam
1184688|NCT02102698|D1 Receptor|d1 receptor
1184689|NCT02102698|Phase 2|phase 2
1184690|NCT02102685|VAC Therapy|vac therapy
1184691|NCT02102685|Neck Abscess|neck abscess
1184692|NCT02102685|Traditional Therapy|traditional therapy
1184693|NCT02102685|Wound Healing|wound healing
1184694|NCT02102659|Nutritional Assessment|nutritional assessment
1184695|NCT02102659|Oral Epithelial Cell|oral epithelial cell
1184696|NCT02102659|Apoptosis|apoptosis
1184697|NCT02102633|bosutinib|bosutinib
1184698|NCT02102633|dabigatran|dabigatran
1184699|NCT02102633|drug interaction|drug interaction
1184700|NCT02102633|p-glycoprotein|p-glycoprotein
1184701|NCT02102633|pharmacokinetics|pharmacokinetics
1184702|NCT02102620|intra-articular injection|intra-articular injection
1184703|NCT02102620|corticosteroid|corticosteroid
1184704|NCT02102620|osteoarthritis|osteoarthritis
1184705|NCT02102620|Interphalangeal joint|interphalangeal joint
1184706|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
1184707|NCT02102594|Myasthenia Gravis|myasthenia gravis
1184708|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
1184709|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
1184710|NCT02102594|proteasome inhibitor|proteasome inhibitor
1184711|NCT02102594|Bortezomib|bortezomib
1184712|NCT02102594|Velcade|velcade
1184713|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
1184714|NCT02102581|Tourniquet|tourniquet
1184715|NCT02102581|Total knee arthroplasty|total knee arthroplasty
1184716|NCT02102581|Blood loss|blood loss
1184717|NCT02102581|Limb swelling|limb swelling
1576619|NCT00476944|Heparin|heparin
1184718|NCT02102581|Limb circumference|limb circumference
1184719|NCT02102542|glycopyrrolate|glycopyrrolate
1184720|NCT02102542|efficacy|efficacy
1184721|NCT02102542|antisialagogue|antisialagogue
1184722|NCT02102529|pain|pain
1184723|NCT02102529|quality of life|quality of life
1184724|NCT02102516|Post operative pain management|post operative pain management
1184725|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
1184726|NCT02102477|Prostatic neoplasms|prostatic neoplasms
1184727|NCT02102477|Locally advanced|locally advanced
1184728|NCT02102477|Radiotherapy|radiotherapy
1184729|NCT02102477|Surgery|surgery
1184730|NCT02102477|Mortality|mortality
1184731|NCT02102451|Interferon-free|interferon-free
1184732|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
1184733|NCT02102451|Treatment as prevention|treatment as prevention
1184734|NCT02102451|Surveillance|surveillance
1184735|NCT02102451|Feasibility|feasibility
1184736|NCT02102438|Elderly patients|elderly patients
1184737|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
1184738|NCT02102438|Omission of anthracyclines|omission of anthracyclines
1184739|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1184740|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
1184741|NCT02102438|Safety information|safety information
1184742|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
1184743|NCT02102425|Exit site infection|exit site infection
1184744|NCT02102425|Exit site care|exit site care
1184745|NCT02102425|Bandage|bandage
1184746|NCT02102425|Prevention|prevention
1184747|NCT02102425|Guidelines|guidelines
1184748|NCT02102412|crc|crc
1184749|NCT02102412|colonoscopy|colonoscopy
1184750|NCT02102412|colon cancer|colon cancer
1184751|NCT02102399|Voice training|voice training
1184752|NCT02102399|Education|education
1184753|NCT02102399|Voice|voice
1184754|NCT02102399|Faculty|faculty
1184755|NCT02102386|elective|elective
1184756|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
1184757|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
1184758|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
1184759|NCT02102347|Physical Therapy Modalities|physical therapy modalities
1184760|NCT02102347|osteoarthritis|osteoarthritis
1184761|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
1184762|NCT02102334|radiograpghic measurements|radiograpghic measurements
1184763|NCT02102334|femoral offset|femoral offset
1184764|NCT02102334|leg length discrepancy|leg length discrepancy
1184765|NCT02102334|cup anteversion|cup anteversion
1184766|NCT02102334|cup inclination|cup inclination
1184767|NCT02102321|hookworm|hookworm
1184768|NCT02102321|albendazole|albendazole
1184769|NCT02102321|iron supplementation|iron supplementation
1184770|NCT02102321|democratic republic of congo|democratic republic of congo
1184771|NCT02102321|subsistence farmers|subsistence farmers
1184772|NCT02102321|randomized control trial|randomized control trial
1184773|NCT02102321|neglected tropical disease|neglected tropical disease
1184774|NCT02102321|helminths|helminths
1184775|NCT02102295|Gingivitis|gingivitis
1184776|NCT02102295|antioxidant|antioxidant
1184777|NCT02102295|dentifrice|dentifrice
1184778|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
1184779|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
1184780|NCT02102282|Pregnancy|pregnancy
1184781|NCT02102282|Breast Cancer|breast cancer
1184782|NCT02102282|Chemotherapy|chemotherapy
1184783|NCT02102282|Surgery|surgery
1184784|NCT02102282|Obstetric managment|obstetric managment
1184785|NCT02102256|deafness|deafness
1184786|NCT02102256|congenital|congenital
1184787|NCT02102256|pediatric|pediatric
1184788|NCT02102256|device|device
1184789|NCT02102243|hypertension|hypertension
1184790|NCT02102243|blood pressure|blood pressure
1184791|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
1184792|NCT02102243|vascular oxidative stress|vascular oxidative stress
1184793|NCT02102243|nitric oxide|nitric oxide
1184794|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
1184795|NCT02102243|endothelium|endothelium
1184796|NCT02102243|endothelial dysfunction|endothelial dysfunction
1184797|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
1184798|NCT02102243|microvascular blood flow|microvascular blood flow
1184799|NCT02102243|flow mediated dilation|flow mediated dilation
1184800|NCT02102243|endothelial cell collection|endothelial cell collection
1184801|NCT02102243|microbubbles|microbubbles
1184802|NCT02102243|Definity|definity
1184803|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1184804|NCT02102230|marijuana abuse|marijuana abuse
1184805|NCT02102230|Veterans|veterans
1184806|NCT02102217|Major Abdominal Surgery|major abdominal surgery
1184807|NCT02102217|C-reactive protein|c-reactive protein
1184808|NCT02102217|Computed Tomography|computed tomography
1184809|NCT02102217|Quality Control|quality control
1184810|NCT02102217|Postoperative complications|postoperative complications
1333136|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
1184811|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
1184812|NCT02102178|oncological pain|oncological pain
1184813|NCT02102178|therapeutic activities|therapeutic activities
1184814|NCT02102178|occupational therapy.|occupational therapy.
1184815|NCT02102165|Aurora|aurora
1184816|NCT02102165|breast cancer|breast cancer
1184817|NCT02102165|metastatic|metastatic
1184818|NCT02102165|molecular screening|molecular screening
1184819|NCT02102165|targeted gene sequencing|targeted gene sequencing
1184820|NCT02102165|molecular aberrations|molecular aberrations
1184821|NCT02102165|exploratory|exploratory
1184822|NCT02102165|biomarker|biomarker
1184823|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
1184824|NCT02102152|bronchiectasis|bronchiectasis
1184825|NCT02102152|chronic infection|chronic infection
1184826|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1184827|NCT02102126|Renal denervation therapy|renal denervation therapy
1184828|NCT02102126|Aortic blood pressure|aortic blood pressure
1184829|NCT02102126|Blood pressure variability|blood pressure variability
1184830|NCT02102126|Arterial stiffness|arterial stiffness
1184831|NCT02102126|Target organ damage|target organ damage
1184832|NCT02102126|Biomarker|biomarker
1184833|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
1184834|NCT02102074|colon and rectal tumors|colon and rectal tumors
1184835|NCT02102074|colon cancer markers|colon cancer markers
1184836|NCT02102061|overweight|overweight
1184837|NCT02102061|exercise|exercise
1184838|NCT02102061|nutrition|nutrition
1184839|NCT02102061|philosophy|philosophy
1184840|NCT02102048|HIV|hiv
1184841|NCT02102048|diabetes|diabetes
1184842|NCT02102048|glucose metabolism|glucose metabolism
1184843|NCT02102048|antiretroviral therapy|antiretroviral therapy
1184844|NCT02102048|ritonavir|ritonavir
1184845|NCT02102048|atazanavir|atazanavir
1184846|NCT02102035|defect|defect
1184847|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
1184848|NCT02102035|dorsal digital island flap|dorsal digital island flap
1184849|NCT02102035|sensory reconstruction.|sensory reconstruction.
1184850|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
1184851|NCT02102022|arginine|arginine
1184852|NCT02102022|arginine deiminase|arginine deiminase
1184853|NCT02102009|Malnutrition|malnutrition
1184854|NCT02102009|Dietary supplement|dietary supplement
1184855|NCT02102009|Nutritional supplement|nutritional supplement
1184856|NCT02102009|Complete enteral formula|complete enteral formula
1184857|NCT02102009|COPD|copd
1184858|NCT02101996|stable isotopes|stable isotopes
1184859|NCT02101996|triacylglycerol|triacylglycerol
1184860|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
1184861|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
1184862|NCT02101970|Breast cancer risk|breast cancer risk
1184863|NCT02101970|DHA|dha
1184864|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
1184865|NCT02101970|EPA|epa
1184866|NCT02101970|Weight Loss|weight loss
1184867|NCT02101931|Bladder Cancer|bladder cancer
1184868|NCT02101931|Laser Diagnosis|laser diagnosis
1184869|NCT02101931|Amino levulinic Acid|amino levulinic acid
1184870|NCT02101931|Photodynamic Detection|photodynamic detection
1184871|NCT02101931|spectra of urine|spectra of urine
1184872|NCT02101892|migraine|migraine
1184873|NCT02101892|Amitriptyline|amitriptyline
1184874|NCT02101892|pain modulation|pain modulation
1184875|NCT02101892|pain psychophysics|pain psychophysics
1184876|NCT02101892|pain neurophysiology|pain neurophysiology
1184877|NCT02101892|preventive treatment|preventive treatment
1184878|NCT02101866|Bioavailability Study|bioavailability study
1184879|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1184880|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
1184881|NCT02101866|Aviragen|aviragen
1184882|NCT02101840|Substance-Related Disorders|substance-related disorders
1185195|NCT02100384|Ultrasonic|ultrasonic
1184883|NCT02101840|Prescription Drug Misuse|prescription drug misuse
1184884|NCT02101840|Analgesics, Opioid|analgesics, opioid
1184885|NCT02101840|Oxycodone|oxycodone
1184886|NCT02101840|Randomized Controlled Trial|randomized controlled trial
1184887|NCT02101840|Cross-Over Studies|cross-over studies
1184888|NCT02101840|Placebo|placebo
1184889|NCT02101840|Healthy Volunteers|healthy volunteers
1184890|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
1184891|NCT02101762|Foley|foley
1184892|NCT02101762|Catheters|catheters
1184893|NCT02101762|CAUTI|cauti
1184894|NCT02101762|ERASE CAUTI|erase cauti
1184895|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
1184896|NCT02101736|Ages 3 - 15 years|ages 3 - 15 years
1184897|NCT02101736|Cabozantinib|cabozantinib
1184898|NCT02101736|XL184|xl184
1184899|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
1184900|NCT02101736|Neurofibromatosis|neurofibromatosis
1184901|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
1184902|NCT02101736|Cometriq|cometriq
1184903|NCT02101736|NF1|nf1
1184904|NCT02101723|Zinc absorption|zinc absorption
1576716|NCT00476619|Contrast|contrast
1184905|NCT02101723|Micronutrient supplement|micronutrient supplement
1184906|NCT02101723|Microbiome|microbiome
1184907|NCT02101723|Kenya|kenya
1184908|NCT02101723|Complementary foods|complementary foods
1184909|NCT02101723|Home fortification|home fortification
1184910|NCT02101710|Bioequivalence|bioequivalence
1184911|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
1184912|NCT02101710|Elantan|elantan
1184913|NCT02101710|Imdur|imdur
1184914|NCT02101710|Korean|korean
1184915|NCT02101710|Healthy|healthy
1184916|NCT02101697|reduce|reduce
1184917|NCT02101697|Indian health providers|indian health providers
1184918|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
1184919|NCT02101671|agitation|agitation
1184920|NCT02101671|anaesthesia|anaesthesia
1184921|NCT02101671|laparoscopy|laparoscopy
1184922|NCT02101671|surgery|surgery
1184923|NCT02101671|delirium|delirium
1184924|NCT02101671|sedation|sedation
1184925|NCT02101671|emergence|emergence
1184926|NCT02101671|steep|steep
1184927|NCT02101671|trendelemburg|trendelemburg
1184928|NCT02101671|position|position
1184929|NCT02101671|delayed|delayed
1184930|NCT02101671|Confusion|confusion
1184931|NCT02101671|Disorientation|disorientation
1184932|NCT02101645|Bioimpedance|bioimpedance
1184933|NCT02101645|Venous ulcer|venous ulcer
1184934|NCT02101645|Edema|edema
1184935|NCT02101645|LIDC|lidc
1184936|NCT02101645|Electrical stimulation|electrical stimulation
1184937|NCT02101632|TMD|tmd
1184938|NCT02101632|bee venom|bee venom
1184939|NCT02101632|muscle tension|muscle tension
1184940|NCT02101632|muscle pain|muscle pain
1184941|NCT02101619|aortic stenosis|aortic stenosis
1184942|NCT02101619|myocardial tissue|myocardial tissue
1184943|NCT02101619|echocardiography|echocardiography
1184944|NCT02101619|MRI|mri
1184945|NCT02101606|Acute Stroke|acute stroke
1184946|NCT02101606|Cerebral Stroke|cerebral stroke
1184947|NCT02101606|Brain Ischemia|brain ischemia
1184948|NCT02101606|Perfusion Imaging|perfusion imaging
1184949|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
1184950|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
1184951|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
1184952|NCT02101593|arginine|arginine
1184953|NCT02101593|arginine deiminase|arginine deiminase
1184954|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
1184955|NCT02101580|arginine|arginine
1184956|NCT02101580|arginine deiminase|arginine deiminase
1184957|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
1184958|NCT02101554|Pediatric|pediatric
1184959|NCT02101554|pain indication|pain indication
1184960|NCT02101554|controlled release morphine|controlled release morphine
1184961|NCT02101541|Atrial fibrillation|atrial fibrillation
1184962|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
1184963|NCT02101541|Heart diseases|heart diseases
1184964|NCT02101541|Cardiovascular diseases|cardiovascular diseases
1184965|NCT02101541|Pathological processes|pathological processes
1184966|NCT02101528|Strength in PD patients|strength in pd patients
1184967|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
1184968|NCT02101515|randomized controlled trial|randomized controlled trial
1184969|NCT02101515|labor complications|labor complications
1184970|NCT02101515|cesarean section|cesarean section
1184971|NCT02101515|second stage|second stage
1184972|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
1184973|NCT02101489|TVT|tvt
1184974|NCT02101489|Stress urinary incontinence|stress urinary incontinence
1184975|NCT02101476|Pain|pain
1184976|NCT02101463|aortic|aortic
1184977|NCT02101463|sm-FBSG|sm-fbsg
1184978|NCT02101463|aneurysms|aneurysms
1184979|NCT02101463|fenestrated|fenestrated
1184980|NCT02101463|stent-grafts|stent-grafts
1184981|NCT02101463|Vascular|vascular
1184982|NCT02101463|Endovascular|endovascular
1184983|NCT02101450|extra-abdominal|extra-abdominal
1184984|NCT02101450|intra-abdominal|intra-abdominal
1184985|NCT02101450|removal of placenta|removal of placenta
1184986|NCT02101450|cesarean section|cesarean section
1184987|NCT02101450|bleeding|bleeding
1184988|NCT02101424|Overdose|overdose
1184989|NCT02101424|Emergency Department|emergency department
1184990|NCT02101424|Supplemental Oxygen|supplemental oxygen
1184991|NCT02101424|Pulse Oximeter|pulse oximeter
1184992|NCT02101424|Capnography|capnography
1184993|NCT02101398|tDCS|tdcs
1184994|NCT02101398|Stroke|stroke
1184995|NCT02101398|Aphasia|aphasia
1184996|NCT02101398|Naming|naming
1184997|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
1184998|NCT02101385|DNA Sequencing|dna sequencing
1184999|NCT02101385|RNA Sequencing|rna sequencing
1185000|NCT02101372|first episode psychosis|first episode psychosis
1185001|NCT02101372|psychoeducation|psychoeducation
1185002|NCT02101372|group therapy|group therapy
1185003|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
1185004|NCT02101333|STEROID SPARING|steroid sparing
1185005|NCT02101333|TOCILIZUMAB|tocilizumab
1185006|NCT02101333|EFFICACY|efficacy
1185007|NCT02101333|SAFETY|safety
1185008|NCT02101320|surgery|surgery
1185009|NCT02101320|nuclear medicine|nuclear medicine
1185010|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
1185011|NCT02101320|Gamma Camera|gamma camera
1185012|NCT02101320|SNOLL|snoll
1185013|NCT02101320|breast cancer|breast cancer
1185014|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
1185015|NCT02101294|repetitive stress disorder|repetitive stress disorder
1185016|NCT02101281|Dry Eye|dry eye
1185017|NCT02101255|Dental caries|dental caries
1185018|NCT02101255|Curodont Repair|curodont repair
1185019|NCT02101255|P11-4|p11-4
1185020|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
1185021|NCT02101229|Glycemic control algorithm|glycemic control algorithm
1185022|NCT02101229|closed loop|closed loop
1185023|NCT02101229|artificial pancreas|artificial pancreas
1185024|NCT02101216|bioequivalence|bioequivalence
1185025|NCT02101216|pharmacokinetics|pharmacokinetics
1185026|NCT02101216|psoriasis|psoriasis
1185027|NCT02101203|HSDD|hsdd
1185028|NCT02101190|BIA 9-1067|bia 9-1067
1185029|NCT02101190|Opicapone|opicapone
1185030|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
1185031|NCT02101177|Viral Hepatitis C|viral hepatitis c
1185032|NCT02101177|Genotype 4|genotype 4
1185033|NCT02101177|SVR|svr
1185034|NCT02101177|Egyptian National Program|egyptian national program
1185035|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
1185036|NCT02101151|vitamin D|vitamin d
1185037|NCT02101151|cholecalciferol|cholecalciferol
1185038|NCT02101151|obesity|obesity
1185039|NCT02101138|Corticosteroids|corticosteroids
1185040|NCT02101138|Eosinophilia|eosinophilia
1185041|NCT02101099|Colonoscopy|colonoscopy
1185042|NCT02101099|Force|force
1185043|NCT02101099|Monitor|monitor
1185044|NCT02101099|Endoscopist|endoscopist
1185045|NCT02101099|Conscious|conscious
1185046|NCT02101099|Sedation|sedation
1185047|NCT02101099|Propofol|propofol
1185048|NCT02101086|umbilical cord blood|umbilical cord blood
1185049|NCT02101086|premature|premature
1185050|NCT02101086|autologous transfusion|autologous transfusion
1185051|NCT02101086|allogeneic transfusion|allogeneic transfusion
1185052|NCT02101060|exercise|exercise
1185053|NCT02101060|aging|aging
1185054|NCT02101060|aerobic capacity|aerobic capacity
1185055|NCT02101060|cardiac function|cardiac function
1185056|NCT02101060|inflammation|inflammation
1185057|NCT02101047|cesarean section|cesarean section
1185058|NCT02101047|hypotension|hypotension
1185059|NCT02101047|phenylephrine|phenylephrine
1185060|NCT02100982|Multimorbidity|multimorbidity
1185061|NCT02100982|Communication|communication
1185062|NCT02100982|Primary Care|primary care
1185063|NCT02100982|Mental Health|mental health
1185064|NCT02100969|MG|mg
1185065|NCT02100969|Hizentra|hizentra
1185066|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
1185067|NCT02100956|chronic pain|chronic pain
1185068|NCT02100956|neuropathic pain|neuropathic pain
1185069|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
1185070|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
1185071|NCT02100930|oral isotretinoin|oral isotretinoin
1185072|NCT02100930|GM-CSF|gm-csf
1185073|NCT02100930|Sargramostim|sargramostim
1185074|NCT02100930|13-260|13-260
1185075|NCT02100917|Bioequivalence|bioequivalence
1185076|NCT02100917|Biosimilarity|biosimilarity
1185077|NCT02100917|Similarity|similarity
1185078|NCT02100917|Pharmacokinetics|pharmacokinetics
1185079|NCT02100917|Phase I|phase i
1185080|NCT02100917|Trastuzumab|trastuzumab
1185081|NCT02100917|Healthy Male Volunteers|healthy male volunteers
1185082|NCT02100917|Single-dose|single-dose
1185083|NCT02100917|HER-2|her-2
1185084|NCT02100917|Oncology|oncology
1185085|NCT02100904|Fibroids|fibroids
1185086|NCT02100904|Radiofrequency ablation|radiofrequency ablation
1185087|NCT02100891|Ewing Sarcoma|ewing sarcoma
1185088|NCT02100891|Neuroblastoma|neuroblastoma
1185089|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
1185090|NCT02100891|Osteosarcoma|osteosarcoma
1185091|NCT02100891|CNS tumors|cns tumors
1185092|NCT02100891|Brain Tumors|brain tumors
1185093|NCT02100839|hypercholesterolemia|hypercholesterolemia
1185094|NCT02100839|apolipoprotein E|apolipoprotein e
1185095|NCT02100839|First in Human|first in human
1185096|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
1185097|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
1185098|NCT02100800|COPD|copd
1185099|NCT02100800|Emphysema|emphysema
1185100|NCT02100800|MRI|mri
1185101|NCT02100800|UTE|ute
1185102|NCT02100800|Quantification|quantification
1185103|NCT02100800|CT|ct
1185104|NCT02100787|tear osmolarity|tear osmolarity
1185105|NCT02100787|keratitis sicca|keratitis sicca
1185106|NCT02100787|ocular surface disease|ocular surface disease
1185107|NCT02100787|TheraTears|theratears
1185108|NCT02100774|bioavailability|bioavailability
1185109|NCT02100774|postprandial period|postprandial period
1185110|NCT02100774|genetic variants|genetic variants
1185111|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
1185112|NCT02100774|vitamin|vitamin
1185113|NCT02100774|carotenoid|carotenoid
1185114|NCT02100774|lutein|lutein
1185115|NCT02100774|lycopene|lycopene
1185116|NCT02100774|tocopherol|tocopherol
1185117|NCT02100774|cholecalciferol|cholecalciferol
1185118|NCT02100761|Voriconazole|voriconazole
1185119|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1185120|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
1185121|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
1185122|NCT02100761|Efficacy|efficacy
1185123|NCT02100761|Safety|safety
1185124|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
1185125|NCT02100748|bunionectomy|bunionectomy
1185126|NCT02100735|sedatives|sedatives
1185127|NCT02100735|analgesics|analgesics
1185128|NCT02100735|protocol|protocol
1185129|NCT02100735|mechanical ventilation|mechanical ventilation
1185130|NCT02100735|analgosedation|analgosedation
1185131|NCT02100683|Occluder|occluder
1185132|NCT02100657|multiple myeloma|multiple myeloma
1185133|NCT02100657|plitidepsin|plitidepsin
1185134|NCT02100657|APLIDIN|aplidin
1185135|NCT02100618|Adolescents|adolescents
1185136|NCT02100618|Adults|adults
1185137|NCT02100618|Immunogenicity|immunogenicity
1185138|NCT02100618|6.5 years|6.5 years
1185139|NCT02100618|Safety|safety
1185140|NCT02100618|Antibody persistence|antibody persistence
1185141|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1185142|NCT02100605|Nasal|nasal
1185143|NCT02100605|Congestion|congestion
1185144|NCT02100605|Decongestion|decongestion
1185145|NCT02100605|Hypertonic|hypertonic
1185146|NCT02100605|Saline solution|saline solution
1185147|NCT02100592|brain injury|brain injury
1185148|NCT02100592|coma|coma
1185149|NCT02100592|intensive care|intensive care
1185150|NCT02100592|early rehabilitation|early rehabilitation
1185151|NCT02100566|Advance Directive|advance directive
1185152|NCT02100553|Postmenopausal Women|postmenopausal women
1185153|NCT02100553|Obese|obese
1185154|NCT02100553|Non-obese|non-obese
1185155|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
1185156|NCT02100553|Pharmacokinetic|pharmacokinetic
1185157|NCT02100540|PMS|pms
1185158|NCT02100540|hot flashes|hot flashes
1185159|NCT02100527|safety|safety
1185160|NCT02100527|tolerability|tolerability
1185161|NCT02100527|pharmacokinetics|pharmacokinetics
1185162|NCT02100527|oral dosing|oral dosing
1185163|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
1185164|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
1185165|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
1185166|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
1185167|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
1185168|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
1185169|NCT02100488|Postprandial glucose control|postprandial glucose control
1185170|NCT02100488|Glucose variability|glucose variability
1185171|NCT02100462|Hypertension|hypertension
1185172|NCT02100462|Platelet activation|platelet activation
1185173|NCT02100462|Platelet aggregation|platelet aggregation
1185174|NCT02100462|Chlorthalidone|chlorthalidone
1185175|NCT02100449|Atelectasis|atelectasis
1185176|NCT02100449|Pneumonia|pneumonia
1185177|NCT02100449|Lung ultrasound|lung ultrasound
1185178|NCT02100449|Doppler|doppler
1185179|NCT02100436|children|children
1185180|NCT02100436|H3N2|h3n2
1185181|NCT02100436|H3N2v|h3n2v
1185182|NCT02100436|influenza|influenza
1185183|NCT02100436|pediatric|pediatric
1185184|NCT02100436|unadjuvanted|unadjuvanted
1185185|NCT02100436|vaccine|vaccine
1185186|NCT02100410|Contact Lens|contact lens
1185187|NCT02100410|Toric|toric
1185188|NCT02100397|Enteric fever|enteric fever
1185189|NCT02100397|Paratyphoid|paratyphoid
1185190|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
1185191|NCT02100397|Challenge study|challenge study
1185192|NCT02100397|Human model of infection|human model of infection
1185193|NCT02100384|peri implant|peri implant
1185196|NCT02100384|Scalers|scalers
1185197|NCT02100371|BMS-833923|bms-833923
1185198|NCT02100371|CA194002|ca194002
1185199|NCT02100358|acute cholecystitis|acute cholecystitis
1185200|NCT02100332|Drug Therapy|drug therapy
1185201|NCT02100319|Pharmacological therapy|pharmacological therapy
1185202|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
1185203|NCT02100280|Neuromuscular blockade|neuromuscular blockade
1185204|NCT02100280|Sugammadex|sugammadex
1185205|NCT02100280|Laparoscopic surgery|laparoscopic surgery
1185206|NCT02100280|IL-6|il-6
1185207|NCT02100241|Young adult|young adult
1185208|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
1185209|NCT02100241|Range of Motion, Articular|range of motion, articular
1185210|NCT02100228|apixaban|apixaban
1185211|NCT02100228|oral anticoagulant|oral anticoagulant
1185212|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
1185213|NCT02100228|cardioversion|cardioversion
1185214|NCT02100215|simulation|simulation
1185215|NCT02100215|competence|competence
1185216|NCT02100215|self-efficacy|self-efficacy
1185217|NCT02100215|novice nurses|novice nurses
1185218|NCT02100202|Dietary supplements|dietary supplements
1185219|NCT02100202|Cotinine level|cotinine level
1185220|NCT02100202|Malondialdehyde|malondialdehyde
1185221|NCT02100202|Chronic smokers|chronic smokers
1185222|NCT02100202|Hyperlipidemia|hyperlipidemia
1185223|NCT02100176|Rehabilitation treatment|rehabilitation treatment
1185224|NCT02100163|Ortho trauma. Virtual Reality. Pain. Anxiety|ortho trauma. virtual reality. pain. anxiety
1185225|NCT02100150|Concussion|concussion
1185226|NCT02100124|reproductive life planning|reproductive life planning
1185227|NCT02100124|action planning|action planning
1185228|NCT02100124|contraceptive use|contraceptive use
1185229|NCT02100124|unintended pregnancy|unintended pregnancy
1185230|NCT02100098|Ankle fracture|ankle fracture
1185231|NCT02100098|Nerve block|nerve block
1185232|NCT02100098|Postoperative pain|postoperative pain
1185233|NCT02100098|Pain profile|pain profile
1185234|NCT02100098|Rebound pain|rebound pain
1185235|NCT02100085|Phase 1 follow up|phase 1 follow up
1185236|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1185237|NCT02100085|Adult|adult
1185238|NCT02100085|Safety|safety
1185239|NCT02100085|Efficacy|efficacy
1185240|NCT02100059|meniscectomy|meniscectomy
1185241|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
1185242|NCT02100059|meniscus|meniscus
1185243|NCT02100046|Ethosuximide|ethosuximide
1185244|NCT02100046|Neuropathic pain|neuropathic pain
1185245|NCT02100046|Pain|pain
1185246|NCT02100046|Quality of life|quality of life
1185247|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
1185248|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
1185249|NCT02100020|physical activity|physical activity
1185250|NCT02100020|exercise guidelines|exercise guidelines
1185251|NCT02100020|multiple sclerosis|multiple sclerosis
1185252|NCT02100007|solid tumors|solid tumors
1185253|NCT02100007|relapsed|relapsed
1185254|NCT02100007|advanced|advanced
1185255|NCT02100007|metastatic|metastatic
1185256|NCT02100007|small cell lung cancer|small cell lung cancer
1185257|NCT02100007|ovarian cancer|ovarian cancer
1185258|NCT02100007|refractory|refractory
1185259|NCT02099994|HIV|hiv
1185260|NCT02099994|vaccine|vaccine
1185261|NCT02099981|Diabetes|diabetes
1185262|NCT02099981|Diabetic|diabetic
1185263|NCT02099981|Retinopathy|retinopathy
1185264|NCT02099981|Ophthalmology|ophthalmology
1185265|NCT02099981|Eye|eye
1185266|NCT02099981|Eyes|eyes
1185267|NCT02099955|spinal cord injury|spinal cord injury
1185268|NCT02099955|vitamin D deficiency|vitamin d deficiency
1185269|NCT02099955|pulmonary function|pulmonary function
1185270|NCT02099955|metabolic diseases|metabolic diseases
1185271|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
1185272|NCT02099942|Valvuloplasty|valvuloplasty
1185273|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1185274|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
1185275|NCT02099929|Coffee|coffee
1185276|NCT02099929|Glucose|glucose
1185277|NCT02099929|Insulin|insulin
1185278|NCT02099929|Diabetes|diabetes
1185279|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1185280|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
1185281|NCT02099903|Heart Failure|heart failure
1185282|NCT02099903|Heart Failure, Systolic|heart failure, systolic
1185283|NCT02099903|Chagas Disease|chagas disease
1185284|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
1185285|NCT02099903|Renal Denervation|renal denervation
1185286|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
1185287|NCT02099890|Chronic Inflammation|chronic inflammation
1185288|NCT02099890|Spinal Cord Injury|spinal cord injury
1185289|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
1185290|NCT02099890|Neuropathic Pain|neuropathic pain
1185291|NCT02099890|Depression|depression
1185292|NCT02099890|Cognitive Impairment|cognitive impairment
1185293|NCT02099890|Somatic Nerve Function|somatic nerve function
1185398|NCT02099526|unmet needs|unmet needs
1185294|NCT02099890|Autonomic Nerve Function|autonomic nerve function
1185295|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
1185296|NCT02099877|Opioids|opioids
1185297|NCT02099877|Opioid analgesia|opioid analgesia
1185298|NCT02099877|Labor analgesia|labor analgesia
1185299|NCT02099838|Pioglitazone|pioglitazone
1185300|NCT02099838|Metformin|metformin
1185301|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1185302|NCT02099825|adult male|adult male
1185303|NCT02099825|anxiety|anxiety
1185304|NCT02099825|public speaking|public speaking
1185305|NCT02099825|healthy controls|healthy controls
1185306|NCT02099825|exposure therapy|exposure therapy
1185307|NCT02099825|social anxiety|social anxiety
1185308|NCT02099825|mifepristone|mifepristone
1185309|NCT02099825|d-cycloserine|d-cycloserine
1185310|NCT02099799|Physical Activity|physical activity
1185311|NCT02099799|COPD Self-Management|copd self-management
1185312|NCT02099799|Internet|internet
1185313|NCT02099799|6-Minute Walk Test|6-minute walk test
1185314|NCT02099799|COPD Exacerbation|copd exacerbation
1185315|NCT02099799|Health-related Quality of Life|health-related quality of life
1185316|NCT02099786|hearing|hearing
1185317|NCT02099786|cisplatin|cisplatin
1185318|NCT02099786|Ototoxicity|ototoxicity
1185319|NCT02099786|Veterans|veterans
1185320|NCT02099773|AAC|aac
1185321|NCT02099773|support worker|support worker
1185322|NCT02099773|direct care staff|direct care staff
1185323|NCT02099773|intellectual disability|intellectual disability
1185324|NCT02099773|learning disability|learning disability
1185325|NCT02099773|communication|communication
1185326|NCT02099773|adults|adults
1185327|NCT02099760|gonorrhea|gonorrhea
1185328|NCT02099760|chlamydia|chlamydia
1185329|NCT02099760|trichomonas|trichomonas
1185330|NCT02099747|Aplastic Anaemia|aplastic anaemia
1185331|NCT02099747|Eltrombopag|eltrombopag
1185332|NCT02099747|HATG|hatg
1185333|NCT02099747|ATGAM|atgam
1185334|NCT02099734|14-016|14-016
1185335|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
1185336|NCT02099721|Syncope|syncope
1185337|NCT02099721|NSVT|nsvt
1185338|NCT02099721|PVC|pvc
1185339|NCT02099721|LVEF|lvef
1185340|NCT02099721|Primary Prevention|primary prevention
1185341|NCT02099721|Secondary Prevention|secondary prevention
1185342|NCT02099721|ATP|atp
1185343|NCT02099721|shock|shock
1185344|NCT02099721|appropriate therapy|appropriate therapy
1185345|NCT02099708|Pharmacological therapy|pharmacological therapy
1185346|NCT02099695|Hyperhidrosis|hyperhidrosis
1185347|NCT02099695|Oxybutynin|oxybutynin
1185348|NCT02099682|Pharmacological therapy|pharmacological therapy
1185349|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
1185350|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
1185351|NCT02099604|Vitamin D|vitamin d
1185352|NCT02099604|Treatment Naïve|treatment naïve
1185353|NCT02099591|Constipation|constipation
1185354|NCT02099591|Colonic Inertia|colonic inertia
1185355|NCT02099591|Dyschezia|dyschezia
1185356|NCT02099591|Pharmacokinetics|pharmacokinetics
1185357|NCT02099591|Naloxegol|naloxegol
1185358|NCT02099591|Paediatric|paediatric
1185359|NCT02099591|Opioids|opioids
1185360|NCT02099591|Opioid induced constipation|opioid induced constipation
1185361|NCT02099591|OIC|oic
1185362|NCT02099591|Phase 1|phase 1
1185363|NCT02099578|Blood pressure|blood pressure
1185364|NCT02099578|Arterial stiffness|arterial stiffness
1185365|NCT02099578|Pulse wave velocity|pulse wave velocity
1185366|NCT02099578|Strawberries|strawberries
1185367|NCT02099578|Endothelial function|endothelial function
1185368|NCT02099578|Oxidative stress|oxidative stress
1185369|NCT02099578|Postmenopausal women|postmenopausal women
1185370|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
1185371|NCT02099565|Statins|statins
1185372|NCT02099565|LDL-cholesterol|ldl-cholesterol
1185373|NCT02099565|Inflammatory markers|inflammatory markers
1185374|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1185375|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
1185376|NCT02099552|XLHED|xlhed
1185377|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
1185378|NCT02099552|HED|hed
1185379|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
1185380|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
1185381|NCT02099539|antitumor|antitumor
1185382|NCT02099539|cancer|cancer
1185383|NCT02099539|immunotherapy|immunotherapy
1185384|NCT02099539|immunochemotherapy|immunochemotherapy
1185385|NCT02099539|interleukin-15|interleukin-15
1185386|NCT02099539|multiple myeloma|multiple myeloma
1185387|NCT02099539|NK cell|nk cell
1185388|NCT02099539|refractory|refractory
1185389|NCT02099539|relapsed|relapsed
1185390|NCT02099539|T cell|t cell
1185391|NCT02099539|white blood cell count|white blood cell count
1185392|NCT02099526|cancer|cancer
1185393|NCT02099526|caregiver|caregiver
1185394|NCT02099526|caregiving|caregiving
1185395|NCT02099526|care give|care give
1185396|NCT02099526|elderly|elderly
1185397|NCT02099526|older adults|older adults
1185399|NCT02099526|post-discharge|post-discharge
1185400|NCT02099526|cancer symptoms|cancer symptoms
1185401|NCT02099513|Mobile Technology|mobile technology
1185402|NCT02099513|Chronic illness|chronic illness
1185403|NCT02099513|Wireless blood pressure device|wireless blood pressure device
1185404|NCT02099513|Wireless scale|wireless scale
1185405|NCT02099513|Pedometer|pedometer
1185406|NCT02099500|Critical Limb Ischemia|critical limb ischemia
1185407|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
1185408|NCT02099500|Lower Limb Ulcer|lower limb ulcer
1185409|NCT02099500|Gangrene|gangrene
1185410|NCT02099500|Amputation|amputation
1185411|NCT02099500|Lower Limb Wound|lower limb wound
1185412|NCT02099487|HGG|hgg
1185413|NCT02099474|HIV-1|hiv-1
1576717|NCT00476619|Nephropathy|nephropathy
1185414|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
1185415|NCT02099474|Raltegravir|raltegravir
1185416|NCT02099474|Pharmacokinetic|pharmacokinetic
1185417|NCT02099435|Gastriointestinal|gastriointestinal
1185418|NCT02099435|Lower gastriointestinal|lower gastriointestinal
1185419|NCT02099435|Digestive|digestive
1185420|NCT02099435|Hemostasis|hemostasis
1185421|NCT02099435|Recurrent bleeding|recurrent bleeding
1185422|NCT02099435|Hemospray|hemospray
1185423|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
1185424|NCT02099409|children|children
1185425|NCT02099409|closed loop|closed loop
1185426|NCT02099409|cross over|cross over
1185427|NCT02099409|overnight|overnight
1185428|NCT02099409|FLORENCED2|florenced2
1185429|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
1185430|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
1185431|NCT02099409|Dexcom G4|dexcom g4
1185432|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
1185433|NCT02099383|Stroke|stroke
1185434|NCT02099383|Dehydration|dehydration
1185435|NCT02099383|Fluid Therapy|fluid therapy
1185436|NCT02099370|Multiple Sclerosis|multiple sclerosis
1185437|NCT02099370|Tecfidera(R)|tecfidera(r)
1185438|NCT02099370|Oral medication|oral medication
1185439|NCT02099370|Adherence|adherence
1185440|NCT02099331|Atrial Fibrillation|atrial fibrillation
1185441|NCT02099331|Reactive Oxygen Species|reactive oxygen species
1185442|NCT02099331|Cardiac Surgery|cardiac surgery
1185443|NCT02099318|Rehearsal Platform|rehearsal platform
1185444|NCT02099305|Adolescent; Depression|adolescent; depression
1185445|NCT02099305|Early intervention (education)|early intervention (education)
1185446|NCT02099305|Randomized Controlled Trial|randomized controlled trial
1185447|NCT02099305|Primary Prevention|primary prevention
1185448|NCT02099305|schools|schools
1185449|NCT02099305|Health Literacy|health literacy
1185450|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
1185451|NCT02099305|Mental Health Services|mental health services
1185452|NCT02099292|lymphoma|lymphoma
1185453|NCT02099292|high dose therapy|high dose therapy
1185454|NCT02099292|DexaBEAM|dexabeam
1185455|NCT02099292|Rituximab|rituximab
1185456|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
1185457|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
1185458|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
1185459|NCT02099266|Leukemia|leukemia
1185460|NCT02099266|Lymphoma|lymphoma
1185462|NCT02099253|Age|age
1185463|NCT02099253|Pharmacodynamics|pharmacodynamics
1185464|NCT02099253|dexmedetomidine|dexmedetomidine
1185465|NCT02099240|Osteomyelitis|osteomyelitis
1185466|NCT02099240|IV Antibiotics|iv antibiotics
1185467|NCT02099240|Oral Antibiotics|oral antibiotics
1185468|NCT02099227|pediatric|pediatric
1185469|NCT02099227|soft tissue infections|soft tissue infections
1185470|NCT02099227|ultrasonography|ultrasonography
1185471|NCT02099227|effectiveness|effectiveness
1185472|NCT02099214|myocardial iron overload|myocardial iron overload
1185473|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
1185474|NCT02099214|3 Tesla MRI|3 tesla mri
1185475|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
1185476|NCT02099214|congestive heart failure|congestive heart failure
1185477|NCT02099201|ACT-389949|act-389949
1185478|NCT02099162|OCT|oct
1185479|NCT02099162|Coronary|coronary
1185480|NCT02099162|Stenting|stenting
1185481|NCT02099149|Group B Streptococcus|group b streptococcus
1185482|NCT02099149|early onset disease|early onset disease
1185483|NCT02099149|late onset disease|late onset disease
1185484|NCT02099149|anticapsular antibodies|anticapsular antibodies
1185485|NCT02099149|serotype specific|serotype specific
1185486|NCT02099123|Survival|survival
1185487|NCT02099123|Functional Disability|functional disability
1185488|NCT02099123|Cardiovascular Disease|cardiovascular disease
1185489|NCT02099123|Diabetes|diabetes
1185490|NCT02099123|Dementia|dementia
1185491|NCT02099123|Cancer|cancer
1185492|NCT02099097|3D Coping Skills Game|3d coping skills game
1185493|NCT02099097|Quit smoking|quit smoking
1185494|NCT02099097|14-062|14-062
1185495|NCT02099071|ACT-389949|act-389949
1185496|NCT02099058|Cancer|cancer
1185497|NCT02099058|Advanced Solid Tumor|advanced solid tumor
1185498|NCT02099058|Neoplasm|neoplasm
1185499|NCT02099032|nutrition|nutrition
1185511|NCT02098954|resistance|resistance
1185512|NCT02098954|erlotinib|erlotinib
1185513|NCT02098954|combined chemotherapy|combined chemotherapy
1185514|NCT02098941|topiramate|topiramate
1185515|NCT02098941|oxcarbazepine|oxcarbazepine
1185516|NCT02098941|levetiracetam|levetiracetam
1185517|NCT02098941|retention rate|retention rate
1185518|NCT02098928|Acupuncture|acupuncture
1185519|NCT02098928|Electro acupuncture|electro acupuncture
1185520|NCT02098928|Menopause|menopause
1185521|NCT02098915|gastroschisis|gastroschisis
1185522|NCT02098915|intestinal motility|intestinal motility
1185523|NCT02098915|prokinetic agents|prokinetic agents
1185524|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
1185525|NCT02098915|time to full enteral feeding|time to full enteral feeding
1185526|NCT02098902|Overweight|overweight
1185527|NCT02098902|Obesity|obesity
1185528|NCT02098902|Overnutrition|overnutrition
1185529|NCT02098902|Weight Loss|weight loss
1185530|NCT02098902|Body Weight|body weight
1185531|NCT02098902|Nutrition Disorders|nutrition disorders
1185532|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
1185533|NCT02098876|neointimal tissue area|neointimal tissue area
1185534|NCT02098876|angulated coronary vessels|angulated coronary vessels
1185535|NCT02098876|wall shear stress|wall shear stress
1185536|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
1185537|NCT02098876|everolimus eluting stent|everolimus eluting stent
1185538|NCT02098863|Sickle Cell Anemia|sickle cell anemia
1185539|NCT02098863|Sickle Cell Disease|sickle cell disease
1185540|NCT02098863|Survival|survival
1185541|NCT02098863|Mortality|mortality
1185542|NCT02098863|End-Order Dysfunction|end-order dysfunction
1185543|NCT02098850|Staphylococcus aureus|staphylococcus aureus
1185544|NCT02098850|bloodstream infection|bloodstream infection
1185545|NCT02098850|bacteremia|bacteremia
1185546|NCT02098837|HIV|hiv
1185547|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
1185548|NCT02098824|treatment|treatment
1185549|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
1185550|NCT02098824|memory impairment|memory impairment
1185551|NCT02098824|executive dysfunction|executive dysfunction
1185552|NCT02098824|neuronal networks|neuronal networks
1185553|NCT02098824|white matter tracts|white matter tracts
1185554|NCT02098824|monoaminergic systems|monoaminergic systems
1185555|NCT02098824|cholinergic systems|cholinergic systems
1185556|NCT02098824|DTI|dti
1185557|NCT02098824|rs-fMRI|rs-fmri
1185558|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
1185559|NCT02098785|VAP|vap
1185560|NCT02098785|liver|liver
1185561|NCT02098785|hepatology|hepatology
1185562|NCT02098785|caffeine|caffeine
1185563|NCT02098772|aortic valve disease|aortic valve disease
1185564|NCT02098772|coronary bypass surgery|coronary bypass surgery
1185565|NCT02098772|cardioplegic solutions|cardioplegic solutions
1185566|NCT02098759|TSC|tsc
1185567|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
1185568|NCT02098759|epilepsy|epilepsy
1185569|NCT02098746|Pharmacological therapy|pharmacological therapy
1185570|NCT02098733|Pharmacological therapy|pharmacological therapy
1185571|NCT02098707|Stabilometric Platform|stabilometric platform
1185572|NCT02098707|Rehabilitation|rehabilitation
1185573|NCT02098707|Balance Disorders|balance disorders
1185574|NCT02098707|Falls|falls
1185575|NCT02098694|Physiotherapy|physiotherapy
1185576|NCT02098694|Outpatient clinic|outpatient clinic
1185577|NCT02098681|Pectus Excavatum|pectus excavatum
1185578|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
1185579|NCT02098668|PCOS|pcos
1185580|NCT02098668|hyperprolactinemia|hyperprolactinemia
1185581|NCT02098668|endometriosis|endometriosis
1185582|NCT02098668|infertility|infertility
1185583|NCT02098655|Stabilometric Platform|stabilometric platform
1185584|NCT02098655|Postural instability|postural instability
1185585|NCT02098642|Gait Disturbances|gait disturbances
1185586|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
1185587|NCT02098629|Myocardial infarction|myocardial infarction
1185588|NCT02098629|myocardial ischemia|myocardial ischemia
1185589|NCT02098629|reperfusion injury|reperfusion injury
1185590|NCT02098616|Hepatitis|hepatitis
1185591|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
1185592|NCT02098616|Hepatitis C|hepatitis c
1185593|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
1185594|NCT02098616|Liver Diseases|liver diseases
1185595|NCT02098616|Digestive System Diseases|digestive system diseases
1185596|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
1185597|NCT02098616|RNA Virus Infections|rna virus infections
1185804|NCT02097706|Cognition|cognition
1185598|NCT02098616|Antiviral Agents|antiviral agents
1185599|NCT02098616|Drug Resistance, Viral|drug resistance, viral
1185600|NCT02098590|Malaria|malaria
1185601|NCT02098590|Plasmodium falciparum|plasmodium falciparum
1185602|NCT02098577|Balance|balance
1185603|NCT02098564|hand therapy|hand therapy
1185604|NCT02098564|activity-based training|activity-based training
1185605|NCT02098564|hand related injuries|hand related injuries
1185606|NCT02098564|sense of coherence|sense of coherence
1185707|NCT02098161|Post-PV MF|post-pv mf
1185607|NCT02098551|atopic dermatitis|atopic dermatitis
1185608|NCT02098551|bet v 1|bet v 1
1185609|NCT02098551|bet v 1 fragments|bet v 1 fragments
1185610|NCT02098551|allergy|allergy
1185611|NCT02098538|Regorafenib|regorafenib
1185612|NCT02098538|13-244|13-244
1185613|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
1185614|NCT02098525|HIV/AIDS|hiv/aids
1185615|NCT02098525|Antiretroviral therapy|antiretroviral therapy
1185616|NCT02098525|Prognosis|prognosis
1185617|NCT02098525|Thailand|thailand
1185618|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
1185619|NCT02098512|Immunotherapy|immunotherapy
1257555|NCT01772173|retina|retina
1185620|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
1185621|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
1185622|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
1185623|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1185624|NCT02098486|Bile duct obstruction|bile duct obstruction
1185625|NCT02098486|Cholangitis|cholangitis
1185626|NCT02098486|Moxifloxacin|moxifloxacin
1185627|NCT02098486|Ceftriaxone|ceftriaxone
1185628|NCT02098486|Sepsis|sepsis
1185629|NCT02098460|the Achilles tendon|the achilles tendon
1185630|NCT02098460|intima-media thickness|intima-media thickness
1185631|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
1185632|NCT02098421|Induction of Labor|induction of labor
1185633|NCT02098421|Pitocin|pitocin
1185634|NCT02098421|Oxytocin|oxytocin
1185635|NCT02098421|Foley bulb|foley bulb
1185636|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
1185637|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
1185638|NCT02098408|Cognitive remediation|cognitive remediation
1185639|NCT02098382|Cervical ripening|cervical ripening
1185640|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1185641|NCT02098369|Supplemental oxygen|supplemental oxygen
1185642|NCT02098369|Adherence|adherence
1185643|NCT02098369|Telephonic education|telephonic education
1185644|NCT02098369|Peer coaching|peer coaching
1185645|NCT02098356|hemodialysis|hemodialysis
1185646|NCT02098356|dialysis|dialysis
1185647|NCT02098356|acidosis|acidosis
1185648|NCT02098356|bicarbonate|bicarbonate
1185649|NCT02098343|Ovarian cancer|ovarian cancer
1185650|NCT02098343|Ovarian carcinoma|ovarian carcinoma
1185651|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
1185652|NCT02098343|Recurrent Cancer|recurrent cancer
1185653|NCT02098343|Resistant Cancer|resistant cancer
1185654|NCT02098330|Vestibular neuritis|vestibular neuritis
1185655|NCT02098330|Vertigo|vertigo
1185656|NCT02098330|Head impulse test|head impulse test
1185657|NCT02098330|Steroid|steroid
1185658|NCT02098317|NAFLD|nafld
1185659|NCT02098317|NASH|nash
1185660|NCT02098317|DHA|dha
1185661|NCT02098317|VITAMIN D|vitamin d
1185662|NCT02098317|OBESITY|obesity
1185663|NCT02098317|CHILDREN|children
1185664|NCT02098304|Caries|caries
1185665|NCT02098304|ICDAS|icdas
1185666|NCT02098304|Lesion activity|lesion activity
1185667|NCT02098304|Demineralisation|demineralisation
1185668|NCT02098304|Imaging|imaging
1185669|NCT02098265|aneurysm|aneurysm
1185670|NCT02098265|transient ischemic attack|transient ischemic attack
1185671|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
1185672|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
1185673|NCT02098252|AVM|avm
1185674|NCT02098252|BAVM|bavm
1185675|NCT02098252|Stroke|stroke
1185676|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
1185677|NCT02098252|Congenital Abnormalities|congenital abnormalities
1185678|NCT02098252|Aneurysm|aneurysm
1185679|NCT02098252|Vascular Malformations|vascular malformations
1185680|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
1185681|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
1185682|NCT02098252|Vascular Diseases|vascular diseases
1185683|NCT02098213|plaque psoriasis|plaque psoriasis
1185684|NCT02098213|DLQI|dlqi
1185685|NCT02098213|VQ Dermato|vq dermato
1185686|NCT02098213|PASI|pasi
1185687|NCT02098213|PASI change|pasi change
1185688|NCT02098213|phototherapy|phototherapy
1185689|NCT02098213|balneotherapy|balneotherapy
1185690|NCT02098213|hydrotherapy|hydrotherapy
1185691|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
1185692|NCT02098213|Visual analogic scale|visual analogic scale
1185693|NCT02098213|SPA treatment Scale|spa treatment scale
1185694|NCT02098213|PSS|pss
1185695|NCT02098200|tricuspid|tricuspid
1185696|NCT02098200|regurgitation|regurgitation
1185697|NCT02098200|repair|repair
1185698|NCT02098200|outcomes|outcomes
1185805|NCT02097693|DBS|dbs
1185699|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
1185700|NCT02098187|Acute Kidney Injury|acute kidney injury
1185701|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
1185702|NCT02098174|Acute kidney injury|acute kidney injury
1185703|NCT02098161|Leukemia|leukemia
1185704|NCT02098161|Primary Myelofibrosis|primary myelofibrosis
1185705|NCT02098161|PMF|pmf
1185706|NCT02098161|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1185708|NCT02098161|Post-Essential Thrombocytosis Myelofibrosis|post-essential thrombocytosis myelofibrosis
1185709|NCT02098161|Post-ET MF|post-et mf
1185710|NCT02098161|LCL-161|lcl-161
1185711|NCT02098161|Questionnaire|questionnaire
1185712|NCT02098161|Survey|survey
1185713|NCT02098161|Phone Call|phone call
1185714|NCT02098096|knee|knee
1185715|NCT02098096|arthritis|arthritis
1185716|NCT02098096|Veterans|veterans
1185717|NCT02098096|strength|strength
1257684|NCT01771653|HCV|hcv
1185718|NCT02098096|exercise|exercise
1185719|NCT02098096|muscle|muscle
1185720|NCT02098083|acute|acute
1185721|NCT02098083|stroke|stroke
1185722|NCT02098083|gait|gait
1185723|NCT02098070|Knee Pain|knee pain
1185724|NCT02098070|Community Study|community study
1185725|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
1185726|NCT02098070|Risk Factors|risk factors
1185727|NCT02098057|IBS-diarrhea|ibs-diarrhea
1185728|NCT02098044|knee osteoarthritis|knee osteoarthritis
1185729|NCT02098044|epidemiology|epidemiology
1185730|NCT02098044|risk factors|risk factors
1185731|NCT02098044|prevalence|prevalence
1185732|NCT02098044|professional football|professional football
1185733|NCT02098031|Child Nutrition Sciences|child nutrition sciences
1185734|NCT02098031|Growth and Development|growth and development
1185735|NCT02098031|Developing Countries|developing countries
1185736|NCT02097992|COPD|copd
1185737|NCT02097992|airway blood flow|airway blood flow
1185738|NCT02097979|glaucoma|glaucoma
1185739|NCT02097979|adherence|adherence
1185740|NCT02097979|medication possession ratio|medication possession ratio
1185741|NCT02097979|intervention|intervention
1185742|NCT02097953|Daptomycin|daptomycin
1185743|NCT02097953|Rifampin|rifampin
1185744|NCT02097953|P-glycoprotein|p-glycoprotein
1185745|NCT02097953|Pharmacokinetic|pharmacokinetic
1185746|NCT02097940|Postural balance|postural balance
1185747|NCT02097940|Athletes|athletes
1185748|NCT02097940|Sports|sports
1185749|NCT02097940|Soccer|soccer
1185750|NCT02097940|Physiotherapy|physiotherapy
1185751|NCT02097927|Appetite|appetite
1185752|NCT02097927|Satiety|satiety
1185753|NCT02097927|Energy intake|energy intake
1185754|NCT02097927|Saliva|saliva
1185755|NCT02097927|Biomarkers|biomarkers
1185756|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
1185757|NCT02097914|Secondhand smoke|secondhand smoke
1185758|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
1185759|NCT02097914|Smoke-free homes|smoke-free homes
1185760|NCT02097914|Smoke-free homes ban|smoke-free homes ban
1185761|NCT02097901|Rotator Cuff|rotator cuff
1185762|NCT02097901|Injury|injury
1185763|NCT02097901|Repair|repair
1185764|NCT02097901|Microfracture|microfracture
1185765|NCT02097901|Healing|healing
1185766|NCT02097875|Skin cancer|skin cancer
1185767|NCT02097875|Basal cell carcinoma|basal cell carcinoma
1185768|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
1185769|NCT02097875|Melanoma|melanoma
1185770|NCT02097862|Degenerative Disc Disease|degenerative disc disease
1185771|NCT02097862|Disc Disease|disc disease
1185772|NCT02097862|Back pain|back pain
1185773|NCT02097862|stem cells|stem cells
1185774|NCT02097862|adipose stem cells|adipose stem cells
1185775|NCT02097862|ADSCs|adscs
1185776|NCT02097849|vaccine|vaccine
1185777|NCT02097849|pneumococcal|pneumococcal
1185778|NCT02097849|meningococcal|meningococcal
1185779|NCT02097849|tetanus diphtheria|tetanus diphtheria
1185780|NCT02097849|immune response|immune response
1185781|NCT02097836|postural control|postural control
1185782|NCT02097836|Targeted Training|targeted training
1185783|NCT02097836|cerebral palsy|cerebral palsy
1185784|NCT02097836|trunk segments|trunk segments
1185785|NCT02097823|olanzapine|olanzapine
1185786|NCT02097823|Nausea and vomiting|nausea and vomiting
1185787|NCT02097823|aprepitant|aprepitant
1185788|NCT02097823|pediatrics|pediatrics
1185789|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
1185790|NCT02097797|Crohn's disease|crohn's disease
1185791|NCT02097797|microbiota|microbiota
1185792|NCT02097797|fecal transplantation|fecal transplantation
1185793|NCT02097784|cirrhosis|cirrhosis
1185794|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
1185795|NCT02097784|acute kidney injury|acute kidney injury
1185796|NCT02097784|diastolic function|diastolic function
1185797|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
1185798|NCT02097732|Metastatic melanoma|metastatic melanoma
1185799|NCT02097732|Brain metastases|brain metastases
1185800|NCT02097732|Radiation therapy|radiation therapy
1185801|NCT02097732|Immune therapy|immune therapy
1185802|NCT02097706|Boderline Personality Disorder|boderline personality disorder
1185803|NCT02097706|Mental Illness|mental illness
1185806|NCT02097693|quality of life|quality of life
1185807|NCT02097693|dystonia|dystonia
1185808|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
1185809|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
1185810|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
1185811|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
1185812|NCT02097654|Hospital acquired|hospital acquired
1185813|NCT02097654|Elderly|elderly
1185814|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
1185815|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1185816|NCT02097628|volume controlled ventilation|volume controlled ventilation
1185817|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
1185818|NCT02097615|soft|soft
1185819|NCT02097615|tissue|tissue
1185820|NCT02097615|infections|infections
1185821|NCT02097602|Reticulated platelets|reticulated platelets
1185822|NCT02097602|noncardiac surgery|noncardiac surgery
1185823|NCT02097602|MACCEs|macces
1185824|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
1185825|NCT02097602|outcome|outcome
1185826|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
1185827|NCT02097589|Health Controls|health controls
1185828|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
1185829|NCT02097563|Mood Disorders|mood disorders
1185830|NCT02097563|Psychosis|psychosis
1185831|NCT02097563|Subthreshold|subthreshold
1185832|NCT02097563|Bipolar Disorder|bipolar disorder
1185833|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
1185834|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
1185835|NCT02097550|Self Care|self care
1185836|NCT02097550|Consumer Participation|consumer participation
1185837|NCT02097550|Patient Participation|patient participation
1185838|NCT02097550|Marketing|marketing
1185839|NCT02097550|Consumer Health Information|consumer health information
1185840|NCT02097511|Drug-drug interaction|drug-drug interaction
1185841|NCT02097511|Pharmacokinetics|pharmacokinetics
1185842|NCT02097511|Pharmacodynamics|pharmacodynamics
1185843|NCT02097498|Simulation|simulation
1185844|NCT02097498|Enhance|enhance
1185845|NCT02097498|Safety|safety
1185846|NCT02097498|Proficiency|proficiency
1185847|NCT02097498|Paramedics.|paramedics.
1185848|NCT02097498|Airway Management|airway management
1185849|NCT02097498|Intubation|intubation
1185850|NCT02097459|Breast cancer|breast cancer
1185851|NCT02097459|Endocrine therapy|endocrine therapy
1185852|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
1185853|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
1185854|NCT02097446|cystectomy|cystectomy
1185855|NCT02097433|Dacomitinib|dacomitinib
1185856|NCT02097433|PF299804|pf299804
1185857|NCT02097433|pharmacokinetics|pharmacokinetics
1185858|NCT02097433|healthy|healthy
1185859|NCT02097433|Chinese|chinese
1185860|NCT02097420|Mitral valve|mitral valve
1185861|NCT02097381|HIV infection|hiv infection
1185863|NCT02097381|microbial translocation|microbial translocation
1185864|NCT02097381|chronic inflammation|chronic inflammation
1185865|NCT02097381|antiretroviral therapy|antiretroviral therapy
1185866|NCT02097381|cART|cart
1185867|NCT02097381|HAART|haart
1185868|NCT02097381|Th17|th17
1185869|NCT02097381|Th1|th1
1185870|NCT02097381|CD4+|cd4+
1185871|NCT02097368|Tongue strength|tongue strength
1185872|NCT02097368|neuromuscular|neuromuscular
1185873|NCT02097368|swallowing|swallowing
1185874|NCT02097355|chronic disease|chronic disease
1185875|NCT02097355|patient portal|patient portal
1185876|NCT02097355|health information technology|health information technology
1185877|NCT02097355|patient provider communication|patient provider communication
1185878|NCT02097355|quality improvement|quality improvement
1185879|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1185880|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
1185881|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
1185882|NCT02097342|Linagliptin|linagliptin
1185883|NCT02097342|Voglibose|voglibose
1185884|NCT02097342|Mixed meal test|mixed meal test
1185885|NCT02097342|GLP-1 response|glp-1 response
1185886|NCT02097329|bioavailability|bioavailability
1185887|NCT02097329|antacid|antacid
1185888|NCT02097329|rabeprazole|rabeprazole
1185889|NCT02097329|famotidine|famotidine
1185890|NCT02097329|palbociclib|palbociclib
1185891|NCT02097316|Glycemic control|glycemic control
1185892|NCT02097316|JewelPump accuracy|jewelpump accuracy
1185893|NCT02097303|Prostate Cancer|prostate cancer
1185894|NCT02097303|Bone Metastasis|bone metastasis
1185895|NCT02097303|Symptomatic|symptomatic
1185896|NCT02097303|Androgen Independent|androgen independent
1185897|NCT02097303|Hormone Refractory|hormone refractory
1185898|NCT02097303|Castrate Resistant|castrate resistant
1185899|NCT02097303|AIPC|aipc
1185900|NCT02097303|pre-chemotherapy|pre-chemotherapy
1185901|NCT02097303|Post-chemotherapy|post-chemotherapy
1185902|NCT02097290|Threshold algorithms|threshold algorithms
1185903|NCT02097290|CRT-D|crt-d
1185904|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
1185905|NCT02097251|Sly syndrome|sly syndrome
1185906|NCT02097251|UX003|ux003
1185907|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
1185908|NCT02097251|rare disease|rare disease
1185909|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
1185910|NCT02097251|metabolic disorder|metabolic disorder
1185911|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
1185912|NCT02097212|TBM|tbm
1185913|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
1185914|NCT02097212|HDAC|hdac
1185915|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
1185916|NCT02097212|OSA|osa
1333137|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
1185917|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
1185918|NCT02097186|Vascular disease|vascular disease
1185919|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
1185920|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
1185921|NCT02097186|Carotid endartrectomy|carotid endartrectomy
1185922|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
1185923|NCT02097186|Major lower limb amputation|major lower limb amputation
1185924|NCT02097160|childhood|childhood
1185925|NCT02097160|healthy|healthy
1185926|NCT02097160|vitamin D|vitamin d
1185927|NCT02097160|bone|bone
1185928|NCT02097160|dairy products|dairy products
1185929|NCT02097147|Viibryd|viibryd
1185930|NCT02097108|HIV infection|hiv infection
1185931|NCT02097108|Raltegravir|raltegravir
1185932|NCT02097108|Switch|switch
1185933|NCT02097108|Hyperlipidemia|hyperlipidemia
1185934|NCT02097108|Women|women
1185935|NCT02097095|Correlates of risk|correlates of risk
1185936|NCT02097095|TB|tb
1185937|NCT02097095|Tuberculosis|tuberculosis
1185938|NCT02097095|Sub-study|sub-study
1185939|NCT02097095|TB-018|tb-018
1185940|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
1185941|NCT02097082|Intermittent Claudication|intermittent claudication
1185942|NCT02097082|Vascular Diseases|vascular diseases
1185943|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
1185944|NCT02097082|Superficial Femoral Artery|superficial femoral artery
1185945|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
1185946|NCT02097069|Myo-inositol|myo-inositol
1185947|NCT02097069|D-chiro-inositol|d-chiro-inositol
1185948|NCT02097069|Insulin resistance|insulin resistance
1185949|NCT02097056|Alzheimer's disease|alzheimer's disease
1185950|NCT02097017|lidocaine|lidocaine
1185951|NCT02097017|laminaria|laminaria
1185952|NCT02097017|dilatation and evacuation|dilatation and evacuation
1185953|NCT02097017|pain|pain
1185954|NCT02097004|chronic hepatitis B|chronic hepatitis b
1185955|NCT02097004|Pegasys|pegasys
1185956|NCT02097004|Euvax B|euvax b
1185957|NCT02097004|Baracrude|baracrude
1185958|NCT02096978|Implant|implant
1185959|NCT02096978|Stability|stability
1185960|NCT02096978|placement|placement
1185961|NCT02096978|Osteotome|osteotome
1185962|NCT02096965|Calcium oxalate|calcium oxalate
1185963|NCT02096965|Calcium phosphate|calcium phosphate
1185964|NCT02096965|Kidney stone|kidney stone
1185965|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1185966|NCT02096952|ADHD|adhd
1185967|NCT02096952|Autism spectrum disorder|autism spectrum disorder
1185968|NCT02096952|ASD|asd
1185969|NCT02096952|High-functioning ASD|high-functioning asd
1185970|NCT02096952|Asperger's disorder|asperger's disorder
1185971|NCT02096952|Asperger's|asperger's
1185972|NCT02096926|Third Molar Extraction|third molar extraction
1185973|NCT02096913|Rho-Inhibition|rho-inhibition
1185974|NCT02096913|Plasticity|plasticity
1185975|NCT02096913|Neurological Function|neurological function
1185976|NCT02096913|RhoA|rhoa
1185977|NCT02096913|Ibuprofen|ibuprofen
1185978|NCT02096913|NSAIDs|nsaids
1185979|NCT02096900|Pre-medication|pre-medication
1185980|NCT02096900|Pre-operative anxiety|pre-operative anxiety
1185981|NCT02096887|education|education
1185982|NCT02096887|compliance|compliance
1185983|NCT02096887|risk factors|risk factors
1185984|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
1185985|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
1185986|NCT02096874|Bevacizumab|bevacizumab
1185987|NCT02096848|otitis media|otitis media
1185988|NCT02096848|microbiology|microbiology
1185989|NCT02096848|vaccines|vaccines
1185990|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
1185991|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1185992|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
1185993|NCT02096835|Tropisetron|tropisetron
1185994|NCT02096835|Dexamethasone|dexamethasone
1185995|NCT02096822|Facilitated tucking|facilitated tucking
1185996|NCT02096822|Non nutritive sucking|non nutritive sucking
1185997|NCT02096822|Preterm|preterm
1185998|NCT02096822|Pain relief|pain relief
1185999|NCT02096809|Bone Conduction|bone conduction
1186000|NCT02096809|Hearing loss - conductive|hearing loss - conductive
1186001|NCT02096809|Osseointegration|osseointegration
1186002|NCT02096809|Prostheses and Implants|prostheses and implants
1186003|NCT02096757|Claudication|claudication
1186004|NCT02096757|Critical Limb Ischemia|critical limb ischemia
1186005|NCT02096757|Endovascular procedure|endovascular procedure
1186006|NCT02096757|Atherosclerosis|atherosclerosis
1186007|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
1186008|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
1186009|NCT02096653|sacroiliac joint|sacroiliac joint
1186010|NCT02096653|low back pain|low back pain
1186011|NCT02096653|steroid injection|steroid injection
1576820|NCT00476333|EMG|emg
1186012|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
1186013|NCT02096614|Adoptive cell transfer|adoptive cell transfer
1186014|NCT02096614|Cell therapy|cell therapy
1186015|NCT02096614|Immunotherapy|immunotherapy
1186016|NCT02096614|MAGE-A4|mage-a4
1186017|NCT02096614|Esophageal cancer|esophageal cancer
1186018|NCT02096614|Melanoma|melanoma
1186019|NCT02096614|Head and neck cancer|head and neck cancer
1186020|NCT02096614|Ovarian cancer|ovarian cancer
1186021|NCT02096614|TCR gene therapy|tcr gene therapy
1186022|NCT02096601|Motor fluctuations|motor fluctuations
1186023|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
1186024|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
1186025|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
1186026|NCT02096588|Breast cancer|breast cancer
1186027|NCT02096588|Adriamycin|adriamycin
1186028|NCT02096588|Simvastatin|simvastatin
1186029|NCT02096588|Statin|statin
1186030|NCT02096588|Echocardiogram|echocardiogram
1186031|NCT02096575|nitrous oxide|nitrous oxide
1186032|NCT02096575|pain|pain
1186033|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
1186034|NCT02096549|cerebral palsy|cerebral palsy
1186035|NCT02096549|Botulinum toxin|botulinum toxin
1186036|NCT02096549|Propofol|propofol
1186037|NCT02096549|Deep sedation|deep sedation
1186038|NCT02096549|Bispectral index monitor|bispectral index monitor
1186039|NCT02096536|Neonate|neonate
1186040|NCT02096536|Vancomycin|vancomycin
1186041|NCT02096536|LC/MS-MS|lc/ms-ms
1186042|NCT02096536|protein binding|protein binding
1186043|NCT02096523|inherited platelet disorders|inherited platelet disorders
1186044|NCT02096523|proteome|proteome
1186045|NCT02096510|Addison Disease|addison disease
1186046|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
1186047|NCT02096484|Metacognitive therapy|metacognitive therapy
1186048|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
1186049|NCT02096484|group therapy|group therapy
1186050|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
1186051|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
1186052|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
1186053|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
1186054|NCT02096471|PD-0325901|pd-0325901
1186055|NCT02096471|Radiographic Response|radiographic response
1186056|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
1186057|NCT02096458|Drug therapy|drug therapy
1186058|NCT02096445|stroke|stroke
1186059|NCT02096445|acute|acute
1186060|NCT02096445|rehabilitation|rehabilitation
1186061|NCT02096445|robot therapy|robot therapy
1186062|NCT02096445|hand function|hand function
1186063|NCT02096445|fine motor skills|fine motor skills
1186064|NCT02096445|neurocognitive|neurocognitive
1186065|NCT02096445|sensory|sensory
1186066|NCT02096445|Perfetti|perfetti
1186067|NCT02096445|haptics|haptics
1186068|NCT02096419|clopidogrel|clopidogrel
1186069|NCT02096419|platelet reactivity|platelet reactivity
1186070|NCT02096419|acute coronary syndrome|acute coronary syndrome
1186071|NCT02096419|tailoring therapy|tailoring therapy
1186072|NCT02096419|outcome|outcome
1186073|NCT02096406|Coronary artery disease|coronary artery disease
1186074|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
1186075|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1186076|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
1186077|NCT02096406|Surgical valve repair|surgical valve repair
1186078|NCT02096406|Valve Replacement|valve replacement
1186079|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1186080|NCT02096380|cycle|cycle
1186081|NCT02096380|induction chemotherapy|induction chemotherapy
1186082|NCT02096380|docetaxel|docetaxel
1186083|NCT02096367|vibrations|vibrations
1186084|NCT02096367|stroke|stroke
1186085|NCT02096367|posture|posture
1186086|NCT02096367|gait|gait
1186087|NCT02096367|readaptation|readaptation
1186088|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
1186089|NCT02096328|Lower respiratory infection|lower respiratory infection
1186090|NCT02096328|POL7080|pol7080
1186091|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
1186092|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
1186093|NCT02096315|POL7080|pol7080
1186094|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
1186095|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
1186096|NCT02096315|Exacerbation|exacerbation
1186097|NCT02096302|Probiotics|probiotics
1186098|NCT02096302|Infant Formula|infant formula
1186099|NCT02096302|Microbiota|microbiota
1186100|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
1186101|NCT02096302|Growth|growth
1186102|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
1186103|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
1186104|NCT02096289|Thioridazine|thioridazine
1186105|NCT02096289|Phase I|phase i
1186106|NCT02096289|Clinical Trial|clinical trial
1186107|NCT02096276|Pregnancy Registry|pregnancy registry
1186108|NCT02096276|Boostrix|boostrix
1186109|NCT02096276|Women|women
1186110|NCT02096276|Cohort|cohort
1186111|NCT02096276|Prospective|prospective
1186112|NCT02096276|Pregnancy outcome|pregnancy outcome
1186113|NCT02096276|Exploratory|exploratory
1186114|NCT02096263|Infants|infants
1186115|NCT02096263|Safety|safety
1186116|NCT02096263|Healthy|healthy
1186117|NCT02096263|Infanrix Hexa|infanrix hexa
1186118|NCT02096263|Immunogenicity|immunogenicity
1186119|NCT02096237|asthma, bronchial|asthma, bronchial
1186120|NCT02096237|immunoadsorbents|immunoadsorbents
1186121|NCT02096237|apheresis|apheresis
1186122|NCT02096237|immunoglobulin E|immunoglobulin e
1186123|NCT02096211|Total hip replacement|total hip replacement
1186124|NCT02096211|Total hip arthroplasty|total hip arthroplasty
1186125|NCT02096211|Hip joint replacement|hip joint replacement
1186126|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
1186127|NCT02096198|Total Hip Replacement|total hip replacement
1186128|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
1186129|NCT02096198|Hip Joint Replacement|hip joint replacement
1186130|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
1186131|NCT02096185|Breast cancer|breast cancer
1186132|NCT02096185|Surgery|surgery
1186133|NCT02096185|Specimen imaging|specimen imaging
1186134|NCT02096159|Hypospadias|hypospadias
1186135|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
1186136|NCT02096146|Plate|plate
1186137|NCT02096146|Hallux valgus|hallux valgus
1186138|NCT02096146|Foot deformity|foot deformity
1186139|NCT02096146|Screw|screw
1186140|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
1186141|NCT02096146|Cost effectiveness|cost effectiveness
1186142|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
1186143|NCT02096120|Periodontitis|periodontitis
1186144|NCT02096107|Everolimus|everolimus
1186145|NCT02096107|Graft dysfunction|graft dysfunction
1186146|NCT02096107|Interstitial fibrosis|interstitial fibrosis
1186147|NCT02096094|Antiseptics|antiseptics
1186148|NCT02096094|Administration cutaneously|administration cutaneously
1186149|NCT02096094|Chlorine compounds|chlorine compounds
1186150|NCT02096094|Infection control|infection control
1186151|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
1186152|NCT02096081|Glabellar Frown Lines|glabellar frown lines
1186153|NCT02096081|Frown Lines|frown lines
1186154|NCT02096081|Facial Wrinkles|facial wrinkles
1186155|NCT02096068|Neuroprotection|neuroprotection
1186156|NCT02096055|Leukemia|leukemia
1186157|NCT02096055|Acute Myeloid Leukemia|acute myeloid leukemia
1186158|NCT02096055|AML|aml
1186159|NCT02096055|Elderly|elderly
1186160|NCT02096055|SGI-110|sgi-110
1186161|NCT02096055|Idarubicin|idarubicin
1186162|NCT02096055|Idamycin|idamycin
1186163|NCT02096055|Leustatin|leustatin
1186164|NCT02096055|2-CdA|2-cda
1186165|NCT02096042|Leukemia|leukemia
1186166|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
1186167|NCT02096042|AML|aml
1186168|NCT02096042|CD30-Positive|cd30-positive
1186169|NCT02096042|Relapsed|relapsed
1186170|NCT02096042|Refractory|refractory
1186171|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
1186172|NCT02096042|SGN-35|sgn-35
1186173|NCT02096042|Adcetris|adcetris
1186174|NCT02096042|5-Azacytidine|5-azacytidine
1186175|NCT02096042|Azacytidine|azacytidine
1186176|NCT02096042|Azacitidine|azacitidine
1186177|NCT02096042|5-aza|5-aza
1186178|NCT02096042|Vidaza|vidaza
1186179|NCT02096042|5-AZC|5-azc
1186180|NCT02096042|AZA-CR|aza-cr
1186181|NCT02096042|Ladakamycin|ladakamycin
1186182|NCT02096042|NSC-102816|nsc-102816
1186183|NCT02096029|smoking|smoking
1186184|NCT02096029|smoking cessation|smoking cessation
1186185|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
1186186|NCT02096029|primary care|primary care
1186187|NCT02096029|comparative effectiveness|comparative effectiveness
1186188|NCT02096016|Surveillance|surveillance
1186189|NCT02096016|Follow up|follow up
1186190|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
1186191|NCT02096003|Intrathecal morphine|intrathecal morphine
1186192|NCT02096003|Primary cesarean section|primary cesarean section
1186193|NCT02096003|Analgesia|analgesia
1186194|NCT02095990|Facial Melasma|facial melasma
1186195|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
1186196|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
1186197|NCT02095977|externalized conductors|externalized conductors
1186198|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
1186199|NCT02095977|electrophysiology|electrophysiology
1186200|NCT02095964|cardiac syndrome X|cardiac syndrome x
1186201|NCT02095964|inflammation|inflammation
1186202|NCT02095964|dyslipidemia|dyslipidemia
1186203|NCT02095938|schizophrenia|schizophrenia
1186204|NCT02095938|brain structure|brain structure
1186205|NCT02095938|treatment response|treatment response
1186206|NCT02095938|solian|solian
1186207|NCT02095938|gene|gene
1186208|NCT02095938|mri|mri
1186209|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
1186210|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
1186211|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
1186212|NCT02095873|Flow mediated dilatation|flow mediated dilatation
1186213|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
1186214|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
1186215|NCT02095847|Uterine Cancer|uterine cancer
1186216|NCT02095847|Endometrial cancer|endometrial cancer
1186217|NCT02095847|Hysterectomy|hysterectomy
1186218|NCT02095847|Hysteroscopy|hysteroscopy
1186219|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
1186220|NCT02095847|HRME|hrme
1186221|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
1186222|NCT02095847|Proflavine|proflavine
1186223|NCT02095834|Myeloma|myeloma
1186224|NCT02095834|Multiple Myeloma|multiple myeloma
1186225|NCT02095834|Relapsed|relapsed
1186226|NCT02095834|Refractory|refractory
1186227|NCT02095834|Carfilzomib|carfilzomib
1186228|NCT02095834|Bendamustine|bendamustine
1186229|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride
1186230|NCT02095834|Bendamustine HCL|bendamustine hcl
1186231|NCT02095834|CEP-18083|cep-18083
1186232|NCT02095834|SDX-105|sdx-105
1186233|NCT02095834|Treanda|treanda
1186234|NCT02095834|Dexamethasone|dexamethasone
1186235|NCT02095834|Decadron|decadron
1186236|NCT02095795|Exercise Therapy|exercise therapy
1186237|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
1186238|NCT02095782|erlotinib|erlotinib
1186239|NCT02095782|chemotherapy|chemotherapy
1186240|NCT02095769|Pharmacogenomics|pharmacogenomics
1186241|NCT02095769|Adverse Drug Reactions|adverse drug reactions
1186242|NCT02095743|Early breast cancer|early breast cancer
1186243|NCT02095743|Chemotherapy|chemotherapy
1186244|NCT02095743|PICC line|picc line
1186245|NCT02095743|Implanted port|implanted port
1186246|NCT02095730|crosslinking|crosslinking
1186247|NCT02095730|cornea|cornea
1186248|NCT02095730|keratoconus|keratoconus
1186249|NCT02095730|ectasia|ectasia
1186250|NCT02095730|irradiance|irradiance
1186251|NCT02095730|riboflavin|riboflavin
1186252|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
1186253|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
1186254|NCT02095678|Hepatoma|hepatoma
1186255|NCT02095678|Liver Cancer, Adult|liver cancer, adult
1186256|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
1186257|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
1186259|NCT02095665|ureteric stents|ureteric stents
1186260|NCT02095665|LUTS|luts
1186261|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
1186262|NCT02095587|Phase 1|phase 1
1186263|NCT02095587|hepatic impairment|hepatic impairment
1186264|NCT02095574|GDC-0199|gdc-0199
1186265|NCT02095574|ADME|adme
1186266|NCT02095574|Relapsed|relapsed
1186267|NCT02095574|Refractory|refractory
1186268|NCT02095574|ABT-199|abt-199
1186269|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1186270|NCT02095561|HPV self testing|hpv self testing
1186271|NCT02095561|screening uptake|screening uptake
1186272|NCT02095561|cervical cáncer|cervical cáncer
1186273|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1186274|NCT02095535|obstetric patients|obstetric patients
1186275|NCT02095535|chloraprep|chloraprep
1186276|NCT02095535|chlorhexidine|chlorhexidine
1186277|NCT02095535|drying time|drying time
1186278|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
1186279|NCT02095496|sleep|sleep
1186280|NCT02095496|intensive care|intensive care
1186281|NCT02095496|mechanical ventilation|mechanical ventilation
1186282|NCT02095470|Laryngoscopy|laryngoscopy
1186283|NCT02095470|Equipment|equipment
1186284|NCT02095470|Video Laryngoscope|video laryngoscope
1186285|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
1186286|NCT02095457|Psychotherapy|psychotherapy
1186287|NCT02095457|Alliance|alliance
1186288|NCT02095457|Feedback Informed Treatment|feedback informed treatment
1186289|NCT02095457|Mental Health Outpatients|mental health outpatients
1186290|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
1186291|NCT02095431|acute kidney injury|acute kidney injury
1186292|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
1186293|NCT02095418|Liver transplantation|liver transplantation
1186294|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
1186295|NCT02095405|Atrial Fibrillation|atrial fibrillation
1186296|NCT02095405|Electrophysiology Study|electrophysiology study
1186297|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
1186298|NCT02095392|soluble phosphate|soluble phosphate
1186299|NCT02095392|phosphorus metabolism|phosphorus metabolism
1186300|NCT02095392|calcium metabolism|calcium metabolism
1186301|NCT02095392|bone metabolism|bone metabolism
1186302|NCT02095392|human study|human study
1186303|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
1186304|NCT02095366|Acute Pain|acute pain
1186305|NCT02095366|Traumatic Pain|traumatic pain
1186306|NCT02095366|Emergency setting|emergency setting
1186307|NCT02095366|Prehospital setting|prehospital setting
1186308|NCT02095366|Analgesia|analgesia
1186309|NCT02095366|Intranasal device|intranasal device
1186310|NCT02095366|Intra veinous injection|intra veinous injection
1186311|NCT02095366|Sufentanil citrate|sufentanil citrate
1186312|NCT02095366|Morphine Sulfate|morphine sulfate
1186313|NCT02095353|Brain tumor|brain tumor
1186314|NCT02095353|extraaxial|extraaxial
1186315|NCT02095353|metastasis|metastasis
1186316|NCT02095353|glioma|glioma
1186317|NCT02095353|primary brain tumor|primary brain tumor
1186318|NCT02095353|secondary brain tumor|secondary brain tumor
1186320|NCT02095353|perfusion|perfusion
1186321|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
1186322|NCT02095353|CBV|cbv
1186323|NCT02095353|CBF|cbf
1186324|NCT02095353|ktrans|ktrans
1186325|NCT02095314|DTP-HB-Hib|dtp-hb-hib
1186326|NCT02095314|Pentavalen|pentavalen
1186327|NCT02095314|Pentabio|pentabio
1186328|NCT02095314|Booster|booster
1186329|NCT02095288|lipidomics|lipidomics
1186330|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
1186331|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
1186332|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
1186333|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
1186334|NCT02095249|prostate cancer|prostate cancer
1186335|NCT02095249|radical prostatectomy|radical prostatectomy
1186336|NCT02095223|Knee injury|knee injury
1186337|NCT02095223|Meniscus injury|meniscus injury
1186338|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
1186339|NCT02095223|Knee ligament injury|knee ligament injury
1186340|NCT02095210|PET scan|pet scan
1186341|NCT02095210|HER2|her2
1186342|NCT02095210|breast cancer|breast cancer
1186343|NCT02095184|Breast Cancer|breast cancer
1186344|NCT02095184|Postmenopausal|postmenopausal
1186345|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
1186346|NCT02095119|Uterine cervical cancer|uterine cervical cancer
1186347|NCT02095119|Palliative|palliative
1186348|NCT02095119|Treatment|treatment
1186349|NCT02095119|Monoclonal antibody|monoclonal antibody
1186350|NCT02095119|Nimotuzumab|nimotuzumab
1186351|NCT02095106|forearm fractures|forearm fractures
1186352|NCT02095106|pediatric fractures|pediatric fractures
1186353|NCT02095106|distal radius|distal radius
1186354|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
1186355|NCT02095093|Navigation|navigation
1186356|NCT02095093|Imageless|imageless
1186357|NCT02095093|THA|tha
1186358|NCT02095093|Computer navigated|computer navigated
1186359|NCT02095080|Leucine|leucine
1186360|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
1186361|NCT02095080|Elderly|elderly
1186362|NCT02095080|Amino acids|amino acids
1186363|NCT02095080|Protein|protein
1186364|NCT02095067|Telemedicine|telemedicine
1186365|NCT02095067|Emergency medical dispatch|emergency medical dispatch
1186366|NCT02095067|Prehospital care|prehospital care
1186367|NCT02095067|Video conference|video conference
1186368|NCT02095054|Advanced Cancers|advanced cancers
1186369|NCT02095054|Advanced malignancy|advanced malignancy
1186370|NCT02095054|Metastatic cancer|metastatic cancer
1186371|NCT02095054|Advanced solid tumor|advanced solid tumor
1186372|NCT02095054|Regorafenib|regorafenib
1186373|NCT02095054|Stivarga|stivarga
1186374|NCT02095054|Cetuximab|cetuximab
1186375|NCT02095054|C225|c225
1186376|NCT02095054|Erbitux|erbitux
1186377|NCT02095054|IMC-C225|imc-c225
1186378|NCT02095054|MOAB C225|moab c225
1186379|NCT02095054|Questionnaire|questionnaire
1186380|NCT02095054|Survey|survey
1186381|NCT02095041|Oxygen saturation.|oxygen saturation.
1186382|NCT02095041|Term infants.|term infants.
1186383|NCT02095041|Saturation trend.|saturation trend.
1186384|NCT02095041|Histogram.|histogram.
1186385|NCT02095041|Public health nurse.|public health nurse.
1186386|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
1186387|NCT02095015|MPS|mps
1186388|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
1186389|NCT02095015|MPS I|mps i
1186390|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
1186391|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
1186392|NCT02095015|MPS II|mps ii
1186393|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1186394|NCT02095015|Hunter syndrome|hunter syndrome
1186395|NCT02095015|MPS VI|mps vi
1186396|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
1186397|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
1186398|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
1186399|NCT02095015|ENT|ent
1186400|NCT02095015|ear, nose and throat|ear, nose and throat
1186498|NCT02094547|Microbiota|microbiota
1186401|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
1186402|NCT02094989|electrocardiogram|electrocardiogram
1186403|NCT02094989|vectorcardiogram|vectorcardiogram
1186404|NCT02094989|telecardiology|telecardiology
1186405|NCT02094989|linear regression|linear regression
1333138|NCT01444404|Solid Tumors|solid tumors
1186406|NCT02094989|individual transformation matrix|individual transformation matrix
1186407|NCT02094989|posture|posture
1186408|NCT02094976|Prone position|prone position
1186409|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
1186410|NCT02094976|Respiratory system compliance|respiratory system compliance
1186411|NCT02094976|Jackson table|jackson table
1186412|NCT02094976|Wilson frame|wilson frame
1186413|NCT02094976|Chest roll|chest roll
1186414|NCT02094963|acute coronary syndrome|acute coronary syndrome
1186415|NCT02094963|coronary disease|coronary disease
1186416|NCT02094963|coronary artery disease|coronary artery disease
1186417|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
1186418|NCT02094950|concurrent radiation|concurrent radiation
1186419|NCT02094937|fluticasone propionate|fluticasone propionate
1186420|NCT02094937|step-down regimen|step-down regimen
1186421|NCT02094937|well-controlled subjects|well-controlled subjects
1186422|NCT02094937|adults|adults
1186423|NCT02094937|switching regimen|switching regimen
1186424|NCT02094937|asthma|asthma
1186425|NCT02094937|fluticasone furoate|fluticasone furoate
1186426|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
1186427|NCT02094924|Candesartan cilexetil|candesartan cilexetil
1186428|NCT02094924|Hypertension|hypertension
1186429|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
1186430|NCT02094924|Healthy adult human subjects|healthy adult human subjects
1186431|NCT02094924|Bioequivalence|bioequivalence
1186432|NCT02094911|Prevention|prevention
1186433|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
1186434|NCT02094911|Primary health care|primary health care
1186435|NCT02094898|Depression|depression
1186436|NCT02094898|Unipolar|unipolar
1186437|NCT02094898|Bipolar|bipolar
1186438|NCT02094898|Suicidal|suicidal
1186439|NCT02094859|Glucose Monitoring|glucose monitoring
1186440|NCT02094846|Cellular phones|cellular phones
1186441|NCT02094846|Type 2 diabetes|type 2 diabetes
1186442|NCT02094846|Glycated hemoglobin|glycated hemoglobin
1186443|NCT02094846|glycemic control|glycemic control
1186444|NCT02094833|Diphtheria|diphtheria
1186445|NCT02094833|Tetanus|tetanus
1186446|NCT02094833|Pertussis|pertussis
1186447|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
1186448|NCT02094833|Hepatitis B|hepatitis b
1186449|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
1186450|NCT02094807|prospective study|prospective study
1186451|NCT02094807|surgical management|surgical management
1186452|NCT02094807|rib fractures|rib fractures
1186453|NCT02094807|trauma|trauma
1186454|NCT02094755|critical limb ischemia, High on-treatment platelet reactivity, HPR, aspirin, clopidogrel|critical limb ischemia, high on-treatment platelet reactivity, hpr, aspirin, clopidogrel
1186455|NCT02094742|screening program|screening program
1186456|NCT02094742|metastatic breast cancer|metastatic breast cancer
1186457|NCT02094742|molecular profile|molecular profile
1186458|NCT02094742|gene sequencing|gene sequencing
1186459|NCT02094729|mild cognitive impairment|mild cognitive impairment
1186460|NCT02094729|Alzheimer's disease|alzheimer's disease
1186461|NCT02094716|Sarcoptes|sarcoptes
1186462|NCT02094716|Scabiei|scabiei
1186463|NCT02094716|Scabies|scabies
1186464|NCT02094716|ectoparasite|ectoparasite
1186465|NCT02094716|parasite|parasite
1186466|NCT02094716|infestation|infestation
1186467|NCT02094716|Renaissance|renaissance
1186468|NCT02094703|female|female
1186469|NCT02094703|age 18-65 years|age 18-65 years
1186470|NCT02094703|storage symptoms|storage symptoms
1186471|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
1186472|NCT02094703|non complicated|non complicated
1186473|NCT02094690|head and neck neoplasms|head and neck neoplasms
1186474|NCT02094690|radiotherapy|radiotherapy
1186475|NCT02094690|physical therapy|physical therapy
1186476|NCT02094690|trismus|trismus
1186477|NCT02094664|Heat|heat
1186478|NCT02094664|Humidification|humidification
1186479|NCT02094664|Oxygen|oxygen
1186480|NCT02094651|Abnormal EEGs|abnormal eegs
1186481|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
1186482|NCT02094625|Cisplatin|cisplatin
1186483|NCT02094625|N-acetylcysteine|n-acetylcysteine
1186484|NCT02094625|Hearing Loss|hearing loss
1186485|NCT02094625|Otoprotection|otoprotection
1186486|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
1186487|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1186488|NCT02094612|Pediatrics|pediatrics
1186489|NCT02094612|Patient Outcome Assessment|patient outcome assessment
1186490|NCT02094573|Drug Therapy|drug therapy
1186491|NCT02094560|therapy refractory|therapy refractory
1186492|NCT02094560|endstage|endstage
1186493|NCT02094560|solid tumours|solid tumours
1186494|NCT02094547|Infant Formula|infant formula
1186495|NCT02094547|Cognition|cognition
1186496|NCT02094547|Neurodevelopment|neurodevelopment
1186497|NCT02094547|Immunity|immunity
1186499|NCT02094534|Diabetes type 1|diabetes type 1
1186500|NCT02094534|Oral Insulin|oral insulin
1186501|NCT02094534|Safety|safety
1186502|NCT02094534|Tolerability|tolerability
1186503|NCT02094534|Phase 2a|phase 2a
1186504|NCT02094534|Randomized|randomized
1186505|NCT02094534|Blinded|blinded
1186506|NCT02094534|Parallel|parallel
1186507|NCT02094508|Parasitemia|parasitemia
1186508|NCT02094508|HIV-Exposed|hiv-exposed
1186509|NCT02094508|HIV-Unexposed|hiv-unexposed
1186510|NCT02094508|Liver Stage|liver stage
1186511|NCT02094508|Randomized|randomized
1186512|NCT02094495|Tamoxifen|tamoxifen
1186513|NCT02094495|Breast cancer|breast cancer
1186514|NCT02094495|Knowkedge|knowkedge
1186515|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
1186516|NCT02094456|diverticular disease|diverticular disease
1186517|NCT02094456|diverticular bleeding|diverticular bleeding
1186518|NCT02094456|endoscopic clipping|endoscopic clipping
1186519|NCT02094456|endoscopy|endoscopy
1186520|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
1186521|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
1186522|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
1186523|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
1186524|NCT02094443|Interferon intolerant|interferon intolerant
1186525|NCT02094417|Anemia, Aplastic|anemia, aplastic
1186526|NCT02094417|Thrombopoietin|thrombopoietin
1186527|NCT02094417|Thrombocytopenia|thrombocytopenia
1186528|NCT02094404|Emergency Department|emergency department
1186529|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
1186530|NCT02094404|Manchester Triage System|manchester triage system
1186531|NCT02094378|Healthy|healthy
1186532|NCT02094378|Esketamine|esketamine
1186533|NCT02094378|Cognitive functioning|cognitive functioning
1186534|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
1186535|NCT02094352|Pain management|pain management
1186536|NCT02094352|Ketamine infusion|ketamine infusion
1186537|NCT02094339|Local analgesia system|local analgesia system
1186538|NCT02094339|Ropivacaine|ropivacaine
1186539|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
1186540|NCT02094339|Postoperative|postoperative
1186541|NCT02094313|Atorvastatin|atorvastatin
1186542|NCT02094313|Human Spermatozoa|human spermatozoa
1186543|NCT02094313|Seminal fluid|seminal fluid
1186544|NCT02094313|Accessory Glands|accessory glands
1186545|NCT02094313|Cholesterol|cholesterol
1186546|NCT02094313|Gonadotropins,|gonadotropins,
1186547|NCT02094313|Testosterone|testosterone
1186548|NCT02094300|Aorta|aorta
1186549|NCT02094300|Thoracic|thoracic
1186550|NCT02094300|Aortic dissection|aortic dissection
1186551|NCT02094300|Rupture|rupture
1186552|NCT02094300|Type B|type b
1186553|NCT02094300|DeBakey type III|debakey type iii
1186554|NCT02094300|Endovascular|endovascular
1186555|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
1186556|NCT02094235|Dermatitis|dermatitis
1186557|NCT02094235|Atopic|atopic
1186558|NCT02094235|Pediatric|pediatric
1186559|NCT02094235|Adolescent|adolescent
1186560|NCT02094235|Child|child
1186561|NCT02094209|External Fixation|external fixation
1186562|NCT02094209|Tibial fracture|tibial fracture
1186563|NCT02094209|Fracture healing|fracture healing
1186564|NCT02094196|Reward- based learning|reward- based learning
1186565|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
1186566|NCT02094196|Relapse Risk|relapse risk
1186567|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
1186568|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1186569|NCT02094196|Dopamine receptor availability|dopamine receptor availability
1186570|NCT02094196|Glutamate|glutamate
1186571|NCT02094157|Atrial fibrillation|atrial fibrillation
1186572|NCT02094157|Mechanical heart valve|mechanical heart valve
1186573|NCT02094157|Stroke|stroke
1186574|NCT02094157|Venous thromboembolism|venous thromboembolism
1186575|NCT02094157|Hemorrhage|hemorrhage
1186576|NCT02094144|Sedentary|sedentary
1186577|NCT02094144|Physical activity|physical activity
1186578|NCT02094144|Brisk walking|brisk walking
1186579|NCT02094144|Postmenopausal women|postmenopausal women
1186580|NCT02094144|Body composition|body composition
1186581|NCT02094144|Balance|balance
1186582|NCT02094144|Muscle strength|muscle strength
1186583|NCT02094144|Depression, bone density|depression, bone density
1186584|NCT02094144|Nutrition|nutrition
1186585|NCT02094144|Biological effects|biological effects
1186586|NCT02094131|incentive spirometry|incentive spirometry
1186587|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
1186588|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
1186589|NCT02094131|physical therapy|physical therapy
1186590|NCT02094131|respiratory muscle training|respiratory muscle training
1186591|NCT02094118|Transfusion|transfusion
1186592|NCT02094118|RBC|rbc
1186593|NCT02094118|cardiac|cardiac
1186594|NCT02094118|surgery|surgery
1186697|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
1186595|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
1333139|NCT01444404|Phase 1|phase 1
1576821|NCT00476333|Kinetics|kinetics
1186596|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
1186597|NCT02094105|esophageal cancer|esophageal cancer
1186598|NCT02094105|screening|screening
1186599|NCT02094105|endoscopy|endoscopy
1186600|NCT02094105|prevention|prevention
1186601|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
1186602|NCT02094092|Infantile colic|infantile colic
1186603|NCT02094092|Maternal mental health.|maternal mental health.
1186604|NCT02094092|Infant crying/fussing|infant crying/fussing
1186605|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
1186606|NCT02094079|hypothyroidism|hypothyroidism
1186607|NCT02094079|pregnancy|pregnancy
1186608|NCT02094066|tranexamic acid|tranexamic acid
1186609|NCT02094066|total hip arthroplasty|total hip arthroplasty
1186610|NCT02094053|Down syndrome|down syndrome
1186611|NCT02094053|regression symptoms|regression symptoms
1186612|NCT02094053|disabled activities of daily living|disabled activities of daily living
1186613|NCT02094040|frailty|frailty
1186614|NCT02094040|readmission|readmission
1186615|NCT02094040|transition|transition
1186616|NCT02094040|discharge|discharge
1186617|NCT02094040|primary care|primary care
1186618|NCT02094027|Obesity|obesity
1186619|NCT02094027|Bariatric surgery|bariatric surgery
1186620|NCT02094027|Binge eating|binge eating
1186621|NCT02094027|Self help|self help
1186622|NCT02094014|Perceptual masking|perceptual masking
1186623|NCT02094014|Auditory stimulation|auditory stimulation
1186624|NCT02094014|Speech|speech
1186625|NCT02094014|Language|language
1186626|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
1186627|NCT02093962|TH-302|th-302
1186628|NCT02093962|TH-CR-415|th-cr-415
1186629|NCT02093962|Pemetrexed|pemetrexed
1186630|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
1186631|NCT02093962|Lung cancer|lung cancer
1186632|NCT02093962|Evofosfamide|evofosfamide
1186633|NCT02093936|airway inflammation|airway inflammation
1186634|NCT02093936|induced sputum|induced sputum
1186635|NCT02093936|normal values|normal values
1186636|NCT02093936|lymphocyte|lymphocyte
1186637|NCT02093936|eosinophil|eosinophil
1186638|NCT02093936|neutrophil|neutrophil
1186640|NCT02093910|multiple myeloma|multiple myeloma
1186641|NCT02093910|peripheral neuropathy|peripheral neuropathy
1186642|NCT02093910|prophylaxis|prophylaxis
1186643|NCT02093884|Pregnancy|pregnancy
1186644|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
1186645|NCT02093884|Reproductive behavior|reproductive behavior
1186646|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
1186647|NCT02093884|Text messaging|text messaging
1186648|NCT02093871|Ovarian cancer|ovarian cancer
1186649|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
1186650|NCT02093871|HEATT|heatt
1186651|NCT02093871|whole body hyperthermia|whole body hyperthermia
1186652|NCT02093871|hyperthermia|hyperthermia
1186653|NCT02093871|PISH|pish
1186654|NCT02093871|Verthermia|verthermia
1186655|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
1186656|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
1186657|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
1186658|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
1186659|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
1186660|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
1186661|NCT02093871|Core HFC|core hfc
1186662|NCT02093871|Lilja|lilja
1186663|NCT02093871|Vertrees|vertrees
1186664|NCT02093871|Bastidas|bastidas
1186665|NCT02093871|total body hyperthermia|total body hyperthermia
1186666|NCT02093858|Metabolic Syndrome|metabolic syndrome
1186667|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
1186668|NCT02093845|DES|des
1186669|NCT02093845|Angina pectoris|angina pectoris
1186670|NCT02093845|Stent|stent
1186671|NCT02093832|femoral head size|femoral head size
1186672|NCT02093832|cup size|cup size
1186673|NCT02093832|Total hip arthroplasty|total hip arthroplasty
1186674|NCT02093767|prebiotics|prebiotics
1186675|NCT02093767|Synergy1|synergy1
1186676|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
1186677|NCT02093715|Bronchiolitis|bronchiolitis
1186678|NCT02093715|FeNO|feno
1186679|NCT02093715|Asthma|asthma
1186680|NCT02093715|wheezing, RSV|wheezing, rsv
1186681|NCT02093676|diabetes|diabetes
1186682|NCT02093676|type 1|type 1
1186683|NCT02093676|adolescents|adolescents
1186684|NCT02093676|parents counselling|parents counselling
1186685|NCT02093663|Mild|mild
1186686|NCT02093663|Moderate|moderate
1186687|NCT02093650|Menopausal symptoms|menopausal symptoms
1186688|NCT02093650|menopause related quality of life|menopause related quality of life
1186689|NCT02093650|black cohosh|black cohosh
1186690|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
1186691|NCT02093650|MENQOL|menqol
1186692|NCT02093650|Kupperman index|kupperman index
1186693|NCT02093650|KI|ki
1186694|NCT02093650|liver function tests|liver function tests
1186695|NCT02093598|pharmacokinetic|pharmacokinetic
1186696|NCT02093598|pharmacodynamic|pharmacodynamic
1186698|NCT02093598|mTOR protein|mtor protein
1186699|NCT02093598|temsirolimus|temsirolimus
1186700|NCT02093598|torisel|torisel
1186701|NCT02093598|biological marker|biological marker
1186702|NCT02093598|phase II|phase ii
1186703|NCT02093585|HIV-1|hiv-1
1186704|NCT02093585|Abacavir|abacavir
1186705|NCT02093585|Platelet activation|platelet activation
1186706|NCT02093585|Thromboelastography|thromboelastography
1186707|NCT02093585|Coagulation|coagulation
1186708|NCT02093572|Clock genes|clock genes
1186709|NCT02093572|Metabolism|metabolism
1186710|NCT02093572|Insulin sensitivity|insulin sensitivity
1186711|NCT02093559|Clinical Trial|clinical trial
1186712|NCT02093559|Naloxone|naloxone
1186713|NCT02093559|Motivational Interviewing|motivational interviewing
1186714|NCT02093546|Endometrial cancer|endometrial cancer
1186715|NCT02093546|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
1186716|NCT02093546|Serous adenocarcinoma|serous adenocarcinoma
1186717|NCT02093546|Undifferentiated carcinoma|undifferentiated carcinoma
1186718|NCT02093546|Mixed epithelial carcinoma|mixed epithelial carcinoma
1186719|NCT02093546|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
1186720|NCT02093546|NOS|nos
1186721|NCT02093546|Companion Protocol to GOG229O|companion protocol to gog229o
1186722|NCT02093546|Biomarkers|biomarkers
1186723|NCT02093546|Circulating tumor cells|circulating tumor cells
1186724|NCT02093546|CTCs|ctcs
1186725|NCT02093546|Blood draw|blood draw
1186726|NCT02093546|Biopsy|biopsy
1186727|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
1186728|NCT02093533|Nephrotic syndrome|nephrotic syndrome
1186729|NCT02093533|Proteinuria|proteinuria
1186730|NCT02093533|Alternative complement pathway|alternative complement pathway
1186731|NCT02093533|Complement inhibition|complement inhibition
1186732|NCT02093533|Eculizumab|eculizumab
1186733|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
1186734|NCT02093520|Spinal Stenosis|spinal stenosis
1186735|NCT02093520|Neurogenic Claudication|neurogenic claudication
1186736|NCT02093507|newborn|newborn
1186737|NCT02093507|foot deformity congenital|foot deformity congenital
1186738|NCT02093494|Septicemia|septicemia
1186739|NCT02093494|Blood culture|blood culture
1186740|NCT02093494|Contamination|contamination
1186741|NCT02093468|Acute limb ischemia|acute limb ischemia
1186742|NCT02093468|ALI|ali
1186743|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
1186744|NCT02093455|Endothelial function|endothelial function
1186745|NCT02093416|Obesity|obesity
1186746|NCT02093416|Leptin|leptin
1186747|NCT02093403|AML|aml
1186748|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
1186749|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1186750|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1186751|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1186752|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1186753|NCT02093377|acute myocardial infarction|acute myocardial infarction
1186754|NCT02093377|sleep apnea|sleep apnea
1186755|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
1186756|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
1186757|NCT02093338|breast pain|breast pain
1186758|NCT02093338|probiotic|probiotic
1186759|NCT02093338|mastitis|mastitis
1186760|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
1186761|NCT02093338|Staphylococcus|staphylococcus
1186762|NCT02093325|eltrombopag , thrombocytopenia, solid tumor|eltrombopag , thrombocytopenia, solid tumor
1186763|NCT02093312|Cancer|cancer
1186764|NCT02093312|Food-delivery|food-delivery
1186765|NCT02093312|Nutritional Intervention|nutritional intervention
1186766|NCT02093312|Quality of life|quality of life
1186767|NCT02093312|Outpatients|outpatients
1186768|NCT02093286|Pentabio Vaccine|pentabio vaccine
1186769|NCT02093286|Safety|safety
1186770|NCT02093286|Infants|infants
1186771|NCT02093286|Booster Dose|booster dose
1186772|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
1186773|NCT02093273|tOPV|topv
1186774|NCT02093273|Antibody response|antibody response
1186775|NCT02093273|Safety|safety
1186776|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
1186777|NCT02093260|Infants|infants
1186778|NCT02093260|Children|children
1186779|NCT02093260|Safety|safety
1186780|NCT02093260|Immunogenicity|immunogenicity
1186781|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
1186782|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
1186783|NCT02093234|community health workers impact on health|community health workers impact on health
1186784|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1186785|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
1186786|NCT02093221|Beta Cell|beta cell
1186787|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
1186788|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
1186789|NCT02093156|bowel preparation|bowel preparation
1186790|NCT02093156|Ottawa Score|ottawa score
1186888|NCT02092844|Insomnia|insomnia
1186791|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
1186792|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
1186793|NCT02093143|Remifentanil|remifentanil
1186794|NCT02093143|Propofol|propofol
1186795|NCT02093143|Target controlled infusion|target controlled infusion
1186796|NCT02093143|Direct laryngoscopy|direct laryngoscopy
1186797|NCT02093143|Tracheoscopy|tracheoscopy
1186798|NCT02093143|Oesophagoscopy|oesophagoscopy
1186799|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
1186800|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
1186801|NCT02093130|Double-blind Trial|double-blind trial
1186802|NCT02093130|Placebo-controlled|placebo-controlled
1186803|NCT02093130|Pomegranate|pomegranate
1186804|NCT02093130|Memory|memory
1186805|NCT02093130|Memory Impairment|memory impairment
1186806|NCT02093130|Cognition|cognition
1186807|NCT02093130|Ages 50-75|ages 50-75
1186808|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
1186809|NCT02093117|Recruitment maneuver|recruitment maneuver
1186810|NCT02093117|Subdural pressure|subdural pressure
1186811|NCT02093117|Brain relaxation|brain relaxation
1186812|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
1186813|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1186814|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
1186815|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
1186816|NCT02093091|clinical performance|clinical performance
1186817|NCT02093091|class I|class i
1186818|NCT02093091|primary teeth|primary teeth
1186819|NCT02093091|dentin bond strength|dentin bond strength
1186820|NCT02093091|Filling of class I|filling of class i
1186821|NCT02093065|severe hemophilia A|severe hemophilia a
1186822|NCT02093065|coated platelets|coated platelets
1186823|NCT02093065|bleeding|bleeding
1186824|NCT02093052|Parenting|parenting
1186825|NCT02093052|Parent child relations|parent child relations
1186826|NCT02093052|Middle childhood outcomes|middle childhood outcomes
1186827|NCT02093039|breast cancer screening|breast cancer screening
1186828|NCT02093039|patient decision aids|patient decision aids
1186829|NCT02093039|informed decision|informed decision
1186830|NCT02093039|empowerment|empowerment
1186831|NCT02093039|randomized control trial|randomized control trial
1186832|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
1186833|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
1186834|NCT02093013|asthma|asthma
1186835|NCT02093013|intervention|intervention
1186836|NCT02093013|medication adherence|medication adherence
1186837|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
1186838|NCT02093013|asthma control|asthma control
1186839|NCT02093013|integrated care|integrated care
1186840|NCT02092987|Hispanic|hispanic
1186841|NCT02092987|Dementia|dementia
1186842|NCT02092987|Caregivers|caregivers
1186843|NCT02092987|Depressive symptoms|depressive symptoms
1186844|NCT02092987|Burden|burden
1186845|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
1186846|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1186847|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
1186848|NCT02092974|young|young
1186849|NCT02092974|older adults|older adults
1186850|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
1186851|NCT02092961|OSKIRA|oskira
1186852|NCT02092961|fostamatinib|fostamatinib
1186853|NCT02092961|CE-MRI|ce-mri
1186854|NCT02092961|DCE-MRI|dce-mri
1186855|NCT02092948|metastatic|metastatic
1186856|NCT02092948|PSCA|psca
1186857|NCT02092948|minibody|minibody
1186858|NCT02092948|PET/CT|pet/ct
1186859|NCT02092935|CDAD|cdad
1186860|NCT02092935|Clostridium Difficile|clostridium difficile
1186861|NCT02092896|Diabetes Mellitus|diabetes mellitus
1186862|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1186863|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
1186864|NCT02092896|Metabolic Diseases|metabolic diseases
1186865|NCT02092896|Cognitive performance|cognitive performance
1186866|NCT02092896|Hypoglycemia|hypoglycemia
1186867|NCT02092896|Insulin|insulin
1186868|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
1186869|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
1186870|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
1186871|NCT02092896|Pharmacologic Actions|pharmacologic actions
1186872|NCT02092896|Incretins|incretins
1186873|NCT02092896|Hormones|hormones
1186874|NCT02092883|Infantile Spasms|infantile spasms
1186875|NCT02092883|Neuroinflammation|neuroinflammation
1186876|NCT02092883|PK11195|pk11195
1186877|NCT02092883|PET|pet
1186878|NCT02092883|ACTH|acth
1186879|NCT02092870|Chronic Wounds|chronic wounds
1186880|NCT02092870|Diabetes|diabetes
1186881|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
1186882|NCT02092870|Diabetic Foot|diabetic foot
1186883|NCT02092857|nutrient|nutrient
1186884|NCT02092857|nutrition|nutrition
1186885|NCT02092857|arachidonic acid|arachidonic acid
1576822|NCT00476333|Kinematics|kinematics
1186886|NCT02092857|essential fatty acids|essential fatty acids
1186887|NCT02092844|Menopause|menopause
1186889|NCT02092844|Hot Flashes|hot flashes
1186890|NCT02092805|VAS|vas
1186891|NCT02092805|VDS|vds
1186892|NCT02092805|HAM-D|ham-d
1186893|NCT02092805|Visceral pain|visceral pain
1186894|NCT02092805|Malignancy|malignancy
1186895|NCT02092805|rTMS|rtms
1186896|NCT02092805|Motor cortex|motor cortex
1186897|NCT02092805|Analgesia|analgesia
1186898|NCT02092805|Dynorphin|dynorphin
1186899|NCT02092766|malaria|malaria
1186900|NCT02092766|anaemia|anaemia
1186901|NCT02092766|artesunate|artesunate
1186902|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
1186903|NCT02092740|Testicular cancer|testicular cancer
1186904|NCT02092727|Dialysis facilities|dialysis facilities
1186905|NCT02092727|African Americans|african americans
1186906|NCT02092727|Racial disparity|racial disparity
1186907|NCT02092727|Kidney Transplantation|kidney transplantation
1186908|NCT02092727|Community-based Participatory Research|community-based participatory research
1186909|NCT02092727|Coalition|coalition
1186910|NCT02092727|Georgia|georgia
1186911|NCT02092688|time to delivery|time to delivery
1186912|NCT02092688|PROM|prom
1186913|NCT02092688|PTL|ptl
1186914|NCT02092688|positive predictive value|positive predictive value
1187039|NCT02092038|neoadjuvant|neoadjuvant
1186915|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1186916|NCT02092675|frequent exacerbator|frequent exacerbator
1186917|NCT02092675|endothelial dysfunction|endothelial dysfunction
1186918|NCT02092675|Flow mediated dilatation|flow mediated dilatation
1186919|NCT02092675|Systemic inflammation|systemic inflammation
1186920|NCT02092649|Omega-3|omega-3
1186921|NCT02092649|Resting metabolic rate|resting metabolic rate
1186922|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
1186923|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
1186924|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
1186925|NCT02092636|NIR/US imaging|nir/us imaging
1186926|NCT02092636|US imaging|us imaging
1186927|NCT02092636|US imaging technique|us imaging technique
1186928|NCT02092623|Female|female
1186929|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
1186930|NCT02092623|Subjective outcome|subjective outcome
1186931|NCT02092584|atherosclerotic|atherosclerotic
1186932|NCT02092584|IGF-1|igf-1
1186933|NCT02092584|IGFBP-3|igfbp-3
1186934|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
1186935|NCT02092545|Obesity|obesity
1186936|NCT02092519|EUSFNA|eusfna
1186937|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
1186938|NCT02092519|pancreatic masses|pancreatic masses
1186939|NCT02092506|H pylori|h pylori
1186940|NCT02092506|therapy|therapy
1186941|NCT02092493|ScopeGuide|scopeguide
1186942|NCT02092493|Colonoscopy|colonoscopy
1186943|NCT02092493|Mental workload|mental workload
1186944|NCT02092480|Feasibility Trial|feasibility trial
1186945|NCT02092480|Educational Intervention|educational intervention
1186946|NCT02092480|Teenage Pregnancy|teenage pregnancy
1186947|NCT02092480|Boys|boys
1186948|NCT02092480|Gender sensitive interventions|gender sensitive interventions
1186949|NCT02092480|Unintended pregnancy|unintended pregnancy
1186950|NCT02092480|Parents|parents
1186951|NCT02092480|Process evaluation|process evaluation
1186952|NCT02092480|Economic costing|economic costing
1186953|NCT02092467|Post-marketing|post-marketing
1186954|NCT02092467|Phase 4|phase 4
1186955|NCT02092467|Open-label|open-label
1186956|NCT02092467|Safety Surveillance|safety surveillance
1186957|NCT02092467|CP690550|cp690550
1186958|NCT02092467|Xeljanz|xeljanz
1186959|NCT02092467|oral treatment|oral treatment
1186960|NCT02092441|Nausea|nausea
1186961|NCT02092441|Vomiting|vomiting
1186962|NCT02092441|Antiemetic|antiemetic
1186963|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
1186965|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
1186966|NCT02092428|MRA|mra
1186967|NCT02092428|3 Tesla MRI|3 tesla mri
1186968|NCT02092415|Tourniquet|tourniquet
1186969|NCT02092415|Muscle perfusion|muscle perfusion
1186970|NCT02092415|Contrast ultrasound|contrast ultrasound
1186971|NCT02092402|Fecal transplantation|fecal transplantation
1186972|NCT02092402|microbiota transplantation|microbiota transplantation
1186973|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
1186974|NCT02092402|IBS|ibs
1186975|NCT02092389|Ulcerative Colitis|ulcerative colitis
1186976|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
1186977|NCT02092389|Adalimumab|adalimumab
1186978|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
1186979|NCT02092389|Calprotectin|calprotectin
1186980|NCT02092376|Bariatric surgery|bariatric surgery
1186981|NCT02092376|vitamin D|vitamin d
1186982|NCT02092376|supplementation|supplementation
1186983|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
1186984|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
1186985|NCT02092311|varicocele|varicocele
1186986|NCT02092311|varicocelectomy|varicocelectomy
1186987|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
1187373|NCT02090374|Asthma|asthma
1186988|NCT02092311|Recurrence of varicocele|recurrence of varicocele
1186989|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
1186990|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
1186991|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
1186992|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
1186993|NCT02092298|HIPEC|hipec
1186994|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
1186995|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
1186996|NCT02092298|Mitomycin C|mitomycin c
1186997|NCT02092298|Mitomycin|mitomycin
1186998|NCT02092298|Cisplatin|cisplatin
1186999|NCT02092298|Platinol-AQ|platinol-aq
1187000|NCT02092298|Platinol|platinol
1187001|NCT02092298|CDDP|cddp
1187002|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
1187003|NCT02092298|Tinver|tinver
1187004|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
1187005|NCT02092220|Bionic Pancreas|bionic pancreas
1187006|NCT02092220|Insulin|insulin
1187007|NCT02092220|Glucagon|glucagon
1187008|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
1187009|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
1187010|NCT02092194|Hemodiafiltration|hemodiafiltration
1187011|NCT02092194|convective volume|convective volume
1187012|NCT02092168|Opicapone|opicapone
1187013|NCT02092168|BIAL|bial
1187014|NCT02092142|Q fever|q fever
1187015|NCT02092142|Coxiella burnetii|coxiella burnetii
1187016|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
1187017|NCT02092103|Premature Birth|premature birth
1187018|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
1187019|NCT02092090|salt substitute|salt substitute
1187020|NCT02092090|sodium reduction|sodium reduction
1187021|NCT02092090|stroke|stroke
1187022|NCT02092090|cluster randomized trial|cluster randomized trial
1187023|NCT02092090|China|china
1187024|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
1187025|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
1187026|NCT02092064|basal proteinuria|basal proteinuria
1187027|NCT02092064|FMF|fmf
1187028|NCT02092064|pregnancy|pregnancy
1187029|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
1187030|NCT02092051|Type 1 diabetes|type 1 diabetes
1187031|NCT02092051|Insulin injections|insulin injections
1187032|NCT02092051|Cross-over|cross-over
1187033|NCT02092038|glioblastoma|glioblastoma
1187034|NCT02092038|temozolomide|temozolomide
1187035|NCT02092038|radiation therapy|radiation therapy
1187036|NCT02092038|radiotherapy|radiotherapy
1187037|NCT02092038|surgery|surgery
1187038|NCT02092038|pre-operative|pre-operative
1187040|NCT02092025|Pharmacological therapy|pharmacological therapy
1187041|NCT02092012|postoperative pain|postoperative pain
1187042|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
1187043|NCT02092012|dexmedetomidine|dexmedetomidine
1187044|NCT02091999|enfortumab vedotin|enfortumab vedotin
1187045|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
1187046|NCT02091999|Safety|safety
1187047|NCT02091999|AGS-22C3E|ags-22c3e
1187048|NCT02091999|EV-101|ev-101
1187049|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
1187050|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
1187051|NCT02091999|ASG-22CE|asg-22ce
1187052|NCT02091999|ASG-22ME|asg-22me
1187053|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
1187054|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
1187055|NCT02091973|everolimus|everolimus
1187056|NCT02091973|tacrolimus|tacrolimus
1187057|NCT02091973|kidney transplantation|kidney transplantation
1187058|NCT02091973|microRNA|microrna
1187059|NCT02091960|Enzalutamide|enzalutamide
1187060|NCT02091960|Trastuzumab|trastuzumab
1187061|NCT02091960|Breast cancer|breast cancer
1187062|NCT02091960|HER2|her2
1187063|NCT02091960|Androgen receptor positive|androgen receptor positive
1187064|NCT02091960|Xtandi|xtandi
1187065|NCT02091947|FMS|fms
1187066|NCT02091947|Urine incontinence|urine incontinence
1187067|NCT02091934|Alcon|alcon
1187068|NCT02091934|Wavelight|wavelight
1187069|NCT02091934|PRK|prk
1187070|NCT02091934|Wavefront-guided|wavefront-guided
1187071|NCT02091934|Wavefront-optimized|wavefront-optimized
1187072|NCT02091934|Myopia|myopia
1187073|NCT02091934|Astigmatism|astigmatism
1187074|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
1187075|NCT02091908|Influenza|influenza
1187076|NCT02091908|H5N1|h5n1
1187077|NCT02091908|aH5N1|ah5n1
1187078|NCT02091908|H5N1 vaccine|h5n1 vaccine
1187079|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
1187080|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
1187081|NCT02091908|Underlying medical conditions|underlying medical conditions
1187082|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
1187083|NCT02091908|Pandemic vaccine|pandemic vaccine
1576931|NCT00475917|Solid tumor|solid tumor
1187084|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
1187085|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
1187086|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
1187089|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
1187090|NCT02091882|Ingestible Event Marker|ingestible event marker
1187095|NCT02091817|face|face
1187096|NCT02091817|memory|memory
1187097|NCT02091804|Attachment theory|attachment theory
1187484|NCT02090049|Appetite|appetite
1187098|NCT02091804|Parent- child relationship|parent- child relationship
1187099|NCT02091804|Child mental health|child mental health
1187100|NCT02091804|Behavioral health|behavioral health
1187101|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
1187102|NCT02091765|Sexual dysfunction|sexual dysfunction
1187103|NCT02091765|Intimacy problems|intimacy problems
1187104|NCT02091765|Breast cancer survivors|breast cancer survivors
1187105|NCT02091765|Internet-based|internet-based
1187106|NCT02091765|Cognitive behavioral therapy|cognitive behavioral therapy
1187107|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
1187108|NCT02091752|Hematologic Diseases|hematologic diseases
1187109|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
1187110|NCT02091752|INC424|inc424
1187111|NCT02091752|Ruxolitinib|ruxolitinib
1187112|NCT02091726|Circumcision|circumcision
1187113|NCT02091726|HIV prevention|hiv prevention
1187114|NCT02091726|Surgical device|surgical device
1187115|NCT02091726|Cyanoacrylate|cyanoacrylate
1187116|NCT02091726|Tissue Adhesive|tissue adhesive
1187117|NCT02091726|voluntary|voluntary
1187118|NCT02091713|FMS|fms
1187119|NCT02091713|functional movement screen|functional movement screen
1187120|NCT02091700|Normal|normal
1187121|NCT02091700|Healthy|healthy
1187122|NCT02091700|Normal healthy patient|normal healthy patient
1187123|NCT02091674|ankle sprain|ankle sprain
1187124|NCT02091674|hyaluronic acid|hyaluronic acid
1187125|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
1187126|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
1187127|NCT02091661|External beam radiotherapy|external beam radiotherapy
1187128|NCT02091661|Efficacy|efficacy
1187129|NCT02091661|Quality of life|quality of life
1187130|NCT02091661|adverse events|adverse events
1187131|NCT02091648|Asthma|asthma
1187132|NCT02091648|Stress|stress
1187133|NCT02091648|Children|children
1187134|NCT02091648|Psychosocial Factors|psychosocial factors
1187135|NCT02091648|Relaxation|relaxation
1187136|NCT02091648|Stress management|stress management
1187137|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
1187138|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
1187139|NCT02091596|Wound|wound
1187140|NCT02091596|Ulcer|ulcer
1187141|NCT02091596|Infected|infected
1187142|NCT02091596|Infection|infection
1187143|NCT02091583|Metabolic syndrome|metabolic syndrome
1187144|NCT02091583|Cardiovascular disease|cardiovascular disease
1187145|NCT02091583|High Oleic Canola Oil|high oleic canola oil
1187146|NCT02091583|DHA|dha
1187147|NCT02091583|β-glucan|β-glucan
1187148|NCT02091583|Barley|barley
1187149|NCT02091583|Cholesterol|cholesterol
1187150|NCT02091583|Lipoproteins|lipoproteins
1187151|NCT02091583|Lipids|lipids
1187152|NCT02091583|Inflammation|inflammation
1187153|NCT02091583|Glucose|glucose
1187154|NCT02091583|Insulin|insulin
1187155|NCT02091583|Satiety|satiety
1187156|NCT02091583|Body composition|body composition
1187157|NCT02091583|Blood pressure|blood pressure
1187158|NCT02091570|Hunger|hunger
1187159|NCT02091570|Fullness|fullness
1187160|NCT02091570|Satiety|satiety
1187161|NCT02091570|Nutrition bar|nutrition bar
1187162|NCT02091570|Crossover|crossover
1187163|NCT02091557|GnRH-a|gnrh-a
1187164|NCT02091557|endometriosis|endometriosis
1187165|NCT02091557|chronic pelvic pain|chronic pelvic pain
1187166|NCT02091557|VAS score|vas score
1187167|NCT02091557|diagnostic accuracy|diagnostic accuracy
1187168|NCT02091544|overweight|overweight
1187169|NCT02091544|obesity|obesity
1187170|NCT02091544|children|children
1187171|NCT02091544|lifestyle intervention|lifestyle intervention
1187172|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
1187173|NCT02091531|PSA|psa
1187174|NCT02091531|13-143|13-143
1187175|NCT02091518|MRI|mri
1187176|NCT02091518|13-239|13-239
1187177|NCT02091518|volunteers|volunteers
1187178|NCT02091518|patients|patients
1187179|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
1187180|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
1187181|NCT02091466|Hypothermia|hypothermia
1187182|NCT02091466|Perioperative Care|perioperative care
1187183|NCT02091466|Anesthesia|anesthesia
1187184|NCT02091466|Spinal|spinal
1187185|NCT02091466|Rewarming|rewarming
1187186|NCT02091453|Brain injury|brain injury
1187187|NCT02091453|stroke|stroke
1187188|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
1187189|NCT02091440|Medical Device|medical device
1187190|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
1187191|NCT02091440|Pumps Heart Assist|pumps heart assist
1187192|NCT02091440|Ventricular Assist Device|ventricular assist device
1187193|NCT02091401|magnesium sulfate|magnesium sulfate
1187194|NCT02091375|cannabidiol|cannabidiol
1187195|NCT02091336|gestational diabetes|gestational diabetes
1187196|NCT02091336|metformin|metformin
1187197|NCT02091336|glyburide|glyburide
1187198|NCT02091336|fetal growth|fetal growth
1187199|NCT02091336|capillar glucose|capillar glucose
1187485|NCT02090049|Satiety|satiety
1187200|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
1187201|NCT02091310|GFT505|gft505
1187202|NCT02091310|TQT|tqt
1187203|NCT02091310|QT/QTc|qt/qtc
1187204|NCT02091310|Pharmacokinetic|pharmacokinetic
1187205|NCT02091310|Healthy subjects|healthy subjects
1187206|NCT02091310|Moxifloxacin|moxifloxacin
1187207|NCT02091297|Buprenorphine|buprenorphine
1187208|NCT02091297|Suboxone|suboxone
1187209|NCT02091297|Subutex|subutex
1187210|NCT02091297|Buprenex|buprenex
1187211|NCT02091297|Caesarean Delivery|caesarean delivery
1187212|NCT02091284|alcoholism|alcoholism
1187213|NCT02091284|tDCS|tdcs
1187214|NCT02091284|dlPFC|dlpfc
1187215|NCT02091284|craving|craving
1187216|NCT02091284|cognition|cognition
1187217|NCT02091271|Evaluation|evaluation
1187218|NCT02091271|Research|research
1187219|NCT02091271|Healthy Volunteers|healthy volunteers
1187220|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
1187221|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
1187222|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
1187223|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
1187224|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
1187225|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
1187226|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
1187227|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
1187228|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
1187229|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
1187230|NCT02091219|Hypovitaminosis D|hypovitaminosis d
1187231|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
1187232|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
1187233|NCT02091206|Cannabidiol|cannabidiol
1187234|NCT02091193|Krill Oil|krill oil
1187235|NCT02091193|Endothelial Function|endothelial function
1187236|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
1187237|NCT02091180|Anesthesia|anesthesia
1187238|NCT02091180|Recovery|recovery
1187239|NCT02091180|laparoscopy|laparoscopy
1187240|NCT02091180|cholecystectomy|cholecystectomy
1187241|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
1187242|NCT02091167|tDCS|tdcs
1187243|NCT02091167|dlPFC|dlpfc
1187244|NCT02091167|craving|craving
1187245|NCT02091167|cognition|cognition
1187246|NCT02091154|Food Intake Regulation|food intake regulation
1187247|NCT02091154|Fruit|fruit
1187248|NCT02091154|Vegetable|vegetable
1187249|NCT02091115|Constipation|constipation
1187250|NCT02091115|ROMA III criteria|roma iii criteria
1187251|NCT02091115|Scale Bristol|scale bristol
1187252|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
1187253|NCT02091076|Wound healing|wound healing
1187254|NCT02091076|Skin graft donor|skin graft donor
1187255|NCT02091063|hematologic malignancies|hematologic malignancies
1187256|NCT02091063|hodgkin|hodgkin
1187257|NCT02091063|hodgkins|hodgkins
1187258|NCT02091063|non-hodgkin|non-hodgkin
1187259|NCT02091063|non-hodgkins|non-hodgkins
1187260|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
1187261|NCT02091063|follicular|follicular
1187262|NCT02091063|lymphoma|lymphoma
1187263|NCT02091063|lymphoid malignancies|lymphoid malignancies
1187264|NCT02091050|3D Brachytherapy|3d brachytherapy
1187265|NCT02091050|cervical cancer|cervical cancer
1187266|NCT02091050|endometrial cancer|endometrial cancer
1187267|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
1187268|NCT02091037|Atopic dermatitis|atopic dermatitis
1187269|NCT02091037|Bacterial colonization|bacterial colonization
1187270|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
1187271|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
1187272|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
1187273|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
1187274|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
1187275|NCT02090998|Migraine Headache|migraine headache
1187276|NCT02090998|Menstrual Migraine|menstrual migraine
1187374|NCT02090374|Biomarkers|biomarkers
1187277|NCT02090998|Vascular Headache|vascular headache
1187278|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
1187279|NCT02090985|Stoma|stoma
1187280|NCT02090985|Peri-stomal|peri-stomal
1187281|NCT02090985|Lipomodelling|lipomodelling
1187282|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
1187283|NCT02090959|Dystrophinopathy|dystrophinopathy
1187284|NCT02090959|Nonsense mutation|nonsense mutation
1187285|NCT02090959|Premature stop codon|premature stop codon
1187486|NCT02090049|Bread|bread
1187286|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
1187287|NCT02090959|DMD/BMD|dmd/bmd
1187288|NCT02090959|PTC124|ptc124
1187289|NCT02090959|Ataluren|ataluren
1187290|NCT02090946|children with physical disabilities|children with physical disabilities
1187291|NCT02090946|home activity programs|home activity programs
1187292|NCT02090946|home programmes|home programmes
1187293|NCT02090946|learning|learning
1187294|NCT02090946|therapeutic relationship|therapeutic relationship
1187295|NCT02090946|phenomenology|phenomenology
1187296|NCT02090946|physiotherapy|physiotherapy
1187297|NCT02090946|clinicians who teach|clinicians who teach
1187298|NCT02090946|parent perspective|parent perspective
1187299|NCT02090946|parent-professional relationships|parent-professional relationships
1187300|NCT02090946|Parents/carers|parents/carers
1187301|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
1187302|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
1187303|NCT02090907|Atherosclerosis|atherosclerosis
1187304|NCT02090907|Cardiovascular disease|cardiovascular disease
1187305|NCT02090907|Endothelial function|endothelial function
1187306|NCT02090907|Prevention|prevention
1187307|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
1187308|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
1187309|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
1187310|NCT02090868|Critical Care|critical care
1187311|NCT02090868|Nutrition|nutrition
1187312|NCT02090868|Malnutrition|malnutrition
1187313|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
1187314|NCT02090842|Milk proteins|milk proteins
1187315|NCT02090842|Blood pressure|blood pressure
1187316|NCT02090842|Vascular function|vascular function
1187317|NCT02090829|Autism|autism
1187318|NCT02090829|Oxytocin|oxytocin
1187319|NCT02090829|Syntocinon|syntocinon
1187320|NCT02090790|dexamethasone|dexamethasone
1187321|NCT02090790|femoral block|femoral block
1187322|NCT02090790|total knee arthroplasty|total knee arthroplasty
1187323|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
1187324|NCT02090751|Dark Adaptation|dark adaptation
1187325|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
1187326|NCT02090725|hyporeflexia|hyporeflexia
1187327|NCT02090725|autonomic Dysfunction|autonomic dysfunction
1187328|NCT02090712|myocardial infarction|myocardial infarction
1187329|NCT02090712|acute coronary syndrome|acute coronary syndrome
1187330|NCT02090712|coronary disease|coronary disease
1187331|NCT02090699|thalassemia major|thalassemia major
1187332|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
1187333|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
1187334|NCT02090699|myocardium|myocardium
1187335|NCT02090699|fibrosis|fibrosis
1187336|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
1187337|NCT02090634|HIV|hiv
1187338|NCT02090634|Bipolar Disorder|bipolar disorder
1187339|NCT02090634|Medication Adherence|medication adherence
1187340|NCT02090621|Liver|liver
1187341|NCT02090621|transplantation|transplantation
1187342|NCT02090621|Immunosuppression|immunosuppression
1187343|NCT02090621|photopheresis|photopheresis
1187344|NCT02090621|extracorporeal|extracorporeal
1187345|NCT02090595|bipolar disorder|bipolar disorder
1187346|NCT02090595|anxiety|anxiety
1187347|NCT02090595|mindfulness|mindfulness
1187348|NCT02090595|high risk|high risk
1187349|NCT02090595|cognitive behavioral|cognitive behavioral
1187350|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
1187351|NCT02090530|Cancer Genomics|cancer genomics
1187352|NCT02090530|Tumor Sequencing|tumor sequencing
1187353|NCT02090517|Nasal telangiectasis|nasal telangiectasis
1187354|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
1187355|NCT02090504|treatment|treatment
1187356|NCT02090504|sodium oxybate|sodium oxybate
1187357|NCT02090504|oxazepam|oxazepam
1187358|NCT02090491|autism|autism
1187359|NCT02090465|Actinic Keratosis|actinic keratosis
1187360|NCT02090452|Telemedicine|telemedicine
1187361|NCT02090452|Mobile|mobile
1187362|NCT02090452|Vital signs|vital signs
1187363|NCT02090452|Prehospital care|prehospital care
1187364|NCT02090452|Emergency medicine|emergency medicine
1187365|NCT02090413|multiple sclerosis|multiple sclerosis
1187366|NCT02090413|flushing|flushing
1187367|NCT02090413|aspirin|aspirin
1187368|NCT02090400|Women|women
1187369|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
1187370|NCT02090400|Bazedoxifene|bazedoxifene
1187372|NCT02090374|Allergy|allergy
1187375|NCT02090374|Chemokines|chemokines
1187376|NCT02090374|Cytokines|cytokines
1187377|NCT02090374|Eosinophil|eosinophil
1187378|NCT02090374|Gene Expression|gene expression
1187379|NCT02090374|Grass pollen|grass pollen
1187380|NCT02090374|Hay Fever|hay fever
1187381|NCT02090374|Human Challenge Study|human challenge study
1187382|NCT02090374|Inflammation|inflammation
1187383|NCT02090374|Innate Immune Response|innate immune response
1187384|NCT02090374|Lipopolysaccharide|lipopolysaccharide
1187589|NCT02089347|Tetanus|tetanus
1187385|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
1187386|NCT02090374|Nasal|nasal
1187387|NCT02090374|Nasorption|nasorption
1187388|NCT02090374|Respiratory|respiratory
1187389|NCT02090374|Respiratory Tract Infection|respiratory tract infection
1187390|NCT02090374|T cells|t cells
1187391|NCT02090374|Tuberculosis|tuberculosis
1187392|NCT02090374|Virus|virus
1187393|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
1187394|NCT02090361|skin graft|skin graft
1187395|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
1187396|NCT02090335|community mental health|community mental health
1187397|NCT02090335|health coach|health coach
1187398|NCT02090335|weight loss|weight loss
1187399|NCT02090335|fitness|fitness
1187400|NCT02090335|serious mental illness|serious mental illness
1187401|NCT02090335|health promotion|health promotion
1187402|NCT02090322|ROP|rop
1187403|NCT02090322|Bevacizumab|bevacizumab
1187404|NCT02090322|No inferiority|no inferiority
1187405|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
1187406|NCT02090283|Simplex|simplex
1187407|NCT02090283|Recessive Dystrophic|recessive dystrophic
1187408|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
1187409|NCT02090270|hair cortisol|hair cortisol
1187410|NCT02090270|stroke|stroke
1187411|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
1187412|NCT02090244|PTH|pth
1187413|NCT02090244|Spinal stenosis|spinal stenosis
1187414|NCT02090244|Teriparatide|teriparatide
1187415|NCT02090231|stroke|stroke
1187416|NCT02090231|dysphagia|dysphagia
1187417|NCT02090231|rTMS|rtms
1187418|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
1187419|NCT02090205|cardiac surgery|cardiac surgery
1187420|NCT02090205|lung injury prevention|lung injury prevention
1187421|NCT02090205|mechanical ventilation|mechanical ventilation
1187422|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
1187423|NCT02090192|Whole-body vibration;|whole-body vibration;
1187424|NCT02090192|Frail Elderly;|frail elderly;
1187425|NCT02090192|Blood flow;|blood flow;
1187426|NCT02090192|Bone density|bone density
1187427|NCT02090192|Mobility;|mobility;
1187428|NCT02090192|Balance;|balance;
1187429|NCT02090192|Muscle strength;|muscle strength;
1187430|NCT02090192|Lower Extremity;|lower extremity;
1187431|NCT02090192|Musculoskeletal System;|musculoskeletal system;
1187432|NCT02090192|Health Status;|health status;
1187433|NCT02090192|Exercise;|exercise;
1187434|NCT02090192|Mechanical Oscillation|mechanical oscillation
1187435|NCT02090179|MPS IIIB|mps iiib
1187436|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
1187437|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
1187438|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
1187439|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
1187440|NCT02090179|Metabolic Diseases|metabolic diseases
1187441|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
1187442|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
1187443|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
1187444|NCT02090153|ORR,|orr,
1187445|NCT02090153|OS,|os,
1187446|NCT02090153|TTP,|ttp,
1187447|NCT02090153|TTF,|ttf,
1187448|NCT02090153|Adverse events,|adverse events,
1187449|NCT02090153|Pharmacokinetics|pharmacokinetics
1187450|NCT02090140|cartilage/transplantation|cartilage/transplantation
1187451|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
1187452|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
1187453|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
1187454|NCT02090140|knee injuries/surgery|knee injuries/surgery
1187455|NCT02090140|knee joint/surgery|knee joint/surgery
1187456|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
1187457|NCT02090140|tissue engineering|tissue engineering
1187458|NCT02090140|tissue scaffolds|tissue scaffolds
1187459|NCT02090140|arthroscopy/methods|arthroscopy/methods
1187460|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
1187461|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
1187462|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
1187463|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
1187464|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
1187465|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
1187466|NCT02090140|stem cells|stem cells
1187467|NCT02090140|tissue engineering/methods|tissue engineering/methods
1187468|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
1187469|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
1187470|NCT02090140|knee joint/pathology|knee joint/pathology
1187471|NCT02090140|platelet-rich plasma|platelet-rich plasma
1187472|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
1187475|NCT02090114|Abiraterone|abiraterone
1187476|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
1187477|NCT02090075|cardiac Computed tomography|cardiac computed tomography
1187478|NCT02090075|coronary calcification|coronary calcification
1187479|NCT02090075|intervention|intervention
1187480|NCT02090075|warfarin|warfarin
1187481|NCT02090075|apixaban|apixaban
1187482|NCT02090062|endoscopic resection|endoscopic resection
1187483|NCT02090062|H. pylori infection|h. pylori infection
1187487|NCT02090049|Dietary fiber|dietary fiber
1187488|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
1187489|NCT02090049|Glycemia|glycemia
1187490|NCT02090049|Insulinemia|insulinemia
1187491|NCT02090036|Efficacy|efficacy
1187492|NCT02090036|Safety|safety
1187493|NCT02090036|Primaquine|primaquine
1187494|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
1187495|NCT02090036|Gametocytes|gametocytes
1187496|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
1187497|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
1187498|NCT02090023|Survival Analysis|survival analysis
1187499|NCT02090023|Validation Studies|validation studies
1187500|NCT02090023|Cohort Studies|cohort studies
1187501|NCT02089997|Pharmacological therapy|pharmacological therapy
1187502|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
1187503|NCT02089984|On-line training|on-line training
1187504|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
1187505|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1187506|NCT02089945|severe aortic stenosis|severe aortic stenosis
1187507|NCT02089945|cognition|cognition
1187508|NCT02089945|functional capacity|functional capacity
1187509|NCT02089945|quality of life|quality of life
1187510|NCT02089932|femoral nerve block|femoral nerve block
1187511|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
1187512|NCT02089867|Ezetimibe|ezetimibe
1187513|NCT02089867|Plant sterol|plant sterol
1187514|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
1187515|NCT02089867|Coronary artery disease|coronary artery disease
1187516|NCT02089867|LDL-cholesterol|ldl-cholesterol
1187517|NCT02089854|triple negative breast cancer|triple negative breast cancer
1187518|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
1187519|NCT02089854|endocrine therapy|endocrine therapy
1187520|NCT02089841|Efficacy|efficacy
1187521|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
1187522|NCT02089841|Malaria|malaria
1187523|NCT02089841|Children|children
1187525|NCT02089789|Natural History|natural history
1187526|NCT02089789|Glycosylation|glycosylation
1187527|NCT02089789|Genetic Disorders|genetic disorders
1187531|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
1187532|NCT02089763|HCC|hcc
1187533|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
1187534|NCT02089763|PEG-BCT-100|peg-bct-100
1187535|NCT02089763|ASS|ass
1187536|NCT02089763|OTC|otc
1187537|NCT02089750|Low Back Pain|low back pain
1187538|NCT02089750|Chiropractic|chiropractic
1187539|NCT02089750|Shoe Orthotics|shoe orthotics
1187540|NCT02089711|Normal subjects|normal subjects
1187541|NCT02089698|Kelman tip|kelman tip
1187542|NCT02089698|Mini-flared|mini-flared
1187543|NCT02089698|phacoemulsification|phacoemulsification
1187544|NCT02089698|cataract|cataract
1187545|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
1187546|NCT02089633|HCC|hcc
1187547|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
1187548|NCT02089633|PEG-BCT-100|peg-bct-100
1187549|NCT02089633|oxaliplatin|oxaliplatin
1187550|NCT02089633|capecitabine|capecitabine
1187551|NCT02089620|Premenstrual syndrome|premenstrual syndrome
1187552|NCT02089620|Oral contraceptive pills|oral contraceptive pills
1187553|NCT02089620|Calcium Supplements|calcium supplements
1187554|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
1187555|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
1187556|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
1187557|NCT02089581|Healthy Volunteer|healthy volunteer
1187558|NCT02089581|Pharmacokinetics|pharmacokinetics
1187559|NCT02089581|Bioequivalence|bioequivalence
1187560|NCT02089568|Living donation|living donation
1187561|NCT02089568|Antibiotics|antibiotics
1187562|NCT02089568|Laparoscopic surgery|laparoscopic surgery
1187563|NCT02089542|thyroidectomy|thyroidectomy
1187564|NCT02089542|parathyroid surgery|parathyroid surgery
1187565|NCT02089542|parathyroid identification|parathyroid identification
1187566|NCT02089542|methylene blue|methylene blue
1187567|NCT02089542|near infrared fluorescence|near infrared fluorescence
1187568|NCT02089542|intraoperative imaging|intraoperative imaging
1187569|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
1187570|NCT02089529|Pain|pain
1187571|NCT02089529|NSAIDs|nsaids
1187572|NCT02089529|Placebo|placebo
1187573|NCT02089529|Placebo intervention|placebo intervention
1187574|NCT02089529|Stress|stress
1187575|NCT02089529|Conditioning|conditioning
1187576|NCT02089516|Frailty|frailty
1187577|NCT02089516|Accelerometry|accelerometry
1187578|NCT02089516|Physical activity|physical activity
1187579|NCT02089516|validity|validity
1187580|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
1187581|NCT02089412|Healthy Subjects|healthy subjects
1187582|NCT02089412|Absorption|absorption
1187583|NCT02089412|High-Fat Meal|high-fat meal
1187584|NCT02089360|Advanced glycation end product|advanced glycation end product
1187585|NCT02089360|coronary|coronary
1187586|NCT02089360|atherosclerosis|atherosclerosis
1187587|NCT02089360|inflammation|inflammation
1187588|NCT02089360|outcome|outcome
1187590|NCT02089347|Diphtheria|diphtheria
1187591|NCT02089347|Pertussis|pertussis
1187592|NCT02089347|TdaP vaccine|tdap vaccine
1187593|NCT02089347|DT vaccine|dt vaccine
1187594|NCT02089334|renal cell carcinoma|renal cell carcinoma
1187595|NCT02089334|clear cell|clear cell
1187596|NCT02089334|renal cancer|renal cancer
1187597|NCT02089334|metastatic renal cancer|metastatic renal cancer
1187598|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
1187599|NCT02089334|Humans|humans
1187600|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
1187601|NCT02089321|low back pain|low back pain
1187602|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
1187603|NCT02089321|active straight leg raise|active straight leg raise
1187604|NCT02089321|active hip abduction|active hip abduction
1187605|NCT02089308|Smoking cessation|smoking cessation
1187606|NCT02089308|Nicotine|nicotine
1187607|NCT02089308|Tobacco Use Disorder|tobacco use disorder
1187608|NCT02089308|Central Nervous System Agents|central nervous system agents
1187609|NCT02089295|dose proportionality|dose proportionality
1187610|NCT02089295|oxycodone|oxycodone
1187611|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
1187612|NCT02089269|neoplasms|neoplasms
1187613|NCT02089269|registry|registry
1187614|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
1187615|NCT02089269|health services research|health services research
1187616|NCT02089269|epidemiology|epidemiology
1187617|NCT02089269|Germany|germany
1187618|NCT02089269|palliative treatment|palliative treatment
1187619|NCT02089269|palliative care|palliative care
1187620|NCT02089269|localized, resectable pancreatic cancer|localized, resectable pancreatic cancer
1187621|NCT02089269|adjuvant treatment|adjuvant treatment
1187622|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
1187623|NCT02089243|Brain Diseases|brain diseases
1187624|NCT02089230|Leukemia|leukemia
1187625|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
1187626|NCT02089230|AML|aml
1187627|NCT02089230|Advanced leukemias|advanced leukemias
1187628|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
1187629|NCT02089230|MDS|mds
1187630|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1187631|NCT02089230|ALL|all
1187632|NCT02089230|Relapsed|relapsed
1187633|NCT02089230|Refractory|refractory
1187634|NCT02089230|MEK 162|mek 162
1187635|NCT02089217|asymptomatic|asymptomatic
1187636|NCT02089217|carotid|carotid
1187637|NCT02089217|stent|stent
1187638|NCT02089217|endarterectomy|endarterectomy
1187639|NCT02089217|embolic protection|embolic protection
1187640|NCT02089217|medical management|medical management
1187641|NCT02089217|hypertension|hypertension
1187642|NCT02089217|hyperlipidemia|hyperlipidemia
1187643|NCT02089217|cognition|cognition
1187644|NCT02089217|risk factor control|risk factor control
1187645|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
1187646|NCT02089204|PET/CT|pet/ct
1187647|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
1187648|NCT02089191|DACP|dacp
1187649|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
1187650|NCT02089191|Tear film stability|tear film stability
1187651|NCT02089191|NIK-BUT|nik-but
1187652|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
1187653|NCT02089152|Diabetes|diabetes
1187654|NCT02089152|Melioidosis|melioidosis
1187655|NCT02089152|stepped wedge trial|stepped wedge trial
1187656|NCT02089152|behaviour change|behaviour change
1187657|NCT02089152|Education program|education program
1187658|NCT02089139|Back pain|back pain
1187659|NCT02089139|Discogel|discogel
1187660|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
1187661|NCT02089074|Secondary Prevention|secondary prevention
1187662|NCT02089074|Pharmacists|pharmacists
1187663|NCT02089074|Directive Counseling|directive counseling
1187664|NCT02089074|Medication Adherence|medication adherence
1187665|NCT02089074|Patient Compliance|patient compliance
1187666|NCT02089048|Amebiasis|amebiasis
1187667|NCT02089048|auranofin|auranofin
1187668|NCT02089048|pharmacodynamics|pharmacodynamics
1188248|NCT02085993|Nplate,|nplate,
1187669|NCT02089048|pharmokinetics|pharmokinetics
1187670|NCT02089035|Milk fatty acids|milk fatty acids
1187671|NCT02089035|Total cholesterol|total cholesterol
1187672|NCT02089035|Vascular function|vascular function
1187673|NCT02089035|Blood pressure|blood pressure
1187674|NCT02089022|Ice|ice
1187675|NCT02089022|Heat|heat
1187676|NCT02089022|Ground reaction forces|ground reaction forces
1187677|NCT02089022|Electromyography|electromyography
1187678|NCT02089022|Lower Limb|lower limb
1187679|NCT02089022|Center of pressure|center of pressure
1187680|NCT02088970|Infectious keratitis|infectious keratitis
1187681|NCT02088970|Corneal cross linking|corneal cross linking
1187682|NCT02088970|Topical antibiotics|topical antibiotics
1187683|NCT02088957|Brivaracetam|brivaracetam
1187684|NCT02088957|Phenytoin|phenytoin
1187685|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
1187686|NCT02088931|Tregs|tregs
1187687|NCT02088931|Kidney transplantation|kidney transplantation
1187688|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
1187689|NCT02088892|BCG challenge study|bcg challenge study
1187690|NCT02088866|Tinnitus|tinnitus
1187691|NCT02088866|Otolaryngology|otolaryngology
1187692|NCT02088853|intestinal|intestinal
1187693|NCT02088853|metabolic control|metabolic control
1187694|NCT02088853|mucosa|mucosa
1187695|NCT02088853|human|human
1187696|NCT02088853|diet|diet
1187697|NCT02088840|SIGNB|signb
1187698|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
1187699|NCT02088840|stem cell transplant|stem cell transplant
1187700|NCT02088827|Exercise|exercise
1187701|NCT02088827|Sedentary Behaviour|sedentary behaviour
1187702|NCT02088827|Type 2 Diabetes|type 2 diabetes
1187703|NCT02088827|Older Adults|older adults
1187704|NCT02088814|posttraumatic stress|posttraumatic stress
1187705|NCT02088814|burns|burns
1187706|NCT02088814|injuries|injuries
1187707|NCT02088814|children|children
1187708|NCT02088801|Intubation; Difficult|intubation; difficult
1187709|NCT02088788|radiation|radiation
1187710|NCT02088788|radiation injury|radiation injury
1187711|NCT02088788|occupational risk|occupational risk
1187712|NCT02088762|margin of safety|margin of safety
1187713|NCT02088749|obesity|obesity
1187714|NCT02088749|weight loss|weight loss
1187715|NCT02088749|treatment|treatment
1187716|NCT02088749|lifestyle|lifestyle
1187717|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
1187718|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
1187719|NCT02088723|Polysomnography|polysomnography
1187720|NCT02088723|Sleep|sleep
1187721|NCT02088723|Patient Positioning|patient positioning
1187722|NCT02088710|Patients´ Expectations|patients´ expectations
1187723|NCT02088710|Breast Cancer|breast cancer
1187724|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
1187725|NCT02088710|Nocebo|nocebo
1187726|NCT02088710|Psycho-oncology|psycho-oncology
1187727|NCT02088710|Satisfaction with information|satisfaction with information
1187728|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
1187729|NCT02088671|NeuroSENSE|neurosense
1187730|NCT02088671|Anesthesia|anesthesia
1187731|NCT02088671|Hypnosis|hypnosis
1187732|NCT02088671|Desflurane|desflurane
1187733|NCT02088671|Propofol|propofol
1187734|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1187735|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
1187736|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1187737|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
1187738|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1187739|NCT02088658|African Americans|african americans
1187740|NCT02088658|Blacks|blacks
1187741|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
1187742|NCT02088658|Randomized Control Trial|randomized control trial
1187743|NCT02088658|Controlled Clinical Trial|controlled clinical trial
1187744|NCT02088658|Behavioral Research|behavioral research
1187745|NCT02088658|Behavioral Medicine|behavioral medicine
1187746|NCT02088645|Calcitonin|calcitonin
1187747|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
1187748|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
1187749|NCT02088645|Gastrin|gastrin
1187750|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
1187751|NCT02088619|psychological wellbeing|psychological wellbeing
1187752|NCT02088619|anxiety|anxiety
1187753|NCT02088619|depression|depression
1187754|NCT02088619|autonomic functioning|autonomic functioning
1187755|NCT02088606|Atrial fibrillation|atrial fibrillation
1187756|NCT02088593|Medical Students|medical students
1187757|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
1187758|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
1187759|NCT02088541|AML|aml
1187760|NCT02088541|Karyopharm|karyopharm
1187761|NCT02088541|Selinexor|selinexor
1187762|NCT02088541|KPT-330|kpt-330
1187763|NCT02088515|Nedaplatin|nedaplatin
1187764|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
1187765|NCT02088502|Coronary Angiography|coronary angiography
1187766|NCT02088502|Side Effects|side effects
1188546|NCT02084563|Leukemia|leukemia
1187767|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
1187768|NCT02088502|Prevention|prevention
1187769|NCT02088489|Atrial flutter|atrial flutter
1187770|NCT02088489|Thermocool catheter|thermocool catheter
1187771|NCT02088489|Thermocool SF catheter|thermocool sf catheter
1187772|NCT02088476|candidemia|candidemia
1187773|NCT02088476|children|children
1187774|NCT02088476|mortality|mortality
1187775|NCT02088476|risk factors|risk factors
1187776|NCT02088463|Mechanical LBP|mechanical lbp
1187777|NCT02088463|Mobilization|mobilization
1187778|NCT02088463|Postpartum|postpartum
1187779|NCT02088450|Cardiovascular complications|cardiovascular complications
1187780|NCT02088450|Clinical trial|clinical trial
1187781|NCT02088450|Elderly|elderly
1187782|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
1187783|NCT02088450|Stroke|stroke
1187784|NCT02088398|relative bioavailability|relative bioavailability
1187785|NCT02088398|food-effect|food-effect
1187786|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
1187787|NCT02088346|Stroke|stroke
1187788|NCT02088346|Thrombolysis|thrombolysis
1187789|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
1187790|NCT02088346|Urokinase|urokinase
1187791|NCT02088346|Telemedicine|telemedicine
1187792|NCT02088333|colorectal cancer screening|colorectal cancer screening
1187793|NCT02088333|computer-assisted instruction|computer-assisted instruction
1187794|NCT02088333|mHealth|mhealth
1187795|NCT02088333|text message|text message
1187796|NCT02088307|cardiovascular supplement|cardiovascular supplement
1187797|NCT02088307|cardiovascular disease|cardiovascular disease
1187798|NCT02088307|coronary artery disease|coronary artery disease
1187799|NCT02088294|obesity|obesity
1187800|NCT02088294|stress|stress
1187801|NCT02088294|intuitive eating|intuitive eating
1187802|NCT02088294|guided imagery|guided imagery
1187803|NCT02088294|adolescents|adolescents
1187804|NCT02088294|insulin resistance|insulin resistance
1187805|NCT02088294|latinos|latinos
1187806|NCT02088294|minorities|minorities
1187807|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
1187808|NCT02088255|Rehabilitation|rehabilitation
1187809|NCT02088255|Gait|gait
1187810|NCT02088255|Stroke|stroke
1187811|NCT02088255|Biomechanics|biomechanics
1187812|NCT02088229|Diabetic Macular Edema|diabetic macular edema
1187813|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
1187814|NCT02088216|Bronchiectasis；|bronchiectasis；
1187815|NCT02088216|Acute exacerbations；|acute exacerbations；
1187816|NCT02088216|Antioxidant；|antioxidant；
1187817|NCT02088216|Anti-inflammatory|anti-inflammatory
1187818|NCT02088177|Cannabis|cannabis
1187819|NCT02088177|Cannabis Dependence|cannabis dependence
1187820|NCT02088177|Cannabis Use Disorder|cannabis use disorder
1187821|NCT02088177|Marijuana|marijuana
1187822|NCT02088177|Naltrexone|naltrexone
1187823|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
1187824|NCT02088177|Treatment|treatment
1187825|NCT02088164|PSA,|psa,
1187826|NCT02088164|asian men,|asian men,
1187827|NCT02088164|survival|survival
1187828|NCT02088151|selective laser therapy|selective laser therapy
1187829|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
1187830|NCT02088151|macular edema|macular edema
1187831|NCT02088151|diabetic retinopathy|diabetic retinopathy
1187832|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
1187833|NCT02088151|age-related macular degeneration|age-related macular degeneration
1187834|NCT02088151|retinal vein occlusion|retinal vein occlusion
1187835|NCT02088138|Thoracic Surgery|thoracic surgery
1187836|NCT02088138|Electrical Stimulation|electrical stimulation
1187837|NCT02088138|Rehabilitation|rehabilitation
1187838|NCT02088138|Quality of Life|quality of life
1187839|NCT02088125|Stroke|stroke
1187840|NCT02088125|Incentive Spirometry|incentive spirometry
1187841|NCT02088125|Breath Stacking|breath stacking
1187842|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
1187843|NCT02088112|NSCLC|nsclc
1187844|NCT02088099|Traumatic brain injury|traumatic brain injury
1187845|NCT02088099|Telehealth|telehealth
1187846|NCT02088099|ehealth|ehealth
1187847|NCT02088099|Mobile Health|mobile health
1187848|NCT02088099|social participation|social participation
1187849|NCT02088099|patient participation|patient participation
1187850|NCT02088099|consumer participation|consumer participation
1187851|NCT02088099|Patient Outcome Assessment|patient outcome assessment
1187852|NCT02088086|Pediatric obesity|pediatric obesity
1187853|NCT02088086|Overweight|overweight
1187854|NCT02088086|Body mass index|body mass index
1187855|NCT02088086|Primary schools|primary schools
1187856|NCT02088086|Secondary schools|secondary schools
1187857|NCT02088047|Autism|autism
1577035|NCT00475553|pelvic pain|pelvic pain
1260433|NCT01759017|IBD|ibd
1187858|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
1187859|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
1187860|NCT02087995|Diabetes Mellitus|diabetes mellitus
1187861|NCT02087956|Women|women
1187862|NCT02087956|Depression|depression
1187863|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
1187864|NCT02087956|Navigation|navigation
1187865|NCT02087943|Atopic Dermatitis|atopic dermatitis
1187866|NCT02087943|Atopic Eczema|atopic eczema
1187867|NCT02087917|hypercholesterolemia|hypercholesterolemia
1187868|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
1187869|NCT02087917|placebo-controlled trial|placebo-controlled trial
1187870|NCT02087904|Pain|pain
1187871|NCT02087904|Osteoarthritis|osteoarthritis
1187872|NCT02087904|Synovitis|synovitis
1187873|NCT02087904|Knee|knee
1187874|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
1187875|NCT02087852|Questionnaire|questionnaire
1187877|NCT02087852|saliva|saliva
1187878|NCT02087852|kidney cancer|kidney cancer
1187879|NCT02087852|13-218|13-218
1187880|NCT02087839|Non-Small Cell Lung Cancer|non-small cell lung cancer
1187881|NCT02087839|Lung Cancer|lung cancer
1187882|NCT02087839|NSCLC|nsclc
1187883|NCT02087839|ZD6474|zd6474
1187884|NCT02087839|ZACTIMA|zactima
1187885|NCT02087839|Vandetanib|vandetanib
1187886|NCT02087839|Inoperable NSCLC|inoperable nsclc
1187887|NCT02087839|Unresectable NSCLC|unresectable nsclc
1187888|NCT02087839|Radiation Therapy|radiation therapy
1187889|NCT02087839|Palliative radiation therapy|palliative radiation therapy
1187890|NCT02087839|Angiogenesis|angiogenesis
1187891|NCT02087813|neuromyelitis optica|neuromyelitis optica
1187892|NCT02087813|optic neuritis|optic neuritis
1187893|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
1187894|NCT02087800|smoking cessation|smoking cessation
1187895|NCT02087800|smoking abstinence|smoking abstinence
1187896|NCT02087800|allopregnanolone|allopregnanolone
1187897|NCT02087787|bone marrow transplant|bone marrow transplant
1187898|NCT02087787|hematologic malignancies|hematologic malignancies
1187899|NCT02087761|ARIES Flu|aries flu
1187900|NCT02087748|DOMS|doms
1187901|NCT02087735|Cranberry|cranberry
1187902|NCT02087735|Proanthocyanidins|proanthocyanidins
1187903|NCT02087735|Urinary catabolites|urinary catabolites
1187904|NCT02087722|Primary Insomnia|primary insomnia
1187905|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
1187906|NCT02087696|methotrexate|methotrexate
1187907|NCT02087696|intolerance|intolerance
1187908|NCT02087696|poor compliance|poor compliance
1187909|NCT02087696|contraindication|contraindication
1187910|NCT02087696|Tocilizumab|tocilizumab
1187911|NCT02087696|monotherapy|monotherapy
1187912|NCT02087683|heart failure|heart failure
1187913|NCT02087683|vitamin D deficiency|vitamin d deficiency
1187914|NCT02087683|ventricular function|ventricular function
1187915|NCT02087683|cytokines|cytokines
1187916|NCT02087670|chronic heart failure|chronic heart failure
1187917|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
1187918|NCT02087670|exercise|exercise
1187919|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
1187920|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
1187921|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
1187922|NCT02087657|Lymphoma|lymphoma
1187923|NCT02087657|Myeloma|myeloma
1187924|NCT02087631|multiple sclerosis|multiple sclerosis
1187925|NCT02087631|quetiapine|quetiapine
1187926|NCT02087631|remyelination|remyelination
1187927|NCT02087618|MCI|mci
1187928|NCT02087618|Alzheimer's|alzheimer's
1187929|NCT02087618|Dementia|dementia
1187930|NCT02087618|Tablet|tablet
1187931|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
1187932|NCT02087618|Cognition|cognition
1187933|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
1187934|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
1187935|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
1187936|NCT02087592|Mediterranean diet|mediterranean diet
1187937|NCT02087592|Structured exercise training|structured exercise training
1187938|NCT02087592|prevention|prevention
1187939|NCT02087579|Psychotic Disorders|psychotic disorders
1187940|NCT02087579|Schizophrenia|schizophrenia
1187941|NCT02087579|Bipolar Disorder|bipolar disorder
1187942|NCT02087579|Depressive Disorder|depressive disorder
1187943|NCT02087579|Antipsychotics|antipsychotics
1187944|NCT02087579|Aripiprazole|aripiprazole
1187945|NCT02087579|Olanzapine|olanzapine
1187946|NCT02087579|Paliperidone|paliperidone
1187947|NCT02087579|Quetiapine|quetiapine
1187948|NCT02087579|Risperidone|risperidone
1187949|NCT02087579|Capillary Concentration|capillary concentration
1187950|NCT02087566|Linezolid|linezolid
1187951|NCT02087566|Pharmacokinetics|pharmacokinetics
1187952|NCT02087566|Haemodialysis|haemodialysis
1187953|NCT02087566|Dosing adjustment|dosing adjustment
1333140|NCT01444404|Clinical Trial|clinical trial
1577036|NCT00475553|headache|headache
1187954|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
1187955|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
1187956|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
1188050|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
1188051|NCT02086890|microcurrent|microcurrent
1188247|NCT02085993|romiplostim,|romiplostim,
1187957|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
1187958|NCT02087553|Blood Transfusion|blood transfusion
1187959|NCT02087553|Iron|iron
1187960|NCT02087553|Packed Red Blood Cells|packed red blood cells
1187961|NCT02087553|PRBC|prbc
1187962|NCT02087553|NTBI|ntbi
1187963|NCT02087527|Cellulitis|cellulitis
1187964|NCT02087527|Soft Tissue Infections|soft tissue infections
1187965|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
1187966|NCT02087527|Corticosteroids|corticosteroids
1187967|NCT02087527|Glucocorticoids|glucocorticoids
1187968|NCT02087527|Dexamethasone|dexamethasone
1187969|NCT02087514|Blood Transfusion|blood transfusion
1187970|NCT02087514|Iron|iron
1187971|NCT02087514|Red Blood Cells|red blood cells
1187972|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1187973|NCT02087501|AAA|aaa
1187974|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
1187975|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
1187976|NCT02087501|EVAR|evar
1187977|NCT02087488|primary insomnia|primary insomnia
1187978|NCT02087488|auricular acupuncture|auricular acupuncture
1187979|NCT02087462|Sciatica|sciatica
1187980|NCT02087462|Electroacupuncture|electroacupuncture
1187981|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
1187982|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, Durvalumab, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, durvalumab, pd-l1
1187983|NCT02087397|Stem Cell|stem cell
1187984|NCT02087397|Erectile Dysfunction|erectile dysfunction
1187985|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
1187986|NCT02087384|HIV|hiv
1187987|NCT02087384|HPV|hpv
1187988|NCT02087384|Vaccination|vaccination
1187989|NCT02087384|Gardasil|gardasil
1187990|NCT02087384|Prophylactic|prophylactic
1187991|NCT02087358|alcohol dependence|alcohol dependence
1187992|NCT02087358|Stress- correlation|stress- correlation
1187993|NCT02087358|genetic|genetic
1187994|NCT02087358|CRHR1|crhr1
1187995|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
1187996|NCT02087306|Adenovirus Infection|adenovirus infection
1187997|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
1187998|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
1187999|NCT02087215|diabetes mellitus|diabetes mellitus
1188000|NCT02087215|foot ulcer|foot ulcer
1188001|NCT02087215|boron|boron
1188002|NCT02087215|wound care|wound care
1188003|NCT02087202|pain|pain
1188004|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
1188005|NCT02087176|NSCLC|nsclc
1188006|NCT02087137|aging|aging
1188007|NCT02087137|memory|memory
1188008|NCT02087137|memory training|memory training
1188009|NCT02087124|Whey protein|whey protein
1188010|NCT02087124|Postprandial lipaemia|postprandial lipaemia
1188011|NCT02087124|Pre-meal|pre-meal
1188012|NCT02087124|Metabolic syndrome|metabolic syndrome
1188013|NCT02087111|Telaprevir|telaprevir
1188014|NCT02087111|Genotype 3 HCV|genotype 3 hcv
1188015|NCT02087098|overactive bladder|overactive bladder
1188016|NCT02087098|solifenacin|solifenacin
1188017|NCT02087098|quality of life|quality of life
1188018|NCT02087072|home visits|home visits
1188019|NCT02087072|transitions of care|transitions of care
1188020|NCT02087072|pharmacist|pharmacist
1188021|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
1188022|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
1188023|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
1188024|NCT02087020|Joint Prosthesis|joint prosthesis
1188025|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
1188026|NCT02087020|Joint Diseases|joint diseases
1188027|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
1188028|NCT02087020|Prostheses and Implants|prostheses and implants
1188029|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
1188030|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
1188031|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
1188032|NCT02086955|Diabetes|diabetes
1188033|NCT02086955|Nursing counseling|nursing counseling
1188034|NCT02086955|Foot ulceration|foot ulceration
1188035|NCT02086955|Outpatient|outpatient
1188036|NCT02086955|Advanced Practice Nurse|advanced practice nurse
1188037|NCT02086929|Trazodone|trazodone
1188038|NCT02086929|Venlafaxine|venlafaxine
1188039|NCT02086929|Major depressive disorder|major depressive disorder
1188040|NCT02086916|Clostridium difficile|clostridium difficile
1188041|NCT02086916|Prediction|prediction
1188042|NCT02086916|Treatment|treatment
1188043|NCT02086916|Failure|failure
1188044|NCT02086903|Ticagrelor|ticagrelor
1188045|NCT02086903|Clopidogrel|clopidogrel
1188046|NCT02086903|Platelet function test|platelet function test
1188047|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
1188048|NCT02086890|acupuncture|acupuncture
1188049|NCT02086890|electroacupuncture|electroacupuncture
1188246|NCT02086006|Coronary artery disease|coronary artery disease
1188052|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1188053|NCT02086864|ADHD|adhd
1188054|NCT02086864|Homeopathy|homeopathy
1188055|NCT02086851|pediatric obesity|pediatric obesity
1188056|NCT02086851|motivational interviewing|motivational interviewing
1188057|NCT02086851|lifestyle intervention|lifestyle intervention
1188058|NCT02086838|Iron deficiency anemia|iron deficiency anemia
1188059|NCT02086838|Pregnancy|pregnancy
1188060|NCT02086838|Iron therapy|iron therapy
1188061|NCT02086799|asthma|asthma
1188062|NCT02086799|thyroid hormones|thyroid hormones
1188063|NCT02086799|treatment|treatment
1188064|NCT02086799|asthma exacerbation|asthma exacerbation
1188065|NCT02086773|Acute Leukemia|acute leukemia
1188066|NCT02086773|Red Cell Transfusion|red cell transfusion
1188067|NCT02086760|hydronephrosis|hydronephrosis
1188068|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
1188069|NCT02086734|Perfusion-CT|perfusion-ct
1188070|NCT02086734|mRCC|mrcc
1188071|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
1188072|NCT02086734|response assessment|response assessment
1188073|NCT02086708|Sonoelastography,|sonoelastography,
1188074|NCT02086708|Diffuse liver disease,|diffuse liver disease,
1188075|NCT02086708|chronic liver disease,|chronic liver disease,
1188076|NCT02086708|NASH,|nash,
1188077|NCT02086708|NAFLD,|nafld,
1188078|NCT02086708|Elevated Transaminases,|elevated transaminases,
1188079|NCT02086708|Liver Biopsy,|liver biopsy,
1188080|NCT02086708|Fibrosis,|fibrosis,
1188081|NCT02086708|METAVIR|metavir
1188082|NCT02086695|Chemotherapy|chemotherapy
1188083|NCT02086695|Cardiotoxicity|cardiotoxicity
1188084|NCT02086682|hemodialysis|hemodialysis
1188085|NCT02086682|dialysis|dialysis
1188086|NCT02086682|renal dialysis|renal dialysis
1188087|NCT02086682|clotting|clotting
1188088|NCT02086682|coagulation|coagulation
1188089|NCT02086682|blood lines|blood lines
1188090|NCT02086656|liver metastases|liver metastases
1188091|NCT02086656|colorectal cancer|colorectal cancer
1188092|NCT02086656|perioperative treatment|perioperative treatment
1188093|NCT02086643|Infraclavicular block|infraclavicular block
1188094|NCT02086643|Brachial Plexus|brachial plexus
1188095|NCT02086643|Retroclavicular Approach|retroclavicular approach
1188096|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
1188097|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
1188098|NCT02086643|Obese Patients|obese patients
1188099|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
1188100|NCT02086630|disparities|disparities
1188101|NCT02086630|antiretroviral|antiretroviral
1188103|NCT02086630|barriers|barriers
1188104|NCT02086630|access|access
1188105|NCT02086630|delay|delay
1188106|NCT02086630|decline|decline
1188107|NCT02086630|discontinue|discontinue
1188108|NCT02086630|African American|african american
1188109|NCT02086630|Black|black
1188110|NCT02086630|Latino|latino
1188111|NCT02086630|Hispanic|hispanic
1188112|NCT02086630|care continuum|care continuum
1188113|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
1188114|NCT02086630|Treatment as Usual|treatment as usual
1188115|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
1188116|NCT02086591|Doxycycline|doxycycline
1188117|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
1188118|NCT02086578|14-028|14-028
1188119|NCT02086565|asthma,|asthma,
1188120|NCT02086565|asthma control,|asthma control,
1188121|NCT02086565|asthma-related quality of life|asthma-related quality of life
1188122|NCT02086565|electronic health record,|electronic health record,
1188123|NCT02086565|portal,|portal,
1188124|NCT02086565|health literacy|health literacy
1188125|NCT02086513|Graft versus Host Disease|graft versus host disease
1188126|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1188127|NCT02086500|Tranexamic acid|tranexamic acid
1188128|NCT02086500|randomized|randomized
1188129|NCT02086500|hemorrhage|hemorrhage
1188130|NCT02086500|blinded|blinded
1188131|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
1188132|NCT02086435|Myomectomy|myomectomy
1188133|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
1188134|NCT02086435|Morcellation|morcellation
1577037|NCT00475553|mood swings|mood swings
1188135|NCT02086435|Risk of dissemination|risk of dissemination
1188136|NCT02086435|Uterine Sarcoma|uterine sarcoma
1188137|NCT02086435|Parasitic myoma|parasitic myoma
1188138|NCT02086396|obesity|obesity
1188139|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
1188140|NCT02086396|pumpkin seed|pumpkin seed
1188141|NCT02086396|diet quality|diet quality
1188142|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
1188143|NCT02086383|Self-Efficacy|self-efficacy
1188144|NCT02086383|Physical Activity|physical activity
1188145|NCT02086370|PBS|pbs
1188146|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
1188147|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
1188148|NCT02086370|Ovarian reserve|ovarian reserve
1188149|NCT02086370|Permanent contraception|permanent contraception
1188150|NCT02086370|Surgical sterilization|surgical sterilization
1188151|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
1188153|NCT02086344|Ovarian reserve|ovarian reserve
1188154|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
1188155|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
1188156|NCT02086344|Ovarian cancer|ovarian cancer
1188157|NCT02086344|Fallopian Tubes|fallopian tubes
1188158|NCT02086318|Ovarian reserve|ovarian reserve
1188159|NCT02086318|Ovarian age|ovarian age
1188160|NCT02086318|Fertility|fertility
1188161|NCT02086318|Reproductive prognosis|reproductive prognosis
1188162|NCT02086318|Distance to menopause|distance to menopause
1188163|NCT02086305|Transitional care|transitional care
1188164|NCT02086305|Supportive and palliative care|supportive and palliative care
1188165|NCT02086292|Injections|injections
1188166|NCT02086292|Lidocaine|lidocaine
1188167|NCT02086292|Pain|pain
1188168|NCT02086292|Healthy volunteers|healthy volunteers
1188169|NCT02086279|AMH levels|amh levels
1188170|NCT02086279|Ovarian reserve|ovarian reserve
1188171|NCT02086279|GnRH analogue|gnrh analogue
1188172|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
1188173|NCT02086279|Ovarian reserve modification|ovarian reserve modification
1188174|NCT02086279|Antral follicle count|antral follicle count
1188175|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
1188176|NCT02086266|Prostatectomy|prostatectomy
1188177|NCT02086266|Urinary Continence|urinary continence
1188178|NCT02086266|Physical Therapy Modalities|physical therapy modalities
1188179|NCT02086266|Pelvic Floor|pelvic floor
1188180|NCT02086266|Randomized Trial.|randomized trial.
1188181|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
1188182|NCT02086227|Bioequivalence|bioequivalence
1188183|NCT02086214|Upper limb|upper limb
1188184|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
1188185|NCT02086214|Children|children
1188186|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
1188187|NCT02086201|major depression|major depression
1188188|NCT02086201|depression|depression
1188189|NCT02086201|depressive disorder|depressive disorder
1188190|NCT02086201|mental health|mental health
1188191|NCT02086201|mental disorder|mental disorder
1188192|NCT02086188|Multiple Sclerosis|multiple sclerosis
1188193|NCT02086188|Overactive Bladder|overactive bladder
1188194|NCT02086188|Incontinence|incontinence
1188195|NCT02086188|Voiding|voiding
1188196|NCT02086188|Bladder Urgency|bladder urgency
1188197|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
1188198|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
1188199|NCT02086162|Schizophrenia|schizophrenia
1188200|NCT02086162|Smoking|smoking
1188201|NCT02086162|Tobacco|tobacco
1188202|NCT02086162|Motivation|motivation
1188203|NCT02086162|Cessation Treatment|cessation treatment
1188204|NCT02086149|Quit smoking|quit smoking
1188205|NCT02086149|Exercise|exercise
1188206|NCT02086149|Tobacco|tobacco
1188207|NCT02086149|Smoking|smoking
1188208|NCT02086136|aortic dissection|aortic dissection
1188209|NCT02086136|diagnosis|diagnosis
1188210|NCT02086136|emergency medicine|emergency medicine
1188211|NCT02086136|d-dimer|d-dimer
1188212|NCT02086123|Analgesia|analgesia
1188213|NCT02086123|Epidural Analgesia|epidural analgesia
1188214|NCT02086123|Narcotic Analgesia|narcotic analgesia
1188215|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
1188216|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
1188217|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
1188218|NCT02086123|NSAIDS|nsaids
1188219|NCT02086110|probiotic|probiotic
1188220|NCT02086110|prebiotic|prebiotic
1188221|NCT02086110|autism|autism
1188222|NCT02086110|oligosaccharides|oligosaccharides
1188223|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
1188224|NCT02086097|pain|pain
1188225|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
1188226|NCT02086097|postoperative dental pain|postoperative dental pain
1188227|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
1188228|NCT02086084|AECOPD|aecopd
1188229|NCT02086084|Non invasive ventilation|non invasive ventilation
1188230|NCT02086084|NIV|niv
1188231|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
1188232|NCT02086084|ECCO2R|ecco2r
1188233|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
1188234|NCT02086058|overactive bladder|overactive bladder
1188235|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
1188236|NCT02086058|children|children
1188237|NCT02086058|gene expression|gene expression
1188238|NCT02086045|Coronary artery disease|coronary artery disease
1188239|NCT02086032|Sleeping quality|sleeping quality
1188240|NCT02086032|menopause|menopause
1188241|NCT02086032|climacteric|climacteric
1188242|NCT02086032|progestin|progestin
1188243|NCT02086032|dydrogesterone|dydrogesterone
1188244|NCT02086032|micronized progesterone|micronized progesterone
1188245|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
1188253|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
1188254|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
1188255|NCT02085928|Tennis elbow|tennis elbow
1188256|NCT02085928|Lateral epicondylitis|lateral epicondylitis
1188257|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
1188258|NCT02085928|Eccentric exercise|eccentric exercise
1188259|NCT02085928|Ultrasonography|ultrasonography
1188260|NCT02085876|patients|patients
1188261|NCT02085876|present|present
1188262|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
1188263|NCT02085811|Kyphoplasty|kyphoplasty
1188264|NCT02085811|at a single level|at a single level
1188265|NCT02085811|(between T11 and L5)|(between t11 and l5)
1188266|NCT02085811|associated surgery|associated surgery
1188267|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
1188273|NCT02085759|Healthy|healthy
1188274|NCT02085733|Arthritis, Septic|arthritis, septic
1188275|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
1188276|NCT02085681|Screening|screening
1188277|NCT02085681|Tele-medicine|tele-medicine
1188278|NCT02085681|Retinal Imaging|retinal imaging
1188279|NCT02085681|Remote diagnosis|remote diagnosis
1188280|NCT02085668|Chronic Heart Failure|chronic heart failure
1188281|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
1188282|NCT02085668|Renal Denervation|renal denervation
1188283|NCT02085668|Symplicity|symplicity
1188284|NCT02085668|Sympathetic activation|sympathetic activation
1188285|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
1188286|NCT02085655|PA-Gemox regimen|pa-gemox regimen
1188287|NCT02085655|thalidomide|thalidomide
1188288|NCT02085642|Stroke|stroke
1188289|NCT02085642|Acupuncture|acupuncture
1188290|NCT02085642|Gait|gait
1188291|NCT02085642|Spasticity|spasticity
1188292|NCT02085629|renal failure, end stage|renal failure, end stage
1188293|NCT02085629|renal transplantation|renal transplantation
1188294|NCT02085629|cell therapy|cell therapy
1188295|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
1188296|NCT02085629|immune tolerance|immune tolerance
1188297|NCT02085629|ONE Study|one study
1188298|NCT02085629|immunotherapy|immunotherapy
1188299|NCT02085616|Smoking cessation|smoking cessation
1188300|NCT02085616|Tobacco cessation|tobacco cessation
1188301|NCT02085616|Quitline|quitline
1188302|NCT02085616|Telephone counselling|telephone counselling
1188303|NCT02085616|Intensity|intensity
1188304|NCT02085603|advanced solid malignancies|advanced solid malignancies
1188305|NCT02085590|BCG vaccine|bcg vaccine
1188306|NCT02085590|Sepsis|sepsis
1188307|NCT02085590|Immunity|immunity
1188308|NCT02085577|Morphine consumption|morphine consumption
1188309|NCT02085577|Postoperative pain|postoperative pain
1188310|NCT02085577|Ketamine|ketamine
1188311|NCT02085577|Side effects|side effects
1188312|NCT02085577|Spine surgery|spine surgery
1188313|NCT02085577|Chronic pain|chronic pain
1188314|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
1188315|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1188316|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
1188317|NCT02085551|visceral emboli|visceral emboli
1188318|NCT02085551|limb ischemia|limb ischemia
1188319|NCT02085551|adverse events|adverse events
1188320|NCT02085551|Indigo System|indigo system
1188321|NCT02085551|aspiration|aspiration
1188322|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
1188323|NCT02085538|renal impairment|renal impairment
1188325|NCT02085538|Cmax|cmax
1188326|NCT02085538|palbociclib|palbociclib
1188327|NCT02085538|normal matched subjects|normal matched subjects
1188328|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
1188329|NCT02085512|Major Depression|major depression
1188330|NCT02085512|Secondary Prevention|secondary prevention
1188331|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
1188332|NCT02085512|Randomized Controlled Trial|randomized controlled trial
1188333|NCT02085499|nasal ventilation|nasal ventilation
1188334|NCT02085499|premature infants|premature infants
1188335|NCT02085499|synchronized ventilation|synchronized ventilation
1188336|NCT02085486|dialysis|dialysis
1188337|NCT02085486|av shunt|av shunt
1188338|NCT02085486|cannulation|cannulation
1188339|NCT02085486|ultrasound|ultrasound
1188340|NCT02085486|outcome|outcome
1188341|NCT02085447|Homelessness|homelessness
1188342|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
1188343|NCT02085447|Antipsychotics|antipsychotics
1188344|NCT02085447|Injectables|injectables
1188345|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
1188346|NCT02085447|Psychotic Disorders|psychotic disorders
1188347|NCT02085447|Schizophrenia|schizophrenia
1188348|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
1188349|NCT02085447|Medication Adherence|medication adherence
1188350|NCT02085447|Medication Non-Adherence|medication non-adherence
1188351|NCT02085447|Community Mental Health Centers|community mental health centers
1188352|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
1188353|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
1188354|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
1188355|NCT02085369|bariatric surgery|bariatric surgery
1188356|NCT02085369|cognitive function|cognitive function
1188357|NCT02085369|gene expression|gene expression
1188359|NCT02085356|PMTCT|pmtct
1188360|NCT02085356|South Africa|south africa
1188361|NCT02085356|Couples|couples
1188362|NCT02085356|Male involvement|male involvement
1188363|NCT02085343|Exposure therapy|exposure therapy
1188364|NCT02085343|Specific phobia|specific phobia
1188365|NCT02085343|Fear of heights|fear of heights
1188366|NCT02085343|Acrophobia|acrophobia
1188367|NCT02085343|Safety behavior fading|safety behavior fading
1188368|NCT02085343|Anti-phobic Actions|anti-phobic actions
1188369|NCT02085317|Microcirculation|microcirculation
1188370|NCT02085317|Leprosy|leprosy
1188371|NCT02085317|Nervous system|nervous system
1188372|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
1188373|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
1188374|NCT02085317|Iontophoresis.|iontophoresis.
1188375|NCT02085304|Glioblastoma|glioblastoma
1188376|NCT02085304|GBM|gbm
1188377|NCT02085304|Radiation|radiation
1188378|NCT02085304|GammaKnife(R)|gammaknife(r)
1188379|NCT02085304|Radiosurgery|radiosurgery
1188380|NCT02085304|Gliadel(R)|gliadel(r)
1188381|NCT02085304|Temozolomide|temozolomide
1188382|NCT02085304|Temodar(R)|temodar(r)
1188383|NCT02085291|septic shock; microcirculation; norepinephrine|septic shock; microcirculation; norepinephrine
1188384|NCT02085278|arteriovenous malformation|arteriovenous malformation
1188385|NCT02085278|Brain|brain
1188386|NCT02085278|AVM|avm
1188387|NCT02085278|Onyx|onyx
1188388|NCT02085278|Micro catheter|micro catheter
1188389|NCT02085278|catheter entrapment,|catheter entrapment,
1188390|NCT02085278|Embolization|embolization
1188391|NCT02085278|Vein Of Galen|vein of galen
1188392|NCT02085265|Alzheimer's Disease|alzheimer's disease
1188393|NCT02085265|Hypertension|hypertension
1188394|NCT02085265|Perindopril|perindopril
1188395|NCT02085265|Telmisartan|telmisartan
1188396|NCT02085265|Brain atrophy|brain atrophy
1188397|NCT02085252|Drug Therapy|drug therapy
1188398|NCT02085239|Breast Biopsy|breast biopsy
1188399|NCT02085239|Ultrasound|ultrasound
1188400|NCT02085239|Lidocaine|lidocaine
1188401|NCT02085239|Ropivacaine|ropivacaine
1188402|NCT02085239|Breast Lesion|breast lesion
1188403|NCT02085226|Stroke|stroke
1188404|NCT02085226|Rehabilitation|rehabilitation
1188405|NCT02085226|Creative Engagement|creative engagement
1188406|NCT02085226|Psychosocial|psychosocial
1188407|NCT02085226|Art|art
1188408|NCT02085213|Retained placenta|retained placenta
1188409|NCT02085213|Manual Removal of Placenta|manual removal of placenta
1188410|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
1188411|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
1188412|NCT02085200|overhead athlete|overhead athlete
1188413|NCT02085200|shoulder exercise|shoulder exercise
1188414|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
1188415|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
1188416|NCT02085200|posterior rotator cuff|posterior rotator cuff
1188417|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
1188418|NCT02085187|Training|training
1188419|NCT02085187|Counselling|counselling
1188420|NCT02085187|Telemedicine|telemedicine
1188421|NCT02085187|Videoconference|videoconference
1188422|NCT02085187|COPD|copd
1188423|NCT02085187|Chronic disease|chronic disease
1188424|NCT02085187|Internet.|internet.
1188425|NCT02085148|Pediatric cancer|pediatric cancer
1188426|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
1188427|NCT02085148|Ewing sarcoma|ewing sarcoma
1188428|NCT02085148|Hepatoblastoma|hepatoblastoma
1188429|NCT02085148|Neuroblastoma|neuroblastoma
1188430|NCT02085148|Wilm's tumor|wilm's tumor
1188431|NCT02085135|depression|depression
1188432|NCT02085135|major depressive disorder|major depressive disorder
1188433|NCT02085135|Alkermes|alkermes
1188434|NCT02085135|ALKS 5461|alks 5461
1188435|NCT02085135|samidorphan|samidorphan
1188436|NCT02085135|buprenorphine|buprenorphine
1188437|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
1188438|NCT02085109|HDL metabolism|hdl metabolism
1188439|NCT02085109|ApoA-I|apoa-i
1188440|NCT02085109|High fat|high fat
1188441|NCT02085109|Theobromine|theobromine
1188442|NCT02085096|Caregivers|caregivers
1188443|NCT02085096|Coping Skills|coping skills
1188444|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
1188445|NCT02085083|Transition|transition
1188446|NCT02085083|Adolescent|adolescent
1188547|NCT02084563|MDS|mds
1188447|NCT02085083|Chronic Disease|chronic disease
1188448|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
1188449|NCT02085044|malnutrition|malnutrition
1188450|NCT02085044|children's health|children's health
1188451|NCT02085044|prevention|prevention
1188452|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
1188453|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
1188454|NCT02085044|chad|chad
1188455|NCT02085044|children|children
1188456|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
1188457|NCT02085031|laparoscopic surgery|laparoscopic surgery
1188458|NCT02085031|minilaparotomy|minilaparotomy
1188459|NCT02085031|stomach neoplasms|stomach neoplasms
1188460|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
1188461|NCT02084992|Congestive Heart Failure|congestive heart failure
1188462|NCT02084992|Disease management|disease management
1188463|NCT02084992|Hospitalization|hospitalization
1188464|NCT02084979|Primary care mental health consultation|primary care mental health consultation
1188465|NCT02084979|Telepsychiatry|telepsychiatry
1188466|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
1188467|NCT02084966|Kidney|kidney
1188468|NCT02084966|Transplantation|transplantation
1188469|NCT02084966|Imaging|imaging
1188470|NCT02084966|Renal function|renal function
1188471|NCT02084966|Optical Coherence Tomography|optical coherence tomography
1188472|NCT02084940|PCOS|pcos
1188473|NCT02084940|OHSS|ohss
1188474|NCT02084940|GnRH antagonist|gnrh antagonist
1188475|NCT02084940|IVF|ivf
1188476|NCT02084940|COH|coh
1188477|NCT02084914|endometrial scratching|endometrial scratching
1188478|NCT02084914|pipelle|pipelle
1188479|NCT02084914|pregnancy rate|pregnancy rate
1188480|NCT02084914|unexplained infertility|unexplained infertility
1188481|NCT02084901|Biodegradable stents|biodegradable stents
1188482|NCT02084901|converage|converage
1188483|NCT02084901|OCT|oct
1188484|NCT02084875|Food effect|food effect
1188485|NCT02084875|pharmacokinetic|pharmacokinetic
1188486|NCT02084875|healthy volunteer|healthy volunteer
1188487|NCT02084862|Tracheostomy|tracheostomy
1188488|NCT02084862|Ultrasound|ultrasound
1188489|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
1188490|NCT02084797|arginine vasopressin|arginine vasopressin
1188491|NCT02084797|sweat sodium|sweat sodium
1188492|NCT02084797|V2 antagonist|v2 antagonist
1188493|NCT02084797|running|running
1188494|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
1188495|NCT02084784|Image guided surgery|image guided surgery
1188496|NCT02084784|Breast cancer;|breast cancer;
1188497|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
1188498|NCT02084784|Indocyanine green|indocyanine green
1188499|NCT02084784|Methylene blue|methylene blue
1188500|NCT02084771|contrast nephropathy|contrast nephropathy
1188501|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
1188502|NCT02084771|acute kidney injury|acute kidney injury
1188503|NCT02084771|prophylaxis|prophylaxis
1188504|NCT02084771|randomized trial|randomized trial
1188505|NCT02084758|COPD|copd
1188506|NCT02084758|nitrate supplementation|nitrate supplementation
1188507|NCT02084758|metabolic efficiency|metabolic efficiency
1188508|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
1188509|NCT02084745|Glaucoma drainage device|glaucoma drainage device
1188510|NCT02084745|Ahmed tube shunt|ahmed tube shunt
1188511|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
1188512|NCT02084680|Prenatal|prenatal
1188513|NCT02084680|Newborn care|newborn care
1188514|NCT02084680|mobile phones|mobile phones
1188515|NCT02084654|prediabetes|prediabetes
1188516|NCT02084654|exenatide|exenatide
1188517|NCT02084654|weight loss|weight loss
1188518|NCT02084654|insulin resistance|insulin resistance
1188519|NCT02084654|acute insulin response|acute insulin response
1188520|NCT02084654|insulin secretion|insulin secretion
1188521|NCT02084641|ectopic fat|ectopic fat
1188522|NCT02084641|obesity|obesity
1188523|NCT02084641|triglyceride storage|triglyceride storage
1188524|NCT02084641|adipocyte|adipocyte
1188525|NCT02084641|overfeeding|overfeeding
1188526|NCT02084641|intrahepatic fat|intrahepatic fat
1188527|NCT02084641|adipocyte proliferation|adipocyte proliferation
1188528|NCT02084641|inflammation|inflammation
1188529|NCT02084641|macrophage|macrophage
1188530|NCT02084615|Aspirin|aspirin
1188531|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
1188532|NCT02084615|Inguinal hernia|inguinal hernia
1188533|NCT02084602|artesunate|artesunate
1188534|NCT02084602|mefloquine|mefloquine
1188535|NCT02084602|falciparum|falciparum
1188536|NCT02084602|peruvian amazon|peruvian amazon
1188537|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
1188538|NCT02084576|Cystoid macular edema|cystoid macular edema
1188539|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
1188541|NCT02084576|phacoemulsification.|phacoemulsification.
1188542|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
1188543|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1188544|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
1188545|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
1188548|NCT02084563|MPN|mpn
1188549|NCT02084563|AML|aml
1188550|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
1188551|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
1188552|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
1188553|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
1188554|NCT02084537|symptomatic|symptomatic
1188555|NCT02084537|infected|infected
1188556|NCT02084537|necrotic collection|necrotic collection
1188557|NCT02084524|vulnerable|vulnerable
1188558|NCT02084524|nutrition|nutrition
1188559|NCT02084524|cancer|cancer
1188560|NCT02084524|colorectal|colorectal
1188561|NCT02084524|tumor|tumor
1188562|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
1188563|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
1188564|NCT02084498|Patient empowerment|patient empowerment
1188565|NCT02084485|COPD|copd
1188566|NCT02084485|LPS|lps
1188567|NCT02084472|atopic eczema|atopic eczema
1188568|NCT02084472|moisturisers|moisturisers
1188569|NCT02084472|alternatives|alternatives
1188570|NCT02084472|affordable|affordable
1188571|NCT02084459|Chronic pain|chronic pain
1188572|NCT02084459|Supportive care|supportive care
1188573|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
1188574|NCT02084459|Autonomy support|autonomy support
1188575|NCT02084459|Nursing intervention|nursing intervention
1188576|NCT02084446|Everolimus|everolimus
1188577|NCT02084446|Tacrolimus|tacrolimus
1188578|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
1188579|NCT02084446|CMV|cmv
1188580|NCT02084446|Graft function|graft function
1188581|NCT02084446|Acute rejection|acute rejection
1188582|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
1188583|NCT02084407|DM1|dm1
1188584|NCT02084407|Cardiopathy|cardiopathy
1188585|NCT02084407|Adult|adult
1188586|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
1188587|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
1188588|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
1188589|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
1188590|NCT02084355|Significant cancer pain|significant cancer pain
1188591|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
1188592|NCT02084342|desmopressin|desmopressin
1188593|NCT02084342|tranexamic acid|tranexamic acid
1188594|NCT02084342|blood loss|blood loss
1188595|NCT02084342|transfusion need|transfusion need
1188596|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
1188597|NCT02084329|Physiotherapy|physiotherapy
1188598|NCT02084329|Physical therapy|physical therapy
1188599|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
1188600|NCT02084329|Rehabilitation|rehabilitation
1188601|NCT02084329|Balance|balance
1188602|NCT02084329|Balance Confidence|balance confidence
1188603|NCT02084329|concussion|concussion
1188604|NCT02084329|Post-Concussion|post-concussion
1188605|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
1188606|NCT02084316|China CDC|china cdc
1188607|NCT02084316|One4All testing algorithm|one4all testing algorithm
1188608|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
1188609|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
1188610|NCT02084290|Crohn's disease|crohn's disease
1188611|NCT02084290|Shared Decision Making|shared decision making
1188612|NCT02084290|Decision Aid|decision aid
1188613|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
1188614|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
1188615|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
1188616|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
1188617|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
1188618|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1188619|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
1188620|NCT02084251|safety,|safety,
1188621|NCT02084251|pharmacokinetics,|pharmacokinetics,
1188622|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
1188623|NCT02084238|SLE, IL-2|sle, il-2
1188624|NCT02084225|low resource|low resource
1188625|NCT02084225|conflict setting|conflict setting
1188626|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
1188627|NCT02084225|acute injuries|acute injuries
1188628|NCT02084225|pain management|pain management
1188629|NCT02084225|education|education
1188630|NCT02084225|ultrasound|ultrasound
1188631|NCT02084225|trauma|trauma
1188632|NCT02084225|emergency department|emergency department
1188633|NCT02084173|alcohol|alcohol
1188634|NCT02084173|60+ years|60+ years
1188635|NCT02084173|treatment|treatment
1188636|NCT02084173|met|met
1188637|NCT02084173|cra|cra
1188638|NCT02084173|multi site|multi site
1188639|NCT02084173|multi country|multi country
1188640|NCT02084173|questionnaire|questionnaire
1188641|NCT02084173|random|random
1188642|NCT02084134|pituitary adenoma|pituitary adenoma
1188643|NCT02084134|Pituitary Tumor|pituitary tumor
1188644|NCT02084134|transsphenoidal resection|transsphenoidal resection
1188742|NCT02083679|Sym004|sym004
1188645|NCT02084134|pituitary cyst|pituitary cyst
1188646|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
1188647|NCT02084108|Frail and dependent older adults|frail and dependent older adults
1188648|NCT02084108|Integrated care|integrated care
1188649|NCT02084108|Home care|home care
1188650|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
1188651|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
1188652|NCT02084108|Palliative care.|palliative care.
1188653|NCT02084043|aerosol delivery|aerosol delivery
1188654|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
1188655|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
1188656|NCT02084043|non invasive ventilation|non invasive ventilation
1188657|NCT02084043|bilevel ventilator|bilevel ventilator
1188658|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
1188659|NCT02084043|Amikacin|amikacin
1188660|NCT02084030|cardiac surgery|cardiac surgery
1188662|NCT02084030|GWAS|gwas
1188663|NCT02084030|Susceptibility gene|susceptibility gene
1188664|NCT02084017|Surgical Site Infection|surgical site infection
1188665|NCT02084017|Vascular Surgery|vascular surgery
1188666|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
1188667|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
1188668|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
1188669|NCT02084004|Bifidobacterium|bifidobacterium
1188670|NCT02083991|NODAT|nodat
1188671|NCT02083991|Renal transplantation|renal transplantation
1188672|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
1188673|NCT02083991|CNI minimization|cni minimization
1188674|NCT02083978|Bipolar Disorder|bipolar disorder
1188675|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
1188676|NCT02083939|Inguinal hernia|inguinal hernia
1188677|NCT02083939|Mesh repair|mesh repair
1188678|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
1188679|NCT02083939|Herniorrhaphy|herniorrhaphy
1188680|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
1188681|NCT02083926|Social Anxiety Disorder|social anxiety disorder
1188682|NCT02083926|SAD|sad
1188683|NCT02083926|Ketamine|ketamine
1188684|NCT02083913|Severely obese|severely obese
1188685|NCT02083913|Bariatric surgery|bariatric surgery
1188686|NCT02083913|Physical activity|physical activity
1188687|NCT02083913|Physical fitness|physical fitness
1188688|NCT02083913|Telehealth|telehealth
1188689|NCT02083913|Quality of life|quality of life
1188690|NCT02083887|Immune response|immune response
1188691|NCT02083887|Vaccine|vaccine
1188692|NCT02083887|Malaria|malaria
1188693|NCT02083874|cannabidiol|cannabidiol
1188694|NCT02083874|CBD|cbd
1188695|NCT02083874|marijuana|marijuana
1188696|NCT02083874|withdrawal|withdrawal
1188697|NCT02083874|treatment|treatment
1188698|NCT02083861|osteoarthritis|osteoarthritis
1188699|NCT02083861|arthritis|arthritis
1188700|NCT02083861|musculoskeletal|musculoskeletal
1188701|NCT02083861|connective tissue disease|connective tissue disease
1188702|NCT02083861|ultrasound|ultrasound
1188703|NCT02083861|pain|pain
1188704|NCT02083861|mobility|mobility
1188705|NCT02083861|heat|heat
1188706|NCT02083861|strength|strength
1188707|NCT02083861|ZetrOZ|zetroz
1188708|NCT02083861|LITUS|litus
1188709|NCT02083861|Sam|sam
1188710|NCT02083861|grade 1|grade 1
1188711|NCT02083861|grade 2|grade 2
1188712|NCT02083848|Locoregional invasion|locoregional invasion
1188713|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
1188714|NCT02083835|post-operative pain|post-operative pain
1188715|NCT02083835|paitent reported outcomes|paitent reported outcomes
1188716|NCT02083835|quality improvement|quality improvement
1188717|NCT02083822|premature baby|premature baby
1188718|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
1188719|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
1188720|NCT02083796|manual therapy|manual therapy
1188721|NCT02083796|rehabilitation|rehabilitation
1188722|NCT02083796|shoulder|shoulder
1188723|NCT02083796|spine|spine
1188724|NCT02083770|Hispanics|hispanics
1188725|NCT02083770|Patient Participation|patient participation
1188726|NCT02083770|Refusal to Participate|refusal to participate
1188727|NCT02083770|Education|education
1188728|NCT02083770|Clinical Trials|clinical trials
1188729|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
1188730|NCT02083744|Congestive Heart Failure|congestive heart failure
1188731|NCT02083744|Self-care|self-care
1188733|NCT02083731|CMV infection|cmv infection
1188734|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
1188735|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1188736|NCT02083718|Poor Graft Function|poor graft function
1188737|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
1188738|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
1188739|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1188740|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
1188741|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1188743|NCT02083666|Phase I|phase i
1188744|NCT02083666|Dose cohorts|dose cohorts
1188745|NCT02083666|Escalating dose|escalating dose
1188746|NCT02083666|Single dose|single dose
1188747|NCT02083666|Multiple dose|multiple dose
1188748|NCT02083666|Safety|safety
1188749|NCT02083666|Tolerability|tolerability
1188750|NCT02083666|Pharmacokinetics|pharmacokinetics
1188751|NCT02083666|Pharmacodynamics|pharmacodynamics
1188752|NCT02083666|volunteers|volunteers
1188753|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
1188754|NCT02083653|Sym004|sym004
1188755|NCT02083653|Best Supportive Care|best supportive care
1188756|NCT02083653|Capecitabine|capecitabine
1188757|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
1188758|NCT02083640|healthy volunteer|healthy volunteer
1188759|NCT02083640|bioavailability|bioavailability
1188760|NCT02083640|palbociclib|palbociclib
1188761|NCT02083640|formulation|formulation
1188762|NCT02083627|Pharmacokinetics|pharmacokinetics
1188763|NCT02083627|Drug-Drug Interaction|drug-drug interaction
1188764|NCT02083627|Intestinal Absorption|intestinal absorption
1188765|NCT02083627|Fidaxomicin|fidaxomicin
1188766|NCT02083627|Rosuvastatin|rosuvastatin
1188767|NCT02083627|Multiple Doses|multiple doses
1188768|NCT02083627|Single Doses|single doses
1188769|NCT02083601|Caregivers|caregivers
1188770|NCT02083601|Spinal Cord Injuries|spinal cord injuries
1188771|NCT02083601|Psychology, Educational|psychology, educational
1188772|NCT02083601|Counseling|counseling
1188773|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
1188774|NCT02083588|Fibromyalgia|fibromyalgia
1188775|NCT02083588|dTMS|dtms
1188776|NCT02083588|pain|pain
1188777|NCT02083588|PFC|pfc
1188778|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
1188779|NCT02083575|vitamin c|vitamin c
1188780|NCT02083575|thalassemia major|thalassemia major
1188781|NCT02083575|iron chelation|iron chelation
1188782|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
1188783|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
1188784|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
1188785|NCT02083536|LDFWART|ldfwart
1188786|NCT02083536|Docetaxel|docetaxel
1188787|NCT02083536|Ovarian Cancer|ovarian cancer
1188788|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
1188789|NCT02083536|Platinum-Resistant|platinum-resistant
1188790|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
1188791|NCT02083510|Colchicine|colchicine
1188792|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
1188793|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
1188794|NCT02083497|kick|kick
1188795|NCT02083497|taping|taping
1188796|NCT02083497|dynamic equilibrium|dynamic equilibrium
1188797|NCT02083458|critical care|critical care
1188798|NCT02083458|catheterization|catheterization
1188799|NCT02083458|axillary vein|axillary vein
1188800|NCT02083445|Traumatic brain injury|traumatic brain injury
1188801|NCT02083445|Exercise|exercise
1188802|NCT02083445|Psychology|psychology
1188803|NCT02083445|Physiology|physiology
1188804|NCT02083445|Progenitor cells|progenitor cells
1188805|NCT02083445|Hypoxia|hypoxia
1188806|NCT02083432|intra-oral injections|intra-oral injections
1188807|NCT02083432|CBT|cbt
1188808|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
1188809|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
1188810|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
1188811|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
1188812|NCT02083406|Malaria|malaria
1188813|NCT02083406|Bio-availability|bio-availability
1188814|NCT02083393|dendritic cell|dendritic cell
1188815|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
1188816|NCT02083380|malaria|malaria
1188817|NCT02083380|OZ439|oz439
1188818|NCT02083380|piperaquine|piperaquine
1188819|NCT02083380|PQP|pqp
1188820|NCT02083354|melanoma|melanoma
1188821|NCT02083354|dabrafenib|dabrafenib
1188822|NCT02083354|trametinib|trametinib
1188823|NCT02083328|heart rate variability|heart rate variability
1188824|NCT02083328|exercise performance|exercise performance
1188825|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
1188826|NCT02083302|campus sexual assault|campus sexual assault
1188827|NCT02083302|bystander intervention|bystander intervention
1188828|NCT02083289|ONO-9054|ono-9054
1188829|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
1188830|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
1188831|NCT02083289|Glaucoma|glaucoma
1188832|NCT02083289|Eye Diseases|eye diseases
1188833|NCT02083289|Mild to moderate|mild to moderate
1188834|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
1188835|NCT02083276|Urethritis|urethritis
1188836|NCT02083276|Genital Diseases, Male|genital diseases, male
1188837|NCT02083263|Lung function|lung function
1188838|NCT02083250|Leukemia|leukemia
1188839|NCT02083250|Blood And Marrow Transplantation|blood and marrow transplantation
1188840|NCT02083250|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1188842|NCT02083250|Acute myeloid leukemia|acute myeloid leukemia
1188843|NCT02083250|AML|aml
1188844|NCT02083250|Myelodysplastic syndrome|myelodysplastic syndrome
1188845|NCT02083250|MDS|mds
1188846|NCT02083250|Allogeneic stem cell transplant|allogeneic stem cell transplant
1188847|NCT02083250|SCT|sct
1188848|NCT02083250|Thymoglobulin|thymoglobulin
1188849|NCT02083250|ATG|atg
1188850|NCT02083250|Antithymocyte Globulin|antithymocyte globulin
1188851|NCT02083250|Fludarabine|fludarabine
1188852|NCT02083250|Fludarabine Phosphate|fludarabine phosphate
1188853|NCT02083250|Fludara|fludara
1188854|NCT02083250|Clofarabine|clofarabine
1188855|NCT02083250|Clofarex|clofarex
1188856|NCT02083250|Clolar|clolar
1188857|NCT02083250|Busulfan|busulfan
1188858|NCT02083250|Busulfex|busulfex
1188859|NCT02083250|Myleran|myleran
1188860|NCT02083250|SAHA|saha
1188861|NCT02083250|Vorinostat|vorinostat
1188862|NCT02083250|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1188863|NCT02083250|MSK-390|msk-390
1188864|NCT02083250|Zolinza|zolinza
1188865|NCT02083237|mild cognitive impairment|mild cognitive impairment
1188866|NCT02083237|memory training|memory training
1188867|NCT02083237|healthy lifestyle|healthy lifestyle
1188868|NCT02083237|psychosocial support|psychosocial support
1188869|NCT02083211|Cervical cancer|cervical cancer
1188870|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
1188871|NCT02083211|Monoclonal antibody|monoclonal antibody
1188872|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
1188873|NCT02083198|balanced fluids|balanced fluids
1188874|NCT02083198|plasmalyte|plasmalyte
1188875|NCT02083185|Drug therapy|drug therapy
1188876|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
1188877|NCT02083172|2D echocardiography|2d echocardiography
1188878|NCT02083172|agreement|agreement
1188879|NCT02083172|pediatrics|pediatrics
1188880|NCT02083133|Diabetes|diabetes
1188881|NCT02083133|Renal Failure|renal failure
1188882|NCT02083133|Dialysis|dialysis
1188883|NCT02083133|End Stage Renal Disease|end stage renal disease
1188884|NCT02083133|Hypoglycemia|hypoglycemia
1188885|NCT02083120|high flow|high flow
1188886|NCT02083120|COPD|copd
1188887|NCT02083120|AIRVO|airvo
1188888|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
1188889|NCT02083107|Intrapartum blood loss|intrapartum blood loss
1188890|NCT02083107|Misoprostol|misoprostol
1188891|NCT02083081|tobacco|tobacco
1188892|NCT02083081|smoking|smoking
1188893|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
1188894|NCT02083055|dexmedetomidine|dexmedetomidine
1188895|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
1188896|NCT02083042|CMV|cmv
1188897|NCT02083042|T-Track CMV|t-track cmv
1188898|NCT02083042|kidney transplantation|kidney transplantation
1188899|NCT02083029|Asthma|asthma
1188900|NCT02083029|Death|death
1188901|NCT02083029|Mechanism|mechanism
1188902|NCT02083029|Syncope|syncope
1188903|NCT02083029|Dive reflex|dive reflex
1188904|NCT02083003|Pain|pain
1188905|NCT02083003|Polyamine|polyamine
1188906|NCT02083003|Cholecystectomy|cholecystectomy
1188907|NCT02082990|Alcohol-related disorders|alcohol-related disorders
1188908|NCT02082990|Alcohol Drinking|alcohol drinking
1188909|NCT02082990|e-health|e-health
1188910|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
1188911|NCT02082990|Quality of Life|quality of life
1188912|NCT02082977|Refractory|refractory
1188913|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
1188914|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
1188915|NCT02082977|Relapsed|relapsed
1188916|NCT02082977|Solid tumors|solid tumors
1188917|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
1188918|NCT02082977|Multiple myeloma|multiple myeloma
1188919|NCT02082977|GSK2816126|gsk2816126
1188920|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1188921|NCT02082938|stroke,|stroke,
1188922|NCT02082938|rehabilitation,|rehabilitation,
1188923|NCT02082938|hemiparesis,|hemiparesis,
1188924|NCT02082938|gait training|gait training
1188925|NCT02082925|Exercise training|exercise training
1188926|NCT02082925|Dyspnea threshold|dyspnea threshold
1188927|NCT02082925|6MWT|6mwt
1188928|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
1188929|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
1188930|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
1188931|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
1188932|NCT02082886|Metastasis|metastasis
1188933|NCT02082886|Carcinomatosis|carcinomatosis
1188934|NCT02082886|Carcinosis|carcinosis
1188935|NCT02082886|Sarcomatosis|sarcomatosis
1188936|NCT02082886|CRS|crs
1188937|NCT02082886|Cytoreductive surgery|cytoreductive surgery
1188938|NCT02082886|HIPEC|hipec
1188939|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
1188940|NCT02082886|Intra-abdominal|intra-abdominal
1188941|NCT02082886|Sugarbaker technique|sugarbaker technique
1188942|NCT02082886|Mitomycin C|mitomycin c
1188943|NCT02082886|Cisplatin|cisplatin
1188944|NCT02082886|Doxorubicin|doxorubicin
1188945|NCT02082886|Oxaliplatin|oxaliplatin
1188946|NCT02082886|Melphalan|melphalan
1188947|NCT02082873|Quantitative EEG|quantitative eeg
1188948|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
1188949|NCT02082873|ICU EEG monitoring|icu eeg monitoring
1188950|NCT02082860|Porphyria|porphyria
1188951|NCT02082860|Gene therapy|gene therapy
1188952|NCT02082860|AAV|aav
1188953|NCT02082860|Liver gene transfer|liver gene transfer
1188954|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
1188955|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
1188956|NCT02082834|VEOTM|veotm
1188957|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
1188958|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
1188959|NCT02082834|Aortic Aneurysm|aortic aneurysm
1188960|NCT02082834|Low dose|low dose
1188961|NCT02082834|Prospective|prospective
1188962|NCT02082834|CTA|cta
1188963|NCT02082808|Dolutegravir|dolutegravir
1188964|NCT02082808|healthy volunteer|healthy volunteer
1188965|NCT02082808|pharmacokinetics|pharmacokinetics
1188966|NCT02082808|daclatasvir|daclatasvir
1188967|NCT02082808|drug interaction|drug interaction
1188968|NCT02082795|Breech presentation|breech presentation
1188969|NCT02082795|External cephalic version|external cephalic version
1188970|NCT02082795|Anaesthesia|anaesthesia
1188971|NCT02082795|Qualitative|qualitative
1188972|NCT02082795|Pregnancy|pregnancy
1188973|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
1188974|NCT02082782|Tumor ablation|tumor ablation
1188975|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
1188976|NCT02082782|Interventional oncology|interventional oncology
1188977|NCT02082782|NanoKnife|nanoknife
1188978|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
1188979|NCT02082769|Gout|gout
1188980|NCT02082769|Uric Acid|uric acid
1188981|NCT02082769|Xanthine oxidase|xanthine oxidase
1188982|NCT02082769|Febuxostat|febuxostat
1188983|NCT02082756|Prediabetes|prediabetes
1188984|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
1188985|NCT02082756|Bifidobacterium|bifidobacterium
1188986|NCT02082743|Myopia|myopia
1188987|NCT02082743|Outdoor activity|outdoor activity
1188988|NCT02082743|Recess outside classroom|recess outside classroom
1188989|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
1188990|NCT02082704|Diabetes|diabetes
1188991|NCT02082704|Education, Patient|education, patient
1188992|NCT02082704|Educational Technology|educational technology
1188993|NCT02082691|G-202|g-202
1188994|NCT02082691|Hepatocellular|hepatocellular
1188995|NCT02082678|Bipolar Disorder|bipolar disorder
1188996|NCT02082678|BPD|bpd
1188997|NCT02082678|Alcohol Use Disorder|alcohol use disorder
1188998|NCT02082678|Alcohol Abuse|alcohol abuse
1188999|NCT02082678|Alcohol Dependence|alcohol dependence
1189000|NCT02082678|Ondansetron|ondansetron
1189001|NCT02082678|Cognition|cognition
1189002|NCT02082678|Mood|mood
1189003|NCT02082665|rosuvastatin|rosuvastatin
1189004|NCT02082665|BRAF V600|braf v600
1189005|NCT02082665|Melanoma|melanoma
1189006|NCT02082665|dabrafenib|dabrafenib
1189007|NCT02082665|midazolam|midazolam
1189008|NCT02082652|Etonogestrel|etonogestrel
1189009|NCT02082652|Efavirenz|efavirenz
1189010|NCT02082652|Nevirapine|nevirapine
1189011|NCT02082652|Pharmacokinetics|pharmacokinetics
1189012|NCT02082639|Adolescents|adolescents
1189013|NCT02082639|Havrix|havrix
1189014|NCT02082639|Immunogenicity|immunogenicity
1189015|NCT02082639|Cervarix|cervarix
1189016|NCT02082639|Safety|safety
1189017|NCT02082626|Phase I|phase i
1189018|NCT02082626|Pediatric|pediatric
1189019|NCT02082626|Cancer|cancer
1189020|NCT02082626|Lymphoma|lymphoma
1189021|NCT02082626|Eribulin|eribulin
1189022|NCT02082613|Testicular hydrocele|testicular hydrocele
1189023|NCT02082613|Hydrocele|hydrocele
1189024|NCT02082613|Sclerotherapy|sclerotherapy
1189025|NCT02082613|Surgery|surgery
1189026|NCT02082613|Complications|complications
1189027|NCT02082587|brain metastases|brain metastases
1189028|NCT02082587|brain mets|brain mets
1189029|NCT02082587|WBRT|wbrt
1189030|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
1189031|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
1189032|NCT02082561|anxiety|anxiety
1189033|NCT02082561|panic disorder|panic disorder
1189034|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
1189035|NCT02082561|social anxiety disorder|social anxiety disorder
1189036|NCT02082548|atrial fibrillation|atrial fibrillation
1189037|NCT02082548|anticoagulation|anticoagulation
1189038|NCT02082548|education|education
1189039|NCT02082548|educational intervention|educational intervention
1189040|NCT02082535|Premature Birth|premature birth
1189041|NCT02082535|Brain Injuries|brain injuries
1189042|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
1189043|NCT02082535|S100B protein human|s100b protein human
1189242|NCT02081547|cytology|cytology
1189044|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
1189045|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
1189046|NCT02082535|Developmental Disabilities|developmental disabilities
1189047|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
1189048|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
1189049|NCT02082522|Klatskin tumor|klatskin tumor
1189050|NCT02082522|Photodynamic therapy|photodynamic therapy
1189051|NCT02082522|Porfimer sodium|porfimer sodium
1189052|NCT02082522|Photofrin|photofrin
1189053|NCT02082522|Gemcitabine|gemcitabine
1189054|NCT02082522|Cisplatin|cisplatin
1189055|NCT02082522|Stents|stents
1189056|NCT02082522|CCA|cca
1189057|NCT02082522|PDT|pdt
1189058|NCT02082522|Bile duct cancer|bile duct cancer
1189059|NCT02082522|Bile duct tumor|bile duct tumor
1189060|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
1189061|NCT02082522|Chemotherapy|chemotherapy
1189062|NCT02082509|Traumatic Brain Injury|traumatic brain injury
1189063|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
1189064|NCT02082509|Brain Imaging|brain imaging
1189065|NCT02082509|Cognition|cognition
1189066|NCT02082496|Obesity|obesity
1189067|NCT02082496|Obesity Genetics|obesity genetics
1189068|NCT02082496|GLP-1|glp-1
1189069|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
1189070|NCT02082483|Kidney Transplant|kidney transplant
1189071|NCT02082483|Screening|screening
1189072|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
1189073|NCT02082457|Constipation|constipation
1189074|NCT02082457|C-IBS|c-ibs
1189075|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
1189076|NCT02082431|Long QT Syndrome|long qt syndrome
1189077|NCT02082418|Mild cognitive impairment|mild cognitive impairment
1189078|NCT02082418|Protein digestion|protein digestion
1189079|NCT02082418|Tryptophan digestion|tryptophan digestion
1189080|NCT02082418|Cognitive function|cognitive function
1189081|NCT02082418|Mood|mood
1189082|NCT02082418|Muscle function|muscle function
1189083|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
1189084|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
1189085|NCT02082366|Atrial fibrillation|atrial fibrillation
1189086|NCT02082366|CPVI|cpvi
1189087|NCT02082366|TCD|tcd
1189088|NCT02082366|nMARQ|nmarq
1189089|NCT02082366|MES|mes
1189090|NCT02082366|microembolic signals|microembolic signals
1189091|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
1189092|NCT02082353|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1189093|NCT02082353|bone marrow transplant (BMT)|bone marrow transplant (bmt)
1189094|NCT02082353|non-transplant|non-transplant
1189095|NCT02082353|factors associated with best outcomes of transplant in CGD|factors associated with best outcomes of transplant in cgd
1189096|NCT02082340|Tuberculosis|tuberculosis
1189097|NCT02082340|Armenia|armenia
1189098|NCT02082340|Clinical trial|clinical trial
1189099|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
1189100|NCT02082340|Self-administered drug intake|self-administered drug intake
1189101|NCT02082327|Fabry Disease|fabry disease
1189102|NCT02082327|Fabry|fabry
1189103|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
1189104|NCT02082327|LSD|lsd
1189105|NCT02082327|Amicus|amicus
1189106|NCT02082327|migalastat HCl|migalastat hcl
1189107|NCT02082327|migalastat|migalastat
1189108|NCT02082327|AT1001|at1001
1189109|NCT02082314|radiofrequency ablation|radiofrequency ablation
1189110|NCT02082314|bone metastases|bone metastases
1189111|NCT02082288|ICSI outcome|icsi outcome
1189112|NCT02082275|Prenatal Care|prenatal care
1189113|NCT02082275|Obstetrics|obstetrics
1189114|NCT02082249|Safety|safety
1189115|NCT02082249|Tolerability|tolerability
1189116|NCT02082249|Efficacy|efficacy
1189117|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1189118|NCT02082249|levodopa|levodopa
1189119|NCT02082249|carbidopa|carbidopa
1189120|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
1189121|NCT02082236|Plasma concentrations|plasma concentrations
1189122|NCT02082223|Quality of life|quality of life
1189123|NCT02082223|Deficits|deficits
1189124|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
1189125|NCT02082197|low testosterone|low testosterone
1189126|NCT02082184|Sensing Technology|sensing technology
1189127|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
1189128|NCT02082171|older adults|older adults
1189129|NCT02082171|physical disability|physical disability
1189130|NCT02082171|multidomain intervention|multidomain intervention
1189131|NCT02082171|prevention|prevention
1189132|NCT02082171|pilot study|pilot study
1189133|NCT02082171|frailty|frailty
1189134|NCT02082171|mobility|mobility
1189135|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
1189136|NCT02082106|alpine skiing|alpine skiing
1189137|NCT02082106|cross country skiing|cross country skiing
1189138|NCT02082106|indoor cycling|indoor cycling
1189139|NCT02082106|physical fitness|physical fitness
1189140|NCT02082106|training status|training status
1189141|NCT02082106|metabolic equivalent|metabolic equivalent
1189142|NCT02082093|Chronic Kidney Disease|chronic kidney disease
1189143|NCT02082093|telemedicine|telemedicine
1189144|NCT02082054|rhinitis|rhinitis
1189145|NCT02082054|seasonal|seasonal
1189146|NCT02082054|allergic|allergic
1189147|NCT02082015|Neuronal plasticity|neuronal plasticity
1189273|NCT02081391|Acute Pain|acute pain
1189148|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
1189149|NCT02082015|Stroke|stroke
1189150|NCT02082015|Upper extremity|upper extremity
1189151|NCT02082015|Function|function
1189152|NCT02082015|Recovery|recovery
1189153|NCT02082002|Multiple scerlosis|multiple scerlosis
1189154|NCT02082002|Fatigue|fatigue
1189155|NCT02082002|Sleep|sleep
1189156|NCT02082002|Somnolence|somnolence
1189157|NCT02082002|Depression|depression
1189158|NCT02082002|Cognitive disorders|cognitive disorders
1189159|NCT02081989|Diabetes|diabetes
1189160|NCT02081989|Renal denervation|renal denervation
1189161|NCT02081963|Nebulized amikacin;|nebulized amikacin;
1189162|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
1189163|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
1189164|NCT02081963|Acute exacerbation.|acute exacerbation.
1189165|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
1189166|NCT02081937|immunotherapy|immunotherapy
1189167|NCT02081937|T lymphocyte|t lymphocyte
1189168|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
1189169|NCT02081924|Infertility|infertility
1189170|NCT02081924|Kisspeptin|kisspeptin
1189171|NCT02081924|Reproductive hormones|reproductive hormones
1189172|NCT02081911|adductor canal|adductor canal
1189173|NCT02081911|femoral|femoral
1189174|NCT02081911|quadriceps|quadriceps
1189175|NCT02081898|low calorie diet|low calorie diet
1189176|NCT02081898|BMI|bmi
1189177|NCT02081898|sphingomyelin|sphingomyelin
1189178|NCT02081898|L-leucine|l-leucine
1189179|NCT02081898|L-phenylalanine|l-phenylalanine
1189180|NCT02081885|Tricalcium phosphate|tricalcium phosphate
1189181|NCT02081885|Chitosan|chitosan
1189182|NCT02081885|Grafting, Bone|grafting, bone
1189183|NCT02081885|Mandibular Fractures|mandibular fractures
1189184|NCT02081872|Pharmacogenomics|pharmacogenomics
1189185|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
1189186|NCT02081846|transitions of care|transitions of care
1189187|NCT02081846|reutilization|reutilization
1189188|NCT02081846|home nurse visit|home nurse visit
1189189|NCT02081846|focus groups|focus groups
1189190|NCT02081846|quality improvement|quality improvement
1189191|NCT02081833|acute respiratory infections|acute respiratory infections
1189192|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
1189193|NCT02081833|children|children
1189194|NCT02081833|child|child
1189195|NCT02081833|symptom diary|symptom diary
1189196|NCT02081833|nasal swabs|nasal swabs
1189197|NCT02081833|stool samples|stool samples
1189198|NCT02081820|hyperglycemia|hyperglycemia
1189199|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1189200|NCT02081820|glycated hemoglobin|glycated hemoglobin
1189201|NCT02081820|outcome|outcome
1189202|NCT02081820|DCI|dci
1189203|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
1189204|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
1189205|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
1189206|NCT02081755|Liver Transplantation|liver transplantation
1189207|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
1189208|NCT02081703|Postsurgical pain|postsurgical pain
1189209|NCT02081703|Total knee arthroplasty|total knee arthroplasty
1189210|NCT02081703|Total knee replacement|total knee replacement
1189211|NCT02081690|PAH-SYMPACT|pah-sympact
1189212|NCT02081690|psychometric instrument|psychometric instrument
1189213|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
1189214|NCT02081664|feasibility pilot study|feasibility pilot study
1189215|NCT02081664|integrated medical care program|integrated medical care program
1189216|NCT02081664|lifestyle|lifestyle
1189217|NCT02081638|Immune Activation|immune activation
1189218|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
1189219|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
1189220|NCT02081625|exon 53 skipping|exon 53 skipping
1189221|NCT02081625|morpholino|morpholino
1189222|NCT02081599|insulin resistance|insulin resistance
1189223|NCT02081586|CBT|cbt
1189224|NCT02081586|Type 2 Diabetes|type 2 diabetes
1189225|NCT02081586|Diabetes Distress|diabetes distress
1189226|NCT02081586|Adherence|adherence
1189227|NCT02081586|Smartphone App|smartphone app
1189228|NCT02081586|Self-management|self-management
1189229|NCT02081573|Brief CBT|brief cbt
1189230|NCT02081573|smartphone app|smartphone app
1189231|NCT02081573|mHealth|mhealth
1189232|NCT02081573|diabetes distress|diabetes distress
1189233|NCT02081573|adherence|adherence
1189234|NCT02081573|cognitive behavioral therapy|cognitive behavioral therapy
1189235|NCT02081560|pharmacokinetics|pharmacokinetics
1189236|NCT02081560|antibiotic|antibiotic
1189237|NCT02081560|Gram negative|gram negative
1189238|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
1189239|NCT02081547|rectal carcinoma|rectal carcinoma
1189240|NCT02081547|recurrence|recurrence
1189241|NCT02081547|pathology|pathology
1189243|NCT02081547|free cancer cells|free cancer cells
1189244|NCT02081547|survival|survival
1189245|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
1189246|NCT02081521|behaviour change|behaviour change
1189247|NCT02081521|diarrhoeal disease|diarrhoeal disease
1189248|NCT02081521|handwashing|handwashing
1189249|NCT02081521|breastfeeding|breastfeeding
1189250|NCT02081521|diarrhoea management|diarrhoea management
1189251|NCT02081508|Memory|memory
1189252|NCT02081495|Neoplasms|neoplasms
1189253|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
1189254|NCT02081495|Ovarian Cancer|ovarian cancer
1189255|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
1189256|NCT02081495|Doxorubicin|doxorubicin
1189257|NCT02081495|DOXIL|doxil
1189258|NCT02081495|CAELYX|caelyx
1189259|NCT02081469|Chronic hepatitis B|chronic hepatitis b
1189260|NCT02081469|HBV|hbv
1189261|NCT02081469|Chemotherapy|chemotherapy
1189262|NCT02081469|Reactivation|reactivation
1189263|NCT02081469|Prophylaxis|prophylaxis
1189264|NCT02081443|coronary artery disease|coronary artery disease
1189265|NCT02081443|platelet function|platelet function
1189266|NCT02081443|ticagrelor|ticagrelor
1189267|NCT02081443|cangrelor|cangrelor
1189268|NCT02081417|Trauma|trauma
1189269|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
1189270|NCT02081417|substance use disorders|substance use disorders
1189271|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
1189272|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
1189274|NCT02081391|Post-operative|post-operative
1189275|NCT02081391|Tapentadol|tapentadol
1189276|NCT02081391|Opioid Treatment|opioid treatment
1189277|NCT02081391|Pediatric Participants|pediatric participants
1189278|NCT02081378|CML|cml
1189279|NCT02081378|Ph+ ALL|ph+ all
1189280|NCT02081352|Dermis|dermis
1189281|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
1189282|NCT02081352|Skin substitutes|skin substitutes
1189283|NCT02081352|Decellularized|decellularized
1189284|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
1189285|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
1189286|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
1189287|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
1189288|NCT02081326|IDDM|iddm
1189289|NCT02081313|Netherton syndrome|netherton syndrome
1189290|NCT02081313|Immune system|immune system
1189291|NCT02081313|Skin barrier|skin barrier
1189292|NCT02081300|Testosterone|testosterone
1189293|NCT02081300|Male hypogonadism|male hypogonadism
1189294|NCT02081300|Low testosterone|low testosterone
1189295|NCT02081300|LPCN 1021|lpcn 1021
1189296|NCT02081300|Androgel|androgel
1189297|NCT02081300|Testim|testim
1189298|NCT02081300|Testopel|testopel
1189299|NCT02081300|Fortesta|fortesta
1189300|NCT02081300|Axiron.|axiron.
1189301|NCT02081300|Hypogonadism|hypogonadism
1189302|NCT02081300|Eunuchism|eunuchism
1189303|NCT02081300|Gonadal Disorders|gonadal disorders
1189304|NCT02081300|Endocrine System Diseases|endocrine system diseases
1189305|NCT02081300|Testosterone enanthate|testosterone enanthate
1189306|NCT02081300|Testosterone undecanoate|testosterone undecanoate
1189307|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
1189308|NCT02081300|Methyltestosterone|methyltestosterone
1189309|NCT02081300|Androgens|androgens
1189310|NCT02081300|Hormones|hormones
1189311|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1189312|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
1189313|NCT02081300|Pharmacologic Actions|pharmacologic actions
1189314|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
1189315|NCT02081300|Antineoplastic Agents|antineoplastic agents
1189316|NCT02081300|Anabolic Agents|anabolic agents
1262307|NCT01749982|arsenic|arsenic
1189317|NCT02081287|Bipolar Disorder|bipolar disorder
1189318|NCT02081287|Depression|depression
1189319|NCT02081287|Inositol|inositol
1189320|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
1189321|NCT02081287|Phytic Acid|phytic acid
1189322|NCT02081287|IP6|ip6
1189323|NCT02081287|Lithium|lithium
1189324|NCT02081287|Lamotrigine|lamotrigine
1189325|NCT02081274|tidal volume|tidal volume
1189326|NCT02081274|congenital heart disease|congenital heart disease
1189327|NCT02081274|mortality|mortality
1189328|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
1189329|NCT02081261|acute kidney injury|acute kidney injury
1189330|NCT02081261|creatinine|creatinine
1189331|NCT02081261|mortality|mortality
1189332|NCT02081235|congenital heart disease|congenital heart disease
1189333|NCT02081235|acute kidney injury|acute kidney injury
1189334|NCT02081235|risk factor|risk factor
1189335|NCT02081235|anesthesia|anesthesia
1189336|NCT02081222|congenital heart disease|congenital heart disease
1189337|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
1189338|NCT02081222|blood loss|blood loss
1189339|NCT02081222|transfusion requirements|transfusion requirements
1189340|NCT02081209|Lipolysis|lipolysis
1189341|NCT02081209|Cryolipolysis|cryolipolysis
1189342|NCT02081209|Fat Reduction|fat reduction
1189343|NCT02081196|Lipolysis|lipolysis
1189344|NCT02081196|Cryolipolysis|cryolipolysis
1189345|NCT02081196|Fat Reduction|fat reduction
1189346|NCT02081144|Standard Care Condition|standard care condition
1189347|NCT02081144|Texting + NRT Condition|texting + nrt condition
1189348|NCT02081131|periampullary cancer|periampullary cancer
1189349|NCT02081131|pancreatic cancer|pancreatic cancer
1189350|NCT02081131|randomized controlled trial|randomized controlled trial
1189351|NCT02081131|Whipple's operation|whipple's operation
1189352|NCT02081131|laparoscopy|laparoscopy
1189353|NCT02081105|ARDS,|ards,
1189354|NCT02081105|PEEP,|peep,
1189355|NCT02081105|lung recruitment,|lung recruitment,
1189356|NCT02081105|lung recruitability,|lung recruitability,
1189357|NCT02081105|Chest-X-Ray,|chest-x-ray,
1189358|NCT02081105|lung imaging,|lung imaging,
1189359|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
1189360|NCT02081105|compliance,|compliance,
1189361|NCT02081105|respiratory mechanics|respiratory mechanics
1189362|NCT02081092|PAP|pap
1189363|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
1189364|NCT02081092|Pulmonary|pulmonary
1189365|NCT02081092|Patients|patients
1189366|NCT02081079|HCV GT 4|hcv gt 4
1189367|NCT02081079|HCV GT 5|hcv gt 5
1189368|NCT02081053|metastatic lesions|metastatic lesions
1189369|NCT02081053|vertebral body|vertebral body
1189370|NCT02081053|ablation|ablation
1189371|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
1189372|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
1189373|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
1189374|NCT02081053|spine|spine
1189375|NCT02081053|vertebral augmentation|vertebral augmentation
1189376|NCT02081053|kyphoplasty|kyphoplasty
1189377|NCT02081053|spinal ablation|spinal ablation
1189378|NCT02081053|pain|pain
1189379|NCT02081053|quality of life|quality of life
1189380|NCT02081040|brainstem|brainstem
1189381|NCT02081040|diaphragm|diaphragm
1189382|NCT02081040|deglutition disorder|deglutition disorder
1189383|NCT02081040|sonography|sonography
1189384|NCT02081014|Hypoglycemia|hypoglycemia
1189385|NCT02081014|Glucagon|glucagon
1189386|NCT02081014|Diabetes|diabetes
1189387|NCT02081001|Hypoglycemia|hypoglycemia
1189388|NCT02081001|Glucagon|glucagon
1189389|NCT02081001|Artificial Pancreas|artificial pancreas
1189390|NCT02080988|stroke|stroke
1189391|NCT02080988|deglutition disorders|deglutition disorders
1189392|NCT02080988|cough|cough
1189393|NCT02080988|aspiration pneumonia|aspiration pneumonia
1189394|NCT02080988|diaphragm|diaphragm
1189395|NCT02080988|respiratory function|respiratory function
1189396|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
1189397|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
1189398|NCT02080936|Experimental approaches|experimental approaches
1189399|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
1189400|NCT02080936|Rehabilitation|rehabilitation
1189401|NCT02080923|Adolescent|adolescent
1189402|NCT02080923|Adolescent Behavior|adolescent behavior
1189403|NCT02080923|Age Factors|age factors
1189404|NCT02080923|Courtship|courtship
1189405|NCT02080923|Randomized Control Trial|randomized control trial
1189406|NCT02080923|Female|female
1189407|NCT02080923|Male|male
1189408|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
1189409|NCT02080923|Risk-Taking|risk-taking
1189410|NCT02080923|Sex Factors|sex factors
1189411|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
1189412|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
1189413|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
1189414|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
1189415|NCT02080923|Dating Violence|dating violence
1189416|NCT02080923|Dating Aggression|dating aggression
1189417|NCT02080923|Perpetration|perpetration
1189418|NCT02080910|Caregiver|caregiver
1189419|NCT02080910|stroke|stroke
1189420|NCT02080910|psychoeducation|psychoeducation
1189421|NCT02080910|problem-solving|problem-solving
1189422|NCT02080897|non-surgical|non-surgical
1189423|NCT02080897|palliative surgery|palliative surgery
1189424|NCT02080871|PAD|pad
1189425|NCT02080871|Stent|stent
1189426|NCT02080871|Claudication|claudication
1189427|NCT02080871|Viabahn|viabahn
1189428|NCT02080871|Gore|gore
1189429|NCT02080871|Endoprosthesis|endoprosthesis
1189430|NCT02080871|Vascular Diseases|vascular diseases
1189431|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
1189432|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
1189433|NCT02080871|Balloon Expandable|balloon expandable
1189434|NCT02080871|Stent-graft|stent-graft
1189435|NCT02080871|VBX|vbx
1189436|NCT02080858|Apixaban|apixaban
1189437|NCT02080858|Ticagrelor|ticagrelor
1189438|NCT02080858|ASA|asa
1189439|NCT02080858|shed blood|shed blood
1189440|NCT02080858|perfusion chamber|perfusion chamber
1189441|NCT02080845|Caffeine|caffeine
1189442|NCT02080845|MRI|mri
1189443|NCT02080845|Brain blood flow|brain blood flow
1189444|NCT02080845|Cognition|cognition
1189445|NCT02080845|Perfusion|perfusion
1189446|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
1189447|NCT02080832|substance abuse|substance abuse
1189448|NCT02080832|cocaine|cocaine
1189449|NCT02080832|impulsivity|impulsivity
1189450|NCT02080832|serotonin|serotonin
1189451|NCT02080832|MRI|mri
1189452|NCT02080819|drug abuse|drug abuse
1189453|NCT02080819|cocaine|cocaine
1189454|NCT02080819|impulsivity|impulsivity
1189455|NCT02080819|dopamine|dopamine
1189456|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
1189457|NCT02080754|Crush induction|crush induction
1189458|NCT02080754|Cricoid pressure|cricoid pressure
1189459|NCT02080754|Sellick maneuver|sellick maneuver
1189460|NCT02080754|Lung aspiration|lung aspiration
1189461|NCT02080754|Aspiration pneumonia|aspiration pneumonia
1189462|NCT02080715|Sleep-wake|sleep-wake
1189463|NCT02080715|regulation|regulation
1189464|NCT02080715|volunteers|volunteers
1189465|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
1189466|NCT02080676|Cannabis|cannabis
1189467|NCT02080676|Intra ocular pressure|intra ocular pressure
1189468|NCT02080676|Ocular perfusion|ocular perfusion
1189469|NCT02080676|Blood pressure|blood pressure
1189470|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
1189471|NCT02080637|Single ventricle|single ventricle
1189472|NCT02080585|Inactivity|inactivity
1189473|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
1189474|NCT02080546|Thermal Injury|thermal injury
1189475|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
1189476|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
1189477|NCT02080533|symptoms|symptoms
1189478|NCT02080533|dyspnea|dyspnea
1189479|NCT02080533|fatigue|fatigue
1189480|NCT02080533|sleep|sleep
1189481|NCT02080520|Prevention|prevention
1189482|NCT02080520|Soy|soy
1189483|NCT02080520|Fermented soy|fermented soy
1189484|NCT02080520|Nattokinase|nattokinase
1189485|NCT02080520|Randomized controlled trial|randomized controlled trial
1189486|NCT02080520|Carotid artery|carotid artery
1189487|NCT02080520|Cognition|cognition
1189488|NCT02080520|Atherothrombosis|atherothrombosis
1189489|NCT02080507|rTMS|rtms
1189490|NCT02080507|depression|depression
1189491|NCT02080507|ECT|ect
1189492|NCT02080494|tranexamic acid|tranexamic acid
1189493|NCT02080494|orthopaedic trauma|orthopaedic trauma
1189494|NCT02080494|pelvic fracture|pelvic fracture
1189495|NCT02080494|hip fracture|hip fracture
1189496|NCT02080494|femur fracture|femur fracture
1189497|NCT02080494|blood loss|blood loss
1189498|NCT02080468|Effect|effect
1189499|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
1189500|NCT02080468|Pharmacokinetics|pharmacokinetics
1189501|NCT02080468|Lomitapide.|lomitapide.
1189502|NCT02080442|COPD|copd
1189503|NCT02080442|Balance|balance
1189504|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
1189505|NCT02080416|EBV|ebv
1189506|NCT02080416|KSHV|kshv
1189507|NCT02080416|malignancy|malignancy
1189508|NCT02080416|lymphoma|lymphoma
1189509|NCT02080416|sarcoma|sarcoma
1189510|NCT02080416|virus-associated|virus-associated
1189511|NCT02080403|Peri-Implantitis|peri-implantitis
1189512|NCT02080403|Periodontal Diseases|periodontal diseases
1189513|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
1189514|NCT02080403|PerioChip|periochip
1189515|NCT02080403|Anti-Infective Agents|anti-infective agents
1189516|NCT02080403|Mouth Diseases|mouth diseases
1189517|NCT02080403|Antiseptics|antiseptics
1189518|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
1189519|NCT02080390|Trastuzumab|trastuzumab
1189520|NCT02080390|Herceptin|herceptin
1189521|NCT02080390|Heart Failure|heart failure
1189522|NCT02080390|Echocardiography|echocardiography
1189523|NCT02080377|Pregnancy|pregnancy
1189524|NCT02080377|Gestational diabetes|gestational diabetes
1189525|NCT02080377|Glycaemic control|glycaemic control
1189526|NCT02080377|Metformin|metformin
1189527|NCT02080364|Alzheimer's disease|alzheimer's disease
1189528|NCT02080364|RAGE|rage
1189529|NCT02080364|ADAS-cog|adas-cog
1189530|NCT02080364|CDR-sb|cdr-sb
1189531|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
1189532|NCT02080325|weight loss|weight loss
1189533|NCT02080325|high protein diet|high protein diet
1189534|NCT02080325|plant protein|plant protein
1189535|NCT02080325|satiety|satiety
1189536|NCT02080325|soy|soy
1189537|NCT02080312|Meniere's disease|meniere's disease
1189538|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
1189539|NCT02080286|spatial neglect|spatial neglect
1189540|NCT02080286|rehabilitation|rehabilitation
1189541|NCT02080286|brain stimulation|brain stimulation
1189542|NCT02080286|tDCS|tdcs
1189543|NCT02080286|prism adaptation|prism adaptation
1189544|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
1189545|NCT02080234|asparaginase|asparaginase
1189546|NCT02080234|GELOX|gelox
1189547|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1189548|NCT02080234|sIL-2R|sil-2r
1189549|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
1189550|NCT02080221|pancreatic cancer|pancreatic cancer
1189551|NCT02080221|metastatic|metastatic
1189552|NCT02080208|hypoxemia|hypoxemia
1189553|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
1189554|NCT02080208|respiratory failure|respiratory failure
1189555|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
1189556|NCT02080182|Acetylcysteine|acetylcysteine
1189557|NCT02080182|Pediatric|pediatric
1189558|NCT02080169|Intensive care unit|intensive care unit
1189559|NCT02080169|Mechanical ventilation|mechanical ventilation
1189560|NCT02080169|Combined sedation|combined sedation
1189561|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
1189562|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
1189563|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
1189564|NCT02080156|Mortality|mortality
1189565|NCT02080156|Questionnaire|questionnaire
1189566|NCT02080156|Biomarker|biomarker
1189567|NCT02080143|Skin temperature measurements|skin temperature measurements
1189568|NCT02080143|Heat patch adhesion|heat patch adhesion
1189569|NCT02080143|Dermal irritation|dermal irritation
1189570|NCT02080130|Gastroenteritis|gastroenteritis
1189571|NCT02080130|diarrhea|diarrhea
1189572|NCT02080117|kidney transplantation|kidney transplantation
1189573|NCT02080117|delayed graft function|delayed graft function
1189574|NCT02080117|creatinine|creatinine
1189575|NCT02080117|graft survival|graft survival
1189576|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
1189577|NCT02080104|oxytocin|oxytocin
1189578|NCT02080104|vaginal delivery|vaginal delivery
1189579|NCT02080104|prophylactic|prophylactic
1189580|NCT02080078|Erlotinib|erlotinib
1189581|NCT02080078|Theophylline|theophylline
1189582|NCT02080078|Diarrhea|diarrhea
1189583|NCT02080065|risk factor|risk factor
1189584|NCT02080065|acute kidney injury|acute kidney injury
1189585|NCT02080065|liver transplantation|liver transplantation
1189586|NCT02080065|postoperative renal function|postoperative renal function
1189587|NCT02080039|Spinal Cord Injury|spinal cord injury
1189588|NCT02080039|Denervation|denervation
1189589|NCT02080039|Electrical Stimulation|electrical stimulation
1189590|NCT02080026|malaria|malaria
1189591|NCT02080026|Plasmodium falciparum|plasmodium falciparum
1189592|NCT02080000|Heart Failure|heart failure
1189593|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1189594|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
1189595|NCT02080000|Optimisation|optimisation
1189596|NCT02079987|Health Literacy|health literacy
1189597|NCT02079987|Care Transition Intervention|care transition intervention
1189598|NCT02079987|Emergency Department Population|emergency department population
1189599|NCT02079987|Access to Care|access to care
1189600|NCT02079974|endometriosis|endometriosis
1189601|NCT02079974|pain|pain
1189602|NCT02079974|fertility|fertility
1189603|NCT02079961|anemia|anemia
1189604|NCT02079961|children|children
1189605|NCT02079961|iron-fortified product|iron-fortified product
1189606|NCT02079961|value chain|value chain
1189607|NCT02079948|Aging|aging
1189608|NCT02079948|Cognitive Function|cognitive function
1189609|NCT02079948|Physical Function|physical function
1189610|NCT02079948|Systematic Inflammation|systematic inflammation
1189611|NCT02079948|Methotrexate|methotrexate
1189612|NCT02079948|Pain Symptoms|pain symptoms
1189613|NCT02079935|BN|bn
1189614|NCT02079935|Binge|binge
1189615|NCT02079935|overconsumption of food|overconsumption of food
1189616|NCT02079935|purging|purging
1189617|NCT02079935|purge|purge
1189618|NCT02079922|Multiple Ascending Dose|multiple ascending dose
1189619|NCT02079922|healthy subjects|healthy subjects
1189620|NCT02079922|Hypercholesterolemia|hypercholesterolemia
1189621|NCT02079922|Hyperlipidemias|hyperlipidemias
1189622|NCT02079922|Dyslipidemias|dyslipidemias
1189623|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
1189624|NCT02079922|Metabolic Diseases|metabolic diseases
1189625|NCT02079909|Alzheimer's Disease|alzheimer's disease
1189626|NCT02079909|Alzheimer's|alzheimer's
1189627|NCT02079896|Dialysis|dialysis
1189628|NCT02079844|Drug therapy|drug therapy
1189629|NCT02079831|Adolescent obesity|adolescent obesity
1189630|NCT02079831|childhood obesity|childhood obesity
1189631|NCT02079831|anthropometry|anthropometry
1189632|NCT02079831|body weights and measures|body weights and measures
1189633|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
1189634|NCT02079818|arteriovenous malformations|arteriovenous malformations
1189635|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
1189636|NCT02079792|Budesonide|budesonide
1189637|NCT02079792|Mucosal Atomization Device|mucosal atomization device
1189638|NCT02079792|Head Position|head position
1189639|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
1189640|NCT02079779|Acute Stroke|acute stroke
1189641|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
1189642|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
1189643|NCT02079727|Condrosulf|condrosulf
1189644|NCT02079727|Chondroitin sulfate|chondroitin sulfate
1189645|NCT02079727|Celebrex|celebrex
1189646|NCT02079727|Knee OA|knee oa
1189647|NCT02079727|Knee osteoarthritis|knee osteoarthritis
1189648|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
1189649|NCT02079714|Injury|injury
1189650|NCT02079701|pneumonia|pneumonia
1189651|NCT02079701|pneumococcus|pneumococcus
1189652|NCT02079701|vaccine|vaccine
1189653|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
1189654|NCT02079701|military recruits|military recruits
1189655|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
1189656|NCT02079688|atopic eczema|atopic eczema
1189657|NCT02079688|atopic dermatitis|atopic dermatitis
1189658|NCT02079688|Phase II|phase ii
1189659|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
1189660|NCT02079688|dermal application|dermal application
1189661|NCT02079688|Proof-of-Concept|proof-of-concept
1189662|NCT02079662|Breast Cancer|breast cancer
1189663|NCT02079662|Radiation Therapy|radiation therapy
1189664|NCT02079662|Radiotherapy|radiotherapy
1189665|NCT02079662|XRT|xrt
1189666|NCT02079662|Aerobic Activity|aerobic activity
1189667|NCT02079662|Dietician Counseling|dietician counseling
1189668|NCT02079662|Dietary Assessment|dietary assessment
1189669|NCT02079662|Yoga|yoga
1189670|NCT02079662|Cognitive Behavior Therapy|cognitive behavior therapy
1189671|NCT02079662|Smoking Cessation Counseling|smoking cessation counseling
1189672|NCT02079662|Questionnaires|questionnaires
1189673|NCT02079662|Surveys|surveys
1189674|NCT02079662|Saliva Samples|saliva samples
1189675|NCT02079662|Blood Samples|blood samples
1189676|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
1189677|NCT02079649|Red eyes|red eyes
1189678|NCT02079649|Eyelid swelling|eyelid swelling
1189679|NCT02079649|Ragweed|ragweed
1189680|NCT02079649|Allergies|allergies
1189681|NCT02079649|Itchy eyes|itchy eyes
1189682|NCT02079649|Ocular redness|ocular redness
1189683|NCT02079649|Chemosis|chemosis
1189684|NCT02079649|Tearing|tearing
1189685|NCT02079649|Watery eyes|watery eyes
1189686|NCT02079623|Pancreatic cancer|pancreatic cancer
1189687|NCT02079623|Electroporation|electroporation
1189688|NCT02079623|Nano knife treatment|nano knife treatment
1189689|NCT02079610|Depression|depression
1189690|NCT02079610|Neurofeedback|neurofeedback
1189691|NCT02079610|Amygdala|amygdala
1189692|NCT02079597|SIRS|sirs
1189693|NCT02079597|Ninj1|ninj1
1189694|NCT02079597|Sepsis|sepsis
1189695|NCT02079597|Healthy|healthy
1189696|NCT02079584|Patient Compliance|patient compliance
1189697|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
1189698|NCT02079584|Quality of Life|quality of life
1189699|NCT02079558|prevention|prevention
1189700|NCT02079558|cesarean section|cesarean section
1189701|NCT02079545|Healthy|healthy
1189702|NCT02079545|Bioavailability|bioavailability
1189703|NCT02079545|Pharmacokinetics|pharmacokinetics
1189704|NCT02079545|Sirukumab|sirukumab
1189705|NCT02079545|Subcutaneous|subcutaneous
1189706|NCT02079545|Male|male
1189707|NCT02079493|osteoarthritis|osteoarthritis
1189708|NCT02079493|knee replacement|knee replacement
1189709|NCT02079493|functional testing|functional testing
1189710|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
1189711|NCT02079467|Replacement, Hip|replacement, hip
1189712|NCT02079467|Postoperative Care|postoperative care
1189713|NCT02079467|Rehabilitation|rehabilitation
1189714|NCT02079441|Anti- TNF|anti- tnf
1189715|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
1189716|NCT02079441|pregnancy|pregnancy
1189717|NCT02079441|infant|infant
1189718|NCT02079441|immunity|immunity
1189719|NCT02079441|Immune function|immune function
1189720|NCT02079428|Heart Failure|heart failure
1189721|NCT02079428|Registry|registry
1189722|NCT02079428|China|china
1189723|NCT02079415|NICU|nicu
1189724|NCT02079402|sepsis|sepsis
1189725|NCT02079402|septic|septic
1189726|NCT02079402|shock|shock
1189728|NCT02079402|intensive|intensive
1189729|NCT02079402|critical|critical
1189730|NCT02079402|resuscitation|resuscitation
1189731|NCT02079402|fluid|fluid
1189732|NCT02079402|IV|iv
1189733|NCT02079402|crystalloid|crystalloid
1189734|NCT02079402|balance|balance
1189735|NCT02079389|colon cancer|colon cancer
1189736|NCT02079389|rectum cancer|rectum cancer
1189737|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
1189738|NCT02079389|LUS|lus
1189739|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
1189740|NCT02079389|CEUS|ceus
1189741|NCT02079389|Peroperative TNM staging|peroperative tnm staging
1189742|NCT02079389|screening for liver metastases|screening for liver metastases
1189743|NCT02079376|diabetes|diabetes
1189744|NCT02079363|Pancreatic Diseases|pancreatic diseases
1189745|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
1189746|NCT02079363|Pancreatitis|pancreatitis
1189747|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
1189748|NCT02079363|DNA methylation|dna methylation
1189749|NCT02079363|Cell-free DNA|cell-free dna
1189750|NCT02079363|Plasma|plasma
1189751|NCT02079324|head and neck cancer|head and neck cancer
1189752|NCT02079324|gene therapy|gene therapy
1189753|NCT02079324|stem cell therapy|stem cell therapy
1189847|NCT02078843|PET/CT|pet/ct
1189754|NCT02079324|immunotherappy|immunotherappy
1189755|NCT02079311|Patient warming|patient warming
1189756|NCT02079311|Active warming|active warming
1189757|NCT02079311|Forced Air Warming|forced air warming
1189758|NCT02079311|Warming blanket|warming blanket
1189759|NCT02079272|Tomotherapy|tomotherapy
1189760|NCT02079272|Breast Cancer|breast cancer
1189761|NCT02079272|Heart|heart
1189762|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
1189763|NCT02079272|Myocardial lesions|myocardial lesions
1189764|NCT02079272|Coronary lesions|coronary lesions
1189765|NCT02079272|Circulating biomarkers|circulating biomarkers
1189766|NCT02079272|Ionizing radiation|ionizing radiation
1189767|NCT02079272|Heart absorbed doses|heart absorbed doses
1189768|NCT02079233|Basic Science|basic science
1189769|NCT02079233|Safety|safety
1189770|NCT02079233|Tolerability|tolerability
1189771|NCT02079233|Efficacy of CLP|efficacy of clp
1189772|NCT02079220|Colorectal Cancer|colorectal cancer
1189773|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
1189774|NCT02079194|Drug-eluting stents|drug-eluting stents
1189775|NCT02079194|aspirin|aspirin
1189776|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
1189777|NCT02079168|Keloid|keloid
1189778|NCT02079168|Cicatrix|cicatrix
1189779|NCT02079168|Keloid prevention|keloid prevention
1189780|NCT02079168|Keloid revision/excision|keloid revision/excision
1189781|NCT02079168|Keloidectomy|keloidectomy
1189904|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
1189782|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
1189783|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
1189784|NCT02079116|Obesity|obesity
1189785|NCT02079116|Lipids|lipids
1189786|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
1189787|NCT02079116|Functional Neuroimaging|functional neuroimaging
1189788|NCT02079103|Virtual reality|virtual reality
1189789|NCT02079103|Stroke|stroke
1189790|NCT02079103|Arm motor function|arm motor function
1189791|NCT02079103|Neurorehabilitation|neurorehabilitation
1189792|NCT02079090|Propofol|propofol
1189793|NCT02079090|Ketamine|ketamine
1189794|NCT02079090|Fentanyl|fentanyl
1189795|NCT02079090|Procedural sedation|procedural sedation
1189796|NCT02079090|children|children
1189797|NCT02079090|Emergency Department|emergency department
1189798|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
1189799|NCT02079064|Splenectomy|splenectomy
1189800|NCT02079064|Desflurane|desflurane
1189801|NCT02079064|Propofol|propofol
1189802|NCT02079064|TCI|tci
1189803|NCT02079064|ROTEM|rotem
1189804|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
1189805|NCT02079025|Prostate Biopsy|prostate biopsy
1189806|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
1189807|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
1189808|NCT02079012|Walking Program|walking program
1189809|NCT02079012|Mental Disorders|mental disorders
1189810|NCT02079012|Physical Activity|physical activity
1189811|NCT02079012|Physical Fitness|physical fitness
1189812|NCT02079012|Anxiety|anxiety
1189813|NCT02079012|Depression|depression
1189814|NCT02079012|Self Determination|self determination
1189815|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
1189816|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
1189817|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
1189818|NCT02078986|Lean Body Mass|lean body mass
1189819|NCT02078986|Muscle Strength|muscle strength
1189820|NCT02078973|Tolvaptan|tolvaptan
1189821|NCT02078973|L-NMMA|l-nmma
1189822|NCT02078973|Healthy subjects|healthy subjects
1189823|NCT02078973|Nephrology|nephrology
1189824|NCT02078960|Chronic Phase|chronic phase
1189825|NCT02078960|Accelerated Phase|accelerated phase
1189827|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
1189828|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
1189829|NCT02078934|Surgical Endoscopy|surgical endoscopy
1189830|NCT02078934|Morbid Obesity|morbid obesity
1189831|NCT02078934|Weight Loss|weight loss
1189832|NCT02078934|Bariatrics|bariatrics
1189833|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
1189834|NCT02078908|Central blood pressure|central blood pressure
1189835|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
1189836|NCT02078908|Renal variables|renal variables
1189837|NCT02078908|Vasoactive hormones|vasoactive hormones
1189838|NCT02078908|Pharmacology|pharmacology
1189839|NCT02078908|Pharmacokinetics|pharmacokinetics
1189840|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
1189841|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
1189842|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
1189843|NCT02078882|Abatacept|abatacept
1189844|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
1189845|NCT02078843|NET|net
1189846|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
1189848|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
1189849|NCT02078843|octreoscan|octreoscan
1189850|NCT02078843|GEP-NET|gep-net
1189851|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
1189852|NCT02078830|Wound Contamination|wound contamination
1189853|NCT02078817|Treatment-resistant|treatment-resistant
1189854|NCT02078804|Colorectal cancer|colorectal cancer
1189855|NCT02078804|Mortality|mortality
1189856|NCT02078804|Incidence|incidence
1189857|NCT02078804|Screening|screening
1189858|NCT02078804|Health-economy|health-economy
1189859|NCT02078791|Fibromyalgia|fibromyalgia
1189860|NCT02078791|Group Problem Solving Technique|group problem solving technique
1189861|NCT02078791|infiltration|infiltration
1189862|NCT02078778|Continuous airway pressure|continuous airway pressure
1189863|NCT02078778|Hypertension|hypertension
1189864|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
1189865|NCT02078765|hypertension|hypertension
1189866|NCT02078765|chronic kidneys disease|chronic kidneys disease
1189867|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
1189868|NCT02078765|24-h blood pressure|24-h blood pressure
1189869|NCT02078765|central blood pressure|central blood pressure
1189870|NCT02078765|peripheral blood pressure|peripheral blood pressure
1189871|NCT02078752|ADC|adc
1189872|NCT02078752|PF-06647263|pf-06647263
1189873|NCT02078752|solid tumors|solid tumors
1189874|NCT02078752|tumors|tumors
1189875|NCT02078752|neoplasm metastasis|neoplasm metastasis
1189876|NCT02078752|TNBC|tnbc
1189877|NCT02078752|Triple negative breast cancer|triple negative breast cancer
1189878|NCT02078739|Yoga|yoga
1189879|NCT02078739|COPD|copd
1189880|NCT02078739|Congestive Heart Failure|congestive heart failure
1189881|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
1189882|NCT02078713|contraception|contraception
1189883|NCT02078713|patient decision support|patient decision support
1189884|NCT02078713|patient decision aid|patient decision aid
1189885|NCT02078713|shared decision making|shared decision making
1189886|NCT02078713|Decision Making, Shared|decision making, shared
1189887|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
1189888|NCT02078700|cancer|cancer
1189889|NCT02078700|early palliative care|early palliative care
1189890|NCT02078700|feasibility|feasibility
1189891|NCT02078687|very preterm|very preterm
1189892|NCT02078687|nutrition|nutrition
1189893|NCT02078687|6 year follow-up|6 year follow-up
1189894|NCT02078687|growth|growth
1189895|NCT02078687|metabolic syndrome|metabolic syndrome
1189896|NCT02078687|allergy|allergy
1189897|NCT02078687|dexa|dexa
1189898|NCT02078674|H7N9|h7n9
1189899|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
1189900|NCT02078661|Dry eye|dry eye
1189901|NCT02078648|Glioma Associated Antigen|glioma associated antigen
1189902|NCT02078648|Vaccine|vaccine
1189903|NCT02078648|Adult|adult
1189905|NCT02078648|Immunotherapy|immunotherapy
1189906|NCT02078635|Arterial plaque|arterial plaque
1189907|NCT02078635|portfolio diet|portfolio diet
1189908|NCT02078635|dietary modification|dietary modification
1189909|NCT02078635|dietary trials|dietary trials
1189910|NCT02078635|Canadian Network|canadian network
1189911|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
1189912|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
1189913|NCT02078622|COPD|copd
1189914|NCT02078622|Respiratory Therapist|respiratory therapist
1189915|NCT02078622|Case Management|case management
1189916|NCT02078622|Education|education
1189917|NCT02078609|AML,|aml,
1189918|NCT02078609|MDS,|mds,
1189919|NCT02078609|PIM,|pim,
1189920|NCT02078609|LGH447,|lgh447,
1189921|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
1189922|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
1189923|NCT02078609|midostaurin,|midostaurin,
1189924|NCT02078609|PKC412|pkc412
1189925|NCT02078596|temper outbursts|temper outbursts
1189926|NCT02078596|pediatric aggression|pediatric aggression
1189927|NCT02078596|irritability|irritability
1189928|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
1189929|NCT02078505|Change in gut microbial population|change in gut microbial population
1189930|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
1189931|NCT02078505|gut microbiome|gut microbiome
1189932|NCT02078505|diet|diet
1189933|NCT02078479|Malignancy|malignancy
1189935|NCT02078479|LANSS|lanss
1189937|NCT02078479|Neuropathic pain|neuropathic pain
1189938|NCT02078479|rTMS|rtms
1189939|NCT02078479|motor cortex|motor cortex
1189940|NCT02078479|analgesia|analgesia
1189941|NCT02078466|Functional assessment|functional assessment
1189942|NCT02078466|readmission|readmission
1189943|NCT02078466|acute care|acute care
1189944|NCT02078466|older medical patients|older medical patients
1189945|NCT02078453|Dental caries|dental caries
1189946|NCT02078453|Diagnosis|diagnosis
1189947|NCT02078453|Visual inspection|visual inspection
1189948|NCT02078453|Radiographic examination|radiographic examination
1189949|NCT02078440|Type 2 Diabetes|type 2 diabetes
1189950|NCT02078440|Children|children
1189951|NCT02078440|Adolescents|adolescents
1189952|NCT02078440|Bioavailability|bioavailability
1189953|NCT02078440|Cycloset|cycloset
1189954|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
1189955|NCT02078401|Optic pathway glioma|optic pathway glioma
1189956|NCT02078401|Ophthalmological screening|ophthalmological screening
1189957|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
1189958|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
1189959|NCT02078323|Linaclotide|linaclotide
1189960|NCT02078310|Dementia,|dementia,
1189962|NCT02078310|geriatric|geriatric
1189963|NCT02078310|volunteers|volunteers
1189964|NCT02078310|patients|patients
1189965|NCT02078297|IL-23|il-23
1189966|NCT02078297|IL-17A|il-17a
1189967|NCT02078297|Skin biopsies|skin biopsies
1189968|NCT02078284|platelet transfusion|platelet transfusion
1189969|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
1189970|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
1189971|NCT02078245|Surveillance|surveillance
1189972|NCT02078245|Screening|screening
1189973|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
1189974|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
1189975|NCT02078232|head of pancreas|head of pancreas
1189976|NCT02078232|19G Flex needle|19g flex needle
1189977|NCT02078232|22G standard needle|22g standard needle
1189978|NCT02078206|Critical illness|critical illness
1189979|NCT02078206|Neurocognition|neurocognition
1189980|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
1189981|NCT02078206|Delirium|delirium
1189982|NCT02078206|Virtual Reality|virtual reality
1189983|NCT02078206|cognitive|cognitive
1189984|NCT02078206|rehabilitation|rehabilitation
1189985|NCT02078206|ICU|icu
1189986|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
1189987|NCT02078154|D-Dimer|d-dimer
1189988|NCT02078154|DVT|dvt
1189989|NCT02078154|Wells score|wells score
1189990|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
1189991|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
1189992|NCT02078089|Refractory cancer pain|refractory cancer pain
1189993|NCT02078076|MRI|mri
1189994|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
1189995|NCT02078076|myopathy|myopathy
1189996|NCT02078076|fibrosis assessment|fibrosis assessment
1189997|NCT02078076|function|function
1189998|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
1189999|NCT02078037|Perihematomal edema|perihematomal edema
1190000|NCT02078037|hemorrhage|hemorrhage
1190001|NCT02078037|normothermia|normothermia
1190002|NCT02078024|Onchocerciasis|onchocerciasis
1190003|NCT02077985|autism|autism
1190004|NCT02077985|electrodermal activity|electrodermal activity
1190005|NCT02077985|cooperation|cooperation
1190006|NCT02077985|anxiety|anxiety
1190007|NCT02077985|distress|distress
1190008|NCT02077985|stress|stress
1190009|NCT02077985|oral care|oral care
1190010|NCT02077985|sensory processing|sensory processing
1190011|NCT02077985|behavior|behavior
1190012|NCT02077985|occupational therapy|occupational therapy
1190013|NCT02077972|PTSD|ptsd
1190014|NCT02077972|Military service|military service
1190015|NCT02077972|depression|depression
1190016|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
1190017|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
1190018|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
1190019|NCT02077933|Solid tumors|solid tumors
1190020|NCT02077933|renal cell carcinoma|renal cell carcinoma
1190021|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
1190022|NCT02077933|breast cancer|breast cancer
1190023|NCT02077933|PI3K inhibitor|pi3k inhibitor
1190024|NCT02077933|BYL719|byl719
1190025|NCT02077933|alpelisib|alpelisib
1190026|NCT02077933|everolimus|everolimus
1190027|NCT02077933|exemestane|exemestane
1190028|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
1190029|NCT02077920|Chlorhexidine|chlorhexidine
1190030|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
1190031|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
1190032|NCT02077894|Whole Genome Sequencing|whole genome sequencing
1190033|NCT02077894|Genetic Eye Disease|genetic eye disease
1190034|NCT02077881|metastatic|metastatic
1190035|NCT02077881|metastasis|metastasis
1190036|NCT02077881|Pancreatic|pancreatic
1190037|NCT02077881|Pancreas|pancreas
1190038|NCT02077881|Cancer|cancer
1190039|NCT02077881|adenocarcinoma|adenocarcinoma
1190040|NCT02077868|CRC|crc
1190041|NCT02077868|mCRC|mcrc
1190042|NCT02077868|maintenance treatment|maintenance treatment
1190043|NCT02077868|immune modulation|immune modulation
1190044|NCT02077868|colorectal cancer|colorectal cancer
1190045|NCT02077868|immunotherapy|immunotherapy
1190046|NCT02077868|metastatic|metastatic
1190047|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
1190048|NCT02077829|Implementation process|implementation process
1190049|NCT02077829|implementation strategy|implementation strategy
1190050|NCT02077829|Implementation research|implementation research
1190051|NCT02077829|evidence based practice|evidence based practice
1190052|NCT02077829|recovery|recovery
1190053|NCT02077829|Illness management and recovery|illness management and recovery
1190054|NCT02077816|body temperature|body temperature
1190055|NCT02077816|Thermometry|thermometry
1190056|NCT02077816|Infrared Rays|infrared rays
1190057|NCT02077816|catheter related infection|catheter related infection
1190058|NCT02077803|Healthy|healthy
1190059|NCT02077803|Canagliflozin|canagliflozin
1190060|NCT02077803|Metformin|metformin
1190061|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
1190062|NCT02077803|Bioequivalence|bioequivalence
1190063|NCT02077803|GLUMETZA®|glumetza®
1190064|NCT02077777|mesalazine|mesalazine
1190065|NCT02077777|colon|colon
1190066|NCT02077777|cancer|cancer
1190067|NCT02077764|heart transplantation,|heart transplantation,
1190068|NCT02077764|rejection|rejection
1190069|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
1190070|NCT02077764|optical coherence tomography|optical coherence tomography
1190071|NCT02077764|speckle tracking|speckle tracking
1190072|NCT02077764|Positron Emission Tomography .|positron emission tomography .
1190073|NCT02077764|exercise capacity|exercise capacity
1190074|NCT02077738|effectiveness|effectiveness
1190075|NCT02077738|elderly|elderly
1190076|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
1190077|NCT02077738|mechanical ventilation|mechanical ventilation
1190078|NCT02077738|pneumonia|pneumonia
1190079|NCT02077738|randomized controlled trial|randomized controlled trial
1190080|NCT02077725|drug related problems|drug related problems
1190081|NCT02077725|comprehensive medication review|comprehensive medication review
1190082|NCT02077725|quality of life|quality of life
1190083|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
1190084|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
1190085|NCT02077686|diabetes|diabetes
1190086|NCT02077686|education|education
1190087|NCT02077686|randomized|randomized
1190088|NCT02077686|prospective|prospective
1190089|NCT02077673|GEJ-cancer|gej-cancer
1190090|NCT02077673|surgery|surgery
1190091|NCT02077673|gastroesophageal resection|gastroesophageal resection
1190092|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
1190093|NCT02077673|anastomotic leakage|anastomotic leakage
1190094|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
1190095|NCT02077647|Knee osteoarthritis|knee osteoarthritis
1190096|NCT02077647|knee osteonecrosis|knee osteonecrosis
1190097|NCT02077647|osteotomy|osteotomy
1190098|NCT02077621|cancer-related fatigue|cancer-related fatigue
1190099|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
1190100|NCT02077621|HRQL|hrql
1190101|NCT02077608|In vitro fertilization|in vitro fertilization
1190102|NCT02077608|Embryotransfer|embryotransfer
1190103|NCT02077608|Hyaluronan|hyaluronan
1190104|NCT02077608|Pregnancy rate|pregnancy rate
1190105|NCT02077608|Implantation rate|implantation rate
1190106|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1190107|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
1190108|NCT02077582|acute ischemic stroke|acute ischemic stroke
1577307|NCT00474747|Cytoxan|cytoxan
1190109|NCT02077569|AKT inhibitor|akt inhibitor
1190110|NCT02077569|AZD5363|azd5363
1190111|NCT02077569|Anti-tumour activity|anti-tumour activity
1190112|NCT02077569|Breast cancer|breast cancer
1190113|NCT02077569|ER positive|er positive
1190114|NCT02077569|Oestrogen positive|oestrogen positive
1190115|NCT02077569|post menopausal|post menopausal
1190116|NCT02077569|chemotherapy required|chemotherapy required
1190117|NCT02077569|no prior cancer treatment|no prior cancer treatment
1190118|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
1190119|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
1190120|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
1190121|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
1190122|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
1190123|NCT02077517|Postoperative complications|postoperative complications
1190124|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
1190125|NCT02077517|Stapled anastomosis|stapled anastomosis
1190126|NCT02077491|Aged|aged
1190127|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1190128|NCT02077491|Body Composition|body composition
1190129|NCT02077491|Dietary Protein|dietary protein
1190130|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
1190131|NCT02077452|Glucokinase activator|glucokinase activator
1190132|NCT02077452|Phase I|phase i
1190133|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
1190134|NCT02077439|Stroke|stroke
1190135|NCT02077439|Hand|hand
1190136|NCT02077439|Upper Extremity|upper extremity
1190137|NCT02077439|Robotics|robotics
1190138|NCT02077426|Functional Capacity|functional capacity
1190139|NCT02077426|Exercise Independence|exercise independence
1190140|NCT02077426|Peripheral|peripheral
1190141|NCT02077426|Strength|strength
1190142|NCT02077413|muscle|muscle
1190143|NCT02077413|eccentric exercise|eccentric exercise
1190144|NCT02077413|T2 MRI|t2 mri
1190145|NCT02077387|Inhibitory control|inhibitory control
1190146|NCT02077387|executive functioning|executive functioning
1190147|NCT02077387|childhood obesity|childhood obesity
1190148|NCT02077387|preschool|preschool
1190149|NCT02077387|snack foods|snack foods
1190150|NCT02077387|caloric intake|caloric intake
1190151|NCT02077374|NAFLD|nafld
1190152|NCT02077374|NASH|nash
1190153|NCT02077361|choroideremia|choroideremia
1190154|NCT02077361|gene therapy|gene therapy
1190155|NCT02077361|gene transfer|gene transfer
1190156|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
1190157|NCT02077348|Ketoacidosis|ketoacidosis
1190158|NCT02077348|Insulin withdrawal|insulin withdrawal
1190159|NCT02077348|Growth hormone injection|growth hormone injection
1190160|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
1190161|NCT02077335|Brachytherapy|brachytherapy
1190162|NCT02077335|Monotherapy|monotherapy
1190163|NCT02077335|HDR|hdr
1190164|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
1190165|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
1190166|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1190167|NCT02077309|T2DM,|t2dm,
1190168|NCT02077309|vascular inflammation,|vascular inflammation,
1190169|NCT02077309|18-FDG-PET,|18-fdg-pet,
1190170|NCT02077309|plaque morphology,|plaque morphology,
1190171|NCT02077309|MRI,|mri,
1190172|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
1190173|NCT02077296|cytokines|cytokines
1190174|NCT02077296|predictive value|predictive value
1190175|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
1190176|NCT02077296|rectal cancer|rectal cancer
1190177|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
1190178|NCT02077283|urinary metabonomics|urinary metabonomics
1190179|NCT02077283|TCM pattern|tcm pattern
1190180|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
1190181|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
1190182|NCT02077270|colonoscopy|colonoscopy
1190183|NCT02077270|acupuncture|acupuncture
1190184|NCT02077270|pain|pain
1190185|NCT02077244|patient|patient
1190186|NCT02077244|intensive care|intensive care
1190187|NCT02077244|follow up|follow up
1190188|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
1190189|NCT02077244|randomized controlled trial|randomized controlled trial
1190190|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
1190191|NCT02077179|Postpartum|postpartum
1190192|NCT02077179|Preeclampsia|preeclampsia
1190193|NCT02077179|Gestational Hypertension|gestational hypertension
1190194|NCT02077179|Gestational Diabetes|gestational diabetes
1190195|NCT02077179|Exercise Intervention|exercise intervention
1190196|NCT02077179|Dietary Intervention|dietary intervention
1190197|NCT02077179|Behavioral Intervention|behavioral intervention
1190198|NCT02077179|Mobile Website|mobile website
1190199|NCT02077179|Mobile Application|mobile application
1190200|NCT02077166|DLBCL|dlbcl
1190201|NCT02077101|HIV|hiv
1190202|NCT02077101|Therapeutic vaccine|therapeutic vaccine
1190203|NCT02077101|acceptability|acceptability
1190204|NCT02077101|representations|representations
1190205|NCT02077088|interventional|interventional
1190206|NCT02077088|doubleblind|doubleblind
1190207|NCT02077088|randomised|randomised
1190208|NCT02077088|pediatric|pediatric
1190209|NCT02077088|prebiotic|prebiotic
1190210|NCT02077088|atopic|atopic
1190211|NCT02077088|dermatitis|dermatitis
1190212|NCT02077088|infant|infant
1190213|NCT02077075|weight loss|weight loss
1190214|NCT02077075|healthy weight|healthy weight
1190215|NCT02077075|overweight|overweight
1190216|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
1190217|NCT02077062|hepatectomy,|hepatectomy,
1190218|NCT02077062|liver regeneration|liver regeneration
1190219|NCT02077062|mediators|mediators
1190220|NCT02077049|elderly|elderly
1190221|NCT02077049|exercise program|exercise program
1190222|NCT02077049|self-training|self-training
1190223|NCT02077049|mobility|mobility
1190224|NCT02077049|computer-based learning games|computer-based learning games
1190225|NCT02077049|serious game|serious game
1190226|NCT02077049|balance|balance
1190227|NCT02077049|training adherence|training adherence
1190228|NCT02077049|training compliance|training compliance
1190229|NCT02077049|Kinect ®|kinect ®
1190230|NCT02077049|Fit Bit ®|fit bit ®
1190231|NCT02077023|Stroke|stroke
1190232|NCT02077023|Heart Attack|heart attack
1190233|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
1190234|NCT02077023|Atrial Fibrillation|atrial fibrillation
1190235|NCT02077010|milrinone|milrinone
1190236|NCT02077010|heart failure|heart failure
1190237|NCT02077010|cardiomyopathy|cardiomyopathy
1190238|NCT02077010|inhaled|inhaled
1190239|NCT02076997|Cancer|cancer
1190240|NCT02076997|High Dose Methotrexate|high dose methotrexate
1190241|NCT02076984|Ventral hernia|ventral hernia
1190242|NCT02076984|Incisional hernia|incisional hernia
1190243|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
1190244|NCT02076971|Lung transplant|lung transplant
1190245|NCT02076971|Quantiferon|quantiferon
1190246|NCT02076971|Immuknow|immuknow
1190247|NCT02076958|Implementation|implementation
1190248|NCT02076958|Cancer|cancer
1190249|NCT02076958|Early detection|early detection
1190250|NCT02076958|Faith-based|faith-based
1190251|NCT02076958|Community health advisor|community health advisor
1190252|NCT02076945|Regional anesthesia|regional anesthesia
1190253|NCT02076945|Diabetic neuropathy|diabetic neuropathy
1190254|NCT02076945|Ultrasound|ultrasound
1190255|NCT02076919|LHA510|lha510
1190256|NCT02076919|First in human|first in human
1190257|NCT02076919|Safety|safety
1190258|NCT02076919|Tolerability|tolerability
1190259|NCT02076919|Pharmacokinetics|pharmacokinetics
1190260|NCT02076919|Elderly|elderly
1190261|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
1190262|NCT02076919|AMD|amd
1190263|NCT02076919|Ocular|ocular
1190264|NCT02076919|Eye drop|eye drop
1190365|NCT02076633|Phase II|phase ii
1190265|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
1190266|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
1190267|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
1190268|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
1190269|NCT02076906|Ewing's sarcoma|ewing's sarcoma
1190270|NCT02076906|osteosarcoma|osteosarcoma
1190271|NCT02076906|neuroblastoma|neuroblastoma
1190272|NCT02076906|Wilms' tumor|wilms' tumor
1190273|NCT02076906|hepatic tumors|hepatic tumors
1190274|NCT02076906|germ cell tumors|germ cell tumors
1190275|NCT02076906|desmoid tumor|desmoid tumor
1190276|NCT02076893|Tonsillectomy|tonsillectomy
1190277|NCT02076893|Pain management|pain management
1190278|NCT02076893|Pediatrics|pediatrics
1190279|NCT02076880|Type 2 diabetes|type 2 diabetes
1190281|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
1190282|NCT02076880|Insulin|insulin
1190283|NCT02076880|GLP-1|glp-1
1190284|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
1190285|NCT02076867|somatic symptoms|somatic symptoms
1190286|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
1190287|NCT02076854|eating disorders|eating disorders
1190288|NCT02076854|anorexia nervosa|anorexia nervosa
1190289|NCT02076854|treatment|treatment
1190290|NCT02076854|technology|technology
1190291|NCT02076828|anemia|anemia
1190292|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
1190293|NCT02076828|iron zinc|iron zinc
1190294|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
1190295|NCT02076815|essential thrombocythemia|essential thrombocythemia
1190296|NCT02076815|high risk patients|high risk patients
1190297|NCT02076815|anagrelide|anagrelide
1190298|NCT02076802|prehypertension|prehypertension
1190299|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
1190300|NCT02076802|cardiovascular disease|cardiovascular disease
1190301|NCT02076789|Device Replacement|device replacement
1190302|NCT02076789|Device Upgrade|device upgrade
1190303|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
1190304|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
1190305|NCT02076776|Stroke|stroke
1190306|NCT02076776|Exercise|exercise
1190307|NCT02076776|Rehabilitation|rehabilitation
1190308|NCT02076776|Neuroplasticity|neuroplasticity
1190309|NCT02076776|Task Practice|task practice
1190310|NCT02076763|Observational|observational
1190311|NCT02076763|Porphyria|porphyria
1190312|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
1190313|NCT02076750|Vitamin D|vitamin d
1190314|NCT02076750|Cholecalciferol|cholecalciferol
1190315|NCT02076750|Skin Pigmentation|skin pigmentation
1190316|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
1190317|NCT02076737|VEOTM|veotm
1190318|NCT02076737|Ultra low-dose|ultra low-dose
1190319|NCT02076737|Abdominal CT|abdominal ct
1190320|NCT02076737|Dose reduction|dose reduction
1190321|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
1190322|NCT02076737|Acute renal colic|acute renal colic
1190323|NCT02076724|Abdominal donor-site|abdominal donor-site
1190324|NCT02076724|Breast reconstruction|breast reconstruction
1190325|NCT02076724|Synthetic mesh|synthetic mesh
1190326|NCT02076724|Biological mesh|biological mesh
1190327|NCT02076711|Aortic Stenosis|aortic stenosis
1190328|NCT02076711|Myocardial efficiency|myocardial efficiency
1190329|NCT02076698|Deep Brain Stimulation|deep brain stimulation
1190330|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
1190331|NCT02076698|Treatment refractory|treatment refractory
1190332|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
1190333|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
1190334|NCT02076685|pharmacogenetics|pharmacogenetics
1190335|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
1190336|NCT02076685|genetic polymorphism|genetic polymorphism
1190337|NCT02076685|isoniazid|isoniazid
1190338|NCT02076672|prevention|prevention
1190339|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
1190340|NCT02076672|benign pleural disease|benign pleural disease
1190341|NCT02076672|asbestosis|asbestosis
1190342|NCT02076659|F8|f8
1190343|NCT02076659|IL10|il10
1190344|NCT02076659|Interleukin|interleukin
1190345|NCT02076659|monoclonal|monoclonal
1190346|NCT02076659|antibody|antibody
1190347|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
1190348|NCT02076646|Interleukin|interleukin
1190349|NCT02076646|IL2|il2
1190350|NCT02076646|monoclonal|monoclonal
1190351|NCT02076646|antibody|antibody
1190352|NCT02076646|cytokine|cytokine
1190353|NCT02076646|Dacarbazine|dacarbazine
1190354|NCT02076646|metastatic|metastatic
1190355|NCT02076646|melanoma|melanoma
1190356|NCT02076646|tumor targeting|tumor targeting
1190357|NCT02076646|Dose definition|dose definition
1190358|NCT02076646|L19|l19
1190359|NCT02076633|L19|l19
1190360|NCT02076633|monoclonal|monoclonal
1190361|NCT02076633|antibody|antibody
1190362|NCT02076633|IL-2|il-2
1190363|NCT02076633|TNFα|tnfα
1190364|NCT02076633|Interleukin|interleukin
1190366|NCT02076633|metastatic melanoma|metastatic melanoma
1190367|NCT02076633|clinical stage III|clinical stage iii
1190368|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
1190369|NCT02076620|L19|l19
1190370|NCT02076620|monoclonal|monoclonal
1190371|NCT02076620|antibody|antibody
1190372|NCT02076620|doxorubicin|doxorubicin
1190373|NCT02076620|TNFα|tnfα
1190374|NCT02076620|solid tumour|solid tumour
1190375|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
1190376|NCT02076620|anthracycline|anthracycline
1190377|NCT02076607|vertebra|vertebra
1190378|NCT02076607|column|column
1190379|NCT02076607|lumbar|lumbar
1190380|NCT02076607|toracica|toracica
1190381|NCT02076607|fracture|fracture
1190382|NCT02076607|burst|burst
1190383|NCT02076568|diabetes|diabetes
1190384|NCT02076568|education|education
1190385|NCT02076568|randomized|randomized
1190386|NCT02076568|prospective|prospective
1190387|NCT02076555|diabetes|diabetes
1190388|NCT02076555|education|education
1190389|NCT02076555|randomized|randomized
1190390|NCT02076555|prospective|prospective
1190391|NCT02076542|diabetes|diabetes
1190392|NCT02076542|education|education
1190393|NCT02076542|randomized|randomized
1190394|NCT02076542|prospective|prospective
1190395|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
1190396|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
1190397|NCT02076503|Neoplasm Staging|neoplasm staging
1190398|NCT02076503|Positron-Emission Tomography|positron-emission tomography
1190399|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
1577308|NCT00474747|Neosar|neosar
1190400|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
1190401|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
1190402|NCT02076477|intervention time|intervention time
1190403|NCT02076477|radiotherapy|radiotherapy
1190404|NCT02076477|oligometastatic|oligometastatic
1190405|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
1190406|NCT02076438|antibiotics|antibiotics
1190407|NCT02076438|diarrhea|diarrhea
1190408|NCT02076438|c diff|c diff
1190409|NCT02076438|Hospitalized patients|hospitalized patients
1190410|NCT02076425|Depressive Disorder, Major|depressive disorder, major
1190411|NCT02076425|Child Psychiatry|child psychiatry
1190412|NCT02076425|Parent-Child Relationship|parent-child relationship
1190413|NCT02076425|Therapy|therapy
1190414|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
1190415|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
1190416|NCT02076360|Preoperative counseling|preoperative counseling
1190417|NCT02076360|Patient satisfaction|patient satisfaction
1190418|NCT02076360|Prolapse|prolapse
1190419|NCT02076360|Sacrocolpopexy|sacrocolpopexy
1190420|NCT02076347|Metformin|metformin
1190421|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
1190422|NCT02076347|Population Management|population management
1190423|NCT02076347|Pharmacist|pharmacist
1190424|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
1190425|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
1190426|NCT02076295|Cognition|cognition
1190427|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
1190428|NCT02076295|Positron Emission Tomography|positron emission tomography
1190429|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1190430|NCT02076282|Optimization|optimization
1190431|NCT02076282|MRI|mri
1190432|NCT02076282|Radiotherapy|radiotherapy
1190433|NCT02076269|HRCT|hrct
1190434|NCT02076269|Dry Powder Inhaler|dry powder inhaler
1190435|NCT02076269|COPD|copd
1190436|NCT02076269|Pharyngometry|pharyngometry
1190437|NCT02076269|Inhalation Profiles|inhalation profiles
1190438|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
1190439|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
1190441|NCT02076243|abraxane|abraxane
1190442|NCT02076243|nab-paclitaxel|nab-paclitaxel
1190443|NCT02076243|unresectable|unresectable
1190444|NCT02076243|metastatic|metastatic
1190445|NCT02076230|14C-TH-302|14c-th-302
1190446|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
1190447|NCT02076230|Evofosfamide|evofosfamide
1190448|NCT02076217|Highly Effective Contraception|highly effective contraception
1190449|NCT02076217|Emergency Contraception|emergency contraception
1190450|NCT02076217|Birth Control|birth control
1190451|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
1190452|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
1190453|NCT02076204|Pregnancy|pregnancy
1190454|NCT02076204|Postpartum programs|postpartum programs
1190455|NCT02076204|Infant health services|infant health services
1190456|NCT02076191|Ruxolitinib|ruxolitinib
1190457|NCT02076191|Decitabine|decitabine
1190458|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1190459|NCT02076191|Combination Therapy|combination therapy
1190460|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1190562|NCT02075697|adalimumab|adalimumab
1190461|NCT02076178|HIV integrase|hiv integrase
1190462|NCT02076178|Intramuscular Injection|intramuscular injection
1190463|NCT02076178|GSK1265744|gsk1265744
1190464|NCT02076165|insomnia|insomnia
1190465|NCT02076165|women|women
1190466|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
1190467|NCT02076139|tuberculosis|tuberculosis
1190468|NCT02076139|treg|treg
1190469|NCT02076139|tolerance|tolerance
1190470|NCT02076139|probiotic|probiotic
1190471|NCT02076139|mycobacteria|mycobacteria
1190472|NCT02076126|Lung maturity|lung maturity
1190473|NCT02076126|RDS|rds
1190474|NCT02076126|Prematurity|prematurity
1190475|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
1190476|NCT02076126|Spectroscopy|spectroscopy
1190477|NCT02076126|Chemometrics|chemometrics
1190478|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
1190479|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
1190480|NCT02076113|spinal fusion|spinal fusion
1190481|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
1190482|NCT02076087|Lipectomy|lipectomy
1190483|NCT02076061|COPD|copd
1190484|NCT02076061|Primary Care|primary care
1190485|NCT02076061|Smoking|smoking
1190486|NCT02076061|Smokers|smokers
1190487|NCT02076061|ex-Smokers|ex-smokers
1190488|NCT02076061|Lung Cancer|lung cancer
1190489|NCT02076061|Cardiovascular Disease|cardiovascular disease
1190490|NCT02076061|Proteomics|proteomics
1190491|NCT02076061|Biomarkers|biomarkers
1190492|NCT02076061|Biobank|biobank
1190493|NCT02076061|Disease Staging|disease staging
1190494|NCT02076061|Gold Stage|gold stage
1190495|NCT02076048|LCPUFA supplementation|lcpufa supplementation
1190496|NCT02076048|Brain Imaging|brain imaging
1190497|NCT02076048|MRI|mri
1190498|NCT02076048|MEG|meg
1190499|NCT02076035|low back pain|low back pain
1190500|NCT02076035|periduroscopy|periduroscopy
1190501|NCT02076035|genetic|genetic
1190502|NCT02076035|genomic|genomic
1190503|NCT02076035|inflammation|inflammation
1190504|NCT02076022|Fat Grafting|fat grafting
1190505|NCT02076022|Pain at amputation site|pain at amputation site
1190506|NCT02076022|prosthetic|prosthetic
1190507|NCT02076009|Multiple Myeloma|multiple myeloma
1190508|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
1190509|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
1190510|NCT02076009|Daratumumab|daratumumab
1190511|NCT02076009|Lenalidomide|lenalidomide
1190512|NCT02076009|Dexamethasone|dexamethasone
1190513|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
1190514|NCT02075983|HIV|hiv
1190515|NCT02075983|Vaccine|vaccine
1190516|NCT02075983|Immunisation|immunisation
1190517|NCT02075983|DNA|dna
1190518|NCT02075983|Adverse events|adverse events
1190519|NCT02075983|Electroporation|electroporation
1190520|NCT02075983|Transcutaneous|transcutaneous
1190521|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
1190522|NCT02075983|Antibody|antibody
1190523|NCT02075983|Intramuscular|intramuscular
1190524|NCT02075983|Immunogenicity|immunogenicity
1190525|NCT02075970|Neonatal|neonatal
1190526|NCT02075970|Anemia|anemia
1190527|NCT02075970|Transfusion|transfusion
1190528|NCT02075970|Erythropoetin|erythropoetin
1190529|NCT02075970|Epoetin Alpha|epoetin alpha
1190530|NCT02075970|Red Blood Cell|red blood cell
1190531|NCT02075970|Survival|survival
1190532|NCT02075970|Pharmacodynamics|pharmacodynamics
1190533|NCT02075970|Model|model
1190534|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
1190535|NCT02075944|Aerobic exercise|aerobic exercise
1190536|NCT02075944|Cognitive function|cognitive function
1190537|NCT02075944|Executive function|executive function
1190538|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
1190539|NCT02075905|Barrett's Esophagus|barrett's esophagus
1190540|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
1190541|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
1190542|NCT02075853|Cerebral palsy|cerebral palsy
1190543|NCT02075853|Pes planus|pes planus
1190544|NCT02075853|Calcaneal lengthening|calcaneal lengthening
1190545|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
1190546|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
1190547|NCT02075775|instability|instability
1190548|NCT02075749|irradiation|irradiation
1190549|NCT02075749|mucositis|mucositis
1190550|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
1190551|NCT02075749|licorice|licorice
1190552|NCT02075749|mucoadhesive film|mucoadhesive film
1190553|NCT02075710|Diet|diet
1190554|NCT02075710|Sugar|sugar
1190555|NCT02075710|Cardiovascular|cardiovascular
1190556|NCT02075710|Lipid|lipid
1190557|NCT02075697|psoriasis|psoriasis
1190558|NCT02075697|biologic therapy|biologic therapy
1190559|NCT02075697|infliximab|infliximab
1190560|NCT02075697|etanercept|etanercept
1190561|NCT02075697|efalizumab|efalizumab
1190563|NCT02075697|ustekinumab|ustekinumab
1190564|NCT02075697|methotrexate|methotrexate
1190565|NCT02075697|cyclosporine|cyclosporine
1190566|NCT02075697|acitretin|acitretin
1190567|NCT02075671|Rosacea|rosacea
1190568|NCT02075671|Photodynamic Therapy|photodynamic therapy
1190569|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
1190570|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
1190571|NCT02075671|Blue Light|blue light
1190572|NCT02075658|renal cell carcinoma|renal cell carcinoma
1190573|NCT02075658|minimally invasive procedures|minimally invasive procedures
1190574|NCT02075658|robotic nephrectomy|robotic nephrectomy
1190575|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
1190576|NCT02075658|pneumoperitoneum|pneumoperitoneum
1190577|NCT02075658|trocars|trocars
1190578|NCT02075658|AirSeal® IFS|airseal® ifs
1190579|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
1190580|NCT02075632|Eczema|eczema
1190581|NCT02075632|Psoriasis|psoriasis
1190582|NCT02075632|Itch|itch
1190583|NCT02075619|Amlodipine|amlodipine
1190584|NCT02075619|Healthy volunteers|healthy volunteers
1190585|NCT02075619|Rosuvastatin|rosuvastatin
1190586|NCT02075619|Dyslipidaemia|dyslipidaemia
1190587|NCT02075619|Pharmacokinetics|pharmacokinetics
1190588|NCT02075619|Hypertension|hypertension
1190589|NCT02075606|NET|net
1190590|NCT02075606|Symptomatic response|symptomatic response
1190591|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
1190592|NCT02075606|midgut region|midgut region
1190593|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
1190594|NCT02075593|pregnant women|pregnant women
1190595|NCT02075593|once daily|once daily
1190596|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
1190597|NCT02075593|HIV-1 Infection|hiv-1 infection
1190598|NCT02075593|integrase inhibitor|integrase inhibitor
1190599|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
1190600|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
1190601|NCT02075567|Exercise|exercise
1190602|NCT02075567|Insulin Reduction|insulin reduction
1190604|NCT02075567|Hypoglycemia|hypoglycemia
1190605|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
1190606|NCT02075541|Immunogenicity|immunogenicity
1190607|NCT02075541|Observer-blind|observer-blind
1190608|NCT02075541|Reactogenicity|reactogenicity
1190609|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1190610|NCT02075541|Safety|safety
1190611|NCT02075528|Paliperidone|paliperidone
1190612|NCT02075528|Treatment response|treatment response
1190613|NCT02075528|Schizophrenia|schizophrenia
1190614|NCT02075528|Early prediction|early prediction
1190615|NCT02075528|Pharmacokinetics|pharmacokinetics
1190616|NCT02075515|Safety|safety
1190617|NCT02075515|Zoster|zoster
1190618|NCT02075515|Immunogenicity|immunogenicity
1190619|NCT02075515|Adults|adults
1190620|NCT02075515|Consistency|consistency
1190621|NCT02075502|claudication|claudication
1190622|NCT02075502|community walking exercise|community walking exercise
1190623|NCT02075502|community-based participatory research|community-based participatory research
1190624|NCT02075502|exercise adherence|exercise adherence
1190625|NCT02075502|endovascular therapy|endovascular therapy
1190626|NCT02075489|Acupressure|acupressure
1190627|NCT02075489|Reiki|reiki
1190628|NCT02075489|EEG|eeg
1190629|NCT02075489|EMG|emg
1190630|NCT02075489|fatigue relief|fatigue relief
1190631|NCT02075489|veterans|veterans
1190632|NCT02075476|Fracture-luxation|fracture-luxation
1190633|NCT02075476|humeral proximal extremity|humeral proximal extremity
1190634|NCT02075476|Hemiarthroplasty|hemiarthroplasty
1190635|NCT02075476|reverse Arthroplasty|reverse arthroplasty
1190636|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
1190637|NCT02075463|GSK1278863|gsk1278863
1190638|NCT02075463|hemodialysis|hemodialysis
1190639|NCT02075463|anemia|anemia
1190640|NCT02075463|Hemoglobin|hemoglobin
1190641|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
1190642|NCT02075463|chronic kidney disease|chronic kidney disease
1190643|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1190644|NCT02075463|pharmacokinetics|pharmacokinetics
1190645|NCT02075450|Cardiac|cardiac
1190646|NCT02075450|Arrest|arrest
1190647|NCT02075450|Simulation|simulation
1190648|NCT02075450|Feedback|feedback
1190649|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
1190650|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
1190651|NCT02075424|stress|stress
1190652|NCT02075424|cortisol|cortisol
1190653|NCT02075424|emergency call center|emergency call center
1190654|NCT02075424|hospital staff|hospital staff
1190655|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1190656|NCT02075411|transplantation allografts|transplantation allografts
1190657|NCT02075411|adolescent|adolescent
1190658|NCT02075411|nerve block|nerve block
1190659|NCT02075411|pain|pain
1190660|NCT02075398|Portable pulse oximeter|portable pulse oximeter
1190661|NCT02075385|Dysphagia|dysphagia
1190662|NCT02075385|speech language therapy|speech language therapy
1190663|NCT02075385|quality of life|quality of life
1190664|NCT02075385|induction chemotherapy|induction chemotherapy
1190665|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1190666|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
1190667|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
1190668|NCT02075372|Hybrid|hybrid
1190669|NCT02075372|Angioplasty|angioplasty
1190670|NCT02075359|Total Energy Expenditure|total energy expenditure
1190671|NCT02075359|Physical Activity Levels|physical activity levels
1190672|NCT02075359|Body Mass Index|body mass index
1190673|NCT02075359|Children|children
1190674|NCT02075346|Patient safety monitors|patient safety monitors
1190675|NCT02075320|CT|ct
1190676|NCT02075320|Chest|chest
1190677|NCT02075320|Lung|lung
1190678|NCT02075307|insulin|insulin
1190679|NCT02075307|diabetes|diabetes
1190680|NCT02075307|obesity|obesity
1190681|NCT02075307|DNA damage|dna damage
1190682|NCT02075307|metabolic syndrome|metabolic syndrome
1190683|NCT02075294|Aged|aged
1190684|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
1190685|NCT02075294|Antiviral Agents|antiviral agents
1190686|NCT02075268|Korean|korean
1190687|NCT02075268|Healthy|healthy
1190688|NCT02075268|Male|male
1333141|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
1264072|NCT01742052|RRMS|rrms
1190689|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
1190690|NCT02075242|HBV|hbv
1190691|NCT02075229|Cochlear Implant|cochlear implant
1190692|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
1190693|NCT02075229|Profound hearing loss|profound hearing loss
1190694|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
1190695|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
1190696|NCT02075229|High frequency hearing loss|high frequency hearing loss
1190697|NCT02075229|CMS-eligible patients|cms-eligible patients
1190698|NCT02075216|Urinary Incontinence|urinary incontinence
1190699|NCT02075216|Children|children
1190700|NCT02075216|Bladder Exstrophy|bladder exstrophy
1190701|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
1190702|NCT02075216|Modern staged repair,|modern staged repair,
1190703|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
1190704|NCT02075203|BCG Vaccinated|bcg vaccinated
1190705|NCT02075177|neuroblastoma|neuroblastoma
1190706|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1190707|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1190708|NCT02075164|NAFLD|nafld
1190709|NCT02075164|NASH|nash
1190710|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
1190711|NCT02075125|Korea|korea
1190712|NCT02075125|Platelet inhibition|platelet inhibition
1190713|NCT02075125|Prasugrel|prasugrel
1190714|NCT02075125|Ticagrelor|ticagrelor
1190715|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1190716|NCT02075112|Soy|soy
1190717|NCT02075112|Isoflavone|isoflavone
1190718|NCT02075112|Radiation Therapy|radiation therapy
1190719|NCT02075112|Cisplatin|cisplatin
1190720|NCT02075099|whole blood donation|whole blood donation
1190721|NCT02075099|donation water drink|donation water drink
1190722|NCT02075099|isotonic drink|isotonic drink
1190723|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
1190724|NCT02075086|angiogenic switch|angiogenic switch
1190725|NCT02075086|plasma cytokines|plasma cytokines
1190726|NCT02075086|Colon cancer|colon cancer
1190727|NCT02075073|Pharmacokinetics|pharmacokinetics
1190728|NCT02075060|low-grade|low-grade
1190729|NCT02075060|NMIBC|nmibc
1190730|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
1190731|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
1190732|NCT02075034|MDS|mds
1190733|NCT02075034|Low risk|low risk
1190734|NCT02075034|Intermediate-1 risk|intermediate-1 risk
1190735|NCT02075034|Intermediate-2 risk|intermediate-2 risk
1190736|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
1190737|NCT02075034|IPSS|ipss
1190738|NCT02075021|relapsed|relapsed
1190739|NCT02075021|refractory|refractory
1190740|NCT02075021|multiple myeloma|multiple myeloma
1190741|NCT02075021|revlimid|revlimid
1190742|NCT02075021|lenalidomide|lenalidomide
1190743|NCT02075021|abraxane|abraxane
1190744|NCT02075021|n-paclitaxel|n-paclitaxel
1190745|NCT02075008|asthma|asthma
1190746|NCT02075008|allergic asthma|allergic asthma
1190747|NCT02075008|QGE031|qge031
1190748|NCT02075008|open-label|open-label
1190749|NCT02075008|IgE|ige
1190750|NCT02075008|long-term safety|long-term safety
1190751|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
1190752|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
1190753|NCT02074969|re-operation rate|re-operation rate
1190754|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
1190755|NCT02074969|GammaNail|gammanail
1190756|NCT02074969|PFNA|pfna
1190757|NCT02074969|Tip-Apex-Distance|tip-apex-distance
1190758|NCT02074969|Parkers-Ratio|parkers-ratio
1190759|NCT02074956|BCG Vaccinated|bcg vaccinated
1190760|NCT02074956|HIV Negative|hiv negative
1190761|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
1190762|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
1190763|NCT02074917|ACL|acl
1190764|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1190765|NCT02074917|outcome assessment|outcome assessment
1190766|NCT02074917|outcome assessment, patient|outcome assessment, patient
1190767|NCT02074917|treatment outcome|treatment outcome
1190768|NCT02074917|exercise test|exercise test
1190769|NCT02074917|anatomic|anatomic
1190770|NCT02074917|anatomical|anatomical
1190771|NCT02074917|single-bundle|single-bundle
1190772|NCT02074917|force platform|force platform
1190773|NCT02074917|postural balance|postural balance
1190774|NCT02074917|biomechanics|biomechanics
1190775|NCT02074917|CT scan|ct scan
1190776|NCT02074917|X-ray computed tomography|x-ray computed tomography
1190777|NCT02074917|tomography|tomography
1190778|NCT02074917|diagnostic imaging|diagnostic imaging
1190779|NCT02074917|knee|knee
1190780|NCT02074917|knee injuries|knee injuries
1190781|NCT02074917|joint instability|joint instability
1190782|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
1190783|NCT02074917|knee surgery|knee surgery
1190784|NCT02074917|arthroscopy|arthroscopy
1190785|NCT02074917|athletes|athletes
1190786|NCT02074917|sports medicine|sports medicine
1190787|NCT02074917|humans|humans
1190788|NCT02074917|prospective studies|prospective studies
1190789|NCT02074917|Randomized Controlled Trial|randomized controlled trial
1190790|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
1190791|NCT02074891|PrEP|prep
1190792|NCT02074891|HIV|hiv
1190793|NCT02074878|Breast Cancer|breast cancer
1190794|NCT02074878|Metastatic|metastatic
1190795|NCT02074878|Crizotinib|crizotinib
1190796|NCT02074878|Sunitinib|sunitinib
1190797|NCT02074878|Xalcori|xalcori
1190798|NCT02074878|Sutent|sutent
1190799|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
1190800|NCT02074839|AML|aml
1190801|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
1190802|NCT02074839|MDS|mds
1190803|NCT02074839|hematologic malignancies|hematologic malignancies
1190804|NCT02074839|IDH|idh
1190805|NCT02074839|Untreated AML|untreated aml
1190806|NCT02074839|IDH1|idh1
1190807|NCT02074839|relapsed AML|relapsed aml
1190808|NCT02074839|refractory AML|refractory aml
1190809|NCT02074813|Inspiratory muscle training|inspiratory muscle training
1190810|NCT02074813|COPD|copd
1190811|NCT02074813|dyspnea|dyspnea
1190812|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
1190813|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
1190814|NCT02074800|Healthy|healthy
1190815|NCT02074800|CNTO 328|cnto 328
1190816|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
1190817|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
1190818|NCT02074800|Safety|safety
1190819|NCT02074800|Pharmacokinetics|pharmacokinetics
1190820|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
1190821|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
1190822|NCT02074761|SIJ fusion|sij fusion
1190823|NCT02074761|SI joint|si joint
1190824|NCT02074761|SIJ|sij
1190825|NCT02074748|Bunion|bunion
1190826|NCT02074748|Foot Arch|foot arch
1190827|NCT02074748|Instability|instability
1190828|NCT02074735|alcohol dependence|alcohol dependence
1190829|NCT02074735|alcohol abuse|alcohol abuse
1190830|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
1190831|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
1190832|NCT02074657|Immunotherapy|immunotherapy
1190834|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
1190835|NCT02074657|Activated natural killer cells|activated natural killer cells
1190836|NCT02074644|Prostatism|prostatism
1190837|NCT02074644|Randomized Controlled Trial|randomized controlled trial
1190838|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
1190839|NCT02074644|Hyperplasia|hyperplasia
1190840|NCT02074644|Prostatic Diseases|prostatic diseases
1190841|NCT02074644|Genital Diseases, Male|genital diseases, male
1190842|NCT02074631|bone mineral content|bone mineral content
1190843|NCT02074631|bone mineral density|bone mineral density
1190844|NCT02074631|bone formation|bone formation
1190845|NCT02074631|bone resorption|bone resorption
1190846|NCT02074631|pamidronate|pamidronate
1190847|NCT02074631|children|children
1190848|NCT02074631|DXA|dxa
1190849|NCT02074631|bone marrow transplant|bone marrow transplant
1190850|NCT02074618|Physical Therapy.|physical therapy.
1190851|NCT02074618|Exercise.|exercise.
1190852|NCT02074618|Rehabilitation.|rehabilitation.
1190853|NCT02074618|Renal Insufficiency.|renal insufficiency.
1190854|NCT02074618|Quality of life.|quality of life.
1190855|NCT02074605|Melanoma|melanoma
1190856|NCT02074605|Interferon|interferon
1190857|NCT02074605|Cognition|cognition
1190858|NCT02074592|Self assessment|self assessment
1190859|NCT02074592|Audit|audit
1190860|NCT02074592|Feedback|feedback
1190861|NCT02074592|Quality|quality
1190862|NCT02074592|Ultrasound|ultrasound
1190863|NCT02074592|Fetal|fetal
1190864|NCT02074592|Biometry|biometry
1190865|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
1190866|NCT02074579|Rome III criteria|rome iii criteria
1190867|NCT02074579|abdominal bloating|abdominal bloating
1190868|NCT02074579|natural|natural
1190869|NCT02074579|herbal|herbal
1190870|NCT02074579|Kampo|kampo
1190871|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
1190872|NCT02074579|Female subjects|female subjects
1190873|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
1190874|NCT02074566|Atrial fibrillation|atrial fibrillation
1190875|NCT02074566|Cryoballoon therapy|cryoballoon therapy
1190876|NCT02074566|Duration|duration
1190877|NCT02074527|congenital heart disease|congenital heart disease
1190878|NCT02074527|cardiac catheterization|cardiac catheterization
1190879|NCT02074527|brazilian electronic registration|brazilian electronic registration
1264337|NCT01740791|HCV|hcv
1190880|NCT02074501|stroke|stroke
1190881|NCT02074501|elderly|elderly
1190882|NCT02074501|caregivers|caregivers
1190883|NCT02074501|empowerment|empowerment
1190884|NCT02074501|self-care|self-care
1190885|NCT02074501|pilot study|pilot study
1190886|NCT02074488|balance|balance
1190887|NCT02074488|gait|gait
1190888|NCT02074462|Voriconazole|voriconazole
1190889|NCT02074462|CRP|crp
1190890|NCT02074462|Inflammation|inflammation
1190891|NCT02074462|Pharmacokinetics|pharmacokinetics
1190892|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1190893|NCT02074449|Right Ventricular Performance|right ventricular performance
1190894|NCT02074449|Treprostinil|treprostinil
1190895|NCT02074449|Remodulin|remodulin
1190896|NCT02074436|hematological malignancies|hematological malignancies
1190897|NCT02074436|thrombocytopenia|thrombocytopenia
1190898|NCT02074436|aminocaproic acid|aminocaproic acid
1190899|NCT02074423|Cinnamon extract|cinnamon extract
1190900|NCT02074423|Postprandial glycemia|postprandial glycemia
1190901|NCT02074423|Glycemic index|glycemic index
1190902|NCT02074423|Pre-diabetes|pre-diabetes
1190903|NCT02074423|Metabolic syndrome|metabolic syndrome
1190904|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
1190905|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
1190906|NCT02074371|ICU|icu
1190907|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
1190908|NCT02074345|Drug therapy|drug therapy
1190909|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
1190910|NCT02074332|Obesity|obesity
1190911|NCT02074332|Physical activity|physical activity
1190912|NCT02074332|Schoolchildren|schoolchildren
1190913|NCT02074332|Intervention Studies|intervention studies
1190914|NCT02074319|Schizophrenia|schizophrenia
1190915|NCT02074319|Anti-Inflammatory|anti-inflammatory
1190916|NCT02074319|Methotrexate|methotrexate
1190917|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
1190918|NCT02074306|endotracheal intubation|endotracheal intubation
1190919|NCT02074306|low energy ultrasound|low energy ultrasound
1190920|NCT02074306|sputum culture|sputum culture
1190921|NCT02074293|Subdermal bloodless space|subdermal bloodless space
1190922|NCT02074293|Subdermal injection|subdermal injection
1190923|NCT02074293|injectable EMG needle|injectable emg needle
1190924|NCT02074293|electrical stimulation|electrical stimulation
1190925|NCT02074293|MRI with Gadolinium|mri with gadolinium
1190926|NCT02074293|Cervical Dystonia|cervical dystonia
1190927|NCT02074293|intramuscular injection|intramuscular injection
1190928|NCT02074293|cervical dystonia,|cervical dystonia,
1190929|NCT02074280|rifaximin|rifaximin
1190930|NCT02074280|endotoxemia|endotoxemia
1190931|NCT02074280|cirrhosis|cirrhosis
1190932|NCT02074280|advanced cirrhosis|advanced cirrhosis
1190933|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
1190934|NCT02074228|symptomatology,|symptomatology,
1190935|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
1190936|NCT02074228|medication response|medication response
1190937|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
1190938|NCT02074215|Alzheimer's disease|alzheimer's disease
1190939|NCT02074215|Aerobic exercise|aerobic exercise
1190940|NCT02074202|18F fluorocholine|18f fluorocholine
1190941|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
1190942|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
1190943|NCT02074202|PET CT scan|pet ct scan
1190944|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1190945|NCT02074176|orexin A|orexin a
1190946|NCT02074176|mRNA|mrna
1190947|NCT02074163|Subdermal bloodless space|subdermal bloodless space
1190948|NCT02074163|Subdermal injection|subdermal injection
1190949|NCT02074163|injectable EMG needle|injectable emg needle
1190950|NCT02074163|electrical stimulation|electrical stimulation
1190951|NCT02074163|MRI with Gadolinium|mri with gadolinium
1190952|NCT02074163|Chronic Migraine|chronic migraine
1190953|NCT02074163|intramuscular injection|intramuscular injection
1190954|NCT02074150|Subdermal bloodless space|subdermal bloodless space
1190955|NCT02074150|Subdermal injection|subdermal injection
1190956|NCT02074150|injectable EMG needle|injectable emg needle
1190957|NCT02074150|electrical stimulation|electrical stimulation
1190958|NCT02074150|MRI with Gadolinium|mri with gadolinium
1190959|NCT02074150|Upper Limb Spasticity|upper limb spasticity
1190960|NCT02074150|intramuscular injection|intramuscular injection
1190961|NCT02074111|Moyamoya disease|moyamoya disease
1190962|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
1190963|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
1190964|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
1190965|NCT02074111|high-resolution MRI|high-resolution mri
1190966|NCT02074098|intubation|intubation
1190967|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1190968|NCT02074098|Manikin study|manikin study
1190969|NCT02074072|Endotracheal intubation|endotracheal intubation
1190970|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
1264489|NCT01740362|550|550
1190971|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
1190972|NCT02074072|Manikin Study|manikin study
1190973|NCT02074020|SLE|sle
1190974|NCT02074020|Lupus|lupus
1190975|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1190976|NCT02074020|Autoimmune Diseases|autoimmune diseases
1190977|NCT02074020|A-623|a-623
1190978|NCT02074020|Blisibimod|blisibimod
1190979|NCT02074020|Nephritis|nephritis
1190980|NCT02074007|Acute Otitis Media|acute otitis media
1190981|NCT02074007|Pain|pain
1190982|NCT02074007|Ear Pain|ear pain
1190983|NCT02074007|Ear Ache|ear ache
1190984|NCT02074007|Ear infection|ear infection
1190985|NCT02074007|middle ear infection|middle ear infection
1190986|NCT02073994|chondrosarcoma|chondrosarcoma
1190987|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
1190988|NCT02073994|glioma|glioma
1190989|NCT02073994|advanced solid tumors|advanced solid tumors
1190990|NCT02073994|IDH1|idh1
1190991|NCT02073994|AG-120|ag-120
1190992|NCT02073981|Parkinson Disease|parkinson disease
1190993|NCT02073955|Stroke|stroke
1190994|NCT02073955|Validation|validation
1190995|NCT02073955|Community Health workers|community health workers
1190996|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
1190997|NCT02073916|Breast Cancer|breast cancer
1190998|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
1190999|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
1191000|NCT02073903|communication|communication
1191001|NCT02073903|14-042|14-042
1191002|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
1191003|NCT02073890|Head Trauma|head trauma
1191004|NCT02073890|Computed Tomography|computed tomography
1191005|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
1191006|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
1191007|NCT02073851|TAVR|tavr
1191008|NCT02073825|Computer-assisted interventions|computer-assisted interventions
1191009|NCT02073825|Alcohol use disorders|alcohol use disorders
1191010|NCT02073825|At-risk drinking|at-risk drinking
1191011|NCT02073825|Spouses|spouses
1191012|NCT02073825|Military|military
1191013|NCT02073825|Brief Intervention|brief intervention
1191014|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
1191015|NCT02073760|Healthcare acquired infections|healthcare acquired infections
1191016|NCT02073760|Cardiac Surgery|cardiac surgery
1191017|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
1191018|NCT02073760|Deep Sternal Infection|deep sternal infection
1191019|NCT02073760|Mediastinitis|mediastinitis
1191020|NCT02073760|Thoracotomy|thoracotomy
1191021|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
1191022|NCT02073760|Sepsis|sepsis
1191023|NCT02073760|Pneumonia|pneumonia
1191024|NCT02073747|Albuterol|albuterol
1191025|NCT02073747|Serum Lactate|serum lactate
1191026|NCT02073747|Lactic Acidosis|lactic acidosis
1191027|NCT02073747|Asthma|asthma
1191029|NCT02073734|dexamethasone|dexamethasone
1191030|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
1191031|NCT02073734|peroperative administration|peroperative administration
1191032|NCT02073695|Proximal humeral fracture|proximal humeral fracture
1191033|NCT02073695|Shoulder|shoulder
1191034|NCT02073695|Orthopaedics|orthopaedics
1191035|NCT02073695|Neutral rotation brace|neutral rotation brace
1191036|NCT02073695|Polysling|polysling
1191037|NCT02073669|latent tuberculosis|latent tuberculosis
1191038|NCT02073669|tuberculin skin test|tuberculin skin test
1191039|NCT02073669|Interferon gamma release assay|interferon gamma release assay
1191040|NCT02073669|immigration|immigration
1191041|NCT02073656|genotype 1|genotype 1
1191042|NCT02073656|genotype 4|genotype 4
1191044|NCT02073630|magnetoencephalography|magnetoencephalography
1191045|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
1191046|NCT02073630|cerebellum|cerebellum
1191047|NCT02073630|gamma rhythms|gamma rhythms
1191048|NCT02073617|DynaCT|dynact
1191049|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
1191050|NCT02073617|TAVR|tavr
1191051|NCT02073604|Congenital mirror movements|congenital mirror movements
1191052|NCT02073604|SMA|sma
1191053|NCT02073604|Movement preparation|movement preparation
1191054|NCT02073604|Movement lateralization|movement lateralization
1191055|NCT02073604|MRI|mri
1191056|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
1191057|NCT02073591|Children|children
1191058|NCT02073591|Atopic Dermatitis|atopic dermatitis
1191059|NCT02073591|Ceradan|ceradan
1191060|NCT02073591|PEST|pest
1191061|NCT02073591|SCORAD|scorad
1191062|NCT02073578|achalasia|achalasia
1191063|NCT02073578|POEM|poem
1191064|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
1191065|NCT02073578|myotomy|myotomy
1191066|NCT02073578|Heller myotomy|heller myotomy
1191067|NCT02073565|intracoronary stent|intracoronary stent
1191068|NCT02073565|drug eluting stent|drug eluting stent
1191069|NCT02073565|sirolimus|sirolimus
1577309|NCT00474747|Fludarabine|fludarabine
1264599|NCT01739933|Sepsis|sepsis
1191070|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
1191071|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
1191072|NCT02073539|Chest compression|chest compression
1191073|NCT02073539|One accelerometer|one accelerometer
1191074|NCT02073539|Manikin Study|manikin study
1191075|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
1191076|NCT02073526|Anti-TNF|anti-tnf
1191077|NCT02073526|TNF-alpha|tnf-alpha
1191078|NCT02073526|Trough level|trough level
1191079|NCT02073526|Drug concentration|drug concentration
1191080|NCT02073526|ELISA|elisa
1191081|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
1191082|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
1191083|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
1191084|NCT02073500|Cytoreductive surgery|cytoreductive surgery
1191085|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1191086|NCT02073500|CRS|crs
1191087|NCT02073500|HIPEC|hipec
1191088|NCT02073500|Prognostic biomarker|prognostic biomarker
1191089|NCT02073500|Predictive biomarker|predictive biomarker
1191090|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
1191091|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
1191092|NCT02073474|cannabinoids|cannabinoids
1191093|NCT02073474|Sativex|sativex
1191094|NCT02073474|THC|thc
1191095|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
1191096|NCT02073474|cannabidiol|cannabidiol
1191097|NCT02073474|CBD|cbd
1191098|NCT02073474|Registry|registry
1191099|NCT02073474|Safety|safety
1191100|NCT02073474|MS|ms
1191101|NCT02073461|Acne Vulgaris|acne vulgaris
1191102|NCT02073448|Acne Vulgaris|acne vulgaris
1191103|NCT02073435|liver transplantation|liver transplantation
1191104|NCT02073435|living donor|living donor
1191105|NCT02073435|Safety|safety
1191106|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
1191107|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
1191108|NCT02073422|Fractional flow reserve|fractional flow reserve
1191109|NCT02073422|Relaxometry|relaxometry
1191110|NCT02073422|Coronary artery disease|coronary artery disease
1191111|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
1191112|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
1191113|NCT02073383|Ultrasound|ultrasound
1191114|NCT02073383|Bupivacaine|bupivacaine
1191115|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
1191116|NCT02073344|overhydration|overhydration
1191117|NCT02073344|end stage renal disease|end stage renal disease
1191118|NCT02073344|renal transplantation|renal transplantation
1191119|NCT02073344|polysomnography|polysomnography
1191120|NCT02073344|bioimpedance|bioimpedance
1191121|NCT02073344|leg fluid shift|leg fluid shift
1191122|NCT02073344|neck circumference|neck circumference
1191124|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
1191125|NCT02073305|end stage renal disease|end stage renal disease
1191126|NCT02073305|cardiovascular events|cardiovascular events
1191127|NCT02073240|Tuberculosis|tuberculosis
1191128|NCT02073240|Infection Control|infection control
1191129|NCT02073227|Healthy Volunteers|healthy volunteers
1191130|NCT02073227|Canagliflozin|canagliflozin
1191131|NCT02073227|Metformin|metformin
1191132|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
1191133|NCT02073175|Postpartum|postpartum
1191134|NCT02073175|Dietary Supplements|dietary supplements
1191135|NCT02073175|Mood Symptoms|mood symptoms
1191136|NCT02073149|Iron|iron
1191137|NCT02073149|Anemia|anemia
1191138|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
1191139|NCT02073149|Ferrous compounds|ferrous compounds
1191140|NCT02073149|Child, preschool|child, preschool
1191141|NCT02073149|Kenya|kenya
1191142|NCT02073123|Metastatic melanoma|metastatic melanoma
1191143|NCT02073123|Stage III melanoma|stage iii melanoma
1191144|NCT02073123|Stage IV melanoma|stage iv melanoma
1191145|NCT02073123|unresectable|unresectable
1191146|NCT02073110|Kidney cancer|kidney cancer
1191147|NCT02073110|Renal mass|renal mass
1191148|NCT02073110|Small renal mass|small renal mass
1191149|NCT02073110|Optical Coherence Tomography|optical coherence tomography
1191150|NCT02073110|OCT|oct
1191151|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
1191152|NCT02073110|DRS|drs
1191153|NCT02073110|Optical Biopsy|optical biopsy
1191154|NCT02073110|OB|ob
1191155|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
1191156|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
1191157|NCT02073006|Chronic|chronic
1191158|NCT02073006|Functional|functional
1191159|NCT02073006|Constipation|constipation
1191160|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
1191161|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
1191162|NCT02072980|DT1|dt1
1191163|NCT02072980|DAILIES TOTAL1®|dailies total1®
1191164|NCT02072980|Lubricity|lubricity
1191165|NCT02072967|Relapsed|relapsed
1191166|NCT02072967|Refractory|refractory
1191167|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1191168|NCT02072967|Bendamustine|bendamustine
1191169|NCT02072941|Advance care planning|advance care planning
1191170|NCT02072941|Latino Health|latino health
1191171|NCT02072941|Medical decision making|medical decision making
1191172|NCT02072941|Health Literacy|health literacy
1191173|NCT02072941|Limited English proficiency|limited english proficiency
1191174|NCT02072941|Aging|aging
1191175|NCT02072902|Cohort|cohort
1191176|NCT02072902|Historical|historical
1191177|NCT02072902|Prospective|prospective
1191178|NCT02072902|Medications|medications
1191179|NCT02072902|Observational|observational
1191180|NCT02072902|Glucose|glucose
1191181|NCT02072902|Control|control
1191182|NCT02072889|Cardiac Surgery|cardiac surgery
1191183|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
1191184|NCT02072889|Optimal Neck Angle|optimal neck angle
1191185|NCT02072876|Stroke|stroke
1191186|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
1191187|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
1191188|NCT02072876|Clinical predictors|clinical predictors
1191189|NCT02072850|Myocardial infarction|myocardial infarction
1191190|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
1191191|NCT02072850|Thrombolysis|thrombolysis
1191192|NCT02072850|Rescue PCI|rescue pci
1191193|NCT02072850|Electrocardiogram|electrocardiogram
1191194|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
1191195|NCT02072850|Area-at-risk|area-at-risk
1191196|NCT02072850|Myocardial salvage|myocardial salvage
1191197|NCT02072850|Infarct size|infarct size
1191198|NCT02072850|Pressure wire|pressure wire
1191199|NCT02072850|Coronary thermodilution|coronary thermodilution
1191200|NCT02072850|Coronary microvascular function|coronary microvascular function
1191201|NCT02072850|Index of microvascular resistance|index of microvascular resistance
1191202|NCT02072850|Heart failure|heart failure
1191203|NCT02072850|Prognosis|prognosis
1191204|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
1191205|NCT02072824|Partial Onset Seizures|partial onset seizures
1191206|NCT02072824|Epilepsy|epilepsy
1191207|NCT02072824|Safety|safety
1191208|NCT02072824|Efficacy|efficacy
1191209|NCT02072824|Tolerability|tolerability
1191210|NCT02072824|Pregabalin|pregabalin
1191211|NCT02072824|Lyrica|lyrica
1191212|NCT02072824|Adjunctive treatment|adjunctive treatment
1191213|NCT02072824|Placebo controlled|placebo controlled
1191214|NCT02072824|blinded|blinded
1191215|NCT02072824|Eligibility Criteria|eligibility criteria
1191216|NCT02072811|AML|aml
1191217|NCT02072798|Randomized Controlled Trial|randomized controlled trial
1191218|NCT02072798|Caesarean Section|caesarean section
1191219|NCT02072798|Surgical Site Infections|surgical site infections
1191220|NCT02072798|Wound Infections|wound infections
1191221|NCT02072798|Infectious Morbidity|infectious morbidity
1191222|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
1191223|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
1191224|NCT02072785|Vincristine Sulfate|vincristine sulfate
1191225|NCT02072759|Insulin sensitivity|insulin sensitivity
1191226|NCT02072759|Metabolic flexibility|metabolic flexibility
1191227|NCT02072746|cirrhosis|cirrhosis
1191228|NCT02072746|alcohol|alcohol
1191229|NCT02072733|frailty|frailty
1191230|NCT02072733|oncogeriatrics|oncogeriatrics
1191231|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
1191232|NCT02072733|multimorbidity|multimorbidity
1191233|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
1191234|NCT02072733|patients|patients
1191235|NCT02072720|Radiotherapy|radiotherapy
1191236|NCT02072720|VEGF|vegf
1191237|NCT02072720|esophagus carcinoma|esophagus carcinoma
1191238|NCT02072720|bevacizumab|bevacizumab
1191239|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
1191240|NCT02072707|RF ablation|rf ablation
1191241|NCT02072707|Epicardial Access|epicardial access
1191744|NCT02070237|Obesity|obesity
1191242|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
1191243|NCT02072694|Obesity|obesity
1191244|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
1191245|NCT02072694|Functional Neuroimaging|functional neuroimaging
1191246|NCT02072668|sickle cell anemia|sickle cell anemia
1191247|NCT02072668|sickle cell disease|sickle cell disease
1191248|NCT02072668|rivaroxaban|rivaroxaban
1191249|NCT02072668|direct Xa inhibition|direct xa inhibition
1191250|NCT02072668|coagulation|coagulation
1191251|NCT02072668|anticoagulation|anticoagulation
1191252|NCT02072629|Antimalarials|antimalarials
1191253|NCT02072629|Antibiotics|antibiotics
1191254|NCT02072629|ORS Zn|ors zn
1191255|NCT02072629|Village Health Volunteers|village health volunteers
1333142|NCT01444391|iontophoresis|iontophoresis
1191256|NCT02072629|Integrated Community Case Management|integrated community case management
1191257|NCT02072616|Circulating Tumor Cells|circulating tumor cells
1191258|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1191259|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
1191260|NCT02072616|CA 19.9|ca 19.9
1191261|NCT02072603|Infant HIV|infant hiv
1191262|NCT02072603|Kenya|kenya
1191263|NCT02072603|HITSystem|hitsystem
1191264|NCT02072603|EID care|eid care
1191265|NCT02072603|Early Infant Diagnosis|early infant diagnosis
1191266|NCT02072590|Celiac disease|celiac disease
1191267|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
1191268|NCT02072590|Endomysial antibodies|endomysial antibodies
1191269|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
1191270|NCT02072590|Small-bowel|small-bowel
1191271|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
1191272|NCT02072538|Stress testing|stress testing
1191273|NCT02072538|Troponin T|troponin t
1191274|NCT02072538|GRACE score|grace score
1191275|NCT02072538|Outcome|outcome
1191276|NCT02072525|Pertussis|pertussis
1191277|NCT02072525|Healthy adults|healthy adults
1191278|NCT02072525|Tetanus|tetanus
1191279|NCT02072525|Human serum samples|human serum samples
1191280|NCT02072525|Streptococcus|streptococcus
1191281|NCT02072525|Diphtheria|diphtheria
1191282|NCT02072525|Plasma|plasma
1191283|NCT02072525|Meningococcus|meningococcus
1191284|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
1191285|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
1191286|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
1191287|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
1191288|NCT02072447|absolute bioavailability,|absolute bioavailability,
1191289|NCT02072447|microdose,|microdose,
1191291|NCT02072434|Atrial fibrillation|atrial fibrillation
1191292|NCT02072434|anti-coagulant|anti-coagulant
1191293|NCT02072434|warfarin|warfarin
1191294|NCT02072434|edoxaban|edoxaban
1191295|NCT02072434|electrical cardioversion|electrical cardioversion
1191296|NCT02072395|morbid obesity|morbid obesity
1191297|NCT02072395|bariatric surgery|bariatric surgery
1191298|NCT02072395|gastric banding|gastric banding
1191299|NCT02072395|gastric plication|gastric plication
1191300|NCT02072382|Hypertension|hypertension
1191301|NCT02072382|Metformin|metformin
1191302|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
1191303|NCT02072369|stroke|stroke
1191304|NCT02072369|hand|hand
1191305|NCT02072369|fingers|fingers
1191306|NCT02072369|rehabilitation|rehabilitation
1191307|NCT02072369|training|training
1191308|NCT02072356|Humanitarian Device|humanitarian device
1191309|NCT02072356|Carcinoma|carcinoma
1191310|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
1191311|NCT02072356|TheraSphere®|therasphere®
1191312|NCT02072356|HUD|hud
1191313|NCT02072343|Capnography|capnography
1191314|NCT02072343|Catheters|catheters
1191315|NCT02072343|Intubation|intubation
1191316|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
1191317|NCT02072317|PFS|pfs
1191318|NCT02072304|mood disorder|mood disorder
1191319|NCT02072304|depressive disorder|depressive disorder
1191320|NCT02072304|mental disorders|mental disorders
1191321|NCT02072304|program acceptability|program acceptability
1191322|NCT02072304|behavioral symptoms|behavioral symptoms
1191323|NCT02072304|suicidal ideation|suicidal ideation
1191324|NCT02072304|patient adherence|patient adherence
1191325|NCT02072265|infrared thermal image|infrared thermal image
1191326|NCT02072265|wound healing|wound healing
1191327|NCT02072265|wound infection|wound infection
1191328|NCT02072252|Depression|depression
1191329|NCT02072252|Anxiety|anxiety
1191330|NCT02072252|Mobile Phone|mobile phone
1191331|NCT02072252|Cellular Phone|cellular phone
1191332|NCT02072252|Mobile Application|mobile application
1191333|NCT02072252|Mobile Intervention|mobile intervention
1191334|NCT02072252|App|app
1191335|NCT02072252|mHealth|mhealth
1191336|NCT02072252|eHealth|ehealth
1191337|NCT02072252|Technology Assisted|technology assisted
1191338|NCT02072252|Internet|internet
1191339|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
1191340|NCT02072252|LGBT|lgbt
1191949|NCT02069262|angiography|angiography
1191341|NCT02072252|Sexual Minorities|sexual minorities
1191342|NCT02072252|Gay|gay
1191343|NCT02072252|Bisexual|bisexual
1191344|NCT02072252|Same Sex Attraction|same sex attraction
1191345|NCT02072252|Males|males
1191346|NCT02072252|Men|men
1191347|NCT02072252|Youth|youth
1191348|NCT02072252|Adolescents|adolescents
1191349|NCT02072252|Young Adults|young adults
1191350|NCT02072239|CABG|cabg
1191351|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
1191352|NCT02072239|Atherosclerosis|atherosclerosis
1191353|NCT02072239|Myocardial Infarction|myocardial infarction
1191354|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
1191355|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
1191356|NCT02072187|Depression|depression
1191357|NCT02072187|Vitamin D|vitamin d
1191358|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
1191359|NCT02072187|Supplements|supplements
1191360|NCT02072187|Non Remitted Depression|non remitted depression
1191361|NCT02072161|Statin|statin
1191362|NCT02072161|LDL|ldl
1191363|NCT02072161|Cholesterol|cholesterol
1191364|NCT02072148|Human Papilloma Virus|human papilloma virus
1191365|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
1191366|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
1191367|NCT02072122|dry eye|dry eye
1191368|NCT02072122|fertility treatment|fertility treatment
1191369|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
1191370|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
1191371|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
1191372|NCT02072109|Bolus nutrition|bolus nutrition
1191373|NCT02072109|Continuous nutrition|continuous nutrition
1191374|NCT02072109|Mesenteric circulation|mesenteric circulation
1191375|NCT02072083|dexmedetomidine|dexmedetomidine
1191376|NCT02072083|intranasal|intranasal
1191377|NCT02072083|strabismus surgery|strabismus surgery
1191378|NCT02072083|premedication|premedication
1191379|NCT02072083|oculocardiac reflex|oculocardiac reflex
1191380|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
1191381|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
1191382|NCT02072044|Anlotinib|anlotinib
1191383|NCT02072031|Anlotinib|anlotinib
1191384|NCT02072031|Sunitinib|sunitinib
1191385|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
1191386|NCT02072018|Peyronie's|peyronie's
1191387|NCT02072018|Peyronie's disease|peyronie's disease
1191388|NCT02072018|Treatment|treatment
1191389|NCT02072018|Clinical Study|clinical study
1191390|NCT02071979|Chronic|chronic
1191391|NCT02071979|Non-healing|non-healing
1191392|NCT02071979|Wounds|wounds
1191393|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
1191394|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
1191395|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
1191396|NCT02071927|leukemia|leukemia
1191397|NCT02071927|glutaminase|glutaminase
1191398|NCT02071927|glutamine|glutamine
1191399|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1191400|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1191401|NCT02071888|Multiple myeloma|multiple myeloma
1191402|NCT02071888|glutaminase|glutaminase
1191403|NCT02071888|glutamine|glutamine
1191404|NCT02071875|Vasospasm|vasospasm
1191405|NCT02071875|Aneurysm|aneurysm
1191406|NCT02071875|SAH|sah
1191407|NCT02071875|Nautilus NeuroWave|nautilus neurowave
1191408|NCT02071862|Tumor metabolism|tumor metabolism
1191409|NCT02071862|Glutaminase|glutaminase
1191410|NCT02071862|Glutamine|glutamine
1191411|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
1191412|NCT02071849|Aortic Insufficiency|aortic insufficiency
1191413|NCT02071849|Aortic Regurgitation|aortic regurgitation
1191414|NCT02071836|web application|web application
1191415|NCT02071836|DWI intervention|dwi intervention
1191416|NCT02071836|DUI intervention|dui intervention
1191417|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
1191723|NCT02070341|quality|quality
1191418|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
1191419|NCT02071823|Opicapone,|opicapone,
1191420|NCT02071823|Parkinson,|parkinson,
1191422|NCT02071823|BIA 9-1067|bia 9-1067
1191423|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
1191424|NCT02071810|Opicapone|opicapone
1191425|NCT02071810|Bial|bial
1191426|NCT02071810|BIA 9-1067|bia 9-1067
1191427|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
1191428|NCT02071797|Cardiac Arrest|cardiac arrest
1191429|NCT02071797|Randomised Controlled trial|randomised controlled trial
1191430|NCT02071797|Pilot study|pilot study
1191431|NCT02071771|DACP Toric|dacp toric
1191432|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
1191433|NCT02071771|Astigmatism|astigmatism
1191434|NCT02071771|Toric|toric
1191435|NCT02071758|Leishmaniasis|leishmaniasis
1191436|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
1191437|NCT02071758|Vaccine|vaccine
1191438|NCT02071758|Adjuvant|adjuvant
1191439|NCT02071758|GLA|gla
1191440|NCT02071758|SLA|sla
1192634|NCT02065986|HIV|hiv
1191441|NCT02071693|subthalamic nucleus|subthalamic nucleus
1191442|NCT02071693|deep brain stimulation|deep brain stimulation
1191443|NCT02071693|cognition|cognition
1191444|NCT02071693|white matter hyperintensities|white matter hyperintensities
1191445|NCT02071680|atrial fibrillation|atrial fibrillation
1191446|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
1191447|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
1191448|NCT02071680|High Frequency Stimulation|high frequency stimulation
1191449|NCT02071680|ganglionated plexuses|ganglionated plexuses
1191450|NCT02071680|123I-mIBG|123i-mibg
1191451|NCT02071680|nuclear imaging|nuclear imaging
1191452|NCT02071667|Chronic sinusitis|chronic sinusitis
1265123|NCT01737775|Age|age
1191453|NCT02071667|Nasal Polyps|nasal polyps
1191454|NCT02071654|Venus P-valve|venus p-valve
1191455|NCT02071615|Brain Activity|brain activity
1191456|NCT02071602|Heart attack|heart attack
1191457|NCT02071602|Myocardial Infarction|myocardial infarction
1191458|NCT02071602|STEMI|stemi
1191459|NCT02071576|Myopia|myopia
1191460|NCT02071576|Hyperopia|hyperopia
1191461|NCT02071576|Proscan|proscan
1191462|NCT02071576|LASIK|lasik
1191463|NCT02071576|TENEO|teneo
1191464|NCT02071576|Excimer|excimer
1191465|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
1191466|NCT02071498|Pillbox|pillbox
1191467|NCT02071498|Non-adherence|non-adherence
1191468|NCT02071498|Applications|applications
1191469|NCT02071498|Patient safety|patient safety
1191470|NCT02071498|Elderly|elderly
1191471|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
1191472|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
1191473|NCT02071459|Multiple system atrophy|multiple system atrophy
1191474|NCT02071446|Deep Brain Stimulation|deep brain stimulation
1191475|NCT02071446|Local Field Potential|local field potential
1191476|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
1191477|NCT02071433|Saphenous nerve block|saphenous nerve block
1191478|NCT02071433|Adductor canal block|adductor canal block
1191479|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
1191480|NCT02071433|Pain management|pain management
1191481|NCT02071433|Day care|day care
1191482|NCT02071407|traumatic brain injury|traumatic brain injury
1191483|NCT02071407|sedation|sedation
1191484|NCT02071407|midazolam|midazolam
1191485|NCT02071394|Xenon|xenon
1191486|NCT02071394|Hypothermia|hypothermia
1191487|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1191488|NCT02071394|Newborn|newborn
1191489|NCT02071394|Neonate|neonate
1191490|NCT02071394|Term|term
1191491|NCT02071394|Neuroprotection|neuroprotection
1191492|NCT02071394|Cooling|cooling
1191493|NCT02071394|HIE|hie
1191494|NCT02071368|Healthy|healthy
1191495|NCT02071368|Canagliflozin|canagliflozin
1191496|NCT02071368|Metformin|metformin
1191497|NCT02071368|JNJ-28431754|jnj-28431754
1191498|NCT02071368|GLUMETZA®|glumetza®
1191499|NCT02071368|Bioequivalence|bioequivalence
1191500|NCT02071368|Fixed Dose Combination|fixed dose combination
1191501|NCT02071355|Healthy|healthy
1191502|NCT02071355|Chinese participants|chinese participants
1191503|NCT02071355|TMC435|tmc435
1191504|NCT02071355|Multiple oral doses|multiple oral doses
1191505|NCT02071355|Pharmacokinetics|pharmacokinetics
1191506|NCT02071355|Safety|safety
1191507|NCT02071355|Tolerability|tolerability
1191508|NCT02071342|acute myocardial infarction|acute myocardial infarction
1191509|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
1191510|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
1191511|NCT02071329|FP-01.1|fp-01.1
1191512|NCT02071329|Influenza A|influenza a
1191513|NCT02071329|Flu|flu
1191514|NCT02071329|Vaccine|vaccine
1191515|NCT02071329|Virus|virus
1191516|NCT02071329|H1N1|h1n1
1191517|NCT02071329|Challenge|challenge
1191518|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
1191519|NCT02071316|Hexacapron|hexacapron
1191520|NCT02071316|hemostasis|hemostasis
1191521|NCT02071303|Pain|pain
1191522|NCT02071303|Hysteroscopy|hysteroscopy
1191523|NCT02071303|Tramadol|tramadol
1191524|NCT02071303|Celecoxib|celecoxib
1191525|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
1191526|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
1191527|NCT02071277|Mechanical ventilation|mechanical ventilation
1191528|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
1191529|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
1191530|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
1191531|NCT02071277|Lung protective ventilation|lung protective ventilation
1191532|NCT02071277|Spontaneous breathing|spontaneous breathing
1191533|NCT02071264|HIV/AIDS|hiv/aids
1191534|NCT02071264|sex work|sex work
1191535|NCT02071264|reproductive health|reproductive health
1191536|NCT02071264|human rights|human rights
1191537|NCT02071264|ethics|ethics
1191538|NCT02071251|Wound complications|wound complications
1191539|NCT02071251|Wound infection|wound infection
1191540|NCT02071251|Wound separation|wound separation
1191541|NCT02071238|Carpal tunnel|carpal tunnel
1191542|NCT02071238|Carpal tunnel release|carpal tunnel release
1191543|NCT02071238|Risk Recall|risk recall
1191544|NCT02071238|Patient satisfaction|patient satisfaction
1191545|NCT02071238|Pamphlet|pamphlet
1191546|NCT02071238|Brochure|brochure
1191547|NCT02071199|Gingivitis|gingivitis
1191548|NCT02071199|Periodontitis|periodontitis
1191549|NCT02071199|ACCS|accs
1191550|NCT02071160|HIE|hie
1191551|NCT02071160|hypothermia|hypothermia
1191552|NCT02071160|encephalopathy|encephalopathy
1191553|NCT02071160|anti oxidants|anti oxidants
1191554|NCT02071160|MRI|mri
1265216|NCT01737450|BKM120|bkm120
1191555|NCT02071147|Follow-up|follow-up
1191556|NCT02071147|No follow-up|no follow-up
1191557|NCT02071147|removal|removal
1191558|NCT02071147|Randomised Controlled Trial|randomised controlled trial
1191559|NCT02071147|6 Weeks|6 weeks
1191560|NCT02071134|Deep brain stimulation|deep brain stimulation
1191561|NCT02071134|Parkinson's disease|parkinson's disease
1191562|NCT02071134|Vercise|vercise
1191563|NCT02071121|BIIB061|biib061
1191564|NCT02071121|Healthy|healthy
1191565|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
1191566|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
1191567|NCT02071095|Poly-ICLC|poly-iclc
1191568|NCT02071095|Adjuvant|adjuvant
1191569|NCT02071082|HIV|hiv
1191570|NCT02071082|HBV|hbv
1191571|NCT02071082|Coinfection|coinfection
1191572|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
1191573|NCT02071069|maintenance therapy|maintenance therapy
1191574|NCT02071069|Cetuximab|cetuximab
1191575|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1191576|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
1191577|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
1191578|NCT02071030|CBCT|cbct
1191579|NCT02071030|Third molar removal|third molar removal
1191580|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
1191581|NCT02071004|acute ischemic stroke|acute ischemic stroke
1191582|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
1191583|NCT02070991|CpcPH|cpcph
1191584|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1191585|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
1191586|NCT02070978|LTE|lte
1191587|NCT02070952|CyberKnife|cyberknife
1191588|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1191589|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
1191590|NCT02070939|Phase 1|phase 1
1191591|NCT02070939|Randomized|randomized
1191592|NCT02070939|Double Blind|double blind
1191593|NCT02070939|Placebo-Controlled|placebo-controlled
1191594|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
1191595|NCT02070939|Safety Tolerability|safety tolerability
1191596|NCT02070939|PK|pk
1191597|NCT02070939|PD|pd
1191598|NCT02070939|PF-06460414|pf-06460414
1191599|NCT02070913|Hypothermia|hypothermia
1191600|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
1191601|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
1191602|NCT02070913|AMI|ami
1191603|NCT02070913|PCI|pci
1191604|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
1191605|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1191606|NCT02070900|PMTCT|pmtct
1191607|NCT02070900|Option B+|option b+
1191608|NCT02070900|ART|art
1191609|NCT02070900|Retention|retention
1191610|NCT02070900|Loss to Follow Up|loss to follow up
1191611|NCT02070900|Time to initiation|time to initiation
1191612|NCT02070900|POC CD4|poc cd4
1191613|NCT02070900|Clinical mentoring|clinical mentoring
1191614|NCT02070900|Costing|costing
1191615|NCT02070900|HIV|hiv
1191616|NCT02070900|AIDS|aids
1191617|NCT02070900|Zimbabwe|zimbabwe
1191618|NCT02070874|pain and symptom management|pain and symptom management
1191619|NCT02070861|Cardiac output|cardiac output
1191620|NCT02070861|Exhaled CO2|exhaled co2
1191621|NCT02070861|Nexfin|nexfin
1191622|NCT02070861|Esophageal Doppler|esophageal doppler
1191623|NCT02070848|red blood cell|red blood cell
1191624|NCT02070848|knee extension exercise|knee extension exercise
1191625|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
1191626|NCT02070835|ReCell|recell
1191627|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
1191628|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
1191629|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
1191630|NCT02070809|wound|wound
1191631|NCT02070809|tissue-engineered skin|tissue-engineered skin
1191632|NCT02070796|Rotigotine|rotigotine
1191633|NCT02070796|Transdermal Patch|transdermal patch
1191634|NCT02070796|Bioequivalence|bioequivalence
1191635|NCT02070783|depression|depression
1191636|NCT02070783|cognition|cognition
1191637|NCT02070783|emotion perception|emotion perception
1191638|NCT02070783|information processing|information processing
1191639|NCT02070757|Ventilator-associated bacterial pneumonia|ventilator-associated bacterial pneumonia
1191640|NCT02070757|Hospital-acquired bacterial pneumonia|hospital-acquired bacterial pneumonia
1191641|NCT02070757|Pneumonia|pneumonia
1191642|NCT02070757|Lung Diseases|lung diseases
1192635|NCT02065986|Prevention|prevention
1191643|NCT02070757|Respiratory Tract Diseases|respiratory tract diseases
1191644|NCT02070757|Respiratory Tract Infections|respiratory tract infections
1191645|NCT02070757|Infection|infection
1191646|NCT02070757|Ventilator-Induced Lung Injury|ventilator-induced lung injury
1191647|NCT02070757|Lung Injury|lung injury
1191648|NCT02070744|CF|cf
1191649|NCT02070731|TAVR|tavr
1191650|NCT02070731|TAVI|tavi
1191651|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
1191652|NCT02070718|hot flashes|hot flashes
1191653|NCT02070718|menopause|menopause
1191654|NCT02070718|kappa agonist|kappa agonist
1191655|NCT02070692|Contraceptive implant|contraceptive implant
1191656|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
1191657|NCT02070692|Etonogestrel implant|etonogestrel implant
1191658|NCT02070679|Alpha-tocopherol|alpha-tocopherol
1191659|NCT02070679|Vitamin E|vitamin e
1191660|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
1191661|NCT02070679|Coronary angiography|coronary angiography
1191662|NCT02070666|ARDS|ards
1191663|NCT02070666|Prevention|prevention
1191664|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
1191665|NCT02070666|low tidal volumes|low tidal volumes
1191666|NCT02070653|Aorta|aorta
1191667|NCT02070653|Aneurysm|aneurysm
1191668|NCT02070653|Antiplatelet|antiplatelet
1191669|NCT02070640|cholecystectomy|cholecystectomy
1191670|NCT02070640|cholecystitis|cholecystitis
1191671|NCT02070627|acute cholecystitis|acute cholecystitis
1191672|NCT02070627|acute cholangitis|acute cholangitis
1191673|NCT02070627|cholecystectomy|cholecystectomy
1191674|NCT02070614|sufentanil|sufentanil
1191675|NCT02070614|metabolism|metabolism
1191676|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
1191677|NCT02070614|gene polymorphism|gene polymorphism
1191678|NCT02070588|TBI|tbi
1191679|NCT02070588|mTBI|mtbi
1191680|NCT02070588|MR|mr
1191681|NCT02070588|MRI|mri
1191682|NCT02070588|Pulse Sequences|pulse sequences
1191683|NCT02070588|NFL|nfl
1191684|NCT02070575|PSA|psa
1191685|NCT02070575|Human Kallikrein 2|human kallikrein 2
1191686|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
1191687|NCT02070575|biochemical recurrence|biochemical recurrence
1191688|NCT02070575|14-041|14-041
1191689|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
1191690|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1191691|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
1191692|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
1191693|NCT02070536|Gene polymorphisms|gene polymorphisms
1191694|NCT02070536|Biomarker|biomarker
1191695|NCT02070484|NuCel|nucel
1191696|NCT02070484|Lumbar Spine|lumbar spine
1191697|NCT02070484|Degenerative Disease|degenerative disease
1191698|NCT02070484|Efficacy|efficacy
1191699|NCT02070484|Fusion|fusion
1191700|NCT02070445|CABG|cabg
1191701|NCT02070445|pilot|pilot
1191702|NCT02070445|ultrasound|ultrasound
1191703|NCT02070445|perioperative|perioperative
1191704|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
1191705|NCT02070432|LUZ11|luz11
1191706|NCT02070432|head and neck cancer|head and neck cancer
1191707|NCT02070432|photodynamic therapy|photodynamic therapy
1191708|NCT02070432|Redaporfin|redaporfin
1191709|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
1191710|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
1191711|NCT02070380|confirmed brain disease|confirmed brain disease
1191712|NCT02070380|highly suspected brain disease|highly suspected brain disease
1191713|NCT02070367|allodynia|allodynia
1191714|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
1191715|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
1191716|NCT02070367|clinical measurement properties|clinical measurement properties
1191717|NCT02070354|Obesity|obesity
1191718|NCT02070354|Bariatric surgery|bariatric surgery
1191719|NCT02070354|Physical Activity|physical activity
1191720|NCT02070354|Nutrition|nutrition
1191721|NCT02070354|Weight Loss|weight loss
1191722|NCT02070341|patient tolerability|patient tolerability
1191724|NCT02070328|Proton Therapy|proton therapy
1191725|NCT02070328|Registry|registry
1191726|NCT02070315|heart failure|heart failure
1191727|NCT02070315|liver failure|liver failure
1191728|NCT02070315|post liver transplant|post liver transplant
1191729|NCT02070289|Multiple dose|multiple dose
1191730|NCT02070289|safety|safety
1191731|NCT02070289|tolerability|tolerability
1191732|NCT02070289|PK|pk
1191733|NCT02070276|Spinal anesthesia|spinal anesthesia
1191734|NCT02070276|Systemic hypotension|systemic hypotension
1191735|NCT02070276|Total fluid amount|total fluid amount
1191736|NCT02070276|Non-invasive fluid responsiveness|non-invasive fluid responsiveness
1191737|NCT02070276|Passive Leg Raising Test|passive leg raising test
1191738|NCT02070263|Food allergy|food allergy
1191739|NCT02070263|Tree nuts|tree nuts
1191740|NCT02070250|Stress management|stress management
1191741|NCT02070250|Coping skills|coping skills
1191742|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
1191743|NCT02070250|Intervention, Psychological|intervention, psychological
1191745|NCT02070237|Obesity, Morbid|obesity, morbid
1191746|NCT02070237|Pregnancy|pregnancy
1191747|NCT02070237|Cesarean|cesarean
1191748|NCT02070237|Venous thromboembolism|venous thromboembolism
1191749|NCT02070237|Deep venous thrombosis|deep venous thrombosis
1191750|NCT02070237|Pulmonary embolism|pulmonary embolism
1191751|NCT02070211|Psychotic Disorder|psychotic disorder
1191752|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
1191753|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
1191754|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
1191755|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
1191756|NCT02070172|headache diagnosis|headache diagnosis
1191757|NCT02070172|flexion rotation test|flexion rotation test
1191758|NCT02070172|range of motion|range of motion
1191759|NCT02070172|upper cervical|upper cervical
1191760|NCT02070159|coronary artery disease|coronary artery disease
1191761|NCT02070159|prasugrel|prasugrel
1191762|NCT02070159|platelet function tests|platelet function tests
1191763|NCT02070133|Chronic Bronchitis|chronic bronchitis
1191765|NCT02070133|Endothelial dysfunction|endothelial dysfunction
1191766|NCT02070133|Systemic inflammation|systemic inflammation
1191767|NCT02070133|BODE index|bode index
1191768|NCT02070133|Uric acid|uric acid
1191769|NCT02070133|Vascular growth factors|vascular growth factors
1191770|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
1191771|NCT02070120|Mitomycin C|mitomycin c
1191772|NCT02070120|Chemoresection|chemoresection
1191773|NCT02070081|Obesity|obesity
1191774|NCT02070081|Bariatric surgery|bariatric surgery
1191775|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
1191776|NCT02070055|Substrate Oxidation|substrate oxidation
1191777|NCT02070055|Fat oxidation|fat oxidation
1191778|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
1191779|NCT02070055|Exercise|exercise
1191780|NCT02070055|indirect calorimetry|indirect calorimetry
1191781|NCT02070055|substrate crossover|substrate crossover
1191782|NCT02070042|Overactive Bladder|overactive bladder
1191783|NCT02070042|Oxybutynin|oxybutynin
1191784|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
1191785|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
1191786|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
1191787|NCT02070029|Low libido|low libido
1191788|NCT02070029|Acupuncture|acupuncture
1191789|NCT02069977|Autism|autism
1191790|NCT02069977|Aripiprazole|aripiprazole
1191791|NCT02069977|Abilify|abilify
1191792|NCT02069951|Laparoscopy|laparoscopy
1191793|NCT02069951|Training|training
1191794|NCT02069951|Simulator|simulator
1191795|NCT02069938|Subjects|subjects
1191796|NCT02069912|Major Depression|major depression
1191797|NCT02069912|Heart Disease|heart disease
1191798|NCT02069912|Hispanics|hispanics
1191799|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
1191800|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
1191801|NCT02069899|Emapalumab|emapalumab
1191802|NCT02069886|Endocrine complications|endocrine complications
1191803|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
1191804|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
1191805|NCT02069873|Group|group
1191806|NCT02069873|Treatment|treatment
1191807|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
1191808|NCT02069873|Women|women
1191809|NCT02069873|Veterans|veterans
1191810|NCT02069860|bona anchored|bona anchored
1191811|NCT02069860|haemodialysis|haemodialysis
1191812|NCT02069860|Mastoid bone|mastoid bone
1191813|NCT02069860|nephrology|nephrology
1191814|NCT02069860|retroauricular anchored devices|retroauricular anchored devices
1191815|NCT02069860|permanent central venous access devices.|permanent central venous access devices.
1191816|NCT02069847|Esophageal stricture formation|esophageal stricture formation
1191817|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
1191818|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
1191819|NCT02069847|Budesonide|budesonide
1191820|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
1191822|NCT02069847|ESD|esd
1191823|NCT02069834|Dolutegravir|dolutegravir
1191824|NCT02069834|Rilpivirine|rilpivirine
1191825|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
1191826|NCT02069834|switch study|switch study
1191827|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
1191828|NCT02069782|Pregnancy|pregnancy
1191829|NCT02069782|postpartum programs|postpartum programs
1191830|NCT02069782|infant health services|infant health services
1191831|NCT02069769|Hospice Care|hospice care
1191832|NCT02069769|Head and Neck cancer|head and neck cancer
1191833|NCT02069769|Gynecological Oncology|gynecological oncology
1191834|NCT02069769|Sarcoma|sarcoma
1191835|NCT02069769|Melanoma|melanoma
1191836|NCT02069756|Duchenne|duchenne
1191837|NCT02069756|Becker|becker
1191838|NCT02069756|Muscular Dystrophy|muscular dystrophy
1191839|NCT02069743|cancer pain|cancer pain
1192636|NCT02065986|Truvada|truvada
1191840|NCT02069730|molecular profiling|molecular profiling
1191841|NCT02069730|selinexor|selinexor
1191842|NCT02069730|tumor tissue|tumor tissue
1191843|NCT02069704|colorectal cancer|colorectal cancer
1191844|NCT02069704|metastatic|metastatic
1191845|NCT02069704|first-line treatment|first-line treatment
1191846|NCT02069704|comparability|comparability
1191848|NCT02069691|rehabilitation,|rehabilitation,
1191849|NCT02069691|leg cycling,|leg cycling,
1191850|NCT02069691|feedback,|feedback,
1191851|NCT02069691|virtual reality|virtual reality
1191852|NCT02069665|pneumonia|pneumonia
1191853|NCT02069665|pediatrics|pediatrics
1191854|NCT02069665|viral|viral
1191855|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
1191856|NCT02069613|mTBI|mtbi
1191857|NCT02069613|concussion|concussion
1191858|NCT02069613|MEG|meg
1191859|NCT02069613|EEG|eeg
1191860|NCT02069613|Blood|blood
1191861|NCT02069613|MRI|mri
1191862|NCT02069613|DTI|dti
1191863|NCT02069613|biomarkers|biomarkers
1191864|NCT02069600|Elderly|elderly
1191865|NCT02069600|CPAP|cpap
1191866|NCT02069600|clinical trial|clinical trial
1191867|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
1191868|NCT02069587|PPROM|pprom
1191869|NCT02069587|PREGNANCY|pregnancy
1191870|NCT02069587|POMEGRANATE|pomegranate
1191871|NCT02069587|OXIDATIVE STRESS|oxidative stress
1191872|NCT02069535|Cupressus arizonica|cupressus arizonica
1191873|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
1191874|NCT02069509|EFACTS|efacts
1191875|NCT02069509|FRDA|frda
1191876|NCT02069483|smoking|smoking
1191877|NCT02069483|smoker|smoker
1191878|NCT02069483|text|text
1191879|NCT02069483|smartphone|smartphone
1191880|NCT02069483|motivation|motivation
1191881|NCT02069483|quitting|quitting
1191882|NCT02069483|cessation|cessation
1191883|NCT02069483|feedback|feedback
1191884|NCT02069483|messages|messages
1191885|NCT02069470|Stepped wedged design|stepped wedged design
1191886|NCT02069470|Early cancer diagnosis|early cancer diagnosis
1191887|NCT02069470|Continuing medical education|continuing medical education
1191888|NCT02069431|inflammation|inflammation
1191889|NCT02069431|physical function|physical function
1191890|NCT02069431|cognitive function|cognitive function
1191891|NCT02069392|schizophrenia|schizophrenia
1191892|NCT02069392|cognition|cognition
1191893|NCT02069392|cognitive remediation|cognitive remediation
1191894|NCT02069392|nicotine|nicotine
1191895|NCT02069379|Metabolic syndrome|metabolic syndrome
1191896|NCT02069379|Insulin resistance|insulin resistance
1191897|NCT02069379|Mu-opioid system|mu-opioid system
1191898|NCT02069379|Depression|depression
1191899|NCT02069379|Emotion regulation|emotion regulation
1191900|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
1191901|NCT02069366|Dronabinol|dronabinol
1191902|NCT02069366|Extinction|extinction
1191903|NCT02069366|fMRI|fmri
1191904|NCT02069353|Cardiac arrest|cardiac arrest
1191905|NCT02069353|Neurological injury|neurological injury
1191906|NCT02069353|Seizures|seizures
1191907|NCT02069353|Spreading depolarizations|spreading depolarizations
1191908|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
1191909|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
1191910|NCT02069327|Femur|femur
1191911|NCT02069327|Fat|fat
1191912|NCT02069327|Emboli|emboli
1191913|NCT02069327|Bone|bone
1191914|NCT02069327|Marrow|marrow
1191915|NCT02069327|proteomic|proteomic
1191916|NCT02069327|proteomics|proteomics
1191917|NCT02069327|metabolomics|metabolomics
1191918|NCT02069327|metabolomic|metabolomic
1191919|NCT02069327|inflammatory|inflammatory
1191920|NCT02069327|cytokine|cytokine
1191921|NCT02069327|chemokine|chemokine
1191922|NCT02069327|anaphlylatoxin|anaphlylatoxin
1191923|NCT02069327|Thromboelastography|thromboelastography
1191924|NCT02069327|Medical Center of the Rockies|medical center of the rockies
1191925|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
1191926|NCT02069327|Injury|injury
1191927|NCT02069327|Fracture|fracture
1191928|NCT02069327|Metabolite|metabolite
1191929|NCT02069327|MCR|mcr
1191930|NCT02069327|TEG|teg
1191931|NCT02069327|FES|fes
1191932|NCT02069301|Behavior Activation|behavior activation
1191933|NCT02069301|Problem solving therapy|problem solving therapy
1191934|NCT02069301|Depression Treatment|depression treatment
1191935|NCT02069301|depression care integration|depression care integration
1191936|NCT02069301|microfinance|microfinance
1191937|NCT02069301|livelihood|livelihood
1191938|NCT02069288|fludrocortisone|fludrocortisone
1191939|NCT02069288|pharmacology|pharmacology
1191940|NCT02069288|septic shock|septic shock
1191941|NCT02069275|Immediate mobilization|immediate mobilization
1191942|NCT02069275|Bedrest|bedrest
1191943|NCT02069275|Coronary angiography|coronary angiography
1191944|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
1191945|NCT02069275|Vascular access complications|vascular access complications
1191946|NCT02069275|Patients comfort|patients comfort
1191947|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
1191948|NCT02069262|laparoscopy|laparoscopy
1191950|NCT02069249|Preschool children|preschool children
1191951|NCT02069249|Sleep problems|sleep problems
1191952|NCT02069249|Nutrition problems|nutrition problems
1191953|NCT02069249|Online intervention|online intervention
1191954|NCT02069249|Psychological functioning|psychological functioning
1191955|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
1191956|NCT02069236|capillary|capillary
1191957|NCT02069236|venous|venous
1191958|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
1191959|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
1191960|NCT02069223|Gastrectomy|gastrectomy
1191961|NCT02069197|ketogenic diet|ketogenic diet
1191962|NCT02069197|obesity|obesity
1191963|NCT02069197|diabetes|diabetes
1191964|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
1191965|NCT02069184|opioid usage requirements|opioid usage requirements
1191966|NCT02069184|pain|pain
1191967|NCT02069184|IV acetaminophen|iv acetaminophen
1191968|NCT02069184|opioid usage|opioid usage
1191969|NCT02069184|c-section|c-section
1191970|NCT02069171|Lower extremity edema|lower extremity edema
1191971|NCT02069171|Lower leg lymphedema|lower leg lymphedema
1191972|NCT02069171|Lower leg edema|lower leg edema
1191973|NCT02069171|Lymphedema|lymphedema
1191974|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
1191975|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
1191976|NCT02069158|Advanced solid tumor|advanced solid tumor
1191977|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
1191978|NCT02069145|Liver Cancer|liver cancer
1191979|NCT02069132|Warfarin|warfarin
1191980|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
1191981|NCT02069132|Atrial Fibrillation|atrial fibrillation
1191982|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
1191983|NCT02069132|elderly|elderly
1191984|NCT02069132|comorbidity|comorbidity
1191985|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
1191986|NCT02069106|triglycerides|triglycerides
1191987|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
1191988|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
1191989|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
1191990|NCT02069106|Fish oil|fish oil
1191991|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
1191992|NCT02069080|Metastasis|metastasis
1191993|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
1191994|NCT02069067|pain|pain
1191995|NCT02069067|neuropathic pain|neuropathic pain
1191996|NCT02069067|intractable pain|intractable pain
1191997|NCT02069067|cancer|cancer
1191998|NCT02069054|asthma|asthma
1191999|NCT02069054|COPD|copd
1192000|NCT02069054|airway inflammation|airway inflammation
1192001|NCT02069054|remodeling|remodeling
1192002|NCT02069054|cytokines|cytokines
1192003|NCT02069054|airway wall thickness|airway wall thickness
1192004|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
1192005|NCT02069028|sepsis|sepsis
1192006|NCT02069028|septic|septic
1192007|NCT02069028|septicemia|septicemia
1192008|NCT02069028|mortality|mortality
1192009|NCT02069028|compliance|compliance
1192010|NCT02069015|Patient education|patient education
1192011|NCT02069015|Hypertension|hypertension
1192012|NCT02069015|Patient activation|patient activation
1192013|NCT02069002|Indoor Air|indoor air
1192014|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
1192015|NCT02069002|Randomized controlled trial|randomized controlled trial
1192016|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1192017|NCT02069002|Applied relaxation|applied relaxation
1192018|NCT02068950|Head and neck cancer|head and neck cancer
1192019|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1192020|NCT02068950|Progressive resistance training|progressive resistance training
1192021|NCT02068950|Exercise|exercise
1192022|NCT02068950|Feasibility|feasibility
1192023|NCT02068950|Weight loss|weight loss
1192024|NCT02068950|LBM|lbm
1192025|NCT02068950|Body composition|body composition
1192026|NCT02068937|Heart Failure|heart failure
1192027|NCT02068937|Therapy|therapy
1192028|NCT02068937|Diuretics|diuretics
1192029|NCT02068937|Algorithms|algorithms
1192030|NCT02068924|Slow freezing|slow freezing
1192031|NCT02068924|Vitrification|vitrification
1192032|NCT02068924|Single embryo transfer|single embryo transfer
1192033|NCT02068911|Neuromuscular disease|neuromuscular disease
1192034|NCT02068911|Home ventilation|home ventilation
1192035|NCT02068911|End tidal CO2|end tidal co2
1192036|NCT02068911|Transcutaneous CO2|transcutaneous co2
1192037|NCT02068911|Monitoring|monitoring
1192038|NCT02068885|Low carbohydrate diet|low carbohydrate diet
1192039|NCT02068885|Low fat diet|low fat diet
1192040|NCT02068885|Glycemic index|glycemic index
1192041|NCT02068885|Weight loss maintenance|weight loss maintenance
1192042|NCT02068872|Obesity|obesity
1192043|NCT02068872|Transplant|transplant
1192044|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
1192045|NCT02068872|Liver Transplantation|liver transplantation
1192046|NCT02068872|Weight Loss|weight loss
1192047|NCT02068846|HIV|hiv
1192740|NCT02065505|Pilates|pilates
1192048|NCT02068846|Salivary Gland Disease|salivary gland disease
1192049|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
1192050|NCT02068846|BK Polyomavirus|bk polyomavirus
1192051|NCT02068833|Microalbuminuria|microalbuminuria
1192052|NCT02068833|Gastrectomy|gastrectomy
1192053|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
1192054|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
1192055|NCT02068820|da Vinci|da vinci
1192056|NCT02068820|Firefly|firefly
1192057|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
1192058|NCT02068820|Fluorescence Imaging|fluorescence imaging
1192059|NCT02068820|SLN|sln
1192060|NCT02068820|SLN mapping|sln mapping
1192061|NCT02068768|fusion|fusion
1192062|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
1192063|NCT02068768|lumbar spine|lumbar spine
1192064|NCT02068768|degenerative disc disease|degenerative disc disease
1192065|NCT02068755|anemia|anemia
1192066|NCT02068755|renal impairment|renal impairment
1192067|NCT02068755|thrombocytopenia|thrombocytopenia
1192068|NCT02068755|anticoagulation|anticoagulation
1192069|NCT02068755|Coronary bypass|coronary bypass
1192070|NCT02068755|Aortic valve surgery|aortic valve surgery
1192071|NCT02068755|Mitral valve surgery|mitral valve surgery
1192072|NCT02068755|red blood cell|red blood cell
1192073|NCT02068755|platelet|platelet
1192074|NCT02068755|fresh frozen plasma|fresh frozen plasma
1192075|NCT02068755|octaplas|octaplas
1192076|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
1192077|NCT02068742|elderly|elderly
1192078|NCT02068742|Mini Mental State Examination|mini mental state examination
1192079|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
1192080|NCT02068742|Geriatric Depression Scale|geriatric depression scale
1192081|NCT02068742|Trail Making Test B-A|trail making test b-a
1192082|NCT02068742|Digit Span|digit span
1192083|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
1192084|NCT02068729|degenerative disc disease|degenerative disc disease
1192085|NCT02068729|DDD|ddd
1192086|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
1192087|NCT02068729|spondylolisthesis|spondylolisthesis
1192088|NCT02068729|L2-S1|l2-s1
1192089|NCT02068716|Healthcare acquired infections|healthcare acquired infections
1192090|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
1192091|NCT02068716|Mediastinitis|mediastinitis
1192092|NCT02068716|Thoracotomy|thoracotomy
1192093|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
1192094|NCT02068703|survey|survey
1192095|NCT02068664|spatial neglect|spatial neglect
1192096|NCT02068664|aphasia|aphasia
1192097|NCT02068651|End-of-life care|end-of-life care
1192098|NCT02068651|Treatment decision making|treatment decision making
1192099|NCT02068651|Advance care planning|advance care planning
1192100|NCT02068638|exercise|exercise
1192101|NCT02068638|isotope labeling, stable|isotope labeling, stable
1192102|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
1192103|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
1192104|NCT02068638|hormones|hormones
1192105|NCT02068625|retinal detachment|retinal detachment
1192106|NCT02068625|rasagiline|rasagiline
1192107|NCT02068625|optical coherence tomography|optical coherence tomography
1192108|NCT02068625|visual acuity|visual acuity
1192109|NCT02068625|neuroprotection|neuroprotection
1192110|NCT02068625|azilect|azilect
1192111|NCT02068612|Executive function,|executive function,
1192112|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
1192113|NCT02068612|cognitive function|cognitive function
1192114|NCT02068599|Osteoarthritis|osteoarthritis
1192115|NCT02068599|OA|oa
1192116|NCT02068599|Arthritis pain|arthritis pain
1192117|NCT02068573|Childhood Asthma|childhood asthma
1192118|NCT02068573|Allergy|allergy
1192119|NCT02068573|House dust mites|house dust mites
1192120|NCT02068573|Indoor air quality|indoor air quality
1192121|NCT02068547|posterior cervical fusion|posterior cervical fusion
1192122|NCT02068547|posterior cervical decompression|posterior cervical decompression
1192714|NCT02065609|Trastuzumab|trastuzumab
1192123|NCT02068534|in-depth individual interview|in-depth individual interview
1192124|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
1192125|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
1192126|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
1192127|NCT02068521|GHD|ghd
1192128|NCT02068521|PGHD|pghd
1192129|NCT02068521|VRS-317|vrs-317
1192130|NCT02068521|Versartis|versartis
1192131|NCT02068521|Growth disorder|growth disorder
1192132|NCT02068521|Long acting growth hormone|long acting growth hormone
1192133|NCT02068521|Growth hormone|growth hormone
1192134|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
1192135|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
1192136|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
1192137|NCT02068521|IGF-I|igf-i
1192138|NCT02068521|Short stature|short stature
1192139|NCT02068521|Height velocity|height velocity
1192140|NCT02068521|Annual height velocity|annual height velocity
1192141|NCT02068521|Growth rate|growth rate
1192142|NCT02068521|Somavaratan|somavaratan
1192143|NCT02068508|Drug therapy|drug therapy
1192144|NCT02068495|Drug therapy|drug therapy
1192145|NCT02068482|Uncomplicated|uncomplicated
1192146|NCT02068482|Symptomatic|symptomatic
1192147|NCT02068456|Drug therapy|drug therapy
1192148|NCT02068443|Drug therapy|drug therapy
1192149|NCT02068430|Corneal Ulcers|corneal ulcers
1192150|NCT02068430|cross-linking|cross-linking
1192151|NCT02068430|UVA|uva
1192152|NCT02068430|Riboflavin|riboflavin
1192153|NCT02068417|IIEF score|iief score
1192154|NCT02068417|ED|ed
1192155|NCT02068404|Tocolysis|tocolysis
1192156|NCT02068404|Preterm labor|preterm labor
1192157|NCT02068404|Nifedipine|nifedipine
1192158|NCT02068404|Pharmacokinetics|pharmacokinetics
1192159|NCT02068391|covert stroke|covert stroke
1192160|NCT02068391|cerebral blood flow|cerebral blood flow
1192161|NCT02068391|grey matter|grey matter
1192162|NCT02068391|attention|attention
1192163|NCT02068391|executive function|executive function
1192164|NCT02068391|aerobic exercise|aerobic exercise
1192165|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
1192166|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
1192167|NCT02068326|Adolescence|adolescence
1192168|NCT02068326|Borderline Personality Disorder|borderline personality disorder
1192169|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
1192170|NCT02068287|Septic Shock|septic shock
1192171|NCT02068287|Hemodynamic|hemodynamic
1192172|NCT02068287|Inflammatory status|inflammatory status
1192173|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
1192174|NCT02068287|Esmolol|esmolol
1192175|NCT02068235|Ponesimod|ponesimod
1192176|NCT02068235|Bioavailability|bioavailability
1192177|NCT02068235|Pharmacokinetics|pharmacokinetics
1192178|NCT02068235|Safety|safety
1192179|NCT02068222|Hepatitis C|hepatitis c
1192180|NCT02068222|HCV|hcv
1192181|NCT02068222|Interferon Free|interferon free
1192182|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
1192183|NCT02068222|Hepatitis C virus|hepatitis c virus
1192184|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
1192185|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
1192186|NCT02068209|Tramadol|tramadol
1192187|NCT02068196|Cancer|cancer
1192188|NCT02068196|Malignant Melanoma|malignant melanoma
1192189|NCT02068196|Ipilimumab|ipilimumab
1192190|NCT02068183|World Trade Center exposure|world trade center exposure
1192191|NCT02068183|cardiovascular risk|cardiovascular risk
1192192|NCT02068183|insulin resistance|insulin resistance
1192193|NCT02068183|post-traumatic stress|post-traumatic stress
1192194|NCT02068183|pulmonary disease|pulmonary disease
1192195|NCT02068170|QT-prolongation|qt-prolongation
1192196|NCT02068170|Torsade de Pointes|torsade de pointes
1192197|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
1192198|NCT02068144|Cranberry Extract|cranberry extract
1192199|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
1192200|NCT02068131|Novaferon|novaferon
1192201|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
1192202|NCT02068131|xeloda|xeloda
1192203|NCT02068118|E health|e health
1192204|NCT02068118|Telecardiology program|telecardiology program
1192205|NCT02068118|Heart failure|heart failure
1192206|NCT02068105|ALKS 5461|alks 5461
1192207|NCT02068105|samidorphan|samidorphan
1192208|NCT02068066|Physical work requirements|physical work requirements
1192209|NCT02068066|Energy expenditure|energy expenditure
1192210|NCT02068066|Physical activity|physical activity
1192211|NCT02068066|Different occupational categories|different occupational categories
1192212|NCT02068066|Aerobic capacity|aerobic capacity
1192213|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
1192214|NCT02068027|Diabetes Mellitus|diabetes mellitus
1192215|NCT02068027|Pain|pain
1192216|NCT02068027|Foot pain|foot pain
1192217|NCT02068027|Neuropathy|neuropathy
1192218|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
1192219|NCT02067988|Radioembolization|radioembolization
1192220|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
1192221|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
1192222|NCT02067988|Liver metastases|liver metastases
1192223|NCT02067975|tryptophan|tryptophan
1192224|NCT02067975|kynurenic acid|kynurenic acid
1192225|NCT02067975|schizophrenia|schizophrenia
1192226|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
1192227|NCT02067962|JIA|jia
1192228|NCT02067962|Gene identification|gene identification
1192229|NCT02067962|Whole exome sequencing|whole exome sequencing
1192230|NCT02067962|Next generation sequencing|next generation sequencing
1192231|NCT02067962|Identification of molecular basis|identification of molecular basis
1192232|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
1192233|NCT02067923|T1D|t1d
1192234|NCT02067923|type 1 diabetes|type 1 diabetes
1192235|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
1192236|NCT02067923|juvenile diabetes|juvenile diabetes
1192237|NCT02067923|autoimmune diabetes|autoimmune diabetes
1192238|NCT02067923|autoimmune|autoimmune
1192239|NCT02067923|anti-CD3 mAb|anti-cd3 mab
1192240|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
1192241|NCT02067923|teplizumab|teplizumab
1192242|NCT02067910|Abatacept|abatacept
1192243|NCT02067910|Subcutaneous|subcutaneous
1192244|NCT02067910|Sjögren's syndrome|sjögren's syndrome
1192245|NCT02067910|Treatment|treatment
1192246|NCT02067910|Safety|safety
1192247|NCT02067910|Efficacy|efficacy
1192248|NCT02067897|Nails, Ingrown|nails, ingrown
1192249|NCT02067897|Children|children
1192250|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
1192251|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1192252|NCT02067871|low-level laser therapy|low-level laser therapy
1192253|NCT02067871|knee osteoarthritis|knee osteoarthritis
1192254|NCT02067871|muscle architecture|muscle architecture
1192255|NCT02067871|functionality|functionality
1192256|NCT02067871|neuromuscular parameters|neuromuscular parameters
1192257|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
1192258|NCT02067845|HIV and STI prevention|hiv and sti prevention
1192259|NCT02067845|Resilient coping|resilient coping
1192260|NCT02067845|Sexual stigma|sexual stigma
1192261|NCT02067845|Depression|depression
1192262|NCT02067845|Safer-sex practices|safer-sex practices
1192263|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
1192264|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
1192265|NCT02067845|Pilot-testing|pilot-testing
1192266|NCT02067819|Tourette's|tourette's
1192267|NCT02067819|Tic Disorder|tic disorder
1192268|NCT02067819|Dental Appliance|dental appliance
1192269|NCT02067819|Oral Orthotic|oral orthotic
1192270|NCT02067819|Mouthguard|mouthguard
1192271|NCT02067806|PASS|pass
1192273|NCT02067806|CES|ces
1192274|NCT02067806|CHLOROPROCAINE|chloroprocaine
1192275|NCT02067793|NRX-1074|nrx-1074
1192276|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
1192277|NCT02067793|Major Depressive Disorder|major depressive disorder
1192278|NCT02067793|Glycine site modulator|glycine site modulator
1192279|NCT02067767|HIV-1 infection|hiv-1 infection
1192280|NCT02067767|Nevirapine|nevirapine
1192281|NCT02067767|Dolutegravir|dolutegravir
1192282|NCT02067767|Anti-retroviral agents|anti-retroviral agents
1192283|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
1192284|NCT02067741|Post-menopausal women|post-menopausal women
1192285|NCT02067741|topical application CR1447|topical application cr1447
1192286|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
1192287|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
1192288|NCT02067728|obesity prevention|obesity prevention
1192289|NCT02067715|Tooth Discoloration|tooth discoloration
1192290|NCT02067715|Bleaching Agents|bleaching agents
1192291|NCT02067715|Tooth Bleaching|tooth bleaching
1192292|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
1192293|NCT02067689|Cognitive function|cognitive function
1192294|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
1192295|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
1192296|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1192297|NCT02067676|Campylobacter jejuni|campylobacter jejuni
1192298|NCT02067663|Postplacental IUD placement|postplacental iud placement
1192299|NCT02067663|LNG-IUS|lng-ius
1192300|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
1192301|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
1192302|NCT02067598|Scapular exercises|scapular exercises
1192303|NCT02067572|oral health|oral health
1192304|NCT02067572|mouthwash|mouthwash
1192305|NCT02067572|salvia|salvia
1192306|NCT02067572|hospice|hospice
1192307|NCT02067572|xerostomia|xerostomia
1192308|NCT02067572|mouth sores|mouth sores
1192309|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
1192310|NCT02067559|PTSD|ptsd
1192311|NCT02067559|Intensive Care Unit|intensive care unit
1192312|NCT02067559|ICU|icu
1192313|NCT02067546|constipation|constipation
1192314|NCT02067520|Post C/S pain relief|post c/s pain relief
1192315|NCT02067507|Human Papillomavirus|human papillomavirus
1192316|NCT02067507|Immunization|immunization
1192317|NCT02067507|Oncogenic viruses|oncogenic viruses
1192318|NCT02067507|Cervical Cancer|cervical cancer
1192319|NCT02067507|Health Disparities|health disparities
1192320|NCT02067494|Low Back Pain|low back pain
1192321|NCT02067494|Chronic Pain|chronic pain
1192322|NCT02067494|Manual Therapy|manual therapy
1192323|NCT02067494|Randomized Clinical Trial|randomized clinical trial
1192324|NCT02067494|Bandages|bandages
1192325|NCT02067481|Breast cancer|breast cancer
1192326|NCT02067481|Survivors|survivors
1192327|NCT02067481|Weight loss|weight loss
1192328|NCT02067481|Diet|diet
1192329|NCT02067481|Physical activity|physical activity
1192330|NCT02067468|Human Papillomavirus|human papillomavirus
1192331|NCT02067468|cervical cancer|cervical cancer
1192332|NCT02067468|health services research|health services research
1192333|NCT02067468|Colombia|colombia
1192334|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1192335|NCT02067455|Right ventricular function|right ventricular function
1192336|NCT02067455|echocardiography|echocardiography
1192337|NCT02067455|left ventricular assist device|left ventricular assist device
1192338|NCT02067455|exercise|exercise
1192339|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
1192340|NCT02067416|neoadjuvant|neoadjuvant
1192341|NCT02067416|mammostrat|mammostrat
1192342|NCT02067416|TLE3|tle3
1192344|NCT02067416|breast cancer|breast cancer
1192345|NCT02067403|Pressure-support|pressure-support
1192346|NCT02067403|Asynchrony|asynchrony
1192347|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
1192348|NCT02067364|hydrocephalus|hydrocephalus
1192349|NCT02067364|CSF shunt|csf shunt
1192350|NCT02067299|Depressive Disorder, Major|depressive disorder, major
1192351|NCT02067299|Major Depressive Disorder|major depressive disorder
1192352|NCT02067299|Insomnia|insomnia
1192353|NCT02067299|JNJ-42847922|jnj-42847922
1192354|NCT02067299|Placebo|placebo
1192355|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1192356|NCT02067221|renal calculi|renal calculi
1192357|NCT02067221|ureteroscopy|ureteroscopy
1192358|NCT02067208|Osteoarthritis|osteoarthritis
1192359|NCT02067208|Cartilage|cartilage
1192360|NCT02067208|Musculoskeletal|musculoskeletal
1192361|NCT02067208|Biomechanics|biomechanics
1192362|NCT02067208|Subtype|subtype
1192363|NCT02067208|Footwear|footwear
1192364|NCT02067208|Orthotics|orthotics
1192365|NCT02067208|Joint Loading|joint loading
1192366|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
1192367|NCT02067169|Transplantation|transplantation
1192368|NCT02067169|CMV infection|cmv infection
1192369|NCT02067169|antiviral resistance|antiviral resistance
1192370|NCT02067156|glioblastoma|glioblastoma
1192371|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
1192372|NCT02067143|De novo|de novo
1192373|NCT02067143|Secondary|secondary
1192374|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
1192375|NCT02067143|Pegylated asparaginase|pegylated asparaginase
1192376|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
1192377|NCT02067130|Beta Thalassemia Major|beta thalassemia major
1192378|NCT02067117|influenza|influenza
1192379|NCT02067091|STEMI|stemi
1192380|NCT02067091|Coronary|coronary
1192381|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
1192382|NCT02067091|Drug eluting stent|drug eluting stent
1192383|NCT02067091|Optical coherence tomography|optical coherence tomography
1192384|NCT02067091|Multislice computed tomography|multislice computed tomography
1192385|NCT02067078|nerve block|nerve block
1192386|NCT02067078|total knee arthroplasty|total knee arthroplasty
1192387|NCT02067078|saphenous nerve block|saphenous nerve block
1192388|NCT02067078|obturator nerve block|obturator nerve block
1192389|NCT02067078|pain|pain
1192390|NCT02067078|opioid consumption|opioid consumption
1192391|NCT02067065|Colonoscopy|colonoscopy
1192392|NCT02067065|Sedation|sedation
1192393|NCT02067065|Propofol|propofol
1192394|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
1192395|NCT02067052|Vulvar neoplasm|vulvar neoplasm
1192396|NCT02067052|sentinel nodes|sentinel nodes
1192397|NCT02067052|chemotherapy|chemotherapy
1192398|NCT02067052|radiotherapy|radiotherapy
1192399|NCT02067039|HIV testing|hiv testing
1192400|NCT02067039|Rapid HIV test|rapid hiv test
1192401|NCT02067039|HIV self-testing|hiv self-testing
1192402|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
1192403|NCT02067039|HIV diagnosis|hiv diagnosis
1192404|NCT02067039|Sexual behavior|sexual behavior
1192405|NCT02067026|overweight|overweight
1192406|NCT02067013|Tractional retinal detachment|tractional retinal detachment
1192407|NCT02067013|Exudative retinal detachment|exudative retinal detachment
1192408|NCT02067013|Macular hole|macular hole
1192409|NCT02067013|Neovascular glaucoma|neovascular glaucoma
1192410|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
1192411|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
1192412|NCT02066974|genomic expression|genomic expression
1192413|NCT02066974|radiotherapy|radiotherapy
1192414|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
1192415|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
1192416|NCT02066961|prostate cancer|prostate cancer
1192418|NCT02066948|MRI|mri
1192419|NCT02066948|Fitness assessment|fitness assessment
1192420|NCT02066948|Meal tolerance test|meal tolerance test
1192421|NCT02066935|immunosuppression|immunosuppression
1192422|NCT02066935|medication nonadherence|medication nonadherence
1192423|NCT02066935|kidney transplantation|kidney transplantation
1192424|NCT02066922|Contact lenses|contact lenses
1192425|NCT02066922|Nearsightedness|nearsightedness
1192426|NCT02066922|Corneal curvature|corneal curvature
1192427|NCT02066922|K-reading|k-reading
1192428|NCT02066922|High minus|high minus
1192429|NCT02066922|Spectacle refraction|spectacle refraction
1192430|NCT02066909|pharmacokinetics|pharmacokinetics
1266327|NCT01732289|Gene|gene
1192431|NCT02066909|safety|safety
1192432|NCT02066909|tolerability|tolerability
1192433|NCT02066909|healthy volunteers|healthy volunteers
1192434|NCT02066909|steady state|steady state
1192435|NCT02066909|multiple doses|multiple doses
1192436|NCT02066909|Japanese subjects|japanese subjects
1192437|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
1192438|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
1192439|NCT02066896|Sjogren Syndrome|sjogren syndrome
1192440|NCT02066896|Sicca Syndrome|sicca syndrome
1192441|NCT02066896|Syndrome, Sicca|syndrome, sicca
1192442|NCT02066870|Icotinib|icotinib
1192443|NCT02066870|Arsenic Trioxide|arsenic trioxide
1192444|NCT02066870|Resistance|resistance
1192445|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
1192446|NCT02066857|Wrist fracture|wrist fracture
1192447|NCT02066857|Radius fracture|radius fracture
1192448|NCT02066857|Elderly|elderly
1192449|NCT02066857|Splint|splint
1192450|NCT02066857|Cast|cast
1192451|NCT02066844|Hip Pain|hip pain
1192452|NCT02066844|Hip Injection|hip injection
1192453|NCT02066844|Hip Fracture|hip fracture
1192454|NCT02066844|Hip Bursitis|hip bursitis
1192455|NCT02066844|Hip Arthritis|hip arthritis
1192456|NCT02066844|Hip Sciatica|hip sciatica
1192457|NCT02066818|local anesthetic|local anesthetic
1192458|NCT02066818|incision and drainage|incision and drainage
1192459|NCT02066818|pain|pain
1192460|NCT02066818|cutaneous abscess|cutaneous abscess
1192461|NCT02066792|Social Phobia|social phobia
1192462|NCT02066753|Cardiac arrest|cardiac arrest
1192463|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
1192464|NCT02066753|Cardioprotectiveness|cardioprotectiveness
1192465|NCT02066753|Hemodynamics|hemodynamics
1192466|NCT02066740|Superficial Femoral Artery|superficial femoral artery
1192467|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
1192468|NCT02066740|Everflex|everflex
1192469|NCT02066740|Entrust|entrust
1192470|NCT02066740|stent|stent
1192471|NCT02066727|Dexmedetomidine|dexmedetomidine
1192472|NCT02066727|obturator nerve block|obturator nerve block
1192473|NCT02066727|lidocaine|lidocaine
1192474|NCT02066727|EC50|ec50
1192475|NCT02066714|Enterovirus Infections|enterovirus infections
1192476|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
1192477|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
1192478|NCT02066714|Herpangina|herpangina
1192479|NCT02066714|Cognition|cognition
1192480|NCT02066714|Neurocognitive|neurocognitive
1192481|NCT02066714|Sequelae|sequelae
1192482|NCT02066714|Outcomes|outcomes
1192483|NCT02066701|Barrett's esophagus|barrett's esophagus
1192484|NCT02066675|Metastatic|metastatic
1192485|NCT02066675|Locally advanced|locally advanced
1192486|NCT02066675|Soft tissue tumors|soft tissue tumors
1192487|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
1192488|NCT02066662|Agatston Score|agatston score
1192489|NCT02066662|Rivaroxaban|rivaroxaban
1192490|NCT02066662|Coumarin|coumarin
1192491|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
1192492|NCT02066662|Atrial Fibrillation|atrial fibrillation
1192493|NCT02066662|Pulmonary Embolism|pulmonary embolism
1192494|NCT02066649|portal hypertension|portal hypertension
1192495|NCT02066649|esophageal varices|esophageal varices
1192496|NCT02066649|variceal bleed|variceal bleed
1192497|NCT02066649|carvedilol|carvedilol
1192498|NCT02066649|variceal band ligation|variceal band ligation
1192499|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
1192500|NCT02066597|Deep vein thrombosis|deep vein thrombosis
1192501|NCT02066597|thrombectomy|thrombectomy
1192502|NCT02066597|percutaneuos|percutaneuos
1192503|NCT02066584|sibling oocytes|sibling oocytes
1192504|NCT02066584|glucose|glucose
1192505|NCT02066584|culture media|culture media
1192506|NCT02066571|Parkinson's disease|parkinson's disease
1192507|NCT02066571|Freezing of gait|freezing of gait
1192508|NCT02066571|Gait|gait
1192509|NCT02066558|Carbon monoxide|carbon monoxide
1192510|NCT02066558|Headache|headache
1192511|NCT02066558|Migraine|migraine
1192512|NCT02066532|Breast Neoplasms|breast neoplasms
1192513|NCT02066532|Breast Cancer|breast cancer
1192514|NCT02066532|Breast Carcinoma|breast carcinoma
1192515|NCT02066532|Breast tumors|breast tumors
1192516|NCT02066532|Cancer of the Breast|cancer of the breast
1192517|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
1192518|NCT02066532|HER2 positive|her2 positive
1192519|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
1192520|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
1192521|NCT02066532|Secondary Breast Cancer|secondary breast cancer
1192522|NCT02066519|Myasthenia gravis|myasthenia gravis
1192523|NCT02066519|physical exercise|physical exercise
1192524|NCT02066519|quality of life|quality of life
1192525|NCT02066519|muscular performance|muscular performance
1192526|NCT02066519|fatigability|fatigability
1192527|NCT02066506|systemic right ventricle|systemic right ventricle
1333143|NCT01444378|Atherosclerosis|atherosclerosis
1192528|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1192529|NCT02066506|congenital heart disease|congenital heart disease
1192530|NCT02066493|giant intracranial aneurysm|giant intracranial aneurysm
1192531|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
1192532|NCT02066467|Heartfailure treatment|heartfailure treatment
1192533|NCT02066467|CRT-D therapy|crt-d therapy
1192534|NCT02066467|Quadripolar lead|quadripolar lead
1192535|NCT02066467|Lead related complication free rate|lead related complication free rate
1192536|NCT02066454|myeloma|myeloma
1192537|NCT02066454|antiXa anticoagulant|antixa anticoagulant
1192538|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
1192539|NCT02066454|iMiDs|imids
1192540|NCT02066441|Vitamin D|vitamin d
1192541|NCT02066441|bone formation|bone formation
1192542|NCT02066441|resorption|resorption
1192543|NCT02066441|mineral density|mineral density
1192544|NCT02066441|inflammation|inflammation
1192545|NCT02066441|flexibility|flexibility
1192546|NCT02066441|balance|balance
1192547|NCT02066441|elderly|elderly
1192548|NCT02066428|BCG Vaccinated|bcg vaccinated
1192549|NCT02066428|HIV Negative|hiv negative
1192550|NCT02066415|Chronic Migraine|chronic migraine
1192551|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
1192552|NCT02066389|Joint Diseases|joint diseases
1192553|NCT02066389|Arthritis|arthritis
1192554|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
1192555|NCT02066389|antirheumatic agents|antirheumatic agents
1192556|NCT02066363|Bioelectrical impedance|bioelectrical impedance
1192557|NCT02066363|Parenteral nutrition|parenteral nutrition
1192558|NCT02066363|Malnutrition|malnutrition
1192559|NCT02066363|Quality of life.|quality of life.
1192560|NCT02066363|Cancer cachexia|cancer cachexia
1192561|NCT02066363|Body composition|body composition
1192562|NCT02066350|Diabetes type 1|diabetes type 1
1192563|NCT02066350|Endothelial dysfunction|endothelial dysfunction
1192564|NCT02066350|Pancreas transplantation|pancreas transplantation
1192565|NCT02066337|Ozone gel|ozone gel
1192566|NCT02066337|Antioxidants|antioxidants
1192567|NCT02066337|Chronic periodontitis|chronic periodontitis
1192568|NCT02066337|Superoxide dismutase|superoxide dismutase
1192569|NCT02066311|lupus|lupus
1192570|NCT02066311|SLE|sle
1192571|NCT02066298|Asthma|asthma
1192572|NCT02066298|Mometasone|mometasone
1192573|NCT02066298|Tiotropium|tiotropium
1192574|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
1192575|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
1192576|NCT02066285|Unresectable|unresectable
1192577|NCT02066285|Locally advanced|locally advanced
1192578|NCT02066285|Metastatic disease|metastatic disease
1192579|NCT02066272|IBD|ibd
1192580|NCT02066272|anti-TNF|anti-tnf
1192581|NCT02066272|biosimilars|biosimilars
1192582|NCT02066272|safety|safety
1192583|NCT02066259|colon cancer|colon cancer
1192584|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
1192585|NCT02066259|colon cancer blood test|colon cancer blood test
1192586|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
1192587|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
1192588|NCT02066233|Barrett's|barrett's
1192589|NCT02066233|esophagus|esophagus
1192590|NCT02066233|reflux|reflux
1192591|NCT02066233|heartburn|heartburn
1192592|NCT02066233|screening|screening
1192593|NCT02066220|pediatric brain tumor|pediatric brain tumor
1192594|NCT02066220|medulloblastoma|medulloblastoma
1192595|NCT02066220|event-free survival (EFS)|event-free survival (efs)
1192596|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
1192597|NCT02066220|overall survival (OS)|overall survival (os)
1192598|NCT02066220|PNET|pnet
1192599|NCT02066220|posterior fossa|posterior fossa
1192600|NCT02066220|chemotherapy|chemotherapy
1192601|NCT02066220|radiotherapy|radiotherapy
1192602|NCT02066220|biological profile|biological profile
1192603|NCT02066220|ß-catenin|ß-catenin
1192604|NCT02066155|diabetes self-management support|diabetes self-management support
1192605|NCT02066155|diabetes-related distress|diabetes-related distress
1192606|NCT02066155|parish nurses|parish nurses
1192607|NCT02066155|peer support|peer support
1192608|NCT02066129|Asthma|asthma
1192609|NCT02066129|Fluticasone|fluticasone
1192610|NCT02066090|acupuncture|acupuncture
1192611|NCT02066090|obesity|obesity
1192612|NCT02066090|metabolomics|metabolomics
1193324|NCT02062892|tacrolimus|tacrolimus
1192613|NCT02066077|Major Depressive Disorder|major depressive disorder
1192614|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
1192615|NCT02066077|Cognition|cognition
1192616|NCT02066077|Memory|memory
1192617|NCT02066064|Colorectal Cancer|colorectal cancer
1192618|NCT02066064|Adenoma|adenoma
1192619|NCT02066064|Standard Colonoscopy|standard colonoscopy
1192620|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
1192621|NCT02066038|chemotherapy|chemotherapy
1192622|NCT02066038|maintenance therapy|maintenance therapy
1192623|NCT02066038|erlotinib|erlotinib
1192624|NCT02066025|breast cancer|breast cancer
1192625|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
1192626|NCT02066025|breast cancer blood test|breast cancer blood test
1192627|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
1192628|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
1192629|NCT02066012|Iron|iron
1192630|NCT02066012|Monocyte|monocyte
1192631|NCT02066012|Macrophage|macrophage
1192632|NCT02066012|Polarization|polarization
1192633|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
1192637|NCT02065960|Feasibility study|feasibility study
1192638|NCT02065960|Early breast cancer|early breast cancer
1192639|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
1192640|NCT02065960|Cyberknife|cyberknife
1192641|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
1192642|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
1192643|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
1192644|NCT02065934|in situ simulation|in situ simulation
1192645|NCT02065934|clinical audit|clinical audit
1192646|NCT02065934|education|education
1192647|NCT02065921|COPD cohort|copd cohort
1192648|NCT02065921|COPD management|copd management
1192649|NCT02065921|exacerbation|exacerbation
1192650|NCT02065908|breast cancer|breast cancer
1192651|NCT02065908|anthracyclines|anthracyclines
1192652|NCT02065908|cardiotoxicity|cardiotoxicity
1192653|NCT02065908|circulating microRNA|circulating microrna
1192654|NCT02065908|biomarker|biomarker
1192655|NCT02065908|serum|serum
1192656|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
1192657|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
1192658|NCT02065895|Closed Loop|closed loop
1192659|NCT02065895|Sensor|sensor
1192660|NCT02065895|Insulin sensitivity|insulin sensitivity
1192661|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
1192662|NCT02065869|ALL|all
1192663|NCT02065869|AML|aml
1192664|NCT02065869|hematologic neoplasms|hematologic neoplasms
1192665|NCT02065869|hematologic malignancies|hematologic malignancies
1192666|NCT02065869|primary immune deficiences|primary immune deficiences
1192667|NCT02065843|Anxiety|anxiety
1192668|NCT02065843|Third molar surgery|third molar surgery
1192669|NCT02065843|Blood pressure|blood pressure
1192670|NCT02065843|Heart rate|heart rate
1192671|NCT02065843|Oxygen saturation|oxygen saturation
1192672|NCT02065830|Robot|robot
1192673|NCT02065830|Spinal Cord Injury|spinal cord injury
1192674|NCT02065830|Gait|gait
1192675|NCT02065830|Quality of life|quality of life
1192676|NCT02065830|Rehabilitation|rehabilitation
1192677|NCT02065830|Lower Limb|lower limb
1192678|NCT02065817|Lipid|lipid
1192679|NCT02065817|Apolipoproteins|apolipoproteins
1192680|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
1192681|NCT02065804|Herniorrhaphy|herniorrhaphy
1192682|NCT02065804|Surgical Equipment|surgical equipment
1192683|NCT02065804|Chronic Pain|chronic pain
1192684|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
1192685|NCT02065804|Laparoscopy|laparoscopy
1192686|NCT02065804|Surgical Outcome|surgical outcome
1192687|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1192688|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
1192689|NCT02065791|Canagliflozin|canagliflozin
1192690|NCT02065791|JNJ-28431754|jnj-28431754
1192691|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
1192692|NCT02065791|Chronic Kidney Disease|chronic kidney disease
1192693|NCT02065791|Macroalbuminuria|macroalbuminuria
1192694|NCT02065752|Healthy Volunteers|healthy volunteers
1192695|NCT02065752|Canagliflozin|canagliflozin
1192696|NCT02065752|Metformin|metformin
1192697|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
1192698|NCT02065739|Healthy|healthy
1192699|NCT02065739|JNJ-42165279|jnj-42165279
1192700|NCT02065739|Itraconazole|itraconazole
1192701|NCT02065739|Pharmacokinetics|pharmacokinetics
1192702|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
1192703|NCT02065700|Methotrexate|methotrexate
1192704|NCT02065700|insufficient responders|insufficient responders
1192705|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
1192706|NCT02065674|FBS|fbs
1192707|NCT02065674|PPBS|ppbs
1192708|NCT02065674|HbA1c%|hba1c%
1192709|NCT02065648|MRA|mra
1192710|NCT02065648|Syngo Native|syngo native
1192711|NCT02065648|Gadolinium|gadolinium
1192712|NCT02065648|Non contrast|non contrast
1192713|NCT02065622|Ulcerative Colitis|ulcerative colitis
1192715|NCT02065596|Sickle Cell Disease|sickle cell disease
1192716|NCT02065596|Sickle Cell Anemia|sickle cell anemia
1192717|NCT02065596|GvHD|gvhd
1192718|NCT02065596|fludarabine|fludarabine
1192719|NCT02065583|Ileus|ileus
1192720|NCT02065583|Equipment and Supplies|equipment and supplies
1192721|NCT02065583|Technology|technology
1192722|NCT02065583|Acoustics|acoustics
1192723|NCT02065570|Crohn's Disease|crohn's disease
1192724|NCT02065557|Ulcerative Colitis|ulcerative colitis
1192725|NCT02065557|adalimumab|adalimumab
1192726|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
1192727|NCT02065544|behavioral weight loss|behavioral weight loss
1192728|NCT02065544|exercise training|exercise training
1192729|NCT02065544|hemoglobin A1c|hemoglobin a1c
1192730|NCT02065531|Low Back Pain|low back pain
1192731|NCT02065531|Chronic Pain|chronic pain
1192732|NCT02065531|Manipulation|manipulation
1192733|NCT02065531|Manual Therapy|manual therapy
1192734|NCT02065531|Randomized Controlled Trial|randomized controlled trial
1192735|NCT02065518|Muscle strength|muscle strength
1192736|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
1192737|NCT02065518|Strength training|strength training
1192738|NCT02065505|Spastic hemiparesis|spastic hemiparesis
1192741|NCT02065505|Respiratory Capacity|respiratory capacity
1192742|NCT02065492|Thalassemia|thalassemia
1192743|NCT02065492|Amlodipine|amlodipine
1192744|NCT02065492|Chelation|chelation
1192745|NCT02065492|T2*|t2*
1192746|NCT02065492|MRI|mri
1192747|NCT02065492|Myocardial Iron|myocardial iron
1192748|NCT02065479|Coronary Artery Disease|coronary artery disease
1192749|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
1192750|NCT02065479|Genetic Polymorphism|genetic polymorphism
1192751|NCT02065479|Pharmacodynamic|pharmacodynamic
1192752|NCT02065453|lap hysterectomy|lap hysterectomy
1192753|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
1192754|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
1192755|NCT02065440|subacute cough|subacute cough
1192756|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
1192757|NCT02065427|Caregiver|caregiver
1192758|NCT02065427|Burden|burden
1192759|NCT02065427|Social support|social support
1192760|NCT02065427|Primary health Care|primary health care
1192761|NCT02065427|Home Care|home care
1192762|NCT02065427|Intervention|intervention
1192763|NCT02065414|Gums|gums
1192764|NCT02065414|Gingiva|gingiva
1192765|NCT02065414|Gingival Inflammation|gingival inflammation
1192766|NCT02065414|Gingival Bleeding|gingival bleeding
1192767|NCT02065375|RTA 408|rta 408
1192768|NCT02065375|Ocular surgery|ocular surgery
1192769|NCT02065375|Cataract surgery|cataract surgery
1192770|NCT02065375|Ocular inflammation|ocular inflammation
1192771|NCT02065375|Ocular pain|ocular pain
1192772|NCT02065375|Eye inflammation|eye inflammation
1192773|NCT02065362|EBV positive|ebv positive
1192774|NCT02065362|TGFbeta|tgfbeta
1192775|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1192776|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1192777|NCT02065349|peripheral neuropathy|peripheral neuropathy
1192778|NCT02065349|PHN|phn
1192779|NCT02065349|pain|pain
1192780|NCT02065349|PDPN|pdpn
1192781|NCT02065336|HBV|hbv
1192782|NCT02065336|Hepatitis|hepatitis
1192783|NCT02065323|Prostate Cancer|prostate cancer
1192784|NCT02065323|Metastatic|metastatic
1192785|NCT02065323|Hormone-sensitive|hormone-sensitive
1192786|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
1192787|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
1192788|NCT02065323|Dovitinib|dovitinib
1192789|NCT02065323|TKI258|tki258
1192790|NCT02065323|Circulating Tumor Cells|circulating tumor cells
1192791|NCT02065310|AGE|age
1192792|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
1192793|NCT02065310|CEdG|cedg
1192794|NCT02065284|MS|ms
1192795|NCT02065284|Ambulation|ambulation
1192796|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
1192797|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
1192798|NCT02065219|Chronic Pain|chronic pain
1192799|NCT02065219|Inguinal Hernia|inguinal hernia
1192800|NCT02065219|Outcome|outcome
1192801|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
1192802|NCT02065206|Focus groups|focus groups
1192803|NCT02065206|Underrepresented Minorities|underrepresented minorities
1192804|NCT02065206|Social Media|social media
1192805|NCT02065206|Clinical Research Careers|clinical research careers
1192806|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
1192807|NCT02065167|cell therapy|cell therapy
1192808|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
1192809|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
1192810|NCT02065154|AML|aml
1192811|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1192812|NCT02065154|ALL|all
1192813|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
1192814|NCT02065154|CML|cml
1192815|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1192816|NCT02065154|CLL|cll
1192817|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
1192818|NCT02065154|NHL|nhl
1192819|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
1192820|NCT02065154|HL|hl
1192821|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
1192822|NCT02065154|MDS|mds
1192823|NCT02065154|myelofibrosis|myelofibrosis
1192824|NCT02065154|severe aplastic anemia|severe aplastic anemia
1192825|NCT02065141|digestion|digestion
1192826|NCT02065141|absorption|absorption
1192827|NCT02065141|protein|protein
1192828|NCT02065141|amino acids|amino acids
1192829|NCT02065141|heart failure|heart failure
1192830|NCT02065141|COPD|copd
1192831|NCT02065115|ice|ice
1192832|NCT02065115|cryotherapy|cryotherapy
1192833|NCT02065115|puncture|puncture
1192834|NCT02065115|pain|pain
1192835|NCT02065102|Rotational atherectomy|rotational atherectomy
1192836|NCT02065102|Angina|angina
1192837|NCT02065102|Optical coherence tomography|optical coherence tomography
1192838|NCT02065102|Intravascular ultrasound|intravascular ultrasound
1192839|NCT02065102|Coronary stent|coronary stent
1192840|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
1192841|NCT02065076|Kayexalate|kayexalate
1192842|NCT02065076|Pre-dialysis|pre-dialysis
1192843|NCT02065076|Outpatients|outpatients
1192844|NCT02065076|Hyperkalemia|hyperkalemia
1192845|NCT02065076|Chronic kidney failure|chronic kidney failure
1192846|NCT02065076|Potassium|potassium
1192847|NCT02065063|MEK inhibitor|mek inhibitor
1192848|NCT02065063|PD-0332991|pd-0332991
1192849|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
1192850|NCT02065063|palbociclib|palbociclib
1192851|NCT02065063|NRAS wild type|nras wild type
1192852|NCT02065063|cutaneous melanoma|cutaneous melanoma
1192853|NCT02065063|GSK1120212|gsk1120212
1192854|NCT02065063|trametinib|trametinib
1192855|NCT02065063|NRAS mutant|nras mutant
1192856|NCT02065063|BRAFV600 wild type|brafv600 wild type
1192857|NCT02065050|Diabetes mellitus|diabetes mellitus
1192858|NCT02065050|Team approach|team approach
1192859|NCT02065037|Insufflation|insufflation
1192860|NCT02065037|Carbon Dioxide|carbon dioxide
1192861|NCT02065037|Colonic Polyps|colonic polyps
1192862|NCT02065037|Colonoscopy|colonoscopy
1192863|NCT02065037|Randomized Controlled Trial|randomized controlled trial
1192864|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
1192865|NCT02065024|plant sterols|plant sterols
1192866|NCT02065024|serum Cholesterol|serum cholesterol
1192867|NCT02065024|bone turnover markers|bone turnover markers
1192868|NCT02064998|Randomized Controlled Trial|randomized controlled trial
1192869|NCT02064998|Alcohol|alcohol
1192870|NCT02064998|Internet|internet
1192871|NCT02064998|Mobile phone|mobile phone
1192872|NCT02064998|Screening|screening
1192873|NCT02064998|Brief intervention|brief intervention
1192874|NCT02064972|Graft vs Host Disease|graft vs host disease
1192875|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1192876|NCT02064972|Biological Marker|biological marker
1192877|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
1192878|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
1192879|NCT02064959|Subdural Hematoma|subdural hematoma
1192880|NCT02064959|Traumatic Brain Injury|traumatic brain injury
1192881|NCT02064959|Hypothermia|hypothermia
1192882|NCT02064946|prostate cancer|prostate cancer
1192883|NCT02064946|bone density|bone density
1192884|NCT02064946|vitamin D|vitamin d
1192885|NCT02064946|micronutrients|micronutrients
1192886|NCT02064946|pharmacologic actions|pharmacologic actions
1192887|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1192888|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1192889|NCT02064933|Genetic Therapy|genetic therapy
1192890|NCT02064907|Drug therapy|drug therapy
1192891|NCT02064894|children|children
1192892|NCT02064894|analgesia|analgesia
1192893|NCT02064894|musculoskeletal injury|musculoskeletal injury
1192894|NCT02064894|emergency|emergency
1192895|NCT02064894|opioids|opioids
1192896|NCT02064881|Postprandial lipemia|postprandial lipemia
1192897|NCT02064881|Diabetes|diabetes
1192898|NCT02064881|Metformin glycinate|metformin glycinate
1192899|NCT02064881|oxidized LDL|oxidized ldl
1192900|NCT02064868|AHF,|ahf,
1192901|NCT02064868|RLX030,|rlx030,
1192902|NCT02064868|SOC,|soc,
1192903|NCT02064868|WHF,|whf,
1192904|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
1192905|NCT02064868|Renal Impairment|renal impairment
1192906|NCT02064855|Spinal stenosis|spinal stenosis
1192907|NCT02064855|Spondylolisthesis|spondylolisthesis
1192908|NCT02064855|Degenerative disc disease|degenerative disc disease
1192909|NCT02064855|Spinal fusion|spinal fusion
1192910|NCT02064855|Allograft|allograft
1192911|NCT02064855|Interbody fusion|interbody fusion
1192912|NCT02064842|Healthy|healthy
1192913|NCT02064842|TMC647055|tmc647055
1192914|NCT02064842|TMC435|tmc435
1192915|NCT02064842|Simeprevir|simeprevir
1192916|NCT02064842|Sovriad|sovriad
1192917|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
1192918|NCT02064829|Metastatic breast cancer|metastatic breast cancer
1192919|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
1192920|NCT02064829|Bioequivalence|bioequivalence
1192921|NCT02064829|IG-001|ig-001
1192922|NCT02064829|nab-paclitaxel|nab-paclitaxel
1192923|NCT02064829|Paclitaxel|paclitaxel
1192924|NCT02064829|Pharmacokinetics|pharmacokinetics
1192925|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1192926|NCT02064816|Interferon beta 1a|interferon beta 1a
1192927|NCT02064816|Rebif®|rebif®
1192928|NCT02064790|Gabapentin|gabapentin
1192929|NCT02064790|Pregabalin|pregabalin
1192930|NCT02064790|Lyrica|lyrica
1192931|NCT02064790|Neurontin|neurontin
1192932|NCT02064790|lumbar|lumbar
1192933|NCT02064790|cervical|cervical
1192934|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
1192935|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
1192936|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
1192937|NCT02064738|AERD|aerd
1192938|NCT02064738|Samter's Triad|samter's triad
1192939|NCT02064738|nasal polyp|nasal polyp
1192940|NCT02064738|aspirin|aspirin
1192941|NCT02064738|diet|diet
1192942|NCT02064738|leukotriene|leukotriene
1192943|NCT02064725|Endometrial cancer|endometrial cancer
1192944|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
1192945|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
1192946|NCT02064725|Sodium cridanimod|sodium cridanimod
1192947|NCT02064725|Virexxa|virexxa
1192948|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
1192949|NCT02064699|Renal transplant|renal transplant
1192950|NCT02064699|CMV|cmv
1192951|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
1192952|NCT02064673|prostate cancer|prostate cancer
1192953|NCT02064673|radical prostatectomy|radical prostatectomy
1192954|NCT02064660|Myopia|myopia
1192955|NCT02064660|Children|children
1192956|NCT02064660|Acupressure|acupressure
1192957|NCT02064660|Refractive error|refractive error
1192958|NCT02064660|Axial length|axial length
1192959|NCT02064660|Korean medicine|korean medicine
1192960|NCT02064647|Insulin Infusion Systems|insulin infusion systems
1192961|NCT02064647|Blood Glucose|blood glucose
1192962|NCT02064634|Shinbaro Capsule|shinbaro capsule
1192963|NCT02064634|Celecoxib|celecoxib
1192964|NCT02064634|Osteoarthritis|osteoarthritis
1192965|NCT02064634|GCSB-5|gcsb-5
1192966|NCT02064634|Discontinuation rate|discontinuation rate
1192967|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
1192968|NCT02064634|NSAIDs|nsaids
1192969|NCT02064634|OASIS|oasis
1192970|NCT02064608|Prostate|prostate
1192971|NCT02064608|Cancer|cancer
1192972|NCT02064608|Prostate Cancer|prostate cancer
1192973|NCT02064608|High Risk|high risk
1192974|NCT02064608|Intermediate Risk|intermediate risk
1192975|NCT02064608|Early disease|early disease
1192976|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
1192977|NCT02064608|Radical Prostatectomy|radical prostatectomy
1192978|NCT02064595|Tibial fractures.|tibial fractures.
1192979|NCT02064595|Fracture fixation.|fracture fixation.
1192980|NCT02064595|External fixators.|external fixators.
1192981|NCT02064595|Intramedullary.|intramedullary.
1192982|NCT02064595|Quality of life.|quality of life.
1192983|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
1192984|NCT02064543|Parkinson's disease|parkinson's disease
1192985|NCT02064543|gait|gait
1192986|NCT02064530|TAP block|tap block
1192987|NCT02064530|dexmedetomidine|dexmedetomidine
1192988|NCT02064530|bupivacaine|bupivacaine
1192989|NCT02064530|postoperative analgesia|postoperative analgesia
1192990|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
1192991|NCT02064504|Respiratory|respiratory
1192992|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
1192993|NCT02064504|healthy subjects|healthy subjects
1192994|NCT02064504|pharmacokinetics|pharmacokinetics
1192995|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
1192996|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
1192997|NCT02064491|EGFR mutant|egfr mutant
1192998|NCT02064491|Erlotinib|erlotinib
1192999|NCT02064491|Treatment Beyond Progression|treatment beyond progression
1193000|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
1193001|NCT02064478|Bone anchored hearing device|bone anchored hearing device
1193002|NCT02064452|behavior problems|behavior problems
1193003|NCT02064452|children|children
1193004|NCT02064452|prevention|prevention
1193005|NCT02064452|parenting|parenting
1193006|NCT02064452|online|online
1193007|NCT02064452|pediatric|pediatric
1193008|NCT02064439|deep vein thrombosis|deep vein thrombosis
1193009|NCT02064439|pulmonary embolism|pulmonary embolism
1193010|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
1193011|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
1193012|NCT02064413|Birth control|birth control
1193013|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
1193014|NCT02064400|Ultrasound|ultrasound
1193015|NCT02064400|Remission|remission
1193016|NCT02064400|Qualitative|qualitative
1193017|NCT02064387|Multiple Myeloma|multiple myeloma
1193018|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
1193019|NCT02064374|Dolutegravir|dolutegravir
1193020|NCT02064374|drug interaction|drug interaction
1193021|NCT02064374|metformin|metformin
1193022|NCT02064374|pharmacokinetics|pharmacokinetics
1193023|NCT02064374|healthy volunteers|healthy volunteers
1193024|NCT02064361|SCUBA diving|scuba diving
1193025|NCT02064361|exercise,|exercise,
1193026|NCT02064361|microparticles|microparticles
1193027|NCT02064361|neutrophil activation,|neutrophil activation,
1193028|NCT02064361|high intensity exercise|high intensity exercise
1193029|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
1193030|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
1193031|NCT02064322|SIJ fusion|sij fusion
1193032|NCT02064322|SI joint|si joint
1193033|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
1193034|NCT02064270|incision care|incision care
1193035|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
1193036|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
1193037|NCT02064270|Knee surgery|knee surgery
1193038|NCT02064270|Hip surgery|hip surgery
1193039|NCT02064257|autonomic nervous system|autonomic nervous system
1193040|NCT02064257|auditory processing disorder|auditory processing disorder
1193041|NCT02064257|social behavior|social behavior
1193043|NCT02064244|kidney|kidney
1193044|NCT02064244|creatinine|creatinine
1193045|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
1193046|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
1193047|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
1193048|NCT02064205|pre-load|pre-load
1193049|NCT02064205|satiety|satiety
1193050|NCT02064205|energy intake|energy intake
1193051|NCT02064205|appetite|appetite
1193052|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
1193053|NCT02064192|sudden cardiac death|sudden cardiac death
1193054|NCT02064192|primary prophylaxis|primary prophylaxis
1193055|NCT02064192|risk stratification|risk stratification
1193056|NCT02064179|Congenital heart disease|congenital heart disease
1193057|NCT02064179|Antiplatelet therapy|antiplatelet therapy
1193058|NCT02064179|Aspirin|aspirin
1193059|NCT02064166|Parkinson disease|parkinson disease
1193060|NCT02064166|Multiple system atrophy|multiple system atrophy
1193061|NCT02064166|Intranasal|intranasal
1193062|NCT02064166|Insulin|insulin
1193063|NCT02064153|Dialysate temperature|dialysate temperature
1193064|NCT02064153|Spent dialysate|spent dialysate
1193065|NCT02064153|Toxin removal|toxin removal
1193066|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
1193067|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
1193068|NCT02064140|ARDS|ards
1193069|NCT02064140|Mechanical Ventilation|mechanical ventilation
1193070|NCT02064140|Tidal volume|tidal volume
1193071|NCT02064140|NMBA|nmba
1193072|NCT02064114|BMI >40|bmi >40
1193073|NCT02064101|Scoliosis|scoliosis
1193074|NCT02064101|EMG|emg
1193075|NCT02064101|Pedicle screw|pedicle screw
1193076|NCT02064101|Neuromonitoring|neuromonitoring
1193077|NCT02064088|Regional anesthesia|regional anesthesia
1193078|NCT02064088|TAP block|tap block
1193079|NCT02064088|Pediatric anesthesia|pediatric anesthesia
1193080|NCT02064088|analgesic effects|analgesic effects
1193081|NCT02064088|pharmacokinetics|pharmacokinetics
1193082|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
1193083|NCT02064075|vasospasm|vasospasm
1193084|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
1193085|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
1193086|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
1193087|NCT02064062|Autologous Stem Cells|autologous stem cells
1193088|NCT02064062|Musculoskeletal|musculoskeletal
1193089|NCT02064049|Hepatitis C virus|hepatitis c virus
1193090|NCT02064049|People who inject drugs|people who inject drugs
1193091|NCT02064049|Drug users|drug users
1193092|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
1193093|NCT02064049|Infectious diseases|infectious diseases
1193094|NCT02064049|Prisoners|prisoners
1193095|NCT02064036|Prostate Cancer|prostate cancer
1193096|NCT02064036|Radiotherapy|radiotherapy
1193097|NCT02064036|Androgen Deprivation|androgen deprivation
1193098|NCT02064023|insulin pump|insulin pump
1193099|NCT02064023|CSII|csii
1193100|NCT02064023|multiple daily injections|multiple daily injections
1193101|NCT02064023|MDI|mdi
1193102|NCT02064023|type 1 diabetes|type 1 diabetes
1193103|NCT02064023|type 2 diabetes|type 2 diabetes
1193104|NCT02064023|pregnancy|pregnancy
1193105|NCT02063971|Skin aging|skin aging
1193106|NCT02063971|Soothing activity|soothing activity
1193107|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
1193108|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
1193109|NCT02063958|Hsp90|hsp90
1193110|NCT02063945|ADHA|adha
1193111|NCT02063945|ODD|odd
1193112|NCT02063945|Conduct disorder|conduct disorder
1193113|NCT02063945|Aggression|aggression
1193114|NCT02063945|Treatment|treatment
1193115|NCT02063945|Methylphenidate|methylphenidate
1193116|NCT02063945|Risperidone|risperidone
1193117|NCT02063932|mucosal microbiome|mucosal microbiome
1193118|NCT02063932|H.pylori|h.pylori
1193119|NCT02063932|intestinal metaplasia|intestinal metaplasia
1193120|NCT02063932|gastric neoplasia|gastric neoplasia
1193121|NCT02063932|endomicroscopy|endomicroscopy
1193122|NCT02063880|HIV-1|hiv-1
1193123|NCT02063880|IRIS|iris
1193124|NCT02063867|HAI|hai
1193125|NCT02063867|MRSA|mrsa
1193126|NCT02063867|VRE|vre
1267226|NCT01728207|NHL|nhl
1193127|NCT02063854|Drug Therapy|drug therapy
1193128|NCT02063802|pediatric obesity|pediatric obesity
1193129|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
1193130|NCT02063802|CLA|cla
1193131|NCT02063802|metformin|metformin
1193132|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
1193133|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1193134|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1193135|NCT02063789|Human Immunoglobulin|human immunoglobulin
1193136|NCT02063789|ITP|itp
1193137|NCT02063789|IVIg|ivig
1193138|NCT02063789|IgIV|igiv
1193139|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
1193140|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
1193141|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
1193142|NCT02063776|Children|children
1193143|NCT02063776|Carotid intima media thickness|carotid intima media thickness
1193144|NCT02063776|Pulse wave velocity|pulse wave velocity
1193145|NCT02063776|Height standard deviation score|height standard deviation score
1193551|NCT02061917|Tobacco|tobacco
1193146|NCT02063763|Adult patients|adult patients
1193147|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
1193148|NCT02063763|Splenectomy|splenectomy
1193149|NCT02063763|TPO-mimetics|tpo-mimetics
1193150|NCT02063763|Eltrombopag|eltrombopag
1193151|NCT02063763|Romiplostim|romiplostim
1193152|NCT02063750|Fibromyalgia|fibromyalgia
1193153|NCT02063750|Muscle strength exercises|muscle strength exercises
1193154|NCT02063750|Pain|pain
1193155|NCT02063750|Quality of life|quality of life
1193156|NCT02063737|Shift work|shift work
1193157|NCT02063737|Fatigue|fatigue
1193158|NCT02063737|Sleepiness|sleepiness
1193159|NCT02063737|Injury|injury
1193160|NCT02063724|Invasive Breast Cancer|invasive breast cancer
1193161|NCT02063724|Breast Cancer|breast cancer
1193162|NCT02063724|Immunotherapy|immunotherapy
1193163|NCT02063724|Vaccine|vaccine
1193164|NCT02063724|Dendritic Cell|dendritic cell
1193165|NCT02063711|Prenatal Yoga|prenatal yoga
1193166|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
1193167|NCT02063711|Yoga, Fetal Response|yoga, fetal response
1193168|NCT02063646|polyphenols|polyphenols
1193169|NCT02063646|memory|memory
1193170|NCT02063646|elderly|elderly
1193171|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
1193172|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
1193173|NCT02063607|Hepatitis C naive|hepatitis c naive
1193174|NCT02063594|Iodixanol|iodixanol
1193175|NCT02063594|Iodinated Contrast|iodinated contrast
1193176|NCT02063594|Liposome|liposome
1193177|NCT02063594|Computed Tomography|computed tomography
1193178|NCT02063594|X-ray Imaging|x-ray imaging
1193179|NCT02063594|Blood pool agent|blood pool agent
1193180|NCT02063594|Biomarker|biomarker
1193181|NCT02063555|Tuberculosis|tuberculosis
1193182|NCT02063555|BCG|bcg
1193183|NCT02063555|HIV|hiv
1193184|NCT02063555|TB Vaccines|tb vaccines
1193185|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
1193186|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
1193187|NCT02063542|Surgery|surgery
1193188|NCT02063529|Colorectal cancer|colorectal cancer
1193189|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
1193190|NCT02063529|Liver metastases|liver metastases
1193191|NCT02063529|Liver resection|liver resection
1193192|NCT02063529|Liver ablation|liver ablation
1193193|NCT02063529|Conversion therapy|conversion therapy
1193194|NCT02063529|FOLFOXIRI|folfoxiri
1193195|NCT02063529|Cetuximab|cetuximab
1193196|NCT02063529|Oxaliplatin|oxaliplatin
1193197|NCT02063529|Irinotecan|irinotecan
1193198|NCT02063529|Leucovorin|leucovorin
1193199|NCT02063516|Airway Cuff|airway cuff
1193200|NCT02063516|Guardian|guardian
1193201|NCT02063516|Proseal|proseal
1193202|NCT02063516|Cuff Pressure|cuff pressure
1193203|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
1193204|NCT02063503|prognostic indicator|prognostic indicator
1193205|NCT02063503|nonspecific|nonspecific
1193206|NCT02063503|chronic|chronic
1193207|NCT02063503|low back pain|low back pain
1193208|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
1193209|NCT02063490|Adherence|adherence
1193210|NCT02063490|dialysis|dialysis
1193211|NCT02063490|intervention|intervention
1193212|NCT02063490|nurse-led|nurse-led
1193213|NCT02063490|phosphate binders|phosphate binders
1193214|NCT02063490|trial|trial
1193215|NCT02063464|Tumorcidal|tumorcidal
1193216|NCT02063464|Monocytes|monocytes
1193217|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
1193218|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
1193219|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
1193220|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
1193221|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
1193222|NCT02063438|Thoracotomy|thoracotomy
1193223|NCT02063438|Pain|pain
1193224|NCT02063438|Intracostal Suture|intracostal suture
1193225|NCT02063438|Pericostal Suture|pericostal suture
1193226|NCT02063425|Motor recovery|motor recovery
1193227|NCT02063425|Fluoxetine|fluoxetine
1193228|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
1193229|NCT02063425|stroke|stroke
1193230|NCT02063399|NPC|npc
1193231|NCT02063399|Cancer screening|cancer screening
1193232|NCT02063399|Plasma EBV DNA|plasma ebv dna
1193233|NCT02063347|innate collateral supply|innate collateral supply
1193234|NCT02063347|collateral|collateral
1193235|NCT02063347|coronary collateral|coronary collateral
1193236|NCT02063347|renal collateral|renal collateral
1193237|NCT02063347|peripheral collateral|peripheral collateral
1193238|NCT02063347|coronary artery disease|coronary artery disease
1193239|NCT02063334|vitamin D3|vitamin d3
1193240|NCT02063334|cholecalciferol|cholecalciferol
1193241|NCT02063334|calcidiol|calcidiol
1193242|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
1193243|NCT02063334|gene expression|gene expression
1193244|NCT02063334|vitamin D receptor|vitamin d receptor
1193245|NCT02063334|randomized controlled trial|randomized controlled trial
1193246|NCT02063334|men|men
1193247|NCT02063334|adults|adults
1193248|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
1193249|NCT02063308|Oxaloacetate|oxaloacetate
1193250|NCT02063308|OAA|oaa
1193251|NCT02063308|AD|ad
1193252|NCT02063308|Alzheimer's Disease|alzheimer's disease
1193253|NCT02063295|Beloranib|beloranib
1193254|NCT02063295|ZGN-440|zgn-440
1193255|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
1193256|NCT02063295|ZGN-433|zgn-433
1193257|NCT02063282|Asymptomatic|asymptomatic
1193258|NCT02063282|Carriage|carriage
1193259|NCT02063282|Colonization|colonization
1193260|NCT02063282|Clostridium difficile|clostridium difficile
1193261|NCT02063282|Colitis|colitis
1193262|NCT02063282|Rectal swab|rectal swab
1193263|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
1193264|NCT02063256|sperm count|sperm count
1193265|NCT02063256|sperm concentration|sperm concentration
1193266|NCT02063256|mobility|mobility
1193267|NCT02063256|diet|diet
1193268|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
1193269|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
1193270|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
1193271|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
1193272|NCT02063191|Atrial Fibrillation|atrial fibrillation
1193273|NCT02063191|Bundle Branch Block|bundle branch block
1193274|NCT02063165|Safflower Oil|safflower oil
1193275|NCT02063165|Linoleic Acid|linoleic acid
1193276|NCT02063165|Dyslipidemia|dyslipidemia
1193277|NCT02063165|Hypertension|hypertension
1193278|NCT02063139|Knemometry|knemometry
1193279|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
1193280|NCT02063126|maximum Heart Rate|maximum heart rate
1193281|NCT02063126|Fatigue|fatigue
1193282|NCT02063126|Pain|pain
1193283|NCT02063126|Sleep|sleep
1193284|NCT02063113|Multiple myeloma,|multiple myeloma,
1193285|NCT02063113|Older patient,|older patient,
1193286|NCT02063113|Treatment,|treatment,
1193287|NCT02063113|Geriatric assessment|geriatric assessment
1193288|NCT02063100|Glomerulonephritis|glomerulonephritis
1193289|NCT02063100|proteinuria|proteinuria
1193290|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
1193291|NCT02063100|Losartan Potassium|losartan potassium
1193292|NCT02063100|efficacy|efficacy
1193293|NCT02063100|safety|safety
1193294|NCT02063087|Head CT|head ct
1193295|NCT02063087|Head Injury|head injury
1193296|NCT02063087|Pediatric|pediatric
1193297|NCT02063087|Emergency Department|emergency department
1193298|NCT02063087|Decision Aids|decision aids
1193299|NCT02063087|Shared Decision Making|shared decision making
1193300|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
1193301|NCT02063061|erectile dysfunction|erectile dysfunction
1193302|NCT02063048|weight loss|weight loss
1193303|NCT02063048|Text Messaging|text messaging
1193304|NCT02063048|Short Message Service|short message service
1193305|NCT02063048|Text Messages|text messages
1193306|NCT02063035|lumbar spine surgery|lumbar spine surgery
1193307|NCT02063035|thoracic spine surgery|thoracic spine surgery
1193308|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
1193309|NCT02062944|Liver Transplant|liver transplant
1193310|NCT02062944|Sirolimus|sirolimus
1193311|NCT02062944|Rapamune|rapamune
1193312|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
1193313|NCT02062944|Withdrawal|withdrawal
1193314|NCT02062931|Primary Infertility|primary infertility
1193315|NCT02062931|Primary Amenorrhea|primary amenorrhea
1193316|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
1193317|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
1193318|NCT02062918|Abdominal belt|abdominal belt
1193319|NCT02062918|Chronic low back pain|chronic low back pain
1193320|NCT02062918|Pain|pain
1193321|NCT02062918|Functional capacity|functional capacity
1193322|NCT02062892|everolimus|everolimus
1193323|NCT02062892|sirolimus|sirolimus
1193325|NCT02062892|vascular endothelial function|vascular endothelial function
1193326|NCT02062892|kidney|kidney
1193327|NCT02062892|Transplantation|transplantation
1193328|NCT02062892|biomarkers|biomarkers
1193329|NCT02062879|pain|pain
1193330|NCT02062879|trauma|trauma
1193331|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
1193332|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1193333|NCT02062840|EEG|eeg
1193334|NCT02062827|Glioma|glioma
1193335|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
1193336|NCT02062788|Early Recovery After Surgery|early recovery after surgery
1193337|NCT02062788|Oral rehydration solution|oral rehydration solution
1193338|NCT02062788|Insulin resistance|insulin resistance
1193339|NCT02062788|Postoperative complication|postoperative complication
1193340|NCT02062749|Colorectal cancer|colorectal cancer
1193341|NCT02062749|Colon Cancer|colon cancer
1193342|NCT02062749|Pediatric|pediatric
1193343|NCT02062749|Adolescent|adolescent
1193344|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
1193345|NCT02062749|HIPEC|hipec
1193346|NCT02062749|Oxaliplatin|oxaliplatin
1193347|NCT02062749|Eloxatin|eloxatin
1193348|NCT02062736|methadone|methadone
1193349|NCT02062736|heroin addiction|heroin addiction
1193350|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
1193351|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
1193352|NCT02062723|methadone|methadone
1193353|NCT02062723|heroin addiction|heroin addiction
1193354|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
1193355|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
1193356|NCT02062710|cough|cough
1193357|NCT02062710|cough reflex|cough reflex
1193358|NCT02062710|capsaicin|capsaicin
1193359|NCT02062710|diphenhydramine|diphenhydramine
1193360|NCT02062710|phenylephrine|phenylephrine
1193361|NCT02062710|dextromethorphan|dextromethorphan
1193362|NCT02062710|placebo|placebo
1193363|NCT02062697|Neoplasms|neoplasms
1193364|NCT02062697|Glandular and Epithelial|glandular and epithelial
1193365|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
1193366|NCT02062697|Ovarian cancer|ovarian cancer
1193367|NCT02062684|IgAN|igan
1193368|NCT02062684|IgA Nephropathy|iga nephropathy
1193369|NCT02062684|A-623|a-623
1193370|NCT02062684|Blisibimod|blisibimod
1193371|NCT02062684|Kidney Disease|kidney disease
1193372|NCT02062684|Persistent proteinuria|persistent proteinuria
1193373|NCT02062671|ADPKD|adpkd
1193374|NCT02062671|denervation|denervation
1193375|NCT02062671|renal denervation|renal denervation
1193376|NCT02062658|OCD|ocd
1193377|NCT02062645|essential hypertension|essential hypertension
1193378|NCT02062619|Stroke|stroke
1193379|NCT02062619|Aphasia|aphasia
1193380|NCT02062619|Acquired reading disorders|acquired reading disorders
1193381|NCT02062619|Central alexia|central alexia
1193382|NCT02062619|Computer based rehabilitation|computer based rehabilitation
1193383|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
1193384|NCT02062619|tDCS|tdcs
1193385|NCT02062619|Magnetoencephalography|magnetoencephalography
1193386|NCT02062619|MEG|meg
1193387|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
1193388|NCT02062619|MRI|mri
1193389|NCT02062606|Scoliosis|scoliosis
1193390|NCT02062606|Spinal Curvatures|spinal curvatures
1193391|NCT02062606|Spinal Diseases|spinal diseases
1193392|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1193393|NCT02062606|Spinal Deformity|spinal deformity
1193394|NCT02062593|Stable angina|stable angina
1193395|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
1193396|NCT02062593|Optimal medical therapy|optimal medical therapy
1193397|NCT02062593|Sham-control|sham-control
1193398|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
1193399|NCT02062580|Immune activation|immune activation
1193400|NCT02062554|Myocardial infarction|myocardial infarction
1193401|NCT02062554|Clinical outcome|clinical outcome
1193402|NCT02062554|Flow-mediated dilation|flow-mediated dilation
1193403|NCT02062554|Inflammation|inflammation
1193404|NCT02062541|functional assessment|functional assessment
1193405|NCT02062541|rehabilitation|rehabilitation
1193406|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
1193407|NCT02062528|EPA|epa
1193408|NCT02062489|breast cancer,|breast cancer,
1193409|NCT02062489|tamoxifen,|tamoxifen,
1193410|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
1193411|NCT02062463|Asthma|asthma
1193412|NCT02062450|Arthroplasty|arthroplasty
1193413|NCT02062450|Hip Replacement|hip replacement
1193414|NCT02062450|Acetabular cup|acetabular cup
1193415|NCT02062450|Dual mobility|dual mobility
1193416|NCT02062450|Hip revision surgery|hip revision surgery
1193417|NCT02062437|Arthroplasty|arthroplasty
1193418|NCT02062437|Hip Replacement|hip replacement
1193419|NCT02062437|Ceramic|ceramic
1193420|NCT02062437|Acetabular cup|acetabular cup
1193421|NCT02062437|Femoral stem|femoral stem
1193422|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
1193423|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
1193424|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
1193425|NCT02062411|adult|adult
1193426|NCT02062398|PNP|pnp
1193427|NCT02062398|Stimulation|stimulation
1193428|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
1193429|NCT02062372|7 T MRI|7 t mri
1193430|NCT02062372|Radiotherapy|radiotherapy
1193431|NCT02062372|Glioblastoma|glioblastoma
1193432|NCT02062372|Biopsy|biopsy
1193433|NCT02062359|Malignant Melanoma|malignant melanoma
1193434|NCT02062359|Metastatic Cancer|metastatic cancer
1193435|NCT02062359|Gene Therapy|gene therapy
1193436|NCT02062359|Immunotherapy|immunotherapy
1193437|NCT02062359|Tumor Regression|tumor regression
1193438|NCT02062346|endothelin;|endothelin;
1193439|NCT02062346|blood pressure;|blood pressure;
1193440|NCT02062346|vasculitis|vasculitis
1193441|NCT02062333|dexmedetomidine|dexmedetomidine
1193442|NCT02062333|esmolol|esmolol
1193443|NCT02062333|stapes reflex|stapes reflex
1193444|NCT02062320|Acute Pain Service|acute pain service
1193445|NCT02062320|postoperative analgesia|postoperative analgesia
1193446|NCT02062320|Caesarean Section|caesarean section
1193447|NCT02062320|non-opioid analgesia|non-opioid analgesia
1193448|NCT02062320|opioid analgesia|opioid analgesia
1193449|NCT02062320|epidural analgesia|epidural analgesia
1193450|NCT02062307|Hypogonadism|hypogonadism
1193451|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
1193452|NCT02062307|Osteoprotegerin|osteoprotegerin
1193453|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
1193454|NCT02062307|Vitamin D|vitamin d
1193455|NCT02062281|Safety|safety
1193456|NCT02062281|Immunogenicity|immunogenicity
1193457|NCT02062281|vaccine|vaccine
1193458|NCT02062281|pneumococcal|pneumococcal
1193459|NCT02062281|influenza|influenza
1193460|NCT02062268|KAP|kap
1193461|NCT02062268|drink driving|drink driving
1193462|NCT02062268|public|public
1193463|NCT02062268|Jiangsu province|jiangsu province
1193464|NCT02062268|China|china
1193465|NCT02062255|Asprin|asprin
1193466|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
1193467|NCT02062255|Obesity|obesity
1193468|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
1193469|NCT02062242|Pelvic Floor|pelvic floor
1193470|NCT02062242|Physical Therapy Specialty|physical therapy specialty
1193471|NCT02062242|Awareness|awareness
1193472|NCT02062242|Electric Stimulation|electric stimulation
1193473|NCT02062242|Palpation|palpation
1193474|NCT02062229|oxidative stress|oxidative stress
1193475|NCT02062229|oxysterols|oxysterols
1193476|NCT02062229|fatty acids|fatty acids
1193477|NCT02062229|seminal fluid|seminal fluid
1193478|NCT02062216|Coronary artery disease|coronary artery disease
1193479|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
1193480|NCT02062216|Inflammatory receptors|inflammatory receptors
1193481|NCT02062203|Akebia|akebia
1193482|NCT02062203|QT interval|qt interval
1193483|NCT02062203|TQT|tqt
1193484|NCT02062203|pharmacokinetic|pharmacokinetic
1193485|NCT02062203|anemia|anemia
1193486|NCT02062203|chronic kidney disease|chronic kidney disease
1193487|NCT02062203|CKD|ckd
1193488|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
1193489|NCT02062203|renal impairment|renal impairment
1193490|NCT02062203|safety|safety
1193491|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
1193492|NCT02062138|rehabilitation|rehabilitation
1193493|NCT02062138|total knee arthroplasty|total knee arthroplasty
1193494|NCT02062138|range of motion|range of motion
1193495|NCT02062138|continuous passive motion|continuous passive motion
1193496|NCT02062138|controlled active motion|controlled active motion
1193497|NCT02062138|postoperative physical therapy|postoperative physical therapy
1193498|NCT02062125|scleroderma|scleroderma
1193499|NCT02062125|calcinosis|calcinosis
1193500|NCT02062112|Bowel preparation solutions|bowel preparation solutions
1193501|NCT02062112|Colonoscopy|colonoscopy
1193502|NCT02062112|Polyethylene glycol|polyethylene glycol
1193503|NCT02062086|Sarcopenia|sarcopenia
1193504|NCT02062086|Mass muscle|mass muscle
1193505|NCT02062086|Quality of life|quality of life
1193506|NCT02062073|head lice|head lice
1193507|NCT02062073|Hatchtech|hatchtech
1193508|NCT02062060|Head Lice|head lice
1193509|NCT02062060|Hatchtech|hatchtech
1193510|NCT02062047|Diabetes Mellitus|diabetes mellitus
1193511|NCT02062047|Chronic Periodontitis|chronic periodontitis
1193512|NCT02062047|Root Planing|root planing
1193513|NCT02062047|Cytokines|cytokines
1193514|NCT02062047|microbiology|microbiology
1193515|NCT02062047|Glycated hemoglobin|glycated hemoglobin
1193516|NCT02062047|diabetic subjects|diabetic subjects
1193517|NCT02062034|Oxidative stress|oxidative stress
1193518|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
1193519|NCT02062034|Ubiquinone|ubiquinone
1193520|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
1193521|NCT02062034|Diabetic retinopathy|diabetic retinopathy
1193522|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
1193523|NCT02062008|Cardiac Disease|cardiac disease
1193524|NCT02061995|Bone Diseases|bone diseases
1193525|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
1193526|NCT02061995|Osteoporosis|osteoporosis
1193527|NCT02061995|Bone Fractures|bone fractures
1193528|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
1193529|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
1193530|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
1193531|NCT02061982|Caffeine|caffeine
1193532|NCT02061982|Cognition|cognition
1193533|NCT02061969|nursing home facility|nursing home facility
1193534|NCT02061969|long-term care facility|long-term care facility
1193535|NCT02061969|older patients|older patients
1193536|NCT02061969|elderly patients|elderly patients
1193537|NCT02061969|hyperglycemia|hyperglycemia
1193538|NCT02061969|type 2 diabetes|type 2 diabetes
1193539|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
1193540|NCT02061943|Laryngeal dystonia|laryngeal dystonia
1193541|NCT02061943|Dystonia|dystonia
1193542|NCT02061943|Severity|severity
1193543|NCT02061930|single tooth|single tooth
1193544|NCT02061930|dental implant|dental implant
1193545|NCT02061930|aesthetics outcome|aesthetics outcome
1193546|NCT02061930|long term|long term
1193547|NCT02061930|soft tissue recession|soft tissue recession
1193548|NCT02061930|pink esthetic score|pink esthetic score
1193549|NCT02061930|white esthetic score|white esthetic score
1193550|NCT02061917|Biomarkers|biomarkers
1193552|NCT02061917|Tobacco-heating|tobacco-heating
1193553|NCT02061917|Smokeless Tobacco|smokeless tobacco
1193554|NCT02061917|Snus|snus
1193555|NCT02061917|Smoking|smoking
1193556|NCT02061917|Exposure|exposure
1193557|NCT02061917|Quality of Life|quality of life
1193558|NCT02061891|Coronary Stenosis|coronary stenosis
1193559|NCT02061891|Coronary Artery Disease|coronary artery disease
1193560|NCT02061891|Acute coronary syndrome|acute coronary syndrome
1193561|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
1193562|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
1193563|NCT02061878|ApoE|apoe
1193564|NCT02061878|beta-amyloid|beta-amyloid
1193565|NCT02061813|Hatchtech|hatchtech
1193566|NCT02061800|Unrelated donor transplant|unrelated donor transplant
1193567|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
1193568|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
1193569|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
1193570|NCT02061800|Related donor transplant|related donor transplant
1193571|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
1193572|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1193573|NCT02061800|Non-malignant disease|non-malignant disease
1193574|NCT02061800|Malignant disease|malignant disease
1193575|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
1193576|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
1193577|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
1193578|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
1193579|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
1193580|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
1193581|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
1193582|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1193583|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
1193584|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
1193585|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
1193586|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
1193587|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
1193588|NCT02061800|Hemoglobinopathies|hemoglobinopathies
1193589|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
1193590|NCT02061800|Sickle Cell Disease|sickle cell disease
1193591|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
1193592|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
1193593|NCT02061735|skin imaging|skin imaging
1193594|NCT02061735|image analysis|image analysis
1193595|NCT02061735|infrared thermography|infrared thermography
1193596|NCT02061735|infantile hemangioma|infantile hemangioma
1193597|NCT02061735|three dimensional imaging|three dimensional imaging
1193598|NCT02061735|color imaging and analysis|color imaging and analysis
1193599|NCT02061735|propranolol|propranolol
1193600|NCT02061735|timolol|timolol
1193601|NCT02061735|ontogeny|ontogeny
1193602|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
1193603|NCT02061709|Rhinitis|rhinitis
1193604|NCT02061709|Seasonal|seasonal
1193605|NCT02061709|Ragweed|ragweed
1193606|NCT02061709|Allergy|allergy
1193607|NCT02061696|Coronary Artery Disease|coronary artery disease
1193608|NCT02061696|Coronary Disease|coronary disease
1193609|NCT02061696|Heart disease|heart disease
1193610|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
1193611|NCT02061696|Arteriosclerosis|arteriosclerosis
1193612|NCT02061696|Atherosclerosis|atherosclerosis
1193613|NCT02061696|Manual Compression|manual compression
1193614|NCT02061670|Ragweed|ragweed
1193615|NCT02061670|Allergy|allergy
1193616|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
1267833|NCT01725529|TMC435|tmc435
1193617|NCT02061670|rhinitis|rhinitis
1193618|NCT02061670|asthma|asthma
1193619|NCT02061618|South Asian|south asian
1193620|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
1193621|NCT02061605|Surgical hemostasis|surgical hemostasis
1193622|NCT02061605|Laser tissue welding|laser tissue welding
1193623|NCT02061605|Tissue sealant|tissue sealant
1193624|NCT02061579|Physical Activity|physical activity
1193625|NCT02061566|Acute kidney injury|acute kidney injury
1193626|NCT02061553|traumatic brain injury|traumatic brain injury
1193628|NCT02061553|head injury|head injury
1193629|NCT02061553|brain injury|brain injury
1193630|NCT02061553|depression|depression
1193631|NCT02061553|anxiety|anxiety
1193632|NCT02061527|ADM|adm
1193633|NCT02061527|Strattice|strattice
1193634|NCT02061527|Breast reconstruction|breast reconstruction
1193635|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
1193636|NCT02061527|IBR|ibr
1193637|NCT02061527|Acellular dermal matrix|acellular dermal matrix
1193638|NCT02061527|Biological mesh|biological mesh
1193639|NCT02061527|Randomized controlled trial|randomized controlled trial
1193640|NCT02061527|RCT|rct
1193641|NCT02061527|Breast cancer|breast cancer
1193642|NCT02061527|Implants|implants
1193643|NCT02061527|Mastectomy|mastectomy
1193644|NCT02061527|Direct-to-implant|direct-to-implant
1193645|NCT02061501|visual cognitive deficits|visual cognitive deficits
1193745|NCT02061098|Microbiota|microbiota
1193646|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
1193647|NCT02061475|Lidocaine patches|lidocaine patches
1193648|NCT02061475|Pain|pain
1193649|NCT02061475|Intravenous cannulation|intravenous cannulation
1193650|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
1193651|NCT02061449|immunostimulation|immunostimulation
1193652|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
1193653|NCT02061423|Invasive Breast Cancer|invasive breast cancer
1193654|NCT02061423|Breast Cancer|breast cancer
1193655|NCT02061423|Immunotherapy|immunotherapy
1193656|NCT02061423|Vaccine|vaccine
1193657|NCT02061423|Dendritic Cell|dendritic cell
1193658|NCT02061423|Neoadjuvant|neoadjuvant
1193659|NCT02061410|Elderly|elderly
1193660|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
1193661|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
1193662|NCT02061397|simvastatin|simvastatin
1193663|NCT02061397|sirolimus|sirolimus
1193664|NCT02061397|everolimus|everolimus
1193665|NCT02061384|Infertility|infertility
1193666|NCT02061371|stroke|stroke
1193667|NCT02061371|spasticity|spasticity
1193668|NCT02061371|physiotherapy|physiotherapy
1193669|NCT02061371|virtual reality|virtual reality
1193670|NCT02061358|Dengue|dengue
1193671|NCT02061358|Arbovirus Infections|arbovirus infections
1193672|NCT02061358|Flaviviridae Infections|flaviviridae infections
1193673|NCT02061358|Flavivirus Infections|flavivirus infections
1193674|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
1193675|NCT02061358|RNA Virus Infections|rna virus infections
1193676|NCT02061358|Virus Diseases|virus diseases
1193677|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
1193678|NCT02061358|Pharmacologic Actions|pharmacologic actions
1193679|NCT02061358|Therapeutic Uses|therapeutic uses
1193680|NCT02061345|Prostate cancer|prostate cancer
1193681|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
1193682|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
1193683|NCT02061332|Breast Cancer|breast cancer
1193684|NCT02061332|DCIS|dcis
1193685|NCT02061332|Immunotherapy|immunotherapy
1193686|NCT02061332|Vaccine|vaccine
1193687|NCT02061332|Dendritic Cell|dendritic cell
1193688|NCT02061306|Celiac disease|celiac disease
1193689|NCT02061306|coeliac disease|coeliac disease
1193690|NCT02061306|microbiome|microbiome
1193691|NCT02061306|gluten|gluten
1193692|NCT02061306|infants|infants
1193693|NCT02061306|pregnancy|pregnancy
1193694|NCT02061306|genetic|genetic
1193695|NCT02061280|Asthma|asthma
1193696|NCT02061280|Clinical Trial Design|clinical trial design
1193697|NCT02061280|Electronic Data Entry|electronic data entry
1193698|NCT02061280|Mobile Devices|mobile devices
1193699|NCT02061280|Home Spirometry|home spirometry
1193700|NCT02061267|Metabolic Syndrome|metabolic syndrome
1193701|NCT02061267|Olive Oil|olive oil
1193702|NCT02061267|Niacin|niacin
1193703|NCT02061254|Venous insufficiency|venous insufficiency
1193704|NCT02061254|Lymphedema|lymphedema
1193705|NCT02061254|Elastograph|elastograph
1193706|NCT02061254|Ultrasonography|ultrasonography
1193707|NCT02061254|Fibrosis|fibrosis
1193708|NCT02061254|Dermis|dermis
1193709|NCT02061254|Hypodermis|hypodermis
1193710|NCT02061254|Skin|skin
1193711|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1193712|NCT02061241|Pacing|pacing
1193713|NCT02061215|CYTOF|cytof
1193714|NCT02061215|CMV|cmv
1193715|NCT02061215|PCR|pcr
1193716|NCT02061215|HLA|hla
1193717|NCT02061202|Sickle Cell Disease|sickle cell disease
1193718|NCT02061202|Pain Crisis|pain crisis
1193719|NCT02061202|Painful Crisis|painful crisis
1193720|NCT02061202|Sickle Pain|sickle pain
1193721|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
1193722|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
1193723|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
1193724|NCT02061176|Hemorrhoids|hemorrhoids
1193725|NCT02061176|Haemorrhoids|haemorrhoids
1193726|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
1193727|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
1193728|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
1193729|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
1193730|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
1193731|NCT02061150|Prevention|prevention
1193732|NCT02061150|Maternal risk factors|maternal risk factors
1193733|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
1193734|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
1193736|NCT02061137|Brain Atrophy|brain atrophy
1193737|NCT02061111|Mitochondria Function|mitochondria function
1193738|NCT02061111|TPO-antibodies|tpo-antibodies
1193739|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
1193740|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
1193741|NCT02061111|Children´s Development|children´s development
1193742|NCT02061098|Pomegranate|pomegranate
1193743|NCT02061098|Cardiovascular|cardiovascular
1193744|NCT02061098|Urolithins|urolithins
1193746|NCT02061098|Polyphenols|polyphenols
1193747|NCT02061098|Nutraceutical|nutraceutical
1193748|NCT02061098|Dietary supplement|dietary supplement
1193749|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
1193750|NCT02061085|Receptor,HER-2|receptor,her-2
1193751|NCT02061085|Eribulin|eribulin
1193752|NCT02061085|Furans, quetones|furans, quetones
1193753|NCT02061085|Antimitotic agent|antimitotic agent
1193754|NCT02061072|pharmacokinetics|pharmacokinetics
1193755|NCT02061072|population pharmacokinetics|population pharmacokinetics
1193756|NCT02061072|hemophilia|hemophilia
1193757|NCT02061072|factor VIII|factor viii
1193758|NCT02061072|factor IX|factor ix
1193759|NCT02061046|Gait|gait
1193760|NCT02061046|Dual task|dual task
1193761|NCT02061033|Hemophilia A|hemophilia a
1193762|NCT02061033|Hemophilia B|hemophilia b
1193763|NCT02061033|Von Willebrand's Disease|von willebrand's disease
1193764|NCT02061033|Endogen thrombin potential|endogen thrombin potential
1193765|NCT02061033|Overall hemostatic potential|overall hemostatic potential
1193766|NCT02061033|Microparticles|microparticles
1193767|NCT02061033|Fibrin clot|fibrin clot
1193768|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
1193769|NCT02061007|skin cancer|skin cancer
1193770|NCT02060981|Randomized controlled trial|randomized controlled trial
1193771|NCT02060981|Primary medication adherence|primary medication adherence
1193772|NCT02060981|Decision-support tool|decision-support tool
1193773|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
1193774|NCT02060981|Antihypertensive medications|antihypertensive medications
1193775|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
1193776|NCT02060968|Promus PREMIER|promus premier
1193777|NCT02060968|Routine Clinical Practice|routine clinical practice
1193778|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
1193779|NCT02060955|Immunotherapy|immunotherapy
1193780|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
1193781|NCT02060955|ALECSAT|alecsat
1193782|NCT02060955|recurrent|recurrent
1193783|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
1193784|NCT02060929|Healthy|healthy
1193785|NCT02060929|Esketamine|esketamine
1193786|NCT02060929|Intranasal|intranasal
1193787|NCT02060929|Nasal Guide|nasal guide
1193788|NCT02060929|Pharmacokinetics|pharmacokinetics
1193789|NCT02060903|Head Lice|head lice
1193790|NCT02060903|Hatchtech|hatchtech
1193791|NCT02060890|Glioblastoma|glioblastoma
1193792|NCT02060877|suspected lung cancer|suspected lung cancer
1193793|NCT02060877|diagnostic work-up|diagnostic work-up
1193794|NCT02060864|enzyme|enzyme
1193795|NCT02060864|gluten|gluten
1193796|NCT02060864|food intolerance|food intolerance
1193797|NCT02060851|EPO|epo
1193798|NCT02060851|Intravenous iron|intravenous iron
1193799|NCT02060851|iron storage|iron storage
1193800|NCT02060851|preterm anemia|preterm anemia
1193801|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
1193802|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1193803|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
1193804|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
1193805|NCT02060799|Dyspnea|dyspnea
1193806|NCT02060799|Emergency Service, Hospital|emergency service, hospital
1193807|NCT02060799|prognosis|prognosis
1193808|NCT02060799|Fatal Outcome|fatal outcome
1193809|NCT02060799|Epidemiology|epidemiology
1193810|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
1193811|NCT02060773|Septic shock|septic shock
1193812|NCT02060773|Early goal directed therapy|early goal directed therapy
1193813|NCT02060773|Fluid resuscitation|fluid resuscitation
1193814|NCT02060773|Hepatic perfusion|hepatic perfusion
1193818|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
1193820|NCT02060760|Renal Function|renal function
1193821|NCT02060734|Whiplash,|whiplash,
1193822|NCT02060734|injection,|injection,
1193823|NCT02060734|lidocaine,|lidocaine,
1193824|NCT02060734|sham needling|sham needling
1193825|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1193826|NCT02060695|Parkinson disease|parkinson disease
1193827|NCT02060682|Fractional Flow Reserve|fractional flow reserve
1193828|NCT02060682|Rapid Exchange|rapid exchange
1193829|NCT02060682|Catheter|catheter
1193830|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
1193831|NCT02060630|Surgical revascularization|surgical revascularization
1193832|NCT02060630|Endovascular revascularization|endovascular revascularization
1193833|NCT02060630|Amputation|amputation
1193834|NCT02060630|Peripheral artery disease|peripheral artery disease
1193835|NCT02060630|Critical limb ischemia|critical limb ischemia
1193836|NCT02060630|claudication|claudication
1193837|NCT02060630|leg pain|leg pain
1193838|NCT02060630|leg ulcer|leg ulcer
1193839|NCT02060630|gangrene|gangrene
1193840|NCT02060617|low back pain|low back pain
1193841|NCT02060617|physical therapy|physical therapy
1193842|NCT02060617|manual therapy|manual therapy
1193843|NCT02060617|manipulation|manipulation
1193844|NCT02060617|exercise|exercise
1193845|NCT02060617|motor control|motor control
1193846|NCT02060617|regional interdependence|regional interdependence
1193847|NCT02060604|ketorolac|ketorolac
1193848|NCT02060604|NSAIDs|nsaids
1193849|NCT02060604|wet macular degeneration|wet macular degeneration
1193850|NCT02060604|choroidal neovascularization|choroidal neovascularization
1193851|NCT02060578|Cancer palliative care|cancer palliative care
1193852|NCT02060578|Dead child|dead child
1193853|NCT02060565|diagnosis|diagnosis
1193854|NCT02060565|survival|survival
1193855|NCT02060565|non-invasive method|non-invasive method
1193856|NCT02060565|cirrhosis|cirrhosis
1193857|NCT02060565|FibroScan|fibroscan
1193858|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
1193859|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
1193860|NCT02060526|Hunter's Syndrome|hunter's syndrome
1193861|NCT02060526|Shire HGT|shire hgt
1193862|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
1193863|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
1193864|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
1193865|NCT02060513|Wounded warriors|wounded warriors
1193866|NCT02060513|Battlefield infection|battlefield infection
1193867|NCT02060513|Acinetobacter|acinetobacter
1193868|NCT02060513|ESBL|esbl
1193869|NCT02060513|MRSA|mrsa
1193871|NCT02060500|GERD|gerd
1193872|NCT02060500|fundoplication|fundoplication
1193873|NCT02060500|cardiaplication|cardiaplication
1193874|NCT02060500|reflux|reflux
1193880|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
1193881|NCT02060474|MCT8|mct8
1193882|NCT02060474|Triac|triac
1193883|NCT02060474|Therapeutic Trial|therapeutic trial
1193884|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
1193885|NCT02060448|Self-injurious behavior|self-injurious behavior
1193886|NCT02060448|NSSI|nssi
1193887|NCT02060448|Anxiety|anxiety
1193888|NCT02060448|Depression|depression
1193889|NCT02060448|Transdiagnostic|transdiagnostic
1193890|NCT02060448|CBT|cbt
1193891|NCT02060448|Unified Protocol|unified protocol
1193892|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1193893|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
1193894|NCT02060422|Epilepsy|epilepsy
1193895|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
1193896|NCT02060422|Seizure|seizure
1193897|NCT02060422|Mindfulness|mindfulness
1193898|NCT02060422|Stress|stress
1193899|NCT02060422|Psychotherapy|psychotherapy
1193900|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
1193901|NCT02060409|decitabine|decitabine
1193902|NCT02060409|spliceosome mutation|spliceosome mutation
1193903|NCT02060383|Cushing's disease|cushing's disease
1193904|NCT02060383|acromegaly|acromegaly
1193905|NCT02060383|pasireotide|pasireotide
1193906|NCT02060383|hyperglycemia|hyperglycemia
1193907|NCT02060370|Genitourinary Cancer|genitourinary cancer
1193908|NCT02060370|Kidney Cancer|kidney cancer
1193909|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1193910|NCT02060370|mRCC|mrcc
1193911|NCT02060370|Sunitinib|sunitinib
1193912|NCT02060370|Sunitinib malate|sunitinib malate
1193913|NCT02060370|SUO11248|suo11248
1193914|NCT02060370|Sutent|sutent
1193915|NCT02060370|Questionnaire|questionnaire
1193916|NCT02060370|Survey|survey
1193917|NCT02060357|Diabetes Mellitus|diabetes mellitus
1193918|NCT02060357|PCI|pci
1193919|NCT02060357|Drug eluting stent|drug eluting stent
1193920|NCT02060357|OCT|oct
1193921|NCT02060344|Cardiovascular Disease|cardiovascular disease
1193922|NCT02060344|Hispanic|hispanic
1193923|NCT02060344|Latinos|latinos
1193924|NCT02060331|Nocturia|nocturia
1193925|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
1193926|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
1193927|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
1193928|NCT02060318|Crohn Disease|crohn disease
1193929|NCT02060318|Regulatory T-cells|regulatory t-cells
1193930|NCT02060318|Infliximab|infliximab
1193931|NCT02060292|COPD|copd
1193932|NCT02060292|Cognitive Function|cognitive function
1193933|NCT02060292|MRI Brain|mri brain
1193934|NCT02060292|Aortic Stiffness|aortic stiffness
1193935|NCT02060292|Cerebrovascular disease|cerebrovascular disease
1193936|NCT02060279|Obesity|obesity
1193937|NCT02060279|Diabetes Mellitus|diabetes mellitus
1193938|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1193939|NCT02060279|Prevention|prevention
1193940|NCT02060279|Behavioral research|behavioral research
1193941|NCT02060279|Metabolic Syndrome|metabolic syndrome
1193942|NCT02060279|Metabolic Disease|metabolic disease
1193943|NCT02060279|Overnutrition|overnutrition
1193944|NCT02060279|Nutrition Disorders|nutrition disorders
1193945|NCT02060279|Overweight|overweight
1193946|NCT02060279|Body weight|body weight
1193947|NCT02060279|Insulin resistance|insulin resistance
1193948|NCT02060279|Carotenoids|carotenoids
1193949|NCT02060279|Dietary Supplement|dietary supplement
1193950|NCT02060279|Physical fitness|physical fitness
1193951|NCT02060279|Sedentary lifestyle|sedentary lifestyle
1193952|NCT02060240|Obesity|obesity
1193953|NCT02060240|Prediabetic State|prediabetic state
1193954|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
1193955|NCT02060240|Insulin Resistance|insulin resistance
1193956|NCT02060240|Endothelium|endothelium
1193957|NCT02060240|Eicosanoids|eicosanoids
1193958|NCT02060240|Nitric Oxide|nitric oxide
1193959|NCT02060240|Regional Blood Flow|regional blood flow
1193960|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
1193961|NCT02060162|antiretroviral therapy|antiretroviral therapy
1193962|NCT02060162|Hepatitis C virus|hepatitis c virus
1193963|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
1193964|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
1193965|NCT02060123|Qigong|qigong
1193966|NCT02060123|Telomerase|telomerase
1193967|NCT02060123|Perceived stress|perceived stress
1193968|NCT02060123|RCT|rct
1193969|NCT02060123|Chinese|chinese
1193970|NCT02060123|Abused women|abused women
1193971|NCT02060123|intervention|intervention
1193972|NCT02060123|Depression|depression
1193973|NCT02060110|CRT|crt
1193974|NCT02060110|HEART FAILURE|heart failure
1193975|NCT02060097|Anti-aging|anti-aging
1193976|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
1193977|NCT02060084|preterm;|preterm;
1193978|NCT02060084|Intestinal flora;|intestinal flora;
1193979|NCT02060084|early Micro-feeding|early micro-feeding
1193980|NCT02060084|Feeding intolerance|feeding intolerance
1193981|NCT02060071|aortic stenosis|aortic stenosis
1193982|NCT02060058|hepatitis C virus|hepatitis c virus
1193983|NCT02060058|hepatitis B virus|hepatitis b virus
1193984|NCT02060058|boceprevir|boceprevir
1193985|NCT02060058|null responder|null responder
1193986|NCT02060058|partial responder|partial responder
1193987|NCT02060058|relapser|relapser
1193988|NCT02060045|bundle|bundle
1193989|NCT02060045|prevention|prevention
1193990|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
1193991|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
1193992|NCT02060019|Pharmacokinetics|pharmacokinetics
1193993|NCT02060019|Pharmacodynamics|pharmacodynamics
1193994|NCT02060019|Safety|safety
1193995|NCT02060019|Tolerability|tolerability
1193996|NCT02060006|TB|tb
1193997|NCT02060006|IRIS|iris
1193998|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
1193999|NCT02059993|hypertension|hypertension
1194000|NCT02059993|coronary heart disease|coronary heart disease
1194001|NCT02059993|metabolic disorder|metabolic disorder
1194002|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
1194003|NCT02059980|OCD|ocd
1194004|NCT02059980|Trichotillomania|trichotillomania
1194005|NCT02059980|Response inhibition|response inhibition
1194006|NCT02059980|Cognitive training|cognitive training
1194007|NCT02059967|Lung|lung
1194008|NCT02059954|Hysterectomy|hysterectomy
1194009|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
1194010|NCT02059928|fluid resuscitation|fluid resuscitation
1194011|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
1194012|NCT02059915|pharmacokinetics|pharmacokinetics
1194013|NCT02059915|bioequivalence|bioequivalence
1194014|NCT02059915|bioavailability|bioavailability
1194015|NCT02059915|oxycodone|oxycodone
1194016|NCT02059902|Pain management|pain management
1194017|NCT02059902|Narcotic consumption|narcotic consumption
1194018|NCT02059902|Skin graft|skin graft
1194019|NCT02059889|Lung|lung
1194020|NCT02059876|breast cancer|breast cancer
1194021|NCT02059876|dose dense|dose dense
1194022|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
1194023|NCT02059876|pathologic complete response|pathologic complete response
1194024|NCT02059863|cluster randomised trial|cluster randomised trial
1194025|NCT02059863|low and middle income countries|low and middle income countries
1194026|NCT02059863|community based intervention|community based intervention
1194027|NCT02059863|complex intervention|complex intervention
1194028|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
1194029|NCT02059811|Kidney Diseases|kidney diseases
1194030|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
1194032|NCT02059811|DASH diet|dash diet
1194033|NCT02059811|Hypertension|hypertension
1194034|NCT02059811|Vascular diseases|vascular diseases
1194035|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
1194036|NCT02059811|Blood pressure|blood pressure
1194037|NCT02059798|Myelopathy|myelopathy
1194038|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
1194039|NCT02059785|Placebo|placebo
1194040|NCT02059785|mRS|mrs
1194041|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
1194042|NCT02059746|cesarean section|cesarean section
1194043|NCT02059746|vaginal birth|vaginal birth
1194044|NCT02059746|twins|twins
1194045|NCT02059746|urinary incontinence|urinary incontinence
1194046|NCT02059746|sexuality|sexuality
1194047|NCT02059746|quality of life|quality of life
1194048|NCT02059733|18F-DTBZ|18f-dtbz
1194049|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
1194050|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1194051|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1194052|NCT02059720|maintenance treatment|maintenance treatment
1194053|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1194054|NCT02059694|Eyelid surgery|eyelid surgery
1194055|NCT02059694|local block/anesthesia|local block/anesthesia
1194056|NCT02059694|hyaluronidase|hyaluronidase
1194057|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
1194058|NCT02059694|Duke Eye Centre|duke eye centre
1194059|NCT02059694|Duke Aesthetic Center|duke aesthetic center
1194060|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
1194061|NCT02059668|biomarkers|biomarkers
1194062|NCT02059668|definitive treatment|definitive treatment
1194063|NCT02059668|adjuvant treatment|adjuvant treatment
1194064|NCT02059668|radiochemotherapy|radiochemotherapy
1194065|NCT02059655|Graves' disease|graves' disease
1194066|NCT02059629|Heart failure|heart failure
1194067|NCT02059629|Eluna pacemaker family|eluna pacemaker family
1194068|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
1194069|NCT02059629|Bradycardia|bradycardia
1194070|NCT02059629|SADE-free rate|sade-free rate
1194071|NCT02059603|Electroacupuncture|electroacupuncture
1194072|NCT02059603|Fast track program|fast track program
1194073|NCT02059603|Postoperative ileus|postoperative ileus
1194074|NCT02059603|Laparoscopic surgery|laparoscopic surgery
1194075|NCT02059603|Colorectal surgery|colorectal surgery
1194076|NCT02059603|Randomized controlled trial|randomized controlled trial
1194077|NCT02059603|Hospital stay|hospital stay
1194078|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
1194079|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
1194080|NCT02059590|Healthy Subjects|healthy subjects
1194081|NCT02059590|BAL8728|bal8728
1194082|NCT02059590|BAL4815|bal4815
1194083|NCT02059577|vitamins|vitamins
1194084|NCT02059577|minerals|minerals
1194085|NCT02059577|essential fatty acids|essential fatty acids
1194086|NCT02059577|Epsom salts|epsom salts
1194087|NCT02059577|carnitine|carnitine
1194088|NCT02059577|digestive enzymes|digestive enzymes
1194089|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
1194090|NCT02059564|Diabetes Mellitus|diabetes mellitus
1194091|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1194092|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
1194093|NCT02059564|Metabolic Diseases|metabolic diseases
1194094|NCT02059564|Endocrine System Diseases|endocrine system diseases
1194095|NCT02059564|Exendin-4|exendin-4
1194096|NCT02059551|pulmonary embolism|pulmonary embolism
1194097|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
1194098|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
1194099|NCT02059551|diagnostic performances|diagnostic performances
1194100|NCT02059538|Obesity|obesity
1194101|NCT02059538|Type 2 diabetes|type 2 diabetes
1194102|NCT02059538|Coronary artery diseases|coronary artery diseases
1194103|NCT02059538|Microbiota|microbiota
1194104|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
1194105|NCT02059525|observational|observational
1194106|NCT02059525|Belgium|belgium
1194107|NCT02059512|ischemic heart disease,|ischemic heart disease,
1268466|NCT01722500|ISCOLE|iscole
1194306|NCT02058589|Adults|adults
1194108|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
1194109|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
1194110|NCT02059460|Terlipressin|terlipressin
1194111|NCT02059460|Acute kidney injury|acute kidney injury
1194112|NCT02059460|Liver transplantation|liver transplantation
1194113|NCT02059460|NGAL|ngal
1194114|NCT02059447|Controlled trial|controlled trial
1194115|NCT02059447|Active control|active control
1194116|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
1194117|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1194118|NCT02059447|Relaxation Therapy|relaxation therapy
1194119|NCT02059421|Johrei therapy|johrei therapy
1194120|NCT02059421|Sleep|sleep
1194121|NCT02059421|CBT-I|cbt-i
1194122|NCT02059421|Critical illness|critical illness
1194123|NCT02059382|daily physical activity|daily physical activity
1194124|NCT02059382|exercise|exercise
1194125|NCT02059382|social support|social support
1194126|NCT02059382|online social network|online social network
1194127|NCT02059369|Atrial fibrillation|atrial fibrillation
1194128|NCT02059369|Recurrence|recurrence
1194129|NCT02059369|CFAE|cfae
1194130|NCT02059369|linear ablation|linear ablation
1194131|NCT02059356|Dementia|dementia
1194132|NCT02059356|Alzheimer's|alzheimer's
1194133|NCT02059356|Alzheimers|alzheimers
1194134|NCT02059356|Cognitive decline|cognitive decline
1194135|NCT02059356|Cognitive impairment|cognitive impairment
1194136|NCT02059356|Memory loss|memory loss
1194137|NCT02059356|Memory disorder|memory disorder
1194138|NCT02059356|Forgetfulness|forgetfulness
1194139|NCT02059356|Confusion|confusion
1194140|NCT02059356|Senile|senile
1194141|NCT02059356|Demented|demented
1194142|NCT02059356|Developmental delay|developmental delay
1194143|NCT02059356|Portal systemic shunting|portal systemic shunting
1194144|NCT02059356|High ammonia level|high ammonia level
1194145|NCT02059356|Elevated ammonia level|elevated ammonia level
1194146|NCT02059343|pharmacokinetics|pharmacokinetics
1194147|NCT02059343|pharmacodynamics|pharmacodynamics
1194148|NCT02059343|safety|safety
1194149|NCT02059343|dexmedetomidine|dexmedetomidine
1194150|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
1194151|NCT02059343|children|children
1194152|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
1194153|NCT02059330|dose-proportionality study|dose-proportionality study
1194154|NCT02059330|Palbociclib|palbociclib
1194155|NCT02059330|PD-0332991|pd-0332991
1194156|NCT02059330|healthy volunteers|healthy volunteers
1194157|NCT02059304|cervical length|cervical length
1194158|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
1194159|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
1194160|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
1194161|NCT02059278|Ocular hypertension|ocular hypertension
1194162|NCT02059239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1194163|NCT02059239|Hodgkin's Lymphoma|hodgkin's lymphoma
1194164|NCT02059239|Lymphoma|lymphoma
1194165|NCT02059239|Transplant|transplant
1194166|NCT02059200|Randomised controlled trial|randomised controlled trial
1194167|NCT02059200|Recurrent depression|recurrent depression
1194168|NCT02059200|Mindfulness training|mindfulness training
1194169|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
1194170|NCT02059200|Fear of Compassion|fear of compassion
1194171|NCT02059200|Added value Compassion|added value compassion
1194172|NCT02059135|Preeclampsia|preeclampsia
1194173|NCT02059135|Preterm preeclampsia|preterm preeclampsia
1194174|NCT02059135|Pregnancy|pregnancy
1194175|NCT02059109|Belmont|belmont
1194176|NCT02059109|Rapid|rapid
1194177|NCT02059109|Infuser|infuser
1194178|NCT02059109|proficiency|proficiency
1194179|NCT02059109|proficient|proficient
1194180|NCT02059109|training|training
1194181|NCT02059096|Multiple Sclerosis|multiple sclerosis
1194182|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1194183|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
1194184|NCT02059096|Cortical excitability|cortical excitability
1194185|NCT02059083|adolescent|adolescent
1194186|NCT02059083|cannabis|cannabis
1194187|NCT02059083|biofeedback|biofeedback
1194188|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
1194189|NCT02059070|Phrenic Nerve|phrenic nerve
1194190|NCT02059070|Respiratory function|respiratory function
1194191|NCT02059070|Pain measurement|pain measurement
1194192|NCT02059044|patient safety|patient safety
1194193|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
1194194|NCT02059044|health services research|health services research
1194195|NCT02059044|adherence|adherence
1194196|NCT02059044|information technology|information technology
1194197|NCT02059031|integrase inhibitor|integrase inhibitor
1194198|NCT02059031|pharmacokinetics|pharmacokinetics
1194200|NCT02059031|relative bioavailability|relative bioavailability
1194201|NCT02059031|food|food
1194202|NCT02059031|GSK1265744|gsk1265744
1194203|NCT02059005|Addiction|addiction
1194204|NCT02059005|Substance Use Disorder|substance use disorder
1194205|NCT02059005|Rehospitalization|rehospitalization
1194206|NCT02059005|Community Disease Management|community disease management
1194207|NCT02059005|Behavioral Health|behavioral health
1194208|NCT02059005|Community Health Worker|community health worker
1194209|NCT02058992|Drug therapy|drug therapy
1194210|NCT02058966|Entacapone|entacapone
1194211|NCT02058966|COMT val158met|comt val158met
1194212|NCT02058966|Methamphetamine|methamphetamine
1194213|NCT02058953|Melanoma|melanoma
1194214|NCT02058953|skin cancer|skin cancer
1194215|NCT02058953|brain metastases|brain metastases
1194216|NCT02058953|craniotomy|craniotomy
1194218|NCT02058927|ART|art
1194219|NCT02058927|children|children
1194220|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
1194221|NCT02058914|metabolism|metabolism
1194222|NCT02058914|endocrine|endocrine
1194223|NCT02058914|lipids|lipids
1194224|NCT02058914|blood glucose|blood glucose
1194225|NCT02058901|sunitinib|sunitinib
1194226|NCT02058901|solid tumors|solid tumors
1194227|NCT02058888|metagenomics|metagenomics
1194228|NCT02058888|antimicrobial resistance|antimicrobial resistance
1194229|NCT02058888|multidrug resistance|multidrug resistance
1194230|NCT02058849|Mucositis|mucositis
1194231|NCT02058849|Beetroot|beetroot
1194232|NCT02058849|Head and neck cancer|head and neck cancer
1194233|NCT02058836|Chronic testicular pain|chronic testicular pain
1194234|NCT02058836|Orchialgia|orchialgia
1194235|NCT02058836|Botulinum toxin|botulinum toxin
1194236|NCT02058836|Botox|botox
1194237|NCT02058836|Urology|urology
1194238|NCT02058823|Hypoxia|hypoxia
1194239|NCT02058823|Sleep apnea|sleep apnea
1194240|NCT02058823|Valsartan|valsartan
1194241|NCT02058823|Amlodipine|amlodipine
1194242|NCT02058823|Healthy subjects|healthy subjects
1194243|NCT02058823|Randomized|randomized
1194244|NCT02058823|Cross-over|cross-over
1194245|NCT02058823|International|international
1194532|NCT02057419|adherence|adherence
1194246|NCT02058823|Sympathetic nervous system|sympathetic nervous system
1194247|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
1194248|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
1194249|NCT02058810|heartfailure|heartfailure
1194250|NCT02058797|Procrastination|procrastination
1194251|NCT02058797|Coherence Therapy|coherence therapy
1194252|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
1194253|NCT02058797|Repertory Grid Technique|repertory grid technique
1194254|NCT02058797|Cognitive Conflicts|cognitive conflicts
1194255|NCT02058797|Personal Dilemmas|personal dilemmas
1194256|NCT02058771|Action potential duration restitution|action potential duration restitution
1194257|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
1194258|NCT02058771|Sudden cardiac death|sudden cardiac death
1194259|NCT02058771|Body-surface potential mapping|body-surface potential mapping
1194260|NCT02058771|Electrocardiogram|electrocardiogram
1194261|NCT02058758|Breast cancer|breast cancer
1194262|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1194263|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
1194264|NCT02058745|Neuro-oncology|neuro-oncology
1194265|NCT02058745|Caregivers|caregivers
1194266|NCT02058745|Intervention Research|intervention research
1194267|NCT02058745|Representational Approach|representational approach
1194268|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
1194269|NCT02058745|Family|family
1194270|NCT02058745|Internet|internet
1194271|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
1194272|NCT02058667|Breast Cancer|breast cancer
1194273|NCT02058667|Paclitaxel|paclitaxel
1194274|NCT02058667|Helical Tomotherapy|helical tomotherapy
1194275|NCT02058667|Chest wall|chest wall
1194276|NCT02058654|Creatine|creatine
1194277|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1194278|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
1194279|NCT02058641|cellular accumulation|cellular accumulation
1194280|NCT02058641|macrophage phenotype|macrophage phenotype
1194281|NCT02058641|cantharidin blister|cantharidin blister
1194282|NCT02058641|M1/M2|m1/m2
1194283|NCT02058641|inflammatory mediators|inflammatory mediators
1194284|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
1194285|NCT02058641|darapladib|darapladib
1194286|NCT02058641|cytokines|cytokines
1194287|NCT02058628|azelaic acid|azelaic acid
1194288|NCT02058628|Clindamycin|clindamycin
1194289|NCT02058628|Benzoyl peroxide|benzoyl peroxide
1194290|NCT02058628|Acne vulgaris|acne vulgaris
1194291|NCT02058615|Male caregivers|male caregivers
1194292|NCT02058615|Breast cancer|breast cancer
1194293|NCT02058615|Intervention|intervention
1194294|NCT02058615|Online toolkit|online toolkit
1194295|NCT02058602|HRCT|hrct
1194296|NCT02058602|Airway morphometry|airway morphometry
1194297|NCT02058602|Resistivity|resistivity
1194298|NCT02058602|Inhalation Profiles|inhalation profiles
1194299|NCT02058602|Inhaler|inhaler
1194300|NCT02058602|Pharyngometry|pharyngometry
1333144|NCT01444378|Claudication|claudication
1194301|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
1194302|NCT02058589|Immunocompromised|immunocompromised
1194303|NCT02058589|Safety|safety
1194304|NCT02058589|≥ 18 years of age|≥ 18 years of age
1194305|NCT02058589|Renal transplant|renal transplant
1194307|NCT02058589|Immunosuppressed|immunosuppressed
1194308|NCT02058589|Immunogenicity|immunogenicity
1194309|NCT02058589|Herpes zoster|herpes zoster
1194310|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
1194311|NCT02058576|Tamsulosin|tamsulosin
1194312|NCT02058576|healthy subject|healthy subject
1194313|NCT02058576|bioequivalence|bioequivalence
1194314|NCT02058576|GI198745|gi198745
1194315|NCT02058576|dutasteride|dutasteride
1194316|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
1194317|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
1194319|NCT02058563|Immunogenicity|immunogenicity
1194320|NCT02058524|Ulcerative Colitis|ulcerative colitis
1194321|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
1194322|NCT02058498|Liver transplant|liver transplant
1194323|NCT02058498|Physical Activity|physical activity
1194324|NCT02058498|Quality of Life|quality of life
1194325|NCT02058485|hypertension|hypertension
1194326|NCT02058485|dexmedetomidine|dexmedetomidine
1194327|NCT02058485|midazolam|midazolam
1194328|NCT02058485|premedication|premedication
1194329|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
1194330|NCT02058433|Chemotherapy|chemotherapy
1194331|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
1194332|NCT02058433|pharmacokinetics|pharmacokinetics
1194333|NCT02058420|bone health|bone health
1194334|NCT02058407|food effect|food effect
1194335|NCT02058407|pharmacokinetics|pharmacokinetics
1194336|NCT02058407|GSK2793660|gsk2793660
1194337|NCT02058407|FTIH|ftih
1194338|NCT02058407|pharmacodynamics|pharmacodynamics
1194339|NCT02058407|safety|safety
1194340|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
1194341|NCT02058394|Phacoemulsification|phacoemulsification
1194342|NCT02058394|Cataract Surgery|cataract surgery
1194343|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1194344|NCT02058368|Quality of Life|quality of life
1194345|NCT02058342|Prader Willi syndrome|prader willi syndrome
1194346|NCT02058342|Obesity|obesity
1194347|NCT02058342|Childhood|childhood
1194348|NCT02058342|Family|family
1194349|NCT02058342|Interactive games|interactive games
1194350|NCT02058342|Playground games|playground games
1194351|NCT02058342|Exercise routine|exercise routine
1194352|NCT02058329|Hip fracture|hip fracture
1194353|NCT02058329|postoperative complications|postoperative complications
1194354|NCT02058329|Depression|depression
1194355|NCT02058329|Environmental Hazards|environmental hazards
1194356|NCT02058329|FIM scores|fim scores
1194357|NCT02058329|Falls|falls
1194358|NCT02058303|hand surgery|hand surgery
1194359|NCT02058303|wrist surgery|wrist surgery
1194360|NCT02058303|finger surgery|finger surgery
1194361|NCT02058303|anesthesia|anesthesia
1194362|NCT02058303|regional anesthesia|regional anesthesia
1194363|NCT02058303|postoperative pain|postoperative pain
1194364|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
1194365|NCT02058277|bosutinib|bosutinib
1194366|NCT02058277|aprepitant|aprepitant
1194367|NCT02058277|drug interaction|drug interaction
1194368|NCT02058277|healthy volunteers|healthy volunteers
1194369|NCT02058277|pharmacokinetics|pharmacokinetics
1194370|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
1194371|NCT02058251|Alcohol|alcohol
1194372|NCT02058251|Oxytocin|oxytocin
1194373|NCT02058251|Stress reactivity|stress reactivity
1194374|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
1194375|NCT02058238|Scoliosis|scoliosis
1194376|NCT02058238|Kyphoscoliosis|kyphoscoliosis
1194377|NCT02058238|Spinal deformity|spinal deformity
1194378|NCT02058238|Spondylosis|spondylosis
1194379|NCT02058225|Infant Nutrition|infant nutrition
1194380|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1194381|NCT02058225|Infant Brain Development|infant brain development
1194382|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
1194383|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
1194384|NCT02058212|ICSI|icsi
1194385|NCT02058212|antioxidants|antioxidants
1194386|NCT02058212|ROS|ros
1194387|NCT02058212|endometriosis|endometriosis
1194388|NCT02058199|gastric bypass|gastric bypass
1194389|NCT02058199|rivaroxaban|rivaroxaban
1194390|NCT02058199|pharmacodynamics|pharmacodynamics
1194391|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
1194392|NCT02058121|Eating disorders|eating disorders
1194393|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
1194394|NCT02058121|Body image|body image
1333256|NCT01443806|Carboxylesterase 1|carboxylesterase 1
1194395|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
1194396|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
1194397|NCT02058082|DNA Damage|dna damage
1194398|NCT02058056|Early prophylactic|early prophylactic
1194399|NCT02058056|cranial irradiation|cranial irradiation
1194400|NCT02058056|hippocampal avoidance|hippocampal avoidance
1194401|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
1194402|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
1194403|NCT02058030|Insertion success|insertion success
1194404|NCT02058030|complication|complication
1194405|NCT02058004|Microaspiration|microaspiration
1194406|NCT02058004|ARDS|ards
1194407|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
1194408|NCT02058004|Cricoid pressure|cricoid pressure
1194409|NCT02057978|Late Lumen Loss|late lumen loss
1194410|NCT02057978|MACE|mace
1194411|NCT02057978|Death|death
1194412|NCT02057978|TLF|tlf
1194413|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
1194414|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
1194415|NCT02057965|Allograft rejection|allograft rejection
1194416|NCT02057965|Fibrosis|fibrosis
1194417|NCT02057952|Weight Management|weight management
1194418|NCT02057952|Diabetes|diabetes
1194419|NCT02057952|Exercise|exercise
1194420|NCT02057952|Portion Control|portion control
1194421|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
1194422|NCT02057939|Prostate cancer|prostate cancer
1194423|NCT02057939|enzalutamide|enzalutamide
1194424|NCT02057939|ADT|adt
1194425|NCT02057939|radiation|radiation
1194426|NCT02057926|Membrane degradation|membrane degradation
1194427|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
1194428|NCT02057913|Penile neoplasms|penile neoplasms
1194429|NCT02057913|Chemotherapy|chemotherapy
1194430|NCT02057913|Vinflunine|vinflunine
1194431|NCT02057913|Phase II|phase ii
1194432|NCT02057900|Postinfarction heart failure|postinfarction heart failure
1194433|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
1194729|NCT02056691|cancer|cancer
1194434|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
1194435|NCT02057900|Fibrin hydrogel|fibrin hydrogel
1194436|NCT02057861|diabetes mellitus|diabetes mellitus
1194437|NCT02057861|neuromuscular blockade|neuromuscular blockade
1194438|NCT02057861|sugammadex|sugammadex
1194439|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
1194440|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
1194441|NCT02057822|Cytokines|cytokines
1194442|NCT02057822|Mediators|mediators
1194443|NCT02057822|Tears|tears
1194444|NCT02057809|Developmental Disabilities|developmental disabilities
1194445|NCT02057809|Family-centered services|family-centered services
1194446|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
1194447|NCT02057796|HIV-1|hiv-1
1194448|NCT02057796|Tuberculosis|tuberculosis
1194449|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
1194450|NCT02057796|ART|art
1194451|NCT02057796|TB diagnosis|tb diagnosis
1194452|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
1194453|NCT02057796|Urine LAM|urine lam
1194454|NCT02057744|Robotic-guided surgery|robotic-guided surgery
1194455|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
1194456|NCT02057744|Spinal fusion|spinal fusion
1194457|NCT02057744|Pedicle screws|pedicle screws
1194458|NCT02057718|Bile duct diseases|bile duct diseases
1194459|NCT02057718|Intrahepatic Cholestasis|intrahepatic cholestasis
1194460|NCT02057718|Cholestasis|cholestasis
1194461|NCT02057718|PFIC|pfic
1194462|NCT02057718|Pruritus|pruritus
1194463|NCT02057718|Cholestatic Liver Disease|cholestatic liver disease
1194464|NCT02057705|MTM|mtm
1194465|NCT02057705|myotubular myopathy|myotubular myopathy
1194466|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
1194467|NCT02057705|inherited myopathies|inherited myopathies
1194468|NCT02057705|neuromuscular diseases|neuromuscular diseases
1194469|NCT02057705|hypotonia|hypotonia
1194470|NCT02057705|genetic mutation|genetic mutation
1194471|NCT02057679|Acute cholecystitis.|acute cholecystitis.
1194472|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
1194473|NCT02057653|Goal-directed fluid management|goal-directed fluid management
1194474|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
1194475|NCT02057601|Fractured neck of femur|fractured neck of femur
1194476|NCT02057601|Postoperative pain|postoperative pain
1194477|NCT02057588|ablation|ablation
1194478|NCT02057575|Open Angle Glaucoma|open angle glaucoma
1194479|NCT02057575|Ocular Hypertension|ocular hypertension
1194480|NCT02057575|Intraocular Pressure|intraocular pressure
1194481|NCT02057575|AR13324|ar13324
1194482|NCT02057575|PG324|pg324
1194483|NCT02057562|Adenoma|adenoma
1194484|NCT02057562|Diverticular disease|diverticular disease
1194485|NCT02057562|Diverticulosis|diverticulosis
1194486|NCT02057562|Colorectal carcinoma|colorectal carcinoma
1194487|NCT02057562|Polyp|polyp
1333257|NCT01443780|Selenium|selenium
1194488|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
1194489|NCT02057510|Head and Neck Cancer|head and neck cancer
1194490|NCT02057510|Radiation Therapy|radiation therapy
1194491|NCT02057484|long-term follow-up|long-term follow-up
1194492|NCT02057484|liver transplant|liver transplant
1194493|NCT02057484|kidney transplant|kidney transplant
1194494|NCT02057484|Advagraf|advagraf
1194495|NCT02057484|Tacrolimus|tacrolimus
1194799|NCT02056483|anxiety|anxiety
1194496|NCT02057471|Adenocarcinoma|adenocarcinoma
1194497|NCT02057471|Anemia|anemia
1194498|NCT02057471|Blood Transfusion|blood transfusion
1194499|NCT02057471|Colorectal surgery|colorectal surgery
1194500|NCT02057471|Preoperative care|preoperative care
1194501|NCT02057471|Perioperative care|perioperative care
1194502|NCT02057471|Postoperative care|postoperative care
1194503|NCT02057471|Iron|iron
1194504|NCT02057471|Hematinics|hematinics
1194505|NCT02057471|Hepcidin|hepcidin
1194506|NCT02057471|Quality of life|quality of life
1194507|NCT02057471|Postoperative complications|postoperative complications
1194508|NCT02057458|arterial stiffness|arterial stiffness
1194509|NCT02057458|flow-mediated dilation|flow-mediated dilation
1194510|NCT02057458|endothelial function|endothelial function
1194511|NCT02057458|pulse wave velocity|pulse wave velocity
1194512|NCT02057458|inflammation|inflammation
1194513|NCT02057458|oxidative stress|oxidative stress
1194514|NCT02057458|pulmonary function test|pulmonary function test
1194515|NCT02057458|Cystic Fibrosis|cystic fibrosis
1194516|NCT02057458|Lung Disease|lung disease
1194517|NCT02057458|Nitric Oxide|nitric oxide
1194518|NCT02057458|Exercise Capacity|exercise capacity
1194520|NCT02057458|Muscle Function|muscle function
1194521|NCT02057458|Sildenafil|sildenafil
1194522|NCT02057458|Viagra|viagra
1194523|NCT02057458|Revatio|revatio
1194524|NCT02057445|cellular therapy|cellular therapy
1194525|NCT02057445|lymphoma|lymphoma
1194526|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
1194527|NCT02057432|I-II Breast Cancer|i-ii breast cancer
1194528|NCT02057419|contraception|contraception
1194529|NCT02057419|contraceptive methods|contraceptive methods
1194530|NCT02057419|sexual lubricant|sexual lubricant
1194531|NCT02057419|user experience|user experience
1194533|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
1194534|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
1194535|NCT02057393|Melanoma|melanoma
1194536|NCT02057393|Sentinel node biopsy|sentinel node biopsy
1194537|NCT02057393|Indocyanine green|indocyanine green
1194538|NCT02057393|Real time lymphangiography|real time lymphangiography
1194539|NCT02057380|Paclitaxel|paclitaxel
1194540|NCT02057380|Linsitinib|linsitinib
1194541|NCT02057380|OSI-774|osi-774
1194542|NCT02057380|Advanced Solid Tumor|advanced solid tumor
1194543|NCT02057380|Tarceva|tarceva
1194544|NCT02057380|Erlotinib|erlotinib
1194545|NCT02057380|OSI-906|osi-906
1194546|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
1194547|NCT02057367|craniotomy|craniotomy
1194548|NCT02057354|Brain|brain
1194549|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1194550|NCT02057354|Brain Mapping|brain mapping
1194551|NCT02057354|Cognition|cognition
1194552|NCT02057354|Exercise|exercise
1194553|NCT02057354|Hippocampus|hippocampus
1194554|NCT02057354|Hydrocortisone|hydrocortisone
1194555|NCT02057354|Learning|learning
1194556|NCT02057354|Memory|memory
1194557|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
1194558|NCT02057354|Nerve Growth Factors|nerve growth factors
1194559|NCT02057354|Neuroimaging|neuroimaging
1194560|NCT02057354|Physical Endurance|physical endurance
1194561|NCT02057354|Physical Fitness|physical fitness
1194562|NCT02057354|Resistance Training|resistance training
1194563|NCT02057354|Walking|walking
1194564|NCT02057341|laminopathy|laminopathy
1194565|NCT02057315|Migraine headache|migraine headache
1194566|NCT02057315|Photophobia|photophobia
1194567|NCT02057315|Phonophobia|phonophobia
1194568|NCT02057315|Aura|aura
1194569|NCT02057315|Topical treatment|topical treatment
1194570|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
1194571|NCT02057289|pediatric|pediatric
1194572|NCT02057289|antifungal|antifungal
1194573|NCT02057289|bone marrow|bone marrow
1194574|NCT02057289|AML or relapsed ALL|aml or relapsed all
1194575|NCT02057263|Vaccine|vaccine
1194576|NCT02057263|Adjuvant|adjuvant
1194577|NCT02057263|Bisphosphonates|bisphosphonates
1194578|NCT02057263|Alendronate|alendronate
1194579|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
1194580|NCT02057224|Renal denervation|renal denervation
1194581|NCT02057224|Hypertension|hypertension
1194582|NCT02057224|Insulin resistance|insulin resistance
1194583|NCT02057224|Adipose tissue function|adipose tissue function
1194584|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
1194585|NCT02057185|work|work
1194586|NCT02057185|job|job
1194587|NCT02057172|glycaemic control|glycaemic control
1194588|NCT02057172|HM11260C|hm11260c
1194589|NCT02057172|placebo|placebo
1194590|NCT02057172|safety|safety
1194591|NCT02057172|tolerability|tolerability
1194592|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
1194593|NCT02057172|efficacy|efficacy
1194594|NCT02057172|T2DM|t2dm
1194595|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
1194596|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
1194597|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
1194598|NCT02057172|blood sugar levels|blood sugar levels
1194599|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
1194600|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
1194601|NCT02057159|SPMS|spms
1194602|NCT02057159|Multiple Sclerosis|multiple sclerosis
1194603|NCT02057159|NeuroVax|neurovax
1194605|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
1194606|NCT02057146|ERCP|ercp
1194607|NCT02057146|IPMN|ipmn
1194608|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
1194609|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
1194610|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
1194611|NCT02057081|Veterans Health|veterans health
1194612|NCT02057081|Veterans|veterans
1194613|NCT02057081|Spouses|spouses
1194614|NCT02057081|Couples|couples
1194615|NCT02057081|Psychotherapy, Group|psychotherapy, group
1194616|NCT02057081|Depression|depression
1194617|NCT02057081|Couples Therapy|couples therapy
1194618|NCT02057081|Family Therapy|family therapy
1194619|NCT02057081|PTSD|ptsd
1194620|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
1194621|NCT02057068|Caregivers|caregivers
1194622|NCT02057068|Telemedicine|telemedicine
1194623|NCT02057068|Sleep Disorders|sleep disorders
1194624|NCT02057068|Meditation|meditation
1194625|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
1194626|NCT02057068|Activity Enhancement|activity enhancement
1194627|NCT02057068|Technology|technology
1194628|NCT02057068|Non-pharmacological sleep intervention|non-pharmacological sleep intervention
1194629|NCT02057055|Antibacterial soaps|antibacterial soaps
1194630|NCT02057055|Microbiome|microbiome
1194631|NCT02057055|Commensal bacteria|commensal bacteria
1194632|NCT02057055|Pyrosequencing|pyrosequencing
1194633|NCT02057055|Innate immunity|innate immunity
1194634|NCT02057042|Peer Support|peer support
1194635|NCT02057042|cCBT|ccbt
1194636|NCT02057042|primary care|primary care
1194637|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
1194638|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
1194639|NCT02057029|Breast Cancer Index|breast cancer index
1194640|NCT02057003|HIV|hiv
1194641|NCT02057003|hepatitis C virus|hepatitis c virus
1194642|NCT02057003|sustained virologic response|sustained virologic response
1194643|NCT02057003|telaprevir|telaprevir
1194644|NCT02057003|boceprevir|boceprevir
1194645|NCT02057003|simeprevir|simeprevir
1194646|NCT02057003|sofosbuvir|sofosbuvir
1194647|NCT02057003|daclatasvir|daclatasvir
1194648|NCT02057003|paritaprevir|paritaprevir
1194649|NCT02057003|pegylated interferon|pegylated interferon
1194650|NCT02057003|ribavirin|ribavirin
1194651|NCT02057003|direct-acting antivirals|direct-acting antivirals
1194652|NCT02057003|dasabuvir|dasabuvir
1194653|NCT02057003|ombitasvir|ombitasvir
1194654|NCT02057003|ledipasvir|ledipasvir
1194655|NCT02057003|velpatasvir|velpatasvir
1194656|NCT02057003|grazoprevir|grazoprevir
1194657|NCT02057003|elbasvir|elbasvir
1194658|NCT02056990|Athletes|athletes
1194659|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1194660|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
1194661|NCT02056977|Mechanical Ventilation|mechanical ventilation
1194662|NCT02056977|Postoperative Complications|postoperative complications
1194663|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
1194664|NCT02056977|Lung Collapse|lung collapse
1194665|NCT02056977|Respiratory Failure|respiratory failure
1194666|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
1194667|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
1194668|NCT02056964|Chest Pain|chest pain
1194669|NCT02056964|Risk Stratification|risk stratification
1194670|NCT02056964|Clinical Decision Aid|clinical decision aid
1194671|NCT02056964|Emergency Department|emergency department
1194672|NCT02056964|Low Risk Chest Pain|low risk chest pain
1194673|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
1194674|NCT02056951|Rehabilitation|rehabilitation
1194675|NCT02056951|Treatment Outcome|treatment outcome
1194676|NCT02056951|Interprofessional Relations|interprofessional relations
1194677|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
1194678|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
1194679|NCT02056951|Cognitive Therapy|cognitive therapy
1194680|NCT02056951|Health Education|health education
1333258|NCT01443780|Q10|q10
1194681|NCT02056951|Workplace related information|workplace related information
1194682|NCT02056951|Multicenter Study|multicenter study
1194683|NCT02056938|Transplantation|transplantation
1194684|NCT02056938|kidney|kidney
1194685|NCT02056938|delayed graft function|delayed graft function
1194686|NCT02056938|induction therapy|induction therapy
1194687|NCT02056938|personalized medicine|personalized medicine
1194688|NCT02056938|First kidney transplantation|first kidney transplantation
1194689|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
1194690|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
1194691|NCT02056912|lipodystrophy|lipodystrophy
1194692|NCT02056912|gene|gene
1194693|NCT02056912|inborn error of metabolism|inborn error of metabolism
1194694|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
1194695|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
1194696|NCT02056873|deep brain stimulation|deep brain stimulation
1194698|NCT02056873|tourette|tourette
1194699|NCT02056873|tourette's|tourette's
1194700|NCT02056873|tourette syndrome|tourette syndrome
1194701|NCT02056873|TS|ts
1194702|NCT02056860|cystic fibrosis|cystic fibrosis
1194703|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
1194704|NCT02056821|stroke|stroke
1194705|NCT02056821|transcranial doppler|transcranial doppler
1194706|NCT02056821|cerebral blood flow|cerebral blood flow
1194707|NCT02056821|cardiac output|cardiac output
1194708|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
1194709|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
1194710|NCT02056782|AML|aml
1194711|NCT02056782|ODSH|odsh
1194712|NCT02056782|ODSH-AML|odsh-aml
1194713|NCT02056782|Cantex|cantex
1194714|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
1194715|NCT02056756|CBD|cbd
1194716|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
1194717|NCT02056730|Hyperparathyroidism|hyperparathyroidism
1194718|NCT02056730|Regpara|regpara
1194719|NCT02056730|FGF 23|fgf 23
1194720|NCT02056704|Dialysis Fistula|dialysis fistula
1194721|NCT02056704|Dialysis Graft|dialysis graft
1194722|NCT02056704|Stenosis|stenosis
1194723|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
1194724|NCT02056704|Angiography|angiography
1194725|NCT02056691|Resectable|resectable
1194726|NCT02056691|non-metastatic|non-metastatic
1194727|NCT02056691|colorectal|colorectal
1194728|NCT02056691|carcinoma|carcinoma
1194730|NCT02056691|neoplasm|neoplasm
1194731|NCT02056691|exercise|exercise
1194732|NCT02056691|effects|effects
1194733|NCT02056691|program|program
1194734|NCT02056691|pre-operative|pre-operative
1194735|NCT02056691|proliferation|proliferation
1194736|NCT02056691|diagnosed|diagnosed
1194737|NCT02056691|surgery|surgery
1194738|NCT02056691|biopsy|biopsy
1194739|NCT02056691|muscle|muscle
1194740|NCT02056691|signalling|signalling
1194741|NCT02056691|IGF1|igf1
1194742|NCT02056691|ki67|ki67
1194743|NCT02056691|p53|p53
1194744|NCT02056691|response|response
1194745|NCT02056691|training|training
1194746|NCT02056691|biochemical|biochemical
1194747|NCT02056691|pathways|pathways
1194748|NCT02056691|glucose|glucose
1194749|NCT02056678|cholecystitis|cholecystitis
1194750|NCT02056678|cholelithiasis|cholelithiasis
1194751|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
1194752|NCT02056678|acetaminophen|acetaminophen
1194753|NCT02056665|Angelman Syndrome|angelman syndrome
1194754|NCT02056665|EFFICACY|efficacy
1194755|NCT02056665|SAFETY|safety
1194756|NCT02056665|MINOCYCLINE|minocycline
1194757|NCT02056665|Pediatrics population|pediatrics population
1194758|NCT02056665|Rare diseases|rare diseases
1194759|NCT02056652|Preterm birth|preterm birth
1194760|NCT02056652|Preterm delivery|preterm delivery
1194761|NCT02056652|short cervix|short cervix
1194762|NCT02056652|pessary|pessary
1194763|NCT02056639|Premature birth|premature birth
1194764|NCT02056639|Premature delivery|premature delivery
1194765|NCT02056639|Short cervix|short cervix
1194766|NCT02056639|Pessary|pessary
1194767|NCT02056626|hypertension|hypertension
1194768|NCT02056613|Blood Donation|blood donation
1194769|NCT02056613|Tissue Procurement|tissue procurement
1194770|NCT02056613|Cellular Therapies|cellular therapies
1194771|NCT02056587|renal cell carcinoma|renal cell carcinoma
1194772|NCT02056587|kidney cancer|kidney cancer
1194773|NCT02056587|bevacizumab failure|bevacizumab failure
1194774|NCT02056587|everolimus|everolimus
1194775|NCT02056574|Endovascular repair|endovascular repair
1194776|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
1194777|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
1194778|NCT02056574|Stroke|stroke
1194779|NCT02056574|Coiling|coiling
1194780|NCT02056574|NA-1|na-1
1194781|NCT02056561|Anesthesia|anesthesia
1194782|NCT02056561|Oxidants|oxidants
1194783|NCT02056561|Antioxidants|antioxidants
1194784|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
1194785|NCT02056548|lymphoma|lymphoma
1194786|NCT02056548|chronic hepatitis B|chronic hepatitis b
1194787|NCT02056535|Alcohol|alcohol
1194788|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
1194789|NCT02056522|Melanoma|melanoma
1194790|NCT02056522|Skin Cancer|skin cancer
1194791|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
1194792|NCT02056496|Pomegranate|pomegranate
1194793|NCT02056496|Ellagic acid|ellagic acid
1194794|NCT02056496|Pharmacokinetics|pharmacokinetics
1194795|NCT02056496|Urolithins|urolithins
1194796|NCT02056496|Bioavailability|bioavailability
1194797|NCT02056483|neoplasms|neoplasms
1194798|NCT02056483|rehabilitation|rehabilitation
1194800|NCT02056483|depression|depression
1194801|NCT02056483|adverse effects|adverse effects
1194802|NCT02056483|health behavior|health behavior
1194803|NCT02056457|Responsible fatherhood|responsible fatherhood
1194804|NCT02056457|Healthy marriage|healthy marriage
1194805|NCT02056457|Healthy relationships|healthy relationships
1194806|NCT02056457|Parenting|parenting
1194807|NCT02056457|Economic self-sufficiency|economic self-sufficiency
1194808|NCT02056444|Blood conservation|blood conservation
1194809|NCT02056444|Tranexamic acid|tranexamic acid
1194810|NCT02056444|Total hip arthroplasty|total hip arthroplasty
1194811|NCT02056431|Diabetes|diabetes
1194812|NCT02056431|Neuropathy|neuropathy
1194813|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
1194814|NCT02056405|Postoperative Ileus|postoperative ileus
1194815|NCT02056405|Mosapride|mosapride
1194816|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
1194817|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
1194818|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
1194819|NCT02056379|stridor|stridor
1194820|NCT02056379|laryngitis|laryngitis
1194821|NCT02056379|budesonide|budesonide
1194822|NCT02056379|dexamethasone|dexamethasone
1194823|NCT02056379|children|children
1194824|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
1194825|NCT02056353|Software|software
1194826|NCT02056353|Algorithm|algorithm
1194827|NCT02056353|Cardiac surgery|cardiac surgery
1194828|NCT02056327|Oral Appliance|oral appliance
1194829|NCT02056262|Bacteria|bacteria
1194830|NCT02056262|microbial community|microbial community
1194831|NCT02056262|hygiene|hygiene
1194832|NCT02056249|hypoglycemia|hypoglycemia
1194833|NCT02056249|Positron Emission Tomography|positron emission tomography
1194834|NCT02056249|norepinephrine transporter|norepinephrine transporter
1194835|NCT02056236|Cardiac arrest|cardiac arrest
1194836|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
1194837|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
1194838|NCT02056236|EEG monitoring|eeg monitoring
1194839|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
1194840|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
1194841|NCT02056223|Preterm infant|preterm infant
1194842|NCT02056223|Paracetamol|paracetamol
1194843|NCT02056223|Ibuprofen|ibuprofen
1194844|NCT02056210|Stem cells|stem cells
1194845|NCT02056210|Bone marrow|bone marrow
1194846|NCT02056171|delirium|delirium
1194847|NCT02056171|pediatrics|pediatrics
1194848|NCT02056171|critical care|critical care
1194849|NCT02056171|quetiapine|quetiapine
1194850|NCT02056158|HIV|hiv
1194851|NCT02056158|COPD|copd
1194852|NCT02056158|Emphysema|emphysema
1194853|NCT02056158|Smoking|smoking
1194854|NCT02056119|Ventilators, mechanical|ventilators, mechanical
1194855|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
1194856|NCT02056119|Nebulizers|nebulizers
1194857|NCT02056119|Equipment Contamination|equipment contamination
1194858|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
1194859|NCT02056119|jet nebulizer|jet nebulizer
1194860|NCT02056119|mechanical ventilation|mechanical ventilation
1194861|NCT02056119|ventilator associated event|ventilator associated event
1194862|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
1194863|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
1194864|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
1194865|NCT02056080|Breast Neoplasm|breast neoplasm
1194866|NCT02056080|Receptor,HER2|receptor,her2
1194867|NCT02056080|Antineoplastic agent|antineoplastic agent
1194868|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
1194869|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
1194870|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
1194871|NCT02056080|quinazolines|quinazolines
1194872|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
1194873|NCT02056054|Liver transplantation|liver transplantation
1194874|NCT02056054|Hepatitis C|hepatitis c
1194875|NCT02056002|Peer-driven intervention|peer-driven intervention
1194876|NCT02056002|Interactive voice response system|interactive voice response system
1194877|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
1194878|NCT02055976|PF-04950615|pf-04950615
1194879|NCT02055976|Japan|japan
1194880|NCT02055963|Head And Neck Cancer|head and neck cancer
1194881|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
1194882|NCT02055963|Minocycline|minocycline
1194883|NCT02055963|Dynacin|dynacin
1194884|NCT02055963|Minocin|minocin
1194885|NCT02055963|Minocin PAC|minocin pac
1194886|NCT02055963|Myrac|myrac
1194887|NCT02055963|Solodyn|solodyn
1194888|NCT02055963|Placebo|placebo
1194889|NCT02055963|Sugar pill|sugar pill
1194890|NCT02055963|Questionnaires|questionnaires
1194891|NCT02055963|Surveys|surveys
1194892|NCT02055950|Kidney transplant|kidney transplant
1194893|NCT02055950|Marginal donors|marginal donors
1194894|NCT02055950|Pulse perfusion|pulse perfusion
1194895|NCT02055950|Graft function|graft function
1194896|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
1195103|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
1194897|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
1194898|NCT02055911|diabetic macular edema|diabetic macular edema
1194899|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
1194900|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
1194902|NCT02055872|Hypoproteinemia|hypoproteinemia
1194903|NCT02055872|Albumin|albumin
1194904|NCT02055872|Diuresis|diuresis
1194905|NCT02055872|Critical illness|critical illness
1194906|NCT02055859|acoustic neuromas|acoustic neuromas
1194907|NCT02055859|radiosurgery|radiosurgery
1194908|NCT02055859|hearing preservation|hearing preservation
1194909|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
1194910|NCT02055807|Atelectasis|atelectasis
1194911|NCT02055807|Ultrasound|ultrasound
1194912|NCT02055807|Recruitment maneuver|recruitment maneuver
1194913|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
1194914|NCT02055794|perineal wound|perineal wound
1194915|NCT02055794|perineal tear|perineal tear
1194916|NCT02055794|perineum|perineum
1194917|NCT02055794|pain|pain
1194918|NCT02055794|childbirth|childbirth
1194919|NCT02055781|Myelofibrosis|myelofibrosis
1194920|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1194921|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1194922|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
1194923|NCT02055781|Polycythemia|polycythemia
1194924|NCT02055781|Polycythemia Vera|polycythemia vera
1194925|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
1194926|NCT02055781|Thrombocythemia|thrombocythemia
1194927|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
1194928|NCT02055781|Bone Marrow Disease|bone marrow disease
1194929|NCT02055781|Hematologic Diseases|hematologic diseases
1195038|NCT02055378|atropine|atropine
1194930|NCT02055781|Blood Platelet Disorders|blood platelet disorders
1194931|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
1194932|NCT02055781|Splenomegaly|splenomegaly
1194933|NCT02055781|Pacritinib|pacritinib
1194934|NCT02055781|MPN-SAF|mpn-saf
1194935|NCT02055781|MPN-SAF TSS|mpn-saf tss
1194936|NCT02055781|Anemia|anemia
1194937|NCT02055781|Myeloproliferative|myeloproliferative
1194938|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
1194939|NCT02055781|Spleen|spleen
1194940|NCT02055781|Spleen volume|spleen volume
1194941|NCT02055781|Thrombocytopenia|thrombocytopenia
1194942|NCT02055781|SB1518|sb1518
1194943|NCT02055755|Diabetes|diabetes
1194944|NCT02055755|Wounds|wounds
1194945|NCT02055755|Wound Healing|wound healing
1194946|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
1194947|NCT02055755|DFU|dfu
1194948|NCT02055755|Clinical Decision Support|clinical decision support
1194949|NCT02055729|bedsore|bedsore
1194950|NCT02055729|bacteria|bacteria
1194951|NCT02055729|colonization|colonization
1194952|NCT02055729|ecology|ecology
1194953|NCT02055703|Healthy Subjects|healthy subjects
1194954|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
1194955|NCT02055690|Pazopanib|pazopanib
1194956|NCT02055690|Votrient|votrient
1194957|NCT02055690|Fosbretabulin|fosbretabulin
1194958|NCT02055677|personality profiles|personality profiles
1194959|NCT02055677|values|values
1194960|NCT02055677|empathy|empathy
1194961|NCT02055677|quality of life|quality of life
1194962|NCT02055677|vegetarians|vegetarians
1194963|NCT02055677|vegans|vegans
1194964|NCT02055651|Worksite|worksite
1194965|NCT02055651|Cardiovascular|cardiovascular
1194966|NCT02055651|Epidemiology|epidemiology
1194967|NCT02055651|Risk factors|risk factors
1194968|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
1194969|NCT02055638|IED|ied
1194970|NCT02055638|Aggression|aggression
1194971|NCT02055638|SRX246|srx246
1194972|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
1194973|NCT02055638|V1a|v1a
1194974|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
1194975|NCT02055625|Immune system diseases|immune system diseases
1194976|NCT02055625|Oral|oral
1194977|NCT02055612|wet AMD|wet amd
1194978|NCT02055612|epidemiology|epidemiology
1194979|NCT02055599|Wound|wound
1194980|NCT02055599|Wound Healing|wound healing
1194981|NCT02055599|Pressure Ulcers|pressure ulcers
1194982|NCT02055599|Chronic Wounds|chronic wounds
1194983|NCT02055599|Clinical Decision Support|clinical decision support
1194984|NCT02055573|Abusive Head Trauma|abusive head trauma
1194985|NCT02055573|Early Literacy|early literacy
1194986|NCT02055573|Parental Education|parental education
1194987|NCT02055573|Low Income|low income
1194988|NCT02055560|colorectal|colorectal
1194989|NCT02055560|OnDose|ondose
1194990|NCT02055560|MyCare|mycare
1194991|NCT02055560|5-FU|5-fu
1194992|NCT02055560|pharmacokinetics|pharmacokinetics
1194993|NCT02055560|exposure|exposure
1194994|NCT02055560|optimization|optimization
1194995|NCT02055560|dose adjustment|dose adjustment
1194996|NCT02055521|Composite tissue allograft|composite tissue allograft
1194997|NCT02055521|operational tolerance|operational tolerance
1194998|NCT02055521|skin rejection|skin rejection
1194999|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
1195000|NCT02055508|Exercise|exercise
1195001|NCT02055508|Physical Activity|physical activity
1195002|NCT02055508|Palliative Care|palliative care
1195003|NCT02055508|Lung Cancer|lung cancer
1195004|NCT02055508|NSCLC|nsclc
1195005|NCT02055495|Painful flatfeet|painful flatfeet
1195006|NCT02055495|Planovagus feet|planovagus feet
1195007|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
1195008|NCT02055495|Lateral column lengthening|lateral column lengthening
1195009|NCT02055495|Kinematic motion analysis|kinematic motion analysis
1195010|NCT02055482|Anemia on CKD|anemia on ckd
1195011|NCT02055469|Achalasia|achalasia
1195012|NCT02055456|Hormones|hormones
1195013|NCT02055456|Androgens|androgens
1195014|NCT02055456|Aplastic Anemia|aplastic anemia
1195015|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
1195016|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1195017|NCT02055456|Telomere|telomere
1195018|NCT02055456|Telomere Shortening|telomere shortening
1195019|NCT02055443|nuclear cardiology|nuclear cardiology
1195020|NCT02055443|chest pain|chest pain
1195021|NCT02055443|cardiac ischemia|cardiac ischemia
1195022|NCT02055443|shortness of breath|shortness of breath
1195024|NCT02055443|EKG|ekg
1195025|NCT02055443|electrocardiogram|electrocardiogram
1195026|NCT02055430|anuria|anuria
1195027|NCT02055430|children|children
1195028|NCT02055430|nephrostomy|nephrostomy
1195029|NCT02055430|stents|stents
1195030|NCT02055430|urinary calculi|urinary calculi
1195031|NCT02055404|astigmatism|astigmatism
1195032|NCT02055404|toric|toric
1195033|NCT02055404|contact lenses|contact lenses
1195034|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
1195035|NCT02055404|molded mark|molded mark
1195036|NCT02055404|rotation mark|rotation mark
1195037|NCT02055378|myopia|myopia
1195039|NCT02055378|anterior chamber depth|anterior chamber depth
1195040|NCT02055378|auricular acupoint|auricular acupoint
1195041|NCT02055378|axial length|axial length
1195042|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
1195043|NCT02055326|Smoking|smoking
1195044|NCT02055326|yoga|yoga
1195046|NCT02055326|intervention|intervention
1195047|NCT02055313|Exceptional patient|exceptional patient
1195048|NCT02055313|Cancer care|cancer care
1195049|NCT02055313|Lung cancer|lung cancer
1195050|NCT02055313|Pancreatic cancer|pancreatic cancer
1195051|NCT02055313|Stomach cancer|stomach cancer
1195052|NCT02055313|Unexplained survival|unexplained survival
1195053|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
1195054|NCT02055287|schizophrenia|schizophrenia
1195055|NCT02055287|schizoaffective disorder|schizoaffective disorder
1195056|NCT02055274|Parkinsons|parkinsons
1195057|NCT02055248|Genetic Counseling|genetic counseling
1195058|NCT02055248|Mobius Syndrome|mobius syndrome
1195059|NCT02055248|Birth Defects|birth defects
1195060|NCT02055248|Congenital Malformations|congenital malformations
1195061|NCT02055248|Gene Identification|gene identification
1195062|NCT02055235|Brain|brain
1195063|NCT02055235|Pain|pain
1195064|NCT02055235|Yoga|yoga
1195065|NCT02055222|COPD|copd
1195066|NCT02055222|Smoking|smoking
1195067|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1195068|NCT02055209|Coronary Artery Calcification|coronary artery calcification
1195069|NCT02055209|African American|african american
1195070|NCT02055209|African-American Families|african-american families
1195071|NCT02055183|Registry|registry
1195072|NCT02055183|Botulinum toxin|botulinum toxin
1195073|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
1195074|NCT02055183|BAT®|bat®
1195075|NCT02055157|Achondroplasia|achondroplasia
1195076|NCT02055157|Dwarfism|dwarfism
1195077|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
1195078|NCT02055157|Bone Diseases|bone diseases
1195079|NCT02055144|NSCLC|nsclc
1195080|NCT02055144|VeriStrat|veristrat
1195081|NCT02055144|chemotherapy|chemotherapy
1195082|NCT02055144|circulating tumor cells|circulating tumor cells
1195083|NCT02055131|vascular access|vascular access
1195084|NCT02055131|hemodialysis|hemodialysis
1195085|NCT02055131|aspirin resistance|aspirin resistance
1195086|NCT02055131|PFA-100|pfa-100
1195087|NCT02055118|hunters disease|hunters disease
1195088|NCT02055118|MPS II|mps ii
1195089|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
1195090|NCT02055118|hunters syndrome|hunters syndrome
1195091|NCT02055118|ert treatment|ert treatment
1195092|NCT02055118|hunter's disease|hunter's disease
1195093|NCT02055118|iduronate sulfatase|iduronate sulfatase
1195094|NCT02055118|MPS society|mps society
1195095|NCT02055118|mps 2|mps 2
1195096|NCT02055118|enlarged adenoids|enlarged adenoids
1195097|NCT02055118|hunter's syndrome|hunter's syndrome
1195098|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
1195099|NCT02055118|chronic ear infection|chronic ear infection
1195100|NCT02055118|mucopolysaccharides|mucopolysaccharides
1195101|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
1195102|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
1195104|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
1195105|NCT02055118|elaprase|elaprase
1195106|NCT02055118|MPSII|mpsii
1195107|NCT02055118|lysosomal storage disease|lysosomal storage disease
1195108|NCT02055118|mps diagnosis|mps diagnosis
1195109|NCT02055118|mps symptoms|mps symptoms
1195110|NCT02055118|idursulfase|idursulfase
1195111|NCT02055118|hunter disease|hunter disease
1195112|NCT02055118|hunter's disease treatment|hunter's disease treatment
1195113|NCT02055118|MPS2|mps2
1195114|NCT02055105|Pediatric Sepsis|pediatric sepsis
1195115|NCT02055092|Young onset dementia|young onset dementia
1195116|NCT02055092|Quality of life|quality of life
1195117|NCT02055092|Specific needs|specific needs
1195118|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
1195119|NCT02055092|Frontotemporal dementia|frontotemporal dementia
1195120|NCT02055092|Alzheimer's disease|alzheimer's disease
1195121|NCT02055092|Healthcare services|healthcare services
1195122|NCT02055079|ADPKD|adpkd
1195124|NCT02055079|Polycystic kidney disease|polycystic kidney disease
1195125|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
1195126|NCT02055079|mTOR-I|mtor-i
1195127|NCT02055079|Sirolimus|sirolimus
1195128|NCT02055066|cancer|cancer
1195129|NCT02055066|c-MET|c-met
1195130|NCT02055053|Post Operative Pain|post operative pain
1195131|NCT02055053|hernia repair|hernia repair
1195132|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
1195133|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
1195134|NCT02055027|Perioperative Period|perioperative period
1195135|NCT02055014|Endobarrier|endobarrier
1195136|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
1195137|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
1195138|NCT02055014|Liraglutide|liraglutide
1195139|NCT02055014|Diabesity|diabesity
1195140|NCT02055014|Type 2 diabetes|type 2 diabetes
1195141|NCT02055014|Obesity|obesity
1195528|NCT02053129|HIV|hiv
1195142|NCT02055001|gender medicine|gender medicine
1195143|NCT02055001|platelet function|platelet function
1195144|NCT02055001|sex hormones|sex hormones
1195145|NCT02055001|antiplatelet drugs|antiplatelet drugs
1195146|NCT02055001|haemostasis|haemostasis
1195147|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
1195148|NCT02054962|Pain|pain
1195149|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
1195150|NCT02054949|Refractory Seizures|refractory seizures
1195151|NCT02054923|colonoscopy|colonoscopy
1195152|NCT02054923|videorecording|videorecording
1195153|NCT02054923|quality indicators|quality indicators
1195154|NCT02054923|screening|screening
1195155|NCT02054923|colorectal cancer|colorectal cancer
1195156|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
1195157|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
1195158|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
1195159|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
1195160|NCT02054858|Computerized Tomography|computerized tomography
1195161|NCT02054858|Contrast enhanced|contrast enhanced
1195162|NCT02054858|Acute Kidney Injury|acute kidney injury
1195163|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
1195164|NCT02054858|RIPC|ripc
1195165|NCT02054845|Body awareness therapy|body awareness therapy
1195166|NCT02054845|Physical therapy|physical therapy
1195167|NCT02054819|lung cancer|lung cancer
1195168|NCT02054819|NSCLC|nsclc
1195169|NCT02054806|PD1|pd1
1195170|NCT02054806|PD-1|pd-1
1195171|NCT02054806|PDL1|pdl1
1195172|NCT02054806|PD-L1|pd-l1
1195173|NCT02054793|metastatic disease|metastatic disease
1195174|NCT02054793|non-metastatic disease|non-metastatic disease
1195175|NCT02054793|prostate cancer|prostate cancer
1195176|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
1195177|NCT02054767|articaine|articaine
1195178|NCT02054767|lidocaine|lidocaine
1195179|NCT02054767|mepivacaine|mepivacaine
1195180|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
1195181|NCT02054767|irreversible pulpitis|irreversible pulpitis
1195182|NCT02054754|Dexanabinol|dexanabinol
1195183|NCT02054754|Oral|oral
1195184|NCT02054754|Safety|safety
1195185|NCT02054754|Tolerability|tolerability
1195186|NCT02054754|Pharmacokinetics|pharmacokinetics
1195187|NCT02054728|right-heart catheterization|right-heart catheterization
1195188|NCT02054728|respiratory muscle training|respiratory muscle training
1195189|NCT02054728|inspiratory resistance|inspiratory resistance
1195190|NCT02054728|hemodynamics|hemodynamics
1195191|NCT02054702|Schizophrenia|schizophrenia
1195192|NCT02054702|Mental Disorders|mental disorders
1195193|NCT02054702|Psychotic Disorders|psychotic disorders
1195194|NCT02054702|Antipsychotic|antipsychotic
1195195|NCT02054702|Cognitive testing|cognitive testing
1195196|NCT02054676|mandible|mandible
1195197|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
1195198|NCT02054676|anatomy|anatomy
1195199|NCT02054676|cross-sectional|cross-sectional
1195200|NCT02054676|dental implants|dental implants
1195201|NCT02054676|classification|classification
1195202|NCT02054676|reliability|reliability
1195203|NCT02054676|validity|validity
1195204|NCT02054663|Acute coronary syndrome|acute coronary syndrome
1195205|NCT02054663|Coronary artery disease|coronary artery disease
1195206|NCT02054663|Antiplatelet therapy|antiplatelet therapy
1195207|NCT02054663|Ticagrelor|ticagrelor
1195208|NCT02054663|Clopidogrel|clopidogrel
1195209|NCT02054650|Chronic low back pain|chronic low back pain
1195210|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
1195211|NCT02054650|Back pain|back pain
1195212|NCT02054650|Diabetes|diabetes
1195213|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
1195214|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
1195215|NCT02054650|OMT|omt
1195216|NCT02054650|Biomarkers|biomarkers
1195217|NCT02054650|Glycemic control|glycemic control
1195218|NCT02054650|Kidney function|kidney function
1195219|NCT02054637|Bile reflux|bile reflux
1195220|NCT02054637|Reflux esophagitis|reflux esophagitis
1195221|NCT02054637|Lanreotide autogel|lanreotide autogel
1195222|NCT02054637|Somatuline|somatuline
1195223|NCT02054637|Endoscopy|endoscopy
1195224|NCT02054637|Impedancemetry|impedancemetry
1195225|NCT02054624|Obesity|obesity
1195226|NCT02054624|Rural Health|rural health
1195227|NCT02054624|Exercise|exercise
1195228|NCT02054624|Weight loss|weight loss
1195229|NCT02054624|Behavior change|behavior change
1195230|NCT02054611|ARDS|ards
1195231|NCT02054611|Chest radiographs|chest radiographs
1195232|NCT02054611|Vignettes|vignettes
1195233|NCT02054611|Online educational video|online educational video
1195234|NCT02054585|dehydration|dehydration
1195235|NCT02054585|pediatric|pediatric
1195236|NCT02054585|glucose|glucose
1195237|NCT02054585|IV fluid|iv fluid
1195238|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
1195239|NCT02054559|localized|localized
1195240|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1195241|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
1195242|NCT02054559|radiotherapy|radiotherapy
1195243|NCT02054533|Crohn's disease|crohn's disease
1195244|NCT02054533|Ulcerative colitis|ulcerative colitis
1195245|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
1195246|NCT02054533|Surgery|surgery
1195247|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
1195248|NCT02054533|Infection|infection
1195249|NCT02054520|Stage IV|stage iv
1195250|NCT02054520|metastatic melanoma|metastatic melanoma
1195251|NCT02054507|Children|children
1195252|NCT02054507|Cognitive outcome|cognitive outcome
1195253|NCT02054507|Prematurity|prematurity
1195254|NCT02054507|Care Network|care network
1195255|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
1195256|NCT02054507|Care resources|care resources
1195257|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
1195258|NCT02054455|PPI|ppi
1195259|NCT02054455|SIBO|sibo
1195260|NCT02054455|LP-F19|lp-f19
1195261|NCT02054442|cetuximab|cetuximab
1195262|NCT02054442|methotrexate|methotrexate
1195263|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
1195264|NCT02054442|palliative chemotherapy|palliative chemotherapy
1195265|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
1195266|NCT02054416|AKA|aka
1195267|NCT02054416|BKA|bka
1195268|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1195269|NCT02054390|inflammation|inflammation
1195270|NCT02054390|metabolic syndrome|metabolic syndrome
1195271|NCT02054390|myonecrosis|myonecrosis
1195272|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
1195273|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
1195274|NCT02054377|cystic fibrosis|cystic fibrosis
1195275|NCT02054377|tai chi|tai chi
1195276|NCT02054364|Eating Disorder|eating disorder
1195277|NCT02054364|Anorexia Nervosa|anorexia nervosa
1195278|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
1195279|NCT02054364|Maudsley|maudsley
1195280|NCT02054364|Family-Based Therapy|family-based therapy
1195282|NCT02054364|Family Therapy|family therapy
1195283|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
1195284|NCT02054364|CRT|crt
1195285|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
1195286|NCT02054351|CLDN6 positive|cldn6 positive
1195287|NCT02054325|Sclerotherapy|sclerotherapy
1195288|NCT02054325|varicose veins|varicose veins
1195289|NCT02054325|veins|veins
1195290|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
1195291|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
1195292|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
1195293|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1195294|NCT02054221|mitral valve|mitral valve
1195295|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
1195296|NCT02054208|stem cells|stem cells
1195297|NCT02054208|alzheimer's disease|alzheimer's disease
1195298|NCT02054208|cognitive ability|cognitive ability
1195299|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
1195300|NCT02054208|cord blood|cord blood
1195301|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
1195302|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
1195303|NCT02054156|Azithromycin|azithromycin
1195304|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
1195305|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
1195306|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
1195307|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
1195308|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
1195309|NCT02054143|sevoflurane|sevoflurane
1195310|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
1195311|NCT02054143|arterial stiffness|arterial stiffness
1195312|NCT02054143|Transcranial Doppler|transcranial doppler
1195313|NCT02054143|SphygmoCor|sphygmocor
1195314|NCT02054130|Asthma|asthma
1195315|NCT02054117|Hemorrhage|hemorrhage
1195316|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
1195317|NCT02054104|Lung Cancer|lung cancer
1195318|NCT02054104|Cancer Vaccine|cancer vaccine
1195319|NCT02054104|Immunotherapy|immunotherapy
1195320|NCT02054104|Adjuvant Therapy|adjuvant therapy
1195321|NCT02054104|Surgical Intervention|surgical intervention
1195322|NCT02054091|Preterm infants|preterm infants
1195323|NCT02054091|Bovine colostrum|bovine colostrum
1195324|NCT02054091|Feeding intolerance|feeding intolerance
1195325|NCT02054091|Postnatal growth|postnatal growth
1195326|NCT02054091|Intestinal maturation|intestinal maturation
1195327|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
1195328|NCT02054065|Urinary Catheter|urinary catheter
1195329|NCT02054065|urinary tract infection|urinary tract infection
1195330|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
1195331|NCT02054052|malignant pleural effusion|malignant pleural effusion
1195332|NCT02054052|bevacizumab|bevacizumab
1195333|NCT02054052|intrapleural injection|intrapleural injection
1195334|NCT02054052|pericardial effusion|pericardial effusion
1195335|NCT02054039|Cardiac surgery|cardiac surgery
1195336|NCT02054039|Spirometry|spirometry
1195337|NCT02054039|Physical Therapy Modalities|physical therapy modalities
1195338|NCT02054039|Postoperative Complications|postoperative complications
1195339|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
1195340|NCT02053974|Anthracycline|anthracycline
1195341|NCT02053974|spironolactone|spironolactone
1195342|NCT02053974|cardiotoxicity|cardiotoxicity
1195343|NCT02053948|Reversal|reversal
1195344|NCT02053948|Surgical technique|surgical technique
1195345|NCT02053948|Pursestring Wound Closure|pursestring wound closure
1195346|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
1195347|NCT02053935|Dopamine|dopamine
1195348|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
1195349|NCT02053935|sepsis|sepsis
1195350|NCT02053935|hyperglycemia|hyperglycemia
1195351|NCT02053935|insulin secretion|insulin secretion
1195352|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
1195353|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
1195354|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1195355|NCT02053909|Antiplatelet therapy|antiplatelet therapy
1195356|NCT02053909|Coronary artery disease|coronary artery disease
1195357|NCT02053909|Secondary prevention|secondary prevention
1195358|NCT02053909|Graft patency|graft patency
1195359|NCT02053896|Type I Gaucher|type i gaucher
1195360|NCT02053896|ISU302|isu302
1195361|NCT02053896|Imiglucerase|imiglucerase
1195362|NCT02053883|SCI|sci
1195363|NCT02053883|spinal cord injury|spinal cord injury
1195364|NCT02053883|biologic drug|biologic drug
1195365|NCT02053883|rho|rho
1195366|NCT02053883|paralysis|paralysis
1195367|NCT02053883|paraplegia|paraplegia
1195368|NCT02053883|tetraplegia|tetraplegia
1195369|NCT02053883|quadriplegia|quadriplegia
1195370|NCT02053883|trauma|trauma
1195371|NCT02053883|central nervous system|central nervous system
1195372|NCT02053883|fibrin sealant|fibrin sealant
1195373|NCT02053883|neurosurgery|neurosurgery
1195374|NCT02053883|cervical|cervical
1195375|NCT02053883|regeneration|regeneration
1195376|NCT02053883|neurotrauma|neurotrauma
1195377|NCT02053870|Adventitious lung sounds|adventitious lung sounds
1195378|NCT02053870|Crackles|crackles
1195380|NCT02053870|Sputum location|sputum location
1195381|NCT02053857|severe acute malnutrition|severe acute malnutrition
1195382|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
1195383|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
1195384|NCT02053844|health care costs|health care costs
1195385|NCT02053844|quality of health care|quality of health care
1195386|NCT02053831|plastic surgery|plastic surgery
1195387|NCT02053818|Cognitive dysfunction|cognitive dysfunction
1195388|NCT02053818|Cardioprotection|cardioprotection
1195389|NCT02053818|Recovery|recovery
1195390|NCT02053818|Renal function|renal function
1195391|NCT02053818|ICU discharge|icu discharge
1195392|NCT02053805|prostate cancer|prostate cancer
1195393|NCT02053805|BRCA1 Syndrome|brca1 syndrome
1195394|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
1195395|NCT02053805|Lynch syndrome|lynch syndrome
1195396|NCT02053805|BRCA2 Syndrome|brca2 syndrome
1195397|NCT02053779|GnRH agonist|gnrh agonist
1195398|NCT02053779|GnRH antagonist|gnrh antagonist
1195399|NCT02053779|Luteal phase|luteal phase
1195400|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
1195401|NCT02053766|Sevoflurane|sevoflurane
1195402|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
1195403|NCT02053766|Propofol|propofol
1195404|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
1195405|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
1195406|NCT02053727|Hepatitis B|hepatitis b
1195407|NCT02053727|Abatacept|abatacept
1195408|NCT02053727|Orencia|orencia
1195409|NCT02053727|entecavir|entecavir
1195410|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1195411|NCT02053701|quantification precision|quantification precision
1195412|NCT02053701|brain|brain
1195413|NCT02053701|brain metabolites|brain metabolites
1195414|NCT02053675|septic shock|septic shock
1195415|NCT02053675|vasopressin|vasopressin
1195416|NCT02053675|microcirculation|microcirculation
1195417|NCT02053675|tissue oxygenation|tissue oxygenation
1195418|NCT02053675|vasopressors|vasopressors
1195419|NCT02053675|hemodynamics|hemodynamics
1195420|NCT02053662|Bladder Cancer|bladder cancer
1195421|NCT02053649|depression|depression
1195422|NCT02053649|major depressive disorder|major depressive disorder
1195423|NCT02053649|postpartum depression|postpartum depression
1195424|NCT02053649|antenatal depression|antenatal depression
1195425|NCT02053649|sleep|sleep
1195426|NCT02053649|circadian|circadian
1195427|NCT02053649|bright light|bright light
1195428|NCT02053597|Primary breast cancer|primary breast cancer
1195429|NCT02053597|Young women|young women
1195430|NCT02053597|Ovarian function|ovarian function
1195431|NCT02053597|Sexual function|sexual function
1195432|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
1195433|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
1195434|NCT02053558|Anesthesiology|anesthesiology
1195435|NCT02053558|Pain|pain
1195436|NCT02053558|TAP block|tap block
1195437|NCT02053558|Gynecology|gynecology
1195438|NCT02053558|Postoperative|postoperative
1195439|NCT02053558|Analgesia|analgesia
1195440|NCT02053532|Trauma|trauma
1195441|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1195442|NCT02053532|Imaging|imaging
1195443|NCT02053532|Neuroimaging|neuroimaging
1195444|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
1195445|NCT02053493|Heart Failure|heart failure
1195446|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
1195447|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
1195448|NCT02053480|hemolytic anemia|hemolytic anemia
1195449|NCT02053480|anemia|anemia
1195450|NCT02053480|enzymopathy|enzymopathy
1195451|NCT02053480|jaundice|jaundice
1195452|NCT02053480|splenectomy|splenectomy
1195453|NCT02053480|health-related quality of life|health-related quality of life
1195454|NCT02053480|Hematologic diseases|hematologic diseases
1195455|NCT02053467|eConsultation|econsultation
1195456|NCT02053467|Specialist care|specialist care
1195457|NCT02053467|Primary health care|primary health care
1195458|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
1195459|NCT02053467|Reducing referral rates|reducing referral rates
1195460|NCT02053454|RNAi therapeutic|rnai therapeutic
1195461|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
1195462|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
1195463|NCT02053428|Head and neck cancer|head and neck cancer
1195464|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
1195465|NCT02053428|Pain|pain
1195466|NCT02053428|Quality of life|quality of life
1195467|NCT02053428|Complication|complication
1195468|NCT02053415|krill oil|krill oil
1195469|NCT02053415|omega-3 index|omega-3 index
1195470|NCT02053415|plasma lipid profile|plasma lipid profile
1195471|NCT02053415|tolerance|tolerance
1195472|NCT02053415|young adults|young adults
1195473|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
1195474|NCT02053389|Patient-Physician communication|patient-physician communication
1195475|NCT02053389|Decision Support Techniques|decision support techniques
1195476|NCT02053389|Health Communication|health communication
1195477|NCT02053389|Physician-Patient Relationship|physician-patient relationship
1195478|NCT02053389|Decision Making|decision making
1195479|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
1195480|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
1195481|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
1195482|NCT02053350|Clostridium difficile|clostridium difficile
1195483|NCT02053350|glutamine|glutamine
1195484|NCT02053350|diarrhea|diarrhea
1195485|NCT02053350|alanyl-glutamine|alanyl-glutamine
1195486|NCT02053324|AvidinOX|avidinox
1195487|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1195488|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1195489|NCT02053311|maintenance therapy|maintenance therapy
1195490|NCT02053311|orteronel|orteronel
1195491|NCT02053311|TAK-700|tak-700
1195492|NCT02053298|Glaucoma|glaucoma
1195493|NCT02053272|Diabetes|diabetes
1195494|NCT02053272|Glycaemic control|glycaemic control
1195495|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
1195496|NCT02053272|Cannabinoids|cannabinoids
1195497|NCT02053233|stroke|stroke
1195498|NCT02053233|robot-assisted therapy|robot-assisted therapy
1195499|NCT02053233|conventional therapy|conventional therapy
1195500|NCT02053233|motor function|motor function
1195501|NCT02053207|Cognitive training|cognitive training
1195502|NCT02053207|Brain training|brain training
1195503|NCT02053207|Plasticity-based training|plasticity-based training
1195504|NCT02053207|Cardiac surgery|cardiac surgery
1195505|NCT02053207|Preoperative|preoperative
1195506|NCT02053207|Cognitive function|cognitive function
1195507|NCT02053194|Inappropriate prescribing|inappropriate prescribing
1195508|NCT02053194|Health Education|health education
1195509|NCT02053194|Community Pharmacy Services|community pharmacy services
1195510|NCT02053194|Medication Therapy Management|medication therapy management
1195511|NCT02053194|Preventive Health Services|preventive health services
1195512|NCT02053194|Polypharmacy|polypharmacy
1195513|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
1195514|NCT02053194|Aged|aged
1195515|NCT02053181|Cadazolid|cadazolid
1195516|NCT02053181|ACT-179811|act-179811
1195517|NCT02053181|Pharmacokinetics|pharmacokinetics
1195518|NCT02053181|Safety|safety
1195519|NCT02053181|Tolerability|tolerability
1195520|NCT02053155|Smoking cessation|smoking cessation
1195521|NCT02053155|perioperative complication|perioperative complication
1195522|NCT02053155|Smokerlyzer|smokerlyzer
1195523|NCT02053155|smokers help line|smokers help line
1195524|NCT02053142|Pharmacokinetics|pharmacokinetics
1195525|NCT02053142|Herpes simplex virus|herpes simplex virus
1195526|NCT02053142|Genital herpes ulcers|genital herpes ulcers
1195527|NCT02053129|tuberculosis|tuberculosis
1195529|NCT02053129|pregnancy|pregnancy
1195530|NCT02053090|Fibromyalgia|fibromyalgia
1195531|NCT02053090|Group Acupuncture|group acupuncture
1195532|NCT02053090|Group Education with Stretching|group education with stretching
1195533|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
1195534|NCT02053090|Pain|pain
1195535|NCT02053090|Sleep|sleep
1195536|NCT02053090|Fatigue|fatigue
1195537|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
1195538|NCT02053064|Nervous systems diseases|nervous systems diseases
1195539|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
1195540|NCT02053064|Metabolic diseases|metabolic diseases
1195541|NCT02053064|Gene therapy|gene therapy
1195542|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
1195543|NCT02053025|appetite|appetite
1195544|NCT02053025|overweight|overweight
1195545|NCT02053025|energy intake|energy intake
1195546|NCT02053025|obesity|obesity
1195547|NCT02053025|gut hormones|gut hormones
1195548|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
1195549|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
1195550|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1195551|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
1195552|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
1195553|NCT02052986|Omega Index|omega index
1195554|NCT02052986|Omega Score|omega score
1195555|NCT02052986|Cardiac Rehab|cardiac rehab
1195556|NCT02052973|Streptococcus mutans|streptococcus mutans
1195557|NCT02052973|Natural products|natural products
1195558|NCT02052947|Alzheimer's disease|alzheimer's disease
1195559|NCT02052947|cerebrovascular disease|cerebrovascular disease
1195560|NCT02052947|Lewy body disease|lewy body disease
1195561|NCT02052947|MRI|mri
1195562|NCT02052947|SPECT|spect
1195563|NCT02052947|CSF|csf
1195564|NCT02052947|biomarkers|biomarkers
1195565|NCT02052947|disability|disability
1195566|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
1195567|NCT02052934|Escherichia coli Infections|escherichia coli infections
1195568|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
1195569|NCT02052934|Immunogenicity|immunogenicity
1195570|NCT02052921|Observation|observation
1195571|NCT02052921|Rectal Resection|rectal resection
1195572|NCT02052921|complete clinical response|complete clinical response
1195573|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
1195574|NCT02052895|Presepsin|presepsin
1195575|NCT02052895|Sepsis|sepsis
1195576|NCT02052895|SIRS|sirs
1195577|NCT02052882|Romiplostim|romiplostim
1195578|NCT02052882|Thrombocytopenia|thrombocytopenia
1195579|NCT02052882|13-132|13-132
1195580|NCT02052869|endotracheal intubation|endotracheal intubation
1195581|NCT02052869|esophageal intubation|esophageal intubation
1195582|NCT02052856|Tunnel Widening|tunnel widening
1195583|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
1195584|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
1195585|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
1195586|NCT02052791|SMA|sma
1195587|NCT02052791|SMN|smn
1195588|NCT02052791|SMNRx|smnrx
1195589|NCT02052791|ISIS-SMNRx|isis-smnrx
1195590|NCT02052791|ISIS 396443|isis 396443
1195591|NCT02052791|IONIS-SMNRx|ionis-smnrx
1195592|NCT02052791|IONIS-SMN Rx|ionis-smn rx
1195593|NCT02052791|Spinraza|spinraza
1195594|NCT02052778|Breast Cancer|breast cancer
1195595|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
1195596|NCT02052778|Gastric Cancer|gastric cancer
1195597|NCT02052778|FGF|fgf
1195598|NCT02052778|FGFR|fgfr
1195599|NCT02052778|FGFR abnormality|fgfr abnormality
1195600|NCT02052778|TAS-120|tas-120
1195601|NCT02052778|Dose Escalation|dose escalation
1195602|NCT02052739|Status Epilepticus|status epilepticus
1195603|NCT02052739|Refractory status epilepticus|refractory status epilepticus
1195604|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
1195605|NCT02052739|SAGE-547|sage-547
1195606|NCT02052739|SAGE|sage
1195607|NCT02052739|Sage Therapeutics|sage therapeutics
1195608|NCT02052713|dutasteride|dutasteride
1195609|NCT02052713|tamsulosin|tamsulosin
1195610|NCT02052713|healthy subject|healthy subject
1195611|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
1195612|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
1195613|NCT02052687|Healthy volunteer|healthy volunteer
1195614|NCT02052674|Precursor to CAUTI|precursor to cauti
1195615|NCT02052661|Infanrix™ hexa|infanrix™ hexa
1195616|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
1195617|NCT02052661|Immunogenicity|immunogenicity
1195618|NCT02052661|Hepatitis B|hepatitis b
1195619|NCT02052661|Adolescents|adolescents
1195620|NCT02052661|Infancy|infancy
1195621|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
1195622|NCT02052661|Safety|safety
1195623|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
1195624|NCT02052648|glioma|glioma
1195625|NCT02052648|gliosarcoma|gliosarcoma
1195626|NCT02052648|malignant brain tumor|malignant brain tumor
1195627|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
1195628|NCT02052622|submental fat reduction|submental fat reduction
1195629|NCT02052596|Boostrix|boostrix
1195630|NCT02052596|Herpes zoster|herpes zoster
1195631|NCT02052596|Immunogenicity|immunogenicity
1195632|NCT02052596|Co-administration|co-administration
1195633|NCT02052596|Adults|adults
1195634|NCT02052596|Safety|safety
1195635|NCT02052583|Cardiac arrest|cardiac arrest
1195636|NCT02052583|Oxymetry|oxymetry
1195637|NCT02052583|Hypothermia|hypothermia
1195638|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
1195639|NCT02052557|Exparel|exparel
1195640|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
1195641|NCT02052557|post operative pain control|post operative pain control
1195642|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
1195643|NCT02052557|colorectal surgery|colorectal surgery
1195644|NCT02052557|marcaine|marcaine
1195645|NCT02052557|long acting local anesthetic|long acting local anesthetic
1195646|NCT02052557|pain medication use after surgery|pain medication use after surgery
1195647|NCT02052544|determination of heparin levels|determination of heparin levels
1195648|NCT02052544|Patients|patients
1195649|NCT02052544|requiring|requiring
1195650|NCT02052544|unfractionated|unfractionated
1195651|NCT02052518|Childhood obesity|childhood obesity
1195652|NCT02052518|Breastfeeding|breastfeeding
1195653|NCT02052518|Introduction of solids|introduction of solids
1195654|NCT02052518|Introduction of juice|introduction of juice
1195655|NCT02052505|inappropriate prescribing|inappropriate prescribing
1195656|NCT02052505|psychiatry|psychiatry
1195657|NCT02052505|medication quality|medication quality
1195658|NCT02052505|patient safety|patient safety
1195659|NCT02052505|medication errors|medication errors
1195660|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
1195661|NCT02052479|PCOS|pcos
1195662|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
1195663|NCT02052479|Hirsutism|hirsutism
1195664|NCT02052479|Hyperandrogenism|hyperandrogenism
1195665|NCT02052479|Insulin Resistance|insulin resistance
1195666|NCT02052466|Shoulder Joint|shoulder joint
1195667|NCT02052466|Computed tomography|computed tomography
1195668|NCT02052453|Pacemaker|pacemaker
1195670|NCT02052453|Surgery|surgery
1195671|NCT02052453|Electrocautery|electrocautery
1195672|NCT02052453|Electromagnetic interference|electromagnetic interference
1195673|NCT02052427|Ischemic heart disease|ischemic heart disease
1195674|NCT02052427|Coronary artery disease|coronary artery disease
1195675|NCT02052427|Chronic Heart Failure|chronic heart failure
1195676|NCT02052427|Cardiovascular disease|cardiovascular disease
1195677|NCT02052427|adult stem cells|adult stem cells
1195678|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
1195679|NCT02052414|side effects|side effects
1195680|NCT02052414|safety|safety
1195681|NCT02052414|efficacy|efficacy
1195682|NCT02052414|Gralise|gralise
1195683|NCT02052414|Fibromyalgia|fibromyalgia
1195684|NCT02052414|gabapentin|gabapentin
1195685|NCT02052401|OLD AGE|old age
1195686|NCT02052401|Elderly|elderly
1195687|NCT02052401|Domiciliary Intervention|domiciliary intervention
1195688|NCT02052401|Occupational Therapy|occupational therapy
1195689|NCT02052401|Rehospitalization|rehospitalization
1195690|NCT02052388|Skin Infection|skin infection
1195691|NCT02052388|Staph aureus|staph aureus
1195692|NCT02052388|MRSA|mrsa
1195693|NCT02052388|MSSA|mssa
1195694|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
1195695|NCT02052388|Wound Infection|wound infection
1195696|NCT02052388|Abscess|abscess
1195697|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
1195698|NCT02052375|ASP2408|asp2408
1195699|NCT02052375|methotrexate|methotrexate
1195700|NCT02052362|absolute bioavailability|absolute bioavailability
1195701|NCT02052362|healthy volunteers|healthy volunteers
1195702|NCT02052349|relative bioavailability|relative bioavailability
1195703|NCT02052349|healthy volunteers|healthy volunteers
1195704|NCT02052336|Drug-Drug interaction|drug-drug interaction
1195705|NCT02052336|Pharmacokinetics|pharmacokinetics
1195706|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
1195707|NCT02052310|Anemia|anemia
1195708|NCT02052310|Chronic Kidney Disease|chronic kidney disease
1195709|NCT02052310|Hemoglobin|hemoglobin
1195710|NCT02052310|End-Stage Renal Disease|end-stage renal disease
1195711|NCT02052310|Incident-Dialysis|incident-dialysis
1195712|NCT02052310|Erythropoieitin|erythropoieitin
1195713|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
1195714|NCT02052310|Roxadustat|roxadustat
1195715|NCT02052310|AZD9941|azd9941
1195716|NCT02052310|ASP1517|asp1517
1195717|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
1195718|NCT02052297|dosimetry|dosimetry
1195719|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
1195720|NCT02052284|ELBW|elbw
1195721|NCT02052284|premature|premature
1195722|NCT02052284|neonate|neonate
1195723|NCT02052284|skin|skin
1195724|NCT02052284|water loss|water loss
1195725|NCT02052271|essential tremor|essential tremor
1195726|NCT02052271|cerebellum|cerebellum
1195727|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
1195728|NCT02052271|electrophysiology|electrophysiology
1195729|NCT02052258|oxytocin|oxytocin
1195730|NCT02052219|Blisibimod|blisibimod
1195731|NCT02052219|IgA nephropathy|iga nephropathy
1195732|NCT02052219|BAFF|baff
1195733|NCT02052219|BLyS|blys
1195734|NCT02052206|osteoarthritis|osteoarthritis
1195735|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
1195736|NCT02052206|shoulder|shoulder
1195737|NCT02052206|shoulder replacement|shoulder replacement
1195738|NCT02052206|accuracy|accuracy
1195739|NCT02052206|computer-assisted|computer-assisted
1195740|NCT02052206|3D|3d
1195741|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
1195742|NCT02052180|Proximal row carpectomy|proximal row carpectomy
1195743|NCT02052180|Post-operative pain control|post-operative pain control
1195744|NCT02052180|Exparel|exparel
1195745|NCT02052180|Marcaine|marcaine
1195746|NCT02052154|Pneumococcal infection|pneumococcal infection
1195747|NCT02052154|Splenectomized|splenectomized
1195748|NCT02052154|vaccination|vaccination
1195749|NCT02052141|Pediatric|pediatric
1195750|NCT02052141|C1 inhibitor|c1 inhibitor
1195751|NCT02052141|HAE|hae
1195752|NCT02052141|Cinryze|cinryze
1195753|NCT02052141|C1 INH|c1 inh
1195754|NCT02052141|Prevention|prevention
1195755|NCT02052128|endometrial cancer|endometrial cancer
1195756|NCT02052128|ovarian cancer|ovarian cancer
1195757|NCT02052128|breast cancer|breast cancer
1195758|NCT02052128|uterine sarcoma|uterine sarcoma
1195759|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
1195760|NCT02052115|breast cancer|breast cancer
1195761|NCT02052115|exercise|exercise
1195762|NCT02052115|weight loss|weight loss
1195763|NCT02052115|executive function|executive function
1195764|NCT02052115|breast cancer survivor|breast cancer survivor
1195765|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
1195766|NCT02052102|radiation therapy|radiation therapy
1195767|NCT02052102|Cardiac toxicity|cardiac toxicity
1195768|NCT02052102|Left-sided breast cancer|left-sided breast cancer
1195769|NCT02052089|Tennis Elbow|tennis elbow
1195770|NCT02052089|lateral epicondylosis|lateral epicondylosis
1195771|NCT02052089|lateral epicondylitis|lateral epicondylitis
1195772|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
1195773|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1195774|NCT02052089|Prolotherapy|prolotherapy
1195775|NCT02052089|Physiotherapy|physiotherapy
1195776|NCT02052076|Energy balance|energy balance
1195777|NCT02052076|meal pattern|meal pattern
1195778|NCT02052076|metabolic syndrome|metabolic syndrome
1195779|NCT02052063|rectocele|rectocele
1195780|NCT02052063|intussusception|intussusception
1195781|NCT02052063|surgery|surgery
1195782|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
1195783|NCT02052037|Type 2 Diabetes|type 2 diabetes
1195785|NCT02052037|Glycemic Control|glycemic control
1195786|NCT02052037|Insulin sensitivity|insulin sensitivity
1195787|NCT02052037|Diet quality|diet quality
1195788|NCT02052024|Spasticity|spasticity
1195789|NCT02052024|Modified Ashworth Scale|modified ashworth scale
1195790|NCT02052024|MYOBLOC|myobloc
1195791|NCT02052024|Botox|botox
1195792|NCT02052024|Muscle Atrophy|muscle atrophy
1195793|NCT02052011|Chest Pain|chest pain
1195794|NCT02052011|Microvascular Angina|microvascular angina
1195795|NCT02052011|Ranolazine|ranolazine
1195796|NCT02052011|Emergency department|emergency department
1195797|NCT02052011|PET|pet
1195798|NCT02051998|Geographic atrophy|geographic atrophy
1195799|NCT02051998|Age-related macular degeneration|age-related macular degeneration
1195800|NCT02051998|Retina|retina
1195801|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
1195802|NCT02051998|Optical coherence tomography|optical coherence tomography
1195803|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
1195804|NCT02051985|Chronic heart failure|chronic heart failure
1195805|NCT02051985|Heart decompensation|heart decompensation
1195806|NCT02051985|Aerobic exercise training|aerobic exercise training
1195807|NCT02051985|Functional capacity|functional capacity
1195808|NCT02051985|Dyspnea|dyspnea
1195809|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
1195810|NCT02051959|Phantom Limb Pain|phantom limb pain
1195811|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1195812|NCT02051959|Amputation|amputation
1195813|NCT02051959|Diabetes Mellitus|diabetes mellitus
1195814|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
1195815|NCT02051933|pilon|pilon
1195816|NCT02051933|tibial plafond|tibial plafond
1195817|NCT02051933|botox|botox
1195818|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
1195819|NCT02051933|ankle functionality|ankle functionality
1195820|NCT02051933|ankle range of motion|ankle range of motion
1195821|NCT02051920|Elastography|elastography
1195822|NCT02051894|Neonates|neonates
1195823|NCT02051894|Dobutamine|dobutamine
1195824|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
1195825|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1195826|NCT02051894|Pleth Variability Index|pleth variability index
1195827|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1195828|NCT02051868|Anal cancer|anal cancer
1195829|NCT02051868|Cancer of the anus|cancer of the anus
1195830|NCT02051868|SCCA|scca
1195831|NCT02051868|Cisplatin-5FU|cisplatin-5fu
1195832|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
1195833|NCT02051868|inoperable|inoperable
1195834|NCT02051868|locally recurrent|locally recurrent
1195835|NCT02051868|metastatic|metastatic
1195836|NCT02051855|Neonates|neonates
1195837|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
1195838|NCT02051855|Pleth Variability Index|pleth variability index
1195839|NCT02051855|Dobutamine|dobutamine
1195840|NCT02051855|Intensive Care|intensive care
1195841|NCT02051842|NAFLD|nafld
1195842|NCT02051842|oxidative stress|oxidative stress
1195843|NCT02051842|malondialdehyde|malondialdehyde
1195844|NCT02051816|Endotracheal Intubation|endotracheal intubation
1195845|NCT02051816|Apneic Oxygenation|apneic oxygenation
1195846|NCT02051816|Respiratory failure|respiratory failure
1195847|NCT02051803|smoking cessation|smoking cessation
1195848|NCT02051803|women|women
1195849|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
1195850|NCT02051738|Healthy|healthy
1195851|NCT02051738|Mebendazole|mebendazole
1195852|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
1195853|NCT02051738|Bioavailability|bioavailability
1195854|NCT02051712|chronic heart failure|chronic heart failure
1195855|NCT02051712|exercise training|exercise training
1195856|NCT02051712|preferred training|preferred training
1195857|NCT02051712|prevention|prevention
1195858|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
1195859|NCT02051699|Weight bearing radiograph|weight bearing radiograph
1195860|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
1195861|NCT02051699|Joint space width|joint space width
1195862|NCT02051699|One-leg standing view|one-leg standing view
1195863|NCT02051686|Acetabulum Fractures|acetabulum fractures
1195864|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
1195865|NCT02051686|Tranexamic Acid|tranexamic acid
1195866|NCT02051673|Kidney Transplantation|kidney transplantation
1195867|NCT02051647|medical students|medical students
1195868|NCT02051647|Basel University|basel university
1195869|NCT02051634|Aging|aging
1195870|NCT02051634|Papaya|papaya
1195871|NCT02051634|Fermented Papaya|fermented papaya
1195872|NCT02051634|Inflammation|inflammation
1195873|NCT02051634|Phytochemicals|phytochemicals
1195874|NCT02051634|Physical function|physical function
1195875|NCT02051634|Quality of life|quality of life
1195876|NCT02051634|Fatigue|fatigue
1195877|NCT02051634|Health|health
1195878|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
1195879|NCT02051621|isthmus ablation|isthmus ablation
1195880|NCT02051621|recurrence|recurrence
1195881|NCT02051595|heart lung machine|heart lung machine
1195882|NCT02051595|blood pump|blood pump
1195883|NCT02051595|cardiac surgery|cardiac surgery
1195884|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
1195885|NCT02051595|circulation|circulation
1195886|NCT02051556|Parkinson's disease|parkinson's disease
1195887|NCT02051556|Freezing of gait|freezing of gait
1195888|NCT02051556|Asymmetry|asymmetry
1195889|NCT02051556|Rehabilitation|rehabilitation
1195890|NCT02051556|Physical therapy|physical therapy
1195891|NCT02051530|mood|mood
1195892|NCT02051530|empathy|empathy
1195893|NCT02051530|mimicry|mimicry
1195894|NCT02051530|emotional reactivity|emotional reactivity
1195895|NCT02051530|prosody|prosody
1195896|NCT02051517|Virectomy|virectomy
1195897|NCT02051504|Type 1 diabetes|type 1 diabetes
1195898|NCT02051504|Glycated hemoglobin|glycated hemoglobin
1195899|NCT02051504|Muscle Oxygenation|muscle oxygenation
1195900|NCT02051504|Exercise|exercise
1195901|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
1195902|NCT02051504|Mitochondrial respiration|mitochondrial respiration
1195903|NCT02051504|Endocannabinoid system|endocannabinoid system
1195904|NCT02051504|Oxidative stress|oxidative stress
1195905|NCT02051478|manipulation|manipulation
1195906|NCT02051478|mobilization|mobilization
1195907|NCT02051478|spine|spine
1195908|NCT02051478|pressure pain|pressure pain
1195909|NCT02051439|Varicose Veins|varicose veins
1195910|NCT02051439|Venous Insufficiency|venous insufficiency
1195911|NCT02051439|Doppler|doppler
1195912|NCT02051439|Duplex|duplex
1195913|NCT02051439|Valsava|valsava
1195914|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
1195915|NCT02051413|Major depression|major depression
1195916|NCT02051413|Antidepressant drug|antidepressant drug
1195917|NCT02051413|Beta-arrestin|beta-arrestin
1195918|NCT02051413|Biomarker|biomarker
1195919|NCT02051413|Predictive factor|predictive factor
1195920|NCT02051400|Intubation|intubation
1195921|NCT02051400|Laryngoscopes|laryngoscopes
1195922|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
1195923|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
1195924|NCT02051348|Helicobacter pylori|helicobacter pylori
1195925|NCT02051348|Mild Indigestion|mild indigestion
1195926|NCT02051335|Drug therapy|drug therapy
1195927|NCT02051309|Smokers|smokers
1195928|NCT02051309|Quit Smoking|quit smoking
1195929|NCT02051309|Treatment|treatment
1195930|NCT02051309|Guanfacine|guanfacine
1195931|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
1195933|NCT02051283|MRI|mri
1195934|NCT02051270|Elderly|elderly
1195935|NCT02051270|Nursing homes|nursing homes
1195936|NCT02051270|Mild cognitive impairment|mild cognitive impairment
1195937|NCT02051244|Alzheimer's Disease|alzheimer's disease
1195938|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
1195939|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
1195940|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
1195941|NCT02051244|Subjective Memory Loss|subjective memory loss
1195942|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
1195943|NCT02051231|Uterine contraction|uterine contraction
1195944|NCT02051231|Oxytocin receptors|oxytocin receptors
1195945|NCT02051231|Oxytocin desensitization|oxytocin desensitization
1195946|NCT02051218|metastatic breast cancer|metastatic breast cancer
1195947|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
1195948|NCT02051218|bone metastases|bone metastases
1195949|NCT02051218|Denosumab|denosumab
1195950|NCT02051218|XGEVA|xgeva
1195951|NCT02051218|de-escalation|de-escalation
1195952|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
1195953|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
1195954|NCT02051192|Social phobia|social phobia
1195955|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
1195956|NCT02051192|Specific phobia|specific phobia
1195957|NCT02051192|Separation anxiety disorder|separation anxiety disorder
1195958|NCT02051192|Selective Mutism|selective mutism
1195959|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
1195960|NCT02051192|Counseling|counseling
1195961|NCT02051192|Behavioral therapy|behavioral therapy
1195962|NCT02051192|Psychotherapy|psychotherapy
1195963|NCT02051192|Exposure|exposure
1195964|NCT02051192|Young Children|young children
1195965|NCT02051179|Repair|repair
1195966|NCT02051179|Replacement|replacement
1195967|NCT02051179|Dental Amalgam|dental amalgam
1195968|NCT02051153|Modafinil|modafinil
1195969|NCT02051153|Cognitive|cognitive
1195970|NCT02051153|Performance|performance
1195971|NCT02051140|Postural Balance|postural balance
1195972|NCT02051140|Walking|walking
1195973|NCT02051140|Giat|giat
1195974|NCT02051140|Cognition|cognition
1195975|NCT02051140|Learning|learning
1195976|NCT02051140|Memory|memory
1195977|NCT02051140|Antioxidants|antioxidants
1195978|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
1195979|NCT02051140|Brain|brain
1195980|NCT02051140|Strawberry|strawberry
1195981|NCT02051127|Exercise|exercise
1195982|NCT02051127|Physical Fitness|physical fitness
1195983|NCT02051127|Stress, Psychological|stress, psychological
1195984|NCT02051127|Cognition|cognition
1195985|NCT02051127|Psychophysiology|psychophysiology
1195986|NCT02051127|Ergometry|ergometry
1195987|NCT02051127|Exercise Test|exercise test
1195988|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
1195989|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
1195990|NCT02051088|Critical limb ischemia|critical limb ischemia
1195991|NCT02051088|Intermittent claudication|intermittent claudication
1195992|NCT02051088|endovascular treatment|endovascular treatment
1195993|NCT02051088|drug-elution|drug-elution
1195994|NCT02051075|IVF|ivf
1195995|NCT02051075|ICSI|icsi
1195996|NCT02051075|Asthenospermia|asthenospermia
1195997|NCT02051075|pentoxyphylline|pentoxyphylline
1195998|NCT02051075|Spermatozoa|spermatozoa
1195999|NCT02051062|Pharmacokinetics|pharmacokinetics
1196000|NCT02051062|BAT|bat
1196001|NCT02051062|Pediatric|pediatric
1196002|NCT02051049|CN|cn
1196003|NCT02051049|UCD|ucd
1196004|NCT02051036|moxibustion|moxibustion
1196005|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
1196006|NCT02051023|dry eye|dry eye
1196007|NCT02051023|dry eye syndrome|dry eye syndrome
1196008|NCT02051023|dry eye disease|dry eye disease
1196009|NCT02051023|steroids|steroids
1196010|NCT02050984|Obesity|obesity
1196011|NCT02050984|Hypertension|hypertension
1196012|NCT02050984|Bariatric Surgery|bariatric surgery
1196013|NCT02050984|Diabetes|diabetes
1196014|NCT02050971|Umbilical Cord Blood|umbilical cord blood
1196015|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
1196016|NCT02050971|Prematurity Complications|prematurity complications
1196017|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
1196018|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
1196019|NCT02050971|Hematologic Diseases|hematologic diseases
1196020|NCT02050971|Lung Diseases|lung diseases
1196021|NCT02050971|Central Nervous System Diseases|central nervous system diseases
1196022|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
1196023|NCT02050971|Vascular Diseases|vascular diseases
1196024|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
1196025|NCT02050971|Prevention,Treatment|prevention,treatment
1196026|NCT02050932|hepcidin|hepcidin
1196027|NCT02050932|iron bioavailability|iron bioavailability
1196028|NCT02050932|iron supplementation|iron supplementation
1197339|NCT02045316|Placenta|placenta
1196030|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
1196031|NCT02050893|septic shock|septic shock
1196032|NCT02050893|sepsis|sepsis
1196033|NCT02050893|fluid responsiveness|fluid responsiveness
1196034|NCT02050893|Midazolam|midazolam
1196035|NCT02050893|Propofol|propofol
1196036|NCT02050893|haemodynamics|haemodynamics
1196037|NCT02050880|Normal Eyes|normal eyes
1196038|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
1196039|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
1196040|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
1196041|NCT02050867|Youth Suicide|youth suicide
1196042|NCT02050867|Suicide|suicide
1196043|NCT02050854|Aripiprazole|aripiprazole
1196044|NCT02050854|Treatment Adherence|treatment adherence
1196045|NCT02050841|Pediatric|pediatric
1196046|NCT02050841|patients|patients
1196047|NCT02050841|replacement|replacement
1196048|NCT02050841|coagulation factors|coagulation factors
1196049|NCT02050841|plasma|plasma
1196050|NCT02050841|s/d plasma|s/d plasma
1196051|NCT02050841|Octaplas|octaplas
1196052|NCT02050841|plasma replacement|plasma replacement
1196053|NCT02050815|MEK162|mek162
1196054|NCT02050815|Hepatic impairment|hepatic impairment
1196055|NCT02050815|Healthy subjects|healthy subjects
1196056|NCT02050802|Macitentan|macitentan
1196057|NCT02050802|Pharmacokinetics|pharmacokinetics
1196058|NCT02050802|Pharmacodynamics|pharmacodynamics
1196059|NCT02050763|HIV|hiv
1196060|NCT02050763|Intimate partner violence|intimate partner violence
1196061|NCT02050763|Community based prevention intervention|community based prevention intervention
1196062|NCT02050763|Uganda|uganda
1196063|NCT02050763|Cluster randomized trial|cluster randomized trial
1196064|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
1196065|NCT02050737|Curative resection|curative resection
1196066|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
1196067|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
1196068|NCT02050724|Thoracoscopy|thoracoscopy
1196069|NCT02050724|Thoracic Surgery|thoracic surgery
1196070|NCT02050724|Video-Assisted|video-assisted
1196071|NCT02050724|Radioactive Tracers|radioactive tracers
1196072|NCT02050724|Radioguided surgery|radioguided surgery
1196073|NCT02050724|Handheld-SPECT|handheld-spect
1196074|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1196075|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
1196076|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
1196077|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
1196078|NCT02050698|hard-soled shoe|hard-soled shoe
1196079|NCT02050698|short leg walking cast|short leg walking cast
1196080|NCT02050698|protected weightbearing|protected weightbearing
1196081|NCT02050672|Myoinositol|myoinositol
1196082|NCT02050672|ART|art
1196083|NCT02050672|EMBRYO QUALITY|embryo quality
1196084|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
1196085|NCT02050646|Liver dysfunction|liver dysfunction
1196086|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
1196087|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
1196088|NCT02050633|Long term outcome|long term outcome
1196089|NCT02050633|Activities of Daily Living|activities of daily living
1196090|NCT02050633|Cognitive Deficiency|cognitive deficiency
1196091|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1196092|NCT02050633|Burden of care|burden of care
1196093|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
1196094|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
1196095|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
1196096|NCT02050568|Genital prolapse|genital prolapse
1196097|NCT02050568|Genital prolapse surgery|genital prolapse surgery
1196098|NCT02050568|Stress urinary incontinence|stress urinary incontinence
1196099|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
1196100|NCT02050542|cancer|cancer
1196101|NCT02050542|prostate|prostate
1196102|NCT02050542|PSA|psa
1196103|NCT02050542|biopsies|biopsies
1196104|NCT02050542|ultrasound|ultrasound
1196105|NCT02050542|MRI|mri
1196106|NCT02050542|fusion of images|fusion of images
1196107|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
1196108|NCT02050529|Pre-eclampsia|pre-eclampsia
1196109|NCT02050529|Eclampsia|eclampsia
1196110|NCT02050529|Labetalol|labetalol
1196111|NCT02050529|Hydralazine|hydralazine
1196112|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
1196113|NCT02050503|Mucositis|mucositis
1196114|NCT02050503|Breakthrough pain|breakthrough pain
1196115|NCT02050503|Head Nad neck cancer|head nad neck cancer
1196116|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
1196117|NCT02050477|Obesity|obesity
1196118|NCT02050477|Bariatric|bariatric
1196119|NCT02050477|Surgery|surgery
1196120|NCT02050477|Sleeve|sleeve
1196121|NCT02050477|Gastroplasty|gastroplasty
1196122|NCT02050477|Laparoscopy|laparoscopy
1196123|NCT02050464|Alzheimer Disease|alzheimer disease
1196124|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
1196125|NCT02050464|Dementia, Vascular|dementia, vascular
1196126|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
1196127|NCT02050464|Diagnosis|diagnosis
1196128|NCT02050464|Risk factors|risk factors
1196129|NCT02050464|Biomarkers|biomarkers
1196130|NCT02050464|AD|ad
1196131|NCT02050464|FTD|ftd
1196132|NCT02050464|VAD|vad
1196133|NCT02050464|MCI|mci
1196134|NCT02050451|radical cystectomy|radical cystectomy
1196135|NCT02050451|urinary diversion|urinary diversion
1196136|NCT02050451|nutrition|nutrition
1196137|NCT02050451|oral supplementation|oral supplementation
1196138|NCT02050451|enteral nutrition|enteral nutrition
1196139|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
1196140|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
1196141|NCT02050438|Quality of Life|quality of life
1196142|NCT02050425|OSA|osa
1196143|NCT02050425|CPAP|cpap
1196144|NCT02050425|exhaled breath|exhaled breath
1196145|NCT02050399|Isometric Exercise|isometric exercise
1196146|NCT02050399|Arterial Pressure|arterial pressure
1196147|NCT02050399|Autonomic Nervous System|autonomic nervous system
1196148|NCT02050399|Cardiovascular system|cardiovascular system
1196149|NCT02050399|Posture|posture
1196150|NCT02050386|Brain arousal systems|brain arousal systems
1196151|NCT02050386|Aging|aging
1196153|NCT02050386|fMRI|fmri
1196154|NCT02050386|Cognition|cognition
1196155|NCT02050373|Mucositis|mucositis
1196156|NCT02050373|Stomatitis|stomatitis
1196157|NCT02050373|Chemotherapy|chemotherapy
1196158|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1196159|NCT02050373|Laser therapy|laser therapy
1196160|NCT02050373|Inflammatory cytokines|inflammatory cytokines
1196161|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
1196162|NCT02050360|Sildenafil|sildenafil
1196163|NCT02050360|Systemic Sclerosis|systemic sclerosis
1196164|NCT02050360|Local cooling|local cooling
1196165|NCT02050360|Microcirculation|microcirculation
1196166|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
1196167|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
1196168|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1196169|NCT02050334|Phase 1|phase 1
1196170|NCT02050334|Healthy Volunteer|healthy volunteer
1196171|NCT02050334|Safety|safety
1196172|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
1196173|NCT02050282|Dyspnea|dyspnea
1196174|NCT02050282|Prehospital|prehospital
1196175|NCT02050282|Biomarker|biomarker
1196176|NCT02050282|Heart failure|heart failure
1196177|NCT02050282|Triage|triage
1196178|NCT02050282|Randomized, controlled study|randomized, controlled study
1196179|NCT02050256|Palliative care|palliative care
1196180|NCT02050256|Continuing medical education|continuing medical education
1196181|NCT02050256|General practitioner|general practitioner
1196182|NCT02050256|Electronic decision support|electronic decision support
1196183|NCT02050243|pediatrics|pediatrics
1196184|NCT02050243|brain tumor|brain tumor
1196185|NCT02050243|CNS|cns
1196186|NCT02050243|fluorescence|fluorescence
1196187|NCT02050243|5ALA|5ala
1196188|NCT02050230|transfusion|transfusion
1196189|NCT02050230|pulmonary hypertension|pulmonary hypertension
1196190|NCT02050230|intensive care medicine|intensive care medicine
1196191|NCT02050217|Helmet|helmet
1196192|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1196193|NCT02050217|Children|children
1196194|NCT02050217|Respiratory Failure|respiratory failure
1196195|NCT02050204|work to family conflict|work to family conflict
1196196|NCT02050204|supervisor support|supervisor support
1196197|NCT02050204|long work hours|long work hours
1196198|NCT02050204|cardiometabolic risk|cardiometabolic risk
1196199|NCT02050204|sleep duration|sleep duration
1196200|NCT02050204|insomnia symptoms|insomnia symptoms
1196201|NCT02050178|Pancreatic Cancer|pancreatic cancer
1196202|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
1196203|NCT02050165|obesity|obesity
1196204|NCT02050165|snacks|snacks
1196205|NCT02050165|satiety|satiety
1196206|NCT02050165|hunger|hunger
1196207|NCT02050152|Amnesia|amnesia
1196208|NCT02050152|Memory|memory
1196209|NCT02050152|Implicit|implicit
1196210|NCT02050152|Explicit|explicit
1196211|NCT02050152|Nitrous Oxide|nitrous oxide
1196212|NCT02050139|L-Cysteine|l-cysteine
1196213|NCT02050139|Peritoneal dialysis|peritoneal dialysis
1196214|NCT02050139|Diuresis|diuresis
1196215|NCT02050139|Glomerular filtration rate|glomerular filtration rate
1196216|NCT02050139|Peritoneal function|peritoneal function
1196217|NCT02050139|Inflammation|inflammation
1196218|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
1196219|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
1196220|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
1196221|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
1196222|NCT02050113|Endovascular Branch Graft|endovascular branch graft
1196223|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
1196224|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1196225|NCT02050113|Endovascular|endovascular
1196226|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
1196227|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
1196228|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
1196229|NCT02050100|early detection|early detection
1196230|NCT02050087|Rotator cuff|rotator cuff
1196231|NCT02050087|Rehabilitation|rehabilitation
1196232|NCT02050048|Pancreatitis|pancreatitis
1196233|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1196234|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1196235|NCT02050048|ERCP|ercp
1196236|NCT02050048|High Volume|high volume
1196237|NCT02050048|Lactated Ringer|lactated ringer
1196238|NCT02050048|Intravenous Administration|intravenous administration
1196239|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
1196240|NCT02050048|Pancreas|pancreas
1196241|NCT02050035|Exercise Therapy|exercise therapy
1196242|NCT02050035|Endothelium, vascular|endothelium, vascular
1196243|NCT02050035|Blood Vessels|blood vessels
1196244|NCT02050022|Biomarkers|biomarkers
1196245|NCT02050022|Genomics|genomics
1196246|NCT02050022|Proteomics|proteomics
1196247|NCT02050022|Diagnostics|diagnostics
1196248|NCT02050022|Prognostics|prognostics
1196249|NCT02049996|Quality of life|quality of life
1196250|NCT02049996|Robotic surgery|robotic surgery
1196251|NCT02049996|Vaginal surgery|vaginal surgery
1196252|NCT02049996|Prolapse repair|prolapse repair
1196253|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
1196254|NCT02049970|Supraclavicular block|supraclavicular block
1196255|NCT02049957|MLN0128|mln0128
1196256|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
1196257|NCT02049944|Obesity|obesity
1196258|NCT02049944|Obesity, Morbid|obesity, morbid
1196259|NCT02049944|Pregnancy|pregnancy
1196260|NCT02049944|Infection; Cesarean Section|infection; cesarean section
1196261|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
1196262|NCT02049918|Respiratory viruses|respiratory viruses
1196263|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
1196264|NCT02049905|unresectable|unresectable
1196265|NCT02049905|metastatic|metastatic
1196266|NCT02049905|locally advanced|locally advanced
1196267|NCT02049905|sarcoma|sarcoma
1196268|NCT02049892|Total Hip Replacement|total hip replacement
1196269|NCT02049892|Metal Ion|metal ion
1196270|NCT02049892|2-5 years after surgery|2-5 years after surgery
1196271|NCT02049892|Asymptomatic|asymptomatic
1196272|NCT02049866|osteoporosis|osteoporosis
1196273|NCT02049866|premenopausal|premenopausal
1196274|NCT02049866|denosumab|denosumab
1196275|NCT02049866|idiopathic|idiopathic
1196276|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
1196277|NCT02049853|acute dyspnea|acute dyspnea
1196278|NCT02049853|heart failure|heart failure
1196279|NCT02049853|diagnostics|diagnostics
1196280|NCT02049853|POCT analysis|poct analysis
1196281|NCT02049853|preclinical area|preclinical area
1196282|NCT02049840|Female sling|female sling
1196283|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
1196284|NCT02049840|Urination Disorders|urination disorders
1196392|NCT02049294|Bronchitis|bronchitis
1196285|NCT02049840|Urologic Diseases|urologic diseases
1196286|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
1196287|NCT02049814|Drug therapy|drug therapy
1196288|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
1196290|NCT02049762|platelet reactivity|platelet reactivity
1196291|NCT02049762|acute coronary syndrome|acute coronary syndrome
1196292|NCT02049749|Child Behavior Problems|child behavior problems
1196293|NCT02049749|Parent Training Program|parent training program
1196294|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
1196295|NCT02049723|Knowledge|knowledge
1196296|NCT02049697|Healthy|healthy
1196297|NCT02049697|Healthy male participants|healthy male participants
1196298|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
1196299|NCT02049697|TPI 1062|tpi 1062
1196300|NCT02049697|Tianeptine|tianeptine
1196301|NCT02049697|Absorption|absorption
1196302|NCT02049697|Metabolism|metabolism
1196303|NCT02049697|Excretion|excretion
1196304|NCT02049697|Pharmacokinetics|pharmacokinetics
1196305|NCT02049658|tumor|tumor
1196306|NCT02049658|cancer|cancer
1196307|NCT02049645|lung cancer|lung cancer
1196308|NCT02049645|breast cancer|breast cancer
1196309|NCT02049632|Breast cancer|breast cancer
1196310|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
1196311|NCT02049632|Micrometastasis|micrometastasis
1196312|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
1196313|NCT02049619|Pharyngeal pack|pharyngeal pack
1196314|NCT02049619|Nausea|nausea
1196315|NCT02049619|Vomiting|vomiting
1196316|NCT02049619|orthognathic surgery|orthognathic surgery
1196317|NCT02049619|maxillary osteotomy|maxillary osteotomy
1196318|NCT02049606|LAYLA|layla
1196319|NCT02049606|Non-inferiority|non-inferiority
1196320|NCT02049606|100mm pain VAS|100mm pain vas
1196321|NCT02049593|protocol specific|protocol specific
1196322|NCT02049580|lymphoma|lymphoma
1196323|NCT02049567|cataract, presbyopia|cataract, presbyopia
1196324|NCT02049554|preconception care|preconception care
1196325|NCT02049554|women's health|women's health
1196326|NCT02049541|BKM120|bkm120
1196327|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
1196328|NCT02049541|PI3K inhibitor|pi3k inhibitor
1196329|NCT02049528|Food Effect|food effect
1196330|NCT02049528|Pharmacokinetic|pharmacokinetic
1196331|NCT02049528|Healthy|healthy
1196332|NCT02049528|Male|male
1196333|NCT02049515|Phase 3|phase 3
1196334|NCT02049515|CLL/SLL|cll/sll
1196335|NCT02049515|PI3K|pi3k
1196336|NCT02049502|ulcerative colitis|ulcerative colitis
1196337|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
1196338|NCT02049489|ICT-121|ict-121
1196339|NCT02049489|glioblastoma|glioblastoma
1196340|NCT02049489|immunotherapy|immunotherapy
1196341|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
1196342|NCT02049489|CD133|cd133
1196343|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
1196344|NCT02049476|Uveitis, Posterior|uveitis, posterior
1196345|NCT02049476|Dexamethasone|dexamethasone
1196346|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
1196347|NCT02049476|Eye Abnormalities|eye abnormalities
1196348|NCT02049476|Eye Diseases|eye diseases
1196349|NCT02049476|Ophthalmology|ophthalmology
1196350|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
1196351|NCT02049476|Vision Disorders|vision disorders
1196352|NCT02049476|Inflammation|inflammation
1196353|NCT02049463|carotid artery|carotid artery
1196354|NCT02049463|sound|sound
1196355|NCT02049463|stenosis|stenosis
1196356|NCT02049463|wall|wall
1196357|NCT02049463|stroke|stroke
1196358|NCT02049450|thalassemia|thalassemia
1196359|NCT02049450|thalassemia major|thalassemia major
1196360|NCT02049450|spleen enlargement|spleen enlargement
1196361|NCT02049450|INC424|inc424
1196362|NCT02049450|ruxolitinib|ruxolitinib
1196363|NCT02049437|HIV|hiv
1196364|NCT02049437|Immune failure|immune failure
1196365|NCT02049437|Tocilizumab|tocilizumab
1196366|NCT02049437|ACTEMRA|actemra
1196367|NCT02049437|Antiretroviral therapy|antiretroviral therapy
1196368|NCT02049437|HAART|haart
1196369|NCT02049411|Ketamine|ketamine
1196370|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
1196371|NCT02049411|geriatric patients|geriatric patients
1196372|NCT02049398|Microbiome|microbiome
1196373|NCT02049398|Saliva|saliva
1196374|NCT02049398|Reliability|reliability
1196375|NCT02049398|Oral Cavity|oral cavity
1196376|NCT02049385|Glutamate|glutamate
1196377|NCT02049385|Pathophysiology|pathophysiology
1196378|NCT02049385|Depression|depression
1196379|NCT02049385|Treatment|treatment
1196380|NCT02049372|complications|complications
1196381|NCT02049372|tonsillectomy|tonsillectomy
1196382|NCT02049372|tonsillotomy|tonsillotomy
1196383|NCT02049359|Diabetes|diabetes
1196384|NCT02049346|Anemia|anemia
1196385|NCT02049346|Hemodialysis|hemodialysis
1196386|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
1196387|NCT02049346|Comparison|comparison
1196388|NCT02049294|Prednisone|prednisone
1196389|NCT02049294|Eosinophils|eosinophils
1196390|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
1196391|NCT02049294|Asthma|asthma
1196393|NCT02049294|Inflammation|inflammation
1196394|NCT02049294|Allergy|allergy
1196395|NCT02049268|alcohol|alcohol
1196396|NCT02049268|nicotine|nicotine
1196397|NCT02049268|addiction|addiction
1196398|NCT02049268|functional MRI|functional mri
1196399|NCT02049268|functional connectivity|functional connectivity
1196400|NCT02049268|brain circuits|brain circuits
1196402|NCT02049242|Hemorrhage|hemorrhage
1196403|NCT02049242|Leiomyoma|leiomyoma
1196404|NCT02049242|Myofibroma|myofibroma
1196405|NCT02049242|Uterine Myomectomy|uterine myomectomy
1196406|NCT02049242|Tourniquet|tourniquet
1196407|NCT02049229|Stent|stent
1196408|NCT02049229|Titanium|titanium
1196409|NCT02049229|drug eluting stent|drug eluting stent
1196410|NCT02049229|myocardial infarction|myocardial infarction
1196411|NCT02049229|stent thrombosis|stent thrombosis
1196412|NCT02049216|knee|knee
1196413|NCT02049216|osteoarthritis|osteoarthritis
1196414|NCT02049216|tape|tape
1196415|NCT02049216|exercise|exercise
1196416|NCT02049216|rocktape|rocktape
1196417|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
1196418|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
1196419|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
1196420|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
1196421|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
1196422|NCT02049190|Neoplasms by Site|neoplasms by site
1196423|NCT02049190|Neoplasms|neoplasms
1196424|NCT02049190|Genital Diseases, Male|genital diseases, male
1196425|NCT02049190|Prostatic Diseases|prostatic diseases
1196426|NCT02049190|onapristone|onapristone
1196427|NCT02049177|Cancer|cancer
1196428|NCT02049177|Epidemiology|epidemiology
1196429|NCT02049177|Head and Neck|head and neck
1196430|NCT02049177|HPV|hpv
1196431|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
1196432|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1196433|NCT02049151|Tecemotide|tecemotide
1196434|NCT02049151|Placebo|placebo
1196435|NCT02049151|NSCLC|nsclc
1196436|NCT02049151|L-BLP25|l-blp25
1197843|NCT02043197|Depression,|depression,
1196437|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
1196438|NCT02049138|Arthritis|arthritis
1196439|NCT02049138|Joint Diseases|joint diseases
1196440|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
1196441|NCT02049138|Antirheumatic agents|antirheumatic agents
1196442|NCT02049125|NGAL|ngal
1196443|NCT02049125|Acute kidney injury|acute kidney injury
1196444|NCT02049125|Cirrhosis|cirrhosis
1196445|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
1196446|NCT02049112|Cross-over|cross-over
1196447|NCT02049112|Salivary equivalent|salivary equivalent
1196448|NCT02049112|Dry mouth|dry mouth
1196449|NCT02049112|Medical device|medical device
1196450|NCT02049086|SBIRT|sbirt
1196451|NCT02049086|Screening|screening
1196452|NCT02049086|Brief Intervention|brief intervention
1196453|NCT02049086|Referral to Treatment|referral to treatment
1196454|NCT02049086|Pain-Management|pain-management
1196455|NCT02049086|Veterans|veterans
1196456|NCT02049073|hearing loss|hearing loss
1196457|NCT02049073|noise induced hearing loss|noise induced hearing loss
1196458|NCT02049073|zonisamide|zonisamide
1196459|NCT02049060|MPM|mpm
1196460|NCT02049060|NSCLC|nsclc
1196461|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
1196462|NCT02049034|GLP-1 agonist|glp-1 agonist
1196463|NCT02049034|Lixisenatide|lixisenatide
1196464|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
1196465|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
1196466|NCT02049034|Gastric emptying|gastric emptying
1196467|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
1196468|NCT02049021|schizophrenia|schizophrenia
1196469|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
1196470|NCT02049021|refractory Schizophrenia|refractory schizophrenia
1196471|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
1196472|NCT02049021|clozapine|clozapine
1196473|NCT02048995|Bipolar Disorder|bipolar disorder
1196474|NCT02048995|Depression|depression
1196475|NCT02048995|Light Therapy|light therapy
1196476|NCT02048995|Contrast Sensitivity|contrast sensitivity
1196477|NCT02048995|Visual Evoked Potential|visual evoked potential
1196478|NCT02048995|Visual or Neural Responses|visual or neural responses
1196479|NCT02048995|Biomarker|biomarker
1196480|NCT02048982|physician prescribing|physician prescribing
1196481|NCT02048982|behavioral economics|behavioral economics
1196482|NCT02048982|primary care practice|primary care practice
1196483|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
1196484|NCT02048969|flumazenil|flumazenil
1196485|NCT02048969|liver cirrhosis|liver cirrhosis
1196486|NCT02048956|knee osteoarthritis|knee osteoarthritis
1196487|NCT02048956|hydrotherapy|hydrotherapy
1196488|NCT02048930|GPRD|gprd
1196489|NCT02048930|effectiveness|effectiveness
1196490|NCT02048930|cost-effectiveness|cost-effectiveness
1196491|NCT02048930|Easyhaler|easyhaler
1196492|NCT02048930|Primary care|primary care
1196493|NCT02048930|DPI|dpi
1196494|NCT02048917|Smoking|smoking
1196495|NCT02048917|Cessation|cessation
1196496|NCT02048917|Bupropion|bupropion
1196497|NCT02048917|Varenicline|varenicline
1196498|NCT02048917|Nicotine|nicotine
1196499|NCT02048917|Counseling|counseling
1196500|NCT02048917|Tobacco|tobacco
1196501|NCT02048904|microalbuminuria|microalbuminuria
1196502|NCT02048904|type 2 diabetes|type 2 diabetes
1196503|NCT02048878|Insomnia|insomnia
1196504|NCT02048865|VTE Cancer|vte cancer
1196505|NCT02048852|menthol|menthol
1196506|NCT02048852|nicotine|nicotine
1196507|NCT02048826|stroke|stroke
1196508|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
1196509|NCT02048800|Children|children
1196510|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
1196511|NCT02048787|Renal impairment|renal impairment
1196512|NCT02048787|Healthy volunteers|healthy volunteers
1196513|NCT02048787|Clinical pharmacology study|clinical pharmacology study
1196514|NCT02048748|Home Care Services|home care services
1196515|NCT02048748|Telemedicine|telemedicine
1196516|NCT02048696|Exercise training|exercise training
1196517|NCT02048696|High intensity interval training|high intensity interval training
1196518|NCT02048696|left ventricular systolic function|left ventricular systolic function
1196519|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
1196520|NCT02048696|heart failure|heart failure
1196521|NCT02048696|myocardial infarction|myocardial infarction
1196522|NCT02048696|coronary artery disease|coronary artery disease
1196523|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
1196524|NCT02048683|Pharmacokinetics|pharmacokinetics
1196525|NCT02048683|Sevoflurane|sevoflurane
1196526|NCT02048683|Burn|burn
1196527|NCT02048683|Sedation|sedation
1196528|NCT02048670|Pilot study|pilot study
1196529|NCT02048670|Assessment of sway phase|assessment of sway phase
1196530|NCT02048670|Therapy trial phase|therapy trial phase
1196531|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
1196532|NCT02048644|Platelets adhesion|platelets adhesion
1196533|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
1196534|NCT02048618|Active Crohn's Disease|active crohn's disease
1196535|NCT02048618|GLPG0634|glpg0634
1196536|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
1196537|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
1196538|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
1196539|NCT02048566|Shock|shock
1196540|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
1196541|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1196542|NCT02048514|Endovascular Procedures|endovascular procedures
1196543|NCT02048501|Weight regain|weight regain
1196544|NCT02048501|Sustain weight loss|sustain weight loss
1196545|NCT02048501|Weight loss|weight loss
1196546|NCT02048501|Gut hormones|gut hormones
1196547|NCT02048488|non small cell lung cancer|non small cell lung cancer
1196548|NCT02048488|NSCLC|nsclc
1196549|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
1196550|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
1196551|NCT02048488|ALK+|alk+
1196552|NCT02048488|TRK+|trk+
1196553|NCT02048488|ALK inhibitor|alk inhibitor
1196554|NCT02048488|TRK inhibitor|trk inhibitor
1196555|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
1196556|NCT02048488|TRKA|trka
1196557|NCT02048488|TRKB|trkb
1196558|NCT02048488|TRKC|trkc
1196559|NCT02048488|advanced malignancy|advanced malignancy
1196560|NCT02048475|desflurane|desflurane
1196561|NCT02048475|electroencephalogram|electroencephalogram
1196562|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
1196563|NCT02048436|Respiratory Rate|respiratory rate
1196564|NCT02048423|suicidal|suicidal
1196565|NCT02048397|Bronchiectasis.|bronchiectasis.
1196566|NCT02048384|rapamycin|rapamycin
1196567|NCT02048384|metformin|metformin
1196568|NCT02048384|pancreatic cancer|pancreatic cancer
1196569|NCT02048384|adenocarcinoma|adenocarcinoma
1196570|NCT02048384|metastatic|metastatic
1196571|NCT02048358|Healthy volunteers|healthy volunteers
1196572|NCT02048358|first in human|first in human
1196573|NCT02048358|2B3-201|2b3-201
1196574|NCT02048358|methylprednisolone|methylprednisolone
1196575|NCT02048358|CNS-targeting|cns-targeting
1196576|NCT02048358|liposomal|liposomal
1196577|NCT02048358|crossover|crossover
1196578|NCT02048358|placebo controlled|placebo controlled
1196579|NCT02048358|active controlled|active controlled
1196580|NCT02048358|multiple sclerosis|multiple sclerosis
1196581|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
1196582|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
1196583|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
1196584|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
1196980|NCT02046837|Adherence|adherence
1196585|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
1196586|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
1196587|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
1196588|NCT02048332|t-cells|t-cells
1196589|NCT02048332|donor|donor
1196590|NCT02048332|transplant|transplant
1196591|NCT02048332|children|children
1196592|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
1196593|NCT02048332|BK virus (BKV)|bk virus (bkv)
1196594|NCT02048319|Liver cyst|liver cyst
1196595|NCT02048319|Hepatic cyst|hepatic cyst
1196596|NCT02048319|Symptomatic|symptomatic
1196597|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
1196598|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1196599|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
1196600|NCT02048306|Family|family
1196601|NCT02048306|Integrated care|integrated care
1196602|NCT02048306|Mixed methods|mixed methods
1196603|NCT02048293|remifentanil|remifentanil
1196604|NCT02048293|propofol|propofol
1196605|NCT02048293|pharmacodynamic|pharmacodynamic
1196606|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
1196607|NCT02048293|orotracheal intubation|orotracheal intubation
1196608|NCT02048293|heart rate|heart rate
1196609|NCT02048293|mean arterial pressure|mean arterial pressure
1196610|NCT02048293|Cooper intubation condition score|cooper intubation condition score
1196611|NCT02048267|Alcoholic|alcoholic
1196612|NCT02048267|Non alcoholic|non alcoholic
1196613|NCT02048267|Idiopathic|idiopathic
1196614|NCT02048267|Tropical|tropical
1196615|NCT02048267|Exocrine dysfunction|exocrine dysfunction
1196616|NCT02048267|Endocrine dysfunction|endocrine dysfunction
1196617|NCT02048267|Pain control|pain control
1196618|NCT02048267|Frey's procedure|frey's procedure
1196619|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
1196620|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
1196621|NCT02048254|brachytherapy|brachytherapy
1196622|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1196623|NCT02048241|childhood|childhood
1196624|NCT02048241|temper|temper
1196625|NCT02048241|explosive|explosive
1196626|NCT02048241|aggression|aggression
1196627|NCT02048241|tantrums|tantrums
1196628|NCT02048241|oppositional|oppositional
1196629|NCT02048241|defiant|defiant
1196630|NCT02048241|conduct|conduct
1196631|NCT02048241|disruptive|disruptive
1196632|NCT02048241|emotional dysregulation|emotional dysregulation
1196633|NCT02048241|special education|special education
1196634|NCT02048228|Clopidogrel,|clopidogrel,
1196635|NCT02048228|Pharmacogenetics,|pharmacogenetics,
1196636|NCT02048228|Platelet reactivity,|platelet reactivity,
1196637|NCT02048228|CYP2C19,|cyp2c19,
1196638|NCT02048228|point-of-care|point-of-care
1196639|NCT02048215|thermogenesis|thermogenesis
1196640|NCT02048215|low-calorie diet|low-calorie diet
1196641|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
1196642|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
1196643|NCT02048215|thermogenic drugs|thermogenic drugs
1196644|NCT02048202|clown|clown
1196645|NCT02048202|neonate|neonate
1196646|NCT02048202|premature|premature
1196647|NCT02048176|Mutism|mutism
1196648|NCT02048163|Meropenem|meropenem
1196649|NCT02048163|Nausea|nausea
1196650|NCT02048163|Pharmacokinetics|pharmacokinetics
1196651|NCT02048124|25d ProCor needle|25d procor needle
1196652|NCT02048124|22 gauge|22 gauge
1196653|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
1196654|NCT02048124|fine needle biopsies|fine needle biopsies
1196655|NCT02048124|Patients|patients
1196656|NCT02048124|presenting|presenting
1196657|NCT02048111|Hemophilia B|hemophilia b
1196658|NCT02048111|Hemophilia A|hemophilia a
1196659|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
1196660|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
1196661|NCT02048111|Hematologic Diseases|hematologic diseases
1196662|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
1196663|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
1196664|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
1196665|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
1196666|NCT02048098|misoprostol|misoprostol
1196667|NCT02048098|Labor, Induced|labor, induced
1196668|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
1196669|NCT02048098|Abortion, Induced|abortion, induced
1196670|NCT02048085|ACS|acs
1196671|NCT02048085|STEMI|stemi
1196672|NCT02048085|Fibrinolysis|fibrinolysis
1196673|NCT02048085|Pharmacodynamics|pharmacodynamics
1196674|NCT02048085|Pharmacokinetics|pharmacokinetics
1196675|NCT02048085|Plavix|plavix
1196676|NCT02048085|Brilinta|brilinta
1196677|NCT02048085|Ticagrelor|ticagrelor
1196678|NCT02048085|Clopidogrel|clopidogrel
1196679|NCT02048072|relapsing remitting|relapsing remitting
1196680|NCT02048072|multiple sclerosis|multiple sclerosis
1196681|NCT02048072|fingolimod|fingolimod
1196682|NCT02048072|Gilenya|gilenya
1196683|NCT02048072|autonomic nervous system|autonomic nervous system
1196684|NCT02048059|ANG1005|ang1005
1196685|NCT02048059|GRN1005|grn1005
1196686|NCT02048059|Low-density lipoprotein receptor-related protein (LRP-1)|low-density lipoprotein receptor-related protein (lrp-1)
1196687|NCT02048059|Targeted therapy|targeted therapy
1196688|NCT02048059|Breast cancer|breast cancer
1196689|NCT02048059|Brain metastases|brain metastases
1196690|NCT02048059|Brain tumor|brain tumor
1196691|NCT02048059|Blood-brain barrier|blood-brain barrier
1196692|NCT02048059|Trastuzumab|trastuzumab
1196693|NCT02048059|Herceptin|herceptin
1196694|NCT02048059|Paclitaxel|paclitaxel
1196695|NCT02048059|Taxol|taxol
1196696|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
1196697|NCT02048059|Triple Negative|triple negative
1196698|NCT02048059|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1196699|NCT02048059|Herceptin 2 (HER2)-positive|herceptin 2 (her2)-positive
1196700|NCT02048059|HER2-negative|her2-negative
1196701|NCT02048059|Metastatic brain tumors|metastatic brain tumors
1196702|NCT02048046|ECMO|ecmo
1196703|NCT02048046|Nutrition therapy|nutrition therapy
1196704|NCT02048033|Obesity|obesity
1196705|NCT02048033|Endogastric suturing|endogastric suturing
1196706|NCT02048033|Jujenal anastomosis|jujenal anastomosis
1196707|NCT02048033|weight regain|weight regain
1196708|NCT02048007|Childhood mortality|childhood mortality
1196709|NCT02048007|Azithromycin|azithromycin
1196710|NCT02048007|Mass treatment|mass treatment
1196711|NCT02048007|Infection|infection
1196712|NCT02048007|Bacterial infections|bacterial infections
1196713|NCT02048007|Trachoma|trachoma
1196714|NCT02048007|Chlamydia infections|chlamydia infections
1196715|NCT02048007|Malaria|malaria
1196716|NCT02048007|Diarrhea|diarrhea
1196717|NCT02048007|Respiratory Infections|respiratory infections
1196718|NCT02048007|Antibiotic resistance|antibiotic resistance
1196719|NCT02048007|Verbal Autopsy|verbal autopsy
1196720|NCT02048007|Microbiome|microbiome
1196721|NCT02047994|Gastric cancer|gastric cancer
1196722|NCT02047994|Gastric cancer mortality|gastric cancer mortality
1196723|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
1196724|NCT02047994|Pepsinogen testing|pepsinogen testing
1196725|NCT02047994|Endoscopy|endoscopy
1196726|NCT02047994|Volatile marker|volatile marker
1196727|NCT02047981|Childhood mortality|childhood mortality
1196728|NCT02047981|Azithromycin|azithromycin
1196729|NCT02047981|Mass treatment|mass treatment
1196730|NCT02047981|Infection|infection
1196731|NCT02047981|Verbal Autopsy|verbal autopsy
1196732|NCT02047968|Wake therapy|wake therapy
1196733|NCT02047968|Sleep deprivation|sleep deprivation
1196734|NCT02047968|Light therapy|light therapy
1196735|NCT02047968|Bipolar depression|bipolar depression
1196736|NCT02047968|Sleep-wake cycle|sleep-wake cycle
1196737|NCT02047968|Major depression|major depression
1196738|NCT02047968|Depression|depression
1196739|NCT02047968|Depressive Disorder|depressive disorder
1196740|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
1196741|NCT02047968|Mood Disorders|mood disorders
1196742|NCT02047968|Mental Disorders|mental disorders
1196743|NCT02047968|Dyssomnias|dyssomnias
1196744|NCT02047968|Sleep Disorders|sleep disorders
1196745|NCT02047968|Affective Disorders|affective disorders
1196746|NCT02047929|Asthma|asthma
1196747|NCT02047929|Shared decision making|shared decision making
1196748|NCT02047929|Participatory methods|participatory methods
1196749|NCT02047929|Practice facilitator|practice facilitator
1196750|NCT02047929|Health coach|health coach
1196751|NCT02047916|Neonates|neonates
1196752|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
1196753|NCT02047916|Pleth variabilty index|pleth variabilty index
1196754|NCT02047890|CDK inhibitor|cdk inhibitor
1196755|NCT02047890|BAY1000394|bay1000394
1196756|NCT02047890|Advanced malignancies|advanced malignancies
1196757|NCT02047890|Japanese|japanese
1196758|NCT02047877|Respiratory Secretions|respiratory secretions
1196759|NCT02047877|Tracheal Secretions|tracheal secretions
1196760|NCT02047877|Bronchial Secretions|bronchial secretions
1196761|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
1196762|NCT02047877|Interleukin 10|interleukin 10
1196763|NCT02047877|Interleukin 12p70|interleukin 12p70
1196764|NCT02047864|Osteoporosis|osteoporosis
1196765|NCT02047864|Sarcopenia|sarcopenia
1196766|NCT02047864|Strength|strength
1196767|NCT02047864|Bone|bone
1196768|NCT02047864|Muscle|muscle
1196769|NCT02047864|Creatine|creatine
1196770|NCT02047825|Multiple sclerosis|multiple sclerosis
1196771|NCT02047825|Dexterity|dexterity
1196772|NCT02047825|Upper limbs|upper limbs
1196773|NCT02047812|Laparotomy|laparotomy
1196774|NCT02047812|General Surgery|general surgery
1196775|NCT02047812|Hospitals,General|hospitals,general
1196776|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
1196777|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
1196778|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
1196779|NCT02047799|elderly people, high blood pressure, vitamin D.|elderly people, high blood pressure, vitamin d.
1196780|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
1196781|NCT02047786|Appendectomy|appendectomy
1196782|NCT02047786|Child|child
1196783|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
1196784|NCT02047786|Hospitals, General|hospitals, general
1196785|NCT02047773|bronchiectasis|bronchiectasis
1196786|NCT02047773|intravenous antibiotics|intravenous antibiotics
1196787|NCT02047773|duration of antibiotic course|duration of antibiotic course
1196788|NCT02047773|side effects|side effects
1196789|NCT02047773|bacterial load|bacterial load
1196790|NCT02047747|Brain|brain
1196791|NCT02047747|Metastasis|metastasis
1196792|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
1196793|NCT02047695|migraine with aura|migraine with aura
1196794|NCT02047695|migraine|migraine
1196795|NCT02047695|case-control study|case-control study
1196796|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
1196797|NCT02047695|brain diseases|brain diseases
1196798|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
1196799|NCT02047643|Type 1 diabetes|type 1 diabetes
1196800|NCT02047643|Hypoglycemia|hypoglycemia
1196801|NCT02047643|Accelerometer|accelerometer
1196802|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
1196803|NCT02047630|Ocular hypertension|ocular hypertension
1196804|NCT02047630|latanoprost|latanoprost
1196805|NCT02047630|generic|generic
1196806|NCT02047630|intraocular pressure|intraocular pressure
1196807|NCT02047617|Muscle Weakness|muscle weakness
1196808|NCT02047617|Exercise therapy|exercise therapy
1196809|NCT02047617|Physiotherapy|physiotherapy
1196810|NCT02047617|Critical illness|critical illness
1196811|NCT02047617|Intensive care|intensive care
1196812|NCT02047617|Mechanical ventilation|mechanical ventilation
1196813|NCT02047617|Rehabilitation|rehabilitation
1196814|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
1196815|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1196816|NCT02047565|punch biopsy|punch biopsy
1196817|NCT02047552|trauma|trauma
1196818|NCT02047552|iron|iron
1196819|NCT02047552|anemia|anemia
1196820|NCT02047552|red blood cell transfusion|red blood cell transfusion
1196821|NCT02047526|Heart Failure|heart failure
1196822|NCT02047526|Cardiovascular disease|cardiovascular disease
1196823|NCT02047526|Congestive Heart Failure|congestive heart failure
1196824|NCT02047500|TH-302|th-302
1196825|NCT02047500|Nab-paclitaxel|nab-paclitaxel
1196826|NCT02047500|Gemcitabine|gemcitabine
1196827|NCT02047500|Evofosfamide|evofosfamide
1196828|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
1196829|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
1196830|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
1196831|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
1196832|NCT02047461|aldehyde oxidase|aldehyde oxidase
1196833|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
1196834|NCT02047448|transition of care|transition of care
1196835|NCT02047448|care transitions|care transitions
1196836|NCT02047448|readmission|readmission
1196837|NCT02047448|medication|medication
1196838|NCT02047448|adherence|adherence
1196839|NCT02047448|medication management|medication management
1196840|NCT02047448|medication reconciliation|medication reconciliation
1196841|NCT02047448|patient counseling|patient counseling
1196842|NCT02047448|pharmacist|pharmacist
1196843|NCT02047435|Social participation|social participation
1196844|NCT02047435|Loneliness|loneliness
1196845|NCT02047435|General practice|general practice
1196846|NCT02047435|Cultural institutions|cultural institutions
1196847|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
1196848|NCT02047383|respiratory infection|respiratory infection
1196849|NCT02047383|physical variables|physical variables
1196850|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
1196851|NCT02047357|Maternal depression|maternal depression
1196852|NCT02047357|Mother|mother
1196853|NCT02047357|Child|child
1196854|NCT02047357|LTP|ltp
1196855|NCT02047357|Learning Through Play|learning through play
1196856|NCT02047357|Healthy thinking|healthy thinking
1196857|NCT02047344|NSCLC|nsclc
1196858|NCT02047331|periarticular drug injection|periarticular drug injection
1196859|NCT02047331|fascia iliaca block|fascia iliaca block
1196860|NCT02047331|knee arthroplasty|knee arthroplasty
1196861|NCT02047305|ESCN|escn
1196862|NCT02047305|RFA|rfa
1196863|NCT02047292|Gait analysis|gait analysis
1196864|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
1196865|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
1196866|NCT02047292|Neck-cup impingement|neck-cup impingement
1196867|NCT02047292|Head-neck ratio|head-neck ratio
1196868|NCT02047292|Hip scores|hip scores
1196869|NCT02047292|Functional assessment|functional assessment
1196870|NCT02047292|Cup size|cup size
1196871|NCT02047292|Range of motion|range of motion
1196872|NCT02047292|Unilateral Primary|unilateral primary
1196873|NCT02047292|Secondary|secondary
1196874|NCT02047279|Atrial fibrillation|atrial fibrillation
1196875|NCT02047279|Mitral valve|mitral valve
1196876|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
1196877|NCT02047253|carfilzomib|carfilzomib
1196878|NCT02047253|prostate cancer|prostate cancer
1197086|NCT02046356|recurrence|recurrence
1196879|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
1196880|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
1196881|NCT02047240|liver cirrhosis|liver cirrhosis
1196882|NCT02047240|glomerular filtration|glomerular filtration
1196883|NCT02047240|cystatin C|cystatin c
1196884|NCT02047227|ESPART|espart
1196885|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
1196886|NCT02047227|Infertility|infertility
1196887|NCT02047227|Pergoveris®|pergoveris®
1196888|NCT02047227|GONAL-f®|gonal-f®
1196889|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
1196890|NCT02047214|Glioblastoma|glioblastoma
1196891|NCT02047214|Radiotherapy|radiotherapy
1196892|NCT02047214|Temozolomide|temozolomide
1196893|NCT02047214|TPI 287|tpi 287
1196894|NCT02047214|Taxoid|taxoid
1196895|NCT02047214|Avastin|avastin
1196896|NCT02047214|Bevacizumab|bevacizumab
1196897|NCT02047201|Head and neck cancer|head and neck cancer
1196898|NCT02047201|PET/CT|pet/ct
1196899|NCT02047201|induction chemotherapy|induction chemotherapy
1196900|NCT02047201|IMRT|imrt
1196901|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
1196902|NCT02047162|diarrhea|diarrhea
1196903|NCT02047162|gastroenteritis|gastroenteritis
1196904|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
1196905|NCT02047162|antimicrobial agents|antimicrobial agents
1196906|NCT02047162|Pakistan|pakistan
1196907|NCT02047162|ambulatory care|ambulatory care
1196908|NCT02047162|bismuth|bismuth
1196909|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
1196910|NCT02047123|commercial flaxseed|commercial flaxseed
1196911|NCT02047123|cholesterol|cholesterol
1196912|NCT02047123|lipidic profile|lipidic profile
1196913|NCT02047123|yoghurt|yoghurt
1196914|NCT02047123|consumption|consumption
1196915|NCT02047110|ABBV-066|abbv-066
1196916|NCT02047110|BI 655066|bi 655066
1196917|NCT02047110|risankizumab|risankizumab
1196918|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
1196919|NCT02047071|Female gender|female gender
1196920|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
1196921|NCT02047058|biomarker|biomarker
1196922|NCT02047058|Q cell|q cell
1196923|NCT02047058|Overall survival|overall survival
1196924|NCT02047058|Progression-free survival|progression-free survival
1196925|NCT02047045|severe chronic constipation|severe chronic constipation
1196926|NCT02047045|randomized controlled|randomized controlled
1196927|NCT02047045|electro-acupuncture|electro-acupuncture
1196928|NCT02047045|prucalopride|prucalopride
1196929|NCT02047032|electroacupuncture|electroacupuncture
1196930|NCT02047032|urinary incontinence|urinary incontinence
1196931|NCT02047032|PFMT|pfmt
1196932|NCT02047032|Solifenacin|solifenacin
1196933|NCT02047019|Drug combination|drug combination
1196934|NCT02047019|Nifedipine GITS|nifedipine gits
1196935|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
1196936|NCT02047019|Hypertension|hypertension
1196937|NCT02047019|Combination therapy|combination therapy
1196938|NCT02047006|Hemodialysis|hemodialysis
1196939|NCT02047006|Rivaroxaban|rivaroxaban
1196940|NCT02047006|AUC|auc
1196941|NCT02046993|Hypertension|hypertension
1196942|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
1196943|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
1196944|NCT02046993|primary care|primary care
1196945|NCT02046967|endovenous laser ablation|endovenous laser ablation
1196946|NCT02046967|endovenous steam ablation|endovenous steam ablation
1196947|NCT02046967|great saphenous veins|great saphenous veins
1196948|NCT02046967|quality of life|quality of life
1196949|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
1196950|NCT02046954|tee|tee
1196951|NCT02046954|toe|toe
1196952|NCT02046954|cardiac surgery|cardiac surgery
1196953|NCT02046941|aphasia|aphasia
1196954|NCT02046941|stroke|stroke
1196955|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
1196956|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1196957|NCT02046928|Leukemia|leukemia
1196958|NCT02046928|Lymphoma|lymphoma
1196959|NCT02046902|coronary artery disease|coronary artery disease
1196960|NCT02046902|cardiac stent|cardiac stent
1196961|NCT02046902|PCI procedure|pci procedure
1196962|NCT02046902|Patient preference|patient preference
1196963|NCT02046876|neck pain|neck pain
1196964|NCT02046876|physiotherapy|physiotherapy
1196965|NCT02046876|adapted swimming|adapted swimming
1196966|NCT02046876|therapeutic exercises|therapeutic exercises
1196967|NCT02046876|health education|health education
1196968|NCT02046863|Parkinson's disease|parkinson's disease
1196969|NCT02046863|Tremor|tremor
1196970|NCT02046863|Bradykinesia|bradykinesia
1196971|NCT02046863|Deep brain stimulation|deep brain stimulation
1196972|NCT02046863|Kinesia|kinesia
1196973|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
1196974|NCT02046837|Prostate cancer|prostate cancer
1196975|NCT02046837|Exercise|exercise
1196976|NCT02046837|Elderly|elderly
1196977|NCT02046837|Quality of life|quality of life
1196978|NCT02046837|Fatigue|fatigue
1196979|NCT02046837|Physical fitness|physical fitness
1196981|NCT02046837|Cost-effectiveness|cost-effectiveness
1196982|NCT02046811|Skin neoplasms|skin neoplasms
1196983|NCT02046811|Radiation|radiation
1196984|NCT02046811|Screening|screening
1196985|NCT02046811|Self-examination|self-examination
1196986|NCT02046811|Comparative effectiveness research|comparative effectiveness research
1196987|NCT02046811|Dermoscopy|dermoscopy
1196988|NCT02046798|Pharmacokinetics|pharmacokinetics
1196989|NCT02046798|ASP3652|asp3652
1196990|NCT02046798|14C radio-labeled|14c radio-labeled
1196991|NCT02046798|Phase 1|phase 1
1196992|NCT02046785|Fluid administration|fluid administration
1196993|NCT02046785|Cardiac output|cardiac output
1196994|NCT02046785|Right atrial pressure|right atrial pressure
1196995|NCT02046785|Resuscitation|resuscitation
1196996|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
1196997|NCT02046772|analgesia|analgesia
1196998|NCT02046772|anaesthetic|anaesthetic
1196999|NCT02046772|bupivacaine|bupivacaine
1197000|NCT02046772|morphine chloride|morphine chloride
1197001|NCT02046733|SCLC|sclc
1197002|NCT02046733|CTLA-4|ctla-4
1197003|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1197004|NCT02046694|ALL|all
1197005|NCT02046694|pediatric|pediatric
1197006|NCT02046694|maintenance|maintenance
1197007|NCT02046694|allopurinol|allopurinol
1197008|NCT02046694|6-MP|6-mp
1197009|NCT02046694|6-mercaptopurine|6-mercaptopurine
1197010|NCT02046681|Medication Adherence|medication adherence
1197011|NCT02046681|Medication Compliance|medication compliance
1197012|NCT02046681|Medication Therapy Management|medication therapy management
1197013|NCT02046681|Side effects|side effects
1197014|NCT02046681|Analgesics|analgesics
1197015|NCT02046681|Emergency Medicine|emergency medicine
1197016|NCT02046681|Home care|home care
1197017|NCT02046681|Aged|aged
1197018|NCT02046681|Acetaminophen|acetaminophen
1197019|NCT02046681|codeine|codeine
1197020|NCT02046681|ibuprofen|ibuprofen
1197021|NCT02046681|Oxycodone|oxycodone
1197022|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
1197023|NCT02046642|Amniotic fluid index;|amniotic fluid index;
1197024|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
1197025|NCT02046642|intervention studies;|intervention studies;
1197026|NCT02046642|maternal care patterns;|maternal care patterns;
1197027|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
1197028|NCT02046642|rest;|rest;
1197029|NCT02046642|sonography;|sonography;
1197030|NCT02046642|transplacental exposure|transplacental exposure
1197031|NCT02046590|Propofol|propofol
1197032|NCT02046590|remifentanil|remifentanil
1197033|NCT02046590|safety|safety
1197034|NCT02046590|gastro-intestinal|gastro-intestinal
1197035|NCT02046590|ERCP|ercp
1197036|NCT02046590|minimally invasive|minimally invasive
1197037|NCT02046590|intubation|intubation
1197038|NCT02046590|ventilation|ventilation
1333259|NCT01443780|dietary supplement|dietary supplement
1272262|NCT01705873|HIV|hiv
1197039|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
1197040|NCT02046577|vitamin D|vitamin d
1197041|NCT02046577|cholecalciferol|cholecalciferol
1197042|NCT02046577|children|children
1197043|NCT02046577|bronchiolitis|bronchiolitis
1197044|NCT02046577|pneumonia|pneumonia
1197045|NCT02046577|prevention|prevention
1197046|NCT02046551|nicotine|nicotine
1197047|NCT02046551|smoking|smoking
1197048|NCT02046551|atomoxetine|atomoxetine
1197049|NCT02046551|stress|stress
1197050|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
1197051|NCT02046512|Probiotics|probiotics
1197052|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
1197053|NCT02046486|ticagrelor|ticagrelor
1197054|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
1197055|NCT02046486|liquid formulation|liquid formulation
1197056|NCT02046447|dystonia|dystonia
1197057|NCT02046447|cervical dystonia|cervical dystonia
1197058|NCT02046447|DYT1|dyt1
1197059|NCT02046447|DYT 1|dyt 1
1197060|NCT02046447|DYT-1|dyt-1
1197061|NCT02046447|Dystonia 1|dystonia 1
1197062|NCT02046447|fMRI|fmri
1197063|NCT02046447|healthy|healthy
1197064|NCT02046447|trihexyphenidyl|trihexyphenidyl
1197065|NCT02046447|Artane|artane
1197066|NCT02046447|Apo-Trihex|apo-trihex
1197067|NCT02046447|Parkin|parkin
1197068|NCT02046447|Pacitane|pacitane
1197069|NCT02046447|Benzhexol|benzhexol
1197070|NCT02046447|Trihex|trihex
1197071|NCT02046408|Smoking|smoking
1197072|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
1197073|NCT02046408|tailored health messages|tailored health messages
1197074|NCT02046408|Patient-facing information technology|patient-facing information technology
1197075|NCT02046408|Mobile health|mobile health
1197076|NCT02046408|behavioral health|behavioral health
1197077|NCT02046395|Type 2 Diabetes|type 2 diabetes
1197078|NCT02046395|Hypertension|hypertension
1197079|NCT02046382|IV Acetaminophen|iv acetaminophen
1197080|NCT02046382|Cesarean Section|cesarean section
1197081|NCT02046382|Pain, Postoperative|pain, postoperative
1197082|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
1197083|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
1197084|NCT02046356|radiofrequency ablation|radiofrequency ablation
1197085|NCT02046356|Milan Criteria|milan criteria
1197087|NCT02046356|risk factor|risk factor
1197088|NCT02046343|physical activity|physical activity
1197089|NCT02046343|prevention|prevention
1197090|NCT02046343|health disparities|health disparities
1197091|NCT02046343|behavior|behavior
1197092|NCT02046343|community based intervention|community based intervention
1197093|NCT02046330|Deep Brain Stimulation|deep brain stimulation
1197094|NCT02046330|Treatment Resistant Depression|treatment resistant depression
1197095|NCT02046330|Major Depressive Disorder|major depressive disorder
1197096|NCT02046330|Depression|depression
1197097|NCT02046330|ECT|ect
1197098|NCT02046330|TNS|tns
1197099|NCT02046304|Sarcoma|sarcoma
1197100|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
1197101|NCT02046304|STS|sts
1197102|NCT02046304|Extremity and Trunk|extremity and trunk
1197103|NCT02046304|Gemcitabine|gemcitabine
1197104|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1197105|NCT02046304|Gemzar|gemzar
1197106|NCT02046304|External beam radiation therapy|external beam radiation therapy
1197107|NCT02046304|EBRT|ebrt
1197108|NCT02046304|Radiotherapy|radiotherapy
1197109|NCT02046304|XRT|xrt
1197110|NCT02046291|umbilical cord transplant|umbilical cord transplant
1197111|NCT02046291|acute leukemia|acute leukemia
1197112|NCT02046291|UCBT|ucbt
1197113|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
1197114|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
1197115|NCT02046291|Multiple Myeloma|multiple myeloma
1197116|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
1197117|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1197118|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
1197119|NCT02046265|Cervical cancer prevention|cervical cancer prevention
1197120|NCT02046226|Critical Limb Ischemia|critical limb ischemia
1197121|NCT02046226|Non Healing Wounds|non healing wounds
1197122|NCT02046226|Diabetic Wounds|diabetic wounds
1197123|NCT02046226|Foot Ulcers|foot ulcers
1197124|NCT02046213|Metabolism and Excretion|metabolism and excretion
1197236|NCT02045862|Overactive Bladder|overactive bladder
1197125|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
1197126|NCT02046187|Ketogenic Diet|ketogenic diet
1197127|NCT02046187|Brain tumor|brain tumor
1197128|NCT02046187|Glioma|glioma
1197129|NCT02046187|Glioblastoma|glioblastoma
1197130|NCT02046187|Radiation|radiation
1197131|NCT02046187|Chemotherapy|chemotherapy
1197132|NCT02046187|temozolomide|temozolomide
1197133|NCT02046174|colon|colon
1197134|NCT02046174|colorectal|colorectal
1197135|NCT02046174|rectal|rectal
1197136|NCT02046174|cancer|cancer
1197137|NCT02046174|macrobead|macrobead
1197138|NCT02046174|stage IV|stage iv
1197139|NCT02046174|metastatic|metastatic
1197140|NCT02046174|biological|biological
1197141|NCT02046174|mouse cells|mouse cells
1197142|NCT02046174|new york|new york
1197143|NCT02046174|new jersey|new jersey
1197144|NCT02046174|clinical research|clinical research
1197145|NCT02046161|colon preparation|colon preparation
1197146|NCT02046148|Maternal vaccine|maternal vaccine
1197147|NCT02046148|IgG|igg
1197148|NCT02046148|IgA|iga
1197149|NCT02046148|GBS|gbs
1197150|NCT02046148|pregnant women|pregnant women
1197151|NCT02046135|Pediatric|pediatric
1197152|NCT02046135|Sodium bicarbonate|sodium bicarbonate
1197153|NCT02046135|Acute kidney injury|acute kidney injury
1197154|NCT02046135|Cardiac surgery|cardiac surgery
1197155|NCT02046109|Repair|repair
1197156|NCT02046109|Replace|replace
1197157|NCT02046109|Composite|composite
1197158|NCT02046109|restoration|restoration
1197159|NCT02046109|failing dental restoration|failing dental restoration
1197160|NCT02046109|filling|filling
1197161|NCT02046109|dental|dental
1197162|NCT02046109|dentistry|dentistry
1197163|NCT02046096|Venous thrombosis|venous thrombosis
1197164|NCT02046096|pulmonary embolism|pulmonary embolism
1197165|NCT02046096|vena cava, inferior|vena cava, inferior
1197166|NCT02046096|vena cava filters|vena cava filters
1197167|NCT02046096|venous thromboembolism|venous thromboembolism
1197168|NCT02046083|Teenager|teenager
1197169|NCT02046083|Peanut|peanut
1197170|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
1197171|NCT02046070|MLN9708|mln9708
1197172|NCT02046070|Newly diagnosed|newly diagnosed
1197173|NCT02046070|NDMM|ndmm
1197174|NCT02046070|IXAZOMIB|ixazomib
1197175|NCT02046070|RRMM|rrmm
1197176|NCT02046057|Sentinel Lymph Node|sentinel lymph node
1197177|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
1197178|NCT02046044|Heart failure|heart failure
1197179|NCT02046044|Digoxin|digoxin
1197180|NCT02046044|Ivabradine|ivabradine
1197181|NCT02046031|Ischemic stroke|ischemic stroke
1197182|NCT02046031|safety|safety
1197183|NCT02046031|Pharmacokinetics|pharmacokinetics
1197184|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
1197185|NCT02046018|Maternal and Child Health|maternal and child health
1197186|NCT02046018|Rural Uganda|rural uganda
1197187|NCT02046005|Family History|family history
1197188|NCT02046005|RA|ra
1197189|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
1197190|NCT02046005|Genetics|genetics
1197191|NCT02046005|Rheumatoid Factor|rheumatoid factor
1197192|NCT02046005|Shared Epitope|shared epitope
1197193|NCT02046005|Anti-CCP|anti-ccp
1197194|NCT02045953|Healthy Subjects|healthy subjects
1197195|NCT02045953|SERETIDE|seretide
1197196|NCT02045953|Pharmocokinetics|pharmocokinetics
1197197|NCT02045953|FLIXOTIDE|flixotide
1197198|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
1197200|NCT02045940|pharmacokinetics|pharmacokinetics
1197201|NCT02045940|SARM|sarm
1197202|NCT02045940|safety|safety
1197203|NCT02045927|sedation|sedation
1197204|NCT02045927|BIS|bis
1197205|NCT02045927|monitoring|monitoring
1197206|NCT02045914|calcium ionophore|calcium ionophore
1197207|NCT02045914|fertilization rate|fertilization rate
1197208|NCT02045914|poor ovarian reserve|poor ovarian reserve
1197209|NCT02045901|Nausea|nausea
1197210|NCT02045901|Vomiting|vomiting
1197211|NCT02045901|Pregnancy|pregnancy
1197212|NCT02045901|Adolescent|adolescent
1197213|NCT02045901|Diclegis|diclegis
1197214|NCT02045901|Morning|morning
1197215|NCT02045901|Sickness|sickness
1197216|NCT02045888|Hamstring|hamstring
1197217|NCT02045888|Tear|tear
1197218|NCT02045888|Muscle|muscle
1197219|NCT02045888|Grade|grade
1197220|NCT02045888|adipose|adipose
1197221|NCT02045888|cells|cells
1197222|NCT02045888|regenerative|regenerative
1197223|NCT02045888|Celution|celution
1197224|NCT02045888|stem|stem
1197225|NCT02045888|cell|cell
1197226|NCT02045888|liposuction|liposuction
1197227|NCT02045888|fat|fat
1197228|NCT02045875|Adherence monitoring|adherence monitoring
1197229|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
1197230|NCT02045862|Solifenacin Succinate|solifenacin succinate
1197231|NCT02045862|Mirabegron|mirabegron
1197232|NCT02045862|Urinary Incontinence|urinary incontinence
1197233|NCT02045862|Combination Therapy|combination therapy
1197234|NCT02045862|Urgency|urgency
1197235|NCT02045862|Nocturia|nocturia
1197338|NCT02045316|Aquaporins|aquaporins
1197237|NCT02045849|pharmacokinetics|pharmacokinetics
1197238|NCT02045849|GSK2140944|gsk2140944
1197239|NCT02045849|tolerability|tolerability
1197240|NCT02045849|drug interaction|drug interaction
1197241|NCT02045849|safety|safety
1197242|NCT02045849|itraconazole|itraconazole
1197243|NCT02045849|elderly healthy subjects|elderly healthy subjects
1197244|NCT02045849|food effect|food effect
1197245|NCT02045849|relative bioavailability|relative bioavailability
1197246|NCT02045836|Pneumovax 23|pneumovax 23
1197247|NCT02045836|Co-administration|co-administration
1197248|NCT02045836|Herpes zoster|herpes zoster
1197249|NCT02045836|Immunogenicity|immunogenicity
1197250|NCT02045836|Safety|safety
1197251|NCT02045836|Adults|adults
1197252|NCT02045810|Measurement|measurement
1197253|NCT02045810|nosiseption|nosiseption
1197254|NCT02045797|Dose ranging|dose ranging
1197255|NCT02045797|Intravenous|intravenous
1197256|NCT02045797|Adaptive design|adaptive design
1197257|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
1197258|NCT02045797|Subjects|subjects
1197259|NCT02045797|infection|infection
1197260|NCT02045797|Oral|oral
1197261|NCT02045797|GSK2140944|gsk2140944
1197262|NCT02045771|Depression|depression
1197263|NCT02045771|Behavioral Activation|behavioral activation
1197264|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
1197265|NCT02045732|Multiple Sclerosis|multiple sclerosis
1197266|NCT02045732|MRI|mri
1197267|NCT02045719|cat´s claw|cat´s claw
1197268|NCT02045719|uncaria tomentosa|uncaria tomentosa
1197269|NCT02045719|quality of life|quality of life
1197270|NCT02045719|no further therapeutic options|no further therapeutic options
1197271|NCT02045706|Community Health Workers|community health workers
1197272|NCT02045706|Service|service
1197273|NCT02045706|Volunteerism|volunteerism
1197274|NCT02045706|Health Behaviors|health behaviors
1197275|NCT02045680|colorectal cancer|colorectal cancer
1197276|NCT02045680|laparoscopy|laparoscopy
1197277|NCT02045680|neuromuscular block|neuromuscular block
1197278|NCT02045680|oxygen delivery|oxygen delivery
1197279|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
1197280|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
1197281|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
1197282|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
1197283|NCT02045641|cardiac surgery|cardiac surgery
1197284|NCT02045641|postoperative treatment|postoperative treatment
1197285|NCT02045641|pleural effusion|pleural effusion
1197286|NCT02045641|physical performance|physical performance
1197287|NCT02045628|Bariatric Surgery|bariatric surgery
1197288|NCT02045628|Health Psychology|health psychology
1197289|NCT02045602|Cancer|cancer
1197290|NCT02045602|Solid Tumors|solid tumors
1197291|NCT02045602|Gemcitabine|gemcitabine
1197292|NCT02045602|Oncolytic virus|oncolytic virus
1197293|NCT02045602|Metastatic|metastatic
1197294|NCT02045602|Pancreatic cancer|pancreatic cancer
1197295|NCT02045589|Cancer|cancer
1197296|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1197297|NCT02045589|Locally advanced|locally advanced
1197298|NCT02045589|Metastatic|metastatic
1197299|NCT02045589|Gemcitabine|gemcitabine
1197300|NCT02045589|Oncolytic virus|oncolytic virus
1197301|NCT02045589|Abraxane®|abraxane®
1197302|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
1197303|NCT02045576|sleep position trainer|sleep position trainer
1197304|NCT02045576|oral appliance therapy|oral appliance therapy
1197305|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
1197307|NCT02045498|cpr|cpr
1197308|NCT02045498|feedback|feedback
1197309|NCT02045498|capnography|capnography
1197310|NCT02045498|outcome|outcome
1197311|NCT02045498|quality|quality
1197312|NCT02045498|resuscitation|resuscitation
1197313|NCT02045472|Influenza|influenza
1197314|NCT02045472|Monoclonal antibody|monoclonal antibody
1197315|NCT02045459|Microvascular Disease|microvascular disease
1197316|NCT02045459|Exercise|exercise
1197317|NCT02045459|Angina|angina
1197318|NCT02045459|Chest pain|chest pain
1197319|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
1197320|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
1197321|NCT02045420|MR Venography|mr venography
1197322|NCT02045420|Flow Quantification|flow quantification
1197323|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
1197324|NCT02045407|Brain Death|brain death
1197325|NCT02045407|Neurological Death|neurological death
1197326|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
1197327|NCT02045407|Computed Tomography Angiography|computed tomography angiography
1197328|NCT02045394|haemoptysis|haemoptysis
1197329|NCT02045394|hemoptysis|hemoptysis
1197330|NCT02045394|airway bleeding|airway bleeding
1197331|NCT02045381|Cancer|cancer
1197332|NCT02045381|MRI|mri
1197333|NCT02045368|refractory|refractory
1197334|NCT02045368|intolerant|intolerant
1197335|NCT02045368|solid tumors|solid tumors
1197336|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
1197337|NCT02045316|Preeclampsia|preeclampsia
1197340|NCT02045303|Sub-acute wound|sub-acute wound
1197341|NCT02045303|Chronic wound|chronic wound
1197342|NCT02045303|wound|wound
1197343|NCT02045303|MIST|mist
1197344|NCT02045303|Soring|soring
1197345|NCT02045303|Contact Ultrasound|contact ultrasound
1197346|NCT02045303|Noncontact ultrasound|noncontact ultrasound
1197347|NCT02045303|Wound Care|wound care
1197348|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
1197349|NCT02045303|Ultrasound|ultrasound
1197350|NCT02045264|Firazyr|firazyr
1197351|NCT02045264|Angioedema|angioedema
1197352|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
1197353|NCT02045264|Vascular Diseases|vascular diseases
1197354|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
1197355|NCT02045264|Urticaria|urticaria
1197356|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
1197357|NCT02045264|Skin Diseases|skin diseases
1197358|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
1197359|NCT02045264|Hypersensitivity|hypersensitivity
1197360|NCT02045264|Immune System Diseases|immune system diseases
1197361|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
1197362|NCT02045264|Icatibant|icatibant
1197363|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1197364|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
1197365|NCT02045264|Analgesics|analgesics
1197366|NCT02045264|Sensory System Agents|sensory system agents
1197367|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
1197368|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
1197369|NCT02045264|Pharmacologic Actions|pharmacologic actions
1197370|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
1197371|NCT02045264|Therapeutic Uses|therapeutic uses
1197372|NCT02045264|Antirheumatic Agents|antirheumatic agents
1197373|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1197374|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
1197375|NCT02045264|Adrenergic Agents|adrenergic agents
1197376|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
1197377|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1197378|NCT02045264|Central Nervous System Agents|central nervous system agents
1197379|NCT02045251|Helicobacter pylori|helicobacter pylori
1197380|NCT02045251|H. pylori|h. pylori
1197381|NCT02045251|Pylera|pylera
1197382|NCT02045238|Bronchiolitis|bronchiolitis
1197383|NCT02045238|Therapeutics|therapeutics
1197384|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
1197385|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
1197386|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
1197387|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
1197388|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
1197389|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
1197390|NCT02045199|Diabetes Mellitus|diabetes mellitus
1197391|NCT02045199|Diabetic Foot|diabetic foot
1197392|NCT02045199|Diabetes Complications|diabetes complications
1197393|NCT02045186|Human Papilloma Virus|human papilloma virus
1197399|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
1197400|NCT02045147|Home Bound Care Transitions|home bound care transitions
1197401|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
1197403|NCT02045082|Traditional fiber swab|traditional fiber swab
1197404|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
1197405|NCT02045082|Quantitative PCR|quantitative pcr
1197406|NCT02045056|Alzheimer disease|alzheimer disease
1197407|NCT02045056|mild cognitive impairment|mild cognitive impairment
1197408|NCT02045056|normal cognition|normal cognition
1197409|NCT02045043|Sudden Cardiac Death|sudden cardiac death
1197410|NCT02045043|Arrhythmias|arrhythmias
1197411|NCT02045043|Congestive Heart Failure|congestive heart failure
1197412|NCT02045043|Cardiomyopathy|cardiomyopathy
1197413|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1197414|NCT02045043|Genomics|genomics
1197415|NCT02045030|metastatic|metastatic
1197416|NCT02045030|colorectal|colorectal
1197417|NCT02045030|cancer|cancer
1197418|NCT02045030|aflibercept|aflibercept
1197419|NCT02045030|FOLFIRI|folfiri
1197426|NCT02045004|Anesthesia|anesthesia
1197427|NCT02045004|Surgery|surgery
1197428|NCT02045004|Geriatrics|geriatrics
1197429|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1197430|NCT02045004|Postoperative delirium|postoperative delirium
1197431|NCT02045004|Dementia|dementia
1197432|NCT02045004|Postoperative complications|postoperative complications
1197433|NCT02045004|Neurological complications|neurological complications
1197434|NCT02045004|Psychological complications|psychological complications
1197435|NCT02044991|Sciatica|sciatica
1197436|NCT02044991|Pelvic girdle pain|pelvic girdle pain
1197437|NCT02044965|urinary tract infection|urinary tract infection
1197438|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
1197439|NCT02044965|probiotics|probiotics
1197440|NCT02044965|neurogenic bladder|neurogenic bladder
1197441|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
1197442|NCT02044952|Crohn's Disease|crohn's disease
1197443|NCT02044952|mesalazine|mesalazine
1198143|NCT02042092|Ultrasound|ultrasound
1197444|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
1197445|NCT02044952|induction remission|induction remission
1197446|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
1197447|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
1197448|NCT02044900|polysomnography|polysomnography
1197449|NCT02044900|heart rate variability|heart rate variability
1197450|NCT02044900|mathematical biomarker|mathematical biomarker
1197451|NCT02044887|Physical activity|physical activity
1197452|NCT02044887|dementia|dementia
1197453|NCT02044887|relative caregivers|relative caregivers
1197454|NCT02044887|podometer|podometer
1197455|NCT02044887|cardiovascular risk|cardiovascular risk
1197456|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
1197457|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
1197458|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1197459|NCT02044822|CLL|cll
1197460|NCT02044783|Adults|adults
1197461|NCT02044783|Elderly|elderly
1197462|NCT02044770|laparoscopic|laparoscopic
1197463|NCT02044770|colectomy|colectomy
1197464|NCT02044770|ENSEAL|enseal
1197465|NCT02044757|Caffeine|caffeine
1197466|NCT02044757|Addiction|addiction
1197467|NCT02044757|Withdrawal symptoms|withdrawal symptoms
1197468|NCT02044757|Pediatric|pediatric
1197469|NCT02044757|Adolescent|adolescent
1197470|NCT02044757|Overweight|overweight
1197471|NCT02044744|Obesity|obesity
1197472|NCT02044744|Pediatric Obesity|pediatric obesity
1197473|NCT02044744|Physical Activity|physical activity
1197474|NCT02044744|Physical Fitness|physical fitness
1197475|NCT02044744|Primary Health Care|primary health care
1197476|NCT02044744|Referral and Consultation|referral and consultation
1197477|NCT02044731|Schools|schools
1197478|NCT02044731|Pediatrics|pediatrics
1197479|NCT02044731|Obesity|obesity
1197480|NCT02044731|Overweight|overweight
1197481|NCT02044731|Intervention Studies|intervention studies
1197482|NCT02044731|African Americans|african americans
1197483|NCT02044731|Family|family
1197484|NCT02044731|Body mass index|body mass index
1197485|NCT02044718|adverse events|adverse events
1197486|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
1197487|NCT02044718|chart review|chart review
1197488|NCT02044705|Primary Health Care|primary health care
1197489|NCT02044705|Pediatrics|pediatrics
1197490|NCT02044705|Obesity|obesity
1197491|NCT02044705|Overweight|overweight
1197492|NCT02044705|Clinical trial|clinical trial
1197493|NCT02044705|Hispanic Americans|hispanic americans
1197494|NCT02044705|Family|family
1197495|NCT02044705|Body mass index|body mass index
1197496|NCT02044692|Hunter syndrome|hunter syndrome
1197497|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1197498|NCT02044692|Hunterase|hunterase
1197499|NCT02044666|Critical Limb Ischemia|critical limb ischemia
1197500|NCT02044666|Amputation|amputation
1197501|NCT02044653|Phase 2|phase 2
1197502|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
1197503|NCT02044614|functionally anuric|functionally anuric
1197504|NCT02044614|Icodextrin|icodextrin
1197505|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
1197506|NCT02044601|Lung Cancer|lung cancer
1197507|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
1197508|NCT02044601|NSCLC|nsclc
1197509|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
1197510|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
1197511|NCT02044601|Radiation therapy|radiation therapy
1197512|NCT02044601|Proton therapy|proton therapy
1197513|NCT02044601|XRT|xrt
1197514|NCT02044601|Carboplatin|carboplatin
1197515|NCT02044601|Paraplatin|paraplatin
1197516|NCT02044601|Paclitaxel|paclitaxel
1197517|NCT02044601|Taxol|taxol
1197518|NCT02044601|Onartuzumab|onartuzumab
1197519|NCT02044601|Erlotinib|erlotinib
1197520|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
1197521|NCT02044601|OSI-774|osi-774
1197522|NCT02044601|CP358774|cp358774
1197523|NCT02044601|Tarceva|tarceva
1197524|NCT02044588|HBsAg(+) donor|hbsag(+) donor
1197525|NCT02044588|HBsAg(-) donor|hbsag(-) donor
1197526|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
1197527|NCT02044588|Kidney allograft|kidney allograft
1197528|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
1197529|NCT02044562|dietary nitrate|dietary nitrate
1197530|NCT02044562|radiotherapy|radiotherapy
1197531|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1197532|NCT02044549|Carbetocin|carbetocin
1197533|NCT02044549|syntometrine|syntometrine
1197534|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
1197535|NCT02044549|cesarean section|cesarean section
1197536|NCT02044536|biopsy; endoscopy; neoplasms|biopsy; endoscopy; neoplasms
1197537|NCT02044523|Chronic liver disease|chronic liver disease
1197538|NCT02044523|Fibrosis|fibrosis
1197539|NCT02044523|Elastography|elastography
1197540|NCT02044523|Ultrasound|ultrasound
1197541|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
1197542|NCT02044523|Diagnostic performance|diagnostic performance
1197543|NCT02044523|Sensitivity and specificity|sensitivity and specificity
1197544|NCT02044510|Multiple Sclerosis|multiple sclerosis
1197545|NCT02044510|Spinal Cord Injuries|spinal cord injuries
1197546|NCT02044510|mirabegron|mirabegron
1197547|NCT02044510|Urodynamics|urodynamics
1197548|NCT02044497|pharmacokinetics|pharmacokinetics
1197549|NCT02044497|pharmacogenomics|pharmacogenomics
1197550|NCT02044497|oral oxycodone|oral oxycodone
1197551|NCT02044497|pediatric surgical patients|pediatric surgical patients
1197552|NCT02044484|HIV|hiv
1197553|NCT02044484|AIDS|aids
1272883|NCT01703429|MS|ms
1197554|NCT02044484|Viral load|viral load
1197555|NCT02044484|Primary care|primary care
1197556|NCT02044471|left ventricular assist device|left ventricular assist device
1197557|NCT02044471|continuous flow|continuous flow
1197558|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
1197559|NCT02044471|hypertension|hypertension
1197560|NCT02044471|sympathetic tone|sympathetic tone
1197561|NCT02044471|endothelial dysfunction|endothelial dysfunction
1197562|NCT02044458|Foley Catheterization|foley catheterization
1197563|NCT02044458|Induction of Labor|induction of labor
1197564|NCT02044458|5 French Stylette|5 french stylette
1197565|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
1197566|NCT02044419|Comparative|comparative
1197567|NCT02044419|Bioavailability|bioavailability
1197568|NCT02044419|lomitapide|lomitapide
1197569|NCT02044341|Acute Otitis Media|acute otitis media
1197570|NCT02044341|Pain|pain
1197571|NCT02044341|Ear Pain|ear pain
1197572|NCT02044341|Ear Ache|ear ache
1197573|NCT02044341|Ear infection|ear infection
1197574|NCT02044341|middle ear infection|middle ear infection
1197575|NCT02044302|pain|pain
1197576|NCT02044302|breast cancer|breast cancer
1197577|NCT02044302|breast implant|breast implant
1197578|NCT02044302|breast reconstruction|breast reconstruction
1197579|NCT02044289|depression|depression
1197580|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
1197581|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1197582|NCT02044276|Neutropenia|neutropenia
1197583|NCT02044276|NHL|nhl
1197584|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
1197585|NCT02044276|R-CHOP-21|r-chop-21
1197586|NCT02044263|Cognitive therapy|cognitive therapy
1197587|NCT02044263|Behavior therapy|behavior therapy
1197588|NCT02044263|Waiting lists|waiting lists
1197589|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
1197590|NCT02044263|Internet|internet
1197591|NCT02044250|Aspirin|aspirin
1197592|NCT02044250|Clopidogrel|clopidogrel
1197593|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
1197594|NCT02044250|Drug-eluting stent|drug-eluting stent
1197595|NCT02044237|trichotillomania|trichotillomania
1197596|NCT02044237|online therapy|online therapy
1197597|NCT02044211|Heart Failure, Systolic|heart failure, systolic
1197598|NCT02044211|Depressive Disorder|depressive disorder
1197599|NCT02044211|Depressive Disorder, Major|depressive disorder, major
1197600|NCT02044211|Mood Disorder|mood disorder
1197601|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
1197602|NCT02044198|Malaria|malaria
1197603|NCT02044198|Vaccine|vaccine
1197604|NCT02044198|Plasmodium|plasmodium
1197605|NCT02044198|Falciparum|falciparum
1197606|NCT02044185|HMGB1 Protein|hmgb1 protein
1197607|NCT02044185|Graft versus Host Disease|graft versus host disease
1197608|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
1197609|NCT02044185|oral mucositis|oral mucositis
1197610|NCT02044172|Prostate cancer|prostate cancer
1197611|NCT02044172|Treatment|treatment
1197612|NCT02044172|Screening|screening
1197613|NCT02044172|Surgery|surgery
1197614|NCT02044172|Radiotherapy|radiotherapy
1197615|NCT02044172|Active monitoring|active monitoring
1197616|NCT02044159|Hydrocortisone|hydrocortisone
1197617|NCT02044159|Pediatrics|pediatrics
1197618|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
1197619|NCT02044107|Diarrhea,|diarrhea,
1197620|NCT02044107|Pneumonia,|pneumonia,
1197621|NCT02044107|Zinc treatment,|zinc treatment,
1197622|NCT02044107|Patient Compliance.|patient compliance.
1197623|NCT02044094|Opioid dependent|opioid dependent
1197624|NCT02044094|Buprenorphine|buprenorphine
1197625|NCT02044094|Suboxone Film|suboxone film
1197626|NCT02044094|Opioid blockade|opioid blockade
1197627|NCT02044094|Hydromorphone challenge|hydromorphone challenge
1197628|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
1197629|NCT02044003|angioplasty|angioplasty
1197630|NCT02044003|dissections|dissections
1197631|NCT02043990|NAVA|nava
1197632|NCT02043990|noninvasive ventilation|noninvasive ventilation
1197633|NCT02043990|infants|infants
1197634|NCT02043977|Propofol|propofol
1197635|NCT02043977|Insomnia|insomnia
1197636|NCT02043977|Sleep disorder|sleep disorder
1197637|NCT02043977|Sleep deprivation|sleep deprivation
1197638|NCT02043977|Chronic insomnia|chronic insomnia
1197639|NCT02043977|Refractory insomnia|refractory insomnia
1197640|NCT02043977|Primary insomnia|primary insomnia
1197641|NCT02043964|Multiple Sclerosis|multiple sclerosis
1197642|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
1197643|NCT02043964|Tears|tears
1197644|NCT02043964|Isoelectric focusing|isoelectric focusing
1197645|NCT02043964|Oligoclonal profile|oligoclonal profile
1197646|NCT02043938|Electroencephalography|electroencephalography
1197647|NCT02043938|pharmacological|pharmacological
1197648|NCT02043925|QT-prolongation|qt-prolongation
1197649|NCT02043925|Torsade de Pointes|torsade de pointes
1197650|NCT02043925|drug interactions|drug interactions
1197651|NCT02043925|psychiatry|psychiatry
1197652|NCT02043912|QT-prolongation|qt-prolongation
1197653|NCT02043912|Torsade de Pointes|torsade de pointes
1197654|NCT02043912|Haloperidol|haloperidol
1197655|NCT02043912|Drug interactions|drug interactions
1197656|NCT02043899|Neuroblastoma|neuroblastoma
1197657|NCT02043899|Positron emission tomography|positron emission tomography
1197658|NCT02043899|124-iodine|124-iodine
1197659|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
1197785|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
1197660|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
1197661|NCT02043873|Clinical Trial|clinical trial
1197662|NCT02043873|Composite Restorations|composite restorations
1197663|NCT02043873|Restorations Repair|restorations repair
1197664|NCT02043873|Replacement Restorations|replacement restorations
1197665|NCT02043873|Operative Dentistry.|operative dentistry.
1197666|NCT02043860|Multiple Myeloma|multiple myeloma
1197667|NCT02043860|High Risk|high risk
1197668|NCT02043860|Intermediate Risk|intermediate risk
1197669|NCT02043860|Symptomatic|symptomatic
1197670|NCT02043847|Multiple Myeloma|multiple myeloma
1197671|NCT02043847|Relapsed|relapsed
1197672|NCT02043847|Refractory|refractory
1197673|NCT02043847|Progressive Disease|progressive disease
1197674|NCT02043847|Symptomatic|symptomatic
1197675|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
1197676|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1197677|NCT02043795|Stent|stent
1197678|NCT02043769|South Africa|south africa
1197679|NCT02043769|Eastern Cape|eastern cape
1197680|NCT02043769|Child ARV|child arv
1197681|NCT02043769|CLWHIV|clwhiv
1197682|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
1197683|NCT02043730|pancreatic cancer|pancreatic cancer
1197684|NCT02043730|locally advanced|locally advanced
1197685|NCT02043730|unresectable cancer|unresectable cancer
1197686|NCT02043717|Cystic Fibrosis|cystic fibrosis
1197687|NCT02043717|Vitamin D|vitamin d
1197688|NCT02043717|Lung function|lung function
1197689|NCT02043704|IV Acetaminophen|iv acetaminophen
1197987|NCT02042742|Punicalagin|punicalagin
1197690|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
1197691|NCT02043704|Pain, Postoperative|pain, postoperative
1197692|NCT02043691|Endovascular|endovascular
1197693|NCT02043691|Aortic|aortic
1197694|NCT02043691|Aneurysm|aneurysm
1197695|NCT02043691|Thoracoabdominal|thoracoabdominal
1197696|NCT02043691|Juxtarenal|juxtarenal
1197697|NCT02043691|Suprarenal|suprarenal
1197698|NCT02043691|Endograft|endograft
1197699|NCT02043691|Fenestrated|fenestrated
1197700|NCT02043691|Branched|branched
1197701|NCT02043691|Complex|complex
1197702|NCT02043691|Abdominal|abdominal
1197703|NCT02043691|Thoracic|thoracic
1197704|NCT02043691|Stent|stent
1197705|NCT02043691|Stentgraft|stentgraft
1197706|NCT02043678|Phase III|phase iii
1197707|NCT02043678|Radium-223 dichloride|radium-223 dichloride
1197708|NCT02043678|Abiraterone acetate|abiraterone acetate
1197709|NCT02043678|Combination therapy|combination therapy
1197710|NCT02043678|Chemotherapy-naive|chemotherapy-naive
1197711|NCT02043678|Bone metastasis|bone metastasis
1197712|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
1197713|NCT02043665|CAVATAK|cavatak
1197714|NCT02043665|KEYNOTE-200|keynote-200
1197715|NCT02043665|pembrolizumab|pembrolizumab
1197716|NCT02043665|lung cancer|lung cancer
1197717|NCT02043665|bladder cancer|bladder cancer
1197718|NCT02043639|rotation|rotation
1197719|NCT02043639|shoulder|shoulder
1197720|NCT02043639|joint|joint
1197722|NCT02043639|abduction,|abduction,
1197723|NCT02043639|internal rotation,|internal rotation,
1197724|NCT02043639|external rotation,|external rotation,
1197725|NCT02043639|flexion|flexion
1197726|NCT02043639|normal|normal
1197727|NCT02043639|joint movement|joint movement
1197728|NCT02043639|physical examination|physical examination
1197729|NCT02043626|childhood nutrition|childhood nutrition
1197730|NCT02043626|physical activity|physical activity
1197731|NCT02043626|school wellness|school wellness
1197732|NCT02043626|school health|school health
1197733|NCT02043626|nutritional policies|nutritional policies
1197734|NCT02043626|childhood obesity|childhood obesity
1197735|NCT02043613|Joint pain|joint pain
1197736|NCT02043613|Context effects|context effects
1197737|NCT02043613|Placebo effect|placebo effect
1197738|NCT02043613|Exercise treatment|exercise treatment
1197739|NCT02043600|Colitis, ulcerative|colitis, ulcerative
1197740|NCT02043600|Yoga|yoga
1197741|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1197742|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
1197743|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
1197744|NCT02043574|Aerobic Exercise|aerobic exercise
1197745|NCT02043574|Treadmill Test|treadmill test
1197746|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
1197747|NCT02043548|dermatomyositis|dermatomyositis
1197748|NCT02043548|polymyositis|polymyositis
1197749|NCT02043548|tocilizumab|tocilizumab
1197750|NCT02043548|Actemra|actemra
1197751|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
1577310|NCT00474747|Fludara|fludara
1197752|NCT02043535|myocardial blood flow|myocardial blood flow
1197753|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
1197754|NCT02043535|carbon dioxide|carbon dioxide
1197755|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
1197756|NCT02043535|positron emission tomography|positron emission tomography
1197757|NCT02043522|123I-mIBG|123i-mibg
1197758|NCT02043522|SPECT Imaging|spect imaging
1197759|NCT02043522|Phantom imaging|phantom imaging
1197760|NCT02043522|Heart failure|heart failure
1197761|NCT02043522|Coronary artery disease|coronary artery disease
1197762|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
1197763|NCT02043522|heart to calibration ratios|heart to calibration ratios
1197764|NCT02043522|Myocardial blood flow|myocardial blood flow
1197765|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
1197766|NCT02043509|smoking cessation|smoking cessation
1197767|NCT02043509|pregnancy|pregnancy
1197768|NCT02043509|cessation support|cessation support
1197769|NCT02043509|tailored text messages|tailored text messages
1197770|NCT02043509|self-help|self-help
1197771|NCT02043509|MiQuit|miquit
1197772|NCT02043496|Binge Eating Disorder|binge eating disorder
1197773|NCT02043496|Binge Eating|binge eating
1197774|NCT02043496|Eating Disorders|eating disorders
1197775|NCT02043496|Obesity|obesity
1197776|NCT02043496|Psychotherapy|psychotherapy
1197777|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
1197778|NCT02043483|CPAP|cpap
1197779|NCT02043483|OSAS|osas
1197780|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
1197781|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
1197782|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
1197783|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
1197784|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
1197786|NCT02043431|Heart failure|heart failure
1197787|NCT02043431|Electronic medical records|electronic medical records
1197788|NCT02043431|Genomics|genomics
1197789|NCT02043431|Biobank|biobank
1197790|NCT02043418|HIV|hiv
1197791|NCT02043418|ARV|arv
1197792|NCT02043418|Pediatric|pediatric
1197793|NCT02043418|Cameroon|cameroon
1197794|NCT02043392|intestinal anastomosis|intestinal anastomosis
1197795|NCT02043392|non-emergent|non-emergent
1197796|NCT02043392|intestinal revision|intestinal revision
1197797|NCT02043392|magnetic compression|magnetic compression
1197798|NCT02043392|anastomotic leak|anastomotic leak
1197799|NCT02043379|congenital heart disease|congenital heart disease
1197800|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
1197801|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
1197802|NCT02043366|Remifentanil|remifentanil
1197803|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
1197804|NCT02043366|Postoperative pain|postoperative pain
1197805|NCT02043366|Pain Intensity|pain intensity
1197806|NCT02043340|Periodontitis|periodontitis
1197807|NCT02043340|Bacterial viability|bacterial viability
1197808|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
1197809|NCT02043340|Indocyanine green|indocyanine green
1197810|NCT02043340|Scaling and root planing|scaling and root planing
1197811|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
1197812|NCT02043327|Colonoscopy|colonoscopy
1197813|NCT02043327|assessment|assessment
1197814|NCT02043327|certification,|certification,
1197815|NCT02043327|simulation,|simulation,
1197816|NCT02043327|standard setting|standard setting
1197817|NCT02043301|pharmacokinetics|pharmacokinetics
1197818|NCT02043301|bioavailability|bioavailability
1197819|NCT02043301|PF-04950615|pf-04950615
1197820|NCT02043288|Pancreatic cancer|pancreatic cancer
1197821|NCT02043288|Platinum|platinum
1197822|NCT02043288|Micelle|micelle
1197823|NCT02043275|resistance training|resistance training
1197824|NCT02043262|Elderly|elderly
1197825|NCT02043262|Home-based rehabilitation|home-based rehabilitation
1197826|NCT02043262|Activities of daily living|activities of daily living
1197827|NCT02043262|Restorative care|restorative care
1197828|NCT02043262|Reablement|reablement
1197829|NCT02043262|Everyday rehabilitation|everyday rehabilitation
1197830|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
1197831|NCT02043249|MILKING OF CORD|milking of cord
1197832|NCT02043249|PREMATURE INFANTS|premature infants
1197833|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
1197834|NCT02043236|Prostate cancer|prostate cancer
1197835|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
1197836|NCT02043236|Bone health|bone health
1197837|NCT02043236|Bone mineral density|bone mineral density
1197838|NCT02043223|Vitamin A|vitamin a
1197839|NCT02043223|Breast milk|breast milk
1197840|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
1197841|NCT02043223|Infant vaccine response|infant vaccine response
1197842|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
1197844|NCT02043197|depressive symptoms,|depressive symptoms,
1197845|NCT02043197|major depressive disorder,|major depressive disorder,
1197846|NCT02043197|Fevarine,|fevarine,
1197847|NCT02043197|fluvoxamine,|fluvoxamine,
1197848|NCT02043197|cognitive function,|cognitive function,
1197849|NCT02043197|neurological disorders,|neurological disorders,
1197850|NCT02043197|sleep state|sleep state
1197851|NCT02043184|Neoplasms|neoplasms
1197852|NCT02043184|Medication Adherence|medication adherence
1197853|NCT02043184|Administration, Oral|administration, oral
1197854|NCT02043184|Symptom Assessment|symptom assessment
1197855|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
1197856|NCT02043184|Depression|depression
1197857|NCT02043184|Behavioral Symptoms|behavioral symptoms
1197858|NCT02043184|Utilization|utilization
1197859|NCT02043158|Ovarian Cancer|ovarian cancer
1197860|NCT02043158|Short term survivors|short term survivors
1197861|NCT02043158|Long term survivors|long term survivors
1197862|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
1197863|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
1197864|NCT02043158|Questionnaire|questionnaire
1197865|NCT02043158|Survey|survey
1197866|NCT02043158|Interview|interview
1197867|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
1197868|NCT02043132|Rotator cuff|rotator cuff
1197869|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
1197870|NCT02043132|Total shoulder|total shoulder
1197871|NCT02043132|Perioperative bleeding|perioperative bleeding
1197872|NCT02043132|Tranexamic acid|tranexamic acid
1197873|NCT02043132|Orthopedic complications|orthopedic complications
1197874|NCT02043132|Hemorrhage|hemorrhage
1197875|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
1197876|NCT02043132|Pathologic Processes|pathologic processes
1197877|NCT02043132|Arthritis|arthritis
1197878|NCT02043132|Joint Diseases|joint diseases
1197879|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
1197880|NCT02043132|Postoperative Complications|postoperative complications
1197881|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
1197882|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
1197883|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1197884|NCT02043132|Pharmacologic Actions|pharmacologic actions
1197885|NCT02043132|Hemostatics|hemostatics
1197886|NCT02043132|Coagulants|coagulants
1197887|NCT02043132|Hematologic Agents|hematologic agents
1197888|NCT02043132|Therapeutic Uses|therapeutic uses
1197889|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
1197890|NCT02043093|Peer Leader prevention model|peer leader prevention model
1197891|NCT02043093|Universal school-based prevention|universal school-based prevention
1197892|NCT02043080|Tuberculosis|tuberculosis
1197893|NCT02043080|HIV|hiv
1197894|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
1197895|NCT02043080|Determine TB-LAM|determine tb-lam
1197896|NCT02043080|UNC|unc
1197897|NCT02043080|Zambia|zambia
1197898|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
1197899|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
1197900|NCT02043067|TB|tb
1197901|NCT02043067|HIV|hiv
1197902|NCT02043067|Extensively resistant TB|extensively resistant tb
1197903|NCT02043067|Extra pulmonary TB|extra pulmonary tb
1197904|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1197905|NCT02043054|Young Adults|young adults
1197906|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1197907|NCT02043054|GLP1 Analogue|glp1 analogue
1197908|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
1197909|NCT02043054|Obesity|obesity
1197910|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
1197911|NCT02043054|Cardiac MRI|cardiac mri
1197912|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1197913|NCT02043028|Chest compression|chest compression
1197914|NCT02043028|Advanced cardiac life support|advanced cardiac life support
1197915|NCT02043028|Posture|posture
1197916|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
1197917|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
1197918|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1197919|NCT02043015|homosexuality|homosexuality
1197920|NCT02043015|male|male
1197921|NCT02043015|South Africa|south africa
1197922|NCT02042989|Advanced Cancers|advanced cancers
1197923|NCT02042989|Advanced solid tumor|advanced solid tumor
1197924|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
1197925|NCT02042989|MLN9708|mln9708
1197926|NCT02042989|Vorinostat|vorinostat
1197927|NCT02042989|SAHA|saha
1197928|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1197929|NCT02042989|MSK-390|msk-390
1197930|NCT02042989|Zolinza|zolinza
1197931|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1197932|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
1197933|NCT02042976|Behavioural intervention|behavioural intervention
1197934|NCT02042976|Quality-of-life|quality-of-life
1197935|NCT02042976|Anxiety|anxiety
1197936|NCT02042976|Depression|depression
1197937|NCT02042976|Physical health status|physical health status
1333145|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1197938|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
1197939|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
1197940|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
1197941|NCT02042950|Lymphoma|lymphoma
1197942|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
1197943|NCT02042950|MCL|mcl
1197944|NCT02042950|Relapsed|relapsed
1197945|NCT02042950|Refractory|refractory
1197946|NCT02042950|Carfilzomib|carfilzomib
1197947|NCT02042937|Knee|knee
1197948|NCT02042937|Hip|hip
1197949|NCT02042937|Muscle Strength|muscle strength
1197950|NCT02042937|Electromyography|electromyography
1197951|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
1197952|NCT02042924|Leukemia|leukemia
1197953|NCT02042924|Lymphoma|lymphoma
1197954|NCT02042924|Myeloma|myeloma
1197955|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
1197956|NCT02042898|Cardiac Surgery|cardiac surgery
1197957|NCT02042898|Transfusion|transfusion
1197958|NCT02042885|Prostate cancer|prostate cancer
1197959|NCT02042872|Spinal Cord Injury|spinal cord injury
1197960|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
1197961|NCT02042872|Zoledronic acid|zoledronic acid
1197962|NCT02042872|Bisphosphonates|bisphosphonates
1197963|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
1197964|NCT02042859|EndoHPB|endohpb
1197965|NCT02042820|Dry Eye|dry eye
1197966|NCT02042781|PG545|pg545
1197967|NCT02042781|Phase I|phase i
1197968|NCT02042781|Progen|progen
1197969|NCT02042781|antimetastatic|antimetastatic
1197970|NCT02042781|antiangiogenic|antiangiogenic
1197971|NCT02042781|advanced cancer patients|advanced cancer patients
1197972|NCT02042781|solid tumors|solid tumors
1197973|NCT02042781|solid tumours|solid tumours
1197974|NCT02042781|tumor microenvironment|tumor microenvironment
1197975|NCT02042768|Glucose|glucose
1197976|NCT02042768|Dialysate|dialysate
1197977|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
1197978|NCT02042768|patients|patients
1197979|NCT02042768|non-diabetic|non-diabetic
1197980|NCT02042755|cataract|cataract
1197981|NCT02042755|IOL|iol
1197982|NCT02042755|trifocal|trifocal
1197983|NCT02042755|FineVision|finevision
1197984|NCT02042742|Cross-over studies|cross-over studies
1197985|NCT02042742|Antioxidants|antioxidants
1197986|NCT02042742|Hydroxytyrosol|hydroxytyrosol
1197988|NCT02042742|Treatment outcome|treatment outcome
1197989|NCT02042742|Inflammatory markers|inflammatory markers
1197990|NCT02042742|Endothelial function|endothelial function
1197991|NCT02042742|Humans|humans
1197992|NCT02042742|Adults|adults
1197993|NCT02042742|volunteers|volunteers
1197994|NCT02042729|volunteer|volunteer
1197995|NCT02042716|preterm and term newborns|preterm and term newborns
1197996|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
1197997|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
1197998|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
1197999|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1198000|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1198001|NCT02042690|chemotherapy|chemotherapy
1198002|NCT02042677|ileostomy|ileostomy
1198003|NCT02042677|1-piece|1-piece
1198004|NCT02042677|assessment|assessment
1198005|NCT02042677|Nova|nova
1198006|NCT02042677|NovaLife|novalife
1198007|NCT02042677|Dansac|dansac
1198008|NCT02042651|ESWT|eswt
1198009|NCT02042651|Chronic pelvic pain|chronic pelvic pain
1198010|NCT02042651|randomized|randomized
1198011|NCT02042651|sham controlled|sham controlled
1198012|NCT02042612|Pharmacokinetics|pharmacokinetics
1198013|NCT02042612|Sevoflurane|sevoflurane
1198014|NCT02042612|Obesity|obesity
1198015|NCT02042612|Sedation|sedation
1198016|NCT02042612|ICU patients|icu patients
1198017|NCT02042599|Pharmacokinetics|pharmacokinetics
1198018|NCT02042599|Sevoflurane|sevoflurane
1198019|NCT02042599|Acute kidney injury|acute kidney injury
1198020|NCT02042599|Sedation|sedation
1198021|NCT02042599|ICU patients|icu patients
1198022|NCT02042534|stroke|stroke
1198023|NCT02042534|TIA|tia
1198024|NCT02042521|Cigarette|cigarette
1198025|NCT02042521|Withdrawal|withdrawal
1198026|NCT02042521|Nicotine|nicotine
1198027|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
1198028|NCT02042482|L-carnitine|l-carnitine
1198029|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
1198030|NCT02042456|breast cancer|breast cancer
1198031|NCT02042456|dense breasts|dense breasts
1198032|NCT02042456|mammography screening|mammography screening
1198033|NCT02042456|Screening techniques|screening techniques
1198034|NCT02042456|women|women
1198035|NCT02042404|Hearing impairment|hearing impairment
1198036|NCT02042404|Hearing loss|hearing loss
1198037|NCT02042391|PTLD|ptld
1198038|NCT02042391|CD20-positive|cd20-positive
1198039|NCT02042391|solid organ transplantation|solid organ transplantation
1198040|NCT02042378|BRCA|brca
1198041|NCT02042378|BRCA mutation|brca mutation
1198042|NCT02042378|germline BRCA|germline brca
1198043|NCT02042378|somatic BRCA|somatic brca
1198044|NCT02042378|PARP inhibitor|parp inhibitor
1198045|NCT02042378|rucaparib|rucaparib
1198046|NCT02042378|CO-338|co-338
1198047|NCT02042378|PF 01367338|pf 01367338
1198048|NCT02042378|AG 14699|ag 14699
1198049|NCT02042378|Clovis|clovis
1198050|NCT02042378|Clovis Oncology|clovis oncology
1198051|NCT02042378|RucaPanc|rucapanc
1198052|NCT02042365|Enhanced recovery,|enhanced recovery,
1198053|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
1198054|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
1198055|NCT02042339|Diabetic ulcer|diabetic ulcer
1198056|NCT02042339|Wound healing|wound healing
1198057|NCT02042339|3-D life-viz- system|3-d life-viz- system
1198058|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
1198059|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
1198060|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
1198061|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
1198062|NCT02042326|Sirolimus|sirolimus
1198063|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
1198064|NCT02042300|XIENCE Xpedition|xience xpedition
1198065|NCT02042300|Routine Clinical Practice|routine clinical practice
1198066|NCT02042300|Alpine|alpine
1198067|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
1198068|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
1198069|NCT02042287|Health Occupations|health occupations
1198070|NCT02042274|Fish oil|fish oil
1198071|NCT02042274|EPA|epa
1198072|NCT02042274|DHA|dha
1198073|NCT02042274|fatty acids|fatty acids
1198074|NCT02042274|genetic variation|genetic variation
1198075|NCT02042274|gene expression|gene expression
1198076|NCT02042248|HIV|hiv
1198077|NCT02042248|Acute HIV Infection|acute hiv infection
1198078|NCT02042248|Chronic HIV Infection|chronic hiv infection
1198079|NCT02042248|AGS-004|ags-004
1198080|NCT02042248|Phase 1|phase 1
1198081|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
1198082|NCT02042248|ART|art
1198083|NCT02042248|UNC|unc
1198084|NCT02042248|Argos Therapeutics|argos therapeutics
1198085|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
1198086|NCT02042248|Immunization|immunization
1198087|NCT02042248|vaccination|vaccination
1198088|NCT02042235|prematurity|prematurity
1198089|NCT02042235|language|language
1198090|NCT02042235|parent-implemented intervention|parent-implemented intervention
1198091|NCT02042235|speech therapy|speech therapy
1198092|NCT02042235|neurodevelopment|neurodevelopment
1198093|NCT02042222|Sickle cell|sickle cell
1198094|NCT02042222|Hydroxyurea|hydroxyurea
1198095|NCT02042222|Dose prediction|dose prediction
1198096|NCT02042222|Maximum tolerated dose|maximum tolerated dose
1198097|NCT02042209|acute coronary syndrome|acute coronary syndrome
1198098|NCT02042209|thoracic pain|thoracic pain
1198099|NCT02042209|prehospital|prehospital
1198100|NCT02042209|diagnostic score|diagnostic score
1198101|NCT02042196|endothelial function|endothelial function
1198102|NCT02042196|women|women
1198103|NCT02042196|estrogen deficiency|estrogen deficiency
1198104|NCT02042196|sex hormones|sex hormones
1198105|NCT02042196|adiposity|adiposity
1198106|NCT02042196|oxidative stress|oxidative stress
1198107|NCT02042196|antioxidants|antioxidants
1198108|NCT02042157|Quality of Life|quality of life
1198109|NCT02042157|Caregivers|caregivers
1198110|NCT02042157|Caregiver burden|caregiver burden
1198111|NCT02042157|Urinary Tract Infections|urinary tract infections
1198112|NCT02042157|Bidet|bidet
1198113|NCT02042157|Women's health|women's health
1198114|NCT02042157|Toileting|toileting
1198115|NCT02042157|Hygiene|hygiene
1198116|NCT02042157|Activities of Daily Living|activities of daily living
1198117|NCT02042157|Functional impairment|functional impairment
1198118|NCT02042157|Geriatrics|geriatrics
1198119|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
1198120|NCT02042131|suicide|suicide
1198121|NCT02042131|suicidal ideation|suicidal ideation
1198122|NCT02042131|ambivalence|ambivalence
1198123|NCT02042131|suicide ambivalence|suicide ambivalence
1198124|NCT02042131|reasons for living|reasons for living
1198125|NCT02042131|reasons for dying|reasons for dying
1198126|NCT02042131|military|military
1198127|NCT02042131|veteran|veteran
1198128|NCT02042131|clinical trial|clinical trial
1198129|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
1198130|NCT02042131|psychotherapy|psychotherapy
1198131|NCT02042131|crisis|crisis
1198132|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
1198133|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
1198134|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
1198135|NCT02042118|Neonatal resuscitation|neonatal resuscitation
1198136|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
1198137|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
1198138|NCT02042118|Uganda|uganda
1198139|NCT02042118|Africa|africa
1198140|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
1198141|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
1198142|NCT02042105|immunohistochemistry|immunohistochemistry
1198144|NCT02042092|MRA|mra
1198145|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
1198146|NCT02042092|Giant Cell Arteritis|giant cell arteritis
1198147|NCT02042092|Takayasu Arteritis|takayasu arteritis
1198148|NCT02042092|Immunological abnormalities|immunological abnormalities
1198149|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
1198150|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
1198151|NCT02042079|hybrid-NOTES|hybrid-notes
1198152|NCT02042066|Resistant Hypertension|resistant hypertension
1198153|NCT02042066|RH|rh
1198154|NCT02042066|RHT|rht
1198155|NCT02042066|Blood Pressure|blood pressure
1198156|NCT02042066|Kidney|kidney
1198157|NCT02042066|Shockwave|shockwave
1198158|NCT02042053|imaging|imaging
1198159|NCT02042053|diagnostic|diagnostic
1198160|NCT02042053|castration resistant|castration resistant
1198161|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
1198162|NCT02042053|immunotherapy|immunotherapy
1198163|NCT02042027|corneal neovascularization|corneal neovascularization
1198164|NCT02042027|Gamunex-C|gamunex-c
1198165|NCT02042027|IVI-g|ivi-g
1198166|NCT02042027|anterior segment inflammation|anterior segment inflammation
1198167|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
1198168|NCT02041988|premedication|premedication
1198169|NCT02041988|oral morphine|oral morphine
1198170|NCT02041988|preemptive analgesia|preemptive analgesia
1198171|NCT02041975|Prebiotics|prebiotics
1198172|NCT02041975|Gut health|gut health
1198173|NCT02041975|Satisfaction|satisfaction
1198174|NCT02041962|Care Management|care management
1198175|NCT02041962|Chronic Care Model|chronic care model
1198176|NCT02041962|Mood Disorders|mood disorders
1198177|NCT02041936|irreversible electroporation|irreversible electroporation
1198178|NCT02041936|Nanoknife|nanoknife
1198179|NCT02041936|pancreatic cancer|pancreatic cancer
1198180|NCT02041923|preterm infant|preterm infant
1198181|NCT02041923|stable infant|stable infant
1198182|NCT02041923|mother-infant interaction|mother-infant interaction
1198183|NCT02041923|health care cost|health care cost
1198184|NCT02041923|H-HOPE intervention|h-hope intervention
1198185|NCT02041923|mother outcomes|mother outcomes
1198186|NCT02041923|infant behavioral organization|infant behavioral organization
1198187|NCT02041923|infant growth|infant growth
1198188|NCT02041897|EUS-FNA|eus-fna
1198189|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
1198190|NCT02041897|Diagnosis|diagnosis
1198288|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
1198191|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
1198192|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
1198193|NCT02041884|Applied Relaxation|applied relaxation
1198194|NCT02041884|Stress-reduction|stress-reduction
1198195|NCT02041884|Smartphone application|smartphone application
1198196|NCT02041884|ADHD|adhd
1198197|NCT02041884|Randomized controlled trial|randomized controlled trial
1198198|NCT02041884|Psychological treatment|psychological treatment
1198199|NCT02041884|Efficacy|efficacy
1198200|NCT02041871|Liver Surgery|liver surgery
1198201|NCT02041871|Hepatectomy|hepatectomy
1198202|NCT02041871|Immunonutrition|immunonutrition
1198203|NCT02041871|Cancer|cancer
1198204|NCT02041871|Morbidity|morbidity
1198205|NCT02041871|Postoperative complication|postoperative complication
1198206|NCT02041858|Alarms|alarms
1198207|NCT02041858|Physiologic Monitoring|physiologic monitoring
1198208|NCT02041858|Critical Care|critical care
1198209|NCT02041858|Alarm fatigue|alarm fatigue
1198210|NCT02041858|Adverse Events|adverse events
1198211|NCT02041845|Radiotherapy|radiotherapy
1198212|NCT02041845|Radiotherapy dosage|radiotherapy dosage
1198213|NCT02041845|Dose fractionation|dose fractionation
1198214|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
1198215|NCT02041845|Thorax|thorax
1198216|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1198217|NCT02041819|Nimotuzumab|nimotuzumab
1198218|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
1198219|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
1198220|NCT02041793|Acute pancreatitis|acute pancreatitis
1198221|NCT02041793|Pseudocyst|pseudocyst
1198222|NCT02041780|Diagnostic|diagnostic
1198223|NCT02041780|Liver fibrosis|liver fibrosis
1198224|NCT02041780|Ishak score|ishak score
1198225|NCT02041780|Fibrotest|fibrotest
1198226|NCT02041780|ShearWave elastography|shearwave elastography
1198227|NCT02041780|Liver biopsies|liver biopsies
1198228|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
1198229|NCT02041741|happiness|happiness
1198230|NCT02041741|well-being|well-being
1198231|NCT02041741|distress|distress
1198232|NCT02041741|positive psychology|positive psychology
1198233|NCT02041715|Virus Diseases|virus diseases
1198234|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
1198235|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
1198236|NCT02041715|RNA Virus Infections|rna virus infections
1198237|NCT02041715|Filoviridae Infections|filoviridae infections
1333146|NCT01444378|Stent|stent
1198238|NCT02041715|Mononegavirales Infections|mononegavirales infections
1198239|NCT02041702|Bradycardia|bradycardia
1198240|NCT02041702|Pacemaker|pacemaker
1198241|NCT02041702|Magnetic|magnetic
1198242|NCT02041702|Conditional|conditional
1198243|NCT02041702|St Jude|st jude
1198244|NCT02041702|Accent|accent
1198245|NCT02041702|Tendril|tendril
1198246|NCT02041689|Children|children
1198247|NCT02041689|Cancer|cancer
1198248|NCT02041689|Learning|learning
1198249|NCT02041689|Education|education
1198250|NCT02041689|Qualitative|qualitative
1198251|NCT02041676|Chest|chest
1198252|NCT02041676|Physiotherapy|physiotherapy
1198253|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
1198254|NCT02041676|Prematurity|prematurity
1198255|NCT02041676|Non Invasive Ventilation|non invasive ventilation
1198256|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
1198257|NCT02041663|cardiac function|cardiac function
1198258|NCT02041663|meningococcal infections|meningococcal infections
1198259|NCT02041663|septic shock|septic shock
1198260|NCT02041663|severe sepsis|severe sepsis
1198261|NCT02041637|liver failure|liver failure
1198262|NCT02041637|etiology|etiology
1198263|NCT02041637|liver transplantation|liver transplantation
1198264|NCT02041624|allergic|allergic
1198265|NCT02041624|rhinitis|rhinitis
1198266|NCT02041624|conjunctivitis|conjunctivitis
1198267|NCT02041624|grass pollen|grass pollen
1198268|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
1198269|NCT02041624|grass mix|grass mix
1198270|NCT02041611|WHO grade III and IV|who grade iii and iv
1198271|NCT02041585|Hospital Readmission|hospital readmission
1198272|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
1198273|NCT02041585|Age and Hospital Readmission|age and hospital readmission
1198274|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
1198275|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
1198276|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
1198277|NCT02041546|Lung lavage,|lung lavage,
1198278|NCT02041546|Surfactant,|surfactant,
1198279|NCT02041546|Duration of mechanical|duration of mechanical
1198280|NCT02041546|ventilation|ventilation
1198281|NCT02041520|Seropositive HIV|seropositive hiv
1198282|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
1198283|NCT02041520|Oxidative stress|oxidative stress
1198284|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
1198285|NCT02041507|Water Immersion|water immersion
1198286|NCT02041507|Water Exchange|water exchange
1198287|NCT02041507|On-demand sedation|on-demand sedation
1198591|NCT02039895|Refractory|refractory
1198289|NCT02041507|Adenoma detection rate|adenoma detection rate
1198290|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
1198291|NCT02041494|Hernia|hernia
1198292|NCT02041494|Ventral|ventral
1198293|NCT02041494|Incisional|incisional
1198294|NCT02041494|Abdominal|abdominal
1198295|NCT02041494|Herniorrhaphy|herniorrhaphy
1198296|NCT02041494|Recurrence|recurrence
1198297|NCT02041494|Infection|infection
1198298|NCT02041494|Mesh|mesh
1198299|NCT02041494|Biologic|biologic
1198300|NCT02041494|Synthetic|synthetic
1198301|NCT02041468|ALK-positive|alk-positive
1198302|NCT02041455|Fibromyalgia|fibromyalgia
1198303|NCT02041455|Melatonin|melatonin
1198304|NCT02041455|Amitriptylin|amitriptylin
1198305|NCT02041455|Imune-pineal axis|imune-pineal axis
1198306|NCT02041442|overactive bladder|overactive bladder
1198307|NCT02041442|cystoscopy|cystoscopy
1198308|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
1198309|NCT02041429|Advanced Breast Cancer|advanced breast cancer
1198310|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
1198311|NCT02041416|Geriatric assessment|geriatric assessment
1198312|NCT02041416|REDCap|redcap
1198313|NCT02041416|touchscreen|touchscreen
1198314|NCT02041416|age 65|age 65
1198315|NCT02041364|Fatigue|fatigue
1198316|NCT02041364|Biomarkers|biomarkers
1198317|NCT02041364|Breast Cancer|breast cancer
1198318|NCT02041351|metastatic breast cancer|metastatic breast cancer
1198319|NCT02041351|taxanes|taxanes
1198320|NCT02041351|heavily pretreated|heavily pretreated
1198321|NCT02041312|Cholesterol|cholesterol
1198322|NCT02041312|Gastric cancer|gastric cancer
1198323|NCT02041312|Stage|stage
1198324|NCT02041299|sickle cell disease|sickle cell disease
1198325|NCT02041299|Iron overload|iron overload
1198326|NCT02041299|Deferiprone|deferiprone
1198327|NCT02041299|Ferriprox|ferriprox
1198328|NCT02041299|deferoxamine|deferoxamine
1198329|NCT02041299|Chelation|chelation
1198330|NCT02041273|bioavailability|bioavailability
1198331|NCT02041273|bioequivalence|bioequivalence
1198332|NCT02041273|AUC|auc
1198333|NCT02041273|Cmax|cmax
1198334|NCT02041260|Adult|adult
1198335|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
1198336|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
1198337|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
1198338|NCT02041234|Diabetes|diabetes
1198339|NCT02041234|surgical treatment|surgical treatment
1198340|NCT02041234|medical treatment|medical treatment
1198341|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
1198342|NCT02041208|Chronic renal anemia|chronic renal anemia
1198343|NCT02041208|Hemoglobin|hemoglobin
1198344|NCT02041208|Kidney transplant|kidney transplant
1198345|NCT02041195|Overweight|overweight
1198346|NCT02041182|youth violence|youth violence
1198347|NCT02041182|doctor-patient communication|doctor-patient communication
1198348|NCT02041182|health risk behaviors|health risk behaviors
1198349|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
1198350|NCT02041130|Heart Failure|heart failure
1198351|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1198352|NCT02041104|Metabolic syndrome|metabolic syndrome
1198353|NCT02041104|4 -week intervention|4 -week intervention
1198354|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
1198355|NCT02041104|Beta-glucans|beta-glucans
1198356|NCT02041104|Abdominal fat|abdominal fat
1198357|NCT02041104|Dyslipidemia|dyslipidemia
1198358|NCT02041104|Insulin resistance|insulin resistance
1198359|NCT02041104|Hypertension|hypertension
1198360|NCT02041104|Gut Microbiota Composition|gut microbiota composition
1198361|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
1198362|NCT02041104|Lipid Profile|lipid profile
1198363|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
1198364|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
1198365|NCT02041078|Liver surgery|liver surgery
1198366|NCT02041078|Blood loss|blood loss
1198367|NCT02041078|CUSA|cusa
1198368|NCT02041078|Hepatic transection|hepatic transection
1198369|NCT02041065|Liver transection|liver transection
1198370|NCT02041065|Bloodloss|bloodloss
1198371|NCT02041065|Operation time|operation time
1198372|NCT02041065|Safety|safety
1198373|NCT02041065|feasibility|feasibility
1198374|NCT02041026|probiotic|probiotic
1198375|NCT02041026|Yoghurt|yoghurt
1198376|NCT02041026|NN20|nn20
1198377|NCT02041013|Asthma|asthma
1198378|NCT02041013|Health Literacy|health literacy
1198379|NCT02041000|COPD|copd
1198380|NCT02041000|pulmonary|pulmonary
1198381|NCT02041000|stem cells|stem cells
1198382|NCT02041000|emphysema|emphysema
1198383|NCT02041000|lungs|lungs
1198384|NCT02040987|Thorough QT study|thorough qt study
1198385|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
1198386|NCT02040961|Patients|patients
1198387|NCT02040961|Undergoing|undergoing
1198388|NCT02040961|Elective|elective
1198389|NCT02040961|Thoracic|thoracic
1198390|NCT02040961|Surgery|surgery
1198391|NCT02040922|Antibiotics|antibiotics
1198392|NCT02040922|Campylobacter|campylobacter
1198393|NCT02040922|Diarrhoea|diarrhoea
1198394|NCT02040922|Enteritis|enteritis
1198395|NCT02040922|Microbiota|microbiota
1198396|NCT02040922|Calprotectin|calprotectin
1198397|NCT02040909|sedation|sedation
1198398|NCT02040909|quality of intubation|quality of intubation
1198399|NCT02040909|hypotension|hypotension
1198400|NCT02040909|pharmacodynamics|pharmacodynamics
1198401|NCT02040909|pharmacokinetics|pharmacokinetics
1198402|NCT02040896|computed tomography|computed tomography
1198403|NCT02040896|emergency|emergency
1198404|NCT02040896|CT scan|ct scan
1198405|NCT02040896|ordering behavior|ordering behavior
1198406|NCT02040896|diagnosis|diagnosis
1198407|NCT02040896|radiation|radiation
1198408|NCT02040883|Schizophrenia|schizophrenia
1198409|NCT02040883|Tandospirone|tandospirone
1198410|NCT02040883|Cognitive Therapy|cognitive therapy
1198411|NCT02040870|Non-Small Cell lung Cancer, NSCLC, ALK, LDK378|non-small cell lung cancer, nsclc, alk, ldk378
1198412|NCT02040857|Breast Cancer|breast cancer
1198413|NCT02040805|compulsive hoarding|compulsive hoarding
1198414|NCT02040805|clutter|clutter
1198415|NCT02040805|hoarding disorder|hoarding disorder
1198416|NCT02040792|COPD|copd
1198417|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1198418|NCT02040779|asthma|asthma
1198419|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
1198420|NCT02040779|beclomethasone|beclomethasone
1198421|NCT02040766|asthma|asthma
1198422|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
1198423|NCT02040766|metered dose inhaler|metered dose inhaler
1198424|NCT02040753|Lifestyle intervention|lifestyle intervention
1198425|NCT02040753|Change of body composition|change of body composition
1198426|NCT02040753|Physical activity|physical activity
1198427|NCT02040753|Weight loss maintenance|weight loss maintenance
1198428|NCT02040727|Myokines|myokines
1198429|NCT02040727|Osteokines|osteokines
1198430|NCT02040727|Glucose homeostasis|glucose homeostasis
1198431|NCT02040727|Puberty|puberty
1198432|NCT02040714|femur head necrosis|femur head necrosis
1198433|NCT02040714|hip|hip
1198434|NCT02040714|pediatric orthopedics|pediatric orthopedics
1198435|NCT02040714|MRI|mri
1198436|NCT02040714|Osteonecrosis|osteonecrosis
1198437|NCT02040714|Bone diseases|bone diseases
1198438|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
1577407|NCT00474318|Obesity|obesity
1198439|NCT02040662|paravertebral block|paravertebral block
1198440|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
1198441|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
1198442|NCT02040662|lung lobectomy|lung lobectomy
1198443|NCT02040649|Critical care|critical care
1198444|NCT02040649|Respiration, artificial|respiration, artificial
1198445|NCT02040636|Pertussis|pertussis
1198446|NCT02040636|Tetanus|tetanus
1198447|NCT02040636|Diphtheria|diphtheria
1198448|NCT02040636|Poliomyelitis|poliomyelitis
1198449|NCT02040636|Hepatitis B|hepatitis b
1198450|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
1198451|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
1198452|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1198453|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
1198454|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
1198455|NCT02040610|Hypofractionated|hypofractionated
1198456|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
1198457|NCT02040584|De Novo Liver Transplant Recipients, Tacrolimus Minimisation, Everolimus, Renal Function|de novo liver transplant recipients, tacrolimus minimisation, everolimus, renal function
1198458|NCT02040545|Infertility|infertility
1198459|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
1198460|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
1198461|NCT02040545|Needle-free treatment|needle-free treatment
1198462|NCT02040519|Overactive bladder|overactive bladder
1198463|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
1198464|NCT02040519|Sacral neuromodulation|sacral neuromodulation
1198465|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
1198466|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
1198467|NCT02040506|Drug therapy|drug therapy
1198468|NCT02040506|CD98|cd98
1198469|NCT02040506|Relapsed|relapsed
1198470|NCT02040506|Refractory|refractory
1198471|NCT02040506|Monoclonal antibody|monoclonal antibody
1198472|NCT02040493|breast cancer|breast cancer
1198473|NCT02040493|IORT|iort
1198474|NCT02040493|brachytherapy|brachytherapy
1198475|NCT02040480|bioavailability|bioavailability
1198476|NCT02040480|food effect|food effect
1198477|NCT02040480|formulation|formulation
1198478|NCT02040480|GSK2110183|gsk2110183
1198479|NCT02040480|afuresertib|afuresertib
1198480|NCT02040480|AKT inhibitor|akt inhibitor
1198481|NCT02040441|Proteomics|proteomics
1198482|NCT02040441|Diabetes|diabetes
1198483|NCT02040441|Chronic kidney disease|chronic kidney disease
1198484|NCT02040441|Diabetic nephropathy|diabetic nephropathy
1198485|NCT02040441|Diabetic retinopathy|diabetic retinopathy
1198486|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
1198487|NCT02040441|Spironolactone|spironolactone
1198488|NCT02040441|Microalbuminuria|microalbuminuria
1198489|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
1198490|NCT02040428|Fibrin Sealant|fibrin sealant
1198491|NCT02040428|Hemostatics|hemostatics
1198492|NCT02040428|Coagulants|coagulants
1198493|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
1198494|NCT02040389|children|children
1198495|NCT02040389|penile|penile
1198496|NCT02040389|inguinal|inguinal
1198497|NCT02040389|kidney parents|kidney parents
1198498|NCT02040389|anxiety|anxiety
1198499|NCT02040376|Paediatrics|paediatrics
1198500|NCT02040376|Medulloblastoma|medulloblastoma
1198501|NCT02040376|Metformin|metformin
1198502|NCT02040363|COPD|copd
1198503|NCT02040363|skeletal muscle|skeletal muscle
1198504|NCT02040363|angiogenesis|angiogenesis
1198505|NCT02040363|exercise training|exercise training
1198506|NCT02040363|intensity|intensity
1198507|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
1198508|NCT02040285|CT colonography|ct colonography
1198509|NCT02040259|ischemic stroke|ischemic stroke
1198510|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
1198511|NCT02040259|Retriever|retriever
1198512|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
1198513|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
1198514|NCT02040168|Ventilation|ventilation
1198515|NCT02040168|PTSD|ptsd
1198516|NCT02040168|sedation|sedation
1198517|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
1198518|NCT02040142|HIPEC|hipec
1198519|NCT02040142|Cytoreduction|cytoreduction
1198520|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
1198521|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
1198522|NCT02040103|Pulmonary Embolism|pulmonary embolism
1198523|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
1198524|NCT02040103|Pharmacologic DVT|pharmacologic dvt
1198525|NCT02040103|Prophylaxis|prophylaxis
1198526|NCT02040103|Critically Ill Patients.|critically ill patients.
1198527|NCT02040077|opioid|opioid
1198528|NCT02040077|overdose|overdose
1198529|NCT02040077|OD|od
1198530|NCT02040077|opiate|opiate
1198531|NCT02040077|prescription opioids|prescription opioids
1198532|NCT02040077|prescription pain medication|prescription pain medication
1198533|NCT02040077|heroin|heroin
1198534|NCT02040077|detoxification|detoxification
1198535|NCT02040077|prevention|prevention
1198536|NCT02040051|intensive care units|intensive care units
1198537|NCT02040051|mechanical ventilation|mechanical ventilation
1198538|NCT02040051|music therapy|music therapy
1198539|NCT02040038|Diabetes|diabetes
1198540|NCT02040038|Virtual Environment|virtual environment
1198541|NCT02040038|Self-Management|self-management
1198542|NCT02040025|hypertension|hypertension
1198543|NCT02040025|diabetes mellitus|diabetes mellitus
1198544|NCT02040025|hemoglobin A1C|hemoglobin a1c
1198545|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
1198546|NCT02040025|EECP|eecp
1198547|NCT02040025|Blood pressure|blood pressure
1198548|NCT02040025|angiogenesis|angiogenesis
1198549|NCT02040025|Coronary Artery Disease|coronary artery disease
1198550|NCT02040025|Coronary Disease|coronary disease
1198551|NCT02040025|Heart Diseases|heart diseases
1198552|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
1198553|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1198554|NCT02039999|chronic|chronic
1198555|NCT02039999|cough|cough
1198556|NCT02039999|challenge|challenge
1198557|NCT02039999|ATP|atp
1198558|NCT02039999|hypersensitivity|hypersensitivity
1198559|NCT02039999|TRPA1|trpa1
1198560|NCT02039986|cystic fibrosis|cystic fibrosis
1198561|NCT02039986|CF|cf
1198562|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
1198563|NCT02039986|CFRD|cfrd
1198564|NCT02039986|kalydeco|kalydeco
1198565|NCT02039986|ivacaftor|ivacaftor
1198566|NCT02039973|HIV|hiv
1198567|NCT02039973|AIDS|aids
1198568|NCT02039973|Tanzania|tanzania
1198569|NCT02039973|depression|depression
1198570|NCT02039973|perinatal|perinatal
1198571|NCT02039973|psychotherapy|psychotherapy
1198572|NCT02039973|task-sharing|task-sharing
1198573|NCT02039973|problem-solving|problem-solving
1198574|NCT02039960|Epidemiology|epidemiology
1198575|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
1198576|NCT02039960|bupropion|bupropion
1198577|NCT02039960|abuse|abuse
1198578|NCT02039947|BRAF V600K mutation|braf v600k mutation
1198579|NCT02039947|Metastatic Melanoma|metastatic melanoma
1198580|NCT02039947|BRAF V600R mutation|braf v600r mutation
1198581|NCT02039947|BRAF V600D mutation|braf v600d mutation
1198582|NCT02039947|BRAF V600E mutation|braf v600e mutation
1198583|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
1198584|NCT02039947|Intracranial|intracranial
1198585|NCT02039934|type 2 diabetes|type 2 diabetes
1198586|NCT02039934|exercise intervention|exercise intervention
1198587|NCT02039934|high intensity interval training|high intensity interval training
1198588|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
1198589|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1198590|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
1198592|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
1198593|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1198594|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
1198595|NCT02039882|Normals|normals
1198596|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
1198597|NCT02039882|Point of Care POC|point of care poc
1198598|NCT02039882|Hypoxanthine|hypoxanthine
1198599|NCT02039882|Inosine|inosine
1198600|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
1198601|NCT02039869|NERD|nerd
1198602|NCT02039869|Non erosive reflux disease|non erosive reflux disease
1198603|NCT02039869|functional dyspepsia|functional dyspepsia
1198604|NCT02039869|erosive esophagitis|erosive esophagitis
1198605|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
1198606|NCT02039869|cell visio|cell visio
1198607|NCT02039869|proton pump inhibitor|proton pump inhibitor
1198608|NCT02039869|sucralfate|sucralfate
1198609|NCT02039856|Patient-centered medical homes|patient-centered medical homes
1198610|NCT02039856|Primary care|primary care
1198611|NCT02039856|Women's health|women's health
1198612|NCT02039856|Veterans|veterans
1198613|NCT02039830|female|female
1198614|NCT02039830|aging|aging
1198615|NCT02039830|physiotherapy|physiotherapy
1198616|NCT02039830|pelvic floor|pelvic floor
1198617|NCT02039830|rehabilitation|rehabilitation
1198618|NCT02039817|pharmacokinetics|pharmacokinetics
1198619|NCT02039817|pharmacodynamics|pharmacodynamics
1198620|NCT02039817|renal impairment|renal impairment
1198621|NCT02039778|Glioblastoma|glioblastoma
1198622|NCT02039778|High-grade Glioma|high-grade glioma
1198623|NCT02039778|Brain Tums|brain tums
1198624|NCT02039778|Temozolomide|temozolomide
1198625|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
1198626|NCT02039778|IMRT|imrt
1198627|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
1198628|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
1198629|NCT02039778|Quality of Life|quality of life
1198630|NCT02039778|Neurocognition|neurocognition
1198631|NCT02039765|Ocular Redness|ocular redness
1198632|NCT02039752|Multivessel|multivessel
1198633|NCT02039739|Orsiro|orsiro
1198634|NCT02039739|Drug Eluting Stent|drug eluting stent
1198635|NCT02039739|Routine Clinical Practice|routine clinical practice
1198636|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1198637|NCT02039739|Coronary Artery Disease|coronary artery disease
1198638|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
1198639|NCT02039726|AML|aml
1198640|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
1198641|NCT02039726|FLT3-ITD|flt3-itd
1198642|NCT02039726|Quizartinib|quizartinib
1198643|NCT02039726|Leukemia|leukemia
1198644|NCT02039726|Tablets|tablets
1198645|NCT02039713|DeSyne|desyne
1198646|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1198647|NCT02039713|Coronary Artery Disease|coronary artery disease
1198648|NCT02039687|neuropathy|neuropathy
1198649|NCT02039687|sarcoidosis|sarcoidosis
1198650|NCT02039674|PD-1|pd-1
1198651|NCT02039674|PD1|pd1
1198652|NCT02039674|Programmed Cell Death-1|programmed cell death-1
1198653|NCT02039674|Programmed Cell Death 1|programmed cell death 1
1198654|NCT02039674|Chemotherapy|chemotherapy
1198655|NCT02039674|Pemetrexed|pemetrexed
1198656|NCT02039674|Paclitaxel|paclitaxel
1198657|NCT02039674|Bevacizumab|bevacizumab
1198658|NCT02039674|Erlotinib|erlotinib
1198659|NCT02039674|Gefitinib|gefitinib
1198660|NCT02039674|Ipilimumab|ipilimumab
1198661|NCT02039674|Carboplatin|carboplatin
1198662|NCT02039661|Curettage;|curettage;
1198663|NCT02039661|Pain Score|pain score
1198664|NCT02039648|Periodontitis|periodontitis
1198920|NCT02038452|carpal|carpal
1198665|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
1198666|NCT02039648|Rumex acetosa L.|rumex acetosa l.
1198667|NCT02039648|Proanthocyanidins|proanthocyanidins
1198668|NCT02039635|cancer|cancer
1198669|NCT02039635|cancer related fatigue|cancer related fatigue
1198670|NCT02039635|Korean red ginseng|korean red ginseng
1198671|NCT02039635|chemotherapy|chemotherapy
1198672|NCT02039583|live birth|live birth
1198673|NCT02039583|infant|infant
1198674|NCT02039583|infant, newborn|infant, newborn
1198675|NCT02039583|second-hand smoke|second-hand smoke
1198676|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
1198677|NCT02039583|smoke-free|smoke-free
1198678|NCT02039583|smoke-free policy|smoke-free policy
1198679|NCT02039570|haemorrhoids|haemorrhoids
1198680|NCT02039570|pelvic reflux|pelvic reflux
1198681|NCT02039531|Knee|knee
1198682|NCT02039531|osteoarthritis|osteoarthritis
1198683|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
1198684|NCT02039531|platelet rich plasma|platelet rich plasma
1198685|NCT02039531|hyaluronic acid|hyaluronic acid
1198686|NCT02039518|Progression free Survival|progression free survival
1198687|NCT02039505|Drug therapy|drug therapy
1198688|NCT02039479|anti-suicide|anti-suicide
1198689|NCT02039479|Lithium|lithium
1198690|NCT02039479|Depression|depression
1198691|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
1198692|NCT02039453|Colonoscopy|colonoscopy
1198693|NCT02039453|sedation|sedation
1198694|NCT02039453|propofol|propofol
1198695|NCT02039453|fentanyl|fentanyl
1198696|NCT02039453|pethidine|pethidine
1198697|NCT02039427|Sore throat|sore throat
1198698|NCT02039427|Hoarseness|hoarseness
1198699|NCT02039427|Intubation|intubation
1198700|NCT02039427|Thyroidectomy|thyroidectomy
1198701|NCT02039427|Ketorolac|ketorolac
1198702|NCT02039427|Dexamethasone|dexamethasone
1198703|NCT02039414|Obesity|obesity
1198704|NCT02039414|Physical Inactivity|physical inactivity
1198705|NCT02039414|Lipid Oxidation|lipid oxidation
1198706|NCT02039414|Oxidative stress|oxidative stress
1198707|NCT02039414|pregnancy|pregnancy
1198708|NCT02039414|neonatal adiposity|neonatal adiposity
1198709|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
1198710|NCT02039401|ALS|als
1198711|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
1198712|NCT02039401|neurodegenerative disease|neurodegenerative disease
1198713|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
1198714|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
1198715|NCT02039388|BRCA1 gene|brca1 gene
1198716|NCT02039388|BRCA2 gene|brca2 gene
1198717|NCT02039388|Mutation|mutation
1198718|NCT02039388|Neoplasms|neoplasms
1198719|NCT02039388|Glandular and Epithelial|glandular and epithelial
1198720|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
1198721|NCT02039388|Ovarian cancer|ovarian cancer
1198722|NCT02039388|Carcinoma in situ|carcinoma in situ
1198723|NCT02039388|family history breast cancer|family history breast cancer
1198724|NCT02039388|family history ovarian cancer|family history ovarian cancer
1198725|NCT02039375|IV tPA|iv tpa
1198726|NCT02039375|Thrombolysis|thrombolysis
1198727|NCT02039375|Stroke|stroke
1198728|NCT02039375|Ischemic|ischemic
1198729|NCT02039375|Monitoring|monitoring
1198730|NCT02039349|Alcoholism|alcoholism
1198731|NCT02039349|Ghrelin|ghrelin
1198732|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
1198733|NCT02039323|Tenofovir|tenofovir
1198734|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
1198735|NCT02039323|Maraviroc|maraviroc
1198736|NCT02039323|Pharmacologic Actions|pharmacologic actions
1198737|NCT02039323|Anti-HIV agents|anti-hiv agents
1198738|NCT02039323|Pharmacodynamics|pharmacodynamics
1198739|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
1198740|NCT02039284|Cerebral palsy|cerebral palsy
1198741|NCT02039284|novel intervention|novel intervention
1198742|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
1198743|NCT02039284|virtual reality|virtual reality
1198744|NCT02039284|cycling training|cycling training
1198745|NCT02039284|constraint-induced therapy|constraint-induced therapy
1198746|NCT02039284|biomechanical|biomechanical
1198747|NCT02039284|physiology|physiology
1198748|NCT02039284|outcome|outcome
1198749|NCT02039271|music|music
1198750|NCT02039271|total knee replacement|total knee replacement
1198751|NCT02039271|Pain management|pain management
1198752|NCT02039258|Healthy Volunteers|healthy volunteers
1198753|NCT02039258|Canagliflozin|canagliflozin
1198754|NCT02039258|Metformin|metformin
1198755|NCT02039258|INVOKANA®|invokana®
1198756|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
1198757|NCT02039245|Healthy Volunteers|healthy volunteers
1198758|NCT02039245|Canagliflozin|canagliflozin
1198759|NCT02039245|Metformin|metformin
1198760|NCT02039245|INVOKANA®|invokana®
1198761|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1198762|NCT02039206|Machado Joseph disease|machado joseph disease
1198763|NCT02039206|Deep TMS|deep tms
1198764|NCT02039206|TMS|tms
1198765|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1198766|NCT02039206|SCA3|sca3
1198767|NCT02039206|Magnetic Stimulation|magnetic stimulation
1198768|NCT02039206|Brainsway|brainsway
1198769|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
1198770|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
1198771|NCT02039193|adherence|adherence
1198772|NCT02039180|phase I|phase i
1198773|NCT02039180|healthy volunteers|healthy volunteers
1198774|NCT02039180|AZD3293|azd3293
1198775|NCT02039180|bioavailability|bioavailability
1198776|NCT02039180|Pharmacokinetics|pharmacokinetics
1198777|NCT02039154|Exercise|exercise
1198778|NCT02039154|Exercise tolerance|exercise tolerance
1198779|NCT02039154|Aging|aging
1198780|NCT02039154|Physical activity|physical activity
1198781|NCT02039141|diabetes prevention program|diabetes prevention program
1198782|NCT02039141|community based interventions|community based interventions
1198783|NCT02039141|childhood obesity|childhood obesity
1198784|NCT02039141|insulin resistance|insulin resistance
1198785|NCT02039141|glucose tolerance|glucose tolerance
1198786|NCT02039141|quality of life|quality of life
1198787|NCT02039141|Latino youth|latino youth
1198788|NCT02039141|physical activity|physical activity
1198789|NCT02039141|nutrition|nutrition
1198790|NCT02039102|hormonal contraceptives|hormonal contraceptives
1198791|NCT02039102|combined pills|combined pills
1198792|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
1198793|NCT02039102|body mass index|body mass index
1198794|NCT02039102|asthma|asthma
1198795|NCT02039102|Scotland|scotland
1198796|NCT02039102|women|women
1198797|NCT02039076|Healthy|healthy
1198798|NCT02039063|Crohn's Disease|crohn's disease
1198799|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1198800|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
1198801|NCT02039050|Impulse oscillometry|impulse oscillometry
1198802|NCT02039024|18F-DTBZ|18f-dtbz
1198803|NCT02039011|Asthma|asthma
1198804|NCT02039011|Long acting beta-agonists|long acting beta-agonists
1198805|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
1198806|NCT02039011|Mannitol challenge|mannitol challenge
1198807|NCT02038998|stroke|stroke
1198808|NCT02038998|periodic acceleration|periodic acceleration
1198809|NCT02038998|endothelium release|endothelium release
1198810|NCT02038998|ischemic penumbra|ischemic penumbra
1198811|NCT02038998|shear stress|shear stress
1198812|NCT02038998|adrenomedullin|adrenomedullin
1198813|NCT02038985|Endometriosis|endometriosis
1198814|NCT02038985|Robotic Surgery|robotic surgery
1198815|NCT02038985|Diagnostic Imaging|diagnostic imaging
1198816|NCT02038959|Parkinson disease|parkinson disease
1198817|NCT02038959|Parkinson's|parkinson's
1198818|NCT02038959|Parkinson's disease|parkinson's disease
1198819|NCT02038959|telemedicine|telemedicine
1198820|NCT02038959|virtual visits|virtual visits
1198821|NCT02038959|video calls|video calls
1198822|NCT02038959|video conferencing|video conferencing
1198823|NCT02038959|virtual house calls|virtual house calls
1198824|NCT02038920|Drug Therapy|drug therapy
1198825|NCT02038907|Norovirus, vaccination|norovirus, vaccination
1198826|NCT02038894|Anesthetic|anesthetic
1198827|NCT02038894|Pediatric|pediatric
1198828|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
1198829|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
1198830|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1198831|NCT02038894|Abdominal Pain|abdominal pain
1198832|NCT02038894|Vomiting|vomiting
1198833|NCT02038894|Sevofluorane|sevofluorane
1198834|NCT02038894|Propofol|propofol
1198835|NCT02038894|Nasal cannula|nasal cannula
1198836|NCT02038894|Intubation|intubation
1198837|NCT02038894|Endotracheal tube|endotracheal tube
1198839|NCT02038868|ASP4901|asp4901
1198840|NCT02038855|Dual-diagnosis|dual-diagnosis
1198841|NCT02038855|Latino|latino
1198842|NCT02038855|Mental health|mental health
1198843|NCT02038855|Substance use|substance use
1198844|NCT02038855|HIV risk|hiv risk
1198845|NCT02038829|COPD|copd
1198846|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
1198847|NCT02038790|opioid dependence|opioid dependence
1198848|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
1198849|NCT02038790|Opioid-Related Disorders|opioid-related disorders
1198850|NCT02038777|Hematologic Malignancies|hematologic malignancies
1198851|NCT02038764|Phase 1|phase 1
1198852|NCT02038764|RN168|rn168
1198853|NCT02038764|Adults|adults
1198854|NCT02038764|Type 1 Diabetes|type 1 diabetes
1198855|NCT02038764|T1D|t1d
1198856|NCT02038751|Genotyping|genotyping
1198857|NCT02038751|Phenotyping|phenotyping
1198858|NCT02038751|Sleep Apnea|sleep apnea
1198859|NCT02038751|Genetic Association Studies|genetic association studies
1198860|NCT02038751|Phenotype|phenotype
1198861|NCT02038738|gallium|gallium
1198862|NCT02038738|Ga|ga
1198863|NCT02038738|PET Scan|pet scan
1198864|NCT02038725|Risks|risks
1198865|NCT02038725|Risk Factors|risk factors
1198866|NCT02038725|ABCD2 score|abcd2 score
1198867|NCT02038725|Predictive Value of Tests|predictive value of tests
1198868|NCT02038725|Risk Assessment|risk assessment
1198869|NCT02038725|Severity of Illness Index|severity of illness index
1198870|NCT02038725|Decision Support Techniques|decision support techniques
1198871|NCT02038712|Obesity|obesity
1198872|NCT02038712|Binge eating disorder|binge eating disorder
1198873|NCT02038712|fMRI|fmri
1198874|NCT02038712|gut hormones|gut hormones
1198875|NCT02038686|Hip fracture|hip fracture
1198876|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
1198877|NCT02038686|Proximal femoral nail|proximal femoral nail
1198878|NCT02038673|ASP5878|asp5878
1198879|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
1198880|NCT02038660|Coronary Artery Disease|coronary artery disease
1198881|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
1198882|NCT02038647|Drug therapy|drug therapy
1198883|NCT02038634|wrist|wrist
1198884|NCT02038634|tendonitis|tendonitis
1198885|NCT02038634|dequervain's|dequervain's
1198886|NCT02038634|tenosynovitis|tenosynovitis
1198887|NCT02038608|Parkinson|parkinson
1198888|NCT02038608|serotonin|serotonin
1198889|NCT02038608|dopamine|dopamine
1198890|NCT02038608|non motor|non motor
1198891|NCT02038608|progression|progression
1198892|NCT02038608|PET|pet
1198893|NCT02038595|brown adipose tissue|brown adipose tissue
1198894|NCT02038582|HIV|hiv
1198895|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
1198896|NCT02038582|Linkages to Care|linkages to care
1198897|NCT02038582|Point of Care CD4|point of care cd4
1199103|NCT02037594|PrEP|prep
1198898|NCT02038582|Point of Care Viral Load|point of care viral load
1198899|NCT02038543|Hyperoxaluria|hyperoxaluria
1198900|NCT02038543|Oxalate|oxalate
1198901|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
1198902|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
1198903|NCT02038517|Insulin secretion|insulin secretion
1198904|NCT02038517|Insulin sensitivity|insulin sensitivity
1198905|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
1198906|NCT02038517|Type 2 diabetes|type 2 diabetes
1198907|NCT02038517|Metabolic syndrome|metabolic syndrome
1198908|NCT02038517|Cardiovascular disease|cardiovascular disease
1198909|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
1198910|NCT02038504|enteral nutrition|enteral nutrition
1198911|NCT02038504|thyroid function|thyroid function
1198912|NCT02038491|Epidural anesthesia|epidural anesthesia
1198913|NCT02038491|Spinal anesthesia|spinal anesthesia
1198914|NCT02038491|nerve blocks|nerve blocks
1198915|NCT02038491|complications|complications
1198916|NCT02038478|Sickle Cell Disease|sickle cell disease
1198917|NCT02038478|Thalassemia|thalassemia
1198918|NCT02038452|hand|hand
1198919|NCT02038452|wrist|wrist
1198921|NCT02038452|tunnel|tunnel
1198922|NCT02038452|syndrome|syndrome
1198923|NCT02038452|pragmatic|pragmatic
1198924|NCT02038452|randomised|randomised
1198925|NCT02038452|steroid|steroid
1198926|NCT02038452|splint|splint
1198927|NCT02038439|Evidence-Based Medicine|evidence-based medicine
1198928|NCT02038439|Evidence Retrieval|evidence retrieval
1198929|NCT02038439|Knowledge Translation|knowledge translation
1198930|NCT02038439|Medical Education|medical education
1198931|NCT02038413|NSCLC|nsclc
1198932|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
1198933|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
1198934|NCT02038413|MAASTRO|maastro
1198935|NCT02038413|age >18 years|age >18 years
1198936|NCT02038335|immune cells|immune cells
1198937|NCT02038335|contraception|contraception
1198938|NCT02038335|intrauterine device|intrauterine device
1198939|NCT02038335|IUD|iud
1198940|NCT02038335|copper|copper
1198941|NCT02038335|microbiota|microbiota
1198942|NCT02038335|DMPA|dmpa
1198943|NCT02038335|etonogestrel|etonogestrel
1198944|NCT02038335|subdermal implant|subdermal implant
1198945|NCT02038335|NET-EN|net-en
1198946|NCT02038335|Jadelle|jadelle
1198947|NCT02038335|Implanon|implanon
1198948|NCT02038335|Cyclofem|cyclofem
1198949|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
1198950|NCT02038309|Acute coronary syndrome|acute coronary syndrome
1198951|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
1198952|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
1198953|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
1198954|NCT02038296|Gemcitabine|gemcitabine
1198955|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
1198956|NCT02038283|Early Detection of Cancer|early detection of cancer
1198957|NCT02038283|Quality of Life|quality of life
1198958|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
1198959|NCT02038283|Direct Service Costs|direct service costs
1198960|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
1198961|NCT02038231|Adolescence|adolescence
1198962|NCT02038231|Substance abuse|substance abuse
1198963|NCT02038231|Mindfulness|mindfulness
1198964|NCT02038218|DM-CHOC-PEN|dm-choc-pen
1198965|NCT02038218|CNS|cns
1198966|NCT02038218|brain|brain
1198967|NCT02038218|melanoma|melanoma
1198968|NCT02038218|lung cancer|lung cancer
1198969|NCT02038218|breast cancer|breast cancer
1198970|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
1198971|NCT02038218|primary brain tumors|primary brain tumors
1198972|NCT02038192|Caregiver|caregiver
1198973|NCT02038192|Dementia|dementia
1198974|NCT02038192|Long Term Care|long term care
1198975|NCT02038192|Hope|hope
1198976|NCT02038192|Quality of Life|quality of life
1198977|NCT02038192|Intervention|intervention
1198978|NCT02038179|Pre-hypertension|pre-hypertension
1198979|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
1198980|NCT02038140|Primary Ankle Replacement|primary ankle replacement
1198981|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
1198982|NCT02038140|Total Ankle Replacement|total ankle replacement
1198983|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
1198984|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
1198985|NCT02038114|Toronto|toronto
1198986|NCT02038114|Ontario|ontario
1198987|NCT02038088|Need general anesthesia|need general anesthesia
1198988|NCT02038075|suicide|suicide
1198989|NCT02038075|suicidal ideation|suicidal ideation
1198990|NCT02038075|military|military
1198991|NCT02038075|veteran|veteran
1198992|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
1198993|NCT02038075|behavioral therapy|behavioral therapy
1198994|NCT02038075|psychotherapy|psychotherapy
1198995|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
1198996|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
1199104|NCT02037594|MSM|msm
1199105|NCT02037594|Demonstration Project|demonstration project
1199106|NCT02037581|integrated care|integrated care
1198997|NCT02038049|Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Magnetic Resonance Imaging, VAY736, monoclonal antibody, gadolinium [Gd]-enhancing lesions, B-Cell|multiple sclerosis, relapsing-remitting multiple sclerosis, magnetic resonance imaging, vay736, monoclonal antibody, gadolinium [gd]-enhancing lesions, b-cell
1198998|NCT02038036|Polycythemia Vera|polycythemia vera
1198999|NCT02038036|Hematologic Diseases|hematologic diseases
1199000|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
1199001|NCT02038036|Bone Marrow Diseases|bone marrow diseases
1199002|NCT02038036|Hydroxyurea|hydroxyurea
1199003|NCT02038036|INC424|inc424
1199004|NCT02038036|Ruxolitinib|ruxolitinib
1199005|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
1199006|NCT02038023|second and third trimester|second and third trimester
1199007|NCT02037997|PFS|pfs
1199008|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
1199009|NCT02037971|Lupus|lupus
1199010|NCT02037971|Sleep disorders|sleep disorders
1199011|NCT02037971|Sleep disturbed|sleep disturbed
1199012|NCT02037971|Physical exercise|physical exercise
1199013|NCT02037971|Aerobic exercise|aerobic exercise
1199014|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
1199015|NCT02037945|Pet Scan|pet scan
1199016|NCT02037945|MRI|mri
1199017|NCT02037945|13-199|13-199
1199018|NCT02037932|Aneurysm|aneurysm
1199019|NCT02037932|Brain Aneurysm|brain aneurysm
1199020|NCT02037906|Renal stones|renal stones
1199021|NCT02037906|SWL|swl
1199022|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
1199023|NCT02037880|MPS|mps
1199024|NCT02037880|Sanfilippo|sanfilippo
1199025|NCT02037867|alcohol|alcohol
1199026|NCT02037867|type 2 diabetes|type 2 diabetes
1199027|NCT02037867|ALT|alt
1199028|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
1199029|NCT02037867|hepatic fibrosis|hepatic fibrosis
1199030|NCT02037867|cirrhosis|cirrhosis
1199031|NCT02037841|Asthma|asthma
1199032|NCT02037841|Nursing|nursing
1199033|NCT02037841|Protocol|protocol
1199034|NCT02037841|PRAM|pram
1199035|NCT02037841|Length of Stay|length of stay
1199036|NCT02037841|Weaning|weaning
1199037|NCT02037841|Clinical pathway|clinical pathway
1199038|NCT02037841|Asthma exacerbation|asthma exacerbation
1199039|NCT02037828|COPD|copd
1199040|NCT02037828|biomarker|biomarker
1199041|NCT02037828|EBC|ebc
1199042|NCT02037828|FEV1|fev1
1199043|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
1199044|NCT02037815|mannitol|mannitol
1199045|NCT02037815|hypertonic saline|hypertonic saline
1199046|NCT02037815|serum osmolality|serum osmolality
1199047|NCT02037815|correlation|correlation
1199048|NCT02037802|caudal|caudal
1199049|NCT02037802|epidural|epidural
1199050|NCT02037802|pediatric|pediatric
1199051|NCT02037802|renal|renal
1199052|NCT02037802|transplant|transplant
1199053|NCT02037802|hemodynamics|hemodynamics
1199054|NCT02037789|pain|pain
1199055|NCT02037789|low back pain|low back pain
1199056|NCT02037789|GWAS|gwas
1199057|NCT02037789|glycomics|glycomics
1199058|NCT02037789|activomics|activomics
1199059|NCT02037776|Rikkunshito|rikkunshito
1199060|NCT02037776|Double blind|double blind
1199061|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
1199062|NCT02037763|Low back pain|low back pain
1199063|NCT02037763|GWAS|gwas
1199064|NCT02037763|Glycomics|glycomics
1199065|NCT02037763|Activomics|activomics
1199066|NCT02037763|Epigenetics|epigenetics
1199067|NCT02037750|foster care|foster care
1199068|NCT02037750|school adjustment|school adjustment
1199069|NCT02037711|Laparoscopic|laparoscopic
1199070|NCT02037711|Levobupivacaine|levobupivacaine
1199071|NCT02037711|Pediatric|pediatric
1199072|NCT02037711|Anesthesia|anesthesia
1199073|NCT02037711|Instillation|instillation
1199074|NCT02037711|surgeries|surgeries
1199075|NCT02037698|CTO|cto
1199076|NCT02037698|CT|ct
1199077|NCT02037698|Revascularization|revascularization
1199078|NCT02037685|Statins|statins
1199079|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
1199080|NCT02037685|Adherence|adherence
1199081|NCT02037685|Motivational interviewing|motivational interviewing
1199082|NCT02037685|Minority populations|minority populations
1199083|NCT02037672|PCOS|pcos
1199084|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
1199085|NCT02037672|roflumilast|roflumilast
1199086|NCT02037672|metformin|metformin
1199087|NCT02037672|obesity|obesity
1199088|NCT02037646|Colorectal cancer|colorectal cancer
1199089|NCT02037646|Screening|screening
1199090|NCT02037646|Fecal occult blood|fecal occult blood
1199091|NCT02037646|Fecal immunochemical test|fecal immunochemical test
1199092|NCT02037646|Qualitative|qualitative
1199093|NCT02037646|Quantitative|quantitative
1199094|NCT02037620|Epidural Stimulation|epidural stimulation
1199095|NCT02037607|Deep vein thrombosis|deep vein thrombosis
1199096|NCT02037607|Children|children
1199097|NCT02037607|Pediatric|pediatric
1199098|NCT02037607|Anti-coagulant|anti-coagulant
1199099|NCT02037607|Neurosurgical procedures|neurosurgical procedures
1199100|NCT02037607|Blood Clot|blood clot
1199101|NCT02037594|HIV|hiv
1199102|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
1199107|NCT02037581|hometreatment|hometreatment
1199108|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
1199109|NCT02037581|psychosis|psychosis
1199110|NCT02037581|schizophrenia|schizophrenia
1199111|NCT02037581|bipolar disorder|bipolar disorder
1199112|NCT02037581|first episode|first episode
1199113|NCT02037568|depression|depression
1199114|NCT02037568|stress|stress
1199115|NCT02037568|caregiving|caregiving
1199116|NCT02037568|anxiety|anxiety
1199117|NCT02037568|psychoeducation intervention|psychoeducation intervention
1199118|NCT02037568|psycho-oncology|psycho-oncology
1199119|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
1199120|NCT02037555|Antithrombin|antithrombin
1199121|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
1199122|NCT02037542|BMI, Lipid profile|bmi, lipid profile
1199123|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
1199124|NCT02037490|Infants|infants
1199125|NCT02037490|Mothers|mothers
1199126|NCT02037490|Social media|social media
1199127|NCT02037490|Obesity prevention|obesity prevention
1199128|NCT02037464|Prostate Cancer|prostate cancer
1199129|NCT02037464|Active Surveillance|active surveillance
1199130|NCT02037464|Radical Prostatectomy|radical prostatectomy
1199131|NCT02037451|Parkinson's disease|parkinson's disease
1199132|NCT02037451|Auditory Cueing|auditory cueing
1199133|NCT02037438|Clinical sleep medicine|clinical sleep medicine
1199134|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
1199135|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
1199136|NCT02037438|Electronic health records|electronic health records
1199137|NCT02037438|Clinical informatics|clinical informatics
1199138|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
1199139|NCT02037438|Sleep specialists|sleep specialists
1199140|NCT02037438|Primary care providers|primary care providers
1199141|NCT02037438|Allied health professionals|allied health professionals
1199142|NCT02037438|Patient-centered care|patient-centered care
1199143|NCT02037425|Chronic Migraine|chronic migraine
1199144|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
1199145|NCT02037425|Headache|headache
1199146|NCT02037425|Migraine|migraine
1199147|NCT02037425|Neuronal regrowth|neuronal regrowth
1199148|NCT02037425|Botox|botox
1199149|NCT02037412|Ticagrelor|ticagrelor
1199150|NCT02037412|strut coverage|strut coverage
1199152|NCT02037412|ACS|acs
1199153|NCT02037412|OCT|oct
1199154|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
1199155|NCT02037399|early gastric cancer|early gastric cancer
1199156|NCT02037399|pain relief|pain relief
1199157|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
1199158|NCT02037399|present pain intensity|present pain intensity
1199159|NCT02037386|Side branch stent|side branch stent
1199160|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
1199161|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
1199162|NCT02037360|Smoking|smoking
1199163|NCT02037360|Cessation|cessation
1199164|NCT02037334|Preterm delivery|preterm delivery
1199165|NCT02037334|Diagnostics|diagnostics
1199166|NCT02037334|Biomechanics|biomechanics
1199167|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
1199168|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
1199169|NCT02037308|Blood pressure|blood pressure
1199170|NCT02037308|Plasma NOx|plasma nox
1199171|NCT02037308|Beetroot|beetroot
1199172|NCT02037295|Gut Microbiota|gut microbiota
1199173|NCT02037295|Obesity|obesity
1199174|NCT02037295|Absorption|absorption
1199175|NCT02037295|Overfeeding|overfeeding
1199176|NCT02037282|HAI Titer|hai titer
1199177|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
1199178|NCT02037282|Immunogenicity|immunogenicity
1199179|NCT02037282|Serum Antibody Response|serum antibody response
1199180|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
1199181|NCT02037243|behavior change|behavior change
1199182|NCT02037243|handwashing|handwashing
1199183|NCT02037243|water treatment|water treatment
1199184|NCT02037243|disgust|disgust
1199185|NCT02037243|shame|shame
1199186|NCT02037243|neighbour|neighbour
1199187|NCT02037243|willingness to pay|willingness to pay
1199188|NCT02037204|IMPACT|impact
1199189|NCT02037204|Chondrons|chondrons
1199190|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
1199191|NCT02037204|Allogeneic MSCs|allogeneic mscs
1199192|NCT02037204|single-stage|single-stage
1199193|NCT02037204|Cartilage repair|cartilage repair
1199194|NCT02037204|Safety|safety
1199195|NCT02037204|Efficacy|efficacy
1199196|NCT02037191|ALOPECIA AREATA|alopecia areata
1199197|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
1199198|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
1199199|NCT02037178|Screening by generalists|screening by generalists
1199200|NCT02037178|Ultrasound|ultrasound
1199201|NCT02037152|Chronic pain|chronic pain
1199202|NCT02037152|Mobile applications|mobile applications
1199203|NCT02037152|Mindfulness|mindfulness
1199204|NCT02037152|Meditation|meditation
1199205|NCT02037152|Telemedicine|telemedicine
1199206|NCT02037152|Cellular phone|cellular phone
1199207|NCT02037152|Pain Management|pain management
1199208|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
1199209|NCT02037139|Hearing loss|hearing loss
1199210|NCT02037139|Screening|screening
1199211|NCT02037139|Primary Care|primary care
1199212|NCT02037113|IVUS|ivus
1199213|NCT02037113|PAD|pad
1199214|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
1199215|NCT02037113|Intravascular ultrasound|intravascular ultrasound
1199216|NCT02037087|Short Message Service|short message service
1199217|NCT02037087|newborn health|newborn health
1199218|NCT02037087|maternal behavior|maternal behavior
1199219|NCT02037087|good household pregnancy practice|good household pregnancy practice
1199220|NCT02037087|care seeking|care seeking
1199221|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
1199222|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1199223|NCT02037022|Autism|autism
1199224|NCT02036983|Ultrasound guided|ultrasound guided
1199225|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
1199226|NCT02036983|Dexamethasone|dexamethasone
1199227|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
1199228|NCT02036983|Local Analgesic|local analgesic
1199229|NCT02036983|Efficacy|efficacy
1199230|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
1199231|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1199232|NCT02036970|PAH|pah
1199233|NCT02036970|Bardoxolone methyl|bardoxolone methyl
1199234|NCT02036970|6-minute walk distance|6-minute walk distance
1199235|NCT02036970|CDDO-me|cddo-me
1199236|NCT02036970|RTA 402|rta 402
1199237|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
1199238|NCT02036970|Interstitial Lung Disease|interstitial lung disease
1199239|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
1199240|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1199241|NCT02036970|Sarcoidosis|sarcoidosis
1199242|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
1199243|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
1199244|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
1199245|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
1199246|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
1199247|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
1199248|NCT02036957|capecitabine|capecitabine
1199249|NCT02036957|dermatologic toxicity|dermatologic toxicity
1199250|NCT02036944|Celiac Disease|celiac disease
1199251|NCT02036944|Celiac Sprue|celiac sprue
1199252|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
1199253|NCT02036931|Joint|joint
1199254|NCT02036931|Osteoarthritis|osteoarthritis
1199255|NCT02036931|Avascular Necrosis|avascular necrosis
1199256|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
1199257|NCT02036918|metastatic|metastatic
1199258|NCT02036918|sipuleucel-T|sipuleucel-t
1199259|NCT02036918|lymphadenectomy|lymphadenectomy
1199260|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
1199261|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
1199262|NCT02036892|Diabetes|diabetes
1199263|NCT02036879|Cystic Fibrosis|cystic fibrosis
1199264|NCT02036879|Loestrin|loestrin
1199265|NCT02036879|Hormone|hormone
1199266|NCT02036866|knee osteoarthritis|knee osteoarthritis
1199267|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
1199268|NCT02036866|arthritis|arthritis
1199269|NCT02036853|Triheptanoin|triheptanoin
1199270|NCT02036853|Glut1 DS|glut1 ds
1199271|NCT02036853|Epilepsy|epilepsy
1199272|NCT02036853|Seizures|seizures
1199273|NCT02036827|Pain, Postoperative|pain, postoperative
1199274|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
1199275|NCT02036827|Laparoscopy|laparoscopy
1199276|NCT02036814|Hypertension|hypertension
1199277|NCT02036814|Nursing|nursing
1199278|NCT02036814|Therapeutic compliance|therapeutic compliance
1199279|NCT02036814|Quality of life|quality of life
1199280|NCT02036814|Health education|health education
1199281|NCT02036801|ARDS|ards
1199282|NCT02036801|Lung|lung
1199283|NCT02036801|Specific Elastance|specific elastance
1199284|NCT02036801|Pediatric patients|pediatric patients
1199285|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
1199286|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1199287|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
1199288|NCT02036762|Functional capacity|functional capacity
1199289|NCT02036762|Quality of life|quality of life
1199290|NCT02036736|Orthopedic Surgery|orthopedic surgery
1199291|NCT02036736|Total hip prosthesis|total hip prosthesis
1199292|NCT02036736|Total knee replacement|total knee replacement
1199293|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
1199294|NCT02036736|Propofol|propofol
1199295|NCT02036736|Desflurane|desflurane
1199296|NCT02036723|Macular Degeneration|macular degeneration
1200364|NCT02031666|ARN-509|arn-509
1199297|NCT02036723|Eye Diseases|eye diseases
1199298|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
1199299|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
1199300|NCT02036723|Geographic Atrophy|geographic atrophy
1199303|NCT02036710|Leptin|leptin
1199304|NCT02036710|Duodenal Switch|duodenal switch
1199305|NCT02036697|Cesarean section|cesarean section
1199306|NCT02036697|spinal anesthesia|spinal anesthesia
1199307|NCT02036697|low dose spinal|low dose spinal
1199308|NCT02036697|bupivacaine|bupivacaine
1199309|NCT02036697|hemodynamics|hemodynamics
1199310|NCT02036697|blood pressure|blood pressure
1199311|NCT02036697|cardiac output|cardiac output
1199312|NCT02036684|Prostate cancer|prostate cancer
1199313|NCT02036684|Radical prostatectomy|radical prostatectomy
1199314|NCT02036684|Prehabilitation|prehabilitation
1199315|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
1199316|NCT02036671|Arteriovenous fistula|arteriovenous fistula
1199317|NCT02036671|Fistula|fistula
1199318|NCT02036671|Chronic kidney disease|chronic kidney disease
1199319|NCT02036671|Percutaneous|percutaneous
1199320|NCT02036671|Kidney Disease|kidney disease
1199321|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
1199322|NCT02036671|Urologic Diseases|urologic diseases
1199323|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
1199324|NCT02036671|Renal Insufficiency|renal insufficiency
1199325|NCT02036671|CKD|ckd
1199326|NCT02036671|hemodialysis|hemodialysis
1199327|NCT02036658|social anxiety|social anxiety
1199328|NCT02036658|treatment|treatment
1199329|NCT02036658|cognitive-behavioral therapy|cognitive-behavioral therapy
1199330|NCT02036658|mindfulness-based stress reduction|mindfulness-based stress reduction
1199331|NCT02036658|emotion regulation|emotion regulation
1199332|NCT02036658|randomized controlled trial|randomized controlled trial
1199333|NCT02036658|neuroimaging|neuroimaging
1199334|NCT02036658|functional magnetic resonance imaging|functional magnetic resonance imaging
1199335|NCT02036658|mediators|mediators
1199336|NCT02036658|mechanisms|mechanisms
1199337|NCT02036619|gestational diabetes|gestational diabetes
1199338|NCT02036619|pregestational diabetes|pregestational diabetes
1199339|NCT02036619|screening|screening
1199340|NCT02036619|diagnostic criteria|diagnostic criteria
1199341|NCT02036619|IADPSG|iadpsg
1199342|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
1199343|NCT02036580|Japan|japan
1199344|NCT02036580|Phase2|phase2
1199345|NCT02036580|Safety|safety
1199346|NCT02036580|Tolerability|tolerability
1199641|NCT02035059|Copeptin|copeptin
1199347|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1199348|NCT02036580|IPF|ipf
1199349|NCT02036580|CAT-354|cat-354
1199350|NCT02036580|Tralokinumab|tralokinumab
1199351|NCT02036541|Glaucoma Implant|glaucoma implant
1199352|NCT02036541|Trabeculectomy|trabeculectomy
1199353|NCT02036541|POAG|poag
1199354|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
1199355|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
1199356|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
1199357|NCT02036528|Foot Ulcer|foot ulcer
1199358|NCT02036528|Diabetic Foot|diabetic foot
1199359|NCT02036528|Gentamicins|gentamicins
1199360|NCT02036528|infection|infection
1199361|NCT02036502|PD1|pd1
1199362|NCT02036502|PD-1|pd-1
1199363|NCT02036502|PDL1|pdl1
1199364|NCT02036502|PD-L1|pd-l1
1199365|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
1199366|NCT02036476|Skin Cancer|skin cancer
1199367|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1199368|NCT02036463|Corticosteroids|corticosteroids
1199369|NCT02036450|atrial fibrillation|atrial fibrillation
1199370|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
1199371|NCT02036450|stroke|stroke
1199372|NCT02036450|implantable loop recorder|implantable loop recorder
1199373|NCT02036450|bleeding|bleeding
1199374|NCT02036450|anticoagulation|anticoagulation
1199375|NCT02036450|hypertension|hypertension
1199376|NCT02036450|diabetes|diabetes
1199377|NCT02036450|heart failure|heart failure
1199378|NCT02036450|mortality|mortality
1199379|NCT02036437|Induction of Labor|induction of labor
1199380|NCT02036437|Misoprostol|misoprostol
1199381|NCT02036411|clomiphene citrate|clomiphene citrate
1199382|NCT02036411|amh|amh
1199383|NCT02036411|inhibin b|inhibin b
1199384|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
1199385|NCT02036398|Nephrostomy|nephrostomy
1199386|NCT02036398|Double J stent|double j stent
1199387|NCT02036398|PleuraL Effusion|pleural effusion
1199388|NCT02036398|Pain|pain
1199389|NCT02036372|glucose|glucose
1199390|NCT02036372|diabetes mellitus|diabetes mellitus
1199391|NCT02036372|perioperative|perioperative
1199392|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
1199393|NCT02036346|ileostomy|ileostomy
1199394|NCT02036346|colorectal resection|colorectal resection
1199395|NCT02036346|dehydration|dehydration
1199396|NCT02036346|nutritional status|nutritional status
1199397|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
1199398|NCT02036333|pediatrics|pediatrics
1199399|NCT02036307|Fish oils|fish oils
1199400|NCT02036307|Triglycerides|triglycerides
1199401|NCT02036307|Blood pressure|blood pressure
1199402|NCT02036294|Patient self-care behaviors|patient self-care behaviors
1199403|NCT02036294|Patient activation|patient activation
1199404|NCT02036294|Family caregiver support|family caregiver support
1199405|NCT02036294|Patient-centered care|patient-centered care
1199406|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
1199407|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
1199408|NCT02036268|Ostomy education|ostomy education
1199409|NCT02036268|Education|education
1199410|NCT02036268|care of ostomy site|care of ostomy site
1199411|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
1199412|NCT02036242|Opioid|opioid
1199413|NCT02036242|Local anesthetic|local anesthetic
1199414|NCT02036242|Labor delivery|labor delivery
1199415|NCT02036242|Safety|safety
1199416|NCT02036229|demodex|demodex
1199417|NCT02036229|demodicidosis|demodicidosis
1199418|NCT02036229|rosacea|rosacea
1199419|NCT02036229|ivermectin|ivermectin
1199420|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
1199421|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
1199422|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
1199423|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
1199424|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
1199425|NCT02036151|Xylitol|xylitol
1199426|NCT02036151|prevention|prevention
1199427|NCT02036151|Mutans streptococci|mutans streptococci
1199428|NCT02036151|caries|caries
1199429|NCT02036151|plaque|plaque
1199430|NCT02036151|children|children
1199431|NCT02036125|Corticosteroid|corticosteroid
1199432|NCT02036125|Ultrasound|ultrasound
1199433|NCT02036125|Guided injection|guided injection
1199434|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
1199435|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
1199436|NCT02036112|Circumferential resection margin|circumferential resection margin
1199437|NCT02036112|Morbidity|morbidity
1199438|NCT02036112|Survival|survival
1199439|NCT02036099|Dementia|dementia
1199440|NCT02036099|Automobile driving|automobile driving
1199441|NCT02036099|Accidents, traffic|accidents, traffic
1199442|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
1199443|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
1199538|NCT02035566|Health Status Disparities|health status disparities
1199444|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
1199445|NCT02036073|erythropoietin|erythropoietin
1199446|NCT02036073|preterm|preterm
1199447|NCT02036073|brain injury|brain injury
1199448|NCT02036073|cerebral palsy|cerebral palsy
1199449|NCT02036073|PVL|pvl
1199450|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
1199451|NCT02036060|Abiraterone acetate|abiraterone acetate
1199452|NCT02036021|pediatric anesthesia|pediatric anesthesia
1199453|NCT02036021|perioperative respiratory events|perioperative respiratory events
1199454|NCT02036021|days of hospitalization|days of hospitalization
1199455|NCT02036021|cost of hospitalization|cost of hospitalization
1199456|NCT02036008|Liver metastases|liver metastases
1199457|NCT02036008|MRI|mri
1199458|NCT02036008|Contrast Agents|contrast agents
1199459|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
1199460|NCT02035956|IVAC MUTANOME|ivac mutanome
1199461|NCT02035956|IVAC|ivac
1199462|NCT02035956|personalized therapy|personalized therapy
1199463|NCT02035956|personalized immuno therapy|personalized immuno therapy
1199464|NCT02035956|RB_0004-01|rb_0004-01
1199465|NCT02035956|Ribological|ribological
1199466|NCT02035956|Melanoma|melanoma
1199467|NCT02035956|cancer vaccine|cancer vaccine
1199468|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
1199469|NCT02035891|colchicine|colchicine
1199470|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
1199471|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
1199472|NCT02035891|overt nephropathy|overt nephropathy
1199473|NCT02035891|Type 2 diabetes|type 2 diabetes
1199474|NCT02035878|anxiety|anxiety
1199475|NCT02035878|depression|depression
1199476|NCT02035878|probiotics|probiotics
1199477|NCT02035878|adult|adult
1199478|NCT02035878|human|human
1199479|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
1199480|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
1199481|NCT02035865|Psychiatric morbidity|psychiatric morbidity
1199482|NCT02035865|Cognitive function|cognitive function
1199483|NCT02035865|Heart transplantation|heart transplantation
1199484|NCT02035865|Mortality|mortality
1199485|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
1199486|NCT02035839|Target Temperature Management|target temperature management
1199487|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
1199488|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
1199489|NCT02035813|metastatic breast cancer|metastatic breast cancer
1199490|NCT02035813|circulating tumor cells|circulating tumor cells
1199491|NCT02035813|everolimus|everolimus
1199492|NCT02035813|eribulin|eribulin
1199493|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
1199494|NCT02035800|Adalimumab|adalimumab
1199495|NCT02035800|Humira|humira
1199496|NCT02035787|metformin|metformin
1199497|NCT02035787|endometrial cancer|endometrial cancer
1199498|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1199499|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
1199500|NCT02035774|Brachial plexus block|brachial plexus block
1199501|NCT02035774|Suprascapular nerve block|suprascapular nerve block
1199502|NCT02035761|MSA|msa
1199503|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
1199504|NCT02035761|Possible or Probable|possible or probable
1199505|NCT02035748|Vitreomacular traction|vitreomacular traction
1199506|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
1199507|NCT02035748|Ocriplasmin|ocriplasmin
1199508|NCT02035748|JETREA|jetrea
1199509|NCT02035735|NBI,|nbi,
1199510|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
1199511|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
1199512|NCT02035709|Therapy|therapy
1199513|NCT02035696|influenza|influenza
1199514|NCT02035696|children|children
1199515|NCT02035696|safety|safety
1199516|NCT02035696|tolerability|tolerability
1199517|NCT02035696|immunogenicity|immunogenicity
1199518|NCT02035683|metabolic response|metabolic response
1199519|NCT02035683|chemotherapy|chemotherapy
1199520|NCT02035670|diagnostic strategy|diagnostic strategy
1199521|NCT02035670|effectiveness|effectiveness
1199522|NCT02035670|fever of unknown origin|fever of unknown origin
1199523|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
1199524|NCT02035657|MCC|mcc
1199525|NCT02035631|Breast Neoplasms|breast neoplasms
1199526|NCT02035631|Recurrence|recurrence
1199527|NCT02035631|Motor Activity|motor activity
1199528|NCT02035631|Diet|diet
1199529|NCT02035631|Quality of Life|quality of life
1199530|NCT02035579|concussion|concussion
1199531|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
1199532|NCT02035579|post-concussion syndrome|post-concussion syndrome
1199533|NCT02035579|adolescents|adolescents
1199534|NCT02035579|sports injury|sports injury
1199535|NCT02035579|aerobic training|aerobic training
1199536|NCT02035579|stretching training|stretching training
1199537|NCT02035566|Minority Health|minority health
1199640|NCT02035059|Adiponectin|adiponectin
1199539|NCT02035566|Health Care Disparities|health care disparities
1199540|NCT02035566|Rural Health|rural health
1199541|NCT02035566|Telemedicine|telemedicine
1199542|NCT02035566|Health Services Research|health services research
1199543|NCT02035566|Social Determinants of Health|social determinants of health
1199544|NCT02035566|Ecological Theory of Health|ecological theory of health
1199545|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
1199546|NCT02035527|head and neck|head and neck
1199547|NCT02035514|multiple sclerosis|multiple sclerosis
1199548|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
1199549|NCT02035514|autologous transplantation|autologous transplantation
1199550|NCT02035514|MRI efficacy|mri efficacy
1199551|NCT02035514|clinical safety|clinical safety
1199552|NCT02035488|Dry powder inhalation|dry powder inhalation
1199553|NCT02035488|Bronchiectasis|bronchiectasis
1199554|NCT02035488|Tobramycin|tobramycin
1199555|NCT02035475|Prevention|prevention
1199556|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
1199557|NCT02035475|Lymphoceles|lymphoceles
1199558|NCT02035475|Prostate Malignancies|prostate malignancies
1199559|NCT02035475|daVinci|davinci
1199560|NCT02035475|Vessel Sealer|vessel sealer
1199561|NCT02035475|EndoWrist One|endowrist one
1199562|NCT02035449|Video laryngoscope|video laryngoscope
1199563|NCT02035449|Pre-hospital|pre-hospital
1199564|NCT02035449|Endotracheal intubation|endotracheal intubation
1199565|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
1199566|NCT02035449|Pre hospital Critical care|pre hospital critical care
1199567|NCT02035449|McGrath MAC|mcgrath mac
1199568|NCT02035449|Airway device|airway device
1199569|NCT02035436|Respiration, artificial|respiration, artificial
1199570|NCT02035436|Critcal care|critcal care
1199571|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
1199572|NCT02035423|Compliance|compliance
1199573|NCT02035423|Milk|milk
1199574|NCT02035410|cardiac devices|cardiac devices
1199575|NCT02035410|prevention|prevention
1199576|NCT02035410|infection|infection
1199577|NCT02035397|botulinum toxin|botulinum toxin
1199578|NCT02035397|Endoscopy|endoscopy
1199579|NCT02035397|Satiation|satiation
1199580|NCT02035397|Diet|diet
1199581|NCT02035397|Weight Loss|weight loss
1199582|NCT02035358|Metastatic|metastatic
1199583|NCT02035358|Recurrent|recurrent
1199584|NCT02035358|Refractory|refractory
1199585|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
1199586|NCT02035358|Kidney|kidney
1199587|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
1199588|NCT02035358|Cancer|cancer
1199589|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
1199590|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
1199591|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
1199592|NCT02035332|Menorrhagia|menorrhagia
1199593|NCT02035332|Endometrial Ablation|endometrial ablation
1199594|NCT02035293|COPD Exacerbation|copd exacerbation
1199595|NCT02035293|Pulmonary embolism|pulmonary embolism
1199596|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
1199597|NCT02035280|Spine|spine
1199598|NCT02035280|Deformity|deformity
1199599|NCT02035280|Fusion|fusion
1199600|NCT02035280|Elderly|elderly
1199601|NCT02035280|SRS-22r|srs-22r
1199602|NCT02035241|Spices|spices
1199603|NCT02035241|Herbs|herbs
1199604|NCT02035241|Functional food|functional food
1199605|NCT02035241|Cardiometabolic risk|cardiometabolic risk
1199606|NCT02035241|Metabolic syndrome|metabolic syndrome
1199607|NCT02035241|Inflammation|inflammation
1199608|NCT02035241|Appetite|appetite
1199609|NCT02035241|Gut hormone|gut hormone
1199610|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1199611|NCT02035228|Lung Hyperinflation|lung hyperinflation
1199612|NCT02035228|Abdominal Muscle|abdominal muscle
1199613|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
1199614|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
1199615|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
1199616|NCT02035215|Atorvastatin|atorvastatin
1199617|NCT02035176|autism|autism
1199619|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1199620|NCT02035176|behavioral assessment|behavioral assessment
1199621|NCT02035176|behavior|behavior
1199622|NCT02035163|Atrial fibrillation|atrial fibrillation
1199623|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
1199624|NCT02035163|cryoablation|cryoablation
1199625|NCT02035163|ganglionic plexi|ganglionic plexi
1199626|NCT02035150|breakfast|breakfast
1199627|NCT02035150|oatmeal|oatmeal
1199628|NCT02035150|appetite|appetite
1199629|NCT02035150|cholesterol|cholesterol
1199630|NCT02035124|Prostate|prostate
1199631|NCT02035124|Metastatic|metastatic
1199632|NCT02035124|Refractory|refractory
1199633|NCT02035124|mCRPC|mcrpc
1199634|NCT02035111|Migraine|migraine
1199635|NCT02035111|Tianshu capsule|tianshu capsule
1199636|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
1199637|NCT02035085|19F MRI|19f mri
1199638|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
1199639|NCT02035059|Fibronectin|fibronectin
1199642|NCT02035059|Cortisol|cortisol
1199643|NCT02035046|Gitelman|gitelman
1199644|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
1199645|NCT02035046|Blood pressure|blood pressure
1199646|NCT02035046|Hypokalemia|hypokalemia
1199647|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
1199648|NCT02034994|school-based intervention|school-based intervention
1199649|NCT02034994|after school physical activity|after school physical activity
1199650|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
1199651|NCT02034994|sedentary behavior|sedentary behavior
1199652|NCT02034994|schoolchildren|schoolchildren
1199653|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
1199654|NCT02034981|genomic alterations.|genomic alterations.
1199655|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
1199656|NCT02034968|Nimotuzumab|nimotuzumab
1199657|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
1199658|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
1199659|NCT02034955|Prostate Cancer|prostate cancer
1199660|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
1199661|NCT02034955|Prostatectomy|prostatectomy
1199662|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
1199663|NCT02034942|non-sedation|non-sedation
1199664|NCT02034929|colon cancer|colon cancer
1199665|NCT02034929|adenoma|adenoma
1199666|NCT02034929|colon polyps|colon polyps
1199667|NCT02034916|Breast cancer|breast cancer
1199668|NCT02034916|BRCA mutation|brca mutation
1199669|NCT02034916|PARP inhibitor|parp inhibitor
1199670|NCT02034916|BRCA 1|brca 1
1199671|NCT02034916|BRCA 2|brca 2
1199672|NCT02034903|Enteral Feeding|enteral feeding
1199673|NCT02034903|Infant, Premature|infant, premature
1199674|NCT02034890|orthotopic neobladder|orthotopic neobladder
1199675|NCT02034890|urinary tract infection|urinary tract infection
1199676|NCT02034890|intravesical instillation|intravesical instillation
1199677|NCT02034890|hyaluronic acid|hyaluronic acid
1199678|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
1199679|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
1199680|NCT02034864|low back pain|low back pain
1199681|NCT02034864|manual therapy|manual therapy
1199682|NCT02034864|randomizer controlled trial|randomizer controlled trial
1199683|NCT02034851|Acute pyelonephritis|acute pyelonephritis
1199684|NCT02034851|Renal scarring|renal scarring
1199685|NCT02034851|Dexamethasone|dexamethasone
1199686|NCT02034851|Children|children
1199687|NCT02034851|Corticoids|corticoids
1199688|NCT02034851|Complementary treatment|complementary treatment
1199689|NCT02034851|Prevention strategy|prevention strategy
1199691|NCT02034838|pharmacokinetic|pharmacokinetic
1199692|NCT02034838|HIV-infected|hiv-infected
1199693|NCT02034838|atazanavir|atazanavir
1199694|NCT02034838|ritonavir|ritonavir
1199695|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
1199696|NCT02034786|Hyaluronic acid|hyaluronic acid
1199697|NCT02034786|Adipose Tissue|adipose tissue
1199698|NCT02034786|Filler Agent|filler agent
1199699|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
1199700|NCT02034760|Frailty|frailty
1199701|NCT02034760|Ageing|ageing
1199702|NCT02034760|Protein supplementation|protein supplementation
1199703|NCT02034760|Protein quality|protein quality
1199704|NCT02034760|Gut microbiota|gut microbiota
1199705|NCT02034760|Metabolome|metabolome
1199706|NCT02034760|Exercise training|exercise training
1199707|NCT02034760|Sarcopenia|sarcopenia
1199708|NCT02034747|Advagraf|advagraf
1199709|NCT02034747|kidney transplant|kidney transplant
1199710|NCT02034747|Corticosteroid|corticosteroid
1199711|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
1199712|NCT02034734|Phase 1|phase 1
1199713|NCT02034734|ASP3652|asp3652
1199714|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1199715|NCT02034734|Multiple doses|multiple doses
1199716|NCT02034721|Muscle damage|muscle damage
1199717|NCT02034721|Muscle soreness|muscle soreness
1199718|NCT02034721|Muscle function|muscle function
1199719|NCT02034721|Innate immune function|innate immune function
1199720|NCT02034721|Inflammation|inflammation
1199721|NCT02034708|Primary brain tumor|primary brain tumor
1199722|NCT02034695|Diabetes mellitus|diabetes mellitus
1199723|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
1199724|NCT02034656|imatinib resistance|imatinib resistance
1199725|NCT02034656|mutation|mutation
1199726|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1199727|NCT02034617|Cognition|cognition
1199728|NCT02034617|Family nursing|family nursing
1199729|NCT02034617|Infant, premature|infant, premature
1199730|NCT02034617|Object attachment|object attachment
1199731|NCT02034617|Stress, physiological|stress, physiological
1199732|NCT02034617|Stress, psychological|stress, psychological
1199733|NCT02034604|Naftopidil|naftopidil
1199734|NCT02034604|safety|safety
1199735|NCT02034539|peripheral artery disease|peripheral artery disease
1199736|NCT02034539|critical limb ischemia|critical limb ischemia
1199737|NCT02034539|VADOplex|vadoplex
1199738|NCT02034539|intermittent foot compression|intermittent foot compression
1199739|NCT02034526|Sinus node disease|sinus node disease
1199740|NCT02034526|Atrial fibrillation|atrial fibrillation
1199741|NCT02034526|Pacing|pacing
1199742|NCT02034500|prevention|prevention
1199743|NCT02034500|Shigella sonnei|shigella sonnei
1199744|NCT02034487|Delayed Puberty|delayed puberty
1199745|NCT02034487|Boys|boys
1199746|NCT02034487|Hormones|hormones
1199747|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
1199748|NCT02034461|Micro-Electrodes|micro-electrodes
1199749|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
1199750|NCT02034461|Amputation|amputation
1199751|NCT02034461|Spinal Cord Injury|spinal cord injury
1199752|NCT02034448|CRRT|crrt
1199753|NCT02034448|Renal|renal
1199754|NCT02034448|Kidney|kidney
1199755|NCT02034448|adults|adults
1199756|NCT02034448|registry|registry
1199757|NCT02034448|AKI|aki
1199758|NCT02034422|Exercise|exercise
1199759|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
1199760|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
1199761|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
1199762|NCT02034370|Interscalene nerve block|interscalene nerve block
1199763|NCT02034370|Shoulder surgery|shoulder surgery
1199764|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
1199765|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
1199766|NCT02034357|Parkinson Disease|parkinson disease
1199767|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
1199768|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
1199769|NCT02034357|Polysomnography|polysomnography
1199770|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
1199771|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
1199772|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
1199773|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1199774|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
1199775|NCT02034344|Healthy|healthy
1199776|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
1199777|NCT02034344|Longitudinal Study|longitudinal study
1199778|NCT02034344|Biomarkers|biomarkers
1199779|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
1199780|NCT02034344|Skin Biopsy|skin biopsy
1199781|NCT02034331|Insulin Sensitivity|insulin sensitivity
1199782|NCT02034331|Microvascular permeability|microvascular permeability
1199783|NCT02034331|Sympathetic nervous system|sympathetic nervous system
1199784|NCT02034318|Fatigue|fatigue
1199785|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
1199786|NCT02034318|Parkinson Disease|parkinson disease
1199787|NCT02034305|Airway Clearance|airway clearance
1199788|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1199789|NCT02034305|Peak Cough Flow|peak cough flow
1199790|NCT02034279|cirrhosis|cirrhosis
1199791|NCT02034266|Type one diabetes|type one diabetes
1199792|NCT02034266|nerve damage|nerve damage
1199793|NCT02034266|neuropathy|neuropathy
1199794|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
1199795|NCT02034266|supplementation|supplementation
1199796|NCT02034266|nutrition|nutrition
1199797|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
1199798|NCT02034253|glutamate|glutamate
1199799|NCT02034253|functional connectivity|functional connectivity
1199800|NCT02034253|structural connectivity|structural connectivity
1199801|NCT02034253|schizophrenia|schizophrenia
1199802|NCT02034253|psychosis|psychosis
1199803|NCT02034227|leukemia|leukemia
1199804|NCT02034214|HIV|hiv
1199805|NCT02034214|adolescents|adolescents
1199806|NCT02034188|multiple sclerosis|multiple sclerosis
1199807|NCT02034188|umbilical cord|umbilical cord
1199808|NCT02034188|mesenchymal|mesenchymal
1199809|NCT02034188|stem cells|stem cells
1199810|NCT02034175|apnea|apnea
1199811|NCT02034175|hypopnea|hypopnea
1199812|NCT02034175|polysomnography|polysomnography
1199813|NCT02034175|respiratory|respiratory
1199814|NCT02034175|cheyne|cheyne
1199815|NCT02034162|Helminth infections|helminth infections
1199816|NCT02034162|Helminths|helminths
1199817|NCT02034162|Pediatric|pediatric
1199818|NCT02034162|Preschool aged|preschool aged
1199819|NCT02034162|School aged|school aged
1199820|NCT02034162|Mebendazole|mebendazole
1199821|NCT02034162|Vermox|vermox
1199822|NCT02034162|Placebo|placebo
1199823|NCT02034149|chronic kidney disease|chronic kidney disease
1199824|NCT02034149|high risk|high risk
1199825|NCT02034149|intervention|intervention
1199826|NCT02034149|hypertension|hypertension
1199827|NCT02034149|hyperglycemia|hyperglycemia
1199828|NCT02034149|hyperlipidemia|hyperlipidemia
1199829|NCT02034123|First time in humans|first time in humans
1199830|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
1199831|NCT02034123|Oncology|oncology
1199832|NCT02034123|GSK2879552|gsk2879552
1199833|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
1199834|NCT02034110|solid tumors|solid tumors
1199835|NCT02034110|efficacy|efficacy
1199836|NCT02034110|BRAF V600E mutation|braf v600e mutation
1199837|NCT02034110|trametinib|trametinib
1199838|NCT02034110|safety|safety
1199839|NCT02034110|Dabrafenib|dabrafenib
1199840|NCT02034097|ROS1|ros1
1199841|NCT02034097|erlotinib|erlotinib
1199842|NCT02034097|EGFR|egfr
1199843|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
1199844|NCT02034097|foretinib|foretinib
1199845|NCT02034084|Transradial approach,|transradial approach,
1199846|NCT02034084|Coronary angiography|coronary angiography
1199847|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
1199848|NCT02034058|Wingspan Stent System|wingspan stent system
1199849|NCT02034058|Wingspan Stent|wingspan stent
1199850|NCT02034058|Intracranial Stent|intracranial stent
1199851|NCT02034058|Ischemic Stroke|ischemic stroke
1199852|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
1199853|NCT02034058|Intracranial Stenosis|intracranial stenosis
1199854|NCT02034032|Osteoarthritis|osteoarthritis
1199855|NCT02034032|Knee|knee
1199856|NCT02034032|Arthritis|arthritis
1199857|NCT02034032|TKA|tka
1199858|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
1199859|NCT02034006|pathological myopia|pathological myopia
1199860|NCT02034006|choroidal neovascularization|choroidal neovascularization
1199861|NCT02034006|ranibizumab|ranibizumab
1199862|NCT02034006|mono-bilateral|mono-bilateral
1199863|NCT02034006|poor visual acuity|poor visual acuity
1199864|NCT02034006|retinal disease|retinal disease
1199865|NCT02034006|eye disease|eye disease
1199866|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
1199867|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
1199868|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
1199869|NCT02033980|NICE classification|nice classification
1199870|NCT02033980|colorectal lesions|colorectal lesions
1199871|NCT02033980|predicting histology|predicting histology
1199872|NCT02033967|liver donor|liver donor
1199873|NCT02033967|hepatectomy|hepatectomy
1199874|NCT02033967|vasodilator|vasodilator
1199875|NCT02033967|central venous pressure|central venous pressure
1199876|NCT02033967|stroke volume variation|stroke volume variation
1199877|NCT02033954|Embolization|embolization
1199878|NCT02033954|Hemorrhage|hemorrhage
1199879|NCT02033954|TIPS|tips
1199880|NCT02033954|GI Bleeding|gi bleeding
1199881|NCT02033954|AV Fistula|av fistula
1199882|NCT02033954|AV Malformation|av malformation
1199883|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
1199884|NCT02033941|Alzheimer's Disease|alzheimer's disease
1199885|NCT02033941|Grapeseed Extract|grapeseed extract
1199886|NCT02033941|Clinical Trial|clinical trial
1199887|NCT02033941|Meganatural-AZ|meganatural-az
1199888|NCT02033941|anti-oligomerization|anti-oligomerization
1199889|NCT02033941|Phase 2|phase 2
1199890|NCT02033941|Dietary Supplement|dietary supplement
1199891|NCT02033941|Nutraceutical|nutraceutical
1199892|NCT02033928|Myeloma|myeloma
1199893|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
1199894|NCT02033928|amyloidosis|amyloidosis
1199895|NCT02033928|stem cell transplant|stem cell transplant
1199896|NCT02033915|Suicide risk assessment|suicide risk assessment
1199897|NCT02033915|interactive discussion group|interactive discussion group
1199898|NCT02033915|suicide attempt|suicide attempt
1199899|NCT02033915|self-harm|self-harm
1199900|NCT02033915|randomized control study|randomized control study
1199901|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
1199902|NCT02033902|Epilepsy|epilepsy
1199903|NCT02033863|Varicocele|varicocele
1199904|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
1199905|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
1199906|NCT02033863|Ovarian Varices|ovarian varices
1199907|NCT02033850|small vessel disease|small vessel disease
1199908|NCT02033850|cognition|cognition
1199909|NCT02033850|treatment|treatment
1199910|NCT02033850|rehabilitation|rehabilitation
1199911|NCT02033850|attention|attention
1199912|NCT02033850|fMRI|fmri
1199913|NCT02033850|vascular dementia|vascular dementia
1199914|NCT02033837|Coronary artery disease|coronary artery disease
1199915|NCT02033837|Cardiac CT|cardiac ct
1199916|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
1199917|NCT02033811|mitral regurgitation|mitral regurgitation
1199918|NCT02033811|MitraClip system|mitraclip system
1199919|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
1199920|NCT02033798|Urodynamics|urodynamics
1199921|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
1199922|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
1199923|NCT02033759|Lymphedema|lymphedema
1199924|NCT02033733|Post cardiac arrest|post cardiac arrest
1199925|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
1199926|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
1199927|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
1199928|NCT02033733|Muscle relaxants|muscle relaxants
1199929|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
1199930|NCT02033733|Microshivering|microshivering
1199931|NCT02033720|postcardiac arrest|postcardiac arrest
1199932|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
1199933|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
1199934|NCT02033720|pulseless electrical activity|pulseless electrical activity
1199935|NCT02033720|asystole|asystole
1199936|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
1199937|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
1199938|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
1199939|NCT02033707|Hallucinogen|hallucinogen
1199940|NCT02033707|Cognitive effects|cognitive effects
1199941|NCT02033707|Subjective effects|subjective effects
1199942|NCT02033694|Lipid|lipid
1199943|NCT02033694|Vulnerable Plaque|vulnerable plaque
1199944|NCT02033694|Plaque|plaque
1199945|NCT02033694|Cholesterol|cholesterol
1199946|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
1199947|NCT02033694|NIRS-IVUS|nirs-ivus
1199948|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
1199949|NCT02033694|Angiography|angiography
1199950|NCT02033694|Coronary Imaging|coronary imaging
1199951|NCT02033681|epinephrine|epinephrine
1199952|NCT02033681|hand|hand
1199953|NCT02033681|ischemia|ischemia
1199954|NCT02033681|lidocaine|lidocaine
1199955|NCT02033681|upper extremity|upper extremity
1199956|NCT02033668|bioavailability|bioavailability
1199957|NCT02033668|Pharmacokinetics|pharmacokinetics
1199958|NCT02033668|intravenous|intravenous
1199959|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
1199960|NCT02033668|amyloid beta|amyloid beta
1199961|NCT02033668|monoclonal antibody|monoclonal antibody
1199962|NCT02033655|weight loss|weight loss
1199963|NCT02033655|older adults|older adults
1199964|NCT02033655|obesity|obesity
1199965|NCT02033629|Anesthesia|anesthesia
1199966|NCT02033629|remifentanil|remifentanil
1199967|NCT02033629|propofol|propofol
1199968|NCT02033629|target-controlled infusion|target-controlled infusion
1199969|NCT02033629|cardiac surgery|cardiac surgery
1199970|NCT02033603|Total knee arthroplasty|total knee arthroplasty
1199971|NCT02033603|Total knee replacement|total knee replacement
1199972|NCT02033603|Femoral Nerve Block|femoral nerve block
1199973|NCT02033603|Adductor Canal Block|adductor canal block
1199974|NCT02033564|Sore Throat|sore throat
1199975|NCT02033564|Intubation|intubation
1199976|NCT02033564|Laryngoscopy|laryngoscopy
1199977|NCT02033564|Anesthesiology|anesthesiology
1199978|NCT02033564|Perioperative|perioperative
1199979|NCT02033564|Airway Management|airway management
1199980|NCT02033551|Gastric Cancer|gastric cancer
1199981|NCT02033551|Lung Cancer|lung cancer
1199982|NCT02033551|PARP Inhibitor|parp inhibitor
1199983|NCT02033551|Ovarian Cancer|ovarian cancer
1199984|NCT02033551|Solid Tumors|solid tumors
1199985|NCT02033551|Breast Cancer|breast cancer
1199986|NCT02033551|Colon Cancer|colon cancer
1199987|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1199988|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
1199989|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
1199990|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
1199991|NCT02033525|Degenerative meniscus|degenerative meniscus
1199992|NCT02033525|Meniscus injury|meniscus injury
1199993|NCT02033525|Meniscal injury|meniscal injury
1199994|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
1199995|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
1199996|NCT02033525|Advanced Therapy|advanced therapy
1199997|NCT02033525|Bone marrow|bone marrow
1199998|NCT02033512|Post-menopause|post-menopause
1199999|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
1200000|NCT02033512|Nanotechnology|nanotechnology
1200001|NCT02033512|Biolipid B2|biolipid b2
1200002|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1577408|NCT00474318|Bariatrics|bariatrics
1200003|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
1200004|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1200005|NCT02033499|Quality of Life|quality of life
1200006|NCT02033486|diffuse optical tomography|diffuse optical tomography
1200007|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
1200008|NCT02033486|breast cancer|breast cancer
1200009|NCT02033486|solid benign lesions|solid benign lesions
1200010|NCT02033486|cysts|cysts
1200011|NCT02033486|malignant lesions|malignant lesions
1200012|NCT02033473|Apelin|apelin
1200013|NCT02033473|insulin|insulin
1200014|NCT02033473|volunteers|volunteers
1200015|NCT02033460|Manual therapy|manual therapy
1200016|NCT02033460|Exercise|exercise
1200017|NCT02033460|Education|education
1200018|NCT02033447|Prostate Cancer|prostate cancer
1200019|NCT02033434|intranasal|intranasal
1200020|NCT02033434|ketamine|ketamine
1200021|NCT02033434|analgesia|analgesia
1200022|NCT02033434|mountain medicine|mountain medicine
1200023|NCT02033434|pre-hospital care|pre-hospital care
1200024|NCT02033434|patient transport|patient transport
1200025|NCT02033434|pilot study|pilot study
1200026|NCT02033434|mountain environment|mountain environment
1200027|NCT02033421|Infective endocarditis|infective endocarditis
1200028|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
1200029|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
1200030|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
1200031|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
1200032|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
1200129|NCT02032966|fibula|fibula
1200033|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
1200034|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
1200035|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
1200036|NCT02033369|Major depressive disorder|major depressive disorder
1200037|NCT02033369|MDD|mdd
1200038|NCT02033369|depression|depression
1200039|NCT02033369|pramipexole|pramipexole
1200040|NCT02033356|adductor canal block|adductor canal block
1200041|NCT02033356|volunteers|volunteers
1200042|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
1200043|NCT02033356|lower limb|lower limb
1200044|NCT02033356|MRI|mri
1200045|NCT02033343|Prostate Cancer|prostate cancer
1200046|NCT02033343|Real-time tracking|real-time tracking
1200047|NCT02033343|Radiotherapy|radiotherapy
1200048|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
1200049|NCT02033330|phenolics|phenolics
1200050|NCT02033330|orange peel|orange peel
1200051|NCT02033330|bioavailability|bioavailability
1200052|NCT02033304|Cesarean section|cesarean section
1200053|NCT02033304|Pain|pain
1200054|NCT02033304|Wound hyperalgesia|wound hyperalgesia
1200055|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
1200056|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
1200057|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
1200058|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
1200059|NCT02033291|Reproducibility|reproducibility
1200060|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
1200061|NCT02033265|Obesity|obesity
1200062|NCT02033265|Performance time|performance time
1200063|NCT02033265|Failure rate|failure rate
1200064|NCT02033265|Acute complications|acute complications
1200065|NCT02033226|Periodontitis|periodontitis
1200066|NCT02033226|Periodontal Regeneration|periodontal regeneration
1200067|NCT02033226|Amniotic membrane|amniotic membrane
1200068|NCT02033226|Guided tissue regeneration|guided tissue regeneration
1200069|NCT02033226|Anti-inflammatory|anti-inflammatory
1200070|NCT02033226|Periodontal Therapy.|periodontal therapy.
1200071|NCT02033213|intraoperative|intraoperative
1200072|NCT02033213|fluid management|fluid management
1200073|NCT02033213|esophageal carcinoma|esophageal carcinoma
1200074|NCT02033213|surgery|surgery
1200075|NCT02033213|gas exchange|gas exchange
1200080|NCT02033200|PDE5 inhibitor|pde5 inhibitor
1200081|NCT02033200|visual acuity|visual acuity
1200082|NCT02033200|intraocular pressure|intraocular pressure
1200083|NCT02033200|pupillometry|pupillometry
1200084|NCT02033200|color vision discrimination|color vision discrimination
1200085|NCT02033200|healthy males|healthy males
1200086|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
1200087|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
1200089|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
1200090|NCT02033161|Abdominal pain|abdominal pain
1200091|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
1200092|NCT02033135|Atherosclerosis|atherosclerosis
1200093|NCT02033135|Intermittent claudication|intermittent claudication
1200094|NCT02033135|Angioplasty|angioplasty
1200095|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
1200096|NCT02033096|stannsoporfin|stannsoporfin
1200097|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
1200098|NCT02033096|heme oxygenase|heme oxygenase
1200099|NCT02033083|abortion|abortion
1200100|NCT02033083|cervical dilation|cervical dilation
1200101|NCT02033070|RFA|rfa
1200102|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
1200103|NCT02033044|borderline personality disorder|borderline personality disorder
1200104|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
1200105|NCT02033044|psychoeducation|psychoeducation
1200106|NCT02033044|psychosocial functioning|psychosocial functioning
1200107|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
1200108|NCT02033031|central retinal thickness|central retinal thickness
1200109|NCT02033031|visual acuity|visual acuity
1200110|NCT02033031|central reintal sensitivity|central reintal sensitivity
1200111|NCT02033018|Aflibercept|aflibercept
1200112|NCT02033018|Myopia|myopia
1200113|NCT02033018|Complications|complications
1200114|NCT02033018|Neovascularization|neovascularization
1200115|NCT02033018|OCT|oct
1200116|NCT02033005|Body Composition|body composition
1200117|NCT02033005|Adipose Tissue|adipose tissue
1200118|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
1200119|NCT02033005|Infant|infant
1200120|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
1200121|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1200122|NCT02032966|outcomes|outcomes
1200123|NCT02032966|surgical|surgical
1200124|NCT02032966|non-surgical|non-surgical
1200125|NCT02032966|ankle|ankle
1200126|NCT02032966|malleolus|malleolus
1200127|NCT02032966|fracture|fracture
1200128|NCT02032966|tibia|tibia
1200130|NCT02032966|bimalleolar|bimalleolar
1200131|NCT02032966|trimalleolar|trimalleolar
1200132|NCT02032953|colorectal cancer|colorectal cancer
1200133|NCT02032953|protein recovery|protein recovery
1200134|NCT02032953|perioperative nutrition|perioperative nutrition
1200135|NCT02032953|hyperinsulinemia|hyperinsulinemia
1200136|NCT02032953|normoglycemia|normoglycemia
1200137|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
1200138|NCT02032953|anabolism|anabolism
1200139|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
1200140|NCT02032927|osteoarthritis|osteoarthritis
1200141|NCT02032927|pain|pain
1200142|NCT02032927|opioids|opioids
1200143|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
1200144|NCT02032914|colon cancer|colon cancer
1200145|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
1200146|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
1200147|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
1200148|NCT02032849|manual air-impingement operation|manual air-impingement operation
1200149|NCT02032849|prolonged intubation|prolonged intubation
1200155|NCT02032810|Stage III Melanoma|stage iii melanoma
1200156|NCT02032810|Stage IV Melanoma|stage iv melanoma
1200157|NCT02032810|HDAC Inhibitor|hdac inhibitor
1200158|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
1200159|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
1200160|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
1200161|NCT02032706|position therapy|position therapy
1200162|NCT02032706|snoring|snoring
1200163|NCT02032706|positional|positional
1200164|NCT02032693|Everycell|everycell
1200165|NCT02032693|DNA damage|dna damage
1200166|NCT02032693|DNA inflammation|dna inflammation
1200167|NCT02032693|DNA stress|dna stress
1200168|NCT02032667|physical activity|physical activity
1200169|NCT02032667|exergames|exergames
1200170|NCT02032654|antibiotics|antibiotics
1200171|NCT02032654|flucloxacillin|flucloxacillin
1200172|NCT02032654|therapy duration|therapy duration
1200173|NCT02032654|cellulitis|cellulitis
1200174|NCT02032654|erysipelas|erysipelas
1200175|NCT02032654|skin infections|skin infections
1200176|NCT02032654|hospital|hospital
1200177|NCT02032641|Non-ablative laser|non-ablative laser
1200178|NCT02032641|Scar revision|scar revision
1200179|NCT02032641|direct brow lift|direct brow lift
1200180|NCT02032628|epigenetics|epigenetics
1200181|NCT02032628|cancer|cancer
1200182|NCT02032628|exercise|exercise
1200183|NCT02032628|intensity|intensity
1200184|NCT02032628|duration|duration
1200185|NCT02032615|anemia|anemia
1200186|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
1200187|NCT02032602|Trigger Point|trigger point
1200188|NCT02032602|Shoulder Pain|shoulder pain
1200189|NCT02032602|Aged|aged
1200190|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
1200191|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
1200192|NCT02032550|Localized prostate cancer|localized prostate cancer
1200193|NCT02032550|Patient preference|patient preference
1200194|NCT02032550|Treatment choice|treatment choice
1200195|NCT02032550|Decision making|decision making
1200196|NCT02032550|Patient centered outcomes|patient centered outcomes
1200197|NCT02032537|callmax cream|callmax cream
1200198|NCT02032537|uremic pruritus|uremic pruritus
1200199|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
1200200|NCT02032498|radiocolloids|radiocolloids
1200201|NCT02032498|Indocyanine Green|indocyanine green
1200202|NCT02032498|complementarity|complementarity
1200203|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
1200204|NCT02032485|colorectal cancer|colorectal cancer
1200205|NCT02032485|Indocyanine Green|indocyanine green
1200206|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
1200207|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1200208|NCT02032472|Arterial Pressure|arterial pressure
1200209|NCT02032472|Hypertension Controlled|hypertension controlled
1200210|NCT02032472|Pharmacies|pharmacies
1200211|NCT02032459|Pregnancy|pregnancy
1200212|NCT02032459|Minority Women|minority women
1200213|NCT02032459|Preterm delivery|preterm delivery
1200214|NCT02032459|Fetal growth restriction|fetal growth restriction
1200215|NCT02032459|Preeclampsia|preeclampsia
1200216|NCT02032459|Gestational Diabetes|gestational diabetes
1200217|NCT02032459|Vitamin D|vitamin d
1200218|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
1200219|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
1200220|NCT02032433|comparative effective|comparative effective
1200221|NCT02032433|relapse prevention|relapse prevention
1200222|NCT02032394|Chlorhexidine|chlorhexidine
1200223|NCT02032394|Povidone-iodine|povidone-iodine
1200224|NCT02032394|bacteriuria|bacteriuria
1200225|NCT02032394|Urinary Catheterization|urinary catheterization
1200226|NCT02032394|Urinary tract infection|urinary tract infection
1200227|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
1200228|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
1200229|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
1200230|NCT02032368|circulating tumour cell;|circulating tumour cell;
1200231|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
1200232|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
1200233|NCT02032368|recurrence|recurrence
1200234|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
1200235|NCT02032316|Renal Stone|renal stone
1200236|NCT02032316|Ureteroscopy|ureteroscopy
1200237|NCT02032316|Ureteral Stent|ureteral stent
1200238|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
1200239|NCT02032316|UURS|uurs
1200240|NCT02032277|Oncology|oncology
1200241|NCT02032277|Triple negative breast cancer|triple negative breast cancer
1200242|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
1200243|NCT02032277|United States Oncology - 12152|united states oncology - 12152
1200244|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
1200245|NCT02032277|Alliance - AFT-04|alliance - aft-04
1200246|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
1200247|NCT02032264|Next generation sequencing|next generation sequencing
1200248|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
1200249|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
1200250|NCT02032199|Gastric bypass|gastric bypass
1200251|NCT02032199|Health-related quality of life|health-related quality of life
1200252|NCT02032199|SF-36|sf-36
1200253|NCT02032199|Questionnaire|questionnaire
1200254|NCT02032199|Treatment guidelines|treatment guidelines
1200255|NCT02032186|magnesium|magnesium
1200256|NCT02032186|prematurity|prematurity
1200257|NCT02032173|Ranibizumab|ranibizumab
1200258|NCT02032173|Diabetic Macular Edema|diabetic macular edema
1200259|NCT02032160|ADITEC|aditec
1200260|NCT02032160|Immunology|immunology
1200261|NCT02032160|Vaccines|vaccines
1200262|NCT02032160|Hepatitis B|hepatitis b
1200263|NCT02032160|Investigational study|investigational study
1200264|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
1200265|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
1200266|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
1200267|NCT02032121|Cancer survivors|cancer survivors
1200268|NCT02032121|Long-term cancer survivor|long-term cancer survivor
1200269|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
1200270|NCT02032095|IVIG|ivig
1200271|NCT02032095|Renal transplantation|renal transplantation
1200272|NCT02032095|desensitization|desensitization
1200273|NCT02032056|Infections|infections
1200274|NCT02032056|Allergy|allergy
1200275|NCT02032056|Immune function|immune function
1200276|NCT02032056|Microbiota|microbiota
1200277|NCT02032056|infant|infant
1200278|NCT02032043|Filariasis|filariasis
1200279|NCT02032043|Onchocerciasis|onchocerciasis
1200280|NCT02032043|Albendazole|albendazole
1200281|NCT02032043|Ivermectin|ivermectin
1200282|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
1200283|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
1200284|NCT02032030|quality of Life|quality of life
1200285|NCT02032030|pain|pain
1200286|NCT02032030|nausea|nausea
1200287|NCT02032030|falls|falls
1200288|NCT02032030|intraoperative awareness|intraoperative awareness
1200289|NCT02032030|anesthesia awareness|anesthesia awareness
1200290|NCT02032030|cognition|cognition
1200291|NCT02032030|activities of daily living|activities of daily living
1200292|NCT02032030|major morbidity|major morbidity
1200293|NCT02032030|all-cause mortality|all-cause mortality
1200294|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
1200295|NCT02032017|Gluteus medius|gluteus medius
1200296|NCT02032017|Approach|approach
1200297|NCT02032017|Rehabilitation|rehabilitation
1200298|NCT02032017|Functional outcome|functional outcome
1200299|NCT02032004|Chronic Heart Failure|chronic heart failure
1200300|NCT02032004|CHF|chf
1200301|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
1200302|NCT02032004|Ischemic Heart Failure|ischemic heart failure
1200303|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
1200304|NCT02032004|Stem Cells|stem cells
1200305|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
1200306|NCT02031991|Bioequivalence|bioequivalence
1200307|NCT02031991|Biosimilarity|biosimilarity
1200308|NCT02031991|Similarity|similarity
1200309|NCT02031991|PK|pk
1200310|NCT02031991|Phase 1|phase 1
1200311|NCT02031991|Bevacizumab|bevacizumab
1200312|NCT02031991|Healthy Volunteers|healthy volunteers
1200313|NCT02031991|Single-Dose|single-dose
1200314|NCT02031991|Oncology|oncology
1200315|NCT02031978|Breast Feeding|breast feeding
1200316|NCT02031978|Infant Nutrition|infant nutrition
1200317|NCT02031978|Childhood Obesity|childhood obesity
1200318|NCT02031978|Infant feeding patterns|infant feeding patterns
1200319|NCT02031978|WIC|wic
1200320|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
1200321|NCT02031952|hepatectomy|hepatectomy
1200322|NCT02031952|lymphadenectomy|lymphadenectomy
1200323|NCT02031952|complication|complication
1200324|NCT02031952|prognosis|prognosis
1200325|NCT02031939|Rectal cancer|rectal cancer
1200326|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1200327|NCT02031939|optimization|optimization
1200328|NCT02031913|Chronic hepatitis B|chronic hepatitis b
1200329|NCT02031913|Hepatic fibrosis|hepatic fibrosis
1200330|NCT02031913|Steatosis|steatosis
1200331|NCT02031887|starter formula|starter formula
1200332|NCT02031887|stool microbiota|stool microbiota
1200333|NCT02031887|infants|infants
1200334|NCT02031887|caesarean section delivery|caesarean section delivery
1200335|NCT02031874|H1N1|h1n1
1200336|NCT02031874|HIV|hiv
1200337|NCT02031874|Immunogenecity|immunogenecity
1200338|NCT02031848|weight loss|weight loss
1200339|NCT02031848|diet|diet
1200340|NCT02031822|Primary Headache|primary headache
1200341|NCT02031822|Greater Occipital Nerve|greater occipital nerve
1200342|NCT02031822|Ultrasound|ultrasound
1200343|NCT02031822|Chronic Pain|chronic pain
1200344|NCT02031822|Cervicogenic|cervicogenic
1200345|NCT02031822|Occipital Neuralgia|occipital neuralgia
1200346|NCT02031822|Migraine|migraine
1200347|NCT02031822|Tension type headache|tension type headache
1200348|NCT02031822|Cluster headache|cluster headache
1200349|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1200350|NCT02031770|vascular endothelial cells|vascular endothelial cells
1200351|NCT02031757|Balance control|balance control
1200352|NCT02031757|Aging|aging
1200353|NCT02031757|Balance reactions|balance reactions
1200354|NCT02031757|Perturbation|perturbation
1200355|NCT02031705|Fibrillation|fibrillation
1200356|NCT02031705|Catheter ablation|catheter ablation
1200357|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
1200358|NCT02031692|Vitamin D|vitamin d
1200359|NCT02031692|Calcium|calcium
1200360|NCT02031692|Prevention|prevention
1200361|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
1200362|NCT02031666|Healthy|healthy
1200363|NCT02031666|JNJ-56021927|jnj-56021927
1200373|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
1200374|NCT02031627|pneumatic compression device|pneumatic compression device
1200376|NCT02031614|blood withdrawal|blood withdrawal
1200377|NCT02031614|phlebotomy|phlebotomy
1200378|NCT02031614|innate immunity|innate immunity
1200379|NCT02031614|Immune reponse|immune reponse
1200380|NCT02031588|Study of commensal flora|study of commensal flora
1200381|NCT02031588|Fluoroquinolones|fluoroquinolones
1200382|NCT02031575|Reproductive Health|reproductive health
1200383|NCT02031575|Contraception|contraception
1200384|NCT02031575|Public Health|public health
1200385|NCT02031575|Sexual Health|sexual health
1200386|NCT02031575|Adolescents|adolescents
1200387|NCT02031575|Mobile Health|mobile health
1200388|NCT02031562|Balance|balance
1200389|NCT02031562|Falls|falls
1200390|NCT02031562|Low back pain|low back pain
1200391|NCT02031562|Geriatric|geriatric
1200392|NCT02031523|endometriosis|endometriosis
1200393|NCT02031523|dysmenorrhea|dysmenorrhea
1200394|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
1200395|NCT02031523|effect/safety|effect/safety
1333147|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
1200396|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
1200397|NCT02031432|cancer-related pain|cancer-related pain
1200398|NCT02031432|cebranopadol|cebranopadol
1200407|NCT02031380|Glaucoma|glaucoma
1200408|NCT02031380|Open angle glaucoma|open angle glaucoma
1200409|NCT02031380|ocular hypertension|ocular hypertension
1200410|NCT02031380|compliance|compliance
1200411|NCT02031354|Lysine Chloride|lysine chloride
1200412|NCT02031328|prostate|prostate
1200413|NCT02031328|radiation|radiation
1200414|NCT02031328|stereotactic body radiation|stereotactic body radiation
1200415|NCT02031315|sudden death|sudden death
1200416|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
1200417|NCT02031302|Lotus|lotus
1200418|NCT02031302|Valve|valve
1200419|NCT02031302|Real world|real world
1200420|NCT02031302|Aortic stenosis|aortic stenosis
1200421|NCT02031302|High risk|high risk
1200422|NCT02031289|Anemia|anemia
1200423|NCT02031289|Iron deficiency|iron deficiency
1200424|NCT02031289|Cardiac surgery|cardiac surgery
1200425|NCT02031289|Perioperative Care|perioperative care
1200426|NCT02031276|ABBV-066|abbv-066
1200427|NCT02031276|BI 655066|bi 655066
1200428|NCT02031276|risankizumab|risankizumab
1200429|NCT02031224|Chronic Kidney Disease|chronic kidney disease
1200430|NCT02031224|Restricted protein diets|restricted protein diets
1200431|NCT02031224|Nutritional status|nutritional status
1200432|NCT02031198|Alzheimer's disease|alzheimer's disease
1200433|NCT02031198|tau|tau
1200434|NCT02031198|dementia|dementia
1200435|NCT02031198|elderly|elderly
1200436|NCT02031198|cognitive|cognitive
1200437|NCT02031198|disease modifying|disease modifying
1200438|NCT02031198|treatment|treatment
1200439|NCT02031198|immunization|immunization
1200440|NCT02031198|vaccine|vaccine
1200441|NCT02031172|Dry Eye Disease|dry eye disease
1200442|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
1200443|NCT02031172|Tear Film|tear film
1200444|NCT02031172|Ocular Surface|ocular surface
1200445|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
1200446|NCT02031159|perioperative hypothermia|perioperative hypothermia
1200447|NCT02031159|zero heat flux|zero heat flux
1200448|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
1200449|NCT02031107|stroke|stroke
1200450|NCT02031107|brain stimulation|brain stimulation
1200451|NCT02031107|electroencephalography|electroencephalography
1200452|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
1200453|NCT02031107|functional connectivity|functional connectivity
1200454|NCT02031068|active rehabilitation|active rehabilitation
1200455|NCT02031068|exercise|exercise
1200456|NCT02031068|concussion|concussion
1200457|NCT02031055|Advanced solid tumors|advanced solid tumors
1200458|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1200459|NCT02031042|breast cancer|breast cancer
1200460|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
1200461|NCT02031042|false negative rate|false negative rate
1200462|NCT02031042|identification rate|identification rate
1200463|NCT02031029|personality scores|personality scores
1200464|NCT02031016|Chronic thoracic pain|chronic thoracic pain
1200465|NCT02031016|Remifentanil|remifentanil
1200466|NCT02031016|Fentanyl|fentanyl
1200467|NCT02031016|sternotomy|sternotomy
1200468|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
1200469|NCT02030990|corneal haze|corneal haze
1200470|NCT02030990|mitomycin-C|mitomycin-c
1200471|NCT02030990|postoperative steroids|postoperative steroids
1200472|NCT02030951|preterm infant behavior|preterm infant behavior
1200473|NCT02030951|tube feeding|tube feeding
1200474|NCT02030951|feeding efficiency|feeding efficiency
1200475|NCT02030938|breast implant|breast implant
1200476|NCT02030938|revision augmentation|revision augmentation
1200477|NCT02030938|stretch deformity|stretch deformity
1200478|NCT02030938|fold malposition|fold malposition
1200479|NCT02030938|bottoming out|bottoming out
1200480|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
1200481|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
1200482|NCT02030899|Cervical vertebrae|cervical vertebrae
1200483|NCT02030899|single|single
1200484|NCT02030899|degenerative disease|degenerative disease
1200485|NCT02030899|Fusion|fusion
1200486|NCT02030899|Sagittal angle|sagittal angle
1200487|NCT02030873|virtual simulation|virtual simulation
1200488|NCT02030873|temporal bone|temporal bone
1200489|NCT02030873|surgical training|surgical training
1200490|NCT02030873|medical education|medical education
1200491|NCT02030873|self-directed learning|self-directed learning
1200492|NCT02030873|final product assessment|final product assessment
1200493|NCT02030873|cognitive load|cognitive load
1200494|NCT02030873|reaction time|reaction time
1200495|NCT02030873|skills training|skills training
1200496|NCT02030873|simulator metrics|simulator metrics
1200497|NCT02030808|Thoracic surgery|thoracic surgery
1200498|NCT02030808|non-muscle relaxant|non-muscle relaxant
1200499|NCT02030808|target-controlled infusion|target-controlled infusion
1200500|NCT02030808|remifentanil|remifentanil
1200501|NCT02030808|surgical conditions|surgical conditions
1200502|NCT02030795|Thoracic surgery|thoracic surgery
1200503|NCT02030795|Arndt® blocker|arndt® blocker
1200504|NCT02030795|lung deflation|lung deflation
1200505|NCT02030795|Disconnection technique|disconnection technique
1200506|NCT02030795|Continuous suction|continuous suction
1200507|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
1200508|NCT02030782|depression|depression
1200509|NCT02030782|quality improvement|quality improvement
1200510|NCT02030782|treatment|treatment
1200511|NCT02030782|adolescents|adolescents
1200512|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
1200513|NCT02030769|Lugol's solution|lugol's solution
1200514|NCT02030769|Pronase|pronase
1200515|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
1200516|NCT02030769|Pretreatment method|pretreatment method
1200517|NCT02030756|constipation|constipation
1200518|NCT02030743|Falls|falls
1200519|NCT02030743|Older adults|older adults
1200520|NCT02030743|Balance|balance
1200521|NCT02030743|Mobility|mobility
1200522|NCT02030743|Visual attention|visual attention
1200523|NCT02030730|Brief Parenting Training|brief parenting training
1200524|NCT02030730|Early Intervention|early intervention
1200525|NCT02030730|Child Behavior|child behavior
1200526|NCT02030730|Greece|greece
1200527|NCT02030717|Spinal anesthesia|spinal anesthesia
1200528|NCT02030717|Epidural anesthesia|epidural anesthesia
1200529|NCT02030717|Klonidin|klonidin
1200530|NCT02030717|renal cell carcinoma|renal cell carcinoma
1200531|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
1200532|NCT02030691|nHFPV|nhfpv
1200533|NCT02030691|nCPAP|ncpap
1200534|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
1200535|NCT02030691|NIRS|nirs
1200536|NCT02030665|Marijuana Dependence|marijuana dependence
1200537|NCT02030665|Individualized treatment|individualized treatment
1200538|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
1200539|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
1200540|NCT02030665|Contingency Management|contingency management
1200541|NCT02030652|premature newborn|premature newborn
1200542|NCT02030652|nasal ventilation|nasal ventilation
1200543|NCT02030652|noninvasive ventilation|noninvasive ventilation
1200544|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
1200545|NCT02030626|Neuropathic pain|neuropathic pain
1200546|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
1200547|NCT02030626|rTMS|rtms
1200548|NCT02030626|tDCS|tdcs
1200549|NCT02030626|placebo controlled study|placebo controlled study
1200550|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1200551|NCT02030613|etanercept|etanercept
1200552|NCT02030587|Hyperaldosteronism|hyperaldosteronism
1200553|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
1200554|NCT02030587|Adrenalectomy|adrenalectomy
1200555|NCT02030587|Catheter ablation|catheter ablation
1200556|NCT02030561|NK cells|nk cells
1200557|NCT02030561|trastuzumab|trastuzumab
1200558|NCT02030561|immunotherapy|immunotherapy
1200559|NCT02030548|CABG|cabg
1200560|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
1200561|NCT02030548|aspirin|aspirin
1200562|NCT02030548|clopidogrel|clopidogrel
1200563|NCT02030548|prasugrel|prasugrel
1200564|NCT02030548|ticagrelor|ticagrelor
1200565|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
1200566|NCT02030522|PTSD|ptsd
1200567|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
1200568|NCT02030522|Military|military
1200569|NCT02030522|Veterans|veterans
1200570|NCT02030522|Exposure therapy|exposure therapy
1200571|NCT02030522|Eye movements|eye movements
1200572|NCT02030509|cancer diagnosis|cancer diagnosis
1200573|NCT02030496|distal radius fractures|distal radius fractures
1200574|NCT02030496|Closed reduction|closed reduction
1200575|NCT02030496|Open reduction internal fixation|open reduction internal fixation
1200576|NCT02030496|Volar plate|volar plate
1200577|NCT02030496|Redislocation|redislocation
1200578|NCT02030496|Unstable fracture|unstable fracture
1200579|NCT02030496|Extra-articular fracture|extra-articular fracture
1200580|NCT02030496|Colles fracture|colles fracture
1200581|NCT02030496|Barton fracture|barton fracture
1200582|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
1200583|NCT02030444|Neoplasms Staging|neoplasms staging
1200584|NCT02030444|Bronchoscopy|bronchoscopy
1200585|NCT02030444|Nuclear Medicine|nuclear medicine
1200586|NCT02030444|Radiology|radiology
1200587|NCT02030392|Functional abdominal pain|functional abdominal pain
1200588|NCT02030392|psychological intervention|psychological intervention
1200589|NCT02030392|quality of life|quality of life
1200590|NCT02030392|Randomized controlled trial|randomized controlled trial
1200591|NCT02030392|children|children
1200592|NCT02030379|Cancer|cancer
1200593|NCT02030353|Lifestyle intervention|lifestyle intervention
1200594|NCT02030353|Internet intervention|internet intervention
1200595|NCT02030353|Breast neoplasms|breast neoplasms
1200596|NCT02030353|Body weight|body weight
1578021|NCT00471744|pediatrics|pediatrics
1200597|NCT02030353|Body weight changes|body weight changes
1200598|NCT02030340|urodynamic investigation|urodynamic investigation
1200599|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
1200600|NCT02030340|catheter|catheter
1200601|NCT02030340|air-charged|air-charged
1200602|NCT02030340|water filled|water filled
1200603|NCT02030327|proteomics|proteomics
1200604|NCT02030327|multiple trauma|multiple trauma
1200605|NCT02030327|organ dysfunction|organ dysfunction
1200606|NCT02030314|Chlorthalidone|chlorthalidone
1200607|NCT02030314|Resistant Hypertension|resistant hypertension
1200608|NCT02030314|Kidney Transplant Patients|kidney transplant patients
1200609|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
1200610|NCT02030301|Herpes|herpes
1200611|NCT02030301|HSV-2|hsv-2
1200612|NCT02030288|alcohol|alcohol
1200613|NCT02030288|substance use|substance use
1200614|NCT02030288|eHealth|ehealth
1200615|NCT02030275|Hypertrophic scar|hypertrophic scar
1200616|NCT02030275|Cicatrix|cicatrix
1200617|NCT02030275|Scar prevention|scar prevention
1200618|NCT02030275|Scar revision|scar revision
1200619|NCT02030249|Pre-diabetes|pre-diabetes
1200620|NCT02030249|Obesity|obesity
1200621|NCT02030249|Low calorie diet|low calorie diet
1200622|NCT02030249|Diet - reducing|diet - reducing
1200623|NCT02030249|Appetite|appetite
1200624|NCT02030249|Visual analogue scale|visual analogue scale
1200625|NCT02030249|Ghrelin|ghrelin
1200626|NCT02030249|Peptide YY|peptide yy
1200627|NCT02030249|Bone mass|bone mass
1200628|NCT02030249|Bone turnover|bone turnover
1200629|NCT02030249|Muscle strength|muscle strength
1200630|NCT02030236|hypothermia, induced|hypothermia, induced
1200631|NCT02030236|rewarming|rewarming
1200632|NCT02030236|therapeutic|therapeutic
1200633|NCT02030236|heart arrest|heart arrest
1200634|NCT02030236|asystole|asystole
1200635|NCT02030236|frostbite|frostbite
1200636|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
1200637|NCT02030223|inguinal hernia repair|inguinal hernia repair
1200638|NCT02030223|acute postoperative pain|acute postoperative pain
1200639|NCT02030223|neuropathic pain|neuropathic pain
1200640|NCT02030210|Quality improvement|quality improvement
1200641|NCT02030210|STEMI|stemi
1200642|NCT02030210|Belgium|belgium
1200643|NCT02030184|Lung cancer|lung cancer
1200644|NCT02030184|Small cell lung cancer|small cell lung cancer
1200645|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
1200646|NCT02030184|Rhenium|rhenium
1200647|NCT02030184|Re 188-P2045|re 188-p2045
1200648|NCT02030171|Chronic low back pain|chronic low back pain
1200649|NCT02030158|Severe sepsis|severe sepsis
1200650|NCT02030158|Septic shock|septic shock
1200651|NCT02030158|Early goal directed therapy|early goal directed therapy
1200652|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
1200653|NCT02030145|COPD|copd
1200654|NCT02030145|Pulmonary|pulmonary
1200655|NCT02030132|Physical activity|physical activity
1200656|NCT02030132|Sedentary lifestyle|sedentary lifestyle
1200657|NCT02030132|Pedometers|pedometers
1200658|NCT02030132|Walking|walking
1200659|NCT02030132|Financial Incentives|financial incentives
1200660|NCT02030132|Behavioral Economics|behavioral economics
1200661|NCT02030119|Sedentary lifestyle|sedentary lifestyle
1200662|NCT02030119|Pedometers|pedometers
1200663|NCT02030119|Obesity|obesity
1200664|NCT02030119|Physical Activity|physical activity
1200665|NCT02030119|Financial Incentives|financial incentives
1200666|NCT02030119|Behavioral Economics|behavioral economics
1200667|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
1200668|NCT02030106|Microbiome|microbiome
1200669|NCT02030106|Preterm Birth|preterm birth
1200670|NCT02030106|Cervical Remodeling|cervical remodeling
1200671|NCT02030106|Preterm delivery|preterm delivery
1200672|NCT02030106|Microbiota|microbiota
1200673|NCT02030093|Alcohol dependence|alcohol dependence
1200674|NCT02030093|Telephone-based continuing care|telephone-based continuing care
1200675|NCT02030093|Outcome monitoring|outcome monitoring
1200676|NCT02030080|Pedometers|pedometers
1200678|NCT02030080|Financial incentives|financial incentives
1200679|NCT02030080|Sedentary lifestyle|sedentary lifestyle
1200680|NCT02030080|Behavioral economics|behavioral economics
1200681|NCT02030067|oncology|oncology
1200682|NCT02030067|tumor|tumor
1200683|NCT02030067|metastatic|metastatic
1200684|NCT02030041|simvastatin|simvastatin
1200685|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
1200686|NCT02030041|vitamin D|vitamin d
1200687|NCT02030041|exercise|exercise
1200688|NCT02030041|mitochondria|mitochondria
1200689|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
1200690|NCT02030028|ACTH gel|acth gel
1200691|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
1200692|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
1200693|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
1200694|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
1200695|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
1200696|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
1200697|NCT02030015|Sandhoff disease|sandhoff disease
1200698|NCT02030015|gangliosidoses|gangliosidoses
1200699|NCT02030015|miglustat|miglustat
1200700|NCT02030015|ketogenic diet|ketogenic diet
1200701|NCT02030015|SYNER-G regimen|syner-g regimen
1200702|NCT02030015|Syner-G|syner-g
1200703|NCT02030015|Zavesca|zavesca
1200704|NCT02030015|Tay-Sachs disease|tay-sachs disease
1200705|NCT02030015|Tay Sachs disease|tay sachs disease
1200706|NCT02029989|Metabolic Syndrome|metabolic syndrome
1200707|NCT02029989|Antipsychotics|antipsychotics
1200708|NCT02029989|Schizophrenia|schizophrenia
1200709|NCT02029989|Bipolar Disorder|bipolar disorder
1200710|NCT02029989|Diabetes|diabetes
1200711|NCT02029989|Dyslipidemia|dyslipidemia
1200712|NCT02029989|Hyperlipidemia|hyperlipidemia
1200713|NCT02029989|Hypertension|hypertension
1200714|NCT02029989|Obesity|obesity
1200715|NCT02029989|Medication Therapy Management|medication therapy management
1200717|NCT02029989|Pharmacist|pharmacist
1200718|NCT02029989|Comprehensive Medication Management|comprehensive medication management
1200719|NCT02029989|CMM|cmm
1200720|NCT02029989|Health Disparity|health disparity
1200721|NCT02029989|Monitoring|monitoring
1200722|NCT02029989|Point of Care Testing|point of care testing
1200723|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
1200724|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
1200725|NCT02029937|Proflavine|proflavine
1200726|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
1200727|NCT02029911|Menorrhagia|menorrhagia
1200728|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
1200729|NCT02029911|Endometrial Ablation|endometrial ablation
1200730|NCT02029898|cesarean section|cesarean section
1200731|NCT02029898|anesthesia|anesthesia
1200732|NCT02029898|children|children
1200733|NCT02029885|Hypertension|hypertension
1200734|NCT02029885|Renal Denervation|renal denervation
1200735|NCT02029872|MRSA|mrsa
1200736|NCT02029872|colonization|colonization
1200737|NCT02029872|decolonization|decolonization
1200738|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
1200739|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
1200740|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
1200741|NCT02029859|preeclampsy|preeclampsy
1200742|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
1200743|NCT02029820|Contrast Nephropathy|contrast nephropathy
1200744|NCT02029820|Prevention|prevention
1200745|NCT02029820|Renalguard|renalguard
1200746|NCT02029794|Cervical Cancer|cervical cancer
1200747|NCT02029794|Cervical Cancer Screening|cervical cancer screening
1200748|NCT02029794|Low Resource setting|low resource setting
1200749|NCT02029794|HPV|hpv
1200750|NCT02029794|Self-Collection|self-collection
1200751|NCT02029794|VIA|via
1200752|NCT02029781|Appendicitis|appendicitis
1200753|NCT02029781|Laparoscopy|laparoscopy
1200754|NCT02029781|Appendectomy|appendectomy
1200755|NCT02029781|Negative appendectomy|negative appendectomy
1200756|NCT02029781|Morbidity|morbidity
1200757|NCT02029768|outcome|outcome
1200758|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
1200759|NCT02029755|local infiltration|local infiltration
1200760|NCT02029755|ropivacaine|ropivacaine
1200761|NCT02029755|heart rate variability|heart rate variability
1200762|NCT02029755|postoperative analgesia|postoperative analgesia
1200763|NCT02029742|Sickle cell disease|sickle cell disease
1200764|NCT02029742|Medication adherence|medication adherence
1200765|NCT02029742|Hydroxyurea|hydroxyurea
1200766|NCT02029742|Community health worker intervention|community health worker intervention
1200767|NCT02029742|Sickle Cell Treatment|sickle cell treatment
1200768|NCT02029729|RTA 408|rta 408
1200769|NCT02029729|RTA 408 Capsules|rta 408 capsules
1200770|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
1200771|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
1200772|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
1200773|NCT02029729|Refractory melanoma|refractory melanoma
1200774|NCT02029729|Relapsed melanoma|relapsed melanoma
1200775|NCT02029716|RTA 408|rta 408
1200776|NCT02029716|RTA 408 Lotion|rta 408 lotion
1200777|NCT02029716|Oxidative stress|oxidative stress
1200778|NCT02029716|Inflammation|inflammation
1200779|NCT02029716|Volunteers|volunteers
1200780|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
1200781|NCT02029703|Knee Pain|knee pain
1200782|NCT02029703|Synvisc-One|synvisc-one
1200783|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
1200784|NCT02029690|arginine|arginine
1200785|NCT02029690|arginine deiminase|arginine deiminase
1200786|NCT02029651|Stroke|stroke
1200787|NCT02029651|Hand|hand
1200788|NCT02029651|Rehabilitation|rehabilitation
1200789|NCT02029651|Game|game
1200790|NCT02029638|Kidney Transplantation|kidney transplantation
1200791|NCT02029638|Renal Transplantation|renal transplantation
1200792|NCT02029612|Tobacco Use Cessation|tobacco use cessation
1200793|NCT02029612|Cancer Prevention|cancer prevention
1200794|NCT02029612|HIV/AIDS|hiv/aids
1200795|NCT02029612|Questionnaires|questionnaires
1200796|NCT02029612|Surveys|surveys
1200797|NCT02029612|Nicotine patch|nicotine patch
1200798|NCT02029612|Breath test|breath test
1200799|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
1200800|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
1200801|NCT02029573|Phase II|phase ii
1200802|NCT02029573|Atorvastatin|atorvastatin
1200803|NCT02029573|Temozolomide|temozolomide
1200804|NCT02029573|Radiotherapy|radiotherapy
1200805|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
1200806|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
1200807|NCT02029534|POAF|poaf
1200808|NCT02029534|A-Fib|a-fib
1200809|NCT02029521|cystic fibrosis|cystic fibrosis
1200810|NCT02029521|growth Failure|growth failure
1200811|NCT02029521|glutathione|glutathione
1200812|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
1200813|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
1200814|NCT02029508|Vertigo|vertigo
1200815|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
1200816|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
1200817|NCT02029495|Brodalumab|brodalumab
1200818|NCT02029495|AMG 827|amg 827
1200819|NCT02029482|ACT-128800|act-128800
1200820|NCT02029469|Humeral Resurfacing|humeral resurfacing
1200821|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
1200822|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
1200823|NCT02029456|thrombolytic therapy|thrombolytic therapy
1200824|NCT02029456|high risk|high risk
1200825|NCT02029456|elderly|elderly
1200826|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1200827|NCT02029430|HIV +|hiv +
1200828|NCT02029430|HIV positive|hiv positive
1200829|NCT02029430|AIDS|aids
1200830|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
1200831|NCT02029430|Sarcoma|sarcoma
1200832|NCT02029430|tumor|tumor
1200833|NCT02029430|cancer|cancer
1200834|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
1200835|NCT02029391|taping|taping
1200836|NCT02029391|manual therapies|manual therapies
1200837|NCT02029365|Infertility|infertility
1200838|NCT02029365|desire for children|desire for children
1200839|NCT02029365|eating disorder|eating disorder
1200840|NCT02029365|anorexia nervosa|anorexia nervosa
1200841|NCT02029365|bulimia nervosa|bulimia nervosa
1200842|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
1200843|NCT02029352|Treatment|treatment
1200844|NCT02029352|Sinecatechins|sinecatechins
1200845|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
1200846|NCT02029339|Acute wound infection|acute wound infection
1200847|NCT02029339|complicated abdominal infection|complicated abdominal infection
1200848|NCT02029339|Cytokines|cytokines
1200849|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
1200850|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
1200851|NCT02029300|pediatrics|pediatrics
1200852|NCT02029300|fiberoptic intubation|fiberoptic intubation
1200853|NCT02029300|oral intubation|oral intubation
1200854|NCT02029300|nasal intubation|nasal intubation
1200855|NCT02029300|children under the age of 2|children under the age of 2
1200856|NCT02029287|Chronic heart failure|chronic heart failure
1200857|NCT02029287|telemedicine|telemedicine
1200858|NCT02029287|health service platform|health service platform
1200859|NCT02029274|Dermatomyositis|dermatomyositis
1200860|NCT02029261|Burn|burn
1200861|NCT02029248|Anorectal malformation|anorectal malformation
1200862|NCT02029248|fecal incontinence|fecal incontinence
1200863|NCT02029248|quality of life|quality of life
1200864|NCT02029248|child|child
1200865|NCT02029235|Adult|adult
1200866|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
1200867|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
1200868|NCT02029170|ankle fracture|ankle fracture
1200869|NCT02029170|weightbearing|weightbearing
1200870|NCT02029170|cast|cast
1200871|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
1200872|NCT02029105|Mesothelioma,|mesothelioma,
1200873|NCT02029105|Pleural diseases,|pleural diseases,
1200874|NCT02029105|Mesothelin,|mesothelin,
1200875|NCT02029105|Osteopontin,|osteopontin,
1200876|NCT02029105|Hyaluronan,|hyaluronan,
1200877|NCT02029105|Syndecan-1|syndecan-1
1200878|NCT02029092|International|international
1200879|NCT02029092|Multicenter|multicenter
1200880|NCT02029092|Observational registry|observational registry
1200881|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1200882|NCT02029092|Stenting|stenting
1200883|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
1200884|NCT02029092|Coronary revascularization|coronary revascularization
1200885|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1200886|NCT02029092|STEMI|stemi
1200887|NCT02029092|NSTEMI|nstemi
1200888|NCT02029092|Ischemia|ischemia
1200889|NCT02029092|Angina|angina
1200890|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1200891|NCT02029092|Small Vessels|small vessels
1200892|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
1200893|NCT02029079|Malnutrition|malnutrition
1200894|NCT02029066|actinic keratosis|actinic keratosis
1200895|NCT02029066|SR-T100|sr-t100
1200896|NCT02029066|pharmacokinetics|pharmacokinetics
1200897|NCT02029053|Vaginal dryness|vaginal dryness
1200898|NCT02029053|Vaginal lubrication|vaginal lubrication
1200899|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
1200900|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
1200901|NCT02029053|Urogenital atrophy|urogenital atrophy
1200902|NCT02029053|Dyspareunia|dyspareunia
1200903|NCT02029053|Painful intercourse|painful intercourse
1200904|NCT02029040|Bronchiolitis|bronchiolitis
1200905|NCT02029040|Hypertonic saline|hypertonic saline
1200906|NCT02029040|Emergency Department|emergency department
1200907|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
1200908|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
1200909|NCT02029014|LAmbre|lambre
1200910|NCT02029001|Solid tumor|solid tumor
1200911|NCT02029001|Recurrent/metastatic|recurrent/metastatic
1200912|NCT02029001|Personalized medicine|personalized medicine
1200913|NCT02029001|Genomic alteration|genomic alteration
1200914|NCT02029001|Targeted therapy|targeted therapy
1200915|NCT02029001|Nilotinib|nilotinib
1200916|NCT02029001|Everolimus|everolimus
1200917|NCT02029001|Sorafenib|sorafenib
1200918|NCT02029001|Lapatinib|lapatinib
1200919|NCT02029001|Pazopanib|pazopanib
1200920|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
1200921|NCT02028962|Smoking cessation|smoking cessation
1200922|NCT02028962|Romanian adults|romanian adults
1200923|NCT02028923|topical morphine|topical morphine
1200924|NCT02028910|gastroenteritis|gastroenteritis
1200925|NCT02028910|pediatrics|pediatrics
1200926|NCT02028910|vomiting|vomiting
1200927|NCT02028897|In vitro fertilization|in vitro fertilization
1200928|NCT02028897|IVF|ivf
1200929|NCT02028897|Embryo culture|embryo culture
1200930|NCT02028897|Blastocyst transfer|blastocyst transfer
1200931|NCT02028832|pain|pain
1200932|NCT02028832|nausea/vomiting|nausea/vomiting
1200933|NCT02028832|anxiety|anxiety
1200934|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
1200935|NCT02028832|pediatric|pediatric
1200936|NCT02028832|oncology|oncology
1200937|NCT02028832|cost-effectiveness|cost-effectiveness
1201036|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
1200938|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
1200939|NCT02028741|neck pain|neck pain
1200940|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
1200941|NCT02028741|thoracic mobilization|thoracic mobilization
1200942|NCT02028728|International|international
1200943|NCT02028728|Multicenter|multicenter
1200944|NCT02028728|Observational registry|observational registry
1200945|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1200946|NCT02028728|Stenting|stenting
1200947|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
1200948|NCT02028728|Coronary revascularization|coronary revascularization
1200949|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1200950|NCT02028728|STEMI|stemi
1200951|NCT02028728|NSTEMI|nstemi
1200952|NCT02028728|Ischemia|ischemia
1200953|NCT02028728|Angina|angina
1200954|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1200955|NCT02028728|Small Vessels|small vessels
1200956|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1200957|NCT02028715|IV Acetaminophen|iv acetaminophen
1200958|NCT02028715|Ofirmev|ofirmev
1200959|NCT02028715|Post-operative pain|post-operative pain
1200960|NCT02028702|red clover|red clover
1200961|NCT02028702|menopause|menopause
1200962|NCT02028702|bioactive compounds|bioactive compounds
1200963|NCT02028702|isoflavones|isoflavones
1200964|NCT02028702|phytoestrogen|phytoestrogen
1200965|NCT02028676|HIV|hiv
1200966|NCT02028676|Africa|africa
1200967|NCT02028676|children|children
1200968|NCT02028676|antiretroviral therapy|antiretroviral therapy
1200969|NCT02028676|laboratory monitoring|laboratory monitoring
1200970|NCT02028676|toxicity|toxicity
1200971|NCT02028676|CD4|cd4
1200972|NCT02028676|induction maintenance|induction maintenance
1200973|NCT02028676|cotrimoxazole|cotrimoxazole
1200974|NCT02028676|prophylaxis|prophylaxis
1200975|NCT02028676|abacavir|abacavir
1200976|NCT02028676|lamivudine|lamivudine
1200977|NCT02028676|once daily|once daily
1200978|NCT02028663|P-CAB|p-cab
1200979|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
1200980|NCT02028650|relapse leukemia|relapse leukemia
1200981|NCT02028650|DSI|dsi
1200982|NCT02028637|asthma|asthma
1200983|NCT02028637|toll like receptor|toll like receptor
1200984|NCT02028637|innate immunity|innate immunity
1200985|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
1200986|NCT02028624|Mediterranean diet|mediterranean diet
1200987|NCT02028624|Lifestyle intervention|lifestyle intervention
1200988|NCT02028624|Adiponectin|adiponectin
1200989|NCT02028624|Telephone counseling|telephone counseling
1200990|NCT02028611|Rib fracture|rib fracture
1200991|NCT02028611|Inverted grayscale|inverted grayscale
1200992|NCT02028598|Clomipramine|clomipramine
1200993|NCT02028598|Premature ejaculation|premature ejaculation
1200994|NCT02028585|low-fat milk|low-fat milk
1200995|NCT02028585|metabolic syndrome|metabolic syndrome
1200996|NCT02028585|lipid profile|lipid profile
1200997|NCT02028585|inflammation|inflammation
1200998|NCT02028585|oxidative stress|oxidative stress
1200999|NCT02028585|endothelial function|endothelial function
1201000|NCT02028572|Structure function correlation|structure function correlation
1201001|NCT02028572|Optical coherence tomography|optical coherence tomography
1201002|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
1201003|NCT02028572|Visual fields|visual fields
1201004|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
1201005|NCT02028559|stones|stones
1201006|NCT02028559|kidney|kidney
1201007|NCT02028559|stone fragments|stone fragments
1201008|NCT02028559|lithotripsy|lithotripsy
1201009|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
1201010|NCT02028533|addiction|addiction
1201011|NCT02028533|oxytocin|oxytocin
1201012|NCT02028533|tolerability|tolerability
1201013|NCT02028507|Palbociclib|palbociclib
1201014|NCT02028507|Capecitabine|capecitabine
1201015|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
1201016|NCT02028507|HER2 negative|her2 negative
1201017|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
1201018|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
1201019|NCT02028507|Fulvestrant|fulvestrant
1201020|NCT02028507|Exemestane|exemestane
1201021|NCT02028507|Aromatase inhibitor|aromatase inhibitor
1201022|NCT02028481|Macular hole|macular hole
1201023|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
1201024|NCT02028481|Macular surgery|macular surgery
1201025|NCT02028481|Air tamponade|air tamponade
1201026|NCT02028468|Femoral Neck Fracture|femoral neck fracture
1201027|NCT02028468|Anterolateral approach|anterolateral approach
1201028|NCT02028468|Trans-gluteal approach|trans-gluteal approach
1201029|NCT02028468|Watson Jones approach|watson jones approach
1201030|NCT02028468|Hardinge approach|hardinge approach
1201031|NCT02028455|pediatric|pediatric
1201032|NCT02028455|young adult|young adult
1201033|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1201034|NCT02028455|CD19|cd19
1201035|NCT02028455|leukemia|leukemia
1201037|NCT02028455|T cell|t cell
1201038|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
1201039|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
1201040|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
1201041|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
1201042|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
1201043|NCT02028416|pancytopenia|pancytopenia
1201044|NCT02028416|aplastic anemia|aplastic anemia
1201045|NCT02028416|ATG|atg
1201046|NCT02028416|Cyclosporin|cyclosporin
1201047|NCT02028390|wounds|wounds
1201048|NCT02028390|thermal|thermal
1201049|NCT02028390|temperature|temperature
1201050|NCT02028390|periwound|periwound
1201051|NCT02028390|camera|camera
1201052|NCT02028390|imaging|imaging
1201053|NCT02028377|Adenocarcinoma|adenocarcinoma
1201054|NCT02028377|imaging|imaging
1201055|NCT02028377|PET|pet
1201056|NCT02028377|MRI|mri
1201057|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
1201058|NCT02028364|HER2 negative|her2 negative
1201059|NCT02028364|NSAI refractory|nsai refractory
1201258|NCT02027571|Diabetes|diabetes
1201060|NCT02028364|Metastatic breast cancer|metastatic breast cancer
1201061|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
1201062|NCT02028351|visual acuity|visual acuity
1201063|NCT02028351|contrast sensitivity|contrast sensitivity
1201064|NCT02028351|cataract|cataract
1201065|NCT02028351|maculopathy|maculopathy
1201066|NCT02028312|Dry Eye|dry eye
1201067|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1201068|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
1201069|NCT02028299|Right Heart Catheterization|right heart catheterization
1201070|NCT02028286|Rosacea|rosacea
1201071|NCT02028273|Neurogenesis|neurogenesis
1201072|NCT02028273|Addiction|addiction
1201073|NCT02028273|Cocaine|cocaine
1201074|NCT02028273|MRI|mri
1201075|NCT02028273|MRS|mrs
1201076|NCT02028247|Autism spectrum disorders|autism spectrum disorders
1201077|NCT02028247|Autism|autism
1201078|NCT02028247|Asperger's syndrome|asperger's syndrome
1201079|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
1201080|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
1201081|NCT02028247|Social phobia|social phobia
1201082|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
1201083|NCT02028247|Specific phobia|specific phobia
1201084|NCT02028247|Separation anxiety disorder|separation anxiety disorder
1201085|NCT02028247|Counseling|counseling
1201086|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
1201087|NCT02028247|Psychotherapy|psychotherapy
1201088|NCT02028221|Breast cancer prevention|breast cancer prevention
1201089|NCT02028221|metformin|metformin
1201090|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
1201091|NCT02028208|Patch Test|patch test
1201092|NCT02028208|Allergy Testing|allergy testing
1201093|NCT02028208|Contact Dermatitis|contact dermatitis
1201094|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
1201095|NCT02028195|Health check|health check
1201096|NCT02028195|Health promotion|health promotion
1201097|NCT02028195|prevention diabetes|prevention diabetes
1201098|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
1201099|NCT02028195|mental health|mental health
1201100|NCT02028182|Patch Test|patch test
1201101|NCT02028182|Allergy Testing|allergy testing
1201102|NCT02028182|Contact dermatitis|contact dermatitis
1201103|NCT02028182|Lyral allergen|lyral allergen
1201104|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
1201105|NCT02028169|Work Productivity|work productivity
1201106|NCT02028169|Anti-TNFs|anti-tnfs
1201107|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
1201108|NCT02028143|Atrial Fibrillation|atrial fibrillation
1201109|NCT02028130|Atrial fibrillation|atrial fibrillation
1201110|NCT02028130|Ablation|ablation
1201111|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
1201112|NCT02028130|Stroke prevention|stroke prevention
1201113|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
1201114|NCT02028078|Endogenous glucose production|endogenous glucose production
1201115|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
1201116|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
1201117|NCT02028078|tracer to technique|tracer to technique
1201118|NCT02028078|pharmacodynamics|pharmacodynamics
1201119|NCT02028078|pharmacokinetics|pharmacokinetics
1201120|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
1201121|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
1201122|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
1201123|NCT02028039|Leukemia|leukemia
1201124|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
1201125|NCT02028039|ALL|all
1201126|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
1201127|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
1201128|NCT02028039|IPI-145|ipi-145
1201129|NCT02028026|Depressive Disorder|depressive disorder
1201130|NCT02028026|Anxiety|anxiety
1201131|NCT02028026|Comorbidity|comorbidity
1201132|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
1201133|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1201134|NCT02028026|Citalopram|citalopram
1201135|NCT02028026|Vilazodone|vilazodone
1201136|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1201137|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
1201138|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
1201139|NCT02028000|Pregnancy|pregnancy
1201140|NCT02028000|Pregnant|pregnant
1201141|NCT02028000|Cesarean Section Delivery|cesarean section delivery
1201142|NCT02027987|valproate acid|valproate acid
1201143|NCT02027987|traumatic brain injury|traumatic brain injury
1201144|NCT02027987|brain protection|brain protection
1201145|NCT02027987|epilepsy|epilepsy
1201146|NCT02027974|Hip|hip
1201147|NCT02027974|Arthroplasty|arthroplasty
1201148|NCT02027974|Arthroplasties|arthroplasties
1201149|NCT02027974|Prosthesis|prosthesis
1201150|NCT02027974|Iconacy|iconacy
1201151|NCT02027974|Osteoarthritis|osteoarthritis
1201152|NCT02027974|Arthritis|arthritis
1201153|NCT02027974|THA|tha
1201154|NCT02027974|THR|thr
1201155|NCT02027974|DJD|djd
1201363|NCT02027233|Vaccines|vaccines
1201156|NCT02027961|Metastatic or Unresectable Melanoma, MEDI4736, dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, medi4736, dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
1201157|NCT02027948|nutritional management algorithm|nutritional management algorithm
1201158|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
1201159|NCT02027948|13-264|13-264
1201160|NCT02027935|Melanoma|melanoma
1201161|NCT02027935|Metastatic|metastatic
1201162|NCT02027935|CD8+ T cells|cd8+ t cells
1201163|NCT02027935|White blood cell|white blood cell
1201164|NCT02027935|Leukapheresis|leukapheresis
1201165|NCT02027935|Cyclophosphamide|cyclophosphamide
1201166|NCT02027935|Cytoxan|cytoxan
1201167|NCT02027935|Neosar|neosar
1201168|NCT02027935|Interleukin-2|interleukin-2
1201169|NCT02027935|Aldesleukin|aldesleukin
1201170|NCT02027935|IL-2|il-2
1201171|NCT02027935|Proleukin|proleukin
1201172|NCT02027935|Ipilimumab|ipilimumab
1201173|NCT02027935|Yervoy|yervoy
1201174|NCT02027935|BMS-734016|bms-734016
1201175|NCT02027935|MDX010|mdx010
1201176|NCT02027922|white spot lesion|white spot lesion
1201177|NCT02027922|caries|caries
1201178|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
1201179|NCT02027896|Perioperative outcomes|perioperative outcomes
1201180|NCT02027883|Defibrillators|defibrillators
1333148|NCT01444352|Pneumococcal infections|pneumococcal infections
1201181|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
1201182|NCT02027870|DES|des
1201183|NCT02027870|CAD|cad
1201184|NCT02027870|EXCEL-II|excel-ii
1201185|NCT02027870|JWMS|jwms
1201186|NCT02027870|PCI|pci
1201187|NCT02027857|brain electrical impedance;|brain electrical impedance;
1201188|NCT02027857|traumatic brain injury;|traumatic brain injury;
1201189|NCT02027857|brain edema;|brain edema;
1201190|NCT02027857|intracranial pressure|intracranial pressure
1201191|NCT02027831|lymph nodes|lymph nodes
1201192|NCT02027818|margins|margins
1201193|NCT02027818|tumorectomy|tumorectomy
1201194|NCT02027805|Steroid-resistant|steroid-resistant
1201195|NCT02027805|Graft vs Host Disease|graft vs host disease
1201196|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
1201197|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1201198|NCT02027805|Stem Cell Transplantation|stem cell transplantation
1201199|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1201200|NCT02027805|Immune System Diseases|immune system diseases
1201201|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
1201202|NCT02027805|Immunotoxins|immunotoxins
1201203|NCT02027805|Immunosuppressive agents|immunosuppressive agents
1201204|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
1201205|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
1201206|NCT02027727|infliximab|infliximab
1201207|NCT02027727|trough level|trough level
1201208|NCT02027727|crohn's disease|crohn's disease
1201209|NCT02027727|ulcerative colitis|ulcerative colitis
1201210|NCT02027714|Discordant|discordant
1201211|NCT02027714|Lesotho|lesotho
1201212|NCT02027714|Couples|couples
1201213|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
1201214|NCT02027714|ART|art
1201215|NCT02027714|Counseling|counseling
1201216|NCT02027714|Male Circumcision|male circumcision
1201217|NCT02027688|Oral feeding|oral feeding
1201218|NCT02027688|Premature|premature
1201219|NCT02027688|Infants|infants
1201220|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
1201221|NCT02027675|exercise|exercise
1201222|NCT02027675|immune function|immune function
1201223|NCT02027675|inflammation|inflammation
1201224|NCT02027675|immunity|immunity
1201225|NCT02027675|diet|diet
1201226|NCT02027675|obesity|obesity
1201227|NCT02027675|asthma|asthma
1201228|NCT02027649|Bladder cancer|bladder cancer
1201229|NCT02027649|Keratin 14|keratin 14
1202070|NCT02024009|gemcitabine|gemcitabine
1201230|NCT02027649|Pronostic marker|pronostic marker
1201231|NCT02027649|Diagnostic marker|diagnostic marker
1201232|NCT02027649|Noninvasive technique|noninvasive technique
1201233|NCT02027636|Depression|depression
1201234|NCT02027636|Latinos|latinos
1201235|NCT02027636|Mental Health|mental health
1201236|NCT02027636|Disparities|disparities
1201237|NCT02027623|Mechanical low back pain|mechanical low back pain
1201238|NCT02027623|Non-specific low back pain|non-specific low back pain
1201239|NCT02027623|Exercise|exercise
1201240|NCT02027623|Motor skill training|motor skill training
1201241|NCT02027610|Infant|infant
1201242|NCT02027610|Bangladesh|bangladesh
1201243|NCT02027610|vitamin A|vitamin a
1201244|NCT02027610|microbiota|microbiota
1201245|NCT02027610|vaccine|vaccine
1201246|NCT02027610|immunity|immunity
1201247|NCT02027597|video games|video games
1201248|NCT02027597|oral health|oral health
1201249|NCT02027597|social cognitive theory|social cognitive theory
1201250|NCT02027597|behavior change|behavior change
1201251|NCT02027597|randomized trial|randomized trial
1201252|NCT02027597|growth modeling|growth modeling
1201253|NCT02027597|minority|minority
1201254|NCT02027597|gender|gender
1201255|NCT02027584|infant, premature|infant, premature
1201256|NCT02027584|infant, newborn|infant, newborn
1201257|NCT02027584|choline|choline
1201270|NCT02027545|cancer screening|cancer screening
1201272|NCT02027519|Self-testing|self-testing
1201273|NCT02027519|Home-based testing|home-based testing
1201274|NCT02027519|Lesotho|lesotho
1201275|NCT02027519|Discordant|discordant
1201276|NCT02027506|ECG|ecg
1201277|NCT02027506|aVL|avl
1201278|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
1201279|NCT02027506|T WAVE|t wave
1201280|NCT02027493|Children|children
1201281|NCT02027493|Chronic hepatitis C|chronic hepatitis c
1201282|NCT02027493|Hansenula polymorpha|hansenula polymorpha
1201283|NCT02027493|Pegylated interferon|pegylated interferon
1201284|NCT02027493|Response rate|response rate
1201285|NCT02027493|Ribavirin|ribavirin
1201286|NCT02027493|Treatment|treatment
1201287|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
1201288|NCT02027480|Biomarkers|biomarkers
1201289|NCT02027480|Nyanza Province|nyanza province
1201290|NCT02027480|Kenya|kenya
1201291|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
1201292|NCT02027467|Herbal|herbal
1201293|NCT02027467|Dietary|dietary
1201294|NCT02027467|CD cells|cd cells
1201295|NCT02027467|Basic research|basic research
1201296|NCT02027454|GSK1265744|gsk1265744
1201297|NCT02027454|HIV|hiv
1201298|NCT02027454|placebo|placebo
1201299|NCT02027454|cardiac repolarization|cardiac repolarization
1201300|NCT02027454|12-lead ECG|12-lead ecg
1201301|NCT02027454|moxifloxacin|moxifloxacin
1201302|NCT02027454|QTc|qtc
1201303|NCT02027441|Serodiscordant|serodiscordant
1201304|NCT02027441|Lesotho|lesotho
1201305|NCT02027441|Home-based testing|home-based testing
1201319|NCT02027415|air pollution|air pollution
1201320|NCT02027415|food|food
1201321|NCT02027415|nitrites|nitrites
1201322|NCT02027415|nitrates|nitrates
1201323|NCT02027415|breath tests/methods|breath tests/methods
1201324|NCT02027389|MSSA, MRSA|mssa, mrsa
1201325|NCT02027376|Advanced Breast Cancer|advanced breast cancer
1201326|NCT02027376|LDE225|lde225
1201327|NCT02027376|Triple Negative|triple negative
1201328|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
1201329|NCT02027376|Her2 negative|her2 negative
1201330|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
1201331|NCT02027363|Maintenance|maintenance
1201332|NCT02027363|First-line treatment|first-line treatment
1201333|NCT02027363|Capecitabine|capecitabine
1201334|NCT02027337|combined oral contraceptives|combined oral contraceptives
1201335|NCT02027337|drospirenone|drospirenone
1201336|NCT02027337|cyproterone|cyproterone
1201337|NCT02027337|hemostasis|hemostasis
1201338|NCT02027337|antioxidants|antioxidants
1201339|NCT02027324|Surgical site infection|surgical site infection
1201340|NCT02027324|Cesarean delivery|cesarean delivery
1201341|NCT02027324|Antisepsis|antisepsis
1201342|NCT02027324|Povidone iodine|povidone iodine
1201343|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
1201344|NCT02027324|Endometritis|endometritis
1201345|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
1201346|NCT02027311|Conscious Sedation|conscious sedation
1201347|NCT02027311|etomidate|etomidate
1201348|NCT02027311|midazolam|midazolam
1201349|NCT02027298|Abatacept|abatacept
1201350|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
1201351|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
1201352|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
1201353|NCT02027272|Eclampsia|eclampsia
1201354|NCT02027259|Diabetes|diabetes
1201355|NCT02027259|Depression|depression
1201356|NCT02027259|Group|group
1201357|NCT02027246|spinal cord injury|spinal cord injury
1201358|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
1201359|NCT02027246|stem cell therapy|stem cell therapy
1201360|NCT02027233|Prevention|prevention
1201361|NCT02027233|Influenza|influenza
1201362|NCT02027233|Adults hospitalized|adults hospitalized
1201364|NCT02027233|Effectiveness|effectiveness
1201365|NCT02027207|Cholera|cholera
1201366|NCT02027207|Oral cholera vaccine|oral cholera vaccine
1201367|NCT02027207|Shanchol|shanchol
1201368|NCT02027207|Protective efficacy|protective efficacy
1201369|NCT02027207|Bangladesh|bangladesh
1201370|NCT02027194|Allergic Rhinitis|allergic rhinitis
1201371|NCT02027194|Chinese herbal medicine|chinese herbal medicine
1201372|NCT02027194|Adolescents|adolescents
1201373|NCT02027194|Double-blinded|double-blinded
1201374|NCT02027194|Randomized controlled trial|randomized controlled trial
1201375|NCT02027168|infertility|infertility
1201376|NCT02027168|elevated FSH|elevated fsh
1201377|NCT02027168|alternative treatment|alternative treatment
1201378|NCT02027168|Clear Passage Approach|clear passage approach
1201379|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
1201380|NCT02027155|healthy volunteers|healthy volunteers
1201381|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1201382|NCT02027129|Cor Pulmonale|cor pulmonale
1201383|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
1201384|NCT02027116|chronic hepatitis C|chronic hepatitis c
1201385|NCT02027116|DNA Vaccine|dna vaccine
1201386|NCT02027116|Electroporation|electroporation
1201387|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
1201388|NCT02027103|Fetuin-A|fetuin-a
1201389|NCT02027103|OPG|opg
1201390|NCT02027103|Metformin|metformin
1201391|NCT02027103|Pioglitazone|pioglitazone
1201392|NCT02027077|physical activity|physical activity
1201393|NCT02027077|diet|diet
1201394|NCT02027077|small change|small change
1201395|NCT02027077|behavior change|behavior change
1201396|NCT02027051|population genetics|population genetics
1201397|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
1201398|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
1201399|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
1201400|NCT02026934|Graft failure|graft failure
1201401|NCT02026934|Graft exhaustion|graft exhaustion
1201402|NCT02026921|Phase II study,|phase ii study,
1201403|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
1201404|NCT02026921|docetaxel|docetaxel
1201405|NCT02026921|Carboplatin|carboplatin
1201406|NCT02026921|Toxicity|toxicity
1201407|NCT02026908|Prostate Artery Embolization|prostate artery embolization
1201408|NCT02026908|PAE|pae
1201409|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1201410|NCT02026908|BPH|bph
1201411|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1201412|NCT02026908|LUTS|luts
1201413|NCT02026882|Airway, Caesarean|airway, caesarean
1201414|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
1201544|NCT02026102|decision aid|decision aid
1201415|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
1201416|NCT02026830|Diabetic foot infections|diabetic foot infections
1201417|NCT02026830|microorganisms|microorganisms
1201418|NCT02026791|Supraglottic airway device|supraglottic airway device
1201419|NCT02026791|I-gel|i-gel
1201420|NCT02026791|SupremeLMA|supremelma
1201421|NCT02026791|Elderly patient|elderly patient
1201422|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
1201423|NCT02026674|urineflow|urineflow
1201424|NCT02026674|luts|luts
1201425|NCT02026674|urine flow|urine flow
1201426|NCT02026674|uroflometry|uroflometry
1201428|NCT02026635|heart failure|heart failure
1201429|NCT02026635|Optivol® cardiac device|optivol® cardiac device
1201430|NCT02026635|Medtronic CareLink|medtronic carelink
1201431|NCT02026622|major depressive disorder|major depressive disorder
1201432|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
1201433|NCT02026622|emotional reactivity|emotional reactivity
1201434|NCT02026609|TIPS|tips
1201435|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
1201436|NCT02026609|Oral glutamine challenge|oral glutamine challenge
1201437|NCT02026609|Psychometric tests|psychometric tests
1201438|NCT02026609|Portal hypertension|portal hypertension
1201439|NCT02026609|Cirrhosis|cirrhosis
1201440|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
1201441|NCT02026596|secondary brain injury|secondary brain injury
1201442|NCT02026570|Prosthesis|prosthesis
1201443|NCT02026570|Falls|falls
1201444|NCT02026570|Training|training
1201445|NCT02026544|low frequency ultrasound|low frequency ultrasound
1201446|NCT02026544|glomerular filtration rate|glomerular filtration rate
1201447|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1201448|NCT02026492|exercise-induced asthma|exercise-induced asthma
1201449|NCT02026492|cold chamber|cold chamber
1201450|NCT02026492|exercise challenge|exercise challenge
1201451|NCT02026492|cold air challenge|cold air challenge
1201452|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
1201453|NCT02026492|methacholine challenge|methacholine challenge
1201454|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
1201455|NCT02026479|post auricular injection|post auricular injection
1201456|NCT02026479|glucocorticoid|glucocorticoid
1201457|NCT02026479|multi-center|multi-center
1201458|NCT02026466|Coronary Artery Disease|coronary artery disease
1201459|NCT02026466|Chronic Total Occlusion|chronic total occlusion
1201460|NCT02026453|Adverse drug events|adverse drug events
1201461|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
1201462|NCT02026414|PrimaVie|primavie
1201463|NCT02026414|Herbal Supplement|herbal supplement
1201464|NCT02026414|Muscle biopsy|muscle biopsy
1201465|NCT02026414|Energy|energy
1201466|NCT02026414|Exercise|exercise
1201467|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
1201468|NCT02026414|Muscle function|muscle function
1201469|NCT02026388|PH|ph
1201470|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
1201471|NCT02026388|hyperoxaluria|hyperoxaluria
1201472|NCT02026388|primary oxalosis|primary oxalosis
1201473|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
1201474|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
1201475|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
1201476|NCT02026388|Dent|dent
1201477|NCT02026388|Dents|dents
1201478|NCT02026388|Dent Disease|dent disease
1201479|NCT02026388|Dent 1|dent 1
1201480|NCT02026388|Dent 2|dent 2
1201481|NCT02026388|Cystinuria|cystinuria
1201482|NCT02026388|APRT|aprt
1201483|NCT02026388|APRT deficiency|aprt deficiency
1201484|NCT02026388|Biobank|biobank
1201485|NCT02026362|HCC|hcc
1201486|NCT02026362|DC|dc
1201487|NCT02026362|CTL|ctl
1201488|NCT02026349|influenza|influenza
1201489|NCT02026349|flu|flu
1201490|NCT02026349|fever|fever
1201491|NCT02026349|cough|cough
1201492|NCT02026349|body aches|body aches
1201493|NCT02026349|headache|headache
1201494|NCT02026349|nasal congestion|nasal congestion
1201495|NCT02026349|body pains|body pains
1201496|NCT02026349|sore throat|sore throat
1201497|NCT02026349|fatigue|fatigue
1201498|NCT02026349|T-705|t-705
1201499|NCT02026349|favipiravir|favipiravir
1201500|NCT02026349|favor|favor
1201501|NCT02026349|flu symptoms|flu symptoms
1201502|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
1201503|NCT02026310|glimepiride|glimepiride
1201504|NCT02026310|metformin|metformin
1201505|NCT02026310|basal insulin|basal insulin
1201506|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1201507|NCT02026310|glucose fluctuation|glucose fluctuation
1278022|NCT01680744|GFR|gfr
1201508|NCT02026310|hypoglycemia|hypoglycemia
1201509|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
1201510|NCT02026297|estimated blood loss|estimated blood loss
1201511|NCT02026297|coagulation|coagulation
1201512|NCT02026297|thromboelastography|thromboelastography
1201513|NCT02026297|tranexamic acid|tranexamic acid
1201514|NCT02026284|Caesarean section|caesarean section
1201515|NCT02026284|Anaesthesia|anaesthesia
1201516|NCT02026284|Questionnaires|questionnaires
1201517|NCT02026245|Arthritis|arthritis
1201518|NCT02026245|rheumatoid|rheumatoid
1201519|NCT02026245|joints|joints
1201520|NCT02026245|swelling|swelling
1201521|NCT02026245|measurement|measurement
1201522|NCT02026245|movement|movement
1201523|NCT02026245|electronic|electronic
1201524|NCT02026245|data|data
1201525|NCT02026245|glove|glove
1201526|NCT02026245|goniometry|goniometry
1201527|NCT02026245|outcome|outcome
1201528|NCT02026245|stiffness|stiffness
1201529|NCT02026232|Type 2 Diabetes|type 2 diabetes
1201530|NCT02026232|Overweight|overweight
1201531|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
1201532|NCT02026206|Pain|pain
1201533|NCT02026167|Chronic Pain|chronic pain
1201534|NCT02026167|Mood|mood
1201535|NCT02026167|Physical Activity|physical activity
1201536|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
1201537|NCT02026128|Uveitis|uveitis
1201538|NCT02026128|Inflammation|inflammation
1201539|NCT02026128|OCT|oct
1201540|NCT02026128|Grading|grading
1201541|NCT02026115|cancer|cancer
1201542|NCT02026115|hospice|hospice
1201543|NCT02026115|pain|pain
1201545|NCT02026102|patient decision making|patient decision making
1201546|NCT02026102|heart failure|heart failure
1201547|NCT02026102|ejection fraction|ejection fraction
1201548|NCT02026102|primary prevention|primary prevention
1201549|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1201550|NCT02026102|ICD|icd
1201551|NCT02026102|pilot trial|pilot trial
1201552|NCT02026102|patient centered health care|patient centered health care
1201553|NCT02026076|low back pain|low back pain
1201554|NCT02026076|traction|traction
1201555|NCT02026076|unloading|unloading
1201556|NCT02026050|dexamethasone|dexamethasone
1201557|NCT02026050|intraarticular injection|intraarticular injection
1201558|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
1201559|NCT02026037|Stress Disorders|stress disorders
1201560|NCT02026037|Post-Traumatic|post-traumatic
1201561|NCT02026037|Burns|burns
1201562|NCT02026037|Brief Psychotherapy|brief psychotherapy
1201563|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
1201564|NCT02026011|alcohol use disorder|alcohol use disorder
1201565|NCT02026011|naltrexone|naltrexone
1201566|NCT02026011|Asian American|asian american
1201567|NCT02026011|pharmacogenetics|pharmacogenetics
1201568|NCT02026011|OPRM1 gene|oprm1 gene
1201569|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
1201570|NCT02025985|Karyopharm|karyopharm
1201571|NCT02025985|KPT-330|kpt-330
1201572|NCT02025985|Selinexor|selinexor
1201573|NCT02025985|SIGN|sign
1201574|NCT02025985|ovarian cancer|ovarian cancer
1201575|NCT02025985|endometrial cancer|endometrial cancer
1201576|NCT02025985|cervical cancer|cervical cancer
1201577|NCT02025985|SINE™|sine™
1201578|NCT02025985|breast cancer|breast cancer
1201579|NCT02025985|HER2 negative|her2 negative
1201580|NCT02025972|Cerebral palsy|cerebral palsy
1201581|NCT02025972|Umbilical cord blood|umbilical cord blood
1201582|NCT02025972|Rehabilitation|rehabilitation
1201583|NCT02025972|Cytokine|cytokine
1201584|NCT02025972|Outcome|outcome
1201585|NCT02025959|staff empowerment|staff empowerment
1201586|NCT02025959|Sleep Apnea|sleep apnea
1201587|NCT02025959|educational intervention|educational intervention
1201588|NCT02025933|Children|children
1201589|NCT02025933|Age 9-12 years|age 9-12 years
1201590|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
1201591|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1201592|NCT02025907|Canagliflozin|canagliflozin
1201593|NCT02025907|Hemoglobin A1c|hemoglobin a1c
1201594|NCT02025907|Metformin|metformin
1201595|NCT02025907|Sitagliptin|sitagliptin
1201596|NCT02025907|T2DM|t2dm
1201597|NCT02025907|JNJ-28431754|jnj-28431754
1201598|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
1201599|NCT02025894|PCVC|pcvc
1201600|NCT02025894|thromboembolic complications|thromboembolic complications
1201601|NCT02025894|infectious complications|infectious complications
1201602|NCT02025894|risk factors|risk factors
1201603|NCT02025868|Africa|africa
1201604|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
1201605|NCT02025868|Adherence reinforcement|adherence reinforcement
1201606|NCT02025868|Third line ART|third line art
1201607|NCT02025868|Second line ART|second line art
1201608|NCT02025868|Virologic failure|virologic failure
1201609|NCT02025868|Adults|adults
1201610|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
1201611|NCT02025855|Methadone|methadone
1201612|NCT02025855|Mechanical ventilation|mechanical ventilation
1201613|NCT02025855|ICU delirium|icu delirium
1201614|NCT02025855|Continuous sedation|continuous sedation
1201615|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
1201616|NCT02025842|Hepatitis B|hepatitis b
1201617|NCT02025829|cystic fibrosis|cystic fibrosis
1201618|NCT02025829|IL-17 neutrophils|il-17 neutrophils
1201619|NCT02025803|Advanced solid tumors|advanced solid tumors
1201620|NCT02025790|Achalasia|achalasia
1201621|NCT02025790|POEM|poem
1201622|NCT02025790|Pneumatic dilatation|pneumatic dilatation
1201623|NCT02025790|Eckardt score|eckardt score
1201624|NCT02025777|Ulcerative Colitis|ulcerative colitis
1201625|NCT02025777|PillCam|pillcam
1201626|NCT02025777|IBD|ibd
1201627|NCT02025751|Diabetes|diabetes
1201628|NCT02025751|Gastroparesis|gastroparesis
1201629|NCT02025751|Delayed gastric emptying|delayed gastric emptying
1201630|NCT02025751|Nausea|nausea
1201631|NCT02025751|Vomiting|vomiting
1201632|NCT02025751|Bloating|bloating
1201633|NCT02025751|Abdominal pain|abdominal pain
1201634|NCT02025751|Early Satiety|early satiety
1201635|NCT02025751|Gastric stasis|gastric stasis
1201636|NCT02025751|Gastropathy|gastropathy
1201637|NCT02025725|Gastroparesis|gastroparesis
1201638|NCT02025725|Diabetic|diabetic
1201639|NCT02025725|Delayed gastric emptying|delayed gastric emptying
1201640|NCT02025725|Gastric stasis|gastric stasis
1201641|NCT02025725|Nausea|nausea
1201642|NCT02025725|Vomiting|vomiting
1201643|NCT02025725|Bloating|bloating
1201644|NCT02025725|Abdominal pain|abdominal pain
1201645|NCT02025725|Early satiety|early satiety
1201646|NCT02025725|Gastropathy|gastropathy
1201647|NCT02025686|Pain|pain
1201648|NCT02025686|Inflammation|inflammation
1201649|NCT02025686|Hyperalgesia|hyperalgesia
1201650|NCT02025686|burn injury|burn injury
1201651|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
1201652|NCT02025660|Mw|mw
1201653|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
1201654|NCT02025660|Mycobacterium w|mycobacterium w
1201655|NCT02025660|Severe sepsis|severe sepsis
1201656|NCT02025660|Septic shock|septic shock
1201657|NCT02025647|Mood disorders|mood disorders
1201658|NCT02025647|Anxiety disorders|anxiety disorders
1201659|NCT02025647|Eating concerns|eating concerns
1201660|NCT02025647|Pain concerns|pain concerns
1201661|NCT02025647|Alcohol abuse|alcohol abuse
1201662|NCT02025647|Self harm|self harm
1201663|NCT02025647|Mental health|mental health
1201664|NCT02025647|Clinical Decision Support|clinical decision support
1201665|NCT02025634|Pain, Postoperative|pain, postoperative
1201666|NCT02025634|Ofirmev|ofirmev
1201667|NCT02025634|Acetaminophen|acetaminophen
1201668|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
1201669|NCT02025634|Arthroscopy|arthroscopy
1201862|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
1201670|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
1201671|NCT02025621|CABG|cabg
1201672|NCT02025621|mitral valve|mitral valve
1201673|NCT02025621|LCOS|lcos
1201674|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
1201675|NCT02025621|levosimendan|levosimendan
1201676|NCT02025608|Restless legs syndrome|restless legs syndrome
1201677|NCT02025595|Brain|brain
1201678|NCT02025595|Genes|genes
1201679|NCT02025595|Environment|environment
1201680|NCT02025595|Etiology|etiology
1201681|NCT02025595|Reward|reward
1201682|NCT02025595|Satiety Response|satiety response
1201683|NCT02025595|Central Nervous System|central nervous system
1201684|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
1201685|NCT02025595|Twins, Monozygotic|twins, monozygotic
1201686|NCT02025595|Overweight|overweight
1201687|NCT02025595|Obesity|obesity
1201688|NCT02025582|idiopathic toe walking|idiopathic toe walking
1201689|NCT02025582|gait disorder|gait disorder
1201690|NCT02025582|gait analysis|gait analysis
1201691|NCT02025582|kinesio taping|kinesio taping
1201692|NCT02025582|ultrasound elastography|ultrasound elastography
1201693|NCT02025582|pediatric|pediatric
1201694|NCT02025582|children|children
1201695|NCT02025582|muscle stiffness|muscle stiffness
1201696|NCT02025582|muscle elasticity|muscle elasticity
1201697|NCT02025569|chronic ankle instability|chronic ankle instability
1201698|NCT02025569|lateral ankle sprain|lateral ankle sprain
1201699|NCT02025569|manual therapy|manual therapy
1201700|NCT02025569|star excursion balance test|star excursion balance test
1201701|NCT02025569|strain and counterstrain|strain and counterstrain
1201702|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
1201703|NCT02025556|Episodic Migraine Headache|episodic migraine headache
1201704|NCT02025556|Migraine Headache|migraine headache
1201705|NCT02025543|MRI|mri
1201706|NCT02025543|Iron overload|iron overload
1201707|NCT02025530|Stillbirth|stillbirth
1201708|NCT02025530|Modifiable risk factors|modifiable risk factors
1201709|NCT02025517|Parkinson's disease|parkinson's disease
1201710|NCT02025517|rehabilitation|rehabilitation
1201711|NCT02025517|kinematics|kinematics
1201712|NCT02025517|cognition|cognition
1333149|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
1578022|NCT00471744|children|children
1201713|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
1201714|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
1201715|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
1201716|NCT02025491|Leishmania braziliensis|leishmania braziliensis
1201717|NCT02025478|children|children
1201718|NCT02025478|bone marrow transplant|bone marrow transplant
1201719|NCT02025478|autologous|autologous
1201720|NCT02025478|allogeneic|allogeneic
1201721|NCT02025478|breastmilk|breastmilk
1201722|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1201723|NCT02025465|Atrial Fibrillation|atrial fibrillation
1201724|NCT02025465|Atrial Flutter|atrial flutter
1201725|NCT02025465|Metoprolol|metoprolol
1201726|NCT02025465|Diltiazem|diltiazem
1201727|NCT02025452|diarrhoea|diarrhoea
1201728|NCT02025452|gastroenteritis|gastroenteritis
1201729|NCT02025452|rapid diagnostics|rapid diagnostics
1201730|NCT02025452|probiotics|probiotics
1201731|NCT02025452|sub-Saharan Africa|sub-saharan africa
1201732|NCT02025439|Traumatic Brain Injury|traumatic brain injury
1201733|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1201734|NCT02025439|Amantadine|amantadine
1201735|NCT02025439|Vegetative State|vegetative state
1201736|NCT02025439|Minimally Conscious State|minimally conscious state
1201737|NCT02025426|Cesarean delivery|cesarean delivery
1201738|NCT02025426|Spinal Anesthesia|spinal anesthesia
1201739|NCT02025400|Rehabilitation|rehabilitation
1201740|NCT02025400|eRehab|erehab
1201741|NCT02025400|Physical Therapy|physical therapy
1201742|NCT02025400|e-Health|e-health
1201743|NCT02025400|Telemedicine|telemedicine
1201744|NCT02025400|Telerehabilitation|telerehabilitation
1201745|NCT02025400|Patient-Centered|patient-centered
1201746|NCT02025374|spinal anesthesia|spinal anesthesia
1201747|NCT02025374|cesarean section|cesarean section
1201748|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
1201749|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
1201750|NCT02025322|HIV/AIDS|hiv/aids
1201751|NCT02025322|Peer Mentoring|peer mentoring
1201752|NCT02025322|Medication Adherence|medication adherence
1201753|NCT02025322|Medication Non-adherent|medication non-adherent
1201754|NCT02025322|Newly diagnosed|newly diagnosed
1201755|NCT02025322|HIV-positive individuals|hiv-positive individuals
1201756|NCT02025322|HIV viral load|hiv viral load
1201757|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
1201758|NCT02025322|Treatment adherence|treatment adherence
1201759|NCT02025322|Health literacy|health literacy
1201760|NCT02025322|Self-efficacy|self-efficacy
1201761|NCT02025309|train of four|train of four
1201762|NCT02025309|neuromuscular recovery|neuromuscular recovery
1201763|NCT02025309|sugammadex|sugammadex
1201764|NCT02025296|Telemedicine|telemedicine
1201765|NCT02025296|Clinical decision support system|clinical decision support system
1201766|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
1201767|NCT02025296|Diabetes Care|diabetes care
1202272|NCT02022930|Knee|knee
1201768|NCT02025296|Multifactorial Intervention|multifactorial intervention
1201769|NCT02025283|Intervertebral disc disease|intervertebral disc disease
1201770|NCT02025283|Radiculopathy|radiculopathy
1201771|NCT02025283|Chronic pain|chronic pain
1201772|NCT02025283|Thermocoagulation|thermocoagulation
1201773|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
1201774|NCT02025257|coronary artery disease|coronary artery disease
1201775|NCT02025257|elderly|elderly
1201776|NCT02025257|exercise|exercise
1201777|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
1201778|NCT02025244|Key hole biopsy|key hole biopsy
1201779|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
1201780|NCT02025244|EUS-FNA|eus-fna
1201781|NCT02025244|Mitototic Activity|mitototic activity
1201782|NCT02025244|GIST|gist
1201783|NCT02025231|reirradiation|reirradiation
1201784|NCT02025231|recurrent glioma|recurrent glioma
1201785|NCT02025231|positron emission tomography|positron emission tomography
1201786|NCT02025231|amino acid tracer|amino acid tracer
1201787|NCT02025218|NSCLC|nsclc
1201788|NCT02025218|EGFR|egfr
1201789|NCT02025218|TKI|tki
1201790|NCT02025218|Re-challenge|re-challenge
1201791|NCT02025218|Lung Cancer|lung cancer
1201792|NCT02025218|Resistance|resistance
1201793|NCT02025192|ONT-380|ont-380
1201794|NCT02025192|Capecitabine|capecitabine
1201795|NCT02025192|Trastuzumab|trastuzumab
1201796|NCT02025192|Xeloda|xeloda
1201797|NCT02025192|Herceptin|herceptin
1202049|NCT02024113|metabolic profile|metabolic profile
1201798|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
1201799|NCT02025192|Breast cancer|breast cancer
1201800|NCT02025192|ARRY-380|arry-380
1201801|NCT02025192|Tucatinib|tucatinib
1201802|NCT02025179|Teriparatide|teriparatide
1201803|NCT02025179|Osteoporosis|osteoporosis
1201804|NCT02025179|Spinal Cord Injury|spinal cord injury
1201805|NCT02025179|Bone Diseases|bone diseases
1201806|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
1201807|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
1201808|NCT02025179|Spinal Cord Diseases|spinal cord diseases
1201809|NCT02025179|Central Nervous System Diseases|central nervous system diseases
1201810|NCT02025179|Nervous System Diseases|nervous system diseases
1201811|NCT02025179|Nervous System|nervous system
1201812|NCT02025179|Wounds and Injuries|wounds and injuries
1201813|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
1201814|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
1201815|NCT02025179|Pharmacologic Actions|pharmacologic actions
1201816|NCT02025179|Vibration|vibration
1201817|NCT02025166|Pain|pain
1201818|NCT02025166|abortion|abortion
1201819|NCT02025166|paracetamol|paracetamol
1201820|NCT02025166|lornoxicam|lornoxicam
1201821|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
1201822|NCT02025140|pain perception|pain perception
1201823|NCT02025140|Effectiveness|effectiveness
1201824|NCT02025140|primary molars|primary molars
1201825|NCT02025140|Behavior|behavior
1201826|NCT02025127|septic shock|septic shock
1201827|NCT02025127|mechanical ventilation|mechanical ventilation
1201828|NCT02025127|enteral nutrition|enteral nutrition
1201829|NCT02025127|trophic feeding|trophic feeding
1201830|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
1201831|NCT02025101|Slow Coronary Flow|slow coronary flow
1201832|NCT02025075|Tomography|tomography
1201833|NCT02025075|Oximetry|oximetry
1201834|NCT02025075|Echocardiography|echocardiography
1201835|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
1201836|NCT02025062|elderly|elderly
1201837|NCT02025062|cancer|cancer
1201838|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
1201839|NCT02025062|functional status|functional status
1201840|NCT02025062|malnutrition|malnutrition
1201841|NCT02025062|survival|survival
1201842|NCT02025049|pancreatitis|pancreatitis
1201843|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
1201844|NCT02025023|Size|size
1201845|NCT02025023|Pain|pain
1201846|NCT02025023|Resolution|resolution
1201847|NCT02025023|Complications|complications
1201848|NCT02025023|Swelling|swelling
1201849|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
1201850|NCT02024997|Pancreatic malignancy|pancreatic malignancy
1201851|NCT02024997|Radiation Therapy|radiation therapy
1201852|NCT02024984|LPFPCCPCOS|lpfpccpcos
1201853|NCT02024971|Drug therapy|drug therapy
1201854|NCT02024958|Adult ICU patients|adult icu patients
1201855|NCT02024958|spontaneous breathing|spontaneous breathing
1201856|NCT02024958|invasive ventilation|invasive ventilation
1201857|NCT02024958|non-invasive ventilation|non-invasive ventilation
1201858|NCT02024945|Drug therapy|drug therapy
1201859|NCT02024906|isoflavone|isoflavone
1201860|NCT02024906|CVD|cvd
1201861|NCT02024906|soy intake|soy intake
1201863|NCT02024893|Humeral retroversion|humeral retroversion
1201864|NCT02024893|dynamic control ratio|dynamic control ratio
1201865|NCT02024893|GIRD|gird
1201866|NCT02024880|in vitro fertilization|in vitro fertilization
1201867|NCT02024880|embryo transfer|embryo transfer
1201868|NCT02024880|transfer catheter|transfer catheter
1201869|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
1201870|NCT02024867|Staphylococcus aureus|staphylococcus aureus
1201871|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
1201872|NCT02024854|Stress, Physiological|stress, physiological
1201873|NCT02024841|Gastric cancer|gastric cancer
1201874|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
1201875|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
1201876|NCT02024841|Cisplatin|cisplatin
1201877|NCT02024841|TS-ONE|ts-one
1201878|NCT02024828|Infant feeding|infant feeding
1201879|NCT02024802|Pain|pain
1201880|NCT02024802|Pain Cream|pain cream
1201881|NCT02024802|Nociceptive pain|nociceptive pain
1201882|NCT02024802|neurologic pain|neurologic pain
1201883|NCT02024802|transdermal|transdermal
1201884|NCT02024802|compounding|compounding
1201885|NCT02024802|compound|compound
1201886|NCT02024776|Training|training
1201887|NCT02024776|Wellness|wellness
1201888|NCT02024776|Aerobic capacity|aerobic capacity
1201889|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
1201890|NCT02024776|Abdominal surgery|abdominal surgery
1201891|NCT02024763|Energy Expenditure|energy expenditure
1201892|NCT02024763|Physical Education|physical education
1201893|NCT02024763|Children|children
1201894|NCT02024763|Randomized Controlled Trial|randomized controlled trial
1201895|NCT02024750|Family centered care|family centered care
1201896|NCT02024750|Patient centered care|patient centered care
1201897|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1201898|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
1201899|NCT02024711|Cataract|cataract
1578207|NCT00471289|Paclitaxel|paclitaxel
1201900|NCT02024711|Intraocular Lens|intraocular lens
1201901|NCT02024711|IOL|iol
1201902|NCT02024711|Aphakia|aphakia
1201903|NCT02024685|Prostate|prostate
1201904|NCT02024685|Localized Prostate Cancer|localized prostate cancer
1201905|NCT02024685|Decision making|decision making
1201906|NCT02024672|Intrauterine devices|intrauterine devices
1201907|NCT02024672|IUDs|iuds
1201908|NCT02024672|postpartum|postpartum
1201909|NCT02024672|contraception|contraception
1201910|NCT02024659|nasal polyps|nasal polyps
1201911|NCT02024659|remodeling|remodeling
1201912|NCT02024659|inflammatory cells|inflammatory cells
1201913|NCT02024659|budesonide|budesonide
1201914|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
1201915|NCT02024646|Brodalumab|brodalumab
1201916|NCT02024646|AMG 827|amg 827
1201917|NCT02024620|depression|depression
1201918|NCT02024620|technology|technology
1201919|NCT02024620|psychotherapy|psychotherapy
1201920|NCT02024620|behavioral activation|behavioral activation
1201921|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
1202175|NCT02023398|High Frequency|high frequency
1201922|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
1201923|NCT02024594|Children, Preschool|children, preschool
1201924|NCT02024594|dental anxiety|dental anxiety
1201925|NCT02024594|Patient Cooperation|patient cooperation
1201926|NCT02024581|pediatric|pediatric
1201927|NCT02024581|dermatology|dermatology
1201928|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
1201929|NCT02024581|pox virus|pox virus
1201930|NCT02024568|Pregabalin|pregabalin
1201931|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
1201932|NCT02024568|Paclitaxel|paclitaxel
1201933|NCT02024568|Pain management|pain management
1201934|NCT02024568|Breast cancer|breast cancer
1201935|NCT02024542|Bariatric Surgery|bariatric surgery
1201937|NCT02024542|Metabolic syndrome|metabolic syndrome
1201938|NCT02024542|Diabetes|diabetes
1201939|NCT02024516|Type 2 diabetes|type 2 diabetes
1201940|NCT02024516|Pomegranate|pomegranate
1201941|NCT02024516|Inflammation|inflammation
1201942|NCT02024516|lipid profiles|lipid profiles
1201943|NCT02024503|stroke|stroke
1201944|NCT02024503|fMRI|fmri
1201945|NCT02024503|DTI|dti
1201946|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
1201947|NCT02024477|endothelial cells|endothelial cells
1201948|NCT02024477|cellular biomarker|cellular biomarker
1201949|NCT02024477|endothelial dysfunction|endothelial dysfunction
1201950|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
1201951|NCT02024464|POAG|poag
1201952|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
1201953|NCT02024464|PXG|pxg
1201954|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
1201955|NCT02024464|PDG|pdg
1201956|NCT02024464|Hydrus|hydrus
1201957|NCT02024451|Radial shock wave|radial shock wave
1201958|NCT02024451|Acupuncture|acupuncture
1201959|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
1201960|NCT02024438|neurotoxicity|neurotoxicity
1201961|NCT02024438|mFOLFOX6|mfolfox6
1202363|NCT02022527|Aspirin,|aspirin,
1201962|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
1201963|NCT02024425|Clinical trials|clinical trials
1201964|NCT02024425|Adult|adult
1201965|NCT02024425|Women|women
1201966|NCT02024425|Functional food|functional food
1201967|NCT02024425|Dietary Supplements|dietary supplements
1201968|NCT02024425|Overweight|overweight
1201969|NCT02024425|Obese|obese
1201970|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
1201971|NCT02024425|Rosmarinus|rosmarinus
1201972|NCT02024425|Oligosaccharides|oligosaccharides
1201973|NCT02024425|Lactulose|lactulose
1201974|NCT02024425|Bioactive peptide|bioactive peptide
1201975|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
1201976|NCT02024412|neurotoxicity|neurotoxicity
1201977|NCT02024412|mFOLFOX6|mfolfox6
1201978|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
1201979|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
1201980|NCT02024386|Guanylate Cyclase|guanylate cyclase
1201981|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
1201982|NCT02024386|Mountaineering|mountaineering
1201983|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
1201984|NCT02024386|Athletic Performance|athletic performance
1201985|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
1201986|NCT02024373|Atorvastatin|atorvastatin
1201987|NCT02024373|oral administration therapy|oral administration therapy
1201988|NCT02024360|obesity|obesity
1201989|NCT02024360|overweight|overweight
1201990|NCT02024360|children|children
1201991|NCT02024360|prevention|prevention
1201992|NCT02024334|JIA|jia
1201993|NCT02024334|LEFLUNOMIDE|leflunomide
1201994|NCT02024334|EFFICACY|efficacy
1201995|NCT02024321|abdominal surgery|abdominal surgery
1201996|NCT02024321|TPN|tpn
1201997|NCT02024321|blood glucose|blood glucose
1201998|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
1201999|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
1202000|NCT02024308|Fludarabine,|fludarabine,
1202001|NCT02024308|recurrence|recurrence
1202002|NCT02024269|macular degeneration|macular degeneration
1202003|NCT02024269|stem cells|stem cells
1202004|NCT02024269|adipose stem cells|adipose stem cells
1202005|NCT02024256|Vaginal delivery|vaginal delivery
1202006|NCT02024256|Perineal swelling|perineal swelling
1202007|NCT02024256|Perineal pain|perineal pain
1202008|NCT02024256|MgSo4|mgso4
1202009|NCT02024256|Magnesium sulfate|magnesium sulfate
1202010|NCT02024256|Cold water|cold water
1202011|NCT02024243|Micro RNA|micro rna
1202012|NCT02024243|Wound|wound
1202013|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
1202014|NCT02024243|VLU|vlu
1202015|NCT02024243|miR210|mir210
1202016|NCT02024243|OSU Comprehensive Wound Center|osu comprehensive wound center
1202017|NCT02024204|World Trade Center Disaster|world trade center disaster
1202018|NCT02024204|Environmental Exposure|environmental exposure
1202019|NCT02024204|Respiratory Physiology|respiratory physiology
1202020|NCT02024204|Inflammation|inflammation
1202021|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
1202022|NCT02024204|Sinus Symptoms|sinus symptoms
1202023|NCT02024204|PTSD|ptsd
1202024|NCT02024204|Anxiety|anxiety
1202025|NCT02024204|Depression|depression
1202026|NCT02024204|Hypersensitivity|hypersensitivity
1202027|NCT02024204|Spirometry|spirometry
1202028|NCT02024204|Oscillometry|oscillometry
1202029|NCT02024191|glutamine|glutamine
1202030|NCT02024191|oxaliplatin|oxaliplatin
1202031|NCT02024191|peripheral neuropathy|peripheral neuropathy
1202032|NCT02024178|Prostate Cancer|prostate cancer
1202033|NCT02024178|Radical Prostatectomy|radical prostatectomy
1202034|NCT02024178|Ultrasound Imaging|ultrasound imaging
1202035|NCT02024165|Ultrasound|ultrasound
1202036|NCT02024165|FSE|fse
1202037|NCT02024165|IUPC|iupc
1202038|NCT02024139|Orthodontic pain|orthodontic pain
1202039|NCT02024139|Chewing gum|chewing gum
1202040|NCT02024126|Knee osteoarthritis|knee osteoarthritis
1202041|NCT02024126|Exercise therapy|exercise therapy
1202042|NCT02024126|RCT|rct
1202043|NCT02024126|Intervention|intervention
1202044|NCT02024126|Knee pain|knee pain
1202045|NCT02024126|Muticenter|muticenter
1202046|NCT02024126|Knee function|knee function
1202047|NCT02024113|validation|validation
1202048|NCT02024113|model|model
1202050|NCT02024113|positron emission tomography|positron emission tomography
1202051|NCT02024061|Adolescents|adolescents
1202052|NCT02024061|Obesity|obesity
1202053|NCT02024061|Physical activity|physical activity
1202054|NCT02024061|Sedentary behavior|sedentary behavior
1202055|NCT02024061|Psychosocial health|psychosocial health
1202056|NCT02024048|Pregnancy|pregnancy
1202057|NCT02024048|OCT|oct
1202058|NCT02024048|Enhanced depth imaging|enhanced depth imaging
1202059|NCT02024048|Choroid|choroid
1202060|NCT02024035|Tomotherapy|tomotherapy
1202061|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
1202062|NCT02024035|Health economic evaluation|health economic evaluation
1202063|NCT02024022|colonoscopy|colonoscopy
1202064|NCT02024022|bowel cleansing|bowel cleansing
1202065|NCT02024022|polyethylene glycol|polyethylene glycol
1202066|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
1202067|NCT02024009|chemoradiotherapy|chemoradiotherapy
1202068|NCT02024009|nelfinavir|nelfinavir
1202069|NCT02024009|abraxane|abraxane
1202071|NCT02024009|radiotherapy|radiotherapy
1202072|NCT02024009|capecitabine|capecitabine
1202073|NCT02023996|HER2 positive|her2 positive
1202074|NCT02023996|PET Imaging|pet imaging
1202075|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
1202076|NCT02023996|13-165|13-165
1202077|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1202078|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1202079|NCT02023983|Low risk|low risk
1202080|NCT02023983|Early discharge|early discharge
1202081|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
1202082|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
1202083|NCT02023957|Primary Care|primary care
1202084|NCT02023957|Randomized|randomized
1202085|NCT02023957|Open Label|open label
1202086|NCT02023957|Efficacy Study|efficacy study
1202087|NCT02023944|Memory|memory
1202088|NCT02023944|Aging|aging
1202089|NCT02023944|Healthy People|healthy people
1202090|NCT02023944|Intervention|intervention
1202091|NCT02023931|Oral mucosa|oral mucosa
1202092|NCT02023931|Nrf2 pathway|nrf2 pathway
1202093|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
1202094|NCT02023931|Head and Neck Cancer|head and neck cancer
1202095|NCT02023918|Growth hormone antagonism|growth hormone antagonism
1202096|NCT02023866|Leigh Syndrome|leigh syndrome
1202097|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
1202098|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
1202099|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
1202100|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
1578208|NCT00471289|TAXUS|taxus
1202101|NCT02023866|POLG-related disorders|polg-related disorders
1202102|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
1202103|NCT02023840|periodontitis|periodontitis
1202104|NCT02023840|pockets|pockets
1202105|NCT02023827|Transtheoretical Model|transtheoretical model
1202106|NCT02023827|Stages of change|stages of change
1202107|NCT02023827|Computer-tailored intervention|computer-tailored intervention
1202108|NCT02023827|Delinquency|delinquency
1202109|NCT02023827|Substance abuse|substance abuse
1202110|NCT02023827|Juvenile offender|juvenile offender
1202111|NCT02023827|Juvenile justice|juvenile justice
1202112|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
1202113|NCT02023801|Menorrhagia|menorrhagia
1202114|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
1202115|NCT02023801|Endometrial Ablation|endometrial ablation
1202116|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
1202117|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1202118|NCT02023788|respiratory tract infection|respiratory tract infection
1202119|NCT02023788|Premature infants|premature infants
1202120|NCT02023762|mitral regurgitation|mitral regurgitation
1202121|NCT02023762|local anaesthesia|local anaesthesia
1202122|NCT02023762|percutaneous repair|percutaneous repair
1202123|NCT02023749|nuts|nuts
1202124|NCT02023749|metabolic syndrome|metabolic syndrome
1202125|NCT02023749|lipid profile|lipid profile
1202126|NCT02023749|inflammation|inflammation
1202127|NCT02023749|oxidative stress|oxidative stress
1202128|NCT02023749|endothelial function|endothelial function
1202129|NCT02023723|Energy Drink|energy drink
1202130|NCT02023723|Electrocardiograph|electrocardiograph
1202131|NCT02023723|Hemodynamic|hemodynamic
1202132|NCT02023710|mucosal melanoma|mucosal melanoma
1202133|NCT02023710|Bevacizumab|bevacizumab
1202134|NCT02023710|Carboplatin|carboplatin
1202135|NCT02023710|Paclitaxel|paclitaxel
1202136|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
1202137|NCT02023684|Lidocaine|lidocaine
1202138|NCT02023684|ropivacaine|ropivacaine
1202139|NCT02023658|HIV|hiv
1202140|NCT02023658|pMTCT|pmtct
1202141|NCT02023645|lutein|lutein
1202142|NCT02023645|cognition|cognition
1202143|NCT02023645|neural efficiency|neural efficiency
1202144|NCT02023645|aging|aging
1202145|NCT02023632|older adults|older adults
1202146|NCT02023632|physical activity|physical activity
1202147|NCT02023632|self-categorization|self-categorization
1202148|NCT02023632|group dynamics|group dynamics
1202149|NCT02023632|self-identity|self-identity
1202150|NCT02023619|Keratoconus|keratoconus
1202151|NCT02023619|Astigmatism|astigmatism
1202152|NCT02023619|Cornea|cornea
1202153|NCT02023619|SD-OCT|sd-oct
1202154|NCT02023606|Impulsive Aggression|impulsive aggression
1202155|NCT02023606|ADHD|adhd
1202156|NCT02023580|Viral suppression|viral suppression
1202157|NCT02023580|Sexual risk|sexual risk
1202158|NCT02023554|azithromycin|azithromycin
1202159|NCT02023554|theophylline|theophylline
1202160|NCT02023554|CYP3A4|cyp3a4
1202161|NCT02023515|weight loss|weight loss
1202162|NCT02023515|metabolic syndrome|metabolic syndrome
1202163|NCT02023515|stress|stress
1202164|NCT02023515|obesity|obesity
1202165|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
1202166|NCT02023502|proteomics|proteomics
1202167|NCT02023502|biomarker|biomarker
1202168|NCT02023424|BDNF|bdnf
1202169|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
1202170|NCT02023424|RETT SYNDROME|rett syndrome
1202171|NCT02023424|COPAXONE|copaxone
1202172|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
1202173|NCT02023411|Teriparatide|teriparatide
1202174|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
1202176|NCT02023398|Waist circumferential reduction|waist circumferential reduction
1202177|NCT02023385|Low Level Laser Therapy|low level laser therapy
1202178|NCT02023385|LLLT|lllt
1202179|NCT02023385|Waist circumferential reduction|waist circumferential reduction
1202180|NCT02023372|NuCel|nucel
1202181|NCT02023372|Lumbar Spine|lumbar spine
1202182|NCT02023372|Degenerative Disease|degenerative disease
1202183|NCT02023372|Efficacy|efficacy
1202184|NCT02023372|Fusion|fusion
1202185|NCT02023359|Advanced breast cancer|advanced breast cancer
1202186|NCT02023359|Everolimus|everolimus
1202187|NCT02023346|Patient-Physician Communication|patient-physician communication
1202188|NCT02023346|Brain cancer|brain cancer
1202189|NCT02023346|13-253|13-253
1202190|NCT02023333|Regorafenib|regorafenib
1202191|NCT02023333|Performance Status|performance status
1202192|NCT02023333|13-211|13-211
1202193|NCT02023281|Depression|depression
1202194|NCT02023281|Exercise|exercise
1202195|NCT02023281|Neurotransmitters|neurotransmitters
1202196|NCT02023281|Catecholimines|catecholimines
1202197|NCT02023281|EEG|eeg
1202198|NCT02023255|Healthy|healthy
1202199|NCT02023255|JNJ-39393406|jnj-39393406
1202200|NCT02023255|Safety|safety
1202201|NCT02023255|Tolerability|tolerability
1202202|NCT02023255|Pharmacokinetics|pharmacokinetics
1202203|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
1278803|NCT01677221|acne|acne
1202204|NCT02023242|POAG|poag
1202205|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
1202206|NCT02023242|PXG|pxg
1202207|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
1202208|NCT02023242|PG|pg
1202209|NCT02023242|Hydrus|hydrus
1202210|NCT02023229|Branched chain aminoacids|branched chain aminoacids
1202211|NCT02023229|Nutritional status|nutritional status
1202212|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
1202213|NCT02023216|Preterm infants|preterm infants
1202214|NCT02023216|Non-nutritive sucking|non-nutritive sucking
1202215|NCT02023216|Pacifier|pacifier
1202216|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
1202217|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
1202218|NCT02023216|Apneas|apneas
1202219|NCT02023216|Bradycardias|bradycardias
1202220|NCT02023216|Hypoxic episodes|hypoxic episodes
1202221|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
1202222|NCT02023190|liver cirrhosis|liver cirrhosis
1202223|NCT02023190|liver transplant|liver transplant
1202224|NCT02023190|nutritional status|nutritional status
1202225|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
1202226|NCT02023177|phase angle|phase angle
1202227|NCT02023177|liver cirrhosis|liver cirrhosis
1202228|NCT02023177|mortality|mortality
1202229|NCT02023177|malnutrition|malnutrition
1202230|NCT02023138|Clinical practice guideline|clinical practice guideline
1202231|NCT02023138|Brain injury|brain injury
1202232|NCT02023138|Acceptability|acceptability
1202233|NCT02023138|Feasibility|feasibility
1202234|NCT02023138|Effectiveness|effectiveness
1202235|NCT02023112|Japanese|japanese
1202236|NCT02023112|Hepatitis C|hepatitis c
1202237|NCT02023112|Treatment naive|treatment naive
1202238|NCT02023112|Treatment experienced|treatment experienced
1202239|NCT02023112|Genotype 2|genotype 2
1202240|NCT02023112|Ombitasvir|ombitasvir
1202241|NCT02023112|Paritaprevir|paritaprevir
1202242|NCT02023112|Ritonavir|ritonavir
1202243|NCT02023112|Ribavirin|ribavirin
1202244|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
1202245|NCT02023099|Hepatitis C|hepatitis c
1202246|NCT02023099|Genotype 1b|genotype 1b
1202247|NCT02023099|Cirrhotic|cirrhotic
1202248|NCT02023099|Treatment Experienced|treatment experienced
1202249|NCT02023099|Treatment Naive|treatment naive
1202250|NCT02023099|Japanese|japanese
1202251|NCT02023099|ombitasvir|ombitasvir
1202252|NCT02023099|paritaprevir|paritaprevir
1202253|NCT02023099|ritonavir|ritonavir
1202254|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
1202255|NCT02023086|Visual field defect|visual field defect
1202256|NCT02023086|Blood oxygenation|blood oxygenation
1202257|NCT02023086|Optic nerve Head|optic nerve head
1202258|NCT02023047|Anal Fissure|anal fissure
1202259|NCT02023047|Nifedipine|nifedipine
1202260|NCT02023034|Parkinson's disease, Physical Therapy, Fatigue, Quality of Life|parkinson's disease, physical therapy, fatigue, quality of life
1202261|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
1202262|NCT02022995|EGFR|egfr
1202263|NCT02022995|cetuximab|cetuximab
1202264|NCT02022995|colon cancer|colon cancer
1202265|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
1202266|NCT02022982|Solid Tumors|solid tumors
1202267|NCT02022969|atelectasis|atelectasis
1202268|NCT02022969|SPO2 - oscillations|spo2 - oscillations
1202269|NCT02022943|Alzheimer's|alzheimer's
1202270|NCT02022943|prevention|prevention
1202271|NCT02022930|Osteoarthritis|osteoarthritis
1202273|NCT02022917|ovarian cancer.|ovarian cancer.
1202274|NCT02022917|tubal cancer|tubal cancer
1202275|NCT02022917|peritoneal cancer|peritoneal cancer
1202276|NCT02022904|prostate cancer|prostate cancer
1202277|NCT02022904|metastatic|metastatic
1202278|NCT02022904|castrate resistant|castrate resistant
1202279|NCT02022891|Sickle cell disease|sickle cell disease
1202280|NCT02022891|psychological support|psychological support
1202281|NCT02022891|quality of life|quality of life
1202282|NCT02022878|Chronic total occlusion|chronic total occlusion
1202283|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
1202284|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
1202285|NCT02022878|Coronary angiography|coronary angiography
1202286|NCT02022865|periodontitis|periodontitis
1202287|NCT02022865|cytokines|cytokines
1202288|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
1202289|NCT02022852|Rectal Cancer|rectal cancer
1202290|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1202291|NCT02022852|Sequential Therapy|sequential therapy
1202292|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
1202293|NCT02022839|ultrasonography|ultrasonography
1202294|NCT02022826|Gastroparesis|gastroparesis
1202295|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
1202296|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
1202297|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
1278967|NCT01676480|ADT|adt
1202298|NCT02022787|RCC|rcc
1202299|NCT02022787|Chemokines|chemokines
1202300|NCT02022787|nephrectomy|nephrectomy
1202301|NCT02022787|partial nephrectomy|partial nephrectomy
1202302|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
1202303|NCT02022761|Adults|adults
1202304|NCT02022761|Laninamivir|laninamivir
1202305|NCT02022735|Deep Brain Stimulation|deep brain stimulation
1202306|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
1202307|NCT02022722|Trigger Point Injections|trigger point injections
1202308|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
1202309|NCT02022722|Dyspareunia|dyspareunia
1202310|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
1202311|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
1202312|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1202313|NCT02022709|Psychotherapy|psychotherapy
1202314|NCT02022709|Pharmacotherapy|pharmacotherapy
1202315|NCT02022709|Citalopram|citalopram
1202316|NCT02022709|Fluoxetine|fluoxetine
1202317|NCT02022709|Paroxetine|paroxetine
1202318|NCT02022709|Sertraline|sertraline
1202319|NCT02022709|Fluvoxamine|fluvoxamine
1202320|NCT02022709|fMRI|fmri
1202321|NCT02022709|Stop Signal Task|stop signal task
1202322|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
1202323|NCT02022696|Gene Therapy|gene therapy
1202324|NCT02022696|Lentiviral Vectors|lentiviral vectors
1202325|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
1202326|NCT02022683|Endobronchial valves|endobronchial valves
1202327|NCT02022670|endothelial function|endothelial function
1202328|NCT02022670|arterial stiffness|arterial stiffness
1202329|NCT02022670|flow-mediated dilation|flow-mediated dilation
1202330|NCT02022670|pulse wave velocity|pulse wave velocity
1202331|NCT02022670|sodium nitrite|sodium nitrite
1202332|NCT02022670|aging|aging
1202333|NCT02022670|vascular diseases|vascular diseases
1202334|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
1202335|NCT02022657|Dried blood spots|dried blood spots
1202336|NCT02022618|Hypertension|hypertension
1202337|NCT02022618|Target organ damage|target organ damage
1202338|NCT02022618|polymorphism|polymorphism
1202339|NCT02022618|Hypertensive patients|hypertensive patients
1202340|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
1202341|NCT02022579|Breast Cancer|breast cancer
1202342|NCT02022579|Diagnosis|diagnosis
1202343|NCT02022579|Malignant|malignant
1202344|NCT02022579|Benign|benign
1202345|NCT02022579|Biopsy|biopsy
1202346|NCT02022566|Osteoarthritis knee|osteoarthritis knee
1202347|NCT02022566|Osteoarthritis hip|osteoarthritis hip
1202348|NCT02022566|Physical activity|physical activity
1202349|NCT02022566|accelerometer|accelerometer
1202350|NCT02022553|rectal cancer|rectal cancer
1202351|NCT02022553|RACHEL|rachel
1202352|NCT02022553|oil chemoembolization|oil chemoembolization
1202353|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1202354|NCT02022540|AMD|amd
1202355|NCT02022540|Macular Degeneration|macular degeneration
1202356|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
1202357|NCT02022540|wet AMD|wet amd
1202358|NCT02022540|neovascular AMD|neovascular amd
1202359|NCT02022540|exudative AMD|exudative amd
1202360|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
1202361|NCT02022527|Heart valve prosthesis|heart valve prosthesis
1202362|NCT02022527|Warfarin,|warfarin,
1202364|NCT02022527|Egypt|egypt
1202365|NCT02022501|Macular Degeneration|macular degeneration
1202366|NCT02022488|Child|child
1202367|NCT02022488|Sevoflurane|sevoflurane
1202368|NCT02022488|Emergence delirium|emergence delirium
1202369|NCT02022488|General anesthesia|general anesthesia
1202370|NCT02022488|Premedication.|premedication.
1202371|NCT02022475|vitamin D|vitamin d
1202372|NCT02022475|fatigue|fatigue
1202373|NCT02022462|Serious mental illnesses|serious mental illnesses
1202374|NCT02022462|peer navigator|peer navigator
1202375|NCT02022462|integrated health care|integrated health care
1202376|NCT02022449|Maternal depression|maternal depression
1202377|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
1202378|NCT02022449|Maternal health outcomes|maternal health outcomes
1202379|NCT02022449|Social support|social support
1202380|NCT02022449|Pediatric cancer|pediatric cancer
1202381|NCT02022410|CAS|cas
1202382|NCT02022410|Length of stay|length of stay
1202383|NCT02022410|Rehabilitation localisation|rehabilitation localisation
1202384|NCT02022410|TKA|tka
1202385|NCT02022397|tracheal intubation|tracheal intubation
1202386|NCT02022397|predicting difficult intubation|predicting difficult intubation
1202387|NCT02022397|general anesthesia|general anesthesia
1202388|NCT02022397|difficult ventilation|difficult ventilation
1202389|NCT02022384|Malignant glioma|malignant glioma
1202390|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
1202391|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
1202392|NCT02022384|Immune|immune
1202393|NCT02022384|Immunophenotyping|immunophenotyping
1202394|NCT02022384|Immune cells|immune cells
1202395|NCT02022384|activation state|activation state
1202396|NCT02022384|Quality of live|quality of live
1202397|NCT02022384|translational research|translational research
1202398|NCT02022358|Osteosarcoma|osteosarcoma
1202399|NCT02022358|Methotrexate|methotrexate
1202400|NCT02022358|Glucarpidase|glucarpidase
1202401|NCT02022358|Mucositis|mucositis
1202402|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
1202403|NCT02022345|Coronary Artery Disease|coronary artery disease
1202404|NCT02022345|Angioplasty|angioplasty
1202405|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
1202406|NCT02022345|Heart disease|heart disease
1202407|NCT02022345|Ischemic Heart Disease|ischemic heart disease
1202408|NCT02022306|Hepatitis C|hepatitis c
1202409|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1202410|NCT02022293|Radiotherapy|radiotherapy
1202411|NCT02022293|Carotid Stenosis|carotid stenosis
1202412|NCT02022293|Atorvastatin|atorvastatin
1202413|NCT02022267|clubfoot|clubfoot
1202414|NCT02022267|gait analysis|gait analysis
1202415|NCT02022267|outcome questionaire|outcome questionaire
1202416|NCT02022267|Ponseti method|ponseti method
1202417|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
1202418|NCT02022241|Luteinizing Hormone|luteinizing hormone
1202419|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1202420|NCT02022241|Ovarian Yield|ovarian yield
1202421|NCT02022241|Ovarian Maturity|ovarian maturity
1202422|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
1202423|NCT02022228|Luteinizing Hormone|luteinizing hormone
1202424|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1202425|NCT02022228|Ovarian Yield|ovarian yield
1202426|NCT02022228|Ovarian Maturity|ovarian maturity
1202427|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
1202428|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
1202429|NCT02022189|Dent|dent
1202430|NCT02022189|Dents|dents
1202431|NCT02022189|Dent Disease|dent disease
1202432|NCT02022189|Renal Biopsy|renal biopsy
1202433|NCT02022189|Kidney Biopsy|kidney biopsy
1202434|NCT02022189|Clinical Biopsy|clinical biopsy
1202435|NCT02022176|Nitrate|nitrate
1202436|NCT02022176|Nitrite|nitrite
1202437|NCT02022176|Nitric oxide|nitric oxide
1202438|NCT02022176|Resting metabolic rate|resting metabolic rate
1202439|NCT02022176|Glucose uptake|glucose uptake
1202440|NCT02022176|Insulin sensitivity|insulin sensitivity
1202441|NCT02022176|Reactive oxygen species production|reactive oxygen species production
1202442|NCT02022176|inorganic nitrate|inorganic nitrate
1202443|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
1202444|NCT02022163|Influenza, Human|influenza, human
1202445|NCT02022163|RNA Virus Infections|rna virus infections
1202446|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
1202447|NCT02022163|Respiratory Tract Infections|respiratory tract infections
1202448|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
1202449|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
1202450|NCT02022163|Immunogenic Factors|immunogenic factors
1202451|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
1202452|NCT02022163|Virus Diseases|virus diseases
1202453|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
1202454|NCT02022163|Infection|infection
1202455|NCT02022150|Paracentesis|paracentesis
1202456|NCT02022150|Liver Cirrhosis|liver cirrhosis
1202457|NCT02022150|ascites|ascites
1202458|NCT02022150|body composition|body composition
1202459|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1202460|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
1202461|NCT02022124|chronic low back pain|chronic low back pain
1202462|NCT02022124|open-label placebo|open-label placebo
1202463|NCT02022046|chronic kidney disease|chronic kidney disease
1202464|NCT02022046|cardiovascular disease|cardiovascular disease
1202465|NCT02022046|nitric oxide|nitric oxide
1202466|NCT02022046|homocysteine|homocysteine
1202467|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
1202468|NCT02022046|methylation|methylation
1202469|NCT02022033|Pancreatic Cancer|pancreatic cancer
1202470|NCT02022033|Adjuvant|adjuvant
1202471|NCT02022033|Pancreas|pancreas
1202472|NCT02022033|Resected|resected
1202473|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
1202474|NCT02022033|adenosquamous cancer|adenosquamous cancer
1202475|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
1202476|NCT02022007|PCOS|pcos
1202477|NCT02022007|IGT|igt
1202478|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
1202479|NCT02021981|Quality Improvement|quality improvement
1202480|NCT02021981|Primary Care|primary care
1202481|NCT02021981|Blood Pressure, High|blood pressure, high
1202482|NCT02021981|Feedback|feedback
1202483|NCT02021981|Knowledge|knowledge
1202484|NCT02021955|randomized controlled trial|randomized controlled trial
1202485|NCT02021955|quality of life|quality of life
1202486|NCT02021955|patient readmission|patient readmission
1202487|NCT02021955|mortality|mortality
1202488|NCT02021955|patient satisfaction|patient satisfaction
1202489|NCT02021955|intervention studies|intervention studies
1579026|NCT00468351|VEGF|vegf
1202490|NCT02021955|multicenter study|multicenter study
1202491|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
1202492|NCT02021942|local recurrent thymoma|local recurrent thymoma
1202493|NCT02021942|reduction of tumor size|reduction of tumor size
1202494|NCT02021942|SOM230 LAR|som230 lar
1202495|NCT02021929|Randomized Controlled Trial|randomized controlled trial
1202496|NCT02021929|Clinical Trial|clinical trial
1202497|NCT02021929|sorafenib|sorafenib
1202498|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
1202499|NCT02021903|arterial hypotension|arterial hypotension
1202500|NCT02021903|postprandial sleepiness|postprandial sleepiness
1202501|NCT02021903|orthostatic hypotension|orthostatic hypotension
1202502|NCT02021903|synucleinopathies|synucleinopathies
1202503|NCT02021903|hyperglycemia|hyperglycemia
1202504|NCT02021890|Dance|dance
1202505|NCT02021890|Physical activity|physical activity
1202506|NCT02021890|Physical fitness|physical fitness
1202507|NCT02021890|Weight loss|weight loss
1202508|NCT02021877|Brain trauma|brain trauma
1202509|NCT02021877|ICP measurement|icp measurement
1202510|NCT02021877|cranial CT / MRI|cranial ct / mri
1202511|NCT02021877|Glasgow Coma Score|glasgow coma score
1202512|NCT02021877|acute TBI|acute tbi
1202513|NCT02021877|EEG|eeg
1202514|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
1202515|NCT02021877|injury mechanism|injury mechanism
1202516|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
1202517|NCT02021851|Dexamethasone,|dexamethasone,
1202518|NCT02021851|Ondansetron|ondansetron
1202519|NCT02021851|Aprepitant|aprepitant
1202520|NCT02021851|PONV|ponv
1202521|NCT02021851|Laparoscopic surgery|laparoscopic surgery
1202522|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
1202523|NCT02021825|mitoxantrone|mitoxantrone
1202524|NCT02021825|neuromyelitis optica|neuromyelitis optica
1202525|NCT02021825|relapse|relapse
1202526|NCT02021799|Gut microbiome|gut microbiome
1202527|NCT02021799|Vaginal microbiome|vaginal microbiome
1202528|NCT02021799|Oral microbiome|oral microbiome
1202529|NCT02021799|Human milk microbiome|human milk microbiome
1202530|NCT02021799|Nutritional Status|nutritional status
1202531|NCT02021773|Headache|headache
1202532|NCT02021773|Migraine|migraine
1202533|NCT02021773|Chronic Migraine|chronic migraine
1202534|NCT02021682|Aβ|aβ
1202535|NCT02021682|ABeta|abeta
1202536|NCT02021682|ABeta kinetics|abeta kinetics
1202537|NCT02021682|Alzheimer's Disease|alzheimer's disease
1202538|NCT02021682|Alzheimer's|alzheimer's
1202539|NCT02021682|amyloid beta|amyloid beta
1202540|NCT02021682|biomarker|biomarker
1202541|NCT02021682|dementia|dementia
1202542|NCT02021682|PET/PIB|pet/pib
1202543|NCT02021669|Antidepressive agents|antidepressive agents
1202544|NCT02021669|Coronary disease|coronary disease
1202545|NCT02021669|Depression|depression
1202546|NCT02021669|Depressive disorder|depressive disorder
1202547|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
1202548|NCT02021630|Obesity|obesity
1202549|NCT02021630|Bariatric Surgery|bariatric surgery
1202550|NCT02021630|Weight Loss|weight loss
1202551|NCT02021630|Physical Activity|physical activity
1202552|NCT02021630|Body Composition|body composition
1202553|NCT02021617|Intraosseous Access|intraosseous access
1202554|NCT02021617|EZ-IO|ez-io
1202555|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
1202556|NCT02021604|HI|hi
1202557|NCT02021604|Hypoglycemia|hypoglycemia
1202558|NCT02021604|FDOPA|fdopa
1202559|NCT02021604|18F-DOPA|18f-dopa
1202560|NCT02021604|Hyperinsulinism|hyperinsulinism
1202561|NCT02021591|Diabetes|diabetes
1202562|NCT02021591|Chronic disease|chronic disease
1202563|NCT02021591|problem solving|problem solving
1202564|NCT02021591|self management|self management
1202565|NCT02021578|Depression|depression
1202566|NCT02021578|Mood disorder|mood disorder
1202567|NCT02021565|Caregivers|caregivers
1202865|NCT02019979|metformin|metformin
1202568|NCT02021565|Activities of Daily Living|activities of daily living
1202569|NCT02021565|Dementia|dementia
1202570|NCT02021565|Veterans|veterans
1202571|NCT02021565|Self-Help Devices|self-help devices
1202572|NCT02021565|Telemedicine|telemedicine
1202573|NCT02021552|Trauma|trauma
1202574|NCT02021552|Sepsis|sepsis
1202575|NCT02021539|Elastography of the cervix|elastography of the cervix
1202576|NCT02021539|Cervical elastography|cervical elastography
1202577|NCT02021539|Predicting delivery|predicting delivery
1202578|NCT02021526|G1D|g1d
1202579|NCT02021526|Glut1 Deficiency|glut1 deficiency
1202580|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
1202581|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
1202582|NCT02021513|SLE|sle
1202583|NCT02021513|Fish Oil|fish oil
1202584|NCT02021513|Omega-3|omega-3
1202585|NCT02021448|OHS|ohs
1202586|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
1202587|NCT02021422|pancreatic cancer|pancreatic cancer
1202588|NCT02021422|pancreas cancer|pancreas cancer
1202589|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1202590|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
1202591|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
1202592|NCT02021409|Anemia on CKD|anemia on ckd
1202593|NCT02021396|Rescue splenic trauma patients at high risk of splenectomy|rescue splenic trauma patients at high risk of splenectomy
1202594|NCT02021383|Weight loss|weight loss
1202595|NCT02021383|Weight maintenance|weight maintenance
1202596|NCT02021383|Contingency Management|contingency management
1202597|NCT02021383|College students|college students
1202598|NCT02021383|Financial incentives|financial incentives
1202599|NCT02021370|Anemia of CKD|anemia of ckd
1202600|NCT02021357|Facial Pain|facial pain
1202601|NCT02021357|Physical Therapy Modalities|physical therapy modalities
1202602|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
1202603|NCT02021357|Exercise Therapy|exercise therapy
1202604|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
1202605|NCT02021318|Non-dialysis|non-dialysis
1202606|NCT02021318|Roxadustat|roxadustat
1202607|NCT02021318|ASP1517|asp1517
1202608|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1202609|NCT02021318|Anemia|anemia
1202610|NCT02021318|Hemoglobin|hemoglobin
1202611|NCT02021305|Toll like Receptors|toll like receptors
1202612|NCT02021305|TLR 4|tlr 4
1202613|NCT02021305|Urinary track infections in children|urinary track infections in children
1202614|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
1202615|NCT02021305|Innate immunity|innate immunity
1202616|NCT02021305|Defence mechanisms|defence mechanisms
1202617|NCT02021305|Immune responses|immune responses
1202618|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1202619|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
1202620|NCT02021279|MatriStem|matristem
1202621|NCT02021279|pelvic floor matrix|pelvic floor matrix
1202622|NCT02021279|ACell|acell
1202623|NCT02021279|native tissue repair|native tissue repair
1202624|NCT02021253|Endotoxemia|endotoxemia
1202625|NCT02021253|Probiotic|probiotic
1202626|NCT02021253|Leaky gut|leaky gut
1202627|NCT02021253|Gut permeability|gut permeability
1202628|NCT02021253|Liver cirrhosis|liver cirrhosis
1202629|NCT02021253|Liver fibrosis|liver fibrosis
1202630|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
1202631|NCT02021227|Acute respiratory failure|acute respiratory failure
1202632|NCT02021227|Mechanical ventilation|mechanical ventilation
1202633|NCT02021227|Rehabilitation|rehabilitation
1202634|NCT02021227|Exercise chair sitting|exercise chair sitting
1202635|NCT02021227|Weaning|weaning
1202636|NCT02021227|Chronic respiratory failure|chronic respiratory failure
1202637|NCT02021214|Methylphenidate|methylphenidate
1202638|NCT02021214|Fear extinction|fear extinction
1202639|NCT02021214|fMRI|fmri
1202640|NCT02021214|mPFC|mpfc
1202641|NCT02021188|Vascular inflammation|vascular inflammation
1202642|NCT02021188|Atherosclerosis|atherosclerosis
1202643|NCT02021188|Positron Emission Tomography|positron emission tomography
1202644|NCT02021188|Molecular Imaging|molecular imaging
1202645|NCT02021188|68Ga-DOTATATE|68ga-dotatate
1202646|NCT02021175|Smoking Cessation|smoking cessation
1202647|NCT02021175|Korean|korean
1202648|NCT02021175|Youth|youth
1202649|NCT02021175|Adolescent|adolescent
1202650|NCT02021175|Dependence|dependence
1202651|NCT02021175|Teen Smoking|teen smoking
1202652|NCT02021175|Smoking and Youth|smoking and youth
1202653|NCT02021175|Youth and Tobacco|youth and tobacco
1202654|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
1202655|NCT02021175|Technology|technology
1202656|NCT02021175|Nicotine Dependence|nicotine dependence
1202657|NCT02021175|Cell Phone|cell phone
1202658|NCT02021175|Smart Phone|smart phone
1202659|NCT02021175|Internet|internet
1202660|NCT02021175|Web|web
1202661|NCT02021162|Multiple sclerosis|multiple sclerosis
1202662|NCT02021162|Gilenya|gilenya
1202663|NCT02021162|Healthy controls|healthy controls
1202664|NCT02021162|Thalamic atrophy|thalamic atrophy
1202665|NCT02021162|MRI|mri
1202866|NCT02019927|NAION|naion
1202666|NCT02021149|Major Depressive Disorder|major depressive disorder
1202667|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
1202668|NCT02021149|Psychotherapy|psychotherapy
1202669|NCT02021149|Therapist and patient alliance|therapist and patient alliance
1202670|NCT02021123|Anidulafungin|anidulafungin
1202671|NCT02021123|Gastric bypass|gastric bypass
1202672|NCT02021123|Morbidly obese|morbidly obese
1202673|NCT02021123|Pharmacokinetics|pharmacokinetics
1202674|NCT02021123|Prophylaxis|prophylaxis
1202675|NCT02021123|Yeast infection|yeast infection
1202676|NCT02021097|Levonorgestrel；|levonorgestrel；
1202677|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
1202678|NCT02021097|Oral Contraceptive|oral contraceptive
1202679|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
1202680|NCT02021032|BPH|bph
1202681|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
1202682|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
1202683|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
1202684|NCT02021006|renal hypodysplasia|renal hypodysplasia
1279436|NCT01674413|IBD|ibd
1202685|NCT02021006|chronic kidney disease|chronic kidney disease
1202686|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
1202687|NCT02020928|Oral Mucositis|oral mucositis
1202688|NCT02020928|chemotherapy|chemotherapy
1202689|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
1202690|NCT02020889|eosinophils|eosinophils
1202691|NCT02020889|SB 240563|sb 240563
1202692|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
1202693|NCT02020889|quality of life|quality of life
1202694|NCT02020889|mepolizumab|mepolizumab
1202695|NCT02020889|safety|safety
1202696|NCT02020889|biomarkers|biomarkers
1202697|NCT02020889|efficacy|efficacy
1202698|NCT02020889|corticosteroids|corticosteroids
1202699|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
1202700|NCT02020850|Toe-Brachial Index|toe-brachial index
1202701|NCT02020850|Ankle-Brachial Index|ankle-brachial index
1202702|NCT02020850|Systolic blood pressure|systolic blood pressure
1202703|NCT02020824|Acrophobia|acrophobia
1202704|NCT02020785|proteinuria|proteinuria
1202705|NCT02020772|primary health care|primary health care
1202706|NCT02020772|Physical Therapy Specialty|physical therapy specialty
1202707|NCT02020772|General Practitioners|general practitioners
1202708|NCT02020772|General Practice|general practice
1202709|NCT02020733|Hysterosalpingography|hysterosalpingography
1202710|NCT02020733|balloon catheter|balloon catheter
1202711|NCT02020733|metal cannula|metal cannula
1202712|NCT02020733|pain assessment|pain assessment
1202713|NCT02020694|Obesity|obesity
1202714|NCT02020694|Insulin resistance|insulin resistance
1202715|NCT02020694|Vitamin D|vitamin d
1202716|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
1202717|NCT02020681|Dental caries|dental caries
1202718|NCT02020681|Curodont Repair|curodont repair
1202719|NCT02020681|P11-4|p11-4
1202720|NCT02020668|Pain|pain
1202721|NCT02020668|Functional capacity|functional capacity
1202722|NCT02020668|Quality of Life|quality of life
1202723|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
1202724|NCT02020642|polysomnography|polysomnography
1202725|NCT02020642|bioimpedance|bioimpedance
1202726|NCT02020642|leg fluid shift|leg fluid shift
1202727|NCT02020642|neck circumference|neck circumference
1202728|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
1202729|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
1202730|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1202731|NCT02020642|Sleep Disorders|sleep disorders
1202732|NCT02020642|Apnea|apnea
1202733|NCT02020642|Kidney Diseases|kidney diseases
1202734|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
1202735|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
1202736|NCT02020642|Renal Insufficiency|renal insufficiency
1202737|NCT02020642|Dyssomnias|dyssomnias
1202738|NCT02020629|Glucagon|glucagon
1202739|NCT02020629|Hypoglycemia|hypoglycemia
1202740|NCT02020629|Counterregulation|counterregulation
1202741|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
1202742|NCT02020603|hemostatic forceps|hemostatic forceps
1202743|NCT02020603|soft coagulation|soft coagulation
1202744|NCT02020603|argon plasma coagulation|argon plasma coagulation
1202745|NCT02020590|Delayed-Union Fractures|delayed-union fractures
1202746|NCT02020590|Impaired Healing|impaired healing
1202747|NCT02020590|Fractures|fractures
1202748|NCT02020590|Orthopedics|orthopedics
1202749|NCT02020590|Bone|bone
1202750|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
1202751|NCT02020564|Processing Speed|processing speed
1202752|NCT02020564|Cognition|cognition
1202753|NCT02020564|Intervention|intervention
1202754|NCT02020564|Traumatic Brain Injury|traumatic brain injury
1202755|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
1202960|NCT02019576|mRCC|mrcc
1202756|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
1202757|NCT02020538|Thoracic surgery|thoracic surgery
1202758|NCT02020538|cardiac surgery|cardiac surgery
1202759|NCT02020538|acute kidney injury|acute kidney injury
1202760|NCT02020538|hyperchloremia|hyperchloremia
1202761|NCT02020538|intravenous fluid|intravenous fluid
1202762|NCT02020486|Healthy|healthy
1202763|NCT02020473|Informed consents|informed consents
1202764|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
1202765|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
1202766|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
1202767|NCT02020460|refractory,|refractory,
1202768|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
1202769|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
1202770|NCT02020421|ischemic stroke|ischemic stroke
1202771|NCT02020421|rehabilitation|rehabilitation
1202772|NCT02020421|aphasia|aphasia
1202773|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
1202774|NCT02020382|microRNAs|micrornas
1202775|NCT02020382|IBD|ibd
1202776|NCT02020382|Crohn's disease|crohn's disease
1202777|NCT02020382|Ulcerative colitis|ulcerative colitis
1202778|NCT02020382|colonic polyps screening|colonic polyps screening
1202779|NCT02020382|controls|controls
1202780|NCT02020356|Alzheimer's disease|alzheimer's disease
1202781|NCT02020356|Neuroleptics|neuroleptics
1202782|NCT02020356|Music therapy|music therapy
1202783|NCT02020330|falciparum, malaria|falciparum, malaria
1202784|NCT02020317|drug interactions|drug interactions
1202785|NCT02020317|Drug Monitoring|drug monitoring
1202786|NCT02020317|Potassium|potassium
1202787|NCT02020317|Hyperkalemia|hyperkalemia
1202788|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
1202789|NCT02020304|labor pain|labor pain
1202790|NCT02020291|Foxy-5|foxy-5
1202791|NCT02020291|Wnt-5A|wnt-5a
1202792|NCT02020278|Hyponatremia|hyponatremia
1202793|NCT02020278|Euvolemic|euvolemic
1202794|NCT02020278|Hypervolemic|hypervolemic
1202795|NCT02020278|Serum sodium|serum sodium
1202796|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
1202797|NCT02020278|Electrolyte abnormality|electrolyte abnormality
1202798|NCT02020278|Electrolyte imbalance|electrolyte imbalance
1202799|NCT02020278|Metabolic disease|metabolic disease
1202800|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
1202801|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
1202802|NCT02020239|physical activity|physical activity
1202803|NCT02020239|females|females
1202804|NCT02020239|body composition|body composition
1202805|NCT02020226|TH-302|th-302
1202806|NCT02020226|Solid Tumors|solid tumors
1202807|NCT02020226|QTc|qtc
1202808|NCT02020226|Cardiac|cardiac
1202809|NCT02020226|Evofosfamide|evofosfamide
1202810|NCT02020213|successful percentage|successful percentage
1202811|NCT02020200|Bipolar Disorder|bipolar disorder
1202812|NCT02020200|Methylphenidate|methylphenidate
1202813|NCT02020200|Cognitive Function|cognitive function
1202814|NCT02020187|Congenital myopathy|congenital myopathy
1202815|NCT02020187|Exercise|exercise
1202816|NCT02020174|Preeclampsia|preeclampsia
1202817|NCT02020174|Eclampsia|eclampsia
1202818|NCT02020174|HELLP|hellp
1202819|NCT02020174|HELLP Syndrome|hellp syndrome
1202820|NCT02020174|Toxemia|toxemia
1202821|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
1202822|NCT02020174|Registry|registry
1202823|NCT02020174|Pregnancy Complication|pregnancy complication
1202824|NCT02020174|Pregnancy|pregnancy
1202825|NCT02020174|Maternal Death|maternal death
1202826|NCT02020174|Premature|premature
1202827|NCT02020174|High Blood Pressure|high blood pressure
1202828|NCT02020174|Hypertension|hypertension
1202829|NCT02020148|pregnancy|pregnancy
1202830|NCT02020148|oxytocin|oxytocin
1202831|NCT02020148|postpartum depression|postpartum depression
1202832|NCT02020148|depression|depression
1202833|NCT02020148|pregnant women|pregnant women
1202834|NCT02020148|mood|mood
1202835|NCT02020148|anxiety|anxiety
1202836|NCT02020148|hormones|hormones
1202837|NCT02020148|women's health|women's health
1202838|NCT02020148|mental health|mental health
1202839|NCT02020148|baby blues|baby blues
1202840|NCT02020148|mood disorders|mood disorders
1202841|NCT02020122|endogenous pain modulation|endogenous pain modulation
1202842|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
1202843|NCT02020122|quantitative sensory testings|quantitative sensory testings
1202844|NCT02020122|duloxetine|duloxetine
1202845|NCT02020122|pregabalin|pregabalin
1202846|NCT02020122|preemptive treatment|preemptive treatment
1202847|NCT02020096|Lumbar plexus block|lumbar plexus block
1202848|NCT02020096|Ultrasound guidance|ultrasound guidance
1202849|NCT02020096|Nerve stimulator|nerve stimulator
1202850|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
1202851|NCT02020070|Ipilimumab|ipilimumab
1202852|NCT02020070|Degarelix|degarelix
1202853|NCT02020070|Radical Prostatectomy|radical prostatectomy
1202854|NCT02020070|13-134|13-134
1202855|NCT02020031|Revision knee joint|revision knee joint
1202856|NCT02020005|menthol cigarettes|menthol cigarettes
1202857|NCT02020005|smoking cessation|smoking cessation
1202858|NCT02019992|sepsis|sepsis
1202859|NCT02019992|mitochondrial DNA|mitochondrial dna
1202860|NCT02019992|systemic inflammation|systemic inflammation
1202861|NCT02019992|outcome|outcome
1202862|NCT02019979|non squamous|non squamous
1202863|NCT02019979|non small cell|non small cell
1202864|NCT02019979|lung cancer|lung cancer
1202867|NCT02019927|Decreased vision|decreased vision
1202868|NCT02019927|Eye trauma|eye trauma
1202870|NCT02019927|Electrical stimulation|electrical stimulation
1202871|NCT02019927|Multiple Sclerosis|multiple sclerosis
1202872|NCT02019927|Optic Neuritis|optic neuritis
1202873|NCT02019914|PTSD|ptsd
1202874|NCT02019914|CPAP|cpap
1202875|NCT02019914|OSA|osa
1202876|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
1202877|NCT02019901|Person-centered care|person-centered care
1202878|NCT02019901|Tight control|tight control
1202879|NCT02019888|Ear, Middle|ear, middle
1202880|NCT02019888|Ear, Inner|ear, inner
1202881|NCT02019888|Audiometry|audiometry
1202882|NCT02019888|Acoustic impedance tests|acoustic impedance tests
1202883|NCT02019875|Vitamin D|vitamin d
1202884|NCT02019875|CYP3A4|cyp3a4
1202885|NCT02019875|Calcium|calcium
1279677|NCT01673282|AED|aed
1202886|NCT02019862|Total hip arthroplasty|total hip arthroplasty
1202887|NCT02019862|TRJ|trj
1202888|NCT02019862|PMCF|pmcf
1202889|NCT02019862|Hip stem|hip stem
1202890|NCT02019849|THA, Plasmafit®|tha, plasmafit®
1202891|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
1202892|NCT02019823|SMS-text|sms-text
1202893|NCT02019823|mobile health|mobile health
1202894|NCT02019823|mHealth|mhealth
1202895|NCT02019823|treatment|treatment
1202896|NCT02019823|adherence|adherence
1202897|NCT02019797|aortic valve replacement|aortic valve replacement
1202898|NCT02019784|Cirrhosis|cirrhosis
1202899|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
1202900|NCT02019771|HIV Infection|hiv infection
1202901|NCT02019771|Men who have sex with men|men who have sex with men
1202902|NCT02019771|Chlamydia|chlamydia
1202903|NCT02019771|Gonorrhea|gonorrhea
1202904|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
1202905|NCT02019745|Flu vaccine|flu vaccine
1202906|NCT02019745|FluMist|flumist
1202907|NCT02019745|Smokers|smokers
1202908|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
1202909|NCT02019732|Mild outcomes|mild outcomes
1202910|NCT02019732|Database|database
1202911|NCT02019732|Influenza-attributable|influenza-attributable
1202912|NCT02019732|Retrospective|retrospective
1202913|NCT02019732|Influenza|influenza
1202914|NCT02019732|United States of America (USA)|united states of america (usa)
1202915|NCT02019719|Hemodialysis|hemodialysis
1202916|NCT02019719|GSK1278863|gsk1278863
1202917|NCT02019719|Pharmacokinetics|pharmacokinetics
1202918|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
1202919|NCT02019719|Chronic Kidney Disease|chronic kidney disease
1202920|NCT02019719|Hemoglobin|hemoglobin
1202921|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
1202922|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
1202923|NCT02019719|Anemia|anemia
1202924|NCT02019706|Cushing Syndrome|cushing syndrome
1202925|NCT02019706|Ectopic ACTH Secretion|ectopic acth secretion
1202926|NCT02019706|Imaging|imaging
1202927|NCT02019693|MET Inhibitor|met inhibitor
1202928|NCT02019693|Sporadic|sporadic
1202929|NCT02019693|Hereditary|hereditary
1202930|NCT02019693|Multifocal|multifocal
1202931|NCT02019693|HGF/MET Pathway|hgf/met pathway
1202932|NCT02019680|Endothelial Function|endothelial function
1202933|NCT02019680|Biomarkers|biomarkers
1202934|NCT02019680|Atherosclerosis|atherosclerosis
1202935|NCT02019680|Blood Flow|blood flow
1202936|NCT02019680|Blood Pressure|blood pressure
1202937|NCT02019667|GABA|gaba
1202938|NCT02019667|Seizures|seizures
1202939|NCT02019667|Neurotransmitters|neurotransmitters
1202940|NCT02019654|Post -Traumatic Stress Disorder (PTSD)|post -traumatic stress disorder (ptsd)
1202941|NCT02019654|Traumatic Brain Injury|traumatic brain injury
1202942|NCT02019654|Neuroendocrine|neuroendocrine
1202943|NCT02019654|Epigenetics|epigenetics
1202944|NCT02019641|Exercise|exercise
1202945|NCT02019641|Interstitial Lung Disease|interstitial lung disease
1202946|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
1202947|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
1202948|NCT02019615|disorders of consciousness|disorders of consciousness
1202949|NCT02019615|minimally conscious state|minimally conscious state
1202950|NCT02019615|traumatic brain injury|traumatic brain injury
1202951|NCT02019615|stroke|stroke
1202952|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
1202953|NCT02019602|Cimzia®|cimzia®
1202954|NCT02019602|CZP|czp
1202955|NCT02019602|Placental transfer|placental transfer
1202956|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
1202957|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
1202958|NCT02019589|SPRY Trial|spry trial
1202959|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1202961|NCT02019576|Clear cell|clear cell
1202962|NCT02019563|pediatrics|pediatrics
1202963|NCT02019563|dental caries|dental caries
1202964|NCT02019563|dental pulp exposure|dental pulp exposure
1202965|NCT02019563|incisor|incisor
1202966|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1202967|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
1202968|NCT02019550|Rebiject II®|rebiject ii®
1202969|NCT02019524|Stage I breast cancer|stage i breast cancer
1202970|NCT02019524|Stage II breast cancer|stage ii breast cancer
1202971|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
1202972|NCT02019524|Male breast cancer|male breast cancer
1202973|NCT02019524|Ovarian cancer|ovarian cancer
1202974|NCT02019511|Orthopedic surgery|orthopedic surgery
1202975|NCT02019511|Infections|infections
1202976|NCT02019511|Steroid|steroid
1202977|NCT02019511|Fast-track|fast-track
1202978|NCT02019511|Total knee arthroplasty|total knee arthroplasty
1202979|NCT02019511|Safety|safety
1202980|NCT02019498|low back pain|low back pain
1202981|NCT02019498|relaxation|relaxation
1202982|NCT02019485|Healthy|healthy
1202983|NCT02019485|Tapentadol|tapentadol
1202984|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
1202985|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
1202986|NCT02019485|Bioequivalence|bioequivalence
1202987|NCT02019485|Fasted Conditions|fasted conditions
1202988|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
1202989|NCT02019472|CNTO 136|cnto 136
1202990|NCT02019472|Sirukumab|sirukumab
1202991|NCT02019472|Adalimumab|adalimumab
1202992|NCT02019472|HUMIRA®|humira®
1202993|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
1202994|NCT02019446|onychomycosis|onychomycosis
1202995|NCT02019446|laser treatment|laser treatment
1202996|NCT02019446|antifungal|antifungal
1202997|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
1202998|NCT02019420|Pneumonia|pneumonia
1202999|NCT02019420|Tedizolid Phosphate|tedizolid phosphate
1203000|NCT02019420|TR-701|tr-701
1203001|NCT02019407|atrial fibrillation|atrial fibrillation
1203002|NCT02019407|atrial flutter|atrial flutter
1203003|NCT02019407|catheter ablation|catheter ablation
1203004|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
1203005|NCT02019342|blood pressure|blood pressure
1203006|NCT02019342|mean arterial pressure|mean arterial pressure
1203007|NCT02019342|MAP|map
1203008|NCT02019342|intraoperative|intraoperative
1203009|NCT02019342|postoperative|postoperative
1203010|NCT02019342|anesthesia|anesthesia
1203011|NCT02019316|Supplementation|supplementation
1203012|NCT02019316|Performance|performance
1203013|NCT02019316|Cognitive Function|cognitive function
1203014|NCT02019316|Muscular Endurance|muscular endurance
1203015|NCT02019316|BioSteel|biosteel
1203016|NCT02019316|BCAA|bcaa
1203017|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
1203018|NCT02019316|Sprint Interval Exercise|sprint interval exercise
1203019|NCT02019264|Diabetes|diabetes
1203020|NCT02019264|Cardiovascular Disease|cardiovascular disease
1203021|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
1203022|NCT02019264|Obesity|obesity
1203023|NCT02019264|Overweight|overweight
1203024|NCT02019264|MACE|mace
1203025|NCT02019264|Conversion to Diabetes|conversion to diabetes
1203026|NCT02019225|dialysis|dialysis
1203027|NCT02019225|hemodialysis|hemodialysis
1203028|NCT02019225|pragmatic trial|pragmatic trial
1203029|NCT02019225|end stage renal disease|end stage renal disease
1203030|NCT02019225|randomized clinical trial|randomized clinical trial
1203031|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
1203032|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
1203033|NCT02019212|SPECT|spect
1203034|NCT02019212|radiation|radiation
1203035|NCT02019186|type 1 diabetes|type 1 diabetes
1203036|NCT02019186|endothelial function|endothelial function
1203037|NCT02019186|adolescents|adolescents
1203038|NCT02019186|vitamin C|vitamin c
1203039|NCT02019186|vitamin E|vitamin e
1203040|NCT02019173|exercise therapy|exercise therapy
1203041|NCT02019173|brain injury|brain injury
1203042|NCT02019173|postural balance|postural balance
1203043|NCT02019160|silver nitrate|silver nitrate
1203044|NCT02019160|sodium fluoride|sodium fluoride
1203045|NCT02019160|silver diamine fluoride|silver diamine fluoride
1203046|NCT02019160|caries|caries
1203047|NCT02019160|non-inferiority trial|non-inferiority trial
1203048|NCT02019147|HIE|hie
1203049|NCT02019147|Biomarker|biomarker
1203050|NCT02019134|chronic neck pain|chronic neck pain
1203051|NCT02019134|relaxation technique|relaxation technique
1203052|NCT02019134|comparative effectiveness research|comparative effectiveness research
1203053|NCT02019108|osteoarthritis|osteoarthritis
1203054|NCT02019108|knee|knee
1203055|NCT02019108|walking|walking
1203057|NCT02019108|gait modification|gait modification
1203058|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
1203059|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1203060|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
1203061|NCT02019095|activin A|activin a
1203062|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
1203063|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
1203064|NCT02019017|Cluster Headache|cluster headache
1203065|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
1203066|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
1203067|NCT02019017|Autonomic Nerve Block|autonomic nerve block
1203068|NCT02018978|HIV prevention|hiv prevention
1203069|NCT02018978|Behavioral intervention|behavioral intervention
1203070|NCT02018978|Community-randomized trial|community-randomized trial
1203071|NCT02018965|HIV|hiv
1203072|NCT02018965|Extended-release Niacin|extended-release niacin
1203073|NCT02018965|Immune activation|immune activation
1203074|NCT02018952|Septic arthritis|septic arthritis
1203075|NCT02018952|Ultrasonography|ultrasonography
1203076|NCT02018952|Prognosis parameters|prognosis parameters
1203077|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
1203078|NCT02018926|Mocetinostat|mocetinostat
1203079|NCT02018926|Azacitidine|azacitidine
1203080|NCT02018926|Vidaza|vidaza
1203081|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
1203082|NCT02018926|HDAC|hdac
1203083|NCT02018926|HMA|hma
1203084|NCT02018926|MDS|mds
1203085|NCT02018900|Synbiotics|synbiotics
1203086|NCT02018900|Intestinal permeability|intestinal permeability
1203087|NCT02018900|Microbiota|microbiota
1203088|NCT02018900|Immune response|immune response
1203089|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1203090|NCT02018848|Attention Training|attention training
1203091|NCT02018848|Attention Bias Modification|attention bias modification
1203092|NCT02018848|Dot-Probe Task|dot-probe task
1203093|NCT02018848|Randomized Controlled Trial|randomized controlled trial
1203094|NCT02018848|Online Treatment|online treatment
1203095|NCT02018848|Washing|washing
1203096|NCT02018848|Checking|checking
1203097|NCT02018822|restorative material|restorative material
1203098|NCT02018809|Medication Adherence|medication adherence
1203099|NCT02018809|High Blood Pressure|high blood pressure
1203100|NCT02018809|Diabetes|diabetes
1203101|NCT02018809|Statins|statins
1203102|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
1203103|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
1203104|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
1203105|NCT02018770|Lasers.|lasers.
1203106|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1203107|NCT02018757|primary liver cancer|primary liver cancer
1203108|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
1203109|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
1203110|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1203111|NCT02018757|arsenic trioxide|arsenic trioxide
1203112|NCT02018757|arsenous anhydride|arsenous anhydride
1203113|NCT02018757|diarsenic trioxide|diarsenic trioxide
1203114|NCT02018757|randomized controlled trial|randomized controlled trial
1203115|NCT02018757|multicenter study|multicenter study
1203116|NCT02018757|HCC|hcc
1203117|NCT02018757|TACE|tace
1203118|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
1203119|NCT02018731|BMD|bmd
1203120|NCT02018731|Metformin|metformin
1203121|NCT02018731|L-citrulline|l-citrulline
1203122|NCT02018718|Skeletal muscle|skeletal muscle
1203123|NCT02018718|Marathon|marathon
1203124|NCT02018718|MRI|mri
1203125|NCT02018705|POEM|poem
1203126|NCT02018705|LHM|lhm
1203127|NCT02018705|Achalasia treatment|achalasia treatment
1203128|NCT02018705|LES sphincter myotomy|les sphincter myotomy
1203129|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
1203130|NCT02018679|Er:YAG|er:yag
1203131|NCT02018679|AFL-assisted|afl-assisted
1203132|NCT02018679|MAL-PDT|mal-pdt
1203133|NCT02018653|Cancer|cancer
1203134|NCT02018653|Diarrhea|diarrhea
1203135|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
1203136|NCT02018653|CASAD|casad
1203137|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
1203138|NCT02018653|Placebo|placebo
1203139|NCT02018653|Sugar pill|sugar pill
1203140|NCT02018653|Questionnaire|questionnaire
1203141|NCT02018653|Survey|survey
1203142|NCT02018640|cancer|cancer
1203143|NCT02018640|tobacco use|tobacco use
1203144|NCT02018640|pregnancy|pregnancy
1203145|NCT02018627|bionic pancreas|bionic pancreas
1203146|NCT02018627|artificial pancreas|artificial pancreas
1203147|NCT02018627|insulin|insulin
1203148|NCT02018627|glucagon|glucagon
1203149|NCT02018627|clamp|clamp
1203150|NCT02018614|Pain|pain
1203151|NCT02018614|elderly|elderly
1203152|NCT02018614|aged 65 or above 65|aged 65 or above 65
1203153|NCT02018614|communication disorders|communication disorders
1203154|NCT02018614|Algoplus® scale|algoplus® scale
1203155|NCT02018588|requirements|requirements
1203156|NCT02018588|amino acid|amino acid
1203157|NCT02018588|tryptophan|tryptophan
1203158|NCT02018575|lysine|lysine
1203159|NCT02018575|bioavailability|bioavailability
1203160|NCT02018575|amino acids|amino acids
1203161|NCT02018575|corn|corn
1203162|NCT02018562|Quality of Life|quality of life
1203163|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
1203164|NCT02018562|Speech|speech
1203165|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
1203166|NCT02018549|COPD|copd
1203167|NCT02018549|placebo|placebo
1203168|NCT02018549|inhalatory profile|inhalatory profile
1203169|NCT02018536|Healthy|healthy
1203170|NCT02018536|TMC435|tmc435
1203171|NCT02018536|GSK2336805|gsk2336805
1203172|NCT02018536|Pharmacokinetic|pharmacokinetic
1203173|NCT02018536|Safety|safety
1203174|NCT02018536|Tolerability|tolerability
1203175|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1203176|NCT02018523|Stage 3B/4|stage 3b/4
1203177|NCT02018523|Maintenance Therapy|maintenance therapy
1203178|NCT02018523|Lenalidomide|lenalidomide
1203179|NCT02018510|Healthy Volunteers|healthy volunteers
1203180|NCT02018510|HIV|hiv
1203181|NCT02018497|Essential arterial hypotension|essential arterial hypotension
1203182|NCT02018497|Arterial hypotension|arterial hypotension
1203183|NCT02018497|Low blood pressure|low blood pressure
1203184|NCT02018497|Hypotension|hypotension
1203185|NCT02018497|Essential arterial hypertension|essential arterial hypertension
1203186|NCT02018497|Syncope|syncope
1203187|NCT02018497|Dysautonomia|dysautonomia
1203188|NCT02018497|Stress|stress
1203189|NCT02018497|Adaptability|adaptability
1203190|NCT02018497|Reactivity|reactivity
1203191|NCT02018497|Homeostasis|homeostasis
1203192|NCT02018497|Allostasis|allostasis
1203193|NCT02018497|Allostatic load|allostatic load
1203194|NCT02018497|Distress|distress
1203195|NCT02018497|Epigenetic|epigenetic
1203196|NCT02018497|Plasticity|plasticity
1203197|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
1203198|NCT02018471|anxiety|anxiety
1203199|NCT02018471|psychoeducational training|psychoeducational training
1203200|NCT02018471|coping|coping
1203201|NCT02018471|relaxation|relaxation
1203202|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
1203203|NCT02018458|Breast Cancer|breast cancer
1203204|NCT02018458|Doxorubicin|doxorubicin
1203205|NCT02018458|Paclitaxel|paclitaxel
1203206|NCT02018458|Cyclophosphamide|cyclophosphamide
1203207|NCT02018458|Carboplatin|carboplatin
1203208|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
1203209|NCT02018406|Neurological Diseases,|neurological diseases,
1203210|NCT02018406|Neurorehabilitation,|neurorehabilitation,
1203211|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
1203212|NCT02018393|FEIBA®|feiba®
1203213|NCT02018367|Barrett's esophagus|barrett's esophagus
1203214|NCT02018367|proflavine|proflavine
1203215|NCT02018367|Microscopic imaging|microscopic imaging
1203216|NCT02018354|Orthopaedics|orthopaedics
1203217|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
1203218|NCT02018354|Anterolateral ligament|anterolateral ligament
1203219|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
1203220|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
1203222|NCT02018315|Glut1 Disorder|glut1 disorder
1203223|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
1203224|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
1203225|NCT02018302|G1D|g1d
1203226|NCT02018302|Glut1 Deficiency|glut1 deficiency
1203227|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
1203228|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
1203229|NCT02018289|Triclosan coated suture|triclosan coated suture
1203230|NCT02018289|Surgical site infection|surgical site infection
1203231|NCT02018289|Fecal peritonitis|fecal peritonitis
1203232|NCT02018289|Superficial|superficial
1203233|NCT02018289|incisional|incisional
1203234|NCT02018276|Lidocaine|lidocaine
1203235|NCT02018276|Magnesium|magnesium
1203236|NCT02018276|Functional recovery|functional recovery
1203237|NCT02018237|Obesity|obesity
1203238|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1203239|NCT02018237|High fructose corn syrup|high fructose corn syrup
1203240|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
1203241|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
1203242|NCT02018211|muscle damage|muscle damage
1203243|NCT02018211|muscle function|muscle function
1203244|NCT02018211|inflammation|inflammation
1203245|NCT02018146|Laryngeal Masks|laryngeal masks
1203246|NCT02018146|Airway Management|airway management
1203247|NCT02018133|CKD|ckd
1203248|NCT02018133|chronic|chronic
1203249|NCT02018133|kidney|kidney
1203250|NCT02018133|vitamin D|vitamin d
1203251|NCT02018120|multiple gingival recession|multiple gingival recession
1203252|NCT02018120|platelet rich fibrin|platelet rich fibrin
1203253|NCT02018120|connective tissue graft|connective tissue graft
1203254|NCT02018120|microsurgery|microsurgery
1203255|NCT02018120|periodontal diseases|periodontal diseases
1203256|NCT02018120|gingival recession|gingival recession
1203257|NCT02018107|Liver Tumor Ablation|liver tumor ablation
1203258|NCT02018107|Liver Neoplasms|liver neoplasms
1203259|NCT02018107|Positron Emission Tomography|positron emission tomography
1203260|NCT02018107|Computed Tomography|computed tomography
1203261|NCT02018094|Amputation|amputation
1203262|NCT02018094|Infection|infection
1203263|NCT02018094|Skin Preparation|skin preparation
1203264|NCT02018094|SSI|ssi
1203265|NCT02018094|Stump|stump
1203266|NCT02018094|Wound|wound
1203267|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
1203268|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
1203269|NCT02018068|Postoperative|postoperative
1203270|NCT02018068|Orthopedic surgery|orthopedic surgery
1203271|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
1203272|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
1203273|NCT02018042|Alopecia Areata|alopecia areata
1203274|NCT02018042|AA|aa
1203275|NCT02018029|Heart failure|heart failure
1203276|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1203277|NCT02018029|collagen peptides|collagen peptides
1203278|NCT02018029|MIBG scintigraphy|mibg scintigraphy
1203279|NCT02018016|Appendectomy|appendectomy
1203280|NCT02018016|Hospitals,General|hospitals,general
1203281|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
1203282|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
1203283|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
1203284|NCT02017990|Renal transplantation|renal transplantation
1203285|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1203286|NCT02017990|Mortality|mortality
1203287|NCT02017990|Graft loss|graft loss
1203288|NCT02017990|Rejection|rejection
1203289|NCT02017977|Laparotomy|laparotomy
1203290|NCT02017977|General Surgery|general surgery
1203291|NCT02017977|Hospitals,General|hospitals,general
1203292|NCT02017977|Hospitals,Rural|hospitals,rural
1203293|NCT02017977|Hospitals,Urban|hospitals,urban
1203294|NCT02017977|Rural Health Services|rural health services
1203295|NCT02017977|Geography, Medical|geography, medical
1203296|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
1203297|NCT02017951|Appendectomy|appendectomy
1203298|NCT02017951|Hospitals,General|hospitals,general
1203299|NCT02017951|Hospitals,Rural|hospitals,rural
1203300|NCT02017951|Hospitals,Urban|hospitals,urban
1203301|NCT02017951|Rural Health Services|rural health services
1203302|NCT02017951|Geography, Medical|geography, medical
1203303|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
1203304|NCT02017938|Fatigue|fatigue
1203305|NCT02017938|electromyography (EMG)|electromyography (emg)
1203306|NCT02017938|central fatigue|central fatigue
1203307|NCT02017938|cycling training|cycling training
1203308|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
1203309|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
1203310|NCT02017925|NSCLC|nsclc
1203311|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
1203312|NCT02017912|MSC-NTF|msc-ntf
1203313|NCT02017912|Cell therapy|cell therapy
1203314|NCT02017912|ALS|als
1203315|NCT02017899|prevention|prevention
1203316|NCT02017899|Shigella sonnei|shigella sonnei
1203317|NCT02017886|Probiotics|probiotics
1203318|NCT02017886|Oral health|oral health
1203319|NCT02017886|Innate immunity|innate immunity
1203320|NCT02017873|bleaching|bleaching
1203321|NCT02017873|smokers|smokers
1203322|NCT02017873|effectiveness|effectiveness
1203323|NCT02017873|pain|pain
1203324|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
1203325|NCT02017847|oxygen consumption|oxygen consumption
1203326|NCT02017847|activity monitors|activity monitors
1203327|NCT02017847|METs|mets
1203328|NCT02017847|intensity|intensity
1203329|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
1203330|NCT02017834|head and neck cancer|head and neck cancer
1203331|NCT02017834|oral cancer|oral cancer
1203332|NCT02017821|Exercise|exercise
1203333|NCT02017821|Oxygen Consumption|oxygen consumption
1203334|NCT02017821|mental health|mental health
1203335|NCT02017808|OCT|oct
1203336|NCT02017808|Copaxone|copaxone
1203337|NCT02017808|Multiple sclerosis|multiple sclerosis
1203338|NCT02017808|relapsing-remitting|relapsing-remitting
1203339|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
1203340|NCT02017782|Dust|dust
1203341|NCT02017782|Ozone|ozone
1203342|NCT02017782|Indoor air quality|indoor air quality
1203343|NCT02017782|Indoor environment|indoor environment
1203344|NCT02017782|Indoor climate|indoor climate
1203345|NCT02017782|Cardiovascular diseases|cardiovascular diseases
1203346|NCT02017782|Full body exposure|full body exposure
1203347|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
1203348|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
1203349|NCT02017782|Respiratory outcomes|respiratory outcomes
1203350|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
1203351|NCT02017782|Acoustic rhinometry|acoustic rhinometry
1203352|NCT02017782|Body inflammatory markers|body inflammatory markers
1203353|NCT02017782|Cytokines|cytokines
1203354|NCT02017782|Exhaled FeNO|exhaled feno
1203355|NCT02017782|Nasal Lavage|nasal lavage
1203356|NCT02017782|Heart rate variability|heart rate variability
1203357|NCT02017782|Blood biomarkers|blood biomarkers
1203358|NCT02017782|Subjective discomfort|subjective discomfort
1203359|NCT02017782|General mucosal irritation|general mucosal irritation
1203360|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
1203361|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
1203561|NCT02016807|Mucositis|mucositis
1203362|NCT02017756|Carotid artery|carotid artery
1203363|NCT02017756|Atherosclerosis|atherosclerosis
1203364|NCT02017756|Vulnerable plaque|vulnerable plaque
1203365|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
1203366|NCT02017756|Arterial wall|arterial wall
1203367|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
1333150|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
1280329|NCT01670526|TBI|tbi
1203368|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
1203369|NCT02017678|JX-594|jx-594
1203370|NCT02017678|Ovarian cancer|ovarian cancer
1203371|NCT02017678|Peritoneal|peritoneal
1203372|NCT02017678|Carcinomatosis|carcinomatosis
1203373|NCT02017678|Vaccinia virus|vaccinia virus
1203374|NCT02017678|Oncolytic virus|oncolytic virus
1203375|NCT02017665|encephalitis|encephalitis
1203376|NCT02017665|viral infections|viral infections
1203377|NCT02017665|central nervous system|central nervous system
1203378|NCT02017652|bowel motility|bowel motility
1203379|NCT02017652|cerebral perfusion|cerebral perfusion
1203380|NCT02017652|intestinal perfusion|intestinal perfusion
1203381|NCT02017626|Fish allergy|fish allergy
1203382|NCT02017626|immunotherapy|immunotherapy
1203383|NCT02017626|hypoallergen|hypoallergen
1203384|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
1203385|NCT02017574|Stroke|stroke
1203386|NCT02017574|Cerebral Infarction|cerebral infarction
1203387|NCT02017561|Diastolic dysfunction|diastolic dysfunction
1203388|NCT02017561|Metabolic syndrome|metabolic syndrome
1203389|NCT02017561|Metformin|metformin
1203390|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
1203391|NCT02017522|PET|pet
1203392|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
1203393|NCT02017522|FDG|fdg
1203394|NCT02017522|Cardiac MRI|cardiac mri
1203395|NCT02017509|Immunophenotype|immunophenotype
1203396|NCT02017509|Immunoscore|immunoscore
1203397|NCT02017509|MRI|mri
1203398|NCT02017509|RNA Later|rna later
1203399|NCT02017496|Breast cancer|breast cancer
1203400|NCT02017496|locally advanced|locally advanced
1203401|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
1203402|NCT02017496|breast conserving surgery|breast conserving surgery
1203403|NCT02017483|ADHD,|adhd,
1203404|NCT02017483|emotion recognition|emotion recognition
1203405|NCT02017483|attention|attention
1203406|NCT02017470|Women Heart Health|women heart health
1203407|NCT02017470|Cardiovascular Disease|cardiovascular disease
1203408|NCT02017470|focus group|focus group
1203409|NCT02017470|advisory board|advisory board
1203410|NCT02017470|one-on-one interview|one-on-one interview
1203411|NCT02017457|Hematology|hematology
1203412|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
1203413|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
1203414|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1203415|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
1203416|NCT02017457|DLI|dli
1203417|NCT02017457|Azacytidine|azacytidine
1203418|NCT02017457|Vidaza|vidaza
1203419|NCT02017457|Overall response rate|overall response rate
1203420|NCT02017457|Relapse|relapse
1203421|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
1203422|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
1203423|NCT02017444|Headaches|headaches
1203424|NCT02017444|Tinnitus|tinnitus
1203425|NCT02017444|Papilledema|papilledema
1203426|NCT02017444|Blindness|blindness
1203427|NCT02017444|Optic Disk|optic disk
1203428|NCT02017444|Intracranial Hypertension|intracranial hypertension
1203429|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
1203430|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
1203431|NCT02017444|Obesity|obesity
1203432|NCT02017431|Diesel exhaust|diesel exhaust
1203433|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
1203434|NCT02017431|Air pollution|air pollution
1203435|NCT02017431|Airway responsiveness|airway responsiveness
1203436|NCT02017431|Allergies|allergies
1203437|NCT02017418|zeaxanthin|zeaxanthin
1203438|NCT02017418|visual function|visual function
1203439|NCT02017418|reaction time|reaction time
1203440|NCT02017418|processing speed|processing speed
1203441|NCT02017405|Digestibility|digestibility
1203442|NCT02017405|Healthy volunteers|healthy volunteers
1203443|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
1203444|NCT02017405|bovine IgG|bovine igg
1203445|NCT02017405|adults|adults
1203446|NCT02017392|postoperative agitation|postoperative agitation
1203447|NCT02017392|endotracheal intubation|endotracheal intubation
1203448|NCT02017392|general anesthesia|general anesthesia
1203449|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
1203450|NCT02017379|melena|melena
1203451|NCT02017379|hematemesis|hematemesis
1203452|NCT02017366|Surgery|surgery
1203453|NCT02017366|Malnutrition|malnutrition
1203454|NCT02017366|Nutrition, Enteral|nutrition, enteral
1203455|NCT02017340|Alzheimer's Disease|alzheimer's disease
1203456|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
1203457|NCT02017340|Nilvadipine|nilvadipine
1203458|NCT02017340|Calcium Channel blocker|calcium channel blocker
1203459|NCT02017340|Elderly|elderly
1203460|NCT02017340|Therapeutic Intervention|therapeutic intervention
1203461|NCT02017314|morbid obesity|morbid obesity
1203462|NCT02017314|postoperative pain|postoperative pain
1203463|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
1203464|NCT02017288|Head and Neck Cancers|head and neck cancers
1203465|NCT02017288|Larynx|larynx
1203466|NCT02017288|Oropharynx|oropharynx
1203467|NCT02017288|Oral Cavity|oral cavity
1203468|NCT02017262|Self-care|self-care
1203469|NCT02017262|Patient education|patient education
1203470|NCT02017236|Food Effect|food effect
1203471|NCT02017236|Health subjects|health subjects
1203472|NCT02017223|Physical activity|physical activity
1203473|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
1203474|NCT02017197|Warfarin|warfarin
1203475|NCT02017197|Drugs, Generic|drugs, generic
1203476|NCT02017197|Anticoagulants|anticoagulants
1203477|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
1203478|NCT02017197|Coumarins|coumarins
1203479|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
1203480|NCT02017171|Kidney Diseases|kidney diseases
1203481|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
1203482|NCT02017171|Diabetes Mellitus|diabetes mellitus
1203483|NCT02017171|Diabetes Complications|diabetes complications
1203484|NCT02017171|Uric acid|uric acid
1203485|NCT02017171|Allopurinol|allopurinol
1203486|NCT02017171|Glomerular filtration rate|glomerular filtration rate
1203487|NCT02017171|Coronary artery disease|coronary artery disease
1203488|NCT02017158|Obesity|obesity
1203489|NCT02017158|Nutrition|nutrition
1203490|NCT02017158|Children|children
1203491|NCT02017145|infection|infection
1203492|NCT02017145|chloraprep|chloraprep
1203493|NCT02017145|chlorhexidine|chlorhexidine
1203494|NCT02017145|lower extremity surgery|lower extremity surgery
1203495|NCT02017145|antiseptic|antiseptic
1203496|NCT02017145|bacterial colonization|bacterial colonization
1203497|NCT02017132|Pomegranate|pomegranate
1203498|NCT02017132|Blood pressure|blood pressure
1203499|NCT02017132|Body composition|body composition
1203500|NCT02017132|Weight-loss|weight-loss
1203501|NCT02017132|Fat mass|fat mass
1203502|NCT02017132|Polyphenols|polyphenols
1203503|NCT02017132|Quality of Life|quality of life
1203504|NCT02017106|Varicose Veins|varicose veins
1203505|NCT02017093|CVA, rehabilitation|cva, rehabilitation
1203506|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
1203507|NCT02017080|fetal fT4|fetal ft4
1203508|NCT02017080|antithyroid antibodies|antithyroid antibodies
1203509|NCT02017080|pregnancy|pregnancy
1203510|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
1203511|NCT02017067|Resistance training|resistance training
1203512|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
1203513|NCT02017067|RFD|rfd
1203514|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
1203515|NCT02017015|Pancreatic cancer|pancreatic cancer
1203516|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
1203517|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
1203518|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
1203519|NCT02017015|Celgene clinical research trials|celgene clinical research trials
1203520|NCT02017002|Esophageal cancer|esophageal cancer
1203521|NCT02017002|minimally invasive|minimally invasive
1203522|NCT02017002|Surgical Procedures|surgical procedures
1203523|NCT02017002|Esophagectomy|esophagectomy
1203524|NCT02016989|Bacterial keratitis|bacterial keratitis
1203525|NCT02016989|OTR4120|otr4120
1203526|NCT02016989|Matrix therapy|matrix therapy
1203527|NCT02016963|Monoclonal Antibody|monoclonal antibody
1203528|NCT02016963|Safety|safety
1203529|NCT02016963|Raxibacumab|raxibacumab
1203530|NCT02016963|HGS1021|hgs1021
1203531|NCT02016963|Immunogenicity|immunogenicity
1203532|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
1203533|NCT02016924|Pediatrics|pediatrics
1203534|NCT02016924|Adolescents|adolescents
1203535|NCT02016924|HIV|hiv
1203536|NCT02016924|HIV-1|hiv-1
1203537|NCT02016924|Treatment experienced|treatment experienced
1203538|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
1203539|NCT02016898|trabeculectomy|trabeculectomy
1203540|NCT02016898|mitomycin-C|mitomycin-c
1203541|NCT02016898|express mini-shunt|express mini-shunt
1203542|NCT02016872|PET/CT|pet/ct
1203543|NCT02016872|18F-FMISO|18f-fmiso
1203544|NCT02016872|tumor hypoxia|tumor hypoxia
1203545|NCT02016872|13-186|13-186
1203546|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
1203547|NCT02016859|ICU neutropenic fever|icu neutropenic fever
1203548|NCT02016859|hip fracture|hip fracture
1203549|NCT02016859|critically ill|critically ill
1203550|NCT02016833|Ovarian Cancer|ovarian cancer
1203551|NCT02016833|Cervical Cancer|cervical cancer
1203552|NCT02016833|Leukemia|leukemia
1203553|NCT02016833|Immunity|immunity
1203554|NCT02016833|WT-1|wt-1
1203555|NCT02016833|Survivin|survivin
1203556|NCT02016833|HPV|hpv
1203557|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
1203558|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
1203559|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
1203560|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1203562|NCT02016807|Sucralfate|sucralfate
1203563|NCT02016807|Prothelial|prothelial
1583290|NCT00453089|VG101|vg101
1203564|NCT02016807|High potency sucralfate|high potency sucralfate
1203565|NCT02016807|Ulcerations|ulcerations
1203566|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
1203567|NCT02016807|Radiation induced mucositis|radiation induced mucositis
1203568|NCT02016807|Chemotherapy colitis|chemotherapy colitis
1203569|NCT02016807|Radiation colitis|radiation colitis
1203570|NCT02016807|Mucosal erosions|mucosal erosions
1203571|NCT02016794|cervical|cervical
1203572|NCT02016794|interbody|interbody
1203573|NCT02016794|spacer|spacer
1203574|NCT02016794|degenerative|degenerative
1203575|NCT02016794|pain|pain
1203576|NCT02016794|neck|neck
1203577|NCT02016794|decompression|decompression
1203578|NCT02016794|fusion|fusion
1203579|NCT02016794|implant|implant
1203580|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
1203581|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
1203582|NCT02016755|Vascular Disease|vascular disease
1203583|NCT02016755|CLI|cli
1203584|NCT02016755|Critical Limb Ischemia|critical limb ischemia
1203585|NCT02016755|PAD|pad
1203586|NCT02016755|AnGes|anges
1203587|NCT02016755|HGF Plasmid|hgf plasmid
1203588|NCT02016755|HGF|hgf
1203589|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
1203590|NCT02016755|gene therapy|gene therapy
1203591|NCT02016742|Pharmacokinetics|pharmacokinetics
1203592|NCT02016729|AML|aml
1203593|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1203594|NCT02016703|erythritol|erythritol
1203595|NCT02016703|polyol|polyol
1203596|NCT02016703|laxation|laxation
1203597|NCT02016703|gastrointestinal|gastrointestinal
1203598|NCT02016703|tolerance|tolerance
1203599|NCT02016703|soft drinks|soft drinks
1203600|NCT02016703|child|child
1203601|NCT02016703|diarrhoea|diarrhoea
1203602|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
1203603|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
1203604|NCT02016690|Down Syndrome|down syndrome
1203605|NCT02016690|Immunocompromised|immunocompromised
1203606|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
1203607|NCT02016677|Breast reduction|breast reduction
1203608|NCT02016677|Mastopexy|mastopexy
1203609|NCT02016677|Sagging|sagging
1203610|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
1203611|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
1203612|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
1203613|NCT02016638|Restless leg syndrome|restless leg syndrome
1203614|NCT02016638|Sleep|sleep
1203615|NCT02016612|Recurrent|recurrent
1203616|NCT02016612|Ptosis|ptosis
1203617|NCT02016612|Reduction|reduction
1203618|NCT02016612|Mammoplasty|mammoplasty
1203619|NCT02016612|Mastopexy|mastopexy
1203620|NCT02016599|Hypotension|hypotension
1203621|NCT02016599|Low blood pressure|low blood pressure
1203622|NCT02016599|Neonate|neonate
1203623|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
1203624|NCT02016573|renal denervation|renal denervation
1203625|NCT02016573|blood pressure|blood pressure
1203626|NCT02016573|cardiovascular risk|cardiovascular risk
1203627|NCT02016573|target organ damage|target organ damage
1203628|NCT02016573|sympathetic activity|sympathetic activity
1203629|NCT02016547|Stroke|stroke
1203630|NCT02016547|Middle Cerebral Artery|middle cerebral artery
1203631|NCT02016547|Thrombectomy|thrombectomy
1203632|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
1203633|NCT02016547|Abciximab|abciximab
1203634|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
1203635|NCT02016521|Exercise|exercise
1203636|NCT02016521|Clothing|clothing
1203637|NCT02016521|Core body temperature|core body temperature
1203638|NCT02016521|Skin Temperature|skin temperature
1203639|NCT02016521|Performance|performance
1203640|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
1203641|NCT02016508|AMD|amd
1203642|NCT02016482|Nail Psoriasis|nail psoriasis
1203643|NCT02016482|Plaque Psoriasis|plaque psoriasis
1203644|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1203645|NCT02016456|Neuronavigation|neuronavigation
1203646|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
1203647|NCT02016443|inguinal hernia|inguinal hernia
1203648|NCT02016430|TMAO|tmao
1203649|NCT02016430|Gut Flora|gut flora
1203650|NCT02016430|Dietary Intervention|dietary intervention
1203651|NCT02016430|Choline|choline
1203652|NCT02016430|Carnitine|carnitine
1203653|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1203654|NCT02016417|Induction chemotherapy|induction chemotherapy
1203655|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1203656|NCT02016417|Gemcitabine|gemcitabine
1203657|NCT02016417|Docetaxel|docetaxel
1203658|NCT02016404|blood pressure|blood pressure
1203659|NCT02016404|sodium|sodium
1203660|NCT02016404|salt|salt
1203661|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
1203662|NCT02016404|potassium|potassium
1203663|NCT02016404|Vietnam|vietnam
1203664|NCT02016404|randomized controlled trial|randomized controlled trial
1203665|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
1203666|NCT02016365|Cardiomyopathy|cardiomyopathy
1203667|NCT02016365|ATTR|attr
1203668|NCT02016365|neuropathy|neuropathy
1203669|NCT02016352|hydrocephalus|hydrocephalus
1203670|NCT02016352|proteomic|proteomic
1203671|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
1203672|NCT02016326|Colonoscopy|colonoscopy
1203673|NCT02016326|High Definition White Light|high definition white light
1203674|NCT02016326|I-Scan|i-scan
1203675|NCT02016326|Adenomas|adenomas
1203676|NCT02016300|cartilage|cartilage
1203677|NCT02016300|microfracture|microfracture
1203678|NCT02016300|knee|knee
1203679|NCT02016300|bracing|bracing
1203680|NCT02016261|Cognitive function|cognitive function
1203681|NCT02016248|CyberKnife|cyberknife
1203682|NCT02016248|Prostate Cancer|prostate cancer
1203683|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
1203684|NCT02016248|SBRT|sbrt
1203685|NCT02016248|Radiosurgery|radiosurgery
1203686|NCT02016248|SABR|sabr
1203687|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
1203688|NCT02016248|Boost|boost
1203689|NCT02016235|Dent|dent
1203690|NCT02016235|Dents|dents
1203691|NCT02016235|Dent Disease|dent disease
1203692|NCT02016235|Phosphorus Supplements|phosphorus supplements
1203693|NCT02016235|FGF 23|fgf 23
1203694|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
1203695|NCT02016222|diagnosis|diagnosis
1203696|NCT02016222|tears|tears
1203697|NCT02016222|isoelectric focusing|isoelectric focusing
1203698|NCT02016222|oligoclonal bands|oligoclonal bands
1203699|NCT02016196|TIPS|tips
1203700|NCT02016196|portal pressure|portal pressure
1203701|NCT02016196|rifaximin|rifaximin
1203702|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
1203703|NCT02016196|microbiota|microbiota
1203704|NCT02016183|Drug Therapy|drug therapy
1203705|NCT02016170|platelet reactivity|platelet reactivity
1203706|NCT02016170|ticagrelor|ticagrelor
1203707|NCT02016170|prasugrel|prasugrel
1203708|NCT02016157|Moxifloxacin|moxifloxacin
1203709|NCT02016157|Chlorhexidine|chlorhexidine
1203710|NCT02016157|In situ gel|in situ gel
1203711|NCT02016157|Chronic periodontitis|chronic periodontitis
1203712|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
1203713|NCT02016131|endoleak|endoleak
1203714|NCT02016131|EVAR|evar
1203715|NCT02016131|AAA|aaa
1203716|NCT02016131|CQDSA|cqdsa
1203717|NCT02016118|RUTI|ruti
1203718|NCT02016105|plaque type psoriasis|plaque type psoriasis
1203719|NCT02016105|equivalent efficacy|equivalent efficacy
1203720|NCT02016105|safety and immunogenicity|safety and immunogenicity
1203721|NCT02016105|GP2017|gp2017
1203722|NCT02016105|Humira®|humira®
1203723|NCT02016092|Parkinson's disease|parkinson's disease
1203724|NCT02016092|biomarkers|biomarkers
1203725|NCT02016092|blood|blood
1203726|NCT02016092|urine,|urine,
1203727|NCT02016092|proteomics|proteomics
1203728|NCT02016092|lipidomics|lipidomics
1203729|NCT02016092|metabolomics|metabolomics
1203730|NCT02016079|randomized controlled trial|randomized controlled trial
1203731|NCT02016079|omega-3|omega-3
1203732|NCT02016079|nutrition|nutrition
1203733|NCT02016079|behavior problems|behavior problems
1203734|NCT02016079|externalizing|externalizing
1203735|NCT02016079|internalizing|internalizing
1203736|NCT02016079|antisocial|antisocial
1203737|NCT02016079|aggressive|aggressive
1203738|NCT02016066|Healthy|healthy
1203739|NCT02016066|CR6261|cr6261
1203740|NCT02016066|Japanese|japanese
1203741|NCT02016066|Safety|safety
1203742|NCT02016066|Pharmacokinetics|pharmacokinetics
1203743|NCT02016066|Immunogenicity|immunogenicity
1203744|NCT02016040|Prostate cancer|prostate cancer
1203745|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
1203746|NCT02016040|Prostate biopsies|prostate biopsies
1203747|NCT02016014|Physical activity|physical activity
1203748|NCT02016014|Alimentation|alimentation
1203749|NCT02016014|Information and communication Technology|information and communication technology
1203750|NCT02016014|Arterial aging|arterial aging
1203751|NCT02016001|fluoride|fluoride
1203752|NCT02016001|dental caries|dental caries
1203753|NCT02016001|prevention|prevention
1203754|NCT02015988|Acute coronary syndrome|acute coronary syndrome
1203755|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1203756|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
1203757|NCT02015988|Simvastatin|simvastatin
1203758|NCT02015988|Fenofibrate|fenofibrate
1203759|NCT02015975|patellar fracture|patellar fracture
1203760|NCT02015975|fracture of patella|fracture of patella
1203761|NCT02015975|patella|patella
1203762|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
1203763|NCT02015975|osteosynthesis|osteosynthesis
1203764|NCT02015975|star-plate|star-plate
1203765|NCT02015975|arrow-plate|arrow-plate
1203766|NCT02015962|Hypokalemia|hypokalemia
1203767|NCT02015962|Intravenous|intravenous
1203768|NCT02015962|Enteral|enteral
1203769|NCT02015962|post-cardiac surgery|post-cardiac surgery
1203770|NCT02015936|stage III cancer|stage iii cancer
1203771|NCT02015936|stage IV cancer|stage iv cancer
1203772|NCT02015936|cancer|cancer
1203773|NCT02015936|advanced stage cancer|advanced stage cancer
1203774|NCT02015936|Nintendo Wii training|nintendo wii training
1203775|NCT02015936|exercise|exercise
1203776|NCT02015936|physical training|physical training
1203777|NCT02015936|physical function|physical function
1203778|NCT02015936|physical fitness test|physical fitness test
1203779|NCT02015923|Colonic cancer|colonic cancer
1203780|NCT02015923|Metastasis|metastasis
1203781|NCT02015884|Incivility|incivility
1203782|NCT02015884|Rudeness|rudeness
1203783|NCT02015884|Aggression|aggression
1203784|NCT02015884|Violent act|violent act
1203785|NCT02015884|Healthcare workers|healthcare workers
1203786|NCT02015884|Emergency unit|emergency unit
1203787|NCT02015832|SYNTAX II Score|syntax ii score
1203788|NCT02015832|Pressure wires|pressure wires
1203789|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
1203790|NCT02015832|fractional flow reserve|fractional flow reserve
1203791|NCT02015832|intravascular ultrasound|intravascular ultrasound
1203792|NCT02015832|Drug eluting stents|drug eluting stents
1203793|NCT02015832|Stents|stents
1203794|NCT02015832|Angioplasty|angioplasty
1203795|NCT02015832|multi slice computed tomography|multi slice computed tomography
1203796|NCT02015806|Quality improvement|quality improvement
1203797|NCT02015806|Randomized controlled trial|randomized controlled trial
1203798|NCT02015806|Medication adherence|medication adherence
1203799|NCT02015806|RxTimer Cap|rxtimer cap
1203800|NCT02015806|PillMinder|pillminder
1203801|NCT02015806|Take-N-Slide|take-n-slide
1203802|NCT02015806|Low-touch devices|low-touch devices
1203803|NCT02015806|Medication management|medication management
1203804|NCT02015793|Crohn's Disease|crohn's disease
1203805|NCT02015793|Pharmacokinetics|pharmacokinetics
1203806|NCT02015780|Drug therapy|drug therapy
1203807|NCT02015767|Drug therapy|drug therapy
1203808|NCT02015728|Refractory|refractory
1203809|NCT02015728|Recurrent|recurrent
1203811|NCT02015728|Tumor|tumor
1203812|NCT02015728|Pediatric|pediatric
1203813|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
1203814|NCT02015728|Sorafenib|sorafenib
1203815|NCT02015728|Everolimus|everolimus
1203816|NCT02015728|Erlotinib|erlotinib
1203817|NCT02015728|Dasatinib|dasatinib
1203818|NCT02015728|Temozolomide|temozolomide
1203819|NCT02015728|Etoposide|etoposide
1203820|NCT02015702|Physicians|physicians
1203821|NCT02015702|Electronic Health Record|electronic health record
1203822|NCT02015702|Education|education
1203823|NCT02015663|Cystic Fibrosis|cystic fibrosis
1203825|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
1203826|NCT02015637|Gonorrhea|gonorrhea
1203827|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
1203828|NCT02015637|bacterial infection|bacterial infection
1203829|NCT02015637|Anti-Infective Agents|anti-infective agents
1203830|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
1203831|NCT02015624|Acute coronary syndromes|acute coronary syndromes
1203832|NCT02015624|Intensive Care Unit|intensive care unit
1203833|NCT02015611|Vitamin D|vitamin d
1203834|NCT02015611|Muscle power|muscle power
1203835|NCT02015611|Muscle fiber|muscle fiber
1203836|NCT02015611|Falls|falls
1203837|NCT02015611|Aging|aging
1203838|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
1203839|NCT02015598|Antioxidant|antioxidant
1203840|NCT02015598|drug treatment|drug treatment
1203841|NCT02015598|oxidative stress|oxidative stress
1203842|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
1203843|NCT02015572|Low back pain|low back pain
1203844|NCT02015572|Return to work|return to work
1203845|NCT02015572|Sickness absence|sickness absence
1203846|NCT02015572|Rehabilitation|rehabilitation
1203847|NCT02015572|Occupational intervention|occupational intervention
1203848|NCT02015546|Major Depressive Disorder|major depressive disorder
1203849|NCT02015546|Vilazodone|vilazodone
1203850|NCT02015533|Healthy|healthy
1203851|NCT02015533|CR8020|cr8020
1203852|NCT02015533|Japanese|japanese
1203853|NCT02015533|Safety|safety
1203854|NCT02015533|Pharmacokinetics|pharmacokinetics
1203855|NCT02015533|Immunogenicity|immunogenicity
1203856|NCT02015494|Safety|safety
1203857|NCT02015494|Immunogenicity|immunogenicity
1203858|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
1203859|NCT02015468|Distal radius fracture|distal radius fracture
1203860|NCT02015468|Wrist fracture|wrist fracture
1203861|NCT02015468|Physiotherapy|physiotherapy
1203862|NCT02015468|Immobilization|immobilization
1203863|NCT02015468|Volar locking plates|volar locking plates
1203864|NCT02015468|Mobilization|mobilization
1203865|NCT02015455|pragmatic trial|pragmatic trial
1203866|NCT02015455|stepped-wedge design|stepped-wedge design
1203867|NCT02015455|cluster-randomized trial|cluster-randomized trial
1203868|NCT02015442|Sucrose in diet|sucrose in diet
1203869|NCT02015429|Food intake|food intake
1203870|NCT02015429|satiety|satiety
1203871|NCT02015429|glycemia|glycemia
1203872|NCT02015429|appetite|appetite
1203873|NCT02015429|blood glucose|blood glucose
1203874|NCT02015429|yellow peas|yellow peas
1203875|NCT02015429|fibre|fibre
1203876|NCT02015429|protein|protein
1203877|NCT02015429|mixed meal|mixed meal
1203878|NCT02015416|Melanoma|melanoma
1203879|NCT02015416|Ovarian cancer|ovarian cancer
1203880|NCT02015416|Sarcoma|sarcoma
1203881|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
1203882|NCT02015416|NSCLC|nsclc
1203883|NCT02015416|Breast cancer|breast cancer
1203884|NCT02015390|bone defects|bone defects
1203885|NCT02015390|iatrogenic resection|iatrogenic resection
1203886|NCT02015390|titanium mesh cage|titanium mesh cage
1203887|NCT02015390|biomembrane|biomembrane
1203888|NCT02015390|Masquelet technique|masquelet technique
1203889|NCT02015364|Achilles tendon|achilles tendon
1203890|NCT02015364|Rupture|rupture
1203891|NCT02015364|Rehabilitation|rehabilitation
1203892|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
1203893|NCT02015351|Choroidal neovascularization|choroidal neovascularization
1203894|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
1203895|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
1203896|NCT02015351|Anti-VEGF|anti-vegf
1203897|NCT02015338|Hemiparesis|hemiparesis
1203898|NCT02015338|Cerebral Palsy|cerebral palsy
1203899|NCT02015338|Congenital Stroke|congenital stroke
1203900|NCT02015338|Congenital Infarct|congenital infarct
1203901|NCT02015325|Water|water
1203902|NCT02015325|Sanitation|sanitation
1203903|NCT02015325|Hygiene|hygiene
1203904|NCT02015325|Education|education
1203905|NCT02015325|Evaluation|evaluation
1203906|NCT02015312|Amyloidosis|amyloidosis
1203907|NCT02015299|Diabetes|diabetes
1203908|NCT02015299|Pulse Wave Velocity|pulse wave velocity
1203909|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
1203910|NCT02015299|Linagliptin|linagliptin
1203911|NCT02015299|Arterial Stiffness|arterial stiffness
1203912|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
1203913|NCT02015286|Growth disorders|growth disorders
1203914|NCT02015286|Saizen|saizen
1203915|NCT02015286|Easypod|easypod
1203916|NCT02015286|Growth hormone|growth hormone
1203917|NCT02015286|Pediatric subject|pediatric subject
1203918|NCT02015273|easypod™|easypod™
1203919|NCT02015273|SAIZEN®|saizen®
1203920|NCT02015260|human papilloma virus infection|human papilloma virus infection
1203921|NCT02015260|Anogenital warts|anogenital warts
1203922|NCT02015260|condylomata acuminata|condylomata acuminata
1203923|NCT02015234|TNX-102 SL|tnx-102 sl
1203924|NCT02015234|bedtime|bedtime
1203925|NCT02015234|sublingual|sublingual
1203926|NCT02015234|12-month|12-month
1203927|NCT02015234|long term safety|long term safety
1203928|NCT02015234|long term efficacy|long term efficacy
1203929|NCT02015234|Fibromyalgia|fibromyalgia
1203930|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
1203931|NCT02015221|venous leg ulcers|venous leg ulcers
1203932|NCT02015221|pneumatic compression|pneumatic compression
1203933|NCT02015208|CLL|cll
1203934|NCT02015208|cytokine signaling|cytokine signaling
1203935|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
1203936|NCT02015208|elderly|elderly
1203937|NCT02015208|p53|p53
1203938|NCT02015195|Jellyfish stings|jellyfish stings
1203939|NCT02015195|Treatment|treatment
1203940|NCT02015195|Humans|humans
1203941|NCT02015195|Topical Treatments|topical treatments
1203942|NCT02015195|Pain|pain
1203943|NCT02015195|Erythema|erythema
1203944|NCT02015182|Bupivacaine|bupivacaine
1203945|NCT02015182|Sensorcaine|sensorcaine
1203946|NCT02015182|Population pharmacokinetics|population pharmacokinetics
1203947|NCT02015182|Children|children
1203948|NCT02015182|Pediatrics|pediatrics
1203949|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
1203950|NCT02015182|Regional Anesthesia|regional anesthesia
1203951|NCT02015169|gastric cancer|gastric cancer
1203952|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1203953|NCT02015169|capecitabine|capecitabine
1203954|NCT02015169|oxaliplatin|oxaliplatin
1203955|NCT02015169|lapatinib|lapatinib
1203956|NCT02015156|Trastuzumab|trastuzumab
1203957|NCT02015156|Healthy Male Volunteers|healthy male volunteers
1203958|NCT02015156|Single-Dose|single-dose
1203959|NCT02015156|Phase 1|phase 1
1203960|NCT02015156|Biosimilarity|biosimilarity
1203961|NCT02015130|Type 2 diabetes|type 2 diabetes
1203962|NCT02015130|hypertension|hypertension
1203963|NCT02015130|individual|individual
1203964|NCT02015104|Urothelial Cancinoma|urothelial cancinoma
1203965|NCT02015104|Vaccines|vaccines
1203966|NCT02015104|Immunotherapy|immunotherapy
1203967|NCT02015104|TICE BCG|tice bcg
1203968|NCT02015104|Intravesical Treatment|intravesical treatment
1203969|NCT02015091|Healthy Subjects|healthy subjects
1203970|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
1203971|NCT02015091|Immunogenicity|immunogenicity
1203972|NCT02015091|Sporozoites|sporozoites
1203973|NCT02015091|Parasitemia|parasitemia
1203974|NCT02015078|Eating Behavior|eating behavior
1203975|NCT02015078|Cancer|cancer
1203976|NCT02015078|Chronic Diseases|chronic diseases
1203977|NCT02015078|Obesity|obesity
1203983|NCT02015039|Occupational Therapy|occupational therapy
1203984|NCT02015039|Botulinum Toxin|botulinum toxin
1203985|NCT02015039|Writer's Cramp|writer's cramp
1203990|NCT02015013|Leukapheresis|leukapheresis
1203991|NCT02015013|Progenitor Cells|progenitor cells
1203992|NCT02015000|Pterygium|pterygium
1203993|NCT02015000|Recurrence|recurrence
1203994|NCT02014987|Running related injury|running related injury
1203995|NCT02014987|Overuse injury|overuse injury
1203996|NCT02014987|Running pattern|running pattern
1203997|NCT02014974|Fractures|fractures
1203998|NCT02014974|burden of fractures|burden of fractures
1203999|NCT02014974|orthopaedic fractures|orthopaedic fractures
1204000|NCT02014974|orthopaedic injuries|orthopaedic injuries
1204001|NCT02014974|orthopaedic trauma|orthopaedic trauma
1204002|NCT02014974|fractures India|fractures india
1204003|NCT02014974|observational study|observational study
1204004|NCT02014974|outcomes of fracture care|outcomes of fracture care
1204005|NCT02014974|wait times India|wait times india
1204006|NCT02014974|epidemiology|epidemiology
1204007|NCT02014948|Low Back Pain|low back pain
1204008|NCT02014948|Physiotherapy|physiotherapy
1204009|NCT02014935|Low-intensity Laser|low-intensity laser
1204010|NCT02014935|Spasticity|spasticity
1204011|NCT02014935|pain,|pain,
1204012|NCT02014935|Fatigue|fatigue
1204013|NCT02014909|KTN3379|ktn3379
1204014|NCT02014909|Advanced cancer|advanced cancer
1204015|NCT02014909|Phase 1|phase 1
1204016|NCT02014909|Monoclonal antibody|monoclonal antibody
1204017|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
1204018|NCT02014909|CDX3379|cdx3379
1204019|NCT02014896|Ischemic Stroke|ischemic stroke
1204020|NCT02014896|Transient Ischemic Attack|transient ischemic attack
1204021|NCT02014896|Transient Neurological Event|transient neurological event
1204022|NCT02014896|Atrial Fibrillation|atrial fibrillation
1204023|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
1204024|NCT02014896|Gene Expression|gene expression
1204025|NCT02014896|RNA|rna
1204026|NCT02014896|Anticoagulant|anticoagulant
1204027|NCT02014896|NOAC|noac
1204028|NCT02014896|Antiplatelet|antiplatelet
1204029|NCT02014896|Cardiac monitoring|cardiac monitoring
1204030|NCT02014896|Point of Care|point of care
1204031|NCT02014896|tPA|tpa
1204032|NCT02014896|Atheroembolic|atheroembolic
1204033|NCT02014870|Influenza|influenza
1204034|NCT02014870|Vaccine|vaccine
1204035|NCT02014870|Virus|virus
1204036|NCT02014870|H1N1|h1n1
1204037|NCT02014870|Challenge|challenge
1204038|NCT02014870|Vismederi|vismederi
1204039|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
1204040|NCT02014844|glioblastoma|glioblastoma
1204041|NCT02014844|aldoxorubicin|aldoxorubicin
1204042|NCT02014844|temozolomide|temozolomide
1204043|NCT02014844|brain cancer|brain cancer
1204044|NCT02014844|brain tumor|brain tumor
1204045|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
1204046|NCT02014831|Stage N3|stage n3
1204047|NCT02014831|Metastasis|metastasis
1204048|NCT02014831|TIP|tip
1204049|NCT02014831|Cetuximab|cetuximab
1204050|NCT02014831|Objective Response Rate|objective response rate
1204051|NCT02014831|Safety profile|safety profile
1204052|NCT02014831|Overall Survival|overall survival
1204053|NCT02014831|Progression Free Survival|progression free survival
1204054|NCT02014831|Quality of Life|quality of life
1204055|NCT02014805|postoperative|postoperative
1204056|NCT02014805|conformal|conformal
1204057|NCT02014805|radiotherapy|radiotherapy
1204058|NCT02014805|thymoma|thymoma
1204059|NCT02014792|Haemodialysis|haemodialysis
1204060|NCT02014792|Heart rate variability|heart rate variability
1204061|NCT02014792|n-3 PUFA|n-3 pufa
1204062|NCT02014779|Randomized Controlled Trial|randomized controlled trial
1204063|NCT02014779|Alcohol|alcohol
1204064|NCT02014779|Internet|internet
1204065|NCT02014779|Internet based therapy|internet based therapy
1204192|NCT02014298|scar texture|scar texture
1204066|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
1204067|NCT02014753|AMI|ami
1204068|NCT02014753|STEMI|stemi
1204069|NCT02014753|ACS|acs
1204070|NCT02014740|Epicardial fat|epicardial fat
1204071|NCT02014740|Type 2 diabetes|type 2 diabetes
1204072|NCT02014740|Obesity|obesity
1204073|NCT02014740|GLP-1 analogs|glp-1 analogs
1204074|NCT02014727|Malaria vaccine|malaria vaccine
1204075|NCT02014727|phase 1,|phase 1,
1204076|NCT02014727|AMA1-DiCO|ama1-dico
1204077|NCT02014701|echocardiogram|echocardiogram
1204078|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
1204079|NCT02014701|myocardial contrast|myocardial contrast
1204080|NCT02014688|Normal subjects|normal subjects
1204082|NCT02014675|CRT-D|crt-d
1204083|NCT02014675|Lead|lead
1204084|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
1204085|NCT02014649|Influenza treatment|influenza treatment
1204086|NCT02014649|pediatric|pediatric
1204087|NCT02014649|laninamivir|laninamivir
1204088|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
1204089|NCT02014636|MK 3475|mk 3475
1204090|NCT02014636|Renal cell carcinoma|renal cell carcinoma
1204091|NCT02014623|Allergic rhinitis|allergic rhinitis
1204092|NCT02014623|Asthma|asthma
1204093|NCT02014623|Regulatory T cells|regulatory t cells
1204094|NCT02014623|IgE|ige
1204095|NCT02014623|IgG4|igg4
1204096|NCT02014610|Neutrophil|neutrophil
1204097|NCT02014610|Lymphocyte|lymphocyte
1204098|NCT02014610|Eosinophil|eosinophil
1204099|NCT02014610|Leukocyte count|leukocyte count
1204100|NCT02014610|Cardiovascular disease|cardiovascular disease
1204101|NCT02014610|Atherosclerosis|atherosclerosis
1204102|NCT02014610|Monocyte|monocyte
1204103|NCT02014610|Basophil|basophil
1204104|NCT02014597|Glaucoma|glaucoma
1204105|NCT02014584|quality of life|quality of life
1204106|NCT02014584|safety|safety
1204107|NCT02014584|sexual function|sexual function
1204108|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
1204109|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
1204110|NCT02014584|dutasteride|dutasteride
1204111|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
1204112|NCT02014571|NS5B|ns5b
1204113|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
1204114|NCT02014571|antiviral activity|antiviral activity
1204115|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
1204116|NCT02014571|Safety|safety
1204117|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
1204118|NCT02014571|GSK2878175|gsk2878175
1204119|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
1204120|NCT02014558|Gilteritinib|gilteritinib
1204121|NCT02014558|ASP2215|asp2215
1204122|NCT02014545|brain metastases|brain metastases
1204123|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
1204124|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
1204125|NCT02014545|lucanthone|lucanthone
1204126|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
1204127|NCT02014532|Chronic periodontitis|chronic periodontitis
1204128|NCT02014532|Scaling and root planing|scaling and root planing
1204129|NCT02014532|C- reactive protein|c- reactive protein
1204130|NCT02014519|Adults|adults
1204131|NCT02014519|Hungary|hungary
1204132|NCT02014519|Bordetella pertussis|bordetella pertussis
1204133|NCT02014519|Seroprevalence|seroprevalence
1204134|NCT02014519|Pertussis antibodies|pertussis antibodies
1204135|NCT02014506|Children and adolescents|children and adolescents
1204136|NCT02014506|Malignant disease|malignant disease
1204137|NCT02014506|Non-malignant disease|non-malignant disease
1204138|NCT02014506|TCRαβ depletion|tcrαβ depletion
1204139|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1204140|NCT02014493|Respiration|respiration
1204141|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
1204142|NCT02014493|Work of breathing|work of breathing
1204143|NCT02014493|Infant, premature|infant, premature
1204144|NCT02014493|Electromyography|electromyography
1204145|NCT02014493|Diaphragm|diaphragm
1204146|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
1204147|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1204148|NCT02014480|Umeclidinium|umeclidinium
1204149|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
1204150|NCT02014480|Vilanterol|vilanterol
1204151|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
1204152|NCT02014454|Propranolol|propranolol
1204153|NCT02014454|Eye drops|eye drops
1204154|NCT02014454|Newborns|newborns
1204155|NCT02014454|Retinal angiogenesis|retinal angiogenesis
1204156|NCT02014454|Retinal neovascularization|retinal neovascularization
1204157|NCT02014415|Alpha-1|alpha-1
1204158|NCT02014415|AAT Deficiency|aat deficiency
1204159|NCT02014415|AATD|aatd
1204160|NCT02014415|Liver|liver
1204161|NCT02014415|Fibrosis|fibrosis
1204162|NCT02014415|Liver Transplant|liver transplant
1204163|NCT02014415|Cirrhosis|cirrhosis
1204164|NCT02014402|Vascular surgery|vascular surgery
1204165|NCT02014402|Hepatic surgery|hepatic surgery
1204166|NCT02014402|Soft tissue surgery|soft tissue surgery
1204167|NCT02014402|Spinal surgery|spinal surgery
1204168|NCT02014389|Retinal Dystrophies|retinal dystrophies
1204169|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
1204170|NCT02014389|Glaucoma|glaucoma
1204171|NCT02014389|Visual Field|visual field
1204172|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
1204173|NCT02014376|Simplex|simplex
1204174|NCT02014376|Recessive Dystrophic|recessive dystrophic
1204175|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
1204176|NCT02014337|Mifepristone|mifepristone
1204177|NCT02014337|Eribulin Mesylate|eribulin mesylate
1204178|NCT02014337|Breast Cancer|breast cancer
1204179|NCT02014337|Ovarian Cancer|ovarian cancer
1204180|NCT02014337|Sarcoma|sarcoma
1204181|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
1204182|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
1204183|NCT02014337|Prostate cancer|prostate cancer
1204184|NCT02014337|Prostatic neoplasms|prostatic neoplasms
1204185|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
1204186|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
1204187|NCT02014311|Coronary Stenosis|coronary stenosis
1204188|NCT02014311|Coronary Artery Disease|coronary artery disease
1204189|NCT02014311|Angina Pectoris|angina pectoris
1204190|NCT02014298|Burns|burns
1204191|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
1204193|NCT02014298|histology|histology
1204194|NCT02014298|laser treatment|laser treatment
1204195|NCT02014298|erbium:glass laser|erbium:glass laser
1204196|NCT02014298|meshed skin-grafts|meshed skin-grafts
1204197|NCT02014298|photothermolysis|photothermolysis
1204198|NCT02014298|skin|skin
1204199|NCT02014285|Acute Respiratory Failure|acute respiratory failure
1204200|NCT02014285|Critical Illness|critical illness
1204201|NCT02014285|Mechanical Ventilation|mechanical ventilation
1204202|NCT02014285|Muscle Architecture|muscle architecture
1204203|NCT02014285|Muscle Ultrasound|muscle ultrasound
1204204|NCT02014272|Bioequivalence|bioequivalence
1204205|NCT02014272|RIN 150|rin 150
1204206|NCT02014272|Healthy volunteers|healthy volunteers
1204207|NCT02014246|Movement Disorders|movement disorders
1204208|NCT02014246|Polymorphisms|polymorphisms
1204209|NCT02014246|DNA|dna
1204210|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
1204211|NCT02014233|Randomized clinical trial|randomized clinical trial
1204212|NCT02014233|Humans|humans
1204213|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
1204214|NCT02014233|Essential fatty acid|essential fatty acid
1204215|NCT02014233|Neuromuscular function|neuromuscular function
1204216|NCT02014233|Wingate|wingate
1204217|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
1204218|NCT02014233|Electromyography|electromyography
1204219|NCT02014233|Seal oil|seal oil
1204220|NCT02014233|Cycling time trial|cycling time trial
1204221|NCT02014233|Placebo controlled|placebo controlled
1204222|NCT02014194|Attentional Bias|attentional bias
1204223|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
1204224|NCT02014181|cystic fibrosis|cystic fibrosis
1204225|NCT02014181|isoprostanes|isoprostanes
1204226|NCT02014181|8-oxo-dGuo|8-oxo-dguo
1204227|NCT02014181|oxidative stress|oxidative stress
1204228|NCT02014181|inflammation|inflammation
1204229|NCT02014181|flaxseed|flaxseed
1204230|NCT02014181|enterodiol|enterodiol
1204231|NCT02014181|enterolactone|enterolactone
1204232|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
1204233|NCT02014103|bioequivalence|bioequivalence
1204234|NCT02014103|tacrolimus|tacrolimus
1204235|NCT02014103|transplant|transplant
1204236|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
1204237|NCT02014090|ECP|ecp
1204238|NCT02014090|Endurance exercise|endurance exercise
1204239|NCT02014090|myocardial perfusion|myocardial perfusion
1204240|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
1204241|NCT02014077|Thoracostomy Tube|thoracostomy tube
1204242|NCT02014077|Empyema|empyema
1204243|NCT02014077|Thoracotomy|thoracotomy
1204244|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
1204245|NCT02014038|Ultrarunners|ultrarunners
1204246|NCT02014038|ultramarathon runners|ultramarathon runners
1204247|NCT02014038|ULTRA|ultra
1204248|NCT02014038|Physical activity|physical activity
1204249|NCT02014038|Health Risks|health risks
1204250|NCT02014038|sedentary|sedentary
1204251|NCT02014038|moderately active|moderately active
1204252|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
1204253|NCT02014025|Open hepatectomy|open hepatectomy
1204254|NCT02014025|large PHC|large phc
1204255|NCT02014025|safety and sensibility|safety and sensibility
1204256|NCT02013986|salivary cortisol|salivary cortisol
1204257|NCT02013986|circadian rhythm|circadian rhythm
1204258|NCT02013986|children|children
1204259|NCT02013986|etomidate|etomidate
1204260|NCT02013973|Anti mullerian hormone|anti mullerian hormone
1204261|NCT02013973|In vitro fertilization|in vitro fertilization
1204262|NCT02013973|Optimal treatment|optimal treatment
1204263|NCT02013973|Randomized controlled trial|randomized controlled trial
1204264|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
1204265|NCT02013921|Physical activity|physical activity
1204266|NCT02013921|Cancer|cancer
1204267|NCT02013908|acupuncture|acupuncture
1204268|NCT02013908|emergency department|emergency department
1204269|NCT02013908|acute pain|acute pain
1204270|NCT02013908|ankle sprain|ankle sprain
1204271|NCT02013908|neck pain|neck pain
1204272|NCT02013908|primary headache|primary headache
1204273|NCT02013895|liver|liver
1204274|NCT02013895|surgery|surgery
1204275|NCT02013895|liver function|liver function
1204276|NCT02013895|GSA|gsa
1204277|NCT02013895|ICG|icg
1204278|NCT02013882|low flow anesthesia|low flow anesthesia
1204279|NCT02013882|wash-in|wash-in
1204280|NCT02013882|desflurane|desflurane
1204281|NCT02013869|fresh gas flow|fresh gas flow
1204282|NCT02013869|quality of anaesthesia|quality of anaesthesia
1204283|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
1204284|NCT02013856|Blood pressure|blood pressure
1204285|NCT02013856|Flavanols|flavanols
1204286|NCT02013856|Cardiovascular disease|cardiovascular disease
1204287|NCT02013843|Pediatric obesity|pediatric obesity
1204288|NCT02013843|Community-based treatment|community-based treatment
1204289|NCT02013843|dyslipidemia|dyslipidemia
1204290|NCT02013843|hypertension|hypertension
1204291|NCT02013843|diabetes|diabetes
1204292|NCT02013778|outside of transplant criteria|outside of transplant criteria
1204293|NCT02013752|Delivery tears|delivery tears
1204294|NCT02013752|Birth injuries|birth injuries
1204295|NCT02013752|Perineal protection device|perineal protection device
1204296|NCT02013713|Cardiology|cardiology
1204297|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
1204298|NCT02013700|IPF|ipf
1204299|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
1204300|NCT02013674|Cardiovascular, Chronic Ischemic Left Ventricular Dysfunction|cardiovascular, chronic ischemic left ventricular dysfunction
1204301|NCT02013661|periodontal debridement|periodontal debridement
1204302|NCT02013661|sutures|sutures
1204303|NCT02013661|tissue reaction|tissue reaction
1204304|NCT02013648|AML|aml
1204305|NCT02013648|Dasatinib|dasatinib
1204306|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
1204307|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
1204308|NCT02013635|thrombin generation|thrombin generation
1204309|NCT02013635|d-dimers|d-dimers
1204310|NCT02013635|clinical evolution|clinical evolution
1204311|NCT02013622|schizophrenia|schizophrenia
1204312|NCT02013622|Mental Disorders|mental disorders
1204313|NCT02013622|Psychotic Disorders|psychotic disorders
1204314|NCT02013622|social avoidance|social avoidance
1204315|NCT02013622|emotional withdrawal|emotional withdrawal
1204316|NCT02013622|passive/apathetic|passive/apathetic
1204317|NCT02013622|social withdrawal|social withdrawal
1204318|NCT02013622|antipsychotic|antipsychotic
1204319|NCT02013609|schizophrenia|schizophrenia
1204320|NCT02013609|Major depressive disorder|major depressive disorder
1204321|NCT02013609|Anxiety Symptoms|anxiety symptoms
1204322|NCT02013609|School, Work environment|school, work environment
1204323|NCT02013609|Mental Disorders|mental disorders
1204324|NCT02013609|Psychotic Disorders|psychotic disorders
1204325|NCT02013609|antipsychotic|antipsychotic
1204326|NCT02013596|hepatic dysfunction|hepatic dysfunction
1204327|NCT02013596|renal dysfunction|renal dysfunction
1204328|NCT02013596|pneumoperitoneum|pneumoperitoneum
1204329|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
1204330|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
1204331|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
1204332|NCT02013583|G1D|g1d
1204333|NCT02013583|Glut1 Deficiency|glut1 deficiency
1204334|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
1204335|NCT02013557|Gestational Diabetes|gestational diabetes
1204336|NCT02013557|Postpartum screening|postpartum screening
1204337|NCT02013557|Text-messages|text-messages
1204338|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
1204339|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
1204340|NCT02013544|Vaginal atrophy|vaginal atrophy
1204341|NCT02013544|Atrophic vaginitis|atrophic vaginitis
1204342|NCT02013544|prasterone|prasterone
1204343|NCT02013544|DHEA|dhea
1204344|NCT02013544|Intrarosa|intrarosa
1204345|NCT02013531|schizophrenia|schizophrenia
1204346|NCT02013531|Major depressive disorder|major depressive disorder
1204347|NCT02013531|Anxiety Symptoms|anxiety symptoms
1204348|NCT02013531|Mental Disorders|mental disorders
1204349|NCT02013531|Psychotic Disorders|psychotic disorders
1204350|NCT02013531|emotional withdrawal|emotional withdrawal
1204351|NCT02013531|antipsychotic|antipsychotic
1204352|NCT02013518|Alzheimers' disease|alzheimers' disease
1204353|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
1204354|NCT02013518|Depression|depression
1204355|NCT02013518|Self-efficacy|self-efficacy
1204356|NCT02013518|Quality of Life|quality of life
1204357|NCT02013505|Colonoscopy|colonoscopy
1204358|NCT02013492|Beta-Blocker|beta-blocker
1204359|NCT02013492|metastatic melanoma|metastatic melanoma
1204360|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
1204361|NCT02013466|Bioavailability|bioavailability
1204362|NCT02013466|Amino Acids|amino acids
1204363|NCT02013466|Elderly|elderly
1204364|NCT02013466|Supplement|supplement
1204365|NCT02013427|chronic|chronic
1204366|NCT02013427|back|back
1204367|NCT02013427|pain|pain
1204368|NCT02013427|brain|brain
1204369|NCT02013427|MRI|mri
1204370|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
1204371|NCT02013401|stress|stress
1204372|NCT02013401|psychophysiology|psychophysiology
1204373|NCT02013401|emotion regulation|emotion regulation
1204374|NCT02013388|N91115|n91115
1204375|NCT02013388|GSNORi|gsnori
1204376|NCT02013388|SNO|sno
1204377|NCT02013388|Cavosonstat|cavosonstat
1204378|NCT02013336|pediatric|pediatric
1204379|NCT02013336|MM-398|mm-398
1583570|NCT00451880|NSCLC|nsclc
1281572|NCT01664936|12-050|12-050
1204380|NCT02013336|cyclophosphamide|cyclophosphamide
1204381|NCT02013336|irinotecan|irinotecan
1204382|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
1204383|NCT02013297|Pediatrics|pediatrics
1204384|NCT02013297|SBRT|sbrt
1204385|NCT02013297|Brain metastasis|brain metastasis
1204386|NCT02013297|Pulmonary metastasis|pulmonary metastasis
1204387|NCT02013297|Spinal metastasis|spinal metastasis
1204388|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
1204389|NCT02013297|Spinal primary tumor|spinal primary tumor
1204390|NCT02013297|Relapsed ependymoma|relapsed ependymoma
1204391|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
1204392|NCT02013297|Local control rate|local control rate
1204393|NCT02013297|Safety|safety
1204394|NCT02013297|Overall survival|overall survival
1204395|NCT02013297|Progression Free Survival|progression free survival
1204396|NCT02013258|Prader Willi syndrome|prader willi syndrome
1204397|NCT02013258|Oxytocin|oxytocin
1204398|NCT02013232|Risperidone;|risperidone;
1204399|NCT02013232|Aripiprazole;|aripiprazole;
1204400|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
1204401|NCT02013232|dose effects|dose effects
1204402|NCT02013193|drug-coated balloon|drug-coated balloon
1204403|NCT02013193|drug-eluting balloon|drug-eluting balloon
1204404|NCT02013193|peripheral artery disease|peripheral artery disease
1204405|NCT02013193|claudication|claudication
1204406|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
1204407|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
1204408|NCT02013141|Gram positive bacteria|gram positive bacteria
1204409|NCT02013141|Telavancin|telavancin
1204410|NCT02013141|VIBATIV|vibativ
1204411|NCT02013141|Pediatric|pediatric
1204412|NCT02013141|Pharmacokinetics|pharmacokinetics
1204413|NCT02013115|infant|infant
1204414|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
1204415|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
1204416|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
1204417|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
1204418|NCT02013063|SPN|spn
1204419|NCT02013063|Lung cancer|lung cancer
1204420|NCT02013063|Diagnostic|diagnostic
1204421|NCT02013063|Computed Tomography|computed tomography
1204422|NCT02013063|CT scan|ct scan
1204423|NCT02013063|FDG-PET scan|fdg-pet scan
1204424|NCT02013063|Dynamic CT scan|dynamic ct scan
1204425|NCT02013063|DCE-CT scan|dce-ct scan
1204426|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
1204427|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
1204428|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
1204429|NCT02013037|cardiac transplantation|cardiac transplantation
1204430|NCT02013037|immunosuppression|immunosuppression
1204431|NCT02013037|acute cellular rejection|acute cellular rejection
1204432|NCT02013037|antibody mediated rejection|antibody mediated rejection
1204433|NCT02013037|sensitization|sensitization
1204434|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
1204435|NCT02013037|panel reactive antibodies|panel reactive antibodies
1204436|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
1204437|NCT02013037|complement activation|complement activation
1204685|NCT02011880|breast cancer|breast cancer
1204438|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
1204439|NCT02013037|terminal complement inhibition|terminal complement inhibition
1204440|NCT02013037|complement C5 binding|complement c5 binding
1204441|NCT02013037|Eculizumab|eculizumab
1204442|NCT02013037|monoclonal antibody|monoclonal antibody
1204443|NCT02013037|donor specific antibodies|donor specific antibodies
1204444|NCT02012985|hyperoxaluria|hyperoxaluria
1204445|NCT02012985|oxalate|oxalate
1204446|NCT02012985|PH|ph
1204447|NCT02012972|Antiretroviral therapy|antiretroviral therapy
1204448|NCT02012972|HIV/AIDS|hiv/aids
1204449|NCT02012972|Non-communicable diseases|non-communicable diseases
1204450|NCT02012972|South Africa|south africa
1204451|NCT02012959|Hyponatremia|hyponatremia
1204452|NCT02012959|Euvolemic|euvolemic
1204453|NCT02012959|Hypervolemic|hypervolemic
1204454|NCT02012959|Serum sodium|serum sodium
1204455|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
1204456|NCT02012959|Electrolyte abnormality|electrolyte abnormality
1204457|NCT02012959|Electrolyte imbalance|electrolyte imbalance
1204458|NCT02012959|Metabolic disease|metabolic disease
1204459|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
1204460|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
1204461|NCT02012920|CYP17|cyp17
1204462|NCT02012920|P450c17a|p450c17a
1204463|NCT02012920|lyase|lyase
1204464|NCT02012920|Prostate Cancer|prostate cancer
1204465|NCT02012894|Obesity|obesity
1204466|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
1281701|NCT01664559|toradol|toradol
1204467|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
1204468|NCT02012894|pH-monitoring|ph-monitoring
1204470|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
1204472|NCT02012868|bariatric surgery|bariatric surgery
1204473|NCT02012842|Metabolic Syndrome|metabolic syndrome
1204474|NCT02012842|Periodontal Disease|periodontal disease
1204475|NCT02012842|Periodontal therapy|periodontal therapy
1204476|NCT02012842|inflammatory markers|inflammatory markers
1204477|NCT02012842|C reactive protein|c reactive protein
1204478|NCT02012842|serum fibrinogen|serum fibrinogen
1204479|NCT02012842|glycated hemoglobin|glycated hemoglobin
1204480|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
1204481|NCT02012816|Uncircumcised men|uncircumcised men
1204482|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
1204483|NCT02012816|Peer-referral incentive|peer-referral incentive
1204484|NCT02012803|Achilles tendon rupture|achilles tendon rupture
1204485|NCT02012803|treatment, elongation|treatment, elongation
1204486|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
1204487|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
1204489|NCT02012777|sickle cell disease|sickle cell disease
1204490|NCT02012777|propanolol|propanolol
1204491|NCT02012777|red blood cell adhesion|red blood cell adhesion
1204492|NCT02012764|Anti-CCP antibody|anti-ccp antibody
1204493|NCT02012764|Inflammatory arthritis|inflammatory arthritis
1204494|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
1204495|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
1204496|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
1204497|NCT02012751|General practice|general practice
1204498|NCT02012751|Dermatoscopy|dermatoscopy
1204499|NCT02012751|Melanoma|melanoma
1204500|NCT02012751|Nevus|nevus
1204501|NCT02012725|Healthy|healthy
1204502|NCT02012725|Myocardial fibrosis|myocardial fibrosis
1204503|NCT02012725|Chronic kidney disease|chronic kidney disease
1204504|NCT02012712|Personal health record|personal health record
1204505|NCT02012712|medication management|medication management
1204506|NCT02012712|patient safety|patient safety
1204507|NCT02012699|Pancreatic Cancer|pancreatic cancer
1204508|NCT02012699|Thyroid Cancer|thyroid cancer
1204509|NCT02012699|Esophageal cancer|esophageal cancer
1204510|NCT02012699|Thymus cancer|thymus cancer
1204511|NCT02012699|Pancreatic tumor|pancreatic tumor
1204512|NCT02012699|Esophageal tumor|esophageal tumor
1204513|NCT02012699|Thymus tumor|thymus tumor
1204514|NCT02012699|Thyroid Tumor|thyroid tumor
1204515|NCT02012699|Thyroid Nodule|thyroid nodule
1204516|NCT02012699|Lung Tumor|lung tumor
1204517|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
1204518|NCT02012686|thyroidectomy|thyroidectomy
1204519|NCT02012686|neck pain|neck pain
1204520|NCT02012686|pain management|pain management
1204521|NCT02012673|COPD|copd
1204522|NCT02012673|Emphysema|emphysema
1204523|NCT02012673|Bronchoscopy|bronchoscopy
1204524|NCT02012673|Lung Volume Reduction|lung volume reduction
1204525|NCT02012647|parkinson|parkinson
1204526|NCT02012647|PD|pd
1204527|NCT02012647|parkinson disease|parkinson disease
1204528|NCT02012647|parkinson's|parkinson's
1204529|NCT02012647|parkinson's disease|parkinson's disease
1204530|NCT02012647|parkinsons|parkinsons
1204531|NCT02012647|parkinsons disease|parkinsons disease
1204532|NCT02012647|TMS|tms
1204533|NCT02012647|DBS|dbs
1204534|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
1204535|NCT02012647|deep brain stimulation|deep brain stimulation
1204536|NCT02012634|Breast Cancer|breast cancer
1204537|NCT02012634|Capecitabine|capecitabine
1204538|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
1204539|NCT02012621|HIV/AIDS|hiv/aids
1204540|NCT02012621|Adherence|adherence
1204541|NCT02012621|Tenofovir|tenofovir
1204542|NCT02012621|Dried Blood Spots|dried blood spots
1204543|NCT02012608|breast|breast
1204544|NCT02012569|skin grafting|skin grafting
1204545|NCT02012569|elective treatment|elective treatment
1204546|NCT02012543|constipation, agar|constipation, agar
1204547|NCT02012530|Articular cartilage|articular cartilage
1204548|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
1204549|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
1204550|NCT02012517|surgical site infection|surgical site infection
1204551|NCT02012517|breast reconstruction|breast reconstruction
1204552|NCT02012517|drains|drains
1204553|NCT02012517|prophylaxis|prophylaxis
1204554|NCT02012491|Spontaneous abortion|spontaneous abortion
1204555|NCT02012491|Early Pregnancy Failure|early pregnancy failure
1204556|NCT02012491|Mifepristone|mifepristone
1204557|NCT02012491|Misoprostol|misoprostol
1204558|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
1204559|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
1204560|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
1204561|NCT02012452|tobacco dependence|tobacco dependence
1204562|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
1281835|NCT01663714|Bexxar|bexxar
1204563|NCT02012439|multiple sclerosis|multiple sclerosis
1204564|NCT02012439|chronic pain|chronic pain
1204565|NCT02012439|treatment|treatment
1204566|NCT02012439|nonpharmacological|nonpharmacological
1204567|NCT02012439|mindfulness|mindfulness
1204568|NCT02012439|cognitive therapy|cognitive therapy
1204569|NCT02012413|knee|knee
1204570|NCT02012413|chondromalacia|chondromalacia
1204571|NCT02012413|patella|patella
1204572|NCT02012413|pulsed signal therapy|pulsed signal therapy
1204574|NCT02012400|Asthma|asthma
1204575|NCT02012400|Exercise|exercise
1204576|NCT02012400|Asthma control|asthma control
1204577|NCT02012400|Physical fitness|physical fitness
1204578|NCT02012400|Quality of life|quality of life
1204579|NCT02012387|Cholinergic urticaria|cholinergic urticaria
1204580|NCT02012387|Omalizumab|omalizumab
1204581|NCT02012374|aphasia|aphasia
1204582|NCT02012374|anomia|anomia
1204583|NCT02012374|speech therapy|speech therapy
1204584|NCT02012374|rehabilitation|rehabilitation
1204585|NCT02012374|neuroplasticity|neuroplasticity
1204586|NCT02012374|fMRI|fmri
1204587|NCT02012374|quality of life|quality of life
1204588|NCT02012361|Ischemic preconditioning|ischemic preconditioning
1204589|NCT02012361|Human limb ischemia|human limb ischemia
1204590|NCT02012361|Total knee arthroplasty|total knee arthroplasty
1204591|NCT02012361|Supplemental inspired helium|supplemental inspired helium
1204592|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
1204593|NCT02012322|Aging|aging
1204594|NCT02012322|Coenzyme Q10|coenzyme q10
1204595|NCT02012322|Q10|q10
1204596|NCT02012322|Quality of Life|quality of life
1204597|NCT02012322|Oxidative Stress|oxidative stress
1204598|NCT02012322|Mitochondrial Function|mitochondrial function
1204599|NCT02012322|Cell Energetics|cell energetics
1204600|NCT02012322|Fatigue|fatigue
1204601|NCT02012322|Ubiquinone|ubiquinone
1204602|NCT02012309|HIV|hiv
1204603|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
1204604|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
1204605|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
1204606|NCT02012309|Prevnar|prevnar
1204607|NCT02012309|Pneumovax|pneumovax
1204608|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
1204609|NCT02012283|spices and vegetables|spices and vegetables
1204610|NCT02012270|Aortic Aneurysm|aortic aneurysm
1204611|NCT02012270|Hernia|hernia
1204612|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
1204613|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
1204614|NCT02012257|electric pulp tester|electric pulp tester
1204615|NCT02012257|local anesthesia|local anesthesia
1204616|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
1204617|NCT02012231|melanoma|melanoma
1204618|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
1204619|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
1204620|NCT02012231|colorectal cancer|colorectal cancer
1204621|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
1204622|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
1204623|NCT02012231|histiocytosis|histiocytosis
1204624|NCT02012231|hairy cell leukemia|hairy cell leukemia
1204625|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
1204626|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
1204627|NCT02012192|High-grade serous|high-grade serous
1204628|NCT02012192|high-grade endometrioid|high-grade endometrioid
1204629|NCT02012192|undifferentiated|undifferentiated
1204630|NCT02012179|Diet|diet
1204631|NCT02012179|Dietary sodium reduction|dietary sodium reduction
1204632|NCT02012179|Salt restriction|salt restriction
1204633|NCT02012179|Nutrition|nutrition
1204634|NCT02012166|Diabetes Mellitus|diabetes mellitus
1204635|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1204636|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
1204637|NCT02012166|Metabolic Diseases|metabolic diseases
1204638|NCT02012166|Endocrine System Diseases|endocrine system diseases
1204639|NCT02012166|Therapeutic Uses|therapeutic uses
1204640|NCT02012166|Pharmacologic Actions|pharmacologic actions
1204641|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1204642|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
1204643|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
1204644|NCT02012153|Kidney transplantation|kidney transplantation
1204645|NCT02012153|Tolerance|tolerance
1204646|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
1204647|NCT02012101|COPD|copd
1204648|NCT02012101|dyspnea|dyspnea
1204649|NCT02012101|exercise|exercise
1204650|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
1204651|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
1204652|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1204653|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1204654|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
1204655|NCT02012062|Nimotuzumab|nimotuzumab
1204656|NCT02012049|Healthy|healthy
1204657|NCT02012049|Risperdal OD|risperdal od
1204658|NCT02012049|Risperdal Quicklet|risperdal quicklet
1204659|NCT02012049|Korea|korea
1205647|NCT02007759|Vitalstim|vitalstim
1204660|NCT02012023|Low anterior resection|low anterior resection
1204661|NCT02012023|Anastomotic leakage|anastomotic leakage
1204662|NCT02012023|Defunctioning stoma|defunctioning stoma
1204663|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
1204664|NCT02012023|Loop ileostomy|loop ileostomy
1204665|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
1204666|NCT02011971|epilepsy|epilepsy
1204667|NCT02011971|cognition|cognition
1204668|NCT02011971|memory|memory
1204669|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
1204670|NCT02011958|HIV positive patients|hiv positive patients
1204671|NCT02011958|Phase III trial|phase iii trial
1204672|NCT02011958|Randomised|randomised
1204673|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
1204674|NCT02011958|Ambisome|ambisome
1204675|NCT02011958|Miltefosine|miltefosine
1204676|NCT02011958|Pentamidine|pentamidine
1204677|NCT02011958|Efficacy|efficacy
1204678|NCT02011958|Safety|safety
1204679|NCT02011906|antioxidant enzymes|antioxidant enzymes
1204680|NCT02011906|omega 3|omega 3
1204681|NCT02011906|vitamin E|vitamin e
1204682|NCT02011906|CAD|cad
1204683|NCT02011906|Sirtuins|sirtuins
1204684|NCT02011906|FOXOs|foxos
1204686|NCT02011880|bone metastasis|bone metastasis
1204687|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
1204688|NCT02011867|Inner Ear Malformations|inner ear malformations
1204689|NCT02011867|Gusher|gusher
1204690|NCT02011867|Cochlear Implantation|cochlear implantation
1204691|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
1204692|NCT02011841|liver cirrhosis|liver cirrhosis
1204693|NCT02011841|ascites|ascites
1204694|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
1204695|NCT02011841|recurrence|recurrence
1204696|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
1204697|NCT02011815|Breast neoplasms|breast neoplasms
1204698|NCT02011815|Circadian rhythm|circadian rhythm
1204699|NCT02011815|sleep|sleep
1204700|NCT02011815|survival|survival
1204701|NCT02011815|distress|distress
1204702|NCT02011815|anxiety|anxiety
1204703|NCT02011815|depression|depression
1204704|NCT02011815|quality of life|quality of life
1204705|NCT02011815|actigraph|actigraph
1204706|NCT02011815|fatigue|fatigue
1204707|NCT02011802|Sorbact TM|sorbact tm
1204708|NCT02011802|Alginates|alginates
1204709|NCT02011802|Dressing|dressing
1204710|NCT02011802|Wound healing|wound healing
1204711|NCT02011789|hypercholesterolemia|hypercholesterolemia
1204712|NCT02011789|inflammation|inflammation
1204713|NCT02011789|citrus limonoids|citrus limonoids
1204714|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
1204715|NCT02011763|Hepatitis A|hepatitis a
1204716|NCT02011763|hepatitis A virus|hepatitis a virus
1204717|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
1204718|NCT02011750|schizophrenia|schizophrenia
1204719|NCT02011750|toxoplasmosis|toxoplasmosis
1204720|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
1204721|NCT02011698|Groin hernia|groin hernia
1204722|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
1204723|NCT02011672|dairy|dairy
1204724|NCT02011672|glucose|glucose
1204725|NCT02011672|inflammation|inflammation
1204726|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
1204727|NCT02011646|diet|diet
1204728|NCT02011646|body weight|body weight
1204729|NCT02011646|eating|eating
1204730|NCT02011646|eating disorder|eating disorder
1204731|NCT02011646|exercise|exercise
1204732|NCT02011581|Overweight|overweight
1204733|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
1204734|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
1204735|NCT02011568|Mild hypothermia|mild hypothermia
1204736|NCT02011568|Moderate hypothermia|moderate hypothermia
1204737|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
1204738|NCT02011542|Gulf War Illness|gulf war illness
1204739|NCT02011516|Marijuana|marijuana
1204740|NCT02011516|Addiction|addiction
1204741|NCT02011516|fMRI|fmri
1204742|NCT02011516|Baclofen|baclofen
1204743|NCT02011516|Treatment|treatment
1204744|NCT02011477|Neural mobilization|neural mobilization
1204745|NCT02011477|Physical therapy|physical therapy
1204746|NCT02011477|Asymptomatic subjects|asymptomatic subjects
1204747|NCT02011451|Multiple Sclerosis|multiple sclerosis
1204748|NCT02011451|Green Tea|green tea
1204749|NCT02011451|ECGC|ecgc
1204750|NCT02011451|Theaphenon|theaphenon
1204751|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
1204752|NCT02011451|NAA|naa
1204753|NCT02011451|Spectroscopy|spectroscopy
1204754|NCT02011451|Brain Atrophy|brain atrophy
1204755|NCT02011451|SIENA|siena
1584119|NCT00449774|Safety|safety
1282086|NCT01662635|ALK,|alk,
1204756|NCT02011438|Social Anxiety|social anxiety
1204757|NCT02011438|Prevention|prevention
1204758|NCT02011438|Peer Relations|peer relations
1204759|NCT02011438|Depression|depression
1204760|NCT02011438|Adolescent|adolescent
1204761|NCT02011438|High School|high school
1204762|NCT02011438|Interpersonal|interpersonal
1204763|NCT02011438|Peer Victimization|peer victimization
1204764|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
1204765|NCT02011425|oral appliance|oral appliance
1204766|NCT02011425|therapy|therapy
1204767|NCT02011425|masseter muscle activity|masseter muscle activity
1204768|NCT02011425|randomized controlled trial|randomized controlled trial
1204769|NCT02011425|mandibular advancement device|mandibular advancement device
1204770|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
1204771|NCT02011425|arousals|arousals
1204772|NCT02011412|Trauma|trauma
1204773|NCT02011412|Scoring Systems|scoring systems
1204774|NCT02011412|Intermountain Risk Score|intermountain risk score
1204775|NCT02011399|brain|brain
1204776|NCT02011399|computer|computer
1204777|NCT02011399|interfaces|interfaces
1204778|NCT02011399|mobility impairments|mobility impairments
1204779|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
1204780|NCT02011360|Prader Willi syndrome|prader willi syndrome
1204781|NCT02011360|childhood obesity|childhood obesity
1204782|NCT02011360|ghrelin|ghrelin
1204783|NCT02011360|appetite regulation|appetite regulation
1204784|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
1204785|NCT02011321|aneurysm|aneurysm
1204786|NCT02011321|vasospasm|vasospasm
1204787|NCT02011321|clevidipine|clevidipine
1204788|NCT02011321|transcranial dopplers|transcranial dopplers
1204789|NCT02011295|OLT|olt
1204790|NCT02011295|Surgical Intervention|surgical intervention
1204791|NCT02011295|BMAC|bmac
1204792|NCT02011282|ICU,|icu,
1204793|NCT02011282|MYOPATHY,|myopathy,
1204794|NCT02011282|NEUROPATHY,|neuropathy,
1204795|NCT02011282|PNEUMONIA|pneumonia
1204796|NCT02011269|TSO|tso
1204797|NCT02011269|Ova|ova
1204798|NCT02011269|Psoriasis|psoriasis
1204799|NCT02011269|plaque psoriasis|plaque psoriasis
1204800|NCT02011269|plaque-type|plaque-type
1204801|NCT02011269|Coronado|coronado
1204802|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1204803|NCT02011256|Transient Ischemic Attack|transient ischemic attack
1204804|NCT02011256|Atrial Fibrillation|atrial fibrillation
1204805|NCT02011256|NOTICE|notice
1204806|NCT02011256|Implantable loop-recorder|implantable loop-recorder
1204807|NCT02011256|Holter-monitoring|holter-monitoring
1204808|NCT02011243|deficit|deficit
1204809|NCT02011243|internal rotation|internal rotation
1204810|NCT02011243|gleno humeral articulation|gleno humeral articulation
1204811|NCT02011243|hand ball|hand ball
1204812|NCT02011230|Dehydration|dehydration
1204813|NCT02011230|Hoist|hoist
1204814|NCT02011230|pain control|pain control
1204815|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
1204816|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
1204817|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
1204818|NCT02011217|Rye|rye
1204819|NCT02011217|Dietary Fibre|dietary fibre
1204820|NCT02011217|Bread|bread
1204821|NCT02011217|Crisp bread|crisp bread
1204822|NCT02011217|Appetite|appetite
1204823|NCT02011217|Satiety|satiety
1204824|NCT02011217|Hunger|hunger
1204825|NCT02011217|Desire to eat|desire to eat
1204826|NCT02011217|Metabolism|metabolism
1204827|NCT02011217|Glucose|glucose
1204828|NCT02011217|Insulin|insulin
1204829|NCT02011217|Gut hormones|gut hormones
1204830|NCT02011217|Gastric emptying rate|gastric emptying rate
1204831|NCT02011191|Biotin|biotin
1204832|NCT02011191|Restless|restless
1204833|NCT02011191|Kidney|kidney
1204834|NCT02011191|Dialysis|dialysis
1204835|NCT02011191|Renal|renal
1204836|NCT02011165|Macular hole|macular hole
1204837|NCT02011165|Vitrectomy|vitrectomy
1204838|NCT02011165|Gas tamponade|gas tamponade
1204839|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
1204840|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
1204841|NCT02011113|Pomalidomide,|pomalidomide,
1204842|NCT02011113|CC-4047,|cc-4047,
1204843|NCT02011113|Dexamethasone,|dexamethasone,
1204844|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
1204845|NCT02011113|phase 2|phase 2
1204846|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
1204847|NCT02011061|Coronary Stenosis|coronary stenosis
1204848|NCT02011061|Coronary Artery Disease|coronary artery disease
1204849|NCT02011061|Angina Pectoris|angina pectoris
1204850|NCT02011035|Oral health|oral health
1204851|NCT02011035|Mouth health|mouth health
1204852|NCT02011035|Halitosis|halitosis
1204853|NCT02011035|Oral bacteria|oral bacteria
1204854|NCT02011035|Sore throat|sore throat
1204855|NCT02011035|Colds|colds
1204856|NCT02011022|Methotrexate,|methotrexate,
1204857|NCT02011022|Pharmacokinetic|pharmacokinetic
1204858|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1204859|NCT02011022|Model|model
1204860|NCT02010970|phase I|phase i
1204861|NCT02010970|healthy volunteers|healthy volunteers
1204862|NCT02010970|AZD3293|azd3293
1204863|NCT02010970|itraconazole|itraconazole
1204864|NCT02010970|diltiazem|diltiazem
1204865|NCT02010970|medazolam|medazolam
1204866|NCT02010970|drug interactions|drug interactions
1204867|NCT02010970|Pharmacokinetics|pharmacokinetics
1204868|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
1204869|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
1204870|NCT02010957|Adrenal tumour|adrenal tumour
1204871|NCT02010944|Solifenacin|solifenacin
1204872|NCT02010944|Mirabegron|mirabegron
1204873|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
1204874|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
1204875|NCT02010944|Pharmacokinetics|pharmacokinetics
1204876|NCT02010944|Bioavailability|bioavailability
1204877|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
1204878|NCT02010918|Glucosamine;|glucosamine;
1204879|NCT02010918|Chondroitin.|chondroitin.
1204880|NCT02010905|Losartan|losartan
1204881|NCT02010879|patent ductus arterioses|patent ductus arterioses
1204882|NCT02010879|ductal closure|ductal closure
1204883|NCT02010879|thrombocyte|thrombocyte
1204884|NCT02010866|internship and residency|internship and residency
1204885|NCT02010866|physicians|physicians
1204886|NCT02010866|prevention|prevention
1204887|NCT02010866|counseling|counseling
1204888|NCT02010866|suicide|suicide
1204889|NCT02010866|depression|depression
1204890|NCT02010866|burnout|burnout
1204891|NCT02010853|Transient Global amnesia|transient global amnesia
1204892|NCT02010853|fMRI|fmri
1204893|NCT02010853|resting state|resting state
1204894|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
1204895|NCT02010827|Diabetes mellitus|diabetes mellitus
1204896|NCT02010827|Glucagon|glucagon
1204897|NCT02010827|Endogenous glucose production|endogenous glucose production
1204898|NCT02010827|Incretin hormones|incretin hormones
1204899|NCT02010814|PCOS|pcos
1204900|NCT02010814|Inflammation|inflammation
1204901|NCT02010814|Body Composition|body composition
1204902|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
1204903|NCT02010801|irreversible electroporation|irreversible electroporation
1204904|NCT02010801|liver cancer|liver cancer
1204905|NCT02010762|Crohn's disease|crohn's disease
1204906|NCT02010762|Vitamin D|vitamin d
1204907|NCT02010762|Postoperative|postoperative
1204908|NCT02010762|Recurrence|recurrence
1204909|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
1204910|NCT02010762|Gastroenteritis|gastroenteritis
1204911|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
1204912|NCT02010762|Digestive System Diseases|digestive system diseases
1204913|NCT02010762|Colonic Diseases|colonic diseases
1204914|NCT02010762|Intestinal Diseases|intestinal diseases
1204915|NCT02010762|Pathologic Processes|pathologic processes
1204916|NCT02010736|Cerebral palsy|cerebral palsy
1204917|NCT02010736|Gait|gait
1204918|NCT02010736|Weight Bearing|weight bearing
1204919|NCT02010736|Rehabilitation|rehabilitation
1204920|NCT02010723|varicosis|varicosis
1204921|NCT02010723|foam sclerotherapy|foam sclerotherapy
1204922|NCT02010723|surgery|surgery
1204923|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
1204924|NCT02010710|labour|labour
1204925|NCT02010710|pregnancy|pregnancy
1204926|NCT02010710|fetal distress|fetal distress
1204927|NCT02010697|smoking cessation|smoking cessation
1204928|NCT02010697|nonsmokers|nonsmokers
1204929|NCT02010697|proxy|proxy
1204930|NCT02010697|mail intervention|mail intervention
1204931|NCT02010697|self-help|self-help
1204932|NCT02010697|behavioral intervention|behavioral intervention
1204933|NCT02010684|Diabetes|diabetes
1204934|NCT02010684|Depression|depression
1204935|NCT02010684|Self care|self care
1204936|NCT02010684|Empowerment|empowerment
1204937|NCT02010684|Behavioral intervention|behavioral intervention
1204938|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
1204939|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1204940|NCT02010671|Pregnancy|pregnancy
1204941|NCT02010671|Cesarean Section|cesarean section
1204943|NCT02010671|Delivery|delivery
1204944|NCT02010645|Leukemia|leukemia
1204945|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
1204946|NCT02010645|MDS|mds
1204947|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
1204948|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1204949|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1204950|NCT02010645|CMML|cmml
1204951|NCT02010645|Eltrombopag|eltrombopag
1204952|NCT02010645|Promacta|promacta
1204953|NCT02010645|Decitabine|decitabine
1204954|NCT02010645|Dacogen|dacogen
1204955|NCT02010632|Clopidogrel|clopidogrel
1204956|NCT02010632|Platelet inhibition|platelet inhibition
1204957|NCT02010632|Platelet aggregation|platelet aggregation
1204958|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
1204959|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
1204960|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
1204961|NCT02010606|Immunotherapy|immunotherapy
1204962|NCT02010606|Cancer stem cells|cancer stem cells
1204963|NCT02010606|Glioma stem cells|glioma stem cells
1204964|NCT02010606|Glioma stem-like cells|glioma stem-like cells
1204965|NCT02010606|Cancer stem-like cells|cancer stem-like cells
1204966|NCT02010606|Neurosphere|neurosphere
1204967|NCT02010606|Therapeutic Uses|therapeutic uses
1204968|NCT02010606|Antineoplastic Agents|antineoplastic agents
1204969|NCT02010606|Neoplasms|neoplasms
1204970|NCT02010606|Immunologic Factors|immunologic factors
1204971|NCT02010606|Interferon Inducers|interferon inducers
1204972|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
1204973|NCT02010606|Pharmacologic Actions|pharmacologic actions
1204974|NCT02010567|rectal cancer|rectal cancer
1204975|NCT02010567|colorectal cancer|colorectal cancer
1204976|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
1204977|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
1204978|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
1204979|NCT02010567|chemoradiotherapy|chemoradiotherapy
1204980|NCT02010567|nanopharmaceutical|nanopharmaceutical
1204981|NCT02010567|CLRX101|clrx101
1204982|NCT02010567|camptothecin|camptothecin
1204983|NCT02010567|capecitabine|capecitabine
1204984|NCT02010554|Multiple Sclerosis|multiple sclerosis
1204985|NCT02010554|Disease modifying medication|disease modifying medication
1204986|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
1204987|NCT02010554|Motivational Interviewing|motivational interviewing
1204988|NCT02010554|Telephone Counseling|telephone counseling
1204989|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
1204990|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
1204991|NCT02010515|sudden cardiac death|sudden cardiac death
1204992|NCT02010515|risk stratification|risk stratification
1204993|NCT02010515|t-wave alternans|t-wave alternans
1204994|NCT02010515|Holter electrocardiography|holter electrocardiography
1204995|NCT02010515|heart rate turbulence|heart rate turbulence
1204996|NCT02010502|Beet root|beet root
1204997|NCT02010502|exercise performance|exercise performance
1204998|NCT02010502|cyclists|cyclists
1204999|NCT02010489|Bariatric Surgery|bariatric surgery
1205000|NCT02010489|Exercise|exercise
1205001|NCT02010489|Physical Fitness|physical fitness
1205002|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
1205003|NCT02010463|reward processing|reward processing
1205004|NCT02010463|impulse control|impulse control
1205005|NCT02010463|obese|obese
1205006|NCT02010463|clinically obese|clinically obese
1205007|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
1205008|NCT02010450|SIDS|sids
1205009|NCT02010450|safe sleep|safe sleep
1205010|NCT02010450|safe sleep message|safe sleep message
1205011|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
1205012|NCT02010424|reduced fertility|reduced fertility
1205013|NCT02010398|Resistance training/methods|resistance training/methods
1205014|NCT02010398|contralateral strength training|contralateral strength training
1205015|NCT02010398|ipsilateral strength training|ipsilateral strength training
1205016|NCT02010398|Isokinetic contraction|isokinetic contraction
1205017|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
1205018|NCT02010398|Electromyography/methods|electromyography/methods
1205019|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
1205020|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
1205021|NCT02010385|RYGB|rygb
1205022|NCT02010385|Bariatric surgery|bariatric surgery
1205023|NCT02010385|Taste|taste
1205024|NCT02010385|Reward|reward
1205025|NCT02010385|Food behaviour|food behaviour
1205026|NCT02010385|Gut hormones|gut hormones
1205027|NCT02010372|Immunization Registry|immunization registry
1205028|NCT02010372|Human Papillomavirus|human papillomavirus
1205029|NCT02010346|Early orthodontic treatment|early orthodontic treatment
1205030|NCT02010346|Class II treatment|class ii treatment
1205031|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
1205032|NCT02010320|population model|population model
1205033|NCT02010320|pharmacokinetic|pharmacokinetic
1205034|NCT02010320|tacrolimus|tacrolimus
1205035|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
1205036|NCT02010320|individualized dosing|individualized dosing
1205037|NCT02010294|Invasive GAS infection|invasive gas infection
1205038|NCT02010294|emm genotypes|emm genotypes
1585895|NCT00445081|SCORAD|scorad
1205039|NCT02010294|Bacterial virulence factors|bacterial virulence factors
1205040|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
1205041|NCT02010281|rTMS|rtms
1205042|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
1205043|NCT02010281|randomized controlled trial|randomized controlled trial
1205044|NCT02010268|Faecal calprotectin|faecal calprotectin
1205045|NCT02010268|Feces|feces
1205046|NCT02010268|Preterm neonates|preterm neonates
1205047|NCT02010268|Enterocolitis|enterocolitis
1205048|NCT02010268|Enteropathy|enteropathy
1205049|NCT02010268|Necrotizing|necrotizing
1205050|NCT02010242|Type 2 diabetes|type 2 diabetes
1205051|NCT02010242|Proteinuria|proteinuria
1205052|NCT02010242|Albuminuria|albuminuria
1205747|NCT02007343|Pseudomonas|pseudomonas
1205053|NCT02010229|Placenta accreta|placenta accreta
1205054|NCT02010229|previous caesarean|previous caesarean
1205055|NCT02010229|placenta praevia|placenta praevia
1205056|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
1205057|NCT02010229|population-based study|population-based study
1205058|NCT02010203|TURBT|turbt
1205059|NCT02010203|Bladder|bladder
1205060|NCT02010203|Cancer|cancer
1205061|NCT02010203|GP96|gp96
1205062|NCT02010203|Vaccine|vaccine
1205063|NCT02010203|Immunotherapy|immunotherapy
1205064|NCT02010203|Heat Biologics|heat biologics
1205066|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
1205067|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
1205068|NCT02010190|Pediatric malignancies|pediatric malignancies
1205069|NCT02010190|Cancer survivors|cancer survivors
1205070|NCT02010190|Coronary artery risk|coronary artery risk
1205071|NCT02010190|Vascular function|vascular function
1205072|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
1205073|NCT02010164|Reproductive aging|reproductive aging
1205074|NCT02010164|Mitochondria|mitochondria
1205075|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
1205076|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1205077|NCT02010151|dispatch|dispatch
1205078|NCT02010151|emergency medicine|emergency medicine
1205079|NCT02010138|Internal Limiting Membrane|internal limiting membrane
1205080|NCT02010138|Metamorphopsia|metamorphopsia
1205081|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
1205082|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1205083|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
1205084|NCT02010125|Bio-specimens|bio-specimens
1205085|NCT02010125|Acute ACL Injury|acute acl injury
1205086|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
1205087|NCT02010112|H.Pylori|h.pylori
1205088|NCT02010086|Intervention|intervention
1205089|NCT02010086|Autism|autism
1205090|NCT02010086|Treatment sensitivity|treatment sensitivity
1205091|NCT02010086|School aged|school aged
1205092|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
1205093|NCT02010086|Social Skills Intervention|social skills intervention
1205094|NCT02010073|Lung|lung
1205095|NCT02010073|ARDS|ards
1205096|NCT02010073|acute|acute
1205097|NCT02010073|respiratory|respiratory
1205098|NCT02010073|syndrome|syndrome
1205099|NCT02010073|prognosis|prognosis
1205100|NCT02010073|outcome research|outcome research
1205101|NCT02010073|respiratory infection|respiratory infection
1205102|NCT02010073|sepsis|sepsis
1205103|NCT02010073|organ failure|organ failure
1205104|NCT02010073|hypoxaemia|hypoxaemia
1205105|NCT02010060|Exercise training|exercise training
1205106|NCT02010060|Non-exercise physical activity|non-exercise physical activity
1205107|NCT02010060|pedometers|pedometers
1205108|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
1205109|NCT02010047|Polymerase chain reaction|polymerase chain reaction
1205110|NCT02010047|Immunohistochemistry|immunohistochemistry
1205111|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
1205112|NCT02010034|TPN|tpn
1205113|NCT02010034|Liver Function|liver function
1205114|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
1205115|NCT02010021|breast cancer|breast cancer
1205116|NCT02010021|postmenopausal|postmenopausal
1205117|NCT02010021|letrozole|letrozole
1205118|NCT02010021|RAD001|rad001
1205119|NCT02010021|Everolimus|everolimus
1205120|NCT02010008|breast cancer|breast cancer
1205121|NCT02010008|cancer disparities|cancer disparities
1205122|NCT02010008|Latino women|latino women
1205123|NCT02010008|Hispanic women|hispanic women
1205124|NCT02010008|mammography|mammography
1205125|NCT02010008|multi-level intervention|multi-level intervention
1205126|NCT02009995|Diabetes Mellitus|diabetes mellitus
1205127|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1205128|NCT02009995|Resistance Training|resistance training
1205129|NCT02009995|Resistance Exercise|resistance exercise
1205130|NCT02009995|Resistance Band|resistance band
1205131|NCT02009995|Thera-band|thera-band
1205132|NCT02009995|elastic band|elastic band
1205133|NCT02009995|exercise band|exercise band
1205134|NCT02009982|Fainting|fainting
1205135|NCT02009982|Ablation|ablation
1205136|NCT02009982|Cardiology|cardiology
1205137|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
1205138|NCT02009969|Psychosis|psychosis
1205139|NCT02009969|Adverse effects|adverse effects
1205140|NCT02009969|Symptom Severity|symptom severity
1205141|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
1205142|NCT02009943|critical illness|critical illness
1205143|NCT02009943|iron supplementation|iron supplementation
1205144|NCT02009943|functional iron deficiency|functional iron deficiency
1205145|NCT02009943|ICU anemia|icu anemia
1205146|NCT02009943|red blood cell transfusion|red blood cell transfusion
1205147|NCT02009930|Enlisted military members|enlisted military members
1205148|NCT02009930|CAC|cac
1205149|NCT02009930|Coronary Artery Calcium|coronary artery calcium
1205150|NCT02009930|Cardiovascular|cardiovascular
1205151|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
1205152|NCT02009917|Non essential Amino acids|non essential amino acids
1205153|NCT02009917|Protein|protein
1205154|NCT02009917|Amino acid|amino acid
1205155|NCT02009904|PKU|pku
1205156|NCT02009904|Phenylketonuria|phenylketonuria
1205157|NCT02009904|Phenylalanine|phenylalanine
1205158|NCT02009904|Children|children
1205159|NCT02009904|Stable isotopes|stable isotopes
1205160|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
1205161|NCT02009891|predictive model|predictive model
1205162|NCT02009891|in vitro fertilization|in vitro fertilization
1205163|NCT02009891|elective single embryo transfer|elective single embryo transfer
1205164|NCT02009878|SIADH|siadh
1205165|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
1205166|NCT02009865|Dyslipidemia|dyslipidemia
1205167|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
1205168|NCT02009865|EPA|epa
1205169|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
1205170|NCT02009865|DHA|dha
1205171|NCT02009852|microRNA-29b|microrna-29b
1205172|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
1205173|NCT02009852|migration|migration
1205174|NCT02009852|prognosis|prognosis
1205175|NCT02009839|anxiety|anxiety
1205176|NCT02009839|frequency of speech|frequency of speech
1205177|NCT02009839|selective mutism|selective mutism
1205178|NCT02009826|Schizophrenia|schizophrenia
1205179|NCT02009826|Psychosis|psychosis
1205180|NCT02009826|Neuroinflammation|neuroinflammation
1205181|NCT02009826|Microglial activation|microglial activation
1205182|NCT02009813|Insulin resistance|insulin resistance
1205183|NCT02009813|Inflammation|inflammation
1205184|NCT02009813|Hypoxia|hypoxia
1205185|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
1205186|NCT02009774|Colonoscopy|colonoscopy
1205187|NCT02009774|Adenoma detection rate|adenoma detection rate
1205188|NCT02009774|Narrow band imaging|narrow band imaging
1205189|NCT02009774|Optical biopsy|optical biopsy
1205190|NCT02009774|Accuracy|accuracy
1205191|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
1205192|NCT02009722|Cesarean Delivery|cesarean delivery
1205193|NCT02009722|Intrathecal Morphine|intrathecal morphine
1205194|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
1205195|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
1205196|NCT02009722|Spinal Anesthesia|spinal anesthesia
1205197|NCT02009709|keratoconus|keratoconus
1205198|NCT02009709|collagen crosslinking|collagen crosslinking
1205199|NCT02009709|crosslinking|crosslinking
1205200|NCT02009709|ectasia|ectasia
1205201|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1205202|NCT02009644|AAA|aaa
1205203|NCT02009644|Aneurysm|aneurysm
1205204|NCT02009631|Solid Tumors|solid tumors
1205205|NCT02009631|Ovarian Cancer|ovarian cancer
1205206|NCT02009631|Colon Cancer|colon cancer
1205207|NCT02009631|Lung Cancer|lung cancer
1205208|NCT02009631|Breast Cancer|breast cancer
1205209|NCT02009631|Gastric Cancer|gastric cancer
1205210|NCT02009618|IBS|ibs
1205211|NCT02009618|Rifaximin|rifaximin
1205212|NCT02009605|icotinib, SCC|icotinib, scc
1205213|NCT02009592|Hepatosteatosis|hepatosteatosis
1205214|NCT02009592|Steatohepatitis|steatohepatitis
1205215|NCT02009592|Rifaximin|rifaximin
1205216|NCT02009592|Inflammatory cytokines|inflammatory cytokines
1205217|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
1205218|NCT02009579|Paclitaxel|paclitaxel
1205219|NCT02009579|Carboplatin|carboplatin
1205220|NCT02009579|Nintedanib|nintedanib
1205221|NCT02009553|Anxiety|anxiety
1205222|NCT02009553|Urodynamics|urodynamics
1205223|NCT02009514|Hemodialysis|hemodialysis
1205224|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
1205225|NCT02009514|Hypoglycemia|hypoglycemia
1205226|NCT02009514|Hyperglycemia|hyperglycemia
1205227|NCT02009501|Infected wounds|infected wounds
1205228|NCT02009501|NPWTi|npwti
1205229|NCT02009501|VAC Instill|vac instill
1205230|NCT02009501|Biofilm|biofilm
1205231|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1205232|NCT02009488|Metformin|metformin
1205233|NCT02009488|Canagliflozin|canagliflozin
1205234|NCT02009488|INVOKANA®|invokana®
1205235|NCT02009488|Insulin sensitivity|insulin sensitivity
1205236|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
1205237|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
1282699|NCT01659541|cough|cough
1205238|NCT02009475|Rehabilitation|rehabilitation
1205239|NCT02009475|Exercise Training|exercise training
1205240|NCT02009475|Interval training|interval training
1205241|NCT02009462|HIV|hiv
1205242|NCT02009462|Facial lipoatrophy|facial lipoatrophy
1205243|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
1205244|NCT02009449|Oncology|oncology
1205245|NCT02009449|Cancer|cancer
1205246|NCT02009449|Solid Tumors|solid tumors
1205247|NCT02009423|Gastro-Intestinal Stromal Tumour, GIST, localized primary tumor, complete surgery, adjuvant therapy.|gastro-intestinal stromal tumour, gist, localized primary tumor, complete surgery, adjuvant therapy.
1205345|NCT02008994|metastatic breast cancer|metastatic breast cancer
1205248|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1205249|NCT02009358|mental health promotion|mental health promotion
1205250|NCT02009358|depression|depression
1205251|NCT02009358|migrant workers|migrant workers
1205252|NCT02009358|China|china
1206342|NCT02004587|Gemigliptin|gemigliptin
1205253|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
1205254|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
1205255|NCT02009345|Registry|registry
1205256|NCT02009345|Coronary artery disease|coronary artery disease
1205257|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
1205258|NCT02009319|EBUS - TBNA|ebus - tbna
1205259|NCT02009319|elastography|elastography
1205260|NCT02009319|strain ratio|strain ratio
1205261|NCT02009319|lung cancer staging|lung cancer staging
1205262|NCT02009306|Palliative|palliative
1205263|NCT02009306|Symptom control|symptom control
1205265|NCT02009306|Opioid|opioid
1205266|NCT02009306|Benzodiazepine|benzodiazepine
1205267|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1205268|NCT02009293|cough|cough
1205269|NCT02009293|quality of life|quality of life
1205270|NCT02009280|Propofol|propofol
1205271|NCT02009280|Lung transplantation|lung transplantation
1205272|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1205273|NCT02009280|Acute kidney injury|acute kidney injury
1205274|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1205275|NCT02009241|Rehabilitation|rehabilitation
1205276|NCT02009241|Exercise|exercise
1205277|NCT02009228|Single-port laparoscopy|single-port laparoscopy
1205278|NCT02009228|Abdominal pain|abdominal pain
1205279|NCT02009228|Ovarian spillage|ovarian spillage
1205280|NCT02009228|Endobag rupture|endobag rupture
1205281|NCT02009228|Ovarian reserve|ovarian reserve
1205282|NCT02009215|Uganda|uganda
1205283|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
1205284|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1205285|NCT02009215|schoolchildren|schoolchildren
1205286|NCT02009215|malaria|malaria
1205287|NCT02009202|Colon preparation|colon preparation
1205288|NCT02009202|Child|child
1205289|NCT02009189|home parenteral nutrition|home parenteral nutrition
1205290|NCT02009189|central venous catheter|central venous catheter
1205291|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
1205292|NCT02009176|Laparoscopic|laparoscopic
1205293|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
1205294|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
1205295|NCT02009176|Micrometastases|micrometastases
1205296|NCT02009137|small breast|small breast
1205297|NCT02009137|augmentation|augmentation
1205298|NCT02009137|breast volume|breast volume
1205299|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
1205300|NCT02009124|spinal cord injury|spinal cord injury
1205301|NCT02009124|stem cell therapy|stem cell therapy
1205302|NCT02009124|bone marrow|bone marrow
1205303|NCT02009124|mononuclear cells|mononuclear cells
1205304|NCT02009124|autologous|autologous
1205305|NCT02009111|Transition to parenthood|transition to parenthood
1205306|NCT02009111|Relationship intervention|relationship intervention
1205307|NCT02009098|Randomized Controlled Trial|randomized controlled trial
1205308|NCT02009098|Caesarean Section|caesarean section
1205309|NCT02009098|preoperative|preoperative
1205310|NCT02009098|intraoperative|intraoperative
1205311|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
1205312|NCT02009098|antibiotics|antibiotics
1205313|NCT02009098|timing|timing
1205314|NCT02009098|surgical site infections|surgical site infections
1205315|NCT02009098|endometritis|endometritis
1205316|NCT02009098|wound infections|wound infections
1205317|NCT02009098|urinary tract infections|urinary tract infections
1205318|NCT02009098|infectious morbidity|infectious morbidity
1205319|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
1205320|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
1205321|NCT02009072|Pterygium surgery|pterygium surgery
1205322|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
1205323|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
1205324|NCT02009059|hypothermia|hypothermia
1205325|NCT02009059|Temperature|temperature
1205326|NCT02009059|epitympanic|epitympanic
1205327|NCT02009059|pre-hospital|pre-hospital
1205328|NCT02009046|Adolescent|adolescent
1205329|NCT02009046|Sex education|sex education
1205330|NCT02009046|Sexuality education|sexuality education
1205331|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
1205332|NCT02009046|Pregnancy|pregnancy
1205333|NCT02009046|Sexual behavior|sexual behavior
1205334|NCT02009046|Sexuality|sexuality
1205335|NCT02009046|Relationship rights|relationship rights
1205336|NCT02009046|Gender norms|gender norms
1205337|NCT02009046|Human rights|human rights
1205338|NCT02009046|Intervention studies|intervention studies
1205339|NCT02009046|Parent intervention|parent intervention
1205340|NCT02009046|Peer intervention|peer intervention
1205341|NCT02009007|cerebral oximeter|cerebral oximeter
1205342|NCT02009007|one lung ventilation|one lung ventilation
1205343|NCT02009007|dopamine|dopamine
1205344|NCT02009007|phenylephrine|phenylephrine
1205346|NCT02008994|breast cancer|breast cancer
1205347|NCT02008994|genomics|genomics
1205348|NCT02008994|personalized medicine|personalized medicine
1205349|NCT02008994|precision oncology|precision oncology
1205350|NCT02008994|breast cancer treatment|breast cancer treatment
1205351|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
1205352|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
1205353|NCT02008994|breast cancer trial|breast cancer trial
1205354|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
1205355|NCT02008955|lysine, indicator amino acid oxidation, elderly females|lysine, indicator amino acid oxidation, elderly females
1205356|NCT02008929|NKCELL|nkcell
1205357|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
1205358|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
1205359|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
1205360|NCT02008877|MPNST|mpnst
1205361|NCT02008877|Sarcoma|sarcoma
1205362|NCT02008877|Ganetespib|ganetespib
1205363|NCT02008877|Sirolimus|sirolimus
1205364|NCT02008877|mTOR inhibitor|mtor inhibitor
1205365|NCT02008877|Heat shock protein|heat shock protein
1205366|NCT02008877|Hsp90|hsp90
1205367|NCT02008864|End stage renal diseases|end stage renal diseases
1205368|NCT02008864|Hemodialysis|hemodialysis
1205369|NCT02008864|Uremic pruritus|uremic pruritus
1205370|NCT02008864|Iranian traditional medicine|iranian traditional medicine
1205371|NCT02008864|Cassia angustifolia|cassia angustifolia
1205372|NCT02008851|Chronic kidney disease|chronic kidney disease
1205373|NCT02008851|Type 2 Diabetes|type 2 diabetes
1205374|NCT02008851|Neo-kidney augment|neo-kidney augment
1205375|NCT02008851|Regenerative medicine|regenerative medicine
1205376|NCT02008825|ViSiGi|visigi
1205377|NCT02008825|Calibration tube|calibration tube
1205378|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
1205379|NCT02008812|Adenovirus|adenovirus
1205380|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
1205381|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
1205382|NCT02008786|Angina|angina
1205383|NCT02008773|schizophrenia|schizophrenia
1205384|NCT02008773|schizoaffective|schizoaffective
1205385|NCT02008773|schizophreniform|schizophreniform
1205386|NCT02008773|inflammatory markers|inflammatory markers
1205387|NCT02008773|HSV1|hsv1
1205388|NCT02008773|cognition|cognition
1205389|NCT02008773|early psychosis|early psychosis
1205390|NCT02008773|valacyclovir|valacyclovir
1205391|NCT02008760|pain|pain
1205392|NCT02008760|quality of life|quality of life
1205393|NCT02008760|ADL|adl
1205394|NCT02008760|DOLO test|dolo test
1205395|NCT02008760|compliance|compliance
1205396|NCT02008760|D3|d3
1205397|NCT02008747|Atrial fibrillation|atrial fibrillation
1205398|NCT02008747|Neuropathic pain|neuropathic pain
1205399|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
1205400|NCT02008747|Lung resection|lung resection
1205401|NCT02008721|Multiple System Atrophy|multiple system atrophy
1205402|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
1205403|NCT02008708|Health|health
1205404|NCT02008708|Microfinance|microfinance
1205405|NCT02008695|Health|health
1205406|NCT02008695|Youth|youth
1205407|NCT02008695|Microfinance|microfinance
1205408|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
1205409|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
1205410|NCT02008656|FLUOROURACIL|fluorouracil
1205411|NCT02008656|LEUCOVORIN|leucovorin
1205412|NCT02008656|OXALIPLATIN|oxaliplatin
1205413|NCT02008656|Total mesorectal excision|total mesorectal excision
1205414|NCT02008656|Chemoradiation therapy|chemoradiation therapy
1205415|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
1205416|NCT02008656|13-213|13-213
1205417|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
1205418|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1205419|NCT02008604|ischemia|ischemia
1205420|NCT02008604|stroke|stroke
1205421|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
1205422|NCT02008604|microbiome|microbiome
1205423|NCT02008604|microbiota|microbiota
1205424|NCT02008604|gut|gut
1205425|NCT02008591|Neuraxial Technique|neuraxial technique
1205426|NCT02008591|Epidural Technique|epidural technique
1205427|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
1205428|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
1205429|NCT02008591|Labor Analgesia|labor analgesia
1205430|NCT02008591|Obstetric|obstetric
1205431|NCT02008578|Antiviral|antiviral
1205432|NCT02008578|Adjunctive Therapy|adjunctive therapy
1205433|NCT02008578|Antibody|antibody
1205434|NCT02008565|Fecal incontinence|fecal incontinence
1205435|NCT02008565|Loperamide|loperamide
1205436|NCT02008565|anal exercises|anal exercises
1205437|NCT02008565|biofeedback|biofeedback
1205438|NCT02008552|Genetic factor|genetic factor
1205439|NCT02008552|Valvulopathy|valvulopathy
1205440|NCT02008552|Mediator|mediator
1205441|NCT02008526|Text Messaging|text messaging
1205442|NCT02008526|mHealth|mhealth
1205443|NCT02008526|Methamphetamine|methamphetamine
1205444|NCT02008526|HIV|hiv
1205445|NCT02008526|AIDS|aids
1205446|NCT02008513|AFFITOPE® AD02|affitope® ad02
1205447|NCT02008513|Alzheimer Disease|alzheimer disease
1205448|NCT02008513|Dementia|dementia
1205449|NCT02008513|Brain Disease|brain disease
1205450|NCT02008513|Nervous System Diseases|nervous system diseases
1205451|NCT02008513|Tauopathies|tauopathies
1205452|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
1205453|NCT02008513|Mental Disorders|mental disorders
1205454|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
1205455|NCT02008500|Gingival Recession|gingival recession
1205456|NCT02008500|Visual Analogue Score|visual analogue score
1205457|NCT02008487|wound|wound
1205458|NCT02008487|palliative care|palliative care
1205459|NCT02008487|hospice|hospice
1205460|NCT02008487|pressure ulcers|pressure ulcers
1205461|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
1205462|NCT02008435|Obesity|obesity
1205463|NCT02008435|Overweight|overweight
1205464|NCT02008435|Lifestyle change|lifestyle change
1205465|NCT02008435|Healthy eating|healthy eating
1205466|NCT02008435|Weight loss|weight loss
1205467|NCT02008435|Exercise|exercise
1205468|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
1205469|NCT02008435|Implementation intentions|implementation intentions
1205470|NCT02008435|Mental imagery|mental imagery
1205471|NCT02008435|Mental practice|mental practice
1205472|NCT02008435|If-then plans|if-then plans
1205473|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
1205474|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
1205475|NCT02008396|MDMA|mdma
1205476|NCT02008396|autism|autism
1205477|NCT02008396|social anxiety|social anxiety
1205478|NCT02008383|Colorectal cancer|colorectal cancer
1205479|NCT02008383|Panitumumab|panitumumab
1205480|NCT02008383|Cabozantinib|cabozantinib
1205481|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
1205482|NCT02008370|Exparel|exparel
1205483|NCT02008357|Cognition|cognition
1205484|NCT02008357|Prevention|prevention
1205485|NCT02008344|influenza|influenza
1205486|NCT02008344|flu|flu
1205487|NCT02008344|fever|fever
1205488|NCT02008344|cough|cough
1205489|NCT02008344|body aches|body aches
1205490|NCT02008344|headache|headache
1205491|NCT02008344|nasal congestion|nasal congestion
1205492|NCT02008344|body pains|body pains
1205493|NCT02008344|sore throat|sore throat
1205494|NCT02008344|fatigue|fatigue
1205495|NCT02008344|T-705|t-705
1205496|NCT02008344|favipiravir|favipiravir
1205497|NCT02008344|favor|favor
1205498|NCT02008344|flu symptoms|flu symptoms
1205499|NCT02008331|chronic kidney disease|chronic kidney disease
1205500|NCT02008331|p-cresol|p-cresol
1205501|NCT02008331|synbiotic|synbiotic
1205502|NCT02008292|smoking|smoking
1205503|NCT02008292|schizophrenia|schizophrenia
1205504|NCT02008292|acetylcholine|acetylcholine
1205505|NCT02008279|Healthy|healthy
1205506|NCT02008279|CNTO 3157|cnto 3157
1205507|NCT02008279|Pharmacokinetics|pharmacokinetics
1205508|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
1205509|NCT02008253|ASTIGMATISM|astigmatism
1205510|NCT02008240|Infertility|infertility
1205511|NCT02008240|Hydrosalpinx|hydrosalpinx
1205512|NCT02008240|IVF-ET|ivf-et
1205513|NCT02008240|Salpingectomy|salpingectomy
1205514|NCT02008214|Pentoxifylline|pentoxifylline
1205515|NCT02008214|Sustained virologic response|sustained virologic response
1205516|NCT02008214|Hepatic fibrosis|hepatic fibrosis
1205517|NCT02008201|dose-response study|dose-response study
1205518|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1205519|NCT02008188|Artificial Pancreas|artificial pancreas
1205520|NCT02008188|Closed Loop Control|closed loop control
1205521|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1205522|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1205523|NCT02008188|Insulin Pump|insulin pump
1205524|NCT02008188|Metabolic Diseases|metabolic diseases
1205525|NCT02008188|Endocrine System Diseases|endocrine system diseases
1205526|NCT02008188|Autoimmune Diseases|autoimmune diseases
1283072|NCT01657682|AML|aml
1205527|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
1205528|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
1205529|NCT02008149|Osteoporosis|osteoporosis
1205530|NCT02008136|myofascial pain|myofascial pain
1205531|NCT02008136|muscle spasm|muscle spasm
1205532|NCT02008136|botulinum toxin|botulinum toxin
1205533|NCT02008136|cervicalgia|cervicalgia
1205534|NCT02008136|lumbago|lumbago
1205535|NCT02008136|low back pain|low back pain
1205536|NCT02008123|Clopidogrel|clopidogrel
1205537|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
1205538|NCT02008123|Primidone|primidone
1205539|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
1205540|NCT02008110|Heart failure|heart failure
1205541|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
1205542|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
1205543|NCT02008110|Clinical outcomes.|clinical outcomes.
1205544|NCT02008097|Ultrasound|ultrasound
1205545|NCT02008097|Ultrasonography|ultrasonography
1205546|NCT02008097|Liver transplantation|liver transplantation
1205547|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
1205548|NCT02008097|Hypertension|hypertension
1205549|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
1205550|NCT02008097|Pregnancy|pregnancy
1205551|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
1205552|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
1205553|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
1205554|NCT02008058|LCCC 1231|lccc 1231
1205555|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1205556|NCT02008058|UNC Lineberger|unc lineberger
1205557|NCT02008058|Prostate Cancer|prostate cancer
1205558|NCT02008058|Pain|pain
1205559|NCT02008045|MRI|mri
1205560|NCT02008045|Imaging|imaging
1205561|NCT02008045|Neurocognitive|neurocognitive
1205562|NCT02008045|White matter injury|white matter injury
1205563|NCT02008032|Mammography|mammography
1205564|NCT02008032|Breast|breast
1205565|NCT02008032|Implants|implants
1205566|NCT02008019|Chondrosarcoma|chondrosarcoma
1205567|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
1205568|NCT02008019|Phase II|phase ii
1205569|NCT02008019|Everolimus|everolimus
1205570|NCT02008019|Success Rate|success rate
1205571|NCT02008019|Progression Free Survival|progression free survival
1205572|NCT02008019|Overall Survival|overall survival
1205573|NCT02008019|Safety|safety
1205574|NCT02008019|Quality of Life|quality of life
1205575|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
1205576|NCT02008006|Follicular Lymphoma|follicular lymphoma
1205577|NCT02008006|Chemosensitive relapse|chemosensitive relapse
1205578|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
1205579|NCT02008006|Bendamustine|bendamustine
1205580|NCT02008006|BeEAM|beeam
1205581|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1205582|NCT02008006|Safety|safety
1205583|NCT02008006|Event Free Survival|event free survival
1205584|NCT02008006|Overall Response Rate|overall response rate
1205585|NCT02008006|Progression Free Survival|progression free survival
1205586|NCT02008006|Overall Survival|overall survival
1205587|NCT02008006|Phase II|phase ii
1205588|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
1205589|NCT02008006|WHO 2 grade|who 2 grade
1205590|NCT02008006|WHO 3a grade|who 3a grade
1205591|NCT02007993|Halitosis,|halitosis,
1205592|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
1205593|NCT02007993|Adolescent|adolescent
1205594|NCT02007980|urological problems|urological problems
1205595|NCT02007980|indwelling urologic stent|indwelling urologic stent
1205596|NCT02007980|kidney stone disease|kidney stone disease
1205597|NCT02007980|urinary system obstruction|urinary system obstruction
1205598|NCT02007980|hydronephrosis|hydronephrosis
1205599|NCT02007980|ureteral damage|ureteral damage
1205600|NCT02007954|HCC|hcc
1205601|NCT02007915|Adolescent|adolescent
1205602|NCT02007915|Avascular Necrosis|avascular necrosis
1205603|NCT02007915|Bisphosphonates|bisphosphonates
1205604|NCT02007915|Pamidronate|pamidronate
1205605|NCT02007902|Preterm baby|preterm baby
1205606|NCT02007902|Total plasma protein|total plasma protein
1205607|NCT02007902|Albumin|albumin
1205608|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
1205609|NCT02007902|Perfusion|perfusion
1205610|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
1205611|NCT02007902|Ultrasound|ultrasound
1205612|NCT02007876|Mobility|mobility
1205613|NCT02007876|Activity|activity
1205614|NCT02007876|Training|training
1205615|NCT02007876|Abdominal|abdominal
1205616|NCT02007876|Surgery|surgery
1205617|NCT02007876|Adult|adult
1205618|NCT02007863|Leukemia|leukemia
1205619|NCT02007863|Myelodysplasia|myelodysplasia
1205620|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
1205621|NCT02007863|ALL|all
1205622|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
1205623|NCT02007863|AML|aml
1205624|NCT02007863|Pediatric|pediatric
1205625|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
1205626|NCT02007850|knee arthroplasty|knee arthroplasty
1205627|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
1205628|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
1205629|NCT02007837|gestational hypertension|gestational hypertension
1205630|NCT02007837|pre-eclampsia|pre-eclampsia
1205631|NCT02007837|preeclampsia|preeclampsia
1205632|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
1205633|NCT02007824|pressure ulcer|pressure ulcer
1205634|NCT02007824|chronic wound|chronic wound
1205635|NCT02007824|tissue necrosis|tissue necrosis
1205636|NCT02007824|slough|slough
1205637|NCT02007824|ultra sound|ultra sound
1205638|NCT02007798|dexmedetomidine|dexmedetomidine
1205639|NCT02007798|supratentorial tumors|supratentorial tumors
1205640|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
1205641|NCT02007785|CO-OP|co-op
1205642|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
1205643|NCT02007759|Dysphagia|dysphagia
1205644|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1205645|NCT02007759|NMES|nmes
1205646|NCT02007759|Neonates|neonates
1205648|NCT02007746|sickle cell disease|sickle cell disease
1205649|NCT02007746|hemochromatosis|hemochromatosis
1205650|NCT02007746|liver fibrosis|liver fibrosis
1205651|NCT02007746|liver cirrhosis|liver cirrhosis
1205652|NCT02007746|FibroScan|fibroscan
1205653|NCT02007746|Ferriscan|ferriscan
1205654|NCT02007746|liver iron|liver iron
1205655|NCT02007733|Diarrhea|diarrhea
1205656|NCT02007733|Dehydration|dehydration
1205657|NCT02007733|Children|children
1205658|NCT02007733|Resuscitation|resuscitation
1205659|NCT02007733|Clinical Prediction Rule|clinical prediction rule
1205660|NCT02007733|Low Income Country|low income country
1205661|NCT02007733|Bangladesh|bangladesh
1205662|NCT02007720|Serelaxin,|serelaxin,
1205663|NCT02007720|WHF,|whf,
1205664|NCT02007720|Likert Scale,|likert scale,
1205665|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
1205666|NCT02007720|RLX030,|rlx030,
1205667|NCT02007720|AHF,|ahf,
1205668|NCT02007720|acute heart failure|acute heart failure
1205669|NCT02007707|Asian American|asian american
1205670|NCT02007707|Vietnamese American|vietnamese american
1205671|NCT02007707|Smoking cessation|smoking cessation
1205672|NCT02007707|Community Health Worker|community health worker
1205673|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
1205674|NCT02007707|Family Intervention|family intervention
1205675|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
1205676|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1205677|NCT02007694|Fear extinction|fear extinction
1205678|NCT02007694|propranolol|propranolol
1205679|NCT02007694|Yohimbine|yohimbine
1205680|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
1205681|NCT02007668|low back pain|low back pain
1205682|NCT02007668|kinesio taping|kinesio taping
1205683|NCT02007655|Cardiovascular|cardiovascular
1205684|NCT02007616|Cognitive aging|cognitive aging
1205685|NCT02007616|Video games training|video games training
1205686|NCT02007616|Attention|attention
1205687|NCT02007616|Memory|memory
1205688|NCT02007616|Wellbeing|wellbeing
1205689|NCT02007616|Speed of processing|speed of processing
1205690|NCT02007616|Executive functions|executive functions
1205691|NCT02007603|chronic hemodialysis|chronic hemodialysis
1205692|NCT02007603|ampicillin|ampicillin
1205693|NCT02007603|sulbactam|sulbactam
1205694|NCT02007603|amoxicillin|amoxicillin
1205695|NCT02007603|clavulanic acid|clavulanic acid
1205696|NCT02007603|pharmacokinetics|pharmacokinetics
1205697|NCT02007577|insulin resistant|insulin resistant
1205698|NCT02007564|Palliative care dyads|palliative care dyads
1205699|NCT02007564|Volunteers|volunteers
1205700|NCT02007564|Community-based|community-based
1205701|NCT02007564|Mixed methods|mixed methods
1205702|NCT02007551|Social Isolation|social isolation
1205703|NCT02007551|Nutrition Assessments|nutrition assessments
1205704|NCT02007551|Food Habits|food habits
1205705|NCT02007551|Meals|meals
1205706|NCT02007551|Self Efficacy|self efficacy
1205707|NCT02007551|Quality of Life|quality of life
1205708|NCT02007551|Peer Group|peer group
1205709|NCT02007538|Lung Cancer|lung cancer
1205710|NCT02007538|Bronchoscopy|bronchoscopy
1205711|NCT02007538|Fine Need Aspiration|fine need aspiration
1205712|NCT02007538|Cytochemical Assays|cytochemical assays
1205713|NCT02007512|advanced breast cancer|advanced breast cancer
1205714|NCT02007512|enzalutamide|enzalutamide
1205715|NCT02007512|MDV3100|mdv3100
1205716|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
1205717|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
1205718|NCT02007512|HER-2 normal|her-2 normal
1205719|NCT02007499|Prehospital emergency care|prehospital emergency care
1205720|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
1205721|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1205722|NCT02007499|CPR|cpr
1205723|NCT02007499|Heart arrest|heart arrest
1205724|NCT02007499|Outcome|outcome
1205725|NCT02007499|Bystander|bystander
1205726|NCT02007486|Heart Failure|heart failure
1205727|NCT02007486|Exercise|exercise
1205728|NCT02007486|Dyspnea|dyspnea
1205729|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
1205730|NCT02007486|Respiratory mechanics|respiratory mechanics
1205731|NCT02007473|Haemovigilance|haemovigilance
1205732|NCT02007473|Plasma|plasma
1205733|NCT02007473|Pathogen reduction|pathogen reduction
1205734|NCT02007473|Methylene Blue|methylene blue
1205735|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
1205736|NCT02007421|Human Papillomavirus,|human papillomavirus,
1205737|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
1205738|NCT02007421|Homosexual Men|homosexual men
1205739|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
1205740|NCT02007421|Cancer Screening|cancer screening
1205741|NCT02007421|HIV|hiv
1205742|NCT02007408|abortion|abortion
1205743|NCT02007408|analgesia|analgesia
1205744|NCT02007408|paracervical block|paracervical block
1205745|NCT02007408|lidocaine spray|lidocaine spray
1205746|NCT02007343|Enterobacteriaceae|enterobacteriaceae
1205748|NCT02007343|Acinetobacter|acinetobacter
1205749|NCT02007343|Stenotrophomonas|stenotrophomonas
1205750|NCT02007343|Mortality|mortality
1205751|NCT02007343|Morbidity|morbidity
1205752|NCT02007343|Cost of Illness|cost of illness
1205753|NCT02007343|Causality|causality
1205754|NCT02007343|Multicenter Study|multicenter study
1205755|NCT02007343|Cohort Studies|cohort studies
1205756|NCT02007343|Case-Control Studies|case-control studies
1205757|NCT02007343|Prospective Studies|prospective studies
1205758|NCT02007343|Follow-up Studies|follow-up studies
1205759|NCT02007330|systemic lidocaine|systemic lidocaine
1205760|NCT02007330|postoperative pain|postoperative pain
1205761|NCT02007330|recovery, pediatric|recovery, pediatric
1205762|NCT02007330|inguinal hernia|inguinal hernia
1205763|NCT02007330|laparoscopy|laparoscopy
1205764|NCT02007317|BCC|bcc
1205765|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
1205766|NCT02007278|diabetes|diabetes
1205767|NCT02007278|hypoglycemia|hypoglycemia
1205768|NCT02007278|glycemic variability|glycemic variability
1205769|NCT02007278|vildagliptin|vildagliptin
1205770|NCT02007278|glimepiride|glimepiride
1205771|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1205772|NCT02007252|AAA|aaa
1205773|NCT02007252|IL-1b|il-1b
1205774|NCT02007252|Abdominal ultrasound|abdominal ultrasound
1205775|NCT02007239|tocilizumab|tocilizumab
1205776|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
1205777|NCT02007239|cytokine|cytokine
1205778|NCT02007239|cytokine release syndrome|cytokine release syndrome
1205779|NCT02007226|Coronary Heart Disease|coronary heart disease
1205780|NCT02007226|spinal cord injury|spinal cord injury
1205781|NCT02007226|risk factor|risk factor
1205782|NCT02007226|postprandial lipemia|postprandial lipemia
1205783|NCT02007213|Neuromuscular Disease|neuromuscular disease
1205784|NCT02007213|Motor Function|motor function
1205785|NCT02007213|Proxy Reported Outcome|proxy reported outcome
1205786|NCT02007213|Young Children|young children
1205787|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
1205788|NCT02007187|Randomized Controlled Trial|randomized controlled trial
1205789|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
1205790|NCT02007174|recurrent pterygium|recurrent pterygium
1205791|NCT02007174|bevacizumab|bevacizumab
1205792|NCT02007174|triple dose|triple dose
1205793|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
1205794|NCT02007148|capecitabine,|capecitabine,
1205795|NCT02007148|second line treatment,|second line treatment,
1205796|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
1205797|NCT02007148|overall survival,|overall survival,
1205798|NCT02007148|tumor response,|tumor response,
1205799|NCT02007148|quality of life|quality of life
1205800|NCT02007122|HD|hd
1205801|NCT02007122|CVVH|cvvh
1205802|NCT02007122|renal replacement therapy|renal replacement therapy
1205803|NCT02007122|ceftaroline|ceftaroline
1205804|NCT02007122|pharmacokinetics|pharmacokinetics
1205805|NCT02007096|Transabdominal plane block|transabdominal plane block
1205806|NCT02007096|ventral hernia|ventral hernia
1205807|NCT02007096|umbilical hernia|umbilical hernia
1205808|NCT02007096|incisional hernia|incisional hernia
1205809|NCT02007096|hernia repair|hernia repair
1205810|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
1205811|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
1205812|NCT02007070|PD1|pd1
1205813|NCT02007070|PD-1|pd-1
1205814|NCT02007070|PDL1|pdl1
1205815|NCT02007070|PD-L1|pd-l1
1205816|NCT02007057|Suprascapular nerve block|suprascapular nerve block
1205817|NCT02007057|Interscalene nerve block|interscalene nerve block
1205818|NCT02007044|Leukemia|leukemia
1585896|NCT00445081|DLQI|dlqi
1205819|NCT02007044|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1205820|NCT02007044|CLL|cll
1205821|NCT02007044|Relapsed|relapsed
1205822|NCT02007044|Ibrutinib|ibrutinib
1205823|NCT02007044|PCI-32765|pci-32765
1205824|NCT02007044|Rituximab|rituximab
1205825|NCT02007044|Rituxan|rituxan
1205826|NCT02007031|Hypertension|hypertension
1205827|NCT02007031|Cold temperature|cold temperature
1205828|NCT02007031|Blood pressure|blood pressure
1205829|NCT02007031|Electrocardiography|electrocardiography
1205830|NCT02007018|Surgical Site Infections|surgical site infections
1205831|NCT02007018|Colorectal Resection|colorectal resection
1205832|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
1205833|NCT02007005|superficial bladder cancer|superficial bladder cancer
1205834|NCT02007005|mistletoe extract|mistletoe extract
1205835|NCT02007005|maximum tolerated dose|maximum tolerated dose
1205836|NCT02007005|marker tumor|marker tumor
1205837|NCT02007005|remission|remission
1205838|NCT02007005|recurrence rate|recurrence rate
1205839|NCT02006979|cardiotoxicity|cardiotoxicity
1205840|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1205841|NCT02006979|Breast Neoplasms|breast neoplasms
1205842|NCT02006979|Exercise|exercise
1205843|NCT02006979|Cardiotoxins|cardiotoxins
1205844|NCT02006979|Echocardiography|echocardiography
1205845|NCT02006979|Speckle tracking|speckle tracking
1205846|NCT02006979|Biological Markers|biological markers
1205847|NCT02006979|Electrocardiography|electrocardiography
1205848|NCT02006966|Systemic lidocaine|systemic lidocaine
1205849|NCT02006966|postoperative pain|postoperative pain
1205850|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
1205851|NCT02006966|VATS|vats
1205852|NCT02006953|gastrostomy|gastrostomy
1205853|NCT02006953|enteral|enteral
1205854|NCT02006940|alveoflex|alveoflex
1205855|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
1205856|NCT02006940|pCLE|pcle
1205857|NCT02006940|alveoscopy|alveoscopy
1205858|NCT02006940|morphology|morphology
1205859|NCT02006940|high resolution computed tomography|high resolution computed tomography
1205860|NCT02006927|Prostate Cancer|prostate cancer
1205861|NCT02006914|Insulin resistance|insulin resistance
1205862|NCT02006914|HIV disease|hiv disease
1205863|NCT02006914|chromium picolinate|chromium picolinate
1205864|NCT02006901|surgical procedures, operative|surgical procedures, operative
1205865|NCT02006901|lumbar vertebrae|lumbar vertebrae
1205866|NCT02006901|decompression, surgical|decompression, surgical
1205867|NCT02006901|microdecompression|microdecompression
1205868|NCT02006901|laminectomy|laminectomy
1205869|NCT02006901|registries|registries
1205870|NCT02006888|Inflammation|inflammation
1205871|NCT02006888|cataract surgery|cataract surgery
1205872|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1205873|NCT02006875|postural|postural
1205874|NCT02006875|balance|balance
1205875|NCT02006875|mobility|mobility
1205876|NCT02006875|leg|leg
1205877|NCT02006875|stroke|stroke
1205878|NCT02006862|olanzapine|olanzapine
1205879|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
1205880|NCT02006849|AfricanAmericans|africanamericans
1205881|NCT02006849|Hypertension|hypertension
1205882|NCT02006849|Proteinuria|proteinuria
1205883|NCT02006849|ApoL1 gene|apol1 gene
1205884|NCT02006836|glycemic index|glycemic index
1205885|NCT02006836|glycemic response|glycemic response
1205886|NCT02006836|diabetes|diabetes
1205887|NCT02006836|pomelo|pomelo
1205888|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
1205889|NCT02006810|Endothelium biomarkers|endothelium biomarkers
1205890|NCT02006810|Atherosclerotic disease|atherosclerotic disease
1205891|NCT02006810|Endothelial function|endothelial function
1205892|NCT02006810|Nutritional stimuli|nutritional stimuli
1205893|NCT02006797|reconciliation|reconciliation
1205894|NCT02006797|discharge|discharge
1205895|NCT02006797|pharmacist|pharmacist
1205896|NCT02006797|drug related problems|drug related problems
1205897|NCT02006771|Meal|meal
1205898|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
1205899|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
1205900|NCT02006719|Frozen Shoulder|frozen shoulder
1205901|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
1205902|NCT02006719|Shoulder Pain|shoulder pain
1205903|NCT02006693|XEN|xen
1205904|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
1205905|NCT02006693|Filtration Device|filtration device
1205906|NCT02006693|Ab interno|ab interno
1205907|NCT02006680|Central Precocious Puberty|central precocious puberty
1205908|NCT02006680|Suppression|suppression
1205909|NCT02006680|Alpha Subunit|alpha subunit
1205910|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
1205911|NCT02006628|GWP42003|gwp42003
1205912|NCT02006628|Cannabinoids|cannabinoids
1205913|NCT02006628|Schizophrenia|schizophrenia
1205914|NCT02006602|Candesartan cilexetil|candesartan cilexetil
1205915|NCT02006602|Healthy adult human subjects|healthy adult human subjects
1205916|NCT02006602|Bioequivalence|bioequivalence
1205917|NCT02006589|Bioequivalence|bioequivalence
1585897|NCT00445081|QALY|qaly
1205918|NCT02006589|Candesartan cilexetil|candesartan cilexetil
1205919|NCT02006589|Healthy adult human subjects|healthy adult human subjects
1205920|NCT02006576|Emphysema|emphysema
1205921|NCT02006576|Prostaglandin E|prostaglandin e
1205922|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
1205923|NCT02006563|Brain Tumor|brain tumor
1205924|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
1205925|NCT02006563|GBM|gbm
1205926|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
1205927|NCT02006563|MTV|mtv
1205928|NCT02006563|Clinical Tumor Volume|clinical tumor volume
1205929|NCT02006563|CTV|ctv
1205930|NCT02006550|Wnt|wnt
1205931|NCT02006550|Notch|notch
1205932|NCT02006550|Hedgehog|hedgehog
1205933|NCT02006550|Tumor Sample|tumor sample
1205934|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
1205935|NCT02006537|Entero-Test|entero-test
1205936|NCT02006537|pharmacokinetics|pharmacokinetics
1205937|NCT02006537|COPD|copd
1205938|NCT02006537|safety|safety
1205939|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
1205940|NCT02006524|primary care|primary care
1205941|NCT02006524|screening|screening
1205942|NCT02006524|influenza vaccination|influenza vaccination
1205943|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
1205944|NCT02006511|groin incision|groin incision
1205945|NCT02006511|incisional VAC|incisional vac
1205946|NCT02006511|Prevena|prevena
1205947|NCT02006511|groin wound|groin wound
1205948|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1205949|NCT02006498|sillymarin|sillymarin
1205950|NCT02006498|randomised trial|randomised trial
1205951|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1205952|NCT02006472|Huntington's Disease|huntington's disease
1205953|NCT02006472|Pridopidine|pridopidine
1205954|NCT02006472|Pride-HD|pride-hd
1205955|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
1205956|NCT02006459|Total pancreatectomy|total pancreatectomy
1205957|NCT02006459|Incretin hormones|incretin hormones
1205958|NCT02006459|Glucagon|glucagon
1205959|NCT02006446|Male infertility|male infertility
1205960|NCT02006446|sperm head vacuoles|sperm head vacuoles
1205961|NCT02006446|sperm morphology|sperm morphology
1205962|NCT02006446|aneuploidy|aneuploidy
1205963|NCT02006446|DNA fragmentation|dna fragmentation
1205964|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
1205965|NCT02006446|telomere abnormalities|telomere abnormalities
1205966|NCT02006394|Inflammation|inflammation
1205967|NCT02006394|Monocytes|monocytes
1205968|NCT02006381|healthy boys|healthy boys
1205969|NCT02006381|plasma oxytocin|plasma oxytocin
1205970|NCT02006381|pediatric|pediatric
1205971|NCT02006368|Volunteers|volunteers
1205972|NCT02006368|Blood Platelets|blood platelets
1205973|NCT02006368|Platelet Transfusion|platelet transfusion
1205974|NCT02006342|Diabetes Mellitus|diabetes mellitus
1205975|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
1205976|NCT02006342|Insulin Glargine|insulin glargine
1205977|NCT02006342|Anion gap|anion gap
1205978|NCT02006342|Metabolic acidosis|metabolic acidosis
1205979|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
1205980|NCT02006303|Green light|green light
1205981|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
1205982|NCT02006303|Prostatic artery embolization|prostatic artery embolization
1205983|NCT02006303|Outcome|outcome
1205984|NCT02006277|healthy volunteers|healthy volunteers
1205985|NCT02006277|taste|taste
1205986|NCT02006277|bioavailability|bioavailability
1205987|NCT02006238|Hot flash|hot flash
1205988|NCT02006238|Farabloc|farabloc
1205989|NCT02006238|menopausal women|menopausal women
1205990|NCT02006225|autologous|autologous
1205991|NCT02006225|stem cell|stem cell
1205992|NCT02006225|transplantation|transplantation
1205993|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
1205994|NCT02006199|mindfulness|mindfulness
1205995|NCT02006199|meditation|meditation
1205996|NCT02006186|Bicycling|bicycling
1205997|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
1205998|NCT02006134|Vasculitis|vasculitis
1205999|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
1206000|NCT02006134|Systemic vasculitis|systemic vasculitis
1206001|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
1206002|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
1206003|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
1206004|NCT02006134|Pediatric vasculitis|pediatric vasculitis
1206005|NCT02006134|Childhood vasculitis|childhood vasculitis
1206006|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1206007|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
1206008|NCT02006134|Takayasu Arteritis|takayasu arteritis
1206009|NCT02006134|Autoimmune|autoimmune
1206010|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
1206011|NCT02006121|Parkinson's disease|parkinson's disease
1206012|NCT02006121|motor fluctuations|motor fluctuations
1206013|NCT02006121|not well controlled|not well controlled
1206014|NCT02006121|medical treatment|medical treatment
1206015|NCT02006108|kidney|kidney
1206016|NCT02006108|transplant|transplant
1206017|NCT02006108|rejection|rejection
1206018|NCT02006108|Feraheme|feraheme
1206019|NCT02006108|ferumoxytol|ferumoxytol
1206020|NCT02006095|carotid artery stenting|carotid artery stenting
1206021|NCT02006095|carotid endarterectomy|carotid endarterectomy
1206022|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1206023|NCT02006095|neuropsychological testing|neuropsychological testing
1206024|NCT02006095|microemboli|microemboli
1206025|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
1206026|NCT02006082|Re-admission to hospital|re-admission to hospital
1206027|NCT02006082|Time to re-admission|time to re-admission
1206028|NCT02006082|Length if hospital stay|length if hospital stay
1206029|NCT02006082|Patient satisfaction|patient satisfaction
1206030|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1206031|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
1206032|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
1206033|NCT02006030|Liver Cancer|liver cancer
1206034|NCT02006030|ADI|adi
1206035|NCT02006030|ADI-PEG 20|adi-peg 20
1206036|NCT02006004|AML|aml
1206037|NCT02005991|PF-05212377|pf-05212377
1206038|NCT02005991|phase 1|phase 1
1206039|NCT02005991|open-label|open-label
1206040|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
1206041|NCT02005991|positron emission tomography|positron emission tomography
1206042|NCT02005991|healthy subjects|healthy subjects
1206043|NCT02005991|brain|brain
1206044|NCT02005991|cortex|cortex
1206045|NCT02005991|alzheimers disease|alzheimers disease
1206046|NCT02005965|Rectal Cancer|rectal cancer
1206047|NCT02005965|Low Rectal Cancer|low rectal cancer
1206048|NCT02005965|MERCURY|mercury
1206049|NCT02005965|Cancer|cancer
1206050|NCT02005965|CRM|crm
1206051|NCT02005965|Circumferential Margin|circumferential margin
1206052|NCT02005965|Quality of Life|quality of life
1206053|NCT02005965|MRI|mri
1206054|NCT02005965|Radiology|radiology
1206055|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
1206056|NCT02005965|Anterior Resection|anterior resection
1206057|NCT02005965|Surgery|surgery
1206058|NCT02005965|Pathology|pathology
1206059|NCT02005939|Pomegranate|pomegranate
1206060|NCT02005939|Blood pressure|blood pressure
1206061|NCT02005939|Insulin sensitivity|insulin sensitivity
1206062|NCT02005939|Cortisol|cortisol
1206063|NCT02005939|Quality of life|quality of life
1206064|NCT02005939|Body composition|body composition
1206065|NCT02005926|Breast cancer|breast cancer
1206066|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
1206067|NCT02005926|Ultrasonography|ultrasonography
1206068|NCT02005926|Fine needle aspiration|fine needle aspiration
1206069|NCT02005900|DHA|dha
1206070|NCT02005900|Omega 3|omega 3
1206071|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
1206072|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
1206073|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
1206074|NCT02005900|HIV|hiv
1206075|NCT02005887|Premenopausal patients|premenopausal patients
1206076|NCT02005887|ER-positive|er-positive
1206077|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
1206078|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
1206079|NCT02005861|osteochondral lesion|osteochondral lesion
1206080|NCT02005861|talus|talus
1206081|NCT02005861|ankle|ankle
1206082|NCT02005861|cartilage repair|cartilage repair
1206083|NCT02005848|Type-1 Diabetes|type-1 diabetes
1206084|NCT02005848|T1D|t1d
1206085|NCT02005848|Diabetes Mellitus|diabetes mellitus
1206086|NCT02005835|HIV|hiv
1206087|NCT02005835|Option B+|option b+
1206088|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1206089|NCT02005822|Cytomegalovirus|cytomegalovirus
1206090|NCT02005822|Congenital infection|congenital infection
1206091|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
1206092|NCT02005822|Valganciclovir|valganciclovir
1206093|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
1206094|NCT02005809|gastric neoplasm|gastric neoplasm
1206095|NCT02005809|second look endoscopy|second look endoscopy
1206096|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
1206097|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
1206098|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
1206099|NCT02005783|safety|safety
1206100|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
1206101|NCT02005757|RA|ra
1206102|NCT02005757|Mizoribine|mizoribine
1206103|NCT02005757|DAS28|das28
1206104|NCT02005757|European League Against Rheumatism|european league against rheumatism
1206105|NCT02005744|CKD-501|ckd-501
1206106|NCT02005731|Low Intensity Shockwave|low intensity shockwave
1206107|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
1206108|NCT02005731|Erectile dysfunction|erectile dysfunction
1206109|NCT02005692|pressure ulcers|pressure ulcers
1206110|NCT02005692|bed sores|bed sores
1206111|NCT02005692|patient turn protocol|patient turn protocol
1206112|NCT02005692|patient movement|patient movement
1206113|NCT02005692|patient monitoring|patient monitoring
1206114|NCT02005679|Prelingual Deafness|prelingual deafness
1206115|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
1206116|NCT02005679|Sign language|sign language
1206117|NCT02005679|Mini-Mental State|mini-mental state
1206118|NCT02005666|Acne Vulgaris|acne vulgaris
1206119|NCT02005666|DUAC|duac
1206120|NCT02005666|CADILA|cadila
1206121|NCT02005666|CLIANTHA|cliantha
1206122|NCT02005653|Lymphatic filariasis|lymphatic filariasis
1206123|NCT02005653|W. bancrofti|w. bancrofti
1206124|NCT02005653|DEC|dec
1206125|NCT02005653|Albendazole|albendazole
1206126|NCT02005653|Doxycycline|doxycycline
1206127|NCT02005627|grass pollen allergy|grass pollen allergy
1206128|NCT02005627|hayfever|hayfever
1206129|NCT02005627|atopy|atopy
1206130|NCT02005627|allergic rhinitis|allergic rhinitis
1206131|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
1206132|NCT02005614|Rational dose selection|rational dose selection
1206133|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
1206134|NCT02005588|amino acid chelated iron|amino acid chelated iron
1206135|NCT02005588|iron salt|iron salt
1206136|NCT02005588|iron deficiency anemia|iron deficiency anemia
1206137|NCT02005536|Poliomyelitis|poliomyelitis
1206138|NCT02005536|Poliovirus|poliovirus
1206139|NCT02005536|Polio|polio
1206140|NCT02005536|IMOVAX POLIO®|imovax polio®
1206141|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
1206142|NCT02005510|cervical cancer|cervical cancer
1206143|NCT02005510|screening|screening
1206144|NCT02005510|human papillomavirus|human papillomavirus
1206145|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1206343|NCT02004561|bariatric_surgery|bariatric_surgery
1206146|NCT02005497|Cancer prevention and control|cancer prevention and control
1206147|NCT02005497|Health promotion|health promotion
1206148|NCT02005497|Workplace|workplace
1206149|NCT02005497|Dissemination|dissemination
1206150|NCT02005497|Implementation|implementation
1206151|NCT02005458|Neutropenia|neutropenia
1206152|NCT02005458|Febrile neutropenia|febrile neutropenia
1206153|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
1206154|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
1206155|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
1206156|NCT02005445|Coronary heart disease|coronary heart disease
1206157|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
1206158|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1206159|NCT02005432|Diabetis|diabetis
1206160|NCT02005432|Retinal Neovascularization|retinal neovascularization
1206161|NCT02005432|laser treatment|laser treatment
1206162|NCT02005419|Pancreatic Cancer|pancreatic cancer
1206163|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1206164|NCT02005419|Metformin|metformin
1206165|NCT02005419|Gemcitabine|gemcitabine
1206166|NCT02005419|Adjuvant Therapy|adjuvant therapy
1206168|NCT02005393|FICE|fice
1206169|NCT02005393|NBI|nbi
1206170|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
1206171|NCT02005367|substance use treatment|substance use treatment
1206172|NCT02005367|person-centered treatment|person-centered treatment
1206173|NCT02005367|residential treatment outcomes|residential treatment outcomes
1206174|NCT02005367|dual diagnosis|dual diagnosis
1206175|NCT02005367|recovery model|recovery model
1206176|NCT02005367|psychosocial treatment|psychosocial treatment
1206177|NCT02005354|Pain|pain
1206178|NCT02005354|Bone marrow aspiration|bone marrow aspiration
1206179|NCT02005354|trephine biopsy|trephine biopsy
1206180|NCT02005341|Lumbar|lumbar
1206181|NCT02005341|fusion|fusion
1206182|NCT02005328|Xerostomia|xerostomia
1206183|NCT02005328|hyposialia|hyposialia
1206184|NCT02005328|hyposalivation|hyposalivation
1206185|NCT02005328|saliva substitute|saliva substitute
1206186|NCT02005328|Salivary Gland|salivary gland
1206187|NCT02005328|Mouth Diseases|mouth diseases
1206188|NCT02005328|Dry mouth|dry mouth
1206189|NCT02005315|Pancreatic Cancer|pancreatic cancer
1206190|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
1206191|NCT02005302|chronic kidney disease|chronic kidney disease
1206192|NCT02005302|mineral and bone disease|mineral and bone disease
1206193|NCT02005302|Malnutrition|malnutrition
1206194|NCT02005302|Vitamin D|vitamin d
1206195|NCT02005302|low protein diet|low protein diet
1206196|NCT02005289|CLL|cll
1206197|NCT02005289|SLL|sll
1206198|NCT02005289|PLL|pll
1206199|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1206200|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1206201|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
1206202|NCT02005289|MOR00208|mor00208
1206203|NCT02005289|MOR208|mor208
1206204|NCT02005276|Sedentary|sedentary
1206205|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
1206206|NCT02005276|Team Studies|team studies
1206207|NCT02005276|Financial Incentives|financial incentives
1206208|NCT02005276|Workplace Wellness|workplace wellness
1206209|NCT02005276|Team Incentives|team incentives
1206210|NCT02005263|Hysteroscopy|hysteroscopy
1206211|NCT02005250|osteoporosis|osteoporosis
1206212|NCT02005250|hyperthyroidism|hyperthyroidism
1206213|NCT02005250|hypothyroidism|hypothyroidism
1206214|NCT02005237|Exercise|exercise
1206215|NCT02005237|Cognition|cognition
1206216|NCT02005237|Neuroimaging|neuroimaging
1206217|NCT02005237|Rehabilitation|rehabilitation
1206218|NCT02005237|Connectivity|connectivity
1206219|NCT02005224|Insulin sensitivity|insulin sensitivity
1206220|NCT02005224|Lipid profile|lipid profile
1206221|NCT02005224|Body composition|body composition
1206222|NCT02005224|Weight|weight
1206223|NCT02005211|AZD3293|azd3293
1206224|NCT02005211|Healthy volunteers|healthy volunteers
1206225|NCT02005211|Young volunteers|young volunteers
1206226|NCT02005211|Elderly volunteers|elderly volunteers
1206227|NCT02005211|Japanese volunteers|japanese volunteers
1206228|NCT02005211|Phase 1|phase 1
1206229|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
1206230|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
1206231|NCT02005159|Enterobacteria|enterobacteria
1206232|NCT02005159|Bacteremia|bacteremia
1206233|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
1206234|NCT02005159|Susceptible|susceptible
1206235|NCT02005159|Prognosis|prognosis
1206236|NCT02005146|Hepatitis B|hepatitis b
1206237|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
1206238|NCT02005146|HBsAg loss|hbsag loss
1206239|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
1206240|NCT02005068|Osteoarticular infections|osteoarticular infections
1206241|NCT02005068|Osteomyelitis|osteomyelitis
1206242|NCT02005068|Joint infections|joint infections
1206243|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
1206344|NCT02004561|pediatric obesity|pediatric obesity
1206244|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
1206245|NCT02005055|Brachytherapy|brachytherapy
1206246|NCT02005055|Radiotherapy|radiotherapy
1206247|NCT02005055|Scar treatment|scar treatment
1206248|NCT02005042|Physical activity|physical activity
1206249|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
1206250|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
1206251|NCT02005042|Accelerometer|accelerometer
1206252|NCT02005042|Smartphone|smartphone
1206253|NCT02005029|Parkinson's Disease|parkinson's disease
1206254|NCT02005029|Levodopa|levodopa
1206255|NCT02005029|motor fluctuations|motor fluctuations
1206256|NCT02005029|gastroparesis|gastroparesis
1206257|NCT02005016|Aphasia|aphasia
1206258|NCT02005016|Language Therapy|language therapy
1206259|NCT02005016|Acquired Language Disorders|acquired language disorders
1206260|NCT02005016|Semantics|semantics
1206261|NCT02005016|Stroke|stroke
1206262|NCT02004990|Children, Plaque|children, plaque
1206263|NCT02004951|Superficial femoral artery|superficial femoral artery
1206264|NCT02004951|paclitaxel|paclitaxel
1206265|NCT02004951|stent|stent
1206266|NCT02004951|self expandable|self expandable
1206267|NCT02004951|restenosis|restenosis
1206268|NCT02004951|endovascular|endovascular
1206269|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
1206270|NCT02004938|measurements|measurements
1206271|NCT02004938|jugular|jugular
1206272|NCT02004938|ultrasound|ultrasound
1206273|NCT02004938|pediatric|pediatric
1206274|NCT02004938|respiratory|respiratory
1206275|NCT02004938|diameter|diameter
1206276|NCT02004925|pneumoperitoneum|pneumoperitoneum
1206277|NCT02004925|free peritoneal air|free peritoneal air
1206278|NCT02004925|ultrasonography|ultrasonography
1206279|NCT02004912|maternal|maternal
1206280|NCT02004912|neonatal|neonatal
1206281|NCT02004912|child|child
1206282|NCT02004912|health services|health services
1206283|NCT02004912|health care|health care
1206284|NCT02004912|Karnataka|karnataka
1206285|NCT02004912|India|india
1206286|NCT02004899|Labor epidural analgesia|labor epidural analgesia
1206287|NCT02004899|Fentanyl|fentanyl
1206288|NCT02004899|Bupivacaine|bupivacaine
1206289|NCT02004899|Onset|onset
1206290|NCT02004886|Diabetes Mellitus|diabetes mellitus
1206291|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1206292|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
1206293|NCT02004886|Metabolic Diseases|metabolic diseases
1206294|NCT02004886|Endocrine System Diseases|endocrine system diseases
1206295|NCT02004886|Therapeutic Uses|therapeutic uses
1206296|NCT02004886|Pharmacologic Actions|pharmacologic actions
1206297|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1206298|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
1206299|NCT02004886|Metformin|metformin
1206300|NCT02004873|pacemaker|pacemaker
1206301|NCT02004873|leadless|leadless
1206302|NCT02004873|single chamber|single chamber
1206303|NCT02004860|local immunosuppressive|local immunosuppressive
1206304|NCT02004860|Maintenance therapy|maintenance therapy
1206305|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
1206306|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
1206307|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
1206308|NCT02004769|Trastuzumab|trastuzumab
1206309|NCT02004769|HER2-positive|her2-positive
1206310|NCT02004769|Capecitabine|capecitabine
1206311|NCT02004769|Docetaxel|docetaxel
1206312|NCT02004769|First-line therapy|first-line therapy
1206313|NCT02004756|pediatric|pediatric
1206314|NCT02004756|fontan|fontan
1206315|NCT02004756|congenital heart disease|congenital heart disease
1206316|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
1206317|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
1206318|NCT02004756|exercise training intervention|exercise training intervention
1206319|NCT02004743|Early Intervention|early intervention
1206320|NCT02004743|Prevention|prevention
1206321|NCT02004743|Risk Factors|risk factors
1206322|NCT02004743|Exposure Therapy|exposure therapy
1206323|NCT02004743|Psychoeducation|psychoeducation
1206324|NCT02004717|advanced solid tumor|advanced solid tumor
1206325|NCT02004717|Phase 1|phase 1
1206326|NCT02004717|Oncology|oncology
1206327|NCT02004652|Prucalopride|prucalopride
1206328|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
1206329|NCT02004652|Postoperative ileus|postoperative ileus
1206330|NCT02004652|Randomised trial|randomised trial
1206331|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
1206332|NCT02004626|Collagenase|collagenase
1206333|NCT02004626|Phase III|phase iii
1206334|NCT02004626|National|national
1206335|NCT02004626|Noninferiority|noninferiority
1206336|NCT02004626|Double-blind|double-blind
1206337|NCT02004626|Multicenter|multicenter
1206338|NCT02004626|Prospective.|prospective.
1206339|NCT02004587|Hepatic impairment|hepatic impairment
1206340|NCT02004587|Pharmacokinetics|pharmacokinetics
1206341|NCT02004587|Pharmacodynamics|pharmacodynamics
1206345|NCT02004561|diabetes|diabetes
1206346|NCT02004535|Hearing loss|hearing loss
1206347|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
1206348|NCT02004535|Cochlear implantation|cochlear implantation
1206349|NCT02004522|Phase 3|phase 3
1206350|NCT02004522|CLL/SLL|cll/sll
1206351|NCT02004522|Pi3K|pi3k
1206352|NCT02004509|atrial fibrillation|atrial fibrillation
1206353|NCT02004509|stroke|stroke
1206354|NCT02004509|pacemaker|pacemaker
1206355|NCT02004509|anticoagulant|anticoagulant
1206356|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
1206357|NCT02004483|ischemia|ischemia
1206358|NCT02004483|strain|strain
1206359|NCT02004483|coronary stenosis|coronary stenosis
1206360|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
1206361|NCT02004470|active suction|active suction
1206362|NCT02004470|lavage and suction|lavage and suction
1206363|NCT02004470|right shoulder pain|right shoulder pain
1206364|NCT02004470|post operative shoulder pain|post operative shoulder pain
1206365|NCT02004457|HIV|hiv
1206366|NCT02004457|Primary care|primary care
1206367|NCT02004457|Engagement|engagement
1206368|NCT02004457|Acceptance|acceptance
1206369|NCT02004457|Disclosure|disclosure
1206370|NCT02004457|Stigma|stigma
1206371|NCT02004444|JC Virus|jc virus
1206372|NCT02004444|Natalizumab|natalizumab
1206373|NCT02004431|Chronic post surgical pain|chronic post surgical pain
1206374|NCT02004431|Orthopaedic|orthopaedic
1206375|NCT02004431|Anxiety|anxiety
1206376|NCT02004431|depression|depression
1206377|NCT02004418|C-Choline PET scans|c-choline pet scans
1206378|NCT02004418|external beam radiotherapy|external beam radiotherapy
1206379|NCT02004405|autonomic nervous system|autonomic nervous system
1206380|NCT02004405|fibromyalgia|fibromyalgia
1206381|NCT02004405|autonomic dysfunction|autonomic dysfunction
1206382|NCT02004405|strengthening|strengthening
1206383|NCT02004405|flexibility|flexibility
1206384|NCT02004405|exercise|exercise
1206385|NCT02004405|heart rate variability|heart rate variability
1206386|NCT02004392|Alzheimer's disease|alzheimer's disease
1206387|NCT02004392|Cognition|cognition
1206388|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
1206389|NCT02004379|HCV|hcv
1206390|NCT02004379|Hepatitis C|hepatitis c
1206391|NCT02004379|telaprevir|telaprevir
1206392|NCT02004379|boceprevir|boceprevir
1206393|NCT02004379|clinical practice|clinical practice
1206394|NCT02004366|Diabetes|diabetes
1206395|NCT02004366|Linagliptin|linagliptin
1206396|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
1206397|NCT02004366|inpatient diabetes|inpatient diabetes
1206398|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
1206399|NCT02004340|pediatric epilepsy|pediatric epilepsy
1206400|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
1206401|NCT02004314|Chloroquine|chloroquine
1206402|NCT02004314|T cell immune activation|t cell immune activation
1206403|NCT02004314|CD4 recovery|cd4 recovery
1206404|NCT02004314|HIV|hiv
1206405|NCT02004301|Formulation behaviour|formulation behaviour
1206406|NCT02004301|Drug absorption profile|drug absorption profile
1206407|NCT02004288|Probiotics|probiotics
1206408|NCT02004288|Anorexia nervosa|anorexia nervosa
1206409|NCT02004288|Constipation|constipation
1206410|NCT02004288|Body weight|body weight
1206411|NCT02004262|cancer|cancer
1206412|NCT02004262|cancer vaccine|cancer vaccine
1206413|NCT02004262|Listeria monocytogenes|listeria monocytogenes
1206414|NCT02004262|Listeria-based vaccine|listeria-based vaccine
1206415|NCT02004262|GVAX|gvax
1206416|NCT02004262|cyclophosphamide|cyclophosphamide
1206417|NCT02004262|Cytoxan|cytoxan
1206418|NCT02004262|immunotherapy|immunotherapy
1206419|NCT02004262|mesothelin|mesothelin
1206420|NCT02004236|tRNS|trns
1206421|NCT02004236|QEEG|qeeg
1206422|NCT02004236|ERP|erp
1206423|NCT02004236|ASD|asd
1206424|NCT02004236|Autism|autism
1206425|NCT02004236|verbal fluency|verbal fluency
1206426|NCT02004236|empathy|empathy
1206427|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
1206428|NCT02004236|tDCS|tdcs
1206429|NCT02004223|Prostate Cancer|prostate cancer
1206430|NCT02004223|Dose escalation|dose escalation
1206431|NCT02004223|Stereotactic|stereotactic
1206432|NCT02004223|SBRT|sbrt
1206433|NCT02004223|Hypofractionation|hypofractionation
1206434|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
1206435|NCT02004210|transarterial radioembolization|transarterial radioembolization
1206436|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1206437|NCT02004184|Pemetrexed|pemetrexed
1206438|NCT02004184|drug therapy|drug therapy
1206439|NCT02004171|electronic cigarette|electronic cigarette
1206440|NCT02004171|nicotine inhaler|nicotine inhaler
1206441|NCT02004171|smoking cessation|smoking cessation
1206442|NCT02004158|Acute coronary syndrome|acute coronary syndrome
1206443|NCT02004158|Health behavior|health behavior
1206444|NCT02004158|Mental health|mental health
1206445|NCT02004145|MDD|mdd
1206446|NCT02004145|Positive Psychology|positive psychology
1206447|NCT02004145|Suicidality|suicidality
1206448|NCT02004080|TBI|tbi
1206449|NCT02004080|ICU|icu
1206450|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
1206451|NCT02004067|Evaporative|evaporative
1206452|NCT02004067|Aqueous deficient|aqueous deficient
1206453|NCT02004067|Dry eye disease|dry eye disease
1206454|NCT02004054|multiple sclerosis|multiple sclerosis
1206455|NCT02004054|diameter pupil|diameter pupil
1206456|NCT02004041|pruritus|pruritus
1206457|NCT02004041|atopic dermatitis|atopic dermatitis
1206458|NCT02004041|VLY-686|vly-686
1206459|NCT02004028|Mesothelioma|mesothelioma
1206460|NCT02004028|adenoma|adenoma
1206461|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
1206462|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
1206463|NCT02004015|Analytical|analytical
1206464|NCT02004015|Diagnostic|diagnostic
1206465|NCT02004015|Anesthesia|anesthesia
1206466|NCT02004015|Analgesia|analgesia
1206467|NCT02003976|knee osteoarthritis|knee osteoarthritis
1206468|NCT02003976|high tibial osteotomy|high tibial osteotomy
1206469|NCT02003976|gait analysis|gait analysis
1206470|NCT02003976|muscular strength|muscular strength
1206471|NCT02003976|body composition|body composition
1206472|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
1206473|NCT02003976|biological markers|biological markers
1206474|NCT02003963|Physical Activity|physical activity
1206475|NCT02003963|Sedentary Behavior|sedentary behavior
1206476|NCT02003963|Video Games|video games
1206477|NCT02003963|Exergames|exergames
1206478|NCT02003911|Asthma|asthma
1206479|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
1206480|NCT02003911|Pediatric|pediatric
1206481|NCT02003911|Azithromycin|azithromycin
1206482|NCT02003911|Macrolide|macrolide
1206483|NCT02003911|Length of Stay|length of stay
1206484|NCT02003911|Hospital Medicine|hospital medicine
1206485|NCT02003898|Diabetes|diabetes
1206486|NCT02003898|Insulin pump|insulin pump
1206487|NCT02003898|Threshold Suspend|threshold suspend
1206488|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
1206489|NCT02003859|IBD|ibd
1206490|NCT02003859|Pediatrics|pediatrics
1206491|NCT02003859|pCLE|pcle
1206492|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
1206493|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
1206494|NCT02003833|Skin Quality|skin quality
1206495|NCT02003833|Wrinkles|wrinkles
1206496|NCT02003833|Filler|filler
1206497|NCT02003820|Autism|autism
1206498|NCT02003820|Dental Caries|dental caries
1206499|NCT02003820|Prevention|prevention
1206500|NCT02003820|Oral Hygiene|oral hygiene
1206501|NCT02003794|acute ischemic stroke|acute ischemic stroke
1206502|NCT02003794|intravenous fluid|intravenous fluid
1206503|NCT02003794|้hydration|้hydration
1206504|NCT02003781|cardiovascular disease|cardiovascular disease
1206505|NCT02003781|metabolic disease|metabolic disease
1206506|NCT02003781|high risk|high risk
1206507|NCT02003781|prospective cohort|prospective cohort
1206508|NCT02003768|pneumoperitoneum|pneumoperitoneum
1206509|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
1206510|NCT02003768|laparoscopy|laparoscopy
1206511|NCT02003768|Patients|patients
1206512|NCT02003768|general anesthesia|general anesthesia
1206513|NCT02003768|diameter|diameter
1206514|NCT02003755|Cerebral palsy|cerebral palsy
1206515|NCT02003755|Continuous passive motion|continuous passive motion
1206516|NCT02003755|Hypertonia|hypertonia
1206518|NCT02003742|BPH|bph
1206519|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
1206520|NCT02003729|Portable Monitor|portable monitor
1206521|NCT02003729|AHI|ahi
1206522|NCT02003729|ESS|ess
1206523|NCT02003729|Cost effectiveness|cost effectiveness
1206524|NCT02003703|Vaccine|vaccine
1206525|NCT02003703|Primary Prevention|primary prevention
1206526|NCT02003703|Immunogenicity|immunogenicity
1206527|NCT02003690|Bipolar disorder|bipolar disorder
1206528|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
1206529|NCT02003690|Psychotherapy|psychotherapy
1206530|NCT02003664|Cocaine|cocaine
1206531|NCT02003664|Treatment|treatment
1206532|NCT02003664|fMRI|fmri
1206533|NCT02003664|Outcomes|outcomes
1206534|NCT02003651|Common cold|common cold
1206535|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1206536|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
1206537|NCT02003625|Multiple myeloma|multiple myeloma
1206538|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
1206539|NCT02003599|Radiodermatitis|radiodermatitis
1206540|NCT02003599|Breast neoplasms|breast neoplasms
1206541|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
1206542|NCT02003586|subjects|subjects
1206543|NCT02003560|breast cancer|breast cancer
1206544|NCT02003560|breast conserving therapy|breast conserving therapy
1206545|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
1206546|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
1206547|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
1206548|NCT02003521|Lung Flute|lung flute
1206549|NCT02003508|Prevalence|prevalence
1206550|NCT02003508|HPV|hpv
1206551|NCT02003508|Human papillomavirus|human papillomavirus
1206552|NCT02003508|Vaccination|vaccination
1206553|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
1206555|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1206556|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
1206558|NCT02003482|Anatomic Changes|anatomic changes
1206559|NCT02003482|Postoperative|postoperative
1206560|NCT02003482|Unresectable|unresectable
1206561|NCT02003469|hypertension|hypertension
1206562|NCT02003469|kidney disease|kidney disease
1206563|NCT02003469|cardiovascular disease|cardiovascular disease
1206564|NCT02003456|positron emission tomography|positron emission tomography
1206565|NCT02003456|rubidium|rubidium
1206566|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
1206567|NCT02003456|viability|viability
1206568|NCT02003456|FDG|fdg
1206569|NCT02003443|Acupressure|acupressure
1206570|NCT02003443|Older Adults|older adults
1206571|NCT02003443|Knee pain|knee pain
1206572|NCT02003443|Pain Treatment|pain treatment
1206573|NCT02003430|gynecologic malignancy|gynecologic malignancy
1206574|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
1206575|NCT02003430|cervical cancer|cervical cancer
1206576|NCT02003430|vaginal cancer|vaginal cancer
1206577|NCT02003430|vulvar cancer|vulvar cancer
1206578|NCT02003430|endometrial cancer|endometrial cancer
1206579|NCT02003417|Prostate cancer|prostate cancer
1206580|NCT02003417|External beam radiation treatment|external beam radiation treatment
1206581|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
1206582|NCT02003417|Definitive treatment|definitive treatment
1206583|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
1206584|NCT02003417|Quality of life|quality of life
1206585|NCT02003404|ostomy appliance|ostomy appliance
1206586|NCT02003391|Open Angle Glaucoma|open angle glaucoma
1206587|NCT02003391|Ocular Hypertension|ocular hypertension
1206588|NCT02003391|Intraocular Pressure|intraocular pressure
1206589|NCT02003378|Chronotropic incompetence|chronotropic incompetence
1206590|NCT02003365|osteoarthritis|osteoarthritis
1206591|NCT02003365|knee|knee
1206592|NCT02003365|corticosteroids|corticosteroids
1206593|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
1206594|NCT02003365|synovial fluid|synovial fluid
1206595|NCT02003352|TBI|tbi
1206596|NCT02003352|PTSD|ptsd
1206597|NCT02003352|Functional Neurology|functional neurology
1206598|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
1206599|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
1206600|NCT02003352|Saccadometry|saccadometry
1206601|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
1206602|NCT02003300|Oxygen uptake|oxygen uptake
1206603|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
1206604|NCT02003287|Deglutition Disorders|deglutition disorders
1206605|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
1206606|NCT02003274|Mixed Meal Test|mixed meal test
1206607|NCT02003274|Insulin Pump|insulin pump
1206608|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
1206609|NCT02003274|Metabolic Control Analysis|metabolic control analysis
1206610|NCT02003274|Closed Loop Control|closed loop control
1206611|NCT02003274|Artificial Pancreas|artificial pancreas
1206612|NCT02003248|Parkinson's disease|parkinson's disease
1206613|NCT02003248|ultrasound|ultrasound
1206614|NCT02003248|dyskinesia|dyskinesia
1206615|NCT02003248|magnetic resonance|magnetic resonance
1206616|NCT02003235|Amblyopia|amblyopia
1206617|NCT02003196|Brain injury|brain injury
1206618|NCT02003196|virus|virus
1206619|NCT02003196|immunosuppression|immunosuppression
1206620|NCT02003196|mechanical ventilation|mechanical ventilation
1206621|NCT02003183|CTE|cte
1206622|NCT02003183|TBI|tbi
1206623|NCT02003183|Cognitive Impairment|cognitive impairment
1206624|NCT02003183|Brain Imaging|brain imaging
1206625|NCT02003183|PET|pet
1206626|NCT02003170|Autism|autism
1206627|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1206628|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
1206629|NCT02003170|Developmental delays|developmental delays
1206630|NCT02003170|Genetic disorder|genetic disorder
1206631|NCT02003170|Mitochondrial disorder|mitochondrial disorder
1206632|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
1206633|NCT02003144|Long-term safety study|long-term safety study
1206634|NCT02003144|Extension trial|extension trial
1206635|NCT02003144|Eculizumab|eculizumab
1206636|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
1206637|NCT02003144|Devic's disease|devic's disease
1206638|NCT02003144|Transverse Myelitis|transverse myelitis
1206639|NCT02003144|Optic Neuritis|optic neuritis
1206640|NCT02003144|Relapse|relapse
1206641|NCT02003144|NMO-IgG|nmo-igg
1206642|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
1206643|NCT02003144|Demyelinating Disorders|demyelinating disorders
1206644|NCT02003131|osteoarthritis|osteoarthritis
1206645|NCT02003131|umbilical cord|umbilical cord
1206646|NCT02003131|mesenchymal|mesenchymal
1206647|NCT02003131|stem cells|stem cells
1206648|NCT02003131|trophic factors|trophic factors
1206663|NCT02003014|Drug Therapy|drug therapy
1206664|NCT02002975|Drug Therapy|drug therapy
1206665|NCT02002949|Hemodialysis|hemodialysis
1206666|NCT02002910|iFR|ifr
1206667|NCT02002910|FFR|ffr
1206668|NCT02002910|Medical Economy|medical economy
1206669|NCT02002910|physiological assessment|physiological assessment
1206670|NCT02002910|SYNTAX score|syntax score
1206671|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
1206675|NCT02002858|smoking|smoking
1206676|NCT02002858|cessation|cessation
1206677|NCT02002858|anxiety|anxiety
1206678|NCT02002858|anxious|anxious
1206679|NCT02002858|depression|depression
1206680|NCT02002858|depressed|depressed
1206681|NCT02002858|smoker|smoker
1206682|NCT02002858|stress|stress
1206683|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
1206684|NCT02002819|Alzheimer's disease|alzheimer's disease
1206685|NCT02002819|AD|ad
1206686|NCT02002819|Early-onset AD|early-onset ad
1206687|NCT02002819|EOAD|eoad
1206688|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
1206689|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
1206690|NCT02002806|Pancreatic cancer|pancreatic cancer
1206691|NCT02002806|Pain|pain
1206692|NCT02002793|pancreatitis|pancreatitis
1206693|NCT02002793|early stage|early stage
1206694|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
1206695|NCT02002780|pediatrics|pediatrics
1206696|NCT02002780|stress|stress
1206697|NCT02002780|cardiac surgery|cardiac surgery
1206698|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
1206699|NCT02002754|cough variant asthma|cough variant asthma
1206700|NCT02002754|bronchodilator|bronchodilator
1206701|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
1206703|NCT02002741|Preterm|preterm
1206704|NCT02002741|Infant|infant
1206705|NCT02002741|Electrocardiography|electrocardiography
1206706|NCT02002741|Paracetamol|paracetamol
1206707|NCT02002741|Acamol|acamol
1206708|NCT02002741|ibuprofen|ibuprofen
1206709|NCT02002741|Placebo|placebo
1206710|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
1206711|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
1206712|NCT02002715|therapeutic effect|therapeutic effect
1206713|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
1206714|NCT02002702|Japanese,|japanese,
1206715|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
1206716|NCT02002702|Renal Impairment|renal impairment
1206717|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
1206718|NCT02002689|hematologic malignancy,|hematologic malignancy,
1206719|NCT02002689|mutation, translocations,|mutation, translocations,
1206720|NCT02002689|signature,|signature,
1206721|NCT02002689|PTCH1,|ptch1,
1206722|NCT02002689|SMO,|smo,
1206723|NCT02002689|LDE225,|lde225,
1206724|NCT02002689|endometrial cancer,|endometrial cancer,
1206725|NCT02002689|colon cancer,|colon cancer,
1206726|NCT02002689|bladder,|bladder,
1206727|NCT02002689|NSCLC|nsclc
1206728|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
1206729|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
1284589|NCT01650792|Stroke|stroke
1206730|NCT02002611|Lobeglitazone|lobeglitazone
1206731|NCT02002611|Warfarin|warfarin
1206732|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1206733|NCT02002611|Drug-Drug interaction|drug-drug interaction
1206734|NCT02002611|Phase 1|phase 1
1206735|NCT02002598|Newly diagnosed|newly diagnosed
1206736|NCT02002598|multiple myeloma|multiple myeloma
1206737|NCT02002598|myeloma|myeloma
1206738|NCT02002598|bendamustine|bendamustine
1206739|NCT02002598|treanda|treanda
1206740|NCT02002598|carfilzomib|carfilzomib
1206741|NCT02002598|dexamethasone|dexamethasone
1206742|NCT02002598|phase I|phase i
1206743|NCT02002598|phase II|phase ii
1206744|NCT02002598|dose escalation|dose escalation
1206745|NCT02002598|transplant|transplant
1206746|NCT02002598|non-transplant, plasma cells|non-transplant, plasma cells
1206747|NCT02002585|Renal protection|renal protection
1206748|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
1206749|NCT02002572|Facial Mimic Muscle|facial mimic muscle
1206750|NCT02002572|MRI|mri
1206751|NCT02002572|Segmentation|segmentation
1206752|NCT02002572|Three dimensional assessment|three dimensional assessment
1206753|NCT02002572|Motion capture|motion capture
1206754|NCT02002572|Movement analysis|movement analysis
1206755|NCT02002572|Digital Image Correlation|digital image correlation
1206756|NCT02002546|Heart Attack|heart attack
1206757|NCT02002546|Myocardial Infarction|myocardial infarction
1206759|NCT02002546|Chest Pain|chest pain
1206760|NCT02002520|Acute pain|acute pain
1206761|NCT02002520|Epigenetic|epigenetic
1206762|NCT02002520|Dental pain|dental pain
1206763|NCT02002468|Risk Communication|risk communication
1206764|NCT02002468|Follow-up|follow-up
1206765|NCT02002468|Organisation of screening|organisation of screening
1206766|NCT02002455|FACBC|facbc
1206767|NCT02002455|PET/CT|pet/ct
1206768|NCT02002455|PET/MRI|pet/mri
1206769|NCT02002455|Radical prostatectomy|radical prostatectomy
1206770|NCT02002455|Radiotherapy|radiotherapy
1206771|NCT02002442|Mouthwash|mouthwash
1206772|NCT02002442|Chlorhexidine|chlorhexidine
1206773|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
1206774|NCT02002442|Saline|saline
1206775|NCT02002442|Implants|implants
1206776|NCT02002442|Saliva Collection|saliva collection
1206777|NCT02002429|Facet joint|facet joint
1206778|NCT02002429|Medial branch block|medial branch block
1206779|NCT02002429|Radiofrequency denervation|radiofrequency denervation
1206780|NCT02002429|Zygapophysial joint|zygapophysial joint
1206781|NCT02002429|Low back pain|low back pain
1206782|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
1206783|NCT02002403|Edema|edema
1206784|NCT02002403|Macular Edema|macular edema
1206785|NCT02002403|Retinal Diseases|retinal diseases
1206786|NCT02002403|Eye Diseases|eye diseases
1206787|NCT02002403|Danazol|danazol
1206788|NCT02002403|Estrogen Antagonists|estrogen antagonists
1206789|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
1206790|NCT02002403|Hormone Antagonists|hormone antagonists
1206791|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1206792|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
1206793|NCT02002403|Pharmacologic Actions|pharmacologic actions
1206794|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
1206795|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
1206796|NCT02002377|aflibercept|aflibercept
1206797|NCT02002364|tracheal intubation|tracheal intubation
1206798|NCT02002338|pterygium surgery|pterygium surgery
1206799|NCT02002338|refractive changes|refractive changes
1206800|NCT02002338|surgical technique|surgical technique
1206801|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1206802|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
1206803|NCT02002312|Lutetium-177|lutetium-177
1206804|NCT02002312|Lu-177|lu-177
1206805|NCT02002312|girentuximab|girentuximab
1206806|NCT02002312|cG250|cg250
1206807|NCT02002312|Monoclonal Antibody|monoclonal antibody
1206808|NCT02002299|colorectal cancer|colorectal cancer
1206809|NCT02002299|surface|surface
1206810|NCT02002299|invasive front|invasive front
1206811|NCT02002299|tumor budding|tumor budding
1206812|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
1206813|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
1206814|NCT02002286|Immune activation|immune activation
1206815|NCT02002247|antioxidants|antioxidants
1206816|NCT02002247|selenium|selenium
1206817|NCT02002247|heart disease|heart disease
1206818|NCT02002247|cardiac surgery|cardiac surgery
1206819|NCT02002247|perioperative|perioperative
1206820|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
1206821|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
1206822|NCT02002221|diabetes,|diabetes,
1206823|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
1206824|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
1206825|NCT02002221|high blood sugar,|high blood sugar,
1206826|NCT02002221|T2DM|t2dm
1206827|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
1206828|NCT02002195|elderly,|elderly,
1206829|NCT02002195|folinic acid,|folinic acid,
1206830|NCT02002195|fluorouracil,|fluorouracil,
1206831|NCT02002195|oxaliplatin,|oxaliplatin,
1206832|NCT02002195|capecitabine,|capecitabine,
1206833|NCT02002195|overall survival,|overall survival,
1206834|NCT02002195|progression free survival|progression free survival
1206835|NCT02002182|HPV|hpv
1206836|NCT02002182|oropharynx|oropharynx
1206837|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
1206838|NCT02002182|head and neck cancer|head and neck cancer
1206839|NCT02002182|transoral robotic surgery|transoral robotic surgery
1206840|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
1206841|NCT02002143|Diabetes|diabetes
1206842|NCT02002143|Older People|older people
1206843|NCT02002143|Seniors|seniors
1206844|NCT02002143|Group Appointments|group appointments
1206845|NCT02002143|Group Medical Visits|group medical visits
1206846|NCT02002143|Shared Appointments|shared appointments
1206847|NCT02002143|Quality of Life|quality of life
1206848|NCT02002143|Physical Activity|physical activity
1206849|NCT02002143|Health care Utilization|health care utilization
1206850|NCT02002143|Depression|depression
1206851|NCT02002143|Anxiety|anxiety
1206852|NCT02002130|Diabetes|diabetes
1206853|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
1206854|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
1206855|NCT02002091|Microangiopathy|microangiopathy
1206856|NCT02002091|Chronic Kidney disease|chronic kidney disease
1206857|NCT02002091|Cardiovascular disease|cardiovascular disease
1206858|NCT02002078|caustic|caustic
1206859|NCT02002078|corticosteroid therapy|corticosteroid therapy
1206860|NCT02002078|stricture|stricture
1206861|NCT02002078|children|children
1206862|NCT02002065|hepatitis A|hepatitis a
1206863|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
1206864|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
1206865|NCT02002065|immune persistence|immune persistence
1206866|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
1206867|NCT02002039|Perinatal asphyxia|perinatal asphyxia
1206868|NCT02002039|erythropoietin|erythropoietin
1206869|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
1206870|NCT02002013|Adult|adult
1206871|NCT02002013|ICU patient|icu patient
1206872|NCT02002013|Fluid resuscitation|fluid resuscitation
1206873|NCT02002013|observational study|observational study
1206874|NCT02002000|Vitamin D deficiency|vitamin d deficiency
1206875|NCT02002000|Musculoskeletal pain|musculoskeletal pain
1206876|NCT02002000|Vitamin D supplementation|vitamin d supplementation
1206877|NCT02001974|HER 2 negative|her 2 negative
1206878|NCT02001974|metastatic breast cancer|metastatic breast cancer
1206879|NCT02001974|Cancer Stem Cells|cancer stem cells
1206880|NCT02001961|Fibrosis|fibrosis
1206881|NCT02001961|collagen metabolism|collagen metabolism
1206882|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
1206883|NCT02001961|biomarkers|biomarkers
1206884|NCT02001961|T1 mapping|t1 mapping
1206886|NCT02001948|Spinal anaesthesia|spinal anaesthesia
1206887|NCT02001948|morphine|morphine
1206888|NCT02001948|postoperative analgesia|postoperative analgesia
1206889|NCT02001948|vomiting|vomiting
1206890|NCT02001935|COPD|copd
1206891|NCT02001935|theophylline|theophylline
1206892|NCT02001935|CYP1A2|cyp1a2
1206893|NCT02001935|CYP2E1|cyp2e1
1206894|NCT02001922|COPD|copd
1206895|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1206896|NCT02001922|Integrated care|integrated care
1206897|NCT02001922|Outcome and process assessment|outcome and process assessment
1206898|NCT02001922|Quality indicators, Health care|quality indicators, health care
1206899|NCT02001922|Self-management,|self-management,
1206900|NCT02001922|Patient empowerment|patient empowerment
1206901|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
1206902|NCT02001909|Regorafenib|regorafenib
1206903|NCT02001909|Neomycin|neomycin
1206904|NCT02001909|Cancer|cancer
1206905|NCT02001909|Pharmacokinetics|pharmacokinetics
1206906|NCT02001909|Safety|safety
1206907|NCT02001896|NSCLC|nsclc
1206908|NCT02001896|EGFR-TKI|egfr-tki
1206909|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
1206910|NCT02001870|Infertility|infertility
1206911|NCT02001870|female age|female age
1206912|NCT02001870|intra-uterine insemination|intra-uterine insemination
1206913|NCT02001870|in vitro fecundation|in vitro fecundation
1206914|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
1206915|NCT02001857|patients,|patients,
1206916|NCT02001857|undergoing|undergoing
1206917|NCT02001857|pelvic|pelvic
1206918|NCT02001857|lymph|lymph
1206919|NCT02001857|node|node
1206920|NCT02001857|dissection.|dissection.
1206921|NCT02001831|Sarcopenia|sarcopenia
1284843|NCT01649492|CYP2C9|cyp2c9
1206922|NCT02001831|Frailty|frailty
1206923|NCT02001831|Aging|aging
1206924|NCT02001831|Skeletal muscle|skeletal muscle
1206925|NCT02001831|Nutrition|nutrition
1206926|NCT02001792|sedation|sedation
1206927|NCT02001792|endoscopy|endoscopy
1206928|NCT02001792|patient positioning|patient positioning
1206929|NCT02001792|hypoxemia|hypoxemia
1206930|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
1206931|NCT02001779|Obstruction/stricture|obstruction/stricture
1206932|NCT02001779|Stent|stent
1206933|NCT02001779|Brachytherapy|brachytherapy
1206934|NCT02001779|Bile duct|bile duct
1206935|NCT02001766|High intensity exercise|high intensity exercise
1206936|NCT02001766|Glycemic control|glycemic control
1206937|NCT02001766|Exercise|exercise
1206938|NCT02001740|shoulder|shoulder
1206939|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
1206940|NCT02001701|vitreomacular traction|vitreomacular traction
1206941|NCT02001701|macular hole|macular hole
1206942|NCT02001701|epiretinal membrane|epiretinal membrane
1206943|NCT02001701|intravitreal gas|intravitreal gas
1206944|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
1206945|NCT02001701|perfluoropropane gas|perfluoropropane gas
1206946|NCT02001701|ocriplasmin|ocriplasmin
1206947|NCT02001701|vitrectomy|vitrectomy
1207042|NCT02001220|screening|screening
1206948|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
1206949|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
1206950|NCT02001662|High pain responders|high pain responders
1206951|NCT02001662|Adductore Canal Block|adductore canal block
1206952|NCT02001662|Analgesics|analgesics
1206953|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
1206954|NCT02001649|suicide|suicide
1206955|NCT02001649|adolescent|adolescent
1206956|NCT02001649|genetic|genetic
1206958|NCT02001636|Bariatric surgery|bariatric surgery
1206959|NCT02001636|Protein malnutrition|protein malnutrition
1206960|NCT02001636|Protein supplementation|protein supplementation
1206961|NCT02001636|Body composition|body composition
1206962|NCT02001636|Body fat mass|body fat mass
1206963|NCT02001636|Protein intake|protein intake
1206964|NCT02001623|ovary cancer|ovary cancer
1206965|NCT02001623|cervix cancer|cervix cancer
1206966|NCT02001623|endometrium cancer|endometrium cancer
1206967|NCT02001623|bladder cancer|bladder cancer
1206968|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
1206969|NCT02001623|esophagus cancer|esophagus cancer
1206970|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
1206971|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
1206972|NCT02001610|microbiota|microbiota
1206973|NCT02001610|probiotics|probiotics
1206974|NCT02001610|fecal markers|fecal markers
1206975|NCT02001597|surgery|surgery
1206976|NCT02001597|robotic|robotic
1206977|NCT02001597|ultrasound|ultrasound
1206978|NCT02001597|guidance|guidance
1206979|NCT02001597|endorectal|endorectal
1206980|NCT02001571|Prostate Cancer|prostate cancer
1206981|NCT02001571|Abiraterone acetate|abiraterone acetate
1206982|NCT02001571|Pharmacokinetics|pharmacokinetics
1206983|NCT02001558|Spinal cord injuries|spinal cord injuries
1206984|NCT02001558|Pressure ulcer|pressure ulcer
1206985|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
1206986|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1206987|NCT02001532|Diabetes Complications|diabetes complications
1206988|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
1206989|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
1206990|NCT02001532|Myocardial Infarction|myocardial infarction
1206991|NCT02001532|Stroke|stroke
1206992|NCT02001532|Vascular Stiffness|vascular stiffness
1206993|NCT02001532|Pulse Wave Analysis|pulse wave analysis
1206994|NCT02001506|breast cancer|breast cancer
1206995|NCT02001506|neoadjuvant|neoadjuvant
1206996|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
1206997|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
1206998|NCT02001428|malaria|malaria
1206999|NCT02001428|vivax|vivax
1207000|NCT02001428|falciparum|falciparum
1207001|NCT02001428|infants|infants
1207002|NCT02001415|Progressive Myopia|progressive myopia
1207003|NCT02001415|Contact Lenses|contact lenses
1207004|NCT02001415|Spectacles|spectacles
1207005|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
1207006|NCT02001402|intervention;follow-up|intervention;follow-up
1207007|NCT02001389|Enzyme occupancy|enzyme occupancy
1207008|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
1207009|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
1207010|NCT02001363|Reperfusion injury|reperfusion injury
1207011|NCT02001363|Liraglutide|liraglutide
1207012|NCT02001337|pancreatic cancer|pancreatic cancer
1207013|NCT02001337|new-onset diabetic|new-onset diabetic
1207014|NCT02001337|diabetes|diabetes
1207015|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
1207016|NCT02001311|chlorhexidine gel|chlorhexidine gel
1207017|NCT02001311|orthodontic brackets|orthodontic brackets
1207018|NCT02001311|orthodontic patients|orthodontic patients
1207019|NCT02001311|bacterial count|bacterial count
1207020|NCT02001311|friction|friction
1207021|NCT02001298|remifentanil|remifentanil
1207022|NCT02001298|nitroprusside|nitroprusside
1207023|NCT02001298|hypotension|hypotension
1207024|NCT02001285|remifentanil|remifentanil
1207025|NCT02001272|Elderly|elderly
1207026|NCT02001272|Vulnerable|vulnerable
1207027|NCT02001272|Ovarian cancer|ovarian cancer
1207028|NCT02001272|Chemotherapy|chemotherapy
1207029|NCT02001259|post-operative pain control|post-operative pain control
1207030|NCT02001259|total knee arthroplasty|total knee arthroplasty
1207031|NCT02001259|epidural steroid injection|epidural steroid injection
1207032|NCT02001246|mindfulness|mindfulness
1207033|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
1207034|NCT02001246|awareness|awareness
1207035|NCT02001246|anger|anger
1207036|NCT02001246|aggression|aggression
1207037|NCT02001233|EV71 vaccine|ev71 vaccine
1207038|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
1207039|NCT02001233|efficacy|efficacy
1207040|NCT02001233|safety|safety
1207041|NCT02001233|immune persistence|immune persistence
1207043|NCT02001220|invasive ventilation|invasive ventilation
1207044|NCT02001220|mechanical ventilation|mechanical ventilation
1207045|NCT02001220|weaning|weaning
1207046|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
1207047|NCT02001194|Sedentary|sedentary
1207048|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
1207049|NCT02001194|Team Studies|team studies
1207050|NCT02001194|Financial Incentives|financial incentives
1207051|NCT02001194|Workplace Wellness|workplace wellness
1207052|NCT02001194|Team Incentives|team incentives
1207053|NCT02001181|Atopic Dermatitis|atopic dermatitis
1207054|NCT02001181|Atopic Eczema|atopic eczema
1207055|NCT02001181|Eczema|eczema
1207056|NCT02001181|topical treatment|topical treatment
1207168|NCT02000739|GI cancer|gi cancer
1207057|NCT02001181|skin diseases|skin diseases
1207058|NCT02001181|tofacitinib|tofacitinib
1207059|NCT02001181|CP-690|cp-690
1207060|NCT02001181|550|550
1207061|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
1207062|NCT02001155|Water drinking test|water drinking test
1207063|NCT02001155|trabeculectomy|trabeculectomy
1207064|NCT02001155|tube shunt|tube shunt
1207065|NCT02001142|Insulin Sensitivity|insulin sensitivity
1207066|NCT02001142|Exercise|exercise
1207067|NCT02001142|Metabolism|metabolism
1207068|NCT02001129|Eye care adherence|eye care adherence
1207069|NCT02001129|health care utilization|health care utilization
1207070|NCT02001116|Quality of care|quality of care
1207071|NCT02001116|Hospital|hospital
1207072|NCT02001116|Children|children
1207073|NCT02001116|WHO guideline|who guideline
1207074|NCT02001103|adjuvant therapy|adjuvant therapy
1207075|NCT02001103|cognitive deficits|cognitive deficits
1207076|NCT02001103|first episode schizophrenia|first episode schizophrenia
1207077|NCT02001103|glutamate hypothesis|glutamate hypothesis
1207078|NCT02001103|memantine|memantine
1207079|NCT02001103|negative symptoms|negative symptoms
1207080|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
1207081|NCT02001090|Heart-Lung Machine|heart-lung machine
1207082|NCT02001090|Coronary Artery Bypass|coronary artery bypass
1207083|NCT02001090|Brachial Artery|brachial artery
1207084|NCT02001090|Vasodilation|vasodilation
1207085|NCT02001090|Regional Blood Flow|regional blood flow
1207086|NCT02001090|Ultrasonography|ultrasonography
1207087|NCT02001064|interventions|interventions
1207088|NCT02001064|technology|technology
1207089|NCT02001064|adherence|adherence
1207090|NCT02001064|ARV|arv
1207091|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
1207092|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
1207093|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
1207094|NCT02001051|Excess of Cortisol|excess of cortisol
1207095|NCT02001025|coronary vessels|coronary vessels
1207096|NCT02001025|coronary stenosis|coronary stenosis
1207097|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1207098|NCT02001025|stents|stents
1207099|NCT02001025|drug-eluting stents|drug-eluting stents
1207100|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
1207101|NCT02001025|optical coherence tomography|optical coherence tomography
1207102|NCT02001012|uncomplicated|uncomplicated
1207103|NCT02001012|plasmodium|plasmodium
1207104|NCT02001012|knowlesi|knowlesi
1207105|NCT02001012|malaria|malaria
1207106|NCT02001012|infection|infection
1207107|NCT02000999|Bile duct stricture|bile duct stricture
1207108|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
1207109|NCT02000999|Pancreatic cancer|pancreatic cancer
1207110|NCT02000999|Chronic pancreatitis|chronic pancreatitis
1207111|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
1207112|NCT02000986|Brain and Nervous System|brain and nervous system
1207113|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1207114|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
1207115|NCT02000960|Glut1 DS|glut1 ds
1207116|NCT02000947|anti-CTLA-4|anti-ctla-4
1207117|NCT02000947|anti-PD-L1|anti-pd-l1
1207118|NCT02000947|immunotherapy|immunotherapy
1207119|NCT02000947|IMTC|imtc
1207120|NCT02000934|TAK-659|tak-659
1207121|NCT02000934|Solid Tumors|solid tumors
1207122|NCT02000934|CLL|cll
1207123|NCT02000934|DLBCL|dlbcl
1207124|NCT02000921|Cigarette Smoking|cigarette smoking
1207125|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
1207126|NCT02000921|Dual Tobacco Use|dual tobacco use
1207127|NCT02000908|gynecological cancer|gynecological cancer
1207128|NCT02000908|ovarian cancer|ovarian cancer
1207129|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
1207130|NCT02000908|cervical caner|cervical caner
1207131|NCT02000908|peripheral neuropathy|peripheral neuropathy
1207132|NCT02000882|Breast Cancer|breast cancer
1207133|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
1207134|NCT02000882|Brain Metastases|brain metastases
1207135|NCT02000882|Capecitabine|capecitabine
1207136|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
1207137|NCT02000843|perforation|perforation
1207138|NCT02000843|tympanoplasty|tympanoplasty
1207139|NCT02000843|conchal cavum approach|conchal cavum approach
1207140|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
1207141|NCT02000843|scar|scar
1207153|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
1207154|NCT02000765|oral|oral
1207155|NCT02000765|ADME|adme
1207156|NCT02000765|IV|iv
1207157|NCT02000765|antibiotic|antibiotic
1207158|NCT02000765|healthy volunteer|healthy volunteer
1207159|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
1207160|NCT02000765|mass balance|mass balance
1207161|NCT02000765|radiolabel|radiolabel
1207162|NCT02000752|Labor|labor
1207163|NCT02000752|Acupuncture|acupuncture
1207164|NCT02000752|Placental expulsion time|placental expulsion time
1207165|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
1207166|NCT02000739|Breast cancer|breast cancer
1207167|NCT02000739|melanoma|melanoma
1207169|NCT02000739|ovarian cancer|ovarian cancer
1207170|NCT02000739|lung cancer|lung cancer
1207171|NCT02000739|metastatic cancer|metastatic cancer
1207172|NCT02000739|brain cancer|brain cancer
1207173|NCT02000739|head and neck cancer|head and neck cancer
1207174|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1207175|NCT02000700|Canagliflozin|canagliflozin
1207176|NCT02000700|JNJ-28431754|jnj-28431754
1207177|NCT02000700|Pharmacokinetics|pharmacokinetics
1207178|NCT02000700|Pharmacodynamics|pharmacodynamics
1207179|NCT02000700|Children|children
1207180|NCT02000700|Adolescents|adolescents
1207181|NCT02000674|tracheal intubation|tracheal intubation
1207182|NCT02000674|pre hospital emergency|pre hospital emergency
1207183|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1207184|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
1207185|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
1207186|NCT02000648|Allergic Rhinitis|allergic rhinitis
1207187|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
1207188|NCT02000648|Chronic urticaria|chronic urticaria
1207189|NCT02000622|Breast Cancer|breast cancer
1207190|NCT02000622|Metastatic|metastatic
1207191|NCT02000622|Olaparib|olaparib
1207193|NCT02000622|PARP inhibitor|parp inhibitor
1207194|NCT02000622|HER2|her2
1207195|NCT02000622|chemotherapy|chemotherapy
1207196|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
1207197|NCT02000596|HER2 overexpressed|her2 overexpressed
1207198|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
1207199|NCT02000596|Elderly|elderly
1207200|NCT02000583|Alzheimer's Disease|alzheimer's disease
1207201|NCT02000583|AD|ad
1207202|NCT02000583|Aerobic Exercise|aerobic exercise
1207203|NCT02000583|Exercise|exercise
1207204|NCT02000570|sitting position|sitting position
1207205|NCT02000570|PPV|ppv
1207206|NCT02000570|SVV|svv
1207207|NCT02000570|PVI|pvi
1207208|NCT02000570|fluid challenge|fluid challenge
1207209|NCT02000570|preload indicators|preload indicators
1207210|NCT02000557|Photographic analysis|photographic analysis
1207211|NCT02000557|Cephalometric analysis|cephalometric analysis
1207212|NCT02000557|Standardized photographs|standardized photographs
1207213|NCT02000557|Angular measurements|angular measurements
1207214|NCT02000557|Linear measurements|linear measurements
1207215|NCT02000557|Malocclusion|malocclusion
1207216|NCT02000557|Facial Profile|facial profile
1207217|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
1207218|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
1207219|NCT02000544|Cardiac surgery|cardiac surgery
1207220|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
1207221|NCT02000518|emergency radiotherapy|emergency radiotherapy
1207222|NCT02000518|MSCC|mscc
1207223|NCT02000518|spine|spine
1207224|NCT02000518|neurological outcome|neurological outcome
1207225|NCT02000466|Women|women
1207226|NCT02000466|Pregnancy exposure|pregnancy exposure
1207227|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
1207228|NCT02000466|Pregnancy outcome|pregnancy outcome
1207229|NCT02000466|Pregnancy Registry|pregnancy registry
1207230|NCT02000453|Quality of Life|quality of life
1207231|NCT02000453|Infection|infection
1207232|NCT02000453|GSK2586184|gsk2586184
1207233|NCT02000453|ulcerative colitis|ulcerative colitis
1207234|NCT02000440|GW856553|gw856553
1207235|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
1207236|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
1207237|NCT02000440|losmapimod|losmapimod
1207238|NCT02000440|nephrotic syndrome|nephrotic syndrome
1207239|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
1207240|NCT02000414|intraperitoneal|intraperitoneal
1207241|NCT02000414|peritoneal dialysis|peritoneal dialysis
1207242|NCT02000414|daptomycin|daptomycin
1207243|NCT02000414|pharmacokinetics|pharmacokinetics
1207244|NCT02000414|peritonitis|peritonitis
1207245|NCT02000375|metastatic breastcancer|metastatic breastcancer
1207246|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
1207247|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
1207248|NCT02000375|Androgen Receptor positve|androgen receptor positve
1207249|NCT02000362|Crohn's Disease|crohn's disease
1207250|NCT02000362|Stem cell|stem cell
1207251|NCT02000362|Cell therapy|cell therapy
1207252|NCT02000362|Auto-immune disease|auto-immune disease
1207253|NCT02000362|furestem|furestem
1207255|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
1207256|NCT02000362|MSCs|mscs
1207257|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
1207258|NCT02000362|hUCB-MSC|hucb-msc
1207259|NCT02000362|UCB-MSC|ucb-msc
1207260|NCT02000362|Umbilical cord Blood|umbilical cord blood
1207261|NCT02000349|infertility|infertility
1207262|NCT02000349|next generation sequencing|next generation sequencing
1207263|NCT02000336|radiographic damage|radiographic damage
1207264|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
1207265|NCT02000323|pancreatitis|pancreatitis
1207266|NCT02000323|enteral nutrition|enteral nutrition
1207267|NCT02000310|Gaucher disease|gaucher disease
1207268|NCT02000310|Fabry disease|fabry disease
1207269|NCT02000310|Pompe disease|pompe disease
1207270|NCT02000310|Niemann-Pick disease|niemann-pick disease
1207271|NCT02000297|Osteoarthritis|osteoarthritis
1207272|NCT02000297|Knee|knee
1207273|NCT02000297|High tibial osteotomy|high tibial osteotomy
1207274|NCT02000297|Calcium phosphate|calcium phosphate
1207275|NCT02000297|Calcium sulfate|calcium sulfate
1207276|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
1207277|NCT02000284|ASD|asd
1207278|NCT02000284|Autism|autism
1207279|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
1207280|NCT02000284|PDD-NOS|pdd-nos
1207281|NCT02000284|Asperger's Syndrome|asperger's syndrome
1207282|NCT02000284|Mitochondrial Disease|mitochondrial disease
1207283|NCT02000284|Developmental Delay|developmental delay
1207284|NCT02000284|Typical Development|typical development
1207285|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1207286|NCT02000258|Double-bundle|double-bundle
1207287|NCT02000258|MRI|mri
1207288|NCT02000258|Graft location|graft location
1207289|NCT02000245|bronchoscopy|bronchoscopy
1207290|NCT02000245|anxiety|anxiety
1207291|NCT02000245|touch|touch
1207292|NCT02000245|sympathy|sympathy
1207293|NCT02000232|gout|gout
1207294|NCT02000232|colchicine|colchicine
1207295|NCT02000219|hyperoxaluria|hyperoxaluria
1207296|NCT02000219|oxalate|oxalate
1207297|NCT02000219|PH|ph
1207298|NCT02000219|dialysis|dialysis
1207299|NCT02000206|Ketamine|ketamine
1207300|NCT02000206|Alfentanil|alfentanil
1207301|NCT02000206|Propofol|propofol
1207302|NCT02000206|Oxygen saturation|oxygen saturation
1207303|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
1207304|NCT02000206|Bronchoscopy|bronchoscopy
1207305|NCT02000167|Electron Transport Chain|electron transport chain
1207306|NCT02000167|Mitochondrial Disease|mitochondrial disease
1207307|NCT02000167|Chromosomal Deletion|chromosomal deletion
1207308|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
1207309|NCT02000128|fluid overload|fluid overload
1207310|NCT02000128|bioimpedance analysis|bioimpedance analysis
1207311|NCT02000128|Randomized Controlled Trial|randomized controlled trial
1207312|NCT02000089|familial pancreas cancer|familial pancreas cancer
1207313|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
1207314|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
1207315|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
1207316|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
1207317|NCT02000089|p16|p16
1207318|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
1207319|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
1207320|NCT02000089|Lynch Syndrome|lynch syndrome
1207321|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
1207322|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
1207323|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
1207324|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
1207325|NCT02000076|Sleep|sleep
1207326|NCT02000076|resting state|resting state
1207327|NCT02000076|functional connectivity|functional connectivity
1207328|NCT02000076|emotional contagion|emotional contagion
1207329|NCT02000076|empathy|empathy
1207330|NCT02000076|emotional regulation|emotional regulation
1207331|NCT02000063|Hepatitis C|hepatitis c
1207332|NCT02000063|acute|acute
1207333|NCT02000063|early chronic|early chronic
1207334|NCT02000050|resectable rectal cancer|resectable rectal cancer
1207335|NCT02000050|up-front chemotherapy|up-front chemotherapy
1207336|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
1207337|NCT02000050|short course radiotherapy|short course radiotherapy
1207338|NCT02000011|patients|patients
1207339|NCT02000011|aged 70 years old|aged 70 years old
1207340|NCT02000011|thoracic,|thoracic,
1207341|NCT02000011|digestive or|digestive or
1207342|NCT02000011|urological|urological
1207343|NCT02000011|resectable|resectable
1207344|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1207345|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
1207346|NCT01999985|Neoplasms|neoplasms
1207347|NCT01999985|Lung Diseases|lung diseases
1207348|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
1207349|NCT01999985|Pleural Diseases|pleural diseases
1207350|NCT01999985|Pleural Neoplasms|pleural neoplasms
1207351|NCT01999985|Lung Neoplasms|lung neoplasms
1207352|NCT01999985|Pleural Effusion|pleural effusion
1207353|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
1207354|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
1207355|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
1207356|NCT01999985|Neoplasms by Site|neoplasms by site
1207357|NCT01999985|EGFR mutation|egfr mutation
1207358|NCT01999985|Afatinib|afatinib
1207359|NCT01999985|Dasatinib|dasatinib
1207360|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1207361|NCT01999985|Gene Mutation|gene mutation
1207362|NCT01999985|T790M mutation.|t790m mutation.
1207565|NCT01998945|Fall Injury|fall injury
1207363|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
1207364|NCT01999972|Carcinoma|carcinoma
1207365|NCT01999972|Renal Cell|renal cell
1207366|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
1207367|NCT01999946|Heroin Dependence|heroin dependence
1207368|NCT01999946|Opioid-Related Disorders|opioid-related disorders
1207369|NCT01999933|Cervical cancer|cervical cancer
1207370|NCT01999933|postoperative risk factor|postoperative risk factor
1207371|NCT01999933|treatment|treatment
1207372|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
1207373|NCT01999920|ASAD|asad
1207374|NCT01999907|asthma|asthma
1207375|NCT01999907|virus diseases|virus diseases
1207376|NCT01999907|pediatric|pediatric
1207377|NCT01999907|RCT|rct
1207378|NCT01999907|steroid|steroid
1207379|NCT01999894|Namenda|namenda
1207380|NCT01999894|Autism|autism
1207381|NCT01999894|Memantine|memantine
1207382|NCT01999894|Pediatric|pediatric
1207383|NCT01999894|Forest Laboratories|forest laboratories
1207384|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
1207385|NCT01999868|ustekinumab|ustekinumab
1207386|NCT01999868|abatacept|abatacept
1207387|NCT01999842|H7N9|h7n9
1207388|NCT01999842|Influenza|influenza
1207389|NCT01999842|Safety|safety
1207390|NCT01999842|Adults|adults
1207391|NCT01999842|Adjuvant|adjuvant
1207392|NCT01999842|Immunogenicity|immunogenicity
1207393|NCT01999816|pressure ulcer|pressure ulcer
1207394|NCT01999816|lifestyle redesign|lifestyle redesign
1207395|NCT01999816|spinal cord injury|spinal cord injury
1207396|NCT01999790|upper lid|upper lid
1207397|NCT01999790|exophthalmos|exophthalmos
1207398|NCT01999790|grave's orbitopathy|grave's orbitopathy
1207399|NCT01999777|Epilepsy|epilepsy
1207400|NCT01999777|seizure clusters|seizure clusters
1207401|NCT01999777|acute repetitive seizures|acute repetitive seizures
1207402|NCT01999777|rescue treatment|rescue treatment
1207403|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
1207404|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
1207405|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
1207406|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
1207407|NCT01999712|heart failure|heart failure
1207408|NCT01999712|left ventricular assist device|left ventricular assist device
1207409|NCT01999712|right ventricular failure|right ventricular failure
1207410|NCT01999699|Heplisav|heplisav
1207411|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
1207412|NCT01999686|DLBS3233|dlbs3233
1207413|NCT01999686|metformin|metformin
1585898|NCT00445081|WLQ|wlq
1207414|NCT01999686|insulin resistance|insulin resistance
1207415|NCT01999686|Female|female
1207416|NCT01999673|SUNRISE|sunrise
1207417|NCT01999673|PPHM 1202|pphm 1202
1207418|NCT01999673|Bavituximab|bavituximab
1207419|NCT01999673|Peregrine|peregrine
1207420|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
1207421|NCT01999660|Radiotherapy|radiotherapy
1207422|NCT01999660|rectal toxicity|rectal toxicity
1207423|NCT01999647|Lower Extremity|lower extremity
1207424|NCT01999647|Sciatic Nerve|sciatic nerve
1207425|NCT01999647|Anesthetics, Local|anesthetics, local
1207426|NCT01999647|Ropivacaine|ropivacaine
1207427|NCT01999647|Ultrasonography|ultrasonography
1207428|NCT01999634|rectum|rectum
1207429|NCT01999634|microdialysis|microdialysis
1207430|NCT01999634|anastomotic leaks|anastomotic leaks
1207431|NCT01999621|organ failure|organ failure
1207432|NCT01999621|intensive care|intensive care
1207433|NCT01999621|palliative care|palliative care
1207434|NCT01999621|patient's wishes|patient's wishes
1207435|NCT01999608|Infertility|infertility
1207436|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1207437|NCT01999595|pad size|pad size
1207438|NCT01999595|pulse frequency|pulse frequency
1207439|NCT01999595|blunt pressure pain|blunt pressure pain
1207440|NCT01999595|healthy humans.|healthy humans.
1207441|NCT01999582|Anemia|anemia
1207442|NCT01999582|End Stage Kidney Disease|end stage kidney disease
1207443|NCT01999582|Chronic Kidney Disease|chronic kidney disease
1207444|NCT01999582|Dialysis|dialysis
1207445|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
1207446|NCT01999543|Blood glucose|blood glucose
1207447|NCT01999530|prazosin|prazosin
1207448|NCT01999530|dopamine|dopamine
1207449|NCT01999530|healthy|healthy
1207450|NCT01999530|Positron Emission Tomography|positron emission tomography
1207451|NCT01999530|PHNO|phno
1207452|NCT01999530|scan|scan
1207453|NCT01999530|effect|effect
1207454|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
1207455|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
1207456|NCT01999504|Peptide YY|peptide yy
1207457|NCT01999504|Glucagon|glucagon
1207458|NCT01999504|Satiety|satiety
1207459|NCT01999504|Meal|meal
1207460|NCT01999504|palaeolithic|palaeolithic
1207461|NCT01999465|Brachial plexus injury|brachial plexus injury
1207462|NCT01999465|Brachial plexus palsy|brachial plexus palsy
1207463|NCT01999465|Neonate|neonate
1207566|NCT01998945|Anxiety|anxiety
1207464|NCT01999452|Paleolithic diet|paleolithic diet
1207465|NCT01999426|Physical Therapy Modalities|physical therapy modalities
1207466|NCT01999426|Pediatrics|pediatrics
1207467|NCT01999426|Critical Care|critical care
1207468|NCT01999426|Respiration, Artificial|respiration, artificial
1207470|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
1207471|NCT01999413|younger patients|younger patients
1207472|NCT01999413|Induction treatment|induction treatment
1207473|NCT01999413|OMEGAVEN|omegaven
1207474|NCT01999387|food|food
1207475|NCT01999387|consumption|consumption
1207476|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
1207477|NCT01999283|Cervical pain|cervical pain
1207478|NCT01999283|yoga|yoga
1207479|NCT01999283|pilates|pilates
1207480|NCT01999283|exercise|exercise
1207481|NCT01999257|Genetic Counseling|genetic counseling
1207482|NCT01999257|Technology|technology
1207483|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
1207484|NCT01999257|Carrier screening|carrier screening
1207485|NCT01999244|Overweight|overweight
1207486|NCT01999244|Obesity|obesity
1207487|NCT01999244|Weight Loss|weight loss
1207488|NCT01999244|Self-monitoring|self-monitoring
1207489|NCT01999244|Food Records|food records
1207490|NCT01999244|Self-weighing|self-weighing
1207491|NCT01999244|Technology|technology
1207492|NCT01999231|Safety|safety
1207493|NCT01999231|Tolerability|tolerability
1207494|NCT01999231|ESAT6|esat6
1207495|NCT01999231|CFP10|cfp10
1207496|NCT01999231|skin test|skin test
1207497|NCT01999231|diagnostic test|diagnostic test
1207498|NCT01999205|workplace|workplace
1207499|NCT01999205|intervention|intervention
1207500|NCT01999205|physical activity|physical activity
1207501|NCT01999205|sedentary behavior|sedentary behavior
1207502|NCT01999205|evaluation|evaluation
1207503|NCT01999192|inadequate response to MTX|inadequate response to mtx
1207504|NCT01999192|Methotrexate|methotrexate
1207505|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
1207506|NCT01999192|Phase 2b|phase 2b
1207507|NCT01999179|catheter related thrombosis|catheter related thrombosis
1207508|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
1207509|NCT01999179|central venous catheters|central venous catheters
1207510|NCT01999179|cancer|cancer
1207511|NCT01999179|Catheters|catheters
1207512|NCT01999153|skin graft|skin graft
1207513|NCT01999153|donor site|donor site
1207514|NCT01999114|Healthy subjects|healthy subjects
1207515|NCT01999114|Opioid|opioid
1207516|NCT01999114|Transdermal|transdermal
1207517|NCT01999114|ECG|ecg
1586270|NCT00443742|Adolescent|adolescent
1207518|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
1207519|NCT01999088|Rosemary extract|rosemary extract
1207520|NCT01999088|Functional meat|functional meat
1207521|NCT01999088|Cardiovascular disease|cardiovascular disease
1207522|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1207523|NCT01999075|Pulmonary complications|pulmonary complications
1207524|NCT01999075|Lung volume recruitment,|lung volume recruitment,
1207525|NCT01999075|Breath-stacking,|breath-stacking,
1207526|NCT01999075|Cough efficacy,|cough efficacy,
1207527|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
1207528|NCT01999062|Breast RT|breast rt
1207529|NCT01999062|Breast radiation therapy|breast radiation therapy
1207530|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
1207531|NCT01999010|psychiatry|psychiatry
1207532|NCT01999010|mental health|mental health
1207533|NCT01999010|major depressive disorder|major depressive disorder
1207534|NCT01999010|self-management|self-management
1207535|NCT01999010|data visualization|data visualization
1207536|NCT01999010|mood diaries|mood diaries
1207537|NCT01999010|electronic diaries|electronic diaries
1207538|NCT01999010|cell phones|cell phones
1207539|NCT01999010|software|software
1207540|NCT01999010|mental health telemetry|mental health telemetry
1207541|NCT01999010|ecological momentary assessment|ecological momentary assessment
1207542|NCT01998997|Delirium|delirium
1207543|NCT01998997|Hospitalized elderly|hospitalized elderly
1207544|NCT01998971|Multiple myeloma|multiple myeloma
1207545|NCT01998971|Daratumumab|daratumumab
1207546|NCT01998971|JNJ-54767414|jnj-54767414
1207547|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
1207548|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
1207549|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
1207550|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
1207551|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
1207552|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
1207553|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
1207554|NCT01998971|Immunomodulatory drug|immunomodulatory drug
1207556|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
1207557|NCT01998958|Intranasal esketamine|intranasal esketamine
1207558|NCT01998958|Efficacy|efficacy
1207560|NCT01998958|JNJ-54135419|jnj-54135419
1207561|NCT01998945|Exposure therapy|exposure therapy
1207562|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
1207563|NCT01998945|Relaxation Training|relaxation training
1207564|NCT01998945|Older Adults|older adults
1207567|NCT01998945|Posttraumatic Stress|posttraumatic stress
1207568|NCT01998932|Venous Ulcer|venous ulcer
1207569|NCT01998932|Leg Ulcer|leg ulcer
1207570|NCT01998932|Metabonomics|metabonomics
1207571|NCT01998932|Ulcer Fluid|ulcer fluid
1207572|NCT01998854|Menorrhagia|menorrhagia
1207573|NCT01998854|Leiomyoma|leiomyoma
1207574|NCT01998854|Uterine Fibroids|uterine fibroids
1207575|NCT01998828|Polycythemia|polycythemia
1207576|NCT01998828|Polycythemia Vera|polycythemia vera
1207577|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
1207578|NCT01998828|Thrombocytosis|thrombocytosis
1207579|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
1207580|NCT01998828|Bone Marrow Diseases|bone marrow diseases
1207581|NCT01998828|Hematologic Diseases|hematologic diseases
1207582|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
1207583|NCT01998828|Blood Platelet Disorders|blood platelet disorders
1207584|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
1207585|NCT01998789|Liver Transplantation|liver transplantation
1207586|NCT01998789|Everolimus|everolimus
1207587|NCT01998789|Immunosuppression|immunosuppression
1207588|NCT01998776|ulcer|ulcer
1207589|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
1207590|NCT01998763|metabolite profile|metabolite profile
1207591|NCT01998763|SNPs|snps
1207592|NCT01998763|bone-turnover marker|bone-turnover marker
1207593|NCT01998750|obesity|obesity
1207594|NCT01998750|genetics|genetics
1207595|NCT01998750|early-onset|early-onset
1207596|NCT01998750|childhood|childhood
1207597|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
1207598|NCT01998724|Chronic bronchitis|chronic bronchitis
1207599|NCT01998724|Emphysema|emphysema
1207600|NCT01998724|Pulmonary|pulmonary
1207601|NCT01998724|COPD|copd
1207602|NCT01998711|Alzheimer's disease|alzheimer's disease
1207603|NCT01998711|Mild cognitive impairment|mild cognitive impairment
1207604|NCT01998711|Memory intervention|memory intervention
1207605|NCT01998711|Strategy use|strategy use
1207606|NCT01998711|Memory group|memory group
1207607|NCT01998698|cataract|cataract
1207608|NCT01998698|phacoemulsification|phacoemulsification
1207609|NCT01998698|monovision|monovision
1207610|NCT01998698|multifocal lens|multifocal lens
1207611|NCT01998685|Prostatectomy|prostatectomy
1207612|NCT01998685|Coagulation Factor|coagulation factor
1207613|NCT01998685|Balanced Anesthesia|balanced anesthesia
1586813|NCT00442832|MRSA|mrsa
1207614|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
1207616|NCT01998646|healthy subjects|healthy subjects
1207617|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1207618|NCT01998633|Chronic Active EBV|chronic active ebv
1207619|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
1207620|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
1207621|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
1207622|NCT01998633|IPEX|ipex
1207623|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1207624|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
1207625|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
1207626|NCT01998620|Hepatitis B|hepatitis b
1207627|NCT01998620|Cholestasis|cholestasis
1207628|NCT01998607|Solid tumours|solid tumours
1207629|NCT01998607|Bone Metastasis|bone metastasis
1207630|NCT01998594|Thumb arthritis|thumb arthritis
1207631|NCT01998594|CMC arthritis|cmc arthritis
1207632|NCT01998594|Arthroplasty|arthroplasty
1207633|NCT01998568|Intraocular pressure|intraocular pressure
1207634|NCT01998568|Corneal edema|corneal edema
1207635|NCT01998568|Tonometer|tonometer
1207636|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
1207637|NCT01998568|Tonopen|tonopen
1207638|NCT01998568|iCare|icare
1207639|NCT01998568|Goldmann applanation|goldmann applanation
1207640|NCT01998542|Head and neck cancers|head and neck cancers
1207641|NCT01998542|tumor vaccine|tumor vaccine
1207642|NCT01998542|immunotherapy|immunotherapy
1207643|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
1207644|NCT01998529|Lung Cancer|lung cancer
1207645|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
1207646|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
1207647|NCT01998529|Lung tumors|lung tumors
1207648|NCT01998529|Sarcomas|sarcomas
1207649|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
1207650|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
1207651|NCT01998529|HITC|hitc
1207652|NCT01998529|Cisplatin|cisplatin
1207653|NCT01998529|Platinol-AQ|platinol-aq
1207654|NCT01998529|Platinol|platinol
1207655|NCT01998529|CDDP|cddp
1207656|NCT01998529|Amifostine|amifostine
1207657|NCT01998529|Ethyol|ethyol
1207658|NCT01998529|Ethiofos|ethiofos
1207659|NCT01998529|Gammaphos|gammaphos
1207660|NCT01998516|Emotional Intelligence|emotional intelligence
1207661|NCT01998503|AL amyloidosis|al amyloidosis
1207662|NCT01998503|bortezomib|bortezomib
1207663|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
1207664|NCT01998477|Influenza|influenza
1207665|NCT01998477|Vaccine|vaccine
1207666|NCT01998477|Flu|flu
1207667|NCT01998477|Children|children
1207668|NCT01998477|Adolescents|adolescents
1207669|NCT01998464|Retinal Vasculitis|retinal vasculitis
1207670|NCT01998464|Optical coherence tomography|optical coherence tomography
1207671|NCT01998464|OCT|oct
1207672|NCT01998464|Imaging|imaging
1207673|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
1207674|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
1207675|NCT01998438|tranexamic acid|tranexamic acid
1207676|NCT01998438|cardiac surgery|cardiac surgery
1207677|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
1207678|NCT01998425|circulating fibrocytes|circulating fibrocytes
1207679|NCT01998425|fibrocyte|fibrocyte
1207680|NCT01998425|NSCLC|nsclc
1207681|NCT01998425|treatment response|treatment response
1207682|NCT01998425|survival|survival
1207683|NCT01998425|stage|stage
1207684|NCT01998399|CAP|cap
1207685|NCT01998399|Pneumonia|pneumonia
1207686|NCT01998399|Intensive Care Unit|intensive care unit
1207687|NCT01998399|Mechanical Ventilation|mechanical ventilation
1207688|NCT01998386|Tooth Whitening|tooth whitening
1207689|NCT01998386|Adolescent|adolescent
1207690|NCT01998386|Clinical Trial|clinical trial
1207691|NCT01998373|Patient training|patient training
1207692|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
1207693|NCT01998373|Quality of life|quality of life
1207694|NCT01998360|Circumcision|circumcision
1207695|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
1207696|NCT01998360|Minimally-invasive|minimally-invasive
1207697|NCT01998360|HIV prevention|hiv prevention
1207698|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1207699|NCT01998334|Continuous Blood Purification|continuous blood purification
1207700|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
1207701|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
1207702|NCT01998321|Articular Deformity|articular deformity
1207703|NCT01998321|Varus|varus
1207704|NCT01998295|Clearance time|clearance time
1207705|NCT01998295|Recurrence time|recurrence time
1207706|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
1207707|NCT01998295|P. falciparum|p. falciparum
1207708|NCT01998295|Uncomplicated malaria|uncomplicated malaria
1207709|NCT01998295|Children|children
1207710|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
1207711|NCT01998256|AV optimization|av optimization
1207712|NCT01998256|Interatrial conduction delay|interatrial conduction delay
1207713|NCT01998243|morbid obesity|morbid obesity
1207714|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
1207715|NCT01998243|bariatric surgery|bariatric surgery
1207716|NCT01998230|esophageal cancer|esophageal cancer
1207717|NCT01998230|esophagectomy|esophagectomy
1207718|NCT01998230|oral feeding|oral feeding
1207719|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
1207720|NCT01998217|remifentanil|remifentanil
1207721|NCT01998217|flurbiprofen|flurbiprofen
1207722|NCT01998217|pancreatic stone|pancreatic stone
1207723|NCT01998204|Parkinson's disease|parkinson's disease
1207724|NCT01998204|propofol|propofol
1207725|NCT01998204|deep brain stimulator|deep brain stimulator
1207726|NCT01998191|mortality|mortality
1207727|NCT01998191|adverse events|adverse events
1207728|NCT01998165|Anesthesia|anesthesia
1207729|NCT01998165|Remifentanil|remifentanil
1207730|NCT01998165|Ultiva|ultiva
1207731|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
1207732|NCT01998113|glyburide|glyburide
1207733|NCT01998113|metformin|metformin
1207734|NCT01998113|oral agents|oral agents
1207735|NCT01998113|insulin|insulin
1207736|NCT01998113|outcomes|outcomes
1207737|NCT01998100|PTSD|ptsd
1207738|NCT01998100|Anxiety|anxiety
1207739|NCT01998100|Behavior Therapy|behavior therapy
1207740|NCT01998100|Prolonged Exposure|prolonged exposure
1207741|NCT01998100|Exercise|exercise
1207742|NCT01998100|Wellness|wellness
1207743|NCT01998100|Post-traumatic|post-traumatic
1207744|NCT01998100|Stress|stress
1207745|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
1207746|NCT01998087|Breastfeeding|breastfeeding
1207747|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
1207748|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
1207749|NCT01998087|Infant feeding attitudes|infant feeding attitudes
1207750|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
1207751|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
1207752|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
1207753|NCT01998048|surgical treatment|surgical treatment
1207754|NCT01998048|Bankart|bankart
1207755|NCT01998048|Latarjet|latarjet
1207756|NCT01998048|redislocation|redislocation
1207757|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
1207758|NCT01998035|Lymphoma|lymphoma
1207759|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
1207760|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
1207761|NCT01998035|Follicular Lymphoma|follicular lymphoma
1207863|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
1207762|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1207763|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1207764|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1207765|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1207766|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
1207767|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
1207768|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
1207769|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1207770|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1207771|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1207772|NCT01998022|hypertension|hypertension
1207773|NCT01998022|knowledge|knowledge
1207774|NCT01998022|blood pressure control|blood pressure control
1207775|NCT01998009|colorectal cancer|colorectal cancer
1207776|NCT01998009|mass screening|mass screening
1207777|NCT01998009|fecal occult blood|fecal occult blood
1207778|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
1207779|NCT01997996|PROLIFT+M|prolift+m
1207780|NCT01997996|Vita sexualis|vita sexualis
1207781|NCT01997983|interstitial cystitis|interstitial cystitis
1207782|NCT01997983|PBS/IC|pbs/ic
1207783|NCT01997983|IC|ic
1207784|NCT01997983|Botox|botox
1207785|NCT01997983|Botulinum toxin|botulinum toxin
1207786|NCT01997983|TC-3 Gel|tc-3 gel
1207787|NCT01997983|TCGel|tcgel
1207788|NCT01997983|TheraCoat|theracoat
1207789|NCT01997970|NEAT|neat
1207790|NCT01997970|Treadmill desk|treadmill desk
1207791|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
1207792|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
1207793|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
1207794|NCT01997957|Efficacy|efficacy
1207795|NCT01997931|bispectral index|bispectral index
1207796|NCT01997931|sedation|sedation
1207797|NCT01997931|intensive care|intensive care
1207798|NCT01997931|mechanical ventilation|mechanical ventilation
1207799|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
1207800|NCT01997918|Haploidentical HSCT|haploidentical hsct
1207801|NCT01997905|Left Atrial Appendage|left atrial appendage
1207802|NCT01997905|LAA|laa
1207803|NCT01997905|Atrial Fibrillation|atrial fibrillation
1207804|NCT01997905|AFib|afib
1207805|NCT01997905|AF|af
1207806|NCT01997905|IRB approved|irb approved
1207807|NCT01997905|clinical|clinical
1207808|NCT01997905|Stroke|stroke
1207809|NCT01997905|TIA|tia
1207810|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
1207811|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
1207812|NCT01997905|OAC|oac
1207813|NCT01997905|trial|trial
1207814|NCT01997905|study|study
1207815|NCT01997905|LAA occlusion|laa occlusion
1207816|NCT01997905|occluded|occluded
1207817|NCT01997905|prevent|prevent
1207818|NCT01997892|CKD|ckd
1207819|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
1207820|NCT01997892|Dialysis|dialysis
1207821|NCT01997892|Hemodialysis|hemodialysis
1207822|NCT01997892|Anemia|anemia
1207823|NCT01997892|Peg epoetin beta|peg epoetin beta
1207824|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
1207825|NCT01997866|Sleep Apnea|sleep apnea
1207826|NCT01997866|Congestive Heart Failure|congestive heart failure
1207827|NCT01997866|Heart Failure|heart failure
1207828|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
1207829|NCT01997853|C Reactive Protein|c reactive protein
1207830|NCT01997853|Host Modulation|host modulation
1207831|NCT01997853|Chronic Periodontitis|chronic periodontitis
1207832|NCT01997840|Multiple Myeloma|multiple myeloma
1207833|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
1207834|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
1207835|NCT01997840|Neoplasms|neoplasms
1207836|NCT01997840|Blood Protein Disorders|blood protein disorders
1208130|NCT01996449|Aldosterone|aldosterone
1207837|NCT01997840|Hematologic Diseases|hematologic diseases
1207838|NCT01997840|Dexamethasone|dexamethasone
1207839|NCT01997840|Dexamethasone acetate|dexamethasone acetate
1207840|NCT01997840|Pomalidomide|pomalidomide
1207841|NCT01997814|Herbal medicine,|herbal medicine,
1207842|NCT01997814|Host modulation therapy,|host modulation therapy,
1207843|NCT01997814|Periodontitis,|periodontitis,
1207844|NCT01997814|Meta-analysis,|meta-analysis,
1207845|NCT01997814|Scaling and root planing.|scaling and root planing.
1207846|NCT01997801|Thyroidectomy|thyroidectomy
1207847|NCT01997801|Endoscopy|endoscopy
1207848|NCT01997801|Ketamine|ketamine
1207849|NCT01997801|Acute Pain|acute pain
1207850|NCT01997801|Chronic Pain|chronic pain
1207851|NCT01997801|Postoperative period|postoperative period
1207852|NCT01997788|Injection, Spinal|injection, spinal
1207853|NCT01997788|Morphine|morphine
1207854|NCT01997788|Analgesia|analgesia
1207855|NCT01997788|Patient-Controlled|patient-controlled
1207856|NCT01997788|Pain|pain
1207857|NCT01997788|Postoperative|postoperative
1207858|NCT01997788|Combined Modality Therapy|combined modality therapy
1207859|NCT01997788|Nephrectomy|nephrectomy
1207860|NCT01997775|IL-6|il-6
1207861|NCT01997775|Metformin|metformin
1207862|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
1207864|NCT01997762|resveratrol,|resveratrol,
1207865|NCT01997762|gestational diabetes,|gestational diabetes,
1207866|NCT01997762|beta cell function|beta cell function
1207867|NCT01997762|history|history
1207868|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
1207869|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1207870|NCT01997736|Catheter Ablation|catheter ablation
1207871|NCT01997736|Ablation Techniques|ablation techniques
1207872|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
1207873|NCT01997684|Colorectal Cancer|colorectal cancer
1207874|NCT01997684|Colonic Obstruction|colonic obstruction
1207875|NCT01997671|Primary Care|primary care
1207876|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
1207877|NCT01997671|Prescription|prescription
1207878|NCT01997671|Adequacy|adequacy
1207879|NCT01997671|Primary prevention|primary prevention
1207880|NCT01997671|Cardiovascular diseases|cardiovascular diseases
1207881|NCT01997671|Electronic Medical records|electronic medical records
1207882|NCT01997671|Clinical Practice Guideline|clinical practice guideline
1207883|NCT01997658|Glucocorticoids|glucocorticoids
1207884|NCT01997658|Total complication rate|total complication rate
1207885|NCT01997658|Hepatectomy.|hepatectomy.
1207886|NCT01997645|Anal fistula|anal fistula
1207887|NCT01997645|Rectal fistula|rectal fistula
1207888|NCT01997645|Intersphincteric fistula|intersphincteric fistula
1207889|NCT01997645|Perianal fistula|perianal fistula
1207890|NCT01997632|Poliomyelitis|poliomyelitis
1207891|NCT01997632|Vaccine|vaccine
1207892|NCT01997619|biological mesh|biological mesh
1207893|NCT01997619|contaminated hernia|contaminated hernia
1207894|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
1207895|NCT01997593|analgesia|analgesia
1207896|NCT01997593|pediatric|pediatric
1207897|NCT01997593|pain|pain
1207898|NCT01997593|laparoscopy|laparoscopy
1207899|NCT01997593|ropivacaine|ropivacaine
1207900|NCT01997580|depression|depression
1207901|NCT01997580|treatment|treatment
1207902|NCT01997580|electrophysiology|electrophysiology
1207903|NCT01997580|biomarker|biomarker
1207904|NCT01997567|Hip Arthroscopy|hip arthroscopy
1207905|NCT01997567|Regional Anesthesia|regional anesthesia
1207906|NCT01997567|Peripheral Nerve block|peripheral nerve block
1207907|NCT01997554|TSH Testing|tsh testing
1207908|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
1207909|NCT01997515|QOR-40|qor-40
1207910|NCT01997515|Pain|pain
1207911|NCT01997515|Hypoxia|hypoxia
1207912|NCT01997515|Gastric Surgery|gastric surgery
1207913|NCT01997515|Obesity|obesity
1207914|NCT01997515|Ketamine|ketamine
1207915|NCT01997502|Hemoglobin|hemoglobin
1207916|NCT01997502|Non-invasive|non-invasive
1207917|NCT01997489|Eye|eye
1207918|NCT01997489|Fabry|fabry
1207919|NCT01997489|vessels|vessels
1207920|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
1207921|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine|q/laiv/flumist® quadrivalent vaccine
1207922|NCT01997450|Inactivated Influenza Vaccine (IIV)|inactivated influenza vaccine (iiv)
1207923|NCT01997450|Effectiveness|effectiveness
1207924|NCT01997450|Influenza|influenza
1207925|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
1207926|NCT01997411|Diabetes Mellitus|diabetes mellitus
1207927|NCT01997411|Glucagon|glucagon
1207928|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
1207929|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
1207930|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
1207931|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
1208035|NCT01997021|older adults|older adults
1207932|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
1207933|NCT01997385|adapted APD|adapted apd
1207934|NCT01997385|dwell time|dwell time
1207935|NCT01997385|fill volume|fill volume
1207937|NCT01997372|SAA|saa
1207938|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
1207939|NCT01997372|cyclosporine|cyclosporine
1207940|NCT01997359|ART initiation|art initiation
1207941|NCT01997359|HIV|hiv
1207942|NCT01997359|AIDS|aids
1207943|NCT01997359|Ethiopia|ethiopia
1207944|NCT01997346|ART initiation|art initiation
1207945|NCT01997346|Ethiopia|ethiopia
1207946|NCT01997346|Clinic observation|clinic observation
1207947|NCT01997346|VCT observation|vct observation
1207948|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
1207949|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
1207950|NCT01997333|Breast cancer|breast cancer
1207951|NCT01997333|Triple negative|triple negative
1207952|NCT01997333|Estrogen|estrogen
1207953|NCT01997333|Progesterone|progesterone
1207954|NCT01997333|HER2 receptors|her2 receptors
1207955|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
1207956|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
1207957|NCT01997333|Breast Neoplasms|breast neoplasms
1207958|NCT01997333|CDX-011|cdx-011
1207959|NCT01997333|gpNMB|gpnmb
1207960|NCT01997333|METRIC|metric
1207961|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
1207962|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
1207963|NCT01997333|TNBC|tnbc
1207964|NCT01997320|Sarcopenia|sarcopenia
1207965|NCT01997320|Frailty|frailty
1207966|NCT01997320|Strength|strength
1207967|NCT01997320|Protein supplementation|protein supplementation
1207968|NCT01997320|Ageing|ageing
1207969|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
1207970|NCT01997294|sequential therapy|sequential therapy
1207971|NCT01997294|atorvastatin|atorvastatin
1207972|NCT01997294|acute myocardial infarction|acute myocardial infarction
1207973|NCT01997281|dietary fiber|dietary fiber
1207974|NCT01997281|diabetes mellitus|diabetes mellitus
1207975|NCT01997281|gut hormone|gut hormone
1207976|NCT01997268|Dyslipidemia|dyslipidemia
1207977|NCT01997268|Hyperlipidemia|hyperlipidemia
1207978|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
1207979|NCT01997268|Metabolic Diseases|metabolic diseases
1207980|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
1207981|NCT01997255|Everolimus|everolimus
1207982|NCT01997255|Epilepsy|epilepsy
1207983|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
1207984|NCT01997255|Port wine stain|port wine stain
1207985|NCT01997255|Glaucoma|glaucoma
1207986|NCT01997242|CORONARY STENT|coronary stent
1207987|NCT01997242|CARDIAC SURGERY|cardiac surgery
1207988|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
1207989|NCT01997229|Myasthenia Gravis|myasthenia gravis
1207990|NCT01997229|Eculizumab|eculizumab
1207991|NCT01997229|safety|safety
1207992|NCT01997229|efficacy|efficacy
1207993|NCT01997216|contact lenses|contact lenses
1207994|NCT01997216|multifocal|multifocal
1207995|NCT01997203|hepatitis C infection|hepatitis c infection
1207996|NCT01997203|vitamin D|vitamin d
1207997|NCT01997190|Immunotherapy|immunotherapy
1207998|NCT01997190|Gene therapy|gene therapy
1207999|NCT01997190|Tumor vaccine|tumor vaccine
1208000|NCT01997177|simulation|simulation
1208001|NCT01997177|training|training
1208002|NCT01997177|colonoscopy|colonoscopy
1208003|NCT01997177|standard setting|standard setting
1286191|NCT01643148|BMI|bmi
1208004|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
1208005|NCT01997112|Blood pressure|blood pressure
1208006|NCT01997112|Hypertension|hypertension
1208007|NCT01997112|Paracetamol|paracetamol
1208008|NCT01997112|Acetaminophen|acetaminophen
1208009|NCT01997099|Drug Library|drug library
1208010|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
1208011|NCT01997099|Medication Safety Software|medication safety software
1208012|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
1208013|NCT01997099|Pump Programming|pump programming
1208014|NCT01997099|Home Infusion Workflow|home infusion workflow
1208015|NCT01997073|Respiratory enthalpy|respiratory enthalpy
1208016|NCT01997073|One Lung Ventilation|one lung ventilation
1208017|NCT01997060|Lifestyle intervention|lifestyle intervention
1208018|NCT01997060|Body weight|body weight
1208019|NCT01997060|Body composition|body composition
1208020|NCT01997060|Weight loss maintenance|weight loss maintenance
1208021|NCT01997060|Physical activity|physical activity
1208022|NCT01997047|Pneumonia|pneumonia
1208023|NCT01997047|bronchiolitis|bronchiolitis
1208024|NCT01997047|asthma|asthma
1208025|NCT01997047|children|children
1208026|NCT01997047|tachypnea|tachypnea
1208027|NCT01997047|developing countries|developing countries
1208028|NCT01997047|diagnostic criteria|diagnostic criteria
1208029|NCT01997034|Weight loss maintenance|weight loss maintenance
1208030|NCT01997034|Body composition|body composition
1208031|NCT01997034|Physical activity|physical activity
1208032|NCT01997034|Lifestyle intervention|lifestyle intervention
1208033|NCT01997021|Sedentary behavior|sedentary behavior
1208034|NCT01997021|physical activity|physical activity
1208040|NCT01996969|biomarker|biomarker
1208041|NCT01996969|gene sequencing|gene sequencing
1208042|NCT01996956|stroke volume variation,|stroke volume variation,
1208043|NCT01996956|cardiac output,|cardiac output,
1208044|NCT01996956|fluid responsiveness,|fluid responsiveness,
1208045|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
1208046|NCT01996943|Atrial Fibrillation|atrial fibrillation
1208047|NCT01996943|Alcohol|alcohol
1208048|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
1208049|NCT01996943|Randomized Clinical Study|randomized clinical study
1208050|NCT01996917|wound closure|wound closure
1208051|NCT01996917|prineo|prineo
1208052|NCT01996917|scar|scar
1208053|NCT01996904|subscapularis tear|subscapularis tear
1208054|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
1208055|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
1208056|NCT01996904|ASES|ases
1208057|NCT01996891|Asthma|asthma
1208058|NCT01996891|Nutrition|nutrition
1208059|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
1208060|NCT01996878|Parkinson's disease|parkinson's disease
1208061|NCT01996878|Genetic Polymorphism|genetic polymorphism
1208063|NCT01996852|Erectile dysfunction|erectile dysfunction
1208064|NCT01996852|ED|ed
1208065|NCT01996852|Prostate|prostate
1208066|NCT01996852|Prostatectomy|prostatectomy
1208067|NCT01996826|Corneal Neovascularization|corneal neovascularization
1208068|NCT01996826|Cornea Blood Vessels|cornea blood vessels
1208069|NCT01996826|Corneal Graft Failure|corneal graft failure
1208070|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
1208071|NCT01996826|Corneal Transplant|corneal transplant
1208072|NCT01996813|arthroscopy|arthroscopy
1208073|NCT01996813|shoulder|shoulder
1208074|NCT01996813|obesity|obesity
1208075|NCT01996813|beach chair|beach chair
1208076|NCT01996813|compression hose|compression hose
1208077|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
1208078|NCT01996735|Endothelial function|endothelial function
1208079|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
1208080|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
1208081|NCT01996709|Multi-purpose solution|multi-purpose solution
1208082|NCT01996709|Lid Papillae|lid papillae
1208083|NCT01996709|Palpebral Roughness|palpebral roughness
1208084|NCT01996696|metformin|metformin
1208085|NCT01996696|metabolic syndrome|metabolic syndrome
1208086|NCT01996696|weight gain|weight gain
1208087|NCT01996683|B-thalassemia|b-thalassemia
1208088|NCT01996683|ferritin|ferritin
1208089|NCT01996657|mechanical valves replacement|mechanical valves replacement
1208090|NCT01996657|INR|inr
1208091|NCT01996657|D-dimer|d-dimer
1208092|NCT01996657|thromboembolic events|thromboembolic events
1208093|NCT01996644|Anorexia, Bulimia, Anxiety, Exposure|anorexia, bulimia, anxiety, exposure
1208094|NCT01996618|Premature Ventricular Beats|premature ventricular beats
1208095|NCT01996618|Premature Heart Beats|premature heart beats
1208096|NCT01996618|Ranolazine|ranolazine
1208097|NCT01996592|chronic pain|chronic pain
1208098|NCT01996592|cesarean section pain|cesarean section pain
1208099|NCT01996579|Critically Ill|critically ill
1208100|NCT01996579|Intensive care|intensive care
1208101|NCT01996579|Nasogastric tube|nasogastric tube
1208102|NCT01996579|Orogastric tube|orogastric tube
1208103|NCT01996579|mechanically ventilated|mechanically ventilated
1208104|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
1208105|NCT01996579|length of stay|length of stay
1208106|NCT01996579|lactoferrin|lactoferrin
1208107|NCT01996579|placebo controlled|placebo controlled
1208108|NCT01996579|antibiotic free days|antibiotic free days
1208109|NCT01996566|taste|taste
1208110|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
1208111|NCT01996566|threshold|threshold
1208112|NCT01996566|sensitivity|sensitivity
1208113|NCT01996566|human|human
1208114|NCT01996553|blood flow, regional|blood flow, regional
1208115|NCT01996553|complications|complications
1208116|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
1208117|NCT01996553|cardiac catheterization|cardiac catheterization
1208118|NCT01996553|radial artery|radial artery
1208119|NCT01996540|gastric neoplasm|gastric neoplasm
1208120|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
1208121|NCT01996540|advanced|advanced
1208122|NCT01996540|palliative care|palliative care
1208123|NCT01996514|Children|children
1208124|NCT01996514|Food advertisement|food advertisement
1208125|NCT01996514|Obesity|obesity
1208126|NCT01996514|Television viewing|television viewing
1208127|NCT01996514|Food intake|food intake
1208128|NCT01996449|Hypertension|hypertension
1208129|NCT01996449|blood pressure|blood pressure
1208138|NCT01996436|cerebral vasospasm|cerebral vasospasm
1208139|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1208140|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
1208141|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
1208142|NCT01996423|Atopic dermatitis|atopic dermatitis
1208144|NCT01996410|Breast Cancer|breast cancer
1208145|NCT01996410|Acupuncture|acupuncture
1208146|NCT01996410|Taxol|taxol
1208147|NCT01996410|Cytoxan|cytoxan
1208148|NCT01996410|Adriamycin|adriamycin
1208149|NCT01996410|Taxotere|taxotere
1208150|NCT01996410|Carboplatin|carboplatin
1208151|NCT01996410|Perjeta|perjeta
1208152|NCT01996410|Chemotherapy|chemotherapy
1208153|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
1208154|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1208155|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
1208156|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
1208157|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
1208158|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
1208159|NCT01996397|Heart failure|heart failure
1208160|NCT01996397|Bundle branch block|bundle branch block
1208161|NCT01996397|CRT response|crt response
1208162|NCT01996384|Vulvodynia|vulvodynia
1208163|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
1208164|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
1208165|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
1208166|NCT01996384|vulvovaginal pain|vulvovaginal pain
1208167|NCT01996384|vulvar pain|vulvar pain
1208168|NCT01996384|vaginal pain|vaginal pain
1208169|NCT01996384|chronic pain|chronic pain
1208170|NCT01996384|lidocaine|lidocaine
1208171|NCT01996384|numbing agent|numbing agent
1208172|NCT01996384|anesthetic cream|anesthetic cream
1208173|NCT01996384|acupuncture|acupuncture
1208174|NCT01996384|electroacupuncture|electroacupuncture
1208175|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
1208176|NCT01996384|manual acupuncture|manual acupuncture
1208177|NCT01996384|classical acupuncture|classical acupuncture
1208178|NCT01996384|non-classical acupuncture|non-classical acupuncture
1208179|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
1208180|NCT01996384|TCM|tcm
1208181|NCT01996384|Chinese medicine|chinese medicine
1208182|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
1208183|NCT01996384|AOM|aom
1208184|NCT01996384|treatment|treatment
1208185|NCT01996384|feasibility|feasibility
1208186|NCT01996384|pilot study|pilot study
1208187|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
1208188|NCT01996384|Tampon Test|tampon test
1208189|NCT01996384|cotton swab test|cotton swab test
1208190|NCT01996384|pain diary|pain diary
1208191|NCT01996384|Research Electronic Data Capture|research electronic data capture
1208192|NCT01996384|REDCap|redcap
1208193|NCT01996358|Succinylcholine|succinylcholine
1208194|NCT01996358|Rocuronium|rocuronium
1208195|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
1208196|NCT01996345|Placenta Previa|placenta previa
1208197|NCT01996345|Vaginal Pessary|vaginal pessary
1208198|NCT01996345|Premature Birth|premature birth
1208199|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1208200|NCT01996319|COPD|copd
1208201|NCT01996306|AXEPT|axept
1208202|NCT01996306|Fluorouracil|fluorouracil
1208203|NCT01996306|CPT-11|cpt-11
1208204|NCT01996306|XELIRI|xeliri
1208205|NCT01996306|Bevacizumab|bevacizumab
1208206|NCT01996306|FOLFIRI|folfiri
1208207|NCT01996306|Capecitabine|capecitabine
1208208|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
1208209|NCT01996293|pregnant|pregnant
1208211|NCT01996293|lamotrigine|lamotrigine
1208212|NCT01996293|lamictal|lamictal
1208213|NCT01996293|women|women
1208214|NCT01996293|female|female
1208215|NCT01996267|neoadjuvant|neoadjuvant
1208216|NCT01996267|breast cancer|breast cancer
1208217|NCT01996267|HER2 positive|her2 positive
1208226|NCT01996241|adolescent girls|adolescent girls
1208227|NCT01996241|female sex work|female sex work
1208228|NCT01996241|age at marriage|age at marriage
1208229|NCT01996241|retention in school|retention in school
1208230|NCT01996241|sexual debut|sexual debut
1208231|NCT01996241|India|india
1208232|NCT01996241|Karnataka|karnataka
1208233|NCT01996228|Type 1 diabetes|type 1 diabetes
1208234|NCT01996228|autoimmune|autoimmune
1208235|NCT01996228|cord blood stem cell|cord blood stem cell
1208236|NCT01996228|stem cell educator|stem cell educator
1208237|NCT01996228|immune modulation|immune modulation
1208238|NCT01996228|children|children
1208239|NCT01996228|Control autoimmunity|control autoimmunity
1208240|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
1208241|NCT01996202|Melanoma|melanoma
1208242|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
1208243|NCT01996176|Sedentary work|sedentary work
1208244|NCT01996176|Office workers|office workers
1208245|NCT01996176|Work|work
1208246|NCT01996176|Workplace intervention|workplace intervention
1208247|NCT01996176|Sitting time|sitting time
1208248|NCT01996150|atopic dermatitis|atopic dermatitis
1208249|NCT01996150|eczema|eczema
1208250|NCT01996150|bleach bath|bleach bath
1208251|NCT01996150|itch|itch
1208252|NCT01996150|skin barrier|skin barrier
1208253|NCT01996150|staphylococcus aureus|staphylococcus aureus
1208254|NCT01996137|Stroke|stroke
1208255|NCT01996137|Treadmill|treadmill
1208256|NCT01996137|Gait Speed|gait speed
1208257|NCT01996124|COPD|copd
1208258|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
1208259|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
1208260|NCT01996124|Cor Pulmonale|cor pulmonale
1208261|NCT01996124|Cardiac performance|cardiac performance
1208262|NCT01996111|plantar fasciitis|plantar fasciitis
1208263|NCT01996085|arterial hypertension|arterial hypertension
1208264|NCT01996085|hemodynamics|hemodynamics
1208265|NCT01996085|impedance cardiography|impedance cardiography
1208266|NCT01996085|hypotensive therapy|hypotensive therapy
1208267|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
1208268|NCT01996072|Parathyroid|parathyroid
1208269|NCT01996059|nutritional status|nutritional status
1208270|NCT01996059|functional jejunal interposition|functional jejunal interposition
1208271|NCT01996059|Roux-en-Y|roux-en-y
1208272|NCT01996059|gastrectomy|gastrectomy
1208273|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
1208274|NCT01996033|Renal Denervation|renal denervation
1208275|NCT01996007|Pneumococcus|pneumococcus
1208276|NCT01996007|Carriage|carriage
1208277|NCT01996007|Children|children
1208278|NCT01996007|Parents|parents
1208279|NCT01996007|Immunogenicity|immunogenicity
1208280|NCT01996007|PCV13|pcv13
1208281|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
1208282|NCT01995981|Pazopanib|pazopanib
1208283|NCT01995981|Positron-Emission Tomography|positron-emission tomography
1208284|NCT01995981|Pharmacokinetics|pharmacokinetics
1208285|NCT01995981|Biomarker|biomarker
1208286|NCT01995968|Stillbirth|stillbirth
1208287|NCT01995968|Fetal growth restriction|fetal growth restriction
1208288|NCT01995968|Small for gestational age|small for gestational age
1208289|NCT01995968|Antenatal detection|antenatal detection
1208290|NCT01995968|Prenatal Care|prenatal care
1208291|NCT01995968|Mass Screening|mass screening
1208292|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
1208293|NCT01995955|coronary artery disease|coronary artery disease
1208294|NCT01995955|index of myocardial resistance|index of myocardial resistance
1208295|NCT01995942|Rectal Cancer|rectal cancer
1208296|NCT01995942|EMVI|emvi
1208297|NCT01995942|Extramural Venous Invasion|extramural venous invasion
1208298|NCT01995942|Microarray|microarray
1208299|NCT01995942|Biomarker|biomarker
1208300|NCT01995942|mrEMVI|mremvi
1208301|NCT01995942|Tumour Regression Grade|tumour regression grade
1208302|NCT01995942|Cancer|cancer
1208303|NCT01995942|Circumferential Resection Margin|circumferential resection margin
1208304|NCT01995942|CRM|crm
1208305|NCT01995942|MRI|mri
1208306|NCT01995942|Radiology|radiology
1208307|NCT01995942|Surgery|surgery
1208308|NCT01995942|Pathology|pathology
1208309|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
1208310|NCT01995929|transnasal endoscopy|transnasal endoscopy
1208311|NCT01995929|functional endoscopy|functional endoscopy
1208312|NCT01995890|nepafenac eye drops|nepafenac eye drops
1208313|NCT01995890|intraocular pressure|intraocular pressure
1208314|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1208315|NCT01995864|Community Psychiatry|community psychiatry
1208316|NCT01995851|Influenza|influenza
1208317|NCT01995851|Vaccine|vaccine
1208318|NCT01995838|Chronic Insomnia|chronic insomnia
1208319|NCT01995838|Adults|adults
1208320|NCT01995838|Elderly|elderly
1208321|NCT01995825|bioequivalence|bioequivalence
1208322|NCT01995825|lamotrigine|lamotrigine
1208323|NCT01995825|epilepsy|epilepsy
1208324|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
1208325|NCT01995786|Fluid Therapy|fluid therapy
1208326|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
1208327|NCT01995786|Hemodynamics|hemodynamics
1208328|NCT01995786|Cost Control|cost control
1208329|NCT01995773|Healthy women|healthy women
1208330|NCT01995773|Quality of life|quality of life
1208331|NCT01995773|Glucose metabolism|glucose metabolism
1208332|NCT01995773|Adrenal reactivity|adrenal reactivity
1208333|NCT01995773|Physical activity|physical activity
1208334|NCT01995773|Body Composition|body composition
1208335|NCT01995760|vancomycin|vancomycin
1208336|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
1208337|NCT01995760|AUC/MIC|auc/mic
1208338|NCT01995747|IgE|ige
1208339|NCT01995747|Atopic Dermatitis|atopic dermatitis
1208340|NCT01995747|antibody|antibody
1208341|NCT01995747|allergy|allergy
1208342|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
1208343|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
1208344|NCT01995721|human papillomavirus|human papillomavirus
1208345|NCT01995721|vaccine|vaccine
1208346|NCT01995721|treatment|treatment
1208347|NCT01995721|immunology|immunology
1208348|NCT01995721|relapse|relapse
1208349|NCT01995708|CT7|ct7
1208350|NCT01995708|MAGE-A3|mage-a3
1208351|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
1208352|NCT01995708|vaccine|vaccine
1208353|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1208354|NCT01995708|13-009|13-009
1208355|NCT01995682|Independent living|independent living
1208356|NCT01995682|walk with or without walking aids|walk with or without walking aids
1208357|NCT01995669|Lymphoma|lymphoma
1208358|NCT01995669|Relapsed Indolent Non-Hodgkin's Lymphoma|relapsed indolent non-hodgkin's lymphoma
1208359|NCT01995669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1208360|NCT01995669|NHL|nhl
1208361|NCT01995669|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
1208362|NCT01995669|Small lymphocytic lymphoma|small lymphocytic lymphoma
1208363|NCT01995669|SLL|sll
1208364|NCT01995669|Follicular lymphoma|follicular lymphoma
1208365|NCT01995669|Marginal zone lymphoma|marginal zone lymphoma
1208366|NCT01995669|Lenalidomide|lenalidomide
1208367|NCT01995669|CC-5013|cc-5013
1208368|NCT01995669|Revlimid|revlimid
1208369|NCT01995669|Obinutuzumab|obinutuzumab
1208370|NCT01995669|GA101|ga101
1208371|NCT01995643|Grape seed extract|grape seed extract
1208372|NCT01995643|Polyphenols|polyphenols
1208373|NCT01995643|Insulin|insulin
1208374|NCT01995643|Oxidative stress Marker|oxidative stress marker
1208375|NCT01995643|Inflammatory marker|inflammatory marker
1208376|NCT01995643|Healthy human|healthy human
1208377|NCT01995617|vaccine|vaccine
1208378|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
1208379|NCT01995617|Strep pneumo|strep pneumo
1208380|NCT01995591|colon cancer|colon cancer
1208381|NCT01995591|sentinel lymph node|sentinel lymph node
1208382|NCT01995591|Indocyanine Green|indocyanine green
1208383|NCT01995578|5'-Azacitidine|5'-azacitidine
1208384|NCT01995578|Stem cell transplant|stem cell transplant
1208385|NCT01995578|13-192|13-192
1208386|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
1208387|NCT01995539|Type 2|type 2
1208388|NCT01995500|CAD|cad
1208389|NCT01995500|PCI|pci
1208390|NCT01995500|ACS|acs
1208391|NCT01995500|non ACS|non acs
1208392|NCT01995500|BioNIR|bionir
1208393|NCT01995500|DES|des
1208394|NCT01995487|more comers|more comers
1208395|NCT01995487|DES|des
1208396|NCT01995487|BioNIR|bionir
1208397|NCT01995487|ACS|acs
1208398|NCT01995487|non ACS|non acs
1208399|NCT01995487|complex lesions|complex lesions
1208400|NCT01995474|EUS|eus
1208401|NCT01995474|pancreatic cancer|pancreatic cancer
1208402|NCT01995474|cytology|cytology
1208403|NCT01995474|fine needle aspiration|fine needle aspiration
1208404|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
1208405|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
1208406|NCT01995422|Major depressive disorder|major depressive disorder
1208407|NCT01995422|Follow-up study|follow-up study
1208408|NCT01995422|Ecological momentary assessment|ecological momentary assessment
1208409|NCT01995422|Physical activity|physical activity
1208410|NCT01995422|Depression|depression
1208411|NCT01995422|Self-esteem|self-esteem
1208412|NCT01995422|Anxiety|anxiety
1208413|NCT01995422|Rumination|rumination
1208414|NCT01995422|Quality of life|quality of life
1208415|NCT01995396|rectal cancer,|rectal cancer,
1208416|NCT01995396|fecal incontinence,|fecal incontinence,
1208417|NCT01995396|severe co-morbidity,|severe co-morbidity,
1208418|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
1208419|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
1208420|NCT01995396|postoperative complications,|postoperative complications,
1208421|NCT01995396|pelvic abscess,|pelvic abscess,
1208422|NCT01995396|perineal infections|perineal infections
1208423|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
1208424|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
1208425|NCT01995370|Cilostazol|cilostazol
1208426|NCT01995370|Aspirin|aspirin
1208427|NCT01995370|Clopidogrel|clopidogrel
1208428|NCT01995331|aplastic anemia;|aplastic anemia;
1208429|NCT01995331|cyclophosphamide;|cyclophosphamide;
1208430|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
1208431|NCT01995331|cyclosporine A|cyclosporine a
1208432|NCT01995318|Kinesiotaping|kinesiotaping
1208433|NCT01995305|fanconi anemia|fanconi anemia
1208434|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
1208435|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
1208436|NCT01995292|spray as you go technique|spray as you go technique
1208437|NCT01995292|anesthesia|anesthesia
1208438|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
1208439|NCT01995279|low back pain|low back pain
1208440|NCT01995279|French Auriculotherapy|french auriculotherapy
1208441|NCT01995279|postural control|postural control
1208442|NCT01995279|balance|balance
1208443|NCT01995279|posture|posture
1208444|NCT01995240|pancreatic cancer|pancreatic cancer
1208445|NCT01995240|MRI|mri
1208446|NCT01995240|reproducibility|reproducibility
1208447|NCT01995240|optimalization|optimalization
1208448|NCT01995227|liver cancer|liver cancer
1208449|NCT01995227|HCC|hcc
1208450|NCT01995227|tumor vaccine|tumor vaccine
1208451|NCT01995227|immunotherapy|immunotherapy
1208452|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
1208453|NCT01995214|Postoperative delirium|postoperative delirium
1208454|NCT01995214|Geriatric|geriatric
1208455|NCT01995214|General anesthesia|general anesthesia
1208456|NCT01995214|Propofol|propofol
1208457|NCT01995214|Sevoflurane|sevoflurane
1208458|NCT01995175|Asthma|asthma
1208459|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
1208460|NCT01995175|Cohort study|cohort study
1208461|NCT01995175|Quarterly phone contacts|quarterly phone contacts
1208462|NCT01995175|Wheeze|wheeze
1208463|NCT01995175|New born|new born
1208464|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
1208465|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
1208466|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
1208467|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
1208468|NCT01995149|Obesity|obesity
1208469|NCT01995149|Overweight.|overweight.
1208470|NCT01995149|Lipids|lipids
1208471|NCT01995136|Glaucoma|glaucoma
1208472|NCT01995136|Ocular hypertension|ocular hypertension
1208473|NCT01995123|Tobacco dependence|tobacco dependence
1208474|NCT01995123|PTSD|ptsd
1208475|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
1208476|NCT01995097|smoking cessation|smoking cessation
1208477|NCT01995097|smoking reduction|smoking reduction
1208478|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
1208479|NCT01995097|pregnancy|pregnancy
1208480|NCT01995097|text message intervention|text message intervention
1208481|NCT01995084|hypoxia|hypoxia
1208482|NCT01995084|HX4|hx4
1208483|NCT01995084|PET|pet
1208484|NCT01995084|cancer|cancer
1208485|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
1208486|NCT01995071|Cirrhosis|cirrhosis
1208487|NCT01995071|Child Pugh A|child pugh a
1208488|NCT01995071|Hepatitis C virus|hepatitis c virus
1208489|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
1208490|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
1208491|NCT01995071|Hepatitis C|hepatitis c
1208492|NCT01995071|Interferon-Free|interferon-free
1208493|NCT01995071|Cirrhotic|cirrhotic
1208494|NCT01995058|CRPC|crpc
1208495|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
1208496|NCT01995058|prostate cancer|prostate cancer
1208497|NCT01995045|Retina|retina
1208498|NCT01995045|Vitreoretinal|vitreoretinal
1208499|NCT01995045|Surgery|surgery
1208500|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
1208501|NCT01995032|DMD|dmd
1208502|NCT01995019|Arthralgia|arthralgia
1208503|NCT01995019|Temporomandibular joint|temporomandibular joint
1208504|NCT01995019|corticosteroids|corticosteroids
1208505|NCT01995019|injection|injection
1208506|NCT01995019|intra-articular|intra-articular
1208507|NCT01995006|Effect|effect
1208508|NCT01995006|metamizole|metamizole
1208509|NCT01995006|salt-depleted|salt-depleted
1208510|NCT01995006|subjects|subjects
1208511|NCT01994993|Antibiotics|antibiotics
1208512|NCT01994993|ampicillin|ampicillin
1208513|NCT01994993|metronidazole|metronidazole
1208514|NCT01994993|clindamycin|clindamycin
1208515|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
1208516|NCT01994993|Safety|safety
1208517|NCT01994993|Infants|infants
1587217|NCT00441298|safety|safety
1208518|NCT01994993|Intra abdominal infections|intra abdominal infections
1208519|NCT01994967|Phase III|phase iii
1208520|NCT01994967|Noninferiority|noninferiority
1208521|NCT01994967|Controlled|controlled
1208522|NCT01994967|Double-blind|double-blind
1208523|NCT01994967|Randomized|randomized
1208524|NCT01994967|Spinal|spinal
1208525|NCT01994967|Anesthetic|anesthetic
1208526|NCT01994967|Lower limb|lower limb
1208527|NCT01994954|newborn intensive care unit|newborn intensive care unit
1208528|NCT01994954|NICU|nicu
1208529|NCT01994954|supplemental oxygen|supplemental oxygen
1208530|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
1208531|NCT01994941|Platelet Reactivity|platelet reactivity
1208532|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
1208533|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
1208534|NCT01994915|exacerbation|exacerbation
1208535|NCT01994915|functionality|functionality
1208536|NCT01994915|occupational therapy|occupational therapy
1208537|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1208538|NCT01994889|amyloidosis|amyloidosis
1208539|NCT01994889|amyloid|amyloid
1208540|NCT01994889|transthyretin|transthyretin
1208541|NCT01994889|TTR|ttr
1208542|NCT01994837|GDC-0199|gdc-0199
1208543|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
1208544|NCT01994837|AML|aml
1208545|NCT01994837|ABT-199|abt-199
1208546|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
1208547|NCT01994837|Myeloid Leukemia|myeloid leukemia
1208548|NCT01994811|cancer|cancer
1208549|NCT01994811|cardiovascular disease|cardiovascular disease
1208550|NCT01994811|diabetes|diabetes
1208551|NCT01994785|Sedation|sedation
1208552|NCT01994785|Endoscopy|endoscopy
1208553|NCT01994785|Capnography|capnography
1208554|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
1208555|NCT01994772|Targeted controlled temperature|targeted controlled temperature
1208556|NCT01994772|Cardiac arrest|cardiac arrest
1208557|NCT01994772|Non shockable rhythm|non shockable rhythm
1208558|NCT01994772|successful resuscitation|successful resuscitation
1208559|NCT01994759|Plantar fasciitis|plantar fasciitis
1208560|NCT01994759|Treatment|treatment
1208561|NCT01994759|Training|training
1208562|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
1208563|NCT01994746|Diabetes Mellitus|diabetes mellitus
1208564|NCT01994746|Hypoglycemia|hypoglycemia
1208565|NCT01994746|Glucagon|glucagon
1208566|NCT01994733|end-stage renal disease|end-stage renal disease
1208567|NCT01994733|hemodialysis|hemodialysis
1208568|NCT01994733|mineral metabolism|mineral metabolism
1208569|NCT01994733|serum phosphate|serum phosphate
1208570|NCT01994733|phosphate binders|phosphate binders
1208571|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
1208572|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
1208573|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
1208574|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1208575|NCT01994707|Troponin T|troponin t
1208576|NCT01994707|Apoptosis|apoptosis
1208577|NCT01994707|Experimental|experimental
1208578|NCT01994707|Cardioprotection|cardioprotection
1208579|NCT01994668|lorazepam|lorazepam
1208580|NCT01994668|intravenous|intravenous
1208581|NCT01994668|pharmacolinetics|pharmacolinetics
1208582|NCT01994668|healthy|healthy
1208583|NCT01994668|Japanese|japanese
1208584|NCT01994655|climacteric symptoms|climacteric symptoms
1208585|NCT01994655|menopause|menopause
1208586|NCT01994655|nurses|nurses
1208587|NCT01994629|meningococcal disease|meningococcal disease
1208588|NCT01994629|children|children
1208589|NCT01994629|vaccination|vaccination
1208590|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
1208591|NCT01994603|Prevention|prevention
1208592|NCT01994603|HIV|hiv
1208593|NCT01994603|AIDS|aids
1208594|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
1208595|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
1208596|NCT01994590|Prostate Cancer|prostate cancer
1208597|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
1208598|NCT01994590|mCRPC|mcrpc
1208599|NCT01994590|Dovitinib|dovitinib
1208600|NCT01994590|TKI258|tki258
1208601|NCT01994590|Abiraterone Acetate|abiraterone acetate
1208602|NCT01994590|Zytiga|zytiga
1208603|NCT01994590|Prednisone|prednisone
1208604|NCT01994577|Emergency Department|emergency department
1208605|NCT01994577|Cardiac troponin|cardiac troponin
1208606|NCT01994577|Myocardial infarction|myocardial infarction
1208607|NCT01994564|OAG|oag
1208608|NCT01994538|Urinary Tract Infections|urinary tract infections
1208609|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
1208610|NCT01994512|Spinal stenosis|spinal stenosis
1208611|NCT01994512|Decompression|decompression
1208612|NCT01994512|Fusion|fusion
1208613|NCT01994512|Olisthesis|olisthesis
1208614|NCT01994486|HCV Genotype 1|hcv genotype 1
1208615|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
1208616|NCT01994486|HCV|hcv
1208617|NCT01994486|TVR|tvr
1208618|NCT01994473|Schizophrenia|schizophrenia
1208619|NCT01994460|Tuberculosis|tuberculosis
1208620|NCT01994447|Informed Consent|informed consent
1208621|NCT01994447|Instructional Films and Video|instructional films and video
1208622|NCT01994447|Consent Comprehension|consent comprehension
1208623|NCT01994447|Multimedia Consent|multimedia consent
1208624|NCT01994447|Parent|parent
1208625|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
1208626|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
1208627|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
1208628|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
1208629|NCT01994421|Classical tape|classical tape
1208630|NCT01994421|No tape|no tape
1208631|NCT01994408|physician inertia|physician inertia
1208632|NCT01994408|hypertension|hypertension
1208633|NCT01994408|telemedicine|telemedicine
1208634|NCT01994408|mobile technology|mobile technology
1208635|NCT01994395|Stroke|stroke
1208636|NCT01994395|Gait|gait
1208637|NCT01994395|Stride Management Assist|stride management assist
1208638|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
1208639|NCT01994382|Leukemia|leukemia
1208640|NCT01994382|Lymphocytic|lymphocytic
1208641|NCT01994382|Chronic|chronic
1208642|NCT01994382|B Cell|b cell
1208643|NCT01994369|Breast Cancer|breast cancer
1208644|NCT01994356|Contraceptive counseling|contraceptive counseling
1208645|NCT01994356|Physician self disclosure|physician self disclosure
1208646|NCT01994356|Satisfaction|satisfaction
1208647|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
1208648|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
1208649|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
1208650|NCT01994330|severe aortic stenosis|severe aortic stenosis
1208651|NCT01994330|Heye´s syndrome|heye´s syndrome
1208652|NCT01994330|desmopressin|desmopressin
1208653|NCT01994330|von Willebrand multimers|von willebrand multimers
1208654|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
1208655|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
1208656|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
1208657|NCT01994291|Chemokine Antagonist|chemokine antagonist
1208658|NCT01994291|Diabetic Macular Edema|diabetic macular edema
1208659|NCT01994291|Diabetes|diabetes
1208660|NCT01994291|Diabetes Mellitus|diabetes mellitus
1208661|NCT01994291|Macular Edema|macular edema
1208662|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
1208663|NCT01994291|Anti-VEGF|anti-vegf
1208664|NCT01994265|Atrial fibrillation|atrial fibrillation
1208665|NCT01994265|Cognition|cognition
1208666|NCT01994265|Cognitive impairment|cognitive impairment
1208667|NCT01994265|Anticoagulation|anticoagulation
1208668|NCT01994265|Dabigatran|dabigatran
1208669|NCT01994265|Warfarin|warfarin
1208670|NCT01994265|Efficacy|efficacy
1208671|NCT01994252|defibrillator|defibrillator
1208672|NCT01994252|cardiac resynchronization|cardiac resynchronization
1208673|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
1208674|NCT01994239|LHRH antagonist|lhrh antagonist
1208675|NCT01994239|Radiotherapy|radiotherapy
1208676|NCT01994213|Famitinib|famitinib
1208677|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
1208678|NCT01994213|GEPNET|gepnet
1208679|NCT01994200|Thyroid cancer|thyroid cancer
1208680|NCT01994200|New diagnosis|new diagnosis
1208681|NCT01994200|Dedicated Nurse|dedicated nurse
1208682|NCT01994200|Interdisciplinary team|interdisciplinary team
1208683|NCT01994200|Randomized Controlled Trial|randomized controlled trial
1208684|NCT01994200|Intervention|intervention
1208685|NCT01994200|Supportive care|supportive care
1208686|NCT01994187|Carotid stenosis|carotid stenosis
1208687|NCT01994187|Angioplasty|angioplasty
1208688|NCT01994187|Carotid endarterectomy|carotid endarterectomy
1208689|NCT01994187|Stroke|stroke
1208690|NCT01994174|vascular|vascular
1208691|NCT01994174|retina|retina
1208692|NCT01994174|Anti-VEGF|anti-vegf
1208693|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
1208694|NCT01994161|ischemic stroke|ischemic stroke
1208695|NCT01994161|intracranial stenting|intracranial stenting
1208696|NCT01994161|vascular risk factor management|vascular risk factor management
1208697|NCT01994148|Trauma|trauma
1208698|NCT01994148|Gastrointestinal injury|gastrointestinal injury
1208699|NCT01994148|Laparoscopy|laparoscopy
1208700|NCT01994109|Sialorrhea|sialorrhea
1208701|NCT01994109|Parkinson's disease|parkinson's disease
1208702|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1208703|NCT01994109|stroke|stroke
1208704|NCT01994109|neuroleptics|neuroleptics
1208705|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
1208706|NCT01994057|EGFR-TKI;|egfr-tki;
1208707|NCT01994057|Pharmacogenetics;|pharmacogenetics;
1208708|NCT01994057|Precision medicine|precision medicine
1208709|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
1208710|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
1208711|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
1208712|NCT01994031|paclitaxel|paclitaxel
1208713|NCT01994018|Vitamin D|vitamin d
1208714|NCT01994018|Interferon Beta|interferon beta
1208715|NCT01994018|Glatiramer Acetate|glatiramer acetate
1208716|NCT01994018|Relapse rates|relapse rates
1208717|NCT01993992|Anesthesia|anesthesia
1208718|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
1208719|NCT01993979|Surveillance|surveillance
1208720|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
1208721|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
1208722|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
1208723|NCT01993966|chemotherapy,|chemotherapy,
1208724|NCT01993966|cytotoxicity,|cytotoxicity,
1208725|NCT01993966|drug resistance,|drug resistance,
1208726|NCT01993966|xenograft.|xenograft.
1208727|NCT01993953|Muscle strength|muscle strength
1208728|NCT01993953|Body composition|body composition
1208729|NCT01993953|Body weight|body weight
1208730|NCT01993953|Resistance training|resistance training
1208731|NCT01993953|Personal training|personal training
1208732|NCT01993953|BodyPump|bodypump
1208733|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
1208734|NCT01993927|Drug Therapy|drug therapy
1208735|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
1208736|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
1208738|NCT01993849|Impulse control|impulse control
1208739|NCT01993849|Depression|depression
1208740|NCT01993849|ADHD|adhd
1208741|NCT01993849|Fingernail Biting|fingernail biting
1208742|NCT01993849|N-Acetylcysteine|n-acetylcysteine
1208744|NCT01993836|isoflurane|isoflurane
1208745|NCT01993836|propofol|propofol
1208746|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
1208747|NCT01993836|inhaled anesthetic|inhaled anesthetic
1208748|NCT01993836|volatile anesthetic|volatile anesthetic
1208749|NCT01993836|anesthesia|anesthesia
1208750|NCT01993836|delirium|delirium
1208751|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
1208752|NCT01993836|Alzheimer's Disease|alzheimer's disease
1208753|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
1208754|NCT01993810|Non small cell lung cancer|non small cell lung cancer
1208755|NCT01993810|NSCLC|nsclc
1208756|NCT01993810|proton radiotherapy|proton radiotherapy
1208757|NCT01993797|Bronchiolitis|bronchiolitis
1208758|NCT01993758|tourniquet pressure|tourniquet pressure
1208759|NCT01993758|total knee arthroplasty|total knee arthroplasty
1208760|NCT01993745|ECMO|ecmo
1208761|NCT01993745|APACH II score|apach ii score
1208762|NCT01993732|Cancer|cancer
1208763|NCT01993732|Cryopreservation|cryopreservation
1208764|NCT01993732|Ovarian Function|ovarian function
1208765|NCT01993732|In Vitro|in vitro
1208766|NCT01993719|Metastatic|metastatic
1208767|NCT01993719|Melanoma|melanoma
1208768|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
1208769|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
1208770|NCT01993706|Healthy Adults|healthy adults
1208771|NCT01993706|Placebo|placebo
1208772|NCT01993706|HIV Prevention|hiv prevention
1208773|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
1208774|NCT01993706|Antibodies|antibodies
1208775|NCT01993693|knee|knee
1208776|NCT01993693|pain|pain
1208777|NCT01993693|osteoarthritis|osteoarthritis
1208778|NCT01993693|ultrasound|ultrasound
1208779|NCT01993654|Pigmented Lesions|pigmented lesions
1208780|NCT01993654|PAM|pam
1208781|NCT01993654|Ocular lesion|ocular lesion
1208976|NCT01992575|OCT|oct
1208782|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
1208783|NCT01993641|MDS|mds
1208784|NCT01993641|pracinostat|pracinostat
1208785|NCT01993641|Hypomethylating Agent|hypomethylating agent
1208786|NCT01993641|HMA|hma
1208787|NCT01993641|azacitadine|azacitadine
1208788|NCT01993641|Vidaza|vidaza
1208789|NCT01993641|decitabine|decitabine
1208790|NCT01993641|dacogen|dacogen
1208791|NCT01993615|FAI|fai
1208792|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
1208793|NCT01993615|hip pain|hip pain
1208794|NCT01993615|hip arthroscopy|hip arthroscopy
1208795|NCT01993615|physical therapy|physical therapy
1208796|NCT01993602|general surgery|general surgery
1208797|NCT01993602|postoperative care|postoperative care
1208798|NCT01993602|breathing exercises|breathing exercises
1208799|NCT01993602|respiratory muscle|respiratory muscle
1208800|NCT01993602|postoperative complications|postoperative complications
1208801|NCT01993602|lung volume measurements|lung volume measurements
1208802|NCT01993602|pulmonary ventilations|pulmonary ventilations
1208803|NCT01993602|thoracic wall|thoracic wall
1208804|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
1208805|NCT01993563|Stroke|stroke
1208806|NCT01993563|Rehabilitation|rehabilitation
1208807|NCT01993563|Motor Imagery|motor imagery
1208808|NCT01993563|Upper Extremity|upper extremity
1208809|NCT01993563|Mirror Therapy|mirror therapy
1208810|NCT01993550|lung cancer|lung cancer
1208811|NCT01993550|family caregiving|family caregiving
1208812|NCT01993550|behavioral intervention|behavioral intervention
1208813|NCT01993550|counseling|counseling
1208814|NCT01993550|symptom management|symptom management
1208815|NCT01993498|cancer toxicities|cancer toxicities
1208816|NCT01993498|cohort|cohort
1208817|NCT01993498|breast cancer|breast cancer
1208818|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
1208819|NCT01993485|endothelial function|endothelial function
1208820|NCT01993485|circulating microparticles|circulating microparticles
1208821|NCT01993459|Quality of Recovery|quality of recovery
1208822|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
1208823|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
1208824|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
1208825|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
1208826|NCT01993355|health-related quality of life,|health-related quality of life,
1208827|NCT01993355|physioterapy,|physioterapy,
1208828|NCT01993355|sophrology,|sophrology,
1209322|NCT01990872|Vitamin D3|vitamin d3
1208829|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
1208830|NCT01993355|motivational interviewing|motivational interviewing
1208831|NCT01993342|adipocytokines|adipocytokines
1208832|NCT01993342|osteoarthritis|osteoarthritis
1208833|NCT01993342|inflammation|inflammation
1208834|NCT01993342|ultrasonography|ultrasonography
1208835|NCT01993316|neurofeedback|neurofeedback
1208837|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
1208838|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
1208839|NCT01993303|PET|pet
1208840|NCT01993303|Rb-82|rb-82
1208841|NCT01993264|Heart disease|heart disease
1208842|NCT01993264|Echocardiogram|echocardiogram
1208843|NCT01993264|Ultrasound|ultrasound
1208844|NCT01993264|Heart defect|heart defect
1208845|NCT01993264|Heart Dysfunction|heart dysfunction
1208846|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
1208847|NCT01993264|Prenatal|prenatal
1208848|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
1208849|NCT01993225|Low Testosterone|low testosterone
1208850|NCT01993212|Low Testosterone|low testosterone
1208851|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
1208852|NCT01993173|Diphtheria|diphtheria
1208853|NCT01993173|Tetanus|tetanus
1208854|NCT01993173|Pertussis|pertussis
1208855|NCT01993173|ADACEL®|adacel®
1208856|NCT01993173|Tdap vaccine|tdap vaccine
1208857|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
1208858|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
1208859|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1208860|NCT01993147|Methylphenidate|methylphenidate
1208861|NCT01993147|Placebo|placebo
1208862|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1208863|NCT01993147|Attention Control|attention control
1208864|NCT01993134|Postoperative infection|postoperative infection
1208865|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
1208866|NCT01993134|Cefazolin|cefazolin
1208867|NCT01993121|diabetes|diabetes
1208868|NCT01993121|exercise|exercise
1208869|NCT01993121|heart|heart
1208870|NCT01993121|cardiovascular|cardiovascular
1208871|NCT01993108|Methylphenidate|methylphenidate
1208872|NCT01993108|Naltrexone|naltrexone
1208873|NCT01993108|Placebo|placebo
1208874|NCT01993108|Neuroimaging|neuroimaging
1208875|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
1208876|NCT01993108|Attention Control|attention control
1208877|NCT01993108|Motor Control|motor control
1208878|NCT01993108|Appetitive Control|appetitive control
1208879|NCT01993095|Multiple Sclerosis|multiple sclerosis
1208880|NCT01993095|Quality of Life|quality of life
1208881|NCT01993095|Functional Fitness|functional fitness
1208882|NCT01993082|Caregivers|caregivers
1208883|NCT01993082|Telomerase|telomerase
1208884|NCT01993082|Telomere Length|telomere length
1208885|NCT01993082|Psychological Stress|psychological stress
1208886|NCT01993082|Cardiovascular Risk|cardiovascular risk
1208887|NCT01993082|Exercise|exercise
1208888|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
1208889|NCT01993043|ROP|rop
1208890|NCT01993043|Bevacizumab|bevacizumab
1208891|NCT01993043|Laser|laser
1208892|NCT01993043|Development|development
1208893|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
1208894|NCT01993017|Depressive Symptoms|depressive symptoms
1208895|NCT01992991|transcranial stimulation|transcranial stimulation
1208896|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
1208897|NCT01992991|Home training|home training
1208898|NCT01992991|Occupational Therapy|occupational therapy
1208899|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
1208900|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
1208901|NCT01992978|hepatectomy|hepatectomy
1208902|NCT01992978|postoperative liver injury|postoperative liver injury
1208903|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
1208904|NCT01992965|critically ill;|critically ill;
1208905|NCT01992939|pulse|pulse
1208906|NCT01992939|heat|heat
1208907|NCT01992939|blood circulation|blood circulation
1208908|NCT01992926|health literacy|health literacy
1208909|NCT01992926|health numeracy|health numeracy
1208910|NCT01992913|Schizophrenia|schizophrenia
1208911|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
1208912|NCT01992913|Cognition|cognition
1208913|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
1208914|NCT01992913|Supported Employment|supported employment
1208915|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
1208916|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
1208917|NCT01992900|Eurartesim|eurartesim
1208918|NCT01992900|ACT|act
1208919|NCT01992887|HIV/AIDS|hiv/aids
1208920|NCT01992887|Retention|retention
1208921|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
1208922|NCT01992874|Neoplasms|neoplasms
1208923|NCT01992874|Pimasertib|pimasertib
1208924|NCT01992874|Cancer|cancer
1208925|NCT01992822|rTMS|rtms
1208926|NCT01992822|fibromyalgia|fibromyalgia
1208927|NCT01992822|experimental pain|experimental pain
1208928|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
1208929|NCT01992809|omega 3|omega 3
1208930|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
1208931|NCT01992783|Resistant Starch|resistant starch
1208932|NCT01992783|Antioxidant Status|antioxidant status
1208933|NCT01992783|Insulin Resistance|insulin resistance
1208934|NCT01992783|Overweight|overweight
1208935|NCT01992783|Obesity|obesity
1208936|NCT01992770|behavioural medicine|behavioural medicine
1208937|NCT01992770|pain|pain
1208938|NCT01992770|physical therapy|physical therapy
1208939|NCT01992770|physical exercise|physical exercise
1208940|NCT01992770|primary care|primary care
1208941|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
1208942|NCT01992757|cardiac surgery|cardiac surgery
1208943|NCT01992744|pregnancy|pregnancy
1208944|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
1208945|NCT01992744|birth outcomes|birth outcomes
1208946|NCT01992731|Age (38-42 years)|age (38-42 years)
1208947|NCT01992731|pregnancy rates|pregnancy rates
1208948|NCT01992731|3 IUI cycles|3 iui cycles
1208949|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
1208950|NCT01992705|pancreatic cancer|pancreatic cancer
1208951|NCT01992692|Parkinson's disease|parkinson's disease
1208952|NCT01992692|remifentanil|remifentanil
1208953|NCT01992692|deep brain stimulator|deep brain stimulator
1208954|NCT01992692|cardiovascular response|cardiovascular response
1208955|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
1208956|NCT01992666|genetic|genetic
1208957|NCT01992666|immunological|immunological
1208958|NCT01992666|pediatric|pediatric
1208959|NCT01992666|mutation|mutation
1208960|NCT01992666|lupus|lupus
1208961|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
1208962|NCT01992627|elbow epicondylosis|elbow epicondylosis
1208963|NCT01992614|Single Ascending Dose|single ascending dose
1208964|NCT01992614|healthy subjects|healthy subjects
1208965|NCT01992614|Hypercholesterolemia|hypercholesterolemia
1208966|NCT01992614|Hyperlipidemias|hyperlipidemias
1208967|NCT01992614|Dyslipidemias|dyslipidemias
1208968|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
1208969|NCT01992614|Metabolic Diseases|metabolic diseases
1208970|NCT01992601|Drug interaction|drug interaction
1208971|NCT01992601|Rosuvastatin|rosuvastatin
1208972|NCT01992601|Telmisartan|telmisartan
1208973|NCT01992601|Pharmacokinetic|pharmacokinetic
1208974|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
1208975|NCT01992575|Retinal vein occlusion|retinal vein occlusion
1208977|NCT01992575|Optical coherence tomography|optical coherence tomography
1208978|NCT01992575|Imaging|imaging
1208979|NCT01992536|Meningococcal|meningococcal
1208980|NCT01992536|Booster|booster
1208981|NCT01992536|MenABCWY|menabcwy
1208982|NCT01992536|Menveo|menveo
1208983|NCT01992536|Vaccine Adolescents|vaccine adolescents
1208984|NCT01992536|Immune Response|immune response
1208985|NCT01992536|N. Meningitidis|n. meningitidis
1208986|NCT01992523|Ticagrelor|ticagrelor
1208987|NCT01992523|antiplatelet|antiplatelet
1208988|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
1208989|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
1208990|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
1208991|NCT01992471|BRCA1 testing|brca1 testing
1208992|NCT01992471|BRCA2 testing|brca2 testing
1208993|NCT01992471|13-215|13-215
1208994|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1208995|NCT01992458|death|death
1208996|NCT01992458|shock|shock
1208997|NCT01992458|mortality|mortality
1208998|NCT01992458|complication|complication
1208999|NCT01992458|sudden death|sudden death
1209000|NCT01992445|suicide|suicide
1209001|NCT01992445|suicidal intent|suicidal intent
1209002|NCT01992445|thought markers|thought markers
1587421|NCT00440622|Gemcitabine|gemcitabine
1287440|NCT01637259|HIV|hiv
1209003|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
1209004|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
1209005|NCT01992432|older woman|older woman
1209006|NCT01992432|breast cancer|breast cancer
1209007|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
1209008|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
1209009|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
1209010|NCT01992393|Epilepsy|epilepsy
1209011|NCT01992393|Schizophrenia|schizophrenia
1209012|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
1209013|NCT01992393|Bipolar Disorder|bipolar disorder
1209014|NCT01992393|Depression|depression
1209015|NCT01992393|Intervention|intervention
1209016|NCT01992393|Treatment|treatment
1209017|NCT01992393|Adherence|adherence
1209018|NCT01992341|sarcomas|sarcomas
1209019|NCT01992341|carcinomas|carcinomas
1209020|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
1209021|NCT01992315|Scar|scar
1209022|NCT01992315|Soft tissue defect|soft tissue defect
1209023|NCT01992302|Rapid cycling|rapid cycling
1209024|NCT01992289|XLHED|xlhed
1209025|NCT01992289|HED|hed
1209026|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
1209027|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
1209028|NCT01992276|Influenza|influenza
1209029|NCT01992276|Virus|virus
1209030|NCT01992276|Monoclonal Antibody|monoclonal antibody
1209031|NCT01992276|Immunization|immunization
1209032|NCT01992276|Treatment|treatment
1209033|NCT01992263|tuberculosis|tuberculosis
1209034|NCT01992263|vitamin D|vitamin d
1209035|NCT01992263|immunity|immunity
1209036|NCT01992250|Cryoablation|cryoablation
1209037|NCT01992237|ALI,|ali,
1209038|NCT01992237|ARDS,|ards,
1209039|NCT01992237|ECMO,|ecmo,
1209040|NCT01992237|energy expenditure,|energy expenditure,
1209041|NCT01992237|mechanical ventilation,|mechanical ventilation,
1209042|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1209043|NCT01992237|Nutrition Assessment|nutrition assessment
1209044|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
1209045|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
1209046|NCT01992224|mechanical ventilation|mechanical ventilation
1209047|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
1209048|NCT01992198|cefoperazone|cefoperazone
1209049|NCT01992198|metronidazole|metronidazole
1209050|NCT01992198|meropenem|meropenem
1209051|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
1209052|NCT01992146|central sensitization|central sensitization
1209053|NCT01992146|endogenous opioids|endogenous opioids
1209054|NCT01992146|humans|humans
1209055|NCT01992146|latent sensitization|latent sensitization
1209056|NCT01992146|naloxone|naloxone
1209057|NCT01992146|open groin hernia repair|open groin hernia repair
1209058|NCT01992146|pain|pain
1209059|NCT01992146|randomized controlled trial|randomized controlled trial
1209060|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
1209061|NCT01992146|target-controlled infusion|target-controlled infusion
1209062|NCT01992133|Former gestational Diabetes|former gestational diabetes
1209063|NCT01992133|Vitamin D deficiency|vitamin d deficiency
1209064|NCT01992133|insulin resistance|insulin resistance
1209065|NCT01992133|beta cell function|beta cell function
1209066|NCT01992120|Simulation|simulation
1209067|NCT01992120|Sepsis|sepsis
1209068|NCT01992120|High-fidelity|high-fidelity
1209069|NCT01992120|Severe Sepsis|severe sepsis
1209070|NCT01992120|Septic Shock|septic shock
1209071|NCT01992120|Education|education
1209072|NCT01992107|Influenza|influenza
1209073|NCT01992107|Influenza vaccine|influenza vaccine
1209074|NCT01992107|Novartis|novartis
1209075|NCT01992107|children|children
1209076|NCT01992094|Influenza|influenza
1209077|NCT01992094|Influenza vaccine|influenza vaccine
1209078|NCT01992094|Novartis|novartis
1209079|NCT01992094|Adults|adults
1209080|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
1209081|NCT01992068|lung cancer|lung cancer
1209082|NCT01992055|Executive dysfunction|executive dysfunction
1209083|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
1209084|NCT01992055|Goal Management Training|goal management training
1209085|NCT01992029|ALS|als
1209086|NCT01992029|miRNA|mirna
1209087|NCT01992029|biomarker|biomarker
1209088|NCT01992029|monocentric observational study|monocentric observational study
1209089|NCT01992016|Prostate cancer|prostate cancer
1209090|NCT01992016|F18 FDG-PET|f18 fdg-pet
1209091|NCT01992016|Imaging|imaging
1209092|NCT01992016|Ranolazine|ranolazine
1209093|NCT01992016|Bone metastases|bone metastases
1209094|NCT01992016|Soft tissue metastases|soft tissue metastases
1209095|NCT01991964|stridor|stridor
1209096|NCT01991964|laryngomalacia|laryngomalacia
1209097|NCT01991964|ultrasound|ultrasound
1209098|NCT01991938|PI3K Inhibitor|pi3k inhibitor
1209099|NCT01991938|mTOR Inhibitor|mtor inhibitor
1209100|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
1209101|NCT01991938|CSC|csc
1209102|NCT01991938|Cancer Stem Cells|cancer stem cells
1209103|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
1209104|NCT01991912|minimally invasive surgery|minimally invasive surgery
1209105|NCT01991912|spinal stenosis|spinal stenosis
1209106|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
1209107|NCT01991899|Tetraviral vaccine|tetraviral vaccine
1209108|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
1209109|NCT01991899|Consistency of production|consistency of production
1209110|NCT01991886|nasal High Flow|nasal high flow
1209111|NCT01991886|premature baby|premature baby
1209112|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
1209113|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
1209114|NCT01991873|maintenance therapy|maintenance therapy
1209115|NCT01991873|Panitumumab|panitumumab
1209116|NCT01991873|Vectibix®|vectibix®
1209117|NCT01991847|colon|colon
1209118|NCT01991847|cancer|cancer
1209119|NCT01991847|prevention|prevention
1209120|NCT01991847|exercise|exercise
1209121|NCT01991847|physical activity|physical activity
1209122|NCT01991847|rectal|rectal
1209123|NCT01991834|laparoscopy|laparoscopy
1209124|NCT01991834|surgical wound infection|surgical wound infection
1209125|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
1209126|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
1209127|NCT01991795|Diabetes|diabetes
1209128|NCT01991795|Coronary artery disease|coronary artery disease
1209129|NCT01991795|Outcome|outcome
1209130|NCT01991795|Prevention|prevention
1209131|NCT01991795|Antiplatelet|antiplatelet
1209132|NCT01991782|Telemedicine|telemedicine
1209133|NCT01991782|Fracture|fracture
1209134|NCT01991782|Orthopaedics|orthopaedics
1209135|NCT01991769|exercise|exercise
1209136|NCT01991769|endothelium|endothelium
1209137|NCT01991769|postprandial period|postprandial period
1209138|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1209139|NCT01991756|AAA|aaa
1209140|NCT01991743|Version|version
1209141|NCT01991743|Pregnancy|pregnancy
1209142|NCT01991743|Vaginal Delivery|vaginal delivery
1209143|NCT01991743|Pain Control|pain control
1209144|NCT01991743|Combined Spinal Epidural|combined spinal epidural
1209145|NCT01991717|Victus|victus
1209146|NCT01991717|lensfragmentation|lensfragmentation
1209147|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
1209148|NCT01991717|capsulotomy,|capsulotomy,
1209149|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
1209150|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
1209151|NCT01991704|incubation|incubation
1209152|NCT01991704|Craving|craving
1209153|NCT01991704|alcohol dependence|alcohol dependence
1209154|NCT01991691|Antineoplastic Agents|antineoplastic agents
1209155|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
1209156|NCT01991665|Vacuum|vacuum
1209157|NCT01991665|Occiput position|occiput position
1209158|NCT01991652|Wilms tumour|wilms tumour
1209159|NCT01991652|Childhood cancer|childhood cancer
1209160|NCT01991652|Africa|africa
1209161|NCT01991639|frailty|frailty
1209162|NCT01991639|community-dwelling|community-dwelling
1209163|NCT01991639|malnutrition|malnutrition
1209164|NCT01991639|physical activity|physical activity
1209165|NCT01991639|nutritional intervention|nutritional intervention
1209166|NCT01991600|iron absorption|iron absorption
1209167|NCT01991600|bioavailability|bioavailability
1209168|NCT01991600|anaemia|anaemia
1209169|NCT01991600|iron deficiency|iron deficiency
1209170|NCT01991600|ferrous sulphate|ferrous sulphate
1209171|NCT01991587|Influenza|influenza
1209172|NCT01991587|Human|human
1209173|NCT01991587|RNA Virus Infections|rna virus infections
1209174|NCT01991587|Immunologic|immunologic
1209175|NCT01991587|Immunogenic Factors|immunogenic factors
1209176|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
1209177|NCT01991587|Virus diseases|virus diseases
1209178|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
1209179|NCT01991587|Infection|infection
1209180|NCT01991574|urinary phosphate|urinary phosphate
1209181|NCT01991574|iron hydroxide|iron hydroxide
1209182|NCT01991574|hypophosphatemia|hypophosphatemia
1209183|NCT01991574|phosphate binder|phosphate binder
1209184|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
1209185|NCT01991561|Influenza, Human|influenza, human
1209186|NCT01991561|RNA Virus Infections|rna virus infections
1209187|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
1209188|NCT01991561|Respiratory Tract Infections|respiratory tract infections
1209189|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
1209190|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
1209191|NCT01991561|Immunogenic Factors|immunogenic factors
1209192|NCT01991561|GLA-SE|gla-se
1209193|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
1209194|NCT01991561|Virus Diseases|virus diseases
1209195|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
1209196|NCT01991561|Infection|infection
1209197|NCT01991548|Insulin pump|insulin pump
1209198|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
1209199|NCT01991470|Children|children
1209201|NCT01991470|Accuracy|accuracy
1209202|NCT01991457|ALL|all
1209203|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
1209204|NCT01991418|thioredoxin reductase|thioredoxin reductase
1209205|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
1209206|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
1209207|NCT01991405|Working Memory Training|working memory training
1209208|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
1209209|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
1209210|NCT01991392|nasogastric tube|nasogastric tube
1209211|NCT01991379|MEK162|mek162
1209212|NCT01991379|Imatinib|imatinib
1209213|NCT01991379|13-162|13-162
1209214|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
1209215|NCT01991366|all cause mortality|all cause mortality
1209216|NCT01991366|Q Wave MI|q wave mi
1209217|NCT01991353|Knee|knee
1209218|NCT01991353|meniscus|meniscus
1209219|NCT01991353|platelet rich plasma|platelet rich plasma
1209220|NCT01991301|graft-versus-host disease|graft-versus-host disease
1209221|NCT01991301|stem cell transplantation|stem cell transplantation
1209222|NCT01991301|matched unrelated donors|matched unrelated donors
1209223|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
1209224|NCT01991301|carfilzumib|carfilzumib
1209225|NCT01991288|Total Knee Replacement|total knee replacement
1209226|NCT01991288|Bupivacaine|bupivacaine
1209227|NCT01991288|Levobupivacaine|levobupivacaine
1209228|NCT01991288|Saphenous Nerve Block|saphenous nerve block
1209229|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
1209230|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
1209231|NCT01991275|Laparoscopy|laparoscopy
1209232|NCT01991275|Injections, Spinal|injections, spinal
1209233|NCT01991275|Morphine|morphine
1209234|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
1209235|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
1209236|NCT01991249|messenger RNA|messenger rna
1209237|NCT01991197|Psoriasis|psoriasis
1209238|NCT01991197|Type 2 Diabetes|type 2 diabetes
1209239|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
1209240|NCT01991197|Sitagliptin|sitagliptin
1209241|NCT01991197|Gliclazide|gliclazide
1209242|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
1209243|NCT01991171|kinesio taping|kinesio taping
1209244|NCT01991171|Muscle activation|muscle activation
1209245|NCT01991171|Muscle inhibition|muscle inhibition
1209246|NCT01991158|GAD-M regimen|gad-m regimen
1209247|NCT01991158|first line chemotherapy|first line chemotherapy
1209248|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
1209249|NCT01991145|Cerebral Palsy|cerebral palsy
1209250|NCT01991145|Umbilical Cord Blood|umbilical cord blood
1209251|NCT01991145|Erythropoietin|erythropoietin
1209252|NCT01991145|Rehabilitation|rehabilitation
1209253|NCT01991132|Dry Eyes|dry eyes
1209254|NCT01991132|Meibomian glands|meibomian glands
1209255|NCT01991132|Algorithm|algorithm
1209256|NCT01991132|MediView software|mediview software
1209257|NCT01991119|Atrial fibrillation|atrial fibrillation
1209258|NCT01991119|Propafenone|propafenone
1209259|NCT01991119|Dronedarone|dronedarone
1209260|NCT01991106|Exercise|exercise
1209261|NCT01991106|Myocardial function|myocardial function
1209262|NCT01991106|Vascular function|vascular function
1209263|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
1209264|NCT01991106|Paediatric obesity|paediatric obesity
1209265|NCT01991106|Visceral adipose tissue|visceral adipose tissue
1209266|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
1209267|NCT01991080|biofeedback|biofeedback
1209268|NCT01991080|relaxation|relaxation
1209269|NCT01991080|Wheat germ juice|wheat germ juice
1209270|NCT01991067|Marrow transplant recipients|marrow transplant recipients
1209271|NCT01991054|Diabetes mellitus|diabetes mellitus
1209272|NCT01991054|HgA1C|hga1c
1209273|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
1209274|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
1209275|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
1209276|NCT01991002|14/21 diet|14/21 diet
1209277|NCT01991002|BMI|bmi
1209278|NCT01991002|biochemical blood markers|biochemical blood markers
1209279|NCT01991002|quality of life|quality of life
1209280|NCT01990989|clopidogrel|clopidogrel
1209281|NCT01990989|pharmacogenomics|pharmacogenomics
1209282|NCT01990989|CYP2C19|cyp2c19
1209283|NCT01990989|platelet aggregation|platelet aggregation
1209284|NCT01990989|score system|score system
1209285|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
1209286|NCT01990989|hemorrhage complications|hemorrhage complications
1209287|NCT01990976|Muscular Dystrophy|muscular dystrophy
1209288|NCT01990976|Facioscapulohumeral|facioscapulohumeral
1209289|NCT01990976|Physical training|physical training
1209290|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
1209291|NCT01990976|Muscle Biopsy|muscle biopsy
1209292|NCT01990963|Brain trauma;|brain trauma;
1209294|NCT01990963|densitometric data|densitometric data
1209295|NCT01990963|CT|ct
1209296|NCT01990950|Aneurysm|aneurysm
1209297|NCT01990950|Aortic Aneurysm|aortic aneurysm
1209298|NCT01990950|Iliac Aneurysm|iliac aneurysm
1209299|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1209300|NCT01990950|Vascular Diseases|vascular diseases
1209301|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
1209302|NCT01990950|Aortic Diseases|aortic diseases
1209303|NCT01990937|oral midazolam|oral midazolam
1209304|NCT01990937|sedation|sedation
1209305|NCT01990937|premedication|premedication
1209306|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1209307|NCT01990937|EGD|egd
1209308|NCT01990924|fluoroscopy|fluoroscopy
1209309|NCT01990924|radiation|radiation
1209310|NCT01990924|transradial|transradial
1209311|NCT01990924|diagnostic|diagnostic
1209312|NCT01990924|angiography|angiography
1209313|NCT01990924|cardiac|cardiac
1209314|NCT01990924|coronary|coronary
1209315|NCT01990924|angioplasty|angioplasty
1209316|NCT01990911|hypertension|hypertension
1209317|NCT01990911|hypertensive heart disease|hypertensive heart disease
1209318|NCT01990911|atrial fibrillation|atrial fibrillation
1209319|NCT01990911|autonomic imbalance|autonomic imbalance
1209320|NCT01990872|Vitamin D status|vitamin d status
1209321|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
1209323|NCT01990872|RCT|rct
1209324|NCT01990872|Calcium intake|calcium intake
1209325|NCT01990872|Dietary requirement|dietary requirement
1209326|NCT01990846|antiviral, influenza|antiviral, influenza
1209327|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
1209328|NCT01990807|high risk|high risk
1209329|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
1209330|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1209331|NCT01990794|Cobalt|cobalt
1209332|NCT01990794|Dietary Supplements|dietary supplements
1209333|NCT01990794|Hematological|hematological
1209334|NCT01990794|Thyroid|thyroid
1209335|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
1209336|NCT01990768|tranexamic acid|tranexamic acid
1209337|NCT01990768|traumatic brain injury|traumatic brain injury
1209338|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
1209339|NCT01990768|prehospital|prehospital
1209340|NCT01990768|neurologic outcome|neurologic outcome
1209341|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
1209342|NCT01990768|disability rating scale|disability rating scale
1209343|NCT01990716|Adult|adult
1209344|NCT01990716|Colonoscopy|colonoscopy
1209345|NCT01990703|Contraception|contraception
1209346|NCT01990703|Birth Control|birth control
1209347|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
1209348|NCT01990703|Mirena IUD|mirena iud
1209349|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
1209350|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
1209351|NCT01990677|csr|csr
1209352|NCT01990677|cscr|cscr
1209353|NCT01990677|eplerenone|eplerenone
1209354|NCT01990677|vision|vision
1209355|NCT01990677|choroid|choroid
1209356|NCT01990677|retina|retina
1209357|NCT01990677|acute|acute
1209358|NCT01990677|chronic|chronic
1209359|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
1209360|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
1209361|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
1209362|NCT01990625|Maternal Mortality|maternal mortality
1209363|NCT01990625|Neonatal Mortality|neonatal mortality
1209364|NCT01990625|Gestational Age Dating|gestational age dating
1209365|NCT01990625|Pregnancy Complications|pregnancy complications
1209366|NCT01990625|Ultrasound|ultrasound
1209367|NCT01990625|Stillbirth|stillbirth
1209368|NCT01990612|Induction of labor|induction of labor
1209369|NCT01990612|Expectant management of labor|expectant management of labor
1209370|NCT01990612|39 weeks gestation|39 weeks gestation
1209371|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
1209372|NCT01990599|airway management|airway management
1209373|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
1209374|NCT01990573|spinal surgery|spinal surgery
1209375|NCT01990573|Methadone|methadone
1209376|NCT01990560|mild hypercortisolism|mild hypercortisolism
1209377|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
1209378|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
1209379|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1209380|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1209381|NCT01990547|Traumatic Event|traumatic event
1209382|NCT01990547|Trauma Survivor|trauma survivor
1209383|NCT01990547|Combat-related PTSD|combat-related ptsd
1209384|NCT01990547|mTBI|mtbi
1209385|NCT01990547|mild TBI|mild tbi
1209386|NCT01990547|PTSD|ptsd
1209387|NCT01990547|Veteran|veteran
1209388|NCT01990534|Lymphoma|lymphoma
1209389|NCT01990534|Hodgkin|hodgkin
1209390|NCT01990534|Relapsed|relapsed
1209391|NCT01990534|Refractory|refractory
1209392|NCT01990534|Antigens, CD30|antigens, cd30
1209393|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
1209394|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
1209395|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
1209396|NCT01990534|Drug Therapy|drug therapy
1209397|NCT01990534|Immunotherapy|immunotherapy
1209398|NCT01990534|Hematologic Diseases|hematologic diseases
1209399|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
1209400|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1209401|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
1209402|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
1209403|NCT01990534|Neoplasms|neoplasms
1209404|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
1209405|NCT01990534|Lymphatic Diseases|lymphatic diseases
1209406|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
1209407|NCT01990534|Immune System Diseases|immune system diseases
1209408|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
1209409|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
1209410|NCT01990534|Immunologic Factors|immunologic factors
1209411|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
1209412|NCT01990534|Pharmacologic Actions|pharmacologic actions
1209413|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
1209414|NCT01990508|traffic-light labels|traffic-light labels
1209415|NCT01990508|financial incentives|financial incentives
1209416|NCT01990508|low-income community|low-income community
1209614|NCT01989299|Safety|safety
1209425|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
1209427|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
1209428|NCT01990456|Ultrasonography|ultrasonography
1209429|NCT01990443|Reslizumab|reslizumab
1209430|NCT01990443|monoclonal antibody|monoclonal antibody
1209431|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
1209432|NCT01990417|Joint range of motion|joint range of motion
1209433|NCT01990417|Resistance Training|resistance training
1209434|NCT01990417|Physical Therapy|physical therapy
1209435|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
1209436|NCT01990404|Severe acute pain|severe acute pain
1209437|NCT01990404|Prehospital setting|prehospital setting
1209438|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
1209439|NCT01990313|Parkinson's Disease|parkinson's disease
1209440|NCT01990313|DBS|dbs
1209441|NCT01990313|Deep Brain Stimulation|deep brain stimulation
1209442|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
1209443|NCT01990300|Drug Therapy|drug therapy
1209444|NCT01990287|Low Back Pain|low back pain
1209445|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
1209446|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
1209447|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
1209448|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
1209449|NCT01990287|Pain|pain
1209450|NCT01990274|Tuberculosis|tuberculosis
1209451|NCT01990274|Diagnosis|diagnosis
1209452|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
1209453|NCT01990274|Point-of-treatment|point-of-treatment
1209454|NCT01990274|Mobile unit|mobile unit
1209455|NCT01990235|Advance care planning|advance care planning
1209456|NCT01990235|Aging|aging
1209457|NCT01990235|Health communication|health communication
1209458|NCT01990235|Health literacy|health literacy
1209459|NCT01990235|Medical decision making|medical decision making
1209460|NCT01990235|primary care|primary care
1209461|NCT01990235|vulnerable population|vulnerable population
1209462|NCT01990235|chronic illness|chronic illness
1209463|NCT01990222|ADHD|adhd
1209464|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
1209465|NCT01990209|orteronel|orteronel
1209466|NCT01990209|TAK-700|tak-700
1209467|NCT01990209|metastatic breast cancer|metastatic breast cancer
1209468|NCT01990196|prostate cancer|prostate cancer
1209469|NCT01990196|hormone therapy|hormone therapy
1209470|NCT01990196|radical prostatectomy|radical prostatectomy
1209471|NCT01990183|preterm infants|preterm infants
1209472|NCT01990183|early intervention|early intervention
1209473|NCT01990183|enrichment|enrichment
1209474|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
1209475|NCT01990183|tele-rehabilitation|tele-rehabilitation
1209476|NCT01990131|computerized intervention|computerized intervention
1209477|NCT01990131|cognitive bias modification|cognitive bias modification
1209478|NCT01990131|anxiety|anxiety
1209479|NCT01990131|suicide|suicide
1209480|NCT01990118|Renal transplant|renal transplant
1209481|NCT01990118|Renal allograft rejection|renal allograft rejection
1209482|NCT01990118|Cyclosporine|cyclosporine
1209483|NCT01990118|Gengraf|gengraf
1209484|NCT01990105|atrial fibrillation|atrial fibrillation
1209485|NCT01990105|anticoagulation|anticoagulation
1209486|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
1209487|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
1209488|NCT01990105|HAS-BLED score|has-bled score
1209489|NCT01990105|CHADS2 score|chads2 score
1209490|NCT01990092|Metanx|metanx
1209491|NCT01990092|B vitamins|b vitamins
1209492|NCT01990092|neuropathy|neuropathy
1209493|NCT01990092|nutrition|nutrition
1209494|NCT01990079|PTSD|ptsd
1209495|NCT01990079|smoking|smoking
1209496|NCT01990066|Quality of Life|quality of life
1209497|NCT01990066|Physical Function|physical function
1209498|NCT01990040|Short Bowel Syndrome|short bowel syndrome
1209499|NCT01990040|SBS|sbs
1209500|NCT01990040|teduglutide|teduglutide
1209501|NCT01990040|Gattex|gattex
1209502|NCT01990027|kidney stone|kidney stone
1209503|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
1209504|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1209505|NCT01989988|Obesity|obesity
1209506|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
1209507|NCT01989988|Duodenum exclusion|duodenum exclusion
1209508|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
1209509|NCT01989975|Connected Care|connected care
1209510|NCT01989962|Aboriginal Health|aboriginal health
1209511|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
1209512|NCT01989962|Cultural Competency|cultural competency
1209513|NCT01989962|Continuing Medical Education|continuing medical education
1209514|NCT01989923|Smoking cessation|smoking cessation
1209515|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
1209516|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
1209517|NCT01989923|electronic cigarettes|electronic cigarettes
1209518|NCT01989923|cervical dysplasia|cervical dysplasia
1209519|NCT01989910|Efavirenz|efavirenz
1209520|NCT01989910|Raltegravir|raltegravir
1209521|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
1209522|NCT01989897|diluent|diluent
1209523|NCT01989897|rhinitis|rhinitis
1209524|NCT01989897|allergic|allergic
1209525|NCT01989871|preterm|preterm
1209526|NCT01989871|oral feeding|oral feeding
1209527|NCT01989871|outcome|outcome
1209528|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
1209529|NCT01989832|cohort|cohort
1209530|NCT01989832|pharmaco-economic|pharmaco-economic
1209531|NCT01989832|kidney|kidney
1209532|NCT01989832|transplantation|transplantation
1209533|NCT01989832|quality of life|quality of life
1209534|NCT01989806|Spinal cord injury|spinal cord injury
1209535|NCT01989806|robotic|robotic
1209536|NCT01989806|locomotion|locomotion
1209537|NCT01989793|sarcopenia|sarcopenia
1209538|NCT01989793|frailty|frailty
1209539|NCT01989793|losartan|losartan
1209540|NCT01989767|sickness absence|sickness absence
1209541|NCT01989767|rehabilitation|rehabilitation
1209542|NCT01989767|mental disorders|mental disorders
1209543|NCT01989767|screening|screening
1209544|NCT01989754|Albuminuria|albuminuria
1209545|NCT01989754|Canagliflozin|canagliflozin
1209546|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
1209547|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1209548|NCT01989754|T2DM|t2dm
1209549|NCT01989754|JNJ-28431754|jnj-28431754
1209550|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
1209551|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
1209552|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
1209553|NCT01989689|PSORIASIS|psoriasis
1209554|NCT01989676|Phase 3|phase 3
1209555|NCT01989676|trastuzumab|trastuzumab
1209556|NCT01989676|Breast Neoplasms|breast neoplasms
1209557|NCT01989663|Healthy Women|healthy women
1209558|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1209559|NCT01989624|diagnosis|diagnosis
1209560|NCT01989624|treatment|treatment
1209561|NCT01989572|locally advanced or stage IV melanoma|locally advanced or stage iv melanoma
1209562|NCT01989572|GM-CSF|gm-csf
1209563|NCT01989572|peptide vaccine|peptide vaccine
1209564|NCT01989546|DNA Damage|dna damage
1209565|NCT01989546|Advanced Solid Tumors|advanced solid tumors
1209566|NCT01989546|BRCA Mutations|brca mutations
1209567|NCT01989546|PARP Inhibitor|parp inhibitor
1209568|NCT01989546|Pharmacodynamics|pharmacodynamics
1209569|NCT01989533|HIV Vaccine|hiv vaccine
1209570|NCT01989533|Adenovirus|adenovirus
1209571|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
1209572|NCT01989507|tobacco smoking|tobacco smoking
1209573|NCT01989507|smoking cessation|smoking cessation
1209574|NCT01989507|nicotine dependence|nicotine dependence
1209575|NCT01989507|tobacco use disorder|tobacco use disorder
1209576|NCT01989494|anesthesiologists|anesthesiologists
1209577|NCT01989494|physical activity|physical activity
1209578|NCT01989494|pedometer|pedometer
1209579|NCT01989494|wellness|wellness
1209580|NCT01989494|exercise|exercise
1209581|NCT01989468|Psoriatic arthritis|psoriatic arthritis
1209582|NCT01989468|AIN457|ain457
1209583|NCT01989468|PsA|psa
1209584|NCT01989468|ACR|acr
1209585|NCT01989468|CASPAR|caspar
1209586|NCT01989468|PASDAS|pasdas
1209587|NCT01989468|secukinumab|secukinumab
1209588|NCT01989468|autoinjector|autoinjector
1209590|NCT01989455|Deferiprone|deferiprone
1209591|NCT01989455|DFP|dfp
1209592|NCT01989455|L1|l1
1209593|NCT01989442|cpap failure|cpap failure
1209594|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1209595|NCT01989442|nasal trauma|nasal trauma
1209596|NCT01989442|ventilation duration|ventilation duration
1209597|NCT01989442|non-invasive ventilation|non-invasive ventilation
1209598|NCT01989429|psoriasis|psoriasis
1209599|NCT01989429|Vitamin D3|vitamin d3
1209600|NCT01989429|topical|topical
1209601|NCT01989429|ointments|ointments
1209602|NCT01989416|colonization|colonization
1209603|NCT01989338|hallux valgus|hallux valgus
1209604|NCT01989338|pain|pain
1209605|NCT01989338|functional status|functional status
1209606|NCT01989338|quality of life|quality of life
1209607|NCT01989312|ultrasound|ultrasound
1209608|NCT01989312|peripheral nerves|peripheral nerves
1209609|NCT01989312|anesthetics|anesthetics
1209610|NCT01989312|local|local
1209611|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1209612|NCT01989299|ILR|ilr
1209613|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
1209615|NCT01989286|Plagiocephaly|plagiocephaly
1209617|NCT01989286|Spine|spine
1209618|NCT01989260|Endometriosis|endometriosis
1209619|NCT01989247|Depression|depression
1209620|NCT01989247|Anxiety|anxiety
1209621|NCT01989247|Randomized Controlled Trial|randomized controlled trial
1209622|NCT01989247|Self Care|self care
1209623|NCT01989247|Intervention Studies|intervention studies
1209624|NCT01989247|Health Education|health education
1209625|NCT01989208|Heart Failure|heart failure
1209626|NCT01989208|Congestive Heart Failure|congestive heart failure
1209627|NCT01989208|Oxidative Stress|oxidative stress
1209628|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
1209629|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
1209630|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
1209631|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
1209632|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
1209633|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
1209634|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
1209635|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
1209636|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
1209637|NCT01989182|Endobronchial Valves|endobronchial valves
1209638|NCT01989182|Intrabronchial Valves|intrabronchial valves
1209639|NCT01989182|Bronchial Valve|bronchial valve
1209640|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1209641|NCT01989182|COPD|copd
1209642|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1209643|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1209644|NCT01989182|BLVR|blvr
1209645|NCT01989182|TLVR|tlvr
1209646|NCT01989182|Emphysema|emphysema
1209647|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
1209648|NCT01989182|Pathologic Process|pathologic process
1209649|NCT01989182|Lung Diseases|lung diseases
1209650|NCT01989182|Respiratory Tract Disease|respiratory tract disease
1209651|NCT01989182|China|china
1209652|NCT01989182|Spiration Valve System (SVS)|spiration valve system (svs)
1209653|NCT01989156|Smoking|smoking
1209654|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
1209655|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
1209656|NCT01989156|Reduced exposure|reduced exposure
1209657|NCT01989156|HPHCs|hphcs
1209658|NCT01989156|Ambulatory|ambulatory
1209659|NCT01989143|Phase 1|phase 1
1209660|NCT01989143|Randomized|randomized
1209661|NCT01989143|Double-blind|double-blind
1209662|NCT01989143|Placebo-controlled|placebo-controlled
1209663|NCT01989143|Dose escalating|dose escalating
1209664|NCT01989143|Single and Multiple doses|single and multiple doses
1209665|NCT01989143|Safety|safety
1209666|NCT01989143|Tolerability|tolerability
1209667|NCT01989143|PK/PD|pk/pd
1209668|NCT01989143|PF-06480605|pf-06480605
1209669|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
1209670|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
1209671|NCT01989130|chlamydia|chlamydia
1209672|NCT01989130|gonorrhea|gonorrhea
1209673|NCT01989130|emergency department|emergency department
1209799|NCT01988584|Cerebral Palsy|cerebral palsy
1209674|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
1209675|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
1209676|NCT01989104|Indirect calorimetry|indirect calorimetry
1209677|NCT01989091|kidney dialysis|kidney dialysis
1209678|NCT01989091|hemodialysis|hemodialysis
1209679|NCT01989091|locking solution|locking solution
1209680|NCT01989091|antimicrobial|antimicrobial
1209681|NCT01989091|thrombolytic|thrombolytic
1209682|NCT01989078|Kidney disorder|kidney disorder
1209683|NCT01989078|Blood disorder|blood disorder
1209684|NCT01989078|Pediatrics|pediatrics
1209685|NCT01989065|Child obesity|child obesity
1209686|NCT01989065|childhood obesity|childhood obesity
1209687|NCT01989065|obesity treatment|obesity treatment
1209688|NCT01989065|text messaging|text messaging
1209689|NCT01989065|Lifestyle|lifestyle
1209690|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
1209691|NCT01989052|CTO|cto
1209692|NCT01989052|Lomustine|lomustine
1209693|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
1209694|NCT01989052|CeeNU|ceenu
1209695|NCT01989052|Malignant Glioma|malignant glioma
1209696|NCT01989052|Pro00047969|pro00047969
1209697|NCT01989052|Desjardins|desjardins
1209698|NCT01989052|Duke|duke
1209699|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
1209700|NCT01989026|BCG|bcg
1209701|NCT01989026|non-specific effects|non-specific effects
1209702|NCT01989026|neonatal mortality|neonatal mortality
1209703|NCT01989026|vaccines|vaccines
1209704|NCT01989013|Parkinson's disease|parkinson's disease
1209705|NCT01989013|Craniosacral therapy|craniosacral therapy
1209706|NCT01989013|cranial osteopathy|cranial osteopathy
1209707|NCT01989000|Pancreatic cancer|pancreatic cancer
1209708|NCT01989000|Hypoxia|hypoxia
1209709|NCT01989000|Vasculature|vasculature
1209710|NCT01989000|Stroma|stroma
1209711|NCT01988987|Gestational diabetes|gestational diabetes
1209712|NCT01988987|Postpartum glucose testing|postpartum glucose testing
1209713|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
1209714|NCT01988987|Diabetes mellitus|diabetes mellitus
1209715|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
1209716|NCT01988961|Golimumab|golimumab
1209717|NCT01988961|CNTO148|cnto148
1209718|NCT01988961|SIMPONI|simponi
1209719|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
1209720|NCT01988948|Human papilloma virus|human papilloma virus
1209721|NCT01988948|Young women|young women
1209722|NCT01988948|I-Share|i-share
1209723|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
1209724|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
1209725|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
1209726|NCT01988909|Safety|safety
1209727|NCT01988909|Efficacy|efficacy
1209728|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
1209729|NCT01988883|Tachycardia|tachycardia
1209730|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
1209731|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
1209732|NCT01988883|Primary Dysautonomias|primary dysautonomias
1209733|NCT01988883|Nervous System Diseases|nervous system diseases
1209734|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
1209735|NCT01988883|Modafinil|modafinil
1209736|NCT01988883|Propranolol|propranolol
1209737|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
1209738|NCT01988883|Neurologic Manifestations|neurologic manifestations
1209739|NCT01988883|Cognitive Symptoms|cognitive symptoms
1209740|NCT01988883|Neuropsychological Tests|neuropsychological tests
1209741|NCT01988857|Vietnam|vietnam
1209742|NCT01988857|Children|children
1209743|NCT01988857|Reactogenicity|reactogenicity
1209744|NCT01988857|BoostrixTM|boostrixtm
1209745|NCT01988857|Safety|safety
1209746|NCT01988857|dTpa|dtpa
1209747|NCT01988857|Booster|booster
1209748|NCT01988857|Healthy|healthy
1209749|NCT01988844|functionality|functionality
1209750|NCT01988844|Cerebral palsy|cerebral palsy
1209751|NCT01988844|Handwriting|handwriting
1209752|NCT01988831|Malignant melanoma|malignant melanoma
1209753|NCT01988831|betablocker|betablocker
1209754|NCT01988831|propranolol|propranolol
1209755|NCT01988831|interventional|interventional
1209756|NCT01988831|prospective|prospective
1209757|NCT01988831|adjuvant|adjuvant
1209758|NCT01988831|recurrence|recurrence
1209759|NCT01988818|wound dressing|wound dressing
1209760|NCT01988818|silicone|silicone
1209761|NCT01988818|standard wound dressing|standard wound dressing
1209762|NCT01988766|Thrombosis|thrombosis
1209763|NCT01988766|Central Venosis Catheter|central venosis catheter
1209764|NCT01988766|Renal Disease|renal disease
1209765|NCT01988766|Vascular Access|vascular access
1209766|NCT01988753|Serum Biomarkers|serum biomarkers
1209767|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
1209768|NCT01988753|Ultrasound imaging|ultrasound imaging
1209769|NCT01988753|Viral hepatitis|viral hepatitis
1209770|NCT01988753|Liver Fibrosis|liver fibrosis
1209771|NCT01988753|Liver disease|liver disease
1209772|NCT01988753|Hepatitis B|hepatitis b
1209773|NCT01988753|Hepatitis C|hepatitis c
1209774|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
1209775|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
1209776|NCT01988740|Abnormal placenta|abnormal placenta
1209777|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
1209778|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
1209779|NCT01988701|GVHD|gvhd
1209780|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
1209781|NCT01988688|deep brain stimulation|deep brain stimulation
1333151|NCT01444339|Pneumococcal Infections|pneumococcal infections
1209782|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
1209783|NCT01988649|Pain|pain
1209784|NCT01988649|Oxytocin|oxytocin
1209785|NCT01988636|Randomized|randomized
1209786|NCT01988636|Double Blinded|double blinded
1209787|NCT01988636|Mali|mali
1209788|NCT01988636|Malaria|malaria
1209789|NCT01988636|Transmission|transmission
1209790|NCT01988623|Intellectual Disabilities|intellectual disabilities
1209791|NCT01988623|Speech Delay|speech delay
1209792|NCT01988623|Language Disorder|language disorder
1209793|NCT01988610|cognition|cognition
1209794|NCT01988610|prediabetes|prediabetes
1209795|NCT01988610|mood|mood
1209796|NCT01988597|Dry Eyes|dry eyes
1209797|NCT01988597|Quality of life|quality of life
1209798|NCT01988597|Utility assessment|utility assessment
1209800|NCT01988584|Brain Injury|brain injury
1209801|NCT01988584|Stem Cells|stem cells
1209802|NCT01988584|Mononuclear Cells|mononuclear cells
1209803|NCT01988584|Bone Morrow|bone morrow
1209804|NCT01988584|Umbilical Cord Blood|umbilical cord blood
1209805|NCT01988571|Stage I breast cancer|stage i breast cancer
1209806|NCT01988571|Stage II breast cancer|stage ii breast cancer
1209807|NCT01988571|Stage III breast cancer|stage iii breast cancer
1209808|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
1209809|NCT01988558|Streptococcus A|streptococcus a
1209810|NCT01988545|GLP-1|glp-1
1209811|NCT01988545|blood flow|blood flow
1209812|NCT01988545|cardiac out put|cardiac out put
1209813|NCT01988545|stroke volume|stroke volume
1209814|NCT01988545|beat to beat|beat to beat
1209815|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
1209816|NCT01988506|IL2,|il2,
1209817|NCT01988506|Interleukin 2,|interleukin 2,
1209818|NCT01988506|ILT101|ilt101
1209819|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
1209820|NCT01988506|Auto-immune disease|auto-immune disease
1209821|NCT01988506|Inflammatory disease|inflammatory disease
1209822|NCT01988506|Inflammation|inflammation
1209823|NCT01988506|Regulatory T cells,|regulatory t cells,
1209824|NCT01988506|Treg|treg
1209825|NCT01988506|Immunoregulation|immunoregulation
1209826|NCT01988506|Immune tolerance|immune tolerance
1209827|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1209828|NCT01988493|MSC2156119J|msc2156119j
1209829|NCT01988493|Sorafenib|sorafenib
1209830|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
1209831|NCT01988480|Guided surgery|guided surgery
1209832|NCT01988480|Sinus graft|sinus graft
1209833|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
1209834|NCT01988441|autophagy|autophagy
1209835|NCT01988441|children|children
1209836|NCT01988441|polymorphism|polymorphism
1209837|NCT01988428|sepsis|sepsis
1209838|NCT01988428|severe sepsis|severe sepsis
1209839|NCT01988428|septic shock|septic shock
1209840|NCT01988402|gout|gout
1209841|NCT01988402|allopurinol|allopurinol
1209842|NCT01988363|greater occipital nerve|greater occipital nerve
1209843|NCT01988363|occipital neuralgia|occipital neuralgia
1209844|NCT01988363|cervicogenic headache|cervicogenic headache
1209845|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
1209846|NCT01988350|pancreatic elastase|pancreatic elastase
1209847|NCT01988350|fecal elastase|fecal elastase
1209848|NCT01988350|smoking|smoking
1209849|NCT01988350|tobacco|tobacco
1209850|NCT01988311|Psilocybin|psilocybin
1209851|NCT01988311|Hallucinogens|hallucinogens
1209852|NCT01988311|Pharmacologic Actions|pharmacologic actions
1209853|NCT01988311|Central Nervous System Agents|central nervous system agents
1209854|NCT01988311|Therapeutic Uses|therapeutic uses
1209855|NCT01988311|Psychotropic Drugs|psychotropic drugs
1209856|NCT01988285|Esophagitis|esophagitis
1209857|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
1209858|NCT01988285|Esophageal Diseases|esophageal diseases
1209859|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
1209860|NCT01988285|Digestive System Diseases|digestive system diseases
1209861|NCT01988272|SPECT/CT|spect/ct
1209862|NCT01988272|Dosimetry|dosimetry
1209863|NCT01988272|Radiation absorbed dose|radiation absorbed dose
1209864|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1209865|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
1209866|NCT01988246|Diabetes|diabetes
1209867|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
1209868|NCT01988233|Physical activity|physical activity
1209869|NCT01988233|Dance|dance
1209870|NCT01988233|Latinos|latinos
1209871|NCT01988233|Aging|aging
1209872|NCT01988233|Older adults|older adults
1209873|NCT01988233|Health disparities|health disparities
1209874|NCT01988220|stroke|stroke
1209875|NCT01988220|sensory deficit|sensory deficit
1209876|NCT01988220|sensory retraining|sensory retraining
1209877|NCT01988220|perceptual learning|perceptual learning
1209878|NCT01988220|lower extremity|lower extremity
1209879|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
1209880|NCT01988207|Voice|voice
1209881|NCT01988207|Hyperfunction|hyperfunction
1209882|NCT01988194|acupuncture|acupuncture
1209883|NCT01988194|postoperative pain|postoperative pain
1209884|NCT01988194|nausea|nausea
1209885|NCT01988194|vomiting|vomiting
1209886|NCT01988194|anxiety|anxiety
1209887|NCT01988194|depression|depression
1209888|NCT01988194|hospitalization|hospitalization
1209889|NCT01988194|inpatient|inpatient
1209890|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
1209891|NCT01988181|Renal Dialysis|renal dialysis
1209892|NCT01988181|Blood Volume Determination|blood volume determination
1209893|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
1209894|NCT01988181|Crossover Studies|crossover studies
1209895|NCT01988168|Suture Techniques|suture techniques
1209896|NCT01988168|Sutures|sutures
1209897|NCT01988168|Surgical Staplers|surgical staplers
1209898|NCT01988142|Spinal Cord Injury|spinal cord injury
1209899|NCT01988142|Passive motion|passive motion
1209900|NCT01988142|Fatigue index|fatigue index
1209901|NCT01988142|Hypertonia|hypertonia
1209902|NCT01988129|sleep|sleep
1209903|NCT01988129|firefighter|firefighter
1209904|NCT01988129|fire|fire
1209905|NCT01988129|apnea|apnea
1209906|NCT01988129|insomnia|insomnia
1209907|NCT01988129|shift|shift
1209908|NCT01988129|narcolepsy|narcolepsy
1209909|NCT01988129|restless leg|restless leg
1209911|NCT01988129|fatigue|fatigue
1209912|NCT01988129|actigraph|actigraph
1209913|NCT01988129|actigraphy|actigraphy
1209914|NCT01988129|actiwatch|actiwatch
1209915|NCT01988129|safety|safety
1209916|NCT01988129|sleepiness|sleepiness
1209917|NCT01988129|sleepy|sleepy
1209918|NCT01988129|work|work
1209919|NCT01988129|hours|hours
1209920|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
1209921|NCT01988129|drowsy|drowsy
1209922|NCT01988116|Chronic kidney disease|chronic kidney disease
1209923|NCT01988116|Anemia of chronic disease|anemia of chronic disease
1209924|NCT01988116|Iron Metabolism|iron metabolism
1209925|NCT01988116|Iron Homeostasis|iron homeostasis
1209926|NCT01988116|Vitamin D|vitamin d
1209927|NCT01988116|Calcitriol|calcitriol
1209928|NCT01988116|hemojuvelin|hemojuvelin
1209929|NCT01988116|hepcidin|hepcidin
1209930|NCT01988116|anemia|anemia
1209931|NCT01988116|ferroportin|ferroportin
1209932|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
1209933|NCT01988090|Breast Cancer|breast cancer
1209934|NCT01988090|Hormone Receptor Positive|hormone receptor positive
1209935|NCT01988090|Vitamin D|vitamin d
1209936|NCT01988064|pulse rate|pulse rate
1209937|NCT01988064|patient education|patient education
1209938|NCT01988064|training|training
1209939|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
1209940|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1209941|NCT01988038|Disease Progression|disease progression
1209942|NCT01987986|cellulite|cellulite
1209943|NCT01987986|dimple|dimple
1209944|NCT01987986|orange peel|orange peel
1209945|NCT01987986|cottage cheese|cottage cheese
1209946|NCT01987986|mattress texture|mattress texture
1209947|NCT01987947|MEMP1972A|memp1972a
1209948|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1209949|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
1209950|NCT01987934|AgNORs|agnors
1209951|NCT01987934|Morphometry|morphometry
1209952|NCT01987921|Acute kidney injury|acute kidney injury
1209953|NCT01987921|Pediatrics|pediatrics
1209954|NCT01987921|Critical Care|critical care
1209955|NCT01987908|Pain|pain
1209956|NCT01987908|Biomarkers|biomarkers
1209957|NCT01987908|6 minute walk test|6 minute walk test
1209958|NCT01987908|5-HMF|5-hmf
1209959|NCT01987908|Pharmacokinetics|pharmacokinetics
1209960|NCT01987908|Analgesic use|analgesic use
1209961|NCT01987908|Sickle cell disease|sickle cell disease
1209962|NCT01987908|Aes-103|aes-103
1209963|NCT01987908|SpO2|spo2
1209964|NCT01987908|Anemia|anemia
1209965|NCT01987908|Hemoglobin|hemoglobin
1209966|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
1209967|NCT01987895|Clostridium difficile infection|clostridium difficile infection
1209968|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
1209969|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
1209970|NCT01987856|aCGH|acgh
1209971|NCT01987856|chromosome|chromosome
1209972|NCT01987856|blastocyst|blastocyst
1209973|NCT01987856|trophectoderm|trophectoderm
1209974|NCT01987856|vitrification|vitrification
1209975|NCT01987856|natural cycle|natural cycle
1209976|NCT01987856|pregnancy|pregnancy
1209977|NCT01987856|live birth|live birth
1209978|NCT01987843|Psoriasis|psoriasis
1209979|NCT01987843|Plaque Psoriasis|plaque psoriasis
1209980|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
1209981|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
1209982|NCT01987817|Peanut|peanut
1209983|NCT01987817|OIT|oit
1209984|NCT01987817|Oral Desensitization|oral desensitization
1209985|NCT01987817|Peanut Allergen|peanut allergen
1209986|NCT01987817|Allergy|allergy
1209987|NCT01987817|Peanut Allergy|peanut allergy
1209988|NCT01987817|Peanut-Allergic Children|peanut-allergic children
1209989|NCT01987817|Children|children
1209990|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
1209991|NCT01987778|Hot flashes|hot flashes
1209992|NCT01987778|Menopause|menopause
1209993|NCT01987778|HRQoL|hrqol
1209994|NCT01987778|Resistance training|resistance training
1209995|NCT01987778|Physical activity|physical activity
1209996|NCT01987778|Adipose tissue|adipose tissue
1209997|NCT01987739|Almorexant|almorexant
1209998|NCT01987739|Zolpidem|zolpidem
1209999|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
1210000|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
1210001|NCT01987700|Dermal Allograft|dermal allograft
1210002|NCT01987700|Mesh|mesh
1210003|NCT01987700|Component Separation|component separation
1210004|NCT01987661|COPD|copd
1210005|NCT01987661|NIV|niv
1210006|NCT01987661|Airtrapping|airtrapping
1210007|NCT01987661|Ventimotion2|ventimotion2
1210008|NCT01987648|Craniotomy|craniotomy
1210009|NCT01987648|Postoperative complications|postoperative complications
1210010|NCT01987648|Perioperative care|perioperative care
1210011|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
1210012|NCT01987648|Postoperative seizure|postoperative seizure
1210013|NCT01987635|Mitral valve disease|mitral valve disease
1210014|NCT01987635|primarily regurgitation|primarily regurgitation
1210015|NCT01987635|necessitating surgical repair|necessitating surgical repair
1210016|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
1210017|NCT01987622|claudication|claudication
1210018|NCT01987622|low back pain|low back pain
1210019|NCT01987622|radiculopathy|radiculopathy
1210020|NCT01987622|acupuncture|acupuncture
1210021|NCT01987622|Korean medicine|korean medicine
1210022|NCT01987622|randomized controlled trial|randomized controlled trial
1210023|NCT01987609|Psoriasis|psoriasis
1210024|NCT01987609|Dendritic cells|dendritic cells
1210025|NCT01987609|Hyaluronidase|hyaluronidase
1210026|NCT01987609|Hylenex|hylenex
1210027|NCT01987570|Xanthine oxidase|xanthine oxidase
1210028|NCT01987570|Magnetic resonance|magnetic resonance
1210029|NCT01987570|Oxidative stress|oxidative stress
1210030|NCT01987570|Inflammation|inflammation
1210031|NCT01987557|treadmill|treadmill
1210032|NCT01987557|parkinson's|parkinson's
1210033|NCT01987557|proprioception|proprioception
1210034|NCT01987557|cadence|cadence
1210035|NCT01987557|step length|step length
1210036|NCT01987557|intrinsic feedback|intrinsic feedback
1210037|NCT01987544|COPD|copd
1210038|NCT01987544|telemonitoring|telemonitoring
1210039|NCT01987544|training|training
1210040|NCT01987544|ergometer|ergometer
1210041|NCT01987544|telemedicine|telemedicine
1210042|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
1210043|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
1210044|NCT01987466|Acute renal failure|acute renal failure
1210045|NCT01987466|Cardiac arrest|cardiac arrest
1210046|NCT01987466|Hypothermia|hypothermia
1210047|NCT01987453|genotype 1|genotype 1
1210048|NCT01987427|Overweight|overweight
1210049|NCT01987427|Obese|obese
1210050|NCT01987427|Weight Management|weight management
1210051|NCT01987414|Stroke|stroke
1210052|NCT01987414|Cardiovascular Accident|cardiovascular accident
1210053|NCT01987414|Task-oriented approach|task-oriented approach
1210054|NCT01987414|Orthosis|orthosis
1210055|NCT01987414|occupational therapy|occupational therapy
1210056|NCT01987401|pulmonary|pulmonary
1210057|NCT01987401|lung|lung
1210058|NCT01987401|military and environmental exposures|military and environmental exposures
1210059|NCT01987401|epidemiologic|epidemiologic
1210060|NCT01987401|observational|observational
1210061|NCT01987401|interview or questionnaire|interview or questionnaire
1210062|NCT01987401|deployment related|deployment related
1210063|NCT01987401|Enduring Freedom|enduring freedom
1210064|NCT01987401|Iraqi Freedom|iraqi freedom
1210065|NCT01987375|HNSCC|hnscc
1210066|NCT01987375|Imaging|imaging
1210067|NCT01987349|Influenza vaccines|influenza vaccines
1210068|NCT01987349|healthy participants|healthy participants
1210069|NCT01987349|immunity to influenza|immunity to influenza
1210070|NCT01987349|identical twins|identical twins
1210071|NCT01987349|fraternal twins|fraternal twins
1210072|NCT01987349|non-twins|non-twins
1210073|NCT01987336|Standard Foley Catheter|standard foley catheter
1210074|NCT01987323|glaucoma|glaucoma
1210075|NCT01987323|raised intraocular pressure|raised intraocular pressure
1210076|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
1210077|NCT01987310|endothelial function|endothelial function
1210078|NCT01987310|liver steatosis|liver steatosis
1210079|NCT01987310|liver fibrosis|liver fibrosis
1210179|NCT01986764|cognition|cognition
1210080|NCT01987310|statin treatment|statin treatment
1210081|NCT01987297|arsenic|arsenic
1210082|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
1210083|NCT01987297|outcome|outcome
1210084|NCT01987271|exercise tolerance|exercise tolerance
1210085|NCT01987271|exercise test|exercise test
1210086|NCT01987271|noninvasive ventilation|noninvasive ventilation
1210087|NCT01987258|Glycemic control|glycemic control
1210088|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
1210089|NCT01987219|familial dysautonomia|familial dysautonomia
1210090|NCT01987206|artificial pancreas|artificial pancreas
1210091|NCT01987193|Proton radiation|proton radiation
1210092|NCT01987193|tumor blood flow|tumor blood flow
1210093|NCT01987180|self-efficacy|self-efficacy
1210094|NCT01987167|acute optic neuritis|acute optic neuritis
1210095|NCT01987115|Trigger Finger|trigger finger
1210096|NCT01987115|Physiotherapy|physiotherapy
1210097|NCT01987115|Fascial Manipulation|fascial manipulation
1210098|NCT01987102|Methotrexate|methotrexate
1210099|NCT01987102|rescue treatment|rescue treatment
1210100|NCT01987089|Insomnia|insomnia
1210101|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
1210102|NCT01987089|Alcoholism|alcoholism
1210103|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
1210104|NCT01987076|DRESS|dress
1210105|NCT01987076|Systemic steroid|systemic steroid
1210106|NCT01987076|Topical steroid|topical steroid
1210107|NCT01987076|Treatment|treatment
1210108|NCT01987063|Twin delivery|twin delivery
1210109|NCT01987063|Planned vaginal delivery|planned vaginal delivery
1210110|NCT01987063|Planned cesarean delivery|planned cesarean delivery
1210111|NCT01987063|Total breech extraction|total breech extraction
1210112|NCT01987063|Internal cephalic version|internal cephalic version
1210113|NCT01987063|External cephalic version|external cephalic version
1210114|NCT01987037|autism spectrum disorder|autism spectrum disorder
1210115|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
1210116|NCT01987037|NP-MOT|np-mot
1210117|NCT01987037|motor skills|motor skills
1210118|NCT01987037|gross motor|gross motor
1210119|NCT01987011|Avian influenza|avian influenza
1210120|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
1210121|NCT01986998|oral methylprednisolone|oral methylprednisolone
1210122|NCT01986998|EDSS|edss
1210123|NCT01986998|gadolinium|gadolinium
1210124|NCT01986972|Toothbrushing|toothbrushing
1210125|NCT01986972|Dental plaque|dental plaque
1210126|NCT01986972|Dentifrice|dentifrice
1210127|NCT01986972|Oral hygiene|oral hygiene
1210128|NCT01986959|Periodontal Dressings|periodontal dressings
1210129|NCT01986959|Surgical crown lengthening|surgical crown lengthening
1210130|NCT01986959|Periodontal surgery|periodontal surgery
1210131|NCT01986920|SK|sk
1210132|NCT01986907|wet AMD|wet amd
1210133|NCT01986907|macular degeneration|macular degeneration
1210134|NCT01986907|ranibizumab|ranibizumab
1210135|NCT01986907|mono-bilateral|mono-bilateral
1210136|NCT01986907|poor visual acuity|poor visual acuity
1210137|NCT01986907|retinal disease|retinal disease
1210138|NCT01986907|eye disease|eye disease
1210139|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
1210140|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
1210141|NCT01986894|TQT|tqt
1210142|NCT01986894|Pharmacokinetic|pharmacokinetic
1210143|NCT01986894|Healthy|healthy
1210144|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
1210145|NCT01986868|CMRA|cmra
1210146|NCT01986868|MRI with contrast|mri with contrast
1210147|NCT01986868|MultiHance|multihance
1210148|NCT01986868|Optimark|optimark
1210149|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
1210150|NCT01986868|MRA|mra
1210151|NCT01986868|MR angiography|mr angiography
1210152|NCT01986842|Muscle protein synthesis|muscle protein synthesis
1210153|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
1210154|NCT01986842|Leucine|leucine
1210155|NCT01986842|Whey protein|whey protein
1210156|NCT01986816|Obesity|obesity
1210157|NCT01986816|Bariatric surgery|bariatric surgery
1210158|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
1210159|NCT01986816|Quality of life|quality of life
1210160|NCT01986816|QALY|qaly
1210161|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
1210162|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
1210163|NCT01986803|Healing score|healing score
1210164|NCT01986803|OFDI|ofdi
1210165|NCT01986790|Health insurance|health insurance
1210166|NCT01986790|Health services accessibility|health services accessibility
1210167|NCT01986790|Decision making|decision making
1210168|NCT01986790|Health literacy|health literacy
1210169|NCT01986777|cognitive complains|cognitive complains
1210170|NCT01986777|RRSO|rrso
1210171|NCT01986777|oophorectomy|oophorectomy
1210172|NCT01986777|memory|memory
1210173|NCT01986777|cognition|cognition
1210174|NCT01986777|early menopause|early menopause
1210175|NCT01986764|oophorectomy|oophorectomy
1210176|NCT01986764|RRSO|rrso
1210177|NCT01986764|menopause|menopause
1210178|NCT01986764|early menopause|early menopause
1210180|NCT01986764|memory|memory
1210181|NCT01986764|brain-imaging|brain-imaging
1210182|NCT01986751|nerve|nerve
1210183|NCT01986751|block|block
1210184|NCT01986751|motor blockade|motor blockade
1210185|NCT01986751|lower extremity pain|lower extremity pain
1210186|NCT01986751|nerve block|nerve block
1210187|NCT01986725|vulvar neoplasia|vulvar neoplasia
1210188|NCT01986725|vulvar cancer|vulvar cancer
1210189|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
1210190|NCT01986725|self management|self management
1210191|NCT01986725|symptom management|symptom management
1210192|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
1210193|NCT01986699|polypectomy|polypectomy
1210194|NCT01986699|laparoscopic|laparoscopic
1210195|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
1210196|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
1210197|NCT01986647|exercise|exercise
1210198|NCT01986647|older adults|older adults
1210199|NCT01986647|mobility disability|mobility disability
1210200|NCT01986634|Laser Resurfacing|laser resurfacing
1210201|NCT01986634|Rhytids|rhytids
1210202|NCT01986634|Perioral|perioral
1210203|NCT01986621|Percutaneous Coronary Intervention|percutaneous coronary intervention
1210204|NCT01986621|Cardiac troponin|cardiac troponin
1210205|NCT01986621|Antiplatelet therapy|antiplatelet therapy
1210206|NCT01986608|Lacosamide|lacosamide
1210207|NCT01986608|Vimpat|vimpat
1210208|NCT01986608|Bioequivalence|bioequivalence
1210209|NCT01986608|Bioavailability|bioavailability
1210210|NCT01986608|Japanese|japanese
1210211|NCT01986595|Neuroblastoma|neuroblastoma
1210212|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
1210213|NCT01986595|cancer genetics|cancer genetics
1210214|NCT01986595|target therapy|target therapy
1210215|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
1210216|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
1210217|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
1210424|NCT01985620|Vaccination|vaccination
1210218|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
1210219|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
1210220|NCT01986595|Pyrosequencing|pyrosequencing
1210221|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
1210222|NCT01986595|Immunohistochemistry|immunohistochemistry
1210223|NCT01986582|Allergic Rhinitis|allergic rhinitis
1210224|NCT01986582|Congestion|congestion
1210225|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
1210226|NCT01986582|Nasal Decongestant|nasal decongestant
1210227|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
1210228|NCT01986569|PET/CT scan|pet/ct scan
1210229|NCT01986569|Estrogen Receptor|estrogen receptor
1210230|NCT01986569|Recurrent breast cancer|recurrent breast cancer
1210231|NCT01986569|Stage IV breast cancer|stage iv breast cancer
1210232|NCT01986543|Pharmacokinetic|pharmacokinetic
1210233|NCT01986530|irisin|irisin
1210234|NCT01986530|adiponectin|adiponectin
1210235|NCT01986530|leptin|leptin
1210236|NCT01986530|lean body mass|lean body mass
1210237|NCT01986530|fat mass|fat mass
1210238|NCT01986517|Feedback|feedback
1210239|NCT01986517|Therapeutic competencies|therapeutic competencies
1210240|NCT01986517|Training|training
1210241|NCT01986504|Infection|infection
1210242|NCT01986504|Cohort|cohort
1210243|NCT01986504|Prospective|prospective
1210244|NCT01986504|Epidemiology|epidemiology
1210245|NCT01986504|Outcome|outcome
1210246|NCT01986491|Healthy|healthy
1210247|NCT01986491|JNJ-39393406|jnj-39393406
1210248|NCT01986491|Relative Bioavailability|relative bioavailability
1210249|NCT01986491|Solid Formulation|solid formulation
1210250|NCT01986465|lateral epicondylitis|lateral epicondylitis
1210251|NCT01986465|treatment|treatment
1210252|NCT01986465|steroid|steroid
1210253|NCT01986465|immobilization|immobilization
1210254|NCT01986452|OSA|osa
1210255|NCT01986452|Apoplexy|apoplexy
1210256|NCT01986452|CPAP|cpap
1210257|NCT01986452|adherence|adherence
1210258|NCT01986452|telemonitoring|telemonitoring
1210259|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
1210260|NCT01986413|COPD|copd
1210261|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
1210262|NCT01986413|NIV|niv
1210263|NCT01986413|respiratory events|respiratory events
1210264|NCT01986413|IVAPS|ivaps
1210265|NCT01986400|Adolescent|adolescent
1210266|NCT01986400|Skype|skype
1210267|NCT01986400|Peer Mentorship|peer mentorship
1210268|NCT01986400|Internet Self-Management|internet self-management
1210269|NCT01986387|adolescent|adolescent
1210270|NCT01986387|Skype|skype
1210271|NCT01986387|peer mentorship|peer mentorship
1210272|NCT01986387|internet self-management|internet self-management
1210273|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
1210274|NCT01986361|Pharyngitis|pharyngitis
1210275|NCT01986361|Sore Throat|sore throat
1210276|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
1210277|NCT01986348|GBM|gbm
1210278|NCT01986348|Glioblastoma|glioblastoma
1210279|NCT01986348|selinexor|selinexor
1210280|NCT01986348|KPT-330|kpt-330
1210281|NCT01986348|Karyopharm|karyopharm
1210282|NCT01986348|brain tumor|brain tumor
1210283|NCT01986348|brain cancer|brain cancer
1210284|NCT01986348|Glioma|glioma
1210285|NCT01986348|Astrocytoma|astrocytoma
1210286|NCT01986348|Oligodendrogliomas|oligodendrogliomas
1210287|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
1210288|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
1210289|NCT01986335|Infants|infants
1210290|NCT01986335|Primary vaccination|primary vaccination
1210291|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
1210292|NCT01986322|Immunogenicity|immunogenicity
1210293|NCT01986322|Infants|infants
1210294|NCT01986322|Safety|safety
1210295|NCT01986309|Postoperative|postoperative
1210296|NCT01986309|Nausea|nausea
1210297|NCT01986309|Vomiting|vomiting
1210298|NCT01986309|Pain|pain
1210299|NCT01986309|Surgery|surgery
1210300|NCT01986283|Abuse potential|abuse potential
1210301|NCT01986283|PF-00345439|pf-00345439
1210302|NCT01986283|drug abuse|drug abuse
1210303|NCT01986244|Osteoarthritis|osteoarthritis
1210304|NCT01986244|Arthritis|arthritis
1210305|NCT01986244|Joint Diseases|joint diseases
1210306|NCT01986231|diabetes|diabetes
1210307|NCT01986231|insulin|insulin
1210308|NCT01986231|glucagon|glucagon
1210309|NCT01986231|glycogen|glycogen
1210310|NCT01986231|MRS|mrs
1210311|NCT01986205|Concussion, mild|concussion, mild
1210312|NCT01986205|Traumatic brain injury|traumatic brain injury
1210313|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
1210314|NCT01986205|Post-concussion symptoms|post-concussion symptoms
1210315|NCT01986205|Headache|headache
1210316|NCT01986192|anticoagulation|anticoagulation
1210317|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
1210318|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
1210319|NCT01986153|Fatty acid, essential|fatty acid, essential
1210320|NCT01986153|Immune system|immune system
1210321|NCT01986153|Home parenteral nutrition|home parenteral nutrition
1210322|NCT01986140|Breast Cancer|breast cancer
1210323|NCT01986140|Alopecia|alopecia
1210324|NCT01986140|Scalp|scalp
1210325|NCT01986140|Cooling|cooling
1210326|NCT01986127|Crohn disease|crohn disease
1210327|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
1210328|NCT01986075|Computer-assisted therapy|computer-assisted therapy
1210329|NCT01986075|Pharmacotherapy|pharmacotherapy
1210330|NCT01986062|ADHD|adhd
1210331|NCT01986062|AR11|ar11
1210332|NCT01986062|classroom design|classroom design
1210333|NCT01986062|amphetamine sulfate|amphetamine sulfate
1210334|NCT01986023|Stroke|stroke
1210335|NCT01986023|Medication Adherence|medication adherence
1210336|NCT01986023|SMS|sms
1210337|NCT01986023|Randomised|randomised
1210338|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
1210339|NCT01985984|Head and neck cancer|head and neck cancer
1210340|NCT01985906|Aorta|aorta
1210341|NCT01985906|Aneurysm|aneurysm
1210342|NCT01985906|Stents|stents
1210343|NCT01985906|Collateral Circulation|collateral circulation
1210344|NCT01985893|Metastatic|metastatic
1210345|NCT01985893|breast|breast
1210346|NCT01985893|cancer|cancer
1210347|NCT01985880|Biomarkers|biomarkers
1210348|NCT01985854|Desflurane|desflurane
1210349|NCT01985854|Propofol|propofol
1210350|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
1210351|NCT01985854|Neurosurgery|neurosurgery
1210352|NCT01985841|Early breast cancer|early breast cancer
1210353|NCT01985841|Primary operable breast cancer|primary operable breast cancer
1210354|NCT01985841|HER2- negative|her2- negative
1210355|NCT01985841|bevacizumab|bevacizumab
1210356|NCT01985828|Prostate neoplasm|prostate neoplasm
1210357|NCT01985828|Prostate Cancer|prostate cancer
1210358|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
1210359|NCT01985815|Deep Brain Stimulation|deep brain stimulation
1210360|NCT01985815|Psychosurgery|psychosurgery
1210361|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
1210362|NCT01985776|Exercise|exercise
1210363|NCT01985776|Electric Stimulation|electric stimulation
1210364|NCT01985763|Genistein|genistein
1210365|NCT01985763|soy supplements|soy supplements
1210366|NCT01985763|phytoestrogens|phytoestrogens
1210367|NCT01985763|colon cancer|colon cancer
1210368|NCT01985763|rectal cancer|rectal cancer
1210369|NCT01985763|colorectal cancer|colorectal cancer
1210370|NCT01985763|metastatic|metastatic
1210371|NCT01985763|stage IV|stage iv
1210372|NCT01985763|FOLFOX|folfox
1210373|NCT01985763|FOLFOX-Avastin|folfox-avastin
1210374|NCT01985763|Chemotherapy|chemotherapy
1210375|NCT01985750|dyspnea|dyspnea
1210376|NCT01985750|fmri|fmri
1210377|NCT01985750|d-cycloserine|d-cycloserine
1210378|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
1210379|NCT01985737|NICUs|nicus
1210380|NCT01985737|Neonates|neonates
1210381|NCT01985737|CLABSI|clabsi
1210382|NCT01985737|Microbiome|microbiome
1210383|NCT01985737|DNA signature|dna signature
1210384|NCT01985737|Catheter infections|catheter infections
1210385|NCT01985724|Early breast cancer|early breast cancer
1210386|NCT01985724|Axillary node positive|axillary node positive
1210387|NCT01985724|HER-2 negative|her-2 negative
1210388|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
1210389|NCT01985724|Dose dense|dose dense
1289163|NCT01629173|insole|insole
1210390|NCT01985724|Docetaxel|docetaxel
1210391|NCT01985724|FEC|fec
1210392|NCT01985711|Motivational Interviewing|motivational interviewing
1210393|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
1210394|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
1210395|NCT01985711|Questionnaires|questionnaires
1210396|NCT01985711|Telemedicine/*methods|telemedicine/*methods
1210397|NCT01985711|Comorbidity|comorbidity
1210398|NCT01985711|Diabetes|diabetes
1210399|NCT01985711|Glucose/metabolism|glucose/metabolism
1210400|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1210401|NCT01985711|Blood Pressure|blood pressure
1210402|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
1210403|NCT01985711|Quality of life|quality of life
1210404|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
1210405|NCT01985711|Randomized Controlled Trials|randomized controlled trials
1210406|NCT01985698|Low rectal cancer|low rectal cancer
1210407|NCT01985698|Robotic|robotic
1210408|NCT01985698|Laparoscopic|laparoscopic
1210409|NCT01985698|Abdominoperineal resection|abdominoperineal resection
1210410|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
1210411|NCT01985672|Infertility|infertility
1210412|NCT01985659|Lymph Node Excision|lymph node excision
1210413|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
1210414|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1210415|NCT01985659|Thoracotomy|thoracotomy
1210416|NCT01985646|Hirschsprung disease|hirschsprung disease
1210417|NCT01985646|conservative treatment|conservative treatment
1210418|NCT01985646|surgery treatment|surgery treatment
1210419|NCT01985646|infants|infants
1210420|NCT01985633|Osteoarthritis|osteoarthritis
1210421|NCT01985633|stem cells|stem cells
1210422|NCT01985633|Platelet gel|platelet gel
1210423|NCT01985633|Functional outcome|functional outcome
1210425|NCT01985620|RSV|rsv
1210426|NCT01985620|Influenza|influenza
1210427|NCT01985620|Prematurity|prematurity
1210428|NCT01985594|preterm labor|preterm labor
1210429|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1210430|NCT01985581|Intuniv extended release|intuniv extended release
1210431|NCT01985581|Executive Function|executive function
1210432|NCT01985581|Quality of Life|quality of life
1210433|NCT01985568|Obesity|obesity
1210434|NCT01985568|weight-loss|weight-loss
1210435|NCT01985568|Physical activity|physical activity
1210436|NCT01985555|Phase I|phase i
1210437|NCT01985555|Safety|safety
1210438|NCT01985555|Pharmacokinetics|pharmacokinetics
1210439|NCT01985516|Pain|pain
1210440|NCT01985516|Urethra|urethra
1210441|NCT01985516|Catheter|catheter
1210442|NCT01985503|positron emission tomography|positron emission tomography
1210443|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
1210444|NCT01985503|brown adipose tissue|brown adipose tissue
1210445|NCT01985503|obesity|obesity
1210446|NCT01985503|cardiovascular disease|cardiovascular disease
1210447|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
1210448|NCT01985490|epiretinal membrane|epiretinal membrane
1210449|NCT01985490|foveal avascular zone|foveal avascular zone
1210450|NCT01985490|internal limiting membrane|internal limiting membrane
1210451|NCT01985477|Myeloma|myeloma
1210452|NCT01985477|Multiple myeloma|multiple myeloma
1210453|NCT01985477|MM|mm
1210454|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1210455|NCT01985477|RR MM|rr mm
1210456|NCT01985477|Lenalidomide|lenalidomide
1210457|NCT01985477|CC-5013|cc-5013
1210458|NCT01985477|Revlimid|revlimid
1210459|NCT01985477|Dexamethasone|dexamethasone
1210460|NCT01985477|Decadron|decadron
1210461|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
1210462|NCT01985477|ATRA|atra
1210463|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
1210464|NCT01985477|Vesanoid|vesanoid
1210465|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
1210466|NCT01985464|umbilical cord|umbilical cord
1210467|NCT01985464|mesenchymal|mesenchymal
1210468|NCT01985464|stem cells|stem cells
1210469|NCT01985451|Lymphoma|lymphoma
1210470|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
1210471|NCT01985438|Nutritional Support|nutritional support
1210472|NCT01985438|Randomized Controlled Trial|randomized controlled trial
1210473|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
1210474|NCT01985438|Nasogastric tube|nasogastric tube
1210475|NCT01985438|Radiation Effects|radiation effects
1210476|NCT01985438|Pakistan|pakistan
1210477|NCT01985412|Rejection|rejection
1210478|NCT01985412|Transplant|transplant
1210479|NCT01985412|Cardiac|cardiac
1210480|NCT01985412|Pulmonary|pulmonary
1210481|NCT01985412|Heart|heart
1210482|NCT01985412|Lung|lung
1210483|NCT01985412|Cell-Free DNA|cell-free dna
1210484|NCT01985412|cfDNA|cfdna
1210485|NCT01985412|Cell|cell
1210486|NCT01985412|Free|free
1210487|NCT01985412|DNA|dna
1210488|NCT01985412|Biopsy|biopsy
1210489|NCT01985412|Non-Invasive|non-invasive
1210490|NCT01985399|HIV|hiv
1210491|NCT01985399|AIDS|aids
1210492|NCT01985399|Aging|aging
1210493|NCT01985386|Iron absorption|iron absorption
1210494|NCT01985386|Slow release iron|slow release iron
1210495|NCT01985386|Gastric delivery system|gastric delivery system
1210496|NCT01985386|Iron deficiency|iron deficiency
1210497|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
1210498|NCT01985373|pharmacokinetics|pharmacokinetics
1210499|NCT01985373|10% IVIG|10% ivig
1210500|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
1210501|NCT01985321|herpes labialis|herpes labialis
1210502|NCT01985321|cold sore|cold sore
1210503|NCT01985269|High risk|high risk
1210504|NCT01985269|ART naive|art naive
1210505|NCT01985256|glioma|glioma
1210506|NCT01985256|glioblastoma|glioblastoma
1210507|NCT01985256|glioblastoma multiforme|glioblastoma multiforme
1210508|NCT01985256|Grade IV astrocytoma|grade iv astrocytoma
1210509|NCT01985256|brain cancer|brain cancer
1210510|NCT01985256|recurrent glioblastoma|recurrent glioblastoma
1210511|NCT01985256|GBM|gbm
1210512|NCT01985256|AA|aa
1210513|NCT01985256|AOD|aod
1210514|NCT01985256|anaplastic astrocytoma|anaplastic astrocytoma
1210515|NCT01985256|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1210516|NCT01985256|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1210517|NCT01985256|malignant glioma|malignant glioma
1210518|NCT01985256|high grade glioma|high grade glioma
1210519|NCT01985243|Dietary diversity|dietary diversity
1210520|NCT01985243|Infant and young child|infant and young child
1210521|NCT01985243|Adolescents|adolescents
1210522|NCT01985243|Anemia|anemia
1210523|NCT01985243|Rural health|rural health
1210524|NCT01985204|iodine|iodine
1210525|NCT01985204|thyroid hormones|thyroid hormones
1210526|NCT01985204|obesity|obesity
1210527|NCT01985204|TSH|tsh
1210528|NCT01985204|dyslipidemia|dyslipidemia
1210529|NCT01985204|insulin resistance|insulin resistance
1210530|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
1210531|NCT01985126|Multiple myeloma|multiple myeloma
1210532|NCT01985126|Daratumumab|daratumumab
1210533|NCT01985126|Proteasome inhibitor|proteasome inhibitor
1210534|NCT01985126|Immunomodulatory drug|immunomodulatory drug
1210535|NCT01985126|IMiD|imid
1210536|NCT01985113|thioredoxin reductase|thioredoxin reductase
1210537|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
1210538|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
1210539|NCT01985074|department|department
1210540|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
1210541|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
1210542|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
1210543|NCT01985035|obesity|obesity
1210544|NCT01985035|diet|diet
1210545|NCT01985035|energy expenditure|energy expenditure
1210546|NCT01985022|autism|autism
1210547|NCT01985022|autism spectrum disorders|autism spectrum disorders
1210548|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
1210549|NCT01985022|toddlers|toddlers
1210550|NCT01985022|intervention|intervention
1210551|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
1210552|NCT01984983|DNA vaccine|dna vaccine
1210553|NCT01984983|electroporation|electroporation
1210554|NCT01984983|intradermal|intradermal
1210555|NCT01984983|intramuscular|intramuscular
1210556|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
1210557|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
1210558|NCT01984970|Thoracic surgery|thoracic surgery
1210559|NCT01984957|ALS|als
1210560|NCT01984957|Motor neuron diseases|motor neuron diseases
1210561|NCT01984957|Transcriptome|transcriptome
1210562|NCT01984944|circadian rhythm|circadian rhythm
1210563|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
1210564|NCT01984931|Trimebutine Maleate|trimebutine maleate
1210565|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
1210566|NCT01984905|angioscan|angioscan
1210567|NCT01984905|aortic dissection|aortic dissection
1210568|NCT01984892|Autologous Vaccination|autologous vaccination
1210569|NCT01984892|Intratumoral Injections|intratumoral injections
1210570|NCT01984892|Intramuscular Injections|intramuscular injections
1210571|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
1210572|NCT01984892|Poly-ICLC|poly-iclc
1210573|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
1210574|NCT01984892|Safety|safety
1210575|NCT01984892|Efficacy|efficacy
1210576|NCT01984892|Autovaccination|autovaccination
1210577|NCT01984892|In Situ|in situ
1210578|NCT01984892|Host Targeted Strategy|host targeted strategy
1210579|NCT01984892|Overall Survival|overall survival
1210580|NCT01984892|Immunotherapy|immunotherapy
1210581|NCT01984892|Adjuvant|adjuvant
1210582|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
1210583|NCT01984853|ACS|acs
1210584|NCT01984853|repository|repository
1210585|NCT01984853|Observational|observational
1210586|NCT01984827|Hyperglycaemia|hyperglycaemia
1210587|NCT01984827|Moxifloxacin|moxifloxacin
1210588|NCT01984827|QTc prolongation|qtc prolongation
1210589|NCT01984827|C-peptide|c-peptide
1210590|NCT01984827|Dead in bed syndrome|dead in bed syndrome
1210591|NCT01984801|SCD1|scd1
1210592|NCT01984801|Gel|gel
1210593|NCT01984801|Topical Administration|topical administration
1210594|NCT01984801|Acne|acne
1210595|NCT01984788|Oral Prophylaxis|oral prophylaxis
1210596|NCT01984775|safety|safety
1210597|NCT01984775|dermal|dermal
1210598|NCT01984775|GSK2894512|gsk2894512
1210599|NCT01984775|Cumulative irritation|cumulative irritation
1210600|NCT01984736|Pharmacokinetic|pharmacokinetic
1210601|NCT01984736|Safety|safety
1210602|NCT01984723|Pharmacokinetic|pharmacokinetic
1210603|NCT01984723|Safety|safety
1210604|NCT01984710|Treatment Resistant Depression|treatment resistant depression
1210605|NCT01984710|Deep Brain Stimulation|deep brain stimulation
1210606|NCT01984710|Psychiatry|psychiatry
1210607|NCT01984710|Neuro Surgery|neuro surgery
1210608|NCT01984684|Bacterial skin infection|bacterial skin infection
1210609|NCT01984684|infection|infection
1210610|NCT01984684|skin|skin
1210611|NCT01984684|delafloxacin|delafloxacin
1210612|NCT01984684|vancomycin|vancomycin
1210613|NCT01984684|aztreonam|aztreonam
1210614|NCT01984684|methicillin-resistant Staphylococcus aureus (MRSA) bacteria|methicillin-resistant staphylococcus aureus (mrsa) bacteria
1210615|NCT01984684|bacterial infection|bacterial infection
1210616|NCT01984684|Anti-Infective Agents|anti-infective agents
1210617|NCT01984658|pancreatic cancer|pancreatic cancer
1210618|NCT01984645|Emergency Visit|emergency visit
1210619|NCT01984645|Secure Health messaging|secure health messaging
1210620|NCT01984645|Inpatient|inpatient
1210621|NCT01984593|Yoga|yoga
1210622|NCT01984593|Hypertension|hypertension
1210623|NCT01984593|Quality of Life|quality of life
1210624|NCT01984593|Primary Health Care|primary health care
1210625|NCT01984593|Stress|stress
1210626|NCT01984593|Anxiety|anxiety
1210627|NCT01984593|Depression|depression
1210628|NCT01984580|Barrett's esophagus|barrett's esophagus
1210629|NCT01984580|Esophagus|esophagus
1210630|NCT01984580|Adenocarcinoma|adenocarcinoma
1210631|NCT01984567|Oxyphytosterols|oxyphytosterols
1210632|NCT01984567|Oxidative stress|oxidative stress
1210633|NCT01984567|Vitamin E|vitamin e
1210634|NCT01984567|Lipoic acid|lipoic acid
1210635|NCT01984541|Pollen|pollen
1210636|NCT01984528|Immunotherapy|immunotherapy
1210637|NCT01984528|Skin prick test|skin prick test
1210638|NCT01984528|Standardization|standardization
1210639|NCT01984528|Alternaria alternata|alternaria alternata
1210640|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
1210641|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
1210642|NCT01984515|Treatment Engagement|treatment engagement
1210643|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
1210644|NCT01984515|Implementation Science|implementation science
1210645|NCT01984502|Larynx Cancer|larynx cancer
1210646|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
1210647|NCT01984476|spinal cord injury|spinal cord injury
1210648|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
1210649|NCT01984476|baroreceptor integrity|baroreceptor integrity
1210650|NCT01984476|sympathetic integrity|sympathetic integrity
1210651|NCT01984476|vagal integrity|vagal integrity
1210652|NCT01984476|autonomic integrity|autonomic integrity
1210653|NCT01984476|arterial stiffness|arterial stiffness
1210654|NCT01984476|cognitive function|cognitive function
1210655|NCT01984476|traumatic brain injury|traumatic brain injury
1210656|NCT01984476|cerebral blood flow|cerebral blood flow
1210657|NCT01984476|white matter hyperintensities|white matter hyperintensities
1210658|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
1210659|NCT01984463|Postoperative pain|postoperative pain
1210660|NCT01984463|Shoulder pain|shoulder pain
1210661|NCT01984463|Thoracotomy|thoracotomy
1210662|NCT01984450|Articular cartilage|articular cartilage
1210663|NCT01984450|Autologous collagen|autologous collagen
1210664|NCT01984450|BMAC|bmac
1210665|NCT01984437|Vascular disease|vascular disease
1210666|NCT01984437|Minimally invasive treatment|minimally invasive treatment
1210667|NCT01984437|Endovascular treatment|endovascular treatment
1210668|NCT01984437|Magellan|magellan
1210669|NCT01984437|Robotic|robotic
1210670|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
1210671|NCT01984346|Atrial Fibrillation|atrial fibrillation
1210672|NCT01984346|Convergent Procedure|convergent procedure
1210673|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
1210674|NCT01984346|Hybrid Procedure|hybrid procedure
1210675|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
1210676|NCT01984346|Arrhythmia|arrhythmia
1210677|NCT01984346|RF Ablation|rf ablation
1210678|NCT01984333|trichotillomania|trichotillomania
1210679|NCT01984333|response inhibition|response inhibition
1210680|NCT01984333|cognitive retraining|cognitive retraining
1210681|NCT01984320|OHSS|ohss
1210682|NCT01984320|ICSI|icsi
1289551|NCT01627431|PAD|pad
1210683|NCT01984320|Coasting|coasting
1210684|NCT01984320|Cabergoline|cabergoline
1210685|NCT01984307|Acute coronary syndrome|acute coronary syndrome
1210686|NCT01984307|Myocardial infarction|myocardial infarction
1210687|NCT01984307|retrospective|retrospective
1210688|NCT01984307|cohort study|cohort study
1210689|NCT01984307|Healthcare resources utilization|healthcare resources utilization
1210690|NCT01984294|HCV genotype 1|hcv genotype 1
1210691|NCT01984294|HCV|hcv
1210692|NCT01984294|Sustained Virologic Response|sustained virologic response
1210693|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
1210694|NCT01984294|Combination Therapy|combination therapy
1210695|NCT01984294|GS-7977|gs-7977
1210696|NCT01984294|GS-5885|gs-5885
1210697|NCT01984294|Ribavirin|ribavirin
1210698|NCT01984294|Open Label|open label
1210699|NCT01984294|Sofosbuvir|sofosbuvir
1210700|NCT01984294|Treatment-Naive|treatment-naive
1210701|NCT01984294|Protease Inhibitors|protease inhibitors
1210702|NCT01984294|PI|pi
1210703|NCT01984294|Treatment experienced|treatment experienced
1210704|NCT01984294|Cirrhotic|cirrhotic
1210705|NCT01984281|Physical Activity|physical activity
1210706|NCT01984281|Pedometers|pedometers
1210707|NCT01984281|Quality of Life|quality of life
1210708|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
1210709|NCT01984268|ACTHAR|acthar
1210710|NCT01984268|Methotrexate|methotrexate
1210711|NCT01984268|Inadequate response|inadequate response
1210712|NCT01984203|Shoulder|shoulder
1210713|NCT01984203|Impingement|impingement
1210714|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
1210715|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
1210716|NCT01984203|Exercise|exercise
1210717|NCT01984203|Physiotherapy|physiotherapy
1210718|NCT01984190|venous thromboembolism|venous thromboembolism
1210719|NCT01984190|deep vein thrombosis|deep vein thrombosis
1210720|NCT01984190|pulmonary emboli|pulmonary emboli
1210721|NCT01984190|hip arthroplasty|hip arthroplasty
1210722|NCT01984190|knee arthroplasty|knee arthroplasty
1210723|NCT01984190|efficacy|efficacy
1210724|NCT01984190|mobile compression device|mobile compression device
1210725|NCT01984190|mechanical device|mechanical device
1210726|NCT01984190|prophylaxis.|prophylaxis.
1210727|NCT01984177|Cocaine|cocaine
1210728|NCT01984177|Substance-Related Disorders|substance-related disorders
1210729|NCT01984177|Drug Addiction|drug addiction
1210730|NCT01984177|Substance Addiction|substance addiction
1210731|NCT01984177|Dopamine|dopamine
1210732|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
1210733|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
1210734|NCT01984177|Stress, Psychological|stress, psychological
1210735|NCT01984177|Corticorelin|corticorelin
1210736|NCT01984177|Neuroendocrine System|neuroendocrine system
1210737|NCT01984177|Cortisol|cortisol
1210738|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
1210739|NCT01984177|Positron-Emission Tomography|positron-emission tomography
1210740|NCT01984177|11C-PHNO|11c-phno
1210741|NCT01984164|cerebrovascular function|cerebrovascular function
1210742|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
1210743|NCT01984138|breast cancer|breast cancer
1210744|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
1210745|NCT01984125|Provider prompts|provider prompts
1210746|NCT01984112|Humerus|humerus
1210747|NCT01984112|fracture|fracture
1210748|NCT01984112|nail|nail
1210749|NCT01984112|plate|plate
1210750|NCT01984112|tuberosity|tuberosity
1210751|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
1210752|NCT01984086|COPD|copd
1210753|NCT01984086|Asthma|asthma
1210754|NCT01984086|Respiratory|respiratory
1210755|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
1210756|NCT01984060|Aging|aging
1210757|NCT01984060|Physical Activity|physical activity
1210758|NCT01984060|Physical Function|physical function
1210760|NCT01984060|Frailty|frailty
1210761|NCT01984060|Autonomous Motivation|autonomous motivation
1210762|NCT01984060|Depression|depression
1210763|NCT01984047|safety|safety
1210764|NCT01984047|GSK3050002|gsk3050002
1210765|NCT01984047|CCR6 receptor|ccr6 receptor
1210766|NCT01984047|single dose escalation|single dose escalation
1210767|NCT01984047|Phase 1|phase 1
1210768|NCT01984047|CCL20|ccl20
1210769|NCT01984034|Educational outreach|educational outreach
1210770|NCT01984034|Academic detailing|academic detailing
1210771|NCT01984034|Guideline adherence|guideline adherence
1210772|NCT01984034|Family Practice|family practice
1210773|NCT01984034|Drug utilization|drug utilization
1210774|NCT01984034|Program evaluation|program evaluation
1210775|NCT01984034|Cost effectiveness|cost effectiveness
1210776|NCT01984021|Physical Therapy Modalities|physical therapy modalities
1210777|NCT01984021|Neck pain|neck pain
1210778|NCT01984021|Acupuncture|acupuncture
1210779|NCT01983995|Breast Cancer|breast cancer
1210780|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
1210781|NCT01983995|Actigraphy|actigraphy
1210782|NCT01983995|Pain|pain
1210784|NCT01983995|Sleep quality|sleep quality
1210785|NCT01983982|Breast Cancer|breast cancer
1210786|NCT01983982|Chemotherapy|chemotherapy
1211099|NCT01982838|pain|pain
1210787|NCT01983982|Chronic Pain|chronic pain
1210788|NCT01983982|Survivorship|survivorship
1210789|NCT01983969|Advanced Cancers|advanced cancers
1210790|NCT01983969|Lymphoma|lymphoma
1210791|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
1210792|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1210793|NCT01983969|Stem cell transplant|stem cell transplant
1210794|NCT01983969|Azacitidine|azacitidine
1210795|NCT01983969|5-azacytidine|5-azacytidine
1210796|NCT01983969|5-aza|5-aza
1210797|NCT01983969|Vidaza|vidaza
1210798|NCT01983969|5-AZC|5-azc
1210799|NCT01983969|AZA-CR|aza-cr
1210800|NCT01983969|Ladakamycin|ladakamycin
1210801|NCT01983969|NSC-102816|nsc-102816
1210802|NCT01983969|Azacytidine|azacytidine
1210803|NCT01983969|Vorinostat|vorinostat
1210804|NCT01983969|SAHA|saha
1210805|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1210806|NCT01983969|MSK-390|msk-390
1210807|NCT01983969|Zolinza|zolinza
1210808|NCT01983969|Gemcitabine|gemcitabine
1210809|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1210810|NCT01983969|Gemzar|gemzar
1210811|NCT01983969|Busulfan|busulfan
1210812|NCT01983969|Busulfex|busulfex
1210813|NCT01983969|Myleran|myleran
1210814|NCT01983969|Melphalan|melphalan
1210815|NCT01983969|Alkeran|alkeran
1210816|NCT01983969|Dexamethasone|dexamethasone
1210817|NCT01983969|Decadron|decadron
1210818|NCT01983969|Caphosol|caphosol
1210819|NCT01983969|Glutamine|glutamine
1210820|NCT01983969|Enterex|enterex
1210821|NCT01983969|Glutapak-10|glutapak-10
1210822|NCT01983969|NutreStore|nutrestore
1210823|NCT01983969|Resource|resource
1210824|NCT01983969|GlutaSolve|glutasolve
1210825|NCT01983969|Sympt-X G.I.|sympt-x g.i.
1210826|NCT01983969|Sympt-X|sympt-x
1210827|NCT01983969|Pyridoxine|pyridoxine
1210828|NCT01983969|Rituximab|rituximab
1210829|NCT01983969|Rituxan|rituxan
1210830|NCT01983956|early palliative care|early palliative care
1210831|NCT01983956|patient empowerment|patient empowerment
1210832|NCT01983956|cancer|cancer
1210833|NCT01983956|assessment|assessment
1210834|NCT01983956|end of life|end of life
1210835|NCT01983930|Memory impairment|memory impairment
1210836|NCT01983930|Meditation|meditation
1210837|NCT01983930|Yoga|yoga
1210838|NCT01983930|memory training|memory training
1210839|NCT01983930|Mild cognitive impairment|mild cognitive impairment
1210840|NCT01983930|MCI|mci
1210841|NCT01983930|geriatric|geriatric
1210842|NCT01983930|fMRI|fmri
1210843|NCT01983917|diabetes|diabetes
1210844|NCT01983917|mobile application|mobile application
1210845|NCT01983917|diabetic retinopathy|diabetic retinopathy
1210846|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
1210847|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
1210848|NCT01983891|food shelf|food shelf
1210849|NCT01983891|nutrition education|nutrition education
1210850|NCT01983891|cooking course|cooking course
1210851|NCT01983852|End of Life Care|end of life care
1210852|NCT01983852|Paediatric|paediatric
1210853|NCT01983852|Experiences|experiences
1210854|NCT01983852|Needs|needs
1210855|NCT01983852|Current Practices|current practices
1210856|NCT01983839|Moxifloxacin|moxifloxacin
1210857|NCT01983839|Pneumonia|pneumonia
1210858|NCT01983839|Pharmacokinetics|pharmacokinetics
1210859|NCT01983826|nitrates|nitrates
1210860|NCT01983826|blood flow|blood flow
1210861|NCT01983826|vascular function|vascular function
1210862|NCT01983826|exercise|exercise
1210863|NCT01983813|Diabetes|diabetes
1210864|NCT01983813|High Blood Pressure|high blood pressure
1210865|NCT01983813|High Cholesterol|high cholesterol
1210866|NCT01983813|Heart Irregularity|heart irregularity
1210867|NCT01983813|Stroke|stroke
1210868|NCT01983800|Mechanical Ventilation|mechanical ventilation
1210869|NCT01983800|Volatile Sedation|volatile sedation
1210870|NCT01983800|Intravenous Sedation|intravenous sedation
1210871|NCT01983800|Delirium|delirium
1210872|NCT01983787|Cystic Fibrosis|cystic fibrosis
1210873|NCT01983787|Continuous infusion|continuous infusion
1210874|NCT01983787|Pharmacokinetics|pharmacokinetics
1210875|NCT01983774|CF|cf
1210876|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
1210877|NCT01983735|TELMINUVO Tab.|telminuvo tab.
1210878|NCT01983735|CKD-828|ckd-828
1210879|NCT01983735|Hypertension|hypertension
1210880|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
1210881|NCT01983735|S-Amlodipine|s-amlodipine
1210882|NCT01983735|Telmisartan|telmisartan
1210883|NCT01983696|low oxygen tension|low oxygen tension
1210884|NCT01983696|embryo quality|embryo quality
1210885|NCT01983683|Clostridium difficile infection|clostridium difficile infection
1210886|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
1210887|NCT01983670|Pre-movement facilitation|pre-movement facilitation
1210888|NCT01983670|Fast goal directed movement|fast goal directed movement
1210889|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
1210890|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
1210891|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
1210892|NCT01983657|Pulmonary|pulmonary
1210893|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
1210894|NCT01983657|PAP|pap
1210895|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
1210896|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
1210897|NCT01983631|Whole body vibration|whole body vibration
1210898|NCT01983631|Reciprocal inhibition|reciprocal inhibition
1210899|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
1210900|NCT01983631|voluntary activation level|voluntary activation level
1210901|NCT01983618|Cerebral ischemia|cerebral ischemia
1210902|NCT01983618|Beachchair position|beachchair position
1210903|NCT01983618|Interscalene nerve block|interscalene nerve block
1210904|NCT01983592|Homeopathy|homeopathy
1210905|NCT01983592|Fatigue|fatigue
1210906|NCT01983592|Chemotherapy|chemotherapy
1210907|NCT01983592|Cancer|cancer
1210908|NCT01983553|Dengue Virus|dengue virus
1210909|NCT01983553|Dengue Fever|dengue fever
1210910|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1210911|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
1210912|NCT01983540|Diphtheria|diphtheria
1210913|NCT01983540|Tetanus|tetanus
1210914|NCT01983540|Whooping Cough|whooping cough
1210915|NCT01983540|Hepatitis B|hepatitis b
1210916|NCT01983540|Poliomyelitis|poliomyelitis
1210917|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
1210918|NCT01983527|Arthrographic distention|arthrographic distention
1210919|NCT01983527|Hydrodilatation|hydrodilatation
1210920|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
1210921|NCT01983514|oxytocin|oxytocin
1210922|NCT01983514|fMRI|fmri
1210923|NCT01983514|social cognition|social cognition
1210924|NCT01983514|heart rate variability|heart rate variability
1210925|NCT01983514|pupillometry|pupillometry
1210926|NCT01983514|eye tracking|eye tracking
1210927|NCT01983501|ONT-380|ont-380
1210928|NCT01983501|T-DM1|t-dm1
1210929|NCT01983501|Kadcyla|kadcyla
1210930|NCT01983501|HER2 positive breast cancer|her2 positive breast cancer
1210931|NCT01983501|Breast cancer|breast cancer
1210932|NCT01983501|ARRY-380|arry-380
1210933|NCT01983501|Tucatinib|tucatinib
1211036|NCT01983137|opioid|opioid
1210934|NCT01983501|Tucatinib (ONT-380)|tucatinib (ont-380)
1210935|NCT01983488|Uveitis|uveitis
1210936|NCT01983488|Vision Loss|vision loss
1210937|NCT01983475|Spinal Cord Injury|spinal cord injury
1210938|NCT01983475|Denosumab|denosumab
1210939|NCT01983475|Osteoporosis|osteoporosis
1210940|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
1210941|NCT01983462|Prehypertension|prehypertension
1210942|NCT01983462|Hypertension|hypertension
1210943|NCT01983462|Obese|obese
1210944|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
1210945|NCT01983462|renin-angiotensin system|renin-angiotensin system
1210946|NCT01983462|Endothelial function|endothelial function
1210947|NCT01983449|Adventitia|adventitia
1210948|NCT01983449|Peripheral Artery Disease|peripheral artery disease
1210949|NCT01983449|Restenosis|restenosis
1210950|NCT01983449|Inflammation|inflammation
1210951|NCT01983449|Anti-Inflammatory|anti-inflammatory
1210952|NCT01983449|Dexamethasone|dexamethasone
1210953|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
1210954|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
1210955|NCT01983423|Endometrial Biopsy|endometrial biopsy
1210956|NCT01983423|Endometrial Sampling|endometrial sampling
1210957|NCT01983423|In Vitro Fertilization|in vitro fertilization
1210958|NCT01983423|Pregnancy|pregnancy
1210959|NCT01983423|Implantation|implantation
1210960|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
1210961|NCT01983410|PDAC carriers|pdac carriers
1210962|NCT01983410|BRCAmut carriers|brcamut carriers
1210963|NCT01983410|Registry|registry
1210964|NCT01983410|13-217|13-217
1210965|NCT01983397|aged, 80 and over|aged, 80 and over
1210966|NCT01983397|Exercise|exercise
1210967|NCT01983397|Cognition|cognition
1210968|NCT01983397|Balance|balance
1210969|NCT01983397|Randomized controlled trial|randomized controlled trial
1210970|NCT01983384|Delirium|delirium
1210971|NCT01983384|Cognition|cognition
1210972|NCT01983384|Surgery|surgery
1210973|NCT01983384|Anesthesia|anesthesia
1210974|NCT01983384|Aging|aging
1210975|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
1210976|NCT01983345|Myelomeningocele|myelomeningocele
1210977|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
1210978|NCT01983345|Spina bifida|spina bifida
1210979|NCT01983332|MDACC|mdacc
1210980|NCT01983332|MOHO|moho
1210981|NCT01983306|Constipation|constipation
1210982|NCT01983306|Opioid|opioid
1210983|NCT01983306|GC C Agonist|gc c agonist
1210984|NCT01983306|Pain|pain
1210985|NCT01983293|Non-left bundle branch block|non-left bundle branch block
1210987|NCT01983293|LV lead pacing location|lv lead pacing location
1210988|NCT01983293|CRT-D|crt-d
1210989|NCT01983280|polysomnography|polysomnography
1210990|NCT01983280|sleep|sleep
1210991|NCT01983280|healing touch|healing touch
1210992|NCT01983280|pediatric burn|pediatric burn
1210993|NCT01983254|coping|coping
1210994|NCT01983254|acute respiratory failure|acute respiratory failure
1210995|NCT01983254|critical illness|critical illness
1210996|NCT01983254|depression|depression
1210997|NCT01983254|anxiety|anxiety
1210998|NCT01983254|post-traumatic stress|post-traumatic stress
1210999|NCT01983254|intensive care unit|intensive care unit
1211000|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
1211001|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1211002|NCT01983241|AATD|aatd
1211003|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
1211004|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
1211005|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
1211006|NCT01983228|Walking|walking
1211007|NCT01983228|African American|african american
1211008|NCT01983228|Telephone Coaching|telephone coaching
1211009|NCT01983228|Pedometer|pedometer
1211010|NCT01983215|groin incisions|groin incisions
1211011|NCT01983202|PCOS|pcos
1211012|NCT01983202|Pregnancy|pregnancy
1211013|NCT01983202|Obstetric|obstetric
1211014|NCT01983189|TMS|tms
1211015|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
1211016|NCT01983189|rTMS|rtms
1211017|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
1211018|NCT01983189|fMRI|fmri
1211019|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
1211020|NCT01983176|Parotid tumor|parotid tumor
1211021|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
1211022|NCT01983176|Facial palsy|facial palsy
1211023|NCT01983150|Population Health|population health
1211024|NCT01983150|Smoking cessation|smoking cessation
1211025|NCT01983150|Young adults|young adults
1211026|NCT01983150|Cancer prevention|cancer prevention
1211027|NCT01983150|Tobacco control strategies|tobacco control strategies
1211028|NCT01983150|Behaviour modification|behaviour modification
1211029|NCT01983150|Social Media|social media
1211030|NCT01983150|Smartphone technology|smartphone technology
1211031|NCT01983137|Chronic pain|chronic pain
1211032|NCT01983137|Severe pain|severe pain
1211033|NCT01983137|oxycodon|oxycodon
1211034|NCT01983137|naloxon|naloxon
1211035|NCT01983137|opioid-induced constipation|opioid-induced constipation
1211037|NCT01983137|quality of life|quality of life
1211038|NCT01983137|laxative|laxative
1211039|NCT01983137|analgesic rescue medication|analgesic rescue medication
1211040|NCT01983124|Advanced Melanoma|advanced melanoma
1211041|NCT01983098|Colorectal cancer|colorectal cancer
1211042|NCT01983098|Metastatic|metastatic
1211043|NCT01983098|Circulating tumor DNA|circulating tumor dna
1211044|NCT01983098|Biomaker|biomaker
1211045|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
1211046|NCT01983085|Nitric oxide|nitric oxide
1211047|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
1211048|NCT01983085|Burns|burns
1211049|NCT01983085|Skin graft donor sites|skin graft donor sites
1211050|NCT01983085|Improved healing|improved healing
1211051|NCT01983085|Vasodilation|vasodilation
1211052|NCT01983085|Angiogenesis|angiogenesis
1211053|NCT01983085|Anti-microbial|anti-microbial
1211054|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
1211055|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
1211056|NCT01982994|Physical Activity Education|physical activity education
1211057|NCT01982994|Caregivers|caregivers
1211058|NCT01982981|perception|perception
1211059|NCT01982981|wellbeing|wellbeing
1211060|NCT01982981|plain water|plain water
1211061|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1211062|NCT01982968|IPF|ipf
1211063|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
1211064|NCT01982968|GER|ger
1211065|NCT01982968|GERD|gerd
1211066|NCT01982955|MSC2156119J|msc2156119j
1211067|NCT01982955|Gefitinib|gefitinib
1211068|NCT01982955|Pemetrexed|pemetrexed
1211069|NCT01982955|Cisplatin|cisplatin
1211070|NCT01982955|MET positive|met positive
1211071|NCT01982955|Tepotinib|tepotinib
1211072|NCT01982955|Carboplatin|carboplatin
1211073|NCT01982955|INSIGHT|insight
1211074|NCT01982916|Allergic Rhinitis|allergic rhinitis
1211075|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
1211076|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
1211077|NCT01982916|PAR|par
1211078|NCT01982903|kidney transplantation|kidney transplantation
1211079|NCT01982903|connective tissue growth factor|connective tissue growth factor
1211080|NCT01982903|fibrosis|fibrosis
1211081|NCT01982890|Telomere length|telomere length
1211082|NCT01982890|Longitudinal observation|longitudinal observation
1211083|NCT01982877|decision making|decision making
1211084|NCT01982877|values elicitation|values elicitation
1211085|NCT01982877|patient centered care|patient centered care
1211086|NCT01982877|Four Supports|four supports
1211087|NCT01982877|Family Support|family support
1211088|NCT01982864|Aminoglycosides|aminoglycosides
1211089|NCT01982864|hemodialysis|hemodialysis
1211090|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
1211091|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
1211092|NCT01982864|Bayesian estimation|bayesian estimation
1211093|NCT01982864|Necessity|necessity
1211094|NCT01982864|of the treatment|of the treatment
1211095|NCT01982864|gentamicin|gentamicin
1211096|NCT01982851|pain|pain
1211097|NCT01982851|epidural|epidural
1211098|NCT01982851|combined spinal epidural|combined spinal epidural
1211100|NCT01982838|epidural|epidural
1211101|NCT01982838|combined spinal epidural|combined spinal epidural
1211102|NCT01982825|Tobacco use cessation|tobacco use cessation
1211103|NCT01982825|Cigarette smoking|cigarette smoking
1211104|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
1211105|NCT01982773|Virtual Hope Box|virtual hope box
1211106|NCT01982760|Rhinoplasty|rhinoplasty
1211107|NCT01982760|Ecchymosis|ecchymosis
1211108|NCT01982760|Edema|edema
1211109|NCT01982747|Cardiac Safety|cardiac safety
1211110|NCT01982747|General Safety|general safety
1211111|NCT01982747|Pharmacokinetics|pharmacokinetics
1211112|NCT01982734|bioavailability|bioavailability
1211113|NCT01982734|curcumin|curcumin
1211114|NCT01982734|pharmacokinetic|pharmacokinetic
1211115|NCT01982734|curcuma longa|curcuma longa
1211116|NCT01982734|age differences|age differences
1211117|NCT01982734|sex differences|sex differences
1211118|NCT01982708|Evaluation|evaluation
1211119|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
1211120|NCT01982695|Cardiomyopathy|cardiomyopathy
1211121|NCT01982695|Losartan|losartan
1211122|NCT01982695|Lisinopril|lisinopril
1211123|NCT01982669|Salty taste|salty taste
1211124|NCT01982669|Urinary sodium excretion|urinary sodium excretion
1211125|NCT01982669|Spicy hedonic|spicy hedonic
1211126|NCT01982669|Blood pressure|blood pressure
1211127|NCT01982617|Transtheoretical Model|transtheoretical model
1211128|NCT01982617|Stages of Change|stages of change
1211129|NCT01982617|Nicotine Dependence|nicotine dependence
1211130|NCT01982617|Severe Mental Illness|severe mental illness
1211131|NCT01982578|Treatment|treatment
1211132|NCT01982578|Genistein|genistein
1211133|NCT01982578|Alzheimer's disease|alzheimer's disease
1211134|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
1211135|NCT01982578|Amyloid beta|amyloid beta
1211136|NCT01982565|Nitric oxide|nitric oxide
1211137|NCT01982565|Nitric oxide dressing|nitric oxide dressing
1211138|NCT01982565|NOx|nox
1211139|NCT01982565|NOx dressing|nox dressing
1211140|NCT01982565|Diabetic|diabetic
1211141|NCT01982565|Foot|foot
1211142|NCT01982565|Ulcers|ulcers
1211143|NCT01982565|Chronic|chronic
1211144|NCT01982552|Plaque psoriasis|plaque psoriasis
1211145|NCT01982552|calcipotriene|calcipotriene
1211146|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
1211147|NCT01982552|topical|topical
1211148|NCT01982539|pain|pain
1211149|NCT01982539|NSAID|nsaid
1211150|NCT01982539|moderate pain|moderate pain
1211151|NCT01982539|mild pain|mild pain
1211152|NCT01982539|acute pain|acute pain
1211153|NCT01982539|mild acute pain|mild acute pain
1211154|NCT01982539|moderate acute pain|moderate acute pain
1211155|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
1211156|NCT01982526|Ovarian reserve|ovarian reserve
1211157|NCT01982526|Antimullerian hormone|antimullerian hormone
1211158|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1211159|NCT01982513|Pregnancy|pregnancy
1211160|NCT01982513|Ultrasound|ultrasound
1211161|NCT01982513|Inferior Vena Cava|inferior vena cava
1211162|NCT01982500|Ovarian Cancer|ovarian cancer
1211163|NCT01982500|Chemotherapy|chemotherapy
1211164|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
1211165|NCT01982500|Bevacizumab|bevacizumab
1211166|NCT01982500|Front Line|front line
1211167|NCT01982474|allergic rhinitis|allergic rhinitis
1211168|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
1211169|NCT01982448|CISPLATIN|cisplatin
1211170|NCT01982448|PACLITAXEL|paclitaxel
1211171|NCT01982435|Diabetes|diabetes
1211172|NCT01982435|Macular Edema|macular edema
1211173|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
1211174|NCT01982422|Nutrition|nutrition
1211175|NCT01982422|Diet|diet
1211176|NCT01982422|Developmental Origins of Disease|developmental origins of disease
1211177|NCT01982396|HIV|hiv
1211178|NCT01982396|paediatric|paediatric
1211179|NCT01982396|Abacavir|abacavir
1211180|NCT01982396|lamivudine|lamivudine
1211181|NCT01982383|CSC|csc
1211182|NCT01982383|Edema|edema
1211183|NCT01982383|Retinopathy|retinopathy
1211184|NCT01982344|mini-exchange-room|mini-exchange-room
1211185|NCT01982344|physical activity|physical activity
1211186|NCT01982344|quality of life|quality of life
1211187|NCT01982344|peritoneal dialysis|peritoneal dialysis
1211188|NCT01982331|H2N2|h2n2
1211189|NCT01982331|vaccine|vaccine
1211190|NCT01982318|Venous Leg Ulcer|venous leg ulcer
1211191|NCT01982318|Leg Ulcer|leg ulcer
1211192|NCT01982318|Venous Hypertension|venous hypertension
1587736|NCT00439387|Serotonin|serotonin
1211193|NCT01982318|Venous Reflux|venous reflux
1211194|NCT01982318|Deep Venous System|deep venous system
1211195|NCT01982318|Chronic leg ulceration|chronic leg ulceration
1211196|NCT01982318|Calf perforator|calf perforator
1211197|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
1211198|NCT01982279|Caloric compensation|caloric compensation
1211301|NCT01981902|Dehydration|dehydration
1211199|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
1211200|NCT01982279|Preschool children|preschool children
1211201|NCT01982279|Maternal feeding practices|maternal feeding practices
1211202|NCT01982279|Maternal eating behavior|maternal eating behavior
1211203|NCT01982279|one year|one year
1211204|NCT01982279|children|children
1211205|NCT01982253|Drug therapy|drug therapy
1211206|NCT01982240|CIC|cic
1211207|NCT01982240|Constipation|constipation
1211208|NCT01982240|Chronic Constipation|chronic constipation
1211209|NCT01982240|Synergy|synergy
1211210|NCT01982240|Plecanatide|plecanatide
1211211|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
1211212|NCT01982227|indocyanine green|indocyanine green
1211213|NCT01982214|osteopenia|osteopenia
1211214|NCT01982214|whole body vibration|whole body vibration
1211215|NCT01982214|women|women
1211216|NCT01982214|bone microarchitecture|bone microarchitecture
1211217|NCT01982214|bone density|bone density
1211218|NCT01982188|single incision sling|single incision sling
1211219|NCT01982188|cough stress test|cough stress test
1211220|NCT01982188|MiniArc|miniarc
1211221|NCT01982188|UDI-6|udi-6
1211222|NCT01982188|UIQ-7|uiq-7
1211223|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
1211224|NCT01982175|Alemtuzumab|alemtuzumab
1211225|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1211226|NCT01982175|CD52|cd52
1211227|NCT01982162|Sputum|sputum
1211228|NCT01982162|Clinical cohorts|clinical cohorts
1211229|NCT01982162|Smokers|smokers
1211230|NCT01982162|Asthma|asthma
1211231|NCT01982162|Biopsies|biopsies
1211232|NCT01982162|Severe asthma|severe asthma
1211233|NCT01982162|Collaborative research|collaborative research
1211234|NCT01982162|Phenotyping|phenotyping
1211235|NCT01982162|Lipidomics|lipidomics
1211236|NCT01982162|Transcriptomics|transcriptomics
1211237|NCT01982162|Proteomics|proteomics
1211238|NCT01982162|Paediatric cohort|paediatric cohort
1211239|NCT01982162|Systems Biology|systems biology
1211445|NCT01981382|genes|genes
1211240|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1211241|NCT01982149|COPD|copd
1211242|NCT01982149|Smokers|smokers
1211243|NCT01982149|Nonsmokers|nonsmokers
1211244|NCT01982110|smoking cessation|smoking cessation
1211245|NCT01982110|mindfulness|mindfulness
1211246|NCT01982110|behavioral intervention|behavioral intervention
1211247|NCT01982097|Non-interventional|non-interventional
1211248|NCT01982097|Nexavar|nexavar
1211249|NCT01982097|Sorafenib|sorafenib
1211250|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
1211251|NCT01982097|Neoadjuvant|neoadjuvant
1211252|NCT01982097|Nephrectomy|nephrectomy
1211253|NCT01982097|Russian Federation|russian federation
1211254|NCT01982084|Group B streptococcus|group b streptococcus
1211255|NCT01982084|Immunisation|immunisation
1211256|NCT01982084|Pregnancy|pregnancy
1211257|NCT01982084|Attitudes|attitudes
1211258|NCT01982071|Micafungin|micafungin
1211259|NCT01982071|candidiasis|candidiasis
1211260|NCT01982071|candidemia|candidemia
1211261|NCT01982071|Open-label design|open-label design
1211262|NCT01982045|Bone graft|bone graft
1211263|NCT01982045|Ceramic|ceramic
1211264|NCT01982045|Spinal fusion|spinal fusion
1211265|NCT01982045|RCT|rct
1211266|NCT01982045|Thoracolumbar region|thoracolumbar region
1211267|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
1211268|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
1211269|NCT01982032|Cardiac MRI|cardiac mri
1211270|NCT01982019|26RFa|26rfa
1211271|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
1211272|NCT01982019|diabetes|diabetes
1211273|NCT01982019|obesity|obesity
1211274|NCT01982006|cataract surgery|cataract surgery
1211275|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
1211276|NCT01982006|phacoemulsification|phacoemulsification
1211277|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
1211278|NCT01982006|Cost Effectiveness|cost effectiveness
1211279|NCT01982006|Hospital Costs|hospital costs
1211280|NCT01981980|Carbon dioxide|carbon dioxide
1211281|NCT01981980|Carboxytherapy|carboxytherapy
1211282|NCT01981980|Radiofrequency|radiofrequency
1211283|NCT01981967|Japanese encephalitis|japanese encephalitis
1211284|NCT01981967|IMOJEV®|imojev®
1211285|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1211286|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
1211287|NCT01981954|Efficacy|efficacy
1211288|NCT01981954|Safety|safety
1211289|NCT01981941|Gabapentin|gabapentin
1211290|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
1211291|NCT01981928|Phase 1|phase 1
1211292|NCT01981928|Healthy Subjects|healthy subjects
1211293|NCT01981928|Safety|safety
1211294|NCT01981928|Tolerability|tolerability
1211295|NCT01981928|Pharmacokinetics|pharmacokinetics
1211296|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
1211297|NCT01981928|Food Effect|food effect
1211298|NCT01981915|Cough augmentation|cough augmentation
1211299|NCT01981915|Peak cough flow|peak cough flow
1211300|NCT01981915|hyperinsufflation|hyperinsufflation
1211302|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
1211303|NCT01981876|Dysplasia|dysplasia
1211304|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1211305|NCT01981863|cardiac surgery|cardiac surgery
1211306|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
1211307|NCT01981863|fibrinolysis|fibrinolysis
1211308|NCT01981863|thromboelastography|thromboelastography
1211309|NCT01981863|D-Dimers|d-dimers
1211310|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
1211311|NCT01981850|fibrosis|fibrosis
1211312|NCT01981837|RNAi therapeutic|rnai therapeutic
1211313|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
1211314|NCT01981811|OPC-14597 Digital|opc-14597 digital
1211315|NCT01981811|Aripiprazole|aripiprazole
1211316|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
1211317|NCT01981811|Treatment Adherence|treatment adherence
1211318|NCT01981811|Ingestible Event Marker|ingestible event marker
1211319|NCT01981798|outpatient intervention program|outpatient intervention program
1211320|NCT01981798|behavioral therapy approach|behavioral therapy approach
1211321|NCT01981798|unspecific back pain|unspecific back pain
1211322|NCT01981798|unspecific neck pain|unspecific neck pain
1211323|NCT01981798|chronic pain|chronic pain
1211324|NCT01981798|physiotherapy|physiotherapy
1211325|NCT01981798|occupational therapy|occupational therapy
1211326|NCT01981798|psychosocial aspects|psychosocial aspects
1211327|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
1211458|NCT01981343|Betaine|betaine
1211328|NCT01981798|health-related quality of life|health-related quality of life
1211329|NCT01981785|Primary immune deficiencies|primary immune deficiencies
1211330|NCT01981785|Autoimmune diseases|autoimmune diseases
1211331|NCT01981785|Inflammatory diseases|inflammatory diseases
1211332|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
1211333|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
1211334|NCT01981785|Immunoglobulin|immunoglobulin
1211335|NCT01981785|IgG|igg
1211336|NCT01981785|IVIG|ivig
1211337|NCT01981785|Recurrent Infections|recurrent infections
1211338|NCT01981759|Schizophrenia|schizophrenia
1211339|NCT01981759|Delusions|delusions
1211340|NCT01981759|D-Cycloserine|d-cycloserine
1211341|NCT01981759|CBT|cbt
1211342|NCT01981746|adductor canal block|adductor canal block
1211343|NCT01981746|healthy volunteers|healthy volunteers
1211344|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
1211345|NCT01981746|lower limb|lower limb
1211346|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
1211347|NCT01981720|PRX-102|prx-102
1211348|NCT01981720|pegunigalsidase alfa|pegunigalsidase alfa
1211349|NCT01981720|Fabry Disease|fabry disease
1211350|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
1211351|NCT01981707|abiraterone acetate|abiraterone acetate
1211352|NCT01981707|enzalutamide|enzalutamide
1211353|NCT01981707|choline pet|choline pet
1211354|NCT01981694|Phase 1|phase 1
1211355|NCT01981694|Randomized|randomized
1211356|NCT01981694|Double Blind|double blind
1211357|NCT01981694|Placebo-Controlled|placebo-controlled
1211358|NCT01981694|Single-Dose Escalation|single-dose escalation
1211359|NCT01981694|Safety|safety
1211360|NCT01981694|Tolerability|tolerability
1211361|NCT01981694|PK|pk
1211362|NCT01981694|PD|pd
1211363|NCT01981694|PF-06649751|pf-06649751
1211364|NCT01981681|Phase 1|phase 1
1211365|NCT01981681|Randomized|randomized
1211366|NCT01981681|Placebo-Controlled|placebo-controlled
1211367|NCT01981681|Multiple Dose Escalation|multiple dose escalation
1211368|NCT01981681|Tolerability|tolerability
1211369|NCT01981681|Safety|safety
1211370|NCT01981681|PK|pk
1211371|NCT01981681|Topical|topical
1211372|NCT01981681|Healthy|healthy
1211373|NCT01981681|PF-06263276|pf-06263276
1211374|NCT01981655|Sodium Lactate|sodium lactate
1211375|NCT01981655|Acute|acute
1211376|NCT01981655|Heart|heart
1211377|NCT01981655|Failure|failure
1211378|NCT01981655|Perfusion|perfusion
1211379|NCT01981629|Shock|shock
1211380|NCT01981629|USCOM|uscom
1211381|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
1211382|NCT01981629|Emergency Department|emergency department
1211383|NCT01981616|Drug therapy|drug therapy
1211384|NCT01981603|Navigators|navigators
1211385|NCT01981603|Kidney Transplant|kidney transplant
1211386|NCT01981603|Hemodialysis|hemodialysis
1211387|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
1211388|NCT01981577|Parkinson Disease|parkinson disease
1211389|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
1211390|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
1211391|NCT01981577|Functional connectivity|functional connectivity
1211392|NCT01981577|Structural connectivity|structural connectivity
1211393|NCT01981564|Pediatric|pediatric
1211394|NCT01981564|Emergency department visit|emergency department visit
1211395|NCT01981551|Desmoid Tumor|desmoid tumor
1211396|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
1211397|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
1211398|NCT01981551|Notch Pathway|notch pathway
1211399|NCT01981538|Web-Based Survey|web-based survey
1211400|NCT01981538|Cancer Caregivers|cancer caregivers
1211401|NCT01981525|TP53 Mutation|tp53 mutation
1211402|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
1211403|NCT01981525|Chemoprevention|chemoprevention
1211404|NCT01981499|PF-05180999|pf-05180999
1211405|NCT01981499|safety|safety
1211406|NCT01981499|tolerability|tolerability
1211407|NCT01981499|pharmacokinetics|pharmacokinetics
1211408|NCT01981499|histamine|histamine
1211409|NCT01981499|wheal|wheal
1211410|NCT01981499|flare|flare
1211411|NCT01981499|migraine|migraine
1211412|NCT01981499|PDE2|pde2
1211413|NCT01981486|PF-05180999|pf-05180999
1211414|NCT01981486|safety|safety
1211415|NCT01981486|tolerability|tolerability
1211416|NCT01981486|pharmacokinetics|pharmacokinetics
1211417|NCT01981486|migraine|migraine
1211418|NCT01981486|PDE2|pde2
1211419|NCT01981486|cAMP|camp
1211420|NCT01981486|cGMP|cgmp
1211421|NCT01981486|cantharidin|cantharidin
1211422|NCT01981486|blister|blister
1211423|NCT01981486|CYP3A induction|cyp3a induction
1211424|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
1211425|NCT01981473|etanercept|etanercept
1211426|NCT01981473|adalimumab|adalimumab
1211427|NCT01981473|infliximab|infliximab
1211428|NCT01981473|anti-drug antibody|anti-drug antibody
1211429|NCT01981473|immunogenicity|immunogenicity
1211430|NCT01981473|drug concentration|drug concentration
1211431|NCT01981447|epilepsy|epilepsy
1211432|NCT01981421|Liver fibrosis|liver fibrosis
1211433|NCT01981421|Elastography|elastography
1211434|NCT01981421|MR Elastography|mr elastography
1211435|NCT01981421|Quantitative imaging|quantitative imaging
1211436|NCT01981395|fenobam|fenobam
1211437|NCT01981395|heat|heat
1211438|NCT01981395|capsaicin|capsaicin
1211439|NCT01981395|hyperalgesia|hyperalgesia
1211440|NCT01981395|allodynia|allodynia
1211441|NCT01981395|mood|mood
1211442|NCT01981395|cognitive function|cognitive function
1211443|NCT01981382|low back pain|low back pain
1211444|NCT01981382|pain sensitivity|pain sensitivity
1211446|NCT01981382|gene expression,|gene expression,
1211447|NCT01981382|quantitative sensory testing|quantitative sensory testing
1211448|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
1211449|NCT01981369|Regional Anesthesia|regional anesthesia
1211450|NCT01981369|Infraclavicular block|infraclavicular block
1211451|NCT01981356|Psychotic Disorders|psychotic disorders
1211452|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
1211453|NCT01981356|Inpatient psychiatry|inpatient psychiatry
1211454|NCT01981356|Schizophrenia|schizophrenia
1211455|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
1211456|NCT01981343|Gallbladder motility|gallbladder motility
1211457|NCT01981343|A-F Betafood|a-f betafood
1211459|NCT01981343|Ejection fraction|ejection fraction
1211460|NCT01981343|Ejection rate|ejection rate
1211461|NCT01981343|Ultrasound|ultrasound
1211462|NCT01981330|vocal fold scarring|vocal fold scarring
1211463|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
1211464|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
1211465|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
1211466|NCT01981317|Stepped Care CBT|stepped care cbt
1211467|NCT01981317|Exposure and Response Prevention|exposure and response prevention
1211468|NCT01981317|Psychotherapy|psychotherapy
1211469|NCT01981317|Counseling|counseling
1211470|NCT01981304|Coronary artery disease|coronary artery disease
1211471|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
1211472|NCT01981291|Lower Extremity|lower extremity
1211473|NCT01981291|Sciatic Nerve|sciatic nerve
1211474|NCT01981291|Anesthesia, Regional|anesthesia, regional
1211475|NCT01981291|Anesthetics, Local|anesthetics, local
1211476|NCT01981291|Mepivacaine|mepivacaine
1211477|NCT01981291|Ultrasonography|ultrasonography
1211478|NCT01981278|Healthy|healthy
1211479|NCT01981278|Tapentadol|tapentadol
1211480|NCT01981278|Bioequivalence|bioequivalence
1211481|NCT01981278|Fasted|fasted
1211482|NCT01981252|Ulthera® System|ulthera® system
1211483|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
1211484|NCT01981252|Ulthera, Inc.|ulthera, inc.
1211485|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
1211486|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
1211487|NCT01981213|Acetaminophen|acetaminophen
1211488|NCT01981213|Suicide|suicide
1211489|NCT01981213|Attempts|attempts
1333260|NCT01443780|elderly population|elderly population
1211490|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
1211491|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
1211492|NCT01981200|COPD acute exacerbation|copd acute exacerbation
1211493|NCT01981200|Physiotherapy|physiotherapy
1211494|NCT01981200|Resistance training|resistance training
1211495|NCT01981200|Muscle strength|muscle strength
1211496|NCT01981200|Handheld dynamometer|handheld dynamometer
1211497|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
1211498|NCT01981161|JC virus|jc virus
1211499|NCT01981161|Zoster infection|zoster infection
1211500|NCT01981135|Controlled Human exposure study|controlled human exposure study
1211501|NCT01981135|Air Pollution|air pollution
1211502|NCT01981135|Temperature|temperature
1211503|NCT01981135|Lung Function|lung function
1211504|NCT01981135|Cardiovascular|cardiovascular
1211505|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
1211506|NCT01981096|pain in children|pain in children
1211507|NCT01981096|musculoskeletal pain|musculoskeletal pain
1211508|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
1211509|NCT01981096|coping skills training|coping skills training
1211510|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
1211511|NCT01981083|Chronic Kidney Disease|chronic kidney disease
1211512|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
1211513|NCT01981083|Subjective Global Assessment|subjective global assessment
1211514|NCT01981083|Hemodialysis|hemodialysis
1211515|NCT01981083|Egg albumin|egg albumin
1211516|NCT01981070|parent support|parent support
1211517|NCT01981070|mindfulness|mindfulness
1211518|NCT01981070|intellectual disability|intellectual disability
1211519|NCT01981070|developmental disability|developmental disability
1211520|NCT01981070|empowerment|empowerment
1211521|NCT01981070|psychological acceptance|psychological acceptance
1211522|NCT01981070|parental stress|parental stress
1211523|NCT01981070|parental depression|parental depression
1211524|NCT01981057|parenteral nutrition|parenteral nutrition
1211525|NCT01981057|Numeta|numeta
1211526|NCT01981057|prescription software Cato Pan|prescription software cato pan
1211527|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
1211528|NCT01980992|Food Allergy|food allergy
1211529|NCT01980992|Wheat Allergy|wheat allergy
1211530|NCT01980992|Oral Immunotherapy|oral immunotherapy
1211531|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
1211532|NCT01980927|Migraine|migraine
1211533|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
1211534|NCT01980914|hypoglycemia|hypoglycemia
1211535|NCT01980914|type 2 diabetes|type 2 diabetes
1211536|NCT01980914|insulin glargine|insulin glargine
1211537|NCT01980914|cardiac function|cardiac function
1211538|NCT01980914|myocardial ischemia|myocardial ischemia
1211539|NCT01980914|cardiac rhythm|cardiac rhythm
1211540|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
1211542|NCT01980849|Nadroparin|nadroparin
1211543|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1211544|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
1211545|NCT01980836|Tocilizumab|tocilizumab
1211546|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
1211547|NCT01980823|Breast Cancer|breast cancer
1211548|NCT01980823|Metformin|metformin
1211549|NCT01980823|Atorvastatin|atorvastatin
1211550|NCT01980823|Ki-67|ki-67
1211551|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
1211552|NCT01980797|Thoracic aortic disease|thoracic aortic disease
1211553|NCT01980797|Genetics|genetics
1211554|NCT01980797|Echocardiography|echocardiography
1211555|NCT01980797|Cardiac CT|cardiac ct
1211556|NCT01980797|Cardiac MRI|cardiac mri
1211557|NCT01980784|Spinal Cord Injury|spinal cord injury
1211558|NCT01980771|HIV|hiv
1211559|NCT01980771|prevention|prevention
1211560|NCT01980771|men|men
1211561|NCT01980771|African American|african american
1211562|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
1211563|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
1211564|NCT01980745|recurrence|recurrence
1211565|NCT01980745|treatment withdrawal|treatment withdrawal
1211566|NCT01980745|chloroquine|chloroquine
1211567|NCT01980745|maintenance of remission|maintenance of remission
1211568|NCT01980706|Baclofen|baclofen
1211569|NCT01980706|Alcohol Dependence|alcohol dependence
1211570|NCT01980667|lurbinectedin|lurbinectedin
1211571|NCT01980667|PM01183|pm01183
1211572|NCT01980667|tumors|tumors
1211573|NCT01980667|cancer|cancer
1211574|NCT01980667|Pharma Mar|pharma mar
1211575|NCT01980654|Pharmacyclics|pharmacyclics
1211576|NCT01980654|PCYC|pcyc
1211577|NCT01980654|Lymphoma|lymphoma
1211578|NCT01980654|Follicular Lymphoma|follicular lymphoma
1211579|NCT01980654|FL|fl
1211580|NCT01980654|Rituximab|rituximab
1211581|NCT01980654|Ibrutinib|ibrutinib
1211583|NCT01980654|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1211584|NCT01980654|NHL|nhl
1211585|NCT01980654|B-cell Lymphoma|b-cell lymphoma
1211586|NCT01980641|Stroke|stroke
1211587|NCT01980641|ADL|adl
1211588|NCT01980641|mHealth|mhealth
1211589|NCT01980641|App|app
1211590|NCT01980641|Adherence|adherence
1211591|NCT01980641|Home|home
1211592|NCT01980641|Environment|environment
1211593|NCT01980641|Tool|tool
1211594|NCT01980641|Advice|advice
1211595|NCT01980641|Smartphone|smartphone
1211596|NCT01980628|MZL|mzl
1211597|NCT01980628|NHL|nhl
1211598|NCT01980628|SMZL|smzl
1211599|NCT01980628|NMZL|nmzl
1211600|NCT01980628|MALT|malt
1211601|NCT01980602|Intermittent claudication|intermittent claudication
1211602|NCT01980602|endothelial function|endothelial function
1211603|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
1211604|NCT01980602|inflammation|inflammation
1211605|NCT01980602|muscle architecture|muscle architecture
1211606|NCT01980589|multiple myeloma|multiple myeloma
1211607|NCT01980576|Pain|pain
1211608|NCT01980576|Sensitization|sensitization
1211609|NCT01980576|Spondylitis|spondylitis
1211610|NCT01980485|smoker|smoker
1211611|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
1211612|NCT01980446|Coma|coma
1211613|NCT01980446|Cardiac arrest|cardiac arrest
1211614|NCT01980446|Neurophysiology|neurophysiology
1211615|NCT01980446|Auditory evoked potential|auditory evoked potential
1211616|NCT01980433|Wilson disease|wilson disease
1211617|NCT01980433|Dystonia|dystonia
1211618|NCT01980433|Movement Disorders|movement disorders
1211619|NCT01980433|Handwriting|handwriting
1211620|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1211621|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
1211622|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
1211623|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
1211624|NCT01980407|S-1|s-1
1211625|NCT01980407|Oxaliplatin|oxaliplatin
1211626|NCT01980407|Leucovorin|leucovorin
1211627|NCT01980407|Gastric Cancer|gastric cancer
1211628|NCT01980394|esophagus|esophagus
1211629|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
1211630|NCT01980394|cancer|cancer
1211631|NCT01980394|tumor seeding|tumor seeding
1211632|NCT01980394|free viable tumor cells|free viable tumor cells
1211633|NCT01980394|surgery|surgery
1211634|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
1211635|NCT01980394|stump washout|stump washout
1211636|NCT01980355|cancer|cancer
1211637|NCT01980355|surgery|surgery
1211638|NCT01980355|oncology|oncology
1211639|NCT01980355|major|major
1211640|NCT01980355|surgical oncology|surgical oncology
1211641|NCT01980355|tranexamic acid|tranexamic acid
1211642|NCT01980342|Long acting reversible contraception|long acting reversible contraception
1211643|NCT01980342|HIV|hiv
1211644|NCT01980329|CYP3A5|cyp3a5
1211645|NCT01980329|maraviroc|maraviroc
1211646|NCT01980329|polymorphism|polymorphism
1211647|NCT01980316|Argatroban|argatroban
1211648|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
1211649|NCT01980316|restenosis|restenosis
1211651|NCT01980303|Japanese|japanese
1211652|NCT01980303|Caucasian|caucasian
1211653|NCT01980303|Anesthetics|anesthetics
1211654|NCT01980303|Intranasal|intranasal
1211655|NCT01980303|Esketamine|esketamine
1211656|NCT01980303|Pharmacokinetics|pharmacokinetics
1211657|NCT01980290|HCV genotype 1|hcv genotype 1
1211658|NCT01980290|Liver Fibrosis|liver fibrosis
1211659|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
1211660|NCT01980264|Melanoma|melanoma
1211661|NCT01980264|Basal Cell Carcinoma|basal cell carcinoma
1211662|NCT01980264|Squamous Cell Carcinoma|squamous cell carcinoma
1211663|NCT01980264|BD, AK|bd, ak
1211664|NCT01980264|melanin|melanin
1211665|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
1211666|NCT01980238|LAR|lar
1211667|NCT01980238|anastomotic leakage|anastomotic leakage
1211668|NCT01980238|Cannula ileostomy|cannula ileostomy
1211669|NCT01980238|loop ileostomy|loop ileostomy
1211670|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
1211671|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
1211672|NCT01980212|thioredoxin reductase|thioredoxin reductase
1211673|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
1211674|NCT01980199|fexinidazole|fexinidazole
1211675|NCT01980199|adults|adults
1211676|NCT01980199|proof of concept|proof of concept
1211677|NCT01980199|efficacy|efficacy
1211678|NCT01980199|safety|safety
1211679|NCT01980199|pharmacokinetic|pharmacokinetic
1211680|NCT01980199|pharmacodynamic|pharmacodynamic
1211681|NCT01980186|transcranial ultrasound|transcranial ultrasound
1211682|NCT01980186|autism|autism
1211683|NCT01980186|cortical dysplasia|cortical dysplasia
1211684|NCT01980186|extra-axial fluid|extra-axial fluid
1211685|NCT01980173|Bakri balloon|bakri balloon
1211686|NCT01980147|Severe Mental Illness|severe mental illness
1211687|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
1211688|NCT01980134|colorectal polyps|colorectal polyps
1211689|NCT01980134|polyps|polyps
1211690|NCT01980121|Respiratory Aspiration|respiratory aspiration
1211691|NCT01980121|Pregnancy|pregnancy
1211692|NCT01980121|Ultrasound|ultrasound
1211693|NCT01980121|Gastric Contents|gastric contents
1211694|NCT01980108|Pregnancy|pregnancy
1211695|NCT01980108|Respiratory Aspiration|respiratory aspiration
1211696|NCT01980108|Gastric Contents|gastric contents
1211697|NCT01980108|Ultrasound|ultrasound
1211698|NCT01980095|Helicobacter pylori|helicobacter pylori
1211699|NCT01980095|H. pylori|h. pylori
1211700|NCT01980095|Dyspepsia|dyspepsia
1211701|NCT01980082|head and neck surgery|head and neck surgery
1211702|NCT01980082|surgical wound infection|surgical wound infection
1211703|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
1211704|NCT01980069|Sugammadex|sugammadex
1211705|NCT01980069|Neostigmine|neostigmine
1211706|NCT01980069|Surgery|surgery
1211707|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
1211708|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
1211709|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
1211710|NCT01980017|Diabetes Education Programs|diabetes education programs
1211711|NCT01979965|Mitral Regurgitation|mitral regurgitation
1211712|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
1211713|NCT01979965|ranolazine|ranolazine
1211714|NCT01979965|maximal medical therapy|maximal medical therapy
1211715|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
1211716|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
1211717|NCT01979913|Ocular Hypertension|ocular hypertension
1211718|NCT01979913|Tafluprost|tafluprost
1211719|NCT01979913|Saflutan|saflutan
1211720|NCT01979913|Intraocular pressure|intraocular pressure
1211721|NCT01979913|Preservative free|preservative free
1211722|NCT01979913|Single dose unit|single dose unit
1211723|NCT01979900|TB Infection|tb infection
1211724|NCT01979900|Lesion Degree|lesion degree
1211725|NCT01979900|Bacteriology Indicators|bacteriology indicators
1211726|NCT01979900|Cavity|cavity
1211727|NCT01979900|Humoral Immunity|humoral immunity
1211728|NCT01979900|Cellular Immunologic Response|cellular immunologic response
1211729|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
1211730|NCT01979848|continence outcomes|continence outcomes
1211731|NCT01979848|sexual function|sexual function
1211732|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
1211733|NCT01979848|thermal imaging|thermal imaging
1211734|NCT01979848|localized hypothermia|localized hypothermia
1211735|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
1211736|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
1211737|NCT01979809|Dietary change|dietary change
1211738|NCT01979809|Young adult|young adult
1211739|NCT01979809|Prevention|prevention
1211740|NCT01979809|Web-based intervention|web-based intervention
1211741|NCT01979809|eCoaching|ecoaching
1211742|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
1211743|NCT01979770|Adolescent|adolescent
1211744|NCT01979770|Nutritional status|nutritional status
1211745|NCT01979770|Body composition|body composition
1211746|NCT01979770|Biochemical status|biochemical status
1211747|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
1211748|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
1211749|NCT01979731|Occupational health|occupational health
1211750|NCT01979731|Ergonomics|ergonomics
1211751|NCT01979731|Environments|environments
1211752|NCT01979731|Prevention and Control|prevention and control
1211754|NCT01979692|The study will|the study will
1211755|NCT01979692|focus on using|focus on using
1211756|NCT01979692|CLM to|clm to
1211757|NCT01979692|distinguish between|distinguish between
1211758|NCT01979692|viable and|viable and
1211759|NCT01979692|necrotic tissue|necrotic tissue
1211760|NCT01979692|at TTNB in real time|at ttnb in real time
1211761|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
1211762|NCT01979640|bronchial cuff|bronchial cuff
1211763|NCT01979640|double lumen tube|double lumen tube
1211764|NCT01979640|blood tight seal|blood tight seal
1211765|NCT01979627|transulnar approach|transulnar approach
1211766|NCT01979627|transradial approach|transradial approach
1211767|NCT01979627|angiography|angiography
1211768|NCT01979627|angioplasty|angioplasty
1211769|NCT01979614|coronary artery disease|coronary artery disease
1211770|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
1211771|NCT01979601|LGT209,|lgt209,
1211772|NCT01979601|PCSK9,|pcsk9,
1211773|NCT01979601|LDL-C|ldl-c
1211774|NCT01979575|Nexfin|nexfin
1211775|NCT01979575|Flotrac|flotrac
1211776|NCT01979575|Esophageal|esophageal
1211777|NCT01979575|Cardiac output|cardiac output
1211778|NCT01979562|Overuse injury|overuse injury
1211779|NCT01979562|Femur|femur
1211780|NCT01979562|Tibia|tibia
1211781|NCT01979562|Running|running
1211782|NCT01979562|Prevention|prevention
1211783|NCT01979549|Adverse events|adverse events
1211784|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1211785|NCT01979549|Sedation|sedation
1211786|NCT01979484|bioavailability|bioavailability
1211787|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
1211788|NCT01979471|Diabetes|diabetes
1211789|NCT01979471|Chronic Kidney Disease|chronic kidney disease
1211790|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
1211791|NCT01979471|Community Pharmacist|community pharmacist
1211792|NCT01979471|Randomized controlled trial|randomized controlled trial
1211793|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
1211794|NCT01979458|Colonoscopy|colonoscopy
1211795|NCT01979445|CAD|cad
1211796|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
1211797|NCT01979419|mild cognitive impairment|mild cognitive impairment
1211798|NCT01979419|Alzheimer's disease|alzheimer's disease
1211799|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
1211800|NCT01979419|amyloid|amyloid
1211801|NCT01979419|plaques|plaques
1211802|NCT01979419|neuroimaging|neuroimaging
1211803|NCT01979419|biomarkers|biomarkers
1211804|NCT01979419|cognition disorder|cognition disorder
1211805|NCT01979419|early detection|early detection
1211806|NCT01979419|pre-dementia|pre-dementia
1211807|NCT01979419|dementia|dementia
1211808|NCT01979419|vascular MCI|vascular mci
1211809|NCT01979406|Anthrax vaccine|anthrax vaccine
1211810|NCT01979393|Locally advanced|locally advanced
1211811|NCT01979393|stage III|stage iii
1211812|NCT01979393|stage IV|stage iv
1211813|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
1211814|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
1211815|NCT01979393|Metastatic|metastatic
1211816|NCT01979380|KD101|kd101
1211817|NCT01979380|Anti-obesity Agents|anti-obesity agents
1211818|NCT01979354|spinal morphine|spinal morphine
1211819|NCT01979354|VATs lobectomy|vats lobectomy
1211820|NCT01979341|dual trigger|dual trigger
1211821|NCT01979341|hCG|hcg
1211822|NCT01979341|GnRH agonist|gnrh agonist
1211823|NCT01979341|ICSI|icsi
1211824|NCT01979341|pregnancy|pregnancy
1211825|NCT01979341|OHSS|ohss
1211826|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
1211827|NCT01979302|Geriatric Depression|geriatric depression
1211828|NCT01979302|Depression Care Management|depression care management
1211829|NCT01979302|home healthcare|home healthcare
1211830|NCT01979302|nurse training intervention|nurse training intervention
1211831|NCT01979289|Executive Dysfunction|executive dysfunction
1211832|NCT01979289|Cognitive Remediation|cognitive remediation
1211833|NCT01979289|Geriatric|geriatric
1211834|NCT01979289|Depression|depression
1211835|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
1211836|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
1211837|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
1211838|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
1211839|NCT01979211|head and neck cancer|head and neck cancer
1211938|NCT01978600|Intraocular Pressure|intraocular pressure
1211840|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
1211841|NCT01979172|LASIK|lasik
1211842|NCT01979172|Intraocular lens|intraocular lens
1211843|NCT01979172|Biometry|biometry
1211844|NCT01979172|IOL master|iol master
1211845|NCT01979159|aphasia|aphasia
1211846|NCT01979159|apraxia of speech|apraxia of speech
1211847|NCT01979159|outcomes|outcomes
1211848|NCT01979146|Cancer|cancer
1211849|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
1211850|NCT01979120|Chronic heart failure|chronic heart failure
1211851|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1211852|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
1211853|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
1211854|NCT01979120|Polysomnography|polysomnography
1211855|NCT01979107|Health behavior|health behavior
1211856|NCT01979107|Chronic disease|chronic disease
1211857|NCT01979107|Proactive action|proactive action
1211858|NCT01979107|General practitioner|general practitioner
1211859|NCT01979107|Preventive health check|preventive health check
1211860|NCT01979107|Social inequality in health|social inequality in health
1211861|NCT01979107|Randomised controlled trial|randomised controlled trial
1211862|NCT01979055|asthma|asthma
1211863|NCT01979055|older adults|older adults
1211864|NCT01979055|elderly|elderly
1211865|NCT01979055|behavior|behavior
1211866|NCT01979042|renal colic|renal colic
1211867|NCT01979042|acute renal failure|acute renal failure
1211868|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
1211869|NCT01978977|mBC|mbc
1211870|NCT01978977|HER2 negative|her2 negative
1211871|NCT01978977|Chemotherapy|chemotherapy
1211872|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
1211873|NCT01978977|Bevacizumab|bevacizumab
1211874|NCT01978977|1st Line|1st line
1211875|NCT01978964|ONT-10|ont-10
1211876|NCT01978964|MUC1|muc1
1211877|NCT01978964|Vaccine|vaccine
1211878|NCT01978964|Phase 1b|phase 1b
1211879|NCT01978964|Solid tumors|solid tumors
1211880|NCT01978964|Maintenance therapy|maintenance therapy
1587737|NCT00439387|Epilepsy|epilepsy
1211881|NCT01978951|Chronic Kidney Disease|chronic kidney disease
1211882|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
1211883|NCT01978951|Village Health Volunteers|village health volunteers
1211884|NCT01978925|Pharmaceutical care|pharmaceutical care
1211885|NCT01978925|Medication Adherence|medication adherence
1211886|NCT01978925|Blood Pressure|blood pressure
1211887|NCT01978925|Diabetes|diabetes
1211888|NCT01978925|Emergency|emergency
1211889|NCT01978886|Diabetes Mellitus|diabetes mellitus
1211890|NCT01978886|frozen shoulder|frozen shoulder
1211891|NCT01978886|adhesive capsulitis|adhesive capsulitis
1211892|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
1211893|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
1211894|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
1211895|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
1211896|NCT01978860|MI Myocardial infarction|mi myocardial infarction
1211897|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
1211898|NCT01978821|Cerebral Palsy|cerebral palsy
1211899|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
1211900|NCT01978821|stem cell therapy|stem cell therapy
1211901|NCT01978795|concussion|concussion
1211902|NCT01978795|high school|high school
1211903|NCT01978795|web-based training|web-based training
1211904|NCT01978795|school-based health care|school-based health care
1211905|NCT01978782|raltegravir|raltegravir
1211906|NCT01978782|citalopram|citalopram
1211907|NCT01978782|pharmacokinetics|pharmacokinetics
1211908|NCT01978782|drug-drug interaction|drug-drug interaction
1211909|NCT01978756|Outpatient clinic|outpatient clinic
1211910|NCT01978756|Breast cancer|breast cancer
1211911|NCT01978756|Late toxicity|late toxicity
1211912|NCT01978743|HIV|hiv
1211913|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
1211914|NCT01978743|neurotoxicity|neurotoxicity
1211915|NCT01978730|vascular dementia|vascular dementia
1211916|NCT01978730|cognition|cognition
1211917|NCT01978730|stroke|stroke
1211918|NCT01978717|Anesthesia|anesthesia
1211919|NCT01978717|T-helper|t-helper
1211920|NCT01978717|MDSCs|mdscs
1211921|NCT01978717|Colorectal cancer|colorectal cancer
1211922|NCT01978717|Fast track|fast track
1211923|NCT01978691|Obesity|obesity
1211924|NCT01978691|Blood glucose|blood glucose
1211925|NCT01978691|Waist circumference|waist circumference
1211926|NCT01978691|Lipid metabolism|lipid metabolism
1211927|NCT01978691|Probiotics|probiotics
1211928|NCT01978691|Prebiotics|prebiotics
1211929|NCT01978691|Dietary supplements|dietary supplements
1211930|NCT01978691|Endotoxemia|endotoxemia
1211931|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
1211932|NCT01978626|Insomnia|insomnia
1211933|NCT01978626|Comorbid insomnia|comorbid insomnia
1211934|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
1211935|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
1211936|NCT01978600|Ocular Hypertension|ocular hypertension
1211937|NCT01978600|Simbrinza™|simbrinza™
1211939|NCT01978587|End-stage Renal Disease|end-stage renal disease
1211940|NCT01978587|Hemodialysis|hemodialysis
1211941|NCT01978587|Pharmacokinetics|pharmacokinetics
1211942|NCT01978574|Cognitive reserve|cognitive reserve
1211943|NCT01978574|intellectual enrichment|intellectual enrichment
1211944|NCT01978548|Alzheimer Disease|alzheimer disease
1211945|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
1211946|NCT01978548|Safety|safety
1211947|NCT01978548|Tolerability|tolerability
1211948|NCT01978548|Pharmacokinetic|pharmacokinetic
1211949|NCT01978548|Proof of Mechanism|proof of mechanism
1211950|NCT01978548|JNJ-54861911|jnj-54861911
1211951|NCT01978535|POTS|pots
1211952|NCT01978522|Randomised trial|randomised trial
1211953|NCT01978522|postal questionnaires|postal questionnaires
1211954|NCT01978522|return rates|return rates
1211955|NCT01978509|Colonoscopy|colonoscopy
1211956|NCT01978483|Humans|humans
1211957|NCT01978483|Adult|adult
1211958|NCT01978483|skin|skin
1211959|NCT01978483|metabolism|metabolism
1211960|NCT01978483|radiation effects|radiation effects
1211961|NCT01978483|Ultraviolet Rays|ultraviolet rays
1211962|NCT01978483|RANKL|rankl
1211963|NCT01978483|RANK Ligand|rank ligand
1211964|NCT01978483|denosumab|denosumab
1211965|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
1211966|NCT01978483|diphencyprone|diphencyprone
1211967|NCT01978483|immunology|immunology
1211968|NCT01978483|immunosuppression|immunosuppression
1211969|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
1211970|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
1211971|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
1211972|NCT01978470|epilepsy|epilepsy
1211973|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
1211974|NCT01978470|partial onset seizures|partial onset seizures
1211975|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
1211976|NCT01978470|neuromodulation|neuromodulation
1211977|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
1211978|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
1211979|NCT01978418|Lung fluid|lung fluid
1211980|NCT01978418|Postnatal adaptation|postnatal adaptation
1211981|NCT01978418|Salbutamol|salbutamol
1211982|NCT01978418|Albuterol|albuterol
1211983|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
1211984|NCT01978405|Type 2 diabetes|type 2 diabetes
1211985|NCT01978405|Nephropathy|nephropathy
1211986|NCT01978405|Contrast medium|contrast medium
1211987|NCT01978405|Alpha lipoic acid|alpha lipoic acid
1211988|NCT01978392|disability|disability
1211989|NCT01978392|self-management|self-management
1211990|NCT01978392|chronic illness|chronic illness
1211991|NCT01978392|chronic pain|chronic pain
1211992|NCT01978392|occupation|occupation
1211993|NCT01978392|> 6 months|> 6 months
1211994|NCT01978379|General Anesthesia|general anesthesia
1211995|NCT01978379|Nociception Level|nociception level
1211996|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
1211997|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
1211998|NCT01978366|anti-fibrotic|anti-fibrotic
1211999|NCT01978366|anti-inflammatory|anti-inflammatory
1212000|NCT01978366|muscle regeneration|muscle regeneration
1212001|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
1212002|NCT01978353|Mild cognitive impairment|mild cognitive impairment
1212003|NCT01978353|Dementia|dementia
1212004|NCT01978353|Alzheimer's disease|alzheimer's disease
1212005|NCT01978353|Memory Training|memory training
1212006|NCT01978353|Cognitive Training|cognitive training
1212007|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
1212008|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
1212009|NCT01978327|Alzheimer's disease|alzheimer's disease
1212010|NCT01978327|GSK2647544|gsk2647544
1212011|NCT01978327|drug-drug interaction|drug-drug interaction
1212012|NCT01978327|healthy subjects|healthy subjects
1212013|NCT01978327|Lp-PLA2|lp-pla2
1212014|NCT01978327|simvastatin|simvastatin
1212015|NCT01978314|Chronic Kidney Disease|chronic kidney disease
1212016|NCT01978314|Acute Kidney Injury|acute kidney injury
1212017|NCT01978314|AKI|aki
1212018|NCT01978314|CKD|ckd
1212019|NCT01978314|Plasma Volume|plasma volume
1212020|NCT01978314|GFR|gfr
1212021|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
1212022|NCT01978314|Blood volume|blood volume
1212023|NCT01978314|mGFR|mgfr
1212024|NCT01978314|measured GFR|measured gfr
1212025|NCT01978314|kidney biomarker|kidney biomarker
1212026|NCT01978314|renal disease|renal disease
1212027|NCT01978314|renal biomarker|renal biomarker
1212028|NCT01978314|Renal function|renal function
1212029|NCT01978314|kidney function|kidney function
1212030|NCT01978314|organ function|organ function
1212031|NCT01978314|kidney monitor|kidney monitor
1212032|NCT01978314|kidney device|kidney device
1212033|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
1212034|NCT01978301|heavy water|heavy water
1212035|NCT01978301|fibrosis|fibrosis
1212036|NCT01978301|deuterium|deuterium
1212037|NCT01978301|collagen degradation|collagen degradation
1212038|NCT01978301|collagen synthesis|collagen synthesis
1212039|NCT01978301|Keloid|keloid
1212040|NCT01978301|patient|patient
1212537|NCT01976494|laparotomy|laparotomy
1212041|NCT01978275|total knee arthroplasty|total knee arthroplasty
1212042|NCT01978275|lumbar plexus block|lumbar plexus block
1212043|NCT01978275|stimulating catheters|stimulating catheters
1212044|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
1212045|NCT01978262|influenza vaccine|influenza vaccine
1212046|NCT01978262|cytokines|cytokines
1212047|NCT01978262|hormones|hormones
1212048|NCT01978262|progesterone|progesterone
1212049|NCT01978249|Colorectal cancer|colorectal cancer
1212050|NCT01978249|Primary tumor resection|primary tumor resection
1212051|NCT01978249|Chemotherapy|chemotherapy
1212052|NCT01978249|Overall survival|overall survival
1212053|NCT01978249|Quality of life|quality of life
1212054|NCT01978236|BRAF V600E mutation|braf v600e mutation
1212055|NCT01978236|brain metastases|brain metastases
1212056|NCT01978236|BRAF V600K mutation|braf v600k mutation
1212057|NCT01978236|Metastatic melanoma|metastatic melanoma
1212058|NCT01978236|BRAF inhibitor|braf inhibitor
1212059|NCT01978236|brain neoplasms|brain neoplasms
1212060|NCT01978236|GSK2118436|gsk2118436
1212061|NCT01978223|Rotarix™|rotarix™
1212062|NCT01978223|Case-control|case-control
1212063|NCT01978223|Venezuela|venezuela
1212064|NCT01978223|Vaccine effectiveness|vaccine effectiveness
1212065|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
1212066|NCT01978223|Children|children
1212067|NCT01978223|Hospitalised|hospitalised
1212068|NCT01978210|autism|autism
1212069|NCT01978210|enuresis|enuresis
1212070|NCT01978210|toilet-training|toilet-training
1212071|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
1212072|NCT01978171|breast neoplasms|breast neoplasms
1212073|NCT01978171|everolimus|everolimus
1212074|NCT01978171|interstitial lung disease|interstitial lung disease
1212075|NCT01978171|pneumonitis|pneumonitis
1212076|NCT01978158|Oxygen|oxygen
1212077|NCT01978158|Hypoxia|hypoxia
1212078|NCT01978158|Hyperoxia|hyperoxia
1212079|NCT01978158|Inflammation|inflammation
1212080|NCT01978158|Innate immunity|innate immunity
1212081|NCT01978145|efficacy|efficacy
1212082|NCT01978145|tolerability|tolerability
1212083|NCT01978145|capsule-based inhaler|capsule-based inhaler
1212084|NCT01978145|quality of life|quality of life
1212086|NCT01978145|multi-dose inhaler|multi-dose inhaler
1212087|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
1212088|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1212089|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
1212090|NCT01978132|primary hypertension|primary hypertension
1212091|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
1212092|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
1212093|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
1212094|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
1212095|NCT01978119|safety|safety
1212096|NCT01978119|Asthma|asthma
1212097|NCT01978119|efficacy|efficacy
1212098|NCT01978119|pharmacodynamics|pharmacodynamics
1212099|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
1212100|NCT01978119|tolerability|tolerability
1212101|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
1212102|NCT01978106|toric calculator|toric calculator
1212103|NCT01978106|toric intraocular lens power|toric intraocular lens power
1212104|NCT01978106|Acrysof|acrysof
1212105|NCT01978106|Tecnis|tecnis
1212106|NCT01978106|iTrace|itrace
1212107|NCT01978093|Conjugate|conjugate
1212108|NCT01978093|Immunogenicity|immunogenicity
1212109|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
1212110|NCT01978093|Haemophilus type b|haemophilus type b
1212111|NCT01978093|Safety|safety
1212112|NCT01978093|Reactogenicity|reactogenicity
1212113|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
1212114|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
1212115|NCT01978067|transvaginal resection|transvaginal resection
1212116|NCT01978067|quality of life|quality of life
1212117|NCT01978067|sexual activity|sexual activity
1212118|NCT01978054|Information Dissemination|information dissemination
1212119|NCT01978054|Information Sharing|information sharing
1212120|NCT01978054|Innovation Diffusion|innovation diffusion
1212121|NCT01978054|Public Health Practice|public health practice
1212122|NCT01978054|Evidence-Based Public Health|evidence-based public health
1212123|NCT01978054|Chronic Disease Prevention|chronic disease prevention
1212124|NCT01978054|Cancer Prevention and Control|cancer prevention and control
1212125|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
1212126|NCT01978028|heart failure|heart failure
1212127|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
1212128|NCT01978015|timolol|timolol
1212129|NCT01978015|prostaglandin analogues|prostaglandin analogues
1212130|NCT01977976|Endometrial injury|endometrial injury
1212131|NCT01977976|Pipelle|pipelle
1212132|NCT01977976|Implantation|implantation
1212133|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
1212134|NCT01977976|IVF|ivf
1212234|NCT01977586|Response assessment|response assessment
1212135|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
1212136|NCT01977937|gabapentin|gabapentin
1212137|NCT01977937|Analgesic Drugs|analgesic drugs
1212138|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
1212139|NCT01977924|sleep apnea|sleep apnea
1212140|NCT01977924|polyphenols|polyphenols
1212141|NCT01977924|endothelial function|endothelial function
1212142|NCT01977911|Airway reconstruction|airway reconstruction
1212143|NCT01977911|Regenerative medicine|regenerative medicine
1212144|NCT01977898|Postdural puncture headache|postdural puncture headache
1212145|NCT01977898|Intrathecal morphine|intrathecal morphine
1212146|NCT01977898|Intrathecal catheter|intrathecal catheter
1212147|NCT01977898|Headache|headache
1212148|NCT01977898|Labor and delivery|labor and delivery
1212149|NCT01977898|Unintentional dural puncture|unintentional dural puncture
1212150|NCT01977885|epigenetics|epigenetics
1212151|NCT01977885|obesity|obesity
1212152|NCT01977885|overweight|overweight
1212153|NCT01977885|high protein diet|high protein diet
1212154|NCT01977885|exercise|exercise
1212155|NCT01977885|post menopausal women|post menopausal women
1212156|NCT01977872|Arthritis|arthritis
1212157|NCT01977872|Physical Activity|physical activity
1212158|NCT01977872|Diet|diet
1212159|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
1212160|NCT01977859|Metabolism|metabolism
1212161|NCT01977859|Insulin infusion|insulin infusion
1212162|NCT01977846|genetic testing|genetic testing
1212163|NCT01977846|ABCA4|abca4
1212164|NCT01977846|Stargardt|stargardt
1212165|NCT01977846|retina|retina
1212166|NCT01977846|retinal degeneration|retinal degeneration
1212167|NCT01977833|BTdiet|btdiet
1212168|NCT01977833|Dtdiet|dtdiet
1291447|NCT01619176|blood|blood
1212169|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
1212170|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
1212171|NCT01977820|Phenylketonuria|phenylketonuria
1212172|NCT01977820|Sapropterin|sapropterin
1212173|NCT01977820|Placebo|placebo
1212174|NCT01977820|Cognitive Abilities|cognitive abilities
1212175|NCT01977820|Kuvan®|kuvan®
1212176|NCT01977807|Myopia|myopia
1212177|NCT01977807|Hyperopia|hyperopia
1212178|NCT01977807|Presbyopia|presbyopia
1212179|NCT01977807|Supracor|supracor
1212180|NCT01977807|Zyoptix|zyoptix
1212181|NCT01977807|Proscan|proscan
1212182|NCT01977807|LASIK|lasik
1212183|NCT01977794|Bisoprolol|bisoprolol
1212184|NCT01977794|Amlodipine|amlodipine
1212185|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
1212186|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
1212187|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
1212188|NCT01977781|GVHD|gvhd
1212189|NCT01977781|Ocular GVHD|ocular gvhd
1212190|NCT01977781|Tacrolimus|tacrolimus
1212191|NCT01977781|Methylprednisolone|methylprednisolone
1212192|NCT01977768|M. vaccae|m. vaccae
1212193|NCT01977768|TB|tb
1212194|NCT01977768|MDR-TB|mdr-tb
1212195|NCT01977768|V7-immunitor|v7-immunitor
1212196|NCT01977729|anxiety|anxiety
1212197|NCT01977716|Peritonitis|peritonitis
1212198|NCT01977716|loss of residual renal function|loss of residual renal function
1212199|NCT01977716|technique survival|technique survival
1212200|NCT01977703|Heart Failure|heart failure
1212201|NCT01977703|Advanced Heart Failure|advanced heart failure
1212202|NCT01977703|LVAD|lvad
1212203|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
1212204|NCT01977703|Heart-Assist Devices|heart-assist devices
1212205|NCT01977664|oocyte maturation failure|oocyte maturation failure
1212206|NCT01977664|Maturation induction in vitro|maturation induction in vitro
1212207|NCT01977651|enzalutamide|enzalutamide
1212208|NCT01977651|Xtandi|xtandi
1212209|NCT01977651|seizure|seizure
1212210|NCT01977651|Central Nervous System|central nervous system
1212211|NCT01977651|MDV3100|mdv3100
1212212|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
1212213|NCT01977638|Advanced solid tumours|advanced solid tumours
1212214|NCT01977638|Lymphoma|lymphoma
1212215|NCT01977638|Myeloma|myeloma
1212216|NCT01977625|Menopause|menopause
1212217|NCT01977625|fMRI|fmri
1212218|NCT01977625|Vyvanse|vyvanse
1212219|NCT01977612|Wound infection|wound infection
1212220|NCT01977612|Wound separation|wound separation
1212221|NCT01977612|Skin staples|skin staples
1212222|NCT01977612|Subcuticular suture|subcuticular suture
1212223|NCT01977599|Text message reminders|text message reminders
1212224|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
1212225|NCT01977599|Social Health Inequalities|social health inequalities
1212226|NCT01977599|Breast Screening|breast screening
1212227|NCT01977599|Screening|screening
1212228|NCT01977599|Public Health Intervention|public health intervention
1212229|NCT01977599|Missed Appointments|missed appointments
1212230|NCT01977599|Non-attendance|non-attendance
1212231|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
1212232|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
1212233|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
1212430|NCT01976884|sepsis|sepsis
1212271|NCT01977495|Opt-out Enrollment|opt-out enrollment
1212273|NCT01977495|financial incentives|financial incentives
1212274|NCT01977482|hemoglobin|hemoglobin
1212275|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
1212276|NCT01977482|Chronic kidney disease|chronic kidney disease
1212277|NCT01977482|hemodialysis|hemodialysis
1212278|NCT01977482|pharmacokinetics|pharmacokinetics
1212279|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1212280|NCT01977482|Anemia|anemia
1212281|NCT01977482|GSK1278863|gsk1278863
1212282|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1212283|NCT01977469|Activities of Daily Living|activities of daily living
1212284|NCT01977469|Mortality|mortality
1212285|NCT01977469|Strength Training|strength training
1212286|NCT01977456|acute ischemic stroke|acute ischemic stroke
1212287|NCT01977456|stroke|stroke
1212288|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
1212289|NCT01977456|t-PA|t-pa
1212290|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1212291|NCT01977456|Activase|activase
1212292|NCT01977456|eptifibatide|eptifibatide
1212293|NCT01977456|Integrilin|integrilin
1212294|NCT01977456|fibrinolytic agents|fibrinolytic agents
1212295|NCT01977456|clot dissolving|clot dissolving
1212296|NCT01977456|blood clot|blood clot
1212297|NCT01977430|Residual renal function|residual renal function
1212298|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
1212299|NCT01977430|Haemodialysis|haemodialysis
1212300|NCT01977417|Endothelial Function|endothelial function
1212301|NCT01977417|Arterial Stiffness|arterial stiffness
1212302|NCT01977417|Inflammation|inflammation
1212303|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
1212304|NCT01977417|Prediabetes|prediabetes
1212305|NCT01977417|Autonomic function|autonomic function
1212306|NCT01977404|Congestive heart failure|congestive heart failure
1212307|NCT01977404|Energy expenditure|energy expenditure
1212308|NCT01977404|Body composition|body composition
1212309|NCT01977404|Caloric intake|caloric intake
1212310|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
1212311|NCT01977365|Nutrition counseling,|nutrition counseling,
1212312|NCT01977365|Caretaker's knowledge|caretaker's knowledge
1212313|NCT01977365|Child growth,|child growth,
1212314|NCT01977365|Prevention,|prevention,
1212315|NCT01977365|Acute malnutrition|acute malnutrition
1212316|NCT01977352|Exparel|exparel
1212317|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
1212318|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
1212319|NCT01977339|Femoral Nerve Block|femoral nerve block
1212320|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
1212321|NCT01977326|task sharing|task sharing
1212322|NCT01977326|task shifting|task shifting
1212323|NCT01977326|prenatal depression|prenatal depression
1212324|NCT01977326|counselling|counselling
1212325|NCT01977326|lay health workers|lay health workers
1212326|NCT01977287|Multiple Sclerosis|multiple sclerosis
1212327|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
1212328|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
1212534|NCT01976494|safety|safety
1212329|NCT01977287|Walking performance|walking performance
1212330|NCT01977287|gait analysis|gait analysis
1212331|NCT01977287|fatigue|fatigue
1212332|NCT01977287|activity monitoring|activity monitoring
1212333|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
1212334|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
1212335|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
1212336|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
1212337|NCT01977196|Infants|infants
1212338|NCT01977196|Phase I|phase i
1212339|NCT01977183|gastrointestinal|gastrointestinal
1212340|NCT01977183|microbiome|microbiome
1212341|NCT01977183|prebiotic|prebiotic
1212342|NCT01977183|starch|starch
1212343|NCT01977170|Adults|adults
1212344|NCT01977170|Hib vaccines|hib vaccines
1212345|NCT01977170|Immunogenicity|immunogenicity
1212346|NCT01977170|Safety|safety
1212347|NCT01977157|Impedance cardiography|impedance cardiography
1212348|NCT01977157|bioimpedance|bioimpedance
1212349|NCT01977157|spectroscopy|spectroscopy
1212350|NCT01977157|extracellular resistance|extracellular resistance
1212351|NCT01977157|body composition|body composition
1212352|NCT01977157|hemodynamics|hemodynamics
1212353|NCT01977157|alcohol|alcohol
1212354|NCT01977144|Single Embryo Transfer|single embryo transfer
1212355|NCT01977144|Double Embryo Transfer|double embryo transfer
1212356|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
1212357|NCT01977144|Aneuploidy|aneuploidy
1212358|NCT01977144|Low Responders|low responders
1212359|NCT01977118|Streptokinase|streptokinase
1212360|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
1212361|NCT01977118|Pancreatic necrosis|pancreatic necrosis
1212362|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
1212363|NCT01977105|Infants|infants
1212364|NCT01977105|Mothers|mothers
1212365|NCT01977105|Social media|social media
1212366|NCT01977105|Obesity prevention|obesity prevention
1212367|NCT01977092|sober living houses|sober living houses
1212368|NCT01977092|HIV|hiv
1212369|NCT01977092|alcohol and drugs|alcohol and drugs
1212370|NCT01977079|pregnancy|pregnancy
1212371|NCT01977079|premature birth|premature birth
1212372|NCT01977079|procalcitonin|procalcitonin
1212373|NCT01977066|pancreatic cancer|pancreatic cancer
1212374|NCT01977066|exercise training|exercise training
1212375|NCT01977066|quality of life|quality of life
1212376|NCT01977066|physical functioning|physical functioning
1212377|NCT01977053|breast cancer|breast cancer
1212378|NCT01977053|colon cancer|colon cancer
1212379|NCT01977053|rectal cancer|rectal cancer
1212380|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
1212381|NCT01977053|phone calls|phone calls
1212382|NCT01977053|emotional states|emotional states
1212383|NCT01977053|quality of life|quality of life
1212384|NCT01977040|Vasa Previa|vasa previa
1212385|NCT01977027|Rehabilitation|rehabilitation
1212386|NCT01977027|Fingers|fingers
1212387|NCT01977027|Grasp|grasp
1212388|NCT01977027|Strength|strength
1212389|NCT01977027|Hand Function|hand function
1212390|NCT01977027|Motor Function|motor function
1212391|NCT01977027|Post Stroke|post stroke
1212392|NCT01977027|Brain Infraction|brain infraction
1212393|NCT01977027|Biomechanis|biomechanis
1212394|NCT01977027|Neuronal Plasticity|neuronal plasticity
1212395|NCT01977027|Weight-Bearing|weight-bearing
1212396|NCT01977001|Primary headache|primary headache
1212397|NCT01977001|Headache|headache
1212398|NCT01977001|MigraineBox|migrainebox
1212399|NCT01976975|Depression|depression
1212400|NCT01976975|Major Depressive Disorder|major depressive disorder
1587839|NCT00439127|radioiodine|radioiodine
1212401|NCT01976975|Bipolar Disorder|bipolar disorder
1212402|NCT01976975|Mania|mania
1212403|NCT01976975|Hypomania|hypomania
1212404|NCT01976975|EEG|eeg
1212405|NCT01976975|MRI|mri
1212406|NCT01976975|Reward|reward
1212407|NCT01976962|Prostatic neoplasms|prostatic neoplasms
1212408|NCT01976962|Radiotherapy|radiotherapy
1212409|NCT01976962|Dose fractionation|dose fractionation
1212410|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
1212411|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
1212412|NCT01976936|Stroke|stroke
1212413|NCT01976936|Rhabdomyolysis|rhabdomyolysis
1212414|NCT01976936|Jaundice|jaundice
1212415|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
1212416|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
1212417|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1212418|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
1212419|NCT01976923|Intraoperative bleeding|intraoperative bleeding
1212420|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
1212421|NCT01976923|Visual acuity|visual acuity
1212422|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
1212423|NCT01976910|Advanced cancers|advanced cancers
1212424|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
1212425|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
1212426|NCT01976910|Advanced cancer|advanced cancer
1212427|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
1212428|NCT01976897|flexion|flexion
1212429|NCT01976897|knee angular position|knee angular position
1212431|NCT01976884|immunosuppression|immunosuppression
1212432|NCT01976884|PD-L1|pd-l1
1212433|NCT01976871|Restless Legs Syndrome|restless legs syndrome
1212434|NCT01976871|Ekbom Syndrome|ekbom syndrome
1212435|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
1212436|NCT01976871|Rotigotine|rotigotine
1212437|NCT01976871|Neupro|neupro
1212438|NCT01976871|Dopamine Agonist|dopamine agonist
1212439|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
1212440|NCT01976845|propofol|propofol
1212441|NCT01976845|midazolam|midazolam
1212442|NCT01976845|sedative|sedative
1212443|NCT01976845|anxiolytic|anxiolytic
1212444|NCT01976845|amnesic|amnesic
1212445|NCT01976845|recall|recall
1212446|NCT01976845|Memory|memory
1212447|NCT01976845|Perioperative outcomes|perioperative outcomes
1212448|NCT01976819|Tracheotomy|tracheotomy
1212449|NCT01976819|Tracheostomy|tracheostomy
1212450|NCT01976819|Speaking valve|speaking valve
1212451|NCT01976819|HME|hme
1212452|NCT01976819|patients|patients
1212453|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
1212454|NCT01976806|DHA|dha
1212455|NCT01976806|Periodontitis|periodontitis
1212456|NCT01976806|Gingivitis|gingivitis
1212457|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
1212458|NCT01976806|Fish oil|fish oil
1212459|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
1212460|NCT01976793|Depression|depression
1212461|NCT01976793|Depressive episode|depressive episode
1212462|NCT01976793|Atypical antipsychotics|atypical antipsychotics
1212463|NCT01976780|Malaria|malaria
1212464|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
1212465|NCT01976780|Early Treatment Failure|early treatment failure
1212466|NCT01976780|Late Treatment Failure|late treatment failure
1212467|NCT01976767|Sputum|sputum
1212468|NCT01976767|Clinical cohorts|clinical cohorts
1212469|NCT01976767|Smokers|smokers
1212470|NCT01976767|Asthma|asthma
1212471|NCT01976767|Biopsies|biopsies
1212472|NCT01976767|Severe asthma|severe asthma
1212473|NCT01976767|Collaborative research|collaborative research
1212474|NCT01976767|Phenotyping|phenotyping
1212475|NCT01976767|Lipidomics|lipidomics
1212476|NCT01976767|Transcriptomics|transcriptomics
1212477|NCT01976767|Proteomics|proteomics
1212478|NCT01976767|Paediatric cohort|paediatric cohort
1212479|NCT01976767|Systems Biology|systems biology
1212480|NCT01976741|Phase I|phase i
1212481|NCT01976741|Dose escalation|dose escalation
1212482|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
1212483|NCT01976741|Bladder cancer|bladder cancer
1212484|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
1212485|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
1212486|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
1212487|NCT01976741|head and neck cancer|head and neck cancer
1212488|NCT01976715|HIV|hiv
1212489|NCT01976715|Treatment Failure|treatment failure
1212490|NCT01976715|Drug Resistance|drug resistance
1212491|NCT01976702|HIV risk behaviors|hiv risk behaviors
1212492|NCT01976702|Pregnant drug abusers|pregnant drug abusers
1212493|NCT01976689|Glucose Regulation|glucose regulation
1212494|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
1212495|NCT01976689|New-onset Diabetes|new-onset diabetes
1212496|NCT01976689|Renal Transplantation|renal transplantation
1212497|NCT01976598|chronic|chronic
1212498|NCT01976598|back|back
1212499|NCT01976598|leg|leg
1212500|NCT01976598|pain|pain
1212501|NCT01976598|sub-sensory|sub-sensory
1212502|NCT01976598|stimulation|stimulation
1212503|NCT01976598|Neuromodulation|neuromodulation
1212504|NCT01976598|Yearwood|yearwood
1212505|NCT01976585|Intratumoral injections|intratumoral injections
1212506|NCT01976585|rhuFlt3L|rhuflt3l
1212507|NCT01976585|Flt3L|flt3l
1212508|NCT01976585|CDX-301|cdx-301
1212509|NCT01976585|Vaccine|vaccine
1212510|NCT01976585|Poly-ICLC|poly-iclc
1212511|NCT01976585|iNHL|inhl
1212512|NCT01976585|TLR3|tlr3
1212513|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
1212514|NCT01976585|Follicular|follicular
1212515|NCT01976585|Marginal Zone|marginal zone
1212516|NCT01976585|SLL|sll
1212517|NCT01976585|Small lymphocytic|small lymphocytic
1212518|NCT01976572|CKD Stage V|ckd stage v
1212519|NCT01976572|dialysis|dialysis
1212520|NCT01976559|ICP|icp
1212521|NCT01976559|Intracranial pressure|intracranial pressure
1212522|NCT01976559|Hydrocephalus|hydrocephalus
1212523|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
1212524|NCT01976559|CSF|csf
1212525|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
1212526|NCT01976559|Noninvasive ICP|noninvasive icp
1212527|NCT01976520|Cancer vaccine|cancer vaccine
1212528|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1212529|NCT01976520|CLL|cll
1212530|NCT01976520|Autologous vaccine|autologous vaccine
1212531|NCT01976520|B cell leukemia|b cell leukemia
1212532|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
1212533|NCT01976494|efficacy|efficacy
1212535|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
1212536|NCT01976494|Upper abdominal surgery|upper abdominal surgery
1212538|NCT01976455|obesity|obesity
1212539|NCT01976455|carbon13|carbon13
1212540|NCT01976455|over-eating|over-eating
1212541|NCT01976455|metabolic chamber|metabolic chamber
1212542|NCT01976455|room calorimeter|room calorimeter
1212543|NCT01976442|Leukemia|leukemia
1212544|NCT01976442|Transfusion|transfusion
1212545|NCT01976429|barotrauma|barotrauma
1212546|NCT01976429|barotitis|barotitis
1212547|NCT01976429|middle ear|middle ear
1212548|NCT01976429|flying|flying
1212549|NCT01976429|diving|diving
1212550|NCT01976429|Eustachian tube|eustachian tube
1212551|NCT01976416|Hydroxyurea|hydroxyurea
1212552|NCT01976390|Kidney|kidney
1212553|NCT01976390|Kidney transplant|kidney transplant
1212554|NCT01976390|Renal failure|renal failure
1212555|NCT01976390|End Stage Renal Disease|end stage renal disease
1212556|NCT01976390|kidney transplant recipient|kidney transplant recipient
1212557|NCT01976364|Tofacitinib|tofacitinib
1212558|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
1212559|NCT01976364|Xeljanz|xeljanz
1212560|NCT01976364|CP-690550|cp-690550
1212561|NCT01976364|Jak-inhibitor|jak-inhibitor
1212562|NCT01976364|oral treatment|oral treatment
1212563|NCT01976364|psoriasis|psoriasis
1212564|NCT01976364|OPAL BALANCE|opal balance
1212565|NCT01976364|methotrexate|methotrexate
1212566|NCT01976364|pruritus|pruritus
1212567|NCT01976364|itch|itch
1212568|NCT01976364|DLQI|dlqi
1212569|NCT01976351|Barrett's esophagus|barrett's esophagus
1212570|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
1212571|NCT01976338|BRVO|brvo
1212572|NCT01976338|macular edema|macular edema
1212573|NCT01976338|vision impairment|vision impairment
1212574|NCT01976338|retinal vein occlusion|retinal vein occlusion
1212575|NCT01976338|ranibizumab|ranibizumab
1212576|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
1212577|NCT01976338|anti-VEGF therapy|anti-vegf therapy
1212578|NCT01976338|RFB002|rfb002
1212579|NCT01976325|decision aid|decision aid
1212580|NCT01976325|imported malaria|imported malaria
1212581|NCT01976325|malaria prevention and control|malaria prevention and control
1212582|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
1212583|NCT01976325|mefloquine|mefloquine
1212584|NCT01976325|lariam|lariam
1212585|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
1212586|NCT01976325|malarone|malarone
1212587|NCT01976325|doxycycline|doxycycline
1212588|NCT01976325|vibramycin|vibramycin
1212589|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
1212590|NCT01976221|Comprehensive referrals|comprehensive referrals
1212591|NCT01976221|Appropriate referring|appropriate referring
1212592|NCT01976221|Priority setting|priority setting
1212593|NCT01976221|Waiting time in hospital|waiting time in hospital
1212594|NCT01976208|Omalizumab|omalizumab
1212595|NCT01976208|IgE|ige
1212596|NCT01976208|Asthma|asthma
1212597|NCT01976195|Thalidomide|thalidomide
1212598|NCT01976195|Dexamethasone|dexamethasone
1212599|NCT01976195|ITP|itp
1212600|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
1212601|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
1212602|NCT01976182|methotrexate|methotrexate
1212603|NCT01976182|cyclophosphamide|cyclophosphamide
1212604|NCT01976182|efficiency|efficiency
1588398|NCT00436995|Anaemia|anaemia
1212605|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
1212606|NCT01976169|Breast Cancer|breast cancer
1212607|NCT01976169|Advanced Breast Cancer|advanced breast cancer
1212608|NCT01976104|Thrombocytopenia|thrombocytopenia
1212609|NCT01976104|Chronic Liver Disease|chronic liver disease
1212610|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
1212611|NCT01976091|LGMD2D|lgmd2d
1212612|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
1212613|NCT01976091|gene transfer|gene transfer
1212614|NCT01976091|adeno-associated virus|adeno-associated virus
1212615|NCT01976078|Voriconazole|voriconazole
1212616|NCT01976078|Pharmacokinetics|pharmacokinetics
1212617|NCT01976078|Ontogeny|ontogeny
1212618|NCT01976078|Modeling|modeling
1212619|NCT01976078|Bayesian|bayesian
1212620|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
1212621|NCT01976065|Immature permanent teeth|immature permanent teeth
1212622|NCT01976065|Regeneration|regeneration
1212623|NCT01976052|Biomarkers|biomarkers
1212624|NCT01976052|Genomics|genomics
1212625|NCT01976039|motorcyclist|motorcyclist
1212626|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
1212627|NCT01976039|physical therapy|physical therapy
1212628|NCT01976026|Flow Diversion|flow diversion
1212629|NCT01976026|Aneurysm|aneurysm
1212630|NCT01976026|Intracranial|intracranial
1212631|NCT01976026|Cerebral|cerebral
1212632|NCT01976026|Vertebral|vertebral
1212633|NCT01976026|blood blister-like|blood blister-like
1212634|NCT01976026|ruptured aneurysm|ruptured aneurysm
1212635|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
1212636|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
1212637|NCT01976026|Best-Standard Treatment|best-standard treatment
1212638|NCT01976013|PT|pt
1212639|NCT01976013|INR|inr
1212640|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
1212641|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
1212642|NCT01976013|ELBW infants|elbw infants
1212643|NCT01975987|Intubation|intubation
1212644|NCT01975987|Bonfils fiberscope|bonfils fiberscope
1212645|NCT01975974|vascular|vascular
1212646|NCT01975974|access|access
1212647|NCT01975974|ultrasound|ultrasound
1212648|NCT01975948|Mental Health|mental health
1212649|NCT01975948|Education and Practice Support Program|education and practice support program
1212650|NCT01975948|Depression|depression
1212651|NCT01975948|Primary Care|primary care
1212652|NCT01975948|Skill-based training|skill-based training
1212653|NCT01975948|Patient centered outcomes|patient centered outcomes
1212654|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
1212655|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
1212656|NCT01975935|obesity|obesity
1212657|NCT01975922|language impairment|language impairment
1212658|NCT01975922|language disorder|language disorder
1212659|NCT01975922|language delay|language delay
1212660|NCT01975922|late talkers|late talkers
1212661|NCT01975922|late talking|late talking
1212662|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
1212663|NCT01975909|SCA|sca
1212664|NCT01975909|Ataxia|ataxia
1212665|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1212666|NCT01975909|TMS|tms
1212667|NCT01975883|Blood Glucose|blood glucose
1212668|NCT01975883|Postoperative Complications|postoperative complications
1212669|NCT01975883|Spine|spine
1212670|NCT01975883|Orthopedic surgery|orthopedic surgery
1212671|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
1212672|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
1212673|NCT01975857|sleep|sleep
1212674|NCT01975857|mind body intervention|mind body intervention
1212675|NCT01975857|mind body bridging|mind body bridging
1212676|NCT01975844|Anemia|anemia
1212677|NCT01975844|End Stage Renal Disease|end stage renal disease
1212678|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
1212679|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
1212680|NCT01975805|cesarean delivery|cesarean delivery
1212681|NCT01975805|chlorhexidine|chlorhexidine
1212682|NCT01975805|iodine|iodine
1212683|NCT01975805|skin disinfectant|skin disinfectant
1212684|NCT01975792|PPROM|pprom
1212685|NCT01975792|Pregnant|pregnant
1212686|NCT01975792|Preterm|preterm
1212687|NCT01975792|Premature, labor|premature, labor
1212688|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
1212689|NCT01975766|Head and neck cancer|head and neck cancer
1212690|NCT01975766|ketogenic diet|ketogenic diet
1212691|NCT01975766|radiotherapy|radiotherapy
1212692|NCT01975766|cisplatin|cisplatin
1212693|NCT01975753|pain|pain
1212694|NCT01975727|PONV|ponv
1212695|NCT01975727|Dexamethasone|dexamethasone
1212696|NCT01975727|Treatment|treatment
1212697|NCT01975714|Glaucoma|glaucoma
1212698|NCT01975714|Ocular hypertension|ocular hypertension
1212699|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
1212700|NCT01975701|BGJ398,|bgj398,
1212701|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
1212702|NCT01975701|recurrent GBM,|recurrent gbm,
1212703|NCT01975701|FGFR,|fgfr,
1292115|NCT01616329|RBC|rbc
1212704|NCT01975662|MRSA|mrsa
1212705|NCT01975662|bacteremia|bacteremia
1212706|NCT01975662|vancomycin|vancomycin
1212707|NCT01975662|daptomycin|daptomycin
1212708|NCT01975649|postmenopausal|postmenopausal
1212709|NCT01975649|hypoactive|hypoactive
1212710|NCT01975649|sexual disorder|sexual disorder
1212711|NCT01975649|androgen|androgen
1212712|NCT01975636|Metabolism and Elimination|metabolism and elimination
1212713|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
1212714|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
1212715|NCT01975571|residual hearing|residual hearing
1212716|NCT01975571|hybrid|hybrid
1212717|NCT01975571|hearing preservation|hearing preservation
1212718|NCT01975545|Down syndrome|down syndrome
1212719|NCT01975545|Caries|caries
1212720|NCT01975545|Dental varnish|dental varnish
1212721|NCT01975519|TRC105|trc105
1212722|NCT01975519|CD105|cd105
1212723|NCT01975519|Endoglin|endoglin
1212724|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
1212725|NCT01975519|STS|sts
1212726|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
1212727|NCT01975519|TKI|tki
1212728|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1212729|NCT01975519|Pazopanib|pazopanib
1212730|NCT01975519|Votrient|votrient
1212731|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
1212732|NCT01975519|Angiosarcoma|angiosarcoma
1212733|NCT01975506|Head Start|head start
1212734|NCT01975506|Occupational Therapy|occupational therapy
1212735|NCT01975493|Infectious Diseases|infectious diseases
1212736|NCT01975493|Paediatrics|paediatrics
1212737|NCT01975493|Neonatology|neonatology
1212738|NCT01975493|Pharmacokinetics|pharmacokinetics
1212739|NCT01975493|Antimicrobials|antimicrobials
1212740|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
1212741|NCT01975467|intramedullary nail|intramedullary nail
1212742|NCT01975467|sling|sling
1212743|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
1212744|NCT01975454|Chemotherapy|chemotherapy
1212745|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
1212746|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
1212747|NCT01975441|Diethycarbamazine|diethycarbamazine
1212748|NCT01975441|Albendazole|albendazole
1212749|NCT01975441|Ivermectin|ivermectin
1212750|NCT01975441|Lymphatic filariasis|lymphatic filariasis
1212751|NCT01975415|Meditation|meditation
1212752|NCT01975415|Sensors|sensors
1212753|NCT01975415|Digital medicine|digital medicine
1212754|NCT01975402|Congestive Heart Failure|congestive heart failure
1212755|NCT01975389|myocardial infarction|myocardial infarction
1212756|NCT01975389|stroke|stroke
1212757|NCT01975389|hyperlipidemia|hyperlipidemia
1212758|NCT01975376|myocardial infarction|myocardial infarction
1212759|NCT01975376|stroke|stroke
1212760|NCT01975376|hyperlipidemia|hyperlipidemia
1212761|NCT01975363|Breast Cancer|breast cancer
1212762|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
1212763|NCT01975324|Ampyra|ampyra
1212764|NCT01975324|NAION|naion
1212765|NCT01975324|Dalfampridine|dalfampridine
1212766|NCT01975298|RRMS|rrms
1212767|NCT01975285|Pain management|pain management
1212768|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
1212769|NCT01975285|Perioperative outcomes|perioperative outcomes
1212770|NCT01975285|Dexamethasone|dexamethasone
1212771|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
1212772|NCT01975285|Analgesic adjuvant|analgesic adjuvant
1212773|NCT01975272|postoperative|postoperative
1212774|NCT01975272|anemia|anemia
1212775|NCT01975272|gynaecologic|gynaecologic
1212776|NCT01975272|surgery|surgery
1212777|NCT01975233|Endovascular|endovascular
1212778|NCT01975233|Brain Aneurysm|brain aneurysm
1212779|NCT01975181|cardiovascular health|cardiovascular health
1212780|NCT01975181|lifestyle modification|lifestyle modification
1212781|NCT01975181|patient reported outcomes|patient reported outcomes
1212782|NCT01975181|risk assessment|risk assessment
1212783|NCT01975168|laser acupuncture|laser acupuncture
1212784|NCT01975168|obesity|obesity
1212785|NCT01975155|Celiac disease|celiac disease
1212786|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
1212787|NCT01975155|mycotoxins|mycotoxins
1212788|NCT01975155|Gluten free diet|gluten free diet
1212789|NCT01975142|Metastatic breast cancer|metastatic breast cancer
1212790|NCT01975142|Primary tumor HER2 negative|primary tumor her2 negative
1212791|NCT01975142|CTC HER2 positive|ctc her2 positive
1212792|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
1212793|NCT01975064|Breast neoplasms|breast neoplasms
1212794|NCT01975064|Colonic neoplasms|colonic neoplasms
1212795|NCT01975064|Rectal neoplasms|rectal neoplasms
1212796|NCT01975051|Kala- azar|kala- azar
1212797|NCT01975051|PKDL|pkdl
1212798|NCT01975051|Treatment|treatment
1212799|NCT01975051|Pathogenesis|pathogenesis
1212800|NCT01975051|Bangladesh|bangladesh
1212801|NCT01975038|Melanin Index|melanin index
1212802|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
1212803|NCT01975038|Spectrophotometry|spectrophotometry
1212804|NCT01975038|Skin Diseases|skin diseases
1212805|NCT01975025|Renal Dialysis|renal dialysis
1212807|NCT01974999|Transplant|transplant
1212808|NCT01974999|Rejection|rejection
1212809|NCT01974986|dehydration|dehydration
1212810|NCT01974986|exercise|exercise
1212811|NCT01974986|rehydration|rehydration
1212812|NCT01974986|sodium|sodium
1212813|NCT01974986|water|water
1212814|NCT01974986|carbohydrate|carbohydrate
1212815|NCT01974973|autism spectrum disorders|autism spectrum disorders
1212816|NCT01974973|stem cells|stem cells
1212817|NCT01974947|Metabolic syndrome|metabolic syndrome
1212818|NCT01974947|Epigenetic|epigenetic
1212819|NCT01974947|Male infertility|male infertility
1212820|NCT01974947|Sperm parameters|sperm parameters
1212821|NCT01974947|Biomarkers|biomarkers
1212822|NCT01974921|Asthma|asthma
1212823|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
1212824|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
1212825|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
1212826|NCT01974895|Children|children
1212827|NCT01974895|Immunogenicity|immunogenicity
1212828|NCT01974895|Fluzone®|fluzone®
1212829|NCT01974895|6 to 35 months of age|6 to 35 months of age
1212830|NCT01974895|Seasonal influenza|seasonal influenza
1212831|NCT01974895|Safety|safety
1212832|NCT01974882|abdominal surgery|abdominal surgery
1212833|NCT01974882|cryotherapy|cryotherapy
1212834|NCT01974882|pain score|pain score
1212835|NCT01974882|narcotic utilization|narcotic utilization
1212836|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
1212837|NCT01974830|alpha-1|alpha-1
1212838|NCT01974830|anti-trypsin|anti-trypsin
1212839|NCT01974830|pulmonary function|pulmonary function
1213745|NCT01970852|Inpatient|inpatient
1212840|NCT01974830|augmentation therayp|augmentation therayp
1212841|NCT01974830|home care|home care
1212842|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
1212843|NCT01974817|end stage renal disease|end stage renal disease
1212844|NCT01974817|dialysis|dialysis
1212846|NCT01974804|Brain metastases|brain metastases
1212847|NCT01974804|13-094|13-094
1212848|NCT01974765|Enzalutamide|enzalutamide
1212849|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
1212850|NCT01974765|13-119|13-119
1212851|NCT01974752|uveal melanoma|uveal melanoma
1212852|NCT01974739|intensive care|intensive care
1212853|NCT01974739|diuretics|diuretics
1212854|NCT01974726|ear|ear
1212855|NCT01974726|middle ear|middle ear
1212856|NCT01974726|Eustachian tube|eustachian tube
1212857|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
1212858|NCT01974726|Eustachian tube function|eustachian tube function
1212859|NCT01974713|CKD progression|ckd progression
1212860|NCT01974713|Inflammation|inflammation
1212861|NCT01974713|FGF23|fgf23
1212862|NCT01974713|Genetic biomarkers|genetic biomarkers
1212863|NCT01974687|Hepatitis C virus|hepatitis c virus
1212864|NCT01974687|HCV|hcv
1212865|NCT01974674|diabetes|diabetes
1212866|NCT01974674|transplantation|transplantation
1212867|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
1212868|NCT01974648|propofol|propofol
1212869|NCT01974648|remifentanil|remifentanil
1212870|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
1212871|NCT01974648|ED50|ed50
1212872|NCT01974635|Spinal Cord Injury|spinal cord injury
1212873|NCT01974635|Robotic therapy|robotic therapy
1212874|NCT01974635|Rehabilitation|rehabilitation
1212875|NCT01974635|Sensation|sensation
1212876|NCT01974635|Movement|movement
1212877|NCT01974635|Proprioception|proprioception
1212878|NCT01974635|Stroke|stroke
1212879|NCT01974635|Acquired Brain Injury|acquired brain injury
1212880|NCT01974609|pain relief|pain relief
1212881|NCT01974609|narcotic pain relief|narcotic pain relief
1212882|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
1212883|NCT01974609|post-operative pain relief|post-operative pain relief
1212884|NCT01974609|carpal tunnel|carpal tunnel
1212885|NCT01974596|Dental implants|dental implants
1212886|NCT01974596|Probiotics|probiotics
1212887|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
1212888|NCT01974596|Periimplant mucositis|periimplant mucositis
1212889|NCT01974596|Cytokines|cytokines
1212890|NCT01974596|Bacterial load|bacterial load
1212891|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
1212892|NCT01974583|regraft|regraft
1212893|NCT01974583|wound healing|wound healing
1212894|NCT01974570|Prehypertension|prehypertension
1212895|NCT01974570|Hypertension|hypertension
1212896|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
1212897|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
1212898|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
1212899|NCT01974570|Blood pressure|blood pressure
1212900|NCT01974557|Cardiac physiology|cardiac physiology
1212901|NCT01974557|ageing|ageing
1212902|NCT01974557|gender differences|gender differences
1212903|NCT01974557|diastole|diastole
1212904|NCT01974557|fluid challenge|fluid challenge
1212905|NCT01974544|diabetes complications|diabetes complications
1212906|NCT01974544|metabolic surgery|metabolic surgery
1212907|NCT01974544|Intensive medicines|intensive medicines
1212908|NCT01974518|Pemphigus|pemphigus
1212909|NCT01974518|Rituximab|rituximab
1212910|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
1212911|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
1212912|NCT01974492|saphenous vein graft|saphenous vein graft
1212913|NCT01974492|composite graft|composite graft
1212914|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
1212915|NCT01974492|graft remodeling|graft remodeling
1212916|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
1212917|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
1212918|NCT01974466|pancreatitis|pancreatitis
1212919|NCT01974466|resuscitation goal|resuscitation goal
1212920|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
1212921|NCT01974440|Lymphoma|lymphoma
1212922|NCT01974440|Follicular lymphoma|follicular lymphoma
1212923|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
1212924|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
1212925|NCT01974440|PCI-32765|pci-32765
1212926|NCT01974440|Ibrutinib|ibrutinib
1212927|NCT01974440|Bendamustine|bendamustine
1212928|NCT01974440|Rituximab|rituximab
1212929|NCT01974440|Cyclophosphamide|cyclophosphamide
1212930|NCT01974440|Doxorubicin|doxorubicin
1212931|NCT01974440|Vincristine|vincristine
1212932|NCT01974440|Prednisone|prednisone
1212933|NCT01974440|R-CHOP|r-chop
1212934|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1212935|NCT01974427|Functional Imaging|functional imaging
1212936|NCT01974427|BOLD Effect|bold effect
1212937|NCT01974427|EEG|eeg
1212938|NCT01974427|MEG|meg
1212939|NCT01974414|oral lichen planus|oral lichen planus
1212940|NCT01974414|cedar honey|cedar honey
1212941|NCT01974414|atrophic|atrophic
1212942|NCT01974414|erosive|erosive
1212943|NCT01974414|pain|pain
1212944|NCT01974414|treatment|treatment
1212945|NCT01974414|clinical trial|clinical trial
1212946|NCT01974401|oral irrigator|oral irrigator
1212947|NCT01974401|leukemia|leukemia
1212948|NCT01974401|blood dyscrasia|blood dyscrasia
1212949|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
1212950|NCT01974401|supra gingival irrigator|supra gingival irrigator
1212951|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
1212952|NCT01974375|Living donor|living donor
1212953|NCT01974375|Liver transplant|liver transplant
1212954|NCT01974375|antifungal prevention|antifungal prevention
1212955|NCT01974362|Monolithic Zirconia|monolithic zirconia
1212956|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
1212957|NCT01974362|Dental Implants|dental implants
1212958|NCT01974362|Fracture|fracture
1212959|NCT01974362|Chipping|chipping
1212960|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
1212961|NCT01974310|Macular Holes|macular holes
1212962|NCT01974310|Non face down positioning|non face down positioning
1212963|NCT01974310|Face down positioning|face down positioning
1212964|NCT01974297|Hyperlipidemia|hyperlipidemia
1212965|NCT01974297|Atorvastatin|atorvastatin
1212966|NCT01974297|Fenofibric acid|fenofibric acid
1212967|NCT01974297|combination|combination
1212968|NCT01974297|monotherapy|monotherapy
1212969|NCT01974245|Cholecalciferol|cholecalciferol
1212970|NCT01974245|Kidney diseases|kidney diseases
1212971|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
1212972|NCT01974219|HIV|hiv
1212973|NCT01974219|COPD|copd
1212974|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1212975|NCT01974219|Smoking|smoking
1212976|NCT01974206|ASP0113|asp0113
1212977|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
1212978|NCT01974206|Kidney Transplantation|kidney transplantation
1212979|NCT01974180|Smoking|smoking
1212980|NCT01974180|COPD|copd
1212981|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1212982|NCT01974180|Healthy Smoker|healthy smoker
1212983|NCT01974180|Non-smoker|non-smoker
1212984|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
1212985|NCT01974154|COPD|copd
1212986|NCT01974154|Smoking|smoking
1212987|NCT01974154|Non-smoker|non-smoker
1212988|NCT01974128|MI|mi
1212989|NCT01974115|Cellulite|cellulite
1212990|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
1212991|NCT01974115|ESWT|eswt
1212992|NCT01974115|Radial shock wave therapy|radial shock wave therapy
1212993|NCT01974115|RSWT|rswt
1212994|NCT01974089|Dysphagia|dysphagia
1212995|NCT01974089|Modified diet|modified diet
1212996|NCT01974089|Community acquired pneumonia|community acquired pneumonia
1212997|NCT01974089|Mortality|mortality
1212998|NCT01974089|Rehospitalization|rehospitalization
1212999|NCT01974063|Smoking|smoking
1213000|NCT01974063|Smoking Cessation|smoking cessation
1213001|NCT01974063|Healthy Smoker|healthy smoker
1213002|NCT01974063|Shisha Smoker|shisha smoker
1213003|NCT01974063|Non-smoker|non-smoker
1213004|NCT01974050|Influenza vaccination|influenza vaccination
1213005|NCT01974024|Dexamethasone|dexamethasone
1213006|NCT01974024|Hiccup|hiccup
1213007|NCT01974024|Chemotherapy|chemotherapy
1213008|NCT01974024|Methylprednisolone|methylprednisolone
1213009|NCT01973998|COPD|copd
1213010|NCT01973998|Emphysema|emphysema
1213011|NCT01973998|Roflumilast|roflumilast
1213012|NCT01973998|readmission|readmission
1213013|NCT01973985|Pleural Effusion|pleural effusion
1213014|NCT01973972|Diabetes|diabetes
1213015|NCT01973972|Obesity|obesity
1213016|NCT01973972|Complex Care|complex care
1213017|NCT01973972|Primary Care|primary care
1213018|NCT01973972|Chronic Disease|chronic disease
1213019|NCT01973946|Cancer|cancer
1213020|NCT01973933|Metformin|metformin
1213021|NCT01973933|Pyrimethamine|pyrimethamine
1213022|NCT01973933|Drug interaction|drug interaction
1213023|NCT01973920|Diabetes Mellitus|diabetes mellitus
1213024|NCT01973920|Oral Insulin|oral insulin
1213025|NCT01973907|Sepsis|sepsis
1213026|NCT01973907|Septic Shock|septic shock
1213027|NCT01973907|Fluid Therapy|fluid therapy
1213028|NCT01973907|Pediatrics|pediatrics
1213029|NCT01973907|Resuscitation|resuscitation
1213030|NCT01973907|Emergency Medicine|emergency medicine
1213031|NCT01973907|Critical Care|critical care
1213032|NCT01973894|PBPK|pbpk
1213033|NCT01973894|Midazolam|midazolam
1213034|NCT01973894|Pharmacokinetics|pharmacokinetics
1213035|NCT01973894|Critically ill patients|critically ill patients
1213036|NCT01973868|Regorafenib|regorafenib
1213037|NCT01973868|Cetuximab|cetuximab
1213038|NCT01973868|Solid tumors|solid tumors
1213039|NCT01973868|Cancer|cancer
1213040|NCT01973868|Safety|safety
1213041|NCT01973868|Tolerability|tolerability
1213042|NCT01973868|Pharmacokinetics|pharmacokinetics
1213043|NCT01973842|GnRH agonist|gnrh agonist
1213044|NCT01973842|OHSS|ohss
1213045|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
1213046|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
1213047|NCT01973816|deep endometriosis;|deep endometriosis;
1213048|NCT01973816|rectal endometriosis;|rectal endometriosis;
1213049|NCT01973816|rectal shaving;|rectal shaving;
1213050|NCT01973816|colorectal resection;|colorectal resection;
1213051|NCT01973816|bowel endometriosis|bowel endometriosis
1213052|NCT01973803|Carpometacarpal joint|carpometacarpal joint
1213053|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
1213054|NCT01973790|Z-338|z-338
1213055|NCT01973790|Functional Dyspepsia|functional dyspepsia
1213056|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
1213057|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
1213058|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
1213059|NCT01973764|Ventricular System|ventricular system
1213060|NCT01973764|Puncture|puncture
1213061|NCT01973764|Ventricular catheter|ventricular catheter
1213062|NCT01973764|Ventriculostomy|ventriculostomy
1213063|NCT01973764|Hydrocephalus|hydrocephalus
1213064|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
1213065|NCT01973764|Intracranial Hypertension|intracranial hypertension
1213066|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
1213067|NCT01973738|raloxifene|raloxifene
1213068|NCT01973738|bazedoxifene|bazedoxifene
1213069|NCT01973738|bone mineral density|bone mineral density
1213070|NCT01973738|bone turnover markers|bone turnover markers
1213071|NCT01973738|bone quality|bone quality
1213072|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
1213073|NCT01973673|prostate cancer|prostate cancer
1213074|NCT01973673|ADT|adt
1213075|NCT01973673|bone health|bone health
1213076|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
1213077|NCT01973660|HER2|her2
1213078|NCT01973660|HER2 positive|her2 positive
1213079|NCT01973660|PAM50|pam50
1213080|NCT01973660|lapatinib|lapatinib
1213081|NCT01973660|trastuzumab|trastuzumab
1213082|NCT01973660|dual HER2 blockade|dual her2 blockade
1213083|NCT01973660|neoadjuvant|neoadjuvant
1213084|NCT01973647|insomnia|insomnia
1213085|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
1213086|NCT01973647|COPD|copd
1213087|NCT01973647|fatigue|fatigue
1213088|NCT01973634|Radiotherapy|radiotherapy
1213089|NCT01973608|Melanoma|melanoma
1213090|NCT01973608|MSB0010445|msb0010445
1213091|NCT01973608|Dose limiting toxicity|dose limiting toxicity
1213092|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
1213093|NCT01973595|almonds|almonds
1213094|NCT01973595|inflammation|inflammation
1213095|NCT01973595|immunity|immunity
1213096|NCT01973595|gut microbiota|gut microbiota
1213097|NCT01973595|stress|stress
1213098|NCT01973595|diet quality|diet quality
1213099|NCT01973582|Hepatitis B|hepatitis b
1213100|NCT01973582|epidemiology|epidemiology
1213101|NCT01973582|youth|youth
1213102|NCT01973582|vaccine|vaccine
1213103|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
1213104|NCT01973569|Denosumab|denosumab
1213105|NCT01973569|RANKL|rankl
1213106|NCT01973569|RANK|rank
1213107|NCT01973569|AMG 162|amg 162
1213108|NCT01973569|joint damage|joint damage
1213109|NCT01973569|Developmental Phase III|developmental phase iii
1213110|NCT01973543|PD|pd
1213111|NCT01973543|Parkinson's disease|parkinson's disease
1213112|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
1213113|NCT01973543|AADC|aadc
1213114|NCT01973543|AAV2-AADC|aav2-aadc
1213115|NCT01973543|AAV2|aav2
1213116|NCT01973543|Viral Vector|viral vector
1213117|NCT01973543|Gene Therapy|gene therapy
1213118|NCT01973543|Gene Transfer|gene transfer
1213119|NCT01973543|MRI|mri
1213120|NCT01973543|PET|pet
1213121|NCT01973543|VY-AADC01|vy-aadc01
1213122|NCT01973530|femoral nerve block|femoral nerve block
1213123|NCT01973530|adductor canal block|adductor canal block
1213124|NCT01973530|steroid|steroid
1213125|NCT01973530|total knee replacement|total knee replacement
1213126|NCT01973517|Multiple sclerosis|multiple sclerosis
1213127|NCT01973517|MRI|mri
1213128|NCT01973517|USPIO|uspio
1213129|NCT01973517|Ferumoxytol|ferumoxytol
1213130|NCT01973517|Feraheme|feraheme
1213131|NCT01973504|Trauma|trauma
1213132|NCT01973504|Hemorrhagic shock|hemorrhagic shock
1213133|NCT01973504|Hemorrhage|hemorrhage
1213134|NCT01973504|Lactic acidosis|lactic acidosis
1213135|NCT01973504|Oxygen therapeutics|oxygen therapeutics
1213136|NCT01973504|Oxygen carriers|oxygen carriers
1213137|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
1213138|NCT01973504|Hemoglobin solutions|hemoglobin solutions
1213139|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
1213140|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
1213237|NCT01973127|alcohol|alcohol
1213141|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1213142|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1213143|NCT01973491|M2736|m2736
1213144|NCT01973478|Major depressive disorder|major depressive disorder
1213145|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
1213146|NCT01973478|Bipolar disorder|bipolar disorder
1213147|NCT01973478|Deep brain stimulation|deep brain stimulation
1213148|NCT01973478|Accumbens|accumbens
1213149|NCT01973465|C-Diff|c-diff
1213150|NCT01973465|Diarrhea|diarrhea
1213151|NCT01973452|Dexmedetomidine|dexmedetomidine
1213152|NCT01973452|Opioid|opioid
1213153|NCT01973452|Thoracic Surgery|thoracic surgery
1213155|NCT01973439|Abacavir|abacavir
1213156|NCT01973439|Lamivudine|lamivudine
1213157|NCT01973439|Pharmacokinetics|pharmacokinetics
1213158|NCT01973426|Robot|robot
1213159|NCT01973426|Thumb|thumb
1213160|NCT01973426|Orthosis|orthosis
1213161|NCT01973426|Hemiplegia|hemiplegia
1213162|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
1213163|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
1213164|NCT01973426|Stroke|stroke
1213165|NCT01973426|Cerebral Palsy|cerebral palsy
1213166|NCT01973426|Grasp assistance|grasp assistance
1213167|NCT01973413|Artificial Pancreas Project|artificial pancreas project
1213168|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1213169|NCT01973413|Insulin pump therapy|insulin pump therapy
1213170|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
1213171|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
1213172|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
1213173|NCT01973413|Closed-to-Range|closed-to-range
1213174|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1213175|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1213176|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
1213177|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
1213178|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
1213179|NCT01973387|Ibrutinib|ibrutinib
1213180|NCT01973387|PCI-32765|pci-32765
1213181|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1213182|NCT01973387|Rituximab|rituximab
1213183|NCT01973387|Asia Pacific region participants|asia pacific region participants
1213184|NCT01973361|Wounds|wounds
1213185|NCT01973361|Lower extremity|lower extremity
1213186|NCT01973361|Diabetes|diabetes
1213187|NCT01973361|Arterial Insufficiency|arterial insufficiency
1213188|NCT01973361|Debridement|debridement
1213189|NCT01973361|Low frequency ultrasound|low frequency ultrasound
1213190|NCT01973361|Contact ultrasound|contact ultrasound
1213191|NCT01973361|Wound clinic|wound clinic
1213192|NCT01973361|Wound bed preparation|wound bed preparation
1213193|NCT01973361|Wound infection|wound infection
1213194|NCT01973361|Chronic wound inflammation|chronic wound inflammation
1213195|NCT01973348|amblyopia|amblyopia
1213196|NCT01973335|acetazolamide|acetazolamide
1213197|NCT01973335|bumetanide|bumetanide
1213198|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
1213199|NCT01973335|diuretics|diuretics
1213200|NCT01973335|heart failure|heart failure
1213201|NCT01973335|natriuresis|natriuresis
1213202|NCT01973335|spironolactone|spironolactone
1213203|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
1213204|NCT01973322|pretreated melanoma|pretreated melanoma
1213205|NCT01973322|vaccination|vaccination
1213206|NCT01973322|autologous dendritic cells|autologous dendritic cells
1213207|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
1213208|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
1213209|NCT01973309|Locally Recurrent|locally recurrent
1213210|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
1213211|NCT01973296|Health Literacy|health literacy
1213212|NCT01973296|Care Transition Intervention|care transition intervention
1213213|NCT01973296|Emergency Department Population|emergency department population
1213214|NCT01973296|Access to Care|access to care
1213215|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
1213216|NCT01973205|Migraine|migraine
1213217|NCT01973205|acetaminophen|acetaminophen
1213218|NCT01973205|aspirin|aspirin
1213219|NCT01973166|Tattoo Removal|tattoo removal
1213220|NCT01973166|Q-switched laser|q-switched laser
1213221|NCT01973166|Nd:YAG laser|nd:yag laser
1213222|NCT01973166|Nanosecond laser|nanosecond laser
1213223|NCT01973166|Picosecond laser|picosecond laser
1213224|NCT01973166|Laser therapy|laser therapy
1213225|NCT01973166|Tattoo|tattoo
1213226|NCT01973166|pulsed-laser|pulsed-laser
1213227|NCT01973166|laser treatment|laser treatment
1213228|NCT01973166|remove tattoo|remove tattoo
1213229|NCT01973166|tattoo clearing|tattoo clearing
1213230|NCT01973166|tattoo lightening|tattoo lightening
1213231|NCT01973166|tattoo lighten|tattoo lighten
1213232|NCT01973153|Obesity prevention|obesity prevention
1213233|NCT01973153|Weight management|weight management
1213234|NCT01973153|Motivational Interviewing|motivational interviewing
1213235|NCT01973140|Tolvaptan|tolvaptan
1213236|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
1213238|NCT01973127|addiction|addiction
1213240|NCT01973127|craving|craving
1213241|NCT01973127|use|use
1213242|NCT01973127|rTMS|rtms
1213243|NCT01973127|EEG|eeg
1213244|NCT01973127|LPP|lpp
1213245|NCT01973127|p300|p300
1213246|NCT01973127|ERN|ern
1213247|NCT01973127|SST|sst
1213248|NCT01973127|CCT|cct
1213249|NCT01973127|AAAT|aaat
1213250|NCT01973114|Menière's disease|menière's disease
1213251|NCT01973114|Vertigo|vertigo
1213252|NCT01973114|Hearing loss|hearing loss
1213253|NCT01973114|Tinnitus|tinnitus
1213254|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
1213255|NCT01973101|Chemoradiation|chemoradiation
1213256|NCT01973101|Chemo-induction|chemo-induction
1213257|NCT01973101|Cisplatin|cisplatin
1213258|NCT01973101|Gemcitabine|gemcitabine
1213259|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
1213260|NCT01973036|foley catheter|foley catheter
1213261|NCT01973036|foley bulb|foley bulb
1213262|NCT01973036|oxytocin|oxytocin
1213263|NCT01973023|botulinum toxin injection|botulinum toxin injection
1213264|NCT01973023|stroke|stroke
1213265|NCT01973023|3D motion analysis|3d motion analysis
1213266|NCT01973023|gait pattern|gait pattern
1213267|NCT01973010|massage|massage
1213268|NCT01973010|low back pain|low back pain
1213269|NCT01972984|Estrogen receptor positive|estrogen receptor positive
1213270|NCT01972971|warfarin|warfarin
1213271|NCT01972971|pharmacist|pharmacist
1213272|NCT01972971|anticoagulation|anticoagulation
1213273|NCT01972945|vaginoscopy|vaginoscopy
1213274|NCT01972945|hysteroscopy|hysteroscopy
1213275|NCT01972945|office hysteroscopy|office hysteroscopy
1213276|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
1213277|NCT01972932|Bio-K+®|bio-k+®
1213278|NCT01972932|Placebo|placebo
1213279|NCT01972932|AAD|aad
1213280|NCT01972932|CDI|cdi
1213281|NCT01972932|hospitalized subjects|hospitalized subjects
1213282|NCT01972906|moxibustion|moxibustion
1213283|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
1213284|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
1213285|NCT01972880|Open-label design|open-label design
1213286|NCT01972880|Bioequivalence|bioequivalence
1213287|NCT01972880|ASP1941|asp1941
1213288|NCT01972867|Focal|focal
1213289|NCT01972867|Prostate|prostate
1213290|NCT01972867|Cancer|cancer
1213291|NCT01972867|Irreversible|irreversible
1213292|NCT01972867|Electroporation|electroporation
1213293|NCT01972867|NanoKnife|nanoknife
1213294|NCT01972854|keratoconus|keratoconus
1213295|NCT01972854|cross-linking|cross-linking
1213296|NCT01972854|KXL|kxl
1213297|NCT01972841|Combination Therapy|combination therapy
1213298|NCT01972841|Mirabegron|mirabegron
1213299|NCT01972841|Overactive Bladder|overactive bladder
1213300|NCT01972841|Urgency|urgency
1213301|NCT01972841|Urinary Incontinence|urinary incontinence
1213302|NCT01972841|Nocturia|nocturia
1213303|NCT01972841|Solifenacin Succinate|solifenacin succinate
1213304|NCT01972828|Septic shock|septic shock
1213305|NCT01972828|Randomized controlled trial|randomized controlled trial
1213306|NCT01972828|Preload dependence|preload dependence
1213307|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
1213308|NCT01972802|HEAD AND NECK|head and neck
1213309|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
1213310|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
1213311|NCT01972789|inject and extend|inject and extend
1213312|NCT01972789|retinal fluid|retinal fluid
1213313|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
1213314|NCT01972750|glioblastoma|glioblastoma
1213315|NCT01972750|recurrence|recurrence
1213316|NCT01972737|Vaccine|vaccine
1213317|NCT01972737|Colon cancer|colon cancer
1213318|NCT01972737|safety|safety
1213319|NCT01972737|tolerability|tolerability
1213320|NCT01972737|antibody responses|antibody responses
1213321|NCT01972737|T cell responses|t cell responses
1213322|NCT01972724|Drug therapy|drug therapy
1213323|NCT01972711|Schizophrenia|schizophrenia
1213324|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
1213325|NCT01972698|Lung Ultrasound|lung ultrasound
1213326|NCT01972698|Simulation|simulation
1213327|NCT01972698|Education|education
1213328|NCT01972698|Web-based learning|web-based learning
1213329|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
1213330|NCT01972659|sugammadex|sugammadex
1213331|NCT01972659|rocuronium|rocuronium
1213332|NCT01972659|magnesium|magnesium
1213333|NCT01972659|female|female
1213334|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
1213335|NCT01972633|endovenous treatment|endovenous treatment
1213336|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
1213337|NCT01972633|Varicosis|varicosis
1213338|NCT01972633|great saphenous vein|great saphenous vein
1213339|NCT01972633|small saphenous vein|small saphenous vein
1213340|NCT01972633|Venous Insufficiency|venous insufficiency
1213341|NCT01972620|gallstones|gallstones
1213342|NCT01972620|cholelithiasis|cholelithiasis
1213343|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
1213345|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
1213346|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
1213347|NCT01972581|baseball|baseball
1213348|NCT01972568|Atacicept|atacicept
1213350|NCT01972542|Postprandial period|postprandial period
1213351|NCT01972542|triglyceride|triglyceride
1213352|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
1213353|NCT01972542|Prediabetic state|prediabetic state
1213354|NCT01972529|Thrombocytopenia|thrombocytopenia
1213355|NCT01972529|Chronic Liver Disease|chronic liver disease
1213356|NCT01972516|Platinum-Sensitive|platinum-sensitive
1213357|NCT01972516|Ovarian Cancer|ovarian cancer
1213358|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
1213359|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
1213360|NCT01972516|High-grade Serous|high-grade serous
1213361|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
1213362|NCT01972503|Liver|liver
1213363|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
1213364|NCT01972503|Tegafur|tegafur
1213365|NCT01972503|oxaliplatin|oxaliplatin
1213366|NCT01972490|colorectal neoplasms|colorectal neoplasms
1213367|NCT01972490|liver metastasis|liver metastasis
1213368|NCT01972490|chemotherapy|chemotherapy
1213369|NCT01972490|avastin|avastin
1213370|NCT01972477|DLBS1449|dlbs1449
1213371|NCT01972477|diabetes mellitus|diabetes mellitus
1213372|NCT01972477|HDL-cholesterol|hdl-cholesterol
1213373|NCT01972464|Progesterone|progesterone
1213374|NCT01972464|Placebo|placebo
1213375|NCT01972464|Postpartum|postpartum
1213376|NCT01972464|Tobacco|tobacco
1213377|NCT01972464|Pregnancy|pregnancy
1213378|NCT01972438|Graft Versus Host Disease|graft versus host disease
1213379|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1213380|NCT01972412|nursing care|nursing care
1213381|NCT01972412|diabetes mellitus|diabetes mellitus
1213382|NCT01972412|phone support|phone support
1213383|NCT01972412|chronic care model|chronic care model
1213384|NCT01972373|VEGF|vegf
1213385|NCT01972373|Fluorescence|fluorescence
1213386|NCT01972373|Endoscopy|endoscopy
1213387|NCT01972373|Rectal cancer|rectal cancer
1213388|NCT01972360|SPECT|spect
1213389|NCT01972360|CMR|cmr
1213390|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
1213391|NCT01972347|Melanoma|melanoma
1213392|NCT01972347|Cutaneous melanoma|cutaneous melanoma
1213393|NCT01972347|Malignant melanoma|malignant melanoma
1213394|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
1213395|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
1213396|NCT01972347|Pyrexia|pyrexia
1213397|NCT01972347|Biomarkers|biomarkers
1213398|NCT01972347|Dabrafenib|dabrafenib
1213399|NCT01972347|Trametinib|trametinib
1213400|NCT01972334|clostridium difficile|clostridium difficile
1213401|NCT01972334|children|children
1213402|NCT01972334|fecal transplant|fecal transplant
1213403|NCT01972321|Community health worker|community health worker
1213404|NCT01972321|Motivation|motivation
1213405|NCT01972321|Performance|performance
1213406|NCT01972321|Quality of care|quality of care
1213407|NCT01972321|Africa|africa
1213408|NCT01972308|asthma|asthma
1213409|NCT01972308|patient advocate|patient advocate
1213410|NCT01972308|health disparity|health disparity
1213411|NCT01972308|patient-provider communication|patient-provider communication
1213412|NCT01972282|Atrial fibrillation|atrial fibrillation
1213413|NCT01972282|Stroke|stroke
1213414|NCT01972282|Thrombus|thrombus
1213415|NCT01972282|Thromboembolism|thromboembolism
1213416|NCT01972282|Left atrial appendage|left atrial appendage
1213417|NCT01972269|Epidural|epidural
1213418|NCT01972269|Labor Analgesia|labor analgesia
1213419|NCT01972269|Bupivacaine|bupivacaine
1213420|NCT01972269|Minimum effective volume|minimum effective volume
1213421|NCT01972243|risk of recurrent|risk of recurrent
1213422|NCT01972217|Olaparib|olaparib
1213423|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
1213424|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
1213425|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
1213426|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
1213427|NCT01972152|Hypoglycemia|hypoglycemia
1213428|NCT01972152|Glucagon|glucagon
1213429|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
1213430|NCT01972139|blood pressure|blood pressure
1213431|NCT01972139|renal denervation|renal denervation
1213432|NCT01972139|HTN-4|htn-4
1213433|NCT01972139|SYMPLICITY|symplicity
1213434|NCT01972113|Vitamin K|vitamin k
1213435|NCT01972113|Vitamin K2|vitamin k2
1213436|NCT01972113|Menaquinone-7|menaquinone-7
1213437|NCT01972113|Osteocalcin|osteocalcin
1213438|NCT01972113|Children|children
1213439|NCT01972113|Obesity|obesity
1213440|NCT01972113|Insulin resistance|insulin resistance
1213441|NCT01972113|Insulin sensitivity|insulin sensitivity
1213442|NCT01972113|Beta-cell function|beta-cell function
1213443|NCT01972113|Prediabetes|prediabetes
1213444|NCT01972113|Matrix Gla protein|matrix gla protein
1213445|NCT01972113|Arterial stiffness|arterial stiffness
1213446|NCT01972113|Endothelial function|endothelial function
1213447|NCT01972100|Low-level laser therapy|low-level laser therapy
1213448|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
1213449|NCT01972074|Autism spectrum disorder|autism spectrum disorder
1213450|NCT01972074|Treatment|treatment
1213451|NCT01972074|Adolescents|adolescents
1213452|NCT01972074|Memantine|memantine
1213453|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1213454|NCT01972074|MRS|mrs
1213455|NCT01972074|Neuroimaging|neuroimaging
1213456|NCT01972048|breast cancer|breast cancer
1213457|NCT01972048|breast cancer screening|breast cancer screening
1213458|NCT01972048|mammogram|mammogram
1213459|NCT01972035|EBV|ebv
1213460|NCT01972035|CMV|cmv
1213461|NCT01972035|Kidney transplant|kidney transplant
1213462|NCT01972035|valganciclovir|valganciclovir
1213463|NCT01972035|valacyclovir|valacyclovir
1213464|NCT01972022|Drug Eluting Stents|drug eluting stents
1213465|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
1213466|NCT01972022|Neoatherosclerosis|neoatherosclerosis
1213467|NCT01972022|Stent Coverage|stent coverage
1213468|NCT01972022|Stent Failure|stent failure
1213469|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
1213470|NCT01971983|Low back pain|low back pain
1213471|NCT01971983|Spinal manipulation|spinal manipulation
1213472|NCT01971983|Osteopathy|osteopathy
1213473|NCT01971983|Muscle energy technique|muscle energy technique
1213474|NCT01971983|Muscle thickness|muscle thickness
1213475|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
1213476|NCT01971970|Pediatric|pediatric
1213477|NCT01971970|Adult|adult
1213478|NCT01971970|Biomarker|biomarker
1213479|NCT01971970|Anti-TNF response|anti-tnf response
1213480|NCT01971970|Infliximab|infliximab
1213481|NCT01971970|Adalimumab|adalimumab
1213482|NCT01971957|ichthyosis|ichthyosis
1213483|NCT01971957|spasticity|spasticity
1213484|NCT01971957|spastic diplegia|spastic diplegia
1213485|NCT01971957|intellectual disability|intellectual disability
1213486|NCT01971944|Beta Blocker|beta blocker
1213487|NCT01971944|Inotrope|inotrope
1213488|NCT01971918|spondyloarthritis|spondyloarthritis
1213489|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
1213490|NCT01971918|secondary treatment failure|secondary treatment failure
1213491|NCT01971892|Abdominal surgery;|abdominal surgery;
1213492|NCT01971892|Postoperative complication;|postoperative complication;
1213493|NCT01971892|Acute respiratory failure;|acute respiratory failure;
1213494|NCT01971892|Hypoxemia;|hypoxemia;
1213495|NCT01971892|Intubation;|intubation;
1213496|NCT01971892|Non-invasive ventilation|non-invasive ventilation
1213497|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
1213498|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
1213499|NCT01971866|Proton radiation|proton radiation
1213500|NCT01971866|AlignRT|alignrt
1213501|NCT01971853|Analgesia|analgesia
1213502|NCT01971840|Physical activity|physical activity
1213503|NCT01971840|Physical fitness|physical fitness
1213504|NCT01971840|Obesity|obesity
1213505|NCT01971840|Adiposity|adiposity
1213506|NCT01971840|Adiposity rebound period|adiposity rebound period
1213507|NCT01971840|Children|children
1213508|NCT01971840|Blood pressure|blood pressure
1213509|NCT01971840|Randomized controlled trials|randomized controlled trials
1213510|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
1213511|NCT01971827|Physical activity|physical activity
1213512|NCT01971827|Obesity|obesity
1213513|NCT01971827|Adiposity rebound period|adiposity rebound period
1213514|NCT01971827|Children with ADHD|children with adhd
1213515|NCT01971827|Children without ADHD|children without adhd
1213516|NCT01971827|Academic performance|academic performance
1213517|NCT01971827|Motor skills|motor skills
1213518|NCT01971827|Health related-quality of life|health related-quality of life
1213519|NCT01971827|Sleep|sleep
1213520|NCT01971801|urinary incontinence|urinary incontinence
1213521|NCT01971801|bowel incontinence|bowel incontinence
1213522|NCT01971801|vitamin D|vitamin d
1213523|NCT01971801|overactive bladder|overactive bladder
1213524|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
1213525|NCT01971801|quality of life|quality of life
1213526|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
1213527|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
1213528|NCT01971775|Gastric Cancer|gastric cancer
1213529|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
1213530|NCT01971762|bacteremia management|bacteremia management
1213531|NCT01971762|blood culture|blood culture
1213532|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
1213533|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
1213534|NCT01971736|1064nm YAG laser|1064nm yag laser
1213535|NCT01971736|laxity|laxity
1213536|NCT01971736|rhytides|rhytides
1213537|NCT01971736|asian|asian
1213538|NCT01971723|Testosterone|testosterone
1213539|NCT01971723|Estrogen|estrogen
1213540|NCT01971723|Insulin|insulin
1213541|NCT01971723|Blood Lipid|blood lipid
1213542|NCT01971723|Glucose|glucose
1213543|NCT01971723|Creatine Kinase|creatine kinase
1213544|NCT01971723|Strength|strength
1213545|NCT01971723|Power Athlete|power athlete
1213546|NCT01971710|HIV|hiv
1213547|NCT01971710|AIDS|aids
1213548|NCT01971710|PMTCT|pmtct
1213549|NCT01971684|ITP|itp
1213550|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1213551|NCT01971684|bleeding score|bleeding score
1213552|NCT01971684|platelet count|platelet count
1213553|NCT01971684|health-related quality of life|health-related quality of life
1213554|NCT01971684|HRQL|hrql
1213555|NCT01971684|Purpura|purpura
1213556|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
1213557|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
1213558|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
1213559|NCT01971684|Hematologic Diseases|hematologic diseases
1213560|NCT01971684|Hemorrhage|hemorrhage
1213561|NCT01971684|Skin Manifestations|skin manifestations
1213562|NCT01971684|Thrombocytopenia|thrombocytopenia
1213563|NCT01971684|Blood Platelet Disorders|blood platelet disorders
1213564|NCT01971684|Immune System Diseases|immune system diseases
1213565|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
1213566|NCT01971684|Autoimmune Diseases|autoimmune diseases
1213567|NCT01971684|Therapeutic Uses|therapeutic uses
1213568|NCT01971658|Multiple myeloma|multiple myeloma
1213569|NCT01971658|Newly Diagnosed|newly diagnosed
1213570|NCT01971645|Dexamethasone|dexamethasone
1213571|NCT01971645|Ropivacaine|ropivacaine
1213572|NCT01971645|Knee arthroscopy|knee arthroscopy
1213573|NCT01971645|Femoral nerve blocks|femoral nerve blocks
1213574|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
1213575|NCT01971645|Adjuvant|adjuvant
1213576|NCT01971645|Pediatrics|pediatrics
1213577|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
1213578|NCT01971567|Insomnia|insomnia
1213579|NCT01971567|Electroencephalic|electroencephalic
1213580|NCT01971567|Biofeedback|biofeedback
1213581|NCT01971567|Neural oscillations|neural oscillations
1213582|NCT01971567|Auto calibration|auto calibration
1213583|NCT01971567|Relaxation|relaxation
1213584|NCT01971541|mindfulness|mindfulness
1213585|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
1213586|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
1213587|NCT01971541|group therapy|group therapy
1213588|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
1213589|NCT01971515|MSC2363318A|msc2363318a
1213590|NCT01971515|Maximum tolerated dose|maximum tolerated dose
1213591|NCT01971515|Dose limiting toxicities|dose limiting toxicities
1213592|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
1213593|NCT01971515|M2698|m2698
1213594|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
1213595|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
1213596|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
1213597|NCT01971515|Tamoxifen|tamoxifen
1213598|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
1213599|NCT01971515|PAM Pathway|pam pathway
1213600|NCT01971515|Targeted Therapy|targeted therapy
1213601|NCT01971515|P70S6K|p70s6k
1213602|NCT01971515|AKT Inhibition|akt inhibition
1213603|NCT01971515|PI3K Pathway|pi3k pathway
1213604|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
1213605|NCT01971450|Non-interventional|non-interventional
1213606|NCT01971450|Ventavis|ventavis
1213607|NCT01971450|Iloprost|iloprost
1213608|NCT01971450|Pulmonary hypertension|pulmonary hypertension
1213609|NCT01971450|Compliance|compliance
1213610|NCT01971450|Russian Federation|russian federation
1213611|NCT01971437|Overactive Bladder|overactive bladder
1213613|NCT01971437|Cystoscopy|cystoscopy
1213614|NCT01971437|Cystodistension|cystodistension
1213616|NCT01971437|Cytokines|cytokines
1213617|NCT01971424|magnesium|magnesium
1213618|NCT01971424|SPPB|sppb
1213619|NCT01971424|strength|strength
1213620|NCT01971424|physical performance|physical performance
1213621|NCT01971424|24 hour magnesuria|24 hour magnesuria
1213622|NCT01971411|Hyperparathyroidism|hyperparathyroidism
1213623|NCT01971411|Hypoparathyroidism|hypoparathyroidism
1213624|NCT01971411|Calcium|calcium
1213625|NCT01971411|Vitamin D|vitamin d
1213626|NCT01971411|Bone mineral density|bone mineral density
1213627|NCT01971411|African American|african american
1213628|NCT01971411|Female|female
1213629|NCT01971411|Elderly|elderly
1213630|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
1213631|NCT01971398|Prevention|prevention
1213632|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
1213633|NCT01971398|Knowledge|knowledge
1213634|NCT01971398|Attitudes|attitudes
1213635|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
1213636|NCT01971346|Psoriasis|psoriasis
1213637|NCT01971346|ENBREL|enbrel
1213638|NCT01971346|etanercept|etanercept
1213639|NCT01971346|anti-TNF|anti-tnf
1213640|NCT01971333|pulse pressure variation|pulse pressure variation
1213641|NCT01971333|stroke volume variation|stroke volume variation
1213642|NCT01971333|plethysmographic variation index|plethysmographic variation index
1213643|NCT01971333|fluid responsiveness|fluid responsiveness
1213644|NCT01971294|Urinary symptoms|urinary symptoms
1213645|NCT01971294|Systemic sclerosis|systemic sclerosis
1213646|NCT01971294|Severity index|severity index
1213647|NCT01971294|Urinary tract infection|urinary tract infection
1213648|NCT01971294|mortality|mortality
1213649|NCT01971294|Quality of life|quality of life
1213650|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1213651|NCT01971281|Pancreas tumor|pancreas tumor
1213652|NCT01971281|Treatment|treatment
1213653|NCT01971281|Minimal toxicity|minimal toxicity
1213654|NCT01971281|TTFields|ttfields
1213655|NCT01971281|Tumor Treating Fields|tumor treating fields
1213656|NCT01971281|Novocure|novocure
1213657|NCT01971268|T3 dental implants|t3 dental implants
1213658|NCT01971268|Marginal bone loss|marginal bone loss
1213659|NCT01971268|Survival rate|survival rate
1213660|NCT01971255|Influenza A|influenza a
1213662|NCT01971255|H1N1|h1n1
1213663|NCT01971255|Challenge Study|challenge study
1213664|NCT01971255|Correlates of Protection|correlates of protection
1213665|NCT01971242|Parkinson's|parkinson's
1213666|NCT01971242|Parkinson's Disease|parkinson's disease
1213667|NCT01971242|Exenatide|exenatide
1213668|NCT01971242|Bydureon|bydureon
1213669|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
1213670|NCT01971203|seroquel XR|seroquel xr
1213671|NCT01971203|quetiapine XR|quetiapine xr
1213672|NCT01971203|major depression|major depression
1213673|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
1213674|NCT01971203|CBT|cbt
1213675|NCT01971203|co-morbid MDD|co-morbid mdd
1213676|NCT01971164|anemia|anemia
1213677|NCT01971164|chronic kidney disease|chronic kidney disease
1213678|NCT01971164|hemodialysis|hemodialysis
1213679|NCT01971151|Chronic|chronic
1213680|NCT01971151|Back pain|back pain
1213681|NCT01971151|Low back|low back
1213682|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1213683|NCT01971125|Heart Diseases|heart diseases
1213684|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
1213685|NCT01971112|Multi-vitamins|multi-vitamins
1213686|NCT01971112|Minerals|minerals
1213687|NCT01971112|Respiratory infections|respiratory infections
1213688|NCT01971112|DTH|dth
1213689|NCT01971112|CRP|crp
1213690|NCT01971112|Cathelicidin|cathelicidin
1213691|NCT01971099|sexual function|sexual function
1213692|NCT01971099|hypoactive|hypoactive
1213693|NCT01971099|desire|desire
1213694|NCT01971099|androgens|androgens
1213695|NCT01971073|schizophrenic patients|schizophrenic patients
1213696|NCT01971073|tDCS|tdcs
1213697|NCT01971073|Executive functions|executive functions
1213698|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1213699|NCT01971060|uterine fibroids|uterine fibroids
1213700|NCT01971060|barbed suture|barbed suture
1213701|NCT01971060|infertility|infertility
1213702|NCT01971060|adhesions|adhesions
1213703|NCT01971047|Diabetes|diabetes
1213704|NCT01971047|Surgery|surgery
1213705|NCT01971047|anesthesiology|anesthesiology
1213706|NCT01971047|endocrinology|endocrinology
1213707|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
1213708|NCT01970995|Conventional cigarettes|conventional cigarettes
1213709|NCT01970995|Reduced exposure|reduced exposure
1213710|NCT01970995|HPHCs|hphcs
1213711|NCT01970995|Ambulatory|ambulatory
1213712|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
1213713|NCT01970982|Conventional cigarette|conventional cigarette
1213714|NCT01970982|Reduced exposure|reduced exposure
1213715|NCT01970982|HPHCs|hphcs
1213716|NCT01970982|Confinement|confinement
1213717|NCT01970969|Atrial Fibrillation|atrial fibrillation
1213718|NCT01970969|Cardiac monitoring|cardiac monitoring
1213719|NCT01970969|Genomics|genomics
1213720|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
1213721|NCT01970930|Tissue banking|tissue banking
1213722|NCT01970917|tear film thickness|tear film thickness
1213723|NCT01970917|optical coherence tomography|optical coherence tomography
1213724|NCT01970917|topical lubricants|topical lubricants
1213725|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
1213726|NCT01970904|Chronic hepatitis C|chronic hepatitis c
1213727|NCT01970904|DEB025|deb025
1213728|NCT01970904|Alisporivir|alisporivir
1213729|NCT01970904|ribavirin therapy|ribavirin therapy
1213730|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
1213731|NCT01970891|Freezing of Gait|freezing of gait
1213732|NCT01970891|Gait|gait
1213733|NCT01970891|Comfort|comfort
1213734|NCT01970891|Pain tolerance|pain tolerance
1213735|NCT01970891|Pain|pain
1213736|NCT01970891|Sensory threshold|sensory threshold
1213737|NCT01970891|Motor threshold|motor threshold
1213738|NCT01970891|Pain threshold|pain threshold
1213739|NCT01970865|Phase 1|phase 1
1213740|NCT01970865|Phase 2|phase 2
1213741|NCT01970865|safety|safety
1213742|NCT01970865|pharmacokinetic|pharmacokinetic
1213743|NCT01970865|pharmacodynamic|pharmacodynamic
1213744|NCT01970865|efficacy|efficacy
1213746|NCT01970852|PHR Portal|phr portal
1213747|NCT01970852|Information Technology|information technology
1213748|NCT01970839|Tourniquet|tourniquet
1213749|NCT01970839|Endoneural|endoneural
1213750|NCT01970839|Ischemia|ischemia
1213751|NCT01970826|aseptic sterilized field|aseptic sterilized field
1213752|NCT01970826|clean sterilized field|clean sterilized field
1213753|NCT01970826|dental implants|dental implants
1213754|NCT01970826|Surgery|surgery
1213755|NCT01970813|Parkinson's disease|parkinson's disease
1213756|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1213757|NCT01970813|acupuncture|acupuncture
1213758|NCT01970813|bee venom acupuncture|bee venom acupuncture
1213759|NCT01970800|IGF-1|igf-1
1213760|NCT01970800|Short Stature|short stature
1213761|NCT01970800|GH|gh
1213762|NCT01970748|Variceal bleeding|variceal bleeding
1213763|NCT01970748|Portal hypertension|portal hypertension
1213764|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
1213765|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
1213766|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
1213767|NCT01970709|Adverse Drug Reactions|adverse drug reactions
1213768|NCT01970709|Emergency Department Visits|emergency department visits
1213769|NCT01970709|Hospitalizations|hospitalizations
1213770|NCT01970709|Pharmacogenomic|pharmacogenomic
1213771|NCT01970696|ovarian|ovarian
1213772|NCT01970696|testicular|testicular
1213773|NCT01970696|stromal|stromal
1213774|NCT01970696|Sertoli|sertoli
1213775|NCT01970696|Leydig|leydig
1213776|NCT01970696|gynandroblastoma|gynandroblastoma
1213777|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
1213778|NCT01970696|DICER1|dicer1
1213779|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
1213780|NCT01970657|VLU|vlu
1213781|NCT01970644|Neoplasm metastasis|neoplasm metastasis
1213782|NCT01970644|Brain neoplasms|brain neoplasms
1213783|NCT01970644|Radiosurgery|radiosurgery
1213784|NCT01970644|Cognition disorders|cognition disorders
1213785|NCT01970644|Cranial irradiation|cranial irradiation
1213786|NCT01970631|Osteoarthritis|osteoarthritis
1213787|NCT01970631|Total Knee Replacement|total knee replacement
1213788|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
1213789|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
1213790|NCT01970631|Physical Activity|physical activity
1213791|NCT01970631|Motivational Interviewing|motivational interviewing
1588399|NCT00436969|Orthovisc|orthovisc
1213792|NCT01970631|Financial Incentives|financial incentives
1213793|NCT01970592|exercise|exercise
1213794|NCT01970592|rehabilitation|rehabilitation
1213795|NCT01970592|walking|walking
1213796|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
1213797|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
1213798|NCT01970553|lurbinectedin|lurbinectedin
1213799|NCT01970553|PM01183|pm01183
1213800|NCT01970553|tumors|tumors
1213801|NCT01970553|cancer|cancer
1213802|NCT01970553|Pharma Mar|pharma mar
1213803|NCT01970540|lurbinectedin|lurbinectedin
1213804|NCT01970540|PM01183|pm01183
1213805|NCT01970540|tumors|tumors
1213806|NCT01970540|cancer|cancer
1213807|NCT01970540|Pharma Mar|pharma mar
1213808|NCT01970501|atrial fibrillation|atrial fibrillation
1213809|NCT01970501|atrial flutter|atrial flutter
1213810|NCT01970501|heart failure|heart failure
1213811|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
1213812|NCT01970501|electrical cardioversion|electrical cardioversion
1213813|NCT01970501|GENETIC-AF|genetic-af
1213814|NCT01970501|Medtronic|medtronic
1213815|NCT01970501|bucindolol|bucindolol
1213816|NCT01970501|pharmacogenetic|pharmacogenetic
1213817|NCT01970501|ARCA|arca
1213818|NCT01970501|Toprol|toprol
1213819|NCT01970501|Toprol-XL|toprol-xl
1213820|NCT01970501|Metoprolol|metoprolol
1213821|NCT01970501|Metoprolol succinate|metoprolol succinate
1213822|NCT01970488|Plaque Psoriasis|plaque psoriasis
1213823|NCT01970475|Arthritis|arthritis
1213824|NCT01970475|Rheumatoid|rheumatoid
1213825|NCT01970436|Prenatal care|prenatal care
1213826|NCT01970436|Pregnancy|pregnancy
1213827|NCT01970436|Obstetrics|obstetrics
1213828|NCT01970436|Telemedicine|telemedicine
1213829|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
1213830|NCT01970410|teriflunomide|teriflunomide
1213831|NCT01970410|natalizumab|natalizumab
1213832|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
1213833|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
1213834|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
1213835|NCT01970384|cortical plasticity|cortical plasticity
1213836|NCT01970371|Gram-negative|gram-negative
1213837|NCT01970371|bacterial infection|bacterial infection
1213838|NCT01970371|antibacterial|antibacterial
1213839|NCT01970371|antimicrobial|antimicrobial
1213840|NCT01970371|CRE|cre
1213841|NCT01970371|CPE|cpe
1213842|NCT01970371|BSI|bsi
1213843|NCT01970371|pneumonia|pneumonia
1213844|NCT01970371|HABP|habp
1213845|NCT01970371|VABP|vabp
1213846|NCT01970371|AP|ap
1213848|NCT01970371|UTI|uti
1213849|NCT01970358|melanoma|melanoma
1213850|NCT01970358|melanoma vaccine|melanoma vaccine
1213851|NCT01970358|adjuvant therapy|adjuvant therapy
1213852|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
1213853|NCT01970345|IGF-1|igf-1
1213854|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
1213855|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
1213856|NCT01970332|Claudication|claudication
1213857|NCT01970332|Myopathy|myopathy
1213858|NCT01970332|Oxidative stress|oxidative stress
1213859|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
1213860|NCT01970332|Biomechanics|biomechanics
1213861|NCT01970332|Inflammation|inflammation
1213862|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
1213863|NCT01970306|ACell MatriStem|acell matristem
1213864|NCT01970306|13-178|13-178
1213865|NCT01970293|Alcohol use|alcohol use
1213867|NCT01970293|Incarcerated women|incarcerated women
1213868|NCT01970293|AA|aa
1213869|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
1213870|NCT01970254|HBV|hbv
1213871|NCT01970254|Cancer Patients|cancer patients
1213872|NCT01970254|chemotherapy|chemotherapy
1213873|NCT01970254|HBV screening strategy|hbv screening strategy
1213874|NCT01970254|HBV care|hbv care
1213875|NCT01970254|chronic HBV|chronic hbv
1213876|NCT01970254|concomitant HBV infection|concomitant hbv infection
1213877|NCT01970254|viral infections|viral infections
1213878|NCT01970241|corticosteroid|corticosteroid
1213879|NCT01970241|diabetes|diabetes
1213880|NCT01970241|insulin|insulin
1213881|NCT01970202|obesity|obesity
1213882|NCT01970202|overweight|overweight
1213883|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
1213884|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
1213885|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
1213886|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
1213887|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
1213888|NCT01970189|Thrombocytopenia|thrombocytopenia
1213889|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
1213890|NCT01970163|Venous stasis ulcer|venous stasis ulcer
1213891|NCT01970163|Wound of the lower extremity|wound of the lower extremity
1213892|NCT01970163|Skin substitute|skin substitute
1213893|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
1213894|NCT01970150|rTMS|rtms
1213895|NCT01970150|Alzheimer Disease|alzheimer disease
1213896|NCT01970150|Memory|memory
1213897|NCT01970150|attention|attention
1213899|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
1213900|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1213901|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
1213902|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
1213903|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1213904|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
1213905|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
1213906|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1213907|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
1213908|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
1213909|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
1213910|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1213911|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
1213912|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
1213913|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
1213914|NCT01970072|Phase Ⅰ study|phase ⅰ study
1213915|NCT01970072|Health|health
1213916|NCT01970059|Hypertension|hypertension
1213917|NCT01970046|SP2086|sp2086
1213918|NCT01970046|Phase III|phase iii
1213919|NCT01970046|combination therapy|combination therapy
1213920|NCT01970033|SP2086|sp2086
1213921|NCT01970033|Phase III|phase iii
1213922|NCT01970033|Monotherapy|monotherapy
1213923|NCT01970020|Healthy|healthy
1213924|NCT01970020|JNJ-38518168|jnj-38518168
1213925|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
1213926|NCT01970020|Absorption|absorption
1213927|NCT01970020|Metabolism|metabolism
1213928|NCT01970020|Excretion|excretion
1213929|NCT01970007|venous|venous
1213930|NCT01970007|outflow obstruction|outflow obstruction
1213931|NCT01970007|iliofemoral vein|iliofemoral vein
1213932|NCT01969994|Epicatechin|epicatechin
1213933|NCT01969994|Flavanols|flavanols
1213934|NCT01969994|Procyanidins|procyanidins
1213935|NCT01969994|Polyphenols|polyphenols
1213936|NCT01969994|Phytonutrients|phytonutrients
1213937|NCT01969994|AMDE|amde
1213938|NCT01969994|Antioxidants|antioxidants
1213939|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
1213940|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
1213941|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
1213942|NCT01969942|Ewings sarcoma|ewings sarcoma
1213943|NCT01969916|Cardiac CT imaging|cardiac ct imaging
1213944|NCT01969916|Myocardial ischemia|myocardial ischemia
1213945|NCT01969916|Myocardial perfusion|myocardial perfusion
1213946|NCT01969916|Vasodilator stress testing|vasodilator stress testing
1213947|NCT01969916|Regadenoson|regadenoson
1213948|NCT01969903|brachial plexus block|brachial plexus block
1213949|NCT01969903|lidocaine|lidocaine
1213950|NCT01969903|dexmedetomidine|dexmedetomidine
1213951|NCT01969903|bradycardia|bradycardia
1213952|NCT01969903|hypotension|hypotension
1213953|NCT01969877|Head and neck cancer|head and neck cancer
1213954|NCT01969877|Cetuximab|cetuximab
1213955|NCT01969877|Cisplatin|cisplatin
1213956|NCT01969877|Radiotherapy|radiotherapy
1213957|NCT01969877|Quality of life|quality of life
1213958|NCT01969877|Human papilloma virus|human papilloma virus
1213959|NCT01969877|Health economy|health economy
1213960|NCT01969877|Biomarker investigations|biomarker investigations
1213961|NCT01969864|Randomized Controlled Trial|randomized controlled trial
1213962|NCT01969864|Healthcare Disparities|healthcare disparities
1213963|NCT01969851|Lacosamide|lacosamide
1213964|NCT01969851|Vimpat|vimpat
1213965|NCT01969851|Epilepsy|epilepsy
1213966|NCT01969851|Children|children
1213967|NCT01969825|Infertility|infertility
1213968|NCT01969825|Intrauterine insemination|intrauterine insemination
1213969|NCT01969825|Male factor infertility|male factor infertility
1213970|NCT01969825|Massage|massage
1213971|NCT01969825|Total motile sperm count|total motile sperm count
1213972|NCT01969812|Infertility|infertility
1213973|NCT01969812|Intrauterine Insemination|intrauterine insemination
1213974|NCT01969812|Slow-release Insemination|slow-release insemination
1213975|NCT01969812|Evie|evie
1213976|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
1213977|NCT01969799|Aerosol antibiotics|aerosol antibiotics
1213978|NCT01969799|Mechanical ventilation|mechanical ventilation
1213979|NCT01969799|Amikacin|amikacin
1213980|NCT01969799|Fosfomycin|fosfomycin
1213981|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
1213982|NCT01969799|Pneumonia|pneumonia
1213983|NCT01969799|Bacterial Infections|bacterial infections
1213984|NCT01969799|Lung Diseases|lung diseases
1213985|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
1213986|NCT01969799|Respiratory Tract Infections|respiratory tract infections
1213987|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
1213988|NCT01969799|Anti-Infective Agents|anti-infective agents
1213989|NCT01969799|Therapeutic Uses|therapeutic uses
1213990|NCT01969799|Pharmacologic Actions|pharmacologic actions
1213991|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
1213992|NCT01969773|Interstitial Cystitis|interstitial cystitis
1213993|NCT01969734|Emphysema|emphysema
1213994|NCT01969734|Moderate COPD|moderate copd
1213995|NCT01969734|Hyperinflation|hyperinflation
1213996|NCT01969734|Endobronchial valves|endobronchial valves
1213997|NCT01969695|ABT-199|abt-199
1213998|NCT01969695|Cancer|cancer
1213999|NCT01969695|GDC-0199|gdc-0199
1214000|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1214001|NCT01969695|Relapsed|relapsed
1214002|NCT01969695|Refractory|refractory
1214003|NCT01969695|Safety|safety
1214004|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1214005|NCT01969682|GDC-0199|gdc-0199
1214006|NCT01969682|Safety|safety
1214007|NCT01969682|Relapsed|relapsed
1214008|NCT01969682|Refractory|refractory
1214009|NCT01969682|ABT-199|abt-199
1214010|NCT01969682|Pharmacokinetics|pharmacokinetics
1214011|NCT01969682|Cancer|cancer
1214012|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1214013|NCT01969669|GDC-0199|gdc-0199
1214014|NCT01969669|Safety|safety
1214015|NCT01969669|Relapsed|relapsed
1214016|NCT01969669|Refractory|refractory
1214017|NCT01969669|ABT-199|abt-199
1214018|NCT01969669|Pharmacokinetics|pharmacokinetics
1214019|NCT01969669|Cancer|cancer
1214020|NCT01969656|vitamin D analog|vitamin d analog
1214021|NCT01969643|Breast cancer|breast cancer
1214022|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
1214023|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
1214024|NCT01969643|Drug therapy|drug therapy
1214025|NCT01969643|Metastatic|metastatic
1214026|NCT01969643|LIV-1 protein, human|liv-1 protein, human
1214027|NCT01969643|Trastuzumab|trastuzumab
1214028|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
1214029|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
1214030|NCT01969604|Sedentary Behaviour|sedentary behaviour
1214031|NCT01969604|Motivational Counselling|motivational counselling
1214032|NCT01969604|Short Text Message Service|short text message service
1214033|NCT01969604|Fatigue|fatigue
1214034|NCT01969604|Pain|pain
1214035|NCT01969604|Self-efficacy|self-efficacy
1214036|NCT01969604|ActivPAL|activpal
1214037|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
1214038|NCT01969578|salivary duct cancer|salivary duct cancer
1214039|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
1214040|NCT01969578|androgen deprivation|androgen deprivation
1214041|NCT01969578|androgen receptor|androgen receptor
1214042|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
1214043|NCT01969526|Frail elderly|frail elderly
1214044|NCT01969513|Vestibular Diseases|vestibular diseases
1214045|NCT01969513|Vertigo|vertigo
1214046|NCT01969513|Primary care|primary care
1214047|NCT01969513|Epley maneuver|epley maneuver
1214048|NCT01969500|Schizophrenia|schizophrenia
1214049|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
1214050|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
1214052|NCT01969500|SMI|smi
1214053|NCT01969500|Psychosis|psychosis
1214054|NCT01969500|Social Dysfunction|social dysfunction
1214055|NCT01969500|Medication Adherence|medication adherence
1214056|NCT01969500|Mobile Application|mobile application
1214057|NCT01969500|EHealth|ehealth
1214058|NCT01969500|E-Health|e-health
1214059|NCT01969500|Health Technology|health technology
1214060|NCT01969500|mHealth|mhealth
1214061|NCT01969500|m-Health|m-health
1214062|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
1214063|NCT01969461|HIV positive|hiv positive
1214064|NCT01969461|Adolescents|adolescents
1214065|NCT01969461|Adolescent Trials Network|adolescent trials network
1214066|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
1214067|NCT01969461|Implementation|implementation
1214068|NCT01969461|Adherence Intervention|adherence intervention
1214069|NCT01969461|Alcohol Intervention|alcohol intervention
1214070|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
1214071|NCT01969448|Immediate reconstruction|immediate reconstruction
1214072|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
1214073|NCT01969448|Breast-Q|breast-q
1214074|NCT01969448|Breast Cancer|breast cancer
1214075|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
1214076|NCT01969409|Lung|lung
1214077|NCT01969409|Fibrosis|fibrosis
1214078|NCT01969396|Biopsy|biopsy
1214079|NCT01969396|Endometrial biopsy|endometrial biopsy
1214080|NCT01969396|Endometrial sampling|endometrial sampling
1214081|NCT01969396|sonohysterography|sonohysterography
1214082|NCT01969383|healthy|healthy
1214083|NCT01969370|Cancer|cancer
1214084|NCT01969370|Cardiovascular disease|cardiovascular disease
1214085|NCT01969370|Neurodegenerative disease|neurodegenerative disease
1214086|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
1214087|NCT01969370|Dysmorphology|dysmorphology
1214088|NCT01969370|Hearing loss|hearing loss
1214089|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
1214090|NCT01969357|Sp2086|sp2086
1214091|NCT01969357|Phase II|phase ii
1214092|NCT01969357|monotherapy|monotherapy
1214093|NCT01969331|Gastritis|gastritis
1214094|NCT01969331|Helicobacter pylori|helicobacter pylori
1214095|NCT01969318|SP2086|sp2086
1214096|NCT01969318|Phase II|phase ii
1214097|NCT01969318|combination therapy|combination therapy
1214098|NCT01969305|Kazakhstan|kazakhstan
1214099|NCT01969305|Central Asia|central asia
1214100|NCT01969305|HIV prevention|hiv prevention
1214101|NCT01969305|Adolescents|adolescents
1214102|NCT01969305|Sexual risk behaviors|sexual risk behaviors
1214103|NCT01969305|Drug abuse prevention|drug abuse prevention
1214104|NCT01969305|Multi-media intervention|multi-media intervention
1214105|NCT01969305|Drug use|drug use
1214106|NCT01969292|colonoscopy|colonoscopy
1214107|NCT01969292|quality assurance|quality assurance
1214108|NCT01969279|Osteoporosis|osteoporosis
1214109|NCT01969279|Bisphosphonate|bisphosphonate
1214110|NCT01969279|Atypical femoral fracture|atypical femoral fracture
1214111|NCT01969279|Side effect|side effect
1214112|NCT01969266|Healthy volunteer|healthy volunteer
1214113|NCT01969266|PCI-32765|pci-32765
1214114|NCT01969266|PCI 45227|pci 45227
1214115|NCT01969266|JNJ-54179060|jnj-54179060
1214116|NCT01969266|Pharmacokinetic|pharmacokinetic
1214117|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
1214118|NCT01969240|Chest Pain|chest pain
1214119|NCT01969240|Decision Aid|decision aid
1214120|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
1214122|NCT01969240|Emergency Department|emergency department
1214123|NCT01969240|Cardiac Testing|cardiac testing
1214124|NCT01969240|Healthcare Utilization|healthcare utilization
1214125|NCT01969240|Patient Centered Outcomes|patient centered outcomes
1214126|NCT01969240|Shared Decision Making|shared decision making
1214127|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
1214128|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
1214129|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
1214130|NCT01969201|GnRH-antagonist|gnrh-antagonist
1214131|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
1214132|NCT01969188|spondyloarthritis|spondyloarthritis
1214133|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
1214134|NCT01969188|psoriatic arthritis|psoriatic arthritis
1214135|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
1214136|NCT01969149|Perioperative glycemic control|perioperative glycemic control
1214137|NCT01969149|Cardiac surgery|cardiac surgery
1214138|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
1214139|NCT01969136|Alzheimer's disease|alzheimer's disease
1214140|NCT01969136|Cognition|cognition
1214141|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
1214142|NCT01969123|Alzheimer's disease|alzheimer's disease
1214143|NCT01969123|Cognition|cognition
1214144|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
1214145|NCT01969110|Immunonutrition|immunonutrition
1214147|NCT01969097|Hemiparesis|hemiparesis
1214148|NCT01969097|tDCS|tdcs
1214149|NCT01969097|Motor cortex|motor cortex
1214445|NCT01967641|suboxone|suboxone
1214150|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
1214151|NCT01969084|Diabetes|diabetes
1214152|NCT01969084|Metabolism|metabolism
1214153|NCT01969084|Linagliptin|linagliptin
1214154|NCT01969084|Tradjenta|tradjenta
1214155|NCT01969084|Glucose|glucose
1214156|NCT01969071|levosimendan|levosimendan
1214157|NCT01969071|mitral valve surgery|mitral valve surgery
1214158|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
1214159|NCT01969071|serum creatinine|serum creatinine
1214160|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
1214161|NCT01969071|ejection fraction|ejection fraction
1214162|NCT01969058|Isotretinoin|isotretinoin
1214163|NCT01969058|HIV-1|hiv-1
1214164|NCT01969058|immunology markers|immunology markers
1214165|NCT01969058|immune activation|immune activation
1214166|NCT01969058|viral suppression|viral suppression
1214167|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
1214168|NCT01969045|anaesthetics|anaesthetics
1214169|NCT01969045|transcutaneous pCO2|transcutaneous pco2
1214170|NCT01969045|capillary pCO2|capillary pco2
1214171|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
1214172|NCT01968993|Degenerative Disc Disease|degenerative disc disease
1214173|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
1214174|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
1214175|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
1214176|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
1214177|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
1214178|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
1214179|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
1214180|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
1214181|NCT01968941|conventional radiotherapy|conventional radiotherapy
1214182|NCT01968941|inoperable patients|inoperable patients
1214183|NCT01968941|local control|local control
1214184|NCT01968941|cancer recurrence|cancer recurrence
1214185|NCT01968941|toxicity|toxicity
1214186|NCT01968941|survival|survival
1214187|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
1214188|NCT01968928|pyruvate kinase|pyruvate kinase
1214189|NCT01968928|drug resistance|drug resistance
1214190|NCT01968928|shikonin|shikonin
1214191|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
1214192|NCT01968902|spasticity|spasticity
1214193|NCT01968902|lower limb|lower limb
1214194|NCT01968902|multiple sclerosis|multiple sclerosis
1214195|NCT01968902|toxin|toxin
1214196|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
1214197|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
1214198|NCT01968889|Mechanical ventilation|mechanical ventilation
1214199|NCT01968889|Weaning|weaning
1214200|NCT01968889|Ultrasound|ultrasound
1214201|NCT01968850|osteoporosis|osteoporosis
1214203|NCT01968850|bone Mineral Density|bone mineral density
1214204|NCT01968850|alendronate|alendronate
1214205|NCT01968850|vitamin D|vitamin d
1214206|NCT01968824|pain|pain
1214207|NCT01968798|ACES|aces
1214208|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
1214209|NCT01968798|Cancer|cancer
1214210|NCT01968798|Aspirin|aspirin
1214211|NCT01968798|Tumor|tumor
1214212|NCT01968772|Fibromyalgia|fibromyalgia
1214213|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
1214214|NCT01968772|Magnesium Chloride|magnesium chloride
1214215|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
1214216|NCT01968759|Chronic kidney disease|chronic kidney disease
1214217|NCT01968759|Sevelamer carbonate|sevelamer carbonate
1214218|NCT01968759|Proteinuria|proteinuria
1214219|NCT01968759|Phosphate binders|phosphate binders
1214220|NCT01968746|Sepsis|sepsis
1214221|NCT01968746|Shock|shock
1214222|NCT01968733|Pneumonia|pneumonia
1214223|NCT01968733|CABP|cabp
1214224|NCT01968733|CAP|cap
1214225|NCT01968733|Macrolide|macrolide
1214226|NCT01968707|surgical prep|surgical prep
1214227|NCT01968707|CHG|chg
1214228|NCT01968707|IPA|ipa
1214229|NCT01968694|endometriosis|endometriosis
1214230|NCT01968694|chronic pain|chronic pain
1214231|NCT01968694|intravenous lidocaine|intravenous lidocaine
1214232|NCT01968668|BAY94-8862|bay94-8862
1214233|NCT01968668|MR antagonist|mr antagonist
1214234|NCT01968668|Diabetic nephropathy|diabetic nephropathy
1214235|NCT01968668|Japanese patients|japanese patients
1214236|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
1214237|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
1214238|NCT01968642|Appropriate Use Criteria|appropriate use criteria
1214239|NCT01968642|Medical Education|medical education
1214240|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
1214241|NCT01968590|Vitamin D|vitamin d
1214242|NCT01968590|Cholecalciferol|cholecalciferol
1214243|NCT01968590|Bone density|bone density
1214244|NCT01968577|Coronary angioplasty|coronary angioplasty
1214245|NCT01968577|Myocardial infarction|myocardial infarction
1214246|NCT01968551|HIV-1|hiv-1
1214247|NCT01968551|HIV|hiv
1214930|NCT01965873|Mortality|mortality
1214248|NCT01968551|Treatment-Experienced|treatment-experienced
1214249|NCT01968525|anemia|anemia
1214250|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
1214251|NCT01968525|tracheal intubation|tracheal intubation
1214252|NCT01968525|anesthesia|anesthesia
1214253|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
1214254|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
1214255|NCT01968512|Control Inhibitory;|control inhibitory;
1214256|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
1214257|NCT01968512|Functional Brain Network;|functional brain network;
1214258|NCT01968512|Go/No Go test.|go/no go test.
1214259|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
1214260|NCT01968473|Parkinson's disease|parkinson's disease
1214261|NCT01968473|Freezing of Gait|freezing of gait
1214262|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1214263|NCT01968473|Comfort|comfort
1214264|NCT01968473|Pain tolerance|pain tolerance
1214265|NCT01968473|Pain|pain
1214266|NCT01968473|Sensory threshold|sensory threshold
1214267|NCT01968473|Motor threshold|motor threshold
1214268|NCT01968473|Pain threshold|pain threshold
1214269|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
1214270|NCT01968434|cough|cough
1214271|NCT01968434|common cold|common cold
1214272|NCT01968434|antitussive agents|antitussive agents
1214273|NCT01968434|mucosal protection|mucosal protection
1214274|NCT01968434|medical device|medical device
1214275|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
1214276|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
1214277|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
1214278|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
1214279|NCT01968408|probiotics|probiotics
1214280|NCT01968382|IMM 124-E|imm 124-e
1214281|NCT01968382|Bovine Colostrum|bovine colostrum
1214282|NCT01968382|Alcoholic|alcoholic
1214283|NCT01968382|Hepatitis|hepatitis
1214284|NCT01968382|LPS|lps
1214285|NCT01968382|Hyper-immune|hyper-immune
1214286|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
1214287|NCT01968369|tomato|tomato
1214288|NCT01968369|arterial stiffness|arterial stiffness
1214289|NCT01968369|lycopene|lycopene
1214290|NCT01968356|surgical skin prep|surgical skin prep
1214291|NCT01968356|CHG|chg
1214292|NCT01968356|IPA|ipa
1214293|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
1214294|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
1214295|NCT01968317|Conservative Medication|conservative medication
1214296|NCT01968304|Iron Status, Cancer|iron status, cancer
1214297|NCT01968291|Health Literacy|health literacy
1214298|NCT01968291|Teach-back|teach-back
1214299|NCT01968291|Emergency|emergency
1214300|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1214301|NCT01968265|T2DM|t2dm
1214302|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
1214303|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
1214304|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
1214305|NCT01968239|BRVO|brvo
1214306|NCT01968239|Macular edema|macular edema
1214307|NCT01968239|Ranibizumab|ranibizumab
1214308|NCT01968239|re-treatment|re-treatment
1214309|NCT01968226|carotid artery disease|carotid artery disease
1214310|NCT01968226|carotid stenosis|carotid stenosis
1214311|NCT01968226|carotid endarterectomy|carotid endarterectomy
1214312|NCT01968226|RDG-K5|rdg-k5
1214313|NCT01968226|PET imaging|pet imaging
1214314|NCT01968213|ARIEL3|ariel3
1214315|NCT01968213|ARIEL 3|ariel 3
1214316|NCT01968213|platinum sensitive|platinum sensitive
1214317|NCT01968213|PARP Inhibitor|parp inhibitor
1214318|NCT01968213|rucaparib|rucaparib
1214319|NCT01968213|homologous recombination|homologous recombination
1214320|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
1214321|NCT01968213|CO-338|co-338
1214322|NCT01968213|PF 01367338|pf 01367338
1214323|NCT01968213|AG 14699|ag 14699
1214324|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
1214325|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
1214326|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
1214327|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
1214328|NCT01968213|gynecological cancer|gynecological cancer
1214329|NCT01968213|Clovis|clovis
1214330|NCT01968213|Clovis Oncology|clovis oncology
1214331|NCT01968200|cancer|cancer
1214332|NCT01968200|chemotherapy|chemotherapy
1214333|NCT01968200|anthracyclines|anthracyclines
1214334|NCT01968174|astigmatism|astigmatism
1214335|NCT01968174|lid surgery|lid surgery
1214336|NCT01968174|older than 40 years|older than 40 years
1214337|NCT01968174|can sign an acceptance form|can sign an acceptance form
1214338|NCT01968174|uper lid surgery|uper lid surgery
1214339|NCT01968148|glucose|glucose
1214340|NCT01968148|cardiac arrest|cardiac arrest
1214341|NCT01968148|resuscitation|resuscitation
1214342|NCT01968148|insulin|insulin
1214343|NCT01968148|GLP-1|glp-1
1215033|NCT01965327|FRDA|frda
1214344|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
1214345|NCT01968122|conventional treatment|conventional treatment
1214346|NCT01968122|stenting|stenting
1214347|NCT01968122|stroke prevention|stroke prevention
1214348|NCT01968122|medical treatment|medical treatment
1214349|NCT01968122|endovascular treatment|endovascular treatment
1214350|NCT01968096|Reflex|reflex
1214351|NCT01968096|Post activation|post activation
1214352|NCT01968096|Spinal cord injury|spinal cord injury
1214353|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
1214354|NCT01968096|Machine driven passive strech|machine driven passive strech
1214355|NCT01968044|renal impairment|renal impairment
1214356|NCT01968031|Parkinson's disease|parkinson's disease
1214357|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
1214358|NCT01968018|Cancer|cancer
1214359|NCT01968018|Chronic Cancer Pain|chronic cancer pain
1214360|NCT01968018|Tramadol HCI|tramadol hci
1214361|NCT01968018|Acetaminophen|acetaminophen
1214362|NCT01968018|Analgesics|analgesics
1214363|NCT01968018|Pain assessment|pain assessment
1214364|NCT01967992|diabetes|diabetes
1214365|NCT01967992|obesity|obesity
1214366|NCT01967992|mindful eating|mindful eating
1214367|NCT01967992|positive affect|positive affect
1214368|NCT01967992|low carbohydrate|low carbohydrate
1214369|NCT01967992|ketogenic|ketogenic
1214370|NCT01967992|diet|diet
1214371|NCT01967940|HIV-1|hiv-1
1214372|NCT01967940|HIV|hiv
1214373|NCT01967940|Treatment-Experienced|treatment-experienced
1214374|NCT01967927|carcinoma|carcinoma
1214375|NCT01967927|cancer|cancer
1214376|NCT01967927|head|head
1214377|NCT01967927|neck|neck
1214378|NCT01967927|otolaryngology|otolaryngology
1214379|NCT01967901|Diabetic nephropathies|diabetic nephropathies
1214380|NCT01967901|Nursing|nursing
1214381|NCT01967901|Multidisciplinary|multidisciplinary
1214382|NCT01967901|Self-care|self-care
1214383|NCT01967901|Quality of Life|quality of life
1214384|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
1214385|NCT01967875|Gastric Cancer|gastric cancer
1214386|NCT01967875|ERCC1|ercc1
1214387|NCT01967875|Platinum|platinum
1214388|NCT01967875|Chemotherapy|chemotherapy
1214389|NCT01967849|obesity|obesity
1214390|NCT01967849|type 2 diabetes|type 2 diabetes
1214391|NCT01967836|Invasive Line|invasive line
1214392|NCT01967836|IV Dressing protection|iv dressing protection
1214393|NCT01967836|Hygiene|hygiene
1214394|NCT01967836|Oncology|oncology
1214395|NCT01967836|Ambulatory Care|ambulatory care
1214396|NCT01967823|Metastatic Cancer|metastatic cancer
1214397|NCT01967823|Gene Therapy|gene therapy
1214398|NCT01967823|Immunotherapy|immunotherapy
1214399|NCT01967823|Tumor Regression|tumor regression
1214400|NCT01967823|Melanoma|melanoma
1214401|NCT01967810|glioma|glioma
1214402|NCT01967810|glioblastoma|glioblastoma
1214403|NCT01967810|brain cancer|brain cancer
1214404|NCT01967810|brain tumor|brain tumor
1214405|NCT01967810|recurrent|recurrent
1214406|NCT01967797|Obesity|obesity
1214407|NCT01967784|Influenza|influenza
1214408|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
1214409|NCT01967771|healthy volunteers|healthy volunteers
1214410|NCT01967771|drug interaction|drug interaction
1214411|NCT01967771|carbamazepine|carbamazepine
1214412|NCT01967771|Dolutegravir|dolutegravir
1214413|NCT01967771|pharmacokinetics|pharmacokinetics
1214414|NCT01967758|Astrocytic Tumors|astrocytic tumors
1214415|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
1214416|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
1214417|NCT01967758|Brain Tumor|brain tumor
1214418|NCT01967758|Brain Cancer|brain cancer
1214419|NCT01967758|Immunotherapy|immunotherapy
1214420|NCT01967745|open appendectomy|open appendectomy
1214421|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
1214422|NCT01967745|appendicitis|appendicitis
1214423|NCT01967732|Smoking|smoking
1214424|NCT01967732|Nicotine absorption|nicotine absorption
1214425|NCT01967732|Modified risk tobacco product|modified risk tobacco product
1214426|NCT01967732|Conventional cigarette|conventional cigarette
1214427|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
1214428|NCT01967732|Nicotine nasal spray|nicotine nasal spray
1214429|NCT01967719|Smoking|smoking
1214430|NCT01967719|Nicotine absorption|nicotine absorption
1214431|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
1214432|NCT01967719|Conventional cigarette|conventional cigarette
1214433|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
1214434|NCT01967706|Smoking|smoking
1214435|NCT01967706|Nicotine absorption|nicotine absorption
1214436|NCT01967706|Candidate modified risk tobacco product|candidate modified risk tobacco product
1214437|NCT01967706|Cigarette|cigarette
1214438|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
1214439|NCT01967706|Nicotine gum|nicotine gum
1214440|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
1214441|NCT01967693|Treatment type|treatment type
1214442|NCT01967693|Outcome|outcome
1214443|NCT01967641|opioid dependence|opioid dependence
1214444|NCT01967641|opioid abuse|opioid abuse
1214446|NCT01967641|prescription pain medications|prescription pain medications
1214447|NCT01967628|Vitamin D|vitamin d
1214448|NCT01967628|Respiratory infection|respiratory infection
1214449|NCT01967628|Innate immunity|innate immunity
1214450|NCT01967615|PCI,|pci,
1214451|NCT01967615|CTO,|cto,
1214452|NCT01967615|bifurcation,|bifurcation,
1214453|NCT01967615|clopidogrel,|clopidogrel,
1214454|NCT01967615|prasugrel,|prasugrel,
1214455|NCT01967615|ticagrelor|ticagrelor
1214456|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1214457|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
1214458|NCT01967602|biomarker|biomarker
1214459|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
1214460|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
1214461|NCT01967576|Mutation in VHL gene|mutation in vhl gene
1214462|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
1214463|NCT01967576|Germline DNA examination|germline dna examination
1214464|NCT01967563|Energy Expenditure|energy expenditure
1214465|NCT01967563|Obesity|obesity
1214466|NCT01967563|Carbohydrate|carbohydrate
1214467|NCT01967563|Fat|fat
1214468|NCT01967563|Ketones|ketones
1214469|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
1214470|NCT01967537|NET|net
1214472|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
1214473|NCT01967537|Surgical Resection|surgical resection
1214474|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
1214475|NCT01967524|Myofascial pain|myofascial pain
1214476|NCT01967524|Perineal pain|perineal pain
1214477|NCT01967524|Chronic pelvic pain|chronic pelvic pain
1214478|NCT01967524|Botulinum toxin type A|botulinum toxin type a
1214479|NCT01967524|Ropivacaïne|ropivacaïne
1214480|NCT01967511|Cross-sectional study|cross-sectional study
1214481|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
1214482|NCT01967511|Fibroblast|fibroblast
1214483|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
1214484|NCT01967511|Cervical Artery Dissection|cervical artery dissection
1214485|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
1214486|NCT01967498|conductive hearing loss|conductive hearing loss
1214487|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1214488|NCT01967485|Medication adherence|medication adherence
1214489|NCT01967485|Disease management|disease management
1214490|NCT01967485|Text message|text message
1214491|NCT01967485|ADHD|adhd
1214492|NCT01967485|Children|children
1214493|NCT01967485|Reminder systems|reminder systems
1214494|NCT01967485|Text Messaging|text messaging
1214495|NCT01967485|Telemedicine|telemedicine
1214496|NCT01967433|Fentanyl|fentanyl
1214497|NCT01967433|Midazolam|midazolam
1214498|NCT01967433|Sedation|sedation
1214499|NCT01967433|Patient tolerance|patient tolerance
1214500|NCT01967433|Duration of colonoscopy|duration of colonoscopy
1214501|NCT01967420|Cognitive remediation|cognitive remediation
1214502|NCT01967420|Social cognition training|social cognition training
1214503|NCT01967420|First episode psychosis|first episode psychosis
1214504|NCT01967420|Schizophrenia|schizophrenia
1214505|NCT01967407|kidney tumor|kidney tumor
1214506|NCT01967407|renal cell cancer|renal cell cancer
1214507|NCT01967407|RCC|rcc
1214508|NCT01967407|irreversible electroporation|irreversible electroporation
1214509|NCT01967407|IRE|ire
1214510|NCT01967407|partial kidney resection|partial kidney resection
1214511|NCT01967407|percutaneous|percutaneous
1214512|NCT01967407|ablation|ablation
1214513|NCT01967407|IRENE|irene
1214514|NCT01967394|Health Care Quality|health care quality
1214515|NCT01967394|Access|access
1214516|NCT01967394|Evaluation|evaluation
1214517|NCT01967368|Influenza vaccine|influenza vaccine
1214518|NCT01967368|intradermal|intradermal
1214519|NCT01967368|intramuscular|intramuscular
1214520|NCT01967368|efficacy|efficacy
1214521|NCT01967368|safety|safety
1214522|NCT01967355|preeclampsia|preeclampsia
1214523|NCT01967355|lipid apheresis|lipid apheresis
1214524|NCT01967355|apheresis|apheresis
1214525|NCT01967342|chronic pain|chronic pain
1214526|NCT01967342|pain|pain
1214527|NCT01967342|chronic pain syndrome|chronic pain syndrome
1214528|NCT01967342|widespread chronic pain|widespread chronic pain
1214529|NCT01967342|back pain|back pain
1214530|NCT01967342|literacy|literacy
1214531|NCT01967342|health literacy|health literacy
1214532|NCT01967342|group therapy|group therapy
1214533|NCT01967342|psychosocial treatment|psychosocial treatment
1214534|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
1214535|NCT01967342|pain education|pain education
1214536|NCT01967342|health disparities|health disparities
1214537|NCT01967342|patient-centered outcomes|patient-centered outcomes
1214538|NCT01967303|Restless legs syndrome|restless legs syndrome
1214539|NCT01967303|Stroke|stroke
1214540|NCT01967303|Transient ischemic attack|transient ischemic attack
1214644|NCT01966900|GLA-AF|gla-af
1214541|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
1214542|NCT01967290|stroke|stroke
1214543|NCT01967290|motor deficits|motor deficits
1214544|NCT01967290|motor rehabilitation|motor rehabilitation
1214545|NCT01967290|neurorehabilitation|neurorehabilitation
1214546|NCT01967290|medical devices|medical devices
1214547|NCT01967290|wearable devices|wearable devices
1214548|NCT01967290|e-health systems|e-health systems
1214549|NCT01967264|Drug therapy|drug therapy
1214550|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
1214551|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
1214552|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
1214553|NCT01967238|immune response|immune response
1214554|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
1214555|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
1214556|NCT01967225|Bacteremia,|bacteremia,
1214557|NCT01967225|Tedizolid|tedizolid
1214558|NCT01967212|stroke|stroke
1214559|NCT01967212|swallowing training|swallowing training
1214560|NCT01967212|game-based|game-based
1214561|NCT01967212|biofeedback|biofeedback
1214562|NCT01967199|drug-eluting stent|drug-eluting stent
1214563|NCT01967199|drug-coated Balloon|drug-coated balloon
1214564|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
1214565|NCT01967186|Type 1 diabetes|type 1 diabetes
1214566|NCT01967186|islets|islets
1214567|NCT01967186|transplantation|transplantation
1214568|NCT01967186|nephropathy|nephropathy
1214569|NCT01967186|intramuscular|intramuscular
1214570|NCT01967173|Asthma|asthma
1214571|NCT01967173|Fluticasone|fluticasone
1214572|NCT01967173|Salmeterol|salmeterol
1214573|NCT01967147|Dry eye|dry eye
1214574|NCT01967147|Lipid deficiency|lipid deficiency
1214575|NCT01967147|Tear film break-up time|tear film break-up time
1214576|NCT01967134|HIV Negative|hiv negative
1214577|NCT01967121|Compex, ice|compex, ice
1214578|NCT01967095|Erlotinib|erlotinib
1214579|NCT01967095|12-278|12-278
1214580|NCT01967095|CNS involvement|cns involvement
1214581|NCT01967082|Cancer Prevention|cancer prevention
1214582|NCT01967082|Tobacco Control Program for Youth|tobacco control program for youth
1214583|NCT01967082|Smoking cessation|smoking cessation
1214584|NCT01967082|Smoking prevention|smoking prevention
1214585|NCT01967082|Smokers|smokers
1214586|NCT01967082|Non smokers|non smokers
1214587|NCT01967082|Students|students
1214588|NCT01967082|University of Houston|university of houston
1214589|NCT01967082|Survey|survey
1214590|NCT01967082|Questionnaire|questionnaire
1214591|NCT01967082|Telephone survey|telephone survey
1214592|NCT01967082|Smart phone application|smart phone application
1214593|NCT01967056|Muscle strength|muscle strength
1214594|NCT01967056|respiratory failure|respiratory failure
1214595|NCT01967056|extubation failure|extubation failure
1214596|NCT01967056|intensive care unit|intensive care unit
1214597|NCT01967056|outcome prediction|outcome prediction
1214598|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
1214599|NCT01967030|breastfeeding|breastfeeding
1214600|NCT01967030|obesity|obesity
1214601|NCT01967030|diabetes|diabetes
1214602|NCT01967030|lactation|lactation
1214603|NCT01967017|Intrauterine device|intrauterine device
1214604|NCT01967017|Paracervical block|paracervical block
1214605|NCT01966991|Down syndrome|down syndrome
1214606|NCT01966991|prenatal screening|prenatal screening
1214607|NCT01966991|trisomy 21|trisomy 21
1214608|NCT01966991|patient satisfaction|patient satisfaction
1214609|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1214610|NCT01966978|Insulin|insulin
1214611|NCT01966978|Insulin, Long-Acting|insulin, long-acting
1214612|NCT01966978|Insulin, Short Acting|insulin, short acting
1214613|NCT01966978|Detemir|detemir
1214614|NCT01966978|Liraglutide|liraglutide
1214615|NCT01966978|GLP-1|glp-1
1214616|NCT01966978|Glucagon Like Peptide|glucagon like peptide
1214617|NCT01966978|Metformin|metformin
1214618|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
1214619|NCT01966978|Elevated A1c|elevated a1c
1214620|NCT01966978|Incretins|incretins
1214621|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
1214622|NCT01966965|ARRUDA, RUTA|arruda, ruta
1214623|NCT01966952|Hypertension|hypertension
1214624|NCT01966939|craniotomy|craniotomy
1214625|NCT01966939|craniectomy|craniectomy
1214626|NCT01966939|temporalis|temporalis
1214627|NCT01966939|TMJ|tmj
1214628|NCT01966939|mastication|mastication
1214629|NCT01966939|QoL|qol
1214630|NCT01966926|self monitoring|self monitoring
1214631|NCT01966926|self weighing|self weighing
1214632|NCT01966926|weight tracking|weight tracking
1214633|NCT01966926|psychosocial outcomes|psychosocial outcomes
1214634|NCT01966926|feasibility|feasibility
1214635|NCT01966913|Germ Cell Tumors|germ cell tumors
1214636|NCT01966913|Bevacizumab|bevacizumab
1214637|NCT01966913|salvage therapy|salvage therapy
1214638|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
1214639|NCT01966900|HIV|hiv
1214640|NCT01966900|Vaccine|vaccine
1214641|NCT01966900|CN54gp140|cn54gp140
1214642|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
1214643|NCT01966900|GLA|gla
1214645|NCT01966887|Heart failure|heart failure
1214646|NCT01966887|Gene therapy|gene therapy
1214647|NCT01966887|Serca2a|serca2a
1214648|NCT01966887|Cardiomyopathy|cardiomyopathy
1214649|NCT01966874|Medical abortion|medical abortion
1214650|NCT01966874|Mifepristone|mifepristone
1214651|NCT01966874|Misoprostol|misoprostol
1214652|NCT01966874|Zacafemyl|zacafemyl
1214653|NCT01966874|Mexico|mexico
1214654|NCT01966861|mechanical ventilation|mechanical ventilation
1214655|NCT01966861|weaning|weaning
1214656|NCT01966861|acute respiratory failure|acute respiratory failure
1214657|NCT01966861|weaning failure|weaning failure
1214658|NCT01966861|lung ultrasound|lung ultrasound
1214659|NCT01966848|Knee|knee
1214660|NCT01966848|osteoarthritis|osteoarthritis
1214661|NCT01966848|arthroplasty|arthroplasty
1214663|NCT01966848|rsa|rsa
1214664|NCT01966835|sleep quality|sleep quality
1214665|NCT01966835|sleep disturbances|sleep disturbances
1214666|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
1214667|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
1214668|NCT01966835|fatigue|fatigue
1214669|NCT01966835|pain|pain
1214670|NCT01966835|polysomnography|polysomnography
1214671|NCT01966835|watt max|watt max
1214672|NCT01966822|Osteoporosis|osteoporosis
1214673|NCT01966822|Bone mineral density|bone mineral density
1214674|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
1214675|NCT01966822|HIV infection|hiv infection
1214676|NCT01966822|Dolutegravir|dolutegravir
1214677|NCT01966822|Integrase inhibitor|integrase inhibitor
1214678|NCT01966809|Brain Tumor|brain tumor
1214679|NCT01966809|Photodynamic Therapy|photodynamic therapy
1214680|NCT01966809|Photochemotherapy|photochemotherapy
1214681|NCT01966809|Astrocytoma|astrocytoma
1214682|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
1214683|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
1214684|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
1214685|NCT01966809|Glioblastoma|glioblastoma
1214686|NCT01966809|GBM|gbm
1214687|NCT01966809|Chordoma|chordoma
1214688|NCT01966809|Germinoma|germinoma
1214689|NCT01966809|Germ Cell Tumor|germ cell tumor
1214690|NCT01966809|Non-germinoma|non-germinoma
1214691|NCT01966809|CNS Lymphoma|cns lymphoma
1214692|NCT01966809|Craniopharyngioma|craniopharyngioma
1214693|NCT01966809|Mixed Glioma|mixed glioma
1214694|NCT01966809|Optic Nerve Glioma|optic nerve glioma
1214695|NCT01966809|Meningioma|meningioma
1214696|NCT01966809|Oligodendroglioma|oligodendroglioma
1214697|NCT01966809|Pituitary Tumors|pituitary tumors
1214698|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
1214699|NCT01966809|DNET|dnet
1214700|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
1214701|NCT01966809|glioma|glioma
1214702|NCT01966809|glioblastoma survivors|glioblastoma survivors
1214703|NCT01966809|what is glioblastoma|what is glioblastoma
1214704|NCT01966809|gbm cancer|gbm cancer
1214705|NCT01966809|oligoastrocytoma|oligoastrocytoma
1214706|NCT01966809|gbm tumor|gbm tumor
1214707|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1214708|NCT01966809|High-Grade Glioma|high-grade glioma
1214709|NCT01966809|high grade glioma|high grade glioma
1214710|NCT01966809|glioblastomas|glioblastomas
1214711|NCT01966809|glioblastoma cancer|glioblastoma cancer
1214712|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1214713|NCT01966809|astrocytoma glioma|astrocytoma glioma
1214714|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
1214715|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
1214716|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
1214717|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
1214718|NCT01966809|gbm grade 4|gbm grade 4
1214719|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
1214720|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
1214721|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
1214722|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
1214723|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
1214724|NCT01966809|glioblastoma trials|glioblastoma trials
1214725|NCT01966809|gbm clinical trials|gbm clinical trials
1214726|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
1214727|NCT01966809|malignant gliomas|malignant gliomas
1214728|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
1214729|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
1214730|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
1214731|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
1214732|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
1214733|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
1214734|NCT01966809|glioblastoma trial|glioblastoma trial
1214735|NCT01966809|brain tumors|brain tumors
1214736|NCT01966809|recurrent brain tumors|recurrent brain tumors
1214737|NCT01966809|glioma grade 3|glioma grade 3
1214738|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
1214739|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
1214740|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
1214741|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
1214742|NCT01966796|pneumonia severity index|pneumonia severity index
1214743|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
1214745|NCT01966757|Batten's Disease|batten's disease
1215630|NCT01962714|Emotion|emotion
1214746|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
1214747|NCT01966757|Restless Leg Syndrome|restless leg syndrome
1214748|NCT01966731|Africa|africa
1214749|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
1214750|NCT01966718|Joint pain|joint pain
1214751|NCT01966718|Repository corticotropin injection|repository corticotropin injection
1214752|NCT01966705|severe health anxiety|severe health anxiety
1214753|NCT01966705|somatic symptom disorder|somatic symptom disorder
1214754|NCT01966705|illness anxiety disorder|illness anxiety disorder
1214755|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
1214756|NCT01966705|bibliotherapy|bibliotherapy
1214757|NCT01966705|internet|internet
1214758|NCT01966705|exposure|exposure
1214759|NCT01966692|Bioequivalence|bioequivalence
1214760|NCT01966692|Fluticasone Propionate|fluticasone propionate
1214761|NCT01966666|Alzheimer's disease|alzheimer's disease
1214762|NCT01966666|mild to moderate|mild to moderate
1214763|NCT01966653|nitrofurantoin|nitrofurantoin
1214764|NCT01966653|fosfomycin|fosfomycin
1214765|NCT01966653|urinary tract infection|urinary tract infection
1214766|NCT01966653|clinical efficacy|clinical efficacy
1214767|NCT01966653|bacteriologic response|bacteriologic response
1214768|NCT01966640|diagnosis of allergy|diagnosis of allergy
1214769|NCT01966640|Basophil Activation Test|basophil activation test
1214770|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
1214771|NCT01966627|childhood obesity|childhood obesity
1214772|NCT01966627|genetic variants|genetic variants
1214773|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
1214774|NCT01966614|BPH|bph
1214775|NCT01966614|Enlarged prostate|enlarged prostate
1333261|NCT01443780|intervention|intervention
1214776|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1214777|NCT01966588|Antipsychotic agents|antipsychotic agents
1214778|NCT01966588|Adverse effects|adverse effects
1214779|NCT01966588|Genomics|genomics
1214780|NCT01966588|Transcriptome|transcriptome
1214781|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
1214782|NCT01966575|Progestin|progestin
1214783|NCT01966575|Endometrial shedding|endometrial shedding
1214784|NCT01966575|Ovulation induction cycles|ovulation induction cycles
1214785|NCT01966575|Clomiphene citrate|clomiphene citrate
1214786|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
1214787|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1214788|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
1214789|NCT01966549|CNTO 6785|cnto 6785
1214790|NCT01966549|Placebo|placebo
1214791|NCT01966510|cord blood transplant|cord blood transplant
1214792|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
1214793|NCT01966497|AML|aml
1214794|NCT01966484|Succinylcholine|succinylcholine
1214795|NCT01966484|Mivacurium|mivacurium
1214796|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
1214797|NCT01966484|Intubating conditions|intubating conditions
1214798|NCT01966484|Short Procedure|short procedure
1214799|NCT01966445|GSK2849330|gsk2849330
1214800|NCT01966445|Oncology|oncology
1214801|NCT01966445|First Time in Human|first time in human
1214802|NCT01966445|HER3|her3
1214803|NCT01966432|Substance abuse|substance abuse
1214804|NCT01966432|Alcohol use|alcohol use
1214805|NCT01966432|Tobacco use|tobacco use
1214806|NCT01966432|Brief intervention|brief intervention
1214807|NCT01966432|Referral to treatment|referral to treatment
1214808|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
1214809|NCT01966419|hyperammonemia|hyperammonemia
1214810|NCT01966419|cirrhosis|cirrhosis
1214811|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
1214812|NCT01966419|OCR-002|ocr-002
1214813|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
1214814|NCT01966406|nasogastric tube|nasogastric tube
1214815|NCT01966393|Type 1 diabetes|type 1 diabetes
1214816|NCT01966393|Hypoglycemia|hypoglycemia
1214817|NCT01966393|Insulin|insulin
1214818|NCT01966393|Glucagon|glucagon
1214819|NCT01966393|Closed-loop strategy|closed-loop strategy
1214820|NCT01966393|Artificial pancreas|artificial pancreas
1214821|NCT01966367|Unrelated donor transplant|unrelated donor transplant
1214822|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
1214823|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1214824|NCT01966367|CD34+ selection|cd34+ selection
1214825|NCT01966367|Non-malignant disease|non-malignant disease
1214826|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
1214827|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
1214828|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
1214829|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
1214830|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
1214831|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
1214832|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
1214833|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1214834|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
1214835|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
1214836|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
1214837|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
1214838|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
1214839|NCT01966367|Hemoglobinopathies|hemoglobinopathies
1214840|NCT01966367|Sickle Cell Disease|sickle cell disease
1214841|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
1214842|NCT01966354|adult|adult
1214843|NCT01966354|catheterization, central venous|catheterization, central venous
1214844|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
1214845|NCT01966354|evidence-based medicine|evidence-based medicine
1214846|NCT01966354|cost-benefit analysis|cost-benefit analysis
1214847|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1214848|NCT01966302|prostacyclin|prostacyclin
1214849|NCT01966302|oral|oral
1214850|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
1214851|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
1214852|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1214853|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
1214854|NCT01966289|Neoplasms by Site|neoplasms by site
1214855|NCT01966289|Neoplasms|neoplasms
1214856|NCT01966289|Digestive System Diseases|digestive system diseases
1214857|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
1214858|NCT01966289|Colonic Diseases|colonic diseases
1214859|NCT01966289|Intestinal Diseases|intestinal diseases
1214860|NCT01966289|Rectal Diseases|rectal diseases
1214861|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
1214862|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
1214863|NCT01966276|central nervous system (CNS)|central nervous system (cns)
1214864|NCT01966276|fatigue|fatigue
1214865|NCT01966276|alertness|alertness
1214866|NCT01966276|brain fog|brain fog
1214867|NCT01966276|mitochondria|mitochondria
1214868|NCT01966276|methylphenidate|methylphenidate
1214869|NCT01966276|Ritalin|ritalin
1214870|NCT01966276|stimulant|stimulant
1214871|NCT01966276|multivitamin|multivitamin
1214872|NCT01966276|multimineral|multimineral
1214873|NCT01966276|micronutrients|micronutrients
1214874|NCT01966276|supplements|supplements
1214875|NCT01966263|total knee arthroplasty|total knee arthroplasty
1214876|NCT01966263|femoral nerve block|femoral nerve block
1214877|NCT01966263|local infiltration analgesia|local infiltration analgesia
1214878|NCT01966263|fast track|fast track
1214879|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
1214880|NCT01966185|virtual simulation|virtual simulation
1214881|NCT01966185|temporal bone|temporal bone
1214882|NCT01966185|surgical training|surgical training
1214883|NCT01966185|medical education|medical education
1214884|NCT01966185|self-directed learning|self-directed learning
1214885|NCT01966185|final product assessment|final product assessment
1214886|NCT01966185|cognitive load|cognitive load
1214887|NCT01966185|reaction time|reaction time
1214888|NCT01966185|skills training|skills training
1214889|NCT01966185|simulator metrics|simulator metrics
1214890|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
1214891|NCT01966133|HCC|hcc
1214892|NCT01966133|Randomised controlled trial|randomised controlled trial
1214893|NCT01966133|TACE|tace
1214894|NCT01966133|Resection|resection
1214895|NCT01966120|Photodynamic Therapy|photodynamic therapy
1214896|NCT01966120|Field-directed Treatment|field-directed treatment
1214897|NCT01966068|Asthma|asthma
1214898|NCT01966068|Pediatrics|pediatrics
1214899|NCT01966068|Health Technology|health technology
1214900|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
1214901|NCT01966068|Web Portal|web portal
1214902|NCT01966042|Refractory angina|refractory angina
1214903|NCT01966042|Cell Therapy|cell therapy
1214904|NCT01966042|Bone Marrow|bone marrow
1214905|NCT01966042|Mononuclear Cells|mononuclear cells
1214906|NCT01966016|LV- Left Ventricular|lv- left ventricular
1214907|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
1214908|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
1214909|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
1214910|NCT01965990|Enteral nutrition|enteral nutrition
1214911|NCT01965990|very low-calorie diet|very low-calorie diet
1214912|NCT01965990|severe obesity|severe obesity
1214913|NCT01965990|weight loss|weight loss
1214914|NCT01965990|ketosis|ketosis
1214915|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
1214916|NCT01965925|Cognition|cognition
1214917|NCT01965925|Sleep problems|sleep problems
1214918|NCT01965925|Bipolar Disorder|bipolar disorder
1214919|NCT01965912|Phenylketonuria|phenylketonuria
1214920|NCT01965912|Kuvan|kuvan
1214921|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
1214922|NCT01965886|osteoarthritis|osteoarthritis
1214923|NCT01965886|knee|knee
1214924|NCT01965886|arthroplasty|arthroplasty
1214925|NCT01965886|replacement|replacement
1214926|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
1214927|NCT01965873|Enteral nutrition|enteral nutrition
1214928|NCT01965873|Fasting|fasting
1214929|NCT01965873|Complications|complications
1214931|NCT01965834|Multiple Myeloma|multiple myeloma
1214932|NCT01965834|Fenofibrate|fenofibrate
1214933|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
1214934|NCT01965821|continuous control|continuous control
1214935|NCT01965821|microaspiration|microaspiration
1214936|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
1214937|NCT01965795|Cognitive function|cognitive function
1214938|NCT01965795|Dietary supplement|dietary supplement
1214939|NCT01965795|Coffee plant extract|coffee plant extract
1214940|NCT01965769|Very low birth weight infants|very low birth weight infants
1214941|NCT01965769|premature|premature
1214942|NCT01965769|nutrition|nutrition
1214943|NCT01965769|gastric residual|gastric residual
1214944|NCT01965756|Alzheimer's Disease|alzheimer's disease
1214945|NCT01965756|Vascular Dementia|vascular dementia
1214946|NCT01965756|Dementia|dementia
1214947|NCT01965756|Memory Impairment|memory impairment
1214948|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
1214949|NCT01965743|social networks|social networks
1214950|NCT01965743|social influence|social influence
1214951|NCT01965743|diffusion of innovation|diffusion of innovation
1214952|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
1214953|NCT01965743|LARC|larc
1214954|NCT01965730|dilated ascending aorta|dilated ascending aorta
1214955|NCT01965717|endoleak|endoleak
1214956|NCT01965717|MMP- 9|mmp- 9
1214957|NCT01965717|biomarker|biomarker
1214958|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
1214959|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
1214960|NCT01965704|NAS|nas
1214961|NCT01965691|Phenylketonuria|phenylketonuria
1214962|NCT01965691|PKU|pku
1214963|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
1214964|NCT01965691|Protein requirements|protein requirements
1214965|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
1214966|NCT01965691|Stable isotopes|stable isotopes
1214967|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
1214968|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
1214969|NCT01965678|quality of life|quality of life
1214970|NCT01965665|Diabetes|diabetes
1214971|NCT01965665|Surgical Intervention|surgical intervention
1214972|NCT01965665|Honey|honey
1214973|NCT01965652|Opioid Induced Constipation|opioid induced constipation
1214974|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
1214975|NCT01965639|Standard of care|standard of care
1214976|NCT01965639|Quality of life|quality of life
1214977|NCT01965639|Disease management|disease management
1214978|NCT01965626|Oseltamivir|oseltamivir
1214979|NCT01965626|Dexamethasone|dexamethasone
1214980|NCT01965626|ITP|itp
1214981|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
1214982|NCT01965600|Endotoxin challenge|endotoxin challenge
1214983|NCT01965587|novasure|novasure
1214984|NCT01965587|Mirena IUS|mirena ius
1214985|NCT01965587|menorrhagia|menorrhagia
1214986|NCT01965587|pelvic pain|pelvic pain
1214987|NCT01965587|ashermanns|ashermanns
1214988|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
1214989|NCT01965548|spleen|spleen
1214990|NCT01965548|injury|injury
1214991|NCT01965548|patient transfer|patient transfer
1214992|NCT01965548|splenectomy|splenectomy
1214993|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
1214994|NCT01965535|Hepatitis C|hepatitis c
1214995|NCT01965535|HCV|hcv
1214996|NCT01965535|Cirrhosis|cirrhosis
1214997|NCT01965522|Breast cancer|breast cancer
1214998|NCT01965522|melatonin|melatonin
1214999|NCT01965522|vitamin d|vitamin d
1215000|NCT01965522|ki67|ki67
1215001|NCT01965509|PEX168|pex168
1215002|NCT01965509|Phase I/II|phase i/ii
1215003|NCT01965509|add on to metformin|add on to metformin
1215004|NCT01965496|PEX168|pex168
1215005|NCT01965496|Phase I|phase i
1215006|NCT01965496|titration|titration
1215007|NCT01965483|radiotherapy|radiotherapy
1215008|NCT01965483|adjuvant|adjuvant
1215009|NCT01965483|weekly hypofractionation|weekly hypofractionation
1215010|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
1215011|NCT01965457|pediatric|pediatric
1215012|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
1215013|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
1215014|NCT01965444|Pressure Ulcers|pressure ulcers
1215015|NCT01965405|HIV|hiv
1215016|NCT01965405|AIDS|aids
1215017|NCT01965405|Nicotine Dependence|nicotine dependence
1215018|NCT01965405|Smoking|smoking
1215019|NCT01965405|Smoking cessation|smoking cessation
1215020|NCT01965405|Contingency Management|contingency management
1215021|NCT01965379|Dialysis|dialysis
1215022|NCT01965379|Phosphorus|phosphorus
1215023|NCT01965379|Diet|diet
1215024|NCT01965366|Dexamethasone|dexamethasone
1215025|NCT01965366|Virtual Reality|virtual reality
1215026|NCT01965366|Military|military
1215027|NCT01965366|PTSD|ptsd
1215725|NCT01962454|D2O|d2o
1215028|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
1215029|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
1215030|NCT01965340|patients|patients
1215031|NCT01965327|Friedreich ataxia|friedreich ataxia
1215032|NCT01965327|Interferon gamma-1b|interferon gamma-1b
1215034|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
1215035|NCT01965314|upper limb surgery|upper limb surgery
1215036|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
1215037|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1215038|NCT01965275|High-dose|high-dose
1215039|NCT01965275|Pulsatile|pulsatile
1215040|NCT01965275|EGFR-TKIs|egfr-tkis
1215041|NCT01965249|Laparotomy|laparotomy
1215042|NCT01965249|short stitch|short stitch
1215043|NCT01965249|long stitch|long stitch
1215044|NCT01965249|MonoMax|monomax
1215045|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
1215046|NCT01965223|Oligometastatic|oligometastatic
1215047|NCT01965223|Neoplasia|neoplasia
1215048|NCT01965223|Radiosurgery|radiosurgery
1215049|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
1215050|NCT01965223|SABR|sabr
1215051|NCT01965223|Metastases to the Lung|metastases to the lung
1215052|NCT01965223|Non Haematological|non haematological
1215053|NCT01965210|Rye|rye
1215054|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
1215055|NCT01965210|Inulin|inulin
1215056|NCT01965210|Plant protein|plant protein
1215057|NCT01965210|Gluten|gluten
1215058|NCT01965210|Porridge|porridge
1215059|NCT01965210|Bread|bread
1215060|NCT01965210|Appetite|appetite
1295057|NCT01603771|MRI|mri
1215061|NCT01965210|Satiety|satiety
1215062|NCT01965210|Hunger|hunger
1215063|NCT01965210|Desire to eat|desire to eat
1215064|NCT01965210|Metabolism|metabolism
1215065|NCT01965210|Glucose|glucose
1215066|NCT01965210|Insulin|insulin
1215067|NCT01965210|Gut hormones|gut hormones
1215068|NCT01965210|Metabolomics|metabolomics
1215069|NCT01965210|Gastric emptying rate|gastric emptying rate
1215070|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
1215071|NCT01965184|child|child
1215072|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
1215073|NCT01965184|CBT|cbt
1215074|NCT01965184|aggression|aggression
1215075|NCT01965184|disruptive behavior|disruptive behavior
1215076|NCT01965184|treatment|treatment
1215077|NCT01965184|frustrative non-reward|frustrative non-reward
1215078|NCT01965171|hematologic malignancy|hematologic malignancy
1215079|NCT01965171|iron overload|iron overload
1215080|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
1215081|NCT01965171|childhood cancer survivors|childhood cancer survivors
1215082|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
1215083|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
1215084|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
1215085|NCT01965132|Psoriatic arthritis|psoriatic arthritis
1215086|NCT01965132|Biologic agents|biologic agents
1215087|NCT01965132|Cohort studies|cohort studies
1215088|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
1215089|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
1215090|NCT01965106|Primary angle closure|primary angle closure
1215091|NCT01965106|Acute angle closure|acute angle closure
1215092|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
1215093|NCT01965093|perioperative|perioperative
1215094|NCT01965093|desaturation|desaturation
1215095|NCT01965093|growth development|growth development
1215096|NCT01965093|intelligence outcome|intelligence outcome
1215097|NCT01965080|Endometrial cancer|endometrial cancer
1215098|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
1215099|NCT01965054|fish oil|fish oil
1215100|NCT01965054|omega-3|omega-3
1215101|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
1215102|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
1215103|NCT01965041|AVA Study|ava study
1215104|NCT01965028|tinnitus|tinnitus
1215105|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
1215106|NCT01965028|tRNS|trns
1215107|NCT01965028|auditory cortex|auditory cortex
1215108|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
1215109|NCT01965015|Heart Failure (HF)|heart failure (hf)
1215110|NCT01965015|Left Atrial Pressure|left atrial pressure
1215111|NCT01964989|Influenza|influenza
1215112|NCT01964989|children|children
1215113|NCT01964950|drug therapy|drug therapy
1215114|NCT01964911|Martorell ulcer|martorell ulcer
1215115|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
1215116|NCT01964911|Pain|pain
1215117|NCT01964911|Continuous nerve block|continuous nerve block
1215118|NCT01964911|Ropivacaïne|ropivacaïne
1215119|NCT01964911|Local anesthesic|local anesthesic
1215120|NCT01964898|Smoking|smoking
1215121|NCT01964898|Mood Management|mood management
1215122|NCT01964898|Depression|depression
1215123|NCT01964898|Behavioral Activation|behavioral activation
1215124|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
1215125|NCT01964898|Myocardial Infarction|myocardial infarction
1215126|NCT01964872|Healthy volunteers|healthy volunteers
1215127|NCT01964872|JNJ-38877618|jnj-38877618
1215128|NCT01964872|Pharmacokinetic|pharmacokinetic
1215129|NCT01964872|Safety|safety
1215130|NCT01964872|Single-ascending dose|single-ascending dose
1215131|NCT01964872|Multiple-ascending dose|multiple-ascending dose
1216010|NCT01961271|Mundipharma|mundipharma
1215132|NCT01964859|healthy skin|healthy skin
1215133|NCT01964859|wounds and injuries|wounds and injuries
1215134|NCT01964859|prosthetics|prosthetics
1215135|NCT01964859|amputations|amputations
1215136|NCT01964859|dermal fibroblasts|dermal fibroblasts
1215137|NCT01964846|inflammation|inflammation
1215138|NCT01964846|high fat meal|high fat meal
1215139|NCT01964846|resveratrol|resveratrol
1215140|NCT01964846|curcumin|curcumin
1215141|NCT01964846|gene expression|gene expression
1215142|NCT01964833|clinical trial|clinical trial
1215143|NCT01964833|DMT2|dmt2
1215144|NCT01964833|periodontitis|periodontitis
1215145|NCT01964833|PDT|pdt
1215146|NCT01964807|Cardiovascular|cardiovascular
1215147|NCT01964807|tobacco|tobacco
1215148|NCT01964807|cigarettes|cigarettes
1215149|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
1215150|NCT01964807|SHS|shs
1215151|NCT01964807|smokeless tobacco|smokeless tobacco
1215152|NCT01964807|chewing tobacco|chewing tobacco
1215153|NCT01964807|snus|snus
1215154|NCT01964807|electronic cigarettes|electronic cigarettes
1215155|NCT01964807|vapor|vapor
1215156|NCT01964807|particles|particles
1215157|NCT01964807|oxidative stress|oxidative stress
1215158|NCT01964807|flow-mediated dilation|flow-mediated dilation
1215159|NCT01964807|FMD|fmd
1215160|NCT01964794|Warfarin|warfarin
1295179|NCT01603277|Asthma|asthma
1215161|NCT01964781|Administration, topical|administration, topical
1215162|NCT01964781|tranexamic acid|tranexamic acid
1215163|NCT01964781|adrenaline|adrenaline
1215164|NCT01964781|bupivacaine|bupivacaine
1215165|NCT01964781|surgery|surgery
1215166|NCT01964755|EBV+|ebv+
1215167|NCT01964755|NHL|nhl
1215168|NCT01964755|HL|hl
1215169|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1215170|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
1215171|NCT01964755|Epstein Barr Virus|epstein barr virus
1215172|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
1215173|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
1215174|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
1215175|NCT01964729|rTMS|rtms
1215176|NCT01964729|Pain threshold|pain threshold
1215177|NCT01964729|Neuromodulation|neuromodulation
1215178|NCT01964729|Myofascial|myofascial
1215179|NCT01964716|Prevenar 13|prevenar 13
1215180|NCT01964716|13vPnC|13vpnc
1215181|NCT01964716|Healthy Subjects|healthy subjects
1215182|NCT01964690|Lactate|lactate
1215183|NCT01964690|Sepsis|sepsis
1215184|NCT01964690|Capillary lactate|capillary lactate
1215185|NCT01964690|Venous lactate|venous lactate
1215186|NCT01964690|Quick test|quick test
1215187|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1215188|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
1215189|NCT01964664|Mindfulness|mindfulness
1215190|NCT01964664|Meditation|meditation
1215191|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
1215192|NCT01964664|Cerebral Palsy|cerebral palsy
1215193|NCT01964664|Cerebral Ataxia|cerebral ataxia
1215194|NCT01964664|Locked-in Syndrome|locked-in syndrome
1215195|NCT01964651|Healthy|healthy
1215196|NCT01964651|JNJ-42165279|jnj-42165279
1215197|NCT01964651|Pharmacokinetics|pharmacokinetics
1215198|NCT01964651|Elderly|elderly
1215199|NCT01964651|Young|young
1215200|NCT01964638|Prostate Cancer|prostate cancer
1215201|NCT01964638|Prostate Biopsy|prostate biopsy
1215202|NCT01964638|Targeted Biopsy|targeted biopsy
1215203|NCT01964625|Chronic GvHD|chronic gvhd
1215204|NCT01964599|Fiber|fiber
1215205|NCT01964599|Gastrointestinal|gastrointestinal
1215206|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
1215207|NCT01964573|Parkinson's Disease|parkinson's disease
1215208|NCT01964573|Rotigotine|rotigotine
1215209|NCT01964573|Pharmacokinetics|pharmacokinetics
1215210|NCT01964573|Healthy subjects|healthy subjects
1215211|NCT01964560|Lacosamide|lacosamide
1215212|NCT01964560|Vimpat|vimpat
1215213|NCT01964560|UCB|ucb
1215214|NCT01964560|Epilepsy|epilepsy
1215215|NCT01964560|Partial Onset Seizures|partial onset seizures
1215216|NCT01964560|Pediatric|pediatric
1215217|NCT01964547|Cognition|cognition
1215218|NCT01964547|Mood|mood
1215219|NCT01964534|Metastatic|metastatic
1215220|NCT01964534|Pancreatic|pancreatic
1215221|NCT01964534|Cancer|cancer
1215222|NCT01964534|Pancreas|pancreas
1215223|NCT01964534|GERCOR|gercor
1215224|NCT01964534|Gemcitabine|gemcitabine
1215225|NCT01964534|LV5FU2|lv5fu2
1215226|NCT01964534|ABI-007|abi-007
1215227|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
1215228|NCT01964482|Hospitalization|hospitalization
1215229|NCT01964482|Older|older
1215230|NCT01964482|Medical patient|medical patient
1215231|NCT01964482|Strength training|strength training
1215232|NCT01964456|Bodily self-consciousness|bodily self-consciousness
1216008|NCT01961271|analgesic|analgesic
1215233|NCT01964456|intersubjective body|intersubjective body
1215234|NCT01964456|Anorexia Nervosa|anorexia nervosa
1215235|NCT01964456|Joint perception task|joint perception task
1216588|NCT01958177|BMMNC|bmmnc
1215236|NCT01964456|Interoceptive awareness|interoceptive awareness
1215237|NCT01964443|Plaque Psoriasis|plaque psoriasis
1215238|NCT01964443|Alexithymia|alexithymia
1215239|NCT01964443|Quality of life|quality of life
1215240|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
1215241|NCT01964430|resected|resected
1215242|NCT01964430|resectable PDA|resectable pda
1215243|NCT01964430|adenocarcinoma|adenocarcinoma
1215244|NCT01964430|surgically resected|surgically resected
1215245|NCT01964430|adjuvant|adjuvant
1215246|NCT01964430|Abraxane|abraxane
1215247|NCT01964430|nab-paclitaxel|nab-paclitaxel
1215248|NCT01964430|ABI-007|abi-007
1215249|NCT01964430|gemcitabine|gemcitabine
1215250|NCT01964430|Gemzar|gemzar
1215251|NCT01964430|Phase 3|phase 3
1215252|NCT01964417|BOWEL PREPARATION|bowel preparation
1215253|NCT01964417|PEG|peg
1215254|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
1215255|NCT01964404|Dronabinol|dronabinol
1215256|NCT01964404|Schizophrenia|schizophrenia
1215257|NCT01964404|Dual Diagnosis|dual diagnosis
1215258|NCT01964404|Substance Abuse|substance abuse
1215259|NCT01964404|Cannabis Use Disorder|cannabis use disorder
1215260|NCT01964378|cancer-related pain|cancer-related pain
1588967|NCT00434954|Byetta|byetta
1215261|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
1215262|NCT01964378|morphine|morphine
1215263|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
1215264|NCT01964378|Numerical Rating Scale|numerical rating scale
1215265|NCT01964326|atorvastatin|atorvastatin
1215266|NCT01964326|Hypercholesterolemia|hypercholesterolemia
1215267|NCT01964313|Acute coronary syndrome|acute coronary syndrome
1215268|NCT01964313|treatment strategy|treatment strategy
1215269|NCT01964313|genetics|genetics
1215270|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
1215271|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
1215272|NCT01964261|Neural|neural
1215273|NCT01964261|Prosthetic|prosthetic
1215274|NCT01964261|Brain machine interface|brain machine interface
1215275|NCT01964261|brain computer interface|brain computer interface
1215276|NCT01964261|brain control|brain control
1215277|NCT01964261|paralysis|paralysis
1215278|NCT01964261|tetraplegia|tetraplegia
1215279|NCT01964261|quadriplegia|quadriplegia
1215280|NCT01964261|spinal cord injury|spinal cord injury
1215281|NCT01964261|stimulation|stimulation
1215282|NCT01964261|sensory feedback|sensory feedback
1215283|NCT01964248|Blood gas analysis|blood gas analysis
1215284|NCT01964248|Arterial puncture|arterial puncture
1215285|NCT01964248|Local anesthesia|local anesthesia
1215286|NCT01964248|Eutectic mixture|eutectic mixture
1215287|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
1215288|NCT01964248|Placebo|placebo
1215289|NCT01964248|Pain Intensity Scale|pain intensity scale
1215290|NCT01964248|Numerical Rating Scale|numerical rating scale
1215291|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
1215292|NCT01964222|Cancer|cancer
1215293|NCT01964222|Clinical trials|clinical trials
1215294|NCT01964222|Informed consent|informed consent
1215295|NCT01964222|Health literacy|health literacy
1215296|NCT01964209|ADHD|adhd
1215297|NCT01964209|Validation|validation
1215298|NCT01964209|Quality Improvement|quality improvement
1215299|NCT01964209|Vanderbilt|vanderbilt
1215300|NCT01964209|Conners 3rd Edition|conners 3rd edition
1215301|NCT01964209|ADHD Measures|adhd measures
1215302|NCT01964209|ADHD Adolescent|adhd adolescent
1215303|NCT01964209|ADHD Questionnaire|adhd questionnaire
1215304|NCT01964209|ICISS|iciss
1215305|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
1215306|NCT01964196|Renal anemia|renal anemia
1215307|NCT01964196|Chronic Renal Failure|chronic renal failure
1215308|NCT01964196|ASP1517|asp1517
1215309|NCT01964183|Open-label design|open-label design
1215310|NCT01964183|Pharmacokinetics|pharmacokinetics
1215311|NCT01964183|Drug-Drug Interaction|drug-drug interaction
1215312|NCT01964183|Mirabegron|mirabegron
1215313|NCT01964170|ASP3550|asp3550
1215314|NCT01964170|Prostate cancer|prostate cancer
1215315|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1215316|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
1215317|NCT01964131|Bioequivalence|bioequivalence
1215318|NCT01964131|pharmacodynamics|pharmacodynamics
1215319|NCT01964131|pharmacokinetics|pharmacokinetics
1215320|NCT01964131|safety|safety
1215321|NCT01964131|tolerability|tolerability
1215322|NCT01964131|D961H|d961h
1215323|NCT01964131|Japanese|japanese
1215324|NCT01964118|intermittent fasting|intermittent fasting
1215325|NCT01964118|obesity|obesity
1215326|NCT01964118|calorie restriction|calorie restriction
1215327|NCT01964105|Hypomastia|hypomastia
1215328|NCT01964105|Augmentation|augmentation
1215329|NCT01964105|Breast|breast
1215330|NCT01964105|3D|3d
1215331|NCT01964105|Breast Q|breast q
1215332|NCT01964092|Disability|disability
1215333|NCT01964092|Individual placement and support|individual placement and support
1215334|NCT01964092|Mental health|mental health
1215335|NCT01964092|Quality of life|quality of life
1215336|NCT01964092|Randomized controlled trial|randomized controlled trial
1215337|NCT01964092|Rehabilitation|rehabilitation
1215338|NCT01964092|Return to work|return to work
1215339|NCT01964092|Supported employment|supported employment
1215340|NCT01964066|therapeutic ERCP|therapeutic ercp
1215341|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
1215342|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
1215343|NCT01964053|Self-management adherence|self-management adherence
1215344|NCT01964053|post acute care|post acute care
1215345|NCT01964053|critical access hospitals|critical access hospitals
1215346|NCT01964053|patient activation|patient activation
1215347|NCT01964053|hospital readmission|hospital readmission
1215348|NCT01964040|femoral nerve block|femoral nerve block
1215349|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
1215350|NCT01964027|second line chemoregime|second line chemoregime
1215351|NCT01964027|gastric cancer|gastric cancer
1215353|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
1215354|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
1215355|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
1215356|NCT01963962|Emergency contraception|emergency contraception
1215357|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
1215358|NCT01963962|Copper IUD|copper iud
1215359|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
1215360|NCT01963936|Infant newborn|infant newborn
1215361|NCT01963936|Laryngeal mask airway|laryngeal mask airway
1215362|NCT01963936|Positive pressure ventilation|positive pressure ventilation
1215363|NCT01963936|Resuscitation|resuscitation
1215364|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
1215365|NCT01963923|Lung Cancer Resection|lung cancer resection
1215366|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
1215367|NCT01963923|Exercise tolerance|exercise tolerance
1215368|NCT01963923|Quality of life|quality of life
1215369|NCT01963910|Mannitol|mannitol
1215370|NCT01963910|TRPV1 receptor|trpv1 receptor
1215372|NCT01963910|Burning pain|burning pain
1215373|NCT01963910|neuropathy|neuropathy
1215374|NCT01963910|neuropathic pain|neuropathic pain
1215375|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
1215376|NCT01963897|Growth|growth
1215377|NCT01963897|Bone health|bone health
1215378|NCT01963897|Puberty|puberty
1215379|NCT01963897|Quality of life|quality of life
1215380|NCT01963884|Extraction Sockets|extraction sockets
1215381|NCT01963884|Ridge dimensions|ridge dimensions
1215382|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
1215383|NCT01963884|Dental Implants|dental implants
1215384|NCT01963884|Bone Physiology|bone physiology
1215385|NCT01963871|chronic low back pain|chronic low back pain
1215386|NCT01963871|low back pain|low back pain
1215387|NCT01963871|yoga|yoga
1215388|NCT01963832|stroke|stroke
1215389|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
1215390|NCT01963832|eCIMT|ecimt
1215391|NCT01963832|Central Nervous System|central nervous system
1215392|NCT01963793|Pruritus|pruritus
1215393|NCT01963780|lung transplantation|lung transplantation
1215394|NCT01963780|lung preservation|lung preservation
1215395|NCT01963780|breathing lung transplant|breathing lung transplant
1215396|NCT01963767|memory|memory
1215397|NCT01963767|cognition|cognition
1215398|NCT01963767|dietary supplements|dietary supplements
1215399|NCT01963754|Articaine 1:100.000|articaine 1:100.000
1215400|NCT01963754|Dental Implants|dental implants
1215401|NCT01963754|Posterior mandible|posterior mandible
1215402|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
1215403|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
1215404|NCT01963741|Leukotriene D4|leukotriene d4
1215405|NCT01963741|allergic rhinitis|allergic rhinitis
1215406|NCT01963741|nasal airway resistance|nasal airway resistance
1215407|NCT01963741|nasal provocation test|nasal provocation test
1215408|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
1215409|NCT01963741|airway inflammation|airway inflammation
1215410|NCT01963741|asthma|asthma
1215411|NCT01963728|post-transplant|post-transplant
1215412|NCT01963728|diabetes mellitus|diabetes mellitus
1215413|NCT01963728|renal transplant|renal transplant
1215414|NCT01963728|kidney transplant|kidney transplant
1215415|NCT01963728|lung transplant|lung transplant
1215416|NCT01963728|heart transplant|heart transplant
1215417|NCT01963728|insulin|insulin
1215418|NCT01963715|IMGN289|imgn289
1215419|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
1215420|NCT01963715|antibody|antibody
1215421|NCT01963715|EGFR|egfr
1215422|NCT01963715|NSCLC|nsclc
1215423|NCT01963715|SCCHN|scchn
1215424|NCT01963715|Head and neck|head and neck
1215425|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
1215426|NCT01963715|Solid tumor|solid tumor
1215427|NCT01963715|Immunogen|immunogen
1215428|NCT01963715|Lung|lung
1215429|NCT01963715|Phase 1|phase 1
1215430|NCT01963702|predictive factor|predictive factor
1215431|NCT01963702|response|response
1215432|NCT01963702|gastric neoplasm|gastric neoplasm
1215433|NCT01963702|oxaliplatin|oxaliplatin
1215434|NCT01963702|docetaxol|docetaxol
1215435|NCT01963702|capecitabine|capecitabine
1215436|NCT01963689|Anxiety|anxiety
1215437|NCT01963689|Self-Esteem|self-esteem
1215438|NCT01963676|schizophrenia|schizophrenia
1215439|NCT01963676|auditory hallucinations|auditory hallucinations
1215440|NCT01963676|transcranial stimulation|transcranial stimulation
1215441|NCT01963676|tDCS|tdcs
1215442|NCT01963676|tACS|tacs
1215443|NCT01963663|YKL-40|ykl-40
1215444|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
1215445|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
1215446|NCT01963663|metformin|metformin
1215447|NCT01963663|pioglitazone|pioglitazone
1215448|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
1215449|NCT01963624|Breast|breast
1215450|NCT01963624|Screening|screening
1215451|NCT01963624|Ultrasound|ultrasound
1215452|NCT01963624|Elastography|elastography
1215453|NCT01963624|Doppler ultrasonography|doppler ultrasonography
1215454|NCT01963611|Multiple Sclerosis|multiple sclerosis
1215455|NCT01963611|Relapsing Remitting|relapsing remitting
1215456|NCT01963611|Plovamer acetate|plovamer acetate
1215457|NCT01963611|Copaxone|copaxone
1215458|NCT01963585|C reactive protein|c reactive protein
1215459|NCT01963585|Airway hyperreactivity|airway hyperreactivity
1215460|NCT01963585|Body mass index|body mass index
1215461|NCT01963572|Breast cancer|breast cancer
1215462|NCT01963572|Care model|care model
1215463|NCT01963572|Physical Therapy|physical therapy
1215464|NCT01963546|diabetic|diabetic
1215465|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
1215466|NCT01963546|stress response|stress response
1215467|NCT01963546|anesthesia|anesthesia
1215468|NCT01963546|dexmedetomidine|dexmedetomidine
1215469|NCT01963533|lung cancer|lung cancer
1215470|NCT01963533|telomere length|telomere length
1215471|NCT01963533|comorbidity|comorbidity
1215472|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
1215473|NCT01963533|chemotherapy|chemotherapy
1215474|NCT01963520|Hip prosthesis infection|hip prosthesis infection
1215475|NCT01963520|Reinfection|reinfection
1215476|NCT01963520|Excision-synovectomy|excision-synovectomy
1215477|NCT01963520|One stage/two stage revision|one stage/two stage revision
1215478|NCT01963520|Antibiotherapy|antibiotherapy
1215479|NCT01963494|Physical activity|physical activity
1215480|NCT01963494|Health-behavior-change|health-behavior-change
1215481|NCT01963494|Dyadic Planning|dyadic planning
1215482|NCT01963494|Individual Planning|individual planning
1215483|NCT01963481|hormonal therapy|hormonal therapy
1215484|NCT01963481|immunotherapy|immunotherapy
1215485|NCT01963468|Hearing Loss|hearing loss
1215486|NCT01963468|Cochlear Implant|cochlear implant
1215487|NCT01963468|Deaf|deaf
1215488|NCT01963468|Hearing Impairment|hearing impairment
1215489|NCT01963468|Hard of Hearing|hard of hearing
1215490|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
1215491|NCT01963455|muscle derived cells|muscle derived cells
1215492|NCT01963429|hepatocellular|hepatocellular
1215493|NCT01963429|Proton|proton
1215494|NCT01963429|RFA|rfa
1215495|NCT01963403|etonogestrel implant|etonogestrel implant
1215496|NCT01963403|birth control|birth control
1215497|NCT01963403|irregular bleeding|irregular bleeding
1215498|NCT01963403|heavy bleeding|heavy bleeding
1215499|NCT01963390|Hypogonadism|hypogonadism
1215500|NCT01963390|Testosterone Deficiency|testosterone deficiency
1215501|NCT01963377|bronchoscopy|bronchoscopy
1215502|NCT01963377|O2-supplementation|o2-supplementation
1215503|NCT01963364|fructans|fructans
1215504|NCT01963364|inulin|inulin
1215505|NCT01963364|oligofructose|oligofructose
1215506|NCT01963364|colonic fermentation|colonic fermentation
1215507|NCT01963364|microbiota|microbiota
1215508|NCT01963364|whoe gut transit|whoe gut transit
1215509|NCT01963351|NSCLC|nsclc
1215510|NCT01963351|Non-squamous|non-squamous
1215511|NCT01963286|ICD|icd
1215512|NCT01963286|CRT-D|crt-d
1215513|NCT01963286|Sudden cardiac death|sudden cardiac death
1215514|NCT01963286|Device settings|device settings
1215515|NCT01963286|Optimized programming strategy|optimized programming strategy
1215516|NCT01963221|elderly|elderly
1215517|NCT01963221|aorta|aorta
1215518|NCT01963221|inflammation|inflammation
1215519|NCT01963221|arterial stiffness|arterial stiffness
1215520|NCT01963221|PET/CT Imaging|pet/ct imaging
1215521|NCT01963221|hypertension|hypertension
1215522|NCT01963221|MRI|mri
1215523|NCT01963208|partial onset seizures|partial onset seizures
1215524|NCT01963208|complex partial seizures|complex partial seizures
1215525|NCT01963208|simple partial seizures|simple partial seizures
1215526|NCT01963208|anticonvulsant|anticonvulsant
1215527|NCT01963208|ganaxolone|ganaxolone
1215528|NCT01963208|neurosteroid|neurosteroid
1215529|NCT01963208|Marinus|marinus
1215530|NCT01963208|epilepsy|epilepsy
1215531|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
1215532|NCT01963195|Self Efficacy|self efficacy
1215533|NCT01963169|Bone Health|bone health
1215534|NCT01963169|Online intervention|online intervention
1215535|NCT01963169|Dissemination|dissemination
1215536|NCT01963169|Theory-based intervention|theory-based intervention
1215537|NCT01963156|Prescription synchronization|prescription synchronization
1215538|NCT01963156|Cardiovascular disease|cardiovascular disease
1215539|NCT01963156|Medication adherence|medication adherence
1215540|NCT01963156|Randomized controlled trial|randomized controlled trial
1215541|NCT01963156|Chronic disease|chronic disease
1215542|NCT01963156|Pharmacy benefit design|pharmacy benefit design
1215543|NCT01963156|Quality improvement|quality improvement
1215544|NCT01963130|Vildagliptin|vildagliptin
1215545|NCT01963130|Portal Vein Pressure|portal vein pressure
1215546|NCT01963130|Hepatosteatosis|hepatosteatosis
1215547|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
1215548|NCT01963104|patient education, hearing screening|patient education, hearing screening
1215549|NCT01963065|Children's environmental health|children's environmental health
1215550|NCT01963065|preterm birth|preterm birth
1215551|NCT01963065|newborns|newborns
1215552|NCT01963065|bisphenol A|bisphenol a
1215553|NCT01963065|BPA|bpa
1215554|NCT01963065|phthalates|phthalates
1215555|NCT01963065|metals exposure|metals exposure
1215556|NCT01963065|very low birth weight|very low birth weight
1215557|NCT01963065|NICU|nicu
1215558|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
1215559|NCT01963052|AGS15E|ags15e
1215560|NCT01963052|AGS15E-13-1|ags15e-13-1
1215561|NCT01963052|ASG-15ME|asg-15me
1215562|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
1215563|NCT01963026|spinal cord injury|spinal cord injury
1215564|NCT01963026|upper extremity|upper extremity
1215565|NCT01963026|skill performance|skill performance
1215566|NCT01963026|motor learning|motor learning
1215567|NCT01963013|Non-returning catheter valve|non-returning catheter valve
1215568|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
1215569|NCT01963013|Critically ill patients|critically ill patients
1215570|NCT01963013|Prevention|prevention
1215571|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
1215572|NCT01963000|Emergency Department|emergency department
1215573|NCT01963000|Standardized Care|standardized care
1215574|NCT01963000|Reduced Mortality|reduced mortality
1215575|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
1215576|NCT01963000|Antibiotic Therapy|antibiotic therapy
1215577|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
1215578|NCT01962961|HIV|hiv
1215579|NCT01962961|Endothelial function|endothelial function
1215580|NCT01962961|Oxidative stress|oxidative stress
1215581|NCT01962961|Cardiovascular disease|cardiovascular disease
1215582|NCT01962961|N-acetylcysteine|n-acetylcysteine
1215583|NCT01962935|Healthy volunteer|healthy volunteer
1215584|NCT01962935|Multiple ascending dose|multiple ascending dose
1215585|NCT01962909|Pancreatic Resection|pancreatic resection
1215586|NCT01962883|Post Concussion Syndrome|post concussion syndrome
1215587|NCT01962883|Vestibular disturbance|vestibular disturbance
1215588|NCT01962883|Balance|balance
1215589|NCT01962883|Dizziness|dizziness
1215590|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
1215591|NCT01962883|Balance Error Scoring System|balance error scoring system
1215592|NCT01962857|Physical activity|physical activity
1215593|NCT01962857|Exercise|exercise
1215594|NCT01962857|Insulin resistance|insulin resistance
1215595|NCT01962857|High intensity interval training|high intensity interval training
1215596|NCT01962857|Fat oxidation|fat oxidation
1215597|NCT01962857|Fitness|fitness
1215598|NCT01962857|Lipids|lipids
1215599|NCT01962857|Blood pressure|blood pressure
1215600|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
1215601|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
1215602|NCT01962844|index of diet quality|index of diet quality
1215603|NCT01962844|nutritional treatment|nutritional treatment
1215605|NCT01962831|labor, induced|labor, induced
1215606|NCT01962831|pregnancy|pregnancy
1215607|NCT01962831|cervical ripening|cervical ripening
1215608|NCT01962831|dinoprostone|dinoprostone
1215609|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
1215610|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1215611|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
1215612|NCT01962818|Functional Residual Capacity|functional residual capacity
1215613|NCT01962818|Electric impedance tomography|electric impedance tomography
1215614|NCT01962792|PCI-32765|pci-32765
1215615|NCT01962792|Multiple Myeloma|multiple myeloma
1215616|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
1215617|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1215618|NCT01962792|Carfilzomib|carfilzomib
1215619|NCT01962792|Dexamethasone|dexamethasone
1215620|NCT01962792|Ibrutinib|ibrutinib
1215621|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
1215622|NCT01962779|Cognitively normal elderly|cognitively normal elderly
1215623|NCT01962779|Alzheimer's disease|alzheimer's disease
1215624|NCT01962779|Prevention|prevention
1215625|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1215626|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
1215627|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
1215628|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
1215629|NCT01962714|Mindfulness|mindfulness
1215631|NCT01962714|Group therapy|group therapy
1215632|NCT01962701|C-section|c-section
1215633|NCT01962688|Heart Failure|heart failure
1215634|NCT01962688|Handheld ultrasound|handheld ultrasound
1215635|NCT01962688|Inferior Vena Cava|inferior vena cava
1215636|NCT01962675|tDCS|tdcs
1215637|NCT01962675|motor training|motor training
1215638|NCT01962675|SCI|sci
1215639|NCT01962662|stroke|stroke
1215640|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
1215641|NCT01962662|EMG biofeedback|emg biofeedback
1215642|NCT01962662|motor function|motor function
1215643|NCT01962662|neural plasticity|neural plasticity
1215644|NCT01962662|force|force
1215645|NCT01962649|Hepatocellular carcinoma|hepatocellular carcinoma
1215646|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
1215647|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1588968|NCT00434954|Amylin|amylin
1295814|NCT01600508|costs|costs
1215648|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1215649|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1215650|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
1215651|NCT01962636|Myelofibrosis|myelofibrosis
1215652|NCT01962636|Myelodysplasia|myelodysplasia
1215653|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1215654|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1215655|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
1215656|NCT01962636|Follicular Lymphoma|follicular lymphoma
1215657|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1215658|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
1215659|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
1215660|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
1215661|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1215662|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
1215663|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1215664|NCT01962636|Multiple Myeloma|multiple myeloma
1215665|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
1215666|NCT01962623|Mood Disorders|mood disorders
1215667|NCT01962623|Irritability|irritability
1215668|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
1215669|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
1215670|NCT01962610|Pain care|pain care
1215671|NCT01962610|emergency|emergency
1215672|NCT01962610|clinical decision support|clinical decision support
1215673|NCT01962610|abdominal pain|abdominal pain
1215674|NCT01962597|hemodialysis|hemodialysis
1215675|NCT01962597|aerobic exercise|aerobic exercise
1215676|NCT01962597|resistance training|resistance training
1215677|NCT01962597|walking speed|walking speed
1215678|NCT01962597|randomized controlled trial|randomized controlled trial
1215679|NCT01962571|Optic neuritis|optic neuritis
1215680|NCT01962571|Multiple Sclerosis|multiple sclerosis
1215681|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
1215682|NCT01962571|Erythropoietin|erythropoietin
1215683|NCT01962558|Tinnitus|tinnitus
1215684|NCT01962558|Medical Device|medical device
1215685|NCT01962558|Randomized|randomized
1215686|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
1215687|NCT01962545|Atrial Fibrillation|atrial fibrillation
1215688|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
1215689|NCT01962545|Stent|stent
1215690|NCT01962545|Anticoagulant therapy|anticoagulant therapy
1215691|NCT01962545|Antiplatelet therapy|antiplatelet therapy
1215692|NCT01962545|Warfarin|warfarin
1215693|NCT01962545|NOAC|noac
1215694|NCT01962545|Aspirin|aspirin
1215695|NCT01962545|Clopidogrel|clopidogrel
1215696|NCT01962532|Neoplasms|neoplasms
1215697|NCT01962532|Lymphoma|lymphoma
1215698|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
1215699|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
1215700|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
1215701|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
1215702|NCT01962532|JNJ-42756493|jnj-42756493
1215703|NCT01962532|Pharmacokinetics|pharmacokinetics
1215704|NCT01962532|Japanese|japanese
1215705|NCT01962532|Asian|asian
1215706|NCT01962532|Pharmacodynamics|pharmacodynamics
1215707|NCT01962519|gastrectomy|gastrectomy
1215708|NCT01962519|gastric cancer|gastric cancer
1215709|NCT01962519|oral feeding|oral feeding
1215710|NCT01962519|complications|complications
1215711|NCT01962506|Chest pain|chest pain
1215712|NCT01962506|Copeptin|copeptin
1215713|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
1215714|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
1215715|NCT01962467|Allergic rhinitis|allergic rhinitis
1215716|NCT01962467|healthy volunteers|healthy volunteers
1215717|NCT01962467|fluticasone furoate|fluticasone furoate
1215718|NCT01962467|levocabastine|levocabastine
1215719|NCT01962467|fixed dose combination|fixed dose combination
1215720|NCT01962467|pharmacokinetics|pharmacokinetics
1215721|NCT01962454|muscle mass|muscle mass
1215722|NCT01962454|dynamic proteomics|dynamic proteomics
1215723|NCT01962454|Duke University|duke university
1215724|NCT01962454|Microbiopsy|microbiopsy
1215726|NCT01962454|testosterone|testosterone
1216589|NCT01958151|colonoscopy|colonoscopy
1215727|NCT01962454|skeletal muscle|skeletal muscle
1215728|NCT01962441|7977|7977
1215729|NCT01962441|GS-7977|gs-7977
1215730|NCT01962441|PSI-7977|psi-7977
1215731|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
1215732|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
1215733|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
1215734|NCT01962428|ticagrelor|ticagrelor
1215735|NCT01962428|loading dose|loading dose
1215736|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
1215737|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
1215738|NCT01962428|the antiplatelet effects|the antiplatelet effects
1215739|NCT01962428|bleeding events|bleeding events
1215740|NCT01962428|major adverse cardiac events|major adverse cardiac events
1588969|NCT00434954|Lilly|lilly
1215741|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
1215742|NCT01962415|Omenn Syndrome|omenn syndrome
1215743|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
1215744|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
1215745|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
1215746|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1215747|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
1215748|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
1215749|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
1215750|NCT01962415|IPEX syndrome|ipex syndrome
1215751|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
1215752|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
1215753|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
1215754|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
1215755|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
1215756|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
1215757|NCT01962415|Osteopetrosis|osteopetrosis
1215758|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
1215759|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
1215760|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
1215761|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
1215762|NCT01962415|Leukodystrophies|leukodystrophies
1215763|NCT01962415|Krabbe Disease|krabbe disease
1215764|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
1215765|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
1215766|NCT01962415|Alpha mannosidosis|alpha mannosidosis
1215767|NCT01962415|Gaucher Disease|gaucher disease
1215768|NCT01962415|Thalassemia major|thalassemia major
1215769|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
1215770|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
1215771|NCT01962415|Crohn's Disease|crohn's disease
1215772|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
1215773|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1215774|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
1215775|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
1215776|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
1215777|NCT01962376|Capecitabine|capecitabine
1215778|NCT01962376|Oxaliplatin|oxaliplatin
1215779|NCT01962376|Bevacizumab|bevacizumab
1215780|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
1215781|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
1215782|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
1215783|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
1215784|NCT01962350|H1-Coil;|h1-coil;
1215785|NCT01962350|Bipolar Depression;|bipolar depression;
1215786|NCT01962350|Cognition.|cognition.
1215787|NCT01962324|Quality of Life|quality of life
1215788|NCT01962324|Radiotherapy|radiotherapy
1215789|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
1215791|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
1215792|NCT01962311|Urine|urine
1215793|NCT01962311|SERUM|serum
1215794|NCT01962311|Diagnosis|diagnosis
1215795|NCT01962285|neuronal inertia|neuronal inertia
1215796|NCT01962285|loss of consciousness|loss of consciousness
1215797|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
1215798|NCT01962285|Bispectral index|bispectral index
1215799|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
1215800|NCT01962272|cancer|cancer
1215801|NCT01962272|radiotherapy|radiotherapy
1215802|NCT01962272|chemotherapy|chemotherapy
1215803|NCT01962272|nutrition|nutrition
1215804|NCT01962272|dietary counseling|dietary counseling
1215805|NCT01962272|quality of life|quality of life
1215806|NCT01962246|Capecitabine|capecitabine
1215807|NCT01962246|Oxaliplatin|oxaliplatin
1215808|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
1215809|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1215810|NCT01962220|HIV/AIDS|hiv/aids
1215811|NCT01962220|PMTCT|pmtct
1216009|NCT01961271|painkiller|painkiller
1216985|NCT01956240|stretching|stretching
1215812|NCT01962220|Pregnant Women|pregnant women
1215813|NCT01962220|Kenya|kenya
1215814|NCT01962220|Maternal Health|maternal health
1215815|NCT01962207|10 years Meningitec|10 years meningitec
1215816|NCT01962207|Safety|safety
1215817|NCT01962207|booster response|booster response
1215818|NCT01962207|Adolescents|adolescents
1215819|NCT01962207|Adults|adults
1215820|NCT01962207|Immunogenicity|immunogenicity
1215821|NCT01962207|Mencevax ACWY|mencevax acwy
1215822|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
1215823|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
1215824|NCT01962168|Neoplasms|neoplasms
1215825|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
1215826|NCT01962168|Digestive System Diseases|digestive system diseases
1215827|NCT01962168|Biliary Tract|biliary tract
1215828|NCT01962168|Stents|stents
1215829|NCT01962155|Fibrosis|fibrosis
1215830|NCT01962155|Liver Cirrhosis|liver cirrhosis
1215831|NCT01962155|non-invasive|non-invasive
1215832|NCT01962155|biopsy|biopsy
1215833|NCT01962155|hepatitis B virus|hepatitis b virus
1215834|NCT01962103|Neuroblastoma|neuroblastoma
1215835|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
1215836|NCT01962103|Soft Tissue|soft tissue
1215837|NCT01962103|Pediatric Oncology|pediatric oncology
1215838|NCT01962103|Abraxane|abraxane
1215839|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
1215840|NCT01962103|nab-paclitaxel|nab-paclitaxel
1215841|NCT01962103|ABI-007|abi-007
1215842|NCT01962103|taxane|taxane
1215843|NCT01962103|solid tumors|solid tumors
1215844|NCT01962090|Neck Pain|neck pain
1215845|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
1215846|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
1215847|NCT01962090|Dentistry|dentistry
1215848|NCT01962090|Range of Motion|range of motion
1215849|NCT01962077|pulpotomy|pulpotomy
1215850|NCT01962077|MTA|mta
1215851|NCT01962077|primary teeth|primary teeth
1215852|NCT01962077|formocresol|formocresol
1215853|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
1215854|NCT01962038|Aging|aging
1215855|NCT01962025|Renal failure|renal failure
1215856|NCT01962025|Hemodialysis|hemodialysis
1215857|NCT01962025|Canulation technique|canulation technique
1215858|NCT01962025|Training time|training time
1215859|NCT01962025|Cost|cost
1215860|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
1215861|NCT01962012|Orthodontic|orthodontic
1215862|NCT01962012|Orthodontic Treatment|orthodontic treatment
1215863|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
1215864|NCT01962012|Malocclusion|malocclusion
1215865|NCT01962012|Device|device
1215866|NCT01962012|AcceleDent Aura|acceledent aura
1215867|NCT01962012|Clear Aligners|clear aligners
1215868|NCT01961999|Acute kidney injury|acute kidney injury
1215869|NCT01961999|Cardiac surgery|cardiac surgery
1215870|NCT01961999|Renal replacement therapy|renal replacement therapy
1215871|NCT01961986|Rotator Cuff|rotator cuff
1215872|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
1215873|NCT01961986|Shoulder Replacement|shoulder replacement
1215874|NCT01961986|Total Shoulder Replacement|total shoulder replacement
1215875|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
1215876|NCT01961986|Arthritis|arthritis
1215877|NCT01961973|Articular cartilage|articular cartilage
1215878|NCT01961973|Chondrocytes|chondrocytes
1215879|NCT01961973|BMAC|bmac
1215880|NCT01961960|ASP7374|asp7374
1215881|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
1215882|NCT01961947|ASP7374|asp7374
1215883|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
1215884|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
1215885|NCT01961934|glioblastoma|glioblastoma
1215886|NCT01961934|high grade brain tumors|high grade brain tumors
1215887|NCT01961934|recurrent|recurrent
1215888|NCT01961934|pseudo-progression|pseudo-progression
1215889|NCT01961934|radionecrosis|radionecrosis
1215890|NCT01961934|carbon acetate|carbon acetate
1215891|NCT01961934|C11 aceate|c11 aceate
1215892|NCT01961934|PET|pet
1215893|NCT01961934|positron emission tomography|positron emission tomography
1215894|NCT01961921|RNAi therapeutic|rnai therapeutic
1215895|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
1215896|NCT01961882|OCV-501|ocv-501
1215897|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
1215898|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
1215899|NCT01961869|black raspberry|black raspberry
1215900|NCT01961869|chemoprevention|chemoprevention
1215901|NCT01961869|oral delivery|oral delivery
1215902|NCT01961856|platelet reactivity|platelet reactivity
1215903|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
1215904|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
1215905|NCT01961843|Castration Resistant|castration resistant
1215906|NCT01961817|Retromolar|retromolar
1215907|NCT01961817|Difficult Intubation|difficult intubation
1215908|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
1215909|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
1215910|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
1215911|NCT01961752|bupivacaine,|bupivacaine,
1215912|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
1215913|NCT01961752|endoscopic|endoscopic
1215914|NCT01961752|submucosal|submucosal
1215915|NCT01961752|dissection|dissection
1215916|NCT01961752|Patients|patients
1215917|NCT01961739|Hemorrhoids|hemorrhoids
1215918|NCT01961739|Lidocaine|lidocaine
1215919|NCT01961713|circulating tumor cells|circulating tumor cells
1215920|NCT01961713|CTC-Chip|ctc-chip
1215921|NCT01961661|intestinal inflammation|intestinal inflammation
1296204|NCT01599065|ICD|icd
1215922|NCT01961661|intestinal microflora|intestinal microflora
1215923|NCT01961661|children|children
1215924|NCT01961648|Apnea|apnea
1215925|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
1215926|NCT01961648|Respiratory chemical drive|respiratory chemical drive
1215928|NCT01961635|Dental Implants|dental implants
1215929|NCT01961635|Zirconia Abutments|zirconia abutments
1215930|NCT01961635|Titanium abutments|titanium abutments
1215931|NCT01961635|Acrylic abutments|acrylic abutments
1215932|NCT01961635|Gingival Healing|gingival healing
1215933|NCT01961635|Inflammation|inflammation
1215934|NCT01961635|Bone loss|bone loss
1215935|NCT01961622|Type 1 diabetes|type 1 diabetes
1215936|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
1215937|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
1215938|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1215939|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
1215940|NCT01961596|Cooling ice spray|cooling ice spray
1215941|NCT01961596|Time to stability|time to stability
1215942|NCT01961596|Jump|jump
1215943|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
1215944|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
1215945|NCT01961557|EEG|eeg
1215946|NCT01961557|Cerebral Palsy|cerebral palsy
1215947|NCT01961557|Knee|knee
1215948|NCT01961544|Breast Cancer|breast cancer
1215949|NCT01961544|Metastatic|metastatic
1215950|NCT01961531|DCIS|dcis
1215951|NCT01961531|IDC|idc
1215952|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
1215953|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
1215954|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
1215955|NCT01961479|Internet-based Therapy|internet-based therapy
1215956|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
1215957|NCT01961453|Hypertension|hypertension
1215958|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
1215959|NCT01961453|Myocardial fibrosis|myocardial fibrosis
1215960|NCT01961427|dietary nitrate|dietary nitrate
1215961|NCT01961427|beetroot juice|beetroot juice
1215962|NCT01961427|exercise performance|exercise performance
1215963|NCT01961427|oxygen consumption|oxygen consumption
1215964|NCT01961414|Exudative|exudative
1215965|NCT01961414|AMD|amd
1215966|NCT01961414|Macular|macular
1215967|NCT01961414|Degeneration|degeneration
1215968|NCT01961414|Aflibercept|aflibercept
1215969|NCT01961414|Eylea|eylea
1215970|NCT01961414|Intravitreal|intravitreal
1215971|NCT01961401|exercise|exercise
1215972|NCT01961401|exercise therapy|exercise therapy
1215973|NCT01961401|insulin resistance|insulin resistance
1215974|NCT01961388|Type 2 Diabetes|type 2 diabetes
1215975|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
1215976|NCT01961362|Interstitial lung disease|interstitial lung disease
1215977|NCT01961362|Connective tissue disease|connective tissue disease
1215978|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
1215979|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1215980|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
1215981|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
1215982|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
1215983|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
1215984|NCT01961323|Hypertension|hypertension
1215985|NCT01961323|high blood pressure|high blood pressure
1215986|NCT01961323|stress echocardiogram|stress echocardiogram
1215987|NCT01961323|nebivolol|nebivolol
1215988|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
1215989|NCT01961310|bacterial translocation|bacterial translocation
1215990|NCT01961310|intestinal microbiota|intestinal microbiota
1215991|NCT01961297|dystonia|dystonia
1215992|NCT01961297|tremor|tremor
1215993|NCT01961297|treatment|treatment
1215994|NCT01961297|sodium oxybate|sodium oxybate
1215995|NCT01961297|brain activity|brain activity
1215996|NCT01961271|Norspan|norspan
1215997|NCT01961271|buprenorphine|buprenorphine
1215998|NCT01961271|transdermal|transdermal
1215999|NCT01961271|patch|patch
1216000|NCT01961271|chronic pain|chronic pain
1216001|NCT01961271|non-malignant|non-malignant
1216002|NCT01961271|osteoarthritis|osteoarthritis
1216003|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
1216004|NCT01961271|lower back pain|lower back pain
1216005|NCT01961271|joint pain|joint pain
1216006|NCT01961271|muscle pain|muscle pain
1216007|NCT01961271|opioid|opioid
1216011|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
1216012|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
1216013|NCT01961232|biomarker|biomarker
1216014|NCT01961232|cardiac|cardiac
1216015|NCT01961232|circulation|circulation
1216016|NCT01961232|heart disease|heart disease
1216017|NCT01961232|lung disease|lung disease
1216018|NCT01961193|critically ill patients|critically ill patients
1216019|NCT01961193|punctal plug|punctal plug
1216020|NCT01961193|corneal injuries|corneal injuries
1216021|NCT01961180|Quality of Life|quality of life
1216022|NCT01961180|Adrenal hyper activity|adrenal hyper activity
1216023|NCT01961180|Glucose metabolism|glucose metabolism
1216024|NCT01961154|Asthma|asthma
1216025|NCT01961154|medication reduction|medication reduction
1216026|NCT01961154|asthma exacerbation|asthma exacerbation
1216027|NCT01961141|Ultrasound Doppler|ultrasound doppler
1216028|NCT01961141|Pulmonary diseases|pulmonary diseases
1216029|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
1216030|NCT01961128|High risk|high risk
1216031|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
1216032|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
1216033|NCT01961102|endometrial cancer|endometrial cancer
1216034|NCT01961102|atypical hyperplasia|atypical hyperplasia
1216035|NCT01961102|curettage|curettage
1216036|NCT01961102|intraoperative rapid section|intraoperative rapid section
1216037|NCT01961050|alcohol|alcohol
1216038|NCT01961050|pregnancy|pregnancy
1216039|NCT01961050|fetal exposure|fetal exposure
1216040|NCT01961050|prevention|prevention
1216041|NCT01961050|FAS|fas
1216042|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
1216043|NCT01961037|Accidental Falls|accidental falls
1216044|NCT01961037|Tai Chi|tai chi
1216045|NCT01961037|Older Adults|older adults
1216046|NCT01961037|Balance|balance
1216047|NCT01961037|Moving for Better Balance|moving for better balance
1216048|NCT01961037|Church|church
1216049|NCT01961037|Congregational Intervention|congregational intervention
1216050|NCT01961037|Rural|rural
1216051|NCT01961037|West Virginia|west virginia
1216052|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
1216053|NCT01961024|Postprandial state|postprandial state
1216054|NCT01961024|Obesity|obesity
1216055|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
1216056|NCT01960998|radical prostatectomy|radical prostatectomy
1216057|NCT01960998|urinary incontinence|urinary incontinence
1216058|NCT01960998|prostate cancer|prostate cancer
1216059|NCT01960998|telehealth|telehealth
1216060|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
1216061|NCT01960985|Balance, Postural|balance, postural
1216062|NCT01960985|Parkinson´s Disease|parkinson´s disease
1216063|NCT01960985|H&Y 1-3|h&y 1-3
1216064|NCT01960985|Exrecice|exrecice
1216065|NCT01960985|Postural adjustments|postural adjustments
1216066|NCT01960985|antecipatory postural|antecipatory postural
1216067|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
1216068|NCT01960972|Blood pressure|blood pressure
1216069|NCT01960972|Hypertension|hypertension
1216070|NCT01960972|Stepped wedge trial design|stepped wedge trial design
1216071|NCT01960946|Hypertension|hypertension
1216072|NCT01960946|Galectin 3|galectin 3
1216073|NCT01960946|Fibrosis|fibrosis
1216074|NCT01960946|Vascular Stiffness|vascular stiffness
1216075|NCT01960946|Echocardiography|echocardiography
1216076|NCT01960933|STEMI|stemi
1216077|NCT01960933|MVD|mvd
1216078|NCT01960933|Full revascularization|full revascularization
1216079|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
1216080|NCT01960933|Primary PCI|primary pci
1216081|NCT01960920|Air Pollution|air pollution
1216082|NCT01960920|Heart Failure|heart failure
1216083|NCT01960920|Endothelium|endothelium
1216084|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
1216085|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
1216087|NCT01960907|CHF|chf
1216088|NCT01960907|SDB|sdb
1216089|NCT01960881|Prostate cancer|prostate cancer
1216090|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
1216091|NCT01960855|Joint Diseases|joint diseases
1216092|NCT01960855|Arthritis|arthritis
1216093|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
1216094|NCT01960855|antirheumatic agents|antirheumatic agents
1216095|NCT01960842|levodopa|levodopa
1216096|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
1216097|NCT01960842|carbidopa|carbidopa
1216098|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1216099|NCT01960842|Safety and Efficacy|safety and efficacy
1216100|NCT01960829|melanoma|melanoma
1216101|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
1216102|NCT01960816|nasal obstruction|nasal obstruction
1216103|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
1216104|NCT01960790|Humira®|humira®
1216105|NCT01960790|Behcet's Disease|behcet's disease
1216106|NCT01960790|Adalimumab|adalimumab
1216107|NCT01960777|Hernia, Inguinal|hernia, inguinal
1216108|NCT01960777|Laparoscopy|laparoscopy
1216109|NCT01960777|Onstep|onstep
1216110|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
1216111|NCT01960764|Bacteria transplant|bacteria transplant
1216112|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
1216113|NCT01960738|Diving|diving
1216114|NCT01960738|Water|water
1216115|NCT01960738|Recreation|recreation
1216116|NCT01960738|Precursor|precursor
1216117|NCT01960725|Gastroenteritis|gastroenteritis
1216118|NCT01960725|Diarrhea|diarrhea
1216119|NCT01960725|Rotavirus|rotavirus
1216120|NCT01960725|Vaccine|vaccine
1216121|NCT01960725|Dehydration|dehydration
1216122|NCT01960699|Prognosis|prognosis
1216123|NCT01960699|Neurological outcome|neurological outcome
1216124|NCT01960699|Resuscitation|resuscitation
1216125|NCT01960699|Biomarker|biomarker
1216126|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
1216127|NCT01960660|Fish Oil|fish oil
1216128|NCT01960660|EPA|epa
1216129|NCT01960660|DHA|dha
1216130|NCT01960660|Omega-Score|omega-score
1216131|NCT01960660|Lipemic Index|lipemic index
1216132|NCT01960660|ethyl esters|ethyl esters
1216133|NCT01960660|triglycerides|triglycerides
1216134|NCT01960660|phospholipids|phospholipids
1216135|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
1216136|NCT01960582|Housing adaptation|housing adaptation
1216137|NCT01960582|Independence|independence
1216138|NCT01960582|Costs|costs
1216139|NCT01960569|Thrombexx|thrombexx
1216140|NCT01960569|Topical r-Hirudin|topical r-hirudin
1216141|NCT01960569|Efficacy|efficacy
1216142|NCT01960569|haematoma|haematoma
1216143|NCT01960556|simulation|simulation
1216144|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
1216145|NCT01960543|Levobupivacaine|levobupivacaine
1216146|NCT01960543|Bupivacaine|bupivacaine
1216147|NCT01960543|Hip fracture|hip fracture
1216148|NCT01960517|Urinary|urinary
1216149|NCT01960517|Incontinence|incontinence
1216150|NCT01960517|Catheter|catheter
1216151|NCT01960504|DREAMS|dreams
1216152|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
1216153|NCT01960504|Scaffold|scaffold
1216154|NCT01960504|Coronary Artery Disease|coronary artery disease
1216155|NCT01960504|Myocardial Ischemia|myocardial ischemia
1216156|NCT01960504|Atherosclerosis|atherosclerosis
1216157|NCT01960465|CPAP treatment|cpap treatment
1216158|NCT01960465|hypertension|hypertension
1216159|NCT01960452|Insomnia|insomnia
1216160|NCT01960452|Primary insomnia|primary insomnia
1216161|NCT01960452|High density EEG|high density eeg
1216162|NCT01960452|Polysomnography|polysomnography
1216163|NCT01960452|Healthy sleeping controls|healthy sleeping controls
1216164|NCT01960439|disease activity|disease activity
1216165|NCT01960439|central reader|central reader
1216166|NCT01960439|endoscopic indices|endoscopic indices
1216167|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
1216168|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
1216169|NCT01960426|Infliximab|infliximab
1216170|NCT01960426|Adalimumab|adalimumab
1216171|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
1216172|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1216173|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
1216174|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1216175|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1216176|NCT01960387|AML|aml
1216177|NCT01960387|clofarabine|clofarabine
1216178|NCT01960387|cytarabine|cytarabine
1216179|NCT01960387|persistent AML|persistent aml
1216180|NCT01960387|induction therapy|induction therapy
1216181|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
1216182|NCT01960348|RNAi therapeutic|rnai therapeutic
1216183|NCT01960348|FAP|fap
1216184|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
1216185|NCT01960348|TTR|ttr
1216186|NCT01960348|Transthyretin|transthyretin
1216187|NCT01960348|Amyloidosis|amyloidosis
1216188|NCT01960335|whey protein intake|whey protein intake
1216189|NCT01960335|obesity|obesity
1216190|NCT01960335|visceral fat|visceral fat
1216191|NCT01960335|resistance exercise training|resistance exercise training
1216192|NCT01960335|sprint interval training|sprint interval training
1216193|NCT01960335|endurance exercise training|endurance exercise training
1216194|NCT01960335|yoga training|yoga training
1216195|NCT01960335|healthy eating|healthy eating
1216196|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
1216197|NCT01960335|leptin|leptin
1216198|NCT01960335|hunger|hunger
1216199|NCT01960322|adherence|adherence
1216200|NCT01960322|nonadherence|nonadherence
1216201|NCT01960322|compliance|compliance
1216202|NCT01960322|noncompliance|noncompliance
1216203|NCT01960322|liver transplantation|liver transplantation
1216204|NCT01960296|clopidogrel|clopidogrel
1216205|NCT01960296|general surgery|general surgery
1217483|NCT01953926|Trastuzumab|trastuzumab
1216206|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
1216207|NCT01960257|tuberculosis|tuberculosis
1216208|NCT01960257|tuberculosis treatment|tuberculosis treatment
1216209|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
1216210|NCT01960257|proteus digital health|proteus digital health
1216211|NCT01960257|digital health feedback system|digital health feedback system
1216212|NCT01960244|familial|familial
1216213|NCT01960244|hypercholesterolemia|hypercholesterolemia
1216215|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
1216216|NCT01960218|gas exchange|gas exchange
1216217|NCT01960218|cardiopulmonary|cardiopulmonary
1216218|NCT01960218|dyspnea|dyspnea
1216219|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
1216220|NCT01960218|heart disease|heart disease
1216221|NCT01960218|cardiovascular disease|cardiovascular disease
1216222|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
1216223|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
1216224|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
1216225|NCT01960192|RR;PFS;OS|rr;pfs;os
1216226|NCT01960153|Heart failure|heart failure
1216227|NCT01960153|Pulmonary hypertension|pulmonary hypertension
1216228|NCT01960153|tadalafil|tadalafil
1216229|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
1216230|NCT01960114|Acetaminophen|acetaminophen
1216231|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
1216232|NCT01960114|Analgesics|analgesics
1216233|NCT01960114|Non-Narcotic Pain|non-narcotic pain
1216234|NCT01960114|Postoperative Pain|postoperative pain
1216235|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
1216236|NCT01960114|Third molar extraction|third molar extraction
1216237|NCT01960101|xerostomia|xerostomia
1216238|NCT01960101|Saliva|saliva
1216239|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
1216240|NCT01960101|antidepressants|antidepressants
1216241|NCT01960101|mouth dryness|mouth dryness
1216242|NCT01960101|milk product|milk product
1216243|NCT01960088|Adolescent vaccines|adolescent vaccines
1216244|NCT01960088|HPV vaccine|hpv vaccine
1216245|NCT01960088|Pharmacies|pharmacies
1216246|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
1216247|NCT01960062|diabetes|diabetes
1216248|NCT01960062|web-based|web-based
1216249|NCT01960062|software|software
1216250|NCT01960062|device|device
1216251|NCT01960049|Postoperative pain|postoperative pain
1216252|NCT01960049|Liver resection|liver resection
1216253|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
1216254|NCT01960036|Substance Use Disorders|substance use disorders
1216255|NCT01960036|Complementary Therapies|complementary therapies
1216256|NCT01960036|Women|women
1216257|NCT01960036|Mind-Body Therapies|mind-body therapies
1216258|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
1216259|NCT01960023|Colorectal cancer|colorectal cancer
1216260|NCT01960023|KRAS|kras
1216261|NCT01960023|BRAF|braf
1216262|NCT01960023|NRAS|nras
1216263|NCT01960023|PIK3CA|pik3ca
1216264|NCT01960023|NSABP|nsabp
1216265|NCT01959958|Nocturnal enuresis|nocturnal enuresis
1216266|NCT01959958|Barriers to treatment|barriers to treatment
1216267|NCT01959945|Prevention|prevention
1216268|NCT01959932|Smoking|smoking
1216269|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
1216270|NCT01959932|Conventional cigarettes|conventional cigarettes
1216271|NCT01959932|Reduced exposure|reduced exposure
1216272|NCT01959932|Confinement|confinement
1216273|NCT01959906|Esophagectomy|esophagectomy
1216274|NCT01959880|Breast Augmentation|breast augmentation
1216275|NCT01959880|Breast Reconstruction|breast reconstruction
1216276|NCT01959880|Breast Revision|breast revision
1216277|NCT01959880|Silicone Gel|silicone gel
1216278|NCT01959880|Contour Profile Gel|contour profile gel
1216279|NCT01959880|Siltex|siltex
1216280|NCT01959880|CPG Styles|cpg styles
1216281|NCT01959867|mastectomy|mastectomy
1216282|NCT01959867|breast reconstruction|breast reconstruction
1216283|NCT01959867|bovine|bovine
1216284|NCT01959867|ADM|adm
1216285|NCT01959867|breast cancer|breast cancer
1216286|NCT01959867|breast implants|breast implants
1216287|NCT01959867|breast expanders|breast expanders
1216288|NCT01959867|radiation therapy|radiation therapy
1216289|NCT01959828|pulmonary hypertension|pulmonary hypertension
1216290|NCT01959828|cardiac surgery|cardiac surgery
1216291|NCT01959828|Glenn surgery|glenn surgery
1216292|NCT01959828|fontan surgery|fontan surgery
1216293|NCT01959828|left ventricular assist device|left ventricular assist device
1216294|NCT01959828|LVAD|lvad
1216295|NCT01959802|Macular pseudohole|macular pseudohole
1216296|NCT01959802|Cone outer segment tips line|cone outer segment tips line
1216297|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
1216298|NCT01959789|Tooth Bleaching|tooth bleaching
1216299|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
1216300|NCT01959763|Metabolic syndrome|metabolic syndrome
1216301|NCT01959763|obesity|obesity
1216302|NCT01959763|overweight|overweight
1216303|NCT01959763|weight loss intervention|weight loss intervention
1216304|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
1216305|NCT01959763|ICT intervention|ict intervention
1216306|NCT01959763|cardiovascular disease|cardiovascular disease
1216307|NCT01959763|persuasive systems design|persuasive systems design
1216308|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
1216309|NCT01959724|Macular detachment|macular detachment
1216310|NCT01959724|Macular retinoschisis|macular retinoschisis
1216311|NCT01959724|Vitrectomy|vitrectomy
1216312|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
1216313|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
1216314|NCT01959646|Immune Function|immune function
1216315|NCT01959646|Aged Garlic Extract|aged garlic extract
1216316|NCT01959646|Supplementation|supplementation
1216317|NCT01959646|Inflammation|inflammation
1216318|NCT01959620|PTSD|ptsd
1216319|NCT01959607|Smoking|smoking
1216320|NCT01959607|Nicotine absorption|nicotine absorption
1216321|NCT01959607|Candidate modified risk tobacco product|candidate modified risk tobacco product
1216322|NCT01959607|Cigarettes|cigarettes
1216323|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
1216324|NCT01959594|multiple doses|multiple doses
1216325|NCT01959594|pharmacokinetics|pharmacokinetics
1216326|NCT01959594|safety|safety
1216327|NCT01959594|tolerability|tolerability
1216328|NCT01959594|healthy volunteers|healthy volunteers
1216329|NCT01959594|steady state|steady state
1216330|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
1216331|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
1216332|NCT01959581|Reaching|reaching
1216333|NCT01959581|Upper extremity function|upper extremity function
1216334|NCT01959581|Preterm Infants|preterm infants
1216335|NCT01959581|Brain injury|brain injury
1216336|NCT01959581|Pediatrics|pediatrics
1216337|NCT01959581|Early Intervention|early intervention
1216338|NCT01959581|Arthrogryposis|arthrogryposis
1216339|NCT01959568|Retinal Detachment|retinal detachment
1216340|NCT01959568|Double Tamponade|double tamponade
1216341|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
1216342|NCT01959568|Vitrectomy|vitrectomy
1216343|NCT01959542|Prostate Cancer|prostate cancer
1216344|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
1216345|NCT01959503|Aorta|aorta
1216346|NCT01959503|Aortic|aortic
1216347|NCT01959503|Reconstruction|reconstruction
1216348|NCT01959503|CABG|cabg
1216349|NCT01959503|Bypass|bypass
1216350|NCT01959464|Assisted reproductive technology|assisted reproductive technology
1216351|NCT01959464|Infertility|infertility
1216352|NCT01959464|Progesterone|progesterone
1216353|NCT01959464|Vaginal gel|vaginal gel
1216354|NCT01959464|Luteal-phase support|luteal-phase support
1216355|NCT01959451|Prasugrel|prasugrel
1216356|NCT01959451|Clopidogrel|clopidogrel
1216357|NCT01959438|Phase I study for safety|phase i study for safety
1216358|NCT01959438|Later Phase II study for responses|later phase ii study for responses
1216359|NCT01959425|Anticoagulation|anticoagulation
1216360|NCT01959425|Oral|oral
1216361|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1216362|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
1216363|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
1216364|NCT01959425|3 months post procedure|3 months post procedure
1216365|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
1216366|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
1216367|NCT01959399|ASP015K|asp015k
1216368|NCT01959399|healthy subjects|healthy subjects
1216369|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
1216370|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
1216371|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
1216372|NCT01959347|urinary incontinence|urinary incontinence
1216373|NCT01959347|midurethral sling|midurethral sling
1216374|NCT01959347|pelvic floor therapy|pelvic floor therapy
1216375|NCT01959334|Diabetes Mellitus|diabetes mellitus
1216376|NCT01959334|Hypoglycemia|hypoglycemia
1216377|NCT01959334|Glucagon|glucagon
1216378|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
1216379|NCT01959334|Immunogenicity|immunogenicity
1216380|NCT01959308|Adherence|adherence
1216381|NCT01959308|Compliance|compliance
1216382|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
1216383|NCT01959308|Liver Transplant|liver transplant
1216384|NCT01959308|Liver Recipients|liver recipients
1216385|NCT01959308|Adult|adult
1216386|NCT01959308|Adolescent|adolescent
1216387|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
1216388|NCT01959282|JNJ-54781532|jnj-54781532
1216389|NCT01959282|Moderate|moderate
1216390|NCT01959282|Severe|severe
1216391|NCT01959282|Active|active
1216392|NCT01959256|Stroke|stroke
1216393|NCT01959256|Visual Field Defect|visual field defect
1216394|NCT01959256|Visual perceptual learning|visual perceptual learning
1216395|NCT01959256|Brain connectivity|brain connectivity
1216396|NCT01959243|Ocular redness|ocular redness
1218492|NCT01949012|Midazolam|midazolam
1216397|NCT01959230|Ocular redness|ocular redness
1216398|NCT01959217|HIV|hiv
1216399|NCT01959217|Substance Abuse|substance abuse
1216400|NCT01959217|Prospective Memory|prospective memory
1216401|NCT01959204|pharmacokinetics|pharmacokinetics
1216402|NCT01959204|safety|safety
1216403|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
1216404|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
1216405|NCT01959152|Cochlear Implant|cochlear implant
1216406|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
1216407|NCT01959152|Cochlear Implantation|cochlear implantation
1216408|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
1216409|NCT01959152|Listening Benefits|listening benefits
1216410|NCT01959152|Adults|adults
1216411|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
1216412|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
1216413|NCT01959152|Electrical Stimulation|electrical stimulation
1216414|NCT01959126|Telomerase|telomerase
1216415|NCT01959126|Telomere length|telomere length
1216416|NCT01959126|Psychological Sress|psychological sress
1216417|NCT01959126|Mindfulness|mindfulness
1216418|NCT01959113|Microbiome|microbiome
1216419|NCT01959113|Bacteria transplant|bacteria transplant
1216420|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
1216421|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1216422|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
1216423|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1216424|NCT01959087|Single port surgery|single port surgery
1216425|NCT01959087|Colonic surgery|colonic surgery
1216426|NCT01959087|Postoperative morbidity|postoperative morbidity
1216427|NCT01959087|Postoperative outcomes|postoperative outcomes
1216428|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
1216429|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
1216430|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
1216431|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
1216432|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
1216433|NCT01959022|PTSD|ptsd
1216434|NCT01959022|Doxazosin|doxazosin
1216435|NCT01959022|Nightmares|nightmares
1216436|NCT01959022|Sleep Disturbance|sleep disturbance
1216437|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
1216438|NCT01958983|dementia|dementia
1216439|NCT01958983|drumming|drumming
1216440|NCT01958983|emotion|emotion
1216441|NCT01958983|cognition|cognition
1216442|NCT01958983|functional MRI|functional mri
1216443|NCT01958970|End Stage Renal Disease|end stage renal disease
1216444|NCT01958970|ESRD|esrd
1216445|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
1216446|NCT01958970|Hemodialysis|hemodialysis
1216447|NCT01958970|Dialysis|dialysis
1216448|NCT01958970|MHD|mhd
1216449|NCT01958970|Protein Energy Wasting|protein energy wasting
1216450|NCT01958970|PEW|pew
1216451|NCT01958957|ischemic stroke|ischemic stroke
1216452|NCT01958957|safety|safety
1216453|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
1216454|NCT01958944|CF|cf
1216455|NCT01958944|Cystic Fibrosis|cystic fibrosis
1216456|NCT01958944|NO|no
1216457|NCT01958944|nitric oxide|nitric oxide
1216458|NCT01958944|inhalation|inhalation
1216459|NCT01958918|neovascular AMD|neovascular amd
1216460|NCT01958918|ranibizumab|ranibizumab
1216461|NCT01958918|aflibercept|aflibercept
1216462|NCT01958918|BCVA|bcva
1216463|NCT01958918|SD OCT|sd oct
1216464|NCT01958892|BPH|bph
1216465|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
1216466|NCT01958866|Fever|fever
1216467|NCT01958866|Body temperature|body temperature
1216468|NCT01958853|Pain|pain
1216469|NCT01958840|Behavioral|behavioral
1216470|NCT01958840|Activation|activation
1216471|NCT01958840|Treatment|treatment
1216472|NCT01958827|Dose Escalation|dose escalation
1216473|NCT01958827|Crohn's Disease|crohn's disease
1216474|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
1216475|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
1216476|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
1216477|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
1216478|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
1216479|NCT01958788|Worry|worry
1216480|NCT01958788|Behavioral experiments|behavioral experiments
1216481|NCT01958788|Safety behaviors|safety behaviors
1216482|NCT01958788|Anxiety|anxiety
1216483|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
1216484|NCT01958762|Screening|screening
1216485|NCT01958762|Cancer|cancer
1216486|NCT01958762|Tobacco|tobacco
1216487|NCT01958762|General Practitioner|general practitioner
1216488|NCT01958762|Precancerous Lesion|precancerous lesion
1216489|NCT01958762|Dysplasia|dysplasia
1216490|NCT01958762|Tobacco vendor|tobacco vendor
1216491|NCT01958723|Problem Specific Template|problem specific template
1216492|NCT01958723|Physician Documentation|physician documentation
1216493|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
1589178|NCT00434252|BEAM|beam
1216494|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
1216495|NCT01958710|Pneumonectomy|pneumonectomy
1216496|NCT01958710|Lobectomy|lobectomy
1216497|NCT01958710|Thoracoplasty|thoracoplasty
1216498|NCT01958697|Nutritional Disorders|nutritional disorders
1216499|NCT01958697|Feeding Behavior|feeding behavior
1216500|NCT01958684|Bleeding pattern|bleeding pattern
1216501|NCT01958684|LNG-IUS|lng-ius
1216502|NCT01958684|Cu-IUD|cu-iud
1216503|NCT01958684|postabortion|postabortion
1216504|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
1216505|NCT01958619|open label|open label
1216506|NCT01958619|healthy volunteers|healthy volunteers
1216507|NCT01958619|pharmacokinetic|pharmacokinetic
1216508|NCT01958619|parallel group|parallel group
1216509|NCT01958606|Stroke|stroke
1216510|NCT01958606|Rehabilitation|rehabilitation
1216511|NCT01958606|Exercise|exercise
1216512|NCT01958606|Intensity|intensity
1216513|NCT01958606|Gait|gait
1216514|NCT01958593|PTSD|ptsd
1216515|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
1216516|NCT01958593|MDMA|mdma
1216517|NCT01958593|psychotherapy|psychotherapy
1216518|NCT01958567|Scleritis|scleritis
1216519|NCT01958567|Episcleritis|episcleritis
1216520|NCT01958567|Optical coherence Tomography|optical coherence tomography
1216521|NCT01958541|Sleep|sleep
1216522|NCT01958541|Insomnia|insomnia
1216523|NCT01958541|Suicidal Symptoms|suicidal symptoms
1216524|NCT01958541|Suicidal Ideation|suicidal ideation
1216525|NCT01958541|Military Veteran|military veteran
1216526|NCT01958541|Service Member|service member
1216527|NCT01958541|Depression|depression
1216528|NCT01958515|Radiation Therapy|radiation therapy
1216529|NCT01958515|Chemotherapy|chemotherapy
1216530|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
1216531|NCT01958502|nonunion|nonunion
1216532|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
1216533|NCT01958502|scaffold|scaffold
1216534|NCT01958502|BMP2|bmp2
1216535|NCT01958502|long bone|long bone
1216536|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1216537|NCT01958476|Opioids|opioids
1216538|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
1216539|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
1216540|NCT01958450|acne scar|acne scar
1216541|NCT01958450|Laser therapy|laser therapy
1216542|NCT01958450|wound healing|wound healing
1216543|NCT01958437|Aging|aging
1216544|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
1216545|NCT01958437|Cognitive Disorders|cognitive disorders
1216546|NCT01958437|Imaging|imaging
1216547|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1216548|NCT01958437|Neurology|neurology
1216549|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
1216550|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
1216551|NCT01958424|metabolic syndrome|metabolic syndrome
1216552|NCT01958424|in vitro fertilization|in vitro fertilization
1216553|NCT01958424|c reactive protein|c reactive protein
1216554|NCT01958424|over-weight women|over-weight women
1216555|NCT01958424|ovarian stimulation|ovarian stimulation
1216556|NCT01958398|Randomized Controlled Trial|randomized controlled trial
1216557|NCT01958398|Alcohol|alcohol
1216558|NCT01958398|Internet|internet
1216559|NCT01958398|Mobile phone|mobile phone
1216560|NCT01958398|Screening|screening
1216561|NCT01958398|Brief intervention|brief intervention
1216562|NCT01958385|Total Body Weight Loss|total body weight loss
1216563|NCT01958359|Randomized Controlled Trial|randomized controlled trial
1216564|NCT01958359|Alcohol|alcohol
1216565|NCT01958359|Telephone|telephone
1216566|NCT01958359|Mobile phone|mobile phone
1216567|NCT01958359|Screening|screening
1216568|NCT01958359|Brief intervention|brief intervention
1216569|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
1216570|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
1216571|NCT01958333|Aerobic Endurance|aerobic endurance
1216572|NCT01958333|Muscular Endurance|muscular endurance
1216573|NCT01958333|Flexibility|flexibility
1216574|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
1216575|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
1216576|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
1216577|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
1216578|NCT01958255|tobacco quit rates|tobacco quit rates
1216579|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
1216580|NCT01958242|pediatric|pediatric
1216581|NCT01958242|blood products|blood products
1216582|NCT01958242|conservation|conservation
1216583|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
1216584|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
1216585|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
1216586|NCT01958177|stem cell|stem cell
1216587|NCT01958177|cerebellar ataxia|cerebellar ataxia
1216590|NCT01958151|deep sedation|deep sedation
1216591|NCT01958151|anxiety|anxiety
1216592|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
1216593|NCT01958138|Propofol|propofol
1216594|NCT01958138|Isoflurane|isoflurane
1216595|NCT01958138|Pediatric patients|pediatric patients
1216596|NCT01958138|Emergence|emergence
1216597|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
1216598|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
1216599|NCT01958125|nVNS|nvns
1216601|NCT01958125|cluster headache|cluster headache
1216602|NCT01958125|non invasive|non invasive
1216603|NCT01958125|gammacore|gammacore
1216604|NCT01958112|Cervical Cancer|cervical cancer
1216605|NCT01958112|Cervical|cervical
1216606|NCT01958112|Cervix|cervix
1216607|NCT01958099|Injury Prevention|injury prevention
1216608|NCT01958086|Neural|neural
1216609|NCT01958086|Prosthetic|prosthetic
1216610|NCT01958086|brain machine interface|brain machine interface
1216611|NCT01958086|brain computer interface|brain computer interface
1216612|NCT01958086|brain control|brain control
1216613|NCT01958086|paralysis|paralysis
1216614|NCT01958086|tetraplegia|tetraplegia
1216615|NCT01958086|quadriplegia|quadriplegia
1216616|NCT01958086|spinal cord injury|spinal cord injury
1216617|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
1216618|NCT01958073|Postmenopausal|postmenopausal
1216619|NCT01958073|Vaginal Estrogen|vaginal estrogen
1216620|NCT01958047|Phase I|phase i
1216621|NCT01958047|ASP3652|asp3652
1216622|NCT01958047|Single dose|single dose
1216623|NCT01958047|Dietary intake|dietary intake
1216624|NCT01958021|HR-positive|hr-positive
1216625|NCT01958021|HER2-negative|her2-negative
1216626|NCT01958021|Advanced breast cancer|advanced breast cancer
1216627|NCT01958021|LEE011|lee011
1216628|NCT01958021|Letrozole|letrozole
1216629|NCT01958021|CDK|cdk
1216630|NCT01958021|CDK4|cdk4
1216631|NCT01958021|CDK6|cdk6
1216632|NCT01958021|CDK4/6|cdk4/6
1216633|NCT01958021|Phase III|phase iii
1216634|NCT01958021|ER-positive|er-positive
1216635|NCT01958021|PR-positive|pr-positive
1216636|NCT01958021|Postmenopausal|postmenopausal
1216637|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
1216638|NCT01957943|Liver transplantation|liver transplantation
1216639|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
1216640|NCT01957943|graft function|graft function
1216641|NCT01957930|HbA1c|hba1c
1216642|NCT01957930|Iontophoresis|iontophoresis
1216643|NCT01957930|Intensified insulin treatment|intensified insulin treatment
1216644|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
1216645|NCT01957930|Type 1 diabetes|type 1 diabetes
1216646|NCT01957917|HIV|hiv
1216647|NCT01957917|Food Insecurity|food insecurity
1216648|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
1216649|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
1216650|NCT01957891|Hypoxia|hypoxia
1216651|NCT01957891|Multiple wavelengths|multiple wavelengths
1216652|NCT01957865|HIV/AIDS|hiv/aids
1216653|NCT01957865|adherence|adherence
1216654|NCT01957865|real time monitoring|real time monitoring
1216655|NCT01957865|SMS|sms
1216656|NCT01957865|mHealth|mhealth
1216657|NCT01957865|social support|social support
1216658|NCT01957826|mesenchymal|mesenchymal
1216659|NCT01957826|stem cells|stem cells
1216660|NCT01957826|transendocardial injection|transendocardial injection
1216661|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
1216662|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
1216663|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
1216664|NCT01957813|DIC Drop-in center|dic drop-in center
1216665|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
1216666|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
1216667|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
1216668|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
1216669|NCT01957813|FP Family planning|fp family planning
1216670|NCT01957813|FGD Focus group discussion|fgd focus group discussion
1216671|NCT01957813|FSW Female sex worker|fsw female sex worker
1216672|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
1216673|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
1216674|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
1216675|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
1216676|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
1216677|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
1216678|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
1216679|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
1216680|NCT01957813|RH Reproductive health|rh reproductive health
1216681|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
1216682|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
1216683|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
1216684|NCT01957800|weight loss|weight loss
1216685|NCT01957800|healthy diet|healthy diet
1216686|NCT01957800|website|website
1216687|NCT01957800|action planning|action planning
1216688|NCT01957800|phone|phone
1216689|NCT01957800|social|social
1216690|NCT01957787|Metastatic lung tumors|metastatic lung tumors
1216691|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
1216692|NCT01957748|Retention|retention
1216693|NCT01957748|Care|care
1216694|NCT01957748|Engagement|engagement
1216695|NCT01957735|metastatic cancer|metastatic cancer
1216696|NCT01957735|solid tumor|solid tumor
1216697|NCT01957735|unresectable tumor|unresectable tumor
1216698|NCT01957735|brain cancer|brain cancer
1216699|NCT01957735|lymphoma|lymphoma
1216700|NCT01957696|Diabetes mellitus|diabetes mellitus
1216701|NCT01957696|Pancreas transplantation|pancreas transplantation
1216702|NCT01957696|Rejection|rejection
1216703|NCT01957696|Surgical complications|surgical complications
1216704|NCT01957696|Allograft biopsies|allograft biopsies
1216705|NCT01957696|Immunological analyses|immunological analyses
1216706|NCT01957696|Pancreas graft survival|pancreas graft survival
1216707|NCT01957683|intracranial aneurysm|intracranial aneurysm
1216708|NCT01957683|bifurcation|bifurcation
1216709|NCT01957683|wide-neck|wide-neck
1216710|NCT01957683|saccular|saccular
1216711|NCT01957683|endovascular treatment|endovascular treatment
1216712|NCT01957683|coil embolization|coil embolization
1216713|NCT01957683|stent|stent
1216714|NCT01957683|bare platinum|bare platinum
1216715|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1216716|NCT01957670|Dry Eye Syndromes|dry eye syndromes
1216717|NCT01957631|Plantar Fasciitis|plantar fasciitis
1216718|NCT01957631|Steroid|steroid
1216719|NCT01957631|Platelet rich plasma|platelet rich plasma
1216720|NCT01957631|Injection|injection
1216721|NCT01957631|Ultrasound|ultrasound
1216722|NCT01957605|prone position|prone position
1216723|NCT01957605|hemodynamic variation|hemodynamic variation
1216724|NCT01957605|mean systemic pressure|mean systemic pressure
1216725|NCT01957579|Phase I|phase i
1216726|NCT01957579|advanced|advanced
1216727|NCT01957579|B cell malignancies|b cell malignancies
1216728|NCT01957579|dose escalation|dose escalation
1216729|NCT01957579|CD19|cd19
1216730|NCT01957579|Japanese|japanese
1216731|NCT01957566|propofol sedation|propofol sedation
1216732|NCT01957566|children|children
1216733|NCT01957566|procedure sedation|procedure sedation
1216734|NCT01957540|ticagrelor|ticagrelor
1216735|NCT01957540|prasugrel|prasugrel
1216736|NCT01957540|endothelial function|endothelial function
1216737|NCT01957527|ticagrelor|ticagrelor
1216738|NCT01957527|endothelial function|endothelial function
1216739|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
1216740|NCT01957501|Major Depressive Disorder|major depressive disorder
1216741|NCT01957501|Bipolar Disorder|bipolar disorder
1216742|NCT01957501|Adolescents|adolescents
1216743|NCT01957501|Biomarker|biomarker
1216744|NCT01957436|prostate|prostate
1216745|NCT01957436|cancer|cancer
1216746|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
1216747|NCT01957436|radiotherapy|radiotherapy
1216748|NCT01957436|abiraterone acetate|abiraterone acetate
1216749|NCT01957436|docetaxel|docetaxel
1216750|NCT01957423|Crohn's disease|crohn's disease
1216751|NCT01957423|whey protein|whey protein
1216752|NCT01957423|soy protein|soy protein
1216753|NCT01957423|nutritional status|nutritional status
1216754|NCT01957423|activity of disease|activity of disease
1216755|NCT01957410|Major Depressive Disorder|major depressive disorder
1216756|NCT01957410|Ketamine|ketamine
1216757|NCT01957410|Evoked potentials|evoked potentials
1216758|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
1216759|NCT01957410|Motor evoked potentials|motor evoked potentials
1216760|NCT01957410|Cortical plasticity|cortical plasticity
1216761|NCT01957371|PTSD|ptsd
1216762|NCT01957371|Yoga|yoga
1216763|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
1216764|NCT01957371|Chronic Pain|chronic pain
1216765|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
1216766|NCT01957345|platelet signalling defects|platelet signalling defects
1216767|NCT01957332|molecular imaging|molecular imaging
1216768|NCT01957332|HER2-PET|her2-pet
1216769|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
1216770|NCT01957332|FES-PET|fes-pet
1216771|NCT01957332|metastatic breast cancer|metastatic breast cancer
1216772|NCT01957332|clinical utility|clinical utility
1216773|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
1216774|NCT01957280|HER3|her3
1216775|NCT01957267|Glaucoma|glaucoma
1216776|NCT01957267|Optical Coherence Tomography|optical coherence tomography
1216777|NCT01957267|Intraocular pressure|intraocular pressure
1216778|NCT01957267|Optic nervehead|optic nervehead
1216779|NCT01957267|Nerve fiber layer|nerve fiber layer
1216780|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
1216781|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
1216981|NCT01956253|Neratinib|neratinib
1216982|NCT01956253|13-2526|13-2526
1216986|NCT01956240|scapular kinematics|scapular kinematics
1216782|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
1216783|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
1216784|NCT01957176|thrombocytopenia|thrombocytopenia
1216785|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
1216786|NCT01957176|, idiopathic thrombocytopenic purpura|, idiopathic thrombocytopenic purpura
1216787|NCT01957176|Eltrombopag|eltrombopag
1216788|NCT01957176|pediatrics|pediatrics
1216789|NCT01957163|dry powder inhaler|dry powder inhaler
1216790|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
1216791|NCT01957163|umeclidinium bromide|umeclidinium bromide
1216792|NCT01957163|safety|safety
1216793|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
1216794|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
1216795|NCT01957163|efficacy|efficacy
1216796|NCT01957163|COPD|copd
1216797|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
1216798|NCT01957137|Urinary|urinary
1216799|NCT01957137|Urge|urge
1216800|NCT01957137|Incontinence|incontinence
1216801|NCT01957098|L-arabinose|l-arabinose
1216802|NCT01957098|D-xylose|d-xylose
1216803|NCT01957098|sucrose|sucrose
1216804|NCT01957098|glucose|glucose
1216805|NCT01957098|insulin|insulin
1216806|NCT01957098|C-peptide|c-peptide
1216807|NCT01957098|GLP-1|glp-1
1216808|NCT01957085|Hepatitis C|hepatitis c
1216809|NCT01957072|Cystic fibrosis|cystic fibrosis
1216810|NCT01957072|Nutrition|nutrition
1216811|NCT01957072|Weight|weight
1216812|NCT01957072|BMI|bmi
1216813|NCT01957072|Behaviour change|behaviour change
1216814|NCT01957059|DMD|dmd
1216815|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
1216816|NCT01957059|Duchenne|duchenne
1216817|NCT01957059|BMN053|bmn053
1216818|NCT01957059|BioMarin|biomarin
1216819|NCT01957046|Opioid induced constipation|opioid induced constipation
1216820|NCT01957046|Laxatives|laxatives
1216821|NCT01957033|whiplash|whiplash
1216822|NCT01957033|neck pain|neck pain
1216823|NCT01957033|manual therapy|manual therapy
1216824|NCT01957033|exercise|exercise
1216825|NCT01957033|dosage|dosage
1216826|NCT01957007|Phase 1|phase 1
1216827|NCT01957007|dose escalation|dose escalation
1216828|NCT01957007|histologically confirmed|histologically confirmed
1216829|NCT01957007|malignancy metastatic|malignancy metastatic
1216830|NCT01956994|Whey Protein|whey protein
1216831|NCT01956994|Arterial Stiffness|arterial stiffness
1216832|NCT01956994|Neurovascular Coupling|neurovascular coupling
1216833|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
1216834|NCT01956994|Hemodynamics|hemodynamics
1216835|NCT01956994|Blood Flow|blood flow
1216836|NCT01956994|Pulsatility|pulsatility
1216837|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
1216838|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
1216839|NCT01956942|GLAUCOMA|glaucoma
1216840|NCT01956942|MICROPULSE|micropulse
1216841|NCT01956942|LASER|laser
1216842|NCT01956942|TRABECULOPLASTY|trabeculoplasty
1216843|NCT01956942|OPEN ANGLE|open angle
1216844|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
1216845|NCT01956929|Insulin Resistance|insulin resistance
1216846|NCT01956929|Prediabetic State|prediabetic state
1216847|NCT01956929|Metformin|metformin
1216848|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
1216849|NCT01956916|Inflammation|inflammation
1216850|NCT01956916|Intestinal microbiota|intestinal microbiota
1216851|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
1216852|NCT01956890|Breast neoplasms|breast neoplasms
1216853|NCT01956890|PET|pet
1216854|NCT01956890|MRI|mri
1216855|NCT01956864|Vitamin D|vitamin d
1216856|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
1216857|NCT01956838|food intake|food intake
1216858|NCT01956838|tastants|tastants
1216859|NCT01956838|obesity|obesity
1216860|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
1216861|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
1216862|NCT01956825|magnesium|magnesium
1216863|NCT01956825|fat content|fat content
1216864|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
1216865|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
1216866|NCT01956812|IMMU-107|immu-107
1216867|NCT01956799|MDS|mds
1216868|NCT01956799|PMF|pmf
1216869|NCT01956799|CMML|cmml
1216870|NCT01956799|AA|aa
1216871|NCT01956786|Amlodipine|amlodipine
1216872|NCT01956786|Folic Acid|folic acid
1216873|NCT01956786|Homocysteine|homocysteine
1216874|NCT01956786|Blood Pressure|blood pressure
1216875|NCT01956773|family health history|family health history
1216876|NCT01956773|prevention|prevention
1216877|NCT01956773|genetic risk|genetic risk
1216878|NCT01956773|clinical decision support|clinical decision support
1216879|NCT01956760|Insomnia|insomnia
1216880|NCT01956734|glioblastoma|glioblastoma
1216881|NCT01956734|first recurrence|first recurrence
1216882|NCT01956734|temozolomide|temozolomide
1216983|NCT01956240|shoulder|shoulder
1216984|NCT01956240|pectoralis minor|pectoralis minor
1216883|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
1216884|NCT01956669|VEGF|vegf
1216885|NCT01956669|Pazopanib|pazopanib
1216886|NCT01956669|Sarcoma|sarcoma
1216887|NCT01956669|GW786034|gw786034
1216888|NCT01956669|Refractory Solid Tumors|refractory solid tumors
1216889|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
1216890|NCT01956643|sham feeding|sham feeding
1216891|NCT01956643|postoperative ileus|postoperative ileus
1216892|NCT01956643|liver transplantation|liver transplantation
1216893|NCT01956591|Treatment efficacy|treatment efficacy
1216894|NCT01956591|Long-term effects|long-term effects
1216895|NCT01956591|Tachyphylaxis|tachyphylaxis
1216896|NCT01956591|Undesirable effects|undesirable effects
1216897|NCT01956591|Side effects|side effects
1216898|NCT01956591|Self-assessment|self-assessment
1216899|NCT01956591|Hyperhidrosis|hyperhidrosis
1216900|NCT01956591|Quality of life|quality of life
1216901|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1216902|NCT01956565|Rehabilitation|rehabilitation
1216903|NCT01956565|Physiotherapy|physiotherapy
1216904|NCT01956565|Patient Compliance|patient compliance
1216905|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
1216906|NCT01956565|Respiratory Muscle Training|respiratory muscle training
1216907|NCT01956552|Metastatic breast cancer|metastatic breast cancer
1216908|NCT01956552|Tumor biopsy|tumor biopsy
1216909|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
1216910|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1216911|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
1216912|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
1216913|NCT01956513|ADC|adc
1216914|NCT01956513|breast cancer|breast cancer
1216915|NCT01956513|complete pathological response|complete pathological response
1216916|NCT01956500|glucosamine|glucosamine
1216917|NCT01956500|inflammation|inflammation
1216918|NCT01956500|quality of life|quality of life
1216919|NCT01956500|physical function|physical function
1216920|NCT01956487|Bioequivalence|bioequivalence
1216921|NCT01956487|RYTHMOL SR®|rythmol sr®
1216922|NCT01956487|Atrial fibrillation|atrial fibrillation
1216923|NCT01956487|Propafenone|propafenone
1216924|NCT01956487|Pharmavokinetics|pharmavokinetics
1216925|NCT01956474|keratoconus|keratoconus
1216926|NCT01956474|cross-linking|cross-linking
1216927|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
1216928|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
1216929|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
1216930|NCT01956474|FFKC|ffkc
1216931|NCT01956474|Radial Keratotomy|radial keratotomy
1216932|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
1216933|NCT01956461|osteoporosis|osteoporosis
1216934|NCT01956461|BMD|bmd
1216935|NCT01956461|teriparatide|teriparatide
1216936|NCT01956461|nursing home|nursing home
1216937|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
1216938|NCT01956448|DES|des
1216939|NCT01956448|Angina pectoris|angina pectoris
1216940|NCT01956448|Stent|stent
1216941|NCT01956409|breast neoplasms|breast neoplasms
1216942|NCT01956409|18F-FCH PET|18f-fch pet
1216943|NCT01956409|MRI|mri
1216944|NCT01956396|male circumcision|male circumcision
1216945|NCT01956396|HIV|hiv
1216946|NCT01956396|Zimbabwe|zimbabwe
1216947|NCT01956383|male circumcision|male circumcision
1216948|NCT01956383|HIV|hiv
1216949|NCT01956383|Zimbabwe|zimbabwe
1216950|NCT01956370|Male Circumcision|male circumcision
1216951|NCT01956370|HIV Prevention|hiv prevention
1216952|NCT01956370|Medical Device|medical device
1216953|NCT01956357|aquatic exercises;|aquatic exercises;
1216954|NCT01956357|deep water running;|deep water running;
1216955|NCT01956357|diabetes;|diabetes;
1216956|NCT01956357|blood glucose;|blood glucose;
1216957|NCT01956357|inflammation.|inflammation.
1216958|NCT01956344|Hoarding Disorder|hoarding disorder
1216959|NCT01956344|Clutter|clutter
1216961|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
1216962|NCT01956344|fMRI|fmri
1216963|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
1216964|NCT01956344|Healthy control|healthy control
1216965|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
1216966|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
1216967|NCT01956318|Varicose vein|varicose vein
1216968|NCT01956318|Crenobalneotherapy|crenobalneotherapy
1216969|NCT01956318|Balneotherapy|balneotherapy
1216970|NCT01956318|Spa therapy|spa therapy
1216971|NCT01956279|Pregnenolone|pregnenolone
1216972|NCT01956279|Gulf War Veteran|gulf war veteran
1216973|NCT01956279|Fatigue|fatigue
1216974|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
1216975|NCT01956279|Cognitive Decline|cognitive decline
1216976|NCT01956279|Placebo Control|placebo control
1216977|NCT01956266|Prosody|prosody
1216978|NCT01956266|Communication|communication
1216979|NCT01956266|Dysarthria|dysarthria
1216980|NCT01956253|Bladder Cancer|bladder cancer
1216987|NCT01956214|hemodialysis|hemodialysis
1216988|NCT01956214|exercise|exercise
1216989|NCT01956214|electrical stimulation|electrical stimulation
1216990|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
1216991|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
1216992|NCT01956175|tracheostomy|tracheostomy
1216993|NCT01956175|decannulation|decannulation
1216994|NCT01956149|gastric cancer|gastric cancer
1216995|NCT01956149|second-line treatment|second-line treatment
1216996|NCT01956149|Cabazitaxel|cabazitaxel
1216997|NCT01956149|response|response
1216998|NCT01956045|Intensive Care Units|intensive care units
1216999|NCT01956045|Judgment|judgment
1217000|NCT01956045|Disability Evaluation|disability evaluation
1217001|NCT01956045|Autonomy|autonomy
1217003|NCT01956032|Parkinson's disease|parkinson's disease
1217004|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
1217005|NCT01956032|Telemedicine|telemedicine
1217006|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
1217007|NCT01955980|CRS|crs
1217008|NCT01955980|without polyposis|without polyposis
1217009|NCT01955967|Effect|effect
1217010|NCT01955967|Lidocaine|lidocaine
1217011|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
1217012|NCT01955954|panic disorder|panic disorder
1217013|NCT01955954|biofeedback|biofeedback
1217014|NCT01955954|breathing training|breathing training
1217015|NCT01955954|Primary diagnosis|primary diagnosis
1217016|NCT01955954|panic attacks|panic attacks
1217017|NCT01955941|Uveal melanoma|uveal melanoma
1217018|NCT01955941|brachytherapy|brachytherapy
1217019|NCT01955941|radiation|radiation
1217020|NCT01955941|ciliary body|ciliary body
1217021|NCT01955941|choroid|choroid
1217022|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
1217023|NCT01955915|choroid|choroid
1217024|NCT01955915|tumor|tumor
1217025|NCT01955915|OCT|oct
1217026|NCT01955915|malignant melanoma|malignant melanoma
1217027|NCT01955902|Opioid dependence|opioid dependence
1217028|NCT01955902|Buprenorphine|buprenorphine
1217029|NCT01955902|Adherence|adherence
1217030|NCT01955902|Substance use|substance use
1217031|NCT01955902|Suboxone|suboxone
1217032|NCT01955889|Exercise|exercise
1217033|NCT01955889|Rehabilitation|rehabilitation
1217034|NCT01955889|Telemedicine|telemedicine
1217035|NCT01955876|Fosrenol|fosrenol
1217036|NCT01955876|hyperphosphatemia|hyperphosphatemia
1217037|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
1217038|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
1217039|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
1217040|NCT01955863|Patient Discharge|patient discharge
1217041|NCT01955824|bronchoscopy|bronchoscopy
1217042|NCT01955824|lignocaine|lignocaine
1217043|NCT01955824|cough|cough
1217044|NCT01955811|platelet transfusion|platelet transfusion
1217045|NCT01955811|Fibrinogen|fibrinogen
1217046|NCT01955811|blood coagulation|blood coagulation
1217047|NCT01955811|Thrombocytopenia|thrombocytopenia
1217048|NCT01955811|in-vitro experiments|in-vitro experiments
1217049|NCT01955811|FGTW|fgtw
1217050|NCT01955811|Fit2012|fit2012
1217051|NCT01955811|factor I|factor i
1217052|NCT01955811|Fibrin|fibrin
1217053|NCT01955798|Laparoscopy|laparoscopy
1217054|NCT01955798|Gyneacological|gyneacological
1217055|NCT01955798|Entry techniques|entry techniques
1217056|NCT01955785|Traumatic brain injury|traumatic brain injury
1217057|NCT01955785|Intracranial pressure|intracranial pressure
1217058|NCT01955785|Ventilation|ventilation
1217059|NCT01955785|Respiratory therapy|respiratory therapy
1217060|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
1217061|NCT01955772|Malignant hemopathy|malignant hemopathy
1217062|NCT01955772|Artificial nutrition|artificial nutrition
1217063|NCT01955694|BAY94-8862|bay94-8862
1217064|NCT01955694|MR antagonist|mr antagonist
1217065|NCT01955694|Heart failure|heart failure
1217066|NCT01955694|Japanese patients|japanese patients
1217067|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
1217068|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
1217069|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
1217070|NCT01955668|B cell lymphomas|b cell lymphomas
1217071|NCT01955655|Baclofen|baclofen
1217072|NCT01955655|cerebral palsy|cerebral palsy
1217073|NCT01955655|colic|colic
1217074|NCT01955655|crying infant|crying infant
1217075|NCT01955655|recurrent crying spells|recurrent crying spells
1217076|NCT01955655|spasticity|spasticity
1217077|NCT01955655|therapy|therapy
1217078|NCT01955642|Clopidogrel|clopidogrel
1217079|NCT01955642|Brain Ischemia|brain ischemia
1217080|NCT01955642|Ischemic attack|ischemic attack
1217081|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
1217082|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
1217083|NCT01955590|Metacognitive therapy|metacognitive therapy
1217084|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
1217085|NCT01955590|Cognitive therapy|cognitive therapy
1217086|NCT01955577|Vitamin D deficiency|vitamin d deficiency
1217087|NCT01955577|Ring fixator|ring fixator
1217088|NCT01955577|Tibial fracture|tibial fracture
1217089|NCT01955525|Acute coronary syndrome|acute coronary syndrome
1217090|NCT01955525|health related quality of life|health related quality of life
1217091|NCT01955525|mortality|mortality
1217092|NCT01955486|flight simulation|flight simulation
1217093|NCT01955486|middle ear|middle ear
1217094|NCT01955486|Eustachian tube function|eustachian tube function
1217095|NCT01955473|Solid tumors|solid tumors
1217097|NCT01955473|Phase 1|phase 1
1217098|NCT01955460|Melanoma|melanoma
1217099|NCT01955460|Metastatic|metastatic
1217100|NCT01955460|T-cells|t-cells
1217101|NCT01955460|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
1217102|NCT01955460|TIL|til
1217103|NCT01955460|DNRII|dnrii
1217104|NCT01955460|NGFR|ngfr
1217105|NCT01955460|Cyclophosphamide|cyclophosphamide
1217106|NCT01955460|Cytoxan|cytoxan
1217107|NCT01955460|Neosar|neosar
1217108|NCT01955460|Mesna|mesna
1217109|NCT01955460|Mesnex|mesnex
1217110|NCT01955460|Fludarabine|fludarabine
1217111|NCT01955460|Fludarabine phosphate|fludarabine phosphate
1217112|NCT01955460|Fludara|fludara
1217113|NCT01955460|Interleukin-2|interleukin-2
1217114|NCT01955460|IL-2|il-2
1217115|NCT01955460|Aldesleukin|aldesleukin
1217116|NCT01955460|Proleukin|proleukin
1217117|NCT01955447|Blood glucose|blood glucose
1217118|NCT01955421|NSCLC|nsclc
1217119|NCT01955421|stage IIIB|stage iiib
1217120|NCT01955421|stage IV)|stage iv)
1217121|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
1217122|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
1217123|NCT01955408|overactive bladder|overactive bladder
1217124|NCT01955408|bladder cancer|bladder cancer
1217125|NCT01955408|Synergo|synergo
1217126|NCT01955408|urodynamic study|urodynamic study
1217127|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
1217128|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1217129|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
1217130|NCT01955382|Parasite Clearance Rate|parasite clearance rate
1217131|NCT01955382|Parasite Half Life|parasite half life
1217132|NCT01955382|Actidose Aqua|actidose aqua
1217133|NCT01955382|Severe Malaria|severe malaria
1217134|NCT01955369|incidence|incidence
1217135|NCT01955369|phenotype|phenotype
1217136|NCT01955369|mortality|mortality
1217137|NCT01955356|Scratching|scratching
1217138|NCT01955356|Endometrial biopsy|endometrial biopsy
1217139|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
1217140|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
1217141|NCT01955343|Immune response|immune response
1217142|NCT01955343|Cancer|cancer
1217143|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
1217144|NCT01955317|Neonate|neonate
1217145|NCT01955317|Bangladesh|bangladesh
1217146|NCT01955317|Health behavior|health behavior
1217147|NCT01955317|Handwashing|handwashing
1217148|NCT01955317|Developing countries|developing countries
1217149|NCT01955317|Infectious disease|infectious disease
1217150|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
1217151|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
1217152|NCT01955278|Parastomal hernia|parastomal hernia
1217153|NCT01955278|Prophylactic|prophylactic
1217154|NCT01955278|Mesh|mesh
1217155|NCT01955265|Positive youth development|positive youth development
1217156|NCT01955265|Sports / physical activity|sports / physical activity
1217157|NCT01955252|Endemic treponematoses|endemic treponematoses
1217158|NCT01955252|Azithromycin|azithromycin
1217159|NCT01955252|Mass drug administration|mass drug administration
1217160|NCT01955252|Eradication|eradication
1217161|NCT01955239|Head and Neck Cancer|head and neck cancer
1217162|NCT01955239|Radiotherapy|radiotherapy
1217163|NCT01955239|IMRT|imrt
1217164|NCT01955239|Stem cell|stem cell
1217165|NCT01955239|Parotid gland|parotid gland
1217166|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
1217167|NCT01955200|Stent implantation|stent implantation
1217168|NCT01955200|Clopidogrel low response|clopidogrel low response
1217169|NCT01955200|Ticagrelor|ticagrelor
1217170|NCT01955200|Cilostazol|cilostazol
1217171|NCT01955200|Clopidogrel|clopidogrel
1217172|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
1217173|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
1217174|NCT01955187|TACROLIMUS|tacrolimus
1217175|NCT01955187|RITUXIMAB|rituximab
1217176|NCT01955174|Botulinum toxin|botulinum toxin
1217177|NCT01955174|Esophageal motility disorder|esophageal motility disorder
1217178|NCT01955174|Distal esophageal spasm|distal esophageal spasm
1217179|NCT01955148|PTB|ptb
1217180|NCT01955148|sPTB|sptb
1217181|NCT01955148|cervical cerclage|cervical cerclage
1217182|NCT01955148|LEEP|leep
1217183|NCT01955148|PROM|prom
1217184|NCT01955148|short cervix|short cervix
1217482|NCT01953926|Fulvestrant|fulvestrant
1217185|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
1217186|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
1217187|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
1217188|NCT01955122|enhanced screening|enhanced screening
1217189|NCT01955109|Food allergy|food allergy
1217190|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
1217191|NCT01955109|Whole peanut extract|whole peanut extract
1217192|NCT01955109|Allergenic product|allergenic product
1217193|NCT01955109|Specific Immunotherapy|specific immunotherapy
1217194|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
1217195|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
1217196|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
1217197|NCT01955083|snoring|snoring
1217198|NCT01955083|radiofrequency|radiofrequency
1217199|NCT01955083|pillar implant|pillar implant
1217200|NCT01955083|snore sound analysis|snore sound analysis
1217201|NCT01955070|Informed consent|informed consent
1217202|NCT01955070|Ethics|ethics
1217203|NCT01955044|neonatal prematurity|neonatal prematurity
1217204|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
1217205|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
1217206|NCT01955031|Telemedicine|telemedicine
1217207|NCT01955031|Telemonitoring|telemonitoring
1217208|NCT01955031|Education|education
1217209|NCT01955031|Nutrition|nutrition
1217210|NCT01955031|Food behaviour|food behaviour
1217211|NCT01955031|Weight|weight
1217212|NCT01955031|Physical activity|physical activity
1217213|NCT01955031|Glycaemia|glycaemia
1217214|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
1217215|NCT01955018|computed tomography|computed tomography
1217216|NCT01955018|radiation|radiation
1217217|NCT01955018|screening|screening
1217218|NCT01955018|asbestos|asbestos
1217219|NCT01955018|workers|workers
1217220|NCT01955018|cancer|cancer
1217221|NCT01955005|Health Records, Personal|health records, personal
1217222|NCT01955005|Delivery of healthcare|delivery of healthcare
1217223|NCT01955005|Consumer Participation|consumer participation
1217224|NCT01955005|Internet|internet
1217225|NCT01954992|glufosfamide|glufosfamide
1217226|NCT01954992|5-FU|5-fu
1217227|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
1217228|NCT01954979|Graft versus Host Disease|graft versus host disease
1217229|NCT01954979|ABATACEPT|abatacept
1217230|NCT01954966|Nicotine|nicotine
1217231|NCT01954966|Smoking|smoking
1217232|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
1217233|NCT01954953|Congenital Deafness|congenital deafness
1217234|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
1217235|NCT01954953|Progressive Hearing Loss|progressive hearing loss
1217236|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
1217237|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
1217238|NCT01954927|Pain control|pain control
1217239|NCT01954914|Plerixafor|plerixafor
1217240|NCT01954914|donor|donor
1217241|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
1217242|NCT01954914|PBSC|pbsc
1217243|NCT01954914|poor donors|poor donors
1217244|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
1217245|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1217246|NCT01954875|multiple sclerosis|multiple sclerosis
1217247|NCT01954875|Parkinson's Disease|parkinson's disease
1217248|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
1217249|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
1217250|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
1217251|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
1217252|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
1217253|NCT01954862|Adenoma detection rate|adenoma detection rate
1217254|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
1217255|NCT01954849|gingivitis|gingivitis
1217256|NCT01954849|inflammation|inflammation
1217257|NCT01954849|plaque|plaque
1217258|NCT01954849|orthodontics|orthodontics
1217259|NCT01954836|short-term fasting|short-term fasting
1217260|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
1217261|NCT01954836|toxicity|toxicity
1217262|NCT01954836|side-effects|side-effects
1217263|NCT01954836|ovarial carinoma|ovarial carinoma
1217264|NCT01954836|breast cancer|breast cancer
1217265|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
1217266|NCT01954810|JECV|jecv
1217267|NCT01954810|IMOJEV|imojev
1217268|NCT01954810|Booster response|booster response
1217269|NCT01954810|Children|children
1217270|NCT01954810|antibody response|antibody response
1217271|NCT01954810|Duration|duration
1217272|NCT01954797|Physical fitness|physical fitness
1217273|NCT01954797|relaxation|relaxation
1217274|NCT01954797|stroke|stroke
1217275|NCT01954797|cerebral ischemia|cerebral ischemia
1217276|NCT01954797|cerebral perfusion|cerebral perfusion
1217277|NCT01954797|biomarkers|biomarkers
1217279|NCT01954771|Diabetes mellitus|diabetes mellitus
1217280|NCT01954771|Coronary artery disease|coronary artery disease
1217281|NCT01954771|SMBG|smbg
1217282|NCT01954771|Elderly|elderly
1217283|NCT01954758|Window of implantation|window of implantation
1217284|NCT01954758|Personalized embryo transfer|personalized embryo transfer
1217285|NCT01954758|Fresh embryo transfer|fresh embryo transfer
1217286|NCT01954758|Delayed embryo transfer|delayed embryo transfer
1217287|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
1217288|NCT01954758|Endometrial receptivity array|endometrial receptivity array
1217289|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
1217290|NCT01954758|Endometrial receptivity test|endometrial receptivity test
1217291|NCT01954745|Bile Duct Cancer|bile duct cancer
1217292|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1217293|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
1217294|NCT01954745|Cabozantinib|cabozantinib
1217295|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
1217296|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
1217297|NCT01954693|Everolimus|everolimus
1217298|NCT01954693|Neurocognitive functioning|neurocognitive functioning
1217299|NCT01954680|bipolar disorder|bipolar disorder
1217300|NCT01954680|child|child
1217301|NCT01954680|adolescent|adolescent
1217302|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
1217303|NCT01954641|breast cancer|breast cancer
1217304|NCT01954641|lung cancer|lung cancer
1217305|NCT01954641|cancer treatments|cancer treatments
1217306|NCT01954641|racial inequity|racial inequity
1217307|NCT01954641|health systems change|health systems change
1217308|NCT01954641|transparency|transparency
1217309|NCT01954641|accountability|accountability
1217310|NCT01954628|Exacerbation of COPD|exacerbation of copd
1217311|NCT01954628|Unstable COPD|unstable copd
1217312|NCT01954615|ACT-281959|act-281959
1217313|NCT01954615|ACT-246475|act-246475
1217314|NCT01954602|Biliary cannulation|biliary cannulation
1217315|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1217316|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
1217317|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
1217318|NCT01954589|ACT-462206|act-462206
1217319|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
1217320|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
1217321|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
1217322|NCT01954563|Tuberculosis|tuberculosis
1217323|NCT01954563|Vaccine|vaccine
1217324|NCT01954563|Immunogenicity|immunogenicity
1217325|NCT01954550|Exercise|exercise
1217326|NCT01954550|Dementia|dementia
1217327|NCT01954550|Cognition|cognition
1217328|NCT01954550|Brain Volume|brain volume
1217329|NCT01954550|Aging|aging
1217330|NCT01954537|Exertional heat illness|exertional heat illness
1217331|NCT01954537|Hydration Status|hydration status
1217332|NCT01954537|Preseason football|preseason football
1217333|NCT01954537|heat stroke|heat stroke
1217334|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
1217335|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
1217336|NCT01954498|Randomized controlled trial|randomized controlled trial
1217337|NCT01954498|Spermatozoa|spermatozoa
1217338|NCT01954498|Sperm|sperm
1217339|NCT01954498|Male Infertility|male infertility
1217340|NCT01954498|Walnuts|walnuts
1217341|NCT01954498|Nutrition|nutrition
1217342|NCT01954498|Male Reproduction|male reproduction
1217343|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
1217344|NCT01954472|Portfolio diet|portfolio diet
1217345|NCT01954472|dietary modification|dietary modification
1217346|NCT01954472|hypercholesterolemia|hypercholesterolemia
1217347|NCT01954472|diabetes|diabetes
1217348|NCT01954472|Exercise|exercise
1217349|NCT01954472|CVD risk|cvd risk
1217350|NCT01954472|glycemic index|glycemic index
1217351|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
1217352|NCT01954472|monounsaturated fat|monounsaturated fat
1217353|NCT01954472|saturated fat|saturated fat
1217354|NCT01954472|nuts|nuts
1217355|NCT01954472|plant sterols|plant sterols
1217356|NCT01954472|vegetable protein|vegetable protein
1217357|NCT01954472|viscous fiber|viscous fiber
1217359|NCT01954459|Type 1 diabetes|type 1 diabetes
1217360|NCT01954459|Continuous glucose sensor|continuous glucose sensor
1217361|NCT01954459|Insupatch|insupatch
1217362|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
1217363|NCT01954433|Cost-utility analyses|cost-utility analyses
1217364|NCT01954433|Upper extremity|upper extremity
1217365|NCT01954433|Orthopedic|orthopedic
1217366|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
1217367|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
1217368|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
1217369|NCT01954420|Pain|pain
1217370|NCT01954420|Fatigue|fatigue
1217371|NCT01954420|Sleep|sleep
1217372|NCT01954420|Cancer|cancer
1217373|NCT01954420|Relaxation|relaxation
1217374|NCT01954420|Distraction|distraction
1217375|NCT01954420|Symptoms|symptoms
1217376|NCT01954407|smoking-related messages|smoking-related messages
1217377|NCT01954407|anti-smoking messages|anti-smoking messages
1217378|NCT01954407|smoking-related beliefs|smoking-related beliefs
1217379|NCT01954407|anti-smoking intentions|anti-smoking intentions
1217380|NCT01954355|advanced solid tumor|advanced solid tumor
1217381|NCT01954355|ovarian cancer|ovarian cancer
1217382|NCT01954355|LDE225|lde225
1217383|NCT01954355|Paclitaxel|paclitaxel
1217384|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
1217385|NCT01954342|Pregnancy|pregnancy
1217386|NCT01954342|Postpartum|postpartum
1217387|NCT01954329|Biomarkers|biomarkers
1217388|NCT01954329|TIA|tia
1217389|NCT01954329|Diagnosis|diagnosis
1217390|NCT01954316|advanced cancer|advanced cancer
1217391|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
1217392|NCT01954316|polo-like kinase 4|polo-like kinase 4
1217393|NCT01954316|PLK4|plk4
1217394|NCT01954316|tablet|tablet
1217395|NCT01954316|dose escalation|dose escalation
1217396|NCT01954316|genetic testing|genetic testing
1217397|NCT01954290|Stroke|stroke
1217398|NCT01954290|Brain Edema|brain edema
1217399|NCT01954290|Brain Herniation|brain herniation
1217400|NCT01954290|Conivaptan|conivaptan
1217401|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
1217402|NCT01954277|Electroacupuncture|electroacupuncture
1217403|NCT01954277|Headache Impact|headache impact
1217404|NCT01954277|BDNF|bdnf
1217405|NCT01954277|TNF|tnf
1217406|NCT01954264|Saharan Western Africa|saharan western africa
1217407|NCT01954264|Epidemiology|epidemiology
1217408|NCT01954264|Post-Approval Programme study|post-approval programme study
1217409|NCT01954264|Malaria|malaria
1217410|NCT01954264|Burden of Disease Study|burden of disease study
1217411|NCT01954251|FLU-D-QIV|flu-d-qiv
1217412|NCT01954251|Adults|adults
1217413|NCT01954251|Safety|safety
1217414|NCT01954251|Immunogenicity|immunogenicity
1217415|NCT01954251|co-administration|co-administration
1217416|NCT01954251|Herpes zoster|herpes zoster
1217417|NCT01954238|Anti-coagulant|anti-coagulant
1217418|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
1217419|NCT01954225|Fistula in ano|fistula in ano
1217420|NCT01954225|Bhagandara|bhagandara
1217421|NCT01954225|Udumbara sutra|udumbara sutra
1217422|NCT01954212|Oral health|oral health
1217423|NCT01954199|Sciatica|sciatica
1217424|NCT01954199|Nerve pain|nerve pain
1217425|NCT01954199|Low back pain|low back pain
1217426|NCT01954186|Oxytocin|oxytocin
1217427|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
1217428|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
1217429|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
1217430|NCT01954121|Levetiracetam|levetiracetam
1217431|NCT01954121|Keppra|keppra
1217432|NCT01954121|Monotherapy|monotherapy
1217433|NCT01954121|China|china
1217434|NCT01954121|Epilepsy|epilepsy
1217435|NCT01954121|Partial-onset Seizures|partial-onset seizures
1217436|NCT01954108|tendinopathy|tendinopathy
1217437|NCT01954108|hyaluronan|hyaluronan
1217438|NCT01954108|tendon|tendon
1217439|NCT01954108|hyaluronic acid|hyaluronic acid
1217440|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
1217441|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
1217442|NCT01954082|Retinopathy|retinopathy
1217443|NCT01954082|Prematurity|prematurity
1217444|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
1217445|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
1217446|NCT01954056|Mechanical ventilation|mechanical ventilation
1217447|NCT01954056|Intubation|intubation
1217448|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
1217449|NCT01954043|melanoma|melanoma
1217450|NCT01954043|dabrafenib|dabrafenib
1217451|NCT01954043|BRAF V600|braf v600
1217452|NCT01954043|rabeprazole|rabeprazole
1217453|NCT01954043|rifampin|rifampin
1217454|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
1217455|NCT01954030|CTO|cto
1217456|NCT01954030|Bevacizumab|bevacizumab
1217457|NCT01954030|Avastin|avastin
1217458|NCT01954030|Malignant Glioma|malignant glioma
1217459|NCT01954030|Pro00044274|pro00044274
1217460|NCT01954030|Desjardins|desjardins
1217461|NCT01954030|Duke|duke
1217462|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
1217463|NCT01953978|Pain|pain
1217464|NCT01953978|Analgesia|analgesia
1217465|NCT01953978|Postoperative|postoperative
1217466|NCT01953978|Dexamethasone|dexamethasone
1217467|NCT01953978|Spine surgery|spine surgery
1217468|NCT01953926|Neratinib|neratinib
1217469|NCT01953926|Nerlynx|nerlynx
1217470|NCT01953926|Breast|breast
1217471|NCT01953926|Gastroesophageal|gastroesophageal
1217472|NCT01953926|Endometrial|endometrial
1217473|NCT01953926|Ovarian|ovarian
1217474|NCT01953926|Biliary Tract|biliary tract
1217475|NCT01953926|Solid Tumors|solid tumors
1217476|NCT01953926|Cancer|cancer
1217477|NCT01953926|HER2|her2
1217478|NCT01953926|HER4|her4
1217479|NCT01953926|EGFR|egfr
1217480|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
1217481|NCT01953926|Paclitaxel|paclitaxel
1217484|NCT01953926|Fibrolamellar Carcinoma|fibrolamellar carcinoma
1217485|NCT01953900|Sarcoma|sarcoma
1217486|NCT01953900|T-Cells|t-cells
1217487|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
1217489|NCT01953887|Phase I|phase i
1217490|NCT01953887|Final formulation EC905|final formulation ec905
1217491|NCT01953887|Solifenacin succinate|solifenacin succinate
1217492|NCT01953887|Tamsulosin HCl|tamsulosin hcl
1217493|NCT01953887|Marketed drugs|marketed drugs
1217494|NCT01953874|heart failure|heart failure
1217495|NCT01953874|congestive heart failure|congestive heart failure
1217496|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
1217497|NCT01953874|chronic heart failure|chronic heart failure
1217498|NCT01953874|left-sided heart failure|left-sided heart failure
1217499|NCT01953874|heart failure decompensation|heart failure decompensation
1217500|NCT01953874|sleep apnea|sleep apnea
1217501|NCT01953874|sleep disordered breathing|sleep disordered breathing
1217502|NCT01953874|central sleep apnea|central sleep apnea
1217503|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
1217504|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
1217505|NCT01953861|Phase I|phase i
1217506|NCT01953861|Combination tablet EC905|combination tablet ec905
1217507|NCT01953861|Omnic OCAS®|omnic ocas®
1217508|NCT01953861|Vesicare®|vesicare®
1217509|NCT01953861|Food effect|food effect
1217510|NCT01953861|Vesomni|vesomni
1217511|NCT01953861|VesiFlow|vesiflow
1217512|NCT01953861|Urizia|urizia
1217513|NCT01953848|Phase I|phase i
1217514|NCT01953848|Combination tablet EC905|combination tablet ec905
1217515|NCT01953848|Steady-state|steady-state
1217516|NCT01953848|Vesomni|vesomni
1217517|NCT01953848|VesiFlow|vesiflow
1217518|NCT01953848|Urizia|urizia
1217519|NCT01953835|Pharmacokinetics|pharmacokinetics
1217520|NCT01953835|GSK2586184|gsk2586184
1217521|NCT01953835|Simvastatin|simvastatin
1217522|NCT01953835|Rosuvastatin|rosuvastatin
1217523|NCT01953835|Poloxamer|poloxamer
1217524|NCT01953822|Observational|observational
1217525|NCT01953822|Cohort|cohort
1217526|NCT01953822|Autoimmune disease|autoimmune disease
1217527|NCT01953822|Cervarix®|cervarix®
1217528|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
1217529|NCT01953822|United Kingdom|united kingdom
1217530|NCT01953809|oral|oral
1217531|NCT01953809|oral contraceptive|oral contraceptive
1217532|NCT01953809|pharmacokinetics|pharmacokinetics
1217533|NCT01953809|drug interaction|drug interaction
1217534|NCT01953809|pharmacodynamics|pharmacodynamics
1217535|NCT01953809|GSK1322322|gsk1322322
1217536|NCT01953809|antibiotic|antibiotic
1217537|NCT01953809|safety|safety
1217538|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
1217539|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
1217540|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
1217541|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
1217542|NCT01953744|L.Guyanensis|l.guyanensis
1217543|NCT01953731|palbociclib|palbociclib
1217544|NCT01953731|PD-0332991|pd-0332991
1217545|NCT01953731|rifampin|rifampin
1217546|NCT01953731|drug-drug interaction study|drug-drug interaction study
1217547|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
1217548|NCT01953705|cognitive decline|cognitive decline
1217549|NCT01953705|MRI|mri
1217550|NCT01953705|endothelial function|endothelial function
1217551|NCT01953705|white matter|white matter
1217552|NCT01953705|executive function|executive function
1217553|NCT01953705|prevention|prevention
1217554|NCT01953705|DTI|dti
1217555|NCT01953705|ASL|asl
1217556|NCT01953692|PD1|pd1
1217557|NCT01953692|PD-1|pd-1
1217558|NCT01953692|PDL1|pdl1
1217559|NCT01953692|PD-L1|pd-l1
1217560|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
1217561|NCT01953614|quantitative encephalography|quantitative encephalography
1217562|NCT01953614|brain computer interface|brain computer interface
1217563|NCT01953614|chiropractic|chiropractic
1217564|NCT01953614|sacro-occipital technique|sacro-occipital technique
1217565|NCT01953575|Mucosal Impedance|mucosal impedance
1217566|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
1217568|NCT01953562|infants|infants
1217569|NCT01953562|NICU|nicu
1217570|NCT01953562|intubated|intubated
1217571|NCT01953562|ventilator|ventilator
1217572|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
1217573|NCT01953523|erectile dysfunction|erectile dysfunction
1217574|NCT01953523|peyronies|peyronies
1217575|NCT01953523|interstitial cystitis|interstitial cystitis
1217576|NCT01953523|cardiomyopathy|cardiomyopathy
1217577|NCT01953523|emphysema|emphysema
1217579|NCT01953523|arthritis|arthritis
1217580|NCT01953523|multiple sclerosis|multiple sclerosis
1217581|NCT01953523|parkinson's|parkinson's
1217582|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
1217583|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
1217584|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
1217585|NCT01953510|Immunization Schedule|immunization schedule
1217586|NCT01953510|Public Health|public health
1217587|NCT01953458|Hepatitis B and C|hepatitis b and c
1217588|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
1217589|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
1217590|NCT01953432|Cocaine|cocaine
1217591|NCT01953432|Doxazosin|doxazosin
1217592|NCT01953432|Cardiovascular Agents|cardiovascular agents
1217593|NCT01953432|Antihypertensive Agents|antihypertensive agents
1217594|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
1217595|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
1217596|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
1217597|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1217598|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
1217599|NCT01953432|Therapeutic Uses|therapeutic uses
1217600|NCT01953432|Pharmacologic Actions|pharmacologic actions
1217601|NCT01953432|Substance-Related Disorders|substance-related disorders
1217602|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
1217603|NCT01953406|lung metastasis|lung metastasis
1217604|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
1217605|NCT01953380|Intervention Studies|intervention studies
1217606|NCT01953380|Eczema|eczema
1217607|NCT01953380|Randomized Controlled Trial|randomized controlled trial
1217608|NCT01953380|Knowledge|knowledge
1217609|NCT01953380|Quality of Life|quality of life
1217610|NCT01953367|Bioequivalence|bioequivalence
1217612|NCT01953367|Cmax|cmax
1217613|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
1217614|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1217615|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
1217616|NCT01953341|Migraine|migraine
1217617|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
1217618|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
1217619|NCT01953302|ventral hernia|ventral hernia
1217620|NCT01953302|infection|infection
1217621|NCT01953302|hematoma|hematoma
1217622|NCT01953302|seroma|seroma
1217623|NCT01953302|recurrence|recurrence
1217624|NCT01953302|mesh technique|mesh technique
1217625|NCT01953289|Appendicitis|appendicitis
1217626|NCT01953289|Free fluid|free fluid
1217627|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
1217628|NCT01953276|Chest pain|chest pain
1217629|NCT01953276|Electrocardiograms|electrocardiograms
1217630|NCT01953276|Risk Stratification|risk stratification
1217631|NCT01953276|Emergency Department|emergency department
1217632|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
1217633|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
1217634|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
1217635|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
1217636|NCT01953250|Colorectal surgery|colorectal surgery
1217637|NCT01953237|Schizophrenia|schizophrenia
1217638|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
1217639|NCT01953237|mobile phones|mobile phones
1217640|NCT01953224|Physical activity|physical activity
1217641|NCT01953224|Video game|video game
1217642|NCT01953224|Mobile|mobile
1217643|NCT01953224|Technology|technology
1217644|NCT01953224|Obesity|obesity
1217645|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
1217646|NCT01953185|elderly|elderly
1217647|NCT01953185|subjects|subjects
1217648|NCT01953146|PCOS|pcos
1217649|NCT01953107|Anemia|anemia
1217650|NCT01953107|Ovarian cancer|ovarian cancer
1217651|NCT01953107|Uterine cancer|uterine cancer
1217652|NCT01953107|Cervical cancer|cervical cancer
1217653|NCT01953107|Oral iron|oral iron
1217654|NCT01953094|Cervical|cervical
1217655|NCT01953081|Enteral feeding|enteral feeding
1217656|NCT01953068|POCD|pocd
1217657|NCT01953068|Executive Reaction Time Test|executive reaction time test
1217658|NCT01953068|Aortic valve surgery|aortic valve surgery
1217659|NCT01953068|Cognitive functions|cognitive functions
1217660|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
1217661|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1217662|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
1217663|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1217664|NCT01953042|Health Education|health education
1217665|NCT01953016|ADA-SCID/SCID all forms|ada-scid/scid all forms
1217666|NCT01953016|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1217667|NCT01953016|GATA2|gata2
1217668|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
1217669|NCT01953016|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
1217670|NCT01952990|Pharmacokinetic|pharmacokinetic
1217671|NCT01952964|exit site infection|exit site infection
1217672|NCT01952964|skin allergy|skin allergy
1217673|NCT01952964|physical damage|physical damage
1217674|NCT01952951|rectal neoplasms|rectal neoplasms
1217675|NCT01952951|radiotherapy|radiotherapy
1217676|NCT01952951|Antineoplastic Agents|antineoplastic agents
1217677|NCT01952938|knee revision surgery,|knee revision surgery,
1217678|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
1217679|NCT01952899|Intensive Care Unit|intensive care unit
1217680|NCT01952899|Delirium|delirium
1217681|NCT01952899|Implementation|implementation
1217682|NCT01952899|Guideline|guideline
1217683|NCT01952886|malignant glioma|malignant glioma
1217684|NCT01952886|antiemetic|antiemetic
1217685|NCT01952886|ondansetron|ondansetron
1217686|NCT01952886|granisetron|granisetron
1217687|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
1217688|NCT01952886|Pro00041233|pro00041233
1217689|NCT01952886|Duke|duke
1217690|NCT01952873|stents|stents
1217691|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
1217692|NCT01952873|coronary artery stenosis|coronary artery stenosis
1217693|NCT01952873|optical coherence tomography|optical coherence tomography
1217694|NCT01952860|Lung Cancer|lung cancer
1217695|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
1217696|NCT01952860|NSCLC|nsclc
1217697|NCT01952860|Caregiving partner|caregiving partner
1217698|NCT01952860|Hatha Yoga|hatha yoga
1217699|NCT01952860|Radiation therapy|radiation therapy
1217700|NCT01952860|XRT|xrt
1217701|NCT01952860|Questionnaires|questionnaires
1217702|NCT01952860|Surveys|surveys
1217703|NCT01952847|Advanced Cancers|advanced cancers
1217704|NCT01952847|Mucositis|mucositis
1217705|NCT01952847|Esophagitis|esophagitis
1217706|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
1217707|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
1217708|NCT01952847|Thoracic malignancies|thoracic malignancies
1217709|NCT01952847|Placebo|placebo
1217710|NCT01952847|Glutamine|glutamine
1217711|NCT01952847|Enterex|enterex
1217712|NCT01952847|Glutapak-10|glutapak-10
1217713|NCT01952847|NutreStore|nutrestore
1217714|NCT01952847|Resource|resource
1217715|NCT01952847|GlutaSolve|glutasolve
1217716|NCT01952847|Sympt-X G.I.|sympt-x g.i.
1217717|NCT01952847|Sympt-X|sympt-x
1217718|NCT01952847|Questionnaires|questionnaires
1217719|NCT01952847|Surveys|surveys
1217720|NCT01952834|coronary artery disease|coronary artery disease
1217721|NCT01952834|probiotic|probiotic
1217722|NCT01952834|endothelial function|endothelial function
1217723|NCT01952834|brachial artery|brachial artery
1217724|NCT01952834|ntric oxide|ntric oxide
1217725|NCT01952821|Head and Neck Cancer|head and neck cancer
1217726|NCT01952821|Physical function|physical function
1217727|NCT01952821|Cancer Related Fatigue|cancer related fatigue
1217728|NCT01952821|Gait Speed|gait speed
1217729|NCT01952821|6MWT|6mwt
1217730|NCT01952821|10-Meter Walk Test|10-meter walk test
1217731|NCT01952821|30-Second Chair Stand|30-second chair stand
1217732|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
1217733|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
1217734|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
1217735|NCT01952756|cilostazol|cilostazol
1217736|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
1217737|NCT01952756|vasculogenesis|vasculogenesis
1217738|NCT01952756|angiogenesis|angiogenesis
1217739|NCT01952756|peripheral arterial disease|peripheral arterial disease
1217740|NCT01952756|biomarkers|biomarkers
1217741|NCT01952743|Atrial Fibrillation|atrial fibrillation
1217742|NCT01952743|Hypertension|hypertension
1217743|NCT01952743|Renal Denervation|renal denervation
1217744|NCT01952730|Stage IV|stage iv
1217745|NCT01952730|Hepatic Lesions|hepatic lesions
1217746|NCT01952691|hallux valgus|hallux valgus
1217747|NCT01952691|pain|pain
1217748|NCT01952691|conservative|conservative
1217749|NCT01952691|treatment|treatment
1217750|NCT01952678|DaTscan|datscan
1217751|NCT01952678|Parkinson's Disease|parkinson's disease
1217752|NCT01952652|Naproxen-codeine|naproxen-codeine
1217753|NCT01952652|preemptive analgesia|preemptive analgesia
1217754|NCT01952652|day case surgery|day case surgery
1217755|NCT01952626|intrathecal|intrathecal
1217756|NCT01952626|morphine|morphine
1217757|NCT01952626|ondansetron|ondansetron
1217758|NCT01952626|palonosetron|palonosetron
1217759|NCT01952626|pruritus|pruritus
1217760|NCT01952613|Foot drop|foot drop
1217761|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
1217762|NCT01952600|Chronic Kidney Disease|chronic kidney disease
1217763|NCT01952600|Hemodialysis|hemodialysis
1217764|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
1217765|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
1217766|NCT01952561|pharmacokinetics|pharmacokinetics
1217767|NCT01952561|vaginal ring|vaginal ring
1217768|NCT01952522|Resistance training|resistance training
1217769|NCT01952522|Walking|walking
1217770|NCT01952522|Weight bearing|weight bearing
1217771|NCT01952496|Cerebral Palsy|cerebral palsy
1217772|NCT01952496|Non ambulatory|non ambulatory
1217773|NCT01952496|Neuromuscular disability|neuromuscular disability
1217774|NCT01952496|Children|children
1217775|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
1217776|NCT01952470|Lung transplantation|lung transplantation
1217777|NCT01952470|Respiratory Tract Infections|respiratory tract infections
1217778|NCT01952470|Respiratory Therapy|respiratory therapy
1217779|NCT01952470|Isotonic Solutions|isotonic solutions
1217780|NCT01952470|Sodium Chloride|sodium chloride
1217781|NCT01952470|Postoperative complications|postoperative complications
1217782|NCT01952470|Postoperative care|postoperative care
1217783|NCT01952470|dornase alpha|dornase alpha
1217784|NCT01952431|Total Lung Capacity|total lung capacity
1217785|NCT01952392|Effectiveness study|effectiveness study
1217786|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
1217787|NCT01952392|Real-life|real-life
1217788|NCT01952392|France|france
1217789|NCT01952379|Melasma|melasma
1217790|NCT01952379|Lymphocytes|lymphocytes
1217791|NCT01952379|Macrophages|macrophages
1217792|NCT01952379|Mast cells|mast cells
1217793|NCT01952379|Interleukin 17|interleukin 17
1217794|NCT01952379|COX-2|cox-2
1217795|NCT01952379|Inflammation|inflammation
1217796|NCT01952366|Aged|aged
1217797|NCT01952366|Depression|depression
1217798|NCT01952366|Cognition|cognition
1217799|NCT01952366|Longitudinal study|longitudinal study
1217800|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
1217801|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
1217802|NCT01952262|ultrasound|ultrasound
1217803|NCT01952262|diaphragm|diaphragm
1217804|NCT01952262|intensive care|intensive care
1217805|NCT01952262|critical care|critical care
1217806|NCT01952249|Ovarian|ovarian
1217807|NCT01952249|Primary Peritoneal|primary peritoneal
1217808|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
1217809|NCT01952236|Smoking|smoking
1217810|NCT01952236|Quit|quit
1217811|NCT01952236|Tobacco|tobacco
1217812|NCT01952236|Abstinence|abstinence
1217813|NCT01952236|Adult|adult
1217814|NCT01952236|Text Messaging|text messaging
1217815|NCT01952236|Web-based|web-based
1217816|NCT01952236|Mobile phone|mobile phone
1217817|NCT01952236|smartphone|smartphone
1217818|NCT01952236|internet|internet
1217819|NCT01952236|web|web
1217820|NCT01952223|adenocarcinome|adenocarcinome
1217821|NCT01952223|prostate|prostate
1217822|NCT01952223|relapse|relapse
1217823|NCT01952223|Radiotherapy|radiotherapy
1217824|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
1217825|NCT01952223|Cabazitaxel|cabazitaxel
1217826|NCT01952197|Passive Leg Raise|passive leg raise
1217827|NCT01952197|Cardiac arrest|cardiac arrest
1217828|NCT01952197|Survival after CPR|survival after cpr
1217829|NCT01952184|vitrification|vitrification
1217830|NCT01952184|oocyte|oocyte
1217831|NCT01952184|donor|donor
1217832|NCT01952184|open|open
1217833|NCT01952184|closed|closed
1217834|NCT01952171|Genomics|genomics
1217835|NCT01952171|Congenital Malformations|congenital malformations
1217836|NCT01952171|Birth Defects|birth defects
1217837|NCT01952171|Heart Disease|heart disease
1217838|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
1217839|NCT01952158|Hospital Infection|hospital infection
1217840|NCT01952158|Colonization|colonization
1217841|NCT01952158|Healthcare Personnel|healthcare personnel
1217842|NCT01952132|Schizophrenia|schizophrenia
1217843|NCT01952119|hypertension|hypertension
1217844|NCT01952106|venepuncture|venepuncture
1217845|NCT01952106|distraction|distraction
1217846|NCT01952106|distress|distress
1217847|NCT01952093|Early intervention|early intervention
1217848|NCT01952093|Mother-child interaction|mother-child interaction
1217849|NCT01952093|Neurodevelopment|neurodevelopment
1217850|NCT01952093|Parenting|parenting
1217851|NCT01952093|Prematurity|prematurity
1217852|NCT01952093|School age|school age
1217853|NCT01952080|Short Bowel Syndrome|short bowel syndrome
1217854|NCT01952080|SBS|sbs
1217855|NCT01952080|Pediatric SBS|pediatric sbs
1217856|NCT01952067|Hip Prosthesis|hip prosthesis
1217857|NCT01952067|surgery|surgery
1217858|NCT01952067|cements|cements
1217859|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
1217860|NCT01952054|Breast cancer|breast cancer
1217861|NCT01952054|Breast carcinoma|breast carcinoma
1217862|NCT01952054|Bone metastasis|bone metastasis
1217863|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
1217864|NCT01952054|Denosumab|denosumab
1217865|NCT01952054|AMG 162|amg 162
1217866|NCT01952054|Prolia|prolia
1217867|NCT01952054|Hormonal agent|hormonal agent
1217868|NCT01952041|Schizophrenia|schizophrenia
1217869|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
1217870|NCT01952041|Mobile Application|mobile application
1217871|NCT01952041|Relapse Signature|relapse signature
1217872|NCT01952041|Relapse|relapse
1217873|NCT01952041|SMI|smi
1217874|NCT01952041|EHealth|ehealth
1217875|NCT01952041|E-Health|e-health
1217876|NCT01952041|Health Technology|health technology
1217877|NCT01952041|mHealth|mhealth
1217878|NCT01952041|m-Health|m-health
1217879|NCT01952028|MDC1A|mdc1a
1217880|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
1217881|NCT01952028|Merosin Deficient|merosin deficient
1217882|NCT01952028|LAMA2|lama2
1217883|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
1217884|NCT01952028|Seizure|seizure
1217885|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
1217886|NCT01952002|Blood Pressure|blood pressure
1217887|NCT01952002|heart rate|heart rate
1217888|NCT01952002|electrocardiogram|electrocardiogram
1217889|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
1217890|NCT01952002|respiratory exercise|respiratory exercise
1217891|NCT01951989|Gaucher disease|gaucher disease
1217892|NCT01951989|Imiglucerase|imiglucerase
1217893|NCT01951989|Pharmacokinetics|pharmacokinetics
1217894|NCT01951976|breast|breast
1217895|NCT01951976|carcinoma|carcinoma
1217896|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
1217897|NCT01951976|post-menopausal|post-menopausal
1217898|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
1217899|NCT01951976|joint pain|joint pain
1217900|NCT01951976|AI-associated joint pain|ai-associated joint pain
1217901|NCT01951963|pain management|pain management
1217902|NCT01951963|ketamine|ketamine
1217903|NCT01951963|morphine|morphine
1217904|NCT01951963|pediatrics|pediatrics
1217905|NCT01951963|emergency medicine|emergency medicine
1217906|NCT01951937|Cognitive Test|cognitive test
1217907|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
1217908|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
1217909|NCT01951911|Pain Management|pain management
1217910|NCT01951911|Ketamine|ketamine
1217911|NCT01951911|Palliative care|palliative care
1217912|NCT01951898|asthma|asthma
1217913|NCT01951898|regulatory T cells|regulatory t cells
1217914|NCT01951898|leukotriene antagonist|leukotriene antagonist
1217915|NCT01951872|caffeine dependence|caffeine dependence
1217916|NCT01951872|caffeine withdrawal|caffeine withdrawal
1217917|NCT01951872|caffeine use disorder|caffeine use disorder
1217918|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
1217919|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
1217920|NCT01951807|Coping|coping
1217921|NCT01951794|HIV infected|hiv infected
1217922|NCT01951794|HIV exposed|hiv exposed
1217923|NCT01951794|HIV-free|hiv-free
1217924|NCT01951781|marker CD64|marker cd64
1217925|NCT01951781|blood sample|blood sample
1217926|NCT01951781|nosocomial infection|nosocomial infection
1217927|NCT01951781|preterm newborn|preterm newborn
1217928|NCT01951755|Inoperable NSCLC|inoperable nsclc
1217929|NCT01951755|TKIs|tkis
1217930|NCT01951742|wrinkles|wrinkles
1217931|NCT01951729|Blood sugar|blood sugar
1217933|NCT01951729|Xenin-25|xenin-25
1217934|NCT01951729|Cholinergic Signaling|cholinergic signaling
1217935|NCT01951729|Atropine|atropine
1217936|NCT01951729|Insulin|insulin
1217937|NCT01951729|Glucagon|glucagon
1217938|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
1217939|NCT01951716|Vagotomy|vagotomy
1217940|NCT01951716|Vagus Nerve|vagus nerve
1217941|NCT01951716|Xenin-25|xenin-25
1217942|NCT01951716|GIP|gip
1217943|NCT01951716|Insulin Secretion|insulin secretion
1217944|NCT01951716|Glucagon Secretion|glucagon secretion
1217945|NCT01951716|Gastric Emptying|gastric emptying
1217946|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
1217947|NCT01951690|FAK inhibitor|fak inhibitor
1217948|NCT01951690|Cancer Stem Cells|cancer stem cells
1217949|NCT01951690|CSC|csc
1217950|NCT01951690|KRAS mutation|kras mutation
1217951|NCT01951677|hepatitis B virus|hepatitis b virus
1217952|NCT01951677|vaccine|vaccine
1217953|NCT01951677|adjuvant|adjuvant
1217954|NCT01951677|prophylaxis|prophylaxis
1217955|NCT01951651|Diabetes|diabetes
1217956|NCT01951638|Worsening Heart Failure|worsening heart failure
1217957|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1217958|NCT01951625|Worsening Heart Failure|worsening heart failure
1217959|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
1217960|NCT01951612|cognitive impairment|cognitive impairment
1217961|NCT01951612|ischemic white matter disease|ischemic white matter disease
1217962|NCT01951612|small vessel disease|small vessel disease
1217963|NCT01951612|transient ischemic attack|transient ischemic attack
1217964|NCT01951612|mild stroke|mild stroke
1217965|NCT01951612|stroke risk|stroke risk
1217966|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
1217967|NCT01951573|contact lenses|contact lenses
1217968|NCT01951573|multifocal|multifocal
1217969|NCT01951573|daily disposable|daily disposable
1217970|NCT01951573|silicone hydrogel|silicone hydrogel
1217971|NCT01951573|presbyopia|presbyopia
1217972|NCT01951547|HbA1c|hba1c
1217973|NCT01951547|hs-CRP|hs-crp
1217974|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
1217975|NCT01951547|oral health education|oral health education
1217976|NCT01951547|probing pocket depth|probing pocket depth
1217977|NCT01951547|plaque index|plaque index
1217978|NCT01951547|gingival bleeding index.|gingival bleeding index.
1217979|NCT01951534|breast reconstruction|breast reconstruction
1217980|NCT01951521|Rectal cancer|rectal cancer
1217981|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
1217982|NCT01951521|Radiotherapy|radiotherapy
1217983|NCT01951521|Boost|boost
1217984|NCT01951521|Dose-escalation|dose-escalation
1217985|NCT01951521|Pathological complete response|pathological complete response
1217986|NCT01951521|Response|response
1217987|NCT01951508|Methylphenidate|methylphenidate
1217988|NCT01951508|Modafinil|modafinil
1217989|NCT01951508|MDMA|mdma
1217990|NCT01951508|fMRI|fmri
1217991|NCT01951508|emotion-processing|emotion-processing
1217992|NCT01951508|social cognition|social cognition
1217993|NCT01951456|Smoking cessation|smoking cessation
1217994|NCT01951456|resistance training|resistance training
1217995|NCT01951443|ginseng|ginseng
1217996|NCT01951443|clinical trial|clinical trial
1217997|NCT01951443|vascular|vascular
1217998|NCT01951443|ginsenosides|ginsenosides
1217999|NCT01951443|blood pressure|blood pressure
1218000|NCT01951430|Adult patients|adult patients
1218001|NCT01951430|Infective events|infective events
1218002|NCT01951430|Antibiotic|antibiotic
1218003|NCT01951430|Antifungal|antifungal
1218004|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
1218005|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
1218006|NCT01951404|Allopurinol|allopurinol
1218007|NCT01951404|End Stage Renal Disease|end stage renal disease
1218008|NCT01951404|Haemodialysis|haemodialysis
1218009|NCT01951404|Renal Replacement Therapy|renal replacement therapy
1218010|NCT01951404|MRI|mri
1218011|NCT01951391|study|study
1218012|NCT01951391|subjects|subjects
1218013|NCT01951378|Asthma|asthma
1218014|NCT01951378|Asthma exacerbation|asthma exacerbation
1218015|NCT01951365|Schwannoma|schwannoma
1218016|NCT01951365|Growth|growth
1218017|NCT01951365|intradural|intradural
1218018|NCT01951365|natural history|natural history
1218019|NCT01951352|study|study
1218020|NCT01951352|meant|meant
1218021|NCT01951352|individuals|individuals
1218022|NCT01951339|diabetes|diabetes
1218023|NCT01951339|type 2 diabetes|type 2 diabetes
1218024|NCT01951339|exercise|exercise
1218025|NCT01951339|echo|echo
1218026|NCT01951339|heart|heart
1218027|NCT01951339|sitagliptin|sitagliptin
1218028|NCT01951339|glimepiride|glimepiride
1218029|NCT01951339|cardiovascular|cardiovascular
1218030|NCT01951326|Crohn's Disease|crohn's disease
1218031|NCT01951326|moderate to severe|moderate to severe
1218032|NCT01951326|remission|remission
1218033|NCT01951326|MAP|map
1218034|NCT01951326|antibiotic|antibiotic
1218035|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
1218036|NCT01951261|Telemonitoring|telemonitoring
1218037|NCT01951261|COPD|copd
1218038|NCT01951261|Home care|home care
1218039|NCT01951248|chronic kidney disease|chronic kidney disease
1218040|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
1218041|NCT01951248|24-h blood pressure|24-h blood pressure
1218042|NCT01951248|central blood pressure|central blood pressure
1218043|NCT01951248|peripheral blood pressure|peripheral blood pressure
1218044|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
1218045|NCT01951209|Human|human
1218046|NCT01951209|Hepatitis C|hepatitis c
1218047|NCT01951209|Cirrhosis|cirrhosis
1218048|NCT01951209|B-cell|b-cell
1218049|NCT01951209|Rifaximin|rifaximin
1218050|NCT01951196|Chronic kidney disease|chronic kidney disease
1218051|NCT01951196|24 hour blood pressure|24 hour blood pressure
1218052|NCT01951196|central blood pressure|central blood pressure
1218053|NCT01951196|peripheral blood pressure|peripheral blood pressure
1218054|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
1218055|NCT01951144|Phase 1|phase 1
1218056|NCT01951144|Single Dose|single dose
1218057|NCT01951144|Pharmacokinetics|pharmacokinetics
1218058|NCT01951144|Safety|safety
1218059|NCT01951144|Toleration|toleration
1218060|NCT01951144|Pharmacodynamics|pharmacodynamics
1218061|NCT01951118|Smell|smell
1218062|NCT01951118|Olfaction Disorders|olfaction disorders
1218063|NCT01951118|Atropine|atropine
1218064|NCT01951118|Donepezil|donepezil
1218065|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
1218066|NCT01951118|Cognition Disorders|cognition disorders
1218067|NCT01951105|Subacute|subacute
1218068|NCT01951105|Back|back
1218069|NCT01951105|Pain|pain
1218070|NCT01951105|Brain|brain
1218071|NCT01951105|MRI|mri
1218072|NCT01951092|HIV|hiv
1218073|NCT01951092|adherence|adherence
1218074|NCT01951092|retention|retention
1218075|NCT01951092|texting|texting
1218076|NCT01951079|Digoxin|digoxin
1218077|NCT01951079|Intra-amniotic injection|intra-amniotic injection
1218078|NCT01951079|feticide|feticide
1218079|NCT01951079|second trimester abortion|second trimester abortion
1218080|NCT01951053|Healthy|healthy
1218081|NCT01951053|Safety|safety
1218082|NCT01951053|Tolerability|tolerability
1218083|NCT01951053|Pharmacokinetics|pharmacokinetics
1218084|NCT01951053|Pharmacodynamics|pharmacodynamics
1218085|NCT01951053|JNJ-40411813|jnj-40411813
1218086|NCT01951053|Positive allosteric modulator|positive allosteric modulator
1218087|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
1218088|NCT01951027|Safety|safety
1218089|NCT01951027|Pharmacokinetics|pharmacokinetics
1218090|NCT01951027|Pharmacodynamics|pharmacodynamics
1218091|NCT01951027|DLT|dlt
1218092|NCT01951027|Immunogenecity|immunogenecity
1218093|NCT01951014|Adolescence|adolescence
1218094|NCT01951014|Pregnancy|pregnancy
1218095|NCT01951014|Telemedicine|telemedicine
1218096|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
1218097|NCT01950936|Infection|infection
1218098|NCT01950936|Antibiotics|antibiotics
1218099|NCT01950936|COLD|cold
1218100|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1218101|NCT01950910|motor neuron disease|motor neuron disease
1218102|NCT01950910|biological markers|biological markers
1218103|NCT01950910|biomarkers|biomarkers
1218104|NCT01950897|muscular dystrophies|muscular dystrophies
1218105|NCT01950897|muscular dystrophy|muscular dystrophy
1218106|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
1218107|NCT01950871|HistoScanning|histoscanning
1218108|NCT01950871|TRUS|trus
1218109|NCT01950871|Prostate cancer|prostate cancer
1218110|NCT01950871|Biopsy guidance|biopsy guidance
1218111|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
1218112|NCT01950832|Structure of Retina|structure of retina
1218113|NCT01950832|Macular Thickness|macular thickness
1218114|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
1218115|NCT01950832|Choroidal Thickness|choroidal thickness
1218116|NCT01950832|PCOS|pcos
1218117|NCT01950832|Optical Coherence Tomography|optical coherence tomography
1218118|NCT01950819|kidney failure|kidney failure
1218119|NCT01950819|dialysis|dialysis
1218120|NCT01950819|renal failure|renal failure
1218121|NCT01950819|transplantation|transplantation
1218122|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
1218123|NCT01950780|Alopecia Areata|alopecia areata
1218124|NCT01950780|Ruxolitinib|ruxolitinib
1218125|NCT01950728|volunteers|volunteers
1218126|NCT01950728|18 to 65 years|18 to 65 years
1218127|NCT01950728|Males and Females|males and females
1218128|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
1218129|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
1218130|NCT01950715|Gastro-colic response|gastro-colic response
1218131|NCT01950715|Multimodal Stimulation|multimodal stimulation
1218132|NCT01950663|Diagnostic Equipment|diagnostic equipment
1218133|NCT01950663|Validation Studies|validation studies
1218134|NCT01950624|Patient Registry|patient registry
1218135|NCT01950624|Down Syndrome|down syndrome
1218136|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
1218137|NCT01950611|arsenic trioxide|arsenic trioxide
1218138|NCT01950611|proteasome inhibition|proteasome inhibition
1218139|NCT01950611|bortezomib|bortezomib
1218140|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
1218141|NCT01950585|Hydroxyurea|hydroxyurea
1218142|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
1218143|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1218144|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
1218145|NCT01950585|CD34 + Cells|cd34 + cells
1218146|NCT01950572|Samples|samples
1218147|NCT01950572|Biobank|biobank
1218148|NCT01950572|Lung Neoplasms|lung neoplasms
1218149|NCT01950572|Ovarian Neoplasms|ovarian neoplasms
1218150|NCT01950559|soy allergy|soy allergy
1218151|NCT01950559|food allergy|food allergy
1218152|NCT01950559|pediatric|pediatric
1218153|NCT01950559|adult|adult
1218154|NCT01950546|silver nanoparticles|silver nanoparticles
1218155|NCT01950546|antimicrobial activity|antimicrobial activity
1218156|NCT01950546|toxicity|toxicity
1218157|NCT01950546|biofilm|biofilm
1218158|NCT01950546|cariostatic agents|cariostatic agents
1218159|NCT01950533|Peanut allergy|peanut allergy
1218160|NCT01950533|Milk allergy|milk allergy
1218161|NCT01950533|Egg allergy|egg allergy
1218162|NCT01950533|Pediatric|pediatric
1218163|NCT01950533|Adult|adult
1218164|NCT01950533|Food allergy|food allergy
1218165|NCT01950520|Adipose Tissue|adipose tissue
1218166|NCT01950520|Adult|adult
1218167|NCT01950520|Body Composition|body composition
1218168|NCT01950520|Brown Adipose Tissue|brown adipose tissue
1218169|NCT01950520|Non-Shivering Thermogenesis|non-shivering thermogenesis
1218170|NCT01950507|Fluconazole|fluconazole
1218171|NCT01950507|Graft Versus Host Disease|graft versus host disease
1218172|NCT01950507|Voriconazole|voriconazole
1218173|NCT01950507|Azoles|azoles
1218174|NCT01950494|hand dermatitis|hand dermatitis
1218175|NCT01950494|health care workers|health care workers
1218176|NCT01950494|hand sanitizer|hand sanitizer
1218177|NCT01950481|LDK378|ldk378
1218178|NCT01950481|pharmacokinetics|pharmacokinetics
1218179|NCT01950481|hepatic impairment|hepatic impairment
1218180|NCT01950468|Parkinson's Disease|parkinson's disease
1218181|NCT01950455|Parkinson's Disease|parkinson's disease
1218182|NCT01950442|malignant strictures|malignant strictures
1218183|NCT01950442|esophageal staging|esophageal staging
1218184|NCT01950429|Microbiome|microbiome
1218185|NCT01950429|Sickle Cell Disease|sickle cell disease
1218186|NCT01950429|Bone Marrow Transplant|bone marrow transplant
1218791|NCT01947712|polyphenols|polyphenols
1218187|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
1218188|NCT01950416|Fibrinolysis|fibrinolysis
1218189|NCT01950416|Ticagrelor|ticagrelor
1218190|NCT01950416|Clopidogrel|clopidogrel
1218191|NCT01950416|Platelet reactivity|platelet reactivity
1218192|NCT01950377|Dopamine Transporter|dopamine transporter
1218193|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
1218194|NCT01950377|Dopamine|dopamine
1218195|NCT01950377|Dopamine Genes|dopamine genes
1218196|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
1218197|NCT01950364|Lymphoma|lymphoma
1218198|NCT01950364|Hodgkin|hodgkin
1218199|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
1218200|NCT01950364|Relapsed|relapsed
1218201|NCT01950364|Refractory|refractory
1218202|NCT01950364|Antigens, CD30|antigens, cd30
1218203|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
1218204|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
1218205|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1218206|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1218207|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
1218208|NCT01950364|Drug Therapy|drug therapy
1218209|NCT01950364|Immunotherapy|immunotherapy
1218210|NCT01950364|Hematologic Diseases|hematologic diseases
1218211|NCT01950351|Prostate Cancer|prostate cancer
1218212|NCT01950351|Localized prostate cancer|localized prostate cancer
1218213|NCT01950351|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1218214|NCT01950351|Proton therapy|proton therapy
1218215|NCT01950351|Radiation therapy|radiation therapy
1218217|NCT01950351|Gray|gray
1218219|NCT01950351|Questionnaire|questionnaire
1218220|NCT01950351|Survey|survey
1218221|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
1218222|NCT01950325|CD4 Count|cd4 count
1218223|NCT01950325|Antiviral|antiviral
1218224|NCT01950325|HIV-1 Infection|hiv-1 infection
1218225|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
1218226|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
1218227|NCT01950312|Inner Ear Disease|inner ear disease
1218228|NCT01950312|Meniere's Disease|meniere's disease
1218229|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
1218230|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
1218231|NCT01950286|chemotherapy|chemotherapy
1218232|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1218233|NCT01950260|Graves' disease|graves' disease
1218234|NCT01950260|Radioactive iodine|radioactive iodine
1218235|NCT01950260|Hypothyroidism|hypothyroidism
1218236|NCT01950221|Double-blind Trial|double-blind trial
1218237|NCT01950221|Placebo-controlled|placebo-controlled
1218238|NCT01950221|Pomegranate|pomegranate
1218239|NCT01950221|Memory|memory
1218240|NCT01950221|Memory Impairment|memory impairment
1218241|NCT01950221|Cognition|cognition
1218242|NCT01950221|Ages 50-75|ages 50-75
1218243|NCT01950208|Assessment|assessment
1218244|NCT01950195|Melanoma|melanoma
1218245|NCT01950195|Metastases|metastases
1218246|NCT01950195|Brain|brain
1218247|NCT01950195|Spine|spine
1218248|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
1218249|NCT01950195|Ipilimumab|ipilimumab
1218250|NCT01950182|Luminal B2 subtype|luminal b2 subtype
1218251|NCT01950182|First line treatment|first line treatment
1218252|NCT01950169|Hip fracture|hip fracture
1218253|NCT01950169|Nutritional supplement|nutritional supplement
1218254|NCT01950169|Bisphosphonates|bisphosphonates
1218255|NCT01950169|Bone mineral density|bone mineral density
1218256|NCT01950169|Body composition|body composition
1218257|NCT01950143|prostate cancer prevention|prostate cancer prevention
1218258|NCT01950143|diet|diet
1218259|NCT01950143|global gene expression|global gene expression
1218260|NCT01950143|metabolic changes|metabolic changes
1218261|NCT01950130|IABP|iabp
1218262|NCT01950130|IABC|iabc
1218263|NCT01950130|coronary artery disease|coronary artery disease
1218264|NCT01950130|prophylactic|prophylactic
1218265|NCT01950130|cardiac assist|cardiac assist
1218266|NCT01950117|nonpedunculated|nonpedunculated
1218267|NCT01950117|neoplastic|neoplastic
1218268|NCT01950117|colorectal|colorectal
1218269|NCT01950117|polyps|polyps
1218270|NCT01950104|Embryo biopsy|embryo biopsy
1218271|NCT01950104|Blastocyst stage|blastocyst stage
1218272|NCT01950104|Day 3|day 3
1218273|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
1218274|NCT01950091|low back pain|low back pain
1218275|NCT01950091|internet|internet
1218277|NCT01950091|prevention|prevention
1218278|NCT01950091|treatment|treatment
1218279|NCT01950078|gene polymorphism|gene polymorphism
1218280|NCT01950078|pain perception|pain perception
1218281|NCT01950078|postoperative pain|postoperative pain
1218282|NCT01950052|VLCD|vlcd
1218283|NCT01950052|Low calorie diet|low calorie diet
1218284|NCT01950052|very low calorie diet|very low calorie diet
1218285|NCT01950052|pre-operative diet|pre-operative diet
1218286|NCT01950052|liver shrinking diet|liver shrinking diet
1218287|NCT01950052|bariatric surgery|bariatric surgery
1218288|NCT01950052|gastric bypass|gastric bypass
1218289|NCT01950039|Obesity|obesity
1218290|NCT01950039|Glucose Intolerance|glucose intolerance
1218291|NCT01950026|skin temperature|skin temperature
1218292|NCT01950026|ethnic groups|ethnic groups
1218293|NCT01950026|cryotherapy|cryotherapy
1218294|NCT01950013|Presbycusis|presbycusis
1218295|NCT01950013|Aging|aging
1218296|NCT01950013|hearing aids|hearing aids
1218297|NCT01950013|hearing training|hearing training
1218298|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
1218299|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
1218300|NCT01949974|Integral Attention Program|integral attention program
1218301|NCT01949974|Advanced cancer|advanced cancer
1218302|NCT01949974|Randomized Clinical Trial|randomized clinical trial
1218303|NCT01949961|intervention|intervention
1218304|NCT01949961|sonothrombolysis|sonothrombolysis
1218305|NCT01949961|Ultrasound treatment|ultrasound treatment
1218306|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
1218307|NCT01949935|Mupirocin|mupirocin
1218308|NCT01949935|Surgical Site Infections|surgical site infections
1218309|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1218310|NCT01949922|regenerative medicine|regenerative medicine
1218311|NCT01949922|fecal incontinence|fecal incontinence
1218312|NCT01949922|muscle fiber injection|muscle fiber injection
1218313|NCT01949909|plasmodium falciparum|plasmodium falciparum
1218314|NCT01949909|long synthetic peptide|long synthetic peptide
1218315|NCT01949909|antibody|antibody
1218316|NCT01949909|T cell|t cell
1218317|NCT01949909|cytokine|cytokine
1218318|NCT01949909|vaccine|vaccine
1218319|NCT01949909|safety|safety
1218320|NCT01949909|phase 1|phase 1
1218321|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
1218322|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
1218323|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
1218324|NCT01949883|Phase 1|phase 1
1218325|NCT01949883|Oncology|oncology
1218326|NCT01949883|BET Inhibitor|bet inhibitor
1218327|NCT01949857|Hepatitis A|hepatitis a
1218328|NCT01949857|Vaccine|vaccine
1218329|NCT01949857|Safety|safety
1218330|NCT01949857|efficacy|efficacy
1218331|NCT01949844|MRI|mri
1218332|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
1218333|NCT01949844|myocardial perfusion|myocardial perfusion
1218334|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
1218335|NCT01949844|Novel MRI Techniques|novel mri techniques
1218336|NCT01949831|functional assessment|functional assessment
1218337|NCT01949831|acute care|acute care
1218338|NCT01949831|older medical patients|older medical patients
1218339|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
1218340|NCT01949753|Exposure therapy|exposure therapy
1218341|NCT01949753|Extinction learning|extinction learning
1218342|NCT01949753|Pregnenolone|pregnenolone
1218343|NCT01949727|AECOPD|aecopd
1218344|NCT01949727|COPD|copd
1218345|NCT01949727|Emphysema|emphysema
1218346|NCT01949727|Chronic bronchitis|chronic bronchitis
1218347|NCT01949675|Cholera|cholera
1218348|NCT01949675|Shanchol™|shanchol™
1218349|NCT01949675|Cholera Vaccine|cholera vaccine
1218350|NCT01949662|Advanced Cancers|advanced cancers
1218351|NCT01949662|Locally advanced cancer|locally advanced cancer
1218352|NCT01949662|Metastatic cancer|metastatic cancer
1218353|NCT01949662|Recurrent cancer|recurrent cancer
1218354|NCT01949662|Incurable cancer|incurable cancer
1218355|NCT01949662|Delirium|delirium
1218356|NCT01949662|Agitation|agitation
1218357|NCT01949662|Lorazepam|lorazepam
1218358|NCT01949662|Haloperidol|haloperidol
1218359|NCT01949662|Placebo|placebo
1218360|NCT01949662|Questionnaires|questionnaires
1218361|NCT01949662|Surveys|surveys
1218362|NCT01949662|Acute palliative care unit|acute palliative care unit
1218363|NCT01949649|body image|body image
1218364|NCT01949649|body dissatisfaction|body dissatisfaction
1218365|NCT01949623|RP|rp
1218366|NCT01949610|Healthy Participants|healthy participants
1218367|NCT01949610|JNJ26489112|jnj26489112
1218368|NCT01949610|14C-JNJ26489112|14c-jnj26489112
1218369|NCT01949610|Absorption|absorption
1218370|NCT01949610|Metabolism|metabolism
1218371|NCT01949610|Excretion|excretion
1218372|NCT01949571|Mirtazapine.|mirtazapine.
1218373|NCT01949571|Addiction.|addiction.
1218374|NCT01949571|Cocaine.|cocaine.
1218375|NCT01949571|Cocaine-craving.|cocaine-craving.
1218376|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
1218377|NCT01949558|diet|diet
1218378|NCT01949558|lifestyle|lifestyle
1218379|NCT01949519|prostate cancer|prostate cancer
1218380|NCT01949519|lycopene|lycopene
1218381|NCT01949519|docetaxel|docetaxel
1218382|NCT01949519|metastatic|metastatic
1218383|NCT01949519|castration resistant|castration resistant
1218684|NCT01948128|Breast|breast
1218384|NCT01949506|Lung metastases|lung metastases
1218385|NCT01949506|Radiation Therapy|radiation therapy
1218386|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1218387|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
1218388|NCT01949493|traction|traction
1218389|NCT01949493|mechanical traction|mechanical traction
1218390|NCT01949493|Phystrac|phystrac
1218391|NCT01949480|Peripheral nerve block|peripheral nerve block
1218392|NCT01949480|Ultrasound guidance|ultrasound guidance
1218393|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
1218394|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
1218395|NCT01949467|ferroportin disease|ferroportin disease
1218396|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
1218397|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
1218398|NCT01949467|hyperferritinemia|hyperferritinemia
1218399|NCT01949467|hepcidin|hepcidin
1218400|NCT01949467|iron fumarate|iron fumarate
1218401|NCT01949467|physiopathological study|physiopathological study
1218402|NCT01949467|diagnosis|diagnosis
1218403|NCT01949467|HFE gene|hfe gene
1218404|NCT01949467|TRF2 gene|trf2 gene
1218405|NCT01949467|iron parameters|iron parameters
1218406|NCT01949467|divalent cations|divalent cations
1218407|NCT01949454|trachoma|trachoma
1218408|NCT01949454|trichiasis|trichiasis
1218409|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
1218410|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
1218411|NCT01949454|fluorometholone|fluorometholone
1218412|NCT01949454|placebo controlled|placebo controlled
1218413|NCT01949441|HDM Allergy|hdm allergy
1218414|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
1218415|NCT01949441|Immunotherapy|immunotherapy
1218416|NCT01949441|ToleroMune HDM|toleromune hdm
1218417|NCT01949428|HDM Allergy|hdm allergy
1218418|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
1218419|NCT01949415|House Dust Mite|house dust mite
1218420|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
1218421|NCT01949415|ToleroMune|toleromune
1218422|NCT01949376|breast cancer|breast cancer
1218423|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
1218424|NCT01949376|cognitive impairment|cognitive impairment
1218425|NCT01949376|adjuvant therapy|adjuvant therapy
1218426|NCT01949376|hormone therapy|hormone therapy
1218427|NCT01949376|hormonal therapy|hormonal therapy
1218428|NCT01949376|chemotherapy|chemotherapy
1218429|NCT01949376|chemo brain|chemo brain
1218430|NCT01949376|MRI|mri
1218431|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
1218432|NCT01949324|MacTel|mactel
1218433|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
1218434|NCT01949298|implant supported over denture|implant supported over denture
1218435|NCT01949285|Spinal cord injury|spinal cord injury
1218436|NCT01949285|Paralysis|paralysis
1218437|NCT01949285|Rehabilitation|rehabilitation
1218438|NCT01949285|Assessment|assessment
1218439|NCT01949285|Theranostics|theranostics
1218440|NCT01949272|ARDS|ards
1218441|NCT01949259|Retrospective|retrospective
1218442|NCT01949259|Lung cancer|lung cancer
1218443|NCT01949246|Biomarkers|biomarkers
1218444|NCT01949220|Inherited|inherited
1218445|NCT01949220|Von Willebrand disease|von willebrand disease
1218446|NCT01949220|Von Willebrand factor|von willebrand factor
1218447|NCT01949220|Deficiency|deficiency
1218448|NCT01949220|safety|safety
1218449|NCT01949207|Incompetent perforating veins|incompetent perforating veins
1218450|NCT01949207|EVLA|evla
1218451|NCT01949207|Phlebectomies|phlebectomies
1218452|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
1218453|NCT01949194|liver metastases|liver metastases
1218454|NCT01949181|Metals|metals
1218455|NCT01949181|Metalloids|metalloids
1218456|NCT01949181|Blood|blood
1218457|NCT01949181|Hair|hair
1218458|NCT01949181|Lung|lung
1218459|NCT01949181|Lung cancer|lung cancer
1218460|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1218461|NCT01949155|otitis media|otitis media
1218462|NCT01949155|otorrhea|otorrhea
1218463|NCT01949155|middle ear effusion|middle ear effusion
1218464|NCT01949155|tympanostomy tubes|tympanostomy tubes
1218465|NCT01949142|otitis media|otitis media
1218466|NCT01949142|otorrhea|otorrhea
1218467|NCT01949142|middle ear effusion|middle ear effusion
1218468|NCT01949142|tympanostomy tubes|tympanostomy tubes
1218469|NCT01949129|stem cell transplantation|stem cell transplantation
1218470|NCT01949129|children and adolescents|children and adolescents
1218471|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
1218472|NCT01949103|Gram-positive|gram-positive
1218473|NCT01949090|H7N1|h7n1
1218474|NCT01949090|AS03 adjuvant|as03 adjuvant
1218475|NCT01949090|Safety|safety
1218476|NCT01949090|Immunogenicity|immunogenicity
1218477|NCT01949090|Influenza|influenza
1218478|NCT01949090|Adults|adults
1218479|NCT01949090|Elderly adults|elderly adults
1218480|NCT01949077|Hepatitis|hepatitis
1218481|NCT01949077|Hepatitis C|hepatitis c
1218482|NCT01949077|Observational study|observational study
1218483|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
1218484|NCT01949051|Allergic rhinitis|allergic rhinitis
1218485|NCT01949051|levocabastine|levocabastine
1218486|NCT01949051|allergen challenge|allergen challenge
1218487|NCT01949038|Pain|pain
1218488|NCT01949038|Discomfort|discomfort
1218489|NCT01949038|Anxiety|anxiety
1218490|NCT01949038|Satisfaction|satisfaction
1218491|NCT01949038|Compliance|compliance
1218493|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
1218494|NCT01949012|Desaturation|desaturation
1218495|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
1218496|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
1218497|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
1218498|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
1218499|NCT01948973|Symptoms|symptoms
1218500|NCT01948973|Quality of Life|quality of life
1218501|NCT01948973|Bowel habits|bowel habits
1218502|NCT01948960|Breast Neoplasms|breast neoplasms
1218503|NCT01948960|everolimus|everolimus
1218504|NCT01948960|pharmacokinetics|pharmacokinetics
1218505|NCT01948960|elderly patients|elderly patients
1218506|NCT01948960|obese patients|obese patients
1218507|NCT01948934|Skin|skin
1218508|NCT01948934|Injury|injury
1218509|NCT01948934|Membrane amniotic|membrane amniotic
1218510|NCT01948934|Wound|wound
1218511|NCT01948921|EGD|egd
1218512|NCT01948921|tolerance|tolerance
1218513|NCT01948921|discomfort|discomfort
1218514|NCT01948908|Sedation|sedation
1218515|NCT01948908|Laceration repair|laceration repair
1218516|NCT01948908|Children|children
1218517|NCT01948908|Intranasal|intranasal
1218518|NCT01948908|Midazolam|midazolam
1218519|NCT01948895|Desvenlafaxine|desvenlafaxine
1218520|NCT01948895|Open-label|open-label
1218521|NCT01948895|Flexible-dose|flexible-dose
1218522|NCT01948895|Dysthymic disorder|dysthymic disorder
1218523|NCT01948895|Anxiety disorders|anxiety disorders
1218524|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
1218525|NCT01948895|Social anxiety disorder|social anxiety disorder
1218526|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
1218527|NCT01948882|Birth control|birth control
1218528|NCT01948869|Phoenix|phoenix
1218529|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
1218530|NCT01948869|efficacy|efficacy
1218531|NCT01948869|safety|safety
1218532|NCT01948856|Recurrent common cold|recurrent common cold
1218533|NCT01948856|laryngitis|laryngitis
1218534|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
1218535|NCT01948856|acute rhinitis|acute rhinitis
1218536|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
1218537|NCT01948856|acute otitis media|acute otitis media
1218538|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
1218539|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
1218540|NCT01948817|Thalassemia|thalassemia
1218541|NCT01948791|Alzheimer's disease|alzheimer's disease
1218542|NCT01948791|ENA713|ena713
1218543|NCT01948791|Chinese patients|chinese patients
1218544|NCT01948791|INSTINCT|instinct
1218545|NCT01948765|xenon anesthesia|xenon anesthesia
1218546|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
1218547|NCT01948752|Nutrition policy|nutrition policy
1218548|NCT01948752|food labelling|food labelling
1218549|NCT01948752|diet|diet
1218550|NCT01948752|obesity|obesity
1218551|NCT01948752|health behavior|health behavior
1218552|NCT01948739|Brain machine interface|brain machine interface
1218553|NCT01948739|Rehabilitation robotics|rehabilitation robotics
1218554|NCT01948739|Stroke|stroke
1218555|NCT01948739|Hemiparesis|hemiparesis
1218556|NCT01948726|Breast cancer|breast cancer
1218557|NCT01948726|Hypofractionation|hypofractionation
1218558|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
1218559|NCT01948726|Toxicity|toxicity
1218560|NCT01948700|Motivational Interviewing|motivational interviewing
1218561|NCT01948700|Problem Drinking|problem drinking
1218562|NCT01948700|Adolescents|adolescents
1218563|NCT01948700|Minority Health|minority health
1218564|NCT01948687|real time elastography|real time elastography
1218565|NCT01948687|hepatitis|hepatitis
1218566|NCT01948648|plant sterols|plant sterols
1218567|NCT01948648|cholesterol|cholesterol
1218568|NCT01948648|colesevelam|colesevelam
1218569|NCT01948648|phytosterolemia|phytosterolemia
1218570|NCT01948648|fish oil|fish oil
1218571|NCT01948635|tracheal cuff shape|tracheal cuff shape
1218572|NCT01948635|microaspiration|microaspiration
1218573|NCT01948635|pepsin|pepsin
1218574|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
1218575|NCT01948622|Anxiety|anxiety
1218576|NCT01948622|Third molar surgery|third molar surgery
1218577|NCT01948622|Blood pressure|blood pressure
1218578|NCT01948622|Heart rate|heart rate
1218579|NCT01948622|Oxygen saturation|oxygen saturation
1218580|NCT01948596|pregnant women|pregnant women
1218581|NCT01948596|depression|depression
1218582|NCT01948596|depressive symptoms|depressive symptoms
1218583|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
1218584|NCT01948583|vaginal dryness|vaginal dryness
1218585|NCT01948583|hyaluronic acid|hyaluronic acid
1218586|NCT01948583|menopause|menopause
1218587|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
1218588|NCT01948557|Breastfeeding|breastfeeding
1218589|NCT01948557|Infants|infants
1218590|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
1218591|NCT01948557|Survival|survival
1218592|NCT01948544|COPD|copd
1218593|NCT01948544|LTOT|ltot
1218594|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
1218595|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
1218596|NCT01948544|Quality of Life|quality of life
1218597|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
1218598|NCT01948531|Antiage|antiage
1218599|NCT01948518|Pulmonary hypertension|pulmonary hypertension
1218600|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
1218601|NCT01948518|Diffusion Capacity|diffusion capacity
1218602|NCT01948505|Craniotomy|craniotomy
1218603|NCT01948466|Nutrition|nutrition
1218604|NCT01948466|Commercials|commercials
1218605|NCT01948466|Elementary|elementary
1218606|NCT01948466|Lunchroom|lunchroom
1218607|NCT01948466|Fruits|fruits
1218608|NCT01948466|Vegetables|vegetables
1218609|NCT01948453|CAD|cad
1218610|NCT01948453|CIMT|cimt
1218611|NCT01948453|FMD|fmd
1218612|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
1218613|NCT01948427|UCD|ucd
1218614|NCT01948427|BUPHENYL|buphenyl
1218615|NCT01948427|RAVICTI|ravicti
1218616|NCT01948427|Urea|urea
1218617|NCT01948427|Urea cycle disorder|urea cycle disorder
1218618|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
1218619|NCT01948427|Benzoate|benzoate
1218620|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
1218621|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
1218622|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
1218623|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
1218624|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
1218625|NCT01948427|Arginine|arginine
1218626|NCT01948427|Citrulline|citrulline
1218627|NCT01948427|Ammonia|ammonia
1218628|NCT01948414|Obesity|obesity
1218629|NCT01948414|Hyperalimentation|hyperalimentation
1218630|NCT01948414|Event-Related Potential|event-related potential
1218631|NCT01948414|P300|p300
1218632|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
1218633|NCT01948375|subject blinding|subject blinding
1218634|NCT01948375|placebo needle|placebo needle
1218635|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
1218636|NCT01948323|Pregnancy|pregnancy
1218637|NCT01948323|Maternal health|maternal health
1218638|NCT01948323|Newborn health|newborn health
1218639|NCT01948323|Information technology|information technology
1218640|NCT01948323|Health education|health education
1218641|NCT01948323|Cellphone|cellphone
1218642|NCT01948323|Touch screen technology|touch screen technology
1218643|NCT01948323|Pregnancy outcome|pregnancy outcome
1218644|NCT01948323|Low-Middle income|low-middle income
1218645|NCT01948323|Nurse-led|nurse-led
1218646|NCT01948323|Nutrition|nutrition
1218647|NCT01948323|Exercise|exercise
1218648|NCT01948284|cecal intubation time|cecal intubation time
1218649|NCT01948284|water exchange|water exchange
1218650|NCT01948284|pain|pain
1218651|NCT01948271|Psoriasis|psoriasis
1218652|NCT01948271|Trichuris suis ova|trichuris suis ova
1218653|NCT01948271|T-lymphocytes|t-lymphocytes
1218654|NCT01948258|Pregnancy|pregnancy
1218655|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
1218656|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
1218657|NCT01948245|Taurolidine|taurolidine
1589286|NCT00433940|Hemangioma|hemangioma
1218658|NCT01948245|Catheter lock solution|catheter lock solution
1218659|NCT01948245|Antimicrobial agent|antimicrobial agent
1218660|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
1218661|NCT01948245|Anti-infective agents|anti-infective agents
1218662|NCT01948206|Sudden Cardiac Death|sudden cardiac death
1218663|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
1218664|NCT01948206|Cardiomyopathy|cardiomyopathy
1218665|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
1218666|NCT01948193|Diphtheria|diphtheria
1218667|NCT01948193|Tetanus|tetanus
1218668|NCT01948193|Whooping Cough|whooping cough
1218669|NCT01948193|Hepatitis B|hepatitis b
1218670|NCT01948193|Poliomyelitis|poliomyelitis
1218671|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
1218672|NCT01948180|NKTCL|nktcl
1218673|NCT01948180|T cell|t cell
1218674|NCT01948180|CITADEL|citadel
1218675|NCT01948180|Epstein-Barr Virus|epstein-barr virus
1218676|NCT01948180|Natural Killer|natural killer
1218677|NCT01948167|Depression|depression
1218678|NCT01948167|Prevention|prevention
1218679|NCT01948167|Adolescents|adolescents
1218680|NCT01948154|Cerebral Palsy|cerebral palsy
1218681|NCT01948154|Early Intervention|early intervention
1218682|NCT01948154|Speech Function|speech function
1218683|NCT01948154|Quality of Life|quality of life
1218685|NCT01948115|Breech presentation|breech presentation
1218686|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
1218687|NCT01948115|external cephalic version|external cephalic version
1218688|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1218689|NCT01948102|motor neuron disease|motor neuron disease
1218690|NCT01948102|biological markers|biological markers
1218691|NCT01948102|biomarkers|biomarkers
1218692|NCT01948089|Chronic Stroke|chronic stroke
1218693|NCT01948089|near transfer|near transfer
1218694|NCT01948089|far transfer|far transfer
1218695|NCT01948089|working memory|working memory
1218696|NCT01948089|fluid intelligence|fluid intelligence
1218697|NCT01948089|cognitive training|cognitive training
1218698|NCT01948089|dual n-back|dual n-back
1218699|NCT01948076|splenomegaly|splenomegaly
1218700|NCT01948076|pleural effusion|pleural effusion
1218701|NCT01948037|hydrotherapy|hydrotherapy
1218702|NCT01948037|randomized controlled trial|randomized controlled trial
1218703|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
1218704|NCT01948037|diabetes|diabetes
1218705|NCT01947998|Rivaroxaban|rivaroxaban
1218706|NCT01947998|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
1218707|NCT01947998|Anticoagulants|anticoagulants
1218708|NCT01947998|Hematologic Agents|hematologic agents
1218709|NCT01947998|Therapeutic Uses|therapeutic uses
1218710|NCT01947998|Observational|observational
1218711|NCT01947998|Venous Thromboembolism|venous thromboembolism
1218712|NCT01947998|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
1218713|NCT01947998|Intracranial Hemorrhages|intracranial hemorrhages
1218714|NCT01947998|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
1218715|NCT01947985|Rivaroxaban|rivaroxaban
1218716|NCT01947985|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
1218717|NCT01947985|Anticoagulants|anticoagulants
1218718|NCT01947985|Hematologic Agents|hematologic agents
1218719|NCT01947985|Therapeutic Uses|therapeutic uses
1218720|NCT01947985|Observational|observational
1218721|NCT01947985|Venous Thromboembolism|venous thromboembolism
1218722|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
1218723|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
1218724|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1218725|NCT01947972|preterm neonate|preterm neonate
1218726|NCT01947972|tailored fortification|tailored fortification
1218727|NCT01947972|nutrition|nutrition
1218728|NCT01947972|maternal breast milk composition|maternal breast milk composition
1218729|NCT01947959|Rivaroxaban|rivaroxaban
1218730|NCT01947959|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
1218731|NCT01947959|Anticoagulants|anticoagulants
1218732|NCT01947959|Hematologic Agents|hematologic agents
1218733|NCT01947959|Therapeutic Uses|therapeutic uses
1218734|NCT01947959|Observational|observational
1218735|NCT01947959|Venous Thromboembolism|venous thromboembolism
1218736|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
1218737|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
1218738|NCT01947959|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
1218739|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
1218740|NCT01947920|Healthy|healthy
1218741|NCT01947920|Pain|pain
1218742|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
1218743|NCT01947920|Tramadol HCl|tramadol hcl
1218744|NCT01947920|Analgesic|analgesic
1218745|NCT01947920|QT prolongation|qt prolongation
1218746|NCT01947920|RWJ-26898-002|rwj-26898-002
1218747|NCT01947907|Human Growth Hormone|human growth hormone
1218748|NCT01947907|rhGH|rhgh
1218749|NCT01947907|hGH|hgh
1218750|NCT01947907|GHD|ghd
1218751|NCT01947881|Diabetic Macular Edema|diabetic macular edema
1218752|NCT01947881|anti-VEGF|anti-vegf
1218753|NCT01947881|Treatment Response|treatment response
1218754|NCT01947842|Smartphone|smartphone
1218755|NCT01947842|adherence|adherence
1218756|NCT01947842|contraceptives|contraceptives
1218757|NCT01947842|college|college
1218758|NCT01947842|females|females
1218759|NCT01947829|hemodialysis|hemodialysis
1218760|NCT01947829|dialysis dose|dialysis dose
1218761|NCT01947816|Ulcerative Colitis|ulcerative colitis
1218762|NCT01947803|Schizophrenia|schizophrenia
1218763|NCT01947803|Paliperidone|paliperidone
1218764|NCT01947803|Safety|safety
1218765|NCT01947803|Effectiveness|effectiveness
1218766|NCT01947803|Chinese|chinese
1218767|NCT01947790|Type 2 diabetes|type 2 diabetes
1218768|NCT01947790|left ventricular mass|left ventricular mass
1218769|NCT01947790|pioglitazone|pioglitazone
1218770|NCT01947777|Phase 1|phase 1
1218771|NCT01947777|Healthy subjects|healthy subjects
1218772|NCT01947777|DDI|ddi
1218773|NCT01947777|CYP3A|cyp3a
1218774|NCT01947764|HIV|hiv
1218775|NCT01947764|Disclosure|disclosure
1218776|NCT01947764|Pediatrics|pediatrics
1218777|NCT01947751|Catheter related infection|catheter related infection
1218778|NCT01947751|Central venous catheter|central venous catheter
1218779|NCT01947751|CVC infection|cvc infection
1218780|NCT01947738|Healthy|healthy
1218781|NCT01947738|Subjects|subjects
1218782|NCT01947738|Safety|safety
1218783|NCT01947738|Tolerability|tolerability
1218784|NCT01947738|VBY891|vby891
1218785|NCT01947738|Maximum|maximum
1218786|NCT01947738|Pharmacodynamic|pharmacodynamic
1218787|NCT01947738|Pharmacokinetic|pharmacokinetic
1218788|NCT01947712|Peripheral arterial disease|peripheral arterial disease
1218789|NCT01947712|Oxidative stress|oxidative stress
1218790|NCT01947712|Cocoa|cocoa
1218792|NCT01947712|NADPH oxidase|nadph oxidase
1218793|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
1218794|NCT01947647|behavior therapy|behavior therapy
1218795|NCT01947647|Randomized Controlled Trials|randomized controlled trials
1218796|NCT01947647|Depressive Disorder|depressive disorder
1218797|NCT01947647|Anxiety Disorders|anxiety disorders
1218798|NCT01947647|comorbidity|comorbidity
1218799|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
1218800|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
1218801|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
1218802|NCT01947595|lifestyle intervention|lifestyle intervention
1218803|NCT01947595|body fat distribution|body fat distribution
1218804|NCT01947595|prevention|prevention
1218805|NCT01947582|multiple sclerosis|multiple sclerosis
1218806|NCT01947582|gait|gait
1218807|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
1218808|NCT01947556|diabetes|diabetes
1218809|NCT01947556|insulin administration|insulin administration
1218810|NCT01947556|hyperglycaemia|hyperglycaemia
1218811|NCT01947556|insulin aspart|insulin aspart
1218812|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
1218813|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
1218814|NCT01947478|Peripheral Artery Disease|peripheral artery disease
1218815|NCT01947478|Experimental|experimental
1218816|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
1218817|NCT01947452|Youth violence reduction|youth violence reduction
1218818|NCT01947452|Youth crime reduction|youth crime reduction
1218819|NCT01947452|School engagement|school engagement
1218820|NCT01947452|Employment|employment
1218821|NCT01947452|Social-emotional learning|social-emotional learning
1218822|NCT01947439|multivessel stenting|multivessel stenting
1218823|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
1218824|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1218825|NCT01947413|BoNTA|bonta
1218826|NCT01947413|stroke|stroke
1218827|NCT01947413|optimal treatment protocol|optimal treatment protocol
1218828|NCT01947413|randomized controlled trial|randomized controlled trial
1218829|NCT01947413|motor control|motor control
1218830|NCT01947413|clinical predictors|clinical predictors
1218952|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
1218831|NCT01947400|Physician and Patient Communication|physician and patient communication
1218832|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
1218833|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
1218834|NCT01947374|Cartilage|cartilage
1218835|NCT01947374|Articular|articular
1218836|NCT01947335|Coronary|coronary
1218837|NCT01947335|Angioplasty|angioplasty
1218838|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
1218839|NCT01947335|Stent|stent
1218840|NCT01947335|Contrast|contrast
1218841|NCT01947335|Acute Renal failure|acute renal failure
1218842|NCT01947335|Intravascular ultrasound|intravascular ultrasound
1218843|NCT01947335|Prevention|prevention
1218844|NCT01947322|Natural killer cell|natural killer cell
1218845|NCT01947322|Haploidentical|haploidentical
1218846|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
1218847|NCT01947322|Chemotherapy|chemotherapy
1218848|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
1218849|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
1218850|NCT01947296|Adverse Effects|adverse effects
1218851|NCT01947296|Cancer Networks|cancer networks
1218852|NCT01947296|Continuity of care|continuity of care
1218853|NCT01947296|Coordination of patient's care|coordination of patient's care
1218854|NCT01947283|Patient-Provider Relationship|patient-provider relationship
1218855|NCT01947283|Shared Decision Making|shared decision making
1218856|NCT01947283|Therapeutic Alliance|therapeutic alliance
1218857|NCT01947283|Mental Health|mental health
1218858|NCT01947283|Minority Health|minority health
1218859|NCT01947283|Patient Activation|patient activation
1218860|NCT01947283|Communication|communication
1218861|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
1218863|NCT01947270|Prevention|prevention
1218864|NCT01947270|Multidisciplinary program|multidisciplinary program
1218865|NCT01947270|Checklist|checklist
1218866|NCT01947270|Stepped wedge design|stepped wedge design
1218867|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
1218868|NCT01947244|Doulas|doulas
1218869|NCT01947244|Parenting|parenting
1218870|NCT01947244|Breast Feeding|breast feeding
1218871|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
1218872|NCT01947244|Child Development|child development
1218873|NCT01947231|neck pain|neck pain
1218874|NCT01947231|chronic|chronic
1218875|NCT01947231|Global Postural Re-education|global postural re-education
1218876|NCT01947231|manual therapy|manual therapy
1218877|NCT01947231|physical therapy|physical therapy
1218878|NCT01947205|Curettage|curettage
1218879|NCT01947205|analgesia|analgesia
1218880|NCT01947205|paracervical block|paracervical block
1218881|NCT01947205|paracetamol|paracetamol
1218882|NCT01947205|lidocaine|lidocaine
1218883|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
1218884|NCT01947192|Chlorhexidine|chlorhexidine
1218885|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
1218886|NCT01947192|Adhesive system|adhesive system
1218887|NCT01947192|Controlled clinical trial|controlled clinical trial
1218888|NCT01947192|Dental restoration|dental restoration
1218889|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
1218890|NCT01947192|Dental restoration failure|dental restoration failure
1218891|NCT01947166|Whipple|whipple
1218892|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
1218893|NCT01947140|Multiple Myeloma|multiple myeloma
1218894|NCT01947140|Lymphoma|lymphoma
1218895|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
1218896|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
1218897|NCT01947140|Follicular Lymphoma|follicular lymphoma
1218898|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1218899|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1218900|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1218901|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1218902|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
1218903|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
1218904|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
1218905|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1218906|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1218907|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1218908|NCT01947127|Lactate|lactate
1218909|NCT01947127|Sepsis|sepsis
1218910|NCT01947127|Septic shock|septic shock
1218911|NCT01947127|Disease progression|disease progression
1218912|NCT01947127|Prognosis|prognosis
1218913|NCT01947114|General anesthesia,|general anesthesia,
1218914|NCT01947114|Children,|children,
1218915|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
1218916|NCT01947114|Remifentanil,|remifentanil,
1218917|NCT01947114|Propofol,|propofol,
1218918|NCT01947114|Ketamine.|ketamine.
1218919|NCT01947101|Stool transplant|stool transplant
1218920|NCT01947101|Ulcerative Colitis|ulcerative colitis
1218921|NCT01947101|Fecal transplant|fecal transplant
1218922|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
1218923|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
1218924|NCT01947075|Fever|fever
1218925|NCT01947075|Tanzania|tanzania
1218926|NCT01947075|Pneumonia|pneumonia
1218927|NCT01947075|HIV|hiv
1218928|NCT01947075|Diabetes|diabetes
1218929|NCT01947075|Indoor Air Pollution|indoor air pollution
1218930|NCT01947062|NSCLC|nsclc
1218931|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
1218932|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
1218933|NCT01947049|Influenza|influenza
1218934|NCT01947049|diagnostic testing|diagnostic testing
1218935|NCT01947049|antiviral treatment|antiviral treatment
1218936|NCT01947049|rapid influenza testing|rapid influenza testing
1218937|NCT01947036|autoimmune disease|autoimmune disease
1218938|NCT01947036|immune-mediated disease|immune-mediated disease
1218939|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
1218940|NCT01947036|IL23 signaling|il23 signaling
1218941|NCT01947036|genetic risk variants|genetic risk variants
1218942|NCT01947010|antibodies|antibodies
1218943|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
1218944|NCT01946958|Triple P|triple p
1218945|NCT01946945|infertility|infertility
1218946|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
1218947|NCT01946945|miscarriage|miscarriage
1218948|NCT01946945|Next Generation Sequencing|next generation sequencing
1218949|NCT01946932|Induced hypothermia|induced hypothermia
1218950|NCT01946932|Mild induced hypothermia|mild induced hypothermia
1218951|NCT01946932|Resuscitation|resuscitation
1218953|NCT01946932|Neurological function|neurological function
1218954|NCT01946932|Cardiovascular diseases|cardiovascular diseases
1218955|NCT01946932|Rehabilitation|rehabilitation
1218956|NCT01946932|Quality of life|quality of life
1218957|NCT01946932|Cognition|cognition
1218958|NCT01946919|Cinepazide|cinepazide
1218959|NCT01946919|Adverse Drug Reaction|adverse drug reaction
1218960|NCT01946919|Safety|safety
1218961|NCT01946919|Real World Study|real world study
1218962|NCT01946893|meditation|meditation
1218963|NCT01946893|education|education
1218964|NCT01946893|stress, psychological|stress, psychological
1218965|NCT01946893|aged|aged
1218966|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
1218967|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
1218968|NCT01946867|Oral cavity Cancer|oral cavity cancer
1218969|NCT01946867|Oropharynx Cancer|oropharynx cancer
1218970|NCT01946854|Gastrointestinal|gastrointestinal
1220148|NCT01941394|GVHD|gvhd
1218971|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
1218972|NCT01946854|Appendiceal cancer|appendiceal cancer
1218973|NCT01946854|Surgically unresectable|surgically unresectable
1218974|NCT01946854|Chemotherapy|chemotherapy
1218975|NCT01946854|Observation|observation
1218976|NCT01946854|Questionnaires|questionnaires
1218977|NCT01946841|Chronic kidney disease|chronic kidney disease
1218978|NCT01946841|Hemodialysis|hemodialysis
1218979|NCT01946841|Severe malnutrition|severe malnutrition
1218980|NCT01946841|Enteral nutrition|enteral nutrition
1218981|NCT01946828|Field Induced Mydriasis|field induced mydriasis
1218984|NCT01946802|Heart arrest|heart arrest
1218985|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1218986|NCT01946802|Hypothermia induced|hypothermia induced
1218987|NCT01946802|Seizures|seizures
1218988|NCT01946802|Electroencephalography|electroencephalography
1218989|NCT01946789|cancer|cancer
1218990|NCT01946789|IL-15|il-15
1218991|NCT01946789|melanoma|melanoma
1218992|NCT01946789|metastatic|metastatic
1218993|NCT01946789|unresectable|unresectable
1218994|NCT01946789|solid tumors|solid tumors
1218995|NCT01946789|renal cell|renal cell
1218996|NCT01946789|non-small cell lung|non-small cell lung
1218997|NCT01946789|squamous cell head and neck|squamous cell head and neck
1218998|NCT01946737|Coronary|coronary
1218999|NCT01946737|Artery|artery
1219000|NCT01946737|Disease|disease
1219001|NCT01946737|Diagnostic|diagnostic
1219002|NCT01946737|Performance|performance
1219003|NCT01946737|Angiography|angiography
1219004|NCT01946711|CRS|crs
1219005|NCT01946711|polyposis|polyposis
1219006|NCT01946672|gynaecological malignancy|gynaecological malignancy
1219007|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
1219008|NCT01946672|lymphedema|lymphedema
1219009|NCT01946672|sentinel node|sentinel node
1219010|NCT01946672|reverse mapping|reverse mapping
1219011|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
1219012|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1219013|NCT01946620|Exacerbations|exacerbations
1219014|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
1219015|NCT01946607|Neuroticism|neuroticism
1219016|NCT01946607|Emotion processing|emotion processing
1219017|NCT01946607|Eye gaze movements|eye gaze movements
1219018|NCT01946607|Heart Rate Variability|heart rate variability
1219019|NCT01946594|fever|fever
1219020|NCT01946594|antipyretics|antipyretics
1219021|NCT01946594|acetaminophen|acetaminophen
1219022|NCT01946594|influenza vaccine|influenza vaccine
1219023|NCT01946594|influenza, human|influenza, human
1219024|NCT01946594|body temperature changes|body temperature changes
1219025|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
1219026|NCT01946594|RNA virus infections|rna virus infections
1219027|NCT01946594|Virus Diseases|virus diseases
1219028|NCT01946594|Respiratory Tract Infections|respiratory tract infections
1219029|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
1219030|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
1219031|NCT01946555|Neuropathic pain|neuropathic pain
1219032|NCT01946555|Major opioid|major opioid
1219033|NCT01946555|Analgesics|analgesics
1219034|NCT01946542|exercise|exercise
1219035|NCT01946542|heart failure|heart failure
1219036|NCT01946542|fatigue|fatigue
1219037|NCT01946542|physical endurance|physical endurance
1219038|NCT01946542|functional food|functional food
1219039|NCT01946516|viral screening|viral screening
1219040|NCT01946503|Short Gut|short gut
1219041|NCT01946503|Short Bowel Syndrome|short bowel syndrome
1219042|NCT01946503|Intestinal Failure|intestinal failure
1219043|NCT01946503|Home parenteral nutrition|home parenteral nutrition
1219044|NCT01946503|Feeding Behavior|feeding behavior
1219045|NCT01946503|Enteral Nutrition|enteral nutrition
1219046|NCT01946503|Parent-Child Relations|parent-child relations
1219047|NCT01946503|Parenteral Nutrition|parenteral nutrition
1219048|NCT01946503|Digestive System Diseases|digestive system diseases
1219049|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
1219050|NCT01946464|edentulous|edentulous
1219051|NCT01946464|bearded|bearded
1219052|NCT01946464|patients|patients
1219053|NCT01946464|requiring|requiring
1219054|NCT01946464|general anesthesia|general anesthesia
1219055|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
1219056|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
1219057|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
1219058|NCT01946438|Influenza|influenza
1219059|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
1219060|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
1219061|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
1219062|NCT01946425|Influenza|influenza
1219063|NCT01946425|Influenza virus vaccine|influenza virus vaccine
1219163|NCT01945996|Hispanic Americans|hispanic americans
1219064|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
1219065|NCT01946412|Cystic Fibrosis|cystic fibrosis
1219066|NCT01946373|Melanoma|melanoma
1219067|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
1219068|NCT01946373|Lymphodepletion|lymphodepletion
1219069|NCT01946373|Adoptive cell transfer|adoptive cell transfer
1219070|NCT01946373|T cells|t cells
1219071|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
1219072|NCT01946373|Fludarabine|fludarabine
1219073|NCT01946373|IL-2|il-2
1219074|NCT01946373|Interleukin-2|interleukin-2
1219075|NCT01946373|Cyclophosphamide|cyclophosphamide
1219076|NCT01946373|Phase I study|phase i study
1219077|NCT01946373|Monocytes|monocytes
1219078|NCT01946373|Autologous|autologous
1219079|NCT01946373|NY-ESO-1|ny-eso-1
1219080|NCT01946347|Insulin Resistance|insulin resistance
1219081|NCT01946347|Hyperglycemia|hyperglycemia
1219082|NCT01946347|Endothelial function|endothelial function
1219083|NCT01946347|Oxidative stress|oxidative stress
1219084|NCT01946308|sleep|sleep
1219085|NCT01946308|sleep efficiency|sleep efficiency
1219086|NCT01946308|active sleep|active sleep
1219087|NCT01946308|quiet sleep|quiet sleep
1219088|NCT01946308|arousals|arousals
1219089|NCT01946308|premature infant|premature infant
1219090|NCT01946308|conformational positioning|conformational positioning
1219091|NCT01946308|mattress|mattress
1219092|NCT01946308|feeding difficulty|feeding difficulty
1219093|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
1219094|NCT01946308|sleep state|sleep state
1219095|NCT01946308|behavioral observation|behavioral observation
1219096|NCT01946308|stress behavior|stress behavior
1219097|NCT01946308|self-regulatory behavior|self-regulatory behavior
1219098|NCT01946308|surgery|surgery
1219099|NCT01946308|gastrointestinal|gastrointestinal
1219100|NCT01946282|neoplasm|neoplasm
1219101|NCT01946282|colorectal|colorectal
1219102|NCT01946282|cancer|cancer
1219103|NCT01946282|uninsured|uninsured
1219104|NCT01946282|FIT|fit
1219105|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
1219106|NCT01946204|Prostate neoplasms|prostate neoplasms
1219107|NCT01946204|Prostate cancer|prostate cancer
1219108|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
1219109|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
1219110|NCT01946204|ARN-509|arn-509
1219111|NCT01946204|Apalutamide|apalutamide
1219112|NCT01946191|Weight maintenance|weight maintenance
1219113|NCT01946191|Electronic health record|electronic health record
1219114|NCT01946191|Primary care|primary care
1219115|NCT01946178|Uterine Fibroids|uterine fibroids
1219116|NCT01946178|Leiomyomas|leiomyomas
1219117|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
1219118|NCT01946178|Ultrasonography|ultrasonography
1219119|NCT01946165|Prostate Cancer|prostate cancer
1219120|NCT01946165|High risk prostate cancer|high risk prostate cancer
1219121|NCT01946165|Abiraterone acetate|abiraterone acetate
1219122|NCT01946165|Zytiga|zytiga
1219123|NCT01946165|Prednisone|prednisone
1219124|NCT01946165|Enzalutamide|enzalutamide
1219125|NCT01946165|MDV3100|mdv3100
1219126|NCT01946165|XTANDI|xtandi
1219127|NCT01946165|Androgen ablation|androgen ablation
1219128|NCT01946165|LHRHa|lhrha
1219129|NCT01946165|Hormonal therapy|hormonal therapy
1219130|NCT01946152|Myeloma|myeloma
1589653|NCT00432822|children|children
1219131|NCT01946152|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1219132|NCT01946152|MM|mm
1219133|NCT01946152|Pomalidomide|pomalidomide
1219134|NCT01946152|CC-4047|cc-4047
1219135|NCT01946152|Dexamethasone|dexamethasone
1219136|NCT01946152|Decadron|decadron
1219137|NCT01946152|C-CSF|c-csf
1219138|NCT01946152|Filgrastim|filgrastim
1219139|NCT01946152|Neupogen|neupogen
1219140|NCT01946152|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
1219141|NCT01946100|multifocal|multifocal
1219142|NCT01946100|genetic|genetic
1219143|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
1219144|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
1219145|NCT01946100|ground glass opacity|ground glass opacity
1219146|NCT01946100|next generation sequencing|next generation sequencing
1219147|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
1219148|NCT01946087|cardiac surgery|cardiac surgery
1219149|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
1219150|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
1219151|NCT01946074|cancer|cancer
1219152|NCT01946074|neoplasm|neoplasm
1219153|NCT01946074|advanced solid tumor|advanced solid tumor
1219154|NCT01946074|colorectal cancer|colorectal cancer
1219155|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
1219156|NCT01946022|infertility|infertility
1219157|NCT01946022|ovulation induction|ovulation induction
1219158|NCT01946022|luteal phase|luteal phase
1219159|NCT01946022|granulosa cells function|granulosa cells function
1219160|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
1219161|NCT01946022|HMG|hmg
1219162|NCT01946022|FSHr|fshr
1219754|NCT01943357|diabetes|diabetes
1219164|NCT01945996|Cellular Phone|cellular phone
1219165|NCT01945996|Behavior|behavior
1219166|NCT01945983|Septic shock|septic shock
1219167|NCT01945983|Severe sepsis|severe sepsis
1219168|NCT01945983|Norepinephrine|norepinephrine
1219169|NCT01945970|Vascular function|vascular function
1219170|NCT01945970|Flow mediated dilation|flow mediated dilation
1219171|NCT01945970|Tea|tea
1219172|NCT01945957|autism|autism
1219173|NCT01945957|brain|brain
1219174|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
1219175|NCT01945957|oxytocin|oxytocin
1219176|NCT01945944|pediatric|pediatric
1219177|NCT01945944|mucolytic|mucolytic
1219178|NCT01945944|respiratory failure|respiratory failure
1219179|NCT01945944|atelectasis|atelectasis
1219180|NCT01945944|hypertonic saline|hypertonic saline
1219181|NCT01945931|Maternal health|maternal health
1219182|NCT01945931|perinatal health|perinatal health
1219183|NCT01945931|mHealth|mhealth
1219184|NCT01945931|smartphone|smartphone
1219185|NCT01945931|mobile phone|mobile phone
1219186|NCT01945931|Ethiopia|ethiopia
1219187|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1219188|NCT01945918|Diabetes Mellitus|diabetes mellitus
1219189|NCT01945918|Primary Health Care|primary health care
1219190|NCT01945918|Self care|self care
1219191|NCT01945905|Tuberculosis|tuberculosis
1219192|NCT01945905|Adherence, medication|adherence, medication
1219193|NCT01945905|Patient compliance|patient compliance
1219194|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
1219195|NCT01945879|pancreatic cancer|pancreatic cancer
1219196|NCT01945879|heparin|heparin
1219197|NCT01945879|thromboembolic events|thromboembolic events
1219198|NCT01945879|bleedings|bleedings
1219199|NCT01945866|Diabetic Macular Edema|diabetic macular edema
1219200|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1219201|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
1219202|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
1219203|NCT01945801|Sleep apnea|sleep apnea
1219204|NCT01945801|Treatment|treatment
1219205|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
1219206|NCT01945801|Diuretic|diuretic
1219207|NCT01945801|Lasilactone|lasilactone
1219208|NCT01945775|Breast cancer|breast cancer
1219209|NCT01945775|BRCA mutation|brca mutation
1219210|NCT01945775|PARP inhibitor|parp inhibitor
1219211|NCT01945775|BRCA 1|brca 1
1219212|NCT01945775|BRCA 2|brca 2
1219213|NCT01945762|RET Mutation|ret mutation
1219214|NCT01945762|DIagnostics|diagnostics
1219215|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
1219216|NCT01945762|MTC|mtc
1219217|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
1219218|NCT01945723|Endoscopy|endoscopy
1219219|NCT01945723|Gastrointestinal tract|gastrointestinal tract
1219220|NCT01945723|Bacterial markers|bacterial markers
1219221|NCT01945723|volunteers|volunteers
1219222|NCT01945710|Tumors|tumors
1219223|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
1219224|NCT01945645|Prevention|prevention
1219225|NCT01945645|Screening|screening
1219226|NCT01945645|Type 2 diabetes|type 2 diabetes
1219227|NCT01945645|Action Competence|action competence
1219228|NCT01945645|Family practice|family practice
1219229|NCT01945645|Health Services Research|health services research
1219230|NCT01945619|CMV|cmv
1219231|NCT01945619|Adenovirus|adenovirus
1219232|NCT01945619|EBV|ebv
1219233|NCT01945619|Stem cell transplant|stem cell transplant
1219234|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
1219235|NCT01945580|POP|pop
1219236|NCT01945580|Transvaginal|transvaginal
1219237|NCT01945580|Native Tissue Repair|native tissue repair
1219238|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
1219239|NCT01945580|Biologic Graft|biologic graft
1219240|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
1219241|NCT01945567|Parkinson's disease|parkinson's disease
1219242|NCT01945567|Essential tremor|essential tremor
1219243|NCT01945567|Tremor|tremor
1219244|NCT01945567|Deep brain stimulation|deep brain stimulation
1219245|NCT01945567|Posterior subthalamic area|posterior subthalamic area
1219246|NCT01945567|Zona incerta|zona incerta
1219247|NCT01945554|infiltrative therapy|infiltrative therapy
1219248|NCT01945554|cervical disc herniation|cervical disc herniation
1219249|NCT01945554|lumbar disc herniation|lumbar disc herniation
1219250|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
1219251|NCT01945541|Body Composition Measurement|body composition measurement
1219252|NCT01945528|Platelet Rich Plasma|platelet rich plasma
1219253|NCT01945528|tendinopathy|tendinopathy
1219254|NCT01945528|epicondylitis|epicondylitis
1219255|NCT01945528|ultrasound|ultrasound
1219256|NCT01945528|injection therapy|injection therapy
1219257|NCT01945528|needle tenotomy|needle tenotomy
1219258|NCT01945515|Stroke|stroke
1219259|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
1219260|NCT01945515|robotic rehabilitation|robotic rehabilitation
1219261|NCT01945515|gait|gait
1219262|NCT01945476|midazolam|midazolam
1219263|NCT01945476|premedication|premedication
1220149|NCT01941394|Relapse|relapse
1219264|NCT01945476|functional recovery|functional recovery
1219265|NCT01945476|breast cancer|breast cancer
1219266|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
1219267|NCT01945424|Pregnancy Registry|pregnancy registry
1219268|NCT01945424|Influenza|influenza
1219269|NCT01945411|Airway Management|airway management
1219270|NCT01945411|Ventilation|ventilation
1219271|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
1219272|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
1219561|NCT01944085|pain score|pain score
1219273|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
1219274|NCT01945398|Vascular Resistance|vascular resistance
1219275|NCT01945398|Exercise|exercise
1219276|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1219277|NCT01945385|Abortion|abortion
1219278|NCT01945385|LARC|larc
1219279|NCT01945385|Contraception|contraception
1219280|NCT01945385|IUD|iud
1219281|NCT01945385|Contraceptive implant|contraceptive implant
1219282|NCT01945385|behavioral change|behavioral change
1219283|NCT01945385|video intervention|video intervention
1219284|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1219285|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
1219286|NCT01945359|Natalizumab|natalizumab
1219287|NCT01945346|PRX167700|prx167700
1219288|NCT01945346|Osteoarthritis|osteoarthritis
1219289|NCT01945333|Cognitive remediation|cognitive remediation
1219290|NCT01945333|Schizophrenia|schizophrenia
1219291|NCT01945333|Schizoaffective disorder|schizoaffective disorder
1219292|NCT01945320|hemodialysis|hemodialysis
1219293|NCT01945320|wasting and malnutrition|wasting and malnutrition
1219294|NCT01945320|nutrition status|nutrition status
1219295|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
1219296|NCT01945320|body composition|body composition
1219297|NCT01945307|Complement|complement
1219298|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
1219299|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
1219300|NCT01945255|Calcification|calcification
1219301|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
1219302|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
1219303|NCT01945255|hemodialysis|hemodialysis
1219304|NCT01945255|metabolic syndrome|metabolic syndrome
1219305|NCT01945242|Drug Therapy|drug therapy
1219306|NCT01945216|Drug therapy|drug therapy
1219307|NCT01945203|Calcification|calcification
1219308|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
1219309|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
1219310|NCT01945203|peritoneal dialysis|peritoneal dialysis
1219311|NCT01945203|metabolic syndrome|metabolic syndrome
1219312|NCT01945177|endoscopy|endoscopy
1219313|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
1219314|NCT01945177|gastric cancer|gastric cancer
1219315|NCT01945164|XL999|xl999
1219316|NCT01945164|Advanced Malignancy|advanced malignancy
1219317|NCT01945151|spastic hemiparesis|spastic hemiparesis
1219318|NCT01945138|Total Pancreatectomy|total pancreatectomy
1219319|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
1219320|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
1219321|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
1219322|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
1219323|NCT01945086|Eczema|eczema
1219324|NCT01945086|Ustekinumab|ustekinumab
1219325|NCT01945086|CNTO1275|cnto1275
1219326|NCT01945086|STELARA|stelara
1219327|NCT01945073|Educational intervention|educational intervention
1219328|NCT01945073|Formal Counselling|formal counselling
1219329|NCT01945073|Knowledge|knowledge
1219330|NCT01945073|Illness Perception|illness perception
1219331|NCT01945060|Artificial Pancreas Project|artificial pancreas project
1219332|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
1219333|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
1219334|NCT01945060|Insulin Pump|insulin pump
1219335|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
1219336|NCT01945060|Closed-Loop Control|closed-loop control
1219337|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
1219338|NCT01945047|depression|depression
1219339|NCT01945047|treatment|treatment
1219340|NCT01945047|ketamine|ketamine
1219341|NCT01945047|ottawa|ottawa
1219342|NCT01945047|treatment-resistant|treatment-resistant
1219343|NCT01945047|infusion|infusion
1219344|NCT01945034|topical ibuprofen|topical ibuprofen
1219345|NCT01945034|ankle sprain|ankle sprain
1219346|NCT01945021|Non small cell lung cancer|non small cell lung cancer
1219347|NCT01945021|NSCLC|nsclc
1219348|NCT01945021|ROS1|ros1
1219349|NCT01945021|ROS1 positive|ros1 positive
1219350|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
1219351|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
1219352|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
1219353|NCT01945021|ROS1 lung cancer|ros1 lung cancer
1219354|NCT01945021|ALK negative|alk negative
1219355|NCT01945021|Lung Carcinoma|lung carcinoma
1219356|NCT01945021|Neoplasm|neoplasm
1219357|NCT01945021|Crizotinib|crizotinib
1219358|NCT01945021|Xalkori|xalkori
1219359|NCT01945021|Previously treated or untreated|previously treated or untreated
1219360|NCT01945021|North East Asian|north east asian
1219361|NCT01945008|HCV|hcv
1219362|NCT01945008|observational study|observational study
1219363|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
1219364|NCT01944982|Immunotherapy|immunotherapy
1219365|NCT01944982|NKAEs|nkaes
1219366|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
1219662|NCT01943617|Hepatitis B|hepatitis b
1219367|NCT01944982|Activated natural killer cells|activated natural killer cells
1219368|NCT01944956|Maturation|maturation
1219369|NCT01944956|preterm infants|preterm infants
1219370|NCT01944956|sucking and swallowing|sucking and swallowing
1219371|NCT01944943|refractory/relapsed|refractory/relapsed
1219372|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1219373|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
1219374|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
1219375|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1219376|NCT01944917|Electromagnetic field|electromagnetic field
1219377|NCT01944917|VAS score|vas score
1219378|NCT01944917|Heart Rate Variability|heart rate variability
1219379|NCT01944904|XOS|xos
1219380|NCT01944904|pre-diabetic|pre-diabetic
1219381|NCT01944904|abnormal glucose levels|abnormal glucose levels
1219382|NCT01944891|Adolescent girls|adolescent girls
1219383|NCT01944891|Mozambique|mozambique
1219384|NCT01944891|Diet|diet
1219385|NCT01944891|Anthropometrics|anthropometrics
1219386|NCT01944891|Serum biomarkers|serum biomarkers
1219387|NCT01944878|Peptic ulcer|peptic ulcer
1219388|NCT01944878|Liver cirrhosis|liver cirrhosis
1219389|NCT01944878|Portal hypertension|portal hypertension
1219390|NCT01944865|Aerobic Interval Training|aerobic interval training
1219391|NCT01944865|Supramaximal Training|supramaximal training
1219392|NCT01944852|icodextrin|icodextrin
1219393|NCT01944852|double dose|double dose
1219394|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
1219395|NCT01944852|DIDo study|dido study
1219396|NCT01944839|Wet AMD|wet amd
1219397|NCT01944839|choroidal neovascularization|choroidal neovascularization
1219398|NCT01944839|Fovista®|fovista®
1219399|NCT01944839|E10030|e10030
1219400|NCT01944839|Lucentis®|lucentis®
1219401|NCT01944826|Dyspnea|dyspnea
1219402|NCT01944826|Angina pectoris|angina pectoris
1219403|NCT01944813|Advance Care planning|advance care planning
1219404|NCT01944813|End-of-life Discussions|end-of-life discussions
1219405|NCT01944813|Questionaires|questionaires
1219406|NCT01944813|Palliative Care|palliative care
1219407|NCT01944800|Ticagrelor|ticagrelor
1219408|NCT01944800|Prasugrel|prasugrel
1219409|NCT01944800|Acute coronary syndrome|acute coronary syndrome
1219410|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
1219411|NCT01944774|Moxifloxacin|moxifloxacin
1219412|NCT01944761|pediatrics|pediatrics
1219413|NCT01944761|Brain Tumor|brain tumor
1219414|NCT01944761|Neuro-radiation|neuro-radiation
1219415|NCT01944761|Exercise|exercise
1219416|NCT01944709|melanoma|melanoma
1219417|NCT01944709|dendritic cells|dendritic cells
1219418|NCT01944709|peptide|peptide
1219419|NCT01944709|Melan-A|melan-a
1589654|NCT00432822|adolescents|adolescents
1219420|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
1219421|NCT01944696|prematurity|prematurity
1219422|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
1219423|NCT01944696|phototherapy|phototherapy
1219424|NCT01944696|cycled phototherapy|cycled phototherapy
1219425|NCT01944696|intermittent phototherapy|intermittent phototherapy
1219426|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
1219427|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1219428|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
1219429|NCT01944657|Exploratory Field Study|exploratory field study
1219430|NCT01944605|Endotoxin|endotoxin
1219431|NCT01944605|Cytokine|cytokine
1219432|NCT01944605|Metabolism|metabolism
1219433|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
1219434|NCT01944592|Pelvic examination|pelvic examination
1219435|NCT01944592|Students|students
1219436|NCT01944553|Spine|spine
1219437|NCT01944553|Accurancy|accurancy
1219438|NCT01944553|Robotic|robotic
1219439|NCT01944553|Screw placement|screw placement
1219440|NCT01944553|Degenerative|degenerative
1219441|NCT01944514|Action potential duration restitution|action potential duration restitution
1219442|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
1219443|NCT01944514|Sudden cardiac death|sudden cardiac death
1219444|NCT01944514|Peri-infarct zone|peri-infarct zone
1219445|NCT01944514|Electrocardiogram|electrocardiogram
1219446|NCT01944501|tinnitus|tinnitus
1219447|NCT01944501|hearing loss|hearing loss
1219448|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
1219449|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
1219450|NCT01944488|Precocious puberty|precocious puberty
1219451|NCT01944488|GnRH-test|gnrh-test
1219452|NCT01944475|Precocious puberty|precocious puberty
1219453|NCT01944475|Premature thelarche|premature thelarche
1219454|NCT01944475|Tanner-stage|tanner-stage
1219455|NCT01944475|GnRH-test|gnrh-test
1220345|NCT01940406|Tremor|tremor
1219456|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
1219457|NCT01944462|pharmacist vaccination|pharmacist vaccination
1219458|NCT01944462|Pneumovax 23|pneumovax 23
1219459|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
1219460|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
1219461|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
1219462|NCT01944436|Pharmacogenomics|pharmacogenomics
1219463|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
1219464|NCT01944436|Adverse events|adverse events
1219465|NCT01944436|Polymorphisms|polymorphisms
1219466|NCT01944436|Acetylcholinesterase|acetylcholinesterase
1219467|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
1219468|NCT01944436|Cognitive enhancers|cognitive enhancers
1219469|NCT01944436|Clinical efficacy|clinical efficacy
1219470|NCT01944436|Cytochrome P450|cytochrome p450
1219471|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
1219472|NCT01944410|PRP|prp
1219473|NCT01944410|TBC|tbc
1219474|NCT01944410|Treatment|treatment
1219475|NCT01944397|Atrial fibrillation|atrial fibrillation
1219476|NCT01944397|Heart failure|heart failure
1219477|NCT01944397|Stroke|stroke
1219478|NCT01944397|Myocardial infarction|myocardial infarction
1219479|NCT01944371|Latent reservoir|latent reservoir
1219480|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
1219481|NCT01944332|gamete treatment|gamete treatment
1219482|NCT01944332|ICSI|icsi
1219483|NCT01944332|IVF|ivf
1219484|NCT01944332|infertility|infertility
1219485|NCT01944332|oocyte activation|oocyte activation
1219486|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
1219487|NCT01944306|Pharmacokinetics|pharmacokinetics
1219488|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
1219489|NCT01944306|Drug Efficacy|drug efficacy
1219490|NCT01944306|Drug Failure|drug failure
1219491|NCT01944306|Contraceptive Agents|contraceptive agents
1219492|NCT01944293|Ketamine|ketamine
1219493|NCT01944293|Midazolam|midazolam
1219494|NCT01944293|Bipolar Disorder|bipolar disorder
1219495|NCT01944293|Major Depressive Episode|major depressive episode
1219496|NCT01944293|Suicidal Ideation|suicidal ideation
1219497|NCT01944293|Suicide|suicide
1219498|NCT01944293|Depression|depression
1219499|NCT01944293|Treatment|treatment
1219500|NCT01944293|Ketamine Treatment|ketamine treatment
1219501|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
1219502|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
1219503|NCT01944254|Cardiac output|cardiac output
1219504|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
1219505|NCT01944241|cervical surgery|cervical surgery
1219506|NCT01944241|LLETZ|lletz
1219507|NCT01944241|LEEP|leep
1219508|NCT01944241|Cone biopsy|cone biopsy
1219509|NCT01944241|Fertility|fertility
1219510|NCT01944228|inflammation|inflammation
1219511|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
1219512|NCT01944228|chronic heart failure|chronic heart failure
1219513|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1219514|NCT01944228|sepsis|sepsis
1219515|NCT01944228|auto-immune diseases|auto-immune diseases
1219516|NCT01944215|Normal subjects|normal subjects
1219517|NCT01944215|Female|female
1219518|NCT01944215|Molecular Breast Imaging|molecular breast imaging
1219519|NCT01944215|Fasting|fasting
1219520|NCT01944215|Exercise|exercise
1219521|NCT01944215|Tracer Uptake|tracer uptake
1219522|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
1219523|NCT01944215|Prandial status|prandial status
1219524|NCT01944215|metabolic status|metabolic status
1219525|NCT01944215|negative mammogram|negative mammogram
1219526|NCT01944215|Caffeine|caffeine
1219527|NCT01944215|External Warming|external warming
1219528|NCT01944202|Echocardiography|echocardiography
1219529|NCT01944202|Appropriate Use Criteria|appropriate use criteria
1219530|NCT01944202|Educational Intervention|educational intervention
1219531|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
1219532|NCT01944176|COPD|copd
1219533|NCT01944176|Statins|statins
1219534|NCT01944176|Cytokines|cytokines
1219535|NCT01944163|Low back pain|low back pain
1219536|NCT01944163|Impact analysis|impact analysis
1219537|NCT01944163|Cluster randomized trial|cluster randomized trial
1219538|NCT01944163|Referral rule|referral rule
1219539|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
1219540|NCT01944150|Hypnosis|hypnosis
1219541|NCT01944150|chronic pain|chronic pain
1219542|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1219543|NCT01944150|nociceptive pain|nociceptive pain
1219544|NCT01944150|neuropathic pain|neuropathic pain
1219545|NCT01944150|complementary therapies|complementary therapies
1219546|NCT01944137|colonic neoplasms|colonic neoplasms
1219547|NCT01944137|Lung neoplasms|lung neoplasms
1219548|NCT01944137|patient-centered nursing|patient-centered nursing
1219549|NCT01944137|breast neoplasms|breast neoplasms
1219550|NCT01944124|Mobile health|mobile health
1219551|NCT01944124|Metabolic syndrome|metabolic syndrome
1219552|NCT01944124|Exercise prescription|exercise prescription
1219553|NCT01944124|Exercise intervention|exercise intervention
1219554|NCT01944124|Disease prevention|disease prevention
1219555|NCT01944124|Rural health|rural health
1219556|NCT01944111|Gastric plication|gastric plication
1219557|NCT01944085|children|children
1219558|NCT01944085|supracondylar fracture|supracondylar fracture
1219559|NCT01944085|pin removal|pin removal
1219560|NCT01944085|analgesia|analgesia
1219562|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1219563|NCT01944072|COPD|copd
1219564|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
1219565|NCT01944072|Aerobic exercise|aerobic exercise
1219566|NCT01944072|CEDOC|cedoc
1219567|NCT01944072|FCM|fcm
1219568|NCT01944072|UNL|unl
1219569|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
1219698|NCT01943500|Colorectal cancer|colorectal cancer
1219570|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
1219571|NCT01944033|β2-agonist|β2-agonist
1219572|NCT01944033|Ipratropium Bromide|ipratropium bromide
1219573|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
1219574|NCT01944033|Emergency departement|emergency departement
1219575|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
1219576|NCT01944020|Energy Balance|energy balance
1219577|NCT01944020|Food Intake|food intake
1219578|NCT01944020|Energy Expenditure|energy expenditure
1219579|NCT01944020|Sleep|sleep
1219580|NCT01944020|Obesity|obesity
1219581|NCT01944007|CLP|clp
1219582|NCT01943994|Psilocybin|psilocybin
1219583|NCT01943994|Smoking cessation|smoking cessation
1219584|NCT01943955|dizziness|dizziness
1219585|NCT01943955|vertigo|vertigo
1219586|NCT01943955|unsteadiness|unsteadiness
1219587|NCT01943955|unbalance|unbalance
1219588|NCT01943955|falls|falls
1219589|NCT01943942|Mexico|mexico
1219590|NCT01943942|Montelukast|montelukast
1219591|NCT01943942|Pharmacokinetics|pharmacokinetics
1219592|NCT01943942|Bioequivalence|bioequivalence
1219593|NCT01943929|Nasal septum|nasal septum
1219594|NCT01943929|Headache|headache
1219595|NCT01943929|Mucosa contact point headache|mucosa contact point headache
1219596|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
1219597|NCT01943916|breast ultrasound|breast ultrasound
1219598|NCT01943916|Imagio|imagio
1219599|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
1219600|NCT01943916|Seno|seno
1219601|NCT01943916|opto-acoustics|opto-acoustics
1219602|NCT01943916|OA|oa
1219603|NCT01943916|angiogenesis|angiogenesis
1219604|NCT01943916|blood map|blood map
1219605|NCT01943890|Hypertonic saline|hypertonic saline
1219606|NCT01943890|Lung physiotherapy|lung physiotherapy
1219607|NCT01943864|pharmacokinetics|pharmacokinetics
1219608|NCT01943864|second line monotherapy|second line monotherapy
1219609|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
1219610|NCT01943864|MEK inhibitor|mek inhibitor
1219611|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
1219612|NCT01943851|leukemia|leukemia
1219613|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
1219614|NCT01943851|BET inhibitor|bet inhibitor
1219615|NCT01943851|lymphoma|lymphoma
1219616|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
1219617|NCT01943851|Oncology|oncology
1219618|NCT01943851|multiple myeloma|multiple myeloma
1219619|NCT01943851|GSK525762|gsk525762
1219620|NCT01943825|Dengue|dengue
1219621|NCT01943825|Dengue fever|dengue fever
1219622|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
1219623|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
1219624|NCT01943825|Flavivirus|flavivirus
1219625|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
1219626|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
1219627|NCT01943799|GS-4774|gs-4774
1219628|NCT01943786|Wild type KRAS|wild type kras
1219629|NCT01943773|delirium|delirium
1219630|NCT01943773|surgery|surgery
1219631|NCT01943773|operation|operation
1219632|NCT01943773|geriatric|geriatric
1219633|NCT01943773|complication|complication
1219634|NCT01943760|Tramadol|tramadol
1219635|NCT01943760|Children|children
1219636|NCT01943760|Hernioplasty|hernioplasty
1219637|NCT01943760|Wound infiltration|wound infiltration
1219638|NCT01943747|sepsis|sepsis
1219639|NCT01943747|severe sepsis|severe sepsis
1219640|NCT01943747|septic shock|septic shock
1219641|NCT01943747|infection|infection
1219642|NCT01943747|organ dysfunction|organ dysfunction
1219643|NCT01943747|quality improvement|quality improvement
1219644|NCT01943734|Information|information
1219645|NCT01943734|Lifestyle|lifestyle
1219646|NCT01943734|Occupational Health|occupational health
1219647|NCT01943695|Breast Cancer|breast cancer
1219648|NCT01943695|Exercise|exercise
1219649|NCT01943695|Chemotherapy|chemotherapy
1219650|NCT01943695|15-178|15-178
1219651|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
1219652|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
1219653|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
1220346|NCT01940393|urticaria|urticaria
1219654|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
1219655|NCT01943682|Lymphoma|lymphoma
1219656|NCT01943682|Leukemia|leukemia
1219657|NCT01943669|Spinal Cord Injury|spinal cord injury
1219658|NCT01943656|Spinal Cord Injury|spinal cord injury
1219659|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
1219660|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
1219661|NCT01943617|Liver Cirrhosis|liver cirrhosis
1219663|NCT01943617|Compensation|compensation
1219664|NCT01943617|Efficacy|efficacy
1219665|NCT01943604|Neuropsychology|neuropsychology
1219666|NCT01943604|Breakfast eating patters|breakfast eating patters
1219668|NCT01943604|Child Psychology|child psychology
1219669|NCT01943591|treatment trial|treatment trial
1219670|NCT01943591|cerebral aneurysm|cerebral aneurysm
1219671|NCT01943591|randomized|randomized
1219672|NCT01943591|coils|coils
1219673|NCT01943591|endovascular|endovascular
1219674|NCT01943591|Aneurysm|aneurysm
1219675|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
1219676|NCT01943591|Vascular Diseases|vascular diseases
1219677|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
1219678|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
1219679|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
1219680|NCT01943591|Brain Diseases|brain diseases
1219681|NCT01943591|Central Nervous System Diseases|central nervous system diseases
1219682|NCT01943591|Nervous System Diseases|nervous system diseases
1219683|NCT01943565|Pregnancy|pregnancy
1219684|NCT01943565|Healthy|healthy
1219685|NCT01943565|Intrathecal|intrathecal
1219686|NCT01943565|Opioids|opioids
1219687|NCT01943565|Spinal|spinal
1219688|NCT01943565|Anesthesia|anesthesia
1219689|NCT01943565|Pain|pain
1219690|NCT01943565|Cesarean|cesarean
1219691|NCT01943565|Delivery|delivery
1219692|NCT01943565|Human|human
1219693|NCT01943526|Ireland|ireland
1219694|NCT01943526|Natalizumab|natalizumab
1219695|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
1219696|NCT01943500|Breast cancer|breast cancer
1219697|NCT01943500|Prostate cancer|prostate cancer
1219699|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
1219700|NCT01943487|Phase I|phase i
1219701|NCT01943487|Verapamil|verapamil
1219702|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
1219703|NCT01943487|Solifenacin|solifenacin
1219704|NCT01943487|Pharmacokinetics|pharmacokinetics
1219705|NCT01943487|EC905|ec905
1219706|NCT01943474|IV Catheter comparison|iv catheter comparison
1219707|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
1219708|NCT01943474|IV Catheter Study|iv catheter study
1219709|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
1219710|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
1219711|NCT01943474|AccuCath Device Performance|accucath device performance
1219712|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
1590128|NCT00431028|Antibiotics|antibiotics
1219713|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
1219714|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
1219715|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
1219716|NCT01943461|Solid Tumors|solid tumors
1219717|NCT01943461|MSB0010718C|msb0010718c
1219718|NCT01943461|anti PD-L1|anti pd-l1
1219719|NCT01943461|avelumab|avelumab
1219720|NCT01943461|Phase 1|phase 1
1219721|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
1219722|NCT01943448|High Myopia|high myopia
1219723|NCT01943448|Optical Coherence Tomography|optical coherence tomography
1219724|NCT01943435|Spinal Stenosis|spinal stenosis
1219725|NCT01943435|Spinal manipulation|spinal manipulation
1219726|NCT01943435|Exercise|exercise
1219727|NCT01943435|Epidural injection|epidural injection
1219728|NCT01943422|advanced|advanced
1219729|NCT01943422|melanoma|melanoma
1219730|NCT01943422|Vemurafenib|vemurafenib
1219731|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
1219732|NCT01943409|Parenteral nutrition|parenteral nutrition
1219733|NCT01943409|lipid emulsion|lipid emulsion
1219734|NCT01943409|Intralipid|intralipid
1219735|NCT01943409|ClinOleic|clinoleic
1219736|NCT01943409|Inflammation|inflammation
1219737|NCT01943409|Infection|infection
1219738|NCT01943409|Bloodstream Infection|bloodstream infection
1219739|NCT01943409|length of stay|length of stay
1219740|NCT01943409|mortality|mortality
1219741|NCT01943396|age-related macular degeneration|age-related macular degeneration
1219742|NCT01943396|AMD|amd
1219743|NCT01943396|rheohemapheresis|rheohemapheresis
1219744|NCT01943396|plasma filtration|plasma filtration
1219745|NCT01943396|electroretinography|electroretinography
1219746|NCT01943396|ERG|erg
1219747|NCT01943396|multifocal ERG|multifocal erg
1219748|NCT01943396|double plasma filtration|double plasma filtration
1219749|NCT01943383|Hypertension|hypertension
1219750|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
1219751|NCT01943370|post-operative irrigation|post-operative irrigation
1219752|NCT01943370|pain|pain
1219753|NCT01943370|debridement|debridement
1219755|NCT01943357|patient education|patient education
1219756|NCT01943357|self management|self management
1219757|NCT01943357|health improvement|health improvement
1219758|NCT01943344|vascular large hole closure|vascular large hole closure
1219759|NCT01943344|arteriotomy closure|arteriotomy closure
1219760|NCT01943344|Large hole vascular closure device|large hole vascular closure device
1219761|NCT01943344|vascular closure device|vascular closure device
1219762|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
1220054|NCT01941862|suicide|suicide
1219763|NCT01943318|Liver Cirrhosis|liver cirrhosis
1219764|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
1219765|NCT01943305|Yellow Fever|yellow fever
1219766|NCT01943305|vaccination|vaccination
1219767|NCT01943305|Japanese encephalitis|japanese encephalitis
1219768|NCT01943305|antibodies|antibodies
1219769|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
1219770|NCT01943292|FAK inhibitor|fak inhibitor
1219771|NCT01943292|Cancer Stem Cells|cancer stem cells
1219772|NCT01943292|CSC|csc
1219773|NCT01943279|medical abortion|medical abortion
1219774|NCT01943279|telephone follow-up|telephone follow-up
1219775|NCT01943279|ultrasound|ultrasound
1219776|NCT01943279|serum hCG|serum hcg
1219777|NCT01943279|methotrexate|methotrexate
1219778|NCT01943279|misoprostol|misoprostol
1219779|NCT01943253|Early gastric cancer,|early gastric cancer,
1219780|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
1219781|NCT01943253|water-jet assisted ESD|water-jet assisted esd
1219782|NCT01943227|humidity|humidity
1219783|NCT01943227|enthalpy|enthalpy
1219784|NCT01943227|mechanical ventilation|mechanical ventilation
1219785|NCT01943214|Diabetes Mellitus|diabetes mellitus
1219786|NCT01943214|Body constitution|body constitution
1219787|NCT01943175|schizophrenia|schizophrenia
1219788|NCT01943175|stem cells|stem cells
1219789|NCT01943175|neurons|neurons
1219790|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
1219791|NCT01943136|impetigo|impetigo
1219792|NCT01943136|papaya extract ointment|papaya extract ointment
1219793|NCT01943123|probiotics,|probiotics,
1219794|NCT01943123|streptococcus mutans,|streptococcus mutans,
1219795|NCT01943123|lactobacilli,|lactobacilli,
1219796|NCT01943123|plaque index,|plaque index,
1219797|NCT01943123|gingival index|gingival index
1219798|NCT01943110|Intradermal injections|intradermal injections
1219799|NCT01943110|Vaccine delivery devices|vaccine delivery devices
1219800|NCT01943071|dementia|dementia
1219801|NCT01943071|day care centre programs|day care centre programs
1219802|NCT01943071|patients|patients
1219803|NCT01943071|family carers|family carers
1219804|NCT01943071|cost-consequence analysis|cost-consequence analysis
1219805|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
1219806|NCT01943006|MPS|mps
1219807|NCT01943006|Heparinoide|heparinoide
1219808|NCT01943006|Infusionphlebitis|infusionphlebitis
1219809|NCT01943006|Prevention|prevention
1219810|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
1219811|NCT01943006|Treatment|treatment
1219812|NCT01942993|melanoma|melanoma
1219813|NCT01942993|unresectable|unresectable
1219814|NCT01942993|mutation|mutation
1219815|NCT01942993|BRAF protein|braf protein
1219816|NCT01942980|Breast cancer|breast cancer
1219817|NCT01942980|one brain metastasis|one brain metastasis
1219818|NCT01942967|Neonate|neonate
1219819|NCT01942967|Hemodynamic|hemodynamic
1219820|NCT01942967|Tissue oxygenation|tissue oxygenation
1219821|NCT01942967|Non invasive ventilation|non invasive ventilation
1219822|NCT01942954|Alcohol Dependence|alcohol dependence
1219823|NCT01942954|Cognitive Therapy|cognitive therapy
1219824|NCT01942954|Executive Function|executive function
1219825|NCT01942954|Mobile Health|mobile health
1219826|NCT01942954|Recovery of Function|recovery of function
1219827|NCT01942954|Rehabilitation|rehabilitation
1219828|NCT01942889|COPD|copd
1219829|NCT01942889|exercise training|exercise training
1219830|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
1219831|NCT01942889|antioxidant|antioxidant
1219832|NCT01942889|muscle|muscle
1219833|NCT01942876|Drugs|drugs
1219834|NCT01942876|at risk|at risk
1219835|NCT01942876|community health center patients|community health center patients
1219836|NCT01942837|Enzalutamid|enzalutamid
1219837|NCT01942837|Prostate Cancer|prostate cancer
1219838|NCT01942811|DRUG PREVENTION|drug prevention
1219839|NCT01942811|BINATIONAL|binational
1219840|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
1219841|NCT01942811|BRIEF INTERVENTION|brief intervention
1219842|NCT01942811|SBIRT|sbirt
1219843|NCT01942798|Rehabilitation|rehabilitation
1219844|NCT01942798|Lower Limb Amputation|lower limb amputation
1219845|NCT01942798|Prosthetic|prosthetic
1219846|NCT01942798|Walking|walking
1219847|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
1219848|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
1219849|NCT01942798|older adults|older adults
1219850|NCT01942798|cognitive computer games|cognitive computer games
1219851|NCT01942798|home-based training|home-based training
1219852|NCT01942798|Nintendo Wii|nintendo wii
1219853|NCT01942798|virtual reality|virtual reality
1220347|NCT01940393|bilastine|bilastine
1219854|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
1219855|NCT01942772|mechanical structure|mechanical structure
1219856|NCT01942772|optimization|optimization
1219857|NCT01942772|dorsiflexion|dorsiflexion
1219858|NCT01942772|plantar flexion|plantar flexion
1219859|NCT01942772|gait|gait
1219860|NCT01942772|servomotor|servomotor
1219861|NCT01942772|ankle rehabilitation|ankle rehabilitation
1219862|NCT01942759|Breast Neoplasms|breast neoplasms
1219863|NCT01942759|Positron-Emission Tomography|positron-emission tomography
1219864|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1219865|NCT01942746|blueberry|blueberry
1219866|NCT01942746|anthocyanin|anthocyanin
1219867|NCT01942746|dark vision|dark vision
1219868|NCT01942746|photo bleaching|photo bleaching
1219869|NCT01942746|Visual Perception|visual perception
1219870|NCT01942746|Photic Stimulation|photic stimulation
1219871|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
1219872|NCT01942694|Prediabetes|prediabetes
1219873|NCT01942694|Vitamin D|vitamin d
1219874|NCT01942681|female|female
1219875|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
1219876|NCT01942668|Vasomotor symptoms|vasomotor symptoms
1219877|NCT01942668|Hot flashes|hot flashes
1219878|NCT01942668|Endometrial protection|endometrial protection
1219879|NCT01942655|HIV|hiv
1219880|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
1219881|NCT01942655|Reservoirs|reservoirs
1219882|NCT01942655|IL-17|il-17
1219883|NCT01942655|IL-23|il-23
1219884|NCT01942655|Intestinal biopsies|intestinal biopsies
1219885|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
1219886|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
1219887|NCT01942616|IPV|ipv
1219888|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
1219889|NCT01942603|Stage III|stage iii
1219890|NCT01942603|Patients|patients
1219891|NCT01942603|Lymphnode Dissections|lymphnode dissections
1219892|NCT01942590|Pompe disease|pompe disease
1219893|NCT01942577|NoSting|nosting
1219894|NCT01942577|Skin protectants|skin protectants
1219895|NCT01942577|Emollients|emollients
1219896|NCT01942577|Skin microbiome|skin microbiome
1219897|NCT01942564|traumatic brain injury|traumatic brain injury
1219898|NCT01942564|photophobia|photophobia
1219899|NCT01942564|photosensitivity|photosensitivity
1219900|NCT01942564|pupil|pupil
1219901|NCT01942538|rTMS|rtms
1219902|NCT01942538|fibromyalgia|fibromyalgia
1219903|NCT01942538|sham|sham
1219904|NCT01942538|maintenance session|maintenance session
1219905|NCT01942538|pain|pain
1219906|NCT01942525|IUGR|iugr
1219907|NCT01942525|aEEG|aeeg
1219908|NCT01942525|preterm infants|preterm infants
1219909|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
1219910|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
1219911|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
1219912|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
1219913|NCT01942499|COPD, exercise, community|copd, exercise, community
1219914|NCT01942486|migraine|migraine
1219915|NCT01942486|photophobia|photophobia
1219916|NCT01942486|light sensitivity|light sensitivity
1219917|NCT01942486|melanopsin cells|melanopsin cells
1219918|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
1219919|NCT01942460|Iron|iron
1219920|NCT01942460|Anemia|anemia
1219921|NCT01942460|Chronic Kidney Disease|chronic kidney disease
1219922|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
1219923|NCT01942460|Inflammation|inflammation
1219924|NCT01942460|Oxidative stress|oxidative stress
1219925|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
1219926|NCT01942447|microbiota|microbiota
1219927|NCT01942447|clostridium difficile|clostridium difficile
1219928|NCT01942447|clostridium difficile infection|clostridium difficile infection
1219929|NCT01942447|Efficacy of FMT|efficacy of fmt
1219930|NCT01942434|Fatty acids|fatty acids
1219931|NCT01942434|Breast milk nutrients|breast milk nutrients
1219932|NCT01942434|Cognitive development|cognitive development
1219933|NCT01942434|Electrophysiology|electrophysiology
1219934|NCT01942434|Long-term assessment|long-term assessment
1219935|NCT01942421|Limbal deficiency|limbal deficiency
1219936|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
1219937|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
1219938|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
1219939|NCT01942408|Atrial fibrillation|atrial fibrillation
1219940|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
1219941|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
1219942|NCT01942395|Diet|diet
1219943|NCT01942395|Sodium|sodium
1219944|NCT01942395|Hypertension|hypertension
1219945|NCT01942395|Potassium|potassium
1219946|NCT01942395|Antioxidants|antioxidants
1219947|NCT01942395|Congestive Heart Failure|congestive heart failure
1220147|NCT01941420|Cytokines under ischemia|cytokines under ischemia
1219948|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1219949|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1219950|NCT01942382|Schizophrenia|schizophrenia
1219951|NCT01942382|JNS010|jns010
1219952|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
1219953|NCT01942382|Clinical Pharmacology|clinical pharmacology
1219954|NCT01942369|Endometriosis|endometriosis
1220265|NCT01940887|Wet AMD|wet amd
1219955|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
1219956|NCT01942304|Maxillary Sinus|maxillary sinus
1219957|NCT01942304|Bone Substitutes|bone substitutes
1219958|NCT01942304|Bone Regeneration|bone regeneration
1219959|NCT01942291|Niacin|niacin
1219960|NCT01942291|Endothelial function|endothelial function
1219961|NCT01942291|Laropiprant|laropiprant
1219962|NCT01942291|HDL|hdl
1219963|NCT01942278|Healthcare|healthcare
1219964|NCT01942278|Patients|patients
1219965|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
1219966|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
1219967|NCT01942239|hypoglycemia|hypoglycemia
1219968|NCT01942239|very low birth weight neonate|very low birth weight neonate
1219969|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
1219970|NCT01942226|Dry eye syndrome|dry eye syndrome
1219971|NCT01942213|Macular|macular
1219972|NCT01942213|Degeneration|degeneration
1219973|NCT01942213|Age related|age related
1219974|NCT01942213|Neovascular|neovascular
1219975|NCT01942200|carcinoma|carcinoma
1219976|NCT01942200|colon cancer|colon cancer
1219977|NCT01942200|colorectal cancer|colorectal cancer
1219978|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
1219979|NCT01942200|treatment cycles|treatment cycles
1219980|NCT01942200|Oxaliplatin|oxaliplatin
1219981|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
1219982|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
1219983|NCT01942200|Packaging Sizes|packaging sizes
1219984|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
1219985|NCT01942174|Methotrexate treatment|methotrexate treatment
1219986|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
1219987|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
1219988|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
1219989|NCT01942135|Fulvestrant|fulvestrant
1219990|NCT01942135|Goserelin|goserelin
1219991|NCT01942135|Hormone receptor-+|hormone receptor-+
1219992|NCT01942135|HER2-negative|her2-negative
1219993|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
1219994|NCT01942135|any menopausal status|any menopausal status
1219995|NCT01942135|PALOMA-3|paloma-3
1219996|NCT01942122|DLBS1442|dlbs1442
1219997|NCT01942122|Endometriosis|endometriosis
1219998|NCT01942122|Pain|pain
1219999|NCT01942122|Visual Analogue Scale|visual analogue scale
1220000|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
1220001|NCT01942109|heart failure|heart failure
1220002|NCT01942109|diuretics|diuretics
1220003|NCT01942109|furosemide|furosemide
1220004|NCT01942109|torasemide|torasemide
1220005|NCT01942070|Cardiovascular Disease|cardiovascular disease
1220006|NCT01942070|Myocardial Infarction|myocardial infarction
1220007|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
1220008|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
1220009|NCT01942070|Primary angioplasty|primary angioplasty
1220010|NCT01942070|Stent|stent
1220011|NCT01942044|Shear stress|shear stress
1220012|NCT01942044|Optical coherence tomography|optical coherence tomography
1220013|NCT01942044|Drug-eluting stents|drug-eluting stents
1220014|NCT01942031|Ischemic stroke|ischemic stroke
1220015|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
1220016|NCT01942031|TIA|tia
1220017|NCT01942031|Atrial fibrillation|atrial fibrillation
1220018|NCT01942031|prevention|prevention
1220019|NCT01942031|primary care|primary care
1220020|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
1220021|NCT01942018|EGOO|egoo
1220022|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
1220023|NCT01942018|POEM|poem
1220024|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
1220025|NCT01942018|GERD|gerd
1220026|NCT01941992|head and neck|head and neck
1220027|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
1220028|NCT01941992|oral mucositis|oral mucositis
1220029|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
1220030|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
1220031|NCT01941953|Metformin|metformin
1220032|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
1220033|NCT01941953|Fluorouracil|fluorouracil
1220034|NCT01941927|Melanoma|melanoma
1220035|NCT01941927|Wild-type|wild-type
1220036|NCT01941927|BRAF|braf
1220037|NCT01941914|Calcium electroporation|calcium electroporation
1220038|NCT01941914|calcium|calcium
1220039|NCT01941914|electroporation|electroporation
1220040|NCT01941914|electrotransfer|electrotransfer
1220041|NCT01941914|keloid|keloid
1220042|NCT01941901|Cutaneous metastases|cutaneous metastases
1220046|NCT01941875|infertility|infertility
1220047|NCT01941875|luteal progesterone|luteal progesterone
1220048|NCT01941862|computerized intervention|computerized intervention
1220049|NCT01941862|cognitive bias modification|cognitive bias modification
1220050|NCT01941862|anxiety|anxiety
1220051|NCT01941862|mood|mood
1220052|NCT01941862|perceived burdensomeness|perceived burdensomeness
1220053|NCT01941862|thwarted belongingness|thwarted belongingness
1220055|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
1220056|NCT01941849|Phaeochromocytoma|phaeochromocytoma
1220057|NCT01941849|Paraganglioma|paraganglioma
1220058|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
1220059|NCT01941849|Vandetanib|vandetanib
1220060|NCT01941849|131I-mIBG|131i-mibg
1220061|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
1220062|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
1220063|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1220065|NCT01941849|Tyrosine Kinase|tyrosine kinase
1220066|NCT01941836|Statin intolerant|statin intolerant
1220067|NCT01941836|Statin tolerant|statin tolerant
1220068|NCT01941836|LDL|ldl
1220069|NCT01941836|Cholesterol|cholesterol
1220070|NCT01941823|acute renal failure|acute renal failure
1220071|NCT01941823|CRRT|crrt
1220072|NCT01941823|continuous dialysis|continuous dialysis
1220073|NCT01941823|carnitine|carnitine
1220074|NCT01941823|cardiac strain|cardiac strain
1220075|NCT01941771|Breast cancer|breast cancer
1220076|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
1220077|NCT01941771|Vinorelbine|vinorelbine
1220078|NCT01941771|Navelbine|navelbine
1220079|NCT01941771|Capecitabine|capecitabine
1220080|NCT01941771|Xeloda|xeloda
1220081|NCT01941771|Antineoplastic Agents|antineoplastic agents
1220082|NCT01941719|Diabetes Mellitus|diabetes mellitus
1220083|NCT01941719|Diabetic Foot|diabetic foot
1220084|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1220085|NCT01941719|Diabetic Foot Education|diabetic foot education
1220086|NCT01941706|Epilepsy|epilepsy
1220087|NCT01941706|Seizure|seizure
1220088|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
1220089|NCT01941706|Mindfulness|mindfulness
1220090|NCT01941706|Depression|depression
1220091|NCT01941706|Depressive symptoms|depressive symptoms
1220092|NCT01941706|prevention|prevention
1220093|NCT01941706|Coping skills|coping skills
1220094|NCT01941706|Quality of life|quality of life
1220095|NCT01941706|Telehealth|telehealth
1220096|NCT01941706|Phone intervention|phone intervention
1220097|NCT01941706|Internet-based intervention|internet-based intervention
1220098|NCT01941693|alcohol|alcohol
1220099|NCT01941693|anxiety|anxiety
1220100|NCT01941693|depression|depression
1301573|NCT01576380|Tumors|tumors
1220101|NCT01941693|comorbidity|comorbidity
1220102|NCT01941693|CBT|cbt
1220103|NCT01941667|Congenital Heart Disease|congenital heart disease
1220104|NCT01941667|Neonates and infants|neonates and infants
1220105|NCT01941667|Telehealth|telehealth
1220106|NCT01941667|Virtual Home Visits|virtual home visits
1220107|NCT01941628|Cesarean section|cesarean section
1220108|NCT01941628|General anesthesia|general anesthesia
1220109|NCT01941628|neuromuscular blockade|neuromuscular blockade
1220110|NCT01941628|Surgical conditions|surgical conditions
1220111|NCT01941602|surgery|surgery
1220112|NCT01941602|enoxaparin|enoxaparin
1220113|NCT01941602|venous thromboembolism|venous thromboembolism
1220114|NCT01941602|perioperative care|perioperative care
1220115|NCT01941576|Heart defects, Congenital|heart defects, congenital
1220116|NCT01941576|rhBNP|rhbnp
1220117|NCT01941576|heart failure|heart failure
1220118|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
1220119|NCT01941537|Atopic Dermatitis|atopic dermatitis
1220120|NCT01941524|Brain oxygenation|brain oxygenation
1220121|NCT01941524|NIRS|nirs
1220122|NCT01941524|aEEG|aeeg
1220123|NCT01941524|surfactant|surfactant
1220124|NCT01941511|QTc|qtc
1220125|NCT01941511|African-American|african-american
1220126|NCT01941511|GMI-1070|gmi-1070
1220127|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
1220128|NCT01941498|nearsighted|nearsighted
1220129|NCT01941498|farsighted|farsighted
1220130|NCT01941498|astigmatism|astigmatism
1220131|NCT01941498|LASIK|lasik
1220132|NCT01941498|refractive surgery|refractive surgery
1220133|NCT01941498|WaveLight|wavelight
1220134|NCT01941485|nearsighted|nearsighted
1220135|NCT01941485|astigmatism|astigmatism
1220136|NCT01941485|LASIK|lasik
1220137|NCT01941485|refractive surgery|refractive surgery
1220138|NCT01941485|WaveLight|wavelight
1220139|NCT01941459|CK-MB|ck-mb
1220140|NCT01941459|troponin-T|troponin-t
1220145|NCT01941420|CK-MB|ck-mb
1220146|NCT01941420|troponin-T|troponin-t
1220150|NCT01941394|Overall Survival|overall survival
1220151|NCT01941381|Otitis Media|otitis media
1220152|NCT01941381|Tympanometry|tympanometry
1220153|NCT01941368|Performance|performance
1220154|NCT01941368|Aerobic Exercise|aerobic exercise
1220155|NCT01941342|Obstructive Jaundice|obstructive jaundice
1220156|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
1220157|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
1220158|NCT01941329|Diabetes|diabetes
1220159|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
1220160|NCT01941329|Ranibizumab|ranibizumab
1220161|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
1220162|NCT01941316|Carfilzomib|carfilzomib
1220163|NCT01941316|Irinotecan|irinotecan
1220164|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
1220165|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
1220166|NCT01941316|Ovarian Cancer|ovarian cancer
1220167|NCT01941316|Gastric Cancer|gastric cancer
1220168|NCT01941316|Esophageal Cancer|esophageal cancer
1220169|NCT01941316|Cervical Cancer|cervical cancer
1220170|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
1220171|NCT01941290|International|international
1220172|NCT01941290|Multicenter|multicenter
1220173|NCT01941290|Observational registry|observational registry
1220174|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
1220175|NCT01941290|Stenting|stenting
1220176|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1220177|NCT01941290|Coronary Revascularization|coronary revascularization
1220178|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1220179|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
1220180|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
1220181|NCT01941290|STEMI|stemi
1220182|NCT01941290|NSTEMI|nstemi
1220183|NCT01941290|Ischemia|ischemia
1220184|NCT01941290|Angina|angina
1220185|NCT01941290|Subgroups|subgroups
1220186|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
1220187|NCT01941290|Small Vessels|small vessels
1220188|NCT01941290|Chronic Total Occlusion|chronic total occlusion
1220189|NCT01941264|malaria|malaria
1220190|NCT01941264|placenta|placenta
1220191|NCT01941264|pregnancy|pregnancy
1220192|NCT01941264|plasmodium falciparum|plasmodium falciparum
1220193|NCT01941264|screening and treatment|screening and treatment
1220194|NCT01941264|rapid diagnostic test|rapid diagnostic test
1220195|NCT01941264|coartem|coartem
1220196|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
1220197|NCT01941264|community health worker|community health worker
1220198|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1220199|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1220200|NCT01941251|Schizophrenia|schizophrenia
1220201|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
1220202|NCT01941251|Treatment|treatment
1220203|NCT01941251|Negative Symptoms|negative symptoms
1220204|NCT01941251|Positive Symptoms|positive symptoms
1220205|NCT01941251|TMS|tms
1220207|NCT01941238|Ramadan|ramadan
1220208|NCT01941238|Fasting|fasting
1220209|NCT01941238|Diabetes|diabetes
1220210|NCT01941238|Type1|type1
1220211|NCT01941238|Insulin|insulin
1220212|NCT01941238|Pump|pump
1220213|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1220214|NCT01941225|Pulmonary vasculature|pulmonary vasculature
1220215|NCT01941225|Inhaled iloprost|inhaled iloprost
1220216|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
1220217|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
1220218|NCT01941225|Oxidative stress|oxidative stress
1220219|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1220220|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
1220221|NCT01941212|Music therapy|music therapy
1220222|NCT01941212|pain|pain
1220223|NCT01941212|gynecological surgeries|gynecological surgeries
1220224|NCT01941186|Children|children
1220225|NCT01941186|Developmental Delays|developmental delays
1220226|NCT01941186|Early Intervention (EI)|early intervention (ei)
1220227|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
1220228|NCT01941147|Acute Stroke|acute stroke
1220229|NCT01941147|Brain Ischemia|brain ischemia
1220230|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
1220231|NCT01941121|HIV Screening|hiv screening
1220232|NCT01941121|Linkage to PrEP|linkage to prep
1220233|NCT01941121|Linkage to Care|linkage to care
1220234|NCT01941121|CCTG|cctg
1220235|NCT01941121|593|593
1220236|NCT01941108|AIDS|aids
1220237|NCT01941108|peer navigation|peer navigation
1220238|NCT01941108|ecological momentary assessment|ecological momentary assessment
1220239|NCT01941108|eMOCHA|emocha
1220240|NCT01941108|Baltimore|baltimore
1220241|NCT01941108|IDU|idu
1220242|NCT01941030|Peripheral Artery Disease|peripheral artery disease
1220243|NCT01941030|Critical Limb Ischemia|critical limb ischemia
1220244|NCT01941030|Orbital Atherectomy|orbital atherectomy
1220245|NCT01941030|Balloon Angioplasty|balloon angioplasty
1220246|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
1220247|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
1220248|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
1220249|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
1220250|NCT01941004|fingolimod|fingolimod
1220251|NCT01940978|Methamphetamine|methamphetamine
1220252|NCT01940978|Methylphenidate|methylphenidate
1220253|NCT01940978|ADHD|adhd
1220254|NCT01940939|schizophrenia|schizophrenia
1220255|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
1220256|NCT01940926|angiogenesis|angiogenesis
1220257|NCT01940926|68Ga-PRGD2|68ga-prgd2
1220258|NCT01940926|18F-FDG|18f-fdg
1220259|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
1220260|NCT01940900|Wet AMD|wet amd
1220261|NCT01940900|choroidal neovascularization|choroidal neovascularization
1220262|NCT01940900|Fovista®|fovista®
1220263|NCT01940900|E10030|e10030
1220264|NCT01940900|Lucentis®|lucentis®
1220266|NCT01940887|choroidal neovascularization|choroidal neovascularization
1220267|NCT01940887|Fovista®|fovista®
1220268|NCT01940887|E10030|e10030
1220269|NCT01940887|Avastin®|avastin®
1220270|NCT01940887|Eylea®|eylea®
1220271|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
1220272|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
1220273|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
1220274|NCT01940874|Coronary artery disease.|coronary artery disease.
1220275|NCT01940848|Iberogast|iberogast
1220276|NCT01940848|efficacy|efficacy
1220277|NCT01940848|safety|safety
1220278|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
1220279|NCT01940796|GVHD|gvhd
1220280|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
1220281|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
1220282|NCT01940770|Bydureon|bydureon
1220283|NCT01940770|Exenatide|exenatide
1220284|NCT01940757|Necator americanus|necator americanus
1220285|NCT01940757|Hookworm Infection|hookworm infection
1220286|NCT01940757|Experimental challenge infection|experimental challenge infection
1220287|NCT01940744|Low back pain|low back pain
1220288|NCT01940744|Non-specific Low back pain|non-specific low back pain
1220289|NCT01940718|Priapism|priapism
1220290|NCT01940718|Sickle cell disease|sickle cell disease
1220291|NCT01940718|Testosterone|testosterone
1220292|NCT01940718|Androgen deficiency|androgen deficiency
1220293|NCT01940705|hearing aids|hearing aids
1220294|NCT01940705|counseling|counseling
1220295|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
1220296|NCT01940705|rehabilitation|rehabilitation
1220297|NCT01940666|Hyperandrogenism/|hyperandrogenism/
1220298|NCT01940666|FAI/|fai/
1220299|NCT01940666|Metabolic syndrome/|metabolic syndrome/
1220300|NCT01940666|Adipocytokines/|adipocytokines/
1220301|NCT01940666|Insulin resistance.|insulin resistance.
1220302|NCT01940640|neonates, DHA|neonates, dha
1220303|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
1220304|NCT01940614|Copeptin|copeptin
1220305|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
1220306|NCT01940614|diabetes insipidus|diabetes insipidus
1220307|NCT01940614|compulsive water drinking|compulsive water drinking
1220308|NCT01940614|water deprivation test|water deprivation test
1220309|NCT01940614|Diabetes insipidus (central and nephrogenic)|diabetes insipidus (central and nephrogenic)
1220310|NCT01940601|solid tumors|solid tumors
1220311|NCT01940601|balugrastim|balugrastim
1220312|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
1220313|NCT01940575|Hyaluronic acid|hyaluronic acid
1220314|NCT01940575|Restylane®|restylane®
1220315|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
1220316|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
1220317|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
1220318|NCT01940562|cord blood transplantation|cord blood transplantation
1220319|NCT01940562|platelets|platelets
1220320|NCT01940562|eltrombopag|eltrombopag
1220321|NCT01940549|PTSD|ptsd
1220322|NCT01940549|tDCS|tdcs
1220323|NCT01940549|Trauma|trauma
1220324|NCT01940536|Hip Fracture|hip fracture
1220325|NCT01940536|Blood Transfusion|blood transfusion
1220326|NCT01940536|Blood Loss|blood loss
1220327|NCT01940536|Tranexamic Acid|tranexamic acid
1220328|NCT01940523|total knee arthroplasty|total knee arthroplasty
1220329|NCT01940523|total knee replacement|total knee replacement
1220330|NCT01940523|tranexamic acid|tranexamic acid
1220331|NCT01940523|osteoarthritis|osteoarthritis
1220332|NCT01940523|degenerative joint disease|degenerative joint disease
1220333|NCT01940471|Hepatitis|hepatitis
1220334|NCT01940471|Tenofovir|tenofovir
1220335|NCT01940471|Viread|viread
1220336|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
1220337|NCT01940419|Reduction of blood loss|reduction of blood loss
1220338|NCT01940419|Surgical complication|surgical complication
1220339|NCT01940419|Hysterectomy|hysterectomy
1220340|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
1220341|NCT01940419|Randomized Controlled Trials|randomized controlled trials
1220342|NCT01940406|Essential Tremor|essential tremor
1220343|NCT01940406|Parkinson Disease|parkinson disease
1220344|NCT01940406|Electrical Stimulation|electrical stimulation
1220348|NCT01940393|fexofenadine|fexofenadine
1220349|NCT01940393|cetirizine|cetirizine
1220350|NCT01940393|ebastine|ebastine
1220351|NCT01940393|desloratadine|desloratadine
1220352|NCT01940367|Overactive Bladder|overactive bladder
1220353|NCT01940367|TENS|tens
1220354|NCT01940367|PTNS|ptns
1220355|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
1220356|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
1220357|NCT01940354|IV Catheter comparison|iv catheter comparison
1220358|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
1220359|NCT01940354|IV Catheter Study|iv catheter study
1220360|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
1220361|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
1220362|NCT01940354|AccuCath Device Performance|accucath device performance
1220363|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
1220364|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
1220365|NCT01940341|Hepatitis|hepatitis
1220366|NCT01940341|Tenofovir|tenofovir
1220367|NCT01940341|Viread|viread
1220368|NCT01940328|Ultrasound Doppler|ultrasound doppler
1220369|NCT01940328|Congestive heart failure|congestive heart failure
1220370|NCT01940328|Pulmonary Edema|pulmonary edema
1220371|NCT01940315|Defender Study|defender study
1220372|NCT01940315|experimental vaccine|experimental vaccine
1220373|NCT01940315|inhalational intoxication|inhalational intoxication
1220374|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
1220375|NCT01940289|algometry|algometry
1220376|NCT01940289|pain|pain
1220377|NCT01940289|VAS|vas
1220378|NCT01940276|Prostate cancer|prostate cancer
1220379|NCT01940276|metastatic|metastatic
1220380|NCT01940276|castrate resistant|castrate resistant
1220381|NCT01940276|abiraterone acetate|abiraterone acetate
1220382|NCT01940276|prednisone|prednisone
1220383|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
1220384|NCT01940263|oxidative stress|oxidative stress
1220385|NCT01940263|dyslipidemia|dyslipidemia
1220386|NCT01940263|inflammation|inflammation
1220387|NCT01940263|apoptosis|apoptosis
1220388|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
1220389|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
1220390|NCT01940250|Magnesium sulphate|magnesium sulphate
1220391|NCT01940237|Depression|depression
1220392|NCT01940237|Psychotherapy|psychotherapy
1220393|NCT01940237|Cancer|cancer
1220394|NCT01940237|Pancreatic Cancer|pancreatic cancer
1220395|NCT01940237|Lung Cancer|lung cancer
1220396|NCT01940237|Colon Cancer|colon cancer
1220397|NCT01940237|Prostate Cancer|prostate cancer
1220398|NCT01940224|Pregabalin|pregabalin
1220399|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
1220400|NCT01940224|Postoperative pain|postoperative pain
1220401|NCT01940224|Opioid consumption|opioid consumption
1220402|NCT01940198|Atazanavir|atazanavir
1220403|NCT01940198|long-term|long-term
1220404|NCT01940198|primary care setting|primary care setting
1220405|NCT01940198|sydney|sydney
1220406|NCT01940159|Schizophrenia|schizophrenia
1220407|NCT01940159|Schizoaffective disorders|schizoaffective disorders
1220408|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
1220409|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
1220410|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
1220411|NCT01940120|Mitral Regurgitation|mitral regurgitation
1220412|NCT01940120|Mitral Insufficiency|mitral insufficiency
1220413|NCT01940120|Mitral Valve|mitral valve
1220414|NCT01940120|MR|mr
1220415|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
1220416|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
1220417|NCT01940120|Alfieri Technique|alfieri technique
1220418|NCT01940120|MitraClip|mitraclip
1220419|NCT01940120|Functional MR|functional mr
1220420|NCT01940120|Degenerative MR|degenerative mr
1220421|NCT01940120|Echocardiogram|echocardiogram
1220422|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1220423|NCT01940120|Heart Failure|heart failure
1220424|NCT01940120|Heart Attack|heart attack
1220425|NCT01940120|EVEREST|everest
1220426|NCT01940120|EVEREST I|everest i
1220427|NCT01940120|EVEREST II|everest ii
1220428|NCT01940120|REALISM|realism
1220429|NCT01940107|breast cancer,|breast cancer,
1220430|NCT01940107|radiotherapy,|radiotherapy,
1220431|NCT01940107|physical therapy,|physical therapy,
1220432|NCT01940107|upper limb|upper limb
1220433|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1220434|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
1220435|NCT01940094|WG|wg
1220436|NCT01940094|GPA|gpa
1220437|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
1220438|NCT01940094|AAV|aav
1220439|NCT01940094|Vasculitis|vasculitis
1220440|NCT01940094|Prednisone|prednisone
1220441|NCT01940094|Glucocorticoid|glucocorticoid
1220442|NCT01940094|Taper|taper
1220443|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
1220566|NCT01939574|PFS|pfs
1220444|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
1220445|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
1220446|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
1220447|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
1220448|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
1220449|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
1220450|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
1220451|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
1220452|NCT01940081|Biopsy|biopsy
1220453|NCT01940081|Genetic Testing|genetic testing
1220454|NCT01940081|Echocardiography|echocardiography
1220455|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
1220456|NCT01940081|Exercise Test|exercise test
1220457|NCT01940068|Hypersensitivity|hypersensitivity
1220458|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
1220459|NCT01940068|Immune System Diseases|immune system diseases
1220460|NCT01940068|Food Hypersensitivity|food hypersensitivity
1220461|NCT01940055|Balance|balance
1220462|NCT01940055|Gait|gait
1220463|NCT01940055|Instrumented Treadmill|instrumented treadmill
1220464|NCT01940055|Recumbent cycle|recumbent cycle
1220465|NCT01940055|Cognitive games|cognitive games
1220466|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
1220467|NCT01940016|Feasibility study|feasibility study
1220468|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
1220469|NCT01940016|health coach|health coach
1220470|NCT01940016|no evidence of disease|no evidence of disease
1220471|NCT01940003|Diabetes, Gestational|diabetes, gestational
1220472|NCT01940003|Pregnancy Outcome|pregnancy outcome
1220473|NCT01940003|Exercise|exercise
1220474|NCT01940003|glycemic control|glycemic control
1220475|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1220476|NCT01939977|Hyperparathyroidism|hyperparathyroidism
1220477|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
1220478|NCT01939977|Paricalcitol|paricalcitol
1220479|NCT01939977|Calcifediol|calcifediol
1220480|NCT01939977|Parathyroid hormone|parathyroid hormone
1220481|NCT01939977|Renal transplantation|renal transplantation
1220482|NCT01939964|Wrinkles|wrinkles
1220483|NCT01939964|Activation Mist|activation mist
1220484|NCT01939951|Asthma|asthma
1220485|NCT01939951|Persistent|persistent
1220486|NCT01939925|patient education|patient education
1220487|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1220488|NCT01939925|comprehension|comprehension
1220489|NCT01939925|consumer health information|consumer health information
1220490|NCT01939899|MLN9708|mln9708
1220491|NCT01939899|Lymphoma|lymphoma
1220492|NCT01939899|IXAZOMIB|ixazomib
1220493|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
1220494|NCT01939886|Malaria transmission|malaria transmission
1220495|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
1220496|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
1220497|NCT01939873|Neonatal outcome|neonatal outcome
1220498|NCT01939847|Metastatic breast cancer|metastatic breast cancer
1220499|NCT01939847|Breast cancer|breast cancer
1220500|NCT01939847|Molecular profiling|molecular profiling
1220501|NCT01939847|Personalized medicine|personalized medicine
1220502|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1220503|NCT01939834|Artificial Pancreas|artificial pancreas
1220504|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1220505|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
1220506|NCT01939821|Fecal incontinence|fecal incontinence
1220507|NCT01939821|attitudes|attitudes
1220508|NCT01939821|knowledge|knowledge
1220509|NCT01939821|quality of care|quality of care
1220510|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1220511|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
1220512|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
1220513|NCT01939769|fMRI|fmri
1220514|NCT01939769|Catecholamines|catecholamines
1220515|NCT01939769|Stress|stress
1220516|NCT01939769|Exercise|exercise
1220517|NCT01939769|Memory|memory
1220518|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
1220519|NCT01939756|Intravesical BCG|intravesical bcg
1220520|NCT01939756|Local toxicity|local toxicity
1220521|NCT01939756|Natural baobab oil|natural baobab oil
1220522|NCT01939730|Lymphoma|lymphoma
1220523|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
1220524|NCT01939730|Rituximab|rituximab
1220525|NCT01939730|Rituxan|rituxan
1220526|NCT01939730|GM-CSF|gm-csf
1220527|NCT01939730|Sargramostim|sargramostim
1220528|NCT01939730|Leukine|leukine
1220529|NCT01939717|Parkinson's disease|parkinson's disease
1220530|NCT01939717|Irish set dancing|irish set dancing
1220531|NCT01939691|difluprednate|difluprednate
1220532|NCT01939691|prednisolone acetate|prednisolone acetate
1220533|NCT01939691|nepafenac|nepafenac
1220534|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
1220535|NCT01939665|LAPC|lapc
1220536|NCT01939665|Irreversible electroporation|irreversible electroporation
1220537|NCT01939665|NanoKnife|nanoknife
1220538|NCT01939665|IRE|ire
1220539|NCT01939665|Safety|safety
1220540|NCT01939665|Efficacy|efficacy
1220541|NCT01939665|Non-thermal ablation|non-thermal ablation
1220542|NCT01939665|Percutaneous ablation|percutaneous ablation
1220543|NCT01939665|Low Energy Direct Current|low energy direct current
1220544|NCT01939652|minilaparotomy|minilaparotomy
1220545|NCT01939652|AAA|aaa
1220546|NCT01939652|fluid regime|fluid regime
1220547|NCT01939639|Oxytocin|oxytocin
1220548|NCT01939639|fMRI|fmri
1220549|NCT01939626|embryo|embryo
1220550|NCT01939626|culture|culture
1220551|NCT01939613|fluid resuscitation|fluid resuscitation
1220552|NCT01939613|burn|burn
1220553|NCT01939613|colloid,|colloid,
1220554|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
1220555|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
1220556|NCT01939600|Resistant starch|resistant starch
1220557|NCT01939600|Ileostomy|ileostomy
1220558|NCT01939600|In vivo|in vivo
1220559|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
1220560|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
1220561|NCT01939587|Asthma|asthma
1220562|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
1220563|NCT01939587|COPD|copd
1220564|NCT01939574|Glioblastoma|glioblastoma
1220565|NCT01939574|Potential Image Biomarkers|potential image biomarkers
1220567|NCT01939574|Bevacizumab|bevacizumab
1220568|NCT01939574|Conventional Therapy|conventional therapy
1220569|NCT01939561|Myotonia|myotonia
1220570|NCT01939561|Lamotrigine|lamotrigine
1220571|NCT01939561|RCT|rct
1220572|NCT01939561|treatment|treatment
1220573|NCT01939548|PF-02545920|pf-02545920
1220574|NCT01939548|schizophrenia|schizophrenia
1220575|NCT01939548|outpatient|outpatient
1220576|NCT01939548|safety|safety
1220577|NCT01939548|efficacy|efficacy
1220578|NCT01939548|suboptimal response|suboptimal response
1220579|NCT01939535|Endometriosis|endometriosis
1220580|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
1220581|NCT01939522|diabetes|diabetes
1220582|NCT01939522|pneumococcal|pneumococcal
1220583|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1220584|NCT01939496|Hypertension|hypertension
1220585|NCT01939496|Canagliflozin|canagliflozin
1220586|NCT01939496|JNJ 28431754|jnj 28431754
1220587|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
1220588|NCT01939496|Blood Glucose|blood glucose
1220589|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1220590|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
1220591|NCT01939483|Irinotecan|irinotecan
1220592|NCT01939483|CAMPTOSAR|camptosar
1220593|NCT01939470|osteoporosis|osteoporosis
1220594|NCT01939470|bone|bone
1220595|NCT01939470|inflammation|inflammation
1220596|NCT01939470|diabetes|diabetes
1220597|NCT01939470|vitamin D|vitamin d
1220598|NCT01939444|Antidotes|antidotes
1220599|NCT01939444|naloxone|naloxone
1220600|NCT01939444|administration, intravenous|administration, intravenous
1220601|NCT01939444|administration, intranasal|administration, intranasal
1220602|NCT01939444|pharmacology|pharmacology
1220603|NCT01939431|Podoconiosis|podoconiosis
1220604|NCT01939431|Gene Expression|gene expression
1220605|NCT01939431|Genomics|genomics
1220606|NCT01939431|Pathogenesis|pathogenesis
1220607|NCT01939418|metastatic breast cancer|metastatic breast cancer
1220608|NCT01939418|triple negative breast cancer|triple negative breast cancer
1220609|NCT01939418|gemcitabine|gemcitabine
1220610|NCT01939418|RAD001|rad001
1220611|NCT01939405|Obesity|obesity
1220612|NCT01939405|Overweight|overweight
1220613|NCT01939405|Physical Activity|physical activity
1220614|NCT01939405|Built Environment|built environment
1220615|NCT01939405|counseling|counseling
1220616|NCT01939392|Resistant hypertension|resistant hypertension
1220617|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
1220618|NCT01939392|Renal artery ablation|renal artery ablation
1220619|NCT01939379|Total knee arthroplasty|total knee arthroplasty
1220620|NCT01939379|nerve block|nerve block
1220621|NCT01939379|Pain control after surgery|pain control after surgery
1220622|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
1220623|NCT01939353|Adult ADHD|adult adhd
1220624|NCT01939327|diffuse large B cell|diffuse large b cell
1220625|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
1220626|NCT01939314|Headache|headache
1220627|NCT01939314|Migraine|migraine
1220628|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
1220629|NCT01939262|Arthritis|arthritis
1220630|NCT01939262|Pain|pain
1220631|NCT01939262|Function|function
1220632|NCT01939262|Diet|diet
1220633|NCT01939262|Vegan|vegan
1220634|NCT01939262|Vegetarian|vegetarian
1220635|NCT01939262|Restriction|restriction
1220636|NCT01939236|chronic heart failure|chronic heart failure
1220637|NCT01939236|traditional Chinese medicine|traditional chinese medicine
1220638|NCT01939236|syndrome differentiation|syndrome differentiation
1220639|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
1220640|NCT01939197|HCV Genotype 4|hcv genotype 4
1220641|NCT01939197|Interferon-Free|interferon-free
1220642|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
1220643|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
1220644|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
1220645|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
1220646|NCT01939197|Cirrhotic|cirrhotic
1220647|NCT01939197|Hepatitis C|hepatitis c
1220648|NCT01939197|HIV-1|hiv-1
1220649|NCT01939197|HCV Genotype 1|hcv genotype 1
1220650|NCT01939171|Thymoglobulin|thymoglobulin
1220651|NCT01939171|Cadaver donor|cadaver donor
1220652|NCT01939171|Kidney injury brain death related|kidney injury brain death related
1220653|NCT01939158|Co-administration|co-administration
1220654|NCT01939158|Safety|safety
1220655|NCT01939158|Persistence|persistence
1220656|NCT01939158|Immunogenicity|immunogenicity
1220657|NCT01939158|Prevenar 13|prevenar 13
1220658|NCT01939158|Meningococcal vaccine|meningococcal vaccine
1220659|NCT01939158|Toddlers|toddlers
1220660|NCT01939158|5 years|5 years
1220661|NCT01939145|hospital admission|hospital admission
1220662|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
1220663|NCT01939132|ACTH|acth
1220664|NCT01939132|Acthar|acthar
1220665|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
1220666|NCT01939119|drinking habits|drinking habits
1220667|NCT01939119|body hydration|body hydration
1220668|NCT01939119|body-fluid balance|body-fluid balance
1220669|NCT01939106|Stoma|stoma
1220670|NCT01939106|Ileostomy|ileostomy
1220671|NCT01939106|pouch|pouch
1220672|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
1220673|NCT01939093|Quetiapine|quetiapine
1220674|NCT01939093|Haloperidol|haloperidol
1220675|NCT01939093|Methamphetamine|methamphetamine
1220676|NCT01939093|Psychosis|psychosis
1220677|NCT01939080|moderate risk|moderate risk
1220678|NCT01939080|high risk|high risk
1220679|NCT01939067|respiratory distress|respiratory distress
1220680|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
1220681|NCT01939067|HHHFNC|hhhfnc
1220682|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
1220683|NCT01939067|NCPAP|ncpap
1220684|NCT01939041|Subacute Stroke|subacute stroke
1220685|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
1220686|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
1220687|NCT01939041|Motor control|motor control
1220688|NCT01939041|Physiological Response|physiological response
1220689|NCT01939015|3D miniplate|3d miniplate
1220690|NCT01939015|angle mandibular fracture|angle mandibular fracture
1220691|NCT01939015|champy technique|champy technique
1220692|NCT01939015|internal rigid fixation|internal rigid fixation
1220693|NCT01939002|flu-like symptoms|flu-like symptoms
1220694|NCT01938989|cataract|cataract
1220695|NCT01938989|intraocular lens|intraocular lens
1220696|NCT01938989|IOL|iol
1220697|NCT01938989|blue light filter|blue light filter
1220698|NCT01938976|Asthma|asthma
1220699|NCT01938976|Tobacco|tobacco
1220700|NCT01938976|Waterpipe|waterpipe
1220701|NCT01938976|Cigarettes|cigarettes
1220702|NCT01938976|Adolescents|adolescents
1220703|NCT01938976|Peer education|peer education
1220704|NCT01938976|Jordan|jordan
1220705|NCT01938963|Depression|depression
1220706|NCT01938963|Hypertension|hypertension
1220707|NCT01938963|Older Adults|older adults
1220708|NCT01938911|Trier social stress test|trier social stress test
1220709|NCT01938911|Oxytocin|oxytocin
1220710|NCT01938911|Hypertension|hypertension
1220711|NCT01938898|Randomized trial|randomized trial
1220712|NCT01938898|Invitation letter|invitation letter
1220713|NCT01938898|Recruitment|recruitment
1220714|NCT01938898|Retention|retention
1220715|NCT01938872|critical limb ischemia|critical limb ischemia
1220716|NCT01938872|drug-eluting balloon|drug-eluting balloon
1220717|NCT01938872|restenosis|restenosis
1220718|NCT01938859|bipolar disorder|bipolar disorder
1220719|NCT01938859|lithium|lithium
1220720|NCT01938859|quetiapine|quetiapine
1220721|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
1220722|NCT01938859|efficacy|efficacy
1220723|NCT01938859|safety|safety
1220724|NCT01938859|Recurrence|recurrence
1220725|NCT01938820|Hepatitis B|hepatitis b
1220726|NCT01938820|Liver Cirrhosis|liver cirrhosis
1220727|NCT01938820|Regression|regression
1220728|NCT01938820|Efficacy|efficacy
1220729|NCT01938807|type 1 diabetes|type 1 diabetes
1220730|NCT01938807|parents|parents
1220731|NCT01938807|mobile application|mobile application
1220732|NCT01938807|diabetes management|diabetes management
1220733|NCT01938781|Hepatitis B|hepatitis b
1220734|NCT01938781|Liver fibrosis|liver fibrosis
1220735|NCT01938781|Regression|regression
1220736|NCT01938781|Efficacy|efficacy
1220737|NCT01938768|Multiple trauma|multiple trauma
1220738|NCT01938768|Polytrauma|polytrauma
1220739|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
1220740|NCT01938768|Tranexamic acid|tranexamic acid
1220741|NCT01938768|Thrombelastometry|thrombelastometry
1220742|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
1220743|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
1220744|NCT01938729|FLOXURIDINE|floxuridine
1220745|NCT01938729|DEXAMETHASONE|dexamethasone
1220746|NCT01938729|GEMCITABINE|gemcitabine
1220747|NCT01938729|Pump|pump
1220748|NCT01938729|13-148|13-148
1220749|NCT01938716|Pancreatic Cancer|pancreatic cancer
1220750|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
1220751|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
1220752|NCT01938716|Pancreatic surgery|pancreatic surgery
1220753|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
1220755|NCT01938716|Gemcitabine|gemcitabine
1220756|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1220757|NCT01938716|Gemzar|gemzar
1220758|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
1220759|NCT01938677|Vestibular schwannoma|vestibular schwannoma
1220760|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
1220761|NCT01938677|Hearing preservation|hearing preservation
1220762|NCT01938664|cocaine|cocaine
1220763|NCT01938664|dependence|dependence
1220764|NCT01938664|pharmacotherapy|pharmacotherapy
1220765|NCT01938638|Advanced malignancies|advanced malignancies
1220766|NCT01938638|TNBC|tnbc
1220767|NCT01938638|DLBCL|dlbcl
1220768|NCT01938638|Gastric cancer|gastric cancer
1220769|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
1220770|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
1220771|NCT01938625|Pharmacokinetics|pharmacokinetics
1220772|NCT01938625|Simeprevir|simeprevir
1220773|NCT01938625|Daclatasvir|daclatasvir
1220774|NCT01938625|Ribavirin|ribavirin
1220775|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
1220776|NCT01938625|TMC435|tmc435
1220777|NCT01938625|BMS-790052|bms-790052
1220778|NCT01938625|RBV|rbv
1220779|NCT01938612|MEDI4736|medi4736
1220780|NCT01938612|Advanced solid tumors|advanced solid tumors
1220781|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
1220782|NCT01938612|biliary tract cancer|biliary tract cancer
1220783|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
1220784|NCT01938612|B7-H1|b7-h1
1220785|NCT01938612|PD-L1|pd-l1
1220786|NCT01938599|Plaque Psoriasis|plaque psoriasis
1220787|NCT01938586|Scar|scar
1220788|NCT01938586|Appearance|appearance
1220789|NCT01938547|perioperative|perioperative
1220790|NCT01938547|blood pressure|blood pressure
1220791|NCT01938547|pediatrics|pediatrics
1220792|NCT01938547|pediatric surgery|pediatric surgery
1220793|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
1220794|NCT01938521|Placebo (PLA)|placebo (pla)
1220795|NCT01938508|dermatitis|dermatitis
1220796|NCT01938508|Minocycline|minocycline
1220797|NCT01938508|bioavailability|bioavailability
1220799|NCT01938495|DPS|dps
1220800|NCT01938495|Diaphragm Pacing|diaphragm pacing
1220801|NCT01938482|SCD1|scd1
1220802|NCT01938482|Topical Administration|topical administration
1220803|NCT01938482|Acne|acne
1220804|NCT01938482|Gel|gel
1220805|NCT01938469|Bariatric|bariatric
1220806|NCT01938469|Gastric Bypass|gastric bypass
1220807|NCT01938469|Gastric Banding,|gastric banding,
1220808|NCT01938469|Incretins|incretins
1220809|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
1220810|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
1220811|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
1220812|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
1220813|NCT01938456|Japanese|japanese
1220814|NCT01938456|Phase Ib|phase ib
1220815|NCT01938456|combination therapy|combination therapy
1220816|NCT01938456|docetaxel|docetaxel
1220817|NCT01938456|MEK inhibitor|mek inhibitor
1220818|NCT01938443|pharmacodynamics|pharmacodynamics
1220819|NCT01938443|MEK inhibitor|mek inhibitor
1220820|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
1220821|NCT01938443|cancer|cancer
1220822|NCT01938443|pharmacokinetic|pharmacokinetic
1220823|NCT01938443|mesothelioma|mesothelioma
1220824|NCT01938443|Phase 1|phase 1
1220825|NCT01938417|tobramycin|tobramycin
1220826|NCT01938417|bone graft substitute|bone graft substitute
1220827|NCT01938417|pharmacokinetics|pharmacokinetics
1220828|NCT01938417|renal failure|renal failure
1220829|NCT01938404|Plasma exchange|plasma exchange
1220830|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
1220831|NCT01938404|TTP|ttp
1220832|NCT01938391|Peripheral Artery Disease|peripheral artery disease
1220833|NCT01938391|PAD|pad
1220834|NCT01938391|Claudication|claudication
1220835|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
1220836|NCT01938391|PVD|pvd
1220837|NCT01938391|Orbital Atherectomy|orbital atherectomy
1220838|NCT01938391|Balloon Angioplasty|balloon angioplasty
1220839|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
1220840|NCT01938378|Octaplas|octaplas
1220841|NCT01938352|Influenza|influenza
1220842|NCT01938352|Virus|virus
1220843|NCT01938352|Monoclonal Antibody|monoclonal antibody
1220844|NCT01938352|Immunization|immunization
1220845|NCT01938352|Treatment|treatment
1220846|NCT01938339|prostate cancer|prostate cancer
1220847|NCT01938339|MRI|mri
1220848|NCT01938339|PET|pet
1220849|NCT01938326|Stomach neoplasm|stomach neoplasm
1220850|NCT01938326|TLDG|tldg
1220851|NCT01938326|SIDG|sidg
1220852|NCT01938326|single-port|single-port
1220853|NCT01938326|inflammatory response|inflammatory response
1220854|NCT01938313|gastric cancer|gastric cancer
1220855|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
1220856|NCT01938313|fast track|fast track
1220857|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
1220858|NCT01938274|Hip|hip
1220859|NCT01938274|Knee|knee
1220860|NCT01938274|Osteoarthritis|osteoarthritis
1220861|NCT01938274|Arthroplasty|arthroplasty
1220862|NCT01938274|Physical Activity|physical activity
1220863|NCT01938274|Expectations|expectations
1220864|NCT01938274|Leisure Activity|leisure activity
1220865|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
1220866|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
1220867|NCT01938248|Atrial Fibrillation|atrial fibrillation
1220868|NCT01938248|Stroke Risk|stroke risk
1220869|NCT01938235|Myocardial infarction|myocardial infarction
1220870|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
1220871|NCT01938235|Reperfusion injury|reperfusion injury
1220872|NCT01938235|Exenatide|exenatide
1220873|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
1220874|NCT01938222|abdominal wall closure|abdominal wall closure
1220875|NCT01938222|short stitch technique|short stitch technique
1220876|NCT01938196|Chronic Constipation|chronic constipation
1220877|NCT01938196|Constipation|constipation
1220878|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
1220879|NCT01938183|chronic periodontitis|chronic periodontitis
1220880|NCT01938183|metronidazole|metronidazole
1220881|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
1220882|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1220883|NCT01938144|Common cold|common cold
1220884|NCT01938144|efficacy|efficacy
1220885|NCT01938144|symptoms|symptoms
1220886|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
1220887|NCT01938144|ibuprofen|ibuprofen
1220888|NCT01938144|phenylephrine|phenylephrine
1220889|NCT01938144|pseudoephedrine|pseudoephedrine
1220890|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
1220891|NCT01938118|Infant diet|infant diet
1220892|NCT01938118|Family diet|family diet
1220893|NCT01938118|Responsive feeding|responsive feeding
1220894|NCT01938118|Infant temperament|infant temperament
1220895|NCT01938118|Physical activity|physical activity
1220896|NCT01938118|Television|television
1220897|NCT01938105|Cervical cancer|cervical cancer
1220898|NCT01938105|Nimotuzumab|nimotuzumab
1220899|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
1220900|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1220901|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
1220902|NCT01938092|Spasm|spasm
1220903|NCT01938092|Pelvic pain|pelvic pain
1220904|NCT01938092|Diazepam|diazepam
1220905|NCT01938092|Female|female
1220906|NCT01938092|Randomized trial|randomized trial
1220907|NCT01938079|ECMO|ecmo
1220908|NCT01938079|Ketamine|ketamine
1220909|NCT01938079|Opiates|opiates
1220910|NCT01938079|Lung failure|lung failure
1220911|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1220912|NCT01938079|Mechanical ventilation|mechanical ventilation
1220913|NCT01938079|Sedation|sedation
1220914|NCT01938066|procellera|procellera
1220915|NCT01938053|STI, STD|sti, std
1220916|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1220917|NCT01938027|Rectal Neoplasms|rectal neoplasms
1220918|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
1220919|NCT01938027|transanal surgery|transanal surgery
1220920|NCT01938014|MPS I|mps i
1220921|NCT01938014|MPS II|mps ii
1220922|NCT01938014|MPS III|mps iii
1220923|NCT01938014|MPS VI|mps vi
1220924|NCT01938014|Krabbe disease|krabbe disease
1220925|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
1220926|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
1220927|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
1220928|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
1220929|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
1220930|NCT01938014|Lysosomal Disease Network|lysosomal disease network
1220931|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
1220932|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1220933|NCT01938014|telephone-based surveillance|telephone-based surveillance
1220934|NCT01938014|Hurler syndrome|hurler syndrome
1220935|NCT01938014|Hunter syndrome|hunter syndrome
1220936|NCT01938014|Scheie syndrome|scheie syndrome
1220937|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
1220938|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
1220939|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
1220940|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
1220941|NCT01937988|Doula|doula
1220942|NCT01937988|Abortion|abortion
1220943|NCT01937988|Pain|pain
1220944|NCT01937988|support|support
1220945|NCT01937949|Aortic aneurysm|aortic aneurysm
1220946|NCT01937936|caregiver stress|caregiver stress
1220947|NCT01937936|depression|depression
1220948|NCT01937936|quality of life|quality of life
1220949|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
1220950|NCT01937910|neuroplastic change|neuroplastic change
1220951|NCT01937910|myelin|myelin
1220952|NCT01937897|Unilateral Massage|unilateral massage
1220953|NCT01937897|Depression|depression
1220954|NCT01937858|HbA1c|hba1c
1220955|NCT01937858|glycated hemoglobin|glycated hemoglobin
1220956|NCT01937858|correlation|correlation
1220957|NCT01937858|diabetes|diabetes
1220958|NCT01937858|renal failure|renal failure
1220959|NCT01937819|BOWEL PREPARATION|bowel preparation
1220960|NCT01937819|SMARTPHONE APPLICATION|smartphone application
1220961|NCT01937806|Chronic hepatitis B|chronic hepatitis b
1220962|NCT01937793|radiation|radiation
1221552|NCT01934777|fibrosis|fibrosis
1220963|NCT01937793|speech-language pathology|speech-language pathology
1220964|NCT01937754|Prehypertension|prehypertension
1220965|NCT01937754|Nitric Oxide|nitric oxide
1220966|NCT01937754|Blood Pressure|blood pressure
1220967|NCT01937754|Functional Capacity|functional capacity
1220968|NCT01937754|Quality of Life|quality of life
1220969|NCT01937728|Hepatitis C|hepatitis c
1220970|NCT01937728|Genotype 1|genotype 1
1220971|NCT01937728|Peg interferon|peg interferon
1220972|NCT01937728|alfa 1a|alfa 1a
1220973|NCT01937728|Ribavirin|ribavirin
1220974|NCT01937689|Breast cancer|breast cancer
1220975|NCT01937689|advanced|advanced
1220976|NCT01937689|Pyrotinib|pyrotinib
1220977|NCT01937689|Phase I|phase i
1220978|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
1220979|NCT01937663|Chronic Constipation|chronic constipation
1220980|NCT01937663|Constipation|constipation
1220981|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
1220982|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
1220983|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
1220984|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
1220985|NCT01937611|dexmedetomidine|dexmedetomidine
1220986|NCT01937611|intramuscular premedication|intramuscular premedication
1220987|NCT01937611|bradycardiac|bradycardiac
1220988|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
1220989|NCT01937585|prostate cancer|prostate cancer
1220990|NCT01937585|partner|partner
1220991|NCT01937585|communication messages|communication messages
1220992|NCT01937585|monitoring style|monitoring style
1220993|NCT01937585|AA men|aa men
1220994|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
1220995|NCT01937572|Computer aided systems|computer aided systems
1220996|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
1220997|NCT01937546|Anal Canal/injuries|anal canal/injuries
1220998|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
1220999|NCT01937546|Labour Stage, Second|labour stage, second
1221000|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
1221001|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
1221002|NCT01937546|perineum/injuries|perineum/injuries
1221003|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
1221004|NCT01937520|acupuncture|acupuncture
1221005|NCT01937520|inflammation|inflammation
1221006|NCT01937520|thyroid|thyroid
1221007|NCT01937520|parathyroid|parathyroid
1221008|NCT01937494|asthma|asthma
1221009|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1221010|NCT01937494|histamine challenge test|histamine challenge test
1221011|NCT01937494|spirometry|spirometry
1221012|NCT01937481|Child, Preschool|child, preschool
1221013|NCT01937481|Parents|parents
1221014|NCT01937481|Family|family
1221015|NCT01937481|Obesity|obesity
1221016|NCT01937481|Overweight|overweight
1221017|NCT01937481|Diet|diet
1221018|NCT01937481|Overnutrition|overnutrition
1221019|NCT01937481|Motor Activity|motor activity
1221020|NCT01937481|Child Care|child care
1221021|NCT01937481|Schools|schools
1221022|NCT01937468|Chronic GVHD|chronic gvhd
1221023|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
1221024|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
1221025|NCT01937455|HIV|hiv
1221026|NCT01937455|AIDS|aids
1221027|NCT01937455|HIV vaccine|hiv vaccine
1221028|NCT01937455|HIV prevention|hiv prevention
1221029|NCT01937455|AAV|aav
1221030|NCT01937455|PG9|pg9
1221031|NCT01937442|Multiple myeloma|multiple myeloma
1221032|NCT01937442|Pharmacokinetics|pharmacokinetics
1221033|NCT01937442|Thalidomide|thalidomide
1221034|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
1221035|NCT01937403|Physical Therapy|physical therapy
1221036|NCT01937403|Return to sport|return to sport
1221037|NCT01937351|Atherectomy|atherectomy
1221038|NCT01937351|Optical Coherence Tomography|optical coherence tomography
1221039|NCT01937351|Lumivascular|lumivascular
1221040|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
1221334|NCT01935700|colchicine|colchicine
1221041|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
1221042|NCT01937312|glaucoma|glaucoma
1221043|NCT01937312|prostaglandin analogue|prostaglandin analogue
1221044|NCT01937312|brinzolamide|brinzolamide
1221045|NCT01937312|brimonidine|brimonidine
1221046|NCT01937299|glaucoma|glaucoma
1221047|NCT01937299|prostaglandin analogue|prostaglandin analogue
1221048|NCT01937299|brinzolamide|brinzolamide
1221049|NCT01937299|brimonidine|brimonidine
1221050|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
1221051|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
1221052|NCT01937247|Operative Time|operative time
1221053|NCT01937247|Operating Rooms|operating rooms
1221054|NCT01937247|Efficiency|efficiency
1221055|NCT01937221|mild cognitive impairment|mild cognitive impairment
1221056|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
1221751|NCT01933815|Bevacizumab|bevacizumab
1221057|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
1221058|NCT01937208|chemoradiation|chemoradiation
1221059|NCT01937208|radiation dose|radiation dose
1221060|NCT01937195|IV Catheter comparison|iv catheter comparison
1221061|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
1221062|NCT01937195|IV Catheter Study|iv catheter study
1221063|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
1221064|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
1221065|NCT01937195|AccuCath Device Performance|accucath device performance
1221066|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
1221067|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
1221068|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
1221069|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
1221070|NCT01937182|Stroke|stroke
1221071|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
1221072|NCT01937182|Serotonin|serotonin
1221073|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
1221074|NCT01937182|Neuroprotection|neuroprotection
1221075|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1221076|NCT01937182|Platelet|platelet
1221077|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
1221078|NCT01937182|Post Stroke Depression|post stroke depression
1590321|NCT00430313|CINV|cinv
1221079|NCT01937143|parent education|parent education
1221080|NCT01937143|immunization|immunization
1221081|NCT01937143|vaccination|vaccination
1221082|NCT01937143|infant|infant
1221083|NCT01937143|pain management|pain management
1221084|NCT01937130|Liver Failure|liver failure
1221085|NCT01937130|Cirrhosis|cirrhosis
1221086|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
1221087|NCT01937117|Breast cancer|breast cancer
1221088|NCT01937117|Preoperative treatment|preoperative treatment
1221089|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
1221090|NCT01937104|Intracranial pressure|intracranial pressure
1221091|NCT01937104|Laparoscopy|laparoscopy
1221092|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
1221093|NCT01937104|Position|position
1221095|NCT01937091|clinical trials|clinical trials
1221096|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
1221097|NCT01937013|emotion|emotion
1221098|NCT01937013|oxytocin|oxytocin
1221099|NCT01937013|fMRI|fmri
1221100|NCT01936961|Cancer|cancer
1221101|NCT01936948|Large colon polyps|large colon polyps
1221102|NCT01936948|Polyp resection|polyp resection
1221103|NCT01936948|Colon cancer screening|colon cancer screening
1221104|NCT01936948|Colonoscopy|colonoscopy
1221105|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
1221106|NCT01936935|Insulin sensitivity|insulin sensitivity
1221107|NCT01936922|Fall accidents|fall accidents
1221108|NCT01936922|Gait|gait
1221109|NCT01936922|Balance|balance
1221110|NCT01936922|Fear of falling|fear of falling
1221111|NCT01936922|Virtual reality|virtual reality
1221112|NCT01936896|Acute myocardial infarction|acute myocardial infarction
1221113|NCT01936896|Heart Failure|heart failure
1221114|NCT01936896|Inflammation|inflammation
1221115|NCT01936883|prostatic neoplasm|prostatic neoplasm
1221116|NCT01936883|brachytherapy|brachytherapy
1221117|NCT01936883|quality of life|quality of life
1221118|NCT01936883|high dose rate|high dose rate
1221119|NCT01936883|low dose rate|low dose rate
1221120|NCT01936870|Toviaz|toviaz
1221121|NCT01936870|Fesoterodine|fesoterodine
1221122|NCT01936870|Post marketing surveillance|post marketing surveillance
1221123|NCT01936870|Japanese|japanese
1221124|NCT01936870|Overactive Bladder|overactive bladder
1221125|NCT01936870|OAB|oab
1221126|NCT01936870|Good post marketing practice|good post marketing practice
1221127|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1221128|NCT01936792|Concussion|concussion
1221129|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
1221130|NCT01936792|Traumatic Brain Injury|traumatic brain injury
1221131|NCT01936779|plasma triglycerides|plasma triglycerides
1221132|NCT01936779|dietary fat|dietary fat
1221133|NCT01936779|liver fat metabolism|liver fat metabolism
1221134|NCT01936779|human|human
1221135|NCT01936766|malaria, falciparum|malaria, falciparum
1221136|NCT01936766|sepsis|sepsis
1221137|NCT01936766|fluid therapy|fluid therapy
1221138|NCT01936766|thermodilution|thermodilution
1221139|NCT01936766|extravascular lung water|extravascular lung water
1221140|NCT01936766|acute kidney injury|acute kidney injury
1221141|NCT01936753|PMTCT|pmtct
1221142|NCT01936753|HIV|hiv
1221143|NCT01936753|Mentor Mothers|mentor mothers
1221144|NCT01936753|Nigeria|nigeria
1221145|NCT01936753|Retention|retention
1221146|NCT01936753|Adherence|adherence
1221147|NCT01936740|Efficacy and Safety|efficacy and safety
1221148|NCT01936727|efficiency and safety|efficiency and safety
1221149|NCT01936714|Efficacy and Safety|efficacy and safety
1221150|NCT01936675|Coronary Artery Disease|coronary artery disease
1221151|NCT01936675|Myocardial Infarction|myocardial infarction
1221152|NCT01936675|Genomic Risk Communication|genomic risk communication
1221153|NCT01936675|Risk Stratification|risk stratification
1221154|NCT01936662|Airway management comparison|airway management comparison
1221155|NCT01936649|Nuclear imaging|nuclear imaging
1221156|NCT01936649|Radiopharmaceutical|radiopharmaceutical
1221157|NCT01936649|Iobenguane|iobenguane
1221158|NCT01936649|I-123|i-123
1221159|NCT01936649|reproducibility|reproducibility
1221160|NCT01936649|Quantitative measurements|quantitative measurements
1221161|NCT01936649|myocardial uptake|myocardial uptake
1221162|NCT01936649|SPECT imaging|spect imaging
1221163|NCT01936649|planar imaging|planar imaging
1221164|NCT01936649|AdreView™|adreview™
1221165|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
1221166|NCT01936636|diary|diary
1221167|NCT01936636|quality of life|quality of life
1221168|NCT01936636|Abstral|abstral
1221169|NCT01936636|BTcP|btcp
1221170|NCT01936623|brief intervention|brief intervention
1221171|NCT01936623|computerized brief intervention|computerized brief intervention
1221172|NCT01936610|Lecture|lecture
1221173|NCT01936610|Role-playing|role-playing
1221174|NCT01936610|Knowledge|knowledge
1221175|NCT01936610|Attitude|attitude
1221176|NCT01936610|Decision making|decision making
1221177|NCT01936610|Type of delivery|type of delivery
1221178|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
1221179|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
1590322|NCT00430313|Cisplatin|cisplatin
1302993|NCT01570582|ECG|ecg
1221180|NCT01936532|multiple myeloma|multiple myeloma
1221181|NCT01936519|Everolimus|everolimus
1221182|NCT01936519|Zortress|zortress
1221183|NCT01936519|Renal Function|renal function
1221184|NCT01936519|Tacrolimus|tacrolimus
1221185|NCT01936519|Cyclosporine|cyclosporine
1221186|NCT01936519|Myfortic|myfortic
1221187|NCT01936519|Mycophenolic Acid|mycophenolic acid
1221188|NCT01936519|Liver Transplantation|liver transplantation
1221189|NCT01936506|Cognitive training|cognitive training
1221190|NCT01936506|Depression|depression
1221191|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
1221192|NCT01936493|Uterine fibroids|uterine fibroids
1221193|NCT01936493|Fibroids|fibroids
1221194|NCT01936493|Uterine leiomyomas|uterine leiomyomas
1221195|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
1221196|NCT01936467|Pancreatic mass|pancreatic mass
1221197|NCT01936467|Pancreatic cancer|pancreatic cancer
1221198|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
1221199|NCT01936467|EUS|eus
1221200|NCT01936467|Fine needle aspiration|fine needle aspiration
1221201|NCT01936467|FNA|fna
1221202|NCT01936467|EUS-FNA|eus-fna
1221203|NCT01936441|Menopause|menopause
1221204|NCT01936441|Vasomotor|vasomotor
1221205|NCT01936441|Symptoms|symptoms
1221206|NCT01936441|Sleep|sleep
1221207|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
1221208|NCT01936415|Knee prosthesis|knee prosthesis
1221209|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1221210|NCT01936376|kidney safety|kidney safety
1221211|NCT01936376|biomarkers|biomarkers
1221212|NCT01936376|serum creatinine|serum creatinine
1221213|NCT01936376|BUN|bun
1221214|NCT01936376|cystic fibrosis|cystic fibrosis
1221215|NCT01936376|head and neck cancer|head and neck cancer
1221216|NCT01936376|renal injury|renal injury
1221217|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
1221218|NCT01936376|aminoglycoside|aminoglycoside
1221219|NCT01936376|cisplatin|cisplatin
1221220|NCT01936376|nephrotoxicity|nephrotoxicity
1221221|NCT01936376|biomarker qualification|biomarker qualification
1221222|NCT01936363|Ovarian Cancer|ovarian cancer
1221223|NCT01936363|Pimasertib|pimasertib
1221224|NCT01936363|Placebo|placebo
1221225|NCT01936363|SAR245409|sar245409
1221226|NCT01936350|Heart failure|heart failure
1221227|NCT01936324|acne vulgaris|acne vulgaris
1221228|NCT01936311|Health Behavior|health behavior
1221229|NCT01936311|Behavior change|behavior change
1221230|NCT01936311|self-management goal|self-management goal
1221231|NCT01936311|health goal|health goal
1221232|NCT01936298|Hand Edema|hand edema
1221233|NCT01936298|Exercise Therapy|exercise therapy
1221234|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
1221235|NCT01936233|Aspirin|aspirin
1221236|NCT01936233|antiviral treatment|antiviral treatment
1222504|NCT01930448|GIP|gip
1221237|NCT01936233|recurrence free survival|recurrence free survival
1221238|NCT01936233|radical therapy|radical therapy
1221239|NCT01936220|Schizophrenia|schizophrenia
1221240|NCT01936220|First-psychotic episode|first-psychotic episode
1221241|NCT01936220|Initial phase|initial phase
1221242|NCT01936220|Relapse prevention|relapse prevention
1221243|NCT01936220|Specialized treatment|specialized treatment
1221244|NCT01936220|Parent groups|parent groups
1221245|NCT01936220|Social functioning|social functioning
1221246|NCT01936207|acute|acute
1221247|NCT01936207|respiratory|respiratory
1221248|NCT01936207|syndrome|syndrome
1221249|NCT01936207|prognosis|prognosis
1221250|NCT01936207|outcome research|outcome research
1221251|NCT01936207|respiratory infection|respiratory infection
1221252|NCT01936207|sepsis|sepsis
1221253|NCT01936207|organ failure|organ failure
1222046|NCT01932502|epilepsy|epilepsy
1221254|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
1221255|NCT01936181|Infliximab|infliximab
1221256|NCT01936181|Biosimilar|biosimilar
1221257|NCT01936168|GSV|gsv
1221258|NCT01936168|Primary Varicose Veins|primary varicose veins
1221259|NCT01936168|Great Saphenous Vein|great saphenous vein
1221260|NCT01936168|Treatment|treatment
1221261|NCT01936155|Joint Mobility|joint mobility
1221262|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
1221263|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1221264|NCT01936155|Goniometry|goniometry
1221265|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
1221266|NCT01936155|Water Displacement|water displacement
1221267|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
1221268|NCT01936142|Kidney|kidney
1221269|NCT01936142|Contrast media|contrast media
1221270|NCT01936142|Prevention|prevention
1221271|NCT01936116|Sonohysterography|sonohysterography
1221272|NCT01936116|catheter placement|catheter placement
1221273|NCT01936116|pain magnitude|pain magnitude
1221274|NCT01936116|vasovagal reaction|vasovagal reaction
1221275|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
1221276|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
1221277|NCT01936103|Intensive statin therapy|intensive statin therapy
1221278|NCT01936103|Left ventricular function|left ventricular function
1221279|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
1221280|NCT01936064|Breast Cancer|breast cancer
1221281|NCT01936064|Jobelyn|jobelyn
1221282|NCT01936064|Sorghum bicolor|sorghum bicolor
1221283|NCT01936038|CPAP|cpap
1221284|NCT01936038|Upper Airway Toning|upper airway toning
1221285|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
1221286|NCT01936025|Diabetes mellitus|diabetes mellitus
1221287|NCT01936012|Lisinopril|lisinopril
1221288|NCT01936012|Bioequivalence|bioequivalence
1221289|NCT01936012|Bioavailability|bioavailability
1221290|NCT01936012|Pharmacokinetic|pharmacokinetic
1221291|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
1221292|NCT01935999|Colostomy|colostomy
1221293|NCT01935999|peristomal skin|peristomal skin
1221294|NCT01935999|stoma|stoma
1221295|NCT01935999|pouch|pouch
1221296|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1221297|NCT01935908|Seizures|seizures
1221298|NCT01935908|Prophylaxis|prophylaxis
1221299|NCT01935908|Levetiracetam|levetiracetam
1221300|NCT01935895|blood pressure reduction|blood pressure reduction
1221301|NCT01935895|vascular reactivity|vascular reactivity
1221302|NCT01935895|combined exercise session|combined exercise session
1221303|NCT01935856|patients|patients
1221304|NCT01935856|receiving|receiving
1221305|NCT01935856|hemodialysis|hemodialysis
1221306|NCT01935856|Secondary|secondary
1221307|NCT01935843|CART-HER-2|cart-her-2
1221308|NCT01935843|HER-2 positive|her-2 positive
1221309|NCT01935843|Advanced|advanced
1221310|NCT01935843|Refactory|refactory
1221311|NCT01935843|Solid tumors|solid tumors
1221312|NCT01935830|PET Imaging|pet imaging
1221313|NCT01935830|Efavirenz|efavirenz
1221314|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
1221315|NCT01935830|Healthy volunteers|healthy volunteers
1221316|NCT01935804|pioglitazone|pioglitazone
1221317|NCT01935804|metformin|metformin
1221318|NCT01935804|hyperglycemic agents|hyperglycemic agents
1221319|NCT01935804|physiological effects of drugs|physiological effects of drugs
1221320|NCT01935804|bone health|bone health
1221321|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
1221322|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
1221323|NCT01935752|fibromuscular|fibromuscular
1221324|NCT01935752|dysplasia|dysplasia
1221325|NCT01935752|endothelium|endothelium
1221326|NCT01935752|microparticles|microparticles
1221327|NCT01935752|microRNA|microrna
1221328|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
1221329|NCT01935726|Interstitial lung disease|interstitial lung disease
1221330|NCT01935726|Connective tissue disease|connective tissue disease
1221331|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
1221332|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1221333|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
1221335|NCT01935687|Instrumented Wheel|instrumented wheel
1221336|NCT01935687|Manual Wheelchair|manual wheelchair
1221337|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
1221338|NCT01935687|Manual wheelchair Users|manual wheelchair users
1221339|NCT01935687|Aged between 18-70 years|aged between 18-70 years
1221340|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
1221342|NCT01935674|Rosuvastatin|rosuvastatin
1221343|NCT01935674|Protease inhibitor switching|protease inhibitor switching
1221344|NCT01935661|Blood transfusion|blood transfusion
1221345|NCT01935661|Hemosiderosis|hemosiderosis
1221346|NCT01935661|ERP|erp
1221347|NCT01935648|Knee arthroplasty|knee arthroplasty
1221348|NCT01935635|CHB|chb
1221349|NCT01935635|Antiviral|antiviral
1221350|NCT01935635|Dentritic cells|dentritic cells
1221351|NCT01935635|Immune Therapy|immune therapy
1222047|NCT01932502|Onfi|onfi
1221352|NCT01935622|heart failure|heart failure
1221353|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
1221354|NCT01935609|traumatic brain injury|traumatic brain injury
1221355|NCT01935609|acquired brain injury|acquired brain injury
1221356|NCT01935596|Anesthesia|anesthesia
1221357|NCT01935596|Randomized study|randomized study
1221358|NCT01935596|Lower limbs surgery|lower limbs surgery
1221359|NCT01935583|traumatic brain injury|traumatic brain injury
1221360|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
1221361|NCT01935570|Digestive and general tolerance|digestive and general tolerance
1221362|NCT01935557|Continuous heparin infusion|continuous heparin infusion
1221363|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
1221364|NCT01935557|during catheter ablation|during catheter ablation
1221365|NCT01935544|Botulinum Toxin|botulinum toxin
1221366|NCT01935544|Ultrasound-guidance|ultrasound-guidance
1221367|NCT01935544|Stroke|stroke
1221368|NCT01935544|Spasticity|spasticity
1221369|NCT01935544|Ultrasonography|ultrasonography
1221370|NCT01935544|Hemiplegia|hemiplegia
1221371|NCT01935531|actinic keratoses|actinic keratoses
1221372|NCT01935531|tumor metabolism|tumor metabolism
1221373|NCT01935531|glycolysis|glycolysis
1221374|NCT01935531|diclofenac|diclofenac
1221375|NCT01935531|warburg effect|warburg effect
1221376|NCT01935505|smoking cessation|smoking cessation
1221377|NCT01935505|intervention model|intervention model
1221378|NCT01935505|Chinese|chinese
1221379|NCT01935505|quitting rate|quitting rate
1221380|NCT01935492|metastatic breast cancer|metastatic breast cancer
1221381|NCT01935492|HER2/neu negative|her2/neu negative
1221382|NCT01935492|paclitaxel|paclitaxel
1221383|NCT01935492|bevacizumab|bevacizumab
1221384|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
1221385|NCT01935492|capecitabine|capecitabine
1221386|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
1221387|NCT01935466|Pioglitazone|pioglitazone
1221388|NCT01935466|Bladder cancer|bladder cancer
1221389|NCT01935466|Type 2 Diabetes|type 2 diabetes
1221390|NCT01935440|HIV, drug use|hiv, drug use
1221391|NCT01935427|Pulse Oximeter|pulse oximeter
1221392|NCT01935427|Stroke Volume|stroke volume
1221393|NCT01935427|Hemorrhagic shock|hemorrhagic shock
1221394|NCT01935427|Compensatory Reserve Index|compensatory reserve index
1221395|NCT01935401|Bulimia Nervosa|bulimia nervosa
1221396|NCT01935401|Bulimia|bulimia
1221397|NCT01935401|Response Inhibition|response inhibition
1221398|NCT01935401|fNIR|fnir
1221399|NCT01935401|Neuroimaging|neuroimaging
1221400|NCT01935388|Mechanical ventilation|mechanical ventilation
1221401|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1221402|NCT01935388|asthma|asthma
1221403|NCT01935388|common canister|common canister
1221404|NCT01935388|MDI|mdi
1221405|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
1221406|NCT01935375|Postpartum Depression|postpartum depression
1221407|NCT01935375|Nurse Midwife|nurse midwife
1221408|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
1221409|NCT01935362|Flavanones|flavanones
1221410|NCT01935362|Bioavailability|bioavailability
1221411|NCT01935362|Blood vessel health|blood vessel health
1221412|NCT01935362|Blood glucose|blood glucose
1221413|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
1221414|NCT01935349|hypertension (HT)|hypertension (ht)
1221415|NCT01935349|Hong Kong|hong kong
1221416|NCT01935336|Lung Cancer|lung cancer
1221417|NCT01935336|Malignancy|malignancy
1221418|NCT01935336|Predictive biomarkers|predictive biomarkers
1221419|NCT01935323|high intensity interval training|high intensity interval training
1221420|NCT01935323|aerobic exercise|aerobic exercise
1221421|NCT01935323|insulin sensitivity|insulin sensitivity
1221422|NCT01935323|obesity|obesity
1221423|NCT01935323|cardiovascular fitness|cardiovascular fitness
1221424|NCT01935310|Photoaging|photoaging
1221425|NCT01935310|imiquimod|imiquimod
1221426|NCT01935310|wrinkles|wrinkles
1221427|NCT01935310|elastosis|elastosis
1221428|NCT01935271|immunosenescence|immunosenescence
1221429|NCT01935271|sarcopenia|sarcopenia
1221430|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
1221431|NCT01935258|Somatization|somatization
1221432|NCT01935258|Psychosomatic therapy|psychosomatic therapy
1221433|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
1221434|NCT01935245|Extracorporeal circulation|extracorporeal circulation
1221435|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
1221436|NCT01935245|Coagulopathy|coagulopathy
1221437|NCT01935245|Thrombocytopathy|thrombocytopathy
1221438|NCT01935245|Platelet dysfunction|platelet dysfunction
1221439|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
1221440|NCT01935219|mild cognitive impairment|mild cognitive impairment
1221441|NCT01935219|seniors|seniors
1221442|NCT01935219|cognitive training|cognitive training
1221443|NCT01935219|driving|driving
1221444|NCT01935219|driving simulation|driving simulation
1221445|NCT01935219|intervention|intervention
1221446|NCT01935219|goal management training|goal management training
1221447|NCT01935219|process speed training|process speed training
1221448|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
1221449|NCT01935206|allodynia|allodynia
1221450|NCT01935206|mechanical pain threshold|mechanical pain threshold
1221451|NCT01935206|naloxone|naloxone
1221452|NCT01935206|endogenous opioids|endogenous opioids
1221453|NCT01935206|pain|pain
1221454|NCT01935193|platelets aggregation|platelets aggregation
1221455|NCT01935193|asa resistance|asa resistance
1221456|NCT01935180|colon polyps|colon polyps
1221457|NCT01935180|adenoma resection|adenoma resection
1221458|NCT01935180|colon cancer screening|colon cancer screening
1221459|NCT01935180|colonoscopy|colonoscopy
1221460|NCT01935180|polyp detection|polyp detection
1221461|NCT01935167|Microalbuminuria|microalbuminuria
1221462|NCT01935154|NSCLC|nsclc
1221463|NCT01935154|Vaccine|vaccine
1221464|NCT01935141|Pulmonary Embolus|pulmonary embolus
1221465|NCT01935141|Radio Contrast Material|radio contrast material
1221466|NCT01935141|Computed Tomography|computed tomography
1221467|NCT01935128|Renal Transplant|renal transplant
1221468|NCT01935128|Immunosuppression|immunosuppression
1221469|NCT01935128|Steroid Avoidance|steroid avoidance
1221470|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
1221471|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
1221472|NCT01935128|Kidney|kidney
1221473|NCT01935115|Depression|depression
1221474|NCT01935115|MDD|mdd
1221475|NCT01935115|Treatment Resistant Depression|treatment resistant depression
1221476|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
1221477|NCT01935115|ECT|ect
1221478|NCT01935115|Ketamine|ketamine
1221479|NCT01935115|Propofol|propofol
1221480|NCT01935115|NMDA|nmda
1221481|NCT01935102|metastatic breast cancer|metastatic breast cancer
1221482|NCT01935102|bevacizumab|bevacizumab
1221483|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
1221484|NCT01935102|VEGF-A|vegf-a
1221485|NCT01935102|VEGFR-2|vegfr-2
1221486|NCT01935102|IL-8|il-8
1221487|NCT01935089|HIV-1|hiv-1
1221488|NCT01935089|Interferon alpha|interferon alpha
1221489|NCT01935089|Integrated DNA|integrated dna
1221490|NCT01935089|Latent reservoir|latent reservoir
1221491|NCT01935076|Maternal obesity|maternal obesity
1221492|NCT01935076|Macrosomic|macrosomic
1221493|NCT01935076|miRNA|mirna
1221494|NCT01935076|Fetal overgrowth|fetal overgrowth
1221495|NCT01935063|Vulvodynia|vulvodynia
1221496|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
1221497|NCT01935063|Vulvar pain|vulvar pain
1221498|NCT01935063|Dyspareunia|dyspareunia
1221499|NCT01935063|Couples therapy|couples therapy
1221500|NCT01935063|Lidocaine|lidocaine
1221501|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
1221502|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
1221503|NCT01935063|Pain|pain
1221504|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
1221505|NCT01935050|Depression|depression
1221506|NCT01935050|Parkinson's disease|parkinson's disease
1221507|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
1221508|NCT01935024|Alzheimer's disease|alzheimer's disease
1221509|NCT01935024|dementia|dementia
1221510|NCT01935024|aerobic exercise|aerobic exercise
1221511|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
1221512|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
1221513|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
1221514|NCT01934985|Ischemia|ischemia
1221515|NCT01934985|Stress test|stress test
1221516|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1221517|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
1221518|NCT01934985|Coronary Angiography|coronary angiography
1221519|NCT01934972|Bipolar disorder|bipolar disorder
1221520|NCT01934946|hip fracture|hip fracture
1221521|NCT01934933|inflammation|inflammation
1221522|NCT01934933|etanercept|etanercept
1221523|NCT01934933|celecoxib|celecoxib
1221524|NCT01934933|ankylsoing spondylitis|ankylsoing spondylitis
1221525|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
1221526|NCT01934894|intracranial metastases|intracranial metastases
1221527|NCT01934894|lapatinib|lapatinib
1221528|NCT01934894|cabazitaxel|cabazitaxel
1221529|NCT01934868|low back pain|low back pain
1221530|NCT01934868|sciatica|sciatica
1221531|NCT01934868|spinal stenosis|spinal stenosis
1221532|NCT01934868|epidural injections|epidural injections
1221533|NCT01934868|prolotherapy|prolotherapy
1222607|NCT01929837|Tinnitus|tinnitus
1221534|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
1221536|NCT01934855|radiotherapy|radiotherapy
1221537|NCT01934855|4D-MRI|4d-mri
1221538|NCT01934855|4D-CT|4d-ct
1221539|NCT01934855|MRI|mri
1221540|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
1221541|NCT01934803|Alcohol Use|alcohol use
1221542|NCT01934803|Microbial Translocation|microbial translocation
1221543|NCT01934803|Inflammation|inflammation
1221544|NCT01934803|Altered Coagulation|altered coagulation
1221545|NCT01934803|Russia|russia
1221546|NCT01934803|Zinc|zinc
1221547|NCT01934803|AMI|ami
1221548|NCT01934803|VACS index|vacs index
1221549|NCT01934803|Reynolds risk score|reynolds risk score
1221550|NCT01934777|NAFLD|nafld
1221551|NCT01934777|NASH|nash
1221553|NCT01934738|Multiple dose|multiple dose
1221554|NCT01934738|safety|safety
1221555|NCT01934738|tolerability|tolerability
1221556|NCT01934738|PK|pk
1221557|NCT01934725|Ischemic Stroke|ischemic stroke
1221558|NCT01934725|Brain Infarction|brain infarction
1221559|NCT01934725|Patent Foramen Ovale|patent foramen ovale
1221560|NCT01934725|Stroke in the Young|stroke in the young
1221561|NCT01934725|Myocardial Infarction|myocardial infarction
1221562|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
1221563|NCT01934725|Pulmonary Embolism|pulmonary embolism
1221564|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
1221565|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1221566|NCT01934725|Prognosis|prognosis
1221567|NCT01934725|Databases, Genetic|databases, genetic
1221568|NCT01934699|Coronary stenosis|coronary stenosis
1221569|NCT01934699|Angina pectoris|angina pectoris
1221570|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
1221571|NCT01934699|2D-Strain|2d-strain
1221572|NCT01934660|Cardiovascular Disease|cardiovascular disease
1221573|NCT01934660|Diabetes Mellitus|diabetes mellitus
1221574|NCT01934660|Inflammation|inflammation
1221575|NCT01934634|Pancreatic Cancer|pancreatic cancer
1221576|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
1221577|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
1221578|NCT01934621|Stroke|stroke
1221579|NCT01934621|Rehabilitation|rehabilitation
1221580|NCT01934621|Cognition|cognition
1221581|NCT01934621|Disability|disability
1221582|NCT01934595|Critically ill|critically ill
1221583|NCT01934595|Protein|protein
1221584|NCT01934595|Supplement|supplement
1221585|NCT01934595|ICU|icu
1221586|NCT01934595|Protein synthesis|protein synthesis
1221587|NCT01934530|implant complications|implant complications
1221588|NCT01934530|esthetics|esthetics
1221589|NCT01934530|soft tissue grafting|soft tissue grafting
1221590|NCT01934504|clinical tolerance|clinical tolerance
1221591|NCT01934504|biomarker(s) identification|biomarker(s) identification
1221592|NCT01934491|Cognitive training|cognitive training
1221593|NCT01934491|Depression|depression
1221594|NCT01934478|Breast|breast
1221595|NCT01934478|Cancer|cancer
1221596|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
1221597|NCT01934478|irradiation|irradiation
1221598|NCT01934465|NSCLC|nsclc
1221599|NCT01934465|Chemotherapy|chemotherapy
1221600|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
1221601|NCT01934465|Bevacizumab|bevacizumab
1221602|NCT01934465|1st Line|1st line
1221603|NCT01934452|complete remission|complete remission
1221604|NCT01934439|Stroke|stroke
1221605|NCT01934439|Rehabilitation|rehabilitation
1221606|NCT01934439|Dyssynergia|dyssynergia
1221607|NCT01934439|Robotics|robotics
1221608|NCT01934439|AMES|ames
1221609|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
1221610|NCT01934426|Admission High Risk Elderly|admission high risk elderly
1221611|NCT01934413|Palliative Care|palliative care
1221612|NCT01934413|Technology|technology
1221613|NCT01934413|Rural|rural
1221614|NCT01934413|Transitional Care|transitional care
1221615|NCT01934400|Osteoporosis|osteoporosis
1221616|NCT01934400|fall prevention|fall prevention
1221617|NCT01934400|high risk population|high risk population
1221618|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
1221619|NCT01934387|Osteoporosis|osteoporosis
1221620|NCT01934387|Aged|aged
1221621|NCT01934387|Prevention|prevention
1221622|NCT01934387|Fracture|fracture
1221623|NCT01934387|FRAX|frax
1221624|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
1221625|NCT01934361|BKM120|bkm120
1221626|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1221627|NCT01934361|rGBM|rgbm
1221628|NCT01934361|buparlisib|buparlisib
1221629|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
1221630|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
1221631|NCT01934322|vulnerable populations|vulnerable populations
1221632|NCT01934322|case management|case management
1221633|NCT01934322|cost savings intervention|cost savings intervention
1221634|NCT01934322|quality of life|quality of life
1221635|NCT01934322|number of emergency department visits|number of emergency department visits
1221636|NCT01934309|tuberculosis|tuberculosis
1221637|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
1221638|NCT01934309|clinical decision support|clinical decision support
1221639|NCT01934309|HIV|hiv
1221640|NCT01934309|Kenya|kenya
1221641|NCT01934309|eHealth|ehealth
1221642|NCT01934296|deep brain stimulation|deep brain stimulation
1221643|NCT01934296|cortical recording|cortical recording
1221644|NCT01934296|neuroprosthesis|neuroprosthesis
1221645|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
1221646|NCT01934231|Amoxicilin|amoxicilin
1221647|NCT01934231|Infection|infection
1221648|NCT01934231|Potassium clavulanate|potassium clavulanate
1221649|NCT01934218|Knee|knee
1221650|NCT01934218|Osteoarthritis|osteoarthritis
1222048|NCT01932502|clonazepam|clonazepam
1221651|NCT01934218|Intra-articular injection|intra-articular injection
1221652|NCT01934205|GSK2140944|gsk2140944
1221653|NCT01934205|pharmacokinetics|pharmacokinetics
1221654|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
1221655|NCT01934205|pulmonary|pulmonary
1221656|NCT01934205|antimicrobial|antimicrobial
1221657|NCT01934205|healthy volunteer|healthy volunteer
1221658|NCT01934192|tolerability|tolerability
1221659|NCT01934192|camicinal|camicinal
1221660|NCT01934192|single dose|single dose
1221661|NCT01934192|acetaminophen|acetaminophen
1221662|NCT01934192|gastric emptying|gastric emptying
1221663|NCT01934192|critically ill|critically ill
1221664|NCT01934192|GSK962040|gsk962040
1221665|NCT01934192|pharmacokinetics|pharmacokinetics
1221666|NCT01934192|pharmacodynamics|pharmacodynamics
1221667|NCT01934192|gut motility|gut motility
1221668|NCT01934153|hyperhidrosis|hyperhidrosis
1221669|NCT01934153|topical|topical
1221670|NCT01934153|[14C] radiolabel|[14c] radiolabel
1221671|NCT01934153|palm|palm
1221672|NCT01934153|GSK573719|gsk573719
1221673|NCT01934153|axilla|axilla
1221674|NCT01934153|Umeclidinium|umeclidinium
1221675|NCT01934140|Healthy|healthy
1221676|NCT01934140|Adults|adults
1221677|NCT01934140|Safety|safety
1221678|NCT01934140|Neisseria meningitidis|neisseria meningitidis
1221679|NCT01934140|Booster response|booster response
1221680|NCT01934140|Immunogenicity|immunogenicity
1221681|NCT01934140|Adolescents|adolescents
1221682|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
1221683|NCT01934140|long-term antibody persistence|long-term antibody persistence
1221684|NCT01934127|Immunogenicity|immunogenicity
1221685|NCT01934127|H7N1|h7n1
1221686|NCT01934127|Influenza|influenza
1221687|NCT01934127|Safety|safety
1221688|NCT01934127|AS03 adjuvant|as03 adjuvant
1221689|NCT01934127|Adults|adults
1221690|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
1221692|NCT01934088|Sedation|sedation
1221693|NCT01934088|NAPS|naps
1221694|NCT01934088|Propofol|propofol
1221695|NCT01934088|Midazolam|midazolam
1221696|NCT01934088|Satisfaction|satisfaction
1221697|NCT01934088|Feasibility|feasibility
1221698|NCT01934075|Obstetric fistula|obstetric fistula
1221699|NCT01934075|Mental health|mental health
1221700|NCT01934075|Tanzania|tanzania
1221701|NCT01934036|Weight loss|weight loss
1221702|NCT01934036|Nutritional supplement|nutritional supplement
1221703|NCT01934036|Waist|waist
1221704|NCT01934036|Body composition|body composition
1221705|NCT01934036|Skinfolds|skinfolds
1221706|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
1221707|NCT01933997|pharmacokinetics|pharmacokinetics
1221708|NCT01933997|metadoxine|metadoxine
1221709|NCT01933984|Bronchodilator agents,|bronchodilator agents,
1221710|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1221711|NCT01933984|endotracheal intubation,|endotracheal intubation,
1221712|NCT01933984|mechanical ventilator|mechanical ventilator
1221713|NCT01933958|Regorafenib|regorafenib
1221714|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1221715|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
1221716|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
1221717|NCT01933919|Adolescent Subjects|adolescent subjects
1221718|NCT01933919|Pediatric Subjects|pediatric subjects
1221719|NCT01933906|CML|cml
1221720|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
1221721|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
1221722|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
1221723|NCT01933906|Interferon|interferon
1221724|NCT01933906|P1101|p1101
1221725|NCT01933906|Imatinib|imatinib
1221726|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
1221727|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1221728|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
1221729|NCT01933880|CONCERTA|concerta
1221730|NCT01933867|water|water
1221731|NCT01933867|colonoscopy|colonoscopy
1221732|NCT01933867|Crohn´s disease|crohn´s disease
1221733|NCT01933867|ulcerative colitis|ulcerative colitis
1221734|NCT01933854|Urinary incontinence|urinary incontinence
1221735|NCT01933854|riverside|riverside
1221737|NCT01933854|Amapa|amapa
1221738|NCT01933841|Post operative residual curarization|post operative residual curarization
1221739|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
1221740|NCT01933828|Lung cancer|lung cancer
1221741|NCT01933828|surgery video-assisted|surgery video-assisted
1221742|NCT01933828|robot|robot
1221743|NCT01933828|surgical treatment|surgical treatment
1221744|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
1221745|NCT01933815|Glioblastoma|glioblastoma
1221746|NCT01933815|Radiotherapy|radiotherapy
1221747|NCT01933815|Temozolomide|temozolomide
1221748|NCT01933815|TPI 287|tpi 287
1221749|NCT01933815|Taxoid|taxoid
1221750|NCT01933815|Avastin|avastin
1221752|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
1221753|NCT01933802|neural progenitors|neural progenitors
1221754|NCT01933802|autologous|autologous
1221755|NCT01933802|bone marrow|bone marrow
1221756|NCT01933802|multiple sclerosis|multiple sclerosis
1221757|NCT01933789|Palliative Care|palliative care
1221758|NCT01933789|End-of-Life Issues|end-of-life issues
1221759|NCT01933789|Patient/Clinician Communication|patient/clinician communication
1221760|NCT01933789|Patient/Family Communication|patient/family communication
1221761|NCT01933789|Concordance|concordance
1221762|NCT01933789|Treatment Preferences|treatment preferences
1221763|NCT01933789|Anxiety|anxiety
1221764|NCT01933789|Depressive Symptoms|depressive symptoms
1221765|NCT01933789|Talking with Your Doctor|talking with your doctor
1221766|NCT01933789|Coping with Serious Illness|coping with serious illness
1221767|NCT01933789|Outpatient Collaboration|outpatient collaboration
1221768|NCT01933776|Diphtheria|diphtheria
1221769|NCT01933776|Tetanus|tetanus
1221770|NCT01933776|Pertussis|pertussis
1221771|NCT01933776|ADACEL®|adacel®
1221772|NCT01933776|Tdap vaccine|tdap vaccine
1221773|NCT01933750|Presbyopia|presbyopia
1221774|NCT01933750|Reading Glasses|reading glasses
1221775|NCT01933750|Near Vision|near vision
1221776|NCT01933737|postural balance;|postural balance;
1221777|NCT01933737|elderly;|elderly;
1221778|NCT01933737|proprioception;|proprioception;
1221779|NCT01933737|prevention;|prevention;
1221780|NCT01933737|fall|fall
1221781|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
1221782|NCT01933724|GPA|gpa
1221783|NCT01933724|Wegeners'|wegeners'
1221784|NCT01933724|WG|wg
1221785|NCT01933724|vasculitis|vasculitis
1221786|NCT01933724|taper|taper
1221787|NCT01933724|prednisone|prednisone
1221788|NCT01933724|glucocorticoid|glucocorticoid
1221789|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
1221790|NCT01933724|AAV|aav
1221791|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
1221792|NCT01933724|Systemic Vasculitis|systemic vasculitis
1221793|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
1221794|NCT01933724|Lung diseases|lung diseases
1221795|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
1221796|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
1221797|NCT01933724|Vascular Diseases|vascular diseases
1221798|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
1221799|NCT01933724|Glucocorticoids|glucocorticoids
1221800|NCT01933724|Hormones|hormones
1221801|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1221802|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
1221803|NCT01933724|Pharmacologic Actions|pharmacologic actions
1221804|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
1221805|NCT01933724|Antineoplastic Agents|antineoplastic agents
1221806|NCT01933724|Therapeutic Uses|therapeutic uses
1221807|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
1221808|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
1221809|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
1221810|NCT01933711|rituximab|rituximab
1221811|NCT01933711|maintenance|maintenance
1221812|NCT01933698|Bioequivalence|bioequivalence
1221813|NCT01933698|Amoxicillin|amoxicillin
1221814|NCT01933698|Human|human
1221815|NCT01933672|Phase 1b|phase 1b
1221816|NCT01933672|type 2 diabetes|type 2 diabetes
1221817|NCT01933672|metformin background|metformin background
1221818|NCT01933672|PF-04937319|pf-04937319
1221819|NCT01933659|Helicobacter pylori|helicobacter pylori
1221820|NCT01933659|deep see water|deep see water
1221821|NCT01933646|Group B streptococcus|group b streptococcus
1221822|NCT01933646|Incidence|incidence
1221823|NCT01933646|Case fatality rate|case fatality rate
1221824|NCT01933646|Serotype distribution|serotype distribution
1221825|NCT01933633|Pregnancy|pregnancy
1221826|NCT01933633|Fertility|fertility
1221827|NCT01933633|exercise|exercise
1221828|NCT01933633|Fertilization in vitro|fertilization in vitro
1221829|NCT01933620|Microbiome|microbiome
1221830|NCT01933620|Nosocomial Infection|nosocomial infection
1221831|NCT01933620|Multidrug Resistance|multidrug resistance
1221832|NCT01933542|Chlorzoxazone|chlorzoxazone
1221833|NCT01933542|Postoperative pain|postoperative pain
1221834|NCT01933542|Spine surgery|spine surgery
1221835|NCT01933542|Opioid consumption|opioid consumption
1221836|NCT01933529|diabetes|diabetes
1221837|NCT01933529|glucose tolerance|glucose tolerance
1221838|NCT01933529|insulin secretion|insulin secretion
1221839|NCT01933529|insulin sensitivity|insulin sensitivity
1221840|NCT01933529|erythropoietin|erythropoietin
1221841|NCT01933529|inflammation|inflammation
1221842|NCT01933529|cytokines|cytokines
1221843|NCT01933516|GP2013|gp2013
1221844|NCT01933516|Japanese|japanese
1221845|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
1221846|NCT01933516|biosimilar|biosimilar
1221847|NCT01933516|CD20|cd20
1221848|NCT01933516|GP13-101|gp13-101
1221849|NCT01933503|MAD|mad
1221850|NCT01933503|SAD|sad
1221851|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
1221852|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
1221853|NCT01933477|Maternal Health|maternal health
1221854|NCT01933477|Child Health|child health
1221855|NCT01933477|HIV infection|hiv infection
1221856|NCT01933477|Antenatal care|antenatal care
1221857|NCT01933477|Postpartum care|postpartum care
1221858|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
1221859|NCT01933477|Breast feeding|breast feeding
1221860|NCT01933477|Antiretrovirals|antiretrovirals
1221861|NCT01933464|Rosacea|rosacea
1221862|NCT01933464|Cromolyn sodium|cromolyn sodium
1221863|NCT01933451|fluid therapy|fluid therapy
1221864|NCT01933451|Intraoperative care|intraoperative care
1221865|NCT01933451|Patient Outcome Assessment|patient outcome assessment
1221866|NCT01933451|pulse pressure variation|pulse pressure variation
1221867|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
1590323|NCT00430313|Oxaliplatin|oxaliplatin
1221868|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
1221869|NCT01933451|esophagectomy|esophagectomy
1221870|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
1221871|NCT01933438|brachial plexus|brachial plexus
1221872|NCT01933438|splint|splint
1221873|NCT01933425|surgical conditions|surgical conditions
1221874|NCT01933425|laparoscopy|laparoscopy
1221875|NCT01933412|Dialysis|dialysis
1221876|NCT01933412|Hepatitis B|hepatitis b
1221877|NCT01933399|Low back pain|low back pain
1221878|NCT01933399|Back brace|back brace
1221879|NCT01933399|Lumbar orthoses|lumbar orthoses
1221880|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
1221881|NCT01933399|Low back pain treatment|low back pain treatment
1221882|NCT01933386|Single Sided Deafness|single sided deafness
1221883|NCT01933386|SSD|ssd
1221884|NCT01933386|Unilateral hearing loss|unilateral hearing loss
1221885|NCT01933373|Randomized|randomized
1221886|NCT01933373|Toupet|toupet
1221887|NCT01933373|Dor|dor
1221888|NCT01933373|Achalasia|achalasia
1221889|NCT01933360|Misoprostol|misoprostol
1221890|NCT01933360|First trimester pregnancy|first trimester pregnancy
1221891|NCT01933360|Surgical abortion|surgical abortion
1221892|NCT01933360|Cervical priming|cervical priming
1221893|NCT01933334|pirfenidone|pirfenidone
1221894|NCT01933334|SSc-ILD|ssc-ild
1221895|NCT01933334|scleroderma|scleroderma
1221896|NCT01933334|systemic sclerosis|systemic sclerosis
1221897|NCT01933334|interstitial lung disease|interstitial lung disease
1221898|NCT01933321|ALS, stem cells|als, stem cells
1221899|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
1221900|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
1221901|NCT01933308|Exercise tolerance|exercise tolerance
1221902|NCT01933308|Functional and quality of life status|functional and quality of life status
1221903|NCT01933308|Cognitive and psychological status|cognitive and psychological status
1221904|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
1221905|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
1221906|NCT01933295|treatment|treatment
1221907|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
1221908|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1221909|NCT01933256|HIP2B|hip2b
1221910|NCT01933256|Placebo|placebo
1221911|NCT01933256|islet β cell|islet β cell
1221912|NCT01933243|Anxiety|anxiety
1221913|NCT01933243|Anorexia nervosa|anorexia nervosa
1221914|NCT01933243|Adolescents|adolescents
1221915|NCT01933243|Fish oil|fish oil
1221916|NCT01933217|TBI|tbi
1221917|NCT01933217|traumatic brain injury|traumatic brain injury
1221918|NCT01933217|ADHD|adhd
1221919|NCT01933217|methylphenidate|methylphenidate
1221920|NCT01933217|Concerta|concerta
1221921|NCT01933217|attention problems|attention problems
1221922|NCT01933204|perimenopause|perimenopause
1221923|NCT01933204|hot flash|hot flash
1221924|NCT01933204|palpitation|palpitation
1221925|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
1221926|NCT01933191|Cortisol, Amylase|cortisol, amylase
1221927|NCT01933178|Dry eyes|dry eyes
1221928|NCT01933178|Cirrus AS-OCT|cirrus as-oct
1221929|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
1221930|NCT01933165|Dry Eyes|dry eyes
1221931|NCT01933165|LipiView|lipiview
1221932|NCT01933165|Lipid thickness|lipid thickness
1221933|NCT01933152|wAMD|wamd
1221934|NCT01933152|anti-VEGF|anti-vegf
1221935|NCT01933139|Informed consent|informed consent
1221936|NCT01933139|preoperative counseling|preoperative counseling
1221937|NCT01933139|hysterectomy|hysterectomy
1221938|NCT01933113|Obesity|obesity
1221939|NCT01933113|Deep Brain Stimulation|deep brain stimulation
1221941|NCT01933100|Functional constipation|functional constipation
1221942|NCT01933100|Brown rice based-meal|brown rice based-meal
1221943|NCT01933100|Polished rice based-meal|polished rice based-meal
1221944|NCT01933100|Wheat based-meal|wheat based-meal
1221945|NCT01933087|Hand hygiene,|hand hygiene,
1221946|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
1221947|NCT01933087|Hospital|hospital
1221948|NCT01933074|Urinary Urgency|urinary urgency
1221949|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
1221950|NCT01933048|influenza|influenza
1221951|NCT01933035|ITP|itp
1221952|NCT01933035|Thrombocytopenia|thrombocytopenia
1221953|NCT01933035|mean platelet mass|mean platelet mass
1221954|NCT01933035|mean platelet component|mean platelet component
1221955|NCT01933022|Exploratory|exploratory
1221956|NCT01933022|Biomarkers|biomarkers
1221957|NCT01933022|Eligard|eligard
1221958|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
1221959|NCT01932996|Smoking Cessation|smoking cessation
1221960|NCT01932996|Smoking Cessation Products|smoking cessation products
1221961|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
1221962|NCT01932983|Neuromuscular blockade|neuromuscular blockade
1221963|NCT01932983|TOF test|tof test
1221964|NCT01932983|Quantitative TOF method|quantitative tof method
1221965|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
1590810|NCT00428545|PS-341|ps-341
1221966|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
1221967|NCT01932957|Laparoscopy|laparoscopy
1221968|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
1221969|NCT01932931|Vitamin D|vitamin d
1221970|NCT01932931|Major depression|major depression
1221971|NCT01932931|SSRIs|ssris
1221972|NCT01932931|Osteoporosis|osteoporosis
1221973|NCT01932918|reactive oxygen species|reactive oxygen species
1221974|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
1221975|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
1221976|NCT01932905|chronic pain|chronic pain
1221977|NCT01932905|assessment|assessment
1221978|NCT01932905|neuropathic pain|neuropathic pain
1221979|NCT01932905|central pain|central pain
1221980|NCT01932905|treatment|treatment
1221981|NCT01932892|transhumeral|transhumeral
1221982|NCT01932866|pre-diabetes|pre-diabetes
1221983|NCT01932866|diabetes risk score|diabetes risk score
1221984|NCT01932866|motivation|motivation
1221985|NCT01932866|Air Force|air force
1221986|NCT01932866|Military|military
1221987|NCT01932866|Lifestyle change|lifestyle change
1221988|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
1221989|NCT01932840|general Canadian population|general canadian population
1221990|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
1221991|NCT01932827|Food labels|food labels
1221992|NCT01932827|General Canadian population|general canadian population
1221993|NCT01932814|Aminoglycosides|aminoglycosides
1221994|NCT01932814|Acute kidney injury|acute kidney injury
1221995|NCT01932814|Severe sepsis|severe sepsis
1221996|NCT01932814|Critically ill patient|critically ill patient
1221997|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
1221998|NCT01932788|pregnancy|pregnancy
1221999|NCT01932788|Vitamin D status|vitamin d status
1222000|NCT01932736|middle ear|middle ear
1222001|NCT01932736|Eustachian tube|eustachian tube
1222002|NCT01932736|fMRI|fmri
1222003|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
1222004|NCT01932710|Leukemia|leukemia
1222005|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
1222007|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
1222008|NCT01932710|MDS|mds
1222009|NCT01932710|Infection risk|infection risk
1222010|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
1222011|NCT01932710|Prophylactic therapy|prophylactic therapy
1222012|NCT01932671|Cardiovascular diseases|cardiovascular diseases
1222013|NCT01932671|Atherosclerosis|atherosclerosis
1222014|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
1222015|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1222016|NCT01932658|autologous|autologous
1222017|NCT01932658|Lymphoablation|lymphoablation
1222018|NCT01932658|hematopoietic|hematopoietic
1222019|NCT01932658|immune system|immune system
1222020|NCT01932645|prostatitis|prostatitis
1222021|NCT01932645|pelvic pain|pelvic pain
1222022|NCT01932645|urinary symptoms|urinary symptoms
1222023|NCT01932645|sexual dysfunction|sexual dysfunction
1222024|NCT01932632|Polypharmacy|polypharmacy
1222025|NCT01932632|De-prescribing|de-prescribing
1222026|NCT01932632|Frailty|frailty
1222027|NCT01932593|multiple sclerosis|multiple sclerosis
1222028|NCT01932593|bone marrow|bone marrow
1222029|NCT01932593|stem cell therapy|stem cell therapy
1222030|NCT01932580|gastric|gastric
1222031|NCT01932580|esophageal|esophageal
1222032|NCT01932580|adenocarcinoma|adenocarcinoma
1222033|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
1222034|NCT01932554|Abciximab|abciximab
1222035|NCT01932554|Integrins|integrins
1222036|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
1222037|NCT01932541|Bipolar Disorder|bipolar disorder
1222038|NCT01932541|Mania|mania
1222039|NCT01932541|Bipolar I|bipolar i
1222040|NCT01932541|Bipolar II|bipolar ii
1222041|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
1222042|NCT01932541|Pediatric|pediatric
1222043|NCT01932528|Absorption|absorption
1222044|NCT01932528|Metabolism|metabolism
1222045|NCT01932528|Excretion|excretion
1222049|NCT01932463|Tremor|tremor
1222050|NCT01932463|Essential Tremor|essential tremor
1222051|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
1222052|NCT01932450|hypertension|hypertension
1222053|NCT01932450|radiofrequency ablation|radiofrequency ablation
1222054|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1222055|NCT01932424|Children|children
1222056|NCT01932398|Alpha|alpha
1222057|NCT01932398|Lateralization|lateralization
1222058|NCT01932398|Attention|attention
1222059|NCT01932398|ADHD|adhd
1222060|NCT01932398|Oscillation|oscillation
1222061|NCT01932385|Sorafenib|sorafenib
1222062|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
1222063|NCT01932385|Best supportive care|best supportive care
1222064|NCT01932385|Survival|survival
1222065|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
1222066|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
1222067|NCT01932372|Tofacitinib|tofacitinib
1222068|NCT01932372|Xeljanz|xeljanz
1222069|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1222070|NCT01932359|Scar outcome|scar outcome
1222071|NCT01932359|Mohs surgery|mohs surgery
1222072|NCT01932359|face|face
1222073|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
1222074|NCT01932333|Healthy|healthy
1222075|NCT01932333|Safety|safety
1222076|NCT01932333|Tolerability|tolerability
1222077|NCT01932333|Pharmacokinetics|pharmacokinetics
1222078|NCT01932333|Pharmacodynamics|pharmacodynamics
1222079|NCT01932333|JNJ-40411813|jnj-40411813
1222080|NCT01932333|Positive allosteric modulator|positive allosteric modulator
1222081|NCT01932320|Healthy|healthy
1222082|NCT01932320|Relative Bioavailability|relative bioavailability
1222083|NCT01932320|Food effect|food effect
1222084|NCT01932320|JNJ-40411813|jnj-40411813
1222085|NCT01932320|Positive allosteric modulator|positive allosteric modulator
1222086|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
1222087|NCT01932320|Ketoconazole|ketoconazole
1222088|NCT01932307|Surgeon neck health|surgeon neck health
1222089|NCT01932294|Advanced Heart Failure|advanced heart failure
1222090|NCT01932294|Refractory Heart Failure|refractory heart failure
1222091|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
1222092|NCT01932294|Ventricular Assist Device|ventricular assist device
1222093|NCT01932294|Medamacs|medamacs
1222094|NCT01932281|muscle power|muscle power
1222095|NCT01932281|muscle fatigue|muscle fatigue
1222096|NCT01932281|SierraSil|sierrasil
1222097|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
1222098|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
1222099|NCT01932255|postoperative complications|postoperative complications
1222100|NCT01932229|Advanced NSCLC|advanced nsclc
1222101|NCT01932229|EGFR mutation|egfr mutation
1222102|NCT01932229|TKIs|tkis
1222103|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
1222104|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
1222105|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1222106|NCT01932216|cosmesis|cosmesis
1222107|NCT01932216|quality of life|quality of life
1222108|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
1222109|NCT01932203|Leukoaraiosis|leukoaraiosis
1222110|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
1222111|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
1222112|NCT01932190|Acute Kidney Injury|acute kidney injury
1222113|NCT01932190|Critical Care|critical care
1222114|NCT01932190|Renal Replacement Therapy|renal replacement therapy
1222115|NCT01932190|Treatment Outcome|treatment outcome
1222116|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
1222117|NCT01932164|Cleft lip and palate|cleft lip and palate
1222118|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
1222119|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
1222120|NCT01932164|tissue engineering|tissue engineering
1222121|NCT01932164|bone tissue engineering|bone tissue engineering
1222122|NCT01932164|bioengineering|bioengineering
1222123|NCT01932151|type-1 HRS|type-1 hrs
1222124|NCT01932151|active bacterial infections|active bacterial infections
1222125|NCT01932151|terlipressin and albumin|terlipressin and albumin
1222126|NCT01932151|kidney function|kidney function
1222127|NCT01932138|Community-based intervention|community-based intervention
1222128|NCT01932138|Community health workers|community health workers
1222129|NCT01932138|Antenatal care|antenatal care
1222130|NCT01932138|HIV|hiv
1222131|NCT01932138|PMTCT|pmtct
1222132|NCT01932138|HIV vertical transmission|hiv vertical transmission
1222133|NCT01932138|Public-sector health systems|public-sector health systems
1222134|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
1222135|NCT01932112|Adenosin effect|adenosin effect
1222136|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
1222137|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
1222138|NCT01932086|male|male
1222139|NCT01932086|Glucose|glucose
1222140|NCT01932086|Triglyceride|triglyceride
1222141|NCT01932086|Glycemic index|glycemic index
1222142|NCT01932086|White rice|white rice
1222143|NCT01932086|Brown rice|brown rice
1222144|NCT01932086|Black rice|black rice
1222145|NCT01932086|Bread|bread
1222146|NCT01932073|Radiation|radiation
1222147|NCT01932073|dermatitis|dermatitis
1222148|NCT01932073|radiodermatitis|radiodermatitis
1222149|NCT01932073|radiotherapy induced|radiotherapy induced
1222150|NCT01932073|skin reactions|skin reactions
1590811|NCT00428545|LDP-341|ldp-341
1304188|NCT01565486|RFS|rfs
1222151|NCT01932073|low level laser therapy|low level laser therapy
1222152|NCT01932073|breast cancer|breast cancer
1222153|NCT01932060|Oxytocin|oxytocin
1222154|NCT01932060|blood loss|blood loss
1222155|NCT01932060|Cesarean delivery|cesarean delivery
1222156|NCT01932034|Vancomycin|vancomycin
1222157|NCT01932034|Pharmacokinetics|pharmacokinetics
1222158|NCT01932034|Pharmacodynamics|pharmacodynamics
1222159|NCT01932034|Decision support|decision support
1222160|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
1222161|NCT01932021|autologous fat transplantation|autologous fat transplantation
1222162|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
1222163|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
1222164|NCT01932008|Chronic kidney disease|chronic kidney disease
1222165|NCT01932008|Body composition|body composition
1222166|NCT01932008|Physical activity|physical activity
1222167|NCT01932008|Physical function|physical function
1222168|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
1222169|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
1222170|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
1222171|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
1222172|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
1222173|NCT01931956|Mitral Regurgitation|mitral regurgitation
1222174|NCT01931956|Mitral Insufficiency|mitral insufficiency
1222175|NCT01931956|Mitral Valve|mitral valve
1222176|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
1222177|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
1222178|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
1222179|NCT01931956|Alfieri Technique|alfieri technique
1222180|NCT01931956|MitraClip|mitraclip
1222181|NCT01931956|Functional MR|functional mr
1222182|NCT01931956|Degenerative MR|degenerative mr
1222183|NCT01931956|Echocardiogram|echocardiogram
1222184|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1222185|NCT01931956|Heart Failure|heart failure
1222186|NCT01931956|Heart Attack|heart attack
1222187|NCT01931956|EVEREST|everest
1222188|NCT01931956|EVEREST I|everest i
1222189|NCT01931956|EVEREST II|everest ii
1222190|NCT01931956|REALISM|realism
1222191|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
1222192|NCT01931930|Perilla frutescens|perilla frutescens
1222193|NCT01931930|bloating|bloating
1222194|NCT01931930|abdominal discomfort|abdominal discomfort
1222195|NCT01931930|human study|human study
1222196|NCT01931930|healthy subjects|healthy subjects
1222197|NCT01931917|Prevention|prevention
1222198|NCT01931917|Parenting|parenting
1222199|NCT01931917|Infants|infants
1222200|NCT01931917|Family programs|family programs
1222201|NCT01931917|Early intervention|early intervention
1222202|NCT01931904|IOP|iop
1222203|NCT01931904|Glaucoma|glaucoma
1222204|NCT01931904|Trabeculectomy|trabeculectomy
1222205|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
1222206|NCT01931878|Restless Legs Syndrome|restless legs syndrome
1222207|NCT01931878|Leg pain|leg pain
1222208|NCT01931878|Sleep|sleep
1222209|NCT01931878|Dysesthesias|dysesthesias
1222210|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
1222211|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
1222212|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
1222213|NCT01931852|Chest pain|chest pain
1222214|NCT01931852|Cardiac MRI|cardiac mri
1222215|NCT01931852|Risk Stratification|risk stratification
1222913|NCT01928316|Imported|imported
1222216|NCT01931852|Emergency Department|emergency department
1222217|NCT01931852|Elevated Troponin|elevated troponin
1222218|NCT01931852|Troponin|troponin
1222219|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
1222220|NCT01931826|Schistosomiasis|schistosomiasis
1222221|NCT01931826|Surgical treatment|surgical treatment
1222222|NCT01931826|Endoscopic treatment|endoscopic treatment
1222223|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
1222224|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
1222225|NCT01931735|menisci|menisci
1222226|NCT01931735|tibial|tibial
1222227|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
1222228|NCT01931722|older men|older men
1222229|NCT01931722|strength training|strength training
1222230|NCT01931722|sarcopenia|sarcopenia
1222231|NCT01931696|Efficacy|efficacy
1222232|NCT01931696|Acupuncture|acupuncture
1222233|NCT01931696|Asthma|asthma
1222234|NCT01931683|LMA removal|lma removal
1222235|NCT01931683|remifentanil|remifentanil
1222236|NCT01931683|propofol|propofol
1222237|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
1222238|NCT01931670|Elagolix|elagolix
1222239|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
1222240|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
1590812|NCT00428545|MLN341|mln341
1222241|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
1222242|NCT01931657|LNG-IUS|lng-ius
1222243|NCT01931657|Mirena|mirena
1222244|NCT01931657|Contraception|contraception
1222245|NCT01931657|Bleeding|bleeding
1222246|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
1222247|NCT01931644|Graft-versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
1222248|NCT01931644|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1222249|NCT01931644|Cancer|cancer
1222250|NCT01931644|Diabetes|diabetes
1222251|NCT01931644|Melanoma|melanoma
1222252|NCT01931644|Hepatitis B|hepatitis b
1222253|NCT01931644|Lupus|lupus
1222254|NCT01931644|Multiple Sclerosis|multiple sclerosis
1222255|NCT01931644|Asthma|asthma
1222256|NCT01931644|Crohn's Disease|crohn's disease
1222257|NCT01931644|Ulcerative Colitis|ulcerative colitis
1222258|NCT01931644|Kidney Disease|kidney disease
1222259|NCT01931644|Alzheimer's Disease|alzheimer's disease
1222260|NCT01931644|Parkinson's Disease|parkinson's disease
1222261|NCT01931644|Huntington's Disease|huntington's disease
1222262|NCT01931644|Rheumatoid Arthritis|rheumatoid arthritis
1222263|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
1222264|NCT01931644|Leukemia|leukemia
1222265|NCT01931644|Lymphoma|lymphoma
1222266|NCT01931644|Myeloma|myeloma
1222267|NCT01931644|CIDP|cidp
1222268|NCT01931644|COPD|copd
1222269|NCT01931644|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
1222270|NCT01931644|Cystic Fibrosis|cystic fibrosis
1222271|NCT01931644|Primary Biliary Cirrhosis|primary biliary cirrhosis
1222272|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1222273|NCT01931631|Diet, Vegetarian|diet, vegetarian
1222274|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
1222275|NCT01931631|Glycemic Index|glycemic index
1222276|NCT01931618|alcohol|alcohol
1222277|NCT01931618|online intervention|online intervention
1222278|NCT01931618|hazardous drinking|hazardous drinking
1222279|NCT01931618|harmful drinking|harmful drinking
1222280|NCT01931618|early intervention|early intervention
1222281|NCT01931618|behavior change intervention|behavior change intervention
1222282|NCT01931592|ESBL|esbl
1222283|NCT01931592|neutropenia|neutropenia
1222284|NCT01931592|eradication|eradication
1222285|NCT01931592|bloodstream infection|bloodstream infection
1222286|NCT01931592|immunosuppression|immunosuppression
1222287|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
1222288|NCT01931566|Drug therapy|drug therapy
1222289|NCT01931540|Obesity|obesity
1222290|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
1222291|NCT01931540|Exercise Therapy|exercise therapy
1222292|NCT01931527|Obesity|obesity
1222293|NCT01931527|Metabolic syndrome|metabolic syndrome
1222294|NCT01931527|Hyperuricemia|hyperuricemia
1222295|NCT01931462|Cancer of the Kidney|cancer of the kidney
1222296|NCT01931462|Renal Cancer|renal cancer
1222297|NCT01931462|Renal Neoplasms|renal neoplasms
1222298|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
1222299|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
1222300|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
1222301|NCT01931449|Pancreas|pancreas
1222302|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
1222303|NCT01931397|Dried blood spots|dried blood spots
1222304|NCT01931397|kidney transplant|kidney transplant
1222305|NCT01931397|Children|children
1222306|NCT01931384|Luteal phase support|luteal phase support
1222307|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
1222308|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
1222309|NCT01931371|fistula in ano|fistula in ano
1222310|NCT01931371|anal fistula|anal fistula
1222311|NCT01931371|recurrence|recurrence
1222312|NCT01931371|costs|costs
1222313|NCT01931345|Rapid HIV testing|rapid hiv testing
1222315|NCT01931345|Motivational Interviewing|motivational interviewing
1222316|NCT01931345|HIV prevention|hiv prevention
1222317|NCT01931345|HIV/AIDS|hiv/aids
1222318|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
1222319|NCT01931345|Randomized trial|randomized trial
1222320|NCT01931332|Arthroplasty|arthroplasty
1222321|NCT01931332|Analgesia|analgesia
1222322|NCT01931319|baclofen withdrawal|baclofen withdrawal
1222323|NCT01931319|interruption|interruption
1222324|NCT01931319|spasticity|spasticity
1222325|NCT01931319|pharmacokinetics|pharmacokinetics
1222326|NCT01931319|tolerability|tolerability
1222327|NCT01931319|intravenous|intravenous
1222328|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
1222329|NCT01931280|Gestational diabetes|gestational diabetes
1222330|NCT01931241|atherosclerosis|atherosclerosis
1222331|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
1222332|NCT01931241|hypercholesteremia|hypercholesteremia
1222333|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
1222334|NCT01931241|hyperlipidemia|hyperlipidemia
1222335|NCT01931228|Intensive care unit|intensive care unit
1222336|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
1222337|NCT01931228|Respiratory failure|respiratory failure
1222338|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
1222339|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
1222340|NCT01931150|Moisturizer|moisturizer
1222341|NCT01931150|rash|rash
1222342|NCT01931150|13-012|13-012
1222343|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
1222344|NCT01931111|physical activity|physical activity
1222345|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
1222346|NCT01931098|Brain Tumors|brain tumors
1222347|NCT01931072|Exercise|exercise
1222348|NCT01931072|High-intensity interval training|high-intensity interval training
1222349|NCT01931072|Moderate training|moderate training
1222350|NCT01931072|Healthy elderly|healthy elderly
1222351|NCT01931072|Skeletal muscle|skeletal muscle
1222352|NCT01931072|DNA-methylation|dna-methylation
1222353|NCT01931072|Gene expression|gene expression
1222354|NCT01931072|subjects|subjects
1222355|NCT01931059|Imaging|imaging
1222356|NCT01931059|Risperidone|risperidone
1222357|NCT01931059|Placebo|placebo
1222358|NCT01931059|antipsychotic|antipsychotic
1222359|NCT01931046|prostate cancer|prostate cancer
1222360|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1222361|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
1222362|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
1222363|NCT01931033|ASD|asd
1222364|NCT01931033|PDD|pdd
1222365|NCT01931033|Oxytocin|oxytocin
1222366|NCT01931033|Syntocinon|syntocinon
1222367|NCT01931033|treatment|treatment
1222368|NCT01931020|Pain|pain
1222369|NCT01931020|Preterm|preterm
1222370|NCT01931020|Neonates|neonates
1222371|NCT01931020|24% Sucrose|24% sucrose
1222372|NCT01931020|25% Dextrose|25% dextrose
1222373|NCT01931007|osteoarthritis|osteoarthritis
1222374|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
1222375|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
1222376|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
1222377|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
1222378|NCT01930981|quality of life|quality of life
1222379|NCT01930981|toxicities|toxicities
1222380|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1222381|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
1222382|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
1222383|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
1222384|NCT01930955|white cell count|white cell count
1222385|NCT01930955|vomiting|vomiting
1222386|NCT01930942|rectal carcinoma|rectal carcinoma
1222387|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
1222388|NCT01930929|Bariatric surgery|bariatric surgery
1222389|NCT01930929|Complications|complications
1222390|NCT01930929|Drugs|drugs
1222391|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
1222392|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
1222393|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
1222394|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
1222395|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
1222396|NCT01930916|Prospective Studies|prospective studies
1222397|NCT01930916|Adult|adult
1222398|NCT01930916|Reproducibility of Results|reproducibility of results
1222399|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
1222400|NCT01930916|Aged|aged
1222401|NCT01930916|Elderly|elderly
1222402|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
1222403|NCT01930877|quality of recovery|quality of recovery
1222404|NCT01930877|spine surgery|spine surgery
1222405|NCT01930877|intravenous lidocaine|intravenous lidocaine
1222406|NCT01930864|metformin|metformin
1222914|NCT01928303|opioids|opioids
1222407|NCT01930864|colorectal cancer|colorectal cancer
1222408|NCT01930864|chemotherapy|chemotherapy
1222409|NCT01930851|Bariatric surgery|bariatric surgery
1222410|NCT01930851|Quality of life|quality of life
1222411|NCT01930851|Complications|complications
1222412|NCT01930838|Bariatric surgery|bariatric surgery
1222413|NCT01930838|Complications|complications
1222414|NCT01930838|Osteoporosis|osteoporosis
1222415|NCT01930838|Neuropathy|neuropathy
1222416|NCT01930838|Vitamine deficiency|vitamine deficiency
1222417|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
1222418|NCT01930812|Bone imaging|bone imaging
1222419|NCT01930773|clopidogrel|clopidogrel
1222420|NCT01930773|prasugrel|prasugrel
1222421|NCT01930773|platelet function testing|platelet function testing
1222422|NCT01930773|genotyping|genotyping
1222423|NCT01930773|peri-procedural MI|peri-procedural mi
1222424|NCT01930760|pediatric|pediatric
1222425|NCT01930760|Childhood Obesity|childhood obesity
1222523|NCT01930370|pediatrics|pediatrics
1222426|NCT01930760|motivational interviewing|motivational interviewing
1222427|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
1222428|NCT01930747|pneumoperitoneum|pneumoperitoneum
1222429|NCT01930747|laparoscopy|laparoscopy
1222430|NCT01930734|Heart Failure|heart failure
1222431|NCT01930734|Dobutamine|dobutamine
1222432|NCT01930708|BG-12|bg-12
1222433|NCT01930695|DX functionality|dx functionality
1222434|NCT01930695|Atrial fibrillation|atrial fibrillation
1222435|NCT01930695|CRT-D indication|crt-d indication
1222436|NCT01930682|Myocardial Infarction|myocardial infarction
1222437|NCT01930682|Catheterization|catheterization
1222438|NCT01930682|Fibrinolysis|fibrinolysis
1222439|NCT01930669|Heart Rate Variability|heart rate variability
1222440|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
1222441|NCT01930669|Critically Ill|critically ill
1222442|NCT01930656|osteoporisis|osteoporisis
1222443|NCT01930656|fracture|fracture
1222444|NCT01930656|risk|risk
1222445|NCT01930656|cost effectiveness|cost effectiveness
1222446|NCT01930656|FRAX|frax
1222447|NCT01930656|mobile device|mobile device
1222448|NCT01930643|Electric muscle stimulation|electric muscle stimulation
1222449|NCT01930643|mechanical ventilation|mechanical ventilation
1222450|NCT01930643|chronic respiratory failure|chronic respiratory failure
1222451|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
1222452|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
1222453|NCT01930630|esophageal cancer;|esophageal cancer;
1222454|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
1222455|NCT01930617|surgery|surgery
1222456|NCT01930617|trephining|trephining
1222457|NCT01930617|drainage|drainage
1222458|NCT01930617|therapeutic irrigation|therapeutic irrigation
1222459|NCT01930617|subdural space|subdural space
1222460|NCT01930617|postoperative complications|postoperative complications
1222461|NCT01930617|mortality|mortality
1222462|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
1222463|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
1222464|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
1222465|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
1222466|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
1222467|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
1222468|NCT01930591|stenting|stenting
1222469|NCT01930591|platelet activity|platelet activity
1222470|NCT01930578|bioimpedance analysis|bioimpedance analysis
1222471|NCT01930578|spectroscopy|spectroscopy
1222472|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
1222473|NCT01930578|extracellular water|extracellular water
1222474|NCT01930565|acne|acne
1222475|NCT01930565|therapeutics|therapeutics
1222476|NCT01930565|clinical trial|clinical trial
1222477|NCT01930565|natural compound|natural compound
1222478|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
1222479|NCT01930565|tea tree oil|tea tree oil
1222480|NCT01930526|COPD|copd
1222481|NCT01930526|Exercise|exercise
1222482|NCT01930526|Cycling|cycling
1222483|NCT01930526|Single leg|single leg
1222484|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
1222485|NCT01930513|Obesity|obesity
1222486|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
1222487|NCT01930513|Exercise|exercise
1222488|NCT01930513|Walking tests|walking tests
1222489|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
1222490|NCT01930513|Physical activity|physical activity
1222491|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
1222492|NCT01930487|intraocular pressure|intraocular pressure
1222493|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
1222494|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
1222495|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
1222496|NCT01930487|choroidal blood flow|choroidal blood flow
1222497|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
1222498|NCT01930448|Bariatric|bariatric
1222499|NCT01930448|Gastric Bypass|gastric bypass
1222500|NCT01930448|Gastric Banding,|gastric banding,
1222501|NCT01930448|Type 2 Diabetes|type 2 diabetes
1222502|NCT01930448|Incretins|incretins
1222503|NCT01930448|GLP-1|glp-1
1222505|NCT01930448|Insulin secretion|insulin secretion
1222506|NCT01930448|insulin sensitivity|insulin sensitivity
1222507|NCT01930435|Quality of Life|quality of life
1222508|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
1222509|NCT01930422|Sham procedure|sham procedure
1222510|NCT01930422|Tobacco consumption|tobacco consumption
1222511|NCT01930422|Craving|craving
1222512|NCT01930409|Femoral Fractures|femoral fractures
1222513|NCT01930409|Hip Fractures|hip fractures
1222514|NCT01930409|Frail older adults|frail older adults
1222515|NCT01930409|Quality of Life|quality of life
1222516|NCT01930409|Feasibility Studies|feasibility studies
1222517|NCT01930396|Hemodialysis|hemodialysis
1222518|NCT01930396|Anticoagulation|anticoagulation
1222519|NCT01930396|Tinzaparin|tinzaparin
1222520|NCT01930396|Unfractionated Heparin|unfractionated heparin
1222521|NCT01930396|Randomized Controlled Trial|randomized controlled trial
1222522|NCT01930383|biomarkers|biomarkers
1222524|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
1304708|NCT01563042|PK|pk
1222525|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
1222526|NCT01930357|Rabies|rabies
1222527|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
1222528|NCT01930357|Imovax® rabies|imovax® rabies
1222529|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
1222530|NCT01930344|stereopsis|stereopsis
1222531|NCT01930344|3D laparoscopy|3d laparoscopy
1222532|NCT01930344|OCHRA|ochra
1222533|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
1222534|NCT01930305|Heating transfusion|heating transfusion
1222535|NCT01930279|T cell markers|t cell markers
1222536|NCT01930227|hypotension|hypotension
1222537|NCT01930227|spinal anesthesia|spinal anesthesia
1222538|NCT01930227|cesarean|cesarean
1222539|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
1222540|NCT01930175|pemphigus|pemphigus
1222541|NCT01930175|blistering disease|blistering disease
1222542|NCT01930162|HSC835|hsc835
1222543|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
1222544|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
1222545|NCT01930162|Umbilical cord blood|umbilical cord blood
1222546|NCT01930162|UCB transplantation|ucb transplantation
1222547|NCT01930149|Cholesterol screening|cholesterol screening
1222548|NCT01930149|High cholesterol|high cholesterol
1222549|NCT01930149|Cardiovascular disease|cardiovascular disease
1222550|NCT01930149|Statin treatment|statin treatment
1222551|NCT01930136|Calorie restriction|calorie restriction
1222552|NCT01930136|Type 2 diabetes|type 2 diabetes
1222553|NCT01930136|Obesity|obesity
1222554|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
1222555|NCT01930123|Fructose|fructose
1222556|NCT01930123|NASH|nash
1222557|NCT01930123|advanced fibrosis|advanced fibrosis
1222558|NCT01930123|biomarker|biomarker
1222559|NCT01930123|magnetic resonance|magnetic resonance
1222560|NCT01930110|Type 1 diabetes|type 1 diabetes
1222561|NCT01930110|Hypoglycemia|hypoglycemia
1222562|NCT01930110|Insulin|insulin
1222563|NCT01930110|Glucagon|glucagon
1222564|NCT01930110|Closed-loop system|closed-loop system
1222565|NCT01930110|Artificial pancreas|artificial pancreas
1222566|NCT01930097|Type 1 diabetes|type 1 diabetes
1222567|NCT01930097|Hypoglycemia|hypoglycemia
1222568|NCT01930097|Insulin|insulin
1222569|NCT01930097|Glucagon|glucagon
1222570|NCT01930097|Closed-loop system|closed-loop system
1222571|NCT01930097|Artificial pancreas|artificial pancreas
1222572|NCT01930097|Carbohydrate counting|carbohydrate counting
1222574|NCT01930084|linkage|linkage
1222575|NCT01930084|retention|retention
1222576|NCT01930032|Clostridium difficile infection|clostridium difficile infection
1222577|NCT01930019|etomidate,|etomidate,
1222578|NCT01930019|thiopental,|thiopental,
1222579|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
1222580|NCT01930006|c-Met|c-met
1222581|NCT01930006|VEGFR|vegfr
1222582|NCT01930006|Ron|ron
1222583|NCT01930006|Cancer|cancer
1222584|NCT01930006|Tumor|tumor
1222585|NCT01930006|Safety|safety
1222586|NCT01930006|Phase 1|phase 1
1222587|NCT01929993|Conization|conization
1222588|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1222589|NCT01929993|Cervix Dysplasia|cervix dysplasia
1222590|NCT01929993|Therapy|therapy
1222591|NCT01929993|Electrosurgery|electrosurgery
1222592|NCT01929980|HSCT|hsct
1222593|NCT01929980|cytopenia|cytopenia
1222594|NCT01929980|immune suppression|immune suppression
1222595|NCT01929980|proteasome inhibitor|proteasome inhibitor
1222596|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
1222597|NCT01929967|Asplenia|asplenia
1222598|NCT01929967|Polysplenia|polysplenia
1222599|NCT01929889|schizophrenia|schizophrenia
1222600|NCT01929889|schizoaffective disorder|schizoaffective disorder
1222601|NCT01929889|iloperidone|iloperidone
1222602|NCT01929889|Fanapt|fanapt
1222603|NCT01929889|social cognition|social cognition
1222604|NCT01929889|cognition|cognition
1222605|NCT01929863|Metformin|metformin
1222606|NCT01929863|Diabetes|diabetes
1222608|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
1222609|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
1222610|NCT01929798|artificial pancreas|artificial pancreas
1222611|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
1222612|NCT01929759|HIV|hiv
1222613|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
1222614|NCT01929759|efavirenz|efavirenz
1222615|NCT01929759|elvitegravir|elvitegravir
1222616|NCT01929759|neurometabolites|neurometabolites
1222617|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
1222618|NCT01929720|cancer|cancer
1222619|NCT01929720|cancer survivors|cancer survivors
1222620|NCT01929720|worry|worry
1222621|NCT01929720|insomnia|insomnia
1222622|NCT01929720|symptoms|symptoms
1222623|NCT01929720|fatigue|fatigue
1222624|NCT01929720|depression|depression
1222625|NCT01929720|anxiety|anxiety
1222626|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
1304811|NCT01562379|wasting|wasting
1222627|NCT01929681|bipolar|bipolar
1222628|NCT01929681|depression|depression
1222629|NCT01929681|alternative treatment|alternative treatment
1222630|NCT01929668|ulcerative colitis|ulcerative colitis
1222631|NCT01929668|bowel preparation|bowel preparation
1222632|NCT01929655|Phase II|phase ii
1222633|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
1222634|NCT01929655|bone metastases|bone metastases
1222635|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
1222636|NCT01929642|self-injury|self-injury
1222637|NCT01929642|Autism|autism
1222638|NCT01929629|Phase 1|phase 1
1222639|NCT01929629|Healthy Volunteers|healthy volunteers
1222640|NCT01929629|First Time in Man|first time in man
1222641|NCT01929629|Pharmacokinetics|pharmacokinetics
1222642|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
1222643|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
1222644|NCT01929590|Colonoscopy|colonoscopy
1222645|NCT01929590|Preparation|preparation
1222646|NCT01929590|Polyp|polyp
1222647|NCT01929590|Polyethylene glycol|polyethylene glycol
1222648|NCT01929577|ASP015K|asp015k
1222649|NCT01929577|healthy subjects|healthy subjects
1222650|NCT01929564|cardiovascular disease|cardiovascular disease
1222651|NCT01929564|risk factor|risk factor
1222652|NCT01929564|broccoli|broccoli
1222653|NCT01929564|GST|gst
1222654|NCT01929564|blood pressure|blood pressure
1222655|NCT01929564|Total cholesterol|total cholesterol
1222656|NCT01929551|glycemic index|glycemic index
1222657|NCT01929538|Chronic pancreatitis|chronic pancreatitis
1222658|NCT01929538|Biliary stricture|biliary stricture
1222659|NCT01929538|Endoscopic treatment|endoscopic treatment
1222660|NCT01929538|cSEMS|csems
1222661|NCT01929499|Colon cancer|colon cancer
1222662|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
1222663|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
1222664|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
1222665|NCT01929473|Pertussis infection|pertussis infection
1222666|NCT01929473|Risk factors|risk factors
1222667|NCT01929447|sleep disorders|sleep disorders
1222668|NCT01929447|sleep apnea|sleep apnea
1222669|NCT01929447|ambulatory device|ambulatory device
1222670|NCT01929447|WatchPAT|watchpat
1222671|NCT01929434|cerebral palsy|cerebral palsy
1222672|NCT01929434|cell transplantation|cell transplantation
1222673|NCT01929434|rehabilitation|rehabilitation
1222674|NCT01929421|colorectal cancer|colorectal cancer
1222675|NCT01929421|gemcitabine|gemcitabine
1222676|NCT01929421|S-1|s-1
1222677|NCT01929395|Breast Cancer|breast cancer
1222678|NCT01929395|Breast Conserving Surgery|breast conserving surgery
1222679|NCT01929395|Breast diagnostics|breast diagnostics
1222680|NCT01929395|Breast imaging|breast imaging
1222681|NCT01929382|dose titration|dose titration
1222682|NCT01929382|FLS|fls
1222683|NCT01929382|flu like symptoms|flu like symptoms
1222684|NCT01929382|Actimmune|actimmune
1222685|NCT01929369|ESRD|esrd
1222687|NCT01929369|AV GRAFTS|av grafts
1222688|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
1222689|NCT01929356|lung function tests|lung function tests
1222690|NCT01929356|chest physiotherapy|chest physiotherapy
1222691|NCT01929343|cocaine|cocaine
1222692|NCT01929343|addiction|addiction
1222693|NCT01929343|lidocaine|lidocaine
1222694|NCT01929343|memory|memory
1222695|NCT01929343|drug abuse|drug abuse
1222696|NCT01929330|Bioequivalence|bioequivalence
1222697|NCT01929330|Healthy Male Volunteers|healthy male volunteers
1222698|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
1222699|NCT01929330|Dutasteride|dutasteride
1222700|NCT01929330|Safety|safety
1222701|NCT01929330|Tolerability|tolerability
1222702|NCT01929317|Ropinirole|ropinirole
1222703|NCT01929317|Parkinson's disease|parkinson's disease
1222704|NCT01929291|Korea|korea
1222705|NCT01929291|Post-marketing surveillance|post-marketing surveillance
1222706|NCT01929291|Boostrix|boostrix
1222707|NCT01929291|Prescribing information|prescribing information
1222708|NCT01929291|Safety|safety
1222709|NCT01929265|INFL|infl
1223411|NCT01926041|community|community
1222710|NCT01929265|Indolent non-follicular|indolent non-follicular
1222711|NCT01929265|untreated INFL|untreated infl
1222712|NCT01929252|dexmedetomidine|dexmedetomidine
1222713|NCT01929252|wound infiltration|wound infiltration
1222714|NCT01929252|postoperative analgesia|postoperative analgesia
1222715|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
1222716|NCT01929174|Congenital heart disease|congenital heart disease
1222717|NCT01929174|Myocardial fibrosis|myocardial fibrosis
1222718|NCT01929174|Diastolic dysfunction|diastolic dysfunction
1222719|NCT01929161|positive emotions|positive emotions
1222720|NCT01929161|meditation|meditation
1222721|NCT01929161|oxytocin|oxytocin
1222722|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
1222723|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
1222724|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
1222725|NCT01929148|ovarian reserve|ovarian reserve
1222726|NCT01929135|Periodontal Disease|periodontal disease
1222727|NCT01929135|Chronic Periodontitis|chronic periodontitis
1222728|NCT01929135|Atorvastatin|atorvastatin
1222729|NCT01929135|Statins|statins
1222730|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
1222731|NCT01929135|Dentifrice|dentifrice
1222732|NCT01929122|Prevention & control|prevention & control
1222733|NCT01929122|Diet|diet
1222734|NCT01929122|Functional food|functional food
1222735|NCT01929122|Nutrition Assessment|nutrition assessment
1222736|NCT01929122|Oryza sativa|oryza sativa
1222737|NCT01929122|Rice Bran|rice bran
1222738|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
1222739|NCT01929122|Legumes|legumes
1222740|NCT01929122|Microbiome|microbiome
1222741|NCT01929122|Metabolomics|metabolomics
1222742|NCT01929122|Prebiotics|prebiotics
1222743|NCT01929083|Torsades de pointes|torsades de pointes
1222744|NCT01929083|Progesterone|progesterone
1222745|NCT01929083|Clinical trial|clinical trial
1222746|NCT01929083|Risk reduction|risk reduction
1222747|NCT01929083|Electrocardiography|electrocardiography
1222748|NCT01929070|HCP1007|hcp1007
1222749|NCT01929070|Rosuvastatin|rosuvastatin
1222750|NCT01929070|Omega-3|omega-3
1222751|NCT01929018|Amputation|amputation
1222752|NCT01929018|Rehabilitation|rehabilitation
1222753|NCT01929018|Exercise|exercise
1222754|NCT01929018|Movement|movement
1222755|NCT01929005|Comprehensive care|comprehensive care
1222756|NCT01929005|Medicare|medicare
1222757|NCT01929005|Cost-sharing|cost-sharing
1222758|NCT01929005|Quality of care|quality of care
1222759|NCT01928992|Mammography|mammography
1222760|NCT01928992|3D|3d
1222761|NCT01928992|Breast Cancer Detection|breast cancer detection
1222762|NCT01928979|LA/LAA Thrombus|la/laa thrombus
1222763|NCT01928979|Atrial Fibrillation|atrial fibrillation
1222764|NCT01928979|Observation|observation
1222765|NCT01928966|dietary fat|dietary fat
1222766|NCT01928966|fat intake|fat intake
1222767|NCT01928966|blood pressure|blood pressure
1222768|NCT01928966|women|women
1222769|NCT01928966|phytoestrogen|phytoestrogen
1222770|NCT01928966|pumpkin seeds|pumpkin seeds
1222771|NCT01928966|cardiovascular disease|cardiovascular disease
1222772|NCT01928966|heart disease|heart disease
1222773|NCT01928966|secoisolariciresinol|secoisolariciresinol
1222774|NCT01928966|monounsaturated fat|monounsaturated fat
1222775|NCT01928966|polyunsaturated fat|polyunsaturated fat
1222776|NCT01928966|feeding study|feeding study
1222777|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
1222778|NCT01928940|Advanced solid tumors|advanced solid tumors
1222779|NCT01928940|BRAF|braf
1222780|NCT01928940|Melanoma|melanoma
1222781|NCT01928888|Acute heartburn episodes|acute heartburn episodes
1222782|NCT01928849|Amputation|amputation
1222783|NCT01928849|Post-amputation Pain|post-amputation pain
1222784|NCT01928849|Neuropathic pain|neuropathic pain
1222785|NCT01928849|Valproic Acid|valproic acid
1222786|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
1222787|NCT01928849|Neuralgia, stump|neuralgia, stump
1222788|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1222789|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
1222790|NCT01928836|Biological Markers|biological markers
1222791|NCT01928836|ROC Curve|roc curve
1222792|NCT01928836|Delayed Diagnosis|delayed diagnosis
1222793|NCT01928823|agoraphobia|agoraphobia
1222794|NCT01928823|panic disorder|panic disorder
1222795|NCT01928823|D-Cycloserine|d-cycloserine
1222796|NCT01928823|DCS|dcs
1222797|NCT01928823|exposure|exposure
1222798|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
1222799|NCT01928823|CBT|cbt
1222800|NCT01928823|augmentation|augmentation
1222801|NCT01928810|Panic Disorder|panic disorder
1222802|NCT01928810|Agoraphobia|agoraphobia
1222803|NCT01928810|Physical Activity|physical activity
1222804|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
1222805|NCT01928784|Low back pain|low back pain
1222806|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
1222807|NCT01928784|Trigger Points|trigger points
1222808|NCT01928771|Asthma,|asthma,
1222809|NCT01928771|Bronchial Diseases,|bronchial diseases,
1222811|NCT01928771|Lung Diseases,|lung diseases,
1222812|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
1222815|NCT01928745|Stewart approach|stewart approach
1222816|NCT01928745|sepsis|sepsis
1222817|NCT01928745|SIRS|sirs
1222818|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
1222819|NCT01928745|CABG|cabg
1222820|NCT01928719|Smoking|smoking
1222821|NCT01928719|Nicotine|nicotine
1222822|NCT01928706|edentulism|edentulism
1222823|NCT01928706|denture liner|denture liner
1222824|NCT01928706|prosthodontics|prosthodontics
1222825|NCT01928706|OHIP EDENT|ohip edent
1222826|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
1333152|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
1222827|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
1222828|NCT01928654|Edema|edema
1222829|NCT01928654|Diabetic|diabetic
1222830|NCT01928654|Laser|laser
1222831|NCT01928654|Treatment|treatment
1222832|NCT01928602|Crossover|crossover
1222833|NCT01928602|Chronic stroke|chronic stroke
1222834|NCT01928602|Stroke|stroke
1222835|NCT01928602|Rehabilitation|rehabilitation
1222836|NCT01928602|Language Therapy|language therapy
1222837|NCT01928602|Aphasia|aphasia
1222838|NCT01928602|Aphasia Therapy|aphasia therapy
1222839|NCT01928602|Computerised Therapy|computerised therapy
1222840|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
1222841|NCT01928602|Tablet|tablet
1222842|NCT01928602|Apps|apps
1222843|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
1222844|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
1222845|NCT01928589|Cyclophosphamide|cyclophosphamide
1222846|NCT01928589|Doxorubicin|doxorubicin
1222847|NCT01928589|Docetaxel|docetaxel
1222848|NCT01928589|Carboplatin|carboplatin
1222849|NCT01928589|Herceptin|herceptin
1222850|NCT01928589|Partial Breast Irradiation|partial breast irradiation
1222851|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
1222852|NCT01928550|Diabetes|diabetes
1222853|NCT01928550|OCT|oct
1222854|NCT01928550|PDR|pdr
1222855|NCT01928537|International Working Group|international working group
1222856|NCT01928537|azacitidine|azacitidine
1222857|NCT01928537|decitabine|decitabine
1222858|NCT01928524|Gastric cancer|gastric cancer
1222859|NCT01928524|Cancer of the esophagus|cancer of the esophagus
1222860|NCT01928524|Oxaliplatin|oxaliplatin
1222861|NCT01928524|Docetaxel|docetaxel
1222862|NCT01928524|S1|s1
1222863|NCT01928511|Hepatitis B virus|hepatitis b virus
1222864|NCT01928511|HBeAg positive|hbeag positive
1222865|NCT01928511|HBeAg negative|hbeag negative
1222866|NCT01928511|antiviral therapy|antiviral therapy
1222867|NCT01928511|nucleoside analogues|nucleoside analogues
1222868|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
1222869|NCT01928498|arteriovenous graft|arteriovenous graft
1222870|NCT01928498|restenosis|restenosis
1222871|NCT01928498|angioplasty|angioplasty
1222872|NCT01928498|drug eluting balloon|drug eluting balloon
1222873|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
1222874|NCT01928459|BGJ398|bgj398
1222875|NCT01928459|BYL719|byl719
1222876|NCT01928459|advanced solid tumor|advanced solid tumor
1222877|NCT01928459|metastatic breast cancer|metastatic breast cancer
1222878|NCT01928459|PK3CA|pk3ca
1222879|NCT01928459|FGFR|fgfr
1222880|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
1222881|NCT01928446|Lithium|lithium
1222882|NCT01928446|Placebo|placebo
1222883|NCT01928446|Double-blind methods|double-blind methods
1222884|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
1222885|NCT01928446|Veterans|veterans
1222886|NCT01928433|Urinary Tract Infection|urinary tract infection
1222887|NCT01928433|Pyelonephritis|pyelonephritis
1222888|NCT01928420|Alzheimer Disease|alzheimer disease
1222889|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
1222890|NCT01928420|Alzheimer's Disease|alzheimer's disease
1222891|NCT01928420|clinical trial|clinical trial
1222892|NCT01928420|dementia|dementia
1222893|NCT01928420|diabetes|diabetes
1222894|NCT01928420|dietary supplements|dietary supplements
1222895|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
1222896|NCT01928420|Therapeutics|therapeutics
1222897|NCT01928420|Brain Diseases|brain diseases
1222898|NCT01928420|Central Nervous System Diseases|central nervous system diseases
1222899|NCT01928420|Nervous System Diseases|nervous system diseases
1222900|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
1222901|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
1222902|NCT01928420|Disorders|disorders
1222903|NCT01928420|Mental Disorders|mental disorders
1222904|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
1222905|NCT01928368|Mild asthma|mild asthma
1222906|NCT01928368|Atopic asthma|atopic asthma
1222907|NCT01928368|Healthy volunteers|healthy volunteers
1222908|NCT01928368|First-in-human|first-in-human
1222909|NCT01928316|Healthy|healthy
1222910|NCT01928316|Bioequivalence|bioequivalence
1222911|NCT01928316|Mizolastine|mizolastine
1222912|NCT01928316|Domestic|domestic
1222915|NCT01928303|chronic pain|chronic pain
1222916|NCT01928303|oxycodone|oxycodone
1222917|NCT01928303|oxymorphone|oxymorphone
1222918|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
1222919|NCT01928277|Symptom assessment agreement|symptom assessment agreement
1222920|NCT01928277|Work of breathing|work of breathing
1222921|NCT01928264|Mental disorders|mental disorders
1222922|NCT01928264|Physical activity|physical activity
1222923|NCT01928264|Disability pension|disability pension
1222924|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
1222925|NCT01928264|Ability to work|ability to work
1222926|NCT01928264|Mental toughness|mental toughness
1222927|NCT01928238|NIV|niv
1222928|NCT01928238|NAVA|nava
1222929|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
1222930|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
1222931|NCT01928225|HSIL|hsil
1222932|NCT01928225|CIN|cin
1222933|NCT01928225|HPV|hpv
1222934|NCT01928225|HPV vaccination|hpv vaccination
1222935|NCT01928225|gardasil|gardasil
1222936|NCT01928225|HIV|hiv
1222937|NCT01928225|cervical dysplasia|cervical dysplasia
1222938|NCT01928225|LEEP|leep
1222939|NCT01928225|cervical cancer|cervical cancer
1222940|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
1222941|NCT01928212|optical coherence tomography|optical coherence tomography
1222942|NCT01928212|Parkinson disease|parkinson disease
1222943|NCT01928199|diabetes|diabetes
1222944|NCT01928199|transplant|transplant
1222945|NCT01928199|kidney|kidney
1222946|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1222947|NCT01928173|Cognitive Therapy|cognitive therapy
1222948|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
1222949|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
1222950|NCT01928147|Phase 1|phase 1
1222951|NCT01928147|Genotype 1|genotype 1
1222952|NCT01928134|Vitamin K2|vitamin k2
1222953|NCT01928134|Vitamin D3|vitamin d3
1222954|NCT01928134|Bioavailability of calcium|bioavailability of calcium
1222955|NCT01928134|volunteers|volunteers
1222956|NCT01928134|Men|men
1222957|NCT01928134|non-pregnant women|non-pregnant women
1222958|NCT01928134|twenty years of age|twenty years of age
1222959|NCT01928121|nurse|nurse
1222960|NCT01928121|expert program|expert program
1222961|NCT01928121|primary care|primary care
1222962|NCT01928121|implementation|implementation
1222963|NCT01928121|interdisciplinary|interdisciplinary
1222964|NCT01928121|effectiveness|effectiveness
1222965|NCT01928121|disease management system|disease management system
1222966|NCT01928095|atherosclerosis|atherosclerosis
1222967|NCT01928095|carotid endartherectomy|carotid endartherectomy
1222968|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
1222969|NCT01928082|Hypercalciuria|hypercalciuria
1222970|NCT01928082|Osteopenia|osteopenia
1222971|NCT01928082|Osteoporosis|osteoporosis
1222972|NCT01928082|Postmenopausal women|postmenopausal women
1222973|NCT01928004|edentulous|edentulous
1222974|NCT01928004|complete denture|complete denture
1222975|NCT01927991|tinnitus|tinnitus
1222976|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
1222977|NCT01927991|internet treatment|internet treatment
1222978|NCT01927978|Esophageal cancer|esophageal cancer
1222979|NCT01927978|18F-FDG PET|18f-fdg pet
1222980|NCT01927978|staging|staging
1222981|NCT01927978|therapy planning|therapy planning
1222982|NCT01927978|therapy response monitoring|therapy response monitoring
1222983|NCT01927978|prognosis|prognosis
1222984|NCT01927965|gastrointestinal tract|gastrointestinal tract
1222985|NCT01927965|GI tract|gi tract
1222986|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
1222987|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
1222988|NCT01927965|GI tumors|gi tumors
1222989|NCT01927965|biliary|biliary
1222990|NCT01927965|gallbladder,|gallbladder,
1222991|NCT01927965|colorectal,|colorectal,
1222992|NCT01927965|gastric,|gastric,
1222993|NCT01927965|hepatocellular|hepatocellular
1222994|NCT01927965|esophageal|esophageal
1222995|NCT01927965|pancreatic|pancreatic
1222996|NCT01927952|hammertoe|hammertoe
1222997|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
1222998|NCT01927926|Energy intake|energy intake
1222999|NCT01927926|appetite|appetite
1223000|NCT01927926|satiety|satiety
1223001|NCT01927926|gut hormones|gut hormones
1223002|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
1223003|NCT01927900|Microbiota|microbiota
1223004|NCT01927900|Prebiotics|prebiotics
1223005|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
1223006|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
1223007|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
1223008|NCT01927874|infiltration|infiltration
1223009|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
1223010|NCT01927874|Postoperative pain|postoperative pain
1223614|NCT01925235|parameters|parameters
1223011|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
1223012|NCT01927809|Hereditary Diseases|hereditary diseases
1223013|NCT01927809|Colon|colon
1223014|NCT01927783|Cardiovascular Disease|cardiovascular disease
1223015|NCT01927783|Obesity|obesity
1223016|NCT01927770|Whole Genome Sequencing|whole genome sequencing
1223017|NCT01927770|Informed Choice|informed choice
1223018|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
1223019|NCT01927757|etanercept|etanercept
1223020|NCT01927757|arthritis|arthritis
1223021|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
1591390|NCT00426556|trastuzumab|trastuzumab
1223022|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
1223023|NCT01927757|ACR20|acr20
1223024|NCT01927757|methotrexate|methotrexate
1223025|NCT01927757|Swollen joints|swollen joints
1223026|NCT01927757|tender joints|tender joints
1223027|NCT01927744|Head and Neck Cancer|head and neck cancer
1223028|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1223029|NCT01927744|SCCHN|scchn
1223030|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
1223031|NCT01927744|Docetaxel|docetaxel
1223032|NCT01927744|Taxotere|taxotere
1223033|NCT01927744|Erlotinib|erlotinib
1223034|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
1223035|NCT01927744|OSI-774|osi-774
1223036|NCT01927744|CP358774|cp358774
1223037|NCT01927744|Tarceva|tarceva
1223038|NCT01927744|Questionnaire|questionnaire
1223039|NCT01927744|Survey|survey
1223040|NCT01927744|Phone call|phone call
1223041|NCT01927731|Blood And Marrow Transplantation|blood and marrow transplantation
1223042|NCT01927731|Cord blood transplantation|cord blood transplantation
1223043|NCT01927731|CBT|cbt
1223044|NCT01927731|Platelet count|platelet count
1223045|NCT01927731|Haploidentical donor stem cell transplant|haploidentical donor stem cell transplant
1223046|NCT01927731|Eltrombopag|eltrombopag
1223047|NCT01927731|Promacta|promacta
1223048|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
1223049|NCT01927718|Myeloma|myeloma
1223050|NCT01927718|Multiple myeloma|multiple myeloma
1223051|NCT01927718|MM|mm
1223052|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
1223053|NCT01927718|ASCT|asct
1223054|NCT01927718|Thalidomide|thalidomide
1223055|NCT01927718|Thalomid|thalomid
1223056|NCT01927718|Lenalidomide|lenalidomide
1223057|NCT01927718|CC-5013|cc-5013
1223058|NCT01927718|Revlimid|revlimid
1223059|NCT01927718|Questionnaires|questionnaires
1223060|NCT01927718|Surveys|surveys
1223061|NCT01927705|Atopic dermatitis|atopic dermatitis
1223062|NCT01927705|Stem cell|stem cell
1223063|NCT01927705|Cell therapy|cell therapy
1223064|NCT01927705|skin disease|skin disease
1223065|NCT01927705|furestem|furestem
1223066|NCT01927705|AD|ad
1223067|NCT01927705|hUCB-MSC|hucb-msc
1223068|NCT01927705|UCB-MSC|ucb-msc
1223069|NCT01927705|Umbilical cord Blood|umbilical cord blood
1223070|NCT01927692|MG|mg
1223071|NCT01927666|glucoraphanin|glucoraphanin
1223072|NCT01927666|broccoli|broccoli
1223073|NCT01927666|gut microbiota|gut microbiota
1223074|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
1223075|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
1223076|NCT01927653|Diffusion MRI|diffusion mri
1223077|NCT01927640|Cocaine|cocaine
1223078|NCT01927640|Dexmedetomidine|dexmedetomidine
1223079|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
1223080|NCT01927627|Prostate cancer|prostate cancer
1223081|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1223082|NCT01927627|Enzalutamide|enzalutamide
1223083|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
1223084|NCT01927614|Cardiac MRI|cardiac mri
1223085|NCT01927614|Cardiac CT|cardiac ct
1223086|NCT01927614|Observational study|observational study
1223087|NCT01927601|TAVR|tavr
1223088|NCT01927601|aortic disease|aortic disease
1223089|NCT01927588|Certican|certican
1223090|NCT01927588|Renal Transplant|renal transplant
1223091|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
1223092|NCT01927575|TOMOSYNTHESIS|tomosynthesis
1223093|NCT01927549|cardiogenic shock|cardiogenic shock
1223094|NCT01927549|infarction|infarction
1223095|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
1223096|NCT01927549|angioplasty|angioplasty
1223097|NCT01927523|Youth violence|youth violence
1223098|NCT01927523|Crime|crime
1223099|NCT01927523|Educational achievement|educational achievement
1223100|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
1223101|NCT01927497|Rectal cancer|rectal cancer
1223102|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
1223103|NCT01927497|Biological Mesh|biological mesh
1223104|NCT01927497|Primary closure|primary closure
1223105|NCT01927484|methotrexate,|methotrexate,
1223106|NCT01927484|osteoarthritis,|osteoarthritis,
1223107|NCT01927484|pain,|pain,
1223108|NCT01927484|function,|function,
1223109|NCT01927484|synovitis|synovitis
1223110|NCT01927471|Menstrual cycles|menstrual cycles
1223111|NCT01927471|Ultrasound|ultrasound
1223112|NCT01927471|Ovary|ovary
1223113|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1223114|NCT01927471|Physical activity|physical activity
1223115|NCT01927471|Diet|diet
1223116|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1223117|NCT01927432|Nutrition|nutrition
1223118|NCT01927432|Metabolism|metabolism
1223119|NCT01927432|Antral follicle growth|antral follicle growth
1223120|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
1223121|NCT01927406|Thyroid Eye Disease|thyroid eye disease
1223122|NCT01927406|Graves' Disease|graves' disease
1223123|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
1223124|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
1223125|NCT01927380|heart rate variability|heart rate variability
1223126|NCT01927380|prostatectomy|prostatectomy
1223127|NCT01927380|steep trendelenburg|steep trendelenburg
1223128|NCT01927380|pneumoperitoneum|pneumoperitoneum
1223129|NCT01927367|Clinical Decision Support System|clinical decision support system
1223130|NCT01927367|Primary Health Care|primary health care
1223131|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
1223132|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
1223133|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
1223134|NCT01927354|microRNA29|microrna29
1223135|NCT01927354|Twist1|twist1
1223136|NCT01927341|MEK162,|mek162,
1223137|NCT01927341|panitumumab,|panitumumab,
1223138|NCT01927341|mutant RAS,|mutant ras,
1223139|NCT01927341|wild-type RAS,|wild-type ras,
1223140|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
1223141|NCT01927341|adult mCRC patient|adult mcrc patient
1223142|NCT01927328|Adenocarcinoma|adenocarcinoma
1223143|NCT01927328|Anemia|anemia
1223144|NCT01927328|Palliative therapy|palliative therapy
1223145|NCT01927328|Palliative care|palliative care
1223146|NCT01927328|Palliative treatments|palliative treatments
1223147|NCT01927328|Chemotherapy|chemotherapy
1223148|NCT01927328|Esophageal Cancer|esophageal cancer
1223149|NCT01927328|Gastric Cancer|gastric cancer
1223150|NCT01927315|Stem cells|stem cells
1223151|NCT01927315|Regeneration|regeneration
1223152|NCT01927315|Angiogenesis|angiogenesis
1223153|NCT01927315|Prevention|prevention
1223154|NCT01927302|Aphasia|aphasia
1223155|NCT01927302|Dysgraphia|dysgraphia
1223156|NCT01927302|Anomia|anomia
1223157|NCT01927302|Agrammatism|agrammatism
1223158|NCT01927302|Stroke|stroke
1223159|NCT01927302|Language Recovery|language recovery
1223160|NCT01927302|Treatment|treatment
1223161|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
1223162|NCT01927289|Ultrasound|ultrasound
1223163|NCT01927289|supraclavicular block|supraclavicular block
1223164|NCT01927289|distal forearm block|distal forearm block
1223165|NCT01927289|Grip Strength|grip strength
1223166|NCT01927289|Satisfaction|satisfaction
1223167|NCT01927276|Schizophrenia|schizophrenia
1223168|NCT01927276|Gluten|gluten
1223169|NCT01927250|cohort study|cohort study
1223170|NCT01927250|diet program|diet program
1223171|NCT01927250|art therapy|art therapy
1223172|NCT01927250|laying-on-of-hands|laying-on-of-hands
1223173|NCT01927250|quality of life|quality of life
1223174|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
1223175|NCT01927237|ARDS|ards
1223176|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
1223177|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
1223178|NCT01927237|permissive hypercapnia|permissive hypercapnia
1223179|NCT01927237|myocardial strain|myocardial strain
1223180|NCT01927211|cesarean section incisions|cesarean section incisions
1223181|NCT01927211|silver|silver
1223182|NCT01927211|C-section|c-section
1223183|NCT01927211|wound infection|wound infection
1223184|NCT01927211|scar appearance|scar appearance
1223185|NCT01927211|pain|pain
1223186|NCT01927185|central venous access|central venous access
1223187|NCT01927185|ultrasonography|ultrasonography
1223188|NCT01927185|subclavian vein|subclavian vein
1223189|NCT01927185|pneumothorax|pneumothorax
1223190|NCT01927185|vessel view|vessel view
1223191|NCT01927159|Tuberculosis|tuberculosis
1223192|NCT01927159|TB|tb
1223193|NCT01927159|Pulmonary|pulmonary
1223194|NCT01927159|Vaccine|vaccine
1223195|NCT01927159|Adjuvant|adjuvant
1223196|NCT01927146|Lauren classification|lauren classification
1223197|NCT01927146|HER2 status|her2 status
1223198|NCT01927146|Resectable gastric cancer|resectable gastric cancer
1223199|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
1223200|NCT01927120|GVHD|gvhd
1223201|NCT01927120|Allogeneic|allogeneic
1223202|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
1223203|NCT01927107|probiotics|probiotics
1223204|NCT01927107|obesity|obesity
1223205|NCT01927107|oxidative stress|oxidative stress
1223206|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
1223207|NCT01927055|NOH|noh
1223208|NCT01927055|OH|oh
1223209|NCT01927055|PD|pd
1223210|NCT01927055|MSA|msa
1223211|NCT01927055|PAF|paf
1223212|NCT01927055|DBH|dbh
1223213|NCT01927042|Eating Disorders|eating disorders
1223214|NCT01927042|Carers|carers
1223215|NCT01927029|twin pregnancy|twin pregnancy
1223216|NCT01927029|progesterone|progesterone
1223217|NCT01927029|preterm delivery|preterm delivery
1223218|NCT01927029|>14 years|>14 years
1223219|NCT01927029|Abscense of cerclage,|abscense of cerclage,
1223220|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
1223221|NCT01927029|history of thrombosis.|history of thrombosis.
1223222|NCT01927029|cervix >15mm|cervix >15mm
1223223|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
1223224|NCT01927016|Esophagus|esophagus
1223225|NCT01927016|Surgery|surgery
1223226|NCT01927016|Outcome assessment|outcome assessment
1223227|NCT01927003|defect,|defect,
1223228|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
1223229|NCT01927003|dorsal digital flap,|dorsal digital flap,
1223230|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
1223231|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
1223232|NCT01926964|Early breast cancer|early breast cancer
1223233|NCT01926964|Oncotype DX|oncotype dx
1223431|NCT01925950|BDP|bdp
1223234|NCT01926964|Genetic profiling|genetic profiling
1223235|NCT01926951|hypertension|hypertension
1223236|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
1223237|NCT01926912|Schizophrenia|schizophrenia
1223238|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
1223239|NCT01926912|Hospital setting|hospital setting
1223240|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
1223241|NCT01926860|Prevenar13|prevenar13
1223242|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1223243|NCT01926860|Epaxal|epaxal
1223244|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
1223245|NCT01926847|Digital ischemia|digital ischemia
1223246|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
1223247|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
1223248|NCT01926834|herbal medicine|herbal medicine
1223249|NCT01926834|traditional chinese medicine|traditional chinese medicine
1223250|NCT01926834|random clinical trial|random clinical trial
1223251|NCT01926795|toddler's fracture|toddler's fracture
1223252|NCT01926795|tibial fracture|tibial fracture
1223253|NCT01926795|children|children
1223254|NCT01926769|Colorectal cancer|colorectal cancer
1223255|NCT01926769|Metformin|metformin
1223256|NCT01926769|FOLFOX6|folfox6
1223257|NCT01926769|FOFIRI|fofiri
1223258|NCT01926769|5FU|5fu
1223259|NCT01926769|irinotecan|irinotecan
1223260|NCT01926769|oxaliplatin|oxaliplatin
1223261|NCT01926756|bacteriuria|bacteriuria
1223262|NCT01926756|straight catheterization|straight catheterization
1223263|NCT01926756|urinary tract infections|urinary tract infections
1223264|NCT01926756|iatrogenic|iatrogenic
1223265|NCT01926743|near infrared|near infrared
1223266|NCT01926743|fluorescence imaging|fluorescence imaging
1223267|NCT01926743|indocyanine green|indocyanine green
1223268|NCT01926743|gastrectomy|gastrectomy
1223269|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
1223270|NCT01926691|dementia|dementia
1223271|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
1223272|NCT01926691|inflammation|inflammation
1223273|NCT01926691|stress|stress
1223274|NCT01926678|swedish massage|swedish massage
1223275|NCT01926678|fatigue|fatigue
1223276|NCT01926678|light touch|light touch
1223277|NCT01926678|inflammation|inflammation
1223278|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
1223279|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
1223280|NCT01926665|MCL|mcl
1223281|NCT01926665|T-cell lymphoma|t-cell lymphoma
1223282|NCT01926665|TCL|tcl
1223283|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1223284|NCT01926665|DLBCL|dlbcl
1223285|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
1223286|NCT01926665|ASCT|asct
1223287|NCT01926665|Carfilzomib|carfilzomib
1223288|NCT01926665|CFZ|cfz
1223289|NCT01926665|Dexamethasone|dexamethasone
1223290|NCT01926665|Decadron|decadron
1223291|NCT01926639|Follicular lymphoma|follicular lymphoma
1223292|NCT01926639|Rituximab|rituximab
1223293|NCT01926639|Autologous dendritic cells|autologous dendritic cells
1223294|NCT01926639|Cancer vaccine|cancer vaccine
1223295|NCT01926626|Nicotine addiction|nicotine addiction
1223296|NCT01926626|Smoking Cessation|smoking cessation
1223297|NCT01926626|Quit Smoking|quit smoking
1223298|NCT01926626|moclobemide|moclobemide
1223299|NCT01926626|Nicotine Patch|nicotine patch
1223300|NCT01926613|Schizophrenia|schizophrenia
1223301|NCT01926613|Chronic Mental Disorder|chronic mental disorder
1223302|NCT01926613|Employment|employment
1223303|NCT01926613|Cognitive remediation|cognitive remediation
1223304|NCT01926613|Vocational rehabilitation|vocational rehabilitation
1223305|NCT01926600|gastric ulcer|gastric ulcer
1223306|NCT01926600|duodenal ulcer|duodenal ulcer
1223307|NCT01926600|re-bleeding rate|re-bleeding rate
1223308|NCT01926600|intragastric pH|intragastric ph
1223309|NCT01926600|proton pump inhibitor|proton pump inhibitor
1223310|NCT01926587|rigosertib|rigosertib
1223311|NCT01926587|ON 01910.Na|on 01910.na
1223312|NCT01926587|azacitidine|azacitidine
1223313|NCT01926587|Vidaza|vidaza
1223314|NCT01926574|absenteeism|absenteeism
1223315|NCT01926574|rehabilitation|rehabilitation
1223316|NCT01926574|return to work|return to work
1223317|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
1223566|NCT01925404|programming|programming
1223318|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
1223319|NCT01926561|Sitting position|sitting position
1223320|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
1223321|NCT01926548|Pharmacokinetics|pharmacokinetics
1223322|NCT01926548|Safety|safety
1223323|NCT01926535|amniotic membrane|amniotic membrane
1223324|NCT01926535|contact lens|contact lens
1223325|NCT01926535|bullous keratopathy|bullous keratopathy
1223326|NCT01926522|Exercise Therapy|exercise therapy
1223327|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
1223328|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
1223329|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
1223330|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
1223331|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
1223332|NCT01926457|Neonatal fat mass|neonatal fat mass
1223333|NCT01926457|Gestational weight gain|gestational weight gain
1223334|NCT01926457|Infant obesity|infant obesity
1223335|NCT01926444|colonoscopy|colonoscopy
1223336|NCT01926444|sedation-free|sedation-free
1223337|NCT01926444|colorectal cancer|colorectal cancer
1223338|NCT01926444|CRC screening|crc screening
1223339|NCT01926444|prevention|prevention
1223340|NCT01926444|analgesia|analgesia
1223341|NCT01926444|colonic|colonic
1223342|NCT01926444|kappa|kappa
1223343|NCT01926444|opioid agonist|opioid agonist
1223344|NCT01926444|pain management|pain management
1223345|NCT01926444|oral|oral
1223346|NCT01926444|hydrogen sulfide|hydrogen sulfide
1223347|NCT01926444|peripheral|peripheral
1223349|NCT01926418|Condoms|condoms
1223350|NCT01926418|Men who have sex with men|men who have sex with men
1223351|NCT01926418|implementation intentions|implementation intentions
1223352|NCT01926418|executive function|executive function
1223353|NCT01926405|hypersomnia|hypersomnia
1223354|NCT01926405|narcolepsy|narcolepsy
1223355|NCT01926405|amylase|amylase
1223356|NCT01926405|salivary sampling|salivary sampling
1223357|NCT01926379|Ethiopia|ethiopia
1223358|NCT01926379|TB|tb
1223359|NCT01926379|tuberculosis|tuberculosis
1223360|NCT01926379|HIV|hiv
1223361|NCT01926379|IPT|ipt
1223362|NCT01926379|isoniazid|isoniazid
1223363|NCT01926379|adherence|adherence
1223364|NCT01926379|combination intervention package|combination intervention package
1223365|NCT01926379|retention|retention
1223366|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
1223367|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
1223368|NCT01926353|Vantris|vantris
1223369|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
1223370|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
1223371|NCT01926301|sepsis|sepsis
1223372|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
1223373|NCT01926301|delirium|delirium
1223374|NCT01926275|COPD|copd
1223375|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
1223376|NCT01926275|Respiratory Muscle Training|respiratory muscle training
1223377|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
1223378|NCT01926249|Alzheimer's disease|alzheimer's disease
1223379|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
1223380|NCT01926210|Poor ovarian response|poor ovarian response
1223381|NCT01926210|in vitro fertilization|in vitro fertilization
1223382|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
1223383|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
1223384|NCT01926184|HIV/AIDS|hiv/aids
1223385|NCT01926184|Treatment as Prevention|treatment as prevention
1223386|NCT01926184|Methamphetamine|methamphetamine
1223387|NCT01926184|Cocaine|cocaine
1223388|NCT01926184|HIV viral Load|hiv viral load
1223389|NCT01926158|Denosumab|denosumab
1223390|NCT01926158|Osteoporosis|osteoporosis
1223391|NCT01926158|Hip replacement|hip replacement
1223392|NCT01926158|Osteoarthritis|osteoarthritis
1223393|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
1223394|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
1223395|NCT01926132|ascorbic acid|ascorbic acid
1223396|NCT01926132|fatigue|fatigue
1223397|NCT01926132|mitochondrial DNA|mitochondrial dna
1223398|NCT01926132|patient for more than 6 months|patient for more than 6 months
1223399|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
1223400|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
1223401|NCT01926106|twin|twin
1223402|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
1223403|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1223404|NCT01926080|Depression|depression
1223405|NCT01926080|Spirituality|spirituality
1223406|NCT01926080|Neonatal death|neonatal death
1223407|NCT01926080|Bereavement|bereavement
1223408|NCT01926080|Randomized controlled trial|randomized controlled trial
1223409|NCT01926067|Accelerometer|accelerometer
1223410|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
1223412|NCT01926041|preventive medicine|preventive medicine
1223413|NCT01926041|prediabetes|prediabetes
1223414|NCT01926041|smoking cessation|smoking cessation
1223415|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
1305850|NCT01558037|CMV|cmv
1223417|NCT01926028|NDV3|ndv3
1223418|NCT01926028|vaginal thrush|vaginal thrush
1223419|NCT01926028|chronic yeast infection|chronic yeast infection
1223420|NCT01925976|obesity|obesity
1223421|NCT01925976|dietetic intervention|dietetic intervention
1223422|NCT01925976|eating behaviors|eating behaviors
1223423|NCT01925976|children|children
1223424|NCT01925976|healthy eating|healthy eating
1223425|NCT01925976|energy dense foods|energy dense foods
1223426|NCT01925963|Normal|normal
1223427|NCT01925963|Traumatic brain injury|traumatic brain injury
1223428|NCT01925963|Neuroimaging|neuroimaging
1223429|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
1223430|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
1223432|NCT01925950|orBec|orbec
1223433|NCT01925950|GVHD|gvhd
1223434|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
1223435|NCT01925950|bone marrow transplant|bone marrow transplant
1223436|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
1223437|NCT01925950|HCT|hct
1223438|NCT01925950|stem cell transplant|stem cell transplant
1223439|NCT01925950|marrow transplant|marrow transplant
1223440|NCT01925950|SCT|sct
1223441|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
1223442|NCT01925937|Coenzyme Q10|coenzyme q10
1223443|NCT01925937|Atorvastatin|atorvastatin
1223444|NCT01925937|clinical trial|clinical trial
1223445|NCT01925937|congestive heart failure|congestive heart failure
1223446|NCT01925924|Dental cements|dental cements
1223447|NCT01925924|Orthodontic adhesives|orthodontic adhesives
1223448|NCT01925924|Glass ionomer cement|glass ionomer cement
1223449|NCT01925924|Tooth demineralization|tooth demineralization
1223450|NCT01925911|Phase 1|phase 1
1223451|NCT01925911|Healthy subjects|healthy subjects
1223452|NCT01925911|DDI|ddi
1223453|NCT01925911|CYP3A|cyp3a
1223454|NCT01925898|Laceration|laceration
1223455|NCT01925898|Sedation|sedation
1223456|NCT01925898|Pediatrics|pediatrics
1223457|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
1223458|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
1223459|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
1223460|NCT01925872|Clopidogrel resistance|clopidogrel resistance
1223461|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
1223462|NCT01925859|EryDex|erydex
1223463|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
1223464|NCT01925846|type three secretory system|type three secretory system
1223465|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
1223466|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
1223467|NCT01925807|Adolescent|adolescent
1223468|NCT01925807|Suicidal Ideation|suicidal ideation
1223469|NCT01925807|Emergency Department|emergency department
1223470|NCT01925807|Crisis|crisis
1223471|NCT01925807|Attachment|attachment
1223472|NCT01925807|Coping|coping
1223473|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
1223474|NCT01925781|Smoking Cessation|smoking cessation
1223475|NCT01925781|Nicotine Addiction|nicotine addiction
1223476|NCT01925781|e-Cigarette|e-cigarette
1223477|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
1223478|NCT01925781|electronic cigarette|electronic cigarette
1223479|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
1223480|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
1223481|NCT01925755|Non-interventional|non-interventional
1223482|NCT01925755|Rivaroxaban|rivaroxaban
1223483|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
1223484|NCT01925755|Russian Federation|russian federation
1223485|NCT01925742|Fetal aneuploidy|fetal aneuploidy
1223486|NCT01925729|middle ear|middle ear
1223487|NCT01925729|allergy|allergy
1223488|NCT01925729|nose|nose
1223489|NCT01925716|cholesterol,LDL|cholesterol,ldl
1223490|NCT01925716|vegetable oils|vegetable oils
1223491|NCT01925716|heart diseases|heart diseases
1223492|NCT01925690|Multiple Sclerosis|multiple sclerosis
1223493|NCT01925690|Disease modifying medication|disease modifying medication
1223494|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
1223495|NCT01925690|Motivational Interviewing|motivational interviewing
1223496|NCT01925690|Telephone Counseling|telephone counseling
1223497|NCT01925677|Transplant|transplant
1223498|NCT01925677|donor|donor
1223499|NCT01925677|nephrectomy|nephrectomy
1223500|NCT01925677|robotic|robotic
1223501|NCT01925677|laparoscopy|laparoscopy
1223502|NCT01925677|single-port|single-port
1223503|NCT01925664|Doulas|doulas
1223504|NCT01925664|Parenting|parenting
1223505|NCT01925664|Breastfeeding|breastfeeding
1223506|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
1223507|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
1223508|NCT01925651|Breast Cancer|breast cancer
1223509|NCT01925651|Bolus|bolus
1223510|NCT01925651|Radiodermatitis|radiodermatitis
1223511|NCT01925638|Healthy Volunteers|healthy volunteers
1223512|NCT01925638|Refametinib|refametinib
1223513|NCT01925638|Ketoconazole|ketoconazole
1223514|NCT01925638|Pharmacokinetics|pharmacokinetics
1223515|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
1223516|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
1223517|NCT01925612|Antigens, CD30|antigens, cd30
1223518|NCT01925612|Drug Therapy|drug therapy
1223519|NCT01925612|Hematologic Diseases|hematologic diseases
1223520|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
1223521|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
1223522|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
1223523|NCT01925599|Nevus|nevus
1223524|NCT01925599|Choroidal Melanoma|choroidal melanoma
1223525|NCT01925599|BAP1 mutation|bap1 mutation
1223526|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
1223527|NCT01925573|Brain Tumor|brain tumor
1223528|NCT01925534|Optiflow|optiflow
1223633|NCT01925183|HIV/HCV|hiv/hcv
1223529|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
1223530|NCT01925534|Noninvasive ventilation|noninvasive ventilation
1223531|NCT01925534|Acute respiratory failure|acute respiratory failure
1223532|NCT01925534|Standard oxygen therapy|standard oxygen therapy
1223533|NCT01925521|Intestinal Infection|intestinal infection
1223534|NCT01925495|otitis media|otitis media
1223535|NCT01925495|middle ear|middle ear
1223536|NCT01925495|feedback pathways|feedback pathways
1223537|NCT01925495|middle-ear pressure|middle-ear pressure
1223538|NCT01925482|middle ear|middle ear
1223539|NCT01925482|otitis|otitis
1223540|NCT01925482|gas exchange|gas exchange
1223541|NCT01925469|Hysterosalpingogram|hysterosalpingogram
1223542|NCT01925469|HSG|hsg
1223543|NCT01925469|Pain relief|pain relief
1223544|NCT01925469|Analgesia|analgesia
1223545|NCT01925469|Benzocaine|benzocaine
1223546|NCT01925456|urge urinary incontinence|urge urinary incontinence
1223547|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
1223548|NCT01925443|low level laser therapy|low level laser therapy
1223549|NCT01925430|Observational|observational
1223550|NCT01925430|Sleep|sleep
1223551|NCT01925430|Algorithm|algorithm
1223552|NCT01925417|Clostridium difficile|clostridium difficile
1223553|NCT01925417|C diff|c diff
1223554|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
1223555|NCT01925417|MRT|mrt
1223556|NCT01925417|microbiota suspension|microbiota suspension
1223557|NCT01925417|CDI|cdi
1223558|NCT01925417|CDAD|cdad
1223559|NCT01925417|Fecal transplant|fecal transplant
1223560|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
1223561|NCT01925417|FMT|fmt
1223562|NCT01925417|Diarrhea|diarrhea
1223563|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
1223564|NCT01925404|Physical activity|physical activity
1223565|NCT01925404|parks|parks
1223567|NCT01925404|public health|public health
1223568|NCT01925391|Pediatric glaucoma|pediatric glaucoma
1223569|NCT01925391|Intraocular pressure|intraocular pressure
1223570|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
1223571|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
1223572|NCT01925391|nitrous oxide|nitrous oxide
1223573|NCT01925391|Tetracaine|tetracaine
1223574|NCT01925378|Cervical Dysplasia|cervical dysplasia
1223575|NCT01925352|ischemic heart disease|ischemic heart disease
1223576|NCT01925352|adenovirus|adenovirus
1223577|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
1223578|NCT01925313|Safety|safety
1223579|NCT01925313|Pharmacokinetics|pharmacokinetics
1223580|NCT01925300|Pharmacokinetics|pharmacokinetics
1223581|NCT01925300|Pharmacodynamics|pharmacodynamics
1223582|NCT01925300|Safety|safety
1223583|NCT01925300|Tolerability|tolerability
1223584|NCT01925287|bioavailability|bioavailability
1223585|NCT01925287|curcumin|curcumin
1223586|NCT01925287|curcuma longa|curcuma longa
1223587|NCT01925287|healthy humans|healthy humans
1223588|NCT01925287|safety|safety
1223589|NCT01925287|sex differences|sex differences
1223590|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
1223591|NCT01925274|colorectal cancer|colorectal cancer
1223592|NCT01925274|KRAS|kras
1223593|NCT01925274|colon cancer|colon cancer
1223594|NCT01925274|mCRC|mcrc
1223595|NCT01925274|CRC|crc
1223596|NCT01925274|PF-05212384|pf-05212384
1223597|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
1223598|NCT01925274|irinotecan|irinotecan
1223599|NCT01925274|cetuximab|cetuximab
1223600|NCT01925274|NRAS|nras
1223601|NCT01925261|knee osteoarthritis|knee osteoarthritis
1223602|NCT01925261|bilateral|bilateral
1223603|NCT01925261|osteoarthritis|osteoarthritis
1223604|NCT01925248|Whey protein|whey protein
1223605|NCT01925248|protein supplement|protein supplement
1223606|NCT01925248|Diabetes|diabetes
1223607|NCT01925248|Type 2 DM|type 2 dm
1223608|NCT01925248|Hyperglycemia|hyperglycemia
1223609|NCT01925248|Insulin secretagogue|insulin secretagogue
1223610|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
1223611|NCT01925235|acute kidney injury|acute kidney injury
1223612|NCT01925235|TAVI|tavi
1223613|NCT01925235|RenPRO trial|renpro trial
1223615|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
1223616|NCT01925209|myositis,|myositis,
1223617|NCT01925209|muscle wasting,|muscle wasting,
1223618|NCT01925209|controlled clinical trial,|controlled clinical trial,
1223619|NCT01925209|randomized,|randomized,
1223620|NCT01925209|body mass,|body mass,
1223621|NCT01925209|muscle function,|muscle function,
1223622|NCT01925209|strength,|strength,
1223623|NCT01925209|performance,|performance,
1223624|NCT01925209|physical function|physical function
1223625|NCT01925196|Motor Neuron Disease|motor neuron disease
1223626|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
1223627|NCT01925196|Cognitive Testing|cognitive testing
1223628|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1223629|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1223630|NCT01925183|Boceprevir|boceprevir
1223631|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
1223632|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
1223634|NCT01925183|Response-guided therapy|response-guided therapy
1223635|NCT01925170|Dense breast tissue|dense breast tissue
1223636|NCT01925170|Breast Cancer Screening|breast cancer screening
1223637|NCT01925170|Molecular Breast Imaging|molecular breast imaging
1223638|NCT01925170|Breast Cancer|breast cancer
1223639|NCT01925170|Breast|breast
1223640|NCT01925105|Polypharmacy|polypharmacy
1223641|NCT01925092|Cushing's disease|cushing's disease
1223642|NCT01925092|Mifepristone|mifepristone
1223643|NCT01925092|Cushing's syndrome|cushing's syndrome
1223644|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
1223645|NCT01925092|Child/pediatric population|child/pediatric population
1223646|NCT01925092|Safety-efficacy|safety-efficacy
1223647|NCT01925079|acute coronary syndrome|acute coronary syndrome
1223648|NCT01925079|statins|statins
1223649|NCT01925079|LDL-C|ldl-c
1223650|NCT01925079|intensive education|intensive education
1223651|NCT01925027|Nano+ DES|nano+ des
1223652|NCT01925027|OCT|oct
1223653|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
1223654|NCT01925027|DAPT|dapt
1223655|NCT01925027|3 month|3 month
1223656|NCT01925014|Appendectomy|appendectomy
1223657|NCT01925014|Appendicitis|appendicitis
1223658|NCT01925014|False Positive Reactions|false positive reactions
1223659|NCT01925014|Humans|humans
1223660|NCT01925014|Radiation Dosage|radiation dosage
1223661|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
1223662|NCT01925014|Young Adult|young adult
1223663|NCT01925001|Sickle cell anemia|sickle cell anemia
1223664|NCT01925001|Sickle cell disease|sickle cell disease
1223665|NCT01925001|Sickling crisis|sickling crisis
1223666|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
1223667|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
1223668|NCT01925001|Oxygen therapeutic|oxygen therapeutic
1223669|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
1223670|NCT01925001|Hemoglobin solution|hemoglobin solution
1223671|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
1223672|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
1223673|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
1223674|NCT01924962|left ventricular function|left ventricular function
1223675|NCT01924962|revascularisation|revascularisation
1223676|NCT01924949|7977|7977
1223677|NCT01924949|5885|5885
1223678|NCT01924949|GS-7977|gs-7977
1223679|NCT01924949|GS-5885|gs-5885
1223680|NCT01924949|SOF|sof
1223681|NCT01924949|LDV|ldv
1223682|NCT01924949|Sofosbuvir|sofosbuvir
1223683|NCT01924949|Ledipasvir|ledipasvir
1223684|NCT01924949|FDC|fdc
1223685|NCT01924923|uveal melanoma|uveal melanoma
1223686|NCT01924923|biopsy|biopsy
1223687|NCT01924923|enucleation|enucleation
1223688|NCT01924923|ocular cancer|ocular cancer
1223689|NCT01924910|Healthy, by self report|healthy, by self report
1223690|NCT01924897|CPET test|cpet test
1223691|NCT01924897|Exercise training|exercise training
1223692|NCT01924897|Prehabilitation|prehabilitation
1223693|NCT01924897|Exercise Test|exercise test
1223694|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
1223695|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
1223696|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
1223697|NCT01924858|PET, healthy subjects|pet, healthy subjects
1223698|NCT01924858|Lp-PLA2|lp-pla2
1223699|NCT01924858|positron emission tomography|positron emission tomography
1223700|NCT01924858|Alzheimer's disease|alzheimer's disease
1223701|NCT01924858|brain exposure|brain exposure
1223702|NCT01924858|GSK2647544|gsk2647544
1223703|NCT01924819|Gastric cancer|gastric cancer
1223704|NCT01924819|Stomach cancer|stomach cancer
1223705|NCT01924819|Chemoradiotherapy|chemoradiotherapy
1223706|NCT01924819|Surgery|surgery
1223707|NCT01924819|Chemotherapy|chemotherapy
1223708|NCT01924819|Neoadjuvant|neoadjuvant
1223709|NCT01924806|debridement|debridement
1223710|NCT01924806|post-debridement|post-debridement
1223711|NCT01924806|infection|infection
1223712|NCT01924806|prevention|prevention
1223713|NCT01924806|wound|wound
1223714|NCT01924806|wound tissue|wound tissue
1223715|NCT01924806|wound management|wound management
1223716|NCT01924806|WoundWand|woundwand
1223717|NCT01924806|wound size reduction|wound size reduction
1223718|NCT01924806|wound bed debridement|wound bed debridement
1223719|NCT01924806|WoundWand Debridement Device|woundwand debridement device
1223720|NCT01924806|chronic wound|chronic wound
1223721|NCT01924806|delayed healing|delayed healing
1223722|NCT01924806|cellular senescence|cellular senescence
1223723|NCT01924806|acute wound|acute wound
1223724|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
1223725|NCT01924806|venous leg ulcers|venous leg ulcers
1223726|NCT01924806|radiofrequency debridement|radiofrequency debridement
1223727|NCT01924806|necrotic tissue|necrotic tissue
1223728|NCT01924806|wound healing|wound healing
1223729|NCT01924806|skin|skin
1223730|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1223731|NCT01924754|HPV|hpv
1223732|NCT01924754|Gardasil|gardasil
1223733|NCT01924754|seroconversion|seroconversion
1223734|NCT01924741|Liver neoplasms|liver neoplasms
1223735|NCT01924741|Liver regeneration|liver regeneration
1223736|NCT01924715|somatoform disorder|somatoform disorder
1223737|NCT01924715|psychotherapy|psychotherapy
1223738|NCT01924715|depression|depression
1223739|NCT01924715|anxiety|anxiety
1223740|NCT01924715|personality disorder|personality disorder
1223741|NCT01924689|Phase 1|phase 1
1223742|NCT01924689|Metastatic Disease|metastatic disease
1223743|NCT01924689|Solid Tumor|solid tumor
1223744|NCT01924689|Malignancy|malignancy
1223745|NCT01924689|Metastases|metastases
1223746|NCT01924689|Clinical Trial|clinical trial
1223747|NCT01924689|Hypoxia|hypoxia
1223748|NCT01924689|Necrosis|necrosis
1223749|NCT01924689|Intratumoral|intratumoral
1223750|NCT01924689|Locally advanced cancer|locally advanced cancer
1223751|NCT01924689|Immunotherapy|immunotherapy
1223752|NCT01924689|Sarcoma|sarcoma
1223753|NCT01924689|Chordoma|chordoma
1223754|NCT01924689|Bacteriolytic|bacteriolytic
1223755|NCT01924676|food effect|food effect
1223756|NCT01924676|pharmacokinetics|pharmacokinetics
1223757|NCT01924676|bioavailability|bioavailability
1223758|NCT01924676|oxycodone|oxycodone
1223759|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
1223760|NCT01924663|Heart Failure|heart failure
1223761|NCT01924663|Acute Kidney Injury|acute kidney injury
1223762|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
1223763|NCT01924663|Pediatric Critical Care|pediatric critical care
1223764|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
1223765|NCT01924663|Respiratory Virus|respiratory virus
1223766|NCT01924611|Dental caries|dental caries
1223767|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
1223768|NCT01924598|Anorexia Nervosa|anorexia nervosa
1223769|NCT01924598|Treatment Development|treatment development
1223770|NCT01924598|Capacity|capacity
1223771|NCT01924598|Neuroimaging|neuroimaging
1223772|NCT01924598|Magnetoencephalography|magnetoencephalography
1223773|NCT01924598|functional MRI|functional mri
1223774|NCT01924598|Reward processing|reward processing
1223775|NCT01924598|Habit formation|habit formation
1223776|NCT01924585|Colorectal|colorectal
1223777|NCT01924585|Surgery|surgery
1223778|NCT01924585|Frailty|frailty
1223779|NCT01924585|Elderly|elderly
1223780|NCT01924585|Quality of Life|quality of life
1223781|NCT01924572|umbilical cord clamping|umbilical cord clamping
1223782|NCT01924572|Placental residual blood volume|placental residual blood volume
1223783|NCT01924572|hematocrit|hematocrit
1223784|NCT01924572|hemoglobin|hemoglobin
1223785|NCT01924572|bilirubin|bilirubin
1223786|NCT01924559|Airway|airway
1223787|NCT01924546|cognition|cognition
1223788|NCT01924546|hydration|hydration
1223789|NCT01924546|schoolchildren|schoolchildren
1223790|NCT01924520|Antipsychotic|antipsychotic
1223791|NCT01924520|FK949E|fk949e
1223792|NCT01924520|Quetiapine|quetiapine
1223793|NCT01924507|Sleep medicine|sleep medicine
1223794|NCT01924507|Sleep apnea|sleep apnea
1223795|NCT01924507|Acute myocardial infarction|acute myocardial infarction
1223796|NCT01924507|Heart failure|heart failure
1223797|NCT01924507|CPAP|cpap
1223798|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
1223799|NCT01924481|Caffeine|caffeine
1223800|NCT01924481|Flavonoids|flavonoids
1223801|NCT01924481|MRI|mri
1223802|NCT01924481|Brain blood flow|brain blood flow
1223803|NCT01924481|Cognition|cognition
1223804|NCT01924481|Perfusion|perfusion
1223805|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
1223806|NCT01924468|Cognitive Control|cognitive control
1223807|NCT01924468|fMRI|fmri
1223808|NCT01924468|Genetics|genetics
1223809|NCT01924468|Dopamine|dopamine
1223810|NCT01924455|HIV|hiv
1223811|NCT01924455|HBV|hbv
1223812|NCT01924442|Coronary Artery Disease|coronary artery disease
1223813|NCT01924442|Off-Pump|off-pump
1223814|NCT01924442|Myocardial Ischemia|myocardial ischemia
1223815|NCT01924442|Heart Disease|heart disease
1223816|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1223817|NCT01924429|ADHD|adhd
1223818|NCT01924429|fMRI|fmri
1223819|NCT01924429|Imaging|imaging
1223820|NCT01924429|Vyvanse|vyvanse
1223821|NCT01924429|Stimulant Medication|stimulant medication
1223822|NCT01924429|Treatment|treatment
1223823|NCT01924429|Clinical Trial|clinical trial
1223824|NCT01924429|Adult|adult
1223825|NCT01924403|TKA|tka
1223826|NCT01924403|Wound Closure|wound closure
1223827|NCT01924403|Wound Perfusion|wound perfusion
1223828|NCT01924390|Tooth extraction|tooth extraction
1223829|NCT01924377|AF|af
1223830|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
1223831|NCT01924364|Facial Trauma|facial trauma
1223832|NCT01924364|Fat Grafts|fat grafts
1223833|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1223834|NCT01924364|Wounded warriors|wounded warriors
1223835|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
1223836|NCT01924351|HER2-positive|her2-positive
1223837|NCT01924351|HER-2 therapy|her-2 therapy
1223838|NCT01924338|Patient|patient
1223839|NCT01924338|localisation|localisation
1223840|NCT01924338|in cranial|in cranial
1223841|NCT01924338|radiation|radiation
1223842|NCT01924338|therapy|therapy
1223843|NCT01924338|thickness of|thickness of
1223844|NCT01924325|apixaban|apixaban
1223845|NCT01924325|clopidogrel|clopidogrel
1223846|NCT01924325|aspirin|aspirin
1223847|NCT01924325|new oral anticoagulant|new oral anticoagulant
1223848|NCT01924325|TIA|tia
1223849|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
1223850|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
1223851|NCT01924286|HIV|hiv
1223852|NCT01924286|Tuberculosis|tuberculosis
1223853|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
1223854|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
1223855|NCT01924286|Glucocorticoids|glucocorticoids
1223856|NCT01924286|Prednisone|prednisone
1223857|NCT01924286|Preventive therapy|preventive therapy
1223858|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
1223859|NCT01924234|Remifentanil|remifentanil
1223860|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
1223861|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
1223862|NCT01924234|Pulmonary aspiration|pulmonary aspiration
1223863|NCT01924208|Timothy|timothy
1223864|NCT01924208|Influenza|influenza
1223865|NCT01924208|Interferon|interferon
1223866|NCT01924208|T cell|t cell
1223867|NCT01924208|Tonsil|tonsil
1223868|NCT01924195|lung|lung
1223869|NCT01924195|Anlotinib|anlotinib
1223870|NCT01924195|AL3818|al3818
1223871|NCT01924195|NSCLC|nsclc
1223872|NCT01924195|Cancer|cancer
1223873|NCT01924182|chronic pain|chronic pain
1223874|NCT01924182|inadequate pain relief|inadequate pain relief
1223875|NCT01924182|intolerable side effects|intolerable side effects
1223876|NCT01924169|Hematologic Disorder|hematologic disorder
1223877|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1223878|NCT01924169|CLL|cll
1223879|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
1223880|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
1223881|NCT01924169|Immunoglobulins|immunoglobulins
1223882|NCT01924169|Immune system's function|immune system's function
1223883|NCT01924169|Lenalidomide|lenalidomide
1223884|NCT01924169|CC-5013|cc-5013
1223885|NCT01924169|Revlimid|revlimid
1223886|NCT01924169|Flu vaccine|flu vaccine
1223887|NCT01924169|TIV|tiv
1223888|NCT01924169|Pneumonia vaccine|pneumonia vaccine
1223889|NCT01924143|ADHD|adhd
1223890|NCT01924143|Fibromyalgia|fibromyalgia
1223891|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
1223892|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
1223893|NCT01924078|breast cancer|breast cancer
1223894|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
1223895|NCT01924078|aromatase inhibitors|aromatase inhibitors
1223896|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
1223897|NCT01924039|Psychosis|psychosis
1223898|NCT01924039|Substance Use|substance use
1223899|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
1223900|NCT01924026|Phenylketonuria|phenylketonuria
1223901|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
1223902|NCT01924026|PKU|pku
1223903|NCT01924026|MHP|mhp
1223904|NCT01924013|Pregnancy|pregnancy
1223905|NCT01924013|Infant Growth|infant growth
1223906|NCT01924013|Vitamin D|vitamin d
1223907|NCT01924013|Bangladesh|bangladesh
1223908|NCT01923987|Short course radiotherapy|short course radiotherapy
1223909|NCT01923987|Modified FOLFOX6|modified folfox6
1223910|NCT01923987|Delayed surgery|delayed surgery
1223911|NCT01923987|Rectal cancer|rectal cancer
1223912|NCT01923987|Synchronous metastasis|synchronous metastasis
1223913|NCT01923987|Liver metastasis|liver metastasis
1223914|NCT01923987|Lung metastasis|lung metastasis
1223915|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
1223916|NCT01923961|>18 years|>18 years
1223917|NCT01923961|Stable condition|stable condition
1223918|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
1223919|NCT01923948|Hepatectomy|hepatectomy
1223920|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
1223921|NCT01923948|Postoperative Pain|postoperative pain
1223922|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
1223923|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
1223924|NCT01923922|CT Perfusion|ct perfusion
1223925|NCT01923922|Survival|survival
1223927|NCT01923909|Osteoarthritis|osteoarthritis
1223928|NCT01923909|Bahrain|bahrain
1223929|NCT01923909|PRP|prp
1223930|NCT01923909|Steroid|steroid
1223931|NCT01923909|WOMAC|womac
1223932|NCT01923909|Oxford Knee Score|oxford knee score
1223933|NCT01923909|Platelet-rich plasma|platelet-rich plasma
1223934|NCT01923896|food refusal|food refusal
1223935|NCT01923896|behavioral intervention|behavioral intervention
1223936|NCT01923896|D-cycloserine|d-cycloserine
1223937|NCT01923844|Newborn|newborn
1223938|NCT01923844|perfusion index|perfusion index
1223939|NCT01923844|pulsatility index|pulsatility index
1223940|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
1223941|NCT01923844|surfactant|surfactant
1223942|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
1223943|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
1223944|NCT01923818|rivaroxaban|rivaroxaban
1223945|NCT01923818|aspirin|aspirin
1223946|NCT01923818|new oral anticoagulant|new oral anticoagulant
1223947|NCT01923818|TIA|tia
1223948|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
1223949|NCT01923792|House Dust Mite Allergy|house dust mite allergy
1223950|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
1223951|NCT01923792|Environmental Exposure Unit|environmental exposure unit
1223952|NCT01923792|Immunotherapy|immunotherapy
1223953|NCT01923792|ToleroMune HDM|toleromune hdm
1223954|NCT01923779|Grass allergy|grass allergy
1223955|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
1223956|NCT01923779|Environmental Exposure Unit|environmental exposure unit
1223957|NCT01923779|Immunotherapy|immunotherapy
1223958|NCT01923779|ToleroMune Grass|toleromune grass
1223959|NCT01923766|Transplantation|transplantation
1223960|NCT01923753|Cystic Fibrosis|cystic fibrosis
1223961|NCT01923753|Neural respiratory drive|neural respiratory drive
1223962|NCT01923753|Airway clearance technique|airway clearance technique
1223963|NCT01923753|Expectoration|expectoration
1223964|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
1223965|NCT01923740|Absorb™ BVS|absorb™ bvs
1223966|NCT01923740|Angioplasty|angioplasty
1223967|NCT01923740|Bioabsorbable|bioabsorbable
1223968|NCT01923740|BVS|bvs
1223969|NCT01923740|Bioresorbable|bioresorbable
1223970|NCT01923740|Coronary Artery Disease|coronary artery disease
1223971|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1223972|NCT01923740|Coronary artery restenosis|coronary artery restenosis
1223973|NCT01923740|Coronary artery stenosis|coronary artery stenosis
1223974|NCT01923740|Coronary scaffold|coronary scaffold
1223975|NCT01923740|Coronary Stent|coronary stent
1223976|NCT01923740|Drug eluting stents|drug eluting stents
1223977|NCT01923740|Everolimus|everolimus
1223978|NCT01923740|Myocardial ischemia|myocardial ischemia
1223979|NCT01923740|Stent thrombosis|stent thrombosis
1223980|NCT01923740|Stents|stents
1223981|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
1223982|NCT01923727|Prostate|prostate
1223983|NCT01923727|PET Scan|pet scan
1223984|NCT01923714|Glaucoma|glaucoma
1223985|NCT01923701|At Risk Mental State|at risk mental state
1223986|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
1223987|NCT01923701|Prodrom|prodrom
1223988|NCT01923701|Paranoia|paranoia
1223989|NCT01923701|Psychosis|psychosis
1223990|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
1223991|NCT01923701|Group|group
1223992|NCT01923701|Family|family
1223993|NCT01923701|ARMS|arms
1223994|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
1223995|NCT01923675|myopia|myopia
1223996|NCT01923675|nearsightedness|nearsightedness
1223997|NCT01923675|axial elongation of the eye|axial elongation of the eye
1223998|NCT01923675|refractive error|refractive error
1223999|NCT01923662|Paraplegia|paraplegia
1224000|NCT01923662|Tetraplegia|tetraplegia
1224001|NCT01923662|Spinal Cord Injury|spinal cord injury
1224002|NCT01923662|FES|fes
1224003|NCT01923649|postoperative dumping|postoperative dumping
1224004|NCT01923649|somatostatin analogues|somatostatin analogues
1224005|NCT01923649|somatulin|somatulin
1224006|NCT01923649|lanreotide|lanreotide
1224007|NCT01923649|dumping syndrome|dumping syndrome
1224008|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
1224009|NCT01923610|Low risk HIV infection|low risk hiv infection
1224010|NCT01923610|HIV Seronegativity|hiv seronegativity
1224011|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
1224012|NCT01923597|Proteinuria|proteinuria
1224013|NCT01923597|Oxidative stress|oxidative stress
1224014|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
1224015|NCT01923545|PEG-G-CSF|peg-g-csf
1224016|NCT01923493|neck pain|neck pain
1224017|NCT01923493|tuina|tuina
1224018|NCT01923467|smoking|smoking
1224019|NCT01923467|nicotine replacement|nicotine replacement
1224020|NCT01923467|internet|internet
1224021|NCT01923454|paracentesis|paracentesis
1224022|NCT01923454|primary acute angle closure|primary acute angle closure
1224023|NCT01923454|iridotomy|iridotomy
1224024|NCT01923454|filtration|filtration
1224025|NCT01923454|glaucoma|glaucoma
1224026|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
1224027|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1224028|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
1224029|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
1224030|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
1224031|NCT01923415|Skin Biopsy|skin biopsy
1224032|NCT01923415|Lesions|lesions
1224033|NCT01923402|Biomarkers|biomarkers
1224034|NCT01923402|Metabolic Profiling|metabolic profiling
1224035|NCT01923402|Metabolomics|metabolomics
1224036|NCT01923402|Tobacco|tobacco
1224037|NCT01923402|Smokeless Tobacco|smokeless tobacco
1224038|NCT01923402|Moist Snuff|moist snuff
1224039|NCT01923389|T2DM|t2dm
1224040|NCT01923389|obesity|obesity
1224041|NCT01923389|safety|safety
1224042|NCT01923389|multiple dose|multiple dose
1224043|NCT01923389|intravenous|intravenous
1224044|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
1224045|NCT01923376|hepatic coma|hepatic coma
1224047|NCT01923376|PSE|pse
1224048|NCT01923376|lactulose|lactulose
1224049|NCT01923376|golytely|golytely
1224050|NCT01923376|cirrhosis|cirrhosis
1224051|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
1224052|NCT01923376|Liver Cirrhosis|liver cirrhosis
1224053|NCT01923376|Fibrosis|fibrosis
1224054|NCT01923376|Brain Damage, Chronic|brain damage, chronic
1224055|NCT01923376|Delirium|delirium
1224056|NCT01923376|Encephalitis|encephalitis
1224057|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
1224058|NCT01923376|Liver Failure|liver failure
1224059|NCT01923376|Liver Diseases|liver diseases
1224060|NCT01923376|Digestive System Diseases|digestive system diseases
1224061|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
1224062|NCT01923376|Brain Diseases|brain diseases
1224063|NCT01923376|Central Nervous System Diseases|central nervous system diseases
1224064|NCT01923376|Nervous System Diseases|nervous system diseases
1224065|NCT01923376|Metabolic Diseases|metabolic diseases
1224066|NCT01923376|Pathologic Processes|pathologic processes
1224067|NCT01923376|Confusion|confusion
1224068|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
1224069|NCT01923376|Neurologic Manifestations|neurologic manifestations
1224070|NCT01923376|Signs and Symptoms|signs and symptoms
1224071|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1224072|NCT01923376|Mental Disorders|mental disorders
1224073|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
1224074|NCT01923376|Virus Diseases|virus diseases
1224075|NCT01923376|Central Nervous System Infections|central nervous system infections
1224076|NCT01923376|Poisoning|poisoning
1224077|NCT01923376|Substance-Related Disorders|substance-related disorders
1224078|NCT01923376|Citric Acid|citric acid
1224079|NCT01923363|pharmacokinetics|pharmacokinetics
1224080|NCT01923363|obesity|obesity
1224081|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
1224082|NCT01923363|pharmacodynamics|pharmacodynamics
1224083|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
1224084|NCT01923350|Weight reduction|weight reduction
1224085|NCT01923350|Behavioral intervention|behavioral intervention
1224086|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
1224087|NCT01923350|Type 2 diabetes|type 2 diabetes
1224088|NCT01923350|Diabetes testing|diabetes testing
1224089|NCT01923337|Colorectal cancer|colorectal cancer
1224090|NCT01923311|Pediatrics|pediatrics
1224091|NCT01923311|Adolescents|adolescents
1224092|NCT01923311|HIV|hiv
1224093|NCT01923311|HIV-1|hiv-1
1224094|NCT01923311|Treatment-experienced|treatment-experienced
1224095|NCT01923246|Alcohol consumption|alcohol consumption
1224096|NCT01923246|Brief intervention|brief intervention
1224097|NCT01923246|Automated techniques|automated techniques
1224098|NCT01923233|liver cancer|liver cancer
1224099|NCT01923233|HCC|hcc
1224100|NCT01923233|tumor vaccine|tumor vaccine
1224101|NCT01923233|immunotherapy|immunotherapy
1224102|NCT01923220|Breast Cancer|breast cancer
1224103|NCT01923220|Radiation Therapy|radiation therapy
1224104|NCT01923220|Radiation Dermatitis|radiation dermatitis
1224105|NCT01923168|Breast Cancer, Pathological Complete Response, neoadjuvant, hormone receptor-positive|breast cancer, pathological complete response, neoadjuvant, hormone receptor-positive
1224106|NCT01923142|Vitiligo|vitiligo
1224107|NCT01923142|Outer-Root-Sheath|outer-root-sheath
1224108|NCT01923142|Melanocytes|melanocytes
1224109|NCT01923142|Hair Follicles|hair follicles
1591391|NCT00426556|paclitaxel|paclitaxel
1224110|NCT01923129|indwelling catheter|indwelling catheter
1224111|NCT01923129|foley|foley
1224112|NCT01923129|duration|duration
1224113|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
1224114|NCT01923116|HIV|hiv
1224115|NCT01923116|HPV|hpv
1224116|NCT01923116|Vaccination|vaccination
1224117|NCT01923116|Treatment|treatment
1224118|NCT01923077|acute myocardial infarction|acute myocardial infarction
1224119|NCT01923077|Statin|statin
1224120|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
1224121|NCT01923077|Strain|strain
1224122|NCT01923077|MSCT|msct
1224123|NCT01923077|plaque|plaque
1224124|NCT01923077|vulnerable plaque|vulnerable plaque
1224125|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1224126|NCT01923051|COPD|copd
1224127|NCT01923051|national database|national database
1224128|NCT01923051|observational|observational
1224129|NCT01923038|atelectasis|atelectasis
1224130|NCT01923038|laparoscopic surgery|laparoscopic surgery
1224131|NCT01923038|anesthesia|anesthesia
1224132|NCT01923038|mechanical ventilation|mechanical ventilation
1224133|NCT01923038|Prevent|prevent
1224134|NCT01923038|shape of the airway|shape of the airway
1224135|NCT01923038|pressure-time curve|pressure-time curve
1224136|NCT01922986|stroke|stroke
1224137|NCT01922986|rehabilitation|rehabilitation
1224138|NCT01922986|hemiplegia|hemiplegia
1224830|NCT01919853|Fatigue|fatigue
1224139|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1224140|NCT01922973|ghrelin|ghrelin
1224141|NCT01922973|growth hormone|growth hormone
1224142|NCT01922973|aging|aging
1224143|NCT01922973|normal volunteers|normal volunteers
1224144|NCT01922960|trauma|trauma
1224145|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1224146|NCT01922908|Ischemic|ischemic
1224147|NCT01922908|Stroke|stroke
1224148|NCT01922908|Stem Cells|stem cells
1224149|NCT01922908|MSC|msc
1224150|NCT01922908|Allogeneic|allogeneic
1224151|NCT01922908|Bone Marrow|bone marrow
1224152|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
1224153|NCT01922895|MELD < 20|meld < 20
1224154|NCT01922895|Probiotic|probiotic
1224155|NCT01922895|Nutritional Supplement|nutritional supplement
1224156|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
1224157|NCT01922882|HIV|hiv
1224158|NCT01922882|Maternal disclosure|maternal disclosure
1224159|NCT01922882|Health promotion|health promotion
1224160|NCT01922882|Maternal mental health|maternal mental health
1224161|NCT01922882|Child behavior|child behavior
1224162|NCT01922869|Absorption|absorption
1224163|NCT01922869|Metabolism|metabolism
1224164|NCT01922869|Excretion|excretion
1224165|NCT01922869|Flavonoids|flavonoids
1224166|NCT01922869|Polyphenols|polyphenols
1224167|NCT01922869|Genes|genes
1224168|NCT01922869|Gut-microflora|gut-microflora
1224169|NCT01922843|Hemodialysis|hemodialysis
1224170|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
1224171|NCT01922830|NAFLD|nafld
1224172|NCT01922830|gut microbiot|gut microbiot
1224173|NCT01922830|Bariatric surgery|bariatric surgery
1224174|NCT01922791|Nutrition|nutrition
1224175|NCT01922791|Probiotics|probiotics
1224176|NCT01922791|Fish oil|fish oil
1224177|NCT01922765|Helicobacter|helicobacter
1224178|NCT01922765|Eradication|eradication
1224179|NCT01922752|CEP-37440|cep-37440
1224180|NCT01922752|Advanced solid tumors|advanced solid tumors
1224181|NCT01922752|Metastatic solid tumors|metastatic solid tumors
1224182|NCT01922739|low back pain|low back pain
1224183|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
1224184|NCT01922739|opioids|opioids
1224185|NCT01922713|biofortification|biofortification
1224186|NCT01922713|vitamin A|vitamin a
1224187|NCT01922713|maize|maize
1224188|NCT01922713|beta-carotene|beta-carotene
1224189|NCT01922713|breastmilk|breastmilk
1224190|NCT01922713|Zambia|zambia
1224191|NCT01922700|Pepper spray|pepper spray
1224192|NCT01922700|bronchospasm|bronchospasm
1224193|NCT01922700|lacrimation|lacrimation
1224194|NCT01922648|RSV|rsv
1224195|NCT01922648|Immune response|immune response
1224196|NCT01922648|Paediatric|paediatric
1224197|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
1224198|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
1224199|NCT01922622|spinal catheter|spinal catheter
1224200|NCT01922622|fractured neck of femur|fractured neck of femur
1224201|NCT01922622|a step up, step down methodology|a step up, step down methodology
1224202|NCT01922609|Carotid stenting|carotid stenting
1224203|NCT01922609|Proximal protection system|proximal protection system
1224204|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
1224205|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
1224206|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
1224207|NCT01922596|Adductor Canal Blockade|adductor canal blockade
1224208|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
1224209|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
1224210|NCT01922570|Enteral nutrition|enteral nutrition
1224211|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
1224212|NCT01922570|Critical illness|critical illness
1224213|NCT01922570|ICU patients|icu patients
1224214|NCT01922570|diarrhea|diarrhea
1224215|NCT01922544|heart failure|heart failure
1224216|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
1224217|NCT01922544|coronary sinus lead|coronary sinus lead
1224218|NCT01922531|mTBI|mtbi
1224219|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
1224220|NCT01922531|Axonal Injury|axonal injury
1224221|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
1224222|NCT01922492|autologous islet transplantation|autologous islet transplantation
1224223|NCT01922492|partial pancreatectomy|partial pancreatectomy
1224224|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
1224225|NCT01922479|Heart Failure|heart failure
1224226|NCT01922479|Anemia|anemia
1224227|NCT01922479|Iron Deficiency|iron deficiency
1224228|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
1224229|NCT01922479|Asian|asian
1224230|NCT01922466|chronic neck pain|chronic neck pain
1224231|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
1224232|NCT01922466|bee venom acupuncture|bee venom acupuncture
1224233|NCT01922466|NSAIDs|nsaids
1224234|NCT01922453|breech presentation|breech presentation
1224235|NCT01922453|vertex presentation|vertex presentation
1224236|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
1224237|NCT01922440|rhPTH(1-84)|rhpth(1-84)
1224238|NCT01922440|Observational study|observational study
1224239|NCT01922440|parathyroid hormone (PTH)|parathyroid hormone (pth)
1224240|NCT01922440|Drug registry|drug registry
1224241|NCT01922414|Staghorn stones|staghorn stones
1224242|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
1224243|NCT01922414|Laser|laser
1224244|NCT01922414|Randomized trial|randomized trial
1224245|NCT01922414|Lithotripsy|lithotripsy
1224246|NCT01922388|Parkinson disease|parkinson disease
1224247|NCT01922388|deep brain stimulation|deep brain stimulation
1224248|NCT01922388|subthalamic nucleus|subthalamic nucleus
1224249|NCT01922388|motor complication|motor complication
1224250|NCT01922388|quality of life|quality of life
1224251|NCT01922362|STSG|stsg
1224252|NCT01922362|wound healing|wound healing
1224253|NCT01922336|Pharmacokinetics|pharmacokinetics
1224254|NCT01922323|Living liver donor|living liver donor
1224255|NCT01922297|Delinquency|delinquency
1224256|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
1224257|NCT01922297|Juveniles|juveniles
1224258|NCT01922297|Family based treatment|family based treatment
1224259|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
1224261|NCT01922284|Vaccine|vaccine
1224262|NCT01922284|Immunisation|immunisation
1224263|NCT01922284|DNA|dna
1224264|NCT01922284|Adverse events|adverse events
1224265|NCT01922284|MVA-C|mva-c
1224266|NCT01922284|GLA-AF|gla-af
1224267|NCT01922284|Antibody|antibody
1224268|NCT01922271|COPD|copd
1224269|NCT01922258|OPC-34712|opc-34712
1224270|NCT01922258|brexpiprazole|brexpiprazole
1224271|NCT01922258|Dementia|dementia
1224272|NCT01922258|Alzheimer's Disease|alzheimer's disease
1224273|NCT01922258|Cognitive Disorders|cognitive disorders
1224274|NCT01922258|Memory|memory
1224275|NCT01922258|Agitation|agitation
1224276|NCT01922245|aphasia|aphasia
1224277|NCT01922245|therapy|therapy
1224278|NCT01922245|stroke|stroke
1224279|NCT01922245|language|language
1224280|NCT01922245|naming|naming
1224281|NCT01922245|quality of life|quality of life
1224282|NCT01922245|tDCS|tdcs
1224283|NCT01922245|treatment|treatment
1224284|NCT01922219|depression|depression
1224285|NCT01922219|cognitive therapy|cognitive therapy
1224286|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
1224287|NCT01922219|CBT|cbt
1224288|NCT01922219|psychotherapy|psychotherapy
1224289|NCT01922219|MDD|mdd
1224290|NCT01922219|major depressive disorder|major depressive disorder
1224291|NCT01922219|MRI|mri
1224292|NCT01922219|fMRI|fmri
1224293|NCT01922206|HIV|hiv
1224294|NCT01922206|Maternal Disclosure|maternal disclosure
1224295|NCT01922180|Chest Computed Tomography|chest computed tomography
1224296|NCT01922167|Aging|aging
1224297|NCT01922167|Frailty|frailty
1224298|NCT01922167|Leucine|leucine
1224299|NCT01922167|Resistance Exercise|resistance exercise
1224300|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
1224301|NCT01922154|Neovascular|neovascular
1224302|NCT01922154|Intraocular pressure|intraocular pressure
1224303|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
1224304|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1224305|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
1224306|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
1224307|NCT01922115|COGNITIVE FUNCTION|cognitive function
1224308|NCT01922115|OVERACTIVE BLADDER|overactive bladder
1224309|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
1224310|NCT01922102|Pathologic myopia (PM), choroidal neovascularization (CNV), ranibizumab, verteporfin PDT, Brilliance|pathologic myopia (pm), choroidal neovascularization (cnv), ranibizumab, verteporfin pdt, brilliance
1224311|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
1224312|NCT01922063|disc herniation surgery|disc herniation surgery
1224313|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
1224314|NCT01922063|randomized|randomized
1224315|NCT01922063|long term|long term
1224316|NCT01922063|follow up|follow up
1224317|NCT01921972|AD, Dementia|ad, dementia
1224318|NCT01921946|Fimasartan|fimasartan
1224319|NCT01921933|End-stage renal disease|end-stage renal disease
1224320|NCT01921933|ESRD|esrd
1224322|NCT01921933|Fistulas|fistulas
1224323|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
1224324|NCT01921907|Actinic keratosis|actinic keratosis
1224325|NCT01921907|topical|topical
1224326|NCT01921907|dermatology|dermatology
1224327|NCT01921907|treatment|treatment
1224328|NCT01921907|clinical study|clinical study
1224329|NCT01921907|double blinded|double blinded
1224330|NCT01921894|asthma|asthma
1224331|NCT01921894|vitamin D|vitamin d
1224332|NCT01921881|Glucose tolerance|glucose tolerance
1224333|NCT01921829|Cardiorenal failure|cardiorenal failure
1224334|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
1224335|NCT01921829|Diuretic resistance|diuretic resistance
1224336|NCT01921829|Volume overload|volume overload
1224337|NCT01921829|Edema|edema
1224338|NCT01921829|Health-related quality of life|health-related quality of life
1224339|NCT01921829|Outcomes|outcomes
1224340|NCT01921829|Treatment protocol|treatment protocol
1224341|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
1224342|NCT01921790|first line chemotherapy|first line chemotherapy
1224343|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
1224344|NCT01921777|Muscle|muscle
1224345|NCT01921777|exercise|exercise
1224346|NCT01921777|soreness|soreness
1224347|NCT01921777|Damage|damage
1224348|NCT01921777|Traumeel|traumeel
1224349|NCT01921777|homeopathy|homeopathy
1224350|NCT01921751|SMAD4|smad4
1224351|NCT01921751|IMRT|imrt
1224352|NCT01921751|gemcitabine|gemcitabine
1224353|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
1224354|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
1224355|NCT01921725|wound healing|wound healing
1224356|NCT01921725|carbon|carbon
1224357|NCT01921712|COPD|copd
1224358|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1224359|NCT01921699|macrophages|macrophages
1224360|NCT01921699|adenocarcinoma|adenocarcinoma
1224361|NCT01921699|chemoresistance|chemoresistance
1224362|NCT01921686|Eosinophil|eosinophil
1224363|NCT01921686|Reflux|reflux
1224364|NCT01921686|Esophagus|esophagus
1224365|NCT01921686|Food allergy|food allergy
1224366|NCT01921686|Trouble Swallowing|trouble swallowing
1224367|NCT01921686|Pediatrics|pediatrics
1224368|NCT01921686|Healthy Volunteers|healthy volunteers
1224369|NCT01921673|Gastric cancer|gastric cancer
1224370|NCT01921673|Phase I/II|phase i/ii
1224371|NCT01921673|Second-line chemotherapy|second-line chemotherapy
1224372|NCT01921673|Dovitinib|dovitinib
1224373|NCT01921673|Docetaxel|docetaxel
1224374|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
1224375|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
1224376|NCT01921621|proficiency based progression|proficiency based progression
1224377|NCT01921621|surgical skill|surgical skill
1224378|NCT01921621|metric validation|metric validation
1224379|NCT01921621|formative feedback|formative feedback
1224380|NCT01921621|simulator model|simulator model
1224381|NCT01921608|Male Circumcision|male circumcision
1224382|NCT01921608|HIV Prevention|hiv prevention
1224383|NCT01921608|HIV Infections|hiv infections
1224384|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
1224385|NCT01921543|Deep Brain Stimulation|deep brain stimulation
1224386|NCT01921543|Major Depressive Disorder|major depressive disorder
1224387|NCT01921543|Psychosurgery|psychosurgery
1224388|NCT01921543|Electrical stimulation|electrical stimulation
1224389|NCT01921530|Posterolateral Fusion|posterolateral fusion
1224390|NCT01921530|Interbody Fusion|interbody fusion
1224391|NCT01921530|Lumbar|lumbar
1224392|NCT01921530|Spinal Stenosis|spinal stenosis
1224393|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
1224394|NCT01921517|Biomechanics|biomechanics
1224395|NCT01921517|Osteogenesis|osteogenesis
1224396|NCT01921504|Functional Dyspepsia|functional dyspepsia
1224397|NCT01921504|Acupuncture|acupuncture
1224398|NCT01921504|Genotype|genotype
1224399|NCT01921504|Ghrelin|ghrelin
1224400|NCT01921465|outpatient care|outpatient care
1224401|NCT01921465|videoconferencing|videoconferencing
1224402|NCT01921465|elective cesarean section|elective cesarean section
1224403|NCT01921452|Hypothyroidism|hypothyroidism
1224404|NCT01921452|Third generation TSH kit|third generation tsh kit
1224405|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
1224406|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
1224407|NCT01921439|smoking|smoking
1224408|NCT01921439|quit smoking|quit smoking
1224409|NCT01921439|smoking cessation|smoking cessation
1224410|NCT01921439|smoking study|smoking study
1224411|NCT01921439|secondhand smoke|secondhand smoke
1224412|NCT01921439|smokers|smokers
1224413|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1224414|NCT01921426|Oral Cavity|oral cavity
1224415|NCT01921426|Oropharynx|oropharynx
1224416|NCT01921426|Radiation|radiation
1224417|NCT01921426|Chemotherapy|chemotherapy
1224418|NCT01921426|Cisplatin|cisplatin
1224419|NCT01921426|Oral Mucositis|oral mucositis
1224420|NCT01921426|Superoxide Dismutase|superoxide dismutase
1224421|NCT01921413|Plasmodium falciparum|plasmodium falciparum
1224422|NCT01921413|Clinical Malaria|clinical malaria
1224423|NCT01921413|Fever|fever
1224424|NCT01921413|Schistosoma hematobium|schistosoma hematobium
1224425|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
1224426|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
1224427|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
1224428|NCT01921400|Placenta|placenta
1224429|NCT01921400|Trophoblast|trophoblast
1224430|NCT01921374|Duchenne;|duchenne;
1224431|NCT01921374|mothers caregivers;|mothers caregivers;
1224432|NCT01921374|sleep;|sleep;
1224433|NCT01921374|hormonal profile;|hormonal profile;
1224434|NCT01921374|cardiac profile;|cardiac profile;
1224435|NCT01921374|biochemical profile;|biochemical profile;
1224436|NCT01921374|inflammatory profile.|inflammatory profile.
1224437|NCT01921361|Shivering|shivering
1224438|NCT01921361|Dexmedetomidine|dexmedetomidine
1224439|NCT01921361|Spinal anesthesia|spinal anesthesia
1224440|NCT01921348|Hay Fever|hay fever
1224441|NCT01921348|Hayfever|hayfever
1224442|NCT01921348|Pollen Allergy|pollen allergy
1224443|NCT01921348|Pollinosis|pollinosis
1224444|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1224445|NCT01921335|ARRY-380|arry-380
1224446|NCT01921335|Trastuzumab|trastuzumab
1224447|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
1224448|NCT01921309|osteoarthritis|osteoarthritis
1224449|NCT01921309|avascular necrosis|avascular necrosis
1224450|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
1224451|NCT01921309|correction of functional deformity|correction of functional deformity
1224452|NCT01921309|dysplasia of the hip|dysplasia of the hip
1224453|NCT01921296|Breast cancer|breast cancer
1224454|NCT01921296|Aromatase inhibitor|aromatase inhibitor
1224455|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
1224456|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
1224457|NCT01921270|Oral Dystonia|oral dystonia
1224458|NCT01921270|Tardive Dystonia|tardive dystonia
1224459|NCT01921270|botulinum toxin|botulinum toxin
1224460|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
1224461|NCT01921257|Cat Allergy|cat allergy
1224462|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
1224463|NCT01921244|Autistic Disorder|autistic disorder
1224464|NCT01921244|Decision Making|decision making
1224465|NCT01921244|Medication Therapy Management|medication therapy management
1224466|NCT01921218|Kidney transplant|kidney transplant
1224467|NCT01921205|Lacosamide|lacosamide
1224468|NCT01921205|Vimpat|vimpat
1224469|NCT01921205|UCB|ucb
1224470|NCT01921205|Epilepsy|epilepsy
1224471|NCT01921205|Partial Onset Seizures|partial onset seizures
1224472|NCT01921205|Pediatric|pediatric
1224473|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
1224474|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
1224475|NCT01921179|Concussion|concussion
1224476|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
1224477|NCT01921166|infertility|infertility
1224478|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
1224479|NCT01921166|fertilization in vitro|fertilization in vitro
1224480|NCT01921166|ovulation inducion|ovulation inducion
1224481|NCT01921166|vitrification|vitrification
1224482|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
1224483|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
1224484|NCT01921101|nutrition|nutrition
1224485|NCT01921101|enteral feeding|enteral feeding
1224486|NCT01921101|parenteral feeding|parenteral feeding
1224487|NCT01921101|hospital malnutrition|hospital malnutrition
1224488|NCT01921088|fMRI|fmri
1224489|NCT01921088|Neurofeedback|neurofeedback
1224490|NCT01921088|Blood pressure|blood pressure
1224491|NCT01921088|Psychophysiology|psychophysiology
1224492|NCT01921075|physiology, normal function|physiology, normal function
1224493|NCT01921062|Distal radius fracture|distal radius fracture
1224494|NCT01921062|Motor imagery|motor imagery
1224495|NCT01921062|Immobilisation|immobilisation
1224496|NCT01921062|Effectivity|effectivity
1224497|NCT01921023|Blood Gas analysis|blood gas analysis
1224498|NCT01920997|Healthy|healthy
1224499|NCT01920997|normal menstrual cycles|normal menstrual cycles
1224500|NCT01920971|chronic low back pain|chronic low back pain
1224501|NCT01920971|infrared energy|infrared energy
1224502|NCT01920971|effects|effects
1224503|NCT01920932|Pediatric cancer|pediatric cancer
1224504|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
1224505|NCT01920932|Targeted therapy|targeted therapy
1224506|NCT01920932|Frontline therapy|frontline therapy
1224507|NCT01920932|Brentuximab vedotin|brentuximab vedotin
1224508|NCT01920932|Quality of Life|quality of life
1224509|NCT01920932|OEPA/COPDac|oepa/copdac
1224510|NCT01920906|Psoriasis|psoriasis
1224511|NCT01920906|Korean|korean
1224512|NCT01920906|Healthy Volunteers|healthy volunteers
1224513|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
1224514|NCT01920880|ACNES|acnes
1224515|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
1224516|NCT01920880|CAWP|cawp
1224517|NCT01920867|Stem Cells|stem cells
1224518|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
1224519|NCT01920867|BMSC|bmsc
1224520|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
1224521|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
1224522|NCT01920867|MSC|msc
1224523|NCT01920867|Eye Disease|eye disease
1224524|NCT01920867|Eye Stem Cells|eye stem cells
1224525|NCT01920867|Ophthalmology|ophthalmology
1224526|NCT01920867|Ophthalmic Disease|ophthalmic disease
1224527|NCT01920867|Retina|retina
1224528|NCT01920867|Retinal Disease|retinal disease
1224529|NCT01920867|Macular Degeneration|macular degeneration
1224530|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
1224531|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
1224532|NCT01920867|Geographic Atrophy|geographic atrophy
1224533|NCT01920867|Dry Macular Degeneration|dry macular degeneration
1224534|NCT01920867|Wet Macular Degeneration|wet macular degeneration
1224535|NCT01920867|Retinal Atrophy|retinal atrophy
1224536|NCT01920867|Retinal Dystrophy|retinal dystrophy
1224537|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
1224538|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
1224539|NCT01920867|Stargardt Disease|stargardt disease
1224540|NCT01920867|Cone Dystrophy|cone dystrophy
1224541|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
1224542|NCT01920867|Maculopathy|maculopathy
1224543|NCT01920867|Optic Nerve Disease|optic nerve disease
1224544|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
1224545|NCT01920867|Optic Atrophy|optic atrophy
1224546|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
1224547|NCT01920867|Optic Nerve Damage|optic nerve damage
1224548|NCT01920867|Optic Nerve Compression|optic nerve compression
1224549|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
1224550|NCT01920867|Devics Syndrome|devics syndrome
1224551|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
1224552|NCT01920841|lipolytic|lipolytic
1224553|NCT01920841|herbal extracts|herbal extracts
1224554|NCT01920841|thigh girth|thigh girth
1224555|NCT01920841|thigh smoothness|thigh smoothness
1224556|NCT01920789|Non-small call lung cancer|non-small call lung cancer
1224557|NCT01920789|Medically inoperable|medically inoperable
1224558|NCT01920789|Stage one|stage one
1224559|NCT01920789|Radiotherapy|radiotherapy
1224560|NCT01920789|SBRT|sbrt
1224561|NCT01920789|Hypofractionation|hypofractionation
1224562|NCT01920789|Conventional fractionation|conventional fractionation
1224563|NCT01920776|critical ultrasound|critical ultrasound
1224564|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
1224565|NCT01920763|Surgical evacuation|surgical evacuation
1224566|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
1224567|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
1224568|NCT01920737|ALL|all
1224569|NCT01920737|Bone Marrow|bone marrow
1224570|NCT01920737|Ph Negative|ph negative
1224571|NCT01920737|Daunorubicin|daunorubicin
1224572|NCT01920737|Vincristine|vincristine
1224573|NCT01920737|Prednisone|prednisone
1224574|NCT01920737|PEG-Asparaginase|peg-asparaginase
1224575|NCT01920737|Methotrexate|methotrexate
1224576|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
1224577|NCT01920737|Cyclophosphamide|cyclophosphamide
1224578|NCT01920737|Cytarabine|cytarabine
1224579|NCT01920737|Leucovorin|leucovorin
1224580|NCT01920737|Dexamethasone|dexamethasone
1224581|NCT01920737|12-266|12-266
1224582|NCT01920724|Preschool children|preschool children
1224583|NCT01920724|Body composition|body composition
1224584|NCT01920711|Heart failure|heart failure
1224585|NCT01920711|preserved ejection fraction|preserved ejection fraction
1224586|NCT01920711|diastolic heart failure|diastolic heart failure
1224587|NCT01920698|Heart Valve Diseases|heart valve diseases
1224588|NCT01920698|Heart failure|heart failure
1224589|NCT01920698|Heart diseases|heart diseases
1224590|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
1224591|NCT01920685|Paranoia|paranoia
1224592|NCT01920685|CBT|cbt
1224593|NCT01920685|Reasoning|reasoning
1224594|NCT01920685|Anxiety|anxiety
1224595|NCT01920659|High Intensity Training|high intensity training
1224596|NCT01920659|Insulin sensitivity|insulin sensitivity
1224597|NCT01920659|Fitness|fitness
1224598|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
1224599|NCT01920607|Fecal Incontinence.|fecal incontinence.
1224600|NCT01920607|Anal Incontinence.|anal incontinence.
1224601|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
1224602|NCT01920607|SNS.|sns.
1224603|NCT01920607|Artificial Sphincters.|artificial sphincters.
1224604|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
1224605|NCT01920594|GSK1278863|gsk1278863
1224606|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
1224607|NCT01920581|CEIP|ceip
1224608|NCT01920581|pharmacodependance|pharmacodependance
1224609|NCT01920581|addictovigilance|addictovigilance
1224712|NCT01920230|Working conditions|working conditions
1224610|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
1224611|NCT01920581|elderly|elderly
1224612|NCT01920568|GSK2371746|gsk2371746
1224613|NCT01920568|Denosumab|denosumab
1224614|NCT01920568|China|china
1224615|NCT01920568|skeletal-related events|skeletal-related events
1224616|NCT01920568|bone metastases|bone metastases
1224617|NCT01920568|bridging study|bridging study
1224618|NCT01920568|solid tumors|solid tumors
1224619|NCT01920555|Depression|depression
1224620|NCT01920555|Treatment Resistant Depression|treatment resistant depression
1224621|NCT01920555|Ketamine|ketamine
1224622|NCT01920555|Antidepressant|antidepressant
1224623|NCT01920555|MDD|mdd
1224624|NCT01920555|Major Depression|major depression
1224625|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
1224626|NCT01920516|Isolated limb infusion|isolated limb infusion
1224627|NCT01920516|Melphalan|melphalan
1224628|NCT01920516|Limb Melanoma|limb melanoma
1224629|NCT01920516|Tumor response|tumor response
1224630|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
1224631|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
1224632|NCT01920503|doxorubicin|doxorubicin
1224633|NCT01920503|tumor response|tumor response
1224634|NCT01920477|Pemphigus|pemphigus
1224635|NCT01920477|(MAB)|(mab)
1224636|NCT01920477|autoimmune disorder|autoimmune disorder
1224637|NCT01920477|human CD20 antigen|human cd20 antigen
1224638|NCT01920477|subcutaneous|subcutaneous
1224639|NCT01920477|Pemphigus vulgaris|pemphigus vulgaris
1224640|NCT01920477|Phase 3|phase 3
1224641|NCT01920477|monoclonal antibody|monoclonal antibody
1224642|NCT01920477|ofatumumab|ofatumumab
1224643|NCT01920477|PV|pv
1224644|NCT01920477|rare disease|rare disease
1224645|NCT01920451|sleep|sleep
1224646|NCT01920451|insomnia|insomnia
1224647|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
1224648|NCT01920451|hypertension|hypertension
1224649|NCT01920451|cardiovascular disease|cardiovascular disease
1224650|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
1224651|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
1224652|NCT01920438|Complications|complications
1224653|NCT01920425|Parkinson's disease|parkinson's disease
1224654|NCT01920425|dyskinesia|dyskinesia
1224655|NCT01920425|fluctuations|fluctuations
1224656|NCT01920425|tremor|tremor
1224657|NCT01920425|bradykinesia|bradykinesia
1224658|NCT01920425|levodopa|levodopa
1224659|NCT01920412|Atrial fibrillation|atrial fibrillation
1224660|NCT01920412|Thrombosis|thrombosis
1224661|NCT01920412|Ischemic stroke|ischemic stroke
1224662|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
1224663|NCT01920412|Intervention method|intervention method
1224664|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
1224665|NCT01920386|Acute Toothache|acute toothache
1224666|NCT01920386|Wontran|wontran
1224667|NCT01920386|Wontran SR Tab.|wontran sr tab.
1224668|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
1224669|NCT01920373|degenerative joint disease|degenerative joint disease
1224670|NCT01920373|temporomandibular joint|temporomandibular joint
1224671|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
1224672|NCT01920360|BALNEOTHERAPY|balneotherapy
1224673|NCT01920360|SULPHUROUS WATERS|sulphurous waters
1224674|NCT01920360|WOMAC|womac
1224675|NCT01920360|LEQUESNE|lequesne
1224676|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
1224677|NCT01920360|SHORT FORM - 36|short form - 36
1224678|NCT01920360|VAS|vas
1224679|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
1224680|NCT01920347|cardiac arrest|cardiac arrest
1224681|NCT01920347|outcome|outcome
1224682|NCT01920347|pupillary reflex|pupillary reflex
1224683|NCT01920334|coronary disease|coronary disease
1224684|NCT01920334|heart diseases|heart diseases
1224685|NCT01920334|enzymes|enzymes
1224686|NCT01920334|sleep|sleep
1224687|NCT01920334|troponin|troponin
1224688|NCT01920334|zolpidem|zolpidem
1224689|NCT01920321|COPD|copd
1224690|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
1224691|NCT01920321|Emphysema|emphysema
1224692|NCT01920321|Hot injury|hot injury
1224693|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1224694|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
1224695|NCT01920269|mitomycin|mitomycin
1224696|NCT01920269|passive diffusion|passive diffusion
1224697|NCT01920269|electromotive drug administration|electromotive drug administration
1224698|NCT01920256|Insulin therapy|insulin therapy
1224699|NCT01920256|Type 2 diabetes|type 2 diabetes
1224700|NCT01920243|Telemedicine|telemedicine
1224701|NCT01920243|self-management|self-management
1224702|NCT01920243|Medical psychology|medical psychology
1224703|NCT01920243|Health psychology|health psychology
1224704|NCT01920243|Rehabilitation|rehabilitation
1224705|NCT01920243|Education, Health|education, health
1224706|NCT01920230|Burnout|burnout
1224707|NCT01920230|Stress|stress
1224708|NCT01920230|Mindfulness|mindfulness
1224709|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
1224710|NCT01920230|Intervention|intervention
1224711|NCT01920230|Effectiveness|effectiveness
1224713|NCT01920230|Work engagement|work engagement
1224714|NCT01920230|Psychological well-being|psychological well-being
1224715|NCT01920230|Life situation|life situation
1224716|NCT01920217|sepsis|sepsis
1224717|NCT01920217|SNP|snp
1224718|NCT01920217|mortality|mortality
1224719|NCT01920204|Mastocytosis|mastocytosis
1224720|NCT01920204|ISM|ism
1224721|NCT01920204|SSM|ssm
1224722|NCT01920191|Glioblastoma|glioblastoma
1224723|NCT01920165|respiratory tract infections|respiratory tract infections
1224724|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
1224725|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
1224726|NCT01920165|hospitalisation|hospitalisation
1224727|NCT01920165|child|child
1224728|NCT01920165|children|children
1224729|NCT01920165|minors|minors
1224730|NCT01920165|infants|infants
1224731|NCT01920165|second-hand smoke|second-hand smoke
1224732|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
1224733|NCT01920165|smoke-free|smoke-free
1224734|NCT01920165|smoke-free policy|smoke-free policy
1224735|NCT01920165|smoke-free legislation|smoke-free legislation
1224736|NCT01920165|public places|public places
1224737|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
1224738|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
1224739|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
1224740|NCT01920113|propofol|propofol
1224741|NCT01920113|remifentanil|remifentanil
1224742|NCT01920113|dexmedetomidine|dexmedetomidine
1224743|NCT01920113|efficacy|efficacy
1224744|NCT01920113|safeness|safeness
1224745|NCT01920100|Health Care Costs|health care costs
1224746|NCT01920100|Genetic Polymorphism|genetic polymorphism
1224747|NCT01920087|Atypical Facial Pain|atypical facial pain
1224748|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
1224749|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
1224750|NCT01920087|Orofacial Pain|orofacial pain
1224751|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
1224752|NCT01920087|Fothergill Disease|fothergill disease
1224753|NCT01920087|Tic Douloureux|tic douloureux
1224754|NCT01920087|Prosopalgia|prosopalgia
1224755|NCT01920074|Anal Fissure|anal fissure
1224756|NCT01920074|Nitroglycerin|nitroglycerin
1224757|NCT01920074|Pediatrics|pediatrics
1224758|NCT01920074|RECTIV®|rectiv®
1224759|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
1224760|NCT01920061|Advanced cancer|advanced cancer
1224761|NCT01920061|solid tumors|solid tumors
1224762|NCT01920061|PI3K|pi3k
1224763|NCT01920061|mTOR|mtor
1224764|NCT01920061|PI3K/mTOR|pi3k/mtor
1224765|NCT01920061|metastatic|metastatic
1224766|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
1224767|NCT01920048|Heart Failure|heart failure
1224768|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
1224769|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
1224770|NCT01920048|Ischemic Heart Disease|ischemic heart disease
1224771|NCT01920048|Revascularization|revascularization
1224772|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
1224773|NCT01920048|Randomized Control Trial|randomized control trial
1224774|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1224775|NCT01920035|Incontinence post RARP|incontinence post rarp
1224776|NCT01920035|Surgery induced incontinence|surgery induced incontinence
1224777|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
1224778|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
1224779|NCT01920022|medical abortion|medical abortion
1224780|NCT01920022|postabortion contraception|postabortion contraception
1224781|NCT01920022|LARC|larc
1224782|NCT01920022|Nexplanon|nexplanon
1224783|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
1224784|NCT01920009|pharmacy care|pharmacy care
1224785|NCT01920009|adherence|adherence
1224786|NCT01920009|coronary heart disease|coronary heart disease
1224787|NCT01919996|Ocular safety|ocular safety
1224788|NCT01919996|azithromycin|azithromycin
1224789|NCT01919996|pharyngitis|pharyngitis
1224790|NCT01919996|tonsillitis|tonsillitis
1224791|NCT01919983|cardiac|cardiac
1224792|NCT01919983|innervation|innervation
1224793|NCT01919983|inflammation|inflammation
1224794|NCT01919983|sudden|sudden
1224795|NCT01919983|death|death
1224796|NCT01919970|Autism|autism
1224797|NCT01919970|Asperger's Syndrome|asperger's syndrome
1224798|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
1224799|NCT01919970|Treatment|treatment
1224800|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
1224801|NCT01919970|Anxiety|anxiety
1224802|NCT01919970|Children|children
1224803|NCT01919970|Therapy|therapy
1224804|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
1224805|NCT01919970|Social Phobia|social phobia
1224806|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
1224807|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
1224808|NCT01919970|Specific Phobia|specific phobia
1224809|NCT01919957|epilepsy|epilepsy
1224810|NCT01919957|surgery|surgery
1224811|NCT01919957|functional MRI|functional mri
1224812|NCT01919957|memory outcome|memory outcome
1224813|NCT01919944|itch|itch
1224814|NCT01919931|Candida albicans|candida albicans
1224815|NCT01919931|Candidiasis|candidiasis
1224816|NCT01919931|Biofilm|biofilm
1224817|NCT01919931|Flow cytometry|flow cytometry
1224818|NCT01919931|Mannose Binding Lectin|mannose binding lectin
1224819|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
1224820|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
1224821|NCT01919892|predictors of response|predictors of response
1224822|NCT01919892|bipolar disorder|bipolar disorder
1224823|NCT01919892|depression|depression
1224824|NCT01919892|lithium treatment|lithium treatment
1224825|NCT01919892|biomarkers|biomarkers
1224826|NCT01919879|Chemotherapy refractory|chemotherapy refractory
1224827|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
1224828|NCT01919879|cross over|cross over
1224829|NCT01919853|Cancer|cancer
1224831|NCT01919853|Mindfulness|mindfulness
1224832|NCT01919853|Meditation|meditation
1224833|NCT01919853|Neoplasms|neoplasms
1224834|NCT01919853|Signs and symptoms|signs and symptoms
1224835|NCT01919840|hemostatic disorders|hemostatic disorders
1224836|NCT01919840|ardiac surgery|ardiac surgery
1224837|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
1224838|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1224839|NCT01919827|Stem cells|stem cells
1224840|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
1224841|NCT01919801|ACE-I|ace-i
1224842|NCT01919801|Firazyr|firazyr
1224843|NCT01919801|icatibant|icatibant
1224844|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
1224845|NCT01919788|Hypoglycemia|hypoglycemia
1224846|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
1224847|NCT01919762|Bacteremia|bacteremia
1224848|NCT01919762|Sepsis|sepsis
1224849|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
1224850|NCT01919762|Staphylococcus aureus|staphylococcus aureus
1224851|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
1224852|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
1224853|NCT01919762|Enterococcus faecalis|enterococcus faecalis
1224854|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
1224855|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
1224856|NCT01919762|Blood culture|blood culture
1224857|NCT01919749|breast cancer metastatic|breast cancer metastatic
1224858|NCT01919749|molecular profiling|molecular profiling
1224859|NCT01919749|sequencing|sequencing
1224860|NCT01919749|profiling|profiling
1224861|NCT01919749|breast cancer|breast cancer
1224862|NCT01919736|knee OA|knee oa
1224864|NCT01919723|Ticagrelor|ticagrelor
1224865|NCT01919723|Eptifibatide|eptifibatide
1224866|NCT01919710|Neutropenia|neutropenia
1224867|NCT01919710|chemotherapy|chemotherapy
1224868|NCT01919710|rHSA/GCSF|rhsa/gcsf
1224869|NCT01919697|Plecantaide|plecantaide
1224870|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
1224871|NCT01919697|Chronic|chronic
1224872|NCT01919697|Idiopathic|idiopathic
1224873|NCT01919697|Constipation|constipation
1224874|NCT01919697|Synergy|synergy
1224876|NCT01919697|CIC study|cic study
1224877|NCT01919697|CIC OLE|cic ole
1224878|NCT01919697|CIC OLE study|cic ole study
1224879|NCT01919697|OLE|ole
1224880|NCT01919697|OLE CIC|ole cic
1224881|NCT01919697|OLE CIC3|ole cic3
1224882|NCT01919697|Open label|open label
1224883|NCT01919697|Open label study|open label study
1224884|NCT01919697|Long term|long term
1224885|NCT01919697|Long term study|long term study
1224886|NCT01919697|Extension|extension
1224887|NCT01919697|Extension study|extension study
1224888|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
1224889|NCT01919671|Ischemic Stroke|ischemic stroke
1224890|NCT01919671|Tongxinluo capsule|tongxinluo capsule
1224891|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
1224892|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
1224893|NCT01919645|Sleep Disorders|sleep disorders
1224894|NCT01919645|Polysomnography|polysomnography
1307724|NCT01550341|HIV|hiv
1224895|NCT01919645|Sleep Stages|sleep stages
1224896|NCT01919645|Physical Exercise|physical exercise
1224897|NCT01919632|lifestyle|lifestyle
1224898|NCT01919632|physical activity|physical activity
1224899|NCT01919632|endothelial function|endothelial function
1224900|NCT01919632|cardiovascular|cardiovascular
1224901|NCT01919632|occupational|occupational
1224902|NCT01919632|prevention|prevention
1224903|NCT01919619|Blood And Marrow Transplantation|blood and marrow transplantation
1224904|NCT01919619|Leukemia|leukemia
1224905|NCT01919619|Lymphoma|lymphoma
1224906|NCT01919619|Allogeneic stem cell transplant|allogeneic stem cell transplant
1224907|NCT01919619|Autologous stem cell transplant|autologous stem cell transplant
1224908|NCT01919619|SCT|sct
1224909|NCT01919619|Lenalidomide CC-5013|lenalidomide cc-5013
1224910|NCT01919619|Revlimid|revlimid
1224911|NCT01919619|Ipilimumab|ipilimumab
1224912|NCT01919619|Yervoy|yervoy
1224913|NCT01919619|BMS-734016|bms-734016
1224914|NCT01919619|MDX010|mdx010
1224915|NCT01919606|hysterectomy|hysterectomy
1224916|NCT01919606|analgesia|analgesia
1224917|NCT01919593|Blood culture|blood culture
1224918|NCT01919593|Contamination|contamination
1224919|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
1224920|NCT01919593|Povidone iodine|povidone iodine
1224921|NCT01919580|Gα12|gα12
1224922|NCT01919580|Oral cancer|oral cancer
1224923|NCT01919567|SOX-9|sox-9
1224924|NCT01919567|Oral cancer|oral cancer
1224925|NCT01919567|arecoline|arecoline
1224926|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
1224927|NCT01919554|Phase I|phase i
1224928|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
1224929|NCT01919541|Colorectal Surgery|colorectal surgery
1224930|NCT01919528|ultrasonography|ultrasonography
1224931|NCT01919528|catheterization|catheterization
1224932|NCT01919528|central line|central line
1224933|NCT01919528|mechanical ventilation|mechanical ventilation
1224934|NCT01919528|intensive care|intensive care
1224935|NCT01919528|axillary vein|axillary vein
1224936|NCT01919515|pediatric|pediatric
1224937|NCT01919515|primary molars|primary molars
1224938|NCT01919515|stainless steel crowns|stainless steel crowns
1224939|NCT01919489|Incretins|incretins
1224940|NCT01919489|Liraglutide|liraglutide
1224941|NCT01919489|Glargine|glargine
1224942|NCT01919489|Randomized controlled trial|randomized controlled trial
1224943|NCT01919489|basal insulin|basal insulin
1224944|NCT01919489|hospital discharge|hospital discharge
1224945|NCT01919489|inpatient diabetes|inpatient diabetes
1224946|NCT01919476|Postprandial|postprandial
1224947|NCT01919476|Insulin resistance|insulin resistance
1224948|NCT01919476|Lipids|lipids
1224949|NCT01919476|Satiety|satiety
1224950|NCT01919476|Almonds|almonds
1224951|NCT01919463|Colonoscopy|colonoscopy
1224952|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
1224953|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
1224954|NCT01919463|Abdominal Compression|abdominal compression
1224955|NCT01919450|PET|pet
1224956|NCT01919450|Lexiscan|lexiscan
1224957|NCT01919450|Regadenoson|regadenoson
1224958|NCT01919450|Rubidium|rubidium
1224959|NCT01919450|Blood Flow Reserve|blood flow reserve
1224960|NCT01919450|Myocardial Perfusion|myocardial perfusion
1224961|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
1224962|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
1224963|NCT01919411|Sinus surgery|sinus surgery
1224964|NCT01919411|Antibiotics|antibiotics
1224965|NCT01919385|Type 1 diabetes|type 1 diabetes
1224966|NCT01919385|Insulin Pump|insulin pump
1224967|NCT01919359|ablative laser|ablative laser
1224968|NCT01919359|soft tissue filler|soft tissue filler
1224969|NCT01919346|Kidney Transplantation|kidney transplantation
1224970|NCT01919346|Delayed Graft Function|delayed graft function
1224971|NCT01919320|SynCardia|syncardia
1224972|NCT01919320|Total Artificial Heart|total artificial heart
1224973|NCT01919320|TAH-t|tah-t
1224974|NCT01919307|Seizures|seizures
1224975|NCT01919307|Convulsions|convulsions
1224976|NCT01919307|Anticonvulsants|anticonvulsants
1224977|NCT01919307|Epilepsy|epilepsy
1224978|NCT01919307|Neurologic|neurologic
1224979|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1224980|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1224981|NCT01919294|hypogonadism|hypogonadism
1224982|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
1224983|NCT01919281|exercise|exercise
1224984|NCT01919281|resistance training|resistance training
1224985|NCT01919281|insulin resistance|insulin resistance
1224986|NCT01919281|high intensity interval training|high intensity interval training
1224987|NCT01919268|Pilates-based exercises|pilates-based exercises
1224988|NCT01919268|Electrotherapy|electrotherapy
1224989|NCT01919268|Interferencial current|interferencial current
1224990|NCT01919255|Colonoscopy|colonoscopy
1224991|NCT01919255|Bowel preparation|bowel preparation
1224992|NCT01919255|Picolight|picolight
1224993|NCT01919255|Clicolon|clicolon
1224994|NCT01919255|Coolprep|coolprep
1224995|NCT01919229|HR-positive|hr-positive
1224996|NCT01919229|HER2-negative|her2-negative
1224997|NCT01919229|Breast cancer|breast cancer
1224998|NCT01919229|LEE011|lee011
1224999|NCT01919229|Letrozole|letrozole
1225001|NCT01919229|CDK4|cdk4
1225002|NCT01919229|CDK6|cdk6
1225003|NCT01919229|CDK4/6|cdk4/6
1225004|NCT01919229|Pharmacodynamics|pharmacodynamics
1225005|NCT01919229|Pre-surgical|pre-surgical
1225006|NCT01919229|Postmenopausal|postmenopausal
1225007|NCT01919177|Heart Failure|heart failure
1225008|NCT01919177|Arterial hemodynamics|arterial hemodynamics
1225009|NCT01919177|Exercise capacity|exercise capacity
1225010|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
1225011|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
1225012|NCT01919164|AS902330|as902330
1225013|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
1225014|NCT01919164|Sprifermin|sprifermin
1225015|NCT01919164|Placebo|placebo
1225016|NCT01919151|survival|survival
1225017|NCT01919125|Chronic hepatitis C|chronic hepatitis c
1225018|NCT01919125|Hepatitis C virus|hepatitis c virus
1225020|NCT01919112|Brain stimulation|brain stimulation
1225021|NCT01919099|Transplantation Costs|transplantation costs
1225022|NCT01919099|Risk Factors|risk factors
1225023|NCT01919099|Transplant Infections|transplant infections
1225024|NCT01919086|Bortezomib|bortezomib
1225025|NCT01919086|Dexamethasone|dexamethasone
1225026|NCT01919086|Lenalidomide|lenalidomide
1225027|NCT01919086|13-064|13-064
1225028|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
1225029|NCT01919047|overactive bladder|overactive bladder
1225030|NCT01919047|mirabegron|mirabegron
1225031|NCT01919047|occurrence of adverse events|occurrence of adverse events
1225032|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
1225033|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
1225034|NCT01919008|FK949E|fk949e
1225035|NCT01919008|Pharmacokinetics|pharmacokinetics
1225036|NCT01919008|Major Depressive Disorder|major depressive disorder
1225037|NCT01918995|CVT3146|cvt3146
1225038|NCT01918995|Regadenoson|regadenoson
1225039|NCT01918982|Aortic aneurysm|aortic aneurysm
1225040|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
1225041|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
1225042|NCT01918969|Healthy blood donors|healthy blood donors
1225043|NCT01918956|immunotherapy|immunotherapy
1225044|NCT01918956|birch pollen|birch pollen
1225045|NCT01918956|seasonal allergy|seasonal allergy
1225046|NCT01918956|up-dosing|up-dosing
1225047|NCT01918943|Spine|spine
1225048|NCT01918943|Aspen device|aspen device
1225049|NCT01918943|PLIF|plif
1225050|NCT01918943|Low back pain|low back pain
1225051|NCT01918930|Melanoma|melanoma
1225052|NCT01918930|Accessible tumors|accessible tumors
1225053|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
1225054|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
1225055|NCT01918917|Dexmedetomidine|dexmedetomidine
1225056|NCT01918917|Analgesia|analgesia
1225057|NCT01918904|calcinosis|calcinosis
1225058|NCT01918904|sodium thiosulfate|sodium thiosulfate
1225059|NCT01918904|topical treatment|topical treatment
1225060|NCT01918904|connective tissue disease|connective tissue disease
1225061|NCT01918891|stroke|stroke
1225062|NCT01918891|transient ischemic attack|transient ischemic attack
1225063|NCT01918891|High blood pressure|high blood pressure
1225064|NCT01918891|Hypertension|hypertension
1225065|NCT01918878|age-related macular degeneration|age-related macular degeneration
1225066|NCT01918878|intravitreal injections|intravitreal injections
1225067|NCT01918878|Aflibercept|aflibercept
1225068|NCT01918878|EYLEA|eylea
1225069|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1225070|NCT01918865|T2DM|t2dm
1225071|NCT01918852|Hand-foot syndrome|hand-foot syndrome
1225072|NCT01918852|Toxicity|toxicity
1225073|NCT01918852|Fluoropyrimidine|fluoropyrimidine
1225074|NCT01918852|Capecitabine|capecitabine
1225075|NCT01918852|Teysuno|teysuno
1225076|NCT01918852|S1|s1
1225077|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
1225078|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
1225079|NCT01918839|Wrinkle improvement|wrinkle improvement
1225080|NCT01918839|Wrinkle correction|wrinkle correction
1225081|NCT01918800|fatigue|fatigue
1225082|NCT01918800|quality of life|quality of life
1225083|NCT01918800|rehabilitation|rehabilitation
1225084|NCT01918800|self management|self management
1225085|NCT01918800|energy effectiveness|energy effectiveness
1225086|NCT01918774|Unemployment|unemployment
1225087|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
1225088|NCT01918774|Mental Disorders|mental disorders
1225089|NCT01918761|NSCLC|nsclc
1225090|NCT01918761|Stage IV|stage iv
1308025|NCT01549119|HIV|hiv
1225091|NCT01918761|Pemetrexed|pemetrexed
1225092|NCT01918761|Dacomitinib|dacomitinib
1225093|NCT01918735|Safety|safety
1225094|NCT01918735|Tolerability|tolerability
1225095|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
1225096|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
1225097|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
1225098|NCT01918722|Hematoma enlargement|hematoma enlargement
1225099|NCT01918722|herbal medicine|herbal medicine
1225100|NCT01918722|traditional chinese medicine|traditional chinese medicine
1225101|NCT01918722|random clinical trial|random clinical trial
1225102|NCT01918696|suicide|suicide
1225103|NCT01918696|anger|anger
1225104|NCT01918696|interpretation modification|interpretation modification
1225105|NCT01918696|computerized treatment|computerized treatment
1225106|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
1225107|NCT01918657|Interventional|interventional
1225108|NCT01918657|Randomized|randomized
1225109|NCT01918657|Double blind|double blind
1225110|NCT01918657|Placebo controlled|placebo controlled
1225111|NCT01918657|Pediatric|pediatric
1225112|NCT01918618|levosimendan|levosimendan
1225113|NCT01918618|renal effects|renal effects
1225114|NCT01918618|cardiac surgery|cardiac surgery
1225115|NCT01918618|left heart insufficiency|left heart insufficiency
1225116|NCT01918605|prostate cancer|prostate cancer
1225117|NCT01918605|brachytherapy|brachytherapy
1225118|NCT01918605|spacer|spacer
1225119|NCT01918605|side effect|side effect
1225120|NCT01918592|bladder cancer|bladder cancer
1225121|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1225122|NCT01918592|radical cystectomy|radical cystectomy
1225123|NCT01918592|lymphadenectomy|lymphadenectomy
1225124|NCT01918592|biomarker|biomarker
1225125|NCT01918553|AMD|amd
1225126|NCT01918553|epidemiology|epidemiology
1225127|NCT01918553|risk factors|risk factors
1225128|NCT01918553|cohort study|cohort study
1225129|NCT01918540|Radiostereometry|radiostereometry
1225130|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
1225131|NCT01918540|Stem design|stem design
1225132|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
1225133|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1225134|NCT01918514|Magnesium sulfate|magnesium sulfate
1225135|NCT01918514|epidural|epidural
1225136|NCT01918514|interscalene|interscalene
1225137|NCT01918514|NMDA receptor|nmda receptor
1225138|NCT01918501|multiple sclerosis|multiple sclerosis
1225139|NCT01918501|Remyelination|remyelination
1225140|NCT01918501|Mitochondria|mitochondria
1225141|NCT01918501|fatty acids|fatty acids
1225142|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
1225143|NCT01918488|Hypertension|hypertension
1225144|NCT01918488|Proteinuria|proteinuria
1225145|NCT01918488|Albuminuria|albuminuria
1225146|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
1225147|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
1225148|NCT01918488|Amiloride|amiloride
1225149|NCT01918475|randomized controlled trial|randomized controlled trial
1225150|NCT01918475|placebo controlled trial|placebo controlled trial
1225151|NCT01918475|cross over trial|cross over trial
1225152|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
1225153|NCT01918462|IL-22|il-22
1225154|NCT01918462|Kupffer cells|kupffer cells
1225155|NCT01918449|OSA|osa
1225156|NCT01918449|CPAP treatment|cpap treatment
1225157|NCT01918449|primary care|primary care
1225158|NCT01918449|efficacy|efficacy
1225159|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1225160|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
1225161|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
1225162|NCT01918423|Childhood adiposity|childhood adiposity
1225163|NCT01918423|Metabolic risk factors|metabolic risk factors
1225164|NCT01918423|Bone mineralization|bone mineralization
1225165|NCT01918410|contact lens|contact lens
1225166|NCT01918410|alginic|alginic
1225167|NCT01918410|dry eyes|dry eyes
1225168|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
1225169|NCT01918384|NPC-14|npc-14
1225170|NCT01918384|Arbekacin|arbekacin
1225171|NCT01918384|nonsense|nonsense
1225172|NCT01918384|readthrough|readthrough
1225173|NCT01918345|Diabetes|diabetes
1225174|NCT01918345|Diabetes Mellitus|diabetes mellitus
1225175|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1225176|NCT01918345|Diabetes, gestational|diabetes, gestational
1225177|NCT01918345|Prevention & control|prevention & control
1225178|NCT01918345|Postpartum Period|postpartum period
1225179|NCT01918345|Mothers|mothers
1225180|NCT01918345|Diet|diet
1225181|NCT01918345|Diabetic Diet|diabetic diet
1225182|NCT01918345|Exercise|exercise
1225183|NCT01918345|Life Style|life style
1225184|NCT01918345|Motivation|motivation
1225185|NCT01918345|Health Behavior|health behavior
1592585|NCT00422591|AML|aml
1225186|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
1225187|NCT01918345|Randomized Controlled Trial|randomized controlled trial
1225188|NCT01918345|Clinical Trial|clinical trial
1225189|NCT01918345|Pilot Projects|pilot projects
1225190|NCT01918345|Feasibility Studies|feasibility studies
1225191|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
1225192|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
1225193|NCT01918306|Metastatic breast cancer|metastatic breast cancer
1225194|NCT01918306|Stage IV breast cancer|stage iv breast cancer
1225195|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
1225197|NCT01918293|SMARTPHONE APPLICATION|smartphone application
1225198|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
1225199|NCT01918280|Azoospermia|azoospermia
1225200|NCT01918280|Seminal analyses|seminal analyses
1225201|NCT01918280|Testicular biopsy|testicular biopsy
1225202|NCT01918241|Pegylation|pegylation
1225203|NCT01918241|G-CSF|g-csf
1225204|NCT01918241|Efficacy|efficacy
1225205|NCT01918241|Satety|satety
1225206|NCT01918202|Enzyme occupancy|enzyme occupancy
1225207|NCT01918202|PET|pet
1225208|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
1225209|NCT01918189|back pain|back pain
1225210|NCT01918189|low back pain|low back pain
1225211|NCT01918189|chronic pain|chronic pain
1225212|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
1225213|NCT01918189|behavior therapy|behavior therapy
1225214|NCT01918176|Palbociclib|palbociclib
1225215|NCT01918176|PD-0332991|pd-0332991
1225216|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
1225217|NCT01918176|DDI|ddi
1225218|NCT01918176|Healthy Volunteers|healthy volunteers
1225219|NCT01918176|Pharmacokinetics|pharmacokinetics
1225220|NCT01918176|Rabeprazole|rabeprazole
1225221|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
1225222|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
1225223|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
1225224|NCT01918072|Women's Health|women's health
1225225|NCT01918072|Hospitals, Veterans|hospitals, veterans
1225226|NCT01918072|Education|education
1225227|NCT01918072|Remote consultation|remote consultation
1225228|NCT01918072|Videoconferencing|videoconferencing
1225229|NCT01918059|Trauma|trauma
1225230|NCT01918059|Eyelid|eyelid
1225231|NCT01918059|Laceration|laceration
1225232|NCT01918059|Tissue adhesive|tissue adhesive
1225233|NCT01918059|suture|suture
1225234|NCT01918059|cosmetic|cosmetic
1225235|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
1225236|NCT01918046|biomarker|biomarker
1225237|NCT01918046|MIOX|miox
1225238|NCT01918033|Rhinitis|rhinitis
1225239|NCT01918033|Allergic Rhinitis|allergic rhinitis
1225240|NCT01918033|Nose Diseases|nose diseases
1225241|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
1225242|NCT01918033|Immune System Diseases|immune system diseases
1225243|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
1225244|NCT01918033|Cholinergic Agents|cholinergic agents
1225245|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
1225246|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
1225247|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
1225248|NCT01918033|Histamine Antagonists|histamine antagonists
1225249|NCT01918033|Histamine Agents|histamine agents
1225250|NCT01918020|Fruit|fruit
1225251|NCT01918020|Vegetables|vegetables
1225252|NCT01918020|Motor Activity|motor activity
1225253|NCT01918007|Apnea|apnea
1225254|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
1225255|NCT01918007|Snoring|snoring
1225256|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
1225257|NCT01918007|Respiration Disorders|respiration disorders
1225258|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
1225259|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
1225260|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1225261|NCT01918007|Dyssomnias|dyssomnias
1225262|NCT01918007|Sleep Disorders|sleep disorders
1225263|NCT01918007|Respiratory Sounds|respiratory sounds
1225264|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
1225265|NCT01917981|Implantable device|implantable device
1225266|NCT01917968|POP|pop
1225267|NCT01917968|Transvaginal|transvaginal
1225268|NCT01917968|Native Tissue Repair|native tissue repair
1225269|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
1225270|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
1225271|NCT01917955|MRI|mri
1225272|NCT01917942|Radiotherapy|radiotherapy
1225273|NCT01917942|Humidification|humidification
1225274|NCT01917942|Mucositis|mucositis
1225275|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
1225276|NCT01917903|walking|walking
1225277|NCT01917903|Parkinson's disease|parkinson's disease
1225278|NCT01917903|traumatic brain injury|traumatic brain injury
1225279|NCT01917903|multiple sclerosis|multiple sclerosis
1225280|NCT01917903|physical therapy|physical therapy
1225281|NCT01917903|falls|falls
1225282|NCT01917903|memory|memory
1225283|NCT01917903|attention|attention
1225284|NCT01917903|multitasking|multitasking
1225285|NCT01917903|exercise|exercise
1225286|NCT01917890|curcumin|curcumin
1225287|NCT01917890|radioprotective|radioprotective
1225288|NCT01917890|radiosensitizer|radiosensitizer
1225289|NCT01917877|Becacizumab|becacizumab
1225290|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
1225291|NCT01917877|irradiation|irradiation
1225292|NCT01917877|chemotherapy|chemotherapy
1225293|NCT01917864|Autism|autism
1225294|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
1225295|NCT01917864|Prosody|prosody
1225296|NCT01917864|Speech treatment|speech treatment
1225297|NCT01917851|Accurate|accurate
1225299|NCT01917851|noninvasive measurement|noninvasive measurement
1225300|NCT01917838|Mental Health Services|mental health services
1225301|NCT01917825|radicular pain|radicular pain
1225302|NCT01917812|physical activity|physical activity
1225303|NCT01917812|exercise|exercise
1225304|NCT01917812|mHealth|mhealth
1225305|NCT01917812|smartphone|smartphone
1225306|NCT01917812|activity tracker|activity tracker
1225307|NCT01917812|pedometer|pedometer
1225308|NCT01917812|text messaging|text messaging
1225309|NCT01917812|SMS|sms
1225310|NCT01917799|Aspirin|aspirin
1225311|NCT01917799|Heparin|heparin
1225312|NCT01917799|pregnancy|pregnancy
1225313|NCT01917799|miscarriage|miscarriage
1225314|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
1225315|NCT01917760|Pharmacokinetics|pharmacokinetics
1225316|NCT01917760|Pharmacodynamics|pharmacodynamics
1225317|NCT01917760|Insulin|insulin
1225318|NCT01917760|C-peptide|c-peptide
1225319|NCT01917760|Glucagon|glucagon
1225320|NCT01917747|Infant hearing screening|infant hearing screening
1225321|NCT01917747|Patient Navigator|patient navigator
1225322|NCT01917734|severe acute malnutrition|severe acute malnutrition
1225323|NCT01917734|severe wasting|severe wasting
1225324|NCT01917734|facility-based care|facility-based care
1225325|NCT01917734|community-based care|community-based care
1225326|NCT01917734|Madhya Pradesh|madhya pradesh
1225327|NCT01917734|India|india
1225328|NCT01917721|Kawasaki disease|kawasaki disease
1225329|NCT01917721|doxycycline|doxycycline
1225330|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
1225331|NCT01917708|non malignant conditions|non malignant conditions
1225332|NCT01917708|blood and marrow transplant|blood and marrow transplant
1225333|NCT01917695|Bulky cervical cancers|bulky cervical cancers
1225334|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1225335|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
1225336|NCT01917682|robotic-assisted PCI|robotic-assisted pci
1225337|NCT01917682|coronary intervention|coronary intervention
1225338|NCT01917682|CorPath PRECISION Registry|corpath precision registry
1225340|NCT01917682|angioplasty|angioplasty
1225341|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
1225342|NCT01917630|Celiac disease|celiac disease
1225343|NCT01917630|Gluten-free diet|gluten-free diet
1225344|NCT01917630|Coeliac disease|coeliac disease
1225345|NCT01917630|Celiac sprue|celiac sprue
1225346|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
1225347|NCT01917604|impacted maxillary canine|impacted maxillary canine
1225348|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
1225349|NCT01917591|Bandages|bandages
1225350|NCT01917591|Biological Dressings|biological dressings
1225351|NCT01917591|Chronic Disease|chronic disease
1225352|NCT01917591|Collagen|collagen
1225353|NCT01917591|Epithelium|epithelium
1225354|NCT01917591|Extracellular Matrix|extracellular matrix
1225355|NCT01917591|Extra Cellular Matrix|extra cellular matrix
1225356|NCT01917591|Fibroblasts|fibroblasts
1225357|NCT01917591|Granulation Tissue|granulation tissue
1225358|NCT01917591|Leg Ulcer|leg ulcer
1225359|NCT01917591|Middle Aged|middle aged
1225360|NCT01917591|Prospective Studies|prospective studies
1225361|NCT01917591|Soft Tissue Injuries|soft tissue injuries
1225362|NCT01917591|Treatment Outcome|treatment outcome
1225363|NCT01917591|Varicose Ulcer|varicose ulcer
1225364|NCT01917591|Wound Healing|wound healing
1225365|NCT01917591|Wounds and Injuries|wounds and injuries
1225366|NCT01917591|biopsy|biopsy
1225367|NCT01917591|autoimmunity|autoimmunity
1225368|NCT01917578|Breast Cancer|breast cancer
1225369|NCT01917578|shrinkage modes|shrinkage modes
1225370|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
1225371|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1225372|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
1225373|NCT01917565|airway management|airway management
1225374|NCT01917565|laryngoscope|laryngoscope
1225375|NCT01917565|Airtraq|airtraq
1225376|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
1225377|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
1225378|NCT01917565|intubation|intubation
1333153|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
1333154|NCT01444326|Keywords;|keywords;
1225379|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
1225381|NCT01917526|PACU|pacu
1225382|NCT01917526|Hypoxemia|hypoxemia
1225383|NCT01917513|Adenoma|adenoma
1225384|NCT01917513|Polyps|polyps
1225385|NCT01917513|CRC|crc
1225386|NCT01917513|Colonoscopy|colonoscopy
1225387|NCT01917513|Detection Yield|detection yield
1225388|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
1225389|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
1225390|NCT01917474|low-lipid diet|low-lipid diet
1225391|NCT01917474|normal lipid intake|normal lipid intake
1225392|NCT01917474|saturated fats reduction|saturated fats reduction
1225393|NCT01917474|headache attacks|headache attacks
1225394|NCT01917448|postoperative pain|postoperative pain
1225395|NCT01917448|spinal morphine|spinal morphine
1225396|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
1225397|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
1225398|NCT01917435|Video-stylet,|video-stylet,
1225399|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
1225400|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
1225401|NCT01917409|Video-stylet ,|video-stylet ,
1225402|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
1225403|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
1225404|NCT01917383|glaucoma|glaucoma
1225793|NCT01915550|Pregnancy|pregnancy
1225405|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
1225406|NCT01917383|ocular hypertension|ocular hypertension
1225407|NCT01917383|adenosine agonist|adenosine agonist
1225408|NCT01917383|eye drop|eye drop
1225409|NCT01917383|trabodenoson|trabodenoson
1225410|NCT01917383|trabecular meshwork|trabecular meshwork
1225411|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1225412|NCT01917370|icc|icc
1225413|NCT01917370|vegf signal pathway|vegf signal pathway
1225414|NCT01917357|Vaccination|vaccination
1225415|NCT01917357|Immunisation|immunisation
1225416|NCT01917357|Virus|virus
1225417|NCT01917357|Diphtheria|diphtheria
1225418|NCT01917357|Pertussis|pertussis
1225419|NCT01917357|Tetanus|tetanus
1225420|NCT01917357|Hepatitis B|hepatitis b
1225421|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
1225422|NCT01917357|Immunity|immunity
1225423|NCT01917344|Phenylketonuria|phenylketonuria
1225424|NCT01917344|MRI|mri
1225425|NCT01917344|Neuropsychological functioning|neuropsychological functioning
1225426|NCT01917344|Neurological functioning|neurological functioning
1225427|NCT01917344|EEG|eeg
1225428|NCT01917331|spirometry|spirometry
1225429|NCT01917331|severe COPD|severe copd
1225430|NCT01917331|lung disease|lung disease
1225431|NCT01917331|fixed combination|fixed combination
1225432|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
1225433|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
1225434|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
1225435|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
1225436|NCT01917305|Bacteria|bacteria
1225437|NCT01917305|bone level|bone level
1225438|NCT01917305|bone loss|bone loss
1225439|NCT01917305|dental implants|dental implants
1225440|NCT01917305|implant design|implant design
1225441|NCT01917305|platform-shifting|platform-shifting
1225442|NCT01917305|platform-matching|platform-matching
1225443|NCT01917292|Periodontitis|periodontitis
1225444|NCT01917292|Prehypertension|prehypertension
1225445|NCT01917292|Periodontal Intervention|periodontal intervention
1225446|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
1225447|NCT01917279|Antineoplastic Agents|antineoplastic agents
1225448|NCT01917279|Therapeutic Uses|therapeutic uses
1225449|NCT01917279|Antimetabolites|antimetabolites
1225450|NCT01917279|Tubulin Modulators|tubulin modulators
1225451|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
1225452|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
1225453|NCT01917279|Capecitabine|capecitabine
1225454|NCT01917279|Docetaxel|docetaxel
1225455|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
1225456|NCT01917240|Monophasic|monophasic
1225457|NCT01917240|Sequential|sequential
1225458|NCT01917240|Media|media
1225459|NCT01917201|Coronary Artery Disease|coronary artery disease
1225460|NCT01917201|Drug Eluting Stents|drug eluting stents
1225461|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
1225462|NCT01917201|Optical Coherence Tomography|optical coherence tomography
1225463|NCT01917201|Intravascular Visualization|intravascular visualization
1225464|NCT01917175|HIV|hiv
1225465|NCT01917175|Cohort|cohort
1225466|NCT01917175|Early HIV infection|early hiv infection
1225467|NCT01917175|Côte d'Ivoire|côte d'ivoire
1225468|NCT01917175|Disease progression|disease progression
1225469|NCT01917162|contact lenses|contact lenses
1225470|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
1225471|NCT01917162|silicone hydrogel|silicone hydrogel
1225472|NCT01917162|contact lens comfort|contact lens comfort
1225473|NCT01917162|near-sighted|near-sighted
1225474|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
1225475|NCT01917149|High dose ACEI/ARB|high dose acei/arb
1225476|NCT01917136|pulmonary hypertension|pulmonary hypertension
1225477|NCT01917136|right ventricular function|right ventricular function
1225478|NCT01917136|11C acetate|11c acetate
1225479|NCT01917136|FDG|fdg
1225480|NCT01917136|ranolazine|ranolazine
1225481|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
1225482|NCT01917084|Passive range of motion|passive range of motion
1225483|NCT01917084|Single ventricle|single ventricle
1225484|NCT01917084|Infants|infants
1225485|NCT01917084|Congenital heart disease|congenital heart disease
1225486|NCT01917058|Alopecia Areata|alopecia areata
1225487|NCT01917058|Abatacept|abatacept
1225488|NCT01917045|sufentanil|sufentanil
1225489|NCT01917045|morphine|morphine
1225490|NCT01917045|postoperative pain control|postoperative pain control
1225491|NCT01917045|body fat percentage|body fat percentage
1225492|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
1225493|NCT01917045|lipid solubility|lipid solubility
1225494|NCT01917032|Trace Elements|trace elements
1225495|NCT01917032|Preschool|preschool
1225496|NCT01917032|Malnutrition|malnutrition
1225497|NCT01917032|Fortified Food|fortified food
1225498|NCT01917019|Japan|japan
1225499|NCT01916980|Dermatitis|dermatitis
1225500|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
1225501|NCT01916980|Skin Diseases|skin diseases
1225502|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
1225503|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
1225504|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
1225505|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
1225506|NCT01916980|Hypersensitivity|hypersensitivity
1225507|NCT01916980|Immune System Diseases|immune system diseases
1225508|NCT01916967|Urticaria|urticaria
1225509|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
1225510|NCT01916967|Skin Diseases|skin diseases
1225511|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
1225512|NCT01916967|Hypersensitivity|hypersensitivity
1225513|NCT01916967|Immune System Diseases|immune system diseases
1225514|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
1225515|NCT01916967|Cholinergic Agents|cholinergic agents
1225516|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
1225517|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
1225518|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
1225519|NCT01916967|Histamine Antagonists|histamine antagonists
1225520|NCT01916967|Histamine Agents|histamine agents
1225521|NCT01916954|Malaria|malaria
1225522|NCT01916954|Pregnancy|pregnancy
1225523|NCT01916954|Plasmodium falciparum|plasmodium falciparum
1225524|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
1225525|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
1225526|NCT01916928|Miscarriage|miscarriage
1225527|NCT01916902|Optical Coherence Tomography|optical coherence tomography
1225528|NCT01916902|Ticagrelor|ticagrelor
1225529|NCT01916889|Delirium|delirium
1225530|NCT01916876|medical in-patients|medical in-patients
1225531|NCT01916876|follow-up care|follow-up care
1225532|NCT01916876|developing country|developing country
1225533|NCT01916837|Breast cancer|breast cancer
1225534|NCT01916837|Feasibility|feasibility
1225535|NCT01916837|Genomic grade index|genomic grade index
1225536|NCT01916824|depression|depression
1225537|NCT01916824|melancholia|melancholia
1225538|NCT01916824|treatment|treatment
1225539|NCT01916811|Low Back Pain|low back pain
1225540|NCT01916811|Load quantitative MRI|load quantitative mri
1225541|NCT01916798|Infertility|infertility
1225542|NCT01916798|intralipid|intralipid
1225543|NCT01916798|invitro fertilization|invitro fertilization
1225544|NCT01916798|repeated implantation failure|repeated implantation failure
1225545|NCT01916798|repeated miscarriage|repeated miscarriage
1225546|NCT01916772|cherubism|cherubism
1225547|NCT01916772|bone tumors|bone tumors
1225548|NCT01916759|immunization|immunization
1225549|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
1225550|NCT01916746|Transvaginal Resection|transvaginal resection
1225551|NCT01916746|treatment|treatment
1225552|NCT01916707|trauma|trauma
1225553|NCT01916707|enoxaparin|enoxaparin
1225554|NCT01916707|weight based|weight based
1225555|NCT01916707|prophylaxis|prophylaxis
1225556|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
1225557|NCT01916694|m Health|m health
1225558|NCT01916694|Smartphone|smartphone
1225559|NCT01916694|Blood glucose monitoring|blood glucose monitoring
1225560|NCT01916681|Induction|induction
1225561|NCT01916681|Labor|labor
1225562|NCT01916681|Cervical foley|cervical foley
1225563|NCT01916681|Misoprostol|misoprostol
1225564|NCT01916681|Pitocin|pitocin
1225565|NCT01916681|Oxytocin|oxytocin
1225566|NCT01916681|Cytotec|cytotec
1225567|NCT01916681|Delivery|delivery
1225568|NCT01916681|IOL|iol
1225569|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
1225570|NCT01916655|Adherence|adherence
1225571|NCT01916655|Chronic Disease|chronic disease
1225572|NCT01916655|Telemedicine|telemedicine
1225573|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
1225574|NCT01916655|Mobile Health|mobile health
1225575|NCT01916642|iv lidocaine|iv lidocaine
1225576|NCT01916642|inducing dose|inducing dose
1225577|NCT01916642|etomidate|etomidate
1225578|NCT01916642|dose response|dose response
1225579|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
1225580|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
1225581|NCT01916590|Post-operative pain|post-operative pain
1225582|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
1225583|NCT01916577|Stem Cell Mobilization|stem cell mobilization
1225584|NCT01916577|Stem Cells|stem cells
1225585|NCT01916577|Transplantation|transplantation
1225586|NCT01916577|Autologous|autologous
1225587|NCT01916564|Bowel preparation|bowel preparation
1225588|NCT01916564|Morning colonoscopy|morning colonoscopy
1225589|NCT01916564|Split-dose|split-dose
1225590|NCT01916564|Same-morning whole-dose|same-morning whole-dose
1225591|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
1225592|NCT01916538|anorexia nervosa|anorexia nervosa
1225593|NCT01916538|genetics|genetics
1225594|NCT01916538|gene|gene
1225595|NCT01916538|eating disorder|eating disorder
1225596|NCT01916525|Acute coronary syndrome|acute coronary syndrome
1225597|NCT01916525|Cost-effectiveness|cost-effectiveness
1225598|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
1225599|NCT01916525|Exercise|exercise
1225600|NCT01916525|Physical activity|physical activity
1225601|NCT01916525|Home monitoring|home monitoring
1225794|NCT01915550|Insulin|insulin
1225602|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
1225603|NCT01916499|Child, adolescent|child, adolescent
1225604|NCT01916499|Coronary artery disease|coronary artery disease
1225605|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
1225606|NCT01916473|Epidural analgesia|epidural analgesia
1225607|NCT01916473|continuous wound infusion|continuous wound infusion
1225608|NCT01916473|ropivacaine|ropivacaine
1225609|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
1225610|NCT01916460|Gastroparesis|gastroparesis
1225611|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
1225612|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
1225613|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
1225614|NCT01916447|Monoclonal Antibody|monoclonal antibody
1225615|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
1225616|NCT01916434|Farmed fish|farmed fish
1225617|NCT01916434|Dietary intervention|dietary intervention
1225618|NCT01916434|Long-term intervention|long-term intervention
1225619|NCT01916434|Omega-3 index|omega-3 index
1225620|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
1225621|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
1225622|NCT01916434|Bleeding time|bleeding time
1225623|NCT01916434|Inflammation|inflammation
1225624|NCT01916434|Oxidative stress|oxidative stress
1225625|NCT01916434|Gut health|gut health
1225626|NCT01916434|Micronutrient availability|micronutrient availability
1225627|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1225628|NCT01916421|lymphadenopathy|lymphadenopathy
1225629|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
1225630|NCT01916408|Exercise|exercise
1225631|NCT01916408|Inflammation|inflammation
1225632|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
1225633|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
1225634|NCT01916408|Flavinoids|flavinoids
1225635|NCT01916395|Migraine|migraine
1225636|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
1225637|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
1225638|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
1225639|NCT01916369|Vascular disease|vascular disease
1225640|NCT01916369|Cardiovascular diseases|cardiovascular diseases
1225641|NCT01916369|Neural stem cell|neural stem cell
1225642|NCT01916356|Infertility|infertility
1225643|NCT01916356|Education|education
1225644|NCT01916356|Risk Factors|risk factors
1225645|NCT01916356|Fertility knowledge|fertility knowledge
1225646|NCT01916356|Fertility myths|fertility myths
1225647|NCT01916343|Laparoscopy|laparoscopy
1225648|NCT01916343|Surgical skills|surgical skills
1225649|NCT01916343|Team training|team training
1225650|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
1225651|NCT01916343|Curriculum|curriculum
1225652|NCT01916304|Drug Therapy|drug therapy
1225653|NCT01916252|Multiple Myeloma|multiple myeloma
1225654|NCT01916252|MEL200|mel200
1225655|NCT01916252|BUMEL|bumel
1225656|NCT01916239|Pomegranate|pomegranate
1225657|NCT01916239|Urolithins|urolithins
1225658|NCT01916239|Colorectal cancer|colorectal cancer
1225659|NCT01916239|Colon cancer|colon cancer
1225660|NCT01916239|Metabolite|metabolite
1225661|NCT01916239|Gene expression|gene expression
1225662|NCT01916239|microRNA|microrna
1225663|NCT01916239|Nutraceutical|nutraceutical
1225664|NCT01916239|Food supplement|food supplement
1225665|NCT01916239|Polyphenol|polyphenol
1225666|NCT01916239|Gut microbiota|gut microbiota
1225667|NCT01916226|cetirizine|cetirizine
1225668|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
1225669|NCT01916226|Quality of Life|quality of life
1225670|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
1225671|NCT01916161|Crohn's disease|crohn's disease
1225672|NCT01916161|ulcerative colitis|ulcerative colitis
1225673|NCT01916161|anxiety|anxiety
1225674|NCT01916161|patient knowledge|patient knowledge
1225675|NCT01916161|information sources|information sources
1225676|NCT01916148|Hypoglycemia|hypoglycemia
1225677|NCT01916148|Hyperinsulinism|hyperinsulinism
1225678|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
1225679|NCT01916135|PET Imaging|pet imaging
1225680|NCT01916135|CT Imaging|ct imaging
1225681|NCT01916135|12-182|12-182
1225682|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
1225683|NCT01916122|PET/CT scan|pet/ct scan
1225684|NCT01916122|Estrogen Receptor|estrogen receptor
1225685|NCT01916122|13-071|13-071
1225686|NCT01916109|Gemcitabine|gemcitabine
1225687|NCT01916109|Carboplatin|carboplatin
1225688|NCT01916109|Panitumumab|panitumumab
1225689|NCT01916109|(GCaP)|(gcap)
1225690|NCT01916109|radical cystectomy|radical cystectomy
1225691|NCT01916109|10-103|10-103
1225692|NCT01916070|syncope|syncope
1225693|NCT01916070|near syncope|near syncope
1225694|NCT01916070|prognosis|prognosis
1225695|NCT01916070|emergency department|emergency department
1225696|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
1225697|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1225698|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
1225699|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
1225700|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
1225701|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
1225702|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
1225703|NCT01916057|Candida spp.|candida spp.
1225704|NCT01916057|Genetic Susceptibility|genetic susceptibility
1225705|NCT01916057|Genotype|genotype
1225706|NCT01916044|caesarean,|caesarean,
1225707|NCT01916044|trial of labor,|trial of labor,
1225708|NCT01916044|ultrasound|ultrasound
1225709|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
1225710|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
1225711|NCT01916018|Genetics|genetics
1225712|NCT01916018|Associated malformations|associated malformations
1225713|NCT01916018|Psychomotor delay|psychomotor delay
1225714|NCT01916018|Mental retardation|mental retardation
1225715|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
1225716|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
1225717|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
1225718|NCT01915940|Glaucoma|glaucoma
1225719|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
1225720|NCT01915940|Ocular Hypertension|ocular hypertension
1225721|NCT01915888|Clinical|clinical
1225722|NCT01915888|Children|children
1225723|NCT01915888|Rotavirus|rotavirus
1225724|NCT01915888|Cost|cost
1225725|NCT01915888|Rotarix vaccination|rotarix vaccination
1225726|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
1225727|NCT01915862|Acute ischemic stroke|acute ischemic stroke
1225728|NCT01915862|Blood pressure variability|blood pressure variability
1225729|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
1225730|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1225731|NCT01915862|Outcome|outcome
1225732|NCT01915836|11-043|11-043
1225733|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
1225734|NCT01915810|Tobacco Use Cessation|tobacco use cessation
1225735|NCT01915810|Smoking Cessation with Physical Activity|smoking cessation with physical activity
1225736|NCT01915810|SCwPA|scwpa
1225737|NCT01915810|Cancer Prevention|cancer prevention
1225738|NCT01915810|African American cigarette smoker|african american cigarette smoker
1225739|NCT01915810|Questionnaires|questionnaires
1225740|NCT01915810|Surveys|surveys
1225741|NCT01915810|Phone Counseling|phone counseling
1225742|NCT01915810|Breath Test|breath test
1225743|NCT01915810|Walking Program|walking program
1225744|NCT01915810|Nicotine Patch|nicotine patch
1225745|NCT01915810|Audio Recorded Focus Group|audio recorded focus group
1225746|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
1225747|NCT01915745|Osteoporosis|osteoporosis
1225748|NCT01915745|Bone densitometry|bone densitometry
1225749|NCT01915745|Fracture|fracture
1225750|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
1225751|NCT01915745|Short message service|short message service
1225752|NCT01915706|Glaucoma drainage device|glaucoma drainage device
1225753|NCT01915706|Baerveldt 350|baerveldt 350
1225754|NCT01915706|Ripcord|ripcord
1225755|NCT01915706|Complications|complications
1225756|NCT01915693|Radiotherapy|radiotherapy
1225757|NCT01915693|stent|stent
1225758|NCT01915693|quality of life|quality of life
1225759|NCT01915654|Cardiac surgery|cardiac surgery
1225760|NCT01915654|Transfusion|transfusion
1225761|NCT01915641|walking capacity|walking capacity
1225762|NCT01915641|COPD|copd
1225763|NCT01915641|OSA|osa
1225764|NCT01915641|CPAP|cpap
1225765|NCT01915628|MACE|mace
1225766|NCT01915628|Safety|safety
1225767|NCT01915628|Efficacy|efficacy
1225768|NCT01915628|On label|on label
1225769|NCT01915628|Myocardial Infarction|myocardial infarction
1225770|NCT01915628|Cardiac death|cardiac death
1225771|NCT01915628|TVR|tvr
1225772|NCT01915628|stent thrombosis|stent thrombosis
1225773|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1225774|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1225775|NCT01915615|CMR|cmr
1225776|NCT01915615|Genetics|genetics
1225777|NCT01915615|Biomarkers|biomarkers
1225778|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
1225779|NCT01915615|T1 mapping|t1 mapping
1225780|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
1225781|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
1225782|NCT01915602|Sorafenib|sorafenib
1225783|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
1225784|NCT01915602|modified RECIST criteria|modified recist criteria
1225785|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
1225786|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
1225787|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
1225788|NCT01915589|modified RECIST criteria|modified recist criteria
1225789|NCT01915563|Mechanical ventilation|mechanical ventilation
1225790|NCT01915563|Weaning|weaning
1225791|NCT01915563|Extubation failure|extubation failure
1225792|NCT01915550|Diabetes mellitus|diabetes mellitus
1225795|NCT01915550|Metformin|metformin
1225796|NCT01915537|poor prognosis|poor prognosis
1225797|NCT01915537|severe RA|severe ra
1225798|NCT01915537|infliximab|infliximab
1225799|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1225800|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
1225802|NCT01915511|Registry|registry
1225803|NCT01915511|1199.174|1199.174
1225804|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
1225805|NCT01915498|AML|aml
1225806|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
1225807|NCT01915498|MDS|mds
1225808|NCT01915498|hematologic malignancies|hematologic malignancies
1225809|NCT01915498|IDH2|idh2
1225810|NCT01915498|Phase I|phase i
1225811|NCT01915498|Phase II|phase ii
1225812|NCT01915498|AG-221|ag-221
1225813|NCT01915498|relapse AML|relapse aml
1225814|NCT01915498|refractory AML|refractory aml
1225815|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
1225816|NCT01915472|Colorectal Cancer|colorectal cancer
1225817|NCT01915472|Rectal Cancer|rectal cancer
1225818|NCT01915472|previously treated|previously treated
1225819|NCT01915459|Stroke|stroke
1225820|NCT01915459|Spasticity|spasticity
1225821|NCT01915446|EVAR|evar
1225822|NCT01915446|endovascular aortic repair|endovascular aortic repair
1225823|NCT01915446|acute kidney failure|acute kidney failure
1225824|NCT01915446|mesenteric ischemia|mesenteric ischemia
1225825|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1225826|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
1225827|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
1225828|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1225829|NCT01915433|Fatigue|fatigue
1225830|NCT01915433|Quality of life|quality of life
1225831|NCT01915433|Paleo|paleo
1225832|NCT01915433|Nutrition|nutrition
1225833|NCT01915433|Ketogenic|ketogenic
1225834|NCT01915420|Drug eluting stent|drug eluting stent
1225835|NCT01915420|Bioabsorbable|bioabsorbable
1225836|NCT01915420|Bioresorbable|bioresorbable
1225837|NCT01915420|Coronary Stent|coronary stent
1225838|NCT01915420|Scaffold|scaffold
1225839|NCT01915420|Stents|stents
1225840|NCT01915420|Angioplasty|angioplasty
1225841|NCT01915420|Coronary Artery Disease|coronary artery disease
1225842|NCT01915420|Stentthrombosis|stentthrombosis
1225843|NCT01915420|Rotational atherectomy|rotational atherectomy
1225844|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
1225845|NCT01915394|Epidemics|epidemics
1225846|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
1225847|NCT01915394|Newborn infants|newborn infants
1225848|NCT01915381|Intellectual disability|intellectual disability
1225849|NCT01915381|mHealth|mhealth
1225850|NCT01915381|App|app
1225851|NCT01915381|Physical activity|physical activity
1225852|NCT01915381|Adherence|adherence
1225853|NCT01915368|Exercise|exercise
1225854|NCT01915368|Rehabilitation|rehabilitation
1225855|NCT01915368|Dose|dose
1225856|NCT01915368|Randomized controlled trial|randomized controlled trial
1225857|NCT01915368|Stroke|stroke
1225858|NCT01915355|onychomycosis|onychomycosis
1225859|NCT01915355|nail|nail
1225860|NCT01915355|fungus|fungus
1592586|NCT00422591|Cytarabine|cytarabine
1225861|NCT01915342|Monosynaptic reflex|monosynaptic reflex
1225862|NCT01915342|H-reflex|h-reflex
1225863|NCT01915329|CRPS|crps
1225864|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
1225865|NCT01915329|cortical reorganization|cortical reorganization
1225866|NCT01915329|2-point-discrimination|2-point-discrimination
1225867|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
1225868|NCT01915290|physical activity|physical activity
1225869|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
1225870|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
1225871|NCT01915264|Diabetes Mellitus|diabetes mellitus
1225872|NCT01915264|Type 2 Diabetes|type 2 diabetes
1225873|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
1225874|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
1225875|NCT01915251|Amoxicilin|amoxicilin
1225876|NCT01915251|Microbiome|microbiome
1225877|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1225878|NCT01915238|AMD|amd
1225879|NCT01915225|Tissue Procurement|tissue procurement
1225880|NCT01915225|Surgery|surgery
1225881|NCT01915225|Metastasectomy|metastasectomy
1225882|NCT01915212|Vaccination|vaccination
1225883|NCT01915212|Replication-Defective|replication-defective
1225884|NCT01915212|Genital Herpes|genital herpes
1225885|NCT01915212|Safety|safety
1225886|NCT01915212|Immune Responses|immune responses
1225887|NCT01915186|DHEA|dhea
1225888|NCT01915186|Poor ovarian reserve|poor ovarian reserve
1225889|NCT01915186|Normal ovarian reserve|normal ovarian reserve
1225890|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
1225891|NCT01915186|Ovarian response|ovarian response
1225892|NCT01915186|Pregnancy outcomes|pregnancy outcomes
1225893|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1225894|NCT01915173|Heartburn|heartburn
1225895|NCT01915173|Dyspepsia|dyspepsia
1225896|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
1225897|NCT01915147|severe chronic pain|severe chronic pain
1225898|NCT01915147|non-malignant pain|non-malignant pain
1225899|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
1225900|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1225901|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
1225902|NCT01915134|chemotherapy|chemotherapy
1225903|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
1225904|NCT01915121|Bladder Cancer|bladder cancer
1225905|NCT01915121|Intervention|intervention
1225906|NCT01915121|Education|education
1225907|NCT01915121|Randomized Controlled Trials|randomized controlled trials
1225908|NCT01915095|spinal cord injury|spinal cord injury
1225909|NCT01915095|neural control|neural control
1225910|NCT01915095|motor function|motor function
1225911|NCT01915095|hand movement|hand movement
1225912|NCT01915082|Lung Function|lung function
1225913|NCT01915082|Allograft Outcome|allograft outcome
1225914|NCT01915069|contraception|contraception
1225915|NCT01915069|Cilostazol|cilostazol
1225916|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
1225917|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
1225918|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
1225919|NCT01915056|GA-driven interventions|ga-driven interventions
1225920|NCT01915056|Toxicity|toxicity
1225921|NCT01915056|Outcomes|outcomes
1225922|NCT01915056|providing information|providing information
1225923|NCT01915056|older cancer patients|older cancer patients
1225924|NCT01915056|first-line chemotherapy|first-line chemotherapy
1225925|NCT01915056|second-line chemotherapy|second-line chemotherapy
1225926|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
1225927|NCT01915030|Muscle|muscle
1225928|NCT01915030|Physical performance|physical performance
1225929|NCT01915030|Protein|protein
1225930|NCT01915030|Diet|diet
1225931|NCT01915030|Caloric restriction|caloric restriction
1225932|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
1225933|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
1225934|NCT01915017|Schizophrenia|schizophrenia
1225935|NCT01915004|Pediatric Urology|pediatric urology
1225936|NCT01915004|Urotherapy|urotherapy
1225937|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
1225938|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
1225939|NCT01915004|Randomized Controlled Trial|randomized controlled trial
1225940|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
1225941|NCT01914991|Orthoses|orthoses
1225942|NCT01914965|Huntington's disease|huntington's disease
1225943|NCT01914965|Apathy|apathy
1225944|NCT01914965|Bupropion|bupropion
1225945|NCT01914952|CaHMB|cahmb
1225946|NCT01914952|HMB free acid|hmb free acid
1225947|NCT01914952|HMB|hmb
1225948|NCT01914939|autism spectrum disorder|autism spectrum disorder
1225949|NCT01914939|social skills deficits|social skills deficits
1225950|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
1225951|NCT01914939|oxytocin|oxytocin
1225952|NCT01914939|young adult|young adult
1225953|NCT01914926|metoprolol|metoprolol
1225954|NCT01914926|diltiazem|diltiazem
1225955|NCT01914926|heart rate|heart rate
1225956|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
1225957|NCT01914913|Bone marrow|bone marrow
1225958|NCT01914913|stem cell|stem cell
1225959|NCT01914913|BMMNC|bmmnc
1225960|NCT01914900|oral cavity cancer|oral cavity cancer
1225961|NCT01914900|induction chemotherapy|induction chemotherapy
1225962|NCT01914900|TP53|tp53
1225963|NCT01914900|beta tubulin II|beta tubulin ii
1225964|NCT01914887|Ulcerative Colitis|ulcerative colitis
1225965|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
1225966|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
1225967|NCT01914874|Community Sample|community sample
1225968|NCT01914835|cocaine dependence|cocaine dependence
1225969|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
1225970|NCT01914835|executive functions|executive functions
1225971|NCT01914822|Ritalin|ritalin
1225972|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
1225973|NCT01914822|experimental pain|experimental pain
1225974|NCT01914796|Phase 1|phase 1
1225975|NCT01914796|Randomized|randomized
1225976|NCT01914796|Double Blind|double blind
1225977|NCT01914796|Placebo-Controlled|placebo-controlled
1225978|NCT01914796|Single-Dose Escalation|single-dose escalation
1225979|NCT01914796|Safety|safety
1225980|NCT01914796|Tolerability|tolerability
1225981|NCT01914796|PK|pk
1225982|NCT01914796|PD|pd
1225983|NCT01914796|PF-06412562|pf-06412562
1225984|NCT01914783|air pollution|air pollution
1225985|NCT01914783|ozone|ozone
1225986|NCT01914783|fine particle|fine particle
1225987|NCT01914783|cytokine|cytokine
1225988|NCT01914783|chemokine|chemokine
1225989|NCT01914783|oxidative stress|oxidative stress
1225990|NCT01914783|inflammation|inflammation
1225991|NCT01914783|heart rate variability|heart rate variability
1225992|NCT01914783|autonomic nervous system|autonomic nervous system
1225993|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
1225994|NCT01914783|plasma catecholamine|plasma catecholamine
1225995|NCT01914770|pooled analyses|pooled analyses
1225996|NCT01914770|quality of life|quality of life
1225997|NCT01914770|SELENA SLEDAI|selena sledai
1225998|NCT01914770|SLE|sle
1225999|NCT01914770|steroid use|steroid use
1226000|NCT01914770|responder rate|responder rate
1226001|NCT01914770|flares|flares
1226002|NCT01914770|belimumab|belimumab
1226003|NCT01914770|BILAG|bilag
1226004|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
1226005|NCT01914744|NHL|nhl
1226006|NCT01914744|HBV|hbv
1226007|NCT01914744|entecavir|entecavir
1226008|NCT01914744|lamivudine|lamivudine
1226009|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
1226010|NCT01914731|Clostridium difficile|clostridium difficile
1226011|NCT01914731|Diarrhea|diarrhea
1226012|NCT01914718|DLBCL|dlbcl
1226013|NCT01914718|DA-EPOCH-R|da-epoch-r
1226014|NCT01914705|Landmark|landmark
1226015|NCT01914705|Ultrasound|ultrasound
1226016|NCT01914705|central venous catheter|central venous catheter
1226017|NCT01914679|Fibromyalgia|fibromyalgia
1226018|NCT01914679|Pain|pain
1226019|NCT01914679|Brain|brain
1226020|NCT01914679|Stimulation|stimulation
1226021|NCT01914679|Device|device
1226022|NCT01914679|Treatment|treatment
1226023|NCT01914666|Chronic Low Back Pain|chronic low back pain
1226024|NCT01914666|CLBP|clbp
1226025|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
1226026|NCT01914627|Psoriasis capitis|psoriasis capitis
1226027|NCT01914627|Scaling|scaling
1226028|NCT01914627|Salicylic acid|salicylic acid
1226029|NCT01914627|Dimethicone|dimethicone
1226030|NCT01914627|Plaque removal|plaque removal
1226031|NCT01914614|Breast Cancer|breast cancer
1226032|NCT01914614|Working Women|working women
1226033|NCT01914601|Laryngoscope|laryngoscope
1226034|NCT01914601|Macintosh|macintosh
1226035|NCT01914601|King Vision|king vision
1226036|NCT01914601|tracheal intubation|tracheal intubation
1226037|NCT01914601|cervical spines|cervical spines
1226038|NCT01914536|POMPE|pompe
1226039|NCT01914536|Glycogenosis type II|glycogenosis type ii
1226040|NCT01914536|Acid maltase deficiency|acid maltase deficiency
1226041|NCT01914523|Laryngoscope|laryngoscope
1226042|NCT01914523|Macintosh|macintosh
1226043|NCT01914523|Glidescope|glidescope
1226044|NCT01914523|King Vision|king vision
1226045|NCT01914523|AirTraq|airtraq
1226046|NCT01914523|tracheal intubation|tracheal intubation
1226047|NCT01914510|ovarian|ovarian
1226048|NCT01914510|cancer|cancer
1226049|NCT01914510|clear cell|clear cell
1226050|NCT01914510|ENMD-2076|enmd-2076
1226051|NCT01914510|oral|oral
1226052|NCT01914510|capsule|capsule
1226053|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
1226054|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
1226055|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1226056|NCT01914484|nilotinib|nilotinib
1226057|NCT01914484|ruxolitinib|ruxolitinib
1226058|NCT01914458|Lung cancer|lung cancer
1226059|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
1226060|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
1226061|NCT01914419|Oxytocin|oxytocin
1226062|NCT01914419|Prevention|prevention
1226063|NCT01914419|Third stage of labor|third stage of labor
1226064|NCT01914419|Hemoglobin|hemoglobin
1226065|NCT01914419|Intravenous|intravenous
1226066|NCT01914419|Intramuscular|intramuscular
1226067|NCT01914419|Bolus|bolus
1226068|NCT01914406|Heart transplant recipients|heart transplant recipients
1226069|NCT01914406|Exercise capacity|exercise capacity
1226070|NCT01914406|endothelial function|endothelial function
1226071|NCT01914406|Quality of life|quality of life
1226072|NCT01914393|Schizophrenia|schizophrenia
1226073|NCT01914393|Autism|autism
1226074|NCT01914393|Lurasidone|lurasidone
1226075|NCT01914393|Latuda|latuda
1226076|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
1226077|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
1226078|NCT01914380|Observational study|observational study
1226079|NCT01914354|T cells|t cells
1226080|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
1226081|NCT01914354|immunosuppression|immunosuppression
1226082|NCT01914341|Infant|infant
1226083|NCT01914341|Newborn|newborn
1226084|NCT01914341|Music|music
1226085|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
1226086|NCT01914328|PORC|porc
1226087|NCT01914328|Surgical Related Outcome|surgical related outcome
1226088|NCT01914328|Surgical Related Mortality|surgical related mortality
1226089|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
1226090|NCT01914315|Rehabilitation|rehabilitation
1226091|NCT01914315|Heart failure|heart failure
1226092|NCT01914315|HFPEF|hfpef
1226093|NCT01914315|Exercise training|exercise training
1226094|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
1226095|NCT01914289|Prognosis|prognosis
1226096|NCT01914289|Resection|resection
1226097|NCT01914289|Radiotherapy|radiotherapy
1226098|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
1226099|NCT01914263|Radical resection|radical resection
1226100|NCT01914250|Frenotomy|frenotomy
1226101|NCT01914250|Pain|pain
1226102|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
1226103|NCT01914237|Aortic Dissection|aortic dissection
1226104|NCT01914237|Endovascular Repair|endovascular repair
1226105|NCT01914224|Prehypertension|prehypertension
1226106|NCT01914224|Hypertension|hypertension
1226107|NCT01914224|Sodium|sodium
1226108|NCT01914224|Potassium|potassium
1226109|NCT01914224|renin|renin
1226110|NCT01914224|aldosterone|aldosterone
1226111|NCT01914198|sleep study|sleep study
1226112|NCT01914198|NCH|nch
1226113|NCT01914185|Childhood|childhood
1226114|NCT01914185|Physical activity|physical activity
1226115|NCT01914185|Nutrition|nutrition
1226116|NCT01914185|Health Promotion|health promotion
1226117|NCT01914172|rare disease|rare disease
1226118|NCT01914172|community-based participatory research|community-based participatory research
1226119|NCT01914172|health promotion|health promotion
1226120|NCT01914172|quantitative research|quantitative research
1226121|NCT01914172|qualitative research|qualitative research
1226122|NCT01914172|focus group|focus group
1226123|NCT01914146|Diabetes|diabetes
1226124|NCT01914146|Insulin|insulin
1226125|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
1226126|NCT01914146|Falls|falls
1226127|NCT01914146|Syncope|syncope
1226128|NCT01914133|Acarbose|acarbose
1226129|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
1226130|NCT01914133|Falls|falls
1226131|NCT01914133|Syncope|syncope
1226132|NCT01914133|Elderly|elderly
1226133|NCT01914120|lung cancer|lung cancer
1226134|NCT01914120|quality of life|quality of life
1226135|NCT01914120|FACT-L|fact-l
1226136|NCT01914107|malignancy|malignancy
1226137|NCT01914107|solid tumor|solid tumor
1226138|NCT01914107|cancer pain|cancer pain
1226139|NCT01914094|Preoperative care|preoperative care
1226140|NCT01914094|Exercise therapy|exercise therapy
1226141|NCT01914094|Cardiac surgery|cardiac surgery
1226142|NCT01914081|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
1226143|NCT01914081|Resveratrol|resveratrol
1226144|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
1226145|NCT01914068|Rectal cancer|rectal cancer
1226146|NCT01914068|Physical fitness|physical fitness
1226147|NCT01914068|Exercise programme|exercise programme
1226148|NCT01914068|Surgery|surgery
1226149|NCT01914068|Stage III/IV|stage iii/iv
1226150|NCT01914068|Locally advanced operable|locally advanced operable
1226151|NCT01914068|patients|patients
1226152|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
1226153|NCT01914042|Neuropathic pain|neuropathic pain
1226154|NCT01914042|Opioids|opioids
1226155|NCT01914042|Sciatica|sciatica
1226156|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
1226157|NCT01913990|Nausea|nausea
1226158|NCT01913990|Vomiting|vomiting
1226159|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
1226160|NCT01913899|phantom limb pain|phantom limb pain
1226161|NCT01913899|mirror therapy|mirror therapy
1226162|NCT01913899|amputees|amputees
1226163|NCT01913899|phantom limb|phantom limb
1226164|NCT01913899|occupational therapy|occupational therapy
1226165|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
1226166|NCT01913886|Myocardial Ischemia|myocardial ischemia
1226167|NCT01913886|Coronary Artery Disease|coronary artery disease
1226168|NCT01913886|Heart Diseases|heart diseases
1226169|NCT01913886|Coronary Disease|coronary disease
1226170|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
1226171|NCT01913886|Arteriosclerosis|arteriosclerosis
1226172|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
1226173|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
1226174|NCT01913873|Cardiac Surgery|cardiac surgery
1226175|NCT01913873|Myocardial injury|myocardial injury
1226176|NCT01913873|Myocardial infarction|myocardial infarction
1226177|NCT01913873|Concentration change|concentration change
1226178|NCT01913860|UTI|uti
1226179|NCT01913860|antibiotics|antibiotics
1226180|NCT01913860|prescribing|prescribing
1226181|NCT01913860|primary care|primary care
1226182|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
1226183|NCT01913808|Postoperative anemia|postoperative anemia
1226184|NCT01913808|Total knee arthroplasty|total knee arthroplasty
1226185|NCT01913808|Iron therapy|iron therapy
1226186|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
1226187|NCT01913769|post-RT|post-rt
1226188|NCT01913769|myocardial perfusion images|myocardial perfusion images
1226189|NCT01913743|fMRI|fmri
1226190|NCT01913743|cognitive strategies|cognitive strategies
1226191|NCT01913743|obesity|obesity
1226192|NCT01913743|weight loss|weight loss
1226193|NCT01913743|mindsets|mindsets
1226194|NCT01913730|Multiple Myeloma|multiple myeloma
1226195|NCT01913730|Refractory|refractory
1226196|NCT01913730|Relapsed|relapsed
1226197|NCT01913717|Prostate cancer|prostate cancer
1226198|NCT01913717|Radiotherapy|radiotherapy
1226199|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
1226200|NCT01913704|venous leg ulcer|venous leg ulcer
1226201|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
1226202|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
1226203|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
1226204|NCT01913691|Immunotherapy|immunotherapy
1226205|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
1226206|NCT01913652|cabazitaxel|cabazitaxel
1226207|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
1226208|NCT01913639|FLUOROURACIL|fluorouracil
1226209|NCT01913639|LEUCOVORIN|leucovorin
1226210|NCT01913639|OXALIPLATIN|oxaliplatin
1226211|NCT01913626|subjective memory complains|subjective memory complains
1226413|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
1226212|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1226213|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1226214|NCT01913600|Coronary Artery Disease|coronary artery disease
1226215|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1226216|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1226217|NCT01913600|STENT THROMBOSIS|stent thrombosis
1226218|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1226219|NCT01913561|Electrocardiogram|electrocardiogram
1226220|NCT01913561|gel electrodes|gel electrodes
1226221|NCT01913561|textile electrodes|textile electrodes
1226222|NCT01913535|Depression|depression
1226223|NCT01913535|Treatment Resistant Depression|treatment resistant depression
1226224|NCT01913535|Antidepressant|antidepressant
1226225|NCT01913535|Major Depression|major depression
1226226|NCT01913535|MDD|mdd
1226227|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
1226228|NCT01913509|poststroke fatigue|poststroke fatigue
1226229|NCT01913509|functional electrical stimulation|functional electrical stimulation
1226230|NCT01913509|stroke rehabilitation|stroke rehabilitation
1226231|NCT01913496|web application|web application
1226232|NCT01913496|nutrition knowledge|nutrition knowledge
1226233|NCT01913496|physical activity|physical activity
1226234|NCT01913470|NAFLD|nafld
1226235|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1226236|NCT01913470|Obesity|obesity
1226237|NCT01913470|Pediatrics|pediatrics
1226238|NCT01913470|Children|children
1226239|NCT01913470|Losartan|losartan
1226240|NCT01913470|Cozaar|cozaar
1226241|NCT01913457|Ultrasound Doppler|ultrasound doppler
1226242|NCT01913457|Lungs|lungs
1226243|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
1226244|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
1226245|NCT01913444|ATryn|atryn
1226246|NCT01913444|Pharmacokinetics|pharmacokinetics
1226247|NCT01913444|ECMO|ecmo
1226248|NCT01913444|Neonates|neonates
1226249|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
1226250|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
1226251|NCT01913418|Methadone|methadone
1226252|NCT01913418|Opiate dependence|opiate dependence
1226253|NCT01913418|Sleep|sleep
1226254|NCT01913379|Phase 1|phase 1
1226255|NCT01913379|MDV3100|mdv3100
1226256|NCT01913379|Gemfibrozil|gemfibrozil
1226257|NCT01913379|Itraconazole|itraconazole
1226258|NCT01913379|Xtandi|xtandi
1226259|NCT01913379|enzalutamide|enzalutamide
1226260|NCT01913340|erythropoietin|erythropoietin
1226261|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
1226262|NCT01913327|cognition|cognition
1226263|NCT01913327|executive function|executive function
1226264|NCT01913327|prefrontal cortex|prefrontal cortex
1226265|NCT01913327|locus coeruleus|locus coeruleus
1226266|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
1226267|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
1226268|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
1226269|NCT01913275|endoscopic stenting|endoscopic stenting
1226270|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
1226271|NCT01913262|depression|depression
1226272|NCT01913262|phq9|phq9
1226273|NCT01913262|phq-9|phq-9
1226274|NCT01913262|standard treatment|standard treatment
1226275|NCT01913249|Anorectal fistula|anorectal fistula
1226276|NCT01913249|LIFT|lift
1226277|NCT01913249|Seton|seton
1226278|NCT01913236|Tailored implementation interventions|tailored implementation interventions
1226279|NCT01913236|Primary care|primary care
1226280|NCT01913236|Depression in the elderly|depression in the elderly
1226281|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
1226282|NCT01913223|jet injector|jet injector
1226283|NCT01913223|saline solution|saline solution
1226284|NCT01913223|safety|safety
1226285|NCT01913223|effectiveness|effectiveness
1226286|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
1226287|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
1226288|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
1226289|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1226290|NCT01913093|Leukemia|leukemia
1226291|NCT01913093|Late effects|late effects
1226293|NCT01913093|Blood folate|blood folate
1226294|NCT01913093|Neurotoxicity|neurotoxicity
1226295|NCT01913093|Methotrexate|methotrexate
1226296|NCT01913093|Pharmacogenetics|pharmacogenetics
1226297|NCT01913093|Cognitive|cognitive
1226298|NCT01913093|Cognitive late effects|cognitive late effects
1226299|NCT01913093|N-PhenoGENICS|n-phenogenics
1226300|NCT01913080|health management|health management
1226301|NCT01913067|brain metastasis|brain metastasis
1226302|NCT01913067|breast cancer|breast cancer
1226303|NCT01913067|HER2 negative|her2 negative
1226304|NCT01913067|NSCLC|nsclc
1226305|NCT01913054|Etomidate|etomidate
1226306|NCT01913054|Propofol|propofol
1226307|NCT01913054|Painless gastroscopy|painless gastroscopy
1226308|NCT01913041|perioperative hypothermia|perioperative hypothermia
1226309|NCT01913041|Epidemiology|epidemiology
1226310|NCT01913041|Tympanic temperature|tympanic temperature
1226311|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
1226312|NCT01912989|motivational interviewing|motivational interviewing
1226313|NCT01912989|obesity|obesity
1226314|NCT01912989|parent|parent
1226315|NCT01912976|Bowen's disease|bowen's disease
1226316|NCT01912976|Er:YAG|er:yag
1226317|NCT01912976|AFL-assisted|afl-assisted
1226318|NCT01912976|MAL-PDT|mal-pdt
1226319|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1226320|NCT01912950|intense pulsed light|intense pulsed light
1226322|NCT01912950|healthy volunteer|healthy volunteer
1226323|NCT01912950|light-based hair removal|light-based hair removal
1226324|NCT01912950|hair removal|hair removal
1226325|NCT01912950|epilation|epilation
1226326|NCT01912950|laser hair removal|laser hair removal
1226327|NCT01912950|permanent hair reduction|permanent hair reduction
1226328|NCT01912937|Paclitaxel|paclitaxel
1226329|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1226330|NCT01912937|Balloon Catheter|balloon catheter
1226331|NCT01912937|Pharmacokinetic|pharmacokinetic
1226332|NCT01912937|Peripheral Artery Disease|peripheral artery disease
1226333|NCT01912937|PAD|pad
1226334|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
1226335|NCT01912846|End-of-life care|end-of-life care
1226336|NCT01912846|Preference of end-of-life care|preference of end-of-life care
1226337|NCT01912846|RCT|rct
1226338|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
1226339|NCT01912833|postpartum depression|postpartum depression
1226340|NCT01912807|Postoperative vomiting|postoperative vomiting
1226341|NCT01912807|Children|children
1226342|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
1226343|NCT01912794|Rehabilitation|rehabilitation
1226344|NCT01912794|Sensory System|sensory system
1226345|NCT01912781|contact lenses|contact lenses
1226346|NCT01912781|contact lens solution|contact lens solution
1226347|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
1226348|NCT01912768|contact lenses|contact lenses
1226349|NCT01912768|contact lens solution|contact lens solution
1226350|NCT01912768|soft contact lenses|soft contact lenses
1226351|NCT01912755|Pulpitis|pulpitis
1226352|NCT01912755|Hot tooth|hot tooth
1226353|NCT01912755|Articaine|articaine
1226354|NCT01912755|Lidocaine|lidocaine
1226355|NCT01912755|Local anesthetics|local anesthetics
1226356|NCT01912742|Weight loss|weight loss
1226357|NCT01912742|Speed of weight loss|speed of weight loss
1226358|NCT01912742|Metabolic compensation|metabolic compensation
1226359|NCT01912742|Diet therapy|diet therapy
1226360|NCT01912729|Depression prevention|depression prevention
1226361|NCT01912729|Technology Assisted|technology assisted
1226362|NCT01912729|Adolescents|adolescents
1226363|NCT01912729|Peer networked|peer networked
1226364|NCT01912716|pancreatitis|pancreatitis
1226365|NCT01912716|ERCP|ercp
1226366|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
1226367|NCT01912677|preeclampsia|preeclampsia
1226368|NCT01912677|anti-hypertension|anti-hypertension
1226369|NCT01912677|labetalol|labetalol
1226370|NCT01912677|nifedipine|nifedipine
1226371|NCT01912677|methyldopa|methyldopa
1226372|NCT01912651|facial skin wound|facial skin wound
1226373|NCT01912651|facial wound|facial wound
1226374|NCT01912651|skin wound|skin wound
1226375|NCT01912651|facial defect|facial defect
1226376|NCT01912651|reconstructive skin graft|reconstructive skin graft
1226377|NCT01912638|Trabeculectomy|trabeculectomy
1226378|NCT01912638|Glaucoma|glaucoma
1226379|NCT01912638|Steroids|steroids
1226380|NCT01912638|Ologen|ologen
1226381|NCT01912638|Viscoelastic|viscoelastic
1226382|NCT01912612|Breast cancer|breast cancer
1226383|NCT01912612|Pain sensitivity|pain sensitivity
1226384|NCT01912599|Glaucoma|glaucoma
1226385|NCT01912599|Intraocular Pressure|intraocular pressure
1226386|NCT01912599|Blood Pressure|blood pressure
1226387|NCT01912586|erectile dysfunction|erectile dysfunction
1226388|NCT01912586|laparoscopic surgery|laparoscopic surgery
1226389|NCT01912586|rectal cancer|rectal cancer
1226390|NCT01912586|sildenafil|sildenafil
1226391|NCT01912586|vacuum erection device|vacuum erection device
1226392|NCT01912573|heroin|heroin
1226393|NCT01912573|prescription pain killers|prescription pain killers
1226394|NCT01912573|narcotics|narcotics
1226395|NCT01912534|Sarcomere Mutations|sarcomere mutations
1226396|NCT01912521|HIV|hiv
1226397|NCT01912521|Stigma|stigma
1226398|NCT01912521|Social support|social support
1226399|NCT01912521|Social network|social network
1226400|NCT01912521|Kenya|kenya
1226401|NCT01912508|cervical length|cervical length
1226402|NCT01912508|cervical curvature|cervical curvature
1226403|NCT01912469|Muscle|muscle
1226404|NCT01912469|exercise|exercise
1226405|NCT01912469|soreness|soreness
1226406|NCT01912469|Damage|damage
1226407|NCT01912469|Traumeel|traumeel
1226408|NCT01912456|Hereditary Angioedema|hereditary angioedema
1226409|NCT01912430|Integrated Care Coaching|integrated care coaching
1226410|NCT01912430|Chronic Care Coaching|chronic care coaching
1226411|NCT01912430|Care Coaching|care coaching
1226412|NCT01912417|HEMODIALYSIS|hemodialysis
1226414|NCT01912417|AEROBIC EXERCISE|aerobic exercise
1226415|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
1226416|NCT01912391|Depression|depression
1226417|NCT01912391|Anxiety|anxiety
1226418|NCT01912391|Headaches|headaches
1226419|NCT01912391|Migraines|migraines
1226420|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
1226421|NCT01912391|Neurodermatitis|neurodermatitis
1226422|NCT01912391|Fibromyalgia|fibromyalgia
1226423|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
1226424|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
1226425|NCT01912365|Fracture|fracture
1226426|NCT01912365|Supracondylar|supracondylar
1226427|NCT01912365|Pediatric|pediatric
1226428|NCT01912365|Orthopedic|orthopedic
1226429|NCT01912352|ADHD|adhd
1226430|NCT01912352|ADRA2A|adra2a
1226431|NCT01912352|Methylphenidate|methylphenidate
1226432|NCT01912352|Response|response
1226433|NCT01912339|Hyperlasia|hyperlasia
1226434|NCT01912339|Retention|retention
1226435|NCT01912339|Prostate|prostate
1226436|NCT01912326|pacemaker|pacemaker
1226437|NCT01912326|atrial fibrillation|atrial fibrillation
1226438|NCT01912313|IBS patients|ibs patients
1226439|NCT01912313|healthy subjects|healthy subjects
1226440|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
1226441|NCT01912287|GAD|gad
1226442|NCT01912287|Yoga|yoga
1226443|NCT01912287|CBT|cbt
1226444|NCT01912274|AML|aml
1226445|NCT01912274|open label|open label
1226446|NCT01912274|nonrandomized|nonrandomized
1226447|NCT01912274|single arm|single arm
1226448|NCT01912274|elderly patients|elderly patients
1226449|NCT01912274|HMA|hma
1226450|NCT01912274|newly diagnosed|newly diagnosed
1592587|NCT00422591|Idarubicin|idarubicin
1226451|NCT01912261|Coronary artery bypass gafting|coronary artery bypass gafting
1226452|NCT01912261|Anemia|anemia
1226453|NCT01912261|Postoperative fatigue|postoperative fatigue
1226454|NCT01912261|Functional Capacity|functional capacity
1226455|NCT01912261|Iron|iron
1226456|NCT01912261|Adherence|adherence
1226457|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
1226458|NCT01912235|Arginine synthesis|arginine synthesis
1226459|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
1226460|NCT01912209|employees|employees
1226461|NCT01912209|metabolic syndrome|metabolic syndrome
1226462|NCT01912209|obesity|obesity
1226463|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
1226464|NCT01912209|weight loss|weight loss
1226465|NCT01912209|diet|diet
1226466|NCT01912196|Depressive Disorder|depressive disorder
1226467|NCT01912183|pediatric obesity|pediatric obesity
1226468|NCT01912183|e-learning|e-learning
1226469|NCT01912183|personal health record|personal health record
1226470|NCT01912183|personal electronic device|personal electronic device
1226471|NCT01912183|pilot|pilot
1226472|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
1226473|NCT01912170|gestational diabetes|gestational diabetes
1226474|NCT01912170|insulin sensitivity|insulin sensitivity
1226475|NCT01912131|13-120|13-120
1226476|NCT01912118|Nociception|nociception
1226477|NCT01912118|General anesthesia|general anesthesia
1226478|NCT01912105|endotracheal tube|endotracheal tube
1226479|NCT01912105|ct scan|ct scan
1226480|NCT01912105|cleaning device|cleaning device
1226481|NCT01912105|biofilm|biofilm
1226482|NCT01912105|mechanical ventilation|mechanical ventilation
1226483|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
1226484|NCT01912040|Safety profile|safety profile
1226485|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
1226486|NCT01912014|stroke|stroke
1226487|NCT01912014|psychosocial|psychosocial
1226488|NCT01912014|intervention|intervention
1226489|NCT01912014|quality of life|quality of life
1226490|NCT01912001|end stage renal disease|end stage renal disease
1226491|NCT01912001|kidney failure|kidney failure
1226492|NCT01912001|home dialysis|home dialysis
1226493|NCT01912001|hemodialysis|hemodialysis
1226494|NCT01912001|peritoneal dialysis|peritoneal dialysis
1226495|NCT01912001|gaps in care|gaps in care
1226496|NCT01912001|co-morbidity|co-morbidity
1226497|NCT01912001|transitions of care settings|transitions of care settings
1226498|NCT01911988|Peripheral immune cells|peripheral immune cells
1226499|NCT01911988|Colorectal Cancers|colorectal cancers
1226500|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
1226501|NCT01911988|Recurrence|recurrence
1226502|NCT01911988|Metastasis|metastasis
1226503|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
1226504|NCT01911975|Painful Neuropathy|painful neuropathy
1226505|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
1226506|NCT01911975|SCN9A|scn9a
1226507|NCT01911949|femoral nerve block|femoral nerve block
1226508|NCT01911949|ultrasound guided|ultrasound guided
1226509|NCT01911949|total hip arthroplasty|total hip arthroplasty
1226510|NCT01911936|CLJM716,|cljm716,
1226511|NCT01911936|Japanese patients,|japanese patients,
1226512|NCT01911936|Neoplasms|neoplasms
1226513|NCT01911910|primary prevention|primary prevention
1226514|NCT01911910|Cardiovascular disease|cardiovascular disease
1226515|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
1226516|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
1226517|NCT01911897|Hypertension|hypertension
1226518|NCT01911884|Rokitansky syndrome|rokitansky syndrome
1226519|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
1226520|NCT01911884|quality of global and sexual life|quality of global and sexual life
1226521|NCT01911871|Thalassemia|thalassemia
1226522|NCT01911871|sickle cell disease|sickle cell disease
1226523|NCT01911871|myelodysplasia|myelodysplasia
1226524|NCT01911871|transfusion|transfusion
1226525|NCT01911871|chelation|chelation
1226526|NCT01911845|HCV Genotype 1|hcv genotype 1
1226527|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
1226528|NCT01911845|Interferon Free|interferon free
1226529|NCT01911845|methadone|methadone
1226531|NCT01911845|Buprenorphine|buprenorphine
1226532|NCT01911845|Hepatitis C|hepatitis c
1226533|NCT01911845|Viekira Pak|viekira pak
1226534|NCT01911845|paritaprevir|paritaprevir
1226535|NCT01911845|Viekira|viekira
1226536|NCT01911845|ombitasvir|ombitasvir
1226537|NCT01911845|dasabuvir|dasabuvir
1226538|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
1226539|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
1226540|NCT01911832|Quality of life|quality of life
1226541|NCT01911832|Width|width
1226542|NCT01911832|Regurgitation|regurgitation
1226543|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
1226544|NCT01911819|New bone Formation|new bone formation
1226545|NCT01911819|Sinus Augmentation|sinus augmentation
1226546|NCT01911819|Bone Graft Materials|bone graft materials
1226547|NCT01911806|Back care pillow|back care pillow
1226548|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
1226549|NCT01911806|randomized controlled trial|randomized controlled trial
1226550|NCT01911793|stoma|stoma
1226551|NCT01911793|ileus|ileus
1226552|NCT01911793|postoperative|postoperative
1226553|NCT01911793|stoma tube|stoma tube
1226554|NCT01911741|Phase I|phase i
1226555|NCT01911741|Enzalutamide|enzalutamide
1226556|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
1226557|NCT01911741|Immediate release oral formulation|immediate release oral formulation
1226558|NCT01911741|Xtandi|xtandi
1226559|NCT01911728|Drug-Drug Interaction|drug-drug interaction
1226560|NCT01911728|Phase 1|phase 1
1226561|NCT01911728|MDV3100|mdv3100
1226562|NCT01911728|Xtandi|xtandi
1226563|NCT01911728|Enzalutamide|enzalutamide
1226564|NCT01911715|Phase 1|phase 1
1226565|NCT01911715|Mass Balance|mass balance
1226566|NCT01911715|MDV3100|mdv3100
1226567|NCT01911715|Xtandi|xtandi
1226568|NCT01911715|Enzalutamide|enzalutamide
1226569|NCT01911715|Metabolism|metabolism
1226570|NCT01911715|Excretion|excretion
1226571|NCT01911689|pancreatitis|pancreatitis
1226572|NCT01911689|MRI|mri
1226573|NCT01911689|APACHEⅡ|apacheⅱ
1226574|NCT01911689|T2*|t2*
1226575|NCT01911689|T2 star|t2 star
1226576|NCT01911650|Achilles|achilles
1226577|NCT01911650|tendinopathy|tendinopathy
1226578|NCT01911637|Healthy|healthy
1226579|NCT01911637|Subjects|subjects
1226580|NCT01911637|Safety|safety
1226581|NCT01911637|Tolerability|tolerability
1226582|NCT01911637|VBY-036|vby-036
1226583|NCT01911637|Maximum|maximum
1226584|NCT01911637|Pharmacodynamic|pharmacodynamic
1226585|NCT01911637|Pharmacokinetic|pharmacokinetic
1226586|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
1226587|NCT01911585|PTSD|ptsd
1226588|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
1226589|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
1226590|NCT01911572|Streptococcus species|streptococcus species
1226591|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
1226592|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
1226593|NCT01911572|Necrotising fasciitis|necrotising fasciitis
1226594|NCT01911572|Sepsis|sepsis
1226595|NCT01911559|Standing-frame|standing-frame
1226597|NCT01911559|Cerebral palsy|cerebral palsy
1226598|NCT01911559|Quadriplegia|quadriplegia
1226599|NCT01911559|Severe diplegia|severe diplegia
1226600|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
1226601|NCT01911494|pre-eclampsia|pre-eclampsia
1226602|NCT01911494|eclampsia|eclampsia
1226603|NCT01911494|maternal mortality|maternal mortality
1226604|NCT01911468|PCOS|pcos
1226605|NCT01911468|obesity|obesity
1226606|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
1226607|NCT01911468|liraglutide|liraglutide
1226608|NCT01911468|metformin|metformin
1226609|NCT01911455|Fragile X Syndrome|fragile x syndrome
1226610|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
1226611|NCT01911429|schizophrenia|schizophrenia
1226612|NCT01911429|Lurasidone|lurasidone
1226613|NCT01911429|Latuda|latuda
1226614|NCT01911403|Femoral Artery puncture|femoral artery puncture
1226615|NCT01911390|High cholesterol.|high cholesterol.
1226616|NCT01911364|Frequent exacerbators|frequent exacerbators
1226617|NCT01911351|nitrous oxide|nitrous oxide
1226618|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
1226619|NCT01911338|Spinal Manipulation|spinal manipulation
1226620|NCT01911338|Teaching|teaching
1226621|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
1226622|NCT01911338|Feedback|feedback
1226623|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
1226624|NCT01911325|NSCLC|nsclc
1226625|NCT01911325|Docetaxel|docetaxel
1226626|NCT01911325|Buparlisib|buparlisib
1226627|NCT01911325|BKM120|bkm120
1226628|NCT01911325|Metastatic|metastatic
1226629|NCT01911325|Stage IIIb|stage iiib
1226630|NCT01911325|Stage IV|stage iv
1226631|NCT01911325|PI3K inhibitor|pi3k inhibitor
1226632|NCT01911299|Choline|choline
1226633|NCT01911299|Glycerophosphocholine|glycerophosphocholine
1226634|NCT01911299|Choline alphoscerate|choline alphoscerate
1226635|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
1226636|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
1226637|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
1226638|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
1226639|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
1226640|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
1226641|NCT01911299|Pregnancy Complications|pregnancy complications
1226642|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
1226643|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
1226644|NCT01911299|Central Nervous System Agents|central nervous system agents
1226645|NCT01911299|Therapeutic Uses|therapeutic uses
1226646|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
1226647|NCT01911273|monoclonal antibody|monoclonal antibody
1226648|NCT01911273|ALK-1|alk-1
1226649|NCT01911273|best supportive care|best supportive care
1226650|NCT01911260|Zinc|zinc
1226651|NCT01911260|Growth|growth
1226652|NCT01911260|Child|child
1226653|NCT01911260|Dietary Supplements|dietary supplements
1226654|NCT01911260|Randomized Controlled Trial|randomized controlled trial
1226655|NCT01911221|Meningococcal disease,|meningococcal disease,
1226656|NCT01911221|Adults|adults
1226659|NCT01911195|General anesthesia|general anesthesia
1226660|NCT01911195|cognition|cognition
1226661|NCT01911195|consciousness|consciousness
1226662|NCT01911182|apnea of prematurity|apnea of prematurity
1226663|NCT01911182|control of breathing|control of breathing
1226664|NCT01911182|newborn|newborn
1226665|NCT01911182|CO2 inhalation|co2 inhalation
1226666|NCT01911169|atherosclerosis|atherosclerosis
1226667|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
1226668|NCT01911169|flow mediated dilation|flow mediated dilation
1226669|NCT01911169|interferon gene signature|interferon gene signature
1226670|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
1226671|NCT01911130|outcomes measures|outcomes measures
1226672|NCT01911130|strength measurement|strength measurement
1226673|NCT01911130|disease progression|disease progression
1226674|NCT01911104|muscle|muscle
1226675|NCT01911104|mitochondrial function|mitochondrial function
1226676|NCT01911104|exercise resistance|exercise resistance
1226677|NCT01911104|human|human
1226678|NCT01911104|myotubes|myotubes
1226679|NCT01911104|epigenetics|epigenetics
1226680|NCT01911091|skeletal muscle|skeletal muscle
1226681|NCT01911091|adipose tissue|adipose tissue
1226682|NCT01911091|metabolism|metabolism
1226683|NCT01911091|oxidation|oxidation
1226684|NCT01911091|mitochondrial capacity|mitochondrial capacity
1226685|NCT01911078|Metabolic syndrome|metabolic syndrome
1226686|NCT01911078|Renal denervation|renal denervation
1226687|NCT01911078|Renal artery|renal artery
1226688|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
1226689|NCT01911065|Herpes zoster|herpes zoster
1226690|NCT01911065|immune response|immune response
1226691|NCT01911065|Zostavax|zostavax
1226692|NCT01911065|twins|twins
1226693|NCT01911065|non-twins|non-twins
1226694|NCT01911052|Bowel preparation|bowel preparation
1226695|NCT01911039|GVHD|gvhd
1226696|NCT01911039|cGVHD|cgvhd
1226697|NCT01911026|Bowel preparation|bowel preparation
1226698|NCT01911013|degenerative cervical disease|degenerative cervical disease
1226699|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
1226700|NCT01911013|plate and cage|plate and cage
1226701|NCT01911013|cage alone|cage alone
1226702|NCT01910987|Multiple Myeloma|multiple myeloma
1226703|NCT01910987|bortezomib|bortezomib
1226704|NCT01910987|Velcade|velcade
1226705|NCT01910987|First or Second Relapse|first or second relapse
1226706|NCT01910987|retreatment|retreatment
1226707|NCT01910987|Prolonged therapy|prolonged therapy
1226708|NCT01910974|oesophagus|oesophagus
1226709|NCT01910974|stomach|stomach
1226710|NCT01910974|intestine|intestine
1226711|NCT01910974|rectum|rectum
1226712|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
1226713|NCT01910935|Physical activity|physical activity
1226714|NCT01910935|Hypertension|hypertension
1226715|NCT01910935|Scheme reference|scheme reference
1226716|NCT01910935|Primary care|primary care
1226717|NCT01910922|vegetable acceptance|vegetable acceptance
1226718|NCT01910922|vegetable intake|vegetable intake
1226719|NCT01910922|vegetable liking|vegetable liking
1226720|NCT01910922|learning mechanisms|learning mechanisms
1226721|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
1226722|NCT01910922|flavor learning|flavor learning
1226723|NCT01910922|replace salt with spice|replace salt with spice
1226724|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
1226725|NCT01910909|unresectable|unresectable
1226726|NCT01910909|small size|small size
1226727|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
1226728|NCT01910883|Safety|safety
1226729|NCT01910883|Tolerability|tolerability
1226730|NCT01910883|Pharmacokinetic|pharmacokinetic
1226731|NCT01910870|Early-relapse|early-relapse
1226732|NCT01910844|triple negative breast cancer|triple negative breast cancer
1226733|NCT01910844|late-relapse|late-relapse
1226734|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
1226735|NCT01910818|radiation|radiation
1226736|NCT01910818|dermatitis|dermatitis
1226737|NCT01910818|laser|laser
1226738|NCT01910818|fractional|fractional
1226739|NCT01910818|CO2|co2
1226740|NCT01910818|chronic|chronic
1226741|NCT01910818|fibrosis|fibrosis
1226742|NCT01910818|scar|scar
1226743|NCT01910805|Gestational diabetes|gestational diabetes
1226744|NCT01910805|Diabetes mellitus|diabetes mellitus
1226745|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
1226746|NCT01910805|diabetes risk|diabetes risk
1226747|NCT01910805|diabetes risk awareness|diabetes risk awareness
1226748|NCT01910805|African-American|african-american
1226749|NCT01910805|Women|women
1226750|NCT01910779|Atrial Fibrillation|atrial fibrillation
1226751|NCT01910779|Cardioversion|cardioversion
1226752|NCT01910779|Biphasic Shock|biphasic shock
1226753|NCT01910766|pcos|pcos
1226754|NCT01910766|coenzymeQ10|coenzymeq10
1226755|NCT01910766|clomiphene citrate|clomiphene citrate
1226756|NCT01910753|Head and neck cancer,|head and neck cancer,
1226757|NCT01910753|physical activity,|physical activity,
1226758|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
1226759|NCT01910740|Randomized Controlled Trial|randomized controlled trial
1226760|NCT01910740|Exercise Movement Techniques|exercise movement techniques
1226761|NCT01910740|Frail Elderly|frail elderly
1226762|NCT01910740|Gait|gait
1226763|NCT01910727|American Indian|american indian
1226764|NCT01910727|Diabetes|diabetes
1226765|NCT01910727|Pre-diabetes|pre-diabetes
1226766|NCT01910727|Family health Coach|family health coach
1226767|NCT01910714|HIV/AIDS|hiv/aids
1226768|NCT01910714|Prevention|prevention
1226769|NCT01910714|American Indian|american indian
1226770|NCT01910714|Substance use|substance use
1226771|NCT01910714|CBPR|cbpr
1226772|NCT01910701|Home visiting interventions|home visiting interventions
1226773|NCT01910701|American Indian|american indian
1226774|NCT01910701|Community based participatory research|community based participatory research
1226775|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
1226776|NCT01910662|Suction Skin Blister|suction skin blister
1226777|NCT01910662|Induration|induration
1226778|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
1226779|NCT01910662|Erythema|erythema
1226780|NCT01910662|Biopsy|biopsy
1226781|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
1226782|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
1226783|NCT01910649|drisapersen|drisapersen
1226784|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1226785|NCT01910623|Quality of life|quality of life
1226786|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
1226787|NCT01910623|Long-term|long-term
1226788|NCT01910623|Aida 0493|aida 0493
1226789|NCT01910623|AIDA 2000|aida 2000
1226790|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
1226791|NCT01910584|quality of life|quality of life
1226792|NCT01910584|sexual activity|sexual activity
1226793|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
1226794|NCT01910584|menorrhagia|menorrhagia
1226795|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
1227878|NCT01905033|Pneumonia|pneumonia
1226796|NCT01910558|Dietary fiber|dietary fiber
1226797|NCT01910558|Fecal fat|fecal fat
1226798|NCT01910558|Saturated fat|saturated fat
1226799|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
1226800|NCT01910519|H5N1 influenza|h5n1 influenza
1226801|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
1226802|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
1226803|NCT01910519|systems biology|systems biology
1226804|NCT01910519|AS03 adjuvant|as03 adjuvant
1226805|NCT01910519|unadjuvanted|unadjuvanted
1226806|NCT01910493|mhealth|mhealth
1226807|NCT01910493|mobile health|mobile health
1226808|NCT01910493|SMS|sms
1226809|NCT01910493|SMS reminders|sms reminders
1226810|NCT01910493|ART retention in care|art retention in care
1226811|NCT01910493|PMTCT|pmtct
1226812|NCT01910493|PMTCT cascade|pmtct cascade
1226813|NCT01910493|retention in care|retention in care
1226814|NCT01910454|Stroke|stroke
1226815|NCT01910454|Occupational Therapy|occupational therapy
1226816|NCT01910454|Cognition|cognition
1226817|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
1226818|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
1226819|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
1226820|NCT01910402|women|women
1226821|NCT01910402|once daily|once daily
1226822|NCT01910402|HIV infection|hiv infection
1226823|NCT01910402|atazanavir|atazanavir
1226824|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
1226825|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
1226826|NCT01910402|integrase inhibitor|integrase inhibitor
1226827|NCT01910402|ritonavir|ritonavir
1226828|NCT01910389|Heart failure|heart failure
1226829|NCT01910389|Pulmonary hypertension|pulmonary hypertension
1226830|NCT01910389|tadalafil|tadalafil
1226831|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
1226832|NCT01910363|poststroke spasticity|poststroke spasticity
1226833|NCT01910363|lower limb|lower limb
1226834|NCT01910363|botulinum toxin|botulinum toxin
1226836|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
1226837|NCT01910337|ASA I patients|asa i patients
1226838|NCT01910324|Juvenile Offenders|juvenile offenders
1226839|NCT01910324|HIV/STD Prevention|hiv/std prevention
1226840|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
1226841|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
1226842|NCT01910298|Breast reconstruction|breast reconstruction
1226843|NCT01910298|Breast implant|breast implant
1226844|NCT01910298|Breast cancer|breast cancer
1226845|NCT01910298|Mastectomy|mastectomy
1226846|NCT01910285|Anesthetic induction|anesthetic induction
1226847|NCT01910285|Intubation conditions|intubation conditions
1226848|NCT01910285|Tooth extraction|tooth extraction
1226849|NCT01910285|Propofol|propofol
1226850|NCT01910285|Sufentanil|sufentanil
1226851|NCT01910285|Remifentanil|remifentanil
1226852|NCT01910272|Radiation attenuation|radiation attenuation
1226853|NCT01910272|Fluoroscopy|fluoroscopy
1226854|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
1226855|NCT01910272|Cardiac Catheterization|cardiac catheterization
1226856|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1226857|NCT01910259|Neuroprotective|neuroprotective
1226858|NCT01910259|Repurposed drugs|repurposed drugs
1226859|NCT01910259|Brain atrophy|brain atrophy
1226860|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
1226861|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
1226862|NCT01910259|Optical Coherence Tomography|optical coherence tomography
1226863|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
1226864|NCT01910259|Amiloride|amiloride
1226865|NCT01910259|Riluzole|riluzole
1226866|NCT01910259|Double blind|double blind
1226867|NCT01910259|Placebo|placebo
1226868|NCT01910259|Fluoxetine|fluoxetine
1226869|NCT01910246|Metformin|metformin
1226870|NCT01910246|Insulin Resistance|insulin resistance
1226871|NCT01910246|Cardiac Function|cardiac function
1226872|NCT01910233|dyspnea|dyspnea
1226873|NCT01910233|registry|registry
1226874|NCT01910233|baseline characteristics|baseline characteristics
1226875|NCT01910233|mortality|mortality
1226876|NCT01910233|risk assessment|risk assessment
1226877|NCT01910233|emergency department|emergency department
1226878|NCT01910142|bone metabolism|bone metabolism
1226879|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
1226880|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
1226881|NCT01910129|nVNS|nvns
1226882|NCT01910129|VNS|vns
1226883|NCT01910129|epilepsy|epilepsy
1226884|NCT01910129|non invasive|non invasive
1226885|NCT01910129|gammacore|gammacore
1226886|NCT01910116|osteoarthritis|osteoarthritis
1226887|NCT01910116|hand|hand
1226888|NCT01910116|Shinbaro|shinbaro
1226889|NCT01910116|GCSB-5|gcsb-5
1226890|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
1226891|NCT01910103|Mammography/methods|mammography/methods
1226892|NCT01910103|Mass Screening|mass screening
1226893|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
1226894|NCT01910103|Predictive Value of Tests|predictive value of tests
1226895|NCT01910103|False Positive Reactions|false positive reactions
1226896|NCT01910090|fasting condition|fasting condition
1226897|NCT01910077|tacrolimus|tacrolimus
1226898|NCT01910077|tacrobell capsule|tacrobell capsule
1226899|NCT01910077|prograf capsule|prograf capsule
1226900|NCT01910077|bioequivalence|bioequivalence
1226901|NCT01910064|Acne Vulgaris|acne vulgaris
1226902|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
1226903|NCT01910025|Arginine|arginine
1226904|NCT01910025|Arginine deiminase|arginine deiminase
1226905|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
1226906|NCT01910012|Arginine|arginine
1226907|NCT01910012|Arginine deiminase|arginine deiminase
1226908|NCT01909999|Dental Implants|dental implants
1226909|NCT01909999|Osseointegration|osseointegration
1226910|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
1226911|NCT01909999|Bone formation|bone formation
1226912|NCT01909986|ONO-4053|ono-4053
1226913|NCT01909986|Healthy adult male subjects|healthy adult male subjects
1226914|NCT01909986|pharmacokinetics|pharmacokinetics
1226915|NCT01909986|metabolism|metabolism
1226916|NCT01909986|excretion|excretion
1226917|NCT01909986|mass balance|mass balance
1226918|NCT01909973|Depression|depression
1226919|NCT01909973|Antidepressant Medication|antidepressant medication
1226920|NCT01909973|Adherence|adherence
1226921|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
1226922|NCT01909973|Telemedicine|telemedicine
1226923|NCT01909973|Primary Care|primary care
1226924|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
1226925|NCT01909960|Flow MRI|flow mri
1226926|NCT01909960|Dementia|dementia
1226927|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
1226928|NCT01909960|Shunt|shunt
1226929|NCT01909947|Respiratory rate variability|respiratory rate variability
1226930|NCT01909947|Heart rate variability|heart rate variability
1226931|NCT01909947|Extubation readiness|extubation readiness
1226932|NCT01909947|Extubation failure|extubation failure
1226933|NCT01909947|Clinical predictors|clinical predictors
1226934|NCT01909934|Lymphoma|lymphoma
1226935|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
1226936|NCT01909934|Relapsed|relapsed
1226937|NCT01909934|Refractory|refractory
1226938|NCT01909934|Antigens, CD30|antigens, cd30
1226939|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
1226940|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
1226941|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1226942|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1226943|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
1226944|NCT01909934|Drug Therapy|drug therapy
1226945|NCT01909934|Immunotherapy|immunotherapy
1226946|NCT01909934|Hematologic Diseases|hematologic diseases
1226947|NCT01909908|Wounds and injuries|wounds and injuries
1226948|NCT01909908|Ulcer|ulcer
1226949|NCT01909908|Diabetic angiopathies|diabetic angiopathies
1226950|NCT01909908|Diabetic foot|diabetic foot
1226951|NCT01909908|Venous insufficiency|venous insufficiency
1226952|NCT01909908|Extracellular matrix|extracellular matrix
1226953|NCT01909882|Family member's massage therapy|family member's massage therapy
1226954|NCT01909882|Vital signs|vital signs
1226955|NCT01909882|Glasgow coma scale|glasgow coma scale
1226956|NCT01909882|Intensive care unit|intensive care unit
1226957|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
1226958|NCT01909882|Iran|iran
1226959|NCT01909869|MACE|mace
1226960|NCT01909869|TVR|tvr
1226961|NCT01909869|MI|mi
1226962|NCT01909869|TLF|tlf
1226963|NCT01909869|Death|death
1226964|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
1226965|NCT01909830|pretreated|pretreated
1226966|NCT01909804|Hepatitis|hepatitis
1226967|NCT01909804|Genotype 1|genotype 1
1226968|NCT01909804|Genotype 3|genotype 3
1226969|NCT01909804|Treatment experienced|treatment experienced
1226970|NCT01909791|Diabetic Macular Edema|diabetic macular edema
1226971|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1226972|NCT01909765|Circumcision|circumcision
1226973|NCT01909765|postoperative pain|postoperative pain
1226974|NCT01909752|Lung cancer|lung cancer
1226975|NCT01909752|DRibble Vaccine|dribble vaccine
1226976|NCT01909752|Imiquimod|imiquimod
1226977|NCT01909752|GM-CSF|gm-csf
1226978|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
1226979|NCT01909752|Cyclophosphamide|cyclophosphamide
1226980|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
1226981|NCT01909726|Hospital Design|hospital design
1226982|NCT01909726|Technology|technology
1226983|NCT01909726|Anxiety|anxiety
1226984|NCT01909713|acne, pediatric|acne, pediatric
1226985|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
1226986|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
1226987|NCT01909687|ISO 15197|iso 15197
1226988|NCT01909687|system accuracy|system accuracy
1226989|NCT01909661|allergy|allergy
1226990|NCT01909661|Cow's milk protein|cow's milk protein
1226991|NCT01909661|Tolerance|tolerance
1226992|NCT01909661|Efficacy|efficacy
1226993|NCT01909661|Infants' growth|infants' growth
1226994|NCT01909622|Vitamin D|vitamin d
1226995|NCT01909622|Milk fortification|milk fortification
1226996|NCT01909622|Children|children
1226997|NCT01909622|Colombia|colombia
1226998|NCT01909609|male|male
1226999|NCT01909583|congenital|congenital
1227000|NCT01909583|surgery|surgery
1227001|NCT01909583|peri-operative|peri-operative
1227002|NCT01909583|counselling|counselling
1227003|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
1227004|NCT01909557|Interferons|interferons
1227005|NCT01909557|Ribavirin|ribavirin
1227006|NCT01909557|Hepatitis C|hepatitis c
1227007|NCT01909557|Fatigue|fatigue
1227008|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1227009|NCT01909544|Muscle fatigue|muscle fatigue
1227010|NCT01909544|Energy metabolism|energy metabolism
1227011|NCT01909544|Muscle oxygenation|muscle oxygenation
1227012|NCT01909531|Deep Brain Stimulation|deep brain stimulation
1227013|NCT01909531|Parkinsons Disease|parkinsons disease
1227014|NCT01909531|Essential Tremor|essential tremor
1227015|NCT01909531|Asleep DBS|asleep dbs
1227016|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
1227017|NCT01909518|surface maturation scoring|surface maturation scoring
1227018|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
1227019|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
1227020|NCT01909492|Multiple Sclerosis|multiple sclerosis
1227021|NCT01909492|MS|ms
1227022|NCT01909492|Relaxin|relaxin
1227023|NCT01909466|OPC-14597|opc-14597
1227024|NCT01909466|Aripiprazole|aripiprazole
1227025|NCT01909466|Schizophrenia|schizophrenia
1227026|NCT01909453|Melanoma|melanoma
1227027|NCT01909453|Cutaneous melanoma|cutaneous melanoma
1227028|NCT01909453|Skin disease|skin disease
1227029|NCT01909453|Skin cancer|skin cancer
1227030|NCT01909453|Skin Neoplasms|skin neoplasms
1227031|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
1227032|NCT01909453|BRAF mutant|braf mutant
1227033|NCT01909453|BRAF V600E|braf v600e
1227034|NCT01909453|BRAF V600K|braf v600k
1227035|NCT01909453|Cancer|cancer
1227036|NCT01909453|LGX818|lgx818
1227037|NCT01909453|MEK162|mek162
1227038|NCT01909453|vemurafenib|vemurafenib
1227039|NCT01909453|combination|combination
1227040|NCT01909453|BRAF inhibitor|braf inhibitor
1227041|NCT01909453|resistance|resistance
1227042|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
1227043|NCT01909453|Prior immunotherapy|prior immunotherapy
1227044|NCT01909453|MEK inhibitor|mek inhibitor
1227045|NCT01909453|Phase III|phase iii
1227046|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
1333155|NCT01444326|Cardiovascular disease|cardiovascular disease
1333156|NCT01444326|Dairy|dairy
1227047|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
1227048|NCT01909427|CNTO 6785|cnto 6785
1227049|NCT01909427|Methotrexate|methotrexate
1227050|NCT01909401|Liver Transplantation|liver transplantation
1227051|NCT01909388|Cancer|cancer
1227052|NCT01909388|Prostate Cancer|prostate cancer
1227053|NCT01909388|Brachytherapy|brachytherapy
1227054|NCT01909388|Dose escalation|dose escalation
1227055|NCT01909388|High Dose Rate|high dose rate
1227056|NCT01909388|MRI-TRUS fusion|mri-trus fusion
1227057|NCT01909388|Detection of DILs by MRI|detection of dils by mri
1227058|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
1227059|NCT01909362|mCRC|mcrc
1227060|NCT01909362|Colorectal Cancer|colorectal cancer
1227061|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
1227062|NCT01909362|Colorectal Tumors|colorectal tumors
1227063|NCT01909362|Genetic mutation testing|genetic mutation testing
1227064|NCT01909362|Tumor tissue sampling|tumor tissue sampling
1227065|NCT01909349|medical rehabilitation|medical rehabilitation
1227066|NCT01909349|aftercare|aftercare
1227067|NCT01909349|multiple health behavior change|multiple health behavior change
1227068|NCT01909349|diet|diet
1227069|NCT01909349|physical activity|physical activity
1227070|NCT01909349|computer|computer
1227071|NCT01909349|international study|international study
1227072|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
1227073|NCT01909349|HABIT|habit
1227074|NCT01909349|HEALTH|health
1227075|NCT01909349|eHealth|ehealth
1227076|NCT01909349|eLearning|elearning
1227077|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
1227078|NCT01909297|airway management|airway management
1227079|NCT01909271|Stroke|stroke
1227080|NCT01909271|Community Health Education|community health education
1227081|NCT01909271|Minority Health|minority health
1227082|NCT01909271|healthcare disparities|healthcare disparities
1227083|NCT01909245|Islet cells|islet cells
1227084|NCT01909245|hypoglycemia|hypoglycemia
1227085|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
1227086|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
1227087|NCT01909245|islet transplant|islet transplant
1227088|NCT01909245|insulin independence|insulin independence
1227089|NCT01909245|insulin dependence|insulin dependence
1227090|NCT01909232|Depression|depression
1227091|NCT01909232|Depressive Disorder|depressive disorder
1227092|NCT01909232|Major depression|major depression
1227093|NCT01909232|Major depressive disorder|major depressive disorder
1227094|NCT01909232|MDD|mdd
1227095|NCT01909232|Treatment resistant depression|treatment resistant depression
1227096|NCT01909232|Treatment intolerant depression|treatment intolerant depression
1227098|NCT01909232|TIMD|timd
1227099|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1227100|NCT01909232|TMS|tms
1227101|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
1227102|NCT01909167|Pregnancy|pregnancy
1227103|NCT01909167|symptoms of depression|symptoms of depression
1227104|NCT01909167|anxiety|anxiety
1227105|NCT01909167|online CBT therapy|online cbt therapy
1227106|NCT01909167|treatment as usual|treatment as usual
1227107|NCT01909167|maternal bonding|maternal bonding
1227108|NCT01909167|postnatal period|postnatal period
1227109|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
1227110|NCT01909154|spinal cord injury|spinal cord injury
1227111|NCT01909154|biology therapy|biology therapy
1227112|NCT01909141|letrozole|letrozole
1227113|NCT01909141|clomiphene citrate|clomiphene citrate
1227114|NCT01909141|pioglitazone|pioglitazone
1227115|NCT01909141|metformin|metformin
1227116|NCT01909141|ovulation induction|ovulation induction
1227117|NCT01909141|PCOS|pcos
1227118|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
1227119|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
1227120|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
1227121|NCT01909050|celiac disease|celiac disease
1227122|NCT01909050|refractory celiac disease|refractory celiac disease
1227123|NCT01909050|gluten sensitivity|gluten sensitivity
1227124|NCT01909037|osteoarthritis|osteoarthritis
1227125|NCT01909037|curcumin|curcumin
1227126|NCT01909037|biomarker|biomarker
1227127|NCT01909037|pain|pain
1227128|NCT01909024|Randomised controlled trial|randomised controlled trial
1227129|NCT01909024|Endovenous laser treatment|endovenous laser treatment
1227130|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
1227131|NCT01908998|Y-Balance test|y-balance test
1227132|NCT01908985|glaucoma|glaucoma
1227133|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
1227134|NCT01908985|aqueous humor|aqueous humor
1227135|NCT01908985|fluorophotometry|fluorophotometry
1227136|NCT01908972|Hemangioma|hemangioma
1227137|NCT01908972|Propranolol|propranolol
1227138|NCT01908972|prednisolone|prednisolone
1227139|NCT01908972|steroid|steroid
1227140|NCT01908959|Hispanic Women|hispanic women
1227141|NCT01908959|Postpartum|postpartum
1227142|NCT01908959|Overweight Hispanic Women|overweight hispanic women
1227143|NCT01908959|Low-income|low-income
1227144|NCT01908959|Physical Activity|physical activity
1227145|NCT01908959|Walking|walking
1227146|NCT01908946|Polio|polio
1227147|NCT01908933|Advanced Emphysema|advanced emphysema
1227148|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
1227149|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
1227150|NCT01908907|Premature Infants|premature infants
1227151|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
1227152|NCT01908907|DHA deficit|dha deficit
1227153|NCT01908881|Child Development|child development
1227154|NCT01908881|Mother-Child relations|mother-child relations
1227155|NCT01908881|Primary Health Care|primary health care
1227156|NCT01908881|Public Policy|public policy
1227157|NCT01908855|somatoform symptoms|somatoform symptoms
1227158|NCT01908855|somatic symptoms|somatic symptoms
1227159|NCT01908855|somatoform disorder|somatoform disorder
1227160|NCT01908855|somatic symptom disorder|somatic symptom disorder
1227161|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
1227162|NCT01908855|emotion regulation training|emotion regulation training
1227163|NCT01908842|Opioid|opioid
1227164|NCT01908842|Dependence|dependence
1227165|NCT01908842|agonist|agonist
1227166|NCT01908842|buprenorphine|buprenorphine
1227167|NCT01908842|naloxone|naloxone
1227168|NCT01908842|BUP/NAL|bup/nal
1227169|NCT01908829|Vesitrim|vesitrim
1227170|NCT01908829|Betanis|betanis
1227171|NCT01908829|Urgency|urgency
1227172|NCT01908829|Frequency|frequency
1227173|NCT01908829|Mirabegron|mirabegron
1227174|NCT01908829|YM178|ym178
1227175|NCT01908829|Betmiga|betmiga
1227176|NCT01908829|Vesicare|vesicare
1227177|NCT01908829|Micturition|micturition
1227178|NCT01908829|YM905|ym905
1227179|NCT01908829|Solifenacin|solifenacin
1227180|NCT01908829|Urinary incontinence|urinary incontinence
1227181|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
1227182|NCT01908829|Myrbetriq|myrbetriq
1227183|NCT01908829|Vesikur|vesikur
1227184|NCT01908829|Urgency incontinence|urgency incontinence
1227185|NCT01908803|AOMT|aomt
1227186|NCT01908803|tympanostomy tubes|tympanostomy tubes
1227187|NCT01908803|Otorrhea|otorrhea
1227188|NCT01908803|anti-infective|anti-infective
1227189|NCT01908790|venous oximeter|venous oximeter
1227190|NCT01908790|non-invasive monitor|non-invasive monitor
1227191|NCT01908790|heart failure (HF)|heart failure (hf)
1227192|NCT01908764|ear tubes|ear tubes
1227193|NCT01908764|tympanostomy tubes|tympanostomy tubes
1227194|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
1227195|NCT01908764|OMTT|omtt
1227196|NCT01908738|Endometrial biopsy|endometrial biopsy
1227197|NCT01908738|paracervical block|paracervical block
1227198|NCT01908738|Lidocaine spray|lidocaine spray
1227199|NCT01908738|women|women
1227200|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
1227202|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
1227203|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
1227204|NCT01908660|HIV|hiv
1227205|NCT01908660|hepatitis C virus|hepatitis c virus
1227206|NCT01908660|hepatitis B virus|hepatitis b virus
1227207|NCT01908660|antiretroviral drugs|antiretroviral drugs
1227208|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
1227209|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
1227210|NCT01908660|protease inhibitors|protease inhibitors
1227211|NCT01908660|integrase inhibitors|integrase inhibitors
1227212|NCT01908660|entry inhibitors|entry inhibitors
1227213|NCT01908660|transaminase elevations|transaminase elevations
1227214|NCT01908660|alanine aminotransferase|alanine aminotransferase
1227215|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
1227216|NCT01908660|bilirubin elevations|bilirubin elevations
1227217|NCT01908660|hepatic fibrosis|hepatic fibrosis
1227218|NCT01908647|mTBI|mtbi
1227219|NCT01908647|PTSD|ptsd
1227220|NCT01908634|Bioavailability|bioavailability
1227221|NCT01908634|Strawberry polyphenols|strawberry polyphenols
1227222|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
1227223|NCT01908621|multiple myeloma|multiple myeloma
1227224|NCT01908621|mobilization|mobilization
1227225|NCT01908621|G-CSF|g-csf
1227226|NCT01908621|filgrastim|filgrastim
1227227|NCT01908621|cytosine arabinoside|cytosine arabinoside
1227228|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
1227229|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
1227230|NCT01908543|Iron deficiency|iron deficiency
1227231|NCT01908543|Nosebleeds|nosebleeds
1227232|NCT01908530|Diabetes,Continuous Glucose Monitoring,Microprobes|diabetes,continuous glucose monitoring,microprobes
1227233|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
1227234|NCT01908517|Electronic Reminders|electronic reminders
1227235|NCT01908491|patient controlled analgesia|patient controlled analgesia
1227236|NCT01908491|wound catheter infusion|wound catheter infusion
1227237|NCT01908491|postoperative pain control|postoperative pain control
1227238|NCT01908491|pectus excavatum|pectus excavatum
1227239|NCT01908491|pain score|pain score
1227240|NCT01908478|locally advanced|locally advanced
1227241|NCT01908478|unresectable|unresectable
1227242|NCT01908478|pancreatic|pancreatic
1227243|NCT01908478|pancreas|pancreas
1227244|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1227245|NCT01908452|Schizophrenia|schizophrenia
1227246|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
1227247|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
1227248|NCT01908439|muscle electrical activity|muscle electrical activity
1227249|NCT01908439|whole-body vibration|whole-body vibration
1227250|NCT01908439|latency|latency
1227251|NCT01908426|cabozantinib|cabozantinib
1227252|NCT01908426|XL184|xl184
1227253|NCT01908426|liver cancer|liver cancer
1227254|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
1227255|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1227257|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
1227258|NCT01908413|Advanced Solid Tumors|advanced solid tumors
1227259|NCT01908413|Lymphoma|lymphoma
1227260|NCT01908413|Open-Label|open-label
1227261|NCT01908413|Dose-Escalation|dose-escalation
1227262|NCT01908413|IAP|iap
1227263|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
1227264|NCT01908387|Oral azacitidine|oral azacitidine
1227265|NCT01908387|CC-486|cc-486
1227266|NCT01908387|Hematological neoplasms|hematological neoplasms
1227267|NCT01908387|Phase 1|phase 1
1227268|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
1227269|NCT01908361|comparative efficacy research|comparative efficacy research
1227270|NCT01908361|combination therapy|combination therapy
1227271|NCT01908361|neurorehabilitation|neurorehabilitation
1227272|NCT01908361|robotic rehabilitation|robotic rehabilitation
1227273|NCT01908361|restraint therapy|restraint therapy
1227274|NCT01908348|Erythritol|erythritol
1227275|NCT01908348|Endothelial function|endothelial function
1227276|NCT01908335|interferon|interferon
1227277|NCT01908335|ribavirin|ribavirin
1227278|NCT01908335|virological response|virological response
1227279|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
1227280|NCT01908322|Intermediate stage|intermediate stage
1227281|NCT01908322|Observational study|observational study
1227282|NCT01908309|acute kidney injury|acute kidney injury
1227283|NCT01908309|contrast media|contrast media
1227284|NCT01908309|cystatin-C|cystatin-c
1227285|NCT01908296|FK949E|fk949e
1227286|NCT01908296|fluvoxamine|fluvoxamine
1227287|NCT01908296|Antipsychotic|antipsychotic
1227288|NCT01908296|Quetiapine|quetiapine
1227289|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
1227290|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
1227291|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
1227292|NCT01908205|Autism|autism
1227293|NCT01908205|Social|social
1227294|NCT01908205|Functioning|functioning
1227295|NCT01908205|Cognition|cognition
1227296|NCT01908205|Repetitive Behaviors|repetitive behaviors
1227297|NCT01908205|Anxiety|anxiety
1227298|NCT01908205|Quality of Life|quality of life
1227299|NCT01908192|Sodium Benzoate|sodium benzoate
1227300|NCT01908192|Schizophrenia|schizophrenia
1227301|NCT01908192|Adolescent|adolescent
1227302|NCT01908192|Antipsychotic|antipsychotic
1227303|NCT01908192|Anti-psychotic|anti-psychotic
1227304|NCT01908192|NMDA|nmda
1227305|NCT01908192|NaBen|naben
1227306|NCT01908192|pediatric|pediatric
1227307|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
1227308|NCT01908153|Picture food type|picture food type
1227309|NCT01908153|Taste type|taste type
1227310|NCT01908127|film modelling|film modelling
1227311|NCT01908127|dental anxiety|dental anxiety
1227312|NCT01908127|cooperative behaviour|cooperative behaviour
1227313|NCT01908127|children|children
1227314|NCT01908114|Polio disease|polio disease
1227315|NCT01908114|Intervention Package|intervention package
1227316|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
1227317|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
1227318|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
1227319|NCT01908088|amniotic membrane|amniotic membrane
1227320|NCT01908075|Primary care|primary care
1227321|NCT01908075|Asthma management|asthma management
1227322|NCT01908075|Real-world|real-world
1227323|NCT01908075|Observational|observational
1227324|NCT01908075|Fostair|fostair
1227325|NCT01908075|Seretide|seretide
1227326|NCT01908062|Substance related disorders|substance related disorders
1227327|NCT01908062|HIV|hiv
1227328|NCT01908062|naltrexone|naltrexone
1227329|NCT01908049|Probiotic|probiotic
1227330|NCT01908049|HIV|hiv
1310832|NCT01537432|IGA|iga
1227331|NCT01908049|Microbial translocation|microbial translocation
1227332|NCT01908049|inflammation|inflammation
1227333|NCT01908049|microbiota composition|microbiota composition
1227334|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
1227335|NCT01908036|CFS|cfs
1227336|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
1227337|NCT01908036|M.E.|m.e.
1227338|NCT01908036|activity monitor|activity monitor
1227339|NCT01908023|exercise therapy|exercise therapy
1227340|NCT01908023|oxygen consumption|oxygen consumption
1227341|NCT01908010|Alzheimer's disease|alzheimer's disease
1227342|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
1227343|NCT01907984|premedication|premedication
1227344|NCT01907984|diclofenac|diclofenac
1227345|NCT01907984|postoperative headache|postoperative headache
1227346|NCT01907984|Visual Analog Scale|visual analog scale
1227347|NCT01907958|Microalbuminuria|microalbuminuria
1227348|NCT01907958|Hypertensive|hypertensive
1227349|NCT01907958|Diabetics|diabetics
1227350|NCT01907958|urine albumin|urine albumin
1227351|NCT01907945|Household water treatment|household water treatment
1227352|NCT01907945|Waterborne illness|waterborne illness
1227353|NCT01907945|ceramic filters|ceramic filters
1227354|NCT01907945|social network|social network
1227355|NCT01907932|splenomegaly|splenomegaly
1227356|NCT01907932|ultrasound|ultrasound
1227357|NCT01907932|VScan|vscan
1227358|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
1227359|NCT01907906|Pathogen reduction technology|pathogen reduction technology
1227360|NCT01907880|breast|breast
1227361|NCT01907880|bone|bone
1227362|NCT01907880|pain|pain
1227363|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
1227364|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
1227365|NCT01907789|Ovary|ovary
1227366|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
1227367|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
1227368|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
1227369|NCT01907789|Ovarian cancer screening|ovarian cancer screening
1227370|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
1227371|NCT01907789|RRSO|rrso
1227372|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
1227373|NCT01907789|PSDO|psdo
1227374|NCT01907789|Questionnaire|questionnaire
1227375|NCT01907789|Quality of life|quality of life
1227376|NCT01907789|QOL|qol
1227377|NCT01907789|Survey|survey
1227378|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
1227379|NCT01907789|Phone call|phone call
1227380|NCT01907763|asthma|asthma
1227381|NCT01907763|SOTB07|sotb07
1227382|NCT01907750|biliary fistula|biliary fistula
1227383|NCT01907750|biliary stricture|biliary stricture
1227384|NCT01907750|biliary drainage tube|biliary drainage tube
1227385|NCT01907724|Chronic hepatitis C|chronic hepatitis c
1227386|NCT01907724|Hepatitis C virus|hepatitis c virus
1227388|NCT01907711|Acupuncture.|acupuncture.
1227389|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
1227390|NCT01907711|Sleep disturbances.|sleep disturbances.
1227391|NCT01907711|Pain.|pain.
1227392|NCT01907711|Cognitive impairment.|cognitive impairment.
1227393|NCT01907698|vaginal intercourse|vaginal intercourse
1227394|NCT01907698|labour|labour
1227395|NCT01907698|term pregnancy|term pregnancy
1227396|NCT01907672|Malaria|malaria
1227397|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
1227398|NCT01907672|Chemical Shops|chemical shops
1227399|NCT01907672|Drug Shops|drug shops
1227400|NCT01907672|Diagnostics|diagnostics
1227401|NCT01907672|Testing for Malaria|testing for malaria
1227402|NCT01907659|Respiratory|respiratory
1227403|NCT01907659|Viruses|viruses
1227404|NCT01907659|Bacterial|bacterial
1227405|NCT01907659|Antibiotics|antibiotics
1227406|NCT01907659|Procalcitonin|procalcitonin
1227504|NCT01907061|acute renal failure|acute renal failure
1227407|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
1227408|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
1227409|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
1227410|NCT01907633|Domperidone|domperidone
1227411|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
1227412|NCT01907633|Metoclopramide|metoclopramide
1227413|NCT01907633|Observational Study|observational study
1227414|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
1227415|NCT01907607|PD-0332991|pd-0332991
1227416|NCT01907607|Orally|orally
1227417|NCT01907607|Efficacy and safety|efficacy and safety
1227418|NCT01907607|Adult patients|adult patients
1227419|NCT01907607|Refractory|refractory
1227420|NCT01907607|Imatinib|imatinib
1227421|NCT01907607|Sunitinib|sunitinib
1227422|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
1227423|NCT01907464|Anorexia nervosa|anorexia nervosa
1227424|NCT01907464|Bone mineral density|bone mineral density
1227425|NCT01907464|Teenagers or young women|teenagers or young women
1227426|NCT01907464|Bone remodelling markers|bone remodelling markers
1227427|NCT01907438|BRCA|brca
1227428|NCT01907438|estrogen|estrogen
1227429|NCT01907438|epithelial breast cells|epithelial breast cells
1227430|NCT01907438|genome profile|genome profile
1227431|NCT01907412|First time parents|first time parents
1227432|NCT01907412|Coparenting|coparenting
1227433|NCT01907412|Family Foundations|family foundations
1227434|NCT01907399|obese patients|obese patients
1227435|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
1227436|NCT01907399|healthy volunteers|healthy volunteers
1227437|NCT01907386|Endoleaks|endoleaks
1227438|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
1227439|NCT01907373|olmesartan|olmesartan
1227440|NCT01907373|probenecid|probenecid
1227441|NCT01907373|pharmacokinetics|pharmacokinetics
1227442|NCT01907373|tolerability|tolerability
1227443|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
1227444|NCT01907347|body composition|body composition
1227445|NCT01907347|phase angle|phase angle
1227446|NCT01907347|mortality|mortality
1227447|NCT01907347|nosocomial infection|nosocomial infection
1227448|NCT01907347|bioimpedance analysis|bioimpedance analysis
1227449|NCT01907347|nutrition|nutrition
1227450|NCT01907334|oscillometry|oscillometry
1227451|NCT01907334|asthma|asthma
1227452|NCT01907334|methacholine|methacholine
1227453|NCT01907321|stroke|stroke
1227454|NCT01907321|dysphagia|dysphagia
1227455|NCT01907321|dystussia|dystussia
1227456|NCT01907321|cough|cough
1227457|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
1227458|NCT01907308|Bladder cancer|bladder cancer
1227459|NCT01907308|Urothelial cancer|urothelial cancer
1227460|NCT01907308|Urothelial carcinoma|urothelial carcinoma
1227461|NCT01907295|idiopathic|idiopathic
1227462|NCT01907295|heritable|heritable
1227463|NCT01907295|anorexigen|anorexigen
1227464|NCT01907282|Schizophrenia|schizophrenia
1227465|NCT01907282|psychosis|psychosis
1227466|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
1227467|NCT01907230|Inactive HBV carrier|inactive hbv carrier
1227468|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
1227469|NCT01907230|HBV reactivation|hbv reactivation
1227470|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
1227471|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
1227472|NCT01907217|ECT|ect
1227473|NCT01907217|electrode placement|electrode placement
1227474|NCT01907217|effectiveness|effectiveness
1227475|NCT01907217|cognition|cognition
1227476|NCT01907217|autobiographical memory|autobiographical memory
1227477|NCT01907191|Hip Arthroscopy|hip arthroscopy
1227478|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
1227479|NCT01907191|Bupivacaine|bupivacaine
1227480|NCT01907178|total knee arthroplasty|total knee arthroplasty
1227481|NCT01907152|malnutrition|malnutrition
1227482|NCT01907152|undernourishment|undernourishment
1227483|NCT01907152|loss of muscle mass|loss of muscle mass
1227484|NCT01907139|comparative efficacy research|comparative efficacy research
1227485|NCT01907139|combination therapy|combination therapy
1227486|NCT01907139|neurorehabilitation|neurorehabilitation
1227487|NCT01907139|robot-assisted therapy|robot-assisted therapy
1227488|NCT01907139|constraint-induced therapy|constraint-induced therapy
1227489|NCT01907126|HIV|hiv
1227490|NCT01907126|Sexually transmitted infections|sexually transmitted infections
1227491|NCT01907126|Sexual abuse|sexual abuse
1227492|NCT01907126|Physical abuse|physical abuse
1227493|NCT01907126|Women|women
1227494|NCT01907126|Prison|prison
1227495|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
1227496|NCT01907087|LINCL|lincl
1227497|NCT01907087|NCL2|ncl2
1227498|NCT01907087|CLN2|cln2
1227499|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
1227500|NCT01907074|liver function tests|liver function tests
1227501|NCT01907074|end stage liver disease|end stage liver disease
1227502|NCT01907074|cirrhosis|cirrhosis
1227503|NCT01907074|living liver donor|living liver donor
1227505|NCT01907061|post liver transplant|post liver transplant
1227506|NCT01907048|Survey|survey
1227507|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
1227508|NCT01907048|Rivaroxaban|rivaroxaban
1227509|NCT01907048|Anticoagulants|anticoagulants
1227510|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1227511|NCT01907022|chronic tinnitus|chronic tinnitus
1227512|NCT01907022|relaxation|relaxation
1227513|NCT01906944|trigger point injection|trigger point injection
1227514|NCT01906944|transversus abdominis plane|transversus abdominis plane
1227515|NCT01906944|abdominal wall pain|abdominal wall pain
1227516|NCT01906931|Interstitial lung disease|interstitial lung disease
1227517|NCT01906931|Oxygen therapy|oxygen therapy
1227518|NCT01906931|Walk|walk
1227519|NCT01906918|ischemia|ischemia
1227520|NCT01906918|reperfusion|reperfusion
1227521|NCT01906918|myocardial ischemia|myocardial ischemia
1227522|NCT01906918|myocardial reperfusion|myocardial reperfusion
1227523|NCT01906866|Sleep disturbance|sleep disturbance
1227524|NCT01906866|Circadian|circadian
1227525|NCT01906866|Prolong release melatonin|prolong release melatonin
1227526|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
1227527|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
1227528|NCT01906866|Angelman Syndrome|angelman syndrome
1227529|NCT01906866|tuberous sclerosis|tuberous sclerosis
1227530|NCT01906853|BCG|bcg
1227531|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
1227532|NCT01906853|Allergy|allergy
1227533|NCT01906853|Immunity|immunity
1227534|NCT01906853|Immune response|immune response
1227535|NCT01906853|Vaccine|vaccine
1227536|NCT01906853|Infants|infants
1227537|NCT01906853|Children|children
1227538|NCT01906853|Infection|infection
1227539|NCT01906840|Chronic renal failure|chronic renal failure
1227540|NCT01906840|Hemodialysis|hemodialysis
1227541|NCT01906840|Oxidative stress|oxidative stress
1227542|NCT01906840|Turmeric|turmeric
1227543|NCT01906827|cholestasis|cholestasis
1227544|NCT01906827|pregnancy|pregnancy
1227545|NCT01906827|p wave dispersion|p wave dispersion
1227546|NCT01906827|arrhythmia|arrhythmia
1227547|NCT01906801|Osteoarthritis|osteoarthritis
1227548|NCT01906801|Glucosamine sulfate|glucosamine sulfate
1227549|NCT01906801|Diacerein|diacerein
1227550|NCT01906801|Randomized controlled trial|randomized controlled trial
1227551|NCT01906775|ICD|icd
1227552|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
1227553|NCT01906775|shock|shock
1227554|NCT01906775|sub-threshold pacing|sub-threshold pacing
1227555|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
1227556|NCT01906749|Acute coronary syndrome|acute coronary syndrome
1227557|NCT01906749|Colchicine|colchicine
1227558|NCT01906710|Adverse Drug Events|adverse drug events
1227559|NCT01906710|Drug related problems|drug related problems
1227560|NCT01906710|Medication Reconciliation|medication reconciliation
1227561|NCT01906710|Medication review|medication review
1227562|NCT01906710|discharge counseling|discharge counseling
1227563|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
1227564|NCT01906710|integrated medicines management|integrated medicines management
1227565|NCT01906710|patient safety|patient safety
1227566|NCT01906684|Acthar Gel|acthar gel
1227567|NCT01906684|MS relapse|ms relapse
1227568|NCT01906684|7T MRI imaging|7t mri imaging
1227569|NCT01906684|Quality of Life|quality of life
1227570|NCT01906671|6-mercaptopurine|6-mercaptopurine
1227571|NCT01906671|Drug formulation|drug formulation
1227572|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
1227573|NCT01906658|Acthar|acthar
1227574|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1227575|NCT01906658|ALS|als
1227576|NCT01906645|Patient Readmission|patient readmission
1227577|NCT01906645|Continuity of Patient Care|continuity of patient care
1227578|NCT01906619|Febrile Seizure|febrile seizure
1227579|NCT01906619|Respiratory physiology|respiratory physiology
1227580|NCT01906619|Respiratory drive|respiratory drive
1227581|NCT01906619|Respiratory alkalosis|respiratory alkalosis
1227582|NCT01906606|child nutritional status|child nutritional status
1227583|NCT01906606|child development|child development
1227584|NCT01906606|maternal depression|maternal depression
1227585|NCT01906593|safety|safety
1227586|NCT01906593|influenza vaccine|influenza vaccine
1227587|NCT01906593|post-marketing|post-marketing
1227588|NCT01906580|HBV|hbv
1227589|NCT01906580|entecavir|entecavir
1227590|NCT01906580|peginterferon|peginterferon
1227591|NCT01906567|cadmium|cadmium
1227592|NCT01906567|lead|lead
1227593|NCT01906567|mercury|mercury
1227594|NCT01906567|preeclampsia|preeclampsia
1227595|NCT01906567|pregnancy|pregnancy
1227596|NCT01906541|X-CGD|x-cgd
1227597|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
1227598|NCT01906541|gene-therapy|gene-therapy
1227599|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
1227600|NCT01906528|Mivacurium|mivacurium
1227601|NCT01906528|Sensitivity|sensitivity
1227602|NCT01906528|Sex|sex
1227603|NCT01906515|Anemia|anemia
1227604|NCT01906515|Blood transfusion|blood transfusion
1227707|NCT01906008|Minocin PAC|minocin pac
1227605|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
1227606|NCT01906515|patient safety|patient safety
1227607|NCT01906489|anemia|anemia
1227608|NCT01906489|chronic kidney disease|chronic kidney disease
1227609|NCT01906489|CKD|ckd
1227610|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
1227611|NCT01906489|renal impairment|renal impairment
1227612|NCT01906489|erythropoietin|erythropoietin
1227613|NCT01906489|kidney|kidney
1227614|NCT01906489|oral anemia treatment|oral anemia treatment
1227615|NCT01906489|hemoglobin|hemoglobin
1227616|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
1227617|NCT01906489|HIF|hif
1227618|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
1227619|NCT01906489|HIF-PHI|hif-phi
1227620|NCT01906489|efficacy|efficacy
1227621|NCT01906489|safety|safety
1227622|NCT01906489|pharmacokinetics|pharmacokinetics
1227623|NCT01906476|Depression|depression
1227624|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
1227625|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
1227626|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
1227627|NCT01906424|spinal cord injury|spinal cord injury
1227628|NCT01906424|quadriplegia|quadriplegia
1227629|NCT01906424|tetraplegia|tetraplegia
1227630|NCT01906424|stimulation|stimulation
1227631|NCT01906398|Refractory epilepsy|refractory epilepsy
1227632|NCT01906398|ketogenic diet|ketogenic diet
1227633|NCT01906398|efficacy|efficacy
1227634|NCT01906385|Glioblastoma|glioblastoma
1227635|NCT01906385|Astrocytoma|astrocytoma
1227636|NCT01906385|Brain Tumor|brain tumor
1227637|NCT01906385|Radiotherapy|radiotherapy
1227638|NCT01906372|dermatomyositis|dermatomyositis
1227639|NCT01906372|polymyositis|polymyositis
1227640|NCT01906359|Interesterified fat|interesterified fat
1227641|NCT01906359|Stereospecific number 2|stereospecific number 2
1227642|NCT01906359|Gut hormones|gut hormones
1227644|NCT01906359|Insulin sensitivity|insulin sensitivity
1227645|NCT01906359|Postprandial lipaemia|postprandial lipaemia
1227646|NCT01906359|Haemostatic markers|haemostatic markers
1227647|NCT01906333|Exercise|exercise
1227648|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
1227649|NCT01906320|anorexia nervosa|anorexia nervosa
1227650|NCT01906320|restricting type|restricting type
1227651|NCT01906320|muscle strength|muscle strength
1227652|NCT01906320|exercise|exercise
1227653|NCT01906320|body composition|body composition
1227654|NCT01906320|physical activity|physical activity
1227655|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
1227656|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1227657|NCT01906281|adipocytokines|adipocytokines
1227658|NCT01906281|osteoarthritis|osteoarthritis
1227659|NCT01906281|cardiovascular risk|cardiovascular risk
1227660|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
1227661|NCT01906268|Social Anxiety Disorder|social anxiety disorder
1227662|NCT01906268|Panic Disorder|panic disorder
1227663|NCT01906268|Antidepressants Resistant|antidepressants resistant
1227664|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
1227665|NCT01906268|Attentional Retraining|attentional retraining
1227666|NCT01906268|Adjuvant Therapy|adjuvant therapy
1227667|NCT01906255|HIV-1|hiv-1
1227668|NCT01906255|Truvada|truvada
1227669|NCT01906255|FTC/TDF|ftc/tdf
1227670|NCT01906255|Pre-exposure prophylaxy|pre-exposure prophylaxy
1227671|NCT01906255|PrEP|prep
1227672|NCT01906255|Adherence|adherence
1227673|NCT01906255|Resistance|resistance
1227674|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
1227675|NCT01906216|sorafenib|sorafenib
1227676|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
1227677|NCT01906203|Ultramarathon|ultramarathon
1227678|NCT01906203|bioelectrical impedance|bioelectrical impedance
1227679|NCT01906203|Phase-Angle|phase-angle
1227680|NCT01906190|influenza vaccine|influenza vaccine
1227681|NCT01906190|immune response|immune response
1227682|NCT01906190|persistence|persistence
1227683|NCT01906164|RSV|rsv
1227684|NCT01906125|Bioequivalence|bioequivalence
1227685|NCT01906125|Cmax|cmax
1227686|NCT01906125|AUC|auc
1227687|NCT01906073|fentanyl|fentanyl
1227688|NCT01906073|administration, intranasal|administration, intranasal
1227689|NCT01906073|morphine|morphine
1227690|NCT01906073|patient satisfaction|patient satisfaction
1227691|NCT01906073|patient preference|patient preference
1227692|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
1227693|NCT01906021|Thermomap|thermomap
1227694|NCT01906021|Hepatic Lesions|hepatic lesions
1227695|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
1227696|NCT01906021|Microwave|microwave
1227697|NCT01906021|Non-Invasive Technique|non-invasive technique
1227698|NCT01906008|Colorectal cancer|colorectal cancer
1227699|NCT01906008|CRC|crc
1227700|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
1227701|NCT01906008|Numbness|numbness
1227702|NCT01906008|Pain|pain
1227703|NCT01906008|Loss of motor function|loss of motor function
1227704|NCT01906008|Minocycline|minocycline
1227705|NCT01906008|Dynacin|dynacin
1227706|NCT01906008|Minocin|minocin
1227708|NCT01906008|Myrac|myrac
1227709|NCT01906008|Solodyn|solodyn
1227710|NCT01906008|Placebo|placebo
1227711|NCT01906008|Questionnaires|questionnaires
1227712|NCT01906008|Surveys|surveys
1227713|NCT01906008|Sensory tests|sensory tests
1227714|NCT01905995|deep brain sitimulation|deep brain sitimulation
1227715|NCT01905995|local field potentials|local field potentials
1227716|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
1227717|NCT01905917|Stroke|stroke
1227718|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
1227719|NCT01905904|seizures|seizures
1227720|NCT01905904|sevoflurane|sevoflurane
1227721|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
1227722|NCT01905891|Field of cancerization|field of cancerization
1227723|NCT01905891|Skin carcinogenesis|skin carcinogenesis
1227724|NCT01905865|Uncertainty|uncertainty
1227725|NCT01905865|Undiagnosed Disease|undiagnosed disease
1227727|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1227728|NCT01905852|Ejection Fraction|ejection fraction
1227729|NCT01905852|Fractional Flow Reserve|fractional flow reserve
1227730|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
1227731|NCT01905839|Rigidity|rigidity
1227732|NCT01905839|Assessment|assessment
1227733|NCT01905839|Parkinson's Disease|parkinson's disease
1227734|NCT01905839|Physiological Measures|physiological measures
1227735|NCT01905826|Hematopoiesis|hematopoiesis
1227736|NCT01905826|Immunodeficiency|immunodeficiency
1227737|NCT01905826|Myelodysplasia/Leukemia|myelodysplasia/leukemia
1227738|NCT01905826|Lymphedema|lymphedema
1227739|NCT01905826|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
1227740|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
1227741|NCT01905800|semicircular canals|semicircular canals
1227742|NCT01905774|Renal Function|renal function
1227743|NCT01905761|obesity|obesity
1227744|NCT01905748|Coagulation|coagulation
1227745|NCT01905735|RA|ra
1227746|NCT01905722|MRI|mri
1227747|NCT01905722|metabolism|metabolism
1227748|NCT01905722|healthy|healthy
1227749|NCT01905722|7 Tesla|7 tesla
1227750|NCT01905709|C diff|c diff
1227751|NCT01905709|CDI|cdi
1227752|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
1227753|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1227754|NCT01905670|cardiac pacing|cardiac pacing
1227755|NCT01905670|electrical stimulation|electrical stimulation
1227756|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
1227757|NCT01905657|PD1|pd1
1227758|NCT01905657|PD-1|pd-1
1227759|NCT01905657|PDL1|pdl1
1227760|NCT01905657|PD-L1|pd-l1
1227761|NCT01905644|Vaginal delivery|vaginal delivery
1227762|NCT01905644|Perineal lesions|perineal lesions
1227763|NCT01905644|Anal sphincter rupture|anal sphincter rupture
1227764|NCT01905644|Ultrasound|ultrasound
1227765|NCT01905618|Medical Education|medical education
1227766|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
1227767|NCT01905618|Physician Delivered Intervention|physician delivered intervention
1227768|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
1227769|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
1227770|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
1227771|NCT01905592|Parp Inhibitor|parp inhibitor
1227772|NCT01905592|BRCA|brca
1227773|NCT01905579|flaremetry|flaremetry
1227774|NCT01905579|aqueous proteins|aqueous proteins
1227775|NCT01905579|clinical grading|clinical grading
1227776|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
1227777|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
1227778|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
1227779|NCT01905566|clopidogrel|clopidogrel
1227780|NCT01905566|ticagrelor|ticagrelor
1227781|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1227782|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
1227783|NCT01905527|Multiple Sclerosis|multiple sclerosis
1227784|NCT01905527|Relapsing-Remitting|relapsing-remitting
1227785|NCT01905527|Rebif|rebif
1227786|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
1227787|NCT01905527|Standard Subgroup|standard subgroup
1227788|NCT01905527|Custom Subgroup|custom subgroup
1227789|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
1227790|NCT01905501|Balanced anesthesia|balanced anesthesia
1227791|NCT01905501|Inhalation anesthesia|inhalation anesthesia
1227792|NCT01905501|Reperfusion injury|reperfusion injury
1227793|NCT01905501|Microsurgical Free flap|microsurgical free flap
1227794|NCT01905475|STEMI|stemi
1227795|NCT01905475|AMI|ami
1227796|NCT01905475|repair|repair
1227797|NCT01905462|Cervarix|cervarix
1227798|NCT01905462|Spontaneous abortion|spontaneous abortion
1227799|NCT01905462|Vaccine|vaccine
1227800|NCT01905462|Human Papillomavirus|human papillomavirus
1227801|NCT01905436|Filariasis|filariasis
1227802|NCT01905436|Onchocerciasis|onchocerciasis
1227803|NCT01905436|Albendazole|albendazole
1227804|NCT01905436|Ivermectin|ivermectin
1227805|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
1228096|NCT01904136|Cytoxan|cytoxan
1227806|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
1227807|NCT01905423|Filariasis|filariasis
1227808|NCT01905423|Albendazole|albendazole
1227809|NCT01905423|Diethylcarbamazine|diethylcarbamazine
1227810|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
1227811|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
1227812|NCT01905384|pancreatic cancer|pancreatic cancer
1227813|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
1227814|NCT01905384|metastatic malignancy|metastatic malignancy
1227815|NCT01905384|jaundice|jaundice
1227816|NCT01905371|amphetamine|amphetamine
1227817|NCT01905371|stroke recovery|stroke recovery
1227818|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1227819|NCT01905319|incidence rate|incidence rate
1227820|NCT01905306|dental implants|dental implants
1227821|NCT01905306|immediate loading|immediate loading
1227822|NCT01905306|full-arch|full-arch
1227823|NCT01905306|computer guided implant surgery|computer guided implant surgery
1227824|NCT01905280|allograft|allograft
1227825|NCT01905280|acellular dermal matrix|acellular dermal matrix
1227826|NCT01905280|alveolar ridge|alveolar ridge
1227827|NCT01905267|mindfulness|mindfulness
1227828|NCT01905267|relapse prevention|relapse prevention
1227829|NCT01905267|recovery|recovery
1227830|NCT01905267|depression|depression
1227831|NCT01905267|adolescents|adolescents
1227832|NCT01905254|Transient elastography|transient elastography
1227833|NCT01905254|mini-laparoscopy|mini-laparoscopy
1227834|NCT01905254|liver biopsy|liver biopsy
1227835|NCT01905254|liver cirrhosis|liver cirrhosis
1227836|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
1227837|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
1227838|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
1227839|NCT01905215|Immunogenicity|immunogenicity
1227840|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
1227841|NCT01905215|Reactogenicity|reactogenicity
1227842|NCT01905215|Vaccination|vaccination
1227843|NCT01905215|Safety|safety
1227844|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
1227845|NCT01905202|Safety|safety
1227846|NCT01905202|Tolerability|tolerability
1227847|NCT01905202|pH control|ph control
1227848|NCT01905202|Bile Acid|bile acid
1227849|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
1227850|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
1227851|NCT01905176|Heart Failure|heart failure
1227852|NCT01905176|Randomized Control Trial|randomized control trial
1227853|NCT01905176|Disease management|disease management
1227854|NCT01905176|Self-care|self-care
1227855|NCT01905176|Nursing|nursing
1227856|NCT01905176|Patient education as topic|patient education as topic
1227857|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
1227858|NCT01905150|pancreatic Cancer|pancreatic cancer
1227859|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
1227860|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
1227861|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
1227862|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
1227863|NCT01905124|Uveitis|uveitis
1227864|NCT01905124|Intermediate uveitis|intermediate uveitis
1227865|NCT01905124|Posterior uveitis|posterior uveitis
1227866|NCT01905098|Detoxification|detoxification
1227867|NCT01905098|Sauna|sauna
1227868|NCT01905098|Hyperthermia|hyperthermia
1227869|NCT01905072|Obesity|obesity
1227870|NCT01905072|Breastfeeding|breastfeeding
1227871|NCT01905072|Educational Intervention|educational intervention
1227872|NCT01905059|HIV infection|hiv infection
1227873|NCT01905059|second line ART|second line art
1227874|NCT01905059|maintenance strategies|maintenance strategies
1227875|NCT01905059|Protease inhibitors|protease inhibitors
1227876|NCT01905059|mono or bi-therapy|mono or bi-therapy
1227877|NCT01905033|Sepsis|sepsis
1227879|NCT01905033|Peritonitis|peritonitis
1227880|NCT01905033|Biomarkers|biomarkers
1227881|NCT01905033|Transcriptomics|transcriptomics
1227882|NCT01905033|Pathogen detection|pathogen detection
1227883|NCT01905020|Type 1 diabetes|type 1 diabetes
1227884|NCT01905020|Hypoglycemia|hypoglycemia
1227885|NCT01905020|Insulin|insulin
1227886|NCT01905020|Glucagon|glucagon
1227887|NCT01905020|Closed-loop system|closed-loop system
1227888|NCT01905020|Artificial pancreas|artificial pancreas
1227889|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1227890|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
1227891|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
1227892|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
1227893|NCT01904994|financial incentive|financial incentive
1227894|NCT01904994|linkage|linkage
1227895|NCT01904994|retention|retention
1227896|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
1227897|NCT01904994|accelerated ART|accelerated art
1227898|NCT01904994|CD4+ count|cd4+ count
1227899|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
1227900|NCT01904903|Cardiac Safety|cardiac safety
1227901|NCT01904890|Asian Americans|asian americans
1228097|NCT01904136|Neosar|neosar
1227902|NCT01904890|colorectal cancer screening|colorectal cancer screening
1227903|NCT01904890|cancer prevention|cancer prevention
1227904|NCT01904890|Filipinos Americans|filipinos americans
1227905|NCT01904890|Hmong Americans|hmong americans
1227906|NCT01904890|Korean Americans|korean americans
1227907|NCT01904890|Randomized Controlled Trials|randomized controlled trials
1227908|NCT01904877|HIV testing|hiv testing
1227909|NCT01904877|linkage|linkage
1227910|NCT01904877|care|care
1227911|NCT01904864|randomized controlled trial|randomized controlled trial
1227912|NCT01904864|iron medication|iron medication
1227913|NCT01904864|Anemia|anemia
1227914|NCT01904864|Hematologic Disease|hematologic disease
1227915|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
1227916|NCT01904864|anemia, nutritional|anemia, nutritional
1227917|NCT01904864|ferrous sulfate|ferrous sulfate
1227918|NCT01904864|NovaFerrum®|novaferrum®
1227919|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
1227920|NCT01904851|Stents|stents
1227921|NCT01904851|Registry|registry
1227922|NCT01904851|Angioplasty|angioplasty
1227923|NCT01904851|Endovascular Procedures|endovascular procedures
1227924|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1227925|NCT01904786|Newborn|newborn
1227926|NCT01904786|Outcomes|outcomes
1227927|NCT01904786|Melatonin|melatonin
1227928|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
1227929|NCT01904760|agitation|agitation
1227930|NCT01904760|delirium|delirium
1227931|NCT01904760|dexmedetomidine|dexmedetomidine
1227932|NCT01904760|head and neck surgery|head and neck surgery
1227933|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
1227934|NCT01904760|flap|flap
1227935|NCT01904747|Food|food
1227936|NCT01904747|Bioavailability|bioavailability
1227937|NCT01904747|Fasted|fasted
1227938|NCT01904747|Fed|fed
1227939|NCT01904734|testosterone|testosterone
1227940|NCT01904734|hypogonadism|hypogonadism
1227941|NCT01904734|pituitary|pituitary
1227942|NCT01904708|Phenylketonuria|phenylketonuria
1227943|NCT01904708|PKU|pku
1227944|NCT01904708|Exercise|exercise
1227945|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
1227946|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
1227947|NCT01904695|resistant hypertension|resistant hypertension
1227948|NCT01904695|causal inference|causal inference
1227949|NCT01904695|a chorot study|a chorot study
1227950|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
1227951|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
1227952|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
1227953|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
1227954|NCT01904669|Fertility|fertility
1227955|NCT01904669|Infertility|infertility
1227956|NCT01904669|Pregnancy|pregnancy
1227957|NCT01904669|Conception|conception
1227958|NCT01904669|Behavioral|behavioral
1227959|NCT01904669|Lifestyle|lifestyle
1227960|NCT01904669|Preconception Care|preconception care
1227961|NCT01904669|Women's Health|women's health
1227962|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
1227963|NCT01904669|Cohort Studies|cohort studies
1227964|NCT01904669|Epidemiology|epidemiology
1227965|NCT01904669|Internet|internet
1227966|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
1227967|NCT01904656|Ohio Appalachia|ohio appalachia
1227968|NCT01904630|gene sequencing|gene sequencing
1227969|NCT01904630|familial|familial
1227970|NCT01904630|risk factors|risk factors
1227971|NCT01904617|Length of labor|length of labor
1227972|NCT01904617|second stage of labor|second stage of labor
1227973|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
1227974|NCT01904617|intravenous glucose|intravenous glucose
1227975|NCT01904604|Peanut Allergy|peanut allergy
1228356|NCT01903083|Radiation|radiation
1227976|NCT01904604|Food Allergy|food allergy
1227977|NCT01904604|Viaskin peanut patch|viaskin peanut patch
1227978|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
1227979|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
1227980|NCT01904604|Whole peanut extract|whole peanut extract
1227981|NCT01904604|Allergenic product|allergenic product
1227982|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
1227983|NCT01904591|Spinal Cord Injury|spinal cord injury
1227984|NCT01904591|Antioxidants|antioxidants
1227985|NCT01904591|tractography|tractography
1227986|NCT01904591|ASIA assessment|asia assessment
1227987|NCT01904578|Menopause|menopause
1227988|NCT01904578|Sleep quality|sleep quality
1227989|NCT01904578|Acupressure|acupressure
1227990|NCT01904565|Hyperthermia,|hyperthermia,
1227991|NCT01904565|Proton beam therapy|proton beam therapy
1227992|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
1227993|NCT01904565|Radiotherapy|radiotherapy
1227994|NCT01904565|Phase I/II trial|phase i/ii trial
1227995|NCT01904552|Apical periodontitis|apical periodontitis
1227996|NCT01904552|Dentaport ZX|dentaport zx
1227997|NCT01904552|electronic apex locators|electronic apex locators
1227998|NCT01904552|i-Root|i-root
1227999|NCT01904552|Raypex 5|raypex 5
1228000|NCT01904552|working length|working length
1228001|NCT01904526|Guanfacine|guanfacine
1228002|NCT01904526|PK/PD|pk/pd
1228003|NCT01904526|Smokers|smokers
1228004|NCT01904513|Metals|metals
1228005|NCT01904513|Pesticides|pesticides
1228006|NCT01904513|Toxicity|toxicity
1228007|NCT01904500|Cesarean delivery|cesarean delivery
1228008|NCT01904474|obesity|obesity
1228009|NCT01904474|overweight|overweight
1228010|NCT01904474|technology|technology
1228011|NCT01904474|internet|internet
1228012|NCT01904474|intervention|intervention
1228013|NCT01904474|adolescents|adolescents
1228014|NCT01904461|tonsillectomy|tonsillectomy
1228015|NCT01904461|children|children
1228016|NCT01904461|vacuum|vacuum
1228017|NCT01904461|medical device|medical device
1228018|NCT01904461|pain|pain
1228019|NCT01904461|hemorrhage|hemorrhage
1228020|NCT01904461|post-surgical complications|post-surgical complications
1228021|NCT01904448|pediatric|pediatric
1228022|NCT01904448|profound hearing loss|profound hearing loss
1228023|NCT01904448|auditory brainstem implant|auditory brainstem implant
1228024|NCT01904448|cochlear implant|cochlear implant
1228025|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
1228026|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
1228027|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
1228028|NCT01904448|cochlear malformation|cochlear malformation
1228029|NCT01904448|CND|cnd
1228030|NCT01904422|Diabetes mellitus.|diabetes mellitus.
1228031|NCT01904422|Periodontitis|periodontitis
1228032|NCT01904422|Periodontal treatment.|periodontal treatment.
1228033|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
1228034|NCT01904344|Sleep|sleep
1228035|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
1228036|NCT01904344|Respiratory pathology|respiratory pathology
1228037|NCT01904331|Cardiotoxicity|cardiotoxicity
1228038|NCT01904331|long-term effects|long-term effects
1228039|NCT01904331|chemotherapy|chemotherapy
1228040|NCT01904331|radiotherapy|radiotherapy
1228041|NCT01904318|male|male
1228042|NCT01904318|Phase I|phase i
1228043|NCT01904318|A dose block-randomized|a dose block-randomized
1228044|NCT01904318|Double-blinded|double-blinded
1228045|NCT01904318|Placebo controlled|placebo controlled
1228046|NCT01904318|Single Dose|single dose
1228047|NCT01904318|dose Escalation|dose escalation
1228048|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
1228049|NCT01904318|Food Effect|food effect
1228050|NCT01904318|Pharmacokinetics|pharmacokinetics
1228051|NCT01904318|health male volunteer|health male volunteer
1228052|NCT01904318|PDF inhibitor|pdf inhibitor
1228053|NCT01904305|Pneumonia|pneumonia
1228054|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
1228055|NCT01904240|Parkinson's disease|parkinson's disease
1228056|NCT01904240|GI tract|gi tract
1228057|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
1228058|NCT01904227|Borderline Personality Disorder|borderline personality disorder
1228059|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
1228060|NCT01904214|renal impairement|renal impairement
1228061|NCT01904214|pharmacokinetics|pharmacokinetics
1228062|NCT01904201|Immune function|immune function
1228063|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
1228064|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
1228065|NCT01904188|microbial identification|microbial identification
1228066|NCT01904188|antibiotic resistance|antibiotic resistance
1228067|NCT01904188|GeneZ and other techniques as developed|genez and other techniques as developed
1228068|NCT01904188|sepsis|sepsis
1228069|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1228070|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
1228071|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
1228072|NCT01904149|Postoperative pain|postoperative pain
1228073|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
1228074|NCT01904149|Analgesics|analgesics
1228075|NCT01904149|Dexketoprofen|dexketoprofen
1228076|NCT01904149|Tramadol|tramadol
1228077|NCT01904136|Leukemia|leukemia
1228078|NCT01904136|Myeloproliferative Diseases|myeloproliferative diseases
1228079|NCT01904136|Blood And Marrow Transplantation|blood and marrow transplantation
1228080|NCT01904136|High Risk Myeloid Malignancies|high risk myeloid malignancies
1228081|NCT01904136|Acute myeloid leukemia|acute myeloid leukemia
1228082|NCT01904136|AML|aml
1228083|NCT01904136|Myelodysplastic syndrome|myelodysplastic syndrome
1228084|NCT01904136|MDS|mds
1228085|NCT01904136|Chronic myeloid leukemia|chronic myeloid leukemia
1228086|NCT01904136|CML|cml
1228087|NCT01904136|Haploidentical Stem-cell Transplantation|haploidentical stem-cell transplantation
1228088|NCT01904136|HaploSCT|haplosct
1228089|NCT01904136|Expanded natural killer cells|expanded natural killer cells
1228090|NCT01904136|NK|nk
1228091|NCT01904136|Melphalan|melphalan
1228092|NCT01904136|Alkeran|alkeran
1228093|NCT01904136|Mesna|mesna
1228094|NCT01904136|Mesnex|mesnex
1228095|NCT01904136|Cyclophosphamide|cyclophosphamide
1228098|NCT01904136|Tacrolimus|tacrolimus
1228099|NCT01904136|Prograf|prograf
1228100|NCT01904136|Mycophenolate mofetil|mycophenolate mofetil
1228101|NCT01904136|MMF|mmf
1228102|NCT01904136|CellCept|cellcept
1228103|NCT01904136|G-CSF|g-csf
1228104|NCT01904136|Filgrastim|filgrastim
1228105|NCT01904136|Neupogen|neupogen
1228106|NCT01904136|Fludarabine|fludarabine
1228107|NCT01904136|Fludarabine phosphate|fludarabine phosphate
1228108|NCT01904136|Fludara|fludara
1228109|NCT01904123|Brain cancer|brain cancer
1228110|NCT01904123|Central nervous system neoplasms|central nervous system neoplasms
1228111|NCT01904123|CNS|cns
1228112|NCT01904123|Melanoma|melanoma
1228113|NCT01904123|Glioblastoma Multiforme|glioblastoma multiforme
1228114|NCT01904123|GBM|gbm
1228115|NCT01904123|Solid tumors|solid tumors
1228116|NCT01904123|Metastatic to the brain|metastatic to the brain
1228117|NCT01904123|WP1066|wp1066
1228118|NCT01904123|Recurrent malignant glioma|recurrent malignant glioma
1228119|NCT01904123|Glioblastoma|glioblastoma
1228120|NCT01904123|Anaplastic glioma|anaplastic glioma
1228121|NCT01904123|Advanced Brain Tumor Imaging|advanced brain tumor imaging
1228122|NCT01904123|ABTI|abti
1228123|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
1228124|NCT01904097|Fibromyalgia|fibromyalgia
1228125|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1228126|NCT01904097|tDCS|tdcs
1228127|NCT01904097|Pregabalin|pregabalin
1228128|NCT01904097|Functional Neuroimaging|functional neuroimaging
1228129|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
1228130|NCT01904097|NIRS|nirs
1228131|NCT01904097|Chronic Pain|chronic pain
1228132|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1228133|NCT01904097|TMS|tms
1228134|NCT01904084|Distal radius fracture|distal radius fracture
1228135|NCT01904071|Hip Fracture|hip fracture
1228136|NCT01904071|Ultrasound|ultrasound
1228137|NCT01904071|Nerve Block|nerve block
1228138|NCT01904058|PBC|pbc
1228139|NCT01904032|Vitamin D|vitamin d
1228140|NCT01904032|Diabetes|diabetes
1228141|NCT01904032|Self-Management|self-management
1228142|NCT01904032|Depression|depression
1228143|NCT01904032|Women|women
1228144|NCT01904019|arthroplasty|arthroplasty
1228145|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
1228146|NCT01904006|grouped embryo culture|grouped embryo culture
1228147|NCT01904006|embryo density|embryo density
1228148|NCT01904006|low oxygen|low oxygen
1228149|NCT01904006|benchtop incubator|benchtop incubator
1228150|NCT01904006|culture condition|culture condition
1228151|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
1228152|NCT01903980|Fat Necrosis|fat necrosis
1228153|NCT01903980|Chest Pain|chest pain
1228154|NCT01903980|Pericardial Necrosis|pericardial necrosis
1228155|NCT01903980|Pleuritic pain|pleuritic pain
1228156|NCT01903967|Pituitary|pituitary
1228157|NCT01903967|CGH array|cgh array
1228158|NCT01903967|Tumor|tumor
1228159|NCT01903941|exercise|exercise
1228160|NCT01903928|cytomegalovirus|cytomegalovirus
1228161|NCT01903928|DNA vaccine|dna vaccine
1228162|NCT01903928|transplantation|transplantation
1228163|NCT01903928|HCT|hct
1228164|NCT01903902|Coronary artery disease|coronary artery disease
1228165|NCT01903902|Balloon angioplasty|balloon angioplasty
1228166|NCT01903902|Drug-eluting balloon|drug-eluting balloon
1228167|NCT01903889|AE adverse event|ae adverse event
1228168|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1228169|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1228170|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
1228171|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1228172|NCT01903889|DCF data collection forms|dcf data collection forms
1228173|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
1228174|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1228175|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1228176|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1228177|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
1228178|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
1228179|NCT01903889|IRB Institutional Review Board|irb institutional review board
1228180|NCT01903889|IU International units|iu international units
1228181|NCT01903889|mg milligram(s)|mg milligram(s)
1228182|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1228183|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
1228184|NCT01903889|SAE serious adverse event|sae serious adverse event
1228185|NCT01903889|µg microgram|µg microgram
1228186|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
1228187|NCT01903889|WB Western Blot|wb western blot
1228188|NCT01903889|ANC Antenatal care|anc antenatal care
1228189|NCT01903889|ARV Antiretroviral|arv antiretroviral
1228190|NCT01903889|C&T Care and treatment|c&t care and treatment
1228191|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
1228192|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
1228281|NCT01903421|Elderly surgical patients|elderly surgical patients
1228193|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
1228194|NCT01903889|FP Family planning|fp family planning
1228195|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
1228196|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
1593181|NCT00419900|hair|hair
1228197|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
1228198|NCT01903889|MCH Maternal/child health|mch maternal/child health
1228199|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
1228200|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
1228201|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
1228202|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
1228203|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
1228204|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
1228205|NCT01903889|TM Technical monitor|tm technical monitor
1228206|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
1228207|NCT01903889|WHO World Health Organization|who world health organization
1228208|NCT01903863|FFP|ffp
1228209|NCT01903863|fresh frozen plasma|fresh frozen plasma
1228210|NCT01903863|ECMO|ecmo
1228211|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1228212|NCT01903863|anticoagulation|anticoagulation
1228213|NCT01903863|transfusion|transfusion
1228214|NCT01903850|Benign central airway obstruction|benign central airway obstruction
1228215|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
1228216|NCT01903850|Spray cryotherapy|spray cryotherapy
1228217|NCT01903850|Endoluminal tumors|endoluminal tumors
1228218|NCT01903850|Airway granulation tissue|airway granulation tissue
1228219|NCT01903837|Schizophrenia|schizophrenia
1228220|NCT01903837|Olanzapine|olanzapine
1228221|NCT01903837|Samidorphan|samidorphan
1228222|NCT01903837|Alkermes|alkermes
1228223|NCT01903824|Irdabisant|irdabisant
1228224|NCT01903824|cognitive impairment|cognitive impairment
1228225|NCT01903811|carfilzomib|carfilzomib
1228226|NCT01903811|relapsed|relapsed
1228227|NCT01903811|refractory|refractory
1228228|NCT01903811|multiple myeloma|multiple myeloma
1228229|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
1228230|NCT01903785|inhaled salbutamol|inhaled salbutamol
1228231|NCT01903785|performance enhancing|performance enhancing
1228232|NCT01903785|cycling|cycling
1228233|NCT01903733|Subjects|subjects
1228234|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
1228235|NCT01903733|CML|cml
1228236|NCT01903733|Bosutinib|bosutinib
1228237|NCT01903733|Extension|extension
1228238|NCT01903707|Schizophrenia|schizophrenia
1228239|NCT01903707|Psychosis|psychosis
1228240|NCT01903707|Cognitive deficits|cognitive deficits
1228241|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
1228242|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
1228243|NCT01903603|cerebral palsy|cerebral palsy
1228244|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
1228245|NCT01903603|MRI|mri
1228246|NCT01903603|Kinematic|kinematic
1228247|NCT01903603|motor control|motor control
1228248|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
1228249|NCT01903577|Ergonomics|ergonomics
1228250|NCT01903577|Robotic Surgery|robotic surgery
1228251|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
1228252|NCT01903564|fetus|fetus
1228253|NCT01903564|fetal arrhythmia|fetal arrhythmia
1228254|NCT01903564|fetal heart rate|fetal heart rate
1228255|NCT01903564|long QT syndrome|long qt syndrome
1228256|NCT01903551|post-operative pain|post-operative pain
1228257|NCT01903551|loco-regional analgesia|loco-regional analgesia
1228258|NCT01903551|minimally invasive surgery|minimally invasive surgery
1228259|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
1228260|NCT01903512|internal derangement|internal derangement
1228261|NCT01903512|conservative treatment|conservative treatment
1228262|NCT01903486|Trouble swallowing|trouble swallowing
1228263|NCT01903486|dysphagia|dysphagia
1228264|NCT01903486|disorder of the esophagus|disorder of the esophagus
1228265|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1228266|NCT01903473|GVHD|gvhd
1228267|NCT01903473|Regulatory T cells|regulatory t cells
1228268|NCT01903473|Steroid refractory|steroid refractory
1228269|NCT01903473|Rapamycin|rapamycin
1228270|NCT01903473|Immune recovery|immune recovery
1228271|NCT01903473|Infusion|infusion
1228272|NCT01903473|HLA-identical sibling|hla-identical sibling
1228273|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
1228274|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
1228275|NCT01903447|Depression|depression
1228276|NCT01903447|Anxiety|anxiety
1228278|NCT01903447|medication treatment|medication treatment
1228279|NCT01903447|psychotherapy|psychotherapy
1228280|NCT01903447|brain function|brain function
1228282|NCT01903421|Alzheimer's disease|alzheimer's disease
1228283|NCT01903421|Dementia|dementia
1228284|NCT01903421|Elderly|elderly
1228285|NCT01903421|Surgery|surgery
1228286|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
1228287|NCT01903395|Health Services Accessibility|health services accessibility
1228288|NCT01903395|Humans|humans
1228289|NCT01903395|Supportive Care Needs|supportive care needs
1228290|NCT01903395|Psychooncology|psychooncology
1228291|NCT01903395|Primary Health Care/*methods|primary health care/*methods
1228292|NCT01903395|Treatment Outcome|treatment outcome
1228293|NCT01903395|Socioeconomic Factors|socioeconomic factors
1228294|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
1228295|NCT01903395|Adult|adult
1228296|NCT01903395|Aged|aged
1228297|NCT01903395|Aged, 80 and over|aged, 80 and over
1228298|NCT01903369|Shear wave|shear wave
1228299|NCT01903369|Elastography|elastography
1228300|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
1228301|NCT01903343|Shear wave|shear wave
1228302|NCT01903343|Elastography|elastography
1228303|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
1228304|NCT01903330|ERC1671|erc1671
1228305|NCT01903330|GM-CSF|gm-csf
1228306|NCT01903330|Cyclophosphamide|cyclophosphamide
1228307|NCT01903330|Bevacizumab|bevacizumab
1228308|NCT01903304|Olive oil|olive oil
1228309|NCT01903304|DTH|dth
1228310|NCT01903304|elderly|elderly
1228311|NCT01903278|interferon|interferon
1228312|NCT01903278|ribavirin|ribavirin
1228313|NCT01903278|sustained virological response|sustained virological response
1228314|NCT01903265|pain|pain
1228315|NCT01903265|sleep|sleep
1228316|NCT01903252|UC|uc
1228317|NCT01903226|spinal cord injury|spinal cord injury
1228318|NCT01903226|physical capacity|physical capacity
1228319|NCT01903226|energy expenditure|energy expenditure
1228320|NCT01903226|training|training
1228321|NCT01903213|Peritoneal dialysis|peritoneal dialysis
1228322|NCT01903213|Bixalomer|bixalomer
1228323|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
1228324|NCT01903213|Kiklin®|kiklin®
1228325|NCT01903200|Antipsychotic|antipsychotic
1228326|NCT01903200|FK949E|fk949e
1228327|NCT01903200|Quetiapine|quetiapine
1228328|NCT01903200|Elderly|elderly
1228329|NCT01903187|hypertension|hypertension
1228330|NCT01903187|resistant hypertension|resistant hypertension
1228331|NCT01903187|renal denervation|renal denervation
1228332|NCT01903174|Breast Cancer|breast cancer
1228333|NCT01903174|Breast Reconstruction|breast reconstruction
1228334|NCT01903174|Breast Tissue Expansion|breast tissue expansion
1228335|NCT01903174|Breast Tissue Expander|breast tissue expander
1228336|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
1228337|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
1228338|NCT01903161|troponin|troponin
1228339|NCT01903161|valve replacement surgery|valve replacement surgery
1228340|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
1228341|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
1228342|NCT01903135|Prevalence|prevalence
1228343|NCT01903135|Bicarbonate|bicarbonate
1228344|NCT01903096|Panic disorder|panic disorder
1228345|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
1228346|NCT01903096|Social phobia|social phobia
1228347|NCT01903096|Specific phobia|specific phobia
1228348|NCT01903096|Major depressive disorder|major depressive disorder
1228349|NCT01903096|Dysthymia|dysthymia
1228350|NCT01903096|Somatizations disorder|somatizations disorder
1228351|NCT01903096|Pain disorder|pain disorder
1228352|NCT01903083|Pancreas|pancreas
1228353|NCT01903083|Pancreatic cancer|pancreatic cancer
1228354|NCT01903083|Immunotherapy|immunotherapy
1228355|NCT01903083|Chemotherapy|chemotherapy
1228357|NCT01903083|Surgery|surgery
1228358|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
1228359|NCT01903057|Mass Drug Administration|mass drug administration
1228360|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
1228361|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
1228362|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
1228363|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
1228364|NCT01903044|Bone marrow|bone marrow
1228365|NCT01903044|Neoangiogenesis|neoangiogenesis
1228366|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
1228367|NCT01902966|Cervical Cancer|cervical cancer
1228368|NCT01902966|Propranolol|propranolol
1228369|NCT01902966|Betachron|betachron
1228370|NCT01902966|Inderal|inderal
1228371|NCT01902966|Beta blocker|beta blocker
1228372|NCT01902966|Questionnaires|questionnaires
1228373|NCT01902966|Surveys|surveys
1228374|NCT01902966|Symptom inventory|symptom inventory
1228375|NCT01902966|Anxiety and depression survey|anxiety and depression survey
1228376|NCT01902966|Pain inventory|pain inventory
1228377|NCT01902966|Quality of life survey|quality of life survey
1228378|NCT01902966|Relaxation audio recording|relaxation audio recording
1228379|NCT01902966|MP3 player|mp3 player
1228380|NCT01902966|Diary|diary
1228381|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
1593581|NCT00418184|inattentive|inattentive
1228382|NCT01902953|colon cancer|colon cancer
1228383|NCT01902953|rectal cancer|rectal cancer
1228384|NCT01902953|immunohistochemistry|immunohistochemistry
1228385|NCT01902927|Exercise tolerance|exercise tolerance
1228386|NCT01902927|Dyspnea|dyspnea
1228387|NCT01902927|Affective distraction|affective distraction
1228388|NCT01902914|hearing aids|hearing aids
1228389|NCT01902914|hearing disability|hearing disability
1228390|NCT01902914|community|community
1228391|NCT01902914|hearing aids service|hearing aids service
1228392|NCT01902901|Whole Genome Sequencing|whole genome sequencing
1228393|NCT01902901|Carrier status|carrier status
1228394|NCT01902901|Genetics|genetics
1228395|NCT01902888|popliteal artery|popliteal artery
1228396|NCT01902888|aneurysm|aneurysm
1228397|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
1228398|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
1228399|NCT01902888|mural thrombus|mural thrombus
1228400|NCT01902888|Viabahn|viabahn
1228401|NCT01902888|Gore|gore
1228402|NCT01902888|Endoprosthesis|endoprosthesis
1228403|NCT01902862|Lymphoma, follicular|lymphoma, follicular
1228404|NCT01902862|Bortezomib|bortezomib
1228405|NCT01902862|Rituximab|rituximab
1228406|NCT01902849|intravenous anesthesia|intravenous anesthesia
1228407|NCT01902849|inhalational anesthesia|inhalational anesthesia
1228408|NCT01902849|interleukins|interleukins
1228409|NCT01902849|colorectal surgery|colorectal surgery
1228410|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
1228411|NCT01902836|Transferon|transferon
1228412|NCT01902836|atopic dermatitis|atopic dermatitis
1228413|NCT01902823|Nurse Navigator|nurse navigator
1228414|NCT01902823|Satisfaction with Care|satisfaction with care
1228415|NCT01902823|Quality of Life|quality of life
1228416|NCT01902823|Symptom Distress|symptom distress
1228417|NCT01902797|Refugee camps|refugee camps
1228418|NCT01902797|Household residence|household residence
1228419|NCT01902797|Treated bednets|treated bednets
1228420|NCT01902797|PCR|pcr
1228421|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
1228422|NCT01902784|Surrogate decision making|surrogate decision making
1228423|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
1228424|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
1228425|NCT01902771|DCV|dcv
1228426|NCT01902771|Pediatric|pediatric
1228427|NCT01902771|Brain Tumor|brain tumor
1228428|NCT01902771|In Situ|in situ
1228429|NCT01902771|Lysate|lysate
1228430|NCT01902771|Tumor Lysate|tumor lysate
1228431|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
1228432|NCT01902771|GBM|gbm
1228433|NCT01902771|Pheresis|pheresis
1228434|NCT01902771|Leukapheresis|leukapheresis
1228435|NCT01902771|High Grade Glioma|high grade glioma
1228436|NCT01902771|HGG|hgg
1228437|NCT01902758|exercise performance|exercise performance
1228438|NCT01902693|HIV|hiv
1228439|NCT01902693|Chemotherapy|chemotherapy
1228440|NCT01902693|Cohort|cohort
1228441|NCT01902693|Cancer|cancer
1228442|NCT01902693|HAART|haart
1228443|NCT01902693|Malignancy|malignancy
1228444|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
1228445|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
1228446|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
1228447|NCT01902654|Osteoarthritis|osteoarthritis
1228448|NCT01902654|cardiovascular disease|cardiovascular disease
1228449|NCT01902641|succinylcholine|succinylcholine
1228450|NCT01902641|rocuronium|rocuronium
1228451|NCT01902641|sugammadex|sugammadex
1228452|NCT01902641|Intubating Conditions|intubating conditions
1228453|NCT01902641|short Procedures|short procedures
1228454|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
1228455|NCT01902563|newborns|newborns
1228456|NCT01902563|preterm infants|preterm infants
1228457|NCT01902563|procedures|procedures
1228458|NCT01902550|Healthy|healthy
1228459|NCT01902550|JNJ-54452840|jnj-54452840
1228460|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
1228461|NCT01902550|Placebo|placebo
1228462|NCT01902550|Male|male
1228463|NCT01902537|Constipation|constipation
1228464|NCT01902537|Prucalopride|prucalopride
1228465|NCT01902524|Chronic Pain|chronic pain
1228466|NCT01902524|Fentanyl-TTS|fentanyl-tts
1228467|NCT01902524|Fentanyl Patch|fentanyl patch
1228468|NCT01902524|Transdermal|transdermal
1228469|NCT01902524|Non-cancer Pain|non-cancer pain
1228470|NCT01902498|aspirin|aspirin
1228471|NCT01902485|Contraception|contraception
1228472|NCT01902485|Medical Abortion|medical abortion
1228473|NCT01902485|Implant|implant
1228474|NCT01902485|Injectable|injectable
1228475|NCT01902485|Quickstart|quickstart
1228476|NCT01902472|HIV-1|hiv-1
1228477|NCT01902472|Truvada|truvada
1228478|NCT01902472|FTC/TDF|ftc/tdf
1228479|NCT01902472|Pre-exposure prophylaxy|pre-exposure prophylaxy
1228480|NCT01902472|PrEP|prep
1228481|NCT01902472|Resistance|resistance
1228482|NCT01902459|Hemostasis|hemostasis
1228483|NCT01902446|Chlorhexidine|chlorhexidine
1593582|NCT00418184|impulsive|impulsive
1312345|NCT01530672|HIV|hiv
1228484|NCT01902446|Randomized Controlled Trial|randomized controlled trial
1228485|NCT01902446|Emergency Medical Services|emergency medical services
1228486|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
1228487|NCT01902407|Pcrit|pcrit
1228488|NCT01902407|Critical closing pressure|critical closing pressure
1228489|NCT01902407|Down syndrome|down syndrome
1228490|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
1228491|NCT01902407|Sleep MRI|sleep mri
1228492|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
1228493|NCT01902368|Gluten free diet|gluten free diet
1228494|NCT01902355|Central Venous Catheterization|central venous catheterization
1228495|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
1228496|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
1228497|NCT01902329|CD33 Antigen|cd33 antigen
1228498|NCT01902329|Immunotherapy|immunotherapy
1228499|NCT01902329|Drug Therapy|drug therapy
1228500|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
1228501|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1228502|NCT01902329|APL|apl
1228503|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1228504|NCT01902316|peptide biomarker|peptide biomarker
1228505|NCT01902316|early diagnosis|early diagnosis
1228506|NCT01902316|label free|label free
1228507|NCT01902303|Herpes Labialis|herpes labialis
1228508|NCT01902303|Herpes Simplex|herpes simplex
1228509|NCT01902303|Herpes|herpes
1228510|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
1228511|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
1228512|NCT01902277|Delirium|delirium
1228513|NCT01902277|Intensive Care Unit|intensive care unit
1228514|NCT01902277|Critical illness|critical illness
1228515|NCT01902264|Levomefolate calcium|levomefolate calcium
1228516|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
1228517|NCT01902264|Neural tube defects|neural tube defects
1228518|NCT01902251|Phase 1|phase 1
1228519|NCT01902251|Prostate cancer|prostate cancer
1228520|NCT01902251|Bioavailability|bioavailability
1228521|NCT01902251|Food effect|food effect
1228522|NCT01902251|Pharmacokinetics|pharmacokinetics
1228523|NCT01902251|Xtandi|xtandi
1228524|NCT01902251|Enzalutamide|enzalutamide
1228525|NCT01902251|MDV3100|mdv3100
1228526|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
1228527|NCT01902238|ethanol|ethanol
1228528|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
1228529|NCT01902225|Lymphoma|lymphoma
1228530|NCT01902225|T-Cell|t-cell
1228531|NCT01902225|Cutaneous|cutaneous
1228532|NCT01902225|Doxil|doxil
1228533|NCT01902225|romidepsin|romidepsin
1228534|NCT01902225|skin|skin
1228535|NCT01902186|HIV|hiv
1228536|NCT01902186|osteopenia|osteopenia
1228537|NCT01902186|t-score|t-score
1228538|NCT01902186|DEXA|dexa
1228539|NCT01902186|tenofovir|tenofovir
1228540|NCT01902186|raltegravir|raltegravir
1228541|NCT01902147|abdominal|abdominal
1228542|NCT01902147|thoracic|thoracic
1228543|NCT01902147|arthroplasty|arthroplasty
1228544|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
1228545|NCT01902134|Postoperative pain|postoperative pain
1228546|NCT01902134|Hip arthroplasty|hip arthroplasty
1228547|NCT01902134|Analgesics|analgesics
1228548|NCT01902134|Dexketoprofen|dexketoprofen
1228549|NCT01902134|Tramadol|tramadol
1228550|NCT01902108|clonidine|clonidine
1228551|NCT01902108|bupivacaine|bupivacaine
1228552|NCT01902108|post-operative pain|post-operative pain
1228553|NCT01902108|arthrodesis|arthrodesis
1228554|NCT01902108|discectomy|discectomy
1228555|NCT01902108|local infiltration|local infiltration
1228556|NCT01902095|tooth pastes|tooth pastes
1228557|NCT01902095|tooth powders|tooth powders
1228558|NCT01902095|Stain Index|stain index
1228559|NCT01902082|ARDS|ards
1228560|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
1228561|NCT01902082|Safety|safety
1228562|NCT01902082|Cytokines|cytokines
1228563|NCT01902069|sweet and fat preference|sweet and fat preference
1228564|NCT01902056|allograft|allograft
1228565|NCT01902056|acellular dermal matrix|acellular dermal matrix
1228566|NCT01902056|Alloderm|alloderm
1228567|NCT01902043|diabetes mellitus|diabetes mellitus
1228568|NCT01902043|cohort study|cohort study
1228569|NCT01902043|quality of care|quality of care
1228570|NCT01902043|quality indicators, Health care|quality indicators, health care
1228571|NCT01902043|quality of Health Care|quality of health care
1228572|NCT01902043|outcome and process assessment|outcome and process assessment
1228573|NCT01902043|health services research|health services research
1228574|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
1228575|NCT01902017|Joint|joint
1228576|NCT01902017|Contracture|contracture
1228577|NCT01902017|Elbow|elbow
1228578|NCT01902017|Fracture|fracture
1228579|NCT01902017|Dislocation|dislocation
1228580|NCT01902004|Major Depression|major depression
1228581|NCT01902004|Geriatric Major Depression|geriatric major depression
1228582|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
1228583|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
1228584|NCT01902004|Older Adults|older adults
1228585|NCT01902004|Geriatric|geriatric
1228586|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
1228587|NCT01902004|Quality of Life|quality of life
1228588|NCT01902004|Disability|disability
1228589|NCT01902004|Comorbidity|comorbidity
1228590|NCT01902004|Medical Burden|medical burden
1228591|NCT01902004|Safety|safety
1228592|NCT01902004|Candidate Genes|candidate genes
1228593|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
1228594|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
1228595|NCT01901991|Radioactive seed localization|radioactive seed localization
1228596|NCT01901991|Wire-guided localization|wire-guided localization
1228597|NCT01901991|Randomized study|randomized study
1228598|NCT01901978|Obesity|obesity
1228599|NCT01901978|Insulin Resistance|insulin resistance
1228600|NCT01901978|Weight loss|weight loss
1228601|NCT01901978|Women|women
1228602|NCT01901952|Self management diabetes intervention|self management diabetes intervention
1228603|NCT01901939|exercise|exercise
1228604|NCT01901939|elderly|elderly
1228605|NCT01901939|activities of daily living|activities of daily living
1228606|NCT01901939|disability|disability
1228607|NCT01901913|Type 1 Diabetes|type 1 diabetes
1228608|NCT01901913|Artificial pancreas|artificial pancreas
1228609|NCT01901913|Closed loop|closed loop
1228610|NCT01901887|Adults|adults
1228611|NCT01901887|Suicidality|suicidality
1228612|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
1228613|NCT01901848|Smoking Cessation|smoking cessation
1228614|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1228615|NCT01901848|Psychotherapy|psychotherapy
1228616|NCT01901822|acellular dermal matrix|acellular dermal matrix
1228617|NCT01901809|Heart failure, diastolic|heart failure, diastolic
1228618|NCT01901809|HFpEF|hfpef
1228619|NCT01901809|Diuretics|diuretics
1228620|NCT01901809|Dopamine|dopamine
1228621|NCT01901796|Anxiety|anxiety
1228622|NCT01901796|Depression|depression
1228623|NCT01901796|CBT|cbt
1228624|NCT01901783|allograft|allograft
1228625|NCT01901783|regeneration|regeneration
1228626|NCT01901783|alveolar ridge|alveolar ridge
1228627|NCT01901770|HPV|hpv
1228628|NCT01901770|Ohio Appalachia|ohio appalachia
1228629|NCT01901770|HPV vaccine|hpv vaccine
1228630|NCT01901770|No evidence of disease|no evidence of disease
1228631|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
1228632|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
1228633|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
1228634|NCT01901731|pelvic venous reflux|pelvic venous reflux
1228635|NCT01901731|recurrent varicose veins|recurrent varicose veins
1228636|NCT01901718|Breakthrough Pain|breakthrough pain
1228637|NCT01901718|Subsys|subsys
1228638|NCT01901718|Fentanyl|fentanyl
1228639|NCT01901718|Opioid|opioid
1228640|NCT01901718|Persistent Pain|persistent pain
1228641|NCT01901705|Psoriasis|psoriasis
1228642|NCT01901705|Indigo Naturalis|indigo naturalis
1228643|NCT01901705|chinese medicine|chinese medicine
1228644|NCT01901692|liver cancer|liver cancer
1228645|NCT01901692|first-line|first-line
1228646|NCT01901692|tumor thrombus|tumor thrombus
1228647|NCT01901692|vascular invasion|vascular invasion
1228648|NCT01901679|Obesity|obesity
1228649|NCT01901679|Post-menopausal|post-menopausal
1228650|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
1228651|NCT01901653|Small cell lung cancer|small cell lung cancer
1228652|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
1228653|NCT01901627|adalimumab|adalimumab
1228654|NCT01901627|Prospective Studies|prospective studies
1228655|NCT01901614|Keratoconus|keratoconus
1228656|NCT01901614|Corneal Opacity|corneal opacity
1228657|NCT01901614|Keratoplasty|keratoplasty
1228658|NCT01901601|KERATOPLASTY|keratoplasty
1228659|NCT01901601|STROMAL OPACITIES|stromal opacities
1228660|NCT01901588|strabismus|strabismus
1228661|NCT01901588|pediatric|pediatric
1228662|NCT01901588|emergence delirium|emergence delirium
1228663|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
1228664|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
1228665|NCT01901562|ductoscopy|ductoscopy
1228666|NCT01901562|nipple discharge|nipple discharge
1228667|NCT01901562|breast|breast
1228668|NCT01901562|papilloma|papilloma
1228669|NCT01901536|First time parents|first time parents
1228670|NCT01901536|Coparenting|coparenting
1228671|NCT01901536|Family Foundations|family foundations
1228672|NCT01901523|Discrepancy|discrepancy
1228673|NCT01901523|Committee on Publication Ethics|committee on publication ethics
1228674|NCT01901523|Correction|correction
1228675|NCT01901523|Erratum|erratum
1228676|NCT01901523|Retraction|retraction
1228677|NCT01901510|polyp|polyp
1228678|NCT01901497|non invasive ventilation|non invasive ventilation
1228679|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
1228680|NCT01901497|bilevel|bilevel
1228681|NCT01901497|nebulization|nebulization
1312578|NCT01529697|Asthma|asthma
1228682|NCT01901497|nebulizer|nebulizer
1228683|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
1228684|NCT01901497|amikacin|amikacin
1228685|NCT01901484|Schistosoma mansoni|schistosoma mansoni
1228686|NCT01901484|morbidity|morbidity
1228687|NCT01901484|chemotherapy|chemotherapy
1228688|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
1228689|NCT01901458|apheresis|apheresis
1228690|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
1228691|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
1228692|NCT01901445|Quality of life|quality of life
1228693|NCT01901445|Constipation|constipation
1228694|NCT01901445|Focus groups|focus groups
1228695|NCT01901445|Health education|health education
1228696|NCT01901445|Problem-based learning|problem-based learning
1228697|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
1228698|NCT01901432|Polycythemia Vera|polycythemia vera
1228699|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
1228700|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
1228701|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1228702|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1228703|NCT01901432|Givinostat|givinostat
1228704|NCT01901419|nitroglycerin|nitroglycerin
1228705|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
1228706|NCT01901419|cardiac surgery|cardiac surgery
1228707|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
1228708|NCT01901393|Post Operative Pain,|post operative pain,
1228709|NCT01901393|Pail relief|pail relief
1228710|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
1228711|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
1228712|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
1228713|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
1228714|NCT01901354|ARDSNet|ardsnet
1228715|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
1228716|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
1228717|NCT01901341|Opioid|opioid
1228718|NCT01901341|Constipation|constipation
1228719|NCT01901341|Chronic|chronic
1228720|NCT01901341|Pain|pain
1228721|NCT01901328|Opioid|opioid
1228722|NCT01901328|Constipation|constipation
1228723|NCT01901328|Chronic|chronic
1228724|NCT01901328|Pain|pain
1228725|NCT01901315|telepsychiatry|telepsychiatry
1228726|NCT01901315|telemental health|telemental health
1228727|NCT01901315|teleassistance|teleassistance
1228728|NCT01901315|health care delivery|health care delivery
1228729|NCT01901315|depression|depression
1228730|NCT01901315|Telemedicine|telemedicine
1228731|NCT01901315|Remote Consultation|remote consultation
1228732|NCT01901315|Videoconferencing|videoconferencing
1228733|NCT01901315|Community Mental Health Services|community mental health services
1228734|NCT01901302|Opioid|opioid
1228735|NCT01901302|Constipation|constipation
1228736|NCT01901302|Chronic|chronic
1228737|NCT01901302|Pain|pain
1228738|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
1228739|NCT01901289|Femoral Artery|femoral artery
1228740|NCT01901289|Popliteal Artery|popliteal artery
1228741|NCT01901289|Drug-Eluting Stent|drug-eluting stent
1228742|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
1228743|NCT01901276|Microbiome|microbiome
1228744|NCT01901276|Clostridium difficile|clostridium difficile
1228745|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
1228746|NCT01901263|Alzheimer Disease|alzheimer disease
1228747|NCT01901263|Dementia|dementia
1228748|NCT01901250|Dental Caries|dental caries
1228749|NCT01901250|Xylitol|xylitol
1228750|NCT01901250|Prevention|prevention
1228751|NCT01901237|Cancer|cancer
1228752|NCT01901237|Adolescent and Young Adult|adolescent and young adult
1228753|NCT01901237|Exercise|exercise
1228754|NCT01901237|Physical Activity|physical activity
1228755|NCT01901237|Quality of Life|quality of life
1228756|NCT01901237|End-of-Life|end-of-life
1228757|NCT01901237|Palliative|palliative
1228758|NCT01901237|Terminal|terminal
1228759|NCT01901237|Yoga|yoga
1228760|NCT01901237|Alternative Therapies|alternative therapies
1228761|NCT01901237|Fitness|fitness
1228762|NCT01901237|Fatigue|fatigue
1228763|NCT01901211|Cerebral palsy|cerebral palsy
1228764|NCT01901211|Interactive computer play|interactive computer play
1228765|NCT01901211|Multi-player gaming|multi-player gaming
1228766|NCT01901211|Exercise|exercise
1228767|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
1228768|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
1228769|NCT01901133|Phase 1|phase 1
1228770|NCT01901133|MDV3100|mdv3100
1228771|NCT01901133|Hepatic Impairment|hepatic impairment
1228772|NCT01901133|Kidney Diseases|kidney diseases
1228773|NCT01901133|Xtandi|xtandi
1228774|NCT01901133|enzalutamide|enzalutamide
1228775|NCT01901120|Betanis®|betanis®
1228776|NCT01901120|mirabegron|mirabegron
1228777|NCT01901120|Overactive Bladder|overactive bladder
1228778|NCT01901107|Hemodialysis|hemodialysis
1228779|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
1228780|NCT01901107|ASP1585|asp1585
1228781|NCT01901107|Hyperphosphatemia|hyperphosphatemia
1228782|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
1228783|NCT01901081|IMES|imes
1228784|NCT01901081|transradial|transradial
1228785|NCT01901081|amputation|amputation
1228786|NCT01901081|myoelectric|myoelectric
1228787|NCT01901081|prosthesis|prosthesis
1228788|NCT01901081|prosthetic control|prosthetic control
1228789|NCT01901068|Laparotomy|laparotomy
1228790|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
1228791|NCT01901068|Sutures|sutures
1228792|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
1228793|NCT01901055|sleep apnea|sleep apnea
1228794|NCT01901055|diabetes|diabetes
1228795|NCT01901042|Quality of life|quality of life
1228796|NCT01901042|Symbiotic|symbiotic
1228797|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
1228798|NCT01901029|Male Reproductive Health|male reproductive health
1228799|NCT01901029|Floating Population|floating population
1228800|NCT01901029|Sexual Behavior|sexual behavior
1228801|NCT01901029|Erectile Dysfunction|erectile dysfunction
1228802|NCT01901029|Premature Ejaculation|premature ejaculation
1228804|NCT01901016|depressive symptoms|depressive symptoms
1228805|NCT01901016|quality of life|quality of life
1228806|NCT01901016|relaxation|relaxation
1228807|NCT01901016|viral load|viral load
1228808|NCT01901016|CD4+ T cell count|cd4+ t cell count
1228809|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
1228810|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
1228811|NCT01900990|tracheotomy|tracheotomy
1228812|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
1228813|NCT01900977|Combination Prevention|combination prevention
1228814|NCT01900964|Regeneration|regeneration
1228815|NCT01900964|Bone regeneration|bone regeneration
1228816|NCT01900964|Grafting, Bone|grafting, bone
1228817|NCT01900964|Allograft|allograft
1228818|NCT01900964|Xenograft|xenograft
1228819|NCT01900951|Small cell lung cancer|small cell lung cancer
1228820|NCT01900951|temozolomide|temozolomide
1228821|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
1228822|NCT01900938|Cholangiopancreatography|cholangiopancreatography
1228823|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
1228824|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
1228825|NCT01900912|sanitation|sanitation
1228826|NCT01900912|diarrhea prevalence|diarrhea prevalence
1228827|NCT01900912|health|health
1228828|NCT01900912|social networks|social networks
1228829|NCT01900912|cooperation|cooperation
1228830|NCT01900899|Healthy|healthy
1228831|NCT01900899|Immunogenicity|immunogenicity
1228832|NCT01900899|Children|children
1228833|NCT01900899|Neisseria meningitidis|neisseria meningitidis
1228834|NCT01900899|Long-term antibody persistence|long-term antibody persistence
1228835|NCT01900899|Safety|safety
1228836|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
1228837|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
1228838|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
1228839|NCT01900873|COPD|copd
1228840|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
1228841|NCT01900873|Dyspnea|dyspnea
1228842|NCT01900860|Vitamin D|vitamin d
1228843|NCT01900860|Bone quality|bone quality
1228844|NCT01900860|Bone density|bone density
1228845|NCT01900860|calcium metabolism|calcium metabolism
1228846|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
1228847|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
1228848|NCT01900860|Quality of life|quality of life
1228849|NCT01900847|Ketamine|ketamine
1228850|NCT01900847|Acute Pain|acute pain
1228851|NCT01900795|Postsurgical pain|postsurgical pain
1228852|NCT01900743|Sarcoma|sarcoma
1228853|NCT01900743|Metastatic|metastatic
1228854|NCT01900743|Regorafenib|regorafenib
1228855|NCT01900730|Breast cancer|breast cancer
1228856|NCT01900730|Metastatic|metastatic
1228857|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
1228858|NCT01900730|Valproic acid|valproic acid
1228859|NCT01900730|VPA|vpa
1228860|NCT01900730|Depakene|depakene
1228861|NCT01900730|Placebo|placebo
1228862|NCT01900730|Pill diary|pill diary
1228863|NCT01900730|Drainage diary|drainage diary
1228864|NCT01900730|Questionnaires|questionnaires
1228865|NCT01900730|Surveys|surveys
1228866|NCT01900691|Esophageal Fistula|esophageal fistula
1228867|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
1228868|NCT01900691|Esophageal Perforation|esophageal perforation
1228869|NCT01900691|Esophageal Stenosis|esophageal stenosis
1228870|NCT01900691|Stents|stents
1228871|NCT01900639|aspirin|aspirin
1228872|NCT01900639|circadian rhythm|circadian rhythm
1228873|NCT01900639|platelet reactivity|platelet reactivity
1228874|NCT01900639|platelet activation|platelet activation
1228875|NCT01900639|time dependent|time dependent
1228876|NCT01900613|child obesity|child obesity
1228877|NCT01900613|Mexican-American|mexican-american
1228878|NCT01900613|Nutrition education|nutrition education
1228879|NCT01900613|Intervention|intervention
1228880|NCT01900587|Healthy|healthy
1228881|NCT01900587|Bio-equivalence|bio-equivalence
1228882|NCT01900587|Tapentadol extended release|tapentadol extended release
1228883|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
1228884|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
1228885|NCT01900574|Ulcerative Colitis|ulcerative colitis
1228886|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
1228887|NCT01900574|Golimumab|golimumab
1228888|NCT01900574|Simponi|simponi
1228889|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
1228890|NCT01900574|Pediatric participants|pediatric participants
1228891|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
1228892|NCT01900561|prostate cancer|prostate cancer
1228893|NCT01900561|survivorship|survivorship
1228894|NCT01900561|intervention|intervention
1228895|NCT01900561|telemedicine|telemedicine
1228896|NCT01900548|Osteopenia|osteopenia
1228897|NCT01900548|Sarcopenia|sarcopenia
1228898|NCT01900548|Osteoporosis|osteoporosis
1228899|NCT01900548|Physical function|physical function
1228900|NCT01900548|Body composition|body composition
1228901|NCT01900548|Muscle protein|muscle protein
1228902|NCT01900548|Leucine|leucine
1228903|NCT01900548|Ketogenic amino acids|ketogenic amino acids
1228904|NCT01900548|Resistance Training|resistance training
1228905|NCT01900548|Whey protein|whey protein
1228906|NCT01900548|Soy protein|soy protein
1228907|NCT01900548|Bone turnover|bone turnover
1228908|NCT01900535|chlorhexidine|chlorhexidine
1228909|NCT01900535|gingivitis|gingivitis
1228910|NCT01900535|periodontitis|periodontitis
1228911|NCT01900522|Drug therapy|drug therapy
1228912|NCT01900509|Childhood leukemia|childhood leukemia
1228913|NCT01900509|Childhood lymphoma|childhood lymphoma
1228914|NCT01900509|Bendamustine|bendamustine
1228915|NCT01900496|cHL|chl
1228916|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
1228917|NCT01900496|Lymphoma|lymphoma
1228918|NCT01900496|relapsed Lymphoma|relapsed lymphoma
1228919|NCT01900496|SGN-35|sgn-35
1228920|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
1228921|NCT01900496|Rituxan|rituxan
1228922|NCT01900496|Rituximab|rituximab
1228923|NCT01900470|Multiple chronic conditions|multiple chronic conditions
1228924|NCT01900444|Japanese encephalitis|japanese encephalitis
1228925|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1228926|NCT01900444|IMOJEV®|imojev®
1228927|NCT01900418|breast cancer|breast cancer
1228928|NCT01900418|aromatase inhibitors|aromatase inhibitors
1228929|NCT01900418|physical activity|physical activity
1228930|NCT01900418|joint pain|joint pain
1228931|NCT01900405|Dexmedetomidine|dexmedetomidine
1228932|NCT01900405|Administration, Intranasal|administration, intranasal
1228933|NCT01900405|Children|children
1228934|NCT01900405|Computerized Tomography|computerized tomography
1228935|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
1228936|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
1228937|NCT01900379|Heart failure|heart failure
1228938|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
1228939|NCT01900366|Obesity|obesity
1228940|NCT01900366|Healthy Volunteers|healthy volunteers
1228941|NCT01900340|GLP-1|glp-1
1228942|NCT01900340|satiation peptides|satiation peptides
1228943|NCT01900340|food intake|food intake
1228944|NCT01900327|pancreatic cancer|pancreatic cancer
1228945|NCT01900327|surgery|surgery
1228946|NCT01900327|chemoradiation|chemoradiation
1228947|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
1228948|NCT01900327|overall survival|overall survival
1228949|NCT01900314|Major Depression|major depression
1228950|NCT01900314|Major Depressive Disorder|major depressive disorder
1228951|NCT01900314|TMS|tms
1228952|NCT01900314|rTMS|rtms
1228953|NCT01900301|exposure|exposure
1228954|NCT01900301|scopolamine|scopolamine
1228955|NCT01900301|extinction learning|extinction learning
1228956|NCT01900301|social anxiety|social anxiety
1228957|NCT01900288|short bowel disorder|short bowel disorder
1228958|NCT01900288|short bowel syndrome|short bowel syndrome
1228959|NCT01900288|home parenteral nutrition|home parenteral nutrition
1228960|NCT01900288|HPN|hpn
1229350|NCT01898338|MRSA|mrsa
1228961|NCT01900288|total parenteral nutrition|total parenteral nutrition
1228962|NCT01900288|TPN|tpn
1228963|NCT01900288|telehealth|telehealth
1228964|NCT01900288|telemedicine|telemedicine
1228965|NCT01900275|Sepsis|sepsis
1228966|NCT01900275|Trauma|trauma
1228967|NCT01900275|Shock|shock
1228968|NCT01900275|Acute kidney injury|acute kidney injury
1228969|NCT01900275|Heparanase|heparanase
1228970|NCT01900262|Biomechanics|biomechanics
1228971|NCT01900262|Ankle Strength|ankle strength
1228972|NCT01900262|Postural Control|postural control
1228973|NCT01900262|Running Mechanics|running mechanics
1228974|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
1312984|NCT01528085|ALL|all
1228975|NCT01900210|Criminal justice|criminal justice
1228976|NCT01900210|substance abuse treatment|substance abuse treatment
1228977|NCT01900210|HIV risk behaviors|hiv risk behaviors
1228978|NCT01900158|Phase I, Phase II, Dose Escalation, Safety, Tolerability,|phase i, phase ii, dose escalation, safety, tolerability,
1229073|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
1228979|NCT01900158|Efficacy, Amphinex induced Photochemical Internalisation, PCI, Amphinex, Gemcitabine, Cisplatin,|efficacy, amphinex induced photochemical internalisation, pci, amphinex, gemcitabine, cisplatin,
1228980|NCT01900158|Inoperable Cholangiocarcinomas, CCA, Cholangiocarcinoma, bile duct cancer, photodynamic therapy|inoperable cholangiocarcinomas, cca, cholangiocarcinoma, bile duct cancer, photodynamic therapy
1228981|NCT01900132|Electrophysiology|electrophysiology
1228982|NCT01900132|Neuromuscular Disease|neuromuscular disease
1228983|NCT01900119|Oral Microbiome|oral microbiome
1228984|NCT01900119|Next Generation Sequencing|next generation sequencing
1228985|NCT01900106|late presenter|late presenter
1228986|NCT01900106|naïve|naïve
1228987|NCT01900106|advanced HIV disease|advanced hiv disease
1228988|NCT01900080|HIV|hiv
1228989|NCT01900080|AIDS|aids
1228990|NCT01900080|Antiretroviral therapy|antiretroviral therapy
1228991|NCT01900080|Retention in care|retention in care
1228992|NCT01900080|Adherence|adherence
1228993|NCT01900080|Cost-effectiveness|cost-effectiveness
1228994|NCT01900054|TAU-284|tau-284
1228995|NCT01900054|Bepotastine besilate|bepotastine besilate
1228996|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
1228997|NCT01900054|children|children
1228998|NCT01900028|oncology,|oncology,
1228999|NCT01900028|cancer,|cancer,
1229000|NCT01900028|tumour,|tumour,
1229001|NCT01900028|anticancer drug,|anticancer drug,
1229002|NCT01900028|pharmacokinetics,|pharmacokinetics,
1229003|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
1229004|NCT01900028|neoplasm,|neoplasm,
1229005|NCT01900028|QT interval|qt interval
1229006|NCT01900002|Liver Cancer|liver cancer
1229007|NCT01900002|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1229008|NCT01900002|HCC|hcc
1229009|NCT01900002|Sorafenib|sorafenib
1229010|NCT01900002|Nexavar|nexavar
1229011|NCT01900002|BAY 43-9006|bay 43-9006
1229012|NCT01900002|Yttrium-90|yttrium-90
1229013|NCT01900002|Microspheres|microspheres
1229014|NCT01900002|Phone calls|phone calls
1229015|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1229016|NCT01899989|Chemotherapy|chemotherapy
1229017|NCT01899989|13-113|13-113
1229018|NCT01899976|covered biliary stent|covered biliary stent
1229019|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
1229020|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
1229021|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
1229022|NCT01899963|Diabetic Macular Edema|diabetic macular edema
1229023|NCT01899963|Telemedicine|telemedicine
1229024|NCT01899963|Teleophthalmology|teleophthalmology
1229025|NCT01899963|Time to Treatment|time to treatment
1229026|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
1229027|NCT01899950|Lysosomal disease|lysosomal disease
1229028|NCT01899937|Endothelial dysfunction|endothelial dysfunction
1229029|NCT01899937|Flow mediated dilation|flow mediated dilation
1229030|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
1229031|NCT01899937|FMD|fmd
1229032|NCT01899898|Refractory epilepsy|refractory epilepsy
1229033|NCT01899898|Dietary therapy|dietary therapy
1229034|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
1229035|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
1229036|NCT01899885|Emergency laparotomy|emergency laparotomy
1229037|NCT01899885|Emergency laparoscopy|emergency laparoscopy
1229038|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1229039|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
1229040|NCT01899872|Endothelial function|endothelial function
1229041|NCT01899872|Exercise|exercise
1229042|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1229043|NCT01899846|Makena|makena
1229044|NCT01899846|Pharmacokinetics|pharmacokinetics
1229045|NCT01899846|Prior preterm delivery|prior preterm delivery
1229046|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
1229047|NCT01899846|17P|17p
1229048|NCT01899833|Coronary Artery Disease|coronary artery disease
1229049|NCT01899833|CAD|cad
1229050|NCT01899781|Lacerations|lacerations
1229051|NCT01899781|Tendons|tendons
1229052|NCT01899781|Antobiotic|antobiotic
1229053|NCT01899768|efficacy|efficacy
1229054|NCT01899768|hypertussive challenge|hypertussive challenge
1229055|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
1229056|NCT01899768|anaesthesia|anaesthesia
1229057|NCT01899768|Safety and tolerability|safety and tolerability
1229058|NCT01899768|capsaicin challenge|capsaicin challenge
1229059|NCT01899768|cough|cough
1229060|NCT01899768|citric acid challenge|citric acid challenge
1229061|NCT01899768|pharmacokinetics|pharmacokinetics
1229062|NCT01899755|monoclonal antibody|monoclonal antibody
1229063|NCT01899755|healthy volunteer|healthy volunteer
1229064|NCT01899755|TNF alpha|tnf alpha
1229065|NCT01899729|plaque psoriasis|plaque psoriasis
1229066|NCT01899729|autoimmune disease|autoimmune disease
1229067|NCT01899729|Toll like receptor|toll like receptor
1229068|NCT01899716|Severe Depression|severe depression
1229069|NCT01899716|Quality of life|quality of life
1229070|NCT01899716|Exercise|exercise
1229071|NCT01899716|BDNF|bdnf
1229072|NCT01899716|TBARS|tbars
1229074|NCT01899703|Pruritus|pruritus
1229075|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
1229076|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
1229077|NCT01899703|GSK2330672|gsk2330672
1229078|NCT01899703|Pharmacokinetics|pharmacokinetics
1229079|NCT01899690|breast reconstruction|breast reconstruction
1229080|NCT01899690|cancer|cancer
1229081|NCT01899690|expander|expander
1229082|NCT01899690|antibiotics|antibiotics
1229083|NCT01899690|infection|infection
1229084|NCT01899690|surgical site infection|surgical site infection
1229085|NCT01899690|surgery|surgery
1229086|NCT01899690|oncology|oncology
1229087|NCT01899690|plastic surgery|plastic surgery
1229088|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
1229089|NCT01899664|peripheral nerves|peripheral nerves
1229090|NCT01899664|quadriplegia|quadriplegia
1229091|NCT01899664|nerve transfer|nerve transfer
1229092|NCT01899664|surgical procedures, operative|surgical procedures, operative
1229093|NCT01899664|hand|hand
1229094|NCT01899664|upper extremity|upper extremity
1229095|NCT01899664|quality of life|quality of life
1229097|NCT01899651|Brain|brain
1229098|NCT01899651|Infants|infants
1229099|NCT01899651|Preterm|preterm
1229100|NCT01899651|Hemorrhage|hemorrhage
1229101|NCT01899651|Bleeding|bleeding
1229102|NCT01899625|Obesity|obesity
1229103|NCT01899625|weight loss|weight loss
1229104|NCT01899625|young adults|young adults
1229105|NCT01899612|menopause|menopause
1229106|NCT01899612|vaginal atrophy|vaginal atrophy
1229107|NCT01899612|cytokine|cytokine
1229108|NCT01899612|IL-1beta|il-1beta
1229109|NCT01899612|IL-6|il-6
1229110|NCT01899612|IL-8|il-8
1229111|NCT01899612|TNF-alpha|tnf-alpha
1229112|NCT01899586|Aging|aging
1229113|NCT01899586|Functional Capacity|functional capacity
1229114|NCT01899586|Exercise Independence|exercise independence
1229115|NCT01899586|Peripheral Adaptations|peripheral adaptations
1229116|NCT01899586|Vascular|vascular
1229117|NCT01899573|Heart failure|heart failure
1229118|NCT01899573|mitral regurgitation|mitral regurgitation
1229119|NCT01899573|mitral valve|mitral valve
1229120|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1229121|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
1229122|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
1229123|NCT01899560|Lung elastance|lung elastance
1229124|NCT01899560|chest wall elastance|chest wall elastance
1229125|NCT01899534|Pregnancy|pregnancy
1229126|NCT01899534|Mental Health|mental health
1229127|NCT01899534|Screening|screening
1229128|NCT01899534|Computer|computer
1229129|NCT01899534|Feasibility|feasibility
1229130|NCT01899521|alcoholism|alcoholism
1229131|NCT01899521|lung health|lung health
1229132|NCT01899521|pulmonary|pulmonary
1229133|NCT01899521|macrophage|macrophage
1229134|NCT01899521|zinc|zinc
1229135|NCT01899521|SAMe|same
1229136|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
1229137|NCT01899521|alveolar|alveolar
1229138|NCT01899495|blood pressure|blood pressure
1229139|NCT01899495|hypertension|hypertension
1229140|NCT01899495|salt sensitivity|salt sensitivity
1229141|NCT01899482|Venous Insufficiency|venous insufficiency
1229142|NCT01899482|Physical Therapy Techniques|physical therapy techniques
1229143|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
1229144|NCT01899443|total hip replacement|total hip replacement
1229145|NCT01899443|total knee replacement|total knee replacement
1229146|NCT01899443|patient outcomes|patient outcomes
1229147|NCT01899443|health services research|health services research
1229148|NCT01899430|PCOS|pcos
1229149|NCT01899430|obesity|obesity
1229150|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
1229151|NCT01899430|liraglutide|liraglutide
1229152|NCT01899430|metformin|metformin
1229153|NCT01899417|osteoarthritis|osteoarthritis
1229154|NCT01899417|knee replacement|knee replacement
1229155|NCT01899417|patient-specific|patient-specific
1229156|NCT01899417|economics|economics
1229157|NCT01899404|Cervical Cancer|cervical cancer
1229351|NCT01898338|bacteremia|bacteremia
1229158|NCT01899404|PET Scan for cervix|pet scan for cervix
1229159|NCT01899404|MRI for cervix|mri for cervix
1229160|NCT01899391|Prostate cancer|prostate cancer
1229161|NCT01899378|probiotics|probiotics
1229162|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
1229163|NCT01899365|information|information
1229164|NCT01899365|emergency department|emergency department
1229165|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
1229166|NCT01899339|Ultrasonic energy|ultrasonic energy
1229167|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
1229168|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
1229169|NCT01899313|methamphetamine dependence|methamphetamine dependence
1229170|NCT01899313|texting|texting
1229171|NCT01899313|short message service|short message service
1229172|NCT01899313|addiction|addiction
1229173|NCT01899313|amphetamine|amphetamine
1229174|NCT01899313|outpatient|outpatient
1229175|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
1229675|NCT01896505|bone|bone
1229176|NCT01899287|workers education|workers education
1229177|NCT01899287|occupational|occupational
1229178|NCT01899209|Obstructed Defecation|obstructed defecation
1229179|NCT01899209|Rectal rectocele|rectal rectocele
1229180|NCT01899209|Intussusception|intussusception
1229181|NCT01899209|STARR|starr
1229182|NCT01899209|Ventral Rectopexy|ventral rectopexy
1229183|NCT01899196|Cardiac surgery|cardiac surgery
1229184|NCT01899183|Chronic cough|chronic cough
1229185|NCT01899183|Esophagus|esophagus
1229186|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
1229187|NCT01899183|Esophageal surgery|esophageal surgery
1229188|NCT01899183|Minimally invasive surgery|minimally invasive surgery
1229189|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
1229190|NCT01899170|deep brain stimulation|deep brain stimulation
1229191|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
1229192|NCT01899170|PET-imaging|pet-imaging
1229193|NCT01899170|personalized treatment|personalized treatment
1229194|NCT01899157|Nutritional status|nutritional status
1229195|NCT01899157|Nutritional situation|nutritional situation
1229196|NCT01899144|Albuterol Spiromax|albuterol spiromax
1229197|NCT01899144|ProAir HFA|proair hfa
1229198|NCT01899144|albuterol sulfate|albuterol sulfate
1229199|NCT01899131|dental implants|dental implants
1229200|NCT01899131|crestal bone|crestal bone
1229201|NCT01899131|gingival margin|gingival margin
1229202|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
1229203|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1229204|NCT01899118|Nimotuzumab|nimotuzumab
1229205|NCT01899092|Genotype 1|genotype 1
1229206|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
1229207|NCT01899092|CHC|chc
1229208|NCT01899092|HCV|hcv
1229209|NCT01899092|Hepatitis|hepatitis
1229210|NCT01899092|RNAi|rnai
1229211|NCT01899092|shRNA|shrna
1229212|NCT01899092|ddRNAi|ddrnai
1229213|NCT01899092|AAV8|aav8
1229214|NCT01899092|AAV|aav
1229215|NCT01899092|Adeno-associated virus|adeno-associated virus
1229216|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
1229217|NCT01899079|Breast Cancer|breast cancer
1229218|NCT01899079|Prosigna|prosigna
1229219|NCT01899079|FFPE|ffpe
1229220|NCT01899079|node negative|node negative
1229221|NCT01899079|estrogen receptor positive|estrogen receptor positive
1229222|NCT01899079|HER2 negative|her2 negative
1229223|NCT01899066|Efficacy|efficacy
1229224|NCT01899053|Solid tumors|solid tumors
1229225|NCT01899053|MLN0128|mln0128
1229226|NCT01899053|MLN1117|mln1117
1229227|NCT01899040|neuromodulation|neuromodulation
1229228|NCT01899040|migraine headache|migraine headache
1229229|NCT01899027|Arterial hypertension|arterial hypertension
1229230|NCT01899027|Radiofrequency ablation|radiofrequency ablation
1229231|NCT01899027|Renal function|renal function
1229232|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
1229233|NCT01899001|PCOS|pcos
1229234|NCT01899001|Depression|depression
1229235|NCT01899001|Anxiety|anxiety
1229236|NCT01899001|Weight loss|weight loss
1229237|NCT01899001|Exercise|exercise
1229238|NCT01899001|Nutrition|nutrition
1229239|NCT01899001|Therapy|therapy
1229240|NCT01899001|Mood symptoms|mood symptoms
1229241|NCT01899001|Stress|stress
1229242|NCT01898975|Neurosurgical patients|neurosurgical patients
1229243|NCT01898975|Fluid loading|fluid loading
1229244|NCT01898975|Fluid responsiveness|fluid responsiveness
1229245|NCT01898975|NICOM|nicom
1229246|NCT01898975|Stroke volume variation|stroke volume variation
1229247|NCT01898975|Pulse pressure variation|pulse pressure variation
1229248|NCT01898975|Total peripheral resistance|total peripheral resistance
1229249|NCT01898975|Gray zone approach|gray zone approach
1229250|NCT01898962|Oligometastases|oligometastases
1229251|NCT01898962|Metastatic cancer|metastatic cancer
1229252|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
1229253|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
1229254|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
1229255|NCT01898949|Brown adipose tissue|brown adipose tissue
1229256|NCT01898949|Brown fat|brown fat
1229352|NCT01898338|therapy|therapy
1229257|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
1229258|NCT01898845|Neoplasms|neoplasms
1229259|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
1229260|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
1229261|NCT01898819|intraocular pressure|intraocular pressure
1229262|NCT01898806|Alopecia Areata|alopecia areata
1229263|NCT01898806|Kenalog|kenalog
1229264|NCT01898806|Triamcinolone|triamcinolone
1229265|NCT01898767|mild|mild
1229266|NCT01898767|asthma|asthma
1229267|NCT01898767|allergic|allergic
1229268|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
1229269|NCT01898741|Pancreatic cancer|pancreatic cancer
1229270|NCT01898741|Radiotherapy|radiotherapy
1229271|NCT01898741|SBRT|sbrt
1229272|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
1229273|NCT01898715|Adrenal cancer|adrenal cancer
1229274|NCT01898715|ACC|acc
1229275|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
1229276|NCT01898676|Depakote ER|depakote er
1229277|NCT01898650|craniosynostosis|craniosynostosis
1229278|NCT01898650|sagittal synostosis|sagittal synostosis
1229279|NCT01898650|metopic synostosis|metopic synostosis
1229280|NCT01898650|coronal synostosis|coronal synostosis
1229281|NCT01898650|lambdoid synostosis|lambdoid synostosis
1229282|NCT01898637|pulmonary embolism|pulmonary embolism
1229283|NCT01898637|pulse oximetry|pulse oximetry
1229284|NCT01898637|change in oxygen saturation|change in oxygen saturation
1229285|NCT01898637|hypoxemia|hypoxemia
1229286|NCT01898637|emergency department|emergency department
1229287|NCT01898637|deep inspiration|deep inspiration
1229288|NCT01898637|vital capacity|vital capacity
1229289|NCT01898637|clinical diagnosis|clinical diagnosis
1229290|NCT01898624|mirabegron|mirabegron
1229291|NCT01898624|Overactive Bladder|overactive bladder
1229292|NCT01898624|Betanis®|betanis®
1229293|NCT01898624|glaucoma|glaucoma
1229294|NCT01898611|Frailty|frailty
1229295|NCT01898611|Sarcopenia|sarcopenia
1229296|NCT01898611|Weight Loss|weight loss
1229297|NCT01898611|Exercise|exercise
1229298|NCT01898611|Aging|aging
1229299|NCT01898611|Ghrelin|ghrelin
1229300|NCT01898611|Elderly|elderly
1229301|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
1229302|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
1229303|NCT01898572|Carotid Plaque|carotid plaque
1229304|NCT01898572|Cardiovascular Disease|cardiovascular disease
1229305|NCT01898559|little cigars|little cigars
1229306|NCT01898559|cigarettes|cigarettes
1229307|NCT01898559|smoking|smoking
1229308|NCT01898546|Ischemic postconditioning|ischemic postconditioning
1229309|NCT01898546|Myocardial Infarction|myocardial infarction
1229310|NCT01898546|Microvascular Obstruction|microvascular obstruction
1229311|NCT01898520|Spasticity|spasticity
1229312|NCT01898507|low nicotine|low nicotine
1229313|NCT01898507|cigarettes|cigarettes
1229314|NCT01898507|NMR|nmr
1229315|NCT01898481|Health care decision making|health care decision making
1229316|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
1229317|NCT01898468|Intracostal Closure Technique|intracostal closure technique
1229318|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
1229319|NCT01898468|Post surgical pain|post surgical pain
1229320|NCT01898468|Post thoracotomy pain|post thoracotomy pain
1229321|NCT01898455|Migraine|migraine
1229322|NCT01898455|Cluster headache|cluster headache
1229323|NCT01898455|headache|headache
1229324|NCT01898442|platelet function|platelet function
1229325|NCT01898442|ticagrelor|ticagrelor
1229326|NCT01898442|STEMI|stemi
1229327|NCT01898429|Treatment Resistant Depression|treatment resistant depression
1229328|NCT01898429|Treatment Refractory Depression|treatment refractory depression
1229329|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
1229330|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
1229331|NCT01898429|Deep brain stimulation|deep brain stimulation
1229332|NCT01898429|DBS|dbs
1229333|NCT01898390|Parkinson's Disease|parkinson's disease
1229334|NCT01898390|Allo-Transplantation|allo-transplantation
1229335|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
1229336|NCT01898377|Children|children
1229337|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
1229338|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
1229339|NCT01898351|High protein diets|high protein diets
1229340|NCT01898351|Satiety|satiety
1229341|NCT01898351|Postprandial effects|postprandial effects
1229342|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
1229343|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
1229344|NCT01898351|Macronutrients metabolism|macronutrients metabolism
1229345|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
1229346|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
1229347|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
1229348|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
1229349|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
1229355|NCT01898299|Schizophrenia|schizophrenia
1229356|NCT01898286|C peptide|c peptide
1229357|NCT01898286|beta cell function|beta cell function
1229358|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
1313482|NCT01525901|SHANK3|shank3
1229359|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
1229360|NCT01898273|Glioma|glioma
1229361|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
1229362|NCT01898273|PET|pet
1229363|NCT01898273|Imaging|imaging
1229364|NCT01898273|Radiopharmaceutical|radiopharmaceutical
1229365|NCT01898273|Diagnostic|diagnostic
1229366|NCT01898260|contact lenses|contact lenses
1229367|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
1229368|NCT01898260|silicone hydrogel|silicone hydrogel
1229369|NCT01898260|contact lens comfort|contact lens comfort
1229370|NCT01898260|near-sighted|near-sighted
1229371|NCT01898247|Thoracentesis|thoracentesis
1229372|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
1229373|NCT01898247|Medical Education|medical education
1229374|NCT01898247|Length of Stay|length of stay
1229375|NCT01898247|Cost of Care|cost of care
1229376|NCT01898234|Hemodynamics|hemodynamics
1229377|NCT01898234|intradialytic hypotension|intradialytic hypotension
1229378|NCT01898234|subjective tolerance|subjective tolerance
1229379|NCT01898234|dialysis membranes|dialysis membranes
1229380|NCT01898234|high flux|high flux
1229381|NCT01898234|low flux|low flux
1229382|NCT01898234|hemodialysis|hemodialysis
1229383|NCT01898208|Bacteremia|bacteremia
1229384|NCT01898208|Fungemia|fungemia
1229385|NCT01898208|Bloodstream infection|bloodstream infection
1229386|NCT01898208|susceptibility|susceptibility
1229387|NCT01898208|MRSA|mrsa
1229388|NCT01898208|VRE|vre
1229389|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
1229392|NCT01898104|rectal|rectal
1229393|NCT01898104|low risk|low risk
1229394|NCT01898104|moderate risk|moderate risk
1229395|NCT01898091|Oral|oral
1229396|NCT01898091|Mucositis|mucositis
1229397|NCT01898091|Stomatitis|stomatitis
1229398|NCT01898091|Radiotherapy|radiotherapy
1229399|NCT01898078|MLN8237|mln8237
1229400|NCT01898078|alisertib|alisertib
1229401|NCT01898078|food effects|food effects
1229402|NCT01898065|Hypoxia|hypoxia
1229403|NCT01898065|radiotherapy|radiotherapy
1229404|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
1229405|NCT01898065|MRI|mri
1229406|NCT01898052|pain control|pain control
1229407|NCT01898052|periarticular injection|periarticular injection
1229408|NCT01898052|Total knee arthroplasty|total knee arthroplasty
1229409|NCT01898052|levobupivacaine|levobupivacaine
1229410|NCT01898052|multimodal drug injection|multimodal drug injection
1229411|NCT01898039|malignant melanoma|malignant melanoma
1229412|NCT01898039|vaccine|vaccine
1229413|NCT01898039|cell line|cell line
1229414|NCT01898039|high risk|high risk
1229415|NCT01898039|residual disease|residual disease
1229416|NCT01898026|PGX|pgx
1229417|NCT01898026|fibre|fibre
1229418|NCT01898026|postprandial glycemia|postprandial glycemia
1229419|NCT01898013|pain|pain
1229420|NCT01898013|pregnenolone|pregnenolone
1229421|NCT01898013|Veterans|veterans
1229422|NCT01898013|clinical trial|clinical trial
1229423|NCT01898013|neurosteroid|neurosteroid
1229424|NCT01898013|allopregnanolone|allopregnanolone
1229425|NCT01898013|low back|low back
1229426|NCT01898013|placebo controlled|placebo controlled
1229427|NCT01898013|randomized|randomized
1229428|NCT01898013|musculoskeletal|musculoskeletal
1229429|NCT01898000|Gingivitis|gingivitis
1229430|NCT01898000|Herbal medicine|herbal medicine
1229431|NCT01898000|Plaque control|plaque control
1229432|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
1229433|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1229434|NCT01897987|Premature infants|premature infants
1229435|NCT01897935|Uveitis|uveitis
1229436|NCT01897896|Chorea|chorea
1229437|NCT01897896|Huntington Disease|huntington disease
1229438|NCT01897870|continuity of care|continuity of care
1229439|NCT01897870|medicines management|medicines management
1229440|NCT01897870|home visit|home visit
1229441|NCT01897870|drug-related problems|drug-related problems
1229442|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
1229565|NCT01897103|Transcriptomics|transcriptomics
1229443|NCT01897857|radial artery cannulation|radial artery cannulation
1229444|NCT01897857|artery blood flow|artery blood flow
1229445|NCT01897857|complication|complication
1229446|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
1229447|NCT01897844|volunteers|volunteers
1229448|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
1229449|NCT01897831|Phase IV clinical studies|phase iv clinical studies
1229450|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
1229451|NCT01897805|Coronary artery disease|coronary artery disease
1229452|NCT01897766|Genotropin|genotropin
1229453|NCT01897766|Somatropin|somatropin
1229454|NCT01897766|Long Term Follow-Up|long term follow-up
1229455|NCT01897766|Special Investigation|special investigation
1229456|NCT01897766|Small for Gestational Age|small for gestational age
1229457|NCT01897766|SGA|sga
1229458|NCT01897753|SGA|sga
1229459|NCT01897753|Growth hormone|growth hormone
1229460|NCT01897740|sildenafil|sildenafil
1229461|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
1229462|NCT01897740|PAH|pah
1229463|NCT01897727|sleep apnea|sleep apnea
1229464|NCT01897727|hypertension|hypertension
1229465|NCT01897727|aldosterone|aldosterone
1229466|NCT01897727|hyperaldosteronism|hyperaldosteronism
1229467|NCT01897727|spironolactone|spironolactone
1229468|NCT01897727|blood pressure|blood pressure
1229469|NCT01897727|resistant|resistant
1229470|NCT01897701|H7N9|h7n9
1229471|NCT01897688|Diabetes|diabetes
1229472|NCT01897688|Islet|islet
1229473|NCT01897688|Pancreas|pancreas
1229474|NCT01897688|Hypoglycemia|hypoglycemia
1229475|NCT01897688|T1D|t1d
1229476|NCT01897688|Transplant|transplant
1229477|NCT01897675|Cutaneous Abscess|cutaneous abscess
1229478|NCT01897675|Emergency Department|emergency department
1229479|NCT01897662|overweight|overweight
1229480|NCT01897662|satiety|satiety
1229481|NCT01897662|functional food|functional food
1229482|NCT01897662|food intake|food intake
1229483|NCT01897662|digestive tolerance|digestive tolerance
1229484|NCT01897649|functional food|functional food
1229485|NCT01897649|digestive tolerance|digestive tolerance
1229486|NCT01897649|microbiota|microbiota
1229487|NCT01897649|bifidogenic effect|bifidogenic effect
1229488|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
1229489|NCT01897636|dendritic cell|dendritic cell
1229490|NCT01897636|vaccination|vaccination
1229491|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
1229492|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
1229493|NCT01897545|Arterial hypertension|arterial hypertension
1229494|NCT01897545|Atrial Fibrillation|atrial fibrillation
1229495|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
1229496|NCT01897519|High risk surgery|high risk surgery
1229497|NCT01897519|Acute Kidney Injury|acute kidney injury
1229498|NCT01897506|Food insecurity|food insecurity
1229499|NCT01897506|Health literacy|health literacy
1229500|NCT01897506|Quality of life|quality of life
1229501|NCT01897402|Central Nervous System Infections|central nervous system infections
1229502|NCT01897402|Meningitis|meningitis
1229503|NCT01897402|toxoid|toxoid
1229504|NCT01897402|Meningococcal vaccine|meningococcal vaccine
1229505|NCT01897402|conjugate vaccines|conjugate vaccines
1229506|NCT01897389|Healthy volunteers|healthy volunteers
1229507|NCT01897389|Bioavailability|bioavailability
1229508|NCT01897389|Abiraterone acetate|abiraterone acetate
1229509|NCT01897389|ZYTIGA|zytiga
1229510|NCT01897376|wound|wound
1229511|NCT01897376|infection|infection
1229512|NCT01897376|cesarean delivery|cesarean delivery
1229513|NCT01897376|obesity|obesity
1229514|NCT01897363|Prader Willi Syndrome|prader willi syndrome
1229515|NCT01897363|Hypoglycemia|hypoglycemia
1229516|NCT01897363|Fasting study|fasting study
1229517|NCT01897350|STEMI|stemi
1229518|NCT01897350|Myocardial edema|myocardial edema
1229519|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
1229520|NCT01897324|Poor Ovarian Response|poor ovarian response
1229521|NCT01897324|Poor Responders|poor responders
1229522|NCT01897324|IVF/ICSI|ivf/icsi
1229523|NCT01897324|Growth Hormone|growth hormone
1229524|NCT01897311|cesarean section|cesarean section
1229525|NCT01897311|pain|pain
1229526|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1229527|NCT01897311|postpartum period|postpartum period
1229528|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1229529|NCT01897298|urban training|urban training
1229530|NCT01897298|physical activity|physical activity
1229531|NCT01897298|active aging|active aging
1229532|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
1229533|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
1229534|NCT01897272|splinting|splinting
1229535|NCT01897272|nerve decompression|nerve decompression
1229536|NCT01897259|tennis elbow|tennis elbow
1229537|NCT01897259|lateral epicondylitis|lateral epicondylitis
1229538|NCT01897246|distal radius malunion|distal radius malunion
1229539|NCT01897246|extra-articular|extra-articular
1229540|NCT01897220|Noncardiac surgery;|noncardiac surgery;
1229541|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
1229542|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
1229543|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
1229544|NCT01897220|Coronary artery disease;|coronary artery disease;
1229545|NCT01897220|Stent thrombosis;|stent thrombosis;
1229546|NCT01897220|Perioperative infarction.|perioperative infarction.
1229547|NCT01897207|prostate cancer|prostate cancer
1229548|NCT01897207|dendritic cells|dendritic cells
1229549|NCT01897207|vaccination|vaccination
1229550|NCT01897181|Central auditory processing|central auditory processing
1229551|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
1229552|NCT01897181|Hearing aids|hearing aids
1593583|NCT00418184|hyperactive|hyperactive
1229553|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
1229554|NCT01897155|analgesics opioid;|analgesics opioid;
1229555|NCT01897155|hyperalgesia;|hyperalgesia;
1229556|NCT01897155|remifentanil;|remifentanil;
1229557|NCT01897155|hypertension.|hypertension.
1229558|NCT01897103|Peripheral Artery Disease|peripheral artery disease
1229559|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
1229560|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1229561|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
1229562|NCT01897103|Amputation|amputation
1229563|NCT01897103|Platelet Activity|platelet activity
1229564|NCT01897103|Thrombin|thrombin
1229566|NCT01897090|Elimination Diet|elimination diet
1229567|NCT01897090|Crohn's disease|crohn's disease
1229568|NCT01897077|Food Allergy|food allergy
1229570|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
1229571|NCT01897064|Schizophrenia|schizophrenia
1229572|NCT01897064|Cognition|cognition
1229573|NCT01897064|Aerobic Exercise|aerobic exercise
1229574|NCT01897051|Liver cirrhosis|liver cirrhosis
1229575|NCT01897051|Portal hypertension|portal hypertension
1229576|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
1229577|NCT01897051|Rifaximin|rifaximin
1229578|NCT01897025|Stroke|stroke
1229579|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
1229580|NCT01897025|Brain-computer interface|brain-computer interface
1229581|NCT01897025|Motor imagery|motor imagery
1229582|NCT01897025|Rehabilitation|rehabilitation
1229583|NCT01896986|Special risk patients|special risk patients
1229584|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
1229585|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
1229586|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
1229587|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1229589|NCT01896973|LUTS|luts
1229590|NCT01896973|Vortx Rx|vortx rx
1229591|NCT01896973|Histotripsy|histotripsy
1229592|NCT01896960|Post spinal hypotension|post spinal hypotension
1229593|NCT01896960|Cesarian Section|cesarian section
1229594|NCT01896960|ET50|et50
1229595|NCT01896960|Bupivacaine|bupivacaine
1229596|NCT01896960|Fentanyl|fentanyl
1229597|NCT01896934|Depression|depression
1229598|NCT01896934|Antidepressants|antidepressants
1229599|NCT01896934|Elderly|elderly
1229600|NCT01896934|Geriatrics|geriatrics
1229601|NCT01896921|HIV|hiv
1229602|NCT01896908|diastolic dysfunction|diastolic dysfunction
1229603|NCT01896908|Sodium restriction|sodium restriction
1229604|NCT01896908|Randomized clinical trial|randomized clinical trial
1229605|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
1229606|NCT01896882|Food and Nutrition Education|food and nutrition education
1229607|NCT01896882|Renal Dialyisis|renal dialyisis
1229608|NCT01896869|Pancreatic Cancer|pancreatic cancer
1229609|NCT01896869|Vaccine|vaccine
1229610|NCT01896869|Immunotherapy|immunotherapy
1229611|NCT01896869|Ipilimumab|ipilimumab
1229612|NCT01896869|CTLA-4|ctla-4
1229613|NCT01896869|antibody|antibody
1229614|NCT01896869|FOLFIRINOX|folfirinox
1229615|NCT01896856|SGI-110|sgi-110
1229616|NCT01896856|irinotecan|irinotecan
1229617|NCT01896856|regorafenib|regorafenib
1229618|NCT01896856|methylation|methylation
1229619|NCT01896856|colorectal|colorectal
1229620|NCT01896856|metastatic|metastatic
1229621|NCT01896856|TAS-102|tas-102
1229622|NCT01896856|lonsurf|lonsurf
1229623|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
1229624|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
1229625|NCT01896830|Clostridium difficile infection|clostridium difficile infection
1229626|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
1229627|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
1229628|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
1229629|NCT01896713|Prostate Cancer|prostate cancer
1229630|NCT01896713|MRI|mri
1229631|NCT01896713|TRUSBx|trusbx
1229632|NCT01896700|Multiple sclerosis|multiple sclerosis
1229633|NCT01896700|postural balance|postural balance
1229634|NCT01896700|walking|walking
1229635|NCT01896687|nonspecific low back pain|nonspecific low back pain
1229636|NCT01896687|chronic low back pain|chronic low back pain
1229637|NCT01896674|Computed tomography|computed tomography
1229638|NCT01896661|Sleep apnea|sleep apnea
1229639|NCT01896661|Hypertension|hypertension
1229640|NCT01896661|Treatment|treatment
1229641|NCT01896661|Diuretics|diuretics
1229642|NCT01896661|Chlorthalidone|chlorthalidone
1229643|NCT01896661|Amlodipine|amlodipine
1229644|NCT01896635|Ulcerative Colitis|ulcerative colitis
1229645|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
1229646|NCT01896635|Fecal Transplantation|fecal transplantation
1229647|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
1229648|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
1229649|NCT01896622|Ritonavir|ritonavir
1229650|NCT01896622|Cobicistat|cobicistat
1229651|NCT01896622|P-Glycoprotein|p-glycoprotein
1229652|NCT01896609|Chronic hepatitis c|chronic hepatitis c
1229653|NCT01896609|Egyptian population|egyptian population
1229654|NCT01896609|Reiferon Retard|reiferon retard
1229655|NCT01896609|Ribavirin|ribavirin
1229656|NCT01896609|Nitazoxanide|nitazoxanide
1229658|NCT01896596|vaccines|vaccines
1229659|NCT01896596|immunogenicity|immunogenicity
1229660|NCT01896596|adverse reactions|adverse reactions
1229661|NCT01896570|atrial fibrillation|atrial fibrillation
1229662|NCT01896570|catheter ablation|catheter ablation
1229663|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
1229664|NCT01896570|mechanisms|mechanisms
1229665|NCT01896557|clopidogrel|clopidogrel
1229666|NCT01896557|omeprazole|omeprazole
1229667|NCT01896557|ranitidin|ranitidin
1229668|NCT01896557|interaction|interaction
1229669|NCT01896557|aggregability|aggregability
1229670|NCT01896544|cholecalciferol|cholecalciferol
1229671|NCT01896544|vitamin D|vitamin d
1229672|NCT01896544|sepsis|sepsis
1229673|NCT01896544|infection|infection
1229674|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
1229676|NCT01896505|soft-tissue|soft-tissue
1229677|NCT01896505|sarcoma|sarcoma
1229678|NCT01896505|KPT-330|kpt-330
1229679|NCT01896505|food|food
1229680|NCT01896505|effects|effects
1229681|NCT01896505|Selinexor|selinexor
1229682|NCT01896492|PCOS,|pcos,
1229683|NCT01896492|NAC,|nac,
1229684|NCT01896492|OVULATION INDUCTION,|ovulation induction,
1229685|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
1229686|NCT01896479|thyroid cancer|thyroid cancer
1229687|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
1229688|NCT01896466|Fall Risk|fall risk
1229689|NCT01896466|Gait|gait
1229690|NCT01896466|Dynamic Balance|dynamic balance
1229691|NCT01896466|Static Balance|static balance
1229692|NCT01896466|Neuromodulation|neuromodulation
1229693|NCT01896440|Pediatric|pediatric
1229694|NCT01896440|Ondansetron|ondansetron
1229695|NCT01896440|Cardiac repolarization|cardiac repolarization
1229696|NCT01896440|QTc interval|qtc interval
1229697|NCT01896427|Third Molar|third molar
1229698|NCT01896427|Edema|edema
1229699|NCT01896427|pain|pain
1229700|NCT01896427|trismus|trismus
1229701|NCT01896414|Metabolic Syndrome|metabolic syndrome
1229702|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
1229703|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
1229704|NCT01896401|Vascular Closure Device|vascular closure device
1229705|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
1229706|NCT01896375|Gutkha|gutkha
1229707|NCT01896375|Pan masala ban|pan masala ban
1229708|NCT01896375|Legislation|legislation
1229709|NCT01896375|Smokeless tobacco|smokeless tobacco
1229710|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
1229711|NCT01896271|kidney cancer|kidney cancer
1229712|NCT01896271|metastatic cancer|metastatic cancer
1229713|NCT01896245|hoarseness|hoarseness
1229714|NCT01896245|sore throat|sore throat
1229715|NCT01896245|intubating conditions|intubating conditions
1229716|NCT01896245|vocal cord injuries|vocal cord injuries
1229717|NCT01896245|sevoflurane|sevoflurane
1229718|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
1229719|NCT01896219|Medical device|medical device
1229720|NCT01896219|CT|ct
1229721|NCT01896219|Needle|needle
1229722|NCT01896219|Navigation|navigation
1229723|NCT01896219|IMACTIS-CT®|imactis-ct®
1229724|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
1229725|NCT01896219|anesthesia needles|anesthesia needles
1229726|NCT01896180|POAG|poag
1229727|NCT01896180|OHT|oht
1229728|NCT01896180|OHTN|ohtn
1229729|NCT01896180|IOP|iop
1229730|NCT01896167|Headache|headache
1229731|NCT01896167|Migraine|migraine
1229732|NCT01896167|Aura|aura
1229733|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
1229734|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
1229735|NCT01896128|stroke|stroke
1229736|NCT01896128|CVA|cva
1229737|NCT01896128|cerebrovascular accident|cerebrovascular accident
1229738|NCT01896128|hemiparesis|hemiparesis
1229739|NCT01896128|impairment|impairment
1229740|NCT01896128|motor recovery|motor recovery
1229741|NCT01896128|neuroplasticity|neuroplasticity
1229742|NCT01896128|nuvigil|nuvigil
1229743|NCT01896128|armodafinil|armodafinil
1229744|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
1229745|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
1229746|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
1229747|NCT01896102|Gene therapy|gene therapy
1229748|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
1229749|NCT01896076|caudal space|caudal space
1229750|NCT01896076|children|children
1229751|NCT01896076|ultrasound evaluation|ultrasound evaluation
1229752|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
1229753|NCT01896050|Joint pain|joint pain
1229754|NCT01896050|Grip strength|grip strength
1229755|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
1229756|NCT01896037|Spinal cord injury|spinal cord injury
1229757|NCT01896037|Tetraplegia|tetraplegia
1229758|NCT01896037|Quadraplegia|quadraplegia
1229759|NCT01896037|Cholesterol|cholesterol
1229760|NCT01896037|HDL-c|hdl-c
1229761|NCT01896037|LDL-c|ldl-c
1229762|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
1229763|NCT01895998|sickle cell disease|sickle cell disease
1229764|NCT01895998|pulmonary hypertension|pulmonary hypertension
1229765|NCT01895998|airway hyperreactivity|airway hyperreactivity
1229766|NCT01895998|acute chest syndrome|acute chest syndrome
1229767|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
1229768|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
1229769|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
1229770|NCT01895946|food effect,|food effect,
1229771|NCT01895946|formulation comparison|formulation comparison
1229772|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
1229773|NCT01895933|Wound healing|wound healing
1229774|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
1229775|NCT01895933|SurgiShield|surgishield
1229776|NCT01895920|HIV|hiv
1229777|NCT01895920|Biofilm|biofilm
1229778|NCT01895920|Transmission|transmission
1229779|NCT01895907|Special Olympics|special olympics
1229780|NCT01895907|occupational therapy|occupational therapy
1229781|NCT01895907|SCOPE|scope
1229782|NCT01895907|life participation improvement|life participation improvement
1229783|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
1229784|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
1229785|NCT01895894|Nephrosis|nephrosis
1229786|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
1229787|NCT01895881|Estradiol|estradiol
1229788|NCT01895868|Ultrasound training|ultrasound training
1229789|NCT01895868|Ultrasound simulation|ultrasound simulation
1229790|NCT01895868|Ultrasound assessment|ultrasound assessment
1229791|NCT01895868|Technology-enhanced learning|technology-enhanced learning
1229792|NCT01895868|virtual reality simulation|virtual reality simulation
1229793|NCT01895842|Leukemia|leukemia
1229794|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
1229795|NCT01895842|MDS|mds
1229796|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
1229797|NCT01895842|Maximum tolerated dose|maximum tolerated dose
1229798|NCT01895842|MTD|mtd
1229799|NCT01895842|Ruxolitinib|ruxolitinib
1229800|NCT01895842|Jakafi|jakafi
1229801|NCT01895842|INCB018424|incb018424
1229802|NCT01895842|INC424|inc424
1229803|NCT01895829|Head and Neck Cancer|head and neck cancer
1229804|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
1229805|NCT01895829|HNSCC|hnscc
1229806|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
1229807|NCT01895829|MRI|mri
1229808|NCT01895829|Ferumoxytol|ferumoxytol
1229809|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
1229810|NCT01895829|USPIO|uspio
1229811|NCT01895829|Contrast agent|contrast agent
1229812|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
1229813|NCT01895829|DCI|dci
1229814|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
1229815|NCT01895803|smoking woman|smoking woman
1229816|NCT01895790|Pancreatic Cancer|pancreatic cancer
1229817|NCT01895790|Pancreatic Duct|pancreatic duct
1229818|NCT01895790|Stent|stent
1229819|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
1229820|NCT01895790|Cancer|cancer
1229821|NCT01895790|Pain|pain
1229822|NCT01895790|Obstructive Pain|obstructive pain
1229823|NCT01895790|Palliative|palliative
1229824|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
1229825|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
1229826|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
1229827|NCT01895751|Unstable Angina|unstable angina
1229828|NCT01895751|Medical therapy|medical therapy
1229829|NCT01895751|Coronary angiogram|coronary angiogram
1229830|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
1229831|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
1229832|NCT01895751|Coronary revascularization|coronary revascularization
1229833|NCT01895751|Health economics|health economics
1229834|NCT01895738|Trauma|trauma
1229835|NCT01895738|Injuries|injuries
1229836|NCT01895738|Violence|violence
1229837|NCT01895738|Adolescent|adolescent
1229838|NCT01895738|WrapAround care|wraparound care
1229839|NCT01895712|International|international
1229840|NCT01895712|Multicenter|multicenter
1229841|NCT01895712|Observational registry|observational registry
1229842|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
1229843|NCT01895712|Stenting|stenting
1229844|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1229845|NCT01895712|Coronary revascularization|coronary revascularization
1229846|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1229847|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
1230145|NCT01894399|HM61713|hm61713
1229848|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
1229849|NCT01895712|STEMI|stemi
1229850|NCT01895712|NSTEMI|nstemi
1229851|NCT01895712|Ischemia|ischemia
1229852|NCT01895712|Angina|angina
1229853|NCT01895712|Subgroups|subgroups
1229854|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
1229855|NCT01895712|Small vessels|small vessels
1229856|NCT01895712|Chronic Total Occlusion|chronic total occlusion
1229857|NCT01895699|Contrast agent|contrast agent
1229858|NCT01895699|endothelium|endothelium
1229859|NCT01895699|Free radical|free radical
1229860|NCT01895699|Alpha lipoic acid|alpha lipoic acid
1229861|NCT01895686|open angle glaucoma|open angle glaucoma
1229862|NCT01895686|narrow angles|narrow angles
1229863|NCT01895686|angle closure glaucoma|angle closure glaucoma
1229864|NCT01895686|gonioscopy|gonioscopy
1229865|NCT01895686|anterior segment OCT|anterior segment oct
1229866|NCT01895673|FDG-PET|fdg-pet
1229867|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
1229868|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
1229869|NCT01895660|P-CIMT|p-cimt
1229870|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
1229871|NCT01895660|Hemiparesis|hemiparesis
1229872|NCT01895660|Cerebral Palsy|cerebral palsy
1229873|NCT01895660|Children|children
1229874|NCT01895647|electric muscle stimulation|electric muscle stimulation
1229875|NCT01895647|respiratory failure|respiratory failure
1229876|NCT01895647|sepsis|sepsis
1229877|NCT01895647|interleukin 6|interleukin 6
1229878|NCT01895647|interleukin 15|interleukin 15
1229879|NCT01895634|Ischemia|ischemia
1229880|NCT01895634|Stroke|stroke
1229881|NCT01895634|Ischemic Stroke|ischemic stroke
1229882|NCT01895634|Thrombectomy|thrombectomy
1229883|NCT01895634|Brain clot|brain clot
1229884|NCT01895634|Cerebrovascular disease|cerebrovascular disease
1229885|NCT01895634|Recanalization|recanalization
1229886|NCT01895634|Revascularization|revascularization
1229887|NCT01895634|Clot Retriever|clot retriever
1229888|NCT01895634|Neurovascular Intervention|neurovascular intervention
1229889|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
1229890|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
1229891|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
1229892|NCT01895608|gait disorder|gait disorder
1229893|NCT01895608|attention|attention
1229894|NCT01895595|obesity|obesity
1229895|NCT01895595|stress|stress
1229896|NCT01895595|intuitive eating|intuitive eating
1229897|NCT01895595|guided imagery|guided imagery
1229898|NCT01895595|latinos|latinos
1229899|NCT01895595|adolescents|adolescents
1229900|NCT01895595|insulin resistance|insulin resistance
1229901|NCT01895582|Ageing|ageing
1229902|NCT01895582|Tuberculosis|tuberculosis
1229903|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
1229904|NCT01895556|Malawi|malawi
1229905|NCT01895556|Risk Compensation|risk compensation
1229906|NCT01895556|Male Circumcision|male circumcision
1229907|NCT01895556|Demand|demand
1229908|NCT01895530|Probiotics|probiotics
1229909|NCT01895530|colorectal cancer|colorectal cancer
1229910|NCT01895530|postoperative infection|postoperative infection
1229911|NCT01895530|immune function|immune function
1229912|NCT01895530|bacterial translocation|bacterial translocation
1229913|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
1229914|NCT01895504|Colonoscopy|colonoscopy
1229915|NCT01895504|Colorectal cancer|colorectal cancer
1229916|NCT01895504|Adenoma|adenoma
1229917|NCT01895478|asthma|asthma
1229918|NCT01895478|pediatrics|pediatrics
1229919|NCT01895478|control|control
1229920|NCT01895478|medication adherence|medication adherence
1229921|NCT01895465|urine collection, contamination|urine collection, contamination
1229922|NCT01895452|Schizophrenia|schizophrenia
1229923|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
1229924|NCT01895439|Multiple Sclerosis|multiple sclerosis
1229925|NCT01895439|Oligodendrocytes|oligodendrocytes
1229926|NCT01895439|Neuroimmunology|neuroimmunology
1229927|NCT01895439|Autoimmune disease|autoimmune disease
1229928|NCT01895413|Cartilage injury|cartilage injury
1229929|NCT01895413|Osteoarthritis|osteoarthritis
1229930|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
1229931|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
1229932|NCT01895374|Laser therapy|laser therapy
1229933|NCT01895374|Biological dressing|biological dressing
1229934|NCT01895374|Amniotic membrane|amniotic membrane
1229935|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
1229936|NCT01895374|wound healing|wound healing
1229937|NCT01895361|SelG1|selg1
1229938|NCT01895361|P-selectin|p-selectin
1229939|NCT01895361|monoclonal antibody|monoclonal antibody
1229940|NCT01895361|sickle cell disease|sickle cell disease
1229941|NCT01895361|sickle cell anemia|sickle cell anemia
1229942|NCT01895361|sickle cell|sickle cell
1229943|NCT01895361|pain crisis|pain crisis
1229944|NCT01895361|pain crises|pain crises
1229945|NCT01895361|vasoocclusion|vasoocclusion
1229946|NCT01895361|vaso-occlusion|vaso-occlusion
1229947|NCT01895361|priapism|priapism
1229948|NCT01895361|hepatic sequestration|hepatic sequestration
1229949|NCT01895361|splenic sequestration|splenic sequestration
1229950|NCT01895361|chest syndrome|chest syndrome
1229951|NCT01895322|Tolvaptan|tolvaptan
1229952|NCT01895322|dialysis|dialysis
1229953|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
1229954|NCT01895309|Etanercept|etanercept
1229955|NCT01895309|Biosimilar|biosimilar
1229956|NCT01895296|dumping syndrome|dumping syndrome
1229957|NCT01895296|OGTT|ogtt
1229958|NCT01895296|hypoglycemia|hypoglycemia
1229959|NCT01895283|Aerobic training|aerobic training
1229960|NCT01895283|VO2max|vo2max
1229961|NCT01895283|Bethlem myopathy|bethlem myopathy
1229962|NCT01895270|opioid dependence|opioid dependence
1229963|NCT01895270|buprenorphine|buprenorphine
1229964|NCT01895270|isradipine|isradipine
1229965|NCT01895270|opioid withdrawal|opioid withdrawal
1229966|NCT01895270|opioid detoxification|opioid detoxification
1229967|NCT01895257|TTP1|ttp1
1229968|NCT01895257|TTP2|ttp2
1229969|NCT01895257|PFS|pfs
1229970|NCT01895257|Safety|safety
1229971|NCT01895257|R0 resection rate|r0 resection rate
1229972|NCT01895257|Quality of life|quality of life
1229973|NCT01895257|Overall Survival|overall survival
1229974|NCT01895244|scleroderma|scleroderma
1230067|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
1229975|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
1229976|NCT01895244|thiotepa|thiotepa
1229977|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
1229978|NCT01895192|sperm morphology|sperm morphology
1229979|NCT01895192|vacuoles|vacuoles
1229980|NCT01895192|fertile|fertile
1229981|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
1229982|NCT01895192|high magnification|high magnification
1229983|NCT01895192|reference values|reference values
1229984|NCT01895179|Time-restricted feeding|time-restricted feeding
1229985|NCT01895179|Intermittent fasting|intermittent fasting
1229986|NCT01895179|Prediabetes|prediabetes
1229987|NCT01895179|Insulin resistance|insulin resistance
1229988|NCT01895179|Glucose tolerance|glucose tolerance
1229989|NCT01895179|Insulin sensitivity|insulin sensitivity
1229990|NCT01895179|Circadian rhythms|circadian rhythms
1229991|NCT01895179|Diurnal|diurnal
1229992|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
1229993|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
1229994|NCT01895166|Transbronchial biopsy|transbronchial biopsy
1229995|NCT01895153|bladder pain syndrome|bladder pain syndrome
1229996|NCT01895153|pentosan polysulfate|pentosan polysulfate
1229997|NCT01895153|hydrodistension|hydrodistension
1229998|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
1229999|NCT01895140|Renal denervation|renal denervation
1230000|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
1230001|NCT01895127|Kidney Transplant|kidney transplant
1230002|NCT01895127|Renal Transplant|renal transplant
1230003|NCT01895127|Rejection|rejection
1230004|NCT01895127|Antibody mediated|antibody mediated
1230005|NCT01895127|Humoral|humoral
1230006|NCT01895127|Eculizumab|eculizumab
1230007|NCT01895114|Renal function|renal function
1230008|NCT01895114|cirrhotic patients|cirrhotic patients
1230009|NCT01895114|transplant evaluation|transplant evaluation
1230010|NCT01895101|blood loss|blood loss
1230011|NCT01895101|tranexamix acid|tranexamix acid
1230012|NCT01895101|cardiac surgery|cardiac surgery
1230013|NCT01895088|presbyopia|presbyopia
1230014|NCT01895075|Budesonide|budesonide
1230015|NCT01895075|Inhalation|inhalation
1230016|NCT01895075|Premature infants|premature infants
1230017|NCT01895062|colonoscopy|colonoscopy
1230018|NCT01895062|oxygen desaturation|oxygen desaturation
1230019|NCT01895049|Tacrolimus|tacrolimus
1230020|NCT01895049|Everolimus|everolimus
1230021|NCT01895049|Cytomegalovirus|cytomegalovirus
1230022|NCT01895049|Thymoglobulin|thymoglobulin
1230023|NCT01895049|Deceased donors|deceased donors
1230024|NCT01895049|Expanded criteria|expanded criteria
1230025|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
1230026|NCT01895010|prevention and treatment|prevention and treatment
1230027|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
1230028|NCT01895010|TACE|tace
1230029|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
1230030|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1230031|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
1230032|NCT01894997|Doppler Ultrasound|doppler ultrasound
1230033|NCT01894984|Schizophrenia|schizophrenia
1230034|NCT01894984|Risperidone|risperidone
1230035|NCT01894984|Risperdal Consta|risperdal consta
1230036|NCT01894984|Oral antipsychotic|oral antipsychotic
1230037|NCT01894958|Fragile X disorder|fragile x disorder
1230038|NCT01894958|Autism|autism
1230039|NCT01894932|Psychotherapy, Group|psychotherapy, group
1230040|NCT01894919|Meningococcal B disease,|meningococcal b disease,
1593778|NCT00417326|ONO-5046Na|ono-5046na
1230041|NCT01894919|Antibody persistence|antibody persistence
1230042|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
1230043|NCT01894906|Pharmacokinetics,|pharmacokinetics,
1230044|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
1230045|NCT01894906|Hemodialysis|hemodialysis
1230046|NCT01894906|chronic therapy;|chronic therapy;
1230047|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
1230048|NCT01894867|MAGNESIUM|magnesium
1230049|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
1230050|NCT01894867|MUSCLE WEAKNESS|muscle weakness
1230051|NCT01894854|Radiostereometry|radiostereometry
1230052|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
1230053|NCT01894854|Stem design|stem design
1230054|NCT01894841|depression|depression
1230055|NCT01894841|prevention|prevention
1230056|NCT01894841|Veterans health|veterans health
1230057|NCT01894828|Nutritional support|nutritional support
1230058|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
1230059|NCT01894828|Malnutrition|malnutrition
1230060|NCT01894815|major depressive disorder|major depressive disorder
1230061|NCT01894815|major depression|major depression
1230062|NCT01894815|depressive disorder|depressive disorder
1230063|NCT01894815|major depressive episode|major depressive episode
1230064|NCT01894802|Tetraplegia|tetraplegia
1230065|NCT01894802|Quadriplegia|quadriplegia
1230066|NCT01894802|Spinal cord injury|spinal cord injury
1230368|NCT01893632|diazepam|diazepam
1230068|NCT01894802|Neuroprosthetic|neuroprosthetic
1230069|NCT01894802|Brain-machine interface|brain-machine interface
1230070|NCT01894802|Brain-computer interface|brain-computer interface
1230071|NCT01894802|Neural activity|neural activity
1230072|NCT01894802|Sensory stimulation|sensory stimulation
1230073|NCT01894802|Microstimulation|microstimulation
1230074|NCT01894789|myocardial blood flow|myocardial blood flow
1230075|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
1230076|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
1230077|NCT01894789|positron emission tomography|positron emission tomography
1230078|NCT01894789|adenosine|adenosine
1230079|NCT01894789|ticagrelor|ticagrelor
1230080|NCT01894789|clopidogrel|clopidogrel
1230081|NCT01894776|healthy volunteers|healthy volunteers
1230082|NCT01894763|esophagus|esophagus
1230083|NCT01894763|cancer|cancer
1230084|NCT01894750|Heart Failure|heart failure
1230085|NCT01894750|Self-Care|self-care
1230086|NCT01894685|Colorectal|colorectal
1230087|NCT01894685|Adenoma|adenoma
1230088|NCT01894685|Recurrence|recurrence
1230089|NCT01894685|Mesalazine|mesalazine
1230090|NCT01894685|Chemoprevention|chemoprevention
1230091|NCT01894672|LGX818|lgx818
1230092|NCT01894672|BRAF Inhibitor|braf inhibitor
1230093|NCT01894672|Stage IV melanoma|stage iv melanoma
1230094|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
1230095|NCT01894672|BRAFV600 mutation|brafv600 mutation
1230096|NCT01894672|13-053|13-053
1230097|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1230098|NCT01894633|Metastasis|metastasis
1230099|NCT01894633|Cloroquine|cloroquine
1230100|NCT01894620|Alzheimer's|alzheimer's
1230101|NCT01894620|rTMS|rtms
1230102|NCT01894620|sleep quality|sleep quality
1230103|NCT01894620|dementia|dementia
1230104|NCT01894620|memory|memory
1230105|NCT01894607|Kidney Cancer|kidney cancer
1230106|NCT01894607|Renal Mass|renal mass
1230107|NCT01894607|Open partial nephrectomy|open partial nephrectomy
1230108|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
1230109|NCT01894607|DEFINITY|definity
1230110|NCT01894607|Contrast agent|contrast agent
1230111|NCT01894607|Phone call|phone call
1230112|NCT01894594|Sickle cell disease|sickle cell disease
1230113|NCT01894594|Chronic kidney disease|chronic kidney disease
1230114|NCT01894594|Bicarbonate therapy|bicarbonate therapy
1230115|NCT01894555|Platelet Transcriptome|platelet transcriptome
1230116|NCT01894555|Coronary Artery Disease|coronary artery disease
1230117|NCT01894555|Myocardial Ischemia|myocardial ischemia
1230118|NCT01894555|Coronary Disease|coronary disease
1230119|NCT01894555|Heart Diseases|heart diseases
1230120|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
1230121|NCT01894555|Arteriosclerosis|arteriosclerosis
1230122|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
1230123|NCT01894555|Vascular Diseases|vascular diseases
1230124|NCT01894555|Aspirin|aspirin
1230125|NCT01894529|ischemic stroke|ischemic stroke
1230126|NCT01894529|immune biomarkers|immune biomarkers
1230127|NCT01894529|stroke-associated infection|stroke-associated infection
1230128|NCT01894529|functional outcome|functional outcome
1230129|NCT01894529|prediction|prediction
1230130|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
1230131|NCT01894464|truancy|truancy
1230132|NCT01894464|attendance|attendance
1230133|NCT01894464|education|education
1230134|NCT01894464|primary school|primary school
1230135|NCT01894464|elementary school|elementary school
1230136|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
1230137|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
1230138|NCT01894438|NAFLD|nafld
1314474|NCT01521351|stroke|stroke
1230139|NCT01894438|NASH|nash
1230140|NCT01894438|Mediterranean diet|mediterranean diet
1230141|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
1230142|NCT01894425|Medically assisted procreation|medically assisted procreation
1230143|NCT01894425|Assisted reproductive technology|assisted reproductive technology
1230144|NCT01894425|Human papilloma virus|human papilloma virus
1230146|NCT01894399|pharmacokinetics|pharmacokinetics
1230147|NCT01894399|Phase I|phase i
1230148|NCT01894399|healthy|healthy
1230149|NCT01894399|olmutinib|olmutinib
1230150|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
1230151|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
1230152|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
1230153|NCT01894386|pharmacokinetics|pharmacokinetics
1230154|NCT01894386|Healthy subjects|healthy subjects
1230155|NCT01894360|Pharmacokinetics|pharmacokinetics
1230156|NCT01894360|Phase 1|phase 1
1230157|NCT01894360|Healthy Subjects|healthy subjects
1230158|NCT01894360|Comparability|comparability
1230159|NCT01894360|Belimumab|belimumab
1230160|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
1230161|NCT01894334|Aortic dissection|aortic dissection
1230162|NCT01894334|acute lung injury|acute lung injury
1230163|NCT01894334|injury mechanism|injury mechanism
1230164|NCT01894334|early intervention|early intervention
1230165|NCT01894321|Acute cholecystitis|acute cholecystitis
1230166|NCT01894321|Elderly|elderly
1230369|NCT01893632|Valium|valium
1230167|NCT01894321|Critically ill patients|critically ill patients
1230168|NCT01894321|Surgical high risk|surgical high risk
1230169|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
1230170|NCT01894321|Cholecystectomy|cholecystectomy
1230171|NCT01894308|Male Hormone Replacement|male hormone replacement
1230172|NCT01894308|Multiple Dose|multiple dose
1230173|NCT01894308|Single Period|single period
1230174|NCT01894308|Phase II|phase ii
1230175|NCT01894308|Dose Ranging|dose ranging
1230176|NCT01894308|Adult Male Subjects|adult male subjects
1230177|NCT01894308|Testosterone Replacement|testosterone replacement
1230178|NCT01894295|Vitamin D analogues|vitamin d analogues
1230179|NCT01894295|Resting Metabolic rate|resting metabolic rate
1230180|NCT01894295|obesity|obesity
1230181|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
1230182|NCT01894282|Manual Therapy|manual therapy
1230183|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
1230184|NCT01894256|oncology,|oncology,
1230185|NCT01894256|cancer,|cancer,
1230186|NCT01894256|neoplasm,|neoplasm,
1230187|NCT01894256|anticancer drug,|anticancer drug,
1230188|NCT01894256|pharmacokinetics,|pharmacokinetics,
1230189|NCT01894256|area under curve,|area under curve,
1230190|NCT01894256|olaparib,|olaparib,
1230191|NCT01894256|solid tumour,|solid tumour,
1230192|NCT01894256|mild renal impairment,|mild renal impairment,
1230193|NCT01894256|moderate renal impairment|moderate renal impairment
1230194|NCT01894243|oncology,|oncology,
1230195|NCT01894243|cancer,|cancer,
1230196|NCT01894243|neoplasm,|neoplasm,
1230197|NCT01894243|anticancer drug,|anticancer drug,
1230198|NCT01894243|pharmacokinetics,|pharmacokinetics,
1230199|NCT01894243|area under curve,|area under curve,
1230200|NCT01894243|olaparib,|olaparib,
1230201|NCT01894243|solid tumour,|solid tumour,
1230202|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
1230203|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
1230204|NCT01894230|high cholesterol|high cholesterol
1230205|NCT01894230|genetic testing|genetic testing
1230206|NCT01894230|medication adherence|medication adherence
1230207|NCT01894230|statins|statins
1230208|NCT01894230|Adverse Effects|adverse effects
1230209|NCT01894230|pharmacogenetics|pharmacogenetics
1230210|NCT01894217|high cholesterol|high cholesterol
1230211|NCT01894217|genetic testing|genetic testing
1230212|NCT01894217|medication adherence|medication adherence
1230213|NCT01894217|statins|statins
1230214|NCT01894217|Adverse Effects|adverse effects
1230215|NCT01894217|Pharmacogenetic|pharmacogenetic
1230216|NCT01894204|HTTPE|httpe
1230217|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
1230218|NCT01894191|adenoma detection rate|adenoma detection rate
1230219|NCT01894191|colonoscopy|colonoscopy
1230220|NCT01894191|water exchange|water exchange
1230221|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
1230222|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
1230223|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
1230224|NCT01894152|XIENCE V EECSS|xience v eecss
1230225|NCT01894152|XIENCE PRIME|xience prime
1230226|NCT01894152|SPIRIT PRIME|spirit prime
1230227|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
1230228|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
1230229|NCT01894152|Coronary Artery Disease|coronary artery disease
1230230|NCT01894152|Coronary Heart Disease|coronary heart disease
1230231|NCT01894152|Cardiovascular Disease|cardiovascular disease
1230232|NCT01894152|Myocardial Infarction|myocardial infarction
1230233|NCT01894152|Stent Thrombosis|stent thrombosis
1230234|NCT01894139|Gestational weight gain|gestational weight gain
1230235|NCT01894139|Obese women|obese women
1230236|NCT01894139|Fetal programming|fetal programming
1230237|NCT01894139|Metabolic disorders|metabolic disorders
1230238|NCT01894139|Development of obesity|development of obesity
1230239|NCT01894139|Development og overweight|development og overweight
1230240|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
1230241|NCT01894113|interstitial lung disease|interstitial lung disease
1230343|NCT01893710|omentum|omentum
1230242|NCT01894113|transbronchial biopsy|transbronchial biopsy
1230243|NCT01894113|cryobiopsy|cryobiopsy
1230244|NCT01894074|Subfertility|subfertility
1230245|NCT01894074|Anovulatory|anovulatory
1230246|NCT01894074|Obese|obese
1230247|NCT01894074|Women|women
1230248|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
1230249|NCT01894061|adult glioblastoma|adult glioblastoma
1230250|NCT01894061|adult gliosarcoma|adult gliosarcoma
1230251|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
1230252|NCT01894061|Bevacizumab-naive|bevacizumab-naive
1230253|NCT01894061|NovoTTF-100A|novottf-100a
1230254|NCT01894048|asthma control|asthma control
1230255|NCT01894048|small airways|small airways
1230256|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
1230257|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
1230258|NCT01894035|Ventavis|ventavis
1230259|NCT01894035|Patient compliance|patient compliance
1230260|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
1230261|NCT01894009|Osteopathic manipulation|osteopathic manipulation
1230262|NCT01894009|Exercise therapy|exercise therapy
1230263|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
1230264|NCT01893996|rheumatoid|rheumatoid
1230265|NCT01893996|arthritis|arthritis
1230266|NCT01893996|cardiovascular|cardiovascular
1230267|NCT01893996|adalimumab|adalimumab
1230268|NCT01893996|tnf|tnf
1230269|NCT01893996|biologic|biologic
1230270|NCT01893983|Mental Health|mental health
1230271|NCT01893983|Veterans Health|veterans health
1230272|NCT01893983|Rural|rural
1230273|NCT01893983|Motivational Interviewing|motivational interviewing
1230274|NCT01893957|breast cancer|breast cancer
1230275|NCT01893957|physical therapy|physical therapy
1230276|NCT01893957|electrical stimulation|electrical stimulation
1230277|NCT01893957|tactile sensitivity|tactile sensitivity
1230278|NCT01893957|flow blood|flow blood
1230279|NCT01893944|Breast cancer|breast cancer
1230280|NCT01893944|vibratory therapy|vibratory therapy
1230281|NCT01893944|virtual reality|virtual reality
1230282|NCT01893931|Geriatrics|geriatrics
1230283|NCT01893931|Emergency Medicine|emergency medicine
1230284|NCT01893931|Care Transitions|care transitions
1230285|NCT01893918|Smoking|smoking
1230286|NCT01893918|Dyspnea|dyspnea
1230287|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
1230288|NCT01893892|Gorlin syndrome|gorlin syndrome
1230289|NCT01893892|Erivedge|erivedge
1230290|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
1230291|NCT01893853|dehydration|dehydration
1230292|NCT01893853|fluid balance|fluid balance
1230293|NCT01893853|exercise|exercise
1230294|NCT01893853|heat|heat
1230295|NCT01893853|body weight|body weight
1230296|NCT01893853|performance|performance
1230297|NCT01893827|Naltrexone|naltrexone
1230298|NCT01893827|Extended-release naltrexone|extended-release naltrexone
1230299|NCT01893827|Oral naltrexone|oral naltrexone
1230300|NCT01893827|Vivitrol|vivitrol
1230301|NCT01893827|XR-NTX|xr-ntx
1230302|NCT01893827|alcohol dependence|alcohol dependence
1230303|NCT01893827|primary care|primary care
1230304|NCT01893827|Medical Management|medical management
1230305|NCT01893801|pancreatic cancer|pancreatic cancer
1230306|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1230307|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
1230308|NCT01893801|pancreas|pancreas
1230309|NCT01893801|pancreatic|pancreatic
1230310|NCT01893788|hypertension|hypertension
1230311|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
1230312|NCT01893788|renin angiotensin system|renin angiotensin system
1230313|NCT01893788|aldosterone|aldosterone
1230314|NCT01893788|aliskiren|aliskiren
1230315|NCT01893788|eplerenone|eplerenone
1230316|NCT01893788|P3NP|p3np
1230317|NCT01893775|Anti CD 122|anti cd 122
1230318|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
1230319|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
1230320|NCT01893762|neutrophil|neutrophil
1230321|NCT01893762|exercise|exercise
1230322|NCT01893762|URTI|urti
1230323|NCT01893762|Innate|innate
1230324|NCT01893762|Immune|immune
1230325|NCT01893749|depression|depression
1230326|NCT01893749|prevention|prevention
1230327|NCT01893749|teen|teen
1230328|NCT01893749|at risk|at risk
1230329|NCT01893749|internet|internet
1230330|NCT01893736|Breastfeeding|breastfeeding
1230331|NCT01893736|professional support|professional support
1230332|NCT01893736|postnatal|postnatal
1594704|NCT00414960|Healthy|healthy
1230333|NCT01893736|interventions|interventions
1230334|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
1230335|NCT01893736|randomized controlled trial|randomized controlled trial
1230336|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
1230337|NCT01893723|analgesia nociception balance|analgesia nociception balance
1230338|NCT01893723|remifentanil|remifentanil
1230339|NCT01893723|analgesia nociception index|analgesia nociception index
1230340|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
1230341|NCT01893710|peritoneal dialysis|peritoneal dialysis
1230342|NCT01893710|parietal peritoneum|parietal peritoneum
1230344|NCT01893710|children|children
1230345|NCT01893684|protein|protein
1230346|NCT01893684|physical function|physical function
1230347|NCT01893684|muscle quality|muscle quality
1230348|NCT01893684|fatigue|fatigue
1230349|NCT01893684|weight loss|weight loss
1230350|NCT01893671|LASIK|lasik
1230351|NCT01893671|corneal power|corneal power
1230352|NCT01893671|astigmatism|astigmatism
1230354|NCT01893671|Optical Coherence Tomography|optical coherence tomography
1230355|NCT01893658|Interstitial Nephritis|interstitial nephritis
1230356|NCT01893658|Nephritis|nephritis
1230357|NCT01893658|Tubulointerstitial|tubulointerstitial
1230358|NCT01893658|Renal disease|renal disease
1230359|NCT01893658|Kidney|kidney
1230360|NCT01893645|Pronto-7|pronto-7
1230361|NCT01893645|SpHb|sphb
1230362|NCT01893645|Obstetric patients|obstetric patients
1230363|NCT01893632|Benzodiazepines|benzodiazepines
1230364|NCT01893632|clonazepam|clonazepam
1230365|NCT01893632|alprazolam|alprazolam
1230366|NCT01893632|Klonopin|klonopin
1230367|NCT01893632|Xanax|xanax
1230370|NCT01893632|lorazepam|lorazepam
1230371|NCT01893632|Ativan|ativan
1230372|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
1230373|NCT01893619|Karnofsky score|karnofsky score
1230374|NCT01893619|supplements|supplements
1230375|NCT01893606|diarrhea|diarrhea
1230376|NCT01893606|abdominal pain|abdominal pain
1230377|NCT01893593|Cardiovascular risk|cardiovascular risk
1230378|NCT01893593|lifestyle change|lifestyle change
1230379|NCT01893593|blood pressure|blood pressure
1230380|NCT01893593|body mass index|body mass index
1230381|NCT01893593|tobacco|tobacco
1230382|NCT01893580|Cancer|cancer
1230383|NCT01893580|Rehabilitation|rehabilitation
1230384|NCT01893580|Exercise|exercise
1230385|NCT01893580|Lung cancer|lung cancer
1230386|NCT01893580|NSCLC|nsclc
1230387|NCT01893541|CIRRHOTIC|cirrhotic
1230388|NCT01893541|VARICEAL BLEEDING|variceal bleeding
1230389|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
1230390|NCT01893489|positron emission tomography|positron emission tomography
1230391|NCT01893489|macrophage|macrophage
1230392|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
1230393|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1230394|NCT01893476|implementation|implementation
1230395|NCT01893463|hemorrhage control|hemorrhage control
1230396|NCT01893463|wound closure|wound closure
1230397|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
1230398|NCT01893450|Exophthalmos|exophthalmos
1230399|NCT01893450|Proptosis|proptosis
1230400|NCT01893450|Quality of life|quality of life
1230401|NCT01893424|Biological Availability|biological availability
1230402|NCT01893424|Pharmacokinetics|pharmacokinetics
1230403|NCT01893385|vitamin D|vitamin d
1230404|NCT01893385|supplementation|supplementation
1230405|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
1230406|NCT01893385|influenza vaccine|influenza vaccine
1230407|NCT01893385|elderly|elderly
1230408|NCT01893372|Leukemia|leukemia
1230409|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
1230411|NCT01893372|Overall response rate|overall response rate
1230412|NCT01893372|ORR|orr
1230413|NCT01893372|Eltrombopag|eltrombopag
1230414|NCT01893372|Promacta|promacta
1230415|NCT01893372|Hypomethylating Agent|hypomethylating agent
1230416|NCT01893359|hyperopia|hyperopia
1230417|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
1230418|NCT01893359|cross-linking|cross-linking
1230419|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
1230420|NCT01893333|cervical cancer|cervical cancer
1230421|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
1230422|NCT01893320|Leukemia|leukemia
1230423|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
1230424|NCT01893320|AML|aml
1230425|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1230426|NCT01893320|MDS|mds
1230427|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1230428|NCT01893320|CMM|cmm
1230429|NCT01893320|Maximum tolerated dose|maximum tolerated dose
1230430|NCT01893320|MTD|mtd
1230431|NCT01893320|Vosaroxin|vosaroxin
1230432|NCT01893320|Decitabine|decitabine
1230433|NCT01893320|Dacogen|dacogen
1230434|NCT01893307|Head And Neck Cancer|head and neck cancer
1230435|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
1333157|NCT01444326|Inflammation|inflammation
1230436|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
1230437|NCT01893307|Acute and late toxicity|acute and late toxicity
1230438|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
1230439|NCT01893307|IMRT|imrt
1230440|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
1230441|NCT01893307|IMPT|impt
1230442|NCT01893307|Modified barium swallow|modified barium swallow
1230443|NCT01893307|MBS|mbs
1230444|NCT01893307|Questionnaires|questionnaires
1230445|NCT01893307|Surveys|surveys
1230446|NCT01893229|Bipolar disorder|bipolar disorder
1230447|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
1230448|NCT01893229|Therapeutics|therapeutics
1230449|NCT01893229|Patient Dropouts|patient dropouts
1230450|NCT01893216|anxiety|anxiety
1230451|NCT01893216|depression|depression
1230452|NCT01893216|sexual dysfunction|sexual dysfunction
1230453|NCT01893216|infertility|infertility
1230454|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
1230455|NCT01893190|nimodipine|nimodipine
1230456|NCT01893190|safety|safety
1230457|NCT01893190|tolerability|tolerability
1230458|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
1230459|NCT01893177|Influenza|influenza
1230460|NCT01893177|Virus|virus
1230461|NCT01893177|Vaccination|vaccination
1230462|NCT01893177|Inflexal V|inflexal v
1230463|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
1230464|NCT01893164|simple decompression|simple decompression
1230465|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
1230466|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
1230467|NCT01893164|severity scale|severity scale
1230468|NCT01893151|Iguratimod|iguratimod
1230469|NCT01893151|MRI|mri
1230470|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
1230471|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
1230472|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
1230473|NCT01893138|Transplantation, Autologous|transplantation, autologous
1230474|NCT01893060|Prematurity|prematurity
1230475|NCT01893060|Central line care|central line care
1230476|NCT01893060|Umbilical line colonization|umbilical line colonization
1230477|NCT01893060|Colonization|colonization
1230478|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
1230479|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
1230480|NCT01893047|breast milk production|breast milk production
1230481|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
1230482|NCT01893034|Arthroscopy|arthroscopy
1230483|NCT01893034|Physiotherapy|physiotherapy
1230484|NCT01893034|Randomised Controlled Trial|randomised controlled trial
1230485|NCT01893008|Esophageal cancer|esophageal cancer
1230486|NCT01893008|Surgery|surgery
1230487|NCT01892995|suicide|suicide
1230488|NCT01892995|ketamine|ketamine
1230489|NCT01892995|low-dose ketamine|low-dose ketamine
1230490|NCT01892995|suicidal ideations|suicidal ideations
1230491|NCT01892995|emergency department|emergency department
1230492|NCT01892982|Maternal Depression|maternal depression
1230493|NCT01892982|Preterm Birth|preterm birth
1230494|NCT01892982|Preterm Outcomes|preterm outcomes
1230495|NCT01892982|Child Development|child development
1230496|NCT01892917|International|international
1230497|NCT01892917|Multicenter|multicenter
1230498|NCT01892917|Observational registry|observational registry
1230499|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1230500|NCT01892917|Stenting|stenting
1230501|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1230502|NCT01892917|Coronary revascularization|coronary revascularization
1230503|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
1230504|NCT01892917|STEMI|stemi
1230505|NCT01892917|NSTEMI|nstemi
1230506|NCT01892917|Ischemia|ischemia
1230507|NCT01892917|Subgroups|subgroups
1230508|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
1230509|NCT01892917|Diabetes|diabetes
1230510|NCT01892917|Small Vessels|small vessels
1230511|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1230512|NCT01892904|YAZ|yaz
1230513|NCT01892904|Flexible regimen|flexible regimen
1230514|NCT01892904|Drospirenone|drospirenone
1230515|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
1230516|NCT01892904|Dysmenorrhea|dysmenorrhea
1230517|NCT01892904|Japanese patients|japanese patients
1230518|NCT01892891|Healthy|healthy
1230519|NCT01892891|Subjects|subjects
1230520|NCT01892891|Safety|safety
1230521|NCT01892891|Tolerability|tolerability
1230522|NCT01892891|VBY036|vby036
1230523|NCT01892891|maximum|maximum
1230524|NCT01892891|pharmacodynamic|pharmacodynamic
1230525|NCT01892891|pharmacokinetic|pharmacokinetic
1230526|NCT01892865|Operating room utilization|operating room utilization
1230527|NCT01892852|Acupuncture|acupuncture
1230528|NCT01892852|Traditional Korean Medicine|traditional korean medicine
1230529|NCT01892826|FET|fet
1230530|NCT01892826|Blastocyst|blastocyst
1230531|NCT01892826|natural cycle|natural cycle
1230532|NCT01892826|hCG|hcg
1230533|NCT01892826|Spontaneous LH pic|spontaneous lh pic
1230534|NCT01892813|Nicotine dependence|nicotine dependence
1230535|NCT01892813|Smoking cessation|smoking cessation
1230536|NCT01892813|Telehealth|telehealth
1230537|NCT01892813|Alcohol use|alcohol use
1230538|NCT01892813|Depression|depression
1230539|NCT01892813|Body weight|body weight
1230540|NCT01892800|Lung Cancer|lung cancer
1230541|NCT01892800|Ventricular function, Right|ventricular function, right
1230542|NCT01892787|Asthma|asthma
1230543|NCT01892787|Small airways|small airways
1230544|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
1230545|NCT01892774|LSPAF|lspaf
1230546|NCT01892774|asymptomatic|asymptomatic
1230547|NCT01892774|exercise tolerance|exercise tolerance
1230648|NCT01892371|Quizartinib|quizartinib
1230548|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
1230549|NCT01892761|mycophenolic acid|mycophenolic acid
1230550|NCT01892761|MPA|mpa
1230551|NCT01892761|MMF|mmf
1230552|NCT01892761|Pharmacokinetics|pharmacokinetics
1230553|NCT01892761|renal transplantation|renal transplantation
1230554|NCT01892748|Lupus|lupus
1230555|NCT01892748|Juvenile|juvenile
1230556|NCT01892748|Cholecalciferol|cholecalciferol
1230557|NCT01892748|Disease activity|disease activity
1230558|NCT01892748|Bone Mass|bone mass
1230559|NCT01892748|Fatigue|fatigue
1230560|NCT01892748|Safety|safety
1230561|NCT01892722|pediatric|pediatric
1230562|NCT01892722|multiple sclerosis|multiple sclerosis
1230563|NCT01892709|acute|acute
1230564|NCT01892709|pain|pain
1230565|NCT01892709|emergency department|emergency department
1230566|NCT01892709|hydromorphone|hydromorphone
1230567|NCT01892709|in ER|in er
1230568|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
1230569|NCT01892696|mechanical ventilation|mechanical ventilation
1230570|NCT01892696|cardiac preload|cardiac preload
1230571|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
1230572|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
1230573|NCT01892683|propofol|propofol
1230574|NCT01892683|exhaled|exhaled
1230575|NCT01892683|monitoring|monitoring
1230576|NCT01892683|anesthesia|anesthesia
1230577|NCT01892670|Blood|blood
1230578|NCT01892670|Whole blood|whole blood
1230579|NCT01892670|Cold-storage|cold-storage
1230580|NCT01892670|Filtration|filtration
1230581|NCT01892670|Transfusion|transfusion
1230582|NCT01892670|Platelet-function|platelet-function
1230583|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
1230584|NCT01892657|Hypoallergenicity|hypoallergenicity
1230585|NCT01892657|Skin Irritation|skin irritation
1230586|NCT01892644|Hemochromatosis|hemochromatosis
1230587|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
1230588|NCT01892644|Iron overload|iron overload
1230589|NCT01892644|Deferasirox|deferasirox
1230590|NCT01892644|Chelation therapy|chelation therapy
1230591|NCT01892644|Venesection|venesection
1230592|NCT01892644|Phlebotomy|phlebotomy
1230593|NCT01892644|Ferritin|ferritin
1230594|NCT01892644|Transfusional siderosis|transfusional siderosis
1230595|NCT01892631|Text messaging|text messaging
1230596|NCT01892605|Mozart K.448|mozart k.448
1230597|NCT01892605|first unprovoked seizure|first unprovoked seizure
1230598|NCT01892605|epileptiform discharges|epileptiform discharges
1230599|NCT01892605|music therapy|music therapy
1230600|NCT01892605|children|children
1230601|NCT01892592|Hypertension|hypertension
1230602|NCT01892592|African American|african american
1230603|NCT01892592|Health Disparities|health disparities
1230604|NCT01892592|Stroke|stroke
1230605|NCT01892592|Cardiovascular Disease|cardiovascular disease
1230606|NCT01892579|Agitation|agitation
1230607|NCT01892579|Dementia|dementia
1230608|NCT01892579|Alzheimer's Disease|alzheimer's disease
1230609|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
1230610|NCT01892566|HIV|hiv
1230611|NCT01892566|mobile health|mobile health
1230612|NCT01892566|spirometry|spirometry
1230613|NCT01892553|Dyspnea|dyspnea
1230614|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1230615|NCT01892553|Perception|perception
1230616|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
1230617|NCT01892527|wild type KRAS|wild type kras
1230618|NCT01892527|C-met overexpression|c-met overexpression
1230619|NCT01892527|Tivantinib|tivantinib
1230620|NCT01892527|Cetuximab|cetuximab
1230621|NCT01892514|osteonecrosis|osteonecrosis
1230622|NCT01892514|bone marrow concentrate|bone marrow concentrate
1230623|NCT01892514|demineralized bone matrix|demineralized bone matrix
1230624|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
1230625|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
1230626|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
1230627|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
1230628|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
1230629|NCT01892501|EUS|eus
1230630|NCT01892488|COPD|copd
1230631|NCT01892488|AE-COPD|ae-copd
1230632|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1594705|NCT00414960|Prevention|prevention
1230633|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
1230634|NCT01892475|Physical Activity|physical activity
1230635|NCT01892475|Incentives|incentives
1230636|NCT01892475|Mental Accounting|mental accounting
1230637|NCT01892475|Older adults|older adults
1230638|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
1230639|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
1230640|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
1230641|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
1230642|NCT01892397|13-067|13-067
1230643|NCT01892371|Leukemia|leukemia
1230644|NCT01892371|Acute Myeloid Leukemia|acute myeloid leukemia
1230645|NCT01892371|AML|aml
1230646|NCT01892371|Myelodysplastic Syndrome|myelodysplastic syndrome
1230647|NCT01892371|MDS|mds
1230649|NCT01892371|AC220|ac220
1230650|NCT01892371|ASP2689|asp2689
1230651|NCT01892371|Cytarabine|cytarabine
1230652|NCT01892371|Ara-C|ara-c
1230653|NCT01892371|Cytosar|cytosar
1230654|NCT01892371|DepoCyt|depocyt
1230655|NCT01892371|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1230657|NCT01892371|Vidaza|vidaza
1230658|NCT01892371|Azacitidine|azacitidine
1230659|NCT01892371|5-Azacytidine|5-azacytidine
1230660|NCT01892371|5-AZA|5-aza
1230661|NCT01892371|5-AZC|5-azc
1230662|NCT01892371|AZA-CR|aza-cr
1230663|NCT01892371|Ladakamycin|ladakamycin
1230664|NCT01892371|NSC-102816|nsc-102816
1230665|NCT01892371|Azacytidine|azacytidine
1230666|NCT01892371|Maximum tolerated dose|maximum tolerated dose
1230667|NCT01892371|MTD|mtd
1230668|NCT01892371|Overall response|overall response
1230669|NCT01892371|Complete remission|complete remission
1230670|NCT01892371|CR|cr
1230671|NCT01892371|Complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
1230672|NCT01892371|Cri|cri
1230673|NCT01892371|Partial remission|partial remission
1230674|NCT01892371|PR|pr
1230675|NCT01892371|Hematologic improvement|hematologic improvement
1230676|NCT01892371|HI|hi
1230677|NCT01892358|injection drug use|injection drug use
1230678|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
1230679|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
1230680|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
1230681|NCT01892345|Optic Neuritis|optic neuritis
1230682|NCT01892345|relapse|relapse
1230683|NCT01892345|eculizumab|eculizumab
1230684|NCT01892345|soliris|soliris
1230685|NCT01892345|NMO-IgG|nmo-igg
1230686|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
1230687|NCT01892345|Demyelinating Disorders|demyelinating disorders
1230688|NCT01892345|NMO|nmo
1230689|NCT01892345|NMOSD|nmosd
1230690|NCT01892293|Multiple Myeloma|multiple myeloma
1230691|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
1230692|NCT01892293|Received initial treatment previously|received initial treatment previously
1230693|NCT01892267|PEGJ|pegj
1230694|NCT01892267|PEG-J|peg-j
1230695|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
1230696|NCT01892267|Feeding tube|feeding tube
1230697|NCT01892267|Gastroparesis|gastroparesis
1230698|NCT01892267|Acute pancreatitis|acute pancreatitis
1230699|NCT01892267|Stroke|stroke
1230700|NCT01892267|Respiratory failure|respiratory failure
1230701|NCT01892267|GERD|gerd
1230702|NCT01892267|Balloon|balloon
1230703|NCT01892267|Self-propelled|self-propelled
1230704|NCT01892254|incretin effect|incretin effect
1230705|NCT01892254|PCOS|pcos
1230706|NCT01892254|insulin resistance|insulin resistance
1230707|NCT01892254|OGTT|ogtt
1230708|NCT01892254|IIGI|iigi
1230709|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
1230710|NCT01892228|antiretroviral therapy|antiretroviral therapy
1230711|NCT01892228|education|education
1230712|NCT01892228|mortality|mortality
1230713|NCT01892215|Uterine incision.|uterine incision.
1230714|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
1230715|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
1230716|NCT01892189|Drug therapy|drug therapy
1230717|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
1230718|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
1230719|NCT01892137|Actinic Keratosis|actinic keratosis
1230720|NCT01892137|Histopathology|histopathology
1230721|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
1230722|NCT01892137|Local Skin Reaction|local skin reaction
1230723|NCT01892124|Motivational Interviewing|motivational interviewing
1230724|NCT01892124|Cognitive Therapy|cognitive therapy
1230725|NCT01892124|Community-Based Participatory Research|community-based participatory research
1230726|NCT01892124|Indians, North American|indians, north american
1230727|NCT01892111|SET|set
1230728|NCT01892111|infertility|infertility
1230729|NCT01892111|IVF/ICSI|ivf/icsi
1230730|NCT01892111|pregnancy|pregnancy
1230731|NCT01892098|Zinc|zinc
1230732|NCT01892098|Bone|bone
1230733|NCT01892098|Adolescents|adolescents
1230734|NCT01892098|Growth|growth
1230735|NCT01892085|Breast milk|breast milk
1230736|NCT01892085|lactogenesis stage two|lactogenesis stage two
1230737|NCT01892085|premature infant|premature infant
1230738|NCT01892085|insufficient milk supply|insufficient milk supply
1230739|NCT01892085|breast milk expression|breast milk expression
1230740|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
1230741|NCT01892072|HCC|hcc
1230742|NCT01892072|VEGF signaling pathway|vegf signaling pathway
1230743|NCT01892059|renal tumour|renal tumour
1230744|NCT01892059|partial nephrectomy|partial nephrectomy
1230745|NCT01892059|laparoscope|laparoscope
1230746|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
1230747|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
1230748|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
1230749|NCT01892046|Hsp90|hsp90
1230754|NCT01892033|Veteran|veteran
1230755|NCT01892007|Hearing loss|hearing loss
1230756|NCT01892007|Hearing aid|hearing aid
1230757|NCT01892007|Speech intelligibility|speech intelligibility
1230758|NCT01892007|Speech perception|speech perception
1230759|NCT01892007|Cognitive training|cognitive training
1230760|NCT01892007|Working memory|working memory
1230761|NCT01892007|Working memory training|working memory training
1230767|NCT01891981|Leukemia|leukemia
1230768|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1230769|NCT01891981|ALL|all
1230770|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
1230771|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
1230772|NCT01891981|Maximum tolerated dose|maximum tolerated dose
1230773|NCT01891981|MTD|mtd
1230774|NCT01891968|Leukemia|leukemia
1230775|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
1230776|NCT01891968|MDS|mds
1230777|NCT01891968|Low or intermediate-1|low or intermediate-1
1230778|NCT01891968|Bortezomib|bortezomib
1230779|NCT01891968|Velcade|velcade
1230780|NCT01891968|LDP-341|ldp-341
1230781|NCT01891968|MLN341|mln341
1230782|NCT01891968|PS-341|ps-341
1230783|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
1230784|NCT01891955|Cereals|cereals
1230785|NCT01891955|Dairy|dairy
1230786|NCT01891955|Dietary carbohydrates|dietary carbohydrates
1230787|NCT01891955|Dietary fiber|dietary fiber
1230788|NCT01891955|Food|food
1230789|NCT01891955|Metabolic syndrome|metabolic syndrome
1230790|NCT01891955|Satiety|satiety
1230791|NCT01891942|Normal|normal
1230792|NCT01891942|subjects|subjects
1230793|NCT01891929|Schizophrenia|schizophrenia
1230794|NCT01891929|Cognitive Remediation|cognitive remediation
1230795|NCT01891929|Working abilities and social functioning|working abilities and social functioning
1230796|NCT01891890|Pediatrics|pediatrics
1230797|NCT01891877|Sickle Cell Trait|sickle cell trait
1230798|NCT01891877|Football|football
1230799|NCT01891877|Sickling|sickling
1230800|NCT01891877|Heat Illness|heat illness
1230801|NCT01891877|SCT|sct
1230802|NCT01891851|Healthy|healthy
1230803|NCT01891851|Hepatitis C|hepatitis c
1230804|NCT01891851|TMC435350|tmc435350
1230805|NCT01891851|Ritonavir|ritonavir
1230806|NCT01891851|Pharmacokinetics|pharmacokinetics
1230807|NCT01891838|surgery|surgery
1230808|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
1230809|NCT01891838|pituitary adenoma|pituitary adenoma
1230810|NCT01891838|mechanical ventilation|mechanical ventilation
1230811|NCT01891838|bleeding|bleeding
1230812|NCT01891825|Atrial fibrillation|atrial fibrillation
1230813|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
1230814|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
1230815|NCT01891812|Sickle cell disease|sickle cell disease
1230816|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
1230817|NCT01891812|Nitrous oxide|nitrous oxide
1230818|NCT01891812|Emergency department|emergency department
1230819|NCT01891799|HIV/AIDS|hiv/aids
1230820|NCT01891799|PMTCT|pmtct
1230821|NCT01891799|Option B+|option b+
1230822|NCT01891799|Swaziland|swaziland
1230823|NCT01891773|Asthma|asthma
1230824|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
1230825|NCT01891773|School Nurses|school nurses
1230826|NCT01891747|gliomas|gliomas
1230827|NCT01891734|Veterans|veterans
1230828|NCT01891734|Health Services|health services
1230829|NCT01891734|Mental Health|mental health
1230830|NCT01891734|Technology|technology
1230831|NCT01891734|Primary Health Care|primary health care
1230832|NCT01891734|Psychotherapy|psychotherapy
1230833|NCT01891721|cognitive training|cognitive training
1230834|NCT01891721|schizophrenia|schizophrenia
1230835|NCT01891721|mismatch negativity|mismatch negativity
1230836|NCT01891721|cognition|cognition
1230837|NCT01891721|functional capacity|functional capacity
1230838|NCT01891721|EEG|eeg
1230839|NCT01891682|Methionine Metabolism|methionine metabolism
1230840|NCT01891682|Parenteral Nutrition|parenteral nutrition
1230841|NCT01891682|Pediatric|pediatric
1230842|NCT01891682|Pediatrics|pediatrics
1230843|NCT01891682|Sepsis|sepsis
1230844|NCT01891682|Observational Study|observational study
1230845|NCT01891669|ADC 5T4|adc 5t4
1230846|NCT01891669|PF-06263507|pf-06263507
1230847|NCT01891669|solid tumors|solid tumors
1230848|NCT01891669|lung cancer|lung cancer
1230849|NCT01891669|breast cancer|breast cancer
1230850|NCT01891669|ovarian cancer|ovarian cancer
1230851|NCT01891669|cancer|cancer
1230852|NCT01891669|tumors|tumors
1230853|NCT01891669|neoplasm metastasis|neoplasm metastasis
1230854|NCT01891656|Motivational Interviewing|motivational interviewing
1230855|NCT01891656|Internet|internet
1230856|NCT01891656|Treatment|treatment
1231134|NCT01890681|child care|child care
1230857|NCT01891656|Substance-Related Disorders|substance-related disorders
1230858|NCT01891656|Criminal Justice|criminal justice
1230859|NCT01891630|African American|african american
1230860|NCT01891630|Asthma|asthma
1230861|NCT01891617|exercise|exercise
1230862|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
1230863|NCT01891617|insulin|insulin
1230864|NCT01891617|gut peptides|gut peptides
1230865|NCT01891617|appetite|appetite
1230866|NCT01891617|metabolism|metabolism
1230867|NCT01891617|glucose|glucose
1230868|NCT01891591|Obesity|obesity
1230869|NCT01891591|Gastric bypass|gastric bypass
1230870|NCT01891591|Energy balance|energy balance
1230871|NCT01891591|Nutritional status|nutritional status
1230872|NCT01891591|Protein balance|protein balance
1230873|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
1230874|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
1230875|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
1230876|NCT01891526|hepatic patients|hepatic patients
1230877|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
1230878|NCT01891513|Physical activity|physical activity
1230879|NCT01891513|Hypertension|hypertension
1230880|NCT01891513|Physical function|physical function
1230881|NCT01891513|Aging|aging
1230882|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
1230883|NCT01891500|Infant, Newborn|infant, newborn
1230884|NCT01891500|Nitric Oxide|nitric oxide
1230885|NCT01891500|Oxidative Stress|oxidative stress
1230886|NCT01891500|Endothelin 1|endothelin 1
1230887|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1230888|NCT01891487|Eyebrow|eyebrow
1230889|NCT01891487|Hypotrichosis|hypotrichosis
1230890|NCT01891487|Thinning|thinning
1230891|NCT01891487|Bimatoprost|bimatoprost
1230892|NCT01891461|total knee arthroplasty|total knee arthroplasty
1230893|NCT01891461|post-operative bleeding|post-operative bleeding
1230894|NCT01891461|floseal|floseal
1230895|NCT01891435|antipyretics|antipyretics
1230896|NCT01891435|oral paracetamol|oral paracetamol
1230897|NCT01891435|intravenous paracetamol|intravenous paracetamol
1230898|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
1230899|NCT01891435|emergency department|emergency department
1230900|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
1230901|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
1230902|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
1230903|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
1230904|NCT01891422|mucolipidoses|mucolipidoses
1230905|NCT01891422|Oligosaccharidoses|oligosaccharidoses
1230906|NCT01891422|Lysosomal Disease|lysosomal disease
1230907|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
1230908|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
1230909|NCT01891422|fucosidosis|fucosidosis
1230910|NCT01891422|galactosialidosis|galactosialidosis
1230911|NCT01891422|alpha mannosidosis|alpha mannosidosis
1230912|NCT01891422|beta mannosidosis|beta mannosidosis
1230913|NCT01891422|mucolipidosis II|mucolipidosis ii
1230914|NCT01891422|mucolipidosis III|mucolipidosis iii
1230915|NCT01891422|Schindler disease|schindler disease
1230916|NCT01891422|sialidosis|sialidosis
1230917|NCT01891409|HIV prevention|hiv prevention
1230918|NCT01891409|Male Circumcision|male circumcision
1230919|NCT01891409|Children|children
1230920|NCT01891409|Childhood|childhood
1230921|NCT01891409|Shang Ring|shang ring
1230922|NCT01891396|Knee osteoarthritis|knee osteoarthritis
1230923|NCT01891396|Hyaluronic acid|hyaluronic acid
1230924|NCT01891396|HA Injection|ha injection
1230925|NCT01891396|Steroid Injection|steroid injection
1230926|NCT01891396|Knee injection|knee injection
1230927|NCT01891383|Dementia|dementia
1230928|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
1230929|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
1230930|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
1230931|NCT01891383|Remote effects of TBI|remote effects of tbi
1230932|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
1230933|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
1230934|NCT01891344|ovarian cancer|ovarian cancer
1230935|NCT01891344|fallopian tube cancer|fallopian tube cancer
1230936|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
1230937|NCT01891344|peritoneal cancer|peritoneal cancer
1594998|NCT00413608|Adults|adults
1230938|NCT01891344|platinum sensitive|platinum sensitive
1230939|NCT01891344|relapsed disease|relapsed disease
1230940|NCT01891344|PARP Inhibitor|parp inhibitor
1230941|NCT01891344|rucaparib|rucaparib
1230942|NCT01891344|homologous recombination|homologous recombination
1230943|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
1230944|NCT01891344|genomic scarring|genomic scarring
1230945|NCT01891344|loss of heterozygosity|loss of heterozygosity
1230946|NCT01891344|CO-338|co-338
1230947|NCT01891344|PF 01367338|pf 01367338
1230948|NCT01891344|AG 14699|ag 14699
1231135|NCT01890681|infant|infant
1230949|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
1230950|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
1230951|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
1230952|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
1230953|NCT01891344|gynecological cancer|gynecological cancer
1230954|NCT01891344|Clovis|clovis
1230955|NCT01891344|Clovis Oncology|clovis oncology
1230956|NCT01891344|ARIEL2|ariel2
1230957|NCT01891344|ARIEL 2|ariel 2
1230958|NCT01891344|ARIEL3|ariel3
1230959|NCT01891344|ARIEL 3|ariel 3
1230960|NCT01891279|short bowel syndrome|short bowel syndrome
1230961|NCT01891279|Elemental formula|elemental formula
1230962|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
1230963|NCT01891279|Enteral feeding|enteral feeding
1230964|NCT01891279|TPN dependency|tpn dependency
1230965|NCT01891279|Intestinal adaptation|intestinal adaptation
1230966|NCT01891279|TPN cholestasis|tpn cholestasis
1230967|NCT01891253|cardiac output|cardiac output
1230968|NCT01891253|mechanical ventilation|mechanical ventilation
1230969|NCT01891253|inert gas rebreathing|inert gas rebreathing
1230970|NCT01891253|pulse contour analysis|pulse contour analysis
1230971|NCT01891240|Diagnostic|diagnostic
1230972|NCT01891240|Pre-eclampsia|pre-eclampsia
1230973|NCT01891240|Pregnancy outcome|pregnancy outcome
1230974|NCT01891240|Mass screening|mass screening
1230975|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1230976|NCT01891227|Bendamustine|bendamustine
1230977|NCT01891227|Capecitabine|capecitabine
1230978|NCT01891227|Pretreated|pretreated
1230979|NCT01891227|Her2 negative|her2 negative
1230980|NCT01891227|Advanced breast cancer|advanced breast cancer
1230981|NCT01891227|Metastatic breast cancer|metastatic breast cancer
1230982|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
1230983|NCT01891227|Taxane pretreatment|taxane pretreatment
1230984|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
1230985|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
1230986|NCT01891201|Bonding|bonding
1230987|NCT01891201|Oxytocin|oxytocin
1230988|NCT01891201|Breastfeeding|breastfeeding
1230989|NCT01891201|Newborn|newborn
1230990|NCT01891201|Delivery|delivery
1230991|NCT01891188|hepatic blood,|hepatic blood,
1230992|NCT01891188|cardiac cath,|cardiac cath,
1230993|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
1230994|NCT01891188|pediatrics|pediatrics
1230995|NCT01891175|Caesarean|caesarean
1230996|NCT01891175|hypotension|hypotension
1230997|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
1230998|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
1230999|NCT01891175|lower extremities|lower extremities
1231000|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
1231001|NCT01891136|Peanut allergy|peanut allergy
1231002|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
1231003|NCT01891123|Breast cancer|breast cancer
1231004|NCT01891123|plasma drug concentration|plasma drug concentration
1231005|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
1231006|NCT01891110|electric stimulation|electric stimulation
1231007|NCT01891110|tilt-table|tilt-table
1231008|NCT01891097|Insomnia|insomnia
1231009|NCT01891097|Acupuncture|acupuncture
1231010|NCT01891097|Electroacupuncture|electroacupuncture
1231011|NCT01891097|Aricular acupuncture|aricular acupuncture
1231012|NCT01891097|Randomized Clinical Trial|randomized clinical trial
1231013|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
1231014|NCT01891084|Influenza|influenza
1231015|NCT01891084|Antipyretics|antipyretics
1231016|NCT01891084|Fever|fever
1231017|NCT01891071|Multiple sclerosis|multiple sclerosis
1231018|NCT01891071|Lung volume recruitment|lung volume recruitment
1231019|NCT01891071|Pulmonary function impairment|pulmonary function impairment
1231020|NCT01891071|Cough impairment|cough impairment
1231021|NCT01891045|Psychotherapy|psychotherapy
1231022|NCT01891045|Drug addiction|drug addiction
1231023|NCT01891045|Drop-out|drop-out
1231024|NCT01891045|OQ-45.2|oq-45.2
1231025|NCT01891045|Clinical trial|clinical trial
1231026|NCT01891045|Randomized Controlled Trail|randomized controlled trail
1231027|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
1231028|NCT01891006|Randomized Controlled Trial|randomized controlled trial
1231029|NCT01891006|Economical Evaluation|economical evaluation
1231030|NCT01891006|Caesarean Section|caesarean section
1231031|NCT01891006|Cesarean Section|cesarean section
1231032|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
1231033|NCT01891006|Surgical Site Infections|surgical site infections
1231034|NCT01891006|Wound Infections|wound infections
1231035|NCT01891006|Infectious Morbidity|infectious morbidity
1231036|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
1231037|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
1231038|NCT01890980|GM-CSF|gm-csf
1231039|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
1231040|NCT01890980|immunotherapy|immunotherapy
1231041|NCT01890980|Montanide|montanide
1231042|NCT01890980|Sargramostim|sargramostim
1231043|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
1231044|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1231046|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
1231047|NCT01890980|SMRP|smrp
1231048|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
1231049|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1231050|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
1231051|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1231052|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1231053|NCT01890941|Dry eye syndromes|dry eye syndromes
1231054|NCT01890941|Corneal diseases|corneal diseases
1231055|NCT01890941|Conjunctival diseases|conjunctival diseases
1231056|NCT01890928|Gluconeogenesis|gluconeogenesis
1231057|NCT01890928|Glycogenolysis|glycogenolysis
1231058|NCT01890928|Pyruvate cycling|pyruvate cycling
1231059|NCT01890928|Glucose production rates|glucose production rates
1231060|NCT01890928|Mitochondria|mitochondria
1231061|NCT01890928|Acylcarnitines|acylcarnitines
1231062|NCT01890915|Spinal cord injury|spinal cord injury
1231063|NCT01890915|Body temperature|body temperature
1231064|NCT01890915|Executive function|executive function
1231065|NCT01890915|Sweat|sweat
1231066|NCT01890889|Total Cholesterol|total cholesterol
1231067|NCT01890889|LDL|ldl
1231068|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
1231069|NCT01890863|asthma|asthma
1231070|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
1231071|NCT01890863|PK equivalence|pk equivalence
1231072|NCT01890863|COPD|copd
1231073|NCT01890863|pharmacokinetics|pharmacokinetics
1231074|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
1231075|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
1231076|NCT01890863|Respiratory|respiratory
1231077|NCT01890850|Risk factors|risk factors
1231078|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
1231079|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
1231080|NCT01890850|Retrospective database study|retrospective database study
1231081|NCT01890837|Rectal Compliance|rectal compliance
1231082|NCT01890837|Rectal Sensation|rectal sensation
1231083|NCT01890837|Rectal Tone|rectal tone
1231084|NCT01890824|Breast Cancer|breast cancer
1231085|NCT01890824|Fat metabolism|fat metabolism
1231086|NCT01890824|Fat digestion|fat digestion
1231087|NCT01890824|physical activity|physical activity
1231088|NCT01890824|muscle function|muscle function
1231090|NCT01890811|Hemodialysis|hemodialysis
1231091|NCT01890811|Protein Digestion|protein digestion
1231092|NCT01890811|Fat Digestion|fat digestion
1231093|NCT01890811|Gut Function|gut function
1231094|NCT01890811|Glucose Absorption|glucose absorption
1231095|NCT01890811|Muscle Function|muscle function
1231096|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1231097|NCT01890798|GSK2402968|gsk2402968
1231098|NCT01890798|drisapersen|drisapersen
1231099|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
1231100|NCT01890772|Vitamin D|vitamin d
1231101|NCT01890772|treatment-naive|treatment-naive
1231102|NCT01890759|Meningitis|meningitis
1231103|NCT01890759|Meningococcal Infection|meningococcal infection
1231104|NCT01890759|Menactra®|menactra®
1231105|NCT01890746|de novo AML|de novo aml
1231106|NCT01890746|Eltrombopag|eltrombopag
1231107|NCT01890746|leukemia|leukemia
1231108|NCT01890746|sAML/MDS|saml/mds
1231109|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
1231110|NCT01890746|secondary acute myeloid|secondary acute myeloid
1231111|NCT01890746|thrombocytopenia|thrombocytopenia
1231112|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
1231113|NCT01890720|Randomized Controlled Trial|randomized controlled trial
1231114|NCT01890720|Economical Evaluation|economical evaluation
1231115|NCT01890720|Caesarean Section|caesarean section
1231116|NCT01890720|postoperative wound treatment|postoperative wound treatment
1231117|NCT01890720|surgical site infections|surgical site infections
1231118|NCT01890720|wound infections|wound infections
1231119|NCT01890720|infectious morbidity|infectious morbidity
1231120|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
1231121|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
1231123|NCT01890707|Gynecology|gynecology
1231124|NCT01890707|Pain|pain
1231125|NCT01890707|Anesthesia|anesthesia
1231126|NCT01890707|Quality of Recovery 40|quality of recovery 40
1231127|NCT01890694|Hyponatremia|hyponatremia
1231128|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
1231129|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
1231130|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
1231131|NCT01890694|Fluid Restriction|fluid restriction
1231132|NCT01890694|Tolvaptan|tolvaptan
1231133|NCT01890681|childhood obesity|childhood obesity
1231136|NCT01890681|toddler|toddler
1231137|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
1231138|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
1231139|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
1231140|NCT01890668|healthy newborns|healthy newborns
1231141|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1231142|NCT01890655|RRMS|rrms
1231143|NCT01890642|Pain|pain
1231144|NCT01890642|Children|children
1231145|NCT01890642|Venipuncture|venipuncture
1231146|NCT01890642|J tip|j tip
1231147|NCT01890642|Lidocaine|lidocaine
1231148|NCT01890642|video observation|video observation
1231149|NCT01890629|diabetes mellitus|diabetes mellitus
1231150|NCT01890603|Care coordination, primary care|care coordination, primary care
1231151|NCT01890603|nurse care management|nurse care management
1231152|NCT01890603|practice facilitation|practice facilitation
1231153|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
1231154|NCT01890590|Cyberknife|cyberknife
1231155|NCT01890577|Chronic kidney disease|chronic kidney disease
1231156|NCT01890577|Dialysis|dialysis
1231157|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
1231158|NCT01890577|South Africa|south africa
1231159|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
1231160|NCT01890538|vertigo|vertigo
1231161|NCT01890538|dimenhydrinate|dimenhydrinate
1231162|NCT01890538|piracetam|piracetam
1231163|NCT01890525|radiation|radiation
1231164|NCT01890499|tolerability|tolerability
1231165|NCT01890499|diet after operation|diet after operation
1231166|NCT01890447|Cocooning|cocooning
1231167|NCT01890447|Web-based questionnaire|web-based questionnaire
1231168|NCT01890447|Italy|italy
1231169|NCT01890447|Pertussis|pertussis
1231170|NCT01890447|Spain|spain
1231171|NCT01890447|Survey|survey
1231172|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
1231173|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
1231174|NCT01890408|Laparotomy|laparotomy
1231175|NCT01890408|Hepatic resection|hepatic resection
1231176|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
1231177|NCT01890408|morphine|morphine
1231178|NCT01890408|post operative recovery|post operative recovery
1231179|NCT01890395|mitochondrial DAMPS|mitochondrial damps
1231180|NCT01890382|resistance exercise|resistance exercise
1231181|NCT01890382|protein|protein
1231182|NCT01890382|creatine|creatine
1231183|NCT01890382|leucine|leucine
1231184|NCT01890382|aging|aging
1231185|NCT01890369|Old Age|old age
1231186|NCT01890369|Sarcopenia|sarcopenia
1231187|NCT01890369|Amino Acid|amino acid
1231188|NCT01890369|Muscle|muscle
1231189|NCT01890356|Depression|depression
1231190|NCT01890356|Treatment|treatment
1231191|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
1231192|NCT01890356|Maintenance|maintenance
1231193|NCT01890330|Canola Oil|canola oil
1231194|NCT01890330|Metabolic Syndrome|metabolic syndrome
1231195|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
1231196|NCT01890317|Cardiogenic shock|cardiogenic shock
1231197|NCT01890317|acute myocardial infarction|acute myocardial infarction
1231198|NCT01890317|mild hypothermia|mild hypothermia
1231199|NCT01890304|Traumatic Brain Injury|traumatic brain injury
1231200|NCT01890304|TBI|tbi
1231201|NCT01890304|Concussion|concussion
1231202|NCT01890304|Sports related injury|sports related injury
1231203|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
1231204|NCT01890278|Brain Cancer|brain cancer
1231205|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
1231206|NCT01890278|IMRT|imrt
1231207|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
1231208|NCT01890213|alphavirus|alphavirus
1231209|NCT01890213|colon cancer|colon cancer
1231210|NCT01890213|immune response|immune response
1231211|NCT01890213|CEA|cea
1231212|NCT01890200|add-on treatment|add-on treatment
1231213|NCT01890200|botanical drug|botanical drug
1231214|NCT01890200|HCV genotype 1|hcv genotype 1
1231215|NCT01890200|TCM-700C|tcm-700c
1231216|NCT01890161|asthma|asthma
1231217|NCT01890148|Asthma|asthma
1231218|NCT01890135|randomized|randomized
1231219|NCT01890135|double blind|double blind
1231220|NCT01890135|blood flow|blood flow
1231221|NCT01890135|muscle perfusion|muscle perfusion
1231222|NCT01890135|safety|safety
1231223|NCT01890122|Drug therapy|drug therapy
1231224|NCT01890109|Vasomotor symptoms; Hot Flashes; Menopause|vasomotor symptoms; hot flashes; menopause
1231225|NCT01890096|HDR|hdr
1231226|NCT01890096|monotherapy|monotherapy
1231227|NCT01890096|low|low
1231228|NCT01890096|intermediate|intermediate
1231229|NCT01890096|prostate cancer|prostate cancer
1231230|NCT01890083|Hepatitis C|hepatitis c
1231231|NCT01890083|Interferon-alpha|interferon-alpha
1231232|NCT01890083|Depression|depression
1231233|NCT01890083|Major Depressive Disorder|major depressive disorder
1231234|NCT01890083|Exercise|exercise
1231331|NCT01889706|obesity|obesity
1231235|NCT01890083|Physical Activity|physical activity
1231236|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
1231237|NCT01890044|VTE|vte
1231238|NCT01890044|DVT|dvt
1231239|NCT01890044|Venous Thromboembolism|venous thromboembolism
1231240|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
1231241|NCT01890044|Pulmonary embolus|pulmonary embolus
1231242|NCT01890044|Trauma|trauma
1231243|NCT01890031|cardiovascular disease|cardiovascular disease
1231244|NCT01890031|cholesterol|cholesterol
1231245|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1231246|NCT01890018|taking a statin medication|taking a statin medication
1231247|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
1231248|NCT01890005|Preeclampsia|preeclampsia
1231249|NCT01890005|Low dose aspirin|low dose aspirin
1231250|NCT01890005|Fetal growth restriction|fetal growth restriction
1231251|NCT01890005|Neonatal death|neonatal death
1231252|NCT01890005|Stillbirth|stillbirth
1231253|NCT01890005|Abruptio placenta|abruptio placenta
1231254|NCT01889992|Heart transplantation|heart transplantation
1231255|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
1231256|NCT01889992|Immunosuppression|immunosuppression
1231257|NCT01889992|Cardiac MRI|cardiac mri
1231258|NCT01889992|M-TOR inhibitor|m-tor inhibitor
1231259|NCT01889979|Pain during labour|pain during labour
1231260|NCT01889979|Duration of labour|duration of labour
1231261|NCT01889979|Apgar score|apgar score
1231262|NCT01889979|Umbilical cord pH|umbilical cord ph
1231263|NCT01889966|vasoreactivity testing|vasoreactivity testing
1231264|NCT01889966|Sildenafil|sildenafil
1231265|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
1231266|NCT01889966|connective tissue disease|connective tissue disease
1231267|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
1231268|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
1231269|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
1231270|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1231271|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
1231272|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
1231273|NCT01889940|Patient Satisfaction|patient satisfaction
1231274|NCT01889940|Psychological Distress|psychological distress
1231275|NCT01889940|Rehabilitation|rehabilitation
1231276|NCT01889940|Training Professionals|training professionals
1231277|NCT01889940|Burnout|burnout
1231278|NCT01889940|Job Content|job content
1231279|NCT01889927|exercise|exercise
1231280|NCT01889927|physiotherapy|physiotherapy
1231281|NCT01889927|lung function|lung function
1231282|NCT01889927|quality of life|quality of life
1231283|NCT01889901|Physical Activity|physical activity
1231284|NCT01889901|Epilepsy|epilepsy
1231285|NCT01889901|Seizures|seizures
1231286|NCT01889901|Quality of Life|quality of life
1231287|NCT01889888|Male urethral stricture|male urethral stricture
1231288|NCT01889888|ADRC|adrc
1231289|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
1231290|NCT01889888|Fat tissue|fat tissue
1231291|NCT01889888|Stem cells|stem cells
1231292|NCT01889862|PKU|pku
1231293|NCT01889862|PEG-PAL|peg-pal
1231294|NCT01889862|Prism|prism
1231295|NCT01889862|BioMarin|biomarin
1231296|NCT01889862|rAvPAL-PEG|ravpal-peg
1231297|NCT01889862|Pegvaliase|pegvaliase
1231298|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
1231299|NCT01889836|Prevention|prevention
1231300|NCT01889823|Oxygen|oxygen
1231301|NCT01889823|Hypoxia|hypoxia
1231302|NCT01889823|Hyperoxia|hyperoxia
1231303|NCT01889823|Inflammation|inflammation
1231304|NCT01889823|Innate immunity|innate immunity
1231305|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
1231306|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
1231307|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
1231308|NCT01889797|NHL|nhl
1231309|NCT01889797|Indolent|indolent
1231310|NCT01889797|Rituximab|rituximab
1231311|NCT01889797|Rituxan|rituxan
1231312|NCT01889797|GA101|ga101
1231313|NCT01889797|Obinutuzumab|obinutuzumab
1231314|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
1231315|NCT01889784|phototherapy|phototherapy
1231316|NCT01889784|physical exercise|physical exercise
1231317|NCT01889784|oxygen consumption|oxygen consumption
1231318|NCT01889784|arterial blood pressure|arterial blood pressure
1231319|NCT01889784|heart rate|heart rate
1231320|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
1231321|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
1231322|NCT01889758|bioequivalence|bioequivalence
1231323|NCT01889758|tacrolimus|tacrolimus
1231324|NCT01889758|kidney|kidney
1231325|NCT01889758|liver|liver
1231326|NCT01889758|transplant|transplant
1231327|NCT01889719|HIV Prevention|hiv prevention
1231328|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
1231329|NCT01889706|metformin,|metformin,
1231330|NCT01889706|insulin resistance,|insulin resistance,
1231332|NCT01889693|positron emission tomography|positron emission tomography
1231333|NCT01889693|macrophage|macrophage
1231334|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
1231335|NCT01889680|colorectal cancer|colorectal cancer
1231336|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
1231337|NCT01889680|ziv-aflibercept|ziv-aflibercept
1231338|NCT01889680|NSABP|nsabp
1231339|NCT01889667|Oral Insulin|oral insulin
1231340|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
1231341|NCT01889667|Safety|safety
1231342|NCT01889667|Pharmacodynamics|pharmacodynamics
1231343|NCT01889667|Pharmacokinetics|pharmacokinetics
1231344|NCT01889628|Glycaemic response|glycaemic response
1231345|NCT01889628|Glycaemic Index|glycaemic index
1231346|NCT01889628|Nutritional formula|nutritional formula
1231347|NCT01889628|Asia|asia
1231348|NCT01889628|Ethnic differences|ethnic differences
1231349|NCT01889628|Chinese|chinese
1231350|NCT01889628|Malay|malay
1231351|NCT01889628|Indian|indian
1231352|NCT01889615|Ovarian cancer|ovarian cancer
1231353|NCT01889615|PET/CT|pet/ct
1231354|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
1231355|NCT01889602|Healthy volunteers|healthy volunteers
1231356|NCT01889602|Topiramate|topiramate
1231357|NCT01889602|Neurocognition|neurocognition
1231358|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
1231359|NCT01889576|glucose|glucose
1231360|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1231361|NCT01889563|heart rate variability|heart rate variability
1231362|NCT01889563|physical training|physical training
1231363|NCT01889550|Screening|screening
1231364|NCT01889550|Downs syndrome|downs syndrome
1231365|NCT01889550|Informed choice|informed choice
1231366|NCT01889550|eHealth|ehealth
1231367|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
1231368|NCT01889511|Text Messaging|text messaging
1231369|NCT01889511|Medication Adherence|medication adherence
1231370|NCT01889511|Oral Agents|oral agents
1231371|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
1231372|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1231373|NCT01889485|Carotid Stenosis|carotid stenosis
1231374|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
1231375|NCT01889485|Health Services Accessibility|health services accessibility
1231376|NCT01889472|CPAP compliance|cpap compliance
1231377|NCT01889472|leaks|leaks
1231378|NCT01889472|Respiratory disturbances index|respiratory disturbances index
1231379|NCT01889472|quality of life|quality of life
1231380|NCT01889446|Propionic acid|propionic acid
1231381|NCT01889446|Food preservatives|food preservatives
1231382|NCT01889433|Hepatitis C|hepatitis c
1231383|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
1231384|NCT01889433|Peginterferon|peginterferon
1231385|NCT01889433|Treatment|treatment
1231386|NCT01889420|myeloma|myeloma
1231387|NCT01889420|relapse|relapse
1231388|NCT01889420|refractory|refractory
1231389|NCT01889420|relapsed|relapsed
1231390|NCT01889420|pomalidomide|pomalidomide
1231391|NCT01889420|pomalyst|pomalyst
1231392|NCT01889420|everolimus|everolimus
1231393|NCT01889420|afinitor|afinitor
1231394|NCT01889420|dexamethasone|dexamethasone
1231395|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
1231396|NCT01889394|pilonidal sinus|pilonidal sinus
1231397|NCT01889394|excision|excision
1231398|NCT01889394|primary wound closure|primary wound closure
1231399|NCT01889394|limberg flap|limberg flap
1231400|NCT01889368|Insulin resistance|insulin resistance
1231401|NCT01889368|Central adiposity|central adiposity
1231402|NCT01889368|Elevated blood pressure|elevated blood pressure
1231403|NCT01889368|Vascular reactivity|vascular reactivity
1231404|NCT01889368|Elevated triglycerides|elevated triglycerides
1231405|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
1231406|NCT01889355|diabetes|diabetes
1231407|NCT01889355|glucose|glucose
1231408|NCT01889355|glucometer|glucometer
1231409|NCT01889342|MCT|mct
1231410|NCT01889342|Metacognitive therapy|metacognitive therapy
1231411|NCT01889342|Anxiety disorders|anxiety disorders
1231412|NCT01889342|Transdiagnostic|transdiagnostic
1231413|NCT01889316|Fetal monitoring|fetal monitoring
1231414|NCT01889316|ECG|ecg
1231415|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1231416|NCT01889303|FOLFOX6|folfox6
1231417|NCT01889303|chemotherapy|chemotherapy
1231418|NCT01889303|docetaxel|docetaxel
1231419|NCT01889303|cisplatin|cisplatin
1231420|NCT01889303|gastric cancer|gastric cancer
1231421|NCT01889290|methylnaltrexone|methylnaltrexone
1231422|NCT01889290|opioid-antagonist|opioid-antagonist
1231423|NCT01889290|Obstipation|obstipation
1231424|NCT01889290|pharmacokinetics|pharmacokinetics
1231425|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
1231426|NCT01889264|Methionine Metabolism|methionine metabolism
1231427|NCT01889264|Enteral Nutrition|enteral nutrition
1231428|NCT01889264|Pediatric|pediatric
1231429|NCT01889264|Pediatrics|pediatrics
1231430|NCT01889264|Sepsis|sepsis
1231431|NCT01889264|Observational Study|observational study
1231533|NCT01888848|Brain|brain
1231432|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
1231433|NCT01889251|Vitreomacular Traction|vitreomacular traction
1231434|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
1231435|NCT01889251|Vitrectomy|vitrectomy
1231436|NCT01889251|Central Visual Field Defect|central visual field defect
1231437|NCT01889251|Blind Spot|blind spot
1231438|NCT01889251|Intravitreal Injection|intravitreal injection
1231439|NCT01889251|Macula|macula
1231440|NCT01889251|Retina|retina
1231441|NCT01889251|Decreased Visual Acuity|decreased visual acuity
1231442|NCT01889251|Visual Complaint|visual complaint
1231443|NCT01889251|SD-OCT|sd-oct
1231444|NCT01889251|Macular Hole|macular hole
1231445|NCT01889238|breast cancer|breast cancer
1231446|NCT01889238|triple negative|triple negative
1231447|NCT01889238|androgen receptor positive|androgen receptor positive
1231448|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
1231449|NCT01889199|hirsutism|hirsutism
1231450|NCT01889199|anovulation|anovulation
1231451|NCT01889199|oligomenorrhea|oligomenorrhea
1231452|NCT01889199|amenorrhea|amenorrhea
1231453|NCT01889199|hyperandrogenism|hyperandrogenism
1231454|NCT01889199|antiandrogen effect|antiandrogen effect
1231455|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1231456|NCT01889186|17 p Deletion|17 p deletion
1231457|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
1231458|NCT01889147|Peak plasma concentration|peak plasma concentration
1231459|NCT01889147|safety and efficacy|safety and efficacy
1231460|NCT01889147|therapeutic agent|therapeutic agent
1231461|NCT01889147|LPS-mediated diseases|lps-mediated diseases
1231462|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
1231463|NCT01889147|Determine half-time|determine half-time
1231464|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
1231465|NCT01889134|RANKL|rankl
1231466|NCT01889134|osteoprotegerin|osteoprotegerin
1231467|NCT01889134|bone mineral density|bone mineral density
1231468|NCT01889134|alendronate|alendronate
1231469|NCT01889134|parathyroidectomy|parathyroidectomy
1231470|NCT01889108|Premature|premature
1231471|NCT01889108|Development|development
1231472|NCT01889108|Motor|motor
1231473|NCT01889108|Cognitive|cognitive
1231474|NCT01889108|Parent|parent
1231475|NCT01889082|Obesity|obesity
1231476|NCT01889082|weight loss|weight loss
1231477|NCT01889082|young adults|young adults
1231478|NCT01889056|Erythropoietin|erythropoietin
1231479|NCT01889056|Cognition|cognition
1231480|NCT01889056|Exercise|exercise
1231481|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1231482|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
1231483|NCT01889043|Polysomnography|polysomnography
1231484|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
1231485|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
1231486|NCT01889017|generic immunosuppressive|generic immunosuppressive
1231487|NCT01889004|Cerebral blood flow|cerebral blood flow
1231488|NCT01889004|Consciousness|consciousness
1231489|NCT01889004|Dexmedetomidine|dexmedetomidine
1231491|NCT01889004|Event related potentials|event related potentials
1231492|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
1231493|NCT01889004|General anesthesia|general anesthesia
1231494|NCT01889004|Positron emission tomography|positron emission tomography
1231495|NCT01889004|Propofol|propofol
1231496|NCT01888991|Glucose|glucose
1231497|NCT01888991|Exercise|exercise
1231498|NCT01888991|Metabolic flexibility|metabolic flexibility
1231499|NCT01888991|Substrate Oxidation|substrate oxidation
1231500|NCT01888991|Food intake|food intake
1231501|NCT01888978|Pancreas|pancreas
1231502|NCT01888978|cancer|cancer
1231503|NCT01888978|metastatic|metastatic
1231504|NCT01888978|chemotherapy|chemotherapy
1231505|NCT01888965|Maintenance therapy|maintenance therapy
1231506|NCT01888965|Adjuvant Therapy|adjuvant therapy
1231507|NCT01888939|Executive Function|executive function
1231508|NCT01888939|Child|child
1231509|NCT01888939|Obesity|obesity
1231510|NCT01888939|Exercise|exercise
1231511|NCT01888939|Insulin Sensitivity|insulin sensitivity
1231512|NCT01888926|rPAS|rpas
1231513|NCT01888926|Dystonia|dystonia
1231514|NCT01888913|Body Weight|body weight
1231515|NCT01888913|Virtual Reality Technology|virtual reality technology
1231516|NCT01888900|Hepatitis C|hepatitis c
1231517|NCT01888900|Non-Responders|non-responders
1231518|NCT01888900|Direct Acting Antivirals|direct acting antivirals
1231519|NCT01888900|Interferon Free|interferon free
1231520|NCT01888900|Cirrhosis|cirrhosis
1231521|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
1231522|NCT01888861|length of stay in ICU|length of stay in icu
1231523|NCT01888861|ventilator free days|ventilator free days
1231524|NCT01888848|Postural Balance|postural balance
1231525|NCT01888848|Walking|walking
1231526|NCT01888848|Gait|gait
1231527|NCT01888848|Cognition|cognition
1231528|NCT01888848|Learning|learning
1231529|NCT01888848|Memory|memory
1231530|NCT01888848|Blueberry|blueberry
1231531|NCT01888848|Antioxidants|antioxidants
1231532|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
1231534|NCT01888835|HIV|hiv
1231535|NCT01888835|sexual behavior|sexual behavior
1231536|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1231537|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
1231538|NCT01888809|teen parents|teen parents
1231539|NCT01888809|early childhood development|early childhood development
1231540|NCT01888809|home visitation|home visitation
1231541|NCT01888809|evidence-based treatment|evidence-based treatment
1231542|NCT01888796|T2DM|t2dm
1231543|NCT01888796|diastolic dysfunction|diastolic dysfunction
1231544|NCT01888783|CRPS Type I|crps type i
1231545|NCT01888783|tactile acuity|tactile acuity
1231546|NCT01888783|2-point-discrimination|2-point-discrimination
1231547|NCT01888783|Grating Orientation Task|grating orientation task
1231548|NCT01888783|sensory signs|sensory signs
1231549|NCT01888757|Bioequivalence|bioequivalence
1231550|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
1231551|NCT01888757|crossover|crossover
1231552|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
1231553|NCT01888744|PGD|pgd
1231554|NCT01888744|GnrH agonist|gnrh agonist
1231555|NCT01888744|GnRH antagonist|gnrh antagonist
1231556|NCT01888731|Bioequivalence|bioequivalence
1231557|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
1231558|NCT01888731|crossover|crossover
1231559|NCT01888705|COPD|copd
1231560|NCT01888705|Complexity|complexity
1231561|NCT01888705|Entropy Sampling|entropy sampling
1231562|NCT01888705|Variability|variability
1231563|NCT01888705|Respiratory Mechanics|respiratory mechanics
1231564|NCT01888705|FOT|fot
1231565|NCT01888692|PET/CT|pet/ct
1231566|NCT01888692|Radiotherapy|radiotherapy
1231567|NCT01888692|Lung Cancer|lung cancer
1231568|NCT01888679|Airway|airway
1231569|NCT01888679|Endotracheal intubation|endotracheal intubation
1231570|NCT01888679|selective intubation|selective intubation
1231571|NCT01888653|PTSD|ptsd
1231572|NCT01888653|Attention Bias to threat|attention bias to threat
1231573|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
1231574|NCT01888640|TENS|tens
1231575|NCT01888640|Fibromyalgia|fibromyalgia
1231576|NCT01888640|Accelerometer|accelerometer
1231577|NCT01888627|Schizophrenia|schizophrenia
1231578|NCT01888627|Bipolar disorder|bipolar disorder
1231579|NCT01888627|Assertive community treatment|assertive community treatment
1231580|NCT01888627|Integrated care|integrated care
1231581|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
1231582|NCT01888614|carbon mono oxide|carbon mono oxide
1231583|NCT01888614|sickle cell|sickle cell
1231584|NCT01888614|hemolysis|hemolysis
1231585|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
1231586|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
1231587|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
1231588|NCT01888588|Epidemiology|epidemiology
1231589|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
1231590|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
1231591|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
1231592|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
1231593|NCT01888575|Epidemiology|epidemiology
1231594|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
1231595|NCT01888497|Sleeplessness|sleeplessness
1231596|NCT01888484|PID|pid
1231597|NCT01888471|Streptococcal disease|streptococcal disease
1231598|NCT01888471|Feasibility|feasibility
1231599|NCT01888471|Infants|infants
1231600|NCT01888458|Adult|adult
1231601|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
1231602|NCT01888458|Cord Blood|cord blood
1231603|NCT01888445|Renal anemia|renal anemia
1231604|NCT01888445|Chronic Renal Failure|chronic renal failure
1231605|NCT01888445|ASP1517|asp1517
1231606|NCT01888432|liver transplantation|liver transplantation
1231607|NCT01888432|everolimus|everolimus
1231608|NCT01888432|tacrolimus|tacrolimus
1231609|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
1231610|NCT01888432|renal function|renal function
1231611|NCT01888432|living donor|living donor
1231612|NCT01888432|RAD001H2307|rad001h2307
1231613|NCT01888432|RAD001H|rad001h
1231614|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
1231615|NCT01888419|Lipotransplantation|lipotransplantation
1231616|NCT01888419|Breast Cancer|breast cancer
1231617|NCT01888419|Pain|pain
1231618|NCT01888406|Obesity|obesity
1231619|NCT01888406|Weight gain prevention|weight gain prevention
1231620|NCT01888406|Eating disorder|eating disorder
1231621|NCT01888406|Binge eating|binge eating
1231622|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
1231623|NCT01888380|Autopsy|autopsy
1231624|NCT01888380|Minimally invasive|minimally invasive
1231625|NCT01888380|Foetuses|foetuses
1231626|NCT01888380|Newborns|newborns
1231627|NCT01888380|Children|children
1231628|NCT01888380|Adolescents|adolescents
1231629|NCT01888354|MS|ms
1231630|NCT01888354|Multiple Sclerosis|multiple sclerosis
1231631|NCT01888315|Hypertension|hypertension
1231632|NCT01888315|Heart Failure|heart failure
1231633|NCT01888315|Sympathetic activity|sympathetic activity
1231634|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
1231635|NCT01888263|Bioequivalence|bioequivalence
1231636|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
1231637|NCT01888263|crossover|crossover
1231638|NCT01888250|Bioequivalence|bioequivalence
1231639|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
1231640|NCT01888250|crossover|crossover
1231641|NCT01888237|Dyspepsia|dyspepsia
1231642|NCT01888237|Helicobacter pylori|helicobacter pylori
1231643|NCT01888237|Clarithromycin resistance|clarithromycin resistance
1231644|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
1231645|NCT01888198|ablation|ablation
1231646|NCT01888198|quality of Life (QOL)|quality of life (qol)
1231647|NCT01888198|kidney|kidney
1231648|NCT01888198|registry|registry
1231649|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
1231650|NCT01888198|13-116|13-116
1231651|NCT01888185|Parkinson's|parkinson's
1231652|NCT01888185|PD|pd
1231653|NCT01888185|nigrostriatal|nigrostriatal
1231654|NCT01888185|substantia nigra|substantia nigra
1231655|NCT01888185|MRI|mri
1231656|NCT01888185|DTI|dti
1231657|NCT01888185|FA|fa
1231658|NCT01888185|R2*|r2*
1231659|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
1231660|NCT01888185|PDBP|pdbp
1231661|NCT01888185|ferritin|ferritin
1231662|NCT01888185|transferrin|transferrin
1231663|NCT01888185|Fe|fe
1231664|NCT01888185|iron protein|iron protein
1231665|NCT01888185|PSP|psp
1231666|NCT01888185|MSA|msa
1231667|NCT01888146|Pain management|pain management
1231668|NCT01888146|Opioid use|opioid use
1231669|NCT01888146|Pragmatic|pragmatic
1231670|NCT01888146|Collaborative care|collaborative care
1231671|NCT01888146|Primary care|primary care
1231672|NCT01888107|Schizophrenia|schizophrenia
1231673|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
1231674|NCT01888107|Antipsychotics|antipsychotics
1231675|NCT01888107|Risperidone|risperidone
1231676|NCT01888107|Long-acting injectable|long-acting injectable
1231677|NCT01888094|Central venous catheter|central venous catheter
1231678|NCT01888094|Complications|complications
1231679|NCT01888094|Ultrasound|ultrasound
1231680|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
1231681|NCT01888094|Critical care|critical care
1231682|NCT01888094|Echocardiography|echocardiography
1231683|NCT01888094|Chest radiographyiography|chest radiographyiography
1231684|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
1231685|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1231686|NCT01888029|mild cognitive impairment|mild cognitive impairment
1231687|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1231688|NCT01888029|Cortical Plasticity|cortical plasticity
1231689|NCT01888003|anemia|anemia
1231690|NCT01887977|Orthognathic surgery|orthognathic surgery
1231691|NCT01887977|Speech production|speech production
1231692|NCT01887977|MRI|mri
1231693|NCT01887964|Diabetes|diabetes
1231694|NCT01887964|Obesity|obesity
1231695|NCT01887964|Cardiovascular disease|cardiovascular disease
1231696|NCT01887964|Metabolic syndrome|metabolic syndrome
1231697|NCT01887925|breast neoplasms|breast neoplasms
1231698|NCT01887925|sleep|sleep
1231699|NCT01887925|anxiety|anxiety
1231700|NCT01887925|depression|depression
1231701|NCT01887925|life quality|life quality
1231702|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
1231703|NCT01887912|Clostridium difficile infection|clostridium difficile infection
1231704|NCT01887912|Cdiffense|cdiffense
1231705|NCT01887899|cortical plasticity|cortical plasticity
1231706|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
1231707|NCT01887873|open angle glaucoma|open angle glaucoma
1231708|NCT01887873|cataract|cataract
1231709|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
1231710|NCT01887847|nicotine|nicotine
1594999|NCT00413608|Male|male
1231711|NCT01887847|pharmacokinetics|pharmacokinetics
1231712|NCT01887834|bloating|bloating
1231713|NCT01887834|constipation|constipation
1231714|NCT01887834|diarrhea|diarrhea
1231716|NCT01887834|mucous|mucous
1231717|NCT01887834|cramping|cramping
1231718|NCT01887808|Determine|determine
1231719|NCT01887808|Hypoallergenicity|hypoallergenicity
1231720|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
1231721|NCT01887795|Informed Consent;|informed consent;
1231722|NCT01887795|Ethical Principles;|ethical principles;
1231723|NCT01887795|Data collection|data collection
1231724|NCT01887782|depression|depression
1231725|NCT01887782|magnetic|magnetic
1231726|NCT01887782|brain stimulation|brain stimulation
1231727|NCT01887782|treatment-resistant|treatment-resistant
1231728|NCT01887769|Lung cancer|lung cancer
1231729|NCT01887769|Body composition analysis|body composition analysis
1231730|NCT01887769|Ct-Scan|ct-scan
1231731|NCT01887769|Muscle mass|muscle mass
1231732|NCT01887769|Cachexia|cachexia
1231733|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
1231734|NCT01887743|GERD|gerd
1231735|NCT01887743|Obesity|obesity
1231736|NCT01887743|Pediatric|pediatric
1231737|NCT01887743|Pantoprazole|pantoprazole
1231738|NCT01887743|CYP2C19|cyp2c19
1231739|NCT01887743|Pharmacokinetic|pharmacokinetic
1231740|NCT01887730|Hand Hygiene|hand hygiene
1231741|NCT01887730|Communicable Diseases|communicable diseases
1231742|NCT01887730|Prevention|prevention
1231743|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
1231744|NCT01887717|portal vein thrombosis|portal vein thrombosis
1231745|NCT01887691|Diabetes|diabetes
1231746|NCT01887691|Prediabetic|prediabetic
1231747|NCT01887691|Prediabetes|prediabetes
1231748|NCT01887691|Glucose intolerance|glucose intolerance
1231749|NCT01887691|Sleep quality|sleep quality
1231750|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
1231751|NCT01887691|Diabetes risk|diabetes risk
1231752|NCT01887691|eszopiclone|eszopiclone
1231753|NCT01887665|substance use disorders|substance use disorders
1231754|NCT01887665|substance abuse|substance abuse
1231755|NCT01887665|substance abuse treatment|substance abuse treatment
1231756|NCT01887665|contingency management|contingency management
1231757|NCT01887652|In Vitro Fertilization|in vitro fertilization
1231758|NCT01887652|ovulation induction|ovulation induction
1231759|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
1231760|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
1231761|NCT01887639|Resistant depression|resistant depression
1231762|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
1231763|NCT01887613|Gabapentin|gabapentin
1231764|NCT01887600|anemia|anemia
1231765|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
1232071|NCT01886261|usability|usability
1231766|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
1231767|NCT01887600|non-dialysis|non-dialysis
1231768|NCT01887548|Crohn's disease|crohn's disease
1231769|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
1231770|NCT01887548|quality of life|quality of life
1231771|NCT01887548|personality|personality
1231772|NCT01887548|neuroticism|neuroticism
1231773|NCT01887535|Healthy|healthy
1231774|NCT01887535|Elderly|elderly
1231775|NCT01887535|Safety|safety
1231776|NCT01887535|Tolerability|tolerability
1231777|NCT01887535|Pharmacokinetic|pharmacokinetic
1231778|NCT01887535|Alzheimer's Disease|alzheimer's disease
1231779|NCT01887535|JNJ-54861911|jnj-54861911
1231780|NCT01887522|Children|children
1231781|NCT01887522|Adolescents|adolescents
1231782|NCT01887522|Young Adults|young adults
1231783|NCT01887509|Rectal cancer|rectal cancer
1231784|NCT01887509|Tumor margin|tumor margin
1231785|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
1231786|NCT01887509|Virtual biopsy|virtual biopsy
1231787|NCT01887509|Fluorescein|fluorescein
1231788|NCT01887496|Varicella|varicella
1231789|NCT01887496|Turkey|turkey
1231790|NCT01887496|hospitalization|hospitalization
1231791|NCT01887496|varicella vaccine|varicella vaccine
1231792|NCT01887483|IBS|ibs
1231793|NCT01887483|bowel function|bowel function
1231794|NCT01887483|probiotic|probiotic
1231795|NCT01887470|Bowel Evacuation|bowel evacuation
1231796|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
1231797|NCT01887457|voriconazole|voriconazole
1231798|NCT01887457|VFEND|vfend
1231799|NCT01887457|individualised|individualised
1231800|NCT01887457|personalised|personalised
1231801|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
1231802|NCT01887444|Probiotics|probiotics
1231803|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
1231804|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1231805|NCT01887431|Adult|adult
1231806|NCT01887431|Insulin Infusion Systems|insulin infusion systems
1231807|NCT01887431|Telecare|telecare
1231808|NCT01887418|Hypogonadism|hypogonadism
1231809|NCT01887418|Testosterone enanthate|testosterone enanthate
1231810|NCT01887405|Adrenaline|adrenaline
1231811|NCT01887405|Auto-injector|auto-injector
1231812|NCT01887405|Jext|jext
1231813|NCT01887405|Epipen|epipen
1231814|NCT01887392|Long-term Care|long-term care
1231815|NCT01887392|Knowledge Translation|knowledge translation
1231816|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
1231817|NCT01887379|Furosemide|furosemide
1231818|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
1231819|NCT01887379|Magnetic marker|magnetic marker
1231820|NCT01887379|Oedema|oedema
1231821|NCT01887366|Cocaine addiction|cocaine addiction
1231822|NCT01887366|TV-1380|tv-1380
1231823|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
1231824|NCT01887353|atrial fibrillation|atrial fibrillation
1231825|NCT01887353|heart failure|heart failure
1231826|NCT01887353|ranolazine|ranolazine
1231827|NCT01887353|cardioversion|cardioversion
1231828|NCT01887353|persistent AF|persistent af
1231829|NCT01887353|paroxysmal AF|paroxysmal af
1231830|NCT01887327|G6PD deficiency|g6pd deficiency
1231831|NCT01887327|ABO incompatibility|abo incompatibility
1231832|NCT01887327|Coombs positive ABO/RH incompatibility|coombs positive abo/rh incompatibility
1231833|NCT01887327|intensive phototherapy in neonates|intensive phototherapy in neonates
1231834|NCT01887327|Hyperbilirubinemia|hyperbilirubinemia
1231835|NCT01887327|Neonatal Jaundice|neonatal jaundice
1231836|NCT01887314|Cancer|cancer
1231837|NCT01887314|Cisplatin|cisplatin
1231838|NCT01887314|Nausea|nausea
1231839|NCT01887314|Ginger|ginger
1231840|NCT01887314|Zingiber officinale|zingiber officinale
1231841|NCT01887314|5HT3|5ht3
1231842|NCT01887314|Dexamethasone|dexamethasone
1231843|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
1231844|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1231845|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
1231846|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
1231847|NCT01887314|Placebo|placebo
1231848|NCT01887314|FLIE|flie
1231849|NCT01887314|BFI|bfi
1231850|NCT01887275|Chronic hepatitis B|chronic hepatitis b
1231851|NCT01887275|Medical Ozone|medical ozone
1231852|NCT01887275|Interferon-α|interferon-α
1231853|NCT01887275|Efficacy|efficacy
1231854|NCT01887262|fluid|fluid
1231855|NCT01887262|edema|edema
1231856|NCT01887223|Encapsulated blebs|encapsulated blebs
1231857|NCT01887223|trabeculectomy failure|trabeculectomy failure
1231858|NCT01887223|glaucoma|glaucoma
1231859|NCT01887210|HIV|hiv
1231860|NCT01887210|youth|youth
1231861|NCT01887210|medical adherence|medical adherence
1231862|NCT01887197|cystic fibrosis|cystic fibrosis
1231863|NCT01887197|mucociliary clearance|mucociliary clearance
1231864|NCT01887197|airway surface liquid|airway surface liquid
1231865|NCT01887197|nuclear medicine|nuclear medicine
1231866|NCT01887197|mannitol|mannitol
1231867|NCT01887171|Liver transplantation|liver transplantation
1231868|NCT01887171|Early allograft dysfunction|early allograft dysfunction
1232072|NCT01886261|gps|gps
1231869|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
1231870|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
1231871|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
1231872|NCT01887145|Surgery|surgery
1231873|NCT01887145|Outcomes|outcomes
1231874|NCT01887132|Sleep Architecture|sleep architecture
1231875|NCT01887132|Autism|autism
1231876|NCT01887132|Language Development|language development
1231877|NCT01887093|coronary artery disease|coronary artery disease
1231878|NCT01887093|walking|walking
1231879|NCT01887093|lipids|lipids
1231880|NCT01887093|inflammatory markers|inflammatory markers
1231881|NCT01887093|time of day|time of day
1231882|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
1231883|NCT01887080|Acute myocardial infarction|acute myocardial infarction
1231884|NCT01887080|Obesity|obesity
1231885|NCT01887080|Microcurrent|microcurrent
1231886|NCT01887067|Hypertension|hypertension
1231887|NCT01887067|Diabetes Mellitus|diabetes mellitus
1231888|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
1231889|NCT01887041|Jaundice|jaundice
1231890|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
1231891|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
1231892|NCT01887041|Quality of Life|quality of life
1231893|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
1231894|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
1231895|NCT01887028|Peritoneum|peritoneum
1231896|NCT01887028|Gene expression|gene expression
1231897|NCT01887028|Post-operative recovery|post-operative recovery
1231898|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
1231899|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
1231900|NCT01887015|Oxygen therapy|oxygen therapy
1231901|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
1231902|NCT01887015|Nasal high flow cannula|nasal high flow cannula
1231903|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
1231904|NCT01887002|IBS|ibs
1231905|NCT01887002|ONO-2952|ono-2952
1231906|NCT01886989|diabetes|diabetes
1231907|NCT01886989|cocoa polyphenols|cocoa polyphenols
1231908|NCT01886989|postprandial glycemia|postprandial glycemia
1231909|NCT01886989|postprandial lipemia|postprandial lipemia
1231910|NCT01886976|multiple myeloma|multiple myeloma
1231911|NCT01886950|CKD stage 5|ckd stage 5
1231912|NCT01886950|Bone histomorphometry|bone histomorphometry
1231913|NCT01886950|Renal transplantation|renal transplantation
1231914|NCT01886924|Tobacco|tobacco
1231915|NCT01886924|Nicotine|nicotine
1231916|NCT01886924|Dependence|dependence
1231917|NCT01886924|Quitline|quitline
1231918|NCT01886911|prosocial behavior|prosocial behavior
1231919|NCT01886911|prosocial|prosocial
1231920|NCT01886911|attention training|attention training
1231921|NCT01886911|attention|attention
1231922|NCT01886911|empathy|empathy
1231923|NCT01886911|emotion recognition|emotion recognition
1231924|NCT01886885|Mindfulness|mindfulness
1231925|NCT01886885|Meditation|meditation
1231926|NCT01886885|Chronic Pain|chronic pain
1231927|NCT01886833|Rotavirus|rotavirus
1231928|NCT01886833|Diarrhoea|diarrhoea
1231929|NCT01886833|Dmmunisation|dmmunisation
1231930|NCT01886833|Seroconversion|seroconversion
1231931|NCT01886833|Breastmilk|breastmilk
1231932|NCT01886833|HIV|hiv
1231933|NCT01886833|Zinc|zinc
1231934|NCT01886833|Vitamin A|vitamin a
1231935|NCT01886833|Failure|failure
1231936|NCT01886820|Dementia|dementia
1231937|NCT01886820|Alzheimer's Disease|alzheimer's disease
1231938|NCT01886820|Terminally Ill|terminally ill
1231939|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
1231940|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
1231941|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
1231942|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
1231943|NCT01886781|no mixed or alternating types|no mixed or alternating types
1231944|NCT01886768|Nasal anesthesia|nasal anesthesia
1231945|NCT01886768|endoscopes|endoscopes
1231946|NCT01886768|transnasal endoscopy|transnasal endoscopy
1231947|NCT01886755|Acute gastroenteritis|acute gastroenteritis
1231948|NCT01886755|Probiotics|probiotics
1231949|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
1231950|NCT01886755|Zinc supplementation|zinc supplementation
1231951|NCT01886755|Infants|infants
1231952|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
1231953|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
1231954|NCT01886742|Morbidly Obese|morbidly obese
1231955|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
1231956|NCT01886729|time shift|time shift
1231957|NCT01886716|Alcohol Abuse|alcohol abuse
1231958|NCT01886716|Alcohol Dependence|alcohol dependence
1231959|NCT01886716|Alcohol Drinking|alcohol drinking
1231960|NCT01886716|Social Anxiety|social anxiety
1231961|NCT01886716|Social Phobia|social phobia
1231962|NCT01886716|Anxiety Disorders|anxiety disorders
1231963|NCT01886703|Physical activity|physical activity
1231964|NCT01886703|Exercise|exercise
1231965|NCT01886703|Quality of Life|quality of life
1232073|NCT01886261|PALMS|palms
1231966|NCT01886703|Radiation Therapy|radiation therapy
1231967|NCT01886703|Breast Cancer|breast cancer
1231968|NCT01886703|Head and Neck Cancer|head and neck cancer
1231969|NCT01886677|prostate cancer|prostate cancer
1231970|NCT01886677|intervention|intervention
1231971|NCT01886677|diet|diet
1231972|NCT01886677|physical activity|physical activity
1231973|NCT01886677|exercise|exercise
1231974|NCT01886677|weight loss|weight loss
1231975|NCT01886677|biomarkers|biomarkers
1231976|NCT01886677|cancer progression|cancer progression
1231977|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1231978|NCT01886651|child|child
1231979|NCT01886651|6-mercaptopurine|6-mercaptopurine
1231980|NCT01886651|methotrexate|methotrexate
1231981|NCT01886638|Platelets|platelets
1231982|NCT01886638|HIV|hiv
1231983|NCT01886638|Cardiovascular disease|cardiovascular disease
1231984|NCT01886638|Acute myocardial infarction|acute myocardial infarction
1231985|NCT01886638|Abacavir|abacavir
1231986|NCT01886638|Antiretrovirals|antiretrovirals
1231987|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
1231988|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1231989|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
1231990|NCT01886612|Doppler Ultrasound|doppler ultrasound
1231991|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
1231992|NCT01886586|memory impairment|memory impairment
1231993|NCT01886586|problem-solving therapy|problem-solving therapy
1231994|NCT01886586|depression prevention|depression prevention
1231995|NCT01886586|caregiver stress|caregiver stress
1231996|NCT01886586|exercise|exercise
1231997|NCT01886534|Heart failure|heart failure
1231998|NCT01886534|Heart diseases|heart diseases
1231999|NCT01886534|Cardiovascular diseases|cardiovascular diseases
1232000|NCT01886534|Health information technology|health information technology
1232001|NCT01886534|Disease management|disease management
1232002|NCT01886534|Patient care management|patient care management
1232003|NCT01886534|Self care|self care
1232004|NCT01886534|Informal caregiver|informal caregiver
1232005|NCT01886534|Care partner|care partner
1232006|NCT01886534|Peer support|peer support
1232007|NCT01886534|Transitional care|transitional care
1232008|NCT01886534|Patient education|patient education
1232009|NCT01886534|Teach-back|teach-back
1232010|NCT01886534|Clinical decision aid|clinical decision aid
1232011|NCT01886443|Liver|liver
1232012|NCT01886443|Transplantation|transplantation
1232013|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
1232014|NCT01886443|Safety|safety
1232015|NCT01886404|HIV|hiv
1232016|NCT01886404|efavirenz|efavirenz
1232017|NCT01886404|Sustiva|sustiva
1232018|NCT01886404|pharmacokinetics|pharmacokinetics
1232019|NCT01886404|Pharmacogenomics|pharmacogenomics
1232020|NCT01886391|Heart Failure|heart failure
1232021|NCT01886391|Dyspnea|dyspnea
1232022|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
1232023|NCT01886391|Fatigue|fatigue
1232024|NCT01886391|Health-related Outcomes|health-related outcomes
1232025|NCT01886378|FAOD|faod
1232026|NCT01886378|VLCAD|vlcad
1232027|NCT01886378|CPT II|cpt ii
1232028|NCT01886378|CPT2|cpt2
1232029|NCT01886378|CPT 2|cpt 2
1232030|NCT01886378|LCHAD|lchad
1232031|NCT01886378|UX007|ux007
1232032|NCT01886378|Triheptanoin|triheptanoin
1232033|NCT01886378|TFP|tfp
1232034|NCT01886378|C7|c7
1232035|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
1232036|NCT01886352|laparoscopic|laparoscopic
1232037|NCT01886352|pain|pain
1232038|NCT01886326|Obesity|obesity
1232039|NCT01886326|energy balance|energy balance
1232040|NCT01886326|variety|variety
1232041|NCT01886326|nut intake|nut intake
1232042|NCT01886313|Herpes Zoster|herpes zoster
1232043|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
1232044|NCT01886313|Shingles|shingles
1232045|NCT01886313|Civamide|civamide
1232046|NCT01886313|Zucapsaicin|zucapsaicin
1232047|NCT01886313|Neuropeptides|neuropeptides
1232048|NCT01886313|TRPV-1|trpv-1
1232049|NCT01886287|endocrine system|endocrine system
1232050|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
1232051|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
1232052|NCT01886287|metastatic|metastatic
1232053|NCT01886287|neuroendocrine|neuroendocrine
1232054|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
1232055|NCT01886287|high-dose octreotide|high-dose octreotide
1232056|NCT01886287|flushing|flushing
1232057|NCT01886287|diarrhea|diarrhea
1232058|NCT01886287|quality of life in patients|quality of life in patients
1232059|NCT01886287|disease-related symptoms|disease-related symptoms
1232060|NCT01886274|EEG|eeg
1232061|NCT01886274|migraine|migraine
1232062|NCT01886274|pain|pain
1232063|NCT01886274|phosphene|phosphene
1232064|NCT01886274|tDCs|tdcs
1232065|NCT01886274|TMS|tms
1232066|NCT01886261|validation|validation
1232067|NCT01886261|physical activity|physical activity
1232068|NCT01886261|place-based interventions|place-based interventions
1232069|NCT01886261|construct validity|construct validity
1232070|NCT01886261|divergent validity|divergent validity
1232193|NCT01885559|polycystic kidney disease|polycystic kidney disease
1232074|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
1232075|NCT01886222|Traumatic brain injury|traumatic brain injury
1232076|NCT01886196|elderly|elderly
1232077|NCT01886196|women|women
1232078|NCT01886196|exercise|exercise
1232079|NCT01886196|pQCT|pqct
1232080|NCT01886196|ibuprofen|ibuprofen
1232081|NCT01886183|Postural Balance|postural balance
1232082|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1232083|NCT01886183|Gait|gait
1232084|NCT01886183|Stroke|stroke
1232085|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
1232086|NCT01886157|trigger finger|trigger finger
1232087|NCT01886157|orthotic intervention|orthotic intervention
1232088|NCT01886144|OA|oa
1232089|NCT01886144|arthritis|arthritis
1232090|NCT01886144|knee OA|knee oa
1232091|NCT01886131|REM behaviour disorder|rem behaviour disorder
1232092|NCT01886131|Subthalamic nucleus|subthalamic nucleus
1232093|NCT01886131|Local field potential|local field potential
1232094|NCT01886131|Motor control|motor control
1232095|NCT01886118|In vitro fertilization|in vitro fertilization
1232096|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
1232097|NCT01886105|Osteosarcoma|osteosarcoma
1232098|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
1232099|NCT01886105|Sarcoma|sarcoma
1232100|NCT01886105|Bone Cancer|bone cancer
1232101|NCT01886092|tinnitus|tinnitus
1232102|NCT01886027|IBS|ibs
1232103|NCT01886027|Relaxation|relaxation
1232104|NCT01886027|Emotional exposure|emotional exposure
1232105|NCT01886027|Emotional Processing|emotional processing
1232106|NCT01886014|pain|pain
1232107|NCT01886014|pain modulation|pain modulation
1232108|NCT01886014|placebo analgesia|placebo analgesia
1232109|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
1232110|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
1232111|NCT01886001|Colonization|colonization
1232112|NCT01886001|Line Colonization|line colonization
1232113|NCT01886001|Umbilical line|umbilical line
1232114|NCT01886001|Umbilical Cord Care|umbilical cord care
1232115|NCT01885988|Erectile dysfunction|erectile dysfunction
1232116|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
1232117|NCT01885975|Personality|personality
1232118|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
1232119|NCT01885962|spinal cord injury|spinal cord injury
1232120|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
1232121|NCT01885949|Metastatic|metastatic
1232122|NCT01885936|LOPD|lopd
1232123|NCT01885936|Pompe Disease|pompe disease
1232124|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
1232125|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1232126|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
1232127|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
1232128|NCT01885897|Lymphoma|lymphoma
1232129|NCT01885897|Myeloma|myeloma
1232130|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1232131|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
1232132|NCT01885884|Supportive Care|supportive care
1232133|NCT01885884|Palliative Care|palliative care
1232134|NCT01885884|Pancreatic Cancer|pancreatic cancer
1232135|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
1232136|NCT01885884|Patient and Caregiver support|patient and caregiver support
1232137|NCT01885871|Sun|sun
1232138|NCT01885871|Age|age
1232139|NCT01885871|Spot|spot
1232140|NCT01885858|health services research|health services research
1232141|NCT01885858|family planning|family planning
1232142|NCT01885858|ethnicity|ethnicity
1232143|NCT01885858|healthcare disparities|healthcare disparities
1232144|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
1232145|NCT01885845|BRASSS-V drape|brasss-v drape
1232146|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
1232147|NCT01885832|stromal vascular fraction|stromal vascular fraction
1232148|NCT01885832|osteoarthritis|osteoarthritis
1232149|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
1232150|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
1232151|NCT01885819|adult stem cells|adult stem cells
1232152|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
1232153|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
1232154|NCT01885767|Neurofibromatosis|neurofibromatosis
1232155|NCT01885767|NF|nf
1232156|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
1232157|NCT01885767|NF1|nf1
1232158|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
1232159|NCT01885767|NF2|nf2
1232160|NCT01885767|Schwannomatosis|schwannomatosis
1232161|NCT01885754|Biopsy|biopsy
1232162|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
1232163|NCT01885754|Muscle strength test|muscle strength test
1232164|NCT01885754|magnetic stimulation|magnetic stimulation
1232165|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
1232166|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
1232167|NCT01885702|Vaccines|vaccines
1232168|NCT01885702|Immunotherapy|immunotherapy
1232169|NCT01885702|CRC|crc
1232170|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
1232171|NCT01885663|Umbilical cord blood|umbilical cord blood
1232172|NCT01885663|Acquired brain injury|acquired brain injury
1232173|NCT01885650|Non invasive ventilation|non invasive ventilation
1232174|NCT01885650|Chest physiotherapy|chest physiotherapy
1232175|NCT01885650|Airway clearance|airway clearance
1232176|NCT01885637|Palliative|palliative
1232177|NCT01885637|Palliation|palliation
1232178|NCT01885637|Cancer|cancer
1232179|NCT01885637|Care|care
1232180|NCT01885637|SPC|spc
1232181|NCT01885637|Caregivers|caregivers
1232182|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
1232183|NCT01885637|Psychological|psychological
1232184|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
1232185|NCT01885637|Place of death|place of death
1232186|NCT01885624|TAB08|tab08
1232187|NCT01885624|healthy volunteers|healthy volunteers
1232188|NCT01885611|Leprosy|leprosy
1232189|NCT01885572|breast reconstruction|breast reconstruction
1232190|NCT01885572|mastectomy|mastectomy
1232191|NCT01885572|mesh|mesh
1232192|NCT01885572|breast cancer|breast cancer
1232194|NCT01885559|polycystic|polycystic
1232195|NCT01885559|kidney|kidney
1232196|NCT01885559|disease|disease
1232197|NCT01885559|adpkd|adpkd
1232198|NCT01885559|halt|halt
1232199|NCT01885559|pkd|pkd
1232200|NCT01885559|blood pressure|blood pressure
1232201|NCT01885559|bp|bp
1232202|NCT01885559|hypertension|hypertension
1232203|NCT01885559|renal|renal
1232204|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
1232205|NCT01885559|RAAS|raas
1232206|NCT01885546|diabetes|diabetes
1232207|NCT01885546|glucose|glucose
1232208|NCT01885546|glucometer|glucometer
1232209|NCT01885533|Graves' disease|graves' disease
1232210|NCT01885533|radioiodine|radioiodine
1232211|NCT01885533|thyroid|thyroid
1232212|NCT01885533|hypothyroidism|hypothyroidism
1232213|NCT01885533|Graves' orbitopathy|graves' orbitopathy
1232214|NCT01885520|low back pain|low back pain
1232215|NCT01885481|dexamethasone|dexamethasone
1232216|NCT01885481|betamethasone|betamethasone
1232217|NCT01885481|epidural steroid injection|epidural steroid injection
1232218|NCT01885481|comparative effectiveness research|comparative effectiveness research
1232219|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
1232220|NCT01885468|proGAV|progav
1232221|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1232222|NCT01885442|mechanical ventilation|mechanical ventilation
1232223|NCT01885442|cycle ergometry|cycle ergometry
1232224|NCT01885442|intensive care unit|intensive care unit
1232225|NCT01885442|rehabilitation|rehabilitation
1232226|NCT01885429|Protein Turnover|protein turnover
1232227|NCT01885429|Resistance Exercise|resistance exercise
1232228|NCT01885429|Whey Protein|whey protein
1232229|NCT01885429|Leucine|leucine
1232230|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
1232231|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
1232232|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
1232233|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
1232234|NCT01885390|Hypertension|hypertension
1232235|NCT01885390|High blood pressure|high blood pressure
1232236|NCT01885390|Resistant blood pressure|resistant blood pressure
1232237|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
1232238|NCT01885377|Subacromial pain|subacromial pain
1232239|NCT01885377|Impingement|impingement
1232240|NCT01885377|Exercises|exercises
1232241|NCT01885377|Physical therapy|physical therapy
1232242|NCT01885377|Primary care|primary care
1232243|NCT01885364|esmolol|esmolol
1232244|NCT01885364|pain|pain
1232245|NCT01885364|propofol|propofol
1232246|NCT01885364|remifentanil|remifentanil
1232247|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
1232248|NCT01885351|Ambulatory Care|ambulatory care
1232249|NCT01885351|Patient-Centered Care|patient-centered care
1232250|NCT01885351|Intervention Studies|intervention studies
1232251|NCT01885351|Longitudinal Studies|longitudinal studies
1232252|NCT01885338|Schizophrenia|schizophrenia
1232253|NCT01885338|Cognition|cognition
1232254|NCT01885338|Neurocognition|neurocognition
1232255|NCT01885338|N-Acetylcysteine|n-acetylcysteine
1232256|NCT01885338|NAC|nac
1232257|NCT01885338|EEG|eeg
1232258|NCT01885325|Physical Activity|physical activity
1232259|NCT01885325|Sedentary Behavior|sedentary behavior
1232260|NCT01885325|Preschool Children|preschool children
1232261|NCT01885312|Drinking|drinking
1232262|NCT01885312|Heavy Drinking|heavy drinking
1232263|NCT01885312|Technology|technology
1232264|NCT01885312|Mobile Phone|mobile phone
1232265|NCT01885312|Text Message|text message
1232266|NCT01885312|Problem Drinking|problem drinking
1232267|NCT01885312|Alcohol Problems|alcohol problems
1232268|NCT01885312|Alcoholism|alcoholism
1232269|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
1232270|NCT01885312|Controlled Drinking|controlled drinking
1232271|NCT01885312|Reduced Drinking|reduced drinking
1232272|NCT01885299|Radiosurgery|radiosurgery
1232273|NCT01885299|CyberKnife|cyberknife
1232274|NCT01885299|Benign tumors|benign tumors
1232275|NCT01885299|Malignant tumors|malignant tumors
1232276|NCT01885299|Cranial tumors|cranial tumors
1232277|NCT01885299|Extracranial tumors|extracranial tumors
1232278|NCT01885299|Lung|lung
1232279|NCT01885299|Liver|liver
1232280|NCT01885299|Pancreas|pancreas
1232281|NCT01885299|Prostate|prostate
1232282|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
1232283|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
1232284|NCT01885286|circumcision|circumcision
1232285|NCT01885286|HIV prevention|hiv prevention
1232286|NCT01885273|pressurized irrigation|pressurized irrigation
1232287|NCT01885273|wound cleansing method|wound cleansing method
1232288|NCT01885273|irrigation|irrigation
1232289|NCT01885273|swabbing|swabbing
1232290|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
1232291|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1232292|NCT01885260|T2DM|t2dm
1232293|NCT01885234|Glycated hemoglobin|glycated hemoglobin
1232294|NCT01885234|HOMA|homa
1232295|NCT01885234|Pregnancy|pregnancy
1232296|NCT01885234|aerobic exercise|aerobic exercise
1232297|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
1232298|NCT01885221|social support|social support
1232299|NCT01885221|partner support|partner support
1333158|NCT01444326|Blood lipids|blood lipids
1333159|NCT01444300|multiple sclerosis|multiple sclerosis
1333160|NCT01444300|postural balance|postural balance
1232300|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
1232301|NCT01885169|Cystic fibrosis|cystic fibrosis
1232302|NCT01885169|Influenza|influenza
1232303|NCT01885169|Vaccine|vaccine
1232304|NCT01885143|Mammography|mammography
1232305|NCT01885117|Influenza,|influenza,
1232306|NCT01885117|Adults,|adults,
1232307|NCT01885117|Elderly,|elderly,
1232308|NCT01885117|Immunology,|immunology,
1232309|NCT01885117|Safety|safety
1232310|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
1232311|NCT01885052|Text Messaging Program|text messaging program
1232312|NCT01885052|Smoking Cessation Aid|smoking cessation aid
1232313|NCT01885039|Cancer|cancer
1232314|NCT01885039|Breast Cancer|breast cancer
1232315|NCT01885039|Molecular Subtypes|molecular subtypes
1232316|NCT01885039|Asian Breast Cancer|asian breast cancer
1232317|NCT01885026|Randomized Controlled Trial|randomized controlled trial
1232318|NCT01885026|Alcohol|alcohol
1232319|NCT01885026|Drugs|drugs
1232320|NCT01885026|Internet|internet
1232321|NCT01885026|Screening|screening
1232322|NCT01885026|Brief intervention|brief intervention
1232323|NCT01885013|HER2 negative|her2 negative
1232324|NCT01885013|metastatic breast cancer|metastatic breast cancer
1232325|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
1232326|NCT01884974|Myeloproliferative disease|myeloproliferative disease
1232327|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
1232328|NCT01884948|at least 1 segment|at least 1 segment
1232329|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
1232330|NCT01884935|Pediatric|pediatric
1232331|NCT01884922|Children|children
1232332|NCT01884922|adolescents|adolescents
1232333|NCT01884922|young adults|young adults
1232334|NCT01884870|Asymptomatic|asymptomatic
1232335|NCT01884870|ureteral|ureteral
1232336|NCT01884870|calculi|calculi
1232337|NCT01884870|renal function|renal function
1232338|NCT01884870|treatment|treatment
1232339|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
1232340|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
1232341|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
1232342|NCT01884805|Wavefront aberrometer|wavefront aberrometer
1232343|NCT01884805|Optical Aberrations|optical aberrations
1232344|NCT01884805|Hyperopia|hyperopia
1232345|NCT01884792|prediabetes|prediabetes
1232346|NCT01884792|physical inactivity|physical inactivity
1232347|NCT01884792|sedentary|sedentary
1232348|NCT01884792|standing|standing
1232349|NCT01884779|HIV|hiv
1232350|NCT01884779|Histoplasmosis|histoplasmosis
1232351|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
1232352|NCT01884779|ELISA test|elisa test
1232353|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
1232354|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
1232355|NCT01884753|antimuscarinic drug|antimuscarinic drug
1232356|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
1232357|NCT01884753|sexual dysfunction|sexual dysfunction
1232358|NCT01884740|GBM|gbm
1232359|NCT01884740|AA|aa
1232360|NCT01884740|FA|fa
1232361|NCT01884740|PXA|pxa
1232362|NCT01884740|AOA|aoa
1232363|NCT01884740|High grade glioma|high grade glioma
1232364|NCT01884727|Obesity|obesity
1232365|NCT01884727|Overweight|overweight
1232366|NCT01884727|Over nutrition|over nutrition
1232367|NCT01884727|nutrition disorders|nutrition disorders
1232368|NCT01884727|energy expenditure|energy expenditure
1232369|NCT01884727|metabolic rate|metabolic rate
1232370|NCT01884714|diabetes|diabetes
1232371|NCT01884714|obesity|obesity
1232372|NCT01884714|metabolism|metabolism
1232373|NCT01884714|clinical study|clinical study
1232374|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
1232375|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
1232376|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
1232377|NCT01884688|Natural Killer Cells|natural killer cells
1232378|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
1232379|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
1232380|NCT01884662|spinal cord injury|spinal cord injury
1232381|NCT01884662|neuropathic pain|neuropathic pain
1232382|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
1232383|NCT01884636|Isavuconazole|isavuconazole
1232384|NCT01884636|Pharmacokinetics|pharmacokinetics
1232385|NCT01884636|Healthy Subjects|healthy subjects
1232386|NCT01884636|BAL8557|bal8557
1232387|NCT01884636|BAL4815|bal4815
1232388|NCT01884636|methotrexate|methotrexate
1232389|NCT01884597|PEARL2|pearl2
1232390|NCT01884597|PCV|pcv
1232391|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1232392|NCT01884571|Immunosuppression|immunosuppression
1232393|NCT01884571|ALS|als
1232394|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
1232395|NCT01884558|Isavuconazole|isavuconazole
1232396|NCT01884558|Pharmacokinetics|pharmacokinetics
1232397|NCT01884558|Healthy Subjects|healthy subjects
1232399|NCT01884558|BAL4815|bal4815
1232400|NCT01884558|metformin|metformin
1232401|NCT01884545|heart disease|heart disease
1232402|NCT01884545|type 2 diabetes|type 2 diabetes
1232403|NCT01884545|genetic testing|genetic testing
1232404|NCT01884545|health coaching|health coaching
1232405|NCT01884545|risk assessment|risk assessment
1232406|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
1232407|NCT01884532|Metal Ions|metal ions
1232408|NCT01884532|Serum|serum
1232409|NCT01884532|Whole Blood|whole blood
1232410|NCT01884532|Metal-on-Metal|metal-on-metal
1232411|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
1232412|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
1232413|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
1232414|NCT01884519|Elderly|elderly
1232415|NCT01884519|Influenza|influenza
1232416|NCT01884519|Safety|safety
1232417|NCT01884519|Adults|adults
1232418|NCT01884519|Immunogenicity|immunogenicity
1232419|NCT01884493|Parkinson's Disease|parkinson's disease
1232420|NCT01884493|Freezing of Gait|freezing of gait
1232421|NCT01884493|movement-related cortical potential|movement-related cortical potential
1232422|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1232423|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
1232424|NCT01884467|Urinary Tract Infections|urinary tract infections
1232425|NCT01884467|Gentamicin|gentamicin
1232426|NCT01884454|sleep|sleep
1232427|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
1232428|NCT01884454|reproduction|reproduction
1232429|NCT01884454|sperm|sperm
1232430|NCT01884454|hormones|hormones
1232431|NCT01884454|men|men
1232432|NCT01884441|Hodgkin|hodgkin
1232433|NCT01884441|Lymphoma|lymphoma
1232434|NCT01884441|refractory|refractory
1232435|NCT01884441|relapsed|relapsed
1232436|NCT01884428|Hodgkin|hodgkin
1232437|NCT01884428|Lymphoma|lymphoma
1232438|NCT01884389|HIV|hiv
1232439|NCT01884389|Chronic disease|chronic disease
1232440|NCT01884389|Early palliative care|early palliative care
1232441|NCT01884389|Patient navigation|patient navigation
1232442|NCT01884376|nerve biopsy|nerve biopsy
1232443|NCT01884376|nerve regeneration|nerve regeneration
1232444|NCT01884376|neuroma pain|neuroma pain
1232445|NCT01884376|loss of sensation|loss of sensation
1232446|NCT01884363|Endothelial function|endothelial function
1232447|NCT01884363|walnuts|walnuts
1232448|NCT01884363|clinical trial|clinical trial
1232449|NCT01884363|Nutrition|nutrition
1232450|NCT01884363|cardiovascular disease|cardiovascular disease
1232451|NCT01884324|Gastroschisis|gastroschisis
1232452|NCT01884324|Cesarean delivery|cesarean delivery
1232453|NCT01884324|Neonatal outcomes|neonatal outcomes
1232454|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
1232455|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
1232456|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
1232457|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
1232458|NCT01884311|Subcutaneous|subcutaneous
1232459|NCT01884311|Immunoglobulins|immunoglobulins
1232460|NCT01884298|remifentanil|remifentanil
1232461|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
1232462|NCT01884298|morbidity|morbidity
1232463|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
1232464|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
1232465|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
1232466|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
1232467|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
1232468|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
1232469|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
1232470|NCT01884259|Larynx|larynx
1232471|NCT01884259|Hypopharynx|hypopharynx
1232472|NCT01884259|Oropharynx|oropharynx
1232473|NCT01884259|Cavum oris|cavum oris
1232474|NCT01884259|docetaxel|docetaxel
1232475|NCT01884259|cisplatin|cisplatin
1232476|NCT01884259|5-fluorouracil|5-fluorouracil
1232477|NCT01884259|Cetuximab|cetuximab
1232478|NCT01884246|lifestyle change|lifestyle change
1232479|NCT01884246|behavior change|behavior change
1232480|NCT01884246|obesity|obesity
1232481|NCT01884246|hypertension|hypertension
1232482|NCT01884246|hyperlipidemia|hyperlipidemia
1232483|NCT01884246|physical inactivity|physical inactivity
1232484|NCT01884246|depression|depression
1232485|NCT01884233|HIV|hiv
1232486|NCT01884233|Opioid Abuse|opioid abuse
1232487|NCT01884233|Mobile technology|mobile technology
1232488|NCT01884220|Wolman Disease|wolman disease
1232489|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
1232490|NCT01884220|Enzyme deficiency|enzyme deficiency
1232491|NCT01884220|Natural History|natural history
1232492|NCT01884220|Medical Records Review|medical records review
1232493|NCT01884194|retinoblastoma|retinoblastoma
1232494|NCT01884194|pineoblastoma|pineoblastoma
1232495|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
1232496|NCT01884129|Circulating tumor cells|circulating tumor cells
1232497|NCT01884129|Head and neck cancer|head and neck cancer
1232498|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
1232499|NCT01884129|Survival|survival
1232500|NCT01884129|Prognosis|prognosis
1232501|NCT01884116|Capsaicin|capsaicin
1232502|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
1232503|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
1232504|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
1232505|NCT01884103|TBI|tbi
1232506|NCT01884103|Trauma|trauma
1232507|NCT01884103|Traumatic Brain Injury|traumatic brain injury
1232508|NCT01884090|Empowerment|empowerment
1232509|NCT01884090|Youth|youth
1232510|NCT01884090|Violence|violence
1232511|NCT01884090|Community|community
1232512|NCT01884090|Prevention|prevention
1232513|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
1232514|NCT01884077|seventy years of age and older|seventy years of age and older
1232515|NCT01884064|focal hand dystonia|focal hand dystonia
1232516|NCT01884064|rehabilitation|rehabilitation
1232517|NCT01884064|rTMS|rtms
1232518|NCT01884064|writer's cramp|writer's cramp
1232519|NCT01884064|clinical|clinical
1232520|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
1232521|NCT01884038|Liver Transplant|liver transplant
1232522|NCT01884038|Prostacyclin|prostacyclin
1232523|NCT01884038|Treprostinil sodium|treprostinil sodium
1232524|NCT01884038|Remodulin|remodulin
1232525|NCT01884038|Reperfusion Injury|reperfusion injury
1232725|NCT01883323|Melanoma|melanoma
1232526|NCT01884038|Primary Nonfunction|primary nonfunction
1232527|NCT01884025|patient centered care|patient centered care
1232528|NCT01884025|physical activity|physical activity
1232529|NCT01884025|behavioral activation|behavioral activation
1232530|NCT01884025|self efficacy|self efficacy
1232531|NCT01884025|serious mental illness|serious mental illness
1232532|NCT01883986|palliative care|palliative care
1232533|NCT01883973|PD|pd
1232534|NCT01883973|DBS|dbs
1232535|NCT01883960|cerebral palsy|cerebral palsy
1232536|NCT01883960|cerebral vascular accident|cerebral vascular accident
1232537|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
1232538|NCT01883960|MRI|mri
1232539|NCT01883960|motor control|motor control
1232540|NCT01883947|Stroke|stroke
1232541|NCT01883947|Massage|massage
1232542|NCT01883947|General Health|general health
1232543|NCT01883947|Independence|independence
1232544|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
1232545|NCT01883934|Embryo donation|embryo donation
1232546|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
1232547|NCT01883921|Immunodeficiencies|immunodeficiencies
1232548|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
1232549|NCT01883921|PIDD|pidd
1232550|NCT01883921|CVID|cvid
1232551|NCT01883921|PI|pi
1232552|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
1232553|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
1232554|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
1232555|NCT01883921|Immunology|immunology
1232556|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
1232557|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
1232558|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
1232559|NCT01883921|IVIg|ivig
1232560|NCT01883921|SCIg|scig
1232561|NCT01883921|Immune Globulin|immune globulin
1232562|NCT01883921|Outcomes Research|outcomes research
1232563|NCT01883921|Immunodeficiency|immunodeficiency
1232564|NCT01883908|Acupuncture therapy|acupuncture therapy
1232565|NCT01883908|Mucositis|mucositis
1232566|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
1232567|NCT01883895|Pain|pain
1232568|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
1232569|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
1232570|NCT01883882|opioid taper|opioid taper
1232571|NCT01883882|chronic pain self-management|chronic pain self-management
1232572|NCT01883882|motivational interviewing|motivational interviewing
1232573|NCT01883869|Platelet inhibition|platelet inhibition
1232574|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
1232575|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
1232576|NCT01883869|CAP|cap
1232577|NCT01883869|HAP|hap
1232578|NCT01883869|ALI|ali
1232579|NCT01883869|Blood Platelets|blood platelets
1232580|NCT01883856|Refractory Glaucoma|refractory glaucoma
1232581|NCT01883856|Intractable Glaucoma|intractable glaucoma
1232582|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
1232583|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
1232584|NCT01883843|Chronic Stroke|chronic stroke
1232585|NCT01883843|tDCS|tdcs
1232586|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
1232587|NCT01883843|task oriented circuit training|task oriented circuit training
1232588|NCT01883843|TOCT|toct
1232589|NCT01883843|gait training|gait training
1232590|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
1232591|NCT01883830|balance disorders|balance disorders
1232592|NCT01883830|attention deficits|attention deficits
1232593|NCT01883830|x-box|x-box
1232594|NCT01883830|gaming|gaming
1232595|NCT01883830|virtual reality|virtual reality
1232596|NCT01883817|ADHD|adhd
1232597|NCT01883804|Diabetes|diabetes
1232598|NCT01883804|Diabetes Mellitus|diabetes mellitus
1232599|NCT01883804|Type 1 Diabetes|type 1 diabetes
1232600|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
1232601|NCT01883791|comorbidity|comorbidity
1232602|NCT01883791|SBIRT|sbirt
1232603|NCT01883778|Attitudes of health personnel|attitudes of health personnel
1232604|NCT01883778|Attitudes of patients|attitudes of patients
1232605|NCT01883778|Medical compliance|medical compliance
1232606|NCT01883778|Cost awareness|cost awareness
1232607|NCT01883778|Cost analysis|cost analysis
1232608|NCT01883778|Patient knowledge|patient knowledge
1232609|NCT01883778|Physician knowledge|physician knowledge
1232610|NCT01883778|Medical economics|medical economics
1232611|NCT01883778|Policy|policy
1232612|NCT01883778|Questionnaires|questionnaires
1232613|NCT01883778|Health literacy|health literacy
1232614|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
1232615|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
1232616|NCT01883739|Parental anxiety|parental anxiety
1232617|NCT01883739|Children's safety|children's safety
1232618|NCT01883739|Family Centered Care|family centered care
1232619|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
1232620|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
1232621|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
1232622|NCT01883713|anemia|anemia
1232624|NCT01883713|methemoglobin|methemoglobin
1232625|NCT01883713|hypoxia|hypoxia
1232626|NCT01883700|Healthy|healthy
1232627|NCT01883700|Glycemic Index|glycemic index
1232628|NCT01883700|Glycemic Load|glycemic load
1232629|NCT01883700|Blood Glucose|blood glucose
1232630|NCT01883700|Arterial Stiffness|arterial stiffness
1232631|NCT01883674|Sarcopenia|sarcopenia
1232632|NCT01883674|Physical capacity|physical capacity
1232633|NCT01883674|Muscle force|muscle force
1232634|NCT01883674|Muscle quality|muscle quality
1232635|NCT01883674|Milk proteins|milk proteins
1232636|NCT01883674|Essential amino acids|essential amino acids
1232637|NCT01883674|Proteins|proteins
1232638|NCT01883674|Resistance training|resistance training
1232639|NCT01883674|Exercise|exercise
1232640|NCT01883661|stem cell|stem cell
1232641|NCT01883661|Multiple Sclerosis|multiple sclerosis
1232642|NCT01883661|BMMNC|bmmnc
1232643|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
1232644|NCT01883622|diabetes|diabetes
1232645|NCT01883622|pregnancy|pregnancy
1232646|NCT01883622|glucose variability|glucose variability
1232647|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
1232648|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
1232649|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
1232650|NCT01883609|Malaria|malaria
1232651|NCT01883609|Vaccine|vaccine
1232652|NCT01883609|Plasmodium|plasmodium
1232653|NCT01883609|Falciparum|falciparum
1232654|NCT01883583|Ultrasound|ultrasound
1232655|NCT01883583|Perfusion Imaging|perfusion imaging
1232656|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
1232657|NCT01883583|Kidney Transplantation|kidney transplantation
1232658|NCT01883583|Graft Rejection|graft rejection
1232659|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
1232660|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
1232661|NCT01883544|Safety|safety
1232662|NCT01883544|Tolerability|tolerability
1232663|NCT01883544|Pharmacokinetics|pharmacokinetics
1232664|NCT01883544|Pharmacodynamics|pharmacodynamics
1232665|NCT01883544|ALXN1007|alxn1007
1232666|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
1232667|NCT01883531|improving lung function|improving lung function
1232668|NCT01883531|paediatric and adolescent|paediatric and adolescent
1232669|NCT01883531|FEV1|fev1
1232670|NCT01883518|Fibrosarcoma|fibrosarcoma
1232671|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
1232672|NCT01883518|Histiocytoma|histiocytoma
1232673|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
1232674|NCT01883518|Chondrosarcoma|chondrosarcoma
1232675|NCT01883518|Synovial Sarcoma|synovial sarcoma
1232676|NCT01883518|Leiomyosarcoma|leiomyosarcoma
1232677|NCT01883518|Liposarcoma|liposarcoma
1232678|NCT01883518|Myosarcoma|myosarcoma
1232679|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
1232680|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
1232681|NCT01883518|NY-ESO-1|ny-eso-1
1232682|NCT01883518|MAGE|mage
1232683|NCT01883518|MAGE A3|mage a3
1232684|NCT01883518|Vaccine|vaccine
1317736|NCT01507636|apraxia|apraxia
1232685|NCT01883518|Immunotherapy|immunotherapy
1232686|NCT01883505|Motor fluctuations|motor fluctuations
1232687|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
1232688|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
1232689|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
1232690|NCT01883505|Patch-pump|patch-pump
1232691|NCT01883492|Only Female|only female
1232692|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
1232693|NCT01883466|Air Pollution|air pollution
1232694|NCT01883466|Biodiesel exhaust|biodiesel exhaust
1232695|NCT01883466|Diesel exhaust|diesel exhaust
1232696|NCT01883466|Vascular function|vascular function
1232697|NCT01883466|Fibrinolysis|fibrinolysis
1232698|NCT01883466|Acute endothelial responses|acute endothelial responses
1232699|NCT01883440|Duration|duration
1232700|NCT01883427|Days with URTI symptoms|days with urti symptoms
1232701|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
1232702|NCT01883401|Strawberries|strawberries
1232703|NCT01883401|Heart health|heart health
1232704|NCT01883401|Anthocyanins|anthocyanins
1232705|NCT01883388|Lung Cancer|lung cancer
1232706|NCT01883388|blood sample|blood sample
1232707|NCT01883375|Palliative Care|palliative care
1232708|NCT01883375|Family|family
1232709|NCT01883375|adaptation, psychological|adaptation, psychological
1232710|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
1232711|NCT01883362|AML|aml
1232712|NCT01883362|FLT3-ITD|flt3-itd
1232713|NCT01883362|midostaurin|midostaurin
1232714|NCT01883362|PKC412|pkc412
1232715|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
1232716|NCT01883362|SCT|sct
1232717|NCT01883362|HSCT|hsct
1232718|NCT01883362|CR1|cr1
1232719|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
1232720|NCT01883323|Measurable|measurable
1232721|NCT01883323|Unresectable|unresectable
1232722|NCT01883323|Stage III|stage iii
1232723|NCT01883323|Stage IV|stage iv
1232724|NCT01883323|Metastatic|metastatic
1232726|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
1232727|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
1232728|NCT01883323|Cyclophosphamide|cyclophosphamide
1232729|NCT01883323|Fludarabine|fludarabine
1232730|NCT01883310|Multiple Sclerosis|multiple sclerosis
1232731|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
1232732|NCT01883310|TOCT|toct
1232733|NCT01883310|task-oriented circuit training|task-oriented circuit training
1232734|NCT01883310|locomotor function|locomotor function
1232735|NCT01883310|mobility|mobility
1232736|NCT01883310|balance|balance
1232737|NCT01883297|Measurable|measurable
1232738|NCT01883297|Recurrent|recurrent
1232739|NCT01883297|Platinum resistant|platinum resistant
1232740|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
1232741|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
1232742|NCT01883297|Autologous dendritic cells|autologous dendritic cells
1232743|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
1232744|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
1232745|NCT01883297|Cyclophosphamide|cyclophosphamide
1232746|NCT01883284|Cystic Fibrosis|cystic fibrosis
1232747|NCT01883284|nasal epithelia|nasal epithelia
1232748|NCT01883284|mucins|mucins
1232749|NCT01883245|Orofacial chronic pain|orofacial chronic pain
1232750|NCT01883245|tDCS|tdcs
1232751|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
1232752|NCT01883245|Brain stimulation|brain stimulation
1232753|NCT01883219|Philadelphia chromosome|philadelphia chromosome
1232754|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1232755|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1232756|NCT01883219|Minimal residual disease|minimal residual disease
1232757|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1232758|NCT01883206|Cytomegalovirus|cytomegalovirus
1232759|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
1232760|NCT01883193|LBW|lbw
1232761|NCT01883193|Length-for-age|length-for-age
1232762|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
1232763|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
1232764|NCT01883193|infant growth|infant growth
1232765|NCT01883193|low-resource settings|low-resource settings
1232766|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
1232767|NCT01883180|Antithymocyte globulin|antithymocyte globulin
1232768|NCT01883180|viral infection|viral infection
1232769|NCT01883128|Biochemical Failure|biochemical failure
1232770|NCT01883128|Radiotherapy|radiotherapy
1232771|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
1232772|NCT01883128|MRI Prostate|mri prostate
1232773|NCT01883128|Whole Body MRI|whole body mri
1232774|NCT01883128|Bone Scan|bone scan
1232775|NCT01883128|Choline PET|choline pet
1333161|NCT01444300|gait|gait
1232776|NCT01883128|Focal Salvage Treatment|focal salvage treatment
1232777|NCT01883128|HIFU|hifu
1232778|NCT01883128|Cryotherapy|cryotherapy
1232779|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
1232780|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
1232781|NCT01883115|Inguinal hernia|inguinal hernia
1232782|NCT01883115|Triport system|triport system
1232783|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1232784|NCT01883076|HLHS|hlhs
1232785|NCT01883076|Congenital Heart Disease|congenital heart disease
1232786|NCT01883076|Umbilical cord blood|umbilical cord blood
1232787|NCT01883076|UCB|ucb
1232788|NCT01883076|Cord blood|cord blood
1232789|NCT01883076|Stem cells|stem cells
1232790|NCT01883076|Regenerative therapy|regenerative therapy
1232791|NCT01883076|Stage II Glenn|stage ii glenn
1232792|NCT01883076|Glenn Surgery|glenn surgery
1232793|NCT01883050|Coronary artery disease|coronary artery disease
1232794|NCT01883050|Percutaneous Intervention|percutaneous intervention
1232795|NCT01883050|Stent|stent
1232796|NCT01883050|Balloon angioplasty|balloon angioplasty
1232797|NCT01883050|Angiogram|angiogram
1232798|NCT01883050|Coronary angiogram|coronary angiogram
1232799|NCT01883037|Cystic Fibrosis|cystic fibrosis
1232800|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
1232801|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
1232802|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
1232803|NCT01883011|Piracetam|piracetam
1232804|NCT01883011|Stroke|stroke
1232805|NCT01883011|Aphasia|aphasia
1232806|NCT01883011|Acute|acute
1232807|NCT01883011|Cerebral|cerebral
1232808|NCT01883011|Ischemic|ischemic
1232809|NCT01883011|Nootropil|nootropil
1232810|NCT01882998|HIV and pregnancy|hiv and pregnancy
1232811|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
1232812|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
1232813|NCT01882998|Africa|africa
1232814|NCT01882998|Uganda|uganda
1232815|NCT01882985|docetaxel|docetaxel
1232816|NCT01882985|lycopene|lycopene
1232817|NCT01882985|prostate cancer|prostate cancer
1233115|NCT01881581|Therapeutic|therapeutic
1232818|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
1232819|NCT01882933|HIPEC|hipec
1232820|NCT01882933|Oxaliplatin|oxaliplatin
1232821|NCT01882933|Signet ring cell|signet ring cell
1232822|NCT01882920|Cytoreductive surgery|cytoreductive surgery
1232823|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1232824|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
1232825|NCT01882907|vildagliptin|vildagliptin
1232826|NCT01882907|metformin|metformin
1232827|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
1232828|NCT01882842|Infertility|infertility
1232829|NCT01882842|Endometrium|endometrium
1232830|NCT01882842|Live birth|live birth
1232831|NCT01882829|depression|depression
1232832|NCT01882829|major depressive disorder|major depressive disorder
1232833|NCT01882829|treatment resistant|treatment resistant
1232834|NCT01882829|Nuedexta|nuedexta
1232835|NCT01882829|dextromethorphan|dextromethorphan
1232836|NCT01882829|antidepressant|antidepressant
1232837|NCT01882829|glutamate|glutamate
1232838|NCT01882829|NMDA receptor|nmda receptor
1232839|NCT01882816|non-anaplastic|non-anaplastic
1232840|NCT01882816|non-medullary|non-medullary
1232841|NCT01882816|radiation|radiation
1232842|NCT01882816|IMRT|imrt
1232843|NCT01882816|Doxorubicin|doxorubicin
1232844|NCT01882816|13-070|13-070
1232845|NCT01882803|PI3K Inhibitor|pi3k inhibitor
1232846|NCT01882790|coronary artery spasm|coronary artery spasm
1232847|NCT01882790|hypertension|hypertension
1233048|NCT01881906|Lung cancer|lung cancer
1232848|NCT01882790|Pathophysiology|pathophysiology
1232849|NCT01882790|atrioventricular block|atrioventricular block
1232850|NCT01882790|blood pressure|blood pressure
1232851|NCT01882790|autonomic nervous function|autonomic nervous function
1232852|NCT01882751|kinematics|kinematics
1232853|NCT01882751|knee joint|knee joint
1232854|NCT01882738|Cervical length|cervical length
1232855|NCT01882738|BMI|bmi
1232856|NCT01882699|Insomnia|insomnia
1232857|NCT01882686|Pain|pain
1232858|NCT01882686|Back Pain|back pain
1232859|NCT01882686|Low Back Pain|low back pain
1232860|NCT01882686|Chronic Low Back Pain|chronic low back pain
1232861|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
1232862|NCT01882686|Intervention|intervention
1232863|NCT01882686|Subclassification|subclassification
1232864|NCT01882686|Multidimensional|multidimensional
1232865|NCT01882673|Tobacco|tobacco
1232866|NCT01882673|nicotine|nicotine
1232867|NCT01882673|dependence|dependence
1232868|NCT01882673|quitline|quitline
1232869|NCT01882647|psoriasis|psoriasis
1232870|NCT01882647|lotion|lotion
1232871|NCT01882647|investigator's global assessment|investigator's global assessment
1232872|NCT01882621|NSCLC|nsclc
1232873|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
1232874|NCT01882621|neurotoxicity|neurotoxicity
1232875|NCT01882608|psychiatry|psychiatry
1232876|NCT01882608|mental health|mental health
1232877|NCT01882608|mood disorders|mood disorders
1232878|NCT01882608|mood diaries|mood diaries
1232879|NCT01882608|electronic diaries|electronic diaries
1232880|NCT01882608|cell phones|cell phones
1232881|NCT01882608|software|software
1232882|NCT01882608|mental health telemetry|mental health telemetry
1232883|NCT01882608|ecological momentary assessment|ecological momentary assessment
1232884|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
1232885|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
1232886|NCT01882556|Post stroke spasticity.|post stroke spasticity.
1232887|NCT01882543|Interstitial cystitis|interstitial cystitis
1232888|NCT01882543|Bladder pain syndrome|bladder pain syndrome
1232889|NCT01882543|IC/BPS|ic/bps
1232890|NCT01882543|AQX-1125|aqx-1125
1232891|NCT01882543|SHIP1|ship1
1232892|NCT01882530|Post operative analgesia ;|post operative analgesia ;
1232893|NCT01882530|Paracetamol ;|paracetamol ;
1232894|NCT01882530|Ketoprofen ;|ketoprofen ;
1232895|NCT01882530|Nefopam ;|nefopam ;
1232896|NCT01882530|Morphine|morphine
1232897|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
1232898|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
1232899|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
1232900|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
1232901|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
1232902|NCT01882491|Osteoarthritis|osteoarthritis
1232903|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
1232904|NCT01882478|Barrett's esophagus|barrett's esophagus
1232905|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
1232906|NCT01882478|Radio Frequency Ablation|radio frequency ablation
1232907|NCT01882478|Cryotherapy|cryotherapy
1232908|NCT01882452|Memory specificity training|memory specificity training
1232909|NCT01882452|Autobiographical memory|autobiographical memory
1232910|NCT01882452|Major depressive disorder|major depressive disorder
1232911|NCT01882439|psoriatic arthritis|psoriatic arthritis
1232912|NCT01882439|tofacitinib|tofacitinib
1232913|NCT01882439|ACR20|acr20
1232914|NCT01882439|HAQ-DI|haq-di
1232915|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
1232916|NCT01882426|CONSTRUCT|construct
1232917|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
1232918|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
1232919|NCT01882400|Osteoporosis|osteoporosis
1232920|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
1232921|NCT01882400|Cystic fibrosis|cystic fibrosis
1232922|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
1232923|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
1232924|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
1232925|NCT01882387|Platelet Engraftment|platelet engraftment
1232926|NCT01882387|Immune Reconstitution|immune reconstitution
1232927|NCT01882387|Mucositis|mucositis
1232928|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
1232929|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
1232930|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
1232931|NCT01882374|Platelet Recovery|platelet recovery
1232932|NCT01882374|Immune Reconstitution|immune reconstitution
1232933|NCT01882374|Mucositis|mucositis
1232934|NCT01882361|opioid addiction|opioid addiction
1232935|NCT01882361|opioid treatment|opioid treatment
1232936|NCT01882361|naloxone|naloxone
1232937|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
1232938|NCT01882335|Human capital formation|human capital formation
1232940|NCT01882322|tacrolimus|tacrolimus
1232941|NCT01882322|immunosuppressant|immunosuppressant
1232942|NCT01882283|serum lipids|serum lipids
1232943|NCT01882283|cholesterol|cholesterol
1233359|NCT01880723|albuterol|albuterol
1232944|NCT01882283|serum cholesterol|serum cholesterol
1232945|NCT01882283|black tea|black tea
1232946|NCT01882283|flavonoids|flavonoids
1232947|NCT01882283|crossover trial|crossover trial
1232948|NCT01882283|randomized control trial|randomized control trial
1232949|NCT01882283|diet controlled|diet controlled
1232950|NCT01882270|pericoronitis|pericoronitis
1232951|NCT01882270|periodontal|periodontal
1232952|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
1232953|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
1232954|NCT01882257|hypercapnia|hypercapnia
1232955|NCT01882257|spinal cord injury|spinal cord injury
1232956|NCT01882244|traumatic brain injury|traumatic brain injury
1232957|NCT01882244|cognition|cognition
1232958|NCT01882244|rehabilitation|rehabilitation
1232959|NCT01882244|attentional regulation|attentional regulation
1232960|NCT01882244|working memory|working memory
1232961|NCT01882231|Osteosarcoma|osteosarcoma
1232962|NCT01882231|Ewing sarcoma|ewing sarcoma
1232963|NCT01882231|Paget's disease|paget's disease
1232964|NCT01882231|bone cancer|bone cancer
1232965|NCT01882231|childhood cancers|childhood cancers
1232966|NCT01882231|DCE MRI|dce mri
1232967|NCT01882231|DW MRI|dw mri
1232968|NCT01882231|CEST MRI|cest mri
1232969|NCT01882231|MT MRI|mt mri
1232970|NCT01882218|Liver cancer|liver cancer
1232971|NCT01882205|Ulcerative colitis|ulcerative colitis
1232973|NCT01882205|chromoendoscopy|chromoendoscopy
1232974|NCT01882205|dysplasia|dysplasia
1232975|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
1232976|NCT01882205|FICE|fice
1232977|NCT01882205|NBI|nbi
1232978|NCT01882205|I-scan|i-scan
1232979|NCT01882192|family|family
1232980|NCT01882192|physical activity|physical activity
1232981|NCT01882192|planning|planning
1232982|NCT01882179|Reperfusion injury|reperfusion injury
1232983|NCT01882179|myocardial infarct size|myocardial infarct size
1232984|NCT01882179|MRI|mri
1232985|NCT01882179|spironolactone|spironolactone
1232986|NCT01882166|Fertilization in Vitro|fertilization in vitro
1232987|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
1232988|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
1232989|NCT01882166|Embryonic Development|embryonic development
1232990|NCT01882140|burns|burns
1232991|NCT01882140|wound healing|wound healing
1232992|NCT01882140|magnetic field therapy|magnetic field therapy
1232993|NCT01882127|Purpura|purpura
1232994|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1232995|NCT01882114|atherosclerosis|atherosclerosis
1232996|NCT01882114|cardiovascular events|cardiovascular events
1232997|NCT01882114|ankle-brachial index|ankle-brachial index
1232998|NCT01882114|carotid disease|carotid disease
1232999|NCT01882114|echocardiography|echocardiography
1233000|NCT01882114|mediterranean diet|mediterranean diet
1233001|NCT01882114|platelet activation|platelet activation
1233002|NCT01882101|Fecal incontinence|fecal incontinence
1233003|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
1233004|NCT01882101|biofeedback|biofeedback
1233005|NCT01882101|quality of life|quality of life
1233006|NCT01882075|Anesthesia|anesthesia
1233007|NCT01882075|Fluid administration|fluid administration
1233008|NCT01882075|Closed-loop|closed-loop
1233009|NCT01882023|EDNOS|ednos
1233010|NCT01882023|adolescents|adolescents
1233011|NCT01882010|Parkinson's disease|parkinson's disease
1233012|NCT01882010|motor function|motor function
1233013|NCT01882010|immune activation|immune activation
1233014|NCT01882010|T cells|t cells
1233015|NCT01882010|CD4|cd4
1233016|NCT01882010|GMCSF|gmcsf
1233017|NCT01882010|leukine|leukine
1233018|NCT01882010|sargramostim|sargramostim
1233019|NCT01882010|magnetoencephalography|magnetoencephalography
1233020|NCT01881997|Procedure|procedure
1233021|NCT01881997|Abscess|abscess
1233022|NCT01881997|Emergency Department|emergency department
1233023|NCT01881997|Opioid|opioid
1233024|NCT01881997|Fentanyl|fentanyl
1233025|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
1233026|NCT01881984|MCAD deficiency|mcad deficiency
1233027|NCT01881984|MCADD|mcadd
1233028|NCT01881984|ACADM deficiency|acadm deficiency
1233029|NCT01881984|MCADH deficiency|mcadh deficiency
1233030|NCT01881984|985A>G mutation|985a>g mutation
1233031|NCT01881984|K304E mutation|k304e mutation
1233032|NCT01881984|Ravicti|ravicti
1233033|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
1233034|NCT01881971|HIV|hiv
1233035|NCT01881971|lung|lung
1233036|NCT01881971|lipids|lipids
1233037|NCT01881971|no lipid lowering medication|no lipid lowering medication
1233038|NCT01881971|normal liver and kidney function|normal liver and kidney function
1233039|NCT01881971|on stable ART regimen|on stable art regimen
1233040|NCT01881971|not pregnant|not pregnant
1233041|NCT01881945|Swallowing|swallowing
1233042|NCT01881945|Hyperventilation|hyperventilation
1233043|NCT01881932|acupuncture therapy|acupuncture therapy
1233044|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
1233045|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
1233046|NCT01881919|Functional Food|functional food
1233047|NCT01881906|aerobic exercise|aerobic exercise
1233049|NCT01881906|psyco-social|psyco-social
1233050|NCT01881893|Quality of life|quality of life
1233051|NCT01881893|Psychosocial Support Systems|psychosocial support systems
1233052|NCT01881893|Randomized Controls as Topic|randomized controls as topic
1233053|NCT01881893|Cognitive Therapy|cognitive therapy
1233054|NCT01881893|Feasibility Studies|feasibility studies
1233055|NCT01881880|Tomosynthesis|tomosynthesis
1233056|NCT01881880|Mammography|mammography
1233057|NCT01881880|Breast cancer|breast cancer
1233058|NCT01881841|Alcohol abuse|alcohol abuse
1233059|NCT01881841|Substance use|substance use
1233060|NCT01881841|Tobacco use disorder|tobacco use disorder
1233061|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
1233062|NCT01881841|Adolescents|adolescents
1233063|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
1233064|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
1233065|NCT01881815|venous leg ulcers|venous leg ulcers
1233066|NCT01881815|pressure sores|pressure sores
1233067|NCT01881815|acute wounds|acute wounds
1233068|NCT01881802|Opioid drug Abuse|opioid drug abuse
1233069|NCT01881802|Morphine|morphine
1233070|NCT01881802|Immune Function|immune function
1233071|NCT01881789|multiple myeloma|multiple myeloma
1233072|NCT01881789|proteasome inhibitor|proteasome inhibitor
1233073|NCT01881789|oprozomib|oprozomib
1233074|NCT01881789|orpozomib tablets|orpozomib tablets
1233075|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
1233076|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
1233077|NCT01881776|General anesthesia|general anesthesia
1233078|NCT01881776|Postoperative pain|postoperative pain
1233079|NCT01881776|Recovery profile|recovery profile
1233080|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
1233081|NCT01881763|Ketamine|ketamine
1233082|NCT01881763|anesthesia|anesthesia
1233083|NCT01881763|depression|depression
1233084|NCT01881763|unipolar|unipolar
1233085|NCT01881763|bipolar|bipolar
1233086|NCT01881750|Autism PRT|autism prt
1233087|NCT01881737|autism|autism
1233088|NCT01881711|hydrocephalus|hydrocephalus
1233089|NCT01881711|CSF shunt|csf shunt
1233090|NCT01881711|shunt malfunction|shunt malfunction
1233091|NCT01881711|shunt obstruction|shunt obstruction
1233092|NCT01881711|ShuntCheck|shuntcheck
1233093|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
1233094|NCT01881698|pregnancy|pregnancy
1233095|NCT01881698|platelet function|platelet function
1233096|NCT01881698|monitoring|monitoring
1233097|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
1233098|NCT01881672|Aspiration pneumonia|aspiration pneumonia
1233099|NCT01881672|Coma|coma
1233100|NCT01881672|Mechanical ventilation|mechanical ventilation
1233101|NCT01881659|cervical cancer|cervical cancer
1233102|NCT01881659|cancer prevention|cancer prevention
1233103|NCT01881659|cervical screening|cervical screening
1233104|NCT01881659|HPV testing|hpv testing
1233105|NCT01881659|triage techniques|triage techniques
1233106|NCT01881646|Neuroinflammation|neuroinflammation
1233107|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1233108|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
1233109|NCT01881620|PET scan|pet scan
1233110|NCT01881620|CT scan|ct scan
1233111|NCT01881620|Diagnostic performance|diagnostic performance
1233112|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
1233113|NCT01881607|Tobacco use|tobacco use
1233114|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
1233116|NCT01881581|Vaccine|vaccine
1233117|NCT01881581|HIV|hiv
1233118|NCT01881581|MVA|mva
1233119|NCT01881581|DNA|dna
1233120|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
1233121|NCT01881555|fractional flow reserve|fractional flow reserve
1233122|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
1233123|NCT01881555|angiography|angiography
1233124|NCT01881542|preeclampsia|preeclampsia
1233125|NCT01881542|proteinuria|proteinuria
1233126|NCT01881542|urine collection|urine collection
1233127|NCT01881529|limited scleroderma|limited scleroderma
1233128|NCT01881529|diffuse scleroderma|diffuse scleroderma
1233129|NCT01881529|Sclerosis|sclerosis
1233130|NCT01881529|Progressive|progressive
1233131|NCT01881529|Limited|limited
1233132|NCT01881503|life-threatening anemia|life-threatening anemia
1233133|NCT01881503|blood alternative|blood alternative
1233134|NCT01881503|HBOC|hboc
1233135|NCT01881490|Crohn's Disease|crohn's disease
1233136|NCT01881490|MRE|mre
1233137|NCT01881490|Pelvic MRI|pelvic mri
1233138|NCT01881490|P-MRI|p-mri
1233139|NCT01881490|colonoscopy|colonoscopy
1233140|NCT01881490|gastroscopy|gastroscopy
1233141|NCT01881477|immobilization|immobilization
1233142|NCT01881477|physical therapy|physical therapy
1233143|NCT01881477|intensive care|intensive care
1233144|NCT01881477|bed rest|bed rest
1233145|NCT01881477|movement|movement
1233146|NCT01881451|Tumour hypoxia|tumour hypoxia
1233147|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
1233148|NCT01881451|Recurrent|recurrent
1233149|NCT01881451|Metastatic|metastatic
1233150|NCT01881438|Retinal Detachment|retinal detachment
1233151|NCT01881438|Fluoroquinolones|fluoroquinolones
1233152|NCT01881438|Ciprofloxacin|ciprofloxacin
1233153|NCT01881438|Levofloxacin|levofloxacin
1233154|NCT01881438|Gatifloxacin|gatifloxacin
1233155|NCT01881438|Gemifloxacin|gemifloxacin
1233156|NCT01881438|Moxifloxacin|moxifloxacin
1233157|NCT01881438|Norfloxacin|norfloxacin
1233158|NCT01881438|Ofloxacin|ofloxacin
1233159|NCT01881438|Beta-Lactam|beta-lactam
1233160|NCT01881425|POAG|poag
1233161|NCT01881412|Asthma|asthma
1233162|NCT01881412|Children|children
1233163|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
1233164|NCT01881412|Emergency Department|emergency department
1233165|NCT01881399|Cholelithiasis|cholelithiasis
1233166|NCT01881399|Gallbladder polyps|gallbladder polyps
1233167|NCT01881399|Fluorescence|fluorescence
1233168|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
1233169|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
1333162|NCT01444300|fatigue|fatigue
1318361|NCT01505140|Diet|diet
1233170|NCT01881399|da Vinci surgical system|da vinci surgical system
1233171|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1233172|NCT01881386|Lactate|lactate
1233173|NCT01881373|Obesity|obesity
1233174|NCT01881373|Child|child
1233175|NCT01881373|Food|food
1233176|NCT01881373|Physical Activity|physical activity
1233177|NCT01881373|Pacific|pacific
1233178|NCT01881360|fibromyalgia|fibromyalgia
1233179|NCT01881360|celiac-type symptoms|celiac-type symptoms
1233180|NCT01881360|gluten-free diet|gluten-free diet
1233181|NCT01881360|hypocaloric diet|hypocaloric diet
1233182|NCT01881347|endothelium|endothelium
1233183|NCT01881347|mitochondria|mitochondria
1233184|NCT01881347|reactive oxygen species|reactive oxygen species
1233185|NCT01881347|vascular biology|vascular biology
1233186|NCT01881347|arterial stiffness|arterial stiffness
1233187|NCT01881347|nitric oxide|nitric oxide
1233188|NCT01881334|Haploidentical Donor|haploidentical donor
1233189|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
1233190|NCT01881334|Allogeneic Transplant|allogeneic transplant
1233191|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
1233192|NCT01881334|High Risk Malignancies|high risk malignancies
1233193|NCT01881334|Metabolic Disorders|metabolic disorders
1233194|NCT01881334|Immune Deficiency|immune deficiency
1233195|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1233196|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
1233197|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
1233199|NCT01881334|AML|aml
1233200|NCT01881334|MDS|mds
1233201|NCT01881334|CGD|cgd
1233202|NCT01881334|SCID|scid
1233203|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
1233204|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
1233205|NCT01881334|Krabbe|krabbe
1233206|NCT01881334|PMD|pmd
1233207|NCT01881334|Hunter's|hunter's
1233208|NCT01881334|Hurler's|hurler's
1233209|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
1233210|NCT01881334|Lymphoma|lymphoma
1233211|NCT01881334|Sickle Cell Disease|sickle cell disease
1233212|NCT01881334|Thalassemia|thalassemia
1233213|NCT01881321|Contraception|contraception
1233214|NCT01881321|Counseling|counseling
1233215|NCT01881295|Potassium|potassium
1233216|NCT01881295|Potato|potato
1233217|NCT01881295|French Fries|french fries
1233218|NCT01881295|Bioavailability|bioavailability
1233219|NCT01881295|Blood Pressure|blood pressure
1233220|NCT01881282|Hemorrhoids|hemorrhoids
1233221|NCT01881282|Carraghenates|carraghenates
1233222|NCT01881282|Mayinglong Musk|mayinglong musk
1233226|NCT01881256|Body composition in preterm infants|body composition in preterm infants
1233227|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
1233229|NCT01881230|Cancer of the Breast|cancer of the breast
1233230|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
1233231|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
1233232|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
1233233|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
1233234|NCT01881230|Basal-like breast cancer|basal-like breast cancer
1233235|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
1233236|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
1233237|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
1233238|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
1233239|NCT01881230|Abraxane|abraxane
1233240|NCT01881230|nab-Paclitaxel|nab-paclitaxel
1233241|NCT01881230|ABI-007|abi-007
1233242|NCT01881230|gemcitabine|gemcitabine
1233243|NCT01881230|Gemzar|gemzar
1233244|NCT01881230|carboplatin|carboplatin
1233245|NCT01881230|Paraplatin|paraplatin
1233246|NCT01881230|Paraplatin AQ|paraplatin aq
1233247|NCT01881230|Phase 2|phase 2
1233248|NCT01881230|Phase 3|phase 3
1233249|NCT01881217|Phase I|phase i
1233250|NCT01881217|Dose escalation|dose escalation
1233251|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
1233252|NCT01881217|FGFR2|fgfr2
1233253|NCT01881204|Hesperidin|hesperidin
1233254|NCT01881204|Osteoporosis|osteoporosis
1233255|NCT01881204|Bone Loss|bone loss
1233256|NCT01881191|multiple sclerosis|multiple sclerosis
1233257|NCT01881191|relapsing remitting|relapsing remitting
1233258|NCT01881191|MRI|mri
1233259|NCT01881191|teriflunomide|teriflunomide
1233260|NCT01881191|aubagio|aubagio
1233261|NCT01881191|gray matter atrophy|gray matter atrophy
1233262|NCT01881191|gray matter pathology|gray matter pathology
1233263|NCT01881178|CRP|crp
1233264|NCT01881178|Nopalea|nopalea
1233265|NCT01881178|Fruit|fruit
1233266|NCT01881178|Juice|juice
1233267|NCT01881152|Stroke|stroke
1233268|NCT01881152|Community education|community education
1233269|NCT01881152|Awareness|awareness
1233270|NCT01881152|Prehospital delay|prehospital delay
1233271|NCT01881139|Exercise|exercise
1318482|NCT01504776|MCL|mcl
1233272|NCT01881139|Lipid|lipid
1233273|NCT01881139|Left ventricular|left ventricular
1233274|NCT01881139|heart function|heart function
1233275|NCT01881100|resin infiltration|resin infiltration
1233276|NCT01881100|randomized clinical trial|randomized clinical trial
1233277|NCT01881100|fluoride varnish|fluoride varnish
1233278|NCT01881100|caries lesion|caries lesion
1233279|NCT01881100|deciduous teeth|deciduous teeth
1233280|NCT01881087|Knee Arthroscopy|knee arthroscopy
1233281|NCT01881087|Levobupivacaine|levobupivacaine
1233282|NCT01881087|Spinal Anesthesia|spinal anesthesia
1233283|NCT01881087|Motor Block|motor block
1233284|NCT01881074|Type II Diabetes|type ii diabetes
1233285|NCT01881074|Periodontal Disease|periodontal disease
1233286|NCT01881074|Periodontitis|periodontitis
1233287|NCT01881074|Gum Disease|gum disease
1233288|NCT01881074|Gingivitis|gingivitis
1233289|NCT01881074|Triclosan|triclosan
1233290|NCT01881074|Inflammatory Markers|inflammatory markers
1233291|NCT01881074|Immune Response|immune response
1233292|NCT01881061|Sonography|sonography
1233293|NCT01881061|ICU|icu
1233294|NCT01881061|PEEP|peep
1233300|NCT01881035|Hypertension|hypertension
1233301|NCT01881035|End stage renal disease|end stage renal disease
1233302|NCT01881022|Breast Cancer|breast cancer
1233303|NCT01881022|Couples|couples
1233304|NCT01881022|Sexual Dysfunction|sexual dysfunction
1233305|NCT01881022|Psychosexual Intervention|psychosexual intervention
1233306|NCT01881022|Sex Therapy|sex therapy
1233307|NCT01881022|Online Support|online support
1233308|NCT01881022|e-health|e-health
1233309|NCT01881009|Diabetes|diabetes
1233310|NCT01881009|Insulin|insulin
1233311|NCT01881009|Closed loop|closed loop
1233312|NCT01881009|Nocturnal glucose control|nocturnal glucose control
1233313|NCT01880996|Ovarian Cancer|ovarian cancer
1233314|NCT01880996|Gynecological Malignancies|gynecological malignancies
1233315|NCT01880996|Chemotherapy|chemotherapy
1233316|NCT01880996|Tai-chi|tai-chi
1233317|NCT01880996|Qigong|qigong
1233318|NCT01880996|Fatigue|fatigue
1233319|NCT01880996|Quality of life|quality of life
1233320|NCT01880996|Sleep disturbance|sleep disturbance
1233321|NCT01880983|EPP|epp
1233322|NCT01880983|Bloomer|bloomer
1233323|NCT01880983|Porphyria|porphyria
1233423|NCT01880515|Skin Rash|skin rash
1233324|NCT01880957|bipolar disorder|bipolar disorder
1233325|NCT01880957|bipolar depression|bipolar depression
1233326|NCT01880957|serotonin transporter|serotonin transporter
1233327|NCT01880957|serotonin receptors|serotonin receptors
1233328|NCT01880957|binding potential|binding potential
1233329|NCT01880957|brain imaging|brain imaging
1233330|NCT01880957|unipolar depression|unipolar depression
1233331|NCT01880944|spine|spine
1233332|NCT01880944|trauma|trauma
1233334|NCT01880944|contrast|contrast
1233335|NCT01880918|Compression Anastomosis|compression anastomosis
1233336|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
1233337|NCT01880879|coronary artery disease|coronary artery disease
1233338|NCT01880879|PCI|pci
1233339|NCT01880879|stent|stent
1233340|NCT01880866|PAH|pah
1233341|NCT01880853|breast cancer|breast cancer
1233342|NCT01880853|screening|screening
1233343|NCT01880853|mammography|mammography
1233344|NCT01880853|ultrasound|ultrasound
1233345|NCT01880827|GIP|gip
1233346|NCT01880827|GLP-1|glp-1
1233347|NCT01880827|type 2 diabetes|type 2 diabetes
1233348|NCT01880827|obesity|obesity
1233349|NCT01880827|splanchnic blood flow|splanchnic blood flow
1233350|NCT01880827|incretin hormones|incretin hormones
1233351|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
1233352|NCT01880801|ITP|itp
1233353|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
1233354|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
1233355|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
1233356|NCT01880762|PET MR development and validation|pet mr development and validation
1233357|NCT01880723|exhaled breath condensate|exhaled breath condensate
1233358|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
1233360|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
1233361|NCT01880723|ion regulation|ion regulation
1233362|NCT01880710|long term follow-up|long term follow-up
1233363|NCT01880710|urinary incontinence|urinary incontinence
1233364|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
1233365|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
1233366|NCT01880697|Influenza|influenza
1233367|NCT01880697|adults|adults
1233368|NCT01880697|elderly|elderly
1233369|NCT01880697|immunology|immunology
1233370|NCT01880697|safety|safety
1233371|NCT01880684|Thermodilution|thermodilution
1233372|NCT01880684|Blood Volume|blood volume
1233373|NCT01880684|Cardiac Output|cardiac output
1233374|NCT01880684|Leg|leg
1233375|NCT01880684|Capnography|capnography
1233376|NCT01880684|Blood Pressure|blood pressure
1233377|NCT01880658|Maintenance therapy|maintenance therapy
1233378|NCT01880658|Capecitabine|capecitabine
1233379|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
1233380|NCT01880658|Post-operation|post-operation
1233381|NCT01880645|Breast Cancer|breast cancer
1233382|NCT01880645|Invasive breast cancer|invasive breast cancer
1233383|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
1233384|NCT01880645|Ultrasound|ultrasound
1233385|NCT01880645|Fine needle aspiration|fine needle aspiration
1233386|NCT01880645|FNA|fna
1233387|NCT01880645|Lymph node surgery|lymph node surgery
1233388|NCT01880645|Partial mastectomy|partial mastectomy
1233389|NCT01880645|Total mastectomy|total mastectomy
1233390|NCT01880632|XELOX|xelox
1233391|NCT01880632|perioperative treatment|perioperative treatment
1233392|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
1233393|NCT01880632|D2 resection|d2 resection
1233394|NCT01880619|Double J|double j
1233395|NCT01880619|Ureteral stents|ureteral stents
1233396|NCT01880619|Symptoms|symptoms
1233397|NCT01880619|Alpha blockers|alpha blockers
1233398|NCT01880619|Anticholinergic|anticholinergic
1233399|NCT01880593|Ketamine|ketamine
1233400|NCT01880593|glutamate|glutamate
1233401|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
1233402|NCT01880593|depression|depression
1233403|NCT01880593|major depressive disorder|major depressive disorder
1233404|NCT01880593|treatment resistant|treatment resistant
1233405|NCT01880593|antidepressant|antidepressant
1233406|NCT01880593|lithium|lithium
1233407|NCT01880567|Lymphoma|lymphoma
1233408|NCT01880567|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
1233409|NCT01880567|R/R MCL|r/r mcl
1233410|NCT01880567|Ibrutinib|ibrutinib
1233411|NCT01880567|PCI-32765|pci-32765
1233412|NCT01880567|Rituximab|rituximab
1233413|NCT01880567|Rituxan|rituxan
1233414|NCT01880567|Newly-Diagnosed Untreated Mantle Cell Lymphoma|newly-diagnosed untreated mantle cell lymphoma
1233415|NCT01880567|MCL|mcl
1233416|NCT01880554|Liver metastases|liver metastases
1233417|NCT01880554|Colorectal primary cancer|colorectal primary cancer
1233418|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1233419|NCT01880554|Sonovue®|sonovue®
1233420|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
1233421|NCT01880515|Lung cancer|lung cancer
1233422|NCT01880515|BIBW 2992|bibw 2992
1233424|NCT01880515|Tetracycline|tetracycline
1233425|NCT01880515|Afatinib|afatinib
1233426|NCT01880502|Healthy, Volunteers|healthy, volunteers
1233427|NCT01880489|transgender women|transgender women
1233428|NCT01880489|sexual risk|sexual risk
1233429|NCT01880489|substance use|substance use
1233430|NCT01880489|HIV prevention|hiv prevention
1233431|NCT01880489|behavioral intervention|behavioral intervention
1233432|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1233433|NCT01880476|Comorbidity|comorbidity
1233434|NCT01880476|Aged|aged
1233435|NCT01880476|Health Services|health services
1233436|NCT01880463|Dry eye disease|dry eye disease
1233437|NCT01880463|incidence|incidence
1233438|NCT01880463|progression|progression
1233439|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
1233440|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
1233441|NCT01880385|bevacizumab|bevacizumab
1233442|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
1233443|NCT01880385|non metastatic|non metastatic
1233444|NCT01880385|Avastin|avastin
1233445|NCT01880372|Diabetes|diabetes
1233446|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
1233447|NCT01880372|Retinopathy|retinopathy
1233448|NCT01880372|Free radical|free radical
1233449|NCT01880372|Retinal diseases|retinal diseases
1233450|NCT01880372|Antioxidants|antioxidants
1233451|NCT01880372|Protective agents|protective agents
1233452|NCT01880372|Thioctic acid|thioctic acid
1233453|NCT01880346|Cystic Fibrosis|cystic fibrosis
1233454|NCT01880346|Vitamin D|vitamin d
1233455|NCT01880346|absorption|absorption
1233456|NCT01880346|vitamin Deficiency|vitamin deficiency
1233457|NCT01880346|fat soluble|fat soluble
1233458|NCT01880333|Refractory epilepsy|refractory epilepsy
1233459|NCT01880333|dietary therapy|dietary therapy
1233460|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
1233461|NCT01880333|Modified Atkin Diet|modified atkin diet
1233462|NCT01880307|Crohn's disease|crohn's disease
1233463|NCT01880307|pediatric|pediatric
1233464|NCT01880307|infliximab|infliximab
1233465|NCT01880307|top-down|top-down
1233466|NCT01880307|ITSKids|itskids
1233467|NCT01880294|Constipation|constipation
1233468|NCT01880294|Chronic constipation|chronic constipation
1233469|NCT01880294|Asia-Pacific|asia-pacific
1233470|NCT01880294|Gastroentrology|gastroentrology
1233471|NCT01880294|Asian participants|asian participants
1233472|NCT01880281|G protein-coupled receptor 99 (GPR99)|g protein-coupled receptor 99 (gpr99)
1233473|NCT01880281|2-oxoglutarate receptor 1 (OXGR1)|2-oxoglutarate receptor 1 (oxgr1)
1233474|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
1233475|NCT01880281|urine|urine
1233476|NCT01880281|pH|ph
1233477|NCT01880281|acidosis|acidosis
1233478|NCT01880281|alkalosis|alkalosis
1233479|NCT01880281|Healthy volunteers|healthy volunteers
1233480|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1233481|NCT01880255|Schizophrenia|schizophrenia
1233482|NCT01880255|Cognition|cognition
1233483|NCT01880255|Working Memory|working memory
1233484|NCT01880242|International|international
1233485|NCT01880242|Multicenter|multicenter
1233486|NCT01880242|Observational registry|observational registry
1233487|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1233488|NCT01880242|Stenting|stenting
1233489|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1233490|NCT01880242|Coronary revascularization|coronary revascularization
1233491|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1233492|NCT01880242|STEMI|stemi
1233493|NCT01880242|NSTEMI|nstemi
1233494|NCT01880242|Ischemia|ischemia
1233495|NCT01880242|Angina|angina
1233496|NCT01880242|Subgroups|subgroups
1233497|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
1233498|NCT01880242|Diabetes|diabetes
1233499|NCT01880242|Small Vessels|small vessels
1233500|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1233501|NCT01880216|Deep vein thrombosis|deep vein thrombosis
1233502|NCT01880216|DVT|dvt
1233503|NCT01880216|Treatment|treatment
1233504|NCT01880216|Low molecular weight heparin|low molecular weight heparin
1233505|NCT01880216|Bemiparin|bemiparin
1233506|NCT01880216|Enoxaparin|enoxaparin
1233507|NCT01880203|thyroid|thyroid
1233508|NCT01880203|elastography SWE|elastography swe
1233509|NCT01880203|indeterminate cytology|indeterminate cytology
1233510|NCT01880164|Scoliosis|scoliosis
1233511|NCT01880164|Kyphosis|kyphosis
1233512|NCT01880164|Sagittal plane deformity|sagittal plane deformity
1233513|NCT01880151|Alzheimer's disease|alzheimer's disease
1233514|NCT01880151|Dementia|dementia
1233515|NCT01880151|Prodromal|prodromal
1233516|NCT01880151|EEG|eeg
1233517|NCT01880151|ERP|erp
1233518|NCT01880151|Biomarkers|biomarkers
1233519|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
1233520|NCT01880125|Tramadol|tramadol
1233521|NCT01880125|Acetaminophen|acetaminophen
1233522|NCT01880125|Pharmacokinetics|pharmacokinetics
1233523|NCT01880125|Sustained release|sustained release
1233524|NCT01880125|Immediate release|immediate release
1233525|NCT01880112|Infection|infection
1233729|NCT01879163|Vaccine|vaccine
1233526|NCT01880112|Cesarean delivery|cesarean delivery
1233527|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
1233528|NCT01880112|Cefazolin dosing|cefazolin dosing
1233529|NCT01880099|addiction|addiction
1233531|NCT01880099|tobacco|tobacco
1233532|NCT01880099|cigarettes|cigarettes
1233533|NCT01880086|Chronic pain|chronic pain
1233534|NCT01880086|Low testosterone|low testosterone
1233535|NCT01880086|Hypogonadism|hypogonadism
1233536|NCT01880086|Opioid analgesics|opioid analgesics
1233537|NCT01880086|Narcotics|narcotics
1233538|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
1233539|NCT01880086|OPIAD|opiad
1233540|NCT01880086|Male infertility|male infertility
1233541|NCT01880086|Clomiphene citrate|clomiphene citrate
1233542|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
1233543|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
1233544|NCT01880060|Worksite|worksite
1233545|NCT01880060|weight loss|weight loss
1233546|NCT01880060|obesity|obesity
1233547|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
1233548|NCT01880047|ITP|itp
1233549|NCT01880047|Eltrombopag|eltrombopag
1233550|NCT01880047|Promacta|promacta
1233551|NCT01880008|positron emission tomography|positron emission tomography
1233552|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
1233553|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
1233554|NCT01880008|radionuclide imaging|radionuclide imaging
1233555|NCT01880008|disease management|disease management
1233556|NCT01880008|radiation therapy|radiation therapy
1233557|NCT01879982|Bipolar disorder|bipolar disorder
1233558|NCT01879982|subtypes|subtypes
1233559|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
1233560|NCT01879956|Executive Functions|executive functions
1233561|NCT01879956|Schizophrenia|schizophrenia
1233562|NCT01879956|Occupational Therapy|occupational therapy
1233563|NCT01879943|Colorectal cancer|colorectal cancer
1233564|NCT01879943|Follow up|follow up
1233565|NCT01879943|Colonoscopy|colonoscopy
1233566|NCT01879943|Videocapsule|videocapsule
1233567|NCT01879930|randomized|randomized
1233568|NCT01879930|placebo-controlled|placebo-controlled
1233569|NCT01879930|double-blind study|double-blind study
1233570|NCT01879930|doxycycline|doxycycline
1233571|NCT01879917|c-peptide|c-peptide
1233572|NCT01879917|insulin|insulin
1233573|NCT01879917|hypoglycemia|hypoglycemia
1233574|NCT01879917|Newly onset|newly onset
1233575|NCT01879917|Diabetes|diabetes
1233576|NCT01879917|Type 1|type 1
1233577|NCT01879917|Beta cell|beta cell
1233578|NCT01879917|Autoimmune|autoimmune
1233579|NCT01879917|Glucagon|glucagon
1233580|NCT01879917|Meal test|meal test
1233581|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
1233582|NCT01879891|Exercise Intensity|exercise intensity
1233583|NCT01879891|Metabolism|metabolism
1233584|NCT01879891|Insulin|insulin
1233585|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1233586|NCT01879878|broccoli sprouts|broccoli sprouts
1233587|NCT01879878|sulforaphane|sulforaphane
1233588|NCT01879878|palliative chemotherapy|palliative chemotherapy
1233589|NCT01879878|cancer stem cells|cancer stem cells
1233590|NCT01879865|PKPD|pkpd
1233591|NCT01879865|Dexmedetomidine|dexmedetomidine
1233592|NCT01879865|Auditory Stimulation|auditory stimulation
1233593|NCT01879865|Cardiac Output|cardiac output
1233594|NCT01879852|Quadriceps strength|quadriceps strength
1233595|NCT01879852|Knee|knee
1233596|NCT01879852|Rehabilitation|rehabilitation
1233597|NCT01879826|Aculaser|aculaser
1233598|NCT01879826|Microlight ML830|microlight ml830
1233599|NCT01879826|Kidney biopsy|kidney biopsy
1233600|NCT01879826|Pain|pain
1233601|NCT01879826|Anxiety|anxiety
1233602|NCT01879826|Sedation|sedation
1233603|NCT01879813|Memory|memory
1233604|NCT01879813|Attention|attention
1233605|NCT01879787|Stroke|stroke
1233606|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
1233607|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
1233608|NCT01879787|mental practice|mental practice
1233609|NCT01879774|Hyponatremia|hyponatremia
1233610|NCT01879761|Immunosuppressed|immunosuppressed
1233611|NCT01879761|Sepsis|sepsis
1233612|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
1233613|NCT01879761|Bacteremia|bacteremia
1233614|NCT01879761|HLA-DR|hla-dr
1233615|NCT01879748|Parkinson's disease|parkinson's disease
1233616|NCT01879748|Azilect|azilect
1233617|NCT01879748|rasagiline mesylate|rasagiline mesylate
1233618|NCT01879722|Drug therapy|drug therapy
1233619|NCT01879709|schizophrenia|schizophrenia
1233620|NCT01879709|Cognition|cognition
1233621|NCT01879709|Independent living skills|independent living skills
1233622|NCT01879683|Hunner's lesion|hunner's lesion
1233623|NCT01879644|ADHD|adhd
1233624|NCT01879644|Neurofeedback|neurofeedback
1233625|NCT01879644|Self-Management|self-management
1233626|NCT01879644|Parental Psychoeducation|parental psychoeducation
1233627|NCT01879644|Social Support|social support
1233730|NCT01879163|Immunogenicity|immunogenicity
1233628|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
1233629|NCT01879618|Fragmin|fragmin
1233630|NCT01879618|dalteparin|dalteparin
1233631|NCT01879618|hemodialysis|hemodialysis
1233632|NCT01879618|anticoagulation|anticoagulation
1233633|NCT01879618|Renal Failure|renal failure
1233634|NCT01879605|Spinal surgery|spinal surgery
1233635|NCT01879605|Bowel preparation|bowel preparation
1233636|NCT01879605|Ileus|ileus
1233637|NCT01879605|Constipation|constipation
1233638|NCT01879605|Well-being|well-being
1233639|NCT01879592|Sickle cell disease|sickle cell disease
1233640|NCT01879592|Asthma|asthma
1233641|NCT01879592|Metabolomics|metabolomics
1233642|NCT01879592|Gene expression|gene expression
1233643|NCT01879579|Insulin|insulin
1233644|NCT01879579|Telemedicine|telemedicine
1233645|NCT01879553|Influenza,|influenza,
1233646|NCT01879553|Adults,|adults,
1233647|NCT01879553|Elderly,|elderly,
1233648|NCT01879553|Immunology,|immunology,
1233649|NCT01879553|Safety|safety
1233650|NCT01879540|Influenza,|influenza,
1233651|NCT01879540|Elderly,|elderly,
1233652|NCT01879540|Immunology,|immunology,
1233653|NCT01879540|Safety|safety
1233654|NCT01879514|IgA nephropathy|iga nephropathy
1233655|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
1233656|NCT01879501|Low vision|low vision
1233657|NCT01879501|Self management|self management
1233658|NCT01879501|Randomized controlled trial|randomized controlled trial
1233659|NCT01879501|Quality of life|quality of life
1233660|NCT01879501|Self efficacy|self efficacy
1233661|NCT01879501|Effectiveness|effectiveness
1233662|NCT01879501|Chronic eye diseases management|chronic eye diseases management
1233663|NCT01879488|Aerosol|aerosol
1233664|NCT01879488|Lung deposition|lung deposition
1233665|NCT01879488|Mechanical ventilation|mechanical ventilation
1233666|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
1233667|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
1233668|NCT01879462|NS5B|ns5b
1233669|NCT01879462|pharmacokinetics|pharmacokinetics
1233670|NCT01879462|GSK2878175|gsk2878175
1233671|NCT01879462|safety|safety
1233672|NCT01879462|FTIH|ftih
1233673|NCT01879462|healthy subjects|healthy subjects
1233674|NCT01879449|Spasticity|spasticity
1233675|NCT01879449|Veterans|veterans
1233676|NCT01879449|Prevalence|prevalence
1233677|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
1233678|NCT01879410|GSK573719|gsk573719
1233679|NCT01879410|lung function|lung function
1233680|NCT01879410|salmeterol (SAL)|salmeterol (sal)
1233681|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
1233682|NCT01879410|GW642444|gw642444
1595000|NCT00413608|Alleles|alleles
1233683|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1233684|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
1233685|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
1233686|NCT01879410|vilanterol (VI)|vilanterol (vi)
1233687|NCT01879397|atherosclerosis|atherosclerosis
1233688|NCT01879397|arteriosclerosis|arteriosclerosis
1233689|NCT01879397|carotid stenosis|carotid stenosis
1233690|NCT01879397|carotid endarterectomy|carotid endarterectomy
1233691|NCT01879397|Stroke|stroke
1233692|NCT01879384|microdialysis|microdialysis
1233693|NCT01879384|bone free flap|bone free flap
1233694|NCT01879384|head and neck|head and neck
1233695|NCT01879384|monitoring free flap|monitoring free flap
1233696|NCT01879384|reconstructive surgery|reconstructive surgery
1233697|NCT01879358|Drug-eluting stent|drug-eluting stent
1233698|NCT01879358|Safety|safety
1233699|NCT01879358|Efficacy|efficacy
1233700|NCT01879345|Anticonvulsant|anticonvulsant
1233701|NCT01879332|Anticonvulsant|anticonvulsant
1233702|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
1233703|NCT01879293|Metformin|metformin
1233704|NCT01879293|Left ventricular mass|left ventricular mass
1233705|NCT01879293|Endothelial dysfunction|endothelial dysfunction
1233706|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
1233707|NCT01879293|aortic pulse wave|aortic pulse wave
1233708|NCT01879280|pterional craniotomy|pterional craniotomy
1233709|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
1233710|NCT01879280|temporalis|temporalis
1233711|NCT01879280|minimally-invasive|minimally-invasive
1233712|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
1233713|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
1233714|NCT01879254|psychosurgery|psychosurgery
1233715|NCT01879254|long-term follow-up|long-term follow-up
1233716|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1233717|NCT01879241|survival time|survival time
1233718|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
1233719|NCT01879241|quality of life|quality of life
1233720|NCT01879241|survival|survival
1233721|NCT01879228|Cystic Fibrosis|cystic fibrosis
1233722|NCT01879228|Diabetes|diabetes
1233723|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
1233724|NCT01879202|multiple sclerosis|multiple sclerosis
1233725|NCT01879202|fatigue|fatigue
1233726|NCT01879202|fatigue severity scale|fatigue severity scale
1233727|NCT01879202|fatigue impact scale|fatigue impact scale
1233728|NCT01879202|quality of life|quality of life
1233731|NCT01879137|Copeptin|copeptin
1233732|NCT01879137|Arginin stimulation test|arginin stimulation test
1233733|NCT01879111|Depressive episode|depressive episode
1233734|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
1233735|NCT01879111|Hypertension|hypertension
1233736|NCT01879098|probiotics|probiotics
1233737|NCT01879098|inflammation|inflammation
1233738|NCT01879098|bile|bile
1233739|NCT01879098|hunger|hunger
1233740|NCT01879098|satiety|satiety
1233741|NCT01879085|advanced|advanced
1233742|NCT01879085|metastatic|metastatic
1233743|NCT01879085|unresectable|unresectable
1233744|NCT01879085|soft|soft
1233745|NCT01879085|tissue|tissue
1233746|NCT01879085|sarcomas|sarcomas
1233747|NCT01879072|Biomarkers|biomarkers
1233748|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1233749|NCT01879059|insulin resistance|insulin resistance
1233750|NCT01879059|exercise|exercise
1233751|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
1233752|NCT01879059|blood flow|blood flow
1233753|NCT01879059|endothelial function|endothelial function
1233754|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
1233755|NCT01879046|articular cartilage|articular cartilage
1233756|NCT01879046|tissue engineering|tissue engineering
1233757|NCT01879046|immunomodulation|immunomodulation
1233758|NCT01879046|osteo-arthritis|osteo-arthritis
1233759|NCT01879033|Obesity|obesity
1233760|NCT01879033|endothelial function|endothelial function
1233761|NCT01879033|Rh-PAT|rh-pat
1233762|NCT01879033|adipocytokines|adipocytokines
1233763|NCT01879020|MT-8995|mt-8995
1233764|NCT01879020|Dyslipidemia|dyslipidemia
1233765|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
1233766|NCT01878994|Overweight|overweight
1233767|NCT01878994|Obesity|obesity
1233768|NCT01878994|Children|children
1233769|NCT01878994|Behaviour|behaviour
1233770|NCT01878994|Physical Activity|physical activity
1233771|NCT01878994|Nutrition|nutrition
1233772|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
1233773|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
1233774|NCT01878955|Polycystic Ovary|polycystic ovary
1233775|NCT01878955|Multicystic Ovary|multicystic ovary
1233777|NCT01878942|Pharmacology|pharmacology
1233778|NCT01878942|Pharmacokinetics|pharmacokinetics
1233779|NCT01878942|Pharmacodynamics|pharmacodynamics
1233780|NCT01878942|Mechanism of action|mechanism of action
1233781|NCT01878942|Psychedelic|psychedelic
1233782|NCT01878942|Serotonin|serotonin
1595001|NCT00413608|Genotype|genotype
1233783|NCT01878942|Prepulse inhibition|prepulse inhibition
1233784|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
1233785|NCT01878942|Long-term psychological effects|long-term psychological effects
1233786|NCT01878929|pollen|pollen
1233787|NCT01878929|allergen immunotherapy|allergen immunotherapy
1233788|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
1233789|NCT01878929|SCIT|scit
1233790|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
1233791|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
1233792|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
1233793|NCT01878916|to compare these results with the control group|to compare these results with the control group
1233794|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
1233795|NCT01878877|Chronic pain|chronic pain
1233796|NCT01878877|neuropathic pain|neuropathic pain
1233797|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
1233798|NCT01878825|Immunogenicity|immunogenicity
1233799|NCT01878825|Trivalent|trivalent
1233800|NCT01878825|Safety|safety
1233801|NCT01878825|Adults|adults
1233802|NCT01878825|Elderly|elderly
1233803|NCT01878825|Influenza|influenza
1233804|NCT01878812|Immunogenicity|immunogenicity
1233805|NCT01878812|Influenza|influenza
1233806|NCT01878812|Adults|adults
1233807|NCT01878812|Safety|safety
1233808|NCT01878812|Elderly|elderly
1233809|NCT01878799|Direct Acting Antiviral|direct acting antiviral
1233810|NCT01878799|Treatment Naive|treatment naive
1233811|NCT01878799|Interferon Sparing|interferon sparing
1233812|NCT01878799|Ribavirin Sparing|ribavirin sparing
1233813|NCT01878786|kidney failure|kidney failure
1233814|NCT01878773|Prostate Cancer|prostate cancer
1233815|NCT01878773|MRI scan|mri scan
1233816|NCT01878773|External beam radiotherapy|external beam radiotherapy
1233817|NCT01878760|APRICOT|apricot
1233818|NCT01878760|Anaesthesia|anaesthesia
1233819|NCT01878760|Children|children
1233820|NCT01878760|kids|kids
1233821|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
1233822|NCT01878760|Observational Trial|observational trial
1233823|NCT01878760|epidemiology|epidemiology
1233824|NCT01878760|severe critical events in|severe critical events in
1233825|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
1233826|NCT01878760|Europe|europe
1233827|NCT01878747|Pediatric|pediatric
1233828|NCT01878747|Pain|pain
1233829|NCT01878747|Postoperative|postoperative
1233928|NCT01878409|Sexuality|sexuality
1233830|NCT01878747|General Anesthesia|general anesthesia
1233831|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
1233832|NCT01878747|Infant Behavior|infant behavior
1233833|NCT01878747|Adolescent Behavior|adolescent behavior
1233834|NCT01878747|Patient Satisfaction|patient satisfaction
1233835|NCT01878721|PET/CT|pet/ct
1233836|NCT01878721|infection|infection
1233837|NCT01878721|vasculitis|vasculitis
1233838|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
1233839|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
1233840|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
1233841|NCT01878708|Oncaspar®|oncaspar®
1233842|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
1233843|NCT01878695|Integrative Medicine|integrative medicine
1233844|NCT01878695|Breast Cancer|breast cancer
1233845|NCT01878695|Stage 0|stage 0
1233846|NCT01878695|Stage 1|stage 1
1233847|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
1233848|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
1233849|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
1233850|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
1233851|NCT01878643|bacterial resistance|bacterial resistance
1233852|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
1233853|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
1233854|NCT01878630|Chronic Heart Failure|chronic heart failure
1233856|NCT01878617|SJMB12|sjmb12
1233857|NCT01878617|Brain Cancer|brain cancer
1233858|NCT01878617|Brain Tumors in Children|brain tumors in children
1233859|NCT01878617|Cisplatin|cisplatin
1233860|NCT01878617|Cyclophosphamide|cyclophosphamide
1233861|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
1233862|NCT01878617|GDC-0449|gdc-0449
1233863|NCT01878617|Gemcitabine|gemcitabine
1233864|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
1233963|NCT01878175|Exercise|exercise
1233865|NCT01878617|Infratentorial|infratentorial
1233866|NCT01878617|Mass in Brain|mass in brain
1233867|NCT01878617|Medulloblastoma|medulloblastoma
1233868|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
1233869|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
1233870|NCT01878617|Molecular|molecular
1233871|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
1233872|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
1233873|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
1233874|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
1233875|NCT01878617|Pemetrexed|pemetrexed
1233876|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
1233877|NCT01878617|Proton Beam Therapy|proton beam therapy
1233878|NCT01878617|Radiation Therapy|radiation therapy
1233879|NCT01878617|Rare Brain Tumor|rare brain tumor
1233880|NCT01878617|Risk|risk
1233881|NCT01878617|SHH|shh
1233882|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
1233883|NCT01878617|St Jude Medullo|st jude medullo
1233884|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
1233885|NCT01878617|St. Jude Medullo|st. jude medullo
1233886|NCT01878617|St. Jude Studies|st. jude studies
1233887|NCT01878617|St. Jude Treatment|st. jude treatment
1233888|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
1233889|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
1233890|NCT01878617|Vincristine|vincristine
1233891|NCT01878617|Vismodegib|vismodegib
1233892|NCT01878617|WNT|wnt
1233893|NCT01878591|labour|labour
1233894|NCT01878591|dystocia|dystocia
1233895|NCT01878591|operative delivery|operative delivery
1233896|NCT01878591|vacuum|vacuum
1233897|NCT01878591|ultrasound|ultrasound
1233898|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
1233899|NCT01878565|HBIg|hbig
1233900|NCT01878565|GM-CSF|gm-csf
1233901|NCT01878565|HBV vaccine|hbv vaccine
1233902|NCT01878565|immune regulatory therapy|immune regulatory therapy
1233903|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
1233904|NCT01878526|heart burn|heart burn
1233905|NCT01878526|regurgitation|regurgitation
1233906|NCT01878526|systemic sclerosis|systemic sclerosis
1233907|NCT01878526|scleroderma|scleroderma
1233908|NCT01878526|proton pump inhibitor|proton pump inhibitor
1233909|NCT01878526|alginic acid|alginic acid
1233910|NCT01878526|omeprazole|omeprazole
1233911|NCT01878526|prokinetic|prokinetic
1233912|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
1233913|NCT01878500|Pelvic floor musculature|pelvic floor musculature
1233914|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
1233915|NCT01878487|Acute MI|acute mi
1233916|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1233917|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
1233918|NCT01878474|MT-8995|mt-8995
1233919|NCT01878474|Dyslipidemia|dyslipidemia
1233920|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
1233921|NCT01878435|Short Message System|short message system
1233922|NCT01878435|SMS reminder|sms reminder
1233923|NCT01878435|mobile phone|mobile phone
1233924|NCT01878435|cell phone|cell phone
1233925|NCT01878435|vaccination|vaccination
1233926|NCT01878435|immunization|immunization
1233927|NCT01878435|mHealth|mhealth
1233929|NCT01878409|Parkinson Disease|parkinson disease
1233930|NCT01878409|BISF|bisf
1233931|NCT01878409|IIEF|iief
1233932|NCT01878409|FSFI|fsfi
1233933|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
1233934|NCT01878383|(HSV)|(hsv)
1233935|NCT01878357|MST|mst
1233936|NCT01878357|Malaria|malaria
1233937|NCT01878357|Indonesia|indonesia
1233938|NCT01878357|Transmission|transmission
1233939|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
1233940|NCT01878305|brain waves|brain waves
1233941|NCT01878305|electroencephalogram|electroencephalogram
1233942|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
1233943|NCT01878305|physiological monitoring|physiological monitoring
1233944|NCT01878305|intensive care|intensive care
1233945|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
1233946|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1233947|NCT01878266|Radiotherapy|radiotherapy
1233948|NCT01878266|Median survival|median survival
1233949|NCT01878253|Total Shoulder Arthoplasty|total shoulder arthoplasty
1233950|NCT01878240|Vascular surgery|vascular surgery
1233951|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
1233952|NCT01878240|endovascular|endovascular
1233953|NCT01878214|Health communication|health communication
1233954|NCT01878214|Smoking cessation|smoking cessation
1233955|NCT01878214|Health behavior|health behavior
1233956|NCT01878214|Construction industry|construction industry
1233957|NCT01878214|Audience segmentation|audience segmentation
1233958|NCT01878201|Fimasartan|fimasartan
1233959|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
1233960|NCT01878201|antihypertension|antihypertension
1233961|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1233962|NCT01878175|Veterans|veterans
1233964|NCT01878162|Prevention|prevention
1233965|NCT01878162|Wellness|wellness
1233966|NCT01878162|Occupation|occupation
1233967|NCT01878162|Work|work
1233968|NCT01878162|Law Enforcement|law enforcement
1233969|NCT01878162|Exercise|exercise
1233970|NCT01878123|Arthritis|arthritis
1233971|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
1233972|NCT01878123|Joint Diseases|joint diseases
1233973|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
1233974|NCT01878123|Rheumatic Diseases|rheumatic diseases
1233975|NCT01878123|Connective Tissue Diseases|connective tissue diseases
1233976|NCT01878123|Autoimmune Diseases|autoimmune diseases
1233977|NCT01878123|Immune System Diseases|immune system diseases
1233978|NCT01878123|Antirheumatic agents|antirheumatic agents
1233979|NCT01878110|Trichotillomania|trichotillomania
1233980|NCT01878110|Hair pulling|hair pulling
1233981|NCT01878110|Behavior therapy|behavior therapy
1233982|NCT01878084|Tissue regeneration|tissue regeneration
1233983|NCT01878084|sol gel bioglass|sol gel bioglass
1233984|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
1233985|NCT01878084|children|children
1233986|NCT01878084|Egyptian|egyptian
1233987|NCT01878084|class II orthodontic cases|class ii orthodontic cases
1233988|NCT01878058|Prostate cancer|prostate cancer
1233989|NCT01878058|Brachytherapy|brachytherapy
1233990|NCT01878058|Seed implant|seed implant
1233991|NCT01878045|American Indians|american indians
1233992|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
1233993|NCT01878045|Kidney Biopsy|kidney biopsy
1233994|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1233995|NCT01878045|Retinopathy|retinopathy
1233996|NCT01878032|Retinal Disease|retinal disease
1233997|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
1233998|NCT01878019|Pain|pain
1233999|NCT01878019|Placebo|placebo
1234000|NCT01878019|Opiate Antagonist|opiate antagonist
1234001|NCT01878006|Opiate Receptor|opiate receptor
1234002|NCT01878006|Genotype|genotype
1234003|NCT01878006|PET Imaging|pet imaging
1234004|NCT01877993|coronary artery spasm|coronary artery spasm
1234005|NCT01877993|pathophysiology|pathophysiology
1234006|NCT01877993|atrioventricular block|atrioventricular block
1234007|NCT01877993|blood pressure|blood pressure
1234008|NCT01877993|autonomic nervous function|autonomic nervous function
1234009|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
1234010|NCT01877954|fluticasone|fluticasone
1234011|NCT01877954|paediatrics|paediatrics
1234012|NCT01877954|real-life|real-life
1234013|NCT01877954|observational|observational
1234014|NCT01877954|primary care|primary care
1234015|NCT01877941|cardiac output|cardiac output
1234016|NCT01877941|pulse oximetry|pulse oximetry
1234017|NCT01877941|hemodynamics|hemodynamics
1234018|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
1234019|NCT01877915|Heart Failure|heart failure
1234020|NCT01877915|Coronary Artery Disease|coronary artery disease
1234021|NCT01877915|Stroke|stroke
1234022|NCT01877915|Myocardial Infarction|myocardial infarction
1234023|NCT01877915|Anticoagulation|anticoagulation
1234024|NCT01877889|Healthy|healthy
1234025|NCT01877889|Canagliflozin|canagliflozin
1234026|NCT01877889|INVOKANA|invokana
1234027|NCT01877889|Dapagliflozin|dapagliflozin
1234028|NCT01877889|FORXIGA|forxiga
1234029|NCT01877889|Pharmacodynamics|pharmacodynamics
1234030|NCT01877863|intradialytic exercise|intradialytic exercise
1234031|NCT01877863|hemodialysis|hemodialysis
1234032|NCT01877837|Stem cell transplant|stem cell transplant
1234033|NCT01877837|Sickle cell|sickle cell
1234034|NCT01877837|Stem cell transplantation|stem cell transplantation
1234035|NCT01877837|Related|related
1234036|NCT01877837|Unrelated|unrelated
1234037|NCT01877824|Surgery|surgery
1234038|NCT01877824|Training|training
1234039|NCT01877811|Lung Cancer|lung cancer
1234040|NCT01877811|RET Inhibitor|ret inhibitor
1234041|NCT01877811|Solid Tumors|solid tumors
1234042|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
1234043|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
1234044|NCT01877811|Squamous NSCLC|squamous nsclc
1234045|NCT01877811|KRAS mutation|kras mutation
1234046|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
1234047|NCT01877772|cuff repair|cuff repair
1234048|NCT01877772|arthroscopic|arthroscopic
1234049|NCT01877772|Trephination|trephination
1234050|NCT01877772|Bone|bone
1234051|NCT01877772|cuff tear|cuff tear
1234052|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
1234053|NCT01877746|ICM|icm
1234054|NCT01877746|myocarditis|myocarditis
1234055|NCT01877746|cardiomyopathy|cardiomyopathy
1234056|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
1234057|NCT01877746|immunosuppression|immunosuppression
1234058|NCT01877733|Resistance training|resistance training
1234059|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
1234060|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
1234061|NCT01877720|postextubation|postextubation
1234062|NCT01877694|pink eye|pink eye
1234063|NCT01877668|psoriatic arthritis|psoriatic arthritis
1234064|NCT01877668|radiographic changes|radiographic changes
1234065|NCT01877668|active comparator|active comparator
1234066|NCT01877668|tofacitinib|tofacitinib
1234067|NCT01877655|ASP0113|asp0113
1234068|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
1234069|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
1234070|NCT01877642|ADASUVE|adasuve
1234071|NCT01877642|inhaled loxapine|inhaled loxapine
1596125|NCT00410059|Tarceva|tarceva
1234072|NCT01877642|drug drug interaction|drug drug interaction
1234073|NCT01877642|lorazepam|lorazepam
1234074|NCT01877642|acute treatment of agitation|acute treatment of agitation
1234075|NCT01877629|Pharmacokinetics|pharmacokinetics
1234076|NCT01877629|Tolerability|tolerability
1234077|NCT01877629|Safety|safety
1234078|NCT01877629|ACT-129968|act-129968
1234079|NCT01877616|sleep disorders|sleep disorders
1234080|NCT01877616|insomnia|insomnia
1234081|NCT01877616|hypersomnia|hypersomnia
1234082|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
1234083|NCT01877616|cardiovascular health|cardiovascular health
1234084|NCT01877616|stroke|stroke
1234085|NCT01877616|ischemic heart disease|ischemic heart disease
1234086|NCT01877616|Atahualpa|atahualpa
1234087|NCT01877551|HIV|hiv
1234088|NCT01877551|Protease inhibitor|protease inhibitor
1234089|NCT01877551|insulin resistance|insulin resistance
1234090|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
1234091|NCT01877525|colorectal polyps|colorectal polyps
1234092|NCT01877525|resect and discard|resect and discard
1234093|NCT01877525|endoscopic prediction|endoscopic prediction
1234094|NCT01877525|histological diagnosis|histological diagnosis
1234095|NCT01877525|narrow band imaging|narrow band imaging
1234096|NCT01877499|Hemodiafiltration|hemodiafiltration
1234097|NCT01877499|Convection volume|convection volume
1234098|NCT01877499|Filtration fraction|filtration fraction
1234099|NCT01877499|Blood flow|blood flow
1234100|NCT01877499|Treatment time|treatment time
1234101|NCT01877486|atrial fibrillation|atrial fibrillation
1234102|NCT01877486|cryoballoon ablation|cryoballoon ablation
1234103|NCT01877486|persistent AF|persistent af
1234104|NCT01877486|paroxysmal AF|paroxysmal af
1234105|NCT01877486|dofetilide|dofetilide
1234106|NCT01877473|atrial fibrillation|atrial fibrillation
1234107|NCT01877473|persistent AF|persistent af
1234108|NCT01877473|catheter ablation|catheter ablation
1234109|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
1234110|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
1234111|NCT01877460|sodium alginate|sodium alginate
1234112|NCT01877460|chocolate milk|chocolate milk
1234113|NCT01877460|satiety|satiety
1234114|NCT01877460|energy intake|energy intake
1234115|NCT01877460|glycemia|glycemia
1234116|NCT01877460|insulinemia|insulinemia
1234117|NCT01877447|tDCS|tdcs
1234118|NCT01877447|Brain stimulation|brain stimulation
1234119|NCT01877447|depressive disorder|depressive disorder
1234120|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
1234121|NCT01877434|Treatment|treatment
1234122|NCT01877434|TESS|tess
1234123|NCT01877421|Reducing plaque|reducing plaque
1234124|NCT01877421|Reducing gingivitis|reducing gingivitis
1234125|NCT01877421|safety|safety
1234126|NCT01877421|proof of concept|proof of concept
1234127|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
1234223|NCT01876992|nutrition|nutrition
1234128|NCT01877408|disposable circumcision device|disposable circumcision device
1234129|NCT01877408|Tissue adhesive|tissue adhesive
1234130|NCT01877408|Open surgical circumcision|open surgical circumcision
1234131|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
1234132|NCT01877395|Rabies|rabies
1234133|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
1234134|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
1234135|NCT01877395|Imovax® Rabies|imovax® rabies
1234136|NCT01877356|ambulatory surgery|ambulatory surgery
1234137|NCT01877356|spinal anesthesia|spinal anesthesia
1234138|NCT01877356|micturition|micturition
1234139|NCT01877356|bladder retention|bladder retention
1234140|NCT01877356|unilateral block|unilateral block
1234141|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
1234142|NCT01877356|prilocaine plain|prilocaine plain
1234143|NCT01877356|local anaesthetic dose|local anaesthetic dose
1234144|NCT01877343|cardiac functional health classification|cardiac functional health classification
1234145|NCT01877343|Congenital heart failure|congenital heart failure
1234146|NCT01877343|chronic heart failure|chronic heart failure
1234147|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
1234148|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
1234149|NCT01877330|interscalene nerve block|interscalene nerve block
1234150|NCT01877317|Audiology|audiology
1234151|NCT01877317|hearing loss|hearing loss
1234152|NCT01877317|hearing healthcare|hearing healthcare
1234153|NCT01877317|mobile app|mobile app
1234154|NCT01877317|hearing aid fitting|hearing aid fitting
1234155|NCT01877317|audiometry|audiometry
1234156|NCT01877317|audiogram|audiogram
1234157|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
1234158|NCT01877278|Osteoarthritis|osteoarthritis
1234264|NCT01876823|Elderly|elderly
1234159|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
1234160|NCT01877278|Device|device
1234161|NCT01877278|Pain|pain
1234162|NCT01877278|Pressure algometry|pressure algometry
1234163|NCT01877252|critical limb ischemia|critical limb ischemia
1234164|NCT01877252|endovascular treatment|endovascular treatment
1234165|NCT01877252|open surgical repair|open surgical repair
1234166|NCT01877252|diabetic foot|diabetic foot
1234167|NCT01877226|Healthy|healthy
1234168|NCT01877226|Tapentadol|tapentadol
1234169|NCT01877213|coaching|coaching
1234170|NCT01877213|therapeutic education|therapeutic education
1234171|NCT01877213|hospital admission|hospital admission
1234172|NCT01877213|quality improvement strategies|quality improvement strategies
1234173|NCT01877213|management program|management program
1234174|NCT01877213|nurse follow up|nurse follow up
1234175|NCT01877213|discharge planning|discharge planning
1234176|NCT01877213|rehospitalization|rehospitalization
1234177|NCT01877187|Primary liver cancer|primary liver cancer
1234178|NCT01877187|Metastatic liver cancer|metastatic liver cancer
1234179|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
1234180|NCT01877174|Reverse Flow|reverse flow
1234181|NCT01877174|Carotid stenting|carotid stenting
1234182|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
1234183|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
1234184|NCT01877135|anal carcinoma|anal carcinoma
1234185|NCT01877135|AIN3|ain3
1234186|NCT01877135|cohort study|cohort study
1234187|NCT01877109|Lymphoma|lymphoma
1234188|NCT01877109|Prognosis|prognosis
1234189|NCT01877109|Biomarker|biomarker
1234190|NCT01877109|Quality of life|quality of life
1234191|NCT01877096|Motivational Interviewing|motivational interviewing
1234192|NCT01877096|Screening Colonoscopy|screening colonoscopy
1234193|NCT01877096|Cancer Prevention|cancer prevention
1234194|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
1234195|NCT01877083|Lung Cancer|lung cancer
1234196|NCT01877083|NSCLC|nsclc
1234197|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
1234198|NCT01877070|assessments|assessments
1234199|NCT01877070|13-076|13-076
1234200|NCT01877057|Pea protein|pea protein
1234201|NCT01877057|Satiety hormone|satiety hormone
1234202|NCT01877057|Ussing Chamber|ussing chamber
1234203|NCT01877044|Prebiotics|prebiotics
1234204|NCT01877044|Intestinal permeability|intestinal permeability
1234205|NCT01877044|Gut barrier function|gut barrier function
1234206|NCT01877044|Immunity|immunity
1234207|NCT01877031|central line|central line
1234208|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
1234209|NCT01877031|virtual reality|virtual reality
1234210|NCT01877031|augmented reality|augmented reality
1234211|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
1234212|NCT01877018|Reminder Systems|reminder systems
1234213|NCT01877018|Patient Participation|patient participation
1234214|NCT01877018|Primary Health Care|primary health care
1234215|NCT01877018|Early Detection of Cancer|early detection of cancer
1234216|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
1234217|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
1234218|NCT01876992|diabetes|diabetes
1234219|NCT01876992|pediatrics|pediatrics
1234220|NCT01876992|obesity|obesity
1234221|NCT01876992|healthy volunteers|healthy volunteers
1234222|NCT01876992|metformin|metformin
1234224|NCT01876992|healthy controls|healthy controls
1234226|NCT01876966|HIV|hiv
1234227|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
1234228|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
1234229|NCT01876940|supraglottic airway|supraglottic airway
1234230|NCT01876940|children|children
1234231|NCT01876940|tracheal intubation|tracheal intubation
1234232|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
1234233|NCT01876927|Locally|locally
1234234|NCT01876927|Advanced|advanced
1234235|NCT01876927|Resectable|resectable
1234236|NCT01876927|Gastric Cancer|gastric cancer
1234237|NCT01876914|Diabetes|diabetes
1234238|NCT01876914|Edema|edema
1234239|NCT01876914|DME|dme
1234240|NCT01876914|OCT|oct
1234241|NCT01876901|Rectal cancer|rectal cancer
1234242|NCT01876901|Coloanal anastomosis|coloanal anastomosis
1234243|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
1234244|NCT01876888|patient satisfaction|patient satisfaction
1234245|NCT01876888|physical therapy|physical therapy
1234246|NCT01876888|MedRisk instrument|medrisk instrument
1234247|NCT01876875|psoriasis|psoriasis
1234248|NCT01876875|obesity|obesity
1234249|NCT01876862|HIV-1|hiv-1
1234250|NCT01876862|chronic infection|chronic infection
1234251|NCT01876862|cure|cure
1234252|NCT01876862|remission|remission
1234253|NCT01876849|diabetes|diabetes
1234254|NCT01876849|exenatide|exenatide
1234255|NCT01876849|Byetta|byetta
1234256|NCT01876849|Amylin|amylin
1234257|NCT01876849|Lilly|lilly
1234258|NCT01876836|i-gel|i-gel
1234259|NCT01876836|C-LMA|c-lma
1234260|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
1234261|NCT01876836|sore troat|sore troat
1234262|NCT01876823|Memory Decline|memory decline
1234263|NCT01876823|Depression|depression
1234265|NCT01876823|Antidepressants|antidepressants
1234266|NCT01876823|Treatment|treatment
1234267|NCT01876823|memantine|memantine
1234268|NCT01876810|Gemfibrozil|gemfibrozil
1234269|NCT01876810|Nicotine Dependence|nicotine dependence
1234270|NCT01876810|Smoking|smoking
1234271|NCT01876810|Cigarettes|cigarettes
1234272|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
1234273|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
1234274|NCT01876758|ECT|ect
1234275|NCT01876758|Memory Training|memory training
1234276|NCT01876758|Cognitive Remediation|cognitive remediation
1234277|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
1234278|NCT01876758|Treatment Resistant Depression|treatment resistant depression
1234279|NCT01876758|Depression|depression
1234280|NCT01876758|Geriatric Depression|geriatric depression
1234281|NCT01876758|Memory Loss|memory loss
1234282|NCT01876758|Cognitive Training|cognitive training
1234283|NCT01876732|hemodialysis|hemodialysis
1234284|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
1234285|NCT01876732|Epogen|epogen
1234286|NCT01876719|ADHD|adhd
1234287|NCT01876719|AR08|ar08
1234288|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
1234289|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
1234290|NCT01876706|UroLift System|urolift system
1234291|NCT01876680|chronic|chronic
1234292|NCT01876680|neck|neck
1234293|NCT01876680|shoulder|shoulder
1234294|NCT01876680|exercise|exercise
1234295|NCT01876654|Total Knee Replacement|total knee replacement
1234296|NCT01876654|Patient specific instrumentation|patient specific instrumentation
1234297|NCT01876641|Metastatic melanoma|metastatic melanoma
1234298|NCT01876641|melanoma|melanoma
1234299|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
1234300|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
1234301|NCT01876641|Decitabine|decitabine
1234302|NCT01876641|Vemurafenib|vemurafenib
1234303|NCT01876628|Clindamycin|clindamycin
1234304|NCT01876628|Cellulitis|cellulitis
1234305|NCT01876628|Flucloxacillin|flucloxacillin
1234306|NCT01876628|Group A streptococcus|group a streptococcus
1234307|NCT01876628|Staphylococcus aureus|staphylococcus aureus
1234308|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
1234309|NCT01876602|adolescents|adolescents
1234310|NCT01876602|exercise|exercise
1234311|NCT01876602|fitness|fitness
1234312|NCT01876602|school-based|school-based
1234313|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1234314|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
1234315|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
1234316|NCT01876576|colonoscopy|colonoscopy
1234317|NCT01876563|thioredoxin|thioredoxin
1234318|NCT01876563|TBP-2|tbp-2
1234319|NCT01876563|thioredoxin reductase|thioredoxin reductase
1234320|NCT01876563|vitamin D|vitamin d
1234321|NCT01876563|DIABETES|diabetes
1234322|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
1234323|NCT01876550|Bactroban® Cream|bactroban® cream
1234324|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
1234325|NCT01876524|Substance Use Disorder|substance use disorder
1234326|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
1234327|NCT01876524|Schizophrenia|schizophrenia
1234328|NCT01876524|Bipolar disorder|bipolar disorder
1234329|NCT01876524|Personality disorder|personality disorder
1234331|NCT01876511|MSS|mss
1234332|NCT01876511|MLH 1|mlh 1
1234333|NCT01876511|MSH 2|msh 2
1234334|NCT01876511|MSH 6|msh 6
1234335|NCT01876511|PMS2|pms2
1234336|NCT01876511|BRAF pV600E|braf pv600e
1234337|NCT01876511|TGFBR2|tgfbr2
1234338|NCT01876511|Mutation load|mutation load
1234339|NCT01876511|tumor mutation load|tumor mutation load
1234340|NCT01876511|mutation burden|mutation burden
1234341|NCT01876511|tumor mutation burden|tumor mutation burden
1234342|NCT01876511|hypermutation|hypermutation
1234343|NCT01876511|POLE|pole
1234344|NCT01876511|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
1234345|NCT01876485|Diabetes Mellitus|diabetes mellitus
1234346|NCT01876485|health literacy|health literacy
1234347|NCT01876485|patient activation|patient activation
1234348|NCT01876485|goals of care|goals of care
1234349|NCT01876394|Healthy|healthy
1234350|NCT01876394|Arterial Stiffness|arterial stiffness
1234351|NCT01876394|Blood Pressure|blood pressure
1234352|NCT01876394|Blood Glucose|blood glucose
1234353|NCT01876394|Vascular Function|vascular function
1234354|NCT01876368|hypertension,|hypertension,
1234355|NCT01876368|LCZ696,|lcz696,
1234356|NCT01876368|olmesartan|olmesartan
1234357|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
1234358|NCT01876342|sports hernia|sports hernia
1234359|NCT01876342|sportsman's hernia|sportsman's hernia
1234360|NCT01876342|chronic groin pain|chronic groin pain
1234361|NCT01876342|open minimal repair|open minimal repair
1234362|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
1234363|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
1234364|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
1234365|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
1234366|NCT01876329|Autoantibodies|autoantibodies
1234367|NCT01876316|Moxifloxacin|moxifloxacin
1234368|NCT01876316|QT interval prolongation|qt interval prolongation
1234369|NCT01876316|Korean|korean
1234370|NCT01876316|Japanese|japanese
1234371|NCT01876290|Anesthesiology|anesthesiology
1234372|NCT01876290|Complications|complications
1234373|NCT01876290|Closed-loop|closed-loop
1234374|NCT01876277|Cancer|cancer
1234375|NCT01876277|Body image|body image
1234376|NCT01876277|Adolescent|adolescent
1234377|NCT01876264|Colorectal surgery|colorectal surgery
1234378|NCT01876264|Colonoscopy|colonoscopy
1234379|NCT01876264|Randomized controlled trial|randomized controlled trial
1234380|NCT01876251|Breast cancer metastatic|breast cancer metastatic
1234381|NCT01876251|docetaxel|docetaxel
1234382|NCT01876251|PF-03084014|pf-03084014
1234383|NCT01876238|Breast Cancer|breast cancer
1234384|NCT01876238|Patient-Doctor Communication|patient-doctor communication
1234385|NCT01876238|Supportive Care|supportive care
1234386|NCT01876225|cervical biopsy|cervical biopsy
1234387|NCT01876225|forced cough|forced cough
1234388|NCT01876225|pain|pain
1234389|NCT01876225|VAS scale|vas scale
1234390|NCT01876212|melanoma|melanoma
1234391|NCT01876212|metastatic|metastatic
1234392|NCT01876212|vaccine|vaccine
1234393|NCT01876212|BRAF|braf
1234394|NCT01876199|HIV-1|hiv-1
1234395|NCT01876199|acute|acute
1234396|NCT01876199|diagnosis|diagnosis
1234397|NCT01876199|pharmacies|pharmacies
1234398|NCT01876199|healthcare facilities|healthcare facilities
1234399|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
1234400|NCT01876186|urodynamic studies|urodynamic studies
1234401|NCT01876186|nerve growth factor|nerve growth factor
1234402|NCT01876173|Sudden cardiac death|sudden cardiac death
1234403|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1234404|NCT01876173|decision aid|decision aid
1234405|NCT01876147|Low vision|low vision
1234406|NCT01876147|Vision testing|vision testing
1234407|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
1234408|NCT01876147|AMD|amd
1234409|NCT01876147|Visual acuity|visual acuity
1234410|NCT01876147|Poor vision|poor vision
1234411|NCT01876147|Quantification|quantification
1234412|NCT01876134|Cardiac surgery|cardiac surgery
1234413|NCT01876134|Acute kidney injury|acute kidney injury
1234414|NCT01876134|Cyr-61|cyr-61
1234415|NCT01876134|Pulse wave analysis|pulse wave analysis
1234416|NCT01876121|NSAIDs|nsaids
1234417|NCT01876121|Acute pain|acute pain
1234418|NCT01876108|Steatohepatitis|steatohepatitis
1234419|NCT01876108|Helicobacter pylori|helicobacter pylori
1234420|NCT01876108|Alanine aminotransferase|alanine aminotransferase
1234421|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
1234422|NCT01876108|Fatty Liver|fatty liver
1234423|NCT01876108|Liver Diseases|liver diseases
1234424|NCT01876108|Digestive System Diseases|digestive system diseases
1234425|NCT01876082|Desmoids tumors|desmoids tumors
1234426|NCT01876082|Pazopanib|pazopanib
1234427|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
1234428|NCT01876082|Cross over|cross over
1234429|NCT01876056|Psychosis|psychosis
1234430|NCT01876056|Culture|culture
1234431|NCT01876056|CBT|cbt
1234432|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
1234433|NCT01876030|Sub acute stroke|sub acute stroke
1234434|NCT01876030|Gait analysis|gait analysis
1234435|NCT01876017|CRF|crf
1234436|NCT01876017|STEM CELL|stem cell
1234437|NCT01876017|CKD|ckd
1234438|NCT01876004|ectopic pregnancy|ectopic pregnancy
1234439|NCT01876004|methotrexate|methotrexate
1234440|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
1234441|NCT01876004|expectant management|expectant management
1234442|NCT01875978|Phytosterols|phytosterols
1234443|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
1234444|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
1234445|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1234446|NCT01875952|Treatment|treatment
1234447|NCT01875952|Isoniazid|isoniazid
1234448|NCT01875939|healthy volunteers|healthy volunteers
1234449|NCT01875913|Curiosity|curiosity
1234450|NCT01875913|Intention|intention
1234451|NCT01875913|Follow Through|follow through
1234452|NCT01875900|neonatal resuscitation|neonatal resuscitation
1234453|NCT01875900|video-assisted learning|video-assisted learning
1234454|NCT01875900|self-directed training|self-directed training
1234455|NCT01875900|simulation|simulation
1234456|NCT01875900|simulation-based training|simulation-based training
1234457|NCT01875900|simulation-based medical education|simulation-based medical education
1234458|NCT01875900|objective structured clinical examination|objective structured clinical examination
1234459|NCT01875874|liver failure|liver failure
1234460|NCT01875874|acute liver failure|acute liver failure
1234461|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
1234462|NCT01875874|primary graft non-function|primary graft non-function
1234463|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
1234464|NCT01875874|ELAD|elad
1234466|NCT01875874|FHF|fhf
1234467|NCT01875874|PNF|pnf
1234468|NCT01875861|Antipsychotic Agents|antipsychotic agents
1234469|NCT01875861|Metabolic Syndrome|metabolic syndrome
1234470|NCT01875861|Quality Improvement|quality improvement
1234471|NCT01875848|pain management|pain management
1234472|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
1234473|NCT01875835|Bare-metal stent|bare-metal stent
1234474|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
1234475|NCT01875835|Optical coherence tomography|optical coherence tomography
1234476|NCT01875822|Curcumin|curcumin
1234477|NCT01875822|Epigenetics|epigenetics
1234478|NCT01875822|Schizophrenia|schizophrenia
1234479|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
1234480|NCT01875822|cognition|cognition
1234481|NCT01875822|negative symptoms|negative symptoms
1234483|NCT01875809|renal denervation|renal denervation
1234484|NCT01875809|catecholamine|catecholamine
1234485|NCT01875809|spill-over|spill-over
1234486|NCT01875809|blood pressure|blood pressure
1234487|NCT01875809|electrophysiology|electrophysiology
1234488|NCT01875809|ablation|ablation
1234489|NCT01875796|cannabis|cannabis
1234490|NCT01875796|marijuana|marijuana
1234491|NCT01875796|anxiety|anxiety
1234492|NCT01875796|transdiagnostic|transdiagnostic
1234493|NCT01875796|dual diagnosis|dual diagnosis
1234494|NCT01875796|cannabis abuse|cannabis abuse
1234495|NCT01875796|cannabis dependence|cannabis dependence
1234496|NCT01875796|cannabis use disorder|cannabis use disorder
1234497|NCT01875783|diabetes|diabetes
1234498|NCT01875783|diabetic macular edema|diabetic macular edema
1234499|NCT01875783|diabetic retinopathy|diabetic retinopathy
1234500|NCT01875783|optical coherence tomography|optical coherence tomography
1234501|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
1234502|NCT01875757|Vitamin D|vitamin d
1234503|NCT01875757|Acute bronchitis|acute bronchitis
1234504|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
1234505|NCT01875757|Recurrent bronchitis|recurrent bronchitis
1234506|NCT01875757|Acute bronchiolitis|acute bronchiolitis
1234507|NCT01875757|Infants|infants
1234508|NCT01875744|constipation|constipation
1234509|NCT01875744|children|children
1234510|NCT01875744|polyethylene glycol|polyethylene glycol
1234511|NCT01875731|Pneumonia|pneumonia
1234512|NCT01875731|Acute respiratory infection|acute respiratory infection
1234513|NCT01875731|Decision-support techniques|decision-support techniques
1234514|NCT01875692|Metagenomic|metagenomic
1234515|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
1234516|NCT01875679|Surgical education|surgical education
1234517|NCT01875679|Deliberate practice|deliberate practice
1234518|NCT01875679|Debriefing|debriefing
1234519|NCT01875679|Behaviour modelling|behaviour modelling
1234520|NCT01875666|breast cancer|breast cancer
1234521|NCT01875666|Kinome|kinome
1234522|NCT01875666|HER two positive|her two positive
1234523|NCT01875653|metastatic melanoma|metastatic melanoma
1234524|NCT01875653|dendritic cells|dendritic cells
1234525|NCT01875653|immunotherapy|immunotherapy
1234526|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
1234527|NCT01875653|overall survival|overall survival
1234528|NCT01875653|autologous|autologous
1234529|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
1234530|NCT01875653|treatment|treatment
1234532|NCT01875653|tumor cells|tumor cells
1234533|NCT01875640|disorder of sex development|disorder of sex development
1234534|NCT01875640|intersex|intersex
1234535|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
1234536|NCT01875640|hypospadias|hypospadias
1234537|NCT01875640|decision support tool|decision support tool
1234538|NCT01875601|NK Cells|nk cells
1234539|NCT01875601|Cytokine|cytokine
1234540|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
1234541|NCT01875601|Immunotherapy|immunotherapy
1234542|NCT01875601|Pediatric|pediatric
1234543|NCT01875588|Healthy Controls|healthy controls
1234544|NCT01875588|HIV-positive|hiv-positive
1234545|NCT01875588|Neurophyschological Testing|neurophyschological testing
1234546|NCT01875588|PET/CT Scan|pet/ct scan
1234547|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
1234548|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
1234549|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
1234550|NCT01875575|ghrelin|ghrelin
1234551|NCT01875575|stomach|stomach
1234552|NCT01875575|small intestine|small intestine
1234553|NCT01875575|gastric emptying|gastric emptying
1234554|NCT01875562|Neck pain|neck pain
1234555|NCT01875562|Cervical radiculopathy|cervical radiculopathy
1234556|NCT01875562|Qishe Pill|qishe pill
1234557|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
1234558|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
1234559|NCT01875536|spasticity|spasticity
1234560|NCT01875536|physiotherapy|physiotherapy
1234561|NCT01875536|Rehabilitation|rehabilitation
1234562|NCT01875523|Renal disease|renal disease
1234563|NCT01875523|renal impairment|renal impairment
1234564|NCT01875523|End stage renal disease|end stage renal disease
1234565|NCT01875523|Healthy volunteer|healthy volunteer
1234566|NCT01875523|Pharmacokinetics|pharmacokinetics
1234567|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
1234568|NCT01875484|miR-126|mir-126
1234569|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
1234570|NCT01875484|Myocardial Infarction|myocardial infarction
1234571|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1234572|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
1234573|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
1234574|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
1234575|NCT01875458|Aclasta|aclasta
1234576|NCT01875458|Actonel|actonel
1234577|NCT01875458|alendronate|alendronate
1234578|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
1234579|NCT01875458|Aredia|aredia
1234580|NCT01875458|Atelvia|atelvia
1234581|NCT01875458|Boniva|boniva
1234582|NCT01875458|Didronel|didronel
1234583|NCT01875458|etidronate|etidronate
1234584|NCT01875458|Fosamax|fosamax
1234585|NCT01875458|Fosamax Plus D|fosamax plus d
1234586|NCT01875458|ibandronate|ibandronate
1234587|NCT01875458|pamidronate|pamidronate
1234588|NCT01875458|Reclast|reclast
1234589|NCT01875458|risedronate|risedronate
1234590|NCT01875458|Skelid|skelid
1234591|NCT01875458|tiludronate|tiludronate
1234592|NCT01875458|zoledronic acid|zoledronic acid
1234593|NCT01875458|Zometa|zometa
1234594|NCT01875458|Bisphosphonate|bisphosphonate
1234595|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
1234596|NCT01875458|Osteoporosis|osteoporosis
1234597|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
1234598|NCT01875445|Inositol|inositol
1234599|NCT01875445|Trichotillomania|trichotillomania
1234600|NCT01875445|Hair Pulling|hair pulling
1234601|NCT01875445|Impulse Control Disorder|impulse control disorder
1234602|NCT01875393|Prostatic Disease|prostatic disease
1234603|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
1234604|NCT01875393|Urogenital neoplasm|urogenital neoplasm
1234605|NCT01875393|Genital disease,male|genital disease,male
1234606|NCT01875393|Male urogenital disease|male urogenital disease
1234607|NCT01875393|Neoplasms|neoplasms
1234608|NCT01875393|Neoplasms by site|neoplasms by site
1234609|NCT01875393|Prostatic neoplasm|prostatic neoplasm
1234610|NCT01875393|Carcinoma|carcinoma
1234611|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
1234612|NCT01875380|frail and unfit patient|frail and unfit patient
1234613|NCT01875380|regorafenib|regorafenib
1234614|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
1234615|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
1234616|NCT01875367|HER2 positive|her2 positive
1234617|NCT01875367|Advanced Breast Cancer|advanced breast cancer
1234618|NCT01875341|type 2 diabetes|type 2 diabetes
1234619|NCT01875341|diabetic nephropathy|diabetic nephropathy
1234620|NCT01875341|hypertension|hypertension
1234621|NCT01875341|sleep apnea|sleep apnea
1234622|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
1234623|NCT01875328|stroke|stroke
1234624|NCT01875328|blood pressure|blood pressure
1234625|NCT01875328|telemedicine|telemedicine
1234626|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
1234627|NCT01875276|Rhinitis|rhinitis
1234628|NCT01875276|Antihistamine|antihistamine
1234629|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
1234630|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
1234631|NCT01875263|catheter related bacteremia|catheter related bacteremia
1234632|NCT01875263|susceptible|susceptible
1234633|NCT01875263|aureus meticillin|aureus meticillin
1234634|NCT01875250|Gene Transfer|gene transfer
1234635|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
1234636|NCT01875250|PSA|psa
1234637|NCT01875250|Immune Response|immune response
1234638|NCT01875250|Immunotherapy|immunotherapy
1234639|NCT01875237|Leukemia|leukemia
1234640|NCT01875237|Myeloma|myeloma
1234641|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
1234642|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
1234643|NCT01875237|MDS|mds
1234644|NCT01875237|Lymphoma|lymphoma
1234645|NCT01875237|Hodgkin disease|hodgkin disease
1234646|NCT01875237|Multiple myeloma|multiple myeloma
1234647|NCT01875237|MM|mm
1234648|NCT01875237|Transplant donor|transplant donor
1234649|NCT01875237|T-cells|t-cells
1234650|NCT01875237|G-versus-host disease|g-versus-host disease
1234651|NCT01875237|GvHD|gvhd
1234652|NCT01875237|G-CSF|g-csf
1234653|NCT01875237|Filgrastim|filgrastim
1234654|NCT01875237|Neupogen|neupogen
1234655|NCT01875237|Fludarabine|fludarabine
1234656|NCT01875237|Fludarabine phosphate|fludarabine phosphate
1234657|NCT01875237|Fludara|fludara
1234658|NCT01875237|Melphalan|melphalan
1234659|NCT01875237|Alkeran|alkeran
1234660|NCT01875237|Alemtuzumab|alemtuzumab
1234661|NCT01875237|CAMPATH-1H|campath-1h
1234662|NCT01875237|Campath|campath
1234663|NCT01875237|Tacrolimus|tacrolimus
1234664|NCT01875237|Prograf|prograf
1234665|NCT01875237|Mini-methotrexate|mini-methotrexate
1234666|NCT01875237|AP 1903|ap 1903
1596126|NCT00410059|OSI-774|osi-774
1234667|NCT01875237|Methylprednisolone|methylprednisolone
1234668|NCT01875237|Depo-Medrol|depo-medrol
1234669|NCT01875237|Medrol|medrol
1234670|NCT01875237|Solu-Medrol|solu-medrol
1234671|NCT01875237|Stem cell infusion|stem cell infusion
1234672|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
1234673|NCT01875237|DLI|dli
1234674|NCT01875237|Questionnaire|questionnaire
1234675|NCT01875237|Survey|survey
1234676|NCT01875224|kidney transplant|kidney transplant
1234677|NCT01875224|diabetes after transplant|diabetes after transplant
1234678|NCT01875224|belatacept|belatacept
1234679|NCT01875198|Splenectomy;|splenectomy;
1234680|NCT01875198|Spleen-preserving|spleen-preserving
1234681|NCT01875185|acute coronary syndrome|acute coronary syndrome
1234682|NCT01875185|clotting|clotting
1234683|NCT01875185|hormones|hormones
1234684|NCT01875185|women|women
1234685|NCT01875172|bupropion SR|bupropion sr
1234686|NCT01875172|randomized controlled trial|randomized controlled trial
1234687|NCT01875172|pregnancy|pregnancy
1234688|NCT01875159|Prematurity|prematurity
1234689|NCT01875159|Apnea of prematurity|apnea of prematurity
1234690|NCT01875159|Intermittent hypoxia|intermittent hypoxia
1234691|NCT01875133|airway disease|airway disease
1234692|NCT01875133|bronchitis|bronchitis
1234693|NCT01875133|emphysema|emphysema
1234694|NCT01875133|lung|lung
1234695|NCT01875120|Anxiety|anxiety
1234696|NCT01875120|Somatoform Disorders|somatoform disorders
1234697|NCT01875068|referrals|referrals
1234698|NCT01875068|nurse practitioners|nurse practitioners
1234699|NCT01875068|physician assistants|physician assistants
1234700|NCT01875068|consultative general internal medicine|consultative general internal medicine
1234701|NCT01875055|Cerebral|cerebral
1234702|NCT01875055|desaturation|desaturation
1234703|NCT01875029|Low back pain|low back pain
1234704|NCT01875029|chronic pain|chronic pain
1234705|NCT01875029|tDCS|tdcs
1234706|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
1234707|NCT01875016|Cryo ablation|cryo ablation
1234708|NCT01875016|Cardiomyopathy|cardiomyopathy
1234709|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
1234710|NCT01874977|fatigue|fatigue
1234711|NCT01874977|physical activity|physical activity
1234712|NCT01874964|HIV Prevention|hiv prevention
1234713|NCT01874964|Opioid-Related Disorders|opioid-related disorders
1234714|NCT01874964|Medication Assisted Treatment|medication assisted treatment
1234715|NCT01874964|Methadone|methadone
1234716|NCT01874951|Depression|depression
1234717|NCT01874951|Recurrence|recurrence
1234718|NCT01874951|Relapse|relapse
1234719|NCT01874951|Antidepressants|antidepressants
1234720|NCT01874951|Naltrexone|naltrexone
1234721|NCT01874951|Drug augmentation|drug augmentation
1234722|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
1234723|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
1234724|NCT01874886|Hippocampus|hippocampus
1234725|NCT01874886|Cannabis|cannabis
1234726|NCT01874886|Geriatrics|geriatrics
1234727|NCT01874886|Neuropsychology|neuropsychology
1234728|NCT01874886|Apolipoprotein E|apolipoprotein e
1234729|NCT01874847|melatonin|melatonin
1234730|NCT01874847|placebo|placebo
1234731|NCT01874847|post-concussion syndrome|post-concussion syndrome
1234732|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
1234733|NCT01874847|concussion|concussion
1234734|NCT01874847|treatment|treatment
1234735|NCT01874847|outcome|outcome
1234736|NCT01874847|children|children
1234737|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
1234738|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
1234739|NCT01874847|sleep|sleep
1234740|NCT01874834|ozone|ozone
1234741|NCT01874834|diesel|diesel
1234742|NCT01874834|lung function|lung function
1234743|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
1234744|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
1234745|NCT01874821|Frozen Shoulder|frozen shoulder
1234746|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
1234747|NCT01874821|ROM|rom
1234748|NCT01874821|Dynasplint|dynasplint
1234749|NCT01874808|movement preparation|movement preparation
1234750|NCT01874808|gait|gait
1234751|NCT01874808|gait initiation|gait initiation
1234752|NCT01874808|postural control|postural control
1234753|NCT01874808|neuroimaging|neuroimaging
1234754|NCT01874795|Autonomic Nervous System|autonomic nervous system
1234755|NCT01874795|Neuromodulation|neuromodulation
1234756|NCT01874795|Exercise|exercise
1234757|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
1234758|NCT01874795|Oxygen uptake|oxygen uptake
1234759|NCT01874782|spinal cord injury|spinal cord injury
1234760|NCT01874782|cardiovascular|cardiovascular
1234761|NCT01874782|orthostatic hypotension|orthostatic hypotension
1234762|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
1234763|NCT01874782|electrotherapy|electrotherapy
1234764|NCT01874769|RDEB|rdeb
1234765|NCT01874769|COL7A1|col7a1
1234766|NCT01874769|Collagen VII|collagen vii
1234767|NCT01874756|schizophrenia|schizophrenia
1234768|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
1320330|NCT01497002|AML|aml
1234769|NCT01874756|cognitive impairment|cognitive impairment
1234770|NCT01874756|negative symptoms|negative symptoms
1234771|NCT01874743|HIV,|hiv,
1234772|NCT01874743|Rosuvastatine,|rosuvastatine,
1234773|NCT01874743|Antiretroviral therapy|antiretroviral therapy
1234774|NCT01874730|colorectal surgery|colorectal surgery
1234775|NCT01874730|fluid therapy|fluid therapy
1234776|NCT01874717|Conscious sedation|conscious sedation
1234777|NCT01874717|Dental anxiety|dental anxiety
1234778|NCT01874717|Oral midazolam|oral midazolam
1234779|NCT01874717|Intravenous midazolam|intravenous midazolam
1234780|NCT01874717|Behaviour|behaviour
1234781|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
1234782|NCT01874691|acute myocardial infarction|acute myocardial infarction
1234783|NCT01874691|China|china
1234784|NCT01874691|Registry|registry
1234785|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1234786|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1234787|NCT01874665|mesenchymal tumor|mesenchymal tumor
1234788|NCT01874639|Hepatectomy|hepatectomy
1234789|NCT01874639|blood loss|blood loss
1234790|NCT01874639|hemostasis|hemostasis
1234791|NCT01874639|coagulation|coagulation
1234792|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
1234793|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
1234794|NCT01874626|acute ankle sprain|acute ankle sprain
1234795|NCT01874626|Grade I or Grade II|grade i or grade ii
1234796|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
1234797|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
1234798|NCT01874613|Bioactive glass|bioactive glass
1234799|NCT01874613|Craniotomy|craniotomy
1234800|NCT01874613|Skull bone defect|skull bone defect
1234801|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
1234802|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
1234803|NCT01874587|xerostomia|xerostomia
1234804|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
1234805|NCT01874574|Corticosteroid|corticosteroid
1234806|NCT01874574|Hyaluronic acid|hyaluronic acid
1234807|NCT01874574|Intra-articular injection|intra-articular injection
1234808|NCT01874561|Custirsen sodium|custirsen sodium
1234809|NCT01874561|TV1011|tv1011
1234810|NCT01874561|OGX-011|ogx-011
1234811|NCT01874561|Thorough QT study|thorough qt study
1234812|NCT01874561|cancer|cancer
1234813|NCT01874548|Autophagy|autophagy
1234814|NCT01874548|Cancer metabolism|cancer metabolism
1234815|NCT01874548|Cervical cancer|cervical cancer
1234816|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
1234817|NCT01874548|Human papillomavirus|human papillomavirus
1234818|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
1234819|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
1234820|NCT01874405|Iron overload|iron overload
1234821|NCT01874405|thalassaemia|thalassaemia
1234822|NCT01874405|deferasirox|deferasirox
1234823|NCT01874405|magnetic resonance|magnetic resonance
1234824|NCT01874405|endocrine function|endocrine function
1234825|NCT01874379|Joint Replacement|joint replacement
1234826|NCT01874379|Hip Replacement|hip replacement
1234827|NCT01874379|Knee Replacement|knee replacement
1235024|NCT01873430|Sunlight|sunlight
1234828|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
1234829|NCT01874353|BRCA|brca
1234830|NCT01874353|Ovarian cancer|ovarian cancer
1234831|NCT01874353|Chemotherapy|chemotherapy
1234832|NCT01874353|PARP Inhibitor|parp inhibitor
1234833|NCT01874353|Platinum sensitive|platinum sensitive
1234834|NCT01874340|Multiple Sclerosis|multiple sclerosis
1234835|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1234836|NCT01874340|AIN457|ain457
1234837|NCT01874340|Secukinumab|secukinumab
1234838|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
1234839|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1234840|NCT01874340|Autoimmune Diseases|autoimmune diseases
1234841|NCT01874340|Nervous System Diseases|nervous system diseases
1234842|NCT01874340|Immune System Diseases|immune system diseases
1234843|NCT01874340|Demyelinating Diseases|demyelinating diseases
1234844|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
1234845|NCT01874288|NHL|nhl
1234846|NCT01874288|Immunocytokine|immunocytokine
1234847|NCT01874288|Lymphoma|lymphoma
1234848|NCT01874288|Non-Hodgkin|non-hodgkin
1234849|NCT01874288|B-cell|b-cell
1234850|NCT01874288|IL (interleukin)|il (interleukin)
1234851|NCT01874249|Hepatic fibrosis|hepatic fibrosis
1234852|NCT01874249|Steatosis|steatosis
1234853|NCT01874249|Noninvasive markers.|noninvasive markers.
1234854|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
1234855|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
1234856|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
1234857|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
1234858|NCT01874197|Branched vessels|branched vessels
1235649|NCT01870492|Activase|activase
1234859|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
1234860|NCT01874145|Multiple Sclerosis|multiple sclerosis
1234861|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1234862|NCT01874145|Glatiramer Acetate|glatiramer acetate
1234863|NCT01874145|Glatiramer|glatiramer
1234864|NCT01874132|Exercise|exercise
1234865|NCT01874132|Blood pressure|blood pressure
1234866|NCT01874132|Lipids|lipids
1234867|NCT01874132|Body composition|body composition
1234868|NCT01874132|Fitness|fitness
1234869|NCT01874132|Bone density|bone density
1234870|NCT01874132|Quality of life|quality of life
1234871|NCT01874119|melanoma|melanoma
1234872|NCT01874119|renal cell carcinoma|renal cell carcinoma
1234873|NCT01874119|interleukin-2|interleukin-2
1234874|NCT01874106|Hemodialysis|hemodialysis
1234875|NCT01874106|Diet|diet
1234876|NCT01874106|Inflammation|inflammation
1234877|NCT01874106|Malnutrition|malnutrition
1234878|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
1234879|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
1234880|NCT01874054|Hodgkin Disease|hodgkin disease
1234881|NCT01874054|Hematologic Diseases|hematologic diseases
1234882|NCT01874054|Drug Therapy|drug therapy
1234883|NCT01874054|Immunotherapy|immunotherapy
1234884|NCT01874054|Antigens, CD30|antigens, cd30
1234885|NCT01874054|Lymphoma|lymphoma
1234886|NCT01874054|monomethylauristatin E|monomethylauristatin e
1234887|NCT01874041|Physical Therapy Modalities|physical therapy modalities
1234888|NCT01874041|Facial Pain|facial pain
1234889|NCT01874041|Orthodontic Appliances|orthodontic appliances
1234890|NCT01874028|Trientine|trientine
1234891|NCT01874028|Pharmacokinetics|pharmacokinetics
1234892|NCT01874015|Crohn's disease|crohn's disease
1234893|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
1234894|NCT01874015|fistula|fistula
1234895|NCT01874002|Stents|stents
1234896|NCT01874002|Stent|stent
1234897|NCT01874002|Drug eluting|drug eluting
1234898|NCT01874002|Drug eluting stent|drug eluting stent
1234899|NCT01874002|Drug eluting stents|drug eluting stents
1234900|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
1234901|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
1234902|NCT01874002|Sirolimus|sirolimus
1234903|NCT01874002|Sirolimus eluting|sirolimus eluting
1234904|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
1234905|NCT01874002|PCI|pci
1234906|NCT01874002|Registry|registry
1234907|NCT01874002|Registries|registries
1234908|NCT01874002|Multi center|multi center
1234909|NCT01874002|Multi centre|multi centre
1234910|NCT01873989|Chronic pain|chronic pain
1234911|NCT01873989|Opioid addiction|opioid addiction
1234912|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
1234913|NCT01873989|Testosterone replacement|testosterone replacement
1234914|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
1234915|NCT01873989|Methadone|methadone
1234916|NCT01873989|Buprenorphine|buprenorphine
1234917|NCT01873937|Lasertherapy|lasertherapy
1234918|NCT01873937|Ledtherapy|ledtherapy
1234919|NCT01873937|TMJs|tmjs
1234920|NCT01873937|pain relief|pain relief
1234921|NCT01873937|oral aperture|oral aperture
1234922|NCT01873924|Batten disease|batten disease
1234923|NCT01873924|NCL|ncl
1235908|NCT01869218|Malignancy|malignancy
1234924|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
1234925|NCT01873911|MPS IIIA|mps iiia
1234926|NCT01873911|MPS IIIB|mps iiib
1234927|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
1234928|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
1234929|NCT01873911|Hurler syndrome|hurler syndrome
1234930|NCT01873911|cognitive decline|cognitive decline
1234932|NCT01873898|femoral artery|femoral artery
1234933|NCT01873898|access site|access site
1234934|NCT01873898|hemostasis|hemostasis
1234935|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
1234936|NCT01873859|Lactic acidosis|lactic acidosis
1234937|NCT01873859|Contrast media|contrast media
1234938|NCT01873859|Angiography|angiography
1234939|NCT01873859|Diabetic|diabetic
1234940|NCT01873859|Metformin|metformin
1234941|NCT01873820|Vitamin C|vitamin c
1234942|NCT01873820|calcium ascorbate|calcium ascorbate
1234943|NCT01873820|ascorbic acid|ascorbic acid
1234944|NCT01873807|Idarubicin|idarubicin
1234945|NCT01873807|Etoposide|etoposide
1234946|NCT01873807|HSCT|hsct
1234947|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1234948|NCT01873794|Fatigue|fatigue
1234949|NCT01873794|Sleep|sleep
1234950|NCT01873794|Quality of life|quality of life
1234951|NCT01873794|Cancer|cancer
1234952|NCT01873794|Light|light
1234953|NCT01873768|Tranexamic acid|tranexamic acid
1234954|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
1234955|NCT01873768|Arthroplasty|arthroplasty
1234956|NCT01873768|Osteoarthritis|osteoarthritis
1234957|NCT01873768|Arthritis|arthritis
1234958|NCT01873768|Joint Diseases|joint diseases
1596319|NCT00409214|GBM|gbm
1234959|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
1234960|NCT01873768|Rheumatic Diseases|rheumatic diseases
1234961|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
1234962|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
1234963|NCT01873768|Pharmacologic Actions|pharmacologic actions
1234964|NCT01873768|Coagulants|coagulants
1234965|NCT01873768|Therapeutic Uses|therapeutic uses
1234966|NCT01873755|asthma|asthma
1234967|NCT01873755|children|children
1234968|NCT01873755|physical activity|physical activity
1234969|NCT01873755|school|school
1234970|NCT01873742|Psychotherapy feedback|psychotherapy feedback
1234971|NCT01873729|ADHD|adhd
1234972|NCT01873729|Naltrexone|naltrexone
1234973|NCT01873729|Adults|adults
1234974|NCT01873716|Atherosclerosis|atherosclerosis
1234975|NCT01873716|Molecular Imaging|molecular imaging
1234976|NCT01873716|Vascular Biology|vascular biology
1234977|NCT01873716|Inflammation|inflammation
1234978|NCT01873716|Fluorescence|fluorescence
1234980|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
1234981|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
1234982|NCT01873703|Untreated|untreated
1234983|NCT01873690|Antibiotics|antibiotics
1234984|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
1234985|NCT01873690|Urinary Tract Infection|urinary tract infection
1234986|NCT01873664|fMRI|fmri
1234987|NCT01873664|Jaw tapping|jaw tapping
1234988|NCT01873664|Memory disorder|memory disorder
1234989|NCT01873664|Mild cognitive impairment|mild cognitive impairment
1234990|NCT01873664|MCI|mci
1234991|NCT01873664|Working memory|working memory
1234992|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
1234993|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
1234994|NCT01873625|osteoarthritis|osteoarthritis
1234995|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
1234996|NCT01873612|Dexmedetomidine|dexmedetomidine
1234997|NCT01873612|Propofol|propofol
1234998|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
1234999|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
1235000|NCT01873573|radiation-induced stricture|radiation-induced stricture
1235001|NCT01873573|anastomotic stricture|anastomotic stricture
1235002|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
1235003|NCT01873573|dilation|dilation
1235004|NCT01873573|steroid injection|steroid injection
1235005|NCT01873573|triamcinolone|triamcinolone
1235006|NCT01873573|difficulty swallowing|difficulty swallowing
1235007|NCT01873560|fractional flow reserve|fractional flow reserve
1235008|NCT01873560|drug eluting stent|drug eluting stent
1235009|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
1235010|NCT01873547|spinal cord injury|spinal cord injury
1235011|NCT01873547|cell transplantation|cell transplantation
1235012|NCT01873547|rehabilitation|rehabilitation
1235013|NCT01873534|Anemia|anemia
1235014|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
1235015|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1235016|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
1235017|NCT01873521|Pediatric patient|pediatric patient
1235018|NCT01873521|Infant|infant
1235019|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
1235020|NCT01873469|radiotherapy|radiotherapy
1235021|NCT01873430|Melatonin|melatonin
1235022|NCT01873430|Sunburn|sunburn
1235023|NCT01873430|Erythema|erythema
1235025|NCT01873430|Ultraviolet rays|ultraviolet rays
1235026|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
1235027|NCT01873391|Pain|pain
1235028|NCT01873391|VAS|vas
1235029|NCT01873391|Multivariate analysis|multivariate analysis
1235030|NCT01873391|Normal saline|normal saline
1235031|NCT01873391|Carbon dioxide|carbon dioxide
1235032|NCT01873378|Uterine myoma|uterine myoma
1235033|NCT01873378|GnRHa|gnrha
1235034|NCT01873378|Hysteroscopy|hysteroscopy
1235035|NCT01873378|Cold loop|cold loop
1235036|NCT01873365|Quality of life|quality of life
1235037|NCT01873365|Herpes zoster|herpes zoster
1235038|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
1235039|NCT01873365|Japan|japan
1235040|NCT01873365|Physician-practice|physician-practice
1235041|NCT01873365|Adults|adults
1235042|NCT01873365|Health economics|health economics
1235043|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
1235044|NCT01873326|newly diagnosed GCT|newly diagnosed gct
1235045|NCT01873326|Intermediate|intermediate
1235046|NCT01873326|Poor-Risk|poor-risk
1235047|NCT01873326|BLEOMYCIN|bleomycin
1235048|NCT01873326|CISPLATIN|cisplatin
1235049|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
1235050|NCT01873326|IFOSFAMIDE|ifosfamide
1235051|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1235052|NCT01873326|13-074|13-074
1235053|NCT01873300|Achalasia|achalasia
1235054|NCT01873300|Dysphagia|dysphagia
1235055|NCT01873300|Endoscopic|endoscopic
1235056|NCT01873300|Myotomy|myotomy
1235057|NCT01873300|Heller|heller
1235058|NCT01873300|NOTES|notes
1235059|NCT01873300|POEM|poem
1235060|NCT01873287|Concussions|concussions
1235061|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
1235062|NCT01873287|PCS|pcs
1235063|NCT01873287|Clinical Prediction Rule|clinical prediction rule
1235064|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1235065|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
1235066|NCT01873261|non-invasive ventilation|non-invasive ventilation
1235067|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
1235068|NCT01873222|Coronary Artery Disease|coronary artery disease
1235069|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
1235070|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
1235071|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
1235072|NCT01873183|echocardiography|echocardiography
1235073|NCT01873183|morbid obesity|morbid obesity
1235074|NCT01873183|bariatric surgery|bariatric surgery
1235075|NCT01873183|venous return|venous return
1235076|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
1235077|NCT01873170|immune cells|immune cells
1235078|NCT01873170|contraception|contraception
1235079|NCT01873170|intrauterine device|intrauterine device
1235080|NCT01873170|IUD|iud
1235081|NCT01873170|copper|copper
1235082|NCT01873170|microflora|microflora
1235083|NCT01873170|DMPA|dmpa
1235084|NCT01873170|etonogestrel|etonogestrel
1235085|NCT01873170|subdermal implant|subdermal implant
1235086|NCT01873157|Kidney transplantation|kidney transplantation
1235087|NCT01873157|Antibody formation|antibody formation
1235088|NCT01873157|Graft rejection|graft rejection
1235089|NCT01873157|Proteasome inhibitors|proteasome inhibitors
1235090|NCT01873157|Randomized controlled trial|randomized controlled trial
1235091|NCT01873144|Bronchiolitis|bronchiolitis
1235092|NCT01873144|Hypertonic saline solution|hypertonic saline solution
1235093|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
1235094|NCT01873144|Respiratory distress|respiratory distress
1235095|NCT01873144|Comfort|comfort
1235096|NCT01873131|hemangioma|hemangioma
1235097|NCT01873131|infantile hemangioma|infantile hemangioma
1235098|NCT01873131|pulsed dye laser|pulsed dye laser
1235099|NCT01873131|PDL|pdl
1235100|NCT01873131|topical beta blocker|topical beta blocker
1235101|NCT01873131|timolol maleate|timolol maleate
1235102|NCT01873131|timolol|timolol
1235103|NCT01873118|hospital discharge|hospital discharge
1235104|NCT01873118|discharge readiness|discharge readiness
1235105|NCT01873118|readmission|readmission
1235106|NCT01873118|Emergency Department visits|emergency department visits
1235107|NCT01873118|Nurse assessment|nurse assessment
1235108|NCT01873092|Oximetry|oximetry
1235109|NCT01873092|Physical Activity|physical activity
1235110|NCT01873079|ERCP|ercp
1235111|NCT01873079|sphincterotomy|sphincterotomy
1235112|NCT01873079|proton pump inhibitor|proton pump inhibitor
1235113|NCT01873066|Type 1 diabetes|type 1 diabetes
1235114|NCT01873066|Closed-loop glucose control|closed-loop glucose control
1235115|NCT01873066|Artificial Pancreas|artificial pancreas
1235116|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1235117|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
1235118|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
1235119|NCT01873053|WIN-34B|win-34b
1235120|NCT01873040|Social Media|social media
1235121|NCT01873040|Vaccine|vaccine
1235122|NCT01873040|Immunization|immunization
1235123|NCT01873027|Coronary Artery Disease|coronary artery disease
1235909|NCT01869218|Tissue|tissue
1235124|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
1235125|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
1235126|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
1235127|NCT01873001|Healthy volunteers|healthy volunteers
1235128|NCT01873001|Drug-drug Interaction|drug-drug interaction
1235129|NCT01873001|Pharmacokinetics|pharmacokinetics
1235130|NCT01873001|Abiraterone|abiraterone
1235131|NCT01873001|JNJ-589485|jnj-589485
1235132|NCT01873001|Abiraterone acetate|abiraterone acetate
1235133|NCT01873001|JNJ-212082|jnj-212082
1235134|NCT01873001|Pioglitazone HCl|pioglitazone hcl
1235135|NCT01872988|antiviral therapy|antiviral therapy
1235136|NCT01872988|intermediate stage|intermediate stage
1235137|NCT01872988|hepatitis B virus|hepatitis b virus
1235138|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1235139|NCT01872962|Induction chemotherapy|induction chemotherapy
1235140|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1235141|NCT01872962|Clinical trial|clinical trial
1235142|NCT01872949|Heart Failure|heart failure
1235143|NCT01872949|NYHA Class III|nyha class iii
1235144|NCT01872949|NYHA Class IV|nyha class iv
1235145|NCT01872923|Amphinex|amphinex
1235146|NCT01872923|PCI|pci
1235147|NCT01872923|Bleomycin|bleomycin
1235148|NCT01872923|Cutaneous malignancies|cutaneous malignancies
1235149|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
1235150|NCT01872923|Safety|safety
1235151|NCT01872923|Phase I|phase i
1235152|NCT01872923|Photochemical Internalisation|photochemical internalisation
1235153|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
1235154|NCT01872923|Head and Neck cancer|head and neck cancer
1235155|NCT01872923|Breast Cancer|breast cancer
1235156|NCT01872923|HNSCC|hnscc
1235157|NCT01872923|SCCHN|scchn
1235158|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
1235159|NCT01872923|Dose finding|dose finding
1235160|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
1235161|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1235162|NCT01872897|GERD|gerd
1235163|NCT01872897|Acid reflux|acid reflux
1235164|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
1235165|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
1235166|NCT01872884|Stroke|stroke
1235167|NCT01872884|Ischemic stroke|ischemic stroke
1235168|NCT01872884|Acute stroke|acute stroke
1235169|NCT01872884|Embolectomy|embolectomy
1235170|NCT01872884|Endovascular therapy|endovascular therapy
1235171|NCT01872884|Intra-arterial therapy|intra-arterial therapy
1235172|NCT01872884|Sedation|sedation
1235173|NCT01872884|Anesthesia|anesthesia
1235174|NCT01872845|Statin|statin
1235175|NCT01872845|CIMT|cimt
1235176|NCT01872845|BES|bes
1235177|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
1235178|NCT01872793|nutritional assessment|nutritional assessment
1235179|NCT01872793|nutritional status|nutritional status
1235180|NCT01872793|mortality|mortality
1235181|NCT01872793|complications|complications
1235182|NCT01872780|CYP2C8|cyp2c8
1235183|NCT01872780|genetic polymorphism|genetic polymorphism
1235184|NCT01872780|rosiglitazone|rosiglitazone
1235185|NCT01872780|Korean|korean
1235186|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
1235187|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
1235188|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
1235189|NCT01872754|Remifentanil|remifentanil
1235190|NCT01872754|Propofol|propofol
1235191|NCT01872754|Sedation|sedation
1235192|NCT01872754|Target Controlled Infusion|target controlled infusion
1235193|NCT01872741|craniotomy,|craniotomy,
1235194|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
1235195|NCT01872741|atrophy,|atrophy,
1235196|NCT01872741|temporal muscle,|temporal muscle,
1235197|NCT01872741|outcome|outcome
1235198|NCT01872728|facial block|facial block
1235199|NCT01872728|levobupivacaine|levobupivacaine
1235200|NCT01872728|regional anesthesia|regional anesthesia
1235201|NCT01872728|rhinoplasty|rhinoplasty
1235202|NCT01872728|outpatient|outpatient
1235203|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
1235204|NCT01872715|Oracea|oracea
1235205|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
1235206|NCT01872702|Malaria elimination|malaria elimination
1235207|NCT01872702|Chemotherapy|chemotherapy
1235208|NCT01872702|Epidemiology|epidemiology
1235209|NCT01872702|South East Asia|south east asia
1235210|NCT01872702|Artemisinin resistance|artemisinin resistance
1235211|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
1235212|NCT01872702|Primaquine|primaquine
1235213|NCT01872676|Thermography|thermography
1235214|NCT01872676|Skin Temperature|skin temperature
1235215|NCT01872676|Manipulation, Spinal|manipulation, spinal
1235216|NCT01872676|Physical Therapy Modalities|physical therapy modalities
1235217|NCT01872663|Morbid obesity|morbid obesity
1235218|NCT01872663|Bariatric surgery|bariatric surgery
1235219|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
1235220|NCT01872663|Spirometry|spirometry
1235221|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
1235222|NCT01872663|Physical therapy speciality|physical therapy speciality
1235223|NCT01872650|postoperative adhesions|postoperative adhesions
1235224|NCT01872650|adhesion prevention|adhesion prevention
1235225|NCT01872650|colorectal surgery|colorectal surgery
1235226|NCT01872650|temporary ostomy|temporary ostomy
1235227|NCT01872611|Diabetes Type I|diabetes type i
1235228|NCT01872611|Diabetes Type II|diabetes type ii
1235229|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
1235230|NCT01872611|Macular edema|macular edema
1235231|NCT01872611|Cataract|cataract
1235232|NCT01872598|Alzheimer|alzheimer
1235233|NCT01872598|dementia|dementia
1235234|NCT01872598|cognitive disease|cognitive disease
1235235|NCT01872598|memory loss|memory loss
1235236|NCT01872598|cerebrovascular disease|cerebrovascular disease
1235237|NCT01872585|Parenting|parenting
1235238|NCT01872585|Mental Illness|mental illness
1235239|NCT01872585|Maternal sensitivity|maternal sensitivity
1235240|NCT01872585|Parent-child relationship|parent-child relationship
1235242|NCT01872533|hypoxia|hypoxia
1235243|NCT01872533|insulin sensitivity|insulin sensitivity
1235244|NCT01872533|altitude|altitude
1235245|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
1235246|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
1235247|NCT01872520|Safety|safety
1235248|NCT01872520|Real World Study|real world study
1235249|NCT01872507|cerebral palsy|cerebral palsy
1596320|NCT00409214|AA|aa
1235250|NCT01872507|autonomic nerveus system|autonomic nerveus system
1235251|NCT01872507|heart rate variability|heart rate variability
1235252|NCT01872494|Local analgesia system|local analgesia system
1235253|NCT01872494|Ropivacaine|ropivacaine
1235254|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
1235255|NCT01872494|Postoperative|postoperative
1235256|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
1235257|NCT01872481|Neuropathic pain|neuropathic pain
1235258|NCT01872481|Antipersonnel landmines|antipersonnel landmines
1235259|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1235260|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
1235261|NCT01872468|Primary Health Care.|primary health care.
1235262|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
1235263|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
1235264|NCT01872429|calcium|calcium
1235265|NCT01872429|phosphorus|phosphorus
1235266|NCT01872429|parathyroid hormone|parathyroid hormone
1235267|NCT01872429|hyperparathyroidism|hyperparathyroidism
1235268|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
1235269|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
1235270|NCT01872416|ifosfamide|ifosfamide
1235271|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
1235272|NCT01872390|Lesotho|lesotho
1235274|NCT01872390|tuberculosis|tuberculosis
1235275|NCT01872390|HIV|hiv
1235276|NCT01872390|antiretroviral therapy|antiretroviral therapy
1235277|NCT01872390|ART|art
1235278|NCT01872390|adherence|adherence
1235279|NCT01872390|combination intervention package|combination intervention package
1235280|NCT01872390|retention|retention
1235281|NCT01872377|pancreas|pancreas
1235282|NCT01872377|pancreatic|pancreatic
1235283|NCT01872377|unresectable|unresectable
1235284|NCT01872377|CyberKnife|cyberknife
1235285|NCT01872377|SBRT|sbrt
1235286|NCT01872364|Hernia repair|hernia repair
1235287|NCT01872364|Hydrocelectomy|hydrocelectomy
1235288|NCT01872364|Global Health|global health
1235289|NCT01872364|Global Disease Burden|global disease burden
1235290|NCT01872364|Surgical Mission|surgical mission
1235291|NCT01872364|Dominican Republic|dominican republic
1235292|NCT01872364|Cost-minimization|cost-minimization
1235293|NCT01872364|Procedural cost|procedural cost
1235294|NCT01872364|Material cost|material cost
1235295|NCT01872364|Item utilization|item utilization
1235296|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
1235297|NCT01872364|Minor procedure|minor procedure
1235298|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
1235299|NCT01872351|mitochondrial disorder|mitochondrial disorder
1235300|NCT01872351|conditioning exercise|conditioning exercise
1235301|NCT01872351|nutraceutical supplements|nutraceutical supplements
1235302|NCT01872351|high protein diet|high protein diet
1235303|NCT01872338|suicide prevention|suicide prevention
1235304|NCT01872338|minfulness-based cognitive therapy|minfulness-based cognitive therapy
1235305|NCT01872338|mindfulness meditation|mindfulness meditation
1235306|NCT01872338|Veterans|veterans
1235307|NCT01872338|safety planning|safety planning
1235308|NCT01872325|cardiac arrest|cardiac arrest
1235309|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
1235310|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
1235311|NCT01872325|agonal breathing|agonal breathing
1235312|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
1235313|NCT01872286|Capsule Endoscopy|capsule endoscopy
1235314|NCT01872273|Metabolic Syndrome|metabolic syndrome
1235315|NCT01872273|Obese|obese
1235316|NCT01872273|Overweight|overweight
1235317|NCT01872273|Hypertension|hypertension
1235318|NCT01872273|Hyperlipidemia|hyperlipidemia
1235319|NCT01872273|Glucose Intolerant|glucose intolerant
1235320|NCT01872273|High blood sugar|high blood sugar
1235321|NCT01872273|Exercise in obesity|exercise in obesity
1235322|NCT01872273|Platelets|platelets
1235323|NCT01872260|Hormone-receptor positive|hormone-receptor positive
1235324|NCT01872234|Heart Failure|heart failure
1235325|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1235326|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
1235327|NCT01872234|Left Bundle Branch Block|left bundle branch block
1235328|NCT01872221|Glioblastoma|glioblastoma
1235329|NCT01872221|Spectroscopy|spectroscopy
1235330|NCT01872221|MRI|mri
1235331|NCT01872221|Glioma stem cells|glioma stem cells
1235332|NCT01872221|Surgery|surgery
1235333|NCT01872221|Radioresistance|radioresistance
1235334|NCT01872208|PAD|pad
1235335|NCT01872208|Atherosclerosis|atherosclerosis
1235336|NCT01872208|Peripheral circulation|peripheral circulation
1235337|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
1235338|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
1235339|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
1235340|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
1235341|NCT01872195|Checklist|checklist
1235342|NCT01872195|In-Hospital Mortality|in-hospital mortality
1235343|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
1235344|NCT01872156|Smoking|smoking
1235345|NCT01872156|Primary care|primary care
1235346|NCT01872130|Moh's Surgery|moh's surgery
1235347|NCT01872130|mosaicing algorithm|mosaicing algorithm
1235348|NCT01872130|intraoperative imaging|intraoperative imaging
1235349|NCT01872130|12-239|12-239
1235350|NCT01872104|rectal cancer|rectal cancer
1235351|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
1235352|NCT01872104|photodynamic therapy|photodynamic therapy
1235353|NCT01872104|chemothrapy|chemothrapy
1235750|NCT01870024|convulsions|convulsions
1235354|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
1235355|NCT01872039|Nicardipine|nicardipine
1235356|NCT01872039|Hypertension|hypertension
1235357|NCT01872039|Calcium blocker|calcium blocker
1235358|NCT01872026|Plasma concentration|plasma concentration
1235359|NCT01872026|Pharmacokinetics|pharmacokinetics
1235360|NCT01872026|Pharmacodynamics|pharmacodynamics
1235361|NCT01872026|ASP7991|asp7991
1235362|NCT01872013|Plasma concentration|plasma concentration
1235363|NCT01872013|Urinary concentration|urinary concentration
1235364|NCT01872013|ASP7991|asp7991
1235365|NCT01872000|Intraocular lens|intraocular lens
1235366|NCT01872000|Phacoemulsification|phacoemulsification
1235367|NCT01871987|FK949E|fk949e
1235368|NCT01871987|Quetiapine|quetiapine
1235369|NCT01871987|Antipsychotic|antipsychotic
1235370|NCT01871974|FK949E|fk949e
1235371|NCT01871974|Antipsychotic|antipsychotic
1235372|NCT01871974|Quetiapine|quetiapine
1235373|NCT01871909|Physical trauma|physical trauma
1235374|NCT01871896|Surgical Endoscopy|surgical endoscopy
1235375|NCT01871896|Morbid Obesity|morbid obesity
1235376|NCT01871896|Weight Loss|weight loss
1235377|NCT01871896|Bariatrics|bariatrics
1235378|NCT01871896|Surgical Revision|surgical revision
1235379|NCT01871883|Sensitive skin|sensitive skin
1235380|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
1235381|NCT01871883|TRPV1|trpv1
1235382|NCT01871883|Transepidermal water loss|transepidermal water loss
1235383|NCT01871883|Skin Phototype|skin phototype
1235384|NCT01871883|Lactic acid test|lactic acid test
1235385|NCT01871883|Skin irritancy tests|skin irritancy tests
1235386|NCT01871818|Multiple sclerosis|multiple sclerosis
1235387|NCT01871818|Rehabilitation|rehabilitation
1235388|NCT01871818|Chronic evolutive disease|chronic evolutive disease
1235389|NCT01871818|Physiotherapy|physiotherapy
1235390|NCT01871818|Resistance training|resistance training
1235391|NCT01871818|Endurance training|endurance training
1235392|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
1235393|NCT01871792|Prevention|prevention
1235394|NCT01871792|Statin|statin
1235395|NCT01871792|Pitavastatin|pitavastatin
1235396|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
1235397|NCT01871766|Radiation therapy|radiation therapy
1235398|NCT01871766|Proton beam|proton beam
1235399|NCT01871740|Folic acid|folic acid
1235400|NCT01871740|Renal function decline|renal function decline
1235401|NCT01871740|Hypertension|hypertension
1235402|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
1235403|NCT01871740|Chronic kidney disease|chronic kidney disease
1235404|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
1235405|NCT01871740|Randomized controlled trial|randomized controlled trial
1235406|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
1235407|NCT01871727|E7777|e7777
1235408|NCT01871714|XLHED|xlhed
1235409|NCT01871714|HED|hed
1235410|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1235411|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
1235412|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
1235413|NCT01871701|Psychotropic drugs|psychotropic drugs
1235414|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
1235415|NCT01871688|neuromodulation|neuromodulation
1235416|NCT01871688|rehabilitation|rehabilitation
1235417|NCT01871675|Lymphoma|lymphoma
1235418|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1235419|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1235420|NCT01871675|T-cell Lymphoma|t-cell lymphoma
1235422|NCT01871675|Bendamustine|bendamustine
1235423|NCT01871675|Hematologic Malignancy|hematologic malignancy
1235424|NCT01871675|Relapsed|relapsed
1235425|NCT01871675|Refractory|refractory
1235426|NCT01871662|HCV|hcv
1235427|NCT01871662|Hepatitis C|hepatitis c
1235428|NCT01871649|psoriatic arthritis|psoriatic arthritis
1235429|NCT01871649|golimumab|golimumab
1235430|NCT01871649|methotrexate|methotrexate
1235431|NCT01871649|minimal disease activity|minimal disease activity
1235432|NCT01871649|safety|safety
1235433|NCT01871649|withdrawal|withdrawal
1235434|NCT01871636|endoscopy|endoscopy
1235435|NCT01871636|WESD|wesd
1235436|NCT01871636|EMR|emr
1235437|NCT01871623|Cleft lip and palate|cleft lip and palate
1235438|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
1235439|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
1235440|NCT01871623|Segmental Osteotomy|segmental osteotomy
1235441|NCT01871623|Stability|stability
1235442|NCT01871610|Traumatic brain injury|traumatic brain injury
1235443|NCT01871610|mild TBI|mild tbi
1235444|NCT01871610|Alzheimer's disease|alzheimer's disease
1235445|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
1235446|NCT01871597|Lung cancer|lung cancer
1235447|NCT01871597|VATS procedure|vats procedure
1235448|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
1235449|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
1235450|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
1235451|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
1235452|NCT01871558|type 2 diabetes|type 2 diabetes
1235453|NCT01871558|basal insulin|basal insulin
1235454|NCT01871558|vildagliptin|vildagliptin
1235455|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
1235456|NCT01871545|HCC|hcc
1235457|NCT01871545|liver cancer|liver cancer
1235458|NCT01871545|liver disease|liver disease
1235459|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
1235460|NCT01871545|MRI|mri
1235461|NCT01871532|Monofollicular Development|monofollicular development
1235462|NCT01871532|Gonal-f®|gonal-f®
1235463|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
1235464|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
1235465|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
1235466|NCT01871480|NSCLC|nsclc
1235467|NCT01871480|CIK|cik
1235468|NCT01871480|Gefitinib|gefitinib
1235469|NCT01871480|Adenocarcinoma|adenocarcinoma
1235470|NCT01871402|psoriasis|psoriasis
1235471|NCT01871402|lotion|lotion
1235472|NCT01871402|investigator's global assessment|investigator's global assessment
1235473|NCT01871376|PCV|pcv
1235474|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
1235475|NCT01871363|Bevacizumab|bevacizumab
1235476|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
1235477|NCT01871350|Cancer|cancer
1235478|NCT01871350|Chemotherapy|chemotherapy
1235479|NCT01871350|Chemo related toxicity|chemo related toxicity
1235480|NCT01871350|Protein digestion|protein digestion
1235481|NCT01871350|Fat digestion|fat digestion
1235482|NCT01871350|Gut function|gut function
1235483|NCT01871350|Glucose absorption|glucose absorption
1235484|NCT01871350|Muscle function|muscle function
1235485|NCT01871337|Multiple Sclerosis|multiple sclerosis
1235486|NCT01871337|urinary incontinence|urinary incontinence
1235487|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
1235488|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
1235489|NCT01871311|cetuximab|cetuximab
1235490|NCT01871311|nilotinib|nilotinib
1235491|NCT01871298|internet and mobile technology use|internet and mobile technology use
1235492|NCT01871298|history of drug use|history of drug use
1235493|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
1235494|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
1235495|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
1235496|NCT01871233|anti-epileptic drug|anti-epileptic drug
1235497|NCT01871233|Extended Access Program|extended access program
1235498|NCT01871233|partial onset seizures|partial onset seizures
1235499|NCT01871233|Perampanel|perampanel
1235500|NCT01871220|Implant Abutments|implant abutments
1235501|NCT01871220|Oral Mucosa Changes|oral mucosa changes
1235502|NCT01871220|Implant Esthetics|implant esthetics
1235503|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
1235504|NCT01871207|Diabetes|diabetes
1235505|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
1235506|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
1235507|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
1235508|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
1235509|NCT01871142|AES103|aes103
1235510|NCT01871142|Exercise|exercise
1235511|NCT01871129|Dexmedetomidine|dexmedetomidine
1235512|NCT01871129|Postoperative Period|postoperative period
1235513|NCT01871129|Airway extubation|airway extubation
1235514|NCT01871129|Systolic Pressure|systolic pressure
1235515|NCT01871116|breast cancer|breast cancer
1235516|NCT01871116|early stage|early stage
1235517|NCT01871116|weight loss|weight loss
1235518|NCT01871103|Soft tissue defect|soft tissue defect
1235519|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
1235520|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
1235521|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
1235522|NCT01871090|Remote Monitoring|remote monitoring
1235523|NCT01871090|Remote Care|remote care
1235524|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1235525|NCT01871090|Pacemaker|pacemaker
1235526|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1235527|NCT01871064|Laparotomy|laparotomy
1235528|NCT01871064|laparoscopic surgery|laparoscopic surgery
1235529|NCT01871064|general anesthesia|general anesthesia
1235530|NCT01871064|Neuromuscular Block|neuromuscular block
1235531|NCT01871038|vaccine effectiveness|vaccine effectiveness
1235532|NCT01871038|rotavirus|rotavirus
1235533|NCT01871038|acute gastroenteritis|acute gastroenteritis
1235534|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1235535|NCT01871012|Nerve Block|nerve block
1235536|NCT01871012|Intraoperative Care|intraoperative care
1235537|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
1235538|NCT01871012|Stress and Inflammation|stress and inflammation
1235539|NCT01870986|Healthy Volunteers|healthy volunteers
1235540|NCT01870986|Phase 1|phase 1
1235541|NCT01870986|PK|pk
1235542|NCT01870986|adalimumab|adalimumab
1235543|NCT01870986|Single-dose|single-dose
1235544|NCT01870986|Immunology|immunology
1235545|NCT01870986|Bioequivalence|bioequivalence
1235546|NCT01870986|Biosimilarity|biosimilarity
1235547|NCT01870986|Similarity.|similarity.
1235548|NCT01870973|postoperative pain|postoperative pain
1235549|NCT01870973|root canal treatment|root canal treatment
1235550|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
1235551|NCT01870947|Obesity|obesity
1235552|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
1235553|NCT01870947|Diet|diet
1235554|NCT01870947|Cancer|cancer
1235555|NCT01870934|Telemedicine|telemedicine
1235556|NCT01870934|Diabetes|diabetes
1235557|NCT01870934|Foot Ulcers|foot ulcers
1235558|NCT01870895|YM060|ym060
1235559|NCT01870895|Ramosetron|ramosetron
1235560|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
1235561|NCT01870882|Opioid-Related Disorders|opioid-related disorders
1235562|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
1235563|NCT01870882|Substance-Related Disorders|substance-related disorders
1235564|NCT01870882|Mental Disorders|mental disorders
1235565|NCT01870882|Cocaine|cocaine
1235566|NCT01870882|Methadone|methadone
1235567|NCT01870882|Therapeutic Uses|therapeutic uses
1235568|NCT01870856|Ocular discomfort|ocular discomfort
1235569|NCT01870856|Contact lenses|contact lenses
1235570|NCT01870856|Myopia|myopia
1235571|NCT01870843|Depressive Disorder, Major|depressive disorder, major
1235572|NCT01870843|Depressive Disorder|depressive disorder
1235573|NCT01870843|Depression|depression
1235574|NCT01870843|Anxiety|anxiety
1235575|NCT01870843|Escitalopram|escitalopram
1235576|NCT01870843|Quality of life|quality of life
1235577|NCT01870843|Social functionality|social functionality
1235578|NCT01870817|Randomized|randomized
1235579|NCT01870817|Jejunostomy|jejunostomy
1235580|NCT01870817|Enteral|enteral
1235581|NCT01870817|Nutrition|nutrition
1235582|NCT01870817|Esophagectomy|esophagectomy
1235583|NCT01870817|Gastrectomy|gastrectomy
1235584|NCT01870804|Statins|statins
1235585|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
1235586|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
1235587|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
1235588|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
1235589|NCT01870778|acute heart failure,|acute heart failure,
1235590|NCT01870778|AHF,|ahf,
1235591|NCT01870778|multi-center,|multi-center,
1235592|NCT01870778|randomized,|randomized,
1235593|NCT01870778|double-blind|double-blind
1235594|NCT01870739|LCZ696,|lcz696,
1235595|NCT01870739|Hypertension,|hypertension,
1235596|NCT01870739|Aortic stiffness,|aortic stiffness,
1235597|NCT01870739|Central blood pressure,|central blood pressure,
1235598|NCT01870739|Cardiovascular MRI|cardiovascular mri
1235599|NCT01870726|Glioblastoma multiforme (GBM), glioblastoma, Grade IV Astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma|glioblastoma multiforme (gbm), glioblastoma, grade iv astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma
1235600|NCT01870713|gastric bypass surgery|gastric bypass surgery
1235601|NCT01870713|proteomics|proteomics
1235602|NCT01870687|vitex agnus castus|vitex agnus castus
1235603|NCT01870687|clinical trial|clinical trial
1235604|NCT01870687|cyclic mastodynia|cyclic mastodynia
1235605|NCT01870687|PMS|pms
1235606|NCT01870687|prospective|prospective
1235607|NCT01870674|safety|safety
1235608|NCT01870674|tolerability|tolerability
1235609|NCT01870674|pharmacokinetics|pharmacokinetics
1235610|NCT01870674|pharmacodynamics|pharmacodynamics
1235611|NCT01870661|Intravenous placement|intravenous placement
1235612|NCT01870661|Ultrasound|ultrasound
1235613|NCT01870648|Low-middle income country|low-middle income country
1235614|NCT01870648|Dehydration|dehydration
1235615|NCT01870648|Intravenous Rehydration|intravenous rehydration
1235616|NCT01870648|Pakistan|pakistan
1235617|NCT01870635|Low-middle income country|low-middle income country
1235618|NCT01870635|Dehydration|dehydration
1235619|NCT01870635|Intravenous Rehydration|intravenous rehydration
1235620|NCT01870635|Pakistan|pakistan
1235621|NCT01870622|Newborn,|newborn,
1235622|NCT01870622|Infant,|infant,
1235623|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
1235624|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
1235625|NCT01870622|Flow waves|flow waves
1235626|NCT01870583|Cesarean delivery|cesarean delivery
1235627|NCT01870583|Surgical site infection|surgical site infection
1235628|NCT01870583|Pregnancy|pregnancy
1235629|NCT01870583|Postpartum|postpartum
1235630|NCT01870570|Glycaemia|glycaemia
1235631|NCT01870570|Insulinemia|insulinemia
1235632|NCT01870557|Diabetes Mellitus|diabetes mellitus
1235633|NCT01870557|Bone|bone
1235634|NCT01870557|Bone Status|bone status
1235635|NCT01870557|Glycemic Markers|glycemic markers
1235636|NCT01870557|Osteoporosis|osteoporosis
1235637|NCT01870557|Osteopenia|osteopenia
1235638|NCT01870544|gastric bypass|gastric bypass
1235639|NCT01870544|microbiota|microbiota
1235640|NCT01870544|probiotic|probiotic
1235641|NCT01870531|Transient Ischemic Attack|transient ischemic attack
1235642|NCT01870518|Parkinson's disease|parkinson's disease
1235643|NCT01870518|Dementia|dementia
1235644|NCT01870505|BYL719|byl719
1235645|NCT01870505|Letrozole|letrozole
1235646|NCT01870505|Exemestane|exemestane
1235647|NCT01870505|13-027|13-027
1235648|NCT01870492|IV-tPA|iv-tpa
1235650|NCT01870492|endovascular therapy|endovascular therapy
1235651|NCT01870479|Malignant Lymphoma|malignant lymphoma
1235652|NCT01870479|Chemotherapy|chemotherapy
1235653|NCT01870479|Music therapy|music therapy
1235654|NCT01870453|Alzheimer Disease|alzheimer disease
1235655|NCT01870453|Dementia|dementia
1235656|NCT01870453|Postoperative Care|postoperative care
1235657|NCT01870453|Cognitive Reserve|cognitive reserve
1235658|NCT01870440|Uveitis|uveitis
1235659|NCT01870440|Macular Edema|macular edema
1235660|NCT01870427|Macular Edema|macular edema
1235661|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
1235662|NCT01870427|CRVO|crvo
1235663|NCT01870427|Aflibercept|aflibercept
1235664|NCT01870427|VEGF Trap-Eye|vegf trap-eye
1235665|NCT01870427|Eylea|eylea
1235666|NCT01870427|Ranibizumab|ranibizumab
1235667|NCT01870427|Bevacizumab|bevacizumab
1235668|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
1235669|NCT01870375|Longitudinal|longitudinal
1235670|NCT01870375|Brain|brain
1235671|NCT01870375|Cognition|cognition
1235672|NCT01870375|Quality-of-Life|quality-of-life
1235673|NCT01870375|Hurler syndrome|hurler syndrome
1235674|NCT01870375|Hunter syndrome|hunter syndrome
1235675|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
1235676|NCT01870375|Scheie syndrome|scheie syndrome
1235677|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
1235678|NCT01870375|MPS I|mps i
1235679|NCT01870375|MPS II|mps ii
1235680|NCT01870375|MPS VI|mps vi
1235681|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
1235682|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
1235683|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
1235684|NCT01870375|MPS IV|mps iv
1235685|NCT01870375|MPS VII|mps vii
1235686|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
1235687|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
1235688|NCT01870375|Morquio syndrome|morquio syndrome
1235689|NCT01870375|Sly syndrome|sly syndrome
1235690|NCT01870349|cytokines|cytokines
1235691|NCT01870349|dental implants|dental implants
1235692|NCT01870349|peri-implantitis|peri-implantitis
1235693|NCT01870310|Heart failure|heart failure
1235694|NCT01870310|Renal denervation|renal denervation
1235695|NCT01870271|PTSD|ptsd
1235696|NCT01870271|childhood sexual abuse|childhood sexual abuse
1235697|NCT01870271|physical abuse|physical abuse
1235698|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
1235699|NCT01870258|Myocardial infarction|myocardial infarction
1235700|NCT01870258|artificial neural networks|artificial neural networks
1235701|NCT01870258|Electrocardiography|electrocardiography
1235702|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
1235703|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
1235704|NCT01870232|dental anesthesia|dental anesthesia
1235705|NCT01870232|Ultrasonography|ultrasonography
1235706|NCT01870219|sevoflurane|sevoflurane
1235707|NCT01870219|ketamine|ketamine
1235708|NCT01870219|QT interval|qt interval
1235709|NCT01870206|Immunogenicity|immunogenicity
1235710|NCT01870206|Safety|safety
1235711|NCT01870206|Efficacy|efficacy
1235910|NCT01869218|Bank|bank
1235712|NCT01870206|Poliomyelitis|poliomyelitis
1235713|NCT01870206|Newborn|newborn
1235714|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
1235715|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
1235716|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
1235717|NCT01870180|EyeBag|eyebag
1235718|NCT01870180|Hot Compress|hot compress
1235719|NCT01870180|Dry Eyes|dry eyes
1235720|NCT01870167|PEG|peg
1235721|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
1235722|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
1235723|NCT01870154|Burnout syndrome|burnout syndrome
1235724|NCT01870154|Job stressors|job stressors
1235725|NCT01870154|Primary Health Care|primary health care
1235726|NCT01870154|Health professional|health professional
1235727|NCT01870141|Glucose Control|glucose control
1235728|NCT01870141|Depression|depression
1235729|NCT01870141|Self-Efficacy|self-efficacy
1235730|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
1235731|NCT01870128|Steroid|steroid
1235732|NCT01870115|Melatonin|melatonin
1235733|NCT01870115|Strontium Citrate|strontium citrate
1235734|NCT01870115|Osteoporosis|osteoporosis
1235735|NCT01870115|Osteopenia|osteopenia
1235736|NCT01870089|Non invasive ventilation|non invasive ventilation
1235737|NCT01870089|Computer-driven system|computer-driven system
1235738|NCT01870089|Acute respiratory failure|acute respiratory failure
1235739|NCT01870063|5 minute bleeding test|5 minute bleeding test
1235740|NCT01870063|swamb|swamb
1235741|NCT01870063|fibtem|fibtem
1235742|NCT01870063|extem|extem
1235743|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
1235744|NCT01870050|prurigo|prurigo
1235745|NCT01870037|OAB, gene therapy|oab, gene therapy
1235746|NCT01870024|status epilepticus|status epilepticus
1235747|NCT01870024|epilepsy|epilepsy
1235748|NCT01870024|seizures|seizures
1235749|NCT01870024|convulsive seizures|convulsive seizures
1235751|NCT01870024|benzodiazepines|benzodiazepines
1235752|NCT01870024|anticonvulsants|anticonvulsants
1235753|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
1235754|NCT01869998|Vortex|vortex
1235755|NCT01869998|Thrombus|thrombus
1235756|NCT01869998|Contrast echocardiography|contrast echocardiography
1235757|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
1235758|NCT01869985|HCP1104|hcp1104
1235759|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
1235760|NCT01869985|Aceclofenac|aceclofenac
1235761|NCT01869972|PKU|pku
1235762|NCT01869972|phenylketonuria|phenylketonuria
1235763|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
1235764|NCT01869972|Kuvan|kuvan
1235765|NCT01869972|sapropterin|sapropterin
1235766|NCT01869946|Hip arthroplasty|hip arthroplasty
1235767|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
1235768|NCT01869920|breastfeeding|breastfeeding
1235769|NCT01869920|education|education
1235770|NCT01869920|intervention|intervention
1235771|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
1235772|NCT01869894|metal stent|metal stent
1235773|NCT01869894|patency|patency
1235774|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
1235775|NCT01869855|traumatic brain injury|traumatic brain injury
1235776|NCT01869855|burr hole trepanation|burr hole trepanation
1235777|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
1235778|NCT01869855|intracranial bleed|intracranial bleed
1235779|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
1235780|NCT01869842|optical coherence tomography|optical coherence tomography
1235781|NCT01869829|Candida|candida
1235782|NCT01869829|Pediatric|pediatric
1235783|NCT01869829|Antifungal|antifungal
1235784|NCT01869738|heart attack|heart attack
1235785|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
1235786|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
1235787|NCT01869725|Imaging|imaging
1235788|NCT01869712|cupping therapy|cupping therapy
1235789|NCT01869712|acupuncture|acupuncture
1235790|NCT01869712|partially randomized|partially randomized
1235791|NCT01869712|patient preference|patient preference
1235792|NCT01869712|fibromyalgia|fibromyalgia
1235793|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
1235794|NCT01869699|Fever|fever
1235795|NCT01869699|Acetaminophen|acetaminophen
1235796|NCT01869699|Critical Care|critical care
1235797|NCT01869699|ICU|icu
1235798|NCT01869699|Febrile|febrile
1235799|NCT01869673|Difficult mask ventilation|difficult mask ventilation
1235800|NCT01869673|extubation|extubation
1235801|NCT01869673|nasal surgery|nasal surgery
1235802|NCT01869660|First hospitalization|first hospitalization
1235803|NCT01869647|kidney stones|kidney stones
1235804|NCT01869634|HIV|hiv
1235805|NCT01869634|cardiovascular risk|cardiovascular risk
1235806|NCT01869634|systemic immune activation|systemic immune activation
1235807|NCT01869608|postpartum screening|postpartum screening
1235808|NCT01869608|type 2 diabetes|type 2 diabetes
1235809|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
1235810|NCT01869582|Fetal hypoxia|fetal hypoxia
1235811|NCT01869582|Birth asphyxia|birth asphyxia
1235812|NCT01869582|Neonatal resuscitation|neonatal resuscitation
1235813|NCT01869569|Radiation|radiation
1235814|NCT01869569|Neuropathic Pain|neuropathic pain
1235815|NCT01869569|Pregabalin|pregabalin
1235816|NCT01869556|pregnancy|pregnancy
1235817|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
1235818|NCT01869556|Cesarean delivery|cesarean delivery
1235819|NCT01869556|failure to progress in labor|failure to progress in labor
1235820|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
1235821|NCT01869504|Pleural effusion|pleural effusion
1235822|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1235823|NCT01869491|GERD|gerd
1235824|NCT01869491|Dyspepsia|dyspepsia
1235825|NCT01869491|Indigestion|indigestion
1235826|NCT01869491|Heartburn|heartburn
1235827|NCT01869491|Acid reflux|acid reflux
1235828|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
1235829|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
1235830|NCT01869452|education|education
1235831|NCT01869452|risk factors|risk factors
1235832|NCT01869452|quality of life|quality of life
1235833|NCT01869452|coronary disease|coronary disease
1235834|NCT01869452|telephone follow up|telephone follow up
1235835|NCT01869452|dedicated nurse|dedicated nurse
1235836|NCT01869439|Pressure Ulcers|pressure ulcers
1235837|NCT01869439|Bed Sores|bed sores
1235838|NCT01869439|Measuring|measuring
1235839|NCT01869439|Visual Images|visual images
1235840|NCT01869439|Thermal Images|thermal images
1235841|NCT01869439|External Wounds|external wounds
1235842|NCT01869439|Area|area
1235843|NCT01869439|Length|length
1235844|NCT01869439|Width|width
1235845|NCT01869439|Gradient|gradient
1235846|NCT01869426|colics|colics
1236536|NCT01866137|Copeptin|copeptin
1235847|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
1235848|NCT01869413|transition cell carcinoma|transition cell carcinoma
1235849|NCT01869413|bladder cancer|bladder cancer
1235850|NCT01869413|radical cystectomy|radical cystectomy
1235851|NCT01869413|cystectomy|cystectomy
1235852|NCT01869413|bladder removal|bladder removal
1235853|NCT01869413|tranexamic acid|tranexamic acid
1235854|NCT01869413|cyklokapron|cyklokapron
1235855|NCT01869374|Depression|depression
1235856|NCT01869374|Brain Stimulation|brain stimulation
1235857|NCT01869374|Seizure therapy|seizure therapy
1235858|NCT01869374|Convulsive Therapy|convulsive therapy
1235859|NCT01869361|preterm labor|preterm labor
1235860|NCT01869361|tocolysis|tocolysis
1235861|NCT01869361|indomethacin|indomethacin
1235862|NCT01869348|Physical activity|physical activity
1235863|NCT01869348|Activity monitor|activity monitor
1235864|NCT01869348|Technology|technology
1235865|NCT01869348|Obesity|obesity
1235866|NCT01869348|Aging muscle|aging muscle
1235867|NCT01869335|breast cancer|breast cancer
1235868|NCT01869335|MRI|mri
1235869|NCT01869335|mammography|mammography
1235870|NCT01869335|microcalcifications|microcalcifications
1235871|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
1235872|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
1235873|NCT01869322|Humerus|humerus
1235874|NCT01869322|Fracture|fracture
1235875|NCT01869322|Sling|sling
1235876|NCT01869322|Splint|splint
1235877|NCT01869322|Coaptation|coaptation
1235878|NCT01869309|Coronary artery disease|coronary artery disease
1235879|NCT01869309|anti-platelet medications|anti-platelet medications
1235880|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
1235881|NCT01869296|unsedated|unsedated
1235882|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
1235883|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
1235884|NCT01869283|Physical Therapy Modalities|physical therapy modalities
1235885|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
1235886|NCT01869283|Skeletal Muscle|skeletal muscle
1235887|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
1235888|NCT01869270|Tay-Sachs disease|tay-sachs disease
1235889|NCT01869270|Sandhoff disease|sandhoff disease
1235890|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
1235891|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
1235892|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
1235893|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
1235894|NCT01869270|retrospective|retrospective
1235895|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
1235896|NCT01869270|GM2-ganglioside|gm2-ganglioside
1235897|NCT01869270|gangliosidoses|gangliosidoses
1235898|NCT01869270|natural history|natural history
1235899|NCT01869270|hexosaminidase|hexosaminidase
1235900|NCT01869257|triclosan|triclosan
1235901|NCT01869257|colorectal|colorectal
1235902|NCT01869257|surgery|surgery
1235903|NCT01869257|surgical site infection|surgical site infection
1235904|NCT01869218|Cancer|cancer
1235905|NCT01869218|Advanced|advanced
1235906|NCT01869218|Solid|solid
1235907|NCT01869218|Hematological|hematological
1235911|NCT01869205|COPD|copd
1235912|NCT01869205|Emphysema|emphysema
1235913|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
1235914|NCT01869205|Endobronchial valve|endobronchial valve
1235915|NCT01869192|Malignant|malignant
1235916|NCT01869192|Neoplasm|neoplasm
1235917|NCT01869192|Cancer|cancer
1235918|NCT01869192|Female|female
1235919|NCT01869192|Breast|breast
1235920|NCT01869192|Stage II|stage ii
1235921|NCT01869192|Stage III|stage iii
1235922|NCT01869179|Well being|well being
1235923|NCT01869179|Low income|low income
1235924|NCT01869179|Choir singing|choir singing
1235925|NCT01869179|Spanish speaking|spanish speaking
1235926|NCT01869179|Community based|community based
1235927|NCT01869179|Seniors|seniors
1235928|NCT01869179|60+ aged adults|60+ aged adults
1235929|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
1235930|NCT01869153|Growth, weight|growth, weight
1235931|NCT01869127|hookworm|hookworm
1235932|NCT01869127|necator americanus|necator americanus
1235933|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
1235934|NCT01869127|shoes|shoes
1235935|NCT01869127|anaemia|anaemia
1235936|NCT01869127|children|children
1235937|NCT01869101|Prediabetes|prediabetes
1235938|NCT01869101|Diabetes prevention|diabetes prevention
1235939|NCT01869088|TACE|tace
1235940|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1235941|NCT01869088|Liver Neoplasms|liver neoplasms
1235942|NCT01869088|overall survival|overall survival
1235943|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
1235944|NCT01869075|Quality Improvement|quality improvement
1235945|NCT01869075|Patient Safety|patient safety
1235946|NCT01869075|Knowledge Translation|knowledge translation
1235947|NCT01869062|CRT|crt
1235948|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
1235949|NCT01869049|macrophage|macrophage
1235950|NCT01869049|spleen tissue|spleen tissue
1235951|NCT01869036|Caudal|caudal
1235952|NCT01869036|anesthesia|anesthesia
1235953|NCT01869036|morphine|morphine
1235954|NCT01869036|children|children
1235955|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
1235956|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
1235957|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
1235958|NCT01869010|HIV infection|hiv infection
1235959|NCT01869010|Antiretroviral treatment|antiretroviral treatment
1235960|NCT01869010|Renal disease|renal disease
1235961|NCT01869010|Renal tubular damage|renal tubular damage
1235962|NCT01869010|Free-water clearance|free-water clearance
1235963|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
1235964|NCT01868997|Ophthalmopathy|ophthalmopathy
1235965|NCT01868971|EndoRings|endorings
1235966|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1235967|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
1235968|NCT01868958|Spine|spine
1235969|NCT01868945|Vitamin D3|vitamin d3
1235970|NCT01868945|Calcifediol 25|calcifediol 25
1235971|NCT01868945|Frail|frail
1235972|NCT01868945|Dose-response|dose-response
1235973|NCT01868932|wheeze|wheeze
1235974|NCT01868932|early childhood|early childhood
1235975|NCT01868932|asthma|asthma
1235976|NCT01868932|bronchiolitis|bronchiolitis
1235977|NCT01868932|infection triggered|infection triggered
1235978|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
1235979|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
1235980|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
1235981|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
1235982|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
1235983|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
1235984|NCT01868906|Brain Tumors|brain tumors
1235985|NCT01868906|Cancer Imaging|cancer imaging
1235986|NCT01868906|Fluoromisonidazole|fluoromisonidazole
1235987|NCT01868906|FMISO PET|fmiso pet
1235988|NCT01868906|Glioblastoma|glioblastoma
1235989|NCT01868906|High Grade Glioma|high grade glioma
1235990|NCT01868906|Hypoxia Modification|hypoxia modification
1235991|NCT01868906|Positron Emission Tomography|positron emission tomography
1235992|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
1235993|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
1235994|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
1235995|NCT01868854|Tip catheter|tip catheter
1235996|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
1235997|NCT01868854|Risk Factot|risk factot
1235998|NCT01868854|Mecanical Function|mecanical function
1235999|NCT01868841|123I-mIBG|123i-mibg
1236000|NCT01868841|AdreView|adreview
1236001|NCT01868841|SPECT|spect
1236002|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
1236003|NCT01868828|Multiple Myeloma|multiple myeloma
1236004|NCT01868828|Combination Therapy|combination therapy
1236005|NCT01868802|Ketamine|ketamine
1236006|NCT01868802|Depression|depression
1236007|NCT01868802|Depressive Disorder|depressive disorder
1236008|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
1236009|NCT01868789|flexible flatfoot|flexible flatfoot
1236010|NCT01868789|computed tomography (CT)|computed tomography (ct)
1236011|NCT01868763|telemedicine|telemedicine
1236012|NCT01868763|coaching|coaching
1236013|NCT01868763|lifestyle change|lifestyle change
1236014|NCT01868763|weight loss|weight loss
1236015|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
1236016|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
1236017|NCT01868737|Premature infant|premature infant
1236018|NCT01868737|Probiotic|probiotic
1236019|NCT01868737|Very Low Birth Weight|very low birth weight
1236020|NCT01868724|Kidney Renal|kidney renal
1236021|NCT01868711|Major Depressive Disorder|major depressive disorder
1236022|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
1236023|NCT01868711|Psychological Mindedness|psychological mindedness
1236024|NCT01868698|Physical Therapy Modalities|physical therapy modalities
1597486|NCT00404157|U2970g|u2970g
1321972|NCT01490203|MRI|mri
1236025|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
1236026|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
1236027|NCT01868698|Diabetes Mellitus|diabetes mellitus
1236028|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
1236029|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
1236030|NCT01868672|Smoke-free homes|smoke-free homes
1236031|NCT01868672|Smoke-free home bans|smoke-free home bans
1236032|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
1236033|NCT01868633|Cesarean delivery|cesarean delivery
1236034|NCT01868633|Analgesia|analgesia
1236035|NCT01868633|Pain|pain
1236036|NCT01868633|Dexamethasone|dexamethasone
1236037|NCT01868633|intrathecal morphine|intrathecal morphine
1236038|NCT01868633|spinal anesthesia|spinal anesthesia
1236039|NCT01868620|Progressive keratoconus|progressive keratoconus
1236040|NCT01868620|standard CXL|standard cxl
1236041|NCT01868620|iontophoretic CXL|iontophoretic cxl
1236042|NCT01868620|keratometry|keratometry
1236043|NCT01868607|Respiratory resistance|respiratory resistance
1236044|NCT01868607|Respiratory reactance|respiratory reactance
1236045|NCT01868607|Adult lung function|adult lung function
1236046|NCT01868607|Forced oscillation technique|forced oscillation technique
1236047|NCT01868607|subjects|subjects
1236048|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
1236049|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
1236050|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
1236051|NCT01868490|CIK|cik
1236052|NCT01868490|Treg|treg
1236053|NCT01868490|Th17|th17
1236054|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
1236055|NCT01868477|MDS|mds
1236056|NCT01868477|myelodysplasia|myelodysplasia
1236057|NCT01868477|blood disorder|blood disorder
1236058|NCT01868477|cytopenias|cytopenias
1236059|NCT01868477|low blood counts|low blood counts
1236060|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
1236061|NCT01868464|challenge|challenge
1236062|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
1236063|NCT01868464|parent protocol|parent protocol
1236064|NCT01868464|TB|tb
1236065|NCT01868464|Tice BCG|tice bcg
1236066|NCT01868464|tuberculosis|tuberculosis
1236067|NCT01868451|DACARBAZINE|dacarbazine
1236068|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
1236069|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
1236070|NCT01868451|VINBLASTINE|vinblastine
1236071|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
1236072|NCT01868451|Early stage|early stage
1236073|NCT01868451|13-034|13-034
1236074|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
1236075|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
1236076|NCT01868438|Pyramax tablet|pyramax tablet
1236077|NCT01868438|Pyramax granules|pyramax granules
1236078|NCT01868438|Bioavailability|bioavailability
1236079|NCT01868412|Wound healing|wound healing
1236080|NCT01868412|Wound infection|wound infection
1236081|NCT01868412|Resin salve|resin salve
1236082|NCT01868412|Medical honey|medical honey
1236083|NCT01868399|dengue virus|dengue virus
1236084|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
1236085|NCT01868386|Salvage therapy|salvage therapy
1236086|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
1236087|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
1236089|NCT01868360|transplant|transplant
1236090|NCT01868360|graft|graft
1236091|NCT01868360|neovascularization|neovascularization
1236092|NCT01868347|obese patients|obese patients
1236093|NCT01868347|specific elastance|specific elastance
1236094|NCT01868347|Trendelenburg Position|trendelenburg position
1236095|NCT01868347|Pneumoperitoneum|pneumoperitoneum
1236096|NCT01868347|robotic surgery|robotic surgery
1236097|NCT01868347|Prostatectomy|prostatectomy
1236098|NCT01868334|influenza vaccine|influenza vaccine
1236099|NCT01868334|PPSV|ppsv
1236100|NCT01868334|Tdap|tdap
1236101|NCT01868334|vaccination|vaccination
1236102|NCT01868334|adult|adult
1236103|NCT01868321|Mechanical ventilation|mechanical ventilation
1236104|NCT01868321|Acute respiratory failure|acute respiratory failure
1236600|NCT01865877|Progression|progression
1236105|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
1236106|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
1236107|NCT01868282|Postoperative pain|postoperative pain
1236108|NCT01868256|myocardial infarction|myocardial infarction
1236109|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
1236110|NCT01868256|prognosis|prognosis
1236111|NCT01868256|early discharge|early discharge
1236112|NCT01868243|Atrial Fibrillation|atrial fibrillation
1236113|NCT01868243|Bioprosthesis|bioprosthesis
1236114|NCT01868243|Stroke|stroke
1236115|NCT01868243|Dabigatran|dabigatran
1236116|NCT01868243|Warfarin|warfarin
1236117|NCT01868204|Obesity|obesity
1236118|NCT01868204|Binge eating disorder|binge eating disorder
1236119|NCT01868204|Pharmacogenetic|pharmacogenetic
1236120|NCT01868204|Food craving|food craving
1236121|NCT01868204|Brain areas|brain areas
1236122|NCT01868204|Topiramate|topiramate
1236123|NCT01868191|Diabetes|diabetes
1236124|NCT01868191|Neuropathy|neuropathy
1236125|NCT01868178|awareness|awareness
1236126|NCT01868165|Cognitive decline|cognitive decline
1236127|NCT01868165|High blood pressure|high blood pressure
1236128|NCT01868165|Hypertension|hypertension
1236129|NCT01868165|Ageing|ageing
1236130|NCT01868165|Dementia|dementia
1236131|NCT01868165|Antihypertensives|antihypertensives
1236132|NCT01868152|sufentanil|sufentanil
1236133|NCT01868152|individual variation|individual variation
1236134|NCT01868152|pain threshold|pain threshold
1236135|NCT01868152|narcotrend index|narcotrend index
1236136|NCT01868139|Cryotherapy|cryotherapy
1236137|NCT01868139|Esophageal cancer|esophageal cancer
1236138|NCT01868139|Esophageal carcinoma|esophageal carcinoma
1236139|NCT01868139|Liquid nitrogen|liquid nitrogen
1236140|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
1236141|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1236142|NCT01868139|Endoscopy|endoscopy
1236143|NCT01868139|Ablation|ablation
1236144|NCT01868126|Santen|santen
1236145|NCT01868126|Eye|eye
1236146|NCT01868126|Glaucoma|glaucoma
1236147|NCT01868126|Ocular hypertension|ocular hypertension
1236148|NCT01868113|Children U-5|children u-5
1236149|NCT01868113|ALRI|alri
1236150|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
1236151|NCT01868100|Cancer|cancer
1236152|NCT01868100|quality of life|quality of life
1236153|NCT01868100|palliative care|palliative care
1236154|NCT01868100|supportive care|supportive care
1236155|NCT01868100|Financial distress|financial distress
1236156|NCT01868087|nutritional supplement|nutritional supplement
1236157|NCT01868087|immune system|immune system
1236158|NCT01868087|RC surgery|rc surgery
1236159|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
1236160|NCT01868048|Spasticity|spasticity
1236161|NCT01868048|Multiple Sclerosis|multiple sclerosis
1236162|NCT01868035|radioimmunotherapy|radioimmunotherapy
1236163|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
1236164|NCT01868022|FGFR1|fgfr1
1236165|NCT01868022|FP1039|fp1039
1236166|NCT01868022|GSK3052230|gsk3052230
1236167|NCT01868022|docetaxel|docetaxel
1236168|NCT01868022|FGFR|fgfr
1236169|NCT01868022|carboplatin|carboplatin
1236170|NCT01868022|HGS1036|hgs1036
1236171|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
1236172|NCT01868022|paclitaxel|paclitaxel
1236173|NCT01868009|fluticasone furoate|fluticasone furoate
1236174|NCT01868009|COPD|copd
1236175|NCT01868009|ELLIPTA|ellipta
1236176|NCT01868009|fluticasone propionate|fluticasone propionate
1236177|NCT01868009|DISKUS|diskus
1236178|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
1236179|NCT01868009|device preference|device preference
1236180|NCT01868009|salmeterol|salmeterol
1236181|NCT01868009|vilanterol|vilanterol
1236182|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
1236183|NCT01867983|Tobacco cessation|tobacco cessation
1236184|NCT01867983|Weight gain prevention|weight gain prevention
1236185|NCT01867970|remote sensing technology|remote sensing technology
1236186|NCT01867970|physical activity|physical activity
1236187|NCT01867970|self-management support|self-management support
1236188|NCT01867970|primary care nursing|primary care nursing
1236189|NCT01867957|anthrax|anthrax
1236190|NCT01867957|vaccine|vaccine
1236191|NCT01867957|bioterrorism|bioterrorism
1236192|NCT01867957|efficacy|efficacy
1236193|NCT01867957|safety|safety
1236194|NCT01867944|Chronic constipation|chronic constipation
1236195|NCT01867944|Hemorrhoids|hemorrhoids
1236196|NCT01867944|Acupressure|acupressure
1236197|NCT01867905|Severe sepsis|severe sepsis
1236198|NCT01867905|Septic shock|septic shock
1236199|NCT01867905|Bacteremia|bacteremia
1236200|NCT01867905|Antibiotics|antibiotics
1236201|NCT01867905|Blood culture positivity|blood culture positivity
1236202|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
1236203|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
1236300|NCT01867424|Prostatectomy|prostatectomy
1237299|NCT01862965|firstline|firstline
1236204|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
1236206|NCT01867801|Coronary disease|coronary disease
1236207|NCT01867801|Ischemia|ischemia
1236208|NCT01867775|Alzheimer's disease|alzheimer's disease
1236209|NCT01867775|Sleep disorders|sleep disorders
1236210|NCT01867775|Mirtazapine|mirtazapine
1236211|NCT01867775|Treatment|treatment
1236212|NCT01867775|Intervention|intervention
1236213|NCT01867775|insomnia|insomnia
1236214|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1236215|NCT01867762|JNJ 49095397|jnj 49095397
1236217|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
1236218|NCT01867762|FEV1|fev1
1236219|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1236220|NCT01867749|Miscarriage|miscarriage
1236221|NCT01867749|Stillbirth|stillbirth
1236222|NCT01867749|Neonatal death|neonatal death
1236223|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
1236224|NCT01867749|Group Therapy|group therapy
1236225|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
1236226|NCT01867736|Stenosis|stenosis
1236227|NCT01867736|Occlusions|occlusions
1236228|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
1236229|NCT01867736|Below the knee arteries|below the knee arteries
1236230|NCT01867736|PTA|pta
1236231|NCT01867736|POBA|poba
1236232|NCT01867736|DRB|drb
1236233|NCT01867723|Cancer internet support program|cancer internet support program
1236234|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
1236235|NCT01867684|Stroke|stroke
1236236|NCT01867684|Acquired brain injury|acquired brain injury
1236237|NCT01867671|Allergy, Peanut|allergy, peanut
1236238|NCT01867671|Peanut allergy|peanut allergy
1236239|NCT01867671|Hypersensitivity|hypersensitivity
1236240|NCT01867671|Immunotherapy|immunotherapy
1236241|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
1236242|NCT01867658|Pleural Air Leak|pleural air leak
1236243|NCT01867658|Pulmonary resection|pulmonary resection
1236244|NCT01867658|Video Assisted|video assisted
1236245|NCT01867658|Robotic Assisted|robotic assisted
1236246|NCT01867645|Critical illness|critical illness
1236247|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
1236248|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
1236249|NCT01867645|Multiple organ failure|multiple organ failure
1236250|NCT01867645|SIRS|sirs
1236251|NCT01867645|Sepsis|sepsis
1236252|NCT01867632|Palatoplasty|palatoplasty
1236253|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
1236254|NCT01867619|Brain Neoplasms|brain neoplasms
1236255|NCT01867619|Melanoma|melanoma
1236256|NCT01867619|Metastatic Melanoma|metastatic melanoma
1236257|NCT01867619|Brain Metastasis|brain metastasis
1236258|NCT01867619|Temozolomide|temozolomide
1236259|NCT01867619|Temodar|temodar
1236260|NCT01867619|Thalidomide|thalidomide
1236261|NCT01867619|Thalomid|thalomid
1236262|NCT01867619|Lomustine|lomustine
1236263|NCT01867619|CCNU|ccnu
1236264|NCT01867619|CeeNU|ceenu
1236265|NCT01867593|Newly diagnosed|newly diagnosed
1236266|NCT01867567|cesarean|cesarean
1236267|NCT01867567|bandage removal|bandage removal
1236268|NCT01867567|infection|infection
1236269|NCT01867567|disruption|disruption
1236270|NCT01867567|satisfaction|satisfaction
1236271|NCT01867567|patient satisfaction|patient satisfaction
1236272|NCT01867554|Intellectual disability|intellectual disability
1236273|NCT01867554|Autism spectrum disorders|autism spectrum disorders
1236274|NCT01867554|gene|gene
1236275|NCT01867554|Next generation sequencing|next generation sequencing
1236276|NCT01867541|cataract surgery|cataract surgery
1236277|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
1236278|NCT01867541|effective lens position|effective lens position
1236279|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
1236280|NCT01867541|predicting the IOL position|predicting the iol position
1236281|NCT01867515|Hearing|hearing
1236282|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
1236283|NCT01867515|Speech Perception|speech perception
1236284|NCT01867463|Antigen|antigen
1236285|NCT01867463|Ookinetes|ookinetes
1236286|NCT01867463|Mosquito|mosquito
1236287|NCT01867463|Membrane|membrane
1236288|NCT01867463|Assay|assay
1236289|NCT01867450|Biomarkers|biomarkers
1236290|NCT01867450|Deisel Exhaust|deisel exhaust
1236291|NCT01867450|Occupational Exposure|occupational exposure
1236292|NCT01867450|Cross-Sectional Study|cross-sectional study
1236293|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
1236294|NCT01867437|Resting Energy Expenditure|resting energy expenditure
1236295|NCT01867437|Obesity|obesity
1236296|NCT01867437|Healthy Volunteers|healthy volunteers
1236297|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
1236298|NCT01867424|OATP1B3|oatp1b3
1236299|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1236301|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
1236302|NCT01867411|Smoking Cessation|smoking cessation
1236303|NCT01867411|Biomarkers|biomarkers
1236304|NCT01867411|fMRI|fmri
1236305|NCT01867411|e-Cigarettes|e-cigarettes
1236306|NCT01867398|Conduct Disorder|conduct disorder
1236307|NCT01867398|Antipsychotic|antipsychotic
1236308|NCT01867398|Treatment Study|treatment study
1236309|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1236310|NCT01867398|Adolescents|adolescents
1236311|NCT01867385|Fatigue|fatigue
1236312|NCT01867385|Chronic Hepatitis|chronic hepatitis
1236313|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
1236314|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
1236315|NCT01867385|Hepatitis|hepatitis
1236316|NCT01867372|Alzheimer's Disease|alzheimer's disease
1236317|NCT01867359|Alzheimer Disease|alzheimer disease
1236318|NCT01867359|Molecular|molecular
1236319|NCT01867359|Molecular Genetics|molecular genetics
1236320|NCT01867359|DNA|dna
1236321|NCT01867346|Cognition|cognition
1236322|NCT01867346|Aging|aging
1236323|NCT01867346|Cognitive Decline|cognitive decline
1236324|NCT01867346|Dementia|dementia
1236325|NCT01867346|Alzheimer's Disease|alzheimer's disease
1236326|NCT01867333|Immunotherapy|immunotherapy
1236327|NCT01867333|Gene Transfer|gene transfer
1236328|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
1236329|NCT01867333|PSA|psa
1236330|NCT01867333|Immune Response|immune response
1236331|NCT01867320|HTLV-1|htlv-1
1236332|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
1236333|NCT01867281|aspirin|aspirin
1236334|NCT01867281|asthma|asthma
1236335|NCT01867281|Aspirin desensitization|aspirin desensitization
1236336|NCT01867281|Aspirin induced asthma|aspirin induced asthma
1236337|NCT01867281|Immune System Diseases|immune system diseases
1236338|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
1236339|NCT01867268|Acetazolamide administration|acetazolamide administration
1236340|NCT01867268|prone positioning|prone positioning
1236341|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
1236342|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
1236343|NCT01867268|wound dehiscence|wound dehiscence
1236344|NCT01867255|venlafaxine|venlafaxine
1236345|NCT01867255|Effexor|effexor
1236346|NCT01867255|antidepressive agent|antidepressive agent
1236347|NCT01867242|cigarette|cigarette
1236348|NCT01867242|snus|snus
1236349|NCT01867242|smoking|smoking
1236350|NCT01867242|tobacco|tobacco
1236351|NCT01867229|pre-menauposal|pre-menauposal
1236352|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
1236353|NCT01867229|no metastases|no metastases
1236354|NCT01867190|CLI|cli
1236355|NCT01867177|HIV|hiv
1236356|NCT01867177|health care utilization|health care utilization
1236357|NCT01867177|HIV testing|hiv testing
1236358|NCT01867177|access to care|access to care
1236359|NCT01867164|Vaginitis|vaginitis
1236360|NCT01867164|Infectious vaginosis|infectious vaginosis
1236361|NCT01867164|Terconazole|terconazole
1236362|NCT01867164|Clindamycin|clindamycin
1236363|NCT01867164|Fluocinolone|fluocinolone
1236364|NCT01867164|Metronidazole|metronidazole
1236365|NCT01867164|Nystatin|nystatin
1236366|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
1236367|NCT01867151|Gluten|gluten
1236368|NCT01867151|Gluten Free Diet|gluten free diet
1236369|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
1236370|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
1236371|NCT01867138|cefazolin|cefazolin
1236372|NCT01867138|vancomycin|vancomycin
1236373|NCT01867138|newborn|newborn
1236374|NCT01867086|ovarian cancer|ovarian cancer
1236375|NCT01867060|Cardiac monitoring|cardiac monitoring
1236376|NCT01867060|Biomarkers|biomarkers
1236377|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
1236378|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
1236379|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
1236380|NCT01867021|50 years and above|50 years and above
1236381|NCT01867021|healthy subjects|healthy subjects
1236382|NCT01866995|Ginseng|ginseng
1236383|NCT01866995|Prostatostasis|prostatostasis
1236384|NCT01866995|Erectile Dysfunction|erectile dysfunction
1236385|NCT01866982|umbilical cord milking|umbilical cord milking
1236386|NCT01866982|delayed cord clamping|delayed cord clamping
1236387|NCT01866943|Blood Loss|blood loss
1236388|NCT01866943|Tranexamic Acid|tranexamic acid
1236389|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
1236390|NCT01866943|Post Op|post op
1236391|NCT01866943|Post Operative|post operative
1236392|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
1236393|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
1236394|NCT01866917|obese|obese
1236395|NCT01866917|robotic surgery|robotic surgery
1236396|NCT01866917|laparoscopic surgery|laparoscopic surgery
1236397|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
1236398|NCT01866891|hemodialysis|hemodialysis
1236399|NCT01866891|microcirculation|microcirculation
1236495|NCT01866345|orthodontics|orthodontics
1236400|NCT01866891|physical perdialytic activity|physical perdialytic activity
1236401|NCT01866891|cycling|cycling
1236402|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
1236403|NCT01866865|BRCA1|brca1
1236404|NCT01866865|BRCA2|brca2
1236405|NCT01866852|Longitudinal Study|longitudinal study
1236406|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1236407|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1236408|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1236409|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1236410|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
1236411|NCT01866826|HIV|hiv
1236412|NCT01866826|Eradication Strategies|eradication strategies
1236413|NCT01866826|Immune Activation|immune activation
1236414|NCT01866813|breast cancer|breast cancer
1236415|NCT01866813|cancer survivors|cancer survivors
1236416|NCT01866800|TAVI|tavi
1236417|NCT01866800|TAVR|tavr
1236418|NCT01866800|CIN|cin
1236419|NCT01866800|AKI|aki
1236420|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
1236421|NCT01866787|Surgical inflammatory response|surgical inflammatory response
1236422|NCT01866722|nicotine dependence|nicotine dependence
1236423|NCT01866722|smoking cessation|smoking cessation
1236424|NCT01866722|lapse|lapse
1236425|NCT01866722|relapse|relapse
1236426|NCT01866722|tobacco|tobacco
1236427|NCT01866722|quit attempts|quit attempts
1236428|NCT01866722|abstinence|abstinence
1236429|NCT01866722|motivation|motivation
1236430|NCT01866722|reduction|reduction
1236431|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
1236432|NCT01866696|Immediate loading,|immediate loading,
1236433|NCT01866696|CAD/CAM|cad/cam
1236434|NCT01866683|Yoga|yoga
1236435|NCT01866683|Electroencephalography|electroencephalography
1236436|NCT01866683|Heart rate variability|heart rate variability
1236437|NCT01866683|Breathing Exercises|breathing exercises
1236438|NCT01866683|Quality of life|quality of life
1236439|NCT01866670|spiritual distress|spiritual distress
1236440|NCT01866670|nursing|nursing
1236441|NCT01866670|breast neoplasms|breast neoplasms
1236442|NCT01866657|cerebral oximetry|cerebral oximetry
1236443|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
1236444|NCT01866657|thoracic surgery|thoracic surgery
1236445|NCT01866657|single lung ventilation|single lung ventilation
1236446|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
1236447|NCT01866618|Natural|natural
1236448|NCT01866618|IVF Cycle|ivf cycle
1236449|NCT01866605|anxiety|anxiety
1236450|NCT01866605|midazolam|midazolam
1236451|NCT01866605|forced-air warming|forced-air warming
1236452|NCT01866592|Psoriasis|psoriasis
1236453|NCT01866592|Cardiovascular Disease|cardiovascular disease
1236454|NCT01866592|Vascular Inflammation|vascular inflammation
1236455|NCT01866592|Lipid Biomarkers|lipid biomarkers
1236456|NCT01866592|Metabolic biomarkers|metabolic biomarkers
1236457|NCT01866592|FDG-PET/CT|fdg-pet/ct
1236458|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
1236459|NCT01866553|CML|cml
1236460|NCT01866553|suboptimal molecular response|suboptimal molecular response
1236461|NCT01866553|nilotinib|nilotinib
1236462|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
1236463|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
1236464|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
1236465|NCT01866527|DDH,|ddh,
1236466|NCT01866527|avascular necrosis,|avascular necrosis,
1236467|NCT01866527|late detected cases|late detected cases
1236468|NCT01866514|EZ-IO|ez-io
1236469|NCT01866514|IO|io
1236470|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
1236471|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
1236472|NCT01866501|IO Access|io access
1236473|NCT01866501|IO Vascular Access|io vascular access
1236474|NCT01866501|EZ-IO|ez-io
1236475|NCT01866488|Labor induction|labor induction
1236476|NCT01866488|Misoprostol|misoprostol
1236477|NCT01866488|Cytotec|cytotec
1236478|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
1236479|NCT01866475|IO access|io access
1236480|NCT01866475|Intraosseous vascular access|intraosseous vascular access
1236481|NCT01866475|EZ-IO|ez-io
1236482|NCT01866436|Cognitive skills|cognitive skills
1236483|NCT01866436|Multimedia|multimedia
1236484|NCT01866436|Education|education
1236485|NCT01866436|Colorectal surgery|colorectal surgery
1236486|NCT01866397|cidofovir|cidofovir
1236487|NCT01866397|cvvh|cvvh
1236488|NCT01866397|renal replacement therapy|renal replacement therapy
1236489|NCT01866397|HCMV|hcmv
1236490|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
1236491|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
1236492|NCT01866371|Retina|retina
1236493|NCT01866371|imaging|imaging
1236494|NCT01866371|retinal degeneration|retinal degeneration
1236496|NCT01866345|Tooth Movement|tooth movement
1236497|NCT01866345|Bone Remodeling|bone remodeling
1236498|NCT01866345|Mandible|mandible
1236499|NCT01866345|Osteotomy|osteotomy
1236500|NCT01866332|back pain|back pain
1236501|NCT01866332|tape|tape
1236502|NCT01866332|chronic|chronic
1236503|NCT01866319|PD-1|pd-1
1236504|NCT01866319|PD1|pd1
1236505|NCT01866319|PD-L1|pd-l1
1236506|NCT01866319|PDL1|pdl1
1236507|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
1236508|NCT01866293|12-240|12-240
1236509|NCT01866280|Sleep|sleep
1236510|NCT01866280|Sleep duration|sleep duration
1236511|NCT01866280|Meals|meals
1236512|NCT01866280|Food intake|food intake
1236513|NCT01866280|Obesity|obesity
1236514|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
1236515|NCT01866267|AIDS|aids
1236516|NCT01866254|Hydromorphone|hydromorphone
1236517|NCT01866254|Morphine|morphine
1236518|NCT01866254|cesarean delivery|cesarean delivery
1236519|NCT01866254|pain management|pain management
1236520|NCT01866254|respiratory depression|respiratory depression
1236521|NCT01866228|Consultation Recording|consultation recording
1236522|NCT01866228|Brain Tumor|brain tumor
1236523|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
1236524|NCT01866228|Quality of Life|quality of life
1236525|NCT01866228|Patient Satisfaction|patient satisfaction
1236526|NCT01866215|gluconeogenesis|gluconeogenesis
1236527|NCT01866215|de novo lipogenesis|de novo lipogenesis
1236528|NCT01866215|intramyocellular lipids|intramyocellular lipids
1236529|NCT01866215|muscle glycogen|muscle glycogen
1236530|NCT01866215|fructose|fructose
1236531|NCT01866189|ischemic stroke|ischemic stroke
1236532|NCT01866189|hypoxic tissues|hypoxic tissues
1236533|NCT01866189|F-MISO uptake|f-miso uptake
1236534|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
1236535|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
1236537|NCT01866137|psychological stress|psychological stress
1236538|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
1236539|NCT01866124|acute malnutrition|acute malnutrition
1236540|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
1236541|NCT01866124|safety nets|safety nets
1236542|NCT01866124|Burkina Faso|burkina faso
1236543|NCT01866098|antipsychotic|antipsychotic
1236544|NCT01866098|severe mental illness|severe mental illness
1236545|NCT01866098|weight loss|weight loss
1236546|NCT01866085|stress urinary incontinence|stress urinary incontinence
1236547|NCT01866085|post prostatectomy|post prostatectomy
1236548|NCT01866072|ACLF|aclf
1236549|NCT01866072|AVH|avh
1236550|NCT01866072|Fibroscan|fibroscan
1236551|NCT01866072|Transient elastography|transient elastography
1236552|NCT01866059|root caries|root caries
1236553|NCT01866059|GIC|gic
1236554|NCT01866059|RMGIC|rmgic
1236555|NCT01866059|Biodentine|biodentine
1236556|NCT01866059|Calcium silicate|calcium silicate
1236557|NCT01866046|battered women|battered women
1236558|NCT01866046|HIV risk|hiv risk
1236559|NCT01866046|STI risk|sti risk
1236560|NCT01866033|Healthy volunteer|healthy volunteer
1236561|NCT01866033|PCI-32765|pci-32765
1236562|NCT01866033|PCI 45227|pci 45227
1236563|NCT01866033|13C6 PCI-32765|13c6 pci-32765
1236564|NCT01866033|Pharmacokinetic|pharmacokinetic
1236565|NCT01866033|Bioavailability|bioavailability
1236566|NCT01866020|aspergillosis|aspergillosis
1236567|NCT01866020|fungal infection|fungal infection
1236568|NCT01866020|ICU|icu
1236569|NCT01866007|Healthy|healthy
1236570|NCT01866007|Guselkumab|guselkumab
1236571|NCT01866007|CNTO1959|cnto1959
1236572|NCT01866007|Pharmacokinetics|pharmacokinetics
1236573|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
1236574|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
1236575|NCT01865994|Cardiac Output|cardiac output
1236576|NCT01865994|esCCO|escco
1236577|NCT01865994|TEE|tee
1236578|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
1236579|NCT01865981|iPS cells|ips cells
1236580|NCT01865981|cardiomyocytes|cardiomyocytes
1236581|NCT01865981|Brugada|brugada
1236582|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
1236583|NCT01865981|electrophysiology|electrophysiology
1236584|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
1236585|NCT01865955|Ultrasound|ultrasound
1236586|NCT01865955|Spinal anesthesia|spinal anesthesia
1236587|NCT01865955|Cesarean section|cesarean section
1236588|NCT01865942|spinal metastases|spinal metastases
1236589|NCT01865942|spine surgery|spine surgery
1236590|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
1236591|NCT01865942|EQ-5D|eq-5d
1236592|NCT01865942|HRQOL|hrqol
1236593|NCT01865903|NSCLC|nsclc
1236594|NCT01865903|sarcopenia|sarcopenia
1236595|NCT01865903|cachexia|cachexia
1236596|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
1236597|NCT01865877|Parkinson's disease|parkinson's disease
1236598|NCT01865877|Motor|motor
1236599|NCT01865877|Non-motor|non-motor
1236601|NCT01865877|Complications|complications
1236602|NCT01865864|CPAP|cpap
1236603|NCT01865864|diurnal blood pressure|diurnal blood pressure
1236604|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
1236605|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
1236606|NCT01865851|Inspired oxygen|inspired oxygen
1236607|NCT01865851|end-tidal oxygen|end-tidal oxygen
1322710|NCT01487330|TAVI|tavi
1236608|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
1236609|NCT01865851|respiratory rate|respiratory rate
1236610|NCT01865851|preoxygenation|preoxygenation
1236611|NCT01865851|classic face mask|classic face mask
1236612|NCT01865851|NuMask|numask
1236613|NCT01865838|Total thyroidectomy|total thyroidectomy
1236614|NCT01865838|Seprafilm|seprafilm
1236615|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
1236616|NCT01865825|Erosive Esophagitis|erosive esophagitis
1236617|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
1236618|NCT01865799|FTC/TDF|ftc/tdf
1236619|NCT01865799|PrEP|prep
1236620|NCT01865799|Truvada|truvada
1236621|NCT01865799|Drug utilization|drug utilization
1236622|NCT01865786|FTC/TDF|ftc/tdf
1236623|NCT01865786|Truvada|truvada
1236624|NCT01865786|PrEP|prep
1236625|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
1236626|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
1236627|NCT01865760|Insulin secretion|insulin secretion
1236628|NCT01865760|Hypoglycemia|hypoglycemia
1236629|NCT01865747|renal cell cancer|renal cell cancer
1236630|NCT01865747|kidney|kidney
1236631|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
1236632|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1236633|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
1236634|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
1236635|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
1236636|NCT01865734|Heel Pain|heel pain
1236637|NCT01865734|Physical Therapy|physical therapy
1236638|NCT01865734|Podiatry|podiatry
1236639|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
1236640|NCT01865734|Exercise Therapy|exercise therapy
1236641|NCT01865721|Bowel cancer screening|bowel cancer screening
1236642|NCT01865721|Analgesia|analgesia
1236643|NCT01865721|Entonox|entonox
1236644|NCT01865721|Pain|pain
1236645|NCT01865721|Side effects|side effects
1236646|NCT01865721|Colonoscopy|colonoscopy
1236647|NCT01865708|Ethanol Lock|ethanol lock
1236648|NCT01865708|Alcohol lock|alcohol lock
1236649|NCT01865708|Urinary catheter|urinary catheter
1236650|NCT01865708|Safety|safety
1236651|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
1236652|NCT01865695|faecal elastase|faecal elastase
1236653|NCT01865695|diarrhoea|diarrhoea
1236654|NCT01865695|coeliac|coeliac
1236655|NCT01865695|creon|creon
1236656|NCT01865695|gastrointestinal|gastrointestinal
1236657|NCT01865682|Ankle|ankle
1236658|NCT01865682|Knee|knee
1236659|NCT01865682|Orthosis|orthosis
1236660|NCT01865682|Kinematics|kinematics
1236661|NCT01865682|Kinetics|kinetics
1236662|NCT01865669|Uterine contraction|uterine contraction
1236663|NCT01865669|Dose response|dose response
1236664|NCT01865669|Oxytocin|oxytocin
1236665|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
1236666|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
1236667|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
1236668|NCT01865643|Laryngoscopy|laryngoscopy
1236669|NCT01865643|Intubation|intubation
1236670|NCT01865643|Glidescope|glidescope
1236671|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
1236672|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
1236673|NCT01865591|hypertension|hypertension
1236674|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
1236675|NCT01865591|resistant hypertension|resistant hypertension
1236676|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1236677|NCT01865565|GIST|gist
1236678|NCT01865565|neoadjuvant|neoadjuvant
1236679|NCT01865565|imatinib|imatinib
1236680|NCT01865552|Pharmacokinetics|pharmacokinetics
1236681|NCT01865539|Chronic lower back pain|chronic lower back pain
1236682|NCT01865539|Custom foot orthotics|custom foot orthotics
1236683|NCT01865539|Veterans|veterans
1236684|NCT01865526|Chronic kidney disease|chronic kidney disease
1236685|NCT01865526|Low protein diet|low protein diet
1236686|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
1236687|NCT01865513|Anaesthesia|anaesthesia
1236688|NCT01865513|Anaesthesiology|anaesthesiology
1236689|NCT01865513|muscle Relaxants|muscle relaxants
1236690|NCT01865513|POPULAR|popular
1236691|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
1236692|NCT01865513|Respiratory failure|respiratory failure
1236693|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
1236694|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
1236695|NCT01865513|Pleural effusion|pleural effusion
1236696|NCT01865513|Atelectasis|atelectasis
1236697|NCT01865513|Pneumothorax|pneumothorax
1236698|NCT01865513|Bronchospasm|bronchospasm
1236699|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
1236700|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
1333163|NCT01444261|iron deficiency|iron deficiency
1236701|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
1236702|NCT01865513|neuromuscular blockade|neuromuscular blockade
1236703|NCT01865513|europe|europe
1236704|NCT01865500|COPD exacerbation|copd exacerbation
1236705|NCT01865500|Nebulized budesonide|nebulized budesonide
1236706|NCT01865500|Parenteral steroid|parenteral steroid
1236707|NCT01865487|BCG Vaccinated|bcg vaccinated
1236708|NCT01865487|HIV Negative|hiv negative
1236709|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
1236710|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
1236711|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
1236712|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
1236713|NCT01865448|Obesity|obesity
1236714|NCT01865448|Inflammation|inflammation
1236715|NCT01865409|Newborn|newborn
1236716|NCT01865409|Prematures|prematures
1236717|NCT01865409|Feeding difficulty|feeding difficulty
1236718|NCT01865409|Kangaroo Care|kangaroo care
1236719|NCT01865409|Heart rate variability|heart rate variability
1236720|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
1236721|NCT01865266|mechanical ventilation|mechanical ventilation
1236722|NCT01865266|ulinastatin for injection|ulinastatin for injection
1236723|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
1236724|NCT01865266|inflammatory factors|inflammatory factors
1236725|NCT01865253|renal denervation|renal denervation
1236726|NCT01865253|blood pressure|blood pressure
1236727|NCT01865253|cardiovascular risk|cardiovascular risk
1236728|NCT01865253|target organ damage|target organ damage
1236729|NCT01865253|sympathetic activity|sympathetic activity
1236730|NCT01865253|chronic kidney disease|chronic kidney disease
1236731|NCT01865253|non-compliance|non-compliance
1236732|NCT01865240|renal denervation|renal denervation
1236733|NCT01865240|blood pressure|blood pressure
1236734|NCT01865240|cardiovascular risk|cardiovascular risk
1236735|NCT01865240|target organ damage|target organ damage
1236736|NCT01865240|sympathetic activity|sympathetic activity
1236737|NCT01865227|Obesity|obesity
1236738|NCT01865227|Bariatric surgery|bariatric surgery
1236739|NCT01865227|Binge Eating Disorder|binge eating disorder
1236740|NCT01865227|Psychological Health|psychological health
1236741|NCT01865227|Counselling|counselling
1236742|NCT01865201|Radiotherapy|radiotherapy
1236743|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
1236744|NCT01865201|Edaravone|edaravone
1236745|NCT01865201|Effectiveness|effectiveness
1236746|NCT01865201|Safety|safety
1236747|NCT01865188|LCZ696,|lcz696,
1236748|NCT01865188|amlodipine,|amlodipine,
1236749|NCT01865188|hypertension,|hypertension,
1236750|NCT01865188|ABPM|abpm
1236751|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
1236752|NCT01865149|Child|child
1236753|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
1236754|NCT01865149|Hydrocephalus|hydrocephalus
1236755|NCT01865149|Intracranial hypertension|intracranial hypertension
1236756|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
1236757|NCT01865123|transcendental meditation|transcendental meditation
1236758|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
1236759|NCT01865123|prolonged exposure|prolonged exposure
1236760|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
1236761|NCT01865110|RCHOP|rchop
1236762|NCT01865110|RHAD|rhad
1236763|NCT01865110|rituximab|rituximab
1236764|NCT01865110|lenalidomide|lenalidomide
1236765|NCT01865097|Imagery|imagery
1236766|NCT01865097|Pain|pain
1236767|NCT01865097|Depression|depression
1236768|NCT01865097|Non-Motor|non-motor
1236769|NCT01865071|ileostomy|ileostomy
1236770|NCT01865071|rectal resection|rectal resection
1236771|NCT01865071|proctectomy|proctectomy
1236772|NCT01865071|stoma closure|stoma closure
1236773|NCT01865071|rectal cancer|rectal cancer
1236774|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
1236775|NCT01864993|gluten|gluten
1236776|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
1236777|NCT01864993|functional disorders|functional disorders
1236778|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
1236779|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
1236780|NCT01864967|capillaries|capillaries
1236781|NCT01864967|macrophags|macrophags
1236782|NCT01864967|fibroblasts|fibroblasts
1236783|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
1236784|NCT01864954|Smoking|smoking
1236785|NCT01864954|Postpartum|postpartum
1236786|NCT01864954|Pregnancy|pregnancy
1236787|NCT01864954|Quit|quit
1236788|NCT01864954|Tobacco|tobacco
1236789|NCT01864954|Abstinence|abstinence
1236790|NCT01864954|Relapse|relapse
1236791|NCT01864954|Relapse prevention|relapse prevention
1236792|NCT01864941|Multiple Sclerosis|multiple sclerosis
1236794|NCT01864941|CCSVI|ccsvi
1236795|NCT01864941|Zamboni|zamboni
1236796|NCT01864941|catheter venography|catheter venography
1236797|NCT01864941|balloon angioplasty|balloon angioplasty
1236798|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
1236799|NCT01864928|ePRISM|eprism
1236800|NCT01864915|colon capsule|colon capsule
1236801|NCT01864915|bowel preparation|bowel preparation
1236802|NCT01864915|booster|booster
1236803|NCT01864915|prucalopride|prucalopride
1236804|NCT01864915|picosalax|picosalax
1236805|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
1236806|NCT01864850|HNSCC|hnscc
1236807|NCT01864850|Elderly|elderly
1236808|NCT01864850|Geriatry|geriatry
1236809|NCT01864837|tongue coating thickness|tongue coating thickness
1236810|NCT01864837|tongue diagnosis system|tongue diagnosis system
1236811|NCT01864837|tongue coating percentage|tongue coating percentage
1236812|NCT01864837|availability|availability
1236813|NCT01864837|diagnostic device|diagnostic device
1236814|NCT01864824|air pollution|air pollution
1236815|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
1236816|NCT01864824|methyl donor|methyl donor
1236817|NCT01864824|DNA methylation|dna methylation
1236818|NCT01864824|mRNA|mrna
1236819|NCT01864824|epigenetics|epigenetics
1236820|NCT01864824|controlled human exposures|controlled human exposures
1236821|NCT01864824|cardiovascular responses|cardiovascular responses
1236822|NCT01864811|infants|infants
1236823|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
1236824|NCT01864811|hand function|hand function
1236825|NCT01864811|early intervention|early intervention
1236826|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
1236827|NCT01864798|Young|young
1236828|NCT01864798|Breast Neoplasms|breast neoplasms
1236829|NCT01864798|Denosumab|denosumab
1236830|NCT01864798|RANKL|rankl
1236831|NCT01864785|Operative treatment|operative treatment
1236832|NCT01864785|internal fixation|internal fixation
1236833|NCT01864785|posterior spinal fusion|posterior spinal fusion
1236834|NCT01864772|HNSCC|hnscc
1236835|NCT01864772|Metastatic|metastatic
1236836|NCT01864772|Recurrent|recurrent
1236837|NCT01864772|Elderly|elderly
1236838|NCT01864772|Geriatry|geriatry
1236839|NCT01864759|melanoma|melanoma
1236840|NCT01864759|oncolytic|oncolytic
1236841|NCT01864759|adenovirus|adenovirus
1236842|NCT01864759|virotherapy|virotherapy
1236843|NCT01864759|locally advanced|locally advanced
1236844|NCT01864759|metastatic|metastatic
1236845|NCT01864733|Chronic heart failure|chronic heart failure
1236846|NCT01864733|Undernutrition|undernutrition
1236847|NCT01864733|Rehabilitation|rehabilitation
1236848|NCT01864733|Physical exercise|physical exercise
1236849|NCT01864733|Nutrition|nutrition
1236850|NCT01864733|n-3 fatty acids|n-3 fatty acids
1236851|NCT01864733|Androgen|androgen
1236852|NCT01864733|Testosterone|testosterone
1236853|NCT01864720|stepped care model|stepped care model
1236854|NCT01864720|insomnia|insomnia
1236855|NCT01864720|cancer|cancer
1236856|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
1236857|NCT01864720|self-help treatment|self-help treatment
1236858|NCT01864720|Internet|internet
1236859|NCT01864720|non-inferiority design|non-inferiority design
1236860|NCT01864720|cost-effectiveness|cost-effectiveness
1236861|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
1236862|NCT01864694|behavioral research|behavioral research
1236863|NCT01864694|diet|diet
1236864|NCT01864694|health information systems|health information systems
1236865|NCT01864681|NSCLC|nsclc
1236866|NCT01864681|TKIs|tkis
1236867|NCT01864681|Metformin|metformin
1236869|NCT01864681|overall survival|overall survival
1236870|NCT01864681|IL-6|il-6
1236871|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
1236872|NCT01864668|lung strain|lung strain
1236873|NCT01864668|small tidal volume|small tidal volume
1236874|NCT01864616|Vitamin D|vitamin d
1236875|NCT01864616|Crohn disease|crohn disease
1236876|NCT01864616|Disease activity|disease activity
1236877|NCT01864616|Inflammation|inflammation
1236878|NCT01864616|prevention|prevention
1236879|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
1236880|NCT01864603|Tuberculosis|tuberculosis
1236881|NCT01864603|Community health campaign|community health campaign
1236882|NCT01864603|PrEP|prep
1236883|NCT01864590|Open Abdomen|open abdomen
1236884|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
1236885|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
1236886|NCT01864590|Mesh|mesh
1236887|NCT01864590|Abdominal reconstruction|abdominal reconstruction
1236888|NCT01864564|Gestational diabetes|gestational diabetes
1236889|NCT01864564|Screening|screening
1236890|NCT01864564|Obesity|obesity
1236891|NCT01864564|Anhydroglucitol|anhydroglucitol
1236892|NCT01864538|TH-302|th-302
1236893|NCT01864538|Advanced Melanoma|advanced melanoma
1236894|NCT01864538|Metastatic|metastatic
1236895|NCT01864538|Biomarker|biomarker
1236896|NCT01864538|Mucosal Melanoma|mucosal melanoma
1236897|NCT01864538|Evofosfamide|evofosfamide
1236898|NCT01864525|voice|voice
1236899|NCT01864525|tremor|tremor
1236900|NCT01864525|essential tremor|essential tremor
1236901|NCT01864525|essential voice tremor|essential voice tremor
1236902|NCT01864525|voice treatment|voice treatment
1236903|NCT01864525|octanoic acid|octanoic acid
1236904|NCT01864525|octanol|octanol
1236905|NCT01864525|voice disorder|voice disorder
1236906|NCT01864525|dysphonia|dysphonia
1236907|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
1236908|NCT01864512|eltrombopag|eltrombopag
1236909|NCT01864512|immune regulation|immune regulation
1236910|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
1236911|NCT01864460|autonomic|autonomic
1236912|NCT01864460|neuropathy|neuropathy
1236913|NCT01864460|balance|balance
1236914|NCT01864460|exercise|exercise
1236916|NCT01864447|Exercise|exercise
1236917|NCT01864447|Diet|diet
1236918|NCT01864447|Weight loss|weight loss
1236919|NCT01864447|DVT|dvt
1236920|NCT01864447|PE|pe
1236921|NCT01864434|Knee Prosthesis|knee prosthesis
1236922|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
1236923|NCT01864434|Cruciate Retaining|cruciate retaining
1236924|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
1236925|NCT01864421|Infant, Newborn|infant, newborn
1236926|NCT01864421|Delivery, Obstetric|delivery, obstetric
1236927|NCT01864421|Umbilical Cord|umbilical cord
1236928|NCT01864408|Patient counseling|patient counseling
1236929|NCT01864408|Patient satisfaction|patient satisfaction
1236930|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
1236931|NCT01864395|cardiovascular surgery|cardiovascular surgery
1236932|NCT01864395|cardiac surgery|cardiac surgery
1236933|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
1236934|NCT01864395|IV fluids|iv fluids
1236935|NCT01864395|blood pressure|blood pressure
1236936|NCT01864395|heart-lung machine|heart-lung machine
1236937|NCT01864395|hemofilter|hemofilter
1236938|NCT01864395|online MUF|online muf
1236939|NCT01864395|offline MUF|offline muf
1236940|NCT01864395|modified ultrafiltration|modified ultrafiltration
1236941|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
1236942|NCT01864395|centrifugation method|centrifugation method
1236943|NCT01864395|blood transfusion|blood transfusion
1236944|NCT01864395|plasma proteins|plasma proteins
1236945|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
1236946|NCT01864395|hemoglobin|hemoglobin
1236947|NCT01864395|clotting factors|clotting factors
1236948|NCT01864395|systemic blood pressure|systemic blood pressure
1236949|NCT01864395|cardiac index|cardiac index
1236950|NCT01864395|cytokines|cytokines
1236951|NCT01864395|post-operative bleeding|post-operative bleeding
1236952|NCT01864395|protamine administration|protamine administration
1236953|NCT01864395|patient size|patient size
1236954|NCT01864395|allogeneic transfusion|allogeneic transfusion
1236955|NCT01864395|total protein|total protein
1236956|NCT01864395|albumin|albumin
1236957|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
1236958|NCT01864395|fluid balance|fluid balance
1236959|NCT01864395|chest tube loss|chest tube loss
1236960|NCT01864395|length of stay|length of stay
1236961|NCT01864395|ventilation time|ventilation time
1236962|NCT01864395|markers of inflammation|markers of inflammation
1236963|NCT01864382|Trunk performance|trunk performance
1236964|NCT01864382|exercise,|exercise,
1236965|NCT01864382|"core stability,"|"core stability,"
1236966|NCT01864382|sitting balance|sitting balance
1236967|NCT01864369|Heart Failure|heart failure
1236968|NCT01864369|e-counseling|e-counseling
1236969|NCT01864369|quality of life|quality of life
1236970|NCT01864369|self-care|self-care
1236971|NCT01864356|IVF failure|ivf failure
1236972|NCT01864356|Repeated IVF failure|repeated ivf failure
1236973|NCT01864356|Implantation failure|implantation failure
1236974|NCT01864356|Repeated implantation failure|repeated implantation failure
1236976|NCT01864356|NT100|nt100
1236977|NCT01864343|Myocardial Infarction|myocardial infarction
1236978|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
1236979|NCT01864343|Reperfusion Injury|reperfusion injury
1236980|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
1236981|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
1236982|NCT01864343|Myocardial Ischemia|myocardial ischemia
1236983|NCT01864330|topical lubricants|topical lubricants
1236984|NCT01864330|optical coherence tomography|optical coherence tomography
1236985|NCT01864330|tear break up time|tear break up time
1236986|NCT01864330|Schirmer I test|schirmer i test
1236987|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
1236988|NCT01864317|Intraocular Pressure|intraocular pressure
1236989|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
1236990|NCT01864317|Visual Field Test|visual field test
1236991|NCT01864304|Williams Syndrome|williams syndrome
1236992|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
1236993|NCT01864291|ABI|abi
1236994|NCT01864291|Nucleus 24|nucleus 24
1236995|NCT01864291|Deafness|deafness
1236996|NCT01864291|Hearing loss|hearing loss
1236997|NCT01864291|Non-tumor|non-tumor
1236998|NCT01864291|Non-NF2|non-nf2
1236999|NCT01864291|Pediatric|pediatric
1237000|NCT01864291|ABI541|abi541
1237001|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
1237002|NCT01864265|functional MRI|functional mri
1237003|NCT01864265|Prediction of Response|prediction of response
1237004|NCT01864265|Certolizumab Pegol|certolizumab pegol
1237005|NCT01864265|RF and/or ACPA positive|rf and/or acpa positive
1237006|NCT01864239|Adherence|adherence
1237007|NCT01864187|Pharmacokinetics|pharmacokinetics
1237008|NCT01864187|Dexmedetomidine|dexmedetomidine
1237009|NCT01864187|Obesity|obesity
1237010|NCT01864122|nutrient biomarkers|nutrient biomarkers
1237011|NCT01864122|food frequency questionnaire|food frequency questionnaire
1237012|NCT01864122|predictors of CVD|predictors of cvd
1237013|NCT01864122|fatty acids|fatty acids
1237014|NCT01864122|phylloquinone|phylloquinone
1237015|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
1237016|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1237017|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
1237018|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
1237019|NCT01864109|IFOSFAMIDE|ifosfamide
1237020|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1237021|NCT01864109|TEMOZOLOMIDE|temozolomide
1237022|NCT01864109|VINCRISTINE|vincristine
1237023|NCT01864109|13-068|13-068
1237024|NCT01864096|localized|localized
1237025|NCT01864096|prostate|prostate
1237026|NCT01864096|cancer|cancer
1237027|NCT01864096|metformin|metformin
1237028|NCT01864096|active surveillance|active surveillance
1237029|NCT01864083|FACBC PET/PEM|facbc pet/pem
1237030|NCT01864083|MR|mr
1237031|NCT01864083|11-177|11-177
1237032|NCT01864070|Liver cancer|liver cancer
1237033|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
1237034|NCT01864070|NET|net
1237035|NCT01864070|Liver dominant disease|liver dominant disease
1237036|NCT01864070|TheraSphere|therasphere
1237037|NCT01864070|Yttrium-90|yttrium-90
1237038|NCT01864070|Y-90|y-90
1237039|NCT01864070|Everolimus|everolimus
1237040|NCT01864070|Afinitor|afinitor
1237041|NCT01864070|Zortress|zortress
1237042|NCT01864070|RAD001|rad001
1237043|NCT01864070|Microspheres|microspheres
1237130|NCT01863706|Oxytocin|oxytocin
1237044|NCT01864057|thiamine deficiency|thiamine deficiency
1237045|NCT01864031|Alcohol|alcohol
1237046|NCT01864031|Drinking|drinking
1237047|NCT01864031|Abstainers|abstainers
1237048|NCT01864031|Former drinkers|former drinkers
1237049|NCT01864031|Ex-drinkers|ex-drinkers
1237050|NCT01864031|Aetiology|aetiology
1237051|NCT01864031|Initial presentation|initial presentation
1237052|NCT01864031|Chronic Stable Angina|chronic stable angina
1237053|NCT01864031|Unstable Angina|unstable angina
1237054|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
1237055|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
1237056|NCT01864031|Heart Failure|heart failure
1237057|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
1237058|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
1237059|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
1237060|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
1237061|NCT01864031|Cardiac Arrest|cardiac arrest
1237062|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1237063|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
1237064|NCT01864031|Ischaemic Stroke|ischaemic stroke
1237065|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
1237066|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
1237067|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
1237068|NCT01864031|Sudden Cardiac Death|sudden cardiac death
1237069|NCT01864031|Unheralded Coronary Death|unheralded coronary death
1237070|NCT01864031|Mortality|mortality
1237071|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
1237072|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1237073|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
1237074|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
1237075|NCT01863992|home ventilation|home ventilation
1237076|NCT01863979|Atrial Fibrillation|atrial fibrillation
1237077|NCT01863979|Thromboembolism|thromboembolism
1237078|NCT01863966|Achalasia|achalasia
1237079|NCT01863966|Hot water drinking therapy|hot water drinking therapy
1237080|NCT01863966|Pneumatic dilation|pneumatic dilation
1237081|NCT01863914|ESRD|esrd
1237082|NCT01863914|Diabetes mellitus|diabetes mellitus
1237083|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
1237084|NCT01863914|Hemodialysis|hemodialysis
1237085|NCT01863914|rosuvastatin|rosuvastatin
1237086|NCT01863875|Cochlear Implant|cochlear implant
1237087|NCT01863875|Hearing loss|hearing loss
1237088|NCT01863875|Language Development|language development
1237089|NCT01863875|Quality of life|quality of life
1237090|NCT01863862|Rectal cancer|rectal cancer
1237091|NCT01863862|Chemoradiation|chemoradiation
1237092|NCT01863862|Complete pathological response|complete pathological response
1237093|NCT01863849|uncontrolled,|uncontrolled,
1237094|NCT01863849|open,|open,
1237095|NCT01863849|multi-centre|multi-centre
1237096|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
1333165|NCT01444248|Amaryl MEX|amaryl mex
1237195|NCT01863407|Intestinal Obstruction|intestinal obstruction
1237097|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
1237098|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
1237099|NCT01863836|Peripheral lung lesion|peripheral lung lesion
1237100|NCT01863836|Fluoroscopy|fluoroscopy
1237101|NCT01863836|Lung cancer|lung cancer
1237102|NCT01863823|Symptomatic patients|symptomatic patients
1237103|NCT01863823|asymptomatic individuals|asymptomatic individuals
1237104|NCT01863823|clinical trial|clinical trial
1237105|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
1237106|NCT01863810|Neuropathic Pain|neuropathic pain
1237107|NCT01863810|Pregabalin|pregabalin
1237108|NCT01863784|Hepatic Impairment|hepatic impairment
1237109|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
1237110|NCT01863784|Normal hepatic function|normal hepatic function
1237111|NCT01863784|Pharmacokinetics|pharmacokinetics
1237112|NCT01863784|JNJ-38518168|jnj-38518168
1237113|NCT01863771|Ulcerative Colitis|ulcerative colitis
1237114|NCT01863771|Japanese|japanese
1237115|NCT01863771|Subcutaneous|subcutaneous
1237116|NCT01863771|Golimumab|golimumab
1237117|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
1237118|NCT01863745|gastrointestinal,|gastrointestinal,
1237119|NCT01863745|stromal,|stromal,
1237120|NCT01863745|tumors,|tumors,
1237121|NCT01863745|GIST,|gist,
1237122|NCT01863745|AMN107,|amn107,
1237123|NCT01863745|nilotinib|nilotinib
1237124|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
1237125|NCT01863719|Colistin|colistin
1237126|NCT01863719|Multi Drug Resistant|multi drug resistant
1237127|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
1237128|NCT01863719|Pneumococcal Infections|pneumococcal infections
1237129|NCT01863706|Misoprostol|misoprostol
1237131|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
1237132|NCT01863706|Third stage of labour|third stage of labour
1237133|NCT01863680|Infertility|infertility
1237134|NCT01863680|COL-1620|col-1620
1237135|NCT01863680|progesterone gel|progesterone gel
1237136|NCT01863680|Fertilization in Vitro|fertilization in vitro
1237137|NCT01863680|Embryo Transfer|embryo transfer
1237138|NCT01863654|Bioequivalence|bioequivalence
1237139|NCT01863654|Mexico|mexico
1237140|NCT01863654|Asthma|asthma
1237141|NCT01863654|Montelukast|montelukast
1237142|NCT01863654|Chewable|chewable
1237143|NCT01863641|lupus nephritis|lupus nephritis
1237144|NCT01863641|proteinuria|proteinuria
1237145|NCT01863641|SLE|sle
1237146|NCT01863641|calcitriol|calcitriol
1237147|NCT01863628|Prodromal Symptoms|prodromal symptoms
1237148|NCT01863628|bipolar disorder|bipolar disorder
1237149|NCT01863628|Neuropsychological Tests|neuropsychological tests
1237150|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
1237151|NCT01863628|Treatment Outcome|treatment outcome
1237152|NCT01863628|aerobic exercise|aerobic exercise
1237153|NCT01863628|psychotherapy|psychotherapy
1237154|NCT01863615|pharmacokinetics|pharmacokinetics
1237155|NCT01863615|Isotretinoin|isotretinoin
1237156|NCT01863615|bioequivalence|bioequivalence
1237157|NCT01863615|Mexico|mexico
1237158|NCT01863576|Chagas disease|chagas disease
1237159|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
1237160|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
1237161|NCT01863576|Omega-3|omega-3
1237162|NCT01863576|Cytokines|cytokines
1237163|NCT01863576|Lipid profile|lipid profile
1237164|NCT01863576|Nutritional assessment|nutritional assessment
1237165|NCT01863563|tonsillectomy|tonsillectomy
1237166|NCT01863563|adenoidectomy|adenoidectomy
1237167|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
1237168|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
1237169|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
1237170|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1237171|NCT01863524|Patients over 65 years old|patients over 65 years old
1237172|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
1237173|NCT01863511|Ultrafiltration|ultrafiltration
1237174|NCT01863511|tolvaptan|tolvaptan
1237175|NCT01863498|pectus excavatum|pectus excavatum
1237176|NCT01863498|pain control|pain control
1237177|NCT01863485|advanced cancer|advanced cancer
1237178|NCT01863459|ADHD|adhd
1237179|NCT01863459|ADD|add
1237180|NCT01863459|Anxiety|anxiety
1237181|NCT01863459|Anxiety Disorders|anxiety disorders
1237182|NCT01863459|Depression|depression
1237183|NCT01863459|Attention|attention
1237184|NCT01863459|Attention Deficit|attention deficit
1237185|NCT01863446|Pregnancy|pregnancy
1237186|NCT01863446|Melatonin|melatonin
1237187|NCT01863446|Contractions|contractions
1237188|NCT01863446|Light|light
1237189|NCT01863420|gastric cancer|gastric cancer
1237190|NCT01863420|rectal cancer|rectal cancer
1237191|NCT01863420|bone marrow toxicity|bone marrow toxicity
1237192|NCT01863420|IMRT|imrt
1237193|NCT01863420|hematologic toxicity|hematologic toxicity
1237194|NCT01863407|Ileus|ileus
1237196|NCT01863407|Intestinal Diseases|intestinal diseases
1237197|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
1237198|NCT01863407|Digestive System Diseases|digestive system diseases
1237199|NCT01863394|Screening|screening
1237200|NCT01863394|Malnutrition|malnutrition
1237201|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
1237202|NCT01863381|Hydrocephalus|hydrocephalus
1237203|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
1237204|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
1237206|NCT01863381|Intracranial pressure|intracranial pressure
1237207|NCT01863381|CSF pressure|csf pressure
1237208|NCT01863381|VIIP|viip
1237209|NCT01863368|Dry eye syndrome|dry eye syndrome
1237210|NCT01863368|Systane Ultra|systane ultra
1237211|NCT01863368|Optive|optive
1237212|NCT01863368|Ocular Surface Staining|ocular surface staining
1237213|NCT01863368|OSDI|osdi
1237214|NCT01863368|Eye drops|eye drops
1237215|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
1237216|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
1237217|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
1237218|NCT01863329|Hydrocephalus|hydrocephalus
1237219|NCT01863329|Intracranial hypertension|intracranial hypertension
1237220|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
1237221|NCT01863303|colorectal cancer|colorectal cancer
1237222|NCT01863303|epidemiology|epidemiology
1237223|NCT01863303|industry|industry
1237224|NCT01863303|genetic|genetic
1237225|NCT01863290|prison|prison
1237226|NCT01863290|reentry|reentry
1237227|NCT01863290|health care utilization|health care utilization
1237228|NCT01863264|dysphagia|dysphagia
1237229|NCT01863264|swallowing|swallowing
1237230|NCT01863264|infant|infant
1237231|NCT01863264|premature|premature
1237232|NCT01863264|neonate|neonate
1237233|NCT01863264|thermal|thermal
1237234|NCT01863264|cold|cold
1237235|NCT01863264|bolus|bolus
1237236|NCT01863264|temperature|temperature
1237237|NCT01863264|deglutition|deglutition
1237238|NCT01863264|NICU|nicu
1237239|NCT01863264|bottle|bottle
1237240|NCT01863264|nippling|nippling
1237241|NCT01863251|Opiates|opiates
1237242|NCT01863251|ATS|ats
1237243|NCT01863251|HIV Risks|hiv risks
1237244|NCT01863238|Cystic Fibrosis|cystic fibrosis
1237245|NCT01863199|Wet AMD|wet amd
1237246|NCT01863199|AMD|amd
1237247|NCT01863199|Choroidal neovascularization|choroidal neovascularization
1237248|NCT01863199|Neovascular membrane|neovascular membrane
1237249|NCT01863186|lofexidine|lofexidine
1237250|NCT01863186|opioid dependence|opioid dependence
1237251|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
1237252|NCT01863186|opioid withdrawal|opioid withdrawal
1237253|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
1237254|NCT01863173|metoprolol succinate|metoprolol succinate
1237255|NCT01863173|echocardiography|echocardiography
1237256|NCT01863173|six minute walk test|six minute walk test
1237257|NCT01863160|Safety|safety
1237258|NCT01863160|Tolerability|tolerability
1237259|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
1237260|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
1237261|NCT01863160|administered topically|administered topically
1237262|NCT01863147|Type 2 diabetes|type 2 diabetes
1237263|NCT01863147|left ventricular mass|left ventricular mass
1237264|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
1237265|NCT01863121|cirrhosis|cirrhosis
1237266|NCT01863121|CTPK|ctpk
1237267|NCT01863121|CTP|ctp
1237268|NCT01863121|MELD|meld
1237269|NCT01863121|Severity Score|severity score
1237270|NCT01863108|Melanoma|melanoma
1237271|NCT01863108|Immunotherapy|immunotherapy
1237272|NCT01863108|Dermatology|dermatology
1237273|NCT01863108|cancer vaccine|cancer vaccine
1237274|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
1237275|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
1237276|NCT01863108|allogeneic|allogeneic
1237277|NCT01863082|Resistant Hypertension|resistant hypertension
1237278|NCT01863069|inhaled|inhaled
1237279|NCT01863069|interferon beta-1a|interferon beta-1a
1237280|NCT01863069|healthy subjects|healthy subjects
1237281|NCT01863056|Sedentary time|sedentary time
1237282|NCT01863056|Non Exercise Activity|non exercise activity
1237283|NCT01863056|Sit Stand Workstation|sit stand workstation
1237284|NCT01863043|Premature Infant|premature infant
1237285|NCT01863043|Nutrition|nutrition
1237286|NCT01863043|Enteral|enteral
1237287|NCT01863030|Resorbable mesh|resorbable mesh
1237288|NCT01863030|Phasix mesh|phasix mesh
1237289|NCT01863017|Obesity|obesity
1237290|NCT01863017|Over weight|over weight
1237291|NCT01862991|Induced Abortion|induced abortion
1237292|NCT01862991|Mifepristone|mifepristone
1237293|NCT01862991|Dilation and Evacuation|dilation and evacuation
1333166|NCT01444235|CAD, ACVB|cad, acvb
1237294|NCT01862991|Cervical Preparation|cervical preparation
1237295|NCT01862991|Osmotic Dilators|osmotic dilators
1237296|NCT01862978|Stroke|stroke
1237297|NCT01862978|Heparin|heparin
1237298|NCT01862978|Nadroparin|nadroparin
1237300|NCT01862965|treatment|treatment
1237301|NCT01862965|prednisone|prednisone
1237302|NCT01862965|everolimus|everolimus
1237303|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
1237304|NCT01862926|connective tissue disease|connective tissue disease
1237305|NCT01862926|interstitial lung disease|interstitial lung disease
1237306|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
1237307|NCT01862926|rituximab|rituximab
1237308|NCT01862926|scleroderma|scleroderma
1237309|NCT01862926|polymyositis|polymyositis
1237310|NCT01862926|dermatomyositis|dermatomyositis
1237311|NCT01862913|depression|depression
1237312|NCT01862913|adolescents|adolescents
1237313|NCT01862900|Breast Cancer|breast cancer
1237314|NCT01862900|Metastatic|metastatic
1237315|NCT01862900|Lung metastases|lung metastases
1237316|NCT01862900|Liver metastases|liver metastases
1237317|NCT01862900|Stereotactic body radiation|stereotactic body radiation
1237318|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
1237319|NCT01862900|MEDI6469|medi6469
1237320|NCT01862900|Immunotherapy|immunotherapy
1237321|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
1237322|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
1237323|NCT01862822|Paediatrics|paediatrics
1237324|NCT01862822|Urinary tract infection|urinary tract infection
1237325|NCT01862822|Urine collection|urine collection
1237326|NCT01862809|Oral Microbiota|oral microbiota
1237327|NCT01862809|Cigarette Smoking|cigarette smoking
1237328|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
1237329|NCT01862796|Food Intake|food intake
1237330|NCT01862796|Weight Loss|weight loss
1237331|NCT01862796|Compliance|compliance
1237332|NCT01862783|Erythrocytes|erythrocytes
1237333|NCT01862783|Parasites|parasites
1237334|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
1237335|NCT01862783|Placenta|placenta
1237336|NCT01862783|Resistant|resistant
1237337|NCT01862770|Lung Cancer|lung cancer
1237338|NCT01862770|Smokers|smokers
1237339|NCT01862770|Genetic Risk Communication|genetic risk communication
1237340|NCT01862770|Smoking Cessation|smoking cessation
1237341|NCT01862757|Obesity|obesity
1237342|NCT01862757|Insulin|insulin
1237343|NCT01862757|Skeletal Muscle|skeletal muscle
1237344|NCT01862757|Strength Testing|strength testing
1237345|NCT01862744|Parkinson's Disease|parkinson's disease
1237346|NCT01862744|MRI|mri
1237347|NCT01862744|Cognitive|cognitive
1237348|NCT01862731|Muscle Force|muscle force
1237349|NCT01862731|Knee|knee
1237350|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
1237351|NCT01862731|Quadriceps|quadriceps
1237352|NCT01862731|Ultrasound|ultrasound
1237353|NCT01862718|Fusion|fusion
1237354|NCT01862718|Tracking|tracking
1237355|NCT01862718|Ablation|ablation
1237356|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
1237357|NCT01862666|Barrett's Esophagus|barrett's esophagus
1237358|NCT01862666|Dysplasia|dysplasia
1237359|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
1237360|NCT01862666|EMR|emr
1237361|NCT01862666|Endoscopy|endoscopy
1237362|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
1237363|NCT01862653|Sleep Disturbance|sleep disturbance
1237364|NCT01862653|Acupuncture|acupuncture
1237365|NCT01862640|OPC-34712|opc-34712
1237366|NCT01862640|brexpiprazole|brexpiprazole
1237367|NCT01862640|Dementia|dementia
1237368|NCT01862640|Alzheimer's Disease|alzheimer's disease
1237369|NCT01862640|Cognitive Disorders|cognitive disorders
1237370|NCT01862640|Memory|memory
1237371|NCT01862640|Agitation|agitation
1237372|NCT01862627|Macular retinoschisis|macular retinoschisis
1237373|NCT01862627|Macular detachment|macular detachment
1237374|NCT01862627|vitrectomy|vitrectomy
1237375|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
1237376|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
1237377|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
1237378|NCT01862588|septic shock|septic shock
1237379|NCT01862588|acute kidney injury|acute kidney injury
1237380|NCT01862588|renal resistive index|renal resistive index
1237381|NCT01862562|Laparoscopic surgery|laparoscopic surgery
1237382|NCT01862562|Colorectal cancer|colorectal cancer
1237383|NCT01862562|Elderly patient|elderly patient
1237384|NCT01862562|Randomized control study|randomized control study
1237385|NCT01862536|Randomized trial|randomized trial
1237386|NCT01862536|COPD|copd
1237387|NCT01862536|tadalafil|tadalafil
1237388|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
1237389|NCT01862536|Pulmonary hypertension|pulmonary hypertension
1237390|NCT01862510|Celiac Disease|celiac disease
1237391|NCT01862510|Hypothyroidism|hypothyroidism
1237392|NCT01862510|Celiac Sprue|celiac sprue
1237393|NCT01862510|Malabsorption|malabsorption
1237394|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
1237395|NCT01862497|Hemodialysis|hemodialysis
1237396|NCT01862497|Hypertension|hypertension
1237397|NCT01862497|Extracellular Volume|extracellular volume
1237398|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
1237399|NCT01862497|Endothelin 1|endothelin 1
1237400|NCT01862497|Carvedilol|carvedilol
1237401|NCT01862484|ADHD|adhd
1237402|NCT01862484|Diet|diet
1237403|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1237404|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
1237405|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1237406|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
1237407|NCT01862471|Doppler Ultrasound|doppler ultrasound
1237408|NCT01862458|empyema|empyema
1237409|NCT01862458|tPA|tpa
1237410|NCT01862458|dornase|dornase
1237411|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
1237412|NCT01862393|electrical stimulation|electrical stimulation
1237413|NCT01862393|torque|torque
1237414|NCT01862380|Adrenocortical function|adrenocortical function
1237415|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
1237416|NCT01862380|21-hydroxylase|21-hydroxylase
1237417|NCT01862380|deficiency|deficiency
1237418|NCT01862380|cortisol|cortisol
1237419|NCT01862380|replacement therapy|replacement therapy
1237420|NCT01862380|Woman|woman
1237421|NCT01862380|Healthy people|healthy people
1237422|NCT01862354|Postoperative analgesia|postoperative analgesia
1237423|NCT01862354|Abdominoplasty|abdominoplasty
1237424|NCT01862354|Continuous wound infusion|continuous wound infusion
1237425|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
1237426|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
1237427|NCT01862354|Regional anesthesia|regional anesthesia
1237428|NCT01862341|Constipation|constipation
1237429|NCT01862341|Bowel movement|bowel movement
1237430|NCT01862341|Intestinal health|intestinal health
1237431|NCT01862328|MLN4924|mln4924
1237432|NCT01862328|Solid Tumors|solid tumors
1237433|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
1237434|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
1237435|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
1237436|NCT01862315|Gemcitabine|gemcitabine
1237437|NCT01862315|Oxaliplatin|oxaliplatin
1237438|NCT01862315|13-066|13-066
1237439|NCT01862302|Prevention delirium|prevention delirium
1237440|NCT01862302|Cardiac surgery|cardiac surgery
1237441|NCT01862289|difficult asthma|difficult asthma
1237442|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
1237443|NCT01862289|prevalence|prevalence
1237444|NCT01862263|Diabetes,|diabetes,
1237445|NCT01862263|Type 2 diabetes,|type 2 diabetes,
1237446|NCT01862263|Diabetes mellitus,|diabetes mellitus,
1237447|NCT01862263|insulin,|insulin,
1237448|NCT01862237|Type II diabetes|type ii diabetes
1237449|NCT01862237|aortic valve stenosis|aortic valve stenosis
1237450|NCT01862237|left ventricular remodeling|left ventricular remodeling
1237451|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
1237452|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
1237453|NCT01862224|JNJ-38518168|jnj-38518168
1237454|NCT01862224|Synovial|synovial
1237455|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
1237456|NCT01862185|semiquantitative|semiquantitative
1237457|NCT01862185|procalcitonin|procalcitonin
1237459|NCT01862185|antibiotics|antibiotics
1237460|NCT01862185|mortality|mortality
1237461|NCT01862172|Cortical focal atrophy|cortical focal atrophy
1237462|NCT01862172|Stroke|stroke
1237463|NCT01862172|Internal capsule|internal capsule
1237464|NCT01862172|Corticospinal tract|corticospinal tract
1237465|NCT01862172|Wallerian degeneration|wallerian degeneration
1237466|NCT01862172|Primary motor area.|primary motor area.
1237467|NCT01862159|bariatric surgery|bariatric surgery
1237468|NCT01862159|postoperative complications|postoperative complications
1237469|NCT01862146|TCA|tca
1237470|NCT01862146|FMD|fmd
1237471|NCT01862146|IMT|imt
1237472|NCT01862146|Smoking|smoking
1237473|NCT01862133|Electronic Health Record|electronic health record
1237474|NCT01862133|Health Information Technology|health information technology
1237475|NCT01862133|Patient Privacy|patient privacy
1237476|NCT01862133|Personal Health Information|personal health information
1237477|NCT01862120|Recently diagnosed|recently diagnosed
1237478|NCT01862120|Regulatory T Cells|regulatory t cells
1237479|NCT01862120|Tolerance Induction|tolerance induction
1237480|NCT01862120|Paediatrics|paediatrics
1237481|NCT01862120|Low dose|low dose
1237482|NCT01862120|IL-2|il-2
1237483|NCT01862107|Biomarkers|biomarkers
1237484|NCT01862107|Immune Responses|immune responses
1237485|NCT01862107|Lumbar Puncture|lumbar puncture
1237486|NCT01862107|Neurological Diseases|neurological diseases
1237487|NCT01862107|Novel Pathogens|novel pathogens
1237488|NCT01862068|Pronostic factors|pronostic factors
1237489|NCT01862068|Neutrophils|neutrophils
1237490|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1237491|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
1597861|NCT00402766|NSSC-716051|nssc-716051
1237492|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
1237493|NCT01862068|Proteomics|proteomics
1237494|NCT01862055|Stress|stress
1237495|NCT01862055|Anxiety|anxiety
1237496|NCT01862055|Cesarean Section|cesarean section
1237497|NCT01862055|Spinal anesthesia|spinal anesthesia
1237498|NCT01862055|Hypotension|hypotension
1237499|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
1237500|NCT01862042|Supportive care|supportive care
1237501|NCT01862042|Palliative care|palliative care
1237502|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
1237503|NCT01862029|Obesity|obesity
1237504|NCT01862029|Roflumilast|roflumilast
1237505|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
1237506|NCT01862029|Pre-Diabetes|pre-diabetes
1237507|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
1237508|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
1237509|NCT01862016|Spontaneous breathing|spontaneous breathing
1237510|NCT01862016|Intensive Care Unit|intensive care unit
1237511|NCT01862003|Colorectal cancer|colorectal cancer
1237512|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
1237513|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
1237514|NCT01862003|FOLFIRI|folfiri
1237515|NCT01862003|AZD8931|azd8931
1237516|NCT01862003|Chemotherapy|chemotherapy
1237517|NCT01862003|EGFR|egfr
1237518|NCT01861990|Glioma|glioma
1237519|NCT01861990|Glioblastoma|glioblastoma
1237520|NCT01861990|Pediatric|pediatric
1237521|NCT01861990|Child|child
1237522|NCT01861990|Brain tumor|brain tumor
1237523|NCT01861990|Astrocytoma|astrocytoma
1237524|NCT01861990|Medulloblastoma|medulloblastoma
1237525|NCT01861990|PNET|pnet
1237526|NCT01861977|Cognitive Therapy|cognitive therapy
1237527|NCT01861977|Health Education|health education
1237528|NCT01861977|Secondary Prevention|secondary prevention
1237529|NCT01861977|Cardiovascular Disease|cardiovascular disease
1237531|NCT01861964|Xylooligosarcharide|xylooligosarcharide
1237532|NCT01861964|Prebiotic|prebiotic
1237533|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
1237534|NCT01861951|firstline treatment|firstline treatment
1237535|NCT01861951|eldery patients|eldery patients
1237536|NCT01861938|melanoma|melanoma
1237537|NCT01861938|vaccine|vaccine
1237740|NCT01860859|cesarean|cesarean
1237538|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
1237539|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
1237540|NCT01861938|Patients with low-burden|patients with low-burden
1237541|NCT01861938|failed|failed
1237542|NCT01861938|respond|respond
1237543|NCT01861938|one treatment line|one treatment line
1237544|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1237545|NCT01861912|Arsenic trioxide|arsenic trioxide
1237546|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
1237547|NCT01861886|Birth control|birth control
1237548|NCT01861886|Permanent Contraception|permanent contraception
1237549|NCT01861873|liver function|liver function
1237550|NCT01861873|galactose|galactose
1237551|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
1237552|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
1237553|NCT01861834|Total parenteral nutrition|total parenteral nutrition
1237554|NCT01861834|TPN|tpn
1237555|NCT01861834|Intestinal Failure|intestinal failure
1237556|NCT01861834|Short Bowel Syndrome|short bowel syndrome
1237557|NCT01861834|Cholestasis|cholestasis
1237558|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
1237559|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1237560|NCT01861821|Epidural catheter|epidural catheter
1237561|NCT01861821|Epidural analgesia|epidural analgesia
1237562|NCT01861821|Labor epidural analgesia|labor epidural analgesia
1237563|NCT01861821|Analgesic efficacy|analgesic efficacy
1237564|NCT01861821|Multiport epidural catheter|multiport epidural catheter
1237565|NCT01861821|Uniport epidural catheter|uniport epidural catheter
1237566|NCT01861821|Flexible epidural catheter|flexible epidural catheter
1237567|NCT01861808|Spinal Cord Injuries|spinal cord injuries
1237568|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
1237569|NCT01861795|Drug therapy|drug therapy
1237570|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
1237571|NCT01861769|Consultation|consultation
1237572|NCT01861756|Shared Decision Making|shared decision making
1237573|NCT01861756|Decision Aids|decision aids
1237574|NCT01861743|Multi-modal Pain Management|multi-modal pain management
1237575|NCT01861743|Lumbar fusion|lumbar fusion
1237576|NCT01861743|misTLIF|mistlif
1237577|NCT01861730|BCG Vaccinated|bcg vaccinated
1237578|NCT01861730|HIV Negative|hiv negative
1237579|NCT01861717|excess growth hormone|excess growth hormone
1237580|NCT01861717|excess GH|excess gh
1237581|NCT01861717|gigantism|gigantism
1237582|NCT01861717|pituitary tumor|pituitary tumor
1237583|NCT01861717|pituitary adenoma|pituitary adenoma
1237584|NCT01861717|growth hormone tumor|growth hormone tumor
1237585|NCT01861717|GH secreting adenoma|gh secreting adenoma
1237586|NCT01861717|Somatuline|somatuline
1237587|NCT01861717|lanreotide|lanreotide
1237588|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
1237589|NCT01861691|Transverse colon cancer|transverse colon cancer
1237590|NCT01861691|Descending colon cancer|descending colon cancer
1237591|NCT01861691|Laparoscopic surgery|laparoscopic surgery
1237592|NCT01861691|Randomized controlled trial|randomized controlled trial
1237593|NCT01861678|Rectal cancer|rectal cancer
1237594|NCT01861678|Anterior resection|anterior resection
1237595|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
1237596|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
1237597|NCT01861678|Randomized controlled trial|randomized controlled trial
1237598|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
1237599|NCT01861600|Stool composition|stool composition
1237600|NCT01861535|VIN|vin
1237601|NCT01861535|Imiquimod|imiquimod
1237602|NCT01861535|Surgery|surgery
1237603|NCT01861535|HPV|hpv
1237604|NCT01861535|Patient satisfaction|patient satisfaction
1237605|NCT01861522|TAU-284|tau-284
1237606|NCT01861522|Bepotastine besilate|bepotastine besilate
1237607|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
1237608|NCT01861522|children|children
1237609|NCT01861509|BP-C1|bp-c1
1237610|NCT01861509|CDBPA|cdbpa
1237611|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
1237612|NCT01861509|Platinum analogue|platinum analogue
1237613|NCT01861509|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
1237614|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
1237615|NCT01861509|Breast cancer|breast cancer
1237616|NCT01861509|Cisplatin|cisplatin
1237617|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
1237618|NCT01861496|Cisplatin|cisplatin
1237619|NCT01861496|Liposomal formulation|liposomal formulation
1237620|NCT01861496|DRP (Drug Response Prediction)|drp (drug response prediction)
1237621|NCT01861457|nasal sanitizer®|nasal sanitizer®
1237622|NCT01861457|S. aureus|s. aureus
1237623|NCT01861457|general bacteria|general bacteria
1237624|NCT01861457|nasal carriage|nasal carriage
1237625|NCT01861457|decolonization|decolonization
1237626|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
1237627|NCT01861418|chronic low back pain|chronic low back pain
1237628|NCT01861418|low back pain|low back pain
1237629|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
1237630|NCT01861418|Chicago manipulation|chicago manipulation
1237631|NCT01861418|EMG median frequency|emg median frequency
1237632|NCT01861418|electromyography|electromyography
1237633|NCT01861418|reliability|reliability
1237634|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
1237635|NCT01861366|Implementation|implementation
1237636|NCT01861366|Guidelines|guidelines
1237637|NCT01861366|Nutrition|nutrition
1237638|NCT01861366|Nursing home|nursing home
1237639|NCT01861327|Carbon dioxide|carbon dioxide
1237640|NCT01861327|aortic aneurysm|aortic aneurysm
1237641|NCT01861327|angioplasty|angioplasty
1237642|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
1237643|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
1237644|NCT01861288|Fecal Calprotectin|fecal calprotectin
1237645|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
1237646|NCT01861288|Endoscopic deep remission|endoscopic deep remission
1237647|NCT01861288|Histopathologic deep remission|histopathologic deep remission
1237648|NCT01861288|Immunological deep remission|immunological deep remission
1237649|NCT01861288|Treatment algorithm|treatment algorithm
1237650|NCT01861275|osa|osa
1237651|NCT01861275|cerebral palsy|cerebral palsy
1237652|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
1237653|NCT01861275|sleep registration|sleep registration
1237654|NCT01861262|emergency|emergency
1237655|NCT01861262|drug poisoning|drug poisoning
1237656|NCT01861262|StO2 measurement|sto2 measurement
1237657|NCT01861262|blood pressure|blood pressure
1237658|NCT01861262|hemodynamic failure|hemodynamic failure
1237659|NCT01861223|acquired resistance|acquired resistance
1237660|NCT01861223|gefitinib|gefitinib
1237661|NCT01861223|erlotinib|erlotinib
1237662|NCT01861210|Homosexuality, Male|homosexuality, male
1237663|NCT01861197|Efficacy|efficacy
1237664|NCT01861197|Dovitinib|dovitinib
1237665|NCT01861197|Squamous NSCLC|squamous nsclc
1237666|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
1237667|NCT01861184|LRTI|lrti
1237668|NCT01861184|Pneumococcal carriage|pneumococcal carriage
1237669|NCT01861158|Parenting|parenting
1237670|NCT01861158|Adolescence|adolescence
1237671|NCT01861158|Delinquency|delinquency
1237672|NCT01861158|Online intervention|online intervention
1237673|NCT01861158|Juvenile Justice|juvenile justice
1237674|NCT01861145|Intranasal steroids|intranasal steroids
1237675|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
1237676|NCT01861106|Allogeneic Donors|allogeneic donors
1597969|NCT00402493|Brimonidine|brimonidine
1237677|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
1237678|NCT01861106|Immunodeficiency|immunodeficiency
1237679|NCT01861106|Myelodysplasia|myelodysplasia
1237680|NCT01861106|Haploidentical|haploidentical
1237681|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
1237682|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
1237683|NCT01861093|National Cord Blood Program|national cord blood program
1237684|NCT01861080|target organ damage|target organ damage
1237685|NCT01861080|incident hypertension|incident hypertension
1237686|NCT01861080|cohort|cohort
1237687|NCT01861054|Cancer Stem Cells|cancer stem cells
1237693|NCT01861028|total knee replacement|total knee replacement
1237694|NCT01861028|total knee arthroplasty|total knee arthroplasty
1237695|NCT01861028|patient-specific|patient-specific
1237697|NCT01861002|Lymphoblastic|lymphoblastic
1237698|NCT01861002|Leukemia|leukemia
1237699|NCT01861002|Azacytidine|azacytidine
1237700|NCT01861002|Refractory|refractory
1237701|NCT01861002|Myelogenous|myelogenous
1237702|NCT01861002|Acute|acute
1237703|NCT01861002|Childhood|childhood
1237704|NCT01861002|Pediatric|pediatric
1237705|NCT01861002|ALL|all
1237706|NCT01861002|AML|aml
1237707|NCT01861002|Methylation|methylation
1237708|NCT01861002|Epigenetic therapy|epigenetic therapy
1237709|NCT01860989|parasitemia|parasitemia
1237710|NCT01860963|ASIL|asil
1237711|NCT01860963|Anal dysplasia|anal dysplasia
1237712|NCT01860963|IBD|ibd
1237713|NCT01860963|HPV DNA|hpv dna
1237714|NCT01860950|Healthy Adults|healthy adults
1237715|NCT01860950|Pain Perception|pain perception
1237721|NCT01860924|exercise|exercise
1237722|NCT01860924|depression|depression
1237723|NCT01860924|smoking|smoking
1237724|NCT01860898|lung|lung
1237725|NCT01860898|cancer|cancer
1237726|NCT01860898|thoracic|thoracic
1237727|NCT01860898|chest|chest
1237728|NCT01860898|pulmonary|pulmonary
1237729|NCT01860885|naloxone|naloxone
1237730|NCT01860885|children|children
1237731|NCT01860885|opioid|opioid
1237732|NCT01860885|respiratory depression|respiratory depression
1237733|NCT01860885|safety|safety
1237734|NCT01860872|Cystic Fibrosis|cystic fibrosis
1237735|NCT01860872|Pulmonary perfusion|pulmonary perfusion
1237736|NCT01860872|Inflammatory markers|inflammatory markers
1237737|NCT01860872|MRI|mri
1237738|NCT01860872|CT of chest|ct of chest
1237739|NCT01860872|Lung Clearance Index|lung clearance index
1237741|NCT01860859|ultrasound|ultrasound
1237742|NCT01860859|hysterotomy|hysterotomy
1237743|NCT01860859|uterus|uterus
1237744|NCT01860859|suture|suture
1237745|NCT01860846|Crohn's Disease|crohn's disease
1237746|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
1237747|NCT01860820|IPC/TEDS|ipc/teds
1237748|NCT01860820|Geko device|geko device
1237749|NCT01860807|methamphetamine|methamphetamine
1237750|NCT01860807|ibudilast|ibudilast
1237751|NCT01860807|HIV|hiv
1237752|NCT01860781|Schizophrenia|schizophrenia
1237753|NCT01860781|Injection|injection
1237754|NCT01860781|Switch|switch
1237755|NCT01860781|Paliperidone|paliperidone
1237756|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
1237757|NCT01860768|Acute aortic dissection|acute aortic dissection
1237758|NCT01860768|Serum biomarkers|serum biomarkers
1237759|NCT01860768|Early diagnosis|early diagnosis
1237760|NCT01860755|Sport-related concussion|sport-related concussion
1237761|NCT01860755|Dizziness|dizziness
1237762|NCT01860755|Neck pain|neck pain
1237763|NCT01860755|Headaches|headaches
1237764|NCT01860755|Physiotherapy|physiotherapy
1237765|NCT01860755|Treatment|treatment
1237766|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
1237767|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
1237768|NCT01860742|Interferon alpha|interferon alpha
1237769|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
1237770|NCT01860703|Ferriprox®|ferriprox®
1237771|NCT01860703|LI|li
1237772|NCT01860703|DFP|dfp
1237773|NCT01860703|Deferiprone|deferiprone
1237774|NCT01860703|Healthy Volunteers|healthy volunteers
1237775|NCT01860690|MTX|mtx
1237776|NCT01860690|Ectopic pregnancy|ectopic pregnancy
1237777|NCT01860690|medical treatment|medical treatment
1237778|NCT01860677|cranial stimulation|cranial stimulation
1237779|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
1237780|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
1237781|NCT01860677|spectroscopy|spectroscopy
1237782|NCT01860664|allergy|allergy
1237783|NCT01860664|allergic|allergic
1237784|NCT01860664|conjunctivitis|conjunctivitis
1237785|NCT01860664|corticosteroid|corticosteroid
1237786|NCT01860664|hydrocortisone|hydrocortisone
1237787|NCT01860664|ophthalmic|ophthalmic
1237788|NCT01860664|ointment|ointment
1237789|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
1237790|NCT01860651|Ulcerative Colitis|ulcerative colitis
1237791|NCT01860651|Crohn´s Disease|crohn´s disease
1237792|NCT01860651|Children|children
1237793|NCT01860651|Adolescence|adolescence
1237897|NCT01860261|AIDS|aids
1237794|NCT01860651|E-health web-monitoring|e-health web-monitoring
1237795|NCT01860651|Adherence|adherence
1237796|NCT01860651|Disease activity|disease activity
1237797|NCT01860651|Fecal Calprotectin|fecal calprotectin
1237798|NCT01860599|prediabetes|prediabetes
1237799|NCT01860599|EPC's|epc's
1237800|NCT01860599|vascular reactivity|vascular reactivity
1237801|NCT01860586|pvr|pvr
1237802|NCT01860586|rd|rd
1237803|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
1237804|NCT01860586|retinal detachment|retinal detachment
1237805|NCT01860586|detachment|detachment
1237806|NCT01860573|Amino acids|amino acids
1237807|NCT01860573|Protein|protein
1237808|NCT01860560|OSA|osa
1237809|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
1237810|NCT01860560|High Flow Therapy|high flow therapy
1237811|NCT01860560|CPAP|cpap
1237812|NCT01860560|HFT|hft
1237813|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
1237814|NCT01860560|Mild OSA|mild osa
1237815|NCT01860560|Moderate OSA|moderate osa
1237816|NCT01860534|pain|pain
1237817|NCT01860534|mydriasis|mydriasis
1237818|NCT01860534|light|light
1237819|NCT01860521|Termination of pregnancy|termination of pregnancy
1237820|NCT01860521|Second trimester|second trimester
1237821|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
1237822|NCT01860521|Continuous epidural infusion|continuous epidural infusion
1237823|NCT01860521|Epidural analgesia|epidural analgesia
1237824|NCT01860521|Legally Induced Abortion|legally induced abortion
1237825|NCT01860508|Progression free Survival|progression free survival
1237826|NCT01860495|growth factors|growth factors
1237827|NCT01860495|periodontal pockets|periodontal pockets
1237828|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
1237829|NCT01860482|GERD|gerd
1237830|NCT01860482|Phase 4|phase 4
1237831|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
1237832|NCT01860456|Imatinib|imatinib
1237833|NCT01860456|Nilotinib|nilotinib
1237834|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1237835|NCT01860456|Pharmacokinetics|pharmacokinetics
1237836|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
1237837|NCT01860456|SLC Transporters|slc transporters
1237838|NCT01860456|Treatment outcome|treatment outcome
1237839|NCT01860456|Toxicity|toxicity
1237840|NCT01860443|depression|depression
1237841|NCT01860443|adolescents|adolescents
1237842|NCT01860430|Locally Advanced|locally advanced
1237843|NCT01860430|Head and Neck Cancer|head and neck cancer
1237844|NCT01860430|Ipilimumab (YERVOY®)|ipilimumab (yervoy®)
1237845|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
1237846|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
1237847|NCT01860417|Low Back Pain|low back pain
1237848|NCT01860417|Nucleus pulposus|nucleus pulposus
1237849|NCT01860417|Stem cell|stem cell
1237850|NCT01860417|Cellular therapy|cellular therapy
1237851|NCT01860417|Regenerative therapy|regenerative therapy
1237852|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
1237853|NCT01860417|Bone marrow|bone marrow
1237854|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
1237855|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
1237856|NCT01860404|Concussion|concussion
1237857|NCT01860404|Branched chain amino acids|branched chain amino acids
1237858|NCT01860404|BCAA|bcaa
1237859|NCT01860404|HIT HEADS|hit heads
1237860|NCT01860391|Silver|silver
1237861|NCT01860391|Fluoride|fluoride
1237862|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
1237863|NCT01860391|Saliva|saliva
1237864|NCT01860378|Whooping Cough|whooping cough
1237865|NCT01860378|Pertussis|pertussis
1237866|NCT01860378|Tdap vaccination|tdap vaccination
1237867|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
1237868|NCT01860365|Quality of life|quality of life
1237869|NCT01860365|Integrative medicine|integrative medicine
1237870|NCT01860365|Supportive care|supportive care
1237871|NCT01860365|Cancer|cancer
1237872|NCT01860365|Chemotherapy|chemotherapy
1237873|NCT01860352|Fish Oil|fish oil
1237874|NCT01860352|colon health|colon health
1237875|NCT01860352|fatty acid metabolism|fatty acid metabolism
1237876|NCT01860339|Huntington's Disease|huntington's disease
1237878|NCT01860339|Huntington Disease|huntington disease
1237879|NCT01860339|Juvenile Huntington's Disease|juvenile huntington's disease
1237880|NCT01860339|JHD|jhd
1237881|NCT01860326|hepatic impairment|hepatic impairment
1237882|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
1237883|NCT01860326|Alisporivir|alisporivir
1237884|NCT01860313|effectiveness|effectiveness
1237885|NCT01860313|distance learning|distance learning
1237886|NCT01860313|mental health|mental health
1237887|NCT01860300|Tic Disorders|tic disorders
1237888|NCT01860300|Tourette Syndrome|tourette syndrome
1237889|NCT01860287|opioid|opioid
1237890|NCT01860287|subjective|subjective
1237891|NCT01860287|stress|stress
1237892|NCT01860287|buprenorphine|buprenorphine
1237893|NCT01860274|Mesh|mesh
1237894|NCT01860274|Graft|graft
1237895|NCT01860274|Patency|patency
1237896|NCT01860261|HIV|hiv
1237898|NCT01860261|sedentary|sedentary
1237899|NCT01860261|fitness|fitness
1237900|NCT01860261|aging|aging
1237901|NCT01860261|V02max|v02max
1237902|NCT01860261|d-dimer|d-dimer
1237903|NCT01860261|IL-6|il-6
1237904|NCT01860261|CRP|crp
1237905|NCT01860261|ChiWalking|chiwalking
1237906|NCT01860261|ChiRunning|chirunning
1237907|NCT01860261|aerobic exercise|aerobic exercise
1237908|NCT01860261|strength training|strength training
1237909|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
1237910|NCT01860248|arterial puncture|arterial puncture
1237911|NCT01860235|Local anesthesia|local anesthesia
1237912|NCT01860235|Pain measurement|pain measurement
1237913|NCT01860235|Pain perception|pain perception
1237914|NCT01860235|Dental anesthesia|dental anesthesia
1237915|NCT01860235|Root planing|root planing
1237916|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
1237917|NCT01860222|CSPH|csph
1237918|NCT01860222|Hepatectomy|hepatectomy
1237919|NCT01860222|percutaneous local ablative|percutaneous local ablative
1237920|NCT01860222|therapy (PLAT)|therapy (plat)
1237921|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
1237922|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
1237923|NCT01860209|overhydration|overhydration
1237924|NCT01860209|end stage renal disease|end stage renal disease
1237925|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
1237926|NCT01860209|polysomnography|polysomnography
1237927|NCT01860209|bioimpedance|bioimpedance
1237928|NCT01860209|leg fluid shift|leg fluid shift
1237929|NCT01860209|neck circumference|neck circumference
1237930|NCT01860183|kidney transplantation|kidney transplantation
1237931|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
1237932|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
1237933|NCT01860183|Chronic|chronic
1237934|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
1237935|NCT01860170|MRD|mrd
1237936|NCT01860170|MUD|mud
1237937|NCT01860170|GVHD|gvhd
1237938|NCT01860157|rTMS|rtms
1237939|NCT01860157|depression|depression
1237940|NCT01860157|magnetic|magnetic
1237941|NCT01860144|bevacizumab|bevacizumab
1237942|NCT01860144|overall survival|overall survival
1237943|NCT01860144|adverse events|adverse events
1237944|NCT01860144|tumor resection rate|tumor resection rate
1237945|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
1237946|NCT01860079|Early discharge|early discharge
1237947|NCT01860079|STEMI|stemi
1237948|NCT01860079|PPCI|ppci
1237949|NCT01860066|COPD|copd
1237950|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
1237951|NCT01860014|Mortality|mortality
1237952|NCT01860014|Newborn|newborn
1237953|NCT01860001|cancer|cancer
1237954|NCT01860001|metabolic acidosis|metabolic acidosis
1237955|NCT01859988|Eczema|eczema
1237956|NCT01859962|Liver diseases|liver diseases
1237957|NCT01859962|Virus diseases|virus diseases
1237958|NCT01859962|Ribavirin|ribavirin
1237959|NCT01859962|protease inhibitor|protease inhibitor
1237960|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
1237961|NCT01859962|NS5A inhibitor|ns5a inhibitor
1237962|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
1237963|NCT01859949|SGA|sga
1237964|NCT01859949|Short Stature|short stature
1237965|NCT01859949|Long-term|long-term
1237966|NCT01859949|Safety|safety
1237967|NCT01859923|Tuberculosis|tuberculosis
1237968|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
1237969|NCT01859923|Mycobacterium Infections|mycobacterium infections
1237970|NCT01859923|Actinomycetales Infections|actinomycetales infections
1237971|NCT01859923|Gram-Positive Infections|gram-positive infections
1237972|NCT01859923|Bacterial Infections|bacterial infections
1237973|NCT01859923|Pediatric|pediatric
1237974|NCT01859884|Kidney transplantation|kidney transplantation
1237975|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
1237976|NCT01859884|Kidney donation|kidney donation
1237977|NCT01859884|Organ donation|organ donation
1237978|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
1237979|NCT01859884|Hepatitis B|hepatitis b
1237980|NCT01859884|Hepatitis C|hepatitis c
1237981|NCT01859884|Infectious disease|infectious disease
1237982|NCT01859884|Disease transmission|disease transmission
1237983|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
1237984|NCT01859884|Web-based intervention|web-based intervention
1237985|NCT01859871|Living kidney donation|living kidney donation
1237986|NCT01859871|End-stage renal disease|end-stage renal disease
1237987|NCT01859871|Latinos|latinos
1237988|NCT01859871|Undocumented Immigrants|undocumented immigrants
1237989|NCT01859871|Bilingual|bilingual
1237990|NCT01859871|Spanish|spanish
1237991|NCT01859871|Website|website
1237992|NCT01859871|Dialysis|dialysis
1237993|NCT01859871|Hispanics|hispanics
1237994|NCT01859871|Transplantation|transplantation
1237995|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
1237996|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
1237997|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
1237998|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
1237999|NCT01859858|Colon cancer|colon cancer
1238000|NCT01859845|Melanoma|melanoma
1238001|NCT01859845|Opportunistic surveillance|opportunistic surveillance
1238002|NCT01859845|Melanoma simulation model|melanoma simulation model
1238003|NCT01859845|Smartphone devices|smartphone devices
1238004|NCT01859832|renal transplant|renal transplant
1238005|NCT01859832|kidney transplantation|kidney transplantation
1238006|NCT01859832|immune status|immune status
1238007|NCT01859832|immunosuppressive medications|immunosuppressive medications
1238008|NCT01859819|Pediatric|pediatric
1238009|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
1238010|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
1238011|NCT01859819|Rituximab|rituximab
1238012|NCT01859819|Liposomal ARA-C|liposomal ara-c
1238013|NCT01859806|periampullary tumour|periampullary tumour
1238014|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
1238015|NCT01859806|PG|pg
1238016|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
1238017|NCT01859793|endothelium, vascular|endothelium, vascular
1238018|NCT01859793|diabetes type 2|diabetes type 2
1238019|NCT01859793|nitric oxide|nitric oxide
1238020|NCT01859793|inflammation|inflammation
1238021|NCT01859780|Poison control|poison control
1238022|NCT01859780|Child resistant packaging|child resistant packaging
1238023|NCT01859780|prescription vials|prescription vials
1238024|NCT01859780|prescription blisters|prescription blisters
1238025|NCT01859780|drug packaging|drug packaging
1238026|NCT01859767|Alzheimer's disease|alzheimer's disease
1238027|NCT01859767|SPECT|spect
1238028|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
1238029|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
1238030|NCT01859754|PID|pid
1238031|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
1238032|NCT01859728|biliary cancer|biliary cancer
1238033|NCT01859728|irinotecan|irinotecan
1238034|NCT01859728|cisplatin|cisplatin
1238035|NCT01859728|gemcitabine|gemcitabine
1238036|NCT01859715|Drug Interactions|drug interactions
1238037|NCT01859715|CYP2D6|cyp2d6
1238038|NCT01859715|opioid efficacy|opioid efficacy
1238039|NCT01859715|pain|pain
1238040|NCT01859715|nausea|nausea
1238041|NCT01859702|Aqueous Humor|aqueous humor
1238042|NCT01859702|Moxifloxacin|moxifloxacin
1238043|NCT01859702|Vigadexa|vigadexa
1238044|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1238045|NCT01859663|Diet|diet
1238046|NCT01859663|Exercise|exercise
1238047|NCT01859663|Questionnaires|questionnaires
1238048|NCT01859663|Health Beliefs|health beliefs
1238049|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
1238050|NCT01859624|LOPD|lopd
1238051|NCT01859624|Pompe Disease|pompe disease
1238052|NCT01859598|diabetes|diabetes
1238053|NCT01859598|basal insulin|basal insulin
1238054|NCT01859598|effectiveness and safety|effectiveness and safety
1238055|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
1238056|NCT01859598|real world clinical practice|real world clinical practice
1238057|NCT01859585|preemptive analgesia|preemptive analgesia
1238058|NCT01859585|lumbar fusion|lumbar fusion
1238059|NCT01859585|Parecoxib|parecoxib
1238060|NCT01859585|Ketorolac|ketorolac
1238061|NCT01859572|Stroke|stroke
1238062|NCT01859572|Cerebral Infarction|cerebral infarction
1238063|NCT01859572|Brain Disorders|brain disorders
1238064|NCT01859572|Central Nervous System Diseases|central nervous system diseases
1238065|NCT01859572|Nervous System Diseases|nervous system diseases
1238066|NCT01859572|Vascular Diseases|vascular diseases
1238067|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
1238068|NCT01859572|Brain Infarction|brain infarction
1238069|NCT01859572|Brain Ischaemia|brain ischaemia
1238070|NCT01859559|ultrasound|ultrasound
1238071|NCT01859559|peripheral intravenous access|peripheral intravenous access
1238072|NCT01859559|operator experience|operator experience
1238073|NCT01859546|SMS|sms
1238074|NCT01859520|Spermatozoa|spermatozoa
1238075|NCT01859520|DNA fragmentation|dna fragmentation
1238076|NCT01859520|Swim-up|swim-up
1238077|NCT01859520|Density gradient|density gradient
1238078|NCT01859507|Vaginismus|vaginismus
1238079|NCT01859507|Botox|botox
1238080|NCT01859507|Sex|sex
1238081|NCT01859507|Clostridium|clostridium
1238082|NCT01859507|Botulinum|botulinum
1238083|NCT01859507|Neurotoxin|neurotoxin
1238084|NCT01859507|Perineal|perineal
1238085|NCT01859507|Muscles|muscles
1238086|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
1238087|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
1238088|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
1238089|NCT01859455|LGT209,|lgt209,
1238090|NCT01859455|drug safety,|drug safety,
1238091|NCT01859455|pharmacokinetics,|pharmacokinetics,
1238092|NCT01859455|pharmacodynamics|pharmacodynamics
1238093|NCT01859429|Cancer patients|cancer patients
1238094|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
1238095|NCT01859429|Structured Screening|structured screening
1238096|NCT01859429|Stepped care|stepped care
1238097|NCT01859403|veteran|veteran
1238098|NCT01859403|obesity|obesity
1238099|NCT01859403|personalized genomics|personalized genomics
1238100|NCT01859390|Antioxidants|antioxidants
1238101|NCT01859390|Vitamins|vitamins
1238102|NCT01859390|Inflammation|inflammation
1238103|NCT01859390|Oxidative stress|oxidative stress
1238104|NCT01859364|Tobacco|tobacco
1238105|NCT01859364|Smoking|smoking
1238106|NCT01859364|Smoking Cessation|smoking cessation
1238107|NCT01859364|Outcome|outcome
1238108|NCT01859364|Nicotine Dependence|nicotine dependence
1238109|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
1238110|NCT01859325|HIV Therapy|hiv therapy
1238111|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
1238112|NCT01859312|Glucocorticoids|glucocorticoids
1238113|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
1238114|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
1238115|NCT01859312|Adrenal|adrenal
1238116|NCT01859299|Oral Tolerance|oral tolerance
1238117|NCT01859299|Uveitis|uveitis
1238118|NCT01859299|AMD|amd
1238119|NCT01859273|renal failure|renal failure
1238120|NCT01859273|medication adherence|medication adherence
1238121|NCT01859273|hypertension|hypertension
1238122|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
1238123|NCT01859247|cervical dystonia|cervical dystonia
1238124|NCT01859247|torticollis|torticollis
1238125|NCT01859247|rTMS|rtms
1238126|NCT01859234|multiple myeloma|multiple myeloma
1238127|NCT01859234|PET scan|pet scan
1238128|NCT01859221|Prostate cancer|prostate cancer
1238129|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
1238130|NCT01859221|Proton radiation|proton radiation
1238131|NCT01859195|HIV/STI|hiv/sti
1238132|NCT01859195|Prevention|prevention
1238133|NCT01859195|Microbicides, Topical|microbicides, topical
1238134|NCT01859169|bili duct neoplasms|bili duct neoplasms
1238135|NCT01859169|bile duct cancer|bile duct cancer
1238136|NCT01859169|photodynamic therapy|photodynamic therapy
1238137|NCT01859169|biliary drainage|biliary drainage
1238138|NCT01859156|Carbon Monoxide|carbon monoxide
1238139|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
1238140|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
1238141|NCT01859156|Capnography|capnography
1238142|NCT01859143|Trivalent|trivalent
1238143|NCT01859143|Influenza|influenza
1238144|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
1238145|NCT01859143|Vaccine|vaccine
1238146|NCT01859143|Prevention|prevention
1238147|NCT01859143|Healthy|healthy
1238148|NCT01859117|Peripheral arterial disease|peripheral arterial disease
1238149|NCT01859117|diabetic foot|diabetic foot
1238150|NCT01859091|Lipolysis|lipolysis
1238151|NCT01859091|Cryolipolysis|cryolipolysis
1238152|NCT01859091|Fat Reduction|fat reduction
1238153|NCT01859065|Non-urgent ED visits|non-urgent ed visits
1238154|NCT01859065|Neonates|neonates
1238155|NCT01859065|Newborn care|newborn care
1238156|NCT01859052|migraine|migraine
1238157|NCT01859052|obesity|obesity
1238158|NCT01859052|low fat diet|low fat diet
1238159|NCT01859052|low carbohydrate diet|low carbohydrate diet
1238160|NCT01859039|Egg allergy|egg allergy
1238161|NCT01859039|Anaphylaxis|anaphylaxis
1238162|NCT01859039|Children|children
1238163|NCT01859039|Influenza vaccine|influenza vaccine
1238164|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
1238165|NCT01859026|EGFR mutation|egfr mutation
1238166|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
1238167|NCT01859026|KRAS mutation|kras mutation
1238168|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1238169|NCT01859026|Advanced-stage IV|advanced-stage iv
1238170|NCT01859000|Adolescents|adolescents
1238171|NCT01859000|Hurricane Katrina|hurricane katrina
1238172|NCT01859000|Family-based treatment|family-based treatment
1238173|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
1238174|NCT01859000|Group CBT|group cbt
1238175|NCT01858974|multiplex PCR|multiplex pcr
1238176|NCT01858974|MALDI-TOF|maldi-tof
1238177|NCT01858974|pneumonia|pneumonia
1238178|NCT01858974|microbiological investigation|microbiological investigation
1238179|NCT01858974|intensive care|intensive care
1238180|NCT01858948|Bipolar disorder|bipolar disorder
1238181|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
1238182|NCT01858948|Obesity|obesity
1238183|NCT01858948|Cardiometabolic risk|cardiometabolic risk
1238184|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
1238185|NCT01858922|ABVE-PC|abve-pc
1238186|NCT01858922|doxorubicin|doxorubicin
1238187|NCT01858922|bleomycin|bleomycin
1238188|NCT01858922|vincristine|vincristine
1238189|NCT01858922|etoposide|etoposide
1238190|NCT01858922|prednisone|prednisone
1238191|NCT01858922|cyclophosphamide|cyclophosphamide
1238192|NCT01858922|DECA|deca
1238193|NCT01858922|decadron|decadron
1238194|NCT01858922|cisplatin|cisplatin
1238195|NCT01858922|cytarabine|cytarabine
1238196|NCT01858922|Radiation|radiation
1238197|NCT01858909|Sepsis|sepsis
1238198|NCT01858896|hypoglycemia|hypoglycemia
1238199|NCT01858896|GLP-1|glp-1
1238200|NCT01858896|Type 2 diabetes|type 2 diabetes
1238201|NCT01858896|endothelial function|endothelial function
1238202|NCT01858870|Lacosamide|lacosamide
1238203|NCT01858870|Partial Crisis|partial crisis
1238204|NCT01858857|geriatric psychiatry|geriatric psychiatry
1238205|NCT01858857|pharmacovigilance|pharmacovigilance
1238206|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
1238207|NCT01858818|real life drinking behavior|real life drinking behavior
1238208|NCT01858818|family history of alcoholism|family history of alcoholism
1238209|NCT01858818|conditioning|conditioning
1238210|NCT01858818|instrumental learning|instrumental learning
1238211|NCT01858818|habitization|habitization
1238212|NCT01858805|esophagus carcinoma|esophagus carcinoma
1238213|NCT01858805|surgery|surgery
1238214|NCT01858805|circulating tumor cells|circulating tumor cells
1238215|NCT01858779|stroke|stroke
1238216|NCT01858779|atrial fibrillation|atrial fibrillation
1238217|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
1238218|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
1238219|NCT01858766|Hepatitis|hepatitis
1238220|NCT01858766|HCV Genotype 1|hcv genotype 1
1238221|NCT01858766|HCV Genotype 2|hcv genotype 2
1238222|NCT01858766|HCV Genotype 3|hcv genotype 3
1238223|NCT01858766|HCV Genotype 4|hcv genotype 4
1238224|NCT01858766|HCV Genotype 5|hcv genotype 5
1238225|NCT01858766|HCV Genotype 6|hcv genotype 6
1238226|NCT01858766|treatment naive|treatment naive
1238227|NCT01858753|burn scars|burn scars
1238228|NCT01858753|restrictive|restrictive
1238229|NCT01858753|contractures|contractures
1238230|NCT01858753|autologous fibroblasts|autologous fibroblasts
1238231|NCT01858727|forced-air|forced-air
1238232|NCT01858727|hypothermia|hypothermia
1238233|NCT01858727|TUR-P surgery|tur-p surgery
1238234|NCT01858727|core temperatures|core temperatures
1238235|NCT01858727|prewarming|prewarming
1238236|NCT01858727|general anaesthesia|general anaesthesia
1238237|NCT01858714|obesity|obesity
1238238|NCT01858714|overweight|overweight
1238239|NCT01858714|weight loss|weight loss
1238240|NCT01858701|myopia|myopia
1238241|NCT01858701|hyperopia|hyperopia
1238242|NCT01858701|astigmatism|astigmatism
1238243|NCT01858701|contact lenses|contact lenses
1238244|NCT01858688|Prostate Cancer|prostate cancer
1238245|NCT01858688|MRI|mri
1238246|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
1238247|NCT01858675|ProADM|proadm
1238248|NCT01858675|ProANP|proanp
1238249|NCT01858675|proendothelin|proendothelin
1238250|NCT01858675|proAVP|proavp
1238251|NCT01858675|Cr 51|cr 51
1238252|NCT01858675|Volemia|volemia
1238253|NCT01858675|fluid management|fluid management
1238254|NCT01858675|ICU patients|icu patients
1238255|NCT01858675|poly trauma patients|poly trauma patients
1238256|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
1238257|NCT01858662|Liver|liver
1238258|NCT01858662|cetuximab|cetuximab
1238259|NCT01858662|Pathological response|pathological response
1238260|NCT01858649|metastatic|metastatic
1238261|NCT01858649|colorectal|colorectal
1238262|NCT01858649|cancer|cancer
1238263|NCT01858649|liver|liver
1238264|NCT01858649|Bevacizumab|bevacizumab
1238265|NCT01858649|Pathological response|pathological response
1238266|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
1238267|NCT01858623|Fixed dose combination|fixed dose combination
1238268|NCT01858623|Pharmacokinetics|pharmacokinetics
1238269|NCT01858623|Losartan|losartan
1238270|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
1238271|NCT01858610|Fixed dose combination|fixed dose combination
1238272|NCT01858610|Pharmacokinetics|pharmacokinetics
1238273|NCT01858610|Irbesartan|irbesartan
1238274|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
1238275|NCT01858610|Pharmacodynamics|pharmacodynamics
1238276|NCT01858610|Normotensive Participants|normotensive participants
1238277|NCT01858597|GDM, FGF|gdm, fgf
1238278|NCT01858584|GER|ger
1238279|NCT01858584|Alginate|alginate
1238280|NCT01858584|Regurgitation|regurgitation
1238281|NCT01858584|questionnaire|questionnaire
1238282|NCT01858571|Childhood Cancer|childhood cancer
1238283|NCT01858532|Diabetes|diabetes
1238284|NCT01858532|Nephropathy|nephropathy
1238285|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
1238286|NCT01858519|antibodies|antibodies
1238287|NCT01858519|porcine viruses|porcine viruses
1238288|NCT01858519|epidemiology|epidemiology
1238289|NCT01858519|prospective|prospective
1238290|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
1238291|NCT01858506|Lifestyle counselling|lifestyle counselling
1238292|NCT01858506|Lifestyle assessment|lifestyle assessment
1238293|NCT01858506|Randomized controlled trial|randomized controlled trial
1238294|NCT01858506|Diabetes education|diabetes education
1597970|NCT00402493|Latanoprost|latanoprost
1238295|NCT01858493|Urinary incontinence|urinary incontinence
1238296|NCT01858493|Falls|falls
1238297|NCT01858493|Quality of life|quality of life
1238298|NCT01858493|Stigma|stigma
1238299|NCT01858493|Community-dwelling older women|community-dwelling older women
1238300|NCT01858493|Continence promotion|continence promotion
1238301|NCT01858480|CHF|chf
1238302|NCT01858467|Airway, Cesarean|airway, cesarean
1238403|NCT01857986|Mechanical ventilation|mechanical ventilation
1238303|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
1238304|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
1238305|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
1238306|NCT01858376|LDL cholesterol|ldl cholesterol
1238307|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
1238308|NCT01858376|hyperlipidemic|hyperlipidemic
1238309|NCT01858376|Capros|capros
1238310|NCT01858376|Natural Supplement|natural supplement
1238311|NCT01858363|Peripheral arterial disease|peripheral arterial disease
1238312|NCT01858363|claudication|claudication
1238313|NCT01858363|drug-coated balloon|drug-coated balloon
1238314|NCT01858363|drug-eluting balloon|drug-eluting balloon
1238315|NCT01858350|CAM|cam
1238316|NCT01858350|Sedation|sedation
1238317|NCT01858350|MRI|mri
1238318|NCT01858350|Music Therapy|music therapy
1238319|NCT01858337|weaning|weaning
1238320|NCT01858337|infants|infants
1238321|NCT01858337|vegetables|vegetables
1238322|NCT01858337|repeated-exposure|repeated-exposure
1238323|NCT01858324|Preeclampsia|preeclampsia
1238324|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
1238325|NCT01858324|Patient education|patient education
1238326|NCT01858324|Educationnal tools|educationnal tools
1238327|NCT01858324|Pamphlet|pamphlet
1238328|NCT01858324|Video|video
1238329|NCT01858324|Knowledge|knowledge
1238330|NCT01858324|Anxiety|anxiety
1238331|NCT01858324|Satisfaction|satisfaction
1238332|NCT01858311|Stroke survivors|stroke survivors
1238333|NCT01858311|TIA survivors|tia survivors
1238334|NCT01858311|Vitamin E|vitamin e
1238335|NCT01858311|Carotech|carotech
1238336|NCT01858311|Tocotrienol|tocotrienol
1238337|NCT01858298|Dental caries|dental caries
1238338|NCT01858298|Quality of Life|quality of life
1238339|NCT01858298|Pulpectomy|pulpectomy
1238340|NCT01858298|Tooth extraction|tooth extraction
1238341|NCT01858285|Epilepsy|epilepsy
1238342|NCT01858285|Ohtahara|ohtahara
1238343|NCT01858285|Dravet|dravet
1238344|NCT01858285|MMPEI|mmpei
1238345|NCT01858285|EMEE|emee
1238346|NCT01858285|EIEE|eiee
1238347|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
1238348|NCT01858246|Bone Conduction|bone conduction
1238349|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
1238350|NCT01858233|Gestational diabetes|gestational diabetes
1238351|NCT01858220|Gastroparesis|gastroparesis
1238352|NCT01858220|Small bowel video capsule|small bowel video capsule
1238353|NCT01858220|gastric retention|gastric retention
1238354|NCT01858207|HCC|hcc
1238355|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
1238356|NCT01858207|liver cancer|liver cancer
1238357|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
1238358|NCT01858194|Catheter Ablation|catheter ablation
1238359|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
1238360|NCT01858142|Pediatric anesthesia|pediatric anesthesia
1238361|NCT01858142|Pre-operative anxiety|pre-operative anxiety
1238362|NCT01858142|parental presence|parental presence
1238363|NCT01858142|children|children
1238364|NCT01858142|elective surgical procedures|elective surgical procedures
1238365|NCT01858142|mask induction|mask induction
1238366|NCT01858129|TTN|ttn
1238367|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
1238368|NCT01858103|MPS IVA Type A|mps iva type a
1238369|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1238370|NCT01858103|MPS IVA|mps iva
1238371|NCT01858103|Morquio A Syndrome|morquio a syndrome
1238372|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
1238373|NCT01858103|LSD|lsd
1238374|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1238375|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
1238376|NCT01858090|spinal anesthesia|spinal anesthesia
1238377|NCT01858090|caesarean section|caesarean section
1238378|NCT01858090|local anesthetics|local anesthetics
1238379|NCT01858090|levobupivacaine|levobupivacaine
1238380|NCT01858090|sufentanil|sufentanil
1238381|NCT01858090|fentanyl|fentanyl
1238382|NCT01858090|above 18 years of age|above 18 years of age
1238383|NCT01858090|pregnant women|pregnant women
1238384|NCT01858090|multiparous|multiparous
1238385|NCT01858090|nulliparous|nulliparous
1238386|NCT01858064|ADHD|adhd
1238387|NCT01858064|OROS-MPH|oros-mph
1238388|NCT01858064|Adults|adults
1238389|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1238390|NCT01858051|Vitamin D|vitamin d
1238391|NCT01858051|Perioperative immune regulation|perioperative immune regulation
1238392|NCT01858051|LL-37|ll-37
1238393|NCT01858051|Hospital-acquired infection|hospital-acquired infection
1238394|NCT01858051|Surgical site infections|surgical site infections
1238395|NCT01858038|Scar|scar
1238396|NCT01858012|insulin resistance|insulin resistance
1238397|NCT01857999|Renin-aldosterone system|renin-aldosterone system
1238398|NCT01857999|Hemodynamic|hemodynamic
1238399|NCT01857999|Low cardiac output|low cardiac output
1238400|NCT01857999|Vasodilation|vasodilation
1238401|NCT01857999|Natriuretic peptide|natriuretic peptide
1238402|NCT01857986|Endotracheal intubation|endotracheal intubation
1238901|NCT01856088|thrombosis|thrombosis
1238404|NCT01857986|Critical care|critical care
1238405|NCT01857973|HCL|hcl
1238406|NCT01857973|Type 1 Diabetes|type 1 diabetes
1238407|NCT01857973|Sensor|sensor
1238408|NCT01857960|Acne|acne
1238409|NCT01857960|Treatment|treatment
1238410|NCT01857960|Cost|cost
1238411|NCT01857960|Behavior|behavior
1238412|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
1238413|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
1238414|NCT01857934|hu14.18K322A|hu14.18k322a
1238415|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
1238416|NCT01857934|Phase II|phase ii
1238417|NCT01857934|Allogeneic NK cells|allogeneic nk cells
1238418|NCT01857908|Adenocarcinoma|adenocarcinoma
1238419|NCT01857908|Abiraterone|abiraterone
1238420|NCT01857908|Abiraterone Acetate|abiraterone acetate
1238421|NCT01857908|Zytiga|zytiga
1238422|NCT01857908|Correlative study|correlative study
1238423|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
1238424|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
1238425|NCT01857895|Nausea|nausea
1238426|NCT01857895|subcutaneous infusion|subcutaneous infusion
1238427|NCT01857895|exenatide|exenatide
1238428|NCT01857882|breast cancer|breast cancer
1238429|NCT01857882|breast reconstruction|breast reconstruction
1238430|NCT01857882|shared decision making|shared decision making
1238431|NCT01857882|decision support intervention|decision support intervention
1238432|NCT01857869|Efficacy|efficacy
1238433|NCT01857869|Sporozoite challenge model|sporozoite challenge model
1238434|NCT01857869|Malaria|malaria
1238435|NCT01857869|Immunogenicity|immunogenicity
1238436|NCT01857869|Malaria- naïve adults|malaria- naïve adults
1238437|NCT01857869|Safety|safety
1238438|NCT01857856|Phospholamban|phospholamban
1238439|NCT01857856|cardiomyopathy|cardiomyopathy
1238440|NCT01857856|Eplerenone|eplerenone
1238441|NCT01857856|presymptomatic|presymptomatic
1238442|NCT01857830|Telomerase|telomerase
1238443|NCT01857830|Telomere Length|telomere length
1238444|NCT01857830|Psychological Stress|psychological stress
1238445|NCT01857830|Amyloid beta proteins|amyloid beta proteins
1238446|NCT01857830|Meditation|meditation
1238447|NCT01857804|peri-implantitis|peri-implantitis
1238448|NCT01857804|surgical therapy|surgical therapy
1238449|NCT01857804|systemic antibiotics|systemic antibiotics
1238450|NCT01857804|local antiseptics|local antiseptics
1238451|NCT01857778|Breastfeeding|breastfeeding
1238452|NCT01857778|Breast tissue|breast tissue
1238453|NCT01857778|Breast pump|breast pump
1238454|NCT01857765|rehabilitation|rehabilitation
1238455|NCT01857765|reconstructive surgery|reconstructive surgery
1238456|NCT01857752|Retinoblastoma|retinoblastoma
1238457|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
1238458|NCT01857726|portal vein invasion|portal vein invasion
1238459|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
1238460|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
1238461|NCT01857674|Laryngeal edema|laryngeal edema
1238462|NCT01857674|Post-extubation|post-extubation
1238463|NCT01857674|Acute respiratory distress|acute respiratory distress
1238464|NCT01857674|Ultrasonography|ultrasonography
1238465|NCT01857674|Intensive care unit|intensive care unit
1238466|NCT01857661|tinnitus|tinnitus
1238467|NCT01857661|hearing loss|hearing loss
1238468|NCT01857661|hearing devices|hearing devices
1238469|NCT01857648|Physical Activity|physical activity
1238470|NCT01857648|Health Promotion|health promotion
1238471|NCT01857648|Primary Health Care|primary health care
1238472|NCT01857648|Intervention Studies|intervention studies
1238473|NCT01857648|Public health Practice|public health practice
1238474|NCT01857635|Acute respiratory failure|acute respiratory failure
1238475|NCT01857635|Hypercapnia|hypercapnia
1238476|NCT01857635|Non invasive ventilation|non invasive ventilation
1238477|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
1238478|NCT01857622|anticoagulant|anticoagulant
1238479|NCT01857622|DU-176b|du-176b
1238480|NCT01857622|edoxaban|edoxaban
1238481|NCT01857622|factor Xa|factor xa
1238482|NCT01857622|oral|oral
1238483|NCT01857622|atrial fibrillation|atrial fibrillation
1238484|NCT01857622|severe renal impairment|severe renal impairment
1238485|NCT01857609|Metformin|metformin
1238486|NCT01857609|Proton pump inhibitor|proton pump inhibitor
1238487|NCT01857609|Drug interaction|drug interaction
1238488|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
1238489|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1238490|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
1238491|NCT01857596|Lorexys|lorexys
1238492|NCT01857596|Premenopausal female health|premenopausal female health
1238493|NCT01857583|anticoagulant|anticoagulant
1238495|NCT01857583|edoxaban|edoxaban
1238496|NCT01857583|factor Xa|factor xa
1238497|NCT01857583|oral|oral
1238498|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
1238499|NCT01857583|severe renal impairment|severe renal impairment
1238500|NCT01857570|Radius fracture|radius fracture
1238501|NCT01857570|Scaphoid fracture|scaphoid fracture
1238502|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
1238503|NCT01857557|Exercise|exercise
1238504|NCT01857557|Fitness program|fitness program
1238505|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
1238506|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
1238507|NCT01857544|Macular Edema|macular edema
1238508|NCT01857531|Smoking Cessation|smoking cessation
1238509|NCT01857531|Quit Smoking|quit smoking
1238510|NCT01857531|Ganaxolone|ganaxolone
1238511|NCT01857531|Nicotine Patch|nicotine patch
1238512|NCT01857505|Total Hip replacement|total hip replacement
1238513|NCT01857505|Fracture table|fracture table
1238514|NCT01857505|DePuySynthes|depuysynthes
1238515|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
1238516|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
1238517|NCT01857492|abdominal pain|abdominal pain
1238518|NCT01857492|pancreatitis|pancreatitis
1238519|NCT01857492|chronic abdominal pain|chronic abdominal pain
1238520|NCT01857492|visceral pain|visceral pain
1238521|NCT01857492|meditation|meditation
1238522|NCT01857492|tDCS|tdcs
1238523|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
1238524|NCT01857492|EEG|eeg
1238525|NCT01857492|Kirtan Kriya|kirtan kriya
1238526|NCT01857479|ABPA|abpa
1238527|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
1238528|NCT01857440|Glaucoma|glaucoma
1238529|NCT01857440|Pupil|pupil
1238530|NCT01857440|Melanopsin|melanopsin
1238531|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
1238532|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
1238533|NCT01857362|Orfadin|orfadin
1238534|NCT01857362|Nitisinone|nitisinone
1238535|NCT01857362|Bioequivalence|bioequivalence
1238536|NCT01857349|Efficacy|efficacy
1238537|NCT01857349|surgical scrubs|surgical scrubs
1238538|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
1238539|NCT01857323|asthma|asthma
1238540|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1238541|NCT01857323|COPD|copd
1238542|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
1238543|NCT01857310|Folic Acid|folic acid
1238544|NCT01857310|Zinc|zinc
1238545|NCT01857310|Semen|semen
1238546|NCT01857310|In vitro fertilization|in vitro fertilization
1238547|NCT01857310|Assisted reproductive technology|assisted reproductive technology
1238548|NCT01857310|Ovulation induction|ovulation induction
1238549|NCT01857310|Intrauterine insemination|intrauterine insemination
1238550|NCT01857310|Pregnancy|pregnancy
1238551|NCT01857310|Live Birth|live birth
1238552|NCT01857310|Abortion, spontaneous|abortion, spontaneous
1238553|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
1238554|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
1238555|NCT01857284|Safety|safety
1238556|NCT01857284|Efficacy|efficacy
1238557|NCT01857258|green tea|green tea
1238558|NCT01857258|catechins|catechins
1238559|NCT01857258|vascular endothelial function|vascular endothelial function
1238560|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
1238561|NCT01857258|oxidative stress|oxidative stress
1238562|NCT01857245|addiction|addiction
1238563|NCT01857245|Adherence (attribute)|adherence (attribute)
1238564|NCT01857245|Adverse effects|adverse effects
1238565|NCT01857245|Agonist|agonist
1238566|NCT01857245|Antiviral Agents|antiviral agents
1238567|NCT01857245|arm|arm
1238568|NCT01857245|base|base
1238569|NCT01857245|care delivery|care delivery
1238570|NCT01857245|Caring|caring
1238571|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
1238572|NCT01857245|Clinic|clinic
1238573|NCT01857245|Clinical Trials|clinical trials
1238574|NCT01857245|Complex|complex
1238575|NCT01857245|Computer Simulation|computer simulation
1238576|NCT01857245|cost|cost
1238577|NCT01857245|cost effective|cost effective
1238578|NCT01857245|cost effectiveness|cost effectiveness
1238579|NCT01857245|Data|data
1238580|NCT01857245|Development|development
1238581|NCT01857245|Directly Observed Therapy|directly observed therapy
1238582|NCT01857245|Disease|disease
1238583|NCT01857245|Dose|dose
1238584|NCT01857245|Drug resistance|drug resistance
1238585|NCT01857245|drug resistant virus|drug resistant virus
1238586|NCT01857245|Educational aspects|educational aspects
1238587|NCT01857245|Epidemic|epidemic
1238588|NCT01857245|experience|experience
1238589|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
1238590|NCT01857245|Fright|fright
1238591|NCT01857245|Genotype|genotype
1238592|NCT01857245|Group Therapy|group therapy
1238593|NCT01857245|Health Care Costs|health care costs
1238594|NCT01857245|Health Personnel|health personnel
1238595|NCT01857245|Healthcare Systems|healthcare systems
1238596|NCT01857245|Hepatitis C|hepatitis c
1238597|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
1238598|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
1238599|NCT01857245|Hepatitis C virus|hepatitis c virus
1238600|NCT01857245|HIV|hiv
1238601|NCT01857245|Homelessness|homelessness
1238602|NCT01857245|improved|improved
1238603|NCT01857245|Incidence|incidence
1238604|NCT01857245|Infection|infection
1239204|NCT01854736|Allergy|allergy
1238605|NCT01857245|Injecting drug user|injecting drug user
1238606|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
1238607|NCT01857245|Intensive Care|intensive care
1238608|NCT01857245|Interferons|interferons
1238609|NCT01857245|Intervention|intervention
1238610|NCT01857245|Knowledge|knowledge
1238611|NCT01857245|Life|life
1238612|NCT01857245|Liver diseases|liver diseases
1238613|NCT01857245|Liver Failure|liver failure
1238614|NCT01857245|liver transplantation|liver transplantation
1238615|NCT01857245|Living Costs|living costs
1238616|NCT01857245|Mental disorders|mental disorders
1238617|NCT01857245|Methadone|methadone
1238618|NCT01857245|methadone clinic/center|methadone clinic/center
1238619|NCT01857245|Modeling|modeling
1238620|NCT01857245|Mortality Vital Statistics|mortality vital statistics
1238621|NCT01857245|Motivation|motivation
1238622|NCT01857245|multidisciplinary|multidisciplinary
1238623|NCT01857245|Opiates|opiates
1238624|NCT01857245|Oral|oral
1238625|NCT01857245|Outcome|outcome
1238626|NCT01857245|Patients|patients
1238627|NCT01857245|Persons|persons
1238628|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
1238629|NCT01857245|Physicians|physicians
1238630|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
1238631|NCT01857245|Play|play
1238632|NCT01857245|Poverty|poverty
1238633|NCT01857245|Primary Health Care|primary health care
1238634|NCT01857245|programs|programs
1238635|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
1238636|NCT01857245|psychosocial|psychosocial
1238637|NCT01857245|Publishing|publishing
1238638|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
1238639|NCT01857245|Randomized|randomized
1238640|NCT01857245|Randomized Controlled Trials|randomized controlled trials
1238641|NCT01857245|randomized trial|randomized trial
1238642|NCT01857245|Recruitment Activity|recruitment activity
1238643|NCT01857245|Regimen|regimen
1238644|NCT01857245|Resistance|resistance
1238645|NCT01857245|Resistance development|resistance development
1238646|NCT01857245|response|response
1238647|NCT01857245|Risk|risk
1238648|NCT01857245|risk perception|risk perception
1238649|NCT01857245|Role|role
1238650|NCT01857245|Site|site
1238651|NCT01857245|skills|skills
1238652|NCT01857245|Social support|social support
1238653|NCT01857245|standard care|standard care
1238654|NCT01857245|substance abuse treatment|substance abuse treatment
1238655|NCT01857245|success|success
1238656|NCT01857245|Time|time
1238657|NCT01857245|Treatment outcome|treatment outcome
1238658|NCT01857245|Treatment Protocols|treatment protocols
1238659|NCT01857245|treatment site|treatment site
1238660|NCT01857245|Trust|trust
1238661|NCT01857245|United States|united states
1238662|NCT01857245|Viral|viral
1238663|NCT01857245|Virus|virus
1238664|NCT01857219|fMRI|fmri
1238665|NCT01857206|Influenza|influenza
1238666|NCT01857206|children and adolescents|children and adolescents
1238667|NCT01857206|trivalent vaccine|trivalent vaccine
1238668|NCT01857206|cell culture|cell culture
1238669|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
1238670|NCT01857193|Open label; dose escalation; ER+; LEE011; CDK4/6; everolimus; advanced breast cancer; mTOR; HR positive; HER2 negative|open label; dose escalation; er+; lee011; cdk4/6; everolimus; advanced breast cancer; mtor; hr positive; her2 negative
1238671|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
1238672|NCT01857167|randomized controlled trial|randomized controlled trial
1238673|NCT01857154|Bone mineral density|bone mineral density
1238674|NCT01857154|Bone mineral content|bone mineral content
1238675|NCT01857154|Bone density|bone density
1238676|NCT01857154|Bone health|bone health
1238677|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1238678|NCT01857141|dexmedetomidine|dexmedetomidine
1238679|NCT01857141|heart rate variability|heart rate variability
1238680|NCT01857141|preemptive epidural|preemptive epidural
1238681|NCT01857141|gastrectomy|gastrectomy
1238682|NCT01857115|Multiple myeloma|multiple myeloma
1238683|NCT01857115|Diagnosis|diagnosis
1238684|NCT01857115|Weekly|weekly
1238685|NCT01857115|CCyd|ccyd
1238686|NCT01857089|Pressure Ulcer|pressure ulcer
1238687|NCT01857089|prevention|prevention
1238688|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1238689|NCT01857076|Grade I obesity|grade i obesity
1238690|NCT01857076|Inadequate glycemic control|inadequate glycemic control
1598565|NCT00400101|Virosome|virosome
1325410|NCT01475877|PRK|prk
1238691|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
1238692|NCT01857011|bariatric surgery|bariatric surgery
1238693|NCT01857011|abdominoplasty|abdominoplasty
1238694|NCT01857011|surgery, plastic|surgery, plastic
1238695|NCT01857011|iron|iron
1238696|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
1238697|NCT01856998|Propofol|propofol
1238698|NCT01856985|Medical abortion|medical abortion
1238699|NCT01856985|Misoprostol|misoprostol
1238700|NCT01856985|Mifepristone|mifepristone
1238701|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
1238702|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
1238703|NCT01856972|Soleus tightness|soleus tightness
1238704|NCT01856959|magnesium sulfate|magnesium sulfate
1238705|NCT01856959|nebulized|nebulized
1239309|NCT01854424|Mortality|mortality
1238706|NCT01856959|lung function|lung function
1238707|NCT01856933|GBM|gbm
1238708|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
1238709|NCT01856933|Gliosarcoma|gliosarcoma
1238710|NCT01856920|Calcitonin|calcitonin
1238711|NCT01856920|T-cells|t-cells
1238712|NCT01856920|Immune Response|immune response
1238713|NCT01856920|HLA Patients|hla patients
1238714|NCT01856920|Vaccine|vaccine
1238715|NCT01856907|prediabetes|prediabetes
1238716|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
1238717|NCT01856907|post gestational diabetes|post gestational diabetes
1238718|NCT01856907|diabetes prevention|diabetes prevention
1238719|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
1238720|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
1238721|NCT01856894|obesity|obesity
1238722|NCT01856881|Type 2 diabetes|type 2 diabetes
1238723|NCT01856868|BMD|bmd
1238724|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
1238725|NCT01856868|epicatechin|epicatechin
1238726|NCT01856868|clinical trial|clinical trial
1238727|NCT01856868|neuromuscular disease|neuromuscular disease
1238728|NCT01856855|Prostate Cancer|prostate cancer
1238729|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
1238730|NCT01856855|Radiation|radiation
1238731|NCT01856855|SBRT|sbrt
1238732|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1238733|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
1238734|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
1238735|NCT01856842|Embolization|embolization
1238736|NCT01856842|reperfusion rates|reperfusion rates
1238737|NCT01856777|Medical Abortion|medical abortion
1238738|NCT01856777|Pregnancy Test|pregnancy test
1238739|NCT01856777|continuing pregnancy|continuing pregnancy
1238740|NCT01856764|Atopic dermatitis|atopic dermatitis
1238741|NCT01856751|Haemophilia|haemophilia
1238742|NCT01856751|TGA|tga
1238743|NCT01856751|TEM|tem
1238744|NCT01856738|Parkinson's disease|parkinson's disease
1238745|NCT01856738|Visual hallucinations|visual hallucinations
1238746|NCT01856738|Rivastigmine|rivastigmine
1238747|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
1238748|NCT01856738|Randomized controlled trial|randomized controlled trial
1238749|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
1238750|NCT01856712|alcohol|alcohol
1238751|NCT01856712|veterans|veterans
1238752|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
1238753|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
1238754|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
1238755|NCT01856686|ADD|add
1238756|NCT01856686|ADHD|adhd
1238757|NCT01856686|Proteins|proteins
1238758|NCT01856686|Dietary|dietary
1238759|NCT01856686|Nutrition|nutrition
1238760|NCT01856686|QEEG|qeeg
1238761|NCT01856686|ERP|erp
1238762|NCT01856686|ICA|ica
1238763|NCT01856673|Mental Health|mental health
1238764|NCT01856673|Displacement|displacement
1238765|NCT01856673|Torture|torture
1238766|NCT01856673|Violence|violence
1238767|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1238768|NCT01856673|Depression|depression
1238769|NCT01856673|Anxiety|anxiety
1238770|NCT01856673|Community-based intervention|community-based intervention
1238771|NCT01856673|Prevention trial|prevention trial
1238772|NCT01856673|Disabled Persons|disabled persons
1238773|NCT01856660|Obesity|obesity
1238774|NCT01856660|Weight Loss|weight loss
1238775|NCT01856660|Body Weight Change|body weight change
1238776|NCT01856660|Taste|taste
1238777|NCT01856660|Taste Phenotype|taste phenotype
1238778|NCT01856660|Lifestyle Intervention|lifestyle intervention
1238779|NCT01856647|Psoriasis|psoriasis
1238780|NCT01856647|Obesity|obesity
1238781|NCT01856634|Tuberculosis|tuberculosis
1238782|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
1238783|NCT01856634|Mycobacterium Infections|mycobacterium infections
1238784|NCT01856634|Actinomycetales Infections|actinomycetales infections
1238785|NCT01856634|Gram-Positive Infections|gram-positive infections
1238786|NCT01856634|Bacterial Infections|bacterial infections
1238787|NCT01856634|Pediatric|pediatric
1598566|NCT00400101|safety|safety
1238788|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
1238789|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
1238790|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
1238791|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
1238792|NCT01856582|children|children
1238793|NCT01856556|safety|safety
1238794|NCT01856556|tolerability|tolerability
1238795|NCT01856556|pharmacokinetics|pharmacokinetics
1238796|NCT01856543|Breast cancer|breast cancer
1238797|NCT01856543|Status post mastectomy|status post mastectomy
1238798|NCT01856543|plan to receive PMRT|plan to receive pmrt
1238799|NCT01856543|Topical|topical
1238800|NCT01856543|steroid cream|steroid cream
1238801|NCT01856543|emollient skin care|emollient skin care
1238802|NCT01856543|Eucerin|eucerin
1238803|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
1238804|NCT01856517|pressor response|pressor response
1238805|NCT01856517|chronotropic response|chronotropic response
1238806|NCT01856504|Heart Disease|heart disease
1238807|NCT01856504|Coronary Artery Disease|coronary artery disease
1238808|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
1238809|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
1238810|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1238811|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
1238812|NCT01856465|Bariatric surgery|bariatric surgery
1238813|NCT01856465|NAFLD|nafld
1238814|NCT01856465|Steatohepatitis|steatohepatitis
1238815|NCT01856465|Simple Steatosis|simple steatosis
1238816|NCT01856465|Intestinal Microbiota|intestinal microbiota
1238817|NCT01856452|Sentinel lymph node|sentinel lymph node
1238818|NCT01856452|multimodal|multimodal
1238819|NCT01856452|breast cancer|breast cancer
1238820|NCT01856439|ProSavin|prosavin
1238821|NCT01856439|Gene therapy|gene therapy
1238822|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
1238823|NCT01856413|Prevention|prevention
1238824|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
1238825|NCT01856413|HBV-DNA negative|hbv-dna negative
1238826|NCT01856413|Liver transplantation|liver transplantation
1238827|NCT01856400|ventricular arrythmias|ventricular arrythmias
1238828|NCT01856400|SERCA2a|serca2a
1238829|NCT01856400|Chronic Kidney Disease|chronic kidney disease
1238830|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
1238831|NCT01856387|preeclampsia|preeclampsia
1238832|NCT01856387|eclampsia|eclampsia
1238833|NCT01856387|prediction|prediction
1238834|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
1238835|NCT01856361|Male infertility|male infertility
1238836|NCT01856361|Low sperm count|low sperm count
1238837|NCT01856361|Poor sperm motility|poor sperm motility
1238838|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
1238839|NCT01856335|Seizures|seizures
1238840|NCT01856335|Epilepsy|epilepsy
1238841|NCT01856322|Colorectal Cancer|colorectal cancer
1238842|NCT01856322|Liver Metastasis|liver metastasis
1238843|NCT01856322|Sulindac|sulindac
1238844|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
1238845|NCT01856309|Sirukumab|sirukumab
1238846|NCT01856309|CNTO 136|cnto 136
1238847|NCT01856309|CNTO136ARA3002|cnto136ara3002
1238848|NCT01856309|SIRROUND-D|sirround-d
1238849|NCT01856309|CNTO136ARA3003|cnto136ara3003
1238850|NCT01856309|SIRROUND-T|sirround-t
1238851|NCT01856309|SIRROUND-LTE|sirround-lte
1238852|NCT01856270|Traumatic brain injury|traumatic brain injury
1238853|NCT01856270|Post-traumatic headache|post-traumatic headache
1238854|NCT01856270|Drug therapy|drug therapy
1238855|NCT01856257|Kidney Transplantation|kidney transplantation
1238856|NCT01856257|Transplantation|transplantation
1238858|NCT01856257|belatacept|belatacept
1238859|NCT01856257|chronic immunosuppression|chronic immunosuppression
1238860|NCT01856244|Parkinson's Disease|parkinson's disease
1238861|NCT01856244|treadmill training|treadmill training
1238862|NCT01856244|gait|gait
1238863|NCT01856244|balance|balance
1238864|NCT01856244|mobility|mobility
1238865|NCT01856231|COPD|copd
1238866|NCT01856231|Physical activity|physical activity
1238867|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
1238868|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
1238869|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
1238870|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
1238871|NCT01856166|Nulliparous|nulliparous
1238872|NCT01856166|Singleton|singleton
1238873|NCT01856166|delivery|delivery
1238874|NCT01856166|pregnancy|pregnancy
1238875|NCT01856153|Bioavailability|bioavailability
1238876|NCT01856153|Strawberry polyphenols|strawberry polyphenols
1238877|NCT01856153|Time Influence|time influence
1238878|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
1238879|NCT01856140|allogeneic stem cell|allogeneic stem cell
1238880|NCT01856127|Sexual Dysfunction|sexual dysfunction
1238881|NCT01856127|Antidepressant|antidepressant
1238882|NCT01856127|Major Depressant|major depressant
1238884|NCT01856127|SNRI|snri
1238885|NCT01856127|Vilazodone|vilazodone
1238886|NCT01856127|Sertraline|sertraline
1238887|NCT01856114|Advanced Cancers|advanced cancers
1238888|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
1238889|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
1238890|NCT01856114|Shortness of breath|shortness of breath
1238891|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
1238892|NCT01856114|FBT|fbt
1238893|NCT01856114|Placebo|placebo
1238894|NCT01856114|Walk tests|walk tests
1238895|NCT01856114|Questionnaires|questionnaires
1238896|NCT01856114|Surveys|surveys
1238897|NCT01856101|TCC|tcc
1238898|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
1238899|NCT01856088|Coronary artery|coronary artery
1238900|NCT01856088|Drug eluting stent|drug eluting stent
1238902|NCT01856075|Atrial Fibrillation|atrial fibrillation
1238903|NCT01856075|Dronedarone|dronedarone
1238904|NCT01856075|Cohort|cohort
1238905|NCT01856075|Effectiveness|effectiveness
1238906|NCT01856062|ovulation induction|ovulation induction
1238907|NCT01856062|dexamethasone|dexamethasone
1238908|NCT01856049|HLHS|hlhs
1238909|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1238910|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
1238911|NCT01856049|Umbilical cord blood|umbilical cord blood
1238912|NCT01856049|Cord blood|cord blood
1238913|NCT01856049|Cardiac regeneration|cardiac regeneration
1238914|NCT01856036|Ductal Histology|ductal histology
1238915|NCT01856036|Unifocal|unifocal
1238916|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
1238917|NCT01856036|her2neu negative|her2neu negative
1238918|NCT01856023|melanoma|melanoma
1238919|NCT01856023|metastatic|metastatic
1238920|NCT01856023|skin cancer|skin cancer
1238921|NCT01856023|Stage IV|stage iv
1238922|NCT01856023|interleukin-2|interleukin-2
1238923|NCT01856010|Dementia|dementia
1238924|NCT01856010|Aggression|aggression
1238925|NCT01856010|Agitation|agitation
1238926|NCT01855984|ADHD|adhd
1238927|NCT01855984|Children|children
1238928|NCT01855984|Tocotrienol|tocotrienol
1238929|NCT01855958|Osteoarthritis|osteoarthritis
1238930|NCT01855958|Electro acupuncture|electro acupuncture
1238931|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
1238932|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1238933|NCT01855958|Pain pressure threshold|pain pressure threshold
1238934|NCT01855958|Conditioned pain modulation|conditioned pain modulation
1238935|NCT01855958|Clinical trial|clinical trial
1238936|NCT01855945|Influenza|influenza
1238937|NCT01855919|Chronic Low Back Pain|chronic low back pain
1238938|NCT01855919|CLBP|clbp
1238939|NCT01855906|Total knee replacement|total knee replacement
1238940|NCT01855906|Gap balanced|gap balanced
1238941|NCT01855906|Measured resection|measured resection
1238942|NCT01855893|Neck pain|neck pain
1238943|NCT01855880|psoriasis|psoriasis
1238944|NCT01855880|dermatology|dermatology
1238945|NCT01855880|monoclonal antibody|monoclonal antibody
1238946|NCT01855867|HIV|hiv
1238947|NCT01855867|PEP|pep
1238948|NCT01855867|nPEP|npep
1238949|NCT01855867|Prophylaxis|prophylaxis
1238950|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
1238951|NCT01855867|exposure to HIV|exposure to hiv
1238952|NCT01855867|HIV prevention|hiv prevention
1238953|NCT01855841|ERCP|ercp
1238954|NCT01855841|virgin papilla|virgin papilla
1238955|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
1238956|NCT01855802|Greece|greece
1238957|NCT01855802|Ophthalmology|ophthalmology
1238958|NCT01855802|Glaucoma|glaucoma
1238959|NCT01855802|Generics|generics
1238960|NCT01855802|Perception|perception
1238961|NCT01855776|Physical Activity/Walking|physical activity/walking
1238962|NCT01855776|Full-time employees|full-time employees
1238963|NCT01855776|RCT|rct
1238964|NCT01855776|Incentives|incentives
1238965|NCT01855776|Wireless pedometer|wireless pedometer
1238966|NCT01855763|gestational diabetes|gestational diabetes
1238967|NCT01855763|type 2 diabetes|type 2 diabetes
1238968|NCT01855763|pregnancy|pregnancy
1238969|NCT01855763|metformin|metformin
1238970|NCT01855763|insulin|insulin
1238971|NCT01855750|Lymphoma|lymphoma
1238972|NCT01855750|B-cell lymphoma|b-cell lymphoma
1238973|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
1238974|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1238975|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1238976|NCT01855750|PCI-32765|pci-32765
1238977|NCT01855750|JNJ-54179060|jnj-54179060
1238978|NCT01855750|Ibrutinib|ibrutinib
1238979|NCT01855750|Rituximab|rituximab
1238980|NCT01855750|Cyclophosphamide|cyclophosphamide
1238981|NCT01855750|Doxorubicin|doxorubicin
1238982|NCT01855750|Vincristine|vincristine
1238983|NCT01855750|Prednisone|prednisone
1238984|NCT01855737|gene guided|gene guided
1238985|NCT01855737|warfarin dose|warfarin dose
1238986|NCT01855737|Chinese|chinese
1238987|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
1238988|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
1238989|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
1238990|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
1238991|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
1238992|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
1238993|NCT01855659|Lung diseases,|lung diseases,
1238994|NCT01855659|Obstructive,|obstructive,
1238995|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
1238996|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
1238997|NCT01855620|Contraception|contraception
1238998|NCT01855620|Implant|implant
1238999|NCT01855620|Obesity|obesity
1239000|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
1239001|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
1239310|NCT01854411|Analgesics|analgesics
1239002|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
1239003|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
1239004|NCT01855503|Metastatic|metastatic
1239005|NCT01855503|Breast Cancer|breast cancer
1239006|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
1239007|NCT01855503|Breast|breast
1239008|NCT01855503|Biopsy|biopsy
1239009|NCT01855503|Molecular|molecular
1239010|NCT01855503|Genetic|genetic
1239011|NCT01855464|pneumothorax|pneumothorax
1239012|NCT01855464|primary pneumothorax|primary pneumothorax
1239013|NCT01855464|lung collapse|lung collapse
1239014|NCT01855451|Human Papilloma Virus|human papilloma virus
1239016|NCT01855451|Oropharyngeal|oropharyngeal
1239017|NCT01855451|Squamous Cell|squamous cell
1239018|NCT01855451|Carcinoma|carcinoma
1239019|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
1239020|NCT01855438|Living donation|living donation
1239021|NCT01855438|Patient education|patient education
1239022|NCT01855438|Kidney transplant candidates|kidney transplant candidates
1239023|NCT01855412|PAD|pad
1239024|NCT01855412|LIBERTY|liberty
1239025|NCT01855412|Observational|observational
1239026|NCT01855399|Peer Support|peer support
1239027|NCT01855399|Self Management|self management
1239028|NCT01855399|Health Disparities|health disparities
1239029|NCT01855373|Blood Sugar|blood sugar
1239030|NCT01855373|Endothelial Function|endothelial function
1239031|NCT01855373|Blood Vessel Health|blood vessel health
1239032|NCT01855360|amyloid|amyloid
1239033|NCT01855360|amyloidosis|amyloidosis
1239034|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
1239035|NCT01855360|senile amyloidosis|senile amyloidosis
1239036|NCT01855360|familial amyloidosis|familial amyloidosis
1239037|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
1239038|NCT01855347|Prematurity|prematurity
1239039|NCT01855347|Hypoxia|hypoxia
1239040|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
1239041|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
1239042|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
1239043|NCT01855347|NICU|nicu
1239044|NCT01855334|Dialysis|dialysis
1239045|NCT01855334|ESRD|esrd
1239046|NCT01855334|Cardiovascular disease|cardiovascular disease
1239047|NCT01855334|spironolactone|spironolactone
1239048|NCT01855334|L-arginine|l-arginine
1239049|NCT01855334|myocardial perfusion|myocardial perfusion
1239455|NCT01854021|Immunity|immunity
1239050|NCT01855334|coronary flow reserve|coronary flow reserve
1239051|NCT01855334|diastolic function|diastolic function
1239052|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
1239053|NCT01855321|vitamin D deficiency|vitamin d deficiency
1239054|NCT01855295|Dialysis|dialysis
1239055|NCT01855295|End Stage Renal Disease|end stage renal disease
1239056|NCT01855295|Protein supplementation|protein supplementation
1239057|NCT01855295|Inflammation|inflammation
1239058|NCT01855295|Quality of Life|quality of life
1239059|NCT01855282|Diabetes Type II,|diabetes type ii,
1239060|NCT01855282|Overweight,|overweight,
1239061|NCT01855282|Obesity,|obesity,
1239062|NCT01855282|Behavioral Intervention,|behavioral intervention,
1239063|NCT01855282|Latino, farm worker|latino, farm worker
1239064|NCT01855282|randomized controlled intervention|randomized controlled intervention
1239065|NCT01855269|probiotic|probiotic
1239066|NCT01855269|infantile colic|infantile colic
1239067|NCT01855256|hyperhidrosis|hyperhidrosis
1239068|NCT01855256|oxybutynin|oxybutynin
1239069|NCT01855243|Type 2 D M|type 2 d m
1239070|NCT01855243|sliding scale insulin|sliding scale insulin
1239071|NCT01855243|70/30 insulin|70/30 insulin
1239072|NCT01855243|basals insulin|basals insulin
1239073|NCT01855243|supplemental insulin|supplemental insulin
1239074|NCT01855217|morbid|morbid
1239075|NCT01855217|obesity|obesity
1239076|NCT01855217|sugammadex|sugammadex
1239077|NCT01855217|pharmacodynamics|pharmacodynamics
1239078|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
1239079|NCT01855204|Urography|urography
1239080|NCT01855204|Radiation dosage|radiation dosage
1239081|NCT01855204|Contrast media|contrast media
1239082|NCT01855178|nocturnal|nocturnal
1239083|NCT01855178|epilepsy|epilepsy
1239084|NCT01855165|chronic heart failure|chronic heart failure
1239085|NCT01855165|drug-drug interactions|drug-drug interactions
1239086|NCT01855165|pharmacist's intervention|pharmacist's intervention
1239087|NCT01855152|Dementia|dementia
1239088|NCT01855152|Care Homes|care homes
1239089|NCT01855152|Quality of life|quality of life
1239090|NCT01855152|Antipsychotic medication|antipsychotic medication
1239091|NCT01855152|Behavioural symptoms|behavioural symptoms
1239092|NCT01855152|Cost effectiveness|cost effectiveness
1239093|NCT01855152|Implementation|implementation
1239094|NCT01855152|Person centred care|person centred care
1239095|NCT01855152|Social interaction|social interaction
1239096|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1239097|NCT01855139|Stroke|stroke
1239098|NCT01855139|Systemic embolism|systemic embolism
1239099|NCT01855139|Oral anticoagulation|oral anticoagulation
1239100|NCT01855139|Real-life setting|real-life setting
1239101|NCT01855139|Preventive measure|preventive measure
1239102|NCT01855126|light|light
1239103|NCT01855126|circadian rhythms|circadian rhythms
1239104|NCT01855126|dim light melatonin onset|dim light melatonin onset
1239105|NCT01855126|sleep|sleep
1239106|NCT01855113|PAIN|pain
1239107|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
1239108|NCT01855113|INVISALIGN|invisalign
1239109|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
1239110|NCT01855100|Prevention of recurrence|prevention of recurrence
1239111|NCT01855100|Oral anticoagulation|oral anticoagulation
1239112|NCT01855100|Real-life setting|real-life setting
1239113|NCT01855074|Schizophrenia|schizophrenia
1239114|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
1239115|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
1239116|NCT01855074|Risperidone|risperidone
1239117|NCT01855074|Risperdal consta|risperdal consta
1239118|NCT01855061|Feasibility studies|feasibility studies
1239119|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
1239120|NCT01855061|Biological markers|biological markers
1239121|NCT01855061|Solid tumors|solid tumors
1239122|NCT01855061|Neoplasm metastasis|neoplasm metastasis
1239123|NCT01855061|Irinotecan|irinotecan
1239124|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
1239125|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
1239126|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
1239127|NCT01855048|endolysin|endolysin
1239128|NCT01855048|Placebo|placebo
1239129|NCT01855035|ischemic stroke|ischemic stroke
1239130|NCT01855035|ECG monitoring|ecg monitoring
1239131|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
1239132|NCT01855022|Motivational interviewing|motivational interviewing
1239133|NCT01855022|Interactive voice response|interactive voice response
1239134|NCT01855022|Hospital readmission|hospital readmission
1239135|NCT01855009|Quality of Life|quality of life
1239136|NCT01855009|Body Weight and Measures|body weight and measures
1239137|NCT01855009|Malnutrition|malnutrition
1239138|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
1239139|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
1239140|NCT01855009|Motor Activity|motor activity
1239141|NCT01855009|Drinking|drinking
1239142|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
1239143|NCT01854983|cervical cancer|cervical cancer
1239144|NCT01854957|Multiple sclerosis|multiple sclerosis
1239145|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
1239146|NCT01854931|Tai Ji Quan|tai ji quan
1239147|NCT01854931|fall prevention|fall prevention
1239148|NCT01854931|community dissemination|community dissemination
1239149|NCT01854918|High cholesterol|high cholesterol
1239150|NCT01854918|Raised cholesterol|raised cholesterol
1239151|NCT01854918|Cholesterol|cholesterol
1239152|NCT01854918|Elevated Cholesterol|elevated cholesterol
1239153|NCT01854892|low back pain|low back pain
1239154|NCT01854892|manipulation|manipulation
1239155|NCT01854892|laser therapy|laser therapy
1239156|NCT01854892|osteopathic|osteopathic
1239157|NCT01854892|chiropractic|chiropractic
1239158|NCT01854892|mobilization|mobilization
1239159|NCT01854892|muscle energy|muscle energy
1239160|NCT01854892|physical therapy|physical therapy
1239161|NCT01854892|muscle|muscle
1239162|NCT01854892|spine|spine
1239163|NCT01854892|adjustment|adjustment
1239164|NCT01854892|rehabilitation|rehabilitation
1239165|NCT01854866|Pleural Effusion|pleural effusion
1239166|NCT01854866|ascites|ascites
1239167|NCT01854866|Malignant|malignant
1239168|NCT01854853|unsafe sex|unsafe sex
1239169|NCT01854853|safer sex|safer sex
1239171|NCT01854853|STI|sti
1239172|NCT01854853|Pregnancy|pregnancy
1239173|NCT01854840|hyaline membrane disease|hyaline membrane disease
1239174|NCT01854840|placenta|placenta
1239175|NCT01854840|betamethasone|betamethasone
1239176|NCT01854827|Biliary atresia|biliary atresia
1239177|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
1239178|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
1239179|NCT01854801|IEI-EMF|iei-emf
1239180|NCT01854801|WI-FI|wi-fi
1239181|NCT01854801|DECT|dect
1239182|NCT01854801|Electro-sensitivity|electro-sensitivity
1239183|NCT01854801|Radiofrequency|radiofrequency
1239184|NCT01854801|EHS|ehs
1239185|NCT01854801|Idiopathic|idiopathic
1239186|NCT01854801|Environmental|environmental
1239187|NCT01854801|Intolerance fields|intolerance fields
1239188|NCT01854801|Mobile phone|mobile phone
1239189|NCT01854788|Airway clearance techniques|airway clearance techniques
1239190|NCT01854788|Mucus clearance|mucus clearance
1239191|NCT01854788|Chest physiotherapy|chest physiotherapy
1239192|NCT01854788|Autogenic drainage|autogenic drainage
1239193|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
1239194|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
1239195|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
1239196|NCT01854775|Adolescents|adolescents
1239197|NCT01854775|HIV-1|hiv-1
1239198|NCT01854775|HIV|hiv
1239199|NCT01854775|Treatment-naive|treatment-naive
1239200|NCT01854762|HIV|hiv
1239201|NCT01854762|Treatment|treatment
1239202|NCT01854762|Pregnancy|pregnancy
1239203|NCT01854749|ESCC|escc
1239205|NCT01854736|Phleum pratense|phleum pratense
1239206|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
1239207|NCT01854736|asthma|asthma
1239208|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
1239209|NCT01854723|Diabetes|diabetes
1239210|NCT01854723|Insulin glargine|insulin glargine
1239211|NCT01854723|NPH insulin|nph insulin
1239212|NCT01854710|ADASUVE|adasuve
1239213|NCT01854710|inhaled loxapine|inhaled loxapine
1239214|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
1239215|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
1239216|NCT01854697|Interferon Free|interferon free
1239217|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
1239218|NCT01854697|Hepatitis C Virus|hepatitis c virus
1239219|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
1239220|NCT01854671|postpartum contraception|postpartum contraception
1239221|NCT01854671|contraceptive counseling|contraceptive counseling
1239222|NCT01854632|influenza vaccine|influenza vaccine
1239223|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
1239224|NCT01854632|efficacy|efficacy
1239226|NCT01854632|Senegal|senegal
1239227|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
1239228|NCT01854619|sinusitis|sinusitis
1239229|NCT01854619|photodisinfection|photodisinfection
1239230|NCT01854619|photodynamic therapy|photodynamic therapy
1239231|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
1239232|NCT01854619|aPDT|apdt
1239233|NCT01854619|PDT|pdt
1239234|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
1239235|NCT01854619|respiratory tract infections|respiratory tract infections
1239236|NCT01854619|respiratory tract diseases|respiratory tract diseases
1239237|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
1239238|NCT01854580|Comparative effectiveness research|comparative effectiveness research
1239239|NCT01854580|health economic evaluation|health economic evaluation
1239240|NCT01854567|Cord Blood|cord blood
1239241|NCT01854567|Stem Cells|stem cells
1239242|NCT01854567|MPC|mpc
1239243|NCT01854567|Mesoblast|mesoblast
1239244|NCT01854567|Expanded|expanded
1239245|NCT01854567|AML|aml
1239246|NCT01854567|ALL|all
1239247|NCT01854567|NHL|nhl
1239248|NCT01854567|Leukemia|leukemia
1239249|NCT01854567|Lymphoma|lymphoma
1239250|NCT01854554|Brain cancer|brain cancer
1239251|NCT01854554|Glioblastoma|glioblastoma
1239252|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
1239253|NCT01854554|GBM|gbm
1239254|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
1239255|NCT01854554|IMPT|impt
1239256|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1239257|NCT01854554|IMRT|imrt
1239258|NCT01854554|Radiotherapy|radiotherapy
1239259|NCT01854554|XRT|xrt
1239260|NCT01854554|Cognitive tests|cognitive tests
1239261|NCT01854554|Thinking skills tests|thinking skills tests
1239262|NCT01854554|Questionnaires|questionnaires
1239263|NCT01854554|Surveys|surveys
1239264|NCT01854554|Quality of life|quality of life
1239265|NCT01854554|QOL|qol
1239266|NCT01854541|Cancer|cancer
1239267|NCT01854541|Radiotherapy|radiotherapy
1239268|NCT01854528|Partial responder|partial responder
1239269|NCT01854528|Interferon free|interferon free
1239270|NCT01854528|Treatment-experienced|treatment-experienced
1239271|NCT01854528|Relapser|relapser
1239272|NCT01854528|Hepatitis C Virus|hepatitis c virus
1239273|NCT01854528|Null responder|null responder
1239274|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
1239275|NCT01854528|paritaprevir|paritaprevir
1239276|NCT01854528|ombitasvir|ombitasvir
1239277|NCT01854528|dasabuvir|dasabuvir
1239278|NCT01854528|ribavirin|ribavirin
1239279|NCT01854528|Viekira PAK|viekira pak
1239280|NCT01854528|Chronic hepatitis C|chronic hepatitis c
1239281|NCT01854502|Young children|young children
1239282|NCT01854502|counseling|counseling
1239283|NCT01854502|fluoride|fluoride
1239284|NCT01854502|xylitol|xylitol
1239285|NCT01854489|Buprenorphine|buprenorphine
1239286|NCT01854489|Rifampicin|rifampicin
1239287|NCT01854489|Interactions|interactions
1239288|NCT01854489|Pharmakokinetics|pharmakokinetics
1239289|NCT01854489|Pharmakodynamics|pharmakodynamics
1239290|NCT01854476|Hemodialysis|hemodialysis
1239291|NCT01854476|Bleeding|bleeding
1239292|NCT01854476|Hemostatic dressing|hemostatic dressing
1239293|NCT01854476|Tranexamic Acid|tranexamic acid
1239294|NCT01854463|DIABETES MELLITUS|diabetes mellitus
1239295|NCT01854463|VITAMIN D|vitamin d
1239296|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
1239297|NCT01854463|FATTY LIVER|fatty liver
1239298|NCT01854463|BONE TURNOVER|bone turnover
1239299|NCT01854450|Occipitoposterior position|occipitoposterior position
1239300|NCT01854450|Maternal posturing|maternal posturing
1239301|NCT01854450|Labor|labor
1239302|NCT01854437|mg oxide|mg oxide
1239303|NCT01854437|hyperphosphatemia|hyperphosphatemia
1239304|NCT01854437|plasma phosphor level|plasma phosphor level
1239305|NCT01854424|Fibrocyte|fibrocyte
1239306|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1239307|NCT01854424|Serum Amyloid P|serum amyloid p
1239308|NCT01854424|Fibrosis|fibrosis
1239311|NCT01854411|Ibuprofene|ibuprofene
1239312|NCT01854411|Ketoprofene|ketoprofene
1239313|NCT01854411|Breastmilk|breastmilk
1239314|NCT01854411|Relative Infant Dose|relative infant dose
1239315|NCT01854411|Theoric Infant Dose|theoric infant dose
1239316|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
1239317|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
1239318|NCT01854398|diastolic function|diastolic function
1239319|NCT01854385|Post-traumatic headache|post-traumatic headache
1239320|NCT01854385|Traumatic brain injury|traumatic brain injury
1239321|NCT01854385|Sumatriptan|sumatriptan
1239322|NCT01854359|Multiple Sclerosis|multiple sclerosis
1239323|NCT01854359|Extension Trial|extension trial
1239324|NCT01854346|Autism spectrum disorder|autism spectrum disorder
1239325|NCT01854346|Social skills training|social skills training
1239326|NCT01854346|Group training|group training
1239327|NCT01854346|Comorbidity|comorbidity
1239328|NCT01854346|Intervention|intervention
1239329|NCT01854346|Evidence-based|evidence-based
1239330|NCT01854333|Diagnostics|diagnostics
1239331|NCT01854333|ADOS|ados
1239332|NCT01854333|ADI-R|adi-r
1239333|NCT01854333|Psychometrics|psychometrics
1239334|NCT01854333|Autism spectrum disorders|autism spectrum disorders
1239335|NCT01854333|Autism|autism
1239336|NCT01854307|Difference of|difference of
1239337|NCT01854307|measurements|measurements
1239338|NCT01854307|before and after|before and after
1239339|NCT01854294|ALS|als
1239340|NCT01854294|motorneuron disease|motorneuron disease
1239341|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
1239342|NCT01854294|neurodegeneration|neurodegeneration
1239343|NCT01854294|neuroprotective|neuroprotective
1239344|NCT01854294|mechanisms of action|mechanisms of action
1239345|NCT01854294|pathways|pathways
1239346|NCT01854294|biomarkers|biomarkers
1239347|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
1239348|NCT01854294|blood biomarkers|blood biomarkers
1239349|NCT01854294|multi-factorial|multi-factorial
1239350|NCT01854294|multisystem|multisystem
1239351|NCT01854294|single target|single target
1239352|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
1239353|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
1239354|NCT01854294|in silico analysis|in silico analysis
1239355|NCT01854294|active site|active site
1239356|NCT01854294|protein|protein
1239357|NCT01854294|peptide|peptide
1239358|NCT01854294|embryonic stage|embryonic stage
1239359|NCT01854294|endogenous|endogenous
1239360|NCT01854294|master regulators|master regulators
1239361|NCT01854294|fetal development|fetal development
1239362|NCT01854294|embryonic development|embryonic development
1239363|NCT01854294|common pathways|common pathways
1239364|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
1239365|NCT01854294|anti-inflammatory|anti-inflammatory
1239366|NCT01854294|anti-apoptotic|anti-apoptotic
1239367|NCT01854294|anti-oxidative|anti-oxidative
1239368|NCT01854294|regenerative|regenerative
1239369|NCT01854294|distress signals|distress signals
1239370|NCT01854294|neurotrophin|neurotrophin
1239371|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
1239372|NCT01854294|ALS model|als model
1239373|NCT01854294|life span|life span
1239374|NCT01854294|disease onset|disease onset
1239375|NCT01854294|grip strength|grip strength
1239376|NCT01854294|protein expression|protein expression
1239377|NCT01854294|DNA microarray|dna microarray
1239378|NCT01854294|differential expression|differential expression
1239379|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
1239380|NCT01854294|rare disease|rare disease
1239381|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
1239382|NCT01854294|neurological deficits|neurological deficits
1239383|NCT01854294|gene mutation|gene mutation
1239384|NCT01854294|misfolded proteins|misfolded proteins
1239385|NCT01854294|inadvertent errors|inadvertent errors
1239386|NCT01854294|modulation of genes|modulation of genes
1239387|NCT01854294|master regulator peptide drug|master regulator peptide drug
1239388|NCT01854294|ALS related genes|als related genes
1239389|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
1239390|NCT01854294|excitotoxicity|excitotoxicity
1239391|NCT01854294|axonal transport|axonal transport
1239392|NCT01854294|oxidative stress|oxidative stress
1239393|NCT01854294|protein aggregation|protein aggregation
1239394|NCT01854294|pathogenesis|pathogenesis
1239395|NCT01854294|target biomarkers|target biomarkers
1239396|NCT01854294|efficacy biomarkers|efficacy biomarkers
1239397|NCT01854281|Patent foramen ovale|patent foramen ovale
1239398|NCT01854281|Catheter-based closure|catheter-based closure
1239399|NCT01854281|Nitrogen bubbles|nitrogen bubbles
1239400|NCT01854281|Decompression sickness|decompression sickness
1239401|NCT01854268|cough|cough
1239402|NCT01854255|Gastric|gastric
1239403|NCT01854255|Cancer|cancer
1239404|NCT01854255|Chemotherapy|chemotherapy
1239405|NCT01854255|Intraperitoneal|intraperitoneal
1239406|NCT01854229|Morphine|morphine
1239407|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
1239408|NCT01854229|Intrathecal Pump|intrathecal pump
1239409|NCT01854216|Rotigotine|rotigotine
1239410|NCT01854216|Neupro|neupro
1239411|NCT01854216|Japanese|japanese
1239412|NCT01854216|Caucasian|caucasian
1239413|NCT01854216|Male|male
1239414|NCT01854216|Female|female
1239415|NCT01854216|Single dose|single dose
1239416|NCT01854216|Pharmacokinetics|pharmacokinetics
1239417|NCT01854203|Cisplatin|cisplatin
1239418|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1239419|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1239420|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1239421|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
1239422|NCT01854190|Resistent hypertension|resistent hypertension
1239423|NCT01854190|Endothelial function|endothelial function
1239424|NCT01854190|Blood pressure|blood pressure
1239425|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
1239426|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
1239427|NCT01854151|Medication errors|medication errors
1239428|NCT01854151|Medication dosing|medication dosing
1239429|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
1239430|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
1239431|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
1239432|NCT01854125|immun function|immun function
1239433|NCT01854125|liver function|liver function
1239434|NCT01854125|ascites|ascites
1239435|NCT01854125|quality of life|quality of life
1239436|NCT01854125|Child-Pugh score|child-pugh score
1239437|NCT01854112|Helical tomotherapy|helical tomotherapy
1239438|NCT01854112|total skin electron therapy|total skin electron therapy
1239439|NCT01854112|TSEB|tseb
1239440|NCT01854112|irradiation 5.|irradiation 5.
1239441|NCT01854099|Brain Tumor|brain tumor
1239442|NCT01854086|osteoporosis|osteoporosis
1239443|NCT01854086|postmenopausal|postmenopausal
1239444|NCT01854086|patient compliance|patient compliance
1239445|NCT01854086|compliance|compliance
1239446|NCT01854086|diphosphonates|diphosphonates
1239447|NCT01854086|bisphosphonates|bisphosphonates
1239448|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
1239449|NCT01854060|Epidimiology|epidimiology
1239450|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
1239451|NCT01854034|Advanced disease|advanced disease
1239452|NCT01854034|EGFR mutation|egfr mutation
1239453|NCT01854021|Anesthesia|anesthesia
1239454|NCT01854021|general|general
1239456|NCT01854021|Tongue neoplasms|tongue neoplasms
1239457|NCT01854021|immune|immune
1239458|NCT01854021|general anesthesia|general anesthesia
1239459|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
1239460|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
1239461|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
1239462|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
1239463|NCT01853995|Skeletal changes|skeletal changes
1239464|NCT01853995|Dental changes|dental changes
1239465|NCT01853956|Mexico|mexico
1239466|NCT01853956|Bioequivalence|bioequivalence
1239467|NCT01853956|Alprazolam|alprazolam
1239468|NCT01853956|Pharmacokinetics|pharmacokinetics
1239469|NCT01853943|Transradial approach|transradial approach
1239470|NCT01853943|radial occlusion|radial occlusion
1239471|NCT01853943|hand grip|hand grip
1239472|NCT01853943|coronary angiography|coronary angiography
1239473|NCT01853930|reading rehabilitation|reading rehabilitation
1239474|NCT01853930|macular degeneration|macular degeneration
1239475|NCT01853930|eccentric viewing|eccentric viewing
1239476|NCT01853904|Bronchoscopy|bronchoscopy
1239477|NCT01853904|BAL|bal
1239478|NCT01853904|Suction|suction
1239479|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
1239480|NCT01853878|Immunotherapy|immunotherapy
1239481|NCT01853878|Antigen-Specific|antigen-specific
1239482|NCT01853865|Endometrial cancer|endometrial cancer
1239483|NCT01853865|Follow-up examination|follow-up examination
1239484|NCT01853813|colorectal cancer|colorectal cancer
1239485|NCT01853813|advanced disease|advanced disease
1239486|NCT01853813|LDH|ldh
1239487|NCT01853800|Relative bioavailability|relative bioavailability
1239488|NCT01853800|Rivaroxaban|rivaroxaban
1239489|NCT01853787|COPD|copd
1239490|NCT01853787|bronchial inflammation|bronchial inflammation
1239491|NCT01853787|NO concentration|no concentration
1239492|NCT01853787|small airways|small airways
1239493|NCT01853787|LABA|laba
1239494|NCT01853787|Small Airways Stretching|small airways stretching
1239495|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
1239496|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
1239497|NCT01853787|Pulmonary desufflation|pulmonary desufflation
1239498|NCT01853774|Tailored navigation|tailored navigation
1239499|NCT01853774|Tailored messages|tailored messages
1239500|NCT01853761|abdominal fat|abdominal fat
1239501|NCT01853761|metabolic syndrome|metabolic syndrome
1239502|NCT01853761|microcurrent|microcurrent
1239503|NCT01853761|aerobic exercise|aerobic exercise
1239504|NCT01853722|DCN01|dcn01
1239505|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
1240518|NCT01849510|stereotaxis|stereotaxis
1239506|NCT01853722|Prophylaxis against infection|prophylaxis against infection
1239507|NCT01853722|Pre-operative prep|pre-operative prep
1239508|NCT01853683|General Surgery|general surgery
1239509|NCT01853644|Cancer|cancer
1239510|NCT01853644|Recurrent|recurrent
1239511|NCT01853644|Ovary|ovary
1239512|NCT01853644|Fallopian Tube|fallopian tube
1239513|NCT01853644|Primary Peritioneal|primary peritioneal
1239514|NCT01853644|Phase II|phase ii
1239515|NCT01853644|Platinum Resistant|platinum resistant
1239516|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1239517|NCT01853631|refractory|refractory
1239518|NCT01853631|recurrent|recurrent
1239519|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
1239520|NCT01853631|CD19|cd19
1239521|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1239522|NCT01853631|CD28|cd28
1239523|NCT01853631|CD137|cd137
1239524|NCT01853631|4-1BB|4-1bb
1239525|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
1239526|NCT01853618|Liver Cancer|liver cancer
1239527|NCT01853618|Monoclonal Antibody|monoclonal antibody
1239528|NCT01853618|CTLA-4|ctla-4
1239529|NCT01853618|Ablative Therapy|ablative therapy
1239530|NCT01853592|Gadolinium Contrast|gadolinium contrast
1239531|NCT01853592|Cardiac MRI|cardiac mri
1239532|NCT01853592|MRA|mra
1239533|NCT01853592|MRI|mri
1239534|NCT01853592|MRI Safety|mri safety
1239535|NCT01853579|Randomized controlled trial|randomized controlled trial
1239536|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
1239537|NCT01853579|Levothyroxine|levothyroxine
1239538|NCT01853579|Depression|depression
1239539|NCT01853566|Muscle Strength|muscle strength
1239540|NCT01853566|Growth Hormone|growth hormone
1239541|NCT01853566|men|men
1239542|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
1239543|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
1239544|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
1239545|NCT01853527|CT coronary angiography|ct coronary angiography
1239546|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
1239547|NCT01853527|Arterial stiffness|arterial stiffness
1239548|NCT01853527|Quality of life|quality of life
1239549|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
1239550|NCT01853514|Low income|low income
1239551|NCT01853514|Fruit and vegetables|fruit and vegetables
1239552|NCT01853514|Conventional produce|conventional produce
1239553|NCT01853514|Organic produce|organic produce
1239554|NCT01853514|Pesticide|pesticide
1239555|NCT01853514|Purchasing behavior|purchasing behavior
1239556|NCT01853514|Message framing|message framing
1239557|NCT01853501|POF|pof
1239558|NCT01853488|Osteoporosis|osteoporosis
1239559|NCT01853488|BMD|bmd
1239560|NCT01853488|SCI|sci
1239561|NCT01853488|DXA|dxa
1239562|NCT01853488|pQCT|pqct
1239563|NCT01853475|pharmacokinetics|pharmacokinetics
1239564|NCT01853475|safety|safety
1239565|NCT01853475|tolerability|tolerability
1239566|NCT01853475|bioavailability|bioavailability
1239567|NCT01853449|Fentanyl Citrate|fentanyl citrate
1239568|NCT01853449|Opioids|opioids
1239569|NCT01853449|Exercise|exercise
1239570|NCT01853436|Breast Cancer|breast cancer
1239571|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
1239572|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
1239573|NCT01853423|Rapamune|rapamune
1239574|NCT01853423|Topical|topical
1239575|NCT01853423|Pediatric|pediatric
1239576|NCT01853423|Safety|safety
1239577|NCT01853423|Efficiency|efficiency
1239578|NCT01853423|Angiofibroma|angiofibroma
1239579|NCT01853423|Skin Cream|skin cream
1239580|NCT01853410|coronary artery disease|coronary artery disease
1239581|NCT01853410|coronary flow reserve|coronary flow reserve
1239582|NCT01853410|endothelial function|endothelial function
1239583|NCT01853384|Venous leg ulcer|venous leg ulcer
1239585|NCT01853384|venous stasis|venous stasis
1239586|NCT01853384|compression|compression
1239587|NCT01853384|venous|venous
1239588|NCT01853384|venous stasis ulcer|venous stasis ulcer
1239589|NCT01853384|vlu|vlu
1239590|NCT01853384|wound|wound
1239591|NCT01853384|varicose veins|varicose veins
1239592|NCT01853384|venous insufficiency|venous insufficiency
1239593|NCT01853384|dvt|dvt
1239594|NCT01853384|deep vein thrombosis|deep vein thrombosis
1239595|NCT01853358|hematological malignancy|hematological malignancy
1239596|NCT01853358|stem cell transplantation|stem cell transplantation
1239597|NCT01853345|Refractory|refractory
1239598|NCT01853345|Recurrent|recurrent
1239599|NCT01853345|High Risk|high risk
1239600|NCT01853332|Cardiovascular Disease|cardiovascular disease
1239601|NCT01853332|Diabetes|diabetes
1239602|NCT01853332|Adjustment|adjustment
1239603|NCT01853332|Adversity|adversity
1239604|NCT01853332|Psychology|psychology
1239605|NCT01853332|Midlife|midlife
1239606|NCT01853332|Functioning|functioning
1239607|NCT01853332|Socioeconomic|socioeconomic
1239608|NCT01853332|Psychosocial outcomes|psychosocial outcomes
1239609|NCT01853319|Regorafenib|regorafenib
1239610|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
1239611|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
1239612|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
1239613|NCT01853306|BRCA mutated|brca mutated
1239614|NCT01853306|Oncology|oncology
1239615|NCT01853293|Alcohol Abuse|alcohol abuse
1239616|NCT01853293|Alcohol Dependence|alcohol dependence
1239617|NCT01853293|Heavy drinking days|heavy drinking days
1239618|NCT01853293|Kudzu|kudzu
1239619|NCT01853280|ADHD|adhd
1239620|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1239621|NCT01853280|Deplin|deplin
1239622|NCT01853280|L-methylfolate|l-methylfolate
1239623|NCT01853280|Natural Treatments|natural treatments
1239624|NCT01853280|Medical Food|medical food
1239625|NCT01853267|Colorectal|colorectal
1239626|NCT01853267|Surgery|surgery
1239627|NCT01853267|Perianal|perianal
1239628|NCT01853267|Abscess|abscess
1239629|NCT01853241|small intestine|small intestine
1239630|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
1239631|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
1239632|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
1239633|NCT01853228|Children|children
1239634|NCT01853228|Decitabine|decitabine
1239635|NCT01853228|DACOGEN|dacogen
1239636|NCT01853228|Cytarabine|cytarabine
1239637|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
1239638|NCT01853202|Cancer|cancer
1239639|NCT01853202|Chemotherapy|chemotherapy
1239640|NCT01853202|Thrombosis|thrombosis
1239641|NCT01853202|Prevention|prevention
1239642|NCT01853202|Exercise|exercise
1239643|NCT01853189|pediatrics|pediatrics
1239644|NCT01853189|asthma|asthma
1239645|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
1239646|NCT01853176|Pain, Postoperative|pain, postoperative
1239647|NCT01853176|Analgesia|analgesia
1239648|NCT01853176|Anesthesia, local|anesthesia, local
1239649|NCT01853176|Abdominoplasty|abdominoplasty
1239650|NCT01853163|Gadolinium|gadolinium
1239651|NCT01853163|Contrast Agent|contrast agent
1239652|NCT01853163|Long-term retention|long-term retention
1239653|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
1239654|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
1239655|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
1239656|NCT01853124|Diarrhea|diarrhea
1239657|NCT01853098|loving-kindness meditation|loving-kindness meditation
1239658|NCT01853098|mindfulness meditation|mindfulness meditation
1239659|NCT01853098|compassion|compassion
1239660|NCT01853072|Diabetes Type I|diabetes type i
1239661|NCT01853072|Diabetes Type II|diabetes type ii
1239662|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
1239663|NCT01853072|macular edema|macular edema
1239664|NCT01853072|Cataract|cataract
1239665|NCT01853059|Anal cancer|anal cancer
1239666|NCT01853059|Squamous cell cancer|squamous cell cancer
1239667|NCT01853059|Radiotherapy|radiotherapy
1239668|NCT01853059|Chemoradiotherapy|chemoradiotherapy
1239669|NCT01853059|Conformational radiotherapy|conformational radiotherapy
1239670|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
1239671|NCT01853059|IMRT|imrt
1239672|NCT01853046|Regorafenib|regorafenib
1239673|NCT01853046|pharmacokinetics|pharmacokinetics
1239674|NCT01853046|safety|safety
1239675|NCT01853046|severe renal impairment|severe renal impairment
1239676|NCT01853046|Solid tumors|solid tumors
1239677|NCT01853033|Tolerability|tolerability
1239678|NCT01853033|Immunogenicity|immunogenicity
1239679|NCT01853033|Safety|safety
1239680|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
1239681|NCT01853033|Pharmacokinetics|pharmacokinetics
1239682|NCT01853020|Cannabinoids|cannabinoids
1239683|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
1239685|NCT01853007|End stage renal disease|end stage renal disease
1239686|NCT01853007|Kidney transplantation|kidney transplantation
1239687|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
1239688|NCT01853007|Patient education|patient education
1239689|NCT01853007|Communication skills training|communication skills training
1239690|NCT01852981|Physical activity promotion|physical activity promotion
1239691|NCT01852981|Intervention|intervention
1239692|NCT01852981|Public Health|public health
1239693|NCT01852968|hypoglycemia|hypoglycemia
1239694|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
1239695|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
1239696|NCT01852968|glucose transport|glucose transport
1239697|NCT01852968|cognitive dysfunction|cognitive dysfunction
1239698|NCT01852955|Outpatient|outpatient
1239699|NCT01852955|Surgery|surgery
1239700|NCT01852955|Breast|breast
1239701|NCT01852955|Pain|pain
1239702|NCT01852942|Infection|infection
1239703|NCT01852942|HIV 1|hiv 1
1239704|NCT01852942|HIV|hiv
1239705|NCT01852942|Losartan|losartan
1239706|NCT01852942|Fibrosis|fibrosis
1239707|NCT01852942|Immune Activation|immune activation
1239708|NCT01852942|Immune Reconstitution|immune reconstitution
1239709|NCT01852929|Memory|memory
1239710|NCT01852916|RDS|rds
1239711|NCT01852903|vitamin C|vitamin c
1239712|NCT01852903|calcium ascorbate|calcium ascorbate
1239713|NCT01852903|ascorbic acid|ascorbic acid
1239714|NCT01852903|bioavailability|bioavailability
1239715|NCT01852890|Ascorbate|ascorbate
1239716|NCT01852890|Vitamin C|vitamin c
1239717|NCT01852890|Radiation|radiation
1239718|NCT01852890|Gemcitabine|gemcitabine
1239719|NCT01852890|Ascorbic Acid|ascorbic acid
1239720|NCT01852877|HIV Diagnosis|hiv diagnosis
1239721|NCT01852877|Case Management|case management
1239722|NCT01852877|Telemedicine|telemedicine
1239723|NCT01852877|Patient Compliance|patient compliance
1239724|NCT01852877|Prisoners|prisoners
1239725|NCT01852864|Prostate cancer|prostate cancer
1239726|NCT01852864|testosterone|testosterone
1239727|NCT01852864|castration|castration
1239728|NCT01852864|degarelix|degarelix
1239729|NCT01852864|proliferation|proliferation
1239730|NCT01852838|lung cancer|lung cancer
1239731|NCT01852838|volatile organic compounds|volatile organic compounds
1239732|NCT01852838|Warburg effect|warburg effect
1239733|NCT01852838|early detection|early detection
1239734|NCT01852799|Multiple myeloma|multiple myeloma
1239736|NCT01852799|ASCT|asct
1239737|NCT01852799|Bone metabolites|bone metabolites
1239738|NCT01852799|Bone marker|bone marker
1239739|NCT01852786|Contraception|contraception
1239740|NCT01852786|Hyperandrogenism|hyperandrogenism
1239741|NCT01852786|Female sexual function|female sexual function
1239742|NCT01852773|blunt|blunt
1239743|NCT01852773|injury|injury
1239744|NCT01852773|aorta|aorta
1239745|NCT01852773|endovascular|endovascular
1239746|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
1239747|NCT01852760|ulcerative colitis|ulcerative colitis
1239748|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
1239749|NCT01852747|Spinal Deformity|spinal deformity
1239750|NCT01852747|Multilevel|multilevel
1239751|NCT01852747|Posterior|posterior
1239752|NCT01852747|Lumbar|lumbar
1239753|NCT01852747|Fusion|fusion
1239754|NCT01852747|Levoscoliosis|levoscoliosis
1239755|NCT01852747|Dextroscoliosis|dextroscoliosis
1239756|NCT01852747|Graft|graft
1239757|NCT01852721|Cardiovascular diseases|cardiovascular diseases
1239758|NCT01852721|Nutritional intervention program|nutritional intervention program
1239759|NCT01852721|Self-Determination Theory|self-determination theory
1239760|NCT01852721|Motivational interviewing|motivational interviewing
1239761|NCT01852721|Gender differences|gender differences
1239762|NCT01852721|Women|women
1239763|NCT01852721|Men|men
1239764|NCT01852721|Motivation|motivation
1239765|NCT01852721|Dietary intakes|dietary intakes
1239766|NCT01852721|Mediterranean diet|mediterranean diet
1239767|NCT01852721|Eating behaviors|eating behaviors
1239768|NCT01852721|Lipid profile|lipid profile
1239769|NCT01852708|22q|22q
1239770|NCT01852708|1p36|1p36
1239771|NCT01852708|Angelman|angelman
1239772|NCT01852708|Cri-du-chat|cri-du-chat
1239773|NCT01852708|Prader-Willi|prader-willi
1239774|NCT01852708|DiGeorge|digeorge
1239775|NCT01852708|Turner syndrome|turner syndrome
1239776|NCT01852708|Patau syndrome|patau syndrome
1239777|NCT01852708|Edwards syndrome|edwards syndrome
1239778|NCT01852708|Down syndrome|down syndrome
1239779|NCT01852695|Family integrated Care|family integrated care
1239780|NCT01852695|Family centered care|family centered care
1239781|NCT01852695|NICU family centered care|nicu family centered care
1239782|NCT01852695|NICU parent program|nicu parent program
1239783|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
1239784|NCT01852682|Hyperphosphatemia|hyperphosphatemia
1598764|NCT00399256|Zinc|zinc
1239785|NCT01852656|Influenza, Human|influenza, human
1239786|NCT01852656|Immunization|immunization
1239787|NCT01852643|Rhinoplasty|rhinoplasty
1239788|NCT01852643|Spreader graft technique|spreader graft technique
1239789|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
1239790|NCT01852643|Rhinomanometry|rhinomanometry
1239791|NCT01852617|Smoking Cessation|smoking cessation
1239792|NCT01852617|Pregnancy|pregnancy
1239793|NCT01852617|Implementation|implementation
1239794|NCT01852617|Knowledge translation|knowledge translation
1239795|NCT01852604|HCV|hcv
1239796|NCT01852604|Hepatitis C|hepatitis c
1239797|NCT01852604|chronic hepatitis C|chronic hepatitis c
1239798|NCT01852604|antiviral|antiviral
1239799|NCT01852591|autologous transplant|autologous transplant
1239800|NCT01852591|multiple myeloma|multiple myeloma
1239801|NCT01852578|Metastatic NSCLC|metastatic nsclc
1239802|NCT01852578|2nd Line|2nd line
1239803|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
1239804|NCT01852578|Progressed|progressed
1239805|NCT01852578|Refractory|refractory
1239806|NCT01852565|CYP3A4|cyp3a4
1239807|NCT01852565|Lp-PLA2|lp-pla2
1239808|NCT01852565|Atherosclerosis|atherosclerosis
1239809|NCT01852565|healthy volunteer|healthy volunteer
1239810|NCT01852565|Drug interaction|drug interaction
1239811|NCT01852552|Aortic stenosis|aortic stenosis
1239812|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1239813|NCT01852552|Aortic valve replacement|aortic valve replacement
1239814|NCT01852552|Costs|costs
1239815|NCT01852552|Cognitive function|cognitive function
1239816|NCT01852552|Quality of life|quality of life
1239817|NCT01852539|LMA insertion|lma insertion
1239818|NCT01852539|dexmedetomidine|dexmedetomidine
1239819|NCT01852539|propofol|propofol
1239820|NCT01852526|degenerative disc disease|degenerative disc disease
1239821|NCT01852526|spondylolisthesis|spondylolisthesis
1239822|NCT01852526|Lumbar spine|lumbar spine
1239823|NCT01852526|fusion|fusion
1239824|NCT01852526|adjacent instability|adjacent instability
1239825|NCT01852487|Pumpkin seed oil|pumpkin seed oil
1239826|NCT01852487|Hair growth|hair growth
1239827|NCT01852487|Men|men
1239828|NCT01852474|motor learning|motor learning
1239829|NCT01852474|cortical plasticity|cortical plasticity
1239830|NCT01852474|direct current stimulation|direct current stimulation
1239831|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
1239832|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1239833|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
1239834|NCT01852409|refractory malignant ascites|refractory malignant ascites
1239835|NCT01852409|Bevacizumab|bevacizumab
1239836|NCT01852409|intraperitoneal|intraperitoneal
1239837|NCT01852409|phase I|phase i
1239838|NCT01852396|Infraclavicular block|infraclavicular block
1239839|NCT01852396|Brachial Plexus|brachial plexus
1239840|NCT01852396|Retroclavicular Approach|retroclavicular approach
1239841|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
1239842|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
1239843|NCT01852383|Duloxetine|duloxetine
1239844|NCT01852383|Antidepressant|antidepressant
1239845|NCT01852383|Depression|depression
1239846|NCT01852383|Dysthymic Disorder|dysthymic disorder
1239847|NCT01852383|Side Effects|side effects
1239848|NCT01852383|Elderly|elderly
1239849|NCT01852370|Lung transplantation|lung transplantation
1239850|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
1239851|NCT01852370|Unrelated Donor|unrelated donor
1239852|NCT01852370|Cadaveric Donor|cadaveric donor
1239853|NCT01852370|Deceased Donor|deceased donor
1239854|NCT01852370|HLA-mismatch|hla-mismatch
1239855|NCT01852370|BOLT|bolt
1239856|NCT01852370|BMT|bmt
1239857|NCT01852370|HSCT|hsct
1239858|NCT01852344|Methylphenidate|methylphenidate
1239859|NCT01852344|Effortful Control|effortful control
1239860|NCT01852344|Attention Control|attention control
1239861|NCT01852344|Cognitive functions|cognitive functions
1239862|NCT01852331|Schizophrenia|schizophrenia
1239863|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
1239864|NCT01852331|Hyperprolactinemia|hyperprolactinemia
1239865|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
1239866|NCT01852331|Chinese herbal medicine|chinese herbal medicine
1239867|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
1239868|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
1239869|NCT01852331|PGD|pgd
1239870|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
1239871|NCT01852331|Liquorice Root|liquorice root
1239872|NCT01852331|Gancao|gancao
1239873|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
1239874|NCT01852331|White Peony Root|white peony root
1239875|NCT01852331|Baishao|baishao
1239876|NCT01852318|uremic pruritus|uremic pruritus
1239877|NCT01852318|pregabalin|pregabalin
1239878|NCT01852318|gabapentin|gabapentin
1239879|NCT01852318|fexofenadine|fexofenadine
1239880|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
1239881|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1239882|NCT01852305|Oximetry|oximetry
1239883|NCT01852305|Bariatric Surgery|bariatric surgery
1239884|NCT01852305|Anesthesia|anesthesia
1239885|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
1239886|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
1239887|NCT01852292|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1239888|NCT01852292|recurrent|recurrent
1239889|NCT01852292|metastatic|metastatic
1239890|NCT01852292|BKM120|bkm120
1239891|NCT01852253|Dental implants|dental implants
1239892|NCT01852253|Periodontal diseases|periodontal diseases
1239893|NCT01852253|Peri-implantitis|peri-implantitis
1239894|NCT01852253|Chlorhexidine|chlorhexidine
1239895|NCT01852253|Microbiology|microbiology
1239896|NCT01852214|Diabetes mellitus|diabetes mellitus
1239897|NCT01852214|Coronary artery disease|coronary artery disease
1239898|NCT01852214|prasugrel|prasugrel
1239899|NCT01852214|ticagrelor|ticagrelor
1239900|NCT01852188|Intrapartum|intrapartum
1239901|NCT01852188|Glove|glove
1239902|NCT01852188|Chorioamnionitis|chorioamnionitis
1239903|NCT01852175|Coronary artery disease|coronary artery disease
1239904|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
1239905|NCT01852175|prasugrel|prasugrel
1239906|NCT01852175|ticagrelor|ticagrelor
1239907|NCT01852162|Coronary artery disease|coronary artery disease
1239908|NCT01852162|antiplatelet therapy|antiplatelet therapy
1239909|NCT01852162|anticoagulant therapy|anticoagulant therapy
1239910|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
1239911|NCT01852149|Coaptation|coaptation
1239912|NCT01852149|Mitral Valve Repair|mitral valve repair
1239913|NCT01852149|Plication|plication
1239914|NCT01852149|Leaflet|leaflet
1239915|NCT01852149|Annulus|annulus
1239916|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
1239917|NCT01852136|pen needle|pen needle
1239918|NCT01852136|insulin|insulin
1240725|NCT01848561|Adalimumab|adalimumab
1239919|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
1239920|NCT01852123|Myocardial infarction|myocardial infarction
1239921|NCT01852123|Unstable angina|unstable angina
1239922|NCT01852123|Myocardial injury|myocardial injury
1239923|NCT01852123|Cluster randomized trial|cluster randomized trial
1239924|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1239925|NCT01852097|Crohn's disease|crohn's disease
1239926|NCT01852097|Ulcerative colitis|ulcerative colitis
1239927|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
1239928|NCT01852097|Medication adherence|medication adherence
1239929|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
1239930|NCT01852032|Breast Cancer|breast cancer
1239932|NCT01851993|Ondansetron|ondansetron
1239933|NCT01851993|Exercise|exercise
1239934|NCT01851980|Furosemide|furosemide
1239935|NCT01851980|Exercise|exercise
1239936|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
1239937|NCT01851967|Major depressive disorder|major depressive disorder
1239938|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
1239939|NCT01851967|Computerized CBT|computerized cbt
1239940|NCT01851967|Online CBT|online cbt
1239941|NCT01851915|Major depression|major depression
1239942|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
1239943|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
1239944|NCT01851915|Alliance|alliance
1239945|NCT01851915|Return to Work|return to work
1239946|NCT01851902|Atrial Fibrillation|atrial fibrillation
1239947|NCT01851902|Atrial Flutter|atrial flutter
1239948|NCT01851902|Arrhythmia|arrhythmia
1239949|NCT01851863|functional dyspepsia|functional dyspepsia
1239950|NCT01851863|depression|depression
1239951|NCT01851863|compliance|compliance
1239952|NCT01851850|PD|pd
1239953|NCT01851850|Off periods|off periods
1239954|NCT01851850|quality of life|quality of life
1239955|NCT01851850|dyskinesia|dyskinesia
1239956|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
1239957|NCT01851811|OSA|osa
1239958|NCT01851798|OSA|osa
1239959|NCT01851798|Sleep disordered breathing|sleep disordered breathing
1239960|NCT01851798|anesthesia|anesthesia
1239961|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
1239962|NCT01851785|Knee Arthroplasty|knee arthroplasty
1239963|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
1239964|NCT01851785|Osteoarthritis|osteoarthritis
1239965|NCT01851785|disparity|disparity
1239966|NCT01851785|joint replacement|joint replacement
1239967|NCT01851772|cervical|cervical
1239968|NCT01851772|cancer|cancer
1239969|NCT01851772|brachytherapy|brachytherapy
1239970|NCT01851772|electronic|electronic
1239971|NCT01851772|device|device
1239972|NCT01851772|applicator|applicator
1239973|NCT01851772|toxicity|toxicity
1239974|NCT01851772|gynecologic|gynecologic
1239975|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
1239976|NCT01851772|x-ray|x-ray
1239977|NCT01851772|safety|safety
1239978|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
1239979|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
1239980|NCT01851746|lobaplatin|lobaplatin
1239981|NCT01851746|docetaxel|docetaxel
1239982|NCT01851746|carboplatin|carboplatin
1239983|NCT01851694|Cystic Fibrosis|cystic fibrosis
1239984|NCT01851694|Diabetes|diabetes
1239985|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
1239986|NCT01851681|dental implants|dental implants
1239987|NCT01851681|wound healing|wound healing
1239988|NCT01851681|amoxicillin|amoxicillin
1239989|NCT01851681|pain|pain
1239990|NCT01851668|vibration|vibration
1239991|NCT01851668|noise|noise
1239992|NCT01851668|transfer|transfer
1239993|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
1239994|NCT01851655|rehabilitation|rehabilitation
1239995|NCT01851655|plyometric|plyometric
1239996|NCT01851642|Macrophage|macrophage
1239997|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1239998|NCT01851642|Cystic Fibrosis|cystic fibrosis
1239999|NCT01851629|Locomotor training|locomotor training
1240000|NCT01851629|Walking recovery|walking recovery
1240001|NCT01851629|Neuroplasticity|neuroplasticity
1240002|NCT01851616|glucose, blood|glucose, blood
1240003|NCT01851603|Schizophrenia|schizophrenia
1240004|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
1240005|NCT01851590|Fungal nail infection|fungal nail infection
1240006|NCT01851590|Resin Lacquer|resin lacquer
1240007|NCT01851590|Amorolfine|amorolfine
1240008|NCT01851590|Terbinafine|terbinafine
1240009|NCT01851577|Coparenting|coparenting
1240010|NCT01851577|Problem solving|problem solving
1240011|NCT01851577|Child development|child development
1240012|NCT01851577|Father involvement|father involvement
1240013|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
1240014|NCT01851564|Varices|varices
1240015|NCT01851564|Liver Cirrhosis|liver cirrhosis
1240016|NCT01851564|Stent|stent
1240018|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1240019|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1240020|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
1240028|NCT01851473|Pharmacokinetics|pharmacokinetics
1240029|NCT01851473|Pharmacodynamics|pharmacodynamics
1240030|NCT01851473|Drug Interactions|drug interactions
1240031|NCT01851473|Acetazolamide|acetazolamide
1240032|NCT01851460|Staphylococcus Infection|staphylococcus infection
1240034|NCT01851460|Hepatic|hepatic
1240035|NCT01851460|CGD|cgd
1240041|NCT01851434|OCT|oct
1240042|NCT01851434|Multiple Sclerosis|multiple sclerosis
1240043|NCT01851434|Optic Neuritis|optic neuritis
1240044|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1240045|NCT01851421|Body Fat|body fat
1240046|NCT01851421|Adult|adult
1240047|NCT01851421|Obesity|obesity
1240048|NCT01851421|Free Fatty Acids|free fatty acids
1240049|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
1240050|NCT01851408|Sorafenib|sorafenib
1240051|NCT01851408|Temsirolimus|temsirolimus
1240052|NCT01851408|Stage IV|stage iv
1240053|NCT01851408|recurrent|recurrent
1240054|NCT01851408|unresectable|unresectable
1240055|NCT01851408|non-choroidal origin|non-choroidal origin
1240056|NCT01851408|CCI-779|cci-779
1240057|NCT01851408|BAY43-9006|bay43-9006
1240058|NCT01851408|metastatic melanoma|metastatic melanoma
1240059|NCT01851395|Palliative|palliative
1240060|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
1240061|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
1240062|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
1240063|NCT01851395|Clonal Evolution|clonal evolution
1240064|NCT01851382|ELISA|elisa
1240065|NCT01851382|Spectrometry|spectrometry
1240066|NCT01851382|Protein Biomarkers|protein biomarkers
1240067|NCT01851382|Proteomic Analyses|proteomic analyses
1240068|NCT01851369|Solid Tumors|solid tumors
1240069|NCT01851369|Lymphomas|lymphomas
1240070|NCT01851369|DNA Damage|dna damage
1240071|NCT01851369|Pharmacodynamics|pharmacodynamics
1240072|NCT01851369|Pharmacokinetics|pharmacokinetics
1240077|NCT01851343|Stem Cell Infusion|stem cell infusion
1240078|NCT01851343|Crohns|crohns
1240079|NCT01851343|Ulcerative Colitis|ulcerative colitis
1240080|NCT01851343|Inflammation|inflammation
1240081|NCT01851343|Diarrhea|diarrhea
1240082|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1240083|NCT01851330|HCV|hcv
1240084|NCT01851330|Sustained Virologic Response|sustained virologic response
1240085|NCT01851330|Direct Acting Antiviral|direct acting antiviral
1240086|NCT01851330|Combination Therapy|combination therapy
1240087|NCT01851330|GS-7977|gs-7977
1240088|NCT01851330|GS-5885|gs-5885
1240089|NCT01851330|Ribavirin|ribavirin
1240090|NCT01851330|Open Label|open label
1240091|NCT01851330|Sofosbuvir|sofosbuvir
1240092|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
1240093|NCT01851330|Hepatitis|hepatitis
1240094|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
1240095|NCT01851330|Hepatitis C|hepatitis c
1240096|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
1240097|NCT01851330|Liver Diseases|liver diseases
1240098|NCT01851330|Digestive System Diseases|digestive system diseases
1240099|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
1240100|NCT01851330|Virus Diseases|virus diseases
1240101|NCT01851330|Enterovirus Infections|enterovirus infections
1240102|NCT01851330|Picornaviridae Infections|picornaviridae infections
1240103|NCT01851330|RNA Virus Infections|rna virus infections
1240104|NCT01851330|Flaviviridae Infections|flaviviridae infections
1240105|NCT01851330|Antiviral Agents|antiviral agents
1240106|NCT01851330|Anti-Infective Agents|anti-infective agents
1240107|NCT01851330|Therapeutic Uses|therapeutic uses
1240108|NCT01851330|Pharmacologic Actions|pharmacologic actions
1240109|NCT01851330|Antimetabolites|antimetabolites
1240110|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1240111|NCT01851304|beta-Glucans|beta-glucans
1240112|NCT01851304|Bitter|bitter
1240113|NCT01851304|Bread|bread
1240114|NCT01851304|Coffee|coffee
1240115|NCT01851304|Gentiana lutea|gentiana lutea
1240116|NCT01851304|Melanoidins|melanoidins
1240117|NCT01851304|Microencapsulation|microencapsulation
1240118|NCT01851278|injection|injection
1240119|NCT01851278|arthritis|arthritis
1240120|NCT01851278|corticosteroid|corticosteroid
1240216|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
1240217|NCT01850758|Partial ACL Tear|partial acl tear
1240317|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
1240121|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
1240122|NCT01851252|Cirrhotics|cirrhotics
1240123|NCT01851252|Esophageal varices|esophageal varices
1240124|NCT01851252|Portal Hypertension|portal hypertension
1240125|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
1240126|NCT01851239|ICU|icu
1240127|NCT01851213|genomics|genomics
1240128|NCT01851213|cancer|cancer
1240129|NCT01851213|registry|registry
1240130|NCT01851213|neoplasm metastasis|neoplasm metastasis
1240131|NCT01851200|Testicular neoplasms|testicular neoplasms
1240132|NCT01851200|Germ Cell cancers|germ cell cancers
1240133|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
1240134|NCT01851200|Metastatic|metastatic
1240135|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
1240136|NCT01851187|Psychological intervention,|psychological intervention,
1240137|NCT01851187|prenatal period,|prenatal period,
1240138|NCT01851187|cesarean section rate,|cesarean section rate,
1240139|NCT01851187|stage of labor|stage of labor
1240140|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
1240141|NCT01851148|migraine|migraine
1240142|NCT01851135|Quality of life|quality of life
1240143|NCT01851135|Neuropsychological disorders|neuropsychological disorders
1240144|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
1240145|NCT01851122|l-theanine|l-theanine
1240146|NCT01851122|alertness|alertness
1240147|NCT01851122|well-being|well-being
1240148|NCT01851109|ovarian cancer|ovarian cancer
1240149|NCT01851109|prevention|prevention
1240150|NCT01851109|prophylactic surgery|prophylactic surgery
1240151|NCT01851109|risk|risk
1240152|NCT01851109|biomarkers|biomarkers
1240153|NCT01851109|screening|screening
1240154|NCT01851109|symptoms|symptoms
1240155|NCT01851096|Hsp90|hsp90
1240156|NCT01851096|SNX-5422|snx-5422
1240157|NCT01851096|Erlotinib|erlotinib
1240158|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
1240159|NCT01851083|Traumatic Brain Injury|traumatic brain injury
1240160|NCT01851083|TBI|tbi
1240161|NCT01851083|pediatric|pediatric
1240162|NCT01851083|acute|acute
1240163|NCT01851083|stem cells|stem cells
1240164|NCT01851057|Epilepsy|epilepsy
1240165|NCT01851044|Platelet Rich Plasma|platelet rich plasma
1240166|NCT01851044|Whole Blood Injection|whole blood injection
1240167|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
1240168|NCT01851044|Tennis Elbow|tennis elbow
1240169|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
1240170|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
1240171|NCT01851031|the retromandibular approach|the retromandibular approach
1240172|NCT01851018|Prostate cancer|prostate cancer
1240173|NCT01851018|brachytherapy|brachytherapy
1240174|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
1240175|NCT01851018|hormonal therapy|hormonal therapy
1240176|NCT01851005|Dexmedetomidine|dexmedetomidine
1240177|NCT01851005|Anesthesia|anesthesia
1240178|NCT01851005|Recovery profile|recovery profile
1240179|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
1240180|NCT01850992|sleep|sleep
1240181|NCT01850992|male hormones|male hormones
1240182|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
1240183|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
1240184|NCT01850953|Varenicline|varenicline
1240185|NCT01850953|Schizophrenia|schizophrenia
1240186|NCT01850953|smoking|smoking
1240187|NCT01850953|Lapse|lapse
1240188|NCT01850940|Cirrhotic Patients|cirrhotic patients
1240189|NCT01850940|Hyponatremia|hyponatremia
1240190|NCT01850940|tolvaptan|tolvaptan
1240191|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
1240192|NCT01850914|Vascular risk factors|vascular risk factors
1240193|NCT01850901|Hypertension|hypertension
1240194|NCT01850901|Renal denervation|renal denervation
1240195|NCT01850901|Sympathetic denervation|sympathetic denervation
1240196|NCT01850888|neuroblastoma|neuroblastoma
1240197|NCT01850888|pheochromocytoma|pheochromocytoma
1240198|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
1240199|NCT01850875|EMDR|emdr
1240200|NCT01850875|Chronic back pain|chronic back pain
1240201|NCT01850875|CBP|cbp
1240202|NCT01850875|treatment|treatment
1240203|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
1240204|NCT01850797|oral anticoagulants|oral anticoagulants
1240205|NCT01850797|ischemic stroke|ischemic stroke
1240206|NCT01850797|blood thinner|blood thinner
1240207|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
1240208|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
1240209|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
1240210|NCT01850771|Disc bulge|disc bulge
1240211|NCT01850771|Disc herniation|disc herniation
1240212|NCT01850771|Disc degeneration|disc degeneration
1240213|NCT01850758|ACL|acl
1240214|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
1240215|NCT01850758|ACL Tear|acl tear
1240218|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
1240219|NCT01850719|Tibial meniscus|tibial meniscus
1240220|NCT01850719|Arthroscopy|arthroscopy
1240221|NCT01850719|Meniscectomy|meniscectomy
1240222|NCT01850719|Conservative treatment|conservative treatment
1240223|NCT01850719|Physical therapy|physical therapy
1240224|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
1240225|NCT01850706|uNGF|ungf
1240226|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
1240227|NCT01850706|detrusor overactivity|detrusor overactivity
1240228|NCT01850706|InterStim|interstim
1240229|NCT01850706|sacral neuromodulation|sacral neuromodulation
1240230|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
1240231|NCT01850706|quality of life|quality of life
1240232|NCT01850706|questionnaire|questionnaire
1240233|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
1240234|NCT01850706|overactive bladder|overactive bladder
1240235|NCT01850693|coronary artery disease|coronary artery disease
1240236|NCT01850693|stroke|stroke
1240237|NCT01850693|coronary CT angiography|coronary ct angiography
1240238|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
1240239|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
1240240|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1240241|NCT01850654|colorectal cancer|colorectal cancer
1240242|NCT01850654|colon cancer|colon cancer
1240243|NCT01850654|rectal cancer|rectal cancer
1240244|NCT01850654|endometrial cancer|endometrial cancer
1240245|NCT01850654|Lynch syndrome|lynch syndrome
1240246|NCT01850654|Ohio colon cancer study|ohio colon cancer study
1240247|NCT01850654|OSU colon study|osu colon study
1240248|NCT01850641|Hemodialysis|hemodialysis
1240249|NCT01850641|Hyperphosphatemia|hyperphosphatemia
1240250|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
1240251|NCT01850628|paclitaxel|paclitaxel
1240252|NCT01850628|trastuzumab|trastuzumab
1240253|NCT01850628|pertuzumab|pertuzumab
1240254|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
1240255|NCT01850628|Proteomics|proteomics
1240256|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
1240257|NCT01850628|Anthracycline therapy|anthracycline therapy
1240258|NCT01850628|Locally advanced|locally advanced
1240259|NCT01850628|Operable|operable
1240260|NCT01850628|Biomarkers|biomarkers
1240261|NCT01850602|Hemodialysis|hemodialysis
1240262|NCT01850602|Hyperphosphatemia|hyperphosphatemia
1240263|NCT01850576|prevention|prevention
1240264|NCT01850576|testing|testing
1240265|NCT01850576|counseling|counseling
1240266|NCT01850576|linkage|linkage
1240267|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
1240268|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
1240269|NCT01850550|Weight loss|weight loss
1240270|NCT01850537|DDD|ddd
1240271|NCT01850537|PROW|prow
1240272|NCT01850537|FUSION|fusion
1240273|NCT01850537|eSPIN|espin
1240274|NCT01850537|Cage|cage
1240275|NCT01850537|IBF|ibf
1240276|NCT01850537|Discectomy|discectomy
1240277|NCT01850537|Lumbar Fusion|lumbar fusion
1240278|NCT01850537|TLIF|tlif
1240279|NCT01850537|MIS|mis
1240280|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
1240281|NCT01850524|multiple myeloma|multiple myeloma
1240282|NCT01850524|MLN9708|mln9708
1240283|NCT01850524|IXAZOMIB|ixazomib
1240284|NCT01850524|Proteasome inhibitor|proteasome inhibitor
1240285|NCT01850524|Tourmaline MM2|tourmaline mm2
1240286|NCT01850511|Nasal obstruction|nasal obstruction
1240287|NCT01850511|Vibrissae|vibrissae
1240288|NCT01850511|Nasal hair|nasal hair
1240289|NCT01850498|Epilepsy|epilepsy
1240290|NCT01850498|Seizure|seizure
1240291|NCT01850498|Motor|motor
1240292|NCT01850498|Motion|motion
1240293|NCT01850498|Accelerometer|accelerometer
1240294|NCT01850485|cardiac arrest|cardiac arrest
1240295|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
1240296|NCT01850485|microcirculation|microcirculation
1240297|NCT01850472|Anhedonia|anhedonia
1240298|NCT01850472|Depression|depression
1240299|NCT01850472|Stress|stress
1240300|NCT01850472|Cortisol|cortisol
1240301|NCT01850472|Inflammatory cytokines|inflammatory cytokines
1240302|NCT01850472|Learning|learning
1240303|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1240304|NCT01850433|BDD|bdd
1240305|NCT01850433|CBT|cbt
1240306|NCT01850420|fibromyalgia|fibromyalgia
1240307|NCT01850420|Myofascial|myofascial
1240308|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
1240309|NCT01850381|Parkinson Disease|parkinson disease
1240310|NCT01850381|Efficacy|efficacy
1240311|NCT01850381|Safety|safety
1240312|NCT01850381|Tolerability|tolerability
1240313|NCT01850381|Phase 2A|phase 2a
1240314|NCT01850381|Pilot trial|pilot trial
1240315|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
1240316|NCT01850381|neuroprotective agent|neuroprotective agent
1240318|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
1240319|NCT01850381|UPDRS|updrs
1240320|NCT01850381|Proof of principle|proof of principle
1240321|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
1240322|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1240323|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
1240324|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
1240325|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
1240326|NCT01850355|Anxiety|anxiety
1240327|NCT01850355|Children|children
1240328|NCT01850355|Adolescents|adolescents
1240329|NCT01850355|Buspar|buspar
1240330|NCT01850355|Buspirone|buspirone
1240331|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
1240332|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
1240333|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
1240334|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
1240335|NCT01850342|ADRC|adrc
1240336|NCT01850342|Micrograft|micrograft
1240337|NCT01850342|Fat tissue|fat tissue
1240338|NCT01850342|Stem cells|stem cells
1240339|NCT01850303|Elderly|elderly
1240340|NCT01850303|lung cancer|lung cancer
1240341|NCT01850303|switch|switch
1240342|NCT01850303|maintenance|maintenance
1240343|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
1240344|NCT01850303|NSCLC|nsclc
1240345|NCT01850290|TBI|tbi
1240346|NCT01850277|Atrial fibrillation|atrial fibrillation
1240347|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
1240348|NCT01850277|Heart failure|heart failure
1240349|NCT01850277|Rhythm control strategy|rhythm control strategy
1240350|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
1240351|NCT01850251|Hip fractures|hip fractures
1240352|NCT01850251|Ageing|ageing
1240353|NCT01850251|Sarcopenia|sarcopenia
1240354|NCT01850251|Function|function
1240355|NCT01850238|Alzheimer disease|alzheimer disease
1240356|NCT01850238|tau protein|tau protein
1240357|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
1240358|NCT01850238|disease-modifying|disease-modifying
1240359|NCT01850212|Treatment Experienced|treatment experienced
1240360|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
1240361|NCT01850212|Female postmenopausal|female postmenopausal
1240362|NCT01850199|Gestational diabetes|gestational diabetes
1240363|NCT01850199|Telemedicine|telemedicine
1240364|NCT01850199|Artificial Intelligence|artificial intelligence
1240365|NCT01850160|Hypertension|hypertension
1240366|NCT01850160|High blood pressure|high blood pressure
1240367|NCT01850160|Drug therapy combination|drug therapy combination
1240368|NCT01850160|Valsartan|valsartan
1240369|NCT01850160|Chlorthalidone|chlorthalidone
1240370|NCT01850160|Safety|safety
1240371|NCT01850160|Efficacy|efficacy
1240372|NCT01850147|sunitinib|sunitinib
1240373|NCT01850147|chemotherapy|chemotherapy
1240374|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
1240375|NCT01850147|NSCLC|nsclc
1240376|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
1240377|NCT01850121|infiximab|infiximab
1240378|NCT01850121|single armed trial|single armed trial
1240379|NCT01850095|acne|acne
1240380|NCT01850095|adult|adult
1240381|NCT01850095|women|women
1240382|NCT01850095|TLR|tlr
1240383|NCT01850095|CD1d|cd1d
1240384|NCT01850095|androgens|androgens
1240385|NCT01850082|Coronary artery disease|coronary artery disease
1240386|NCT01850082|CABG|cabg
1240387|NCT01850082|Coronary revascularization|coronary revascularization
1240388|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
1240389|NCT01850082|Saphenous vein graft|saphenous vein graft
1240390|NCT01850082|Graft failure|graft failure
1598765|NCT00399256|Cystatin C|cystatin c
1240391|NCT01850069|Intracranial hypertension|intracranial hypertension
1240392|NCT01850069|intracranial elastance|intracranial elastance
1240393|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
1240394|NCT01850017|Opiate consumption|opiate consumption
1240395|NCT01850017|Visual Analogue Scale|visual analogue scale
1240397|NCT01849991|Fussiness|fussiness
1240398|NCT01849991|Gas|gas
1240399|NCT01849991|Hydrogen Breath|hydrogen breath
1240400|NCT01849991|Fecal Calprotectin|fecal calprotectin
1240401|NCT01849978|breast cancer|breast cancer
1240402|NCT01849978|survivor|survivor
1240403|NCT01849978|exercise|exercise
1240404|NCT01849978|physical activity|physical activity
1240405|NCT01849978|strenuous exercise|strenuous exercise
1240406|NCT01849978|moderate exercise|moderate exercise
1240407|NCT01849978|enjoyable exercise|enjoyable exercise
1240408|NCT01849978|enjoy exercise|enjoy exercise
1240409|NCT01849978|breast cancer survivor|breast cancer survivor
1240410|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
1240411|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
1240412|NCT01849952|glioblastoma|glioblastoma
1240413|NCT01849952|miRNA|mirna
1240414|NCT01849952|GBM|gbm
1240415|NCT01849952|astrocytoma|astrocytoma
1240416|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
1240417|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1240418|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
1240419|NCT01849939|Preemptive immunointervention|preemptive immunointervention
1240420|NCT01849913|neck pain|neck pain
1240421|NCT01849913|hydrocortisone|hydrocortisone
1240422|NCT01849913|stress|stress
1240423|NCT01849913|electromyography|electromyography
1240424|NCT01849913|adolescent|adolescent
1240425|NCT01849913|low-level laser therapy|low-level laser therapy
1240426|NCT01849900|Menstrual cycle|menstrual cycle
1240427|NCT01849900|Ovulation time|ovulation time
1240428|NCT01849900|pregnancy recognition|pregnancy recognition
1240429|NCT01849900|Community-based participatory research|community-based participatory research
1240430|NCT01849900|Unintended pregnancy|unintended pregnancy
1240431|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
1240432|NCT01849861|Ranges of TSH|ranges of tsh
1240433|NCT01849861|Elderly Population|elderly population
1240434|NCT01849835|rate of positive detection|rate of positive detection
1240435|NCT01849822|neural|neural
1240436|NCT01849822|prosthetic|prosthetic
1240437|NCT01849822|brain machine interface|brain machine interface
1240438|NCT01849822|brain computer interface|brain computer interface
1240439|NCT01849822|brain control|brain control
1240440|NCT01849822|paralysis|paralysis
1240441|NCT01849822|tetraplegia|tetraplegia
1240442|NCT01849822|quadriplegia|quadriplegia
1240443|NCT01849822|spinal cord injury|spinal cord injury
1240444|NCT01849796|tDCS|tdcs
1240445|NCT01849796|Neuropathic|neuropathic
1240446|NCT01849796|Facial|facial
1240447|NCT01849796|Pain|pain
1240448|NCT01849796|Neuralgia|neuralgia
1240449|NCT01849796|deafferentation|deafferentation
1240450|NCT01849796|Trigeminal|trigeminal
1240451|NCT01849770|SALS|sals
1240452|NCT01849770|Mexiletine|mexiletine
1240453|NCT01849770|Safety|safety
1240454|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
1240455|NCT01849757|prime|prime
1240456|NCT01849757|crystalloid|crystalloid
1240457|NCT01849757|albumin|albumin
1240458|NCT01849757|HES 130/0.4|hes 130/0.4
1240459|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
1240460|NCT01849744|FAK inhibitor|fak inhibitor
1240461|NCT01849744|Cancer Stem Cells|cancer stem cells
1240462|NCT01849744|CSC|csc
1240463|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
1240464|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
1240465|NCT01849731|Diabetes self-management,|diabetes self-management,
1240466|NCT01849731|Quality of diabetes care|quality of diabetes care
1240467|NCT01849705|Obesity|obesity
1240468|NCT01849705|MC4R|mc4r
1240469|NCT01849705|Blood pressure|blood pressure
1240470|NCT01849705|Blood glucose|blood glucose
1240471|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
1240472|NCT01849692|Wet AMD|wet amd
1240473|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1240474|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1240475|NCT01849679|Dysphagia|dysphagia
1240476|NCT01849679|extubation|extubation
1240477|NCT01849679|aspiration|aspiration
1240478|NCT01849653|vaginal swabs|vaginal swabs
1240479|NCT01849653|diagnosis|diagnosis
1240480|NCT01849640|Malaria|malaria
1240481|NCT01849640|Drug resistance|drug resistance
1240482|NCT01849640|DHA-piperaquine|dha-piperaquine
1240483|NCT01849640|Cambodia|cambodia
1240484|NCT01849640|Transmission Blocking|transmission blocking
1240485|NCT01849627|weight loss maintenance|weight loss maintenance
1240486|NCT01849588|Hepatitis C positive|hepatitis c positive
1240487|NCT01849575|Ultrasonography|ultrasonography
1240488|NCT01849575|Cardiovascular diseases|cardiovascular diseases
1240489|NCT01849575|Prevention|prevention
1240490|NCT01849575|Risk communication|risk communication
1240491|NCT01849575|Risk assessment|risk assessment
1240492|NCT01849575|Behavioral change|behavioral change
1240493|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
1240494|NCT01849562|Genotype 1|genotype 1
1240495|NCT01849562|Hepatitis C|hepatitis c
1240496|NCT01849562|Liver Diseases|liver diseases
1240497|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
1240498|NCT01849562|ribavirin|ribavirin
1240499|NCT01849562|antiviral agents|antiviral agents
1240500|NCT01849562|anti-infective agents|anti-infective agents
1240501|NCT01849562|protease inhibitors|protease inhibitors
1240502|NCT01849562|NS5a inhibitors|ns5a inhibitors
1240503|NCT01849549|neuropsychological Study|neuropsychological study
1240504|NCT01849549|brain Imaging|brain imaging
1240505|NCT01849536|Open angle glaucoma|open angle glaucoma
1240506|NCT01849536|Corneal biomechanics|corneal biomechanics
1240507|NCT01849536|Intra ocular pressure|intra ocular pressure
1240508|NCT01849536|IOP|iop
1240509|NCT01849536|IOP fluctuation|iop fluctuation
1240510|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
1240511|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
1240512|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
1240513|NCT01849523|Website|website
1240514|NCT01849523|Information|information
1240515|NCT01849523|Psychosocial support|psychosocial support
1240516|NCT01849510|spinal metastases|spinal metastases
1240517|NCT01849510|vertebral body|vertebral body
1240519|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
1240520|NCT01849510|hypofractionated|hypofractionated
1240521|NCT01849510|dose intensified|dose intensified
1240522|NCT01849510|dose elevation|dose elevation
1240523|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
1240524|NCT01849484|meningioma|meningioma
1240525|NCT01849484|skull base meningioma|skull base meningioma
1240526|NCT01849484|pituitary adenoma|pituitary adenoma
1240527|NCT01849484|brain metastases|brain metastases
1240528|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
1240529|NCT01849471|socioeconomic aspects|socioeconomic aspects
1240530|NCT01849471|costs of therapy|costs of therapy
1240531|NCT01849471|follow-up costs|follow-up costs
1240532|NCT01849471|primary radiation|primary radiation
1240533|NCT01849471|percutaneous|percutaneous
1240534|NCT01849471|interstitial|interstitial
1240535|NCT01849393|Adolescents|adolescents
1240536|NCT01849393|Medication Compliance|medication compliance
1240537|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
1240538|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
1240539|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1240540|NCT01849380|S-1|s-1
1240541|NCT01849341|COPD|copd
1240542|NCT01849302|Appetite|appetite
1240543|NCT01849302|Satiety hormones|satiety hormones
1240544|NCT01849302|Dietary Protein|dietary protein
1240545|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
1240546|NCT01849237|Septic Shock|septic shock
1240547|NCT01849237|Neutropenia|neutropenia
1240548|NCT01849237|Procalcitonin|procalcitonin
1240549|NCT01849237|Interleukin-6|interleukin-6
1240550|NCT01849237|Interleukin-10|interleukin-10
1240551|NCT01849237|C-reactive protein|c-reactive protein
1240552|NCT01849237|Survival|survival
1240553|NCT01849237|Organ dysfunction|organ dysfunction
1240554|NCT01849224|Lower extremity edema|lower extremity edema
1240555|NCT01849224|Lower leg lymphedema|lower leg lymphedema
1240556|NCT01849224|Lower leg edema|lower leg edema
1240557|NCT01849224|Lymphedema|lymphedema
1240558|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
1240559|NCT01849224|Exercise|exercise
1240560|NCT01849211|ventilation|ventilation
1240561|NCT01849211|face mask|face mask
1240562|NCT01849211|NMBA|nmba
1240563|NCT01849198|accelerometry|accelerometry
1240564|NCT01849198|neuromuscular block|neuromuscular block
1240565|NCT01849198|m. trapezius|m. trapezius
1240566|NCT01849185|Hypercholesterolemia|hypercholesterolemia
1240567|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
1240568|NCT01849159|Hypoxia|hypoxia
1240569|NCT01849159|Emphysema|emphysema
1240570|NCT01849133|Breast cancer|breast cancer
1240571|NCT01849133|conservative surgery|conservative surgery
1240572|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
1240573|NCT01849133|mobile linear accelerator|mobile linear accelerator
1240574|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
1240575|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
1240576|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
1240577|NCT01849120|peripheral perfusion|peripheral perfusion
1240578|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
1240579|NCT01849107|Plasma citrulline|plasma citrulline
1240580|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1240581|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
1240582|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
1240583|NCT01849029|PTSD|ptsd
1240584|NCT01849029|HIV risk|hiv risk
1240585|NCT01849029|sexual risk|sexual risk
1240586|NCT01849029|substance use|substance use
1240587|NCT01849029|alcohol misuse|alcohol misuse
1240588|NCT01849029|Substance Abuse|substance abuse
1240589|NCT01849029|Substance Addiction|substance addiction
1240590|NCT01849029|Substance Dependence|substance dependence
1240591|NCT01849029|Substance Use Disorders|substance use disorders
1240592|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
1240593|NCT01849029|Binge Drinking|binge drinking
1240594|NCT01849029|Sexual Partners|sexual partners
1240595|NCT01849029|Sexual Behavior|sexual behavior
1240596|NCT01849029|Unsafe Sex|unsafe sex
1240597|NCT01849016|Sickle Cell Disease|sickle cell disease
1240598|NCT01849016|Sickle Cell Anemia|sickle cell anemia
1240599|NCT01849016|Pain|pain
1240600|NCT01849016|N-Acetylcysteine|n-acetylcysteine
1240601|NCT01849016|Acetylcysteine|acetylcysteine
1240602|NCT01849016|Oxidative stress|oxidative stress
1240603|NCT01849003|Long QT Syndrome|long qt syndrome
1240604|NCT01849003|LQTS|lqts
1240605|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
1240606|NCT01849003|LQT-3|lqt-3
1240607|NCT01849003|prolonged QT interval|prolonged qt interval
1240608|NCT01849003|GS-6615|gs-6615
1240609|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
1240610|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1240611|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
1240612|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
1240613|NCT01848990|Hylenex|hylenex
1240614|NCT01848990|Halozyme|halozyme
1240615|NCT01848990|Phase 4|phase 4
1240616|NCT01848977|Measures|measures
1240617|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
1240618|NCT01848977|ischemia|ischemia
1240619|NCT01848977|reperfusion|reperfusion
1240620|NCT01848964|amputation|amputation
1240621|NCT01848964|prosthesis|prosthesis
1240622|NCT01848964|stump|stump
1240623|NCT01848964|socket|socket
1240624|NCT01848964|pressure|pressure
1240625|NCT01848964|gait|gait
1240626|NCT01848964|posture|posture
1240627|NCT01848938|female|female
1240628|NCT01848938|stress urinary incontinence|stress urinary incontinence
1240629|NCT01848938|treatment|treatment
1240630|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
1240631|NCT01848938|smartphone|smartphone
1240632|NCT01848938|internet|internet
1240633|NCT01848938|life style|life style
1240634|NCT01848938|eHealth|ehealth
1240635|NCT01848925|SANGUINATE|sanguinate
1240636|NCT01848899|Coronary angiography|coronary angiography
1240637|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
1240638|NCT01848899|Contrast media|contrast media
1240639|NCT01848899|Platelet activity|platelet activity
1240640|NCT01848899|Thrombin generation|thrombin generation
1240641|NCT01848899|Fibrinolysis|fibrinolysis
1240642|NCT01848886|ERAH|erah
1240643|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
1240644|NCT01848886|Y-graft|y-graft
1240645|NCT01848886|Radial Artery Harvest|radial artery harvest
1240646|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
1240647|NCT01848886|CABG|cabg
1240648|NCT01848886|Radial Artery Conduit|radial artery conduit
1240649|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
1240650|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
1240651|NCT01848873|Hypertension|hypertension
1240652|NCT01848873|MTHFR C677T|mthfr c677t
1240653|NCT01848860|Pneumothorax|pneumothorax
1240654|NCT01848860|thoracoscopy|thoracoscopy
1240655|NCT01848860|mesh|mesh
1240656|NCT01848860|pleurodesis|pleurodesis
1240657|NCT01848860|treatment|treatment
1240658|NCT01848847|Hysteroscopy|hysteroscopy
1240659|NCT01848847|Bladder|bladder
1240660|NCT01848847|Pain|pain
1240661|NCT01848847|Feasibility|feasibility
1240662|NCT01848847|Duration|duration
1240663|NCT01848834|PD-1|pd-1
1240664|NCT01848834|PD1|pd1
1240665|NCT01848834|PD-L1|pd-l1
1240666|NCT01848834|PDL1|pdl1
1240667|NCT01848821|OASIS ultra|oasis ultra
1240668|NCT01848821|faster healing time|faster healing time
1240669|NCT01848821|better healing quality|better healing quality
1240670|NCT01848821|standard of care|standard of care
1240671|NCT01848795|Type 2 Diabetes|type 2 diabetes
1240672|NCT01848795|Obesity|obesity
1240673|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
1240674|NCT01848795|intestinal bypass|intestinal bypass
1240675|NCT01848795|endoscopy|endoscopy
1240676|NCT01848782|abstract|abstract
1240677|NCT01848782|meta-analysis|meta-analysis
1240678|NCT01848782|systematic review|systematic review
1240679|NCT01848782|interpretation|interpretation
1240680|NCT01848782|results|results
1240681|NCT01848782|quality|quality
1240682|NCT01848782|bias|bias
1240683|NCT01848782|spin|spin
1240684|NCT01848782|limits|limits
1240685|NCT01848782|limitation|limitation
1240686|NCT01848782|risk of bias|risk of bias
1240687|NCT01848769|Asthma|asthma
1240688|NCT01848769|ICS+LABA|ics+laba
1240689|NCT01848769|Children|children
1240690|NCT01848769|Inhalation|inhalation
1240691|NCT01848769|pMDI|pmdi
1240692|NCT01848756|SNX-5422|snx-5422
1240693|NCT01848756|HER2 positive cancer|her2 positive cancer
1240694|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
1240695|NCT01848704|spin|spin
1240696|NCT01848704|interpretation|interpretation
1240697|NCT01848704|bias|bias
1240698|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
1240699|NCT01848652|Myocet|myocet
1240700|NCT01848652|efficacy|efficacy
1240701|NCT01848652|safety|safety
1240702|NCT01848639|chronic kidney disease|chronic kidney disease
1240703|NCT01848639|end-stage renal disease|end-stage renal disease
1240704|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
1240705|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
1240706|NCT01848639|aldosterone antagonist|aldosterone antagonist
1240707|NCT01848639|spironolactone|spironolactone
1240708|NCT01848600|limitation|limitation
1240709|NCT01848600|quality|quality
1240710|NCT01848600|bias|bias
1240711|NCT01848600|meta-analysis|meta-analysis
1240712|NCT01848600|interpretation|interpretation
1240713|NCT01848600|abstract|abstract
1240714|NCT01848587|Pregnancy|pregnancy
1240715|NCT01848587|Acupuncture|acupuncture
1240716|NCT01848587|Pelvic and low back pain|pelvic and low back pain
1240717|NCT01848587|Impairment|impairment
1240718|NCT01848587|Economic evaluation|economic evaluation
1240719|NCT01848574|Understanding|understanding
1240720|NCT01848574|Patients|patients
1240721|NCT01848574|Emergency|emergency
1240722|NCT01848574|Information|information
1240723|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
1240724|NCT01848561|Gastroenteritis|gastroenteritis
1240726|NCT01848561|Ulcerative Colitis|ulcerative colitis
1240727|NCT01848561|Registry|registry
1240728|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
1240729|NCT01848561|Colitis|colitis
1240730|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
1240731|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
1240732|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
1240733|NCT01848522|qualitative study|qualitative study
1240734|NCT01848522|rehabilitation|rehabilitation
1240735|NCT01848522|physical therapy|physical therapy
1240736|NCT01848522|patient education|patient education
1240737|NCT01848522|health care|health care
1240738|NCT01848522|administration|administration
1240739|NCT01848522|patient satisfaction|patient satisfaction
1240740|NCT01848522|handicap|handicap
1240741|NCT01848509|CPAP|cpap
1240742|NCT01848509|adherence|adherence
1240743|NCT01848509|SAOS|saos
1240744|NCT01848509|telemedicine|telemedicine
1240745|NCT01848483|Early Palliative Care|early palliative care
1240746|NCT01848483|Motivational Interviewing|motivational interviewing
1240747|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
1240748|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
1240749|NCT01848457|Osteosarcoma|osteosarcoma
1240750|NCT01848457|Cancer|cancer
1240751|NCT01848457|Nephrotoxicity|nephrotoxicity
1240752|NCT01848457|Ototoxicity|ototoxicity
1240753|NCT01848457|Cisplatin|cisplatin
1240754|NCT01848457|High-dose methotrexate|high-dose methotrexate
1240755|NCT01848457|Biomarkers|biomarkers
1240756|NCT01848457|Patient reported outcomes|patient reported outcomes
1240757|NCT01848444|Public Health|public health
1240758|NCT01848444|Epidemiology|epidemiology
1240759|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
1240760|NCT01848444|Perinatal period|perinatal period
1240761|NCT01848418|ICF|icf
1240762|NCT01848418|Core sets|core sets
1240763|NCT01848418|Systemic sclerosis|systemic sclerosis
1240764|NCT01848418|Function|function
1240765|NCT01848418|Evaluation|evaluation
1240766|NCT01848392|Cystic fibrosis|cystic fibrosis
1240767|NCT01848392|Adults|adults
1240768|NCT01848392|Physical activity|physical activity
1240769|NCT01848366|Frequency|frequency
1240770|NCT01848366|urgency|urgency
1240771|NCT01848366|incontinence|incontinence
1240772|NCT01848340|mass balance|mass balance
1240773|NCT01848340|GSK1265744|gsk1265744
1240774|NCT01848340|supratherapeutic|supratherapeutic
1240775|NCT01848340|integrase inhibitor|integrase inhibitor
1240776|NCT01848340|healthy volunteer|healthy volunteer
1240777|NCT01848327|Cognition|cognition
1240778|NCT01848327|Neuropsychology|neuropsychology
1240779|NCT01848327|Multiple Sclerosis|multiple sclerosis
1240780|NCT01848301|Optical Coherence Tomography|optical coherence tomography
1240781|NCT01848301|OCT|oct
1240782|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
1240783|NCT01848301|Donor Specific Antibodies|donor specific antibodies
1240784|NCT01848301|Acetylcholine|acetylcholine
1240785|NCT01848301|Coronary endothelial function|coronary endothelial function
1240786|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
1240983|NCT01847430|Healthy|healthy
1240787|NCT01848301|Heart transplantation|heart transplantation
1240788|NCT01848288|Cataract|cataract
1240789|NCT01848288|Phacoemulsification|phacoemulsification
1240790|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
1240791|NCT01848262|ECALMIST|ecalmist
1240792|NCT01848262|InSurE|insure
1240793|NCT01848262|CPAP|cpap
1240794|NCT01848262|Ventilation|ventilation
1240795|NCT01848262|Vascular Catheter|vascular catheter
1240796|NCT01848249|deceased donors|deceased donors
1240797|NCT01848249|kidney donor|kidney donor
1240798|NCT01848249|transplant recipients|transplant recipients
1240799|NCT01848249|kidney transplant|kidney transplant
1240800|NCT01848249|delayed graft function|delayed graft function
1240801|NCT01848249|biomarkers|biomarkers
1240802|NCT01848249|end stage renal disease|end stage renal disease
1240803|NCT01848249|graft failure|graft failure
1240804|NCT01848223|quality of life|quality of life
1240805|NCT01848223|QoL|qol
1240806|NCT01848223|late menopause|late menopause
1240807|NCT01848210|Drug therapy|drug therapy
1240808|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
1240809|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
1240810|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
1240811|NCT01848184|Panacea|panacea
1240812|NCT01848171|Hypothyroidism|hypothyroidism
1240813|NCT01848171|Lipid|lipid
1240814|NCT01848171|Atherosclerosis|atherosclerosis
1240815|NCT01848171|Oxidative Stress|oxidative stress
1240816|NCT01848171|Chronic Inflammation|chronic inflammation
1240817|NCT01848171|Endothelial Function|endothelial function
1240818|NCT01848171|Adipocytokine|adipocytokine
1240819|NCT01848171|L-thyroxine|l-thyroxine
1240820|NCT01848158|acupuncture|acupuncture
1240821|NCT01848158|pediatric|pediatric
1240822|NCT01848158|critical care|critical care
1240823|NCT01848158|mechanical ventilation|mechanical ventilation
1240824|NCT01848158|sedation|sedation
1240825|NCT01848158|comfort|comfort
1240826|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1240827|NCT01848145|Ofatumumab|ofatumumab
1240828|NCT01848145|Rapid Infusion|rapid infusion
1240829|NCT01848132|Lymphoma|lymphoma
1240830|NCT01848132|Large B-Cell|large b-cell
1240831|NCT01848119|Gabapentin|gabapentin
1240832|NCT01848119|Cesarean section|cesarean section
1240833|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
1240834|NCT01848106|Coronary Artery Disease|coronary artery disease
1240835|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
1240836|NCT01848106|Regado|regado
1240837|NCT01848106|Reg 1|reg 1
1240838|NCT01848106|bivalirudin|bivalirudin
1240839|NCT01848093|lung|lung
1240840|NCT01848093|airway|airway
1240841|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
1240842|NCT01848093|mucus|mucus
1240843|NCT01848080|Telemedicine|telemedicine
1240844|NCT01848080|Telerehabilitation|telerehabilitation
1240845|NCT01848080|Acute Stroke|acute stroke
1240846|NCT01848080|Tai Chi|tai chi
1240847|NCT01848080|Tai Ji|tai ji
1240848|NCT01848080|Rehabilitation|rehabilitation
1240849|NCT01848080|Home care services|home care services
1240850|NCT01848080|Single blind method|single blind method
1240851|NCT01848080|Randomized controlled trial|randomized controlled trial
1240852|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
1240853|NCT01848041|Blepharoptosis|blepharoptosis
1240854|NCT01848041|Ptosis|ptosis
1240855|NCT01848028|Patient registry|patient registry
1240856|NCT01848028|Germany|germany
1240857|NCT01848028|Psoriasis|psoriasis
1240858|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
1240859|NCT01848028|Efalizumab|efalizumab
1240860|NCT01848028|Psonet|psonet
1240861|NCT01848028|Effectiveness|effectiveness
1240862|NCT01848028|Safety|safety
1240863|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
1240864|NCT01847976|breast|breast
1240865|NCT01847976|bone pain|bone pain
1240866|NCT01847963|Urolithiasis|urolithiasis
1240867|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
1240868|NCT01847963|Siddha|siddha
1240869|NCT01847963|Sindhuvallathy|sindhuvallathy
1240870|NCT01847963|Kidney stones|kidney stones
1240871|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
1240872|NCT01847898|Osteoporosis|osteoporosis
1240873|NCT01847898|Vertebral Body|vertebral body
1240874|NCT01847898|Compression Fracture|compression fracture
1240875|NCT01847898|Kyphoplasty|kyphoplasty
1240876|NCT01847885|electrical stimulation|electrical stimulation
1240877|NCT01847885|neurostimulation|neurostimulation
1240878|NCT01847885|neuromodulation|neuromodulation
1240879|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
1240880|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
1240881|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
1240882|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
1240883|NCT01847872|Gambia|gambia
1240884|NCT01847872|IPV|ipv
1240885|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
1240886|NCT01847872|Non-interference study|non-interference study
1240887|NCT01847872|IM Jet injector|im jet injector
1240888|NCT01847872|ID Jet Injector|id jet injector
1240889|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
1240890|NCT01847859|Post-operative|post-operative
1240891|NCT01847859|Nurses|nurses
1240892|NCT01847859|Cardiac|cardiac
1240893|NCT01847859|Echocardiography|echocardiography
1240894|NCT01847859|Pocket-size|pocket-size
1240895|NCT01847859|Hand-held|hand-held
1240896|NCT01847820|ROM|rom
1240897|NCT01847820|PROM|prom
1240898|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
1240899|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
1240900|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
1240901|NCT01847781|Cellular immunity|cellular immunity
1240902|NCT01847781|Vaccine immunity|vaccine immunity
1240903|NCT01847781|Antimicrobial peptides|antimicrobial peptides
1240904|NCT01847768|asthma|asthma
1240905|NCT01847768|rhinovirus|rhinovirus
1240906|NCT01847768|remodeling mediators|remodeling mediators
1240907|NCT01847768|human rhinovirus infection|human rhinovirus infection
1240908|NCT01847729|Opiate dependence|opiate dependence
1240909|NCT01847729|Opiate substitution treatment|opiate substitution treatment
1240910|NCT01847729|co-addictions|co-addictions
1240911|NCT01847729|Patients addicted to opiates|patients addicted to opiates
1240912|NCT01847729|methadone|methadone
1240913|NCT01847729|buprenorhine|buprenorhine
1240914|NCT01847729|morphine|morphine
1240915|NCT01847729|OST in place|ost in place
1240916|NCT01847729|pathological gambling|pathological gambling
1240917|NCT01847729|pharmacokinetic|pharmacokinetic
1240918|NCT01847729|pharmacogenetic|pharmacogenetic
1240919|NCT01847729|polymorphism|polymorphism
1240920|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
1240921|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
1240922|NCT01847716|Muscle weakness|muscle weakness
1240923|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
1240924|NCT01847716|Transforming growth factor beta|transforming growth factor beta
1240925|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
1240926|NCT01847690|Addison Disease|addison disease
1240927|NCT01847677|ovarian cancer|ovarian cancer
1240928|NCT01847677|neoadyuvant|neoadyuvant
1240929|NCT01847677|bevacizumab|bevacizumab
1240930|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
1240931|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
1240932|NCT01847651|cirrhosis|cirrhosis
1240933|NCT01847651|lateral vastus|lateral vastus
1240934|NCT01847651|muscle biopsy|muscle biopsy
1240935|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
1240936|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
1240937|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1240938|NCT01847651|cognitive testing|cognitive testing
1240939|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
1240940|NCT01847651|Cogstate|cogstate
1240941|NCT01847651|urine metabonomics|urine metabonomics
1240942|NCT01847651|plasma metabonomics|plasma metabonomics
1240943|NCT01847651|muscle metabonomics|muscle metabonomics
1240944|NCT01847638|Retinal edema|retinal edema
1240945|NCT01847638|Cataract|cataract
1240946|NCT01847638|inflammation|inflammation
1240947|NCT01847612|per operative cholangiography|per operative cholangiography
1240948|NCT01847612|liver resection|liver resection
1240949|NCT01847612|biliary fistula|biliary fistula
1240950|NCT01847599|educational intervention|educational intervention
1240951|NCT01847599|adherence|adherence
1240952|NCT01847599|capecitabine|capecitabine
1240953|NCT01847599|lapatinib|lapatinib
1240954|NCT01847586|Alzheimer's Disease|alzheimer's disease
1240955|NCT01847586|Brain stimulation|brain stimulation
1240956|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
1240957|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
1240958|NCT01847573|anti-fibrotic|anti-fibrotic
1240959|NCT01847573|anti-inflammatory|anti-inflammatory
1240960|NCT01847573|muscle regeneration|muscle regeneration
1240961|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
1240962|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
1240963|NCT01847495|Liver metastasis|liver metastasis
1240964|NCT01847495|Cyberknife|cyberknife
1240965|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1240966|NCT01847495|SBRT|sbrt
1240967|NCT01847495|Irinotecan HCl|irinotecan hcl
1240968|NCT01847495|CPT-11|cpt-11
1240969|NCT01847482|Cardiac arrest|cardiac arrest
1240970|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
1240971|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
1240972|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
1240973|NCT01847482|Japan|japan
1240974|NCT01847469|Alcohol Dependence|alcohol dependence
1240975|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1240976|NCT01847469|Zonisamide|zonisamide
1240977|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
1240978|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
1240979|NCT01847456|insulin action in the brain|insulin action in the brain
1240980|NCT01847443|nicotine|nicotine
1240981|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
1240982|NCT01847443|nicotine gum|nicotine gum
1240984|NCT01847430|Hepatitis B|hepatitis b
1240985|NCT01847430|Adolescents|adolescents
1240986|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
1240987|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
1240988|NCT01847417|Pantoprazole|pantoprazole
1240989|NCT01847417|Fixed dose combination|fixed dose combination
1240990|NCT01847404|Fixed dose combination|fixed dose combination
1240991|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
1240992|NCT01847404|Pantoprazole|pantoprazole
1240993|NCT01847391|Ischemic Heart Disease|ischemic heart disease
1240994|NCT01847391|Heart Disease|heart disease
1240995|NCT01847378|ventricular tachycardia|ventricular tachycardia
1240996|NCT01847378|catheter ablation|catheter ablation
1240997|NCT01847378|chagas disease|chagas disease
1240998|NCT01847378|epicardial mapping|epicardial mapping
1240999|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
1241000|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
1241001|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
1241003|NCT01847352|Hypoxia|hypoxia
1241004|NCT01847352|Pulmonary hypertension|pulmonary hypertension
1241005|NCT01847352|Iron deficiency|iron deficiency
1241006|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
1241007|NCT01847300|alcohol abuse|alcohol abuse
1241008|NCT01847300|tobacco dependence|tobacco dependence
1241009|NCT01847300|substance abuse|substance abuse
1241010|NCT01847300|SBIRT|sbirt
1241011|NCT01847287|Multiple sclerosis|multiple sclerosis
1241012|NCT01847287|Tysabri|tysabri
1241013|NCT01847287|MRI|mri
1241014|NCT01847287|Natalizumab|natalizumab
1241015|NCT01847274|ovarian cancer|ovarian cancer
1241016|NCT01847274|platinum sensitive|platinum sensitive
1241017|NCT01847274|gBRCAmut|gbrcamut
1241018|NCT01847274|BRCA|brca
1241019|NCT01847274|high-grade serous histology|high-grade serous histology
1241020|NCT01847274|PARP inhibitor|parp inhibitor
1241021|NCT01847261|soy|soy
1241022|NCT01847261|whey|whey
1241023|NCT01847261|muscle|muscle
1241024|NCT01847261|older|older
1241025|NCT01847261|mTOR|mtor
1241026|NCT01847261|sarcopenia|sarcopenia
1241027|NCT01847248|sepsis|sepsis
1241028|NCT01847248|biomarker|biomarker
1241029|NCT01847248|HSPA12B|hspa12b
1241030|NCT01847235|Temozolomide|temozolomide
1241031|NCT01847209|lung nodule|lung nodule
1241032|NCT01847209|lung cancer|lung cancer
1241033|NCT01847209|lung mass|lung mass
1241034|NCT01847196|Pulmonary Embolism|pulmonary embolism
1241035|NCT01847196|PE|pe
1241036|NCT01847196|DVT|dvt
1241037|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
1241038|NCT01847196|VTE|vte
1241039|NCT01847196|Venous Thromboembolism|venous thromboembolism
1241040|NCT01847196|prophylaxis|prophylaxis
1241041|NCT01847196|thromboprophylaxis|thromboprophylaxis
1241042|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
1241043|NCT01847196|prophylactic|prophylactic
1241044|NCT01847196|prevention|prevention
1241045|NCT01847196|Inferior vena cava filter|inferior vena cava filter
1241046|NCT01847196|IVC filter|ivc filter
1241047|NCT01847196|filter|filter
1241048|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
1241049|NCT01847196|trauma|trauma
1241050|NCT01847196|critically-ill|critically-ill
1241051|NCT01847183|heavy drinking|heavy drinking
1241052|NCT01847183|prevention|prevention
1241053|NCT01847183|high school|high school
1241054|NCT01847183|adolescence|adolescence
1241055|NCT01847157|recovery of function|recovery of function
1241056|NCT01847157|stroke|stroke
1241057|NCT01847157|Upper extremity|upper extremity
1241058|NCT01847157|Motor|motor
1241059|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
1241060|NCT01847131|Rhinitis|rhinitis
1241061|NCT01847131|Oxymetazoline|oxymetazoline
1241062|NCT01847092|albuminuria|albuminuria
1241063|NCT01847066|wrinkles|wrinkles
1241064|NCT01847066|acne scars|acne scars
1241065|NCT01847066|pigmentation|pigmentation
1241066|NCT01847053|Cinnamon|cinnamon
1241067|NCT01847053|Bioavailability|bioavailability
1241068|NCT01847053|Glucose|glucose
1241069|NCT01847053|Proanthocyanidins|proanthocyanidins
1241070|NCT01847040|Traumatic Brain Injury|traumatic brain injury
1241071|NCT01847040|Epidemiology|epidemiology
1241072|NCT01847040|Concussion|concussion
1241073|NCT01847040|Outcomes|outcomes
1241074|NCT01847040|PTSD|ptsd
1241075|NCT01847040|Prospective|prospective
1241076|NCT01847040|Longitudinal|longitudinal
1241077|NCT01847040|Military|military
1241078|NCT01847040|Symptoms|symptoms
1241079|NCT01847040|Validation|validation
1241080|NCT01847040|Screening|screening
1241081|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
1241082|NCT01847027|Healthy|healthy
1241083|NCT01847027|Stem cells|stem cells
1241084|NCT01847027|Aging|aging
1241085|NCT01847027|Increase stem cell replacement|increase stem cell replacement
1241086|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
1241087|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1241088|NCT01847014|psychometric instrument|psychometric instrument
1241089|NCT01847014|PAH-SYMPACT|pah-sympact
1241090|NCT01847001|Breast Cancer|breast cancer
1241091|NCT01847001|Neoadjuvant|neoadjuvant
1241092|NCT01847001|Experimental|experimental
1241093|NCT01847001|Biomarker|biomarker
1241094|NCT01847001|Breast imaging|breast imaging
1241095|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
1241096|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
1241097|NCT01846988|Auto PAP|auto pap
1241098|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
1241100|NCT01846988|CPAP|cpap
1241101|NCT01846975|Abatacept|abatacept
1241102|NCT01846975|Low disease activity|low disease activity
1241103|NCT01846975|Intravenous|intravenous
1241104|NCT01846975|Subcutaneous|subcutaneous
1241105|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
1241106|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
1241107|NCT01846962|budesonide|budesonide
1241108|NCT01846962|fluticasione|fluticasione
1241109|NCT01846962|six-foods elimination diet|six-foods elimination diet
1241110|NCT01846936|one lung ventilation|one lung ventilation
1241111|NCT01846936|efficacy|efficacy
1241112|NCT01846936|bronchial blocker|bronchial blocker
1241113|NCT01846910|Cessation|cessation
1241114|NCT01846845|Amputee|amputee
1241115|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
1241116|NCT01846832|Infection|infection
1241117|NCT01846832|Triple therapy|triple therapy
1241118|NCT01846832|TMC435|tmc435
1241119|NCT01846832|simeprevir|simeprevir
1241120|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
1241121|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
1241122|NCT01846832|PEGASYS|pegasys
1241123|NCT01846832|COPEGUS|copegus
1241124|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
1241125|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
1241126|NCT01846793|BPH|bph
1241127|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
1241128|NCT01846793|LUTS|luts
1241426|NCT01845207|Frailty|frailty
1241144|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
1241145|NCT01846715|Kidney disease|kidney disease
1241146|NCT01846715|Renal insufficiency|renal insufficiency
1241147|NCT01846715|CKD|ckd
1241148|NCT01846715|Autologous cell therapy|autologous cell therapy
1241149|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
1241150|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
1241151|NCT01846663|Liver Failure|liver failure
1241152|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
1241153|NCT01846663|Liver Diseases|liver diseases
1241154|NCT01846663|Brain Diseases|brain diseases
1241155|NCT01846663|Rifaximin|rifaximin
1241156|NCT01846663|Cirrhosis|cirrhosis
1241171|NCT01846572|Stroke|stroke
1241172|NCT01846572|Clopidogrel|clopidogrel
1241173|NCT01846572|Aggregometry|aggregometry
1241174|NCT01846572|Antiplatelet therapy|antiplatelet therapy
1241175|NCT01846572|Platelet function tests|platelet function tests
1241176|NCT01846559|Immune system processes|immune system processes
1241177|NCT01846546|Traumatic brain injury;|traumatic brain injury;
1241178|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
1241179|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
1241180|NCT01846546|Prognosis|prognosis
1241181|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
1241182|NCT01846507|HMB|hmb
1241183|NCT01846507|Lysteda|lysteda
1241184|NCT01846481|Cocaine|cocaine
1241185|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
1241186|NCT01846468|renal insufficiency,|renal insufficiency,
1241187|NCT01846455|Hepatic|hepatic
1241188|NCT01846455|Hepatitis C Virus|hepatitis c virus
1241189|NCT01846455|Suboxone|suboxone
1241190|NCT01846455|Buprenorphine|buprenorphine
1241191|NCT01846455|Naloxone|naloxone
1241192|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
1241193|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
1241194|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
1241195|NCT01846442|DHEA|dhea
1241196|NCT01846442|Prasterone|prasterone
1241197|NCT01846442|Vaginorm|vaginorm
1241198|NCT01846442|Menopause|menopause
1241199|NCT01846442|Intrarosa|intrarosa
1241200|NCT01846429|cancer|cancer
1241201|NCT01846429|pain fibers|pain fibers
1241202|NCT01846429|acid levels|acid levels
1241203|NCT01846429|tumor related pain|tumor related pain
1241204|NCT01846429|cancer related pain|cancer related pain
1241205|NCT01846429|sodium bicarbonate|sodium bicarbonate
1241206|NCT01846429|pain reliever|pain reliever
1241207|NCT01846429|metastatic|metastatic
1241208|NCT01846429|unresectable|unresectable
1241209|NCT01846429|solid malignancy|solid malignancy
1241210|NCT01846429|hematologic malignancy|hematologic malignancy
1241211|NCT01846429|multiple myeloma|multiple myeloma
1241212|NCT01846429|lymphoma|lymphoma
1241213|NCT01846377|video game|video game
1241214|NCT01846377|diet|diet
1241215|NCT01846377|physical activity|physical activity
1241216|NCT01846377|sedentary behavior|sedentary behavior
1241217|NCT01846377|obesity|obesity
1241218|NCT01846377|diabetes|diabetes
1241219|NCT01846364|Thyroid|thyroid
1241220|NCT01846364|DIM|dim
1241221|NCT01846351|choroidal neovascularization|choroidal neovascularization
1241903|NCT01842984|Depression|depression
1241222|NCT01846351|epiretinal membrane|epiretinal membrane
1241223|NCT01846351|anti-VEGF|anti-vegf
1241224|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
1241225|NCT01846299|Vision Impairment|vision impairment
1241226|NCT01846286|Neuropathic Pain|neuropathic pain
1241227|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
1241228|NCT01846286|acute pain|acute pain
1241229|NCT01846286|pain management|pain management
1241230|NCT01846286|genome-wide analyses|genome-wide analyses
1241231|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1241232|NCT01846286|chronic pain|chronic pain
1241233|NCT01846286|neuropathic|neuropathic
1241234|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
1241235|NCT01846247|stroke|stroke
1241236|NCT01846234|Multiple Sclerosis|multiple sclerosis
1241237|NCT01846234|Salt|salt
1241238|NCT01846221|Analgesia|analgesia
1241239|NCT01846221|Epidural|epidural
1241240|NCT01846221|Pregnancy|pregnancy
1241241|NCT01846221|Labor|labor
1241242|NCT01846221|Clonidine|clonidine
1241243|NCT01846221|Fentanyl|fentanyl
1241244|NCT01846221|Bupivacaine|bupivacaine
1241245|NCT01846221|Childbirth|childbirth
1241246|NCT01846208|Egg Allergy|egg allergy
1241247|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
1241248|NCT01846208|Food Allergy|food allergy
1241249|NCT01846195|blood loss|blood loss
1241250|NCT01846182|Gulf War Illness|gulf war illness
1241251|NCT01846182|Pregabalin|pregabalin
1241252|NCT01846182|Duloxetine|duloxetine
1241253|NCT01846182|Gulf War Veterans|gulf war veterans
1241254|NCT01846182|Cymbalta|cymbalta
1241255|NCT01846182|Lyrica|lyrica
1241256|NCT01846169|food insecurity|food insecurity
1241257|NCT01846169|older adults|older adults
1241258|NCT01846169|nutrition|nutrition
1241259|NCT01846169|food deliveries|food deliveries
1241260|NCT01846156|convulsion rate|convulsion rate
1241261|NCT01846130|Bed rest,|bed rest,
1241262|NCT01846117|lignans|lignans
1241263|NCT01846117|oxidative stress|oxidative stress
1241264|NCT01846117|inflammation|inflammation
1241265|NCT01846117|aging|aging
1241266|NCT01846117|muscle weakness|muscle weakness
1241267|NCT01846117|pain|pain
1241268|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
1241269|NCT01846013|Sit-Stand Workstations|sit-stand workstations
1241270|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
1241271|NCT01846000|temporomandibular joint|temporomandibular joint
1241272|NCT01846000|temporomandibular disorder|temporomandibular disorder
1241273|NCT01846000|electromyography|electromyography
1241274|NCT01846000|low-level laser therapy|low-level laser therapy
1241275|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
1241276|NCT01845987|CNTO 1959|cnto 1959
1241277|NCT01845987|Psoriasis|psoriasis
1241278|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
1241279|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
1241280|NCT01845974|Atrial Fibrillation|atrial fibrillation
1241281|NCT01845948|parents|parents
1241282|NCT01845948|school transition|school transition
1241283|NCT01845948|parental-child relationship|parental-child relationship
1241284|NCT01845935|Cryoablation|cryoablation
1241285|NCT01845935|Venous vascular malformation|venous vascular malformation
1241286|NCT01845935|MRI|mri
1241287|NCT01845935|safety|safety
1241288|NCT01845935|pain|pain
1241289|NCT01845922|Refeeding Syndrome|refeeding syndrome
1241290|NCT01845922|low sodium|low sodium
1241291|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
1241292|NCT01845922|hypopotassemia|hypopotassemia
1241293|NCT01845922|hypophosphatemia|hypophosphatemia
1241294|NCT01845909|Sudden cardiac death|sudden cardiac death
1241295|NCT01845909|Young adults|young adults
1241296|NCT01845909|Cardiac Disease|cardiac disease
1241297|NCT01845909|Arrhythmia|arrhythmia
1241298|NCT01845909|Sports|sports
1241299|NCT01845896|high intensity interval training|high intensity interval training
1241300|NCT01845896|combined training|combined training
1241301|NCT01845896|insulin resistance|insulin resistance
1241302|NCT01845896|muscle contractile properties|muscle contractile properties
1241303|NCT01845857|Long term health problems|long term health problems
1241304|NCT01845857|chronic disease|chronic disease
1241305|NCT01845831|Diabetes|diabetes
1241306|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
1241307|NCT01845831|Sitagliptin|sitagliptin
1241308|NCT01845831|Glargine|glargine
1241309|NCT01845831|RCT|rct
1241310|NCT01845831|basal insulin|basal insulin
1241311|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
1241312|NCT01845831|inpatient diabetes|inpatient diabetes
1241313|NCT01845818|work productivity|work productivity
1241314|NCT01845818|multicenter study|multicenter study
1241315|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
1241316|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
1241317|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
1241318|NCT01845740|lupus|lupus
1241319|NCT01845740|SLE|sle
1598766|NCT00399256|Creatinine|creatinine
1241320|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
1241321|NCT01845727|Topical treatment|topical treatment
1241322|NCT01845727|Colombia|colombia
1241323|NCT01845714|Keratoconus|keratoconus
1241324|NCT01845714|Corneal cross Linking|corneal cross linking
1241325|NCT01845714|Topo guided PRK|topo guided prk
1241326|NCT01845714|Quality of Life|quality of life
1241327|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
1241328|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
1241427|NCT01845207|Elderly|elderly
1241329|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
1241330|NCT01845688|Randomized Control Trial|randomized control trial
1241331|NCT01845675|temozolomide|temozolomide
1241332|NCT01845675|endostatin|endostatin
1241333|NCT01845675|advanced|advanced
1241334|NCT01845675|well-differentiated|well-differentiated
1241335|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
1241336|NCT01845662|splenectomy|splenectomy
1241337|NCT01845662|embolization|embolization
1241338|NCT01845662|observation|observation
1241339|NCT01845662|blood transfusion|blood transfusion
1241340|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
1241341|NCT01845649|Dyspareunia|dyspareunia
1241342|NCT01845649|Postmenopausal|postmenopausal
1241343|NCT01845636|Olfaction|olfaction
1241344|NCT01845636|Donepezil|donepezil
1241345|NCT01845636|Alzheimer's Disease|alzheimer's disease
1241346|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
1241347|NCT01845636|Memory|memory
1241348|NCT01845623|Asthma|asthma
1241349|NCT01845623|Indacaterol|indacaterol
1241350|NCT01845623|QAB149|qab149
1241351|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
1241352|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
1241353|NCT01845558|Muscle soreness|muscle soreness
1241354|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
1241355|NCT01845558|Inflammation|inflammation
1241356|NCT01845558|Proteolytic enzymes|proteolytic enzymes
1241357|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
1241358|NCT01845545|microfinance|microfinance
1241359|NCT01845545|under five mortality|under five mortality
1241360|NCT01845545|underweight|underweight
1241361|NCT01845545|malnutrition|malnutrition
1241362|NCT01845506|wireless pressure sensor|wireless pressure sensor
1241363|NCT01845506|Elderly|elderly
1241364|NCT01845493|asthma|asthma
1241365|NCT01845493|Asthmatics|asthmatics
1241366|NCT01845493|allergic|allergic
1241367|NCT01845493|allergies|allergies
1241368|NCT01845480|health promotion|health promotion
1241369|NCT01845480|obesity prevention|obesity prevention
1241370|NCT01845480|Childhood obesity|childhood obesity
1241371|NCT01845480|home-based|home-based
1241372|NCT01845480|Lifestyle intervention|lifestyle intervention
1241373|NCT01845480|Body composition|body composition
1241374|NCT01845480|quality of life|quality of life
1241375|NCT01845480|physical activity|physical activity
1241376|NCT01845480|nutrition|nutrition
1241377|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
1241378|NCT01845454|Barrett's Esophagus|barrett's esophagus
1241379|NCT01845454|Spray cryotherapy|spray cryotherapy
1241380|NCT01845441|Dexmedetomidine|dexmedetomidine
1241381|NCT01845441|Endovascular procedure|endovascular procedure
1241382|NCT01845441|Stroke|stroke
1241383|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
1241384|NCT01845441|Conscious sedation|conscious sedation
1241385|NCT01845428|nephrotic|nephrotic
1241386|NCT01845428|hyperlipidemia|hyperlipidemia
1241387|NCT01845428|oxLDL|oxldl
1241388|NCT01845428|kidney|kidney
1241389|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
1241390|NCT01845402|Adolescent|adolescent
1241391|NCT01845402|Heart Defects, Congenital|heart defects, congenital
1241392|NCT01845389|Anesthesia|anesthesia
1241393|NCT01845389|Regional|regional
1241394|NCT01845389|Epidural|epidural
1241395|NCT01845389|Continuous spinal|continuous spinal
1241396|NCT01845389|Wiley Catheter|wiley catheter
1241397|NCT01845389|Geriatric|geriatric
1241398|NCT01845389|TURP|turp
1241399|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
1241400|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
1241401|NCT01845363|Obesity|obesity
1241402|NCT01845363|Bariatric surgery|bariatric surgery
1241403|NCT01845363|Cefazolin|cefazolin
1241404|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
1241405|NCT01845363|administration and dosage|administration and dosage
1241406|NCT01845324|Pregnancy|pregnancy
1241407|NCT01845324|Diabetes Mellitus|diabetes mellitus
1241408|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
1241409|NCT01845285|aortic valve disease|aortic valve disease
1241410|NCT01845285|aortic stenosis|aortic stenosis
1241411|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
1241412|NCT01845285|Effective orifice area|effective orifice area
1241413|NCT01845246|Colistin|colistin
1241414|NCT01845246|Polymyxins|polymyxins
1241415|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
1328741|NCT01462383|ECG|ecg
1241416|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
1241417|NCT01845220|Broccoli sprouts|broccoli sprouts
1241418|NCT01845220|alcohol sensitivity|alcohol sensitivity
1241419|NCT01845220|sulforaphane|sulforaphane
1241420|NCT01845220|alcohol metabolism|alcohol metabolism
1241421|NCT01845220|in the Asian Community|in the asian community
1241422|NCT01845207|Aortic stenosis|aortic stenosis
1241423|NCT01845207|Aortic valve replacement|aortic valve replacement
1241424|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1241425|NCT01845207|Outcomes|outcomes
1241428|NCT01845194|pharmacokinetic|pharmacokinetic
1241429|NCT01845194|heritability|heritability
1241430|NCT01845194|drug membrane transport|drug membrane transport
1241431|NCT01845194|drug biotransformation|drug biotransformation
1241432|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
1241433|NCT01845181|Asthma|asthma
1241434|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
1241435|NCT01845181|COPD|copd
1241436|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
1241437|NCT01845168|NSAID and Aspirin|nsaid and aspirin
1241438|NCT01845168|Computer-alert|computer-alert
1241439|NCT01845168|General practitioner|general practitioner
1241440|NCT01845155|Tinnitus|tinnitus
1241441|NCT01845155|music therapy|music therapy
1241442|NCT01845155|directive counselling|directive counselling
1241443|NCT01845155|acoustic stimulation|acoustic stimulation
1241444|NCT01845155|group comparison|group comparison
1241445|NCT01845155|subjective evaluation|subjective evaluation
1241446|NCT01845155|pitch|pitch
1241447|NCT01845142|vitamin D|vitamin d
1241448|NCT01845142|vitamin D deficiency|vitamin d deficiency
1241449|NCT01845142|immune cells|immune cells
1241450|NCT01845142|pharmacokinetic|pharmacokinetic
1241451|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
1241452|NCT01845116|PNALD|pnald
1241453|NCT01845116|Cholestasis|cholestasis
1241454|NCT01845116|Omegaven®|omegaven®
1241455|NCT01845116|Short Bowel Syndrome|short bowel syndrome
1241456|NCT01845103|ANGINA|angina
1241457|NCT01845103|Thoracoscopic|thoracoscopic
1241458|NCT01845064|type 2 diabetes|type 2 diabetes
1241459|NCT01845064|diabetes mellitus|diabetes mellitus
1241460|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
1241461|NCT01845064|HbA1c|hba1c
1241462|NCT01845064|blood glucose|blood glucose
1241463|NCT01845064|glucose control|glucose control
1241464|NCT01845064|DiaMedica|diamedica
1241465|NCT01845064|DM-199|dm-199
1241466|NCT01845064|DM199|dm199
1241467|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
1241468|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
1241469|NCT01845051|Migraine|migraine
1241470|NCT01845051|allergic rhinitis|allergic rhinitis
1241471|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
1241472|NCT01845051|nasal symptoms|nasal symptoms
1241473|NCT01845051|signs of allergy.|signs of allergy.
1241474|NCT01845025|Asthma|asthma
1241475|NCT01845025|formoterol fumarate|formoterol fumarate
1241476|NCT01845025|Foradil|foradil
1241477|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
1241478|NCT01845025|fluticasone propionate|fluticasone propionate
1241479|NCT01845025|safety|safety
1241480|NCT01845012|Short daily hemodialysis|short daily hemodialysis
1241481|NCT01845012|Low dialysate flow|low dialysate flow
1241482|NCT01845012|End stage renal disease|end stage renal disease
1241483|NCT01844999|Prostate cancer|prostate cancer
1241484|NCT01844999|Decision|decision
1241485|NCT01844986|BRCA|brca
1241486|NCT01844986|Ovarian Cancer|ovarian cancer
1241487|NCT01844986|Chemotherapy|chemotherapy
1241488|NCT01844986|PARP inhibitor|parp inhibitor
1241489|NCT01844986|First Line|first line
1241490|NCT01844986|FIGO Stage III|figo stage iii
1241491|NCT01844986|FIGO Stage IV|figo stage iv
1241492|NCT01844960|Single Incision Surgery|single incision surgery
1241493|NCT01844960|SILS|sils
1241494|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
1241495|NCT01844960|Morbid Obesity|morbid obesity
1241496|NCT01844960|Bariatric Surgery|bariatric surgery
1241497|NCT01844934|Knee Arthroplasty|knee arthroplasty
1241498|NCT01844934|Knee Replacement|knee replacement
1241499|NCT01844934|Prehabilitation|prehabilitation
1241500|NCT01844882|The effects|the effects
1241501|NCT01844882|dietary|dietary
1241502|NCT01844882|fiber|fiber
1241503|NCT01844882|kidney function|kidney function
1241504|NCT01844882|CKD patients|ckd patients
1241505|NCT01844869|omacetaxine|omacetaxine
1241506|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
1241507|NCT01844869|pharmacokinetics|pharmacokinetics
1241508|NCT01844869|hematologic malignancies|hematologic malignancies
1241509|NCT01844869|advanced solid tumors|advanced solid tumors
1241510|NCT01844843|Drug eluting stents|drug eluting stents
1241511|NCT01844843|coronary artery disease|coronary artery disease
1241512|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
1241513|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
1241514|NCT01844830|operative|operative
1241515|NCT01844830|dental procedure|dental procedure
1241516|NCT01844817|untreated|untreated
1241517|NCT01844817|metastatic|metastatic
1241518|NCT01844817|OGX-427|ogx-427
1241519|NCT01844804|Bioequivalence|bioequivalence
1241520|NCT01844804|Biosimilarity|biosimilarity
1241521|NCT01844804|Similarity|similarity
1241522|NCT01844804|PK|pk
1241523|NCT01844804|Phase 1|phase 1
1241524|NCT01844804|Infliximab|infliximab
1241525|NCT01844804|Healthy Volunteers|healthy volunteers
1241526|NCT01844804|Single-dose|single-dose
1241527|NCT01844804|Immunology|immunology
1241528|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
1241529|NCT01844791|OCZ103-OS|ocz103-os
1241818|NCT01843400|Regorafenib|regorafenib
1241530|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
1241531|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
1241532|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
1241533|NCT01844778|colistimethate|colistimethate
1241534|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
1241535|NCT01844765|Tasigna|tasigna
1241536|NCT01844765|nilotinib treatment|nilotinib treatment
1241537|NCT01844765|chronic phase|chronic phase
1241538|NCT01844765|Ph+ CML|ph+ cml
1241539|NCT01844765|accelerated phase|accelerated phase
1241540|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
1241541|NCT01844765|pediatric|pediatric
1241542|NCT01844765|24 month treatment|24 month treatment
1241543|NCT01844752|acne|acne
1241544|NCT01844739|Propionibacterium acnes|propionibacterium acnes
1241545|NCT01844739|acne|acne
1241546|NCT01844726|healthy individuals|healthy individuals
1241547|NCT01844726|schizophrenia|schizophrenia
1241548|NCT01844726|schizoaffective disorder|schizoaffective disorder
1241549|NCT01844726|learning|learning
1241550|NCT01844726|memory|memory
1241551|NCT01844726|cognitive enhancement|cognitive enhancement
1241552|NCT01844726|fMRI|fmri
1241553|NCT01844713|Kidney transplant|kidney transplant
1241554|NCT01844713|Renal transplant|renal transplant
1241555|NCT01844713|Sun protection|sun protection
1241556|NCT01844713|Skin cancer|skin cancer
1241557|NCT01844700|MC4R genotype|mc4r genotype
1241558|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
1241559|NCT01844700|pediatric population|pediatric population
1241560|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
1241561|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
1241562|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
1241563|NCT01844648|Parkinson's disease|parkinson's disease
1241564|NCT01844648|Sialorrhea|sialorrhea
1241565|NCT01844648|Tropicamide|tropicamide
1241566|NCT01844648|Non-motor symptoms|non-motor symptoms
1241567|NCT01844648|Thin strip delivery|thin strip delivery
1241568|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
1241569|NCT01844609|Comprehension|comprehension
1241570|NCT01844609|Verbal Learning|verbal learning
1241571|NCT01844609|Writing|writing
1241572|NCT01844609|Testing|testing
1241573|NCT01844596|linkage to care|linkage to care
1241574|NCT01844596|hypertension management|hypertension management
1241575|NCT01844596|behavioral science|behavioral science
1241576|NCT01844596|cardiovascular health|cardiovascular health
1241577|NCT01844596|global health|global health
1241578|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
1241579|NCT01844596|linking and retaining|linking and retaining
1241580|NCT01844596|community health workers|community health workers
1241581|NCT01844596|CHWs|chws
1241582|NCT01844596|behavioral communication strategy|behavioral communication strategy
1241583|NCT01844596|smartphone-based tool|smartphone-based tool
1241584|NCT01844596|electronic health record|electronic health record
1241585|NCT01844596|retention to care|retention to care
1241586|NCT01844557|Head And Neck Cancer|head and neck cancer
1241587|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
1241588|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
1241589|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
1241590|NCT01844557|Laryngeal cancer|laryngeal cancer
1241591|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
1241592|NCT01844557|Swallowing exercises|swallowing exercises
1241593|NCT01844557|Videotape|videotape
1241594|NCT01844557|Videocamera|videocamera
1241595|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
1241596|NCT01844557|Questionnaires|questionnaires
1241597|NCT01844557|Surveys|surveys
1241598|NCT01844544|drug related problems|drug related problems
1241599|NCT01844544|clinical pharmacist|clinical pharmacist
1241600|NCT01844544|femoral neck fractures|femoral neck fractures
1241601|NCT01844544|orthopedic patients|orthopedic patients
1241602|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
1241603|NCT01844492|intensive care|intensive care
1241604|NCT01844492|surrogate decision making|surrogate decision making
1241605|NCT01844492|patient centered care|patient centered care
1241606|NCT01844492|Palliative Care|palliative care
1241607|NCT01844492|End of Life|end of life
1241608|NCT01844492|Quality of Communication|quality of communication
1241609|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
1241610|NCT01844479|diabetic foot|diabetic foot
1242004|NCT01842399|Aging|aging
1241611|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
1241612|NCT01844466|improvement of deficits|improvement of deficits
1241613|NCT01844466|stroke patients|stroke patients
1241614|NCT01844453|Subfertility|subfertility
1241615|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
1241616|NCT01844440|GERD|gerd
1241617|NCT01844440|tLESR|tlesr
1241618|NCT01844440|impedance|impedance
1241619|NCT01844440|manometry|manometry
1241620|NCT01844427|ADHD|adhd
1241621|NCT01844427|Executive function deficits|executive function deficits
1241622|NCT01844427|Psychiatry|psychiatry
1241623|NCT01844427|Psychopharmacology|psychopharmacology
1241624|NCT01844427|Namenda|namenda
1241625|NCT01844414|Homeless Men|homeless men
1241626|NCT01844414|Parolees|parolees
1241627|NCT01844414|Hepatitis B|hepatitis b
1241628|NCT01844414|Hepatitis C|hepatitis c
1241630|NCT01844414|Community Drug Treatment|community drug treatment
1241631|NCT01844414|Recidivism|recidivism
1241632|NCT01844401|persistent asthma|persistent asthma
1241633|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
1241634|NCT01844401|ProAir® HFA|proair® hfa
1241635|NCT01844401|Pediatric Patients|pediatric patients
1241636|NCT01844401|Phase 1|phase 1
1241637|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
1241638|NCT01844375|walking capacity|walking capacity
1241639|NCT01844362|uterus|uterus
1241640|NCT01844362|transplantation|transplantation
1241641|NCT01844362|infertility|infertility
1241642|NCT01844349|North Africa|north africa
1241643|NCT01844349|Urban women|urban women
1241644|NCT01844349|Double burden of malnutrition|double burden of malnutrition
1241645|NCT01844349|Iron depletion|iron depletion
1241646|NCT01844349|Overweight/obesity|overweight/obesity
1241647|NCT01844349|Metabolic syndrome|metabolic syndrome
1241648|NCT01844349|Abdominal obesity|abdominal obesity
1241649|NCT01844349|Excess body fat|excess body fat
1241650|NCT01844284|Absorb™ BVS|absorb™ bvs
1241651|NCT01844284|Angioplasty|angioplasty
1241652|NCT01844284|Bioabsorbable|bioabsorbable
1241653|NCT01844284|Bioreabsorbable|bioreabsorbable
1241654|NCT01844284|BVS|bvs
1241655|NCT01844284|Coronary Artery Disease|coronary artery disease
1241656|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1241657|NCT01844284|Coronary artery restenosis|coronary artery restenosis
1241658|NCT01844284|Coronary artery stenosis|coronary artery stenosis
1241659|NCT01844284|Coronary scaffold|coronary scaffold
1241660|NCT01844284|Coronary Stent|coronary stent
1241661|NCT01844284|Drug eluting stents|drug eluting stents
1241662|NCT01844284|Everolimus|everolimus
1241663|NCT01844284|Myocardial ischemia|myocardial ischemia
1241664|NCT01844284|Stent thrombosis|stent thrombosis
1241665|NCT01844284|Stents|stents
1241666|NCT01844271|LLLT|lllt
1241667|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
1241668|NCT01844271|phototherapy parameter|phototherapy parameter
1241669|NCT01844258|pediatric cataract|pediatric cataract
1241670|NCT01844258|lens regeneration|lens regeneration
1241671|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
1241672|NCT01844258|visual axis opacification|visual axis opacification
1241673|NCT01844258|visual function|visual function
1241674|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
1241675|NCT01844245|Ampullary carcinoma|ampullary carcinoma
1241676|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1241677|NCT01844245|Radiofrequency ablation|radiofrequency ablation
1241678|NCT01844232|Multiple sclerosis|multiple sclerosis
1241679|NCT01844232|spasticity|spasticity
1241680|NCT01844232|arbaclofen|arbaclofen
1241681|NCT01844219|aortic surgery|aortic surgery
1241682|NCT01844219|acute kidney injury|acute kidney injury
1241683|NCT01844219|gray zone approach|gray zone approach
1241684|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
1241685|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
1241686|NCT01844206|Post-operative analgesia|post-operative analgesia
1241687|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
1241688|NCT01844206|Pain management after cesarean|pain management after cesarean
1241689|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
1241690|NCT01844180|IBS|ibs
1241691|NCT01844180|ONO-2952|ono-2952
1241692|NCT01844167|noxipoint|noxipoint
1241693|NCT01844167|physical therapy|physical therapy
1241694|NCT01844167|cervical pain|cervical pain
1241695|NCT01844167|trigger point|trigger point
1241696|NCT01844167|neck pain|neck pain
1241697|NCT01844167|TENS|tens
1241698|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1241699|NCT01844141|phenol|phenol
1241700|NCT01844141|ingrown toenail|ingrown toenail
1241701|NCT01844141|chemical matricectomy|chemical matricectomy
1598960|NCT00398359|Children|children
1241702|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
1241703|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
1241704|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
1241705|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
1241706|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
1241707|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
1241708|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
1241709|NCT01844050|Chinese herbal medicine|chinese herbal medicine
1241710|NCT01844050|diabetes symptoms|diabetes symptoms
1241711|NCT01844011|fetal movement|fetal movement
1241712|NCT01844011|pregnancy|pregnancy
1241713|NCT01843998|Early stage|early stage
1241714|NCT01843998|Stage 1A|stage 1a
1241715|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1241717|NCT01843985|Stage IV cancer|stage iv cancer
1241718|NCT01843985|Survival|survival
1241719|NCT01843959|adenovirus-36|adenovirus-36
1241720|NCT01843959|Emirati population|emirati population
1241721|NCT01843920|eye|eye
1241722|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
1241723|NCT01843920|topical|topical
1241724|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
1241725|NCT01843881|Gastric Bypass|gastric bypass
1241726|NCT01843881|bariatric surgery|bariatric surgery
1241727|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
1241728|NCT01843868|Lymphoma|lymphoma
1241729|NCT01843868|Non-Hodgkin|non-hodgkin
1241730|NCT01843868|Emesis|emesis
1241731|NCT01843868|Chemotherapy|chemotherapy
1241732|NCT01843868|Nausea|nausea
1241733|NCT01843868|Vomiting|vomiting
1241734|NCT01843868|Aprepitant|aprepitant
1241735|NCT01843855|Gastric Bypass|gastric bypass
1241736|NCT01843855|bariatric surgery|bariatric surgery
1241737|NCT01843855|glucose metabolism|glucose metabolism
1241738|NCT01843829|Oesophageal cancer|oesophageal cancer
1241739|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
1241740|NCT01843816|obesity|obesity
1241741|NCT01843816|body shape|body shape
1241742|NCT01843816|height|height
1241743|NCT01843816|weight|weight
1241744|NCT01843803|patient centered care|patient centered care
1241745|NCT01843803|collaborative decision making|collaborative decision making
1241746|NCT01843803|cost impact|cost impact
1241747|NCT01843777|hearing loss|hearing loss
1241748|NCT01843777|hearing aids|hearing aids
1241749|NCT01843777|motivational interviewing|motivational interviewing
1241750|NCT01843777|counseling|counseling
1241751|NCT01843777|rehabilitation|rehabilitation
1241753|NCT01843764|malaria|malaria
1241754|NCT01843764|treatment follow up|treatment follow up
1241755|NCT01843764|diagnosis|diagnosis
1241756|NCT01843725|breast cancer|breast cancer
1241757|NCT01843725|digestive cancer|digestive cancer
1241758|NCT01843712|Caloric compensation|caloric compensation
1241759|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
1241760|NCT01843712|Children|children
1241761|NCT01843712|Parental feeding practices|parental feeding practices
1241762|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
1241763|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
1241764|NCT01843686|Skin Grafting|skin grafting
1241765|NCT01843686|Magellan® System|magellan® system
1241766|NCT01843686|Wounds|wounds
1241767|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
1241768|NCT01843673|Larynx|larynx
1241769|NCT01843660|Low back pain|low back pain
1241770|NCT01843660|Shoulder pain|shoulder pain
1241771|NCT01843660|Neck pain|neck pain
1241772|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
1241773|NCT01843660|Paracetamol|paracetamol
1241774|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
1241775|NCT01843608|Physical treatment|physical treatment
1241776|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
1241777|NCT01843608|Side cancer effect treatment|side cancer effect treatment
1241778|NCT01843582|Keyword: blind spot|keyword: blind spot
1241779|NCT01843569|In Vitro Maturation|in vitro maturation
1241780|NCT01843569|IVM|ivm
1241781|NCT01843569|Natural cycle IVF|natural cycle ivf
1241782|NCT01843569|PCOS|pcos
1241783|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
1241784|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
1241785|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
1241786|NCT01843517|Pain|pain
1241787|NCT01843517|Facilitation|facilitation
1241788|NCT01843517|Inhibition|inhibition
1241789|NCT01843517|Oxytocin|oxytocin
1241790|NCT01843517|Postpartum|postpartum
1241791|NCT01843504|platelet rich plasma|platelet rich plasma
1241792|NCT01843504|PRP|prp
1241793|NCT01843504|plasma|plasma
1241794|NCT01843504|plasma injection|plasma injection
1241795|NCT01843504|patellar tendinopathy|patellar tendinopathy
1241796|NCT01843504|patella tendon|patella tendon
1241797|NCT01843504|patella|patella
1241798|NCT01843504|ultrasound|ultrasound
1241799|NCT01843504|shear wave ultrasound|shear wave ultrasound
1241800|NCT01843504|tendinosis|tendinosis
1241801|NCT01843504|tendinopathy|tendinopathy
1241802|NCT01843504|tendinitis|tendinitis
1241803|NCT01843504|jumper's knee|jumper's knee
1241804|NCT01843478|women|women
1241805|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
1241806|NCT01843478|cervical cancer screening|cervical cancer screening
1241807|NCT01843478|Pap testing|pap testing
1241808|NCT01843478|human papillomavirus|human papillomavirus
1241809|NCT01843465|atrial fibrillation|atrial fibrillation
1241810|NCT01843465|balloon cryoablation|balloon cryoablation
1241811|NCT01843465|pulmonary veins|pulmonary veins
1241812|NCT01843439|Acute exacerbation|acute exacerbation
1241813|NCT01843439|Quality of life|quality of life
1241814|NCT01843439|Magnesium deficiency|magnesium deficiency
1241815|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
1241816|NCT01843426|Comorbidity|comorbidity
1241817|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1241819|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
1241820|NCT01843387|Diabetic nephropathy|diabetic nephropathy
1241821|NCT01843387|Chronic kidney disease|chronic kidney disease
1241822|NCT01843387|Metabolic disease|metabolic disease
1241823|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
1241824|NCT01843374|tremelimumab|tremelimumab
1241825|NCT01843374|pleural, peritoneal|pleural, peritoneal
1241826|NCT01843374|malignant mesothelioma|malignant mesothelioma
1241827|NCT01843374|CTLA-4|ctla-4
1241828|NCT01843361|Stroke|stroke
1241829|NCT01843361|Clopidogrel|clopidogrel
1241830|NCT01843361|Aggregometry|aggregometry
1241831|NCT01843361|Antiplatelet therapy|antiplatelet therapy
1241832|NCT01843361|Platelet function tests|platelet function tests
1241833|NCT01843348|Transplant|transplant
1241834|NCT01843348|Renal transplant|renal transplant
1241835|NCT01843348|Rejection,allograf|rejection,allograf
1241836|NCT01843348|Rejection|rejection
1241837|NCT01843348|Xenograft rejection|xenograft rejection
1241838|NCT01843348|Host vs graft disease|host vs graft disease
1241839|NCT01843348|Kidney Transplant|kidney transplant
1241840|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
1241841|NCT01843335|Ultrasound|ultrasound
1241842|NCT01843322|Image guided therapy|image guided therapy
1241843|NCT01843322|Endovascular procedures|endovascular procedures
1241844|NCT01843322|Angiography|angiography
1241845|NCT01843322|Vascular surgical procedures|vascular surgical procedures
1241846|NCT01843296|Spinal Anesthesia|spinal anesthesia
1241847|NCT01843296|Bupivacaine|bupivacaine
1241848|NCT01843296|Fentanyl|fentanyl
1241849|NCT01843296|Magnesium sulfate|magnesium sulfate
1241850|NCT01843296|Postoperative Pain|postoperative pain
1241851|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
1241852|NCT01843283|Family Caregivers|family caregivers
1241853|NCT01843283|Intervention studies|intervention studies
1241854|NCT01843270|general anesthesia|general anesthesia
1241855|NCT01843270|body weight|body weight
1241856|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
1241857|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
1241858|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
1241859|NCT01843244|plethysmography|plethysmography
1241860|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
1241861|NCT01843231|Weight Loss Intervention|weight loss intervention
1241862|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
1241863|NCT01843179|Newly diagnosed|newly diagnosed
1241864|NCT01843179|Complete Remission|complete remission
1241865|NCT01843166|Pessary|pessary
1241866|NCT01843166|Patient Satisfaction|patient satisfaction
1241867|NCT01843166|Estrogen Cream|estrogen cream
1241868|NCT01843153|pain score|pain score
1241869|NCT01843140|cancer|cancer
1241870|NCT01843140|fertility preservation|fertility preservation
1241871|NCT01843140|infertility|infertility
1241872|NCT01843140|pregnancy|pregnancy
1241873|NCT01843114|Retinal blood flow|retinal blood flow
1241874|NCT01843114|Retinal vessel diameter|retinal vessel diameter
1241875|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
1241876|NCT01843114|Retinal blood velocities|retinal blood velocities
1241877|NCT01843101|Optical Coherence Tomography|optical coherence tomography
1241878|NCT01843101|Cornea|cornea
1241879|NCT01843101|Imaging|imaging
1241880|NCT01843088|Pain|pain
1241881|NCT01843088|exercise|exercise
1241882|NCT01843088|muscle|muscle
1241883|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
1241884|NCT01843036|Child Abuse|child abuse
1241885|NCT01843036|Child Neglect|child neglect
1241886|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
1241887|NCT01843036|Child Well-Care Compliance|child well-care compliance
1241888|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
1241889|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
1241890|NCT01843036|Mother Mental Health|mother mental health
1241891|NCT01843036|Family Connections to Community Resources|family connections to community resources
1241892|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
1241893|NCT01843023|opioid dependence|opioid dependence
1241894|NCT01843010|NSAIDs|nsaids
1241895|NCT01843010|Hyperalgesia|hyperalgesia
1241896|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
1241897|NCT01842997|Flu|flu
1241898|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
1241899|NCT01842997|Safety|safety
1241900|NCT01842997|pregnant women|pregnant women
1241901|NCT01842984|Loneliness|loneliness
1241902|NCT01842984|Social isolation|social isolation
1241904|NCT01842984|Older adults|older adults
1241905|NCT01842984|Social competence|social competence
1241906|NCT01842984|Social integration|social integration
1241907|NCT01842971|two stage hepatectomy|two stage hepatectomy
1241908|NCT01842971|liver metastasis|liver metastasis
1241909|NCT01842971|colorectal cancer|colorectal cancer
1241910|NCT01842958|Dental Implant|dental implant
1241911|NCT01842945|Procrastination|procrastination
1241912|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
1241913|NCT01842945|randomized controlled trial|randomized controlled trial
1241914|NCT01842932|Colonoscopy|colonoscopy
1241915|NCT01842932|Anticholinergics|anticholinergics
1241916|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
1241917|NCT01842906|acute mountain sickness|acute mountain sickness
1241918|NCT01842906|prevention|prevention
1241919|NCT01842906|high altitude|high altitude
1241920|NCT01842893|fentanyl|fentanyl
1241921|NCT01842893|breakthrough pain|breakthrough pain
1241922|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
1241923|NCT01842880|MicroRNAs|micrornas
1241924|NCT01842880|Chagas disease|chagas disease
1241925|NCT01842880|Biomarkers|biomarkers
1241926|NCT01842867|Syndecan-4|syndecan-4
1241927|NCT01842867|Chagas disease|chagas disease
1241928|NCT01842867|Biomarkers|biomarkers
1241929|NCT01842854|Galectin-3|galectin-3
1241930|NCT01842854|Chagas disease|chagas disease
1241931|NCT01842854|Biomarkers|biomarkers
1241932|NCT01842789|Acessa|acessa
1241933|NCT01842789|Fibroids|fibroids
1241934|NCT01842789|Halt|halt
1241935|NCT01842789|Targeting Animation|targeting animation
1241936|NCT01842789|Image Overlay|image overlay
1241937|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
1241938|NCT01842789|RFA|rfa
1241939|NCT01842763|Chronic daily headache|chronic daily headache
1241940|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
1241941|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
1241942|NCT01842763|occipital nerves|occipital nerves
1241943|NCT01842763|network|network
1241944|NCT01842763|database|database
1241945|NCT01842737|Low Back Pain|low back pain
1241946|NCT01842737|Chiropractic|chiropractic
1241947|NCT01842737|Spinal Manipulation|spinal manipulation
1241948|NCT01842737|Massage|massage
1241949|NCT01842698|Thoracotomy surgery|thoracotomy surgery
1241950|NCT01842698|Anesthesia|anesthesia
1241951|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
1241952|NCT01842698|Post-operative pain|post-operative pain
1241953|NCT01842685|Overactive Bladder|overactive bladder
1241954|NCT01842685|Bladder Distention|bladder distention
1241955|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
1241956|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
1241957|NCT01842672|clofarabine|clofarabine
1241958|NCT01842672|mitoxantrone|mitoxantrone
1241959|NCT01842659|MI|mi
1241960|NCT01842659|amniocentesis|amniocentesis
1241961|NCT01842659|cord blood|cord blood
1241962|NCT01842659|placenta|placenta
1241963|NCT01842659|Silver Russell Syndrome|silver russell syndrome
1241964|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
1241965|NCT01842646|Leukemia|leukemia
1241966|NCT01842646|Myeloid Malignancies|myeloid malignancies
1241967|NCT01842620|Metformin|metformin
1241968|NCT01842620|Bioequivalence|bioequivalence
1241969|NCT01842607|eosinophils|eosinophils
1241970|NCT01842607|mepolizumab|mepolizumab
1241971|NCT01842607|SB-240563|sb-240563
1241972|NCT01842607|safety|safety
1241973|NCT01842607|extension study|extension study
1241974|NCT01842607|Severe refractory asthma|severe refractory asthma
1241975|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
1241976|NCT01842581|Liver Failure|liver failure
1241977|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
1241978|NCT01842581|Liver Diseases|liver diseases
1241979|NCT01842581|Brain Diseases|brain diseases
1241980|NCT01842581|Rifaximin|rifaximin
1241981|NCT01842581|Cirrhosis|cirrhosis
1241982|NCT01842568|Cardiac surgery|cardiac surgery
1241983|NCT01842568|Troponin|troponin
1241984|NCT01842568|Vascular events|vascular events
1241985|NCT01842568|Myocardial injury|myocardial injury
1241986|NCT01842568|Observational cohort study|observational cohort study
1241987|NCT01842568|Public health|public health
1241988|NCT01842555|PDT|pdt
1241989|NCT01842555|Photodynamic therapy|photodynamic therapy
1241990|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
1241991|NCT01842503|alcohol dependence|alcohol dependence
1241992|NCT01842503|cue reactivity|cue reactivity
1241993|NCT01842503|alcohol self administration|alcohol self administration
1241994|NCT01842490|Biomarker|biomarker
1241995|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
1241996|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
1241997|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
1241998|NCT01842425|Liver volume|liver volume
1241999|NCT01842425|Gastric bypass|gastric bypass
1242000|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
1242001|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
1242002|NCT01842412|Exercise|exercise
1242003|NCT01842399|Vascular Stiffness|vascular stiffness
1242005|NCT01842399|Resveratrol|resveratrol
1242006|NCT01842399|Aerobic Capacity|aerobic capacity
1242007|NCT01842399|Inflammation|inflammation
1242008|NCT01842386|Anti-CD20|anti-cd20
1242009|NCT01842386|Anticytokine Autoanitbody-Associated Disease|anticytokine autoanitbody-associated disease
1242010|NCT01842386|Rituximab|rituximab
1242011|NCT01842373|topical anesthetics|topical anesthetics
1242012|NCT01842373|laser resurfacing|laser resurfacing
1242013|NCT01842360|Vaccine|vaccine
1242014|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1242015|NCT01842334|Nicotine Dependence|nicotine dependence
1242016|NCT01842334|Smoking Cessation|smoking cessation
1242017|NCT01842334|D-cycloserine|d-cycloserine
1242018|NCT01842321|locally advanced|locally advanced
1242019|NCT01842321|metastatic|metastatic
1242020|NCT01842321|Breast Cancer|breast cancer
1242021|NCT01842321|Molecular Apocrine|molecular apocrine
1242022|NCT01842321|HER2-negative|her2-negative
1242023|NCT01842321|Abiraterone acetate|abiraterone acetate
1242024|NCT01842295|Obesity|obesity
1242025|NCT01842295|Bariatric surgery|bariatric surgery
1242026|NCT01842295|Sperm quality|sperm quality
1242027|NCT01842295|Fertility|fertility
1242028|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
1242029|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
1242030|NCT01842282|obesity|obesity
1242031|NCT01842282|amlexanox|amlexanox
1242032|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
1242034|NCT01842256|Telminouveau|telminouveau
1242035|NCT01842256|Atorvastatin|atorvastatin
1242036|NCT01842256|Pharmacokinetic|pharmacokinetic
1242037|NCT01842256|Healthy volunteers|healthy volunteers
1242038|NCT01842243|Ventricular dysfunction|ventricular dysfunction
1242039|NCT01842243|MRI|mri
1242040|NCT01842243|Echocardiography|echocardiography
1242041|NCT01842243|Pacemakers|pacemakers
1242042|NCT01842230|Telminuvo|telminuvo
1242043|NCT01842230|Telmisartan|telmisartan
1242044|NCT01842230|S-amlodipine|s-amlodipine
1242045|NCT01842230|Atorvastatin|atorvastatin
1242046|NCT01842230|pharmacokinetics|pharmacokinetics
1242047|NCT01842230|Healthy volunteers|healthy volunteers
1242048|NCT01842217|18F-FES PET|18f-fes pet
1242049|NCT01842217|Nuclear Medicine|nuclear medicine
1242050|NCT01842217|Premenopausal|premenopausal
1242051|NCT01842217|Postmenopausal|postmenopausal
1242052|NCT01842217|Estrogen receptor|estrogen receptor
1242053|NCT01842217|Anxiety|anxiety
1242054|NCT01842217|Depression|depression
1242055|NCT01842217|Cognition|cognition
1242056|NCT01842204|inguinal hernia|inguinal hernia
1242057|NCT01842191|R-R MS|r-r ms
1242058|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
1242059|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
1242060|NCT01842126|Sciatica|sciatica
1242061|NCT01842100|Induced abortion|induced abortion
1242062|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
1242063|NCT01842100|Sexually transmitted infections|sexually transmitted infections
1242064|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
1242065|NCT01842100|Screen-and-treat approach|screen-and-treat approach
1242066|NCT01842087|Chronic Kidney Disease|chronic kidney disease
1242067|NCT01842087|Fiber|fiber
1242068|NCT01842087|BUN|bun
1242069|NCT01842087|Serum Creatinine|serum creatinine
1242070|NCT01842087|Uremic Symptoms|uremic symptoms
1242071|NCT01842087|Quality of Life|quality of life
1242072|NCT01842074|bortezomib|bortezomib
1242073|NCT01842074|desensitization|desensitization
1242074|NCT01842074|living kidney transplantation|living kidney transplantation
1242075|NCT01842061|active living|active living
1242076|NCT01842061|retirement|retirement
1242077|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
1242078|NCT01842048|Hyperthermia|hyperthermia
1242079|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
1242080|NCT01842035|regadenoson|regadenoson
1242081|NCT01842035|sudden cardiac death|sudden cardiac death
1242082|NCT01842035|heart rate response|heart rate response
1242083|NCT01842022|Glycemic load|glycemic load
1242084|NCT01842022|memory|memory
1242085|NCT01842022|mood|mood
1242086|NCT01842009|transcranial stimulation|transcranial stimulation
1242087|NCT01842009|direct current|direct current
1242088|NCT01841983|Total worker health|total worker health
1242089|NCT01841983|Sleep|sleep
1242090|NCT01841983|MSDs|msds
1242091|NCT01841983|Diet|diet
1242092|NCT01841983|Physical Activity|physical activity
1242093|NCT01841957|Bilateral Cataract|bilateral cataract
1242094|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
1242095|NCT01841957|ISBCS|isbcs
1242096|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
1242097|NCT01841944|Aged|aged
1242098|NCT01841944|Myocardial Infarction|myocardial infarction
1242099|NCT01841931|Opioids|opioids
1242100|NCT01841931|Dependence|dependence
1242101|NCT01841931|Buprenorphine|buprenorphine
1242102|NCT01841931|Pain|pain
1242103|NCT01841905|Alzheimer's Disease|alzheimer's disease
1242104|NCT01841905|Family History|family history
1242105|NCT01841905|Memory Concerns|memory concerns
1242106|NCT01841866|post operative sore throat|post operative sore throat
1242107|NCT01841866|laryngeal mask airway|laryngeal mask airway
1242108|NCT01841866|children|children
1242109|NCT01841853|Elderly|elderly
1242110|NCT01841853|Health promotion|health promotion
1242111|NCT01841853|Randomized controlled study|randomized controlled study
1242112|NCT01841853|Immigrant|immigrant
1242113|NCT01841853|Vulnerable population|vulnerable population
1242114|NCT01841853|ADL|adl
1242115|NCT01841853|KASAM|kasam
1242116|NCT01841853|Implementation|implementation
1242118|NCT01841840|Hemiparetic|hemiparetic
1242119|NCT01841840|Passive Vibration|passive vibration
1242120|NCT01841840|Arterial Stiffness|arterial stiffness
1242121|NCT01841840|Pulse Wave Velocity|pulse wave velocity
1242122|NCT01841840|Wave Reflection|wave reflection
1242123|NCT01841840|Body Composition|body composition
1242124|NCT01841840|Autonomic Function|autonomic function
1242125|NCT01841814|Lymphoma|lymphoma
1242126|NCT01841814|Osteoporosis|osteoporosis
1242127|NCT01841814|Chemotherapy|chemotherapy
1242128|NCT01841814|Patient with|patient with
1242129|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
1242130|NCT01841775|Genotype 2/3|genotype 2/3
1242131|NCT01841775|Interferon α 2b|interferon α 2b
1242132|NCT01841775|Ribavirin|ribavirin
1242133|NCT01841775|Pharmacovigilance|pharmacovigilance
1242134|NCT01841762|PAH-SYMPACT|pah-sympact
1242135|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1242136|NCT01841762|psychometric instrument|psychometric instrument
1242137|NCT01841749|Breast cancer|breast cancer
1242138|NCT01841710|Bitter Taste|bitter taste
1242139|NCT01841710|Pediatric Medications|pediatric medications
1242140|NCT01841697|Diabetes Mellitus|diabetes mellitus
1242141|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1242142|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
1242143|NCT01841697|Metabolic Diseases|metabolic diseases
1242144|NCT01841697|Endocrine System Diseases|endocrine system diseases
1242145|NCT01841697|Glimepiride|glimepiride
1242146|NCT01841697|Metformin|metformin
1242147|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
1242148|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
1242149|NCT01841697|Pharmacologic Actions|pharmacologic actions
1242150|NCT01841684|HoFH|hofh
1242151|NCT01841671|Polio|polio
1242152|NCT01841671|IPV|ipv
1242153|NCT01841671|bOPV|bopv
1242154|NCT01841671|mOPV|mopv
1242155|NCT01841671|vaccination|vaccination
1242156|NCT01841658|Folate Status|folate status
1242157|NCT01841658|Folate Biomarkers|folate biomarkers
1242158|NCT01841645|CLA-enriched butter|cla-enriched butter
1242159|NCT01841645|CLA metabolism|cla metabolism
1242160|NCT01841645|inflammation|inflammation
1242161|NCT01841632|Liver transplantation|liver transplantation
1242162|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
1242163|NCT01841632|Solid organ transplantation|solid organ transplantation
1242164|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
1242165|NCT01841606|Spinal anesthesia|spinal anesthesia
1242166|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
1242167|NCT01841606|Ondansetron|ondansetron
1242168|NCT01841580|Tear proteins profiles|tear proteins profiles
1242169|NCT01841580|Longitudinal|longitudinal
1242170|NCT01841580|Ocular surface damage|ocular surface damage
1242171|NCT01841580|Trabeculectomy|trabeculectomy
1242172|NCT01841567|hip|hip
1242173|NCT01841567|knee|knee
1242174|NCT01841554|Mitral Valve|mitral valve
1242175|NCT01841554|Annuloplasty|annuloplasty
1242176|NCT01841541|Tuberculosis|tuberculosis
1242177|NCT01841541|Informal providers|informal providers
1242178|NCT01841541|Informal carers|informal carers
1242179|NCT01841541|Barriers to health system|barriers to health system
1242180|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
1242181|NCT01841528|Infertility|infertility
1242182|NCT01841528|In-vitro fertilization|in-vitro fertilization
1242183|NCT01841528|fresh embryo transfer|fresh embryo transfer
1242184|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
1242185|NCT01841502|telaprevir|telaprevir
1242186|NCT01841502|paroxetine|paroxetine
1242187|NCT01841502|interaction|interaction
1242188|NCT01841502|pharmacokinetics|pharmacokinetics
1242189|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1242190|NCT01841489|CLL|cll
1242191|NCT01841476|Peripheral blood|peripheral blood
1242192|NCT01841476|HSC|hsc
1242193|NCT01841476|Mobilization|mobilization
1242194|NCT01841476|CXCR4|cxcr4
1242195|NCT01841476|volunteers|volunteers
1242196|NCT01841463|Malignant Melanoma|malignant melanoma
1242197|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
1242198|NCT01841450|Trabecular meshwork|trabecular meshwork
1242199|NCT01841450|iStent|istent
1242200|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
1242201|NCT01841437|Trabecular meshwork|trabecular meshwork
1242202|NCT01841437|iStent|istent
1242203|NCT01841424|dietary counseling|dietary counseling
1242204|NCT01841424|food diary|food diary
1242205|NCT01841424|obesity|obesity
1242206|NCT01841424|pregnancy|pregnancy
1242207|NCT01841424|weight gain|weight gain
1242306|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
1242208|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
1242209|NCT01841398|Cardiovascular|cardiovascular
1242210|NCT01841398|Prevention|prevention
1242211|NCT01841398|Ethnicity|ethnicity
1242212|NCT01841398|Culture|culture
1242213|NCT01841398|Internet|internet
1242214|NCT01841398|Text Message|text message
1242215|NCT01841385|Exercise|exercise
1242216|NCT01841385|spirometry|spirometry
1242217|NCT01841385|muscle strength|muscle strength
1242218|NCT01841385|physical therapy modalities|physical therapy modalities
1242219|NCT01841372|Obesity|obesity
1242220|NCT01841372|Overweight|overweight
1242221|NCT01841372|Weight Maintenance|weight maintenance
1242222|NCT01841359|Hypoglycemia|hypoglycemia
1242223|NCT01841359|Gastric bypass surgery|gastric bypass surgery
1242224|NCT01841346|Outcome after PCI|outcome after pci
1242225|NCT01841346|Middle Eastern Patients|middle eastern patients
1242226|NCT01841333|Lymphoblastic leukemia in remission|lymphoblastic leukemia in remission
1242227|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
1242228|NCT01841333|Recurrent lymphoblastic leukemia|recurrent lymphoblastic leukemia
1242229|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
1242230|NCT01841281|Asthma|asthma
1242231|NCT01841281|Severe Asthma|severe asthma
1242232|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
1242233|NCT01841255|Preoxygenation|preoxygenation
1242234|NCT01841255|Device|device
1242235|NCT01841255|Tolerability|tolerability
1242236|NCT01841255|Efficacy|efficacy
1242237|NCT01841242|Infection|infection
1242238|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
1242239|NCT01841242|Heart Failure|heart failure
1242240|NCT01841216|Gluteus Maximus|gluteus maximus
1242241|NCT01841216|Gluteus Medius|gluteus medius
1242243|NCT01841216|EMG|emg
1242244|NCT01841216|Perceived Exertion|perceived exertion
1242245|NCT01841216|Thera-Band|thera-band
1242246|NCT01841203|Diagnosis|diagnosis
1242247|NCT01841203|Rapid tests|rapid tests
1242248|NCT01841203|non-treponemal serology|non-treponemal serology
1242249|NCT01841203|eradication|eradication
1242250|NCT01841190|Prognosis|prognosis
1242251|NCT01841190|Sepsis|sepsis
1242252|NCT01841190|Septic shock|septic shock
1242253|NCT01841190|Procalcitonin|procalcitonin
1242254|NCT01841190|SOFA|sofa
1242255|NCT01841177|Congenital Heart Disease|congenital heart disease
1242256|NCT01841177|Pediatrics|pediatrics
1242257|NCT01841177|Milrinone|milrinone
1242258|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
1242259|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
1242260|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
1242261|NCT01841164|LTE4|lte4
1242262|NCT01841164|asthma|asthma
1242263|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
1242264|NCT01841164|bronchoprovocation|bronchoprovocation
1242265|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
1242266|NCT01841164|human|human
1242267|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
1242268|NCT01841138|colonoscopy|colonoscopy
1242269|NCT01841138|bowel preparation|bowel preparation
1242270|NCT01841138|electrolytes|electrolytes
1242271|NCT01841138|osmolality|osmolality
1242272|NCT01841138|water|water
1242273|NCT01841125|Alzheimer's Disease|alzheimer's disease
1242274|NCT01841125|depressive disorder|depressive disorder
1242275|NCT01841073|Prediabetes|prediabetes
1242276|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
1242277|NCT01841073|Appetite|appetite
1242278|NCT01841073|Glucose homeostasis|glucose homeostasis
1242279|NCT01841073|Weight management|weight management
1242280|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
1242281|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
1242282|NCT01841034|Male|male
1242283|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
1242284|NCT01841021|Relapsed|relapsed
1242285|NCT01841021|Refractory|refractory
1242286|NCT01841021|CD30 Receptor|cd30 receptor
1242287|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
1242288|NCT01841008|[C17.800.621]|[c17.800.621]
1242289|NCT01840995|stellate ganglion block|stellate ganglion block
1242290|NCT01840982|Mixed grains|mixed grains
1242291|NCT01840982|Glycemic index|glycemic index
1598961|NCT00398359|Behavioral|behavioral
1242292|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
1242293|NCT01840982|Giant embryonic rice|giant embryonic rice
1242294|NCT01840982|diabetes|diabetes
1242295|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
1242296|NCT01840969|common carotid artery|common carotid artery
1242297|NCT01840969|speckle tracking analysis|speckle tracking analysis
1242298|NCT01840969|peak strain|peak strain
1242299|NCT01840956|End-stage Renal Disease|end-stage renal disease
1242300|NCT01840956|Hemodialysis|hemodialysis
1242301|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
1242302|NCT01840956|Renal Dialysis|renal dialysis
1242303|NCT01840956|Hemodiafiltration|hemodiafiltration
1242304|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
1242305|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
1242407|NCT01840592|12-259|12-259
1242307|NCT01840956|Kidney Diseases|kidney diseases
1242308|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
1242309|NCT01840956|Renal Insufficiency|renal insufficiency
1242310|NCT01840956|Urologic Diseases|urologic diseases
1242311|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
1242312|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
1242313|NCT01840943|Carcinoma|carcinoma
1242314|NCT01840943|Malignancy|malignancy
1242315|NCT01840943|Ovarian carcinoma|ovarian carcinoma
1242316|NCT01840943|CAELYX|caelyx
1242317|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
1242318|NCT01840943|Topotecan|topotecan
1242319|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
1242320|NCT01840943|Chinese patients|chinese patients
1242321|NCT01840930|Cohort|cohort
1242322|NCT01840930|Cerebral Palsy|cerebral palsy
1242323|NCT01840930|Children|children
1242324|NCT01840930|Pain|pain
1242325|NCT01840930|Orthopedic complications|orthopedic complications
1242326|NCT01840930|Epidemiology|epidemiology
1242327|NCT01840865|young healthy subjects|young healthy subjects
1242328|NCT01840865|brain stimulation|brain stimulation
1242329|NCT01840865|tSOS|tsos
1242330|NCT01840865|tDCS|tdcs
1242331|NCT01840865|sleep|sleep
1242332|NCT01840865|daytime sleep|daytime sleep
1242334|NCT01840865|memory|memory
1242335|NCT01840865|memory consolidation|memory consolidation
1242336|NCT01840839|aging|aging
1242337|NCT01840839|cognitive decline|cognitive decline
1242338|NCT01840839|brain stimulation|brain stimulation
1242339|NCT01840839|tSOS|tsos
1242340|NCT01840839|tDCS|tdcs
1242341|NCT01840839|sleep|sleep
1242343|NCT01840839|daytime sleep|daytime sleep
1242344|NCT01840839|memory|memory
1242345|NCT01840839|memory consolidation|memory consolidation
1242346|NCT01840826|Rehospitalization|rehospitalization
1242347|NCT01840826|Reutilization|reutilization
1242348|NCT01840826|Depressive Symptoms|depressive symptoms
1242349|NCT01840826|Pharmacotherapy|pharmacotherapy
1242350|NCT01840826|Cognitive Therapy|cognitive therapy
1242351|NCT01840826|Self-help|self-help
1242352|NCT01840826|Complementary Therapies|complementary therapies
1242353|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
1242354|NCT01840813|Retained placenta|retained placenta
1242355|NCT01840813|Active management of third stage of labour|active management of third stage of labour
1242356|NCT01840800|Postoperative pain|postoperative pain
1242357|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1242358|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
1242359|NCT01840800|opioid consumption|opioid consumption
1242360|NCT01840761|delayed vasospasm,|delayed vasospasm,
1242361|NCT01840761|medicine,|medicine,
1242362|NCT01840761|standardization|standardization
1242363|NCT01840735|CF|cf
1242364|NCT01840735|Cystic Fibrosis|cystic fibrosis
1242365|NCT01840735|PK|pk
1242366|NCT01840722|HIV|hiv
1242367|NCT01840722|HCV|hcv
1242368|NCT01840722|Substance abuse|substance abuse
1242369|NCT01840722|women|women
1242370|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
1242371|NCT01840709|Psychotherapy|psychotherapy
1242372|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1242373|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
1242374|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
1242375|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
1242376|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
1242377|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
1242378|NCT01840670|Inferior Vena Cava|inferior vena cava
1242379|NCT01840670|Central Venous Pressure|central venous pressure
1242380|NCT01840670|Abdominal Pressure|abdominal pressure
1242381|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
1242382|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
1242383|NCT01840657|centronuclear myopathy|centronuclear myopathy
1242384|NCT01840657|myotubularin|myotubularin
1242385|NCT01840657|MTM1 gene|mtm1 gene
1242386|NCT01840657|mutation|mutation
1242387|NCT01840657|survival|survival
1242388|NCT01840657|adverse event|adverse event
1242389|NCT01840657|disease complication|disease complication
1242390|NCT01840657|hospital admission|hospital admission
1242391|NCT01840657|emergency room visit|emergency room visit
1242392|NCT01840657|motor function|motor function
1242393|NCT01840657|respiratory function|respiratory function
1242394|NCT01840657|natural history study|natural history study
1242395|NCT01840631|Obesity|obesity
1242396|NCT01840631|Nutritional counseling|nutritional counseling
1242397|NCT01840631|Physical activity|physical activity
1242398|NCT01840631|Food diary|food diary
1242399|NCT01840618|insulin function|insulin function
1242400|NCT01840618|sleep apnea|sleep apnea
1242401|NCT01840618|girls|girls
1242402|NCT01840618|PCOS|pcos
1242403|NCT01840618|insulin action|insulin action
1242404|NCT01840592|Liver|liver
1242405|NCT01840592|Sorafenib|sorafenib
1242406|NCT01840592|Doxorubicin|doxorubicin
1242408|NCT01840566|Relapsed|relapsed
1242409|NCT01840566|Refractory|refractory
1242410|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1242411|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
1242412|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
1242413|NCT01840566|12-117|12-117
1242414|NCT01840540|renal artery stenosis|renal artery stenosis
1242415|NCT01840540|renovascular hypertension|renovascular hypertension
1242416|NCT01840540|ischemic nephropathy|ischemic nephropathy
1242417|NCT01840540|chronic kidney disease|chronic kidney disease
1242418|NCT01840527|Biomarker|biomarker
1242419|NCT01840527|BRAF|braf
1242420|NCT01840527|blood-based|blood-based
1242421|NCT01840514|recipient|recipient
1242422|NCT01840501|Healthy|healthy
1242423|NCT01840501|JNJ-42721458|jnj-42721458
1242424|NCT01840501|Male|male
1242425|NCT01840501|Safety|safety
1242426|NCT01840501|Tolerability|tolerability
1242427|NCT01840501|Pharmacokinetics|pharmacokinetics
1242428|NCT01840501|Pharmacodynamics|pharmacodynamics
1242429|NCT01840501|Immunogenicity|immunogenicity
1242430|NCT01840436|MUCIPLIQ|mucipliq
1242431|NCT01840436|Matrix therapy|matrix therapy
1242432|NCT01840436|RGTA|rgta
1242433|NCT01840436|Oral mucositis|oral mucositis
1242434|NCT01840423|First in man study|first in man study
1242435|NCT01840423|Volunteer study|volunteer study
1242436|NCT01840410|Vision Impairment|vision impairment
1242437|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
1242438|NCT01840397|S-100B|s-100b
1242439|NCT01840397|NSE|nse
1242440|NCT01840384|Healthy infants|healthy infants
1242441|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
1242442|NCT01840371|ERCP|ercp
1242443|NCT01840371|Sedation|sedation
1242444|NCT01840371|Fentanyl|fentanyl
1242445|NCT01840371|Propofol|propofol
1242446|NCT01840358|Hypoglycemias|hypoglycemias
1242447|NCT01840358|Insulin pump|insulin pump
1242448|NCT01840358|Children|children
1242449|NCT01840345|uncontrolled|uncontrolled
1242450|NCT01840345|neuropathic pain|neuropathic pain
1242451|NCT01840332|thyroid cancer|thyroid cancer
1242452|NCT01840280|carcinoma|carcinoma
1242453|NCT01840280|colorectal cancer|colorectal cancer
1242454|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
1242455|NCT01840280|treatment cycles|treatment cycles
1242456|NCT01840280|Irinotecan|irinotecan
1242457|NCT01840280|Irinotecan onkovis|irinotecan onkovis
1242458|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
1242459|NCT01840280|Packaging Sizes|packaging sizes
1242460|NCT01840267|pneumoperitoneum|pneumoperitoneum
1242461|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
1242462|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
1242463|NCT01840267|intracranial pressure|intracranial pressure
1242464|NCT01840254|PONV|ponv
1242465|NCT01840254|IV PCA|iv pca
1242466|NCT01840254|dexmedetomidine|dexmedetomidine
1242467|NCT01840254|Female|female
1242468|NCT01840254|non-smoking|non-smoking
1242469|NCT01840254|lumbar spine surgery|lumbar spine surgery
1242470|NCT01840241|sodium bicarbonate|sodium bicarbonate
1242471|NCT01840241|acute kidney injury|acute kidney injury
1242472|NCT01840241|OPCAB|opcab
1242473|NCT01840228|Preterm|preterm
1242474|NCT01840228|Progesterone|progesterone
1242475|NCT01840189|Addison disease|addison disease
1242476|NCT01840189|Type 1 diabetes|type 1 diabetes
1242477|NCT01840189|treatment|treatment
1242478|NCT01840176|McCall culdoplasty|mccall culdoplasty
1242479|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
1242480|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
1242481|NCT01840176|Sexual function|sexual function
1242482|NCT01840124|Fibroids|fibroids
1242483|NCT01840124|Radiofrequency ablation|radiofrequency ablation
1242484|NCT01840111|smoking environment|smoking environment
1242485|NCT01840111|cue-exposure|cue-exposure
1242486|NCT01840111|cigarettes|cigarettes
1242487|NCT01840111|nicotine|nicotine
1242488|NCT01840111|fMRI|fmri
1242489|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
1242490|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
1242491|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
1242492|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
1242493|NCT01840072|Ischemic stroke|ischemic stroke
1242494|NCT01840072|Hypertension|hypertension
1242495|NCT01840072|Antihypertensive Agents|antihypertensive agents
1242496|NCT01840072|Randomized Controlled Trial|randomized controlled trial
1242497|NCT01840059|Cardiac Failure|cardiac failure
1242498|NCT01840059|Autonomic Denervation|autonomic denervation
1242499|NCT01840020|bariatric surgery|bariatric surgery
1242500|NCT01840020|alcohol drinking|alcohol drinking
1242501|NCT01840020|alcoholism|alcoholism
1242502|NCT01840020|ethanol|ethanol
1242503|NCT01840020|metabolism|metabolism
1242504|NCT01839994|prostate cancer,|prostate cancer,
1242505|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
1242506|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
1242507|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
1242508|NCT01839994|randomized trial|randomized trial
1242509|NCT01839942|Hernia, Ventral|hernia, ventral
1242510|NCT01839929|tacrolimus|tacrolimus
1242511|NCT01839929|immunosuppressant|immunosuppressant
1242512|NCT01839929|FK506|fk506
1242513|NCT01839903|Smoking|smoking
1242514|NCT01839903|Tobacco|tobacco
1242515|NCT01839903|Emergency Department|emergency department
1242516|NCT01839890|Paclitaxel|paclitaxel
1242517|NCT01839890|stent|stent
1242518|NCT01839890|Acute infarction|acute infarction
1242519|NCT01839890|Systolic time elevation|systolic time elevation
1242520|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
1242521|NCT01839864|Promotoras|promotoras
1242522|NCT01839864|Hispanic Adults|hispanic adults
1242523|NCT01839864|metabolic syndrome|metabolic syndrome
1242524|NCT01839864|rural|rural
1242525|NCT01839864|patient attitudes|patient attitudes
1242526|NCT01839864|provider cultural competency|provider cultural competency
1242527|NCT01839864|patient activation measure|patient activation measure
1242528|NCT01839851|Hair cortisol|hair cortisol
1242529|NCT01839851|asthma|asthma
1242530|NCT01839851|allergic rhinitis|allergic rhinitis
1242531|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
1242532|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
1242533|NCT01839838|Women|women
1242534|NCT01839838|age 50 and above|age 50 and above
1242535|NCT01839838|with|with
1242536|NCT01839838|that has been|that has been
1242537|NCT01839838|surgically excised|surgically excised
1242538|NCT01839825|elderly|elderly
1242539|NCT01839825|fall|fall
1242540|NCT01839825|acute illness|acute illness
1242541|NCT01839825|care giver|care giver
1242542|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
1242543|NCT01839812|Cortisol|cortisol
1242544|NCT01839812|Dexamethasone|dexamethasone
1242545|NCT01839799|Patients|patients
1242546|NCT01839799|with|with
1242547|NCT01839799|resected|resected
1242548|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
1242549|NCT01839786|Doppler|doppler
1242550|NCT01839786|Valsalva|valsalva
1242551|NCT01839773|Stomach Neoplasms|stomach neoplasms
1242552|NCT01839773|Cancer of Stomach|cancer of stomach
1242553|NCT01839773|Gastric Cancer|gastric cancer
1242554|NCT01839773|Gastric Neoplasms|gastric neoplasms
1242555|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
1242556|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
1242557|NCT01839773|Stomach Cancer|stomach cancer
1242558|NCT01839773|paclitaxel|paclitaxel
1242559|NCT01839773|Taxol|taxol
1242560|NCT01839760|Influenza|influenza
1242561|NCT01839760|Virus|virus
1242562|NCT01839760|Viral shedding|viral shedding
1242563|NCT01839760|Epidemiology|epidemiology
1242564|NCT01839747|Pediatric|pediatric
1242565|NCT01839734|CD4+|cd4+
1242566|NCT01839721|Probiotics|probiotics
1242567|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
1242568|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
1242569|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
1242570|NCT01839721|diet|diet
1242571|NCT01839721|nutrition|nutrition
1242572|NCT01839708|Intervention|intervention
1242573|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
1242574|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
1242575|NCT01839695|TEVAR|tevar
1242576|NCT01839682|StabiliT|stabilit
1242577|NCT01839682|Kyphoplasty|kyphoplasty
1242578|NCT01839682|Vertebral|vertebral
1242579|NCT01839682|Compression|compression
1242580|NCT01839682|Fracture|fracture
1242581|NCT01839682|Osteoporosis|osteoporosis
1242582|NCT01839669|conservative therapy|conservative therapy
1242583|NCT01839669|Foot-Function-Index|foot-function-index
1242584|NCT01839669|functional movement changes|functional movement changes
1242585|NCT01839669|non-surgical treatment|non-surgical treatment
1242586|NCT01839669|pes planovalgus|pes planovalgus
1242587|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
1242588|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
1242589|NCT01839656|SMA|sma
1242590|NCT01839656|SMN|smn
1242591|NCT01839656|SMNRx|smnrx
1242592|NCT01839656|ISIS-SMNRx|isis-smnrx
1242593|NCT01839656|ISIS 396443|isis 396443
1242594|NCT01839656|IONIS-SMNRx|ionis-smnrx
1242595|NCT01839656|Spinraza|spinraza
1242596|NCT01839656|Nusinersen|nusinersen
1242597|NCT01839643|pharmacokinetic|pharmacokinetic
1242598|NCT01839630|Sorafenib|sorafenib
1242599|NCT01839630|Hepatocellular cancer|hepatocellular cancer
1242600|NCT01839630|TACE combination|tace combination
1242601|NCT01839630|Treatment pattern|treatment pattern
1242602|NCT01839630|Safety|safety
1242603|NCT01839630|Effectiveness|effectiveness
1242604|NCT01839617|parenteral nutrition|parenteral nutrition
1242605|NCT01839617|early nutrition|early nutrition
1242606|NCT01839617|abdominal surgery|abdominal surgery
1242607|NCT01839617|cancer|cancer
1242608|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
1242609|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
1242610|NCT01839604|AZD9150,|azd9150,
1242611|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
1242612|NCT01839578|cytokines|cytokines
1242613|NCT01839578|blood purification|blood purification
1242614|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
1242615|NCT01839565|Adverse events|adverse events
1242616|NCT01839565|Osteosynthesis|osteosynthesis
1242617|NCT01839565|Quality of life|quality of life
1242618|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
1242619|NCT01839552|Lazanda|lazanda
1242716|NCT01839110|right ventricular function|right ventricular function
1242620|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
1242621|NCT01839539|colorectal cancer|colorectal cancer
1242622|NCT01839539|DC-CIK|dc-cik
1242623|NCT01839539|CRC|crc
1242624|NCT01839526|Fabry disease|fabry disease
1242625|NCT01839513|Analgesia/nociception index|analgesia/nociception index
1242626|NCT01839513|Desflurane|desflurane
1242627|NCT01839513|Remifentanil|remifentanil
1242628|NCT01839513|Orthopedic surgery|orthopedic surgery
1242629|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
1242630|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
1242631|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
1242632|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
1242633|NCT01839487|PEGPH20|pegph20
1242634|NCT01839487|Gemcitabine|gemcitabine
1242635|NCT01839487|Nab-paclitaxel|nab-paclitaxel
1242636|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
1242637|NCT01839474|Controlled trial|controlled trial
1242638|NCT01839474|Pneumonia|pneumonia
1242639|NCT01839474|Children|children
1242640|NCT01839461|Pharmacogenetics|pharmacogenetics
1242641|NCT01839461|postoperative|postoperative
1242642|NCT01839461|pediatric|pediatric
1242643|NCT01839461|opioid|opioid
1242644|NCT01839461|perioperative|perioperative
1242645|NCT01839461|respiratory depression|respiratory depression
1242646|NCT01839461|chronic pain|chronic pain
1242647|NCT01839448|post partum diabetes|post partum diabetes
1242648|NCT01839448|impaired fasting glucose|impaired fasting glucose
1242649|NCT01839435|appendectomy|appendectomy
1242650|NCT01839435|acute appendicitis|acute appendicitis
1242651|NCT01839435|outpatient|outpatient
1242652|NCT01839409|Circadian Rhythm|circadian rhythm
1242653|NCT01839409|Exercise|exercise
1242654|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
1242655|NCT01839409|Postural Balance|postural balance
1242656|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
1242657|NCT01839370|Pramlintide|pramlintide
1242658|NCT01839370|Closed Loop|closed loop
1242659|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1242660|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
1242661|NCT01839357|Rivaroxaban|rivaroxaban
1242662|NCT01839357|Oral anticoagulant|oral anticoagulant
1242663|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
1242664|NCT01839357|Left atrial thrombus|left atrial thrombus
1242665|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
1242666|NCT01839357|Thrombus resolution|thrombus resolution
1242667|NCT01839357|Stroke|stroke
1242668|NCT01839357|Thromboembolism|thromboembolism
1242669|NCT01839344|hyperglycemia|hyperglycemia
1242670|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1242671|NCT01839344|endothelial dysfunction|endothelial dysfunction
1242672|NCT01839344|quercetin|quercetin
1242673|NCT01839344|Acarbose|acarbose
1242674|NCT01839344|glucose tolerance|glucose tolerance
1242675|NCT01839344|maltose|maltose
1242676|NCT01839331|osteoarthritis|osteoarthritis
1242677|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
1242678|NCT01839318|Soft contact lenses|soft contact lenses
1242679|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
1242680|NCT01839318|Tear Film Break Up Time|tear film break up time
1242681|NCT01839318|Contact lens wettability|contact lens wettability
1242682|NCT01839305|Kinematics|kinematics
1242683|NCT01839305|Fibromyalgia|fibromyalgia
1242684|NCT01839305|Physical Therapy|physical therapy
1242685|NCT01839305|3D Kinematics|3d kinematics
1242686|NCT01839305|Heart Rate Frequency|heart rate frequency
1242687|NCT01839305|Hydrotherapy|hydrotherapy
1599047|NCT00398034|fatigue|fatigue
1242688|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
1242689|NCT01839292|palliative treatment|palliative treatment
1242690|NCT01839292|stent|stent
1242691|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
1242692|NCT01839253|antihypertensive agents|antihypertensive agents
1242693|NCT01839253|hemodynamic|hemodynamic
1242694|NCT01839253|anesthetics reduction|anesthetics reduction
1242695|NCT01839253|orthognathic surgery|orthognathic surgery
1242696|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
1242697|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
1242698|NCT01839227|elderly|elderly
1242699|NCT01839201|anesthesia|anesthesia
1242700|NCT01839201|modification of dreaming|modification of dreaming
1242701|NCT01839201|suggestions|suggestions
1242702|NCT01839162|Transradial approach|transradial approach
1242703|NCT01839162|shield drape|shield drape
1242704|NCT01839162|radiation|radiation
1242705|NCT01839162|PTCA|ptca
1242706|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
1242707|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
1242708|NCT01839149|Oxytocin|oxytocin
1242709|NCT01839149|Intranasal oxytocin|intranasal oxytocin
1242710|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
1242711|NCT01839136|Health Services Accessibility|health services accessibility
1242712|NCT01839136|Ovulation Induction|ovulation induction
1242713|NCT01839136|Embryo Transfer|embryo transfer
1242714|NCT01839123|Amputee|amputee
1242715|NCT01839110|pulmonary hypertension|pulmonary hypertension
1242717|NCT01839110|ranolazine|ranolazine
1242718|NCT01839097|PTCL|ptcl
1242719|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
1242720|NCT01839097|Belinostat|belinostat
1242721|NCT01839084|Xenon|xenon
1242722|NCT01839084|Isoflurane|isoflurane
1242723|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
1242724|NCT01839084|Nephroprotection|nephroprotection
1242725|NCT01839084|Partial nephrectomy|partial nephrectomy
1242726|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
1242727|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
1242728|NCT01839045|Woman|woman
1242729|NCT01839045|Breast Cancer|breast cancer
1242730|NCT01839045|Cancer|cancer
1242731|NCT01839045|Mammogram|mammogram
1242732|NCT01839045|Ultrasound|ultrasound
1242733|NCT01839045|Imaging|imaging
1242734|NCT01839045|Biomarkers|biomarkers
1242735|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
1242736|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
1242737|NCT01839019|Healthy volunteers|healthy volunteers
1242738|NCT01839006|hydronephrosis|hydronephrosis
1242739|NCT01839006|ultrasonography|ultrasonography
1242740|NCT01839006|Kidney Function Test|kidney function test
1242741|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
1242742|NCT01838993|anesthetics,|anesthetics,
1242743|NCT01838993|local,|local,
1242744|NCT01838993|lidocaine;|lidocaine;
1242745|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
1242746|NCT01838993|complications,|complications,
1242747|NCT01838993|intubation,|intubation,
1242748|NCT01838993|intratracheal.|intratracheal.
1242749|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
1242750|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
1242751|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
1242752|NCT01838967|oral administration|oral administration
1242753|NCT01838967|healthy male subjects|healthy male subjects
1242754|NCT01838954|hand osteoarthritis|hand osteoarthritis
1242755|NCT01838954|short-wave diathermy|short-wave diathermy
1242756|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
1242758|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
1242759|NCT01838941|infantile Refsum disease|infantile refsum disease
1242760|NCT01838941|PEX1 mutation|pex1 mutation
1242761|NCT01838941|Betaine|betaine
1242762|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
1242763|NCT01838928|Ultrasound|ultrasound
1242764|NCT01838928|Minimum effective concentration|minimum effective concentration
1242765|NCT01838928|Bupivacaine|bupivacaine
1242766|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
1242767|NCT01838915|HIV|hiv
1242768|NCT01838915|immunoactivation|immunoactivation
1242769|NCT01838915|bacterial translocation|bacterial translocation
1242770|NCT01838915|prebiotics|prebiotics
1242771|NCT01838915|glutamine|glutamine
1242772|NCT01838915|microbiota|microbiota
1242773|NCT01838902|Malaria|malaria
1242774|NCT01838902|Falciparum|falciparum
1242775|NCT01838902|Direct membrane feeding|direct membrane feeding
1242776|NCT01838902|QT-NASBA|qt-nasba
1242777|NCT01838902|Asexual parasite|asexual parasite
1242778|NCT01838902|Asymptomatic carrier|asymptomatic carrier
1242779|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
1242780|NCT01838902|Transmission blocking|transmission blocking
1242781|NCT01838902|Sexual stage|sexual stage
1242782|NCT01838902|Primaquine|primaquine
1242783|NCT01838902|Dihydroartemisinin|dihydroartemisinin
1242784|NCT01838902|Piperaquine|piperaquine
1242785|NCT01838902|Gambia|gambia
1242786|NCT01838902|Africa|africa
1242787|NCT01838889|Culturally adapted|culturally adapted
1242788|NCT01838889|Group psychological intervention|group psychological intervention
1242789|NCT01838889|British South Asian women|british south asian women
1242790|NCT01838889|CBT|cbt
1242791|NCT01838876|Major Depressive Disorder|major depressive disorder
1242792|NCT01838876|MDD|mdd
1242793|NCT01838876|Depression|depression
1242794|NCT01838863|coagulopathy|coagulopathy
1242795|NCT01838863|hemorrhagic shock|hemorrhagic shock
1242796|NCT01838863|plasma|plasma
1242797|NCT01838863|blood product transfusion|blood product transfusion
1242798|NCT01838824|Processing Speed|processing speed
1242799|NCT01838824|Intervention|intervention
1242800|NCT01838824|Multiple Sclerosis|multiple sclerosis
1242801|NCT01838824|Cognition|cognition
1242802|NCT01838811|Processing Speed|processing speed
1242803|NCT01838811|Intervention|intervention
1242804|NCT01838811|Traumatic Brain Injury|traumatic brain injury
1242805|NCT01838811|Cognition|cognition
1242806|NCT01838798|cognitive disorders|cognitive disorders
1242807|NCT01838798|quality of life|quality of life
1242808|NCT01838798|Intensive care|intensive care
1242809|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
1242810|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
1242811|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
1242812|NCT01838759|Hypervolemia|hypervolemia
1242813|NCT01838759|Hypovolemia|hypovolemia
1242814|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
1242815|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
1242816|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
1242817|NCT01838746|Survival|survival
1242818|NCT01838746|Acute coronary syndrome|acute coronary syndrome
1242819|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
1242820|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
1242821|NCT01838746|Younge patient|younge patient
1242822|NCT01838720|renal cell carcinoma|renal cell carcinoma
1242823|NCT01838720|ischemia|ischemia
1242824|NCT01838720|radio frequency ablation|radio frequency ablation
1242825|NCT01838707|postoperative|postoperative
1242826|NCT01838707|spine surgery|spine surgery
1242827|NCT01838655|Albinism|albinism
1242828|NCT01838655|Nitisinone|nitisinone
1242830|NCT01838655|Vision Loss|vision loss
1242831|NCT01838642|Monoclonal Antibody|monoclonal antibody
1242832|NCT01838642|AP24534|ap24534
1242833|NCT01838642|RET Mutation Positive|ret mutation positive
1242834|NCT01838642|RET Mutation Negative|ret mutation negative
1242835|NCT01838642|RET Inhibitor|ret inhibitor
1242836|NCT01838616|Severe chronic low back pain|severe chronic low back pain
1242837|NCT01838616|Neuropathic pain|neuropathic pain
1242838|NCT01838616|Constipation|constipation
1242839|NCT01838590|Liver Diseases|liver diseases
1242840|NCT01838590|Digestive System Diseases|digestive system diseases
1242841|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
1242842|NCT01838590|Virus Diseases|virus diseases
1242843|NCT01838590|Enterovirus Infections|enterovirus infections
1242844|NCT01838590|Picornaviridae Infections|picornaviridae infections
1242845|NCT01838590|RNA Virus Infections|rna virus infections
1242846|NCT01838590|Flaviviridae Infections|flaviviridae infections
1242847|NCT01838590|Antiviral Agents|antiviral agents
1242848|NCT01838590|Anti-Infective Agents|anti-infective agents
1242849|NCT01838590|Therapeutic Uses|therapeutic uses
1242850|NCT01838590|Pharmacologic Actions|pharmacologic actions
1242851|NCT01838590|Antimetabolites|antimetabolites
1242852|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1242853|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
1242854|NCT01838590|HCV|hcv
1242855|NCT01838590|Sustained Virologic Response|sustained virologic response
1242856|NCT01838590|Direct Acting Antiviral|direct acting antiviral
1242857|NCT01838590|Combination Therapy|combination therapy
1242858|NCT01838590|GS-7977|gs-7977
1242859|NCT01838590|Ribavirin|ribavirin
1242860|NCT01838590|Open Label|open label
1242861|NCT01838590|Sofosbuvir|sofosbuvir
1242862|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
1242863|NCT01838590|Hepatitis|hepatitis
1242864|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
1242865|NCT01838590|Hepatitis C|hepatitis c
1242866|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
1242867|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
1242868|NCT01838564|Children|children
1242869|NCT01838564|Quality of Life|quality of life
1242870|NCT01838564|Health Information technology|health information technology
1242871|NCT01838564|Patient reported outcomes|patient reported outcomes
1242872|NCT01838525|sepsis|sepsis
1242873|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
1242874|NCT01838525|diagnosis|diagnosis
1242875|NCT01838525|prognosis|prognosis
1242876|NCT01838525|SIRS|sirs
1242877|NCT01838486|Interstitial cystitis|interstitial cystitis
1242878|NCT01838486|painful bladder syndrome|painful bladder syndrome
1242879|NCT01838486|bladder hydrodistention|bladder hydrodistention
1242880|NCT01838486|hyperthermia|hyperthermia
1242881|NCT01838473|smokeless tobacco|smokeless tobacco
1242882|NCT01838473|Nicotine|nicotine
1242883|NCT01838473|Cadmium|cadmium
1242884|NCT01838473|lead|lead
1242885|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
1242886|NCT01838447|Vitamin D|vitamin d
1242887|NCT01838447|Congenital Heart Disease|congenital heart disease
1242888|NCT01838447|Cardiac Surgery|cardiac surgery
1242889|NCT01838447|Pediatrics|pediatrics
1242890|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
1242891|NCT01838408|screening colonoscopy|screening colonoscopy
1242892|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
1242893|NCT01838408|colonoscopy|colonoscopy
1242894|NCT01838395|AML|aml
1242895|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
1242896|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
1242897|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
1242898|NCT01838382|pain|pain
1242899|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
1242900|NCT01838356|Depression|depression
1242901|NCT01838356|Vascular depression|vascular depression
1242902|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
1242903|NCT01838356|Coronary artery disease|coronary artery disease
1242904|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
1243005|NCT01837862|Glioma|glioma
1242905|NCT01838356|Cognitive impairment|cognitive impairment
1242906|NCT01838330|Kidney Disease|kidney disease
1242907|NCT01838330|Fiber|fiber
1242908|NCT01838330|Dietary Intervention|dietary intervention
1242909|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
1242910|NCT01838291|Ferriprox|ferriprox
1242911|NCT01838291|Deferiprone|deferiprone
1242912|NCT01838291|DFP|dfp
1242913|NCT01838291|L1|l1
1242914|NCT01838278|Vojta therapy|vojta therapy
1242915|NCT01838278|Exercise Movement Technique|exercise movement technique
1242916|NCT01838278|Early intervention|early intervention
1242917|NCT01838252|Ectropion|ectropion
1242918|NCT01838252|Hyaluronic Acid|hyaluronic acid
1242919|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1242920|NCT01838252|Lower eyelid retraction|lower eyelid retraction
1242921|NCT01838239|Fish oil|fish oil
1242922|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
1242923|NCT01838226|Chronic Disease|chronic disease
1242924|NCT01838226|Prevention|prevention
1242925|NCT01838226|cardiovascular disease|cardiovascular disease
1242926|NCT01838213|Urinary tract infection|urinary tract infection
1242927|NCT01838213|ESBL|esbl
1242928|NCT01838213|treatment|treatment
1242929|NCT01838213|carriage|carriage
1242930|NCT01838213|risk factors|risk factors
1242931|NCT01838213|water contamination|water contamination
1242932|NCT01838200|BCG|bcg
1242933|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
1242934|NCT01838200|Ipilimumab|ipilimumab
1242935|NCT01838200|YERVOY|yervoy
1242936|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
1242937|NCT01838200|Metastatic Melanoma|metastatic melanoma
1242938|NCT01838174|Optic Neuritis|optic neuritis
1242939|NCT01838161|adolescents|adolescents
1242940|NCT01838161|immunizations|immunizations
1242941|NCT01838148|coronary artery disease|coronary artery disease
1242942|NCT01838148|angina, stable|angina, stable
1242943|NCT01838148|exercise test|exercise test
1242944|NCT01838148|biological Markers|biological markers
1242945|NCT01838148|SPECT|spect
1242946|NCT01838135|wheelchair|wheelchair
1242947|NCT01838135|manual wheelchair|manual wheelchair
1242948|NCT01838135|rehabilitation|rehabilitation
1242949|NCT01838135|self-efficacy|self-efficacy
1242950|NCT01838135|older adults|older adults
1242951|NCT01838135|feasibility|feasibility
1242952|NCT01838135|intervention|intervention
1242953|NCT01838135|training|training
1242954|NCT01838122|PCOS|pcos
1242955|NCT01838122|HbA1C|hba1c
1242956|NCT01838122|Insulin resistance|insulin resistance
1242957|NCT01838122|OGTT|ogtt
1242958|NCT01838122|HOMA-IR|homa-ir
1242959|NCT01838122|HOMA-B-cell|homa-b-cell
1242960|NCT01838070|Hepatitis A|hepatitis a
1242961|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
1242962|NCT01838070|AVAXIM 160U|avaxim 160u
1242963|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
1242964|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
1242965|NCT01838031|thyroid function|thyroid function
1242966|NCT01838031|thyroid antibody|thyroid antibody
1242967|NCT01838031|pregnancy outcome|pregnancy outcome
1242968|NCT01838031|childhood cognitive function|childhood cognitive function
1242969|NCT01838018|PKAN|pkan
1242970|NCT01838018|brain iron|brain iron
1242971|NCT01838018|NBIA|nbia
1242972|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
1242973|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
1242974|NCT01838005|Contingency management|contingency management
1242975|NCT01838005|conditional cash transfer|conditional cash transfer
1242976|NCT01838005|PMTCT|pmtct
1242977|NCT01838005|Retention|retention
1242978|NCT01838005|HIV|hiv
1333167|NCT01444222|Myocardial contractility|myocardial contractility
1242979|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
1242980|NCT01837979|dried blood spots|dried blood spots
1242981|NCT01837979|cell-free fetal DNA|cell-free fetal dna
1242982|NCT01837979|detection rate|detection rate
1242983|NCT01837979|cost-effectiveness|cost-effectiveness
1242984|NCT01837966|re-operative anxiety|re-operative anxiety
1242985|NCT01837966|breast surgery|breast surgery
1242986|NCT01837966|lavender oil|lavender oil
1242987|NCT01837966|aromatherapy|aromatherapy
1243110|NCT01837407|nerve flap|nerve flap
1242988|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
1242989|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
1242990|NCT01837888|wheelchair|wheelchair
1242991|NCT01837888|manual wheelchair|manual wheelchair
1242992|NCT01837888|rehabilitation|rehabilitation
1242993|NCT01837888|self-efficacy|self-efficacy
1242994|NCT01837888|older adults|older adults
1242995|NCT01837888|feasibility|feasibility
1242996|NCT01837888|intervention|intervention
1242997|NCT01837888|training|training
1242998|NCT01837888|Wheelchair mobility|wheelchair mobility
1242999|NCT01837875|Intervention|intervention
1243000|NCT01837875|Quality of life|quality of life
1243001|NCT01837875|African American|african american
1243002|NCT01837875|Stress|stress
1243003|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
1243004|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
1243006|NCT01837862|Optic Nerve Glioma|optic nerve glioma
1243007|NCT01837862|mebendazole|mebendazole
1243008|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
1243009|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
1243010|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
1243011|NCT01837862|gliosarcoma|gliosarcoma
1243012|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1243013|NCT01837862|DIPG|dipg
1243014|NCT01837862|low-grade glioma|low-grade glioma
1243015|NCT01837862|high-grade glioma|high-grade glioma
1243016|NCT01837862|brainstem glioma|brainstem glioma
1243017|NCT01837862|pediatric|pediatric
1243018|NCT01837849|heart failure|heart failure
1243019|NCT01837849|rhBNP|rhbnp
1243020|NCT01837849|Dobutamine|dobutamine
1243021|NCT01837836|Health education|health education
1243022|NCT01837836|water handling practices|water handling practices
1243023|NCT01837836|Bacteriological quality of water|bacteriological quality of water
1243024|NCT01837823|Coronary artery disease|coronary artery disease
1243025|NCT01837823|Lipid|lipid
1243026|NCT01837823|Regression|regression
1243027|NCT01837823|Plaque|plaque
1243028|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
1243029|NCT01837810|post operative hemorrhage|post operative hemorrhage
1243030|NCT01837810|complications|complications
1243031|NCT01837810|tonsillectomy|tonsillectomy
1243032|NCT01837758|Platelet function|platelet function
1243033|NCT01837758|hemofiltration|hemofiltration
1243034|NCT01837758|Multiplate|multiplate
1243035|NCT01837732|Chronic pain|chronic pain
1243036|NCT01837732|elderly|elderly
1243037|NCT01837732|relational touch|relational touch
1243038|NCT01837706|Empathy|empathy
1243039|NCT01837706|Communication|communication
1243040|NCT01837706|Physician litigation|physician litigation
1243041|NCT01837693|cervical cancer screening|cervical cancer screening
1243043|NCT01837693|cervical cancer|cervical cancer
1243044|NCT01837693|biomarkers|biomarkers
1243045|NCT01837693|sensitivity and specificity|sensitivity and specificity
1243046|NCT01837680|Insulin, Long-Acting|insulin, long-acting
1243047|NCT01837654|Detrusor Overactivity|detrusor overactivity
1243048|NCT01837654|Plantarflexion|plantarflexion
1243049|NCT01837654|Urgency|urgency
1243050|NCT01837628|Urodynamic|urodynamic
1243051|NCT01837628|Paraffin oil|paraffin oil
1243052|NCT01837628|Lidocaine gel|lidocaine gel
1243053|NCT01837628|Pain|pain
1243054|NCT01837615|Ulcerative Colitis|ulcerative colitis
1243055|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
1243056|NCT01837615|Low Level Light Therapy|low level light therapy
1243057|NCT01837615|Safety|safety
1243058|NCT01837615|Efficacy|efficacy
1243059|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
1243060|NCT01837602|newly diagnosed|newly diagnosed
1243061|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
1243062|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
1243063|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
1243064|NCT01837576|Calcipotriol|calcipotriol
1243065|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
1243066|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
1243067|NCT01837550|hearing loss|hearing loss
1243068|NCT01837550|patient education|patient education
1243069|NCT01837550|patient participation|patient participation
1243070|NCT01837550|structured rehabilitation|structured rehabilitation
1243071|NCT01837550|counseling|counseling
1243072|NCT01837550|Internet|internet
1243073|NCT01837524|Dietary advice|dietary advice
1243074|NCT01837524|Nutritional knowledge|nutritional knowledge
1243075|NCT01837524|Self-efficacy|self-efficacy
1243076|NCT01837524|Nutrition|nutrition
1243077|NCT01837511|Tumor antigens|tumor antigens
1243078|NCT01837511|Asiatic patients|asiatic patients
1243079|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
1243080|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1243081|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
1243082|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
1243083|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
1243084|NCT01837485|Gut flora|gut flora
1243085|NCT01837485|Probiotics|probiotics
1243086|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
1243087|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
1243088|NCT01837472|Gut flora|gut flora
1243089|NCT01837472|Probiotics|probiotics
1243090|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
1243091|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
1243092|NCT01837459|Vascular function|vascular function
1243093|NCT01837459|Arterial stiffness|arterial stiffness
1243094|NCT01837459|Polysomnography|polysomnography
1243095|NCT01837459|Cytokines|cytokines
1243096|NCT01837446|mucositis|mucositis
1243097|NCT01837446|topical morphine|topical morphine
1243098|NCT01837446|pain|pain
1243099|NCT01837446|head and neck carcinoma|head and neck carcinoma
1243100|NCT01837433|Efficacy|efficacy
1243101|NCT01837433|safety|safety
1243102|NCT01837433|short|short
1243103|NCT01837433|term|term
1243104|NCT01837433|subacute thyroiditis|subacute thyroiditis
1243105|NCT01837407|Soft tissue loss|soft tissue loss
1243106|NCT01837407|nerve defect|nerve defect
1243213|NCT01837004|aging|aging
1243107|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
1243108|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
1243109|NCT01837407|Composite Flap|composite flap
1243111|NCT01837407|nerve transfer|nerve transfer
1243112|NCT01837394|Nerve block|nerve block
1243113|NCT01837394|Ultrasound|ultrasound
1243114|NCT01837394|postoperative pain|postoperative pain
1243115|NCT01837394|Saphenous nerve|saphenous nerve
1243116|NCT01837394|Obturator nerve|obturator nerve
1243117|NCT01837329|Non-Squamous|non-squamous
1243118|NCT01837329|NSCLC|nsclc
1243119|NCT01837329|Adenocarcinoma|adenocarcinoma
1243120|NCT01837329|Lung Cancer|lung cancer
1243121|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
1243122|NCT01837329|Copper|copper
1243123|NCT01837329|Carboplatin|carboplatin
1243124|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
1243125|NCT01837329|Newly Diagnosed|newly diagnosed
1243126|NCT01837329|Chemo-naive|chemo-naive
1243127|NCT01837316|pharmacodynamics|pharmacodynamics
1243128|NCT01837316|FF/VI|ff/vi
1243129|NCT01837316|asthma|asthma
1243130|NCT01837316|duration of action|duration of action
1243131|NCT01837303|Cervical dysplasia|cervical dysplasia
1243132|NCT01837303|Cervical cancer|cervical cancer
1243133|NCT01837290|Renal failure,|renal failure,
1243134|NCT01837290|hip fracture,|hip fracture,
1243135|NCT01837290|spinal anesthesia,|spinal anesthesia,
1243136|NCT01837290|dexmedetomidine|dexmedetomidine
1243137|NCT01837290|patient|patient
1243138|NCT01837264|Magellan MAR01|magellan mar01
1243139|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
1243140|NCT01837264|Compartment Syndrome|compartment syndrome
1243141|NCT01837264|Battlefield Trauma|battlefield trauma
1243142|NCT01837264|Fasciotomy|fasciotomy
1243143|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
1243144|NCT01837251|Bevacizumab|bevacizumab
1243145|NCT01837251|Gemcitabine|gemcitabine
1243147|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1243148|NCT01837251|Carboplatin|carboplatin
1243149|NCT01837251|best therapeutic index|best therapeutic index
1243150|NCT01837251|progression-free survival|progression-free survival
1243151|NCT01837238|hemodialysis|hemodialysis
1243152|NCT01837238|physical function|physical function
1243153|NCT01837225|Fluorescence Imaging|fluorescence imaging
1243154|NCT01837225|Breast Tumor Margins|breast tumor margins
1243155|NCT01837225|Real-time Assessment|real-time assessment
1243156|NCT01837199|Periodontal disease|periodontal disease
1243157|NCT01837199|Scaling and root planing|scaling and root planing
1243158|NCT01837199|Metronidazole|metronidazole
1243159|NCT01837199|Amoxicillin|amoxicillin
1243160|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
1243161|NCT01837199|Periodontal treatment|periodontal treatment
1243162|NCT01837186|Surgery|surgery
1243163|NCT01837186|NSCLC|nsclc
1243164|NCT01837173|Adenocarcinoma|adenocarcinoma
1243165|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
1243166|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
1243167|NCT01837173|Esophagectomy|esophagectomy
1243168|NCT01837160|Angiogenesis|angiogenesis
1243169|NCT01837160|Fibrosis|fibrosis
1243170|NCT01837160|Aortic Stenosis|aortic stenosis
1243171|NCT01837160|Imaging|imaging
1243172|NCT01837160|CT-PET|ct-pet
1243173|NCT01837160|PET-CT|pet-ct
1243174|NCT01837160|Cardiac MRI|cardiac mri
1243175|NCT01837147|primary prevention|primary prevention
1243176|NCT01837147|sedentary|sedentary
1243177|NCT01837147|overweight|overweight
1243178|NCT01837147|obesity|obesity
1243179|NCT01837147|breast cancer|breast cancer
1243180|NCT01837147|post-menopausal|post-menopausal
1243181|NCT01837147|women|women
1243182|NCT01837134|telemedicine|telemedicine
1243183|NCT01837134|overweight|overweight
1243184|NCT01837134|obesity|obesity
1243185|NCT01837121|not-attended rate|not-attended rate
1243186|NCT01837121|re-visit|re-visit
1243187|NCT01837121|vision|vision
1243188|NCT01837121|knowledge|knowledge
1243189|NCT01837121|satisfaction|satisfaction
1243190|NCT01837108|healthy|healthy
1243191|NCT01837095|Overall survival|overall survival
1243192|NCT01837095|Progression free survival|progression free survival
1243193|NCT01837082|Heart Failure|heart failure
1243194|NCT01837082|Iron Deficiency|iron deficiency
1243195|NCT01837082|Anemia|anemia
1243196|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
1243197|NCT01837069|Hypertension|hypertension
1243198|NCT01837069|Diabetes|diabetes
1243199|NCT01837069|Coronary Artery Disease|coronary artery disease
1243200|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
1243201|NCT01837056|Toxoplasma gondii|toxoplasma gondii
1243202|NCT01837056|Toxocara canis|toxocara canis
1243203|NCT01837043|Delayed Graft Function|delayed graft function
1243204|NCT01837043|Renal Transplantation|renal transplantation
1243205|NCT01837043|Kidney Transplant|kidney transplant
1243206|NCT01837017|Falls,|falls,
1243207|NCT01837017|Balance,|balance,
1243208|NCT01837017|Gait,|gait,
1243209|NCT01837017|Older adults|older adults
1243210|NCT01837004|adherence|adherence
1243211|NCT01837004|cognition|cognition
1243212|NCT01837004|exercise|exercise
1243214|NCT01836991|gastric cancer|gastric cancer
1243215|NCT01836991|surgery|surgery
1243216|NCT01836991|surgery safety|surgery safety
1243217|NCT01836991|effect|effect
1243218|NCT01836965|Aspergers|aspergers
1243219|NCT01836965|Social Skills|social skills
1243220|NCT01836965|Adolescents|adolescents
1243221|NCT01836965|High-functioning Autism|high-functioning autism
1243222|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
1243224|NCT01836939|Trichuris suis ova|trichuris suis ova
1243225|NCT01836939|TSO|tso
1243226|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
1243227|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
1243228|NCT01836926|intersphincteric resection|intersphincteric resection
1243229|NCT01836926|rectal cancer|rectal cancer
1243230|NCT01836926|low rectal cancer|low rectal cancer
1243231|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
1243232|NCT01836926|Abdominoperineal resection|abdominoperineal resection
1243233|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
1243234|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
1243235|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
1243236|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
1243237|NCT01836913|PET/CT|pet/ct
1243238|NCT01836913|Esophageal cancer|esophageal cancer
1243239|NCT01836913|Radiotherapy|radiotherapy
1243241|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
1243242|NCT01836887|Polyphenol|polyphenol
1243243|NCT01836887|Fruit|fruit
1243244|NCT01836887|Metabolic|metabolic
1243245|NCT01836887|Healthy|healthy
1243246|NCT01836874|Migraine|migraine
1243247|NCT01836874|Indian|indian
1243248|NCT01836874|Topiramate|topiramate
1243249|NCT01836861|Phase I|phase i
1243250|NCT01836861|healthy male volunteers|healthy male volunteers
1243251|NCT01836861|ADME|adme
1243252|NCT01836861|Bioavailability|bioavailability
1243253|NCT01836861|PI3K inhibitor|pi3k inhibitor
1243254|NCT01836861|Absorption|absorption
1243255|NCT01836861|Distribution|distribution
1243256|NCT01836861|Metabolism|metabolism
1243257|NCT01836861|Excretion|excretion
1243258|NCT01836861|safety|safety
1243259|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
1243260|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
1243261|NCT01836848|indocyanine green|indocyanine green
1243262|NCT01836848|secondary ischemia|secondary ischemia
1243263|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
1243264|NCT01836835|Pregnancy|pregnancy
1243265|NCT01836835|Nausea|nausea
1243266|NCT01836835|Nutritional status|nutritional status
1243267|NCT01836835|Questionnaire|questionnaire
1243268|NCT01836835|Case-control|case-control
1243269|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
1243270|NCT01836822|sarcoidosis|sarcoidosis
1243271|NCT01836822|bronchoscopy|bronchoscopy
1243272|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
1243273|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
1333262|NCT01443780|All-cause mortality|all-cause mortality
1243274|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
1243275|NCT01836809|Total Artificial Heart|total artificial heart
1243276|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
1243277|NCT01836809|Natriuretic peptides|natriuretic peptides
1243278|NCT01836809|Heart Failure|heart failure
1243279|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
1243280|NCT01836783|Allograft|allograft
1243281|NCT01836783|Amnion Allograft|amnion allograft
1243282|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
1243283|NCT01836757|osteoarthritis|osteoarthritis
1243284|NCT01836757|CAM treatments|cam treatments
1243286|NCT01836731|weight-for age|weight-for age
1243287|NCT01836731|height-for-age|height-for-age
1243288|NCT01836731|water sanitation facilities|water sanitation facilities
1243289|NCT01836731|hygiene behavior|hygiene behavior
1243290|NCT01836718|Hepatitis C Virus|hepatitis c virus
1243291|NCT01836718|Liver Transplantation|liver transplantation
1243292|NCT01836718|Antiviral Therapy|antiviral therapy
1243293|NCT01836718|HCV|hcv
1243294|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
1243295|NCT01836653|Bevacizumab|bevacizumab
1243296|NCT01836653|Cetuximab|cetuximab
1243297|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
1243298|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
1243299|NCT01836653|liver metastasis|liver metastasis
1243300|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
1243301|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
1243302|NCT01836627|Hyperinsufflation|hyperinsufflation
1243303|NCT01836627|Cough Assist|cough assist
1243304|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
1243305|NCT01836601|safety|safety
1243306|NCT01836601|patient experience|patient experience
1243307|NCT01836601|family-centered rounds|family-centered rounds
1243308|NCT01836575|Advanced NSCLC|advanced nsclc
1243309|NCT01836575|PS2|ps2
1243310|NCT01836575|Pemetrexed|pemetrexed
1243311|NCT01836575|First line|first line
1243312|NCT01836575|non squamous|non squamous
1243313|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
1243314|NCT01836536|High grade glioma|high grade glioma
1243315|NCT01836536|Bevacizumab|bevacizumab
1243316|NCT01836536|Chemotherapy|chemotherapy
1243317|NCT01836536|Myeloid Cells|myeloid cells
1243318|NCT01836536|Treg|treg
1243319|NCT01836510|Heart Failure|heart failure
1243320|NCT01836510|Remote Monitoring|remote monitoring
1243321|NCT01836510|Lung Edema|lung edema
1243322|NCT01836510|Patient Monitoring|patient monitoring
1243323|NCT01836510|Prediction|prediction
1243324|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
1243325|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
1243326|NCT01836458|Malaria, KAE609|malaria, kae609
1243327|NCT01836432|Pancreatic Cancer|pancreatic cancer
1243328|NCT01836432|Immunotherapy|immunotherapy
1243329|NCT01836432|Vaccine Therapy|vaccine therapy
1243330|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
1243331|NCT01836419|elderly patients|elderly patients
1243332|NCT01836406|ketorolac|ketorolac
1243333|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
1243334|NCT01836406|partial nephrectomy|partial nephrectomy
1243335|NCT01836393|Plai|plai
1243336|NCT01836393|Efficacy|efficacy
1243337|NCT01836393|OA knee|oa knee
1243338|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
1243339|NCT01836367|Actinic Keratosis|actinic keratosis
1243340|NCT01836367|Face|face
1243341|NCT01836367|Scalp|scalp
1243342|NCT01836367|Ingenol Mebutate|ingenol mebutate
1243343|NCT01836354|stroke|stroke
1243344|NCT01836354|interactive educational intervention|interactive educational intervention
1243345|NCT01836354|acute ischemic stroke|acute ischemic stroke
1243346|NCT01836354|transient ischemic attack|transient ischemic attack
1243347|NCT01836341|Afatinib|afatinib
1243348|NCT01836341|Cisplatin|cisplatin
1243349|NCT01836341|Carboplatin|carboplatin
1243350|NCT01836341|Pemetrexed|pemetrexed
1243351|NCT01836341|Radiation therapy|radiation therapy
1243352|NCT01836341|EGFR mutation|egfr mutation
1243353|NCT01836341|12-279|12-279
1243354|NCT01836328|Methadone|methadone
1243355|NCT01836328|Pain|pain
1243356|NCT01836328|Neoplasms|neoplasms
1243357|NCT01836328|Ratio|ratio
1243358|NCT01836237|Surgical site infection rate|surgical site infection rate
1243359|NCT01836237|Wound protector use|wound protector use
1243360|NCT01836237|Whipple|whipple
1243361|NCT01836211|Chest pain|chest pain
1243362|NCT01836211|Acute coronary syndrome|acute coronary syndrome
1243363|NCT01836211|Cardiac biomarkers|cardiac biomarkers
1243364|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
1243365|NCT01836211|Emergency department|emergency department
1243366|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
1243367|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
1243368|NCT01836159|iPad|ipad
1243369|NCT01836159|Fine Motor Function|fine motor function
1243370|NCT01836159|Ischemic Stroke|ischemic stroke
1243371|NCT01836159|Visual Neglect|visual neglect
1243372|NCT01836120|second-line chemotherapy|second-line chemotherapy
1243373|NCT01836120|Raltitrexed|raltitrexed
1243374|NCT01836107|Clinical notes|clinical notes
1243375|NCT01836107|Communication between physicians|communication between physicians
1243376|NCT01836107|Quality|quality
1243377|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
1243378|NCT01836094|Methylene Blue|methylene blue
1243379|NCT01836094|Memory|memory
1243380|NCT01836094|Mental Fatigue|mental fatigue
1243381|NCT01836094|Brain metabolism|brain metabolism
1243382|NCT01836094|fMRI|fmri
1243383|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
1243384|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
1243386|NCT01836094|DMS|dms
1243387|NCT01836081|fluid responsiveness|fluid responsiveness
1243388|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
1243389|NCT01836081|coronary disease|coronary disease
1243390|NCT01836068|HIV positive|hiv positive
1243391|NCT01836068|HIV-1|hiv-1
1243392|NCT01836068|Bone Marrow Transplant|bone marrow transplant
1243393|NCT01836068|Allogeneic BMT|allogeneic bmt
1243394|NCT01836068|BMT|bmt
1243395|NCT01836055|Multiple Sclerosis|multiple sclerosis
1243396|NCT01836055|White Matter Lesions|white matter lesions
1243397|NCT01836055|Contrast Agent|contrast agent
1243398|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
1243399|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
1243400|NCT01836042|Trabecular meshwork|trabecular meshwork
1243401|NCT01836042|iStent|istent
1243402|NCT01836029|SCCHN|scchn
1243403|NCT01836029|HNSCC|hnscc
1243404|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1243405|NCT01836016|Comparative effectiveness research|comparative effectiveness research
1243406|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
1243407|NCT01836016|Humans|humans
1243408|NCT01836016|Treatment Outcome|treatment outcome
1243409|NCT01836003|Pregnancy|pregnancy
1243507|NCT01835587|allogeneic,|allogeneic,
1243410|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
1243411|NCT01836003|Short Message Service (SMS)|short message service (sms)
1243412|NCT01836003|HIV infection|hiv infection
1243413|NCT01836003|CD4 testing|cd4 testing
1243414|NCT01836003|Antiretroviral therapy|antiretroviral therapy
1243415|NCT01835990|venous thromboembolism|venous thromboembolism
1243416|NCT01835990|trauma|trauma
1243417|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
1243418|NCT01835977|Focal therapy|focal therapy
1243419|NCT01835977|Irreversible electroporation|irreversible electroporation
1243420|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
1243421|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
1243422|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1243423|NCT01835951|Simulation|simulation
1243424|NCT01835951|Debriefing|debriefing
1243425|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
1243426|NCT01835951|Cardiac Arrest|cardiac arrest
1243427|NCT01835951|Pregnancy|pregnancy
1243428|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
1243429|NCT01835938|entry inhibitor|entry inhibitor
1243430|NCT01835938|kinase inhibitor|kinase inhibitor
1243431|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
1243432|NCT01835925|rectal cancer|rectal cancer
1243433|NCT01835925|stage II|stage ii
1243434|NCT01835925|stage III|stage iii
1243435|NCT01835912|performance|performance
1243436|NCT01835912|speed|speed
1243437|NCT01835912|exertion|exertion
1243438|NCT01835860|BPH|bph
1243439|NCT01835834|zirconia crown|zirconia crown
1243440|NCT01835821|zirconia|zirconia
1243441|NCT01835821|crown|crown
1243442|NCT01835821|IPS e.max CAD|ips e.max cad
1243443|NCT01835808|Fractional flow reserve|fractional flow reserve
1243444|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
1243445|NCT01835795|Myofascial Trigger Point|myofascial trigger point
1243446|NCT01835795|Low Back Pain|low back pain
1243447|NCT01835795|Lumbago|lumbago
1243448|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
1243449|NCT01835795|High-Energy Shock Waves|high-energy shock waves
1243450|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
1243451|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
1243452|NCT01835782|ALS|als
1243453|NCT01835782|L-Serine|l-serine
1243454|NCT01835782|BMAA|bmaa
1243455|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
1243456|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
1243457|NCT01835717|Cognitive normal|cognitive normal
1243458|NCT01835717|Exogenous factors|exogenous factors
1243459|NCT01835717|Endogenous factors|endogenous factors
1243460|NCT01835717|Episodic memory test|episodic memory test
1243461|NCT01835717|Executive function test|executive function test
1243462|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
1333263|NCT01443780|cardiac function|cardiac function
1243463|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
1243464|NCT01835691|Chronic Kidney Disease|chronic kidney disease
1243465|NCT01835691|Vitamin D|vitamin d
1243466|NCT01835691|Vitamin D2|vitamin d2
1243467|NCT01835691|Vitamin D3|vitamin d3
1243468|NCT01835652|Exercise|exercise
1243469|NCT01835652|Parkinson's Disease|parkinson's disease
1243470|NCT01835652|Positron Emission Tomography|positron emission tomography
1243471|NCT01835652|fMRI|fmri
1243472|NCT01835639|Glomerular Disease|glomerular disease
1243473|NCT01835639|Vitamin D|vitamin d
1243474|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
1243475|NCT01835639|Minimal change disease|minimal change disease
1243476|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
1243477|NCT01835639|Membranous Nephropathy|membranous nephropathy
1243478|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
1243479|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
1243480|NCT01835639|FSGS|fsgs
1243481|NCT01835639|IgA Nephropathy|iga nephropathy
1243482|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
1243483|NCT01835626|Skin cancer|skin cancer
1243484|NCT01835626|Radiation therapy|radiation therapy
1243485|NCT01835626|Vismodegib|vismodegib
1243486|NCT01835626|Head and neck cancer|head and neck cancer
1243487|NCT01835626|Cutaneous malignancy|cutaneous malignancy
1243488|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
1243489|NCT01835613|Early RA|early ra
1243490|NCT01835613|RA|ra
1243491|NCT01835613|IL-6|il-6
1243492|NCT01835613|IL-6R|il-6r
1243493|NCT01835613|Inhibitor|inhibitor
1243494|NCT01835613|Inhibition|inhibition
1243495|NCT01835613|Tocilizumab|tocilizumab
1243496|NCT01835613|Biomarkers|biomarkers
1243497|NCT01835613|DMARDs|dmards
1243498|NCT01835613|Biological|biological
1243499|NCT01835613|DAS|das
1243500|NCT01835613|SDAI|sdai
1243501|NCT01835613|AR/BIOM|ar/biom
1243502|NCT01835613|OEG|oeg
1243503|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
1243504|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
1243505|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
1243506|NCT01835587|transplantation,|transplantation,
1243508|NCT01835587|HSCT.|hsct.
1243509|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
1243510|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
1243511|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
1243512|NCT01835496|sickle cell disease|sickle cell disease
1243513|NCT01835496|iron overload|iron overload
1243514|NCT01835496|pharmacokinetics|pharmacokinetics
1243515|NCT01835496|Ferriprox|ferriprox
1243516|NCT01835496|deferiprone|deferiprone
1243517|NCT01835457|Endotoxemia|endotoxemia
1243518|NCT01835457|Autonomic Nervous System|autonomic nervous system
1243519|NCT01835457|Inflammation|inflammation
1243520|NCT01835457|Meditation|meditation
1243521|NCT01835457|Concentration|concentration
1243522|NCT01835457|Iceman|iceman
1243523|NCT01835457|LPS|lps
1243524|NCT01835457|Cortisol|cortisol
1243525|NCT01835457|Catecholamines|catecholamines
1243526|NCT01835444|Physician Assistant|physician assistant
1243527|NCT01835444|Substitution|substitution
1243528|NCT01835444|Hospital ward care|hospital ward care
1243529|NCT01835444|Secondary health care|secondary health care
1243530|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
1243531|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
1243532|NCT01835392|Heart defects, congenital|heart defects, congenital
1243533|NCT01835392|cardiac surgery|cardiac surgery
1243534|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
1243535|NCT01835379|Diabetes|diabetes
1243536|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
1243537|NCT01835379|Diabetic Foot Wound|diabetic foot wound
1243538|NCT01835379|Non-healing foot wound|non-healing foot wound
1243539|NCT01835379|Oasis|oasis
1243540|NCT01835379|Diabetic neuropathy|diabetic neuropathy
1243541|NCT01835353|prasugrel|prasugrel
1243542|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
1243543|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
1243544|NCT01835327|thoracic surgery|thoracic surgery
1243545|NCT01835327|cerebral oximetry|cerebral oximetry
1243546|NCT01835262|pain|pain
1243547|NCT01835262|Ketamine|ketamine
1243548|NCT01835262|Emergency Medicine|emergency medicine
1243549|NCT01835262|morphine|morphine
1243550|NCT01835249|Hypertension|hypertension
1243551|NCT01835249|Nighttime blood pressure|nighttime blood pressure
1243552|NCT01835236|Breast cancer|breast cancer
1243553|NCT01835236|HER2-positive|her2-positive
1243554|NCT01835236|Metastases|metastases
1243555|NCT01835197|Phase 1|phase 1
1243556|NCT01835197|Randomized|randomized
1243557|NCT01835197|Double Blind|double blind
1243558|NCT01835197|Placebo-Controlled|placebo-controlled
1243559|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
1243560|NCT01835197|Safety|safety
1243561|NCT01835197|Tolerability|tolerability
1243563|NCT01835197|PD|pd
1243564|NCT01835197|Pf-04965842|pf-04965842
1243565|NCT01835132|Scleritis|scleritis
1243566|NCT01835132|IL-1|il-1
1243567|NCT01835119|gynecological malignancies|gynecological malignancies
1243568|NCT01835119|postoperative|postoperative
1243569|NCT01835119|bowel activity|bowel activity
1243570|NCT01835119|gum chewing|gum chewing
1243571|NCT01835106|Postoperative Care|postoperative care
1243572|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
1243573|NCT01835067|Macular degeneration|macular degeneration
1243574|NCT01835067|Submacular haemorrhage|submacular haemorrhage
1243575|NCT01835054|Mitral regurgitation|mitral regurgitation
1243576|NCT01835054|Mitral valve prolapse|mitral valve prolapse
1243577|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
1243578|NCT01835054|Stress echocardiography|stress echocardiography
1243579|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
1243580|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
1243581|NCT01835054|Cardiac neurohormones|cardiac neurohormones
1243582|NCT01835054|Visceral obesity|visceral obesity
1243583|NCT01835054|Cardiometabolic risk|cardiometabolic risk
1243584|NCT01835054|Risk stratification|risk stratification
1243585|NCT01835028|Aortic Stenosis|aortic stenosis
1243586|NCT01835028|Low Flow|low flow
1243587|NCT01835028|Low Gradient|low gradient
1243588|NCT01835028|Left Ventricle|left ventricle
1243589|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
1243590|NCT01835015|First in human|first in human
1243591|NCT01835015|Safety|safety
1243592|NCT01835015|Tolerability|tolerability
1243593|NCT01835015|Serum PK|serum pk
1243594|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
1243595|NCT01835015|Age-related macular degeneration|age-related macular degeneration
1243596|NCT01835015|AMD|amd
1243597|NCT01835015|Geographic Atrophy|geographic atrophy
1243598|NCT01835015|Choroidal neovascularization|choroidal neovascularization
1243697|NCT01834456|Utilization|utilization
1243599|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
1243600|NCT01834976|cardiac biomarker|cardiac biomarker
1243601|NCT01834976|congenital heart disease|congenital heart disease
1243602|NCT01834976|surgery|surgery
1243603|NCT01834937|ExAblate|exablate
1243604|NCT01834937|MRgFUS|mrgfus
1243605|NCT01834937|Bone Metastases|bone metastases
1243606|NCT01834937|Pain Palliation|pain palliation
1243607|NCT01834924|Health literacy|health literacy
1243608|NCT01834924|Patient education|patient education
1243609|NCT01834911|Huntington disease|huntington disease
1243611|NCT01834911|tetrabenazine|tetrabenazine
1243612|NCT01834911|Stroop|stroop
1243613|NCT01834898|postoperative|postoperative
1243614|NCT01834898|analgesia|analgesia
1243615|NCT01834898|adverse effects|adverse effects
1243616|NCT01834898|opioid|opioid
1243617|NCT01834898|oxycodone|oxycodone
1243618|NCT01834885|COPD|copd
1243619|NCT01834859|weight reduction programs|weight reduction programs
1243620|NCT01834859|diet|diet
1243621|NCT01834859|Caloric restriction|caloric restriction
1243622|NCT01834859|weight loss|weight loss
1243623|NCT01834859|weight gain|weight gain
1243624|NCT01834846|comparative study|comparative study
1243625|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
1243626|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
1243627|NCT01834820|Bronchiolitis|bronchiolitis
1243628|NCT01834820|Epinephrine|epinephrine
1243629|NCT01834820|Dexamethasone|dexamethasone
1243630|NCT01834820|Hospitalization|hospitalization
1243631|NCT01834820|Hypertonic Saline|hypertonic saline
1243632|NCT01834794|Tobacco Use|tobacco use
1243633|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
1243634|NCT01834742|Moviprep|moviprep
1243635|NCT01834742|PEG3350|peg3350
1243636|NCT01834742|Laxative|laxative
1243637|NCT01834742|Stool Output|stool output
1243638|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
1243639|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
1243640|NCT01834690|Health status/drug effects|health status/drug effects
1243641|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
1243642|NCT01834677|Depression|depression
1243643|NCT01834677|Neurocognition|neurocognition
1243644|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
1243645|NCT01834677|Parkinson's Disease|parkinson's disease
1243646|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
1243647|NCT01834651|liver metastasis|liver metastasis
1243648|NCT01834651|lung metastasis|lung metastasis
1243649|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
1243650|NCT01834651|prostate cancer|prostate cancer
1243651|NCT01834638|schizophrenia|schizophrenia
1243652|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
1243653|NCT01834599|placental oxygenation|placental oxygenation
1243654|NCT01834599|obstetric anesthesia|obstetric anesthesia
1243655|NCT01834599|NIRS|nirs
1243656|NCT01834599|cerebral oximetry|cerebral oximetry
1243657|NCT01834599|cerebral oximeter|cerebral oximeter
1243658|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
1243659|NCT01834573|IBD|ibd
1243660|NCT01834573|quality of life|quality of life
1243661|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
1243662|NCT01834560|deep brain stimulation|deep brain stimulation
1243663|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
1243664|NCT01834547|chess, cognition|chess, cognition
1243665|NCT01834521|Breast cancer|breast cancer
1243666|NCT01834521|psychosocial|psychosocial
1243667|NCT01834521|website|website
1243668|NCT01834521|empowerment|empowerment
1243669|NCT01834508|Experienced Treatment|experienced treatment
1243670|NCT01834495|Peripheral artery disease|peripheral artery disease
1243671|NCT01834495|atherosclerosis|atherosclerosis
1243672|NCT01834495|stent|stent
1243673|NCT01834482|seizures|seizures
1243674|NCT01834482|epilepsy|epilepsy
1243675|NCT01834482|adult|adult
1243676|NCT01834482|intractable|intractable
1243677|NCT01834482|medically refractory|medically refractory
1243678|NCT01834482|Atkins|atkins
1243679|NCT01834482|ketogenic|ketogenic
1243680|NCT01834482|diet|diet
1243681|NCT01834469|Ovarian,metastasis|ovarian,metastasis
1243682|NCT01834456|Medically Complex Children|medically complex children
1243683|NCT01834456|Family Experience in Healthcare|family experience in healthcare
1243684|NCT01834456|Patient Centered Care|patient centered care
1243685|NCT01834456|Family Centered Care|family centered care
1243686|NCT01834456|Case Management|case management
1243687|NCT01834456|Care Management|care management
1243688|NCT01834456|Care Coordination|care coordination
1243689|NCT01834456|Care Plan|care plan
1243690|NCT01834456|Extensivist|extensivist
1243691|NCT01834456|Medical Home|medical home
1243692|NCT01834456|Children with Special Health Care Needs|children with special health care needs
1243693|NCT01834456|Coordinated Care|coordinated care
1243694|NCT01834456|Quality in Healthcare|quality in healthcare
1243695|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
1243696|NCT01834456|Cost|cost
1243698|NCT01834456|Impact on Family|impact on family
1243699|NCT01834456|Quality of Life|quality of life
1243700|NCT01834456|Palliative Care|palliative care
1244101|NCT01832727|OPZ|opz
1243701|NCT01834456|Complex Chronic Conditions|complex chronic conditions
1243702|NCT01834456|Life-limiting illness|life-limiting illness
1243703|NCT01834456|Integrative Care|integrative care
1243704|NCT01834456|Primary Care|primary care
1243705|NCT01834456|Comprehensive Care|comprehensive care
1243706|NCT01834456|Behavioral Care|behavioral care
1243707|NCT01834443|spatial neglect|spatial neglect
1243708|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
1243709|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
1243710|NCT01834404|Obesity|obesity
1243711|NCT01834404|BMI|bmi
1243712|NCT01834404|Incretin|incretin
1243713|NCT01834404|Satiety|satiety
1243714|NCT01834404|Phentermine|phentermine
1243715|NCT01834404|Topiramate|topiramate
1243716|NCT01834378|diabetes|diabetes
1243717|NCT01834378|insulin resistance|insulin resistance
1243718|NCT01834378|exercise|exercise
1243719|NCT01834365|Hypertension|hypertension
1243720|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
1243721|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
1243722|NCT01834339|vestibuloplasty|vestibuloplasty
1243723|NCT01834326|dental implants|dental implants
1243724|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
1243725|NCT01834313|Willingness-to-pay|willingness-to-pay
1243726|NCT01834313|Patient-centredness|patient-centredness
1243727|NCT01834313|Health insurers|health insurers
1243728|NCT01834313|Fertility care|fertility care
1243729|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
1243730|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
1243731|NCT01834300|B cell function|b cell function
1243732|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
1243733|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
1243734|NCT01834287|Physical Activity|physical activity
1243735|NCT01834287|Latinas|latinas
1243736|NCT01834287|Web-based|web-based
1243737|NCT01834287|Spanish-language|spanish-language
1243738|NCT01834274|Drug Therapy|drug therapy
1243739|NCT01834261|oxytocin|oxytocin
1243740|NCT01834261|trust|trust
1243741|NCT01834261|kinship|kinship
1243742|NCT01834261|kin selection|kin selection
1243743|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
1243744|NCT01834235|Pancreatic cancer|pancreatic cancer
1243745|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
1243746|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
1243747|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
1243748|NCT01834209|Prostate neoplasms|prostate neoplasms
1243749|NCT01834209|Prostate cancer|prostate cancer
1243750|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
1599048|NCT00398034|cognition|cognition
1243751|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
1243752|NCT01834209|Abiraterone acetate|abiraterone acetate
1243753|NCT01834209|Prednisone|prednisone
1243754|NCT01834209|Prednisolone|prednisolone
1243755|NCT01834209|Early access program|early access program
1243756|NCT01834196|retinal vascular disease|retinal vascular disease
1243757|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
1243758|NCT01834196|SSOCT|ssoct
1243759|NCT01834183|Metastatic|metastatic
1243760|NCT01834170|Pancreatic cancer|pancreatic cancer
1243761|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1243762|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
1243763|NCT01834144|Type 1 Diabetes|type 1 diabetes
1243764|NCT01834144|Hypoglycaemia|hypoglycaemia
1243765|NCT01834144|Glycaemic variability|glycaemic variability
1243766|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
1243767|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
1243768|NCT01834131|hypertension|hypertension
1243769|NCT01834131|community health worker|community health worker
1243770|NCT01834131|home health education|home health education
1243771|NCT01834131|medication adherence|medication adherence
1243772|NCT01834131|mobile health|mobile health
1243773|NCT01834131|physician education|physician education
1243774|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
1243775|NCT01834131|implementation|implementation
1243776|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
1243777|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
1243778|NCT01834092|Endothelia|endothelia
1243779|NCT01834092|Glycocalyx|glycocalyx
1243780|NCT01834092|Reperfusion|reperfusion
1243781|NCT01834092|Plasma|plasma
1243782|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
1243783|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
1243784|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
1243785|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1243786|NCT01834040|Muscular Dystrophy|muscular dystrophy
1243787|NCT01834040|Myopathy|myopathy
1243788|NCT01834027|music|music
1243789|NCT01834027|stress|stress
1243790|NCT01834027|anxiety|anxiety
1243791|NCT01834027|post-surgical|post-surgical
1243792|NCT01834027|pain|pain
1243793|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
1244102|NCT01832727|ONX 0912|onx 0912
1243794|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
1243795|NCT01834001|MRI|mri
1243796|NCT01834001|Prostate Cancer|prostate cancer
1243797|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
1243798|NCT01834001|Radiation|radiation
1243799|NCT01834001|Biochemical Failure|biochemical failure
1243800|NCT01833988|bionic pancreas|bionic pancreas
1243801|NCT01833988|artificial pancreas|artificial pancreas
1243802|NCT01833988|insulin|insulin
1243803|NCT01833988|glucagon|glucagon
1243804|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
1243805|NCT01833988|outpatient|outpatient
1243806|NCT01833988|insulin pump|insulin pump
1243807|NCT01833988|pediatrics|pediatrics
1243808|NCT01833988|children|children
1243809|NCT01833988|camp|camp
1243810|NCT01833988|summer camp|summer camp
1243811|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
1243812|NCT01833962|Lumbar fusion rates|lumbar fusion rates
1243813|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
1243814|NCT01833962|Baxter Healthcare|baxter healthcare
1243815|NCT01833962|Other synthetic bone graft|other synthetic bone graft
1243816|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
1243817|NCT01833936|Achilles|achilles
1243818|NCT01833923|Advanced cancer|advanced cancer
1243819|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1243820|NCT01833910|Education|education
1243821|NCT01833897|Bipolar Disorder|bipolar disorder
1243822|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
1243823|NCT01833884|Cytokines|cytokines
1243824|NCT01833884|TARC|tarc
1243825|NCT01833884|IL-6|il-6
1243826|NCT01833884|IL1-RA|il1-ra
1243827|NCT01833884|sCD30|scd30
1243828|NCT01833884|TNFR1|tnfr1
1243829|NCT01833845|HCV|hcv
1243830|NCT01833845|Hepatitis C|hepatitis c
1243831|NCT01833845|Hep-C|hep-c
1243832|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
1243833|NCT01833832|Rare Tumor|rare tumor
1243834|NCT01833832|Poor Prognosis|poor prognosis
1243835|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
1243836|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
1243837|NCT01833819|Propofol,|propofol,
1243838|NCT01833819|Dexmedetomidine,|dexmedetomidine,
1243839|NCT01833819|Lidocaine,|lidocaine,
1243840|NCT01833819|Remifentanil,|remifentanil,
1243841|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
1599049|NCT00398034|libido|libido
1243842|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
1243843|NCT01833793|Mirena|mirena
1243844|NCT01833793|Contraception|contraception
1243845|NCT01833793|Amenorrhea|amenorrhea
1243846|NCT01833780|carriage status|carriage status
1243847|NCT01833780|Culture|culture
1243848|NCT01833780|PCR|pcr
1243849|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
1243850|NCT01833715|Pain, Postoperative|pain, postoperative
1243851|NCT01833715|Analgesics, Opioid|analgesics, opioid
1243852|NCT01833715|Methadone|methadone
1243853|NCT01833715|Morphine|morphine
1243854|NCT01833702|Sickle cell|sickle cell
1243855|NCT01833702|Pain|pain
1243856|NCT01833689|glucose response|glucose response
1243857|NCT01833689|glycaemic index|glycaemic index
1243858|NCT01833676|sevoflurane|sevoflurane
1243859|NCT01833676|desflurane|desflurane
1243860|NCT01833676|protective airway reflexes|protective airway reflexes
1243861|NCT01833676|elderly|elderly
1243862|NCT01833663|Overactive Bladder|overactive bladder
1243863|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
1243864|NCT01833663|Estrogen|estrogen
1243865|NCT01833650|thyroid cancer|thyroid cancer
1243866|NCT01833650|radioiodine treatment|radioiodine treatment
1243867|NCT01833650|xerostomia|xerostomia
1243868|NCT01833650|sialadenitis|sialadenitis
1243869|NCT01833637|Advanced Care Planning|advanced care planning
1243870|NCT01833637|Palliative Care|palliative care
1243871|NCT01833637|Women|women
1243872|NCT01833598|Chronic tendinopathy|chronic tendinopathy
1243873|NCT01833598|platelet rich plasma|platelet rich plasma
1243874|NCT01833598|tendonitis|tendonitis
1243875|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
1243876|NCT01833598|pain|pain
1243877|NCT01833598|shoulder|shoulder
1243878|NCT01833598|knee|knee
1243879|NCT01833598|ankle|ankle
1243880|NCT01833598|foot|foot
1243881|NCT01833585|critical limb ischemia|critical limb ischemia
1243882|NCT01833585|atherosclerosis|atherosclerosis
1243883|NCT01833585|ischemic ulcer|ischemic ulcer
1243884|NCT01833585|rest pain|rest pain
1243885|NCT01833585|gangrene|gangrene
1243886|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
1243887|NCT01833572|EGFR mutation|egfr mutation
1243888|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1243889|NCT01833572|gefitinib|gefitinib
1243890|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
1243891|NCT01833546|Solid tumor|solid tumor
1243892|NCT01833546|Pancreatic cancer|pancreatic cancer
1243893|NCT01833546|TH-302|th-302
1243894|NCT01833546|gemcitabine|gemcitabine
1243895|NCT01833546|Evofosfamide|evofosfamide
1243896|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
1243897|NCT01833533|Hepatitis C Virus|hepatitis c virus
1243898|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
1243899|NCT01833533|Hepatitis C|hepatitis c
1243900|NCT01833533|Treatment-Naïve|treatment-naïve
1243901|NCT01833533|Interferon-Free|interferon-free
1243902|NCT01833533|Paritaprevir|paritaprevir
1243903|NCT01833533|Ombitasvir|ombitasvir
1243904|NCT01833533|Dasabuvir|dasabuvir
1243905|NCT01833533|Ribavirin|ribavirin
1243906|NCT01833533|Viekira PAK|viekira pak
1243907|NCT01833520|Sarcoma|sarcoma
1243908|NCT01833520|Osteosarcoma|osteosarcoma
1243909|NCT01833520|recurrent or metastatic|recurrent or metastatic
1243910|NCT01833520|Ra-223 dichloride|ra-223 dichloride
1243911|NCT01833520|Radium-223 chloride|radium-223 chloride
1243912|NCT01833520|Alpharadin|alpharadin
1243913|NCT01833507|increased activity|increased activity
1243914|NCT01833507|weight loss|weight loss
1243915|NCT01833507|obesity|obesity
1243916|NCT01833494|Hemodialysis|hemodialysis
1243917|NCT01833494|Hyperphosphatemia|hyperphosphatemia
1243918|NCT01833481|Surgical approach|surgical approach
1243919|NCT01833481|Direct-anterior|direct-anterior
1243920|NCT01833481|Anterior-lateral|anterior-lateral
1243921|NCT01833481|Posterior-lateral|posterior-lateral
1243922|NCT01833481|Hip implant|hip implant
1243923|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
1243924|NCT01833481|Total Hip replacement|total hip replacement
1243925|NCT01833481|Hip replacement|hip replacement
1243926|NCT01833481|Hip prosthesis|hip prosthesis
1243927|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
1243928|NCT01833468|Psoriatic arthritis|psoriatic arthritis
1243929|NCT01833468|Foot|foot
1243930|NCT01833468|FAOS|faos
1243931|NCT01833468|SpA-TRI|spa-tri
1243932|NCT01833442|OCD|ocd
1243933|NCT01833442|YBOCS|ybocs
1243934|NCT01833429|Resistant hypertension|resistant hypertension
1243935|NCT01833429|White-coat phenomenon|white-coat phenomenon
1243936|NCT01833429|Heart rate variability|heart rate variability
1243937|NCT01833429|autonomic activity|autonomic activity
1243938|NCT01833416|CMV infection|cmv infection
1243939|NCT01833416|CMV disease|cmv disease
1243940|NCT01833416|Natural history|natural history
1243941|NCT01833416|Kidney transplant|kidney transplant
1243942|NCT01833403|bariatric surgery, l|bariatric surgery, l
1243943|NCT01833403|liver insulin resistance,|liver insulin resistance,
1243944|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
1243945|NCT01833390|HXe|hxe
1243946|NCT01833390|MagniXene|magnixene
1243947|NCT01833377|obesity|obesity
1243948|NCT01833377|overweight|overweight
1243949|NCT01833377|BMI|bmi
1243950|NCT01833364|Parkinson's Disease|parkinson's disease
1243951|NCT01833364|Deep Brain Stimulation|deep brain stimulation
1243952|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
1243953|NCT01833351|Phase I|phase i
1243954|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
1243955|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
1243956|NCT01833351|IV Vitamin C,|iv vitamin c,
1243957|NCT01833351|Oncology|oncology
1243958|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
1243959|NCT01833338|optical coherence tomography|optical coherence tomography
1243960|NCT01833338|intravascular ultrasound|intravascular ultrasound
1243961|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
1243962|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
1243963|NCT01833325|Macular Degeneration|macular degeneration
1243964|NCT01833325|Proton radiation|proton radiation
1243965|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
1243966|NCT01833312|acute ischemic stroke|acute ischemic stroke
1243967|NCT01833312|hypothermia|hypothermia
1243968|NCT01833299|TACE|tace
1243969|NCT01833299|Sorafenib|sorafenib
1243970|NCT01833299|overall survival|overall survival
1243971|NCT01833299|time to progression|time to progression
1243972|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
1243973|NCT01833286|repeat hepatectomy|repeat hepatectomy
1243974|NCT01833286|radiofrequency ablation|radiofrequency ablation
1243975|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1243976|NCT01833247|epilepsy|epilepsy
1243977|NCT01833247|lactic acid|lactic acid
1243978|NCT01833247|saliva|saliva
1243979|NCT01833247|postictal|postictal
1243980|NCT01833234|epilepsy|epilepsy
1243981|NCT01833234|quality of life|quality of life
1243982|NCT01833234|seizure severity|seizure severity
1243983|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
1243984|NCT01833234|questionnaire|questionnaire
1243985|NCT01833234|patient reported outcomes|patient reported outcomes
1243986|NCT01833221|facial palsy|facial palsy
1243987|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
1243988|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
1243989|NCT01833195|molecular diagnostics|molecular diagnostics
1243990|NCT01833195|heart transplantation|heart transplantation
1243991|NCT01833195|risk factors|risk factors
1243992|NCT01833195|prognosis|prognosis
1243993|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
1243994|NCT01833182|falls and ADL performance|falls and adl performance
1243999|NCT01833169|PI3K pathway activation|pi3k pathway activation
1244000|NCT01833169|P13K activated tumors|p13k activated tumors
1244001|NCT01833169|BKM120|bkm120
1244002|NCT01833169|signature|signature
1244003|NCT01833169|AML|aml
1244004|NCT01833169|acute myelogenous leukemia|acute myelogenous leukemia
1244005|NCT01833169|cervical|cervical
1244006|NCT01833169|ovarian|ovarian
1244007|NCT01833169|hepatobiliary|hepatobiliary
1244008|NCT01833169|buparlisib|buparlisib
1244009|NCT01833156|local edema|local edema
1244010|NCT01833156|dielectric constant values|dielectric constant values
1244011|NCT01833156|validation study|validation study
1244012|NCT01833143|KRAS-Mutant|kras-mutant
1244013|NCT01833143|Bortezomib|bortezomib
1244014|NCT01833143|KRAS G12D|kras g12d
1244015|NCT01833143|12-222|12-222
1244021|NCT01833104|Healthy subjects|healthy subjects
1244022|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
1244023|NCT01833039|Ibrutinib|ibrutinib
1244024|NCT01833026|pulmonary disease|pulmonary disease
1244025|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
1244026|NCT01833026|spirometry|spirometry
1244027|NCT01833026|primary healthcare|primary healthcare
1244028|NCT01833026|guideline-based therapy|guideline-based therapy
1244029|NCT01833013|Endometriosis|endometriosis
1244030|NCT01833013|Cohort study|cohort study
1244031|NCT01833013|fertility|fertility
1244032|NCT01833013|pregnancy|pregnancy
1244033|NCT01833013|assisted reproductive technics|assisted reproductive technics
1244034|NCT01833013|laparoscopy|laparoscopy
1244035|NCT01833000|rectal bleeding|rectal bleeding
1244036|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
1244037|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
1244038|NCT01833000|mesenteric doppler|mesenteric doppler
1244039|NCT01832987|co-trimoxazole|co-trimoxazole
1244040|NCT01832987|sulfamethoxazole|sulfamethoxazole
1244041|NCT01832987|tuberculosis|tuberculosis
1244042|NCT01832987|pharmacokinetics|pharmacokinetics
1244043|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
1244044|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
1244045|NCT01832974|Metastatic Cancer|metastatic cancer
1244046|NCT01832961|COPD|copd
1244047|NCT01832961|physiotherapy care|physiotherapy care
1244048|NCT01832961|lung function testing|lung function testing
1244049|NCT01832961|inflammation|inflammation
1244050|NCT01832935|Glargin|glargin
1244052|NCT01832935|Cost-effectiveness|cost-effectiveness
1244053|NCT01832922|bendamustine|bendamustine
1244054|NCT01832922|rituximab|rituximab
1244055|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1244056|NCT01832922|comorbidities|comorbidities
1244057|NCT01832922|renal insufficiency|renal insufficiency
1244058|NCT01832909|metabolizable energy|metabolizable energy
1244059|NCT01832909|walnuts|walnuts
1244060|NCT01832909|Atwater factors|atwater factors
1244061|NCT01832909|energy value|energy value
1244062|NCT01832896|Hereditary Angioedema|hereditary angioedema
1244063|NCT01832896|Children|children
1244064|NCT01832896|Adolescents|adolescents
1244065|NCT01832896|Ecallantide|ecallantide
1244066|NCT01832857|metastatic|metastatic
1244067|NCT01832857|advanced|advanced
1244068|NCT01832857|solid tumor|solid tumor
1244069|NCT01832857|cancer|cancer
1244070|NCT01832857|colon cancer|colon cancer
1244071|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
1244072|NCT01832857|breast cancer|breast cancer
1244073|NCT01832857|lung cancer|lung cancer
1244074|NCT01832857|gastric cancer|gastric cancer
1244075|NCT01832857|esophageal cancer|esophageal cancer
1244076|NCT01832844|Scan control|scan control
1244077|NCT01832844|Epidural infiltration|epidural infiltration
1244078|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
1244079|NCT01832818|Total Disc Replacement|total disc replacement
1244080|NCT01832805|depression|depression
1244081|NCT01832779|Achalasia|achalasia
1244082|NCT01832766|schizophrenia|schizophrenia
1244083|NCT01832766|dronabinol|dronabinol
1244084|NCT01832766|P50|p50
1244085|NCT01832766|cannabis|cannabis
1244086|NCT01832766|memory|memory
1244087|NCT01832766|symptoms|symptoms
1244088|NCT01832753|Down syndrome|down syndrome
1244089|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
1244090|NCT01832753|thyroid|thyroid
1244091|NCT01832753|levothyroxine|levothyroxine
1244092|NCT01832740|young healthy subjects|young healthy subjects
1244093|NCT01832740|brain stimulation|brain stimulation
1244094|NCT01832740|tSOS|tsos
1244095|NCT01832740|tDCS|tdcs
1244096|NCT01832740|sleep|sleep
1244097|NCT01832740|memory|memory
1244098|NCT01832740|memory consolidation|memory consolidation
1244099|NCT01832727|multiple myeloma|multiple myeloma
1244100|NCT01832727|oprozomib|oprozomib
1244103|NCT01832727|Onyx|onyx
1244104|NCT01832727|proteasome inhibitor|proteasome inhibitor
1244105|NCT01832727|oprozomib tablets|oprozomib tablets
1244106|NCT01832714|Concussion|concussion
1244107|NCT01832714|mTBI|mtbi
1244108|NCT01832714|military|military
1244109|NCT01832714|MACE|mace
1244110|NCT01832714|NKI|nki
1244111|NCT01832714|NOTC|notc
1244112|NCT01832714|VNG|vng
1244113|NCT01832714|VOG|vog
1244114|NCT01832714|Neuro Kinetics|neuro kinetics
1244115|NCT01832714|oculomotor|oculomotor
1244116|NCT01832714|vestibular|vestibular
1244117|NCT01832714|reaction time|reaction time
1244118|NCT01832714|I-Portal|i-portal
1244119|NCT01832714|eye tracking|eye tracking
1244120|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
1244121|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
1244122|NCT01832688|anemia|anemia
1244123|NCT01832688|gestational weight gain|gestational weight gain
1244124|NCT01832675|Endoscopy|endoscopy
1244125|NCT01832675|Anesthetics, Local|anesthetics, local
1244126|NCT01832675|Bupivacaine|bupivacaine
1244127|NCT01832675|Lidocaine|lidocaine
1244128|NCT01832649|Exercise|exercise
1244129|NCT01832649|Cocaine dependence|cocaine dependence
1244130|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
1244131|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
1244132|NCT01832636|Tropical enteropathy|tropical enteropathy
1244133|NCT01832623|Vitamin D|vitamin d
1244134|NCT01832623|bone|bone
1244135|NCT01832623|cardiovascular status|cardiovascular status
1244136|NCT01832623|nutritional status|nutritional status
1244137|NCT01832584|Red Grapes|red grapes
1244138|NCT01832584|polyphenols|polyphenols
1244139|NCT01832584|cyclists|cyclists
1244140|NCT01832584|resveratrol|resveratrol
1244141|NCT01832584|aerobic fitness|aerobic fitness
1244142|NCT01832584|trained|trained
1244143|NCT01832571|HIV|hiv
1244144|NCT01832571|PrEP|prep
1244145|NCT01832571|Female Sex Workers|female sex workers
1244146|NCT01832571|Kenya|kenya
1244147|NCT01832545|Aquatic exercise|aquatic exercise
1244148|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
1244149|NCT01832545|Exercise|exercise
1244150|NCT01832545|Pain|pain
1244151|NCT01832545|Obesity.|obesity.
1244152|NCT01832532|Sleep Apnea|sleep apnea
1244153|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
1244154|NCT01832532|liraglutide|liraglutide
1244155|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
1244156|NCT01832532|Orexin|orexin
1244157|NCT01832532|leptin,|leptin,
1244158|NCT01832519|Cystic Fibrosis|cystic fibrosis
1244159|NCT01832519|CF|cf
1244160|NCT01832519|MRI|mri
1244161|NCT01832519|vascularization|vascularization
1244162|NCT01832519|perfusion|perfusion
1244163|NCT01832506|Solid Tumors|solid tumors
1244164|NCT01832506|MSC2156119J|msc2156119j
1244165|NCT01832506|c-Met inhibitor|c-met inhibitor
1244166|NCT01832506|Japanese|japanese
1244167|NCT01832506|Phase 1|phase 1
1244168|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
1244169|NCT01832480|metronidazole|metronidazole
1244170|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
1244171|NCT01832467|previously treated|previously treated
1244172|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
1244173|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
1244174|NCT01832415|First line treatment|first line treatment
1244175|NCT01832415|Ovarian cancer|ovarian cancer
1244176|NCT01832415|Avastin|avastin
1244177|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
1244178|NCT01832402|Advanced Cancers|advanced cancers
1244179|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
1244180|NCT01832402|Shortness of breath|shortness of breath
1244181|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
1244182|NCT01832402|Placebo nasal spray|placebo nasal spray
1244183|NCT01832402|Walk test|walk test
1244184|NCT01832402|Questionnaires|questionnaires
1244185|NCT01832402|Surveys|surveys
1244186|NCT01832402|Mental ability tests|mental ability tests
1244187|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
1244188|NCT01832389|vasospasm|vasospasm
1244189|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
1244190|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
1244191|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
1244192|NCT01832376|Calcific tendinitis|calcific tendinitis
1244193|NCT01832376|Shoulder|shoulder
1244194|NCT01832376|Needle lavage|needle lavage
1244195|NCT01832376|Ultrasound-guided|ultrasound-guided
1244196|NCT01832363|Severe asthma|severe asthma
1244197|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
1244198|NCT01832363|MagniXene|magnixene
1244199|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
1244200|NCT01832363|HXe|hxe
1244201|NCT01832363|HyXe|hyxe
1244202|NCT01832324|Food Allergy|food allergy
1244203|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
1244204|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
1244205|NCT01832324|iNKT Cells|inkt cells
1244206|NCT01832324|T cells|t cells
1244207|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
1244208|NCT01832311|cataract|cataract
1244209|NCT01832311|cytokines|cytokines
1244210|NCT01832311|chemokines|chemokines
1244211|NCT01832311|aqueous humor|aqueous humor
1244212|NCT01832298|Tolerability|tolerability
1244213|NCT01832298|Pharmacokinetics|pharmacokinetics
1244214|NCT01832285|fluvoxamine|fluvoxamine
1244215|NCT01832285|cognition|cognition
1244216|NCT01832285|schizophrenia|schizophrenia
1244217|NCT01832285|protein expression|protein expression
1244218|NCT01832272|Osteoarthritis|osteoarthritis
1244219|NCT01832272|Knee|knee
1244220|NCT01832272|Total knee arthroplasty|total knee arthroplasty
1244221|NCT01832272|Tourniquet|tourniquet
1244222|NCT01832272|Early release|early release
1244223|NCT01832272|Reinflation|reinflation
1244224|NCT01832246|endoscopy|endoscopy
1244225|NCT01832246|endosonography|endosonography
1244226|NCT01832246|stomach cancer|stomach cancer
1244227|NCT01832246|tumor staging|tumor staging
1244228|NCT01832220|Genomics|genomics
1244229|NCT01832220|Microbiome|microbiome
1244230|NCT01832220|Microflora|microflora
1244231|NCT01832220|Virome|virome
1244232|NCT01832220|Alpha-1|alpha-1
1244233|NCT01832194|Scrotal pain|scrotal pain
1244234|NCT01832194|Botox|botox
1244235|NCT01832181|Diabetes|diabetes
1244236|NCT01832181|MiTy|mity
1244237|NCT01832181|Metformin in Women|metformin in women
1244238|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
1244239|NCT01832155|Yoga|yoga
1244240|NCT01832155|Knee osteoarthritis|knee osteoarthritis
1244241|NCT01832155|Symptom management|symptom management
1244242|NCT01832155|Older women|older women
1244243|NCT01832155|Pain|pain
1244244|NCT01832155|Stiffness|stiffness
1244245|NCT01832155|Physical function)|physical function)
1244246|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
1244247|NCT01832155|Quality of sleep|quality of sleep
1244248|NCT01832155|Quality of life|quality of life
1244249|NCT01832116|Pancreatic cancer|pancreatic cancer
1244250|NCT01832116|Ovarian cancer|ovarian cancer
1244251|NCT01832090|aging|aging
1244252|NCT01832090|hands|hands
1244253|NCT01832077|sensibility|sensibility
1244254|NCT01832077|specificity|specificity
1244255|NCT01832077|positive predictive value|positive predictive value
1244256|NCT01832077|negative predictive value|negative predictive value
1244257|NCT01832077|Cost-effectiveness|cost-effectiveness
1244258|NCT01832064|chronic disease|chronic disease
1244259|NCT01832064|patient education|patient education
1244260|NCT01832064|self management|self management
1244261|NCT01832051|HER2-PET|her2-pet
1244262|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
1244263|NCT01832051|metastatic breast cancer|metastatic breast cancer
1244264|NCT01832051|clinical dilemma|clinical dilemma
1244265|NCT01832038|Lacosamide|lacosamide
1244266|NCT01832038|Epilepsy|epilepsy
1244267|NCT01832038|Partial-onset Seizures|partial-onset seizures
1244268|NCT01832025|intraoperative|intraoperative
1244269|NCT01832025|postoperative|postoperative
1244270|NCT01832025|complications|complications
1244271|NCT01832025|discomfort|discomfort
1244272|NCT01832025|external|external
1244273|NCT01832025|internal|internal
1244274|NCT01832025|maxillary|maxillary
1244275|NCT01832025|elevation|elevation
1244276|NCT01832025|implant|implant
1244277|NCT01832025|reconstruction|reconstruction
1244278|NCT01832025|bone|bone
1244279|NCT01832025|sinus|sinus
1244280|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
1244281|NCT01831999|Web-based|web-based
1244282|NCT01831999|HIV Assessment|hiv assessment
1244283|NCT01831999|Outreach|outreach
1244284|NCT01831999|Retention|retention
1244285|NCT01831999|Substance Abuse Treatment|substance abuse treatment
1244286|NCT01831986|Schizophrenia|schizophrenia
1244287|NCT01831986|Schizoaffective disorder|schizoaffective disorder
1244288|NCT01831986|Pregnenolone|pregnenolone
1244289|NCT01831986|L-Theanine|l-theanine
1244290|NCT01831986|Augmentation|augmentation
1244291|NCT01831960|Intrepid|intrepid
1244292|NCT01831960|cortexolone|cortexolone
1244293|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
1244294|NCT01831960|anti-androgen|anti-androgen
1244295|NCT01831947|age-related macular degeneration|age-related macular degeneration
1244296|NCT01831947|Ranibizumab|ranibizumab
1244297|NCT01831934|Mitochondrial disorder|mitochondrial disorder
1244298|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
1244299|NCT01831934|Adolescents and adults|adolescents and adults
1244300|NCT01831934|Immune response|immune response
1244301|NCT01831934|Metabolic response|metabolic response
1244302|NCT01831921|pre diabetes|pre diabetes
1244303|NCT01831921|obesity|obesity
1244304|NCT01831921|weight loss|weight loss
1244305|NCT01831921|lifestyle|lifestyle
1244306|NCT01831921|prevention|prevention
1244307|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
1244308|NCT01831895|Hypertension|hypertension
1244309|NCT01831895|Carotid Sinus|carotid sinus
1244418|NCT01831453|omega-3|omega-3
1244310|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
1244311|NCT01831869|L-thyroxine|l-thyroxine
1244312|NCT01831869|Lipid|lipid
1244313|NCT01831869|endothelial function|endothelial function
1244314|NCT01831869|inflammatory factor|inflammatory factor
1244315|NCT01831869|adipocytokine|adipocytokine
1244316|NCT01831856|Cardiovascular diseases|cardiovascular diseases
1244317|NCT01831856|Chronic Heart Failure|chronic heart failure
1244318|NCT01831843|core body temperature|core body temperature
1244319|NCT01831843|humidity|humidity
1244320|NCT01831843|circuit temperature|circuit temperature
1244321|NCT01831830|traumatic brain injury|traumatic brain injury
1244322|NCT01831830|occupational therapy|occupational therapy
1244323|NCT01831830|family|family
1244324|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
1244325|NCT01831804|pharmacodynamics|pharmacodynamics
1244326|NCT01831804|pharmacokinetics|pharmacokinetics
1244327|NCT01831804|ischemic|ischemic
1244328|NCT01831791|male pattern hair loss|male pattern hair loss
1244329|NCT01831791|hair growth|hair growth
1244330|NCT01831791|hair restoration|hair restoration
1244331|NCT01831791|Dutasteride|dutasteride
1244332|NCT01831791|Androgenetic alopecia|androgenetic alopecia
1244333|NCT01831791|safety|safety
1244334|NCT01831791|efficacy|efficacy
1244335|NCT01831778|mammography|mammography
1244336|NCT01831778|screening|screening
1244337|NCT01831752|Diabetes|diabetes
1244338|NCT01831752|Type 1|type 1
1244339|NCT01831752|Continuous glucose monitor|continuous glucose monitor
1244340|NCT01831739|Genomics|genomics
1244341|NCT01831739|Microbiome|microbiome
1244342|NCT01831739|Microflora|microflora
1244343|NCT01831739|Virome|virome
1244344|NCT01831726|Solid tumor malignancy|solid tumor malignancy
1244345|NCT01831726|hematologic malignancy|hematologic malignancy
1244346|NCT01831726|mutation|mutation
1244347|NCT01831726|translocations|translocations
1244348|NCT01831726|FGFR|fgfr
1244349|NCT01831726|PDGFR|pdgfr
1244350|NCT01831726|VEGF|vegf
1244351|NCT01831726|cKIT|ckit
1244352|NCT01831726|FLT3|flt3
1244353|NCT01831726|CSR1|csr1
1244354|NCT01831726|Trk|trk
1244355|NCT01831726|RET|ret
1244356|NCT01831726|TKI258|tki258
1244357|NCT01831726|dovitinib|dovitinib
1244358|NCT01831726|signature|signature
1244359|NCT01831726|AML|aml
1244360|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
1244361|NCT01831726|GIST|gist
1244362|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1244363|NCT01831726|Head and Neck cancer|head and neck cancer
1244364|NCT01831726|Melanoma|melanoma
1244365|NCT01831726|NSCLC|nsclc
1244366|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
1244367|NCT01831726|lung cancer|lung cancer
1244368|NCT01831726|ovarian cancer|ovarian cancer
1244369|NCT01831726|thyroid cancer|thyroid cancer
1244370|NCT01831726|amplification|amplification
1244371|NCT01831648|IGF1|igf1
1244372|NCT01831648|standards|standards
1244373|NCT01831648|Assays|assays
1244374|NCT01831648|Z-score|z-score
1244375|NCT01831648|Healthy volunteers|healthy volunteers
1244376|NCT01831648|Population|population
1244377|NCT01831622|Decision-Making|decision-making
1244378|NCT01831622|functional MRI|functional mri
1244379|NCT01831622|pharmacological MRI|pharmacological mri
1244380|NCT01831622|Reinforcement Learning|reinforcement learning
1244381|NCT01831622|Methylphenidate|methylphenidate
1244382|NCT01831609|Gastrointestinal|gastrointestinal
1244383|NCT01831609|Genitourinary|genitourinary
1244384|NCT01831609|Rare Cancer|rare cancer
1244385|NCT01831583|sleep apnea|sleep apnea
1244386|NCT01831570|Hand osteoarthritis|hand osteoarthritis
1244387|NCT01831570|predictive factors|predictive factors
1244388|NCT01831570|erosive hand OA|erosive hand oa
1244389|NCT01831544|Heart Failure|heart failure
1244390|NCT01831518|Heart Failure|heart failure
1244391|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1244392|NCT01831518|ECG Imaging|ecg imaging
1244393|NCT01831518|Body Surface Mapping|body surface mapping
1244394|NCT01831505|personalized medicine|personalized medicine
1244395|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
1244396|NCT01831505|chemotherapy|chemotherapy
1244397|NCT01831505|lymphoma|lymphoma
1244398|NCT01831505|microinjection|microinjection
1244399|NCT01831492|performance|performance
1244400|NCT01831492|acidosis|acidosis
1244401|NCT01831492|oxidative stress|oxidative stress
1244402|NCT01831492|inflammation|inflammation
1244403|NCT01831492|oxygen uptake|oxygen uptake
1244404|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
1244405|NCT01831466|plaque psoriasis|plaque psoriasis
1244406|NCT01831466|vulgaris|vulgaris
1244407|NCT01831466|topical treatment|topical treatment
1244408|NCT01831466|skin diseases|skin diseases
1244409|NCT01831466|papulosquamous|papulosquamous
1244410|NCT01831466|Tofacitinib|tofacitinib
1244411|NCT01831466|CP-690550|cp-690550
1244412|NCT01831466|Xeljanz|xeljanz
1244413|NCT01831466|psoriasis|psoriasis
1244414|NCT01831466|moderate|moderate
1244415|NCT01831466|severe|severe
1244416|NCT01831466|itch|itch
1244417|NCT01831466|nail psoriasis|nail psoriasis
1244419|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
1244420|NCT01831453|quality of life|quality of life
1244421|NCT01831440|depression|depression
1244422|NCT01831440|remission|remission
1244423|NCT01831440|Pharmacotherapy|pharmacotherapy
1244424|NCT01831440|psychotherapy|psychotherapy
1244425|NCT01831440|neuroimaging|neuroimaging
1244426|NCT01831440|psychology|psychology
1244427|NCT01831427|ulcerative colitis|ulcerative colitis
1244428|NCT01831427|moderate|moderate
1244429|NCT01831427|severe|severe
1244430|NCT01831414|Lung function|lung function
1244431|NCT01831414|Water immersion|water immersion
1244432|NCT01831414|Balneotherapy|balneotherapy
1244433|NCT01831401|Acetabular component inclination|acetabular component inclination
1244434|NCT01831388|Dyspnea|dyspnea
1244435|NCT01831388|Breath Training Exercise|breath training exercise
1244436|NCT01831388|12-261|12-261
1244437|NCT01831336|International|international
1244438|NCT01831336|Multicenter|multicenter
1244439|NCT01831336|Observational registry|observational registry
1244440|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1244441|NCT01831336|Stenting|stenting
1244442|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1244443|NCT01831336|Coronary revascularization|coronary revascularization
1244444|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
1244445|NCT01831336|STEMI|stemi
1244446|NCT01831336|NSTEMI|nstemi
1244447|NCT01831336|Ischemia|ischemia
1244448|NCT01831336|Angina|angina
1244449|NCT01831336|Subgroups|subgroups
1244450|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
1244451|NCT01831336|Diabetes|diabetes
1244452|NCT01831336|Small Vessels|small vessels
1244453|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1244454|NCT01831310|Colorectal cancer|colorectal cancer
1244455|NCT01831310|nutrition|nutrition
1244456|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
1244457|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
1244458|NCT01831310|glutamine|glutamine
1244459|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
1244460|NCT01831271|Exercise, Physical|exercise, physical
1244461|NCT01831271|Physical Activity|physical activity
1244462|NCT01831271|Outcome Measures|outcome measures
1244463|NCT01831219|osteoarthritis|osteoarthritis
1244464|NCT01831219|arthroplasty|arthroplasty
1244465|NCT01831219|hip arthroplasty|hip arthroplasty
1244466|NCT01831206|corneal ulcer|corneal ulcer
1244467|NCT01831206|keratitis|keratitis
1244468|NCT01831180|hair|hair
1244469|NCT01831180|scalp|scalp
1244470|NCT01831180|blood flow|blood flow
1244471|NCT01831180|Caucasian|caucasian
1244472|NCT01831180|Histamine stimulation|histamine stimulation
1244473|NCT01831180|Wake Forest|wake forest
1244474|NCT01831167|dynamic light application|dynamic light application
1244475|NCT01831167|sustained attention|sustained attention
1244476|NCT01831167|divided attention|divided attention
1244477|NCT01831167|nursing|nursing
1244478|NCT01831154|Glycemic control|glycemic control
1244479|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
1244480|NCT01831141|Glomerular filtration rate|glomerular filtration rate
1244481|NCT01831141|Chronic kidney damage|chronic kidney damage
1244482|NCT01831141|Hypertension|hypertension
1244483|NCT01831141|Proteinuria|proteinuria
1244484|NCT01831128|Congestive Heart Failure|congestive heart failure
1244485|NCT01831128|Central Sleep Apnea|central sleep apnea
1244486|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
1244487|NCT01831115|heart failure|heart failure
1244488|NCT01831115|BNP|bnp
1244489|NCT01831115|acute dyspnoea|acute dyspnoea
1244490|NCT01831102|insulin resistance|insulin resistance
1244491|NCT01831102|ethnic disparities|ethnic disparities
1244492|NCT01831102|adiponectin|adiponectin
1244493|NCT01831076|Breast cancer|breast cancer
1244494|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1244495|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1244496|NCT01831076|Postmenopausal|postmenopausal
1244497|NCT01831076|Exemestane|exemestane
1244498|NCT01831076|Tamoxifen|tamoxifen
1244499|NCT01831063|Seizure|seizure
1244500|NCT01831063|Caregivers|caregivers
1244501|NCT01831063|Family Centered Care|family centered care
1244502|NCT01831063|Learning modality|learning modality
1244503|NCT01831050|Poliovirus|poliovirus
1244504|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
1244505|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
1244506|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
1244507|NCT01831050|Stool shedding index|stool shedding index
1244508|NCT01831050|Polio eradication|polio eradication
1244509|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
1244510|NCT01831037|Regressed cirrhosis|regressed cirrhosis
1244511|NCT01831037|Hepatitis C|hepatitis c
1244512|NCT01831037|Hepatitis B|hepatitis b
1244513|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
1244514|NCT01831037|FibroTest|fibrotest
1244515|NCT01831037|FibroSure|fibrosure
1244516|NCT01831037|FibroScan|fibroscan
1244517|NCT01831037|Transient elastography|transient elastography
1244518|NCT01831024|Cold cap|cold cap
1244519|NCT01831024|Scalp cooling|scalp cooling
1244520|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
1244521|NCT01831024|Breast cancer|breast cancer
1244522|NCT01831011|randomized trial|randomized trial
1244523|NCT01831011|acute ischemic stroke|acute ischemic stroke
1244524|NCT01831011|mildronate|mildronate
1244525|NCT01830998|Dementia|dementia
1244526|NCT01830998|Olfactory|olfactory
1244527|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
1244528|NCT01830946|Protein|protein
1244529|NCT01830946|Metabolism|metabolism
1244530|NCT01830946|Nighttime eating|nighttime eating
1244531|NCT01830946|Exercise Training|exercise training
1244532|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
1244533|NCT01830920|Acute Kidney Injury|acute kidney injury
1244534|NCT01830920|AKI|aki
1244535|NCT01830920|Cardiac surgery|cardiac surgery
1244536|NCT01830907|Malnutrition|malnutrition
1244537|NCT01830907|Gastric cancer|gastric cancer
1244538|NCT01830907|preoperative nutrition|preoperative nutrition
1244539|NCT01830881|pain|pain
1244540|NCT01830881|anxiety|anxiety
1244541|NCT01830881|surgical abortion|surgical abortion
1244542|NCT01830881|midazolam|midazolam
1244543|NCT01830881|benzodiazepine|benzodiazepine
1244544|NCT01830868|ZNS|zns
1244545|NCT01830868|AED|aed
1244546|NCT01830868|Partial Onset Seizures|partial onset seizures
1244547|NCT01830868|Retention Rate|retention rate
1244548|NCT01830868|Seizure Control|seizure control
1244549|NCT01830868|Antiepileptic|antiepileptic
1244550|NCT01830868|Secondary generalization|secondary generalization
1244551|NCT01830868|Seizure freedom rates|seizure freedom rates
1244552|NCT01830842|Nicotine|nicotine
1244553|NCT01830842|Smoking|smoking
1244554|NCT01830842|Cigarettes|cigarettes
1244555|NCT01830842|Reinforcement Learning|reinforcement learning
1244556|NCT01830842|fMRI|fmri
1244557|NCT01830829|BPH|bph
1244558|NCT01830829|CPPS|cpps
1244559|NCT01830816|Relapsed|relapsed
1244560|NCT01830816|Refractory|refractory
1244561|NCT01830816|Multiple Myeloma|multiple myeloma
1244562|NCT01830816|Advanced solid tumors|advanced solid tumors
1244563|NCT01830803|howRU|howru
1244564|NCT01830803|howRwe|howrwe
1244565|NCT01830803|reliability|reliability
1244566|NCT01830803|quality of life|quality of life
1244567|NCT01830803|quality of care|quality of care
1244568|NCT01830803|patient satisfaction|patient satisfaction
1599229|NCT00397280|HV|hv
1244569|NCT01830751|self treatment technique|self treatment technique
1244570|NCT01830751|chronic|chronic
1244571|NCT01830751|non specific|non specific
1244572|NCT01830751|LBP|lbp
1244573|NCT01830751|control trunk flexion|control trunk flexion
1244574|NCT01830751|diurnal|diurnal
1244575|NCT01830738|laparoscopy|laparoscopy
1244576|NCT01830738|hysterectomy|hysterectomy
1244577|NCT01830738|single-port trocar|single-port trocar
1244578|NCT01830738|surgical technique|surgical technique
1244579|NCT01830738|trocar|trocar
1244580|NCT01830725|Xanthine Oxidase|xanthine oxidase
1244581|NCT01830725|Gout|gout
1244582|NCT01830725|Hyperuricemia|hyperuricemia
1244583|NCT01830725|SNP|snp
1244584|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1244585|NCT01830699|Rilonacept|rilonacept
1244586|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
1244587|NCT01830699|Corticosteroid Injection|corticosteroid injection
1244588|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
1244589|NCT01830673|T-regulatory cells|t-regulatory cells
1244590|NCT01830673|TH1, TH2 cells|th1, th2 cells
1244591|NCT01830673|specific IgE|specific ige
1244592|NCT01830673|specific IgG|specific igg
1244593|NCT01830673|specific IgG4|specific igg4
1244594|NCT01830673|IL2|il2
1244595|NCT01830673|IL5|il5
1244596|NCT01830673|IL10|il10
1244597|NCT01830673|IL12/23|il12/23
1244598|NCT01830673|Y-IFN|y-ifn
1244599|NCT01830673|TNF-a|tnf-a
1244600|NCT01830634|Community-dwelling elderly|community-dwelling elderly
1244601|NCT01830634|Rehabilitation|rehabilitation
1244602|NCT01830634|Theraband|theraband
1244603|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
1244604|NCT01830582|MRI|mri
1244605|NCT01830582|rectum|rectum
1244606|NCT01830582|13-019|13-019
1244607|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
1244608|NCT01830569|Evidence-Based practice|evidence-based practice
1244609|NCT01830569|Family Practice|family practice
1244610|NCT01830543|Atrial Fibrillation|atrial fibrillation
1244611|NCT01830543|Irregular heart beat|irregular heart beat
1244612|NCT01830543|rivaroxaban|rivaroxaban
1244613|NCT01830543|aspirin|aspirin
1244614|NCT01830543|clopidogrel|clopidogrel
1244615|NCT01830543|prasugrel|prasugrel
1244616|NCT01830543|ticagrelor|ticagrelor
1244617|NCT01830543|vitamin K antagonist|vitamin k antagonist
1244618|NCT01830530|arterial hypertension|arterial hypertension
1244619|NCT01830530|high altitude|high altitude
1244620|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
1244621|NCT01830530|combination treatment|combination treatment
1244622|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
1244623|NCT01830530|calcium antagonist|calcium antagonist
1244624|NCT01830504|thyroid cancers|thyroid cancers
1244625|NCT01830504|refractory|refractory
1244626|NCT01830504|PI3K inhibitor|pi3k inhibitor
1244882|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
1244627|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
1244628|NCT01830465|relapsed|relapsed
1244629|NCT01830465|progressed|progressed
1244630|NCT01830452|Chronic pain|chronic pain
1244631|NCT01830452|Progrip Mesh|progrip mesh
1244632|NCT01830452|Self gripping mesh|self gripping mesh
1244633|NCT01830452|Lichtenstein|lichtenstein
1244634|NCT01830439|tuberculosis|tuberculosis
1244637|NCT01830439|food effect|food effect
1244638|NCT01830439|pretomanid|pretomanid
1244639|NCT01830439|CL-009|cl-009
1244640|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
1244641|NCT01830400|ESL|esl
1244642|NCT01830400|Partial onset seizures|partial onset seizures
1244643|NCT01830400|Retention Rate|retention rate
1244644|NCT01830400|Seizure Control|seizure control
1244645|NCT01830400|Antiepileptic|antiepileptic
1244646|NCT01830400|Secondary Generalisation|secondary generalisation
1244647|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
1244648|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
1244649|NCT01830387|Endoscopic Staplers|endoscopic staplers
1244650|NCT01830374|Bulimia nervosa|bulimia nervosa
1244651|NCT01830374|Eating disorder|eating disorder
1244652|NCT01830374|Weight suppression|weight suppression
1244653|NCT01830374|Dieting|dieting
1244654|NCT01830361|AML|aml
1244655|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
1244656|NCT01830361|c-KIT|c-kit
1244657|NCT01830361|FLT3-ITD|flt3-itd
1244658|NCT01830361|t(8;21)|t(8;21)
1244659|NCT01830361|chemotherapy|chemotherapy
1244660|NCT01830361|midostaurin|midostaurin
1244661|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
1244662|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
1244663|NCT01830322|metastatic|metastatic
1244664|NCT01830322|pancreatic|pancreatic
1244665|NCT01830322|adenocarcinoma|adenocarcinoma
1244666|NCT01830322|cancer|cancer
1244667|NCT01830309|Food-Effect|food-effect
1244668|NCT01830309|Pharmacokinetics|pharmacokinetics
1244669|NCT01830309|Pharmacodynamics|pharmacodynamics
1244670|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
1244671|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
1244672|NCT01830296|remifentanil and|remifentanil and
1244673|NCT01830296|morphine.|morphine.
1244674|NCT01830270|medical oncology|medical oncology
1244675|NCT01830270|chemotherapy optimization|chemotherapy optimization
1244676|NCT01830270|dose density|dose density
1244677|NCT01830244|chemotherapy|chemotherapy
1244678|NCT01830244|nab paclitaxel|nab paclitaxel
1244679|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
1244680|NCT01830244|breast cancer|breast cancer
1244681|NCT01830244|pathologic complete response|pathologic complete response
1244683|NCT01830231|Vinflunine|vinflunine
1244684|NCT01830231|Cabazitaxel|cabazitaxel
1244685|NCT01830231|Metastatic|metastatic
1244686|NCT01830231|Locally advance|locally advance
1244687|NCT01830192|endometrial cancer|endometrial cancer
1244688|NCT01830192|score|score
1244689|NCT01830192|nomogram|nomogram
1244690|NCT01830192|ultrasound|ultrasound
1244691|NCT01830192|HE4|he4
1244692|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
1244693|NCT01830153|Bone sarcomas|bone sarcomas
1244694|NCT01830153|RAD001|rad001
1244695|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
1244696|NCT01830114|alcohol abuse|alcohol abuse
1244697|NCT01830114|drug abuse|drug abuse
1244698|NCT01830114|hazardous alcohol use|hazardous alcohol use
1244699|NCT01830114|hazardous drug use|hazardous drug use
1244700|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
1244701|NCT01830101|re-irradiation|re-irradiation
1244702|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
1244703|NCT01830036|cardiological treatment|cardiological treatment
1244704|NCT01830036|sleep Apnea|sleep apnea
1244705|NCT01830023|cardiac ultrasound|cardiac ultrasound
1244706|NCT01830023|vitality|vitality
1244707|NCT01830023|data|data
1244708|NCT01830023|patients|patients
1244709|NCT01830023|examined|examined
1244710|NCT01829984|Injection Teaching|injection teaching
1244711|NCT01829984|13-057|13-057
1244712|NCT01829971|microRNA|microrna
1244713|NCT01829971|Advanced cancer|advanced cancer
1244714|NCT01829958|Geriatric|geriatric
1244715|NCT01829958|Toxicity|toxicity
1244716|NCT01829958|rituximab|rituximab
1244717|NCT01829958|prednisone|prednisone
1244718|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
1244719|NCT01829958|13-028|13-028
1244720|NCT01829932|Diet|diet
1244721|NCT01829919|Menopause|menopause
1244722|NCT01829919|Hot flashes|hot flashes
1244723|NCT01829919|Vasomotor symptoms|vasomotor symptoms
1244724|NCT01829919|Climacteric symptoms|climacteric symptoms
1244725|NCT01829919|perimenopause|perimenopause
1244726|NCT01829919|Mesafem|mesafem
1244727|NCT01829919|Brisdelle|brisdelle
1244728|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
1244729|NCT01829906|weight loss|weight loss
1244935|NCT01828918|prediction|prediction
1244730|NCT01829906|bariatric surgery|bariatric surgery
1244731|NCT01829906|gastric bypass|gastric bypass
1244732|NCT01829906|health education|health education
1244733|NCT01829906|nutrition therapy|nutrition therapy
1244734|NCT01829906|diet|diet
1244735|NCT01829906|exercise|exercise
1244736|NCT01829906|cognitive therapy|cognitive therapy
1244737|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1244738|NCT01829893|pharmacokinetics|pharmacokinetics
1244739|NCT01829893|bioequivalence|bioequivalence
1244740|NCT01829893|finasteirde|finasteirde
1244741|NCT01829893|tamsulosin|tamsulosin
1244742|NCT01829880|Chronic heart failure|chronic heart failure
1244743|NCT01829880|Bisoprolol|bisoprolol
1244744|NCT01829880|Ramipril|ramipril
1244745|NCT01829880|Pharmacokinetic|pharmacokinetic
1244746|NCT01829880|Cachexia|cachexia
1244747|NCT01829880|Body composition|body composition
1244748|NCT01829880|Renal function|renal function
1244749|NCT01829880|Iohexol|iohexol
1244750|NCT01829841|MRCC|mrcc
1244751|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1244752|NCT01829841|Famitinib|famitinib
1244753|NCT01829841|Sunitinib|sunitinib
1244754|NCT01829828|Pain|pain
1244755|NCT01829828|Cancer pain|cancer pain
1244756|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
1244757|NCT01829828|Opioid analgesics|opioid analgesics
1244758|NCT01829815|Child|child
1244759|NCT01829815|Parents|parents
1244760|NCT01829815|Parenting|parenting
1244761|NCT01829815|Child Development|child development
1244762|NCT01829815|Parent Child Relations|parent child relations
1244763|NCT01829815|Malaria|malaria
1244764|NCT01829815|Primary Prevention|primary prevention
1244765|NCT01829815|Punishment|punishment
1244766|NCT01829815|Education|education
1244767|NCT01829802|HIV|hiv
1244768|NCT01829802|Raltegravir|raltegravir
1244769|NCT01829802|Boosted atazanavir|boosted atazanavir
1244770|NCT01829789|Adolescents|adolescents
1244771|NCT01829789|Teens|teens
1244772|NCT01829789|Parents|parents
1244773|NCT01829789|Parenting|parenting
1244774|NCT01829789|Substance Abuse|substance abuse
1244775|NCT01829789|Treatment Efficacy|treatment efficacy
1244776|NCT01829776|Accidental falls|accidental falls
1244777|NCT01829776|Multiple Sclerosis|multiple sclerosis
1244778|NCT01829776|Education|education
1244779|NCT01829776|Exercise|exercise
1244780|NCT01829776|Postural balance|postural balance
1244781|NCT01829750|Univentricular heart|univentricular heart
1244782|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
1244783|NCT01829737|RBC Polymorphism|rbc polymorphism
1244784|NCT01829737|Acquired Immunity|acquired immunity
1244785|NCT01829724|Functional Brain Imaging|functional brain imaging
1244786|NCT01829724|Cerebral Palsy|cerebral palsy
1244787|NCT01829724|Motion Analysis|motion analysis
1244788|NCT01829724|Macro- EMG|macro- emg
1244789|NCT01829711|Moxetumomab Paudotox|moxetumomab paudotox
1244790|NCT01829711|CAT-8015|cat-8015
1244791|NCT01829711|anti-CD22 recombination immunotoxin|anti-cd22 recombination immunotoxin
1244792|NCT01829711|Biologic Therapy|biologic therapy
1244793|NCT01829711|Recombinant Immunotoxin|recombinant immunotoxin
1244794|NCT01829711|Monoclonal Antibody|monoclonal antibody
1244795|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
1244796|NCT01829711|Targeted Therapy|targeted therapy
1244797|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
1244798|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
1244799|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
1244800|NCT01829646|DWI|dwi
1244801|NCT01829646|DCE MRI|dce mri
1244802|NCT01829646|ADC|adc
1244803|NCT01829646|FDG PET|fdg pet
1244804|NCT01829646|Hypoxia|hypoxia
1244805|NCT01829646|Prognostic and predictive model|prognostic and predictive model
1244806|NCT01829620|suicide|suicide
1244807|NCT01829620|suicide intervention|suicide intervention
1244808|NCT01829620|suicide prevention|suicide prevention
1244809|NCT01829620|military|military
1244810|NCT01829620|military suicide|military suicide
1244811|NCT01829620|caring letters|caring letters
1244812|NCT01829620|caring contacts|caring contacts
1244813|NCT01829620|text messages|text messages
1244814|NCT01829594|Case Management|case management
1244815|NCT01829594|Frail Elderly|frail elderly
1244816|NCT01829594|Health Services Administration|health services administration
1244817|NCT01829594|Delivery of Health Care|delivery of health care
1244818|NCT01829594|Accidental Falls|accidental falls
1244819|NCT01829594|Health Status|health status
1244820|NCT01829594|Health Care Economics|health care economics
1244821|NCT01829542|flow-mediated dilation|flow-mediated dilation
1244822|NCT01829542|blueberry polyphenols|blueberry polyphenols
1244823|NCT01829542|dose-dependency|dose-dependency
1244824|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
1244825|NCT01829503|Phase II|phase ii
1244826|NCT01829503|decitabine|decitabine
1244827|NCT01829503|cytarabine|cytarabine
1244828|NCT01829503|older patients|older patients
1244829|NCT01829503|newly diagnosed|newly diagnosed
1244831|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
1244832|NCT01829490|Vaccine|vaccine
1244833|NCT01829490|Immunogenicity|immunogenicity
1244834|NCT01829477|Drug Therapy|drug therapy
1244835|NCT01829464|Drug Therapy|drug therapy
1244836|NCT01829438|exercise tolerance|exercise tolerance
1244837|NCT01829438|6MWT|6mwt
1244838|NCT01829425|Hypnosis|hypnosis
1244839|NCT01829425|Mind-Body Therapy|mind-body therapy
1244840|NCT01829425|Anticholinergics|anticholinergics
1244841|NCT01829425|fMRI|fmri
1244842|NCT01829425|Functional Neuroimaging|functional neuroimaging
1244843|NCT01829425|Gyrus Cinguli|gyrus cinguli
1244844|NCT01829425|Female Urogenital Diseases|female urogenital diseases
1244845|NCT01829399|Tourniquet pain|tourniquet pain
1244846|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
1244847|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
1244848|NCT01829373|lung cancer|lung cancer
1244849|NCT01829347|liver failure|liver failure
1244850|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
1244851|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
1244852|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
1244853|NCT01829347|steroid failure|steroid failure
1244854|NCT01829347|Lille criteria|lille criteria
1244855|NCT01829347|ELAD|elad
1244856|NCT01829334|dental caries|dental caries
1244857|NCT01829308|implementation|implementation
1244858|NCT01829308|SBIRT|sbirt
1244859|NCT01829308|alcohol screening|alcohol screening
1244860|NCT01829308|drug screening|drug screening
1244861|NCT01829308|Brief Intervention|brief intervention
1244862|NCT01829308|Referral to Treatment|referral to treatment
1244863|NCT01829308|adolescents|adolescents
1244864|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
1244865|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
1244866|NCT01829282|Implementation|implementation
1244867|NCT01829282|HIV|hiv
1244868|NCT01829282|serodiscordant couples|serodiscordant couples
1244869|NCT01829282|African American|african american
1244870|NCT01829282|Cultural congruency|cultural congruency
1244871|NCT01829243|Milnacipran|milnacipran
1244872|NCT01829243|Fibromyalgia|fibromyalgia
1244873|NCT01829243|Neurocognition|neurocognition
1244874|NCT01829178|cisplatin|cisplatin
1244875|NCT01829178|nephrotoxicity|nephrotoxicity
1244876|NCT01829178|antioxidant|antioxidant
1244877|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
1244878|NCT01829152|heart failure|heart failure
1244879|NCT01829139|Common bile duct stone|common bile duct stone
1244880|NCT01829139|Gallbladder in situ|gallbladder in situ
1244881|NCT01829139|Choleretics|choleretics
1244883|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
1244884|NCT01829113|OGX-427|ogx-427
1244885|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
1244886|NCT01829113|SCRI|scri
1244887|NCT01829113|OncoGenex|oncogenex
1244888|NCT01829113|NSCLC|nsclc
1244889|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
1244890|NCT01829100|Adolescent|adolescent
1244891|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
1244892|NCT01829100|Behavioral activation|behavioral activation
1244893|NCT01829100|Exposure therapy|exposure therapy
1244894|NCT01829100|Depressive Disorder|depressive disorder
1244895|NCT01829100|Anxiety Disorders|anxiety disorders
1244896|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
1244897|NCT01829074|Hoarseness|hoarseness
1244898|NCT01829074|Throat Clearing|throat clearing
1244899|NCT01829074|Globus Sensation|globus sensation
1244900|NCT01829061|Type I Diabetes|type i diabetes
1244901|NCT01829061|Type II Diabetes|type ii diabetes
1244902|NCT01829061|HbA1C|hba1c
1244903|NCT01829048|PF-02545920|pf-02545920
1244904|NCT01829048|safety|safety
1244905|NCT01829048|schizophrenia|schizophrenia
1244906|NCT01829035|TACE|tace
1244907|NCT01829035|Sorafenib|sorafenib
1244908|NCT01829022|Myoma|myoma
1244909|NCT01829022|Uterine myomectomy|uterine myomectomy
1244910|NCT01829009|Sarcopenia|sarcopenia
1244911|NCT01829009|Elderly|elderly
1244912|NCT01829009|Women|women
1244913|NCT01829009|Resistance|resistance
1244914|NCT01829009|Exercise|exercise
1244915|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
1244916|NCT01828996|Chronic prostatitis|chronic prostatitis
1244917|NCT01828996|Shock wave therapy|shock wave therapy
1244918|NCT01828996|Prostate|prostate
1244919|NCT01828996|Pelvic floor|pelvic floor
1244920|NCT01828996|Pain|pain
1244921|NCT01828983|Telephone|telephone
1244922|NCT01828983|Support groups|support groups
1244923|NCT01828983|Social support|social support
1244924|NCT01828983|Depression|depression
1244925|NCT01828970|Diabetes Mellitus|diabetes mellitus
1244926|NCT01828970|Hemodialysis|hemodialysis
1244927|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
1244928|NCT01828970|Insulin analogues|insulin analogues
1244929|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
1244930|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1244931|NCT01828957|Premature infants|premature infants
1244932|NCT01828944|Vitamin D|vitamin d
1244933|NCT01828944|bone loss|bone loss
1244934|NCT01828918|early diagnosis|early diagnosis
1244936|NCT01828918|prognosis|prognosis
1244937|NCT01828905|tibia fracture|tibia fracture
1244938|NCT01828905|bone graft|bone graft
1244939|NCT01828905|iliac crest|iliac crest
1244940|NCT01828905|bone graft substitute|bone graft substitute
1244941|NCT01828905|Cerament|cerament
1244942|NCT01828905|void filler|void filler
1244943|NCT01828905|quality of life|quality of life
1244944|NCT01828905|pain|pain
1244945|NCT01828905|costs of care|costs of care
1244946|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
1244947|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
1244948|NCT01828892|Single low output GI fistulas|single low output gi fistulas
1244949|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
1244950|NCT01828879|Tacrolimus|tacrolimus
1244951|NCT01828866|EMDR|emdr
1244952|NCT01828866|Alcohol|alcohol
1244953|NCT01828866|Relapse|relapse
1244954|NCT01828866|Craving|craving
1244955|NCT01828853|Membrane sweeping|membrane sweeping
1244956|NCT01828853|Membrane stripping|membrane stripping
1244957|NCT01828853|Maternal outcomes|maternal outcomes
1244958|NCT01828853|Neonatal outcomes|neonatal outcomes
1244959|NCT01828840|morphine|morphine
1244960|NCT01828840|fentanyl|fentanyl
1244961|NCT01828840|methadone|methadone
1244962|NCT01828840|epidural|epidural
1244963|NCT01828840|intravenous|intravenous
1244964|NCT01828840|pain|pain
1244965|NCT01828840|analgesia|analgesia
1244966|NCT01828827|tuberculosis|tuberculosis
1244968|NCT01828827|PA-824|pa-824
1244969|NCT01828827|food effect,|food effect,
1244970|NCT01828827|bioavailability|bioavailability
1244971|NCT01828827|pretomanid|pretomanid
1244972|NCT01828827|CL-003|cl-003
1244973|NCT01828814|pediatrics|pediatrics
1244974|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
1244975|NCT01828814|corn soy blend|corn soy blend
1244976|NCT01828814|cash transfer|cash transfer
1244977|NCT01828814|prevention of malnutrition|prevention of malnutrition
1244978|NCT01828814|Niger|niger
1244979|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
1244980|NCT01828801|Metal Ions|metal ions
1244981|NCT01828801|Serum|serum
1244982|NCT01828801|Whole Blood|whole blood
1244983|NCT01828801|Metal-on-Metal|metal-on-metal
1244984|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
1244985|NCT01828788|Sternotomy|sternotomy
1244986|NCT01828788|Anesthesia|anesthesia
1244987|NCT01828788|Post-operative pain|post-operative pain
1244989|NCT01828762|Immunotherapy|immunotherapy
1244990|NCT01828762|TC|tc
1244991|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
1244992|NCT01828749|CT|ct
1244993|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
1244994|NCT01828736|Urothelial carcinoma|urothelial carcinoma
1244995|NCT01828736|Trastuzumab|trastuzumab
1244996|NCT01828736|Treatment|treatment
1244997|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
1244998|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
1244999|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
1245000|NCT01828723|SVF|svf
1245001|NCT01828723|Antria|antria
1245002|NCT01828723|Shah Rahimian|shah rahimian
1245003|NCT01828723|Leonard Maliver|leonard maliver
1245004|NCT01828723|David Bizousky|david bizousky
1245005|NCT01828723|Rahul Gore|rahul gore
1245006|NCT01828723|Lee Quist|lee quist
1245007|NCT01828723|Dudley McNitt|dudley mcnitt
1245008|NCT01828710|Myo-inositol|myo-inositol
1245009|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
1245010|NCT01828710|semen parameters|semen parameters
1245011|NCT01828710|IVF|ivf
1245012|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
1245013|NCT01828697|Pregnancy|pregnancy
1245014|NCT01828697|Venous thrombosis|venous thrombosis
1245015|NCT01828684|Migraine with Aura|migraine with aura
1245016|NCT01828684|Migraine without Aura|migraine without aura
1245017|NCT01828684|Photophobia|photophobia
1245018|NCT01828684|Chronic Daily Headache|chronic daily headache
1245019|NCT01828671|Soy|soy
1245020|NCT01828671|Corn|corn
1245021|NCT01828671|Flour|flour
1245022|NCT01828671|Tortilla|tortilla
1245023|NCT01828671|Glycemic|glycemic
1245024|NCT01828671|Glucose,|glucose,
1245025|NCT01828671|glycemic index|glycemic index
1245026|NCT01828658|hemodialysis|hemodialysis
1245027|NCT01828658|fluid management|fluid management
1245028|NCT01828658|bioimpedance|bioimpedance
1245029|NCT01828658|mortality|mortality
1245030|NCT01828658|arterial stiffness|arterial stiffness
1245031|NCT01828645|gastric emptying|gastric emptying
1245032|NCT01828645|whey protein|whey protein
1245033|NCT01828645|carbohydrate|carbohydrate
1245034|NCT01828645|fasting|fasting
1245035|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
1245036|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1245037|NCT01828619|Busulfan|busulfan
1245038|NCT01828619|Fludarabine|fludarabine
1245039|NCT01828606|leg lymphedema|leg lymphedema
1245040|NCT01828606|volume measurement|volume measurement
1245041|NCT01828606|compression therapy|compression therapy
1245042|NCT01828606|interface pressure|interface pressure
1245043|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
1245044|NCT01828606|volume change|volume change
1245045|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1245046|NCT01828580|Gallbladder removal|gallbladder removal
1245047|NCT01828580|laparoscope holder|laparoscope holder
1245048|NCT01828567|veterans|veterans
1245049|NCT01828567|health risk assessment|health risk assessment
1245050|NCT01828567|primary prevention|primary prevention
1245051|NCT01828567|shared decision making|shared decision making
1245052|NCT01828567|Healthy Living Assessment|healthy living assessment
1245053|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
1245054|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
1245055|NCT01828554|Advanced Solid Tumors|advanced solid tumors
1245056|NCT01828541|Burn injuries|burn injuries
1245057|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1245058|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1245059|NCT01828528|Obesity|obesity
1245060|NCT01828528|Bariatric surgery|bariatric surgery
1245061|NCT01828528|Weight loss|weight loss
1245062|NCT01828502|Cotinine|cotinine
1245063|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
1245064|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
1245065|NCT01828476|prostate cancer|prostate cancer
1245066|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1245067|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
1245068|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
1245069|NCT01828424|acute pain|acute pain
1245070|NCT01828411|Cardiac surgery|cardiac surgery
1245071|NCT01828411|Echocardiography|echocardiography
1245072|NCT01828411|Cerebral perfusion|cerebral perfusion
1245073|NCT01828411|Intraoperative period|intraoperative period
1245074|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
1245075|NCT01828385|Rocuronium|rocuronium
1245076|NCT01828385|Sugammadex sodium|sugammadex sodium
1245077|NCT01828385|Magnesium|magnesium
1245078|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1245079|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
1245080|NCT01828385|Pharmacologic Actions|pharmacologic actions
1245081|NCT01828372|concomitant diseases|concomitant diseases
1245082|NCT01828372|multiple drug consumption|multiple drug consumption
1245083|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
1245084|NCT01828372|TDM|tdm
1245085|NCT01828372|drug monitoring|drug monitoring
1245086|NCT01828372|drug level|drug level
1245087|NCT01828372|quantification|quantification
1245088|NCT01828372|drug|drug
1245089|NCT01828372|drug concentration|drug concentration
1245090|NCT01828372|concentration|concentration
1245091|NCT01828372|therapeutic range|therapeutic range
1245092|NCT01828372|therapeutic index|therapeutic index
1245093|NCT01828346|TL32711|tl32711
1245094|NCT01828346|Birinapant|birinapant
1245095|NCT01828346|5-Azacitidine|5-azacitidine
1245096|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
1245097|NCT01828346|MDS|mds
1245098|NCT01828346|Relapsed|relapsed
1245099|NCT01828346|Refractory|refractory
1245100|NCT01828346|Failed|failed
1245101|NCT01828346|open-label|open-label
1245102|NCT01828346|non-Randomized|non-randomized
1245103|NCT01828346|dose-escalation|dose-escalation
1245104|NCT01828346|dose-expansion|dose-expansion
1245105|NCT01828333|Malaria|malaria
1245106|NCT01828333|Severe|severe
1245107|NCT01828333|Artesunate|artesunate
1245108|NCT01828333|Quinine|quinine
1245109|NCT01828333|Democratic Republic of Congo|democratic republic of congo
1245110|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
1245111|NCT01828294|MG|mg
1245112|NCT01828268|HIV|hiv
1245113|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
1245114|NCT01828242|HbA1C|hba1c
1245115|NCT01828229|Inactivity|inactivity
1245116|NCT01828229|Obesity|obesity
1245117|NCT01828229|Type 2 diabetes|type 2 diabetes
1245118|NCT01828229|glucose metabolism|glucose metabolism
1245119|NCT01828229|Lipid metabolism|lipid metabolism
1245120|NCT01828229|Cognitive function|cognitive function
1245121|NCT01828203|minocycline|minocycline
1245122|NCT01828203|randomized control trial|randomized control trial
1245123|NCT01828203|phase 3|phase 3
1245124|NCT01828203|spinal cord injury|spinal cord injury
1245125|NCT01828190|crohn's disease|crohn's disease
1245126|NCT01828190|perianal fistulas|perianal fistulas
1245127|NCT01828190|TNF alpha blockers|tnf alpha blockers
1245128|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1245129|NCT01828177|PreCision|precision
1245130|NCT01828177|PDI-320|pdi-320
1245131|NCT01828177|Foam|foam
1245132|NCT01828164|Orthodontics|orthodontics
1245133|NCT01828164|Braces|braces
1245134|NCT01828164|Tooth|tooth
1245135|NCT01828151|Pressure ulcer|pressure ulcer
1245136|NCT01828151|Noninvasive ventilation|noninvasive ventilation
1245137|NCT01828138|Proteinuria|proteinuria
1245138|NCT01828138|Pregnancy|pregnancy
1245139|NCT01828138|Hypertension|hypertension
1245140|NCT01828138|Plasmin|plasmin
1245141|NCT01828138|Plasminogen|plasminogen
1245142|NCT01828138|Aldosterone|aldosterone
1245143|NCT01828138|Angiotensin|angiotensin
1245144|NCT01828138|Renin|renin
1245145|NCT01828138|sodium chloride|sodium chloride
1245146|NCT01828138|epithelial sodium channel|epithelial sodium channel
1245147|NCT01828138|Placenta|placenta
1245148|NCT01828125|Type 1 diabetes|type 1 diabetes
1245149|NCT01828125|Hypoglycemia|hypoglycemia
1245150|NCT01828125|Glucagon|glucagon
1245151|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
1245152|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
1245154|NCT01828112|LDK378|ldk378
1245155|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1245156|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
1245157|NCT01828112|lung cancer|lung cancer
1245158|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
1245159|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
1245160|NCT01828112|Non small cell lung cancer|non small cell lung cancer
1245161|NCT01828112|NSCLC|nsclc
1245162|NCT01828112|chemotherapy|chemotherapy
1245163|NCT01828112|ALK-positive|alk-positive
1245164|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
1245165|NCT01828112|crizotinib|crizotinib
1245166|NCT01828099|Non-Small Cell Lung Cancer|non-small cell lung cancer
1245167|NCT01828099|NSCLC|nsclc
1245168|NCT01828099|ALK|alk
1245169|NCT01828099|LDK378|ldk378
1245170|NCT01828099|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1245171|NCT01828099|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
1245172|NCT01828099|lung cancer|lung cancer
1245173|NCT01828099|lung adenocarcinoma|lung adenocarcinoma
1245174|NCT01828099|Non small cell lung carcinoma|non small cell lung carcinoma
1245175|NCT01828099|Non small cell lung cancer|non small cell lung cancer
1599230|NCT00397267|Dyspnea|dyspnea
1245176|NCT01828099|non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
1245177|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
1245178|NCT01828034|Gemcitabine|gemcitabine
1245179|NCT01828034|Cisplatin|cisplatin
1245180|NCT01828034|MEK162|mek162
1245181|NCT01828034|13-004|13-004
1245182|NCT01828021|HER2 2+|her2 2+
1245183|NCT01828021|FISH non-amplified|fish non-amplified
1245184|NCT01828021|Relapsed|relapsed
1245185|NCT01828021|Refractory|refractory
1245186|NCT01828021|Advanced|advanced
1245187|NCT01828021|Margetuximab|margetuximab
1245188|NCT01828021|MGAH22|mgah22
1245189|NCT01828008|Mabthera|mabthera
1245190|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
1245191|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
1245192|NCT01827995|follow up|follow up
1245193|NCT01827995|medical abortion|medical abortion
1245194|NCT01827995|rural India|rural india
1245196|NCT01827982|Healthy|healthy
1245197|NCT01827982|Safety|safety
1245198|NCT01827982|Tolerability|tolerability
1245199|NCT01827982|Pharmacokinetic|pharmacokinetic
1245200|NCT01827982|Alzheimer's Disease|alzheimer's disease
1245201|NCT01827982|JNJ-54861911|jnj-54861911
1245202|NCT01827969|Women|women
1245203|NCT01827969|breast tumor|breast tumor
1245204|NCT01827969|planned mastectomy|planned mastectomy
1245205|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
1245206|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
1245207|NCT01827956|Cetuximab efficacy|cetuximab efficacy
1245208|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
1245209|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
1245210|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
1245211|NCT01827891|acute kidney injury|acute kidney injury
1245212|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
1245213|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
1245214|NCT01827839|Adults|adults
1245215|NCT01827839|Safety|safety
1245216|NCT01827839|Immunogenicity|immunogenicity
1245217|NCT01827839|Zoster|zoster
1245218|NCT01827826|Intervention|intervention
1245219|NCT01827826|Telephone|telephone
1245220|NCT01827826|Diabetes|diabetes
1245221|NCT01827826|Prevention|prevention
1245222|NCT01827813|prostate-specific antigen|prostate-specific antigen
1245223|NCT01827813|digital rectal examination|digital rectal examination
1245224|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
1245225|NCT01827813|needle biopsy|needle biopsy
1245226|NCT01827813|prostate cancer|prostate cancer
1245227|NCT01827800|weight loss|weight loss
1245228|NCT01827800|primary care|primary care
1245229|NCT01827800|eHealth|ehealth
1245230|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
1245231|NCT01827774|Graft repair|graft repair
1245232|NCT01827761|chemotherapy teaching|chemotherapy teaching
1245233|NCT01827761|questionnaire|questionnaire
1245234|NCT01827748|Autorefractor|autorefractor
1245235|NCT01827735|Interleukin 2|interleukin 2
1245236|NCT01827735|Type 1 diabetes|type 1 diabetes
1245237|NCT01827735|T regulatory cells|t regulatory cells
1245238|NCT01827735|Adaptive trial|adaptive trial
1245239|NCT01827722|Macular edema|macular edema
1245536|NCT01826487|PTC124|ptc124
1245240|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
1245241|NCT01827722|CRVO|crvo
1245242|NCT01827722|Retinal vein occlusion|retinal vein occlusion
1245243|NCT01827722|RVO|rvo
1245244|NCT01827722|Ozurdex|ozurdex
1245245|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
1245246|NCT01827722|Lucentis|lucentis
1245247|NCT01827722|Ranibizumab|ranibizumab
1245248|NCT01827709|DWI|dwi
1245249|NCT01827709|ADC|adc
1245250|NCT01827709|DCE-MRI|dce-mri
1245251|NCT01827709|FDG-PET|fdg-pet
1245252|NCT01827709|SUV|suv
1245253|NCT01827709|Hypoxia|hypoxia
1245254|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1245255|NCT01827696|Muscle|muscle
1245256|NCT01827696|Soreness|soreness
1245257|NCT01827696|Muscle function|muscle function
1245258|NCT01827696|Damage|damage
1245259|NCT01827696|Ginseng|ginseng
1245260|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
1245261|NCT01827683|fibromyalgia|fibromyalgia
1245262|NCT01827683|chronic pain syndrome|chronic pain syndrome
1245263|NCT01827657|plasma|plasma
1245264|NCT01827657|tolerability|tolerability
1245265|NCT01827657|safety|safety
1245266|NCT01827657|matched control|matched control
1245267|NCT01827657|GSK2336805|gsk2336805
1245268|NCT01827657|hepatic impairment|hepatic impairment
1245269|NCT01827657|pharmacokinetics|pharmacokinetics
1245270|NCT01827644|AKT inhibitor|akt inhibitor
1245271|NCT01827644|formulation|formulation
1245272|NCT01827644|food effect|food effect
1245273|NCT01827644|bioavailability|bioavailability
1245274|NCT01827644|GSK2110183|gsk2110183
1245275|NCT01827631|healthy|healthy
1245276|NCT01827631|GSK1605786|gsk1605786
1245277|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
1245278|NCT01827631|Chinese subjects|chinese subjects
1245279|NCT01827631|pharmacokinetics|pharmacokinetics
1245280|NCT01827618|bladder|bladder
1245281|NCT01827618|Cancer|cancer
1245282|NCT01827618|Cystectomy|cystectomy
1245283|NCT01827618|Rapamycin|rapamycin
1245284|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
1245285|NCT01827605|RIT|rit
1245286|NCT01827605|Zevalin|zevalin
1245287|NCT01827579|Transplant|transplant
1245288|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
1245289|NCT01827579|Infection|infection
1245290|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
1245291|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
1245292|NCT01827579|Adult|adult
1245293|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1245294|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
1245295|NCT01827566|Celiac Disease|celiac disease
1245296|NCT01827566|Gluten Sensitivity|gluten sensitivity
1245297|NCT01827566|Gluten|gluten
1245298|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
1245299|NCT01827566|Gluten free flour|gluten free flour
1245300|NCT01827553|pancreatic cancer|pancreatic cancer
1245301|NCT01827553|chemoradiotherapy|chemoradiotherapy
1245302|NCT01827553|chemotherapy|chemotherapy
1245303|NCT01827553|FOLFIRINOX|folfirinox
1245304|NCT01827553|gemcitabine|gemcitabine
1245305|NCT01827540|HIV/AIDS|hiv/aids
1245306|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
1245307|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
1245308|NCT01827540|Midazolam|midazolam
1245309|NCT01827540|Healthy Subjects|healthy subjects
1245310|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
1245311|NCT01827527|Validation|validation
1245312|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1245313|NCT01827527|Optical Spectroscopy|optical spectroscopy
1245314|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
1245315|NCT01827501|postoperative delirium|postoperative delirium
1245316|NCT01827501|hemodynamic management|hemodynamic management
1245317|NCT01827501|goal directed therapy|goal directed therapy
1245318|NCT01827475|musculoskeletal pain|musculoskeletal pain
1245319|NCT01827475|acetaminophen|acetaminophen
1245320|NCT01827475|ibuprofen|ibuprofen
1245321|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
1245322|NCT01827462|elderly|elderly
1245323|NCT01827462|immunosenescence|immunosenescence
1245324|NCT01827462|longitudinal study|longitudinal study
1245325|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
1245326|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
1245327|NCT01827462|young adults|young adults
1245328|NCT01827449|rewarming|rewarming
1245329|NCT01827449|core cooling|core cooling
1245330|NCT01827449|afterdrop|afterdrop
1245331|NCT01827449|hospital treatment|hospital treatment
1245332|NCT01827449|hypothermia|hypothermia
1245333|NCT01827436|pediatric stroke|pediatric stroke
1245334|NCT01827436|hemiplegia|hemiplegia
1245335|NCT01827436|physical therapy|physical therapy
1245336|NCT01827436|gait training|gait training
1245337|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
1245338|NCT01827436|gait asymmetry|gait asymmetry
1245339|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
1245340|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
1245537|NCT01826487|Ataluren|ataluren
1245341|NCT01827423|clinical marker|clinical marker
1245342|NCT01827423|hidden reccurence|hidden reccurence
1245343|NCT01827423|surgery|surgery
1245344|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
1245345|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
1245346|NCT01827358|antibacterial agent|antibacterial agent
1245347|NCT01827358|children|children
1245348|NCT01827358|colonisation|colonisation
1245349|NCT01827358|critically ill|critically ill
1245350|NCT01827358|infants|infants
1245351|NCT01827358|mupirocin|mupirocin
1245352|NCT01827358|prevention|prevention
1245353|NCT01827358|Staphylococcus aureus|staphylococcus aureus
1245354|NCT01827345|Vitamin D|vitamin d
1245355|NCT01827345|Falls|falls
1245356|NCT01827345|Balance|balance
1245357|NCT01827345|Physical Function|physical function
1245358|NCT01827332|marijuana|marijuana
1245359|NCT01827332|substance abuse|substance abuse
1245360|NCT01827332|drug abuse|drug abuse
1245361|NCT01827332|marijuana dependence|marijuana dependence
1245362|NCT01827332|drug addiction|drug addiction
1245363|NCT01827319|Angina|angina
1245364|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
1245365|NCT01827280|endothelial function|endothelial function
1245366|NCT01827280|microvascular function|microvascular function
1245367|NCT01827280|incretins|incretins
1245368|NCT01827280|diabetes mellitus|diabetes mellitus
1245369|NCT01827280|postprandial lipemia|postprandial lipemia
1245370|NCT01827267|Lung cancer|lung cancer
1245371|NCT01827267|Puma|puma
1245372|NCT01827267|neratinib|neratinib
1245373|NCT01827267|HKI-272|hki-272
1245374|NCT01827267|PB-272|pb-272
1245375|NCT01827267|Nerlynx|nerlynx
1245376|NCT01827254|sutent rechallenge|sutent rechallenge
1245377|NCT01827241|Gastroenterology|gastroenterology
1245378|NCT01827241|Colonoscopy|colonoscopy
1245379|NCT01827241|Screening|screening
1245380|NCT01827241|Surveillance|surveillance
1245381|NCT01827241|Symptom evaluation|symptom evaluation
1245382|NCT01827241|Chart review|chart review
1245383|NCT01827241|Data review|data review
1245384|NCT01827241|Examination findings|examination findings
1245385|NCT01827241|Resection techniques|resection techniques
1245386|NCT01827241|Pathology reports|pathology reports
1245387|NCT01827228|HIV|hiv
1245388|NCT01827228|transmission prevention|transmission prevention
1245389|NCT01827228|social network and venue|social network and venue
1245390|NCT01827228|community intervention|community intervention
1245391|NCT01827228|treatment as prevention|treatment as prevention
1245392|NCT01827228|recent infection|recent infection
1245393|NCT01827228|phylogenetics|phylogenetics
1245394|NCT01827228|infection chains|infection chains
1245395|NCT01827215|Preconception Care|preconception care
1245396|NCT01827215|Racial Disparities|racial disparities
1245397|NCT01827215|Health Information Technology|health information technology
1245398|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
1245399|NCT01827202|RAS blockade|ras blockade
1245400|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
1245401|NCT01827176|Characteristic|characteristic
1245402|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
1245403|NCT01827176|Children|children
1245404|NCT01827163|Paclitaxel|paclitaxel
1245405|NCT01827163|Trastuzumab|trastuzumab
1245406|NCT01827163|Lapatinib|lapatinib
1245408|NCT01827163|13-002|13-002
1245409|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
1245410|NCT01827137|12-288|12-288
1245411|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
1245412|NCT01827111|Melanoma|melanoma
1245413|NCT01827111|Metastatic Melanoma|metastatic melanoma
1245414|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
1245415|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
1245416|NCT01827111|Cutaneous melanoma|cutaneous melanoma
1245417|NCT01827111|Progression-free survival|progression-free survival
1245418|NCT01827111|(PFS)|(pfs)
1245419|NCT01827111|ABI-007|abi-007
1245420|NCT01827111|Nab-paclitaxel|nab-paclitaxel
1245421|NCT01827111|Paclitaxel|paclitaxel
1245422|NCT01827111|Abraxane|abraxane
1245423|NCT01827111|Ipilimumab|ipilimumab
1245424|NCT01827111|Yervoy|yervoy
1245425|NCT01827111|BMS-734016|bms-734016
1245426|NCT01827111|MDX010|mdx010
1245427|NCT01827098|Immature teeth|immature teeth
1245428|NCT01827098|Calcium Hydroxide|calcium hydroxide
1245429|NCT01827098|Blood clot|blood clot
1245430|NCT01827098|Revascularization|revascularization
1245431|NCT01827098|Revitalization|revitalization
1245432|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
1245433|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
1245434|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
1245435|NCT01827046|ICH|ich
1245733|NCT01825473|apnea|apnea
1245436|NCT01827046|brain hemorrhage|brain hemorrhage
1245437|NCT01827046|minimally invasive surgery|minimally invasive surgery
1245438|NCT01827046|rt-PA|rt-pa
1245439|NCT01827007|norepinephrine infusion|norepinephrine infusion
1245440|NCT01827007|under 48 hours in ICU|under 48 hours in icu
1245441|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
1245442|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
1245443|NCT01826942|Scar prevention|scar prevention
1245444|NCT01826942|CO2 fractional laser|co2 fractional laser
1245445|NCT01826929|Health Services Research|health services research
1245446|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
1245447|NCT01826929|Primary Care|primary care
1245448|NCT01826929|Secondary Prevention.|secondary prevention.
1245449|NCT01826903|Depression|depression
1245450|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
1245451|NCT01826903|Child Development|child development
1245452|NCT01826890|Ventilator Weaning|ventilator weaning
1245453|NCT01826890|Mechanical Ventilation|mechanical ventilation
1245454|NCT01826890|Critical Care|critical care
1245455|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1245456|NCT01826890|Diaphragm|diaphragm
1245457|NCT01826851|Pain management|pain management
1245458|NCT01826851|Anesthetic, local|anesthetic, local
1245459|NCT01826851|Nerve blockade|nerve blockade
1245460|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1245461|NCT01826851|Analgesics, opioid|analgesics, opioid
1245462|NCT01826851|Postoperative complications|postoperative complications
1245463|NCT01826851|Bupivacaine|bupivacaine
1245464|NCT01826838|Prostate Cancer|prostate cancer
1245465|NCT01826825|aging|aging
1245466|NCT01826825|cognition|cognition
1245467|NCT01826825|surgery|surgery
1245468|NCT01826799|sleep|sleep
1245469|NCT01826799|noise|noise
1245470|NCT01826799|ICU|icu
1245471|NCT01826799|delirium|delirium
1245472|NCT01826799|RCSQ|rcsq
1245473|NCT01826786|Healthy|healthy
1245474|NCT01826786|Anxiety Disorders|anxiety disorders
1245475|NCT01826786|Anxiety Modulation|anxiety modulation
1245476|NCT01826786|Male|male
1245477|NCT01826773|CardioPET|cardiopet
1245478|NCT01826773|Coronary Artery Disease|coronary artery disease
1245479|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
1245480|NCT01826773|Coronary Angiography|coronary angiography
1245481|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
1245482|NCT01826747|intrauterine insemination|intrauterine insemination
1245483|NCT01826747|luteal phase|luteal phase
1245484|NCT01826747|gonadotrophins|gonadotrophins
1245485|NCT01826734|dacryolith|dacryolith
1245486|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
1245487|NCT01826734|composition|composition
1245488|NCT01826734|chemical analysis|chemical analysis
1245489|NCT01826734|infrared spectrometry|infrared spectrometry
1245490|NCT01826734|scanning electron microscopy|scanning electron microscopy
1245491|NCT01826734|elemental analysis|elemental analysis
1245492|NCT01826721|Solid organ transplantation|solid organ transplantation
1245493|NCT01826721|Immunosuppression|immunosuppression
1245494|NCT01826721|Education|education
1245495|NCT01826721|E-learning|e-learning
1245496|NCT01826721|Medication knowledge|medication knowledge
1245497|NCT01826721|Patient satisfaction|patient satisfaction
1245498|NCT01826721|Medication adherence|medication adherence
1245499|NCT01826708|Chromosomal translocations|chromosomal translocations
1245500|NCT01826708|psychomotor delay|psychomotor delay
1245501|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
1245502|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
1245503|NCT01826656|intramembranous bone healing|intramembranous bone healing
1245504|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
1245505|NCT01826656|tooth extraction|tooth extraction
1245506|NCT01826630|CLn Body Wash|cln body wash
1245507|NCT01826630|CLn BodyWash|cln bodywash
1245508|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
1245509|NCT01826617|Asian Men|asian men
1245510|NCT01826604|cesarean section|cesarean section
1245511|NCT01826604|Pregnant|pregnant
1245512|NCT01826565|success|success
1245513|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
1245514|NCT01826552|Drug-eluting stent|drug-eluting stent
1245515|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
1245516|NCT01826552|Coronary heart disease|coronary heart disease
1245517|NCT01826552|Cobalt chromium|cobalt chromium
1245518|NCT01826539|Dorsal digital nerve|dorsal digital nerve
1245519|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
1245520|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
1245521|NCT01826539|dorsal digital island flap|dorsal digital island flap
1245522|NCT01826539|finger pulp defect.|finger pulp defect.
1245523|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
1245524|NCT01826513|Efficacy|efficacy
1245525|NCT01826513|Subjective feedback|subjective feedback
1245526|NCT01826513|Preference|preference
1245527|NCT01826500|embryo transfer|embryo transfer
1245528|NCT01826500|IVF cycle|ivf cycle
1245529|NCT01826500|endometriosis|endometriosis
1245530|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
1245531|NCT01826487|Dystrophinopathy|dystrophinopathy
1245532|NCT01826487|Nonsense mutation|nonsense mutation
1245533|NCT01826487|Premature stop codon|premature stop codon
1245534|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
1245535|NCT01826487|DMD/BMD|dmd/bmd
1245538|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
1245539|NCT01826474|DMD|dmd
1245540|NCT01826474|Prosensa|prosensa
1245541|NCT01826474|Duchenne|duchenne
1245542|NCT01826461|atopic dermatitis|atopic dermatitis
1245543|NCT01826461|eczema|eczema
1245544|NCT01826461|PDI-192|pdi-192
1245545|NCT01826461|Precision|precision
1245546|NCT01826422|Muscular Dystrophy|muscular dystrophy
1245547|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1245548|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
1245549|NCT01826422|Omega 3|omega 3
1245550|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
1245551|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
1245552|NCT01826383|Infant|infant
1245553|NCT01826383|Immunization|immunization
1245554|NCT01826357|metabolic syndrome|metabolic syndrome
1245555|NCT01826357|cluster analysis|cluster analysis
1245556|NCT01826357|PCOS|pcos
1245557|NCT01826318|Stress|stress
1245558|NCT01826318|coping|coping
1245559|NCT01826318|simulation|simulation
1245560|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
1245561|NCT01826279|Obesity|obesity
1245562|NCT01826279|Gastric bypass surgery|gastric bypass surgery
1245563|NCT01826279|Resveratrol|resveratrol
1245564|NCT01826279|Insulin sensitivity|insulin sensitivity
1245565|NCT01826279|Lipid turnover|lipid turnover
1245566|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
1245567|NCT01826279|Liver|liver
1245568|NCT01826266|PER977|per977
1599231|NCT00397267|Cough|cough
1245569|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
1245570|NCT01826266|Assessment|assessment
1245571|NCT01826266|D-dimer|d-dimer
1245572|NCT01826266|Enrollment|enrollment
1245573|NCT01826266|Investigational drug|investigational drug
1245574|NCT01826266|Investigational treatment|investigational treatment
1245575|NCT01826266|Period|period
1245576|NCT01826266|Premature subject withdrawal|premature subject withdrawal
1245577|NCT01826266|Prothrombin time|prothrombin time
1245578|NCT01826266|Randomization number|randomization number
1245579|NCT01826266|Study discontinuation|study discontinuation
1245580|NCT01826266|Study drug|study drug
1245581|NCT01826266|Subject number|subject number
1245582|NCT01826266|Study treatment|study treatment
1245583|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
1245584|NCT01826253|Hypovolemia|hypovolemia
1245585|NCT01826253|Fluid challenge|fluid challenge
1245586|NCT01826253|Fluid expansion|fluid expansion
1245587|NCT01826253|Oxygene delivery|oxygene delivery
1245588|NCT01826253|Cardiac output|cardiac output
1245589|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
1245590|NCT01826227|18F-FDG|18f-fdg
1245591|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
1245592|NCT01826227|13-017|13-017
1245593|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
1245594|NCT01826214|AML|aml
1245595|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1245596|NCT01826214|ALL|all
1245597|NCT01826214|leukemia|leukemia
1245598|NCT01826214|acute|acute
1245599|NCT01826214|LDE225|lde225
1245600|NCT01826214|adult patients|adult patients
1245601|NCT01826214|relapsed/refractory|relapsed/refractory
1245602|NCT01826201|psoriasis|psoriasis
1245603|NCT01826188|Crohn's disease|crohn's disease
1245604|NCT01826188|IBD Cannabis|ibd cannabis
1245605|NCT01826188|THC|thc
1245606|NCT01826188|CBD|cbd
1245607|NCT01826175|Optical Coherence Tomography|optical coherence tomography
1245608|NCT01826175|ticagrelor|ticagrelor
1245609|NCT01826175|clopidogrel|clopidogrel
1245610|NCT01826123|Coagulopathy|coagulopathy
1245611|NCT01826123|Hemorrhage|hemorrhage
1245612|NCT01826123|Cardiac surgery|cardiac surgery
1245613|NCT01826123|Point-of-Care testing|point-of-care testing
1245614|NCT01826123|POC|poc
1245615|NCT01826123|ROTEM|rotem
1245616|NCT01826123|multiplate|multiplate
1245617|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
1245618|NCT01826097|Cytology|cytology
1245619|NCT01826097|Whole body massage vibration|whole body massage vibration
1245620|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
1245621|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
1245622|NCT01826071|Sever's disease|sever's disease
1245623|NCT01826071|apophysitis|apophysitis
1245624|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
1245625|NCT01826058|Radiosurgery|radiosurgery
1245626|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
1245627|NCT01826006|Myocardial Infarction|myocardial infarction
1245628|NCT01826006|No-reflow|no-reflow
1245629|NCT01826006|Primary PCI|primary pci
1245630|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
1245734|NCT01825473|preterm|preterm
1245735|NCT01825473|reflux|reflux
1245631|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
1245632|NCT01825993|Peridural catheter|peridural catheter
1245633|NCT01825993|Morphine PCA|morphine pca
1245634|NCT01825993|Transabdominal Block|transabdominal block
1245635|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
1245636|NCT01825954|Fibromyalgia|fibromyalgia
1245637|NCT01825954|Pain|pain
1245638|NCT01825954|Brain|brain
1245639|NCT01825954|Stimulation|stimulation
1245640|NCT01825954|Device|device
1245641|NCT01825941|migraine|migraine
1245642|NCT01825941|headache|headache
1245643|NCT01825941|metoclopramide|metoclopramide
1245644|NCT01825941|diphenhydramine|diphenhydramine
1245645|NCT01825928|Methamphetamine|methamphetamine
1245646|NCT01825928|paliperidone|paliperidone
1245647|NCT01825915|Laparoscopic|laparoscopic
1245648|NCT01825915|Hysterectomy|hysterectomy
1245649|NCT01825915|Total|total
1245650|NCT01825915|Subtotal|subtotal
1245651|NCT01825915|Recovery|recovery
1245652|NCT01825915|Outcomes|outcomes
1245653|NCT01825915|Surgery|surgery
1245654|NCT01825863|Laparoscopy|laparoscopy
1245655|NCT01825863|Adult|adult
1245656|NCT01825863|Nerve block|nerve block
1245657|NCT01825863|Ultrasonography|ultrasonography
1245658|NCT01825837|bipolar I disorder|bipolar i disorder
1245659|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
1245660|NCT01825837|BIA 2-093|bia 2-093
1245661|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
1245662|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
1245663|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
1245664|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
1245665|NCT01825811|Osteoarthritis|osteoarthritis
1245666|NCT01825811|Fibrin-glue|fibrin-glue
1245667|NCT01825811|Degenerative Arthritis|degenerative arthritis
1245668|NCT01825798|Metformin|metformin
1245669|NCT01825798|Overweight|overweight
1245670|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
1245671|NCT01825798|Medication|medication
1245672|NCT01825798|Randomized Clinical Trial|randomized clinical trial
1245673|NCT01825798|Children|children
1245674|NCT01825772|Cross-Sectional Studies|cross-sectional studies
1245675|NCT01825772|Prevalence|prevalence
1245676|NCT01825772|Peri-Implantitis|peri-implantitis
1245677|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
1245678|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
1245679|NCT01825694|Substance Abuse|substance abuse
1245680|NCT01825694|Traumatic Stress|traumatic stress
1245681|NCT01825681|positive affect|positive affect
1245682|NCT01825681|caregivers|caregivers
1245683|NCT01825681|caregiving|caregiving
1245684|NCT01825681|stress|stress
1245685|NCT01825681|mood|mood
1245686|NCT01825681|dementia|dementia
1245687|NCT01825681|Alzheimer's|alzheimer's
1245688|NCT01825681|FTD|ftd
1245689|NCT01825681|Lewy|lewy
1245690|NCT01825681|mindfulness|mindfulness
1245691|NCT01825681|help|help
1245692|NCT01825642|Prostate cancer|prostate cancer
1245693|NCT01825642|sexual function|sexual function
1245694|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
1245695|NCT01825642|nerve-sparing|nerve-sparing
1245696|NCT01825642|radical prostatectomy|radical prostatectomy
1245697|NCT01825629|Pain|pain
1245698|NCT01825629|Temporomandibular joint|temporomandibular joint
1245699|NCT01825629|Manual therapy|manual therapy
1245700|NCT01825629|Physical therapy|physical therapy
1245701|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
1245702|NCT01825616|Strength|strength
1245703|NCT01825616|Anaerobic power|anaerobic power
1245704|NCT01825616|Muscle soreness|muscle soreness
1245705|NCT01825616|Immune function|immune function
1245706|NCT01825590|hemodialysis|hemodialysis
1245707|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
1245708|NCT01825577|Alzheimer Dementia|alzheimer dementia
1245709|NCT01825577|Gait|gait
1245710|NCT01825564|G-tube|g-tube
1245711|NCT01825564|Feeding tube|feeding tube
1245712|NCT01825564|Feeding tube placement verification|feeding tube placement verification
1245713|NCT01825564|Enteral feeding|enteral feeding
1245714|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1245715|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
1245716|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1245717|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
1245718|NCT01825538|Advanced care planning|advanced care planning
1245719|NCT01825512|chronic iron overload|chronic iron overload
1245720|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
1245721|NCT01825512|beta thalassaemia major|beta thalassaemia major
1245722|NCT01825512|chelating agents|chelating agents
1245723|NCT01825512|deferiprone|deferiprone
1245724|NCT01825512|deferasirox|deferasirox
1245725|NCT01825512|children|children
1245726|NCT01825512|paediatrics|paediatrics
1245727|NCT01825499|Birth weight|birth weight
1245728|NCT01825499|Gestational age|gestational age
1245729|NCT01825499|Very low birth weight|very low birth weight
1245730|NCT01825486|Balance|balance
1245731|NCT01825486|Gait characteristics|gait characteristics
1245732|NCT01825473|neonate|neonate
1245736|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
1245737|NCT01825473|impedance|impedance
1245738|NCT01825473|erythromycin|erythromycin
1245739|NCT01825473|desaturation|desaturation
1245740|NCT01825473|bradycardia|bradycardia
1245741|NCT01825473|hypoxia|hypoxia
1245742|NCT01825460|Cervical spine|cervical spine
1245743|NCT01825460|Neck pain|neck pain
1245744|NCT01825460|Manual therapy|manual therapy
1245745|NCT01825460|Controlled clinical trial|controlled clinical trial
1245746|NCT01825447|abuse potential|abuse potential
1245747|NCT01825447|abuse liability|abuse liability
1245748|NCT01825447|drug liking|drug liking
1245749|NCT01825447|oxycodone|oxycodone
1245750|NCT01825447|naltrexone|naltrexone
1245751|NCT01825447|intravenous|intravenous
1245752|NCT01825447|pharmacodynamic|pharmacodynamic
1245753|NCT01825434|chronic constipation|chronic constipation
1245754|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
1245755|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
1245756|NCT01825421|Infant|infant
1245757|NCT01825421|Infection|infection
1245758|NCT01825421|Newborn|newborn
1245759|NCT01825421|Antibiotics|antibiotics
1245760|NCT01825421|Neutrophil CD64|neutrophil cd64
1245761|NCT01825421|Blood Culture|blood culture
1245762|NCT01825369|congenital heart disease|congenital heart disease
1245763|NCT01825369|ventricular septal defect|ventricular septal defect
1245764|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
1245765|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
1245766|NCT01825369|nitric oxide|nitric oxide
1245767|NCT01825343|fall|fall
1245768|NCT01825343|burn|burn
1245769|NCT01825343|road traffic crash|road traffic crash
1599232|NCT00397254|Migraine|migraine
1245770|NCT01825330|Alzheimer's Disease|alzheimer's disease
1245771|NCT01825330|Alzheimer's|alzheimer's
1245772|NCT01825330|TMS|tms
1245773|NCT01825330|Cognitive Training|cognitive training
1245774|NCT01825330|NeuroAD|neuroad
1245775|NCT01825317|Alzheimer's disease|alzheimer's disease
1245776|NCT01825317|TMS|tms
1245777|NCT01825317|NeuroAd|neuroad
1245778|NCT01825317|cognitive training|cognitive training
1245779|NCT01825317|ADAS-Cog|adas-cog
1245780|NCT01825304|mechanical ventilation|mechanical ventilation
1245781|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
1245782|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
1245783|NCT01825291|sleep apnea|sleep apnea
1245784|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
1245785|NCT01825291|CPAP treatment|cpap treatment
1245786|NCT01825278|respiratory rate|respiratory rate
1245787|NCT01825278|tidal volume|tidal volume
1245788|NCT01825278|minute ventilation|minute ventilation
1245789|NCT01825278|obese patients|obese patients
1245790|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
1245791|NCT01825265|Neoplasm Metastasis|neoplasm metastasis
1245792|NCT01825265|Breast Cancer|breast cancer
1245793|NCT01825265|Docetaxel|docetaxel
1245794|NCT01825265|RAD001|rad001
1245795|NCT01825265|Taxotere|taxotere
1245796|NCT01825252|HIV|hiv
1245797|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
1245798|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
1245799|NCT01825239|cardiomyopathy|cardiomyopathy
1245800|NCT01825239|left ventricular lead|left ventricular lead
1245801|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
1245802|NCT01825213|Liver disease|liver disease
1245803|NCT01825213|Multi Spectral CT|multi spectral ct
1245804|NCT01825200|Influenza|influenza
1245805|NCT01825148|Diabetes|diabetes
1245806|NCT01825135|muscle strength|muscle strength
1245807|NCT01825135|muscle function|muscle function
1245808|NCT01825135|functional status|functional status
1245809|NCT01825109|Rotavirus|rotavirus
1245810|NCT01825109|Immunogenicity|immunogenicity
1245811|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
1245812|NCT01825096|cerebral metabolism|cerebral metabolism
1245813|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
1245814|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
1245815|NCT01825083|Hypercarbia|hypercarbia
1245816|NCT01825083|TOSCA monitor|tosca monitor
1245817|NCT01825083|Ketamine|ketamine
1245818|NCT01825083|Fentanyl|fentanyl
1245819|NCT01825083|Intraoperative monitoring|intraoperative monitoring
1245820|NCT01825070|Montmorency tart cherries|montmorency tart cherries
1245821|NCT01825070|Inflammation|inflammation
1245822|NCT01825070|Uric acid|uric acid
1245823|NCT01825057|implementation study|implementation study
1245824|NCT01825057|motivational interviewing|motivational interviewing
1245825|NCT01825057|substance use|substance use
1245826|NCT01825044|Traumatic Brain Injury|traumatic brain injury
1245827|NCT01825044|TBI|tbi
1245828|NCT01825044|ciclosporin|ciclosporin
1245829|NCT01825044|pharmacokinetic|pharmacokinetic
1245830|NCT01825044|safety|safety
1245831|NCT01825044|microdialysis|microdialysis
1245832|NCT01825044|mitochondrial protection|mitochondrial protection
1245833|NCT01825031|HIV|hiv
1245834|NCT01825018|HIV|hiv
1245835|NCT01825018|AIDS|aids
1245836|NCT01825018|treatment adherence|treatment adherence
1245837|NCT01825005|cervical cancer|cervical cancer
1245838|NCT01824966|Esophagectomy|esophagectomy
1245839|NCT01824966|Signet Ring Cells|signet ring cells
1245840|NCT01824953|Gastric atrophy|gastric atrophy
1245841|NCT01824953|Helicobacter pylori|helicobacter pylori
1245842|NCT01824953|Pepsinogen|pepsinogen
1245843|NCT01824953|Gastric cancer|gastric cancer
1245844|NCT01824953|Gastric adenoma|gastric adenoma
1245845|NCT01824940|Cluster randomized trial|cluster randomized trial
1245846|NCT01824940|Nutrition|nutrition
1245847|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
1245848|NCT01824940|Environmental enteropathy|environmental enteropathy
1245849|NCT01824914|videolaryngoscope|videolaryngoscope
1245850|NCT01824914|tracheal intubation|tracheal intubation
1245851|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
1245852|NCT01824914|airway evaluation|airway evaluation
1245853|NCT01824914|sedation|sedation
1245854|NCT01824914|anesthesia|anesthesia
1245855|NCT01824901|AZD4547|azd4547
1245856|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1245857|NCT01824888|JUC|juc
1245858|NCT01824888|hand rub|hand rub
1245859|NCT01824888|European standard|european standard
1245860|NCT01824862|clinically significant macular edema|clinically significant macular edema
1245861|NCT01824862|foveal thickness|foveal thickness
1245862|NCT01824862|foveal sensitivity|foveal sensitivity
1245863|NCT01824862|perimetry|perimetry
1245864|NCT01824862|diabetic retinopathy|diabetic retinopathy
1245865|NCT01824849|Vocal cords|vocal cords
1245866|NCT01824849|Vocal cord paralysis|vocal cord paralysis
1245867|NCT01824849|Arytenoid cartilage|arytenoid cartilage
1245868|NCT01824823|afatinib|afatinib
1245869|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1245870|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
1245871|NCT01824810|myoActivation|myoactivation
1245872|NCT01824810|Neural Prolotherapy|neural prolotherapy
1245873|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
1245874|NCT01824810|myofascial pain|myofascial pain
1245875|NCT01824797|Bone mineral density|bone mineral density
1245876|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
1245877|NCT01824797|roux-en-y|roux-en-y
1245878|NCT01824797|postmenopausal females|postmenopausal females
1245879|NCT01824797|bone loss|bone loss
1245880|NCT01824784|Normal Eyes|normal eyes
1245881|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
1245882|NCT01824771|Plasma lactate|plasma lactate
1245883|NCT01824771|Critical illness|critical illness
1245884|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
1245885|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1245886|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
1245887|NCT01824706|cranial prosthesis|cranial prosthesis
1245888|NCT01824680|Obesity|obesity
1245889|NCT01824680|Appetite regulation|appetite regulation
1245890|NCT01824680|Hormones|hormones
1245891|NCT01824680|Adolescents|adolescents
1245892|NCT01824680|Exercise|exercise
1245893|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1245894|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
1245895|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
1245896|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
1245897|NCT01824654|Endovascular Procedures|endovascular procedures
1245898|NCT01824654|Radiography, Interventional|radiography, interventional
1245899|NCT01824641|Acute myocardial infarction|acute myocardial infarction
1245900|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
1245901|NCT01824641|Coronary physiology|coronary physiology
1245902|NCT01824615|Sunitinib|sunitinib
1245903|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
1245904|NCT01824615|clear cell carcinoma|clear cell carcinoma
1245905|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
1245906|NCT01824589|traumatic brain injury|traumatic brain injury
1245907|NCT01824589|TBI|tbi
1245908|NCT01824589|ITPR|itpr
1245909|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
1245910|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
1245911|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
1245912|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
1245913|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
1245914|NCT01824576|ITPR|itpr
1245915|NCT01824576|CPP|cpp
1245916|NCT01824576|TBI|tbi
1245917|NCT01824576|traumatic brain injury|traumatic brain injury
1245918|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
1245919|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
1245920|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
1245921|NCT01824537|Vaccination|vaccination
1245922|NCT01824537|Cervical cancer prevention|cervical cancer prevention
1245923|NCT01824537|Herd immunity|herd immunity
1245924|NCT01824524|Pain|pain
1245925|NCT01824524|Hydromorphone|hydromorphone
1245926|NCT01824524|OROS|oros
1245927|NCT01824511|smoking|smoking
1245928|NCT01824511|nicotine|nicotine
1245929|NCT01824511|tobacco|tobacco
1245930|NCT01824511|anhedonia|anhedonia
1245931|NCT01824511|reward|reward
1245932|NCT01824511|withdrawal|withdrawal
1245933|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
1245934|NCT01824498|sex hormones|sex hormones
1245935|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
1245936|NCT01824485|Osteoarthritis|osteoarthritis
1245937|NCT01824485|Knee|knee
1245938|NCT01824485|Viscosupplementation|viscosupplementation
1245939|NCT01824485|Clinical Trial|clinical trial
1246434|NCT01822314|breast|breast
1245940|NCT01824459|Non-intestinal type gastric cancer|non-intestinal type gastric cancer
1245941|NCT01824459|Advance Gastric Cancer|advance gastric cancer
1245942|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
1245943|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1245944|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
1245946|NCT01824459|ORR,|orr,
1245947|NCT01824459|TTP,|ttp,
1245948|NCT01824459|TTF,|ttf,
1245949|NCT01824459|safety|safety
1245950|NCT01824433|venlafaxine|venlafaxine
1245951|NCT01824433|fluoxetine|fluoxetine
1245952|NCT01824433|postmenopause|postmenopause
1245953|NCT01824433|major depressive disorder|major depressive disorder
1245954|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
1245955|NCT01824420|Antimuscarinic agent|antimuscarinic agent
1245956|NCT01824407|foot|foot
1245957|NCT01824407|ulcers|ulcers
1245958|NCT01824407|diabetes|diabetes
1245959|NCT01824407|wound|wound
1245960|NCT01824407|healing|healing
1245961|NCT01824394|nMARQ|nmarq
1245962|NCT01824394|Atrial Fibrillation|atrial fibrillation
1245963|NCT01824394|Drug Refractory|drug refractory
1245964|NCT01824394|Radio Frequency|radio frequency
1245965|NCT01824381|extensive wounds|extensive wounds
1245966|NCT01824381|amniotic membrane|amniotic membrane
1245967|NCT01824381|healing|healing
1245968|NCT01824381|patients|patients
1245969|NCT01824381|phase granulation|phase granulation
1245970|NCT01824329|Bladder Cancer|bladder cancer
1245971|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1245972|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
1245973|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
1245974|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
1245975|NCT01824225|aflibercept|aflibercept
1245976|NCT01824225|intravitreal injection|intravitreal injection
1245977|NCT01824212|Ventricular fibrillation|ventricular fibrillation
1245978|NCT01824212|Cardiac arrest|cardiac arrest
1245979|NCT01824212|Mobile technology|mobile technology
1245980|NCT01824199|Esophagitis|esophagitis
1245981|NCT01824173|muscle|muscle
1245982|NCT01824173|mitochondria|mitochondria
1245983|NCT01824173|amino acids|amino acids
1245984|NCT01824173|exercise|exercise
1245985|NCT01824147|ASS-Nonresponse|ass-nonresponse
1245986|NCT01824147|cardiac|cardiac
1245987|NCT01824147|surgery|surgery
1245988|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
1245989|NCT01824121|stem cell therapy|stem cell therapy
1245990|NCT01824108|Lumbar disc herniation|lumbar disc herniation
1245991|NCT01824108|Wallis interspinous implants|wallis interspinous implants
1245992|NCT01824108|lumbar discectomy|lumbar discectomy
1245993|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
1245994|NCT01824082|phantom pain|phantom pain
1245995|NCT01824082|traumatic limb amputation|traumatic limb amputation
1245996|NCT01824082|amputees|amputees
1245997|NCT01824069|Critical Ischemia|critical ischemia
1245998|NCT01824069|Amputation|amputation
1245999|NCT01824056|18F-FDG|18f-fdg
1246000|NCT01824043|diabetic retinopathy|diabetic retinopathy
1246001|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
1246002|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
1246003|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
1246004|NCT01824017|Type 2 diabetes|type 2 diabetes
1246005|NCT01824017|metabolic syndrome|metabolic syndrome
1246006|NCT01824017|oxidative stress|oxidative stress
1246007|NCT01824017|GSH|gsh
1246008|NCT01824004|Gastric cancer|gastric cancer
1246009|NCT01824004|Adjuvant|adjuvant
1246010|NCT01824004|Chemoradiotherapy|chemoradiotherapy
1246011|NCT01824004|S-1|s-1
1246012|NCT01824004|Cisplatin|cisplatin
1246013|NCT01823991|polyphenolics|polyphenolics
1246014|NCT01823991|anthocyanins|anthocyanins
1246015|NCT01823991|n-3 fatty acids|n-3 fatty acids
1246016|NCT01823978|metastatic|metastatic
1246017|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
1246018|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
1246019|NCT01823978|Dendritic cell|dendritic cell
1246020|NCT01823978|BPX-201|bpx-201
1246021|NCT01823978|BPX201|bpx201
1246022|NCT01823978|AP1903|ap1903
1246023|NCT01823952|HAMS|hams
1246024|NCT01823952|ORS|ors
1246025|NCT01823952|Cholera|cholera
1246026|NCT01823952|Diarrhea|diarrhea
1246027|NCT01823939|Cholera|cholera
1246028|NCT01823939|V. Cholerae O1|v. cholerae o1
1246029|NCT01823939|iOWH032|iowh032
1246030|NCT01823939|diarrhoea|diarrhoea
1246031|NCT01823939|pharmacokinetic|pharmacokinetic
1246032|NCT01823939|Bangladesh|bangladesh
1246033|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
1246034|NCT01823926|noninvasive ventilation|noninvasive ventilation
1246035|NCT01823926|residual volume|residual volume
1246036|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
1246037|NCT01823926|radioaerosol|radioaerosol
1246038|NCT01823926|nebulization.|nebulization.
1246039|NCT01823913|Pharmacokinetics|pharmacokinetics
1246040|NCT01823900|Pharmacokinetics|pharmacokinetics
1246041|NCT01823887|Heart Failure|heart failure
1246042|NCT01823887|Vagus Nerve|vagus nerve
1246043|NCT01823887|VNS|vns
1246044|NCT01823874|Virtual reality analgesia|virtual reality analgesia
1246045|NCT01823874|pain control|pain control
1246046|NCT01823848|constipation|constipation
1246047|NCT01823848|enema|enema
1246048|NCT01823822|Anorexia nervosa|anorexia nervosa
1246049|NCT01823822|Protein supplements|protein supplements
1246050|NCT01823822|IGF-I|igf-i
1246051|NCT01823809|Coronary Artery Disease|coronary artery disease
1246052|NCT01823809|Computed Tomography|computed tomography
1246053|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
1246054|NCT01823809|Fractional Flow Reserve|fractional flow reserve
1246055|NCT01823796|Fibromyalgia|fibromyalgia
1246056|NCT01823796|balance|balance
1246057|NCT01823796|falls|falls
1246058|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
1246059|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
1246060|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
1246061|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
1246062|NCT01823783|Muscle biopsy|muscle biopsy
1246063|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
1246064|NCT01823770|Rotigotine|rotigotine
1246065|NCT01823770|HTA|hta
1246066|NCT01823770|Cardiovascular diseases|cardiovascular diseases
1246067|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
1246068|NCT01823770|dopaminergic agonist|dopaminergic agonist
1246069|NCT01823770|Sympathetic overactivity|sympathetic overactivity
1246070|NCT01823770|blood pressure|blood pressure
1246071|NCT01823757|elderly|elderly
1246072|NCT01823757|potential inappropriate medications|potential inappropriate medications
1246073|NCT01823757|pharmaceutical care|pharmaceutical care
1246074|NCT01823757|quality of life|quality of life
1246075|NCT01823757|medical expenditure|medical expenditure
1246076|NCT01823744|micronutrient|micronutrient
1246077|NCT01823744|genomic|genomic
1246078|NCT01823744|SAM/SAH ratio|sam/sah ratio
1246079|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
1246080|NCT01823692|Radius Fracture|radius fracture
1246081|NCT01823692|Sensitivity|sensitivity
1246082|NCT01823692|Reduction|reduction
1246083|NCT01823692|Adequacy|adequacy
1246084|NCT01823666|Dementia|dementia
1246085|NCT01823666|Alzheimer's disease|alzheimer's disease
1246086|NCT01823666|mild cognitive impairment|mild cognitive impairment
1246087|NCT01823640|HRV|hrv
1246088|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
1246089|NCT01823640|Resistance|resistance
1246090|NCT01823627|COPD|copd
1246091|NCT01823627|Psychiatric inpatient|psychiatric inpatient
1246092|NCT01823627|Smoking|smoking
1246093|NCT01823614|HIV infection|hiv infection
1246094|NCT01823614|tropism determination|tropism determination
1246095|NCT01823614|genotypic methodic|genotypic methodic
1246096|NCT01823614|R5-tropic variant|r5-tropic variant
1246097|NCT01823614|X4-tropic variant|x4-tropic variant
1246098|NCT01823601|Well-Being|well-being
1246099|NCT01823601|Life Management Program|life management program
1246100|NCT01823601|Breathing|breathing
1246101|NCT01823601|Meditation|meditation
1246102|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
1246103|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
1246104|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
1246105|NCT01823575|double-J stent|double-j stent
1246106|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
1246107|NCT01823562|Prostate Cancer|prostate cancer
1246108|NCT01823562|Surgery|surgery
1246109|NCT01823549|CAM|cam
1246110|NCT01823549|Alternative Medicine|alternative medicine
1246111|NCT01823536|Meningitis|meningitis
1246112|NCT01823510|Antiplatelet|antiplatelet
1246113|NCT01823510|Ticagrelor|ticagrelor
1246114|NCT01823510|Clopidogrel|clopidogrel
1246115|NCT01823510|Thrombosis|thrombosis
1246116|NCT01823510|Diabetes|diabetes
1246117|NCT01823510|Coronary Artery Disease|coronary artery disease
1246118|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
1246119|NCT01823497|neonate|neonate
1246120|NCT01823497|pain|pain
1246121|NCT01823497|morphine|morphine
1246122|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
1246123|NCT01823484|hemofilter|hemofilter
1246124|NCT01823484|coagulation|coagulation
1246125|NCT01823484|CRRT|crrt
1246126|NCT01823484|critically ill|critically ill
1246127|NCT01823471|HNPCC|hnpcc
1246128|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
1246129|NCT01823471|Lynch syndrome|lynch syndrome
1246130|NCT01823471|i-scan|i-scan
1246131|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
1246132|NCT01823471|chromo-endoscopy|chromo-endoscopy
1246133|NCT01823471|high definition endoscopy|high definition endoscopy
1246134|NCT01823471|polyp detection|polyp detection
1246135|NCT01823471|adenoma detection|adenoma detection
1246136|NCT01823471|adenoma miss rate|adenoma miss rate
1246137|NCT01823458|behavioral economics|behavioral economics
1246138|NCT01823458|incentives|incentives
1246139|NCT01823458|health behavior|health behavior
1246140|NCT01823458|exercise|exercise
1246141|NCT01823445|Xylitol|xylitol
1246142|NCT01823445|Dental caries|dental caries
1246143|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
1246144|NCT01823393|heparin|heparin
1246145|NCT01823393|hemorrhagic|hemorrhagic
1246146|NCT01823393|ischemic|ischemic
1246147|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1246148|NCT01823380|Vitamin D|vitamin d
1246149|NCT01823380|Blood Levels|blood levels
1246150|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
1246151|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
1246152|NCT01823367|pre-diabetes|pre-diabetes
1246153|NCT01823367|lifestyle interventions|lifestyle interventions
1246154|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
1246155|NCT01823354|Restless Legs Syndrome|restless legs syndrome
1246156|NCT01823354|Polysomnography|polysomnography
1246157|NCT01823354|Executive cognition|executive cognition
1246158|NCT01823341|Type 1 Diabetes|type 1 diabetes
1246159|NCT01823341|Hypoglycemia|hypoglycemia
1246160|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
1246161|NCT01823341|Pump Suspension|pump suspension
1246162|NCT01823328|Intubation|intubation
1246163|NCT01823328|Airway|airway
1246164|NCT01823328|Emergent intubation|emergent intubation
1246165|NCT01823328|Rapid sequence intubation|rapid sequence intubation
1246166|NCT01823328|Rapid sequence induction|rapid sequence induction
1246167|NCT01823328|RSI|rsi
1246168|NCT01823328|Ketamine|ketamine
1246169|NCT01823328|Etomidate|etomidate
1246170|NCT01823328|Sepsis|sepsis
1246171|NCT01823328|Sedative|sedative
1246172|NCT01823328|Sedation|sedation
1246173|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
1246174|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
1246175|NCT01823302|reported by caregivers|reported by caregivers
1246176|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
1246177|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
1246178|NCT01823289|Itraconazole|itraconazole
1246179|NCT01823250|Hispanic|hispanic
1246180|NCT01823250|adolescent|adolescent
1246181|NCT01823250|drug abuse treatment|drug abuse treatment
1246182|NCT01823250|evidence-based|evidence-based
1246183|NCT01823250|family therapy|family therapy
1246184|NCT01823250|adaptive family treatment|adaptive family treatment
1246185|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
1246186|NCT01823237|Dystonia|dystonia
1246187|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1246188|NCT01823237|Rehabilitation|rehabilitation
1246189|NCT01823237|Plasticity|plasticity
1246190|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
1246191|NCT01823211|Heart rate variability|heart rate variability
1246192|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
1246193|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1246194|NCT01823198|Leukemia|leukemia
1246195|NCT01823198|Acute myeloid leukemia|acute myeloid leukemia
1246196|NCT01823198|AML|aml
1246197|NCT01823198|Myelodysplastic syndromes|myelodysplastic syndromes
1246198|NCT01823198|MDS|mds
1246199|NCT01823198|Blood And Marrow Transplantation|blood and marrow transplantation
1246200|NCT01823198|Myeloproliferative Diseases|myeloproliferative diseases
1246201|NCT01823198|High Risk Myeloid Malignancies|high risk myeloid malignancies
1246202|NCT01823198|Allogeneic stem cell transplant|allogeneic stem cell transplant
1246203|NCT01823198|Natural Killer Cells|natural killer cells
1246204|NCT01823198|NK|nk
1246205|NCT01823198|Immune cells|immune cells
1246206|NCT01823198|Stem cell transplant|stem cell transplant
1246207|NCT01823198|Busulfan|busulfan
1246208|NCT01823198|Busulfex|busulfex
1246209|NCT01823198|Myleran|myleran
1246210|NCT01823198|Interleukin-2|interleukin-2
1246211|NCT01823198|IL-2|il-2
1246212|NCT01823198|Aldesleukin|aldesleukin
1246213|NCT01823198|Proleukin|proleukin
1246214|NCT01823198|Thymoglobulin|thymoglobulin
1246215|NCT01823198|Antithymocyte globulin|antithymocyte globulin
1246216|NCT01823198|ATG|atg
1246217|NCT01823198|G-CSF|g-csf
1246218|NCT01823198|Filgrastim|filgrastim
1246219|NCT01823198|Neupogen|neupogen
1246220|NCT01823198|Tacrolimus|tacrolimus
1246221|NCT01823198|Prograf|prograf
1246222|NCT01823198|Methotrexate|methotrexate
1246223|NCT01823185|Clopidogrel|clopidogrel
1246224|NCT01823185|Ticagrelor|ticagrelor
1246225|NCT01823185|Prasugrel|prasugrel
1246226|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
1246227|NCT01823185|Dammam University|dammam university
1246228|NCT01823185|King Fahd Hospital|king fahd hospital
1246229|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
1246230|NCT01823172|breast cancer|breast cancer
1246231|NCT01823172|melanoma|melanoma
1246232|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
1246233|NCT01823172|lymphadenectomy|lymphadenectomy
1246234|NCT01823159|retigabine|retigabine
1246235|NCT01823159|cortical excitability|cortical excitability
1246236|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1246237|NCT01823146|oxytocin|oxytocin
1246238|NCT01823146|socioemotional functioning|socioemotional functioning
1246239|NCT01823146|trust|trust
1246240|NCT01823146|amygdala|amygdala
1246241|NCT01823146|aging|aging
1246242|NCT01823120|Self harm|self harm
1246243|NCT01823120|Emergency Department|emergency department
1246244|NCT01823120|Repetition|repetition
1246245|NCT01823120|Supportive Text messages|supportive text messages
1246246|NCT01823120|Interactive|interactive
1246247|NCT01823107|Meso BioMatrix|meso biomatrix
1246248|NCT01823107|Breast|breast
1246249|NCT01823107|Breast Cancer|breast cancer
1246250|NCT01823107|Mastectomy|mastectomy
1246251|NCT01823107|Biologic Mesh|biologic mesh
1246252|NCT01823107|Breast Reconstruction|breast reconstruction
1246253|NCT01823094|lung cancer|lung cancer
1246254|NCT01823094|computed tomography|computed tomography
1246255|NCT01823094|blood flow|blood flow
1246256|NCT01823068|Lung cancer|lung cancer
1246257|NCT01823068|RET fusion|ret fusion
1246258|NCT01823068|Vandetanib|vandetanib
1246259|NCT01823042|Crohn's Disease|crohn's disease
1246260|NCT01823042|maintain remission|maintain remission
1246261|NCT01823042|postoperative recurrence|postoperative recurrence
1246262|NCT01823042|surgery|surgery
1246263|NCT01823042|living quality|living quality
1246264|NCT01823029|Crohn's Disease|crohn's disease
1246265|NCT01823029|intravenous iron|intravenous iron
1246266|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
1246267|NCT01823029|Oxidative Stress|oxidative stress
1246268|NCT01823029|inflammation|inflammation
1246269|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
1246270|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1246271|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
1246272|NCT01823003|Radiosurgery|radiosurgery
1246273|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
1246274|NCT01822990|Peripheral arterial disease|peripheral arterial disease
1246275|NCT01822990|Inflammation|inflammation
1246276|NCT01822990|Nitric oxide|nitric oxide
1246277|NCT01822990|Endothelial dysfunction|endothelial dysfunction
1246278|NCT01822977|gut microbiota|gut microbiota
1246279|NCT01822977|proton pump inhibitor|proton pump inhibitor
1246280|NCT01822977|Clostridium difficile infection|clostridium difficile infection
1246281|NCT01822977|Fecal microbiome|fecal microbiome
1246282|NCT01822977|single episode of CDI|single episode of cdi
1246283|NCT01822951|DAT Study|dat study
1246284|NCT01822925|Diabetes|diabetes
1246285|NCT01822925|Pain|pain
1246286|NCT01822925|Neuropathy|neuropathy
1246287|NCT01822912|Skilled Nursing Facility|skilled nursing facility
1246288|NCT01822912|Heart Failure|heart failure
1246289|NCT01822912|Transitional Care|transitional care
1246290|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
1246291|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
1246292|NCT01822899|GSK573719|gsk573719
1246293|NCT01822899|lung function|lung function
1246294|NCT01822899|GW642444|gw642444
1246295|NCT01822899|salmeterol (SAL)|salmeterol (sal)
1246296|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
1246297|NCT01822899|vilanterol (VI)|vilanterol (vi)
1246298|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1246299|NCT01822886|T-cell lymphoma|t-cell lymphoma
1246300|NCT01822886|Romidepsin|romidepsin
1246301|NCT01822860|Hypertension|hypertension
1246302|NCT01822860|Endothelial dysfunction|endothelial dysfunction
1246303|NCT01822847|adrenal|adrenal
1246304|NCT01822847|steroids|steroids
1246305|NCT01822847|cortisol|cortisol
1246306|NCT01822847|stress|stress
1246307|NCT01822821|Males or females|males or females
1246308|NCT01822821|18 years of age or older.|18 years of age or older.
1246309|NCT01822821|Non-emergency|non-emergency
1246310|NCT01822821|cardiac surgery|cardiac surgery
1246311|NCT01822821|midline sternotomy.|midline sternotomy.
1246312|NCT01822808|acute heart failure|acute heart failure
1246313|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
1246314|NCT01822808|hydralazine|hydralazine
1246315|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
1246316|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1246317|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
1246318|NCT01822782|Perineal tear|perineal tear
1246319|NCT01822782|Perineal lesion|perineal lesion
1246320|NCT01822782|Vaginal flora|vaginal flora
1246321|NCT01822782|Birth|birth
1246322|NCT01822769|congenital heart disease|congenital heart disease
1246323|NCT01822769|adult congenital heart disease|adult congenital heart disease
1246324|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
1246325|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
1246326|NCT01822769|exercise|exercise
1246327|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1246328|NCT01822769|peak vO2|peak vo2
1246329|NCT01822769|quality of life|quality of life
1246330|NCT01822743|Osteopathy|osteopathy
1246331|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
1246332|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
1246333|NCT01822743|Pcrit|pcrit
1246334|NCT01822743|Polysomnography|polysomnography
1246335|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
1246435|NCT01822314|cancer|cancer
1246336|NCT01822730|Aripiprazole|aripiprazole
1246337|NCT01822730|Risperidone|risperidone
1246338|NCT01822717|Diabetes|diabetes
1246339|NCT01822717|Visual Impairment|visual impairment
1246340|NCT01822717|Blindness|blindness
1246341|NCT01822717|Foot Care|foot care
1246342|NCT01822717|Self-Management|self-management
1246343|NCT01822704|Stroke|stroke
1246344|NCT01822704|Exercise|exercise
1246345|NCT01822704|Rehabilitation|rehabilitation
1246346|NCT01822704|Vibration|vibration
1246347|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
1246348|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
1246349|NCT01822691|refractory cytopenias|refractory cytopenias
1246350|NCT01822691|dysplastic morphological features|dysplastic morphological features
1246351|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1246352|NCT01822652|Neuroblastoma|neuroblastoma
1246353|NCT01822652|Solid tumor|solid tumor
1246354|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
1246355|NCT01822652|CAR T cells|car t cells
1246356|NCT01822652|Gene Therapy|gene therapy
1246357|NCT01822652|Relapsed|relapsed
1246358|NCT01822652|Refractory|refractory
1246359|NCT01822639|Hypertension|hypertension
1246360|NCT01822639|enalapril maleate|enalapril maleate
1246361|NCT01822639|healthy volunteers|healthy volunteers
1246362|NCT01822639|amlodipine|amlodipine
1246363|NCT01822639|pharmacokinetics|pharmacokinetics
1246364|NCT01822626|overweight|overweight
1246365|NCT01822626|obesity|obesity
1246366|NCT01822626|children|children
1246367|NCT01822626|BMI|bmi
1246368|NCT01822626|counseling|counseling
1246369|NCT01822626|pediatrician|pediatrician
1246370|NCT01822613|esophageal cancer|esophageal cancer
1246371|NCT01822600|hypoalbuminemia|hypoalbuminemia
1246372|NCT01822600|peptic ulcer|peptic ulcer
1246373|NCT01822600|rebleeding|rebleeding
1246374|NCT01822600|hospitalization|hospitalization
1246375|NCT01822587|Drug Abuse|drug abuse
1246376|NCT01822587|Cocaine|cocaine
1246377|NCT01822587|Addiction|addiction
1246378|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
1246379|NCT01822561|Eplerenone|eplerenone
1246380|NCT01822561|Optical Coherence Tomography|optical coherence tomography
1246381|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
1246382|NCT01822561|Subretinal Fluid|subretinal fluid
1246383|NCT01822548|EPC|epc
1246384|NCT01822548|diabetes|diabetes
1246385|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
1246386|NCT01822535|Quadriplegia|quadriplegia
1246387|NCT01822535|Spinal Cord Injuries|spinal cord injuries
1246388|NCT01822535|Body Temperature Regulation|body temperature regulation
1246389|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
1246390|NCT01822483|Renal transplantation|renal transplantation
1246391|NCT01822483|mycophenolic acid|mycophenolic acid
1246392|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
1246393|NCT01822483|mycophenolate sodium|mycophenolate sodium
1246394|NCT01822483|area under the curve|area under the curve
1246395|NCT01822470|functional dyspepsia|functional dyspepsia
1246396|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
1246397|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
1246398|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
1246399|NCT01822470|diarrhea|diarrhea
1246400|NCT01822470|bloating|bloating
1246401|NCT01822470|post prandial fullness|post prandial fullness
1246402|NCT01822470|weight loss|weight loss
1246403|NCT01822444|Colorectal Cancer|colorectal cancer
1246404|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
1246405|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
1246406|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
1246407|NCT01822444|Colon Cancer|colon cancer
1246408|NCT01822444|Rectal Cancer|rectal cancer
1246409|NCT01822418|Schizophrenia|schizophrenia
1246410|NCT01822418|Depression|depression
1246411|NCT01822418|Cognition|cognition
1246412|NCT01822418|Agomelatine|agomelatine
1246413|NCT01822418|Antidepressant|antidepressant
1246414|NCT01822392|Online treatment|online treatment
1246415|NCT01822392|Treatment of conduct problems|treatment of conduct problems
1246416|NCT01822392|Parent training|parent training
1246417|NCT01822366|Children|children
1246418|NCT01822366|Adolescents|adolescents
1246419|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
1246420|NCT01822366|Low- and Middle-Income Countries (LAMIC)|low- and middle-income countries (lamic)
1246421|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
1246422|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
1246423|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
1246424|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1246425|NCT01822366|Kenya|kenya
1246426|NCT01822366|Tanzania|tanzania
1246427|NCT01822366|East Africa|east africa
1246428|NCT01822366|Mental Health|mental health
1246429|NCT01822353|food allergy|food allergy
1246430|NCT01822353|milk allergy|milk allergy
1246431|NCT01822353|egg allergy|egg allergy
1246432|NCT01822353|nut allergy|nut allergy
1246433|NCT01822340|AGHD|aghd
1246436|NCT01822314|unilateral|unilateral
1246437|NCT01822314|non metastatic|non metastatic
1246438|NCT01822314|HER2 negative|her2 negative
1246439|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
1246440|NCT01822301|Facial Trauma|facial trauma
1246441|NCT01822301|Fat Grafts|fat grafts
1246442|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1246443|NCT01822301|Wounded warriors|wounded warriors
1246444|NCT01822288|Menopause|menopause
1246445|NCT01822288|Tibolone|tibolone
1246446|NCT01822288|Estradiol|estradiol
1246447|NCT01822288|Hormone therapy|hormone therapy
1246448|NCT01822275|GBM|gbm
1246449|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
1246450|NCT01822262|cholecystolithiasis|cholecystolithiasis
1246451|NCT01822249|Rett syndrome|rett syndrome
1246452|NCT01822249|EPI-743|epi-743
1246453|NCT01822249|Edison|edison
1246454|NCT01822236|low back pain|low back pain
1246455|NCT01822236|Manual Therapy|manual therapy
1246456|NCT01822236|Randomized Controlled Trial|randomized controlled trial
1246457|NCT01822236|Quality of life|quality of life
1246458|NCT01822223|Dental Implants|dental implants
1246459|NCT01822223|Implant abutments|implant abutments
1246460|NCT01822210|Botulinum Toxins|botulinum toxins
1246461|NCT01822210|Injections|injections
1246462|NCT01822210|Stomach|stomach
1246463|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
1246464|NCT01822197|Phototherapy|phototherapy
1246465|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
1246466|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
1246467|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
1246468|NCT01822184|Observational study|observational study
1246469|NCT01822184|Cognitive impairment|cognitive impairment
1246470|NCT01822171|Heart Failure|heart failure
1246471|NCT01822171|Medication Therapy Management|medication therapy management
1246472|NCT01822158|Vaginal Delivery|vaginal delivery
1246473|NCT01822158|Debrief|debrief
1246474|NCT01822158|Medical Team Communication|medical team communication
1246475|NCT01822158|Obstetrical Safety|obstetrical safety
1246476|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
1246477|NCT01822145|ventricular tachycardia|ventricular tachycardia
1246478|NCT01822145|ventricular fibrillation|ventricular fibrillation
1246479|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
1246480|NCT01822080|Endometriosis|endometriosis
1246481|NCT01822080|Efficacy|efficacy
1246482|NCT01822080|Safety|safety
1246483|NCT01822080|Dienogest|dienogest
1246484|NCT01822041|healthy volunteers|healthy volunteers
1246485|NCT01822041|mass balance study|mass balance study
1246486|NCT01822041|Pharmacokinetics|pharmacokinetics
1246487|NCT01822028|diarrhea|diarrhea
1246488|NCT01822002|Vertigo|vertigo
1246489|NCT01822002|Nystagmus|nystagmus
1246490|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
1246491|NCT01822002|Treatment outcome|treatment outcome
1246492|NCT01821963|Infection|infection
1246493|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
1246494|NCT01821963|Hepatitis C virus|hepatitis c virus
1246495|NCT01821963|HCV|hcv
1246496|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
1246497|NCT01821963|HCC|hcc
1246498|NCT01821963|Liver Transplantation|liver transplantation
1246499|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
1246500|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
1246501|NCT01821963|Ribavirin|ribavirin
1246502|NCT01821963|RBV|rbv
1246503|NCT01821963|Telaprevir|telaprevir
1246504|NCT01821963|Incivek|incivek
1246505|NCT01821963|Antiviral drugs|antiviral drugs
1246506|NCT01821950|Mental health|mental health
1246507|NCT01821950|Substance use|substance use
1246508|NCT01821950|Substance use initiation|substance use initiation
1246509|NCT01821950|Education|education
1246510|NCT01821950|Mind Body Therapies|mind body therapies
1246511|NCT01821950|Yoga|yoga
1246512|NCT01821950|Meditation|meditation
1246513|NCT01821950|Adolescent|adolescent
1246514|NCT01821950|Adolescence|adolescence
1246515|NCT01821950|Child|child
1246516|NCT01821950|Children|children
1246517|NCT01821950|Middle School|middle school
1246518|NCT01821898|Eosinophil|eosinophil
1246519|NCT01821898|Reflux|reflux
1246520|NCT01821898|Esophagus|esophagus
1246521|NCT01821898|Food allergy|food allergy
1246522|NCT01821898|Trouble Swallowing|trouble swallowing
1246523|NCT01821898|Pediatrics|pediatrics
1246524|NCT01821885|Spirometry|spirometry
1246525|NCT01821885|screening|screening
1246526|NCT01821885|smoking cessation|smoking cessation
1246527|NCT01821885|tobacco|tobacco
1246528|NCT01821885|COPD|copd
1246529|NCT01821872|paracetamol|paracetamol
1246530|NCT01821872|acetaminophen|acetaminophen
1246531|NCT01821872|AM404|am404
1246532|NCT01821872|CSF|csf
1246533|NCT01821872|pharmacokinetics|pharmacokinetics
1246534|NCT01821833|omega-3|omega-3
1246535|NCT01821833|fatty acids|fatty acids
1246536|NCT01821833|paclitaxel|paclitaxel
1246537|NCT01821833|acute pain syndrome|acute pain syndrome
1246538|NCT01821833|peripheral neuropathy|peripheral neuropathy
1246539|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
1246540|NCT01821820|Inflammation|inflammation
1246541|NCT01821820|Oxidative stress|oxidative stress
1246542|NCT01821820|Immune dysfunction|immune dysfunction
1246543|NCT01821820|Metabolites|metabolites
1246544|NCT01821807|spinal anesthesia|spinal anesthesia
1246545|NCT01821807|spinal needle|spinal needle
1246546|NCT01821807|cesarean section|cesarean section
1246547|NCT01821807|headache|headache
1246548|NCT01821807|backache|backache
1246549|NCT01821781|Immune deficiency|immune deficiency
1246550|NCT01821781|Immune disorders|immune disorders
1246551|NCT01821781|Immune dysregulatory|immune dysregulatory
1246552|NCT01821781|Reduced Intensity|reduced intensity
1246553|NCT01821781|Alemtuzumab|alemtuzumab
1246554|NCT01821781|Campath|campath
1246555|NCT01821742|Shock|shock
1246556|NCT01821742|Fluid bolus|fluid bolus
1246557|NCT01821742|Cardiac output|cardiac output
1246558|NCT01821742|Children in intensive care|children in intensive care
1246559|NCT01821729|Locally Advanced|locally advanced
1246560|NCT01821716|standardization|standardization
1246561|NCT01821716|skin prick test|skin prick test
1246562|NCT01821716|inmunotherapy|inmunotherapy
1246563|NCT01821690|Traumatic Brain Injury|traumatic brain injury
1246564|NCT01821690|Buspirone|buspirone
1246565|NCT01821690|Behavior|behavior
1246566|NCT01821690|Irritability|irritability
1246567|NCT01821690|Aggression|aggression
1246568|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
1246569|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
1246570|NCT01821664|microbiology|microbiology
1246571|NCT01821664|antimicrobial therapy|antimicrobial therapy
1246572|NCT01821651|TAVI|tavi
1246573|NCT01821651|MitraClip|mitraclip
1246574|NCT01821651|image modality|image modality
1246575|NCT01821651|echocardiography|echocardiography
1246576|NCT01821651|angiography|angiography
1246577|NCT01821638|Heart failure|heart failure
1246578|NCT01821638|Cognition|cognition
1246579|NCT01821638|Brain|brain
1246580|NCT01821638|Older adults|older adults
1246581|NCT01821625|Thrombocytopenia|thrombocytopenia
1246582|NCT01821625|HCV|hcv
1246583|NCT01821625|Hepatitis|hepatitis
1246584|NCT01821625|Platelets|platelets
1246585|NCT01821625|Eltrombopag|eltrombopag
1246586|NCT01821625|Liver Disease|liver disease
1246587|NCT01821625|Antiviral Treatment|antiviral treatment
1246588|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
1246589|NCT01821599|Knee|knee
1246590|NCT01821599|Rehabilitation|rehabilitation
1246591|NCT01821586|Diarrhoea;|diarrhoea;
1246592|NCT01821586|Severe malnutrition;|severe malnutrition;
1246593|NCT01821586|Benefiber;|benefiber;
1246594|NCT01821586|ReSoMal;|resomal;
1246595|NCT01821586|modified ORS|modified ors
1246596|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
1246597|NCT01821560|Nicotine Addiction|nicotine addiction
1246598|NCT01821560|fMRI|fmri
1246599|NCT01821560|Baclofen|baclofen
1246600|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
1246601|NCT01821495|NPC,DC-CIK|npc,dc-cik
1246602|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
1246603|NCT01821469|bipolar disorders|bipolar disorders
1246604|NCT01821469|euthymic|euthymic
1246605|NCT01821469|psychotherapy|psychotherapy
1246606|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
1246607|NCT01821456|hematological malignancies|hematological malignancies
1246608|NCT01821456|cancer|cancer
1246609|NCT01821456|chemotherapy|chemotherapy
1246610|NCT01821456|anti-infectives|anti-infectives
1246611|NCT01821456|treatment|treatment
1246612|NCT01821456|outcome|outcome
1246613|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
1246614|NCT01821430|Chronic Pain|chronic pain
1246615|NCT01821430|Narcotic Abuse|narcotic abuse
1246616|NCT01821430|Opioid related disorders|opioid related disorders
1246617|NCT01821430|Opiate substitution treatment|opiate substitution treatment
1246618|NCT01821430|Buprenorphrine|buprenorphrine
1246619|NCT01821430|Pregabalin|pregabalin
1246620|NCT01821430|Methadone|methadone
1246621|NCT01821417|dental implants|dental implants
1246622|NCT01821417|screw-vent dental implants|screw-vent dental implants
1246623|NCT01821404|Apoptosis|apoptosis
1246624|NCT01821404|Atorvastatin|atorvastatin
1246625|NCT01821404|Inflammation|inflammation
1246626|NCT01821404|Pre-surgical trial|pre-surgical trial
1246627|NCT01821404|Proliferation|proliferation
1246628|NCT01821404|Prostate cancer|prostate cancer
1246629|NCT01821391|actinic keratoses|actinic keratoses
1246630|NCT01821391|photodynamic therapy|photodynamic therapy
1246631|NCT01821391|natural daylight|natural daylight
1246632|NCT01821378|Schizophrenia|schizophrenia
1246633|NCT01821378|Lurasidone|lurasidone
1246634|NCT01821378|Latuda|latuda
1246635|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
1246636|NCT01821326|capsule endoscopy|capsule endoscopy
1246637|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
1246638|NCT01821326|rebleeding|rebleeding
1246639|NCT01821326|risk factors|risk factors
1246640|NCT01821313|Childhood obesity|childhood obesity
1246641|NCT01821313|Inflammation|inflammation
1246642|NCT01821313|Endothelial function|endothelial function
1246643|NCT01821313|Exercise|exercise
1246644|NCT01821300|Down syndrome|down syndrome
1246645|NCT01821300|Philadelphia|philadelphia
1246646|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
1246647|NCT01821300|Body composition|body composition
1246648|NCT01821300|Obesity|obesity
1246649|NCT01821300|Cardiovascular|cardiovascular
1246650|NCT01821222|Maternal health|maternal health
1246651|NCT01821222|Neonatal health|neonatal health
1246652|NCT01821222|mHealth|mhealth
1246653|NCT01821222|Mobile phones|mobile phones
1246654|NCT01821222|Access to health services|access to health services
1246655|NCT01821222|Health behavior|health behavior
1599233|NCT00397254|rizatriptan|rizatriptan
1246656|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
1246657|NCT01821196|Tumor Markers, Biological|tumor markers, biological
1246658|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
1246659|NCT01821196|adenocarcinoma|adenocarcinoma
1246660|NCT01821170|ADHD|adhd
1246661|NCT01821170|children|children
1246662|NCT01821170|cognitive remediation|cognitive remediation
1246663|NCT01821170|virtual reality|virtual reality
1246664|NCT01821157|crown lengthening|crown lengthening
1246665|NCT01821157|gingivoplasty|gingivoplasty
1246666|NCT01821157|surgical procedures|surgical procedures
1246667|NCT01821157|gingivectomy|gingivectomy
1246668|NCT01821157|esthetic surgery|esthetic surgery
1246669|NCT01821144|dietary salt|dietary salt
1246670|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
1246671|NCT01821144|blood pressure|blood pressure
1246672|NCT01821131|flax|flax
1246673|NCT01821131|muffin|muffin
1246674|NCT01821131|cholesterol|cholesterol
1246675|NCT01821131|lignan|lignan
1246677|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
1246678|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
1246679|NCT01821118|functional MRI|functional mri
1246680|NCT01821118|randomized|randomized
1246681|NCT01821118|double blind|double blind
1246682|NCT01821118|safety|safety
1246683|NCT01821118|efficacy|efficacy
1246684|NCT01821105|computed tomography|computed tomography
1246685|NCT01821105|CT scan|ct scan
1246686|NCT01821105|positron emission tomography|positron emission tomography
1246687|NCT01821105|PET|pet
1246688|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
1246689|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
1246690|NCT01821079|Single dose|single dose
1246691|NCT01821079|Relative Bioavailability|relative bioavailability
1246692|NCT01821079|Food effect|food effect
1246693|NCT01821079|Healthy subjects|healthy subjects
1246694|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
1246695|NCT01821066|PD-0332991|pd-0332991
1246696|NCT01821066|palbociclib|palbociclib
1246697|NCT01821066|tamoxifen|tamoxifen
1246698|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
1246699|NCT01821053|Preeclampsia|preeclampsia
1246700|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
1246701|NCT01821053|diabetes mellitus|diabetes mellitus
1246702|NCT01821053|proteinuria|proteinuria
1246703|NCT01821053|plasminogen|plasminogen
1246704|NCT01821053|plasmin|plasmin
1246705|NCT01821053|renin|renin
1246706|NCT01821053|aldosterone|aldosterone
1246707|NCT01821053|angiotensin|angiotensin
1246708|NCT01821053|epithelial sodium channel|epithelial sodium channel
1246709|NCT01821053|ENaC|enac
1246710|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
1246711|NCT01821040|PMR|pmr
1246712|NCT01821040|Modified release prednisone|modified release prednisone
1246713|NCT01821027|Healthy|healthy
1246714|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1246715|NCT01821027|Pharmacokinetics|pharmacokinetics
1246716|NCT01821027|Pharmacodynamics|pharmacodynamics
1246717|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
1246718|NCT01821014|Diagnostic concordance|diagnostic concordance
1246719|NCT01821014|Treatment concordance|treatment concordance
1246720|NCT01821014|patient satisfaction|patient satisfaction
1246721|NCT01821014|physician satisfaction|physician satisfaction
1246722|NCT01821014|Medical Outreach Clinics|medical outreach clinics
1246723|NCT01821014|Medical Brigades|medical brigades
1246724|NCT01821014|Medical Missions|medical missions
1246725|NCT01821014|Telemedicine|telemedicine
1246726|NCT01821014|Videoconference|videoconference
1246727|NCT01821014|diagnoses|diagnoses
1246728|NCT01821014|treatments|treatments
1246729|NCT01821014|Satellite Internet|satellite internet
1246730|NCT01821014|VSAT|vsat
1246731|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
1246732|NCT01821001|Adenomyosis|adenomyosis
1246733|NCT01821001|Dysmenorrhea|dysmenorrhea
1246734|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
1246735|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
1246736|NCT01821001|Menorrhagia|menorrhagia
1246737|NCT01820975|Muscle protein synthesis|muscle protein synthesis
1246738|NCT01820975|Dietary protein|dietary protein
1246739|NCT01820962|hematological patients|hematological patients
1246740|NCT01820962|central venous catheters|central venous catheters
1246741|NCT01820962|catheter related thrombosis|catheter related thrombosis
1246742|NCT01820962|catheter related infections|catheter related infections
1246743|NCT01820962|concentrated citrate|concentrated citrate
1246744|NCT01820949|patient blood management|patient blood management
1246745|NCT01820949|patients safety|patients safety
1246746|NCT01820936|Healthy volunteers|healthy volunteers
1246747|NCT01820936|PCI-32765|pci-32765
1246748|NCT01820936|PCI-45227|pci-45227
1246749|NCT01820936|Pharmacokinetics|pharmacokinetics
1246750|NCT01820871|T2DM|t2dm
1246751|NCT01820871|smartphone application|smartphone application
1246752|NCT01820871|serum fasting glucose|serum fasting glucose
1246753|NCT01820871|HbA1c|hba1c
1246754|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
1246755|NCT01820845|Esophageal Doppler|esophageal doppler
1246756|NCT01820845|Scoliosis|scoliosis
1246757|NCT01820845|Children|children
1246758|NCT01820845|Age < 18 years|age < 18 years
1246759|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
1246760|NCT01820832|mild proteinuria|mild proteinuria
1246761|NCT01820832|calcitriol|calcitriol
1246762|NCT01820832|renal function|renal function
1246763|NCT01820832|blood pressure|blood pressure
1246764|NCT01820819|Inpatient|inpatient
1246765|NCT01820819|Liver cirrhosis|liver cirrhosis
1246766|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
1246767|NCT01820819|Physician's Practice Patterns|physician's practice patterns
1246768|NCT01820819|Liver Transplantation|liver transplantation
1246769|NCT01820819|Delivery of Health Care|delivery of health care
1246770|NCT01820819|Resource Allocation|resource allocation
1246771|NCT01820793|antibiotic resistance|antibiotic resistance
1246772|NCT01820793|E.coli|e.coli
1246773|NCT01820793|cefoxitin|cefoxitin
1246774|NCT01820793|pyelonephritis|pyelonephritis
1246775|NCT01820780|Heart failure|heart failure
1246776|NCT01820780|Disease management program|disease management program
1246777|NCT01820767|Chronic Kidney Disease|chronic kidney disease
1246778|NCT01820767|Vd-stadium.|vd-stadium.
1246779|NCT01820767|Inflammatory patterns|inflammatory patterns
1246780|NCT01820767|Paricalcitol|paricalcitol
1246781|NCT01820767|Atorvastatin|atorvastatin
1246782|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
1246783|NCT01820754|Lung Cancer|lung cancer
1246784|NCT01820754|Non Small Cell|non small cell
1246785|NCT01820702|bone metabolism|bone metabolism
1246786|NCT01820702|acid base balance|acid base balance
1246787|NCT01820702|bed rest|bed rest
1246788|NCT01820663|stroke|stroke
1246789|NCT01820663|ketones|ketones
1246790|NCT01820663|ketogenic diet|ketogenic diet
1246791|NCT01820663|impairment|impairment
1246792|NCT01820663|disability|disability
1246793|NCT01820650|osteoarthritis|osteoarthritis
1246794|NCT01820650|knee replacement|knee replacement
1246795|NCT01820650|patient-specific|patient-specific
1246796|NCT01820637|atherosclerosis|atherosclerosis
1246798|NCT01820637|PPA|ppa
1246799|NCT01820637|lower extremities|lower extremities
1246800|NCT01820637|stenting|stenting
1246801|NCT01820637|paclitaxel|paclitaxel
1246802|NCT01820585|fibromyalgia|fibromyalgia
1246803|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
1246804|NCT01820585|ESL|esl
1246805|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
1246806|NCT01820533|Smoking|smoking
1246807|NCT01820533|Cellular phones|cellular phones
1246808|NCT01820533|Low income population|low income population
1246809|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
1246810|NCT01820507|Endotracheal intubation|endotracheal intubation
1246811|NCT01820507|Mechanical ventilation|mechanical ventilation
1246812|NCT01820494|growth|growth
1246813|NCT01820494|infants|infants
1246814|NCT01820481|Asthma|asthma
1246815|NCT01820481|Bronchial Diseases|bronchial diseases
1246816|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
1246817|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
1246818|NCT01820481|Lung Diseases|lung diseases
1246819|NCT01820455|MRSA decolonization|mrsa decolonization
1246820|NCT01820455|MRSA subtyping|mrsa subtyping
1246821|NCT01820455|MRSA infection rates|mrsa infection rates
1246822|NCT01820442|lofexidine|lofexidine
1246823|NCT01820442|buprenorphine|buprenorphine
1246824|NCT01820442|interaction|interaction
1246825|NCT01820442|pharmacodynamic|pharmacodynamic
1246826|NCT01820442|ECG|ecg
1246827|NCT01820442|QTc|qtc
1246828|NCT01820429|Platelet aggregation|platelet aggregation
1246829|NCT01820429|Aspirin|aspirin
1246830|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
1246831|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
1246832|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
1246833|NCT01820390|Parkinson's Disease|parkinson's disease
1246834|NCT01820390|Essential Tremor|essential tremor
1246835|NCT01820377|Peer-mentoring|peer-mentoring
1246836|NCT01820377|Obesity|obesity
1246837|NCT01820377|Type 2 Diabetes|type 2 diabetes
1246838|NCT01820377|Physical Activity|physical activity
1246839|NCT01820377|After-school program|after-school program
1246840|NCT01820364|open-label study|open-label study
1246841|NCT01820364|BRAF inhibitor|braf inhibitor
1246842|NCT01820364|LGX818|lgx818
1246843|NCT01820364|MEK1620|mek1620
1246844|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
1246845|NCT01820364|Pi3K inhibitor|pi3k inhibitor
1246846|NCT01820364|FGFR|fgfr
1246847|NCT01820364|c-Met|c-met
1246848|NCT01820364|CDK4/6|cdk4/6
1246849|NCT01820364|metastatic melanoma|metastatic melanoma
1246850|NCT01820364|BRAF|braf
1246851|NCT01820364|V600|v600
1246852|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
1246853|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
1246854|NCT01820325|NSCLC|nsclc
1246855|NCT01820325|stage IV|stage iv
1246856|NCT01820325|BKM120|bkm120
1246857|NCT01820286|Bipolar disorder|bipolar disorder
1246858|NCT01820286|Depression|depression
1246859|NCT01820286|Positive psychology|positive psychology
1246860|NCT01820273|Type 2 diabetes|type 2 diabetes
1246861|NCT01820273|Bariatric surgery|bariatric surgery
1246862|NCT01820273|incretines|incretines
1246863|NCT01820273|GLP-1|glp-1
1246865|NCT01820273|gastric bypass|gastric bypass
1246866|NCT01820273|foregut|foregut
1246867|NCT01820273|hindgut|hindgut
1246868|NCT01820247|Crohn's Disease|crohn's disease
1246869|NCT01820247|enteral nutrition|enteral nutrition
1246870|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
1246871|NCT01820247|induction remission|induction remission
1246872|NCT01820234|Skin cancer|skin cancer
1246873|NCT01820234|Teledermatology|teledermatology
1246874|NCT01820234|Screening|screening
1246875|NCT01820234|Store-and-forward|store-and-forward
1246876|NCT01820221|cesarean delivery|cesarean delivery
1246877|NCT01820221|wound complications|wound complications
1246878|NCT01820221|skin closure methods|skin closure methods
1246879|NCT01820195|Contrast Nephropathy|contrast nephropathy
1246880|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
1246881|NCT01820195|Prophylaxy|prophylaxy
1246882|NCT01820117|long-term health outcomes|long-term health outcomes
1246883|NCT01820078|Chronic|chronic
1246884|NCT01820078|Kidney|kidney
1246885|NCT01820078|Disease|disease
1246886|NCT01820078|Proteinuria|proteinuria
1246887|NCT01820078|Albuminuria|albuminuria
1246888|NCT01820078|Paricalcitol|paricalcitol
1246889|NCT01820052|Fibromyalgia|fibromyalgia
1246890|NCT01820039|e-health intervention|e-health intervention
1246891|NCT01820039|infertility|infertility
1246892|NCT01820039|primary care|primary care
1246893|NCT01820039|referral rate|referral rate
1246894|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
1246895|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
1246896|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
1246897|NCT01820013|Sacroiliac Joint|sacroiliac joint
1246898|NCT01820013|Sacroiliitis|sacroiliitis
1246899|NCT01820013|Physiotherapy|physiotherapy
1246900|NCT01820013|Physical Therapy|physical therapy
1246901|NCT01820013|Orthotic Devices|orthotic devices
1246902|NCT01819987|Overweight|overweight
1246904|NCT01819987|childhood obesity prevention|childhood obesity prevention
1246905|NCT01819987|Chinese American|chinese american
1246906|NCT01819948|Breast cancer|breast cancer
1246907|NCT01819948|Stage 0-IIIA|stage 0-iiia
1246908|NCT01819948|No evidence of disease|no evidence of disease
1246909|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
1246910|NCT01819935|outcomes|outcomes
1246911|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1246912|NCT01819922|metabolic parameters|metabolic parameters
1246913|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
1246914|NCT01819909|Rotator cuff repair|rotator cuff repair
1246915|NCT01819909|Shoulder|shoulder
1246916|NCT01819909|Surgery|surgery
1246917|NCT01819909|Rehabilitation|rehabilitation
1246918|NCT01819909|Pulleys|pulleys
1246919|NCT01819909|Jackins|jackins
1246920|NCT01819870|Carvedilol|carvedilol
1246921|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
1246922|NCT01819870|Dilatrend Tablet|dilatrend tablet
1246923|NCT01819870|Pharmacokinetics|pharmacokinetics
1246924|NCT01819870|Healthy male subjects|healthy male subjects
1246925|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
1246926|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
1246927|NCT01819844|Bionic pancreas|bionic pancreas
1246928|NCT01819844|Artificial pancreas|artificial pancreas
1246929|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
1246930|NCT01819831|proton radiation|proton radiation
1246931|NCT01819831|preoperative radiation|preoperative radiation
1246932|NCT01819818|Schizophrenia|schizophrenia
1246933|NCT01819818|Paliperidone palmitate|paliperidone palmitate
1246934|NCT01819818|Invega|invega
1246935|NCT01819818|Sustenna|sustenna
1246936|NCT01819818|Korea|korea
1246937|NCT01819805|Chronic pain|chronic pain
1246938|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
1246939|NCT01819805|Non-malignant|non-malignant
1246940|NCT01819805|Pain|pain
1246941|NCT01819805|Extended release tablet|extended release tablet
1246942|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
1246943|NCT01819805|Tramadol HCl|tramadol hcl
1246944|NCT01819805|Acetaminophen|acetaminophen
1246945|NCT01819805|Ultracet ER|ultracet er
1246946|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
1246947|NCT01819766|Cancer|cancer
1246948|NCT01819766|Colorectal Cancer|colorectal cancer
1246949|NCT01819766|Neoplasm|neoplasm
1246950|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
1246951|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
1246952|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1246953|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
1246954|NCT01819766|Neoplasms by Site|neoplasms by site
1246955|NCT01819766|Neoplasms|neoplasms
1246956|NCT01819766|Digestive System Diseases|digestive system diseases
1599234|NCT00397228|Parkinson|parkinson
1335822|NCT01433523|HDM|hdm
1246957|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
1246958|NCT01819766|Colonic Diseases|colonic diseases
1246959|NCT01819766|Intestinal Diseases|intestinal diseases
1246960|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
1246961|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1246962|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
1246963|NCT01819753|urinary Stones|urinary stones
1246964|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
1246965|NCT01819727|PKU|pku
1246966|NCT01819727|PEG-PAL|peg-pal
1246967|NCT01819727|BioMarin|biomarin
1246968|NCT01819727|rAv-PAL PEG|rav-pal peg
1246969|NCT01819727|BMN 165|bmn 165
1246970|NCT01819727|open label|open label
1246971|NCT01819727|Prism301|prism301
1246972|NCT01819727|Pegvaliase|pegvaliase
1246973|NCT01819714|Snoezelen|snoezelen
1246974|NCT01819714|Multi-sensorial care session|multi-sensorial care session
1246975|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
1246976|NCT01819714|Dementia|dementia
1246977|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
1246978|NCT01819688|cytokine release|cytokine release
1246979|NCT01819675|Neuronal plasticity|neuronal plasticity
1246980|NCT01819675|Neurotransmitter agents|neurotransmitter agents
1246981|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
1246982|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
1246983|NCT01819675|Stroke|stroke
1246984|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
1246985|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
1246986|NCT01819649|selenium|selenium
1246987|NCT01819649|selenium supplementation|selenium supplementation
1246988|NCT01819649|randomised controlled trial|randomised controlled trial
1246989|NCT01819649|prevention|prevention
1246990|NCT01819636|Blood triglyceride|blood triglyceride
1246991|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
1246992|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
1246993|NCT01819636|lipid metabolism|lipid metabolism
1246994|NCT01819636|Cardiovascular risk|cardiovascular risk
1246995|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
1246996|NCT01819623|Cognitive training|cognitive training
1246997|NCT01819610|Postoperative pain management|postoperative pain management
1246998|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
1246999|NCT01819597|Atherosclerosis|atherosclerosis
1247000|NCT01819597|Stroke|stroke
1247001|NCT01819597|EDAS|edas
1247002|NCT01819597|Angiogenesis|angiogenesis
1247003|NCT01819571|pulse pressure variation|pulse pressure variation
1247004|NCT01819571|fluid responsiveness|fluid responsiveness
1247005|NCT01819571|diastolic dysfunction|diastolic dysfunction
1247006|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
1247007|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
1247008|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
1247009|NCT01819558|allograft|allograft
1247010|NCT01819558|WT1 expression|wt1 expression
1247011|NCT01819545|Alzheimer's disease|alzheimer's disease
1247012|NCT01819545|diagnosis|diagnosis
1247013|NCT01819545|MicRNA|micrna
1247014|NCT01819545|mRNA|mrna
1247015|NCT01819532|neonate|neonate
1247016|NCT01819532|umbilical cord|umbilical cord
1247017|NCT01819532|cord milking|cord milking
1247018|NCT01819532|prematurity|prematurity
1247019|NCT01819519|Intervention studies|intervention studies
1247020|NCT01819519|Pregnancy|pregnancy
1247021|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
1247022|NCT01819506|rehabilitation|rehabilitation
1247023|NCT01819506|occupational therapy|occupational therapy
1247024|NCT01819506|upper extremity|upper extremity
1247025|NCT01819493|Diabetes Prevention|diabetes prevention
1247026|NCT01819493|Lifestyle Intervention|lifestyle intervention
1247027|NCT01819493|African American Families|african american families
1247028|NCT01819480|Surgery|surgery
1247029|NCT01819480|Robotic|robotic
1247030|NCT01819480|Carcinoma|carcinoma
1247031|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
1247032|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
1247033|NCT01819454|extraesophageal reflux|extraesophageal reflux
1247034|NCT01819454|Restech system|restech system
1247035|NCT01819454|antireflux therapy|antireflux therapy
1247134|NCT01818921|ZGN-433|zgn-433
1247036|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
1247037|NCT01819428|EGFR mutation|egfr mutation
1247038|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
1247039|NCT01819428|Firstline therapy|firstline therapy
1247040|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
1247041|NCT01819415|wet AMD|wet amd
1247042|NCT01819415|Omega-3|omega-3
1247043|NCT01819415|VEGF|vegf
1247044|NCT01819415|Lipidomics|lipidomics
1247046|NCT01819415|EPA|epa
1247047|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
1247048|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
1247049|NCT01819389|suboptimal response|suboptimal response
1247050|NCT01819389|imatinib|imatinib
1247051|NCT01819389|nilotinib|nilotinib
1247052|NCT01819376|Obesity|obesity
1247053|NCT01819376|Overweight|overweight
1247054|NCT01819376|Adolescents|adolescents
1247055|NCT01819376|Teenagers|teenagers
1247056|NCT01819376|Facebook|facebook
1247057|NCT01819376|Social Networks|social networks
1247058|NCT01819363|Pleural effusion|pleural effusion
1247059|NCT01819363|Pleural elastance|pleural elastance
1247060|NCT01819363|Pleurodesis|pleurodesis
1247061|NCT01819363|Quality of life|quality of life
1247062|NCT01819363|Computed Tomography|computed tomography
1247063|NCT01819350|Dental caries|dental caries
1247064|NCT01819350|Sucrose|sucrose
1247065|NCT01819350|Oral administration|oral administration
1247066|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
1247067|NCT01819350|Pediatric medicines|pediatric medicines
1247068|NCT01819324|breast cancer survivors|breast cancer survivors
1247069|NCT01819324|lifestyle intervention|lifestyle intervention
1247070|NCT01819324|health behaviors|health behaviors
1247071|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
1247072|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
1247073|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
1247074|NCT01819259|Nonsmoker|nonsmoker
1247075|NCT01819259|ADHD|adhd
1247076|NCT01819259|Nicotine|nicotine
1247077|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
1247078|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
1247079|NCT01819181|TAVI|tavi
1247080|NCT01819181|women|women
1247081|NCT01819181|aortic stenosis|aortic stenosis
1247082|NCT01819181|VARC2|varc2
1247083|NCT01819155|influenza|influenza
1247084|NCT01819155|influenza vaccine|influenza vaccine
1247085|NCT01819155|immunogenicity|immunogenicity
1247086|NCT01819155|Africa|africa
1247087|NCT01819155|Senegal|senegal
1247088|NCT01819142|non healing wound|non healing wound
1247089|NCT01819142|pressure ulcer|pressure ulcer
1247090|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
1247091|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
1247092|NCT01819103|Mortality|mortality
1247093|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
1247094|NCT01819103|Drug Adherence|drug adherence
1247095|NCT01819103|Drug Compliance|drug compliance
1247096|NCT01819103|Health-related quality of life|health-related quality of life
1247097|NCT01819090|Neuromuscular disorder|neuromuscular disorder
1247098|NCT01819090|Mechanical ventilation|mechanical ventilation
1247099|NCT01819090|Speech|speech
1247100|NCT01819090|Respiratory failure|respiratory failure
1247101|NCT01819077|Cervical cancer|cervical cancer
1247102|NCT01819077|TMMR|tmmr
1247103|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
1247104|NCT01819077|register study|register study
1247105|NCT01819064|Atropine|atropine
1247106|NCT01819064|bradycardia|bradycardia
1247107|NCT01819064|tachycardia|tachycardia
1247108|NCT01819025|Depression|depression
1247109|NCT01819025|Behavioral activation|behavioral activation
1247110|NCT01819025|Smartphone application|smartphone application
1247111|NCT01819025|Face-to-face|face-to-face
1247112|NCT01819025|Blended therapy|blended therapy
1247113|NCT01819012|Isoflurane|isoflurane
1247114|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
1247115|NCT01819012|tissue Doppler imaging|tissue doppler imaging
1247116|NCT01819012|Monitoring|monitoring
1247117|NCT01819012|echocardiography|echocardiography
1247118|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
1247119|NCT01818973|Rectal Cancer|rectal cancer
1247120|NCT01818973|Bevacizumab|bevacizumab
1247121|NCT01818973|capecitabine|capecitabine
1247122|NCT01818973|oxaliplatin|oxaliplatin
1247123|NCT01818973|preoporative IMRT|preoporative imrt
1247124|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
1247125|NCT01818947|Lung cancer|lung cancer
1247126|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
1247127|NCT01818947|gefitinib|gefitinib
1247128|NCT01818947|Iressa|iressa
1247129|NCT01818934|hip dysplasia|hip dysplasia
1247130|NCT01818934|screening|screening
1247131|NCT01818921|Beloranib|beloranib
1247132|NCT01818921|ZGN-440|zgn-440
1247133|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
1247135|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1247136|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1247137|NCT01818908|DA-EPOCH|da-epoch
1247138|NCT01818908|rituximab|rituximab
1247139|NCT01818895|Mechanical ventilation|mechanical ventilation
1247140|NCT01818895|End of life|end of life
1247141|NCT01818895|Extubation|extubation
1247142|NCT01818895|Terminal weaning|terminal weaning
1247143|NCT01818895|Complicated grief|complicated grief
1247144|NCT01818882|Vscan|vscan
1247145|NCT01818882|portable ultrasound|portable ultrasound
1247146|NCT01818882|emergency care|emergency care
1247147|NCT01818882|emergency room|emergency room
1247148|NCT01818869|Safety,|safety,
1247149|NCT01818869|tolerability,|tolerability,
1247150|NCT01818869|Phase I,|phase i,
1247151|NCT01818869|pharmacokinetic,|pharmacokinetic,
1247152|NCT01818869|pharmacodynamic,|pharmacodynamic,
1247153|NCT01818869|inhaled|inhaled
1247154|NCT01818856|Chronic hepatitis C|chronic hepatitis c
1247155|NCT01818856|HIV-infection|hiv-infection
1247156|NCT01818856|Drug interaction|drug interaction
1247157|NCT01818843|Carbon monoxide|carbon monoxide
1247158|NCT01818843|safety|safety
1247159|NCT01818843|Adverse Reaction|adverse reaction
1247160|NCT01818843|newborn|newborn
1247161|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
1247162|NCT01818817|regional anesthesia|regional anesthesia
1247163|NCT01818817|breast surgery|breast surgery
1247164|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1247165|NCT01818765|Endocardial|endocardial
1247166|NCT01818765|Pacing|pacing
1247167|NCT01818739|Endometrial Cancer|endometrial cancer
1247168|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
1247169|NCT01818726|Aplastic anemia, deferasirox, renal function|aplastic anemia, deferasirox, renal function
1247170|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
1247171|NCT01818661|apraxia of speech|apraxia of speech
1247172|NCT01818661|non-fluent aphasia|non-fluent aphasia
1247173|NCT01818661|aphasia|aphasia
1247174|NCT01818622|Bipolar disorder|bipolar disorder
1247175|NCT01818622|Mania|mania
1247176|NCT01818622|Blue-blockers|blue-blockers
1247177|NCT01818622|Virtual darkness therapy|virtual darkness therapy
1247178|NCT01818622|Actigraphy|actigraphy
1247179|NCT01818622|Randomized controlled trial|randomized controlled trial
1247180|NCT01818609|sarcopenia|sarcopenia
1247181|NCT01818609|muscle|muscle
1247182|NCT01818609|reduced activity|reduced activity
1247183|NCT01818609|insulin sensitivity|insulin sensitivity
1247184|NCT01818609|protein|protein
1247185|NCT01818609|step reduction|step reduction
1247186|NCT01818609|muscle protein synthesis|muscle protein synthesis
1247187|NCT01818609|whey protein|whey protein
1247188|NCT01818609|leg strength|leg strength
1247189|NCT01818609|whole body protein|whole body protein
1247191|NCT01818596|HIV-1 Infected|hiv-1 infected
1247192|NCT01818596|Treatment Experienced|treatment experienced
1247193|NCT01818596|Treatment Naive|treatment naive
1247194|NCT01818583|Atrial fibrillation|atrial fibrillation
1247195|NCT01818583|Atrial flutter|atrial flutter
1247196|NCT01818583|Potassium|potassium
1247197|NCT01818583|Cardioversion|cardioversion
1247198|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
1247199|NCT01818557|glucose monitoring|glucose monitoring
1247200|NCT01818557|gestational diabetes|gestational diabetes
1247201|NCT01818544|Elastase Inhibition|elastase inhibition
1247202|NCT01818531|Partial knee replacement|partial knee replacement
1247203|NCT01818518|Preterm delivery|preterm delivery
1247204|NCT01818518|Premature delivery|premature delivery
1247205|NCT01818518|Premature birth|premature birth
1247206|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
1247207|NCT01818505|gouty arthritis|gouty arthritis
1247208|NCT01818505|Hyperuricemia|hyperuricemia
1247209|NCT01818505|metabolic syndrome|metabolic syndrome
1247210|NCT01818505|osteoarthritis|osteoarthritis
1247211|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
1247212|NCT01818492|Emapalumab|emapalumab
1247213|NCT01818453|Mood Disorders|mood disorders
1247214|NCT01818453|Depression|depression
1247215|NCT01818453|Genetics|genetics
1247216|NCT01818453|Treatment response|treatment response
1247217|NCT01818453|Treatment study|treatment study
1247218|NCT01818440|Surgical Navigation|surgical navigation
1247219|NCT01818440|Liver|liver
1247220|NCT01818440|Cancer|cancer
1247221|NCT01818440|Image-guided Therapy|image-guided therapy
1247222|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
1247223|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
1247224|NCT01818414|Abortion techniques|abortion techniques
1247225|NCT01818414|Abortion Induced methods|abortion induced methods
1247226|NCT01818414|Dilatation and Curettage|dilatation and curettage
1247227|NCT01818401|Ancillary tailored|ancillary tailored
1247228|NCT01818401|medico-economic study,|medico-economic study,
1247229|NCT01818401|total knee replacement|total knee replacement
1247230|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
1247231|NCT01818362|Influenza|influenza
1247232|NCT01818362|T cells|t cells
1247233|NCT01818349|stroke|stroke
1247234|NCT01818349|exercise|exercise
1247235|NCT01818349|muscle strength|muscle strength
1247236|NCT01818349|gait|gait
1247237|NCT01818349|rehabilitation|rehabilitation
1247238|NCT01818336|penicillin allergy|penicillin allergy
1247239|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
1247240|NCT01818323|Immunotherapy|immunotherapy
1247241|NCT01818323|Head and Neck Cancer|head and neck cancer
1247242|NCT01818323|Phase I trial|phase i trial
1247243|NCT01818323|Maximum tolerated dose|maximum tolerated dose
1247244|NCT01818310|ischemia|ischemia
1247245|NCT01818310|diabetes mellitus|diabetes mellitus
1247246|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
1247247|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
1247248|NCT01818284|Normal allogeneic donors|normal allogeneic donors
1247249|NCT01818284|Stem cell mobilization|stem cell mobilization
1247250|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
1247251|NCT01818284|PBPC|pbpc
1247252|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1247253|NCT01818284|HSCT|hsct
1247254|NCT01818284|Donating blood stem cells|donating blood stem cells
1247255|NCT01818284|C-CSF|c-csf
1247256|NCT01818284|Neupogen|neupogen
1247257|NCT01818284|Filgrastim|filgrastim
1247258|NCT01818284|Plerixafor|plerixafor
1247259|NCT01818284|Mobozil|mobozil
1247260|NCT01818284|Apheresis|apheresis
1247261|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
1247262|NCT01818271|group-exercise,|group-exercise,
1247263|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
1247264|NCT01818271|instrumented treadmill|instrumented treadmill
1247265|NCT01818258|HIV|hiv
1247266|NCT01818258|Children|children
1247267|NCT01818258|HAART|haart
1247268|NCT01818258|Malnourished|malnourished
1247269|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
1247270|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
1247271|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
1247272|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
1247273|NCT01818219|Pressure support|pressure support
1247274|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1247275|NCT01818206|Cystic Fibrosis|cystic fibrosis
1247276|NCT01818206|Bacteriophages|bacteriophages
1247277|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
1247278|NCT01818206|Sputum|sputum
1247279|NCT01818193|Pulmonary transplant|pulmonary transplant
1247280|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
1247281|NCT01818167|HS|hs
1247282|NCT01818167|Acne Inversa|acne inversa
1247283|NCT01818167|Velpeau's disease|velpeau's disease
1247284|NCT01818167|Verneuil's disease|verneuil's disease
1247285|NCT01818154|phototherapy|phototherapy
1247286|NCT01818154|light emitting diode|light emitting diode
1247287|NCT01818154|minimal erythema dose|minimal erythema dose
1247288|NCT01818154|narrowband UVB|narrowband uvb
1247289|NCT01818115|POAG|poag
1247290|NCT01818115|PXG|pxg
1247291|NCT01818115|IOL Surgery|iol surgery
1247292|NCT01818115|CE Surgery|ce surgery
1247293|NCT01818024|healthy volunteer|healthy volunteer
1247294|NCT01818024|TNFR1|tnfr1
1247295|NCT01818024|domain antibody|domain antibody
1247296|NCT01818024|Lung injury|lung injury
1247297|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
1247298|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
1247299|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
1247300|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
1247301|NCT01817972|Crohn's Disease|crohn's disease
1247302|NCT01817972|Crohn's colitis|crohn's colitis
1247303|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
1247304|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
1247305|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
1247306|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
1247307|NCT01817946|Congenital Myopathy|congenital myopathy
1247308|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
1247309|NCT01817946|Myotubular Myopathy|myotubular myopathy
1247310|NCT01817946|Myotubularin|myotubularin
1247311|NCT01817946|MTM1 Gene|mtm1 gene
1247312|NCT01817946|Genetic testing|genetic testing
1247313|NCT01817946|Sequencing|sequencing
1247314|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
1247315|NCT01817946|CGH array|cgh array
1247316|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
1247317|NCT01817907|Arousal Threshold|arousal threshold
1247318|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
1247319|NCT01817868|Hemophilia|hemophilia
1247320|NCT01817868|Turkey|turkey
1247321|NCT01817868|Observational|observational
1247322|NCT01817868|Adult|adult
1247323|NCT01817855|Phase 1,|phase 1,
1247324|NCT01817855|Safety,|safety,
1247325|NCT01817855|Tolerability,|tolerability,
1247326|NCT01817855|Healthy,|healthy,
1247327|NCT01817855|COPD patients|copd patients
1247328|NCT01817842|mHealth|mhealth
1247330|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
1247331|NCT01817842|Personal Informatics|personal informatics
1247332|NCT01817842|Tobacco Quitline|tobacco quitline
1247333|NCT01817803|Heart failure|heart failure
1247334|NCT01817803|diuretics|diuretics
1247335|NCT01817803|kidney|kidney
1247336|NCT01817803|glomerular filtration rate|glomerular filtration rate
1247337|NCT01817777|Socioeconomic category|socioeconomic category
1247338|NCT01817777|Medication compliance|medication compliance
1247339|NCT01817777|Metformin|metformin
1247340|NCT01817777|small pack|small pack
1247341|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
1247342|NCT01817764|vilanterol (VI)|vilanterol (vi)
1247343|NCT01817764|salmeterol (SAL)|salmeterol (sal)
1247344|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
1247345|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
1247346|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1247347|NCT01817764|GW642444|gw642444
1247348|NCT01817764|GSK573719|gsk573719
1247349|NCT01817764|lung function|lung function
1247350|NCT01817751|central nervous system|central nervous system
1247351|NCT01817751|Brain and Nervous System|brain and nervous system
1247352|NCT01817738|Metastatic|metastatic
1247353|NCT01817738|Castrate-refractory|castrate-refractory
1247354|NCT01817725|Therapeutic vaccine|therapeutic vaccine
1247355|NCT01817725|HBsAg clearance|hbsag clearance
1247356|NCT01817725|Immune clearance|immune clearance
1247357|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
1247358|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
1247359|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
1247360|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
1247361|NCT01817712|PTSD|ptsd
1247362|NCT01817712|Supported employment|supported employment
1247363|NCT01817712|IPS|ips
1247364|NCT01817712|CWT|cwt
1247365|NCT01817712|TWP|twp
1247366|NCT01817712|Individual placement and support|individual placement and support
1247367|NCT01817712|Compensated work therapy|compensated work therapy
1247368|NCT01817712|Transitional work program|transitional work program
1247369|NCT01817699|Cholecalciferol|cholecalciferol
1247370|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
1247371|NCT01817699|Hematinics|hematinics
1247372|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
1247373|NCT01817699|Neoplasms|neoplasms
1247374|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
1247375|NCT01817699|Graft Rejection|graft rejection
1247376|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
1247377|NCT01817660|endovascular repair|endovascular repair
1247378|NCT01817660|open surgical repair|open surgical repair
1247379|NCT01817660|comparative study|comparative study
1247380|NCT01817647|AL|al
1247381|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
1247382|NCT01817647|reduce postoperative complications|reduce postoperative complications
1247383|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
1247384|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
1247385|NCT01817634|Malnutrition.|malnutrition.
1247386|NCT01817621|Body Image Disturbance|body image disturbance
1247387|NCT01817621|Medication Adherence|medication adherence
1247388|NCT01817621|Sexual Risk Behavior|sexual risk behavior
1247389|NCT01817621|HIV|hiv
1247390|NCT01817621|MSM|msm
1247391|NCT01817608|sf-36|sf-36
1247392|NCT01817608|Katz|katz
1247393|NCT01817595|Type 2 Diabetes|type 2 diabetes
1247394|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
1247395|NCT01817595|iphone|iphone
1247396|NCT01817595|meter|meter
1247397|NCT01817582|Dry Eye Disease|dry eye disease
1247398|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
1247399|NCT01817569|Byetta|byetta
1247400|NCT01817569|Exenatide|exenatide
1247401|NCT01817543|venous leg ulcers|venous leg ulcers
1247402|NCT01817543|non healing wounds|non healing wounds
1247403|NCT01817530|Uterine Fibroids|uterine fibroids
1247404|NCT01817530|Leiomyomata|leiomyomata
1247405|NCT01817530|Elagolix|elagolix
1247406|NCT01817530|Menorrhagia|menorrhagia
1247407|NCT01817530|Elagolix sodium|elagolix sodium
1247408|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
1247409|NCT01817530|ABT-620|abt-620
1247410|NCT01817504|Renal failure,|renal failure,
1247411|NCT01817504|Transplantectomy|transplantectomy
1247412|NCT01817504|Immunosuppression|immunosuppression
1247413|NCT01817504|Sensitization|sensitization
1247414|NCT01817491|Vegan Diet|vegan diet
1247415|NCT01817491|Hypercholesterolemia|hypercholesterolemia
1247416|NCT01817491|American Heart Association Diet|american heart association diet
1247417|NCT01817491|Cardiovascular Risk|cardiovascular risk
1247418|NCT01817491|Obesity|obesity
1247419|NCT01817478|conjunctival flora|conjunctival flora
1247420|NCT01817439|oral Amiodarone|oral amiodarone
1247421|NCT01817439|IV Amiodarone|iv amiodarone
1247422|NCT01817439|phlebitis|phlebitis
1247423|NCT01817439|thrombophlebitis|thrombophlebitis
1247424|NCT01817439|adverse events|adverse events
1247425|NCT01817413|Calcium hydroxide|calcium hydroxide
1247426|NCT01817413|Pulp regeneration|pulp regeneration
1247427|NCT01817413|Regenerative endodontics|regenerative endodontics
1247428|NCT01817413|Pulp revitalisation|pulp revitalisation
1247429|NCT01817413|Triple antibiotic paste|triple antibiotic paste
1247430|NCT01817413|Root canal therapy|root canal therapy
1247431|NCT01817413|Root end closure|root end closure
1247432|NCT01817413|Tooth root|tooth root
1247433|NCT01817413|Tooth apex|tooth apex
1336409|NCT01431326|anxiety|anxiety
1247434|NCT01817413|Dental trauma|dental trauma
1247435|NCT01817413|Non-vital|non-vital
1247436|NCT01817413|Immature|immature
1247437|NCT01817413|Incisor|incisor
1247438|NCT01817413|Periapical periodontitis|periapical periodontitis
1247439|NCT01817413|Dental pulp|dental pulp
1247440|NCT01817374|Breast Cancer|breast cancer
1247441|NCT01817374|Definity|definity
1247442|NCT01817374|Ultrasound|ultrasound
1247443|NCT01817361|oral health|oral health
1247444|NCT01817348|Adhesive capsulitis|adhesive capsulitis
1247445|NCT01817348|Frozen shoulder|frozen shoulder
1247446|NCT01817348|Shoulder pain|shoulder pain
1247447|NCT01817348|Intra-articular injection|intra-articular injection
1247448|NCT01817348|Lidocaine injection|lidocaine injection
1247449|NCT01817348|Physiotherapy|physiotherapy
1247450|NCT01817348|Manipulation|manipulation
1247451|NCT01817348|Stretch exercise|stretch exercise
1247452|NCT01817322|kidney transplantation|kidney transplantation
1247453|NCT01817309|renal failure|renal failure
1247454|NCT01817309|survival|survival
1247455|NCT01817309|peritoneal failure|peritoneal failure
1247456|NCT01817296|Klinefelter|klinefelter
1247457|NCT01817296|Fertility|fertility
1247458|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
1247459|NCT01817283|Triptolide|triptolide
1247460|NCT01817283|immune activation|immune activation
1247461|NCT01817283|inflammation|inflammation
1247462|NCT01817283|CD4 T cell|cd4 t cell
1247463|NCT01817257|Cancer|cancer
1247464|NCT01817257|Thrombosis|thrombosis
1247465|NCT01817257|Venous thromboembolism|venous thromboembolism
1247466|NCT01817257|Deep vein thrombosis|deep vein thrombosis
1247467|NCT01817257|Pulmonary embolus|pulmonary embolus
1247468|NCT01817244|care management|care management
1247469|NCT01817244|depression|depression
1247470|NCT01817244|elderly|elderly
1247471|NCT01817244|Korea|korea
1247472|NCT01817231|breast cancer|breast cancer
1247473|NCT01817231|vitamin D|vitamin d
1247474|NCT01817231|25 OH vitamin D|25 oh vitamin d
1247475|NCT01817218|PRP|prp
1247476|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
1247477|NCT01817218|primary care|primary care
1247478|NCT01817192|Non-Squamous|non-squamous
1247479|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
1247480|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
1247481|NCT01817166|cholecalciferol|cholecalciferol
1247482|NCT01817166|vitamin D|vitamin d
1247483|NCT01817166|immune disease|immune disease
1247484|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
1247485|NCT01817140|oral cancer|oral cancer
1247486|NCT01817140|mandibular invasion|mandibular invasion
1247487|NCT01817140|SWIFT MRI|swift mri
1247488|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
1247489|NCT01817114|PCI|pci
1247490|NCT01817114|STEMI|stemi
1247491|NCT01817114|LAD|lad
1247492|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
1247493|NCT01817088|Parkinson disease|parkinson disease
1247494|NCT01817088|Stereotaxis Technique|stereotaxis technique
1247495|NCT01817088|Subthalamic nucleus|subthalamic nucleus
1247496|NCT01817062|Capillary leakage|capillary leakage
1247497|NCT01817062|Acute Abdomen|acute abdomen
1247498|NCT01817062|Low birth weight|low birth weight
1247499|NCT01817049|prevention|prevention
1247500|NCT01817049|sport injury|sport injury
1247501|NCT01817049|soccer|soccer
1247502|NCT01817049|youth|youth
1247503|NCT01817049|neuromuscular training|neuromuscular training
1247504|NCT01817049|intervention|intervention
1247505|NCT01817049|behaviour|behaviour
1247506|NCT01817036|vitamin D|vitamin d
1247507|NCT01817036|deficiency|deficiency
1247508|NCT01817036|dose response|dose response
1247509|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1247510|NCT01817023|current chemotherapy|current chemotherapy
1247511|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1247512|NCT01817023|low-risk|low-risk
1247513|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
1247514|NCT01817010|Muscle Strength|muscle strength
1247515|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
1247516|NCT01816997|Statins|statins
1247517|NCT01816997|Glucose homeostasis|glucose homeostasis
1247518|NCT01816997|Diabetes|diabetes
1247519|NCT01816997|Impaired fasting glucose|impaired fasting glucose
1247520|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
1247521|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1247522|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
1247523|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
1247524|NCT01816958|ketamine infusion|ketamine infusion
1247525|NCT01816958|neuromodulation|neuromodulation
1247526|NCT01816958|synergistic effect|synergistic effect
1247527|NCT01816958|remission|remission
1247528|NCT01816945|Depression|depression
1247529|NCT01816945|Stress|stress
1247530|NCT01816945|Social support|social support
1247531|NCT01816945|Social capital|social capital
1247532|NCT01816945|Maternal|maternal
1247533|NCT01816893|Hypoglycemia|hypoglycemia
1247534|NCT01816893|Autonomic Nervous System|autonomic nervous system
1247535|NCT01816893|baroreflex sensitivity|baroreflex sensitivity
1247536|NCT01816893|muscle sympathetic nerve activity|muscle sympathetic nerve activity
1247537|NCT01816893|lower body negative pressure|lower body negative pressure
1247539|NCT01816867|Treatment|treatment
1247540|NCT01816867|laparoscopic|laparoscopic
1247541|NCT01816867|open technique|open technique
1247542|NCT01816854|SFA,|sfa,
1247543|NCT01816854|stent,|stent,
1247544|NCT01816854|endovascular|endovascular
1247545|NCT01816854|Patient outcome|patient outcome
1247546|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
1247547|NCT01816841|Oral Examination|oral examination
1247548|NCT01816841|oral cancer|oral cancer
1247549|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
1247550|NCT01816815|PK/PD|pk/pd
1247551|NCT01816815|BAY1002670|bay1002670
1247552|NCT01816802|In vitro fertilization|in vitro fertilization
1247553|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
1247554|NCT01816802|Time-lapse image recording|time-lapse image recording
1247555|NCT01816802|Image analysis software|image analysis software
1247556|NCT01816789|Starting dose|starting dose
1247557|NCT01816789|rFSH|rfsh
1247558|NCT01816789|controlled|controlled
1247559|NCT01816789|ovarian|ovarian
1247560|NCT01816789|stimulation|stimulation
1247561|NCT01816789|IVF/ICSI|ivf/icsi
1247562|NCT01816789|cycles|cycles
1247563|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1247564|NCT01816763|Primary Health Care|primary health care
1247565|NCT01816763|Medical Informatics|medical informatics
1247566|NCT01816750|CT coronary angiography|ct coronary angiography
1247567|NCT01816750|Coronary disease|coronary disease
1247568|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
1247569|NCT01816750|Diagnostic value|diagnostic value
1247570|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
1247571|NCT01816750|iterative reconstruction|iterative reconstruction
1247572|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
1247573|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
1247574|NCT01816724|NOCTURIA|nocturia
1247575|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
1247576|NCT01816724|N-QOL|n-qol
1247577|NCT01816711|Frail elderly|frail elderly
1247578|NCT01816711|Hip fracture|hip fracture
1247579|NCT01816711|Vitamin D|vitamin d
1247580|NCT01816711|Geriatrics|geriatrics
1247581|NCT01816698|Hypertension|hypertension
1247582|NCT01816698|Taurine|taurine
1247583|NCT01816698|Metabolism|metabolism
1247584|NCT01816672|Wagner 1|wagner 1
1247585|NCT01816672|Wagner 2|wagner 2
1247586|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
1247587|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
1247588|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
1247589|NCT01816659|Colonic lesion|colonic lesion
1247590|NCT01816659|Biomarker|biomarker
1247591|NCT01816659|Metformin-ER|metformin-er
1247592|NCT01816659|Metformin|metformin
1247593|NCT01816659|Extended release|extended release
1247594|NCT01816659|Colonoscopy|colonoscopy
1247595|NCT01816659|Colon cancer surgery|colon cancer surgery
1247596|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
1247597|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
1247598|NCT01816646|Bleeding from bladder|bleeding from bladder
1247599|NCT01816646|Foley catheter|foley catheter
1247600|NCT01816646|Probenecid|probenecid
1247601|NCT01816646|Cidofovir|cidofovir
1247602|NCT01816646|Vistide|vistide
1247603|NCT01816633|non healing wound|non healing wound
1247604|NCT01816620|POEMS Syndrome|poems syndrome
1247605|NCT01816620|lenalidomide|lenalidomide
1247606|NCT01816620|newly diagnosed|newly diagnosed
1247607|NCT01816620|plasma cell disorder|plasma cell disorder
1247608|NCT01816620|Dexamethasone|dexamethasone
1247609|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
1247610|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1247611|NCT01816594|HER2, breast cancer, neoadjuvant, PI3K inhibitor, first line chemotherapy, trastuzumab, GBG, SOLTI, BIG|her2, breast cancer, neoadjuvant, pi3k inhibitor, first line chemotherapy, trastuzumab, gbg, solti, big
1247612|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
1247613|NCT01816542|patch-testing|patch-testing
1247614|NCT01816542|personal-care|personal-care
1247615|NCT01816542|cosmetic|cosmetic
1247616|NCT01816542|dermatitis|dermatitis
1247617|NCT01816542|allergy|allergy
1247618|NCT01816542|sensitive skin|sensitive skin
1247619|NCT01816516|childhood obesity|childhood obesity
1247620|NCT01816516|low-income|low-income
1247621|NCT01816516|maternal responsiveness|maternal responsiveness
1247622|NCT01816516|infant feeding|infant feeding
1247623|NCT01816516|infant feeding practices|infant feeding practices
1247624|NCT01816516|infant feeding style|infant feeding style
1247625|NCT01816516|primary prevention|primary prevention
1336652|NCT01430572|RAD001|rad001
1247626|NCT01816503|Pain|pain
1247627|NCT01816503|Cancer pain|cancer pain
1247628|NCT01816503|Fentanyl|fentanyl
1247629|NCT01816503|Fentanyl matrix|fentanyl matrix
1247630|NCT01816503|Opioid analgesic|opioid analgesic
1247631|NCT01816464|Influenza|influenza
1247632|NCT01816464|Vaccination|vaccination
1247633|NCT01816451|aerobic capacity|aerobic capacity
1247634|NCT01816451|cardiorespiratory training|cardiorespiratory training
1247635|NCT01816451|blood lactate concentration|blood lactate concentration
1247636|NCT01816451|heart rate|heart rate
1247637|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
1247638|NCT01816425|Dental Prosthesis|dental prosthesis
1247639|NCT01816425|Dental Prosthesis Design|dental prosthesis design
1247640|NCT01816412|Arms|arms
1247641|NCT01816412|Experimental|experimental
1247642|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
1247643|NCT01816412|Active Comparator|active comparator
1247644|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
1247645|NCT01816386|acupuncture|acupuncture
1247646|NCT01816386|anaesthetic recovery|anaesthetic recovery
1247647|NCT01816386|perioperative care|perioperative care
1247648|NCT01816386|Age 18+|age 18+
1247649|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
1247650|NCT01816386|Surgery: Uterus|surgery: uterus
1247651|NCT01816386|Surgery: Adnex|surgery: adnex
1247652|NCT01816386|Surgery: Ovaries|surgery: ovaries
1247653|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
1247654|NCT01816360|Womens health|womens health
1247655|NCT01816360|Menopause|menopause
1247656|NCT01816360|Complementary therapies|complementary therapies
1247657|NCT01816360|Aromatherapy|aromatherapy
1247658|NCT01816360|Essential oils|essential oils
1247659|NCT01816360|Yogatherapy|yogatherapy
1247660|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
1247661|NCT01816334|sciatica|sciatica
1247662|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1247663|NCT01816334|Glucocorticoids|glucocorticoids
1247664|NCT01816308|AF|af
1247665|NCT01816308|MCI|mci
1247666|NCT01816282|TKR|tkr
1247667|NCT01816282|Blood loss|blood loss
1247668|NCT01816282|Fibrin Sealant|fibrin sealant
1247669|NCT01816269|Helicobacter pylori|helicobacter pylori
1247670|NCT01816269|Dental scaling|dental scaling
1247671|NCT01816269|Eradication|eradication
1247672|NCT01816269|Reinfection|reinfection
1247673|NCT01816269|Helicobacter status|helicobacter status
1247674|NCT01816243|Chronic Pain|chronic pain
1247675|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
1247676|NCT01816243|TTS-fentanyl|tts-fentanyl
1247677|NCT01816243|Durogesic|durogesic
1247678|NCT01816217|Difficult intubation|difficult intubation
1247679|NCT01816217|Complications|complications
1247680|NCT01816217|Intensive care units|intensive care units
1247681|NCT01816217|Videolaryngoscope|videolaryngoscope
1247682|NCT01816217|Laryngoscopy|laryngoscopy
1247683|NCT01816204|anxiety treatment|anxiety treatment
1247684|NCT01816204|anxiety online treatment|anxiety online treatment
1247685|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
1247686|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
1247687|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
1247688|NCT01816178|Voice Output Communication|voice output communication
1247689|NCT01816165|diabetes|diabetes
1247690|NCT01816165|insulin|insulin
1247691|NCT01816165|blood vessel|blood vessel
1247692|NCT01816165|type 1|type 1
1247693|NCT01816152|light treatment|light treatment
1247694|NCT01816152|circadian rhythms|circadian rhythms
1247695|NCT01816152|sleep|sleep
1247696|NCT01816152|agitation|agitation
1247697|NCT01816152|depression|depression
1247698|NCT01816139|vaginal dryness|vaginal dryness
1247699|NCT01816139|vaginal atrophy|vaginal atrophy
1247700|NCT01816139|estrogen|estrogen
1247701|NCT01816113|PvDBP|pvdbp
1247702|NCT01816113|Malaria|malaria
1247703|NCT01816113|Plasmodium vivax|plasmodium vivax
1247704|NCT01816100|multiple sclerosis|multiple sclerosis
1247705|NCT01816100|exercise|exercise
1247706|NCT01816100|MEG|meg
1247707|NCT01816100|DTI|dti
1247708|NCT01816100|Brain changes|brain changes
1247709|NCT01816074|Mothers|mothers
1247710|NCT01816074|ADHD|adhd
1247711|NCT01816074|Treatment|treatment
1247712|NCT01816074|Child|child
1247713|NCT01816061|Veterans Health|veterans health
1247714|NCT01816061|Social Adjustment|social adjustment
1247715|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
1247716|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1247717|NCT01816061|Independent Living|independent living
1247718|NCT01816061|Goals|goals
1247719|NCT01816061|Education|education
1247720|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
1247721|NCT01816022|CMPN|cmpn
1247722|NCT01816022|Fracture|fracture
1247723|NCT01816022|Osteoporosis|osteoporosis
1247724|NCT01816022|Biochemical Bone Markers|biochemical bone markers
1247725|NCT01816009|infection|infection
1247726|NCT01816009|antibiotic|antibiotic
1247727|NCT01816009|prosthesis|prosthesis
1247728|NCT01815996|Pregnancy|pregnancy
1247729|NCT01815996|pulmonary embolism|pulmonary embolism
1247831|NCT01815632|CNS repair|cns repair
1247730|NCT01815996|myocardial infarction|myocardial infarction
1247731|NCT01815996|autoimmune disease|autoimmune disease
1247732|NCT01815996|healthy controls|healthy controls
1247733|NCT01815983|Laryngoscopy|laryngoscopy
1247734|NCT01815983|Tracheal Intubation|tracheal intubation
1247735|NCT01815983|Video Laryngoscopy|video laryngoscopy
1247737|NCT01815970|exercise|exercise
1247738|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
1247739|NCT01815970|COPD|copd
1247740|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
1247741|NCT01815957|coronary microcirculation|coronary microcirculation
1247742|NCT01815957|coronary artery disease|coronary artery disease
1247743|NCT01815957|myocardial disease|myocardial disease
1247744|NCT01815957|ischemia|ischemia
1247745|NCT01815944|onset time|onset time
1247746|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
1247747|NCT01815944|ropivacaine|ropivacaine
1247748|NCT01815944|normal saline|normal saline
1247749|NCT01815944|dextrose 5%|dextrose 5%
1247750|NCT01815918|Orthopedic Procedures|orthopedic procedures
1247751|NCT01815918|Prostheses and Implants|prostheses and implants
1247752|NCT01815918|Joint Prosthesis|joint prosthesis
1247753|NCT01815918|Knee Prosthesis|knee prosthesis
1247754|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
1247755|NCT01815918|Thromboembolism|thromboembolism
1247756|NCT01815918|Inflammation|inflammation
1247757|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
1247758|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
1247759|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
1247760|NCT01815918|BSF-2|bsf-2
1247761|NCT01815918|IFN-beta 2|ifn-beta 2
1247762|NCT01815918|MGI-2|mgi-2
1247763|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1247764|NCT01815918|Steroids|steroids
1247765|NCT01815918|Pregnenediones|pregnenediones
1247766|NCT01815918|Hydrocortisone|hydrocortisone
1247767|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
1247768|NCT01815918|Therapeutic Uses|therapeutic uses
1247769|NCT01815892|Hemodialysis|hemodialysis
1247770|NCT01815892|Response to Furosemide|response to furosemide
1247771|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
1247772|NCT01815879|liver metastases|liver metastases
1247773|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
1247774|NCT01815879|retrospective data analysis|retrospective data analysis
1247775|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
1247776|NCT01815853|pre-operative,|pre-operative,
1247777|NCT01815853|chemoradiotherapy,|chemoradiotherapy,
1247778|NCT01815853|chemotherapy,|chemotherapy,
1247779|NCT01815853|treatment|treatment
1247780|NCT01815853|outcome|outcome
1247781|NCT01815814|spasticity|spasticity
1247782|NCT01815814|cerebral palsy|cerebral palsy
1247783|NCT01815814|hemiplegia|hemiplegia
1247784|NCT01815814|hemiparesis|hemiparesis
1247785|NCT01815814|diplegia|diplegia
1247786|NCT01815814|paraplegia|paraplegia
1247787|NCT01815814|quadriplegia|quadriplegia
1247788|NCT01815814|quadriparesis|quadriparesis
1247789|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
1247790|NCT01815775|flow MRI|flow mri
1247791|NCT01815775|dementia|dementia
1247792|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
1247793|NCT01815775|shunt|shunt
1247794|NCT01815762|bioimpedance|bioimpedance
1247795|NCT01815762|overhydration|overhydration
1247796|NCT01815762|hemodialysis|hemodialysis
1247797|NCT01815762|arterial stiffness|arterial stiffness
1247798|NCT01815762|mortality|mortality
1247799|NCT01815736|HIV|hiv
1247800|NCT01815736|HIV 1 Infected|hiv 1 infected
1247801|NCT01815736|Virologically-Suppressed|virologically-suppressed
1247802|NCT01815723|Psoriasis|psoriasis
1247803|NCT01815723|Dimethyl fumarate|dimethyl fumarate
1247804|NCT01815723|Fumaderm®|fumaderm®
1247805|NCT01815710|Clinical Pathways|clinical pathways
1247806|NCT01815710|Knowledge translation|knowledge translation
1247807|NCT01815710|Evaluation|evaluation
1247808|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1247809|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1247810|NCT01815697|Urinary Retention|urinary retention
1247811|NCT01815697|Vascular Endothelium|vascular endothelium
1247812|NCT01815697|Counterpulsation, External|counterpulsation, external
1247813|NCT01815684|Phase I|phase i
1247814|NCT01815684|ASP3652|asp3652
1247815|NCT01815684|Dose escalation|dose escalation
1247816|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
1247817|NCT01815671|colonoscopy|colonoscopy
1247818|NCT01815671|technique|technique
1247819|NCT01815671|tilt|tilt
1247820|NCT01815671|insertion|insertion
1247821|NCT01815671|safety|safety
1247822|NCT01815671|efficacy|efficacy
1247823|NCT01815645|Cocaine related disorders|cocaine related disorders
1247824|NCT01815645|Contingency Management|contingency management
1247825|NCT01815645|psychosocial treatment|psychosocial treatment
1247826|NCT01815632|multiple sclerosis|multiple sclerosis
1247827|NCT01815632|progressive MS|progressive ms
1247828|NCT01815632|stem cell|stem cell
1247829|NCT01815632|cell therapy|cell therapy
1247830|NCT01815632|neurodegeneration|neurodegeneration
1247832|NCT01815606|Pancreas|pancreas
1247835|NCT01815606|19Gauge|19gauge
1247836|NCT01815606|25Gauge|25gauge
1247837|NCT01815606|35mm mass|35mm mass
1247838|NCT01815593|Erectile Dysfunction|erectile dysfunction
1247839|NCT01815593|Vascular Endothelium|vascular endothelium
1247840|NCT01815593|Counterpulsation, External|counterpulsation, external
1247841|NCT01815580|HIV|hiv
1247842|NCT01815580|Treatment as Prevention|treatment as prevention
1247843|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
1247844|NCT01815567|Hypertension|hypertension
1247845|NCT01815567|Retinal Disorder|retinal disorder
1247846|NCT01815567|Cognitive impairment|cognitive impairment
1247847|NCT01815554|Tetraplegia|tetraplegia
1247848|NCT01815554|Spinal Cord Injury|spinal cord injury
1247849|NCT01815554|Ventilator|ventilator
1247850|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
1247851|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
1247852|NCT01815541|osteoarticular|osteoarticular
1247853|NCT01815541|infections|infections
1247854|NCT01815541|tolerance|tolerance
1247855|NCT01815541|teicoplanin|teicoplanin
1247856|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
1247857|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
1247858|NCT01815502|Single ventricle|single ventricle
1247859|NCT01815502|Fontan|fontan
1247860|NCT01815502|Sildenafil|sildenafil
1247861|NCT01815502|Pressure-Volume Loops|pressure-volume loops
1247862|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
1247863|NCT01815489|Pancreatitis|pancreatitis
1247864|NCT01815489|Infection|infection
1247865|NCT01815489|Bacteria|bacteria
1247866|NCT01815489|Microbiology|microbiology
1247867|NCT01815476|DCIS|dcis
1247868|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
1247869|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
1247870|NCT01815463|stool|stool
1247871|NCT01815463|monoclonal antibody|monoclonal antibody
1247872|NCT01815463|Adnab-9|adnab-9
1247873|NCT01815463|FOBT|fobt
1247874|NCT01815463|FIT|fit
1247875|NCT01815463|iFOBT|ifobt
1247876|NCT01815463|colonoscopy|colonoscopy
1247877|NCT01815463|barium enema|barium enema
1247878|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
1247879|NCT01815424|Tofacitinib|tofacitinib
1247880|NCT01815424|CP-690|cp-690
1247881|NCT01815424|550|550
1247882|NCT01815424|Xeljanz|xeljanz
1247883|NCT01815424|Jak-Inhibitor|jak-inhibitor
1247884|NCT01815424|Oral Treatment|oral treatment
1247885|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
1247886|NCT01815424|Pruritus|pruritus
1247887|NCT01815424|Itch|itch
1247888|NCT01815424|DLQI|dlqi
1247889|NCT01815424|moderate|moderate
1247890|NCT01815424|severe|severe
1247891|NCT01815424|chronic|chronic
1247892|NCT01815424|plaque psoriasis|plaque psoriasis
1247893|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
1247894|NCT01815411|symptom score|symptom score
1247895|NCT01815411|fatigue|fatigue
1247896|NCT01815411|life quality|life quality
1247897|NCT01815411|cytokines|cytokines
1247898|NCT01815411|mRNA expression|mrna expression
1247899|NCT01815411|Quality of Life|quality of life
1247900|NCT01815411|Signs and Symptoms|signs and symptoms
1247901|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
1247902|NCT01815385|Term gestation|term gestation
1247903|NCT01815385|Environmental exposure|environmental exposure
1247904|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
1247905|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
1247906|NCT01815385|Adiposity|adiposity
1247907|NCT01815385|Cytosine methylation|cytosine methylation
1247908|NCT01815372|nerve blocks|nerve blocks
1247909|NCT01815372|ultrasound-guided|ultrasound-guided
1247910|NCT01815372|leg surgery|leg surgery
1247911|NCT01815359|ICARuS|icarus
1247912|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
1247913|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1247914|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
1247915|NCT01815359|Leucovorin|leucovorin
1247916|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
1247917|NCT01815359|Mitomycin|mitomycin
1247918|NCT01815359|12-289|12-289
1247919|NCT01815346|Breast Cancer|breast cancer
1247920|NCT01815346|Breast cancer survivors|breast cancer survivors
1247921|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
1247922|NCT01815346|CIPN|cipn
1247923|NCT01815346|Acupuncture treatments|acupuncture treatments
1247924|NCT01815346|Quality of life|quality of life
1247925|NCT01815346|Hand function|hand function
1247926|NCT01815346|Balance|balance
1247927|NCT01815346|Questionnaires|questionnaires
1247928|NCT01815346|Surveys|surveys
1247929|NCT01815333|Cancer of Lymph Node|cancer of lymph node
1247930|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
1247932|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
1247933|NCT01815333|USPIO|uspio
1247934|NCT01815333|Feraheme|feraheme
1247935|NCT01815333|Ferumoxytole|ferumoxytole
1247936|NCT01815320|Renal Transplant|renal transplant
1247937|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1247938|NCT01815320|Acute allograft rejection|acute allograft rejection
1247939|NCT01815294|Ovarian cancer|ovarian cancer
1247940|NCT01815294|Breast cancer|breast cancer
1247941|NCT01815294|Solid malignancy|solid malignancy
1247942|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
1247943|NCT01815294|Metastatic cancer|metastatic cancer
1247944|NCT01815294|DOXIL/CAELYX|doxil/caelyx
1247945|NCT01815294|Doxorubicin HCL|doxorubicin hcl
1247946|NCT01815294|Bioequivalence|bioequivalence
1247947|NCT01815268|Randomized Controlled Trial|randomized controlled trial
1247948|NCT01815268|Influenza|influenza
1247949|NCT01815268|Influenza vaccine|influenza vaccine
1247950|NCT01815268|Flu Vaccine|flu vaccine
1247951|NCT01815268|Fluzone|fluzone
1247952|NCT01815268|HD Fluzone|hd fluzone
1247953|NCT01815268|Nursing Home|nursing home
1247954|NCT01815268|Hospitalization|hospitalization
1247955|NCT01815268|Mortality|mortality
1247956|NCT01815268|Health Care worker vaccination|health care worker vaccination
1247957|NCT01815268|ADL decline|adl decline
1247958|NCT01815268|Effectiveness|effectiveness
1247959|NCT01815268|Elderly|elderly
1247960|NCT01815268|Morbidity|morbidity
1247961|NCT01815268|Nursing Home resident|nursing home resident
1247962|NCT01815268|Frail|frail
1247963|NCT01815268|Institutionalized|institutionalized
1247964|NCT01815268|Epidemiology|epidemiology
1247965|NCT01815268|CDC|cdc
1247966|NCT01815268|US|us
1247967|NCT01815268|city|city
1247968|NCT01815255|TDF-based regimen|tdf-based regimen
1247969|NCT01815255|HIV-infected children|hiv-infected children
1247970|NCT01815255|Thai|thai
1247971|NCT01815255|generic|generic
1247972|NCT01815255|safety and efficacy|safety and efficacy
1247973|NCT01815255|renal status|renal status
1247974|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
1247975|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
1247976|NCT01815229|endotracheal|endotracheal
1247977|NCT01815229|intubation|intubation
1247978|NCT01815216|Bariatric surgery|bariatric surgery
1247979|NCT01815216|Cognition|cognition
1247980|NCT01815216|Satiety hormones|satiety hormones
1247981|NCT01815216|Brain networks|brain networks
1247982|NCT01815216|Inhibitory control|inhibitory control
1247983|NCT01815216|Food intake|food intake
1247984|NCT01815203|Caffeine effects|caffeine effects
1247985|NCT01815203|Inhibitory control|inhibitory control
1247986|NCT01815190|immune complex vasculitis|immune complex vasculitis
1247987|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
1247988|NCT01815190|IgA vasculitis|iga vasculitis
1247989|NCT01815190|IgA nephropathy|iga nephropathy
1247990|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
1247991|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
1247992|NCT01815125|Brain concussion|brain concussion
1247993|NCT01815125|Post-concussion syndrome|post-concussion syndrome
1247994|NCT01815125|Emergency department|emergency department
1247995|NCT01815125|Ondansetron|ondansetron
1247996|NCT01815112|Neurodegenerative disease|neurodegenerative disease
1247997|NCT01815112|Elderly|elderly
1247998|NCT01815112|Dementia|dementia
1247999|NCT01815112|FDG-PET|fdg-pet
1248000|NCT01815112|MRI|mri
1248001|NCT01815112|Neuroimaging|neuroimaging
1248002|NCT01815086|Radioimmunoimaging|radioimmunoimaging
1248003|NCT01815086|AL Amyloidosis|al amyloidosis
1248004|NCT01815086|PET/CT|pet/ct
1248005|NCT01815047|Vitamin D|vitamin d
1248006|NCT01815047|Pregnancy|pregnancy
1248007|NCT01815047|Inflammation|inflammation
1248008|NCT01815047|Infection|infection
1248009|NCT01815047|Placenta|placenta
1248010|NCT01815047|Cytokine|cytokine
1248011|NCT01815047|Microbiome|microbiome
1248012|NCT01815008|Platelet aggregation|platelet aggregation
1248013|NCT01815008|Clopidogrel|clopidogrel
1248014|NCT01815008|Platelet transcriptome|platelet transcriptome
1248015|NCT01814995|behavioural|behavioural
1248016|NCT01814995|diabetes prevention|diabetes prevention
1248017|NCT01814995|overweight|overweight
1248018|NCT01814995|physical activity|physical activity
1248019|NCT01814995|gestational diabetes|gestational diabetes
1248020|NCT01814982|Traumatic brain injury|traumatic brain injury
1248021|NCT01814982|JNJ-17299425|jnj-17299425
1248022|NCT01814982|Intracranial pressure|intracranial pressure
1248023|NCT01814982|Intravascular bolus injection|intravascular bolus injection
1248024|NCT01814969|Rectal neoplasm|rectal neoplasm
1248025|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
1248215|NCT01814046|Uveal Melanoma|uveal melanoma
1248026|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
1248027|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
1248028|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
1248029|NCT01814943|Epidemiology|epidemiology
1248030|NCT01814891|vitamin A|vitamin a
1248031|NCT01814891|maize|maize
1248032|NCT01814891|total body reserves|total body reserves
1248224|NCT01814007|Lipolysis|lipolysis
1248033|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
1248034|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
1248035|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
1248036|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
1248037|NCT01814878|Pain, Postoperative|pain, postoperative
1248038|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
1248039|NCT01814878|Acetaminophen|acetaminophen
1248040|NCT01814878|Ultracet|ultracet
1248041|NCT01814865|Post-menopausal|post-menopausal
1248042|NCT01814865|ER+|er+
1248043|NCT01814865|Stage I-IIIA|stage i-iiia
1248044|NCT01814865|Operable|operable
1248045|NCT01814865|Breast Cancer|breast cancer
1248046|NCT01814852|Low Intensity Shockwave|low intensity shockwave
1248047|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
1248048|NCT01814852|Erectile dysfunction|erectile dysfunction
1248049|NCT01814839|RNAi therapeutic|rnai therapeutic
1248050|NCT01814826|MLN4924|mln4924
1248051|NCT01814826|Acute|acute
1248052|NCT01814826|Myelogenous|myelogenous
1248053|NCT01814826|Leukemia|leukemia
1248054|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
1248055|NCT01814787|Type 2 Diabetes|type 2 diabetes
1248056|NCT01814787|Pediatrics|pediatrics
1248057|NCT01814787|Computerized Decision Support System|computerized decision support system
1248058|NCT01814748|Diabetes Mellitus|diabetes mellitus
1248059|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1248060|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
1248061|NCT01814748|Metabolic Diseases|metabolic diseases
1248062|NCT01814748|Endocrine System Diseases|endocrine system diseases
1248063|NCT01814748|Metformin|metformin
1248064|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
1248065|NCT01814748|Pharmacologic Actions|pharmacologic actions
1248066|NCT01814748|Therapeutic Uses|therapeutic uses
1248067|NCT01814722|HIV Infections|hiv infections
1248068|NCT01814722|Anti-HIV Agents|anti-hiv agents
1248069|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
1248070|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
1248071|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
1248072|NCT01814722|Protease inhibitors|protease inhibitors
1248073|NCT01814696|Heart Failure|heart failure
1248074|NCT01814696|Congestive Heart Failure|congestive heart failure
1248075|NCT01814696|Medication Adherence|medication adherence
1248076|NCT01814696|Medication Compliance|medication compliance
1248077|NCT01814696|Telemedicine|telemedicine
1248078|NCT01814696|Telehealth|telehealth
1248079|NCT01814683|Vivax malaria|vivax malaria
1248080|NCT01814683|Primaquine|primaquine
1248081|NCT01814683|Placebo|placebo
1248082|NCT01814683|Recurrence|recurrence
1248083|NCT01814657|Infertility|infertility
1248084|NCT01814605|Sciatic Nerve Block|sciatic nerve block
1248085|NCT01814605|Subgluteal space|subgluteal space
1248086|NCT01814605|Infragluteal space|infragluteal space
1248087|NCT01814592|coronally positioned flap|coronally positioned flap
1248088|NCT01814592|connective tissue|connective tissue
1248089|NCT01814592|gingival margin|gingival margin
1248090|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
1248091|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
1248092|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
1248093|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
1248094|NCT01814592|surgical flaps|surgical flaps
1248095|NCT01814592|Treatment outcome|treatment outcome
1248096|NCT01814579|vaginal|vaginal
1248097|NCT01814579|cuff|cuff
1248098|NCT01814579|robotic|robotic
1248099|NCT01814579|hysterectomy|hysterectomy
1248100|NCT01814579|vloc|vloc
1248101|NCT01814579|v-loc|v-loc
1248102|NCT01814579|vicryl|vicryl
1248103|NCT01814579|unidirectional|unidirectional
1248104|NCT01814579|barbed|barbed
1248105|NCT01814579|suture|suture
1248106|NCT01814527|Fish oil|fish oil
1248107|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
1248108|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
1248109|NCT01814527|Mild Concussion|mild concussion
1248110|NCT01814527|Brain Concussion|brain concussion
1248111|NCT01814527|Cerebral Concussion|cerebral concussion
1248112|NCT01814514|hypertensive|hypertensive
1248113|NCT01814514|phase|phase
1248114|NCT01814514|success rate|success rate
1248115|NCT01814514|AGV|agv
1599235|NCT00397228|imaging|imaging
1248116|NCT01814501|Metastatic colon cancer|metastatic colon cancer
1248117|NCT01814488|Active acute leukemia|active acute leukemia
1248118|NCT01814488|PIF|pif
1248119|NCT01814488|Allogeneic transplant|allogeneic transplant
1248120|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
1248316|NCT01813552|liver|liver
1248121|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1248122|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
1248123|NCT01814488|Cord Blood|cord blood
1248124|NCT01814488|Family Haploidentical donor|family haploidentical donor
1248125|NCT01814475|myelofibrosis|myelofibrosis
1248126|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
1248127|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1248128|NCT01814475|Progression Free Survival|progression free survival
1248129|NCT01814475|thrombocythemia vera|thrombocythemia vera
1248130|NCT01814475|polycythemia vera|polycythemia vera
1248131|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
1248132|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
1248133|NCT01814462|Pulse wave analysis|pulse wave analysis
1248134|NCT01814449|Breast cancer|breast cancer
1248136|NCT01814449|Hypoxia related gene|hypoxia related gene
1248137|NCT01814449|Endocrine therapy|endocrine therapy
1248138|NCT01814449|Treatment resistance|treatment resistance
1248139|NCT01814423|Plasmodium falciparum|plasmodium falciparum
1248140|NCT01814423|malaria|malaria
1248141|NCT01814423|chloroquine|chloroquine
1248142|NCT01814423|pharmacokinetic|pharmacokinetic
1248143|NCT01814423|children|children
1248144|NCT01814410|Intravenous Ethanol|intravenous ethanol
1248145|NCT01814410|Intravenous Nicotine|intravenous nicotine
1248146|NCT01814410|Interactive effects|interactive effects
1248147|NCT01814410|cognition|cognition
1248148|NCT01814410|subjective effects|subjective effects
1248149|NCT01814410|healthy subjects|healthy subjects
1248150|NCT01814397|Aromatase inhibitor|aromatase inhibitor
1248151|NCT01814397|Pain threshold|pain threshold
1248152|NCT01814384|Ancillary tailored|ancillary tailored
1248153|NCT01814384|medico-economic study,|medico-economic study,
1248154|NCT01814384|total knee replacement|total knee replacement
1248155|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
1248156|NCT01814371|Abscesses|abscesses
1248157|NCT01814371|Furunculosis|furunculosis
1248158|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
1248159|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
1248160|NCT01814371|MRSA|mrsa
1248161|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
1248162|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
1248163|NCT01814332|Sleep|sleep
1248164|NCT01814319|heart failure|heart failure
1248165|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
1248166|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
1248167|NCT01814293|Pediatric|pediatric
1248168|NCT01814293|Upper Respiratory infection|upper respiratory infection
1248169|NCT01814293|Over the Counter Drugs|over the counter drugs
1248170|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
1248171|NCT01814293|Vaporizer|vaporizer
1248172|NCT01814280|Medication errors|medication errors
1248173|NCT01814280|Medication review|medication review
1248174|NCT01814280|Risk stratification|risk stratification
1248175|NCT01814280|Patient safety|patient safety
1248176|NCT01814267|innovative care|innovative care
1248177|NCT01814267|telemedicine|telemedicine
1248178|NCT01814267|cost effectiveness|cost effectiveness
1248179|NCT01814267|diabetes|diabetes
1248180|NCT01814241|Peanut allergy|peanut allergy
1248181|NCT01814215|Obesity|obesity
1248182|NCT01814215|Prevention and Control|prevention and control
1248183|NCT01814215|Diet|diet
1248184|NCT01814215|Motor Activity|motor activity
1248185|NCT01814215|Intervention Studies|intervention studies
1248186|NCT01814215|Child, Preschool|child, preschool
1248187|NCT01814215|Child Care|child care
1248188|NCT01814215|Food Habits|food habits
1248189|NCT01814215|Feeding Behavior|feeding behavior
1248190|NCT01814215|Child Behavior|child behavior
1248191|NCT01814163|First line treatment|first line treatment
1248192|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
1248193|NCT01814150|Docetaxel|docetaxel
1248194|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
1248195|NCT01814150|Outcome|outcome
1248196|NCT01814111|Hypertension|hypertension
1248197|NCT01814111|Atrial Fibrillation|atrial fibrillation
1248198|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
1248199|NCT01814111|Heart Diseases|heart diseases
1248200|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
1248201|NCT01814098|Depressive Disorder, Major|depressive disorder, major
1248202|NCT01814098|Escitalopram|escitalopram
1248203|NCT01814098|Lexapro|lexapro
1248204|NCT01814085|Major Depressive Disorder|major depressive disorder
1248205|NCT01814085|Escitalopram|escitalopram
1248206|NCT01814085|Lexapro|lexapro
1248207|NCT01814059|Sirolimus|sirolimus
1248208|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
1248209|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
1248210|NCT01814059|T -Cells|t -cells
1248211|NCT01814059|Food Allergy|food allergy
1248212|NCT01814046|Metastatic|metastatic
1248213|NCT01814046|Ocular Melanoma|ocular melanoma
1248214|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
1248216|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
1248218|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
1248219|NCT01814033|Total Knee Replacement|total knee replacement
1248220|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
1248221|NCT01814033|Total Knee Range of Motion|total knee range of motion
1248222|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
1248223|NCT01814020|DSO|dso
1248225|NCT01814007|Cryolipolysis|cryolipolysis
1248226|NCT01814007|Fat Reduction|fat reduction
1248227|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
1248228|NCT01813968|Ischemic postconditioning|ischemic postconditioning
1248229|NCT01813968|Adult cardiac surgery|adult cardiac surgery
1248230|NCT01813968|Aortic valve surgery|aortic valve surgery
1248231|NCT01813968|Swan-Ganz|swan-ganz
1248232|NCT01813968|Cardiac index|cardiac index
1248233|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
1248234|NCT01813955|Psychophysiology|psychophysiology
1248235|NCT01813955|Cognition|cognition
1248236|NCT01813955|Schizophrenia|schizophrenia
1248237|NCT01813955|Papaverine|papaverine
1248238|NCT01813942|clinical narrative report|clinical narrative report
1248239|NCT01813942|time series data|time series data
1248240|NCT01813942|missing value|missing value
1248241|NCT01813929|Diabetes|diabetes
1248242|NCT01813929|Insulin|insulin
1248243|NCT01813929|Metformin|metformin
1248244|NCT01813929|Vascular|vascular
1248245|NCT01813929|Vessels|vessels
1248246|NCT01813929|Type 1|type 1
1248247|NCT01813916|Osteoarthritis|osteoarthritis
1248248|NCT01813916|synovial fluid|synovial fluid
1248249|NCT01813916|hyaluronic acid|hyaluronic acid
1248250|NCT01813890|Bunionectomy|bunionectomy
1248251|NCT01813890|Acute pain|acute pain
1248252|NCT01813890|Post-operative pain|post-operative pain
1248253|NCT01813890|Tapentadol IR|tapentadol ir
1248254|NCT01813890|Analgesia|analgesia
1248255|NCT01813890|Hallux valgus|hallux valgus
1248256|NCT01813864|treatment planning|treatment planning
1248257|NCT01813864|resource guide|resource guide
1248258|NCT01813864|service matching|service matching
1248259|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
1248260|NCT01813864|CASPAR resource guide|caspar resource guide
1248261|NCT01813864|Improved treatment planning|improved treatment planning
1248262|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
1248263|NCT01813825|Mammosite|mammosite
1248264|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
1248265|NCT01813734|RET gene mutation|ret gene mutation
1248266|NCT01813721|NHL|nhl
1248267|NCT01813721|Breast Cancer|breast cancer
1248268|NCT01813721|Lung Cancer|lung cancer
1248269|NCT01813708|Type 2 Diabetes|type 2 diabetes
1248270|NCT01813708|Intensive Life-Style|intensive life-style
1248271|NCT01813708|Collaborative Education|collaborative education
1248272|NCT01813708|Clinical Trial|clinical trial
1248273|NCT01813708|Metabolic Control|metabolic control
1248274|NCT01813695|Preemptive genetic testing|preemptive genetic testing
1248275|NCT01813695|Pain|pain
1248276|NCT01813695|Pediatrics|pediatrics
1248277|NCT01813695|Orthopedics|orthopedics
1248278|NCT01813695|Pectus excavatum|pectus excavatum
1248279|NCT01813695|Scoliosis|scoliosis
1248280|NCT01813682|preterm infant|preterm infant
1248281|NCT01813682|anemia|anemia
1248282|NCT01813682|iron fortified TPN|iron fortified tpn
1248283|NCT01813669|Childhood anxiety|childhood anxiety
1248284|NCT01813669|Pediatric Pain|pediatric pain
1248285|NCT01813669|Yoga|yoga
1248286|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
1248287|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
1248288|NCT01813656|Aripiprazole|aripiprazole
1248289|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
1248290|NCT01813643|Aripiprazole|aripiprazole
1248291|NCT01813643|Risperidone|risperidone
1248292|NCT01813630|Turner's Syndrome|turner's syndrome
1248293|NCT01813630|Short Stature|short stature
1248294|NCT01813630|Dwarfism|dwarfism
1248295|NCT01813617|Polymyositis|polymyositis
1248296|NCT01813617|Dermatomyositis|dermatomyositis
1248297|NCT01813617|Muscle endurance|muscle endurance
1248298|NCT01813617|Muscle stength|muscle stength
1248299|NCT01813617|Outcome|outcome
1248300|NCT01813604|Polio|polio
1248301|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
1248302|NCT01813604|oral polio vaccine|oral polio vaccine
1248303|NCT01813604|vaccine trial|vaccine trial
1248304|NCT01813591|Chronic Migraine|chronic migraine
1248305|NCT01813591|Headache|headache
1248306|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
1248307|NCT01813578|Systemic sclerosis|systemic sclerosis
1248308|NCT01813578|Exercise|exercise
1248309|NCT01813578|Physical capacity|physical capacity
1248310|NCT01813578|Aerobic capacity|aerobic capacity
1248311|NCT01813578|Muscle function|muscle function
1248312|NCT01813578|Fatigue|fatigue
1248314|NCT01813552|Hepatitis C|hepatitis c
1248315|NCT01813552|antiviral drugs|antiviral drugs
1248317|NCT01813539|malignancy|malignancy
1248318|NCT01813513|HCV|hcv
1248319|NCT01813513|Hepatitis C Virus|hepatitis c virus
1248320|NCT01813513|Hepatitis C|hepatitis c
1248321|NCT01813513|antiviral drugs|antiviral drugs
1248322|NCT01813513|liver|liver
1248323|NCT01813474|Cancer|cancer
1248324|NCT01813474|Tumour|tumour
1248325|NCT01813474|Solid Malignancies|solid malignancies
1248326|NCT01813461|BAL8557|bal8557
1248327|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
1248713|NCT01811680|Hemiplegia|hemiplegia
1248328|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
1248329|NCT01813448|Fidaxomicin|fidaxomicin
1248330|NCT01813448|OPT-80|opt-80
1248331|NCT01813448|Healthy Subjects|healthy subjects
1248332|NCT01813435|CAD|cad
1248333|NCT01813435|ACS|acs
1248334|NCT01813435|All comers|all comers
1248335|NCT01813435|DAPT|dapt
1248336|NCT01813435|PCI|pci
1248337|NCT01813422|Cholesterol|cholesterol
1248338|NCT01813422|High Cholesterol|high cholesterol
1248339|NCT01813422|Elevated Cholesterol|elevated cholesterol
1248340|NCT01813422|Raised Cholesterol|raised cholesterol
1248341|NCT01813396|shoulder|shoulder
1248342|NCT01813396|muscle stiffness|muscle stiffness
1248343|NCT01813396|shoulder physical activity|shoulder physical activity
1248344|NCT01813396|range of motion|range of motion
1248345|NCT01813396|joint mobility|joint mobility
1248346|NCT01813383|Celiac disease|celiac disease
1248347|NCT01813383|HLA-DQ2.2|hla-dq2.2
1248348|NCT01813383|HLA-DQ2.5|hla-dq2.5
1248349|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
1248350|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
1248351|NCT01813370|TAX 3503|tax 3503
1248352|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
1248353|NCT01813370|12-225|12-225
1248354|NCT01813357|HIV|hiv
1248355|NCT01813357|Cardiovascular disease|cardiovascular disease
1248356|NCT01813357|Inflammation|inflammation
1248357|NCT01813357|Statin|statin
1248358|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
1248359|NCT01813344|Hyper-CVAD|hyper-cvad
1248360|NCT01813344|first-line treatment|first-line treatment
1248361|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
1248362|NCT01813305|Diabetes Mellitus|diabetes mellitus
1248363|NCT01813305|Debridement|debridement
1248364|NCT01813305|Standard of Care|standard of care
1248365|NCT01813305|wounds|wounds
1248366|NCT01813292|male patients|male patients
1248367|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
1248368|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
1248369|NCT01813253|second line|second line
1248370|NCT01813214|melanoma|melanoma
1248371|NCT01813214|vemurafenib|vemurafenib
1248372|NCT01813214|cobitmetinib|cobitmetinib
1248373|NCT01813201|Testosterone|testosterone
1248374|NCT01813201|Anabolic deterioration|anabolic deterioration
1248375|NCT01813188|Fractures|fractures
1248376|NCT01813188|Bone|bone
1248377|NCT01813188|Stem Cells|stem cells
1248378|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
1248379|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
1248380|NCT01813136|pazopanib|pazopanib
1248381|NCT01813136|intermittent administration|intermittent administration
1248382|NCT01813136|time to treatment failure|time to treatment failure
1248383|NCT01813136|TUTHYREF|tuthyref
1248384|NCT01813123|gender-specific|gender-specific
1248385|NCT01813123|web-based|web-based
1248386|NCT01813123|drug abuse|drug abuse
1248387|NCT01813123|prevention|prevention
1248388|NCT01813110|inflammation|inflammation
1248389|NCT01813110|omega-3|omega-3
1248390|NCT01813110|fish oil|fish oil
1248391|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
1248392|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
1248393|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
1248394|NCT01813071|Bacterial Infections|bacterial infections
1248395|NCT01813071|Gastroenteritis|gastroenteritis
1248396|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
1248397|NCT01813071|Digestive System Diseases|digestive system diseases
1248398|NCT01813071|Intestinal Diseases|intestinal diseases
1248399|NCT01813071|Shigellosis|shigellosis
1248400|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
1248401|NCT01813045|Angiogenesis|angiogenesis
1248402|NCT01813045|Fibrosis|fibrosis
1248403|NCT01813045|Myocardial Infarction|myocardial infarction
1248404|NCT01813045|Imaging|imaging
1248405|NCT01813045|CT-PET|ct-pet
1248406|NCT01813045|PET-CT|pet-ct
1248407|NCT01813045|Cardiac MRI|cardiac mri
1248408|NCT01813032|firefighters|firefighters
1248409|NCT01813032|police officers|police officers
1248410|NCT01813032|emergency service professionals|emergency service professionals
1248411|NCT01813032|myocardial infarction|myocardial infarction
1248412|NCT01813032|endothelial function|endothelial function
1248413|NCT01813032|thrombosis|thrombosis
1248513|NCT01812551|osteoporosis|osteoporosis
1248514|NCT01812551|alendronate|alendronate
1248414|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
1248415|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
1248416|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
1248417|NCT01812980|Influenza|influenza
1248418|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
1248419|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
1248420|NCT01812954|cost utility analysis|cost utility analysis
1248421|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
1248422|NCT01812954|systemic treatment|systemic treatment
1248423|NCT01812941|burns|burns
1248424|NCT01812941|trauma|trauma
1248425|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
1248426|NCT01812928|Pain control|pain control
1248427|NCT01812928|Diclofenac|diclofenac
1248428|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
1248429|NCT01812915|Cuff pressure|cuff pressure
1248430|NCT01812915|Cylindrical cuff|cylindrical cuff
1248431|NCT01812915|Endotracheal tube|endotracheal tube
1248432|NCT01812915|Nitrous oxide|nitrous oxide
1248433|NCT01812915|Tapered cuff|tapered cuff
1248434|NCT01812902|Prostate cancer|prostate cancer
1248435|NCT01812902|Prostate specific antigen|prostate specific antigen
1248436|NCT01812902|lymphadenectomy|lymphadenectomy
1248437|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
1248438|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
1248439|NCT01812902|Immunohistochemistry|immunohistochemistry
1248440|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
1248441|NCT01812863|Pain Management|pain management
1248442|NCT01812863|Child|child
1248443|NCT01812863|Surgery|surgery
1248444|NCT01812850|Temporomandibular joint|temporomandibular joint
1248445|NCT01812850|Orofacial muscular complex|orofacial muscular complex
1248446|NCT01812850|Bruxism|bruxism
1248447|NCT01812850|Clenching|clenching
1248448|NCT01812850|Orthodontic treatment|orthodontic treatment
1248449|NCT01812850|Invisalign®|invisalign®
1248450|NCT01812837|actinic keratosis|actinic keratosis
1248451|NCT01812837|microneedles|microneedles
1248452|NCT01812837|photodynamic therapy|photodynamic therapy
1248453|NCT01812837|levulan|levulan
1248454|NCT01812837|Aminolevulinic acid|aminolevulinic acid
1248455|NCT01812824|Preconception Health|preconception health
1248456|NCT01812824|Health Information Technology|health information technology
1248457|NCT01812824|Reproductive Life Plan|reproductive life plan
1248458|NCT01812824|Healthcare Disparities|healthcare disparities
1248459|NCT01812824|Low birth-weight|low birth-weight
1248460|NCT01812824|Preterm Delivery|preterm delivery
1248461|NCT01812811|pulse wave analysis|pulse wave analysis
1248462|NCT01812811|pulse wave velocity|pulse wave velocity
1248463|NCT01812811|Arteriograph24|arteriograph24
1248464|NCT01812811|Ambulatory|ambulatory
1248465|NCT01812811|diabetes|diabetes
1248466|NCT01812811|reproducibility|reproducibility
1248467|NCT01812811|diurnal variation|diurnal variation
1248468|NCT01812798|Peanut allergy|peanut allergy
1248469|NCT01812798|Threshold|threshold
1248470|NCT01812798|Modelling|modelling
1248471|NCT01812798|Risk assessment|risk assessment
1248472|NCT01812785|Fever|fever
1248473|NCT01812785|Children|children
1248474|NCT01812785|Non-malaria fevers|non-malaria fevers
1248475|NCT01812785|Diagnosis|diagnosis
1248476|NCT01812772|urinary stents|urinary stents
1248477|NCT01812772|ureteroscopy|ureteroscopy
1248478|NCT01812759|Pain|pain
1248479|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
1248480|NCT01812759|Emergency Department|emergency department
1248481|NCT01812759|ED|ed
1248482|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
1248483|NCT01812759|Lazanda|lazanda
1248484|NCT01812759|Placebo nasal spray|placebo nasal spray
1248485|NCT01812759|Hydromorphone PCA|hydromorphone pca
1248486|NCT01812759|Dilaudid|dilaudid
1248487|NCT01812694|Pregnancy|pregnancy
1248488|NCT01812694|Weight Control|weight control
1248489|NCT01812694|Weight Gain|weight gain
1248490|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
1248491|NCT01812655|pain|pain
1248492|NCT01812655|anxiety|anxiety
1248493|NCT01812655|children|children
1248494|NCT01812655|adolescents|adolescents
1248495|NCT01812655|burn|burn
1248496|NCT01812655|virtual reality|virtual reality
1248497|NCT01812655|distraction|distraction
1248498|NCT01812642|Schizophrenia|schizophrenia
1248499|NCT01812642|JNJ-37822681|jnj-37822681
1248500|NCT01812642|Placebo|placebo
1248501|NCT01812616|Cancer|cancer
1248502|NCT01812616|Safety|safety
1248503|NCT01812603|Cancer|cancer
1248504|NCT01812603|Safety|safety
1248505|NCT01812564|Platelet rich plasma|platelet rich plasma
1248506|NCT01812564|Interventional|interventional
1248507|NCT01812564|Randomized|randomized
1248508|NCT01812564|Double-blind|double-blind
1248509|NCT01812551|cystic fibrosis|cystic fibrosis
1248510|NCT01812551|children|children
1248511|NCT01812551|adolescents|adolescents
1248512|NCT01812551|low bone mass|low bone mass
1248515|NCT01812551|fractures|fractures
1248516|NCT01812525|Bronchiolitis|bronchiolitis
1248517|NCT01812525|Moderate to Severe|moderate to severe
1248518|NCT01812525|Hypertonic saline|hypertonic saline
1248519|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
1248520|NCT01812525|Standard therapy|standard therapy
1248521|NCT01812525|Wang score|wang score
1248522|NCT01812525|in-patients|in-patients
1248523|NCT01812512|Heart Failure|heart failure
1248524|NCT01812512|Communication|communication
1248525|NCT01812512|Telemedicine|telemedicine
1248526|NCT01812512|Veterans|veterans
1248527|NCT01812512|Nurse-patient relations|nurse-patient relations
1248528|NCT01812499|blood transfusion|blood transfusion
1248529|NCT01812499|adverse event|adverse event
1248530|NCT01812499|incident reporting|incident reporting
1248531|NCT01812473|protein binding|protein binding
1248532|NCT01812473|voriconazole|voriconazole
1248533|NCT01812473|pediatrics|pediatrics
1248534|NCT01812473|hematology|hematology
1248535|NCT01812473|intensive care|intensive care
1248536|NCT01812473|albumin|albumin
1248537|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
1248538|NCT01812460|COPD|copd
1248539|NCT01812460|muscle strength|muscle strength
1248540|NCT01812460|resistance training|resistance training
1248541|NCT01812460|Physiotherapi|physiotherapi
1248542|NCT01812460|m. quadriceps|m. quadriceps
1248543|NCT01812460|Acute exacerbation|acute exacerbation
1248544|NCT01812447|Endobronchial Valves|endobronchial valves
1248545|NCT01812447|Intrabronchial Valves|intrabronchial valves
1248546|NCT01812447|Bronchial Valve|bronchial valve
1248547|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1248548|NCT01812447|COPD|copd
1248549|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1248550|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1248551|NCT01812447|BLVR|blvr
1248552|NCT01812447|TLVR|tlvr
1248553|NCT01812447|Emphysema|emphysema
1248554|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
1248555|NCT01812447|Pathologic Process|pathologic process
1248556|NCT01812447|Lung Diseases|lung diseases
1248557|NCT01812447|Respiratory Tract Disease|respiratory tract disease
1248558|NCT01812395|thyroidectomy|thyroidectomy
1248559|NCT01812395|ultrasonic dissector|ultrasonic dissector
1248560|NCT01812395|harmonic focus device|harmonic focus device
1248561|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
1248562|NCT01812382|Penetration|penetration
1248563|NCT01812382|Antibiotic|antibiotic
1248564|NCT01812382|Microdialysis|microdialysis
1248565|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
1248566|NCT01812382|Feasibility|feasibility
1248567|NCT01812356|Atrial fibrillation|atrial fibrillation
1248568|NCT01812356|maze operation|maze operation
1248569|NCT01812356|cryoablation|cryoablation
1248570|NCT01812343|Ankle Brachial Index|ankle brachial index
1248571|NCT01812343|Maximal Exercise Test|maximal exercise test
1248572|NCT01812330|ACS|acs
1248573|NCT01812330|CR|cr
1248574|NCT01812330|PCI|pci
1248575|NCT01812330|Platelet funtion|platelet funtion
1248576|NCT01812330|Ticagrelor|ticagrelor
1248577|NCT01812317|firefighters|firefighters
1248578|NCT01812317|fire-simulation training|fire-simulation training
1248579|NCT01812317|myocardial infarction|myocardial infarction
1248580|NCT01812317|endothelial function|endothelial function
1248581|NCT01812317|thrombosis|thrombosis
1248582|NCT01812291|Major Depression|major depression
1248583|NCT01812291|Minor Depression|minor depression
1248584|NCT01812291|Sub-Threshold Depression|sub-threshold depression
1248585|NCT01812291|Affective Condition|affective condition
1248586|NCT01812291|Mood Disorder|mood disorder
1248587|NCT01812291|Light Affective Disorder|light affective disorder
1248588|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
1248589|NCT01812291|Diabetes Mellitus|diabetes mellitus
1248590|NCT01812291|Diabetes-Related Distress|diabetes-related distress
1248591|NCT01812291|Self-Care Behaviour|self-care behaviour
1248592|NCT01812291|Glycaemic Control|glycaemic control
1248593|NCT01812291|Inflammatory Markers|inflammatory markers
1248594|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
1248595|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1248596|NCT01812252|bone marrow transplant|bone marrow transplant
1248597|NCT01812252|hypomethylating agent|hypomethylating agent
1248598|NCT01812252|induction chemotherapy|induction chemotherapy
1248599|NCT01812239|premature birth|premature birth
1337908|NCT01425372|vaccine|vaccine
1248600|NCT01812239|twins|twins
1248601|NCT01812239|short cervix|short cervix
1248602|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
1248603|NCT01812187|Alcohol|alcohol
1248604|NCT01812187|Alcohol Abuse|alcohol abuse
1248605|NCT01812187|Alcohol Dependence|alcohol dependence
1248606|NCT01812187|Veterans|veterans
1248607|NCT01812174|heart valve|heart valve
1248608|NCT01812161|Electro-acupuncture|electro-acupuncture
1248609|NCT01812161|HCG stimulation test|hcg stimulation test
1248610|NCT01812161|Menstrual frequency|menstrual frequency
1248611|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
1248612|NCT01812161|Randomized|randomized
1248613|NCT01812161|controlled|controlled
1248614|NCT01812161|trial|trial
1248615|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
1248616|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
1248617|NCT01812148|Oxaliplatin|oxaliplatin
1248618|NCT01812148|Cytoreductive surgery|cytoreductive surgery
1248619|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
1248620|NCT01812109|Acute Scrotum|acute scrotum
1248621|NCT01812109|Testicular Torsion|testicular torsion
1248622|NCT01812096|multiple myeloma|multiple myeloma
1248623|NCT01812096|bortezomib|bortezomib
1248624|NCT01812096|Subcutaneous|subcutaneous
1248625|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
1248626|NCT01812070|smoking cessation|smoking cessation
1248627|NCT01812070|quit smoking|quit smoking
1248628|NCT01812057|Anesthesia|anesthesia
1248629|NCT01812057|Cesarean Section|cesarean section
1248630|NCT01812057|Pain, Postoperative|pain, postoperative
1248631|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1248632|NCT01812057|Dexamethasone|dexamethasone
1248633|NCT01812057|Injections, Spinal|injections, spinal
1248634|NCT01812057|morphine|morphine
1248635|NCT01812031|PET/CT|pet/ct
1248636|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
1248637|NCT01812031|lung neoplasms|lung neoplasms
1248638|NCT01812031|respiratory motion|respiratory motion
1248639|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
1248640|NCT01812018|Pulmonary metastases|pulmonary metastases
1248641|NCT01812005|MLN8237|mln8237
1248642|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
1248643|NCT01812005|Rituximab|rituximab
1248644|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
1248645|NCT01811966|preoperative volume substitution|preoperative volume substitution
1248646|NCT01811966|hypovolemia|hypovolemia
1248647|NCT01811966|preoperative fasting|preoperative fasting
1248648|NCT01811940|cocaine dependence|cocaine dependence
1248649|NCT01811940|adderall|adderall
1248650|NCT01811940|topiramate|topiramate
1248651|NCT01811914|focused TTE|focused tte
1248652|NCT01811914|intraoperative TTE|intraoperative tte
1248653|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
1248654|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
1248655|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
1248656|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
1248657|NCT01811875|Haemophilia A|haemophilia a
1248658|NCT01811862|Acupuncture|acupuncture
1248659|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1248660|NCT01811862|13-038|13-038
1248661|NCT01811849|diabetes|diabetes
1248662|NCT01811823|Tuberculosis|tuberculosis
1248663|NCT01811823|HIV infection|hiv infection
1248664|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
1248665|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
1248666|NCT01811797|Erectile Dysfunction|erectile dysfunction
1248667|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
1248668|NCT01811797|Low intensity shockwaves|low intensity shockwaves
1248669|NCT01811784|Nipah virus infection|nipah virus infection
1248670|NCT01811784|date palm sap|date palm sap
1248671|NCT01811784|community intervention|community intervention
1248672|NCT01811784|capacity building|capacity building
1248673|NCT01811784|disease prevention|disease prevention
1248674|NCT01811784|Bangladesh|bangladesh
1248675|NCT01811784|Healthy Community people|healthy community people
1248676|NCT01811784|Sap harvesters|sap harvesters
1248677|NCT01811784|Date palm three owners|date palm three owners
1248678|NCT01811784|Date palm sap consumers|date palm sap consumers
1248679|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
1248680|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
1248681|NCT01811745|Aged|aged
1248682|NCT01811745|Cognition|cognition
1248683|NCT01811745|Exercise|exercise
1248684|NCT01811745|Falls|falls
1248685|NCT01811745|Gait|gait
1248686|NCT01811745|Physical function|physical function
1248687|NCT01811745|Dual-task|dual-task
1248688|NCT01811745|Music|music
1248689|NCT01811745|Postural Balance|postural balance
1248690|NCT01811745|Randomized controlled trial|randomized controlled trial
1248691|NCT01811732|Bacterial skin infection|bacterial skin infection
1248692|NCT01811732|skin infection|skin infection
1248693|NCT01811732|infection|infection
1248694|NCT01811732|skin|skin
1248695|NCT01811732|delafloxacin|delafloxacin
1248696|NCT01811732|vancomycin|vancomycin
1248697|NCT01811732|aztreonam|aztreonam
1248698|NCT01811732|MRSA bacteria|mrsa bacteria
1248699|NCT01811732|bacterial infection|bacterial infection
1248700|NCT01811732|Anti-Infective Agents|anti-infective agents
1248701|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
1248702|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
1248703|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
1248704|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
1248705|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
1248706|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
1248707|NCT01811719|Maternal Life Course|maternal life course
1248708|NCT01811693|Stroke|stroke
1248709|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
1248710|NCT01811693|Prehospital|prehospital
1248711|NCT01811693|Antihypertensive|antihypertensive
1248712|NCT01811680|Stroke|stroke
1248714|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
1248715|NCT01811667|Vascular Abnormalities|vascular abnormalities
1248716|NCT01811654|Patellofemoral|patellofemoral
1248717|NCT01811654|Hyaluronan|hyaluronan
1248718|NCT01811654|Intra-articular|intra-articular
1248719|NCT01811654|Hyaluronic acid|hyaluronic acid
1248720|NCT01811641|season of conception|season of conception
1248721|NCT01811641|maternal nutritional status|maternal nutritional status
1248722|NCT01811641|infant DNA methylation|infant dna methylation
1248723|NCT01811628|Cancer Prevention|cancer prevention
1248724|NCT01811628|Tobacco Use Cessation|tobacco use cessation
1248725|NCT01811628|Smokers|smokers
1248726|NCT01811628|Recent quitters|recent quitters
1248727|NCT01811628|Latino|latino
1248728|NCT01811628|Hispanic|hispanic
1248729|NCT01811628|Information|information
1248730|NCT01811628|Interview|interview
1248731|NCT01811628|Questionnaire|questionnaire
1248732|NCT01811628|Survey|survey
1248733|NCT01811628|Audio-recorded|audio-recorded
1248734|NCT01811602|Training|training
1248735|NCT01811602|Physiotherapy|physiotherapy
1248736|NCT01811602|Pelvic floor muscles|pelvic floor muscles
1248737|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
1248738|NCT01811576|Growth hormone deficiency|growth hormone deficiency
1248739|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
1248740|NCT01811576|TV-1106|tv-1106
1248741|NCT01811563|Total Knee Replacement|total knee replacement
1248742|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
1248743|NCT01811563|Functional Outcomes|functional outcomes
1248744|NCT01811563|Patient Reported Outcomes|patient reported outcomes
1248745|NCT01811537|Artificial Chordae|artificial chordae
1248746|NCT01811537|Mitral Valve Repair|mitral valve repair
1248747|NCT01811524|Brain tumor|brain tumor
1248748|NCT01811524|Glioma|glioma
1248749|NCT01811524|Meningioma|meningioma
1248750|NCT01811524|Diagnosis|diagnosis
1248751|NCT01811524|Prognosis|prognosis
1248752|NCT01811524|Heredity|heredity
1248753|NCT01811472|Multi-center,|multi-center,
1248754|NCT01811472|randomized,|randomized,
1248755|NCT01811472|double-blind,|double-blind,
1248756|NCT01811472|NAFLD,|nafld,
1248757|NCT01811472|elevated triglycerides|elevated triglycerides
1248758|NCT01811459|Delirium|delirium
1248760|NCT01811459|Burn patients|burn patients
1248761|NCT01811459|Antipsychotics|antipsychotics
1248762|NCT01811459|Haloperidol|haloperidol
1248763|NCT01811459|Quetiapine|quetiapine
1248764|NCT01811433|Postoperative Period|postoperative period
1248765|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
1248766|NCT01811433|Postoperative Complications|postoperative complications
1248767|NCT01811433|Pulse Oximetry|pulse oximetry
1248768|NCT01811420|dental caries|dental caries
1248769|NCT01811420|caries removal|caries removal
1248770|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
1248771|NCT01811394|sacral chordoma|sacral chordoma
1248772|NCT01811394|chordoma|chordoma
1248773|NCT01811394|carbon ion therapy|carbon ion therapy
1248774|NCT01811394|proton therapy|proton therapy
1248775|NCT01811394|hypofractionation|hypofractionation
1248776|NCT01811381|Alzheimer|alzheimer
1248777|NCT01811381|Prevention|prevention
1248778|NCT01811381|mild cognitive impairment|mild cognitive impairment
1248779|NCT01811381|physical exercise|physical exercise
1248780|NCT01811381|synergism|synergism
1248781|NCT01811381|curcumin|curcumin
1248782|NCT01811381|dietary supplement|dietary supplement
1248783|NCT01811381|anti-inflammatory|anti-inflammatory
1248784|NCT01811381|anti-tau|anti-tau
1248785|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
1248786|NCT01811381|plasma-exosomes|plasma-exosomes
1248787|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
1248788|NCT01811355|Muscle cramps|muscle cramps
1248789|NCT01811355|Cramp|cramp
1248791|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1248792|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
1248793|NCT01811355|Motor Neuron Disease|motor neuron disease
1248794|NCT01811355|MND|mnd
1248795|NCT01811342|Hemoglobin|hemoglobin
1248796|NCT01811342|Patient Monitoring|patient monitoring
1248797|NCT01811277|palliative chemotherapy|palliative chemotherapy
1248798|NCT01811277|ORR|orr
1248799|NCT01811277|PFS|pfs
1248800|NCT01811277|OS|os
1248801|NCT01811277|safety|safety
1248802|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
1248803|NCT01811264|Metastatic|metastatic
1248804|NCT01811264|Quality of life|quality of life
1248805|NCT01811264|Decision making|decision making
1248806|NCT01811251|Co-analgesia|co-analgesia
1248807|NCT01811251|Dexamethasone|dexamethasone
1248808|NCT01811251|Pregabalin|pregabalin
1248809|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
1248810|NCT01811251|Post-operative pain|post-operative pain
1248811|NCT01811238|spinal disorders|spinal disorders
1248812|NCT01811225|Women|women
1248813|NCT01811225|Pregnancy|pregnancy
1248814|NCT01811225|Smoking|smoking
1248815|NCT01811199|Thyroid cancer|thyroid cancer
1248816|NCT01811199|Breast cancer|breast cancer
1248817|NCT01811199|Dexamethasone|dexamethasone
1248818|NCT01811199|Emesis|emesis
1248819|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
1248820|NCT01811173|multimorbidity|multimorbidity
1248821|NCT01811173|primary care|primary care
1248822|NCT01811173|physician - nurse team|physician - nurse team
1248823|NCT01811173|proactive monitoring|proactive monitoring
1248824|NCT01811173|support for self-care|support for self-care
1248825|NCT01811173|primary caregiver|primary caregiver
1248826|NCT01811160|Melatonin|melatonin
1248827|NCT01811160|Second generation antipsychotic|second generation antipsychotic
1248828|NCT01811160|bipolar disorder|bipolar disorder
1248829|NCT01811160|schizophrenia|schizophrenia
1248830|NCT01811160|Metabolic|metabolic
1248831|NCT01811147|Bipolar|bipolar
1248832|NCT01811147|Depression|depression
1248833|NCT01811147|Mania|mania
1248834|NCT01811147|Hypomania|hypomania
1248835|NCT01811147|fMRI|fmri
1248836|NCT01811147|antidepressant|antidepressant
1248837|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
1248838|NCT01811121|Glioblastoma|glioblastoma
1248839|NCT01811121|5ALA|5ala
1248840|NCT01811121|fluorescence|fluorescence
1248841|NCT01811121|resection|resection
1248842|NCT01811108|mCRC|mcrc
1248843|NCT01811108|KRAS mutation|kras mutation
1248844|NCT01811108|Chemotherapy|chemotherapy
1248845|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
1248846|NCT01811108|Bevacizumab|bevacizumab
1248847|NCT01811108|1st Line|1st line
1248848|NCT01811095|Robotics|robotics
1248849|NCT01811095|Computer-assisted surgery|computer-assisted surgery
1248850|NCT01811095|Computer simulation|computer simulation
1248851|NCT01811095|Gynecology|gynecology
1248852|NCT01811095|General surgery|general surgery
1248853|NCT01811069|Obese patients|obese patients
1248854|NCT01811069|Upper airway patency|upper airway patency
1248855|NCT01811056|medical abortion|medical abortion
1248856|NCT01811056|mifepristone|mifepristone
1248857|NCT01811043|breast biopsy|breast biopsy
1248858|NCT01811043|anxiety|anxiety
1248859|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
1248860|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
1248861|NCT01810952|glucocorticoids|glucocorticoids
1248862|NCT01810952|hyperglycemia|hyperglycemia
1248863|NCT01810952|diabetes mellitus|diabetes mellitus
1248864|NCT01810939|Chronic Kidney Disease|chronic kidney disease
1248865|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
1248866|NCT01810939|Hyperkalemia|hyperkalemia
1248867|NCT01810926|indication for HSCT|indication for hsct
1248868|NCT01810926|matched related donor|matched related donor
1248869|NCT01810926|MRD|mrd
1248870|NCT01810926|Matched Unrelated Donor|matched unrelated donor
1248871|NCT01810926|MUD|mud
1248872|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
1248873|NCT01810887|Healthy|healthy
1248874|NCT01810887|Darunavir|darunavir
1248875|NCT01810887|JNS011|jns011
1248876|NCT01810887|Ritonavir|ritonavir
1248877|NCT01810874|extraperitoneal|extraperitoneal
1248878|NCT01810874|transperitoneal|transperitoneal
1248879|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
1248880|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
1248881|NCT01810874|ovarian cancer|ovarian cancer
1248882|NCT01810874|surgical staging|surgical staging
1248883|NCT01810861|serotype distribution|serotype distribution
1248884|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
1248885|NCT01810861|pneumonia|pneumonia
1248886|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
1248887|NCT01810848|Osteoarthritis|osteoarthritis
1248888|NCT01810848|Synvisc|synvisc
1248889|NCT01810848|Hylan G-F 20|hylan g-f 20
1248890|NCT01810848|Exercise|exercise
1248891|NCT01810848|Cardiovascular risk|cardiovascular risk
1248892|NCT01810848|Knee pain|knee pain
1248893|NCT01810848|Pain|pain
1248894|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
1248895|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
1248896|NCT01810835|France|france
1248897|NCT01810822|oxidative stress|oxidative stress
1248898|NCT01810822|genetic susceptibility|genetic susceptibility
1248899|NCT01810822|GPX4|gpx4
1248900|NCT01810822|NOX2|nox2
1248901|NCT01810809|Osteoarthritis|osteoarthritis
1248902|NCT01810809|Hip|hip
1248903|NCT01810809|Viscosupplementation|viscosupplementation
1248904|NCT01810809|Clinical Trial|clinical trial
1248905|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
1248906|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
1248907|NCT01810770|Bone Metastasis|bone metastasis
1248908|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
1248909|NCT01810731|HIV|hiv
1248910|NCT01810731|pregnancy|pregnancy
1248911|NCT01810731|influenza vaccine safety|influenza vaccine safety
1248913|NCT01810718|steroid therapy|steroid therapy
1248914|NCT01810718|Nilotinib|nilotinib
1248915|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
1248916|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
1248917|NCT01810718|Tasigna|tasigna
1248918|NCT01810718|MTD|mtd
1248919|NCT01810705|myeloid|myeloid
1248920|NCT01810705|leukemia|leukemia
1248921|NCT01810679|aortic valve replacement|aortic valve replacement
1248922|NCT01810679|aortic stenosis|aortic stenosis
1248923|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
1248924|NCT01810679|Perceval|perceval
1248925|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
1248926|NCT01810653|Macrogol|macrogol
1248927|NCT01810640|Liver biopsy|liver biopsy
1248928|NCT01810640|organ donation|organ donation
1248929|NCT01810640|donor management|donor management
1248930|NCT01810627|Prostate|prostate
1248931|NCT01810627|Cancer|cancer
1248932|NCT01810614|ADPKD|adpkd
1248933|NCT01810614|PKD|pkd
1248934|NCT01810614|Kidney Disease|kidney disease
1248935|NCT01810614|ADPKD diet|adpkd diet
1248936|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
1248937|NCT01810588|Allogeneic transplant|allogeneic transplant
1248938|NCT01810588|Hematologic Malignancies|hematologic malignancies
1248939|NCT01810588|Acute Leukemia|acute leukemia
1248940|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
1248941|NCT01810588|Lymphoma|lymphoma
1248942|NCT01810588|Myeloma|myeloma
1248943|NCT01810562|Stroke|stroke
1248944|NCT01810562|Tactile|tactile
1248945|NCT01810562|Sensibility|sensibility
1248946|NCT01810562|Stimulation|stimulation
1248947|NCT01810562|Extremities|extremities
1248948|NCT01810562|Arm|arm
1248949|NCT01810562|Leg|leg
1248950|NCT01810549|Fatigue|fatigue
1248951|NCT01810536|Cystic fibrosis|cystic fibrosis
1248952|NCT01810536|oxygen|oxygen
1248953|NCT01810536|respiratory failure|respiratory failure
1248954|NCT01810523|Acute|acute
1248955|NCT01810523|lower|lower
1248956|NCT01810523|extremity|extremity
1248957|NCT01810523|not requiring|not requiring
1248958|NCT01810523|diagnostic|diagnostic
1248959|NCT01810523|imaging|imaging
1248960|NCT01810510|respiration, artificial|respiration, artificial
1248961|NCT01810497|External ear|external ear
1248962|NCT01810497|Ear abnormalities|ear abnormalities
1248963|NCT01810497|External ear cartilages|external ear cartilages
1248964|NCT01810484|Ulthera® System|ulthera® system
1248965|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
1248966|NCT01810484|Ulthera, Inc.|ulthera, inc.
1248967|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
1248968|NCT01810458|Liver|liver
1248969|NCT01810458|Fibrosis|fibrosis
1248970|NCT01810458|Alpha-1|alpha-1
1248971|NCT01810458|AAT|aat
1248972|NCT01810458|AATD|aatd
1248973|NCT01810445|Bladder Cancer|bladder cancer
1248974|NCT01810445|Laser|laser
1248975|NCT01810445|Optical|optical
1248976|NCT01810419|splenomegaly|splenomegaly
1248977|NCT01810419|ultrasound|ultrasound
1248978|NCT01810419|Vscan|vscan
1248979|NCT01810367|PFS|pfs
1248980|NCT01810354|Cefazolin|cefazolin
1248981|NCT01810354|Tissue concentration|tissue concentration
1248982|NCT01810354|infection|infection
1248983|NCT01810354|cesarean section|cesarean section
1248984|NCT01810354|obese|obese
1248985|NCT01810341|Autism|autism
1248986|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
1248987|NCT01810341|RNA|rna
1248988|NCT01810341|Gene expression|gene expression
1248989|NCT01810341|Developmental Delay|developmental delay
1248990|NCT01810341|Metabolites|metabolites
1248991|NCT01810341|DNA|dna
1248992|NCT01810302|Vasospasm|vasospasm
1248993|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
1248994|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1248995|NCT01810302|Nicardipine|nicardipine
1248996|NCT01810302|Intrathecal|intrathecal
1248997|NCT01810302|SAH|sah
1248998|NCT01810302|aSAH|asah
1248999|NCT01810289|HIV, ART, CD4|hiv, art, cd4
1249000|NCT01810276|traumatic head injury|traumatic head injury
1249001|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
1249002|NCT01810276|platelets|platelets
1249003|NCT01810276|anti-platelet therapy|anti-platelet therapy
1249004|NCT01810276|plavix|plavix
1249005|NCT01810276|asprin|asprin
1249006|NCT01810263|stroke|stroke
1249007|NCT01810263|malnutrition|malnutrition
1249008|NCT01810263|high protein|high protein
1249009|NCT01810211|Shoulder|shoulder
1249010|NCT01810211|Surgery|surgery
1249011|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
1249012|NCT01810211|Flexibility|flexibility
1249013|NCT01810211|Range of Motion|range of motion
1249014|NCT01810198|Coronary Artery Disease|coronary artery disease
1249015|NCT01810198|Cardiac CT|cardiac ct
1249016|NCT01810198|Catheterization|catheterization
1249017|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
1249018|NCT01810185|Crohn's disease|crohn's disease
1249019|NCT01810185|Ulcerative colitis|ulcerative colitis
1249020|NCT01810185|Naltrexone|naltrexone
1249021|NCT01810185|Low Dose Naltrexone|low dose naltrexone
1249022|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
1249023|NCT01810172|lobectomy|lobectomy
1249024|NCT01810172|segmentectomy|segmentectomy
1249025|NCT01810172|pneumothorax|pneumothorax
1249026|NCT01810172|pleural|pleural
1249027|NCT01810172|digital|digital
1249028|NCT01810172|air leak|air leak
1249029|NCT01810159|substance use disorders|substance use disorders
1249030|NCT01810159|implementation science|implementation science
1249031|NCT01810159|collaborative care|collaborative care
1249032|NCT01810159|opiate disorders|opiate disorders
1249033|NCT01810159|alcohol disorders|alcohol disorders
1249034|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
1249035|NCT01810133|Comorbidity|comorbidity
1249036|NCT01810120|Hematologic|hematologic
1249037|NCT01810120|Malignant|malignant
1249038|NCT01810120|Non-Malignant|non-malignant
1249039|NCT01810120|Allogeneic|allogeneic
1249040|NCT01810120|Transplant|transplant
1249041|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1249042|NCT01810120|Pediatric|pediatric
1249043|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1249044|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
1249045|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
1249046|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
1249047|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
1249048|NCT01810094|fixation|fixation
1249049|NCT01810094|fixateur interne|fixateur interne
1249050|NCT01810094|minimal invasive|minimal invasive
1249051|NCT01810094|percutaneous|percutaneous
1249052|NCT01810081|Cholelithiasis|cholelithiasis
1249053|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
1249054|NCT01810081|H.Pylori infection|h.pylori infection
1249055|NCT01810081|Gastric mucosa|gastric mucosa
1249056|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
1249057|NCT01810042|age-related macular degeneration|age-related macular degeneration
1249058|NCT01810042|choroidal neovascularization|choroidal neovascularization
1249059|NCT01810042|ranibizumab|ranibizumab
1249060|NCT01810042|indocyanine angiography|indocyanine angiography
1249061|NCT01810029|transcendental meditation|transcendental meditation
1249062|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
1249063|NCT01810016|NY-ESO-1|ny-eso-1
1249064|NCT01810016|Metastatic Melanoma|metastatic melanoma
1249065|NCT01810016|Ipilimumab|ipilimumab
1249066|NCT01810016|Phase I|phase i
1249067|NCT01810016|Adjuvant|adjuvant
1249068|NCT01810016|Immunologic|immunologic
1249069|NCT01810016|Vaccination|vaccination
1249070|NCT01810016|Immunotherapy|immunotherapy
1249071|NCT01810016|Neoplasm|neoplasm
1249072|NCT01810003|Cardiovascular disease|cardiovascular disease
1249073|NCT01810003|Inflammation|inflammation
1249074|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
1249075|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
1249076|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
1249077|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
1249078|NCT01809977|Keratoconus|keratoconus
1249079|NCT01809977|remove|remove
1249080|NCT01809977|cornea|cornea
1249081|NCT01809977|visual acuity|visual acuity
1249082|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
1249083|NCT01809938|Pre-operative fasting|pre-operative fasting
1249084|NCT01809938|Ultrasound|ultrasound
1249085|NCT01809938|Paracetamol Absorption|paracetamol absorption
1249086|NCT01809912|solid tumor|solid tumor
1249087|NCT01809899|Trauma|trauma
1249088|NCT01809899|Abuse|abuse
1249089|NCT01809899|Domestic Violence|domestic violence
1249090|NCT01809899|Rape|rape
1249091|NCT01809899|Assault|assault
1249092|NCT01809899|MRI|mri
1249093|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
1249094|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
1599433|NCT00396513|PCOS|pcos
1249095|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
1249096|NCT01809873|Malaria|malaria
1249097|NCT01809873|Diagnostics|diagnostics
1249098|NCT01809873|Health Services|health services
1249099|NCT01809860|isavuconazole|isavuconazole
1249100|NCT01809860|sirolimus|sirolimus
1249101|NCT01809860|BAL8557|bal8557
1249102|NCT01809860|Healthy Volunteers|healthy volunteers
1249103|NCT01809847|CLL|cll
1249104|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
1249105|NCT01809847|Leukemia|leukemia
1249106|NCT01809847|HLA|hla
1249107|NCT01809847|Histocompatibility|histocompatibility
1249108|NCT01809847|HCT|hct
1249109|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1249110|NCT01809847|Ofatumumab|ofatumumab
1249111|NCT01809847|CD20|cd20
1249112|NCT01809821|Hypertension|hypertension
1249113|NCT01809821|Sleep Disorders|sleep disorders
1249114|NCT01809821|Insomnia|insomnia
1249115|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
1249116|NCT01809821|Internet treatment|internet treatment
1249117|NCT01809808|Acromegaly|acromegaly
1249118|NCT01809808|Pituitary tumor|pituitary tumor
1249119|NCT01809795|Obesity|obesity
1249120|NCT01809795|Exercise|exercise
1249121|NCT01809795|Blueberry Plant|blueberry plant
1249122|NCT01809743|Coronary artery disease|coronary artery disease
1249123|NCT01809743|Regadenoson|regadenoson
1249124|NCT01809743|Adenosine|adenosine
1249125|NCT01809743|Maximal hyperemia|maximal hyperemia
1249126|NCT01809743|Fractional flow reserve|fractional flow reserve
1249128|NCT01809691|Prostate cancer|prostate cancer
1249129|NCT01809691|TAK-700|tak-700
1249130|NCT01809691|Bicalutamide|bicalutamide
1249131|NCT01809691|S1216|s1216
1249132|NCT01809691|androgen therapy|androgen therapy
1249133|NCT01809691|Phase III|phase iii
1249134|NCT01809678|Smoking|smoking
1249135|NCT01809678|Tobacco|tobacco
1249136|NCT01809678|Yoga|yoga
1249137|NCT01809665|ICD therapy|icd therapy
1249138|NCT01809665|CRT-P therapy|crt-p therapy
1249139|NCT01809665|MRI|mri
1249140|NCT01809652|Pacemaker|pacemaker
1249141|NCT01809652|Defibrillator|defibrillator
1249142|NCT01809652|Remote Consultation|remote consultation
1249143|NCT01809639|Concussion|concussion
1249144|NCT01809613|Parkinson disease|parkinson disease
1249145|NCT01809613|Deep Brain Stimulation|deep brain stimulation
1249146|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1249147|NCT01809574|Interstitial lung disease|interstitial lung disease
1249148|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1249149|NCT01809574|Connective tissue disease|connective tissue disease
1249150|NCT01809561|endometriosis|endometriosis
1249151|NCT01809561|telomere|telomere
1249152|NCT01809561|telomerase|telomerase
1249153|NCT01809548|complementary feeding|complementary feeding
1249154|NCT01809548|premature infant|premature infant
1249155|NCT01809548|body composition|body composition
1249156|NCT01809548|atopy|atopy
1249157|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
1249158|NCT01809548|obesity|obesity
1249159|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
1249160|NCT01809535|post-EVL ulcer|post-evl ulcer
1249161|NCT01809535|variceal bleeding|variceal bleeding
1249162|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
1249163|NCT01809522|Urinary continence|urinary continence
1249164|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
1249165|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
1249166|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
1249167|NCT01809496|hearing loss|hearing loss
1249168|NCT01809496|hearing aids|hearing aids
1249169|NCT01809496|spouses|spouses
1249170|NCT01809496|rehabilitation|rehabilitation
1249171|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
1249172|NCT01809483|bandage contact lens|bandage contact lens
1249173|NCT01809483|pressure patching|pressure patching
1249174|NCT01809483|erosion area|erosion area
1249175|NCT01809483|pain scale|pain scale
1249176|NCT01809470|Blood pressure|blood pressure
1249177|NCT01809470|Appetite|appetite
1249178|NCT01809470|Heart rate|heart rate
1249179|NCT01809470|Salivary cortisol|salivary cortisol
1249180|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
1249181|NCT01809431|gestational diabetes|gestational diabetes
1249182|NCT01809431|women|women
1249183|NCT01809431|infants|infants
1249184|NCT01809431|blood glucose|blood glucose
1249185|NCT01809431|weight|weight
1249186|NCT01809431|adiposity|adiposity
1249187|NCT01809431|health behaviors|health behaviors
1249188|NCT01809431|self-efficacy|self-efficacy
1249189|NCT01809392|Decitabine|decitabine
1249190|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1249191|NCT01809392|Wilms' tumor 1|wilms' tumor 1
1249192|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
1249193|NCT01809392|Regulatory T cell|regulatory t cell
1249194|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
1249195|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
1249196|NCT01809353|Healthy|healthy
1249197|NCT01809353|Japanese|japanese
1249198|NCT01809353|Caucasian|caucasian
1249199|NCT01809353|Male|male
1249200|NCT01809353|Pharmacokinetic|pharmacokinetic
1249201|NCT01809353|JNJ-54452840|jnj-54452840
1249202|NCT01809340|Depressive Disorder|depressive disorder
1249203|NCT01809340|Major Depressive Disorder|major depressive disorder
1249204|NCT01809340|Depression|depression
1249205|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
1249206|NCT01809340|Anti-depressant|anti-depressant
1249207|NCT01809340|Ketamine|ketamine
1249208|NCT01809340|Minocycline|minocycline
1249209|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1249210|NCT01809327|Diabetes Mellitus|diabetes mellitus
1249211|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1249212|NCT01809327|Metformin|metformin
1249213|NCT01809301|Bioavailability|bioavailability
1249214|NCT01809288|Women|women
1249215|NCT01809288|Diet|diet
1249216|NCT01809288|Obesity|obesity
1249217|NCT01809288|African|african
1249218|NCT01809288|African Americans|african americans
1249219|NCT01809275|Crohn's Disease|crohn's disease
1249220|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
1249221|NCT01809275|CDAI|cdai
1249222|NCT01809249|Living donor liver transplantation|living donor liver transplantation
1249223|NCT01809249|Donar safety|donar safety
1249224|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
1249225|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
1249226|NCT01809210|metastatic,|metastatic,
1249227|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
1249228|NCT01809197|Refractive error|refractive error
1249229|NCT01809197|Myopia|myopia
1249230|NCT01809197|Hyperopia|hyperopia
1249231|NCT01809197|Astigmatism|astigmatism
1249232|NCT01809197|Presbyopia|presbyopia
1249233|NCT01809197|Contact lenses|contact lenses
1249234|NCT01809197|Contact lens solution|contact lens solution
1249235|NCT01809197|Comfort|comfort
1249236|NCT01809145|sarcoidosis|sarcoidosis
1249237|NCT01809145|occupational exposure|occupational exposure
1249238|NCT01809145|MELISA|melisa
1249239|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
1249240|NCT01809132|pentoxifylline|pentoxifylline
1249241|NCT01809132|zinc|zinc
1249242|NCT01809132|anakinra|anakinra
1249243|NCT01809132|glucocorticoids|glucocorticoids
1249244|NCT01809132|MELD score|meld score
1249245|NCT01809132|Intestinal mucosa|intestinal mucosa
1249246|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
1249247|NCT01809106|cancer pain|cancer pain
1249248|NCT01809106|major opioid|major opioid
1249249|NCT01809106|analgesics|analgesics
1249250|NCT01809093|PEDF|pedf
1249251|NCT01809093|TSP1|tsp1
1249252|NCT01809093|Thrombospondin|thrombospondin
1249253|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
1249254|NCT01809093|Wills Eye Institute|wills eye institute
1249255|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
1249256|NCT01809093|Vitreous levels|vitreous levels
1249257|NCT01809093|Mid Atlantic Retina|mid atlantic retina
1249258|NCT01809093|Blood draw|blood draw
1249259|NCT01809093|Blood test|blood test
1249260|NCT01809067|stress|stress
1249261|NCT01809067|anxiety|anxiety
1249262|NCT01809067|MRI|mri
1249263|NCT01809067|aromatherapy|aromatherapy
1249264|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
1249265|NCT01809028|cell block, number of passes|cell block, number of passes
1249266|NCT01809015|Oral Anticoagulation|oral anticoagulation
1249267|NCT01809015|Regular Medical Care|regular medical care
1249268|NCT01809015|Coagulation Service|coagulation service
1249269|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
1249270|NCT01809015|Quality of therapy|quality of therapy
1249271|NCT01809015|Atrial fibrillation|atrial fibrillation
1249272|NCT01809015|Venous thromboembolism|venous thromboembolism
1249273|NCT01809015|Bypass surgery|bypass surgery
1249274|NCT01809015|Prosthetic heart valve|prosthetic heart valve
1249275|NCT01808989|peripheral artery disease|peripheral artery disease
1249276|NCT01808989|tcpo2|tcpo2
1249277|NCT01808989|treadmill walking test|treadmill walking test
1249278|NCT01808989|intermittent claudication|intermittent claudication
1249279|NCT01808963|Enthalpy|enthalpy
1249280|NCT01808963|Physiologic Monitors|physiologic monitors
1249281|NCT01808963|Critical Care Medicine|critical care medicine
1249282|NCT01808911|Acquired haemophilia|acquired haemophilia
1249283|NCT01808911|Comparative and randomized study|comparative and randomized study
1249284|NCT01808911|Cyclophosphamide|cyclophosphamide
1249285|NCT01808911|Rituximab|rituximab
1249286|NCT01808898|Ablation|ablation
1249287|NCT01808898|Outpatient|outpatient
1249288|NCT01808885|safety|safety
1249289|NCT01808885|multiple sclerosis|multiple sclerosis
1249290|NCT01808885|olesoxime|olesoxime
1249291|NCT01808885|double-blind|double-blind
1249292|NCT01808885|randomized|randomized
1249293|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
1249294|NCT01808859|Thigh Tourniquet|thigh tourniquet
1249295|NCT01808846|Obesity|obesity
1249296|NCT01808846|Insulin Resistance|insulin resistance
1249297|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
1249298|NCT01808846|glucose|glucose
1249299|NCT01808846|fructose|fructose
1249300|NCT01808846|hypothalamus|hypothalamus
1249301|NCT01808846|neuronal circuits|neuronal circuits
1249302|NCT01808846|feeding behavior|feeding behavior
1249303|NCT01808833|Frailty|frailty
1249304|NCT01808833|Geriatric oncology|geriatric oncology
1249305|NCT01808820|Malignant Glioma|malignant glioma
1249306|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
1249307|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
1249308|NCT01808820|High Grade Glioma|high grade glioma
1249309|NCT01808820|HGG|hgg
1249310|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
1249311|NCT01808820|DC Vaccine|dc vaccine
1249312|NCT01808820|Leukapheresis|leukapheresis
1249313|NCT01808807|cesarean section rate|cesarean section rate
1249314|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
1249315|NCT01808794|membranes|membranes
1249316|NCT01808794|Mucograft|mucograft
1249317|NCT01808794|Dynamatrixw|dynamatrixw
1249318|NCT01808794|ridge|ridge
1249319|NCT01808794|preservation|preservation
1249320|NCT01808794|bone|bone
1249321|NCT01808794|allograft|allograft
1249322|NCT01808794|extraction|extraction
1249323|NCT01808794|site|site
1249324|NCT01808794|healing|healing
1249325|NCT01808781|Power|power
1249326|NCT01808781|muscle strength|muscle strength
1249327|NCT01808781|total knee replacement|total knee replacement
1249328|NCT01808781|physical activity behavior|physical activity behavior
1249513|NCT01807936|lymphadenectomy|lymphadenectomy
1249329|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
1249330|NCT01808755|D Mannose|d mannose
1249331|NCT01808755|cystitis|cystitis
1249332|NCT01808755|antibiotic treatment|antibiotic treatment
1249333|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
1249334|NCT01808729|coronary artery disease|coronary artery disease
1249335|NCT01808716|low-level laser therapy|low-level laser therapy
1249336|NCT01808716|muscle damage|muscle damage
1249337|NCT01808703|Periodontitis|periodontitis
1249338|NCT01808703|Periodontal pocket|periodontal pocket
1249339|NCT01808703|Periodontal diseases|periodontal diseases
1249340|NCT01808690|Adolescent|adolescent
1249341|NCT01808690|Youth|youth
1249342|NCT01808690|Diabetes|diabetes
1249343|NCT01808690|Insulin Resistance|insulin resistance
1249344|NCT01808690|Cardiovascular|cardiovascular
1249345|NCT01808690|Metformin|metformin
1249346|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
1249347|NCT01808677|NSCLC|nsclc
1249348|NCT01808677|Thoracic reirradiation|thoracic reirradiation
1249349|NCT01808677|Proton beam therapy|proton beam therapy
1249350|NCT01808677|PBT|pbt
1249351|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
1249352|NCT01808677|IMRT|imrt
1249353|NCT01808677|Registry|registry
1249354|NCT01808677|Data|data
1249355|NCT01808638|Adenocarcinoma|adenocarcinoma
1249356|NCT01808638|Pancreas|pancreas
1249357|NCT01808638|Gemcitabine|gemcitabine
1249358|NCT01808638|Atu027|atu027
1249359|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
1249360|NCT01808586|Neck|neck
1249361|NCT01808586|chronic pain|chronic pain
1249362|NCT01808586|facet injection|facet injection
1249363|NCT01808573|Neratinib|neratinib
1249364|NCT01808573|Nerlynx|nerlynx
1249365|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
1249366|NCT01808521|TTP|ttp
1249367|NCT01808508|Down syndrome|down syndrome
1249368|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1249369|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
1249370|NCT01808508|sham or placebo CPAP|sham or placebo cpap
1249371|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
1249372|NCT01808495|Fibulin-1|fibulin-1
1249373|NCT01808495|Nuclear accumulation|nuclear accumulation
1249374|NCT01808482|monoclonal antibody|monoclonal antibody
1249375|NCT01808482|Multiple Sclerosis|multiple sclerosis
1249376|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
1249377|NCT01808456|kidney transplant|kidney transplant
1249378|NCT01808456|heart transplant|heart transplant
1249379|NCT01808456|lung transplant|lung transplant
1249380|NCT01808456|influenza vaccine|influenza vaccine
1249381|NCT01808443|cryotherapy|cryotherapy
1249382|NCT01808443|laser|laser
1249383|NCT01808443|cutaneous warts|cutaneous warts
1249384|NCT01808430|NSCLC|nsclc
1249385|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
1249386|NCT01808404|Mindfulness|mindfulness
1249387|NCT01808404|Guided Self-Help|guided self-help
1249388|NCT01808404|College|college
1249389|NCT01808391|Coronary artery disease|coronary artery disease
1249390|NCT01808391|Heart disease|heart disease
1249391|NCT01808391|Myocardial ischemia|myocardial ischemia
1249392|NCT01808391|Cardiovascular disease|cardiovascular disease
1249393|NCT01808391|Arteriosclerosis|arteriosclerosis
1249394|NCT01808391|Vascular disease|vascular disease
1333264|NCT01443767|Cardiac Output|cardiac output
1249395|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
1249396|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
1249397|NCT01808365|Neisseria meningitidis|neisseria meningitidis
1249398|NCT01808365|Philippines|philippines
1249399|NCT01808365|carriage|carriage
1249400|NCT01808365|meningococcus|meningococcus
1249401|NCT01808352|AE adverse event|ae adverse event
1249402|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1249403|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1249404|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
1249405|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1249406|NCT01808352|DCF data collection forms|dcf data collection forms
1249407|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
1249408|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1249409|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1249410|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1249411|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
1249412|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
1249413|NCT01808352|IRB Institutional Review Board|irb institutional review board
1250105|NCT01805232|Falciaparum|falciaparum
1249414|NCT01808352|IU International units|iu international units
1249415|NCT01808352|mg milligram(s)|mg milligram(s)
1249416|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1249417|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
1249418|NCT01808352|SAE serious adverse event|sae serious adverse event
1249419|NCT01808352|µg microgram|µg microgram
1249514|NCT01807910|Obesity|obesity
1249420|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
1249421|NCT01808352|WB Western Blot|wb western blot
1249422|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
1249423|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1249424|NCT01808287|Aortic Stenosis|aortic stenosis
1249425|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1249426|NCT01808274|Aortic Stenosis|aortic stenosis
1249427|NCT01808261|Ischemic Stroke|ischemic stroke
1249428|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1249429|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1249430|NCT01808248|HCV|hcv
1249431|NCT01808248|Sustained Virologic Response|sustained virologic response
1249432|NCT01808248|Direct Acting Antiviral|direct acting antiviral
1249433|NCT01808248|Combination Therapy|combination therapy
1249434|NCT01808248|Treatment-Naïve|treatment-naïve
1249435|NCT01808248|GS-7977|gs-7977
1249436|NCT01808248|Ribavirin|ribavirin
1249437|NCT01808248|RBV|rbv
1249438|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
1249439|NCT01808248|PEG|peg
1249440|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
1249441|NCT01808248|Hepatitis|hepatitis
1249442|NCT01808248|Hepatitis A|hepatitis a
1249443|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
1249444|NCT01808248|Hepatitis C|hepatitis c
1249445|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
1249446|NCT01808248|Liver Diseases|liver diseases
1249447|NCT01808248|Digestive System Diseases|digestive system diseases
1249448|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
1249449|NCT01808248|Virus Diseases|virus diseases
1249450|NCT01808248|Enterovirus Infections|enterovirus infections
1249451|NCT01808248|Picornaviridae Infections|picornaviridae infections
1249452|NCT01808248|RNA Virus Infections|rna virus infections
1249453|NCT01808248|Flaviviridae Infections|flaviviridae infections
1249454|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
1249455|NCT01808248|Interferon-alpha|interferon-alpha
1249456|NCT01808248|Antiviral Agents|antiviral agents
1249457|NCT01808248|Anti-Infective Agents|anti-infective agents
1249458|NCT01808248|Therapeutic Uses|therapeutic uses
1249459|NCT01808248|Pharmacologic Actions|pharmacologic actions
1249460|NCT01808248|Antimetabolites|antimetabolites
1249461|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1249462|NCT01808248|Immunologic Factors|immunologic factors
1249463|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
1249464|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
1249465|NCT01808196|Connective Tissue Disorders|connective tissue disorders
1249466|NCT01808196|Drug trial|drug trial
1249467|NCT01808183|supracondylar|supracondylar
1249468|NCT01808183|pediatric|pediatric
1249469|NCT01808183|humerus|humerus
1249470|NCT01808183|NIRS|nirs
1249471|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
1249472|NCT01808183|compartment perfusion|compartment perfusion
1249473|NCT01808170|Laparoscopy|laparoscopy
1249474|NCT01808170|AMH|amh
1249475|NCT01808170|AFC|afc
1249476|NCT01808170|Endometrioma|endometrioma
1249477|NCT01808170|ovarian reserve|ovarian reserve
1249478|NCT01808170|Ovarian cystectomy|ovarian cystectomy
1249479|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
1249480|NCT01808157|atopic dermatitis|atopic dermatitis
1249481|NCT01808157|pruritus|pruritus
1339027|NCT01421238|Framing|framing
1249482|NCT01808144|Gout|gout
1249483|NCT01808131|Gout|gout
1249484|NCT01808118|Spondylitis|spondylitis
1249485|NCT01808118|Spondylarthropathy|spondylarthropathy
1249486|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
1249487|NCT01808118|Spondyloarthritis|spondyloarthritis
1249488|NCT01808118|Spinal Diseases|spinal diseases
1249489|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
1249490|NCT01808118|Arthritis|arthritis
1249491|NCT01808118|Joint Diseases|joint diseases
1249492|NCT01808118|Adalimumab|adalimumab
1249493|NCT01808118|Antirheumatic Agents|antirheumatic agents
1249494|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
1249495|NCT01808092|Ceftazidime,|ceftazidime,
1249496|NCT01808092|Meropenem,|meropenem,
1249497|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
1249498|NCT01808092|Anti-Infective Agents,|anti-infective agents,
1249499|NCT01808092|Therapeutic Uses,|therapeutic uses,
1249500|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
1249501|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
1249502|NCT01808040|breast cancer|breast cancer
1249503|NCT01808040|ER positive|er positive
1249504|NCT01808040|PR positive|pr positive
1249505|NCT01808040|post menopausal|post menopausal
1249506|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
1249507|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
1249508|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
1249509|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
1249510|NCT01807962|Cortisone|cortisone
1249511|NCT01807962|Anesthetics, Local|anesthetics, local
1249512|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
1249515|NCT01807910|NAFLD|nafld
1249516|NCT01807910|NASH|nash
1249517|NCT01807910|Steatosis|steatosis
1249518|NCT01807897|Heart Failure|heart failure
1249519|NCT01807897|Sleep Apnea|sleep apnea
1249520|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
1249521|NCT01807897|Exercise Test|exercise test
1249522|NCT01807884|Microaspiration|microaspiration
1249523|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
1249524|NCT01807884|Amylase|amylase
1249525|NCT01807884|Mechanical ventilation|mechanical ventilation
1249526|NCT01807884|Suction|suction
1249527|NCT01807871|nicotine dependence|nicotine dependence
1249528|NCT01807871|smoking cessation|smoking cessation
1249529|NCT01807871|lapse|lapse
1249530|NCT01807871|relapse|relapse
1249531|NCT01807871|tobacco|tobacco
1249532|NCT01807871|nicotine patch|nicotine patch
1249533|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
1249534|NCT01807871|NRT|nrt
1249535|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
1249536|NCT01807858|Sepsis|sepsis
1249537|NCT01807858|Length of hospital stay|length of hospital stay
1249538|NCT01807858|Mortality|mortality
1249539|NCT01807845|Casein micelles|casein micelles
1249540|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
1249541|NCT01807845|Bioavailability|bioavailability
1249542|NCT01807845|Nanoencapsulation|nanoencapsulation
1249543|NCT01807845|Nutrition|nutrition
1249544|NCT01807832|chronic cough|chronic cough
1249545|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
1249546|NCT01807832|capsaicin|capsaicin
1249547|NCT01807819|Heart Failure|heart failure
1249548|NCT01807819|Myocardial Strain|myocardial strain
1249549|NCT01807819|Functional Capacity|functional capacity
1249550|NCT01807806|veterans, military, families|veterans, military, families
1249551|NCT01807793|Stroke|stroke
1249552|NCT01807793|TIA|tia
1249553|NCT01807793|African American|african american
1249554|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
1249555|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
1249556|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
1249557|NCT01807741|Bipolar Disorder|bipolar disorder
1249558|NCT01807741|Depression|depression
1249559|NCT01807728|Quality of life|quality of life
1249560|NCT01807728|Participation|participation
1249561|NCT01807728|Training|training
1249562|NCT01807715|first trimester|first trimester
1249563|NCT01807715|surgical abortion|surgical abortion
1249564|NCT01807715|contraception|contraception
1249565|NCT01807702|dichloroacetate|dichloroacetate
1249566|NCT01807702|pyruvate|pyruvate
1249567|NCT01807702|lactate|lactate
1249568|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
1249569|NCT01807689|Dry mouth|dry mouth
1249570|NCT01807689|Dry eyes|dry eyes
1249571|NCT01807689|Saliva|saliva
1249572|NCT01807689|Salivary gland biopsy|salivary gland biopsy
1249573|NCT01807663|neuromuscular disease|neuromuscular disease
1249574|NCT01807650|Split-Thickness Skin Graft Donor Site|split-thickness skin graft donor site
1249575|NCT01807650|Split-thickness skin graft|split-thickness skin graft
1249576|NCT01807650|STSG|stsg
1249577|NCT01807650|Wound healing|wound healing
1249578|NCT01807650|Skin grafting|skin grafting
1249579|NCT01807650|Superficial wound|superficial wound
1249580|NCT01807650|Partial-thickness wound|partial-thickness wound
1249581|NCT01807650|Time to wound closure|time to wound closure
1249582|NCT01807624|Pharmacokinetic|pharmacokinetic
1249583|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
1249584|NCT01807611|NK cell|nk cell
1249585|NCT01807585|GSV|gsv
1249586|NCT01807559|Single Sided Deafness|single sided deafness
1249587|NCT01807559|Conductive Hearing Loss|conductive hearing loss
1249588|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
1249589|NCT01807559|SSD|ssd
1249590|NCT01807546|Head and neck cancer|head and neck cancer
1249591|NCT01807546|Platinum-resistant|platinum-resistant
1249592|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
1249593|NCT01807533|Environment|environment
1249594|NCT01807533|Gene|gene
1249595|NCT01807533|Intervention|intervention
1249596|NCT01807533|Neurodevelopment|neurodevelopment
1249597|NCT01807533|Pathways|pathways
1249598|NCT01807533|Preterm infants|preterm infants
1249599|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
1249600|NCT01807520|Severe nail psoriasis|severe nail psoriasis
1249601|NCT01807520|psoriasis|psoriasis
1249602|NCT01807520|Secukinumab|secukinumab
1249603|NCT01807507|Veins|veins
1249604|NCT01807507|Vascular Access|vascular access
1249605|NCT01807481|Mircera|mircera
1249606|NCT01807481|PD|pd
1249607|NCT01807481|Maitenance|maitenance
1249608|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
1250106|NCT01805232|Malaria|malaria
1249609|NCT01807468|natural killer cell therapy|natural killer cell therapy
1249610|NCT01807468|pediatric solid tumor|pediatric solid tumor
1249611|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
1249612|NCT01807442|Positive Psychology|positive psychology
1249613|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
1249614|NCT01807429|Ketamine,|ketamine,
1249615|NCT01807429|Midazolam,|midazolam,
1249616|NCT01807429|Morphine,|morphine,
1249617|NCT01807429|visual analogue score|visual analogue score
1249618|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
1249619|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1249620|NCT01807403|Deep brain stimulation|deep brain stimulation
1249621|NCT01807403|Subthalamic nucleus|subthalamic nucleus
1249622|NCT01807403|Caudate nucleus|caudate nucleus
1249623|NCT01807403|Nucleus accumbens|nucleus accumbens
1249624|NCT01807390|Minimally invasive surgery|minimally invasive surgery
1249625|NCT01807390|Patient perspectives|patient perspectives
1249626|NCT01807390|Lung cancer|lung cancer
1249627|NCT01807390|Esophageal cancer|esophageal cancer
1249628|NCT01807390|Pain|pain
1249629|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
1249630|NCT01807364|Cardiovascular risk|cardiovascular risk
1249631|NCT01807364|Microvascular dysfunction|microvascular dysfunction
1249632|NCT01807351|Diabetes Mellitus|diabetes mellitus
1249633|NCT01807351|Hypertension|hypertension
1249634|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
1249635|NCT01807351|Primary Health Care|primary health care
1249636|NCT01807351|Chinese|chinese
1249637|NCT01807312|colonoscopy|colonoscopy
1249638|NCT01807299|Physical Training|physical training
1249639|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
1249640|NCT01807299|Omega 3|omega 3
1249641|NCT01807286|Myeloma|myeloma
1249642|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
1249643|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
1249644|NCT01807286|Pomalidomide|pomalidomide
1249645|NCT01807286|Melphalan|melphalan
1249646|NCT01807286|Alkeran|alkeran
1249647|NCT01807286|Dexamethasone|dexamethasone
1249648|NCT01807286|Decadron|decadron
1249649|NCT01807286|Questionnaires|questionnaires
1249650|NCT01807286|Surveys|surveys
1249651|NCT01807273|hemiplegic|hemiplegic
1249652|NCT01807273|time up and go test|time up and go test
1249653|NCT01807273|motion analysis|motion analysis
1249654|NCT01807273|center of mass|center of mass
1249655|NCT01807247|Strengthening muscle|strengthening muscle
1249656|NCT01807247|Central nervous system diseases|central nervous system diseases
1249657|NCT01807247|Gait|gait
1249658|NCT01807221|Heart Decompensation|heart decompensation
1249659|NCT01807208|Acute myocardial infarction|acute myocardial infarction
1249660|NCT01807208|patient education|patient education
1249661|NCT01807208|prevention|prevention
1249662|NCT01807195|contrast|contrast
1249663|NCT01807195|Intensive care unit|intensive care unit
1249664|NCT01807195|Acute kidney injury|acute kidney injury
1249665|NCT01807169|colon|colon
1249666|NCT01807169|endoscopy|endoscopy
1249667|NCT01807169|resection|resection
1249668|NCT01807169|clopidogrel|clopidogrel
1249669|NCT01807156|Tivozanib|tivozanib
1249670|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
1249671|NCT01807156|Angiogenesis|angiogenesis
1249672|NCT01807130|Heart Failure|heart failure
1249673|NCT01807130|Medical Therapy|medical therapy
1249674|NCT01807130|ICD|icd
1249675|NCT01807130|CRT|crt
1249676|NCT01807104|Anterior Approach|anterior approach
1249677|NCT01807104|Posterior Approach|posterior approach
1249678|NCT01807078|Coronary artery disease|coronary artery disease
1249679|NCT01807039|hip fracture|hip fracture
1249680|NCT01807039|proximal femur|proximal femur
1249681|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
1249682|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
1249683|NCT01807039|subcapital fracture|subcapital fracture
1249684|NCT01807039|safety issue|safety issue
1249685|NCT01807039|anesthesia|anesthesia
1249686|NCT01807013|cirrhosis|cirrhosis
1249687|NCT01807013|liver|liver
1249688|NCT01807013|elastometry|elastometry
1249689|NCT01807013|ultrasound|ultrasound
1249690|NCT01807013|laparoscopy|laparoscopy
1249691|NCT01807013|diagnosis|diagnosis
1249692|NCT01806987|school readiness|school readiness
1249693|NCT01806987|literacy|literacy
1249694|NCT01806987|social emotional skills|social emotional skills
1249695|NCT01806987|self regulation|self regulation
1249696|NCT01806987|caregiver involvement|caregiver involvement
1249697|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
1249698|NCT01806974|Periodontitis|periodontitis
1249699|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
1249700|NCT01806974|anti-interleukin 6|anti-interleukin 6
1249701|NCT01806974|immunotherapy|immunotherapy
1249702|NCT01806974|inflammation|inflammation
1249703|NCT01806974|bacteria|bacteria
1249704|NCT01806974|periodontal sulci|periodontal sulci
1249705|NCT01806974|periodontal pockets|periodontal pockets
1249706|NCT01806935|associated|associated
1249707|NCT01806935|aged population|aged population
1249708|NCT01806922|Yoga|yoga
1249709|NCT01806922|Stroke|stroke
1249710|NCT01806922|Standing balance|standing balance
1249711|NCT01806922|Depression|depression
1249712|NCT01806909|Flu Vaccine|flu vaccine
1249713|NCT01806909|Healthy Volunteer|healthy volunteer
1249714|NCT01806883|Hemiparesis,|hemiparesis,
1249715|NCT01806883|Rehabilitation,|rehabilitation,
1249716|NCT01806883|WII,|wii,
1249717|NCT01806883|Upper limb,|upper limb,
1249718|NCT01806883|Movement strategies.|movement strategies.
1249720|NCT01806870|ART|art
1249721|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1249722|NCT01806857|ALS|als
1249723|NCT01806857|Nuedexta|nuedexta
1249724|NCT01806857|Bulbar function|bulbar function
1249725|NCT01806857|motor neurons|motor neurons
1249726|NCT01806844|Cardiac arrest|cardiac arrest
1249727|NCT01806844|Cerebral oxygenation|cerebral oxygenation
1249728|NCT01806844|Pre-hospital|pre-hospital
1249729|NCT01806805|Movement disorder|movement disorder
1249730|NCT01806805|Myoclonus dystonia|myoclonus dystonia
1249731|NCT01806805|DYT 11|dyt 11
1249732|NCT01806805|Antiepileptic drugs|antiepileptic drugs
1249733|NCT01806805|Zonisamide|zonisamide
1249734|NCT01806805|Clinical Trial|clinical trial
1249735|NCT01806805|Double-mind method|double-mind method
1249736|NCT01806792|Osteoporosis|osteoporosis
1249737|NCT01806779|Nicotine addiction|nicotine addiction
1249738|NCT01806779|Cigarette smoking|cigarette smoking
1249739|NCT01806779|Smoking cessation|smoking cessation
1249740|NCT01806779|Zyban|zyban
1249741|NCT01806779|Chantix|chantix
1249742|NCT01806779|Nicotine patches|nicotine patches
1249743|NCT01806779|varenicline|varenicline
1249744|NCT01806779|bupropion|bupropion
1249745|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
1249746|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
1249747|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
1249748|NCT01806766|young patient|young patient
1249749|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
1249750|NCT01806753|Sedation|sedation
1249751|NCT01806753|Propofol|propofol
1249752|NCT01806753|Midazolam|midazolam
1249753|NCT01806740|DCE-MRI|dce-mri
1249754|NCT01806740|Sorafenib response|sorafenib response
1249755|NCT01806727|Diabetes|diabetes
1249756|NCT01806727|Diabetes Self Management|diabetes self management
1249757|NCT01806727|LIFT Diabetes|lift diabetes
1249758|NCT01806727|Weight Loss|weight loss
1249759|NCT01806727|Diet|diet
1249760|NCT01806727|Physical Activity|physical activity
1249761|NCT01806727|Overweight|overweight
1249762|NCT01806727|Obese|obese
1249763|NCT01806714|HPV vaccination|hpv vaccination
1249764|NCT01806714|Adolescent well care|adolescent well care
1249765|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
1249766|NCT01806714|HPV|hpv
1249767|NCT01806701|fMRI|fmri
1249768|NCT01806701|neuroimaging|neuroimaging
1249769|NCT01806701|PTSD|ptsd
1249770|NCT01806701|adolescent|adolescent
1249771|NCT01806701|trauma|trauma
1249772|NCT01806701|brain|brain
1249773|NCT01806688|satiety|satiety
1249774|NCT01806688|appetite|appetite
1249775|NCT01806688|snack|snack
1249776|NCT01806662|Atopic Dermatitis|atopic dermatitis
1249777|NCT01806662|Eczema|eczema
1249778|NCT01806649|esophageal cancer|esophageal cancer
1249779|NCT01806649|second line therapy|second line therapy
1249780|NCT01806649|BKM120|bkm120
1249781|NCT01806636|Coil|coil
1249782|NCT01806636|RePneu|repneu
1249783|NCT01806636|PneumRx|pneumrx
1249784|NCT01806636|LVRC|lvrc
1249785|NCT01806610|Randomized|randomized
1249786|NCT01806610|Placebo-controlled trial|placebo-controlled trial
1249787|NCT01806610|BPS804|bps804
1249788|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
1249789|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
1249790|NCT01806597|Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques|skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques
1249791|NCT01806584|Vascular Injury|vascular injury
1249792|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
1249793|NCT01806584|Hemodialysis Access|hemodialysis access
1249794|NCT01806558|Breast cancer|breast cancer
1249795|NCT01806558|molecular breast imaging|molecular breast imaging
1249796|NCT01806558|breast|breast
1249797|NCT01806558|breast lesion|breast lesion
1249798|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
1249799|NCT01806545|Vascular Injury|vascular injury
1249800|NCT01806545|Hemodialysis Access|hemodialysis access
1249801|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
1249802|NCT01806532|respiration, artificial|respiration, artificial
1249803|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
1249804|NCT01806519|neck pain|neck pain
1249805|NCT01806519|motor control|motor control
1249806|NCT01806519|intervention|intervention
1249807|NCT01806519|forward head posture|forward head posture
1249808|NCT01806506|Bariatric surgery|bariatric surgery
1249809|NCT01806506|Gastric bypass|gastric bypass
1249810|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
1249811|NCT01806506|Weight loss|weight loss
1249812|NCT01806506|Lipoproteins|lipoproteins
1249813|NCT01806506|Insulin resistance|insulin resistance
1249814|NCT01806506|Incretins|incretins
1249815|NCT01806506|Quality of life|quality of life
1249816|NCT01806493|body composition|body composition
1249817|NCT01806493|obesity|obesity
1249911|NCT01805908|imaging|imaging
1249818|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
1249819|NCT01806415|Fenobam,|fenobam,
1249820|NCT01806415|Pharmacokinetics|pharmacokinetics
1249821|NCT01806415|side effects|side effects
1249822|NCT01806389|Breast milk|breast milk
1249823|NCT01806389|Breastfeeding|breastfeeding
1249824|NCT01806389|Lactation|lactation
1249825|NCT01806389|Buprenorphine|buprenorphine
1249826|NCT01806389|Opioid|opioid
1249827|NCT01806363|Pharmacokinetics|pharmacokinetics
1249828|NCT01806363|Safety|safety
1249829|NCT01806363|Male|male
1249830|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
1249831|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
1249832|NCT01806337|alemtuzumab|alemtuzumab
1249833|NCT01806337|consolidation|consolidation
1249834|NCT01806311|Pharmacokinetics|pharmacokinetics
1249835|NCT01806311|Safety|safety
1249836|NCT01806311|Male|male
1249837|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
1249838|NCT01806298|Saizen®|saizen®
1249839|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
1249840|NCT01806298|Somatropin|somatropin
1249841|NCT01806285|Respiratory Virus|respiratory virus
1249842|NCT01806272|rhGM-CSF|rhgm-csf
1249843|NCT01806272|Oral Mucositis|oral mucositis
1249844|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
1249845|NCT01806272|Chemoradiotherapy|chemoradiotherapy
1249846|NCT01806246|rehabilitation|rehabilitation
1249847|NCT01806246|adolescent|adolescent
1249848|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
1249849|NCT01806246|psychoeducation|psychoeducation
1249850|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1249851|NCT01806220|Chronic Laryngitis|chronic laryngitis
1249852|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
1249853|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
1249854|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1249855|NCT01806168|Civilians|civilians
1249856|NCT01806168|Neurostimulation|neurostimulation
1249857|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1249858|NCT01806155|craniotomy|craniotomy
1249859|NCT01806155|headache|headache
1249860|NCT01806155|postoperative|postoperative
1249861|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
1249862|NCT01806116|higher-risk|higher-risk
1249863|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
1249864|NCT01806116|relapsed /refractory|relapsed /refractory
1249865|NCT01806116|decitabine|decitabine
1249866|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
1249867|NCT01806116|bridge therapy|bridge therapy
1249868|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
1249869|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
1249870|NCT01806103|physician prescribing|physician prescribing
1333265|NCT01443767|esCCO|escco
1249871|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
1249872|NCT01806103|respiratory tract infections|respiratory tract infections
1249873|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
1249874|NCT01806077|Vascular Diseases|vascular diseases
1249875|NCT01806077|Coronary Artery Disease|coronary artery disease
1249876|NCT01806077|Coronary Disease|coronary disease
1249877|NCT01806077|Arteriosclerosis|arteriosclerosis
1249878|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1249879|NCT01806064|TRC105|trc105
1249880|NCT01806064|CD105|cd105
1249881|NCT01806064|RCC|rcc
1249882|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
1249883|NCT01806064|Axitinib|axitinib
1249884|NCT01806064|INLYTA|inlyta
1249885|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1249886|NCT01806038|Adverse events|adverse events
1249887|NCT01806038|Drug interactions|drug interactions
1249888|NCT01806038|Healthcare utilization|healthcare utilization
1249889|NCT01806038|Discharge medication counseling|discharge medication counseling
1249890|NCT01806025|Cystic Fibrosis|cystic fibrosis
1249891|NCT01806025|Haptoglobin|haptoglobin
1249892|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
1249893|NCT01806012|Leiomyomas|leiomyomas
1249894|NCT01806012|Adenomyosis|adenomyosis
1249895|NCT01805999|Ispaghula|ispaghula
1249896|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
1249897|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
1249898|NCT01805999|MRI|mri
1249899|NCT01805999|gastrointestinal|gastrointestinal
1249900|NCT01805999|stomach|stomach
1249901|NCT01805999|small bowel|small bowel
1249902|NCT01805999|colon|colon
1249903|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
1250107|NCT01805206|Prematurity|prematurity
1249904|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
1249905|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
1249907|NCT01805921|Vaccine|vaccine
1249908|NCT01805908|metastatic|metastatic
1249909|NCT01805908|breast cancer|breast cancer
1249910|NCT01805908|herceptin|herceptin
1249912|NCT01805908|tumour response|tumour response
1249913|NCT01805908|adenocarcinoma|adenocarcinoma
1249914|NCT01805908|SPECT-CT|spect-ct
1249915|NCT01805908|pertuzumab|pertuzumab
1249916|NCT01805908|trastuzumab|trastuzumab
1249917|NCT01805908|locally advanced|locally advanced
1249918|NCT01805895|Stroke|stroke
1249919|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
1249920|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
1249921|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
1249922|NCT01805895|Hemorrhage|hemorrhage
1249923|NCT01805895|Minocycline|minocycline
1249924|NCT01805882|Interferon Sparing|interferon sparing
1249925|NCT01805882|Directly Acting Antiviral|directly acting antiviral
1249926|NCT01805882|Ribavarin Sparing|ribavarin sparing
1249927|NCT01805869|Third Molar|third molar
1249928|NCT01805869|Specimen Acquisition|specimen acquisition
1249929|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
1249930|NCT01805856|AMP|amp
1249931|NCT01805856|surgical site infection|surgical site infection
1249932|NCT01805856|SSI|ssi
1249933|NCT01805856|thyroid|thyroid
1249934|NCT01805856|thyroidectomy|thyroidectomy
1249935|NCT01805856|parathyroid|parathyroid
1249936|NCT01805856|surgery|surgery
1249937|NCT01805843|Pulmonary hypertension|pulmonary hypertension
1249938|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
1249939|NCT01805843|dasatinib|dasatinib
1249940|NCT01805843|nilotinib|nilotinib
1249941|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
1249942|NCT01805817|lipid profile|lipid profile
1249943|NCT01805817|bleeding scores|bleeding scores
1249944|NCT01805817|menstrual pattern|menstrual pattern
1249945|NCT01805817|beneficial|beneficial
1249946|NCT01805817|side effects|side effects
1249947|NCT01805817|changes in a year period|changes in a year period
1249948|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
1249949|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
1249950|NCT01805791|UC|uc
1249951|NCT01805791|Patients|patients
1249952|NCT01805791|active|active
1249953|NCT01805791|mild|mild
1249954|NCT01805791|moderate|moderate
1249955|NCT01805765|menopausal syndrome|menopausal syndrome
1249956|NCT01805765|climacteric syndrome|climacteric syndrome
1249957|NCT01805765|Hot flashes|hot flashes
1249958|NCT01805765|Sweat|sweat
1249959|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
1249960|NCT01805752|HIV/AIDS|hiv/aids
1249961|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1249962|NCT01805739|CT|ct
1249963|NCT01805739|MRI|mri
1249964|NCT01805739|angiography|angiography
1249965|NCT01805739|echocardiography|echocardiography
1249966|NCT01805739|rotational C-arm CT|rotational c-arm ct
1249967|NCT01805726|bronchoscopy|bronchoscopy
1249968|NCT01805726|sedation|sedation
1249969|NCT01805726|pulmonary function|pulmonary function
1249970|NCT01805726|tolerance|tolerance
1249971|NCT01805726|xylocain|xylocain
1249972|NCT01805726|dexmedetomidine|dexmedetomidine
1249973|NCT01805726|alfentanil|alfentanil
1249974|NCT01805713|Biomarkers|biomarkers
1249975|NCT01805700|type 1|type 1
1249976|NCT01805700|diabetes|diabetes
1249977|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
1249978|NCT01805700|cardiac output|cardiac output
1249979|NCT01805700|glucose|glucose
1249980|NCT01805700|cognitive performance|cognitive performance
1249981|NCT01805674|menopause|menopause
1249982|NCT01805674|quality of life|quality of life
1249983|NCT01805674|soy isoflavones|soy isoflavones
1249984|NCT01805674|magnolia extract|magnolia extract
1249985|NCT01805661|early ambulation|early ambulation
1249986|NCT01805661|knee arthroplasty|knee arthroplasty
1249987|NCT01805648|ITP|itp
1249988|NCT01805648|rhTPO|rhtpo
1249989|NCT01805635|Children|children
1249990|NCT01805635|Asthma|asthma
1249991|NCT01805635|Allergic rhinitis|allergic rhinitis
1249992|NCT01805635|Atopic dermatitis|atopic dermatitis
1249993|NCT01805635|Urticaria|urticaria
1249994|NCT01805635|Healthy|healthy
1249995|NCT01805622|community-based participatory research|community-based participatory research
1249996|NCT01805622|colorectal cancer screening|colorectal cancer screening
1249997|NCT01805609|practice nurse|practice nurse
1249998|NCT01805609|clinical Nurse|clinical nurse
1249999|NCT01805609|inpatient staff|inpatient staff
1250000|NCT01805609|inpatient social worker|inpatient social worker
1250001|NCT01805609|didactic training sessions|didactic training sessions
1250002|NCT01805609|13-030|13-030
1250003|NCT01805596|coronary artery disease|coronary artery disease
1250004|NCT01805596|endothelial function|endothelial function
1250005|NCT01805596|antiplatelet agent|antiplatelet agent
1250006|NCT01805570|platelet inhibitor|platelet inhibitor
1250007|NCT01805570|ST-segment Elevation|st-segment elevation
1250008|NCT01805570|Myocardial Infarction|myocardial infarction
1250010|NCT01805570|prasugrel|prasugrel
1250011|NCT01805570|ticagrelor|ticagrelor
1250012|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1250013|NCT01805557|Bortezomib|bortezomib
1250014|NCT01805544|SF36 questionnaire|sf36 questionnaire
1250015|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
1250016|NCT01805544|Satisfaction|satisfaction
1250017|NCT01805544|Quality of Life|quality of life
1250018|NCT01805544|Rivaroxaban|rivaroxaban
1250019|NCT01805544|Prevention & control|prevention & control
1250020|NCT01805544|Pulmonary embolism|pulmonary embolism
1250021|NCT01805531|SF36 questionnaire|sf36 questionnaire
1250022|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
1250023|NCT01805531|Satisfaction|satisfaction
1250024|NCT01805531|Quality of Life|quality of life
1250025|NCT01805531|Rivaroxaban|rivaroxaban
1250026|NCT01805531|Stroke prevention|stroke prevention
1250027|NCT01805518|CNSVS|cnsvs
1250028|NCT01805518|Tower of London|tower of london
1250029|NCT01805518|Letter-Number Test|letter-number test
1250030|NCT01805518|Trail Making Test|trail making test
1250031|NCT01805518|Vital signs|vital signs
1250032|NCT01805518|Mood|mood
1250033|NCT01805518|Suicidal ideation|suicidal ideation
1250034|NCT01805518|ECG|ecg
1250035|NCT01805518|Physical exam|physical exam
1250036|NCT01805518|Blood|blood
1250037|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
1250038|NCT01805518|Cytokines|cytokines
1250039|NCT01805518|Side effects|side effects
1250040|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
1250041|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
1250042|NCT01805505|Female infertility|female infertility
1250043|NCT01805505|Oocyte donation|oocyte donation
1250044|NCT01805505|Embryo transfer|embryo transfer
1250045|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
1250046|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
1250047|NCT01805492|Heart diseases|heart diseases
1250048|NCT01805492|Cardiovascular diseases|cardiovascular diseases
1250049|NCT01805492|Lifestyle modification|lifestyle modification
1250050|NCT01805492|Diet|diet
1250051|NCT01805492|Exercise|exercise
1250052|NCT01805479|exercise|exercise
1250053|NCT01805479|depression|depression
1250054|NCT01805479|traumatic brain injury|traumatic brain injury
1250055|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
1250056|NCT01805453|Glioblastoma|glioblastoma
1250057|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
1250058|NCT01805453|Losartan|losartan
1250059|NCT01805453|steroids|steroids
1250060|NCT01805453|Radiotherapy|radiotherapy
1250061|NCT01805453|Edema|edema
1250062|NCT01805453|Randomized trial|randomized trial
1250063|NCT01805440|Adolescent|adolescent
1250064|NCT01805440|Bipolar Disorder|bipolar disorder
1250065|NCT01805440|Bipolar Depression|bipolar depression
1250066|NCT01805440|Manic Depression|manic depression
1250067|NCT01805440|Neuroimaging|neuroimaging
1250068|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1250069|NCT01805440|Uridine|uridine
1250070|NCT01805440|Pyrimidines|pyrimidines
1250071|NCT01805427|trough concentration|trough concentration
1250072|NCT01805427|weight|weight
1250073|NCT01805427|HIV|hiv
1250074|NCT01805427|virological failure|virological failure
1250075|NCT01805414|inpatient diabetes|inpatient diabetes
1250076|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
1250077|NCT01805401|Decision-making|decision-making
1250078|NCT01805401|Impulse control|impulse control
1250079|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
1250080|NCT01805401|Brain stimulation|brain stimulation
1250081|NCT01805401|Neuromodulation|neuromodulation
1250082|NCT01805401|tDCS|tdcs
1250083|NCT01805401|Iowa Gambling Task|iowa gambling task
1250084|NCT01805401|Stroop Word-Color Task|stroop word-color task
1250085|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
1250086|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
1250087|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
1250088|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
1250089|NCT01805336|cognitive impairment|cognitive impairment
1250090|NCT01805336|virtual reality|virtual reality
1250091|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
1250092|NCT01805310|Prolapse|prolapse
1250093|NCT01805310|Cathartics|cathartics
1250094|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
1250095|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1250096|NCT01805284|pneumonia|pneumonia
1250097|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
1250098|NCT01805258|India|india
1250099|NCT01805258|Nevirapine|nevirapine
1250100|NCT01805258|Rifampicin|rifampicin
1250101|NCT01805258|Efavirenz|efavirenz
1250102|NCT01805258|HIV|hiv
1250103|NCT01805258|TB|tb
1250104|NCT01805232|severe|severe
1250108|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
1250109|NCT01805206|Biomarkers|biomarkers
1250110|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
1250111|NCT01805206|Feeding|feeding
1250112|NCT01805193|Coronary heart disease|coronary heart disease
1250113|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
1250114|NCT01805193|positron emission tomography|positron emission tomography
1250115|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
1250116|NCT01805193|myocardial perfusion|myocardial perfusion
1250117|NCT01805193|myocardial blood flow|myocardial blood flow
1250118|NCT01805167|Subject with cochlear implant|subject with cochlear implant
1250119|NCT01805141|Cervix Uteri|cervix uteri
1250120|NCT01805128|Schizophrenia|schizophrenia
1250121|NCT01805128|Autistic Disorder|autistic disorder
1250122|NCT01805128|social cognition|social cognition
1250123|NCT01805115|hysteroscopy|hysteroscopy
1250124|NCT01805115|misoprostol|misoprostol
1250125|NCT01805102|In vitro fertilization|in vitro fertilization
1250126|NCT01805102|implantation|implantation
1250127|NCT01805102|miscarriage|miscarriage
1250128|NCT01805102|live birth|live birth
1250129|NCT01805063|firefighters|firefighters
1250130|NCT01805063|myocardial infarction|myocardial infarction
1250131|NCT01805063|endothelial function|endothelial function
1250132|NCT01805063|thrombosis|thrombosis
1250133|NCT01805063|fire suppression|fire suppression
1250134|NCT01805063|non-fire emergency duty|non-fire emergency duty
1250135|NCT01805063|sedentary shift|sedentary shift
1250136|NCT01805050|HAGL|hagl
1250137|NCT01805050|Shoulder instability|shoulder instability
1250138|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
1250139|NCT01804998|phase 3|phase 3
1250140|NCT01804998|early gastric cancer|early gastric cancer
1250141|NCT01804972|Patient information|patient information
1250142|NCT01804972|Vascular disease|vascular disease
1250143|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
1250144|NCT01804972|Varicose veins|varicose veins
1250145|NCT01804972|Web based information|web based information
1250146|NCT01804933|profound muscle relaxation|profound muscle relaxation
1250147|NCT01804933|muscle trauma|muscle trauma
1250148|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
1250149|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
1250150|NCT01804907|HAART adherence|haart adherence
1250151|NCT01804907|HIV|hiv
1250152|NCT01804907|Fatigue|fatigue
1250153|NCT01804907|treatment|treatment
1250154|NCT01804868|case vignette|case vignette
1250155|NCT01804868|nurse|nurse
1250156|NCT01804868|critical assessment|critical assessment
1250157|NCT01804868|randomized controlled trial|randomized controlled trial
1250158|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
1250159|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
1250160|NCT01804816|Chronic Heart Failure|chronic heart failure
1250161|NCT01804816|Heart Failure|heart failure
1250162|NCT01804803|glycated hemoglobin|glycated hemoglobin
1250163|NCT01804803|hyperglycemia|hyperglycemia
1250164|NCT01804803|hypoglycemia|hypoglycemia
1250165|NCT01804803|insulin|insulin
1250166|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
1339926|NCT01417520|ECD|ecd
1250167|NCT01804803|telemedicine|telemedicine
1250168|NCT01804790|rectum|rectum
1250169|NCT01804790|cancer|cancer
1250170|NCT01804790|locally advanced|locally advanced
1250171|NCT01804777|ENaC|enac
1250172|NCT01804777|Amiloride|amiloride
1250173|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
1250174|NCT01804777|Hypertension|hypertension
1250175|NCT01804777|Type II Diabetes|type ii diabetes
1250176|NCT01804777|Natriuresis|natriuresis
1250177|NCT01804777|Proteinuria|proteinuria
1250178|NCT01804764|Severe Sepsis|severe sepsis
1250179|NCT01804764|Septic Shock|septic shock
1250180|NCT01804764|Sepsis Six bundle|sepsis six bundle
1250181|NCT01804738|Ethnic differences|ethnic differences
1250182|NCT01804738|Inter-individual variability|inter-individual variability
1250183|NCT01804738|Glycemic response|glycemic response
1250184|NCT01804738|Insulin response|insulin response
1250185|NCT01804738|Mastication|mastication
1250186|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
1250187|NCT01804738|Gastric emptying|gastric emptying
1250188|NCT01804738|Metagenome|metagenome
1250189|NCT01804725|bike seats|bike seats
1250190|NCT01804725|Erectile dysfunction|erectile dysfunction
1250191|NCT01804725|Perineum|perineum
1250192|NCT01804725|Impotence|impotence
1250193|NCT01804712|Prostate|prostate
1250194|NCT01804712|Cancer|cancer
1250195|NCT01804712|Castration-resistant|castration-resistant
1250196|NCT01804712|Rituximab|rituximab
1250197|NCT01804712|neoadjuvant|neoadjuvant
1250198|NCT01804712|Rituxan|rituxan
1250199|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
1250200|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1250201|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
1250202|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
1250203|NCT01804686|Follicular lymphoma|follicular lymphoma
1250204|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1250205|NCT01804686|PCI-32765|pci-32765
1250206|NCT01804686|Ibrutinib|ibrutinib
1250207|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1250208|NCT01804686|IMBRUVICA|imbruvica
1250209|NCT01804686|JNJ-54179060|jnj-54179060
1250210|NCT01804673|Postoperative Pain|postoperative pain
1250211|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
1250212|NCT01804673|IONSYS|ionsys
1250213|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
1250214|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
1250215|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
1250216|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
1250217|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
1250218|NCT01804647|Primary progressive MS|primary progressive ms
1250219|NCT01804647|Secondary progressive MS|secondary progressive ms
1250220|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
1250221|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
1250222|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
1250223|NCT01804634|Solid Tumors|solid tumors
1250224|NCT01804634|Neuroblastoma|neuroblastoma
1250225|NCT01804634|Osteosarcoma|osteosarcoma
1250226|NCT01804634|Ewing Sarcoma|ewing sarcoma
1250227|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
1250228|NCT01804634|Hepatoblastoma|hepatoblastoma
1250229|NCT01804634|Melanoma|melanoma
1250230|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
1250231|NCT01804634|brain tumors|brain tumors
1250232|NCT01804621|Exercise|exercise
1250233|NCT01804621|Nutrition|nutrition
1250234|NCT01804621|Mammography|mammography
1250235|NCT01804621|Colorectal screening|colorectal screening
1250236|NCT01804595|Worksite intervention|worksite intervention
1250237|NCT01804595|Sun protection intervention|sun protection intervention
1250238|NCT01804595|Operating Engineers|operating engineers
1250239|NCT01804582|Family navigator|family navigator
1250240|NCT01804582|Patient Centered Outcomes|patient centered outcomes
1250241|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
1250242|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
1250243|NCT01804530|solid tumors|solid tumors
1250244|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
1250245|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
1250246|NCT01804530|TGCT|tgct
1250247|NCT01804517|migraine|migraine
1250248|NCT01804504|Metabolic syndrome|metabolic syndrome
1250249|NCT01804504|Eating out of home|eating out of home
1250250|NCT01804504|Nutrition education|nutrition education
1250251|NCT01804465|castration resistant|castration resistant
1250252|NCT01804465|prostate|prostate
1250253|NCT01804465|cancer|cancer
1250254|NCT01804465|ipilimumab|ipilimumab
1250255|NCT01804465|provenge|provenge
1250256|NCT01804465|SipT|sipt
1250257|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
1250258|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
1250259|NCT01804452|Biomarker|biomarker
1250260|NCT01804452|Neuroimaging|neuroimaging
1250262|NCT01804452|Tau|tau
1250263|NCT01804452|Oculomotor|oculomotor
1250264|NCT01804439|Heart diseases|heart diseases
1250265|NCT01804439|Cardiovascular diseases|cardiovascular diseases
1250266|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
1250267|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
1250268|NCT01804439|Brain diseases|brain diseases
1250269|NCT01804439|Central nervous system diseases|central nervous system diseases
1250270|NCT01804439|Nervous system diseases|nervous system diseases
1250271|NCT01804439|Atherosclerosis|atherosclerosis
1250272|NCT01804439|Arteriosclerosis|arteriosclerosis
1250273|NCT01804439|Pathologic processes|pathologic processes
1250274|NCT01804439|Acute myocardial infarction|acute myocardial infarction
1250275|NCT01804439|Myocardial infarction|myocardial infarction
1250276|NCT01804439|Myocardial ischemia|myocardial ischemia
1250277|NCT01804439|Infarction|infarction
1250278|NCT01804439|Necrosis|necrosis
1250279|NCT01804439|Unstable angina|unstable angina
1250280|NCT01804439|Chronic stable angina|chronic stable angina
1250281|NCT01804439|Stable angina|stable angina
1250282|NCT01804439|Angina pectoris|angina pectoris
1250283|NCT01804439|Chest pain|chest pain
1250284|NCT01804439|Pain|pain
1250285|NCT01804439|Signs and symptoms|signs and symptoms
1250286|NCT01804439|Ischemia|ischemia
1250287|NCT01804439|Ischemic stroke|ischemic stroke
1250288|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
1250289|NCT01804439|Stroke|stroke
1250290|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
1250291|NCT01804439|Transient ischemic attack|transient ischemic attack
1250292|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
1250293|NCT01804439|Aneurysm|aneurysm
1250294|NCT01804439|Aortic aneurysm|aortic aneurysm
1250295|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
1250296|NCT01804439|Aortic diseases|aortic diseases
1250297|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
1250298|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
1250299|NCT01804439|Vascular diseases|vascular diseases
1250300|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
1250301|NCT01804439|Sudden coronary death|sudden coronary death
1250302|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
1250303|NCT01804439|Sudden cardiac death|sudden cardiac death
1250304|NCT01804439|Cardiac arrest|cardiac arrest
1250305|NCT01804439|Heart failure|heart failure
1250307|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
1250308|NCT01804426|Cortisol|cortisol
1250516|NCT01803763|Fc Receptor|fc receptor
1250309|NCT01804426|Alpha-Amylase|alpha-amylase
1250310|NCT01804426|bio-Markers|bio-markers
1250311|NCT01804413|Pegvisomant|pegvisomant
1250312|NCT01804413|Growth hormone|growth hormone
1250313|NCT01804413|Cortisol|cortisol
1250314|NCT01804413|Glucagon|glucagon
1250315|NCT01804413|Insulin|insulin
1250316|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
1250317|NCT01804387|Telbivudine|telbivudine
1250318|NCT01804387|Adefovir|adefovir
1250319|NCT01804387|Lamivudine resistance|lamivudine resistance
1250320|NCT01804374|osteosarcoma|osteosarcoma
1250321|NCT01804374|sorafenib|sorafenib
1250322|NCT01804374|everolimus|everolimus
1250323|NCT01804374|sarcoma|sarcoma
1250324|NCT01804361|Dry Eye Syndromes|dry eye syndromes
1250325|NCT01804348|PROM|prom
1250326|NCT01804335|Lymphoma|lymphoma
1250327|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
1250328|NCT01804335|CTCL|ctcl
1250329|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
1250330|NCT01804322|epilepsy|epilepsy
1250331|NCT01804322|chronic comorbidities|chronic comorbidities
1250332|NCT01804322|educational strategies|educational strategies
1250333|NCT01804322|drug interactions|drug interactions
1250334|NCT01804322|drug adverse effects|drug adverse effects
1250335|NCT01804309|axyllary lymph node|axyllary lymph node
1250336|NCT01804309|sentinel lymph node|sentinel lymph node
1250337|NCT01804309|lymphatic drainage|lymphatic drainage
1250338|NCT01804309|early breast cancer|early breast cancer
1250339|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
1250340|NCT01804296|Teen|teen
1250341|NCT01804296|Adolescent|adolescent
1250342|NCT01804296|Depression|depression
1250343|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1250344|NCT01804296|TMS|tms
1250345|NCT01804270|Teen|teen
1250346|NCT01804270|Adolescent|adolescent
1250347|NCT01804270|Depression|depression
1250348|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1250349|NCT01804270|TMS|tms
1250350|NCT01804257|Adherence|adherence
1250351|NCT01804257|Bipolar disorder|bipolar disorder
1250352|NCT01804257|Cellular phone|cellular phone
1250353|NCT01804257|Cloud computing|cloud computing
1250354|NCT01804257|Computers|computers
1250355|NCT01804257|Computers, handheld|computers, handheld
1250356|NCT01804257|Digital health|digital health
1250357|NCT01804257|Digital health feedback system|digital health feedback system
1250358|NCT01804257|Ingestion Sensor|ingestion sensor
1250359|NCT01804257|Medication adherence|medication adherence
1250360|NCT01804257|Medication non-adherence|medication non-adherence
1250361|NCT01804257|Medication nonadherence|medication nonadherence
1250362|NCT01804257|Mobile phone|mobile phone
1250363|NCT01804257|Mobile health|mobile health
1250364|NCT01804257|Patient adherence|patient adherence
1250365|NCT01804257|Patient non-adherence|patient non-adherence
1250366|NCT01804257|Patient nonadherence|patient nonadherence
1250367|NCT01804257|Schizophrenia|schizophrenia
1250368|NCT01804257|Telehealth|telehealth
1250369|NCT01804257|Telemedicine|telemedicine
1250370|NCT01804257|Telenursing|telenursing
1250371|NCT01804257|Wearable sensor|wearable sensor
1250373|NCT01804244|Pharmacokinetics|pharmacokinetics
1250374|NCT01804244|Japanese|japanese
1250375|NCT01804231|Prostate Cancer|prostate cancer
1250376|NCT01804231|PET|pet
1250377|NCT01804231|MRI|mri
1250378|NCT01804231|Hybrid|hybrid
1250379|NCT01804231|Recurrence|recurrence
1250380|NCT01804231|Fluorocholine|fluorocholine
1250381|NCT01804205|magnesium sulfate|magnesium sulfate
1250382|NCT01804205|rocuronium|rocuronium
1250383|NCT01804205|neuromuscular block|neuromuscular block
1250384|NCT01804205|onset time|onset time
1250385|NCT01804205|elderly|elderly
1250386|NCT01804192|Acu-TENS|acu-tens
1250387|NCT01804192|MAP|map
1250388|NCT01804192|HR|hr
1250389|NCT01804192|HRV|hrv
1250390|NCT01804179|colon|colon
1250391|NCT01804179|rectum|rectum
1250392|NCT01804179|cancer|cancer
1250393|NCT01804179|screening|screening
1250394|NCT01804179|questionnaire|questionnaire
1250395|NCT01804179|testing|testing
1250396|NCT01804179|educational materials|educational materials
1250397|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
1250398|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
1250399|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
1250400|NCT01804127|DLBCL|dlbcl
1250401|NCT01804127|R-CHOP|r-chop
1250402|NCT01804127|PET/CT|pet/ct
1250403|NCT01804088|Peripheral artery disease|peripheral artery disease
1250404|NCT01804088|Iliac arteries|iliac arteries
1250405|NCT01804088|Balloon-expandable stent|balloon-expandable stent
1250406|NCT01804075|NAS|nas
1250407|NCT01804075|NICU|nicu
1250408|NCT01804075|EMMC|emmc
1250409|NCT01804049|metformin|metformin
1250410|NCT01804049|muscle|muscle
1250411|NCT01804049|insulin resistance|insulin resistance
1250412|NCT01804049|sarcopenia|sarcopenia
1250413|NCT01804049|older adults|older adults
1250718|NCT01802918|single dose|single dose
1250414|NCT01804049|impaired fasting glucose|impaired fasting glucose
1250415|NCT01803997|Child|child
1250416|NCT01803997|Nutrition|nutrition
1250417|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
1250418|NCT01803997|Fruit & Vegetable|fruit & vegetable
1250419|NCT01803997|Children Cooking|children cooking
1250420|NCT01803984|Migraine|migraine
1250421|NCT01803984|Brain structure|brain structure
1250422|NCT01803984|MRI|mri
1250423|NCT01803971|cardiac arrest|cardiac arrest
1250424|NCT01803971|peripheral venous access|peripheral venous access
1250425|NCT01803971|intraosseous access|intraosseous access
1250426|NCT01803945|Parkinson's disease|parkinson's disease
1250427|NCT01803945|cognitive impairment|cognitive impairment
1250428|NCT01803945|movement disorder|movement disorder
1250429|NCT01803932|intimate partner violence|intimate partner violence
1250430|NCT01803932|gender|gender
1250431|NCT01803932|primary prevention intervention|primary prevention intervention
1250432|NCT01803932|conflict|conflict
1250433|NCT01803932|Cote d'Ivoire|cote d'ivoire
1250434|NCT01803932|Ivory Coast|ivory coast
1250435|NCT01803919|Spinal cord injuries|spinal cord injuries
1250436|NCT01803919|Urinary tract infection|urinary tract infection
1250437|NCT01803919|Urinary catheters|urinary catheters
1250438|NCT01803919|Protocol|protocol
1250439|NCT01803919|Randomized clinical trial|randomized clinical trial
1250440|NCT01803906|mitochondrial disorder|mitochondrial disorder
1250441|NCT01803906|mitochondria|mitochondria
1250442|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
1250443|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
1250444|NCT01803906|respiratory chain disorders|respiratory chain disorders
1250445|NCT01803906|mitochondrial disease|mitochondrial disease
1250446|NCT01803906|melas|melas
1250447|NCT01803906|kearns sayer|kearns sayer
1250448|NCT01803906|NARP|narp
1250449|NCT01803906|MNGIE|mngie
1250450|NCT01803906|LHON|lhon
1250451|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
1250452|NCT01803906|Leigh's disease|leigh's disease
1250453|NCT01803893|In vitro fertilization|in vitro fertilization
1250454|NCT01803893|implantation|implantation
1250455|NCT01803893|miscarriage|miscarriage
1250456|NCT01803893|live birth|live birth
1250457|NCT01803880|Articular cartilage|articular cartilage
1250458|NCT01803880|Cartilage lesion|cartilage lesion
1250459|NCT01803880|Cartilage defect|cartilage defect
1250460|NCT01803880|Radiofrequency|radiofrequency
1250461|NCT01803880|Debridement|debridement
1250462|NCT01803880|Cartilage|cartilage
1250463|NCT01803880|Coblation|coblation
1250464|NCT01803880|Knee|knee
1250465|NCT01803880|Meniscus|meniscus
1250466|NCT01803880|Meniscectomy|meniscectomy
1250467|NCT01803880|MR imaging|mr imaging
1250468|NCT01803880|Mechanical debridement|mechanical debridement
1250469|NCT01803880|Mechanical shaver|mechanical shaver
1250470|NCT01803880|Torn meniscus|torn meniscus
1250471|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
1250472|NCT01803880|Damaged cartilage|damaged cartilage
1250473|NCT01803867|MS|ms
1250474|NCT01803867|Multiple Sclerosis|multiple sclerosis
1250475|NCT01803841|Coronary artery disease|coronary artery disease
1250476|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
1250477|NCT01803828|Genders|genders
1250478|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
1250479|NCT01803828|miRNAs|mirnas
1250480|NCT01803828|Chemokines|chemokines
1250481|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
1250482|NCT01803815|hypertension|hypertension
1250483|NCT01803815|antihypertensive drugs|antihypertensive drugs
1250484|NCT01803802|childhood sexual abuse|childhood sexual abuse
1250485|NCT01803802|depression|depression
1250486|NCT01803802|PTSD|ptsd
1250487|NCT01803802|sexual function|sexual function
1250488|NCT01803802|women|women
1250489|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
1250490|NCT01803789|Single Kirschner Wires|single kirschner wires
1250491|NCT01803789|Double Kirschner Wires|double kirschner wires
1250492|NCT01803776|child|child
1250493|NCT01803776|physical activity|physical activity
1250494|NCT01803776|sedentary activity|sedentary activity
1250495|NCT01803776|nutrition|nutrition
1250496|NCT01803776|diet|diet
1250497|NCT01803776|body composition|body composition
1250498|NCT01803776|overweight|overweight
1250499|NCT01803776|obesity|obesity
1250500|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
1250501|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
1250502|NCT01803776|physical fitness|physical fitness
1250503|NCT01803776|cardiovascular system|cardiovascular system
1250504|NCT01803776|musculoskeletal system|musculoskeletal system
1250505|NCT01803776|bone mineral density|bone mineral density
1250506|NCT01803776|oral health|oral health
1250507|NCT01803776|quality of life|quality of life
1250508|NCT01803776|wellbeing|wellbeing
1250509|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
1250510|NCT01803776|health economics|health economics
1250511|NCT01803763|Omalizumab|omalizumab
1250512|NCT01803763|Xolair|xolair
1250513|NCT01803763|Urticaria|urticaria
1250514|NCT01803763|basophils|basophils
1250515|NCT01803763|chronic Urticaria|chronic urticaria
1250517|NCT01803750|Primary Care Providers|primary care providers
1250518|NCT01803750|Latino Populations|latino populations
1250519|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
1250520|NCT01803750|semi-structured interviews|semi-structured interviews
1250521|NCT01803750|13-031|13-031
1250522|NCT01803737|Weight Loss|weight loss
1250523|NCT01803737|Physical Activity|physical activity
1250524|NCT01803737|Dietary Intake|dietary intake
1250525|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
1250526|NCT01803737|Motivation|motivation
1250527|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
1250528|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
1250529|NCT01803724|Lactulose breath test|lactulose breath test
1250530|NCT01803724|Glucose breath test|glucose breath test
1250531|NCT01803724|Rifaximin|rifaximin
1250532|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
1250533|NCT01803711|Fish oil|fish oil
1250534|NCT01803711|Depression|depression
1250535|NCT01803711|cancer|cancer
1250536|NCT01803711|diabetes|diabetes
1250537|NCT01803711|high blood pressure|high blood pressure
1250538|NCT01803711|cardiovascular|cardiovascular
1250539|NCT01803698|Pregnancy|pregnancy
1250540|NCT01803698|Gestational weight gain|gestational weight gain
1250541|NCT01803698|Primary care|primary care
1250542|NCT01803698|Guidelines|guidelines
1250543|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
1250544|NCT01803685|Surgical removal|surgical removal
1250545|NCT01803685|Endovascular embolism|endovascular embolism
1250546|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
1250547|NCT01803685|Outcomes|outcomes
1250548|NCT01803672|Adventure-Based training|adventure-based training
1250549|NCT01803672|Health education|health education
1250550|NCT01803672|childhood cancer|childhood cancer
1250551|NCT01803672|physical activity|physical activity
1250552|NCT01803659|b-carotene|b-carotene
1250553|NCT01803659|breastmilk|breastmilk
1250554|NCT01803659|vitamin A|vitamin a
1250555|NCT01803568|Myokine|myokine
1250556|NCT01803568|Insulin sensitivity|insulin sensitivity
1250557|NCT01803568|Exercise|exercise
1250558|NCT01803568|Skeletal muscle|skeletal muscle
1250559|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
1250560|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
1250561|NCT01803555|Asthma|asthma
1599434|NCT00396513|Statin|statin
1250562|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
1250563|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
1250564|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
1250565|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
1250566|NCT01803529|thorax|thorax
1250567|NCT01803529|Intercostal Muscles|intercostal muscles
1250568|NCT01803529|massage|massage
1250569|NCT01803529|heat-pack|heat-pack
1250570|NCT01803529|hot temperature|hot temperature
1250571|NCT01803516|Quality of Life|quality of life
1250572|NCT01803516|Assessments|assessments
1250573|NCT01803516|Radiation|radiation
1250574|NCT01803516|Telangiectasias|telangiectasias
1250575|NCT01803516|13-013|13-013
1250576|NCT01803464|Botox|botox
1250577|NCT01803464|Muscle strength|muscle strength
1250578|NCT01803451|gastric bypass|gastric bypass
1250579|NCT01803451|glucose metabolism|glucose metabolism
1250580|NCT01803451|hypoglycemia|hypoglycemia
1250581|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1250582|NCT01803438|Cryoablation|cryoablation
1250583|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
1250584|NCT01803425|Post-marketing surveillance|post-marketing surveillance
1250585|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
1250586|NCT01803425|Healthy infants and children|healthy infants and children
1250587|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
1250588|NCT01803425|Synflorix™|synflorix™
1250589|NCT01803425|Sri Lanka|sri lanka
1250590|NCT01803412|GSK2402968|gsk2402968
1250591|NCT01803412|open-label extension|open-label extension
1250592|NCT01803412|safety|safety
1250593|NCT01803412|drisapersen|drisapersen
1250594|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1250595|NCT01803412|tolerability|tolerability
1250596|NCT01803412|Quality of Life|quality of life
1250597|NCT01803399|cardiac repolarization|cardiac repolarization
1250598|NCT01803399|oral|oral
1250599|NCT01803399|QTc|qtc
1250600|NCT01803399|GSK1322322|gsk1322322
1250601|NCT01803399|antibiotic|antibiotic
1250602|NCT01803399|12-lead ECG|12-lead ecg
1250603|NCT01803399|placebo|placebo
1250604|NCT01803399|IV|iv
1250605|NCT01803399|moxifloxacin|moxifloxacin
1250606|NCT01803386|ALS|als
1250608|NCT01803373|Healthy|healthy
1250609|NCT01803373|Biological Availability|biological availability
1250610|NCT01803373|Bioavailability|bioavailability
1250611|NCT01803373|TMC207|tmc207
1250612|NCT01803373|Bedaquiline|bedaquiline
1250613|NCT01803373|R207910|r207910
1250614|NCT01803347|phase III|phase iii
1250615|NCT01803347|Adipose derived stem cells|adipose derived stem cells
1250616|NCT01803347|Anal fistula|anal fistula
1250617|NCT01803347|Cell therapy|cell therapy
1250618|NCT01803347|Stem cell therapy|stem cell therapy
1250619|NCT01803334|surgical incision|surgical incision
1250620|NCT01803334|laparoscopy|laparoscopy
1250621|NCT01803334|pain|pain
1250622|NCT01803321|SJIA|sjia
1250623|NCT01803308|Hepatitis C Infection|hepatitis c infection
1250624|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
1250625|NCT01803308|First In Human|first in human
1250626|NCT01803308|Single Ascending Dose|single ascending dose
1250627|NCT01803308|Multiple Ascending Dose|multiple ascending dose
1250628|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1250629|NCT01803295|Intravesical instillation|intravesical instillation
1250630|NCT01803295|Mitomycin C|mitomycin c
1250631|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
1250632|NCT01803295|Drug retention|drug retention
1250633|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
1250634|NCT01803295|Urologic Neoplasms|urologic neoplasms
1250635|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
1250636|NCT01803295|Urologic Diseases|urologic diseases
1250637|NCT01803295|Mitomycin|mitomycin
1250638|NCT01803282|Solid Tumor|solid tumor
1250639|NCT01803282|NSCLC|nsclc
1250640|NCT01803282|Pancreatic|pancreatic
1250641|NCT01803282|Esophagogastric|esophagogastric
1250642|NCT01803282|Colorectal|colorectal
1250643|NCT01803282|Breast|breast
1250644|NCT01803230|children|children
1250645|NCT01803204|Anxiety|anxiety
1250646|NCT01803204|Orthognathic surgery|orthognathic surgery
1250647|NCT01803204|Patient educational as topic|patient educational as topic
1250648|NCT01803204|Patient educational handout|patient educational handout
1250649|NCT01803204|Pamphlets|pamphlets
1250650|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
1250651|NCT01803191|Bacteriuria|bacteriuria
1250652|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
1250653|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
1250654|NCT01803178|vascular function|vascular function
1250655|NCT01803178|plant sterols|plant sterols
1250656|NCT01803178|blood lipids|blood lipids
1250657|NCT01803165|emesis,post operative.|emesis,post operative.
1250658|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
1250659|NCT01803165|wound infection, post operative.|wound infection, post operative.
1250660|NCT01803165|pain, post operative.|pain, post operative.
1250661|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
1250662|NCT01803165|Anesthesiology/methods|anesthesiology/methods
1250663|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
1250664|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
1250665|NCT01803165|Risk Factors|risk factors
1250666|NCT01803165|Thrombosis|thrombosis
1250667|NCT01803165|Treatment Outcome|treatment outcome
1250668|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
1250669|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
1250670|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
1250671|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
1250672|NCT01803152|Dendritic Cell|dendritic cell
1250673|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
1250674|NCT01803152|MDSC|mdsc
1250675|NCT01803152|MDSC Inhibition|mdsc inhibition
1250676|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
1250678|NCT01803113|Pregnancy|pregnancy
1250679|NCT01803113|hCG|hcg
1250680|NCT01803100|Bacterial Colonization|bacterial colonization
1250681|NCT01803087|adolescents|adolescents
1250682|NCT01803087|adults|adults
1250683|NCT01803061|Head and neck cancer|head and neck cancer
1250684|NCT01803061|Quality of life|quality of life
1250685|NCT01803061|Symptom-burden|symptom-burden
1250686|NCT01803061|Late effects|late effects
1250687|NCT01803048|Traumatic Brain Injury|traumatic brain injury
1250688|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
1250689|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
1250690|NCT01803048|Cognition|cognition
1250691|NCT01803035|Impetigo|impetigo
1250692|NCT01803035|LTX-109|ltx-109
1250693|NCT01803035|Topical|topical
1250694|NCT01803035|Antibiotic|antibiotic
1250695|NCT01803035|Placebo|placebo
1250696|NCT01803035|Lytic|lytic
1250697|NCT01803035|Peptide|peptide
1250698|NCT01803035|Gram Positive|gram positive
1250699|NCT01803022|Venous Thromboembolism|venous thromboembolism
1250700|NCT01803022|Cancer|cancer
1250701|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
1250702|NCT01802983|Aged|aged
1250703|NCT01802983|Multiple organ failure|multiple organ failure
1250704|NCT01802983|Extubation|extubation
1250705|NCT01802983|Prognosis|prognosis
1250706|NCT01802983|MODS|mods
1250707|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
1250708|NCT01802970|Anakinra|anakinra
1250709|NCT01802970|Nab Paclitaxel|nab paclitaxel
1250710|NCT01802970|Capecitabine|capecitabine
1250711|NCT01802970|Eribulin|eribulin
1250712|NCT01802970|Vinorelbin|vinorelbin
1250713|NCT01802931|GSK239512|gsk239512
1250714|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
1250715|NCT01802931|drug-drug interaction|drug-drug interaction
1250716|NCT01802931|pharmacokinetics|pharmacokinetics
1250717|NCT01802931|ketoconazole|ketoconazole
1250719|NCT01802918|HIV|hiv
1250720|NCT01802918|maturation inhibitor|maturation inhibitor
1250721|NCT01802918|GSK2838232|gsk2838232
1250722|NCT01802918|FTIH|ftih
1250723|NCT01802918|healthy subjects|healthy subjects
1250724|NCT01802905|neoplasm|neoplasm
1250725|NCT01802905|metastatic cancer|metastatic cancer
1250726|NCT01802905|cancer genome|cancer genome
1250727|NCT01802905|genomic analysis|genomic analysis
1250728|NCT01802905|adults|adults
1250729|NCT01802892|ronacaleret|ronacaleret
1250730|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
1250731|NCT01802892|CD34+cells|cd34+cells
1250732|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
1250733|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
1250734|NCT01802892|stem cell mobilization|stem cell mobilization
1250735|NCT01802892|plerixafor|plerixafor
1250736|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
1250737|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
1250738|NCT01802879|Panobinostat,|panobinostat,
1250739|NCT01802866|Geographic atrophy|geographic atrophy
1250740|NCT01802866|GA|ga
1250741|NCT01802866|Dry AMD|dry amd
1250742|NCT01802827|airway colonization|airway colonization
1250743|NCT01802827|tracheobronchitis|tracheobronchitis
1250744|NCT01802827|pneumonia|pneumonia
1250745|NCT01802814|ALL|all
1250746|NCT01802788|Aortic Stenosis|aortic stenosis
1250747|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
1250748|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
1250749|NCT01802788|TAVR|tavr
1250750|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
1250751|NCT01802788|TAVI|tavi
1250752|NCT01802749|second line|second line
1250753|NCT01802749|platinum sensitive|platinum sensitive
1250754|NCT01802749|first line bevacizumab|first line bevacizumab
1250755|NCT01802749|biologic factors|biologic factors
1250756|NCT01802749|clinical factors|clinical factors
1250757|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
1250758|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
1250759|NCT01802697|volunteers|volunteers
1250760|NCT01802684|unresectable|unresectable
1250761|NCT01802684|metastatic|metastatic
1250762|NCT01802684|colorectal|colorectal
1250763|NCT01802684|cancer|cancer
1250764|NCT01802684|OPTIMOX|optimox
1250765|NCT01802684|aflibercept|aflibercept
1250766|NCT01802671|Low back pain|low back pain
1250767|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
1250768|NCT01802671|internet|internet
1250769|NCT01802671|disability|disability
1250770|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
1250771|NCT01802645|neoadjuvant|neoadjuvant
1250772|NCT01802645|cetuximab|cetuximab
1250773|NCT01802645|irinotecan|irinotecan
1250774|NCT01802645|bevacizumab|bevacizumab
1250775|NCT01802645|oxaliplatin|oxaliplatin
1250776|NCT01802645|5-FU|5-fu
1250777|NCT01802645|Resection|resection
1250778|NCT01802645|colorectal liver metastases|colorectal liver metastases
1250779|NCT01802645|liver resection|liver resection
1250780|NCT01802645|Chemotherapy|chemotherapy
1250781|NCT01802645|k-ras|k-ras
1250782|NCT01802645|non-resectable|non-resectable
1250783|NCT01802632|Oncology,|oncology,
1250784|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
1250785|NCT01802632|Metastatic,|metastatic,
1250786|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
1250787|NCT01802632|T790M resistance mutation|t790m resistance mutation
1250788|NCT01802606|surgery|surgery
1250789|NCT01802606|administration|administration
1250790|NCT01802606|infection|infection
1250791|NCT01802593|Pediatric|pediatric
1250792|NCT01802593|Crohn's disease|crohn's disease
1250793|NCT01802593|Infliximab|infliximab
1250794|NCT01802593|Thiopurine|thiopurine
1250795|NCT01802554|Behavioral Activation|behavioral activation
1250796|NCT01802554|Caregiver|caregiver
1250797|NCT01802554|Dementia|dementia
1250798|NCT01802554|Cardiovascular Disease|cardiovascular disease
1250799|NCT01802554|Alzheimer's Disease|alzheimer's disease
1250800|NCT01802554|Coagulation|coagulation
1250801|NCT01802541|diacylglycerol oil|diacylglycerol oil
1250802|NCT01802541|insulin sensitivity|insulin sensitivity
1250803|NCT01802541|type 2 diabetes|type 2 diabetes
1250804|NCT01802541|cardiovascular disease|cardiovascular disease
1250805|NCT01802541|risk factors|risk factors
1250806|NCT01802528|obturator externus|obturator externus
1250807|NCT01802515|addiction|addiction
1250809|NCT01802515|methadone|methadone
1250810|NCT01802515|opiates|opiates
1250811|NCT01802515|atomoxetine|atomoxetine
1250812|NCT01802502|tuberculous meningitis|tuberculous meningitis
1250813|NCT01802502|rifampicin|rifampicin
1250814|NCT01802502|bioequivalence|bioequivalence
1250815|NCT01802502|oral administration|oral administration
1250816|NCT01802502|intravenous administration|intravenous administration
1250817|NCT01802489|Optic neuritis|optic neuritis
1250818|NCT01802489|Multiple sclerosis|multiple sclerosis
1250819|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
1250820|NCT01802489|Axonal loss|axonal loss
1250821|NCT01802489|Neuroprotection|neuroprotection
1250822|NCT01802489|MRI|mri
1250823|NCT01802489|Optical coherence tomography|optical coherence tomography
1250824|NCT01802489|Amiloride|amiloride
1250825|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
1250826|NCT01802476|PD-0332991|pd-0332991
1250827|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
1250828|NCT01802424|Open trial|open trial
1250829|NCT01802424|Indicative prevention|indicative prevention
1250830|NCT01802424|Youth anxiety|youth anxiety
1250831|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
1250832|NCT01802411|liposome bupivacaine|liposome bupivacaine
1250833|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
1250834|NCT01802411|intercostal nerve block|intercostal nerve block
1250835|NCT01802411|postoperative pain|postoperative pain
1250836|NCT01802398|Risk Stratification|risk stratification
1250837|NCT01802398|Syncope|syncope
1250838|NCT01802398|Geriatric|geriatric
1250839|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
1250840|NCT01802385|cryptococcus|cryptococcus
1250841|NCT01802385|meningitis|meningitis
1250842|NCT01802385|yeast|yeast
1250843|NCT01802385|fungus|fungus
1250844|NCT01802372|Hypertension|hypertension
1250845|NCT01802372|High Blood Pressure|high blood pressure
1250846|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
1250847|NCT01802372|Health Insurance Coverage|health insurance coverage
1250848|NCT01802372|Low income countries|low income countries
1250849|NCT01802372|Ghana|ghana
1250850|NCT01802372|Low resource settings|low resource settings
1250851|NCT01802372|Comparative Effectiveness|comparative effectiveness
1250852|NCT01802372|Global Health|global health
1250853|NCT01802359|Erectile dysfunction|erectile dysfunction
1250854|NCT01802359|Mirodenafil|mirodenafil
1250855|NCT01802359|Bravonto|bravonto
1250856|NCT01802307|Focal therapy|focal therapy
1250857|NCT01802307|Brachytherapy|brachytherapy
1250858|NCT01802307|Active surveillance|active surveillance
1250859|NCT01802307|low risk cancer|low risk cancer
1250860|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
1250861|NCT01802294|Child|child
1250862|NCT01802294|Parents|parents
1250863|NCT01802268|sirolimus|sirolimus
1250864|NCT01802268|tacrolimus|tacrolimus
1250865|NCT01802268|early conversion|early conversion
1250866|NCT01802255|Inhalatory sedation|inhalatory sedation
1250867|NCT01802255|Sevoflurane|sevoflurane
1250868|NCT01802255|AnaConDa|anaconda
1250869|NCT01802255|Nephrotoxicity|nephrotoxicity
1250870|NCT01802255|Hepatotoxicity|hepatotoxicity
1250871|NCT01802255|Midazolam|midazolam
1250872|NCT01802255|Propofol|propofol
1250873|NCT01802242|Prostate Cancer|prostate cancer
1250874|NCT01802242|Prostate tumour|prostate tumour
1250875|NCT01802242|Prostate radiotherapy|prostate radiotherapy
1250876|NCT01802242|prostate cancer treatment|prostate cancer treatment
1250877|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
1250878|NCT01802216|periodontal disease|periodontal disease
1250879|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
1250880|NCT01802203|Barrett esophagus|barrett esophagus
1250881|NCT01802203|Esophageal dysplasia|esophageal dysplasia
1250882|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
1250883|NCT01802203|Esophageal cancer|esophageal cancer
1250884|NCT01802203|Endobronchial cancer|endobronchial cancer
1250885|NCT01802203|Central airway cancer|central airway cancer
1250886|NCT01802203|Central airway precancerous disease|central airway precancerous disease
1250887|NCT01802203|Central airway granulation tissue|central airway granulation tissue
1250888|NCT01802203|Central airway papillomatosis|central airway papillomatosis
1250889|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
1250890|NCT01802203|Central airway tuberculosis|central airway tuberculosis
1250891|NCT01802203|Tracheal stenosis|tracheal stenosis
1250892|NCT01802203|Bronchial stenosis|bronchial stenosis
1250893|NCT01802190|Genetic deafness|genetic deafness
1250894|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
1250895|NCT01802177|Alopecia areata|alopecia areata
1250896|NCT01802177|Excimer|excimer
1250897|NCT01802177|UVB|uvb
1250898|NCT01802151|probiotics|probiotics
1250899|NCT01802151|microbiota|microbiota
1250900|NCT01802151|survival|survival
1250901|NCT01802151|gastrointestinal|gastrointestinal
1250902|NCT01802151|wellness|wellness
1250903|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
1250904|NCT01802112|Colonic transit|colonic transit
1250905|NCT01802112|Dietary Fiber|dietary fiber
1250906|NCT01802112|Radiopaque marker|radiopaque marker
1250907|NCT01802099|mechanical ventilation|mechanical ventilation
1250908|NCT01802099|early enteral nutrition|early enteral nutrition
1250909|NCT01802099|intensive care unit|intensive care unit
1250910|NCT01802099|early parenteral nutrition|early parenteral nutrition
1250911|NCT01802099|critical care medicine|critical care medicine
1250912|NCT01802099|nosocomial infection|nosocomial infection
1250913|NCT01802099|mortality|mortality
1250915|NCT01802099|vasoactive drug|vasoactive drug
1250916|NCT01802086|Children|children
1250917|NCT01802086|Pain|pain
1250918|NCT01802086|Vaccination|vaccination
1250919|NCT01802086|Emla|emla
1250920|NCT01802086|Pneumococcal|pneumococcal
1250921|NCT01802086|Painscale|painscale
1250922|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
1250923|NCT01802073|biliary scarring|biliary scarring
1250924|NCT01802073|obstruction|obstruction
1250925|NCT01802060|Persona|persona
1250926|NCT01802060|E3G|e3g
1250927|NCT01802060|LH|lh
1250928|NCT01802060|ovulation|ovulation
1250929|NCT01802047|Mothers of Preterms|mothers of preterms
1250930|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
1250931|NCT01802047|mother milk feeding|mother milk feeding
1250932|NCT01802021|chinese medicine|chinese medicine
1250933|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
1250934|NCT01802021|immunosuppression|immunosuppression
1250935|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
1250936|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
1250937|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
1250938|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
1250939|NCT01801969|Brain injuries|brain injuries
1250940|NCT01801969|Rehabilitation services|rehabilitation services
1250941|NCT01801969|Return to Work|return to work
1250942|NCT01801969|Quality of life|quality of life
1250943|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
1250944|NCT01801956|Physical activity|physical activity
1250945|NCT01801956|Physical inactivity|physical inactivity
1250946|NCT01801956|Motivational interview|motivational interview
1250947|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
1250948|NCT01801956|Primary care|primary care
1250949|NCT01801956|Community care|community care
1250950|NCT01801930|OCV-C02|ocv-c02
1250951|NCT01801930|Colorectal Cancer|colorectal cancer
1250952|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
1250953|NCT01801917|Polymyositis|polymyositis
1250954|NCT01801917|Myositis|myositis
1250955|NCT01801917|PM|pm
1250956|NCT01801917|chronic muscle inflammation|chronic muscle inflammation
1250957|NCT01801917|inflammatory myopathy|inflammatory myopathy
1599435|NCT00396513|Metformin|metformin
1250958|NCT01801917|inclusion body myositis|inclusion body myositis
1250959|NCT01801904|cetuximab-refractory|cetuximab-refractory
1250960|NCT01801891|Venous ulceration|venous ulceration
1250961|NCT01801891|Leg ulcers|leg ulcers
1250962|NCT01801891|Venous haemodynamics|venous haemodynamics
1250963|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
1250964|NCT01801891|SNMES|snmes
1250965|NCT01801878|breast cancer|breast cancer
1250966|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
1250967|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
1250968|NCT01801865|NICU|nicu
1250969|NCT01801865|MRI|mri
1250970|NCT01801865|Neonatal|neonatal
1250971|NCT01801865|Cincinnati|cincinnati
1250972|NCT01801813|Neuro-surgery|neuro-surgery
1250973|NCT01801813|Post-operative complications|post-operative complications
1250974|NCT01801813|Neuro-ICU resources|neuro-icu resources
1250975|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
1250976|NCT01801774|post-operative inflammation|post-operative inflammation
1250977|NCT01801774|steroid|steroid
1250978|NCT01801774|intraocular pressure|intraocular pressure
1250979|NCT01801748|wheat allergy|wheat allergy
1250980|NCT01801748|wheat outgrowing|wheat outgrowing
1250981|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
1250982|NCT01801748|omega-5-gliadin|omega-5-gliadin
1250983|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
1250984|NCT01801709|Brain Gene Therapy|brain gene therapy
1250985|NCT01801709|Adeno Associated vector|adeno associated vector
1250986|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
1250987|NCT01801709|Leukodystrophies|leukodystrophies
1250988|NCT01801696|Massage|massage
1250989|NCT01801696|effectiveness|effectiveness
1250990|NCT01801696|autism|autism
1250991|NCT01801696|parent stress|parent stress
1250992|NCT01801683|EBM|ebm
1250993|NCT01801683|general practice|general practice
1250994|NCT01801670|itch|itch
1250995|NCT01801670|pruritus|pruritus
1250996|NCT01801670|skin|skin
1250997|NCT01801670|vorinostat|vorinostat
1250998|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1250999|NCT01801670|mycosis fungoides|mycosis fungoides
1251000|NCT01801657|bronchiectasis|bronchiectasis
1251001|NCT01801657|exacerbation|exacerbation
1251002|NCT01801657|virus|virus
1251003|NCT01801644|bladder cancer|bladder cancer
1251004|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1251005|NCT01801644|gem/cis|gem/cis
1251006|NCT01801631|Type 2 diabetes|type 2 diabetes
1251007|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
1251008|NCT01801631|Distress|distress
1251009|NCT01801631|Self-efficacy|self-efficacy
1251010|NCT01801631|Quality of Life|quality of life
1251011|NCT01801631|Depression|depression
1251012|NCT01801631|Primary care|primary care
1251013|NCT01801631|Illness representations|illness representations
1251014|NCT01801618|HIV|hiv
1251015|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
1251016|NCT01801618|Virological failure|virological failure
1251017|NCT01801618|Drug resistance|drug resistance
1251018|NCT01801618|Cambodia|cambodia
1251019|NCT01801618|Adherence|adherence
1251020|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
1251021|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
1251022|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
1251023|NCT01801592|Respiratory disease|respiratory disease
1251024|NCT01801592|Peripheral artery disease|peripheral artery disease
1251025|NCT01801579|Ankle Brachial Index|ankle brachial index
1251026|NCT01801579|Maximal exercise|maximal exercise
1251027|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
1251028|NCT01801566|Prostheses and Implants|prostheses and implants
1251029|NCT01801566|Denture, Complete, Lower|denture, complete, lower
1251030|NCT01801553|spinal manipulation|spinal manipulation
1251031|NCT01801553|low back pain|low back pain
1251032|NCT01801553|manual therapy|manual therapy
1251033|NCT01801553|clinical predictive rule|clinical predictive rule
1251034|NCT01801527|Telehealth|telehealth
1251035|NCT01801527|Fatigue|fatigue
1251036|NCT01801527|Breast cancer|breast cancer
1251037|NCT01801527|Exercise|exercise
1251038|NCT01801527|Quality of life|quality of life
1251039|NCT01801527|Telerehabilitation|telerehabilitation
1251040|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
1251041|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
1251042|NCT01801475|Term pregnancy|term pregnancy
1251043|NCT01801475|Cesarean section|cesarean section
1251044|NCT01801462|Medical education|medical education
1251045|NCT01801462|Simulation|simulation
1251046|NCT01801462|Ultrasound training|ultrasound training
1251047|NCT01801462|Patient safety|patient safety
1251048|NCT01801449|DIRA|dira
1251049|NCT01801449|Clinical Trial|clinical trial
1251050|NCT01801449|IL-1|il-1
1251051|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
1251052|NCT01801449|Rilonacept|rilonacept
1251053|NCT01801436|Multiple Myeloma|multiple myeloma
1341032|NCT01412944|AIN457|ain457
1251054|NCT01801436|Bortezomib|bortezomib
1251055|NCT01801436|Velcade|velcade
1251056|NCT01801423|transcranial Doppler|transcranial doppler
1251057|NCT01801423|stroke|stroke
1251058|NCT01801423|sickle cell anemia|sickle cell anemia
1251059|NCT01801423|Nigeria|nigeria
1251060|NCT01801423|hydroxyurea|hydroxyurea
1251061|NCT01801423|low income country|low income country
1251062|NCT01801410|pre-eclampsia|pre-eclampsia
1251063|NCT01801410|labor induction|labor induction
1251064|NCT01801410|misoprostol|misoprostol
1251065|NCT01801410|Foley catheter|foley catheter
1251066|NCT01801384|pregnancy|pregnancy
1251067|NCT01801384|cigarette smoking|cigarette smoking
1251068|NCT01801384|incentives|incentives
1251069|NCT01801384|smoking cessation|smoking cessation
1251070|NCT01801384|birth outcomes|birth outcomes
1251071|NCT01801371|Glioma|glioma
1251072|NCT01801371|Diagnostic imaging|diagnostic imaging
1251073|NCT01801371|Integrin receptor|integrin receptor
1251074|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
1251075|NCT01801371|PET/CT|pet/ct
1251076|NCT01801358|Melanoma,|melanoma,
1251077|NCT01801358|melanoma of the eye,|melanoma of the eye,
1251078|NCT01801358|uveal,|uveal,
1251079|NCT01801358|MEK162,|mek162,
1251080|NCT01801358|AEB071|aeb071
1251081|NCT01801345|Human Performance|human performance
1251082|NCT01801345|Clinical Performance|clinical performance
1251083|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
1251084|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
1251085|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
1251086|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
1251087|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
1251088|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
1251089|NCT01801293|RSV infection|rsv infection
1251090|NCT01801280|immunosuppressive medication|immunosuppressive medication
1251091|NCT01801280|mycophenolic acid|mycophenolic acid
1251092|NCT01801280|interaction|interaction
1251093|NCT01801280|proton pump inhibitor|proton pump inhibitor
1251094|NCT01801280|pantoprazole|pantoprazole
1251095|NCT01801280|renal transplant patients|renal transplant patients
1251096|NCT01801280|pharmacokinetics|pharmacokinetics
1251097|NCT01801280|pharmacodynamics|pharmacodynamics
1251098|NCT01801280|bioavailability|bioavailability
1251099|NCT01801267|Hydrocephalus|hydrocephalus
1251100|NCT01801267|Pediatric|pediatric
1251101|NCT01801267|Ventricular shunt|ventricular shunt
1251102|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
1251103|NCT01801267|Third ventriculostomy|third ventriculostomy
1251104|NCT01801267|Randomized controlled trial|randomized controlled trial
1251105|NCT01801254|Obesity|obesity
1251106|NCT01801254|Type II diabetes|type ii diabetes
1251107|NCT01801254|Cardiovascular disease|cardiovascular disease
1251108|NCT01801254|Health behavior promotion|health behavior promotion
1251109|NCT01801254|Neuroeconomics|neuroeconomics
1251110|NCT01801254|EEG biofeedback|eeg biofeedback
1251111|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
1251112|NCT01801254|EEG|eeg
1251113|NCT01801176|proved by biopsy|proved by biopsy
1251114|NCT01801150|Diabetes|diabetes
1251115|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
1251116|NCT01801150|Glycemic control|glycemic control
1251117|NCT01801150|Prevalence|prevalence
1251118|NCT01801150|SAHS|sahs
1251119|NCT01801150|life quality|life quality
1251120|NCT01801124|analgesia|analgesia
1251121|NCT01801124|hernia repair|hernia repair
1251122|NCT01801098|TAVI|tavi
1251123|NCT01801098|complete AV-block|complete av-block
1251124|NCT01801098|HV-interval|hv-interval
1251125|NCT01801098|permanent pacemaker|permanent pacemaker
1251126|NCT01801085|Time-and-Motion|time-and-motion
1251127|NCT01801085|Neoplasm|neoplasm
1251128|NCT01801085|Colorectal Cancer|colorectal cancer
1251129|NCT01801059|colon cancer|colon cancer
1251130|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
1251131|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
1251132|NCT01801033|Thyroid Hormone Action|thyroid hormone action
1251133|NCT01801033|Deiodinases|deiodinases
1251134|NCT01801033|Hypothyroid|hypothyroid
1251135|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
1251136|NCT01801020|temperature|temperature
1251137|NCT01800994|convenience|convenience
1251138|NCT01800981|Functionality|functionality
1251139|NCT01800981|extremities|extremities
1251140|NCT01800981|ROM|rom
1251141|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
1251142|NCT01800955|physical therapy|physical therapy
1251143|NCT01800955|diathermy|diathermy
1251144|NCT01800955|knee|knee
1251145|NCT01800955|osteoarthritis|osteoarthritis
1251146|NCT01800955|pain|pain
1251147|NCT01800955|physical function|physical function
1251148|NCT01800942|prevention|prevention
1251149|NCT01800942|bacterial infection|bacterial infection
1251150|NCT01800942|neonates|neonates
1251151|NCT01800942|women in labour|women in labour
1251152|NCT01800942|Azithromycin|azithromycin
1251153|NCT01800916|ileostomy|ileostomy
1251154|NCT01800916|Subjects|subjects
1251155|NCT01800890|stoma ileostomy|stoma ileostomy
1251156|NCT01800877|hypotension|hypotension
1251157|NCT01800877|vasopressors|vasopressors
1251158|NCT01800877|titration|titration
1251159|NCT01800877|tissue perfusion|tissue perfusion
1251160|NCT01800877|organ failure|organ failure
1251161|NCT01800851|Kidney transplantation|kidney transplantation
1251162|NCT01800851|Energy expenditure|energy expenditure
1251163|NCT01800851|Weight gain|weight gain
1251164|NCT01800851|Insulin resistance|insulin resistance
1251165|NCT01800825|Pregnancy|pregnancy
1251166|NCT01800825|Prematurity|prematurity
1251167|NCT01800825|Preterm birth|preterm birth
1251168|NCT01800825|bacterial vaginosis|bacterial vaginosis
1251169|NCT01800799|Urinary tract infection|urinary tract infection
1251170|NCT01800799|Urothelium|urothelium
1251171|NCT01800799|Inflammation|inflammation
1251172|NCT01800799|Apoptosis|apoptosis
1251174|NCT01800773|exposure treatment|exposure treatment
1251175|NCT01800773|clinical trial|clinical trial
1251176|NCT01800773|trauma|trauma
1251177|NCT01800760|healthy|healthy
1251178|NCT01800760|obese|obese
1251179|NCT01800760|women|women
1251180|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
1251181|NCT01800747|Acute respiratory infections|acute respiratory infections
1251182|NCT01800747|Pediatrics|pediatrics
1251183|NCT01800747|Satisfaction|satisfaction
1251184|NCT01800734|Mixed meal test|mixed meal test
1251185|NCT01800734|Insulin pump|insulin pump
1251186|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
1251187|NCT01800734|Metabolic control analysis|metabolic control analysis
1251188|NCT01800734|Closed loop control|closed loop control
1251189|NCT01800734|Artificial pancreas|artificial pancreas
1251191|NCT01800721|testing|testing
1251192|NCT01800721|Social Network|social network
1251193|NCT01800721|African American|african american
1251194|NCT01800721|MSM|msm
1251195|NCT01800721|Men who have sex with men|men who have sex with men
1251196|NCT01800695|GBM|gbm
1251197|NCT01800682|Healthy|healthy
1251198|NCT01800682|Tramodol|tramodol
1251199|NCT01800682|Ultram|ultram
1251200|NCT01800669|Computer based clinical decision support|computer based clinical decision support
1251201|NCT01800669|medical legal partnership|medical legal partnership
1251202|NCT01800669|child|child
1251203|NCT01800669|pediatrics|pediatrics
1251204|NCT01800643|Busulfan|busulfan
1251205|NCT01800643|plasmatic dosage|plasmatic dosage
1251206|NCT01800643|Stem Cell Transplantation|stem cell transplantation
1251207|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
1251208|NCT01800565|precocious puberty|precocious puberty
1251209|NCT01800565|urinary LH|urinary lh
1251210|NCT01800565|GnRH stimulation test|gnrh stimulation test
1251211|NCT01800565|gonadotropins|gonadotropins
1251212|NCT01800552|Infiltration|infiltration
1251213|NCT01800552|Extravasation|extravasation
1251214|NCT01800552|Leaking|leaking
1251215|NCT01800552|PIV Infiltration|piv infiltration
1251216|NCT01800552|IV Infiltration|iv infiltration
1251217|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
1251218|NCT01800552|Ultrasound Imaging|ultrasound imaging
1251219|NCT01800539|Autism|autism
1251220|NCT01800539|Early Intervention|early intervention
1251221|NCT01800539|Minority|minority
1251222|NCT01800526|Sickle Cell Disease|sickle cell disease
1251223|NCT01800526|Sickle Cell Anemia|sickle cell anemia
1251224|NCT01800513|Implantation Failure|implantation failure
1251225|NCT01800513|In-vitro Fertilization|in-vitro fertilization
1251226|NCT01800513|Infertility|infertility
1251227|NCT01800513|Endometrial Biopsy|endometrial biopsy
1251228|NCT01800487|Drug-induced liver injury|drug-induced liver injury
1251229|NCT01800487|Tuberculosis|tuberculosis
1251230|NCT01800487|Silymarin|silymarin
1251231|NCT01800461|Participation|participation
1251232|NCT01800461|Occupational Therapy|occupational therapy
1251233|NCT01800461|Valued Activities|valued activities
1251234|NCT01800448|Respiratory monitoring|respiratory monitoring
1251235|NCT01800448|cardiac monitoring|cardiac monitoring
1251236|NCT01800448|skin conductance monitoring|skin conductance monitoring
1251237|NCT01800448|variability|variability
1251238|NCT01800409|Tetraplegia|tetraplegia
1251239|NCT01800396|Bacterial infection|bacterial infection
1251240|NCT01800396|Dairy|dairy
1251241|NCT01800396|Diarrhea|diarrhea
1251242|NCT01800396|Diet|diet
1251243|NCT01800396|E.Coli|e.coli
1251244|NCT01800396|Gastroenteritis|gastroenteritis
1251245|NCT01800396|Milk|milk
1251246|NCT01800396|Stool consistency|stool consistency
1251247|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
1251248|NCT01800383|fear conditioning|fear conditioning
1251249|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
1251250|NCT01800383|GABA|gaba
1251251|NCT01800370|Healthy|healthy
1251252|NCT01800370|Male|male
1251253|NCT01800357|randomized trial|randomized trial
1251254|NCT01800357|acute ischemic stroke|acute ischemic stroke
1251255|NCT01800357|mildronate|mildronate
1251256|NCT01800344|Airway Cuff|airway cuff
1251258|NCT01800344|Ultra|ultra
1251259|NCT01800344|Cuff Pressure|cuff pressure
1251260|NCT01800344|Ventilation|ventilation
1251261|NCT01800344|Anesthesia|anesthesia
1251262|NCT01800344|Intubation|intubation
1251263|NCT01800318|NESAP|nesap
1251264|NCT01800318|sucrose|sucrose
1251265|NCT01800318|pain|pain
1251266|NCT01800318|infants|infants
1251267|NCT01800305|PK & PD study|pk & pd study
1251268|NCT01800305|rhEPO|rhepo
1251269|NCT01800305|Pegylated rhEPO|pegylated rhepo
1251270|NCT01800305|male healthy subject|male healthy subject
1251271|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
1251272|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
1251273|NCT01800292|sildenafil|sildenafil
1251274|NCT01800292|echocardiography|echocardiography
1251275|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
1251276|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
1251277|NCT01800292|speckle tracking|speckle tracking
1251278|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
1251279|NCT01800266|Supervision|supervision
1251280|NCT01800266|Implementation|implementation
1251281|NCT01800266|Community Based Mental Health Services|community based mental health services
1251282|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
1251283|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
1251284|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
1251285|NCT01800266|Children|children
1251286|NCT01800266|Adolescents|adolescents
1251287|NCT01800214|neurodengeneration|neurodengeneration
1251288|NCT01800214|neuroimaging|neuroimaging
1251289|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
1251290|NCT01800188|Dialysis|dialysis
1251291|NCT01800188|Incretin hormones|incretin hormones
1251292|NCT01800149|Tooth extraction|tooth extraction
1251293|NCT01800149|Ridge Preservation|ridge preservation
1251294|NCT01800149|Ridge Augmentation|ridge augmentation
1251295|NCT01800149|Guided Bone Regeneration|guided bone regeneration
1251296|NCT01800136|pain|pain
1251297|NCT01800136|neuropathic|neuropathic
1251298|NCT01800136|cortical stimulation|cortical stimulation
1251299|NCT01800136|motor cortex|motor cortex
1251300|NCT01800136|plasticity|plasticity
1251301|NCT01800136|rTMS|rtms
1251302|NCT01800136|tDCS|tdcs
1251303|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
1251304|NCT01800097|stroke|stroke
1251305|NCT01800097|fatigue|fatigue
1251306|NCT01800097|modafinil|modafinil
1251307|NCT01800084|ASIR|asir
1251308|NCT01800084|image acquisition|image acquisition
1251309|NCT01800084|FBP|fbp
1251310|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
1251311|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
1251312|NCT01800071|Vaccination|vaccination
1251313|NCT01800045|Narcolepsy|narcolepsy
1251314|NCT01800045|Cataplexy|cataplexy
1251315|NCT01800045|Sleep disorder|sleep disorder
1251316|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
1251317|NCT01800006|Atrial Fibrillation|atrial fibrillation
1251318|NCT01800006|Observation|observation
1251319|NCT01800006|Stroke|stroke
1251320|NCT01800006|Embolism|embolism
1251424|NCT01799603|Healthy|healthy
1251321|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
1251322|NCT01799993|Intubation|intubation
1251323|NCT01799993|Mechanical ventilation|mechanical ventilation
1251324|NCT01799993|Amikacin|amikacin
1251325|NCT01799980|Lung cancer|lung cancer
1251326|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
1251327|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
1251328|NCT01799980|Staging|staging
1251329|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
1251330|NCT01799967|minimally invasive|minimally invasive
1251331|NCT01799967|Achalasia|achalasia
1251332|NCT01799967|Paraesophageal hernia|paraesophageal hernia
1251333|NCT01799967|GERD|gerd
1251334|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
1251335|NCT01799967|Zenker's diverticulum|zenker's diverticulum
1251336|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
1251337|NCT01799902|Observational|observational
1251338|NCT01799902|Non-Interventional Prospective|non-interventional prospective
1251339|NCT01799902|Phase IV Treatment|phase iv treatment
1251340|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
1251341|NCT01799902|Solifenacin|solifenacin
1251342|NCT01799889|GS-US-339-0102|gs-us-339-0102
1251343|NCT01799889|SYK inhibitor|syk inhibitor
1251344|NCT01799889|GS-9973|gs-9973
1251345|NCT01799889|entospletinib|entospletinib
1251346|NCT01799889|CLL|cll
1251347|NCT01799889|leukemia|leukemia
1251348|NCT01799889|lymphoma|lymphoma
1251349|NCT01799889|MCL|mcl
1251350|NCT01799889|DLBCL|dlbcl
1251351|NCT01799889|iNHL|inhl
1251352|NCT01799889|FL|fl
1251353|NCT01799889|MZL|mzl
1251354|NCT01799889|LPL|lpl
1251355|NCT01799889|SLL|sll
1251357|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
1251358|NCT01799876|knee|knee
1251359|NCT01799876|cartilage|cartilage
1251360|NCT01799876|microfracture|microfracture
1251361|NCT01799876|cell therapy|cell therapy
1251362|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
1251363|NCT01799863|Ketorolac|ketorolac
1251364|NCT01799863|Artificial tears|artificial tears
1251365|NCT01799850|muscle|muscle
1251366|NCT01799850|glucose transporters|glucose transporters
1251367|NCT01799850|GLUT4|glut4
1251368|NCT01799850|GLUT5|glut5
1251369|NCT01799850|Actos|actos
1251370|NCT01799837|PTSD|ptsd
1251371|NCT01799811|allograft|allograft
1251372|NCT01799811|limb salvage|limb salvage
1251373|NCT01799811|patency|patency
1251374|NCT01799811|Cryopreserved|cryopreserved
1251375|NCT01799811|open bypass|open bypass
1251376|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
1251377|NCT01799798|COL1A1/A2|col1a1/a2
1251378|NCT01799798|Denosumab|denosumab
1251379|NCT01799798|Bisphosphonates|bisphosphonates
1251380|NCT01799798|Children|children
1251381|NCT01799798|Areal bone mineral density|areal bone mineral density
1251382|NCT01799759|Body Mass Percentile|body mass percentile
1251383|NCT01799759|Authoritative parenting|authoritative parenting
1251384|NCT01799759|Online interventions|online interventions
1251385|NCT01799759|Prevention|prevention
1251386|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
1251387|NCT01799733|Women|women
1251388|NCT01799733|Depression|depression
1251389|NCT01799733|Light therapy|light therapy
1251390|NCT01799733|Wake therapy|wake therapy
1251391|NCT01799733|Phase|phase
1251392|NCT01799733|Chronobiology|chronobiology
1251393|NCT01799720|blood cholesterol|blood cholesterol
1251394|NCT01799720|blood lipid profile|blood lipid profile
1251395|NCT01799720|triglycerides|triglycerides
1251396|NCT01799720|commercial pills|commercial pills
1251397|NCT01799720|fish oil|fish oil
1251398|NCT01799720|lipid peroxidation|lipid peroxidation
1251399|NCT01799720|Circulating lipidic profile|circulating lipidic profile
1251400|NCT01799707|vision|vision
1251401|NCT01799707|restoration|restoration
1251402|NCT01799707|visual field|visual field
1251403|NCT01799694|Urinary incontinence|urinary incontinence
1251404|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
1251405|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
1251406|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
1251407|NCT01799668|Psychotherapy|psychotherapy
1251408|NCT01799668|Preferences|preferences
1251409|NCT01799642|dyspnea|dyspnea
1251410|NCT01799642|exercise|exercise
1251411|NCT01799642|cystic fibrosis|cystic fibrosis
1251412|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
1251413|NCT01799629|Glycerin suppositories|glycerin suppositories
1251414|NCT01799629|Feeding intolerance|feeding intolerance
1251415|NCT01799629|preterm infants|preterm infants
1251416|NCT01799629|prophylactic use|prophylactic use
1251417|NCT01799629|elimination of meconium|elimination of meconium
1251418|NCT01799616|MODIC changes|modic changes
1251419|NCT01799616|Chronic low back pain|chronic low back pain
1251420|NCT01799616|Pamidronate|pamidronate
1251421|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
1251422|NCT01799616|Vertebrae|vertebrae
1251423|NCT01799616|Intervertebral disc|intervertebral disc
1251425|NCT01799603|TMC435|tmc435
1251426|NCT01799603|G008|g008
1251427|NCT01799590|Migraine|migraine
1251428|NCT01799590|Topiramate|topiramate
1251429|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
1251430|NCT01799564|Geographic atrophy|geographic atrophy
1251431|NCT01799564|Age-related macular degeneration|age-related macular degeneration
1251432|NCT01799564|Fundus autofluorescence|fundus autofluorescence
1251433|NCT01799551|Depression|depression
1251434|NCT01799551|Culture|culture
1251435|NCT01799551|CBT|cbt
1251436|NCT01799551|Adaptation|adaptation
1251437|NCT01799538|Albuterol|albuterol
1251438|NCT01799538|Bronchodilator|bronchodilator
1251439|NCT01799538|Nebulizer|nebulizer
1251440|NCT01799538|Metered Dose Inhaler|metered dose inhaler
1251441|NCT01799525|Aneurysm|aneurysm
1251442|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
1251443|NCT01799525|vasospasm|vasospasm
1251444|NCT01799525|cerebral ischemia|cerebral ischemia
1251445|NCT01799525|stroke|stroke
1251446|NCT01799512|medical ICU patients|medical icu patients
1251447|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
1251448|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1251449|NCT01799499|Intravesical instillation|intravesical instillation
1251450|NCT01799499|Mitomycin C|mitomycin c
1251451|NCT01799499|Hydrogel|hydrogel
1251452|NCT01799499|Reverse thermal gelation|reverse thermal gelation
1251453|NCT01799499|Drug retention|drug retention
1251454|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
1251455|NCT01799499|Carcinoma|carcinoma
1251456|NCT01799499|Urologic Neoplasms|urologic neoplasms
1251457|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
1251458|NCT01799499|Neoplasms by Site|neoplasms by site
1251459|NCT01799499|Neoplasms|neoplasms
1251460|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
1251461|NCT01799499|Urologic Diseases|urologic diseases
1251462|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1251463|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
1251464|NCT01799499|Mitomycin|mitomycin
1251465|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
1251466|NCT01799499|Antineoplastic Agents|antineoplastic agents
1251467|NCT01799499|Therapeutic Uses|therapeutic uses
1251468|NCT01799499|Pharmacologic Actions|pharmacologic actions
1251469|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
1251470|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
1251471|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1251472|NCT01799499|Alkylating Agents|alkylating agents
1251473|NCT01799486|Telbivudine|telbivudine
1251474|NCT01799486|renoprotective efficacy|renoprotective efficacy
1251475|NCT01799486|liver cirrhosis|liver cirrhosis
1251477|NCT01799473|PAH|pah
1251478|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
1251479|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
1251480|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
1251481|NCT01799447|Early intervention|early intervention
1251482|NCT01799447|Intervention study|intervention study
1251483|NCT01799447|Infant mother relations|infant mother relations
1251484|NCT01799447|First time mothers|first time mothers
1251485|NCT01799447|Parental program|parental program
1251486|NCT01799447|Marte Meo method|marte meo method
1251487|NCT01799447|Video guidances|video guidances
1251488|NCT01799369|Surgical Apgar Score|surgical apgar score
1251489|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
1251490|NCT01799343|Prenatal care|prenatal care
1251491|NCT01799343|Blood flow velocity|blood flow velocity
1251492|NCT01799343|Hydrotherapy|hydrotherapy
1251493|NCT01799343|Fetalplacental circulation|fetalplacental circulation
1251494|NCT01799343|Uteroplacental circulation|uteroplacental circulation
1251495|NCT01799330|COPD|copd
1251496|NCT01799330|Rehabilitation|rehabilitation
1251497|NCT01799330|Exercise|exercise
1251498|NCT01799330|TCEMS|tcems
1251499|NCT01799304|Locomotion|locomotion
1251500|NCT01799304|cerebral palsy|cerebral palsy
1251501|NCT01799304|Postural; Defect|postural; defect
1251502|NCT01799291|Decision Making|decision making
1251503|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
1251504|NCT01799291|Assessment|assessment
1251505|NCT01799291|Intervention|intervention
1251608|NCT01798927|Parkinson's disease|parkinson's disease
1251506|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
1251507|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
1251508|NCT01799265|OSA|osa
1251509|NCT01799265|AutoPAP|autopap
1251510|NCT01799265|PAP|pap
1251511|NCT01799265|sleep disordered breathing|sleep disordered breathing
1251512|NCT01799265|CPAP|cpap
1251513|NCT01799265|Apnea hypopnea index|apnea hypopnea index
1251514|NCT01799265|AHI|ahi
1251515|NCT01799252|medical abortion|medical abortion
1251516|NCT01799252|doxycycline|doxycycline
1251517|NCT01799252|antibiotics|antibiotics
1251518|NCT01799252|adherence|adherence
1251519|NCT01799252|nausea|nausea
1251520|NCT01799239|stoma ileostomy|stoma ileostomy
1251521|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
1251522|NCT01799213|NSAID|nsaid
1251523|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
1251524|NCT01799200|Collegiate Athletes|collegiate athletes
1251525|NCT01799200|Hip Pathomorphology|hip pathomorphology
1251526|NCT01799200|Age-Matched Controls|age-matched controls
1251527|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
1251528|NCT01799200|Dysplasia|dysplasia
1251529|NCT01799187|Immature Permanent Teeth|immature permanent teeth
1251530|NCT01799161|NSCLC|nsclc
1251531|NCT01799161|Lung Cancer|lung cancer
1251532|NCT01799161|gp96|gp96
1251533|NCT01799161|gp96 Vaccine|gp96 vaccine
1251534|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
1251535|NCT01799148|Acute coronary syndrome|acute coronary syndrome
1251536|NCT01799148|Air pollution.|air pollution.
1251537|NCT01799148|Inflammation.|inflammation.
1251538|NCT01799148|Oxidative Stress.|oxidative stress.
1251539|NCT01799148|Prognosis|prognosis
1251540|NCT01799109|magnesium sulfate|magnesium sulfate
1251541|NCT01799109|nebulization|nebulization
1251542|NCT01799109|lung function|lung function
1251543|NCT01799083|Advanced solid tumors|advanced solid tumors
1251544|NCT01799083|B cell lymphoma|b cell lymphoma
1251545|NCT01799070|Prediction|prediction
1251546|NCT01799070|Transcranial Doppler|transcranial doppler
1251547|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
1251548|NCT01799057|Intermittent Claudication|intermittent claudication
1251549|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
1251550|NCT01799057|Vascular Diseases|vascular diseases
1251551|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
1251552|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
1251553|NCT01799057|Atherosclerosis|atherosclerosis
1251554|NCT01799057|Insulin Resistance|insulin resistance
1251555|NCT01799057|Glucose Metabolism|glucose metabolism
1251556|NCT01799057|Blood Glucose|blood glucose
1251557|NCT01799057|Metformin|metformin
1251558|NCT01799057|Biguanides|biguanides
1251559|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
1251560|NCT01799057|Endothelium, Vascular|endothelium, vascular
1251561|NCT01799057|Hemorheology|hemorheology
1251562|NCT01799057|Blood Circulation|blood circulation
1251563|NCT01799057|Regional Blood Flow|regional blood flow
1251564|NCT01799057|Microcirculation|microcirculation
1251565|NCT01799057|Exercise|exercise
1251566|NCT01799057|Physical Fitness|physical fitness
1251567|NCT01799057|Exercise Test|exercise test
1251568|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
1251569|NCT01799057|Quality of Life|quality of life
1251570|NCT01799057|Plethysmography|plethysmography
1251571|NCT01799044|Irreversible electroporation|irreversible electroporation
1251572|NCT01799044|IRE|ire
1251573|NCT01799044|Electroporation|electroporation
1251574|NCT01799044|Colorectal liver metastases|colorectal liver metastases
1251575|NCT01799044|CRLM|crlm
1251576|NCT01799044|Safety|safety
1251577|NCT01799044|Feasibility|feasibility
1251578|NCT01799044|Efficacy|efficacy
1251579|NCT01799044|Single-center|single-center
1251580|NCT01799044|Low Energy Direct Current|low energy direct current
1251581|NCT01799044|Ablate-and-resect|ablate-and-resect
1251582|NCT01799044|Nonthermal ablation|nonthermal ablation
1251583|NCT01799044|Ablation|ablation
1251584|NCT01799018|Xanthine Oxidase|xanthine oxidase
1251585|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
1251586|NCT01799005|flavanols|flavanols
1251587|NCT01799005|diet|diet
1251588|NCT01799005|endothelial function|endothelial function
1251589|NCT01799005|blood pressure|blood pressure
1251590|NCT01799005|FLAVIOLA|flaviola
1251591|NCT01798992|ejection fraction|ejection fraction
1251592|NCT01798992|beta-blocker|beta-blocker
1251593|NCT01798992|carvedilol|carvedilol
1251594|NCT01798992|metoprolol|metoprolol
1251595|NCT01798992|myocardial gene expression|myocardial gene expression
1251596|NCT01798992|human heart|human heart
1251597|NCT01798992|ventricular remodeling|ventricular remodeling
1251598|NCT01798992|wall stress|wall stress
1251599|NCT01798992|adrenergic signaling|adrenergic signaling
1251600|NCT01798992|myosin heavy chain|myosin heavy chain
1251601|NCT01798953|Ulcerative Colitis|ulcerative colitis
1251602|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1251603|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
1251604|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
1251605|NCT01798953|Surgical outcome|surgical outcome
1251606|NCT01798953|Functional outcome|functional outcome
1251607|NCT01798953|Failure|failure
1251609|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
1251610|NCT01798927|gait|gait
1251611|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
1251612|NCT01798901|AML|aml
1251613|NCT01798901|AR-42|ar-42
1251614|NCT01798901|Decitabine|decitabine
1251615|NCT01798888|Deep Brain Stimulation|deep brain stimulation
1251616|NCT01798888|Alcohol Dependence|alcohol dependence
1251617|NCT01798875|pcos|pcos
1251618|NCT01798875|metformin|metformin
1251619|NCT01798875|oral contraception|oral contraception
1251620|NCT01798875|cyproterone acetate|cyproterone acetate
1251621|NCT01798862|Failed IVF cycles|failed ivf cycles
1251622|NCT01798862|IVF outcome parameters|ivf outcome parameters
1251623|NCT01798862|endometrial injury|endometrial injury
1251624|NCT01798862|hysteroscopy|hysteroscopy
1251625|NCT01798862|pipelle sampling|pipelle sampling
1251626|NCT01798862|Repeated implantation failures|repeated implantation failures
1251627|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
1251628|NCT01798823|children|children
1251629|NCT01798823|asthma|asthma
1251630|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
1251631|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
1251632|NCT01798810|Resource Utilization and Cost|resource utilization and cost
1251633|NCT01798797|Heart Failure|heart failure
1251634|NCT01798797|HFRS|hfrs
1251635|NCT01798797|OptiVol|optivol
1251636|NCT01798797|ICD|icd
1251637|NCT01798797|CRT-D|crt-d
1251638|NCT01798771|primary brain tumor|primary brain tumor
1251639|NCT01798771|malignant glioma|malignant glioma
1251640|NCT01798771|intraoperative MRI|intraoperative mri
1251641|NCT01798771|5-ALA|5-ala
1251642|NCT01798745|Heart failure|heart failure
1251643|NCT01798745|JNJ-54452840|jnj-54452840
1251644|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
1251645|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
1251646|NCT01798745|Antibodies|antibodies
1251647|NCT01798745|Auto antibodies|auto antibodies
1251648|NCT01798745|Systolic function|systolic function
1251649|NCT01798719|NAFLD|nafld
1251650|NCT01798719|Clinical Trial|clinical trial
1251651|NCT01798719|Mediterranean Diet|mediterranean diet
1251652|NCT01798719|Low Glycemic Index|low glycemic index
1251653|NCT01798693|Shoulder|shoulder
1251654|NCT01798693|Supplement|supplement
1251655|NCT01798693|Amino Acids|amino acids
1251656|NCT01798693|Collagen|collagen
1251657|NCT01798693|Standard of Care|standard of care
1251658|NCT01798641|Hydrocephalus|hydrocephalus
1251659|NCT01798641|Cross-over|cross-over
1251660|NCT01798628|Healthy volunteers|healthy volunteers
1251661|NCT01798628|Abiraterone acetate|abiraterone acetate
1251662|NCT01798628|Pharmacokinetics|pharmacokinetics
1251663|NCT01798602|H1N1|h1n1
1251664|NCT01798602|Rosuvastatin|rosuvastatin
1251665|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
1251666|NCT01798563|Parkinson|parkinson
1251667|NCT01798563|Parkinson Disease|parkinson disease
1251668|NCT01798550|Enoxaparin dosing|enoxaparin dosing
1251669|NCT01798550|Obesity|obesity
1251670|NCT01798524|Transplant|transplant
1251671|NCT01798524|Kidney|kidney
1251672|NCT01798524|England|england
1251673|NCT01798511|enteral nutrition|enteral nutrition
1251674|NCT01798511|acute pancreatitis|acute pancreatitis
1251675|NCT01798511|oral food intolerance|oral food intolerance
1251676|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
1251677|NCT01798472|treatment|treatment
1251678|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
1251679|NCT01798472|cemented arthroplasty|cemented arthroplasty
1251680|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1251681|NCT01798459|Methylphenidate|methylphenidate
1251682|NCT01798459|Placebo|placebo
1251683|NCT01798459|State anxiety|state anxiety
1251684|NCT01798446|Renal cell carcinoma|renal cell carcinoma
1251685|NCT01798446|Nonclear cell|nonclear cell
1251686|NCT01798446|Temsirolimus resistance|temsirolimus resistance
1251687|NCT01798433|Angioplasty|angioplasty
1251688|NCT01798433|Transluminal|transluminal
1251689|NCT01798433|Percutaneous Coronary|percutaneous coronary
1251690|NCT01798420|COPD|copd
1251691|NCT01798420|Diabetes|diabetes
1251692|NCT01798420|steroids|steroids
1251693|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
1251694|NCT01798407|Deep Brain Stimulation|deep brain stimulation
1251695|NCT01798407|Major Depressive Disorder|major depressive disorder
1251696|NCT01798407|Depression|depression
1251697|NCT01798407|Lateral Habenula|lateral habenula
1251698|NCT01798407|Intractable Depression|intractable depression
1251699|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
1251700|NCT01798394|pregnant|pregnant
1251701|NCT01798394|smoker|smoker
1251702|NCT01798394|cigarette|cigarette
1251703|NCT01798394|tobacco|tobacco
1251704|NCT01798355|Dental Fear|dental fear
1251705|NCT01798355|Dental Phobia|dental phobia
1251706|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
1251707|NCT01798355|Specific Phobia|specific phobia
1251803|NCT01797900|NPC|npc
1251708|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
1251709|NCT01798355|Self Efficacy|self efficacy
1251710|NCT01798342|preoperative care|preoperative care
1251711|NCT01798342|maltodextrine|maltodextrine
1251712|NCT01798342|glutamine|glutamine
1251713|NCT01798342|gastric residual volume|gastric residual volume
1251714|NCT01798342|MRI|mri
1251715|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
1251716|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
1251717|NCT01798329|portal vein thrombosis|portal vein thrombosis
1251718|NCT01798316|IV Acetaminophen|iv acetaminophen
1251719|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1251720|NCT01798316|Postoperative nausea|postoperative nausea
1251721|NCT01798316|Postoperative vomiting|postoperative vomiting
1251818|NCT01797835|intervention|intervention
1251722|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
1251723|NCT01798277|Ventricular tachycardia|ventricular tachycardia
1251724|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
1251725|NCT01798277|Ablation|ablation
1251726|NCT01798277|Coronary artery disease|coronary artery disease
1251727|NCT01798277|Ischemic heart disease|ischemic heart disease
1251728|NCT01798277|Amiodarone|amiodarone
1251729|NCT01798277|Sotalol|sotalol
1251730|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
1251731|NCT01798277|Therapeutic Uses|therapeutic uses
1251732|NCT01798277|Pharmacologic Actions|pharmacologic actions
1251733|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
1251734|NCT01798277|Atrial Fibrillation|atrial fibrillation
1251735|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
1251736|NCT01798277|Heart Diseases|heart diseases
1251737|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
1251738|NCT01798277|Pathologic Processes|pathologic processes
1251739|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1251740|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
1251741|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
1251742|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
1600130|NCT00393731|induction|induction
1251743|NCT01798225|Periodontal Disease|periodontal disease
1251744|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1251745|NCT01798225|Gullah African Americans|gullah african americans
1251746|NCT01798212|GERD|gerd
1251747|NCT01798199|Alzheimer|alzheimer
1251748|NCT01798199|virtual reality system|virtual reality system
1251749|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
1251750|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
1251751|NCT01798173|Cirrhosis|cirrhosis
1251752|NCT01798173|Environmental risk factors|environmental risk factors
1251753|NCT01798173|Nutrition|nutrition
1251754|NCT01798173|Metabolic syndrome|metabolic syndrome
1251755|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
1251756|NCT01798147|TACE|tace
1251757|NCT01798147|SIRT|sirt
1251758|NCT01798134|To show safety|to show safety
1251759|NCT01798134|and efficacy|and efficacy
1251760|NCT01798134|investigational product|investigational product
1251761|NCT01798121|PPD|ppd
1251762|NCT01798121|Tuberculosis|tuberculosis
1251763|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
1251764|NCT01798108|Radium-223|radium-223
1251765|NCT01798108|Radium-223 dichloride|radium-223 dichloride
1251766|NCT01798108|Alpharadin|alpharadin
1251767|NCT01798095|TB, Aplisol|tb, aplisol
1251768|NCT01798056|≥18 years of age|≥18 years of age
1251769|NCT01798056|Chemotherapy|chemotherapy
1251770|NCT01798056|Solid tumours|solid tumours
1251771|NCT01798056|Immunogenicity|immunogenicity
1251772|NCT01798056|Herpes Zoster|herpes zoster
1251773|NCT01798056|Safety|safety
1251774|NCT01798056|Shingles|shingles
1251775|NCT01798030|Vitamin D|vitamin d
1251776|NCT01798030|Diabetes|diabetes
1251777|NCT01798030|Osteoporosis|osteoporosis
1251778|NCT01798030|Cardiovascular Risk|cardiovascular risk
1251779|NCT01798017|menstrual regulation|menstrual regulation
1251780|NCT01798017|mifepristone|mifepristone
1251781|NCT01798017|misoprostol|misoprostol
1251782|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
1251783|NCT01797978|Sepsis|sepsis
1251784|NCT01797978|Septic shock|septic shock
1251785|NCT01797978|Methylene blue|methylene blue
1251786|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
1251787|NCT01797952|oral mucositis|oral mucositis
1251788|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1251789|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
1251790|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
1251791|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
1251792|NCT01797926|pharmacokinetics|pharmacokinetics
1251793|NCT01797926|Hypertension|hypertension
1251794|NCT01797926|losartan|losartan
1251795|NCT01797926|healthy volunteers|healthy volunteers
1251796|NCT01797926|amlodipine|amlodipine
1251797|NCT01797900|adjuvants|adjuvants
1251798|NCT01797900|inductive|inductive
1251799|NCT01797900|concurrent|concurrent
1251800|NCT01797900|chemoradiotherapy|chemoradiotherapy
1251801|NCT01797900|high-risk|high-risk
1251802|NCT01797900|locally advanced|locally advanced
1251804|NCT01797887|Burnout-Syndrome|burnout-syndrome
1251805|NCT01797887|Ayurveda|ayurveda
1251806|NCT01797887|Ayurvedic|ayurvedic
1251807|NCT01797887|Traditional Indian Medicine|traditional indian medicine
1251808|NCT01797887|CAM|cam
1251809|NCT01797887|Whole Medical System|whole medical system
1251810|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
1251811|NCT01797874|pazopanib maintenance|pazopanib maintenance
1251812|NCT01797874|efficacy|efficacy
1251813|NCT01797874|SCLC|sclc
1251814|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
1251815|NCT01797861|photodynamic therapy|photodynamic therapy
1251816|NCT01797861|micropulse laser|micropulse laser
1251817|NCT01797835|adolescents|adolescents
1251819|NCT01797835|motivational interviewing|motivational interviewing
1251820|NCT01797835|alcohol and drug use|alcohol and drug use
1251821|NCT01797783|Myopia|myopia
1251822|NCT01797783|Presbyopia|presbyopia
1251823|NCT01797783|Refractive error|refractive error
1251824|NCT01797783|Contact lenses|contact lenses
1251825|NCT01797783|Multifocal|multifocal
1251826|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
1251827|NCT01797770|Colon Cancer|colon cancer
1251828|NCT01797757|EPA|epa
1251829|NCT01797757|LC-PUFA|lc-pufa
1251830|NCT01797757|Orlistat|orlistat
1251831|NCT01797757|Obesity|obesity
1251832|NCT01797744|Stroke|stroke
1251833|NCT01797744|Dizziness|dizziness
1251834|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
1251835|NCT01797744|Balance|balance
1251836|NCT01797731|Orthalign|orthalign
1251837|NCT01797731|KneeAlign|kneealign
1251838|NCT01797731|Total Knee Replacement|total knee replacement
1251839|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
1251840|NCT01797731|Degenerative joint disease|degenerative joint disease
1251841|NCT01797731|Osteoarthritis|osteoarthritis
1251842|NCT01797731|Unilateral|unilateral
1251843|NCT01797718|Puberty|puberty
1251844|NCT01797718|Constitutional|constitutional
1251845|NCT01797718|Delay|delay
1251846|NCT01797718|Letrozole|letrozole
1251847|NCT01797718|Testosterone|testosterone
1251848|NCT01797692|prostate cancer cured|prostate cancer cured
1251849|NCT01797692|aged patients|aged patients
1251850|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
1251851|NCT01797640|Tibia Fractures|tibia fractures
1251852|NCT01797640|Medial Fractures|medial fractures
1251853|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
1251854|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
1251855|NCT01797627|Ventricular Size|ventricular size
1251856|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
1251857|NCT01797627|Quality of Life|quality of life
1251858|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
1251859|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
1251860|NCT01797614|weaning|weaning
1251861|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
1251862|NCT01797588|Pain|pain
1251863|NCT01797588|Periarticular infiltration|periarticular infiltration
1251864|NCT01797588|Adductor canal block|adductor canal block
1251865|NCT01797588|Postoperative|postoperative
1251866|NCT01797575|Bipolar Disorder|bipolar disorder
1251867|NCT01797575|Mood Disorder|mood disorder
1251868|NCT01797575|Bipolar Depression|bipolar depression
1251869|NCT01797575|Mood Swings|mood swings
1251870|NCT01797562|Contact dermatitis|contact dermatitis
1251871|NCT01797562|Eczema|eczema
1251872|NCT01797549|Traumatic brain injury|traumatic brain injury
1251873|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
1251874|NCT01797523|Endometrial cancer|endometrial cancer
1251875|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
1251876|NCT01797523|Metformin|metformin
1251877|NCT01797523|Letrozole|letrozole
1251878|NCT01797523|Femara|femara
1251879|NCT01797523|Everolimus|everolimus
1251880|NCT01797523|Afinitor|afinitor
1251881|NCT01797523|Zortress|zortress
1251882|NCT01797523|RAD001|rad001
1251883|NCT01797497|Parents|parents
1251884|NCT01797497|Primary Care Providers|primary care providers
1251885|NCT01797497|Specialists|specialists
1251886|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
1251887|NCT01797497|Referral|referral
1251888|NCT01797497|Health Outcomes|health outcomes
1251889|NCT01797497|Self-Efficacy|self-efficacy
1251890|NCT01797497|Communication|communication
1251891|NCT01797484|ischemia|ischemia
1251892|NCT01797484|myocardium|myocardium
1251893|NCT01797484|Ranolazine|ranolazine
1251894|NCT01797484|dyskinesia|dyskinesia
1251895|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
1251896|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
1251897|NCT01797471|NSCLC|nsclc
1251898|NCT01797471|Lung Cancer|lung cancer
1251899|NCT01797458|Class II carious primary molar|class ii carious primary molar
1251900|NCT01797458|Non-Restorative Caries Treatment|non-restorative caries treatment
1251901|NCT01797458|Hall Technique|hall technique
1251902|NCT01797458|Conventional restorations|conventional restorations
1251903|NCT01797458|Children|children
1251904|NCT01797445|HIV|hiv
1251905|NCT01797445|Treatment Naive|treatment naive
1251906|NCT01797445|HIV 1 Infected|hiv 1 infected
1251907|NCT01797445|Women|women
1251908|NCT01797445|Female|female
1251909|NCT01797419|Respiratory|respiratory
1251910|NCT01797419|Syncytial|syncytial
1251911|NCT01797419|Virus|virus
1251912|NCT01797419|RSV|rsv
1251913|NCT01797380|Depression|depression
1251914|NCT01797380|HIV|hiv
1251915|NCT01797367|HIV|hiv
1251916|NCT01797367|COPD|copd
1251917|NCT01797367|FEV1|fev1
1251918|NCT01797367|respiratory function|respiratory function
1251919|NCT01797354|patients at the end of treatment|patients at the end of treatment
1251920|NCT01797341|Renal Transplantation|renal transplantation
1252122|NCT01796470|GS-1101|gs-1101
1251921|NCT01797341|Kidney transplantation|kidney transplantation
1251922|NCT01797341|Pancreas Transplantation|pancreas transplantation
1251923|NCT01797341|Tacrolimus|tacrolimus
1251924|NCT01797341|Advagraf|advagraf
1251925|NCT01797341|Prograf|prograf
1251926|NCT01797341|Drug Adherence|drug adherence
1251927|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
1251928|NCT01797302|Obesity|obesity
1251929|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
1251930|NCT01797302|Vascular Function|vascular function
1251931|NCT01797302|Insulin resistance|insulin resistance
1251932|NCT01797302|metabolic syndrome|metabolic syndrome
1251933|NCT01797289|syncope|syncope
1251934|NCT01797289|pulmonary embolism|pulmonary embolism
1251935|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
1251936|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
1251937|NCT01797276|acidosis|acidosis
1251938|NCT01797276|orphan disease|orphan disease
1251939|NCT01797263|fibromyalgia|fibromyalgia
1251940|NCT01797263|yoga|yoga
1251941|NCT01797263|exercise|exercise
1251942|NCT01797263|pain|pain
1251943|NCT01797237|surgery|surgery
1251944|NCT01797237|fixation|fixation
1600131|NCT00393731|misoprostol|misoprostol
1251945|NCT01797237|intramedullary nail|intramedullary nail
1251946|NCT01797224|Autoimmune disease|autoimmune disease
1251947|NCT01797224|certolizumab pegol|certolizumab pegol
1251948|NCT01797224|Cimzia|cimzia
1251949|NCT01797224|pregnancy|pregnancy
1251950|NCT01797224|birth defect|birth defect
1251951|NCT01797224|birth outcome|birth outcome
1251952|NCT01797224|TNF|tnf
1251953|NCT01797224|Tumor necrosis factor|tumor necrosis factor
1251954|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
1251955|NCT01797198|Phase I|phase i
1251956|NCT01797198|ASP3652|asp3652
1251957|NCT01797198|Gemfibrozil|gemfibrozil
1251958|NCT01797198|Repaglinide|repaglinide
1251959|NCT01797198|Pharmacokinetics|pharmacokinetics
1251960|NCT01797185|baclofen, spasticity|baclofen, spasticity
1251961|NCT01797172|nucleoplasty|nucleoplasty
1251962|NCT01797172|pulsed radio frequency|pulsed radio frequency
1251963|NCT01797172|herniated disc|herniated disc
1251964|NCT01797172|cervical|cervical
1251965|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
1251966|NCT01797172|cervical radiculopathy|cervical radiculopathy
1251967|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1251968|NCT01797159|PCI|pci
1251969|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
1251970|NCT01797120|Post-Menopausal Patients|post-menopausal patients
1251971|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
1251972|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
1251973|NCT01797120|Fulvestrant|fulvestrant
1251974|NCT01797120|Faslodex|faslodex
1251975|NCT01797120|mTOR Inhibitor|mtor inhibitor
1251976|NCT01797120|Everolimus|everolimus
1251977|NCT01797120|RAD001|rad001
1251978|NCT01797120|Afinitor|afinitor
1251979|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
1251980|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
1251981|NCT01797068|ED UTILIZATION|ed utilization
1251982|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
1251983|NCT01797068|PATIENT NAVIGATION|patient navigation
1251984|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
1251985|NCT01797068|HEALTH DISPARITIES|health disparities
1251986|NCT01797055|transferrin|transferrin
1251987|NCT01797055|anemia|anemia
1251988|NCT01797055|iron overload|iron overload
1251989|NCT01797042|Fructose|fructose
1251990|NCT01797042|High fructose corn syrup|high fructose corn syrup
1251991|NCT01797042|Energy regulation|energy regulation
1251992|NCT01797042|Ectopic fat|ectopic fat
1251993|NCT01797042|Understanding|understanding
1251994|NCT01797042|potential|potential
1251995|NCT01797016|Myocardial Infarction|myocardial infarction
1251996|NCT01797016|flow cytometry|flow cytometry
1251997|NCT01797016|Blood Cell Count|blood cell count
1251998|NCT01797016|Platelet Activation|platelet activation
1251999|NCT01797003|osteoarthritis|osteoarthritis
1252000|NCT01797003|osteotomy|osteotomy
1252001|NCT01797003|closing|closing
1252002|NCT01797003|opening|opening
1252003|NCT01797003|wedge|wedge
1252004|NCT01797003|kne|kne
1252005|NCT01797003|tibia|tibia
1252006|NCT01796990|physical activity|physical activity
1252007|NCT01796990|psychological well-being|psychological well-being
1252107|NCT01796496|Low back pain.|low back pain.
1252008|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
1252009|NCT01796990|adults|adults
1252010|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
1252011|NCT01796977|NSM|nsm
1252012|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
1252013|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
1252014|NCT01796964|Wet|wet
1252015|NCT01796964|Exudative|exudative
1252016|NCT01796964|AMD|amd
1252017|NCT01796964|Intravitreal injection|intravitreal injection
1252018|NCT01796964|Retina|retina
1252019|NCT01796938|Lacosamide|lacosamide
1252020|NCT01796938|Vimpat|vimpat
1252021|NCT01796938|Single Dose|single dose
1252022|NCT01796938|Pharmacokinetics|pharmacokinetics
1252023|NCT01796938|Renal Impairment|renal impairment
1252024|NCT01796925|Apnea|apnea
1252025|NCT01796925|Respiration Disorders|respiration disorders
1252026|NCT01796925|Signs and Symptoms|signs and symptoms
1252027|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
1252028|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
1252029|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
1252030|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
1252031|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1252032|NCT01796925|Sleep Disorders|sleep disorders
1252033|NCT01796925|Nervous System Diseases|nervous system diseases
1252034|NCT01796899|Healthy Volunteers|healthy volunteers
1252035|NCT01796899|Brivaracetam|brivaracetam
1252036|NCT01796873|Female|female
1252037|NCT01796873|Hispanic|hispanic
1252038|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
1252039|NCT01796860|Gait|gait
1252040|NCT01796860|AFO|afo
1252041|NCT01796860|MS|ms
1252042|NCT01796847|ICU|icu
1252043|NCT01796847|Hyperglycemia|hyperglycemia
1252044|NCT01796847|Length of stay|length of stay
1252045|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1252046|NCT01796834|Diabetes Management|diabetes management
1252047|NCT01796834|Stress Reduction|stress reduction
1252048|NCT01796834|Diabetes Testing|diabetes testing
1252049|NCT01796821|Condyloma acuminata|condyloma acuminata
1252050|NCT01796821|Genital warts|genital warts
1252051|NCT01796821|Condylomata acuminata|condylomata acuminata
1252052|NCT01796821|Venereal warts|venereal warts
1252053|NCT01796808|pedal|pedal
1252054|NCT01796808|atrophy|atrophy
1252055|NCT01796808|fat grafting|fat grafting
1252056|NCT01796808|adipose tissue|adipose tissue
1252057|NCT01796795|common wart|common wart
1252058|NCT01796795|verruca vulgaris|verruca vulgaris
1252059|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1252060|NCT01796769|Telemedicine|telemedicine
1252061|NCT01796769|Patient Compliance|patient compliance
1252062|NCT01796756|Handover|handover
1252063|NCT01796756|Handoff|handoff
1252064|NCT01796756|Signout|signout
1252065|NCT01796756|Quality Improvement|quality improvement
1252066|NCT01796756|General Internal Medicine|general internal medicine
1252067|NCT01796743|MRI|mri
1252068|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
1252069|NCT01796743|Heart failure risk stratification|heart failure risk stratification
1252070|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
1252071|NCT01796730|efficacy|efficacy
1252072|NCT01796730|safety|safety
1252073|NCT01796730|Bambuterol tablets|bambuterol tablets
1252074|NCT01796730|COPD|copd
1252075|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
1252076|NCT01796717|MIC|mic
1252077|NCT01796704|functional capacity|functional capacity
1252078|NCT01796704|NYHA class|nyha class
1252079|NCT01796691|Clopidogrel|clopidogrel
1252080|NCT01796691|aspirin|aspirin
1252081|NCT01796691|low response|low response
1252082|NCT01796691|platelet aggregation|platelet aggregation
1252083|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
1252084|NCT01796691|Coronary Stent Implantation|coronary stent implantation
1252085|NCT01796678|sickle cell disease|sickle cell disease
1252086|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
1252087|NCT01796678|arginine|arginine
1252088|NCT01796678|nitric oxide|nitric oxide
1252089|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
1252090|NCT01796652|Home therapy|home therapy
1252091|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
1252092|NCT01796574|status epilepticus|status epilepticus
1252093|NCT01796574|seizure|seizure
1252094|NCT01796574|epilepsy|epilepsy
1252095|NCT01796574|ketogenic diet|ketogenic diet
1252096|NCT01796574|modified Atkins diet|modified atkins diet
1252097|NCT01796548|Detrusor function, overactive|detrusor function, overactive
1252098|NCT01796548|Urinary incontinence|urinary incontinence
1252099|NCT01796548|Oxybutynin|oxybutynin
1252100|NCT01796548|Lyrinel|lyrinel
1252101|NCT01796509|Quality of life,|quality of life,
1252102|NCT01796509|Sequela disorders,|sequela disorders,
1252103|NCT01796509|Socio-professional impact,|socio-professional impact,
1252104|NCT01796509|Anxiety, depression,|anxiety, depression,
1252105|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
1252106|NCT01796509|ICU acquired paresis.|icu acquired paresis.
1252108|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
1252109|NCT01796496|Randomized controlled trial.|randomized controlled trial.
1252110|NCT01796496|Chronic pain.|chronic pain.
1252111|NCT01796483|Parkinson disease|parkinson disease
1252112|NCT01796483|STN-DBS|stn-dbs
1252113|NCT01796483|Impulsivity|impulsivity
1252114|NCT01796483|Akinesia|akinesia
1252115|NCT01796483|Noradrenergic|noradrenergic
1252116|NCT01796483|system|system
1252117|NCT01796470|GS-US-339-0103|gs-us-339-0103
1252118|NCT01796470|SYK inhibitor|syk inhibitor
1252119|NCT01796470|PI3K inhibitor|pi3k inhibitor
1252120|NCT01796470|GS-9973|gs-9973
1252121|NCT01796470|GS 9973|gs 9973
1252123|NCT01796470|GS 1101|gs 1101
1252124|NCT01796470|Cal-101|cal-101
1252125|NCT01796470|Cal 101|cal 101
1252126|NCT01796470|idelalisib|idelalisib
1252127|NCT01796470|leukemia|leukemia
1252128|NCT01796470|lymphoma|lymphoma
1252129|NCT01796470|CLL|cll
1252130|NCT01796470|MCL|mcl
1252131|NCT01796470|DLBCL|dlbcl
1252132|NCT01796470|iNHL|inhl
1252133|NCT01796470|FL|fl
1252134|NCT01796470|MZL|mzl
1252135|NCT01796470|LPL|lpl
1252136|NCT01796470|SLL|sll
1252137|NCT01796470|WM|wm
1252138|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
1252139|NCT01796457|Hepatitis B|hepatitis b
1252140|NCT01796457|Immunology|immunology
1252141|NCT01796457|HBV|hbv
1252142|NCT01796457|Immune tolerant|immune tolerant
1252143|NCT01796457|Immune active|immune active
1252144|NCT01796444|Breast Cancer|breast cancer
1252145|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1333266|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
1252146|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
1252147|NCT01796392|emphysema|emphysema
1252148|NCT01796392|endobronchial valve|endobronchial valve
1252149|NCT01796392|treatments|treatments
1252150|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
1252151|NCT01796392|lung volume reduction|lung volume reduction
1252152|NCT01796353|heart disease|heart disease
1252153|NCT01796353|sexual dysfunction|sexual dysfunction
1252154|NCT01796353|exercise test|exercise test
1252155|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
1252156|NCT01796353|complex intervention|complex intervention
1252157|NCT01796340|cue exposure|cue exposure
1252158|NCT01796340|childhood|childhood
1252159|NCT01796340|overeating|overeating
1252160|NCT01796340|overweight|overweight
1252161|NCT01796340|obese|obese
1252162|NCT01796340|treatment|treatment
1252163|NCT01796327|dacomitinib|dacomitinib
1252164|NCT01796327|PF-00299804|pf-00299804
1252165|NCT01796327|pharmacokinetics|pharmacokinetics
1252166|NCT01796327|bioavailability|bioavailability
1252289|NCT01795729|Heart transplant|heart transplant
1252167|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
1252168|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
1252169|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
1252170|NCT01796314|quality of life|quality of life
1252171|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1252172|NCT01796288|NSCLC|nsclc
1252173|NCT01796288|oligometastatic|oligometastatic
1252174|NCT01796288|second-line|second-line
1252175|NCT01796288|Radiotherapy|radiotherapy
1252176|NCT01796288|Erlotinib|erlotinib
1252177|NCT01796262|ADHD|adhd
1252178|NCT01796262|DHA|dha
1252179|NCT01796262|neuropsychological task|neuropsychological task
1252180|NCT01796262|fNIRS|fnirs
1252181|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
1252182|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
1252183|NCT01796262|cognition|cognition
1252184|NCT01796262|behavior|behavior
1252185|NCT01796249|Analgesia Nociception Index|analgesia nociception index
1252186|NCT01796249|ANI|ani
1252187|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
1252188|NCT01796236|Bone anchored implant|bone anchored implant
1252189|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
1252190|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
1252191|NCT01796236|Holgers Index|holgers index
1252192|NCT01796236|Implant stability|implant stability
1252193|NCT01796223|Community mental health services|community mental health services
1252194|NCT01796223|Psychotherapy|psychotherapy
1252195|NCT01796223|Physician-Patient Relations|physician-patient relations
1252196|NCT01796223|Norway|norway
1252197|NCT01796210|Analgesia/nociception index|analgesia/nociception index
1252198|NCT01796210|Bispectral index|bispectral index
1252199|NCT01796210|Propofol|propofol
1252200|NCT01796210|Remifentanil|remifentanil
1252201|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
1252202|NCT01796210|Endoscopy|endoscopy
1252203|NCT01796210|Ear-nose-throat|ear-nose-throat
1252204|NCT01796184|Inflammation|inflammation
1252205|NCT01796184|Glycation|glycation
1252206|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
1252207|NCT01796184|Adult population|adult population
1252208|NCT01796171|Radioimmunotherapy|radioimmunotherapy
1252209|NCT01796171|Lu-177|lu-177
1252210|NCT01796171|Phase I study|phase i study
1252211|NCT01796171|Phase II study|phase ii study
1252212|NCT01796171|Betalutin|betalutin
1252213|NCT01796158|adolescents|adolescents
1252214|NCT01796158|alcohol abuse|alcohol abuse
1252215|NCT01796158|drug abuse|drug abuse
1252216|NCT01796158|substance use|substance use
1252217|NCT01796132|Depression|depression
1252218|NCT01796132|Lactation|lactation
1252219|NCT01796132|Breastfeeding|breastfeeding
1252220|NCT01796132|Pharmacokinetics|pharmacokinetics
1252221|NCT01796132|Antidepressant|antidepressant
1252222|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
1252223|NCT01796106|caries infiltration|caries infiltration
1252224|NCT01796106|caries progression|caries progression
1252225|NCT01796106|Icon|icon
1252226|NCT01796093|Digoxin|digoxin
1252227|NCT01796093|Ivabradine|ivabradine
1252228|NCT01796093|Cardiac failure|cardiac failure
1252229|NCT01796093|Economics|economics
1252230|NCT01796067|Motivational intervention|motivational intervention
1252231|NCT01796067|Positive Parenting Intervention|positive parenting intervention
1252232|NCT01796067|Obesity|obesity
1252233|NCT01796067|Physical Activity|physical activity
1252234|NCT01796067|Diet|diet
1252235|NCT01796067|African American|african american
1252236|NCT01796067|Adolescent|adolescent
1252237|NCT01796054|Perceived stress|perceived stress
1252238|NCT01796054|Burnout|burnout
1252239|NCT01796054|Mindfulness|mindfulness
1252240|NCT01796054|Intent to leave nursing|intent to leave nursing
1252241|NCT01796028|Prostate Cancer|prostate cancer
1252242|NCT01796015|paediatrics|paediatrics
1342532|NCT01407393|obesity|obesity
1252243|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
1252244|NCT01796015|ultrasound|ultrasound
1252245|NCT01796002|PTCL|ptcl
1252246|NCT01795989|Coil|coil
1252247|NCT01795989|MRI|mri
1252248|NCT01795989|safety|safety
1252249|NCT01795989|efficacy|efficacy
1252250|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
1252251|NCT01795989|Cincinnati|cincinnati
1252252|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
1252253|NCT01795976|Oesophageal cancer|oesophageal cancer
1252254|NCT01795963|intimate partner violence|intimate partner violence
1252255|NCT01795950|cell therapy|cell therapy
1252256|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
1252257|NCT01795898|Osteoarthritis|osteoarthritis
1252258|NCT01795898|Low back pain|low back pain
1252259|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
1252260|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
1252261|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
1252262|NCT01795885|Contraception|contraception
1252263|NCT01795859|Huntington disease|huntington disease
1252264|NCT01795859|Chorea|chorea
1252265|NCT01795859|Tetrabenazine|tetrabenazine
1252266|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
1252267|NCT01795833|Prediabetes|prediabetes
1252268|NCT01795833|Prediabetic State|prediabetic state
1252269|NCT01795820|ticagrelor|ticagrelor
1252270|NCT01795820|clopidogrel|clopidogrel
1252271|NCT01795820|platelet aggregation|platelet aggregation
1252272|NCT01795781|Anticoagulant measurement|anticoagulant measurement
1252273|NCT01795781|Anticoagulant reversal|anticoagulant reversal
1252274|NCT01795781|Dabigatran|dabigatran
1252275|NCT01795781|Rivaroxaban|rivaroxaban
1252276|NCT01795768|Non randomised|non randomised
1252277|NCT01795768|Open label|open label
1252278|NCT01795768|Multicentre|multicentre
1252279|NCT01795768|Phase II biomarker study|phase ii biomarker study
1252280|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
1252281|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
1252282|NCT01795755|clinical trial|clinical trial
1252283|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
1252284|NCT01795755|psychotherapy|psychotherapy
1252285|NCT01795742|Asthma|asthma
1252286|NCT01795742|Nebulizers|nebulizers
1252287|NCT01795742|Salbutamol|salbutamol
1252288|NCT01795742|Developing Countries|developing countries
1252290|NCT01795729|Coronary artery disease|coronary artery disease
1252291|NCT01795729|Allograft vascular disease|allograft vascular disease
1252292|NCT01795729|Coronary stent|coronary stent
1252293|NCT01795729|Optimal medical therapy|optimal medical therapy
1252294|NCT01795729|Prognosis|prognosis
1252295|NCT01795703|Prostate Cancer|prostate cancer
1252296|NCT01795703|Abiraterone Acetate|abiraterone acetate
1252297|NCT01795703|JNJ-212082|jnj-212082
1252298|NCT01795690|Anemia|anemia
1252299|NCT01795690|Cancer|cancer
1252300|NCT01795690|Hemoglobin|hemoglobin
1252301|NCT01795690|Quality of Life|quality of life
1252302|NCT01795690|FACT-An|fact-an
1252303|NCT01795690|FACT-GP|fact-gp
1252304|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
1252305|NCT01795690|Epoetin|epoetin
1252306|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
1252307|NCT01795690|Blood Transfusions|blood transfusions
1252308|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
1252412|NCT01795235|men|men
1252309|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
1252310|NCT01795664|Asthma|asthma
1252311|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
1252312|NCT01795664|Seretide Evohaler|seretide evohaler
1252313|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
1252314|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
1252315|NCT01795651|teaching|teaching
1252316|NCT01795651|knowledge translation|knowledge translation
1252317|NCT01795651|ICU|icu
1252318|NCT01795651|postgraduate|postgraduate
1252319|NCT01795651|lecture|lecture
1252320|NCT01795638|anthropometrics|anthropometrics
1252321|NCT01795638|weight|weight
1252322|NCT01795638|nutrition|nutrition
1252323|NCT01795586|breast - female|breast - female
1252324|NCT01795586|advanced breast cancer|advanced breast cancer
1252325|NCT01795586|histologically confirmed|histologically confirmed
1252326|NCT01795586|cytologically confirmed|cytologically confirmed
1252327|NCT01795586|metastatic|metastatic
1252328|NCT01795586|locally advanced|locally advanced
1252329|NCT01795586|unresectable|unresectable
1252330|NCT01795573|GVHD|gvhd
1252331|NCT01795573|AML|aml
1252332|NCT01795573|ALL|all
1252333|NCT01795573|MDS|mds
1252334|NCT01795573|CLL|cll
1252335|NCT01795573|NHL|nhl
1252336|NCT01795573|HL|hl
1252337|NCT01795573|MM|mm
1252338|NCT01795560|Periappendicular abscess|periappendicular abscess
1252339|NCT01795560|Ultrasound|ultrasound
1252340|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
1252341|NCT01795508|Parent training|parent training
1252342|NCT01795508|Child behavior|child behavior
1252343|NCT01795508|Randomized Controlled Trials|randomized controlled trials
1252344|NCT01795495|Spinal Fusion|spinal fusion
1252345|NCT01795495|Scoliosis|scoliosis
1252346|NCT01795495|Methadone|methadone
1252347|NCT01795495|Magnesium|magnesium
1252348|NCT01795495|Adolescents|adolescents
1252349|NCT01795495|Back Surgery|back surgery
1252350|NCT01795482|perioperative hypothermia|perioperative hypothermia
1252351|NCT01795482|prewarming|prewarming
1252352|NCT01795482|preoperative warming|preoperative warming
1252353|NCT01795482|general anaesthesia|general anaesthesia
1252354|NCT01795482|epidural anaesthesia|epidural anaesthesia
1252355|NCT01795482|temperature measurement|temperature measurement
1252356|NCT01795469|POTS|pots
1252357|NCT01795469|Orthostatic|orthostatic
1252358|NCT01795469|Adolescent|adolescent
1252359|NCT01795456|Takayasu's arteritis|takayasu's arteritis
1252360|NCT01795456|Giant Cell arteritis|giant cell arteritis
1252361|NCT01795456|Arteritis|arteritis
1252362|NCT01795456|Vasculitis|vasculitis
1252363|NCT01795456|Aortitis|aortitis
1252364|NCT01795456|Disease Activity|disease activity
1252365|NCT01795456|Carotidynia|carotidynia
1252366|NCT01795456|Neovascularization|neovascularization
1252367|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
1252368|NCT01795443|vibration|vibration
1252369|NCT01795443|proprioception|proprioception
1252370|NCT01795417|wrinkles|wrinkles
1252371|NCT01795417|rhytids|rhytids
1252372|NCT01795417|periorbital|periorbital
1252373|NCT01795404|IBSR|ibsr
1252374|NCT01795404|Cancer Survivors|cancer survivors
1252375|NCT01795404|Katie Byron|katie byron
1252376|NCT01795404|Quality of Life|quality of life
1252377|NCT01795404|Stress|stress
1252378|NCT01795404|Stress reduction|stress reduction
1252379|NCT01795391|Prevention|prevention
1252380|NCT01795391|Dressings|dressings
1252381|NCT01795391|Catheters|catheters
1252382|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
1252383|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1252384|NCT01795378|donor natural killer cells|donor natural killer cells
1252385|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
1252386|NCT01795352|EGFR,|egfr,
1252387|NCT01795352|lung cancer,|lung cancer,
1252388|NCT01795352|mutated|mutated
1252389|NCT01795339|AZD3293|azd3293
1252390|NCT01795339|Healthy volunteers|healthy volunteers
1252391|NCT01795339|Elderly volunteers|elderly volunteers
1252392|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
1252393|NCT01795339|AD patients|ad patients
1252394|NCT01795339|Phase 1|phase 1
1252395|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
1252396|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
1252397|NCT01795326|Metabolic monitoring|metabolic monitoring
1252398|NCT01795326|Seroquel®|seroquel®
1252399|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
1252400|NCT01795287|tibial fracture|tibial fracture
1252401|NCT01795287|intramedullary nailing|intramedullary nailing
1252402|NCT01795287|spinal anesthesia|spinal anesthesia
1252403|NCT01795287|patient safety|patient safety
1252404|NCT01795261|HIV|hiv
1252405|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
1252406|NCT01795248|incretin|incretin
1252407|NCT01795248|glucose homeostasis|glucose homeostasis
1252408|NCT01795248|GLP-1|glp-1
1252409|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
1252410|NCT01795248|liraglutide|liraglutide
1252411|NCT01795248|Victoza|victoza
1252413|NCT01795222|conscious sedation|conscious sedation
1252414|NCT01795222|stress psychological|stress psychological
1252415|NCT01795222|dental care for children|dental care for children
1252416|NCT01795222|child behavior|child behavior
1252417|NCT01795222|saliva|saliva
1252418|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
1252419|NCT01795209|Macular edema|macular edema
1252420|NCT01795209|Ranibizumab|ranibizumab
1252421|NCT01795196|pediatric extubation failure|pediatric extubation failure
1252422|NCT01795196|weaning|weaning
1252423|NCT01795196|integrated pulmonary index|integrated pulmonary index
1252424|NCT01795196|mechanical ventilation|mechanical ventilation
1252425|NCT01795196|extubation readiness|extubation readiness
1252426|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
1252427|NCT01795196|Endotracheal Extubation|endotracheal extubation
1252428|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
1252429|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
1252430|NCT01795196|Physiologic Deadspace|physiologic deadspace
1252431|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
1252432|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
1252433|NCT01795170|Lysine Restricted Diet|lysine restricted diet
1252434|NCT01795157|decision support systems, clinical|decision support systems, clinical
1252435|NCT01795157|decision making, computer assisted|decision making, computer assisted
1252436|NCT01795157|evidence based practice|evidence based practice
1342822|NCT01406249|XP|xp
1252437|NCT01795157|practice guidelines as topic|practice guidelines as topic
1252438|NCT01795131|Nutritional anemia|nutritional anemia
1252439|NCT01795131|Vitamin B12|vitamin b12
1252440|NCT01795131|flu vaccine|flu vaccine
1252441|NCT01795131|immunity|immunity
1252442|NCT01795092|Cellulitis|cellulitis
1252443|NCT01795092|Outpatient Medicine|outpatient medicine
1252444|NCT01795079|transcranial stimulation|transcranial stimulation
1252445|NCT01795079|direct current|direct current
1252446|NCT01795053|ADHD preschoolers|adhd preschoolers
1252447|NCT01795053|playtraining|playtraining
1252448|NCT01795053|child-focused intervention|child-focused intervention
1252449|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
1252450|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
1252451|NCT01795040|randomized controlled trial|randomized controlled trial
1252452|NCT01795027|gastric cancer|gastric cancer
1252453|NCT01795027|chemotherapy|chemotherapy
1252454|NCT01795027|D2 resection|d2 resection
1252455|NCT01795027|S-1|s-1
1252456|NCT01795001|pathophysiology|pathophysiology
1252457|NCT01794988|Acute Pain|acute pain
1252458|NCT01794988|Low Back Pain|low back pain
1252459|NCT01794988|Back Pain|back pain
1252460|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1252461|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
1252462|NCT01794988|Pain Education|pain education
1252463|NCT01794975|PET|pet
1252464|NCT01794975|striatum|striatum
1252465|NCT01794975|receptor occupancy|receptor occupancy
1252466|NCT01794975|noradrenaline|noradrenaline
1252467|NCT01794975|alpha2c|alpha2c
1252468|NCT01794962|Classification|classification
1252469|NCT01794962|LBP|lbp
1252470|NCT01794962|Cognitive functional therapy|cognitive functional therapy
1252471|NCT01794962|Manual Therapy|manual therapy
1252472|NCT01794949|Angioplasty|angioplasty
1252473|NCT01794949|Atherosclerosis|atherosclerosis
1252474|NCT01794949|Wound Healing|wound healing
1252475|NCT01794936|Prostate cancer|prostate cancer
1252476|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
1252477|NCT01794936|VTI Probe|vti probe
1252478|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
1252479|NCT01794923|ibuprofen|ibuprofen
1252480|NCT01794923|topical|topical
1252481|NCT01794910|Pregnancy|pregnancy
1252482|NCT01794910|Pelvic Floor|pelvic floor
1252483|NCT01794910|Muscle strength|muscle strength
1252484|NCT01794910|Exercise therapy|exercise therapy
1252485|NCT01794910|natural childbirth|natural childbirth
1252486|NCT01794910|cesarean section|cesarean section
1252487|NCT01794910|physiotherapy|physiotherapy
1252488|NCT01794884|Glutamine|glutamine
1252489|NCT01794884|Cardiosurgery|cardiosurgery
1252490|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
1252491|NCT01794884|Cardiac function|cardiac function
1252492|NCT01794884|Recovery|recovery
1252493|NCT01794845|SCCHN|scchn
1252494|NCT01794845|Head and Neck Cancer|head and neck cancer
1252495|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
1252496|NCT01794845|Recurrent|recurrent
1252497|NCT01794832|HRQoL|hrqol
1252498|NCT01794832|Aortic stenosis|aortic stenosis
1252499|NCT01794832|Aortic valve surgery|aortic valve surgery
1252500|NCT01794819|antibiotics|antibiotics
1252501|NCT01794819|primary care|primary care
1252502|NCT01794819|radiology/radiography|radiology/radiography
1252503|NCT01794819|respiratory tract infections|respiratory tract infections
1252504|NCT01794793|SOM230,|som230,
1252505|NCT01794793|roll-over study|roll-over study
1252506|NCT01794793|pasireotide LAR|pasireotide lar
1252507|NCT01794793|Cushing's disease|cushing's disease
1252508|NCT01794793|Acromegaly|acromegaly
1252509|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
1252510|NCT01794793|pituitary tumors|pituitary tumors
1252511|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
1252512|NCT01794793|EAS|eas
1252513|NCT01794793|Dumping Syndrome|dumping syndrome
1252514|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
1252515|NCT01794793|bRAF|braf
1252516|NCT01794793|nRAS|nras
1252517|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
1252518|NCT01794754|Hand osteoarthritis|hand osteoarthritis
1252519|NCT01794754|CMC1-joint|cmc1-joint
1252520|NCT01794754|surgery|surgery
1253202|NCT01791673|Glaucoma|glaucoma
1252521|NCT01794754|occupational therapy|occupational therapy
1252522|NCT01794754|hand exercises|hand exercises
1252523|NCT01794754|assistive devices|assistive devices
1252524|NCT01794754|orthoses|orthoses
1252525|NCT01794728|Pain Management|pain management
1252526|NCT01794715|Heart failure|heart failure
1252527|NCT01794715|Nurse led|nurse led
1252528|NCT01794715|Outpatient clinic|outpatient clinic
1252529|NCT01794715|Echocardiography|echocardiography
1252530|NCT01794715|Pocket-size|pocket-size
1252531|NCT01794715|Ultrasound|ultrasound
1252532|NCT01794702|Leukemia|leukemia
1252533|NCT01794702|Acute Leukemia|acute leukemia
1252534|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
1252535|NCT01794702|AML|aml
1252536|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1252537|NCT01794702|ALL|all
1252538|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
1252539|NCT01794702|MTD|mtd
1252540|NCT01794702|Response Rate|response rate
1252541|NCT01794702|Decitabine|decitabine
1252542|NCT01794702|Dacogen|dacogen
1252543|NCT01794702|Idarubicin|idarubicin
1252544|NCT01794702|Idamycin|idamycin
1252545|NCT01794702|Cytarabine|cytarabine
1252546|NCT01794702|Ara-C|ara-c
1252547|NCT01794702|Cytosar|cytosar
1252548|NCT01794702|DepoCyt|depocyt
1252549|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1252550|NCT01794676|Pancreatic cancer|pancreatic cancer
1252551|NCT01794676|Thymic cancer|thymic cancer
1252552|NCT01794676|Parathyroid disease|parathyroid disease
1252553|NCT01794676|MEN1 syndrome|men1 syndrome
1252554|NCT01794676|Genomic DNA|genomic dna
1252555|NCT01794676|MEN1 gene sequence|men1 gene sequence
1252556|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
1252557|NCT01794663|renal transplantation|renal transplantation
1252558|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
1252559|NCT01794637|End stage liver disease|end stage liver disease
1252560|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
1252561|NCT01794637|Liver transplantation|liver transplantation
1252562|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
1252563|NCT01794624|TMD|tmd
1252564|NCT01794624|TMJD|tmjd
1252565|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
1252566|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
1252567|NCT01794624|Pain Catastrophizing|pain catastrophizing
1252568|NCT01794624|Cognitive Therapy|cognitive therapy
1252569|NCT01794624|Behavioral Therapy|behavioral therapy
1252570|NCT01794598|Heart failure|heart failure
1252571|NCT01794598|depression|depression
1252572|NCT01794598|depression care education|depression care education
1252573|NCT01794585|traumatic brain injury|traumatic brain injury
1252574|NCT01794585|balance deficits|balance deficits
1252575|NCT01794585|virtual reality|virtual reality
1252576|NCT01794585|home-based therapy|home-based therapy
1252577|NCT01794572|Multiple Myeloma|multiple myeloma
1252578|NCT01794572|Relapse|relapse
1252579|NCT01794572|Complete Remission|complete remission
1252580|NCT01794572|Very Good Partial Remission|very good partial remission
1252581|NCT01794559|Depression, EEG, QEEG, mTBI, PTSD, efficiency, safety, suicidality|depression, eeg, qeeg, mtbi, ptsd, efficiency, safety, suicidality
1252582|NCT01794546|pediatric obesity|pediatric obesity
1252583|NCT01794546|telehealth|telehealth
1252584|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
1252585|NCT01794533|Infiltration injection|infiltration injection
1252586|NCT01794533|Fentanyl|fentanyl
1252587|NCT01794533|Lidocaine|lidocaine
1252588|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
1252589|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
1252590|NCT01794520|multiple myeloma|multiple myeloma
1252591|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
1252592|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
1252593|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
1252594|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
1252595|NCT01794507|multiple myeloma|multiple myeloma
1252596|NCT01794494|Peripheal arterial disease|peripheal arterial disease
1252597|NCT01794494|Critical limb ischemia|critical limb ischemia
1252598|NCT01794494|Bypass surgery|bypass surgery
1252599|NCT01794494|Subintimal angioplasty|subintimal angioplasty
1252600|NCT01794494|Health related cost|health related cost
1252601|NCT01794468|Dermal blood flow|dermal blood flow
1252602|NCT01794468|critically ill|critically ill
1252603|NCT01794455|Depression|depression
1252604|NCT01794455|Depressive Disorder|depressive disorder
1252605|NCT01794455|Geriatrics|geriatrics
1252606|NCT01794455|Hypertension|hypertension
1252607|NCT01794429|Obesity|obesity
1252795|NCT01793558|newborn|newborn
1252608|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
1252609|NCT01794429|Drug-induced adipositas|drug-induced adipositas
1252610|NCT01794429|Schizophrenia|schizophrenia
1252611|NCT01794429|GLP-1 analogue|glp-1 analogue
1252612|NCT01794429|cerebral effects|cerebral effects
1252613|NCT01794403|Prostate Cancer|prostate cancer
1252614|NCT01794403|Prostate|prostate
1252615|NCT01794403|Radiation Therapy|radiation therapy
1252616|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
1252617|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
1252618|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
1252619|NCT01794403|AHRT|ahrt
1252620|NCT01794403|EHRT|ehrt
1252621|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
1252622|NCT01794390|Asthma|asthma
1252623|NCT01794390|Pulmojet|pulmojet
1252624|NCT01794390|Inhalers|inhalers
1252625|NCT01794390|Respiratory|respiratory
1252626|NCT01794390|Inhaler Technique|inhaler technique
1252627|NCT01794390|Critical Errors|critical errors
1252628|NCT01794377|Obesity|obesity
1252629|NCT01794364|T2DM|t2dm
1252630|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
1252631|NCT01794325|Occupational radiation exposure|occupational radiation exposure
1252632|NCT01794325|Transradial approach|transradial approach
1252633|NCT01794325|Transfemoral approach|transfemoral approach
1252634|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1252635|NCT01794299|Graft-versus-host disease|graft-versus-host disease
1252636|NCT01794299|Immune reconstitution|immune reconstitution
1252637|NCT01794299|Alloreactive T-cells|alloreactive t-cells
1252638|NCT01794299|Photodepletion|photodepletion
1252639|NCT01794299|Photodynamic treatment|photodynamic treatment
1252640|NCT01794299|TH9402|th9402
1252641|NCT01794299|Transplant-related mortality|transplant-related mortality
1252642|NCT01794299|Hematologic malignancy|hematologic malignancy
1252643|NCT01794273|Ephedrine|ephedrine
1252644|NCT01794273|Phenylephrine|phenylephrine
1252645|NCT01794273|Vasopressor|vasopressor
1252646|NCT01794273|Carotid surgery|carotid surgery
1252647|NCT01794273|Hypotension|hypotension
1252648|NCT01794273|Haemodynamics|haemodynamics
1252649|NCT01794273|Brain ischemia|brain ischemia
1252650|NCT01794273|Tissue perfusion|tissue perfusion
1252651|NCT01794273|Stroke|stroke
1252652|NCT01794273|anaesthesia;|anaesthesia;
1252653|NCT01794260|Osteoarthritis|osteoarthritis
1252654|NCT01794260|Moderate ot severe pain|moderate ot severe pain
1252655|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
1252656|NCT01794221|circumcision|circumcision
1252657|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
1252658|NCT01794221|phimosis|phimosis
1252659|NCT01794208|in-vitro fertilization|in-vitro fertilization
1252660|NCT01794208|reproductive disorder|reproductive disorder
1252661|NCT01794195|Parkinson's disease|parkinson's disease
1252662|NCT01794195|Apathy|apathy
1252663|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
1252664|NCT01794195|tractography|tractography
1252665|NCT01794156|Inference-based therapy|inference-based therapy
1252666|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
1252667|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
1252668|NCT01794156|Randomized clinical trial|randomized clinical trial
1252669|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
1252670|NCT01794143|Comparative effectiveness research|comparative effectiveness research
1252671|NCT01794143|Clinical trial|clinical trial
1252672|NCT01794143|Patient-centered outcomes|patient-centered outcomes
1252673|NCT01794117|Anakinra|anakinra
1252674|NCT01794117|Pustular Psoriasis|pustular psoriasis
1252675|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
1252676|NCT01794117|DITRA|ditra
1252677|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
1252678|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
1252679|NCT01794104|Advanced Malignancies|advanced malignancies
1252680|NCT01794104|Pharmacodynamics|pharmacodynamics
1252681|NCT01794104|DNA Damage|dna damage
1252682|NCT01794104|Pharmacokinetics|pharmacokinetics
1252683|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1252684|NCT01794091|Diabetes|diabetes
1252685|NCT01794078|Acute Mountain Sickness|acute mountain sickness
1252686|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
1252687|NCT01794026|diffusion weighted|diffusion weighted
1252688|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
1252689|NCT01794026|surgery|surgery
1252690|NCT01794026|histopathology|histopathology
1252691|NCT01794013|Parent training|parent training
1252692|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
1252693|NCT01794013|Children with developmental disabilities|children with developmental disabilities
1252694|NCT01793987|blood loss between two groups|blood loss between two groups
1252695|NCT01793974|LADA|lada
1252696|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
1252697|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
1252698|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
1252699|NCT01793935|Schizophrenia|schizophrenia
1252700|NCT01793935|Sensoril|sensoril
1252996|NCT01792739|Diarrhea|diarrhea
1252701|NCT01793935|Withania Somnifera extract|withania somnifera extract
1252702|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
1252703|NCT01793935|Stress|stress
1252704|NCT01793935|Inflammation|inflammation
1252705|NCT01793935|Immunomodulation|immunomodulation
1252706|NCT01793909|Type 2 Diabetes|type 2 diabetes
1252707|NCT01793909|Exercise Impairment|exercise impairment
1252708|NCT01793909|Blood Flow|blood flow
1252709|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
1252710|NCT01793909|Exercise Training|exercise training
1252711|NCT01793896|Metabolic syndrome|metabolic syndrome
1252712|NCT01793896|Ageing|ageing
1252713|NCT01793896|Mitochondrial density|mitochondrial density
1252714|NCT01793896|Oxidative damage|oxidative damage
1252715|NCT01793896|Inflammatory mediators|inflammatory mediators
1252716|NCT01793896|AMPK|ampk
1252717|NCT01793896|Adipogenesis|adipogenesis
1252718|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
1252719|NCT01793870|pharmacokinetic|pharmacokinetic
1252720|NCT01793870|carvedilol|carvedilol
1252721|NCT01793870|Stable isotope technique|stable isotope technique
1252722|NCT01793857|Primary caregiver|primary caregiver
1252723|NCT01793857|Survey|survey
1252724|NCT01793857|Acute Otitis Media|acute otitis media
1252725|NCT01793857|Ear infection|ear infection
1252726|NCT01793857|Panama|panama
1252727|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
1252728|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
1252729|NCT01793844|DFS|dfs
1252730|NCT01793844|OS|os
1252731|NCT01793831|Crohn's diseases|crohn's diseases
1252732|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
1252733|NCT01793831|Fecal transplantation|fecal transplantation
1252734|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
1252735|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
1252736|NCT01793818|Vaccine|vaccine
1252737|NCT01793818|HIV-1|hiv-1
1252738|NCT01793818|Tat|tat
1252739|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
1252740|NCT01793740|sickle cell disease|sickle cell disease
1252741|NCT01793740|pediatric|pediatric
1252742|NCT01793740|learning disability|learning disability
1252743|NCT01793740|cognitive impairment|cognitive impairment
1252744|NCT01793740|memory|memory
1252745|NCT01793740|attention|attention
1252746|NCT01793740|Children with sickle cell disease|children with sickle cell disease
1252747|NCT01793727|infants|infants
1252748|NCT01793727|general anesthesia|general anesthesia
1252749|NCT01793727|tracheal intubation|tracheal intubation
1252750|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
1252751|NCT01793701|Cervical Cancer, Intensity-modulated radiotherapy|cervical cancer, intensity-modulated radiotherapy
1252752|NCT01793688|UNASYN-S|unasyn-s
1252753|NCT01793688|High Dose|high dose
1252754|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
1252755|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
1252756|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
1252757|NCT01793662|TASC Type D Lesions|tasc type d lesions
1252758|NCT01793662|Open aortic surgery|open aortic surgery
1252759|NCT01793649|Respiratory health|respiratory health
1252760|NCT01793649|Cystic Fibrosis|cystic fibrosis
1252761|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1252762|NCT01793623|atrial fibrillation|atrial fibrillation
1252763|NCT01793623|genetics|genetics
1252764|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
1252765|NCT01793623|heart disease|heart disease
1252766|NCT01793610|MDMA|mdma
1252767|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
1252768|NCT01793610|sleep|sleep
1252769|NCT01793610|Depression|depression
1252770|NCT01793610|Safety|safety
1252771|NCT01793597|ticagrelor|ticagrelor
1252772|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
1252773|NCT01793597|platelet function|platelet function
1252774|NCT01793597|receptor binding|receptor binding
1252775|NCT01793597|platelet reactivity|platelet reactivity
1252776|NCT01793597|reversible binding|reversible binding
1252777|NCT01793584|Comparative effectiveness|comparative effectiveness
1252778|NCT01793584|Surgical success|surgical success
1252779|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
1252780|NCT01793571|Adult|adult
1252781|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
1252782|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
1252783|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
1252784|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
1252785|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
1252786|NCT01793571|Humans|humans
1252787|NCT01793571|Nerve Block/Methods|nerve block/methods
1252788|NCT01793571|Pain Measurement/Methods|pain measurement/methods
1252789|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
1252790|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
1252791|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
1252792|NCT01793558|hypothermia|hypothermia
1252793|NCT01793558|Postoperative shivering|postoperative shivering
1252794|NCT01793558|cesarean section|cesarean section
1252796|NCT01793545|Endometrial Cancer|endometrial cancer
1252797|NCT01793545|Gynecological Cancers|gynecological cancers
1252798|NCT01793545|Screening|screening
1252799|NCT01793532|PET Imaging|pet imaging
1252800|NCT01793532|Epilepsy|epilepsy
1252801|NCT01793532|Inflammation|inflammation
1252802|NCT01793532|Brain Imaging|brain imaging
1252803|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
1252804|NCT01793519|Autoimmune Diseases|autoimmune diseases
1252805|NCT01793519|Anti-TNF|anti-tnf
1252806|NCT01793506|immunodeficiency|immunodeficiency
1252807|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
1252808|NCT01793493|Cognitive Stimulation|cognitive stimulation
1252809|NCT01793493|Aging|aging
1252810|NCT01793493|Elderly|elderly
1252811|NCT01793493|Randomized Controlled Trial|randomized controlled trial
1252812|NCT01793480|Methadone in cancer pain|methadone in cancer pain
1252813|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
1252814|NCT01793389|gingival recession|gingival recession
1252815|NCT01793389|fibrin|fibrin
1252816|NCT01793389|connective tissue|connective tissue
1252817|NCT01793389|root coverage|root coverage
1252818|NCT01793389|microsurgery|microsurgery
1252819|NCT01793389|case-control studies|case-control studies
1252820|NCT01793363|Tracheotomy|tracheotomy
1252821|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
1252822|NCT01793363|Lung ultrasound score|lung ultrasound score
1252823|NCT01793350|Diabetes|diabetes
1252824|NCT01793350|Mellitus|mellitus
1252825|NCT01793350|Painful|painful
1252826|NCT01793350|Neuropathy|neuropathy
1252827|NCT01793350|Peripheral|peripheral
1252828|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
1252829|NCT01793324|Metabolic monitoring|metabolic monitoring
1252830|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
1252831|NCT01793311|intraocular pressure|intraocular pressure
1252832|NCT01793311|caffeine|caffeine
1252833|NCT01793311|dosage|dosage
1252834|NCT01793246|lung cancer|lung cancer
1252835|NCT01793246|lung neoplasms|lung neoplasms
1252836|NCT01793246|lung transplant|lung transplant
1252837|NCT01793194|venous insufficiency|venous insufficiency
1252838|NCT01793194|varicose veins|varicose veins
1252839|NCT01793194|pregnancy|pregnancy
1252840|NCT01793194|DVT|dvt
1252841|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
1252842|NCT01793181|Vitamin d deficiency|vitamin d deficiency
1252843|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
1252844|NCT01793168|Rare Diseases|rare diseases
1252845|NCT01793168|Neglected Diseases|neglected diseases
1252846|NCT01793168|Orphan Diseases|orphan diseases
1252847|NCT01793168|Rare Disease Research|rare disease research
1252848|NCT01793168|Registries|registries
1252849|NCT01793168|WAGR Syndrome|wagr syndrome
1252850|NCT01793168|Ataxia|ataxia
1252851|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
1252852|NCT01793168|Stickler Syndrome|stickler syndrome
1252853|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
1252854|NCT01793168|Kawasaki Disease|kawasaki disease
1252855|NCT01793168|Batten Disease|batten disease
1252856|NCT01793168|Mucolipidosis IV|mucolipidosis iv
1252857|NCT01793168|Klippel-Feil Syndrome|klippel-feil syndrome
1252858|NCT01793168|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
1252859|NCT01793168|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
1252860|NCT01793168|Undiagnosed|undiagnosed
1252861|NCT01793168|Uncommon Disease|uncommon disease
1252862|NCT01793168|Kabuki Syndrome|kabuki syndrome
1252863|NCT01793168|Hypersomnia|hypersomnia
1252864|NCT01793168|Hyperacusis|hyperacusis
1252865|NCT01793168|Kleine-Levin Syndrome|kleine-levin syndrome
1252866|NCT01793168|Marinesco-Sjogren Syndrome|marinesco-sjogren syndrome
1252867|NCT01793168|Leiomyosarcoma|leiomyosarcoma
1252868|NCT01793168|4p-/Wolf-Hirschhorn Syndrome|4p-/wolf-hirschhorn syndrome
1252869|NCT01793168|Hypophosphatasia|hypophosphatasia
1252870|NCT01793168|Narcolepsy|narcolepsy
1252871|NCT01793168|Wiedermann-Steiner Syndrome|wiedermann-steiner syndrome
1252872|NCT01793168|Breast Implant-Associated Anaplastic Large Cell Lymphoma|breast implant-associated anaplastic large cell lymphoma
1252873|NCT01793168|Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)|autoimmune/inflammatory syndrome induced by adjuvants (asia)
1252874|NCT01793168|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
1252875|NCT01793168|Behcet's Disease|behcet's disease
1252876|NCT01793155|Lung cancer surgery|lung cancer surgery
1252877|NCT01793155|Inspiratory muscle training|inspiratory muscle training
1252878|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
1252879|NCT01793155|Functional outcomes|functional outcomes
1252880|NCT01793155|Health related quality of life|health related quality of life
1252881|NCT01793142|Osteoporosis|osteoporosis
1252882|NCT01793142|postmenopausal|postmenopausal
1252883|NCT01793142|SERM|serm
1252884|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
1252885|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
1252886|NCT01793129|Hypothermia|hypothermia
1252887|NCT01793129|Neonatal depression|neonatal depression
1252888|NCT01793129|Perinatal asphyxia|perinatal asphyxia
1252889|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
1252890|NCT01793116|Moderately Preterm|moderately preterm
1252891|NCT01793090|Cobalamin C defect|cobalamin c defect
1252892|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
1252893|NCT01793090|Visual function|visual function
1252894|NCT01793090|VEP|vep
1252895|NCT01793090|ERG|erg
1252896|NCT01793090|antioxidant drugs|antioxidant drugs
1252897|NCT01793077|Prostate Cancer|prostate cancer
1252898|NCT01793077|Phase 4|phase 4
1252899|NCT01793077|Data collection|data collection
1252900|NCT01793077|Observational|observational
1252901|NCT01793077|Depo-Eligard|depo-eligard
1252902|NCT01793077|Prospective|prospective
1252903|NCT01793077|Non-interventional|non-interventional
1252904|NCT01793077|Treatment|treatment
1252905|NCT01793064|Pedometer,|pedometer,
1252906|NCT01793064|adaptive,|adaptive,
1252907|NCT01793064|exercise,|exercise,
1252908|NCT01793064|reinforcement,|reinforcement,
1252909|NCT01793064|goal setting,|goal setting,
1252910|NCT01793064|technology,|technology,
1252911|NCT01793064|email,|email,
1252912|NCT01793064|weight loss|weight loss
1252913|NCT01793064|mHealth|mhealth
1252914|NCT01793064|eHealth|ehealth
1252915|NCT01793051|Myeloma|myeloma
1252916|NCT01793051|Multiple Myeloma|multiple myeloma
1252917|NCT01793051|MM|mm
1252918|NCT01793051|Symptom Burden|symptom burden
1252919|NCT01793051|Symptom reduction|symptom reduction
1252920|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
1252921|NCT01793051|Minocycline|minocycline
1252922|NCT01793051|Dynacin|dynacin
1252923|NCT01793051|Minocin|minocin
1252924|NCT01793051|Minocin PAC|minocin pac
1252925|NCT01793051|Myrac|myrac
1252926|NCT01793051|Solodyn|solodyn
1252927|NCT01793051|Placebo|placebo
1252928|NCT01793051|Sugar pill|sugar pill
1252929|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
1252930|NCT01793051|MDASI|mdasi
1252931|NCT01793051|Questionnaires|questionnaires
1252932|NCT01793051|Surveys|surveys
1252933|NCT01793038|PCOS|pcos
1252934|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
1252935|NCT01793038|Aromatase inhibitors|aromatase inhibitors
1252936|NCT01793025|leukemia|leukemia
1252937|NCT01793025|myeloid|myeloid
1252938|NCT01793025|acute|acute
1252939|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
1252940|NCT01793025|allogeneic|allogeneic
1252941|NCT01793025|transient chimerism|transient chimerism
1252942|NCT01793025|cell therapy|cell therapy
1252943|NCT01793025|immunotherapy|immunotherapy
1252944|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
1252945|NCT01793012|antibiotics|antibiotics
1252946|NCT01793012|inflammation parameters|inflammation parameters
1252947|NCT01793012|critically ill patients|critically ill patients
1252948|NCT01793012|septicaemia|septicaemia
1252949|NCT01793012|intensive care unit|intensive care unit
1252950|NCT01792999|Breast CT|breast ct
1252951|NCT01792986|Diabetes|diabetes
1252952|NCT01792986|Fasting|fasting
1252953|NCT01792986|Pre-diabetes|pre-diabetes
1252954|NCT01792986|Hemoglobin A1C|hemoglobin a1c
1252955|NCT01792973|HIV|hiv
1252956|NCT01792973|HPV|hpv
1252957|NCT01792973|Women|women
1252958|NCT01792973|Thailand|thailand
1252959|NCT01792973|Antiretrovirals|antiretrovirals
1252960|NCT01792973|Cervical cancer|cervical cancer
1252961|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
1252962|NCT01792921|Age 7-10 years old|age 7-10 years old
1252963|NCT01792921|regular education system|regular education system
1252964|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
1252965|NCT01792908|ankle lateral ligament|ankle lateral ligament
1252966|NCT01792908|athletic tape|athletic tape
1252967|NCT01792908|position sense|position sense
1252968|NCT01792908|Proprioception|proprioception
1252969|NCT01792895|Posterior Neck Pain|posterior neck pain
1252970|NCT01792895|Cervical spine pain|cervical spine pain
1252971|NCT01792895|Manual therapy|manual therapy
1252972|NCT01792856|coaching|coaching
1252973|NCT01792856|early psychosis|early psychosis
1252974|NCT01792856|schizophrenia|schizophrenia
1252975|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
1252976|NCT01792817|Cluster Headache|cluster headache
1252977|NCT01792817|GammaCore|gammacore
1252978|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
1252979|NCT01792817|nVNS|nvns
1252980|NCT01792817|VNS|vns
1252981|NCT01792817|non invasive|non invasive
1252982|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
1252983|NCT01792804|Staphylococcus aureus|staphylococcus aureus
1252984|NCT01792804|Bloodstream infection|bloodstream infection
1252985|NCT01792804|Oral switch|oral switch
1252986|NCT01792778|IV Catheters|iv catheters
1252987|NCT01792778|Blood control|blood control
1252988|NCT01792765|urolithiasis|urolithiasis
1252989|NCT01792765|radiation free|radiation free
1252990|NCT01792765|ultrasound guidance|ultrasound guidance
1252991|NCT01792765|ureteroscopy|ureteroscopy
1252992|NCT01792752|HIV/AIDS|hiv/aids
1252993|NCT01792752|Drug Users|drug users
1252994|NCT01792752|Puerto Rico|puerto rico
1252995|NCT01792739|Probiotics|probiotics
1252997|NCT01792739|Intentive care units|intentive care units
1252998|NCT01792726|breast cancer|breast cancer
1252999|NCT01792726|radiotherapy|radiotherapy
1253000|NCT01792726|TARGIT|targit
1253001|NCT01792726|Intrabeam|intrabeam
1253002|NCT01792713|Skin alterations|skin alterations
1253003|NCT01792713|Atopic Dermatitis|atopic dermatitis
1253004|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
1253005|NCT01792674|Education|education
1253006|NCT01792674|Patient simulation|patient simulation
1253007|NCT01792674|In situ simulation|in situ simulation
1253008|NCT01792674|Stress|stress
1253009|NCT01792661|Chronic Kidney Disease|chronic kidney disease
1253010|NCT01792661|Electronic Health Record|electronic health record
1333267|NCT01443767|PiCCO|picco
1253011|NCT01792661|Personal Health Record|personal health record
1253012|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
1253013|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
1253014|NCT01792661|Patient Navigator|patient navigator
1253015|NCT01792648|Almond|almond
1253016|NCT01792648|Carbohydrate|carbohydrate
1253017|NCT01792648|Diet|diet
1253018|NCT01792648|Cholesterol|cholesterol
1253019|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1253020|NCT01792635|Pharmacodynamics|pharmacodynamics
1253021|NCT01792635|Safety & Tolerability|safety & tolerability
1253022|NCT01792622|Instrument Development|instrument development
1253023|NCT01792622|Patient Reported Outcomes|patient reported outcomes
1253024|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
1253025|NCT01792609|Scoliosis|scoliosis
1253026|NCT01792609|Cobb Angle|cobb angle
1253027|NCT01792609|Screw Density|screw density
1253028|NCT01792609|Outcomes Measures|outcomes measures
1253029|NCT01792583|pregnancy|pregnancy
1253030|NCT01792570|HIV-1|hiv-1
1253031|NCT01792570|darunavir|darunavir
1253032|NCT01792570|rilpivirine|rilpivirine
1253033|NCT01792570|strategic study|strategic study
1253034|NCT01792557|Pilonidal sinus|pilonidal sinus
1253035|NCT01792557|Crystallized phenol|crystallized phenol
1253036|NCT01792557|Limberg Flap|limberg flap
1253037|NCT01792557|Modified Limberg Flap|modified limberg flap
1253038|NCT01792557|Karydakis|karydakis
1253039|NCT01792557|Recurrence|recurrence
1253040|NCT01792557|Complications|complications
1253041|NCT01792557|Recovery duration|recovery duration
1253042|NCT01792557|Time to return to work|time to return to work
1253043|NCT01792531|children|children
1253044|NCT01792531|obesity|obesity
1253045|NCT01792531|treatment|treatment
1253046|NCT01792531|family|family
1253047|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
1253048|NCT01792492|Optical Devices|optical devices
1253049|NCT01792492|Spectrum Analysis|spectrum analysis
1253050|NCT01792492|Thyroid diseases|thyroid diseases
1253051|NCT01792479|NSCLC|nsclc
1253052|NCT01792479|lung cancer|lung cancer
1253053|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
1253054|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
1253055|NCT01792453|MRI|mri
1253056|NCT01792453|Small bowel water volumes|small bowel water volumes
1253057|NCT01792453|Gastric volumes|gastric volumes
1253058|NCT01792401|Critical illness|critical illness
1253059|NCT01792401|Dietary supplements|dietary supplements
1253060|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
1253061|NCT01792388|Crohn's Disease|crohn's disease
1253062|NCT01792388|Vitamin D|vitamin d
1253063|NCT01792388|Intestinal Permeability|intestinal permeability
1253064|NCT01792388|Tara Raftery|tara raftery
1253065|NCT01792375|Cervical ripening|cervical ripening
1253066|NCT01792375|Dinoprostone|dinoprostone
1253067|NCT01792375|Labor induction|labor induction
1253068|NCT01792375|Membrane sweeping|membrane sweeping
1253069|NCT01792375|Nulliparous women|nulliparous women
1253070|NCT01792375|Trial|trial
1253071|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
1253072|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
1253073|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1253074|NCT01792336|Motor Cortex|motor cortex
1253075|NCT01792336|Focal Hand Dystonia|focal hand dystonia
1253076|NCT01792336|Facilitation|facilitation
1253077|NCT01792323|insulin pump therapy|insulin pump therapy
1253078|NCT01792323|insulin bolus|insulin bolus
1253079|NCT01792323|rapid acting insulin|rapid acting insulin
1253080|NCT01792323|insulin lispro|insulin lispro
1253081|NCT01792323|pharmacodynamics|pharmacodynamics
1253082|NCT01792323|pharmacokinetics|pharmacokinetics
1253083|NCT01792323|glucose clamp|glucose clamp
1253084|NCT01792310|Glioma|glioma
1253085|NCT01792310|Solid Tumours|solid tumours
1253086|NCT01792310|Minerval|minerval
1253087|NCT01792297|Sarcopenia|sarcopenia
1253088|NCT01792297|Osteoporosis|osteoporosis
1253089|NCT01792297|Cognition|cognition
1253090|NCT01792297|Inflammation|inflammation
1253091|NCT01792271|COPD|copd
1253092|NCT01792271|Chronic Bronchitis|chronic bronchitis
1253093|NCT01792271|Hypertonic Saline|hypertonic saline
1253094|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
1253095|NCT01792258|Intensive Care Unit|intensive care unit
1253096|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
1253097|NCT01792258|Weaning failure|weaning failure
1253098|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
1253099|NCT01792232|Diesel exhaust|diesel exhaust
1253100|NCT01792232|Air pollution|air pollution
1253101|NCT01792232|Airway responsiveness|airway responsiveness
1253102|NCT01792232|Allergies|allergies
1253397|NCT01790594|pancreas|pancreas
1253103|NCT01792219|interprofessional learning|interprofessional learning
1253104|NCT01792219|interprofessional collaboration|interprofessional collaboration
1253105|NCT01792219|residents|residents
1253106|NCT01792219|nursing homes|nursing homes
1333367|NCT01443377|neoadjuvant|neoadjuvant
1253107|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
1253108|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
1253109|NCT01792206|CKD|ckd
1253110|NCT01792180|Gait speed|gait speed
1253111|NCT01792180|Mobility|mobility
1253112|NCT01792180|Falls|falls
1253113|NCT01792180|Fall risk|fall risk
1253114|NCT01792180|Self-management|self-management
1253115|NCT01792180|Mental wellbeing|mental wellbeing
1253116|NCT01792180|Elderly|elderly
1253117|NCT01792115|Fatty Liver|fatty liver
1253118|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
1253119|NCT01792115|Vitamin E|vitamin e
1253120|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1253121|NCT01792102|Multiple Myeloma|multiple myeloma
1253122|NCT01792102|Carfilzomib|carfilzomib
1253123|NCT01792102|Krypolis|krypolis
1253124|NCT01792102|60 minute infusion|60 minute infusion
1253125|NCT01792089|de novo lipogenesis|de novo lipogenesis
1253126|NCT01792089|fructose|fructose
1253127|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
1253128|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
1253129|NCT01792050|IDO|ido
1253130|NCT01792050|IDO Inhibitor|ido inhibitor
1253131|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
1253132|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
1253133|NCT01791985|Breast Cancer|breast cancer
1253134|NCT01791985|AZD4547|azd4547
1253135|NCT01791985|Safety Run-In|safety run-in
1253136|NCT01791985|FGFR1|fgfr1
1253137|NCT01791985|ER positive breast cancer|er positive breast cancer
1253138|NCT01791985|Single arm phase IIa study|single arm phase iia study
1253139|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
1253140|NCT01791972|Spiromax®|spiromax®
1253141|NCT01791972|Albuterol sulfate|albuterol sulfate
1253142|NCT01791946|lazy eye|lazy eye
1253143|NCT01791946|cross eye|cross eye
1253144|NCT01791946|cross eyed|cross eyed
1253145|NCT01791933|LBP|lbp
1253146|NCT01791933|Neck pain|neck pain
1253147|NCT01791933|Integrative package|integrative package
1253148|NCT01791933|CAM|cam
1253149|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
1253150|NCT01791868|Sodium valproate|sodium valproate
1253151|NCT01791868|Refractory status epilepticus|refractory status epilepticus
1253152|NCT01791868|Mortality|mortality
1253153|NCT01791868|Epilepsy|epilepsy
1253154|NCT01791868|Intensive Care Unit|intensive care unit
1253155|NCT01791868|Neurological sequela|neurological sequela
1253156|NCT01791868|Quality of life|quality of life
1253157|NCT01791868|Adult|adult
1253158|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
1253159|NCT01791855|healthy|healthy
1253160|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
1253161|NCT01791842|tocilizumab|tocilizumab
1253162|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
1253163|NCT01791829|Luminal A|luminal a
1253164|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
1253165|NCT01791816|Vasovagal Syncope|vasovagal syncope
1253166|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
1253167|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
1253168|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
1253169|NCT01791816|Orthostatic Stress|orthostatic stress
1253170|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
1253171|NCT01791816|Phenylephrine|phenylephrine
1253172|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
1253173|NCT01791803|Smoking cessation|smoking cessation
1253174|NCT01791803|Tobacco abstinence|tobacco abstinence
1253175|NCT01791803|hypnotherapy|hypnotherapy
1253176|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
1253177|NCT01791790|old Subjects|old subjects
1253178|NCT01791790|Controls|controls
1253179|NCT01791790|brain stimulation|brain stimulation
1253180|NCT01791790|tSOS|tsos
1253181|NCT01791790|tDCS|tdcs
1253182|NCT01791790|sleep|sleep
1253183|NCT01791790|memory|memory
1253184|NCT01791790|memory consolidation|memory consolidation
1253185|NCT01791777|fidelity|fidelity
1253186|NCT01791777|implementation science|implementation science
1253187|NCT01791777|competence|competence
1253188|NCT01791777|training|training
1253189|NCT01791777|coaching|coaching
1253190|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
1253191|NCT01791738|Patient-Specific Instruments|patient-specific instruments
1253192|NCT01791738|Acetabular Cup Placement|acetabular cup placement
1253193|NCT01791738|Accuracy|accuracy
1253194|NCT01791699|atrial fibrillation|atrial fibrillation
1253195|NCT01791699|paroxysmal|paroxysmal
1253196|NCT01791699|persistent|persistent
1253197|NCT01791699|ablation|ablation
1253198|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
1253199|NCT01791699|recurrence|recurrence
1253200|NCT01791686|Dense Deposit Disease|dense deposit disease
1253201|NCT01791686|DDD|ddd
1253203|NCT01791673|Cyclocoagulation|cyclocoagulation
1253204|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
1253205|NCT01791673|Ciliary Body|ciliary body
1253206|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
1253207|NCT01791647|myoinositol|myoinositol
1253208|NCT01791647|metformin|metformin
1253209|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
1253210|NCT01791647|menstrual pattern|menstrual pattern
1253211|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
1253212|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
1253213|NCT01791621|Elimination diet|elimination diet
1253214|NCT01791621|Food allergies|food allergies
1253215|NCT01791608|Child, Preschool|child, preschool
1253216|NCT01791608|Dietary Zinc|dietary zinc
1253217|NCT01791608|Zinc sulfate|zinc sulfate
1253218|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
1253219|NCT01791595|Phase I|phase i
1253220|NCT01791595|Cancer|cancer
1253221|NCT01791595|Solid Tumours|solid tumours
1253222|NCT01791595|Prostate Cancer|prostate cancer
1253223|NCT01791595|Gastric Cancer|gastric cancer
1253224|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1253225|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
1253226|NCT01791595|lactate|lactate
1253227|NCT01791556|HIV|hiv
1253228|NCT01791556|AIDS|aids
1253229|NCT01791556|Kenya|kenya
1253230|NCT01791556|viral load|viral load
1253231|NCT01791556|Antiretroviral therapy|antiretroviral therapy
1253232|NCT01791556|randomized clinical trial|randomized clinical trial
1253233|NCT01791556|ART monitoring|art monitoring
1253234|NCT01791556|treatment failure|treatment failure
1253235|NCT01791556|HIV resistance|hiv resistance
1253236|NCT01791543|ventricular tachycardia|ventricular tachycardia
1253237|NCT01791543|ablation|ablation
1253238|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
1253239|NCT01791530|VAT|vat
1253240|NCT01791530|VAP|vap
1253241|NCT01791530|Transition from VAT to VAP|transition from vat to vap
1253242|NCT01791504|Abdominoplasty|abdominoplasty
1253243|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
1253244|NCT01791465|HIV|hiv
1253245|NCT01791465|Diabetes|diabetes
1253246|NCT01791400|Metoclopramide|metoclopramide
1253247|NCT01791400|Sumatriptan|sumatriptan
1253248|NCT01791400|migraine|migraine
1253249|NCT01791400|headache|headache
1253250|NCT01791387|Renal cell|renal cell
1253251|NCT01791387|Kidney|kidney
1253252|NCT01791387|Cancer|cancer
1253253|NCT01791387|Metastatic carcinoma|metastatic carcinoma
1253254|NCT01791374|Advanced Solid Tumors|advanced solid tumors
1253255|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
1253256|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
1253257|NCT01791374|Gastric Cancer|gastric cancer
1253258|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
1253259|NCT01791335|Glottis|glottis
1253260|NCT01791335|Respiratory Muscles|respiratory muscles
1253261|NCT01791335|Upper airway|upper airway
1253262|NCT01791335|Noninvasive ventilation|noninvasive ventilation
1253263|NCT01791309|Vemurafenib|vemurafenib
1253264|NCT01791309|Panitumumab|panitumumab
1253265|NCT01791309|V600E BRAF mutation|v600e braf mutation
1253266|NCT01791309|colon|colon
1253267|NCT01791309|12-221|12-221
1253268|NCT01791296|sedation|sedation
1253269|NCT01791296|sleep|sleep
1253270|NCT01791296|delirium|delirium
1253271|NCT01791296|critical illness|critical illness
1253272|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
1253273|NCT01791296|intensive care|intensive care
1253274|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
1253275|NCT01791283|Arterial waveform analysis|arterial waveform analysis
1253276|NCT01791283|Esofageal doppler|esofageal doppler
1253277|NCT01791283|Ultrasound|ultrasound
1253278|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
1253279|NCT01791283|Limits of agreement|limits of agreement
1253280|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
1253281|NCT01791270|Hypertension|hypertension
1253282|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
1253283|NCT01791270|Cardiovascular Risk|cardiovascular risk
1253284|NCT01791257|delayed|delayed
1253285|NCT01791257|cerebral|cerebral
1253286|NCT01791257|ischemia|ischemia
1253287|NCT01791257|microrna|microrna
1253288|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
1253289|NCT01791257|subarachnoid|subarachnoid
1253290|NCT01791257|hemorrhage|hemorrhage
1253291|NCT01791244|Multiple Sclerosis|multiple sclerosis
1253292|NCT01791244|Relapsing-Remitting|relapsing-remitting
1253293|NCT01791244|Rebif|rebif
1253294|NCT01791244|RebiSmart|rebismart
1253295|NCT01791244|Patient support program|patient support program
1253296|NCT01791231|Healthy|healthy
1253297|NCT01791231|Male|male
1253298|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1253299|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
1253300|NCT01791231|Absorption|absorption
1253301|NCT01791231|Metabolism|metabolism
1253302|NCT01791231|Excretion|excretion
1253303|NCT01791231|Radioactivity|radioactivity
1253502|NCT01789970|opioids|opioids
1253304|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
1600132|NCT00393731|oxytocin|oxytocin
1253305|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1253306|NCT01791218|Quality of life|quality of life
1253307|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
1253308|NCT01791114|Insulin sensitivity|insulin sensitivity
1253309|NCT01791114|Diabetes Prevention|diabetes prevention
1253310|NCT01791114|Obesity|obesity
1253311|NCT01791114|Brown adipose tissue|brown adipose tissue
1253312|NCT01791101|Thrombocytopenia|thrombocytopenia
1253313|NCT01791101|Eltrombopag|eltrombopag
1253314|NCT01791075|DSAEK|dsaek
1253315|NCT01791075|Tan Endoglide|tan endoglide
1253316|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
1253317|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
1253318|NCT01791062|hyaluronan|hyaluronan
1253319|NCT01791062|hyaluronic acid|hyaluronic acid
1253320|NCT01791049|Gram-positive|gram-positive
1253321|NCT01791049|Infections|infections
1253322|NCT01791049|Bacterial infections|bacterial infections
1253323|NCT01791036|Adductor canal block|adductor canal block
1253324|NCT01791036|Femoral Nerve Block|femoral nerve block
1253325|NCT01791023|Depression|depression
1253326|NCT01791023|Physical exercise|physical exercise
1253327|NCT01791023|Stress|stress
1253328|NCT01791010|Breathing exercises|breathing exercises
1253329|NCT01791010|Aged|aged
1253330|NCT01790997|DLBS1033|dlbs1033
1253331|NCT01790997|Lumbrokinase|lumbrokinase
1253332|NCT01790997|Acute ischemic stroke|acute ischemic stroke
1253333|NCT01790997|Bleeding profile|bleeding profile
1253334|NCT01790997|Clinical outcome|clinical outcome
1253335|NCT01790997|Aspirin|aspirin
1253336|NCT01790997|Clopidogrel|clopidogrel
1253337|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
1253338|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
1253339|NCT01790971|Spinal morphine|spinal morphine
1253340|NCT01790932|Metastatic|metastatic
1253341|NCT01790932|Triple Negative|triple negative
1253342|NCT01790919|Depression, Adults|depression, adults
1253343|NCT01790906|Chronic Heart Failure|chronic heart failure
1253344|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
1253345|NCT01790893|Histoplasmosis|histoplasmosis
1253346|NCT01790880|Aphasia|aphasia
1253347|NCT01790880|Stroke|stroke
1253348|NCT01790880|Speech Rehabilitation|speech rehabilitation
1253349|NCT01790854|prasugrel|prasugrel
1253350|NCT01790854|antiplatelet|antiplatelet
1253351|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
1253352|NCT01790815|Acute Malnutrition|acute malnutrition
1253353|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
1253354|NCT01790815|Screening|screening
1253355|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
1253356|NCT01790776|urethrography|urethrography
1253357|NCT01790763|Burn|burn
1253358|NCT01790763|Second-degree|second-degree
1253359|NCT01790750|PDA|pda
1253360|NCT01790750|Echo|echo
1253361|NCT01790750|PES|pes
1253362|NCT01790750|Handheld echo system|handheld echo system
1253363|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
1253364|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
1253365|NCT01790711|Gut bacteria|gut bacteria
1253366|NCT01790711|Bacteria|bacteria
1253367|NCT01790711|Fecal transplant|fecal transplant
1253368|NCT01790711|Bacteriotherapy|bacteriotherapy
1253369|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
1253370|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
1253371|NCT01790698|Staphylococcus aureus|staphylococcus aureus
1253372|NCT01790698|Immunopathogenesis|immunopathogenesis
1253373|NCT01790672|Antioxidants|antioxidants
1253374|NCT01790672|Central Nervous System Agents|central nervous system agents
1253375|NCT01790672|Wine|wine
1253376|NCT01790659|leishmaniasis|leishmaniasis
1253377|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
1253378|NCT01790659|Leishmania panamensis|leishmania panamensis
1253379|NCT01790659|L panamensis|l panamensis
1253380|NCT01790659|Paromomycin|paromomycin
1253381|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
1253382|NCT01790633|rapid test|rapid test
1253383|NCT01790633|screening|screening
1253384|NCT01790633|ELISA|elisa
1253385|NCT01790633|hepatitis B virus|hepatitis b virus
1253386|NCT01790633|hepatitis C virus|hepatitis c virus
1253387|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
1253388|NCT01790633|access to care|access to care
1253389|NCT01790620|Severe sepsis|severe sepsis
1253390|NCT01790620|Septic shock|septic shock
1253391|NCT01790620|Acute renal failure|acute renal failure
1253392|NCT01790620|Acute kidney injury|acute kidney injury
1253393|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
1253394|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
1253395|NCT01790594|transplantation|transplantation
1253396|NCT01790594|kidney|kidney
1253398|NCT01790594|immunosuppression|immunosuppression
1253399|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
1253400|NCT01790581|Chronic Ankle Instability|chronic ankle instability
1253401|NCT01790555|Postsurgical|postsurgical
1253402|NCT01790555|Pain|pain
1253403|NCT01790555|THC|thc
1253404|NCT01790555|Sensitization|sensitization
1253405|NCT01790542|Iron|iron
1253406|NCT01790542|Intestinal inflammation|intestinal inflammation
1253407|NCT01790542|ROS|ros
1253408|NCT01790516|Head and neck cancer|head and neck cancer
1253409|NCT01790516|genetic testing|genetic testing
1253410|NCT01790516|cisplatin|cisplatin
1253411|NCT01790516|erbitux|erbitux
1253412|NCT01790516|radiation therapy|radiation therapy
1253413|NCT01790503|glioblastoma|glioblastoma
1253414|NCT01790503|GBM|gbm
1253415|NCT01790477|Tonsillectomy|tonsillectomy
1253416|NCT01790477|Acupuncture|acupuncture
1253417|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
1253418|NCT01790464|Airway anesthesia|airway anesthesia
1253419|NCT01790464|Awake intubation|awake intubation
1253420|NCT01790451|focal therapy|focal therapy
1253421|NCT01790451|irreversible electroporation|irreversible electroporation
1253422|NCT01790451|prostate cancer|prostate cancer
1253423|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
1253424|NCT01790399|SENTINEL NODE|sentinel node
1253425|NCT01790386|hemostasis|hemostasis
1253426|NCT01790386|thromboelastography|thromboelastography
1253427|NCT01790386|coagulation|coagulation
1253428|NCT01790386|TEG|teg
1253429|NCT01790373|Suubi|suubi
1253430|NCT01790373|Adolescents|adolescents
1253431|NCT01790373|Poverty|poverty
1253432|NCT01790373|Economic empowerment interventions|economic empowerment interventions
1253433|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
1253434|NCT01790373|Wisepill|wisepill
1253435|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
1253436|NCT01790373|Medical event monitoring system|medical event monitoring system
1253437|NCT01790373|Uganda|uganda
1253438|NCT01790360|MSM|msm
1253439|NCT01790360|HIV|hiv
1253440|NCT01790360|Substance Abuse|substance abuse
1253441|NCT01790360|Sexual Behavior|sexual behavior
1253442|NCT01790347|Exercise|exercise
1253443|NCT01790347|Aerobic|aerobic
1253444|NCT01790347|Resistance training|resistance training
1253445|NCT01790347|Pregnancy|pregnancy
1253446|NCT01790347|Maternal weight gain|maternal weight gain
1253447|NCT01790347|IOM recommendations|iom recommendations
1253448|NCT01790295|Myelofibrosis|myelofibrosis
1253449|NCT01790295|Stem cell transplant|stem cell transplant
1253450|NCT01790295|Ruxolitinib|ruxolitinib
1253451|NCT01790282|luteal support|luteal support
1253452|NCT01790282|high responder|high responder
1253453|NCT01790282|ICSI|icsi
1253454|NCT01790282|ivf|ivf
1253455|NCT01790282|cycle outcome|cycle outcome
1253456|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1253457|NCT01790269|NK cells|nk cells
1253458|NCT01790269|Fingolimod|fingolimod
1253459|NCT01790204|mutant p53|mutant p53
1253460|NCT01790204|watercress|watercress
1253461|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
1253462|NCT01790204|oral cells of smokers|oral cells of smokers
1253463|NCT01790191|Children|children
1253464|NCT01790191|Eating behaviour|eating behaviour
1253465|NCT01790191|Intake|intake
1253466|NCT01790191|Liking|liking
1253467|NCT01790191|Conditioned liking|conditioned liking
1253468|NCT01790191|Flavour|flavour
1253469|NCT01790191|Nutrient|nutrient
1253470|NCT01790191|Vegetable|vegetable
1253471|NCT01790165|Onychomycosis|onychomycosis
1253472|NCT01790165|Open Label|open label
1253473|NCT01790165|PK|pk
1253474|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
1253475|NCT01790074|cervicogenic headache|cervicogenic headache
1253476|NCT01790074|trigger point|trigger point
1253477|NCT01790074|sternocleidomastoid|sternocleidomastoid
1253478|NCT01790074|manual therapy|manual therapy
1253479|NCT01790061|Gut bacteria|gut bacteria
1253480|NCT01790061|Gut flora|gut flora
1253481|NCT01790061|Bacteriotherapy|bacteriotherapy
1253482|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
1253483|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
1253484|NCT01790061|Ulcerative colitis|ulcerative colitis
1253485|NCT01790048|MAM|mam
1253486|NCT01790009|ADME|adme
1253487|NCT01790009|Flavanols|flavanols
1253488|NCT01790009|Age|age
1253489|NCT01790009|Pharmacokinetics|pharmacokinetics
1253490|NCT01789996|6 minute walk test|6 minute walk test
1253491|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1253492|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
1253493|NCT01789983|Physical Activity|physical activity
1253494|NCT01789983|Chemotherapy|chemotherapy
1253496|NCT01789983|Geriatric|geriatric
1253497|NCT01789983|Walking|walking
1253498|NCT01789983|Geriatric Assessment|geriatric assessment
1253499|NCT01789983|Geriatric Oncology|geriatric oncology
1253500|NCT01789970|chronic low back pain|chronic low back pain
1600341|NCT00392951|Treatment|treatment
1253501|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
1253503|NCT01789944|Childhood Obesity|childhood obesity
1253504|NCT01789918|Hypertension|hypertension
1253505|NCT01789918|Blood pressure|blood pressure
1253506|NCT01789918|Renal denervation|renal denervation
1253507|NCT01789905|Tygacil|tygacil
1253508|NCT01789905|Tigecycline|tigecycline
1253509|NCT01789905|Post marketing surveillance|post marketing surveillance
1253510|NCT01789905|Japanese|japanese
1253511|NCT01789905|Infection|infection
1253512|NCT01789879|Levonorgestrel|levonorgestrel
1253513|NCT01789879|Efavirenz|efavirenz
1253514|NCT01789879|Nevirapine|nevirapine
1253515|NCT01789879|Pharmacokinetics|pharmacokinetics
1253516|NCT01789866|DHA|dha
1253517|NCT01789866|lutein|lutein
1253518|NCT01789866|cognitive development|cognitive development
1253519|NCT01789866|fMRI|fmri
1253520|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
1253521|NCT01789840|BPH|bph
1253522|NCT01789840|Prostate|prostate
1253523|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
1253524|NCT01789840|enlarged prostate|enlarged prostate
1253525|NCT01789840|LUTS|luts
1253526|NCT01789840|urinary retention|urinary retention
1253527|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
1253528|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1253529|NCT01789814|bivalirudin|bivalirudin
1253530|NCT01789762|Platelet transfusions|platelet transfusions
1253531|NCT01789762|Pathogen reduction|pathogen reduction
1253532|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
1253533|NCT01789749|snare tip soft coagulation|snare tip soft coagulation
1253534|NCT01789749|endoscopic mucosal resection|endoscopic mucosal resection
1253535|NCT01789749|adenoma recurrence|adenoma recurrence
1253536|NCT01789749|adenoma|adenoma
1253537|NCT01789749|colonoscopy|colonoscopy
1253538|NCT01789736|Glaucoma|glaucoma
1253539|NCT01789736|Ocular hypertension|ocular hypertension
1253540|NCT01789736|AR-12286|ar-12286
1253541|NCT01789736|Travoprost|travoprost
1253542|NCT01789710|smoking|smoking
1253543|NCT01789710|homelessness|homelessness
1253544|NCT01789710|contingency management|contingency management
1253545|NCT01789684|cluster|cluster
1253546|NCT01789684|genetic counseling|genetic counseling
1253547|NCT01789684|breast cancer|breast cancer
1253548|NCT01789684|HBOC|hboc
1253549|NCT01789684|provider intervention|provider intervention
1253550|NCT01789671|Childhood Obesity|childhood obesity
1253551|NCT01789658|Oral Mucositis|oral mucositis
1253552|NCT01789658|Children|children
1253553|NCT01789658|Cryotherapy|cryotherapy
1253554|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1253555|NCT01789645|Carpal tunnel|carpal tunnel
1253556|NCT01789645|Physical therapy|physical therapy
1253557|NCT01789645|Surgery|surgery
1253558|NCT01789645|Efficacy|efficacy
1253559|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
1253560|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
1253561|NCT01789580|problem gambling prevention|problem gambling prevention
1253562|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
1253563|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1253564|NCT01789554|Bystander CPR|bystander cpr
1253565|NCT01789554|Mobile phone positioning system|mobile phone positioning system
1253566|NCT01789528|Phase I,|phase i,
1253567|NCT01789528|open label,|open label,
1253568|NCT01789528|CAZ-AVI,|caz-avi,
1253569|NCT01789528|CXL,|cxl,
1253570|NCT01789528|healthy volunteers,|healthy volunteers,
1253571|NCT01789528|intestinal flora.|intestinal flora.
1253572|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
1253573|NCT01789476|pain|pain
1253574|NCT01789476|acute pain|acute pain
1253575|NCT01789476|kappa agonis|kappa agonis
1253576|NCT01789476|opioid analgesia|opioid analgesia
1253577|NCT01789476|bunionectomy|bunionectomy
1253578|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
1253579|NCT01789476|physiological effects of drugs|physiological effects of drugs
1253580|NCT01789476|surgery|surgery
1253581|NCT01789476|post-operative|post-operative
1253582|NCT01789476|post-operative complications|post-operative complications
1253583|NCT01789450|sensitivity|sensitivity
1253584|NCT01789450|section of periareolar dermis|section of periareolar dermis
1253585|NCT01789450|breast reduction|breast reduction
1253586|NCT01789437|retinal vein occlusion|retinal vein occlusion
1253587|NCT01789437|systemic hypertension|systemic hypertension
1253588|NCT01789437|arteriolar diameter|arteriolar diameter
1253589|NCT01789385|Deep brain stimulation|deep brain stimulation
1253590|NCT01789385|Parkinson|parkinson
1253591|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1253592|NCT01789372|yoga|yoga
1253593|NCT01789372|quality of life|quality of life
1253594|NCT01789372|blood pressure|blood pressure
1253595|NCT01789372|heart rate|heart rate
1253596|NCT01789372|heart rate variability|heart rate variability
1253597|NCT01789359|anthocyanin|anthocyanin
1253598|NCT01789359|bioavailability|bioavailability
1253599|NCT01789359|urine|urine
1253600|NCT01789359|long-term|long-term
1253601|NCT01789346|Scar|scar
1253602|NCT01789346|Scars|scars
1253603|NCT01789346|Surgical Scar|surgical scar
1253604|NCT01789346|Surgical Scars|surgical scars
1253605|NCT01789346|Cicatrix|cicatrix
1253606|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
1253607|NCT01789346|Keloid|keloid
1253608|NCT01789346|Hypertrophic Scar|hypertrophic scar
1253609|NCT01789346|Surgical Incision|surgical incision
1253610|NCT01789346|Scarring|scarring
1253611|NCT01789346|Abdominoplasty|abdominoplasty
1253612|NCT01789346|Tummy Tuck|tummy tuck
1253613|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
1253614|NCT01789346|Breast Augmentation|breast augmentation
1253615|NCT01789346|Thyroidectomy|thyroidectomy
1253616|NCT01789333|Keratoconus|keratoconus
1253617|NCT01789333|Ectasia|ectasia
1253618|NCT01789333|UVA light|uva light
1253619|NCT01789333|riboflavin|riboflavin
1253620|NCT01789333|post-LASIK|post-lasik
1253621|NCT01789333|irregular astigmatism|irregular astigmatism
1253622|NCT01789320|uveitis|uveitis
1253623|NCT01789320|intermediate uveitis|intermediate uveitis
1253624|NCT01789320|posterior uveitis|posterior uveitis
1253625|NCT01789320|panuveitis|panuveitis
1253626|NCT01789320|noninfectious uveitis|noninfectious uveitis
1253627|NCT01789320|microneedle|microneedle
1253628|NCT01789320|suprachoroidal space|suprachoroidal space
1253629|NCT01789320|SCS|scs
1253630|NCT01789320|inflammation|inflammation
1253631|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
1253632|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
1253633|NCT01789320|TA|ta
1253634|NCT01789320|Triesence|triesence
1253635|NCT01789320|injection|injection
1253636|NCT01789320|IVT|ivt
1253637|NCT01789320|intravitreal|intravitreal
1253638|NCT01789320|corticosteroid|corticosteroid
1253639|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
1253640|NCT01789320|temporal arteritis|temporal arteritis
1253641|NCT01789320|vitreous haze|vitreous haze
1253642|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
1253643|NCT01789294|food allergy|food allergy
1253644|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
1253645|NCT01789268|acute|acute
1253646|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
1253647|NCT01789268|infants|infants
1253648|NCT01789268|Lymphocyte|lymphocyte
1253649|NCT01789268|premature|premature
1253650|NCT01789268|respiratory viral infections|respiratory viral infections
1253651|NCT01789229|Breast cancer|breast cancer
1253652|NCT01789229|Ovarian cancer|ovarian cancer
1253653|NCT01789229|Endometrium carcinoma|endometrium carcinoma
1253654|NCT01789229|Cervix carcinoma,|cervix carcinoma,
1253655|NCT01789229|Mamma carcinoma,|mamma carcinoma,
1253656|NCT01789229|Prostata carcinoma|prostata carcinoma
1253657|NCT01789229|Colon carcinoma|colon carcinoma
1253658|NCT01789229|Rectal carcinoma|rectal carcinoma
1253659|NCT01789229|Bronchus carcinoma|bronchus carcinoma
1253660|NCT01789229|NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer)|nsclc (non small cell lung cancer) & sclc (small cell lung cancer)
1253661|NCT01789229|Prostate carcinoma|prostate carcinoma
1253662|NCT01789216|Pilon fractures|pilon fractures
1253663|NCT01789216|Calcaneus fractures|calcaneus fractures
1253664|NCT01789216|Acute pain|acute pain
1253665|NCT01789216|Chronic pain|chronic pain
1253666|NCT01789216|Isolated|isolated
1253667|NCT01789216|unilateral|unilateral
1253668|NCT01789216|Grade I|grade i
1253669|NCT01789216|Grade II|grade ii
1253670|NCT01789216|open|open
1253671|NCT01789216|closed|closed
1253672|NCT01789203|BK infection|bk infection
1253673|NCT01789203|BK viremia|bk viremia
1253674|NCT01789203|BK nephropathy|bk nephropathy
1253675|NCT01789203|polyomavirus|polyomavirus
1253676|NCT01789203|fluoroquinolone|fluoroquinolone
1253677|NCT01789203|ciprofloxacin|ciprofloxacin
1253678|NCT01789190|Honeymoon|honeymoon
1253679|NCT01789190|Type 1 diabetes|type 1 diabetes
1253680|NCT01789177|Spirometry|spirometry
1253681|NCT01789177|Postoperative Care|postoperative care
1253682|NCT01789164|TBI|tbi
1253683|NCT01789164|fNIRS|fnirs
1253684|NCT01789164|hypercapnea|hypercapnea
1253685|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
1253686|NCT01789151|arthritis|arthritis
1253687|NCT01789151|nuclear imaging|nuclear imaging
1253688|NCT01789151|rheumatoid|rheumatoid
1253689|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
1253690|NCT01789151|glucosamine|glucosamine
1253691|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
1253692|NCT01789138|Adherence|adherence
1253693|NCT01789138|Intervention|intervention
1253694|NCT01789125|anxiety|anxiety
1253695|NCT01789125|stress|stress
1253696|NCT01789125|smoking|smoking
1253697|NCT01789125|cessation|cessation
1253698|NCT01789099|Lung cancer|lung cancer
1253699|NCT01789099|Peptide vaccine|peptide vaccine
1253700|NCT01789073|Postoperative|postoperative
1253701|NCT01789073|Complications|complications
1253702|NCT01789073|Elective|elective
1253703|NCT01789073|Surgery|surgery
1253704|NCT01789073|GI surgery|gi surgery
1253705|NCT01789073|Immunonutrition|immunonutrition
1253706|NCT01789073|Immune-enhancing|immune-enhancing
1253707|NCT01789073|Immune-modulating|immune-modulating
1253708|NCT01789073|Nutrition|nutrition
1253709|NCT01789073|Pancreatic cancer|pancreatic cancer
1253710|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
1253711|NCT01789047|Parkinson's disease|parkinson's disease
1253712|NCT01789047|dyskinesia|dyskinesia
1253713|NCT01789047|Indonesia|indonesia
1253714|NCT01789047|amantadine|amantadine
1253715|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
1253716|NCT01789021|ISO 15197|iso 15197
1253717|NCT01789021|system accuracy|system accuracy
1253718|NCT01789008|Transient elastography|transient elastography
1253719|NCT01789008|Alcoholic liver disease|alcoholic liver disease
1253720|NCT01789008|liver fibrosis|liver fibrosis
1253721|NCT01788982|Thyroid Cancer|thyroid cancer
1253722|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
1253723|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
1253724|NCT01788969|Gait training|gait training
1253725|NCT01788969|Lexapro|lexapro
1253726|NCT01788969|Tizanidine|tizanidine
1253727|NCT01788956|venous oximeter|venous oximeter
1253728|NCT01788956|CO-Oximeter|co-oximeter
1253729|NCT01788956|ICU Patients|icu patients
1253730|NCT01788956|Sepsis|sepsis
1253731|NCT01788956|non-invasive device|non-invasive device
1253732|NCT01788943|positron emission tomography|positron emission tomography
1253733|NCT01788943|nicotine receptor|nicotine receptor
1253734|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
1253735|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
1253736|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
1253737|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
1253738|NCT01788904|Bowel necrosis|bowel necrosis
1253739|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
1253740|NCT01788891|multicenter|multicenter
1253741|NCT01788891|pediatrics|pediatrics
1253742|NCT01788891|Asian|asian
1253743|NCT01788891|treatment failure|treatment failure
1253744|NCT01788891|renal status|renal status
1253745|NCT01788891|toxicities|toxicities
1253746|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
1253747|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
1253748|NCT01788878|socio-professional future|socio-professional future
1253749|NCT01788865|covered Metal stent|covered metal stent
1253750|NCT01788865|ureteral obstruction|ureteral obstruction
1253752|NCT01788852|HIV|hiv
1253753|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
1253754|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
1253755|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
1253756|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
1253757|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
1253758|NCT01788852|anal and pap smear|anal and pap smear
1253759|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
1253760|NCT01788839|premenopausal|premenopausal
1253761|NCT01788839|postmenopausal|postmenopausal
1253762|NCT01788839|12-249|12-249
1253763|NCT01788839|Fertility|fertility
1253764|NCT01788826|Ventral hernia|ventral hernia
1253765|NCT01788826|surgical meshes|surgical meshes
1253766|NCT01788826|polypropylenes|polypropylenes
1253767|NCT01788813|Repeat Dose Safety|repeat dose safety
1253768|NCT01788813|Allergic Asthma|allergic asthma
1253769|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
1253770|NCT01788813|Allergic Rhinitis|allergic rhinitis
1253771|NCT01788813|TLR7 Agonist|tlr7 agonist
1253772|NCT01788813|Pharmacodynamics|pharmacodynamics
1253773|NCT01788800|Panic disorder|panic disorder
1253774|NCT01788800|Physical activity|physical activity
1253775|NCT01788787|Cancer Prevention|cancer prevention
1253776|NCT01788787|Tobacco Use Cessation|tobacco use cessation
1253777|NCT01788787|Ask Advise Connect|ask advise connect
1253778|NCT01788787|AAC|aac
1253779|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
1253780|NCT01788787|Texas Quitline|texas quitline
1253781|NCT01788787|Saliva sample|saliva sample
1253782|NCT01788787|Telephone Counseling|telephone counseling
1253783|NCT01788787|Nicotine replacement|nicotine replacement
1253784|NCT01788787|Interviews|interviews
1253785|NCT01788774|Pharmacokinetics|pharmacokinetics
1253786|NCT01788774|Safety|safety
1253787|NCT01788774|Risperidone ISM®|risperidone ism®
1253788|NCT01788774|Intramuscular|intramuscular
1253789|NCT01788774|Schizophrenia|schizophrenia
1253790|NCT01788761|Probiotics|probiotics
1253791|NCT01788761|Feeding Tolerance|feeding tolerance
1253792|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
1253793|NCT01788748|fractional|fractional
1253794|NCT01788748|bipolar|bipolar
1253795|NCT01788748|radiofrequency|radiofrequency
1253796|NCT01788748|striae|striae
1253797|NCT01788748|infrared|infrared
1253798|NCT01788748|combined|combined
1253799|NCT01788735|unexplained infertility|unexplained infertility
1253800|NCT01788735|asthma|asthma
1253801|NCT01788735|allergy|allergy
1253802|NCT01788709|colonoscopy|colonoscopy
1253803|NCT01788709|preparation|preparation
1253804|NCT01788696|Parkinsonism|parkinsonism
1254113|NCT01787500|RO5185426|ro5185426
1253805|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
1253806|NCT01788683|Rotator Cuff|rotator cuff
1253807|NCT01788683|Rotator Cuff Tear|rotator cuff tear
1253808|NCT01788683|Supraspinatus Tear|supraspinatus tear
1253809|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
1253810|NCT01788657|Depression|depression
1253811|NCT01788657|Internet|internet
1253812|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
1253813|NCT01788644|Child adiposity|child adiposity
1253814|NCT01788644|Infancy|infancy
1253815|NCT01788644|Motor activity|motor activity
1253816|NCT01788644|Feeding behavior|feeding behavior
1253817|NCT01788644|Sleep|sleep
1253818|NCT01788644|Stress, Physiological|stress, physiological
1253819|NCT01788618|Cognitive functions|cognitive functions
1253820|NCT01788618|Quality of life|quality of life
1253821|NCT01788618|Cancer|cancer
1253822|NCT01788605|hematologic malignancies|hematologic malignancies
1253823|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1253824|NCT01788605|ramosetron|ramosetron
1253825|NCT01788605|emesis|emesis
1253826|NCT01788592|coronary artery disease|coronary artery disease
1253827|NCT01788592|drug eluting stent|drug eluting stent
1253828|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
1253829|NCT01788579|Drug Abuse|drug abuse
1253830|NCT01788579|Criminal Justice|criminal justice
1253831|NCT01788553|remission|remission
1253832|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
1253833|NCT01788540|Recurrent miscarriage|recurrent miscarriage
1253834|NCT01788540|Implantation failure|implantation failure
1253835|NCT01788540|Intralipid|intralipid
1253836|NCT01788540|ICSI / IVF failure|icsi / ivf failure
1253837|NCT01788527|Diabetes|diabetes
1253838|NCT01788527|Type 1|type 1
1253840|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
1253841|NCT01788527|HGM|hgm
1253842|NCT01788527|HbA1c|hba1c
1253843|NCT01788488|procalcitonin|procalcitonin
1253844|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
1253845|NCT01788488|pneumonia|pneumonia
1253846|NCT01788475|Diabetic Macular Edema|diabetic macular edema
1253847|NCT01788475|DME|dme
1253848|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
1253849|NCT01788462|Tesamorelin|tesamorelin
1253850|NCT01788462|Egrifta|egrifta
1253851|NCT01788462|HIV|hiv
1253852|NCT01788462|Lipodystrophy|lipodystrophy
1253853|NCT01788462|Sleep Apnea|sleep apnea
1253854|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
1253855|NCT01788436|Schizophrenia|schizophrenia
1253856|NCT01788436|Young healthy volunteers|young healthy volunteers
1253857|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
1253858|NCT01788436|Learning performance|learning performance
1253859|NCT01788423|presbycusis|presbycusis
1253860|NCT01788423|hearing aids|hearing aids
1253861|NCT01788410|Cryoablation|cryoablation
1253862|NCT01788410|Nerves|nerves
1253863|NCT01788410|Facet joint|facet joint
1253864|NCT01788410|Pain|pain
1253865|NCT01788410|Neuralgia|neuralgia
1253866|NCT01788410|Neuropathy|neuropathy
1253867|NCT01788410|Image-guided|image-guided
1253868|NCT01788397|physical disabilities|physical disabilities
1253869|NCT01788397|rehabilitation|rehabilitation
1253870|NCT01788384|acne|acne
1253871|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
1253872|NCT01788384|Acanya|acanya
1253873|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
1253874|NCT01788358|Drug combination|drug combination
1253875|NCT01788358|Nifedipine GITS|nifedipine gits
1253876|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
1253877|NCT01788358|Hypertension|hypertension
1253878|NCT01788358|Combination therapy|combination therapy
1253879|NCT01788345|non-invasion ventilation|non-invasion ventilation
1253880|NCT01788345|Boussignac|boussignac
1253881|NCT01788332|NSCLC|nsclc
1253882|NCT01788332|non-small cell|non-small cell
1253883|NCT01788332|lung cancer|lung cancer
1253884|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
1253885|NCT01788319|glaucoma|glaucoma
1253886|NCT01788306|Elevated risk|elevated risk
1253887|NCT01788306|opioid overdose|opioid overdose
1253888|NCT01788293|Fluid management|fluid management
1253889|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
1253890|NCT01788293|monitoring|monitoring
1253891|NCT01788293|high-risk surgery|high-risk surgery
1253892|NCT01788267|Cystic Fibrosis|cystic fibrosis
1253893|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
1253894|NCT01788267|Bone Mass Density|bone mass density
1253895|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
1253896|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
1333168|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
1253897|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
1253898|NCT01788241|coronary artery disease|coronary artery disease
1253899|NCT01788241|Atherosclerosis|atherosclerosis
1253900|NCT01788241|Coronary Stenosis|coronary stenosis
1253901|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
1254114|NCT01787500|Cetuximab|cetuximab
1253902|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
1253903|NCT01788241|Mild Stenosis|mild stenosis
1253904|NCT01788241|Vascular Irregularities|vascular irregularities
1253905|NCT01788241|Psychosocial factors|psychosocial factors
1253906|NCT01788241|Personality|personality
1253907|NCT01788241|Type D personality|type d personality
1253908|NCT01788241|Hostility|hostility
1253909|NCT01788241|Depression|depression
1253911|NCT01788241|Fatigue|fatigue
1253912|NCT01788241|Social Support|social support
1253913|NCT01788241|Socioeconomic Status|socioeconomic status
1253914|NCT01788241|Patient Reported Outcomes|patient reported outcomes
1253915|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
1253916|NCT01788241|Health Status|health status
1253917|NCT01788241|Quality of Life|quality of life
1253918|NCT01788241|Chest pain|chest pain
1253919|NCT01788241|Cardiac risk factors|cardiac risk factors
1253920|NCT01788241|Metabolic Syndrome|metabolic syndrome
1253922|NCT01788241|Obesity|obesity
1253923|NCT01788241|Waist Circumference|waist circumference
1253924|NCT01788241|Lifestyle|lifestyle
1253925|NCT01788241|Smoking|smoking
1253926|NCT01788241|Alcohol use|alcohol use
1253927|NCT01788241|Activity|activity
1253928|NCT01788241|Hypertension|hypertension
1253929|NCT01788241|Diabetes|diabetes
1253930|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
1253931|NCT01788241|Coronary angiography|coronary angiography
1253932|NCT01788241|Computed Tomography|computed tomography
1253933|NCT01788228|Vaccine|vaccine
1253934|NCT01788228|Occupational exposure|occupational exposure
1253935|NCT01788228|Influenza|influenza
1253936|NCT01788228|H5N1|h5n1
1253937|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1253938|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
1253939|NCT01788215|Androgen Excess in Women|androgen excess in women
1253940|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
1253941|NCT01788189|Lymphoma|lymphoma
1253942|NCT01788189|CD20|cd20
1253943|NCT01788189|Relapse|relapse
1253944|NCT01788189|Lenalidomide|lenalidomide
1253945|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
1253946|NCT01788176|drug therapy|drug therapy
1253947|NCT01788176|zoledronic acid|zoledronic acid
1253948|NCT01788163|EGFR|egfr
1253949|NCT01788163|aNSCLC|ansclc
1253950|NCT01788163|mutation status|mutation status
1253951|NCT01788163|diagnostic study|diagnostic study
1253952|NCT01788163|Russia|russia
1253953|NCT01788163|China|china
1253954|NCT01788163|Asia|asia
1253955|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
1253956|NCT01788124|Speculum|speculum
1253957|NCT01788124|Metal|metal
1253958|NCT01788124|Plastic|plastic
1253959|NCT01788124|Visual Analoge Scale|visual analoge scale
1253960|NCT01788124|Discomfort|discomfort
1253961|NCT01788085|GERD|gerd
1253962|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
1253963|NCT01788072|Oxytocin|oxytocin
1253964|NCT01788072|Adults|adults
1253965|NCT01788059|nonunion|nonunion
1253966|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
1253967|NCT01788059|long bone|long bone
1253968|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
1253969|NCT01788007|Actinic Keratosis|actinic keratosis
1253970|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
1253971|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
1253972|NCT01787968|Congenital transmission|congenital transmission
1253973|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
1253974|NCT01787968|Chagas disease|chagas disease
1253975|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
1253976|NCT01787942|Lipid thickness|lipid thickness
1253977|NCT01787942|Blepharoplasty|blepharoplasty
1253978|NCT01787942|Tear break up time|tear break up time
1253979|NCT01787942|Corneal staining|corneal staining
1253980|NCT01787916|type 1 diabetes|type 1 diabetes
1253981|NCT01787916|overweight|overweight
1253982|NCT01787916|insulin|insulin
1253983|NCT01787916|liraglutide|liraglutide
1253984|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
1253985|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
1253986|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
1253987|NCT01787903|Glucose control|glucose control
1253988|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
1253989|NCT01787864|Barrett's Esophagus|barrett's esophagus
1253990|NCT01787864|Intestinal metaplasia|intestinal metaplasia
1253991|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
1253992|NCT01787864|Gastric Cardia|gastric cardia
1253993|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
1253994|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
1253995|NCT01787851|Heart failure|heart failure
1253996|NCT01787851|Anaplerosis|anaplerosis
1253997|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
1254115|NCT01787500|C225|c225
1253998|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
1253999|NCT01787825|intestinal disease|intestinal disease
1254000|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
1254001|NCT01787825|crohn disease|crohn disease
1254002|NCT01787825|ulcer|ulcer
1254003|NCT01787825|celiac disease|celiac disease
1254004|NCT01787825|angioectasia|angioectasia
1254005|NCT01787825|polyp|polyp
1254006|NCT01787799|Drug-eluting stents|drug-eluting stents
1254007|NCT01787786|Crohn's Disease|crohn's disease
1254008|NCT01787786|Ulcerative Colitis|ulcerative colitis
1254009|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
1254010|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
1254011|NCT01787773|Vena Cava Filters|vena cava filters
1254012|NCT01787747|Pharmacokinetics|pharmacokinetics
1254013|NCT01787747|Healthy Volunteers|healthy volunteers
1254014|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
1254015|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
1254016|NCT01787721|Gait|gait
1254017|NCT01787721|Ankle joint|ankle joint
1254018|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
1254019|NCT01787708|Vitiligo|vitiligo
1254020|NCT01787708|red|red
1254021|NCT01787708|laser|laser
1254022|NCT01787708|light|light
1254023|NCT01787695|Vitiligo|vitiligo
1254024|NCT01787695|UVA1|uva1
1254025|NCT01787695|Phototherapy|phototherapy
1254026|NCT01787682|CHF|chf
1254027|NCT01787682|Protein digestion|protein digestion
1254028|NCT01787682|Fat digestion|fat digestion
1254029|NCT01787682|Gut function|gut function
1254030|NCT01787682|Glucose absorption|glucose absorption
1254031|NCT01787682|Muscle function|muscle function
1254032|NCT01787669|diabetic macular oedema|diabetic macular oedema
1254033|NCT01787669|diabetic macular edema|diabetic macular edema
1254034|NCT01787669|diabetic retinopathy|diabetic retinopathy
1254035|NCT01787669|dexamethasone|dexamethasone
1254036|NCT01787669|Ozurdex|ozurdex
1254037|NCT01787669|Avastin|avastin
1254038|NCT01787669|bevacizumab|bevacizumab
1254039|NCT01787669|DME|dme
1254040|NCT01787669|DMO|dmo
1254041|NCT01787643|height-adjustable desk|height-adjustable desk
1254042|NCT01787643|office workers|office workers
1254043|NCT01787643|sitting occupations|sitting occupations
1254044|NCT01787643|energy expenditure|energy expenditure
1254045|NCT01787643|BMI|bmi
1254046|NCT01787643|Weight|weight
1254047|NCT01787643|Lower fat diet|lower fat diet
1254048|NCT01787630|Prostatic cancer|prostatic cancer
1254049|NCT01787630|Radiotherapy|radiotherapy
1254050|NCT01787630|Hyaluronic acid|hyaluronic acid
1254051|NCT01787617|Exercise Training|exercise training
1254052|NCT01787617|Strength Training|strength training
1254053|NCT01787617|African American Men|african american men
1254054|NCT01787617|Insulin Resistance|insulin resistance
1254055|NCT01787604|Valve-sparing|valve-sparing
1254056|NCT01787604|Valve repair|valve repair
1254057|NCT01787591|Vitamin E|vitamin e
1254058|NCT01787591|Metabolic syndrome|metabolic syndrome
1254059|NCT01787591|Liver disease|liver disease
1254060|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
1254061|NCT01787591|Fatty liver|fatty liver
1254062|NCT01787591|Dairy consumption|dairy consumption
1254063|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
1254064|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
1254065|NCT01787578|sobetirome|sobetirome
1254066|NCT01787578|thyroid|thyroid
1254067|NCT01787578|thyromimetic|thyromimetic
1254068|NCT01787565|non-interventional|non-interventional
1254069|NCT01787565|clinical|clinical
1254070|NCT01787565|investigation|investigation
1254071|NCT01787565|low|low
1254072|NCT01787565|back|back
1254073|NCT01787565|pain|pain
1254074|NCT01787565|painPREMIER|painpremier
1254075|NCT01787552|Dose escalation|dose escalation
1254076|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
1254077|NCT01787552|MTD|mtd
1254078|NCT01787552|Safety Expansion|safety expansion
1254079|NCT01787552|Safety|safety
1254080|NCT01787552|Efficacy|efficacy
1254081|NCT01787552|Myelofibrosis|myelofibrosis
1254082|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
1254083|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
1254084|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
1254085|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
1254086|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
1254087|NCT01787552|Combination Treatment|combination treatment
1254088|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
1600342|NCT00392951|Sirolimus|sirolimus
1254089|NCT01787552|Smoothened inhibitor|smoothened inhibitor
1254090|NCT01787552|JAK inhibitor|jak inhibitor
1254091|NCT01787539|gastric cancer|gastric cancer
1254107|NCT01787500|Metastatic|metastatic
1254108|NCT01787500|Unresectable|unresectable
1254109|NCT01787500|BRAF mutant, KRAS wild type colorectal cancer|braf mutant, kras wild type colorectal cancer
1254110|NCT01787500|BRAF mutant, KRAS wild type solid tumor cancers|braf mutant, kras wild type solid tumor cancers
1254111|NCT01787500|Vemurafenib|vemurafenib
1254112|NCT01787500|PLX4032|plx4032
1254116|NCT01787500|Erbitux|erbitux
1254117|NCT01787500|IMC-C225|imc-c225
1254118|NCT01787500|Irinotecan|irinotecan
1254119|NCT01787500|CPT-11|cpt-11
1254120|NCT01787500|Camptosar|camptosar
1254121|NCT01787487|Leukemia|leukemia
1254122|NCT01787487|Myelofibrosis|myelofibrosis
1254123|NCT01787487|Myelodysplastic syndrome|myelodysplastic syndrome
1254124|NCT01787487|Myeloproliferative neoplasm|myeloproliferative neoplasm
1254125|NCT01787487|Ruxolitinib|ruxolitinib
1254126|NCT01787487|RUX|rux
1254127|NCT01787487|Jakafi|jakafi
1254128|NCT01787487|INCB018424|incb018424
1254129|NCT01787487|INC424|inc424
1254130|NCT01787487|Azacitidine|azacitidine
1254131|NCT01787487|AZA|aza
1254132|NCT01787487|5-Azacitidine|5-azacitidine
1254133|NCT01787487|5-aza|5-aza
1254134|NCT01787487|Vidaza|vidaza
1254135|NCT01787487|5-AZC|5-azc
1254136|NCT01787487|AZA-CR|aza-cr
1254137|NCT01787487|Ladakamycin|ladakamycin
1254138|NCT01787487|NSC-102816|nsc-102816
1254156|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
1254157|NCT01787448|repeat insult patch test|repeat insult patch test
1254158|NCT01787435|Asthma,|asthma,
1254159|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
1254160|NCT01787435|pregnancy,|pregnancy,
1254161|NCT01787435|epidemiology|epidemiology
1254162|NCT01787422|Telemedicine|telemedicine
1254163|NCT01787383|Actinic Keratosis|actinic keratosis
1254164|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
1254165|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
1254166|NCT01787357|Healthy|healthy
1254167|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1254168|NCT01787357|Pharmacokinetics|pharmacokinetics
1254169|NCT01787357|Moxifloxacin|moxifloxacin
1254170|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
1254171|NCT01787357|QT/QTc Interval|qt/qtc interval
1254172|NCT01787357|Therapeutic dose|therapeutic dose
1254173|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
1254174|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
1254175|NCT01787305|microbiome|microbiome
1254176|NCT01787305|commensals|commensals
1254177|NCT01787305|autoantibodies|autoantibodies
1254178|NCT01787305|autoreactive T cells|autoreactive t cells
1254179|NCT01787292|Exercise|exercise
1254180|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
1254181|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1254182|NCT01787292|Aging|aging
1254183|NCT01787214|glucose variability|glucose variability
1254184|NCT01787214|glycemia|glycemia
1254185|NCT01787214|type-2 diabetes|type-2 diabetes
1254186|NCT01787175|Medication Therapy Management|medication therapy management
1254187|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
1254188|NCT01787175|Medical Informatics|medical informatics
1254189|NCT01787175|Patient Care Management|patient care management
1254579|NCT01785472|LCZ696|lcz696
1254190|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
1254191|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
1254192|NCT01787162|pulmonary hypertension|pulmonary hypertension
1254193|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
1254194|NCT01787149|ENIA11|enia11
1254195|NCT01787149|DMARDs|dmards
1254196|NCT01787149|RA|ra
1254197|NCT01787149|TNF|tnf
1254198|NCT01787110|Acute coronary syndrome|acute coronary syndrome
1254199|NCT01787110|Acute myocardial infarction|acute myocardial infarction
1254200|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
1254201|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
1254202|NCT01787110|STEMI|stemi
1254203|NCT01787110|NSTEMI|nstemi
1254204|NCT01787110|Oxygen|oxygen
1254205|NCT01787110|Unstable angina|unstable angina
1254206|NCT01787110|Randomised trial|randomised trial
1254207|NCT01787110|CMR|cmr
1254208|NCT01787110|Mortality|mortality
1254209|NCT01787110|RCRT|rcrt
1254210|NCT01787110|RRCT|rrct
1254211|NCT01787084|Aortic Stenosis|aortic stenosis
1254212|NCT01787084|TAVR|tavr
1254213|NCT01787071|fluids|fluids
1254214|NCT01787071|crtically ill patients|crtically ill patients
1254215|NCT01787071|functional hemodynamics|functional hemodynamics
1254216|NCT01787071|cvp|cvp
1254217|NCT01787058|WASH|wash
1254218|NCT01787058|schoolchildren|schoolchildren
1254219|NCT01787058|absenteeism|absenteeism
1254220|NCT01787045|SEPSIS|sepsis
1254221|NCT01787006|non resectable|non resectable
1254222|NCT01787006|locally advanced|locally advanced
1254223|NCT01787006|Cetuximab|cetuximab
1254224|NCT01787006|radiation|radiation
1254225|NCT01786967|overactive bladder|overactive bladder
1254226|NCT01786967|urge urinary incontinence|urge urinary incontinence
1254227|NCT01786967|pharmacogenetics|pharmacogenetics
1254228|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
1254229|NCT01786954|intraocular pressure|intraocular pressure
1254230|NCT01786954|applanation|applanation
1254231|NCT01786954|rebound|rebound
1254232|NCT01786954|tonometry|tonometry
1254520|NCT01785680|MAM|mam
1254233|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
1254234|NCT01786941|Insulin Sensitivity|insulin sensitivity
1254235|NCT01786941|Exercise|exercise
1254236|NCT01786941|Leucine|leucine
1254237|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1254238|NCT01786928|exacerbation|exacerbation
1254239|NCT01786928|resistance training|resistance training
1254240|NCT01786928|muscle force|muscle force
1254241|NCT01786902|growth hormone|growth hormone
1254242|NCT01786876|AME|ame
1254243|NCT01786876|Radiolabelled|radiolabelled
1254244|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
1254245|NCT01786850|Noninvasive treatment|noninvasive treatment
1254246|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
1254247|NCT01786850|Magnetic Resonance|magnetic resonance
1254248|NCT01786837|constipation|constipation
1254249|NCT01786837|gastric emptying|gastric emptying
1254250|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
1254251|NCT01786824|hydration strategy|hydration strategy
1254252|NCT01786824|L-carnitine|l-carnitine
1254253|NCT01786798|Transvaginal sonography|transvaginal sonography
1254254|NCT01786798|Endometrial thickness|endometrial thickness
1254255|NCT01786798|Endometrial pattern|endometrial pattern
1254256|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
1254257|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
1254258|NCT01786798|Endometrial cancer|endometrial cancer
1254259|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
1254260|NCT01786772|meniscus|meniscus
1254261|NCT01786772|quadriceps strength|quadriceps strength
1254262|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
1254263|NCT01786772|cryotherapy|cryotherapy
1254264|NCT01786772|compression|compression
1254265|NCT01786772|vasopneumatic compression|vasopneumatic compression
1254266|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
1254267|NCT01786759|lipids|lipids
1254268|NCT01786759|preterm infants|preterm infants
1254269|NCT01786759|parenteral nutrition|parenteral nutrition
1254270|NCT01786759|liver function|liver function
1254271|NCT01786746|depression|depression
1254272|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
1254273|NCT01786746|culture|culture
1254274|NCT01786746|Chinese Americans|chinese americans
1254275|NCT01786746|psychotherapy|psychotherapy
1254276|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
1254277|NCT01786733|Continuity of Care|continuity of care
1254278|NCT01786733|Behavioral Activation|behavioral activation
1254279|NCT01786733|Depression|depression
1254280|NCT01786720|COPD|copd
1254281|NCT01786720|Triple Therapy|triple therapy
1254282|NCT01786720|ICS|ics
1254283|NCT01786720|LABA|laba
1254284|NCT01786720|LAMA|lama
1254285|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1254286|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
1254287|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
1254288|NCT01786707|Stem cells (SC)|stem cells (sc)
1254289|NCT01786694|rectum|rectum
1254290|NCT01786694|microdialysis|microdialysis
1254291|NCT01786694|quality of life|quality of life
1254292|NCT01786681|Morbid obesity|morbid obesity
1254293|NCT01786681|Bariatric Surgery|bariatric surgery
1254294|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
1254295|NCT01786681|Spirometry|spirometry
1254296|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
1254297|NCT01786681|Physical Therapy Specialty|physical therapy specialty
1254298|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
1254299|NCT01786668|Spondylitis|spondylitis
1254300|NCT01786668|Ankylosing|ankylosing
1254301|NCT01786668|Spondyloarthritis|spondyloarthritis
1254302|NCT01786668|Spondyloarthropathy|spondyloarthropathy
1254303|NCT01786668|Oral preparation|oral preparation
1254304|NCT01786655|local anesthetic|local anesthetic
1254305|NCT01786655|neosaxitoxin|neosaxitoxin
1254306|NCT01786655|neoSTX|neostx
1254307|NCT01786655|bupivacaine|bupivacaine
1254308|NCT01786655|safety|safety
1254309|NCT01786655|phase 1|phase 1
1254310|NCT01786655|pharmacokinetic|pharmacokinetic
1254311|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
1254312|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
1254313|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
1254314|NCT01786577|Executive Decline|executive decline
1600343|NCT00392951|Rapamycin|rapamycin
1254315|NCT01786577|Post-operative cognitive change|post-operative cognitive change
1254316|NCT01786564|diabetes|diabetes
1254317|NCT01786564|sleep|sleep
1254318|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
1254319|NCT01786525|LDKT|ldkt
1254320|NCT01786525|African American|african american
1254321|NCT01786525|Disparity|disparity
1254322|NCT01786525|Education|education
1254323|NCT01786525|Patient Support|patient support
1254324|NCT01786512|Pharmacokinetics|pharmacokinetics
1254325|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
1254326|NCT01786512|AMG 423|amg 423
1254327|NCT01786512|Double-blind|double-blind
1254328|NCT01786512|Randomized|randomized
1254329|NCT01786512|Placebo-controlled|placebo-controlled
1254330|NCT01786512|Oral forumlation|oral forumlation
1254331|NCT01786512|CK-1827452|ck-1827452
1254332|NCT01786512|Cardiac myosin activator|cardiac myosin activator
1254333|NCT01786499|Burnout|burnout
1254334|NCT01786499|Stress|stress
1254335|NCT01786499|Provider|provider
1254336|NCT01786499|Relaxation Response|relaxation response
1254337|NCT01786434|colonoscopy|colonoscopy
1254338|NCT01786434|pain|pain
1254339|NCT01786421|Ethanol|ethanol
1254340|NCT01786421|Lipemia|lipemia
1254341|NCT01786421|Postprandial|postprandial
1254342|NCT01786421|Triglyceride|triglyceride
1254343|NCT01786395|UF-021|uf-021
1254344|NCT01786395|unoprostone|unoprostone
1254345|NCT01786395|rp|rp
1254346|NCT01786369|Schizophrenia|schizophrenia
1254347|NCT01786369|Psychotic Disorders|psychotic disorders
1254348|NCT01786369|Bipolar Disorder|bipolar disorder
1254349|NCT01786369|Antipsychotic Agents|antipsychotic agents
1254350|NCT01786369|Drug Monitoring|drug monitoring
1254351|NCT01786356|posterior capsule opacification|posterior capsule opacification
1254352|NCT01786356|PCO|pco
1254353|NCT01786356|after cataract|after cataract
1254354|NCT01786356|intraocular lens|intraocular lens
1254355|NCT01786343|Leukemia|leukemia
1254356|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
1254357|NCT01786343|AML|aml
1254358|NCT01786343|Response rates|response rates
1254359|NCT01786343|Decitabine|decitabine
1254360|NCT01786343|Dacogen|dacogen
1254361|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
1254362|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
1254363|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
1254364|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
1254365|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
1254366|NCT01786291|VE/VCO2|ve/vco2
1254367|NCT01786278|adenocarcinoma|adenocarcinoma
1254368|NCT01786278|esophago-gastric junction|esophago-gastric junction
1254369|NCT01786278|dysphagia|dysphagia
1254370|NCT01786278|brachytherapy|brachytherapy
1254371|NCT01786278|endoscopic stenting|endoscopic stenting
1254372|NCT01786265|Prostate Cancer|prostate cancer
1254373|NCT01786265|PSA Progression After Prostatectomy and/or Radiotherapy|psa progression after prostatectomy and/or radiotherapy
1254374|NCT01786265|Prostate specific antigen|prostate specific antigen
1254375|NCT01786265|PSA|psa
1254376|NCT01786265|Luteinizing-hormone-releasing hormone|luteinizing-hormone-releasing hormone
1254377|NCT01786265|LHRH|lhrh
1254378|NCT01786265|Finite maximal androgen ablation|finite maximal androgen ablation
1254379|NCT01786265|Lupron|lupron
1254380|NCT01786265|Leuprolide Acetate|leuprolide acetate
1254381|NCT01786265|Lupron Depot|lupron depot
1254382|NCT01786265|Zoladex|zoladex
1254383|NCT01786265|Goserelin|goserelin
1254384|NCT01786265|Degarelix|degarelix
1254385|NCT01786265|Abiraterone Acetate|abiraterone acetate
1254386|NCT01786265|Zytiga|zytiga
1254387|NCT01786265|Prednisone|prednisone
1254388|NCT01786252|embryo|embryo
1254389|NCT01786252|implantation|implantation
1254390|NCT01786252|blastocyst|blastocyst
1254391|NCT01786252|in vitro fertilization|in vitro fertilization
1254392|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
1254393|NCT01786239|Adolescence|adolescence
1254394|NCT01786239|Adult|adult
1254395|NCT01786239|Antipsychotic Agents|antipsychotic agents
1254396|NCT01786239|Female|female
1254397|NCT01786239|Human|human
1254398|NCT01786239|Male|male
1254399|NCT01786239|Risperidone|risperidone
1254400|NCT01786239|Omega-3|omega-3
1254401|NCT01786239|Schizophrenia|schizophrenia
1254402|NCT01786239|Schizophreniform|schizophreniform
1254403|NCT01786239|Schizoaffective|schizoaffective
1254404|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
1254405|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
1254406|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
1254407|NCT01786200|colon|colon
1254408|NCT01786200|cancer|cancer
1254409|NCT01786200|NSAID|nsaid
1254410|NCT01786200|inflammation|inflammation
1254411|NCT01786187|Lung Cancer|lung cancer
1254412|NCT01786187|Symptoms|symptoms
1254413|NCT01786174|ALS|als
1254414|NCT01786174|Gilenya|gilenya
1254415|NCT01786174|Fingolimod|fingolimod
1254416|NCT01786148|HIV/AIDS|hiv/aids
1254417|NCT01786148|Adherence|adherence
1254418|NCT01786148|Self-management|self-management
1254419|NCT01786148|Antiretroviral therapy|antiretroviral therapy
1254420|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
1254421|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
1254422|NCT01786135|Antigens, CD19|antigens, cd19
1254423|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
1254424|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
1254425|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1254426|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
1254427|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
1254428|NCT01786135|Drug Therapy|drug therapy
1254429|NCT01786135|Monomethylauristatin F|monomethylauristatin f
1254430|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
1254521|NCT01785680|SAM|sam
1254431|NCT01786122|physical exercise|physical exercise
1254432|NCT01786122|Health Related Quality of Life|health related quality of life
1254433|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1254434|NCT01786122|digestive system neoplasms|digestive system neoplasms
1254435|NCT01786122|breast neoplasms|breast neoplasms
1254436|NCT01786109|anandamide|anandamide
1254437|NCT01786109|cannabinoid|cannabinoid
1254438|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
1254439|NCT01786109|gastric|gastric
1254440|NCT01786109|motility|motility
1254441|NCT01786109|small bowel|small bowel
1254442|NCT01786109|sensory|sensory
1254443|NCT01786109|motor|motor
1254444|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
1254445|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
1254446|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
1254447|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
1254448|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
1254449|NCT01786096|Burkitt Leukemia|burkitt leukemia
1254450|NCT01786096|Monomethylauristatin F|monomethylauristatin f
1254451|NCT01786096|Antigens, CD19|antigens, cd19
1254452|NCT01786096|Drug Therapy|drug therapy
1254453|NCT01786083|family caregivers|family caregivers
1254454|NCT01786083|dependency|dependency
1254455|NCT01786083|Problem Solving Technique|problem solving technique
1254456|NCT01786083|home based nursing|home based nursing
1254457|NCT01786044|patient education|patient education
1254458|NCT01786044|primary health care|primary health care
1254459|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
1254460|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
1254461|NCT01786018|Thiotepa|thiotepa
1254462|NCT01786018|Busulfan|busulfan
1254463|NCT01786018|Fludarabin|fludarabin
1254464|NCT01785992|Oestrogen receptor|oestrogen receptor
1254465|NCT01785992|Locally advanced|locally advanced
1254466|NCT01785992|Metastatic|metastatic
1254467|NCT01785992|Breast cancer|breast cancer
1254468|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
1254469|NCT01785966|Critical care|critical care
1254470|NCT01785966|quality improvement|quality improvement
1254471|NCT01785966|checklist|checklist
1254472|NCT01785940|Interscalene Block|interscalene block
1254473|NCT01785940|Perineural catheter|perineural catheter
1254474|NCT01785940|Ropivacaine|ropivacaine
1254475|NCT01785940|Postoperative pain|postoperative pain
1254476|NCT01785940|Home regional|home regional
1254477|NCT01785927|Antituberculosis|antituberculosis
1254478|NCT01785927|Dry powder aerosols|dry powder aerosols
1254479|NCT01785927|Inhalation|inhalation
1254480|NCT01785901|asthma|asthma
1254481|NCT01785901|control rate|control rate
1254482|NCT01785901|budesonide/formoterol|budesonide/formoterol
1254483|NCT01785901|Non-Interventional study|non-interventional study
1254484|NCT01785888|EGFR,|egfr,
1254485|NCT01785888|aNSCLC,|ansclc,
1254486|NCT01785888|mutation status,|mutation status,
1254487|NCT01785888|diagnostic study,|diagnostic study,
1254488|NCT01785888|Europe,|europe,
1254489|NCT01785888|Japan|japan
1254580|NCT01785459|headache|headache
1254581|NCT01785459|migraine|migraine
1254582|NCT01785459|bupivacaine|bupivacaine
1254490|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
1254491|NCT01785862|sore throat pain|sore throat pain
1254492|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
1254493|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
1254494|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
1254495|NCT01785823|analgesia|analgesia
1254496|NCT01785823|fentanyl|fentanyl
1254497|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
1254498|NCT01785758|complications, renal;|complications, renal;
1254499|NCT01785758|kidney, failure;|kidney, failure;
1254500|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
1254501|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
1254502|NCT01785758|safety, drug|safety, drug
1254503|NCT01785758|sugammadex|sugammadex
1254504|NCT01785745|conservative treatment|conservative treatment
1254505|NCT01785745|shoulder|shoulder
1254506|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
1254507|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
1254508|NCT01785745|pain|pain
1254509|NCT01785719|Weight Loss|weight loss
1254510|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1254511|NCT01785719|Ovarian Follicle Development|ovarian follicle development
1254512|NCT01785719|Metabolism|metabolism
1254513|NCT01785693|Nerve block|nerve block
1254514|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
1254515|NCT01785693|Postoperative analgesia|postoperative analgesia
1254516|NCT01785693|Peripheral circulation|peripheral circulation
1254517|NCT01785693|Levobupivacaine|levobupivacaine
1254518|NCT01785693|Clonidine|clonidine
1254519|NCT01785693|Pain|pain
1254522|NCT01785654|Reventilation collapse|reventilation collapse
1254523|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
1254524|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
1254525|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
1254526|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
1254527|NCT01785641|peritoneal dialysis|peritoneal dialysis
1254528|NCT01785641|peritonitis|peritonitis
1254529|NCT01785628|Parkinson's disease|parkinson's disease
1254530|NCT01785628|dementia|dementia
1254531|NCT01785628|NMDA|nmda
1254532|NCT01785628|event related potential|event related potential
1254533|NCT01785628|Bereitschaftspotential|bereitschaftspotential
1254534|NCT01785615|metabolic syndrome|metabolic syndrome
1254535|NCT01785615|atorvastatin|atorvastatin
1254536|NCT01785615|women|women
1254537|NCT01785602|Atopic eczema|atopic eczema
1254538|NCT01785602|Skin Diseases|skin diseases
1254539|NCT01785589|coronary artery disease|coronary artery disease
1254540|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
1254541|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
1254542|NCT01785589|invasive coronary angiography|invasive coronary angiography
1254543|NCT01785576|couples|couples
1254544|NCT01785576|head and neck cancer|head and neck cancer
1254545|NCT01785576|oncology|oncology
1254546|NCT01785576|spousal support|spousal support
1254547|NCT01785563|NAVA|nava
1254548|NCT01785563|NIV-NAVA|niv-nava
1254549|NCT01785563|VLBW|vlbw
1254550|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
1254551|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
1254552|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
1254553|NCT01785537|e-cigarette smoking|e-cigarette smoking
1254554|NCT01785537|cigarette smoking|cigarette smoking
1254555|NCT01785537|cardiovascular disease|cardiovascular disease
1254556|NCT01785537|hospitalization|hospitalization
1254557|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
1254558|NCT01785537|observational study|observational study
1254559|NCT01785537|efficacy|efficacy
1254560|NCT01785537|safety|safety
1254561|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
1254562|NCT01785524|Vascular Diseases|vascular diseases
1254563|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
1254564|NCT01785524|Diabetes|diabetes
1254565|NCT01785524|Exercise|exercise
1254566|NCT01785524|Functional Capacity|functional capacity
1254567|NCT01785511|hypertension|hypertension
1254568|NCT01785511|UV radiation|uv radiation
1254569|NCT01785511|coronary flow reserve|coronary flow reserve
1254570|NCT01785511|nitric oxide|nitric oxide
1254571|NCT01785498|children|children
1254572|NCT01785498|quality of life|quality of life
1254573|NCT01785498|physical activity|physical activity
1254574|NCT01785498|healthy lifestyle|healthy lifestyle
1254575|NCT01785485|Integrative medicine|integrative medicine
1254576|NCT01785485|primary care|primary care
1254577|NCT01785485|cost-effectiveness|cost-effectiveness
1254578|NCT01785472|Essential hypertension|essential hypertension
1254583|NCT01785446|Dexmedetomidine|dexmedetomidine
1254584|NCT01785446|Cisatracurion infusion|cisatracurion infusion
1254585|NCT01785446|Sufentanil|sufentanil
1254586|NCT01785446|Recovery Index|recovery index
1254587|NCT01785446|Closed loop computer control system|closed loop computer control system
1254588|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
1254589|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
1254590|NCT01785407|Iron bio availability|iron bio availability
1254591|NCT01785407|Hepcidin|hepcidin
1254592|NCT01785407|Iron absorption|iron absorption
1254593|NCT01785394|pollinosis|pollinosis
1254594|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
1254595|NCT01785394|exhaled breath temperature|exhaled breath temperature
1254596|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
1254597|NCT01785368|guidelines|guidelines
1254598|NCT01785368|referral guidelines|referral guidelines
1254599|NCT01785368|exam delays|exam delays
1254600|NCT01785368|exam relevance|exam relevance
1254601|NCT01785355|periodontal disease|periodontal disease
1254602|NCT01785355|CKD|ckd
1254603|NCT01785355|nutrition|nutrition
1254604|NCT01785355|inflammation|inflammation
1254605|NCT01785355|anemia response to ESA|anemia response to esa
1254606|NCT01785355|quality of life|quality of life
1254607|NCT01785355|hemodialysis|hemodialysis
1254608|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
1254609|NCT01785303|CBT|cbt
1254610|NCT01785303|CPAP|cpap
1254611|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
1254612|NCT01785303|Combination treatment|combination treatment
1254613|NCT01785290|Delirium|delirium
1254614|NCT01785290|Survival|survival
1254615|NCT01785290|Side-effects|side-effects
1254616|NCT01785290|QoL|qol
1254617|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
1254618|NCT01785277|SCIM|scim
1254619|NCT01785277|Spinal cord injury|spinal cord injury
1254620|NCT01785277|Traumatic spine injury|traumatic spine injury
1254621|NCT01785264|Achilles|achilles
1254622|NCT01785264|Tendon|tendon
1254623|NCT01785264|Rupture|rupture
1254624|NCT01785264|Acute|acute
1254625|NCT01785264|Treatment|treatment
1254626|NCT01785264|Outcome measure|outcome measure
1254627|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
1254628|NCT01785251|NMES|nmes
1254629|NCT01785251|Deep vein thrombosis|deep vein thrombosis
1254630|NCT01785251|DVT|dvt
1254631|NCT01785251|total hip arthroplasty|total hip arthroplasty
1254632|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
1254633|NCT01785238|preterm infants|preterm infants
1254634|NCT01785238|acute renal failure|acute renal failure
1254635|NCT01785238|nephronic reduction|nephronic reduction
1254636|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
1254637|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
1254638|NCT01785199|body posture|body posture
1254639|NCT01785199|ultra-wideband|ultra-wideband
1254640|NCT01785186|TB|tb
1254641|NCT01785186|Tuberculosis|tuberculosis
1254642|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
1254643|NCT01785186|Pulmonary|pulmonary
1254644|NCT01785186|SQ109|sq109
1254645|NCT01785186|High dose rifampicin|high dose rifampicin
1254646|NCT01785186|moxifloxacin|moxifloxacin
1254647|NCT01785173|Endoscopes|endoscopes
1254648|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
1254649|NCT01785173|Transnasal endoscopy|transnasal endoscopy
1254650|NCT01785173|Nasal anesthesia|nasal anesthesia
1254651|NCT01785147|Tobacco addition|tobacco addition
1254652|NCT01785134|Obesity|obesity
1254653|NCT01785134|Bariatric Surgery|bariatric surgery
1254654|NCT01785134|Insulin Sensitivity|insulin sensitivity
1254655|NCT01785108|Diamyd|diamyd
1254656|NCT01785108|Diabetes|diabetes
1254657|NCT01785108|Juvenile Diabetes|juvenile diabetes
1254658|NCT01785108|Diabetes type 1|diabetes type 1
1254659|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
1254660|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
1254661|NCT01785108|Type 1 diabetes|type 1 diabetes
1254662|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
1254663|NCT01785108|rhGAD65|rhgad65
1254664|NCT01785108|GAD|gad
1254665|NCT01785108|GAD65|gad65
1254666|NCT01785108|GAD-alum|gad-alum
1254667|NCT01785108|Diabetes Mellitus|diabetes mellitus
1254668|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1254669|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
1254670|NCT01785108|Metabolic Diseases|metabolic diseases
1254671|NCT01785108|Vitamin D|vitamin d
1254672|NCT01785108|Ibuprofen|ibuprofen
1254673|NCT01785082|13-C-Methacetin|13-c-methacetin
1254674|NCT01785082|partial liver resection|partial liver resection
1254675|NCT01785082|liver function tests|liver function tests
1254676|NCT01785056|Systemic Sclerosis|systemic sclerosis
1254677|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
1254678|NCT01785056|SSc|ssc
1254679|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
1254680|NCT01785043|Difficult control|difficult control
1254681|NCT01785017|critical|critical
1254682|NCT01785017|asthma|asthma
1254683|NCT01785017|children|children
1254684|NCT01785004|Adiposity|adiposity
1254685|NCT01785004|Body composition|body composition
1254686|NCT01785004|Vitamin D|vitamin d
1254687|NCT01785004|Adipokines|adipokines
1254688|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
1254689|NCT01784991|Pain|pain
1254690|NCT01784991|Opioids|opioids
1254691|NCT01784991|Hydromorphone|hydromorphone
1254692|NCT01784991|regimen|regimen
1254693|NCT01784978|cancer|cancer
1254694|NCT01784978|renal|renal
1254695|NCT01784978|metastatic|metastatic
1254696|NCT01784978|clear|clear
1254697|NCT01784978|cell|cell
1254698|NCT01784978|Sunitinib|sunitinib
1254699|NCT01784978|Everolimus|everolimus
1254700|NCT01784978|Alternating|alternating
1254701|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
1254702|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
1254703|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
1254704|NCT01784926|cataract surgery|cataract surgery
1254705|NCT01784926|scleral suturing|scleral suturing
1254706|NCT01784926|Verisyse|verisyse
1254707|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
1254708|NCT01784913|Prostate|prostate
1254709|NCT01784913|cancer|cancer
1254710|NCT01784913|vaccine|vaccine
1254711|NCT01784874|Rabies|rabies
1254712|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
1254713|NCT01784874|Imovax® Rabies|imovax® rabies
1254714|NCT01784848|high blood pressure|high blood pressure
1254715|NCT01784848|hypertension|hypertension
1254716|NCT01784848|bariatric surgery|bariatric surgery
1254717|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
1254718|NCT01784848|obesity|obesity
1254719|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
1254720|NCT01784835|neonatology|neonatology
1254721|NCT01784835|neonatal care|neonatal care
1254722|NCT01784835|prematurity|prematurity
1254723|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
1254724|NCT01784835|length of stay|length of stay
1254725|NCT01784822|Ventral hernia|ventral hernia
1254726|NCT01784822|Graft repair|graft repair
1254727|NCT01784809|HIV|hiv
1254728|NCT01784809|STIs|stis
1254729|NCT01784809|Condom Use|condom use
1254730|NCT01784809|Criminal Justice|criminal justice
1254731|NCT01784809|Drug Use|drug use
1254732|NCT01784796|cardiovascular disease|cardiovascular disease
1254733|NCT01784796|women's health|women's health
1254734|NCT01784796|psychological stress|psychological stress
1254735|NCT01784796|Veterans|veterans
1254736|NCT01784796|stroke|stroke
1254737|NCT01784783|HIV transmission|hiv transmission
1254738|NCT01784783|PMTCT|pmtct
1254739|NCT01784783|Discordancy|discordancy
1254740|NCT01784783|Home-based testing|home-based testing
1254741|NCT01784783|Couple counseling|couple counseling
1254742|NCT01784783|Couple testing|couple testing
1254743|NCT01784783|Facility delivery|facility delivery
1254744|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
1254745|NCT01784783|Family planning|family planning
1254746|NCT01784783|Postpartum contraceptives|postpartum contraceptives
1254747|NCT01784783|Linkage to care|linkage to care
1254748|NCT01784783|ART initiation|art initiation
1254749|NCT01784770|Legionnaires' disease|legionnaires' disease
1254750|NCT01784770|Legionella pneumophila|legionella pneumophila
1254751|NCT01784770|Zithromax|zithromax
1254752|NCT01784770|Zithromac|zithromac
1254753|NCT01784770|Japanese|japanese
1254754|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1254755|NCT01784744|Autism|autism
1254756|NCT01784744|ASD|asd
1254757|NCT01784744|Aspergers|aspergers
1254758|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
1254759|NCT01784692|Immulina|immulina
1254760|NCT01784692|Elderly|elderly
1254761|NCT01784692|Immune|immune
1254762|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1254763|NCT01784679|GNE Myopathy|gne myopathy
1254764|NCT01784679|Nonaka Disease|nonaka disease
1254765|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
1254766|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
1254767|NCT01784679|ultragenyx|ultragenyx
1254768|NCT01784679|rare disease|rare disease
1254769|NCT01784666|Bipolar Disorder|bipolar disorder
1254770|NCT01784666|Depression|depression
1254771|NCT01784666|Lithium|lithium
1254772|NCT01784666|Valproate|valproate
1254773|NCT01784666|Isradipine|isradipine
1254774|NCT01784653|Substance abuse|substance abuse
1254775|NCT01784653|Drug abuse|drug abuse
1254776|NCT01784653|Alcohol abuse|alcohol abuse
1254777|NCT01784653|Tobacco|tobacco
1254778|NCT01784653|Adolescent|adolescent
1254779|NCT01784627|substance use|substance use
1254780|NCT01784627|alcohol abuse|alcohol abuse
1254781|NCT01784627|cannabis abuse|cannabis abuse
1254782|NCT01784627|nicotine dependence|nicotine dependence
1254783|NCT01784627|adolescents|adolescents
1254784|NCT01784601|Interscalene block|interscalene block
1254785|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
1254786|NCT01784575|Quality of care|quality of care
1254787|NCT01784575|Pediatric|pediatric
1254788|NCT01784575|Pregnancy|pregnancy
1254789|NCT01784575|Low-income|low-income
1254790|NCT01784575|Low literacy|low literacy
1254791|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1254792|NCT01784549|NSCL|nscl
1254793|NCT01784549|biomarkers|biomarkers
1254794|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
1254795|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
1254796|NCT01784523|antiphospholipid positive|antiphospholipid positive
1254797|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
1254798|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
1254799|NCT01784471|Foot Symptoms|foot symptoms
1254800|NCT01784471|Diabetes|diabetes
1254801|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
1254802|NCT01784471|Magic Foot shoe|magic foot shoe
1254803|NCT01784458|severe sepsis|severe sepsis
1254804|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
1600344|NCT00392951|Lymph Nodes|lymph nodes
1254805|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
1254806|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
1254807|NCT01784432|low-level laser therapy|low-level laser therapy
1254808|NCT01784432|muscle performance|muscle performance
1254809|NCT01784432|strength training|strength training
1254810|NCT01784432|gene expression|gene expression
1254811|NCT01784432|microarrays|microarrays
1254812|NCT01784419|Cystic fibrosis|cystic fibrosis
1254813|NCT01784419|Ivacaftor|ivacaftor
1254814|NCT01784419|Genotype|genotype
1254815|NCT01784419|Phenotype|phenotype
1254816|NCT01784419|Sweat chloride|sweat chloride
1254817|NCT01784419|Pancreatic sufficient|pancreatic sufficient
1254818|NCT01784406|Self-management intervention|self-management intervention
1254819|NCT01784406|Psychosocial care|psychosocial care
1254820|NCT01784406|Autonomy-supportive|autonomy-supportive
1254821|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
1254822|NCT01784406|Guided self-Determination|guided self-determination
1254823|NCT01784367|Hypercapnia|hypercapnia
1254824|NCT01784367|noninvasive ventilation|noninvasive ventilation
1254825|NCT01784367|acute respiratory failure|acute respiratory failure
1254826|NCT01784367|endotracheal intubation|endotracheal intubation
1254827|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
1254828|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
1254829|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
1254830|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
1254831|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
1254832|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
1254833|NCT01784289|Interleukin 7|interleukin 7
1254834|NCT01784289|adipose tissue|adipose tissue
1254835|NCT01784276|Children|children
1254836|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
1254837|NCT01784276|Electronic Screen Media|electronic screen media
1254838|NCT01784276|Dental fear|dental fear
1254839|NCT01784263|Intervention|intervention
1254840|NCT01784263|Autism|autism
1254841|NCT01784263|Treatment sensitivity|treatment sensitivity
1254842|NCT01784263|School aged|school aged
1254843|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
1254844|NCT01784250|Clonidine|clonidine
1254845|NCT01784250|Propranolol|propranolol
1254846|NCT01784250|Third molar|third molar
1254847|NCT01784250|Anxiety|anxiety
1254848|NCT01784237|Endoscopes|endoscopes
1254849|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
1254850|NCT01784237|Transnasal endoscopy|transnasal endoscopy
1254851|NCT01784237|Anterior meatoscopy|anterior meatoscopy
1254852|NCT01784198|pregnancy|pregnancy
1254853|NCT01784198|protein requirements|protein requirements
1254854|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
1254855|NCT01784198|Stable isotopes|stable isotopes
1254856|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
1254857|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
1254858|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
1254859|NCT01784185|mediastinal sampling|mediastinal sampling
1254860|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
1254861|NCT01784172|efficacy|efficacy
1254862|NCT01784172|safety|safety
1254863|NCT01784172|electroacupuncture|electroacupuncture
1254864|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
1254865|NCT01784133|rosacea|rosacea
1254866|NCT01784120|breast cancer|breast cancer
1254867|NCT01784120|doxorubicin|doxorubicin
1254868|NCT01784120|genexol-PM|genexol-pm
1254869|NCT01784120|paclitaxel|paclitaxel
1254870|NCT01784107|SCLC|sclc
1254871|NCT01784107|belotecan|belotecan
1254872|NCT01784107|Ifosfamide|ifosfamide
1254873|NCT01784081|palliative care|palliative care
1254874|NCT01784081|decision aid|decision aid
1254875|NCT01784068|Ph+ CML-CP|ph+ cml-cp
1254876|NCT01784068|chronic phase|chronic phase
1254877|NCT01784068|nilotinib treatment|nilotinib treatment
1254878|NCT01784068|2 years treatment|2 years treatment
1254879|NCT01784068|MR 4.5|mr 4.5
1254880|NCT01784068|Loss of MR 4|loss of mr 4
1254881|NCT01784068|Loss of MMR|loss of mmr
1254882|NCT01784055|NeoChord|neochord
1254883|NCT01784055|DS1000|ds1000
1254884|NCT01784055|Mitral Valve|mitral valve
1254885|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
1254886|NCT01784055|MR|mr
1254887|NCT01784055|Mitral Valve Repair|mitral valve repair
1254888|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
1254889|NCT01784055|Artificial Chordae|artificial chordae
1254890|NCT01784042|breast cancer|breast cancer
1254891|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
1254892|NCT01784029|adolescents|adolescents
1254893|NCT01784029|minority|minority
1254894|NCT01783964|Elacytarabine|elacytarabine
1254895|NCT01783964|pharmacokinetic|pharmacokinetic
1254896|NCT01783964|Microdose|microdose
1254897|NCT01783964|Mass Balance Recovery|mass balance recovery
1254898|NCT01783951|Gastric cancer|gastric cancer
1254899|NCT01783951|S-1|s-1
1254900|NCT01783951|DC-CIK|dc-cik
1254901|NCT01783951|T cell|t cell
1254902|NCT01783912|Smoking|smoking
1254903|NCT01783912|Nicotine Dependence|nicotine dependence
1254904|NCT01783912|Mental Disorders|mental disorders
1254905|NCT01783886|Diabetic Macular Edema|diabetic macular edema
1254906|NCT01783886|DME|dme
1254907|NCT01783886|VEGF Trap-Eye|vegf trap-eye
1254908|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
1254909|NCT01783860|Azithromycin|azithromycin
1254910|NCT01783860|Doxycycline|doxycycline
1254911|NCT01783860|Posterior Blepharitis|posterior blepharitis
1254912|NCT01783847|Erythropoietin|erythropoietin
1254913|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
1254914|NCT01783847|Visual function|visual function
1254915|NCT01783834|Pemetrexed|pemetrexed
1254916|NCT01783834|Gefitinib|gefitinib
1254917|NCT01783834|iressa|iressa
1254918|NCT01783834|alimta|alimta
1254919|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1254920|NCT01783808|COPD|copd
1254921|NCT01783808|Physical capacity|physical capacity
1254922|NCT01783808|Physical activity|physical activity
1254923|NCT01783808|Inflammatory markers|inflammatory markers
1254924|NCT01783808|Health related quality of life|health related quality of life
1254925|NCT01783795|Dent|dent
1254926|NCT01783795|Dents|dents
1254927|NCT01783795|Dent Disease|dent disease
1254928|NCT01783795|Dent genetic testing|dent genetic testing
1254929|NCT01783795|CLCN5|clcn5
1254930|NCT01783795|OCRL1|ocrl1
1254931|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
1254932|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
1254933|NCT01783782|Capsule Endoscopy|capsule endoscopy
1254934|NCT01783782|colon cleansing|colon cleansing
1254935|NCT01783782|children|children
1254936|NCT01783782|age 2 -18 years|age 2 -18 years
1254937|NCT01783769|neurosurgery|neurosurgery
1254938|NCT01783769|operating room personnel|operating room personnel
1254939|NCT01783769|sterile procedures|sterile procedures
1254940|NCT01783769|infection|infection
1254941|NCT01783769|Conditions requiring surgery|conditions requiring surgery
1254942|NCT01783743|Trichiasis|trichiasis
1254943|NCT01783743|Trachoma|trachoma
1254944|NCT01783743|Mass treatment|mass treatment
1254945|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
1254946|NCT01783704|hip fracture|hip fracture
1254947|NCT01783704|randomized controlled trial|randomized controlled trial
1254948|NCT01783704|exercise|exercise
1254949|NCT01783691|Sickle cell disease|sickle cell disease
1254950|NCT01783652|Adolescent depression|adolescent depression
1254951|NCT01783652|internet intervention|internet intervention
1254952|NCT01783639|Carotid|carotid
1254953|NCT01783639|Carotid artery stenting|carotid artery stenting
1254954|NCT01783639|Stent|stent
1254955|NCT01783639|Embolic protection|embolic protection
1254956|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
1254957|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
1254958|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
1254959|NCT01783600|balloon catheter|balloon catheter
1254960|NCT01783574|Depression|depression
1254961|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1254962|NCT01783561|caffeine|caffeine
1254963|NCT01783561|intubation|intubation
1254964|NCT01783561|hemodynamic|hemodynamic
1254965|NCT01783548|allergic rhinitis|allergic rhinitis
1254966|NCT01783548|pediatric subjects|pediatric subjects
1254967|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
1254968|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
1254969|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
1254970|NCT01783483|CABG|cabg
1254971|NCT01783483|Valve replacement|valve replacement
1254972|NCT01783483|sternal closure|sternal closure
1254973|NCT01783483|midline sternotomy|midline sternotomy
1254974|NCT01783483|sternal plates|sternal plates
1254975|NCT01783470|adipose tissue, brown|adipose tissue, brown
1254976|NCT01783470|obesity|obesity
1254977|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
1254978|NCT01783470|thermogenesis|thermogenesis
1254979|NCT01783470|metabolism|metabolism
1254980|NCT01783457|First psychotic episode|first psychotic episode
1254981|NCT01783457|Individual psychoeducation|individual psychoeducation
1254982|NCT01783457|Telemedicine|telemedicine
1254983|NCT01783457|BDNF|bdnf
1254984|NCT01783457|Oxidative stress|oxidative stress
1254985|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer|estrogen receptor positive, locally advanced, metastatic breast cancer
1254986|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
1254987|NCT01783418|pediatric cancer|pediatric cancer
1254988|NCT01783418|adolescence|adolescence
1254989|NCT01783418|quality of life|quality of life
1254990|NCT01783418|sleep|sleep
1254991|NCT01783418|affect|affect
1254992|NCT01783418|health psychology|health psychology
1254993|NCT01783405|LDLR mutation|ldlr mutation
1254994|NCT01783405|Statin|statin
1254995|NCT01783405|Cardiovascular disease|cardiovascular disease
1254996|NCT01783392|overactive bladder|overactive bladder
1254997|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
1254998|NCT01783392|placebo PTNS|placebo ptns
1254999|NCT01783379|invasive fungal infection|invasive fungal infection
1255000|NCT01783379|micafungin|micafungin
1255001|NCT01783379|intensive care|intensive care
1255002|NCT01783379|pharmacokinetics|pharmacokinetics
1255003|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
1255004|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
1255005|NCT01783353|verruca|verruca
1255006|NCT01783340|Malaria|malaria
1255007|NCT01783340|P falciparum|p falciparum
1255008|NCT01783340|Chloroquine|chloroquine
1255009|NCT01783340|Azithromycin|azithromycin
1255010|NCT01783340|Immunization|immunization
1255011|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1255012|NCT01783327|Self care|self care
1255013|NCT01783327|Coping skills|coping skills
1255014|NCT01783327|Adolescent|adolescent
1255015|NCT01783327|Internet|internet
1255016|NCT01783327|Intervention Studies|intervention studies
1255017|NCT01783327|Chronic Disease|chronic disease
1255018|NCT01783314|hepatic fibrosis|hepatic fibrosis
1255019|NCT01783314|Eovist|eovist
1255612|NCT01780545|Docetaxel|docetaxel
1255020|NCT01783314|gadoxetate disodium|gadoxetate disodium
1255021|NCT01783314|biomarker|biomarker
1255022|NCT01783314|liver biopsy|liver biopsy
1255023|NCT01783314|liver function|liver function
1255024|NCT01783314|MRI|mri
1255025|NCT01783314|Hepatitis C|hepatitis c
1255026|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
1255027|NCT01783301|ovarian stimulation|ovarian stimulation
1255028|NCT01783301|antimullerian hormone|antimullerian hormone
1255029|NCT01783301|antral follicle count|antral follicle count
1255030|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
1255031|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
1255032|NCT01783288|orthostatic intolerance|orthostatic intolerance
1255033|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
1255034|NCT01783288|POTS|pots
1255035|NCT01783275|Obesity|obesity
1255036|NCT01783275|Type 2 diabetes|type 2 diabetes
1255037|NCT01783275|Liver|liver
1255038|NCT01783236|VATS|vats
1255039|NCT01783236|thoracic surgery|thoracic surgery
1255040|NCT01783236|acetaminophen|acetaminophen
1255041|NCT01783236|ofirmev|ofirmev
1255042|NCT01783236|lung surgery|lung surgery
1255043|NCT01783236|thoracoscopic|thoracoscopic
1255044|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
1255045|NCT01783158|head and neck carcinoma|head and neck carcinoma
1255046|NCT01783158|chromoendoscopy|chromoendoscopy
1255047|NCT01783158|Lugol's solution|lugol's solution
1255048|NCT01783158|esophageal carcinoma|esophageal carcinoma
1255049|NCT01783158|synchronous tumors|synchronous tumors
1255050|NCT01783158|deglutition|deglutition
1255051|NCT01783158|deglutition disorders|deglutition disorders
1255052|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
1255053|NCT01783145|survivorship care|survivorship care
1255054|NCT01783145|testicular cancer|testicular cancer
1255055|NCT01783145|shared care model|shared care model
1255056|NCT01783119|Ulcerative Colitis|ulcerative colitis
1255057|NCT01783119|Aloe Vera|aloe vera
1255058|NCT01783106|Crohn's|crohn's
1255059|NCT01783106|antibiotics|antibiotics
1255060|NCT01783106|hydroxychloroquine|hydroxychloroquine
1255061|NCT01783106|ciprofloxacin|ciprofloxacin
1255062|NCT01783106|doxycycline|doxycycline
1255063|NCT01783080|Chronic depression|chronic depression
1255064|NCT01783080|Dysthymic disorder|dysthymic disorder
1255065|NCT01783080|Double Depression|double depression
1255066|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
1255067|NCT01783080|Work impairment|work impairment
1255068|NCT01783080|Unemployment|unemployment
1255069|NCT01783067|Biofortification|biofortification
1255070|NCT01783067|Pearl millet|pearl millet
1255071|NCT01783067|Iron absorption|iron absorption
1255072|NCT01783067|Zinc absorption|zinc absorption
1255073|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
1255074|NCT01783054|SURGERY|surgery
1255075|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
1255076|NCT01783041|Prematurity|prematurity
1255077|NCT01783041|Carnitine supplementation|carnitine supplementation
1255078|NCT01783041|Neonatal Intensive Care|neonatal intensive care
1255079|NCT01783041|MRI|mri
1255080|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
1255081|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
1255082|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
1255083|NCT01783028|asthma|asthma
1255084|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
1255085|NCT01783015|etanercept|etanercept
1255086|NCT01783015|methotrexate|methotrexate
1255087|NCT01783015|infliximab|infliximab
1255088|NCT01783015|adalimumab|adalimumab
1255089|NCT01783015|anti-drug antibody|anti-drug antibody
1255090|NCT01782989|geographic atrophy|geographic atrophy
1255091|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
1255092|NCT01782989|macular degeneration|macular degeneration
1255093|NCT01782989|dry macular degeneration|dry macular degeneration
1255094|NCT01782989|dry AMD|dry amd
1255095|NCT01782976|Glioblastoma|glioblastoma
1255096|NCT01782976|GBM|gbm
1255097|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
1255098|NCT01782976|Recurrent|recurrent
1255099|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
1255100|NCT01782976|MDASI-BT|mdasi-bt
1255101|NCT01782976|Questionnaire|questionnaire
1255102|NCT01782976|Survey|survey
1255103|NCT01782963|Newly diagnosed|newly diagnosed
1255104|NCT01782950|HIV|hiv
1255105|NCT01782950|Tuberculosis|tuberculosis
1255106|NCT01782950|Antituberculosis drugs|antituberculosis drugs
1255107|NCT01782911|Androgen|androgen
1255108|NCT01782911|IVF|ivf
1255109|NCT01782911|Resveratrol|resveratrol
1255110|NCT01782911|PCOS.|pcos.
1255111|NCT01782898|Anesthesia|anesthesia
1255112|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
1255113|NCT01782898|Pain|pain
1255114|NCT01782898|Quality of recovery|quality of recovery
1255115|NCT01782885|Osteoarthritis|osteoarthritis
1255116|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
1255117|NCT01782885|Intra-articular|intra-articular
1255118|NCT01782885|Injection|injection
1255119|NCT01782807|Ovarian function|ovarian function
1255120|NCT01782807|Hysterectomy|hysterectomy
1255121|NCT01782807|Salpingectomy|salpingectomy
1255122|NCT01782807|Anti mullerian hormone|anti mullerian hormone
1255123|NCT01782794|Vaccination|vaccination
1255124|NCT01782794|Acceptability|acceptability
1255125|NCT01782794|General population|general population
1255126|NCT01782794|Hepatitis B|hepatitis b
1255127|NCT01782794|Vaccine coverage|vaccine coverage
1255128|NCT01782781|Analgesia|analgesia
1255129|NCT01782781|Local infiltration analgesia|local infiltration analgesia
1255130|NCT01782781|Pain, relief|pain, relief
1255131|NCT01782781|Pain, Postoperative|pain, postoperative
1255132|NCT01782781|Ropivacaine|ropivacaine
1255133|NCT01782781|Ketorolac|ketorolac
1255134|NCT01782781|Epinephrine|epinephrine
1255135|NCT01782781|Adrenergic Agonists|adrenergic agonists
1255136|NCT01782781|Sympathomimetics|sympathomimetics
1255137|NCT01782781|Therapeutic Uses|therapeutic uses
1255138|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1255139|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
1255140|NCT01782781|Analgesics|analgesics
1255141|NCT01782781|Opioids|opioids
1255142|NCT01782781|Morphine|morphine
1255143|NCT01782781|Pain|pain
1255144|NCT01782781|Postoperative Complications|postoperative complications
1255145|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
1255146|NCT01782781|Anesthetics, Local|anesthetics, local
1255147|NCT01782781|Anesthetics|anesthetics
1255148|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
1255149|NCT01782755|Probiotics|probiotics
1255150|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
1255151|NCT01782755|Infection|infection
1255152|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
1255153|NCT01782755|C-Difficile|c-difficile
1255154|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
1255155|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
1255156|NCT01782729|Tacrolimus|tacrolimus
1255157|NCT01782716|Mortality|mortality
1255158|NCT01782716|Length|length
1255159|NCT01782716|hospitalization|hospitalization
1255160|NCT01782716|cardiac surgery|cardiac surgery
1255161|NCT01782716|patients|patients
1255162|NCT01782703|Atopic Dermatitis|atopic dermatitis
1255163|NCT01782703|Filaggrin|filaggrin
1255164|NCT01782703|Biomarkers|biomarkers
1255165|NCT01782703|Eczema|eczema
1255166|NCT01782664|PASI|pasi
1255167|NCT01782664|DLQI|dlqi
1255168|NCT01782664|GSK2586184|gsk2586184
1255169|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
1255170|NCT01782664|PGA|pga
1255171|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
1255172|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
1255173|NCT01782664|serum neopterin|serum neopterin
1255174|NCT01782664|skin biopsy|skin biopsy
1255175|NCT01782664|ACR response criteria|acr response criteria
1255176|NCT01782664|VAS itch score|vas itch score
1255177|NCT01782651|HER2 positive|her2 positive
1255178|NCT01782651|Breast Cancer|breast cancer
1255179|NCT01782651|treatment patterns|treatment patterns
1255180|NCT01782638|Parkinson's disease|parkinson's disease
1255181|NCT01782638|Deep brain stimulation|deep brain stimulation
1255182|NCT01782638|Gait|gait
1255183|NCT01782638|Freezing|freezing
1255184|NCT01782638|Electrode placements|electrode placements
1255185|NCT01782625|diving|diving
1255186|NCT01782625|cognitive impairment|cognitive impairment
1255187|NCT01782625|nitrogen narcosis|nitrogen narcosis
1255188|NCT01782625|narcosis|narcosis
1255189|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
1255190|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
1255191|NCT01782625|immersion|immersion
1255192|NCT01782612|Balanced Anesthesia|balanced anesthesia
1255193|NCT01782612|Nerve Block|nerve block
1255194|NCT01782612|Postoperative Recovery|postoperative recovery
1255195|NCT01782612|Delirium|delirium
1255196|NCT01782612|Postoperative Complications|postoperative complications
1255198|NCT01782612|Inflammation|inflammation
1255199|NCT01782586|kidney transplant|kidney transplant
1255200|NCT01782586|gene expression markers|gene expression markers
1255201|NCT01782586|renal allograft function|renal allograft function
1255202|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
1255203|NCT01782573|surgical site culture|surgical site culture
1255204|NCT01782573|surgical site infection|surgical site infection
1255205|NCT01782573|liver tumors|liver tumors
1255206|NCT01782573|hepatectomy|hepatectomy
1255207|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
1255208|NCT01782560|Laryngomalacia|laryngomalacia
1255209|NCT01782560|Acid-reflux|acid-reflux
1255210|NCT01782547|diabetes mellitus|diabetes mellitus
1255211|NCT01782547|adolescents|adolescents
1255212|NCT01782521|Bracket failure rate|bracket failure rate
1255213|NCT01782521|Orthodontic bonding|orthodontic bonding
1255214|NCT01782521|Primer|primer
1255215|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
1255216|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
1255217|NCT01782495|Chronic Hepatitis|chronic hepatitis
1255218|NCT01782495|Interferon-Free|interferon-free
1255219|NCT01782495|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1255917|NCT01779258|dermatitis|dermatitis
1255220|NCT01782495|Renal Transplant|renal transplant
1255221|NCT01782495|Liver Transplant|liver transplant
1255222|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
1255223|NCT01782482|Color contact lenses|color contact lenses
1255224|NCT01782482|Refractive error|refractive error
1255225|NCT01782482|Myopia|myopia
1255226|NCT01782469|Synovitis|synovitis
1255227|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
1255228|NCT01782443|Progressive|progressive
1255229|NCT01782443|Metastatic|metastatic
1255230|NCT01782430|Preoxygenation|preoxygenation
1255231|NCT01782430|Intubation|intubation
1255232|NCT01782417|osteoarthritis|osteoarthritis
1255233|NCT01782417|Hispanic|hispanic
1255234|NCT01782417|behavior|behavior
1255235|NCT01782417|intervention|intervention
1255236|NCT01782417|Spanish|spanish
1255237|NCT01782391|mild cognitive impairment|mild cognitive impairment
1255238|NCT01782391|dementia|dementia
1255239|NCT01782391|MCI|mci
1255240|NCT01782391|brain stimulation|brain stimulation
1255241|NCT01782391|tSOS|tsos
1255242|NCT01782391|tDCS|tdcs
1255243|NCT01782391|sleep|sleep
1255244|NCT01782391|memory|memory
1255245|NCT01782391|memory consolidation|memory consolidation
1255246|NCT01782378|Persian Gulf Syndrome|persian gulf syndrome
1255247|NCT01782378|Veterans Health|veterans health
1255248|NCT01782378|Executive Function|executive function
1255249|NCT01782378|Memory|memory
1255250|NCT01782378|Attention|attention
1255251|NCT01782378|Cognition|cognition
1255252|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
1255253|NCT01782378|Phototherapy|phototherapy
1255254|NCT01782378|Light Therapy|light therapy
1255255|NCT01782378|Depression|depression
1255256|NCT01782365|mild cognitive impairment|mild cognitive impairment
1255257|NCT01782365|dementia|dementia
1255258|NCT01782365|MCI|mci
1255259|NCT01782365|brain stimulation|brain stimulation
1255260|NCT01782365|tSOS|tsos
1255261|NCT01782365|tDCS|tdcs
1255262|NCT01782365|sleep|sleep
1255263|NCT01782365|nap|nap
1255264|NCT01782365|daytime sleep|daytime sleep
1255265|NCT01782365|memory|memory
1255266|NCT01782365|memory consolidation|memory consolidation
1255267|NCT01782352|age-related macular degeneration|age-related macular degeneration
1255268|NCT01782352|incidence|incidence
1255269|NCT01782352|progression|progression
1255270|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
1255271|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
1255272|NCT01782287|Brain metastasis|brain metastasis
1255273|NCT01782287|Lung cancer|lung cancer
1255274|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
1255275|NCT01782274|Brain metastasis|brain metastasis
1255276|NCT01782274|Breast cancer|breast cancer
1255277|NCT01782261|autoimmune disease|autoimmune disease
1255278|NCT01782261|diabetes type 1|diabetes type 1
1255279|NCT01782261|incretin effect|incretin effect
1255280|NCT01782222|Parkinson's Disease|parkinson's disease
1255281|NCT01782222|Rotigotine|rotigotine
1255282|NCT01782222|Apathy|apathy
1255283|NCT01782222|Nonmotor|nonmotor
1255284|NCT01782222|Motor|motor
1255285|NCT01782222|Neupro|neupro
1255286|NCT01782209|BK virus viremia|bk virus viremia
1255287|NCT01782209|renal transplant|renal transplant
1255288|NCT01782209|other viral pathogens|other viral pathogens
1255289|NCT01782183|sore throat|sore throat
1255290|NCT01782183|thermal camera photo|thermal camera photo
1255291|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
1255292|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
1255293|NCT01782183|exudates on tonsils|exudates on tonsils
1255294|NCT01782183|petechiae of the palate|petechiae of the palate
1255295|NCT01782170|Gingivitis|gingivitis
1255296|NCT01782170|Biomarkers|biomarkers
1255297|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
1255298|NCT01782157|dementia|dementia
1255299|NCT01782144|Obesity|obesity
1255300|NCT01782144|Foot pain|foot pain
1255301|NCT01782105|weight gain|weight gain
1255302|NCT01782105|healthy lifestyle|healthy lifestyle
1255303|NCT01782105|gestational diabetes|gestational diabetes
1255304|NCT01782105|adipokins|adipokins
1255305|NCT01782105|glycemic regulation|glycemic regulation
1255306|NCT01782092|diabetes|diabetes
1255307|NCT01782079|Lactobacillus brevis|lactobacillus brevis
1255308|NCT01782079|Oral health|oral health
1255309|NCT01782079|Bacterial adhesion|bacterial adhesion
1255310|NCT01782040|Premenstrual syndrome|premenstrual syndrome
1255311|NCT01782040|Physical distress|physical distress
1255312|NCT01782040|Behavioral changes|behavioral changes
1255313|NCT01782027|healthy controls|healthy controls
1255314|NCT01782027|Tangier Disease|tangier disease
1255315|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
1255316|NCT01782027|apoA-I|apoa-i
1255317|NCT01782027|LCAT deficiency|lcat deficiency
1255318|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
1255319|NCT01782027|CETP deficiency|cetp deficiency
1255320|NCT01782014|Screening colonoscopy|screening colonoscopy
1255321|NCT01782014|Water method|water method
1255322|NCT01782014|Carbon dioxide method|carbon dioxide method
1255323|NCT01782014|Air method|air method
1255324|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
1255325|NCT01782014|Adenoma Detection Rate|adenoma detection rate
1255326|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
1255327|NCT01782001|Vitamin A|vitamin a
1255328|NCT01782001|Zinc|zinc
1255329|NCT01782001|Malaria|malaria
1255330|NCT01782001|Morbidity|morbidity
1255331|NCT01782001|MRDR|mrdr
1255332|NCT01781988|lung cancer|lung cancer
1255333|NCT01781988|gemcitabine|gemcitabine
1255334|NCT01781988|carboplatin|carboplatin
1255335|NCT01781988|pemetrexed|pemetrexed
1255336|NCT01781949|HIV infection|hiv infection
1255337|NCT01781949|Targeted screening|targeted screening
1255338|NCT01781949|Nontargeted screening|nontargeted screening
1255339|NCT01781949|Emergency department|emergency department
1255340|NCT01781949|Urgent care|urgent care
1255341|NCT01781949|Effectiveness|effectiveness
1255342|NCT01781923|Cognitive remediation|cognitive remediation
1255343|NCT01781923|Social Cognition|social cognition
1255344|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
1255345|NCT01781897|acupuncture|acupuncture
1255346|NCT01781897|electro-acupuncture|electro-acupuncture
1255347|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
1255348|NCT01781871|immunogenicity|immunogenicity
1255349|NCT01781871|solid organ transplant|solid organ transplant
1255350|NCT01781858|Pulmonary embolism|pulmonary embolism
1255351|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1255352|NCT01781858|Venous thromboembolism|venous thromboembolism
1255353|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
1255354|NCT01781780|Obesity|obesity
1255355|NCT01781780|Weight Loss|weight loss
1255356|NCT01781780|Breakfast|breakfast
1255357|NCT01781767|UCP2|ucp2
1255358|NCT01781767|Thyroid function|thyroid function
1255359|NCT01781767|Thyroid carcinoma|thyroid carcinoma
1255360|NCT01781754|Glycemic control|glycemic control
1255361|NCT01781754|Metabolic control|metabolic control
1255362|NCT01781754|Oxidative stress|oxidative stress
1255363|NCT01781754|Diabetes|diabetes
1255364|NCT01781728|recurrent|recurrent
1255365|NCT01781728|unresectable|unresectable
1255366|NCT01781728|residual|residual
1255367|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1255368|NCT01781728|palliative management|palliative management
1255369|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
1255370|NCT01781689|cortical activation|cortical activation
1255371|NCT01781689|motor function|motor function
1255372|NCT01781689|activity of daily living|activity of daily living
1255373|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
1255374|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
1255375|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
1255376|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
1255377|NCT01781650|Adenoma detection rate|adenoma detection rate
1255477|NCT01781078|MRI|mri
1255378|NCT01781650|Adenoma resection rate|adenoma resection rate
1255379|NCT01781637|Xolair|xolair
1255380|NCT01781637|omalizumab|omalizumab
1255381|NCT01781637|peanut|peanut
1255382|NCT01781637|oral desensitization|oral desensitization
1255383|NCT01781611|lupus|lupus
1255384|NCT01781611|dipyridamole|dipyridamole
1255385|NCT01781598|Total knee arthroplasty|total knee arthroplasty
1600345|NCT00392951|Spleen|spleen
1255386|NCT01781598|Patient specific instruments|patient specific instruments
1255387|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
1255388|NCT01781598|Alignment|alignment
1255389|NCT01781598|Learning curve|learning curve
1255390|NCT01781598|VISIONAIRE|visionaire
1255391|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
1255392|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
1255393|NCT01781585|hemodynamic stability,|hemodynamic stability,
1255394|NCT01781585|Intracranial pressure|intracranial pressure
1255395|NCT01781546|drug eluting balloon|drug eluting balloon
1255396|NCT01781546|bare metal stent|bare metal stent
1255397|NCT01781546|coronary artery disease|coronary artery disease
1255398|NCT01781546|acute coronary syndrome|acute coronary syndrome
1255399|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
1255401|NCT01781546|BMS|bms
1255402|NCT01781520|Pancreatic Cancer|pancreatic cancer
1255403|NCT01781520|S1|s1
1255404|NCT01781520|DC-CIK|dc-cik
1255405|NCT01781507|Asthma|asthma
1255406|NCT01781507|Allergic rhinitis|allergic rhinitis
1255407|NCT01781507|Cetirizine|cetirizine
1255408|NCT01781507|Impulse oscillometry|impulse oscillometry
1255409|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
1255410|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
1255411|NCT01781481|Decision-support tool|decision-support tool
1255412|NCT01781481|Integrated Health Care|integrated health care
1255413|NCT01781481|Case Complexity|case complexity
1255918|NCT01779258|eczema|eczema
1255414|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1255415|NCT01781416|cardiovascular risk|cardiovascular risk
1255416|NCT01781416|SCORE|score
1255417|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
1255418|NCT01781416|risk factors|risk factors
1255419|NCT01781403|Temozolomide|temozolomide
1255420|NCT01781403|capecitabine|capecitabine
1255421|NCT01781403|rectal cancer|rectal cancer
1255422|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
1255423|NCT01781390|STEMI|stemi
1255424|NCT01781390|Heart Attack|heart attack
1255425|NCT01781390|AMI|ami
1255426|NCT01781390|Stem Cells|stem cells
1255427|NCT01781377|NAUSEA|nausea
1255428|NCT01781377|VOMITING|vomiting
1255429|NCT01781377|CESAREAN SECTION|cesarean section
1255430|NCT01781377|PREVENTION|prevention
1255431|NCT01781377|PROPOFOL|propofol
1255432|NCT01781364|Brain Oscillations|brain oscillations
1255433|NCT01781364|Cognitive Performance|cognitive performance
1255434|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
1255435|NCT01781299|Breast Cancer|breast cancer
1255436|NCT01781299|Mastectomy|mastectomy
1255437|NCT01781299|Immediate reconstruction|immediate reconstruction
1255438|NCT01781286|Obesity|obesity
1255439|NCT01781286|Snacking|snacking
1255440|NCT01781286|Appetite|appetite
1255441|NCT01781286|Protein|protein
1255442|NCT01781286|Soy|soy
1255443|NCT01781286|Reward driven eating|reward driven eating
1255444|NCT01781286|Satiety|satiety
1255445|NCT01781273|impaired driving|impaired driving
1255446|NCT01781260|Prone position|prone position
1255447|NCT01781260|Cardiac output|cardiac output
1255448|NCT01781260|Liver Circulation|liver circulation
1255449|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1255450|NCT01781247|Myocardial Infarction|myocardial infarction
1255451|NCT01781247|Psychotherapy|psychotherapy
1255452|NCT01781247|Preventive Therapy|preventive therapy
1255453|NCT01781247|Randomized Controlled Trial|randomized controlled trial
1255454|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
1255455|NCT01781247|Psychological Stress|psychological stress
1255456|NCT01781247|Biomarkers|biomarkers
1255457|NCT01781195|Advagraf|advagraf
1255458|NCT01781195|MELD-score|meld-score
1255459|NCT01781195|Na-MELD-score|na-meld-score
1255460|NCT01781195|liver function|liver function
1255461|NCT01781195|LiMAx-test|limax-test
1255462|NCT01781195|infection rate|infection rate
1255463|NCT01781195|HLA-DR status|hla-dr status
1255464|NCT01781195|immunostatus|immunostatus
1255465|NCT01781169|Vitamin D,|vitamin d,
1255466|NCT01781169|Oral supplementation,|oral supplementation,
1255467|NCT01781169|Obese males|obese males
1255468|NCT01781156|phosphorus|phosphorus
1255469|NCT01781156|hemodialysis|hemodialysis
1255470|NCT01781156|cardiac biomarkers|cardiac biomarkers
1255471|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
1255472|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
1255473|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
1255474|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
1255475|NCT01781078|Single chamber pacing|single chamber pacing
1255476|NCT01781078|Dual chamber pacing|dual chamber pacing
1255478|NCT01781078|MR scans|mr scans
1255479|NCT01781052|Iloprost Compliance|iloprost compliance
1255480|NCT01781039|"hair cell"|"hair cell"
1255481|NCT01781039|"hearing aid"|"hearing aid"
1255482|NCT01781039|"hearing loss"|"hearing loss"
1255483|NCT01781039|"auditory nerve"|"auditory nerve"
1255484|NCT01781039|synaptopathy|synaptopathy
1255485|NCT01781026|B-raf V600E|b-raf v600e
1255486|NCT01781026|V600K mutation|v600k mutation
1255487|NCT01781026|metastatic melanoma|metastatic melanoma
1255488|NCT01781013|Depression screening|depression screening
1255489|NCT01781013|Depression monitoring|depression monitoring
1255490|NCT01781013|Chronic illness|chronic illness
1255491|NCT01781013|Behavioral health|behavioral health
1255492|NCT01781013|Care management|care management
1255493|NCT01781013|Automatic telephone assessment|automatic telephone assessment
1255494|NCT01781013|Clinical decision support|clinical decision support
1255495|NCT01781013|Suicide alert|suicide alert
1255496|NCT01781000|Cognitive Training|cognitive training
1255497|NCT01781000|Neuroplasticity|neuroplasticity
1255499|NCT01781000|MATRICS|matrics
1255500|NCT01780987|DVT|dvt
1255501|NCT01780987|PE|pe
1255502|NCT01780987|VTE|vte
1255503|NCT01780974|Hypertension|hypertension
1255504|NCT01780974|Vascular Risk|vascular risk
1255505|NCT01780974|Alzheimer's Risk|alzheimer's risk
1255506|NCT01780974|fish oil|fish oil
1255507|NCT01780974|Lipoic acid|lipoic acid
1255508|NCT01780961|Esophageal Cancer|esophageal cancer
1255509|NCT01780961|ESBX|esbx
1255510|NCT01780948|Drug Interaction|drug interaction
1255511|NCT01780948|Pharmacokinetics|pharmacokinetics
1255512|NCT01780948|Everolimus|everolimus
1255513|NCT01780948|Atorvastatin|atorvastatin
1255514|NCT01780922|Inflammation|inflammation
1255515|NCT01780922|Oxidative Stress|oxidative stress
1255516|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
1255517|NCT01780896|Topographical Memory|topographical memory
1255518|NCT01780896|Non-Topographical Memory|non-topographical memory
1255519|NCT01780896|Vestibular Function|vestibular function
1255520|NCT01780896|Alzheimer's Disease|alzheimer's disease
1255521|NCT01780883|melatonin|melatonin
1255522|NCT01780883|childhood autism|childhood autism
1255523|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
1255524|NCT01780883|autistic disorder|autistic disorder
1255525|NCT01780883|dose-effect relation|dose-effect relation
1255526|NCT01780870|Overweight|overweight
1255527|NCT01780870|Obesity|obesity
1255528|NCT01780870|Obese|obese
1255529|NCT01780870|Weight loss|weight loss
1255530|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
1255531|NCT01780857|psoriasis|psoriasis
1255532|NCT01780844|Kidney Transplantation|kidney transplantation
1255533|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
1255534|NCT01780844|ASKP1240|askp1240
1255535|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
1255536|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
1255537|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
1255538|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
1255539|NCT01780818|Adenoma detection rate|adenoma detection rate
1255540|NCT01780818|Adenoma resection rate|adenoma resection rate
1255541|NCT01780792|multiple sclerosis|multiple sclerosis
1255542|NCT01780792|mobility|mobility
1255543|NCT01780792|cognition|cognition
1255544|NCT01780792|neuroplasticity|neuroplasticity
1255545|NCT01780792|videogame play|videogame play
1255546|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
1255547|NCT01780779|Patient outcome assessment|patient outcome assessment
1255548|NCT01780779|Treatment response|treatment response
1255549|NCT01780779|Histopathology|histopathology
1255550|NCT01780766|Whole body MRI|whole body mri
1255551|NCT01780766|Multiple myeloma|multiple myeloma
1255552|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
1255553|NCT01780766|Whole body scan|whole body scan
1255554|NCT01780753|Primaquine|primaquine
1255555|NCT01780753|Vivax malaria|vivax malaria
1255556|NCT01780753|G6PD|g6pd
1255557|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
1255558|NCT01780740|Atrial fibrillation|atrial fibrillation
1255559|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
1255560|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1255561|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
1255562|NCT01780727|echocardiography|echocardiography
1255563|NCT01780727|hemodynamic management|hemodynamic management
1255564|NCT01780714|smoking|smoking
1255565|NCT01780714|cigarette|cigarette
1255566|NCT01780714|exposure|exposure
1255567|NCT01780714|biomarker|biomarker
1255568|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
1255569|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
1255570|NCT01780714|THS 2.1|ths 2.1
1255571|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
1255572|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
1255573|NCT01780701|fatty acid synthase|fatty acid synthase
1255574|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
1255575|NCT01780688|Smoking|smoking
1255576|NCT01780688|Nicotine profile|nicotine profile
1255577|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1255578|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
1255580|NCT01780649|ICSI|icsi
1333169|NCT01444222|exercise capacity|exercise capacity
1255581|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
1255582|NCT01780649|Spermatozoa|spermatozoa
1255583|NCT01780649|male infertility|male infertility
1255584|NCT01780649|vacuoles|vacuoles
1255585|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
1255586|NCT01780636|Botulinum toxin A|botulinum toxin a
1255587|NCT01780636|Botox|botox
1255588|NCT01780636|Constipation|constipation
1255589|NCT01780623|fatigue|fatigue
1255590|NCT01780623|sleep|sleep
1255591|NCT01780623|quality of life|quality of life
1255592|NCT01780623|light|light
1255593|NCT01780623|cancer|cancer
1255594|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
1255595|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
1255596|NCT01780610|irregular cycle|irregular cycle
1255597|NCT01780610|randomized controlled trial|randomized controlled trial
1255598|NCT01780597|Heart transplantation|heart transplantation
1255599|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
1255600|NCT01780597|Cardiac function|cardiac function
1255601|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
1255602|NCT01780571|Obesity|obesity
1255603|NCT01780571|general anaesthesia|general anaesthesia
1255604|NCT01780571|preoxygenation|preoxygenation
1255605|NCT01780571|atelectasis|atelectasis
1255606|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
1255607|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
1255608|NCT01780558|natural cycles|natural cycles
1255609|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
1255610|NCT01780558|randomized controlled trial|randomized controlled trial
1255611|NCT01780545|OGX-427|ogx-427
1255613|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
1255614|NCT01780506|HIV|hiv
1255615|NCT01780506|Treatment Naive|treatment naive
1255616|NCT01780506|HIV 1 Infected|hiv 1 infected
1255617|NCT01780506|Female|female
1255618|NCT01780506|Women|women
1255619|NCT01780493|Nipple|nipple
1255620|NCT01780493|Technique|technique
1255621|NCT01780493|Ureter|ureter
1255622|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
1255623|NCT01780480|Ischemic Stroke|ischemic stroke
1255624|NCT01780480|Convalescence|convalescence
1255625|NCT01780480|Randomized Controlled Trial|randomized controlled trial
1255626|NCT01780480|Pilot Study|pilot study
1255627|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
1255628|NCT01780467|Loss aversion|loss aversion
1255629|NCT01780467|Dopamine|dopamine
1255630|NCT01780467|Parkinson's disease|parkinson's disease
1255631|NCT01780454|End Stage Renal Disease|end stage renal disease
1255632|NCT01780454|Renal Transplant|renal transplant
1255633|NCT01780454|Bone Marrow Transplant|bone marrow transplant
1255634|NCT01780454|Tolerance|tolerance
1255635|NCT01780454|Chimerism|chimerism
1255636|NCT01780454|ESRD|esrd
1255637|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
1255638|NCT01780441|TSC|tsc
1255639|NCT01780441|Autism|autism
1255640|NCT01780441|ASD|asd
1255641|NCT01780441|Biomarkers|biomarkers
1255642|NCT01780441|Infants|infants
1255643|NCT01780428|Pain|pain
1255644|NCT01780428|Nausea|nausea
1255645|NCT01780428|Vomiting|vomiting
1255646|NCT01780415|Blastocoele fluid|blastocoele fluid
1255647|NCT01780415|Human DNA|human dna
1255648|NCT01780415|molecular diagnosis|molecular diagnosis
1255649|NCT01780402|feeding difficulty|feeding difficulty
1255650|NCT01780402|eating difficulty|eating difficulty
1255651|NCT01780402|dementia|dementia
1255652|NCT01780402|nursing home|nursing home
1255653|NCT01780402|careful hand feeding|careful hand feeding
1255654|NCT01780389|Knee|knee
1255655|NCT01780389|Pain|pain
1255656|NCT01780389|Osteoarthritis|osteoarthritis
1255657|NCT01780376|whole-body vibration|whole-body vibration
1255658|NCT01780376|latency|latency
1255659|NCT01780376|reflex response|reflex response
1255660|NCT01780376|muscle|muscle
1255661|NCT01780337|Oxytocin|oxytocin
1255662|NCT01780337|Arrhythmia|arrhythmia
1255663|NCT01780298|COPD|copd
1255664|NCT01780298|Biomarkers|biomarkers
1255665|NCT01780298|Cigarette Smoke|cigarette smoke
1255666|NCT01780298|Lung Inflammation|lung inflammation
1255667|NCT01780298|FEV|fev
1255668|NCT01780298|Sputum|sputum
1255669|NCT01780285|Hiatal hernia|hiatal hernia
1255670|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
1255671|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
1255672|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
1255673|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
1255674|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
1255675|NCT01780285|PTFE|ptfe
1255676|NCT01780285|Nitinol|nitinol
1255677|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
1255678|NCT01780259|Healthy|healthy
1255679|NCT01780259|Esketamine|esketamine
1255680|NCT01780259|Pharmacokinetics|pharmacokinetics
1255681|NCT01780259|Intranasal|intranasal
1255682|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
1255683|NCT01780246|SMA|sma
1255684|NCT01780246|SMN|smn
1255685|NCT01780246|SMNRx|smnrx
1255686|NCT01780246|ISIS-SMNRx|isis-smnrx
1255687|NCT01780246|ISIS 396443|isis 396443
1255688|NCT01780220|abiraterone|abiraterone
1255689|NCT01780220|biochemically-relapsing|biochemically-relapsing
1255690|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
1255691|NCT01780181|lung cancer|lung cancer
1255692|NCT01780181|traditional Chinese medicine|traditional chinese medicine
1255693|NCT01780168|Inborn Error of Metabolism|inborn error of metabolism
1255694|NCT01780168|Metabolism|metabolism
1255695|NCT01780168|UCD|ucd
1255696|NCT01780168|Immunity|immunity
1255697|NCT01780168|Nutrition|nutrition
1255698|NCT01780168|Mitochondrial Disease|mitochondrial disease
1255699|NCT01780155|Oxidative Stress|oxidative stress
1255700|NCT01780155|Hyperoxia|hyperoxia
1255701|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
1255702|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
1255703|NCT01780155|Very Low Birth Rate|very low birth rate
1255704|NCT01780142|Airflow Obstruction|airflow obstruction
1255705|NCT01780142|Airflow Inflammation|airflow inflammation
1255706|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
1255707|NCT01780142|Exacerbations|exacerbations
1255708|NCT01780142|Quality of Life|quality of life
1255709|NCT01780116|schizophrenia|schizophrenia
1255710|NCT01780116|adherence therapy|adherence therapy
1255711|NCT01780116|medication|medication
1255712|NCT01780116|randomized controlled trial|randomized controlled trial
1255713|NCT01780116|cost-effectiveness|cost-effectiveness
1255714|NCT01780090|autism|autism
1255715|NCT01780090|prosody|prosody
1255716|NCT01780090|speech|speech
1255717|NCT01780090|autism spectrum disorder|autism spectrum disorder
1255718|NCT01780077|Scar|scar
1255919|NCT01779258|emollient|emollient
1255719|NCT01780077|Scar prevention|scar prevention
1255720|NCT01780077|Fibrosis|fibrosis
1255721|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1255722|NCT01780051|Pharmacokinetics|pharmacokinetics
1255723|NCT01780038|Cigarette Smoking|cigarette smoking
1255724|NCT01780038|Nicotine Dependence|nicotine dependence
1255725|NCT01780038|Smoking Abstinence|smoking abstinence
1255726|NCT01780038|Health Literacy|health literacy
1255727|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
1255728|NCT01780038|Heredity|heredity
1255729|NCT01780025|Hearing|hearing
1255730|NCT01780025|Thresholds|thresholds
1255731|NCT01780025|Coupling to the inner ear|coupling to the inner ear
1255732|NCT01780012|osteoporosis|osteoporosis
1255733|NCT01780012|fragility fracture|fragility fracture
1255734|NCT01780012|secondary prevention|secondary prevention
1255735|NCT01779999|central venous catheters|central venous catheters
1255736|NCT01779999|thrombosis|thrombosis
1255737|NCT01779999|secondary prevention|secondary prevention
1255738|NCT01779973|Skype|skype
1255739|NCT01779973|compliance|compliance
1255740|NCT01779973|remote dosing|remote dosing
1255741|NCT01779973|suboxone|suboxone
1255742|NCT01779973|opiate|opiate
1255743|NCT01779973|opiates|opiates
1255744|NCT01779973|heroin|heroin
1255745|NCT01779973|oxycontin|oxycontin
1255746|NCT01779973|Philadelphia|philadelphia
1255747|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1255748|NCT01779960|Motor activity|motor activity
1255749|NCT01779960|Climatologic station|climatologic station
1255750|NCT01779908|Vitamin D supplementation|vitamin d supplementation
1255751|NCT01779908|Insulin resistance|insulin resistance
1255752|NCT01779895|Dust mite|dust mite
1255753|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
1255754|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
1255755|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
1255756|NCT01779843|Newly diagnosed|newly diagnosed
1255757|NCT01779804|foot , ankle, injury|foot , ankle, injury
1255758|NCT01779791|Lymphoma|lymphoma
1255759|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
1255760|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
1255761|NCT01779791|PCI-32765|pci-32765
1255762|NCT01779791|Ibrutinib|ibrutinib
1255763|NCT01779791|IMBRUVICA|imbruvica
1255764|NCT01779765|IBS|ibs
1255765|NCT01779765|Diarrhea|diarrhea
1255766|NCT01779765|Constipation|constipation
1255767|NCT01779765|Fibers|fibers
1255768|NCT01779739|vaginal prolapse|vaginal prolapse
1255769|NCT01779739|sexual function|sexual function
1255770|NCT01779739|sexual dysfunction|sexual dysfunction
1255771|NCT01779739|prolapse surgery|prolapse surgery
1255772|NCT01779726|Organization|organization
1255773|NCT01779726|of fast track|of fast track
1255774|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1255775|NCT01779713|Vasospasm|vasospasm
1255776|NCT01779713|Transcriptomic|transcriptomic
1255777|NCT01779713|Case-Control Study|case-control study
1255778|NCT01779700|psychosis|psychosis
1255779|NCT01779700|schizophrenia|schizophrenia
1255780|NCT01779700|cognition|cognition
1255781|NCT01779700|fingolimod|fingolimod
1255782|NCT01779687|pharmacokinetic|pharmacokinetic
1255783|NCT01779687|interaction|interaction
1255784|NCT01779687|cholesterol|cholesterol
1255785|NCT01779687|raltegravir|raltegravir
1255786|NCT01779687|atorvastatin|atorvastatin
1255787|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
1255788|NCT01779648|deep vein thrombosis|deep vein thrombosis
1255789|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
1255790|NCT01779648|venous hemodynamics|venous hemodynamics
1255791|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
1255792|NCT01779635|Circuit lifespan|circuit lifespan
1255793|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
1255794|NCT01779635|Anticoagulation free|anticoagulation free
1255795|NCT01779635|Bleeding risk|bleeding risk
1255796|NCT01779635|Acute kidney injury|acute kidney injury
1255797|NCT01779635|Critical illness|critical illness
1255798|NCT01779622|mixed meal¨|mixed meal¨
1255799|NCT01779622|insulin|insulin
1255800|NCT01779622|glucagon|glucagon
1255802|NCT01779622|GLP-1|glp-1
1255803|NCT01779596|diabetes|diabetes
1255804|NCT01779596|endothelial function|endothelial function
1255805|NCT01779596|exercise|exercise
1255806|NCT01779596|blood flow|blood flow
1255807|NCT01779596|bosentan|bosentan
1255808|NCT01779583|Advanced gastric cancer|advanced gastric cancer
1255809|NCT01779570|Influenza|influenza
1255810|NCT01779570|Macrolide|macrolide
1255811|NCT01779570|Anti-inflammatory|anti-inflammatory
1255812|NCT01779557|CAPD|capd
1255813|NCT01779557|efficacy|efficacy
1255814|NCT01779557|safety|safety
1255815|NCT01779557|survival rate|survival rate
1255816|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
1255817|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
1255818|NCT01779518|HCV|hcv
1255819|NCT01779518|Sustained Virologic Response|sustained virologic response
1255820|NCT01779518|Direct Acting Antiviral|direct acting antiviral
1255821|NCT01779518|GS-7977|gs-7977
1255822|NCT01779518|Pegylated interferon|pegylated interferon
1255823|NCT01779518|Ribavirin|ribavirin
1255824|NCT01779518|Open Label|open label
1255825|NCT01779518|Sofosbuvir|sofosbuvir
1255826|NCT01779518|Liver transplant|liver transplant
1255827|NCT01779518|Hepatitis|hepatitis
1255828|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
1255829|NCT01779518|Hepatitis C|hepatitis c
1255830|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
1255831|NCT01779518|Liver Diseases|liver diseases
1255832|NCT01779518|Digestive System Diseases|digestive system diseases
1255833|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
1255834|NCT01779518|Virus Diseases|virus diseases
1255835|NCT01779518|Enterovirus Infections|enterovirus infections
1255836|NCT01779518|Picornaviridae Infections|picornaviridae infections
1255837|NCT01779518|RNA Virus Infections|rna virus infections
1255838|NCT01779518|Flaviviridae Infections|flaviviridae infections
1255839|NCT01779518|Antiviral Agents|antiviral agents
1255840|NCT01779518|Anti-Infective Agents|anti-infective agents
1255841|NCT01779518|Therapeutic Uses|therapeutic uses
1255842|NCT01779518|Pharmacologic Actions|pharmacologic actions
1255843|NCT01779518|Antimetabolites|antimetabolites
1255844|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1255845|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
1255846|NCT01779479|German Breast Group|german breast group
1255847|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
1255848|NCT01779479|GBG|gbg
1255849|NCT01779479|GBG 74|gbg 74
1255850|NCT01779479|Genevieve|genevieve
1255851|NCT01779479|Breast Cancer|breast cancer
1255852|NCT01779479|Primary Breast Cancer|primary breast cancer
1255853|NCT01779479|Cabazitaxel|cabazitaxel
1255854|NCT01779479|Paclitaxel|paclitaxel
1255855|NCT01779479|neo-adjuvant|neo-adjuvant
1255856|NCT01779479|triple negative|triple negative
1255857|NCT01779479|luminal B|luminal b
1255858|NCT01779453|Atorvastatin|atorvastatin
1255859|NCT01779453|Drug-drug interaction|drug-drug interaction
1255860|NCT01779453|Combination therapy|combination therapy
1255861|NCT01779440|Mental Illness|mental illness
1255862|NCT01779440|Tobacco Smoking|tobacco smoking
1255863|NCT01779440|Young Adults|young adults
1255864|NCT01779440|Treatment Engagement|treatment engagement
1255865|NCT01779440|Motivational Intervention|motivational intervention
1255866|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
1255867|NCT01779427|intracranial edema|intracranial edema
1255868|NCT01779427|brain edema|brain edema
1255869|NCT01779427|craniocerebral trauma|craniocerebral trauma
1255870|NCT01779427|head injury|head injury
1255871|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
1255872|NCT01779427|subdural hematoma|subdural hematoma
1255873|NCT01779427|brain concussion|brain concussion
1255874|NCT01779427|head injuries, closed|head injuries, closed
1255875|NCT01779427|epidural hematoma|epidural hematoma
1255876|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
1255877|NCT01779427|cortical contusion|cortical contusion
1255878|NCT01779427|wounds and injuries|wounds and injuries
1255879|NCT01779427|disorders of environmental origin|disorders of environmental origin
1255880|NCT01779427|trauma, nervous system|trauma, nervous system
1255881|NCT01779427|brain injuries|brain injuries
1255882|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1255883|NCT01779427|attention|attention
1255884|NCT01779414|Suicide Ideation|suicide ideation
1255885|NCT01779401|PCI|pci
1255886|NCT01779401|platelet function monitoring|platelet function monitoring
1255887|NCT01779401|Thrombelastography|thrombelastography
1255888|NCT01779401|clopidogrel|clopidogrel
1255889|NCT01779401|cilostazol|cilostazol
1255890|NCT01779401|in-stent thrombosis|in-stent thrombosis
1255891|NCT01779388|Lung nodule|lung nodule
1255892|NCT01779388|PET scanner|pet scanner
1255893|NCT01779388|Bronchoscopy|bronchoscopy
1255894|NCT01779388|Electromagnetic navigation|electromagnetic navigation
1255895|NCT01779375|Children|children
1255896|NCT01779375|Pediatric|pediatric
1255897|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1255898|NCT01779349|acoustic vibration|acoustic vibration
1255899|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
1255900|NCT01779323|SUI|sui
1255901|NCT01779323|stress urinary incontinence|stress urinary incontinence
1255902|NCT01779323|male|male
1255903|NCT01779323|transobturator sling|transobturator sling
1255904|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
1255905|NCT01779297|mechanical ventilation|mechanical ventilation
1255906|NCT01779297|ICU|icu
1255907|NCT01779284|glaucoma|glaucoma
1255908|NCT01779284|fixed combinations|fixed combinations
1255909|NCT01779284|24-hour monitoring|24-hour monitoring
1255910|NCT01779271|Pelubi|pelubi
1255911|NCT01779271|Pelubiprofen|pelubiprofen
1255912|NCT01779271|Loxoprofen|loxoprofen
1255913|NCT01779271|Anti-pyretic|anti-pyretic
1255914|NCT01779271|Fever|fever
1255915|NCT01779258|xerosis|xerosis
1255916|NCT01779258|dry skin|dry skin
1255920|NCT01779258|corticosteroid|corticosteroid
1255921|NCT01779258|flare|flare
1255922|NCT01779232|endometriosis|endometriosis
1255923|NCT01779232|ivf|ivf
1255924|NCT01779232|ovarian reserve|ovarian reserve
1255925|NCT01779232|danazol|danazol
1255926|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
1255927|NCT01779219|stereotactic biopsy|stereotactic biopsy
1255928|NCT01779219|brain tumor|brain tumor
1255929|NCT01779219|frameless stereotaxy|frameless stereotaxy
1255930|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
1255931|NCT01779193|group B streptococcus|group b streptococcus
1255932|NCT01779193|pregnancy|pregnancy
1255933|NCT01779193|probiotics|probiotics
1255934|NCT01779180|Vitamin A supplementation|vitamin a supplementation
1255935|NCT01779180|BCG vaccination|bcg vaccination
1255936|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
1255937|NCT01779180|measles vaccination|measles vaccination
1255938|NCT01779180|atopy|atopy
1255939|NCT01779167|WM|wm
1255940|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
1255941|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
1255942|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
1255943|NCT01779154|eosinophilic colitis|eosinophilic colitis
1255944|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
1255945|NCT01779141|Pregnancy|pregnancy
1255946|NCT01779141|Insulin Pump|insulin pump
1255947|NCT01779141|Glucose Sensor|glucose sensor
1255948|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
1255949|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
1255950|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
1255951|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
1255952|NCT01779089|diabetic nephropathy|diabetic nephropathy
1255953|NCT01779089|diabetic kidney disease|diabetic kidney disease
1255954|NCT01779089|minocycline|minocycline
1255955|NCT01779089|proteinuria|proteinuria
1255956|NCT01779089|albuminuria|albuminuria
1255957|NCT01779063|lymphedema|lymphedema
1255958|NCT01779063|self-care|self-care
1255959|NCT01779063|breast cancer|breast cancer
1255960|NCT01779024|Addiction|addiction
1255961|NCT01779024|Alcohol|alcohol
1255962|NCT01779024|Alcohol Clamp|alcohol clamp
1255963|NCT01778998|incision|incision
1255964|NCT01778998|pre-cut|pre-cut
1255965|NCT01778998|wound architecture|wound architecture
1255966|NCT01778998|OCT|oct
1255967|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
1255968|NCT01778985|Menopause|menopause
1255969|NCT01778985|Estrogen|estrogen
1255970|NCT01778985|Premarin|premarin
1255971|NCT01778972|Fall prevention|fall prevention
1255972|NCT01778972|Home exercise|home exercise
1255973|NCT01778972|Strength training|strength training
1255974|NCT01778972|Balance training|balance training
1255975|NCT01778946|Nicotine|nicotine
1255976|NCT01778946|Down Syndrome|down syndrome
1255977|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
1255978|NCT01778946|Event Related Potential|event related potential
1255979|NCT01778946|Memory|memory
1255980|NCT01778946|Attention|attention
1255981|NCT01778946|Trisomy 21|trisomy 21
1255982|NCT01778946|Neuroprotection|neuroprotection
1255983|NCT01778946|Cognitive Enhancement|cognitive enhancement
1255984|NCT01778946|Alzheimer's Disease|alzheimer's disease
1255985|NCT01778946|Dementia|dementia
1255986|NCT01778946|APOE|apoe
1255987|NCT01778933|Renal cell carcinoma|renal cell carcinoma
1255988|NCT01778933|Renal nodules|renal nodules
1255989|NCT01778907|Pharmacogenetics|pharmacogenetics
1255990|NCT01778907|Depression|depression
1255991|NCT01778907|Depressive Disorder|depressive disorder
1255992|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
1255993|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
1255994|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
1255995|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
1255996|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
1255997|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
1255998|NCT01778907|Multicenter studies|multicenter studies
1255999|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
1256000|NCT01778894|Echocardiography|echocardiography
1256001|NCT01778881|Bruxism|bruxism
1256002|NCT01778881|Physical therapy modalities|physical therapy modalities
1256003|NCT01778881|Massage|massage
1256004|NCT01778881|Muscle stretching exercises|muscle stretching exercises
1256005|NCT01778881|Relaxation therapy|relaxation therapy
1256006|NCT01778881|Imagination|imagination
1256007|NCT01778855|stroke|stroke
1256008|NCT01778855|hypothermia|hypothermia
1256009|NCT01778855|thrombolysis|thrombolysis
1256010|NCT01778855|imaging|imaging
1256011|NCT01778855|collateral circulation|collateral circulation
1256012|NCT01778855|recanalization|recanalization
1256013|NCT01778855|reperfusion|reperfusion
1256014|NCT01778842|antiplatelet effect|antiplatelet effect
1256015|NCT01778842|prasugrel|prasugrel
1256016|NCT01778842|clopidogrel|clopidogrel
1256017|NCT01778842|acute coronary syndrome|acute coronary syndrome
1256018|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
1256019|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
1256020|NCT01778777|inverse prosthesis|inverse prosthesis
1256021|NCT01778777|safety|safety
1256022|NCT01778777|universe reverse|universe reverse
1256023|NCT01778751|Self-Management Support|self-management support
1256024|NCT01778751|Depression|depression
1256025|NCT01778751|Home Telehealth|home telehealth
1256026|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
1256027|NCT01778712|Multi-level intervention|multi-level intervention
1256028|NCT01778712|Menopause|menopause
1256029|NCT01778712|Body composition|body composition
1256030|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
1256031|NCT01778712|Visceral adipose tissue|visceral adipose tissue
1256032|NCT01778712|Perceived stress|perceived stress
1256033|NCT01778712|Computed tomography|computed tomography
1256034|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
1256035|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
1256036|NCT01778699|caries incidence|caries incidence
1256037|NCT01778699|plaque-pH|plaque-ph
1256038|NCT01778686|Positron Emission Tomography|positron emission tomography
1256039|NCT01778686|Serotonin|serotonin
1256040|NCT01778686|5-HT2A|5-ht2a
1256041|NCT01778686|Radioligand|radioligand
1256042|NCT01778660|Fecal Incontinence|fecal incontinence
1256043|NCT01778660|Treatment options|treatment options
1256044|NCT01778660|Patient Satisfaction|patient satisfaction
1256045|NCT01778647|ADHD|adhd
1256046|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
1256047|NCT01778647|CGI|cgi
1256048|NCT01778647|Conners rating scale|conners rating scale
1256049|NCT01778647|Stimulants|stimulants
1256050|NCT01778634|Ureaplasma parvum|ureaplasma parvum
1256051|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
1256052|NCT01778634|prematurity|prematurity
1256053|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1256054|NCT01778634|azithromycin|azithromycin
1256055|NCT01778621|Acupuncture|acupuncture
1256056|NCT01778621|AMH|amh
1256057|NCT01778621|Infertility|infertility
1256058|NCT01778621|PCOS|pcos
1256059|NCT01778621|Pregnancy rate|pregnancy rate
1256060|NCT01778608|Sedation|sedation
1256061|NCT01778595|Microbiome|microbiome
1256062|NCT01778595|Feces|feces
1256063|NCT01778595|Cancer Screening|cancer screening
1256064|NCT01778582|Emotion|emotion
1256065|NCT01778582|Informed Consent|informed consent
1256066|NCT01778569|Psoriasis|psoriasis
1256067|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
1256068|NCT01778569|Inflammation|inflammation
1256069|NCT01778569|Lipoproteins|lipoproteins
1256070|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
1256071|NCT01778556|Lipodystrophy|lipodystrophy
1256072|NCT01778556|Leptin|leptin
1256073|NCT01778556|Energy Expenditure|energy expenditure
1256074|NCT01778556|Diabetes|diabetes
1256079|NCT01778530|Radiotherapy|radiotherapy
1256080|NCT01778530|Malignant Glioma|malignant glioma
1256081|NCT01778530|Progression|progression
1256082|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
1256083|NCT01778504|Children and Adolescents|children and adolescents
1256084|NCT01778504|Natural History Study|natural history study
1256085|NCT01778504|Neurodevelopmental Disorders|neurodevelopmental disorders
1256086|NCT01778504|Autism|autism
1256087|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
1256088|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
1256089|NCT01778491|Phenotype|phenotype
1256090|NCT01778491|Phenotypes|phenotypes
1256091|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
1256096|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
1256097|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
1256098|NCT01778465|Asthma|asthma
1256099|NCT01778465|Aspirin sensitivity|aspirin sensitivity
1256100|NCT01778465|Salicylate|salicylate
1256101|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
1256102|NCT01778439|Phase 1|phase 1
1256103|NCT01778439|Dose escalation|dose escalation
1256104|NCT01778439|relapsed or refractory|relapsed or refractory
1256105|NCT01778439|solid tumor|solid tumor
1256106|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
1256107|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
1256108|NCT01778426|Painstim devices|painstim devices
1256109|NCT01778426|Efficacy|efficacy
1256110|NCT01778426|Safety|safety
1256111|NCT01778400|Ultrasound|ultrasound
1256112|NCT01778400|Radiofrequency|radiofrequency
1256113|NCT01778400|Ethanol|ethanol
1256114|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
1256115|NCT01778400|Thyroid nodule|thyroid nodule
1256116|NCT01778400|Thyroid|thyroid
1256117|NCT01778374|Emergency Medicine|emergency medicine
1256118|NCT01778374|Screening|screening
1256119|NCT01778374|Point of care testing|point of care testing
1256120|NCT01778374|Video assisted counseling|video assisted counseling
1256121|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
1256122|NCT01778361|low bone mineral density|low bone mineral density
1256123|NCT01778361|osteopenia|osteopenia
1256124|NCT01778361|osteoporosis|osteoporosis
1256125|NCT01778361|fracture|fracture
1256126|NCT01778348|Type 1 diabetes|type 1 diabetes
1256127|NCT01778348|Closed-loop glucose control|closed-loop glucose control
1256128|NCT01778348|Artificial Pancreas|artificial pancreas
1256129|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1256130|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
1256131|NCT01778335|recanalization|recanalization
1256132|NCT01778335|endovascular|endovascular
1256133|NCT01778335|thrombectomy|thrombectomy
1256134|NCT01778309|aseptic inflammation|aseptic inflammation
1256135|NCT01778309|skeletal muscle function|skeletal muscle function
1256136|NCT01778309|exercise|exercise
1256137|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
1256138|NCT01778296|dorsal digital artery;|dorsal digital artery;
1256139|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
1256140|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
1256141|NCT01778270|pleural effusion|pleural effusion
1256142|NCT01778270|pleural drainage|pleural drainage
1256143|NCT01778270|thorax impedance|thorax impedance
1256144|NCT01778270|respiration parameters|respiration parameters
1256145|NCT01778270|heart sounds analysis|heart sounds analysis
1256146|NCT01778257|Mate extracts|mate extracts
1256147|NCT01778257|Obesity|obesity
1256148|NCT01778257|abdominal fat|abdominal fat
1256149|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
1256150|NCT01778231|Focus|focus
1256151|NCT01778231|uptake|uptake
1256152|NCT01778231|Lutein|lutein
1256153|NCT01778231|Zeaxanthin|zeaxanthin
1256154|NCT01778231|individuals|individuals
1256155|NCT01778218|Coronary Artery Disease|coronary artery disease
1256156|NCT01778218|CAD|cad
1256157|NCT01778192|Bowel preparation|bowel preparation
1256158|NCT01778192|Polyethylene glycol|polyethylene glycol
1256159|NCT01778192|Sodium picosulphate|sodium picosulphate
1256160|NCT01778179|Lentigines|lentigines
1256161|NCT01778179|Cryotherapy|cryotherapy
1256162|NCT01778179|hyperpigmentation|hyperpigmentation
1256163|NCT01778166|Early enteral nutrition|early enteral nutrition
1256164|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
1256165|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
1256166|NCT01778153|Fitness training|fitness training
1256167|NCT01778153|Personal training|personal training
1256168|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
1256169|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
1256170|NCT01778127|Cancer Survivor|cancer survivor
1256171|NCT01778127|Physical Activity|physical activity
1256172|NCT01778127|Health Outcomes|health outcomes
1256173|NCT01778127|Rewards-Based Intervention|rewards-based intervention
1256174|NCT01778127|Cardiovascular Health|cardiovascular health
1256175|NCT01778127|Musculoskeletal Health|musculoskeletal health
1256176|NCT01778127|Exercise|exercise
1256177|NCT01778114|Vitamin D2|vitamin d2
1256178|NCT01778114|Vitamin D3|vitamin d3
1256179|NCT01778114|Vitamin D|vitamin d
1256180|NCT01778114|Orange Juice|orange juice
1256181|NCT01778101|preterm infants|preterm infants
1256183|NCT01778101|impedance|impedance
1256184|NCT01778101|pH|ph
1256185|NCT01778101|monitoring|monitoring
1256186|NCT01778101|lansoprazole|lansoprazole
1256187|NCT01778075|Healthy|healthy
1256188|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
1256189|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
1256190|NCT01778075|Acetaminophen|acetaminophen
1256191|NCT01778075|Bioequivalence|bioequivalence
1256192|NCT01778036|Neck movement|neck movement
1256193|NCT01778036|motor control|motor control
1256194|NCT01778036|disability|disability
1256195|NCT01778036|psychological variables|psychological variables
1256196|NCT01778036|Head Movements|head movements
1256197|NCT01778036|Physical therapy|physical therapy
1256198|NCT01778036|Fear avoidance|fear avoidance
1256199|NCT01778036|Self Efficacy|self efficacy
1256200|NCT01778036|Catastrophizing|catastrophizing
1256201|NCT01778036|Fly test|fly test
1256202|NCT01778036|Postural sway|postural sway
1256203|NCT01778010|cocaine|cocaine
1256204|NCT01778010|modafinil|modafinil
1256205|NCT01778010|self-administration|self-administration
1256206|NCT01778010|DRD4|drd4
1256207|NCT01777906|nasal polyps|nasal polyps
1256208|NCT01777906|nasal steriod sprays|nasal steriod sprays
1256209|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
1256210|NCT01777893|Obesity|obesity
1256211|NCT01777893|High protein diet|high protein diet
1256212|NCT01777893|Low GI|low gi
1256213|NCT01777893|Physical activity|physical activity
1256214|NCT01777815|NeoChord|neochord
1256215|NCT01777815|DS1000|ds1000
1256216|NCT01777815|Mitral Valve|mitral valve
1256217|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
1256218|NCT01777815|MR|mr
1256219|NCT01777815|Mitral Valve Repair|mitral valve repair
1256220|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
1256221|NCT01777815|Artificial Chordae|artificial chordae
1256222|NCT01777789|fMRI|fmri
1256223|NCT01777789|Dementia|dementia
1256224|NCT01777789|Alzheimer's disease|alzheimer's disease
1256225|NCT01777789|functional neuroimaging|functional neuroimaging
1256226|NCT01777789|Memory|memory
1256227|NCT01777776|Open-label dose escalation|open-label dose escalation
1256228|NCT01777776|BRAF inhibitor|braf inhibitor
1256229|NCT01777776|LEE011|lee011
1256230|NCT01777776|CDK4/6|cdk4/6
1256231|NCT01777776|LGX818|lgx818
1256232|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
1256233|NCT01777776|Metastatic melanoma|metastatic melanoma
1256234|NCT01777776|BRAF|braf
1256235|NCT01777776|V600|v600
1256236|NCT01777750|Myocardial Infarction|myocardial infarction
1256237|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
1256238|NCT01777750|Reperfusion Injury|reperfusion injury
1256239|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
1256240|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
1256241|NCT01777750|Pathologic Processes|pathologic processes
1256242|NCT01777750|Myocardial Ischemia|myocardial ischemia
1256243|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1256244|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1256245|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
1256246|NCT01777711|mental contrasting|mental contrasting
1256247|NCT01777711|weight loss|weight loss
1256248|NCT01777711|obese couples|obese couples
1256249|NCT01777711|obesity|obesity
1256250|NCT01777711|overweight|overweight
1256251|NCT01777711|planning|planning
1256252|NCT01777711|health|health
1256253|NCT01777711|diet|diet
1256254|NCT01777711|exercise|exercise
1256255|NCT01777711|physical activity|physical activity
1256256|NCT01777711|goal|goal
1256257|NCT01777711|goal-setting|goal-setting
1256258|NCT01777698|body composition|body composition
1256259|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
1256260|NCT01777698|chemoembolization|chemoembolization
1256261|NCT01777685|Sulpiride|sulpiride
1256262|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
1256263|NCT01777685|Pharmacokinetics|pharmacokinetics
1256264|NCT01777659|exercise|exercise
1256265|NCT01777659|neuromodulation|neuromodulation
1256266|NCT01777659|blood flow|blood flow
1256267|NCT01777659|exercise capacity|exercise capacity
1256268|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
1256269|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1256270|NCT01777646|Neuroprotection|neuroprotection
1256271|NCT01777646|Neurodegeneration|neurodegeneration
1256272|NCT01777646|Stem cells|stem cells
1256273|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
1256274|NCT01777594|HCC|hcc
1256275|NCT01777594|liver|liver
1256276|NCT01777594|liver cancer|liver cancer
1256277|NCT01777594|sorafenib|sorafenib
1256278|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
1256279|NCT01777555|Parkinson's Disease|parkinson's disease
1256280|NCT01777555|Motor fluctuations|motor fluctuations
1256281|NCT01777555|levodopa|levodopa
1256282|NCT01777555|inhaled drugs|inhaled drugs
1256283|NCT01777555|Off episodes|off episodes
1256284|NCT01777542|Rett syndrome|rett syndrome
1256285|NCT01777542|RTT|rtt
1256286|NCT01777542|IGF-1|igf-1
1256287|NCT01777542|autism spectrum disorder|autism spectrum disorder
1256288|NCT01777529|Measles|measles
1256289|NCT01777529|Mumps|mumps
1256290|NCT01777529|Rubella|rubella
1256291|NCT01777516|Platelet Aggregation|platelet aggregation
1256292|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
1256293|NCT01777516|Salicylic Acid|salicylic acid
1256294|NCT01777503|acute coronary syndrome|acute coronary syndrome
1256295|NCT01777503|elderly|elderly
1256296|NCT01777503|percutaneous revascularization|percutaneous revascularization
1256297|NCT01777503|antiaggregant drugs|antiaggregant drugs
1256298|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
1256299|NCT01777490|Frail Elderly|frail elderly
1256300|NCT01777490|Long-term Care|long-term care
1256301|NCT01777490|Quality of Life|quality of life
1256302|NCT01777451|Whole Body Imaging|whole body imaging
1256303|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
1256304|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
1256305|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
1256306|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
1256307|NCT01777412|NMO|nmo
1256308|NCT01777412|NMOSD|nmosd
1256309|NCT01777412|NMO-IgG|nmo-igg
1256310|NCT01777412|Aquaporin-4|aquaporin-4
1256311|NCT01777412|AQP4|aqp4
1256312|NCT01777412|anti-AQP4|anti-aqp4
1256313|NCT01777386|scar|scar
1256314|NCT01777386|contracture|contracture
1256315|NCT01777386|perforator flap|perforator flap
1256316|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
1256317|NCT01777386|perforator vessel|perforator vessel
1256318|NCT01777386|artery diameter|artery diameter
1256319|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
1256320|NCT01777360|severe|severe
1256321|NCT01777360|uncontrolled|uncontrolled
1256421|NCT01777100|Patient controlled analgesia|patient controlled analgesia
1256322|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
1256323|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
1256324|NCT01777347|Hypertonic saline|hypertonic saline
1256325|NCT01777347|Hospitalization|hospitalization
1256326|NCT01777347|Infants|infants
1256327|NCT01777347|Hospital admissions|hospital admissions
1256328|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
1256329|NCT01777347|Bronchiolitis|bronchiolitis
1256330|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
1256331|NCT01777347|Bronchial Diseases|bronchial diseases
1256332|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
1256333|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
1256334|NCT01777347|Respiratory Tract Infections|respiratory tract infections
1256335|NCT01777347|Virus Diseases|virus diseases
1256336|NCT01777321|Herpes Zoster|herpes zoster
1256337|NCT01777321|Intramuscular|intramuscular
1256338|NCT01777321|Subcutaneous|subcutaneous
1256339|NCT01777321|Safety|safety
1256340|NCT01777321|≥50 years of age|≥50 years of age
1256341|NCT01777321|Adults|adults
1256342|NCT01777321|Immunogenicity|immunogenicity
1256343|NCT01777321|Elderly|elderly
1256344|NCT01777308|Immunogenicity|immunogenicity
1256345|NCT01777308|Booster|booster
1256346|NCT01777308|Healthy|healthy
1256347|NCT01777308|Vaccine response|vaccine response
1256348|NCT01777308|Safety|safety
1256349|NCT01777308|Neisseria meningiditis|neisseria meningiditis
1256350|NCT01777308|Antibody persistence|antibody persistence
1256351|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
1256352|NCT01777295|Adults|adults
1256353|NCT01777295|Reactogenicity|reactogenicity
1256354|NCT01777295|Naive|naive
1256355|NCT01777295|Immune responses|immune responses
1256356|NCT01777295|Read-outs|read-outs
1256357|NCT01777295|Hepatitis B|hepatitis b
1256358|NCT01777295|Healthy|healthy
1256359|NCT01777282|albiglutide|albiglutide
1256360|NCT01777282|Japanese|japanese
1256361|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
1256362|NCT01777282|GSK716155|gsk716155
1256363|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
1256364|NCT01777256|adaptive design|adaptive design
1256365|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
1256366|NCT01777256|pharmacodynamics|pharmacodynamics
1256367|NCT01777243|pharmacokinetic|pharmacokinetic
1256368|NCT01777243|systemic amyloidosis|systemic amyloidosis
1256369|NCT01777243|safety|safety
1256370|NCT01777243|dose escalation|dose escalation
1256371|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
1256372|NCT01777243|biomarker|biomarker
1256373|NCT01777243|GSK2315698|gsk2315698
1256374|NCT01777243|GSK2398852|gsk2398852
1256375|NCT01777243|SAP|sap
1256376|NCT01777243|pharmacodynamic|pharmacodynamic
1256377|NCT01777243|co-administration|co-administration
1256378|NCT01777243|intravenous|intravenous
1256379|NCT01777217|Urination Disorder|urination disorder
1256380|NCT01777217|Overactive Bladder|overactive bladder
1256381|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
1256382|NCT01777217|Vesicare|vesicare
1256383|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
1256384|NCT01777178|bicarbonate|bicarbonate
1256385|NCT01777178|dialysis|dialysis
1256386|NCT01777165|GFR|gfr
1256387|NCT01777165|Acute Kidney Injury|acute kidney injury
1256388|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
1256389|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
1256390|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
1256391|NCT01777152|Antigens, CD30|antigens, cd30
1256392|NCT01777152|Drug Therapy|drug therapy
1256393|NCT01777152|Hematologic Diseases|hematologic diseases
1256394|NCT01777152|Lymphoma|lymphoma
1256395|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
1256396|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
1256397|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1256398|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1256399|NCT01777139|Retigabine|retigabine
1256400|NCT01777139|Drug-Resistant|drug-resistant
1256401|NCT01777139|Epilepsy|epilepsy
1256402|NCT01777139|Partial-Onset Seizures|partial-onset seizures
1256403|NCT01777139|Safety and Tolerability|safety and tolerability
1256404|NCT01777139|Immediate Release|immediate release
1256405|NCT01777139|Long-Term|long-term
1256406|NCT01777139|Adjunctive Therapy|adjunctive therapy
1256407|NCT01777139|Asian Subjects|asian subjects
1256408|NCT01777139|Efficacy|efficacy
1256409|NCT01777139|GW582892|gw582892
1256410|NCT01777126|cystectomy|cystectomy
1256411|NCT01777126|parenteral nutrition|parenteral nutrition
1256412|NCT01777126|discharge|discharge
1256413|NCT01777126|outcome|outcome
1256414|NCT01777113|Chronic Stroke|chronic stroke
1256415|NCT01777113|Gait|gait
1256416|NCT01777113|Exercise|exercise
1256417|NCT01777113|High intensity aerobic training|high intensity aerobic training
1256418|NCT01777113|Strength training|strength training
1256419|NCT01777113|Randomized controlled trial|randomized controlled trial
1256420|NCT01777100|Postoperative pain|postoperative pain
1256537|NCT01776515|Wontran|wontran
1256422|NCT01777100|Hyperalgesia|hyperalgesia
1256423|NCT01777100|Remifentanil|remifentanil
1256424|NCT01777100|Sufentanil|sufentanil
1256425|NCT01777100|Morphine|morphine
1256426|NCT01777100|Abdominal surgery|abdominal surgery
1256427|NCT01777100|Safety|safety
1256428|NCT01777087|Pain|pain
1256429|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1256430|NCT01777074|Vaccination|vaccination
1256431|NCT01777074|Acceptability|acceptability
1256432|NCT01777074|Hepatitis B|hepatitis b
1256433|NCT01777061|Prostate Cancer|prostate cancer
1256434|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
1256435|NCT01777061|PET Scan|pet scan
1256436|NCT01777061|FDG-PET|fdg-pet
1256437|NCT01777061|[11C]Acetate|[11c]acetate
1256438|NCT01777061|C11-Acetate|c11-acetate
1256439|NCT01777035|mechanical ventilation|mechanical ventilation
1256440|NCT01777035|physical therapy|physical therapy
1256441|NCT01777035|occupational therapy|occupational therapy
1256442|NCT01777035|ICU acquired weakness|icu acquired weakness
1256443|NCT01777035|critical illness myopathy|critical illness myopathy
1256444|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
1256445|NCT01777009|Total Knee Replacement|total knee replacement
1256446|NCT01777009|Patellar Eversion|patellar eversion
1256447|NCT01777009|Surgical Exposure|surgical exposure
1256448|NCT01777009|Outcomes|outcomes
1256449|NCT01777009|Quadriceps Strength|quadriceps strength
1256450|NCT01777009|Straight Leg Raise|straight leg raise
1256451|NCT01777009|SF-36|sf-36
1256452|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
1256453|NCT01776970|Motor Neuron Disease|motor neuron disease
1256454|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1256455|NCT01776970|Cannabinoids|cannabinoids
1256456|NCT01776970|Sativex|sativex
1256457|NCT01776970|Spasticity|spasticity
1256458|NCT01776957|Abortion rate|abortion rate
1256459|NCT01776957|Intrauterine device|intrauterine device
1256460|NCT01776944|Resting energy expenditure|resting energy expenditure
1256461|NCT01776944|Handheld calorimeter|handheld calorimeter
1256462|NCT01776944|Obese and overweight|obese and overweight
1256463|NCT01776944|Pediatrics|pediatrics
1256464|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
1256465|NCT01776931|Lysine requirements|lysine requirements
1256466|NCT01776931|Pregnancy|pregnancy
1256467|NCT01776931|Dietary protein|dietary protein
1256468|NCT01776918|POLG1 Mutation|polg1 mutation
1256469|NCT01776918|Phenylketonuria|phenylketonuria
1256470|NCT01776905|Melanoma|melanoma
1256471|NCT01776905|Cancer|cancer
1256472|NCT01776892|Collagenase|collagenase
1256473|NCT01776892|Needle aponeurotomy|needle aponeurotomy
1256474|NCT01776866|Coronary Angiography|coronary angiography
1256491|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
1256492|NCT01776840|Rituximab|rituximab
1256493|NCT01776827|GERD|gerd
1256494|NCT01776827|Hiatal Hernia|hiatal hernia
1256495|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
1256496|NCT01776827|Biologic Mesh|biologic mesh
1256497|NCT01776814|Entecair|entecair
1256498|NCT01776814|Tenofovir|tenofovir
1256499|NCT01776801|intracranial baroreflex|intracranial baroreflex
1256500|NCT01776762|Nutrition|nutrition
1256501|NCT01776762|Rehabilitation|rehabilitation
1256502|NCT01776762|Weightloss|weightloss
1256503|NCT01776749|low back pain|low back pain
1256504|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
1256505|NCT01776749|spinal cord stimulation|spinal cord stimulation
1256506|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
1256507|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
1256508|NCT01776736|Scoliosis|scoliosis
1256509|NCT01776736|Posture correction|posture correction
1256510|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1256511|NCT01776723|CMML|cmml
1256512|NCT01776723|Leukemia|leukemia
1256513|NCT01776710|Intermittent claudication|intermittent claudication
1256514|NCT01776710|Behavior therapy|behavior therapy
1256515|NCT01776710|Walking|walking
1256516|NCT01776710|Exercise|exercise
1256517|NCT01776710|Patient education|patient education
1256518|NCT01776710|Randomized controlled trial|randomized controlled trial
1256519|NCT01776658|Ocular pain|ocular pain
1256520|NCT01776658|Dry Eye Syndrome|dry eye syndrome
1256521|NCT01776658|siRNA|sirna
1256522|NCT01776658|RNAi|rnai
1256523|NCT01776658|TRPV1|trpv1
1256524|NCT01776619|Safety|safety
1256525|NCT01776619|tolerability|tolerability
1256526|NCT01776619|PK|pk
1256527|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
1256528|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
1256529|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
1256530|NCT01776580|sexual dysfunction|sexual dysfunction
1256531|NCT01776567|coronary artery disease|coronary artery disease
1256532|NCT01776567|stents|stents
1256533|NCT01776567|optical imaging|optical imaging
1256534|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
1256535|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
1256536|NCT01776515|Low back pain|low back pain
1256538|NCT01776515|Wontran SR Tab.|wontran sr tab.
1256539|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
1256540|NCT01776489|Food allergy|food allergy
1256541|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
1256542|NCT01776489|Biomarker|biomarker
1256543|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
1256544|NCT01776489|Anaphylaxis|anaphylaxis
1256545|NCT01776476|glutamine dipeptide|glutamine dipeptide
1256546|NCT01776476|randomized controlled trial|randomized controlled trial
1256547|NCT01776476|insulin resistance|insulin resistance
1256548|NCT01776476|critical illness|critical illness
1256549|NCT01776476|trauma|trauma
1256550|NCT01776463|Z-360|z-360
1256551|NCT01776463|Japanese|japanese
1256552|NCT01776463|pK|pk
1256553|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1256572|NCT01776398|COPD|copd
1256573|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1256574|NCT01776398|Lung disease|lung disease
1256581|NCT01776385|(C08.528.778)|(c08.528.778)
1256582|NCT01776385|[C19.642.713]|[c19.642.713]
1256583|NCT01776385|mesothelium|mesothelium
1256584|NCT01776372|Drainage|drainage
1256585|NCT01776372|Chest tubes|chest tubes
1256586|NCT01776372|Randomized Controlled Trial|randomized controlled trial
1256587|NCT01776359|Muscle|muscle
1256588|NCT01776359|Protein|protein
1256589|NCT01776359|Diet|diet
1256590|NCT01776359|Exercise|exercise
1256591|NCT01776333|ICU|icu
1256592|NCT01776320|Erectile Dysfunction|erectile dysfunction
1256593|NCT01776320|Topical Alprostadil|topical alprostadil
1256594|NCT01776307|BBI608|bbi608
1256595|NCT01776294|Prehypertension|prehypertension
1256596|NCT01776294|Prevalence|prevalence
1256597|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
1256598|NCT01776281|effects|effects
1256599|NCT01776281|KMC|kmc
1256600|NCT01776281|LBW|lbw
1256601|NCT01776281|preterm|preterm
1256602|NCT01776281|temperature|temperature
1256603|NCT01776281|breastfeeding|breastfeeding
1256604|NCT01776281|secondary hospitals|secondary hospitals
1256605|NCT01776268|antimicrobial proteins|antimicrobial proteins
1256606|NCT01776255|Obesity|obesity
1256607|NCT01776255|Overweight|overweight
1256608|NCT01776255|Lifestyle|lifestyle
1256609|NCT01776255|American Indian|american indian
1256610|NCT01776242|low back pain|low back pain
1256611|NCT01776242|elderly|elderly
1256612|NCT01776242|back pain|back pain
1256613|NCT01776242|lumbar pain|lumbar pain
1256614|NCT01776242|over 65|over 65
1256615|NCT01776229|nightmare|nightmare
1256616|NCT01776229|PTSD|ptsd
1256617|NCT01776229|trauma|trauma
1256618|NCT01776229|children|children
1256619|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
1256620|NCT01776229|stress|stress
1256621|NCT01776229|sleep|sleep
1256622|NCT01776216|Endothelial function|endothelial function
1256623|NCT01776216|Dairy|dairy
1256624|NCT01776177|Allergic asthma|allergic asthma
1256625|NCT01776177|Omalizumab therapy|omalizumab therapy
1256626|NCT01776177|IgE profile|ige profile
1256627|NCT01776164|Friedreich|friedreich
1256628|NCT01776164|ataxia|ataxia
1256629|NCT01776164|FRDA|frda
1256630|NCT01776164|FA|fa
1256631|NCT01776164|recessive|recessive
1256632|NCT01776164|neurodegenerative|neurodegenerative
1256633|NCT01776164|cerebellum|cerebellum
1256634|NCT01776151|HIV|hiv
1256635|NCT01776151|cardiovascular diseases|cardiovascular diseases
1256636|NCT01776151|vascular stiffness|vascular stiffness
1256637|NCT01776138|Elderly|elderly
1256638|NCT01776138|Chemotherapy|chemotherapy
1256639|NCT01776138|Cystectomy|cystectomy
1256640|NCT01776138|Radical Cystectomy|radical cystectomy
1256641|NCT01776138|University of North Carolina|university of north carolina
1256642|NCT01776138|Cancer|cancer
1256643|NCT01776138|Bladder Cancer|bladder cancer
1256644|NCT01776138|Bladder|bladder
1256645|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
1256646|NCT01776125|Scoliosis|scoliosis
1256647|NCT01776112|schizophrenia|schizophrenia
1256648|NCT01776112|negative symptoms|negative symptoms
1256649|NCT01776112|cognitive deficits|cognitive deficits
1256650|NCT01776112|synaptic plasticity|synaptic plasticity
1256651|NCT01776099|type 2 diabetes|type 2 diabetes
1256652|NCT01776099|nutrition|nutrition
1256653|NCT01776099|fibers|fibers
1256654|NCT01776073|Transplantation|transplantation
1256655|NCT01776073|Healthcare Disparities|healthcare disparities
1256656|NCT01776073|Quality Assurance|quality assurance
1256657|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
1256658|NCT01776060|Multiple Sclerosis|multiple sclerosis
1256659|NCT01776060|biomarker|biomarker
1256660|NCT01776060|'omic|'omic
1256661|NCT01776060|progression|progression
1256662|NCT01776034|Self Care|self care
1256663|NCT01776034|Exercise|exercise
1256664|NCT01776034|Weight management|weight management
1256665|NCT01776021|Urinary tract infection|urinary tract infection
1256666|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
1256667|NCT01776021|Cranberry|cranberry
1256668|NCT01776021|Prevention|prevention
1256669|NCT01776021|E-coli|e-coli
1257079|NCT01774110|acute|acute
1256670|NCT01775995|Chronic Pain|chronic pain
1256671|NCT01775995|Low Back Pain|low back pain
1256672|NCT01775982|French language validation|french language validation
1256673|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
1256674|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
1256675|NCT01775943|Mutation|mutation
1256676|NCT01775943|Lung cancer|lung cancer
1256677|NCT01775943|Drug sensitivity|drug sensitivity
1256683|NCT01775891|pilsicainide|pilsicainide
1256684|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
1256685|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1256686|NCT01775891|catheter ablation|catheter ablation
1256687|NCT01775878|Diabetes|diabetes
1256688|NCT01775878|HbA1c|hba1c
1256689|NCT01775878|Fructosamine|fructosamine
1256690|NCT01775878|Blood Pressure|blood pressure
1256691|NCT01775878|Telemonitoring|telemonitoring
1256692|NCT01775865|aortic stiffness|aortic stiffness
1256693|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
1256694|NCT01775865|vascular aging|vascular aging
1256695|NCT01775865|oxidative stress|oxidative stress
1256696|NCT01775865|inflammation|inflammation
1256697|NCT01775865|nitric oxide|nitric oxide
1256698|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
1256699|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
1256700|NCT01775852|Depression|depression
1256701|NCT01775852|Illness Management|illness management
1256702|NCT01775852|Behavioral treatment|behavioral treatment
1256703|NCT01775852|Impairment|impairment
1256704|NCT01775826|physical activity|physical activity
1256705|NCT01775826|sedentary behavior|sedentary behavior
1256706|NCT01775826|accelerometer|accelerometer
1256707|NCT01775826|GPS|gps
1256708|NCT01775826|GIS|gis
1256709|NCT01775826|machine learning|machine learning
1256710|NCT01775813|Insulin resistance|insulin resistance
1256711|NCT01775813|Puberty|puberty
1256712|NCT01775813|Obesity|obesity
1256713|NCT01775813|Hypogonadism|hypogonadism
1256714|NCT01775813|Gonadal dysfunction|gonadal dysfunction
1256715|NCT01775813|Metformin|metformin
1256716|NCT01775787|smoking|smoking
1256717|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1256718|NCT01775774|Acute Lung Injury|acute lung injury
1256719|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
1256720|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
1256721|NCT01775748|Grape juice|grape juice
1256722|NCT01775735|headache|headache
1256723|NCT01775735|pain|pain
1256724|NCT01775735|chronic|chronic
1256725|NCT01775709|middler ear infection|middler ear infection
1256726|NCT01775696|Alzheimer's disease|alzheimer's disease
1256727|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
1256728|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
1256729|NCT01775696|Inflammation|inflammation
1256730|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
1256731|NCT01775696|Blood markers|blood markers
1256732|NCT01775696|MRI|mri
1256733|NCT01775683|homelessness|homelessness
1256734|NCT01775670|Arthrosis|arthrosis
1256735|NCT01775657|pulmonary air leak|pulmonary air leak
1256736|NCT01775657|Thopaz|thopaz
1256737|NCT01775657|digital|digital
1256738|NCT01775657|analog|analog
1256739|NCT01775657|randomized|randomized
1256740|NCT01775618|Hemophilia A|hemophilia a
1256741|NCT01775618|Factor VIII|factor viii
1256742|NCT01775618|Prophylaxis|prophylaxis
1256743|NCT01775618|Pediatric|pediatric
1256744|NCT01775605|Subject|subject
1256745|NCT01775592|P.f resistance|p.f resistance
1256746|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
1256747|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
1256748|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
1256749|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
1256750|NCT01775553|Carfilzomib|carfilzomib
1256751|NCT01775540|Dry eye|dry eye
1256752|NCT01775540|Artificial tears|artificial tears
1256753|NCT01775540|Ocular surface inflammation|ocular surface inflammation
1256754|NCT01775501|sorafenib|sorafenib
1256755|NCT01775501|FOLFOX|folfox
1256756|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1256757|NCT01775488|BPH|bph
1256758|NCT01775488|LUTS|luts
1256759|NCT01775488|Vortx Rx|vortx rx
1256760|NCT01775488|Histotripsy|histotripsy
1256761|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1256762|NCT01775462|XLHED|xlhed
1256763|NCT01775449|Anticancer drug;|anticancer drug;
1256764|NCT01775449|Oxaliplatin;|oxaliplatin;
1256765|NCT01775449|Digestive cancer system|digestive cancer system
1256766|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
1256767|NCT01775449|Hyperalgesia;|hyperalgesia;
1256768|NCT01775449|Allodynia;|allodynia;
1256769|NCT01775449|Dysesthesia|dysesthesia
1256770|NCT01775449|Polyamines depleted diet|polyamines depleted diet
1256771|NCT01775436|palliative care|palliative care
1256772|NCT01775436|HIV/AIDS|hiv/aids
1258059|NCT01769898|HAT|hat
1256773|NCT01775436|quality of life|quality of life
1256774|NCT01775436|adherence|adherence
1256775|NCT01775436|spiritual|spiritual
1256776|NCT01775436|threat appraisal|threat appraisal
1256777|NCT01775436|treatment congruence|treatment congruence
1256778|NCT01775436|treatment preferences|treatment preferences
1256779|NCT01775436|dialysis|dialysis
1256780|NCT01775436|hospitalization|hospitalization
1256781|NCT01775436|communication|communication
1256782|NCT01775436|family intervention|family intervention
1256985|NCT01774565|Insulin|insulin
1256783|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
1256784|NCT01775436|decision making|decision making
1256785|NCT01775436|advance care planning|advance care planning
1256786|NCT01775436|end of life|end of life
1256787|NCT01775397|Clostridium|clostridium
1256788|NCT01775397|Difficile|difficile
1256789|NCT01775397|Infections|infections
1256790|NCT01775397|Immunosuppression|immunosuppression
1256791|NCT01775397|Fidaxomicin|fidaxomicin
1256792|NCT01775397|Vancomycin|vancomycin
1256793|NCT01775397|Efficacy|efficacy
1256794|NCT01775397|Stem Cells|stem cells
1256795|NCT01775397|Transplantation|transplantation
1256796|NCT01775397|Adult|adult
1256797|NCT01775397|Dificid|dificid
1256798|NCT01775384|Inflammation|inflammation
1256799|NCT01775384|Oxidative stress|oxidative stress
1256800|NCT01775384|Immune dysfunction|immune dysfunction
1256801|NCT01775384|Metabolomics.|metabolomics.
1256802|NCT01775371|Pain|pain
1256803|NCT01775371|Emergency|emergency
1256804|NCT01775371|Analgesia|analgesia
1256805|NCT01775371|ED patients|ed patients
1256806|NCT01775371|acute pain|acute pain
1256807|NCT01775371|IV opioid|iv opioid
1256808|NCT01775345|Partial meniscectomy|partial meniscectomy
1256809|NCT01775345|Physiotherapy|physiotherapy
1256810|NCT01775345|Isokinetics|isokinetics
1256811|NCT01775345|Cost-effectiveness|cost-effectiveness
1256813|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
1256814|NCT01775293|WSRS|wsrs
1256815|NCT01775293|Rhytidectomy|rhytidectomy
1256816|NCT01775254|Colon Cancer|colon cancer
1256817|NCT01775254|FOLFOX|folfox
1256818|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
1256819|NCT01775254|Open Colectomy|open colectomy
1256820|NCT01775254|Robotic Colectomy|robotic colectomy
1256821|NCT01775254|Quality of Life|quality of life
1256822|NCT01775254|Sexual Function|sexual function
1256823|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
1256824|NCT01775254|Demands of Illness|demands of illness
1256825|NCT01775254|Cancer Survivor|cancer survivor
1256826|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
1256827|NCT01775215|Left Ventricular Function|left ventricular function
1256828|NCT01775215|Aortic Valve Replacement|aortic valve replacement
1256829|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
1256830|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
1256831|NCT01775215|Longitudinal Strain|longitudinal strain
1256832|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
1256833|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
1256834|NCT01775189|Relative abuse potential study|relative abuse potential study
1256835|NCT01775189|Chronic pain|chronic pain
1256836|NCT01775189|oxycodone|oxycodone
1256837|NCT01775189|naltrexone|naltrexone
1256838|NCT01775189|opioid-related disorders|opioid-related disorders
1256839|NCT01775189|drug abusers|drug abusers
1256840|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
1256841|NCT01775163|Energy|energy
1256842|NCT01775163|Metabolism|metabolism
1256843|NCT01775163|Weight Loss|weight loss
1256844|NCT01775163|Exercise|exercise
1256845|NCT01775150|mobile phone text messaging|mobile phone text messaging
1256846|NCT01775150|maternality|maternality
1256847|NCT01775150|infant|infant
1256848|NCT01775150|death rate|death rate
1256849|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
1256850|NCT01775124|Macular degeneration,|macular degeneration,
1256851|NCT01775124|age-related macular degeneration (ARMD),|age-related macular degeneration (armd),
1256852|NCT01775124|vision loss,|vision loss,
1256853|NCT01775124|macula damage,|macula damage,
1256854|NCT01775124|retina damage,|retina damage,
1256855|NCT01775124|dry macular degeneration,|dry macular degeneration,
1256856|NCT01775124|wet macular degeneration,|wet macular degeneration,
1256857|NCT01775124|AMD|amd
1256858|NCT01775111|strength training|strength training
1256859|NCT01775111|protein supplementation|protein supplementation
1256860|NCT01775111|sarcopenia|sarcopenia
1256861|NCT01775098|Gout|gout
1256862|NCT01775098|uric acid|uric acid
1256863|NCT01775098|allopurinol|allopurinol
1256864|NCT01775085|Interventions|interventions
1256865|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
1256866|NCT01775085|Discussion Group (DG)|discussion group (dg)
1256867|NCT01775085|Modules|modules
1256868|NCT01775085|Sessions|sessions
1256869|NCT01775085|12-291|12-291
1256870|NCT01775072|tissue|tissue
1256871|NCT01775072|blood|blood
1256872|NCT01775072|salvia|salvia
1256873|NCT01775072|buccal swab|buccal swab
1256874|NCT01775072|Genomic Profiling|genomic profiling
1256875|NCT01775072|Solid Tumors|solid tumors
1256876|NCT01775072|hematologic cancer|hematologic cancer
1256877|NCT01775072|Clinical Assay|clinical assay
1256878|NCT01775072|Research Assay|research assay
1256879|NCT01775072|12-245|12-245
1256880|NCT01775046|Valiant|valiant
1256881|NCT01775046|Captivia|captivia
1256882|NCT01775046|Stent Graft|stent graft
1256883|NCT01775046|Thoracic|thoracic
1256884|NCT01775046|Aortic|aortic
1256885|NCT01775033|Pediatrics|pediatrics
1256986|NCT01774565|Closed-Loop|closed-loop
1256886|NCT01775033|Emergency medical services|emergency medical services
1256887|NCT01775033|Emergency Treatment|emergency treatment
1256888|NCT01775033|Telemedicine|telemedicine
1256889|NCT01775007|Lens|lens
1256890|NCT01775007|Cornea|cornea
1256891|NCT01775007|Stiffness|stiffness
1256892|NCT01775007|Brillouin Shift|brillouin shift
1256893|NCT01775007|Young Modulus|young modulus
1256894|NCT01774994|volunteers|volunteers
1256895|NCT01774942|Diabetes Mellitus|diabetes mellitus
1256896|NCT01774942|C-Reactive Protein|c-reactive protein
1256897|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
1256898|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
1256899|NCT01774929|Osteoarthritis|osteoarthritis
1256900|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
1256901|NCT01774929|Durogesic|durogesic
1256902|NCT01774903|Low Back Pain|low back pain
1256903|NCT01774903|TTS-fentanyl|tts-fentanyl
1256904|NCT01774903|Durogesic|durogesic
1256905|NCT01774877|xinfeng capsule;|xinfeng capsule;
1256906|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
1256907|NCT01774877|randomized;|randomized;
1256908|NCT01774877|double-blind;|double-blind;
1256909|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
1256910|NCT01774851|Esophagus Cancer|esophagus cancer
1256911|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
1256912|NCT01774851|Stomach Cancer|stomach cancer
1256913|NCT01774851|Her2 Positive|her2 positive
1256914|NCT01774851|Her2+|her2+
1256915|NCT01774851|Esophageal Cancer|esophageal cancer
1256916|NCT01774851|Metastatic|metastatic
1256917|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
1256919|NCT01774812|vitamin D|vitamin d
1256920|NCT01774812|hemodialysis|hemodialysis
1256921|NCT01774812|sudden cardiac death|sudden cardiac death
1256922|NCT01774812|heart rate variability|heart rate variability
1256923|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
1256924|NCT01774799|advanced dementia|advanced dementia
1600705|NCT00391586|erlotinib|erlotinib
1256925|NCT01774799|advance care planning|advance care planning
1256926|NCT01774799|nursing home|nursing home
1256927|NCT01774760|18F-EF5|18f-ef5
1256928|NCT01774760|PET/CT|pet/ct
1256929|NCT01774760|Reproducibility|reproducibility
1256930|NCT01774747|Pharmacokinetics|pharmacokinetics
1256931|NCT01774734|Chronic neck pain|chronic neck pain
1256932|NCT01774734|Neck strength exerciser|neck strength exerciser
1256933|NCT01774734|Biofeedback|biofeedback
1256934|NCT01774734|Physiotherapy|physiotherapy
1256935|NCT01774734|Strengthening exercise|strengthening exercise
1256936|NCT01774734|Randomized trials|randomized trials
1256937|NCT01774721|first-line|first-line
1256938|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
1256939|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
1256940|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
1256941|NCT01774721|EGFR|egfr
1256942|NCT01774721|Archer|archer
1256943|NCT01774721|mutation|mutation
1256944|NCT01774721|dacomitinib|dacomitinib
1256945|NCT01774721|SFJ|sfj
1256946|NCT01774721|PF-00299804|pf-00299804
1256947|NCT01774695|IBS|ibs
1256948|NCT01774695|physical activity|physical activity
1256949|NCT01774695|exercise|exercise
1256950|NCT01774682|obesity|obesity
1256951|NCT01774682|surgery|surgery
1256952|NCT01774669|ischemic stroke|ischemic stroke
1256953|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
1256954|NCT01774669|upper limb|upper limb
1256955|NCT01774669|virtual reality|virtual reality
1256956|NCT01774669|physiotherapy|physiotherapy
1256957|NCT01774669|occupational therapy|occupational therapy
1256958|NCT01774656|heart-assist device|heart-assist device
1256959|NCT01774643|Pancreatic cancer|pancreatic cancer
1256960|NCT01774643|Liver metastases|liver metastases
1256961|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
1256962|NCT01774643|Blood samples|blood samples
1256963|NCT01774643|Xenografts|xenografts
1256964|NCT01774643|Murine|murine
1256965|NCT01774643|Genomic profiling|genomic profiling
1256966|NCT01774643|Circulating biomarkers|circulating biomarkers
1256967|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
1256968|NCT01774617|portal hypertension|portal hypertension
1256969|NCT01774617|elastography|elastography
1256970|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
1256971|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
1256972|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
1256973|NCT01774604|Indomethacin|indomethacin
1258254|NCT01768962|Vaginal use|vaginal use
1256974|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
1256975|NCT01774591|Post Menopause|post menopause
1256976|NCT01774591|Female|female
1256977|NCT01774591|Obese|obese
1256978|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
1256979|NCT01774578|Vaccine Therapy|vaccine therapy
1256980|NCT01774578|Immunotherapy|immunotherapy
1256981|NCT01774578|Second line therapy|second line therapy
1256982|NCT01774578|Progressive|progressive
1256983|NCT01774578|Relapsed|relapsed
1256984|NCT01774565|Diabetes|diabetes
1256987|NCT01774565|Real-time CGM|real-time cgm
1256988|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
1256989|NCT01774565|Hospital|hospital
1256990|NCT01774539|Fracture|fracture
1256991|NCT01774539|Physeal injury|physeal injury
1256992|NCT01774539|Diffusion MRI|diffusion mri
1256993|NCT01774500|biomarkers|biomarkers
1256994|NCT01774500|Emergency Department|emergency department
1256995|NCT01774500|Seizures|seizures
1256996|NCT01774500|epilepsy|epilepsy
1256997|NCT01774500|S100b|s100b
1256998|NCT01774500|copeptin|copeptin
1256999|NCT01774487|Biliary Atresia|biliary atresia
1257000|NCT01774487|Pentoxifylline|pentoxifylline
1257001|NCT01774487|Trental|trental
1257002|NCT01774487|Serum bilirubin|serum bilirubin
1257003|NCT01774487|Conjugated bilirubin|conjugated bilirubin
1257004|NCT01774487|Liver transplantation|liver transplantation
1257005|NCT01774487|Fibrosis|fibrosis
1257006|NCT01774474|Prevention|prevention
1257007|NCT01774448|Dementia|dementia
1257008|NCT01774448|Spouse Caregiver|spouse caregiver
1257009|NCT01774448|Depression|depression
1257010|NCT01774448|Mind Body Therapy|mind body therapy
1257011|NCT01774448|Cognitive Therapy|cognitive therapy
1257012|NCT01774448|Quality of Life|quality of life
1257013|NCT01774448|Attention|attention
1257014|NCT01774448|Memory|memory
1257015|NCT01774435|Schizophrenia|schizophrenia
1257016|NCT01774435|Schizophrenic|schizophrenic
1257017|NCT01774435|Stable Schizophrenic|stable schizophrenic
1257018|NCT01774422|Hypercapnia|hypercapnia
1257019|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
1257020|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
1257021|NCT01774422|Noninvasive ventilation|noninvasive ventilation
1257022|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
1257023|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
1257024|NCT01774383|Parkinson's disease|parkinson's disease
1257025|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
1257026|NCT01774383|oscillation|oscillation
1257027|NCT01774383|local field potential|local field potential
1257028|NCT01774344|Regorafenib|regorafenib
1257029|NCT01774344|BAY73-4506|bay73-4506
1257030|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
1257031|NCT01774318|preterm infants|preterm infants
1257032|NCT01774318|aEEG|aeeg
1257033|NCT01774318|conventional EEG|conventional eeg
1257034|NCT01774318|polysomnography|polysomnography
1257035|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
1257036|NCT01774266|Gastric Cancer|gastric cancer
1257037|NCT01774266|DNA methylation|dna methylation
1257038|NCT01774266|Reprimo|reprimo
1257039|NCT01774266|cell-free DNA|cell-free dna
1257040|NCT01774266|non-invasive|non-invasive
1257041|NCT01774253|DIPG|dipg
1257042|NCT01774240|Delirium|delirium
1257043|NCT01774240|Cardiac surgery|cardiac surgery
1257044|NCT01774240|DOS scale|dos scale
1257045|NCT01774227|Refractory glaucoma|refractory glaucoma
1257046|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
1257047|NCT01774227|Dark iris|dark iris
1257048|NCT01774227|Pops-titration|pops-titration
1257049|NCT01774227|Slow-coagulation|slow-coagulation
1257050|NCT01774227|Neovascular glaucoma|neovascular glaucoma
1257051|NCT01774214|Resuscitation|resuscitation
1257052|NCT01774214|Shock|shock
1257053|NCT01774214|Fluid Therapy|fluid therapy
1257054|NCT01774214|Pediatrics|pediatrics
1257055|NCT01774201|Multiple sclerosis|multiple sclerosis
1257056|NCT01774201|Self-assessment|self-assessment
1257057|NCT01774201|Physical endurance|physical endurance
1257058|NCT01774201|Respiratory function|respiratory function
1257059|NCT01774201|Fatigue|fatigue
1257060|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
1257061|NCT01774188|intraocular pressure|intraocular pressure
1257062|NCT01774188|Pen type tonometer|pen type tonometer
1257063|NCT01774175|Bowel preparation|bowel preparation
1257064|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
1257065|NCT01774175|Picosulfate|picosulfate
1257066|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
1257067|NCT01774162|Fine needle aspiration|fine needle aspiration
1257068|NCT01774162|Fine needle biopsy|fine needle biopsy
1257069|NCT01774162|ProCore|procore
1257070|NCT01774136|community health workers|community health workers
1257071|NCT01774136|HIV|hiv
1257072|NCT01774136|PMTCT|pmtct
1257073|NCT01774136|antenatal|antenatal
1257074|NCT01774136|postnatal|postnatal
1257075|NCT01774136|breastfeeding|breastfeeding
1257076|NCT01774136|South Africa|south africa
1257077|NCT01774110|stroke|stroke
1257078|NCT01774110|gait|gait
1257080|NCT01774097|Peripheral Artery Disease|peripheral artery disease
1257081|NCT01774097|Intermittent Claudication|intermittent claudication
1257082|NCT01774097|Autologous Stem Cells|autologous stem cells
1257083|NCT01774097|ALDH cells|aldh cells
1257084|NCT01774097|Claudicants|claudicants
1257085|NCT01774097|PAD|pad
1257086|NCT01774097|Peak Walking Time|peak walking time
1257087|NCT01774097|MRI|mri
1257088|NCT01774097|Vascular Flow|vascular flow
1257089|NCT01774097|Anatomy|anatomy
1257090|NCT01774097|Perfusion|perfusion
1257091|NCT01774084|Insulin sensitivity|insulin sensitivity
1257092|NCT01774084|Beta cell function|beta cell function
1257093|NCT01774084|Carbohydrate preload|carbohydrate preload
1257094|NCT01774084|Elective hip replacement|elective hip replacement
1257095|NCT01774084|Double-blind randomized control study|double-blind randomized control study
1257096|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
1257098|NCT01774071|pet scan|pet scan
1257099|NCT01774071|12-178|12-178
1257100|NCT01774058|blood flow volume|blood flow volume
1257101|NCT01774058|ilomedin|ilomedin
1257102|NCT01774058|measurement|measurement
1257103|NCT01774058|intraarterial|intraarterial
1257104|NCT01774058|neuropathy|neuropathy
1257105|NCT01774045|Major depressive disorder|major depressive disorder
1257106|NCT01774045|Depression|depression
1257107|NCT01774019|Pancreatic|pancreatic
1257108|NCT01774019|Periampullary Cancer|periampullary cancer
1257109|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
1257110|NCT01774019|Resectable|resectable
1257111|NCT01774006|In vitro fertilization|in vitro fertilization
1257112|NCT01774006|Embryo transfer|embryo transfer
1257113|NCT01774006|Embryo culture|embryo culture
1257114|NCT01774006|individual culture|individual culture
1257115|NCT01774006|Group culture|group culture
1257116|NCT01774006|embryo quality|embryo quality
1257117|NCT01774006|Pregnancy rate|pregnancy rate
1257118|NCT01774006|Implantation|implantation
1257119|NCT01773993|Lyrica|lyrica
1257120|NCT01773993|pregabalin|pregabalin
1257121|NCT01773993|Good post marketing practice|good post marketing practice
1257122|NCT01773993|Post Marketing Surveillance|post marketing surveillance
1257123|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1257124|NCT01773993|Fibromyalgia|fibromyalgia
1257125|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
1257126|NCT01773967|LGG|lgg
1257127|NCT01773967|Probiotic|probiotic
1257128|NCT01773967|Gastroenteritis|gastroenteritis
1257129|NCT01773967|acute gastroenteritis|acute gastroenteritis
1257131|NCT01773967|pediatric|pediatric
1257132|NCT01773967|RCT|rct
1257133|NCT01773954|amd|amd
1257134|NCT01773954|age related macular degeneration|age related macular degeneration
1257135|NCT01773954|macular degeneration|macular degeneration
1257136|NCT01773954|neovascular|neovascular
1257137|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
1257138|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
1257139|NCT01773889|FIGO (Int Federation of Gyn and Ob )Stage III or Stage IV|figo (int federation of gyn and ob )stage iii or stage iv
1257140|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
1257141|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
1257142|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
1257143|NCT01773876|effectiveness|effectiveness
1257144|NCT01773876|micafungin versus placebo|micafungin versus placebo
1257145|NCT01773876|pharmacokinetic|pharmacokinetic
1257146|NCT01773876|pharmacodynamic|pharmacodynamic
1257147|NCT01773876|tolerance|tolerance
1257148|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
1257149|NCT01773863|Acute myocardial infarction|acute myocardial infarction
1257150|NCT01773863|Platelet activation|platelet activation
1257151|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
1257152|NCT01773863|Thrombosis|thrombosis
1257153|NCT01773863|Isoprosantes|isoprosantes
1257154|NCT01773863|NADPH oxidase|nadph oxidase
1257155|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
1257156|NCT01773850|breast cancer|breast cancer
1257157|NCT01773837|asthenia|asthenia
1257158|NCT01773837|advanced cancer|advanced cancer
1257159|NCT01773837|randomized controlled trial|randomized controlled trial
1257160|NCT01773824|antibiotic|antibiotic
1257161|NCT01773824|prescription rate|prescription rate
1257162|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
1257163|NCT01773811|Narrative Writing|narrative writing
1257164|NCT01773759|Immunizations|immunizations
1257165|NCT01773759|Child care|child care
1257166|NCT01773759|School health promotion|school health promotion
1257167|NCT01773746|neonatal|neonatal
1257168|NCT01773746|resuscitation|resuscitation
1257169|NCT01773746|room air|room air
1257170|NCT01773720|cardiac index|cardiac index
1257171|NCT01773720|coronary artery bypass|coronary artery bypass
1257172|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
1257173|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
1257174|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
1257175|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
1257176|NCT01773694|Post-operative management|post-operative management
1257177|NCT01773694|Post-operative complications|post-operative complications
1257178|NCT01773694|Post-operative treatment|post-operative treatment
1257179|NCT01773694|water|water
1257180|NCT01773694|skin|skin
1257181|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
1257182|NCT01773655|somatic|somatic
1257183|NCT01773655|germline|germline
1257184|NCT01773655|mutations|mutations
1257185|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
1257186|NCT01773655|12-235|12-235
1257187|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
1257188|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
1257189|NCT01773642|Uganda|uganda
1257190|NCT01773629|Depression|depression
1257191|NCT01773629|Pregnancy|pregnancy
1257192|NCT01773629|Postpartum|postpartum
1257193|NCT01773629|Perinatal|perinatal
1257194|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
1257195|NCT01773616|Lupus|lupus
1257196|NCT01773616|Nephritis|nephritis
1257197|NCT01773603|Time-lapse|time-lapse
1257198|NCT01773603|morphokinetics|morphokinetics
1257199|NCT01773603|blastocyst transfer|blastocyst transfer
1257200|NCT01773603|eSET|eset
1257201|NCT01773577|EHR|ehr
1257202|NCT01773577|VHR|vhr
1257203|NCT01773577|Electronic Health Record|electronic health record
1257204|NCT01773564|Dressings, Prevention,|dressings, prevention,
1257205|NCT01773538|quality of life|quality of life
1257206|NCT01773512|Intravascular ultrasound|intravascular ultrasound
1257207|NCT01773512|Virtual histology|virtual histology
1257208|NCT01773512|Optical coherence tomography|optical coherence tomography
1257209|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
1257210|NCT01773512|Statins|statins
1257211|NCT01773512|Retinal imaging|retinal imaging
1257212|NCT01773499|cellulitis|cellulitis
1257213|NCT01773499|ultrasound|ultrasound
1257214|NCT01773486|Obesity|obesity
1257215|NCT01773486|Insulin Resistance|insulin resistance
1257216|NCT01773486|Endothelial dysfunction|endothelial dysfunction
1257217|NCT01773486|Blood pressure|blood pressure
1257218|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
1257219|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
1257220|NCT01773460|progress under this treatment|progress under this treatment
1257221|NCT01773395|Advanced|advanced
1257222|NCT01773369|cerebral palsy|cerebral palsy
1257223|NCT01773369|physical therapy|physical therapy
1257224|NCT01773369|rehabilitation|rehabilitation
1257225|NCT01773356|Obesity|obesity
1257226|NCT01773356|Body Weight|body weight
1257227|NCT01773356|Body Composition|body composition
1257228|NCT01773356|Metabolism|metabolism
1257229|NCT01773356|Resting Energy Expenditure|resting energy expenditure
1257230|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
1257231|NCT01773330|high resolution manometry|high resolution manometry
1257232|NCT01773330|provocative swallow|provocative swallow
1257233|NCT01773330|impedence|impedence
1257234|NCT01773304|Obesity|obesity
1257235|NCT01773304|Adults|adults
1257236|NCT01773304|Bone metabolism|bone metabolism
1257237|NCT01773304|Metabolic profile|metabolic profile
1257238|NCT01773304|Dairy protein|dairy protein
1257239|NCT01773304|Meat protein|meat protein
1257240|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
1257241|NCT01773278|Antioxidant treatment|antioxidant treatment
1257242|NCT01773278|Oxysterols|oxysterols
1257243|NCT01773278|Cholesterol deficiency|cholesterol deficiency
1257244|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
1257245|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
1257246|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
1257247|NCT01773252|RLS|rls
1257248|NCT01773252|RTLS|rtls
1257249|NCT01773252|PFO|pfo
1257250|NCT01773252|ASD|asd
1257251|NCT01773252|shunt|shunt
1257252|NCT01773252|cardiac|cardiac
1257253|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
1257254|NCT01773252|interventional cardiology|interventional cardiology
1257255|NCT01773252|stroke|stroke
1257256|NCT01773252|migraine|migraine
1257257|NCT01773252|aura|aura
1257258|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
1257259|NCT01773252|decompression illness|decompression illness
1257260|NCT01773252|neurology|neurology
1257261|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
1257262|NCT01773252|TEE|tee
1257263|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
1257264|NCT01773252|TTE|tte
1257265|NCT01773252|transcranial Doppler|transcranial doppler
1257266|NCT01773252|ultrasound|ultrasound
1257267|NCT01773252|TCD|tcd
1257268|NCT01773252|power m Mode|power m mode
1257269|NCT01773252|indocyanine green dye|indocyanine green dye
1257270|NCT01773252|ICG|icg
1257271|NCT01773252|Valsalva|valsalva
1257272|NCT01773239|social cognition|social cognition
1257273|NCT01773239|cognitive deficits|cognitive deficits
1257274|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
1257275|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
1257276|NCT01773239|remediation|remediation
1257277|NCT01773239|computer training|computer training
1257278|NCT01773239|cognitive training exercises|cognitive training exercises
1257279|NCT01773226|Autologous Protein Solution|autologous protein solution
1257280|NCT01773226|APS|aps
1257281|NCT01773226|Osteoarthritis|osteoarthritis
1257282|NCT01773226|Injection|injection
1257283|NCT01773213|Lower urinary tract|lower urinary tract
1257284|NCT01773213|Bladder|bladder
1257285|NCT01773213|Neuropathic bladder|neuropathic bladder
1257286|NCT01773213|Overactive bladder|overactive bladder
1257287|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
1257288|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1257289|NCT01773200|vasospasm|vasospasm
1257290|NCT01773200|BNP|bnp
1257291|NCT01773187|Myelofibrosis|myelofibrosis
1257292|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1257293|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1257294|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
1257295|NCT01773187|Polycythemia|polycythemia
1257296|NCT01773187|Polycythemia Vera|polycythemia vera
1257297|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
1257298|NCT01773187|Thrombocythemia|thrombocythemia
1257299|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
1257300|NCT01773187|Bone Marrow Disease|bone marrow disease
1257301|NCT01773187|Hematologic Diseases|hematologic diseases
1257302|NCT01773187|Blood Platelet Disorders|blood platelet disorders
1257303|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
1257304|NCT01773187|Splenomegaly|splenomegaly
1257305|NCT01773187|Pacritinib|pacritinib
1257306|NCT01773187|MPN-SAF|mpn-saf
1257307|NCT01773187|MPN-SAF TSS|mpn-saf tss
1257308|NCT01773187|Anemia|anemia
1257309|NCT01773187|Myeloproliferative|myeloproliferative
1257310|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
1257311|NCT01773187|Spleen|spleen
1257312|NCT01773187|Spleen volume|spleen volume
1257313|NCT01773187|Thrombocytopenia|thrombocytopenia
1257314|NCT01773187|SB1518|sb1518
1257315|NCT01773161|Cerebral Palsy|cerebral palsy
1257316|NCT01773161|Hip surgery|hip surgery
1257317|NCT01773161|Quality of Life|quality of life
1257318|NCT01773135|threatened preterm labor|threatened preterm labor
1257319|NCT01773135|ACTH|acth
1257320|NCT01773135|PTL|ptl
1257321|NCT01773109|Male and female subjects 18 years of age and older|male and female subjects 18 years of age and older
1257322|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
1257323|NCT01773109|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral TKI).|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral tki).
1257324|NCT01773096|opioid-induced|opioid-induced
1257325|NCT01773083|Inhalation trauma|inhalation trauma
1257326|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
1257327|NCT01773083|heparin nebulization|heparin nebulization
1257328|NCT01773083|mechanical ventilation|mechanical ventilation
1257329|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
1257330|NCT01773070|Hepatitis C virus|hepatitis c virus
1257331|NCT01773070|Direct Acting Antiviral|direct acting antiviral
1257332|NCT01773070|Sustained Virologic Response|sustained virologic response
1257333|NCT01773070|Hepatitis C|hepatitis c
1257334|NCT01773070|Persistence of treatment-emergent substitutions|persistence of treatment-emergent substitutions
1257335|NCT01773057|Computerized Decision Support System|computerized decision support system
1257336|NCT01773057|Heart failure|heart failure
1257337|NCT01773057|Effects on quality of care|effects on quality of care
1257338|NCT01773057|Process of care|process of care
1257339|NCT01773057|Patient outcomes|patient outcomes
1257340|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
1257341|NCT01773031|MR pancreatography|mr pancreatography
1257342|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
1257343|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
1257344|NCT01772979|Trabectedin|trabectedin
1257345|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
1257346|NCT01772979|BRCAness|brcaness
1257347|NCT01772979|Ovarian cancer|ovarian cancer
1257348|NCT01772966|neck|neck
1257349|NCT01772966|pain|pain
1257350|NCT01772966|chronic|chronic
1257351|NCT01772966|manipulation|manipulation
1257352|NCT01772966|control|control
1257353|NCT01772966|randomized trial|randomized trial
1257354|NCT01772953|AML|aml
1257355|NCT01772953|MDS|mds
1257356|NCT01772953|Treosulfan|treosulfan
1257357|NCT01772940|First-line therapy|first-line therapy
1257358|NCT01772940|Protease inhibitor|protease inhibitor
1257359|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
1257360|NCT01772940|Resource-limited setting|resource-limited setting
1257361|NCT01772927|parenteral nutrition|parenteral nutrition
1257362|NCT01772927|Very low birth weight infants|very low birth weight infants
1257363|NCT01772927|preterm infants|preterm infants
1257364|NCT01772927|biochemical tolerance|biochemical tolerance
1257365|NCT01772927|nutritional intake|nutritional intake
1257366|NCT01772914|Copeptin|copeptin
1257367|NCT01772914|eating|eating
1257368|NCT01772914|glucose tolerance test|glucose tolerance test
1257369|NCT01772914|mixed meal test|mixed meal test
1257370|NCT01772914|physiological|physiological
1257371|NCT01772901|influenza|influenza
1257372|NCT01772901|influenza vaccines|influenza vaccines
1257373|NCT01772901|infectious disease|infectious disease
1257374|NCT01772901|pregnancy|pregnancy
1257375|NCT01772875|urinary catheter|urinary catheter
1257376|NCT01772875|UTI|uti
1257377|NCT01772875|bladder lavage|bladder lavage
1257378|NCT01772862|childhood|childhood
1257379|NCT01772862|cancer|cancer
1257380|NCT01772862|physical activity|physical activity
1257381|NCT01772862|quality of life|quality of life
1257382|NCT01772849|childhood|childhood
1257383|NCT01772849|cancer|cancer
1257384|NCT01772849|education|education
1257385|NCT01772849|physical activity|physical activity
1257386|NCT01772849|quality of life|quality of life
1257387|NCT01772823|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
1257388|NCT01772810|Paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury|paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury
1257389|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
1257390|NCT01772784|subjects|subjects
1257391|NCT01772771|Cancer|cancer
1257392|NCT01772771|Molecular testing|molecular testing
1257393|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
1257394|NCT01772771|Bladder|bladder
1257395|NCT01772771|Bone|bone
1257396|NCT01772771|Breast|breast
1257397|NCT01772771|Cytology|cytology
1257398|NCT01772771|Endocrine|endocrine
1257399|NCT01772771|Gynecology|gynecology
1257400|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
1257401|NCT01772771|genitourinary|genitourinary
1257402|NCT01772771|Research Biorepository|research biorepository
1257403|NCT01772771|Head and Neck|head and neck
1257404|NCT01772771|Aerodigestive Tract|aerodigestive tract
1257405|NCT01772771|Hematopathology|hematopathology
1257406|NCT01772771|Human Cancer Genetics|human cancer genetics
1257407|NCT01772771|Kidney|kidney
1257408|NCT01772771|Leukemia|leukemia
1257409|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
1257410|NCT01772771|Lymphoma|lymphoma
1257411|NCT01772771|Melanoma|melanoma
1257412|NCT01772771|Neurology|neurology
1257413|NCT01772771|Brain|brain
1257414|NCT01772771|Non-Melanoma Skin|non-melanoma skin
1257415|NCT01772771|Pancreas|pancreas
1257416|NCT01772771|Pediatrics|pediatrics
1257417|NCT01772771|Prostate|prostate
1257418|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
1257419|NCT01772771|Plasma|plasma
1257420|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
1257421|NCT01772771|Thoracic|thoracic
1257422|NCT01772771|Lung|lung
1257423|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
1257424|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
1257425|NCT01772758|CF, cystic fibrosis, exercise|cf, cystic fibrosis, exercise
1257426|NCT01772745|single incision|single incision
1257427|NCT01772745|cholecystectomy|cholecystectomy
1257428|NCT01772745|laparoscopy|laparoscopy
1257429|NCT01772732|Simotinib|simotinib
1257430|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
1257431|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
1257432|NCT01772706|Head and neck cancer|head and neck cancer
1257433|NCT01772706|Low level laser therapy|low level laser therapy
1257434|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
1257435|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
1257436|NCT01772680|Thalassemia|thalassemia
1257437|NCT01772680|Diabetes|diabetes
1257438|NCT01772680|Zinc|zinc
1257439|NCT01772680|Iron-Overload|iron-overload
1257440|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
1257441|NCT01772667|interstitial lung disease|interstitial lung disease
1257442|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
1257443|NCT01772667|exercise capacity|exercise capacity
1257444|NCT01772667|physical activity|physical activity
1257445|NCT01772667|quality of life|quality of life
1257446|NCT01772654|Epilepsy|epilepsy
1257447|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
1257448|NCT01772654|Brain lesions|brain lesions
1257449|NCT01772654|Cerebral blood flow|cerebral blood flow
1257450|NCT01772641|cigarette|cigarette
1257451|NCT01772641|smoking|smoking
1257452|NCT01772641|cessation|cessation
1257453|NCT01772641|varenicline|varenicline
1257454|NCT01772641|scheduled reduction|scheduled reduction
1257455|NCT01772641|craving|craving
1257456|NCT01772628|Communication|communication
1257457|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
1257458|NCT01772628|Sexual and reproductive health|sexual and reproductive health
1257459|NCT01772628|Adolescents|adolescents
1257460|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
1257461|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1257462|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
1257463|NCT01772602|Motor Neuron Disease|motor neuron disease
1257464|NCT01772576|Reliance|reliance
1257465|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1257466|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
1257467|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
1257468|NCT01772537|thoracoabdominal|thoracoabdominal
1257469|NCT01772537|aneurysm|aneurysm
1257470|NCT01772537|open|open
1257471|NCT01772537|stent|stent
1257472|NCT01772537|cardiopulmonary|cardiopulmonary
1257473|NCT01772537|abdominal|abdominal
1257474|NCT01772537|bypass|bypass
1257475|NCT01772524|Migraine Disorders|migraine disorders
1257476|NCT01772524|Phase 1|phase 1
1257477|NCT01772524|ALD403|ald403
1257478|NCT01772511|questionnaire|questionnaire
1257479|NCT01772511|prior therapy|prior therapy
1257480|NCT01772511|prior study volunteer|prior study volunteer
1257481|NCT01772511|prior study patient|prior study patient
1257482|NCT01772511|cancer|cancer
1257483|NCT01772511|oncology|oncology
1257484|NCT01772498|depression|depression
1257485|NCT01772498|anxiety|anxiety
1257486|NCT01772498|sleep|sleep
1257487|NCT01772498|pain|pain
1257488|NCT01772498|biofeedback|biofeedback
1257489|NCT01772498|breathing|breathing
1257490|NCT01772498|resonant|resonant
1257491|NCT01772459|Scoliosis|scoliosis
1257492|NCT01772459|Adolescents|adolescents
1257493|NCT01772459|Questionnaire|questionnaire
1257494|NCT01772459|Reliability|reliability
1257495|NCT01772446|diabetes|diabetes
1257496|NCT01772446|management|management
1257497|NCT01772446|glycated hemoglobin|glycated hemoglobin
1257498|NCT01772446|preventive activities|preventive activities
1257499|NCT01772433|Low Back Pain|low back pain
1257500|NCT01772433|Topical Olive Oil|topical olive oil
1257501|NCT01772433|Phonophoresis|phonophoresis
1257502|NCT01772407|Colon Cancer Surgery|colon cancer surgery
1257503|NCT01772407|Laparoscopy|laparoscopy
1257504|NCT01772407|Open surgery|open surgery
1257505|NCT01772407|Costs|costs
1257506|NCT01772407|Mortality|mortality
1257507|NCT01772407|Morbidity|morbidity
1257508|NCT01772407|Quality of life|quality of life
1257509|NCT01772394|Anorexia Nervosa|anorexia nervosa
1257510|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
1257511|NCT01772394|Randomized clinical trial|randomized clinical trial
1600706|NCT00391586|NSCLC|nsclc
1257512|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
1257513|NCT01772368|Asthma|asthma
1257514|NCT01772368|dry powder inhaler|dry powder inhaler
1257515|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
1257516|NCT01772368|bronchodilation|bronchodilation
1257517|NCT01772368|bronchodilator|bronchodilator
1257518|NCT01772368|metered dose inhaler|metered dose inhaler
1257519|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
1257520|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
1257521|NCT01772342|Sleep Fragmentation|sleep fragmentation
1257522|NCT01772342|Quality of Life|quality of life
1257523|NCT01772342|Air Filters|air filters
1257524|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
1257525|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
1257526|NCT01772277|Mitomycin C|mitomycin c
1257527|NCT01772251|Diabetes Mellitus|diabetes mellitus
1257528|NCT01772251|Oral Insulin|oral insulin
1257529|NCT01772238|Mexico|mexico
1257530|NCT01772238|Respiratory infections|respiratory infections
1257531|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
1257532|NCT01772238|Bioequivalence|bioequivalence
1257533|NCT01772225|Observational Retrospective|observational retrospective
1257534|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
1257535|NCT01772225|Patients|patients
1257536|NCT01772225|Stage IB-IIIA|stage ib-iiia
1257537|NCT01772225|Burden of Illness|burden of illness
1257538|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1257539|NCT01772212|Mexico|mexico
1257540|NCT01772212|terbinafine|terbinafine
1257541|NCT01772212|mycoses|mycoses
1257542|NCT01772212|pharmacokinetics|pharmacokinetics
1257543|NCT01772199|GSK239512|gsk239512
1257544|NCT01772199|remyelination|remyelination
1257545|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
1257546|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1257547|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
1257548|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
1257549|NCT01772186|Freezing of gait|freezing of gait
1257550|NCT01772186|Parkinson's disease|parkinson's disease
1257551|NCT01772186|Somatosensory stimulation|somatosensory stimulation
1257552|NCT01772186|Fall prevention|fall prevention
1257553|NCT01772173|diabetes|diabetes
1257554|NCT01772173|computer|computer
1257556|NCT01772173|vessel|vessel
1257557|NCT01772173|analysis|analysis
1257558|NCT01772160|Adults|adults
1257559|NCT01772160|Italy|italy
1257560|NCT01772160|Herpes Zoster|herpes zoster
1257561|NCT01772160|Complications|complications
1257562|NCT01772160|Quality of life|quality of life
1257563|NCT01772160|Surveillance|surveillance
1257564|NCT01772160|Burden|burden
1257565|NCT01772160|Cost|cost
1257566|NCT01772160|Incidence|incidence
1257567|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
1257568|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
1258255|NCT01768962|Rectal use|rectal use
1257569|NCT01772108|Heart Valve Diseases|heart valve diseases
1257570|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
1257571|NCT01772095|Elderly|elderly
1257572|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
1257573|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
1257574|NCT01772056|Randomized Controlled Trial|randomized controlled trial
1257575|NCT01772056|Child|child
1257576|NCT01772056|Fluticasone|fluticasone
1258167|NCT01769326|Stroke|stroke
1257577|NCT01772056|Preventive therapy|preventive therapy
1257578|NCT01772043|muscular dystrophy|muscular dystrophy
1257579|NCT01772043|tissue bank|tissue bank
1257580|NCT01772030|Atrial Fibrillation|atrial fibrillation
1257581|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
1257582|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
1257583|NCT01772017|OSA|osa
1257584|NCT01772017|Snoring|snoring
1257585|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
1257586|NCT01772004|Solid Tumors|solid tumors
1257587|NCT01772004|MSB0010718C|msb0010718c
1257588|NCT01772004|Phase 1|phase 1
1257589|NCT01772004|Pharmacokinetic|pharmacokinetic
1257590|NCT01772004|anti PD-L1|anti pd-l1
1257591|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1257592|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
1257593|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
1257594|NCT01772004|Ovarian cancer|ovarian cancer
1257595|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
1257596|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
1257597|NCT01772004|Melanoma|melanoma
1257598|NCT01772004|Urothelial carcinoma|urothelial carcinoma
1257599|NCT01772004|Bladder cancer|bladder cancer
1257600|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
1257601|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
1257602|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
1257603|NCT01771991|fibrosis|fibrosis
1349312|NCT01378260|PAD|pad
1257604|NCT01771991|radiation|radiation
1257605|NCT01771991|neck|neck
1257606|NCT01771991|cancer|cancer
1257607|NCT01771991|Sodermix|sodermix
1257608|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
1257609|NCT01771978|cardiac surgery|cardiac surgery
1257610|NCT01771978|oxidative stress markers|oxidative stress markers
1257611|NCT01771978|troponin|troponin
1257612|NCT01771978|diltiazem|diltiazem
1257613|NCT01771978|acetylcystein|acetylcystein
1257614|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
1257615|NCT01771952|Anterior Knee Pain|anterior knee pain
1257616|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
1257617|NCT01771952|Synvisc-One|synvisc-one
1257618|NCT01771952|Hyaluronic Acid|hyaluronic acid
1257619|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
1257620|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
1257621|NCT01771926|resistant starch|resistant starch
1257622|NCT01771926|lifestyle intervention|lifestyle intervention
1257623|NCT01771913|adipocytes|adipocytes
1257624|NCT01771913|cell transplantations|cell transplantations
1257625|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
1257626|NCT01771913|immunophenotyping|immunophenotyping
1257627|NCT01771913|adipose tissue|adipose tissue
1257628|NCT01771913|breast reconstruction|breast reconstruction
1257629|NCT01771913|mammaplasty|mammaplasty
1257630|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
1257631|NCT01771913|fat necrosis|fat necrosis
1257632|NCT01771900|heart failure|heart failure
1257633|NCT01771900|exercise|exercise
1257634|NCT01771900|adherence to exercise|adherence to exercise
1257635|NCT01771887|Diabetic Type2|diabetic type2
1257636|NCT01771887|education|education
1257637|NCT01771887|self-management behaviors|self-management behaviors
1257638|NCT01771887|self-efficacy|self-efficacy
1257639|NCT01771887|HbA1c|hba1c
1257640|NCT01771874|MDMA|mdma
1257641|NCT01771874|pharmacokinetics|pharmacokinetics
1257642|NCT01771874|pharmacodynamics|pharmacodynamics
1257643|NCT01771874|emotions|emotions
1257644|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
1257645|NCT01771874|Interaction study|interaction study
1257646|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
1257647|NCT01771848|Malaria|malaria
1257648|NCT01771848|Plasmodium falciparum|plasmodium falciparum
1257649|NCT01771835|diabetes mellitus|diabetes mellitus
1257650|NCT01771835|retinal venous pressure|retinal venous pressure
1257651|NCT01771835|endothelin-1|endothelin-1
1257652|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
1257653|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
1257654|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
1257655|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
1257656|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
1257657|NCT01771783|RAS-Peptide Profile|ras-peptide profile
1257658|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
1258554|NCT01767779|Epilepsy|epilepsy
1257659|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
1257660|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
1257661|NCT01771783|Renin-inhibitor|renin-inhibitor
1257662|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
1257663|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
1257664|NCT01771770|oxygen partial pressure|oxygen partial pressure
1257665|NCT01771770|mountain sickness|mountain sickness
1257666|NCT01771757|retinal venous pressure|retinal venous pressure
1257667|NCT01771757|reduced ambient pressure|reduced ambient pressure
1257668|NCT01771757|oxygen partial pressure|oxygen partial pressure
1257669|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
1257670|NCT01771705|Transplantation|transplantation
1257671|NCT01771705|Kidney|kidney
1257672|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
1257673|NCT01771705|NFAT|nfat
1257674|NCT01771705|tacrolimus|tacrolimus
1257675|NCT01771692|Orthodontics|orthodontics
1257676|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
1257677|NCT01771679|Bone Marrow Cells|bone marrow cells
1257678|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
1257679|NCT01771679|Skin Wrinkling|skin wrinkling
1257680|NCT01771679|Solar Aging of Skin|solar aging of skin
1257681|NCT01771679|Intravenous Administration|intravenous administration
1257682|NCT01771653|Hepatitis C infection|hepatitis c infection
1257683|NCT01771653|Hepatitis C Virus|hepatitis c virus
1257685|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
1257686|NCT01771614|Glucotoxicity|glucotoxicity
1257687|NCT01771614|Exercise|exercise
1257688|NCT01771614|Beta-cell function|beta-cell function
1257689|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
1257690|NCT01771562|HIV-1|hiv-1
1257691|NCT01771562|Child|child
1257692|NCT01771562|Adolescent|adolescent
1257693|NCT01771562|Growth|growth
1257694|NCT01771562|Lipodystrophy|lipodystrophy
1257695|NCT01771562|ARV treatment|arv treatment
1257696|NCT01771562|Senegal|senegal
1257697|NCT01771549|Adriamycin|adriamycin
1257698|NCT01771549|Trastuzumab|trastuzumab
1257699|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
1257700|NCT01771549|Troponin|troponin
1257701|NCT01771523|thyroidectomy|thyroidectomy
1257702|NCT01771523|drain use|drain use
1257703|NCT01771497|Breast CT|breast ct
1257704|NCT01771484|tachycardia|tachycardia
1257705|NCT01771484|pots|pots
1257706|NCT01771484|orthostatic intolerance|orthostatic intolerance
1257707|NCT01771471|back pain|back pain
1257708|NCT01771471|intervertebral disc|intervertebral disc
1257709|NCT01771471|lumbar spine|lumbar spine
1257710|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
1257711|NCT01771458|Solid Tumor|solid tumor
1257712|NCT01771458|Refractory|refractory
1257713|NCT01771458|Molecular profile|molecular profile
1257714|NCT01771458|Targeted treatment|targeted treatment
1257715|NCT01771445|IL-1|il-1
1257716|NCT01771445|IL-6|il-6
1257717|NCT01771445|Inflammation|inflammation
1257718|NCT01771419|loop-tip|loop-tip
1257719|NCT01771419|ERCP|ercp
1257720|NCT01771419|cannulation of CBD|cannulation of cbd
1257721|NCT01771393|arthroscanner|arthroscanner
1257722|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
1257723|NCT01771354|Volunteers|volunteers
1257724|NCT01771354|Identify|identify
1257725|NCT01771354|Biomarkers|biomarkers
1257726|NCT01771354|Vaccine Safety|vaccine safety
1257727|NCT01771341|NAVA|nava
1257728|NCT01771341|post operative|post operative
1257729|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
1257730|NCT01771315|total knee arthroplasty|total knee arthroplasty
1257731|NCT01771315|telephone follow-up|telephone follow-up
1257732|NCT01771315|physical function|physical function
1257733|NCT01771315|health related quality of life|health related quality of life
1257734|NCT01771315|self-efficacy|self-efficacy
1257735|NCT01771302|PRGF-Endoret|prgf-endoret
1257736|NCT01771302|Bone graft|bone graft
1257737|NCT01771302|Maxillary sinus|maxillary sinus
1257738|NCT01771302|Vertical bone augmentation|vertical bone augmentation
1257739|NCT01771289|Lung Cancer|lung cancer
1257740|NCT01771276|POSE|pose
1257741|NCT01771263|Anesthesia|anesthesia
1257742|NCT01771263|Propofol|propofol
1257743|NCT01771263|Remifentanil|remifentanil
1257744|NCT01771263|NeuroSENSE|neurosense
1257745|NCT01771237|HIV infection|hiv infection
1257746|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
1257747|NCT01771211|MCI|mci
1257748|NCT01771211|Word-retrieval|word-retrieval
1257749|NCT01771211|tDCS|tdcs
1257750|NCT01771211|fMRI|fmri
1257751|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
1257752|NCT01771198|Refractory to treatment|refractory to treatment
1257753|NCT01771198|SIMVASTATIN|simvastatin
1257754|NCT01771185|Diabetes|diabetes
1257755|NCT01771185|metabolic surgery|metabolic surgery
1257756|NCT01771185|insulin resistance|insulin resistance
1257757|NCT01771159|Spinal cord injury|spinal cord injury
1257758|NCT01771159|Urinary dysfunction|urinary dysfunction
1257759|NCT01771159|Bladder drainage|bladder drainage
1257760|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
1257761|NCT01771146|Pancreatic Cancer|pancreatic cancer
1257762|NCT01771146|Cancer of Pancreas|cancer of pancreas
1257763|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
1257764|NCT01771146|Neoadjuvant|neoadjuvant
1257765|NCT01771133|Obesity|obesity
1257766|NCT01771133|Maternal Welfare|maternal welfare
1257767|NCT01771133|Child Welfare|child welfare
1257768|NCT01771133|Nutritional Sciences|nutritional sciences
1257769|NCT01771133|Clinical Trial|clinical trial
1257770|NCT01771133|Pregnancy|pregnancy
1257771|NCT01771133|Physical activity|physical activity
1257772|NCT01771133|Fetal Development|fetal development
1257773|NCT01771133|Metabolic Diseases|metabolic diseases
1257774|NCT01771133|Life style|life style
1257775|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
1257776|NCT01771133|LIFE-Moms|life-moms
1257777|NCT01771120|Asthma|asthma
1257778|NCT01771120|Rhinitis|rhinitis
1257779|NCT01771120|Control|control
1257780|NCT01771120|Burden|burden
1257781|NCT01771081|Longitudinal Studies,|longitudinal studies,
1257782|NCT01771081|Observation|observation
1257783|NCT01771081|Epidemiology|epidemiology
1257784|NCT01771055|Trauma|trauma
1257785|NCT01771055|Hypovolemia|hypovolemia
1257786|NCT01771042|weight loss|weight loss
1257787|NCT01771042|metabolic syndrome|metabolic syndrome
1257788|NCT01771042|sympathetic nervous system|sympathetic nervous system
1257789|NCT01771042|insulin resistance|insulin resistance
1257790|NCT01771042|glucose tolerance|glucose tolerance
1257791|NCT01771029|Procalcitonin|procalcitonin
1257792|NCT01771029|Infection|infection
1257793|NCT01771029|Point-of-Care|point-of-care
1257794|NCT01771016|Emergency contraception|emergency contraception
1257795|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
1600826|NCT00391131|PID|pid
1257796|NCT01771016|Community pharmacies|community pharmacies
1257797|NCT01771016|Pharmaceutical care|pharmaceutical care
1257798|NCT01771016|Time to access|time to access
1257799|NCT01771016|Written assessments|written assessments
1257800|NCT01771016|Switzerland|switzerland
1257801|NCT01771003|Partial nephrectomy|partial nephrectomy
1257802|NCT01771003|renal cell carcinoma|renal cell carcinoma
1257803|NCT01771003|Renal Function|renal function
1257804|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
1257805|NCT01770990|depression|depression
1257806|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
1257807|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
1257808|NCT01770990|manualized psychotherapy|manualized psychotherapy
1257809|NCT01770990|telephone counseling|telephone counseling
1257810|NCT01770990|telephone psychological treatment|telephone psychological treatment
1257811|NCT01770990|telephone-administered therapy|telephone-administered therapy
1257812|NCT01770990|low-intensity treatment|low-intensity treatment
1257813|NCT01770990|motivational mail|motivational mail
1257814|NCT01770990|reminder|reminder
1257815|NCT01770990|letter|letter
1257816|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
1257817|NCT01770977|Muscle performance|muscle performance
1257818|NCT01770977|Aerobic performance|aerobic performance
1257819|NCT01770977|Lactate|lactate
1257820|NCT01770977|Creatine kinase|creatine kinase
1257821|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
1257822|NCT01770938|Muscle performance|muscle performance
1257823|NCT01770938|Gene expression|gene expression
1257824|NCT01770938|Functional performance|functional performance
1257825|NCT01770912|facial pain|facial pain
1257826|NCT01770912|temporomandibular joint|temporomandibular joint
1257827|NCT01770912|arthrocentesis|arthrocentesis
1257828|NCT01770912|steroid|steroid
1257829|NCT01770899|Montelukast|montelukast
1257830|NCT01770899|Singulair|singulair
1257831|NCT01770899|status asthmaticus|status asthmaticus
1257832|NCT01770886|Drug Safety|drug safety
1257833|NCT01770873|Youth|youth
1257834|NCT01770873|Violence|violence
1257835|NCT01770873|Assault-injured|assault-injured
1257836|NCT01770873|Mentoring|mentoring
1257837|NCT01770873|Emergency Room|emergency room
1257838|NCT01770873|Urban|urban
1257839|NCT01770860|Adhesive Bandages|adhesive bandages
1257840|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
1257841|NCT01770821|sip drink|sip drink
1257842|NCT01770821|protein|protein
1257843|NCT01770821|muscle strength|muscle strength
1257844|NCT01770821|6 minutes walking test|6 minutes walking test
1257845|NCT01770808|Bloating|bloating
1257846|NCT01770808|Flatulence|flatulence
1257847|NCT01770808|Stomach discomfort|stomach discomfort
1257848|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
1257849|NCT01770795|gemcitabine|gemcitabine
1257850|NCT01770795|genexol-PM|genexol-pm
1257851|NCT01770795|paclitaxel|paclitaxel
1257852|NCT01770782|Palatal Expansion Technique|palatal expansion technique
1257853|NCT01770782|Orthognathic Surgery|orthognathic surgery
1257854|NCT01770782|Three Dimensional images|three dimensional images
1257855|NCT01770769|Femoral Neck Fracture|femoral neck fracture
1257856|NCT01770769|undisplaced|undisplaced
1257857|NCT01770769|minimally displaced|minimally displaced
1257858|NCT01770769|internal fixation|internal fixation
1257859|NCT01770769|hemiarthroplasty|hemiarthroplasty
1257860|NCT01770769|harris hip score|harris hip score
1257861|NCT01770769|hospital cost|hospital cost
1257862|NCT01770769|society cost|society cost
1257863|NCT01770769|quality of life|quality of life
1257864|NCT01770769|Timed Up and go test|timed up and go test
1257865|NCT01770756|Hypertension|hypertension
1257866|NCT01770756|High blood pressure|high blood pressure
1257867|NCT01770756|Willpower|willpower
1257868|NCT01770756|Self care|self care
1257869|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
1257870|NCT01770743|toxin neutralization assay|toxin neutralization assay
1258168|NCT01769313|Cataract|cataract
1257871|NCT01770730|urine LAM strip test|urine lam strip test
1257872|NCT01770730|diagnostics|diagnostics
1257873|NCT01770730|tuberculosis|tuberculosis
1257874|NCT01770704|Bipolar disorder|bipolar disorder
1257875|NCT01770704|Clinical management|clinical management
1257876|NCT01770704|Clinical outcomes|clinical outcomes
1257877|NCT01770678|Children|children
1257878|NCT01770678|Cerebral Palsy|cerebral palsy
1257879|NCT01770678|Randomised|randomised
1257880|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
1257881|NCT01770652|Renal Impairment|renal impairment
1257882|NCT01770652|Kidney Impairment|kidney impairment
1257883|NCT01770652|Kidney Disease|kidney disease
1257884|NCT01770652|Ferriprox|ferriprox
1257885|NCT01770652|Deferiprone|deferiprone
1257886|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
1257887|NCT01770652|L1|l1
1257888|NCT01770639|charcot foot|charcot foot
1257889|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
1257890|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
1257891|NCT01770639|midfoot fusion|midfoot fusion
1257892|NCT01770613|Adult|adult
1257893|NCT01770613|Allogeneic|allogeneic
1257894|NCT01770613|Stem|stem
1257895|NCT01770613|Cells|cells
1257896|NCT01770613|Myocardial|myocardial
1257897|NCT01770613|Infarction|infarction
1257898|NCT01770600|Age 19 to 64|age 19 to 64
1257899|NCT01770600|Medically stable|medically stable
1257900|NCT01770600|No current or history of psychosis|no current or history of psychosis
1257901|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
1257902|NCT01770587|Insomnia|insomnia
1257903|NCT01770587|Sleep|sleep
1257904|NCT01770587|Behavioral Medicine|behavioral medicine
1257905|NCT01770587|Suicide|suicide
1257906|NCT01770587|Suicidal Ideation|suicidal ideation
1257907|NCT01770574|calcaneal lengthening|calcaneal lengthening
1257908|NCT01770574|calcium ceramics|calcium ceramics
1257909|NCT01770574|noninferiority|noninferiority
1257910|NCT01770574|radiostereometric analysis|radiostereometric analysis
1257911|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
1257912|NCT01770522|Bodyweight|bodyweight
1257913|NCT01770522|Physical Acivitiy|physical acivitiy
1257914|NCT01770522|Diet|diet
1257915|NCT01770522|Bodymass index|bodymass index
1257916|NCT01770522|Pregnancy|pregnancy
1257917|NCT01770522|Postnatal|postnatal
1257918|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
1257919|NCT01770509|Venous ulcer|venous ulcer
1257920|NCT01770509|Stasis ulcer|stasis ulcer
1257921|NCT01770509|Varicose ulcer|varicose ulcer
1257922|NCT01770496|immunization|immunization
1257923|NCT01770496|vaccination|vaccination
1257924|NCT01770496|immunization information system|immunization information system
1257925|NCT01770496|immunization registry|immunization registry
1257926|NCT01770496|reminder / recall|reminder / recall
1257927|NCT01770483|Nitazoxanide,|nitazoxanide,
1257928|NCT01770483|Sustained viral response|sustained viral response
1257929|NCT01770483|Type 2 DIABETICS|type 2 diabetics
1257930|NCT01770470|serum phosphate|serum phosphate
1257931|NCT01770470|chitosan|chitosan
1257932|NCT01770470|kidney disease|kidney disease
1257933|NCT01770470|salivary phosphate|salivary phosphate
1257934|NCT01770457|ICU population|icu population
1257935|NCT01770444|Acute coronary syndrome|acute coronary syndrome
1257936|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
1257937|NCT01770444|Radiation dose reduction|radiation dose reduction
1257938|NCT01770444|Medical radiation exposure|medical radiation exposure
1257939|NCT01770431|Huaier Granule;|huaier granule;
1257940|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
1257941|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
1257942|NCT01770431|Safety.|safety.
1257943|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
1257944|NCT01770418|Cancer|cancer
1257945|NCT01770418|Lung|lung
1257946|NCT01770418|Proton|proton
1257947|NCT01770418|Radiation|radiation
1257948|NCT01770405|endomicroscopy|endomicroscopy
1257949|NCT01770405|needle-based|needle-based
1257950|NCT01770405|pancreatic|pancreatic
1257951|NCT01770405|cyst|cyst
1257952|NCT01770405|mass|mass
1257953|NCT01770405|EUSFNA|eusfna
1257954|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
1257955|NCT01770366|obesity|obesity
1257956|NCT01770366|weight loss surgery|weight loss surgery
1257957|NCT01770366|virtual support|virtual support
1257958|NCT01770366|wireless devices|wireless devices
1257959|NCT01770366|Internet|internet
1257960|NCT01770353|solid tumors|solid tumors
1257961|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
1257962|NCT01770353|Colorectal Cancer|colorectal cancer
1257963|NCT01770353|MM-398|mm-398
1257964|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
1257965|NCT01770353|Ferumoxytol|ferumoxytol
1257966|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
1257967|NCT01770353|Pancreatic Cancer|pancreatic cancer
1257968|NCT01770353|Ovarian Cancer|ovarian cancer
1257969|NCT01770353|Gastric Cancer|gastric cancer
1257970|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
1257971|NCT01770353|Head and Neck Cancer|head and neck cancer
1257972|NCT01770353|TNBC|tnbc
1257973|NCT01770340|radical prostatectomy|radical prostatectomy
1257974|NCT01770340|erectile function|erectile function
1257975|NCT01770340|nerve grafting|nerve grafting
1257976|NCT01770340|allogenic|allogenic
1257977|NCT01770340|prostate cancer|prostate cancer
1257978|NCT01770340|Allogenic nerve graft|allogenic nerve graft
1257979|NCT01770340|Time required for nerve grafting|time required for nerve grafting
1257980|NCT01770314|Opioid Pain Medication|opioid pain medication
1257981|NCT01770314|Medication Safety|medication safety
1257982|NCT01770314|Correct storage|correct storage
1257983|NCT01770314|Correct disposal|correct disposal
1257984|NCT01770314|Correct Use|correct use
1257985|NCT01770288|Anerobic exercise|anerobic exercise
1257986|NCT01770288|Pain|pain
1257987|NCT01770288|Analgesia|analgesia
1257988|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
1257989|NCT01770288|psychological stress|psychological stress
1257990|NCT01770275|esophagus|esophagus
1257991|NCT01770249|dysphagia|dysphagia
1257992|NCT01770210|hypercholesterolemia|hypercholesterolemia
1257993|NCT01770210|atorvastatin|atorvastatin
1257994|NCT01770210|cardiovascular events|cardiovascular events
1257995|NCT01770197|China|china
1257996|NCT01770197|Stroke|stroke
1257997|NCT01770197|Thrombolytic therapy|thrombolytic therapy
1257998|NCT01770184|Self-management|self-management
1257999|NCT01770184|Rehabilitation|rehabilitation
1258000|NCT01770184|Occupational Therapy|occupational therapy
1258001|NCT01770171|endometrial cancer|endometrial cancer
1258002|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
1258003|NCT01770171|bevacizumab|bevacizumab
1258004|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1258005|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
1258006|NCT01770158|Interleukin-2|interleukin-2
1258007|NCT01770145|Motor symptoms|motor symptoms
1258008|NCT01770145|Parkinson's Disease|parkinson's disease
1258009|NCT01770145|Delayed Onset|delayed onset
1258010|NCT01770145|Akinesia|akinesia
1258011|NCT01770145|Hypomobility|hypomobility
1258012|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
1258013|NCT01770145|Dopamine agonist|dopamine agonist
1258014|NCT01770145|Apomorphine|apomorphine
1258015|NCT01770145|Apokyn|apokyn
1258016|NCT01770145|Levodopa|levodopa
1258017|NCT01770119|Measles|measles
1258018|NCT01770119|Mumps|mumps
1258019|NCT01770119|Rubella|rubella
1258020|NCT01770119|Pediatric|pediatric
1258021|NCT01770119|Solid-organ transplant|solid-organ transplant
1258022|NCT01770119|serology|serology
1258023|NCT01770119|vaccine|vaccine
1258024|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
1258025|NCT01770106|Bone density|bone density
1258026|NCT01770106|Bone microarchitecture|bone microarchitecture
1258027|NCT01770106|HR-pQCT|hr-pqct
1258028|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
1258029|NCT01770054|metabolic syndrome|metabolic syndrome
1258030|NCT01770054|diabetes mellitus|diabetes mellitus
1258031|NCT01770028|Obesity|obesity
1258032|NCT01770028|Pregnancy|pregnancy
1258033|NCT01770028|Spouse|spouse
1258034|NCT01770028|Weight loss|weight loss
1258035|NCT01770028|Behavioral|behavioral
1258036|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
1258037|NCT01769963|Advanced glycation end-products|advanced glycation end-products
1258038|NCT01769963|chronic kidney disease|chronic kidney disease
1258039|NCT01769963|nutrition|nutrition
1258040|NCT01769963|inflammation|inflammation
1258041|NCT01769963|insulin resistance|insulin resistance
1258042|NCT01769963|endothelial function|endothelial function
1258043|NCT01769950|Choline PET|choline pet
1258044|NCT01769950|Choline PET-CT|choline pet-ct
1258045|NCT01769950|Positron emission tomography|positron emission tomography
1258046|NCT01769950|Prostate cancer|prostate cancer
1258047|NCT01769937|Lupus|lupus
1258048|NCT01769937|SLE|sle
1258049|NCT01769937|ACTH|acth
1258050|NCT01769937|Acthar|acthar
1258051|NCT01769924|Kidney donors|kidney donors
1258052|NCT01769924|Arterial stiffness|arterial stiffness
1258053|NCT01769924|Blood pressure|blood pressure
1258054|NCT01769924|Nephrectomy|nephrectomy
1258055|NCT01769898|Bronchiectasis|bronchiectasis
1258056|NCT01769898|Theophylline|theophylline
1258057|NCT01769898|Therapeutic Uses|therapeutic uses
1258058|NCT01769898|HDAC|hdac
1258060|NCT01769898|Random placebo study|random placebo study
1258061|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
1258062|NCT01769898|corticosteroid|corticosteroid
1258063|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
1258064|NCT01769859|Bipolar Disorder|bipolar disorder
1258065|NCT01769859|Major Depressive Disorder|major depressive disorder
1258066|NCT01769859|Genetics|genetics
1258067|NCT01769833|HBsAg|hbsag
1258068|NCT01769833|Chronic hepatitis B|chronic hepatitis b
1258069|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
1258366|NCT01768533|pediatric|pediatric
1258070|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
1258071|NCT01769820|Dexamethasone|dexamethasone
1258072|NCT01769820|glucocorticoid|glucocorticoid
1258073|NCT01769807|Sleep apnea|sleep apnea
1258074|NCT01769807|CPAP treatment|cpap treatment
1258075|NCT01769807|Plasma nitrate|plasma nitrate
1258076|NCT01769807|Urinary norepinephrine|urinary norepinephrine
1258077|NCT01769807|Blood pressure|blood pressure
1258078|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
1258079|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
1258080|NCT01769794|Enterovirus|enterovirus
1258081|NCT01769794|Fever|fever
1258082|NCT01769781|endometriosis recurrence|endometriosis recurrence
1258083|NCT01769781|pelvic pain|pelvic pain
1258084|NCT01769781|aromatase inhibitor|aromatase inhibitor
1333170|NCT01444209|pituitary gland|pituitary gland
1333171|NCT01444196|ACU|acu
1333172|NCT01444196|acquired cold urticaria|acquired cold urticaria
1333173|NCT01444183|Epilepsy|epilepsy
1258085|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
1258086|NCT01769755|Crohn's disease|crohn's disease
1258087|NCT01769755|Fistula|fistula
1258088|NCT01769755|Diarrhea|diarrhea
1258089|NCT01769755|Colon|colon
1258090|NCT01769755|Stem cells|stem cells
1258091|NCT01769742|Pneumonia|pneumonia
1258092|NCT01769742|promotion of activity|promotion of activity
1258093|NCT01769729|integrated primary care|integrated primary care
1258094|NCT01769729|depression|depression
1258095|NCT01769729|chronic low back pain|chronic low back pain
1258096|NCT01769716|Global developmental delay|global developmental delay
1258097|NCT01769716|Umbilical cord blood|umbilical cord blood
1258098|NCT01769716|Rehabilitation|rehabilitation
1258099|NCT01769690|PD|pd
1258100|NCT01769690|Parkinson's Disease|parkinson's disease
1258101|NCT01769690|DBS|dbs
1258102|NCT01769690|deep brain stimulation|deep brain stimulation
1258103|NCT01769677|Bioequivalence|bioequivalence
1258104|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
1258105|NCT01769664|Acne vulgaris|acne vulgaris
1258106|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
1258107|NCT01769664|Duac® Topical Gel|duac® topical gel
1258108|NCT01769651|drug user patients|drug user patients
1258109|NCT01769651|addiction nurses|addiction nurses
1258110|NCT01769651|overdose risk|overdose risk
1258111|NCT01769638|Orally disintegrating Film|orally disintegrating film
1258112|NCT01769638|Film Coated Tablet|film coated tablet
1258113|NCT01769638|Sildenafil|sildenafil
1258114|NCT01769638|Pharmacokinetics|pharmacokinetics
1258115|NCT01769625|breast|breast
1258116|NCT01769625|high risk women|high risk women
1258117|NCT01769625|biomarkers|biomarkers
1258118|NCT01769625|vitamin D|vitamin d
1258119|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
1258120|NCT01769586|Sedation|sedation
1258121|NCT01769586|Endoscopy|endoscopy
1258122|NCT01769586|Diphenhydramine|diphenhydramine
1258123|NCT01769586|Midazolam|midazolam
1258124|NCT01769573|normal|normal
1258125|NCT01769560|tailored intervention|tailored intervention
1258126|NCT01769560|college aged students|college aged students
1258127|NCT01769560|HPV|hpv
1258128|NCT01769521|Glaucoma|glaucoma
1258129|NCT01769521|IOP|iop
1258130|NCT01769521|Blood pressure|blood pressure
1258131|NCT01769521|ECG|ecg
1258132|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
1258133|NCT01769508|5-Fluorouracil|5-fluorouracil
1258134|NCT01769508|Oxaliplatin|oxaliplatin
1258135|NCT01769508|Lapatinib|lapatinib
1258136|NCT01769508|Radiation Therapy|radiation therapy
1258137|NCT01769508|Surgery|surgery
1258138|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
1258139|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
1258140|NCT01769482|microvascular angina|microvascular angina
1258141|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
1258142|NCT01769482|Heart disease|heart disease
1258143|NCT01769482|Ischemia|ischemia
1258144|NCT01769482|Cardiac MRI|cardiac mri
1258145|NCT01769469|Tenofovir|tenofovir
1258146|NCT01769469|Emtricitabine|emtricitabine
1258147|NCT01769469|Truvada|truvada
1258148|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
1258149|NCT01769469|HIV prevention|hiv prevention
1258150|NCT01769469|PrEP|prep
1258151|NCT01769456|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
1258152|NCT01769443|desensitization therapy|desensitization therapy
1258153|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
1258154|NCT01769443|plasmapheresis|plasmapheresis
1258155|NCT01769430|influenza virus|influenza virus
1258156|NCT01769430|aerosol transmission|aerosol transmission
1258157|NCT01769430|contact transmission|contact transmission
1258158|NCT01769430|large droplet transmission|large droplet transmission
1258159|NCT01769430|airborne infection|airborne infection
1258160|NCT01769391|NSCLC|nsclc
1258161|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
1258162|NCT01769352|cystoid macular edema|cystoid macular edema
1258163|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
1258164|NCT01769339|Miconazole|miconazole
1258165|NCT01769339|Hydrocortisone|hydrocortisone
1258166|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
1258169|NCT01769313|Laser-assisted|laser-assisted
1258170|NCT01769313|Femtosecond|femtosecond
1258171|NCT01769300|Clinical decision support|clinical decision support
1258172|NCT01769300|Electronic health records|electronic health records
1258173|NCT01769300|Electronic medical records|electronic medical records
1258425|NCT01768286|Flaviviridae Infections|flaviviridae infections
1258174|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
1258175|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
1258176|NCT01769287|Atrial fibrillation|atrial fibrillation
1258177|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
1258178|NCT01769287|12 months post-operatively|12 months post-operatively
1258179|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
1258180|NCT01769261|quality of health care|quality of health care
1258181|NCT01769261|continuity of patient care|continuity of patient care
1258182|NCT01769261|adverse effects|adverse effects
1258183|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
1258184|NCT01769248|EUS|eus
1258185|NCT01769248|FNA|fna
1258186|NCT01769248|FNB|fnb
1258187|NCT01769235|Acne Vulgaris|acne vulgaris
1258188|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
1258189|NCT01769235|Acanya® Gel|acanya® gel
1258190|NCT01769196|Idiopathic|idiopathic
1258191|NCT01769196|Pulmonary|pulmonary
1258192|NCT01769196|Fibrosis|fibrosis
1258193|NCT01769196|IPF|ipf
1258194|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1258195|NCT01769170|CMV|cmv
1258196|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
1258197|NCT01769170|CMV seropositive|cmv seropositive
1258198|NCT01769144|wound healing|wound healing
1258199|NCT01769144|wound infection|wound infection
1258200|NCT01769144|pain|pain
1258201|NCT01769144|pruritus|pruritus
1258202|NCT01769144|cicatrix|cicatrix
1258203|NCT01769144|dressings|dressings
1258204|NCT01769144|acticoat absorbent|acticoat absorbent
1258205|NCT01769144|BCT|bct
1258206|NCT01769144|KoCarbonAg|kocarbonag
1258207|NCT01769131|cervix|cervix
1258208|NCT01769131|Allis|allis
1258209|NCT01769131|Tenaculum|tenaculum
1258210|NCT01769131|gynecology|gynecology
1258211|NCT01769118|Autonomic nervous system|autonomic nervous system
1258212|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
1258213|NCT01769105|Lipiflow|lipiflow
1258214|NCT01769092|Epilepsy|epilepsy
1258215|NCT01769092|Seizure|seizure
1258216|NCT01769092|Fish Oil|fish oil
1258217|NCT01769053|Acute Lung Injury|acute lung injury
1258218|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
1258219|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
1258220|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
1258221|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
1258222|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
1258223|NCT01769040|Ascites|ascites
1258224|NCT01769040|Haemodynamics|haemodynamics
1258225|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
1258226|NCT01769040|Pathophysiology|pathophysiology
1258227|NCT01769014|adherence|adherence
1258228|NCT01769001|Fabry disease|fabry disease
1258229|NCT01769001|Alpha galactosidase deficiency|alpha galactosidase deficiency
1258230|NCT01769001|Metabolic storage disease|metabolic storage disease
1258231|NCT01768975|Knee|knee
1258232|NCT01768975|Osteoarthritis|osteoarthritis
1258233|NCT01768975|OA|oa
1258234|NCT01768975|Knee pain|knee pain
1258235|NCT01768975|Moderate pain|moderate pain
1258236|NCT01768975|Severe pain|severe pain
1258237|NCT01768975|Inflammation|inflammation
1258238|NCT01768975|Safety|safety
1258239|NCT01768975|Efficacy|efficacy
1258240|NCT01768975|Randomized|randomized
1258241|NCT01768975|Topical|topical
1258242|NCT01768975|Gel|gel
1258243|NCT01768975|Olatec|olatec
1258244|NCT01768975|OLT1177|olt1177
1258245|NCT01768975|Joint Diseases|joint diseases
1258246|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
1258247|NCT01768975|Rheumatic Diseases|rheumatic diseases
1258248|NCT01768975|Arthritis|arthritis
1258249|NCT01768975|Therapeutic|therapeutic
1258250|NCT01768975|Analgesic|analgesic
1258251|NCT01768962|Microbicides|microbicides
1258252|NCT01768962|Tenofovir|tenofovir
1258253|NCT01768962|Reduced-glycerin|reduced-glycerin
1258256|NCT01768962|Pharmacokinetics|pharmacokinetics
1258257|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
1258258|NCT01768949|Echocardiography|echocardiography
1258259|NCT01768949|Recruitment maneuver|recruitment maneuver
1258260|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
1258261|NCT01768936|PCT|pct
1258262|NCT01768936|procalcitonin|procalcitonin
1258263|NCT01768936|peritonitis|peritonitis
1258264|NCT01768936|sepsis|sepsis
1258265|NCT01768936|focus index|focus index
1258266|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
1258267|NCT01768923|Arterial stiffness|arterial stiffness
1258268|NCT01768923|SDAI remission group|sdai remission group
1258269|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
1258270|NCT01768910|lower urinary tract|lower urinary tract
1258271|NCT01768910|bladder|bladder
1258272|NCT01768910|supraspinal control|supraspinal control
1258273|NCT01768910|neuroimaging|neuroimaging
1258274|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
1258275|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
1258276|NCT01768910|functional connectivity|functional connectivity
1258277|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
1258278|NCT01768910|overactive bladder|overactive bladder
1350268|NCT01374360|PNH|pnh
1258279|NCT01768910|multiple sclerosis|multiple sclerosis
1258280|NCT01768910|spinal cord injury|spinal cord injury
1258281|NCT01768884|Infants|infants
1258282|NCT01768884|Bronchiolitis|bronchiolitis
1258283|NCT01768884|NO|no
1258284|NCT01768884|inhalation|inhalation
1258285|NCT01768858|Arthritis|arthritis
1258286|NCT01768858|Morbus Crohn|morbus crohn
1258287|NCT01768858|Adherence|adherence
1258288|NCT01768858|Spondylitis|spondylitis
1258289|NCT01768858|Ulcerative colitis|ulcerative colitis
1258290|NCT01768858|Monoclonals|monoclonals
1258291|NCT01768858|Rheumatoid|rheumatoid
1258292|NCT01768858|Antibodies|antibodies
1258293|NCT01768858|Ankylosing|ankylosing
1258294|NCT01768858|Plaque psoriasis|plaque psoriasis
1258295|NCT01768858|Psoriatic|psoriatic
1258296|NCT01768858|Crohn´s disease|crohn´s disease
1258297|NCT01768858|Antirheumatic Agents|antirheumatic agents
1258298|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
1258426|NCT01768286|Antiviral Agents|antiviral agents
1258299|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1258300|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
1258301|NCT01768845|Multiple myeloma|multiple myeloma
1258302|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
1258303|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
1258304|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1258305|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
1258306|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
1258307|NCT01768845|Cord Blood|cord blood
1258308|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
1258309|NCT01768845|UBC transplantation|ubc transplantation
1258310|NCT01768832|Parkinson disease|parkinson disease
1258311|NCT01768832|walking|walking
1258312|NCT01768832|fMRI|fmri
1258313|NCT01768832|exercise|exercise
1258314|NCT01768832|dance|dance
1258315|NCT01768832|treadmill|treadmill
1258316|NCT01768819|aging|aging
1258317|NCT01768819|exercise|exercise
1258318|NCT01768819|muscle strength|muscle strength
1258319|NCT01768819|physical activity|physical activity
1258320|NCT01768806|Autism|autism
1258321|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
1258322|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
1258323|NCT01768806|Intensive Early Intervention|intensive early intervention
1258324|NCT01768806|Parent Training|parent training
1258325|NCT01768793|Obesity|obesity
1258326|NCT01768793|Pregnancy|pregnancy
1258327|NCT01768793|Body Weight Changes|body weight changes
1258328|NCT01768793|Diet Therapy|diet therapy
1258329|NCT01768780|spinal anesthesia|spinal anesthesia
1258330|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
1258331|NCT01768780|sensory block level|sensory block level
1258332|NCT01768754|Exercise testing|exercise testing
1258333|NCT01768754|Functional status|functional status
1258334|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
1258335|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
1258336|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
1258337|NCT01768715|Liver transplantation|liver transplantation
1258338|NCT01768715|Survival|survival
1258339|NCT01768715|Alcoholism|alcoholism
1258340|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
1258341|NCT01768689|adherence|adherence
1258342|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
1258343|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1258344|NCT01768676|healthy male|healthy male
1258345|NCT01768650|traumatic brain injury|traumatic brain injury
1258346|NCT01768650|chronic pain|chronic pain
1258347|NCT01768650|headache|headache
1258348|NCT01768650|Veteran|veteran
1258349|NCT01768637|Chronic kidney disease|chronic kidney disease
1258350|NCT01768637|Platelet function|platelet function
1258351|NCT01768637|aspirin|aspirin
1258352|NCT01768637|antiplatelet agent|antiplatelet agent
1258353|NCT01768624|chronic kidney disease|chronic kidney disease
1258354|NCT01768624|dialysis|dialysis
1258355|NCT01768624|pre dialysis education|pre dialysis education
1258356|NCT01768624|transplantation|transplantation
1258357|NCT01768624|conservative care|conservative care
1258358|NCT01768598|Wrist Fracture|wrist fracture
1258359|NCT01768598|Adolescents|adolescents
1258360|NCT01768598|Risk Taking Behaviour|risk taking behaviour
1258361|NCT01768598|Bone Microstructure|bone microstructure
1258362|NCT01768546|Diabetes Prevention Program|diabetes prevention program
1258363|NCT01768546|obesity|obesity
1258364|NCT01768546|activity|activity
1258365|NCT01768546|diabetes|diabetes
1258367|NCT01768533|obesity|obesity
1258368|NCT01768533|prevention|prevention
1258369|NCT01768533|health behaviors|health behaviors
1258370|NCT01768533|guidelines|guidelines
1258371|NCT01768481|Obesity|obesity
1258372|NCT01768481|Dyslipidemia|dyslipidemia
1258373|NCT01768481|Cholesterol|cholesterol
1258374|NCT01768481|Intima media thickness|intima media thickness
1258375|NCT01768468|LAYLA|layla
1258376|NCT01768468|Non-inferiority|non-inferiority
1258377|NCT01768468|100mm pain VAS|100mm pain vas
1258378|NCT01768442|Head and neck cancer|head and neck cancer
1258379|NCT01768403|Hypercholesterolemia|hypercholesterolemia
1258380|NCT01768403|Cardiovascular disease|cardiovascular disease
1258381|NCT01768403|Hypertension|hypertension
1258382|NCT01768403|Coronary Heart disease|coronary heart disease
1258383|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
1258384|NCT01768390|caries|caries
1258385|NCT01768390|prevention|prevention
1258386|NCT01768390|orthodontics|orthodontics
1258387|NCT01768390|fixed appliances|fixed appliances
1258388|NCT01768390|adolescents|adolescents
1258389|NCT01768377|Awake intubation|awake intubation
1258390|NCT01768377|Nerve block|nerve block
1258391|NCT01768377|Sedation|sedation
1258392|NCT01768377|Physician satisfaction|physician satisfaction
1258393|NCT01768351|anemia|anemia
1258394|NCT01768351|chronic kidney disease|chronic kidney disease
1258395|NCT01768351|vitamin D|vitamin d
1258396|NCT01768351|paricalcitol|paricalcitol
1258397|NCT01768351|hyperparathyroidism|hyperparathyroidism
1258398|NCT01768325|ProCore Needle|procore needle
1258399|NCT01768299|abortion|abortion
1258400|NCT01768299|medical abortion|medical abortion
1258401|NCT01768299|mifepristone|mifepristone
1258402|NCT01768299|misoprostol|misoprostol
1258403|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1258404|NCT01768286|HCV|hcv
1258405|NCT01768286|Sustained Virologic Response|sustained virologic response
1258406|NCT01768286|Direct Acting Antiviral|direct acting antiviral
1258407|NCT01768286|Combination Therapy|combination therapy
1258408|NCT01768286|GS-7977|gs-7977
1258409|NCT01768286|GS-5885|gs-5885
1258410|NCT01768286|Ribavirin|ribavirin
1258411|NCT01768286|Open Label|open label
1258412|NCT01768286|Sofosbuvir|sofosbuvir
1258413|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
1258414|NCT01768286|Hepatitis|hepatitis
1258415|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
1258416|NCT01768286|Hepatitis C|hepatitis c
1258417|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
1258418|NCT01768286|Liver Diseases|liver diseases
1258419|NCT01768286|Digestive System Diseases|digestive system diseases
1258420|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
1258421|NCT01768286|Virus Diseases|virus diseases
1258422|NCT01768286|Enterovirus Infections|enterovirus infections
1258423|NCT01768286|Picornaviridae Infections|picornaviridae infections
1258424|NCT01768286|RNA Virus Infections|rna virus infections
1258427|NCT01768286|Anti-Infective Agents|anti-infective agents
1258428|NCT01768286|Therapeutic Uses|therapeutic uses
1258429|NCT01768286|Pharmacologic Actions|pharmacologic actions
1258430|NCT01768286|Antimetabolites|antimetabolites
1258431|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1258432|NCT01768273|PA-824,|pa-824,
1258433|NCT01768273|midazolam|midazolam
1258434|NCT01768273|drug-drug interaction|drug-drug interaction
1258435|NCT01768273|pharmacokinetics|pharmacokinetics
1258436|NCT01768273|pretomanid|pretomanid
1258437|NCT01768273|CL-006|cl-006
1258438|NCT01768260|visual acuity|visual acuity
1258439|NCT01768260|artery flow velocity|artery flow velocity
1258440|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
1258441|NCT01768260|Ischemic|ischemic
1258442|NCT01768260|Optic Neuropathy|optic neuropathy
1258443|NCT01768247|endometrium|endometrium
1258444|NCT01768247|thickness|thickness
1258445|NCT01768247|pregnancy|pregnancy
1258446|NCT01768247|HCG|hcg
1258447|NCT01768247|frozen cycles|frozen cycles
1258448|NCT01768234|cognition|cognition
1258449|NCT01768234|hydration|hydration
1258450|NCT01768234|schoolchildren|schoolchildren
1258451|NCT01768221|Palliative Care|palliative care
1258452|NCT01768221|Caregiver Outlook|caregiver outlook
1258453|NCT01768195|Lymphoma|lymphoma
1258454|NCT01768195|Hepatitis B Virus|hepatitis b virus
1258455|NCT01768195|Therapeutic Uses|therapeutic uses
1258456|NCT01768195|Antiviral Agents|antiviral agents
1258457|NCT01768195|rituximab|rituximab
1258458|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
1258459|NCT01768169|metabolic syndrome,|metabolic syndrome,
1258460|NCT01768169|waist, blood pressure,|waist, blood pressure,
1258461|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
1258462|NCT01768169|HDL cholesterol,|hdl cholesterol,
1258463|NCT01768169|triglycerides|triglycerides
1258464|NCT01768156|ovarian cancer|ovarian cancer
1258465|NCT01768156|biomarker|biomarker
1258466|NCT01768156|metastatic|metastatic
1258467|NCT01768143|Propofol|propofol
1258468|NCT01768143|Sedation|sedation
1258469|NCT01768143|Endoscopy|endoscopy
1258470|NCT01768143|nonanesthesiologist|nonanesthesiologist
1258568|NCT01767701|raltegravir|raltegravir
1258471|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
1258472|NCT01768104|SMTs|smts
1258473|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1258474|NCT01768104|GISTs|gists
1258475|NCT01768104|Leiomyoma|leiomyoma
1258476|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
1258477|NCT01768104|ESTD|estd
1258478|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
1258479|NCT01768104|STER|ster
1258480|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
1258482|NCT01768091|Esophageal achalasia|esophageal achalasia
1258483|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
1258484|NCT01768091|POEM|poem
1258485|NCT01768091|Pneumatic dilation|pneumatic dilation
1258486|NCT01768065|NEPAP|nepap
1258487|NCT01768065|CPAP|cpap
1258488|NCT01768065|alternative|alternative
1258489|NCT01768065|OSAS|osas
1258490|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
1258491|NCT01768039|Multiple sclerosis|multiple sclerosis
1258492|NCT01768039|Vitamin D|vitamin d
1258493|NCT01768039|EDSS|edss
1258494|NCT01768039|ARR|arr
1258495|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
1258496|NCT01768026|Type VII Collagen|type vii collagen
1258497|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
1258498|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
1258499|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
1258500|NCT01768000|Psychosis|psychosis
1258501|NCT01768000|Psychosis NOS|psychosis nos
1258502|NCT01768000|Schizophrenia|schizophrenia
1258503|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
1258504|NCT01768000|Bipolar Disorder|bipolar disorder
1258505|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
1258506|NCT01767987|ACS|acs
1258507|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
1258508|NCT01767987|PCI|pci
1258509|NCT01767987|Ranolazine|ranolazine
1258510|NCT01767987|Coronary Angiogram|coronary angiogram
1258511|NCT01767987|Cardioprotectant|cardioprotectant
1258512|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
1258513|NCT01767948|Hepatic Impairment|hepatic impairment
1258514|NCT01767948|PCI 32765|pci 32765
1258515|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
1258516|NCT01767948|Pharmacokinetics|pharmacokinetics
1258517|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
1258518|NCT01767922|SOD|sod
1258519|NCT01767922|melon juce|melon juce
1258520|NCT01767922|perceived stress|perceived stress
1258521|NCT01767909|Intranasal insulin|intranasal insulin
1258522|NCT01767909|Alzheimer's disease|alzheimer's disease
1258523|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
1258524|NCT01767909|Dementia|dementia
1258525|NCT01767909|Brain diseases|brain diseases
1258526|NCT01767909|Memory problems|memory problems
1258527|NCT01767909|Mental disorders|mental disorders
1258528|NCT01767909|Cognitive disorders|cognitive disorders
1258529|NCT01767896|Influenza vaccine|influenza vaccine
1258530|NCT01767883|Chronic Kidney Disease|chronic kidney disease
1258531|NCT01767883|CKD|ckd
1258532|NCT01767883|TRANSLATE|translate
1258533|NCT01767883|Practice Facilitation|practice facilitation
1258534|NCT01767883|Practice-based research|practice-based research
1258535|NCT01767883|CKD Guidelines|ckd guidelines
1258536|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
1258537|NCT01767870|colonoscopy|colonoscopy
1258538|NCT01767870|sigmoidoscopy|sigmoidoscopy
1258539|NCT01767870|fecal immunochemical test|fecal immunochemical test
1258540|NCT01767857|Pivotal|pivotal
1258541|NCT01767857|Colorectal|colorectal
1258542|NCT01767857|Survival|survival
1258543|NCT01767857|Phase 3|phase 3
1258544|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
1258545|NCT01767844|Arthritis|arthritis
1258546|NCT01767844|Rheumatology|rheumatology
1258547|NCT01767844|Creatine|creatine
1258548|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1258549|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1258550|NCT01767831|Simulation-based Education|simulation-based education
1258551|NCT01767818|Parkinson's Disease|parkinson's disease
1258552|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
1258553|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
1258555|NCT01767779|TSC|tsc
1258556|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
1258557|NCT01767779|Infants|infants
1258558|NCT01767779|Seizures|seizures
1258559|NCT01767779|Biomarkers|biomarkers
1258560|NCT01767779|EEG|eeg
1258561|NCT01767753|Glaucoma|glaucoma
1258562|NCT01767753|SLT|slt
1258563|NCT01767740|Rotator Cuff Tear|rotator cuff tear
1258564|NCT01767740|Supraspinatus Tear|supraspinatus tear
1258565|NCT01767727|surgical flap;|surgical flap;
1258566|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
1258567|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1258569|NCT01767701|MS|ms
1258570|NCT01767701|RRMS|rrms
1258571|NCT01767701|Charcot Project|charcot project
1258572|NCT01767688|Diabetes Mellitus|diabetes mellitus
1258573|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1258574|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
1258575|NCT01767688|Metabolic Diseases|metabolic diseases
1258576|NCT01767688|Endocrine System Diseases|endocrine system diseases
1258577|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
1258578|NCT01767675|Carboplatin|carboplatin
1258579|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
1258581|NCT01767662|TCV|tcv
1258582|NCT01767649|Pregnancy|pregnancy
1258583|NCT01767649|Remodelling|remodelling
1258584|NCT01767649|Extracellular matrix|extracellular matrix
1258585|NCT01767649|Biomarkers|biomarkers
1258586|NCT01767597|rapid test|rapid test
1258587|NCT01767597|screening|screening
1258588|NCT01767597|ELISA|elisa
1258589|NCT01767597|hepatitis B virus|hepatitis b virus
1258590|NCT01767597|access to care|access to care
1258591|NCT01767584|Pharmacokinetics|pharmacokinetics
1258592|NCT01767584|Bioequivalence|bioequivalence
1258593|NCT01767584|Mexico|mexico
1258594|NCT01767584|Cephalexin|cephalexin
1258595|NCT01767571|Mexico|mexico
1258596|NCT01767571|Respiratory infections|respiratory infections
1258597|NCT01767571|Bioequivalence|bioequivalence
1258598|NCT01767571|Cepphalexin|cepphalexin
1258599|NCT01767532|Cephalexin|cephalexin
1258600|NCT01767532|Respiratory infections|respiratory infections
1258601|NCT01767532|Mexico|mexico
1258602|NCT01767532|Bioequivalence|bioequivalence
1258603|NCT01767506|Trachoma|trachoma
1258604|NCT01767506|Azithromycin|azithromycin
1258605|NCT01767506|Mass treatment|mass treatment
1258606|NCT01767493|Multiple sclerosis|multiple sclerosis
1258607|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
1258608|NCT01767480|Subacute Stroke|subacute stroke
1258609|NCT01767480|Brain Reorganization|brain reorganization
1258610|NCT01767480|Sensory Motor|sensory motor
1258611|NCT01767480|Physiological Marker|physiological marker
1258612|NCT01767467|Immunogenicity|immunogenicity
1258613|NCT01767467|Safety|safety
1258614|NCT01767467|Herpes zoster|herpes zoster
1258615|NCT01767467|Vaccination|vaccination
1258616|NCT01767467|Haematologic malignancies|haematologic malignancies
1258617|NCT01767454|BRAF V600E|braf v600e
1258618|NCT01767454|Melanoma|melanoma
1258619|NCT01767454|V600K|v600k
1258620|NCT01767454|Trametinib|trametinib
1258621|NCT01767454|Dabrafenib|dabrafenib
1258622|NCT01767454|Ipilimumab|ipilimumab
1258623|NCT01767441|bariatric surgery|bariatric surgery
1258624|NCT01767441|gastric bypass|gastric bypass
1258625|NCT01767441|gastric banding|gastric banding
1258626|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
1258627|NCT01767441|weight loss|weight loss
1258628|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1258629|NCT01767441|GLP1|glp1
1258630|NCT01767441|obesity|obesity
1258631|NCT01767441|mixed meal test|mixed meal test
1258632|NCT01767415|brain tumor|brain tumor
1258633|NCT01767415|resection|resection
1258634|NCT01767415|indigo carmine dye|indigo carmine dye
1258635|NCT01767402|Safety|safety
1258636|NCT01767402|Pneumococcal Infections|pneumococcal infections
1258637|NCT01767402|Immunogenicity|immunogenicity
1258638|NCT01767402|PhtD vaccine|phtd vaccine
1258639|NCT01767402|Healthy adults|healthy adults
1258640|NCT01767402|Reactogenicity|reactogenicity
1258641|NCT01767389|utilization|utilization
1258642|NCT01767389|acute pancreatitis|acute pancreatitis
1258643|NCT01767389|Exenatide|exenatide
1258644|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
1258645|NCT01767389|liraglutide|liraglutide
1258646|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
1258647|NCT01767389|adherence|adherence
1258648|NCT01767376|Young adults|young adults
1258649|NCT01767376|Adolescents|adolescents
1258650|NCT01767376|Reactogenicity|reactogenicity
1258651|NCT01767376|Diphtheria|diphtheria
1258652|NCT01767376|pertussis|pertussis
1258653|NCT01767376|Immunogenicity|immunogenicity
1258654|NCT01767376|Tetanus|tetanus
1258655|NCT01767376|Meningococcal vaccines|meningococcal vaccines
1258656|NCT01767376|Safety|safety
1258657|NCT01767376|Neisseria meningitidis|neisseria meningitidis
1258658|NCT01767376|Healthy|healthy
1258659|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
1258660|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
1258661|NCT01767363|Prostate cancer mortality|prostate cancer mortality
1258662|NCT01767350|Pediatric transplantation|pediatric transplantation
1258663|NCT01767350|Pharmacogenetics|pharmacogenetics
1258664|NCT01767350|Pharmacokinetics|pharmacokinetics
1258665|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
1258666|NCT01767350|CYP3A|cyp3a
1258667|NCT01767350|Pgp|pgp
1258668|NCT01767337|microneedle-based delivery|microneedle-based delivery
1258669|NCT01767337|hollow microneedle|hollow microneedle
1258670|NCT01767337|intracutaneous|intracutaneous
1258671|NCT01767337|drug delivery|drug delivery
1258672|NCT01767324|microneedle-based array|microneedle-based array
1258673|NCT01767324|hollow microneedle|hollow microneedle
1258674|NCT01767324|intracutaneous|intracutaneous
1258675|NCT01767324|drug delivery|drug delivery
1258676|NCT01767324|vaccine delivery|vaccine delivery
1258677|NCT01767311|Alzheimer's Disease|alzheimer's disease
1258679|NCT01767298|Fixed dose combination|fixed dose combination
1258680|NCT01767298|Pharmacokinetics|pharmacokinetics
1258681|NCT01767298|Valsartan|valsartan
1258682|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
1258683|NCT01767285|Etonogestrel Implant|etonogestrel implant
1258684|NCT01767285|Implanon|implanon
1258685|NCT01767285|Nexplanon|nexplanon
1258686|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
1258687|NCT01767272|Fexofenadine|fexofenadine
1258688|NCT01767272|Pharmacokinetics|pharmacokinetics
1258689|NCT01767272|Bioavailability|bioavailability
1258690|NCT01767272|Linearity|linearity
1258691|NCT01767272|HPLC|hplc
1258692|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
1258693|NCT01767259|Fixed dose combination|fixed dose combination
1258694|NCT01767259|Pharmacokinetics|pharmacokinetics
1258695|NCT01767259|Valsartan|valsartan
1258696|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
1258697|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
1258698|NCT01767233|ERCP|ercp
1258699|NCT01767233|Pancreatic stenting|pancreatic stenting
1258700|NCT01767220|ventricular tachycardia|ventricular tachycardia
1258701|NCT01767220|endocardial ablation|endocardial ablation
1258702|NCT01767220|epicardial ablation|epicardial ablation
1258703|NCT01767181|Light therapy|light therapy
1258704|NCT01767181|physical exercise|physical exercise
1258705|NCT01767181|night shift workers|night shift workers
1258706|NCT01767181|genetic markers|genetic markers
1258707|NCT01767181|PBMCs|pbmcs
1258708|NCT01767142|Lipolysis|lipolysis
1258709|NCT01767142|Cryolipolysis|cryolipolysis
1258710|NCT01767142|Fat Reduction|fat reduction
1258711|NCT01767129|levodopa|levodopa
1258712|NCT01767129|dyskinesia|dyskinesia
1258713|NCT01767129|parkinson's disease|parkinson's disease
1258714|NCT01767129|AVP-923|avp-923
1258715|NCT01767129|dextromethorphan|dextromethorphan
1258716|NCT01767129|quinidine|quinidine
1258717|NCT01767116|Interferon-Free|interferon-free
1258718|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
1258719|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
1258720|NCT01767116|Hepatitis C Virus|hepatitis c virus
1258721|NCT01767116|Hepatitis C|hepatitis c
1258722|NCT01767116|Treatment-Naive|treatment-naive
1258723|NCT01767116|Paritaprevir|paritaprevir
1258724|NCT01767116|Ombitasvir|ombitasvir
1258725|NCT01767116|Dasabuvir|dasabuvir
1258726|NCT01767116|Viekira PAK|viekira pak
1258727|NCT01767116|Ribavirin|ribavirin
1258728|NCT01767103|Hepatic Impairment|hepatic impairment
1258729|NCT01767103|Liver Impairment|liver impairment
1258730|NCT01767103|Liver Disease|liver disease
1258731|NCT01767103|Ferriprox®|ferriprox®
1258732|NCT01767103|LI|li
1258733|NCT01767103|DFP|dfp
1258734|NCT01767103|Deferiprone|deferiprone
1258735|NCT01767090|Endometriosis|endometriosis
1258736|NCT01767090|ASP1707|asp1707
1258737|NCT01767090|Pelvic pain|pelvic pain
1258738|NCT01767090|Double-blind|double-blind
1258739|NCT01767090|Placebo-controlled|placebo-controlled
1258740|NCT01767090|Phase 2|phase 2
1258741|NCT01767077|Saturated fat|saturated fat
1258742|NCT01767077|Dairy products|dairy products
1258743|NCT01767077|Milk fat globule membrane|milk fat globule membrane
1258744|NCT01767077|Cholesterol|cholesterol
1258745|NCT01767077|Butter|butter
1258746|NCT01767077|Cream|cream
1258747|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
1258748|NCT01767051|PCOS|pcos
1258749|NCT01767051|Children|children
1258750|NCT01767051|Cardiovascular|cardiovascular
1258751|NCT01767051|Follow-up|follow-up
1258752|NCT01767025|Influence|influence
1258753|NCT01767025|oxytocin|oxytocin
1258754|NCT01767025|automatic imitation|automatic imitation
1258755|NCT01767025|behaviour|behaviour
1258756|NCT01767025|volunteers|volunteers
1258757|NCT01766999|pulse oximetry|pulse oximetry
1258758|NCT01766999|tumescent anesthesia|tumescent anesthesia
1258759|NCT01766960|Bile acids|bile acids
1258760|NCT01766960|Pharmacokinetics|pharmacokinetics
1258761|NCT01766947|Glaucoma|glaucoma
1258762|NCT01766947|Deep sclerectomy|deep sclerectomy
1258763|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
1258764|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
1258765|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
1258766|NCT01766934|filgrastim|filgrastim
1258767|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
1258768|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
1258769|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
1258770|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
1258771|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
1258772|NCT01766895|uremia|uremia
1258773|NCT01766895|HBV|hbv
1258774|NCT01766895|HCV|hcv
1258775|NCT01766895|seroclearance|seroclearance
1258776|NCT01766882|Hemodialysis|hemodialysis
1258777|NCT01766882|Blood Pressure|blood pressure
1258778|NCT01766882|Hydration Status|hydration status
1258779|NCT01766882|Low-sodium diet|low-sodium diet
1258780|NCT01766869|Prostate Cancer|prostate cancer
1258781|NCT01766869|MRI/MRS|mri/mrs
1258782|NCT01766856|perforation|perforation
1258783|NCT01766856|tympanoplasty|tympanoplasty
1258784|NCT01766856|myringoplasty|myringoplasty
1258785|NCT01766856|Eustachian tube function|eustachian tube function
1258786|NCT01766856|tympanostomy tube|tympanostomy tube
1258787|NCT01766817|IPF|ipf
1258788|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1258789|NCT01766804|Bovine Colostrum|bovine colostrum
1258790|NCT01766804|Inflammation|inflammation
1258791|NCT01766804|Infection|infection
1258792|NCT01766804|Toxicity|toxicity
1258793|NCT01766791|resistance exercise|resistance exercise
1258794|NCT01766791|muscle mass|muscle mass
1258795|NCT01766791|abdominal fat|abdominal fat
1258796|NCT01766791|strength|strength
1258797|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
1258798|NCT01766791|myocardial mass|myocardial mass
1258799|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
1258800|NCT01766739|GL-ONC1|gl-onc1
1258801|NCT01766739|pleural effusion|pleural effusion
1258802|NCT01766739|12-169|12-169
1258803|NCT01766726|HIV|hiv
1258804|NCT01766726|Atherosclerosis|atherosclerosis
1258805|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
1258806|NCT01766687|Chronic Kidney Disease|chronic kidney disease
1258807|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
1258808|NCT01766687|water intake|water intake
1258809|NCT01766687|fluid intake|fluid intake
1258810|NCT01766687|renal decline|renal decline
1258811|NCT01766674|Kyphosis|kyphosis
1258812|NCT01766648|Distal|distal
1258813|NCT01766648|Femur|femur
1258814|NCT01766648|Locking|locking
1258815|NCT01766648|Screw|screw
1258816|NCT01766648|Fracture|fracture
1258817|NCT01766648|Healing|healing
1258818|NCT01766622|Apoptosis|apoptosis
1258819|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
1258820|NCT01766622|PET Imaging|pet imaging
1258821|NCT01766622|TL32711|tl32711
1258822|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
1258823|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
1258824|NCT01766596|Ophthalmology|ophthalmology
1258825|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
1258826|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
1258827|NCT01766570|insulin sensitivity,|insulin sensitivity,
1258828|NCT01766570|glucose tolerance,|glucose tolerance,
1258829|NCT01766570|inflammatory markers,|inflammatory markers,
1258830|NCT01766570|lipid profile,|lipid profile,
1258831|NCT01766570|oxidative stress,|oxidative stress,
1258832|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
1258833|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
1258834|NCT01766544|asthma|asthma
1258835|NCT01766544|COPD|copd
1258836|NCT01766544|guidelines|guidelines
1258837|NCT01766544|knowledge transfer|knowledge transfer
1258838|NCT01766544|medical education|medical education
1258839|NCT01766544|care gaps|care gaps
1258840|NCT01766531|Bioelectrical impedance|bioelectrical impedance
1258841|NCT01766531|Nutrition|nutrition
1258842|NCT01766531|Phase angle|phase angle
1258843|NCT01766531|ICU patients|icu patients
1258844|NCT01766518|liver transplantation|liver transplantation
1258845|NCT01766518|LT|lt
1258846|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
1258847|NCT01766518|MMF|mmf
1258848|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
1258849|NCT01766492|prostate cancer|prostate cancer
1258850|NCT01766492|CyberKnife|cyberknife
1258851|NCT01766479|Colorectal cancer|colorectal cancer
1258852|NCT01766479|colorectal neoplasia|colorectal neoplasia
1258853|NCT01766479|CT colonography|ct colonography
1258854|NCT01766479|advanced neoplasia|advanced neoplasia
1258855|NCT01766479|colonoscopy|colonoscopy
1258856|NCT01766479|family history|family history
1258857|NCT01766453|South Asian|south asian
1258858|NCT01766453|Cardiovascular|cardiovascular
1258859|NCT01766453|Exercise|exercise
1258860|NCT01766453|Obesity|obesity
1258861|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
1258862|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
1258863|NCT01766401|GAD|gad
1258864|NCT01766375|idarubicin|idarubicin
1258865|NCT01766375|busulfan|busulfan
1258866|NCT01766375|cyclophosphamide|cyclophosphamide
1258867|NCT01766375|pretreatment|pretreatment
1258868|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
1258869|NCT01766349|Esophageal cancer|esophageal cancer
1259073|NCT01765465|Rowachol|rowachol
1258870|NCT01766349|Respiratory muscle strength|respiratory muscle strength
1258871|NCT01766349|Pulmonary function testing|pulmonary function testing
1258872|NCT01766349|Functional exercise capacity|functional exercise capacity
1258873|NCT01766336|Agitation|agitation
1258874|NCT01766336|Aggression|aggression
1258875|NCT01766336|AD patients|ad patients
1258876|NCT01766323|Morphine|morphine
1258877|NCT01766323|Palliation|palliation
1258879|NCT01766323|Hospice|hospice
1258880|NCT01766323|Sleepiness|sleepiness
1258881|NCT01766323|Modafinil|modafinil
1258882|NCT01766310|Folic acid|folic acid
1258883|NCT01766310|Folate|folate
1258884|NCT01766310|Homocysteine|homocysteine
1258885|NCT01766310|Obese|obese
1258886|NCT01766310|Children|children
1258887|NCT01766297|Breast Cancer|breast cancer
1258888|NCT01766297|Proton|proton
1258889|NCT01766297|Radiation|radiation
1258890|NCT01766284|Human Papillomavirus|human papillomavirus
1258891|NCT01766284|Optical Coherence Tomography|optical coherence tomography
1258892|NCT01766284|Imaging Systems|imaging systems
1258893|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1258894|NCT01766284|Cervical Cancer|cervical cancer
1258895|NCT01766284|Cervical Dysplasia|cervical dysplasia
1258896|NCT01766271|Coronary heart disease|coronary heart disease
1258897|NCT01766271|cardiovascular disease|cardiovascular disease
1258898|NCT01766271|risk|risk
1258899|NCT01766258|Parkinson's Disease|parkinson's disease
1258900|NCT01766258|Motor-fluctuation|motor-fluctuation
1258901|NCT01766258|Wearing-off|wearing-off
1258902|NCT01766245|mm|mm
1258903|NCT01766206|conjugate vaccine|conjugate vaccine
1258904|NCT01766206|phase IV clinical trial|phase iv clinical trial
1258905|NCT01766206|Neisseria meningitidis|neisseria meningitidis
1258906|NCT01766193|Delivery, obstetric|delivery, obstetric
1258907|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
1258908|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
1258909|NCT01766193|Cesarean Section|cesarean section
1258910|NCT01766193|Obstetrical Forceps|obstetrical forceps
1258911|NCT01766193|Epidemiology|epidemiology
1258912|NCT01766193|Norway|norway
1258913|NCT01766180|Memory|memory
1258914|NCT01766180|Fruitflow|fruitflow
1258915|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
1258916|NCT01766180|Cerebral blood flow|cerebral blood flow
1258917|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
1258918|NCT01766180|Maximal VO2|maximal vo2
1258919|NCT01766167|Genotype 2|genotype 2
1258920|NCT01766154|tirofiban|tirofiban
1258921|NCT01766154|pharmacokinetic|pharmacokinetic
1258922|NCT01766154|renal insufficiency|renal insufficiency
1258923|NCT01766154|Phase 1|phase 1
1258924|NCT01766154|pharmacodynamic|pharmacodynamic
1258925|NCT01766141|Spinal manipulation|spinal manipulation
1258926|NCT01766141|Tumor necrosis factor|tumor necrosis factor
1258927|NCT01766141|Interleukin 1|interleukin 1
1258928|NCT01766141|Interleukin 10|interleukin 10
1258929|NCT01766141|Inflammatory cytokines|inflammatory cytokines
1258930|NCT01766128|Parkinson disease|parkinson disease
1258931|NCT01766128|Early stage|early stage
1258932|NCT01766128|Zonisamide|zonisamide
1258933|NCT01766128|UPDRS|updrs
1258934|NCT01766115|HCV|hcv
1258935|NCT01766115|needlestick|needlestick
1258936|NCT01766115|occupational|occupational
1258937|NCT01766115|transmission|transmission
1258938|NCT01766115|health care worker|health care worker
1258939|NCT01766115|telaprevir|telaprevir
1258940|NCT01766102|Mammography|mammography
1258941|NCT01766089|Caesarean delivery|caesarean delivery
1258942|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
1258943|NCT01766089|remifentanil|remifentanil
1258944|NCT01766089|dexmedetomidine|dexmedetomidine
1258945|NCT01766089|cardiovascular response|cardiovascular response
1258946|NCT01766076|immune activation|immune activation
1258947|NCT01766076|antiretroviral therapy|antiretroviral therapy
1258948|NCT01766076|atorvastatin|atorvastatin
1258949|NCT01766076|immune exhaustion|immune exhaustion
1258950|NCT01766076|adults|adults
1258951|NCT01766076|Africa|africa
1258952|NCT01766063|Multiple Sclerosis|multiple sclerosis
1258953|NCT01766063|Sleep|sleep
1258954|NCT01766063|Quality of life|quality of life
1258955|NCT01766063|Observational study|observational study
1258956|NCT01766037|obesity|obesity
1258957|NCT01766037|obese|obese
1258958|NCT01766037|weight loss|weight loss
1258959|NCT01766024|interferon beta-1a|interferon beta-1a
1258960|NCT01766024|pharmacokinetics|pharmacokinetics
1258961|NCT01766024|pharmacodynamics|pharmacodynamics
1258962|NCT01766024|volunteers|volunteers
1259062|NCT01765530|Microbial Diversity|microbial diversity
1258963|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
1258964|NCT01765985|palmoplantar|palmoplantar
1258965|NCT01765959|Insomnia|insomnia
1258966|NCT01765959|Auricular acupuncture|auricular acupuncture
1258967|NCT01765959|CBT|cbt
1258968|NCT01765946|Insulin resistance|insulin resistance
1258969|NCT01765946|Prediabetes|prediabetes
1258970|NCT01765946|Longevity genes|longevity genes
1258971|NCT01765946|Inflammation|inflammation
1258972|NCT01765946|Metformin|metformin
1258973|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
1258974|NCT01765894|glucose homeostasis|glucose homeostasis
1258975|NCT01765894|endogenous glucose production|endogenous glucose production
1351092|NCT01370954|NAC|nac
1258976|NCT01765894|moderate exercise|moderate exercise
1258977|NCT01765894|type 2 diabetes|type 2 diabetes
1258978|NCT01765894|metformin|metformin
1258979|NCT01765881|Induction of labor|induction of labor
1258980|NCT01765881|cervical ripening|cervical ripening
1258981|NCT01765881|misoprostol,|misoprostol,
1258982|NCT01765881|prostaglandin|prostaglandin
1258983|NCT01765881|cost-effectiveness|cost-effectiveness
1258984|NCT01765868|Betrixaban|betrixaban
1258985|NCT01765868|Healthy|healthy
1258986|NCT01765868|Bioavailability|bioavailability
1258987|NCT01765855|Betrixaban|betrixaban
1258988|NCT01765855|Healthy|healthy
1258989|NCT01765855|Mass Balance|mass balance
1258990|NCT01765842|Lupus Nephritis|lupus nephritis
1258991|NCT01765842|remission|remission
1258992|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
1258993|NCT01765829|Non Affective Psychosis|non affective psychosis
1258994|NCT01765829|First episode|first episode
1258995|NCT01765829|Discontinuation scheme|discontinuation scheme
1258996|NCT01765816|Exercise|exercise
1258997|NCT01765816|Elderly|elderly
1258998|NCT01765816|Blood volume|blood volume
1258999|NCT01765816|Hemoglobin|hemoglobin
1259000|NCT01765803|Mellaril|mellaril
1259001|NCT01765803|Thioridazine|thioridazine
1259002|NCT01765803|CD34+|cd34+
1259003|NCT01765803|Stem cells|stem cells
1259004|NCT01765803|Progenitor cells|progenitor cells
1259005|NCT01765803|Peripheral blood|peripheral blood
1259006|NCT01765803|mobilization|mobilization
1259007|NCT01765803|circulation|circulation
1259008|NCT01765777|Low back pain|low back pain
1259009|NCT01765777|Lower back pain|lower back pain
1259010|NCT01765777|Chronic back pain|chronic back pain
1259011|NCT01765751|Cervical pain|cervical pain
1259012|NCT01765751|Neck pain|neck pain
1259013|NCT01765751|Arm pain|arm pain
1259014|NCT01765738|PICC|picc
1259015|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
1259016|NCT01765725|Coping|coping
1259017|NCT01765725|Patient education|patient education
1259018|NCT01765712|PRP|prp
1259019|NCT01765712|BPTB|bptb
1259020|NCT01765712|VAS|vas
1259021|NCT01765712|Anterior Knee Pain|anterior knee pain
1259022|NCT01765673|Swallowing|swallowing
1259023|NCT01765673|Stroke|stroke
1259024|NCT01765673|Sensory stimulation|sensory stimulation
1259025|NCT01765673|Home based therapy|home based therapy
1259026|NCT01765673|Head and Neck Cancer|head and neck cancer
1259027|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1259028|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
1259029|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
1259030|NCT01765647|Celiac disease|celiac disease
1259031|NCT01765647|AGY|agy
1259032|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1259033|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
1259034|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
1259035|NCT01765621|health care expenditure|health care expenditure
1259036|NCT01765621|drug drug interactions|drug drug interactions
1259037|NCT01765621|electronic decision support systems|electronic decision support systems
1259038|NCT01765621|pharmacogenetics|pharmacogenetics
1259039|NCT01765621|Potential Reduction|potential reduction
1259040|NCT01765608|Zonisamide|zonisamide
1259041|NCT01765608|Zonegran|zonegran
1259042|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
1259043|NCT01765608|Apnea|apnea
1259044|NCT01765608|Respiration Disorders|respiration disorders
1259045|NCT01765608|Sleep Disorders|sleep disorders
1259046|NCT01765608|Obesity|obesity
1259047|NCT01765608|Anti-Obesity Agents|anti-obesity agents
1259048|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
1259049|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
1259050|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
1259051|NCT01765608|Sulfonamides|sulfonamides
1259052|NCT01765608|Therapeutic Uses|therapeutic uses
1259053|NCT01765608|Pharmacologic Actions|pharmacologic actions
1259054|NCT01765595|health care expenditure|health care expenditure
1259055|NCT01765595|drug drug interactions|drug drug interactions
1259056|NCT01765595|electronic decision support systems|electronic decision support systems
1259057|NCT01765595|Potential reduction|potential reduction
1259058|NCT01765530|Medical Devices|medical devices
1259059|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
1259060|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
1259061|NCT01765530|Endotracheal Tube|endotracheal tube
1259063|NCT01765530|Anti-Resistance|anti-resistance
1259064|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
1259065|NCT01765517|Diabetes Mellitus|diabetes mellitus
1259066|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
1259067|NCT01765491|colonoscopy|colonoscopy
1259068|NCT01765491|bowel preparation|bowel preparation
1259069|NCT01765491|polyethylene glycol|polyethylene glycol
1259070|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
1259071|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
1333174|NCT01444183|seizures|seizures
1259072|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1259074|NCT01765439|bile acids|bile acids
1259075|NCT01765439|metabolism|metabolism
1259076|NCT01765439|probiotics|probiotics
1259077|NCT01765426|Prophylactic vaccination|prophylactic vaccination
1259078|NCT01765413|To identify|to identify
1259079|NCT01765413|biomarkers|biomarkers
1259080|NCT01765413|of vaccine safety|of vaccine safety
1259081|NCT01765413|Volunteers|volunteers
1259082|NCT01765400|Heart failure|heart failure
1259083|NCT01765400|Antiplatelet therapy|antiplatelet therapy
1259084|NCT01765400|Platelet aggregation|platelet aggregation
1259085|NCT01765400|Clopidogrel|clopidogrel
1259086|NCT01765400|Prasugrel|prasugrel
1259087|NCT01765387|Spatherpy|spatherpy
1259088|NCT01765387|Aerobic exercise|aerobic exercise
1259089|NCT01765374|rituximab|rituximab
1259090|NCT01765374|sonography|sonography
1259091|NCT01765374|clinical response|clinical response
1259092|NCT01765348|language impairment|language impairment
1259093|NCT01765348|language disorders|language disorders
1259094|NCT01765348|syntax treatment|syntax treatment
1259095|NCT01765348|narrative-based treatment|narrative-based treatment
1259096|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
1259097|NCT01765309|Tissue expanders|tissue expanders
1259098|NCT01765309|Botulinum toxin|botulinum toxin
1259099|NCT01765309|Botox|botox
1259100|NCT01765283|CN,|cn,
1259101|NCT01765283|UCD|ucd
1259102|NCT01765270|Diabetes|diabetes
1259103|NCT01765270|Diabetes Mellitus|diabetes mellitus
1259104|NCT01765270|Type 2 Diabetes|type 2 diabetes
1259105|NCT01765270|Cardiovascular Disease|cardiovascular disease
1259106|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1259107|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
1259108|NCT01765257|Apathy|apathy
1259109|NCT01765257|Rasagiline|rasagiline
1259110|NCT01765244|Corneal trophic ulcers, limbal deficiency, cornea blindness|corneal trophic ulcers, limbal deficiency, cornea blindness
1259111|NCT01765231|Lymphoma|lymphoma
1259112|NCT01765231|Hepatitis B virus|hepatitis b virus
1259113|NCT01765231|Therapeutic Uses|therapeutic uses
1259114|NCT01765231|Antiviral Agents|antiviral agents
1259115|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1259116|NCT01765218|HIE|hie
1259117|NCT01765218|Perinatal depression|perinatal depression
1259118|NCT01765218|Whole body cooling|whole body cooling
1259119|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
1259120|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
1259121|NCT01765205|newborn|newborn
1259122|NCT01765192|Drug therapy|drug therapy
1259123|NCT01765179|testosterone|testosterone
1259124|NCT01765179|male hypogonadism|male hypogonadism
1259125|NCT01765179|low testosterone|low testosterone
1259126|NCT01765166|Social Skill Training|social skill training
1259127|NCT01765166|Social Interaction|social interaction
1259128|NCT01765166|Peer relations|peer relations
1259129|NCT01765153|physical therapy|physical therapy
1259130|NCT01765153|rehabilitation|rehabilitation
1259131|NCT01765153|neuroplasticity|neuroplasticity
1259132|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
1259133|NCT01765101|knee osteoarthritis|knee osteoarthritis
1259134|NCT01765101|therapeutic effect|therapeutic effect
1259135|NCT01765101|insole|insole
1259136|NCT01765088|High-grade glioma|high-grade glioma
1259137|NCT01765088|chemotherapy|chemotherapy
1259138|NCT01765088|Temozolomide|temozolomide
1259139|NCT01765088|Interferon-alpha|interferon-alpha
1259140|NCT01765075|Electrophysiological mapping|electrophysiological mapping
1259141|NCT01765075|Multi-electrode catheter|multi-electrode catheter
1259142|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
1259143|NCT01765062|Cross bite|cross bite
1259144|NCT01765062|Haas appliance|haas appliance
1259145|NCT01765062|Lateral cephalograms|lateral cephalograms
1259146|NCT01765049|breast density change|breast density change
1259147|NCT01765049|endocrine therapy response|endocrine therapy response
1259148|NCT01765049|aromatase inhibitor|aromatase inhibitor
1259149|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
1259150|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1259151|NCT01765010|Vitamin D|vitamin d
1259152|NCT01765010|Serum sclerostin|serum sclerostin
1259153|NCT01765010|Serum dickkopf1|serum dickkopf1
1259154|NCT01764984|total knee arthroplasty|total knee arthroplasty
1259155|NCT01764984|trabecular metal|trabecular metal
1259156|NCT01764984|bone mineral density|bone mineral density
1259157|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
1259365|NCT01764035|Mindfulness|mindfulness
1259158|NCT01764958|mother-infant interaction|mother-infant interaction
1259159|NCT01764958|general movements|general movements
1259160|NCT01764958|preterm infants|preterm infants
1259161|NCT01764893|Overactive Bladder|overactive bladder
1259162|NCT01764880|Heparanase inhibitor|heparanase inhibitor
1259163|NCT01764880|Multiple myeloma|multiple myeloma
1259164|NCT01764867|major depressive disorder|major depressive disorder
1259165|NCT01764867|algorithm guided treatment|algorithm guided treatment
1259166|NCT01764867|treatment as usual|treatment as usual
1259167|NCT01764867|escitalopram|escitalopram
1259168|NCT01764867|mirtazapine|mirtazapine
1259169|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
1259170|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
1259171|NCT01764867|remission|remission
1259172|NCT01764867|relapse|relapse
1259173|NCT01764867|quality of life|quality of life
1259174|NCT01764854|Hemodialysis|hemodialysis
1259175|NCT01764841|Ciprofloxacin|ciprofloxacin
1259176|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
1259177|NCT01764841|Exacerbation|exacerbation
1259178|NCT01764841|Bronchiectasis|bronchiectasis
1259179|NCT01764828|Phase I|phase i
1259180|NCT01764828|Pharmacokinetics|pharmacokinetics
1259181|NCT01764828|Safety measurements|safety measurements
1259182|NCT01764802|Psychosexual Intervention|psychosexual intervention
1259183|NCT01764802|Cancer|cancer
1259184|NCT01764802|Gynecologic Cancer|gynecologic cancer
1259185|NCT01764802|Breast Cancer|breast cancer
1259186|NCT01764789|psychological intervention|psychological intervention
1259187|NCT01764789|breast cancer|breast cancer
1259188|NCT01764789|gynecologic cancer|gynecologic cancer
1259189|NCT01764776|LDE225|lde225
1259190|NCT01764776|Pharmacokinetics|pharmacokinetics
1259191|NCT01764776|PK|pk
1259192|NCT01764776|Postmenopausal women|postmenopausal women
1259193|NCT01764776|normal hepatic function|normal hepatic function
1259194|NCT01764776|mild hepatic impairment|mild hepatic impairment
1259195|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
1259196|NCT01764776|severe hepatic impairment|severe hepatic impairment
1259197|NCT01764750|Intrasite|intrasite
1259198|NCT01764750|Antibiotic|antibiotic
1259199|NCT01764750|Vancomycin|vancomycin
1259200|NCT01764750|Infection|infection
1259201|NCT01764750|Pharmacokinetics|pharmacokinetics
1259202|NCT01764737|VX15/2503|vx15/2503
1259203|NCT01764737|Semaphorin 4D|semaphorin 4d
1259204|NCT01764737|SEMA4D|sema4d
1259205|NCT01764737|CD100|cd100
1259206|NCT01764737|safety|safety
1259207|NCT01764737|tolerability|tolerability
1259208|NCT01764737|pharmacokinetics|pharmacokinetics
1259209|NCT01764737|immunogenicity|immunogenicity
1259210|NCT01764737|multiple sclerosis|multiple sclerosis
1259211|NCT01764737|monoclonal antibody|monoclonal antibody
1259212|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
1259213|NCT01764724|General canadian population|general canadian population
1259214|NCT01764711|POTS|pots
1259215|NCT01764698|anxiety disorders|anxiety disorders
1259216|NCT01764698|substance use disorders|substance use disorders
1259217|NCT01764698|treatment effectiveness|treatment effectiveness
1259218|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
1259219|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1259220|NCT01764672|Healthy Adults|healthy adults
1259221|NCT01764672|Methylphenidate|methylphenidate
1259222|NCT01764672|Functional connectivity|functional connectivity
1259223|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1259224|NCT01764659|4D-CT|4d-ct
1259225|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
1259226|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
1259227|NCT01764646|Prostate cancer|prostate cancer
1259228|NCT01764646|Radiation therapy|radiation therapy
1259229|NCT01764633|High cholesterol|high cholesterol
1259230|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
1259231|NCT01764633|Lowering cholesterol|lowering cholesterol
1259232|NCT01764633|Lowering high cholesterol|lowering high cholesterol
1259233|NCT01764633|Hypercholesterolemia|hypercholesterolemia
1259234|NCT01764620|shoulder|shoulder
1259235|NCT01764620|muscle fatigue|muscle fatigue
1259236|NCT01764620|kinematics|kinematics
1259237|NCT01764620|athletes|athletes
1259238|NCT01764607|Squamous|squamous
1259239|NCT01764607|Renal|renal
1259240|NCT01764607|Transplant|transplant
1259241|NCT01764594|Lupus|lupus
1259242|NCT01764594|SLE|sle
1259243|NCT01764581|immune monitoring|immune monitoring
1259244|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
1259245|NCT01764581|randomized controlled trial|randomized controlled trial
1259246|NCT01764581|immunosuppression management|immunosuppression management
1259247|NCT01764581|infection|infection
1259248|NCT01764581|rejection|rejection
1259249|NCT01764581|liver transplantation|liver transplantation
1259250|NCT01764581|Cylex|cylex
1259251|NCT01764568|Metacognitive training|metacognitive training
1259252|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
1259253|NCT01764568|Clinical trial|clinical trial
1259254|NCT01764568|Group intervention|group intervention
1259255|NCT01764568|Group therapy|group therapy
1259256|NCT01764568|Schizophrenia|schizophrenia
1259257|NCT01764568|Psychosis|psychosis
1259258|NCT01764568|Cognitive remediation|cognitive remediation
1259259|NCT01764542|Ulcerative colitis|ulcerative colitis
1259260|NCT01764542|dysplasia|dysplasia
1259261|NCT01764542|risk factor|risk factor
1259262|NCT01764542|surgery|surgery
1259263|NCT01764516|zinc|zinc
1259264|NCT01764516|selenium|selenium
1259265|NCT01764516|serum|serum
1259266|NCT01764516|epilepsy|epilepsy
1259267|NCT01764516|antioxidants|antioxidants
1259268|NCT01764503|ampullary tumors|ampullary tumors
1259269|NCT01764503|endoscopic treatment|endoscopic treatment
1259271|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
1259273|NCT01764425|P7435|p7435
1259274|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
1259275|NCT01764425|Single ascending dose|single ascending dose
1259276|NCT01764425|Multiple ascending dose|multiple ascending dose
1259277|NCT01764425|Pharmacokinetics|pharmacokinetics
1259278|NCT01764412|Healthy women|healthy women
1259279|NCT01764412|Menstrual cycle|menstrual cycle
1259280|NCT01764412|Hepcidin|hepcidin
1259281|NCT01764412|Seric iron|seric iron
1259282|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
1259283|NCT01764386|obesity, overweight|obesity, overweight
1259284|NCT01764373|Pain|pain
1259285|NCT01764373|Fitness|fitness
1259286|NCT01764373|Diabetes|diabetes
1259287|NCT01764373|Aerobic Exercise|aerobic exercise
1259288|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
1259289|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
1259290|NCT01764334|Coronary angiogram|coronary angiogram
1259291|NCT01764334|Diagnosis|diagnosis
1259292|NCT01764334|Coronary revascularization|coronary revascularization
1259293|NCT01764334|Prognosis|prognosis
1259294|NCT01764334|Health economics|health economics
1259300|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
1259301|NCT01764282|HIV|hiv
1259302|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
1259303|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
1259304|NCT01764282|intervention|intervention
1259305|NCT01764256|rotavirus|rotavirus
1259306|NCT01764256|vaccine|vaccine
1259307|NCT01764243|Alzheimer's Disease|alzheimer's disease
1259308|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
1259309|NCT01764243|Cognitive function|cognitive function
1259310|NCT01764243|Dementia|dementia
1259311|NCT01764243|Central Nervous System Agents|central nervous system agents
1259312|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
1259313|NCT01764230|Hodgkin disease|hodgkin disease
1259314|NCT01764217|Cervix Cancer|cervix cancer
1259315|NCT01764217|SUV|suv
1259316|NCT01764217|Radiotherapy|radiotherapy
1259317|NCT01764217|Outcome Prediction|outcome prediction
1259318|NCT01764217|Imaging|imaging
1259319|NCT01764217|PET|pet
1259320|NCT01764178|Pitavastatin|pitavastatin
1259321|NCT01764178|Valsartan|valsartan
1259322|NCT01764165|COPD|copd
1259323|NCT01764165|Sleep|sleep
1259324|NCT01764165|Supplemental oxygen|supplemental oxygen
1259325|NCT01764165|Breathing mechanics|breathing mechanics
1259326|NCT01764165|nasal insufflation|nasal insufflation
1259327|NCT01764152|Prevention,|prevention,
1259328|NCT01764152|influenza,|influenza,
1259329|NCT01764152|adults hospitalized,|adults hospitalized,
1259330|NCT01764152|vaccines,|vaccines,
1259331|NCT01764152|Effectiveness|effectiveness
1259332|NCT01764139|Minimal knee changes|minimal knee changes
1259333|NCT01764126|Safety|safety
1259334|NCT01764126|immunogenicity|immunogenicity
1259335|NCT01764126|pneumococcal|pneumococcal
1259336|NCT01764126|protein|protein
1259337|NCT01764126|vaccine|vaccine
1259338|NCT01764113|Obesity|obesity
1259339|NCT01764113|Adolescence|adolescence
1259340|NCT01764113|Mindful Eating|mindful eating
1259341|NCT01764087|Stomach Neoplasms|stomach neoplasms
1259342|NCT01764087|Breast Neoplasms|breast neoplasms
1259343|NCT01764087|Carcinoma|carcinoma
1259344|NCT01764087|Neoplasms|neoplasms
1259345|NCT01764087|Paclitaxel|paclitaxel
1259346|NCT01764087|Tubulin Modulators|tubulin modulators
1259347|NCT01764087|Antimitotic Agents|antimitotic agents
1259348|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
1259349|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
1259350|NCT01764087|Pharmacologic Actions|pharmacologic actions
1259351|NCT01764074|Bipolar Disorder|bipolar disorder
1259352|NCT01764074|Sleep Intervention|sleep intervention
1259353|NCT01764074|Suicide|suicide
1259354|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
1259355|NCT01764074|Sleep Quality|sleep quality
1259356|NCT01764061|Red Cells|red cells
1259357|NCT01764061|Blood donors|blood donors
1259358|NCT01764048|pain management|pain management
1259359|NCT01764048|cesarean section|cesarean section
1259360|NCT01764035|Psychotherapy|psychotherapy
1259361|NCT01764035|Bipolar Disorder|bipolar disorder
1259362|NCT01764035|Sleep Problems|sleep problems
1259363|NCT01764035|Insomnia|insomnia
1259364|NCT01764035|Hypersomnia|hypersomnia
1259366|NCT01764035|Meditation|meditation
1259367|NCT01764035|Sleep Disturbance|sleep disturbance
1259368|NCT01764022|breast cancer|breast cancer
1259369|NCT01764022|trastuzumab|trastuzumab
1259370|NCT01764009|Advanced Melanoma|advanced melanoma
1259371|NCT01764009|Metastatic Melanoma|metastatic melanoma
1259372|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
1259373|NCT01763996|Drug therapy|drug therapy
1259374|NCT01763983|Multiple Sclerosis|multiple sclerosis
1259375|NCT01763983|Stress, Psychological|stress, psychological
1259376|NCT01763983|Psychological Stress|psychological stress
1259377|NCT01763983|Emotional Stress|emotional stress
1259378|NCT01763983|Cognitive Deficits|cognitive deficits
1259379|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
1259380|NCT01763970|Stereotactic|stereotactic
1259381|NCT01763970|Radiotherapy|radiotherapy
1259382|NCT01763970|Hypofractionated|hypofractionated
1259383|NCT01763944|diet|diet
1259384|NCT01763944|prostate cancer|prostate cancer
1259385|NCT01763944|carbohydrate|carbohydrate
1259386|NCT01763944|lifestyle|lifestyle
1259387|NCT01763931|Digoxin|digoxin
1259388|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
1259389|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
1259390|NCT01763892|Pediatric|pediatric
1259391|NCT01763892|Traumatic Brain Injury|traumatic brain injury
1259392|NCT01763892|TBI|tbi
1259393|NCT01763892|Apolipoprotein E|apolipoprotein e
1259394|NCT01763892|apo-E|apo-e
1259395|NCT01763892|Vasospasm|vasospasm
1259396|NCT01763892|Genetics|genetics
1259397|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
1259398|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
1259399|NCT01763892|Endothelin 1|endothelin 1
1259400|NCT01763879|Thoracic surgery|thoracic surgery
1259401|NCT01763879|one lung ventilation|one lung ventilation
1259402|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
1259403|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
1259404|NCT01763879|right ventricular function|right ventricular function
1259405|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
1259406|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1259407|NCT01763853|Pulmonary edema|pulmonary edema
1259408|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
1259409|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
1259410|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
1259411|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
1259412|NCT01763853|Hypovolemia|hypovolemia
1259413|NCT01763853|Crystalloid|crystalloid
1259414|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
1259415|NCT01763853|Intensive care unit|intensive care unit
1259416|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
1259417|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
1259418|NCT01763801|chemo port|chemo port
1259419|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
1259420|NCT01763801|P maximal wave|p maximal wave
1259421|NCT01763801|P submaximal wave|p submaximal wave
1259422|NCT01763801|catheter tip|catheter tip
1259423|NCT01763775|weight|weight
1259424|NCT01763775|total body water|total body water
1259425|NCT01763775|body fat|body fat
1259426|NCT01763775|muscle mass|muscle mass
1259427|NCT01763775|bone mass|bone mass
1259428|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
1259429|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
1259430|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
1259431|NCT01763762|Stress urinary incontinence|stress urinary incontinence
1259432|NCT01763762|Comparative study|comparative study
1259433|NCT01763723|Intense pulsed light,|intense pulsed light,
1259434|NCT01763723|UV-exposure,|uv-exposure,
1259435|NCT01763723|skin type,|skin type,
1259436|NCT01763723|safety,|safety,
1259437|NCT01763723|pigment,|pigment,
1259438|NCT01763723|home-use|home-use
1259439|NCT01763723|subjects|subjects
1259440|NCT01763710|Breast cancer|breast cancer
1259441|NCT01763710|Neurotoxicity|neurotoxicity
1259442|NCT01763697|Taste acuity|taste acuity
1259443|NCT01763697|Feeding behavior|feeding behavior
1259444|NCT01763697|opioid|opioid
1259445|NCT01763697|Quantitative assessment|quantitative assessment
1259446|NCT01763684|Osteoarthritis|osteoarthritis
1259447|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
1259448|NCT01763684|Osteonecrosis|osteonecrosis
1259449|NCT01763684|Arthritis|arthritis
1259450|NCT01763684|Knee Arthritis|knee arthritis
1259451|NCT01763684|Knee Replacement|knee replacement
1259452|NCT01763671|Lung cancer|lung cancer
1259453|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
1259454|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
1259456|NCT01763645|bevacizumab|bevacizumab
1259457|NCT01763645|pharmacokinetics|pharmacokinetics
1259458|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
1259459|NCT01763632|Neonatal|neonatal
1259460|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
1259461|NCT01763619|Cervical DDD|cervical ddd
1259463|NCT01763619|degenerative disc disease|degenerative disc disease
1259464|NCT01763619|C3-C7|c3-c7
1259465|NCT01763606|Enoxaparin|enoxaparin
1259466|NCT01763606|Aspirin|aspirin
1259467|NCT01763606|stroke|stroke
1259468|NCT01763606|12-264|12-264
1259469|NCT01763593|Patients having cataract|patients having cataract
1259470|NCT01763580|Glomerulonephritis|glomerulonephritis
1259471|NCT01763580|Tacrolimus|tacrolimus
1259472|NCT01763580|Nephrotic syndrome|nephrotic syndrome
1259473|NCT01763567|Medtronic|medtronic
1259474|NCT01763567|Diabetes|diabetes
1259475|NCT01763567|Hospital|hospital
1259476|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
1259477|NCT01763567|Intensive Care Unit|intensive care unit
1259478|NCT01763554|Lu-177|lu-177
1259479|NCT01763554|Lutetium-177|lutetium-177
1259480|NCT01763554|DOTA-TATE|dota-tate
1259481|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
1259482|NCT01763554|radiopharmaceutical|radiopharmaceutical
1259483|NCT01763541|Natriuretic Peptides|natriuretic peptides
1259484|NCT01763528|body weight|body weight
1259485|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
1259486|NCT01763515|Joint Diseases|joint diseases
1259487|NCT01763515|Arthritis|arthritis
1259488|NCT01763515|Osteoarthritis|osteoarthritis
1259489|NCT01763502|Cognitive development|cognitive development
1259490|NCT01763502|Anemia|anemia
1259491|NCT01763502|Preschool|preschool
1259492|NCT01763502|Food transfers|food transfers
1259493|NCT01763502|Cash transfers|cash transfers
1259494|NCT01763502|Early childhood|early childhood
1259495|NCT01763502|Nutrition|nutrition
1259496|NCT01763489|randomized controlled trial|randomized controlled trial
1259497|NCT01763489|applicability|applicability
1259498|NCT01763489|ASSIST tool|assist tool
1259499|NCT01763489|surgery|surgery
1259500|NCT01763489|digestive cancer|digestive cancer
1259501|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
1259502|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
1259503|NCT01763476|atherectomy|atherectomy
1259504|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
1259505|NCT01763463|COPD|copd
1259506|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
1259507|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
1259508|NCT01763450|Bevacizumab|bevacizumab
1259509|NCT01763450|conversion therapy|conversion therapy
1259510|NCT01763450|liver metastases|liver metastases
1259511|NCT01763450|colorectal cancer|colorectal cancer
1259512|NCT01763450|objective response rate|objective response rate
1259513|NCT01763437|Chalazia|chalazia
1259514|NCT01763437|Chalazion|chalazion
1259515|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
1259516|NCT01763437|Rosacea|rosacea
1259517|NCT01763437|Ocular rosacea|ocular rosacea
1259518|NCT01763411|Cataract|cataract
1259519|NCT01763411|Vision|vision
1259520|NCT01763411|Intraocular lens|intraocular lens
1259521|NCT01763411|Multifocal|multifocal
1259522|NCT01763411|Monofocal|monofocal
1259523|NCT01763385|Erlotinib|erlotinib
1259524|NCT01763385|brain radiotherapy|brain radiotherapy
1259525|NCT01763385|NSCLC|nsclc
1259526|NCT01763385|brain metastases|brain metastases
1259527|NCT01763372|Arthroscopic|arthroscopic
1259528|NCT01763372|Iliopsoas|iliopsoas
1259529|NCT01763372|MRI|mri
1259530|NCT01763359|acetabular fracture|acetabular fracture
1259531|NCT01763359|pelvic fracture|pelvic fracture
1259532|NCT01763359|hip adductor strength|hip adductor strength
1259533|NCT01763359|obturator nerve palsy|obturator nerve palsy
1259534|NCT01763359|modified Stoppa approach|modified stoppa approach
1259535|NCT01763346|type 2 diabetes|type 2 diabetes
1259536|NCT01763346|prediabetes|prediabetes
1259537|NCT01763346|obesity|obesity
1259538|NCT01763346|gastric banding|gastric banding
1259539|NCT01763346|metformin|metformin
1259540|NCT01763320|ischemic stroke|ischemic stroke
1259541|NCT01763320|intracranial stenting|intracranial stenting
1259542|NCT01763320|vascular risk factor management|vascular risk factor management
1259543|NCT01763307|EGFRI|egfri
1259544|NCT01763307|COLON CANCER|colon cancer
1259545|NCT01763307|SKIN TOXICITY|skin toxicity
1259546|NCT01763307|RECONVAL K1 cream|reconval k1 cream
1259547|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
1259548|NCT01763294|tDCS|tdcs
1259549|NCT01763294|neurostimulation|neurostimulation
1259550|NCT01763294|seizures|seizures
1259551|NCT01763268|Immunogenicity|immunogenicity
1259552|NCT01763268|Reactogenicity|reactogenicity
1259553|NCT01763268|Trivivac|trivivac
1259554|NCT01763268|Measles|measles
1259555|NCT01763268|Mump|mump
1259556|NCT01763268|Rubella|rubella
1259557|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
1259651|NCT01762813|Colon cancer|colon cancer
1259558|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
1259559|NCT01763216|depressive symptoms|depressive symptoms
1259560|NCT01763216|clinical depression|clinical depression
1259561|NCT01763216|visual processing speed|visual processing speed
1259562|NCT01763216|anxiety|anxiety
1259563|NCT01763216|pain|pain
1259564|NCT01763216|health-related quality of life|health-related quality of life
1259565|NCT01763203|Self-management|self-management
1259566|NCT01763203|Chronic Care Model|chronic care model
1259567|NCT01763203|Community health worker|community health worker
1259568|NCT01763177|nebulizer|nebulizer
1259569|NCT01763177|oxygen|oxygen
1259570|NCT01763177|post-operative sore throat|post-operative sore throat
1259571|NCT01763164|Melanoma|melanoma
1259572|NCT01763164|Cutaneous melanoma|cutaneous melanoma
1259573|NCT01763164|Skin disease|skin disease
1259574|NCT01763164|Skin cancer|skin cancer
1259575|NCT01763164|Skin Neoplasms|skin neoplasms
1259576|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
1259577|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
1259578|NCT01763125|Breast cancer|breast cancer
1259579|NCT01763125|Ovarian cancer|ovarian cancer
1259580|NCT01763125|Endometrium carcinoma|endometrium carcinoma
1259581|NCT01763125|Cervix carcinoma,|cervix carcinoma,
1259582|NCT01763125|Mamma carcinoma,|mamma carcinoma,
1259583|NCT01763125|Prostata carcinoma|prostata carcinoma
1259584|NCT01763125|Colon carcinoma|colon carcinoma
1259585|NCT01763125|Rectal carcinoma|rectal carcinoma
1259586|NCT01763125|Bronchus carcinoma|bronchus carcinoma
1259587|NCT01763125|NSCLC & SCLC (Non Small Cell Lung Cancer & Small Cell Lung Cancer))|nsclc & sclc (non small cell lung cancer & small cell lung cancer))
1259588|NCT01763125|Prostate carcinoma|prostate carcinoma
1259589|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
1259590|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
1259591|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
1259592|NCT01763099|Cord Blood|cord blood
1259593|NCT01763099|Graft failure|graft failure
1259594|NCT01763086|Poor Graft Function|poor graft function
1259595|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
1259596|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1259597|NCT01763086|Third-party Donors|third-party donors
1259598|NCT01763060|ards|ards
1259599|NCT01763060|ecmo|ecmo
1259600|NCT01763060|h1n1|h1n1
1259601|NCT01763060|pandemics|pandemics
1259602|NCT01763021|Healthy participants|healthy participants
1259603|NCT01763021|PCI-32765|pci-32765
1259604|NCT01763021|Rifampin|rifampin
1259605|NCT01763021|PCI-45227|pci-45227
1259606|NCT01763021|CYP3A4|cyp3a4
1259607|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
1259608|NCT01763008|Nosocomial Infection|nosocomial infection
1259609|NCT01763008|Intraabdominal Infections|intraabdominal infections
1259610|NCT01763008|Urinary Tract Infection|urinary tract infection
1259611|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
1259612|NCT01763008|Doripenem|doripenem
1259613|NCT01763008|Doribax|doribax
1259614|NCT01763008|Filipino|filipino
1259615|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
1259616|NCT01762956|Pelvic floor|pelvic floor
1259617|NCT01762956|Physical Therapy|physical therapy
1259618|NCT01762956|Prostate cancer|prostate cancer
1259619|NCT01762956|Radiotherapy|radiotherapy
1259620|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
1259621|NCT01762904|Antiseptics|antiseptics
1259622|NCT01762904|Administration cutaneously|administration cutaneously
1259623|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
1259624|NCT01762891|Coumadin|coumadin
1259625|NCT01762891|celecoxib|celecoxib
1259626|NCT01762891|rofecoxib|rofecoxib
1259627|NCT01762891|acetaminophen|acetaminophen
1259628|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
1259629|NCT01762878|pharmacodynamics|pharmacodynamics
1259630|NCT01762878|pharmacokinetics|pharmacokinetics
1259631|NCT01762878|healthy volunteers|healthy volunteers
1259632|NCT01762878|Pi3K-delta|pi3k-delta
1259633|NCT01762878|GSK2269557|gsk2269557
1259634|NCT01762878|safety|safety
1259635|NCT01762878|dry powder inhaler|dry powder inhaler
1259636|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
1259637|NCT01762852|Benlysta|benlysta
1259638|NCT01762852|efficacy|efficacy
1259639|NCT01762852|proteinuria|proteinuria
1259640|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
1259641|NCT01762852|GSK1550188|gsk1550188
1259642|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
1259643|NCT01762852|safety|safety
1259644|NCT01762852|placebo|placebo
1259645|NCT01762852|BLyS|blys
1259646|NCT01762852|belimumab|belimumab
1259647|NCT01762852|Lymphostat-B|lymphostat-b
1259648|NCT01762852|membrane attack complex|membrane attack complex
1259649|NCT01762826|Inositol|inositol
1259650|NCT01762826|GDM|gdm
1259652|NCT01762813|rectal cancer|rectal cancer
1259950|NCT01761396|Therapy|therapy
1259653|NCT01762813|liver metastasis|liver metastasis
1259654|NCT01762813|survival|survival
1259655|NCT01762813|biomarker|biomarker
1259656|NCT01762813|molecular profile|molecular profile
1259657|NCT01762774|COPD|copd
1259658|NCT01762774|forearm blood flow|forearm blood flow
1259659|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
1259660|NCT01762761|eltrombopag|eltrombopag
1259661|NCT01762761|TPO-R agonist|tpo-r agonist
1259662|NCT01762761|Chronic ITP|chronic itp
1259663|NCT01762748|Probiotic|probiotic
1259664|NCT01762748|liver|liver
1259665|NCT01762748|transplant|transplant
1259666|NCT01762748|permeability|permeability
1259667|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
1259668|NCT01762722|Oximetry|oximetry
1259669|NCT01762722|Hypoxemia|hypoxemia
1259670|NCT01762722|Tissue oxygenation|tissue oxygenation
1259671|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
1259672|NCT01762709|one lung ventilation|one lung ventilation
1259673|NCT01762709|low tidal volume|low tidal volume
1259674|NCT01762709|acute lung injury|acute lung injury
1259675|NCT01762709|lung water content|lung water content
1259676|NCT01762696|marijuana|marijuana
1259677|NCT01762696|intervention|intervention
1259678|NCT01762696|adolescent, young adult|adolescent, young adult
1259679|NCT01762696|primary care|primary care
1259680|NCT01762696|mobile|mobile
1259681|NCT01762683|pregnancy|pregnancy
1259682|NCT01762683|obesity|obesity
1259683|NCT01762683|differentiation|differentiation
1259684|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
1259685|NCT01762670|BV|bv
1259686|NCT01762657|Type 1 Diabetes|type 1 diabetes
1259687|NCT01762657|Insulin Independence|insulin independence
1259688|NCT01762657|Beta Regeneration|beta regeneration
1259689|NCT01762657|Immune Tolerance Agent|immune tolerance agent
1259690|NCT01762657|Lanzoprazole|lanzoprazole
1259691|NCT01762657|Cyclosporine|cyclosporine
1259692|NCT01762644|Type 1 Diabetes|type 1 diabetes
1259693|NCT01762644|Insulin Independence|insulin independence
1259694|NCT01762644|Beta Regeneration|beta regeneration
1259695|NCT01762644|Immune Tolerance Agent|immune tolerance agent
1259696|NCT01762644|Omeprazole|omeprazole
1259697|NCT01762644|Cyclosporine|cyclosporine
1259698|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
1259699|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
1259700|NCT01762579|Gluten|gluten
1259701|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1259702|NCT01762579|Rectoscopy|rectoscopy
1259703|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
1259704|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
1259705|NCT01762566|Bloating|bloating
1259706|NCT01762566|Swelling|swelling
1259707|NCT01762540|Protein breakdown|protein breakdown
1259708|NCT01762540|Insulin resistance|insulin resistance
1259709|NCT01762540|Glucose intolerance|glucose intolerance
1259710|NCT01762540|Lipolysis|lipolysis
1259711|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
1259712|NCT01762527|Bladder cancer|bladder cancer
1259713|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1259714|NCT01762514|Amifostine|amifostine
1259715|NCT01762514|Myelosuppression|myelosuppression
1259716|NCT01762514|Xerostomia|xerostomia
1259717|NCT01762514|Mucositis|mucositis
1259718|NCT01762501|Hypertension|hypertension
1259719|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
1259720|NCT01762488|Renal Denervation|renal denervation
1259721|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
1259722|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
1259723|NCT01762475|Hypercapnia|hypercapnia
1259724|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
1259725|NCT01762449|Scleroderma|scleroderma
1259726|NCT01762449|interstitial lung disease|interstitial lung disease
1259727|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
1259728|NCT01762371|ACL|acl
1259729|NCT01762371|Knee|knee
1259730|NCT01762371|Ligament|ligament
1259731|NCT01762371|Cruciate|cruciate
1259732|NCT01762371|Anterior|anterior
1259733|NCT01762358|ACL|acl
1259734|NCT01762358|Ligament|ligament
1259735|NCT01762358|Knee|knee
1259736|NCT01762345|Stress urinary incontinence|stress urinary incontinence
1259737|NCT01762345|SUI|sui
1259738|NCT01762332|nociception|nociception
1259739|NCT01762332|analgesia|analgesia
1259740|NCT01762332|intraoperative monitoring|intraoperative monitoring
1259741|NCT01762293|CRC|crc
1259742|NCT01762293|Famitinib|famitinib
1259743|NCT01762293|Phase II|phase ii
1259744|NCT01762293|Colorectal Cancer|colorectal cancer
1259745|NCT01762280|Famitinib|famitinib
1259746|NCT01762280|Advanced Solid tumor|advanced solid tumor
1259747|NCT01762280|Phase I|phase i
1259748|NCT01762254|pain score|pain score
1259749|NCT01762254|complication|complication
1259750|NCT01762241|Prostate cancer|prostate cancer
1600827|NCT00391131|SCIG|scig
1352091|NCT01366716|Ethics|ethics
1259751|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
1259752|NCT01762241|Exercise|exercise
1259753|NCT01762241|Xbox|xbox
1260144|NCT01760434|scoliosis|scoliosis
1259754|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
1259755|NCT01762228|Elderly|elderly
1259756|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
1259757|NCT01762228|TRPV1 agonist|trpv1 agonist
1259758|NCT01762215|Epilepsy|epilepsy
1259759|NCT01762215|Seizure|seizure
1259760|NCT01762215|Veteran|veteran
1259761|NCT01762202|CLL|cll
1259762|NCT01762202|Fludarabine|fludarabine
1259763|NCT01762202|Cyclophosphamide|cyclophosphamide
1259764|NCT01762202|Ofatumumab|ofatumumab
1259765|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
1259766|NCT01762189|Neonatal|neonatal
1259767|NCT01762189|Incidence|incidence
1259768|NCT01762189|Risk factors|risk factors
1259769|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
1259770|NCT01762176|Usual care|usual care
1259771|NCT01762176|Intensive Care|intensive care
1259772|NCT01762176|Boolean criteria|boolean criteria
1259773|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
1259774|NCT01762150|collected duct carcinoma|collected duct carcinoma
1259775|NCT01762150|sorafenib|sorafenib
1259776|NCT01762137|Aneurysm|aneurysm
1259777|NCT01762137|Coiling|coiling
1259778|NCT01762137|Flow Diversion|flow diversion
1259779|NCT01762124|Pulmonary valve|pulmonary valve
1259780|NCT01762124|Congenital heart disease|congenital heart disease
1259781|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
1259782|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
1259783|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
1259784|NCT01762111|In-Vitro fertilization|in-vitro fertilization
1259785|NCT01762098|In vitro fertilization|in vitro fertilization
1259786|NCT01762098|Hysteroscopy|hysteroscopy
1259787|NCT01762098|Endometrial biopsy|endometrial biopsy
1259788|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
1259789|NCT01762085|nerve decompression surgery|nerve decompression surgery
1259790|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
1259791|NCT01762059|bionic pancreas|bionic pancreas
1259792|NCT01762059|artificial pancreas|artificial pancreas
1259793|NCT01762059|insulin|insulin
1259794|NCT01762059|glucagon|glucagon
1259795|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
1259796|NCT01762059|CGM|cgm
1259797|NCT01762059|outpatient|outpatient
1259798|NCT01762059|insulin pump|insulin pump
1259799|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1259800|NCT01762046|Pharmacogenetics|pharmacogenetics
1259801|NCT01762046|Genetics|genetics
1259802|NCT01762046|Obesity|obesity
1259803|NCT01762033|Renal cell carcinoma|renal cell carcinoma
1259804|NCT01762033|Renal cell cancer|renal cell cancer
1259805|NCT01762033|ASONEP|asonep
1259806|NCT01762033|Sonepcizumab|sonepcizumab
1259807|NCT01762020|Women with Breast Cancer|women with breast cancer
1259808|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
1259809|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
1259810|NCT01761994|nafamostat mesilate|nafamostat mesilate
1259811|NCT01761994|heparin|heparin
1259812|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
1259813|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
1259814|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
1259815|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
1259816|NCT01761981|HHT|hht
1259817|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
1259818|NCT01761968|Polycythemia Vera|polycythemia vera
1259819|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
1259820|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
1259821|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1259822|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1259823|NCT01761968|Givinostat|givinostat
1259824|NCT01761955|body weight|body weight
1259825|NCT01761955|lipids|lipids
1259826|NCT01761955|glucose|glucose
1259827|NCT01761955|insulin|insulin
1259828|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
1259829|NCT01761942|anorexia nervosa|anorexia nervosa
1259830|NCT01761942|efficacy|efficacy
1259831|NCT01761942|safety|safety
1259832|NCT01761929|oligometastatic|oligometastatic
1259833|NCT01761929|oligometastases|oligometastases
1259834|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
1259835|NCT01761929|radiation therapy|radiation therapy
1259836|NCT01761929|Oligometastasis|oligometastasis
1259837|NCT01761929|Stereotactic ablative body|stereotactic ablative body
1259838|NCT01761929|radiotherapy|radiotherapy
1259839|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
1259840|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
1259841|NCT01761890|Early phase|early phase
1259842|NCT01761890|CML|cml
1259843|NCT01761890|Dasatinib|dasatinib
1259944|NCT01761448|ECG- vest|ecg- vest
1259945|NCT01761435|Influenza|influenza
1259844|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
1259845|NCT01761851|Resting metabolic rate|resting metabolic rate
1259846|NCT01761851|nutrition status|nutrition status
1259847|NCT01761851|dietary intake|dietary intake
1259848|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
1259849|NCT01761838|low back pain|low back pain
1259850|NCT01761838|experimental pain|experimental pain
1259851|NCT01761838|spinal stiffness|spinal stiffness
1259852|NCT01761838|lumbar multifidus|lumbar multifidus
1259853|NCT01761838|degeneration|degeneration
1259854|NCT01761812|Prostate cancer|prostate cancer
1259855|NCT01761812|MRI|mri
1259856|NCT01761812|Elastography|elastography
1259857|NCT01761812|Gadofosveset|gadofosveset
1259858|NCT01761799|Influenza|influenza
1259859|NCT01761799|Pertussis|pertussis
1259860|NCT01761799|Vaccination|vaccination
1259861|NCT01761786|Myocardial Infarction|myocardial infarction
1259862|NCT01761786|Thrombosis|thrombosis
1259863|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
1259864|NCT01761786|Myocardial Ischemia|myocardial ischemia
1259865|NCT01761786|Heart Diseases|heart diseases
1259866|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
1259867|NCT01761786|Vascular Diseases|vascular diseases
1259868|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
1259869|NCT01761786|Genetic Testing|genetic testing
1259870|NCT01761786|Clopidogrel|clopidogrel
1259871|NCT01761786|Prasugrel|prasugrel
1259872|NCT01761786|Ticagrelor|ticagrelor
1259873|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1259874|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
1259875|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
1259876|NCT01761734|Influenza vaccination|influenza vaccination
1259877|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
1259878|NCT01761721|Robotics (MeSH)|robotics (mesh)
1259879|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
1259880|NCT01761708|umbilical hernia repair|umbilical hernia repair
1259881|NCT01761708|epigastric hernia repair|epigastric hernia repair
1259882|NCT01761708|C-Qur V-patch|c-qur v-patch
1259883|NCT01761708|Size tailored repair|size tailored repair
1259884|NCT01761708|preperitoneal repair|preperitoneal repair
1259885|NCT01761708|abdominal hernia|abdominal hernia
1259886|NCT01761708|dual sided mesh|dual sided mesh
1259887|NCT01761708|trocar-site hernia|trocar-site hernia
1259888|NCT01761656|stable angina|stable angina
1259889|NCT01761656|unstable angina|unstable angina
1259890|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
1259891|NCT01761656|PCI|pci
1259892|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
1259893|NCT01761656|major adverse cardiac events|major adverse cardiac events
1259894|NCT01761643|PrEP|prep
1259895|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
1259896|NCT01761643|Text Messaging|text messaging
1259897|NCT01761643|Truvada|truvada
1259898|NCT01761643|iTab|itab
1259899|NCT01761643|CCTG|cctg
1259900|NCT01761643|595|595
1259901|NCT01761630|Asthma|asthma
1259902|NCT01761630|Severe Asthma|severe asthma
1259903|NCT01761630|SARP|sarp
1259904|NCT01761617|Yoga|yoga
1259905|NCT01761617|Chronic Low Back Pain|chronic low back pain
1259906|NCT01761617|CAM|cam
1259907|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
1259908|NCT01761617|Minorities|minorities
1259909|NCT01761591|CAD|cad
1259910|NCT01761591|PCI|pci
1259911|NCT01761591|BMS|bms
1259912|NCT01761591|Svelte|svelte
1259913|NCT01761591|Acrobat|acrobat
1259914|NCT01761591|direct stenting|direct stenting
1259915|NCT01761591|RCT|rct
1259916|NCT01761578|Bioresorbable|bioresorbable
1259917|NCT01761578|Coronary|coronary
1259918|NCT01761578|Stent|stent
1259919|NCT01761578|Vascular Remodeling|vascular remodeling
1259920|NCT01761578|Angioplasty|angioplasty
1259921|NCT01761578|Coronary Artery Disease|coronary artery disease
1259922|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
1259923|NCT01761539|pancreatitis|pancreatitis
1259924|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
1259925|NCT01761526|Rotigotine|rotigotine
1259926|NCT01761526|Neupro|neupro
1259927|NCT01761526|Japanese|japanese
1259928|NCT01761526|Caucasian|caucasian
1259929|NCT01761526|Male|male
1259930|NCT01761526|Female|female
1259931|NCT01761526|Single dose|single dose
1259932|NCT01761526|Pharmacokinetics|pharmacokinetics
1259933|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
1259934|NCT01761500|Childhood and adolescence;|childhood and adolescence;
1259935|NCT01761500|Survival Rate|survival rate
1259936|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
1259937|NCT01761474|Air insufflatioin|air insufflatioin
1259938|NCT01761474|ERCP|ercp
1259939|NCT01761474|Sedation|sedation
1259940|NCT01761448|Coronary Artery Disease|coronary artery disease
1259941|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
1259942|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
1259943|NCT01761448|guided exercise|guided exercise
1259946|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
1259947|NCT01761396|Anxiety|anxiety
1259948|NCT01761396|Fear|fear
1259949|NCT01761396|Worry|worry
1259951|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
1259952|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
1259953|NCT01761383|Nintendo Wii|nintendo wii
1259954|NCT01761383|Quality of Life|quality of life
1259955|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
1259956|NCT01761370|Intra-gastric balloon|intra-gastric balloon
1259957|NCT01761357|Aortic valve stenosis|aortic valve stenosis
1259958|NCT01761357|Quality of life|quality of life
1259959|NCT01761357|Burden co morbidities|burden co morbidities
1259960|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1259961|NCT01761357|Geriatric assessment|geriatric assessment
1259962|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
1259963|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
1259964|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
1259965|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
1259966|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1259967|NCT01761318|Steatosis|steatosis
1259968|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
1259969|NCT01761305|Brace|brace
1259970|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
1259971|NCT01761305|Physical activity|physical activity
1259972|NCT01761279|Colonic polyps|colonic polyps
1259973|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
1259974|NCT01761266|Neoplasms|neoplasms
1259975|NCT01761266|Cancer|cancer
1259976|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
1259977|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
1259978|NCT01761227|Vascular dementia|vascular dementia
1259979|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
1259980|NCT01761227|Randomized Controlled trial|randomized controlled trial
1259981|NCT01761227|Chinese Medicine|chinese medicine
1259982|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
1259983|NCT01761201|Prophylaxis|prophylaxis
1259984|NCT01761201|Tuberculosis|tuberculosis
1259985|NCT01761201|Transplant recipients|transplant recipients
1259986|NCT01761201|Transplant waiting list|transplant waiting list
1259987|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
1259988|NCT01761149|remifentanil,|remifentanil,
1259989|NCT01761149|opioid,|opioid,
1259990|NCT01761149|hyperalgesia,|hyperalgesia,
1259991|NCT01761149|visual analogue score|visual analogue score
1259992|NCT01761149|thyroidectomy,|thyroidectomy,
1259993|NCT01761123|Prevention of Influenza|prevention of influenza
1259994|NCT01761110|Opioid dependence|opioid dependence
1259995|NCT01761110|Injection drug use|injection drug use
1259996|NCT01761110|Buprenorphine|buprenorphine
1259997|NCT01761110|Opioid agonist treatment|opioid agonist treatment
1259998|NCT01761110|Access to care|access to care
1259999|NCT01761110|HIV risk behaviors|hiv risk behaviors
1260000|NCT01761110|Opioids|opioids
1260001|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
1260002|NCT01761084|Osteoporosis|osteoporosis
1260003|NCT01761084|Spine fracture|spine fracture
1260004|NCT01761084|Vertebral fracture|vertebral fracture
1260005|NCT01761084|Exercise Interventions|exercise interventions
1260006|NCT01761084|Exercise|exercise
1260007|NCT01761058|Asthma|asthma
1260008|NCT01761058|Bronchial Diseases|bronchial diseases
1260009|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
1260010|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
1260011|NCT01761058|Lung Diseases|lung diseases
1260012|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
1260013|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
1260014|NCT01761058|Hypersensitivity|hypersensitivity
1260015|NCT01761058|Immune System Disease|immune system disease
1260016|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
1260017|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
1260018|NCT01761045|Satiety|satiety
1260019|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
1260020|NCT01761045|Consommé Soups|consommé soups
1260021|NCT01761045|Snack Intake|snack intake
1260022|NCT01761032|Tanning|tanning
1260023|NCT01761032|neuroimaging|neuroimaging
1260024|NCT01761032|dopamine|dopamine
1260025|NCT01761032|MRI|mri
1260026|NCT01761032|SPECT|spect
1260027|NCT01761019|psoriasis|psoriasis
1260028|NCT01761019|Taclonex|taclonex
1260029|NCT01761019|Acitretin|acitretin
1260030|NCT01761019|Methotrexate|methotrexate
1260031|NCT01761006|COPD|copd
1260032|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1260033|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
1260034|NCT01761006|NIOX MINO|niox mino
1260035|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
1260036|NCT01760993|Not Required|not required
1260037|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
1260038|NCT01760967|Dexmedetomidine|dexmedetomidine
1260039|NCT01760967|sepsis|sepsis
1260040|NCT01760967|mortality|mortality
1260041|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
1260042|NCT01760967|organ failure|organ failure
1260043|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
1260044|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
1260045|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
1260046|NCT01760954|Endometriosis associated pain|endometriosis associated pain
1260047|NCT01760954|Elagolix|elagolix
1260048|NCT01760941|Urology|urology
1260049|NCT01760941|Prostate|prostate
1260050|NCT01760941|Breast|breast
1260051|NCT01760941|Lung|lung
1260052|NCT01760941|Chest|chest
1260053|NCT01760915|asthma|asthma
1260054|NCT01760915|severe|severe
1260055|NCT01760902|Inflammation|inflammation
1260056|NCT01760876|Optical Coherence Tomography|optical coherence tomography
1260057|NCT01760876|Biofreedom Stent|biofreedom stent
1260058|NCT01760863|Revision|revision
1260059|NCT01760863|Knee|knee
1260060|NCT01760863|Hip|hip
1260061|NCT01760863|Arthroplasty|arthroplasty
1260062|NCT01760863|Oral|oral
1260063|NCT01760863|Antibiotics|antibiotics
1260064|NCT01760863|Infection|infection
1260065|NCT01760837|cow's milk allergy|cow's milk allergy
1260066|NCT01760837|baked milk|baked milk
1260067|NCT01760837|tolerance|tolerance
1260068|NCT01760837|infants and children|infants and children
1260069|NCT01760824|Sequential|sequential
1260070|NCT01760824|Quadruple|quadruple
1260071|NCT01760824|First|first
1260072|NCT01760824|Line|line
1260073|NCT01760824|Helicobacter|helicobacter
1260074|NCT01760824|pylori|pylori
1260075|NCT01760824|infection|infection
1260076|NCT01760811|tongue|tongue
1260077|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
1260078|NCT01760811|locally advanced|locally advanced
1260079|NCT01760811|cetuximab|cetuximab
1260080|NCT01760798|osteoporosis|osteoporosis
1260081|NCT01760798|Teriparatide|teriparatide
1260082|NCT01760785|Veterans|veterans
1260083|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
1260084|NCT01760785|Alcoholism|alcoholism
1260085|NCT01760772|heart disease|heart disease
1260086|NCT01760772|GLP-1|glp-1
1260087|NCT01760772|Exendin-9|exendin-9
1260088|NCT01760772|postprandial lipids|postprandial lipids
1260089|NCT01760759|HIV|hiv
1260090|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
1260091|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1260092|NCT01760746|Vitrectomy|vitrectomy
1260093|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
1260094|NCT01760707|Diabetes mellitus|diabetes mellitus
1260095|NCT01760707|Peripheral neuropathy|peripheral neuropathy
1260096|NCT01760707|Exercise|exercise
1260097|NCT01760707|Balance performance|balance performance
1260098|NCT01760694|Pancreatic|pancreatic
1260099|NCT01760694|Pancreas|pancreas
1260100|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
1260101|NCT01760694|Chemotherapy|chemotherapy
1260102|NCT01760668|Sex chromosome|sex chromosome
1260103|NCT01760668|Turner Syndrome|turner syndrome
1260104|NCT01760668|Marfan syndrome|marfan syndrome
1260105|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
1260106|NCT01760668|Aortic Aneurysm|aortic aneurysm
1260107|NCT01760668|Epigenetics|epigenetics
1260108|NCT01760668|Transcriptome|transcriptome
1260109|NCT01760668|non-coding RNA|non-coding rna
1260110|NCT01760668|Electron microscopy|electron microscopy
1260111|NCT01760668|Proteomics|proteomics
1260112|NCT01760642|metabolite profiles|metabolite profiles
1260113|NCT01760642|pharmacokinetics|pharmacokinetics
1260114|NCT01760642|CYP3A|cyp3a
1260115|NCT01760642|metabolomics|metabolomics
1260116|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
1260117|NCT01760616|Huaier Granule;|huaier granule;
1260118|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
1260119|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
1260120|NCT01760616|Safety.|safety.
1260121|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
1260122|NCT01760590|neck pain|neck pain
1260123|NCT01760590|cervical pain|cervical pain
1260124|NCT01760590|pain pressure thresholds|pain pressure thresholds
1260125|NCT01760590|pain catastrophizing|pain catastrophizing
1260126|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
1260127|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
1260128|NCT01760564|miglustat|miglustat
1260129|NCT01760551|Fracture|fracture
1260130|NCT01760551|Trauma|trauma
1260131|NCT01760551|impairment|impairment
1260132|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
1600828|NCT00391131|Ig|ig
1260133|NCT01760538|Heart rate variability|heart rate variability
1260134|NCT01760538|Exercise training|exercise training
1260135|NCT01760525|p53, solid tumor|p53, solid tumor
1260136|NCT01760512|Gastric bypass|gastric bypass
1260137|NCT01760512|Robot-assisted surgery|robot-assisted surgery
1260138|NCT01760512|Conventional laparoscopy|conventional laparoscopy
1260139|NCT01760512|Pain assessment|pain assessment
1260140|NCT01760512|Health economics outcomes|health economics outcomes
1260141|NCT01760499|skin|skin
1260142|NCT01760499|metastatic|metastatic
1260143|NCT01760473|opioid dependence|opioid dependence
1260145|NCT01760434|long-term outcomes|long-term outcomes
1260146|NCT01760434|sagittal plane|sagittal plane
1260147|NCT01760434|quality of life|quality of life
1260148|NCT01760434|curve progression|curve progression
1260149|NCT01760434|pulmonary function|pulmonary function
1260150|NCT01760382|Acute myocardial infarction|acute myocardial infarction
1260151|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
1260152|NCT01760382|primary PCI|primary pci
1260153|NCT01760382|reperfusion therapy|reperfusion therapy
1260154|NCT01760382|angioplasty|angioplasty
1260155|NCT01760382|stent|stent
1260156|NCT01760356|Liver transplantation|liver transplantation
1260157|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
1260158|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
1260159|NCT01760356|Calcineurin pathway|calcineurin pathway
1260160|NCT01760356|Tacrolimus|tacrolimus
1260161|NCT01760356|interindividual variability|interindividual variability
1260162|NCT01760304|COPD|copd
1260163|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
1260164|NCT01760278|Embryoscope|embryoscope
1260165|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
1260166|NCT01760278|Cetrorelix|cetrorelix
1260167|NCT01760278|Gonal-F|gonal-f
1260168|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
1260169|NCT01760265|artery calcium score|artery calcium score
1260170|NCT01760265|carotid intima media|carotid intima media
1260171|NCT01760265|ankle brachial index|ankle brachial index
1260172|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
1260173|NCT01760252|Pancreatic Cancer|pancreatic cancer
1260174|NCT01760239|Adolescent Hypertension|adolescent hypertension
1260175|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
1260176|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
1260177|NCT01760226|DLBCL|dlbcl
1260178|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1260179|NCT01760226|dose adjusted|dose adjusted
1260180|NCT01760226|EPOCH|epoch
1260181|NCT01760226|Etoposide|etoposide
1260182|NCT01760226|Doxorubicin|doxorubicin
1260183|NCT01760226|Vincristine|vincristine
1260184|NCT01760226|Cyclophosphamide|cyclophosphamide
1260185|NCT01760226|Prednisone|prednisone
1260186|NCT01760226|Rituximab|rituximab
1260187|NCT01760200|Coronary angioplasty|coronary angioplasty
1260188|NCT01760200|Coronary stent|coronary stent
1260189|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
1260190|NCT01760200|drug eluting balloon|drug eluting balloon
1260191|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
1260192|NCT01760161|postoperative pain|postoperative pain
1260193|NCT01760161|opioid consumption|opioid consumption
1260194|NCT01760161|termanalgesia|termanalgesia
1260195|NCT01760161|plasmaropivacain level|plasmaropivacain level
1260196|NCT01760148|Hepatitis C Virus|hepatitis c virus
1260198|NCT01760148|Interferon|interferon
1260199|NCT01760148|Prediction|prediction
1260200|NCT01760148|SVR|svr
1260201|NCT01760148|Sustained Virus Response|sustained virus response
1260202|NCT01760135|trauma|trauma
1260203|NCT01760135|nutrition|nutrition
1260204|NCT01760135|hyperglycemia|hyperglycemia
1260205|NCT01760122|peginterferon|peginterferon
1260206|NCT01760122|HBeAg Positive|hbeag positive
1260207|NCT01760122|Chronic hepatitis B|chronic hepatitis b
1260208|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
1260209|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
1260210|NCT01760109|Phase IV|phase iv
1260211|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1260212|NCT01760096|Anemia|anemia
1260213|NCT01760096|Hematologic Diseases|hematologic diseases
1260214|NCT01760096|bone marrow failure|bone marrow failure
1260215|NCT01760096|Immunologic Factors|immunologic factors
1260216|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
1260217|NCT01760096|Levamisole|levamisole
1260218|NCT01760096|cyclosporine A|cyclosporine a
1260219|NCT01760070|cancer|cancer
1260220|NCT01760070|endoscopy|endoscopy
1260221|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
1260222|NCT01760044|tissue oxygenation|tissue oxygenation
1260223|NCT01760044|perfusion status|perfusion status
1260224|NCT01760031|preconditioning|preconditioning
1260225|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
1260226|NCT01760031|renal faliure|renal faliure
1260227|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
1260228|NCT01760005|Alzheimer's|alzheimer's
1352723|NCT01364194|Placebo|placebo
1260229|NCT01760005|Alzheimer's Disease|alzheimer's disease
1260230|NCT01760005|Dementia|dementia
1260231|NCT01760005|Mutation|mutation
1260232|NCT01760005|Genetic Mutation|genetic mutation
1260233|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
1260234|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
1260330|NCT01759550|Force Triad|force triad
1260235|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
1260236|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
1260237|NCT01760005|DIAN|dian
1260238|NCT01760005|DIAN-TU|dian-tu
1260239|NCT01760005|DIAN TU|dian tu
1260240|NCT01759992|Frail elderly|frail elderly
1260241|NCT01759992|Muscle weakness|muscle weakness
1260242|NCT01759992|Institutionalization|institutionalization
1260243|NCT01759992|Respiratory muscle training|respiratory muscle training
1260244|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
1260245|NCT01759979|Choledocholithiasis|choledocholithiasis
1260246|NCT01759966|Heart transplantation|heart transplantation
1260247|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
1260248|NCT01759966|Acute rejection|acute rejection
1260249|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
1260250|NCT01759953|Diabetes Mellitus|diabetes mellitus
1260251|NCT01759953|Insulin|insulin
1260252|NCT01759953|Video Games|video games
1260253|NCT01759953|Medical Education|medical education
1260254|NCT01759953|Educational Technology|educational technology
1260255|NCT01759953|Continuing Medical Education|continuing medical education
1260256|NCT01759940|carotid|carotid
1260257|NCT01759940|endarterectomy|endarterectomy
1260258|NCT01759940|cervical block|cervical block
1260259|NCT01759927|Physical activity counselor|physical activity counselor
1260260|NCT01759927|Workplace intervention|workplace intervention
1260261|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
1260262|NCT01759901|hepatectomy|hepatectomy
1260263|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
1260264|NCT01759862|kidney transplant|kidney transplant
1260265|NCT01759862|Aminophylline|aminophylline
1260266|NCT01759862|pediatric|pediatric
1260267|NCT01759849|Asthma|asthma
1260268|NCT01759849|β-chain signaling|β-chain signaling
1260269|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
1260270|NCT01759849|sputum|sputum
1260271|NCT01759849|bone marrow aspirate|bone marrow aspirate
1260272|NCT01759849|blood collection|blood collection
1260273|NCT01759849|-methacholine challenge|-methacholine challenge
1260274|NCT01759836|Prostatectomy|prostatectomy
1260275|NCT01759836|Statins|statins
1260276|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
1260277|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
1260278|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
1260279|NCT01759771|Prostate Cancer|prostate cancer
1260280|NCT01759771|Vitamin D3|vitamin d3
1260281|NCT01759771|Active surveillance|active surveillance
1260282|NCT01759758|boxer's fracture|boxer's fracture
1260283|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
1260284|NCT01759758|metacarpal fracture|metacarpal fracture
1260285|NCT01759732|Aplastic anemia|aplastic anemia
1260286|NCT01759732|T cell dose|t cell dose
1260287|NCT01759732|CD3 depletion|cd3 depletion
1260288|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1260289|NCT01759719|platinum-chromium stents|platinum-chromium stents
1260290|NCT01759719|concertina effect|concertina effect
1260291|NCT01759719|stent deformation|stent deformation
1260292|NCT01759719|everolimus eluting stents|everolimus eluting stents
1260293|NCT01759719|stent lenght|stent lenght
1260294|NCT01759693|Platelet activation|platelet activation
1260295|NCT01759680|Risk of falls|risk of falls
1260296|NCT01759680|Whole Body Vibration|whole body vibration
1260297|NCT01759680|Nursing Home|nursing home
1260298|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
1260299|NCT01759667|Respiratory Quotient;|respiratory quotient;
1260300|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
1260301|NCT01759667|Energy Expenditure.|energy expenditure.
1260302|NCT01759641|Dialysis|dialysis
1260303|NCT01759641|Monitoring|monitoring
1260304|NCT01759641|Cardiovascular stability|cardiovascular stability
1260305|NCT01759641|biosignals|biosignals
1260306|NCT01759628|Steatohepatitis,|steatohepatitis,
1260307|NCT01759628|Helicobacter pylori,|helicobacter pylori,
1260308|NCT01759628|Insulin resistance,|insulin resistance,
1260309|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
1260310|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
1260311|NCT01759615|Preterm|preterm
1260313|NCT01759615|AREDF|aredf
1260314|NCT01759615|Early feeding|early feeding
1260315|NCT01759615|Late feeding|late feeding
1260316|NCT01759615|Feed intolerence|feed intolerence
1260317|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
1260318|NCT01759602|Neuromyelitis optica|neuromyelitis optica
1260319|NCT01759602|Devic's disease|devic's disease
1260321|NCT01759602|Devic|devic
1260322|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
1260323|NCT01759576|Renal Insufficiency|renal insufficiency
1260324|NCT01759576|Healthy|healthy
1260325|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1260326|NCT01759576|Pharmacokinetics|pharmacokinetics
1260327|NCT01759576|Pharmacodynamics|pharmacodynamics
1260328|NCT01759576|Dialysis|dialysis
1260329|NCT01759550|Gastric Procedures|gastric procedures
1260331|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
1260332|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
1260333|NCT01759524|local anaesthesia|local anaesthesia
1260334|NCT01759524|analgesia|analgesia
1260335|NCT01759524|bupivacaine|bupivacaine
1260336|NCT01759524|lidocaine|lidocaine
1260337|NCT01759524|clonidine|clonidine
1260338|NCT01759524|sciatic nerve|sciatic nerve
1260339|NCT01759524|saphenous nerve|saphenous nerve
1260340|NCT01759511|Idiopathic|idiopathic
1260341|NCT01759511|Pulmonary|pulmonary
1260342|NCT01759511|Fibrosis|fibrosis
1260343|NCT01759511|IPF|ipf
1260344|NCT01759498|Inflammation|inflammation
1260345|NCT01759498|Pain intensity|pain intensity
1260346|NCT01759498|Flexibility|flexibility
1260347|NCT01759498|RICE protocol|rice protocol
1260348|NCT01759498|Swelling|swelling
1260349|NCT01759485|Clozapine|clozapine
1260350|NCT01759485|Schizophrenia|schizophrenia
1260351|NCT01759485|Vitamin-D|vitamin-d
1260352|NCT01759485|Treatment-resistant|treatment-resistant
1260353|NCT01759472|leukotriene|leukotriene
1260354|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
1260355|NCT01759420|Ondansetron|ondansetron
1260356|NCT01759420|QT interval|qt interval
1260357|NCT01759420|QTc|qtc
1260358|NCT01759420|QT prolongation|qt prolongation
1260359|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
1260360|NCT01759381|Spinal Deformity|spinal deformity
1260361|NCT01759381|Complex Spinal Surgery|complex spinal surgery
1260362|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
1260363|NCT01759381|Post-Operative Infection|post-operative infection
1260364|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
1260365|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
1260366|NCT01759329|overweight|overweight
1260367|NCT01759329|body weight|body weight
1260368|NCT01759329|coffee|coffee
1260369|NCT01759290|Angioplasty|angioplasty
1260370|NCT01759290|Bioabsorbable|bioabsorbable
1260371|NCT01759290|Bioresorbable|bioresorbable
1260372|NCT01759290|BVS|bvs
1260373|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1260374|NCT01759290|Coronary Scaffold|coronary scaffold
1260375|NCT01759290|Coronary Stent|coronary stent
1260376|NCT01759264|Fecal Calprotectin|fecal calprotectin
1260377|NCT01759264|Crohn's Disease|crohn's disease
1260378|NCT01759264|Adalimumab|adalimumab
1260379|NCT01759251|Meniere Disease|meniere disease
1260380|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
1260381|NCT01759251|Vertigo|vertigo
1260382|NCT01759238|colorectal cancer|colorectal cancer
1260383|NCT01759238|metastases|metastases
1260384|NCT01759238|non resectable|non resectable
1260385|NCT01759238|chemoradiation|chemoradiation
1260386|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
1260387|NCT01759212|stem cell implantation|stem cell implantation
1260388|NCT01759212|coronary artery disease|coronary artery disease
1260389|NCT01759212|left ventricular assist device|left ventricular assist device
1260390|NCT01759199|COPD|copd
1260391|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
1260392|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
1260393|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
1260394|NCT01759186|Asthma|asthma
1260395|NCT01759186|Biomakers|biomakers
1260396|NCT01759186|Phenotype|phenotype
1260397|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
1260398|NCT01759173|Concussion|concussion
1260399|NCT01759160|Target control infusion|target control infusion
1260400|NCT01759160|propofol|propofol
1260401|NCT01759160|cardiac depression|cardiac depression
1260402|NCT01759160|induction of anesthesia|induction of anesthesia
1260403|NCT01759160|hemodynamics|hemodynamics
1260404|NCT01759134|Premature neonate|premature neonate
1260405|NCT01759134|Post-discharge|post-discharge
1260406|NCT01759134|Formula|formula
1260407|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
1260408|NCT01759121|subthreshold|subthreshold
1260409|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
1260410|NCT01759121|PASCAL|pascal
1260411|NCT01759121|endpoint management|endpoint management
1260412|NCT01759108|xerostomia|xerostomia
1260413|NCT01759108|rebamipide|rebamipide
1260414|NCT01759108|efficacy|efficacy
1260415|NCT01759108|safety|safety
1260416|NCT01759095|adherence|adherence
1352970|NCT01363154|Music|music
1260417|NCT01759095|electronic monitoring|electronic monitoring
1260418|NCT01759095|primary care|primary care
1260419|NCT01759095|community pharmacy|community pharmacy
1260420|NCT01759095|multidrug blister pack|multidrug blister pack
1260421|NCT01759095|pill box|pill box
1260422|NCT01759056|Ulcerative colitis|ulcerative colitis
1260423|NCT01759043|coronary artery disease|coronary artery disease
1260424|NCT01759043|Myocardial Infarction|myocardial infarction
1260425|NCT01759043|Radial Artery|radial artery
1260426|NCT01759043|Catheters|catheters
1260427|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
1260428|NCT01759030|rituximab|rituximab
1260429|NCT01759030|biosimilar|biosimilar
1260430|NCT01759030|interchangeability|interchangeability
1260431|NCT01759017|Crohn's disease|crohn's disease
1260432|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
1260434|NCT01759017|Infliximab|infliximab
1260435|NCT01759017|PET|pet
1260436|NCT01759017|PET/CT|pet/ct
1260437|NCT01759004|lipoedema|lipoedema
1260438|NCT01759004|obesity|obesity
1260439|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
1260440|NCT01758952|Peri-operative stroke|peri-operative stroke
1260441|NCT01758952|incidence|incidence
1260442|NCT01758952|risk factors|risk factors
1260443|NCT01758952|prospective|prospective
1260444|NCT01758939|Peg Interferon,|peg interferon,
1260445|NCT01758939|Ribavirin,|ribavirin,
1260446|NCT01758939|HCV,|hcv,
1260447|NCT01758939|Genotype IV.|genotype iv.
1260448|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
1260449|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
1260450|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1260451|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
1260452|NCT01758913|prostaglandin|prostaglandin
1260453|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
1260454|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
1260455|NCT01758874|Critical limb ischemia|critical limb ischemia
1260456|NCT01758874|Phlebotomy|phlebotomy
1260457|NCT01758874|Amputation|amputation
1260458|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
1260459|NCT01758874|Fontaine stage IV|fontaine stage iv
1260460|NCT01758861|Erythropoietin|erythropoietin
1260461|NCT01758861|acute kidney injury|acute kidney injury
1260462|NCT01758861|valvular heart surgery|valvular heart surgery
1260463|NCT01758848|overactive bladder|overactive bladder
1260464|NCT01758848|pelvic floor muscles|pelvic floor muscles
1260465|NCT01758848|deep abdominal muscles|deep abdominal muscles
1260466|NCT01758835|ER-stress-test negative|er-stress-test negative
1260467|NCT01758835|unimalleolar|unimalleolar
1260468|NCT01758835|fibula|fibula
1260469|NCT01758835|Weber-B fractures|weber-b fractures
1260470|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
1260471|NCT01758822|endotracheal suction|endotracheal suction
1260472|NCT01758822|non vigorous neonates|non vigorous neonates
1260473|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
1260474|NCT01758809|Postoperative Pain|postoperative pain
1260475|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
1260476|NCT01758809|Bupivacaine|bupivacaine
1260477|NCT01758809|Major Pulmonary Resection|major pulmonary resection
1260478|NCT01758809|Post Pulmonary Resection|post pulmonary resection
1260479|NCT01758796|ER-stress positive|er-stress positive
1260480|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
1260481|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
1260482|NCT01758770|osteoporosis|osteoporosis
1260483|NCT01758770|osteoarthritis|osteoarthritis
1260484|NCT01758770|bone mineral density|bone mineral density
1260485|NCT01758770|computed xray tomography|computed xray tomography
1260486|NCT01758770|liver steatosis|liver steatosis
1260487|NCT01758770|obesity|obesity
1260488|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1260489|NCT01758757|Vitrectomy|vitrectomy
1260490|NCT01758744|COPD PH|copd ph
1260491|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
1260492|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
1260493|NCT01758744|Disease|disease
1260494|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
1260495|NCT01758731|Head and Neck Cancer|head and neck cancer
1260496|NCT01758731|Heavy drinking|heavy drinking
1260497|NCT01758731|Smoking|smoking
1260498|NCT01758718|Down's syndrome|down's syndrome
1260499|NCT01758718|entropion|entropion
1260500|NCT01758718|lid plasty|lid plasty
1260501|NCT01758705|Psoriasis|psoriasis
1260502|NCT01758705|Related to Health Quality of Life|related to health quality of life
1260503|NCT01758705|Patient Reported Outcomes|patient reported outcomes
1260504|NCT01758705|Venezuelan Patients|venezuelan patients
1260505|NCT01758692|spinal cord injury|spinal cord injury
1260506|NCT01758692|autonomic integrity|autonomic integrity
1260507|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
1260508|NCT01758692|baroreceptor integrity|baroreceptor integrity
1260509|NCT01758692|sympathetic integrity|sympathetic integrity
1260510|NCT01758692|vagal integrity|vagal integrity
1260511|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
1260512|NCT01758653|CO poisoning|co poisoning
1260513|NCT01758640|mechanical heart valve|mechanical heart valve
1260514|NCT01758640|pregnancy|pregnancy
1260515|NCT01758640|warfarin|warfarin
1260516|NCT01758640|phenindione|phenindione
1260517|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
1260518|NCT01758627|chronic kidney disease,|chronic kidney disease,
1260519|NCT01758627|refractory heart failure|refractory heart failure
1260520|NCT01758614|carotid artery occlusion|carotid artery occlusion
1260521|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
1260522|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
1260524|NCT01758601|white fish|white fish
1260525|NCT01758601|Metabolic syndrome|metabolic syndrome
1260526|NCT01758601|Cardiovascular risk|cardiovascular risk
1260527|NCT01758588|Primary myelofibrosis|primary myelofibrosis
1260528|NCT01758588|PMF|pmf
1260529|NCT01758575|Patients|patients
1260530|NCT01758549|pancreatitis|pancreatitis
1260531|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
1260532|NCT01758549|hyperamylasemia|hyperamylasemia
1260533|NCT01758536|ischemic stroke|ischemic stroke
1260534|NCT01758536|neural function|neural function
1260535|NCT01758536|life quality|life quality
1260536|NCT01758523|neuroactive steroids|neuroactive steroids
1260537|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1260538|NCT01758510|ALS|als
1260539|NCT01758510|Neurodegenerative disease|neurodegenerative disease
1260540|NCT01758510|Motor Neuron Disease|motor neuron disease
1260541|NCT01758510|Central Nervous System Disease|central nervous system disease
1260542|NCT01758510|Neuromuscular Disease|neuromuscular disease
1260543|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
1260544|NCT01758510|stem cell therapy|stem cell therapy
1260545|NCT01758510|intrathecal injection|intrathecal injection
1260546|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
1260547|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
1260548|NCT01758484|Supportive/palliative care|supportive/palliative care
1260549|NCT01758471|Type 2 Diabetes|type 2 diabetes
1260550|NCT01758471|gut microbiome|gut microbiome
1260551|NCT01758471|incretin|incretin
1260552|NCT01758471|Sulfonylurea|sulfonylurea
1260553|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
1260554|NCT01758445|Breast|breast
1260555|NCT01758445|Cancer|cancer
1260556|NCT01758445|Radiation|radiation
1260557|NCT01758445|Proton|proton
1260558|NCT01758432|Healthy volunteers|healthy volunteers
1260559|NCT01758419|post-RT|post-rt
1260560|NCT01758419|myocardial perfusion images|myocardial perfusion images
1260561|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
1260562|NCT01758393|IgG4-related disease|igg4-related disease
1260563|NCT01758393|IgG4-RD|igg4-rd
1260564|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1260565|NCT01758380|Ramadan|ramadan
1260566|NCT01758380|Vildagliptin|vildagliptin
1260567|NCT01758380|Hypoglycemia|hypoglycemia
1260568|NCT01758367|demethylating agent|demethylating agent
1260569|NCT01758367|immunogenicity|immunogenicity
1260570|NCT01758367|decitabine(DAC)|decitabine(dac)
1260571|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
1260572|NCT01758367|AML|aml
1260573|NCT01758354|Pompe disease|pompe disease
1260574|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
1260575|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
1260576|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
1260577|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
1260578|NCT01758328|BUSULFAN|busulfan
1260579|NCT01758328|FLUDARABINE|fludarabine
1260580|NCT01758328|G-CSF|g-csf
1260581|NCT01758328|MELPHALAN|melphalan
1260582|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
1260583|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
1260584|NCT01758328|12-175|12-175
1260585|NCT01758315|Ambulatory|ambulatory
1260586|NCT01758315|Outpatient|outpatient
1260587|NCT01758315|Malpractice|malpractice
1260588|NCT01758315|Quality Improvement|quality improvement
1260589|NCT01758315|Patient Safety|patient safety
1260590|NCT01758302|taste test|taste test
1260591|NCT01758302|food consumption|food consumption
1260592|NCT01758302|hunger|hunger
1260593|NCT01758289|Venezuelan Patients|venezuelan patients
1260594|NCT01758289|Depressive Symptoms|depressive symptoms
1260595|NCT01758289|Health Related Quality of Life|health related quality of life
1260596|NCT01758276|smoking, pregnancy|smoking, pregnancy
1260597|NCT01758263|Hypertension|hypertension
1260598|NCT01758263|Health Care Cost|health care cost
1260599|NCT01758263|Monthly health care cost|monthly health care cost
1260600|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
1260601|NCT01758250|Systemic sclerosis|systemic sclerosis
1260602|NCT01758250|Scleroderma|scleroderma
1260603|NCT01758250|Morphea|morphea
1260604|NCT01758250|Dermatomyositis|dermatomyositis
1260605|NCT01758250|Cutaneous lupus|cutaneous lupus
1260606|NCT01758250|Vasculitis|vasculitis
1260607|NCT01758250|Sickle Cell Disease|sickle cell disease
1260608|NCT01758250|Graft versus Host Disease|graft versus host disease
1260609|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
1260610|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
1260611|NCT01758237|Visual Disturbances|visual disturbances
1260612|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
1260613|NCT01758224|Multiple Sclerosis|multiple sclerosis
1260614|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
1260615|NCT01758224|Pulmonary Function|pulmonary function
1260616|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
1260617|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1260618|NCT01758211|Neuronavigation|neuronavigation
1260619|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
1260620|NCT01758185|Immunogenicity|immunogenicity
1260621|NCT01758185|Safety|safety
1260622|NCT01758185|Consistence|consistence
1260820|NCT01757145|Eltrombopag|eltrombopag
1260623|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
1260624|NCT01758172|postoperative patient|postoperative patient
1260625|NCT01758172|colloid|colloid
1260626|NCT01758172|albumin|albumin
1260627|NCT01758172|hetastarch|hetastarch
1260628|NCT01758146|Breast cancer|breast cancer
1260629|NCT01758146|obesity|obesity
1260630|NCT01758146|aromatase inhibitors|aromatase inhibitors
1260631|NCT01758146|postmenopausal|postmenopausal
1260632|NCT01758120|IgA nephropathy|iga nephropathy
1260633|NCT01758120|Cyclophosphamide|cyclophosphamide
1260634|NCT01758120|prednisone|prednisone
1260635|NCT01758094|hypogonadism|hypogonadism
1260636|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
1260637|NCT01758094|Testosterone treatment|testosterone treatment
1260638|NCT01758068|Preterms|preterms
1260639|NCT01758068|Coconut Oil application|coconut oil application
1260640|NCT01758068|Trans epidermal water loss|trans epidermal water loss
1260641|NCT01758068|Weight gain|weight gain
1260642|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
1260643|NCT01758042|Kidney|kidney
1260644|NCT01758042|Chronic Kidney Disease|chronic kidney disease
1260646|NCT01758042|Bone Marrow|bone marrow
1260647|NCT01758042|Bone Marrow Transplant|bone marrow transplant
1260648|NCT01758042|BMT|bmt
1260649|NCT01758042|Leukemia|leukemia
1260650|NCT01758042|AML|aml
1260651|NCT01758042|ALL|all
1260652|NCT01758042|CML|cml
1260653|NCT01758042|CLL|cll
1260654|NCT01758042|MM|mm
1260655|NCT01758042|NHL|nhl
1260656|NCT01758042|MDS|mds
1260657|NCT01758029|quality of life|quality of life
1260658|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
1260659|NCT01758029|partner|partner
1260660|NCT01758029|questionnaire|questionnaire
1260661|NCT01758003|Physical Activity|physical activity
1260662|NCT01758003|Sedentary Behaviour|sedentary behaviour
1260663|NCT01758003|Healthy Volunteer|healthy volunteer
1260664|NCT01758003|Quality of Life|quality of life
1260665|NCT01758003|Exercise Capacity|exercise capacity
1260666|NCT01758003|Transtheoretical Model|transtheoretical model
1260667|NCT01757990|dental caries|dental caries
1260668|NCT01757990|Stevioside|stevioside
1260669|NCT01757990|Rebaudioside|rebaudioside
1260670|NCT01757990|plaque pH|plaque ph
1260671|NCT01757990|Streptococcus mutans|streptococcus mutans
1260672|NCT01757977|Vivasight DL|vivasight dl
1260673|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
1260674|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
1260675|NCT01757964|Crohns Disease|crohns disease
1260676|NCT01757964|Ulcerative Colitis|ulcerative colitis
1260677|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
1260679|NCT01757951|Ankle|ankle
1260680|NCT01757951|Fracture|fracture
1260681|NCT01757951|medial malleolus|medial malleolus
1260682|NCT01757951|Osteosynthesis|osteosynthesis
1260683|NCT01757938|HIV|hiv
1260684|NCT01757938|Prevention|prevention
1260685|NCT01757938|Adult Male Circumcision|adult male circumcision
1260686|NCT01757938|Uganda|uganda
1260687|NCT01757938|Shang Ring|shang ring
1260688|NCT01757925|activity|activity
1260689|NCT01757925|gaming|gaming
1260690|NCT01757925|obesity|obesity
1260691|NCT01757925|Active Gaming|active gaming
1260692|NCT01757925|Control|control
1260693|NCT01757912|mechanical ventilation|mechanical ventilation
1260694|NCT01757899|ALI|ali
1260695|NCT01757899|Acute Lung Injury|acute lung injury
1260696|NCT01757899|ARDS|ards
1260697|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1260698|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
1260699|NCT01757899|Inflammatory Response|inflammatory response
1260700|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
1260701|NCT01757847|Binge-Eating Disorder|binge-eating disorder
1260702|NCT01757847|Obesity|obesity
1600926|NCT00390793|Cytoxan|cytoxan
1353367|NCT01361724|PD|pd
1260703|NCT01757847|emotional eating|emotional eating
1260704|NCT01757834|Thyroid Nodule|thyroid nodule
1260705|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
1260706|NCT01757834|Differential Diagnosis|differential diagnosis
1260707|NCT01757834|Elastography|elastography
1260708|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
1260709|NCT01757834|Sonoelastography|sonoelastography
1260710|NCT01757821|Stroke|stroke
1260711|NCT01757821|rTMS|rtms
1260712|NCT01757821|TMS|tms
1260713|NCT01757808|PAH|pah
1260714|NCT01757808|Ranolazine|ranolazine
1260715|NCT01757808|right ventricle|right ventricle
1260716|NCT01757808|Safety|safety
1260717|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1260718|NCT01757795|acute ischemic stroke|acute ischemic stroke
1260719|NCT01757795|ischemic stroke|ischemic stroke
1260720|NCT01757795|stroke|stroke
1260721|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
1260918|NCT01756729|Treatment|treatment
1260722|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
1260723|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
1260724|NCT01757743|Oedema formation|oedema formation
1260725|NCT01757717|radiation therapy|radiation therapy
1260726|NCT01757717|HDR brachytherapy|hdr brachytherapy
1260727|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
1260728|NCT01757717|12-260|12-260
1260729|NCT01757704|Cardiac de-airing|cardiac de-airing
1260730|NCT01757704|Air emboli|air emboli
1260731|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
1260732|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
1260733|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
1260734|NCT01757691|Optic neuritis|optic neuritis
1260735|NCT01757678|Coronary Artery Disease Computed Fractional Flow Reserve|coronary artery disease computed fractional flow reserve
1260736|NCT01757665|Aortic valve replacement|aortic valve replacement
1260737|NCT01757665|Mitral valve replacement|mitral valve replacement
1260738|NCT01757626|Bone Marrow|bone marrow
1260739|NCT01757626|Hu3F8|hu3f8
1260740|NCT01757626|GM-CSF|gm-csf
1260741|NCT01757626|12-230|12-230
1260742|NCT01757587|Type 2 Diabetes|type 2 diabetes
1260743|NCT01757587|Galvus|galvus
1260744|NCT01757587|basal insulin|basal insulin
1260745|NCT01757587|HbA1c|hba1c
1260746|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
1260747|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
1260748|NCT01757574|alemtuzumab|alemtuzumab
1260749|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
1260750|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1260751|NCT01757561|propofol|propofol
1260752|NCT01757561|sevoflurane|sevoflurane
1260753|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
1260754|NCT01757535|Maintenance therapy|maintenance therapy
1260755|NCT01757535|AML|aml
1260756|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
1260757|NCT01757535|oral Azacitidine|oral azacitidine
1260758|NCT01757535|best supportive care|best supportive care
1260759|NCT01757535|complete remission|complete remission
1260760|NCT01757509|Parkinson's disease|parkinson's disease
1260761|NCT01757509|Set dancing|set dancing
1260762|NCT01757496|Bronchiolitis|bronchiolitis
1260763|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
1260764|NCT01757496|Cough Assist|cough assist
1260765|NCT01757496|Physiotherapy|physiotherapy
1260766|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
1260767|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
1260768|NCT01757470|drug utilisation study,|drug utilisation study,
1260769|NCT01757470|post marketing commitments|post marketing commitments
1260770|NCT01757457|inflammation|inflammation
1260771|NCT01757457|thrombosis|thrombosis
1260772|NCT01757457|platelets|platelets
1260773|NCT01757457|adhesion molecules|adhesion molecules
1260774|NCT01757457|endothelium|endothelium
1260775|NCT01757418|Sickle Cell Disease|sickle cell disease
1260776|NCT01757418|Pain|pain
1260777|NCT01757418|Immune Globulin|immune globulin
1260778|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
1260779|NCT01757392|Treatment|treatment
1260780|NCT01757392|common wart lesions|common wart lesions
1260781|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
1260782|NCT01757379|Short chain fatty acids|short chain fatty acids
1260783|NCT01757379|Acetate|acetate
1260784|NCT01757379|Propionate|propionate
1260785|NCT01757379|Butyrate|butyrate
1260786|NCT01757379|Bioavailability|bioavailability
1260787|NCT01757314|arterial lines|arterial lines
1260788|NCT01757301|Pain|pain
1260789|NCT01757301|Depression|depression
1260790|NCT01757301|Anxiety|anxiety
1260791|NCT01757301|Musculoskeletal|musculoskeletal
1260792|NCT01757301|Fibromyalgia|fibromyalgia
1260793|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
1260794|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
1260795|NCT01757275|prevention of rebleeding|prevention of rebleeding
1600927|NCT00390793|Vincristine|vincristine
1260796|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
1260797|NCT01757262|Coronary Heart Disease|coronary heart disease
1260798|NCT01757236|Antibiotic|antibiotic
1260799|NCT01757236|linezolid|linezolid
1260800|NCT01757236|linezolid/rifampin|linezolid/rifampin
1260801|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
1260802|NCT01757210|Aprepitant|aprepitant
1260803|NCT01757210|Pediatrics|pediatrics
1260804|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
1260806|NCT01757184|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
1260807|NCT01757184|Lysosomal Storage Disease|lysosomal storage disease
1260808|NCT01757184|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
1260809|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
1260810|NCT01757184|Acid lipase disease|acid lipase disease
1260811|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1260812|NCT01757184|LAL Deficiency|lal deficiency
1260813|NCT01757184|LIPA Deficiency|lipa deficiency
1260814|NCT01757184|Wolman disease|wolman disease
1260815|NCT01757171|Gastric Cancer|gastric cancer
1260816|NCT01757158|lung cancer|lung cancer
1260817|NCT01757158|lobectomy|lobectomy
1260818|NCT01757158|local recurrence|local recurrence
1260819|NCT01757145|Cord blood transplantation|cord blood transplantation
1260821|NCT01757145|Platelet engraftment|platelet engraftment
1260822|NCT01757106|xenon anesthesia|xenon anesthesia
1260823|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
1260824|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
1260825|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
1260826|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
1260827|NCT01757093|WEANING VENTILATOR|weaning ventilator
1260828|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
1260829|NCT01757067|ablations|ablations
1260830|NCT01757067|CHF|chf
1260831|NCT01757067|PVC|pvc
1260832|NCT01757054|probiotic|probiotic
1260833|NCT01757054|LGG|lgg
1260834|NCT01757054|BB-12|bb-12
1260835|NCT01757054|fecal recovery|fecal recovery
1260836|NCT01757054|healthy subjects|healthy subjects
1260837|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
1260838|NCT01757041|Maternal|maternal
1260839|NCT01757041|Newborn|newborn
1260840|NCT01757041|Africa|africa
1260841|NCT01757028|Maternal and newborn health|maternal and newborn health
1260842|NCT01757028|Africa|africa
1260843|NCT01757015|COPD|copd
1260844|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1260845|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
1260846|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
1260847|NCT01757015|GOLD group B and D|gold group b and d
1260848|NCT01757015|NVA237|nva237
1260849|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
1260850|NCT01757002|Urban adolescents|urban adolescents
1260851|NCT01757002|Acute asthma|acute asthma
1260852|NCT01757002|Asthma|asthma
1260853|NCT01757002|Computer tailoring|computer tailoring
1260854|NCT01757002|Web-based intervention|web-based intervention
1260855|NCT01757002|Puff City|puff city
1260856|NCT01756950|Influenza|influenza
1260857|NCT01756950|Virus|virus
1260858|NCT01756950|Monoclonal|monoclonal
1260859|NCT01756950|Antibody|antibody
1260860|NCT01756950|Immunization|immunization
1260861|NCT01756950|Treatment|treatment
1260862|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
1260863|NCT01756924|prosthetic joint infection|prosthetic joint infection
1260864|NCT01756924|hip arthroplasty|hip arthroplasty
1260865|NCT01756924|MRSA|mrsa
1260866|NCT01756924|knee arthroplasty|knee arthroplasty
1260867|NCT01756911|MFM|mfm
1260868|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
1260869|NCT01756911|Multilayer stent|multilayer stent
1260870|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
1260871|NCT01756898|Atopic Dermatitis|atopic dermatitis
1260872|NCT01756898|eczema|eczema
1260873|NCT01756885|Smoking cessation|smoking cessation
1260874|NCT01756885|Nicotine dependence|nicotine dependence
1260875|NCT01756885|Varenicline|varenicline
1260876|NCT01756885|Chantix|chantix
1260877|NCT01756885|Cancer|cancer
1260878|NCT01756872|infertility|infertility
1260879|NCT01756872|Assisted reproductive technology|assisted reproductive technology
1260880|NCT01756872|ovarian reserve|ovarian reserve
1260881|NCT01756859|Portal hypertension|portal hypertension
1260882|NCT01756859|HVPG|hvpg
1260883|NCT01756859|MRI|mri
1260884|NCT01756846|HEART score|heart score
1260885|NCT01756846|risk score|risk score
1260886|NCT01756846|impact|impact
1260887|NCT01756846|chest pain|chest pain
1260888|NCT01756833|abdominal|abdominal
1260889|NCT01756833|aortic|aortic
1260890|NCT01756833|aneurysm|aneurysm
1260891|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
1260892|NCT01756820|transverse ligament|transverse ligament
1260893|NCT01756820|carpal tunnel release|carpal tunnel release
1260894|NCT01756820|endoscopic|endoscopic
1260895|NCT01756820|minimal invasive|minimal invasive
1260896|NCT01756820|mini-open|mini-open
1260897|NCT01756820|median nerve|median nerve
1260898|NCT01756807|Optical Coherence Tomography|optical coherence tomography
1260899|NCT01756807|Geneous Stent|geneous stent
1260900|NCT01756807|Combo Stent|combo stent
1260901|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
1260902|NCT01756794|Liver transplantation|liver transplantation
1260903|NCT01756794|Alcohol relapse|alcohol relapse
1260904|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
1260905|NCT01756781|PD-0332991|pd-0332991
1260906|NCT01756781|Midazolam|midazolam
1260907|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
1260908|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
1260909|NCT01756768|Phase 1|phase 1
1260910|NCT01756768|Mass Balance study|mass balance study
1260911|NCT01756768|Radio-labeled dose|radio-labeled dose
1260912|NCT01756768|PD-0332991|pd-0332991
1260913|NCT01756755|Sepsis|sepsis
1260914|NCT01756742|Pleural Effusion|pleural effusion
1260915|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
1260916|NCT01756742|Length of stay|length of stay
1260917|NCT01756729|Brain tumor|brain tumor
1260919|NCT01756729|Minimal toxicity|minimal toxicity
1260920|NCT01756729|GBM|gbm
1260921|NCT01756729|Glioblastoma|glioblastoma
1260922|NCT01756729|Recurrent|recurrent
1260923|NCT01756729|TTFields|ttfields
1260924|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
1260925|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
1260926|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
1260927|NCT01756690|blood component transfusion|blood component transfusion
1260928|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1260929|NCT01756690|blood coagulation|blood coagulation
1260930|NCT01756651|Intranasal fentanyl|intranasal fentanyl
1260931|NCT01756651|Cystoscopy|cystoscopy
1260932|NCT01756638|Prostate cancer|prostate cancer
1260933|NCT01756638|Abiraterone acetate|abiraterone acetate
1260934|NCT01756638|JNJ-212082|jnj-212082
1260935|NCT01756625|cetuximab|cetuximab
1260936|NCT01756625|nicotine|nicotine
1260937|NCT01756625|magnesium|magnesium
1260938|NCT01756586|popliteal block|popliteal block
1260939|NCT01756586|analgesia duration|analgesia duration
1260940|NCT01756573|block duration|block duration
1260941|NCT01756573|analgesia|analgesia
1260942|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
1260943|NCT01756560|block duration|block duration
1260944|NCT01756547|Nephrocalcinosis|nephrocalcinosis
1260945|NCT01756547|Extreme premature|extreme premature
1260946|NCT01756521|QT,|qt,
1260947|NCT01756521|QTc,|qtc,
1260948|NCT01756521|electrocardiogram,|electrocardiogram,
1260949|NCT01756521|moxifloxacin|moxifloxacin
1260950|NCT01756508|eculizumab|eculizumab
1260951|NCT01756508|kidney transplantation|kidney transplantation
1260952|NCT01756508|reperfusion|reperfusion
1260953|NCT01756508|rejection|rejection
1260954|NCT01756508|infection|infection
1260955|NCT01756495|QTc,|qtc,
1260956|NCT01756495|GW856553 .|gw856553 .
1260957|NCT01756495|P38,|p38,
1260958|NCT01756482|Respiratory|respiratory
1260959|NCT01756482|Syncytial|syncytial
1260960|NCT01756482|Virus|virus
1260961|NCT01756482|Infections|infections
1260962|NCT01756482|RSV|rsv
1260963|NCT01756456|Keratitis|keratitis
1260964|NCT01756456|Corneal Ulcer|corneal ulcer
1260965|NCT01756443|sciatic nerve block|sciatic nerve block
1260966|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
1260967|NCT01756443|sequential injection|sequential injection
1260968|NCT01756443|premixed injection|premixed injection
1260969|NCT01756443|local anaesthetics|local anaesthetics
1260970|NCT01756430|Carvedilol SR|carvedilol sr
1260971|NCT01756430|Carvedilol IR|carvedilol ir
1260972|NCT01756430|Hypertension|hypertension
1260973|NCT01756430|Essential Hypertension|essential hypertension
1260974|NCT01756417|Healthy|healthy
1260975|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1260976|NCT01756417|Metformin|metformin
1260977|NCT01756417|Pharmacokinetics|pharmacokinetics
1260978|NCT01756417|Pharmacodynamics|pharmacodynamics
1260979|NCT01756404|Healthy|healthy
1260980|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1260981|NCT01756404|Pharmacokinetics|pharmacokinetics
1260982|NCT01756404|Pharmacodynamics|pharmacodynamics
1260983|NCT01756404|Obesity|obesity
1260984|NCT01756391|pediatric|pediatric
1260985|NCT01756391|childhood|childhood
1260986|NCT01756391|allergy|allergy
1260987|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
1260988|NCT01756352|FET|fet
1260989|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
1260990|NCT01756352|GBM|gbm
1260991|NCT01756352|Response to treatment|response to treatment
1260992|NCT01756352|Avastin|avastin
1260993|NCT01756352|Brain Tumor|brain tumor
1260994|NCT01756339|Pneumonia|pneumonia
1260995|NCT01756339|CABP|cabp
1260996|NCT01756339|CAP|cap
1260997|NCT01756339|Macrolide|macrolide
1260998|NCT01756326|Non-Union Fractures|non-union fractures
1353728|NCT01360320|EGCG|egcg
1260999|NCT01756326|Impaired Healing|impaired healing
1261000|NCT01756326|Fractures|fractures
1261001|NCT01756326|Orthopedics|orthopedics
1261002|NCT01756326|Bone|bone
1261003|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
1261004|NCT01756300|Essential Hypertension|essential hypertension
1261005|NCT01756300|Renal Denervation|renal denervation
1261006|NCT01756300|Vascular Disease|vascular disease
1261007|NCT01756300|Renal Catheter Ablation|renal catheter ablation
1261008|NCT01756300|Primary Hypertension|primary hypertension
1261009|NCT01756261|EYLEA|eylea
1261010|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
1261011|NCT01756261|QOL|qol
1261012|NCT01756248|EYLEA|eylea
1261013|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
1261014|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
1261015|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
1261016|NCT01756235|Physical Activity|physical activity
1261017|NCT01756235|Adalimumab|adalimumab
1261018|NCT01756235|Humira®|humira®
1261019|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
1261020|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
1261021|NCT01756222|BAV|bav
1261725|NCT01752920|Tumour|tumour
1261022|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
1261023|NCT01756170|cervical cancer|cervical cancer
1261024|NCT01756170|radiotherapy|radiotherapy
1261025|NCT01756170|postoperative therapy|postoperative therapy
1261026|NCT01756170|chemotherapy|chemotherapy
1261027|NCT01756157|Crossover|crossover
1261028|NCT01756157|Prevention|prevention
1261029|NCT01756157|Hereditary Angioedema|hereditary angioedema
1261030|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
1261031|NCT01756157|C1 inhibitor|c1 inhibitor
1261032|NCT01756157|Subcutaneous|subcutaneous
1261033|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
1261034|NCT01756092|Breast Cancer|breast cancer
1261035|NCT01756092|Lumpectomy|lumpectomy
1261036|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
1261037|NCT01756066|Obesity|obesity
1261038|NCT01756066|Weight loss program|weight loss program
1261039|NCT01756066|incentives|incentives
1261040|NCT01756053|Smoking|smoking
1261041|NCT01756053|Tobacco|tobacco
1261042|NCT01756040|intestinal permeability|intestinal permeability
1261043|NCT01756040|preterm infants|preterm infants
1261044|NCT01756040|dual sugar test|dual sugar test
1261045|NCT01756027|Rosacea|rosacea
1261046|NCT01756027|Ulthera System|ulthera system
1261047|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
1261048|NCT01756027|Ulthera, Inc.|ulthera, inc.
1261049|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
1261050|NCT01755988|Telemedicine|telemedicine
1261051|NCT01755988|Heart Failure|heart failure
1261052|NCT01755988|Self care|self care
1261053|NCT01755988|Quality of life|quality of life
1261054|NCT01755988|Mortality|mortality
1261055|NCT01755988|Hospitalization|hospitalization
1261056|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
1261057|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
1261058|NCT01755975|12-170|12-170
1261059|NCT01755962|diet|diet
1261060|NCT01755962|obese|obese
1261061|NCT01755962|overweight|overweight
1261062|NCT01755962|exercise|exercise
1261063|NCT01755962|resistance training|resistance training
1261064|NCT01755962|nutrition|nutrition
1261065|NCT01755962|glycemic load|glycemic load
1261066|NCT01755962|body composition|body composition
1261067|NCT01755962|weight training|weight training
1261068|NCT01755962|lifestyle|lifestyle
1261069|NCT01755949|atrial fibrillation|atrial fibrillation
1261070|NCT01755949|catheter ablation|catheter ablation
1261071|NCT01755949|colchicine|colchicine
1261072|NCT01755949|c reactive protein|c reactive protein
1261073|NCT01755949|CRP|crp
1261074|NCT01755936|Aortic Stenosis|aortic stenosis
1261075|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1261076|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
1261077|NCT01755936|T1 mapping techniques|t1 mapping techniques
1261078|NCT01755936|Replacement fibrosis|replacement fibrosis
1261079|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
1261080|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
1261081|NCT01755923|wild-type EGFR|wild-type egfr
1261082|NCT01755923|gefitinib|gefitinib
1261083|NCT01755923|docetaxel|docetaxel
1261084|NCT01755923|second-line therapy|second-line therapy
1261085|NCT01755910|Breast Surgery|breast surgery
1261086|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
1261087|NCT01755910|HRV|hrv
1261088|NCT01755910|Autonomic Nervous System|autonomic nervous system
1261089|NCT01755884|Wheat allergy|wheat allergy
1261090|NCT01755884|Immunotherapy|immunotherapy
1261091|NCT01755884|Desensitization|desensitization
1261092|NCT01755884|Food allergy|food allergy
1261093|NCT01755884|T cells|t cells
1261094|NCT01755858|elamipretide|elamipretide
1261095|NCT01755845|cervical cancer|cervical cancer
1261096|NCT01755845|radiotherapy|radiotherapy
1261097|NCT01755845|postoperative therapy|postoperative therapy
1261098|NCT01755845|chemotherapy|chemotherapy
1261099|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
1261100|NCT01755832|text message|text message
1261101|NCT01755832|> 18 years|> 18 years
1261102|NCT01755832|Norwegian speaking|norwegian speaking
1261103|NCT01755806|Aortic annulus|aortic annulus
1261104|NCT01755806|Aortic calcification|aortic calcification
1261105|NCT01755806|Multislice computed tomography|multislice computed tomography
1261106|NCT01755806|Cardiac cycle|cardiac cycle
1261107|NCT01755767|MET diagnostic-high|met diagnostic-high
1261108|NCT01755767|Unresectable|unresectable
1261109|NCT01755767|Hepatocellular|hepatocellular
1261110|NCT01755767|Carcinoma|carcinoma
1261111|NCT01755767|c-Met inhibitor|c-met inhibitor
1261112|NCT01755728|Paracetamol|paracetamol
1261113|NCT01755728|Acetaminophen|acetaminophen
1261114|NCT01755728|PDA|pda
1261115|NCT01755728|Preterm infants|preterm infants
1261116|NCT01755715|Abortion|abortion
1261117|NCT01755715|Contraception|contraception
1261118|NCT01755715|Intrauterine Devices|intrauterine devices
1261119|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
1261120|NCT01755702|caffeine|caffeine
1261121|NCT01755702|paracetamol|paracetamol
1261830|NCT01752426|Leukemia|leukemia
1261122|NCT01755702|tension headache|tension headache
1261123|NCT01755689|pertussis|pertussis
1261124|NCT01755689|Meningococcal meningitis|meningococcal meningitis
1261125|NCT01755689|Meningococcal infections|meningococcal infections
1261126|NCT01755689|HPV|hpv
1261127|NCT01755689|Neisseria meningitidis|neisseria meningitidis
1261128|NCT01755689|Vaccines, conjugate|vaccines, conjugate
1261129|NCT01755689|tetanus|tetanus
1261130|NCT01755689|diphtheria|diphtheria
1261131|NCT01755689|Meningococcal vaccines|meningococcal vaccines
1261132|NCT01755689|Immunogenicity|immunogenicity
1261133|NCT01755663|CT coronary|ct coronary
1261134|NCT01755663|Coronary arterial disease|coronary arterial disease
1261135|NCT01755663|ivabradine|ivabradine
1261136|NCT01755663|metoprolol|metoprolol
1261137|NCT01755650|18F FPM|18f fpm
1261138|NCT01755650|PET/CT|pet/ct
1261139|NCT01755650|microdosing|microdosing
1261140|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
1261141|NCT01755624|NSCLC|nsclc
1261142|NCT01755624|Brain metastases|brain metastases
1261143|NCT01755624|Treatment|treatment
1261144|NCT01755624|Minimal toxicity|minimal toxicity
1261145|NCT01755624|TTFields|ttfields
1261146|NCT01755624|TTF|ttf
1261147|NCT01755624|Tumor Treating Fields|tumor treating fields
1261148|NCT01755624|NovoCure|novocure
1261149|NCT01755611|Minocycline|minocycline
1261150|NCT01755611|Mexico|mexico
1261151|NCT01755611|Acne|acne
1261152|NCT01755611|bioequivalence|bioequivalence
1261153|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
1261154|NCT01755598|Efficacy|efficacy
1261155|NCT01755598|Adults|adults
1261156|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
1261157|NCT01755598|Endemic region|endemic region
1261158|NCT01755585|Radiation therapy|radiation therapy
1261159|NCT01755585|5-fluorouracil|5-fluorouracil
1261160|NCT01755585|Cisplatin|cisplatin
1261161|NCT01755585|Pharmacokinetics|pharmacokinetics
1261162|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
1261163|NCT01755572|Type 2 Diabetes|type 2 diabetes
1261164|NCT01755572|Hypertension|hypertension
1261165|NCT01755572|Liraglutide|liraglutide
1261166|NCT01755572|GLP-1|glp-1
1261167|NCT01755559|malaria|malaria
1261168|NCT01755559|artemisinin|artemisinin
1261169|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
1261170|NCT01755559|Plasmodium falciparum|plasmodium falciparum
1261171|NCT01755559|efficacy|efficacy
1261172|NCT01755546|Chronic Pain|chronic pain
1261173|NCT01755546|CLBP|clbp
1261174|NCT01755546|Chronic Low Back Pain|chronic low back pain
1261175|NCT01755546|Back Pain|back pain
1261176|NCT01755546|Osteoarthritis|osteoarthritis
1261177|NCT01755546|OA|oa
1261178|NCT01755546|Neuropathic Pain|neuropathic pain
1261179|NCT01755546|Nerve pain|nerve pain
1261180|NCT01755546|Painful neuropathy|painful neuropathy
1261181|NCT01755533|adolescent substance use|adolescent substance use
1261182|NCT01755533|rural substance use|rural substance use
1261183|NCT01755533|middle school prevention|middle school prevention
1261184|NCT01755533|implementation processes|implementation processes
1261185|NCT01755533|implementation quality|implementation quality
1261186|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
1261187|NCT01755533|dissemination|dissemination
1261188|NCT01755520|CABG|cabg
1261189|NCT01755520|CAD|cad
1261190|NCT01755520|antiplatelet drug|antiplatelet drug
1261191|NCT01755520|Ticagrelor|ticagrelor
1261192|NCT01755520|Aspirin|aspirin
1261193|NCT01755507|PSC|psc
1261194|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
1333175|NCT01444183|stress reduction|stress reduction
1600928|NCT00390793|Vincasar|vincasar
1261195|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
1261196|NCT01755455|Cystic fibrosis|cystic fibrosis
1261197|NCT01755455|Iron|iron
1261198|NCT01755455|Hepcidin|hepcidin
1261199|NCT01755455|Anemia|anemia
1261200|NCT01755455|Erythropoiesis|erythropoiesis
1261201|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
1261202|NCT01755442|Type 2 diabetes|type 2 diabetes
1261203|NCT01755416|Type 1 diabetes|type 1 diabetes
1261204|NCT01755416|closed loop|closed loop
1261205|NCT01755416|artificial pancreas|artificial pancreas
1261206|NCT01755416|insulin|insulin
1261207|NCT01755416|victoza|victoza
1261208|NCT01755416|liraglutide|liraglutide
1261209|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
1261210|NCT01755338|inflammatory markers|inflammatory markers
1261211|NCT01755338|heart surgery|heart surgery
1261212|NCT01755338|neuronal damage|neuronal damage
1261213|NCT01755338|blood brain barrier|blood brain barrier
1261214|NCT01755299|Energy drinks|energy drinks
1261215|NCT01755299|Wakefulness|wakefulness
1261216|NCT01755299|Caffeine|caffeine
1261217|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
1261218|NCT01755273|Diabetes|diabetes
1261219|NCT01755260|POPF|popf
1261220|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
1261221|NCT01755260|enteral nutrition|enteral nutrition
1261222|NCT01755260|parenteral nutrition|parenteral nutrition
1261223|NCT01755247|acne|acne
1261224|NCT01755234|Outpatient|outpatient
1261225|NCT01755234|Surgery|surgery
1261226|NCT01755234|Anesthesia|anesthesia
1261227|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
1261228|NCT01755221|Extraesophageal reflux|extraesophageal reflux
1261229|NCT01755221|Reflux laryngitis|reflux laryngitis
1261230|NCT01755221|Posterior laryngitis|posterior laryngitis
1261629|NCT01753180|PCI|pci
1261231|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
1261232|NCT01755221|Restech pH probe|restech ph probe
1261233|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
1261234|NCT01755195|XL184|xl184
1261235|NCT01755195|Metastatic Refractory|metastatic refractory
1261236|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
1261237|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
1261238|NCT01755182|locoregional treatment|locoregional treatment
1261239|NCT01755182|liver metastases|liver metastases
1261240|NCT01755182|transarterial embolization|transarterial embolization
1261241|NCT01755182|upfront treatment|upfront treatment
1261242|NCT01755182|inoperable|inoperable
1261243|NCT01755182|octreotide|octreotide
1261244|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
1261245|NCT01755182|pulmonary primary|pulmonary primary
1261246|NCT01755182|primary unknown origin|primary unknown origin
1261247|NCT01755182|systemic therapy|systemic therapy
1261248|NCT01755169|Chronic pain|chronic pain
1261249|NCT01755169|Child|child
1261250|NCT01755169|Pediatric|pediatric
1261251|NCT01755169|Ketamine|ketamine
1261252|NCT01755130|Breast Cancer|breast cancer
1261253|NCT01755130|LOUIS-3D|louis-3d
1261254|NCT01755130|Breast Study|breast study
1261255|NCT01755130|x-ray|x-ray
1261256|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
1261257|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
1261258|NCT01755130|Breast lesions|breast lesions
1261259|NCT01755130|Ductal carcinomas|ductal carcinomas
1261260|NCT01755130|Lobular carcinomas|lobular carcinomas
1261261|NCT01755130|Fibroadenomas|fibroadenomas
1261262|NCT01755078|Phosphate binder|phosphate binder
1261263|NCT01755065|laparoscopic surgery|laparoscopic surgery
1261264|NCT01755065|teenager|teenager
1261265|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
1261266|NCT01755052|Geriatrics|geriatrics
1261267|NCT01755052|Cardiology|cardiology
1261268|NCT01755052|Aging|aging
1261269|NCT01755052|Heart Attack|heart attack
1261270|NCT01755052|Risk Factors|risk factors
1261271|NCT01755052|Quality of Care|quality of care
1261272|NCT01755052|Risk Models|risk models
1261273|NCT01755026|Cesarean Delivery|cesarean delivery
1261274|NCT01755026|Wound infection|wound infection
1261275|NCT01755026|Obesity|obesity
1261276|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
1261277|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
1261278|NCT01755013|Biliary Stricture|biliary stricture
1261279|NCT01755013|Biliary obstruction|biliary obstruction
1261280|NCT01755013|Bile Duct Cancer|bile duct cancer
1261281|NCT01755013|PDT|pdt
1261282|NCT01755013|Photodynamic Therapy|photodynamic therapy
1261283|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
1261284|NCT01755013|Laser|laser
1261285|NCT01754987|Vitamins|vitamins
1261286|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
1261287|NCT01754987|Integrative Medicine|integrative medicine
1261288|NCT01754987|Complementary Medicine|complementary medicine
1261289|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
1261290|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1261291|NCT01754987|Pharmacologic Actions|pharmacologic actions
1261292|NCT01754987|Protective Agents|protective agents
1261293|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
1261294|NCT01754987|Micronutrients|micronutrients
1261295|NCT01754987|Growth Substances|growth substances
1261296|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1261297|NCT01754987|Antineoplastic Agents|antineoplastic agents
1261298|NCT01754987|Therapeutic Uses|therapeutic uses
1261299|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
1261300|NCT01754987|Liver Cancer|liver cancer
1261301|NCT01754948|asthma|asthma
1261302|NCT01754948|reactive airway disease|reactive airway disease
1261303|NCT01754948|cough|cough
1261304|NCT01754948|air pollution|air pollution
1261305|NCT01754948|nano particles|nano particles
1261306|NCT01754922|exercise tolerance|exercise tolerance
1261307|NCT01754922|Veterans|veterans
1261308|NCT01754922|operation enduring freedom|operation enduring freedom
1261309|NCT01754922|operation Iraqi freedom|operation iraqi freedom
1261310|NCT01754909|lung cancer|lung cancer
1261311|NCT01754909|radiation pneumonitis|radiation pneumonitis
1261312|NCT01754909|mitigation|mitigation
1261313|NCT01754909|enalapril|enalapril
1261314|NCT01754909|placebo|placebo
1261315|NCT01754896|colorectal cancer|colorectal cancer
1261316|NCT01754896|fecal immunochemical test|fecal immunochemical test
1261317|NCT01754896|fecal occult blood test|fecal occult blood test
1261318|NCT01754896|screening|screening
1261319|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
1261320|NCT01754883|Lithium|lithium
1261321|NCT01754870|CLL|cll
1261322|NCT01754870|SLL|sll
1261323|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
1261324|NCT01754857|Bendamustine|bendamustine
1261325|NCT01754857|Rituximab|rituximab
1261326|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1261327|NCT01754844|Phase 1|phase 1
1261328|NCT01754844|Healthy Volunteers|healthy volunteers
1261329|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
1261330|NCT01754844|First Time in Man|first time in man
1261331|NCT01754844|Pharmacokinetics|pharmacokinetics
1261332|NCT01754844|Pharmacodynamics|pharmacodynamics
1261333|NCT01754831|children|children
1261334|NCT01754831|fluoride varnish|fluoride varnish
1261335|NCT01754818|Pharmacokinetics|pharmacokinetics
1261336|NCT01754818|volunteers|volunteers
1261337|NCT01754805|ASP015K|asp015k
1261338|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
1261339|NCT01754779|calcium phosphate|calcium phosphate
1261340|NCT01754779|urolithiasis|urolithiasis
1261341|NCT01754779|kidney stones|kidney stones
1261342|NCT01754779|hypercalciuria|hypercalciuria
1261343|NCT01754753|Mental well-being|mental well-being
1261344|NCT01754753|Befriending|befriending
1261345|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
1261346|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
1261347|NCT01754727|Effectiveness|effectiveness
1261348|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
1261349|NCT01754727|Adalimumab|adalimumab
1261350|NCT01754727|Humira®|humira®
1261351|NCT01754714|Steatohepatitis|steatohepatitis
1261352|NCT01754662|Type 2 diabetes|type 2 diabetes
1261353|NCT01754662|Cardiovascular risk|cardiovascular risk
1261354|NCT01754662|Endothelial function|endothelial function
1261355|NCT01754662|Insulin resistance|insulin resistance
1261356|NCT01754662|Soy|soy
1261357|NCT01754662|Isoflavones|isoflavones
1261358|NCT01754662|Cocoa|cocoa
1261359|NCT01754662|Diet|diet
1261360|NCT01754649|intrauterine device|intrauterine device
1261361|NCT01754649|insertion failure|insertion failure
1261362|NCT01754636|Colorectal neoplasms|colorectal neoplasms
1261363|NCT01754636|Elderly|elderly
1261364|NCT01754636|Randomized clinical trials|randomized clinical trials
1261365|NCT01754636|Inclusion.|inclusion.
1261366|NCT01754623|Pancreas|pancreas
1261367|NCT01754623|Pancreatic|pancreatic
1261368|NCT01754623|Neoplasms|neoplasms
1261369|NCT01754623|Stereotactic|stereotactic
1261370|NCT01754623|Radiosurgery|radiosurgery
1261371|NCT01754623|Borderline|borderline
1261372|NCT01754623|Resectable|resectable
1261373|NCT01754623|Gastrointestinal|gastrointestinal
1261374|NCT01754623|Gemcitabine|gemcitabine
1261375|NCT01754623|Capecitabine|capecitabine
1261376|NCT01754623|Fluorouracil|fluorouracil
1261377|NCT01754623|Docetaxel|docetaxel
1261378|NCT01754623|SBRT|sbrt
1261379|NCT01754623|GTX Chemotherapy|gtx chemotherapy
1261380|NCT01754610|family trauma|family trauma
1261381|NCT01754610|multi-family therapy|multi-family therapy
1261382|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
1261383|NCT01754610|poverty|poverty
1261384|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
1261385|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
1261386|NCT01754584|molecular weight|molecular weight
1261387|NCT01754584|mucociliary differentiation|mucociliary differentiation
1261388|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
1261389|NCT01754571|medication overuse headache|medication overuse headache
1261390|NCT01754545|Infusions, Intravenous|infusions, intravenous
1261391|NCT01754545|Plasma|plasma
1261392|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
1261393|NCT01754532|Schizophrenia|schizophrenia
1261394|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
1261395|NCT01754532|Stress|stress
1261396|NCT01754532|Cortisol|cortisol
1261397|NCT01754532|PANSS|panss
1261398|NCT01754506|leg ulcers|leg ulcers
1261399|NCT01754506|wounds|wounds
1261400|NCT01754506|fish oil|fish oil
1261401|NCT01754506|lipid mediators|lipid mediators
1261402|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
1261403|NCT01754493|Major Depression|major depression
1261404|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
1261405|NCT01754493|Somatization|somatization
1261406|NCT01754493|Cymbalta|cymbalta
1261407|NCT01754493|Duloxetine|duloxetine
1261408|NCT01754480|Fibrin Sealant|fibrin sealant
1261409|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
1261410|NCT01754480|Hepatic Resection|hepatic resection
1261411|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
1261412|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
1261413|NCT01754441|SMA|sma
1261414|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
1261415|NCT01754428|Respiratory|respiratory
1261416|NCT01754428|Syncytial|syncytial
1261417|NCT01754428|Virus|virus
1261418|NCT01754428|RSV|rsv
1261419|NCT01754415|Aging|aging
1261420|NCT01754415|Chronic illness|chronic illness
1261421|NCT01754415|Resistance circuit training|resistance circuit training
1261422|NCT01754402|Multiple Myeloma|multiple myeloma
1261423|NCT01754376|Metastatic|metastatic
1261424|NCT01754376|Unresectable|unresectable
1261425|NCT01754376|V600E mutation|v600e mutation
1261426|NCT01754363|Osteoarthritis|osteoarthritis
1261427|NCT01754350|ketogenic diet|ketogenic diet
1261428|NCT01754350|glioma|glioma
1261429|NCT01754350|fasting|fasting
1261430|NCT01754350|reirradiation|reirradiation
1261431|NCT01754350|nutrition|nutrition
1261432|NCT01754337|Type 1 diabetes|type 1 diabetes
1261433|NCT01754337|Hypoglycemia|hypoglycemia
1261434|NCT01754337|Insulin|insulin
1261435|NCT01754337|Glucagon|glucagon
1261436|NCT01754337|Closed-loop system|closed-loop system
1261437|NCT01754337|Artificial pancreas|artificial pancreas
1261438|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1261439|NCT01754324|Pharmacokinetics|pharmacokinetics
1261440|NCT01754324|Methadone|methadone
1261441|NCT01754324|Neonate|neonate
1261442|NCT01754324|Newborn|newborn
1261443|NCT01754311|HTLV-I|htlv-i
1261444|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
1261445|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
1261446|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
1261447|NCT01754298|retro-articular drilling|retro-articular drilling
1261448|NCT01754298|trans-articular drilling|trans-articular drilling
1261449|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
1261450|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
1261451|NCT01754272|mCRC|mcrc
1261452|NCT01754272|Aflibercept|aflibercept
1261453|NCT01754272|FOLFIRI|folfiri
1261454|NCT01754272|translational research|translational research
1261455|NCT01754272|retrospective|retrospective
1261456|NCT01754272|noninterventional|noninterventional
1261457|NCT01754272|biomarkers|biomarkers
1261458|NCT01754272|angiogenesis|angiogenesis
1261459|NCT01754259|type 1 diabetes|type 1 diabetes
1261460|NCT01754259|type 2 diabetes|type 2 diabetes
1261461|NCT01754259|exertion angina|exertion angina
1261462|NCT01754259|suspected CAD|suspected cad
1261463|NCT01754259|known CAD|known cad
1261464|NCT01754194|Gastric Sleeve|gastric sleeve
1261465|NCT01754194|Gastric Bypass|gastric bypass
1261466|NCT01754194|Roux en Y|roux en y
1261467|NCT01754194|Morbid Obesity|morbid obesity
1261468|NCT01754194|Laparoscopy|laparoscopy
1261469|NCT01754181|Glycemic control algorithm|glycemic control algorithm
1261470|NCT01754181|closed loop|closed loop
1261471|NCT01754181|artificial pancreas|artificial pancreas
1261472|NCT01754168|Parkinson disease|parkinson disease
1261473|NCT01754168|Cognition|cognition
1261474|NCT01754155|Vitamin E|vitamin e
1261475|NCT01754155|Zimmer|zimmer
1261477|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
1261478|NCT01754129|Caregiver|caregiver
1261479|NCT01754129|Quality of Life|quality of life
1261480|NCT01754129|Parkinson's Disease|parkinson's disease
1261481|NCT01754116|healthy subjects|healthy subjects
1261482|NCT01754116|GSK1265744 LAP|gsk1265744 lap
1261483|NCT01754116|integrase inhibitor|integrase inhibitor
1261484|NCT01754116|HIV-1 infection|hiv-1 infection
1261485|NCT01754116|long acting retroviral|long acting retroviral
1261486|NCT01754116|relative bioavailability|relative bioavailability
1261487|NCT01754103|blind|blind
1261488|NCT01754103|tactile stimulation|tactile stimulation
1261489|NCT01754103|cross-modality|cross-modality
1261490|NCT01754103|visual qualia|visual qualia
1261491|NCT01754103|resting state MRI|resting state mri
1261492|NCT01754103|functional connectivity|functional connectivity
1261493|NCT01754103|neuroplasticity|neuroplasticity
1261494|NCT01754090|alcohol|alcohol
1261495|NCT01754090|online intervention|online intervention
1261496|NCT01754090|hazardous drinking|hazardous drinking
1261497|NCT01754090|harmful drinking|harmful drinking
1261498|NCT01754090|early intervention|early intervention
1261499|NCT01754090|behavior change intervention|behavior change intervention
1261500|NCT01754077|Language|language
1261501|NCT01754077|Behavior change|behavior change
1261502|NCT01754077|Intervention|intervention
1261503|NCT01754077|Home visiting|home visiting
1261504|NCT01754077|Child language development|child language development
1261505|NCT01754064|Bradycardia|bradycardia
1261506|NCT01754064|Tachycardia|tachycardia
1261507|NCT01754064|Arrhythimas|arrhythimas
1261508|NCT01754064|ICD|icd
1261509|NCT01754064|pacemaker|pacemaker
1261510|NCT01754064|pacing lead|pacing lead
1261511|NCT01754038|Patient Reported Outcomes|patient reported outcomes
1261512|NCT01754038|PRO|pro
1261513|NCT01754038|Registry|registry
1261514|NCT01754025|Gene Mutation|gene mutation
1261515|NCT01754012|Nutrition|nutrition
1261516|NCT01754012|Dietary intervention|dietary intervention
1261517|NCT01754012|Aging|aging
1261518|NCT01754012|Inflammation|inflammation
1261519|NCT01754012|Elderly|elderly
1261520|NCT01754012|Europe|europe
1261521|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
1261522|NCT01753999|nasal symptoms|nasal symptoms
1261523|NCT01753999|nasal inflammation|nasal inflammation
1261524|NCT01753999|CPAP|cpap
1261525|NCT01753973|Metabolic syndrome|metabolic syndrome
1261526|NCT01753973|Renal transplantation|renal transplantation
1261527|NCT01753895|Healthy Volunteers|healthy volunteers
1261528|NCT01753882|Gait training|gait training
1261529|NCT01753882|Lexapro|lexapro
1261530|NCT01753882|Tizanidine|tizanidine
1261531|NCT01753843|Preterm Birth|preterm birth
1261532|NCT01753830|Double-blind|double-blind
1261533|NCT01753830|Randomized|randomized
1261534|NCT01753830|Intraarticular injection|intraarticular injection
1261535|NCT01753830|Hyaluronic acid|hyaluronic acid
1261536|NCT01753830|Placebo|placebo
1261537|NCT01753830|Knee osteoarthritis|knee osteoarthritis
1261538|NCT01753817|Coronary catheterization|coronary catheterization
1261539|NCT01753817|Transradial patency|transradial patency
1261540|NCT01753804|DMD|dmd
1261541|NCT01753804|Myopathy|myopathy
1261542|NCT01753804|Natural History|natural history
1261543|NCT01753804|Muscular dystrophy|muscular dystrophy
1261544|NCT01753804|Biomarkers|biomarkers
1261545|NCT01753804|Muscle testing|muscle testing
1261546|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
1261547|NCT01753765|occipital neuralgia|occipital neuralgia
1261548|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
1261549|NCT01753700|crossover|crossover
1261550|NCT01753700|UHT milk|uht milk
1261551|NCT01753700|Pasteurised milk|pasteurised milk
1261552|NCT01753700|supplement|supplement
1261553|NCT01753687|break up time|break up time
1261554|NCT01753687|tear film thickness|tear film thickness
1261555|NCT01753687|tear film osmolarity|tear film osmolarity
1261556|NCT01753687|objective scattering index|objective scattering index
1261557|NCT01753687|impression cytology|impression cytology
1261558|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
1261559|NCT01753687|visual acuity|visual acuity
1261560|NCT01753687|fluorescein staining|fluorescein staining
1261561|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
1261562|NCT01753661|Hearing loss|hearing loss
1261563|NCT01753661|Language|language
1261564|NCT01753661|Behavior change|behavior change
1261565|NCT01753661|Early Intervention|early intervention
1261566|NCT01753661|Home visiting|home visiting
1261567|NCT01753648|retinal blood flow|retinal blood flow
1261568|NCT01753648|retinal blood velocity|retinal blood velocity
1261569|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
1261570|NCT01753648|retinal vessel diameter|retinal vessel diameter
1261571|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
1261572|NCT01753635|Baska mask|baska mask
1261573|NCT01753635|LMA|lma
1261574|NCT01753635|single use LMA device|single use lma device
1261575|NCT01753635|laryngeal mask airway|laryngeal mask airway
1261576|NCT01753635|supraglottic airway device|supraglottic airway device
1261577|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
1261578|NCT01753609|Over weight|over weight
1261579|NCT01753609|Obesity|obesity
1261580|NCT01753596|topical lubricants|topical lubricants
1261581|NCT01753596|tear film thickness|tear film thickness
1261582|NCT01753596|break up time|break up time
1261583|NCT01753596|ocular surface disease index|ocular surface disease index
1261584|NCT01753596|Schirmer I test|schirmer i test
1261585|NCT01753583|optical coherence tomography|optical coherence tomography
1261586|NCT01753583|corneal abrasion|corneal abrasion
1261587|NCT01753583|corneal infiltrate|corneal infiltrate
1261588|NCT01753570|Feron|feron
1261589|NCT01753557|Pegasys|pegasys
1261590|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
1261591|NCT01753531|Influenza Type A|influenza type a
1261592|NCT01753531|Influenza Type B|influenza type b
1261593|NCT01753531|Flu|flu
1261594|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
1261595|NCT01753518|Subcuticular suture|subcuticular suture
1261596|NCT01753518|Subcuticular staple|subcuticular staple
1261597|NCT01753518|Skin closure|skin closure
1261598|NCT01753518|Incision closure|incision closure
1261599|NCT01753518|Wound|wound
1261600|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
1261601|NCT01753492|Intraocular pressure|intraocular pressure
1261602|NCT01753492|glaucoma|glaucoma
1261603|NCT01753492|trabeculectomy|trabeculectomy
1261604|NCT01753492|Ologen|ologen
1261605|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1261606|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1261607|NCT01753453|Tumour cell mobilization|tumour cell mobilization
1261608|NCT01753440|coronary artery disease|coronary artery disease
1261609|NCT01753440|heart failure|heart failure
1261610|NCT01753440|stem cells implantation|stem cells implantation
1261611|NCT01753427|COPD,|copd,
1261612|NCT01753427|symptoms,|symptoms,
1261613|NCT01753427|Non-Interventional study,|non-interventional study,
1261614|NCT01753414|Lung Cancer|lung cancer
1261615|NCT01753401|SLE|sle
1261616|NCT01753401|Lupus|lupus
1261617|NCT01753375|Multiple Sclerosis|multiple sclerosis
1261618|NCT01753375|Relapsing rate|relapsing rate
1261619|NCT01753375|Expanded disability status scale|expanded disability status scale
1261620|NCT01753375|Vitamin D3|vitamin d3
1261621|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
1261622|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
1261623|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
1261624|NCT01753245|Gene polymorphism|gene polymorphism
1261625|NCT01753232|DALI adsorber|dali adsorber
1261626|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
1261627|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
1261628|NCT01753180|CTO|cto
1261630|NCT01753180|Angioplasty|angioplasty
1261631|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
1261632|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
1261633|NCT01753154|Hydration status|hydration status
1261634|NCT01753154|Residual renal function|residual renal function
1261635|NCT01753154|Body composition monitor|body composition monitor
1261636|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
1261637|NCT01753154|Cancer antigen 125|cancer antigen 125
1261638|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
1261639|NCT01753141|Smoking Cessation|smoking cessation
1261640|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
1261641|NCT01753115|toxin neutralization assay|toxin neutralization assay
1261642|NCT01753102|Estradiol|estradiol
1261643|NCT01753102|Vulvar atrophy|vulvar atrophy
1261644|NCT01753102|vaginal atrophy|vaginal atrophy
1261645|NCT01753089|Metastatic|metastatic
1261646|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1261647|NCT01753076|efficacy|efficacy
1261648|NCT01753076|ozanezumab|ozanezumab
1261649|NCT01753076|safety|safety
1261650|NCT01753063|Obesity|obesity
1261651|NCT01753063|Children|children
1261652|NCT01753063|Adolescents|adolescents
1261653|NCT01753063|Attrition|attrition
1261654|NCT01753037|Hyperandrogenism|hyperandrogenism
1261655|NCT01753037|Inflammation|inflammation
1261656|NCT01753037|Insulin sensitivity|insulin sensitivity
1261657|NCT01753037|Body composition|body composition
1261658|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
1261659|NCT01753024|fecal elastase-1|fecal elastase-1
1261660|NCT01753024|amylase|amylase
1261661|NCT01753024|lipase|lipase
1261662|NCT01753024|critical illness|critical illness
1261663|NCT01753024|enteral nutrition|enteral nutrition
1261664|NCT01753024|malnutrition|malnutrition
1261665|NCT01753024|sepsis|sepsis
1261666|NCT01753024|diabetes|diabetes
1261667|NCT01753024|hyperlactacidemia|hyperlactacidemia
1261668|NCT01753024|hemodialysis|hemodialysis
1261669|NCT01753024|mechanical ventilation|mechanical ventilation
1261670|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
1261671|NCT01753011|Transobturator sling|transobturator sling
1261672|NCT01753011|TOT|tot
1261673|NCT01752998|pain|pain
1261674|NCT01752998|depression|depression
1261675|NCT01752998|substance use|substance use
1261676|NCT01752972|Arsenic|arsenic
1261677|NCT01752972|Keratosis|keratosis
1261678|NCT01752972|Linoleic acid|linoleic acid
1261679|NCT01752972|Palm|palm
1261680|NCT01752972|Spirulina|spirulina
1261681|NCT01752972|Vitamin E|vitamin e
1261682|NCT01752972|Zinc|zinc
1261683|NCT01752920|FGFR|fgfr
1261684|NCT01752920|ARQ 087|arq 087
1261685|NCT01752920|Targeted therapy|targeted therapy
1261686|NCT01752920|Molecular therapy|molecular therapy
1261687|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1261688|NCT01752920|TKI|tki
1261689|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
1261690|NCT01752920|RTK|rtk
1261691|NCT01752920|Biomarker|biomarker
1354640|NCT01356160|HCV|hcv
1261692|NCT01752920|Phase 1|phase 1
1261693|NCT01752920|Phase I|phase i
1261694|NCT01752920|Solid tumor|solid tumor
1261695|NCT01752920|Liver Cancer|liver cancer
1261696|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
1261697|NCT01752920|Biliary tract cancer|biliary tract cancer
1261698|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
1261699|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
1261700|NCT01752920|FGFR inhibitor|fgfr inhibitor
1261701|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
1261702|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
1261703|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
1261704|NCT01752920|FGFR pathway|fgfr pathway
1261705|NCT01752920|FGFR signaling|fgfr signaling
1261706|NCT01752920|Fibroblast growth factor|fibroblast growth factor
1261707|NCT01752920|FGFR1|fgfr1
1261708|NCT01752920|FGFR2|fgfr2
1261709|NCT01752920|FGFR3|fgfr3
1261710|NCT01752920|FGFR4|fgfr4
1261711|NCT01752920|FGF|fgf
1261712|NCT01752920|FGF19|fgf19
1261713|NCT01752920|FGF21|fgf21
1261714|NCT01752920|FGF23|fgf23
1261715|NCT01752920|FGFR mutation|fgfr mutation
1261716|NCT01752920|FGFR gene fusion|fgfr gene fusion
1261717|NCT01752920|FGFR gene translocation|fgfr gene translocation
1261718|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
1261719|NCT01752920|FGFR2 fusion|fgfr2 fusion
1261720|NCT01752920|FGFR2 translocation|fgfr2 translocation
1261721|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
1261722|NCT01752920|Phase I Clinical Trial|phase i clinical trial
1261723|NCT01752920|Clinical oncology|clinical oncology
1261724|NCT01752920|Tumor|tumor
1261726|NCT01752907|Breast cancer|breast cancer
1261727|NCT01752907|Chemotherapy|chemotherapy
1261728|NCT01752907|Pegfilgrastim|pegfilgrastim
1261729|NCT01752907|Neulasta|neulasta
1261730|NCT01752907|Bone Pain|bone pain
1261731|NCT01752907|Education|education
1261732|NCT01752881|Influenza|influenza
1261733|NCT01752881|Vaccine|vaccine
1261734|NCT01752881|Immunogenicity|immunogenicity
1261735|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
1261736|NCT01752842|Diabetes|diabetes
1261737|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
1261738|NCT01752842|Triglycerides|triglycerides
1261739|NCT01752829|Obesity|obesity
1261740|NCT01752829|gastric|gastric
1261741|NCT01752829|banding|banding
1261742|NCT01752829|Weight|weight
1261743|NCT01752829|co-morbidities|co-morbidities
1261744|NCT01752829|dilatation|dilatation
1261745|NCT01752829|Excess weight loss|excess weight loss
1261746|NCT01752829|adjustable gastric banding|adjustable gastric banding
1261747|NCT01752816|endurance training,|endurance training,
1261748|NCT01752816|strength training,|strength training,
1261749|NCT01752816|aerobic capacity,|aerobic capacity,
1261750|NCT01752816|muscle strenght|muscle strenght
1261751|NCT01752816|physical capacity|physical capacity
1261752|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
1261753|NCT01752790|Biologics|biologics
1261754|NCT01752790|Immunomodulators|immunomodulators
1261755|NCT01752790|Top-down|top-down
1261756|NCT01752790|step-up|step-up
1261757|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
1261758|NCT01752751|Neck cancer|neck cancer
1261759|NCT01752751|Head cancer|head cancer
1261760|NCT01752751|Lung cancer|lung cancer
1261761|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
1261762|NCT01752725|vessel sealing|vessel sealing
1261763|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
1261764|NCT01752712|Oxytocin|oxytocin
1261765|NCT01752712|Social function|social function
1261766|NCT01752712|CBSST|cbsst
1261767|NCT01752699|neuropathic pain,|neuropathic pain,
1261768|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
1261769|NCT01752699|methadone,|methadone,
1261770|NCT01752686|Triple negative breast cancer|triple negative breast cancer
1261771|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
1261772|NCT01752673|randomized controlled study|randomized controlled study
1261773|NCT01752660|Exercise therapy|exercise therapy
1261774|NCT01752660|Aerobic training|aerobic training
1261775|NCT01752660|Endurance training|endurance training
1261776|NCT01752647|lung cancer|lung cancer
1261777|NCT01752647|screening|screening
1261778|NCT01752647|low dose|low dose
1261779|NCT01752647|computed tomography|computed tomography
1261780|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
1261781|NCT01752621|Acromegaly|acromegaly
1261782|NCT01752621|mortality|mortality
1261783|NCT01752621|morbidity|morbidity
1261784|NCT01752621|incidence|incidence
1261785|NCT01752621|prevalence|prevalence
1261786|NCT01752608|Depression|depression
1261787|NCT01752608|Real-time|real-time
1261788|NCT01752608|iPhone|iphone
1261789|NCT01752608|CBT|cbt
1261790|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
1261791|NCT01752582|BuMA|buma
1261792|NCT01752582|EXCEL|excel
1261793|NCT01752582|OCT|oct
1354715|NCT01355861|aging|aging
1261794|NCT01752582|stent|stent
1261795|NCT01752582|neointima formation|neointima formation
1261796|NCT01752569|HIV|hiv
1261797|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
1261798|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
1261799|NCT01752569|HAART|haart
1261800|NCT01752569|AIDS|aids
1261801|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
1261802|NCT01752543|Vasopressin|vasopressin
1261803|NCT01752543|Exercise capacity|exercise capacity
1261804|NCT01752543|Conivaptan|conivaptan
1261805|NCT01752530|ADHD|adhd
1261806|NCT01752517|small cell lung cancer|small cell lung cancer
1261807|NCT01752517|chemotherapy|chemotherapy
1261808|NCT01752517|vinorelbine|vinorelbine
1261809|NCT01752517|ifosfamide|ifosfamide
1261810|NCT01752517|third-line treatment|third-line treatment
1261811|NCT01752504|HIV prevention|hiv prevention
1261812|NCT01752504|HIV positive communities|hiv positive communities
1261813|NCT01752491|Ascorbate|ascorbate
1261814|NCT01752491|Ascorbic acid|ascorbic acid
1261815|NCT01752491|Vitamin C|vitamin c
1261816|NCT01752491|Radiation|radiation
1261817|NCT01752491|Temozolomide|temozolomide
1261818|NCT01752478|ptosis|ptosis
1261819|NCT01752478|retina surgery|retina surgery
1261820|NCT01752478|droopy eye lid|droopy eye lid
1261821|NCT01752465|Health behaviour|health behaviour
1261822|NCT01752465|Antipsychotic agents|antipsychotic agents
1261823|NCT01752465|Adverse effects|adverse effects
1261824|NCT01752465|Goals|goals
1261825|NCT01752465|Life style|life style
1261826|NCT01752439|Chronic Migraine|chronic migraine
1261827|NCT01752439|Medication Overuse Headache|medication overuse headache
1261828|NCT01752439|Refractory|refractory
1261829|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
1261831|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1261832|NCT01752426|CLL|cll
1261833|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1261834|NCT01752426|SLL|sll
1261835|NCT01752426|PCI-32765|pci-32765
1261836|NCT01752426|Ibrutinib|ibrutinib
1261837|NCT01752426|Btk inhibitor|btk inhibitor
1261838|NCT01752426|Heavy water|heavy water
1261839|NCT01752426|2H2O|2h2o
1261840|NCT01752413|Iron depletion|iron depletion
1261841|NCT01752413|blood donors|blood donors
1261842|NCT01752413|iron replacement|iron replacement
1261843|NCT01752400|Advanced|advanced
1261844|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
1261845|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
1261846|NCT01752361|Transit time|transit time
1261847|NCT01752348|sepsis|sepsis
1261848|NCT01752348|cytokine release|cytokine release
1261849|NCT01752348|fever|fever
1261850|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
1261851|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
1261852|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
1261853|NCT01752309|Ultrasound|ultrasound
1261854|NCT01752309|Predictive|predictive
1261855|NCT01752309|Prognosis|prognosis
1261856|NCT01752296|Morquio|morquio
1261857|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
1261858|NCT01752296|Psychological health|psychological health
1261859|NCT01752283|Videoassited|videoassited
1261860|NCT01752283|Thyroidectomy|thyroidectomy
1261861|NCT01752283|Minimal invasive surgery|minimal invasive surgery
1261862|NCT01752283|General anesthesia|general anesthesia
1261863|NCT01752283|Hypnosis|hypnosis
1261864|NCT01752257|Melanoma|melanoma
1261865|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
1261866|NCT01752218|Femto-second Laser|femto-second laser
1261867|NCT01752218|arcuate incision|arcuate incision
1261868|NCT01752218|corneal astigmatism|corneal astigmatism
1261869|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
1261870|NCT01752218|Cataract|cataract
1261871|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
1261872|NCT01752205|Erlotinib|erlotinib
1261873|NCT01752205|Chemoradiotherapy|chemoradiotherapy
1261874|NCT01752192|Rehabilitation|rehabilitation
1261875|NCT01752192|Telemedicine|telemedicine
1261876|NCT01752192|Heart patients|heart patients
1261877|NCT01752192|Social media|social media
1261878|NCT01752192|Organisational aspects|organisational aspects
1261879|NCT01752179|Kinesio taping|kinesio taping
1261880|NCT01752179|Piriformis syndrome|piriformis syndrome
1261881|NCT01752179|Trigger point|trigger point
1261882|NCT01752166|Candida|candida
1261883|NCT01752166|Candidemia|candidemia
1261884|NCT01752166|Blood culture|blood culture
1261885|NCT01752166|Diagnostics|diagnostics
1261886|NCT01752153|Focus|focus
1261887|NCT01752153|immunomodulatory effect|immunomodulatory effect
1261888|NCT01752153|of silymarin|of silymarin
1261889|NCT01752153|on cell mediated immunity|on cell mediated immunity
1261890|NCT01752153|Beta-Thalassemia|beta-thalassemia
1261891|NCT01752153|major patients.|major patients.
1261892|NCT01752140|Prostate cancer|prostate cancer
1261893|NCT01752140|Prostate biopsy|prostate biopsy
1261894|NCT01752140|Vienna nomogram|vienna nomogram
1261895|NCT01752127|Drug-eluting stent|drug-eluting stent
1261896|NCT01752127|diabetes|diabetes
1261897|NCT01752127|small vessel disease|small vessel disease
1261898|NCT01752114|Precancerous conditions|precancerous conditions
1261899|NCT01752114|Carcinoma|carcinoma
1261900|NCT01752101|Precancerous Conditions|precancerous conditions
1261901|NCT01752101|Carcinoma|carcinoma
1261902|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
1261903|NCT01752075|Multiple myeloma|multiple myeloma
1261904|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
1261905|NCT01752062|CML|cml
1261906|NCT01752062|Pregnancy|pregnancy
1261907|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1261908|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
1261909|NCT01752049|vascular malformations|vascular malformations
1261910|NCT01752049|HHT|hht
1261911|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
1261912|NCT01752036|SRS|srs
1261913|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
1261914|NCT01751984|statin intolerance|statin intolerance
1261915|NCT01751945|EmONC|emonc
1261916|NCT01751945|Neonatal mortality|neonatal mortality
1261917|NCT01751945|Perinatal mortality|perinatal mortality
1261918|NCT01751919|CML|cml
1261919|NCT01751919|GIST|gist
1261920|NCT01751906|Absorb™ BVS|absorb™ bvs
1261921|NCT01751906|Angioplasty|angioplasty
1261922|NCT01751906|Bioabsorbable|bioabsorbable
1261923|NCT01751906|BVS|bvs
1261924|NCT01751906|Bioresorbable|bioresorbable
1261925|NCT01751906|Coronary Artery Disease|coronary artery disease
1261926|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
1261927|NCT01751906|Coronary artery restenosis|coronary artery restenosis
1261928|NCT01751906|Coronary artery stenosis|coronary artery stenosis
1261929|NCT01751906|Coronary scaffold|coronary scaffold
1261930|NCT01751906|Coronary Stent|coronary stent
1262032|NCT01751438|Surgery|surgery
1261931|NCT01751906|Drug eluting stents|drug eluting stents
1261932|NCT01751906|Everolimus|everolimus
1261933|NCT01751906|Myocardial ischemia|myocardial ischemia
1261934|NCT01751906|Stent thrombosis|stent thrombosis
1261935|NCT01751906|Stents|stents
1261936|NCT01751893|Hand-foot syndrome|hand-foot syndrome
1261937|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1261938|NCT01751893|capecitabine|capecitabine
1261939|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1261940|NCT01751893|henna|henna
1261941|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
1261942|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
1261943|NCT01751867|Dacogen|dacogen
1261944|NCT01751867|Oncology|oncology
1261945|NCT01751867|Decitabine|decitabine
1261946|NCT01751867|Bone marrow disorders|bone marrow disorders
1261947|NCT01751854|pharmacology|pharmacology
1261948|NCT01751854|rehabilitation|rehabilitation
1261949|NCT01751854|locomotion|locomotion
1261950|NCT01751828|Depression|depression
1261951|NCT01751828|Major Depressive Disorder|major depressive disorder
1261952|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
1261953|NCT01751802|Self-Injury|self-injury
1261954|NCT01751789|illicit opioid drug use|illicit opioid drug use
1261955|NCT01751789|health service utilization|health service utilization
1261956|NCT01751737|prostate|prostate
1261957|NCT01751737|cancer|cancer
1261958|NCT01751737|biopsy|biopsy
1261959|NCT01751737|18F-choline|18f-choline
1261960|NCT01751737|PET|pet
1261961|NCT01751737|MRI|mri
1261962|NCT01751724|Premature infants|premature infants
1261963|NCT01751724|Caffeine|caffeine
1261964|NCT01751724|Methylxanthines|methylxanthines
1261965|NCT01751724|Mechanical ventilation|mechanical ventilation
1261966|NCT01751724|Oxygen|oxygen
1261967|NCT01751724|Weaning|weaning
1261968|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1261969|NCT01751698|Autism|autism
1261970|NCT01751698|Minimally Verbal|minimally verbal
1261971|NCT01751698|School Age|school age
1261972|NCT01751685|kyphosis|kyphosis
1261973|NCT01751672|SBIRT|sbirt
1261974|NCT01751672|Substance Use|substance use
1261975|NCT01751672|Screening|screening
1261976|NCT01751672|Brief Intervention|brief intervention
1261977|NCT01751672|Primary Care|primary care
1261978|NCT01751633|Burst fractures|burst fractures
1261979|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
1261980|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
1261981|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
1261982|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
1261983|NCT01751633|Quality of life|quality of life
1261984|NCT01751633|Functional outcome|functional outcome
1261985|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
1261986|NCT01751581|Obesity|obesity
1261987|NCT01751581|Resting Metabolic Rate|resting metabolic rate
1261988|NCT01751581|Sleep|sleep
1261989|NCT01751581|Eating|eating
1261990|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
1261991|NCT01751529|renal malignancy|renal malignancy
1261992|NCT01751529|Pilot Study|pilot study
1261993|NCT01751529|LCCC 1219|lccc 1219
1261994|NCT01751529|UNC Lineberger|unc lineberger
1261995|NCT01751529|kidney cancer|kidney cancer
1261996|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1261997|NCT01751529|ultrasound|ultrasound
1261998|NCT01751503|Foot drop deformity|foot drop deformity
1261999|NCT01751503|gold standard treatment|gold standard treatment
1262000|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
1262001|NCT01751503|Interosseous route|interosseous route
1262002|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
1262003|NCT01751490|shoulder|shoulder
1262004|NCT01751490|instability|instability
1262005|NCT01751490|atraumatic|atraumatic
1262006|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
1262007|NCT01751477|Probiotics|probiotics
1262008|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
1262010|NCT01751464|violence|violence
1262011|NCT01751464|injury|injury
1262012|NCT01751464|emergency department|emergency department
1262013|NCT01751464|intervention|intervention
1262014|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
1262015|NCT01751451|DEGARELIX|degarelix
1262016|NCT01751451|PREDNISONE|prednisone
1262017|NCT01751451|12-187|12-187
1262018|NCT01751438|Prostate cancer|prostate cancer
1262019|NCT01751438|Prostate carcinoma|prostate carcinoma
1262020|NCT01751438|Metastatic|metastatic
1262021|NCT01751438|M1|m1
1262022|NCT01751438|Best Systemic Therapy|best systemic therapy
1262023|NCT01751438|BST|bst
1262024|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
1262025|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
1262026|NCT01751438|Radiation|radiation
1262027|NCT01751438|Radiation Therapy|radiation therapy
1262028|NCT01751438|External beam radiation therapy|external beam radiation therapy
1262029|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
1262030|NCT01751438|Xray therapy|xray therapy
1262031|NCT01751438|XRT|xrt
1262033|NCT01751425|Leukemia|leukemia
1262034|NCT01751425|Chronic Myeloid Leukemia|chronic myeloid leukemia
1262035|NCT01751425|CML|cml
1262036|NCT01751425|Minimal Residual Disease|minimal residual disease
1262037|NCT01751425|Philadelphia chromosome|philadelphia chromosome
1262038|NCT01751425|(Ph)-positive|(ph)-positive
1262039|NCT01751425|BCR/ABL-positive|bcr/abl-positive
1262040|NCT01751425|Ruxolitinib|ruxolitinib
1262041|NCT01751425|Jakafi|jakafi
1262042|NCT01751425|INCB018424|incb018424
1262043|NCT01751425|INC424|inc424
1262044|NCT01751425|TKI|tki
1262045|NCT01751425|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1262046|NCT01751412|Hodgkin|hodgkin
1262047|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1262048|NCT01751412|Mediastinal|mediastinal
1262049|NCT01751412|Adult Lymphoma|adult lymphoma
1262050|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
1262051|NCT01751386|Addiction|addiction
1262052|NCT01751386|Cue-Induced Craving|cue-induced craving
1262053|NCT01751386|Craving|craving
1262054|NCT01751386|Anxiety|anxiety
1262055|NCT01751386|Alcohol Consumption|alcohol consumption
1262056|NCT01751373|Botulinum Toxin|botulinum toxin
1262057|NCT01751373|Rehabilitation|rehabilitation
1262058|NCT01751373|Electromyography|electromyography
1262059|NCT01751373|Electroencephalography|electroencephalography
1262060|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1262061|NCT01751347|Local anesthetics|local anesthetics
1262062|NCT01751347|Elective hand surgeries|elective hand surgeries
1262063|NCT01751334|Arthroplasty|arthroplasty
1262064|NCT01751334|Replacement|replacement
1262065|NCT01751334|Knee|knee
1262066|NCT01751334|Rotational Alignment|rotational alignment
1262067|NCT01751282|Stem Cells|stem cells
1262068|NCT01751282|chronic wounds|chronic wounds
1262069|NCT01751282|fibrin|fibrin
1262070|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
1262071|NCT01751256|Postcesarean Section|postcesarean section
1262072|NCT01751256|Postoperative Pain|postoperative pain
1262073|NCT01751256|Care, Postoperative|care, postoperative
1262074|NCT01751256|Anesthesia, Local|anesthesia, local
1262075|NCT01751256|Breast Feeding|breast feeding
1262076|NCT01751256|Morphine|morphine
1262077|NCT01751256|Pain Measurement|pain measurement
1262078|NCT01751256|levobupivacaine|levobupivacaine
1262079|NCT01751230|pregnancy|pregnancy
1262080|NCT01751230|weight loss|weight loss
1262081|NCT01751217|Substance Abuse|substance abuse
1262082|NCT01751217|Adolescents|adolescents
1262083|NCT01751217|Families|families
1262084|NCT01751217|Functional Family Therapy|functional family therapy
1262085|NCT01751217|Video|video
1262086|NCT01751217|Teleconferencing|teleconferencing
1262087|NCT01751217|Telemedicine|telemedicine
1262088|NCT01751165|≥ 50 years of age|≥ 50 years of age
1262089|NCT01751165|Herpes zoster|herpes zoster
1262090|NCT01751165|Safety|safety
1262091|NCT01751165|Immunogenicity|immunogenicity
1262092|NCT01751165|Adults|adults
1262093|NCT01751139|Endemic regions|endemic regions
1262094|NCT01751139|Brazil|brazil
1262095|NCT01751139|Incidence|incidence
1262096|NCT01751139|Surveillance|surveillance
1262097|NCT01751139|Dengue|dengue
1262098|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
1262099|NCT01751126|ciclosporin|ciclosporin
1262100|NCT01751126|cyclosporine|cyclosporine
1262101|NCT01751087|abortion, induced|abortion, induced
1262102|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
1262103|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
1262104|NCT01751061|chronic critical illness|chronic critical illness
1262105|NCT01751061|decision making|decision making
1262106|NCT01751061|decision aid|decision aid
1262107|NCT01751061|decisional support|decisional support
1262108|NCT01751061|critical illness|critical illness
1262109|NCT01751061|intensive care unit|intensive care unit
1262110|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
1262111|NCT01751022|heart failure|heart failure
1262112|NCT01751022|cardiac pacing|cardiac pacing
1262113|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
1262114|NCT01751022|left ventricular lead|left ventricular lead
1262115|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
1262116|NCT01750983|Advanced Cancers|advanced cancers
1262117|NCT01750983|Advanced Malignancies|advanced malignancies
1262118|NCT01750983|Metastatic cancers|metastatic cancers
1262119|NCT01750983|Ipilimumab|ipilimumab
1262120|NCT01750983|Yervoy|yervoy
1262121|NCT01750983|BMS-734016|bms-734016
1262122|NCT01750983|MDX010|mdx010
1262123|NCT01750983|Lenalidomide|lenalidomide
1262124|NCT01750983|CC-5013|cc-5013
1262125|NCT01750983|Revlimid|revlimid
1262126|NCT01750944|Blood pressure site|blood pressure site
1262127|NCT01750944|Good health|good health
1262128|NCT01750944|Brachial blood pressure|brachial blood pressure
1262129|NCT01750944|Ankle|ankle
1262131|NCT01750944|Walking test|walking test
1262132|NCT01750944|Exercise|exercise
1262133|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
1262134|NCT01750918|MEK inhibitor|mek inhibitor
1262135|NCT01750918|anti-EGFR antibody|anti-egfr antibody
1262136|NCT01750918|colorectal cancer|colorectal cancer
1262137|NCT01750918|BRAF inhibitor|braf inhibitor
1262138|NCT01750879|peanut|peanut
1262139|NCT01750879|allergy|allergy
1262140|NCT01750879|food|food
1262141|NCT01750879|immunotherapy|immunotherapy
1262142|NCT01750879|tolerance|tolerance
1262143|NCT01750879|desensitization|desensitization
1262144|NCT01750866|Prostrate Cancer|prostrate cancer
1262145|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
1262146|NCT01750866|Cabazitaxel|cabazitaxel
1262147|NCT01750827|platelet function|platelet function
1262148|NCT01750827|atherosclerosis,|atherosclerosis,
1262149|NCT01750827|SB-659032|sb-659032
1262150|NCT01750801|clinical trial|clinical trial
1262151|NCT01750801|mouthwash|mouthwash
1262152|NCT01750801|propolis|propolis
1262153|NCT01750801|plaque|plaque
1262154|NCT01750801|gingivitis|gingivitis
1262155|NCT01750801|compliance|compliance
1262156|NCT01750788|Stroke|stroke
1262157|NCT01750788|Embolism|embolism
1262158|NCT01750788|Atrial Fibrillation|atrial fibrillation
1262159|NCT01750775|sinus bradycardia|sinus bradycardia
1262160|NCT01750775|ventricular premature contraction|ventricular premature contraction
1262161|NCT01750749|Venous ulcer|venous ulcer
1262162|NCT01750749|Cell therapy|cell therapy
1262163|NCT01750736|Augmented Exercise|augmented exercise
1262164|NCT01750736|Cervicalgia|cervicalgia
1262165|NCT01750736|Manual Therapy|manual therapy
1262166|NCT01750736|Manipulation|manipulation
1262167|NCT01750736|Quantitative Sensory|quantitative sensory
1262168|NCT01750723|Acetazolamide|acetazolamide
1262169|NCT01750723|Headache|headache
1262170|NCT01750723|Migraine|migraine
1262171|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
1262172|NCT01750710|Isokinetic|isokinetic
1262173|NCT01750710|Electromyography|electromyography
1262174|NCT01750710|Walking|walking
1262175|NCT01750684|Acute|acute
1262176|NCT01750684|Traumatic|traumatic
1262178|NCT01750684|Spinal Cord Injury|spinal cord injury
1262179|NCT01750671|ICU|icu
1262180|NCT01750671|Body composition|body composition
1262181|NCT01750671|Nutrition|nutrition
1262182|NCT01750671|Survival|survival
1262183|NCT01750671|Morbidity|morbidity
1262184|NCT01750658|Biomarkers|biomarkers
1262185|NCT01750658|Exacerbations|exacerbations
1262186|NCT01750658|COPD|copd
1262187|NCT01750593|radiofrequency|radiofrequency
1262188|NCT01750593|thyroid|thyroid
1262189|NCT01750593|nodule|nodule
1262190|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
1262191|NCT01750567|untreated CLL patients|untreated cll patients
1262192|NCT01750567|genomic deletion 11q|genomic deletion 11q
1262193|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
1262194|NCT01750515|Acupuncture|acupuncture
1262195|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
1262196|NCT01750489|COPD|copd
1262197|NCT01750476|oral contraception|oral contraception
1262198|NCT01750476|Depo-Provera|depo-provera
1262199|NCT01750476|Mirena|mirena
1262200|NCT01750463|Pediatric critically ill|pediatric critically ill
1262201|NCT01750463|Masimo|masimo
1262202|NCT01750463|hemoglobin|hemoglobin
1262203|NCT01750463|monitoring|monitoring
1262204|NCT01750463|UNC|unc
1262205|NCT01750463|PICU|picu
1262206|NCT01750450|Pressure Volume Area|pressure volume area
1262207|NCT01750450|Pressure Flow Area|pressure flow area
1262208|NCT01750450|Myocardial Work|myocardial work
1262209|NCT01750437|NERD|nerd
1262210|NCT01750424|Scar|scar
1262211|NCT01750424|Fat Grafting|fat grafting
1262212|NCT01750424|Adipose Grafting|adipose grafting
1262213|NCT01750424|3-D imaging|3-d imaging
1262214|NCT01750424|Manchester Scar Scale|manchester scar scale
1262215|NCT01750411|Severe Asthma|severe asthma
1262216|NCT01750411|SARP|sarp
1262217|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
1262218|NCT01750385|Esophageal Achalasia|esophageal achalasia
1262219|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
1262220|NCT01750385|blood culture|blood culture
1262221|NCT01750385|procalcitonin levels|procalcitonin levels
1262222|NCT01750372|Artificial limbs|artificial limbs
1262223|NCT01750372|Questionnaires|questionnaires
1262224|NCT01750372|Mobility limitation|mobility limitation
1262225|NCT01750359|antioxidants|antioxidants
1262226|NCT01750359|curcumin|curcumin
1262227|NCT01750359|depression|depression
1262228|NCT01750346|Blepharospasm|blepharospasm
1262229|NCT01750346|Treatment|treatment
1262230|NCT01750346|Dystonia|dystonia
1262231|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
1262232|NCT01750320|Breast CT|breast ct
1262233|NCT01750320|Biopsy|biopsy
1262234|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1262235|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
1262236|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
1262237|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
1262238|NCT01750307|Omega 3|omega 3
1262239|NCT01750307|Randomised Control Trial|randomised control trial
1262240|NCT01750307|Fish oil|fish oil
1262241|NCT01750307|Supplementation|supplementation
1262242|NCT01750307|Reading|reading
1262243|NCT01750307|Spelling|spelling
1262244|NCT01750307|Behaviour|behaviour
1262245|NCT01750307|Emotional lability|emotional lability
1262246|NCT01750294|hypertension|hypertension
1262247|NCT01750294|kidney disease|kidney disease
1262248|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
1262249|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
1262250|NCT01750281|Metastatic|metastatic
1262251|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
1262252|NCT01750268|TBI|tbi
1262253|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
1262254|NCT01750268|veterans|veterans
1262255|NCT01750268|co-occurring disorders|co-occurring disorders
1262256|NCT01750268|pharmacotherapy|pharmacotherapy
1262257|NCT01750255|Pharmaceutical care|pharmaceutical care
1262258|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
1262259|NCT01750255|Bipolar disorder|bipolar disorder
1262260|NCT01750255|Pharmacy services|pharmacy services
1262261|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
1262262|NCT01750190|anemia|anemia
1262263|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
1262264|NCT01750190|non-dialysis|non-dialysis
1262265|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
1262266|NCT01750190|End-Stage Renal Disease|end-stage renal disease
1262267|NCT01750190|erythropoeitin|erythropoeitin
1262268|NCT01750190|ASP1517|asp1517
1262269|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
1262270|NCT01750190|AZD9941|azd9941
1262271|NCT01750164|Breast Cancer|breast cancer
1262272|NCT01750125|Doppler|doppler
1262273|NCT01750112|Pectus excavatum|pectus excavatum
1262274|NCT01750112|funnel chest|funnel chest
1262275|NCT01750112|sunken chest|sunken chest
1262276|NCT01750099|Labor|labor
1262277|NCT01750099|analgesia|analgesia
1262278|NCT01750099|epidural|epidural
1262279|NCT01750099|spinal|spinal
1262280|NCT01750086|osteoporosis|osteoporosis
1262281|NCT01750086|postmenopausal|postmenopausal
1262282|NCT01750086|denosumab|denosumab
1262283|NCT01750086|teriparatide|teriparatide
1262284|NCT01750086|alendronate|alendronate
1262285|NCT01750086|Forteo®|forteo®
1262286|NCT01750086|Prolia®|prolia®
1262287|NCT01750047|pain perception|pain perception
1262288|NCT01750047|postoperative pain|postoperative pain
1262289|NCT01750047|demography|demography
1262290|NCT01750047|smoking|smoking
1262291|NCT01750047|alcohol|alcohol
1262292|NCT01750034|Burns|burns
1262293|NCT01750034|Wounds and injuries|wounds and injuries
1262294|NCT01750034|Bandages|bandages
1262295|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1262296|NCT01750008|Menorrhagia|menorrhagia
1262297|NCT01750008|Heavy Bleeding|heavy bleeding
1262298|NCT01750008|Myomas|myomas
1262299|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
1262300|NCT01750008|RFA|rfa
1262301|NCT01750008|Leiomyoma|leiomyoma
1262302|NCT01750008|Fibroids|fibroids
1262303|NCT01749995|Elderly cancer patients|elderly cancer patients
1262304|NCT01749995|Screening tool|screening tool
1262305|NCT01749995|Cognitive impairment|cognitive impairment
1262306|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
1262308|NCT01749982|Bangladesh|bangladesh
1262309|NCT01749982|choline|choline
1262310|NCT01749982|betaine|betaine
1262311|NCT01749982|methylation|methylation
1262312|NCT01749956|Rectal Cancer|rectal cancer
1262313|NCT01749956|Chemoradiation|chemoradiation
1262314|NCT01749956|Aflibercept|aflibercept
1262315|NCT01749956|Surgery|surgery
1262316|NCT01749930|Intraocular pressure|intraocular pressure
1262317|NCT01749917|Parkinson.|parkinson.
1262318|NCT01749917|Dexterity.|dexterity.
1262319|NCT01749917|Balance.|balance.
1262320|NCT01749917|Exercises.|exercises.
1262321|NCT01749904|Intraocular pressure|intraocular pressure
1262322|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
1262323|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
1262324|NCT01749813|Crohn's Disease|crohn's disease
1262325|NCT01749813|Immunomodulators|immunomodulators
1262326|NCT01749800|TBI|tbi
1262327|NCT01749800|Attention deficits|attention deficits
1262328|NCT01749800|Upper extremity weakness|upper extremity weakness
1262329|NCT01749787|arthritis|arthritis
1262330|NCT01749787|rheumatoid|rheumatoid
1262331|NCT01749787|methotrexate|methotrexate
1262332|NCT01749787|leflunomide|leflunomide
1262333|NCT01749774|Physical activity|physical activity
1262334|NCT01749774|Testicular cancer|testicular cancer
1262335|NCT01749774|Chemotherapy|chemotherapy
1262336|NCT01749774|Feasibility|feasibility
1262337|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
1262338|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
1262339|NCT01749761|hemodialysis,|hemodialysis,
1262340|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
1262341|NCT01749748|Breast diseases|breast diseases
1262342|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1262343|NCT01749722|Colorectal Cancer|colorectal cancer
1262344|NCT01749722|Polyp|polyp
1262345|NCT01749722|Adenoma|adenoma
1262346|NCT01749722|Detection Rate|detection rate
1262347|NCT01749722|Colonoscopy|colonoscopy
1262348|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
1262447|NCT01749215|Veterans|veterans
1262349|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
1262350|NCT01749722|G-Eye procedure|g-eye procedure
1262351|NCT01749722|G-Eye system|g-eye system
1262352|NCT01749709|Stroke|stroke
1262353|NCT01749709|Recovery|recovery
1262354|NCT01749709|Music|music
1262355|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
1262356|NCT01749696|Connective tissue|connective tissue
1262357|NCT01749696|Elastin|elastin
1262358|NCT01749696|Collagen|collagen
1262359|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
1262360|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
1262361|NCT01749657|biomechanics|biomechanics
1262362|NCT01749657|outcomes|outcomes
1262363|NCT01749657|foot|foot
1262364|NCT01749657|orthotic device|orthotic device
1262365|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
1262366|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
1262367|NCT01749631|Intratracheal intubation|intratracheal intubation
1262368|NCT01749631|Difficult to intubate|difficult to intubate
1262369|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
1262370|NCT01749618|SpA|spa
1262371|NCT01749618|PsA|psa
1262372|NCT01749618|Randomized|randomized
1262373|NCT01749618|Behavioural Change|behavioural change
1262374|NCT01749592|hearing loss|hearing loss
1262375|NCT01749592|cochlear implant|cochlear implant
1262376|NCT01749592|PET|pet
1262377|NCT01749592|EEG|eeg
1262378|NCT01749592|MEG|meg
1262379|NCT01749579|propofol|propofol
1262380|NCT01749579|midazolam|midazolam
1262381|NCT01749579|duration of recovery|duration of recovery
1262382|NCT01749579|emergency procedure|emergency procedure
1262383|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
1262384|NCT01749527|24-hour pad test|24-hour pad test
1262385|NCT01749527|Activity|activity
1262386|NCT01749527|Stress urinary incontinence|stress urinary incontinence
1262387|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
1262388|NCT01749488|Dietitian|dietitian
1262389|NCT01749488|Nutritional recommendations|nutritional recommendations
1262390|NCT01749488|ICU nutrition|icu nutrition
1262391|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1262392|NCT01749462|COPD,|copd,
1262393|NCT01749462|Oxis,|oxis,
1262394|NCT01749449|high protein|high protein
1262395|NCT01749449|high carbohydrate|high carbohydrate
1262396|NCT01749449|meal frequency|meal frequency
1262397|NCT01749449|abdominal body fat|abdominal body fat
1262398|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
1262399|NCT01749436|Atelectasis|atelectasis
1262400|NCT01749436|Pneumoperitoneum|pneumoperitoneum
1262401|NCT01749436|Hypoxemia|hypoxemia
1262402|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
1262403|NCT01749371|Inflammation|inflammation
1262404|NCT01749371|Oxidative Stress|oxidative stress
1262405|NCT01749371|Malondialdehyde|malondialdehyde
1262406|NCT01749371|Isoprostanes|isoprostanes
1262407|NCT01749371|Lung Dysfunction|lung dysfunction
1262408|NCT01749371|Wound Healing|wound healing
1262409|NCT01749358|stroke|stroke
1262410|NCT01749358|hemiparesis|hemiparesis
1262411|NCT01749358|physical therapy|physical therapy
1262412|NCT01749358|occupational therapy|occupational therapy
1262413|NCT01749358|neurorehabilitation|neurorehabilitation
1262414|NCT01749358|patient focused|patient focused
1262415|NCT01749358|motor learning|motor learning
1262416|NCT01749358|motor control|motor control
1262417|NCT01749358|skill acquisition|skill acquisition
1262418|NCT01749358|skill training|skill training
1262419|NCT01749358|motor recovery|motor recovery
1262420|NCT01749358|task oriented training|task oriented training
1262421|NCT01749358|task specific training|task specific training
1262422|NCT01749358|arm function|arm function
1262423|NCT01749358|hand function|hand function
1262424|NCT01749358|upper extremity|upper extremity
1262425|NCT01749358|arm therapy|arm therapy
1262426|NCT01749358|physical rehabilitation|physical rehabilitation
1262427|NCT01749358|arm rehabilitation|arm rehabilitation
1262428|NCT01749358|motor function|motor function
1262429|NCT01749332|blood draw|blood draw
1262430|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
1262431|NCT01749332|12-236|12-236
1262432|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
1262433|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
1262434|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1262435|NCT01749280|MRI|mri
1262436|NCT01749280|USPIO|uspio
1262437|NCT01749267|dentin remineralization|dentin remineralization
1262438|NCT01749267|caries regression|caries regression
1262439|NCT01749254|Culprit plaques|culprit plaques
1262440|NCT01749254|Vulnerable Plaques|vulnerable plaques
1262441|NCT01749254|PET|pet
1262442|NCT01749254|calcification|calcification
1262443|NCT01749254|inflammation|inflammation
1262444|NCT01749228|Fed|fed
1262445|NCT01749215|pharmacotherapy|pharmacotherapy
1262446|NCT01749215|alcohol dependence|alcohol dependence
1262448|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
1262449|NCT01749202|Omega 3 Index|omega 3 index
1262450|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
1262451|NCT01749202|Red Blood Cells|red blood cells
1262453|NCT01749189|soy|soy
1262454|NCT01749189|whey|whey
1262455|NCT01749189|casein|casein
1262456|NCT01749189|muscle|muscle
1262457|NCT01749189|strength|strength
1262458|NCT01749189|protein|protein
1262459|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
1262460|NCT01749137|Overweight|overweight
1262461|NCT01749124|mental illness|mental illness
1262462|NCT01749124|depression|depression
1262463|NCT01749124|schizophrenia|schizophrenia
1262464|NCT01749124|bipolar disorder|bipolar disorder
1262465|NCT01749124|IVR|ivr
1262466|NCT01749124|automated|automated
1262467|NCT01749124|telephone|telephone
1262468|NCT01749111|bone marrow transplantation|bone marrow transplantation
1262469|NCT01749111|graft versus host disease|graft versus host disease
1262470|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
1262471|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
1262472|NCT01749111|Myeloproliferative disease|myeloproliferative disease
1262473|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
1262474|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
1262475|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1262476|NCT01749098|PF-04958242|pf-04958242
1262477|NCT01749098|ketamine|ketamine
1262478|NCT01749098|cognition|cognition
1262479|NCT01749098|healthy volunteers|healthy volunteers
1262480|NCT01749085|PF-04449913|pf-04449913
1262481|NCT01749085|Food Effect|food effect
1262482|NCT01749085|Drug-drug interaction|drug-drug interaction
1262483|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
1262484|NCT01749085|Pharmacokinetics|pharmacokinetics
1262485|NCT01749072|non small cell lung cancer|non small cell lung cancer
1262486|NCT01749072|chemotherapy|chemotherapy
1262487|NCT01749072|gefitinib|gefitinib
1262488|NCT01749072|vinorelbine|vinorelbine
1262489|NCT01749072|ifosfamide|ifosfamide
1262490|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
1262491|NCT01749033|Intubation|intubation
1262492|NCT01749033|Airway|airway
1355606|NCT01352091|AI|ai
1262493|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
1262494|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
1262495|NCT01749007|Veterans|veterans
1262496|NCT01749007|HIV|hiv
1262497|NCT01749007|AIDS|aids
1262498|NCT01749007|Cognitive Functioning|cognitive functioning
1262499|NCT01749007|Suicide|suicide
1262500|NCT01748994|Obesity|obesity
1262501|NCT01748994|Fat distribution|fat distribution
1262502|NCT01748994|Adipogenesis|adipogenesis
1262503|NCT01748994|Adipocyte|adipocyte
1262504|NCT01748994|Preadipocyte|preadipocyte
1262505|NCT01748994|Ectopic fat|ectopic fat
1262506|NCT01748981|Pulmonary function|pulmonary function
1262507|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
1262508|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
1262509|NCT01748981|High-intensity training|high-intensity training
1262510|NCT01748981|Surgery|surgery
1262511|NCT01748968|Veterans|veterans
1262512|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
1262513|NCT01748968|Self-Directed Violence|self-directed violence
1262514|NCT01748955|Major Depressive Disorder|major depressive disorder
1262515|NCT01748955|MDD|mdd
1262516|NCT01748955|Reward|reward
1262517|NCT01748955|BOLD signal|bold signal
1262518|NCT01748955|Suicide|suicide
1262519|NCT01748929|Global Health|global health
1262520|NCT01748929|Deworming|deworming
1262521|NCT01748929|Postpartum|postpartum
1262522|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
1262523|NCT01748929|Pregnant Women|pregnant women
1262524|NCT01748916|Papaya|papaya
1262525|NCT01748916|Carrot|carrot
1262526|NCT01748916|Tomato|tomato
1262527|NCT01748916|Carotenoids|carotenoids
1262528|NCT01748916|Lycopene|lycopene
1262529|NCT01748916|Beta-carotene|beta-carotene
1262530|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
1262531|NCT01748903|intracranial aneurysm|intracranial aneurysm
1262532|NCT01748903|cerebral aneurysm|cerebral aneurysm
1262533|NCT01748903|packing density|packing density
1262534|NCT01748903|Target Coils|target coils
1262535|NCT01748903|aneurysm embolization|aneurysm embolization
1262536|NCT01748877|shingles,|shingles,
1262537|NCT01748877|neuropathic pain|neuropathic pain
1262538|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
1262539|NCT01748877|sleep|sleep
1262540|NCT01748864|Volunteers|volunteers
1262541|NCT01748825|MK-1775|mk-1775
1262542|NCT01748825|Refractory|refractory
1262543|NCT01748825|Solid Tumors|solid tumors
1262544|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
1262545|NCT01748825|Tyrosine Kinase|tyrosine kinase
1262546|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
1262547|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
1262548|NCT01748799|Cannabis dependence|cannabis dependence
1262549|NCT01748799|Sativex|sativex
1262550|NCT01748786|Fibromyalgia|fibromyalgia
1262551|NCT01748786|Mindfulness|mindfulness
1262552|NCT01748786|On-line intervention|on-line intervention
1262553|NCT01748786|Chronic pain|chronic pain
1262554|NCT01748760|Suicide Attempts|suicide attempts
1262555|NCT01748760|Suicidal Ideation|suicidal ideation
1262556|NCT01748734|Depression|depression
1262557|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
1262558|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
1262559|NCT01748708|Treatment resistant depression|treatment resistant depression
1262560|NCT01748708|Treatment resistance|treatment resistance
1262561|NCT01748708|Randomized controlled trial|randomized controlled trial
1262562|NCT01748695|Neuropathic pain|neuropathic pain
1262563|NCT01748695|Spinal cord injury|spinal cord injury
1262564|NCT01748682|Very low calorie diet|very low calorie diet
1262565|NCT01748682|liquid diet|liquid diet
1262566|NCT01748682|visceral fat|visceral fat
1262567|NCT01748682|liver fat.|liver fat.
1262568|NCT01748669|Arsenic|arsenic
1262569|NCT01748669|Arsenicosis|arsenicosis
1262570|NCT01748669|Garlic oil|garlic oil
1262571|NCT01748669|Keratosis|keratosis
1262572|NCT01748656|Noninvasive ventilation|noninvasive ventilation
1262573|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
1262574|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
1262575|NCT01748604|Lymphedema|lymphedema
1262576|NCT01748604|Physical Therapies|physical therapies
1262577|NCT01748604|Randomized controlled study|randomized controlled study
1262578|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
1262579|NCT01748604|Manual lymph drainage|manual lymph drainage
1262580|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
1262581|NCT01748604|Multilayer bandages|multilayer bandages
1262582|NCT01748578|Healthy|healthy
1262583|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
1262584|NCT01748578|Dry Eye|dry eye
1262585|NCT01748565|biomarkers|biomarkers
1262586|NCT01748565|oxidative stress|oxidative stress
1262587|NCT01748565|BPD|bpd
1262588|NCT01748565|prematurity|prematurity
1262589|NCT01748526|Healthy|healthy
1600929|NCT00390793|Doxorubicin|doxorubicin
1262590|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1262591|NCT01748526|Pharmacokinetics|pharmacokinetics
1262592|NCT01748526|Pharmacodynamics|pharmacodynamics
1262593|NCT01748526|Indian|indian
1262594|NCT01748513|morbidly obese patients,|morbidly obese patients,
1262595|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
1262596|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
1262597|NCT01748513|TTE,|tte,
1262598|NCT01748513|rapid weight loss,|rapid weight loss,
1262599|NCT01748513|venous return,|venous return,
1262600|NCT01748513|bariatric surgery,|bariatric surgery,
1262601|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
1262602|NCT01748513|stroke volume,|stroke volume,
1262603|NCT01748513|diastolic function,|diastolic function,
1262604|NCT01748513|hypervolemia,|hypervolemia,
1262605|NCT01748513|hypovolemia|hypovolemia
1262606|NCT01748500|metastatic|metastatic
1262607|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
1262608|NCT01748461|cycle ergometer|cycle ergometer
1262609|NCT01748461|physical activity|physical activity
1262610|NCT01748461|physical fitness|physical fitness
1262611|NCT01748461|assisted living facility|assisted living facility
1262612|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
1262613|NCT01748448|Vitamin D|vitamin d
1262614|NCT01748448|Cholecalciferol|cholecalciferol
1262615|NCT01748435|Neuropathic pain|neuropathic pain
1262616|NCT01748435|Lower limb amputation|lower limb amputation
1262617|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
1262618|NCT01748422|Neuropathic pain|neuropathic pain
1262619|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
1262620|NCT01748422|End stage renal disease|end stage renal disease
1262621|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
1262622|NCT01748396|FGF-23|fgf-23
1262623|NCT01748396|Calcitriol|calcitriol
1262624|NCT01748396|Calcium carbonate|calcium carbonate
1262625|NCT01748396|CKD Stage 3|ckd stage 3
1262626|NCT01748383|Bone marrow cells|bone marrow cells
1262627|NCT01748383|Acute myocardial infarction|acute myocardial infarction
1262628|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
1262629|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
1262630|NCT01748370|vitamin D|vitamin d
1262631|NCT01748370|hypogonadism|hypogonadism
1262632|NCT01748370|testosterone|testosterone
1262633|NCT01748370|intervention|intervention
1262634|NCT01748357|Tuberculosis|tuberculosis
1262635|NCT01748357|Volatile organic compounds|volatile organic compounds
1262636|NCT01748357|exhaled breath|exhaled breath
1262637|NCT01748357|Siemens|siemens
1262638|NCT01748331|Heart Failure|heart failure
1262639|NCT01748331|Hyponatremia|hyponatremia
1262640|NCT01748331|Fluid restriction|fluid restriction
1262641|NCT01748318|Community acquired MRSA|community acquired mrsa
1262642|NCT01748318|New Mexico Honey|new mexico honey
1262643|NCT01748305|GDM|gdm
1262644|NCT01748305|A1GDM|a1gdm
1262645|NCT01748305|A2GDM|a2gdm
1262646|NCT01748292|Age related|age related
1262647|NCT01748292|Macular|macular
1262648|NCT01748292|sub retinal fluid|sub retinal fluid
1262649|NCT01748292|Age related Macular degeneration|age related macular degeneration
1262650|NCT01748279|COPD|copd
1262651|NCT01748279|Atorvastatin|atorvastatin
1262652|NCT01748279|statins|statins
1262653|NCT01748279|COPD treatment|copd treatment
1262654|NCT01748279|microarrays|microarrays
1262655|NCT01748266|StO2|sto2
1262656|NCT01748266|microcirculation|microcirculation
1262657|NCT01748266|NIRS|nirs
1262658|NCT01748227|self-management|self-management
1262659|NCT01748227|peer support|peer support
1262660|NCT01748227|social support|social support
1262661|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
1262662|NCT01748214|high flow nasal cannula|high flow nasal cannula
1262663|NCT01748214|hearing outcomes|hearing outcomes
1262664|NCT01748214|noise exposure|noise exposure
1262665|NCT01748214|preterm infants|preterm infants
1262666|NCT01748201|Osteoarthritis|osteoarthritis
1262667|NCT01748201|Hemarthrosis|hemarthrosis
1262668|NCT01748201|Hemophilia A|hemophilia a
1262669|NCT01748201|Hemophilia B|hemophilia b
1262670|NCT01748201|Viscosupplementation|viscosupplementation
1262671|NCT01748188|Subacromial syndrome|subacromial syndrome
1262672|NCT01748188|Dexketoprofen|dexketoprofen
1262673|NCT01748188|Phonophoresis|phonophoresis
1262674|NCT01748188|Iontophoresis|iontophoresis
1262675|NCT01748188|Ultrasounds|ultrasounds
1262676|NCT01748188|VAS|vas
1262677|NCT01748188|DASH score|dash score
1262678|NCT01748188|Constant score|constant score
1262679|NCT01748175|Severe asthma|severe asthma
1262680|NCT01748175|longitudinal study|longitudinal study
1262681|NCT01748175|phenotypes|phenotypes
1262682|NCT01748162|croup|croup
1262683|NCT01748162|recurrent croup|recurrent croup
1262684|NCT01748162|barky cough|barky cough
1262685|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
1262686|NCT01748149|pediatrics|pediatrics
1355861|NCT01350960|LDL|ldl
1262687|NCT01748149|children|children
1262688|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
1262689|NCT01748123|Pragmatic|pragmatic
1262690|NCT01748123|Comparative Effectiveness|comparative effectiveness
1262691|NCT01748110|quality of life|quality of life
1262692|NCT01748110|erectile function|erectile function
1262693|NCT01748097|infiltration|infiltration
1262694|NCT01748097|extravasation|extravasation
1262695|NCT01748097|sodium bicarbonate|sodium bicarbonate
1262696|NCT01748097|capnography|capnography
1262697|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
1262698|NCT01748097|chemotherapy|chemotherapy
1262699|NCT01748084|Systemic sclerosis|systemic sclerosis
1262700|NCT01748084|Arthritis|arthritis
1262701|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
1262702|NCT01748084|Quality of life|quality of life
1262703|NCT01748084|Scleroderma|scleroderma
1262704|NCT01748084|Lung fibrosis|lung fibrosis
1262705|NCT01748084|Randomised controled trial|randomised controled trial
1262706|NCT01748071|fentanyl|fentanyl
1262707|NCT01748071|sufentanil|sufentanil
1262708|NCT01748071|individual variation|individual variation
1262709|NCT01748071|pain threshold|pain threshold
1262710|NCT01748071|nacro-trend index|nacro-trend index
1262711|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
1262712|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1262713|NCT01748045|Late Prematurity|late prematurity
1262714|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
1262715|NCT01748032|depression|depression
1262716|NCT01748032|intervention studies|intervention studies
1262717|NCT01748019|ST1968|st1968
1262718|NCT01748019|Camptothecin|camptothecin
1262719|NCT01748019|Solid tumors|solid tumors
1262720|NCT01748019|Topoisomerase I|topoisomerase i
1262721|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
1262722|NCT01747980|Gaucher disease|gaucher disease
1262723|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
1262724|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
1262725|NCT01747967|Antibodies|antibodies
1262726|NCT01747967|Beta cells|beta cells
1262727|NCT01747967|C-peptide|c-peptide
1262728|NCT01747967|GAD|gad
1262729|NCT01747967|Glucose|glucose
1262730|NCT01747967|Glycemia|glycemia
1262731|NCT01747967|Insulin|insulin
1262732|NCT01747967|Meal test|meal test
1262733|NCT01747967|Pancreas|pancreas
1262734|NCT01747967|Proinsulin,|proinsulin,
1262735|NCT01747967|T lymphocytes|t lymphocytes
1262736|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
1262737|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
1262738|NCT01747954|Respiratory Mechanics|respiratory mechanics
1262739|NCT01747928|usability study|usability study
1262740|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
1262741|NCT01747915|Epilepsy|epilepsy
1262742|NCT01747915|Safety|safety
1262743|NCT01747915|Efficacy|efficacy
1262744|NCT01747915|Tolerability|tolerability
1262745|NCT01747915|Pregabalin|pregabalin
1262746|NCT01747915|Lyrica|lyrica
1263650|NCT01743768|Phase 1|phase 1
1262747|NCT01747915|Adjunctive treatment|adjunctive treatment
1262748|NCT01747915|Placebo Controlled|placebo controlled
1262749|NCT01747915|Blinded|blinded
1262750|NCT01747889|chest tube|chest tube
1262751|NCT01747889|lung resection|lung resection
1262752|NCT01747889|patient satisfaction|patient satisfaction
1262753|NCT01747889|mobility|mobility
1262754|NCT01747876|Phase 1|phase 1
1262755|NCT01747876|pediatric|pediatric
1262756|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
1262757|NCT01747876|dose escalation|dose escalation
1262758|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
1262759|NCT01747876|MRT|mrt
1262760|NCT01747876|neuroblastoma|neuroblastoma
1262761|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
1262762|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
1262763|NCT01747837|Renal catheter ablation|renal catheter ablation
1262764|NCT01747837|Ventricular tachycardia|ventricular tachycardia
1262765|NCT01747824|agitation|agitation
1262766|NCT01747824|excited delirium|excited delirium
1262767|NCT01747824|pain|pain
1262768|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
1262769|NCT01747824|UICD|uicd
1262770|NCT01747824|visual analog scale|visual analog scale
1262771|NCT01747824|VAS|vas
1262772|NCT01747824|altered mental status|altered mental status
1262773|NCT01747824|AMS|ams
1262774|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
1262775|NCT01747811|Concussion|concussion
1262776|NCT01747811|Sleep problems|sleep problems
1262777|NCT01747811|brain imaging|brain imaging
1262778|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
1262779|NCT01747785|Heart failure|heart failure
1262780|NCT01747785|HFpEF|hfpef
1262781|NCT01747785|Dyspnea|dyspnea
1262782|NCT01747785|Fatigue|fatigue
1262783|NCT01747785|Shortness of Breath|shortness of breath
1262784|NCT01747785|exercise|exercise
1262785|NCT01747785|strain|strain
1262786|NCT01747785|myocardial deformation|myocardial deformation
1262787|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
1262788|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
1262789|NCT01747772|Non-focal Liver Disease|non-focal liver disease
1262790|NCT01747772|Fibrosis|fibrosis
1262791|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
1262792|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
1262793|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
1262794|NCT01747759|Total knee arthroplasty|total knee arthroplasty
1262795|NCT01747759|Selfcare|selfcare
1262796|NCT01747759|Booklet|booklet
1262797|NCT01747759|Rehabilitation|rehabilitation
1262798|NCT01747746|Rivaroxaban|rivaroxaban
1262799|NCT01747746|Warfarin|warfarin
1262800|NCT01747746|Anticoagulation|anticoagulation
1262801|NCT01747746|Stroke|stroke
1262802|NCT01747746|Thrombo-embolism|thrombo-embolism
1262803|NCT01747746|Bleeding|bleeding
1262804|NCT01747746|Atrial Fibrillation|atrial fibrillation
1262805|NCT01747746|Cardioversion|cardioversion
1262806|NCT01747733|Endoscopy|endoscopy
1262807|NCT01747733|ERCP|ercp
1262808|NCT01747733|PCS|pcs
1262809|NCT01747733|Sedation|sedation
1262810|NCT01747733|Bispectral index|bispectral index
1262811|NCT01747720|breast cancer|breast cancer
1262812|NCT01747720|mammographic breast density|mammographic breast density
1262813|NCT01747720|vitamin D|vitamin d
1262814|NCT01747720|prevention|prevention
1262815|NCT01747720|randomized controlled trial|randomized controlled trial
1262816|NCT01747707|gastric cancer|gastric cancer
1262817|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
1262818|NCT01747707|chemotherapy|chemotherapy
1262819|NCT01747707|docetaxel|docetaxel
1262820|NCT01747707|cisplatin|cisplatin
1262821|NCT01747707|S-1|s-1
1262822|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
1262823|NCT01747681|chondral defect|chondral defect
1262824|NCT01747681|microfracture|microfracture
1262825|NCT01747681|arthroscopy|arthroscopy
1262826|NCT01747681|cartilage repair|cartilage repair
1262827|NCT01747681|outcome study|outcome study
1262828|NCT01747681|Lysholm score|lysholm score
1262829|NCT01747668|Mother and Infant Pairs|mother and infant pairs
1262830|NCT01747655|Early Observational Advanced|early observational advanced
1262831|NCT01747655|Parkinson's Disease|parkinson's disease
1262832|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
1262833|NCT01747642|Oncoxin|oncoxin
1262834|NCT01747642|Surafenib|surafenib
1262835|NCT01747629|Asthma|asthma
1262836|NCT01747629|dry powder inhaler|dry powder inhaler
1262837|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
1262838|NCT01747629|SABA|saba
1262839|NCT01747629|bronchoconstriction|bronchoconstriction
1262840|NCT01747629|bronchodilation|bronchodilation
1262841|NCT01747629|bronchodilator|bronchodilator
1262842|NCT01747629|metered dose inhaler|metered dose inhaler
1262843|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
1262844|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
1262845|NCT01747616|contact lenses|contact lenses
1262846|NCT01747616|safety and tolerability|safety and tolerability
1262847|NCT01747603|Late preterm infant|late preterm infant
1262848|NCT01747603|Complications|complications
1262849|NCT01747603|Hospital readmissions|hospital readmissions
1262850|NCT01747603|Follow-up|follow-up
1262851|NCT01747603|Pilot study|pilot study
1262852|NCT01747577|Muscarine antagonist|muscarine antagonist
1262853|NCT01747577|Prostatectomy|prostatectomy
1262854|NCT01747577|Uroflowmetry|uroflowmetry
1262855|NCT01747564|Pharmacokinetics|pharmacokinetics
1262856|NCT01747564|Mirabegron|mirabegron
1262857|NCT01747564|Phase 1|phase 1
1262858|NCT01747564|YM178|ym178
1262859|NCT01747551|Advanced|advanced
1262860|NCT01747538|Uveitis|uveitis
1262861|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
1262862|NCT01747538|Intermediate Uveitis|intermediate uveitis
1262863|NCT01747538|Posterior Uveitis|posterior uveitis
1262864|NCT01747538|Panuveitis|panuveitis
1262865|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
1262866|NCT01747512|thyroidectomy|thyroidectomy
1262867|NCT01747512|thyroid neoplasms|thyroid neoplasms
1262868|NCT01747473|Subjects|subjects
1262869|NCT01747460|Subjects|subjects
1262870|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
1262871|NCT01747395|Heart Failure|heart failure
1262872|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
1262873|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
1262874|NCT01747382|Chronic Kidney Disease|chronic kidney disease
1262875|NCT01747382|Symplicity catheters|symplicity catheters
1262876|NCT01747382|Renal denervation|renal denervation
1262877|NCT01747369|surveillance study|surveillance study
1262878|NCT01747369|prospective|prospective
1262879|NCT01747369|observational|observational
1262880|NCT01747369|health center-based|health center-based
1262881|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
1262882|NCT01747369|pneumonia, viral|pneumonia, viral
1262883|NCT01747369|meningitis, bacterial|meningitis, bacterial
1262884|NCT01747369|Africa south of the Sahara|africa south of the sahara
1262885|NCT01747343|Incontinence|incontinence
1262886|NCT01747343|Enuresis|enuresis
1262887|NCT01747330|cystic fibrosis|cystic fibrosis
1262888|NCT01747317|FFR|ffr
1262889|NCT01747317|fractional flow reserve|fractional flow reserve
1262890|NCT01747317|CT|ct
1262891|NCT01747317|Computed Tomography|computed tomography
1262892|NCT01747304|Atypical Femur Fracture|atypical femur fracture
1262893|NCT01747304|DXA|dxa
1262894|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
1262895|NCT01747278|prophylaxis|prophylaxis
1262896|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
1262897|NCT01747239|Ovarian cancer|ovarian cancer
1262898|NCT01747239|Platinum refractory|platinum refractory
1262899|NCT01747226|Oral malodor|oral malodor
1262900|NCT01747226|Halitosis|halitosis
1262901|NCT01747226|Bad Breath|bad breath
1262902|NCT01747226|Mouth rinses|mouth rinses
1262903|NCT01747226|Mouthwashes|mouthwashes
1262904|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
1262905|NCT01747226|Zinc ions|zinc ions
1262906|NCT01747226|Chlorhexidine|chlorhexidine
1262907|NCT01747213|Neurodegenerative|neurodegenerative
1262908|NCT01747213|Cholinergic|cholinergic
1262909|NCT01747213|Single Dose|single dose
1262910|NCT01747213|Inhibitor|inhibitor
1262911|NCT01747213|Tolerability|tolerability
1262912|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
1262913|NCT01747187|Septic shock|septic shock
1262914|NCT01747187|Critical care|critical care
1262915|NCT01747187|cardiac failure|cardiac failure
1262916|NCT01747174|STEMI|stemi
1262917|NCT01747174|Microvascular Obstruction|microvascular obstruction
1262918|NCT01747174|No-reflow|no-reflow
1262919|NCT01747174|Adenosine|adenosine
1262920|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
1262921|NCT01747148|Antisense|antisense
1262922|NCT01747148|Influenza|influenza
1262923|NCT01747148|IV Injection|iv injection
1262924|NCT01747148|RNA Based Therapeutic|rna based therapeutic
1262925|NCT01747148|RNA Interference|rna interference
1262926|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
1262927|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
1262928|NCT01747135|Neurodegeneration|neurodegeneration
1262929|NCT01747122|epidurals|epidurals
1262930|NCT01747122|wound catheters|wound catheters
1262931|NCT01747122|liver resection|liver resection
1262932|NCT01747122|liver surgery|liver surgery
1262933|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
1262934|NCT01747109|Preoxygenation|preoxygenation
1262935|NCT01747109|Crash induction|crash induction
1262936|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
1262937|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
1262938|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
1262939|NCT01747096|DOTANOC|dotanoc
1262940|NCT01747070|Electro Acupuncture|electro acupuncture
1262941|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
1262942|NCT01747070|Chronic pain|chronic pain
1262943|NCT01747070|Cortical Excitability|cortical excitability
1262944|NCT01747044|Fibromyalgia|fibromyalgia
1262945|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
1262946|NCT01747044|Milnacipran|milnacipran
1262947|NCT01747031|iFR|ifr
1262948|NCT01747031|FFR|ffr
1262949|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
1262959|NCT01747005|ERAS|eras
1262960|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
1262961|NCT01746979|TH-302|th-302
1262962|NCT01746979|Evofosfamide|evofosfamide
1262963|NCT01746979|Pancreatic Cancer|pancreatic cancer
1262964|NCT01746979|EMR200592-001|emr200592-001
1262965|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
1262966|NCT01746966|anterior shoulder US|anterior shoulder us
1262967|NCT01746966|rotator interval|rotator interval
1262968|NCT01746940|Surgery|surgery
1262969|NCT01746940|Surgeries|surgeries
1262970|NCT01746940|Nasal|nasal
1262971|NCT01746940|Cavities|cavities
1262972|NCT01746940|Diagnosis|diagnosis
1262973|NCT01746940|Diagnostic|diagnostic
1262974|NCT01746940|Nose|nose
1262975|NCT01746940|Rhinoplasty|rhinoplasty
1262976|NCT01746940|Endoscopy|endoscopy
1262977|NCT01746940|Bronchoscopy|bronchoscopy
1262978|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
1262979|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
1262980|NCT01746901|Chronic pain|chronic pain
1262981|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
1262982|NCT01746875|Photochemotherapy|photochemotherapy
1262983|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
1262984|NCT01746875|Aflibercept|aflibercept
1262985|NCT01746862|Saizen®|saizen®
1262986|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
1262987|NCT01746862|Idiopathic short stature|idiopathic short stature
1262988|NCT01746862|Height velocity|height velocity
1262989|NCT01746862|Bone age|bone age
1262990|NCT01746849|LUPRON DEPOT|lupron depot
1356236|NCT01349465|TMC435|tmc435
1262991|NCT01746849|PALIFERMIN|palifermin
1262992|NCT01746849|12-077|12-077
1263002|NCT01746823|Keratoconus|keratoconus
1263003|NCT01746823|Proteomics|proteomics
1263004|NCT01746810|Metastatic|metastatic
1263005|NCT01746810|Lung Cancer|lung cancer
1263006|NCT01746810|NSCLC|nsclc
1263007|NCT01746797|infertility|infertility
1263008|NCT01746797|depression|depression
1263009|NCT01746797|IVF|ivf
1263010|NCT01746797|IUI|iui
1263011|NCT01746797|fertility treatment|fertility treatment
1263012|NCT01746784|Cystic Fibrosis|cystic fibrosis
1263013|NCT01746784|F508del-CFTR|f508del-cftr
1263014|NCT01746784|N6022|n6022
1263015|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
1263016|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
1263017|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
1263018|NCT01746693|retinal vessel diameter|retinal vessel diameter
1263019|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
1263020|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
1263021|NCT01746693|inner retinal function|inner retinal function
1263022|NCT01746693|flicker response|flicker response
1263023|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
1263024|NCT01746680|RA|ra
1263025|NCT01746680|tacrolimus|tacrolimus
1263026|NCT01746680|Disease Activity Score 28|disease activity score 28
1263027|NCT01746680|EULAR|eular
1263028|NCT01746667|Social Anxiety Disorder|social anxiety disorder
1263029|NCT01746667|Social Phobia|social phobia
1263030|NCT01746667|Virtual Reality|virtual reality
1263031|NCT01746667|Exposure|exposure
1263032|NCT01746654|S.aureus|s.aureus
1263033|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
1263034|NCT01746654|Nasal carrier status|nasal carrier status
1263035|NCT01746654|Prophylaxis|prophylaxis
1263036|NCT01746641|Remifentanil|remifentanil
1263037|NCT01746641|Propofol|propofol
1263038|NCT01746641|Sedation|sedation
1263039|NCT01746641|Endoscopy|endoscopy
1263040|NCT01746641|Gastroenterology|gastroenterology
1263041|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
1263042|NCT01746628|type 0 myomata|type 0 myomata
1263043|NCT01746628|type 1 myomata|type 1 myomata
1263044|NCT01746628|type 2 myomata|type 2 myomata
1263045|NCT01746628|bleeding|bleeding
1263046|NCT01746628|hemorrhage|hemorrhage
1263047|NCT01746628|hysteroscopy|hysteroscopy
1263048|NCT01746628|FloSeal|floseal
1263049|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
1263050|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
1263051|NCT01746615|fourier-domain OCT|fourier-domain oct
1263052|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
1263053|NCT01746602|topical lubricants|topical lubricants
1263054|NCT01746602|tear film thickness|tear film thickness
1263055|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
1263056|NCT01746602|break up time|break up time
1263057|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
1263058|NCT01746589|LASIK|lasik
1263059|NCT01746576|volunteers|volunteers
1263060|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1263061|NCT01746563|Ranibizumab|ranibizumab
1263062|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
1263063|NCT01746524|Arthroplasty|arthroplasty
1263064|NCT01746524|Replacement|replacement
1263065|NCT01746524|Knee|knee
1263066|NCT01746511|glycerin suppositories|glycerin suppositories
1263067|NCT01746511|glycerin shaves|glycerin shaves
1263068|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
1263069|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
1263070|NCT01746511|jaundice|jaundice
1263071|NCT01746511|neonatal jaundice|neonatal jaundice
1263072|NCT01746511|prematurity|prematurity
1263073|NCT01746498|Alzheimer disease|alzheimer disease
1263074|NCT01746498|Direct current stimulation|direct current stimulation
1263075|NCT01746498|cognitive function|cognitive function
1263076|NCT01746498|memory|memory
1263077|NCT01746485|Volunteers|volunteers
1263078|NCT01746459|Sustainability of Innovations|sustainability of innovations
1263079|NCT01746459|Knowledge Translation|knowledge translation
1263080|NCT01746459|Gerontology|gerontology
1263081|NCT01746459|Mobility|mobility
1263082|NCT01746420|elbow|elbow
1263083|NCT01746407|Emergency Department|emergency department
1263084|NCT01746407|Infection|infection
1263085|NCT01746407|Sepsis|sepsis
1263086|NCT01746394|obesity|obesity
1263087|NCT01746394|pregnant women|pregnant women
1263088|NCT01746394|nutrition assessment|nutrition assessment
1263089|NCT01746394|health behavior|health behavior
1263090|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1263091|NCT01746381|non-invasive ventilation|non-invasive ventilation
1263092|NCT01746381|home ventilation|home ventilation
1263093|NCT01746381|IVAPS|ivaps
1263094|NCT01746381|neuromuscular diseases|neuromuscular diseases
1263095|NCT01746368|advance directives|advance directives
1263096|NCT01746355|atypical facial pain|atypical facial pain
1263097|NCT01746355|atypical odontalgia|atypical odontalgia
1263098|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1263099|NCT01746355|neuropathic pain|neuropathic pain
1263100|NCT01746355|chronic pain|chronic pain
1263101|NCT01746355|assessment|assessment
1263102|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
1263103|NCT01746303|Working memory|working memory
1263104|NCT01746303|Long-term memory|long-term memory
1263105|NCT01746303|Neurocognition|neurocognition
1263106|NCT01746303|Dietary supplementation|dietary supplementation
1263107|NCT01746303|dementia|dementia
1263108|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
1263109|NCT01746277|non small cell lung cancer|non small cell lung cancer
1263110|NCT01746277|chemotherapy|chemotherapy
1263111|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
1263112|NCT01746277|retreatment|retreatment
1263113|NCT01746264|Obesity|obesity
1263114|NCT01746264|Endothelial dysfunction|endothelial dysfunction
1263115|NCT01746264|Vitamin D deficiency|vitamin d deficiency
1263116|NCT01746251|EGFR mutation|egfr mutation
1263117|NCT01746251|Resected|resected
1263118|NCT01746238|soft tissue|soft tissue
1263119|NCT01746238|high grade|high grade
1263120|NCT01746225|Metastatic|metastatic
1263121|NCT01746225|Breast|breast
1263122|NCT01746225|Cancer|cancer
1263123|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
1263124|NCT01746225|No previous chemotherapy|no previous chemotherapy
1263125|NCT01746212|Degenerative Disc Disease|degenerative disc disease
1263126|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
1263127|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
1263128|NCT01746212|Oswestry Disability Index|oswestry disability index
1263129|NCT01746212|Visual Analog Scale|visual analog scale
1263130|NCT01746212|Stand-alone ALIF|stand-alone alif
1263131|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
1263132|NCT01746212|Fusion rate|fusion rate
1263133|NCT01746212|Disc Height|disc height
1263134|NCT01746212|Mean Optical Density|mean optical density
1263135|NCT01746212|Integrated Optical Density|integrated optical density
1263136|NCT01746173|T Cell lymphoma|t cell lymphoma
1263137|NCT01746160|dental implant|dental implant
1263138|NCT01746160|healing|healing
1263139|NCT01746160|implant stability|implant stability
1263140|NCT01746147|MDS|mds
1263141|NCT01746147|AML|aml
1263142|NCT01746147|allogeneic SCT|allogeneic sct
1263143|NCT01746108|Pneumococcal infection|pneumococcal infection
1263144|NCT01746108|Synflorix|synflorix
1263145|NCT01746108|Children|children
1263146|NCT01746108|Immunogenicity|immunogenicity
1263147|NCT01746108|Safety|safety
1263148|NCT01746095|Cystic Fibrosis|cystic fibrosis
1263149|NCT01746095|MRSA|mrsa
1263150|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1263151|NCT01746095|Lung infection|lung infection
1263152|NCT01746095|AeroVanc|aerovanc
1263153|NCT01746095|Vancomycin|vancomycin
1263154|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
1263155|NCT01746069|smoking|smoking
1263156|NCT01746069|smoke cessation|smoke cessation
1263157|NCT01746069|sms|sms
1263158|NCT01746069|quit smoke|quit smoke
1263159|NCT01746056|Warts|warts
1263160|NCT01746056|Verruca|verruca
1263161|NCT01746056|Heat patch|heat patch
1263162|NCT01746043|Esophageal cancer|esophageal cancer
1263163|NCT01746043|Chemotherapy|chemotherapy
1263164|NCT01746043|Radiation therapy|radiation therapy
1263165|NCT01746043|XRT|xrt
1263166|NCT01746043|Chemoradiation|chemoradiation
1263167|NCT01746043|CXRT|cxrt
1263168|NCT01746043|Symptom Burden|symptom burden
1263169|NCT01746043|Armodafinil|armodafinil
1263170|NCT01746043|Nuvigil|nuvigil
1263171|NCT01746043|Minocycline|minocycline
1263172|NCT01746043|Dynacin|dynacin
1263173|NCT01746043|Minocin|minocin
1263174|NCT01746043|Minocin PAC|minocin pac
1263175|NCT01746043|Myrac|myrac
1263176|NCT01746043|Solodyn|solodyn
1263177|NCT01746043|Placebo|placebo
1263178|NCT01746043|Sugar pill|sugar pill
1263179|NCT01746043|Questionnaires|questionnaires
1263180|NCT01746043|Surveys|surveys
1263181|NCT01745952|Epilepsies, Partial|epilepsies, partial
1263182|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1263183|NCT01745939|Back pain|back pain
1263184|NCT01745913|Leukemia|leukemia
1263185|NCT01745913|Lymphoma|lymphoma
1263186|NCT01745900|Diabetes|diabetes
1263187|NCT01745900|Gestational Diabetes|gestational diabetes
1263188|NCT01745900|Female|female
1263189|NCT01745887|Dry Eye Syndrome|dry eye syndrome
1263190|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
1263191|NCT01745874|Rectal cancer|rectal cancer
1263192|NCT01745874|Whole-body MRI|whole-body mri
1263193|NCT01745874|FDG-PET-CT|fdg-pet-ct
1263194|NCT01745874|preoperative staging|preoperative staging
1263195|NCT01745848|Roflumilast|roflumilast
1263196|NCT01745848|COPD|copd
1263197|NCT01745822|Hepatitis B|hepatitis b
1263198|NCT01745822|Hepatitis B sAg|hepatitis b sag
1263199|NCT01745822|Hepatitis B eAg|hepatitis b eag
1263200|NCT01745822|pregnancy|pregnancy
1263201|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1263202|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
1263203|NCT01745796|Transmission modes|transmission modes
1263204|NCT01745718|prostate cancer|prostate cancer
1263205|NCT01745718|targeted biopsies|targeted biopsies
1263206|NCT01745718|cytological imprints|cytological imprints
1263207|NCT01745718|histology|histology
1263208|NCT01745705|Manipulation|manipulation
1263209|NCT01745705|Balance|balance
1263210|NCT01745705|Proprioception|proprioception
1263211|NCT01745679|Ceftriaxone|ceftriaxone
1263212|NCT01745679|Adverse drug effects|adverse drug effects
1263213|NCT01745679|Therapeutic monitoring|therapeutic monitoring
1263214|NCT01745679|Meningitis|meningitis
1263215|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
1263216|NCT01745640|Multiple myeloma|multiple myeloma
1263217|NCT01745640|dexamethasone|dexamethasone
1263218|NCT01745640|pomalidomide|pomalidomide
1263219|NCT01745640|response|response
1263220|NCT01745640|safety|safety
1263221|NCT01745640|del 17p|del 17p
1263222|NCT01745640|t 4-14|t 4-14
1263223|NCT01745614|Bioequivalence|bioequivalence
1263224|NCT01745614|Nimesulide|nimesulide
1263225|NCT01745614|Pharmacokinetics|pharmacokinetics
1263226|NCT01745614|Mexico|mexico
1263227|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
1263228|NCT01745588|Clarithromycin|clarithromycin
1263229|NCT01745588|Biaxin|biaxin
1263230|NCT01745588|DEXAMETHASONE|dexamethasone
1263231|NCT01745588|(ClaPD)|(clapd)
1263232|NCT01745588|Stem cell|stem cell
1263233|NCT01745588|12-138|12-138
1263234|NCT01745575|Bioequivalence|bioequivalence
1263235|NCT01745575|Alprazolam|alprazolam
1263236|NCT01745575|Anxiety disorders|anxiety disorders
1263237|NCT01745575|Mexico|mexico
1263238|NCT01745562|Alprazolam|alprazolam
1263239|NCT01745562|Anxiety disorders|anxiety disorders
1263240|NCT01745562|Bioequivalence|bioequivalence
1263241|NCT01745562|Mexico|mexico
1263242|NCT01745549|diabetes|diabetes
1263243|NCT01745549|insulin therapy|insulin therapy
1263244|NCT01745549|needle|needle
1263245|NCT01745536|Oocyte vitrification|oocyte vitrification
1263246|NCT01745536|survival rate|survival rate
1263247|NCT01745536|egg banking|egg banking
1263248|NCT01745536|ovum donation|ovum donation
1263249|NCT01745523|Oocyte vitrification|oocyte vitrification
1263250|NCT01745523|survival rate|survival rate
1263251|NCT01745523|egg banking|egg banking
1263252|NCT01745523|ovum donation|ovum donation
1263253|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
1263254|NCT01745510|n-3 fatty acids|n-3 fatty acids
1263255|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
1263256|NCT01745510|preterm infants|preterm infants
1263257|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
1263258|NCT01745497|Insomnia|insomnia
1263259|NCT01745484|SPECT|spect
1263260|NCT01745484|Toxicity|toxicity
1263261|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
1263262|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
1263263|NCT01745484|Radiation pneumonitis|radiation pneumonitis
1263264|NCT01745484|Randomized study|randomized study
1263265|NCT01745471|Abdominal Adipose|abdominal adipose
1263266|NCT01745471|Gluteal Adipose|gluteal adipose
1263267|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
1263268|NCT01745471|Obesity|obesity
1263269|NCT01745471|Women|women
1263270|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
1263271|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
1263272|NCT01745432|ADBLOCK|adblock
1263273|NCT01745432|Adhesion Barrier System|adhesion barrier system
1263274|NCT01745432|laparoscopic surgery|laparoscopic surgery
1263275|NCT01745432|myomectomy|myomectomy
1263276|NCT01745419|COPD|copd
1263277|NCT01745419|Exacerbation|exacerbation
1263278|NCT01745419|Haptoglobin|haptoglobin
1263279|NCT01745393|Smoking Cessation|smoking cessation
1263280|NCT01745393|Secondhand Smoke|secondhand smoke
1263281|NCT01745393|Passive Smoking|passive smoking
1263282|NCT01745393|Cotinine|cotinine
1263283|NCT01745393|Nicotine Replacement Products|nicotine replacement products
1263284|NCT01745380|operative|operative
1263285|NCT01745380|dental procedure|dental procedure
1263286|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
1263287|NCT01745367|triple negative breast cancer|triple negative breast cancer
1263288|NCT01745367|paclitaxel|paclitaxel
1263289|NCT01745367|pharmacokinetics|pharmacokinetics
1263290|NCT01745367|biomarkers|biomarkers
1263291|NCT01745367|metastatic breast cancer|metastatic breast cancer
1263292|NCT01745367|mBC|mbc
1263293|NCT01745367|TNBC|tnbc
1263294|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
1263295|NCT01745328|antibiotics|antibiotics
1263296|NCT01745328|traditional chinese medicine|traditional chinese medicine
1263297|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
1263298|NCT01745315|LigaSure|ligasure
1263299|NCT01745315|EnSeal|enseal
1600930|NCT00390793|Adriamycin|adriamycin
1263300|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
1263301|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
1263302|NCT01745315|advanced bipolar device|advanced bipolar device
1263303|NCT01745302|lung cancer|lung cancer
1263304|NCT01745302|traditional Chinese medicine|traditional chinese medicine
1263305|NCT01745302|EGFR-TKI|egfr-tki
1263306|NCT01745289|Breast Cancer|breast cancer
1263307|NCT01745289|Survival|survival
1263308|NCT01745289|Recurrence|recurrence
1263309|NCT01745276|Pin fixation|pin fixation
1263310|NCT01745276|Osteotomy|osteotomy
1263311|NCT01745276|hemicallotasis|hemicallotasis
1263312|NCT01745250|lip|lip
1263313|NCT01745250|fillers|fillers
1263314|NCT01745250|Hyaluronic acid|hyaluronic acid
1263315|NCT01745237|Sarcoidosis|sarcoidosis
1263316|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
1263317|NCT01745198|homocysteinemia|homocysteinemia
1263318|NCT01745198|dementia|dementia
1263319|NCT01745198|depression|depression
1263320|NCT01745198|vitamin B12|vitamin b12
1263321|NCT01745198|folate|folate
1263322|NCT01745198|mild cognitive impairment|mild cognitive impairment
1263323|NCT01745198|alzheimer's|alzheimer's
1263324|NCT01745198|homocysteine|homocysteine
1263325|NCT01745185|Fabry Disease|fabry disease
1263326|NCT01745185|immunity|immunity
1263327|NCT01745185|antibody|antibody
1263328|NCT01745159|tacrolimus|tacrolimus
1263329|NCT01745159|Protopic|protopic
1263330|NCT01745159|pediatric|pediatric
1263331|NCT01745159|atopic dermatitis|atopic dermatitis
1263332|NCT01745159|China|china
1263333|NCT01745146|traumatic brain injury|traumatic brain injury
1263334|NCT01745146|TBI|tbi
1263335|NCT01745146|head injury|head injury
1263336|NCT01745146|brain injury|brain injury
1263337|NCT01745146|Psych-educational treatment|psych-educational treatment
1263338|NCT01745146|Anger|anger
1263339|NCT01745146|irritability|irritability
1263340|NCT01745146|anger management|anger management
1263341|NCT01745133|Olux E foam|olux e foam
1263342|NCT01745133|Sorilux foam|sorilux foam
1263343|NCT01745120|gene therapy|gene therapy
1263344|NCT01745120|beta thalassemia|beta thalassemia
1263345|NCT01745120|hemoglobin|hemoglobin
1263346|NCT01745120|anemia|anemia
1263347|NCT01745120|CD34|cd34
1263348|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
1263349|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
1263350|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
1263351|NCT01745107|survival|survival
1263352|NCT01745094|mirabegron|mirabegron
1263353|NCT01745094|solifenacin|solifenacin
1263852|NCT01742962|Orgasm|orgasm
1263354|NCT01745068|fragility fracture|fragility fracture
1263355|NCT01745068|osteoporosis|osteoporosis
1263356|NCT01745068|fall prevention|fall prevention
1263357|NCT01745068|integrated program|integrated program
1263358|NCT01745068|interorganizational collaboration|interorganizational collaboration
1263359|NCT01745068|Canada|canada
1263360|NCT01745068|controlled clinical trial|controlled clinical trial
1263361|NCT01745068|evaluation|evaluation
1263362|NCT01745055|Pharmacokinetics|pharmacokinetics
1263363|NCT01745055|oral JAK inhibitor|oral jak inhibitor
1263364|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
1263365|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1263366|NCT01745042|Postmenopausal Women|postmenopausal women
1263367|NCT01745042|Body Composition|body composition
1263368|NCT01745042|Metabolic Syndrome|metabolic syndrome
1263369|NCT01745042|Menopause Symptoms|menopause symptoms
1263370|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
1263371|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
1263372|NCT01745029|Transit time|transit time
1263373|NCT01745016|dietary supplement|dietary supplement
1263374|NCT01745016|carnosine|carnosine
1263375|NCT01745003|Fibromyalgia|fibromyalgia
1263376|NCT01744990|Nuts|nuts
1263377|NCT01744990|allergy|allergy
1263378|NCT01744990|Oral food challenge|oral food challenge
1263379|NCT01744990|skin testing|skin testing
1263380|NCT01744990|basophil activation tests|basophil activation tests
1263381|NCT01744990|specific IgE's|specific ige's
1263382|NCT01744964|apomorphine|apomorphine
1263383|NCT01744964|dopamine transporter gene|dopamine transporter gene
1263384|NCT01744964|SLC6A3|slc6a3
1263385|NCT01744964|cold pressor test|cold pressor test
1263386|NCT01744964|tolerance|tolerance
1263387|NCT01744964|experimental pain|experimental pain
1263388|NCT01744964|dopamine agonist|dopamine agonist
1263389|NCT01744951|Adoption|adoption
1263390|NCT01744951|Foster care|foster care
1263391|NCT01744951|Substance abuse|substance abuse
1263392|NCT01744951|Older children|older children
1263393|NCT01744951|Mental health|mental health
1263394|NCT01744938|Postoperative Complications,|postoperative complications,
1263395|NCT01744938|mortality,|mortality,
1263396|NCT01744938|length of Stay,|length of stay,
1263397|NCT01744938|economics|economics
1263398|NCT01744912|Lymphoma|lymphoma
1263399|NCT01744912|monoclonal antibody|monoclonal antibody
1263400|NCT01744912|immunomodulatory agent|immunomodulatory agent
1263401|NCT01744912|ublituximab|ublituximab
1263402|NCT01744912|lenalidomide|lenalidomide
1263403|NCT01744899|Lumbosacral spine|lumbosacral spine
1263404|NCT01744899|Nerve roots|nerve roots
1263405|NCT01744899|Sitting|sitting
1263406|NCT01744899|H-reflex|h-reflex
1263407|NCT01744886|One-Lung Ventilation|one-lung ventilation
1263408|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
1263409|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
1263410|NCT01744834|Reward-based learning|reward-based learning
1263411|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
1263412|NCT01744834|Functional imaging|functional imaging
1263413|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
1263414|NCT01744821|High Risk|high risk
1263415|NCT01744808|Healthy|healthy
1263416|NCT01744808|Normal|normal
1263417|NCT01744795|cardiac output|cardiac output
1263418|NCT01744795|thermodilution|thermodilution
1263419|NCT01744795|esophageal doppler|esophageal doppler
1263420|NCT01744795|trending ability|trending ability
1263421|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
1263422|NCT01744782|Cysteamine|cysteamine
1263423|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
1263424|NCT01744782|CTNS Protein, Human|ctns protein, human
1263425|NCT01744782|Orphan Disease|orphan disease
1263426|NCT01744769|thyroid cancer|thyroid cancer
1263427|NCT01744769|hypothyroidism|hypothyroidism
1263428|NCT01744769|metabolic parameters|metabolic parameters
1263429|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
1263430|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
1263431|NCT01744756|Recurrent pterygium|recurrent pterygium
1263432|NCT01744743|preconception|preconception
1263433|NCT01744743|hypothyroidism|hypothyroidism
1263434|NCT01744743|neurocognitive development|neurocognitive development
1263435|NCT01744730|Bacterial infections|bacterial infections
1263436|NCT01744730|Obesity|obesity
1263437|NCT01744730|pharmacokinetics|pharmacokinetics
1263438|NCT01744730|clindamycin|clindamycin
1263439|NCT01744717|Pain|pain
1263440|NCT01744717|mechanical ventilation|mechanical ventilation
1263441|NCT01744717|uncommunicative|uncommunicative
1263442|NCT01744717|Adult ICU patients pain|adult icu patients pain
1263443|NCT01744704|Nerve Growth Factor|nerve growth factor
1263444|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
1263445|NCT01744704|Eye Drops|eye drops
1263446|NCT01744704|rh-NGF|rh-ngf
1263447|NCT01744691|CLL|cll
1263448|NCT01744691|SLL|sll
1263449|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
1263450|NCT01744652|Advanced Cancers|advanced cancers
1263451|NCT01744652|Advanced Malignancies|advanced malignancies
1263452|NCT01744652|Unresectable|unresectable
1263453|NCT01744652|Metastatic|metastatic
1263454|NCT01744652|Crizotinib|crizotinib
1263455|NCT01744652|PF-02341066|pf-02341066
1263456|NCT01744652|Xalkori|xalkori
1263457|NCT01744652|Dasatinib|dasatinib
1263458|NCT01744652|BMS-354825|bms-354825
1263459|NCT01744652|Sprycel|sprycel
1263460|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
1263461|NCT01744639|Radioablation|radioablation
1263560|NCT01744158|register|register
1263462|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1263463|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1263464|NCT01744613|Clopidogrel|clopidogrel
1263465|NCT01744613|platelet inhibition|platelet inhibition
1263466|NCT01744613|antiplatelet therapy|antiplatelet therapy
1263467|NCT01744613|peripheral arterial disease|peripheral arterial disease
1263468|NCT01744613|endovascular treatment|endovascular treatment
1263469|NCT01744613|angioplasty|angioplasty
1263470|NCT01744613|stenting|stenting
1263471|NCT01744600|Dementia|dementia
1263472|NCT01744600|Music Therapy|music therapy
1263473|NCT01744587|EBV|ebv
1263474|NCT01744587|EGCG|egcg
1263475|NCT01744561|Exercise|exercise
1263476|NCT01744561|Motivation|motivation
1263477|NCT01744561|Feedback|feedback
1263478|NCT01744561|web-based diary|web-based diary
1263479|NCT01744561|pedometer|pedometer
1263480|NCT01744535|smartphone|smartphone
1263481|NCT01744535|smartphone app|smartphone app
1263482|NCT01744535|smartphone application|smartphone application
1263483|NCT01744535|obesity|obesity
1263484|NCT01744535|overweight|overweight
1263485|NCT01744535|self monitoring|self monitoring
1263486|NCT01744496|Parkinson's Disease|parkinson's disease
1263487|NCT01744496|Rotigotine|rotigotine
1263488|NCT01744496|Chronic Pain|chronic pain
1263489|NCT01744496|Nonmotor symptoms|nonmotor symptoms
1263490|NCT01744483|pneumonia|pneumonia
1263491|NCT01744483|endotracheal intubation|endotracheal intubation
1263492|NCT01744470|Renal|renal
1263493|NCT01744470|Transplantation|transplantation
1263494|NCT01744470|Tacrolimus|tacrolimus
1263495|NCT01744457|tear film osmolarity|tear film osmolarity
1263496|NCT01744457|objective scattering index|objective scattering index
1263497|NCT01744457|tear break up time|tear break up time
1263498|NCT01744457|Schirmer I test|schirmer i test
1263499|NCT01744418|ESRD|esrd
1263500|NCT01744418|HEMODIALYSIS|hemodialysis
1601031|NCT00390416|Docetaxel|docetaxel
1263501|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
1263502|NCT01744418|Renal Dialysis|renal dialysis
1263503|NCT01744418|Hemodiafiltration|hemodiafiltration
1263504|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
1263505|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
1263506|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
1263507|NCT01744405|Chagas disease|chagas disease
1263508|NCT01744405|lactation|lactation
1263509|NCT01744405|breastmilk|breastmilk
1263510|NCT01744405|postpartum period|postpartum period
1263511|NCT01744405|infants|infants
1263512|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
1263513|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
1263514|NCT01744405|parasitology|parasitology
1263515|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
1263516|NCT01744405|nifurtimox|nifurtimox
1263517|NCT01744353|newly diagnosed|newly diagnosed
1263518|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
1263519|NCT01744353|pancreatic cancer|pancreatic cancer
1263520|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
1263521|NCT01744353|pancreas|pancreas
1263522|NCT01744340|Head and Neck|head and neck
1263523|NCT01744340|Colon|colon
1263524|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
1263525|NCT01744301|Seizure|seizure
1263526|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
1263527|NCT01744301|Epidemiology|epidemiology
1263528|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
1263529|NCT01744288|pharmacodynamic,|pharmacodynamic,
1263530|NCT01744288|Ticagrelor,|ticagrelor,
1263531|NCT01744288|Clopidogrel,|clopidogrel,
1263532|NCT01744288|Platelets|platelets
1263533|NCT01744275|Epilepsy|epilepsy
1263534|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
1263535|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
1263536|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
1263537|NCT01744249|axitinib|axitinib
1263538|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
1263539|NCT01744223|iCaspase9|icaspase9
1263540|NCT01744223|iCasp9|icasp9
1263541|NCT01744223|Inducible Caspase|inducible caspase
1263542|NCT01744223|AP1903|ap1903
1263543|NCT01744223|Dimerizer drug|dimerizer drug
1263544|NCT01744223|T depleted|t depleted
1263545|NCT01744223|Suicide gene|suicide gene
1263546|NCT01744223|CD-34 selection|cd-34 selection
1263547|NCT01744223|haplotransplantation|haplotransplantation
1263548|NCT01744223|Graft versus host disease|graft versus host disease
1263549|NCT01744223|Allogenic transplantation|allogenic transplantation
1263550|NCT01744197|Pain control|pain control
1263948|NCT01742559|Treatment|treatment
1263551|NCT01744197|Needle stick pain|needle stick pain
1263552|NCT01744197|Venipuncture pain|venipuncture pain
1263553|NCT01744184|gastroscopy|gastroscopy
1263554|NCT01744184|diagnostic|diagnostic
1263555|NCT01744184|entonox|entonox
1263556|NCT01744158|cerebral palsy|cerebral palsy
1263557|NCT01744158|spasticity|spasticity
1263558|NCT01744158|dystonia|dystonia
1263559|NCT01744158|hypertonia|hypertonia
1263561|NCT01744158|motor function|motor function
1263562|NCT01744132|eye care utilization|eye care utilization
1263563|NCT01744132|ophthalmology|ophthalmology
1263564|NCT01744132|educational intervention|educational intervention
1263565|NCT01744132|public health screening|public health screening
1263566|NCT01744093|HIV|hiv
1263567|NCT01744093|COPD|copd
1263568|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1263569|NCT01744093|Emphysema|emphysema
1263570|NCT01744080|Rotator cuff|rotator cuff
1263571|NCT01744067|Renal transplantation|renal transplantation
1263572|NCT01744067|Interventional study|interventional study
1263573|NCT01744067|Glomerular filtration rate|glomerular filtration rate
1263574|NCT01744067|Renal function|renal function
1263575|NCT01744067|Proteinuria|proteinuria
1263576|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
1263577|NCT01744067|Blood pressure|blood pressure
1263578|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
1263579|NCT01744067|Heart rate variability|heart rate variability
1263580|NCT01744067|Pulse wave velocity|pulse wave velocity
1263581|NCT01744067|Lipids|lipids
1263582|NCT01744067|Blood glucose|blood glucose
1263583|NCT01744067|Bone mineral density|bone mineral density
1263584|NCT01744067|Body composition|body composition
1263585|NCT01744067|Fat distribution|fat distribution
1263586|NCT01744067|Body mass index|body mass index
1263587|NCT01744067|Fatty acid composition|fatty acid composition
1263588|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
1263589|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
1263590|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
1263591|NCT01744067|Fatty acids|fatty acids
1263592|NCT01744067|Gas chromatography|gas chromatography
1263593|NCT01744067|Interstitial fibrosis|interstitial fibrosis
1263594|NCT01744067|Inflammation|inflammation
1263595|NCT01744041|depression|depression
1263596|NCT01744041|pregnancy|pregnancy
1263597|NCT01744041|postpartum|postpartum
1263598|NCT01744041|psychotherapy|psychotherapy
1263599|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
1263600|NCT01744015|Low back pain|low back pain
1263601|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
1263602|NCT01743976|neuropathic pain|neuropathic pain
1263603|NCT01743976|diabetic neuropathy|diabetic neuropathy
1263604|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
1263605|NCT01743963|efficacy|efficacy
1263606|NCT01743963|glucocorticoid|glucocorticoid
1263607|NCT01743950|Glioblastoma|glioblastoma
1263608|NCT01743950|anaplastic glioma|anaplastic glioma
1263609|NCT01743937|Ischemic preconditioning|ischemic preconditioning
1263610|NCT01743937|Ticagrelor|ticagrelor
1263611|NCT01743937|Antiplatelet therapy|antiplatelet therapy
1263612|NCT01743937|Acute coronary syndrome|acute coronary syndrome
1263613|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
1263614|NCT01743911|Tadalafil|tadalafil
1263615|NCT01743911|Resistant Hypertension|resistant hypertension
1263616|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
1263617|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
1263618|NCT01743885|Hemangioma|hemangioma
1263619|NCT01743885|Beta-blocker|beta-blocker
1263620|NCT01743885|Acebutolol|acebutolol
1263621|NCT01743885|Propranolol|propranolol
1263622|NCT01743885|Randomized controlled trial|randomized controlled trial
1263623|NCT01743885|Infants|infants
1263624|NCT01743872|Optical Coherence Tomography|optical coherence tomography
1263625|NCT01743872|Contrast|contrast
1263626|NCT01743872|Dextran|dextran
1263627|NCT01743872|Carbon Dioxide|carbon dioxide
1263628|NCT01743872|Imaging|imaging
1263629|NCT01743872|Catheter|catheter
1263630|NCT01743872|Lower Extremity Artery|lower extremity artery
1263631|NCT01743859|Myeloid|myeloid
1263632|NCT01743859|Leukemia|leukemia
1263633|NCT01743807|Relapsed|relapsed
1263634|NCT01743807|Minimal Residual Disease|minimal residual disease
1263635|NCT01743807|MRD|mrd
1263636|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1263637|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
1263638|NCT01743807|ALL|all
1263639|NCT01743807|AML|aml
1263640|NCT01743807|GNKG168|gnkg168
1263641|NCT01743807|Pediatric|pediatric
1263642|NCT01743807|Childhood|childhood
1263643|NCT01743781|comprehensive eye examination|comprehensive eye examination
1263644|NCT01743781|acceptance|acceptance
1263645|NCT01743781|glaucoma|glaucoma
1263646|NCT01743781|diabetic retinopathy|diabetic retinopathy
1263647|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
1263648|NCT01743768|Asthma|asthma
1263649|NCT01743768|Healthy subjects|healthy subjects
1263651|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
1263652|NCT01743768|Oral inhalation|oral inhalation
1263653|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
1263654|NCT01743755|Dexamethasone|dexamethasone
1263655|NCT01743755|Corticosteroid|corticosteroid
1263656|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
1263657|NCT01743729|SAR 1118|sar 1118
1263658|NCT01743716|Major Depressive Disorder|major depressive disorder
1263660|NCT01743716|depression|depression
1263661|NCT01743716|adolescent|adolescent
1263662|NCT01743703|traumatic injuries|traumatic injuries
1263663|NCT01743703|Whole-body MRI|whole-body mri
1263664|NCT01743703|Skeletal survey|skeletal survey
1263665|NCT01743703|Children|children
1263666|NCT01743703|Diagnostic|diagnostic
1263667|NCT01743690|Probiotic|probiotic
1263668|NCT01743690|Candida|candida
1263669|NCT01743690|Oral Lichen Planus|oral lichen planus
1263670|NCT01743677|TQT study|tqt study
1263671|NCT01743677|CP-690,550|cp-690,550
1263672|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
1263673|NCT01743664|Multiple Sclerosis|multiple sclerosis
1263674|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
1263675|NCT01743664|Psychotherapy|psychotherapy
1263676|NCT01743664|Anxiety|anxiety
1263677|NCT01743664|Depression|depression
1263678|NCT01743664|Quality of Life|quality of life
1263679|NCT01743651|spasticity|spasticity
1263680|NCT01743651|multiple sclerosis|multiple sclerosis
1263681|NCT01743651|arbaclofen|arbaclofen
1263682|NCT01743612|healthy subject|healthy subject
1263683|NCT01743612|hand blood flow|hand blood flow
1263684|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
1263685|NCT01743586|Lung cancer|lung cancer
1263686|NCT01743586|Chest physiotherapy|chest physiotherapy
1263687|NCT01743586|Respiratory muscle strength|respiratory muscle strength
1263688|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
1263689|NCT01743586|Quality of life|quality of life
1263690|NCT01743560|Breast Neoplasms|breast neoplasms
1263691|NCT01743560|Neoplasms|neoplasms
1263692|NCT01743560|Breast diseases|breast diseases
1263693|NCT01743560|Skin diseases|skin diseases
1263694|NCT01743560|Exemestane|exemestane
1601032|NCT00390416|Cisplatin|cisplatin
1263695|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
1263696|NCT01743560|Everolimus|everolimus
1263697|NCT01743560|Antineoplastic Agents|antineoplastic agents
1263698|NCT01743560|Therapeutic Uses|therapeutic uses
1263699|NCT01743560|Pharmacologic Actions|pharmacologic actions
1263700|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
1263701|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
1263702|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
1263703|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
1263704|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1263705|NCT01743547|Women|women
1263706|NCT01743547|Yoga|yoga
1263707|NCT01743547|Ovarian Cancer|ovarian cancer
1263708|NCT01743547|Lifestyle|lifestyle
1263709|NCT01743521|Hepatitis C|hepatitis c
1263710|NCT01743521|Individualised therapy|individualised therapy
1263711|NCT01743521|Response-guided therapy|response-guided therapy
1263712|NCT01743521|Telaprevir|telaprevir
1263713|NCT01743521|PEG-IFN|peg-ifn
1263714|NCT01743521|Ribavirin|ribavirin
1263715|NCT01743521|Hepatitis|hepatitis
1263716|NCT01743508|incomplete abortion|incomplete abortion
1263717|NCT01743508|misoprostol treatment|misoprostol treatment
1263718|NCT01743508|midwife|midwife
1263719|NCT01743508|uganda|uganda
1263720|NCT01743495|Medical Costs|medical costs
1263721|NCT01743495|improved IADLs|improved iadls
1263722|NCT01743495|and/or ADL's|and/or adl's
1263723|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
1263724|NCT01743482|Testicular Cancer|testicular cancer
1263725|NCT01743482|Germ Cell Tumors|germ cell tumors
1263726|NCT01743482|Salvage Therapy|salvage therapy
1263727|NCT01743482|Pazopanib|pazopanib
1263728|NCT01743469|Advanced|advanced
1263729|NCT01743469|Metastatic|metastatic
1263730|NCT01743469|Hepatocellular cancer|hepatocellular cancer
1263731|NCT01743469|Ovarian cancer|ovarian cancer
1263732|NCT01743469|Renal cell cancer|renal cell cancer
1263733|NCT01743469|Gastric carcinoma|gastric carcinoma
1263734|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1263735|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1263736|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
1263737|NCT01743456|Postoperative delirium|postoperative delirium
1263738|NCT01743443|Corneal sensitivity|corneal sensitivity
1263739|NCT01743443|Cross-linking|cross-linking
1263740|NCT01743443|Keratoconus|keratoconus
1263741|NCT01743430|telerehabilitation|telerehabilitation
1263742|NCT01743430|stroke|stroke
1263743|NCT01743430|Berg balance scale|berg balance scale
1263744|NCT01743430|stroke impact scale|stroke impact scale
1263745|NCT01743430|mobility|mobility
1263746|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
1263747|NCT01743417|malaria|malaria
1263748|NCT01743417|neuropsychology|neuropsychology
1263749|NCT01743417|attention|attention
1263750|NCT01743417|working memory|working memory
1263751|NCT01743404|atherosclerosis|atherosclerosis
1263752|NCT01743404|inflammation|inflammation
1263753|NCT01743404|intima-media thickness|intima-media thickness
1263754|NCT01743391|IVF treatment|ivf treatment
1263755|NCT01743391|Office-hysteroscopy|office-hysteroscopy
1263756|NCT01743391|Endometrial biopsy|endometrial biopsy
1263757|NCT01743352|Large arteries|large arteries
1263758|NCT01743352|stiffness|stiffness
1263759|NCT01743352|intima media thickness|intima media thickness
1263760|NCT01743352|ultrasound imaging|ultrasound imaging
1263761|NCT01743339|Randomized Controlled Trial|randomized controlled trial
1263762|NCT01743339|Cognitive Therapy|cognitive therapy
1263763|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1263764|NCT01743339|Depression|depression
1263765|NCT01743339|Sleep|sleep
1263766|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
1263767|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
1263768|NCT01743313|metabolic syndrome|metabolic syndrome
1263769|NCT01743313|joint replacement|joint replacement
1263770|NCT01743313|osteoarthritis|osteoarthritis
1263771|NCT01743300|sunitinib|sunitinib
1263772|NCT01743300|pharmacokinetics|pharmacokinetics
1263773|NCT01743300|phenotyping|phenotyping
1263774|NCT01743300|interaction|interaction
1263775|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
1263776|NCT01743274|acute coronary syndromes|acute coronary syndromes
1263777|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
1263778|NCT01743274|angioplasty|angioplasty
1263779|NCT01743274|fractional flow reserve|fractional flow reserve
1263780|NCT01743274|optical coherence tomography|optical coherence tomography
1263781|NCT01743261|severe brain injury|severe brain injury
1263782|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
1263783|NCT01743248|vestibular schwannoma|vestibular schwannoma
1263784|NCT01743248|balance|balance
1263785|NCT01743248|psychological factors|psychological factors
1263786|NCT01743235|HSDD|hsdd
1263787|NCT01743209|androgen antagonists|androgen antagonists
1263788|NCT01743196|Folic acid|folic acid
1263789|NCT01743196|Folate|folate
1263790|NCT01743196|Pharmacokinetics|pharmacokinetics
1601603|NCT00388232|biomass|biomass
1263791|NCT01743196|Women of Child Bearing Age|women of child bearing age
1263792|NCT01743183|hypertension|hypertension
1263793|NCT01743170|Blood pressure control|blood pressure control
1263794|NCT01743170|Hypertension|hypertension
1263795|NCT01743170|Office blood pressure|office blood pressure
1263796|NCT01743170|Self-measured blood pressure|self-measured blood pressure
1263797|NCT01743170|Telemonitoring|telemonitoring
1263798|NCT01743144|emergence agitation in children|emergence agitation in children
1263799|NCT01743144|sevoflurane|sevoflurane
1263800|NCT01743144|general anesthesia|general anesthesia
1263801|NCT01743144|magnesium sulphate|magnesium sulphate
1263802|NCT01743105|diaphragm movement|diaphragm movement
1263803|NCT01743105|ultrasound|ultrasound
1263804|NCT01743105|emergency room|emergency room
1263805|NCT01743092|Pathological gambling|pathological gambling
1263806|NCT01743092|treatment|treatment
1263807|NCT01743092|online counselling|online counselling
1263808|NCT01743092|webinar|webinar
1263809|NCT01743092|workbook|workbook
1263810|NCT01743079|Telbivudine|telbivudine
1263811|NCT01743079|Lamivudine|lamivudine
1263812|NCT01743079|safety|safety
1263813|NCT01743079|efficacy|efficacy
1263814|NCT01743079|pregnancy|pregnancy
1263816|NCT01743066|Arsenicosis|arsenicosis
1263817|NCT01743066|Buccal cells|buccal cells
1263818|NCT01743066|Serum|serum
1263819|NCT01743066|Vitamin E|vitamin e
1263820|NCT01743066|Cholesterol|cholesterol
1263821|NCT01743040|Coronary Artery Disease|coronary artery disease
1263822|NCT01743040|Nuclear Stress Test|nuclear stress test
1263823|NCT01743040|CT Angiography|ct angiography
1263824|NCT01743040|Angiography|angiography
1263825|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
1263826|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
1263827|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
1263828|NCT01743027|Itching eyes|itching eyes
1263829|NCT01743027|Ocular allergies|ocular allergies
1263830|NCT01743027|PATADAY|pataday
1263831|NCT01743027|PATANOL|patanol
1263832|NCT01743014|diabetes|diabetes
1263833|NCT01743014|diabetic nephropathy|diabetic nephropathy
1263834|NCT01743014|vascular inflammation|vascular inflammation
1263835|NCT01743014|oxidative stress|oxidative stress
1263836|NCT01743014|endothelial dysfunction|endothelial dysfunction
1263837|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
1263838|NCT01743014|High sensitivity CRP|high sensitivity crp
1263839|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
1263840|NCT01743014|isoprostane|isoprostane
1263841|NCT01743014|clopidogrel|clopidogrel
1263842|NCT01743014|ramipril|ramipril
1263843|NCT01743014|carotid intima media thickness|carotid intima media thickness
1263844|NCT01743001|exercise capacity|exercise capacity
1263845|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
1263846|NCT01742988|PI3K|pi3k
1263847|NCT01742988|HDAC|hdac
1263848|NCT01742988|Open-Label|open-label
1263849|NCT01742988|Dose-Escalation|dose-escalation
1263850|NCT01742962|Prostatectomy|prostatectomy
1263851|NCT01742962|Prostate cancer|prostate cancer
1263853|NCT01742962|Urinary incontinence|urinary incontinence
1263854|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
1263855|NCT01742962|Penis|penis
1263856|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
1263857|NCT01742962|Pain|pain
1263858|NCT01742962|Anorgasmia|anorgasmia
1263859|NCT01742962|Penile shortening|penile shortening
1263958|NCT01742507|Stent, OCT|stent, oct
1263860|NCT01742962|Erectile dysfunction|erectile dysfunction
1263861|NCT01742923|hypertension|hypertension
1263862|NCT01742923|medication adherence|medication adherence
1263863|NCT01742923|motivational interviewing|motivational interviewing
1263864|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
1263865|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
1263866|NCT01742897|Durogesic|durogesic
1263867|NCT01742884|Dry Eye Syndrome|dry eye syndrome
1263868|NCT01742871|Antivitamin K|antivitamin k
1263869|NCT01742871|Bleeding|bleeding
1263870|NCT01742871|Haemorrhage|haemorrhage
1263871|NCT01742871|Nutritional status|nutritional status
1263872|NCT01742871|impedancemetry|impedancemetry
1263873|NCT01742845|Ultrasound-guided|ultrasound-guided
1263874|NCT01742845|regional anaesthesia|regional anaesthesia
1263875|NCT01742845|Cervical block|cervical block
1263876|NCT01742832|Vilazodone|vilazodone
1263877|NCT01742832|Citalopram|citalopram
1263878|NCT01742832|Major Depressive Disorder|major depressive disorder
1263879|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
1263880|NCT01742806|Gastric cancer|gastric cancer
1263881|NCT01742806|Minimally invasive surgery|minimally invasive surgery
1263882|NCT01742806|Distal gastrectomy|distal gastrectomy
1263883|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
1263884|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
1263885|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
1263886|NCT01742793|multiple myeloma|multiple myeloma
1263887|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
1263888|NCT01742780|IO Access|io access
1263889|NCT01742780|IO Vascular Access|io vascular access
1263890|NCT01742780|EZ-IO|ez-io
1263891|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
1263892|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
1263893|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
1263894|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
1263895|NCT01742741|Insulin Pump|insulin pump
1263896|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
1263897|NCT01742741|Open Loop treatment|open loop treatment
1263898|NCT01742741|Diabetes Assistant|diabetes assistant
1263899|NCT01742741|DiAs|dias
1263900|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
1263901|NCT01742728|antibody titer|antibody titer
1263902|NCT01742715|ARDS|ards
1263903|NCT01742715|Lung compliance|lung compliance
1263904|NCT01742702|Blood pressure|blood pressure
1263905|NCT01742702|Hypertension|hypertension
1263906|NCT01742702|Arterial stiffness|arterial stiffness
1263907|NCT01742702|Cardiac output|cardiac output
1263908|NCT01742702|Vascular resistance|vascular resistance
1263909|NCT01742702|Pulse wave reflection|pulse wave reflection
1263910|NCT01742702|Head-up tilt|head-up tilt
1263911|NCT01742689|Renal colic|renal colic
1263912|NCT01742689|Pain|pain
1263913|NCT01742689|Desmopressin|desmopressin
1263914|NCT01742689|Urinary obstruction|urinary obstruction
1263915|NCT01742689|Indomethacin|indomethacin
1263916|NCT01742676|tacrolimus|tacrolimus
1263917|NCT01742676|kidney|kidney
1263918|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
1263919|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
1263920|NCT01742663|Actinic Keratosis|actinic keratosis
1263921|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
1263922|NCT01742637|Acne Vulgaris|acne vulgaris
1263923|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
1263924|NCT01742637|Epiduo®|epiduo®
1263925|NCT01742624|immunosuppressant|immunosuppressant
1263926|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
1263927|NCT01742624|NODAT|nodat
1263929|NCT01742611|Not on dialysis|not on dialysis
1263930|NCT01742611|ASP1585|asp1585
1263931|NCT01742611|Bixalomer|bixalomer
1263932|NCT01742598|TAVI|tavi
1263933|NCT01742598|TAVR|tavr
1263934|NCT01742598|aortic stenosis|aortic stenosis
1263935|NCT01742598|Transcatheter|transcatheter
1263936|NCT01742598|valvular heart disease|valvular heart disease
1263937|NCT01742598|aortic valve stenosis|aortic valve stenosis
1263938|NCT01742598|aortic valve replacement|aortic valve replacement
1263939|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1263940|NCT01742585|CKD|ckd
1263941|NCT01742585|Not on dialysis|not on dialysis
1263942|NCT01742585|ASP1585|asp1585
1263943|NCT01742585|Bixalomer|bixalomer
1263944|NCT01742572|weight loss|weight loss
1263945|NCT01742572|obesity|obesity
1263946|NCT01742572|overweight|overweight
1263947|NCT01742572|diet|diet
1263949|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
1263950|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
1263951|NCT01742546|combine therapy|combine therapy
1263952|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
1263953|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
1263954|NCT01742533|Stem Cell Therapy|stem cell therapy
1263955|NCT01742520|Preterm infant|preterm infant
1263957|NCT01742520|neurodevelopment|neurodevelopment
1263959|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
1263960|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
1263961|NCT01742494|Water-jet assisted|water-jet assisted
1263962|NCT01742481|childhood cancer survivors|childhood cancer survivors
1263963|NCT01742481|long-term follow-up care|long-term follow-up care
1263964|NCT01742481|health communication|health communication
1263965|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
1263966|NCT01742481|longterm survivors|longterm survivors
1263967|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
1263968|NCT01742455|Peripheral artery disease|peripheral artery disease
1263969|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
1263970|NCT01742455|Vascular Diseases|vascular diseases
1263971|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
1263972|NCT01742455|Coronary Artery Disease|coronary artery disease
1263973|NCT01742455|Myocardial Ischemia|myocardial ischemia
1263974|NCT01742455|Arteriosclerosis|arteriosclerosis
1263975|NCT01742455|Pathologic Processes|pathologic processes
1263976|NCT01742442|Cancer|cancer
1263977|NCT01742442|elderly OR older|elderly or older
1263978|NCT01742442|chemotherapy|chemotherapy
1263979|NCT01742442|geriatric assessment|geriatric assessment
1263980|NCT01742429|Helicobacter pylori|helicobacter pylori
1263981|NCT01742429|second line treatment|second line treatment
1263982|NCT01742416|Arterial Cannulation|arterial cannulation
1263983|NCT01742416|Ultrasound|ultrasound
1263984|NCT01742416|Palpation Method|palpation method
1263985|NCT01742416|Pediatrics|pediatrics
1263986|NCT01742416|Cardiac Surgery|cardiac surgery
1263987|NCT01742416|Craniotomies|craniotomies
1263988|NCT01742416|Cranial Vault Surgery|cranial vault surgery
1263989|NCT01742416|Abdominal Procedures|abdominal procedures
1263990|NCT01742403|Prostate|prostate
1263991|NCT01742403|IGRT|igrt
1263992|NCT01742403|VMAT|vmat
1263993|NCT01742390|schizophrenia|schizophrenia
1263994|NCT01742390|risperidone|risperidone
1263995|NCT01742390|paliperidone|paliperidone
1263996|NCT01742390|aripiprazole|aripiprazole
1263997|NCT01742377|GERD|gerd
1263998|NCT01742377|Dyspepsia|dyspepsia
1263999|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
1264000|NCT01742377|Minimal change erosions|minimal change erosions
1264001|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
1264002|NCT01742364|DSJI|dsji
1264003|NCT01742364|BCG|bcg
1264004|NCT01742364|tuberculosis|tuberculosis
1264005|NCT01742364|intradermal delivery|intradermal delivery
1264006|NCT01742364|South Africa|south africa
1264007|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1264008|NCT01742338|COPD|copd
1264009|NCT01742338|Chronic bronchitis|chronic bronchitis
1264010|NCT01742338|emphysema|emphysema
1264011|NCT01742338|Corticosteroids|corticosteroids
1264012|NCT01742325|fatigue|fatigue
1264013|NCT01742325|walking|walking
1264014|NCT01742325|childhood cancer|childhood cancer
1264015|NCT01742325|sleep disturbance|sleep disturbance
1264016|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1264017|NCT01742312|oesophageal cancer|oesophageal cancer
1264018|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
1264019|NCT01742299|Glivec/Gleevec|glivec/gleevec
1264020|NCT01742299|CML|cml
1264021|NCT01742299|GIST|gist
1264022|NCT01742299|Imatinib mesylate|imatinib mesylate
1264023|NCT01742286|pediatric|pediatric
1264024|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
1264025|NCT01742286|ALK|alk
1264026|NCT01742286|ALK-activated tumors|alk-activated tumors
1264027|NCT01742286|neuroblastoma|neuroblastoma
1264028|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
1264029|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
1264030|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
1264031|NCT01742260|Cranioplasty|cranioplasty
1264032|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
1264033|NCT01742260|Bioceramic polymer|bioceramic polymer
1264034|NCT01742247|Moisturizer, laser|moisturizer, laser
1264035|NCT01742221|Safety and Tolerability, Cytokines, Acute Radiation Syndrome, Hematopoietic Syndrome, Radiation Countermeasure|safety and tolerability, cytokines, acute radiation syndrome, hematopoietic syndrome, radiation countermeasure
1264036|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
1264037|NCT01742195|Bronchoscopy|bronchoscopy
1264038|NCT01742195|Patient satisfaction|patient satisfaction
1264039|NCT01742182|Parkinson's Disease|parkinson's disease
1264040|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
1264041|NCT01742182|Circadian Rhythms|circadian rhythms
1264042|NCT01742182|Light Therapy|light therapy
1264043|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
1264044|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
1264045|NCT01742156|CAD|cad
1264046|NCT01742156|microangiopathy|microangiopathy
1264047|NCT01742156|patients|patients
1264048|NCT01742156|more likely|more likely
1264049|NCT01742156|to have tortuosity|to have tortuosity
1264050|NCT01742156|of conjunctival vessels|of conjunctival vessels
1264051|NCT01742143|Quality of life|quality of life
1264052|NCT01742143|cancer|cancer
1264053|NCT01742143|12-223|12-223
1264969|NCT01738308|pain|pain
1264054|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
1264055|NCT01742130|Contrast media|contrast media
1264056|NCT01742130|Angiography|angiography
1264057|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
1264058|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
1264059|NCT01742117|angioplasty|angioplasty
1264060|NCT01742104|glaucoma|glaucoma
1264061|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
1264062|NCT01742104|observational study|observational study
1264063|NCT01742104|quality of life|quality of life
1264064|NCT01742091|Postmenopausal females|postmenopausal females
1264065|NCT01742091|Volunteers|volunteers
1264066|NCT01742078|Postmenopausal females|postmenopausal females
1264067|NCT01742078|Volunteers|volunteers
1264068|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
1264069|NCT01742065|Cancer Screening|cancer screening
1264070|NCT01742065|Pragmatic Trial|pragmatic trial
1264071|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1264073|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
1264074|NCT01742013|Chronic Fatigue|chronic fatigue
1264075|NCT01742013|CFS|cfs
1264076|NCT01742013|ICF|icf
1264077|NCT01742013|human placenta|human placenta
1264078|NCT01742000|postmenopause|postmenopause
1264079|NCT01742000|phytoestrogen|phytoestrogen
1264080|NCT01742000|atherosclerosis|atherosclerosis
1264081|NCT01742000|intima-media thickness|intima-media thickness
1264082|NCT01741974|perimenopause|perimenopause
1264083|NCT01741974|phytoestrogen|phytoestrogen
1264084|NCT01741974|atherosclerosis|atherosclerosis
1264085|NCT01741974|intima-media thickness|intima-media thickness
1264086|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
1264087|NCT01741961|glaucoma drainage device|glaucoma drainage device
1264088|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
1264089|NCT01741948|Hormonal contraceptives|hormonal contraceptives
1264090|NCT01741922|Low dose|low dose
1264091|NCT01741922|aspirin|aspirin
1264092|NCT01741922|ASA|asa
1264093|NCT01741922|Hypertension|hypertension
1264094|NCT01741922|blood pressure|blood pressure
1264095|NCT01741909|azythromycin|azythromycin
1264096|NCT01741909|community acquired pneumonia|community acquired pneumonia
1264097|NCT01741909|intravenous|intravenous
1264098|NCT01741909|oral|oral
1264099|NCT01741883|Randomized Controlled Trial|randomized controlled trial
1264100|NCT01741883|Patients´ Expectations|patients´ expectations
1264101|NCT01741883|Breast Cancer|breast cancer
1264102|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
1264103|NCT01741883|Nocebo|nocebo
1264104|NCT01741870|Nutritional supplement|nutritional supplement
1264105|NCT01741870|Nutritional status|nutritional status
1264106|NCT01741870|Physical functional activity|physical functional activity
1264107|NCT01741870|Nursing home elderly|nursing home elderly
1264108|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1264109|NCT01741844|TMC125|tmc125
1264110|NCT01741844|Etravirine|etravirine
1264111|NCT01741844|Intelence|intelence
1264112|NCT01741844|AIDS|aids
1264113|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1264114|NCT01741831|AIDS|aids
1264115|NCT01741831|TMC114|tmc114
1264116|NCT01741831|Darunavir|darunavir
1264117|NCT01741831|Prezista|prezista
1264118|NCT01741818|IVC|ivc
1264119|NCT01741818|ultrasonography|ultrasonography
1264120|NCT01741818|IVC collapsibility index|ivc collapsibility index
1264121|NCT01741818|IVC diameter|ivc diameter
1264122|NCT01741792|Relapsed DLBCL|relapsed dlbcl
1264123|NCT01741792|Refractory DLBCL|refractory dlbcl
1264124|NCT01741792|adult DLBCL|adult dlbcl
1264125|NCT01741792|Lymphoma|lymphoma
1264126|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1264127|NCT01741792|Lymphatic diseases|lymphatic diseases
1264128|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
1264129|NCT01741792|bispecific antibody|bispecific antibody
1264130|NCT01741792|anti-CD19|anti-cd19
1264131|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
1264132|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
1264133|NCT01741779|whole body vibration training|whole body vibration training
1264134|NCT01741779|hypocaloric diet|hypocaloric diet
1264135|NCT01741779|prehypertension|prehypertension
1264136|NCT01741779|hypertension|hypertension
1264137|NCT01741779|obesity|obesity
1264138|NCT01741779|arterial function|arterial function
1264139|NCT01741779|arterial stiffness|arterial stiffness
1264140|NCT01741779|pulse wave velocity|pulse wave velocity
1264141|NCT01741779|autonomic function|autonomic function
1264142|NCT01741779|endothelial function|endothelial function
1264350|NCT01740752|couples|couples
1264143|NCT01741779|adipocytokines|adipocytokines
1264144|NCT01741766|prehypertension|prehypertension
1264145|NCT01741766|hypertension|hypertension
1264146|NCT01741766|obesity|obesity
1264147|NCT01741766|stretching|stretching
1264148|NCT01741766|arterial function|arterial function
1264149|NCT01741766|arterial stiffness|arterial stiffness
1264150|NCT01741766|pulse wave velocity|pulse wave velocity
1264151|NCT01741766|autonomic function|autonomic function
1264152|NCT01741766|endothelial function|endothelial function
1264153|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
1264154|NCT01741753|Castrate Resistant|castrate resistant
1264155|NCT01741753|Metastatic|metastatic
1264156|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
1264157|NCT01741675|Questionnaires|questionnaires
1264158|NCT01741675|Quality of Life|quality of life
1264159|NCT01741675|Response rate|response rate
1264160|NCT01741649|Surgical wound infection|surgical wound infection
1264161|NCT01741649|Clorhexidine|clorhexidine
1264162|NCT01741649|Povidone|povidone
1264163|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
1264164|NCT01741610|Ephedrine|ephedrine
1264165|NCT01741610|Fluid Therapy|fluid therapy
1264166|NCT01741610|Hypotension|hypotension
1264167|NCT01741558|Myocardial Ischemia|myocardial ischemia
1264168|NCT01741558|Myocardial Infarction|myocardial infarction
1264169|NCT01741558|Methotrexate|methotrexate
1264170|NCT01741558|Inflammation|inflammation
1264171|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
1264172|NCT01741558|Inflammation Mediators|inflammation mediators
1264173|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
1264174|NCT01741532|PKAN|pkan
1264175|NCT01741532|NBIA|nbia
1264176|NCT01741532|Deferiprone|deferiprone
1264177|NCT01741532|Ferriprox|ferriprox
1264178|NCT01741519|PK|pk
1264179|NCT01741519|PD|pd
1264180|NCT01741519|landiolol|landiolol
1264181|NCT01741519|esmolol|esmolol
1264182|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
1264183|NCT01741506|Lung cancer|lung cancer
1264184|NCT01741506|Surgery|surgery
1264185|NCT01741506|Thromboembolism|thromboembolism
1264186|NCT01741506|Bleeding|bleeding
1264187|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
1264188|NCT01741493|Methotrexate|methotrexate
1264189|NCT01741493|Tolerability|tolerability
1264190|NCT01741493|Pharmacokinetics|pharmacokinetics
1264191|NCT01741493|Safety|safety
1264192|NCT01741493|Tofacitinib|tofacitinib
1264193|NCT01741480|Outcomes|outcomes
1264194|NCT01741480|Early warning systems|early warning systems
1264195|NCT01741480|ICU transfer|icu transfer
1264196|NCT01741454|Tolterodine|tolterodine
1264197|NCT01741454|Tamsulosin|tamsulosin
1264198|NCT01741454|Ureteral Obstruction|ureteral obstruction
1264199|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
1264200|NCT01741441|Weakly acidic reflux|weakly acidic reflux
1264201|NCT01741441|Gastric emptying|gastric emptying
1264202|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
1264203|NCT01741428|CVD Risk score|cvd risk score
1264204|NCT01741428|Physical activity|physical activity
1264205|NCT01741428|Overweight|overweight
1264206|NCT01741428|Cholesterol|cholesterol
1264207|NCT01741428|LDL-Cholesterol|ldl-cholesterol
1264208|NCT01741428|HDL-Cholesterol|hdl-cholesterol
1264209|NCT01741428|Triglycerides|triglycerides
1264210|NCT01741428|HbA1C|hba1c
1264211|NCT01741428|Quality of life|quality of life
1264212|NCT01741402|Control posture|control posture
1264213|NCT01741402|Gait|gait
1264214|NCT01741402|Virtual Reality|virtual reality
1264215|NCT01741402|Elderly|elderly
1264216|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
1264217|NCT01741363|iFOBT|ifobt
1264218|NCT01741363|one-day sample|one-day sample
1264219|NCT01741363|two-day sample|two-day sample
1264220|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
1264221|NCT01741350|Methadone-maintenance|methadone-maintenance
1264222|NCT01741350|HIV|hiv
1264223|NCT01741350|Risk behavior|risk behavior
1264224|NCT01741350|Injection drug use|injection drug use
1264225|NCT01741350|Condom use|condom use
1264226|NCT01741350|Health care participation|health care participation
1264227|NCT01741350|Opioid replacement therapy|opioid replacement therapy
1264228|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
1264229|NCT01741337|heart failure|heart failure
1264230|NCT01741337|all coronary reperfusions|all coronary reperfusions
1264231|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
1264232|NCT01741311|viral load|viral load
1264233|NCT01741311|HIV|hiv
1264234|NCT01741311|CD4|cd4
1264235|NCT01741311|methadone maintenance|methadone maintenance
1264236|NCT01741311|substance use|substance use
1264237|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
1264238|NCT01741298|Metabolic syndrome|metabolic syndrome
1264239|NCT01741285|Asthma|asthma
1264240|NCT01741285|Adenosine|adenosine
1264241|NCT01741285|Small airways|small airways
1264242|NCT01741285|Smokers|smokers
1264243|NCT01741285|Ex-smokers|ex-smokers
1264244|NCT01741272|rotator cuff tear|rotator cuff tear
1264245|NCT01741272|arthroscopically assisted|arthroscopically assisted
1264246|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
1264247|NCT01741272|functional outcome|functional outcome
1264248|NCT01741259|analgesia|analgesia
1264249|NCT01741259|meperidine|meperidine
1264250|NCT01741259|epidural|epidural
1264251|NCT01741246|Episodic migraine|episodic migraine
1264252|NCT01741246|Chronic migraine|chronic migraine
1264253|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
1264254|NCT01741246|Positron emission tomography|positron emission tomography
1264255|NCT01741233|SNPs|snps
1264256|NCT01741233|vitamin D|vitamin d
1264257|NCT01741233|Vitamin D status|vitamin d status
1264258|NCT01741233|UVB irradiation|uvb irradiation
1264259|NCT01741233|genetics|genetics
1264260|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
1264261|NCT01741181|Diabetes mellitus|diabetes mellitus
1264262|NCT01741181|Endothelial Function|endothelial function
1264263|NCT01741142|Major Depressive Disorder|major depressive disorder
1264264|NCT01741129|Nasal CPAP|nasal cpap
1264265|NCT01741129|Nasal IMV|nasal imv
1264266|NCT01741129|Surfactant|surfactant
1264267|NCT01741129|Preterm infants|preterm infants
1264268|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
1264269|NCT01741116|TKI258|tki258
1264270|NCT01741116|FGF23|fgf23
1264271|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
1264272|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
1264273|NCT01741077|pregnancy|pregnancy
1264274|NCT01741077|folic acid supplementation|folic acid supplementation
1264275|NCT01741077|reproduction|reproduction
1264276|NCT01741077|folate|folate
1264277|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1264278|NCT01741064|Renal Transplantation|renal transplantation
1264279|NCT01741064|Myocardial Infarction|myocardial infarction
1264280|NCT01741064|Fracture|fracture
1264281|NCT01741064|Graft Failure|graft failure
1264282|NCT01741051|Air pollution|air pollution
1264283|NCT01741051|Particulate matter|particulate matter
1264284|NCT01741051|Mongolia|mongolia
1264285|NCT01741051|Pregnancy|pregnancy
1264286|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
1264287|NCT01741051|Fetal growth|fetal growth
1264288|NCT01741051|Birth weight|birth weight
1264289|NCT01741051|Gestational age|gestational age
1264290|NCT01741038|Cancer Vaccine|cancer vaccine
1264291|NCT01741038|AlloStim®|allostim®
1264292|NCT01741038|Immunovative|immunovative
1264293|NCT01741038|Immunotherapy|immunotherapy
1264294|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
1264295|NCT01741038|Cryoablation|cryoablation
1264296|NCT01741012|Lupus|lupus
1264297|NCT01740986|Asthma|asthma
1264298|NCT01740973|SILC|silc
1264299|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
1264300|NCT01740973|trocar-site hernia|trocar-site hernia
1264301|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
1264302|NCT01740960|THC|thc
1264303|NCT01740960|Cannabis|cannabis
1264304|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
1264305|NCT01740947|anastomotic leakage|anastomotic leakage
1264306|NCT01740947|colorectal cancer|colorectal cancer
1264307|NCT01740934|rosacea|rosacea
1264308|NCT01740934|anatabine|anatabine
1264309|NCT01740934|Anatabloc|anatabloc
1264310|NCT01740934|dermatology|dermatology
1264311|NCT01740921|GLP-1 analogues|glp-1 analogues
1264312|NCT01740921|microvascular|microvascular
1264313|NCT01740921|inflammation|inflammation
1264314|NCT01740921|fat tissue|fat tissue
1264315|NCT01740921|clot structure|clot structure
1264316|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
1264317|NCT01740908|stem cell|stem cell
1264318|NCT01740882|incisional hernia|incisional hernia
1264319|NCT01740882|mesh fixation|mesh fixation
1264320|NCT01740882|absorbable tacks|absorbable tacks
1264321|NCT01740869|autism|autism
1264322|NCT01740869|autism spectrum|autism spectrum
1264323|NCT01740869|stem cells|stem cells
1264324|NCT01740869|children|children
1264325|NCT01740856|cardiac catheterization|cardiac catheterization
1264326|NCT01740856|safety|safety
1264327|NCT01740856|nursing care|nursing care
1264328|NCT01740856|rest|rest
1264329|NCT01740856|Patients|patients
1264330|NCT01740817|diabetes|diabetes
1264331|NCT01740817|obesity|obesity
1264332|NCT01740817|inflammation|inflammation
1264333|NCT01740804|Circulating tumor cell|circulating tumor cell
1264334|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
1264335|NCT01740804|chemotherapy|chemotherapy
1264336|NCT01740791|Hepatitis C|hepatitis c
1264338|NCT01740791|Genotype 1|genotype 1
1264339|NCT01740791|Genotype 2|genotype 2
1264340|NCT01740791|Genotype 3|genotype 3
1264341|NCT01740791|Genotype 4|genotype 4
1264342|NCT01740791|Genotype 5|genotype 5
1264343|NCT01740791|Genotype 6|genotype 6
1264344|NCT01740791|Liver Disease|liver disease
1264345|NCT01740778|Diabetes|diabetes
1264346|NCT01740778|Medical Device|medical device
1264347|NCT01740778|Lancing|lancing
1264348|NCT01740752|anorexia nervosa|anorexia nervosa
1264349|NCT01740752|eating disorder|eating disorder
1264351|NCT01740752|relationships|relationships
1264352|NCT01740752|couple therapy|couple therapy
1264353|NCT01740739|Health Risk Appraisal|health risk appraisal
1264354|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
1264355|NCT01740726|Depression|depression
1264356|NCT01740726|Behavioral Activation|behavioral activation
1264357|NCT01740726|Fluoxetine|fluoxetine
1264358|NCT01740726|Prozac|prozac
1264359|NCT01740726|Treatment|treatment
1264360|NCT01740726|Therapy|therapy
1264361|NCT01740726|Psychotherapy|psychotherapy
1264362|NCT01740726|Antidepressant|antidepressant
1264363|NCT01740726|Intervention|intervention
1264364|NCT01740713|chronic iron overload|chronic iron overload
1264365|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
1264366|NCT01740713|beta thalassaemia major|beta thalassaemia major
1264367|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
1264368|NCT01740700|Endovascular|endovascular
1264369|NCT01740700|Fenestration|fenestration
1264370|NCT01740700|Juxtarenal|juxtarenal
1264371|NCT01740700|Off-the-shelf|off-the-shelf
1264372|NCT01740700|Pararenal|pararenal
1264373|NCT01740687|Endometrial Ablation|endometrial ablation
1264374|NCT01740687|Permanent Sterilization|permanent sterilization
1264375|NCT01740687|Essure|essure
1264376|NCT01740687|NovaSure|novasure
1264377|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
1264378|NCT01740674|internet data collection|internet data collection
1264379|NCT01740674|longitudinal research|longitudinal research
1264380|NCT01740674|cohort retention|cohort retention
1264381|NCT01740648|MEK Inhibitor|mek inhibitor
1264382|NCT01740648|Trametinib|trametinib
1264383|NCT01740648|Rectal Cancers|rectal cancers
1264384|NCT01740648|KRAS|kras
1264385|NCT01740648|BRAF|braf
1264386|NCT01740648|NRAS Mutant|nras mutant
1264387|NCT01740648|Fluorouracil|fluorouracil
1264388|NCT01740635|rehabilitation|rehabilitation
1264389|NCT01740635|wheelchair|wheelchair
1264390|NCT01740635|manual wheelchair|manual wheelchair
1264391|NCT01740635|wheelchair users|wheelchair users
1264392|NCT01740635|older adults|older adults
1264393|NCT01740635|cognitive computer games|cognitive computer games
1264394|NCT01740635|home-based training|home-based training
1264395|NCT01740635|community mobility|community mobility
1264396|NCT01740622|Injury|injury
1264397|NCT01740622|Injury Prevention|injury prevention
1264398|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
1264399|NCT01740622|Injury Hazards|injury hazards
1264400|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
1264401|NCT01740609|Phase 1|phase 1
1264402|NCT01740609|RN168|rn168
1264403|NCT01740609|Healthy Volunteers|healthy volunteers
1264404|NCT01740596|NYHA III|nyha iii
1264405|NCT01740596|NYHA IV|nyha iv
1264406|NCT01740596|ACC Stage C|acc stage c
1264407|NCT01740596|Heart Failure|heart failure
1264408|NCT01740596|Congestive Heart Failure|congestive heart failure
1264409|NCT01740596|C-Pulse|c-pulse
1264410|NCT01740596|Counterpulsation|counterpulsation
1264411|NCT01740596|Heart Assist|heart assist
1264412|NCT01740596|Sunshine Heart|sunshine heart
1264413|NCT01740596|Left Heart Failure|left heart failure
1264414|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
1264415|NCT01740570|Brain cancer|brain cancer
1264416|NCT01740570|Malignant glioma|malignant glioma
1264417|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
1264418|NCT01740570|Gliosarcoma|gliosarcoma
1264419|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
1264420|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1264421|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1264422|NCT01740570|Cabazitaxel|cabazitaxel
1264423|NCT01740570|Jevtana|jevtana
1264424|NCT01740557|Melanoma|melanoma
1264425|NCT01740557|Metastatic Melanoma|metastatic melanoma
1264426|NCT01740557|Stage III in-transit, subcutaneous, or regional nodal disease|stage iii in-transit, subcutaneous, or regional nodal disease
1264427|NCT01740557|Cytoxan|cytoxan
1264428|NCT01740557|Cyclophosphamide|cyclophosphamide
1264429|NCT01740557|Neosar|neosar
1264430|NCT01740557|Mesna|mesna
1264431|NCT01740557|Mesnex|mesnex
1264432|NCT01740557|Fludarabine|fludarabine
1264433|NCT01740557|Fludarabine Phosphate|fludarabine phosphate
1264434|NCT01740557|Fludara|fludara
1264435|NCT01740557|IL-2|il-2
1264436|NCT01740557|Interleukin-2|interleukin-2
1264437|NCT01740557|Aldesleukin|aldesleukin
1264438|NCT01740557|Proleukin|proleukin
1264439|NCT01740557|T-cells|t-cells
1264440|NCT01740557|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
1264442|NCT01740557|CXCR2|cxcr2
1264443|NCT01740531|S303 treated RBCs|s303 treated rbcs
1264444|NCT01740505|energy cost of walking|energy cost of walking
1264445|NCT01740505|energy metabolism|energy metabolism
1264446|NCT01740505|aged|aged
1264447|NCT01740505|older adult|older adult
1264448|NCT01740505|exercise|exercise
1264449|NCT01740505|gait|gait
1264450|NCT01740505|walking|walking
1264451|NCT01740505|aerobic|aerobic
1264452|NCT01740505|motor skill|motor skill
1264453|NCT01740492|Ketamine|ketamine
1264454|NCT01740492|Acute pain|acute pain
1264455|NCT01740492|Pain control|pain control
1264456|NCT01740492|Pain|pain
1264457|NCT01740479|STEMI|stemi
1264458|NCT01740479|ticagrelor|ticagrelor
1264459|NCT01740479|multi-vessel disease|multi-vessel disease
1264460|NCT01740479|culprit lesion|culprit lesion
1264461|NCT01740466|Prevalence|prevalence
1264462|NCT01740466|Vision disorders|vision disorders
1264463|NCT01740466|Eye diseases|eye diseases
1264464|NCT01740466|Visual acuity|visual acuity
1264465|NCT01740466|Primary health care|primary health care
1264466|NCT01740440|Healthy females|healthy females
1264467|NCT01740427|breast cancer|breast cancer
1264468|NCT01740427|postmenopausal women|postmenopausal women
1264469|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
1264470|NCT01740427|HER2 negative|her2 negative
1264471|NCT01740427|locoregionally recurrent|locoregionally recurrent
1264472|NCT01740427|metastatic|metastatic
1264473|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
1264474|NCT01740427|PALOMA-2|paloma-2
1264475|NCT01740414|prescription opioid abuse|prescription opioid abuse
1264476|NCT01740414|pain|pain
1264477|NCT01740414|opioid withdrawal|opioid withdrawal
1264478|NCT01740414|oxycodone|oxycodone
1264479|NCT01740414|ibudilast|ibudilast
1264480|NCT01740401|Melanoma|melanoma
1264481|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
1264482|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
1264483|NCT01740401|Progression Free Survival|progression free survival
1264484|NCT01740401|Interventional Therapy|interventional therapy
1264485|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
1264486|NCT01740401|Immunotherapy|immunotherapy
1264487|NCT01740401|T Cell Activation|t cell activation
1264488|NCT01740362|CP-690|cp-690
1264490|NCT01740362|pharmacokinetics|pharmacokinetics
1264491|NCT01740362|renal impairment|renal impairment
1264492|NCT01740323|Breast Cancer|breast cancer
1264493|NCT01740323|Chemotherapy|chemotherapy
1264494|NCT01740323|Radiotherapy|radiotherapy
1264495|NCT01740323|NF-kB|nf-kb
1264496|NCT01740323|DNA Binding|dna binding
1264497|NCT01740323|Curcumin|curcumin
1264498|NCT01740323|IL-6|il-6
1264499|NCT01740323|TNF|tnf
1264500|NCT01740323|sTNFR2|stnfr2
1264501|NCT01740323|IL-1-ra|il-1-ra
1264502|NCT01740323|Fatigue|fatigue
1264503|NCT01740323|Cytokine|cytokine
1264504|NCT01740310|pregnancy,|pregnancy,
1264505|NCT01740310|vaccine acceptance,|vaccine acceptance,
1264506|NCT01740310|vaccination,|vaccination,
1264507|NCT01740310|influenza,|influenza,
1264508|NCT01740310|pertussis,|pertussis,
1264509|NCT01740310|Tdap,|tdap,
1264510|NCT01740310|minority,|minority,
1264511|NCT01740310|African-American|african-american
1264512|NCT01740297|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,
1264513|NCT01740271|breast cancer|breast cancer
1264514|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
1264515|NCT01740271|adjuvant therapy|adjuvant therapy
1264516|NCT01740271|neoadjuvant|neoadjuvant
1264517|NCT01740258|malignant glioma|malignant glioma
1264518|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
1264519|NCT01740258|glioblastoma|glioblastoma
1264520|NCT01740258|gliosarcoma|gliosarcoma
1264521|NCT01740258|adult brain tumor|adult brain tumor
1264522|NCT01740245|Laser therapy|laser therapy
1264523|NCT01740245|Cervical lesions|cervical lesions
1264524|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
1264525|NCT01740245|Chlorhexidine|chlorhexidine
1264526|NCT01740219|Health promotion|health promotion
1264527|NCT01740219|Religion and medicine|religion and medicine
1264528|NCT01740219|Hispanic Americans|hispanic americans
1264529|NCT01740219|Randomized controlled trial|randomized controlled trial
1264530|NCT01740219|Program evaluation|program evaluation
1264531|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
1264532|NCT01740219|Mass screening|mass screening
1264533|NCT01740219|Female|female
1264534|NCT01740219|Male|male
1264535|NCT01740219|Preventive Health Services/methods|preventive health services/methods
1264536|NCT01740219|Adult|adult
1264537|NCT01740219|Organizations|organizations
1264538|NCT01740193|Pain|pain
1264539|NCT01740193|Regional Anesthesia|regional anesthesia
1264540|NCT01740193|ultrasound|ultrasound
1264541|NCT01740193|transversus abdominis plane|transversus abdominis plane
1264542|NCT01740193|herniorrhaphy|herniorrhaphy
1264543|NCT01740193|pediatrics|pediatrics
1264544|NCT01740167|prodrome|prodrome
1264545|NCT01740167|mental illness|mental illness
1264546|NCT01740167|health promotion|health promotion
1264547|NCT01740167|lifestyle behavior|lifestyle behavior
1264548|NCT01740141|Pain|pain
1264549|NCT01740128|spinal cord injuries|spinal cord injuries
1264550|NCT01740128|paraplegia|paraplegia
1264551|NCT01740128|postural balance|postural balance
1264552|NCT01740128|locomotor activity|locomotor activity
1264553|NCT01740128|exercise therapy|exercise therapy
1264554|NCT01740128|electromyography|electromyography
1264555|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
1264556|NCT01740115|HIV|hiv
1264557|NCT01740115|Alcohol Use|alcohol use
1264558|NCT01740115|Bone Disease|bone disease
1264559|NCT01740115|Bone Mineral Density|bone mineral density
1264560|NCT01740115|Bone Microarchitecture|bone microarchitecture
1264561|NCT01740115|Substance Dependence|substance dependence
1264562|NCT01740102|Ischemic preconditioning|ischemic preconditioning
1264563|NCT01740102|Coronary artery bypass|coronary artery bypass
1264564|NCT01740102|Preoperative care|preoperative care
1265455|NCT01736436|Transfusion|transfusion
1264565|NCT01740102|Postoperative period|postoperative period
1264566|NCT01740089|Hepatitis C|hepatitis c
1264567|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
1264568|NCT01740089|Peginterferon|peginterferon
1264569|NCT01740089|Treatment|treatment
1264570|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
1264571|NCT01740037|Chronic care program|chronic care program
1264572|NCT01740037|Nurse specialist|nurse specialist
1264573|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
1264574|NCT01740024|Immunotherapy|immunotherapy
1264575|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
1264576|NCT01740024|Skin Prick Test|skin prick test
1264577|NCT01740024|Dose Response Prick Test|dose response prick test
1264578|NCT01739985|Postoperative|postoperative
1264579|NCT01739985|Vomiting|vomiting
1264580|NCT01739985|Children|children
1264581|NCT01739985|Prophylaxis|prophylaxis
1264582|NCT01739985|Droperidol|droperidol
1264583|NCT01739985|Ondansetron|ondansetron
1264584|NCT01739985|Dexamethasone|dexamethasone
1264585|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
1264586|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
1264587|NCT01739959|Fournier's gangrene|fournier's gangrene
1264588|NCT01739959|Cellulitis|cellulitis
1264589|NCT01739959|Serum Lactate|serum lactate
1264590|NCT01739933|Delirium|delirium
1264591|NCT01739933|Delirium/coma-free days|delirium/coma-free days
1264592|NCT01739933|Long term cognitive impairment|long term cognitive impairment
1264593|NCT01739933|Sedation|sedation
1264594|NCT01739933|Intensive care|intensive care
1264595|NCT01739933|Mechanical Ventilation|mechanical ventilation
1264596|NCT01739933|Dexmedetomidine|dexmedetomidine
1264597|NCT01739933|Propofol|propofol
1264598|NCT01739933|Coma-free days|coma-free days
1264600|NCT01739933|Organ dysfunction|organ dysfunction
1264601|NCT01739933|Acute Respiratory Distress|acute respiratory distress
1264602|NCT01739933|Markers of inflammation|markers of inflammation
1264603|NCT01739920|Povidone-Iodine|povidone-iodine
1264604|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
1264605|NCT01739920|Endophthalmitis|endophthalmitis
1264606|NCT01739920|Preoperative procedures|preoperative procedures
1264607|NCT01739907|Iron deficiency|iron deficiency
1264608|NCT01739907|Menstruating women|menstruating women
1264609|NCT01739907|Vitamin D|vitamin d
1264610|NCT01739907|Functional food|functional food
1264611|NCT01739894|Advanced gastric cancer|advanced gastric cancer
1264612|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
1264613|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
1264614|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
1264615|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
1264616|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
1264617|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
1264618|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
1264619|NCT01739881|Confocal Endoscopy|confocal endoscopy
1264620|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
1264621|NCT01739868|Pre-diabetes|pre-diabetes
1264622|NCT01739868|Type 2 diabetes|type 2 diabetes
1264623|NCT01739868|Biomarkers|biomarkers
1264624|NCT01739868|Diabetes risk score|diabetes risk score
1264625|NCT01739842|Alcohol consumption|alcohol consumption
1264626|NCT01739842|Kudzu extract|kudzu extract
1264627|NCT01739842|Cerebral blood flow|cerebral blood flow
1264628|NCT01739829|xenotransplantation|xenotransplantation
1264629|NCT01739829|type 1 diabetes|type 1 diabetes
1264630|NCT01739829|porcine islets|porcine islets
1264631|NCT01739816|Compliance|compliance
1264632|NCT01739816|Adherence|adherence
1264633|NCT01739816|Polypharmacy|polypharmacy
1264634|NCT01739816|Medicines use|medicines use
1264635|NCT01739816|Medication review|medication review
1264636|NCT01739816|Pharmaceutical care|pharmaceutical care
1264637|NCT01739816|Primary care|primary care
1264638|NCT01739816|Drug related problem|drug related problem
1264639|NCT01739816|Patient safety|patient safety
1264640|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
1264641|NCT01739803|Quality of life|quality of life
1264642|NCT01739803|Economic outcomes|economic outcomes
1264643|NCT01739790|COPD|copd
1264644|NCT01739790|Chronic Bronchitis|chronic bronchitis
1264645|NCT01739790|N-acetylcysteine|n-acetylcysteine
1264646|NCT01739777|Heart Failure|heart failure
1264647|NCT01739777|Coronary Heart Disease|coronary heart disease
1264648|NCT01739777|Adult Stem Cells|adult stem cells
1264649|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
1264650|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
1264852|NCT01738763|Insulin|insulin
1264651|NCT01739777|Left Ventricular Function|left ventricular function
1264652|NCT01739777|Intravenous Injection|intravenous injection
1264653|NCT01739751|COPD|copd
1264654|NCT01739751|Physical activity|physical activity
1264655|NCT01739751|Pedometers|pedometers
1264656|NCT01739751|steps|steps
1264657|NCT01739751|non pharmacological treatment|non pharmacological treatment
1264658|NCT01739751|rehabilitation|rehabilitation
1264659|NCT01739751|exercise|exercise
1265456|NCT01736436|Anemia|anemia
1264660|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
1264661|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
1264662|NCT01739712|Diabetes|diabetes
1264663|NCT01739712|Sleep problems|sleep problems
1264664|NCT01739712|School|school
1264665|NCT01739712|Neurobehavioral|neurobehavioral
1264666|NCT01739699|craniotomy|craniotomy
1264667|NCT01739699|brain surgery|brain surgery
1264668|NCT01739699|acetaminophen|acetaminophen
1264669|NCT01739699|Tylenol|tylenol
1264670|NCT01739686|Quality of Life|quality of life
1264671|NCT01739686|Symptoms|symptoms
1264672|NCT01739686|Palliative care|palliative care
1264673|NCT01739686|Symptom management|symptom management
1264674|NCT01739686|Disease management|disease management
1264675|NCT01739686|Health delivery|health delivery
1264676|NCT01739673|Infectious Keratitis|infectious keratitis
1264677|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
1264678|NCT01739660|Hemodialysis|hemodialysis
1264679|NCT01739660|pegloticase|pegloticase
1264680|NCT01739647|AZD3293|azd3293
1264681|NCT01739647|Healthy volunteers|healthy volunteers
1264682|NCT01739647|Elderly volunteers|elderly volunteers
1264683|NCT01739647|Phase 1|phase 1
1264684|NCT01739647|Single Ascending Dose Study|single ascending dose study
1264685|NCT01739634|Diarrhea|diarrhea
1264686|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
1264687|NCT01739608|CRC|crc
1264688|NCT01739569|Diet treatment|diet treatment
1264689|NCT01739569|Mental Health|mental health
1264690|NCT01739569|Reaction time|reaction time
1264691|NCT01739569|State of moods|state of moods
1264692|NCT01739569|Working hours|working hours
1264693|NCT01739569|Medical Hospital Staff|medical hospital staff
1264694|NCT01739556|antiplatelet therapy|antiplatelet therapy
1264695|NCT01739556|primary PCI|primary pci
1264696|NCT01739556|modification|modification
1264697|NCT01739517|Short bowel syndrome|short bowel syndrome
1264698|NCT01739517|Cholestasis|cholestasis
1264699|NCT01739517|Omegaven|omegaven
1264700|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
1264701|NCT01739504|Arthritis|arthritis
1264702|NCT01739504|Joint pain|joint pain
1264703|NCT01739504|Articular cartilage|articular cartilage
1264704|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
1264705|NCT01739504|Autologous|autologous
1264706|NCT01739504|Adipose tissue|adipose tissue
1264707|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1264708|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
1264709|NCT01739491|Leukemia|leukemia
1264710|NCT01739491|Filipino|filipino
1264711|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
1264712|NCT01739465|Pathologic|pathologic
1264713|NCT01739465|Digestive System|digestive system
1264714|NCT01739465|Neoplasms|neoplasms
1264715|NCT01739465|Neoplasms by Site|neoplasms by site
1264716|NCT01739465|Digestive System Diseases|digestive system diseases
1264717|NCT01739465|Bile Duct Diseases|bile duct diseases
1264718|NCT01739465|Biliary Tract Diseases|biliary tract diseases
1264719|NCT01739465|Pathological Conditions|pathological conditions
1264720|NCT01739465|Constriction|constriction
1264721|NCT01739465|Adenocarcinoma|adenocarcinoma
1264722|NCT01739465|Carcinoma|carcinoma
1264723|NCT01739452|Low-risk MDS|low-risk mds
1264724|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
1264725|NCT01739452|retrospective|retrospective
1264726|NCT01739426|LigaSure V (TM)|ligasure v (tm)
1264727|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
1264728|NCT01739400|exercise capacity|exercise capacity
1264729|NCT01739387|Flutiform®|flutiform®
1264730|NCT01739387|Asthma|asthma
1264731|NCT01739387|COPD|copd
1264732|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
1264733|NCT01739374|mesh implants|mesh implants
1264734|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1264735|NCT01739335|Mifepristone|mifepristone
1264736|NCT01739335|Veterans|veterans
1264737|NCT01739335|Clinical Trial|clinical trial
1264738|NCT01739322|skin prick test|skin prick test
1264739|NCT01739322|inmunotherapy|inmunotherapy
1264740|NCT01739322|standarization|standarization
1264741|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
1264742|NCT01739296|osteoarthritis|osteoarthritis
1264743|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
1264744|NCT01739296|foot orthoses|foot orthoses
1264745|NCT01739296|orthotic insoles|orthotic insoles
1264746|NCT01739270|analgesia|analgesia
1264747|NCT01739270|regional anesthesia|regional anesthesia
1264748|NCT01739270|surgery|surgery
1264749|NCT01739270|duration of analgesia|duration of analgesia
1264850|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
1264851|NCT01738763|Glucose|glucose
1264750|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
1264751|NCT01739244|Glaucoma|glaucoma
1264752|NCT01739244|Open Angle Glaucoma|open angle glaucoma
1264753|NCT01739244|Ocular Hypertension|ocular hypertension
1264754|NCT01739244|IOP|iop
1264755|NCT01739244|RNAi|rnai
1264756|NCT01739244|siRNA|sirna
1264757|NCT01739244|beta inhibitor|beta inhibitor
1264758|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
1264759|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
1264760|NCT01739179|Shunt Complications|shunt complications
1264761|NCT01739179|Shunt Failure|shunt failure
1264762|NCT01739179|Hydrocephalus|hydrocephalus
1264763|NCT01739166|Health Services Research|health services research
1264764|NCT01739166|Quality Assurance|quality assurance
1264765|NCT01739153|Dairy|dairy
1264766|NCT01739153|Cheese|cheese
1264767|NCT01739153|Blood lipid concentrations|blood lipid concentrations
1264768|NCT01739153|Blood lipid sizes|blood lipid sizes
1264769|NCT01739153|Fecal fat|fecal fat
1264770|NCT01739153|Fat digestibility|fat digestibility
1264771|NCT01739153|bile acids|bile acids
1264772|NCT01739127|Antipsychotic agents|antipsychotic agents
1264773|NCT01739127|Adverse effects|adverse effects
1264774|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
1264775|NCT01739114|Lung aeration|lung aeration
1264776|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1264777|NCT01739114|Positive Pressure Respiration|positive pressure respiration
1264778|NCT01739114|Sustained Inflation|sustained inflation
1264779|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
1264780|NCT01739088|Congenital heart disease|congenital heart disease
1264781|NCT01739088|pediatrics|pediatrics
1264782|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
1264783|NCT01739088|long term outcomes|long term outcomes
1264784|NCT01739062|PSA test|psa test
1264785|NCT01739062|Prostate cancer|prostate cancer
1264786|NCT01739062|Genetic screening|genetic screening
1264788|NCT01739036|Vaccine|vaccine
1264789|NCT01739036|Plasmodium|plasmodium
1264790|NCT01739036|Falciparum|falciparum
1264791|NCT01739023|paraplegia|paraplegia
1264792|NCT01739023|cell therapy|cell therapy
1264793|NCT01739023|Schwann cells|schwann cells
1264794|NCT01739023|spinal cord injury|spinal cord injury
1264795|NCT01738997|Benign|benign
1264796|NCT01738997|Esophageal strictures|esophageal strictures
1264797|NCT01738997|Esophagus|esophagus
1264798|NCT01738997|Balloon Dilation|balloon dilation
1264799|NCT01738984|exercise|exercise
1264800|NCT01738984|video|video
1264801|NCT01738984|DVD|dvd
1264802|NCT01738984|mother|mother
1264803|NCT01738984|infant|infant
1264804|NCT01738971|emergency contraception|emergency contraception
1264805|NCT01738971|community pharmacy|community pharmacy
1264806|NCT01738958|Probiotic bacteria|probiotic bacteria
1264807|NCT01738958|Caries dentalis|caries dentalis
1264808|NCT01738958|QLF|qlf
1264809|NCT01738932|endometriosis|endometriosis
1264810|NCT01738932|mannan-binding lectin|mannan-binding lectin
1264811|NCT01738932|immunology|immunology
1264812|NCT01738893|Gabapentin|gabapentin
1264813|NCT01738893|Bioequivalence|bioequivalence
1264814|NCT01738893|Pharmacokinetics|pharmacokinetics
1264815|NCT01738893|Mexico|mexico
1264816|NCT01738867|Pharmacogenetics|pharmacogenetics
1264817|NCT01738867|OPRM1|oprm1
1264818|NCT01738867|Pharmacodynamics|pharmacodynamics
1264819|NCT01738867|Addiction|addiction
1264820|NCT01738867|mu opioid receptors|mu opioid receptors
1264821|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
1264822|NCT01738854|airway sealing|airway sealing
1264823|NCT01738854|intracuff pressure|intracuff pressure
1264824|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
1264825|NCT01738841|Priorix-Tetra™|priorix-tetra™
1264826|NCT01738841|MMRV|mmrv
1264827|NCT01738841|children|children
1264828|NCT01738841|Post-marketing surveillance|post-marketing surveillance
1264829|NCT01738841|Philippines|philippines
1264830|NCT01738815|bladder cancer|bladder cancer
1264831|NCT01738815|hematuria|hematuria
1264832|NCT01738815|sodium valproate|sodium valproate
1264833|NCT01738815|valproic acid|valproic acid
1264834|NCT01738802|Type 2 Diabetes|type 2 diabetes
1264835|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
1264836|NCT01738802|micronutrient|micronutrient
1264837|NCT01738802|anti-oxidant|anti-oxidant
1264838|NCT01738789|Adnexal masses|adnexal masses
1264839|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
1264840|NCT01738789|Ovarian tumor|ovarian tumor
1264841|NCT01738776|hip fracture|hip fracture
1264842|NCT01738776|risk factors|risk factors
1264843|NCT01738776|vitamin K1|vitamin k1
1264844|NCT01738776|vitamin D|vitamin d
1264845|NCT01738776|bone turnover markers|bone turnover markers
1264846|NCT01738776|osteocalcin|osteocalcin
1264847|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
1264848|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
1264849|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
1264853|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
1264854|NCT01738750|surgical choice|surgical choice
1264855|NCT01738750|cost of care|cost of care
1264856|NCT01738750|decision making|decision making
1264857|NCT01738750|health care|health care
1264858|NCT01738750|health care cost|health care cost
1264859|NCT01738750|pediatric|pediatric
1264860|NCT01738750|children|children
1264861|NCT01738750|appendicitis|appendicitis
1264862|NCT01738750|patient satisfaction|patient satisfaction
1264863|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1264864|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
1264865|NCT01738711|Anxiety|anxiety
1264866|NCT01738711|Quality of life|quality of life
1264867|NCT01738685|Breast Cancer.|breast cancer.
1264868|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
1264869|NCT01738672|Nitrous oxide|nitrous oxide
1264870|NCT01738672|labor and delivery|labor and delivery
1264871|NCT01738672|analgesia|analgesia
1264872|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
1264873|NCT01738646|vorinostat|vorinostat
1264874|NCT01738646|SAHA|saha
1264875|NCT01738646|bevacizumab|bevacizumab
1264876|NCT01738646|AVASTIN|avastin
1264877|NCT01738646|malignant glioma|malignant glioma
1264879|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
1264880|NCT01738646|brain tumor|brain tumor
1264881|NCT01738633|Esophageal Cancer|esophageal cancer
1264882|NCT01738633|Quality of Life|quality of life
1264883|NCT01738620|esophageal cancer|esophageal cancer
1264884|NCT01738620|sleep disturbance|sleep disturbance
1264885|NCT01738620|quality of life|quality of life
1264886|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
1264887|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
1264888|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1264889|NCT01738581|sensorimotor retraining|sensorimotor retraining
1264890|NCT01738568|High intensity aerobic training|high intensity aerobic training
1264891|NCT01738555|amdoxovir|amdoxovir
1264892|NCT01738555|zidovudine|zidovudine
1264894|NCT01738555|HAART|haart
1264895|NCT01738555|antiretroviral|antiretroviral
1264896|NCT01738542|Bosentan|bosentan
1264897|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
1264898|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
1264899|NCT01738529|Crohn´disease|crohn´disease
1264900|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
1264901|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
1264902|NCT01738490|Bone anchored implant|bone anchored implant
1264903|NCT01738490|Implant stability|implant stability
1264904|NCT01738490|Wide diameter implant|wide diameter implant
1264905|NCT01738490|Linear incision|linear incision
1264906|NCT01738490|Ponto|ponto
1264907|NCT01738477|Booster|booster
1264908|NCT01738477|Tdap|tdap
1264909|NCT01738477|Immunogenicity|immunogenicity
1264910|NCT01738477|Repeat dose|repeat dose
1264911|NCT01738477|Safety|safety
1264912|NCT01738477|BoostrixTM|boostrixtm
1264913|NCT01738477|Persistence|persistence
1264914|NCT01738464|Pelvic Pain|pelvic pain
1264915|NCT01738464|Interstitial Cystitis|interstitial cystitis
1264916|NCT01738464|Microbiome|microbiome
1264917|NCT01738464|Prostatitis|prostatitis
1264918|NCT01738464|Chronic|chronic
1264919|NCT01738464|Depression|depression
1264920|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
1264921|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
1264922|NCT01738451|Holter monitor|holter monitor
1264923|NCT01738451|BRAF inhibitor|braf inhibitor
1264924|NCT01738451|GSK2118436|gsk2118436
1264925|NCT01738451|safety|safety
1264926|NCT01738451|cancer|cancer
1264927|NCT01738451|QTc|qtc
1264928|NCT01738451|pharmacokinetics|pharmacokinetics
1264929|NCT01738438|Metastatic|metastatic
1264930|NCT01738438|Triple Negative|triple negative
1264931|NCT01738438|Stage IV|stage iv
1264932|NCT01738425|GIC-1001|gic-1001
1264933|NCT01738425|opioid agonist|opioid agonist
1264934|NCT01738425|sulfide|sulfide
1264935|NCT01738425|colonoscopy|colonoscopy
1264936|NCT01738425|gicare|gicare
1264937|NCT01738425|Phase I|phase i
1264938|NCT01738425|safety|safety
1264939|NCT01738425|tolerability|tolerability
1264940|NCT01738425|pharmacokinetics|pharmacokinetics
1264941|NCT01738425|healthy subjects|healthy subjects
1264942|NCT01738425|single ascending dose|single ascending dose
1264943|NCT01738425|multiple ascending dose|multiple ascending dose
1264944|NCT01738425|SAD|sad
1264945|NCT01738425|MAD|mad
1264946|NCT01738425|food effect|food effect
1264947|NCT01738412|Stroke|stroke
1264948|NCT01738399|Insulin resistance|insulin resistance
1264949|NCT01738399|Coffee|coffee
1264950|NCT01738399|Glucose metabolism|glucose metabolism
1264951|NCT01738386|Adaptation|adaptation
1264952|NCT01738386|Coping|coping
1264953|NCT01738386|Presenile Dementia|presenile dementia
1264954|NCT01738386|Caregiver Burden|caregiver burden
1264955|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
1264956|NCT01738373|lymphoma|lymphoma
1264957|NCT01738373|multiple myeloma|multiple myeloma
1264958|NCT01738360|Arsenic trioxide|arsenic trioxide
1264959|NCT01738360|Systemic Lupus|systemic lupus
1264960|NCT01738360|clinically|clinically
1264961|NCT01738360|biologically active|biologically active
1264962|NCT01738334|Meditation|meditation
1264963|NCT01738334|Cognition|cognition
1264964|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1264965|NCT01738308|Healing Touch|healing touch
1264966|NCT01738308|Pediatrics|pediatrics
1264967|NCT01738308|surgery|surgery
1264968|NCT01738308|stress|stress
1264970|NCT01738308|Pediatric Stress|pediatric stress
1264971|NCT01738308|maladaptive behaviors|maladaptive behaviors
1264972|NCT01738308|energy medicine|energy medicine
1264973|NCT01738308|emergence delirium|emergence delirium
1264974|NCT01738308|emergence agitation|emergence agitation
1264975|NCT01738308|length of stay|length of stay
1264976|NCT01738308|ease of wake up|ease of wake up
1264977|NCT01738308|distress parents|distress parents
1264978|NCT01738308|distress pediatric patients|distress pediatric patients
1264979|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
1264980|NCT01738295|acetylcholine|acetylcholine
1264981|NCT01738295|cholinergic system|cholinergic system
1264982|NCT01738295|visual perception|visual perception
1264983|NCT01738295|visual attention|visual attention
1264984|NCT01738295|multiple objects tracking|multiple objects tracking
1264985|NCT01738295|perceptual learning|perceptual learning
1264986|NCT01738295|vision training|vision training
1264987|NCT01738282|baclofene|baclofene
1264988|NCT01738282|Alcohol dependence|alcohol dependence
1264989|NCT01738282|Maintenance of abstinence|maintenance of abstinence
1264990|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
1264991|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
1264992|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
1264993|NCT01738256|Psychological Stress|psychological stress
1264994|NCT01738256|Metabolic Syndrome|metabolic syndrome
1264995|NCT01738256|Overweight|overweight
1264996|NCT01738256|Life Style|life style
1264997|NCT01738243|Thyroid|thyroid
1264998|NCT01738243|Thyroid Eye Disease|thyroid eye disease
1264999|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
1265000|NCT01738243|Eyelid Retraction|eyelid retraction
1265001|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
1265002|NCT01738217|Intra-operative imaging|intra-operative imaging
1265003|NCT01738217|NIR Fluorescence|nir fluorescence
1265004|NCT01738217|Liver surgery|liver surgery
1265005|NCT01738217|Tumoral margins|tumoral margins
1265006|NCT01738204|endometriosis|endometriosis
1265007|NCT01738204|dysmenorrhea|dysmenorrhea
1265008|NCT01738204|pelvic pain|pelvic pain
1265009|NCT01738204|women's health|women's health
1265010|NCT01738204|adolescence|adolescence
1265011|NCT01738204|biorepository|biorepository
1265012|NCT01738204|observational|observational
1265013|NCT01738204|women|women
1265014|NCT01738204|female|female
1265015|NCT01738204|gynecology|gynecology
1265016|NCT01738204|fertility|fertility
1265017|NCT01738204|infertility|infertility
1265018|NCT01738191|Parkinson's disease|parkinson's disease
1265019|NCT01738165|Prospective|prospective
1265020|NCT01738165|Multi-Center|multi-center
1265021|NCT01738165|Pilot Study|pilot study
1265022|NCT01738165|Single Arm|single arm
1265023|NCT01738165|Safety|safety
1265024|NCT01738165|Efficacy|efficacy
1265025|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
1265026|NCT01738152|vaginal dryness|vaginal dryness
1265027|NCT01738152|12-232|12-232
1265028|NCT01738139|Advanced Cancers|advanced cancers
1265029|NCT01738139|Advanced Malignancies|advanced malignancies
1265030|NCT01738139|Metastatic|metastatic
1265031|NCT01738139|Unresectable|unresectable
1265032|NCT01738139|Ipilimumab|ipilimumab
1265033|NCT01738139|Yervoy|yervoy
1265034|NCT01738139|BMS-734016|bms-734016
1265035|NCT01738139|MDX010|mdx010
1265036|NCT01738139|Imatinib Mesylate|imatinib mesylate
1265037|NCT01738139|Imatinib|imatinib
1265038|NCT01738139|Gleevec|gleevec
1265039|NCT01738139|STI 571|sti 571
1265040|NCT01738139|NSC-716051|nsc-716051
1265041|NCT01738126|cerebellum|cerebellum
1265042|NCT01738126|fMRI|fmri
1265043|NCT01738126|DTI|dti
1265044|NCT01738126|pain|pain
1265045|NCT01738126|heat|heat
1265046|NCT01738126|noxious|noxious
1265047|NCT01738126|aversion|aversion
1265048|NCT01738126|unpleasantness|unpleasantness
1265049|NCT01738126|anger|anger
1265050|NCT01738126|aversive stimulus|aversive stimulus
1265051|NCT01738126|motor|motor
1265052|NCT01738126|human|human
1265053|NCT01738126|image analysis|image analysis
1265054|NCT01738126|perception|perception
1265055|NCT01738126|central nervous system|central nervous system
1265056|NCT01738126|sensory|sensory
1265057|NCT01738126|somatosensory cortex|somatosensory cortex
1265058|NCT01738126|trigeminal system|trigeminal system
1265059|NCT01738126|white matter|white matter
1265060|NCT01738113|Ilizarov|ilizarov
1265061|NCT01738113|distraction osteogenesis|distraction osteogenesis
1265062|NCT01738113|Muscle architecture|muscle architecture
1265063|NCT01738113|muscle mechanics|muscle mechanics
1265064|NCT01738113|Rehabilitation|rehabilitation
1265065|NCT01738087|patients|patients
1265066|NCT01738087|Adult|adult
1265067|NCT01738074|rotavirus|rotavirus
1265068|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
1265069|NCT01738074|Phase three clinical trials|phase three clinical trials
1265070|NCT01738061|Older workers|older workers
1265071|NCT01738061|Multidimensional intervention|multidimensional intervention
1265072|NCT01738061|Worksite health promotion|worksite health promotion
1265073|NCT01738061|Taiwan|taiwan
1265074|NCT01738048|Pain|pain
1265075|NCT01738048|Neuropathic pain|neuropathic pain
1265076|NCT01738048|Chronic pain|chronic pain
1265077|NCT01738035|IgA nephropathy|iga nephropathy
1265078|NCT01738022|Sleep apnea|sleep apnea
1265079|NCT01738022|Pathophysiology|pathophysiology
1265080|NCT01738009|Sleep Apnea|sleep apnea
1265081|NCT01738009|Pathophysiology|pathophysiology
1265082|NCT01737983|cystic fibrosis|cystic fibrosis
1265083|NCT01737983|probiotics|probiotics
1265084|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
1265085|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
1265086|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
1265087|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
1265088|NCT01737931|SPM 962|spm 962
1265089|NCT01737931|rotigotine|rotigotine
1265090|NCT01737931|application site reaction|application site reaction
1265091|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
1265092|NCT01737905|Asthma|asthma
1265093|NCT01737905|Safety|safety
1265094|NCT01737905|Efficacy|efficacy
1265095|NCT01737905|Epinephrine|epinephrine
1265096|NCT01737905|Bronchodilator|bronchodilator
1265097|NCT01737905|Metered dose inhaler|metered dose inhaler
1265098|NCT01737892|Asthma|asthma
1265099|NCT01737892|Pharmacokinetics|pharmacokinetics
1265100|NCT01737892|Epinephrine|epinephrine
1265101|NCT01737892|Bronchodilator|bronchodilator
1265102|NCT01737892|Metered dose inhaler|metered dose inhaler
1265103|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
1265104|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
1265105|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
1265106|NCT01737853|Ocular Hypertension|ocular hypertension
1265107|NCT01737853|Ganfort|ganfort
1265108|NCT01737840|dyspepsia|dyspepsia
1265109|NCT01737840|pantoprazole|pantoprazole
1265110|NCT01737840|ranitidine|ranitidine
1265111|NCT01737840|emergency department|emergency department
1265112|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
1265113|NCT01737814|sickle cell disease|sickle cell disease
1265114|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
1265115|NCT01737801|Lung function|lung function
1265116|NCT01737801|Physiotherapy|physiotherapy
1265117|NCT01737788|Cervical cerclage|cervical cerclage
1265118|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
1265119|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
1265120|NCT01737775|ultrasonography|ultrasonography
1265121|NCT01737775|respiratory distress|respiratory distress
1265122|NCT01737775|abdominal surgery|abdominal surgery
1265124|NCT01737775|gender|gender
1265125|NCT01737775|biometric|biometric
1265126|NCT01737775|body mass index|body mass index
1265127|NCT01737775|ASA score|asa score
1265128|NCT01737775|smoking status|smoking status
1265129|NCT01737775|history of respiratory disease|history of respiratory disease
1265130|NCT01737762|Venous leg ulcer|venous leg ulcer
1265131|NCT01737762|ulcer|ulcer
1265132|NCT01737762|Venous stasis|venous stasis
1265133|NCT01737762|compression|compression
1265134|NCT01737762|venous|venous
1265135|NCT01737762|venous stasis ulcer|venous stasis ulcer
1265136|NCT01737762|vlu|vlu
1265137|NCT01737762|wound|wound
1265138|NCT01737762|varicose veins|varicose veins
1265139|NCT01737762|venous insufficiency|venous insufficiency
1265140|NCT01737762|dvt|dvt
1265141|NCT01737762|deep vein thrombosis|deep vein thrombosis
1265142|NCT01737749|Stroke|stroke
1265143|NCT01737736|Stroke|stroke
1265144|NCT01737723|Stroke|stroke
1265145|NCT01737710|Influenza Vaccines|influenza vaccines
1265146|NCT01737710|Dermatitis|dermatitis
1265147|NCT01737710|Injections, Intradermal|injections, intradermal
1265148|NCT01737710|Injections, Intramuscular|injections, intramuscular
1265149|NCT01737710|Skin Diseases|skin diseases
1265150|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
1265151|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
1265152|NCT01737710|Hypersensitivity|hypersensitivity
1265153|NCT01737710|Immune System Diseases|immune system diseases
1265154|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
1265155|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
1265156|NCT01737671|Brain tumor|brain tumor
1266141|NCT01733173|fMRI|fmri
1265157|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
1265158|NCT01737671|Ependymoma involving brain|ependymoma involving brain
1265159|NCT01737671|Ependymoma involving spine|ependymoma involving spine
1265160|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
1265161|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
1265162|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
1265163|NCT01737671|AT/RT|at/rt
1265164|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
1265165|NCT01737671|Methotrexate|methotrexate
1265166|NCT01737671|Medulloblastoma|medulloblastoma
1265167|NCT01737671|ATRT|atrt
1265168|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
1265169|NCT01737671|Ependymoma|ependymoma
1265170|NCT01737671|Pediatric brain tumor|pediatric brain tumor
1265171|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
1265172|NCT01737632|Adolescents|adolescents
1265173|NCT01737632|Residential Treatment|residential treatment
1265174|NCT01737632|Outpatient Treatment|outpatient treatment
1265175|NCT01737632|Substance Abuse|substance abuse
1265176|NCT01737632|Delinquency|delinquency
1265177|NCT01737632|Family Therapy|family therapy
1265178|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
1265179|NCT01737619|Gynecologic cancer|gynecologic cancer
1265180|NCT01737619|Endometrial Cancer|endometrial cancer
1265181|NCT01737619|Lymph Nodes Metastasis|lymph nodes metastasis
1265182|NCT01737619|Surgical Staging|surgical staging
1265183|NCT01737619|False negative rate|false negative rate
1265184|NCT01737619|Detection of positive lymph nodes|detection of positive lymph nodes
1265185|NCT01737619|Histologically confirmed high grade endometrial cancer|histologically confirmed high grade endometrial cancer
1265186|NCT01737619|Sentinel lymph node mapping|sentinel lymph node mapping
1265187|NCT01737606|Cerebral pulsatility|cerebral pulsatility
1265188|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
1265189|NCT01737606|MRI|mri
1265190|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
1265191|NCT01737606|Cognitive tasks|cognitive tasks
1265192|NCT01737606|Aging|aging
1265193|NCT01737593|acetaminophen|acetaminophen
1265194|NCT01737593|emergence agitation|emergence agitation
1265195|NCT01737593|children|children
1265196|NCT01737593|sevoflurane|sevoflurane
1265197|NCT01737580|influenza, human|influenza, human
1265198|NCT01737580|influenza vaccines|influenza vaccines
1265199|NCT01737580|older adults|older adults
1265200|NCT01737580|immune response|immune response
1265201|NCT01737554|Central venous access device|central venous access device
1265202|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
1265203|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
1265204|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
1265205|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
1265206|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1265207|NCT01737541|Therapeutic Uses|therapeutic uses
1265208|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
1265209|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
1265210|NCT01737476|age 18-65|age 18-65
1265211|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
1265212|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
1265213|NCT01737450|PI3K inhibitor|pi3k inhibitor
1265214|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
1265215|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
1265217|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
1265218|NCT01737398|FAP|fap
1265219|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
1265220|NCT01737398|TTR|ttr
1265221|NCT01737398|Transthyretin|transthyretin
1265222|NCT01737398|Amyloidosis|amyloidosis
1265223|NCT01737385|microcirculation|microcirculation
1265224|NCT01737385|proximal humeral fractures|proximal humeral fractures
1265225|NCT01737385|O2C|o2c
1265226|NCT01737372|Multiple Sclerosis|multiple sclerosis
1265227|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1265228|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
1265229|NCT01737359|amdoxovir|amdoxovir
1265230|NCT01737359|zidovudine|zidovudine
1265231|NCT01737359|tenofovir DF|tenofovir df
1265232|NCT01737359|HIV|hiv
1265233|NCT01737359|HAART|haart
1265234|NCT01737359|antiretroviral|antiretroviral
1265235|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
1265236|NCT01737320|gram negative bacteremia|gram negative bacteremia
1265237|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
1265238|NCT01737320|safety|safety
1265239|NCT01737320|efficacy|efficacy
1265240|NCT01737320|short-course|short-course
1265241|NCT01737307|Fluoride Varnish|fluoride varnish
1265242|NCT01737307|CPP-ACP paste|cpp-acp paste
1265243|NCT01737307|Dry mouth|dry mouth
1265244|NCT01737307|Burning sensation|burning sensation
1265245|NCT01737307|Chemotherapy|chemotherapy
1265246|NCT01737294|Phase IV|phase iv
1265247|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
1265248|NCT01737294|QUTENZA|qutenza
1265249|NCT01737281|Smoking|smoking
1265250|NCT01737281|Tobacco control|tobacco control
1265251|NCT01737281|Counseling|counseling
1265252|NCT01737281|mental health|mental health
1265253|NCT01737268|patients|patients
1265254|NCT01737268|Major depressive episode|major depressive episode
1265255|NCT01737268|FK949E|fk949e
1265256|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
1265257|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
1265258|NCT01737255|TP53|tp53
1265457|NCT01736423|YM060|ym060
1265259|NCT01737255|Psychological Impact|psychological impact
1265260|NCT01737242|Prostate cancer|prostate cancer
1265261|NCT01737242|PSA|psa
1265262|NCT01737216|Aged|aged
1265263|NCT01737216|patients|patients
1265264|NCT01737203|Viagra|viagra
1265265|NCT01737203|ODT|odt
1265266|NCT01737203|bioquivalence|bioquivalence
1265267|NCT01737190|esophageal pressure|esophageal pressure
1265268|NCT01737190|ARDSnet protocol|ardsnet protocol
1265269|NCT01737177|MCL|mcl
1265270|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
1265271|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
1265272|NCT01737164|Glucose|glucose
1359149|NCT01337427|MS|ms
1265273|NCT01737164|Lipid|lipid
1265274|NCT01737164|Metabolism|metabolism
1265275|NCT01737164|Non Diabetic|non diabetic
1265276|NCT01737164|Healthy|healthy
1265277|NCT01737138|Resistant hypertension|resistant hypertension
1265278|NCT01737138|All-cause mortality|all-cause mortality
1265279|NCT01737138|Renal function|renal function
1265280|NCT01737112|Lung Cancer|lung cancer
1265281|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
1265282|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
1265283|NCT01737112|SPECT/CT|spect/ct
1265284|NCT01737112|efficacy and safety|efficacy and safety
1265285|NCT01737099|omega-3|omega-3
1265286|NCT01737099|DHA|dha
1265287|NCT01737099|triglycerides|triglycerides
1265288|NCT01737099|lipids|lipids
1265289|NCT01737099|cardiovascular|cardiovascular
1265290|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
1265291|NCT01737073|chronic pain|chronic pain
1265292|NCT01737073|opioid|opioid
1265293|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
1265294|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
1265295|NCT01737047|HIV|hiv
1265296|NCT01737047|Ageing|ageing
1265297|NCT01737034|partitioning of weight gain|partitioning of weight gain
1265298|NCT01737034|refeeding|refeeding
1265299|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
1265300|NCT01737034|glycemic index|glycemic index
1265301|NCT01737021|PICU|picu
1265302|NCT01737021|Critical illness|critical illness
1265303|NCT01737021|Outcomes|outcomes
1265304|NCT01737021|Mental health|mental health
1265305|NCT01737021|Education|education
1265306|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
1265307|NCT01737021|Pilot|pilot
1265308|NCT01737021|Feasibility|feasibility
1265309|NCT01737008|Head and neck|head and neck
1265310|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
1265311|NCT01737008|Phase 1|phase 1
1265312|NCT01737008|Dacomitinib|dacomitinib
1265313|NCT01737008|Radiation|radiation
1265314|NCT01737008|Radiotherapy|radiotherapy
1265315|NCT01737008|Chemotherapy|chemotherapy
1265316|NCT01737008|Chemoradiation|chemoradiation
1265317|NCT01737008|Chemoradiotherapy|chemoradiotherapy
1265318|NCT01737008|Cisplatin|cisplatin
1265319|NCT01737008|Pharmacokinetics|pharmacokinetics
1265320|NCT01737008|Maximum tolerated dose|maximum tolerated dose
1265321|NCT01737008|Safety|safety
1265322|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
1265323|NCT01737008|Previously Untreated|previously untreated
1265324|NCT01737008|Local or Locally Advanced|local or locally advanced
1265325|NCT01736995|Substance Abuse|substance abuse
1265326|NCT01736995|Adolescents|adolescents
1265327|NCT01736995|Families|families
1265328|NCT01736995|Functional Family Therapy|functional family therapy
1265329|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
1265330|NCT01736995|Motivational Therapy|motivational therapy
1265331|NCT01736995|Contingency Management|contingency management
1265332|NCT01736982|Cigarette Smoking|cigarette smoking
1265333|NCT01736982|Homeless|homeless
1265334|NCT01736982|Contingency Management|contingency management
1265335|NCT01736982|Smoking Cessation|smoking cessation
1265336|NCT01736956|aortic stenosis|aortic stenosis
1265337|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
1265338|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
1265339|NCT01736943|Bortezomib|bortezomib
1265340|NCT01736943|Doxil|doxil
1265341|NCT01736930|Type 1 Diabetes|type 1 diabetes
1265342|NCT01736930|Hypoglycemia|hypoglycemia
1265343|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
1265344|NCT01736930|Pump Suspension|pump suspension
1265345|NCT01736917|Fosaprepitant|fosaprepitant
1265346|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
1265347|NCT01736917|Dexamethasone|dexamethasone
1265348|NCT01736917|Germ Cell Tumors|germ cell tumors
1265349|NCT01736917|Testis Cancer|testis cancer
1265350|NCT01736917|Rescue Medications|rescue medications
1265351|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
1265353|NCT01736904|XELIRI|xeliri
1265354|NCT01736891|Motor fluctuations|motor fluctuations
1265355|NCT01736891|Parkinson´s Disease|parkinson´s disease
1265356|NCT01736891|Rasagiline|rasagiline
1265357|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
1265358|NCT01736878|Sorafenib|sorafenib
1265359|NCT01736878|Efficacy|efficacy
1265360|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
1265361|NCT01736852|PROM|prom
1265458|NCT01736423|Ramosetron|ramosetron
1265362|NCT01736852|Cervical Ripening|cervical ripening
1265363|NCT01736852|Induced Labor|induced labor
1265364|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
1265365|NCT01736826|plasma free DNA concentration|plasma free dna concentration
1265366|NCT01736813|colorectal cancer|colorectal cancer
1265367|NCT01736813|liver metastases|liver metastases
1265368|NCT01736813|chemotherapy|chemotherapy
1265369|NCT01736813|chemokine|chemokine
1265370|NCT01736813|CCR5 inhibition|ccr5 inhibition
1265371|NCT01736800|Temozolomide|temozolomide
1265372|NCT01736800|Topotecan|topotecan
1265373|NCT01736800|Central Nervous System Metastases|central nervous system metastases
1265374|NCT01736800|Chemotherapy|chemotherapy
1265375|NCT01736800|Brain Metastases|brain metastases
1265376|NCT01736800|Solid Tumors|solid tumors
1265377|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
1265378|NCT01736787|immunity|immunity
1265379|NCT01736774|Manual therapy|manual therapy
1265380|NCT01736774|Exercise|exercise
1265381|NCT01736748|obesity|obesity
1265382|NCT01736748|physical activity|physical activity
1265383|NCT01736748|metabolism|metabolism
1265384|NCT01736748|environment|environment
1265385|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
1265386|NCT01736748|for age and sex|for age and sex
1265387|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
1265388|NCT01736722|Metastatic cancer|metastatic cancer
1265389|NCT01736722|Brain Tumor|brain tumor
1265390|NCT01736722|Visualase|visualase
1265391|NCT01736722|Treatment resistant|treatment resistant
1265392|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
1265393|NCT01736722|Magnetic Imaging|magnetic imaging
1265394|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
1265395|NCT01736709|immunogenicity,|immunogenicity,
1265396|NCT01736709|safety|safety
1265397|NCT01736696|Psoriasis|psoriasis
1265398|NCT01736696|PASI|pasi
1265399|NCT01736696|plaques|plaques
1265400|NCT01736696|skin biopsy|skin biopsy
1265401|NCT01736696|immunomodulation|immunomodulation
1265402|NCT01736683|ACE-011|ace-011
1265403|NCT01736683|anemia|anemia
1265404|NCT01736683|dose-ranging|dose-ranging
1265405|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
1265406|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
1265407|NCT01736683|multicenter|multicenter
1265408|NCT01736683|open-label|open-label
1265409|NCT01736683|parallel|parallel
1265410|NCT01736683|phase 2|phase 2
1265411|NCT01736683|randomized|randomized
1265412|NCT01736683|Sotatercept|sotatercept
1265413|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
1265414|NCT01736683|hemoglobin|hemoglobin
1265415|NCT01736683|transfusions|transfusions
1265416|NCT01736644|blood loss|blood loss
1265417|NCT01736644|bipolar sealer|bipolar sealer
1265418|NCT01736644|aquamantys|aquamantys
1265419|NCT01736644|total knee replacement|total knee replacement
1265420|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
1265421|NCT01736631|social phobia|social phobia
1265422|NCT01736631|bipolar disorder|bipolar disorder
1265423|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
1265424|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
1265425|NCT01736605|Massage|massage
1265426|NCT01736605|Meditation|meditation
1265427|NCT01736605|Breast Cancer|breast cancer
1265428|NCT01736605|Breast Surgery|breast surgery
1265429|NCT01736605|Breast Reconstruction|breast reconstruction
1265430|NCT01736566|Primary Care|primary care
1265431|NCT01736566|Cardiology|cardiology
1265432|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1265433|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
1265434|NCT01736566|Whole Genome Sequencing|whole genome sequencing
1265435|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
1265436|NCT01736553|Healthy controls|healthy controls
1265437|NCT01736553|Infants|infants
1265438|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
1265439|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
1265440|NCT01736514|Uric acid lowering drug|uric acid lowering drug
1265441|NCT01736488|Hypertension|hypertension
1265442|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
1265443|NCT01736488|Neurohormonal markers|neurohormonal markers
1265444|NCT01736488|Blood Pressure Response|blood pressure response
1265445|NCT01736488|Exercise|exercise
1265447|NCT01736462|Endothelial cell density|endothelial cell density
1265448|NCT01736449|pterygium|pterygium
1265449|NCT01736449|bevacizumab|bevacizumab
1265450|NCT01736449|recurrence of pterygium|recurrence of pterygium
1265451|NCT01736436|MDS|mds
1265452|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
1265453|NCT01736436|Low and intermediate risk|low and intermediate risk
1265454|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
1265459|NCT01736423|long term study|long term study
1265460|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
1265461|NCT01736423|Female|female
1265462|NCT01736397|CKD|ckd
1265463|NCT01736397|Chronic Kidney Disease|chronic kidney disease
1265464|NCT01736397|Phosphorus|phosphorus
1265465|NCT01736397|Iron Deficiency|iron deficiency
1265466|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
1265467|NCT01736397|Elevated Phosphorus|elevated phosphorus
1265468|NCT01736371|Sevoflurane|sevoflurane
1265469|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
1265470|NCT01736371|Closed loop computer control system|closed loop computer control system
1265471|NCT01736371|Recovery Index|recovery index
1265472|NCT01736358|Sprix|sprix
1265473|NCT01736358|Intranasal ketoralac|intranasal ketoralac
1265474|NCT01736358|Ketoralac|ketoralac
1265475|NCT01736358|Urolithiasis|urolithiasis
1265476|NCT01736358|Kidney stone|kidney stone
1265477|NCT01736358|Uretal stone|uretal stone
1265478|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
1265479|NCT01736358|URS|urs
1265480|NCT01736358|Pain management|pain management
1265481|NCT01736358|Pain|pain
1265482|NCT01736332|Methamphetamine|methamphetamine
1265483|NCT01736332|Amphetamines|amphetamines
1265484|NCT01736332|Opiates|opiates
1265485|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
1265486|NCT01736332|Intranasal amphetamines|intranasal amphetamines
1265487|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
1265488|NCT01736319|Recrudescence|recrudescence
1265489|NCT01736319|DHA-PPQ|dha-ppq
1265490|NCT01736319|Parasite Clearance Rate|parasite clearance rate
1265491|NCT01736306|Breast Cancer|breast cancer
1265492|NCT01736306|Breast Milk|breast milk
1265493|NCT01736306|Epigenetics|epigenetics
1265494|NCT01736293|Retinal Degeneration|retinal degeneration
1265495|NCT01736280|Symptoms|symptoms
1265496|NCT01736280|Immunogenetics|immunogenetics
1265497|NCT01736280|Digestive Disorders|digestive disorders
1265498|NCT01736280|Gastrointestinal|gastrointestinal
1265499|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
1265500|NCT01736267|ABI|abi
1265501|NCT01736267|Nucleus 24|nucleus 24
1265502|NCT01736267|Deafness|deafness
1265503|NCT01736267|Hearing loss|hearing loss
1265504|NCT01736267|Non-tumor|non-tumor
1265505|NCT01736267|Non-NF2|non-nf2
1265506|NCT01736267|ABI541|abi541
1265507|NCT01736228|xenotransplantation|xenotransplantation
1265508|NCT01736228|type 1 diabetes|type 1 diabetes
1265509|NCT01736228|porcine islets|porcine islets
1265510|NCT01736215|Anemia - cancer related|anemia - cancer related
1265511|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
1265512|NCT01736202|oral fat|oral fat
1265513|NCT01736202|insulin sensitivity|insulin sensitivity
1265514|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
1265515|NCT01736176|Safety and efficacy|safety and efficacy
1265516|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
1265517|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
1265518|NCT01736176|carbidopa|carbidopa
1265519|NCT01736176|levodopa|levodopa
1265520|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
1265521|NCT01736150|Hemodialysis|hemodialysis
1265522|NCT01736137|Heart failure|heart failure
1265523|NCT01736137|Autonomic Nervous System|autonomic nervous system
1265524|NCT01736137|Heart rate|heart rate
1265525|NCT01736137|Quality of life|quality of life
1265526|NCT01736124|computerize cognitive training|computerize cognitive training
1265527|NCT01736124|dementia|dementia
1265528|NCT01736124|cognitive decline|cognitive decline
1265529|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1265530|NCT01736111|obesity|obesity
1265531|NCT01736111|weight loss|weight loss
1265532|NCT01736111|text message|text message
1265533|NCT01736085|tobacco cessation|tobacco cessation
1265534|NCT01736085|smoking cessation|smoking cessation
1265535|NCT01736085|nicotine|nicotine
1265536|NCT01736085|telephone counseling|telephone counseling
1265537|NCT01736085|self-help|self-help
1265538|NCT01736085|smoking abstinence|smoking abstinence
1265539|NCT01736085|tobacco use disorder|tobacco use disorder
1265540|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
1265541|NCT01736085|voucher|voucher
1265542|NCT01736072|Rectal Cancer|rectal cancer
1265543|NCT01736072|Colorectal Cancer|colorectal cancer
1265544|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
1265545|NCT01736072|Robotic Surgery|robotic surgery
1265546|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
1265547|NCT01736059|Stem cells|stem cells
1265548|NCT01736059|intravitreal|intravitreal
1265549|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
1265550|NCT01736059|retinal disease|retinal disease
1265551|NCT01736059|clinical trial|clinical trial
1265552|NCT01736059|autologous|autologous
1265553|NCT01736046|CT Enterography|ct enterography
1265554|NCT01736046|Crohn's Disease|crohn's disease
1265555|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
1265556|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
1265557|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
1265558|NCT01736033|Proscar|proscar
1265559|NCT01736033|Finasteride|finasteride
1265560|NCT01736033|alpha blocker|alpha blocker
1265561|NCT01736033|Tamsulosin|tamsulosin
1265562|NCT01736033|Harnal D|harnal d
1601766|NCT00387855|suicide|suicide
1265563|NCT01736007|alopecia areata child|alopecia areata child
1265564|NCT01736007|scalp|scalp
1265565|NCT01735994|Eating disorders|eating disorders
1265566|NCT01735994|body image|body image
1265567|NCT01735994|female athletes|female athletes
1265568|NCT01735994|female athlete triad|female athlete triad
1265569|NCT01735994|eating disorder prevention|eating disorder prevention
1265570|NCT01735994|cluster randomization|cluster randomization
1265571|NCT01735994|risk factors|risk factors
1265572|NCT01735994|prevention|prevention
1265573|NCT01735981|Huntington's Disease|huntington's disease
1265574|NCT01735981|gait|gait
1265575|NCT01735981|exercise|exercise
1265576|NCT01735981|balance|balance
1265577|NCT01735981|video game|video game
1265578|NCT01735968|Imatinib mesylate|imatinib mesylate
1265579|NCT01735968|BYL719|byl719
1265580|NCT01735968|GIST|gist
1265581|NCT01735955|Tasigna|tasigna
1265583|NCT01735955|GIST|gist
1265584|NCT01735955|nilotinib|nilotinib
1265585|NCT01735890|Safety|safety
1265586|NCT01735890|Pharmacokinetics|pharmacokinetics
1265587|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
1265588|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
1265589|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
1265590|NCT01735851|Paravertebral block|paravertebral block
1265591|NCT01735851|pain|pain
1265592|NCT01735851|postoperative|postoperative
1265593|NCT01735825|coronary artery disease|coronary artery disease
1265594|NCT01735825|stent|stent
1265595|NCT01735825|restenosis|restenosis
1265596|NCT01735812|cryoablation|cryoablation
1265597|NCT01735812|uterine fibroid|uterine fibroid
1265598|NCT01735812|uterine myoma|uterine myoma
1265599|NCT01735812|who completed her family planning|who completed her family planning
1265600|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
1265601|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
1265602|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
1265603|NCT01735786|Colonic Polyps|colonic polyps
1265604|NCT01735773|hemodialysis|hemodialysis
1265605|NCT01735773|inflammation|inflammation
1265606|NCT01735773|iron|iron
1265607|NCT01735773|peritoneal dialysis|peritoneal dialysis
1265608|NCT01735773|prohepcidin|prohepcidin
1265609|NCT01735773|uremia|uremia
1265610|NCT01735760|airway management|airway management
1265611|NCT01735760|cricothyroid membrane|cricothyroid membrane
1265612|NCT01735747|Lymphoma|lymphoma
1265613|NCT01735734|Skin disease|skin disease
1265614|NCT01735734|Capillary Malformation|capillary malformation
1265615|NCT01735734|Laser therapy|laser therapy
1265616|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
1265617|NCT01735721|Bone Transplantation|bone transplantation
1265618|NCT01735721|Bone Substitute|bone substitute
1265619|NCT01735708|pain|pain
1265620|NCT01735708|depression|depression
1265621|NCT01735708|HIV|hiv
1265622|NCT01735708|adherence|adherence
1265623|NCT01735695|Meconium|meconium
1265624|NCT01735695|concentration|concentration
1265625|NCT01735695|level|level
1265626|NCT01735682|older adults|older adults
1265627|NCT01735682|exercise|exercise
1265628|NCT01735682|balance|balance
1265629|NCT01735682|gait|gait
1265630|NCT01735682|fall|fall
1265631|NCT01735682|rehabilitation|rehabilitation
1265632|NCT01735682|vibration|vibration
1265633|NCT01735682|muscle|muscle
1265634|NCT01735669|Remifentanil|remifentanil
1265635|NCT01735669|Breech presentation|breech presentation
1265636|NCT01735669|Nitrous oxide|nitrous oxide
1265637|NCT01735669|Pregnancy complications|pregnancy complications
1265638|NCT01735669|Caesarean section|caesarean section
1265639|NCT01735669|Fetal version|fetal version
1265640|NCT01735656|Coronary heart disease;|coronary heart disease;
1265641|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
1265642|NCT01735656|Bifurcation lesion;|bifurcation lesion;
1265643|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
1265644|NCT01735656|clinical trial|clinical trial
1265645|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
1265646|NCT01735643|physical activity|physical activity
1265647|NCT01735643|lifestyle change|lifestyle change
1265648|NCT01735643|motivation|motivation
1265649|NCT01735643|patient empowerment|patient empowerment
1265650|NCT01735630|Agitation|agitation
1265651|NCT01735630|Aggression|aggression
1265652|NCT01735630|patients|patients
1265653|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
1265654|NCT01735617|glucocorticoids|glucocorticoids
1265655|NCT01735617|cortisol|cortisol
1265656|NCT01735617|adrenal|adrenal
1265657|NCT01735591|Liver cirrhosis|liver cirrhosis
1265658|NCT01735591|Liver transplantation|liver transplantation
1265659|NCT01735591|Probiotics|probiotics
1265660|NCT01735591|Mortality|mortality
1265661|NCT01735591|Liver function|liver function
1265662|NCT01735591|Infections|infections
1265663|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
1265664|NCT01735565|NET formation|net formation
1265665|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
1601767|NCT00387855|depression|depression
1265666|NCT01735565|post-engraftment immune system|post-engraftment immune system
1265667|NCT01735552|gut reperfusion injury|gut reperfusion injury
1265668|NCT01735552|blood transfusions|blood transfusions
1265669|NCT01735552|premature infants|premature infants
1265670|NCT01735552|anemia|anemia
1265671|NCT01735552|regional oxygen saturations|regional oxygen saturations
1265672|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
1265673|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
1265674|NCT01735539|old age|old age
1265675|NCT01735539|sarcopenia|sarcopenia
1265676|NCT01735539|essential amino acid|essential amino acid
1265677|NCT01735539|arginine|arginine
1265678|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
1265679|NCT01735539|muscle microcirculation|muscle microcirculation
1265680|NCT01735539|muscle protein synthesis|muscle protein synthesis
1265681|NCT01735526|Allogeneic and autologous|allogeneic and autologous
1265682|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
1265683|NCT01735526|Lung diffusing capacity|lung diffusing capacity
1265684|NCT01735526|for nitric oxide|for nitric oxide
1265685|NCT01735526|carbon monoxide|carbon monoxide
1265686|NCT01735526|Lung tissue density|lung tissue density
1265687|NCT01735526|microvascular damage|microvascular damage
1265688|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
1265689|NCT01735513|embolic protection device|embolic protection device
1265690|NCT01735513|EmbolX|embolx
1265691|NCT01735513|efficacy|efficacy
1265692|NCT01735513|during transaortic TAVI|during transaortic tavi
1265693|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
1265694|NCT01735500|Prei-procedural|prei-procedural
1265695|NCT01735500|Elevation|elevation
1265696|NCT01735500|cardia Troponin T|cardia troponin t
1265697|NCT01735500|in stable|in stable
1265698|NCT01735500|unknown|unknown
1265699|NCT01735474|manual therapy|manual therapy
1265700|NCT01735474|respiratory disease|respiratory disease
1265701|NCT01735474|thoracic movement|thoracic movement
1265702|NCT01735448|smoking cessation|smoking cessation
1265703|NCT01735448|tobacco|tobacco
1265704|NCT01735448|addiction|addiction
1265705|NCT01735448|Aboriginal|aboriginal
1265706|NCT01735448|youth|youth
1265707|NCT01735448|Indigenous|indigenous
1265708|NCT01735448|pharmacological|pharmacological
1265709|NCT01735448|focus group|focus group
1265710|NCT01735448|interview|interview
1265711|NCT01735435|geriatric patients|geriatric patients
1265712|NCT01735435|nutritional support|nutritional support
1265713|NCT01735422|Infertility|infertility
1265714|NCT01735422|Ovulation induction|ovulation induction
1265715|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
1265716|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
1265717|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
1265718|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
1265719|NCT01735409|Abraxane|abraxane
1265720|NCT01735409|Cisplatin|cisplatin
1265721|NCT01735409|Dose|dose
1265722|NCT01735396|African American men|african american men
1265723|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
1265724|NCT01735396|castration resistant|castration resistant
1265725|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
1265726|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
1265727|NCT01735357|Cardiovascular risk|cardiovascular risk
1265728|NCT01735357|Platelet function|platelet function
1265729|NCT01735357|Endothelial function|endothelial function
1265730|NCT01735357|Vascular function|vascular function
1265731|NCT01735357|young males|young males
1265732|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
1265733|NCT01735305|Coronary Artery Disease|coronary artery disease
1265734|NCT01735305|antiplatelet therapy|antiplatelet therapy
1265735|NCT01735292|Ventilation, timer|ventilation, timer
1265736|NCT01735279|tobacco dependence|tobacco dependence
1265737|NCT01735279|tobacco treatment|tobacco treatment
1265738|NCT01735279|omega 3 series|omega 3 series
1265739|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
1265740|NCT01735266|Colonoscopy|colonoscopy
1265741|NCT01735253|metabolic surgery|metabolic surgery
1265742|NCT01735253|gastric bypass|gastric bypass
1265743|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
1265744|NCT01735253|type 2 DM|type 2 dm
1265745|NCT01735240|Phase I,|phase i,
1265746|NCT01735240|healthy volunteers,|healthy volunteers,
1265747|NCT01735240|fixed-sequence,|fixed-sequence,
1265748|NCT01735240|open-label,|open-label,
1265749|NCT01735240|ketoconazole,|ketoconazole,
1265750|NCT01735240|combination,|combination,
1265751|NCT01735240|safety|safety
1265752|NCT01735227|pantoprazole|pantoprazole
1265753|NCT01735227|omeprazole|omeprazole
1265754|NCT01735227|anti - platelet effect|anti - platelet effect
1265755|NCT01735188|Natural history study|natural history study
1265756|NCT01735175|biosimilars|biosimilars
1266171|NCT01733004|Phase I|phase i
1265757|NCT01735175|Pegfilgrastim,|pegfilgrastim,
1265758|NCT01735175|G-CSF,|g-csf,
1265759|NCT01735175|neutropenia,|neutropenia,
1265760|NCT01735175|breast cancer,|breast cancer,
1265761|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
1265762|NCT01735175|supportive care|supportive care
1265763|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
1265764|NCT01735162|Renal angina|renal angina
1265765|NCT01735162|AKI|aki
1265766|NCT01735162|Pediatric Intensive Care|pediatric intensive care
1265767|NCT01735123|infant formula|infant formula
1265768|NCT01735123|diet|diet
1265769|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
1265770|NCT01735123|autoimmunity|autoimmunity
1265771|NCT01735097|Arsenic|arsenic
1265772|NCT01735097|Keratosis|keratosis
1265773|NCT01735097|Nigella sativa|nigella sativa
1265774|NCT01735097|Palm|palm
1265775|NCT01735097|Vitamin E|vitamin e
1265776|NCT01735084|randomized controlled trial|randomized controlled trial
1265777|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
1265778|NCT01735084|booster dose|booster dose
1265779|NCT01735084|immunogenicity|immunogenicity
1265780|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
1265781|NCT01735084|Australian Indigenous|australian indigenous
1265782|NCT01735084|pediatric|pediatric
1265783|NCT01735071|ovarian cancer|ovarian cancer
1265784|NCT01735071|bevacizumab|bevacizumab
1265785|NCT01735071|trabectedin|trabectedin
1265786|NCT01735071|carboplatin|carboplatin
1265787|NCT01735071|randomized trial|randomized trial
1265788|NCT01735071|phase II|phase ii
1265789|NCT01735032|focal epilepsy|focal epilepsy
1265790|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
1265791|NCT01735032|multimodal imaging|multimodal imaging
1265792|NCT01735032|SEEG|seeg
1265793|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
1265794|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
1265795|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
1265796|NCT01735006|vaccine|vaccine
1265797|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1265798|NCT01735006|cervical Cancer|cervical cancer
1265799|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
1265800|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
1265801|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
1265802|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
1265803|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
1265804|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
1265805|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
1265806|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
1265807|NCT01734954|Nerve block|nerve block
1265808|NCT01734954|Sciatic nerve|sciatic nerve
1265809|NCT01734954|Ultrasonography|ultrasonography
1265810|NCT01734954|Orthopedics|orthopedics
1265811|NCT01734954|Hallux Valgus|hallux valgus
1265812|NCT01734954|Amputation|amputation
1265813|NCT01734954|Arthrodesis|arthrodesis
1265814|NCT01734954|Arthroscopy|arthroscopy
1265815|NCT01734954|Fracture fixation|fracture fixation
1265816|NCT01734954|Osteotomy|osteotomy
1265817|NCT01734954|Tendon transfer|tendon transfer
1265818|NCT01734954|Tenodesis|tenodesis
1265819|NCT01734954|Tenotomy|tenotomy
1265820|NCT01734954|Orthopedic procedure|orthopedic procedure
1265821|NCT01734941|Autism|autism
1265822|NCT01734941|Trichuris Suis Ova|trichuris suis ova
1265823|NCT01734941|Behavior|behavior
1265824|NCT01734941|Irritability|irritability
1265825|NCT01734928|Multiple Myeloma|multiple myeloma
1265826|NCT01734928|Pomalidomide|pomalidomide
1265827|NCT01734915|Advanced|advanced
1265828|NCT01734915|EGFR mutation|egfr mutation
1265829|NCT01734889|nitisinone|nitisinone
1265830|NCT01734889|Orfadin|orfadin
1265831|NCT01734889|suspension|suspension
1265832|NCT01734889|taste|taste
1265833|NCT01734889|acceptability|acceptability
1265834|NCT01734876|Parkinson´s disease|parkinson´s disease
1265835|NCT01734876|Pain|pain
1265836|NCT01734876|Sleep|sleep
1265837|NCT01734876|HPA axis function|hpa axis function
1265838|NCT01734876|Health Related Quality of Life|health related quality of life
1265839|NCT01734850|HIV-1|hiv-1
1265840|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
1265841|NCT01734837|appendical stump closure|appendical stump closure
1266142|NCT01733173|DTI|dti
1265842|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
1265843|NCT01734811|Vaccine|vaccine
1265844|NCT01734811|Bronchospasm|bronchospasm
1265845|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
1265846|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
1265847|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
1265848|NCT01734798|Radical Cystectomy|radical cystectomy
1265849|NCT01734759|medication palatability|medication palatability
1265850|NCT01734759|medication taste|medication taste
1265851|NCT01734746|ovarian cancer|ovarian cancer
1265852|NCT01734746|sentinel node|sentinel node
1265853|NCT01734733|Parkinson's Disease|parkinson's disease
1265854|NCT01734733|Xenotransplantation|xenotransplantation
1265855|NCT01734733|choroid plexus|choroid plexus
1265856|NCT01734707|atherosclerosis|atherosclerosis
1265857|NCT01734707|regression|regression
1265858|NCT01734707|Allicor|allicor
1265859|NCT01734707|garlic|garlic
1265860|NCT01734707|intima-media thickness|intima-media thickness
1265861|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
1265862|NCT01734629|Coronary Disease|coronary disease
1265863|NCT01734629|COPD|copd
1265864|NCT01734629|Spirometry|spirometry
1265865|NCT01734629|Coronary tomography|coronary tomography
1265866|NCT01734616|Microvascular|microvascular
1265867|NCT01734616|Muscle|muscle
1265868|NCT01734616|Nutrition|nutrition
1265869|NCT01734616|Exercise|exercise
1265870|NCT01734616|Ageing|ageing
1265871|NCT01734603|Assessment|assessment
1265872|NCT01734603|Rehabilitation|rehabilitation
1265873|NCT01734603|Walking Constant Test|walking constant test
1265874|NCT01734603|Walking Graded test|walking graded test
1265875|NCT01734603|Six minute Walking test|six minute walking test
1265876|NCT01734603|Walking Distance|walking distance
1265877|NCT01734590|Flour,|flour,
1265878|NCT01734590|carbohydrate,|carbohydrate,
1265879|NCT01734590|digestibility|digestibility
1265880|NCT01734590|subjects|subjects
1265881|NCT01734577|Back pain|back pain
1265882|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
1265883|NCT01734551|neonatal withdrawal|neonatal withdrawal
1265884|NCT01734551|Pharmacologic treatment|pharmacologic treatment
1265885|NCT01734525|candidemia|candidemia
1265886|NCT01734525|intensive care unit|intensive care unit
1265887|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
1265888|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
1265889|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
1265890|NCT01734512|everolimus|everolimus
1265891|NCT01734512|mTOR inhibition|mtor inhibition
1265892|NCT01734499|Breast cancer|breast cancer
1265893|NCT01734499|Survivorship|survivorship
1265894|NCT01734499|Coping|coping
1265895|NCT01734499|Quality of Life|quality of life
1265896|NCT01734473|COPD|copd
1265897|NCT01734473|Protein synthesis|protein synthesis
1265898|NCT01734473|Protein breakdown|protein breakdown
1265899|NCT01734473|Muscle wasting|muscle wasting
1265900|NCT01734473|Leucine|leucine
1265901|NCT01734473|Hydrolyzed|hydrolyzed
1265902|NCT01734473|Casein protein|casein protein
1265903|NCT01734473|Carbohydrates|carbohydrates
1265904|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
1265905|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
1265906|NCT01734421|Smoking cessation|smoking cessation
1265907|NCT01734421|Primary health care|primary health care
1265908|NCT01734421|Young people|young people
1265909|NCT01734421|Cellular phone|cellular phone
1265910|NCT01734408|immunogenicity|immunogenicity
1265911|NCT01734408|safety|safety
1265912|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
1265913|NCT01734395|Alzheimer's disease|alzheimer's disease
1265914|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
1265915|NCT01734395|Galantamine|galantamine
1265916|NCT01734395|Razadyne|razadyne
1265917|NCT01734395|Reminyl|reminyl
1265918|NCT01734369|Dermatomyositis|dermatomyositis
1265919|NCT01734369|Inclusion Body Myositis|inclusion body myositis
1265920|NCT01734369|Myositis|myositis
1265921|NCT01734369|Polymyositis|polymyositis
1265922|NCT01734369|Military|military
1265924|NCT01734356|fibroblast|fibroblast
1265925|NCT01734356|arrhythmias|arrhythmias
1265926|NCT01734356|valvulopathies|valvulopathies
1265927|NCT01734356|electrophysiology|electrophysiology
1265928|NCT01734356|genetics|genetics
1265929|NCT01734343|posterior capsule opacification|posterior capsule opacification
1265930|NCT01734343|PCO|pco
1265931|NCT01734343|after cataract|after cataract
1265932|NCT01734343|intraocular lens|intraocular lens
1265933|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
1265934|NCT01734330|Smokers|smokers
1265935|NCT01734330|randomized clinical trial|randomized clinical trial
1265936|NCT01734304|vaccination|vaccination
1265937|NCT01734304|postremission therapy|postremission therapy
1265938|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
1265939|NCT01734304|dendritic cells|dendritic cells
1265940|NCT01734291|Family psychoeducation|family psychoeducation
1265941|NCT01734291|Major depressive disorder|major depressive disorder
1265943|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
1265945|NCT01734174|left ventricular volume|left ventricular volume
1265946|NCT01734174|ejection volume|ejection volume
1265947|NCT01734161|cesarean section|cesarean section
1265948|NCT01734161|nausea|nausea
1265949|NCT01734161|vomiting|vomiting
1265950|NCT01734161|dexamethasone|dexamethasone
1265951|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
1265952|NCT01734161|antiemetics|antiemetics
1265953|NCT01734148|pediatric|pediatric
1265954|NCT01734148|sleep difficulties in children|sleep difficulties in children
1265955|NCT01734148|Sleep Education|sleep education
1265956|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
1265957|NCT01734135|heart failure|heart failure
1265958|NCT01734135|cardiac imaging|cardiac imaging
1265959|NCT01734135|quality of care|quality of care
1265960|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
1265961|NCT01734122|Essential Tremor|essential tremor
1265962|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
1265963|NCT01734122|Quality of Life|quality of life
1265964|NCT01734122|Severity of Tremor|severity of tremor
1265965|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
1265966|NCT01734109|Irrigation Therapy|irrigation therapy
1265967|NCT01734109|Pressure Ulcers|pressure ulcers
1265968|NCT01734109|Sacral Ulcers|sacral ulcers
1265969|NCT01734096|hypertension|hypertension
1265970|NCT01734096|obesity|obesity
1265971|NCT01734096|white coat hypertension|white coat hypertension
1265972|NCT01734096|resistant hypertension|resistant hypertension
1265973|NCT01734083|rehabilitation|rehabilitation
1265974|NCT01734083|exercise|exercise
1265975|NCT01734083|fall|fall
1265976|NCT01734083|muscle|muscle
1265977|NCT01734083|vibration|vibration
1265978|NCT01734083|mobility|mobility
1265979|NCT01734083|cognition|cognition
1265980|NCT01734070|anthocyanins|anthocyanins
1265981|NCT01734070|catechins|catechins
1265982|NCT01734070|chlorogenic acid|chlorogenic acid
1265983|NCT01734070|flavanol glycosides|flavanol glycosides
1265984|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
1265985|NCT01734057|rhTPO|rhtpo
1265986|NCT01734057|Rituximab|rituximab
1265987|NCT01734057|Dexamethasone|dexamethasone
1265988|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
1265989|NCT01734044|rhTPO|rhtpo
1265990|NCT01734044|Dexamethasone|dexamethasone
1265991|NCT01733953|Cardiovascular Disease|cardiovascular disease
1265992|NCT01733953|Childhood ALL|childhood all
1265993|NCT01733953|Childhood NHL|childhood nhl
1265994|NCT01733927|HIV screening|hiv screening
1265995|NCT01733927|Rapid test for HIV|rapid test for hiv
1265996|NCT01733914|shoulder pain|shoulder pain
1265997|NCT01733914|acupuncture|acupuncture
1265998|NCT01733901|Coronary heart disease|coronary heart disease
1265999|NCT01733901|PCI|pci
1266000|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
1266001|NCT01733901|Hypertension|hypertension
1266002|NCT01733901|Diabetes|diabetes
1266003|NCT01733888|caries|caries
1266004|NCT01733888|caries infiltration|caries infiltration
1266005|NCT01733888|fluorosis treatment|fluorosis treatment
1266006|NCT01733875|Safety|safety
1266007|NCT01733875|Pharmacokinetics|pharmacokinetics
1266008|NCT01733875|Food effect|food effect
1266009|NCT01733875|Healthy subjects|healthy subjects
1266010|NCT01733862|Impact|impact
1266011|NCT01733862|Vaccination|vaccination
1266012|NCT01733862|Hospitalizations|hospitalizations
1266013|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
1266014|NCT01733862|Japan|japan
1266015|NCT01733849|Bulgaria|bulgaria
1266016|NCT01733849|Primary care settings|primary care settings
1266017|NCT01733849|Children|children
1266018|NCT01733849|Latvia|latvia
1266019|NCT01733849|Acute gastroenteritis|acute gastroenteritis
1266020|NCT01733810|Esophagitis|esophagitis
1266021|NCT01733810|Reflux esophagitis|reflux esophagitis
1266022|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
1266023|NCT01733810|Acid|acid
1266024|NCT01733810|Inflammation|inflammation
1266025|NCT01733810|Esophagus|esophagus
1266026|NCT01733810|Cytokines|cytokines
1266027|NCT01733810|Esophageal squamous cell|esophageal squamous cell
1266028|NCT01733810|Reflux|reflux
1266029|NCT01733810|Squamous epithelium|squamous epithelium
1266030|NCT01733797|Trismus|trismus
1266031|NCT01733797|Therabite|therabite
1266032|NCT01733797|Wooden spatula|wooden spatula
1266033|NCT01733797|Head and Neck cancer|head and neck cancer
1266034|NCT01733784|Sleep Apnea|sleep apnea
1266035|NCT01733784|Pathophysiology|pathophysiology
1266036|NCT01733771|complementary medicine|complementary medicine
1266037|NCT01733771|hospitalized|hospitalized
1266038|NCT01733758|albiglutide|albiglutide
1266039|NCT01733758|Japanese|japanese
1266040|NCT01733758|GSK716155|gsk716155
1266041|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
1266042|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
1266052|NCT01733693|Methadone|methadone
1266053|NCT01733693|Cognition|cognition
1266054|NCT01733680|ADHD|adhd
1266055|NCT01733680|executive function|executive function
1266056|NCT01733680|emotional self-regulation|emotional self-regulation
1266057|NCT01733667|synechia|synechia
1266058|NCT01733667|Fess|fess
1266059|NCT01733667|sinus surgery|sinus surgery
1266060|NCT01733654|depression|depression
1266061|NCT01733654|major depressive disorder|major depressive disorder
1266062|NCT01733628|Hypertension|hypertension
1266063|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
1266064|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
1266065|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
1266066|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
1266067|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
1266068|NCT01733615|MPS Type IVA|mps type iva
1266069|NCT01733615|MPS Type IV|mps type iv
1266070|NCT01733615|Morquio Syndrome|morquio syndrome
1266172|NCT01733004|ErbB3|erbb3
1266071|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
1266072|NCT01733615|Urine biomarkers|urine biomarkers
1266073|NCT01733589|Recombinant human endostatin|recombinant human endostatin
1266074|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
1266075|NCT01733589|chemoradiotherapy|chemoradiotherapy
1266076|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
1266077|NCT01733563|fructose|fructose
1266078|NCT01733563|lipogenesis|lipogenesis
1266079|NCT01733563|beta-oxidation|beta-oxidation
1266080|NCT01733550|Intraocular Pressure|intraocular pressure
1266081|NCT01733550|Tonometry, Ocular|tonometry, ocular
1266082|NCT01733550|iCare|icare
1266083|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
1266084|NCT01733524|adolescence|adolescence
1266085|NCT01733524|self care|self care
1266086|NCT01733485|Asthma|asthma
1266087|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
1266088|NCT01733485|Inflammation|inflammation
1266089|NCT01733472|anaesthetic techniques|anaesthetic techniques
1266090|NCT01733472|subarachnoid|subarachnoid
1266091|NCT01733472|analgesia|analgesia
1266092|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
1266093|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
1266094|NCT01733407|inherited neuropathies|inherited neuropathies
1266095|NCT01733394|Epilepsy|epilepsy
1266096|NCT01733394|Generic|generic
1266097|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
1266098|NCT01733368|CRT|crt
1266099|NCT01733368|Optimization|optimization
1266100|NCT01733368|Responders|responders
1266101|NCT01733329|Buccal Misoprostol|buccal misoprostol
1266102|NCT01733329|Uterine Atony|uterine atony
1266103|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
1266104|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
1266105|NCT01733316|Cysteamine|cysteamine
1266106|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
1266107|NCT01733316|Orphan Disease|orphan disease
1266108|NCT01733316|CTNS Protein, Human|ctns protein, human
1266109|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
1266110|NCT01733290|Dysfunctional voiding|dysfunctional voiding
1266111|NCT01733277|Neuropathic pain|neuropathic pain
1266112|NCT01733277|Knee osteoarthritis|knee osteoarthritis
1266113|NCT01733277|MRI|mri
1266114|NCT01733238|PNT2258|pnt2258
1266115|NCT01733238|Lymphoma|lymphoma
1266116|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1266117|NCT01733238|NHL|nhl
1266118|NCT01733212|Nausea|nausea
1266119|NCT01733212|Vomiting|vomiting
1266120|NCT01733212|Cesaraen|cesaraen
1266121|NCT01733212|Ginger|ginger
1266122|NCT01733212|cesarean section|cesarean section
1266123|NCT01733199|Parkinson's disease|parkinson's disease
1266124|NCT01733199|Behavioural addictions|behavioural addictions
1266125|NCT01733199|Pathological gambling|pathological gambling
1266126|NCT01733199|Dopamine agonist|dopamine agonist
1266127|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
1266128|NCT01733199|Pharmacokinetic|pharmacokinetic
1266129|NCT01733199|Pramipexole|pramipexole
1266130|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
1266131|NCT01733186|MSC|msc
1266132|NCT01733186|cartilage lesion|cartilage lesion
1266133|NCT01733186|cartilage defect|cartilage defect
1266134|NCT01733186|degenerative arthritis|degenerative arthritis
1266135|NCT01733186|stem cell implantation|stem cell implantation
1266136|NCT01733173|mass in posterior fossa|mass in posterior fossa
1266137|NCT01733173|benign|benign
1266138|NCT01733173|malignant|malignant
1266139|NCT01733173|surgical resection|surgical resection
1266140|NCT01733173|MRI|mri
1266143|NCT01733173|12-121|12-121
1266144|NCT01733160|Atrial Fibrillation|atrial fibrillation
1266145|NCT01733160|Stroke|stroke
1266146|NCT01733160|Anticoagulants|anticoagulants
1266147|NCT01733147|Barrett's esophagus|barrett's esophagus
1266148|NCT01733147|Obesity|obesity
1266149|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
1266150|NCT01733134|acute heart failure|acute heart failure
1266151|NCT01733134|emergency department|emergency department
1266152|NCT01733134|copeptin|copeptin
1266153|NCT01733134|adh antagonists|adh antagonists
1266154|NCT01733108|Healthy|healthy
1266155|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1266156|NCT01733108|Pharmacokinetics|pharmacokinetics
1266157|NCT01733108|Pharmacodynamics|pharmacodynamics
1266158|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
1266159|NCT01733056|Dermatology|dermatology
1266160|NCT01733056|Influenza Vaccine|influenza vaccine
1266161|NCT01733030|PTSD|ptsd
1266162|NCT01733017|heart failure|heart failure
1266163|NCT01733017|nutrition therapy|nutrition therapy
1266164|NCT01733017|symptoms|symptoms
1266165|NCT01733017|quality of life|quality of life
1266166|NCT01733017|lycopene|lycopene
1266167|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
1266168|NCT01733004|Cancer|cancer
1266169|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
1266170|NCT01733004|Oncology|oncology
1266173|NCT01733004|IGF-1R|igf-1r
1266174|NCT01733004|Everolimus|everolimus
1266175|NCT01733004|Gemcitabine|gemcitabine
1266176|NCT01733004|Abraxane|abraxane
1266177|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
1266178|NCT01732991|Greenlight laser|greenlight laser
1266179|NCT01732991|Prostatic photovaporization|prostatic photovaporization
1266180|NCT01732991|Prostatic MRI|prostatic mri
1266181|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
1266182|NCT01732991|Urinary irritative signs|urinary irritative signs
1266183|NCT01732991|Postoperative necrotic area|postoperative necrotic area
1266184|NCT01732978|Crying record|crying record
1266185|NCT01732978|Newborn|newborn
1266186|NCT01732965|Vitiligo|vitiligo
1266187|NCT01732965|Phototherapy|phototherapy
1266188|NCT01732965|Photochemotherapy|photochemotherapy
1266189|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
1266190|NCT01732926|iNHL|inhl
1266191|NCT01732926|indolent NHL|indolent nhl
1266192|NCT01732926|follicular lymphoma|follicular lymphoma
1266193|NCT01732926|CAL-101|cal-101
1266194|NCT01732926|rituximab|rituximab
1266195|NCT01732926|bendamustine|bendamustine
1266196|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
1266197|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
1266198|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1266199|NCT01732926|LPL|lpl
1266200|NCT01732926|WM|wm
1266201|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
1266202|NCT01732926|MZL|mzl
1266203|NCT01732926|SLL|sll
1266204|NCT01732926|FL|fl
1266205|NCT01732926|GS-1101|gs-1101
1266206|NCT01732926|PI3K inhibitor|pi3k inhibitor
1266207|NCT01732926|idelalisib|idelalisib
1266208|NCT01732913|iNHL|inhl
1266209|NCT01732913|indolent NHL|indolent nhl
1266210|NCT01732913|follicular lymphoma|follicular lymphoma
1266211|NCT01732913|CAL-101|cal-101
1266212|NCT01732913|Rituximab|rituximab
1266213|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
1266214|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
1266215|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1266216|NCT01732913|LPL|lpl
1266217|NCT01732913|WM|wm
1266218|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
1266219|NCT01732913|MZL|mzl
1266220|NCT01732913|SLL|sll
1266221|NCT01732913|FL|fl
1266222|NCT01732913|GS-1101|gs-1101
1266223|NCT01732913|idelalisib|idelalisib
1266224|NCT01732900|In vitro fertilization|in vitro fertilization
1266225|NCT01732900|Assisted reproduction|assisted reproduction
1266226|NCT01732900|pregnancy outcome|pregnancy outcome
1266227|NCT01732900|cumulus cells|cumulus cells
1266228|NCT01732887|cochlear implants|cochlear implants
1266229|NCT01732887|speech comprehension|speech comprehension
1266230|NCT01732887|cognitive training|cognitive training
1266231|NCT01732887|cognitive fitness|cognitive fitness
1266232|NCT01732887|intervention|intervention
1266233|NCT01732887|memory|memory
1266234|NCT01732887|attention|attention
1266235|NCT01732887|rehabilitation|rehabilitation
1266236|NCT01732874|DHA|dha
1266237|NCT01732874|Preterm infant|preterm infant
1266238|NCT01732874|Inflammation|inflammation
1266239|NCT01732874|Growth|growth
1266240|NCT01732874|Developement|developement
1266241|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1266242|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
1266243|NCT01732848|Volunteers|volunteers
1266244|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
1266245|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
1266246|NCT01732809|wrinkles|wrinkles
1266247|NCT01732809|botulinum toxin|botulinum toxin
1266248|NCT01732783|Wild-type RAS|wild-type ras
1266249|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
1266250|NCT01732783|Vectibix|vectibix
1266251|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
1266252|NCT01732731|Cerebral palsy|cerebral palsy
1266253|NCT01732731|treadmill training|treadmill training
1266254|NCT01732718|sickle cell disease|sickle cell disease
1266255|NCT01732718|endothelial function|endothelial function
1266256|NCT01732718|albuminuria|albuminuria
1266257|NCT01732718|atorvastatin|atorvastatin
1266258|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
1266259|NCT01732705|Type 2 diabetes|type 2 diabetes
1266260|NCT01732705|Insulin sensitivity|insulin sensitivity
1266261|NCT01732705|High intensity interval training|high intensity interval training
1266262|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
1266263|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
1266264|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
1601859|NCT00387478|Allergy|allergy
1266265|NCT01732653|virtual reality,|virtual reality,
1266266|NCT01732653|falls,|falls,
1266267|NCT01732653|elderly,|elderly,
1266268|NCT01732653|Parkinson's disease,|parkinson's disease,
1266269|NCT01732653|MCI|mci
1266270|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1266271|NCT01732627|Meningitis|meningitis
1266272|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
1266273|NCT01732627|Menactra®|menactra®
1266274|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
1266275|NCT01732614|Diabetic Macular Edema|diabetic macular edema
1266276|NCT01732614|DME|dme
1266277|NCT01732614|Laser|laser
1266278|NCT01732614|Topcon|topcon
1266279|NCT01732614|EndPoint Management|endpoint management
1266280|NCT01732601|Suicide Attempt|suicide attempt
1266281|NCT01732601|Suicidal Ideation|suicidal ideation
1266282|NCT01732601|NSSI|nssi
1266283|NCT01732601|Substance Use|substance use
1266284|NCT01732588|Bioavailability|bioavailability
1266285|NCT01732575|everyday activities|everyday activities
1266286|NCT01732575|rehabilitation|rehabilitation
1266287|NCT01732575|mental illness|mental illness
1266288|NCT01732575|occupational therapy|occupational therapy
1266289|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
1266290|NCT01732562|Patient Expectations|patient expectations
1266291|NCT01732562|Patient Satisfaction|patient satisfaction
1266292|NCT01732562|Patient Education|patient education
1266293|NCT01732562|e-Learning|e-learning
1266294|NCT01732523|Carotid stenosis|carotid stenosis
1266295|NCT01732523|Vasa Vasorum|vasa vasorum
1266296|NCT01732523|Ultrasonography|ultrasonography
1266297|NCT01732497|Underarm Hair|underarm hair
1266298|NCT01732497|Underarm Hair Reduction|underarm hair reduction
1266299|NCT01732497|Axillary Hair|axillary hair
1266300|NCT01732497|Axillary Hair Reduction|axillary hair reduction
1266301|NCT01732497|Underarm Odor|underarm odor
1266302|NCT01732497|Axillary Odor|axillary odor
1266303|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
1266304|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
1266305|NCT01732393|Quercetin|quercetin
1266306|NCT01732393|Chemotherapy|chemotherapy
1266307|NCT01732393|Mucositis|mucositis
1266308|NCT01732393|Hematologic Malignancies|hematologic malignancies
1266309|NCT01732367|Tenofovir|tenofovir
1266310|NCT01732367|Lamivudine|lamivudine
1266311|NCT01732367|Adefovir|adefovir
1266312|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
1266313|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
1266314|NCT01732341|STEMI|stemi
1266315|NCT01732341|BMS|bms
1266316|NCT01732341|Self-expanding stent|self-expanding stent
1266317|NCT01732315|Adolescent vaccination|adolescent vaccination
1266318|NCT01732315|Immunization rates|immunization rates
1266319|NCT01732315|Barriers to vaccination|barriers to vaccination
1266320|NCT01732315|Attitudes|attitudes
1266321|NCT01732315|Intentions|intentions
1266322|NCT01732302|Drug Utilization Review|drug utilization review
1266323|NCT01732302|Aged|aged
1266324|NCT01732302|Aged, 80 and over|aged, 80 and over
1266325|NCT01732302|Primary Health Care|primary health care
1266326|NCT01732289|Age-related hearing loss|age-related hearing loss
1266328|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
1266329|NCT01732289|environmental factors|environmental factors
1266330|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
1266331|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
1266332|NCT01732276|Gefitinib|gefitinib
1266333|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
1266334|NCT01732250|Resistant Bacteria|resistant bacteria
1266335|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
1266336|NCT01732250|Colistin|colistin
1266337|NCT01732237|Healthy|healthy
1266338|NCT01732237|JNJ-42396302|jnj-42396302
1266339|NCT01732237|JNJ-42692507|jnj-42692507
1266340|NCT01732237|JNJ-53773187|jnj-53773187
1266928|NCT01729416|rate|rate
1266341|NCT01732237|Pharmacokinetics|pharmacokinetics
1266342|NCT01732211|Phase 2|phase 2
1266343|NCT01732211|Randomized|randomized
1266344|NCT01732211|Double Blind|double blind
1266345|NCT01732211|Placebo Controlled|placebo controlled
1266346|NCT01732211|Parallel|parallel
1266347|NCT01732211|20 Week Safety|20 week safety
1266348|NCT01732211|Tolerability|tolerability
1266349|NCT01732211|and Efficacy Study|and efficacy study
1266350|NCT01732185|Congenital lung malformation|congenital lung malformation
1266351|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
1266352|NCT01732185|Cystic lung disease|cystic lung disease
1266353|NCT01732172|Urethritis|urethritis
1266354|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
1266355|NCT01732159|Ambulatory surgery|ambulatory surgery
1266356|NCT01732159|Checklist|checklist
1266357|NCT01732159|Cancellation|cancellation
1266358|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1602156|NCT00386542|needle-free|needle-free
1266359|NCT01732146|Term neonate|term neonate
1266360|NCT01732146|Neuroprotection|neuroprotection
1266361|NCT01732146|erythropoietin|erythropoietin
1266362|NCT01732133|Hypotension|hypotension
1266363|NCT01732133|Cesarean delivery|cesarean delivery
1266364|NCT01732120|off-clamp|off-clamp
1266365|NCT01732120|partial nephrectomy|partial nephrectomy
1266366|NCT01732120|renal cancer treatment|renal cancer treatment
1266367|NCT01732120|renal ischemia|renal ischemia
1266368|NCT01732107|Dovitinib|dovitinib
1266369|NCT01732107|FGFR3 Mutations|fgfr3 mutations
1266370|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
1266371|NCT01732094|Poor ovarian response|poor ovarian response
1266372|NCT01732094|Poor ovarian responders|poor ovarian responders
1266373|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
1266374|NCT01732081|Hepatitis B|hepatitis b
1266375|NCT01732068|Poor ovarian response|poor ovarian response
1266376|NCT01732068|Poor ovarian responders|poor ovarian responders
1266377|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
1266378|NCT01732055|Pregnancy|pregnancy
1266379|NCT01732055|Antenatal|antenatal
1266380|NCT01732055|Major Depressive Disorder|major depressive disorder
1266381|NCT01732055|Psychotherapy|psychotherapy
1266382|NCT01732055|Antidepressant Medication|antidepressant medication
1266383|NCT01732055|Partners|partners
1266384|NCT01732055|Spouses|spouses
1266385|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
1266386|NCT01732042|retinal venous pressure|retinal venous pressure
1266387|NCT01732029|pulse oximeter|pulse oximeter
1266388|NCT01732029|oxygen saturation|oxygen saturation
1266389|NCT01732029|heart rate|heart rate
1266390|NCT01732029|calibration|calibration
1266391|NCT01732029|accuracy|accuracy
1266392|NCT01732016|pulse oximeter|pulse oximeter
1266393|NCT01732016|oxygen saturation|oxygen saturation
1266394|NCT01732016|heart rate|heart rate
1266395|NCT01732016|calibration|calibration
1266396|NCT01732016|accuracy|accuracy
1266397|NCT01732003|Omega-3|omega-3
1266398|NCT01732003|Skeletal Muscle|skeletal muscle
1266399|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
1266400|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
1266401|NCT01732003|Exercise|exercise
1266402|NCT01732003|Membrane Composition|membrane composition
1266403|NCT01732003|Lipid Metabolism|lipid metabolism
1266404|NCT01731990|Peripheral artery disease|peripheral artery disease
1266405|NCT01731990|Intermittent claudication|intermittent claudication
1266406|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
1266407|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
1266408|NCT01731964|Macular Degeneration|macular degeneration
1266409|NCT01731964|Visual Impairment|visual impairment
1266410|NCT01731964|Implantable Telescope|implantable telescope
1266411|NCT01731951|Myelofibrosis|myelofibrosis
1266412|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
1266413|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
1266414|NCT01731951|Imetelstat|imetelstat
1266415|NCT01731951|GRN163L|grn163l
1266416|NCT01731938|Fibrin Sealant|fibrin sealant
1266417|NCT01731938|Soft tissue open surgery|soft tissue open surgery
1266418|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
1266419|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
1266420|NCT01731925|progressive|progressive
1266421|NCT01731925|advanced|advanced
1266422|NCT01731925|metastatic|metastatic
1266423|NCT01731899|major depression|major depression
1266424|NCT01731899|fibromyalgia|fibromyalgia
1266425|NCT01731899|agomelatine|agomelatine
1266426|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
1266427|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
1266428|NCT01731886|Stem cell transplant|stem cell transplant
1266429|NCT01731886|plasma cell myeloma|plasma cell myeloma
1266430|NCT01731886|multiple myeloma|multiple myeloma
1266431|NCT01731873|postoperative pain|postoperative pain
1266432|NCT01731873|children|children
1266433|NCT01731873|pharmacogenetic|pharmacogenetic
1266434|NCT01731873|opioid adverse effects|opioid adverse effects
1266435|NCT01731873|respiratory depression|respiratory depression
1266436|NCT01731873|analgesia|analgesia
1266437|NCT01731873|genetic polymorphisms|genetic polymorphisms
1266438|NCT01731860|PET/CT|pet/ct
1266439|NCT01731860|Philips|philips
1266440|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
1266441|NCT01731834|Pain|pain
1266442|NCT01731834|Stress|stress
1266443|NCT01731834|Physiotherapy|physiotherapy
1266444|NCT01731834|Children|children
1266445|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
1266446|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
1266447|NCT01731808|Nursing counseling|nursing counseling
1266448|NCT01731808|diabetic foot|diabetic foot
1266449|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
1266450|NCT01731782|colorectal surgery|colorectal surgery
1266451|NCT01731769|Seroma Formation|seroma formation
1266452|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
1266453|NCT01731769|Breast cancer|breast cancer
1266454|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
1266455|NCT01731756|Palm|palm
1266456|NCT01731756|Arsenic|arsenic
1266457|NCT01731756|Keratosis|keratosis
1266458|NCT01731756|Salicylic acid|salicylic acid
1266459|NCT01731756|Azadirachta indica|azadirachta indica
1266460|NCT01731756|Neem|neem
1266461|NCT01731730|Postsurgical pain|postsurgical pain
1266462|NCT01731730|Total knee arthroplasty|total knee arthroplasty
1266463|NCT01731730|Total knee replacement|total knee replacement
1266464|NCT01731717|depression|depression
1266465|NCT01731717|stepped care|stepped care
1266466|NCT01731717|evidence-based medicine|evidence-based medicine
1266467|NCT01731717|health services research|health services research
1266468|NCT01731717|psychotherapy|psychotherapy
1266469|NCT01731717|complex intervention|complex intervention
1266470|NCT01731717|guideline|guideline
1266471|NCT01731704|5 or more brain metastases|5 or more brain metastases
1266472|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
1266473|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
1266474|NCT01731665|Crohn's disease|crohn's disease
1266475|NCT01731665|ulcerative colitis|ulcerative colitis
1266476|NCT01731665|epidemiology|epidemiology
1266477|NCT01731665|Korea|korea
1266478|NCT01731652|bladder cancer|bladder cancer
1266479|NCT01731652|carcinoma in situ|carcinoma in situ
1266480|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
1266481|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1266482|NCT01731587|exploratory study|exploratory study
1266483|NCT01731587|L-BLP25|l-blp25
1266484|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
1266485|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
1266486|NCT01731561|Renal limited forms|renal limited forms
1266487|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
1266488|NCT01731561|Rituximab|rituximab
1266489|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
1266490|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
1266491|NCT01731509|fetoscopy|fetoscopy
1266492|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
1266493|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
1266494|NCT01731509|fetal surgery|fetal surgery
1266495|NCT01731509|fetal lung|fetal lung
1266496|NCT01731496|Human Papillomavirus|human papillomavirus
1266497|NCT01731483|virulence factors|virulence factors
1266498|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
1266499|NCT01731444|blood loss|blood loss
1266500|NCT01731444|burn|burn
1266501|NCT01731444|hemostasis|hemostasis
1266502|NCT01731431|Gestational Diabetes,|gestational diabetes,
1266503|NCT01731431|Insulin,|insulin,
1266504|NCT01731431|Glyburide,|glyburide,
1266505|NCT01731431|Glycemia|glycemia
1266506|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
1266507|NCT01731418|Depression|depression
1266508|NCT01731418|Intimate Partner violence|intimate partner violence
1266509|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
1266510|NCT01731405|Medication Guides|medication guides
1266511|NCT01731405|FDA|fda
1266512|NCT01731405|Prototype|prototype
1266513|NCT01731405|Format|format
1266514|NCT01731392|Diarrhea|diarrhea
1266515|NCT01731392|Children|children
1266516|NCT01731392|Lactobacilli|lactobacilli
1266517|NCT01731379|spectroscopy|spectroscopy
1266518|NCT01731379|nerve|nerve
1266519|NCT01731379|muscle|muscle
1266520|NCT01731379|fat|fat
1266521|NCT01731353|invasive fungal infection|invasive fungal infection
1266522|NCT01731353|Web-based registry|web-based registry
1266523|NCT01731340|Calcium Supplements|calcium supplements
1266524|NCT01731340|Dairy Foods|dairy foods
1266525|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
1266526|NCT01731340|Osteoporosis|osteoporosis
1266527|NCT01731340|Postmenopause|postmenopause
1266528|NCT01731340|Vitamin D|vitamin d
1266529|NCT01731340|Micronutrients|micronutrients
1266530|NCT01731340|Primary Prevention|primary prevention
1266531|NCT01731340|Bone Health|bone health
1266532|NCT01731327|Phase 1|phase 1
1266533|NCT01731327|relative bioavailability|relative bioavailability
1266534|NCT01731327|modified release|modified release
1266535|NCT01731327|tofacitinib|tofacitinib
1266536|NCT01731327|CP-690|cp-690
1266538|NCT01731327|pharmacokinetic|pharmacokinetic
1266539|NCT01731301|Chronic hepatitis C|chronic hepatitis c
1266540|NCT01731301|HCV|hcv
1266541|NCT01731301|End stage renal disease|end stage renal disease
1266542|NCT01731301|ESRD|esrd
1266543|NCT01731301|Boceprevir|boceprevir
1266544|NCT01731301|Ribavirin|ribavirin
1266545|NCT01731301|Peg-interferon|peg-interferon
1266546|NCT01731301|Triple therapy|triple therapy
1266547|NCT01731288|pregnancy|pregnancy
1266548|NCT01731288|childbirth|childbirth
1266549|NCT01731288|pain|pain
1266550|NCT01731288|vulvodynia|vulvodynia
1602365|NCT00385736|Adalimumab|adalimumab
1266551|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
1266552|NCT01731275|Healthy volunteers|healthy volunteers
1266553|NCT01731275|immunogenicity|immunogenicity
1266554|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
1266555|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
1266556|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
1266557|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
1266558|NCT01731262|Synovitis|synovitis
1266559|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
1268395|NCT01722851|Recurrent|recurrent
1266560|NCT01731249|Birch pollen extract solution|birch pollen extract solution
1266561|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1266562|NCT01731236|Carnitine metabolism|carnitine metabolism
1266563|NCT01731236|gut flora|gut flora
1266564|NCT01731223|Insomnia|insomnia
1266565|NCT01731223|Primary health care|primary health care
1266566|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
1266567|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
1266568|NCT01731171|mania|mania
1266569|NCT01731171|manic episode|manic episode
1266570|NCT01731171|mixed episode|mixed episode
1266571|NCT01731171|bipolar disorder|bipolar disorder
1266572|NCT01731171|schizoaffective disorder|schizoaffective disorder
1266573|NCT01731171|probiotics|probiotics
1266574|NCT01731171|probiotic supplement|probiotic supplement
1266575|NCT01731171|relapse prevention|relapse prevention
1266576|NCT01731171|new mood episode|new mood episode
1266577|NCT01731171|re-hospitalization|re-hospitalization
1266578|NCT01731145|Tremor|tremor
1266579|NCT01731145|SNUMAP|snumap
1266580|NCT01731145|accelerometry|accelerometry
1266581|NCT01731145|gyroscope|gyroscope
1266582|NCT01731145|clinical rating scale|clinical rating scale
1266583|NCT01731132|HRQoL|hrqol
1266584|NCT01731132|IUD|iud
1266585|NCT01731132|Contraception|contraception
1266586|NCT01731132|SEC-QoL|sec-qol
1266587|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
1266588|NCT01731093|aged|aged
1266589|NCT01731093|health|health
1266590|NCT01731093|brain|brain
1266591|NCT01731054|lupus nephritis|lupus nephritis
1266592|NCT01731054|normal healthy volunteer|normal healthy volunteer
1266593|NCT01731054|MRI|mri
1266594|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
1266595|NCT01731002|Glaucoma|glaucoma
1266596|NCT01730989|menopause|menopause
1266597|NCT01730989|Kupperman|kupperman
1266598|NCT01730989|hot flushes|hot flushes
1266599|NCT01730989|isoflavones|isoflavones
1266600|NCT01730989|magnolia|magnolia
1266601|NCT01730989|chaste tree|chaste tree
1266602|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
1266603|NCT01730924|Atrial fibrillation|atrial fibrillation
1266604|NCT01730924|Contact force|contact force
1266605|NCT01730924|Ablation|ablation
1266606|NCT01730911|Bleeding|bleeding
1266607|NCT01730911|Cramping|cramping
1266608|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
1266609|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
1266610|NCT01730911|Intrauterine device removal|intrauterine device removal
1266611|NCT01730859|Balance exercise|balance exercise
1266612|NCT01730859|Ankle|ankle
1266613|NCT01730859|Postural stability|postural stability
1266614|NCT01730859|Taping|taping
1266615|NCT01730859|Biodex|biodex
1266616|NCT01730846|smoking lapse behavior|smoking lapse behavior
1266617|NCT01730846|smoking cessation|smoking cessation
1266618|NCT01730846|doxazosin|doxazosin
1266619|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
1266620|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
1266621|NCT01730846|stress|stress
1266622|NCT01730807|Atrial Flutter|atrial flutter
1266623|NCT01730807|Ablation|ablation
1266624|NCT01730807|Type I Atrial Flutter|type i atrial flutter
1266625|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
1266626|NCT01730794|Acute Respiratory Failure|acute respiratory failure
1266627|NCT01730794|Mechanical Ventilation|mechanical ventilation
1266628|NCT01730794|NAVA|nava
1266629|NCT01730794|Lung protective ventilation|lung protective ventilation
1266630|NCT01730794|invasive ventilation|invasive ventilation
1266631|NCT01730794|noninvasive ventilation|noninvasive ventilation
1266632|NCT01730781|Cannabis dependence|cannabis dependence
1266633|NCT01730781|Brain Imaging|brain imaging
1266634|NCT01730781|Schizophrenia|schizophrenia
1266635|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
1266636|NCT01730755|Polycythemia|polycythemia
1266637|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
1266638|NCT01730716|ALS|als
1266639|NCT01730703|walking|walking
1266640|NCT01730703|incentives|incentives
1266641|NCT01730703|elderly|elderly
1266642|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
1266643|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
1266644|NCT01730677|Lapatinib|lapatinib
1266645|NCT01730677|Vinorelbine|vinorelbine
1266646|NCT01730664|ertapenem|ertapenem
1266647|NCT01730664|tuberculosis|tuberculosis
1266648|NCT01730664|pharmacokinetics|pharmacokinetics
1266649|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
1266650|NCT01730638|thyroid,|thyroid,
1266651|NCT01730638|endocrine tumour|endocrine tumour
1266652|NCT01730638|Nuclear medicine,|nuclear medicine,
1266653|NCT01730638|molecular imaging|molecular imaging
1266654|NCT01730638|ImmunoTEP|immunotep
1268396|NCT01722838|Black MSM|black msm
1266655|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
1266656|NCT01730625|Attention biases|attention biases
1266657|NCT01730625|Anxious children|anxious children
1266658|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1266659|NCT01730612|ImmunoTEP|immunotep
1266660|NCT01730612|HER2 negative|her2 negative
1266661|NCT01730612|Breast Cancer|breast cancer
1266662|NCT01730586|Colorectal Cancer|colorectal cancer
1266663|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
1266664|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
1266665|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
1266666|NCT01730586|Colorectal|colorectal
1266667|NCT01730586|Small bowel cancer|small bowel cancer
1266668|NCT01730586|Abraxane|abraxane
1266669|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
1266670|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
1266671|NCT01730586|ABI-007|abi-007
1266672|NCT01730573|interscalene|interscalene
1266673|NCT01730573|suprascapular|suprascapular
1266674|NCT01730573|axillary|axillary
1266675|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
1266676|NCT01730547|Multiple Sclerosis|multiple sclerosis
1266677|NCT01730547|Autoimmune diseases|autoimmune diseases
1266678|NCT01730534|Phase IIIb|phase iiib
1266679|NCT01730534|T2DM|t2dm
1266680|NCT01730534|cardiovascular events|cardiovascular events
1266681|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
1266682|NCT01730495|CFS|cfs
1266683|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
1266684|NCT01730495|CFS/ME|cfs/me
1266685|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
1266686|NCT01730495|TNF-alpha|tnf-alpha
1266687|NCT01730495|Etanercept|etanercept
1266688|NCT01730482|excretion|excretion
1266689|NCT01730482|healthy volunteer|healthy volunteer
1266690|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
1266691|NCT01730482|AT1001|at1001
1266692|NCT01730482|pharmacokinetics|pharmacokinetics
1266693|NCT01730482|Fabry disease|fabry disease
1266694|NCT01730469|Pharmacokinetics|pharmacokinetics
1266695|NCT01730469|GR181413|gr181413
1266696|NCT01730469|Safety|safety
1266697|NCT01730469|AT1001|at1001
1266698|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
1266699|NCT01730443|traumatic brain injury|traumatic brain injury
1266700|NCT01730430|non-AD dementias|non-ad dementias
1266701|NCT01730430|healthy elderly controls|healthy elderly controls
1266702|NCT01730417|Phase 1|phase 1
1266703|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
1266704|NCT01730417|radiation dosimetry|radiation dosimetry
1266705|NCT01730378|Influenza vaccine|influenza vaccine
1266706|NCT01730365|spectroscopy|spectroscopy
1266707|NCT01730365|tumour|tumour
1266708|NCT01730365|biopsy|biopsy
1266709|NCT01730365|malignancy|malignancy
1266710|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1266711|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
1266712|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
1266713|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
1266714|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
1266715|NCT01730352|children|children
1266716|NCT01730352|adolescents|adolescents
1266717|NCT01730339|Skin scarring|skin scarring
1266718|NCT01730339|cicatrix|cicatrix
1266719|NCT01730339|breast scar|breast scar
1266720|NCT01730339|hypertrophic scar|hypertrophic scar
1266721|NCT01730326|Headache|headache
1266722|NCT01730326|paracetamol|paracetamol
1266723|NCT01730326|dexketoprofen|dexketoprofen
1266724|NCT01730326|emergency department|emergency department
1266725|NCT01730313|Nodding syndrome|nodding syndrome
1266726|NCT01730287|Stepwise Excavation|stepwise excavation
1266727|NCT01730287|Pulpal vitality|pulpal vitality
1266728|NCT01730287|Deep caries lesions|deep caries lesions
1266729|NCT01730287|Clinical symptoms|clinical symptoms
1266730|NCT01730287|Radiographic evaluation|radiographic evaluation
1266731|NCT01730261|Traumatic Brain Injury|traumatic brain injury
1266732|NCT01730261|TBI|tbi
1266733|NCT01730261|Executive Dysfunction|executive dysfunction
1266734|NCT01730261|Emotional Regulation|emotional regulation
1266735|NCT01730261|Problem Solving|problem solving
1266736|NCT01730261|Self-regulation|self-regulation
1266737|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
1266738|NCT01730261|Metacognitive Strategies|metacognitive strategies
1266739|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
1266740|NCT01730261|Online Therapy|online therapy
1266741|NCT01730261|Group therapy|group therapy
1266742|NCT01730261|Group videoconference|group videoconference
1266743|NCT01730261|Telehealth|telehealth
1266744|NCT01730261|Telerehabilitation|telerehabilitation
1266745|NCT01730248|Myelofibrosis,|myelofibrosis,
1266746|NCT01730248|PMF,|pmf,
1266747|NCT01730248|PPV-MF,|ppv-mf,
1266748|NCT01730248|PET-MF,|pet-mf,
1266749|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
1266750|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
1266751|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1266752|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1266753|NCT01730222|stage III disease|stage iii disease
1266754|NCT01730222|stage IV disease|stage iv disease
1266755|NCT01730222|chemotherapy|chemotherapy
1266756|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
1266757|NCT01730209|TSC|tsc
1266758|NCT01730209|Autism|autism
1266759|NCT01730209|Learning problems|learning problems
1266760|NCT01730209|Everolimus|everolimus
1266761|NCT01730209|RAD001|rad001
1266762|NCT01730209|Treatment|treatment
1266763|NCT01730209|Cognition|cognition
1266764|NCT01730209|Intellectual disability|intellectual disability
1266765|NCT01730170|Epilepsy|epilepsy
1266766|NCT01730170|Pregnancy|pregnancy
1266767|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
1266768|NCT01730144|Nasal Cells|nasal cells
1266769|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
1266770|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
1266771|NCT01730131|Multiple Sclerosis|multiple sclerosis
1266772|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
1266773|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
1266774|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
1266775|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
1266776|NCT01730118|Breast Cancer|breast cancer
1266777|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
1266778|NCT01730105|Adipose Tissue|adipose tissue
1266779|NCT01730105|Body Composition|body composition
1266780|NCT01730105|Body Weight Regulation|body weight regulation
1266781|NCT01730105|Brown Adipose Tissue|brown adipose tissue
1266782|NCT01730092|Vascular Inflammation|vascular inflammation
1266783|NCT01730092|Microarray|microarray
1266784|NCT01730092|Right Ventricular Function|right ventricular function
1266785|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
1266786|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
1266787|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1266788|NCT01730079|Autism|autism
1266789|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
1266790|NCT01730079|Brain Activity|brain activity
1266791|NCT01730066|Probiotics|probiotics
1266792|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
1266793|NCT01730066|Oropharyngeal flora|oropharyngeal flora
1266794|NCT01730066|CRP|crp
1266795|NCT01730066|WBC|wbc
1266796|NCT01729949|Nutrition|nutrition
1266797|NCT01729949|Polyphenols|polyphenols
1266798|NCT01729949|Berries|berries
1266799|NCT01729949|Overweight|overweight
1266800|NCT01729949|Lipid Panels|lipid panels
1266801|NCT01729936|Sitting time|sitting time
1266802|NCT01729936|Overweight|overweight
1266803|NCT01729936|Obese|obese
1266804|NCT01729936|Primary Health Care|primary health care
1266805|NCT01729910|overweight|overweight
1266806|NCT01729910|obesity|obesity
1266807|NCT01729910|rural|rural
1266808|NCT01729910|primary care|primary care
1266809|NCT01729897|gastroscopy|gastroscopy
1266810|NCT01729897|sedation|sedation
1266811|NCT01729897|etomidate|etomidate
1266812|NCT01729871|Atrial Fibrillation|atrial fibrillation
1266813|NCT01729871|Irregular heart beat|irregular heart beat
1266814|NCT01729871|Catheter Ablation|catheter ablation
1266815|NCT01729871|Rivaroxaban|rivaroxaban
1266816|NCT01729793|TNFalpha|tnfalpha
1266818|NCT01729793|postprandial|postprandial
1266819|NCT01729793|digestive|digestive
1266820|NCT01729793|inflammation|inflammation
1266821|NCT01729793|IL1beta|il1beta
1266822|NCT01729793|CRP|crp
1266823|NCT01729793|CBC|cbc
1266824|NCT01729793|ESR|esr
1266825|NCT01729780|EEG-NF|eeg-nf
1266826|NCT01729780|Neurofeedback|neurofeedback
1266827|NCT01729780|Prevention|prevention
1266828|NCT01729780|ACS|acs
1266829|NCT01729741|Drain or no drain|drain or no drain
1266830|NCT01729741|Thyroid surgery|thyroid surgery
1266831|NCT01729741|Randomized Trial|randomized trial
1266832|NCT01729728|Tonsillectomy|tonsillectomy
1266833|NCT01729728|Dental surgery|dental surgery
1266834|NCT01729728|Ear surgery|ear surgery
1266835|NCT01729728|Nose surgery|nose surgery
1266836|NCT01729728|Throat surgery|throat surgery
1266837|NCT01729715|Pediatric|pediatric
1266838|NCT01729715|Insomnia|insomnia
1266839|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
1266840|NCT01729702|2- BNP|2- bnp
1266841|NCT01729702|3- NT-proBNP|3- nt-probnp
1266842|NCT01729702|4- Neurohormons|4- neurohormons
1266843|NCT01729663|melanoma|melanoma
1361207|NCT01328652|LPR|lpr
1266844|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
1266845|NCT01729663|therapeutic vaccine|therapeutic vaccine
1266846|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
1266847|NCT01729650|Psychotic Disorders,|psychotic disorders,
1266848|NCT01729650|Heart Diseases|heart diseases
1266849|NCT01729637|Lung Transplantation|lung transplantation
1266850|NCT01729637|Respiratory Mechanics|respiratory mechanics
1266851|NCT01729637|Isolated lung perfusion|isolated lung perfusion
1266852|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
1266853|NCT01729637|Lung mechanics|lung mechanics
1266854|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
1269004|NCT01720147|FA|fa
1266855|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
1266856|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
1266857|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
1266858|NCT01729611|Scleroderma|scleroderma
1266859|NCT01729611|Cirrhosis|cirrhosis
1266860|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
1266861|NCT01729598|safety and tolerability|safety and tolerability
1266862|NCT01729585|cystic fibrosis|cystic fibrosis
1266863|NCT01729585|quality of life|quality of life
1266864|NCT01729572|schizophrenia|schizophrenia
1266865|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
1266866|NCT01729572|disease management|disease management
1266867|NCT01729572|treatment|treatment
1266868|NCT01729572|rehabilitation|rehabilitation
1266869|NCT01729572|pharmacotherapy|pharmacotherapy
1266870|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
1266871|NCT01729559|deep vein thrombosis|deep vein thrombosis
1266872|NCT01729559|pulmonary embolism|pulmonary embolism
1266873|NCT01729559|trauma|trauma
1266874|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
1266875|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
1266876|NCT01729546|POCT|poct
1266877|NCT01729546|System Accuracy|system accuracy
1266878|NCT01729533|ICSI|icsi
1266879|NCT01729533|IMSI|imsi
1266880|NCT01729533|Pregnancy|pregnancy
1266881|NCT01729533|Sperm morphology|sperm morphology
1266882|NCT01729533|Unexplained infertility|unexplained infertility
1266883|NCT01729520|Total knee arthroplasty|total knee arthroplasty
1266884|NCT01729520|Total knee replacement|total knee replacement
1266885|NCT01729520|Strength training|strength training
1266886|NCT01729520|Resistance training|resistance training
1266887|NCT01729520|Physical therapy modalities|physical therapy modalities
1266888|NCT01729520|Fatigue|fatigue
1266889|NCT01729507|Smoking cessation|smoking cessation
1266890|NCT01729507|Add on and smoking cessation|add on and smoking cessation
1266891|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
1266892|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
1266893|NCT01729494|belatacept|belatacept
1266894|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
1266895|NCT01729494|alemtuzumab|alemtuzumab
1266896|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
1266897|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
1266898|NCT01729468|Prevention|prevention
1266899|NCT01729468|Pre-eclampsia|pre-eclampsia
1266900|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
1266901|NCT01729468|Primiparous Women|primiparous women
1266902|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
1266903|NCT01729468|First Quarter|first quarter
1266904|NCT01729455|Belimumab|belimumab
1266905|NCT01729455|Connective Tissue Diseases|connective tissue diseases
1266906|NCT01729455|Lupus|lupus
1266907|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
1266908|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1266909|NCT01729455|Autoimmune Diseases|autoimmune diseases
1266911|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
1266912|NCT01729455|Autoimmune Disease|autoimmune disease
1266913|NCT01729455|Antibodies|antibodies
1266914|NCT01729455|Immune System Diseases|immune system diseases
1266915|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
1266916|NCT01729429|Intervention Studies|intervention studies
1266917|NCT01729429|Health Services Research|health services research
1266918|NCT01729429|Cancer of Cervix|cancer of cervix
1266919|NCT01729416|colon|colon
1266920|NCT01729416|cancer|cancer
1266921|NCT01729416|screening|screening
1266922|NCT01729416|water exchange|water exchange
1266923|NCT01729416|air|air
1266924|NCT01729416|method|method
1266925|NCT01729416|polyp|polyp
1266926|NCT01729416|adenoma|adenoma
1266927|NCT01729416|detection|detection
1266929|NCT01729416|sedation|sedation
1266930|NCT01729416|time|time
1266931|NCT01729416|procedure|procedure
1266932|NCT01729390|Feeding behavior|feeding behavior
1266933|NCT01729364|elective CABG|elective cabg
1266934|NCT01729364|renal impairment|renal impairment
1266935|NCT01729364|GFR|gfr
1266936|NCT01729364|renal blood flow|renal blood flow
1266937|NCT01729364|colloid|colloid
1266938|NCT01729364|crystalloid|crystalloid
1266939|NCT01729364|thermodilution technique|thermodilution technique
1266940|NCT01729364|oxygen supply demand|oxygen supply demand
1266941|NCT01729351|Primary Care|primary care
1266942|NCT01729351|Particle size|particle size
1266943|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
1266944|NCT01729351|Asthma Management|asthma management
1266945|NCT01729351|Maintenance Therapy|maintenance therapy
1266946|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
1266947|NCT01729351|Smoking|smoking
1266948|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1266949|NCT01729325|Aggressive Behavior|aggressive behavior
1266950|NCT01729325|Appetitive Aggression|appetitive aggression
1266951|NCT01729325|Resilience|resilience
1266952|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
1266953|NCT01729299|ghrelin|ghrelin
1266954|NCT01729299|glucose control|glucose control
1266955|NCT01729299|GLP-1|glp-1
1266956|NCT01729299|Exendin (9-39)|exendin (9-39)
1266957|NCT01729299|insulin|insulin
1266958|NCT01729260|Glioblastoma|glioblastoma
1266959|NCT01729260|mebendazole|mebendazole
1266960|NCT01729260|temozolomide|temozolomide
1266961|NCT01729247|Asthma|asthma
1266962|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
1266963|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
1266964|NCT01729221|Hepatitis C virus|hepatitis c virus
1266965|NCT01729208|myopia progression|myopia progression
1266966|NCT01729208|myopia control|myopia control
1266967|NCT01729195|bioabsorbable implant|bioabsorbable implant
1266968|NCT01729195|bone screw|bone screw
1266969|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
1266970|NCT01729195|syndesmosis injury|syndesmosis injury
1266971|NCT01729195|ankle fracture|ankle fracture
1266972|NCT01729195|ciprofloxacin|ciprofloxacin
1266973|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
1266974|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
1266975|NCT01729182|Nexium|nexium
1266976|NCT01729169|Sarcoidosis|sarcoidosis
1266977|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
1266978|NCT01729169|18-FDG PET|18-fdg pet
1266979|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
1266980|NCT01729156|Type 2 diabetes|type 2 diabetes
1266981|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
1266982|NCT01729156|Dyslipidemia|dyslipidemia
1266983|NCT01729156|Metformin|metformin
1266984|NCT01729143|black pepper|black pepper
1266985|NCT01729143|metabolic chamber|metabolic chamber
1266986|NCT01729143|respiratory chamber|respiratory chamber
1266987|NCT01729117|Type 2 diabetes|type 2 diabetes
1266988|NCT01729117|Obesity|obesity
1266989|NCT01729117|Insulin|insulin
1266990|NCT01729117|Hispanic|hispanic
1266991|NCT01729117|Low-income|low-income
1266992|NCT01729117|Meal replacement|meal replacement
1266993|NCT01729104|Lymphoma|lymphoma
1266994|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
1266995|NCT01729104|MCL|mcl
1266996|NCT01729104|Relapsed|relapsed
1266997|NCT01729104|Refractory|refractory
1266998|NCT01729104|Carfilzomib|carfilzomib
1266999|NCT01729104|Rituximab|rituximab
1267000|NCT01729104|Rituxan|rituxan
1267001|NCT01729104|Lenalidomide|lenalidomide
1267002|NCT01729104|CC-5013|cc-5013
1267003|NCT01729104|Revlimid|revlimid
1267004|NCT01729091|Myeloma|myeloma
1267005|NCT01729091|Multiple myeloma|multiple myeloma
1267006|NCT01729091|MM|mm
1267007|NCT01729091|Umbilical cord blood|umbilical cord blood
1267008|NCT01729091|UCB|ucb
1267009|NCT01729091|Natural killer cells|natural killer cells
1267010|NCT01729091|NK|nk
1267011|NCT01729091|Autologous stem cell transplant|autologous stem cell transplant
1267012|NCT01729091|Stem cell infusion|stem cell infusion
1267013|NCT01729091|High dose chemotherapy|high dose chemotherapy
1267014|NCT01729091|Lenalidomide|lenalidomide
1267015|NCT01729091|CC-5013|cc-5013
1267016|NCT01729091|Revlimid|revlimid
1267017|NCT01729091|Melphalan|melphalan
1267018|NCT01729091|Alkeran|alkeran
1267019|NCT01729091|G-CSF|g-csf
1267020|NCT01729091|Filgrastim|filgrastim
1267021|NCT01729091|Neupogen|neupogen
1267022|NCT01729091|Elotuzumab|elotuzumab
1267023|NCT01729091|Dexamethasone|dexamethasone
1267024|NCT01729091|Decadron|decadron
1267025|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
1267026|NCT01729052|Acupuncture|acupuncture
1267027|NCT01729052|Children|children
1267028|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
1267029|NCT01729052|Postoperative pain|postoperative pain
1267030|NCT01729052|Parental attitudes|parental attitudes
1267031|NCT01729052|Parental expectations|parental expectations
1267032|NCT01729039|rehabilitation|rehabilitation
1267033|NCT01729039|aged|aged
1267034|NCT01729039|aged, 80 and over|aged, 80 and over
1267035|NCT01729039|vestibular diseases|vestibular diseases
1267036|NCT01729026|Veterans|veterans
1267037|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
1267038|NCT01729026|dog adoption|dog adoption
1267039|NCT01729026|companion animal|companion animal
1267040|NCT01729013|vitamin D|vitamin d
1267041|NCT01729013|fat|fat
1267042|NCT01729013|biopsy|biopsy
1267043|NCT01729000|prematurity|prematurity
1267044|NCT01729000|infection control|infection control
1267045|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
1267046|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
1267047|NCT01728974|Pathophysiology|pathophysiology
1267048|NCT01728961|HIV 1|hiv 1
1267049|NCT01728961|NVP|nvp
1267050|NCT01728961|malaria|malaria
1267051|NCT01728961|Children|children
1267052|NCT01728961|Youth|youth
1267053|NCT01728961|nevirapine|nevirapine
1267054|NCT01728961|Coartem Dispersible|coartem dispersible
1267055|NCT01728961|Artemether|artemether
1267056|NCT01728961|Lumefantrine|lumefantrine
1267057|NCT01728961|Pharmacokinetics|pharmacokinetics
1267058|NCT01728948|Sorafenib|sorafenib
1267059|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
1267060|NCT01728948|elderly|elderly
1267061|NCT01728948|effectiveness|effectiveness
1267062|NCT01728948|safety|safety
1267063|NCT01728935|HBV|hbv
1267064|NCT01728935|Tenofovir|tenofovir
1267065|NCT01728935|HBV DNA|hbv dna
1267066|NCT01728935|HBsAg|hbsag
1267067|NCT01728935|Resistance|resistance
1267068|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
1267069|NCT01728922|Multiple sclerosis|multiple sclerosis
1267070|NCT01728922|Vitamin D|vitamin d
1267071|NCT01728922|Immune response|immune response
1267072|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
1267073|NCT01728922|Cytokine|cytokine
1267074|NCT01728909|Oxytocin|oxytocin
1267075|NCT01728909|Syntocinon|syntocinon
1267076|NCT01728909|Social Cognition|social cognition
1267077|NCT01728909|Social Approach Behaviors|social approach behaviors
1267078|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
1267079|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
1267080|NCT01728883|Diabetic Macular Edema|diabetic macular edema
1267081|NCT01728883|Macular Edema|macular edema
1267082|NCT01728883|Maculopathy|maculopathy
1267083|NCT01728883|home monitoring|home monitoring
1267084|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
1267085|NCT01728883|Psychophysical Testing|psychophysical testing
1267086|NCT01728870|Pediatric|pediatric
1267087|NCT01728870|Crohn's disease|crohn's disease
1267088|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
1267089|NCT01728870|Diet|diet
1267090|NCT01728870|Enteral Nutrition|enteral nutrition
1267091|NCT01728857|Lipolysis|lipolysis
1267092|NCT01728857|Cryolipolysis|cryolipolysis
1267093|NCT01728857|Fat Reduction|fat reduction
1267094|NCT01728831|Red Cell Transfusion|red cell transfusion
1267095|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
1267096|NCT01728831|Traumatic brain injury|traumatic brain injury
1267097|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
1267098|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
1267099|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
1267100|NCT01728792|Prophylactic vaccination|prophylactic vaccination
1267101|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
1267102|NCT01728766|Bangladeshi infants|bangladeshi infants
1267103|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
1267104|NCT01728766|small-for-gestational-age|small-for-gestational-age
1267105|NCT01728766|plasma zinc|plasma zinc
1267106|NCT01728740|Bioequivalence|bioequivalence
1267107|NCT01728740|Acarbose|acarbose
1267108|NCT01728740|Metformin|metformin
1267110|NCT01728727|liver cirrhosis|liver cirrhosis
1267111|NCT01728727|end stage liver disease|end stage liver disease
1267112|NCT01728727|umbilical cord|umbilical cord
1267113|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
1267114|NCT01728727|HBV|hbv
1267115|NCT01728714|Diabetes; compliance|diabetes; compliance
1267116|NCT01728701|Malaria|malaria
1267117|NCT01728701|Plasmodium falciparum|plasmodium falciparum
1267118|NCT01728701|PfSPZ Challenge|pfspz challenge
1267119|NCT01728701|Chemoprophylaxis|chemoprophylaxis
1267120|NCT01728701|PfSPZ-CVac|pfspz-cvac
1267121|NCT01728688|liver cirrhosis|liver cirrhosis
1267122|NCT01728688|stem cell|stem cell
1267123|NCT01728688|peripheral blood|peripheral blood
1267124|NCT01728688|autologous|autologous
1267125|NCT01728688|HBV|hbv
1267126|NCT01728688|end stage liver disease|end stage liver disease
1267127|NCT01728675|Aging|aging
1267128|NCT01728675|Skeletal muscle|skeletal muscle
1267129|NCT01728675|Biomarkers|biomarkers
1267130|NCT01728675|Adaptation|adaptation
1267131|NCT01728662|emphysema|emphysema
1267132|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
1267133|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
1267134|NCT01728649|Mild Hypothermia|mild hypothermia
1267135|NCT01728649|Stroke|stroke
1267136|NCT01728649|Hypothermia|hypothermia
1267137|NCT01728623|Thyroid cancer|thyroid cancer
1267138|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
1267139|NCT01728610|probiotic|probiotic
1267140|NCT01728610|pain|pain
1267141|NCT01728610|bloating|bloating
1267142|NCT01728610|diarrhoea|diarrhoea
1267143|NCT01728610|constipation|constipation
1333176|NCT01444170|eccentric exercise|eccentric exercise
1267144|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
1267146|NCT01728571|asthma|asthma
1267147|NCT01728571|pulmonary function|pulmonary function
1267148|NCT01728571|pneumonia|pneumonia
1267149|NCT01728558|Sedation|sedation
1267150|NCT01728558|Delirium|delirium
1267151|NCT01728558|Goal Directed|goal directed
1267152|NCT01728558|Dexmedetomidine|dexmedetomidine
1267153|NCT01728558|Mortality|mortality
1267154|NCT01728558|Mechanical ventilation|mechanical ventilation
1267155|NCT01728558|Intensive care|intensive care
1267156|NCT01728558|Critically Ill|critically ill
1267157|NCT01728545|Cord blood registry|cord blood registry
1267158|NCT01728545|Umbilical Cord Blood|umbilical cord blood
1267159|NCT01728545|fetal blood|fetal blood
1267160|NCT01728545|placenta|placenta
1267161|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
1267162|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
1267163|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1267164|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
1267165|NCT01728545|TNC|tnc
1267166|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
1267167|NCT01728545|human leukocyte antigen|human leukocyte antigen
1267168|NCT01728545|HLA|hla
1267169|NCT01728545|allogeneic transplantation|allogeneic transplantation
1267170|NCT01728519|Allergy|allergy
1267171|NCT01728519|Birch Pollen|birch pollen
1267172|NCT01728519|Immunotherapy|immunotherapy
1267173|NCT01728506|breast cancer survivor|breast cancer survivor
1267174|NCT01728506|Weight loss|weight loss
1267175|NCT01728506|Exercise|exercise
1267176|NCT01728493|Prevalence|prevalence
1267177|NCT01728493|Primary aldosteronism|primary aldosteronism
1267178|NCT01728493|Organ damage|organ damage
1267179|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
1267180|NCT01728441|PAD|pad
1267181|NCT01728441|stenting|stenting
1267182|NCT01728441|angioplasty|angioplasty
1267183|NCT01728428|hemifacial spasm|hemifacial spasm
1267184|NCT01728428|observational study|observational study
1267185|NCT01728428|clinical manifestation|clinical manifestation
1267186|NCT01728428|treatment|treatment
1267187|NCT01728428|Chinese|chinese
1267188|NCT01728415|Exercise|exercise
1267189|NCT01728415|Hemodialysis|hemodialysis
1267190|NCT01728415|Physical therapy|physical therapy
1267191|NCT01728415|high-intensity|high-intensity
1267192|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
1267193|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
1267194|NCT01728389|intrabone|intrabone
1267195|NCT01728389|intra-bone|intra-bone
1267196|NCT01728389|leukemia|leukemia
1267197|NCT01728389|lymphoma|lymphoma
1267198|NCT01728363|Staphylococcal|staphylococcal
1267199|NCT01728350|traumatic brain injury|traumatic brain injury
1267200|NCT01728350|volunteering|volunteering
1267201|NCT01728350|well being|well being
1267202|NCT01728350|cortisol|cortisol
1267203|NCT01728337|botulinum toxin,|botulinum toxin,
1267204|NCT01728337|wrinkles|wrinkles
1267205|NCT01728298|House Dust Mite|house dust mite
1267206|NCT01728298|allergy|allergy
1267207|NCT01728298|rhinitis|rhinitis
1267208|NCT01728298|asthma|asthma
1267209|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
1267210|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
1267211|NCT01728285|allergen tablets|allergen tablets
1267212|NCT01728285|compliance|compliance
1267213|NCT01728285|electronic compliance device|electronic compliance device
1267214|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
1267215|NCT01728246|Osteoarthritis|osteoarthritis
1267216|NCT01728246|Celecoxib|celecoxib
1267217|NCT01728246|Tramadol|tramadol
1267218|NCT01728246|Paracetamol|paracetamol
1267219|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
1267220|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
1267221|NCT01728233|Dacomitinib|dacomitinib
1267222|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
1267223|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
1267224|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1267225|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
1267227|NCT01728207|CLL|cll
1267228|NCT01728207|follicular lymphoma|follicular lymphoma
1267229|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
1267230|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
1267231|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1267232|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
1267233|NCT01728194|Depression|depression
1267234|NCT01728194|Depressive Disorder|depressive disorder
1267235|NCT01728194|Behavioral Symptoms|behavioral symptoms
1267236|NCT01728194|Mood Disorders|mood disorders
1267237|NCT01728194|Mental Disorders|mental disorders
1267238|NCT01728194|Escitalopram|escitalopram
1267239|NCT01728194|Central Nervous System Agents|central nervous system agents
1267240|NCT01728194|Therapeutic Uses|therapeutic uses
1267241|NCT01728194|Pharmacologic Actions|pharmacologic actions
1361654|NCT01326871|TCR|tcr
1267242|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
1267243|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
1267244|NCT01728194|Antidepressive Agents|antidepressive agents
1267245|NCT01728194|Psychotropic Drugs|psychotropic drugs
1267246|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1267247|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
1267248|NCT01728194|Serotonin Agents|serotonin agents
1267249|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1267250|NCT01728194|fMRI|fmri
1267251|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
1267252|NCT01728168|lupin|lupin
1267253|NCT01728168|peanut|peanut
1267254|NCT01728168|soy|soy
1267255|NCT01728168|pea|pea
1267256|NCT01728168|legumes|legumes
1267257|NCT01728168|cross-reactivity|cross-reactivity
1267258|NCT01728168|sensitization|sensitization
1267259|NCT01728168|atopy|atopy
1267473|NCT01727167|carbon monoxide|carbon monoxide
1267260|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
1267261|NCT01728142|DANA|dana
1267262|NCT01728142|ANAM|anam
1267263|NCT01728142|Concussion|concussion
1267264|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
1267265|NCT01728129|Concussion|concussion
1267266|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
1267267|NCT01728129|DANA|dana
1267268|NCT01728129|MACE|mace
1267269|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
1267270|NCT01728090|handwashing|handwashing
1267271|NCT01728090|hand sanitizer|hand sanitizer
1267272|NCT01728090|absenteeism|absenteeism
1267273|NCT01728090|school age children|school age children
1267274|NCT01728090|preschool children|preschool children
1267275|NCT01728077|Brivaracetam|brivaracetam
1267276|NCT01728077|Long-term Follow-up|long-term follow-up
1267277|NCT01728077|Epilepsy|epilepsy
1267278|NCT01728077|Partial Onset Seizures|partial onset seizures
1267279|NCT01728077|Adjunctive treatment|adjunctive treatment
1267280|NCT01728064|Friedreich's|friedreich's
1267281|NCT01728064|Ataxia|ataxia
1267282|NCT01728064|FRDA|frda
1267283|NCT01728064|FA|fa
1267284|NCT01728064|EPI-743|epi-743
1267285|NCT01728064|Edison|edison
1267286|NCT01728038|Bronchiolitis|bronchiolitis
1267287|NCT01728038|Cough|cough
1267288|NCT01728038|Ear Infection|ear infection
1267289|NCT01728038|Respiratory Infection|respiratory infection
1267290|NCT01728038|Wheezing|wheezing
1267291|NCT01728025|Long QT syndrome|long qt syndrome
1267292|NCT01728025|Ranolazine|ranolazine
1267293|NCT01728012|Successful transplantation|successful transplantation
1267294|NCT01728012|Long-term observation|long-term observation
1267295|NCT01727999|TPO response|tpo response
1267296|NCT01727999|ITP|itp
1267297|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
1267298|NCT01727973|Graves' orbitopathy|graves' orbitopathy
1267299|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
1267300|NCT01727973|Thyroid eye disease|thyroid eye disease
1267301|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1267302|NCT01727973|Doxycycline|doxycycline
1267303|NCT01727973|EUGOGO|eugogo
1267304|NCT01727973|CAS|cas
1267305|NCT01727960|Education|education
1267306|NCT01727960|Neck pain|neck pain
1267307|NCT01727960|Shoulder pain|shoulder pain
1267308|NCT01727960|Prevalence|prevalence
1267309|NCT01727960|Associated factors|associated factors
1267310|NCT01727960|Students|students
1267311|NCT01727934|Antisense|antisense
1267312|NCT01727934|miR-122 antagonist|mir-122 antagonist
1267313|NCT01727934|host factor|host factor
1267314|NCT01727934|Chronic hepatitis C|chronic hepatitis c
1267315|NCT01727934|Hepatitis C|hepatitis c
1267316|NCT01727921|ProCore FNA biopsy|procore fna biopsy
1267317|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
1267318|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
1267319|NCT01727882|Paroled offenders|paroled offenders
1267320|NCT01727882|Interactive Voice Response|interactive voice response
1267321|NCT01727882|Stress|stress
1267322|NCT01727882|Mental symptoms|mental symptoms
1267323|NCT01727882|Alcohol consumption|alcohol consumption
1267324|NCT01727882|Substance use|substance use
1267325|NCT01727856|rehabilitation|rehabilitation
1267326|NCT01727856|physical therapy|physical therapy
1267327|NCT01727856|telemedicine|telemedicine
1267328|NCT01727843|fracture|fracture
1267329|NCT01727843|hip|hip
1267330|NCT01727843|tranexamic acid|tranexamic acid
1267331|NCT01727843|topical|topical
1267332|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1267333|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
1267334|NCT01727817|Artificial Pancreas|artificial pancreas
1267335|NCT01727817|Insulin Pump|insulin pump
1267336|NCT01727817|Closed Loop|closed loop
1267337|NCT01727817|Open Loop|open loop
1267338|NCT01727817|Diabetes Assistant|diabetes assistant
1267339|NCT01727817|DiAs|dias
1267340|NCT01727817|Cell Phone|cell phone
1267341|NCT01727791|pharmacokinetic|pharmacokinetic
1267342|NCT01727791|pregabalin|pregabalin
1267343|NCT01727791|lactation|lactation
1267344|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
1267345|NCT01727739|Tibial tunnel widening|tibial tunnel widening
1267346|NCT01727739|Interference screws|interference screws
1267347|NCT01727726|OPC-34712|opc-34712
1267348|NCT01727726|brexpiprazole|brexpiprazole
1267349|NCT01727726|Major Depressive Disorder|major depressive disorder
1267350|NCT01727726|Adjunctive Treatment|adjunctive treatment
1267351|NCT01727713|Tourette Syndrome|tourette syndrome
1267352|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
1267353|NCT01727713|Brain Diseases|brain diseases
1267354|NCT01727713|Central Nervous System Diseases|central nervous system diseases
1267355|NCT01727713|Tic Disorders|tic disorders
1267357|NCT01727713|Movement Disorders|movement disorders
1267358|NCT01727713|Mental Disorders|mental disorders
1267359|NCT01727713|Aripiprazole|aripiprazole
1267360|NCT01727700|Tourette Syndrome|tourette syndrome
1267361|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
1267362|NCT01727700|Brain Diseases|brain diseases
1267363|NCT01727700|Central Nervous System Diseases|central nervous system diseases
1267364|NCT01727700|Tic Disorders|tic disorders
1267365|NCT01727700|Tics|tics
1267366|NCT01727700|Movement Disorders|movement disorders
1267367|NCT01727700|Mental Disorders|mental disorders
1267368|NCT01727700|Aripiprazole|aripiprazole
1267369|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
1267370|NCT01727674|Depression|depression
1267371|NCT01727674|experiences of communication|experiences of communication
1267372|NCT01727661|diabetes mellitus|diabetes mellitus
1267373|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
1267374|NCT01727661|lung function|lung function
1267375|NCT01727661|muscular oxygenation|muscular oxygenation
1267376|NCT01727648|Stroke rehabilitation|stroke rehabilitation
1267377|NCT01727648|Comparative efficacy research|comparative efficacy research
1267378|NCT01727648|Combined therapy|combined therapy
1267379|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
1267380|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
1267381|NCT01727648|Kinematic analysis|kinematic analysis
1267382|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
1267383|NCT01727609|Preterm|preterm
1267384|NCT01727609|Very low birth weight|very low birth weight
1267385|NCT01727609|Feeding|feeding
1267386|NCT01727609|Enteral|enteral
1267387|NCT01727609|Milk|milk
1267388|NCT01727609|Sepsis|sepsis
1267389|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
1267390|NCT01727583|Healthy|healthy
1267391|NCT01727570|Cancer|cancer
1267392|NCT01727570|Colon|colon
1267393|NCT01727570|Rectum|rectum
1267394|NCT01727570|Surgery|surgery
1267395|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
1267396|NCT01727544|superior semicircular canal|superior semicircular canal
1267397|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
1267398|NCT01727544|vestibular dizziness|vestibular dizziness
1267399|NCT01727531|chloroquine|chloroquine
1267400|NCT01727531|WBRT|wbrt
1267401|NCT01727531|survival|survival
1267402|NCT01727531|brain metastasis|brain metastasis
1267403|NCT01727531|radiotherapy|radiotherapy
1267404|NCT01727531|SNPs|snps
1267405|NCT01727531|gene coding|gene coding
1267406|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
1267407|NCT01727518|natural history|natural history
1267408|NCT01727518|lung function|lung function
1267409|NCT01727518|general population|general population
1267410|NCT01727518|COPD|copd
1267411|NCT01727505|hypoxemia|hypoxemia
1267412|NCT01727505|desaturation|desaturation
1267413|NCT01727505|mechanical ventilation|mechanical ventilation
1267414|NCT01727505|preterm infants|preterm infants
1267415|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
1267416|NCT01727492|prevention|prevention
1267417|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
1267418|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
1267419|NCT01727492|young population|young population
1267420|NCT01727479|Peak VO2 consumption|peak vo2 consumption
1267421|NCT01727479|3km time trial|3km time trial
1267422|NCT01727479|fatigue perception|fatigue perception
1267423|NCT01727479|lactate|lactate
1267424|NCT01727479|time to complete|time to complete
1267425|NCT01727440|severe acne|severe acne
1267426|NCT01727440|severe acne vulgaris|severe acne vulgaris
1267427|NCT01727440|acne|acne
1267428|NCT01727440|acne vulgaris|acne vulgaris
1267429|NCT01727440|isotretinoin|isotretinoin
1267430|NCT01727440|Accutane|accutane
1267431|NCT01727440|Sortret|sortret
1267432|NCT01727440|Amnesteem|amnesteem
1267433|NCT01727440|Claravis|claravis
1267434|NCT01727440|Clarus|clarus
1267435|NCT01727440|Decutan|decutan
1267436|NCT01727440|Isotane|isotane
1267437|NCT01727440|Izotek|izotek
1267438|NCT01727440|Oratane|oratane
1267439|NCT01727440|Isotret|isotret
1267449|NCT01727401|medical patient|medical patient
1602963|NCT00382954|Elderly|elderly
1267450|NCT01727401|vein thromboembolism|vein thromboembolism
1267451|NCT01727401|prophylaxis|prophylaxis
1267452|NCT01727401|thrombocytopenia|thrombocytopenia
1267453|NCT01727388|rectal examination|rectal examination
1267454|NCT01727388|colorectal cancer|colorectal cancer
1267455|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
1267456|NCT01727362|Breast Cancer|breast cancer
1267457|NCT01727362|Acupuncture|acupuncture
1267458|NCT01727362|Quality of Life|quality of life
1267459|NCT01727258|Tooth Sensitivity|tooth sensitivity
1267460|NCT01727232|ITP|itp
1267461|NCT01727232|Rituximab|rituximab
1267462|NCT01727232|Efficacy|efficacy
1267463|NCT01727232|Anti-CD20|anti-cd20
1267464|NCT01727232|Regimen|regimen
1267465|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
1267466|NCT01727206|Tocilizumab|tocilizumab
1267467|NCT01727206|Treatment|treatment
1267468|NCT01727206|Phase II|phase ii
1267469|NCT01727193|myasthenia gravis|myasthenia gravis
1267470|NCT01727193|leflunomide|leflunomide
1267471|NCT01727167|cardiac disease|cardiac disease
1267472|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
1267879|NCT01725269|AIR001|air001
1267474|NCT01727141|COPD, QVA149|copd, qva149
1267475|NCT01727128|Hepatic impairment|hepatic impairment
1267476|NCT01727128|Clinical pharmacology study|clinical pharmacology study
1267477|NCT01727128|Volunteer study|volunteer study
1267478|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
1267479|NCT01727063|Coronary artery disease|coronary artery disease
1267480|NCT01727063|Angina pectoris|angina pectoris
1267481|NCT01727063|Myocardial ischemia|myocardial ischemia
1267482|NCT01727063|Cardiac surgery|cardiac surgery
1267483|NCT01727037|Emphysema|emphysema
1267484|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1267485|NCT01727037|COPD|copd
1267486|NCT01727037|Bulla|bulla
1267487|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
1267488|NCT01727037|Lung volume reduction|lung volume reduction
1267489|NCT01727024|Breezhaler|breezhaler
1267490|NCT01727024|Respimat|respimat
1267491|NCT01727024|Indacaterol|indacaterol
1267492|NCT01727024|Tiotropium|tiotropium
1267493|NCT01727011|Single fraction|single fraction
1267494|NCT01727011|Elderly|elderly
1267495|NCT01727011|Breast Irradiation|breast irradiation
1267496|NCT01726959|methotrexate|methotrexate
1267497|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
1267498|NCT01726946|HCV|hcv
1267499|NCT01726946|CHC|chc
1267500|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
1267501|NCT01726920|Migraine|migraine
1267502|NCT01726920|Naratriptan|naratriptan
1267503|NCT01726920|Naproxen|naproxen
1267504|NCT01726907|submandibular gland|submandibular gland
1267505|NCT01726907|robotic|robotic
1267506|NCT01726907|endoscopic|endoscopic
1267507|NCT01726907|face lift|face lift
1267508|NCT01726907|hairline|hairline
1267509|NCT01726894|Focal Therapy|focal therapy
1267510|NCT01726881|chronic|chronic
1267511|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
1267512|NCT01726855|tendon repair|tendon repair
1267513|NCT01726829|Type 1 Diabetes|type 1 diabetes
1267514|NCT01726829|Artificial Pancreas|artificial pancreas
1267515|NCT01726829|Closed Loop|closed loop
1267516|NCT01726816|Diabetic nephropathy|diabetic nephropathy
1267517|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
1267518|NCT01726816|Probucol|probucol
1267519|NCT01726803|Low Back Pain|low back pain
1267520|NCT01726803|Primary Care|primary care
1267521|NCT01726803|Physical Therapy|physical therapy
1267522|NCT01726790|corneal endothelium|corneal endothelium
1267523|NCT01726790|Bevacizumab|bevacizumab
1267524|NCT01726790|Intravitreal injection|intravitreal injection
1267525|NCT01726790|Confoscan|confoscan
1267526|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
1267527|NCT01726777|Diabetes|diabetes
1267528|NCT01726777|Vitamin D|vitamin d
1267529|NCT01726777|Oral glucose tolerance|oral glucose tolerance
1267530|NCT01726777|Blood glucose|blood glucose
1267531|NCT01726777|Insulin resistance|insulin resistance
1267532|NCT01726751|Spinal cord stimulation|spinal cord stimulation
1267533|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
1267534|NCT01726751|Abdominal pain|abdominal pain
1267535|NCT01726751|Diarrhea|diarrhea
1267551|NCT01726725|desflurane|desflurane
1267552|NCT01726712|Patient Care Management|patient care management
1267553|NCT01726712|Primary Health Care|primary health care
1267554|NCT01726712|HIV|hiv
1267555|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
1267556|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
1267557|NCT01726673|Stroke|stroke
1267558|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
1267559|NCT01726673|Cerebral Stroke|cerebral stroke
1267560|NCT01726673|CVA|cva
1267561|NCT01726673|Robotic therapy|robotic therapy
1267562|NCT01726673|Upper extremity recovery|upper extremity recovery
1267563|NCT01726673|tDCS|tdcs
1267564|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
1267565|NCT01726660|Stroke|stroke
1267566|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
1602964|NCT00382954|Velcade|velcade
1267567|NCT01726660|Cerebral stroke|cerebral stroke
1267568|NCT01726660|CVA|cva
1267569|NCT01726660|robotic therapy|robotic therapy
1267570|NCT01726660|upper extremity recovery|upper extremity recovery
1267571|NCT01726660|kinematic training|kinematic training
1267572|NCT01726647|obese women|obese women
1267573|NCT01726647|fat mass distribution|fat mass distribution
1267574|NCT01726647|Metabolomic profiles|metabolomic profiles
1267575|NCT01726634|upper limb|upper limb
1267576|NCT01726634|functional test|functional test
1267577|NCT01726634|elastic tape|elastic tape
1267578|NCT01726595|critical care|critical care
1267579|NCT01726595|severe sepsis|severe sepsis
1267580|NCT01726595|microvascular function|microvascular function
1267581|NCT01726595|ultrasound|ultrasound
1267582|NCT01726582|pancreas|pancreas
1267583|NCT01726582|adenocarcinoma|adenocarcinoma
1267584|NCT01726582|molecular profile|molecular profile
1267585|NCT01726582|molecular profiling|molecular profiling
1267586|NCT01726582|pancreatic cancer|pancreatic cancer
1267587|NCT01726582|pancreas cancer|pancreas cancer
1267588|NCT01726582|cancer|cancer
1267589|NCT01726582|molecular target|molecular target
1267590|NCT01726582|pancreas head|pancreas head
1267591|NCT01726582|pancreas neck|pancreas neck
1267592|NCT01726582|pancreas uncinate|pancreas uncinate
1267593|NCT01726582|pancreas body|pancreas body
1267594|NCT01726582|pancreas tail|pancreas tail
1267595|NCT01726569|glaucoma|glaucoma
1267596|NCT01726569|educational intervention|educational intervention
1267597|NCT01726569|post-operative satisfaction|post-operative satisfaction
1267598|NCT01726569|knowledges|knowledges
1267599|NCT01726556|Pleural effusion|pleural effusion
1267600|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
1267601|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
1267602|NCT01726543|canaloplasty|canaloplasty
1267603|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
1267604|NCT01726543|glaucoma|glaucoma
1267605|NCT01726543|cataract|cataract
1267606|NCT01726543|ophthalmology|ophthalmology
1267607|NCT01726543|glaucoma surgery|glaucoma surgery
1267608|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
1267609|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1267610|NCT01726517|HCV|hcv
1267611|NCT01726517|Sustained Virologic Response|sustained virologic response
1267612|NCT01726517|Direct Acting Antiviral|direct acting antiviral
1267613|NCT01726517|Combination Therapy|combination therapy
1267614|NCT01726517|GS-7977|gs-7977
1267615|NCT01726517|GS-5885|gs-5885
1267616|NCT01726517|Ribavirin|ribavirin
1267617|NCT01726517|Open Label|open label
1267618|NCT01726517|Sofosbuvir|sofosbuvir
1267619|NCT01726517|Treatment-Naïve|treatment-naïve
1267620|NCT01726517|Protease Inhibitors|protease inhibitors
1267621|NCT01726517|PI|pi
1267622|NCT01726504|chronic functional constipation|chronic functional constipation
1267623|NCT01726504|electro-acupuncture|electro-acupuncture
1267624|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
1267625|NCT01726504|efficacy|efficacy
1267626|NCT01726504|safety|safety
1267627|NCT01726491|Insulin resistance|insulin resistance
1267628|NCT01726491|Exercise|exercise
1267629|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
1267630|NCT01726491|Obesity|obesity
1267631|NCT01726491|Epigenetic studies|epigenetic studies
1267632|NCT01726478|Oxytocin|oxytocin
1267633|NCT01726478|Uterine tone|uterine tone
1267634|NCT01726478|Mulago Hospital|mulago hospital
1267635|NCT01726478|Dose|dose
1267636|NCT01726478|Side effects|side effects
1267637|NCT01726465|N-Acetylcysteine|n-acetylcysteine
1267638|NCT01726465|Methylprednisolone|methylprednisolone
1267639|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
1267640|NCT01726465|Pringle manoeuvre|pringle manoeuvre
1267641|NCT01726465|Hepatic resection|hepatic resection
1267642|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
1267643|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
1267644|NCT01726413|Diabetic neuropathy|diabetic neuropathy
1267645|NCT01726400|Hepatitis C|hepatitis c
1267646|NCT01726400|Interferon|interferon
1267647|NCT01726400|Ribavirin|ribavirin
1267648|NCT01726400|Hepcidin|hepcidin
1267649|NCT01726400|Iron metabolism|iron metabolism
1267650|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
1267651|NCT01726361|Adolescents|adolescents
1267652|NCT01726361|Disadvantaged families|disadvantaged families
1267653|NCT01726361|Out-of-home placement|out-of-home placement
1267654|NCT01726361|Conduct Disorder|conduct disorder
1267655|NCT01726361|Family program|family program
1267656|NCT01726361|Denmark|denmark
1267657|NCT01726361|Youth|youth
1267658|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
1267659|NCT01726348|HIV-1|hiv-1
1267660|NCT01726348|TMC114|tmc114
1267661|NCT01726348|Darunavir|darunavir
1267662|NCT01726348|Ritonavir|ritonavir
1267663|NCT01726348|Filipino|filipino
1267664|NCT01726335|Schizophrenia|schizophrenia
1267665|NCT01726335|Risperidone|risperidone
1267666|NCT01726335|Risperdal consta|risperdal consta
1267667|NCT01726283|fruste keratoconus|fruste keratoconus
1267668|NCT01726283|ectasia|ectasia
1267669|NCT01726257|Infrarenal|infrarenal
1267670|NCT01726257|Abdominal|abdominal
1267671|NCT01726257|Aortic|aortic
1267672|NCT01726257|Aneurysm|aneurysm
1267673|NCT01726257|AAA|aaa
1267674|NCT01726257|Endologix|endologix
1267675|NCT01726257|EVAS|evas
1267676|NCT01726257|EndoVascular|endovascular
1267677|NCT01726257|Sealing|sealing
1267678|NCT01726257|System|system
1267679|NCT01726231|Laparoscopic access|laparoscopic access
1267680|NCT01726231|Abdominal wall lifting|abdominal wall lifting
1267681|NCT01726231|Direct trocar insertion|direct trocar insertion
1267682|NCT01726231|Safety endoscopy|safety endoscopy
1267683|NCT01726218|Stroke|stroke
1267684|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
1267685|NCT01726218|Neurology|neurology
1267686|NCT01726218|Neurophysiology|neurophysiology
1267687|NCT01726218|Neuroscience|neuroscience
1267688|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1267689|NCT01726179|caries infiltration|caries infiltration
1267690|NCT01726179|caries arrest|caries arrest
1267691|NCT01726179|dental anxiety|dental anxiety
1267692|NCT01726179|dental stress|dental stress
1267693|NCT01726166|Infant|infant
1267694|NCT01726166|contamination rates|contamination rates
1267695|NCT01726166|urinary catheterization|urinary catheterization
1267696|NCT01726166|suprapubic aspiration|suprapubic aspiration
1267697|NCT01726153|Condom Use|condom use
1267698|NCT01726153|HIV+ gay males|hiv+ gay males
1267699|NCT01726153|Intervention|intervention
1267700|NCT01726153|Tailored|tailored
1267701|NCT01726153|On-line|on-line
1267702|NCT01726153|Internet|internet
1267703|NCT01726153|Web-based|web-based
1267704|NCT01726140|intubation|intubation
1267705|NCT01726140|respiratory failure|respiratory failure
1267706|NCT01726140|cardiac surgery|cardiac surgery
1267707|NCT01726114|Diabetes|diabetes
1267708|NCT01726114|Diabetes Mellitus|diabetes mellitus
1267709|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
1267710|NCT01726088|Modafinil|modafinil
1267711|NCT01726088|p50|p50
1267712|NCT01726088|Attentional Bias|attentional bias
1267713|NCT01726075|diabetic retinopathy|diabetic retinopathy
1267714|NCT01726062|Motivational Incentives|motivational incentives
1267715|NCT01726062|Motivational Interviewing|motivational interviewing
1267716|NCT01726062|Secondhand Smoke|secondhand smoke
1267717|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
1267718|NCT01726062|NICU|nicu
1267719|NCT01726062|High respiratory risk infants|high respiratory risk infants
1267720|NCT01726062|Low birth weight infants|low birth weight infants
1267721|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
1267722|NCT01726062|Smoking|smoking
1267723|NCT01726062|Contingency management|contingency management
1267724|NCT01726062|Infants|infants
1267725|NCT01726062|Children|children
1267726|NCT01726049|HFpEF|hfpef
1267727|NCT01726049|PH|ph
1267728|NCT01726036|neonatal circumcision|neonatal circumcision
1267729|NCT01726036|neonatal surgical pain|neonatal surgical pain
1267730|NCT01726036|Mogen|mogen
1267731|NCT01726036|Gomco|gomco
1267732|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
1267733|NCT01726023|Metronidazole,|metronidazole,
1267734|NCT01726023|Meropenem,|meropenem,
1267735|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
1267736|NCT01726023|Anti-Infective Agents,|anti-infective agents,
1267737|NCT01726023|Therapeutic Uses,|therapeutic uses,
1267738|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
1267739|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
1267740|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
1267741|NCT01725997|ac joint dislocation|ac joint dislocation
1267742|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
1267743|NCT01725997|hook plate|hook plate
1267744|NCT01725997|Rockwood|rockwood
1267745|NCT01725984|Male Incontinence|male incontinence
1267746|NCT01725984|AdVance Male Sling|advance male sling
1267747|NCT01725984|AdVance XP Male Sling|advance xp male sling
1267748|NCT01725984|Male Sling|male sling
1267749|NCT01725971|Silicosis|silicosis
1267838|NCT01725464|thoracotomy|thoracotomy
1267750|NCT01725971|forced oscillations|forced oscillations
1267751|NCT01725971|respiratory mechanics|respiratory mechanics
1267752|NCT01725945|DASH|dash
1267753|NCT01725945|diet|diet
1267754|NCT01725945|asthma|asthma
1267755|NCT01725945|adults|adults
1267756|NCT01725945|asthma control|asthma control
1267757|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
1267758|NCT01725919|motor|motor
1267759|NCT01725919|stroke|stroke
1267760|NCT01725919|hemiparesis|hemiparesis
1267761|NCT01725919|rehabilitation|rehabilitation
1267762|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
1267763|NCT01725919|CI therapy|ci therapy
1267764|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
1267765|NCT01725893|Claw Toe|claw toe
1267766|NCT01725880|Spinal Cord Injury|spinal cord injury
1267767|NCT01725880|HuCNS-SC cells|hucns-sc cells
1602965|NCT00382954|Idarubicin|idarubicin
1267768|NCT01725880|Human Neural Stem Cells|human neural stem cells
1267769|NCT01725880|Neural Stem Cells|neural stem cells
1267770|NCT01725880|Stem Cells|stem cells
1267771|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
1267772|NCT01725867|myofascial pain|myofascial pain
1267773|NCT01725867|manual myofascial release|manual myofascial release
1267774|NCT01725867|physical therapy|physical therapy
1267775|NCT01725867|oral appliance|oral appliance
1267776|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
1267777|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
1267778|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
1267779|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
1267780|NCT01725828|Cricothyroid membrane|cricothyroid membrane
1267781|NCT01725828|Ultrasound|ultrasound
1267782|NCT01725828|Neck landmarks|neck landmarks
1267783|NCT01725828|External palpation|external palpation
1267784|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
1267785|NCT01725776|Pulmonary hypertension|pulmonary hypertension
1267786|NCT01725776|Cardiac surgery|cardiac surgery
1267787|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1267788|NCT01725750|Traumatic Brain Injury|traumatic brain injury
1267789|NCT01725750|TBI|tbi
1267790|NCT01725750|Fatigue|fatigue
1267791|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
1267792|NCT01725750|PTBIF|ptbif
1267793|NCT01725750|Depressed Mood|depressed mood
1267794|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
1267795|NCT01725750|Circadian Rhythm|circadian rhythm
1267796|NCT01725750|Anxiety|anxiety
1267797|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
1267798|NCT01725750|Intervention|intervention
1267799|NCT01725750|Treatment|treatment
1267800|NCT01725737|ADHD|adhd
1267801|NCT01725737|GlyTI-M|glyti-m
1267802|NCT01725724|Autologous blood transfusion|autologous blood transfusion
1267803|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
1267804|NCT01725724|Infection rate|infection rate
1267805|NCT01725685|healthy volunteers|healthy volunteers
1267806|NCT01725685|Umeclidinium|umeclidinium
1267807|NCT01725685|tolerability|tolerability
1267808|NCT01725685|Safety|safety
1267809|NCT01725685|Fluticasone Furoate|fluticasone furoate
1267810|NCT01725685|Pharmacokinetics|pharmacokinetics
1267811|NCT01725672|healthy volunteers|healthy volunteers
1267812|NCT01725672|Diabetes mellitus|diabetes mellitus
1267813|NCT01725672|glimepiride|glimepiride
1267814|NCT01725672|pharmacokinetics|pharmacokinetics
1267815|NCT01725672|metformin|metformin
1267816|NCT01725659|Stroke|stroke
1267817|NCT01725659|electric stimulation|electric stimulation
1267818|NCT01725659|robotics|robotics
1267819|NCT01725659|motor learning|motor learning
1267820|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
1267821|NCT01725633|Stretching|stretching
1267822|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
1267823|NCT01725633|14-170|14-170
1267824|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
1267825|NCT01725581|OSAT|osat
1267826|NCT01725581|Pelvic Examination|pelvic examination
1267827|NCT01725581|Validation|validation
1267828|NCT01725581|Reliability|reliability
1267829|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
1267830|NCT01725542|Quadruple therapy|quadruple therapy
1267831|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
1267832|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
1267834|NCT01725529|Ribavirin|ribavirin
1267835|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
1267836|NCT01725503|creatine synthesis|creatine synthesis
1267837|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
1267839|NCT01725464|oxygen saturation|oxygen saturation
1267840|NCT01725464|postoperative|postoperative
1267841|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
1267842|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
1267843|NCT01725438|Genetic analysis|genetic analysis
1267844|NCT01725438|Trisomy 21|trisomy 21
1267845|NCT01725438|Down's Syndrome|down's syndrome
1267846|NCT01725425|snack food (chips)|snack food (chips)
1267847|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
1267848|NCT01725425|mood|mood
1267849|NCT01725399|post-operative vomiting|post-operative vomiting
1267850|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
1267851|NCT01725360|asthma|asthma
1267852|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
1602966|NCT00382954|Bortezomib|bortezomib
1362377|NCT01323699|Anxiety|anxiety
1267853|NCT01725347|nutrition assessment|nutrition assessment
1267854|NCT01725347|children|children
1267855|NCT01725347|preschool|preschool
1267856|NCT01725347|eating behavior|eating behavior
1267857|NCT01725347|Head Start|head start
1267858|NCT01725347|digital technology|digital technology
1267859|NCT01725334|Schizophrenia|schizophrenia
1267860|NCT01725334|Negative Symptoms|negative symptoms
1267861|NCT01725334|Treatment Resistance|treatment resistance
1267862|NCT01725334|Deep Brain Stimulation|deep brain stimulation
1267863|NCT01725334|Electrical Stimulation|electrical stimulation
1267864|NCT01725334|Mental Disorders|mental disorders
1267865|NCT01725334|Brain Diseases|brain diseases
1267866|NCT01725334|Neurologic Manifestations|neurologic manifestations
1267867|NCT01725334|Signs and Symptoms|signs and symptoms
1267868|NCT01725321|Colonoscopy|colonoscopy
1267869|NCT01725321|colonic adenoma|colonic adenoma
1267870|NCT01725321|serrated polyps|serrated polyps
1267871|NCT01725308|FK949E|fk949e
1267872|NCT01725308|Major depressive episode|major depressive episode
1267873|NCT01725308|patients|patients
1267874|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
1267875|NCT01725295|physical therapy|physical therapy
1267876|NCT01725295|hydrotherapy|hydrotherapy
1267877|NCT01725282|patients|patients
1267878|NCT01725282|FK949E|fk949e
1267880|NCT01725269|sodium nitrite|sodium nitrite
1267881|NCT01725269|PAH|pah
1267882|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1267883|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
1267884|NCT01725256|AIR001|air001
1267885|NCT01725256|sodium nitrite|sodium nitrite
1267886|NCT01725256|PAH|pah
1267887|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1267888|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
1267889|NCT01725243|pregnancy|pregnancy
1267890|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
1267891|NCT01725243|Cesarean delivery|cesarean delivery
1267892|NCT01725243|carbetocin|carbetocin
1267893|NCT01725243|failure to progress in labor|failure to progress in labor
1267894|NCT01725230|Fostamatinib,|fostamatinib,
1267895|NCT01725230|simvastatin,|simvastatin,
1267896|NCT01725230|rosuvastatin,|rosuvastatin,
1267897|NCT01725230|Phase I,|phase i,
1267898|NCT01725230|Healthy Subjects,|healthy subjects,
1267899|NCT01725230|Pharmacokinetics|pharmacokinetics
1267900|NCT01725217|Meningitis|meningitis
1267901|NCT01725217|children|children
1267902|NCT01725217|adolescents|adolescents
1267903|NCT01725217|adults|adults
1267904|NCT01725217|MenACWY|menacwy
1267905|NCT01725204|dasatinib|dasatinib
1267906|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
1267907|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
1267908|NCT01725204|Interferon-alpha|interferon-alpha
1267909|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
1267910|NCT01725178|Dementia|dementia
1267911|NCT01725178|Memory disorders|memory disorders
1267912|NCT01725178|Physical fitness|physical fitness
1267913|NCT01725165|Lung cancer|lung cancer
1267914|NCT01725165|Non-Small Cell Lung Cancer|non-small cell lung cancer
1267915|NCT01725165|NSCLC|nsclc
1267916|NCT01725165|Oligometastatic Disease|oligometastatic disease
1267917|NCT01725165|Chemotherapy|chemotherapy
1267918|NCT01725165|Surgical control|surgical control
1267919|NCT01725165|primary and metastatic sites of disease|primary and metastatic sites of disease
1267920|NCT01725165|Radiation therapy|radiation therapy
1267921|NCT01725165|external beam radiation|external beam radiation
1267922|NCT01725165|2D/conventional techniques|2d/conventional techniques
1267923|NCT01725165|three-dimensional conformal therapy|three-dimensional conformal therapy
1267924|NCT01725165|intensity modulated radiation therapy|intensity modulated radiation therapy
1267925|NCT01725165|IMRT|imrt
1267926|NCT01725165|stereotactic radiosurgery|stereotactic radiosurgery
1267927|NCT01725165|SRS|srs
1267928|NCT01725165|proton beam therapy|proton beam therapy
1267929|NCT01725165|PBT|pbt
1267930|NCT01725152|fragile x syndrome|fragile x syndrome
1267931|NCT01725152|ganaxolone|ganaxolone
1267932|NCT01725152|anxiety|anxiety
1267933|NCT01725152|attention|attention
1267934|NCT01725152|pediatric|pediatric
1267935|NCT01725126|metformin|metformin
1267936|NCT01725126|diabetes|diabetes
1267937|NCT01725126|obesity|obesity
1267938|NCT01725126|liraglutide|liraglutide
1267939|NCT01725100|GSK1120212|gsk1120212
1267940|NCT01725100|DMSO content|dmso content
1267941|NCT01725100|pharmacokinetics|pharmacokinetics
1267942|NCT01725100|solid tumors|solid tumors
1267943|NCT01725100|MEK inhibitor|mek inhibitor
1267944|NCT01725100|dissolution|dissolution
1267945|NCT01725100|trametinib|trametinib
1267946|NCT01725100|relative bioavailability|relative bioavailability
1267947|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
1267948|NCT01725048|Major depressive disorder|major depressive disorder
1267949|NCT01725048|Neoplasms|neoplasms
1603475|NCT00381173|plasmid DNA|plasmid dna
1267950|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
1267951|NCT01725035|Fatty Liver|fatty liver
1267952|NCT01725035|Hepatic Steatosis|hepatic steatosis
1267953|NCT01725035|Gene variants|gene variants
1267954|NCT01725022|stem cell transplant|stem cell transplant
1267955|NCT01725022|bowel microbiota|bowel microbiota
1267956|NCT01725022|home care|home care
1267957|NCT01725009|Healthy volunteers|healthy volunteers
1267958|NCT01725009|Japanese|japanese
1267959|NCT01725009|Caucasian|caucasian
1267960|NCT01724983|pain|pain
1267961|NCT01724983|mood|mood
1267962|NCT01724983|depression|depression
1267963|NCT01724983|respiration|respiration
1267964|NCT01724970|anesthesia|anesthesia
1267965|NCT01724970|postanesthetic recovery|postanesthetic recovery
1267966|NCT01724970|ventilation|ventilation
1267967|NCT01724970|bariatric surgery|bariatric surgery
1267968|NCT01724957|Fractional flow reserve,|fractional flow reserve,
1267969|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
1267970|NCT01724957|intracoronary ECG,|intracoronary ecg,
1267971|NCT01724957|coronary stent|coronary stent
1267972|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
1267973|NCT01724957|icECG|icecg
1267974|NCT01724944|Interval debulking surgery|interval debulking surgery
1267976|NCT01724944|NACT|nact
1267977|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1267978|NCT01724944|Lymphadenectomy|lymphadenectomy
1267979|NCT01724944|Ovarian cancer|ovarian cancer
1267980|NCT01724931|antifolate|antifolate
1267981|NCT01724931|antiinflammatory|antiinflammatory
1267982|NCT01724931|autoimmune disease|autoimmune disease
1267983|NCT01724931|hematological treatment|hematological treatment
1267984|NCT01724931|rheumatic disease|rheumatic disease
1267985|NCT01724931|folic acid antagonist|folic acid antagonist
1267986|NCT01724931|enzyme inhibitor|enzyme inhibitor
1267987|NCT01724918|IV lacosamide|iv lacosamide
1267988|NCT01724918|focal epilepsy|focal epilepsy
1267989|NCT01724918|EEG|eeg
1267990|NCT01724918|EKG|ekg
1267991|NCT01724905|Diet|diet
1267992|NCT01724905|Obesity|obesity
1267993|NCT01724905|Chronic disease|chronic disease
1267994|NCT01724879|philadelphia chromosome|philadelphia chromosome
1267995|NCT01724879|BCR-ABL|bcr-abl
1267996|NCT01724879|ALL|all
1267997|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1267998|NCT01724879|dasatinib|dasatinib
1267999|NCT01724879|Sprycel|sprycel
1268000|NCT01724853|Carpometacarpal|carpometacarpal
1268001|NCT01724853|osteoarthritis|osteoarthritis
1268002|NCT01724853|outcome measures|outcome measures
1268003|NCT01724827|Dental caries|dental caries
1268004|NCT01724827|inlays|inlays
1268005|NCT01724827|composite resins|composite resins
1268006|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
1268007|NCT01724827|bicuspid|bicuspid
1268008|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
1268009|NCT01724801|EGFR mutant|egfr mutant
1268010|NCT01724775|complete mesocolic excision|complete mesocolic excision
1268011|NCT01724775|colon cancer|colon cancer
1268012|NCT01724775|efficacy|efficacy
1268013|NCT01724775|safety|safety
1268014|NCT01724762|Baths|baths
1268015|NCT01724762|Anxiety|anxiety
1268016|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
1268017|NCT01724762|Education, Nursing|education, nursing
1268018|NCT01724749|Atherosclerosis|atherosclerosis
1268019|NCT01724749|Sodium-Fluoride|sodium-fluoride
1268020|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
1268021|NCT01724749|18F-NaF|18f-naf
1268022|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
1268023|NCT01724749|18F-FDG|18f-fdg
1268024|NCT01724749|FDG|fdg
1268025|NCT01724749|Positron emission tomography|positron emission tomography
1268026|NCT01724749|PET|pet
1268027|NCT01724736|microbiome|microbiome
1268028|NCT01724736|prebiotic|prebiotic
1268029|NCT01724736|cobiotic|cobiotic
1268030|NCT01724736|NM504|nm504
1268031|NCT01724736|GI microbiome|gi microbiome
1268032|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
1268033|NCT01724723|tuberculosis|tuberculosis
1268034|NCT01724723|hepatitis B virus|hepatitis b virus
1268035|NCT01724723|viral load|viral load
1268036|NCT01724723|entecavir|entecavir
1268037|NCT01724697|liver cirrhosis|liver cirrhosis
1268038|NCT01724697|end stage liver disease|end stage liver disease
1268039|NCT01724697|HBV|hbv
1268040|NCT01724697|autologous|autologous
1268041|NCT01724697|stem cell|stem cell
1268042|NCT01724697|bone morrow|bone morrow
1268043|NCT01724671|MRSA|mrsa
1268044|NCT01724671|Bacteremia|bacteremia
1268045|NCT01724671|ABSSSI|absssi
1268046|NCT01724671|Pneumonia|pneumonia
1268047|NCT01724671|Vancomycin|vancomycin
1268048|NCT01724671|Ceftaroline|ceftaroline
1268049|NCT01724658|female sexual function|female sexual function
1268050|NCT01724658|postmenopause|postmenopause
1268051|NCT01724658|testosterone|testosterone
1268052|NCT01724645|Korean Traditional diets|korean traditional diets
1268053|NCT01724645|hypertension|hypertension
1268054|NCT01724645|diabetes|diabetes
1268055|NCT01724632|Overweight|overweight
1268056|NCT01724632|Obesity|obesity
1268057|NCT01724632|Weight Loss|weight loss
1268058|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
1268059|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
1268060|NCT01724606|12-046|12-046
1268061|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
1268062|NCT01724567|Interval Training|interval training
1268063|NCT01724567|Weight Loss|weight loss
1268064|NCT01724567|Secondary Prevention|secondary prevention
1268065|NCT01724567|Rehabilitation|rehabilitation
1268066|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
1268067|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
1268068|NCT01724515|insulin resistance|insulin resistance
1268069|NCT01724502|insulin resistance|insulin resistance
1268070|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
1268071|NCT01724463|Sepsis|sepsis
1268072|NCT01724463|Severe Sepsis|severe sepsis
1268073|NCT01724463|Septic Shock|septic shock
1268074|NCT01724463|Electronic Health Record|electronic health record
1268075|NCT01724463|Health Screening|health screening
1268076|NCT01724463|Goal Directed Therapy|goal directed therapy
1268077|NCT01724463|Infant|infant
1268078|NCT01724463|Child|child
1268079|NCT01724463|Pediatric|pediatric
1268080|NCT01724463|Adolescent|adolescent
1268081|NCT01724463|Critical Illness|critical illness
1268082|NCT01724463|Outcomes Research|outcomes research
1268083|NCT01724463|Resource Utilization|resource utilization
1268084|NCT01724450|Breast Cancer|breast cancer
1268085|NCT01724450|Heart Failure|heart failure
1268086|NCT01724450|Cardiotoxicity|cardiotoxicity
1268087|NCT01724450|Biomarkers|biomarkers
1268088|NCT01724411|Overweight and Obesity|overweight and obesity
1268089|NCT01724411|Appetite|appetite
1268090|NCT01724411|Gut hormones and obesity|gut hormones and obesity
1268091|NCT01724411|Resistant Starch|resistant starch
1268092|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
1268093|NCT01724411|SmartPill|smartpill
1268094|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
1268095|NCT01724398|plasma exchange|plasma exchange
1268096|NCT01724398|liver failure|liver failure
1268097|NCT01724398|hepatitis B virus|hepatitis b virus
1268098|NCT01724385|bevacizumab,|bevacizumab,
1268099|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
1268100|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
1268101|NCT01724359|Schizophrenia|schizophrenia
1268102|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
1268103|NCT01724359|Antipsychotic agents|antipsychotic agents
1268104|NCT01724346|CLL, SLL|cll, sll
1268105|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
1268106|NCT01724333|Oral health|oral health
1268107|NCT01724333|Quality of life|quality of life
1268108|NCT01724333|Questionnaires|questionnaires
1268109|NCT01724333|Patient reported|patient reported
1268110|NCT01724333|outcomes|outcomes
1268111|NCT01724320|solid tumors|solid tumors
1268112|NCT01724320|first-in-man|first-in-man
1268113|NCT01724320|phase I|phase i
1268114|NCT01724320|cancer|cancer
1268115|NCT01724320|galectin|galectin
1268116|NCT01724281|lateral ventricles|lateral ventricles
1268117|NCT01724281|Asymetry|asymetry
1268118|NCT01724255|Caesarian section|caesarian section
1268119|NCT01724255|Surgical Wound|surgical wound
1268120|NCT01724242|Vaginal dryness|vaginal dryness
1268121|NCT01724242|Breast Cancer|breast cancer
1268122|NCT01724242|Urinary Incontinence|urinary incontinence
1268123|NCT01724242|Quality of Life|quality of life
1268124|NCT01724242|Sexual Satisfaction|sexual satisfaction
1268125|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
1268126|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
1268127|NCT01724229|Perineal skin care|perineal skin care
1268128|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
1268129|NCT01724203|Probiotics for infants|probiotics for infants
1268130|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
1268131|NCT01724190|Type 1 Diabetes|type 1 diabetes
1268132|NCT01724190|Vitamin D|vitamin d
1268133|NCT01724190|Clinical Remission|clinical remission
1268134|NCT01724177|Lenalidomide|lenalidomide
1268135|NCT01724177|ATL|atl
1268136|NCT01724177|ATLL|atll
1268137|NCT01724138|deferasirox|deferasirox
1268138|NCT01724125|serious mental illness|serious mental illness
1268139|NCT01724099|Obesity|obesity
1268140|NCT01724099|Herbal product|herbal product
1268141|NCT01724099|Korean Medicine|korean medicine
1268142|NCT01724086|Chronic hepatitis C|chronic hepatitis c
1268143|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
1268144|NCT01724086|TMC647055|tmc647055
1268146|NCT01724086|Ritonavir|ritonavir
1268147|NCT01724086|Ribavirin|ribavirin
1268148|NCT01724086|Genotype 1a|genotype 1a
1268149|NCT01724086|Genotype 1b|genotype 1b
1268150|NCT01724086|GSK2336805|gsk2336805
1268151|NCT01724073|food to food fortification strategy|food to food fortification strategy
1268152|NCT01724073|leafy vegetable|leafy vegetable
1268153|NCT01724073|iron|iron
1268154|NCT01724073|zinc|zinc
1268155|NCT01724073|vitamin A|vitamin a
1268156|NCT01724073|growth|growth
1268157|NCT01724047|Autism|autism
1268158|NCT01724047|School Based Intervention|school based intervention
1268159|NCT01724034|Weaning|weaning
1268160|NCT01724034|Mechanical Ventilation|mechanical ventilation
1268161|NCT01724034|Lung Ultrasound|lung ultrasound
1268162|NCT01723995|nipple/injure|nipple/injure
1268163|NCT01723995|breastfeeding|breastfeeding
1268164|NCT01723995|pain|pain
1268165|NCT01723995|laser|laser
1268166|NCT01723956|Cervical Dysplasia|cervical dysplasia
1268167|NCT01723956|Cin 2|cin 2
1268168|NCT01723956|Cin 3|cin 3
1268169|NCT01723956|HIV positive women|hiv positive women
1268170|NCT01723956|South Africa|south africa
1268171|NCT01723904|Rotigotine|rotigotine
1268172|NCT01723904|Neupro|neupro
1268173|NCT01723865|Heart failure|heart failure
1268174|NCT01723865|Remote Monitoring|remote monitoring
1268175|NCT01723865|ICD|icd
1268176|NCT01723865|Follow-up|follow-up
1268177|NCT01723852|Vitamin D|vitamin d
1268178|NCT01723852|Infectious diseases|infectious diseases
1268179|NCT01723852|cognitive development|cognitive development
1268180|NCT01723852|Bone mineral density|bone mineral density
1268181|NCT01723852|Immunoregulation|immunoregulation
1268182|NCT01723852|Allergy|allergy
1268183|NCT01723852|Growth|growth
1268184|NCT01723839|CLL|cll
1268185|NCT01723839|FCR|fcr
1268186|NCT01723839|Rituximab|rituximab
1268187|NCT01723839|Lenalidomide|lenalidomide
1268188|NCT01723839|Cyclophosphamide|cyclophosphamide
1268189|NCT01723813|Immunotherapy|immunotherapy
1268190|NCT01723813|Tumor-specific peptides|tumor-specific peptides
1268191|NCT01723813|GM-CT-01|gm-ct-01
1268192|NCT01723761|air pollution|air pollution
1268193|NCT01723761|pacemaker|pacemaker
1268194|NCT01723761|ICD|icd
1268195|NCT01723761|remote monitoring|remote monitoring
1268196|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
1268197|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
1268198|NCT01723748|Acromegaly|acromegaly
1268199|NCT01723748|Somatostatin treatment|somatostatin treatment
1268200|NCT01723748|metabolic effect|metabolic effect
1268201|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1268202|NCT01723722|Methadone|methadone
1268203|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
1268204|NCT01723722|dDTO|ddto
1268205|NCT01723722|Phenobarbital|phenobarbital
1268206|NCT01723709|multiple sclerosis|multiple sclerosis
1268207|NCT01723709|immune response|immune response
1268208|NCT01723709|genetic|genetic
1268209|NCT01723709|progression|progression
1268210|NCT01723709|relapse|relapse
1268211|NCT01723709|biomarkers|biomarkers
1268212|NCT01723709|disease|disease
1268213|NCT01723709|proteomics|proteomics
1268214|NCT01723709|genome|genome
1268215|NCT01723709|gene|gene
1268216|NCT01723696|In-utero smoke;|in-utero smoke;
1268217|NCT01723696|Pulmonary function testing;|pulmonary function testing;
1268218|NCT01723696|Wheeze;|wheeze;
1268219|NCT01723696|Vitamin C;|vitamin c;
1268220|NCT01723696|Forced expiratory flows|forced expiratory flows
1268221|NCT01723683|Preterm infants|preterm infants
1268222|NCT01723683|RDS|rds
1268223|NCT01723683|Surfactant|surfactant
1268224|NCT01723683|MISTCPAP|mistcpap
1268225|NCT01723683|CPAP|cpap
1268226|NCT01723657|Leukemia|leukemia
1268227|NCT01723657|Myeloid|myeloid
1268228|NCT01723657|Acute|acute
1268229|NCT01723657|Young|young
1268230|NCT01723657|CETLAM|cetlam
1268231|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
1268232|NCT01723631|Multiple sclerosis|multiple sclerosis
1268233|NCT01723631|TRAP|trap
1268234|NCT01723631|TRAP-Myéline|trap-myéline
1268235|NCT01723605|insitu repair|insitu repair
1268236|NCT01723605|intestinal motility|intestinal motility
1268237|NCT01723592|chemotherapy|chemotherapy
1268238|NCT01723592|vaginal flora|vaginal flora
1268239|NCT01723553|aphasia|aphasia
1268240|NCT01723553|logopenic|logopenic
1268241|NCT01723553|PCA|pca
1268242|NCT01723553|LPA|lpa
1268243|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
1268244|NCT01723527|Cocaine|cocaine
1268245|NCT01723527|Heroin|heroin
1268246|NCT01723527|HIV|hiv
1268247|NCT01723527|Contingency Management|contingency management
1268248|NCT01723527|Incentives|incentives
1268249|NCT01723527|Criminal Justice|criminal justice
1268250|NCT01723527|Methadone|methadone
1268251|NCT01723527|Buprenorphine|buprenorphine
1268252|NCT01723527|Employment|employment
1268253|NCT01723527|Job Training|job training
1268254|NCT01723527|Wage Subsidies|wage subsidies
1268255|NCT01723514|Migraine|migraine
1268256|NCT01723501|chlorhexidine|chlorhexidine
1268257|NCT01723501|sepsis|sepsis
1268258|NCT01723501|neonatal|neonatal
1268259|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
1268260|NCT01723488|AD|ad
1268261|NCT01723475|Phase I|phase i
1362929|NCT01321541|NHL|nhl
1268262|NCT01723475|Dose Escalation|dose escalation
1268263|NCT01723475|Prostate cancer|prostate cancer
1268264|NCT01723475|Antibodies|antibodies
1268265|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
1268266|NCT01723436|Decision fatigue|decision fatigue
1268267|NCT01723423|breast cancer|breast cancer
1268268|NCT01723423|evidence based medicine|evidence based medicine
1268269|NCT01723423|reconstruction|reconstruction
1268270|NCT01723423|mastectomy|mastectomy
1268271|NCT01723423|outcomes|outcomes
1268272|NCT01723423|quality of life|quality of life
1268273|NCT01723384|methamphetamine|methamphetamine
1268274|NCT01723384|alcohol|alcohol
1268275|NCT01723384|HIV|hiv
1268276|NCT01723384|sexual behavior|sexual behavior
1268277|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
1268278|NCT01723371|Pediatrics|pediatrics
1268279|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
1268280|NCT01723371|Carvedilol|carvedilol
1268281|NCT01723371|Beta-blockers|beta-blockers
1268282|NCT01723358|pediatrics|pediatrics
1268283|NCT01723358|dysphagia|dysphagia
1268284|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
1268285|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
1268286|NCT01723345|short-term MACE|short-term mace
1268287|NCT01723345|long-term MACE|long-term mace
1268288|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
1268289|NCT01723319|ADHD|adhd
1268290|NCT01723319|TMS|tms
1268291|NCT01723319|brain stimulation|brain stimulation
1268292|NCT01723319|clinical improvement|clinical improvement
1268293|NCT01723306|T cells|t cells
1268294|NCT01723306|gene transfer|gene transfer
1268295|NCT01723306|immunotherapy|immunotherapy
1268296|NCT01723306|metastatic cancers|metastatic cancers
1268297|NCT01723306|lung cancer|lung cancer
1268298|NCT01723306|gastric cancer|gastric cancer
1268299|NCT01723306|colorectal cancer|colorectal cancer
1268300|NCT01723306|solid tumors|solid tumors
1268301|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
1268302|NCT01723267|IVF|ivf
1268303|NCT01723267|3D ultrasound|3d ultrasound
1268304|NCT01723267|SonoAVC|sonoavc
1268305|NCT01723267|patients in IVF treatment|patients in ivf treatment
1268306|NCT01723254|Vaccines|vaccines
1268307|NCT01723254|Phase 1|phase 1
1268308|NCT01723254|Allergic Rhinitis|allergic rhinitis
1268309|NCT01723241|volunteers|volunteers
1268310|NCT01723228|Parkinson's Disease|parkinson's disease
1268311|NCT01723228|Cognition|cognition
1268312|NCT01723228|Rasagiline|rasagiline
1268313|NCT01723215|Attention bias modification|attention bias modification
1268314|NCT01723215|resilience|resilience
1268315|NCT01723215|combat|combat
1268316|NCT01723215|PTSD|ptsd
1268317|NCT01723215|Depression|depression
1268318|NCT01723215|Anxiety|anxiety
1268319|NCT01723202|BRAF|braf
1268320|NCT01723202|BRAFi|brafi
1268321|NCT01723202|thyroid cancer|thyroid cancer
1268322|NCT01723202|thyroid carcinoma|thyroid carcinoma
1268323|NCT01723189|central apnoeas|central apnoeas
1268324|NCT01723189|stroke|stroke
1268325|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
1268326|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
1268327|NCT01723176|critical care ultrasound|critical care ultrasound
1268328|NCT01723163|veteran|veteran
1268329|NCT01723163|smoking cessation|smoking cessation
1268330|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
1268331|NCT01723137|Pain|pain
1268332|NCT01723137|Pain measurement|pain measurement
1268333|NCT01723137|Visual analog scale|visual analog scale
1268334|NCT01723137|Anxiety|anxiety
1268335|NCT01723137|Stress|stress
1268336|NCT01723137|Opioid|opioid
1268337|NCT01723137|Emergency department|emergency department
1268338|NCT01723137|Demographics|demographics
1268339|NCT01723124|Dense breast tissue|dense breast tissue
1268340|NCT01723124|breast cancer screening|breast cancer screening
1268341|NCT01723124|molecular breast imaging|molecular breast imaging
1268342|NCT01723124|breast cancer|breast cancer
1268343|NCT01723124|breast|breast
1268344|NCT01723111|hepcidin|hepcidin
1268345|NCT01723111|ESA|esa
1268346|NCT01723111|hemodialysis|hemodialysis
1268347|NCT01723111|peritoneal dialysis|peritoneal dialysis
1268348|NCT01723111|iron metabolism|iron metabolism
1268349|NCT01723111|dialysis modality|dialysis modality
1268350|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
1268351|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
1268352|NCT01723085|Myomectomy|myomectomy
1268353|NCT01723085|Laparotomy|laparotomy
1268457|NCT01722539|malaria|malaria
1268354|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
1268355|NCT01723046|Upper extremity|upper extremity
1268356|NCT01723046|Rehabilitation|rehabilitation
1268357|NCT01723046|Robot assisted therapy|robot assisted therapy
1268358|NCT01723046|Robotics|robotics
1268359|NCT01723046|Devices|devices
1268360|NCT01723046|Orthosis|orthosis
1268361|NCT01723046|clinical outcome|clinical outcome
1268362|NCT01723033|PTSD|ptsd
1268363|NCT01723033|OCD|ocd
1268364|NCT01723020|Solid Tumors|solid tumors
1268365|NCT01723020|Multiple Myeloma|multiple myeloma
1268366|NCT01723007|Weight loss|weight loss
1268367|NCT01723007|cholesterol|cholesterol
1268368|NCT01722968|Metastatic breast cancer|metastatic breast cancer
1268369|NCT01722955|Prewarmed fluid|prewarmed fluid
1268370|NCT01722955|monitored anesthesia care|monitored anesthesia care
1268371|NCT01722955|core body temperature|core body temperature
1268372|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
1268373|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
1268374|NCT01722942|sudden cardiac death|sudden cardiac death
1268375|NCT01722942|primary prevention of death|primary prevention of death
1268376|NCT01722942|amiodarone|amiodarone
1268377|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1268378|NCT01722903|colorectal cancer|colorectal cancer
1268379|NCT01722903|liver metastases|liver metastases
1268380|NCT01722903|lung metastases|lung metastases
1268381|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
1268382|NCT01722890|durable complete response|durable complete response
1268383|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
1268384|NCT01722890|molecular characteristics|molecular characteristics
1268385|NCT01722890|trastuzumab|trastuzumab
1268386|NCT01722877|Restenosis|restenosis
1268387|NCT01722877|aspiration|aspiration
1268388|NCT01722877|in-stent restenosis|in-stent restenosis
1268389|NCT01722877|atherectomy|atherectomy
1268390|NCT01722877|superficial femoral artery|superficial femoral artery
1268391|NCT01722877|popliteal artery|popliteal artery
1268392|NCT01722851|Breast Cancer|breast cancer
1268393|NCT01722851|miRNAs|mirnas
1268394|NCT01722851|Newly diagnosed|newly diagnosed
1268397|NCT01722838|HIV Prevention|hiv prevention
1268398|NCT01722799|angioplasty|angioplasty
1268399|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1268400|NCT01722799|Drug elluting Balloon|drug elluting balloon
1268401|NCT01722799|Coronary Balloon|coronary balloon
1268402|NCT01722799|Dilatation|dilatation
1268403|NCT01722786|severe bleeding|severe bleeding
1268404|NCT01722786|dabigatran|dabigatran
1268405|NCT01722786|rivaroxaban|rivaroxaban
1268406|NCT01722786|apixaban|apixaban
1268407|NCT01722786|edoxaban|edoxaban
1268408|NCT01722786|PCC|pcc
1268409|NCT01722786|aPCC|apcc
1268410|NCT01722786|rVIIa|rviia
1268411|NCT01722786|hemodialysis|hemodialysis
1268412|NCT01722786|antidots|antidots
1268413|NCT01722786|idarucizumab|idarucizumab
1268414|NCT01722773|COPD|copd
1268415|NCT01722760|Neonatal|neonatal
1268416|NCT01722760|Preterm|preterm
1268417|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1268418|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
1268419|NCT01722760|Oxygen|oxygen
1268420|NCT01722760|Vitamin A|vitamin a
1268421|NCT01722760|Vitamin D|vitamin d
1268422|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
1268423|NCT01722760|Reference material|reference material
1268424|NCT01722734|Malaria|malaria
1268425|NCT01722734|ACTs|acts
1268426|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
1268427|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
1268428|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
1268429|NCT01722708|Preterm labor|preterm labor
1268430|NCT01722708|Late abortion|late abortion
1268431|NCT01722708|bacterial vaginosis|bacterial vaginosis
1268432|NCT01722682|Diabetes|diabetes
1268433|NCT01722669|quercetin|quercetin
1268434|NCT01722669|isoquercetin|isoquercetin
1268435|NCT01722669|pharmacokinetic|pharmacokinetic
1268436|NCT01722669|pharmacodynamic|pharmacodynamic
1268437|NCT01722656|PED|ped
1268438|NCT01722656|AMD|amd
1268439|NCT01722656|CNV|cnv
1268440|NCT01722630|dopamine|dopamine
1268441|NCT01722630|laparoscopy|laparoscopy
1268442|NCT01722630|fluid management|fluid management
1268443|NCT01722578|Cirrhosis|cirrhosis
1268444|NCT01722578|Encephalopathy|encephalopathy
1268445|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
1268446|NCT01722565|Parastomal hernias|parastomal hernias
1268447|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
1268448|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
1268449|NCT01722552|HIV|hiv
1268450|NCT01722552|AIDS|aids
1268451|NCT01722552|antiretroviral therapy|antiretroviral therapy
1268452|NCT01722552|adherence|adherence
1268453|NCT01722552|China|china
1268454|NCT01722539|intermittent|intermittent
1268455|NCT01722539|preventive|preventive
1268456|NCT01722539|treatment|treatment
1268458|NCT01722539|soil transmitted helminths|soil transmitted helminths
1268459|NCT01722539|schistosomiasis|schistosomiasis
1268460|NCT01722539|schoolchildren|schoolchildren
1268461|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
1268462|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
1363222|NCT01320449|EPO|epo
1268463|NCT01722500|International|international
1268464|NCT01722500|Childhood|childhood
1268465|NCT01722500|Obesity|obesity
1268467|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
1268468|NCT01722500|PBRC|pbrc
1268469|NCT01722500|longitudinal|longitudinal
1268470|NCT01722500|multinational|multinational
1268471|NCT01722487|CLL, SLL|cll, sll
1268472|NCT01722474|Pulse Wave Analysis|pulse wave analysis
1268473|NCT01722474|Arterial Stiffness|arterial stiffness
1268474|NCT01722461|Excessive underarm sweating|excessive underarm sweating
1268475|NCT01722448|muscle|muscle
1268476|NCT01722448|muscle dysfunction|muscle dysfunction
1268477|NCT01722448|choline|choline
1268478|NCT01722448|exercise|exercise
1268479|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
1268480|NCT01722448|rhabdomyolysis|rhabdomyolysis
1268481|NCT01722435|opioid dependence|opioid dependence
1268482|NCT01722435|opiate substitution treatment|opiate substitution treatment
1268483|NCT01722435|methadone|methadone
1268484|NCT01722435|completion|completion
1268485|NCT01722435|termination|termination
1268486|NCT01722422|sepsis|sepsis
1268487|NCT01722422|shock|shock
1268488|NCT01722422|hyperoxia|hyperoxia
1268489|NCT01722422|hypertonic saline|hypertonic saline
1268490|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
1268491|NCT01722357|bariatric surgery|bariatric surgery
1268492|NCT01722357|physical activity|physical activity
1268493|NCT01722357|morbid obesity|morbid obesity
1268494|NCT01722344|Severe mental illness|severe mental illness
1268495|NCT01722344|Vocational rehabilitation|vocational rehabilitation
1268496|NCT01722344|Supported employment|supported employment
1268497|NCT01722344|Individual placement and support|individual placement and support
1268498|NCT01722344|Cognitive remediation|cognitive remediation
1268499|NCT01722344|Social skill training|social skill training
1268500|NCT01722279|bariatric surgery|bariatric surgery
1268501|NCT01722279|long-term outcomes|long-term outcomes
1268502|NCT01722279|obesity|obesity
1268503|NCT01722266|Liraglutide|liraglutide
1268504|NCT01722266|Glucagon|glucagon
1268505|NCT01722266|Systolic blood pressure|systolic blood pressure
1268506|NCT01722266|Weight|weight
1268507|NCT01722266|Carbohydrate intake|carbohydrate intake
1268508|NCT01722266|Insulin dose|insulin dose
1268509|NCT01722266|HbA1c|hba1c
1268510|NCT01722266|Post-prandial glucagon|post-prandial glucagon
1268511|NCT01722253|electroacupuncture|electroacupuncture
1268512|NCT01722253|acupuncture|acupuncture
1268513|NCT01722253|pain management|pain management
1268514|NCT01722214|Psoriasis|psoriasis
1268515|NCT01722214|Vascular Inflammation|vascular inflammation
1268516|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
1268517|NCT01722214|Ascending aorta|ascending aorta
1268518|NCT01722214|Pet scan|pet scan
1268519|NCT01722214|MRI|mri
1268520|NCT01722188|Optim|optim
1268521|NCT01722188|Insulation|insulation
1268522|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
1268523|NCT01722149|re-directed T cells|re-directed t cells
1268524|NCT01722149|FAP|fap
1268525|NCT01722149|fibroblast activation protein|fibroblast activation protein
1268526|NCT01722149|CD8 positive T cells|cd8 positive t cells
1268527|NCT01722149|pleural effusion|pleural effusion
1268528|NCT01722123|Decision fatigue|decision fatigue
1268529|NCT01722071|Oxytocin|oxytocin
1268530|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1268531|NCT01722071|Social|social
1268532|NCT01722071|Motivation|motivation
1268533|NCT01722058|peptide|peptide
1268534|NCT01722058|colon|colon
1268535|NCT01722058|flat lesions|flat lesions
1268536|NCT01722045|AMD|amd
1268537|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
1268538|NCT01722019|venous insufficiency|venous insufficiency
1268539|NCT01722006|methamphetamine|methamphetamine
1268540|NCT01722006|subjective|subjective
1268541|NCT01722006|conditioning|conditioning
1268542|NCT01722006|preference|preference
1268543|NCT01721993|oral zoledronic acid|oral zoledronic acid
1268544|NCT01721967|chest pain|chest pain
1268545|NCT01721967|dyspnea|dyspnea
1268546|NCT01721954|colon|colon
1268547|NCT01721954|rectum|rectum
1268548|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
1268549|NCT01721954|liver metastases|liver metastases
1268550|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
1268551|NCT01721941|HCC|hcc
1268552|NCT01721941|liver cancer|liver cancer
1268553|NCT01721941|hepatoma|hepatoma
1268554|NCT01721941|TACE|tace
1268555|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
1268556|NCT01721941|TH302|th302
1268557|NCT01721928|Acute kidney injury|acute kidney injury
1268558|NCT01721928|Deep venous thrombosis|deep venous thrombosis
1268559|NCT01721928|Dialysis|dialysis
1268560|NCT01721928|Prophylaxis|prophylaxis
1268561|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1268562|NCT01721915|glucose metabolism|glucose metabolism
1268563|NCT01721915|Vitamin D deficiency|vitamin d deficiency
1268564|NCT01721915|vitamin D supplementation|vitamin d supplementation
1268565|NCT01721915|pharmakogenetics|pharmakogenetics
1268566|NCT01721915|women|women
1268567|NCT01721863|Atrial Fibrillation|atrial fibrillation
1268568|NCT01721863|Exercise Training|exercise training
1268569|NCT01721863|Endothelial Function|endothelial function
1268570|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
1268571|NCT01721863|Exercise Capacity|exercise capacity
1268572|NCT01721863|Quality of Life|quality of life
1268573|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
1268574|NCT01721824|Supported employment|supported employment
1268575|NCT01721824|Individual Placement and Support|individual placement and support
1268576|NCT01721824|Workability|workability
1268577|NCT01721824|Return to work|return to work
1268578|NCT01721798|AE adverse event|ae adverse event
1268579|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1268580|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1268581|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
1268582|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1268583|NCT01721798|DCF data collection forms|dcf data collection forms
1268584|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
1268585|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1268586|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1268587|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1268588|NCT01721798|ICH International Council for Harmonization|ich international council for harmonization
1268589|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
1268590|NCT01721798|IRB Institutional Review Board|irb institutional review board
1268591|NCT01721798|IU International units|iu international units
1268592|NCT01721798|mg milligram(s)|mg milligram(s)
1268593|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1268594|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
1268595|NCT01721798|SAE serious adverse event|sae serious adverse event
1268596|NCT01721798|µg microgram|µg microgram
1268597|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
1268598|NCT01721798|WB Western Blot|wb western blot
1268599|NCT01721785|Nodal imaging|nodal imaging
1268600|NCT01721785|Restaging|restaging
1268601|NCT01721733|EPI743|epi743
1268602|NCT01721733|Leigh syndrome|leigh syndrome
1268603|NCT01721733|respiratory chain disease|respiratory chain disease
1268604|NCT01721733|mitochondrial disorders|mitochondrial disorders
1268605|NCT01721720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1268606|NCT01721720|Behavioral Phenotype|behavioral phenotype
1268607|NCT01721720|Brain Development|brain development
1268608|NCT01721720|Complex Disease|complex disease
1268609|NCT01721720|Social Networks|social networks
1268610|NCT01721707|glaucoma|glaucoma
1268611|NCT01721707|ocular hypertension|ocular hypertension
1268612|NCT01721707|latanoprost|latanoprost
1268613|NCT01721707|brinzolamide|brinzolamide
1268614|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
1268615|NCT01721694|blepharitis|blepharitis
1268616|NCT01721694|keratitis|keratitis
1268617|NCT01721694|conjunctivitis|conjunctivitis
1268618|NCT01721655|Spironolactone|spironolactone
1268619|NCT01721655|Preterm Infants|preterm infants
1268620|NCT01721655|Chronic Lung Disease|chronic lung disease
1268621|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1268622|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
1268623|NCT01721642|access|access
1268624|NCT01721642|closure|closure
1268625|NCT01721642|trans-apical|trans-apical
1268626|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
1268627|NCT01721642|TAVI|tavi
1268628|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
1268629|NCT01721642|TAVR|tavr
1268630|NCT01721629|Nasal cpap weaning|nasal cpap weaning
1268631|NCT01721629|Premature infants|premature infants
1268632|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
1268633|NCT01721629|Randomized controlled trial|randomized controlled trial
1268634|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
1268635|NCT01721603|melanoma|melanoma
1268636|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
1268637|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
1268638|NCT01721603|dabrafenib|dabrafenib
1268640|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
1268641|NCT01721590|Coronary Heart Disease|coronary heart disease
1268642|NCT01721590|Tongxinluo|tongxinluo
1268643|NCT01721577|glioblastoma|glioblastoma
1268644|NCT01721577|gliosarcoma|gliosarcoma
1268645|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
1268646|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1268647|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1268648|NCT01721577|AXL1717|axl1717
1268649|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
1268650|NCT01721577|picropodophyllin|picropodophyllin
1268651|NCT01721551|Dialysis fatigue,|dialysis fatigue,
1268652|NCT01721551|exercise intolerance,|exercise intolerance,
1268653|NCT01721551|muscle atrophy,|muscle atrophy,
1268654|NCT01721551|cachexia,|cachexia,
1268655|NCT01721551|disability,|disability,
1268656|NCT01721551|Sleep disorders|sleep disorders
1268657|NCT01721551|Depression|depression
1268658|NCT01721551|Mental Fatigue,|mental fatigue,
1268659|NCT01721551|Cognitive function|cognitive function
1268660|NCT01721551|Physical Fatigue|physical fatigue
1268661|NCT01721538|stroke|stroke
1268662|NCT01721538|prevention|prevention
1268663|NCT01721538|obesity|obesity
1268664|NCT01721538|weight reduction|weight reduction
1268665|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
1268666|NCT01721525|CARBOPLATIN|carboplatin
1268667|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
1268668|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1268669|NCT01721525|OROPHARYNX|oropharynx
1268670|NCT01721525|HPV associated|hpv associated
1268671|NCT01721525|12-150|12-150
1268672|NCT01721512|Prospective observational study|prospective observational study
1268673|NCT01721512|Breast feeding|breast feeding
1268674|NCT01721512|Infant formula|infant formula
1268675|NCT01721512|Infant|infant
1268676|NCT01721512|Indonesia|indonesia
1268677|NCT01721499|Stress|stress
1268678|NCT01721499|obesity|obesity
1268679|NCT01721499|overeating|overeating
1268680|NCT01721486|tonsillitis|tonsillitis
1268681|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
1268682|NCT01721486|obstructed air passages|obstructed air passages
1268683|NCT01721486|swallowing difficulties|swallowing difficulties
1268684|NCT01721473|Tobacco|tobacco
1268685|NCT01721473|Positron Emission Tomography|positron emission tomography
1268686|NCT01721473|Marijuana|marijuana
1268687|NCT01721473|Caffeine|caffeine
1268688|NCT01721473|Menthol|menthol
1268689|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
1268690|NCT01721460|Microelectrode recording|microelectrode recording
1268691|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
1268692|NCT01721447|Atrial fibrillation|atrial fibrillation
1268693|NCT01721447|stroke|stroke
1268694|NCT01721447|TEE|tee
1268695|NCT01721447|Left atrial thrombus|left atrial thrombus
1268696|NCT01721434|levosimendan|levosimendan
1268697|NCT01721434|diaphragm function|diaphragm function
1268698|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
1268699|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
1268700|NCT01721421|haemodialysis|haemodialysis
1268701|NCT01721421|Crossover|crossover
1268702|NCT01721421|Treatment time|treatment time
1268703|NCT01721421|nutritional status|nutritional status
1268704|NCT01721395|Cough|cough
1268705|NCT01721395|Nocturnal Cough|nocturnal cough
1268706|NCT01721395|Agave|agave
1268707|NCT01721395|Sleep Quality|sleep quality
1268708|NCT01721395|Childhood cough|childhood cough
1268709|NCT01721382|cystic fibrosis|cystic fibrosis
1268710|NCT01721382|CF|cf
1268711|NCT01721382|CFRD|cfrd
1268712|NCT01721382|sitagliptin|sitagliptin
1268713|NCT01721382|incretins|incretins
1268714|NCT01721382|GLP1|glp1
1268715|NCT01721382|GIP|gip
1268716|NCT01721382|beta cell function|beta cell function
1268717|NCT01721382|adolescents|adolescents
1268718|NCT01721330|ADHD|adhd
1268719|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1268720|NCT01721330|Psychopharmacology|psychopharmacology
1268721|NCT01721330|Psychiatry|psychiatry
1268722|NCT01721330|Non-stimulant treatment|non-stimulant treatment
1268723|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
1268724|NCT01721317|Adjunctive Treatment|adjunctive treatment
1268725|NCT01721317|Safety|safety
1268726|NCT01721317|Efficacy|efficacy
1268727|NCT01721317|Epilepsy|epilepsy
1268728|NCT01721317|Tolerability|tolerability
1268729|NCT01721317|Immediate Release|immediate release
1268730|NCT01721317|GW582892|gw582892
1268731|NCT01721317|Dose-Optimization|dose-optimization
1268732|NCT01721317|Partial-Onset Seizures|partial-onset seizures
1268733|NCT01721304|decision making|decision making
1268734|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
1268735|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
1268736|NCT01721304|satisfaction|satisfaction
1268737|NCT01721304|regret|regret
1268738|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
1268739|NCT01721291|ASTHMA|asthma
1268740|NCT01721291|SALBUTAMOL|salbutamol
1268741|NCT01721291|ALBUTEROL|albuterol
1268742|NCT01721291|VENTOLIN|ventolin
1268743|NCT01721291|LUNG PHYSIOLOGY|lung physiology
1268744|NCT01721291|LUNG DEPOSITION|lung deposition
1268745|NCT01721291|INHALERS|inhalers
1268746|NCT01721291|DRUG THERAPY|drug therapy
1268747|NCT01721265|HCV|hcv
1268748|NCT01721265|Hepatitis C|hepatitis c
1268749|NCT01721265|IDX184|idx184
1268750|NCT01721265|IDX719|idx719
1268751|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
1268752|NCT01721252|Erlotinib|erlotinib
1268753|NCT01721252|TarcevaTM|tarcevatm
1268754|NCT01721252|proteomic signature|proteomic signature
1268755|NCT01721239|ICU|icu
1268756|NCT01721239|Follow-up consultations|follow-up consultations
1268757|NCT01721239|Quality of life|quality of life
1268758|NCT01721239|Sense Of Coherence|sense of coherence
1268759|NCT01721239|RCT multicenter study|rct multicenter study
1268760|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
1268761|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
1268762|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
1268763|NCT01721226|information technology and ART adherence|information technology and art adherence
1268764|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
1268765|NCT01721213|Epilepsy|epilepsy
1268766|NCT01721213|survey|survey
1268767|NCT01721213|retigabine|retigabine
1268768|NCT01721213|patient information leaflet|patient information leaflet
1268769|NCT01721213|physician's guide|physician's guide
1268770|NCT01721213|Trobalt™|trobalt™
1268771|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
1268772|NCT01721200|web based interactive learning tool|web based interactive learning tool
1268773|NCT01721187|fMRI|fmri
1268774|NCT01721187|Satiety|satiety
1268775|NCT01721187|Willingness to Pay|willingness to pay
1268776|NCT01721187|Incentive Delay|incentive delay
1268777|NCT01721187|Dietary Disinhibition|dietary disinhibition
1268778|NCT01721174|Pancreatic cancer|pancreatic cancer
1268779|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
1268780|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
1268781|NCT01721161|Optic Neuritis|optic neuritis
1268782|NCT01721135|moxifloxacin|moxifloxacin
1268783|NCT01721135|GSK2190915|gsk2190915
1268784|NCT01721135|pharmacokinetics|pharmacokinetics
1268785|NCT01721135|QTc|qtc
1268786|NCT01721109|Adolescents|adolescents
1268787|NCT01721109|HIV-1|hiv-1
1268788|NCT01721109|HIV|hiv
1268789|NCT01721109|Treatment Naive|treatment naive
1268790|NCT01721096|Angioplasty|angioplasty
1268791|NCT01721096|Drug eluting stents|drug eluting stents
1268792|NCT01721096|Stents|stents
1268793|NCT01721096|Real world|real world
1268794|NCT01721083|intramuscular injection|intramuscular injection
1268795|NCT01721083|bunch|bunch
1268796|NCT01721083|z-track|z-track
1268797|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
1268798|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
1268799|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
1268800|NCT01721018|Oncolytic virus|oncolytic virus
1268801|NCT01721018|HSV1716|hsv1716
1268802|NCT01721018|Mesothelioma|mesothelioma
1268803|NCT01721018|MPM|mpm
1268804|NCT01721018|Woll|woll
1268805|NCT01721018|Sheffield|sheffield
1268806|NCT01721018|Weston Park|weston park
1268807|NCT01721018|Virttu|virttu
1268808|NCT01721018|Crusade|crusade
1268809|NCT01721005|atrial fibrillation|atrial fibrillation
1268810|NCT01721005|thromboembolism|thromboembolism
1268811|NCT01721005|patient education|patient education
1268812|NCT01720979|TBI|tbi
1268813|NCT01720979|Traumatic Brain Injury|traumatic brain injury
1268814|NCT01720979|Children|children
1268815|NCT01720979|Prognosis|prognosis
1268816|NCT01720979|Neurocognition|neurocognition
1268817|NCT01720966|Adhesions|adhesions
1268818|NCT01720966|laparoscopy|laparoscopy
1268819|NCT01720966|laparotomy|laparotomy
1268820|NCT01720966|liver resection|liver resection
1268821|NCT01720966|colorectal malignancy|colorectal malignancy
1268822|NCT01720953|Borderline Personality Disorder|borderline personality disorder
1268823|NCT01720953|Mentalization Based Therapy|mentalization based therapy
1268824|NCT01720953|DNA methylation|dna methylation
1268825|NCT01720953|BDNF|bdnf
1268826|NCT01720953|Cortisol|cortisol
1268827|NCT01720953|Neuropsychology|neuropsychology
1268828|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
1268829|NCT01720888|Autologous|autologous
1268830|NCT01720888|Bone Marrow|bone marrow
1268831|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
1268832|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
1268833|NCT01720862|migraine|migraine
1268834|NCT01720862|episodic migraine|episodic migraine
1268835|NCT01720862|chronic migraine|chronic migraine
1268836|NCT01720862|obesity|obesity
1268837|NCT01720862|non-obese|non-obese
1268838|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
1268839|NCT01720823|polysomnography|polysomnography
1268840|NCT01720823|Home monitoring|home monitoring
1268841|NCT01720797|Malocclusion|malocclusion
1268842|NCT01720797|Accelerated tooth movement|accelerated tooth movement
1268843|NCT01720797|Braces|braces
1268844|NCT01720797|Orthodontic treatment|orthodontic treatment
1268845|NCT01720797|Propel|propel
1268846|NCT01720771|bacteriotherapy|bacteriotherapy
1268847|NCT01720771|caries|caries
1268848|NCT01720771|preschool children|preschool children
1268849|NCT01720771|probiotics|probiotics
1268850|NCT01720745|EUS|eus
1268851|NCT01720745|FNA|fna
1268852|NCT01720745|Wet suction|wet suction
1268853|NCT01720745|Dry suction|dry suction
1268854|NCT01720745|Solid lesions|solid lesions
1268855|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1268856|NCT01720719|Dyslipidemias|dyslipidemias
1603577|NCT00380757|fatigue|fatigue
1268857|NCT01720719|Diabetes Mellitus|diabetes mellitus
1269161|NCT01719354|Aftercare|aftercare
1268858|NCT01720719|atorvastatin|atorvastatin
1268859|NCT01720719|Vitamin E|vitamin e
1268860|NCT01720706|Liver tumour|liver tumour
1268861|NCT01720706|Kidney tumour|kidney tumour
1268862|NCT01720706|Hepatectomy|hepatectomy
1268863|NCT01720706|Nephrectomy|nephrectomy
1268864|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
1268865|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
1268866|NCT01720693|partial nephrectomy|partial nephrectomy
1268867|NCT01720693|hypoperfusion|hypoperfusion
1268868|NCT01720693|renal function|renal function
1268869|NCT01720680|COPD|copd
1268870|NCT01720680|Functional Imaging|functional imaging
1268871|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
1268872|NCT01720680|Lung Function|lung function
1268873|NCT01720680|AlphaCore|alphacore
1268874|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
1268875|NCT01720667|Seizures|seizures
1268876|NCT01720667|Neonates|neonates
1268877|NCT01720667|Anticonvulsants|anticonvulsants
1268878|NCT01720667|Treatment|treatment
1268879|NCT01720667|Levetiracetam|levetiracetam
1268880|NCT01720667|Phenobarbital|phenobarbital
1268881|NCT01720654|Expedited Partner Therapy|expedited partner therapy
1268882|NCT01720654|MSM|msm
1268883|NCT01720654|Peru|peru
1268884|NCT01720654|Gonorrhea|gonorrhea
1268885|NCT01720654|Chlamydia|chlamydia
1268886|NCT01720641|MSM|msm
1268887|NCT01720641|Transgender Women|transgender women
1268888|NCT01720641|Partner Notification|partner notification
1268889|NCT01720641|Syphilis|syphilis
1268890|NCT01720641|Peru|peru
1268891|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
1268892|NCT01720615|EEG|eeg
1268893|NCT01720615|AEP|aep
1268894|NCT01720615|Propofol|propofol
1268895|NCT01720615|Sevoflurane|sevoflurane
1268896|NCT01720615|Remifentanil|remifentanil
1268897|NCT01720615|General anesthesia|general anesthesia
1268898|NCT01720589|Obesity|obesity
1268899|NCT01720589|Dietary fat|dietary fat
1268900|NCT01720589|Energy expenditure|energy expenditure
1268901|NCT01720589|Food intake|food intake
1268902|NCT01720563|Cancer-related fatigue|cancer-related fatigue
1268903|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
1268904|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1268905|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1268906|NCT01720550|Cancer-related fatigue|cancer-related fatigue
1268907|NCT01720550|Palliative Treatment|palliative treatment
1268908|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
1268909|NCT01720537|High Cholesterol|high cholesterol
1268910|NCT01720537|Dyslipidemia|dyslipidemia
1268911|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
1268912|NCT01720524|newborn|newborn
1268913|NCT01720524|neonates|neonates
1268914|NCT01720524|iv sildenafil|iv sildenafil
1268915|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
1268916|NCT01720472|Aging|aging
1268917|NCT01720472|Healthy Aging|healthy aging
1268918|NCT01720472|Physical Performance|physical performance
1268919|NCT01720472|Physical Functioning|physical functioning
1268920|NCT01720472|Cognitive Functioning|cognitive functioning
1268921|NCT01720472|Fitness|fitness
1268922|NCT01720472|Physical Activity|physical activity
1268923|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
1268924|NCT01720420|edentulous|edentulous
1268925|NCT01720420|maxilla|maxilla
1268926|NCT01720420|mandible|mandible
1268927|NCT01720420|dental implant|dental implant
1268928|NCT01720420|bar|bar
1268929|NCT01720420|overdenture|overdenture
1268930|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
1268931|NCT01720420|survival rate|survival rate
1268932|NCT01720420|technical complications|technical complications
1268933|NCT01720420|marginal bone level|marginal bone level
1268934|NCT01720420|soft tissue|soft tissue
1268935|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
1268936|NCT01720381|monitoring|monitoring
1268937|NCT01720381|blood glucose|blood glucose
1268938|NCT01720381|intensive care unit|intensive care unit
1268939|NCT01720368|IBD|ibd
1268940|NCT01720368|Crohn's|crohn's
1268941|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
1268942|NCT01720342|Aortic valve stenosis|aortic valve stenosis
1268943|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
1268944|NCT01720342|"Real world patients"|"real world patients"
1268945|NCT01720316|Glycine|glycine
1268946|NCT01720316|Glycine decarboxylase|glycine decarboxylase
1268947|NCT01720316|Psychosis|psychosis
1268948|NCT01720316|Mutation|mutation
1268949|NCT01720277|Randomized Controlled Trial|randomized controlled trial
1268950|NCT01720277|Influenza|influenza
1268951|NCT01720277|Influenza vaccine|influenza vaccine
1268952|NCT01720277|Flu Vaccine|flu vaccine
1268953|NCT01720277|Fluzone|fluzone
1268954|NCT01720277|HD Fluzone|hd fluzone
1268955|NCT01720277|Nursing Homes|nursing homes
1268956|NCT01720277|Hospitalization|hospitalization
1268957|NCT01720277|Mortality|mortality
1269162|NCT01719328|yoga,|yoga,
1268958|NCT01720277|Health Care worker vaccination|health care worker vaccination
1268959|NCT01720277|ADL decline|adl decline
1268960|NCT01720277|Pilot|pilot
1268961|NCT01720277|Effectiveness|effectiveness
1268962|NCT01720251|allergic rhinitis|allergic rhinitis
1268963|NCT01720251|birch pollen|birch pollen
1268964|NCT01720251|immunotherapy|immunotherapy
1268965|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
1268966|NCT01720238|Early Antiviral Therapy|early antiviral therapy
1268967|NCT01720238|Cost Effectiveness|cost effectiveness
1268968|NCT01720225|Leukemia|leukemia
1268969|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
1268970|NCT01720225|MDS|mds
1268971|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
1268972|NCT01720225|Decitabine|decitabine
1268973|NCT01720225|DAC|dac
1268974|NCT01720225|Dacogen|dacogen
1268975|NCT01720225|Azacitidine|azacitidine
1268976|NCT01720225|AZA|aza
1268977|NCT01720225|5-azacytidine|5-azacytidine
1268978|NCT01720225|5-aza|5-aza
1268979|NCT01720225|Vidaza|vidaza
1268980|NCT01720225|5-AZC|5-azc
1268981|NCT01720225|AZA-CR|aza-cr
1268982|NCT01720225|Ladakamycin|ladakamycin
1268983|NCT01720225|NSC-102816|nsc-102816
1268984|NCT01720212|YM178|ym178
1268985|NCT01720212|Mirabegron|mirabegron
1268986|NCT01720212|OCAS|ocas
1268987|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
1268988|NCT01720212|PK|pk
1268989|NCT01720212|Safety|safety
1268990|NCT01720199|universal prevention|universal prevention
1268991|NCT01720199|primary prevention|primary prevention
1268992|NCT01720199|health promotion|health promotion
1268993|NCT01720199|wellbeing|wellbeing
1268994|NCT01720199|smoking|smoking
1268995|NCT01720199|alcohol|alcohol
1268996|NCT01720199|diet|diet
1268997|NCT01720199|physical activity|physical activity
1268998|NCT01720199|emotional and social skills|emotional and social skills
1268999|NCT01720186|Lung Cancer|lung cancer
1269000|NCT01720186|PET/CT|pet/ct
1269001|NCT01720186|FDG|fdg
1269002|NCT01720186|Respiratory synchronization|respiratory synchronization
1269003|NCT01720147|Fanconi Anemia|fanconi anemia
1269005|NCT01720147|Quercetin|quercetin
1269006|NCT01720043|multiple myeloma|multiple myeloma
1269007|NCT01720030|Renal|renal
1269008|NCT01720030|Acute Kidney Injury|acute kidney injury
1269009|NCT01720030|AKI|aki
1269010|NCT01720030|Levosimendan|levosimendan
1269011|NCT01720030|Simdax|simdax
1269012|NCT01720030|Renal perfusion|renal perfusion
1269013|NCT01720030|Mortality|mortality
1269014|NCT01720030|Renal flow|renal flow
1269015|NCT01720017|Airtraq|airtraq
1269016|NCT01720017|laryngoscope|laryngoscope
1269017|NCT01720017|airway|airway
1269018|NCT01720017|difficult|difficult
1269019|NCT01720017|training|training
1269020|NCT01720017|manikin|manikin
1269021|NCT01720004|human labour|human labour
1269022|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
1269023|NCT01720004|pilot trial|pilot trial
1269024|NCT01719991|Primary care|primary care
1269025|NCT01719991|Self-management|self-management
1269026|NCT01719991|Self-support|self-support
1269027|NCT01719991|Nurse case management|nurse case management
1269028|NCT01719978|Local Anaesthetics|local anaesthetics
1269029|NCT01719978|Mepivacaine|mepivacaine
1269030|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1269031|NCT01719978|Hemodynamic|hemodynamic
1269032|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
1269033|NCT01719965|Community Advisory Board|community advisory board
1269034|NCT01719965|Focus Group Discussion|focus group discussion
1269035|NCT01719965|Interview|interview
1269036|NCT01719965|Community Engagement|community engagement
1269037|NCT01719965|Thailand|thailand
1269038|NCT01719952|pregnancy|pregnancy
1269039|NCT01719952|anaesthesia|anaesthesia
1269040|NCT01719952|caesarean section|caesarean section
1269041|NCT01719926|Colorectal|colorectal
1269042|NCT01719926|Esophageal|esophageal
1269043|NCT01719926|Indomethacin|indomethacin
1269044|NCT01719926|PIFA|pifa
1269045|NCT01719900|Dietary intervention|dietary intervention
1269046|NCT01719900|Dietary fibre|dietary fibre
1269047|NCT01719900|Obesity|obesity
1269048|NCT01719900|Metabolic syndrome|metabolic syndrome
1269049|NCT01719900|Weight loss|weight loss
1269050|NCT01719900|Glucose regulation|glucose regulation
1269051|NCT01719900|Pulse fibre|pulse fibre
1269052|NCT01719887|humerus|humerus
1269053|NCT01719887|humeral|humeral
1269054|NCT01719887|shaft|shaft
1269055|NCT01719887|diaphysis|diaphysis
1269056|NCT01719887|fracture|fracture
1269057|NCT01719887|RCT|rct
1269058|NCT01719874|Influenza|influenza
1269059|NCT01719874|monoclonal antibody|monoclonal antibody
1269060|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
1269061|NCT01719835|T-Cell Lymphoma|t-cell lymphoma
1269062|NCT01719835|Untreated|untreated
1363880|NCT01317485|rinsing|rinsing
1269063|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
1269064|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
1269065|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
1269163|NCT01719328|exercise|exercise
1269066|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
1269067|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
1269068|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
1269069|NCT01719809|Glaucoma|glaucoma
1269070|NCT01719809|Eye Drop|eye drop
1269071|NCT01719809|Eye Drop Technique|eye drop technique
1269072|NCT01719809|Training|training
1269073|NCT01719809|Instilling Eye Drops|instilling eye drops
1269074|NCT01719783|influenza|influenza
1269075|NCT01719783|vaccine|vaccine
1269076|NCT01719783|pandemic|pandemic
1269077|NCT01719770|cardiac arrest|cardiac arrest
1269078|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
1269079|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
1269080|NCT01719770|shivering|shivering
1269081|NCT01719770|serum drug levels|serum drug levels
1269082|NCT01719770|basal metabolism|basal metabolism
1269083|NCT01719757|Targin, Cancer Pain|targin, cancer pain
1269084|NCT01719744|ENMD-2076|enmd-2076
1269085|NCT01719744|advanced|advanced
1269086|NCT01719744|metastatic|metastatic
1269087|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
1269088|NCT01719731|BPD|bpd
1269089|NCT01719718|ventral hernia|ventral hernia
1269090|NCT01719705|caesarean delivery|caesarean delivery
1269091|NCT01719705|spinal anesthesia|spinal anesthesia
1269092|NCT01719705|pregabalin|pregabalin
1269093|NCT01719705|postoperative pain|postoperative pain
1269094|NCT01719705|morphine|morphine
1269095|NCT01719679|school located vaccine program|school located vaccine program
1269096|NCT01719666|MPFL|mpfl
1269097|NCT01719666|patella|patella
1269098|NCT01719666|dislocation|dislocation
1269099|NCT01719666|release|release
1269100|NCT01719653|Colonoscopy|colonoscopy
1269101|NCT01719653|Bowel Preparation|bowel preparation
1269102|NCT01719653|MiraLAX|miralax
1269103|NCT01719653|Gatorade|gatorade
1269104|NCT01719653|PEG-3350|peg-3350
1269105|NCT01719653|MoviPrep|moviprep
1269106|NCT01719653|SUPREP|suprep
1269107|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
1269108|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
1269109|NCT01719640|mesenchymal stem cells|mesenchymal stem cells
1269110|NCT01719640|bone marrow mononeclear cells|bone marrow mononeclear cells
1269111|NCT01719640|type 2 diabetes mellitus|type 2 diabetes mellitus
1269112|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
1269113|NCT01719614|Healthy participants|healthy participants
1269114|NCT01719614|Rilpivirine|rilpivirine
1269115|NCT01719614|Metformin|metformin
1269116|NCT01719614|Pharmacokinetics|pharmacokinetics
1269117|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
1269118|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
1269119|NCT01719601|Tapentadol IR|tapentadol ir
1269120|NCT01719601|Nucynta IR|nucynta ir
1269121|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
1269122|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
1269123|NCT01719588|Tapentadol PR|tapentadol pr
1269124|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
1269125|NCT01719588|Nucynta PR|nucynta pr
1269126|NCT01719549|Gastric Cancer|gastric cancer
1269127|NCT01719549|Dovitinib|dovitinib
1269128|NCT01719523|Tourette syndrome|tourette syndrome
1269129|NCT01719523|Tics|tics
1269130|NCT01719523|Tic Disorders|tic disorders
1269131|NCT01719510|Group B Streptococcus,|group b streptococcus,
1269132|NCT01719510|Vaginal screening|vaginal screening
1269133|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
1269134|NCT01719510|Meningitis|meningitis
1269135|NCT01719510|Neonatal infection|neonatal infection
1269136|NCT01719510|PCR|pcr
1269137|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
1269138|NCT01719445|Energy Intake|energy intake
1269139|NCT01719432|Filgrastim|filgrastim
1269140|NCT01719432|Obese|obese
1269141|NCT01719432|Non-obese|non-obese
1269142|NCT01719432|Pharmacokinetics|pharmacokinetics
1269143|NCT01719406|Gestational diabetes|gestational diabetes
1269144|NCT01719406|Exercise|exercise
1269145|NCT01719406|Diet|diet
1269146|NCT01719406|Fruits|fruits
1269147|NCT01719406|Vegetables|vegetables
1269148|NCT01719406|Whole grains|whole grains
1269149|NCT01719406|pregnancy weight|pregnancy weight
1269150|NCT01719393|Asthma|asthma
1269151|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
1269152|NCT01719393|lung function|lung function
1269153|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
1269154|NCT01719393|metabolites|metabolites
1269155|NCT01719393|exhaled breath condensate|exhaled breath condensate
1603578|NCT00380757|quality|quality
1269156|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
1269157|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
1269158|NCT01719367|Post-atenolol|post-atenolol
1269159|NCT01719354|Community Mental Health Centers|community mental health centers
1269160|NCT01719354|Norway|norway
1269164|NCT01719328|affect|affect
1269165|NCT01719328|mind/body therapies|mind/body therapies
1269166|NCT01719328|stress, psychological|stress, psychological
1269167|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
1269168|NCT01719302|gemcitabine|gemcitabine
1269169|NCT01719302|docetaxel|docetaxel
1269170|NCT01719302|pazopanib|pazopanib
1269171|NCT01719289|depression|depression
1269172|NCT01719289|problem solving|problem solving
1269173|NCT01719263|emphysema|emphysema
1269174|NCT01719263|InterVapor|intervapor
1269175|NCT01719263|treatments|treatments
1269176|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
1269177|NCT01719263|lung volume reduction|lung volume reduction
1269178|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
1269179|NCT01719237|Onset|onset
1269180|NCT01719237|Duration|duration
1269181|NCT01719237|Upper Limb Block|upper limb block
1269182|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
1269183|NCT01719237|Ropivacaine|ropivacaine
1269184|NCT01719237|Chloroprocaine|chloroprocaine
1269185|NCT01719211|MVP, mitral valve|mvp, mitral valve
1269186|NCT01719198|adenoma|adenoma
1269187|NCT01719198|calprotectin|calprotectin
1269188|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
1269189|NCT01719159|Monoclonal antibodies|monoclonal antibodies
1269190|NCT01719159|Mabthera|mabthera
1269191|NCT01719159|Intrathecal treatment|intrathecal treatment
1269192|NCT01719146|Anemia|anemia
1269193|NCT01719146|Chronic Kidney Disease|chronic kidney disease
1269194|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
1269195|NCT01719146|Erythropoietin|erythropoietin
1269196|NCT01719146|Iron|iron
1269197|NCT01719146|Iron Deficiency|iron deficiency
1269198|NCT01719133|allergy|allergy
1269199|NCT01719133|birch|birch
1269200|NCT01719120|Insomnia|insomnia
1269201|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1269202|NCT01719120|Internet-Based|internet-based
1269203|NCT01719120|Self-Help|self-help
1269204|NCT01719120|Randomized Controlled Trial|randomized controlled trial
1269205|NCT01719107|Functional abdominal pain|functional abdominal pain
1269206|NCT01719107|Probiotics|probiotics
1269207|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
1269208|NCT01719081|Sacroiliac Joint|sacroiliac joint
1269209|NCT01719081|Ultrasound|ultrasound
1269210|NCT01719081|Fluoroscopy|fluoroscopy
1269211|NCT01719081|Chronic Pain|chronic pain
1269212|NCT01719068|Mesothelioma|mesothelioma
1269213|NCT01719068|Lung Cancer|lung cancer
1269214|NCT01719068|Early Detection|early detection
1269215|NCT01719055|stimulation|stimulation
1269216|NCT01719055|implantable|implantable
1269217|NCT01719055|pulse generator|pulse generator
1269218|NCT01719055|back pain|back pain
1269219|NCT01719055|chronic pain|chronic pain
1269220|NCT01719055|leg pain|leg pain
1269221|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
1269222|NCT01719029|gestational diabetes|gestational diabetes
1269223|NCT01719029|diet therapy|diet therapy
1269224|NCT01719016|Reversible ischemia|reversible ischemia
1269225|NCT01719016|microvascular dysfunction|microvascular dysfunction
1269226|NCT01718977|Intervention|intervention
1269227|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
1269228|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
1269229|NCT01718977|carotid-to-femoral pulse wave velocity|carotid-to-femoral pulse wave velocity
1269230|NCT01718951|spondyloarthropathy|spondyloarthropathy
1269231|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
1269232|NCT01718938|Gastroparesis|gastroparesis
1269233|NCT01718938|Diabetic|diabetic
1269234|NCT01718938|Idiopathic|idiopathic
1269235|NCT01718938|Delayed gastric emptying|delayed gastric emptying
1269236|NCT01718912|periodontal disease|periodontal disease
1269237|NCT01718912|bleeding on probing|bleeding on probing
1269238|NCT01718912|periodontal pockets|periodontal pockets
1269239|NCT01718912|disabled|disabled
1269240|NCT01718886|Obesity|obesity
1269241|NCT01718886|Weight loss|weight loss
1269242|NCT01718886|Weight control|weight control
1269243|NCT01718886|Intragastric balloon|intragastric balloon
1269244|NCT01718886|gastric balloon|gastric balloon
1269245|NCT01718873|metastatic|metastatic
1269246|NCT01718873|stage IV|stage iv
1269247|NCT01718860|Cost Analysis|cost analysis
1269248|NCT01718860|Postoperative Complications|postoperative complications
1269249|NCT01718860|Length of Stay|length of stay
1269250|NCT01718860|Intensive Care Units|intensive care units
1269251|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
1269252|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
1269253|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
1269254|NCT01718834|prophylactic vaccine|prophylactic vaccine
1269255|NCT01718834|chronic HCV patients|chronic hcv patients
1269256|NCT01718834|healthy risk volunteers|healthy risk volunteers
1269257|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
1269258|NCT01718808|KRAS|kras
1269259|NCT01718808|BRAF|braf
1269260|NCT01718808|Wild-type Metastatic|wild-type metastatic
1269261|NCT01718808|Cetuximab|cetuximab
1269262|NCT01718808|Capecitabine|capecitabine
1269263|NCT01718808|Phase II Trial|phase ii trial
1269264|NCT01718808|Elderly Patients|elderly patients
1269265|NCT01718795|Airway|airway
1269266|NCT01718795|Cardiac Arrest|cardiac arrest
1269268|NCT01718795|Ventilation|ventilation
1269269|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
1269270|NCT01718769|Nutritional assessment|nutritional assessment
1269271|NCT01718769|children|children
1269272|NCT01718769|malnutrition|malnutrition
1269273|NCT01718756|Orthopaedic|orthopaedic
1269274|NCT01718756|General anaesthesia|general anaesthesia
1269275|NCT01718756|lornoxicam|lornoxicam
1269276|NCT01718756|patient controlled analgesia|patient controlled analgesia
1269277|NCT01718756|morphine consumption|morphine consumption
1269278|NCT01718743|Myeloma|myeloma
1269279|NCT01718743|Multiple Myeloma|multiple myeloma
1269280|NCT01718743|MM|mm
1269281|NCT01718743|Post Autologous Stem Cell Transplant|post autologous stem cell transplant
1269282|NCT01718743|Lenalidomide|lenalidomide
1269283|NCT01718743|CC-5013|cc-5013
1269284|NCT01718743|Revlimid|revlimid
1269285|NCT01718743|MLN9708|mln9708
1269286|NCT01718743|Questionnaire|questionnaire
1269287|NCT01718743|Survey|survey
1269288|NCT01718730|TMS|tms
1269289|NCT01718730|Adolescent|adolescent
1269290|NCT01718730|Child|child
1269291|NCT01718730|MDD|mdd
1269292|NCT01718730|Major depressive disorder|major depressive disorder
1269293|NCT01718730|Mild MDD|mild mdd
1269294|NCT01718730|Mild depression|mild depression
1269295|NCT01718730|SSRI|ssri
1269296|NCT01718730|Motor cortex|motor cortex
1269297|NCT01718730|Cortical excitability|cortical excitability
1269298|NCT01718730|Cortical inhibition|cortical inhibition
1269299|NCT01718730|Cortical silent period|cortical silent period
1269300|NCT01718730|Motor threshold|motor threshold
1269301|NCT01718730|Intracortical facilitation|intracortical facilitation
1269302|NCT01718730|Intracortical inhibition|intracortical inhibition
1269303|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
1269304|NCT01718730|Glutamate|glutamate
1269305|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
1269306|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1269307|NCT01718730|MRS|mrs
1269308|NCT01718717|Thoracotomy|thoracotomy
1269309|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
1269310|NCT01718717|Arrythmiogenesis|arrythmiogenesis
1269311|NCT01718717|Atrial fibrillation|atrial fibrillation
1269312|NCT01718717|Sympathetic outflow|sympathetic outflow
1269313|NCT01718704|rehabilitation|rehabilitation
1269314|NCT01718704|erectile dysfunction|erectile dysfunction
1269315|NCT01718704|incontinence|incontinence
1269316|NCT01718678|Multiple sclerosis|multiple sclerosis
1269317|NCT01718678|Melatonin|melatonin
1269318|NCT01718678|Fatigue|fatigue
1269319|NCT01718678|Quality of life|quality of life
1269320|NCT01718652|Healthy|healthy
1269321|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1269322|NCT01718652|Pharmacokinetics|pharmacokinetics
1269323|NCT01718652|Cyclosporine|cyclosporine
1269324|NCT01718600|carotid artery stenting|carotid artery stenting
1269325|NCT01718600|neuropsychological testing|neuropsychological testing
1269326|NCT01718600|microembolization|microembolization
1269327|NCT01718600|MRI|mri
1269328|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
1269329|NCT01718587|liver cirrhosis|liver cirrhosis
1269330|NCT01718587|antiviral therapy|antiviral therapy
1269331|NCT01718574|self-help book|self-help book
1269332|NCT01718574|support service|support service
1269333|NCT01718561|Airway assessment|airway assessment
1269334|NCT01718561|Intubation|intubation
1269335|NCT01718561|Mask ventilation|mask ventilation
1269336|NCT01718535|Cyp2C19|cyp2c19
1269337|NCT01718535|Genotyping|genotyping
1269338|NCT01718535|Spartan|spartan
1269339|NCT01718535|Comparison|comparison
1269340|NCT01718535|Sequencing|sequencing
1269341|NCT01718496|dyspnea|dyspnea
1269342|NCT01718496|COPD|copd
1269343|NCT01718496|exercise tolerance|exercise tolerance
1269344|NCT01718496|opioids|opioids
1269345|NCT01718496|morphine|morphine
1269346|NCT01718496|single dose oral Morphine|single dose oral morphine
1269347|NCT01718470|Systolic blood pressure|systolic blood pressure
1269348|NCT01718470|Heart rate|heart rate
1269349|NCT01718470|Laryngeal mask|laryngeal mask
1269350|NCT01718470|Endotracheal tube|endotracheal tube
1269351|NCT01718470|craniotomy|craniotomy
1269352|NCT01718457|Endobarrier|endobarrier
1269353|NCT01718457|Diabetes|diabetes
1269354|NCT01718457|Obesity|obesity
1269355|NCT01718457|Weight|weight
1269356|NCT01718457|BMI|bmi
1269357|NCT01718457|Lipid profile|lipid profile
1269358|NCT01718457|fatty liver|fatty liver
1269359|NCT01718457|gut peptides|gut peptides
1269360|NCT01718457|HbA1c|hba1c
1269361|NCT01718444|PCOS|pcos
1269362|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
1269363|NCT01718444|Infertility|infertility
1269364|NCT01718444|Anovulation|anovulation
1269365|NCT01718444|Clomiphene citrate|clomiphene citrate
1269366|NCT01718444|Clomid|clomid
1269367|NCT01718444|Progestin|progestin
1269368|NCT01718444|Provera|provera
1269369|NCT01718444|Progesterone|progesterone
1269467|NCT01717950|Hookworm|hookworm
1269370|NCT01718444|Endometrial shedding|endometrial shedding
1269371|NCT01718392|combined training|combined training
1269372|NCT01718392|insulin resistance|insulin resistance
1269373|NCT01718379|Myelodysplasia|myelodysplasia
1269374|NCT01718340|PCOS|pcos
1269375|NCT01718340|Hyper insulinaemia|hyper insulinaemia
1269376|NCT01718340|metformin|metformin
1269377|NCT01718340|recurrent abortion|recurrent abortion
1269378|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
1269379|NCT01718314|Hysteroscopy|hysteroscopy
1269380|NCT01718314|Misoprostol|misoprostol
1269381|NCT01718314|Lidocaine|lidocaine
1269382|NCT01718314|Visual analogue score|visual analogue score
1269383|NCT01718301|HCV|hcv
1269384|NCT01718301|HIV|hiv
1269385|NCT01718301|Coinfection|coinfection
1269386|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
1269387|NCT01718275|Appendicitis|appendicitis
1269388|NCT01718275|Pediatrics|pediatrics
1269389|NCT01718275|Children|children
1269390|NCT01718275|Non-operative|non-operative
1269391|NCT01718262|Ropivacaine Level|ropivacaine level
1269392|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
1269393|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
1269394|NCT01718249|Post-coma|post-coma
1269395|NCT01718249|Consciousness|consciousness
1269396|NCT01718249|Vegetative state|vegetative state
1269397|NCT01718249|Minimally conscious state|minimally conscious state
1269398|NCT01718236|caesarean section|caesarean section
1269399|NCT01718236|rocuronium|rocuronium
1269400|NCT01718236|sugammadex|sugammadex
1269401|NCT01718210|GM-CSF|gm-csf
1269402|NCT01718210|recurrent implantation failure|recurrent implantation failure
1269403|NCT01718210|pregnancy rate|pregnancy rate
1269404|NCT01718210|IVF|ivf
1269405|NCT01718197|Severe Asthma|severe asthma
1269406|NCT01718197|Bronchoscopy|bronchoscopy
1269407|NCT01718184|sulcoflex|sulcoflex
1269408|NCT01718184|toric|toric
1269409|NCT01718184|corneal implantation|corneal implantation
1269410|NCT01718171|Appendicitis|appendicitis
1269411|NCT01718171|SIRS|sirs
1269412|NCT01718171|C-reactive protein|c-reactive protein
1269413|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
1269414|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
1269415|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
1269416|NCT01718132|quality markers|quality markers
1269417|NCT01718106|coronary artery disease|coronary artery disease
1269418|NCT01718106|drug eluting stent|drug eluting stent
1269419|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
1269420|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
1269421|NCT01718106|restenosis|restenosis
1269422|NCT01718106|late thrombosis|late thrombosis
1269423|NCT01718093|Adolescents|adolescents
1269424|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
1269425|NCT01718067|Chest physiotherapy|chest physiotherapy
1269426|NCT01718067|Rehabilitation|rehabilitation
1269427|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
1269428|NCT01718054|Vascular function|vascular function
1269429|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
1269430|NCT01718054|Chloroquine|chloroquine
1269431|NCT01718054|Children|children
1269432|NCT01718054|Growth|growth
1269433|NCT01718054|Nitric Oxide|nitric oxide
1269434|NCT01718041|Growth hormone|growth hormone
1269435|NCT01718041|Growth hormone deficiency|growth hormone deficiency
1269436|NCT01718041|Growth|growth
1269437|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
1269438|NCT01718041|Long acting growth hormone|long acting growth hormone
1269439|NCT01718041|GHD|ghd
1269440|NCT01718041|PGHD|pghd
1269441|NCT01718041|VRS 317|vrs 317
1269442|NCT01718041|Exten|exten
1269443|NCT01718041|Versartis|versartis
1269444|NCT01718028|Systane BALANCE|systane balance
1269445|NCT01718028|Dry eye|dry eye
1269446|NCT01718028|lipid deficiency|lipid deficiency
1269447|NCT01718028|NITFBUT|nitfbut
1269448|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1269449|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
1269450|NCT01718015|Diabetes Mellitus|diabetes mellitus
1269451|NCT01718015|CD-163|cd-163
1269452|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
1269453|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
1269454|NCT01718015|Mass spectrometry|mass spectrometry
1269455|NCT01718002|Nursing|nursing
1269456|NCT01718002|Simulation|simulation
1269457|NCT01718002|Education|education
1269458|NCT01717989|Dialysis|dialysis
1269459|NCT01717989|Prospective Payment System|prospective payment system
1269460|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
1269461|NCT01717989|End Stage Renal Disease|end stage renal disease
1269462|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
1269463|NCT01717976|emergency department use|emergency department use
1269464|NCT01717976|Veterans|veterans
1269465|NCT01717950|Human Hookworm|human hookworm
1269466|NCT01717950|Necator americanus|necator americanus
1269468|NCT01717950|Hookworm Disease|hookworm disease
1269469|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
1269470|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
1269471|NCT01717950|Neglected Tropical Disease|neglected tropical disease
1269472|NCT01717950|Na-APR-1|na-apr-1
1269473|NCT01717937|retinovascular disease|retinovascular disease
1269474|NCT01717937|imaging|imaging
1269475|NCT01717937|fluorescein angiography|fluorescein angiography
1269476|NCT01717937|FA|fa
1269477|NCT01717937|angiography|angiography
1269478|NCT01717937|optical coherence tomography|optical coherence tomography
1269479|NCT01717937|OCT|oct
1269480|NCT01717937|phase variance|phase variance
1269481|NCT01717937|comparison|comparison
1269482|NCT01717937|age-related macular degeneration|age-related macular degeneration
1269483|NCT01717937|diabetic retinopathy|diabetic retinopathy
1269484|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
1269485|NCT01717937|retinal vein occlusion|retinal vein occlusion
1269486|NCT01717937|retinal artery occlusion|retinal artery occlusion
1269487|NCT01717924|Signet ring cell|signet ring cell
1269488|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
1269489|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
1269490|NCT01717924|surgery|surgery
1269491|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
1269492|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
1269493|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
1269494|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
1269495|NCT01717885|Pharmacokinetics|pharmacokinetics
1269496|NCT01717885|Antimalarial|antimalarial
1269497|NCT01717885|HIV|hiv
1269498|NCT01717885|Antiretrovirals|antiretrovirals
1269499|NCT01717885|Childhood development|childhood development
1269500|NCT01717885|Pregnancy|pregnancy
1269501|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
1269502|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
1269503|NCT01717846|Apoptosos|apoptosos
1269504|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
1269505|NCT01717846|T cells, B cells|t cells, b cells
1269506|NCT01717846|DAS28|das28
1269507|NCT01717846|Clinical Disease activity Index|clinical disease activity index
1269508|NCT01717846|CDAI|cdai
1269509|NCT01717833|ICU acquired weakness|icu acquired weakness
1269510|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
1269511|NCT01717833|post ICU rehabilitation|post icu rehabilitation
1269512|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
1269513|NCT01717833|handgrip|handgrip
1269514|NCT01717820|Obesity|obesity
1269515|NCT01717820|Postmenopausal women|postmenopausal women
1269516|NCT01717820|Body composition|body composition
1269517|NCT01717820|Resveratrol|resveratrol
1269518|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
1269519|NCT01717820|Bone formation|bone formation
1269520|NCT01717820|Adipose metabolism|adipose metabolism
1269521|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
1269522|NCT01717807|lung cancer|lung cancer
1269523|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
1269524|NCT01717807|erlotinib|erlotinib
1269525|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
1269526|NCT01717794|operative time|operative time
1269527|NCT01717794|laparoscopy|laparoscopy
1269528|NCT01717794|total hysterectomy|total hysterectomy
1269529|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
1269530|NCT01717794|endometrial cancer|endometrial cancer
1269531|NCT01717794|Thunderbeat|thunderbeat
1269532|NCT01717781|operative time|operative time
1269533|NCT01717781|laparoscopy|laparoscopy
1269534|NCT01717781|radical hysterectomy|radical hysterectomy
1269535|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
1269536|NCT01717781|cervical cancer|cervical cancer
1269537|NCT01717781|thunderbeat|thunderbeat
1269538|NCT01717768|hypogonadism|hypogonadism
1269539|NCT01717768|Gonadal Disorders|gonadal disorders
1269540|NCT01717768|Endocrine System Diseases|endocrine system diseases
1269541|NCT01717768|Testosterone|testosterone
1269542|NCT01717768|Testosterone enanthate|testosterone enanthate
1269543|NCT01717768|Testosterone undecanoate|testosterone undecanoate
1269544|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
1269545|NCT01717768|Methyltestosterone|methyltestosterone
1269546|NCT01717768|Androgens|androgens
1269547|NCT01717768|Hormones|hormones
1269548|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1269549|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
1269550|NCT01717768|Pharmacologic Actions|pharmacologic actions
1364454|NCT01315886|PID|pid
1269551|NCT01717768|Therapeutic Uses|therapeutic uses
1269552|NCT01717768|Anabolic Agents|anabolic agents
1269553|NCT01717755|basilar|basilar
1269554|NCT01717755|stroke|stroke
1269555|NCT01717755|mechanical|mechanical
1269556|NCT01717755|thrombolysis|thrombolysis
1269557|NCT01717755|intra-arterial|intra-arterial
1269558|NCT01717755|trombectomy|trombectomy
1269559|NCT01717742|Randomized controlled trial|randomized controlled trial
1269560|NCT01717742|Pleural Empyema|pleural empyema
1269561|NCT01717742|tPA|tpa
1269562|NCT01717742|DNase|dnase
1269664|NCT01717417|cone beam|cone beam
1269563|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
1269565|NCT01717716|obesity|obesity
1269566|NCT01717716|glucose|glucose
1269567|NCT01717716|sucrose|sucrose
1269568|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
1269569|NCT01717703|prevention|prevention
1269570|NCT01717690|MRSA|mrsa
1269571|NCT01717690|chlorhexidine|chlorhexidine
1269572|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1269573|NCT01717664|MAP|map
1269574|NCT01717664|antibiotic|antibiotic
1269575|NCT01717664|Interferon beta 1-a|interferon beta 1-a
1269576|NCT01717664|MS|ms
1269577|NCT01717664|MRI|mri
1269578|NCT01717664|EDSS|edss
1269579|NCT01717664|relapse rate|relapse rate
1269580|NCT01717651|Atrophy|atrophy
1269581|NCT01717651|Muscle wasting|muscle wasting
1269582|NCT01717651|Sepsis|sepsis
1269583|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
1269584|NCT01717625|montelukast|montelukast
1269585|NCT01717625|BPD|bpd
1269586|NCT01717625|singulair|singulair
1269587|NCT01717625|prematurity|prematurity
1269588|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
1269589|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
1269590|NCT01717599|Diclofenac|diclofenac
1269591|NCT01717599|NSAID|nsaid
1269592|NCT01717586|preeclampsia|preeclampsia
1269593|NCT01717586|pravastatin|pravastatin
1269594|NCT01717586|Pravachol®|pravachol®
1269595|NCT01717586|statin|statin
1269596|NCT01717586|high-risk pregnancy|high-risk pregnancy
1269597|NCT01717586|safety|safety
1269598|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
1269599|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
1269600|NCT01717586|neonatal mortality|neonatal mortality
1269601|NCT01717586|premature delivery|premature delivery
1269602|NCT01717586|preemie|preemie
1269603|NCT01717573|STEMI|stemi
1269604|NCT01717573|No-reflow|no-reflow
1269605|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
1269606|NCT01717573|Deferred stenting|deferred stenting
1269607|NCT01717560|chronic hepatitis C|chronic hepatitis c
1269608|NCT01717560|illicit drug use|illicit drug use
1269609|NCT01717560|Substance-Related Disorders|substance-related disorders
1269610|NCT01717560|multidisciplinary care|multidisciplinary care
1269611|NCT01717560|integrated care|integrated care
1269612|NCT01717560|mental health care|mental health care
1269613|NCT01717560|intensive case management|intensive case management
1269614|NCT01717547|Veterans|veterans
1269615|NCT01717547|Yoga|yoga
1269616|NCT01717547|Stress|stress
1269617|NCT01717534|Diarrhea|diarrhea
1269618|NCT01717534|Children|children
1269619|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
1269620|NCT01717521|hysterectomy|hysterectomy
1269621|NCT01717521|gynecological abdominal surgery|gynecological abdominal surgery
1269622|NCT01717508|MDD|mdd
1269623|NCT01717508|depression|depression
1269624|NCT01717508|major depressive disorder|major depressive disorder
1269625|NCT01717508|adolescent|adolescent
1269626|NCT01717495|Pacemaker|pacemaker
1269627|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
1269628|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
1269629|NCT01717495|Venous thrombosis|venous thrombosis
1269630|NCT01717495|Pulmonary embolism|pulmonary embolism
1269631|NCT01717495|Phlebography|phlebography
1269632|NCT01717495|Biological markers|biological markers
1269633|NCT01717495|Computed tomography angiography|computed tomography angiography
1269634|NCT01717482|Bronchoscopy|bronchoscopy
1269635|NCT01717482|Metformin|metformin
1269636|NCT01717469|Pacemaker|pacemaker
1269637|NCT01717469|Pacemaker implantation|pacemaker implantation
1269638|NCT01717469|Coronary sinus|coronary sinus
1269639|NCT01717469|Ventricular dysfunction|ventricular dysfunction
1269640|NCT01717469|Right ventricular pacing|right ventricular pacing
1269641|NCT01717469|Left ventricular pacing|left ventricular pacing
1269642|NCT01717456|Fecal incontinence|fecal incontinence
1269643|NCT01717456|Frail elders|frail elders
1269644|NCT01717456|Home health care|home health care
1269645|NCT01717456|Nurse|nurse
1269646|NCT01717456|Patient education|patient education
1269647|NCT01717443|Human Papillomavirus|human papillomavirus
1269648|NCT01717443|Renal transplantation|renal transplantation
1269649|NCT01717430|Injections, epidural|injections, epidural
1269650|NCT01717430|Injections, intra-articular|injections, intra-articular
1269651|NCT01717430|Chronic pain|chronic pain
1269652|NCT01717430|Neck pain|neck pain
1269653|NCT01717430|Back pain|back pain
1269654|NCT01717430|Low back pain|low back pain
1269655|NCT01717430|Sciatica|sciatica
1269656|NCT01717430|Sacroiliac joint|sacroiliac joint
1269657|NCT01717430|Corticosteroids|corticosteroids
1269658|NCT01717430|Dexamethasone|dexamethasone
1269659|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
1269660|NCT01717430|Adrenal insufficiency|adrenal insufficiency
1269661|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
1269662|NCT01717417|impacted canine|impacted canine
1269663|NCT01717417|miniscrew|miniscrew
1269665|NCT01717404|IBS|ibs
1269666|NCT01717391|radiotherapy|radiotherapy
1269667|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
1269668|NCT01717391|chemotherapy|chemotherapy
1269669|NCT01717391|bone marrow|bone marrow
1269670|NCT01717378|Patient Recruitment|patient recruitment
1269671|NCT01717378|Research Subject Recruitment|research subject recruitment
1269672|NCT01717378|Research Subject Selection|research subject selection
1269673|NCT01717378|Selection of Subjects|selection of subjects
1269674|NCT01717378|Health Surveys|health surveys
1269675|NCT01717378|Health Questionnaires|health questionnaires
1269676|NCT01717378|Health Interviews|health interviews
1269677|NCT01717365|SCOPE|scope
1269678|NCT01717352|Weight loss|weight loss
1269679|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1269680|NCT01717274|Hot water irrigation|hot water irrigation
1269681|NCT01717261|breast cancer|breast cancer
1269682|NCT01717261|early breast cancer|early breast cancer
1269683|NCT01717261|partial breast irradiation|partial breast irradiation
1269684|NCT01717261|preoperative radiation|preoperative radiation
1269685|NCT01717222|Lignocaine|lignocaine
1269686|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1269687|NCT01717222|Pain relief|pain relief
1269688|NCT01717209|heart failure|heart failure
1269689|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
1269690|NCT01717209|heart failure, right-sided|heart failure, right-sided
1269691|NCT01717209|heart-assist devices|heart-assist devices
1269692|NCT01717209|Heart Transplantation|heart transplantation
1269693|NCT01717196|sample adequacy|sample adequacy
1269694|NCT01717196|diagnostic accuracy|diagnostic accuracy
1269695|NCT01717196|complications|complications
1269696|NCT01717183|Patient|patient
1269697|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
1269698|NCT01717157|Healthy|healthy
1269699|NCT01717157|Fentanyl|fentanyl
1269700|NCT01717157|Transdermal patch|transdermal patch
1269701|NCT01717157|DUROGESIC|durogesic
1269702|NCT01717144|therapeutic education|therapeutic education
1269703|NCT01717144|Parkinson's disease|parkinson's disease
1269704|NCT01717144|quality of life|quality of life
1269705|NCT01717131|Invasive breast cancer|invasive breast cancer
1269706|NCT01717118|Evaluation|evaluation
1269707|NCT01717118|Immunogenicity|immunogenicity
1269708|NCT01717118|Levels|levels
1269709|NCT01717118|Women|women
1269710|NCT01717118|HPV|hpv
1269711|NCT01717118|Vaccine|vaccine
1269712|NCT01717118|Mexico|mexico
1269713|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1269714|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
1269715|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
1269716|NCT01717066|ginsenoside Rg3|ginsenoside rg3
1269717|NCT01717040|Bipolar Disorder|bipolar disorder
1269718|NCT01717040|Insulin Resistance|insulin resistance
1269719|NCT01717027|pharmacokinetics|pharmacokinetics
1269720|NCT01717027|bioavailability|bioavailability
1269721|NCT01717027|oxycodone|oxycodone
1269722|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
1269723|NCT01717014|rectal cancer|rectal cancer
1269724|NCT01717014|stapler|stapler
1269725|NCT01717001|kinematics|kinematics
1269726|NCT01717001|knee joint|knee joint
1269727|NCT01716988|Micafungin|micafungin
1269728|NCT01716988|pharmacokinetics|pharmacokinetics
1269729|NCT01716988|invasive candidiasis|invasive candidiasis
1269730|NCT01716988|intensive care|intensive care
1269731|NCT01716975|Schizophrenia|schizophrenia
1269732|NCT01716975|Cognition|cognition
1269733|NCT01716975|Cognition Impairment|cognition impairment
1269734|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
1269735|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
1269736|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
1269737|NCT01716949|rectal cancer|rectal cancer
1269738|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
1269739|NCT01716949|hyperthermia|hyperthermia
1269740|NCT01716949|radiation|radiation
1269741|NCT01716949|chemoradiation|chemoradiation
1269742|NCT01716949|5-FU|5-fu
1269743|NCT01716949|capecitabine|capecitabine
1269744|NCT01716949|oxaliplatin|oxaliplatin
1269745|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
1269746|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
1269747|NCT01716884|STEMI|stemi
1269748|NCT01716884|reperfution|reperfution
1269749|NCT01716884|primary PCI|primary pci
1269750|NCT01716858|Schizophrenia|schizophrenia
1269751|NCT01716858|Sulforaphane|sulforaphane
1269752|NCT01716858|Psychosis|psychosis
1269753|NCT01716858|Cognition|cognition
1269754|NCT01716858|Oxidative stress|oxidative stress
1269755|NCT01716858|Antioxidant|antioxidant
1269756|NCT01716858|Anti-inflammatory|anti-inflammatory
1269757|NCT01716845|autism|autism
1269758|NCT01716845|autism spectrum disorders|autism spectrum disorders
1269759|NCT01716845|RNA|rna
1269760|NCT01716845|gene expression|gene expression
1269761|NCT01716845|developmental delay|developmental delay
1269863|NCT01716494|asthma|asthma
1269762|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
1269763|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
1269764|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
1269765|NCT01716806|Hematologic Diseases|hematologic diseases
1269766|NCT01716806|Hodgkin Disease|hodgkin disease
1269767|NCT01716806|Antigens, CD30|antigens, cd30
1269768|NCT01716806|Lymphoma|lymphoma
1269769|NCT01716806|monomethylauristatin E|monomethylauristatin e
1269770|NCT01716806|Drug Therapy|drug therapy
1269771|NCT01716793|Primary AML|primary aml
1269772|NCT01716793|Risk-adapted treatment|risk-adapted treatment
1269773|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
1269774|NCT01716793|CD34+ cell selection|cd34+ cell selection
1269775|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
1269776|NCT01716767|hand pain|hand pain
1269777|NCT01716767|wrist pain|wrist pain
1269778|NCT01716767|arm pain|arm pain
1269779|NCT01716767|topical menthol|topical menthol
1269780|NCT01716754|asthma|asthma
1269781|NCT01716754|asthma control|asthma control
1269782|NCT01716754|allergy|allergy
1269783|NCT01716754|atopic|atopic
1269784|NCT01716754|IgE|ige
1269785|NCT01716754|double-blind|double-blind
1269786|NCT01716754|placebo|placebo
1269787|NCT01716754|omalizumab|omalizumab
1269788|NCT01716741|Gaucher disease|gaucher disease
1269789|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
1269790|NCT01716741|metabolic disease|metabolic disease
1269791|NCT01716741|medical records review|medical records review
1269792|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
1269793|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
1269794|NCT01716728|Wolman Disease|wolman disease
1269795|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
1269796|NCT01716728|Metabolic Disease|metabolic disease
1269797|NCT01716728|Recessive Inheritance|recessive inheritance
1269798|NCT01716702|Prostate Cancer|prostate cancer
1269799|NCT01716702|Psychosocial Intervention|psychosocial intervention
1269800|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
1269801|NCT01716702|Online Intervention|online intervention
1269802|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
1269803|NCT01716663|Atrial fibrillation|atrial fibrillation
1269804|NCT01716663|Observational|observational
1269805|NCT01716663|Acute procedural outcomes|acute procedural outcomes
1269806|NCT01716663|Ablation|ablation
1269807|NCT01716650|ankle|ankle
1269808|NCT01716650|saphenous nerve block|saphenous nerve block
1269809|NCT01716637|Alzheimer's Disease|alzheimer's disease
1269810|NCT01716637|Dementia|dementia
1269811|NCT01716637|Cognitive decline|cognitive decline
1269812|NCT01716637|Cognitive disorder|cognitive disorder
1269813|NCT01716637|Degenerative brain disease|degenerative brain disease
1269814|NCT01716637|Cognitive impairment|cognitive impairment
1269815|NCT01716637|Memory loss|memory loss
1269816|NCT01716637|TNF-alpha|tnf-alpha
1269817|NCT01716624|Pediatric|pediatric
1269818|NCT01716611|liver cirrhosis|liver cirrhosis
1269819|NCT01716611|hyponatemia|hyponatemia
1269820|NCT01716611|ascites|ascites
1269821|NCT01716611|vaptans|vaptans
1269822|NCT01716611|antidiuretic hormon|antidiuretic hormon
1269823|NCT01716611|arginine vasopressin|arginine vasopressin
1269824|NCT01716598|COPD|copd
1269825|NCT01716598|TLD Therapy|tld therapy
1269826|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
1269827|NCT01716598|IPS|ips
1269828|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
1269829|NCT01716598|Holaira, Inc.|holaira, inc.
1269830|NCT01716585|Hepatitis C Virus|hepatitis c virus
1269831|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
1269832|NCT01716585|Hepatitis C|hepatitis c
1269833|NCT01716585|Treatment-Naïve|treatment-naïve
1269834|NCT01716585|Interferon-Free|interferon-free
1269835|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
1269836|NCT01716585|Viekira Pak|viekira pak
1269837|NCT01716585|ombitasvir|ombitasvir
1269838|NCT01716585|paritaprevir|paritaprevir
1269839|NCT01716585|dasabuvir|dasabuvir
1269840|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
1269841|NCT01716572|Endoscopy|endoscopy
1269842|NCT01716572|Erythromycin|erythromycin
1269843|NCT01716572|Gastric lavage|gastric lavage
1269844|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
1269845|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
1269846|NCT01716546|DCF|dcf
1269847|NCT01716533|Serological|serological
1269848|NCT01716533|Adults|adults
1269849|NCT01716533|Clostridium difficile|clostridium difficile
1269850|NCT01716533|Adult CDI patients|adult cdi patients
1269851|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1269852|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
1269853|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1269854|NCT01716520|vilanterol|vilanterol
1269855|NCT01716520|umeclidinium|umeclidinium
1269856|NCT01716507|RRD|rrd
1269857|NCT01716507|Rhegmatogenous|rhegmatogenous
1269858|NCT01716507|Retinal|retinal
1269859|NCT01716507|Detachment|detachment
1269860|NCT01716507|PPV|ppv
1269861|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
1269862|NCT01716507|Gauge|gauge
1269864|NCT01716481|Stroke|stroke
1269865|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
1269866|NCT01716481|Stem cells|stem cells
1269867|NCT01716481|Neurogenesis|neurogenesis
1269868|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
1269869|NCT01716468|Low carbohydrate|low carbohydrate
1269870|NCT01716442|rituximab|rituximab
1269871|NCT01716442|nephrotic|nephrotic
1269872|NCT01716442|refractory|refractory
1269873|NCT01716429|vegetarian|vegetarian
1269874|NCT01716429|vegan|vegan
1269875|NCT01716429|low calorie|low calorie
1269876|NCT01716429|weight Loss|weight loss
1269877|NCT01716429|infertility|infertility
1269878|NCT01716429|PCOS|pcos
1269879|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
1269880|NCT01716377|Neck Pain|neck pain
1269881|NCT01716377|Musculoskeletal pain|musculoskeletal pain
1269882|NCT01716377|Venlafaxine|venlafaxine
1269883|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
1269884|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
1269885|NCT01716351|Yoga|yoga
1269886|NCT01716351|Electrophysiology|electrophysiology
1269887|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1269888|NCT01716351|Psychosocial|psychosocial
1269889|NCT01716351|Anxiety|anxiety
1269890|NCT01716351|Self-Compassion|self-compassion
1269891|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
1269892|NCT01716338|glyburide|glyburide
1269893|NCT01716338|glybenclamide|glybenclamide
1269894|NCT01716338|hypoglycemia|hypoglycemia
1269895|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
1269896|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
1269897|NCT01716299|HIV|hiv
1269898|NCT01716299|Diagnostics|diagnostics
1269899|NCT01716247|Mammography (CESM)|mammography (cesm)
1269900|NCT01716247|MRI|mri
1269901|NCT01716247|Breast screening|breast screening
1269902|NCT01716247|12-214|12-214
1269903|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
1269904|NCT01716208|Complement|complement
1269905|NCT01716208|Monoclonal Antibody|monoclonal antibody
1269906|NCT01716195|Human Papillomavirus|human papillomavirus
1269907|NCT01716195|HPV|hpv
1269908|NCT01716143|atrial fibrillation|atrial fibrillation
1269909|NCT01716143|catheter ablation|catheter ablation
1269910|NCT01716143|Mapping|mapping
1269911|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
1269912|NCT01716117|Large aneurysm|large aneurysm
1269913|NCT01716117|Giant aneurysm|giant aneurysm
1269914|NCT01716117|Wide neck aneurysm|wide neck aneurysm
1269915|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
1269916|NCT01716078|Brachial Plexus|brachial plexus
1269917|NCT01716078|Nerve Block|nerve block
1269918|NCT01716078|Nerve Conduction|nerve conduction
1269919|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
1269920|NCT01716052|Mammogram|mammogram
1269921|NCT01716052|Ibuprofen|ibuprofen
1269922|NCT01716052|Pain management|pain management
1269923|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
1269924|NCT01716026|high myopia|high myopia
1269925|NCT01716026|choroidal neovascularization|choroidal neovascularization
1269926|NCT01716000|vaginal gel|vaginal gel
1269927|NCT01716000|vaginal coating|vaginal coating
1269928|NCT01716000|sensory perceptions|sensory perceptions
1269929|NCT01715987|Hepatitis B|hepatitis b
1269930|NCT01715987|Antiviral|antiviral
1269931|NCT01715987|Tubular dysfunction|tubular dysfunction
1269932|NCT01715987|Entecavir|entecavir
1269933|NCT01715987|Tenofovir|tenofovir
1269934|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
1269935|NCT01715961|70 years old|70 years old
1269936|NCT01715961|DLBCL|dlbcl
1269937|NCT01715961|Rituximab-CHOP|rituximab-chop
1269938|NCT01715961|Sarcopenia|sarcopenia
1269939|NCT01715948|CROS hearing aid|cros hearing aid
1269940|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
1269941|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
1269942|NCT01715935|everolimus|everolimus
1269943|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
1269944|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
1364947|NCT01313689|CLL|cll
1269945|NCT01715922|HIV Infections|hiv infections
1269946|NCT01715922|Oral treatment|oral treatment
1269947|NCT01715922|High dose of fluconazole|high dose of fluconazole
1269948|NCT01715922|Flucytosine|flucytosine
1269949|NCT01715922|Burundi|burundi
1269950|NCT01715922|Ivory Coast|ivory coast
1269951|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
1269952|NCT01715896|Golimumab|golimumab
1269953|NCT01715896|Mavrilimumab|mavrilimumab
1269954|NCT01715883|Lung transplant|lung transplant
1269955|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
1269956|NCT01715883|Sodium Nitrite|sodium nitrite
1269957|NCT01715870|Age related macular degeneration|age related macular degeneration
1269958|NCT01715870|Food habits|food habits
1269959|NCT01715870|Life style|life style
1269960|NCT01715870|Risk factors|risk factors
1269961|NCT01715870|questionnaire|questionnaire
1269962|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
1269963|NCT01715857|Physician's Practice Patterns|physician's practice patterns
1269964|NCT01715857|Chinese|chinese
1269965|NCT01715857|Sevoflurane|sevoflurane
1269966|NCT01715844|L-citrulline|l-citrulline
1269967|NCT01715844|ADMA|adma
1269968|NCT01715844|Asthma|asthma
1269969|NCT01715844|Obesity|obesity
1269970|NCT01715805|MDD|mdd
1269971|NCT01715805|Major Depressive Disorder|major depressive disorder
1269972|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
1269973|NCT01715792|United Kingdom|united kingdom
1269974|NCT01715792|Influenza|influenza
1269975|NCT01715792|H1N1|h1n1
1269976|NCT01715792|Pandemrix™|pandemrix™
1269977|NCT01715779|Liver transplantation|liver transplantation
1269978|NCT01715779|ENABLE|enable
1269979|NCT01715779|observational|observational
1269980|NCT01715779|mortality|mortality
1269981|NCT01715779|Thromboembolic Events|thromboembolic events
1269982|NCT01715779|Hepatic decompensation|hepatic decompensation
1269983|NCT01715779|Long-Term follow-up|long-term follow-up
1269984|NCT01715779|TEE|tee
1269985|NCT01715766|Proteomics study|proteomics study
1269986|NCT01715766|biomarker study of pain|biomarker study of pain
1269987|NCT01715753|Function|function
1269988|NCT01715753|Muscle mass|muscle mass
1269989|NCT01715740|Chinese herbal medicine|chinese herbal medicine
1269990|NCT01715740|Urticaria|urticaria
1269991|NCT01715740|Antipruritics|antipruritics
1269992|NCT01715740|Phase III clinical trial|phase iii clinical trial
1269993|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
1269994|NCT01715727|parkinson disease|parkinson disease
1269995|NCT01715727|parkinsonism|parkinsonism
1269996|NCT01715727|diagnosis|diagnosis
1269997|NCT01715727|differential diagnosis|differential diagnosis
1269998|NCT01715714|Coronary Artery Disease|coronary artery disease
1269999|NCT01715714|Statins|statins
1270000|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1270001|NCT01715714|Cardiac Surgery|cardiac surgery
1270002|NCT01715675|asthma|asthma
1270003|NCT01715675|allergy|allergy
1270004|NCT01715675|sitostanol|sitostanol
1270005|NCT01715675|cytokines|cytokines
1270006|NCT01715675|Th1|th1
1270007|NCT01715675|Treg|treg
1270008|NCT01715675|antibodies|antibodies
1270009|NCT01715675|IgE|ige
1270010|NCT01715675|vaccination|vaccination
1270011|NCT01715662|rehabilitation|rehabilitation
1270012|NCT01715662|lower limb amputation|lower limb amputation
1270013|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
1270014|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
1270015|NCT01715662|older adults|older adults
1270016|NCT01715662|cognitive computer games|cognitive computer games
1270017|NCT01715662|home-based training|home-based training
1270018|NCT01715662|Nintendo Wii|nintendo wii
1270019|NCT01715662|virtual reality|virtual reality
1270020|NCT01715649|Type 2 diabetes|type 2 diabetes
1270021|NCT01715649|self-management|self-management
1270022|NCT01715649|remote patient monitoring|remote patient monitoring
1270023|NCT01715623|polymorphism|polymorphism
1270024|NCT01715623|serum Ig|serum ig
1270025|NCT01715597|uterine leiomyoma|uterine leiomyoma
1270026|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
1270027|NCT01715597|intraoperative blood loss|intraoperative blood loss
1270028|NCT01715597|ascorbic acid|ascorbic acid
1270029|NCT01715584|Hypertension|hypertension
1270030|NCT01715584|Sevoflurane|sevoflurane
1270031|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
1270032|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
1270033|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
1270034|NCT01715571|erectile dysfunction|erectile dysfunction
1270035|NCT01715571|vibratory stimulation|vibratory stimulation
1270036|NCT01715571|viberect|viberect
1270037|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
1270038|NCT01715545|vitrification|vitrification
1270039|NCT01715545|clinical outcome|clinical outcome
1270040|NCT01715532|Huachansu|huachansu
1270041|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
1270042|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1270043|NCT01715532|randomized controlled trial|randomized controlled trial
1270044|NCT01715519|Vilazodone|vilazodone
1270045|NCT01715519|PTSD|ptsd
1270046|NCT01715519|Depression|depression
1270047|NCT01715506|Dementia|dementia
1270048|NCT01715506|Resident|resident
1270049|NCT01715506|Nursinghome|nursinghome
1270050|NCT01715506|Use of restraint|use of restraint
1270051|NCT01715506|Agitation|agitation
1270052|NCT01715493|COPD|copd
1270053|NCT01715493|Asthma|asthma
1270054|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
1270055|NCT01715480|broccoli sprout|broccoli sprout
1270056|NCT01715480|sickle cell|sickle cell
1270057|NCT01715480|NRF2|nrf2
1270058|NCT01715467|Dupuytren|dupuytren
1270059|NCT01715467|Contracture|contracture
1270060|NCT01715467|Auxilium|auxilium
1270061|NCT01715467|XIAFLEX|xiaflex
1270062|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
1270063|NCT01715441|KRAS mutation|kras mutation
1270064|NCT01715441|Sorafenib|sorafenib
1270065|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
1270066|NCT01715415|Hepatitis C|hepatitis c
1270067|NCT01715415|Treatment-Experienced|treatment-experienced
1270068|NCT01715415|Null responder|null responder
1270069|NCT01715415|Partial Responder|partial responder
1270070|NCT01715415|Chronic Hepatitis|chronic hepatitis
1270071|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
1270072|NCT01715415|Interferon-Free|interferon-free
1270073|NCT01715415|Hepatitis C Virus|hepatitis c virus
1270074|NCT01715415|Relapser|relapser
1270075|NCT01715415|Non responder|non responder
1270076|NCT01715415|Viekira Pak|viekira pak
1270077|NCT01715415|ombitasvir|ombitasvir
1270078|NCT01715415|ribavirin|ribavirin
1270079|NCT01715415|ritonavir|ritonavir
1270080|NCT01715415|paritaprevir|paritaprevir
1270081|NCT01715415|dasabuvir|dasabuvir
1270082|NCT01715402|liver tumor|liver tumor
1270083|NCT01715402|carcinoma|carcinoma
1270084|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
1270085|NCT01715402|metastasis|metastasis
1270086|NCT01715389|Asthma|asthma
1270087|NCT01715389|Goals|goals
1270088|NCT01715389|Shared Decision Making|shared decision making
1270089|NCT01715389|Patient Portal|patient portal
1270090|NCT01715389|Electronic Medical Record|electronic medical record
1270091|NCT01715376|traditional chinese medicine|traditional chinese medicine
1270092|NCT01715376|complementary therapies|complementary therapies
1270093|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
1270094|NCT01715350|Alzheimer's Disease|alzheimer's disease
1270095|NCT01715337|muscle fibre|muscle fibre
1270096|NCT01715337|capillary|capillary
1270097|NCT01715337|rehabilitation|rehabilitation
1270098|NCT01715337|exercise training|exercise training
1270099|NCT01715324|In vitro fertilization|in vitro fertilization
1270100|NCT01715324|Antagonist protocol|antagonist protocol
1270101|NCT01715324|Growth Hormone|growth hormone
1270102|NCT01715311|COPD|copd
1270103|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1270104|NCT01715311|indacaterol|indacaterol
1270105|NCT01715311|tiotropium|tiotropium
1270106|NCT01715298|Anticholinergic|anticholinergic
1270107|NCT01715298|Antimuscarinic|antimuscarinic
1270108|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1270109|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1270110|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1270111|NCT01715298|COPD|copd
1270112|NCT01715298|LAMA|lama
1270113|NCT01715298|Lung Disease|lung disease
1270114|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
1270115|NCT01715298|Lung Function|lung function
1270116|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
1270117|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1270118|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
1270119|NCT01715285|Prostate neoplasms|prostate neoplasms
1270120|NCT01715285|Prostate cancer|prostate cancer
1270121|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
1270122|NCT01715285|Abiraterone acetate|abiraterone acetate
1270123|NCT01715285|ZYTIGA|zytiga
1270124|NCT01715285|Prednisone|prednisone
1270125|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
1270126|NCT01715259|Renal insufficiency|renal insufficiency
1270127|NCT01715259|Renal impairment|renal impairment
1270128|NCT01715259|End-stage renal disease|end-stage renal disease
1270129|NCT01715259|Abiraterone acetate|abiraterone acetate
1270130|NCT01715259|Pharmacokinetics|pharmacokinetics
1270131|NCT01715246|healthy babbies|healthy babbies
1270132|NCT01715246|infant formula|infant formula
1270133|NCT01715246|growth|growth
1270134|NCT01715246|HMO|hmo
1270135|NCT01715220|Nitroglycerin|nitroglycerin
1270136|NCT01715220|Biliary Colic|biliary colic
1270137|NCT01715220|Cholelithiasis|cholelithiasis
1270138|NCT01715220|Abdominal Pain.|abdominal pain.
1270139|NCT01715194|OSAS|osas
1270140|NCT01715194|CPAP|cpap
1270141|NCT01715194|Adherence|adherence
1270142|NCT01715194|Telemedicine|telemedicine
1270143|NCT01715168|Doxil generic|doxil generic
1270144|NCT01715168|Caelyx generic|caelyx generic
1270145|NCT01715168|generic treatment|generic treatment
1270146|NCT01715168|ovarian cancer|ovarian cancer
1270147|NCT01715168|ovary|ovary
1270148|NCT01715168|progressed|progressed
1270149|NCT01715168|recurred cancer|recurred cancer
1270150|NCT01715168|platinum based therapy|platinum based therapy
1270151|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
1270152|NCT01715155|retrospective study,|retrospective study,
1270153|NCT01715155|disease progression,|disease progression,
1270154|NCT01715155|clinical management|clinical management
1270155|NCT01715142|Pancreatic cancer|pancreatic cancer
1270156|NCT01715142|Nab-paclitaxel|nab-paclitaxel
1270157|NCT01715142|Gemcitabine|gemcitabine
1270158|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1270159|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
1270160|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
1270161|NCT01715116|Patient Safety|patient safety
1270162|NCT01715116|Quality of life|quality of life
1270163|NCT01715103|HIV infection|hiv infection
1270164|NCT01715103|mucosa|mucosa
1270165|NCT01715103|immunological parameters|immunological parameters
1270166|NCT01715103|genital sampling|genital sampling
1270167|NCT01715103|healthy women volunteers|healthy women volunteers
1270168|NCT01715077|melanoma|melanoma
1270169|NCT01715077|stage IV|stage iv
1270170|NCT01715077|stage III|stage iii
1270171|NCT01715077|unresectable|unresectable
1270172|NCT01715064|Prostate Cancer|prostate cancer
1270173|NCT01715064|Exercise|exercise
1270174|NCT01715064|Cortical Inhibition|cortical inhibition
1270175|NCT01715064|Cortical Silent Period|cortical silent period
1270176|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1270178|NCT01715051|D-serine|d-serine
1270179|NCT01715051|Drug dependence|drug dependence
1270180|NCT01715038|malnutrition|malnutrition
1270181|NCT01715038|stunting|stunting
1270182|NCT01715038|LNS|lns
1270183|NCT01715038|micronutrient powder|micronutrient powder
1270184|NCT01715038|hemoglobin|hemoglobin
1270185|NCT01715025|measured|measured
1270186|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
1270187|NCT01715025|combined oral contraceptive|combined oral contraceptive
1270188|NCT01715025|alkaline haematin method|alkaline haematin method
1270189|NCT01715012|Burn|burn
1270190|NCT01715012|Diabetes|diabetes
1270191|NCT01715012|Skin graft|skin graft
1270192|NCT01715012|Donor site|donor site
1270193|NCT01714999|olecranon|olecranon
1270194|NCT01714999|prepatellar|prepatellar
1270195|NCT01714999|bursa|bursa
1270196|NCT01714999|trauma|trauma
1270197|NCT01714999|laceration|laceration
1270198|NCT01714999|bursectomy|bursectomy
1270199|NCT01714999|bursa reconstruction|bursa reconstruction
1270200|NCT01714986|Diabetes mellitus|diabetes mellitus
1270201|NCT01714986|Depression|depression
1270202|NCT01714986|Anxiety|anxiety
1270203|NCT01714986|Alexithymia|alexithymia
1270204|NCT01714986|Self Image|self image
1270205|NCT01714986|HbA1c|hba1c
1270206|NCT01714986|Psychoeducation|psychoeducation
1270207|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
1270208|NCT01714934|MICROASPIRATION|microaspiration
1270209|NCT01714908|NSCLC|nsclc
1270210|NCT01714908|EGFR mutation|egfr mutation
1270211|NCT01714908|unresectable|unresectable
1270212|NCT01714908|erlotinib|erlotinib
1270213|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
1270214|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
1270215|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
1270216|NCT01714895|Glucose clamp|glucose clamp
1270217|NCT01714882|Infertility|infertility
1270218|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
1270219|NCT01714882|Stress Management|stress management
1270220|NCT01714882|Stress Reduction|stress reduction
1270221|NCT01714869|Swedish massage|swedish massage
1270222|NCT01714869|massage|massage
1270223|NCT01714869|osteoarthritis|osteoarthritis
1270224|NCT01714869|knee|knee
1270225|NCT01714843|ASP0456|asp0456
1270226|NCT01714843|constipation|constipation
1270227|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1270228|NCT01714843|linaclotide|linaclotide
1270229|NCT01714804|Bone Morphogenetic Protein (BMP)|bone morphogenetic protein (bmp)
1270230|NCT01714804|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
1270231|NCT01714804|Fusion rates|fusion rates
1270232|NCT01714804|Interbody fusion|interbody fusion
1270233|NCT01714804|Lumbar spine|lumbar spine
1270234|NCT01714804|Transverse lumbar interbody fusion (TLIF)|transverse lumbar interbody fusion (tlif)
1270235|NCT01714804|Patient reported outcomes|patient reported outcomes
1270236|NCT01714804|Posterolateral lumbar fusion (PLF)|posterolateral lumbar fusion (plf)
1270237|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
1270238|NCT01714791|Osteopathic Medicine|osteopathic medicine
1270239|NCT01714791|Vital Capacity|vital capacity
1270240|NCT01714791|Quality of Life|quality of life
1270241|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
1270242|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
1270243|NCT01714752|Diagnosis|diagnosis
1270244|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
1270245|NCT01714752|Exercise echocardiography|exercise echocardiography
1270246|NCT01714752|Left atrial remodeling|left atrial remodeling
1270247|NCT01714726|MEDI2070|medi2070
1270248|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
1270249|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
1270250|NCT01714713|Schizophrenia|schizophrenia
1270251|NCT01714713|Cognition|cognition
1270252|NCT01714713|Cognition Impairment|cognition impairment
1270253|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
1270254|NCT01714700|protein|protein
1270255|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
1270256|NCT01714700|overweight|overweight
1270257|NCT01714674|cardiac troponin T|cardiac troponin t
1270258|NCT01714674|cTnT|ctnt
1270259|NCT01714674|exercise|exercise
1270260|NCT01714674|dietary nitrate|dietary nitrate
1270261|NCT01714661|Schizophrenia|schizophrenia
1270262|NCT01714661|Cognition|cognition
1270263|NCT01714661|Cognition Impairment|cognition impairment
1270264|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
1270265|NCT01714648|OVULATION INDUCTION|ovulation induction
1270266|NCT01714635|cataract|cataract
1270267|NCT01714635|IOL|iol
1270268|NCT01714635|intraocular lens|intraocular lens
1270269|NCT01714622|metabolic syndrome|metabolic syndrome
1270270|NCT01714622|insulin resistance|insulin resistance
1270271|NCT01714622|gastric cancer|gastric cancer
1270272|NCT01714609|portal hypertension|portal hypertension
1270273|NCT01714609|sorafenib|sorafenib
1270274|NCT01714596|Oral Antibiotic|oral antibiotic
1270275|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
1270276|NCT01714596|Wound infection|wound infection
1270277|NCT01714596|Randomized Controlled Trial|randomized controlled trial
1270278|NCT01714583|Mechanical ventilation|mechanical ventilation
1270279|NCT01714583|ARDS|ards
1270280|NCT01714583|acute lung injury|acute lung injury
1270281|NCT01714583|cardiac function|cardiac function
1270282|NCT01714583|cardiac index|cardiac index
1270283|NCT01714583|heart-lung interaction|heart-lung interaction
1270284|NCT01714531|Mild TBI|mild tbi
1270285|NCT01714518|Interstitial Lung Disease|interstitial lung disease
1270286|NCT01714518|Diagnosis|diagnosis
1270287|NCT01714518|Cryobiopsy|cryobiopsy
1270288|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
1270289|NCT01714518|Lung biopsy|lung biopsy
1270290|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1270291|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
1270292|NCT01714505|Artificial Pancreas|artificial pancreas
1270293|NCT01714505|Insulin Pump|insulin pump
1270294|NCT01714505|Closed Loop control|closed loop control
1270295|NCT01714505|Open Loop treatment|open loop treatment
1270296|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1270297|NCT01714492|in vivo mechanics|in vivo mechanics
1270298|NCT01714492|kinematics|kinematics
1270299|NCT01714492|fluoroscopy|fluoroscopy
1270300|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
1270301|NCT01714440|genetic variation|genetic variation
1270302|NCT01714440|recipient genotypes|recipient genotypes
1270303|NCT01714440|donor genotypes|donor genotypes
1270304|NCT01714414|HIV|hiv
1270305|NCT01714414|Fozivudine|fozivudine
1270306|NCT01714414|Zidovudine|zidovudine
1270307|NCT01714414|FATI|fati
1270308|NCT01714388|remifentanil|remifentanil
1270309|NCT01714388|heart rate|heart rate
1270310|NCT01714388|autonomic nervous system|autonomic nervous system
1270311|NCT01714388|heart rate variability|heart rate variability
1270312|NCT01714388|autonomic nervous activity|autonomic nervous activity
1270313|NCT01714388|vagotonic effect|vagotonic effect
1270314|NCT01714388|single dose|single dose
1270315|NCT01714362|oculocardiac effect|oculocardiac effect
1270316|NCT01714362|bradycardia|bradycardia
1270317|NCT01714362|HRV|hrv
1270318|NCT01714349|Spinal cord injury|spinal cord injury
1270319|NCT01714349|nerve transfer|nerve transfer
1270320|NCT01714349|tetraplegia|tetraplegia
1270321|NCT01714349|quadriplegia|quadriplegia
1270322|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
1270323|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
1270324|NCT01714323|Cigarette smoking|cigarette smoking
1270325|NCT01714323|Tobacco smoking|tobacco smoking
1270326|NCT01714323|Tobacco use disorder|tobacco use disorder
1270327|NCT01714310|severe mood dysregulation|severe mood dysregulation
1270328|NCT01714310|irritability|irritability
1270329|NCT01714310|lisdexamfetamine|lisdexamfetamine
1270330|NCT01714310|fluoxetine|fluoxetine
1270331|NCT01714310|newly recognized syndrome|newly recognized syndrome
1270332|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
1270333|NCT01714297|blood loss|blood loss
1270334|NCT01714297|wound discharge|wound discharge
1270335|NCT01714297|thromboprophylaxis|thromboprophylaxis
1270336|NCT01714297|biomarkers|biomarkers
1270337|NCT01714284|psoriasis|psoriasis
1270338|NCT01714258|cardiac output|cardiac output
1270339|NCT01714258|fick method|fick method
1270340|NCT01714258|thermodilution|thermodilution
1365424|NCT01311557|Tetanus|tetanus
1270341|NCT01714245|Eczema|eczema
1270342|NCT01714245|Atopic Dermatitis|atopic dermatitis
1270343|NCT01714245|Compromised Skin|compromised skin
1270344|NCT01714245|Inflamed Skin|inflamed skin
1270345|NCT01714219|prostatic neoplasms|prostatic neoplasms
1270346|NCT01714219|prostatectomy|prostatectomy
1270347|NCT01714219|robotics|robotics
1270348|NCT01714219|urinary incontinence|urinary incontinence
1270349|NCT01714206|Healthy|healthy
1270350|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1270351|NCT01714206|Pharmacokinetics|pharmacokinetics
1270352|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
1270353|NCT01714193|Healthy|healthy
1270354|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1270355|NCT01714193|Pharmacokinetics|pharmacokinetics
1270356|NCT01714193|Contraceptives, Oral|contraceptives, oral
1270357|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
1270358|NCT01714193|Levonorgestrel|levonorgestrel
1270359|NCT01714193|LEVORA|levora
1270360|NCT01714180|Acyclovir|acyclovir
1270361|NCT01714180|Pharmacokinetics|pharmacokinetics
1270362|NCT01714180|Obese|obese
1270363|NCT01714180|Non-obese|non-obese
1270364|NCT01714180|Weight|weight
1270365|NCT01714180|Distribution|distribution
1270366|NCT01714180|Clearance|clearance
1270367|NCT01714167|Chronic|chronic
1270368|NCT01714167|Ischemic Stroke|ischemic stroke
1270369|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
1270370|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
1270371|NCT01714141|Technology based intervention|technology based intervention
1270372|NCT01714141|Emerging adults|emerging adults
1270373|NCT01714141|African Americans|african americans
1270374|NCT01714141|Asthma|asthma
1270375|NCT01714141|Controller medications|controller medications
1270376|NCT01714141|Motivational intervention|motivational intervention
1270377|NCT01714128|NCI protocol #8762|nci protocol #8762
1270378|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
1270379|NCT01714128|recurrent breast cancer|recurrent breast cancer
1270380|NCT01714128|stage IV breast cancer|stage iv breast cancer
1270381|NCT01714102|Obesity|obesity
1270382|NCT01714102|Insulin resistance|insulin resistance
1270383|NCT01714102|Metabolic syndrome|metabolic syndrome
1270384|NCT01714102|Pre-diabetes|pre-diabetes
1270385|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1270386|NCT01714089|RR-MS|rr-ms
1270387|NCT01714063|pediatric|pediatric
1270388|NCT01714063|asthma|asthma
1270389|NCT01714063|metered dose inhaler|metered dose inhaler
1270390|NCT01714063|valved holding chamber|valved holding chamber
1270391|NCT01714063|pMDI|pmdi
1270392|NCT01714063|VHC|vhc
1270393|NCT01714050|seasonal affective disorder|seasonal affective disorder
1270394|NCT01714050|winter depression|winter depression
1270395|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
1270396|NCT01714050|light therapy|light therapy
1270397|NCT01714037|Safety|safety
1270398|NCT01714037|Efficacy|efficacy
1270399|NCT01714037|HSP90|hsp90
1270400|NCT01714037|Debio 0932|debio 0932
1270502|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
1270401|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
1270402|NCT01714024|Dental|dental
1270403|NCT01714024|Implant|implant
1270404|NCT01714024|UNC Dental School|unc dental school
1270405|NCT01714024|Trabecular Metal|trabecular metal
1270406|NCT01714024|Titanium|titanium
1270407|NCT01714024|Healthy Volunteers|healthy volunteers
1270408|NCT01714024|Diabetic|diabetic
1270409|NCT01714024|Osteopenic|osteopenic
1270410|NCT01714024|Bone Inductive Properties|bone inductive properties
1270411|NCT01714024|Osseous Healing|osseous healing
1270412|NCT01714024|GO Health|go health
1270413|NCT01714024|Offenbacher|offenbacher
1270414|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
1270415|NCT01714011|Randomized|randomized
1270416|NCT01714011|Controlled|controlled
1270417|NCT01714011|Trial|trial
1270418|NCT01714011|Safety|safety
1270419|NCT01714011|Efficacy|efficacy
1270420|NCT01714011|Aripiprazole|aripiprazole
1270421|NCT01714011|Ziprasidone|ziprasidone
1270422|NCT01714011|Metabolic Syndrome|metabolic syndrome
1270423|NCT01713998|Ulthera® System|ulthera® system
1270424|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
1270425|NCT01713998|Ulthera, Inc.|ulthera, inc.
1270426|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1270427|NCT01713985|Ulthera® System|ulthera® system
1270428|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
1270429|NCT01713985|Ulthera, Inc.|ulthera, inc.
1270430|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1270431|NCT01713972|BRAFi|brafi
1270432|NCT01713972|BRAF-mutated|braf-mutated
1270433|NCT01713959|Underarm sweating|underarm sweating
1270434|NCT01713946|TSC seizures,|tsc seizures,
1270435|NCT01713946|TSC epilepsy,|tsc epilepsy,
1270436|NCT01713946|mTOR inhibitor,|mtor inhibitor,
1270437|NCT01713946|RAD001,|rad001,
1270438|NCT01713946|Everolimus|everolimus
1270439|NCT01713933|Ulthera® System|ulthera® system
1603982|NCT00378859|Insulin|insulin
1270440|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
1270441|NCT01713933|Ulthera, Inc.|ulthera, inc.
1270442|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
1270443|NCT01713907|Ulthera® System|ulthera® system
1270444|NCT01713907|Ulthera, Inc.|ulthera, inc.
1270445|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1270446|NCT01713894|Counseling|counseling
1270447|NCT01713894|Limits of viability|limits of viability
1270448|NCT01713881|Polyp|polyp
1270449|NCT01713881|colonoscopy|colonoscopy
1270450|NCT01713881|surveillance|surveillance
1270451|NCT01713868|Breastfeeding|breastfeeding
1270452|NCT01713868|Safe Sleep|safe sleep
1270453|NCT01713868|Messaging|messaging
1270454|NCT01713868|Social Media|social media
1270455|NCT01713855|ITP|itp
1270456|NCT01713855|Rituximab|rituximab
1270457|NCT01713855|Vaccine|vaccine
1270458|NCT01713855|Immune Reconstitution|immune reconstitution
1270459|NCT01713842|Tocilizumab|tocilizumab
1270460|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
1270461|NCT01713842|Glucocorticotherapy|glucocorticotherapy
1270462|NCT01713842|PMR-AS|pmr-as
1270463|NCT01713829|cranberry|cranberry
1270464|NCT01713829|gamma delta T cell|gamma delta t cell
1270465|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
1270466|NCT01713829|proliferation|proliferation
1270467|NCT01713816|Glutathione|glutathione
1270468|NCT01713816|Ascorbate|ascorbate
1270469|NCT01713816|Alzheimer's disease|alzheimer's disease
1270470|NCT01713816|Aging|aging
1270471|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1270472|NCT01713790|physical functional performance|physical functional performance
1270473|NCT01713790|postural balance|postural balance
1270474|NCT01713790|reaction time|reaction time
1270475|NCT01713790|mobility|mobility
1270476|NCT01713790|muscle strength|muscle strength
1270477|NCT01713790|cognition|cognition
1270478|NCT01713777|Seizures|seizures
1270479|NCT01713764|diabetes|diabetes
1270480|NCT01713764|obesity|obesity
1270481|NCT01713764|mindful eating|mindful eating
1270482|NCT01713764|positive affect|positive affect
1270483|NCT01713764|low carbohydrate|low carbohydrate
1270484|NCT01713764|diet|diet
1270485|NCT01713751|Surgical site infection|surgical site infection
1270486|NCT01713751|Cesarean section|cesarean section
1270487|NCT01713738|ITP|itp
1270488|NCT01713738|rituximab|rituximab
1270489|NCT01713738|bleeding score|bleeding score
1270490|NCT01713738|platelet count|platelet count
1270491|NCT01713738|health-related quality of life|health-related quality of life
1270492|NCT01713738|HRQL|hrql
1270493|NCT01713725|Chronic urticaria|chronic urticaria
1270494|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
1270495|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
1270496|NCT01713725|UAS7|uas7
1270497|NCT01713712|Pregnancy|pregnancy
1270498|NCT01713712|Obesity|obesity
1270499|NCT01713712|Nutrition therapy|nutrition therapy
1270500|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
1270501|NCT01713686|Ulthera® System|ulthera® system
1270503|NCT01713686|Ulthera, Inc.|ulthera, inc.
1270504|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
1270505|NCT01713673|Hyperhidrosis|hyperhidrosis
1270506|NCT01713673|Axillary sweating|axillary sweating
1270507|NCT01713673|Ulthera® System|ulthera® system
1270508|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
1270509|NCT01713673|Ulthera, Inc.|ulthera, inc.
1270510|NCT01713660|Cataract surgery|cataract surgery
1270511|NCT01713660|Femtosecond laser|femtosecond laser
1270512|NCT01713660|Corneal incisions|corneal incisions
1270513|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
1270514|NCT01713634|Bone resorption|bone resorption
1270515|NCT01713634|Diet|diet
1270516|NCT01713621|P. falciparum|p. falciparum
1270517|NCT01713621|malaria|malaria
1270518|NCT01713608|malaria|malaria
1270519|NCT01713608|dose escalation|dose escalation
1270520|NCT01713608|safety|safety
1270521|NCT01713608|tolerability|tolerability
1270522|NCT01713608|maximum tolerated dose|maximum tolerated dose
1270523|NCT01713595|Acute Lung Injury|acute lung injury
1270524|NCT01713595|Mechanical Ventilation|mechanical ventilation
1270525|NCT01713569|Ulthera® System|ulthera® system
1270526|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
1270527|NCT01713569|Ulthera, Inc.|ulthera, inc.
1270528|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1270529|NCT01713556|PTSD, Propranolol|ptsd, propranolol
1270530|NCT01713543|falls|falls
1270531|NCT01713517|Mosquito Control|mosquito control
1270532|NCT01713517|Insecticide Resistance|insecticide resistance
1270533|NCT01713491|brain ischemia|brain ischemia
1270534|NCT01713491|thrombolytic therapy|thrombolytic therapy
1270535|NCT01713491|Impaired cognition|impaired cognition
1270536|NCT01713491|dementia|dementia
1270537|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
1604255|NCT00378638|lymph|lymph
1270538|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
1270539|NCT01713478|echocardiography|echocardiography
1270540|NCT01713478|specific biomarkers|specific biomarkers
1270541|NCT01713478|vascular assessment|vascular assessment
1270542|NCT01713465|Diabetes|diabetes
1270543|NCT01713465|Hypertension|hypertension
1270544|NCT01713465|Hypercholesterolemia|hypercholesterolemia
1270545|NCT01713465|Obesity|obesity
1270546|NCT01713452|Surgical Stomas|surgical stomas
1270547|NCT01713452|ileostomy|ileostomy
1270548|NCT01713452|surgical site infection|surgical site infection
1270549|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
1270550|NCT01713439|Retroviral vector injections|retroviral vector injections
1270551|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
1270552|NCT01713439|Lymphotactin|lymphotactin
1270553|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
1270554|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
1270555|NCT01713426|Qutenza|qutenza
1270556|NCT01713426|NGX-4010|ngx-4010
1270557|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
1270558|NCT01713426|Pregabalin|pregabalin
1270559|NCT01713413|Oxymizer|oxymizer
1270560|NCT01713413|endurance time|endurance time
1270561|NCT01713413|exercise test|exercise test
1270562|NCT01713413|nasal cannula|nasal cannula
1270563|NCT01713413|COPD|copd
1270564|NCT01713413|ILD|ild
1270565|NCT01713413|oxygenation|oxygenation
1270566|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
1270567|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
1270568|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
1270569|NCT01713374|endothelial function|endothelial function
1270570|NCT01713374|sympathetic nervous system|sympathetic nervous system
1270571|NCT01713361|total knee arthroplasty|total knee arthroplasty
1270572|NCT01713361|Prophylaxis|prophylaxis
1270573|NCT01713348|CGM|cgm
1270574|NCT01713348|MDI|mdi
1270575|NCT01713322|parent education|parent education
1270576|NCT01713322|pain management|pain management
1270577|NCT01713322|immunization|immunization
1270578|NCT01713322|infant|infant
1270579|NCT01713309|Filgrastim|filgrastim
1270580|NCT01713309|G-CSF|g-csf
1270581|NCT01713309|Heparin-binding protein|heparin-binding protein
1270582|NCT01713309|critically ill|critically ill
1270583|NCT01713309|acute respiratory failure|acute respiratory failure
1270584|NCT01713296|SCLC|sclc
1270585|NCT01713296|2nd Line|2nd line
1270586|NCT01713296|Relapsed or Refractory|relapsed or refractory
1270587|NCT01713270|Hypertension|hypertension
1270588|NCT01713270|Atrial Fibrillation|atrial fibrillation
1270589|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
1270590|NCT01713270|Heart Diseases|heart diseases
1270591|NCT01713257|Critically ill patients|critically ill patients
1270592|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
1270593|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
1270594|NCT01713244|Hepatectomy|hepatectomy
1270595|NCT01713244|Recurrence|recurrence
1270596|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
1270597|NCT01713231|high-dose vitamin D|high-dose vitamin d
1270598|NCT01713231|bone density|bone density
1270599|NCT01713231|muscle function|muscle function
1270600|NCT01713218|Pancreas|pancreas
1270601|NCT01713218|Cancer|cancer
1270602|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
1270603|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1270604|NCT01713218|Dynamic imaging|dynamic imaging
1270727|NCT01712620|Pulmonary Hypertension|pulmonary hypertension
1270605|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
1270606|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
1270607|NCT01713153|prevention|prevention
1270608|NCT01713153|misoprostol|misoprostol
1270609|NCT01713153|Uniject|uniject
1270610|NCT01713153|oxytocin|oxytocin
1270611|NCT01713140|strength training|strength training
1270612|NCT01713140|resistance training|resistance training
1270613|NCT01713140|fatigue|fatigue
1270614|NCT01713140|knee extension|knee extension
1270615|NCT01713140|total knee arthroplasty|total knee arthroplasty
1270616|NCT01713140|total knee replacement|total knee replacement
1270617|NCT01713140|electromyography|electromyography
1270618|NCT01713140|physical therapy modalities|physical therapy modalities
1270619|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1270620|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
1270621|NCT01713101|Hematemesis|hematemesis
1270622|NCT01713101|Melena|melena
1270623|NCT01713101|Tranexamic acid|tranexamic acid
1270624|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
1270625|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1270626|NCT01713075|Symbicort|symbicort
1270627|NCT01713075|long-term use|long-term use
1270628|NCT01713049|FLT PET|flt pet
1270629|NCT01713049|breast neoplasms|breast neoplasms
1270630|NCT01713049|mammography|mammography
1270631|NCT01713049|breast ultrasound|breast ultrasound
1270632|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
1270633|NCT01713023|type 1 diabetes|type 1 diabetes
1270634|NCT01713023|fructose|fructose
1270635|NCT01713023|glucose|glucose
1270636|NCT01713023|TAS1R2|tas1r2
1270637|NCT01713023|oxidative stress|oxidative stress
1270638|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
1270639|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
1270640|NCT01713010|Mechanical Ventilation|mechanical ventilation
1270641|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
1270642|NCT01713010|Respiration Disorders|respiration disorders
1270643|NCT01713010|Traumatic Brain Injury|traumatic brain injury
1270644|NCT01713010|Weaning Failure|weaning failure
1270645|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
1270646|NCT01712997|Treatment of|treatment of
1270647|NCT01712984|Influenza|influenza
1270648|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
1270649|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
1270650|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
1270651|NCT01712971|surgery|surgery
1270652|NCT01712971|pancreas|pancreas
1270653|NCT01712971|tumour|tumour
1270654|NCT01712971|blood loss|blood loss
1270655|NCT01712958|CRC miRNA|crc mirna
1270656|NCT01712945|Alemtuzumab|alemtuzumab
1270657|NCT01712945|Palifermin|palifermin
1270658|NCT01712945|Reconstitution|reconstitution
1270664|NCT01712893|adjuvant therapy|adjuvant therapy
1270665|NCT01712893|Ovarian suppression|ovarian suppression
1270667|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1270668|NCT01712854|Long acting beta agonist|long acting beta agonist
1270669|NCT01712841|Dry AMD|dry amd
1270670|NCT01712841|Age-related macular degeneration|age-related macular degeneration
1270671|NCT01712841|Optical coherenece tomography|optical coherenece tomography
1270672|NCT01712841|Imaging|imaging
1270673|NCT01712841|Blood flow|blood flow
1270674|NCT01712828|Lenalidomide,|lenalidomide,
1270675|NCT01712828|Revlimid,|revlimid,
1270676|NCT01712828|pharmacokinetics,|pharmacokinetics,
1270677|NCT01712828|healthy male subjects|healthy male subjects
1270683|NCT01712776|Vapocoolant|vapocoolant
1270684|NCT01712763|Endometriosis|endometriosis
1270685|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
1270686|NCT01712763|Degarelix|degarelix
1270687|NCT01712763|Recurrence|recurrence
1270688|NCT01712763|Pelvic Pain|pelvic pain
1270689|NCT01712750|Regional tissue oximetry|regional tissue oximetry
1270690|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
1270691|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
1270692|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
1270693|NCT01712724|exercise therapy|exercise therapy
1270694|NCT01712724|rehabilitation|rehabilitation
1270695|NCT01712711|Steatohepatitis,|steatohepatitis,
1270696|NCT01712711|Helicobacter pylori,|helicobacter pylori,
1270697|NCT01712711|Insulin resistance,|insulin resistance,
1270698|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
1270699|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
1270700|NCT01712698|trauma|trauma
1270701|NCT01712698|spinal cord injury|spinal cord injury
1270702|NCT01712698|cervical spine|cervical spine
1270703|NCT01712685|Kidney Neoplasm|kidney neoplasm
1270704|NCT01712685|RCC|rcc
1270705|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
1270706|NCT01712685|CAIX Staining|caix staining
1270707|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
1270708|NCT01712672|Dental Plaque|dental plaque
1270709|NCT01712672|Biofilm|biofilm
1270710|NCT01712672|Bacterial Interactions|bacterial interactions
1270711|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
1270712|NCT01712672|Oral Streptococci|oral streptococci
1270713|NCT01712659|JAK 1/2|jak 1/2
1270714|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
1270715|NCT01712659|HTLV-1|htlv-1
1270716|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
1270717|NCT01712646|Oxytocin|oxytocin
1270718|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
1270719|NCT01712646|Double Blind|double blind
1270720|NCT01712633|fMRI|fmri
1270721|NCT01712633|Brain Perfusion|brain perfusion
1270722|NCT01712620|Microarray|microarray
1270723|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
1270724|NCT01712620|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
1270725|NCT01712620|Neurohormonal Axis|neurohormonal axis
1270726|NCT01712620|Vascular Inflammation|vascular inflammation
1270728|NCT01712620|Cardiovascular Disease|cardiovascular disease
1270729|NCT01712620|Vascular Disease|vascular disease
1270730|NCT01712607|laparoscopy|laparoscopy
1270731|NCT01712607|surgery|surgery
1270732|NCT01712607|warm-up|warm-up
1270733|NCT01712607|preoperative|preoperative
1270734|NCT01712607|surgical skills|surgical skills
1270735|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
1270736|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
1270737|NCT01712555|Anophthalmic orbits|anophthalmic orbits
1270738|NCT01712555|autologous fat|autologous fat
1270739|NCT01712555|platelet rich plasma|platelet rich plasma
1270740|NCT01712555|orbital atrophy|orbital atrophy
1270741|NCT01712555|anophthalmos|anophthalmos
1270742|NCT01712555|cannula|cannula
1270743|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
1270744|NCT01712529|endothelium|endothelium
1270745|NCT01712529|exercise|exercise
1270746|NCT01712516|COPD, QVA149|copd, qva149
1270747|NCT01712503|Cataract|cataract
1270748|NCT01712503|Astigmatism|astigmatism
1270749|NCT01712503|Toric|toric
1270750|NCT01712503|Phacoemulsification|phacoemulsification
1270751|NCT01712503|Intraocular lens|intraocular lens
1270752|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
1270753|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
1270754|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
1270755|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
1270756|NCT01712490|Antigens, CD-30|antigens, cd-30
1270757|NCT01712490|Immunotherapy|immunotherapy
1270758|NCT01712490|Lymphoma|lymphoma
1270759|NCT01712490|Lymphoma, Classical|lymphoma, classical
1270760|NCT01712490|ECHELON-1|echelon-1
1270761|NCT01712451|adiposity|adiposity
1270762|NCT01712438|Previously untreated patients|previously untreated patients
1270763|NCT01712425|vaccine|vaccine
1270764|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
1270765|NCT01712373|Multiple sclerosis|multiple sclerosis
1270766|NCT01712373|Ginseng|ginseng
1270767|NCT01712373|Fatigue|fatigue
1270768|NCT01712373|Quality of life|quality of life
1270769|NCT01712360|Tinea Pedis|tinea pedis
1270770|NCT01712360|Tinea Cruris|tinea cruris
1270771|NCT01712360|Athlete foot|athlete foot
1270772|NCT01712360|Jock itch|jock itch
1270773|NCT01712321|Social Anxiety Disorder|social anxiety disorder
1270774|NCT01712321|Social Anxiety|social anxiety
1270775|NCT01712321|Social Phobia|social phobia
1270776|NCT01712321|SAD|sad
1270777|NCT01712308|Leukemia|leukemia
1270778|NCT01712308|Myeloproliferative Neoplasm|myeloproliferative neoplasm
1270779|NCT01712308|MPN|mpn
1270780|NCT01712308|Associated Myelofibrosis|associated myelofibrosis
1270781|NCT01712308|Anemia|anemia
1270782|NCT01712308|Sotatercept|sotatercept
1270783|NCT01712308|ACE-011|ace-011
1270784|NCT01712295|Warts|warts
1270785|NCT01712295|salicylic acid|salicylic acid
1270786|NCT01712295|ethyl pyruvate|ethyl pyruvate
1270787|NCT01712282|Physical Activity|physical activity
1270788|NCT01712282|Accelerometer|accelerometer
1270789|NCT01712256|CD4|cd4
1270790|NCT01712256|Clinical trial|clinical trial
1270791|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
1270792|NCT01712256|HIV|hiv
1270793|NCT01712256|Immunomodulary|immunomodulary
1270794|NCT01712256|Infection|infection
1270795|NCT01712256|Phase II|phase ii
1270796|NCT01712256|Re-boost|re-boost
1270797|NCT01712256|Vaccine|vaccine
1270798|NCT01712256|Vacc-4x|vacc-4x
1270799|NCT01712230|hormone therapy|hormone therapy
1270800|NCT01712230|obesity|obesity
1270801|NCT01712230|menopause|menopause
1270802|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
1270803|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
1270804|NCT01712230|metabolic syndrome|metabolic syndrome
1270805|NCT01712230|women's health|women's health
1270806|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
1270807|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
1270808|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
1270809|NCT01712204|Hyperuricemia|hyperuricemia
1270810|NCT01712204|Gouty arthritis|gouty arthritis
1270811|NCT01712191|NUsurface|nusurface
1270812|NCT01712191|Meniscus|meniscus
1270813|NCT01712191|Knee|knee
1270814|NCT01712191|KOOS|koos
1270815|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
1270816|NCT01712165|Folic acid supplement|folic acid supplement
1270817|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
1270818|NCT01712165|Homocysteine concentration|homocysteine concentration
1270819|NCT01712165|Plasma Folate concentration|plasma folate concentration
1270820|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
1270821|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
1270822|NCT01712152|carrier|carrier
1270823|NCT01712152|cardiac MRI|cardiac mri
1270824|NCT01712152|myocardial fibrosis|myocardial fibrosis
1270825|NCT01712152|female|female
1270826|NCT01712087|spasticity|spasticity
1270827|NCT01712087|muscle spasticity|muscle spasticity
1270828|NCT01712087|muscle rigidity|muscle rigidity
1270829|NCT01712087|motor neuron disease|motor neuron disease
1270830|NCT01712087|hyperreflexia|hyperreflexia
1270831|NCT01712074|Randomized|randomized
1270832|NCT01712074|Double Blind|double blind
1270833|NCT01712074|Safety and Efficacy|safety and efficacy
1270834|NCT01712061|Diabetic nephropathy|diabetic nephropathy
1270835|NCT01712061|type 2 diabetes|type 2 diabetes
1270836|NCT01712061|albuminuria|albuminuria
1270837|NCT01712061|chemokine antagonist|chemokine antagonist
1270838|NCT01712035|Wet AMD|wet amd
1270839|NCT01712035|Age-related macular degeneration|age-related macular degeneration
1270840|NCT01712035|Optical coherenece tomography|optical coherenece tomography
1270841|NCT01712035|Imaging|imaging
1366059|NCT01308931|IUD|iud
1270842|NCT01712035|Blood flow|blood flow
1270843|NCT01712009|Breast cancer|breast cancer
1270844|NCT01712009|Chemotherapy|chemotherapy
1270845|NCT01712009|Neulasta|neulasta
1270846|NCT01712009|Pegfilgrastim|pegfilgrastim
1270847|NCT01712009|Naproxen|naproxen
1270848|NCT01712009|Loratadine|loratadine
1270849|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
1270850|NCT01712009|Anti-histamine|anti-histamine
1270851|NCT01712009|Bone Pain|bone pain
1270852|NCT01711996|hydronephrosis|hydronephrosis
1270853|NCT01711996|biopsy|biopsy
1270854|NCT01711996|biomarker|biomarker
1270855|NCT01711957|Complications|complications
1270856|NCT01711957|Mortality|mortality
1270857|NCT01711957|Liver transplantation|liver transplantation
1270858|NCT01711957|Platelet count|platelet count
1270859|NCT01711957|Survival|survival
1270860|NCT01711944|childhood cancer|childhood cancer
1270861|NCT01711944|Internet communication|internet communication
1270862|NCT01711944|parents|parents
1270863|NCT01711944|caregivers|caregivers
1270864|NCT01711944|problem solving|problem solving
1270865|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
1270866|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
1270867|NCT01711931|everolimus|everolimus
1270868|NCT01711931|biolimus|biolimus
1270869|NCT01711918|gastroparesis|gastroparesis
1270870|NCT01711918|domperidone|domperidone
1270871|NCT01711918|nausea|nausea
1270872|NCT01711918|vomiting|vomiting
1270873|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
1270874|NCT01711892|Prostate Cancer|prostate cancer
1270875|NCT01711892|Exercise|exercise
1270876|NCT01711892|Soccer|soccer
1270877|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
1270878|NCT01711892|Body Composition|body composition
1270879|NCT01711892|Cardiovascular fitness|cardiovascular fitness
1270880|NCT01711892|Bone Health|bone health
1270881|NCT01711892|Health Related Quality of Life|health related quality of life
1270882|NCT01711866|Rotigotine|rotigotine
1270883|NCT01711866|Neupro|neupro
1270884|NCT01711866|Switch|switch
1270885|NCT01711866|Dopamine agonists|dopamine agonists
1270886|NCT01711840|Bronchial asthma|bronchial asthma
1270887|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
1270888|NCT01711827|isavuconazole|isavuconazole
1270889|NCT01711827|prednisone|prednisone
1270890|NCT01711827|prednisolone|prednisolone
1270891|NCT01711827|BAL8557|bal8557
1270892|NCT01711827|healthy volunteers|healthy volunteers
1270893|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
1270894|NCT01711814|ASP015K|asp015k
1270895|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
1270896|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
1270897|NCT01711788|Intrabone infusion|intrabone infusion
1270898|NCT01711788|Platelet recovery|platelet recovery
1270899|NCT01711788|Neutrophil recovery|neutrophil recovery
1270900|NCT01711788|Pediatric patients|pediatric patients
1270901|NCT01711736|Immunogenicity|immunogenicity
1270902|NCT01711736|Children|children
1270903|NCT01711736|Safety|safety
1270904|NCT01711736|Seasonal influenza|seasonal influenza
1270905|NCT01711736|Fluarix|fluarix
1270906|NCT01711723|darapladib|darapladib
1270907|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
1270908|NCT01711723|healthy volunteer|healthy volunteer
1270909|NCT01711723|renal impairment|renal impairment
1270910|NCT01711723|pharmacokinetics|pharmacokinetics
1270911|NCT01711710|Breast cancer|breast cancer
1270912|NCT01711710|reconstruction|reconstruction
1270913|NCT01711710|augmentation|augmentation
1270914|NCT01711710|cohesive silicone gel|cohesive silicone gel
1270915|NCT01711710|breast implant|breast implant
1270916|NCT01711710|rupture|rupture
1270917|NCT01711710|capsular contracture|capsular contracture
1270918|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
1270919|NCT01711684|Melanoma|melanoma
1270920|NCT01711645|Acellular|acellular
1270921|NCT01711645|Adacel®|adacel®
1270922|NCT01711645|Diptheria toxoids|diptheria toxoids
1270923|NCT01711645|Pertussis|pertussis
1270924|NCT01711645|postpartum|postpartum
1270925|NCT01711645|Tdap|tdap
1270926|NCT01711645|Tetanus|tetanus
1270927|NCT01711645|women|women
1270928|NCT01711632|VEMURAFENIB|vemurafenib
1270929|NCT01711632|BRAF Inhibitor|braf inhibitor
1270930|NCT01711632|12-200|12-200
1270931|NCT01711632|Zelboraf™|zelboraf™
1270932|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
1270933|NCT01711606|registry|registry
1270934|NCT01711606|non-interventional trial|non-interventional trial
1270935|NCT01711606|patient-related outcome study|patient-related outcome study
1270936|NCT01711606|drug utilization|drug utilization
1270937|NCT01711606|effectiveness|effectiveness
1270938|NCT01711606|treatment patterns|treatment patterns
1270939|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
1270940|NCT01711606|quality of life|quality of life
1270941|NCT01711606|economics|economics
1270942|NCT01711593|Asthma|asthma
1270943|NCT01711593|Allergic|allergic
1270944|NCT01711593|Inflammation|inflammation
1270945|NCT01711593|Airway|airway
1270946|NCT01711593|Challenge|challenge
1270947|NCT01711593|Chemokines|chemokines
1270948|NCT01711593|Tolerization|tolerization
1270949|NCT01711580|Recurrent glioma|recurrent glioma
1270950|NCT01711580|Quality of life|quality of life
1270951|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
1270952|NCT01711580|Anaplastic glioma|anaplastic glioma
1270953|NCT01711580|Cognition|cognition
1270954|NCT01711580|Re-irradiation|re-irradiation
1270955|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
1270956|NCT01711567|TENOFOVIR|tenofovir
1270957|NCT01711567|ENTECAVIR|entecavir
1270958|NCT01711567|PARTIAL RESPONDER|partial responder
1270959|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
1270960|NCT01711502|epidemiology,|epidemiology,
1270961|NCT01711502|retrospective cohort|retrospective cohort
1270962|NCT01711489|isavuconazole|isavuconazole
1270963|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
1270964|NCT01711489|BAL8557|bal8557
1270965|NCT01711489|BAL4815|bal4815
1270966|NCT01711489|healthy volunteers|healthy volunteers
1270967|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
1270968|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
1270969|NCT01711489|CellCept|cellcept
1270970|NCT01711476|PCOS|pcos
1270971|NCT01711476|Bdiet|bdiet
1270972|NCT01711476|Ddiet|ddiet
1270973|NCT01711476|OGTT|ogtt
1270974|NCT01711463|Pharmacodynamics|pharmacodynamics
1270975|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
1270976|NCT01711463|novel dry powder device|novel dry powder device
1270977|NCT01711463|Safety and tolerability|safety and tolerability
1270978|NCT01711463|vilanterol(VI)|vilanterol(vi)
1270979|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
1270980|NCT01711463|Pharmacokinetics|pharmacokinetics
1270981|NCT01711437|colonoscopy|colonoscopy
1270982|NCT01711437|colon cleansing|colon cleansing
1270983|NCT01711437|children|children
1270984|NCT01711437|age 2 -18 years|age 2 -18 years
1270985|NCT01711411|HIV prevention|hiv prevention
1270986|NCT01711411|PrePex|prepex
1270987|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
1270988|NCT01711411|non-surgical|non-surgical
1270989|NCT01711411|medical device|medical device
1270990|NCT01711411|wound healing|wound healing
1270991|NCT01711411|Kenya|kenya
1270992|NCT01711398|solid tumor|solid tumor
1270993|NCT01711398|peptide|peptide
1270994|NCT01711385|Oral Health|oral health
1270995|NCT01711385|Prediabetes|prediabetes
1270996|NCT01711385|Diabetes|diabetes
1270997|NCT01711385|Periodontitis|periodontitis
1270998|NCT01711385|Early Identification|early identification
1270999|NCT01711385|Prevention|prevention
1271000|NCT01711372|ADHD|adhd
1271001|NCT01711320|Omeprazole|omeprazole
1271002|NCT01711320|Metformin|metformin
1271003|NCT01711307|Achilles|achilles
1271004|NCT01711307|Rupture|rupture
1271005|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
1271007|NCT01711294|EUS-FNA|eus-fna
1271008|NCT01711281|Heart Failure|heart failure
1271009|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
1271010|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
1271011|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1271012|NCT01711281|Home Monitoring|home monitoring
1271013|NCT01711281|Reverse Remodeling|reverse remodeling
1271014|NCT01711268|Sunitinib|sunitinib
1271015|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
1271117|NCT01710800|impedance|impedance
1271016|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
1271017|NCT01711268|Pharmacokinetic|pharmacokinetic
1271018|NCT01711268|Treatment toxicity|treatment toxicity
1271019|NCT01711255|Multiple sclerosis|multiple sclerosis
1271020|NCT01711255|Coagulation|coagulation
1271021|NCT01711255|Alternative Medicine|alternative medicine
1271022|NCT01711255|Clotting|clotting
1271023|NCT01711255|Complementary Medicine|complementary medicine
1271024|NCT01711255|Inflammation|inflammation
1271025|NCT01711242|gastric cancer|gastric cancer
1271026|NCT01711242|radiotherapy|radiotherapy
1271027|NCT01711242|postoperative therapy|postoperative therapy
1271028|NCT01711242|chemotherapy|chemotherapy
1271029|NCT01711229|oral acetaminophen|oral acetaminophen
1271030|NCT01711229|IV acetaminophen|iv acetaminophen
1271031|NCT01711229|Ofirmev|ofirmev
1271032|NCT01711229|equianalgesic|equianalgesic
1271033|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1271034|NCT01711216|Dydrogesterone|dydrogesterone
1271035|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
1271036|NCT01711216|Progestins|progestins
1271037|NCT01711203|Spondylolysis|spondylolysis
1271038|NCT01711203|Spondylolisthesis|spondylolisthesis
1271039|NCT01711203|Rehabilitation|rehabilitation
1271040|NCT01711203|Physical Therapy|physical therapy
1271041|NCT01711203|Children|children
1271042|NCT01711190|glaucoma|glaucoma
1271043|NCT01711190|trabeculectomy|trabeculectomy
1271044|NCT01711190|astigmatism|astigmatism
1271045|NCT01711190|intraocular pressure|intraocular pressure
1366304|NCT01307735|edema|edema
1271046|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
1271047|NCT01711177|retinal oximetry|retinal oximetry
1271048|NCT01711164|HCV|hcv
1271049|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
1271050|NCT01711164|FGL2|fgl2
1271051|NCT01711151|ILD|ild
1271052|NCT01711138|Physical Activity|physical activity
1271053|NCT01711138|Physical Fitness|physical fitness
1271054|NCT01711138|Transportation|transportation
1271055|NCT01711138|Environment Design|environment design
1271056|NCT01711138|Child|child
1271057|NCT01711138|Adolescent|adolescent
1271058|NCT01711086|asthma|asthma
1271059|NCT01711086|dry powder inhaler|dry powder inhaler
1271060|NCT01711047|catheter ablation|catheter ablation
1271061|NCT01711047|atrial fibrillation|atrial fibrillation
1271062|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
1271063|NCT01711047|linear ablation|linear ablation
1271064|NCT01711047|CFAE ablation|cfae ablation
1271065|NCT01711034|Solid tumors|solid tumors
1271066|NCT01711021|ADHD|adhd
1271067|NCT01711008|Breakfast size|breakfast size
1271068|NCT01711008|Exercise|exercise
1271069|NCT01711008|Cognitive performance|cognitive performance
1271070|NCT01711008|Mood|mood
1271071|NCT01711008|Appetite|appetite
1271072|NCT01711008|Active women|active women
1271073|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
1271074|NCT01710943|Web-based CBT|web-based cbt
1271075|NCT01710943|PTSD|ptsd
1271076|NCT01710943|Alcohol Misuse|alcohol misuse
1271077|NCT01710943|Substance Misuse|substance misuse
1271078|NCT01710943|Integrated Primary Care|integrated primary care
1271079|NCT01710943|OEF/OIF Veterans|oef/oif veterans
1271080|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
1271081|NCT01710917|Chronic pain|chronic pain
1271082|NCT01710917|Severe pain|severe pain
1271083|NCT01710917|Oxycodon|oxycodon
1271084|NCT01710917|Naloxon|naloxon
1271085|NCT01710917|Opioid-induced constipation|opioid-induced constipation
1271086|NCT01710917|Opioid|opioid
1271087|NCT01710917|Quality of life|quality of life
1271088|NCT01710917|Laxative|laxative
1271089|NCT01710917|Analgesic rescue medication|analgesic rescue medication
1271090|NCT01710904|Chronic pain|chronic pain
1271091|NCT01710904|Severe pain|severe pain
1271092|NCT01710904|Oxycodone|oxycodone
1271093|NCT01710904|Naloxone|naloxone
1271094|NCT01710904|Opioid-induced constipation|opioid-induced constipation
1271095|NCT01710904|Opioid|opioid
1271096|NCT01710904|Quality of life|quality of life
1271097|NCT01710904|Laxative|laxative
1271098|NCT01710904|Analgesic rescue medication|analgesic rescue medication
1271099|NCT01710891|endotracheal intubation|endotracheal intubation
1271100|NCT01710891|direct laryngoscopy|direct laryngoscopy
1271101|NCT01710891|video laryngoscopy|video laryngoscopy
1271102|NCT01710865|Caries prevention|caries prevention
1271103|NCT01710865|pit and fissure sealants|pit and fissure sealants
1271104|NCT01710852|Atrial Fibrillation|atrial fibrillation
1271105|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1271106|NCT01710852|AF|af
1271107|NCT01710839|CRVO|crvo
1271108|NCT01710839|BRVO|brvo
1271109|NCT01710839|HRVO|hrvo
1271110|NCT01710839|Macular edema|macular edema
1271111|NCT01710839|vein occlusion|vein occlusion
1271112|NCT01710813|pompe disease|pompe disease
1271113|NCT01710813|alglucosidase alfa|alglucosidase alfa
1271114|NCT01710813|anaphylaxis|anaphylaxis
1271115|NCT01710813|severe cutaneous|severe cutaneous
1271116|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
1271118|NCT01710800|reflux|reflux
1271119|NCT01710800|GERD|gerd
1271120|NCT01710787|operative|operative
1271121|NCT01710787|dental procedure|dental procedure
1271122|NCT01710774|Diabetic Foot|diabetic foot
1271123|NCT01710774|Diabetes Mellitus|diabetes mellitus
1271124|NCT01710774|Foot Ulcer|foot ulcer
1271125|NCT01710774|Wound Healing|wound healing
1271126|NCT01710774|Delivery of Health Care|delivery of health care
1271127|NCT01710774|Depression|depression
1271128|NCT01710774|sequela|sequela
1271129|NCT01710774|Sick Leave|sick leave
1271130|NCT01710774|Quality of Life|quality of life
1271131|NCT01710774|Amputation|amputation
1271132|NCT01710761|nitric oxide|nitric oxide
1271133|NCT01710761|cycling performance|cycling performance
1271134|NCT01710761|lactate|lactate
1271135|NCT01710761|VO2|vo2
1271136|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
1271137|NCT01710748|Drug eluting stent|drug eluting stent
1271138|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
1271139|NCT01710748|Diabetes Mellitus|diabetes mellitus
1271140|NCT01710735|TP|tp
1271141|NCT01710735|Myofascial pain|myofascial pain
1271142|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
1271143|NCT01710683|Discectomy|discectomy
1271144|NCT01710683|1st postoperative day|1st postoperative day
1271145|NCT01710683|Intensive exercise training|intensive exercise training
1271146|NCT01710683|Randomized controlled trial|randomized controlled trial
1271147|NCT01710670|Brivaracetam|brivaracetam
1271148|NCT01710670|Ethanol|ethanol
1271149|NCT01710670|Pharmacodynamics|pharmacodynamics
1271150|NCT01710670|Pharmacokinetic|pharmacokinetic
1271151|NCT01710670|Interaction|interaction
1271152|NCT01710657|Lacosamide|lacosamide
1271153|NCT01710657|Epilepsy|epilepsy
1271154|NCT01710657|Partial Onset Seizures|partial onset seizures
1271155|NCT01710631|Sleep|sleep
1271156|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
1271157|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
1271158|NCT01710605|Circulating tumor cells|circulating tumor cells
1271159|NCT01710605|Breast Cancer|breast cancer
1271160|NCT01710605|Hormone-receptors positive|hormone-receptors positive
1271161|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
1271162|NCT01710579|endoscopic myotomy|endoscopic myotomy
1271163|NCT01710579|high resolution manometry|high resolution manometry
1271164|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
1271165|NCT01710566|prevention|prevention
1271166|NCT01710566|oxytocin|oxytocin
1271167|NCT01710566|misoprostol|misoprostol
1271168|NCT01710566|Uniject|uniject
1271169|NCT01710566|community|community
1271170|NCT01710527|Healthy Volunteers|healthy volunteers
1271171|NCT01710488|COPD exacerbation|copd exacerbation
1271172|NCT01710488|fluoroquinolones,|fluoroquinolones,
1271173|NCT01710449|Lung Transplant|lung transplant
1271174|NCT01710423|Obesity|obesity
1271175|NCT01710423|Nutrition|nutrition
1271176|NCT01710423|Home Food Preparation|home food preparation
1271177|NCT01710423|Peer Mentoring|peer mentoring
1271178|NCT01710423|Early Head Start|early head start
1271179|NCT01710423|Cooking|cooking
1271180|NCT01710423|Diet|diet
1271181|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
1271182|NCT01710410|nicotine dependence|nicotine dependence
1271183|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1271184|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
1271185|NCT01710410|nicotine patch|nicotine patch
1271186|NCT01710410|addiction|addiction
1271187|NCT01710410|smoking cessation|smoking cessation
1271188|NCT01710410|neuroplasticity|neuroplasticity
1271189|NCT01710397|Antiretroviral therapy|antiretroviral therapy
1271190|NCT01710397|South Africa|south africa
1271191|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
1271192|NCT01710332|Persistent|persistent
1271193|NCT01710332|Central|central
1271194|NCT01710332|Serous|serous
1271195|NCT01710332|Chorioretinopathy|chorioretinopathy
1271196|NCT01710332|Regeneron|regeneron
1271197|NCT01710332|CSR|csr
1271198|NCT01710332|CSCR|cscr
1271199|NCT01710319|Immunoregulation|immunoregulation
1271200|NCT01710319|Natural Killer Cells|natural killer cells
1271201|NCT01710306|Women|women
1271202|NCT01710306|Veterans|veterans
1271203|NCT01710306|PTSD|ptsd
1271204|NCT01710293|Electronic Health Records|electronic health records
1271205|NCT01710293|Diagnostic Delay|diagnostic delay
1271206|NCT01710293|Triggers|triggers
1271207|NCT01710280|Lipemia|lipemia
1271208|NCT01710280|Vascular function|vascular function
1271209|NCT01710280|Blood pressure|blood pressure
1271210|NCT01710254|MRI|mri
1271211|NCT01710254|Atrial Fibrillation|atrial fibrillation
1271212|NCT01710228|MS|ms
1271213|NCT01710228|Natalizumab|natalizumab
1271214|NCT01710228|copaxone|copaxone
1271215|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
1271216|NCT01710215|Colorectal Cancer|colorectal cancer
1271217|NCT01710215|Colon Cancer|colon cancer
1271218|NCT01710215|Mass Screening|mass screening
1271219|NCT01710215|Health Services Research|health services research
1271220|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
1271221|NCT01710202|Hydrocortisone|hydrocortisone
1271222|NCT01710202|Cortisol|cortisol
1271223|NCT01710202|Testosterone|testosterone
1271224|NCT01710202|Stress|stress
1271225|NCT01710202|Serotonin|serotonin
1271226|NCT01710202|5-HTTLPR|5-httlpr
1271227|NCT01710202|Amygdala|amygdala
1271228|NCT01710202|Depression|depression
1271229|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
1271230|NCT01710163|Lithium Carbonate|lithium carbonate
1271231|NCT01710163|Lithium|lithium
1271232|NCT01710163|Central Nervous System Agents|central nervous system agents
1271233|NCT01710163|Therapeutic Uses|therapeutic uses
1271234|NCT01710163|Pharmacologic Actions|pharmacologic actions
1271235|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
1271236|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1271237|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
1271238|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
1271239|NCT01710163|Antimanic Agents|antimanic agents
1271240|NCT01710163|Tranquilizing Agents|tranquilizing agents
1271241|NCT01710163|Central Nervous System Depressants|central nervous system depressants
1271242|NCT01710163|Psychotropic Drugs|psychotropic drugs
1271243|NCT01710163|Sensory System Agents|sensory system agents
1271244|NCT01710163|Antipsychotic Agents|antipsychotic agents
1604256|NCT00378638|node|node
1271245|NCT01710163|Antidepressive Agents|antidepressive agents
1271246|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
1271247|NCT01710150|CTI ablation|cti ablation
1271248|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
1271249|NCT01710150|PVI|pvi
1271250|NCT01710137|Smoking cessation|smoking cessation
1271251|NCT01710137|Nicotine dependence|nicotine dependence
1271252|NCT01710137|Varenicline|varenicline
1271253|NCT01710137|Chantix|chantix
1271254|NCT01710137|HIV|hiv
1271255|NCT01710137|AIDS|aids
1271256|NCT01710124|grocery purchases|grocery purchases
1271257|NCT01710124|financial incentives|financial incentives
1271258|NCT01710124|obesogenic home food environment|obesogenic home food environment
1271259|NCT01710111|Human challenge model|human challenge model
1271260|NCT01710111|Quarantine study|quarantine study
1271261|NCT01710111|Influenza virus|influenza virus
1271262|NCT01710111|Modes of transmission|modes of transmission
1271263|NCT01710111|Droplet spray|droplet spray
1271264|NCT01710111|Droplet nuclei|droplet nuclei
1271265|NCT01710111|Secondary attack rate|secondary attack rate
1271266|NCT01710111|Face shield|face shield
1271267|NCT01710111|Hand hygiene|hand hygiene
1271268|NCT01710111|Fomites|fomites
1271269|NCT01710111|Environmental deposition|environmental deposition
1271270|NCT01710111|Environmental dispersion|environmental dispersion
1271271|NCT01710098|testosterone|testosterone
1271272|NCT01710098|S3-Adherence|s3-adherence
1271273|NCT01710098|Quality of Life|quality of life
1271274|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
1271275|NCT01710085|Curative surgery|curative surgery
1271276|NCT01710085|Recurrence|recurrence
1271277|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
1271278|NCT01710059|Health Status Disparities|health status disparities
1271279|NCT01710059|Minority Health|minority health
1271280|NCT01710059|Pediatrics|pediatrics
1271281|NCT01710059|Behavioral Intervention|behavioral intervention
1271282|NCT01710059|Cellular Phone|cellular phone
1271283|NCT01710059|Peer Group|peer group
1271284|NCT01710046|plaque psoriasis|plaque psoriasis
1271285|NCT01710046|tofacitinib|tofacitinib
1271286|NCT01710046|biopsy|biopsy
1271287|NCT01710046|Janus Kinase|janus kinase
1271288|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
1271289|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
1271290|NCT01710033|CP-690,550|cp-690,550
1271291|NCT01710033|kidney transplant|kidney transplant
1271292|NCT01710020|CP-690|cp-690
1271293|NCT01710020|550|550
1271294|NCT01710020|pharmacokinetics|pharmacokinetics
1271295|NCT01710020|end-stage renal disease|end-stage renal disease
1271296|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1271297|NCT01709994|cardiovascular events|cardiovascular events
1271298|NCT01709994|chronic kidney disease|chronic kidney disease
1271299|NCT01709994|bleedings|bleedings
1271300|NCT01709994|progression|progression
1271301|NCT01709994|antiinflammatory effects|antiinflammatory effects
1271302|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
1271303|NCT01709968|Quality of life|quality of life
1271304|NCT01709968|Quality of sleep|quality of sleep
1271305|NCT01709955|Obesity|obesity
1271306|NCT01709955|Overweight|overweight
1271307|NCT01709955|Glucomannan|glucomannan
1271308|NCT01709942|GnRH antagonist|gnrh antagonist
1271309|NCT01709942|PCOS|pcos
1271310|NCT01709942|OHSS|ohss
1271311|NCT01709942|COH|coh
1271312|NCT01709942|IVF|ivf
1271313|NCT01709916|Glaucoma|glaucoma
1271314|NCT01709916|intra ocular pressure|intra ocular pressure
1271315|NCT01709916|diurnal fluctuations|diurnal fluctuations
1271316|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1271317|NCT01709877|Multiport laparoscopy|multiport laparoscopy
1271318|NCT01709877|Single Port Laparoscopy|single port laparoscopy
1271319|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
1271320|NCT01709864|Anticholinergic|anticholinergic
1271321|NCT01709864|Antimuscarinic|antimuscarinic
1271322|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1271323|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1271324|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1271325|NCT01709864|COPD|copd
1271326|NCT01709864|LAMA|lama
1271327|NCT01709864|Lung Disease|lung disease
1271328|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
1271329|NCT01709864|Lung Function|lung function
1271330|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
1271331|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1271332|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
1271333|NCT01709851|Type 1 diabetes|type 1 diabetes
1271334|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
1271335|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
1271336|NCT01709838|Non-transfusion dependent thalassemia, NTDT|non-transfusion dependent thalassemia, ntdt
1271337|NCT01709825|probiotics|probiotics
1271338|NCT01709825|cold|cold
1271339|NCT01709825|flu|flu
1271340|NCT01709825|immune function|immune function
1271341|NCT01709825|microbiota|microbiota
1271342|NCT01709799|Cognitive Training|cognitive training
1271343|NCT01709799|Aging|aging
1271344|NCT01709799|Seniors|seniors
1271345|NCT01709786|Hemorrhage|hemorrhage
1271346|NCT01709786|Hemoglobin|hemoglobin
1271347|NCT01709786|Non-invasive monitoring|non-invasive monitoring
1271348|NCT01709786|Medical device accuracy|medical device accuracy
1271349|NCT01709760|ENIA11|enia11
1271350|NCT01709760|MTX|mtx
1271351|NCT01709760|RA|ra
1271352|NCT01709760|TNF|tnf
1271353|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
1271354|NCT01709747|Hydromorphone|hydromorphone
1271355|NCT01709747|Pain|pain
1271356|NCT01709747|Chronic Pain|chronic pain
1271357|NCT01709747|Implantable Pump|implantable pump
1271358|NCT01709747|Pump|pump
1271359|NCT01709747|Intrathecal|intrathecal
1271360|NCT01709734|prostate cancer CRPC|prostate cancer crpc
1271361|NCT01709721|Hydromorphone|hydromorphone
1271362|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
1271363|NCT01709721|Pain Management|pain management
1271364|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
1271365|NCT01709708|Migraine|migraine
1271366|NCT01709708|Headache|headache
1271367|NCT01709708|Chronic Migraine|chronic migraine
1271368|NCT01709708|Marcaine|marcaine
1271369|NCT01709708|Tx360|tx360
1271370|NCT01709695|Intuniv|intuniv
1271474|NCT01709123|Hyperketonemia|hyperketonemia
1271371|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1271373|NCT01709682|atrial fibrillation|atrial fibrillation
1271374|NCT01709682|arrhythmias|arrhythmias
1271375|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
1271376|NCT01709669|acute coronary syndrome|acute coronary syndrome
1271377|NCT01709669|gratitude|gratitude
1271378|NCT01709669|health behavior|health behavior
1271379|NCT01709669|myocardial infarction|myocardial infarction
1271380|NCT01709669|unstable angina|unstable angina
1271381|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
1271382|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
1271383|NCT01709604|hemoperfusion|hemoperfusion
1271384|NCT01709604|continuous blood purification|continuous blood purification
1271385|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
1271386|NCT01709565|Sepsis|sepsis
1271387|NCT01709565|Lactic acid|lactic acid
1271388|NCT01709565|Shock|shock
1271389|NCT01709565|Resuscitation|resuscitation
1271390|NCT01709539|Cancer diagnosis center|cancer diagnosis center
1271391|NCT01709539|Time to diagnosis|time to diagnosis
1271392|NCT01709539|Survival|survival
1271393|NCT01709539|Health economics|health economics
1271394|NCT01709539|Biomarkers|biomarkers
1271395|NCT01709526|Psychosocial functioning|psychosocial functioning
1271396|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
1271397|NCT01709526|Psychiatric diseases|psychiatric diseases
1271398|NCT01709487|HIPEC|hipec
1271399|NCT01709487|ovarian carcinoma|ovarian carcinoma
1271400|NCT01709487|Bordet|bordet
1271401|NCT01709474|SLE|sle
1271402|NCT01709474|Vitamin D3|vitamin d3
1271403|NCT01709474|Vitamin D deficiency|vitamin d deficiency
1271404|NCT01709474|IFN alpha expression|ifn alpha expression
1271405|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
1271406|NCT01709448|Papillomavirus Infections|papillomavirus infections
1271407|NCT01709448|HIV|hiv
1271408|NCT01709422|Propofol|propofol
1271409|NCT01709422|Midazolam|midazolam
1271410|NCT01709422|Meperidine|meperidine
1271411|NCT01709409|Prematurity|prematurity
1271412|NCT01709383|Aphasia|aphasia
1271413|NCT01709383|Stroke|stroke
1271414|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1271415|NCT01709383|Neuroplasticity|neuroplasticity
1271416|NCT01709357|manual therapy|manual therapy
1271417|NCT01709357|trigger point|trigger point
1271418|NCT01709357|range of motion|range of motion
1271419|NCT01709357|pain threshold|pain threshold
1271420|NCT01709357|pain perception|pain perception
1271421|NCT01709292|Thyroid Cancer|thyroid cancer
1271422|NCT01709292|ERK|erk
1271423|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
1271424|NCT01709292|Biomarkers|biomarkers
1271425|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
1271426|NCT01709292|PTC|ptc
1271427|NCT01709292|BRAF mutated|braf mutated
1271428|NCT01709292|Vemurafenib|vemurafenib
1271429|NCT01709292|PLX4032|plx4032
1271430|NCT01709292|RO5185426|ro5185426
1271431|NCT01709292|Zelboraf™|zelboraf™
1271432|NCT01709279|Ischemic heart failure|ischemic heart failure
1271433|NCT01709279|Myocardial regeneration|myocardial regeneration
1271434|NCT01709279|ADRC|adrc
1271435|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
1271436|NCT01709240|Chitosan|chitosan
1271437|NCT01709240|Plasma|plasma
1271438|NCT01709240|Incision Closure|incision closure
1271439|NCT01709227|Acute kidney injury|acute kidney injury
1271440|NCT01709227|AKI|aki
1271441|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
1271442|NCT01709214|Osteoarthritis|osteoarthritis
1271443|NCT01709214|Knee|knee
1271444|NCT01709214|Pain|pain
1271445|NCT01709214|Chronic|chronic
1271446|NCT01709214|OA|oa
1271447|NCT01709214|Arthritis|arthritis
1271448|NCT01709201|Alcohol abuse|alcohol abuse
1271449|NCT01709201|Drug abuse|drug abuse
1271450|NCT01709201|Diabetes Mellitus|diabetes mellitus
1271451|NCT01709201|Persistent Asthma|persistent asthma
1271452|NCT01709201|Juvenile Arthritis|juvenile arthritis
1271453|NCT01709201|Ulcerative Colitis|ulcerative colitis
1271454|NCT01709188|Musical Dual Task Training|musical dual task training
1271455|NCT01709188|dementia|dementia
1271456|NCT01709188|attention control|attention control
1271457|NCT01709188|dual task cost|dual task cost
1271458|NCT01709188|gait stability|gait stability
1271459|NCT01709175|Cancer|cancer
1271460|NCT01709175|Breast Cancer|breast cancer
1271461|NCT01709175|Gynecologic Cancer|gynecologic cancer
1271462|NCT01709175|Strength Training|strength training
1271463|NCT01709175|Exercise|exercise
1271464|NCT01709175|Physical Activity|physical activity
1271465|NCT01709175|Fatigue|fatigue
1271466|NCT01709175|Quality of Life|quality of life
1271467|NCT01709175|Strength|strength
1271468|NCT01709175|Fitness|fitness
1271469|NCT01709175|Cancer Survivor|cancer survivor
1271470|NCT01709175|Survivor|survivor
1271471|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
1271472|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
1271473|NCT01709123|Hyperglycemia|hyperglycemia
1271475|NCT01709110|Bone Loss|bone loss
1271476|NCT01709110|Vertebral fractures|vertebral fractures
1271477|NCT01709097|Adherence|adherence
1271478|NCT01709097|Compliance|compliance
1271479|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
1271480|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
1271481|NCT01709097|The Portal|the portal
1271482|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
1271483|NCT01709084|HIV-1|hiv-1
1271484|NCT01709084|Infectious diseases|infectious diseases
1271485|NCT01709084|Ribonucleic acid|ribonucleic acid
1271486|NCT01709084|RNA|rna
1271487|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1271488|NCT01709084|Emtricitabine|emtricitabine
1271489|NCT01709084|Rilpivirine|rilpivirine
1271490|NCT01709084|Efavirenz|efavirenz
1271491|NCT01709084|Edurant|edurant
1271492|NCT01709084|TMC278|tmc278
1271493|NCT01709084|R278474|r278474
1271494|NCT01709084|Fixed dose combination|fixed dose combination
1271495|NCT01709071|Vaccination|vaccination
1271496|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
1271497|NCT01709071|poliomyelitis|poliomyelitis
1271498|NCT01709071|Sabin strains|sabin strains
1271499|NCT01709058|Back Pain|back pain
1271500|NCT01709058|Therapeutics|therapeutics
1271501|NCT01709058|Aged|aged
1271502|NCT01709058|Injections, Intramuscular|injections, intramuscular
1271503|NCT01709058|Oxygen|oxygen
1271504|NCT01709058|Ozone|ozone
1271505|NCT01709058|Geriatric Assessment|geriatric assessment
1271506|NCT01709058|Trace Elements|trace elements
1271507|NCT01709058|Oxidative stress|oxidative stress
1271508|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
1271509|NCT01709045|Carotid Arteries|carotid arteries
1271510|NCT01709032|Thalassemia|thalassemia
1271511|NCT01709032|Chelation|chelation
1271512|NCT01709032|Transfusion|transfusion
1271513|NCT01709032|Safety|safety
1271514|NCT01709006|Head and neck cancer|head and neck cancer
1271515|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1271516|NCT01708980|Electromyography|electromyography
1271517|NCT01708980|Resistance training|resistance training
1271518|NCT01708980|Physical Therapy Modalities|physical therapy modalities
1271519|NCT01708967|transnasal endoscopy|transnasal endoscopy
1271520|NCT01708967|pretreatment method|pretreatment method
1271521|NCT01708954|erlotinib|erlotinib
1271522|NCT01708954|cabozantinib|cabozantinib
1271523|NCT01708954|non-small cell lung cancer|non-small cell lung cancer
1271524|NCT01708928|Ulthera® System|ulthera® system
1271525|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
1271526|NCT01708928|Ulthera, Inc.|ulthera, inc.
1271527|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271528|NCT01708876|uncomplicated|uncomplicated
1271529|NCT01708876|plasmodium|plasmodium
1271530|NCT01708876|knowlesi|knowlesi
1271531|NCT01708876|malaria|malaria
1271532|NCT01708876|infection|infection
1271533|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1271534|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
1271535|NCT01708863|Glenn procedure|glenn procedure
1271536|NCT01708863|Congenital heart defect|congenital heart defect
1271537|NCT01708863|Congenital heart disease|congenital heart disease
1271538|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
1271539|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1271540|NCT01708837|Bispectral index|bispectral index
1271541|NCT01708824|colorectal cancer|colorectal cancer
1271542|NCT01708824|cancer survivor|cancer survivor
1271543|NCT01708824|western pattern diet|western pattern diet
1271544|NCT01708824|physical activity|physical activity
1604257|NCT00378638|positive|positive
1271545|NCT01708824|behavioral intervention|behavioral intervention
1271546|NCT01708824|acceptability|acceptability
1271547|NCT01708824|feasibility|feasibility
1271548|NCT01708824|randomized controlled trial|randomized controlled trial
1271549|NCT01708824|compliance|compliance
1271550|NCT01708811|Contractility|contractility
1271551|NCT01708811|human|human
1271552|NCT01708811|myometrium|myometrium
1271553|NCT01708811|hyponatraemia|hyponatraemia
1271554|NCT01708798|Diastolic heart failure|diastolic heart failure
1271555|NCT01708785|obesity|obesity
1271556|NCT01708785|overweight|overweight
1271557|NCT01708785|overweight children|overweight children
1271558|NCT01708785|overweight parents|overweight parents
1271559|NCT01708785|overeating|overeating
1271560|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
1271561|NCT01708785|families with overweight child|families with overweight child
1271562|NCT01708785|body mass index|body mass index
1271563|NCT01708785|BMI|bmi
1271564|NCT01708785|weight|weight
1271565|NCT01708785|childhood obesity|childhood obesity
1271566|NCT01708785|treatment|treatment
1271567|NCT01708785|cue exposure treatment|cue exposure treatment
1271568|NCT01708785|cravings|cravings
1271569|NCT01708785|habituation to food cues|habituation to food cues
1271570|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
1271571|NCT01708785|intervention|intervention
1271572|NCT01708785|experiments|experiments
1271573|NCT01708785|family based treatment|family based treatment
1271774|NCT01707979|Vagus|vagus
1271574|NCT01708785|behavioral treatment|behavioral treatment
1271575|NCT01708772|TNF alpha|tnf alpha
1271576|NCT01708772|SOFA score|sofa score
1271577|NCT01708759|Serum Il-8|serum il-8
1271578|NCT01708759|IL8 polymorphism|il8 polymorphism
1271579|NCT01708759|critically ill patients|critically ill patients
1271580|NCT01708733|HCV carrier|hcv carrier
1271581|NCT01708733|Chinese herbal medicine|chinese herbal medicine
1271582|NCT01708733|Liver function|liver function
1271583|NCT01708733|HCV RNA titer|hcv rna titer
1271584|NCT01708720|Vaccination|vaccination
1271585|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
1271586|NCT01708720|Polio|polio
1271587|NCT01708720|Sabin|sabin
1271588|NCT01708681|Seafood|seafood
1271589|NCT01708681|Meat|meat
1271590|NCT01708681|Egg|egg
1271591|NCT01708681|Milk|milk
1271592|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
1271593|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
1271594|NCT01708681|Triglycerides|triglycerides
1271595|NCT01708681|Cholesterol|cholesterol
1271596|NCT01708681|Postprandial incretins|postprandial incretins
1271597|NCT01708681|Postprandial hormones|postprandial hormones
1271598|NCT01708668|Fever|fever
1271599|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
1271600|NCT01708668|Labor analgesia|labor analgesia
1271601|NCT01708668|Epidural analgesia|epidural analgesia
1271602|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
1271603|NCT01708655|Cystic Fibrosis|cystic fibrosis
1271604|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
1271605|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
1271606|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
1271607|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
1271608|NCT01708577|heart rate|heart rate
1271609|NCT01708577|sweating|sweating
1271610|NCT01708577|respiration|respiration
1271611|NCT01708577|acceleration of body movement|acceleration of body movement
1271612|NCT01708577|heart activity.|heart activity.
1271613|NCT01708551|Hyperhidrosis|hyperhidrosis
1271614|NCT01708551|Axillary sweating|axillary sweating
1271615|NCT01708551|Ulthera® System|ulthera® system
1271616|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
1271617|NCT01708551|Ulthera, Inc.|ulthera, inc.
1271618|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
1271619|NCT01708525|Ulthera® System|ulthera® system
1271718|NCT01708226|children|children
1271620|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
1271621|NCT01708525|Ulthera, Inc.|ulthera, inc.
1271622|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271623|NCT01708512|Ulthera® System|ulthera® system
1271624|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
1271625|NCT01708512|Ulthera, Inc.|ulthera, inc.
1271626|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271627|NCT01708499|Ulthera® System|ulthera® system
1271628|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
1271629|NCT01708499|Ulthera, Inc.|ulthera, inc.
1271630|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271631|NCT01708486|asthma|asthma
1271632|NCT01708486|Dry Powder Inhalers|dry powder inhalers
1271633|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
1271634|NCT01708460|Ulthera® System|ulthera® system
1271635|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
1271636|NCT01708460|Ulthera, Inc.|ulthera, inc.
1271637|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271638|NCT01708434|Skin laxity|skin laxity
1271639|NCT01708434|Knees|knees
1271640|NCT01708408|biorepository|biorepository
1271641|NCT01708408|biobank|biobank
1271642|NCT01708408|registry|registry
1271643|NCT01708408|community|community
1271644|NCT01708408|biospecimens|biospecimens
1271645|NCT01708408|volunteers|volunteers
1271646|NCT01708408|chronic disease|chronic disease
1271647|NCT01708408|longitudinal|longitudinal
1271648|NCT01708408|blood|blood
1271649|NCT01708408|electronic health records|electronic health records
1271650|NCT01708408|follow-up|follow-up
1271651|NCT01708395|Ulcerative colitis|ulcerative colitis
1271652|NCT01708382|Ulthera® System|ulthera® system
1271653|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
1271654|NCT01708382|Ulthera, Inc.|ulthera, inc.
1271655|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271656|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
1271657|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
1271658|NCT01708369|alcohol|alcohol
1271659|NCT01708369|pharmacokinetics|pharmacokinetics
1271660|NCT01708356|Air Pollution|air pollution
1271661|NCT01708356|Particulate Matter|particulate matter
1271662|NCT01708356|Exercise|exercise
1271663|NCT01708356|Respiratory Rate|respiratory rate
1271664|NCT01708356|Inflammation|inflammation
1271665|NCT01708356|Oxidative Stress|oxidative stress
1271666|NCT01708356|Plethysmography|plethysmography
1271667|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
1271668|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
1271669|NCT01708343|acupuncture,|acupuncture,
1271670|NCT01708343|sleep quality,|sleep quality,
1271671|NCT01708343|pain threshold.|pain threshold.
1271672|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
1271673|NCT01708330|missed abortion|missed abortion
1271674|NCT01708330|incomplete abortion|incomplete abortion
1271675|NCT01708330|nonviable pregnancy|nonviable pregnancy
1271676|NCT01708330|topical lidocaine|topical lidocaine
1271677|NCT01708317|ACASI|acasi
1271678|NCT01708317|Gonorrhea|gonorrhea
1271679|NCT01708317|Chlamydia|chlamydia
1271680|NCT01708317|Emergency Department|emergency department
1271681|NCT01708317|Youth|youth
1271682|NCT01708317|Adolescents|adolescents
1271683|NCT01708317|Computer|computer
1271684|NCT01708317|Questionnaire|questionnaire
1271685|NCT01708304|Dementia|dementia
1271686|NCT01708304|Alzheimer's Disease|alzheimer's disease
1271687|NCT01708304|Exercise|exercise
1271688|NCT01708304|Caregiver|caregiver
1271689|NCT01708304|Behavior modification|behavior modification
1271690|NCT01708291|youth|youth
1271691|NCT01708291|Stress|stress
1271692|NCT01708291|mindfulness|mindfulness
1271693|NCT01708291|foster care|foster care
1271694|NCT01708291|stress reduction|stress reduction
1271695|NCT01708291|high risk teens|high risk teens
1271696|NCT01708278|COPD|copd
1271697|NCT01708278|Emphysema|emphysema
1271698|NCT01708278|chronic bronchitis|chronic bronchitis
1271699|NCT01708278|Quercetin|quercetin
1271700|NCT01708278|flavonoids|flavonoids
1271701|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
1271702|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
1271703|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
1271704|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
1271705|NCT01708265|Mitral Valve Repair|mitral valve repair
1271706|NCT01708265|Watchful Waiting|watchful waiting
1271707|NCT01708252|Ulthera® System|ulthera® system
1271708|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
1271709|NCT01708252|Ulthera, Inc.|ulthera, inc.
1271710|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1271711|NCT01708239|Pregnancy|pregnancy
1271712|NCT01708239|Deep vein thrombosis|deep vein thrombosis
1271713|NCT01708239|Clinical probability|clinical probability
1271714|NCT01708239|D-Dimer|d-dimer
1271715|NCT01708239|Compression ultrasonography|compression ultrasonography
1271716|NCT01708226|OCD|ocd
1271717|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
1271719|NCT01708213|soft tissue|soft tissue
1271720|NCT01708213|augmentation|augmentation
1271721|NCT01708213|correction|correction
1271722|NCT01708213|wrinkles|wrinkles
1271723|NCT01708200|Memory|memory
1271724|NCT01708200|Intervention|intervention
1271725|NCT01708200|Computerized|computerized
1271726|NCT01708200|Psychoeducational|psychoeducational
1271727|NCT01708200|Mental Illness|mental illness
1271728|NCT01708187|Peroneal tendon|peroneal tendon
1271729|NCT01708174|medulloblastoma,|medulloblastoma,
1271730|NCT01708174|relapsed,|relapsed,
1271731|NCT01708174|pediatric,|pediatric,
1271732|NCT01708174|children,|children,
1271733|NCT01708174|adults,|adults,
1271734|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
1271735|NCT01708174|LDE225|lde225
1271736|NCT01708161|PIK3CA mutation|pik3ca mutation
1271737|NCT01708161|advanced solid tumor|advanced solid tumor
1271738|NCT01708161|breast cancer|breast cancer
1271739|NCT01708161|ovarian cancer|ovarian cancer
1271740|NCT01708161|cancers with a mass|cancers with a mass
1271741|NCT01708161|bulky tumor|bulky tumor
1271742|NCT01708161|nodule|nodule
1271743|NCT01708161|lump|lump
1271744|NCT01708161|advanced cancer|advanced cancer
1271745|NCT01708161|advanced solid malignancies|advanced solid malignancies
1271746|NCT01708122|Intranasal fentanyl|intranasal fentanyl
1271747|NCT01708122|Cystoscopy|cystoscopy
1271748|NCT01708070|asthma|asthma
1271749|NCT01708070|depression|depression
1271750|NCT01708070|anxiety|anxiety
1271751|NCT01708057|COPD|copd
1271752|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1271753|NCT01708044|Pramlintide,|pramlintide,
1271754|NCT01708044|insulin,|insulin,
1271755|NCT01708044|type 1 diabetes,|type 1 diabetes,
1271756|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
1271757|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
1271758|NCT01708018|Pregnancy|pregnancy
1271759|NCT01708018|Stress, Psychological|stress, psychological
1271760|NCT01708018|Low Back Pain|low back pain
1271761|NCT01708018|Breech Presentation|breech presentation
1271762|NCT01708018|Relaxation|relaxation
1271763|NCT01708018|Hydrotherapy|hydrotherapy
1271764|NCT01708018|Acupressure|acupressure
1271765|NCT01708018|WATSU|watsu
1271766|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
1271767|NCT01708005|Vitamin D|vitamin d
1271768|NCT01708005|Cholecalciferol|cholecalciferol
1271769|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
1271770|NCT01707979|Near infrared light|near infrared light
1271771|NCT01707979|Diabetic neuropathy|diabetic neuropathy
1271772|NCT01707979|Sensory neuropathy|sensory neuropathy
1271773|NCT01707979|Autonomic neuropathy|autonomic neuropathy
1271775|NCT01707979|Sudomotor function|sudomotor function
1271776|NCT01707979|Monofilament|monofilament
1271777|NCT01707979|Impedance|impedance
1271778|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1271779|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1271780|NCT01707966|maintenance therapy|maintenance therapy
1271781|NCT01707966|orteronel|orteronel
1271782|NCT01707966|TAK-700|tak-700
1271784|NCT01707914|oxidative stress|oxidative stress
1271785|NCT01707914|dyslipidemia|dyslipidemia
1271786|NCT01707914|inflammation|inflammation
1271787|NCT01707901|GERD|gerd
1271788|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
1271789|NCT01707862|Surgery|surgery
1271790|NCT01707862|Smooth muscle tumor|smooth muscle tumor
1271791|NCT01707849|Hepatitis C|hepatitis c
1271792|NCT01707849|Liver Fibrosis|liver fibrosis
1271793|NCT01707849|m-TOR inhibitors|m-tor inhibitors
1271794|NCT01707810|Liver transplatation|liver transplatation
1271795|NCT01707797|dental caries|dental caries
1271796|NCT01707797|high risk|high risk
1271797|NCT01707797|dental cavities|dental cavities
1271798|NCT01707797|children dental care|children dental care
1271799|NCT01707784|Pregnancy|pregnancy
1271800|NCT01707784|Stress|stress
1271801|NCT01707784|Anxiety|anxiety
1271802|NCT01707784|Cortisol|cortisol
1271803|NCT01707784|Copeptin|copeptin
1271804|NCT01707784|Gestational diabetes|gestational diabetes
1271805|NCT01707758|pancreatic cancer|pancreatic cancer
1271806|NCT01707758|nanoparticle|nanoparticle
1271807|NCT01707758|proteases|proteases
1271808|NCT01707758|cell survival|cell survival
1271809|NCT01707758|tumor progression|tumor progression
1271810|NCT01707758|angiogenesis|angiogenesis
1271811|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
1271812|NCT01707732|Obesity|obesity
1271813|NCT01707732|thromboprophylaxis|thromboprophylaxis
1271814|NCT01707732|Enoxaparin|enoxaparin
1271815|NCT01707719|Alzheimer's disease|alzheimer's disease
1271816|NCT01707719|Oxidative stress|oxidative stress
1271817|NCT01707719|HPA axis|hpa axis
1271818|NCT01707706|Insomnia|insomnia
1271819|NCT01707706|Depression|depression
1271820|NCT01707706|Electroacupuncture|electroacupuncture
1271821|NCT01707706|Acupuncture|acupuncture
1271822|NCT01707706|Randomized Clinical Trial|randomized clinical trial
1271823|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
1271824|NCT01707693|physical activity|physical activity
1271825|NCT01707693|prevention|prevention
1271826|NCT01707693|coronary heart disease|coronary heart disease
1271827|NCT01707693|women|women
1271828|NCT01707680|weaning|weaning
1271829|NCT01707680|mechanical ventilation|mechanical ventilation
1271830|NCT01707680|dexmedetomidine|dexmedetomidine
1271831|NCT01707680|propofol|propofol
1271832|NCT01707680|midazolam|midazolam
1271833|NCT01707654|defect;|defect;
1271834|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
1271835|NCT01707654|proper digital nerve;|proper digital nerve;
1271836|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
1271837|NCT01707628|NHL|nhl
1271838|NCT01707628|influenza vaccination|influenza vaccination
1271839|NCT01707628|rituximab|rituximab
1271840|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
1271841|NCT01707602|Intradermal|intradermal
1271842|NCT01707602|transcutaneous|transcutaneous
1271843|NCT01707602|influenza|influenza
1271844|NCT01707602|routes of vaccination|routes of vaccination
1271845|NCT01707602|T cell responses|t cell responses
1271846|NCT01707602|humoral responses|humoral responses
1271848|NCT01707602|clinical trial|clinical trial
1271849|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
1271850|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
1271851|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
1271852|NCT01707589|monitoring|monitoring
1271853|NCT01707589|heart rate|heart rate
1271854|NCT01707589|respiration rate|respiration rate
1271855|NCT01707589|temperature|temperature
1271856|NCT01707589|motion|motion
1271857|NCT01707589|noninvasive|noninvasive
1271858|NCT01707589|physiologic parameters|physiologic parameters
1271859|NCT01707589|NICU|nicu
1271860|NCT01707576|Follow-Up Studies|follow-up studies
1271861|NCT01707576|Adolescent|adolescent
1271862|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
1271863|NCT01707576|Attempted/prevention & control|attempted/prevention & control
1271864|NCT01707576|Self-report questionnaire|self-report questionnaire
1271865|NCT01707576|emmergency department|emmergency department
1271866|NCT01707576|parental perception|parental perception
1271867|NCT01707576|Emergency|emergency
1271868|NCT01707563|Marfan syndrome|marfan syndrome
1271869|NCT01707563|Variability|variability
1271870|NCT01707563|Fibrillin 1|fibrillin 1
1271871|NCT01707563|clinical expression|clinical expression
1271872|NCT01707537|OCV|ocv
1271873|NCT01707537|cholera|cholera
1271874|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
1271875|NCT01707511|Colon surgery|colon surgery
1271876|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
1271877|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
1271878|NCT01707498|BCI|bci
1271879|NCT01707498|TETRAPLEGIA|tetraplegia
1271880|NCT01707498|COMMUNICATION|communication
1271881|NCT01707498|P300|p300
1271882|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
1271883|NCT01707485|Antibiotics|antibiotics
1271884|NCT01707472|Liver Fibrosis|liver fibrosis
1271885|NCT01707472|Fibrosis|fibrosis
1271886|NCT01707472|HIV|hiv
1271887|NCT01707472|HCV|hcv
1271888|NCT01707472|GS-6624|gs-6624
1271889|NCT01707472|Hepatitis|hepatitis
1271890|NCT01707472|Hepatitis C|hepatitis c
1271891|NCT01707459|platelet function|platelet function
1271892|NCT01707459|perioperative complications|perioperative complications
1271893|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
1271894|NCT01707459|thromboelastography|thromboelastography
1271895|NCT01707459|polymorphism analysis|polymorphism analysis
1271896|NCT01707459|coronary stents|coronary stents
1271897|NCT01707459|non-cardiac surgery|non-cardiac surgery
1271898|NCT01707446|Cardiac surgery|cardiac surgery
1271899|NCT01707446|Delirium|delirium
1271900|NCT01707446|Cerebral Oximetry|cerebral oximetry
1271901|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
1271902|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
1271903|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
1271904|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
1271905|NCT01707433|GALNS|galns
1271906|NCT01707420|pediatric pain|pediatric pain
1271907|NCT01707420|post operative pain|post operative pain
1271908|NCT01707420|opioids|opioids
1271909|NCT01707420|emergence agitation|emergence agitation
1271910|NCT01707420|preoperative anxiety|preoperative anxiety
1271911|NCT01707420|pharmacogenomics|pharmacogenomics
1271912|NCT01707407|CC-4047|cc-4047
1271913|NCT01707407|Pomalidomide|pomalidomide
1271914|NCT01707407|Ketoconazole|ketoconazole
1271915|NCT01707407|Fluvoxamine|fluvoxamine
1271916|NCT01707407|Carbamazepine|carbamazepine
1271917|NCT01707407|DDI|ddi
1271918|NCT01707407|safety|safety
1271919|NCT01707407|tolerability|tolerability
1271920|NCT01707407|pharmacokinetic|pharmacokinetic
1271921|NCT01707368|Psoriasis|psoriasis
1271922|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
1271923|NCT01707368|Plaque Psoriasis|plaque psoriasis
1271924|NCT01707368|Daivobet® Gel|daivobet® gel
1271925|NCT01707368|Germany|germany
1272027|NCT01706874|Prophylaxis|prophylaxis
1271926|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
1271927|NCT01707342|Healthy male participants|healthy male participants
1271928|NCT01707342|Absolute bioavailability|absolute bioavailability
1271929|NCT01707342|Bioavailability|bioavailability
1271930|NCT01707342|Pharmacokinetics|pharmacokinetics
1271931|NCT01707342|Simeprevir|simeprevir
1271932|NCT01707342|TMC435|tmc435
1271933|NCT01707342|[3H]-TMC435|[3h]-tmc435
1271934|NCT01707342|Hepatitis C virus|hepatitis c virus
1271935|NCT01707342|HCV|hcv
1271936|NCT01707316|Healthy|healthy
1271937|NCT01707316|JNJ-28431754|jnj-28431754
1271938|NCT01707316|Canagliflozin|canagliflozin
1271939|NCT01707316|Pharmacokinetics|pharmacokinetics
1271940|NCT01707316|Pharmacodynamics|pharmacodynamics
1271941|NCT01707303|ICU|icu
1271942|NCT01707303|Critical Care|critical care
1271943|NCT01707303|Intensive Care|intensive care
1271944|NCT01707303|Critical Illness|critical illness
1271945|NCT01707303|Acute Respiratory Failure|acute respiratory failure
1271946|NCT01707303|Mechanical Ventilation|mechanical ventilation
1271947|NCT01707303|Physical Therapy|physical therapy
1271948|NCT01707303|Strength|strength
1271949|NCT01707303|Functional Status|functional status
1271950|NCT01707303|Short Physical Performance Battery|short physical performance battery
1271951|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1271952|NCT01707277|Inspiratory muscle training|inspiratory muscle training
1271953|NCT01707277|Exercise capacity|exercise capacity
1271954|NCT01707264|AL amyloidosis|al amyloidosis
1271955|NCT01707264|Primary amyloidosis|primary amyloidosis
1271956|NCT01707251|Obesity, Morbid|obesity, morbid
1271957|NCT01707251|Bariatric Surgery|bariatric surgery
1271958|NCT01707251|Laparoscopy|laparoscopy
1271959|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
1271960|NCT01707251|Analgesia|analgesia
1271961|NCT01707251|Morphine|morphine
1271962|NCT01707225|GI Bleeding|gi bleeding
1271963|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
1271964|NCT01707225|LVAD|lvad
1271965|NCT01707212|parent education|parent education
1271966|NCT01707212|pain management|pain management
1271967|NCT01707212|immunization|immunization
1271968|NCT01707212|infant|infant
1271969|NCT01707199|P. falciparum|p. falciparum
1271970|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1271971|NCT01707199|Artesunate|artesunate
1271972|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
1271973|NCT01707173|SIDS|sids
1271974|NCT01707121|morbidity|morbidity
1271975|NCT01707121|sick-leave|sick-leave
1271976|NCT01707121|hospital stay|hospital stay
1271977|NCT01707108|dental implants|dental implants
1271978|NCT01707108|bone loss|bone loss
1271979|NCT01707095|Electrosurgery|electrosurgery
1271980|NCT01707095|Radiofrequency energy|radiofrequency energy
1271981|NCT01707095|Monopolar instruments|monopolar instruments
1271982|NCT01707095|Capacitive coupling|capacitive coupling
1271983|NCT01707095|Thermal injury|thermal injury
1271984|NCT01707095|Surgical complications|surgical complications
1271985|NCT01707056|levothyroxine|levothyroxine
1271986|NCT01707056|synthroid|synthroid
1271987|NCT01707056|coffee|coffee
1271988|NCT01707056|absorption|absorption
1271989|NCT01707056|tea|tea
1271990|NCT01707056|thyroid carcinoma|thyroid carcinoma
1271991|NCT01707043|plaque psoriasis|plaque psoriasis
1271992|NCT01707043|taclonex|taclonex
1271993|NCT01707043|crossover|crossover
1271994|NCT01707030|clinical trial|clinical trial
1271995|NCT01707030|veteran|veteran
1271996|NCT01707030|substance use disorder|substance use disorder
1271997|NCT01706978|rotator cuff tear|rotator cuff tear
1271998|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
1271999|NCT01706952|Bleeding|bleeding
1272000|NCT01706952|Topical Vasocontriction|topical vasocontriction
1272001|NCT01706952|Cocaine|cocaine
1272002|NCT01706952|Adrenaline|adrenaline
1272003|NCT01706939|Reduced radiotherapy|reduced radiotherapy
1272004|NCT01706939|Randomization, Phase III|randomization, phase iii
1272005|NCT01706939|Reduced radiation therapy|reduced radiation therapy
1272006|NCT01706939|head and neck|head and neck
1272007|NCT01706939|oropharynx|oropharynx
1272008|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
1272009|NCT01706939|nasopharynx primary|nasopharynx primary
1272010|NCT01706939|HPV|hpv
1272011|NCT01706939|p16|p16
1272012|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
1272013|NCT01706926|Mavrilimumab|mavrilimumab
1272014|NCT01706926|CAM-3001|cam-3001
1272015|NCT01706887|Nedd4-2|nedd4-2
1272016|NCT01706887|blood pressure|blood pressure
1272017|NCT01706887|polymorphism|polymorphism
1272018|NCT01706887|salt intake|salt intake
1272019|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
1272020|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
1272021|NCT01706887|no active disease|no active disease
1272022|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
1272023|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
1272024|NCT01706874|P.gingivalis|p.gingivalis
1272025|NCT01706874|Periodontal disease|periodontal disease
1272026|NCT01706874|Plaque control|plaque control
1272028|NCT01706874|Oral hygiene instruction|oral hygiene instruction
1272029|NCT01706835|solid tumor|solid tumor
1272030|NCT01706835|aldoxorubicin|aldoxorubicin
1272031|NCT01706835|phase 1|phase 1
1272032|NCT01706835|pharmacokinetic|pharmacokinetic
1272033|NCT01706835|INNO-206|inno-206
1272034|NCT01706796|Pain|pain
1272035|NCT01706744|Hospital Readmissions|hospital readmissions
1272036|NCT01706744|Community Health Services|community health services
1272037|NCT01706744|Preventive Health Services|preventive health services
1272038|NCT01706744|Norway|norway
1272039|NCT01706731|Buddhist monks|buddhist monks
1272040|NCT01706731|CBT|cbt
1272041|NCT01706731|elderly|elderly
1272042|NCT01706731|depression|depression
1272043|NCT01706718|Beetroot|beetroot
1272044|NCT01706718|Blood pressure|blood pressure
1272045|NCT01706718|Vascular function|vascular function
1272046|NCT01706705|Cervical Cancer|cervical cancer
1272047|NCT01706705|Radiation therapy|radiation therapy
1272048|NCT01706705|XRT|xrt
1272049|NCT01706705|External beam therapy|external beam therapy
1272050|NCT01706705|Brachytherapy|brachytherapy
1272051|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
1272052|NCT01706705|ICBT|icbt
1272053|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
1272054|NCT01706705|Computed tomography|computed tomography
1272055|NCT01706705|CT|ct
1272056|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
1272057|NCT01706705|MRI|mri
1272058|NCT01706705|MRI compatible applicators|mri compatible applicators
1272059|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
1272060|NCT01706705|2D treatment planning|2d treatment planning
1272061|NCT01706692|Methotrexate|methotrexate
1272062|NCT01706692|Acitretin|acitretin
1272063|NCT01706692|Cyclosporine A|cyclosporine a
1272064|NCT01706692|Systemic PUVA|systemic puva
1272065|NCT01706692|Infliximab|infliximab
1272066|NCT01706692|Adalimumab|adalimumab
1272067|NCT01706692|Etanercept|etanercept
1272068|NCT01706692|Ustekinumab|ustekinumab
1272069|NCT01706692|Fumaric acids|fumaric acids
1272070|NCT01706692|Psoriasis|psoriasis
1272071|NCT01706692|Psoriatic arthritis|psoriatic arthritis
1272072|NCT01706692|Skin disease|skin disease
1272073|NCT01706679|Healthy volunteers|healthy volunteers
1272074|NCT01706666|Maintenance|maintenance
1272075|NCT01706666|Consolidation|consolidation
1272076|NCT01706653|Polyphenol|polyphenol
1272077|NCT01706653|Fruit|fruit
1272078|NCT01706653|Metabolic|metabolic
1272079|NCT01706653|Healthy|healthy
1272080|NCT01706627|cancer|cancer
1272081|NCT01706627|melatonin|melatonin
1272082|NCT01706627|adjuvant therapy|adjuvant therapy
1272083|NCT01706627|quality of life|quality of life
1272084|NCT01706627|survival|survival
1272085|NCT01706627|adverse events|adverse events
1272086|NCT01706627|oxidative stress|oxidative stress
1272087|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
1272088|NCT01706562|Neutropenia|neutropenia
1272089|NCT01706562|Hematologic malignancy|hematologic malignancy
1272090|NCT01706562|Itraconazole|itraconazole
1272091|NCT01706562|Fungal infection|fungal infection
1272092|NCT01706562|Antifungal agent|antifungal agent
1272093|NCT01706562|Neutropenic fever|neutropenic fever
1272094|NCT01706549|Chronic pain|chronic pain
1272095|NCT01706549|Hysterectomy|hysterectomy
1272096|NCT01706549|Quality of life|quality of life
1272097|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
1272098|NCT01706523|Autism|autism
1272099|NCT01706523|Asperger|asperger
1272100|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
1272101|NCT01706510|Clopidogrel|clopidogrel
1272102|NCT01706510|Ticagrelor|ticagrelor
1272103|NCT01706510|Coronary Artery Disease|coronary artery disease
1272104|NCT01706510|Myocardial Ischemia|myocardial ischemia
1272105|NCT01706510|Coronary Disease|coronary disease
1272106|NCT01706510|Heart Diseases|heart diseases
1272107|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
1272108|NCT01706510|Arteriosclerosis|arteriosclerosis
1272109|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
1272110|NCT01706510|Vascular Diseases|vascular diseases
1272111|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1272112|NCT01706510|Hematologic Agents|hematologic agents
1272113|NCT01706510|Therapeutic Uses|therapeutic uses
1272114|NCT01706510|Pharmacologic Actions|pharmacologic actions
1272115|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
1272116|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
1272117|NCT01706510|Purinergic Antagonists|purinergic antagonists
1272118|NCT01706510|Purinergic Agents|purinergic agents
1272119|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
1272120|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
1272121|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
1272122|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
1272123|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
1272124|NCT01706497|early warning monitor|early warning monitor
1272125|NCT01706497|outcome prediction|outcome prediction
1272126|NCT01706484|randomized clinical trial|randomized clinical trial
1272127|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
1272128|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
1272129|NCT01706484|exacerbation|exacerbation
1272130|NCT01706484|pharmacoeconomic|pharmacoeconomic
1272131|NCT01706484|quality of life|quality of life
1272132|NCT01706471|verLowCNI|verlowcni
1272133|NCT01706458|Vaccine|vaccine
1272134|NCT01706458|pTVG-HP|ptvg-hp
1272135|NCT01706458|Prostate Cancer|prostate cancer
1272136|NCT01706458|Castrate Resistant|castrate resistant
1272137|NCT01706445|cystic fibrosis|cystic fibrosis
1272138|NCT01706445|exercise|exercise
1272139|NCT01706445|children|children
1272140|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
1272141|NCT01706445|muscle strength|muscle strength
1272142|NCT01706445|pulmonary function|pulmonary function
1272143|NCT01706445|quality of life|quality of life
1272144|NCT01706419|vitamin A|vitamin a
1272146|NCT01706419|zinc|zinc
1272147|NCT01706419|school children|school children
1272148|NCT01706419|fortified rice|fortified rice
1272149|NCT01706419|morbidity|morbidity
1272150|NCT01706419|growth|growth
1272151|NCT01706406|female sexual arousal|female sexual arousal
1272152|NCT01706406|female sexual desire|female sexual desire
1272153|NCT01706406|psychoeducational intervention|psychoeducational intervention
1272154|NCT01706393|probiotics|probiotics
1272155|NCT01706393|intestinal microbiome|intestinal microbiome
1272156|NCT01706393|radiotherapy|radiotherapy
1272157|NCT01706380|Substance use disorders|substance use disorders
1272158|NCT01706380|Adolescents|adolescents
1272159|NCT01706380|Retention|retention
1272160|NCT01706380|Mobile telephone|mobile telephone
1272161|NCT01706380|Follow-up|follow-up
1272162|NCT01706380|Interactive voice response|interactive voice response
1272163|NCT01706367|Clostridium difficile|clostridium difficile
1272164|NCT01706367|vaccine|vaccine
1272165|NCT01706354|end stage renal disease|end stage renal disease
1272166|NCT01706354|vascular access|vascular access
1272167|NCT01706354|regional anaesthesia|regional anaesthesia
1272168|NCT01706341|cesarean section|cesarean section
1272169|NCT01706341|intravenous fluid|intravenous fluid
1272170|NCT01706341|a glucose-containing solution|a glucose-containing solution
1272171|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
1272172|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
1272173|NCT01706328|Vilanterol (VI)|vilanterol (vi)
1272174|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
1272175|NCT01706328|FEV1|fev1
1272176|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
1272177|NCT01706328|COPD|copd
1272178|NCT01706302|General Practice Research Database|general practice research database
1272179|NCT01706302|Burden of Disease|burden of disease
1272180|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
1272181|NCT01706302|Hospital Episode Statistics|hospital episode statistics
1272182|NCT01706302|Office of National Statistics|office of national statistics
1272183|NCT01706302|RSV|rsv
1272184|NCT01706289|diabetes|diabetes
1272185|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
1272186|NCT01706289|VAP 1|vap 1
1272187|NCT01706237|Myopia|myopia
1272188|NCT01706237|LASIK|lasik
1272189|NCT01706224|Pertussis antibodies|pertussis antibodies
1272190|NCT01706224|Bordetella pertussis|bordetella pertussis
1272191|NCT01706224|sero-prevalence|sero-prevalence
1272192|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
1272193|NCT01706224|Spain|spain
1272194|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
1272195|NCT01706198|respiratory|respiratory
1272196|NCT01706198|adult|adult
1272197|NCT01706198|asthma|asthma
1272198|NCT01706185|Patients|patients
1272199|NCT01706185|Tumor antigens|tumor antigens
1272200|NCT01706185|Bladder cancer|bladder cancer
1272201|NCT01706172|TMD|tmd
1272202|NCT01706172|temporomandibular|temporomandibular
1272203|NCT01706172|dextrose|dextrose
1272204|NCT01706172|prolotherapy|prolotherapy
1272205|NCT01706146|atrial fibrillation|atrial fibrillation
1272206|NCT01706146|reveal xt|reveal xt
1272207|NCT01706146|oral anticoagulation|oral anticoagulation
1272208|NCT01706146|dabigatran|dabigatran
1272209|NCT01706146|rivaroxaban|rivaroxaban
1272210|NCT01706146|apixaban|apixaban
1272211|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
1272212|NCT01706120|prognostic factors|prognostic factors
1272213|NCT01706120|biologic factors|biologic factors
1272214|NCT01706120|clinical factors|clinical factors
1272215|NCT01706120|routine clinical practice|routine clinical practice
1272216|NCT01706107|Quality of life|quality of life
1272217|NCT01706094|stroke|stroke
1272218|NCT01706094|head position|head position
1272219|NCT01706081|acupuncture|acupuncture
1272220|NCT01706068|acute ECG changes|acute ecg changes
1272221|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
1272222|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
1272223|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
1272224|NCT01706055|Interferon|interferon
1272225|NCT01706003|Migraine|migraine
1272226|NCT01706003|Headaches|headaches
1272227|NCT01706003|Telemedicine|telemedicine
1272228|NCT01705990|HIV|hiv
1272229|NCT01705990|AIDS|aids
1272230|NCT01705990|HIV vaccine|hiv vaccine
1272231|NCT01705990|HIV prevention|hiv prevention
1272232|NCT01705977|Antibodies|antibodies
1272233|NCT01705977|Lupus|lupus
1272234|NCT01705977|SLE|sle
1272235|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
1272236|NCT01705977|Autoimmune Disease|autoimmune disease
1272237|NCT01705977|Belimumab|belimumab
1272238|NCT01705964|Status asthmaticus|status asthmaticus
1272239|NCT01705964|Asthma exacerbation|asthma exacerbation
1272240|NCT01705964|Epinephrine|epinephrine
1272241|NCT01705964|Adjunctive therapy|adjunctive therapy
1272242|NCT01705951|Smoking|smoking
1272243|NCT01705951|Insulin resistance|insulin resistance
1272244|NCT01705951|Metabolic Syndrome|metabolic syndrome
1272245|NCT01705951|Endothelial Function|endothelial function
1272246|NCT01705951|Smoking Cessation|smoking cessation
1272247|NCT01705951|Resistance Training|resistance training
1272248|NCT01705951|Nicotine Replacement|nicotine replacement
1272249|NCT01705951|Exercise|exercise
1272250|NCT01705951|Cardiovascular Disease|cardiovascular disease
1272251|NCT01705951|Arterial Stiffness|arterial stiffness
1272252|NCT01705951|Body Composition|body composition
1272253|NCT01705912|fall|fall
1272254|NCT01705912|prevention|prevention
1272255|NCT01705899|Type 1 Diabetes|type 1 diabetes
1272256|NCT01705899|Islet transplant|islet transplant
1272257|NCT01705899|Kidney transplant|kidney transplant
1272258|NCT01705886|Osteoarthritis|osteoarthritis
1272259|NCT01705886|Joint Disease|joint disease
1272260|NCT01705886|Arthritis|arthritis
1272261|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
1272263|NCT01705873|cardiovascular|cardiovascular
1272264|NCT01705873|risk|risk
1272265|NCT01705873|mortality|mortality
1272266|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
1272267|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1272268|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1272269|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
1272270|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
1272271|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
1272272|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
1272273|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
1272274|NCT01705847|GS-9820|gs-9820
1272275|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
1272276|NCT01705834|Arthritis|arthritis
1272277|NCT01705834|Stiffness|stiffness
1272278|NCT01705834|Range of movement|range of movement
1272279|NCT01705834|Goniometry|goniometry
1272280|NCT01705834|Digital|digital
1272281|NCT01705834|Dataglove|dataglove
1272282|NCT01705834|Outcome|outcome
1272283|NCT01705821|Skull base|skull base
1272284|NCT01705821|Pituitary|pituitary
1272285|NCT01705821|Robotics|robotics
1272286|NCT01705821|Endonasal surgery|endonasal surgery
1272287|NCT01705821|Sinus surgery|sinus surgery
1272288|NCT01705769|treatment|treatment
1272289|NCT01705769|severe acute malnutrition|severe acute malnutrition
1272290|NCT01705756|Colchicine|colchicine
1272291|NCT01705756|Anakinra|anakinra
1272292|NCT01705756|Colchicine resistance|colchicine resistance
1272293|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
1272294|NCT01705743|anaesthesia|anaesthesia
1272295|NCT01705743|middle aged|middle aged
1272296|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
1272297|NCT01705743|sevoflurane|sevoflurane
1272298|NCT01705743|nitrous oxide|nitrous oxide
1272299|NCT01705743|isoelectric EEG|isoelectric eeg
1272300|NCT01705678|Males|males
1272301|NCT01705678|Metabolic syndrome|metabolic syndrome
1272302|NCT01705678|Otherwise healthy|otherwise healthy
1272303|NCT01705652|nexrutine|nexrutine
1272304|NCT01705652|prostate cancer|prostate cancer
1272305|NCT01705639|diabetes|diabetes
1272306|NCT01705639|melatonin|melatonin
1272307|NCT01705639|glucose tolerance|glucose tolerance
1272308|NCT01705639|sleep|sleep
1272309|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
1272310|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
1272311|NCT01705626|Nervous System Diseases|nervous system diseases
1272312|NCT01705626|Metabolism, Inborn Errors|metabolism, inborn errors
1272313|NCT01705626|Genetic Diseases, Inborn|genetic diseases, inborn
1272314|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1272315|NCT01705613|ADHD|adhd
1272316|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
1272317|NCT01705613|Cost-effectiveness|cost-effectiveness
1272318|NCT01705613|Cost-utility|cost-utility
1272319|NCT01705613|QALYs|qalys
1272320|NCT01705600|Central Sensitization|central sensitization
1272321|NCT01705600|Low Back Pain|low back pain
1272322|NCT01705600|Pain|pain
1272323|NCT01705600|Pain Catastrophizing|pain catastrophizing
1272324|NCT01705600|Brence|brence
1272325|NCT01705587|osteoporosis|osteoporosis
1272326|NCT01705587|atypical femoral fractures|atypical femoral fractures
1272327|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
1272328|NCT01705587|postmenopausal women|postmenopausal women
1272329|NCT01705587|bone loss|bone loss
1272330|NCT01705574|HIV-1|hiv-1
1272331|NCT01705574|HIV|hiv
1272332|NCT01705574|Treatment-Naive|treatment-naive
1272333|NCT01705574|Women|women
1272334|NCT01705574|WAVES|waves
1272335|NCT01705561|fertility|fertility
1272336|NCT01705561|chemotherapy|chemotherapy
1272337|NCT01705561|breast cancer|breast cancer
1272338|NCT01705561|latin american women|latin american women
1272339|NCT01705561|pre menopausal|pre menopausal
1272340|NCT01705548|Brain metastasis|brain metastasis
1272341|NCT01705535|Fecal incontinence|fecal incontinence
1272342|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
1272343|NCT01705535|Physiotherapy|physiotherapy
1272344|NCT01705522|IBD|ibd
1272345|NCT01705522|ulcerative colitis|ulcerative colitis
1272346|NCT01705522|Crohn's disease|crohn's disease
1272347|NCT01705522|NAFLD|nafld
1272348|NCT01705522|biomarkers|biomarkers
1272349|NCT01705522|vitamin D|vitamin d
1272350|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
1272351|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
1272352|NCT01705496|Phase II|phase ii
1272353|NCT01705496|FIAU|fiau
1272354|NCT01705496|Fialuridine|fialuridine
1272355|NCT01705496|Prosthetic|prosthetic
1272356|NCT01705496|Joint|joint
1272357|NCT01705496|Infection|infection
1272358|NCT01705496|PET-CT|pet-ct
1272359|NCT01705483|ASP9853|asp9853
1272360|NCT01705483|Docetaxel|docetaxel
1272361|NCT01705483|Paclitaxel|paclitaxel
1272362|NCT01705470|Furosemide|furosemide
1272363|NCT01705470|Anemia|anemia
1272364|NCT01705470|LV dysfunction|lv dysfunction
1272365|NCT01705470|blood transfusion|blood transfusion
1272366|NCT01705457|multiple sclerosis|multiple sclerosis
1272367|NCT01705457|Vitamin A|vitamin a
1272368|NCT01705457|retinoic acid receptor|retinoic acid receptor
1272369|NCT01705457|retinoic x receptor|retinoic x receptor
1272370|NCT01705444|Urinary retention|urinary retention
1272371|NCT01705444|Foley catheter|foley catheter
1272372|NCT01705444|The Spanner|the spanner
1272373|NCT01705444|Quality of life|quality of life
1272374|NCT01705431|Emotional Disturbance|emotional disturbance
1272375|NCT01705431|Behavioral Disturbance|behavioral disturbance
1272376|NCT01705431|EBD|ebd
1272377|NCT01705431|Middle School|middle school
1272378|NCT01705431|Special Education|special education
1272379|NCT01705431|School Psychology|school psychology
1272380|NCT01705418|Parkinson disease|parkinson disease
1272381|NCT01705418|Deep brain stimulation|deep brain stimulation
1272382|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
1272383|NCT01705405|cancer|cancer
1272384|NCT01705405|prostate|prostate
1272385|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
1272386|NCT01705366|Osteoarthritis|osteoarthritis
1272387|NCT01705366|Joint Disease|joint disease
1272388|NCT01705366|Arthritis|arthritis
1272389|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
1272390|NCT01705353|Stroke|stroke
1272391|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
1272392|NCT01705353|HMGB-1|hmgb-1
1272393|NCT01705353|cytokines|cytokines
1272394|NCT01705353|functional recovery|functional recovery
1272395|NCT01705353|inflammation|inflammation
1272396|NCT01705353|immune response|immune response
1272397|NCT01705327|Parkinson's|parkinson's
1272398|NCT01705327|Biomarkers|biomarkers
1272399|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
1272400|NCT01705314|human influenza children|human influenza children
1272401|NCT01705288|laparotomy|laparotomy
1272402|NCT01705288|hysterectomy|hysterectomy
1272403|NCT01705262|compliance|compliance
1272404|NCT01705262|Bowel preparations|bowel preparations
1272405|NCT01705262|Moviprep|moviprep
1272406|NCT01705262|Phosphoral|phosphoral
1272407|NCT01705223|prophylactic|prophylactic
1272408|NCT01705223|vaccine|vaccine
1272409|NCT01705184|Stop and go|stop and go
1272410|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
1272411|NCT01705184|Non-squamous|non-squamous
1272412|NCT01705184|Bevacizumab|bevacizumab
1272413|NCT01705171|IBS|ibs
1272414|NCT01705171|fructose intolerance|fructose intolerance
1272415|NCT01705171|GLUT 5|glut 5
1272416|NCT01705171|GLUT 2|glut 2
1272417|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
1272418|NCT01705158|sensitive in platin|sensitive in platin
1272419|NCT01705145|Cystic Fibrosis|cystic fibrosis
1272420|NCT01705119|Mechanically Ventilated|mechanically ventilated
1272421|NCT01705119|Critical Care|critical care
1272422|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
1272423|NCT01705080|Renal Denervation|renal denervation
1272424|NCT01705080|Renal artery|renal artery
1272425|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
1272426|NCT01705054|Angina|angina
1272427|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
1272428|NCT01705054|Quality of Life|quality of life
1272429|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
1272430|NCT01705015|exercise|exercise
1272431|NCT01705002|phase 1|phase 1
1272432|NCT01705002|dose escalating|dose escalating
1272433|NCT01705002|prodrug|prodrug
1272434|NCT01705002|mitomycin C|mitomycin c
1272435|NCT01705002|Capecitabine|capecitabine
1272436|NCT01704989|Glaucoma, SLT|glaucoma, slt
1272437|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
1272438|NCT01704963|B-cell malignancies|b-cell malignancies
1272439|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
1272440|NCT01704963|PCI-32765|pci-32765
1272441|NCT01704963|Tumor|tumor
1272442|NCT01704963|Pharmacokinetics|pharmacokinetics
1272443|NCT01704963|Japanese|japanese
1272444|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
1272445|NCT01704937|Clostridium difficile|clostridium difficile
1272446|NCT01704937|Diarrhea|diarrhea
1272447|NCT01704924|Prevena|prevena
1272448|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
1272449|NCT01704924|Incisional wound vac|incisional wound vac
1272450|NCT01704911|Transradial|transradial
1272451|NCT01704911|Transfemoral|transfemoral
1272452|NCT01704911|Coronary Intervention|coronary intervention
1272453|NCT01704898|efavirenz|efavirenz
1272454|NCT01704898|bioequivalence|bioequivalence
1272455|NCT01704898|fasting|fasting
1272456|NCT01704898|healthy volunteers|healthy volunteers
1272457|NCT01704885|Childhood Cancer|childhood cancer
1272458|NCT01704885|Sibling Play intervention|sibling play intervention
1272459|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
1272460|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
1272461|NCT01704872|Neuroblastoma|neuroblastoma
1272462|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
1272463|NCT01704872|ch14.18/CHO|ch14.18/cho
1272464|NCT01704859|fracture|fracture
1272465|NCT01704833|Psychosis|psychosis
1272466|NCT01704833|Paranoia|paranoia
1272467|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
1272468|NCT01704833|Delusions|delusions
1272469|NCT01704833|Group Therapy|group therapy
1272470|NCT01704820|Colon Polyps|colon polyps
1272471|NCT01704820|Colon Cancer screening|colon cancer screening
1272472|NCT01704820|Colonoscopy|colonoscopy
1272473|NCT01704807|Low Back Pain|low back pain
1272474|NCT01704807|Chronic|chronic
1272475|NCT01704807|Orthotic Device|orthotic device
1272476|NCT01704807|Applied Kinesiology|applied kinesiology
1272477|NCT01704807|Manual Muscle Testing|manual muscle testing
1272478|NCT01704807|Chiropractic|chiropractic
1272479|NCT01704794|Sickle Cell Anemia|sickle cell anemia
1272480|NCT01704794|Quality of Life|quality of life
1272481|NCT01704794|Antioxidant|antioxidant
1272482|NCT01704794|Anti inflammatory|anti inflammatory
1272483|NCT01704794|Sorghum bicolor|sorghum bicolor
1272485|NCT01704781|Clinical trial|clinical trial
1272486|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
1272487|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
1272488|NCT01704781|HIV|hiv
1272489|NCT01704781|Immunomodulatory|immunomodulatory
1272490|NCT01704781|Infection|infection
1272491|NCT01704781|Lenalidomide|lenalidomide
1272492|NCT01704781|Phase I/II|phase i/ii
1272493|NCT01704781|Vaccine|vaccine
1272494|NCT01704781|Vacc-4x|vacc-4x
1272495|NCT01704768|Randomized Controlled Trial|randomized controlled trial
1272496|NCT01704768|School-Based Intervention|school-based intervention
1272497|NCT01704755|Cirrhosis|cirrhosis
1272498|NCT01704755|Hepatitis C|hepatitis c
1272499|NCT01704755|Child Pugh A|child pugh a
1272500|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
1272501|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
1272502|NCT01704755|Cirrhotic|cirrhotic
1272503|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
1272504|NCT01704755|Hepatitis C Virus|hepatitis c virus
1272505|NCT01704755|ombitasvir|ombitasvir
1272506|NCT01704755|paritaprevir|paritaprevir
1272507|NCT01704755|dasabuvir|dasabuvir
1272508|NCT01704755|Interferon-Free|interferon-free
1272509|NCT01704755|Viekira Pak|viekira pak
1272510|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1272511|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
1272512|NCT01704742|Kenya|kenya
1272513|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
1272514|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1272515|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
1272516|NCT01704729|Myopia|myopia
1272517|NCT01704729|Focus groups|focus groups
1272518|NCT01704729|refraction|refraction
1272519|NCT01704729|Glasses|glasses
1272520|NCT01704729|spectacles|spectacles
1272521|NCT01704716|neuroblastoma|neuroblastoma
1272522|NCT01704716|immunotherapy|immunotherapy
1272523|NCT01704716|MAT|mat
1272524|NCT01704716|antibody treatment|antibody treatment
1272525|NCT01704703|colorectal cancer|colorectal cancer
1272526|NCT01704703|FOLFIRI|folfiri
1272527|NCT01704703|Panitumumab|panitumumab
1272528|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
1272529|NCT01704703|highly sensitive techniques|highly sensitive techniques
1272530|NCT01704690|Esophageal cancer|esophageal cancer
1272531|NCT01704690|Chemotherapy|chemotherapy
1272532|NCT01704690|Efficacy|efficacy
1272533|NCT01704690|Toxicity|toxicity
1272534|NCT01704677|Chronic low back pain|chronic low back pain
1272535|NCT01704677|Degenerated disc|degenerated disc
1272536|NCT01704677|Total disc replacement|total disc replacement
1272537|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
1272538|NCT01704677|Long term results|long term results
1272539|NCT01704664|malnutrition,|malnutrition,
1272540|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
1272541|NCT01704664|immunonutrition,|immunonutrition,
1272542|NCT01704664|gastrectomy,|gastrectomy,
1272543|NCT01704664|lymphocytes,|lymphocytes,
1272544|NCT01704664|interleukin,|interleukin,
1272545|NCT01704664|blood platelets,|blood platelets,
1272546|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
1272547|NCT01704651|Ovary|ovary
1272548|NCT01704651|Ovarian|ovarian
1272549|NCT01704651|Fallopian|fallopian
1272550|NCT01704651|Peritoneal|peritoneal
1272551|NCT01704651|Cancer|cancer
1272552|NCT01704651|Gynecological|gynecological
1272553|NCT01704651|Female|female
1272554|NCT01704625|pain|pain
1272555|NCT01704625|headache|headache
1272556|NCT01704612|local anesthetic|local anesthetic
1272557|NCT01704612|sciatic|sciatic
1272558|NCT01704612|diabetes|diabetes
1272559|NCT01704612|block|block
1272560|NCT01704612|duration|duration
1272561|NCT01704599|Psoriasis|psoriasis
1272562|NCT01704599|Adalimumab|adalimumab
1272563|NCT01704599|B vitamins|b vitamins
1272564|NCT01704599|Homocysteine|homocysteine
1272565|NCT01704599|Folic acid|folic acid
1272566|NCT01704599|Cyanocobalamin|cyanocobalamin
1272567|NCT01704599|Pyridoxine|pyridoxine
1272568|NCT01704599|Vitamin B6|vitamin b6
1272569|NCT01704599|Vitamin B9|vitamin b9
1272570|NCT01704599|Vitamin B12|vitamin b12
1272571|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
1272572|NCT01704586|PET/CT|pet/ct
1272573|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
1272574|NCT01704586|I-124|i-124
1272575|NCT01704586|Quality of life|quality of life
1272576|NCT01704573|PET Scan|pet scan
1272577|NCT01704547|Breast cancer|breast cancer
1272578|NCT01704547|Lumpectomy|lumpectomy
1272579|NCT01704547|Breast Irradiation|breast irradiation
1272580|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
1272581|NCT01704534|Acne ectopica|acne ectopica
1272582|NCT01704534|Inverse acne|inverse acne
1272583|NCT01704534|Ustekinumab|ustekinumab
1272584|NCT01704534|Stelara|stelara
1272585|NCT01704521|Hepatitis C|hepatitis c
1272586|NCT01704521|HCV|hcv
1272587|NCT01704521|Hemophilia|hemophilia
1272588|NCT01704508|Falciparum malaria|falciparum malaria
1272589|NCT01704508|children|children
1272590|NCT01704508|treatment|treatment
1272591|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
1272592|NCT01704495|Exacerbation,|exacerbation,
1272593|NCT01704495|Safety|safety
1272594|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
1272595|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
1272596|NCT01704456|dyspareunia|dyspareunia
1272597|NCT01704456|vulvodynia|vulvodynia
1272598|NCT01704456|mindfulness|mindfulness
1272599|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
1272600|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
1272601|NCT01704443|dyspareunia|dyspareunia
1272602|NCT01704443|vulvodynia|vulvodynia
1272603|NCT01704443|mindfulness|mindfulness
1272604|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
1272605|NCT01704430|Cardiac surgery|cardiac surgery
1272606|NCT01704430|Cardiac bypass|cardiac bypass
1272607|NCT01704430|Intensive Care|intensive care
1272608|NCT01704430|Nosocomial infection|nosocomial infection
1272609|NCT01704430|Glutamine|glutamine
1272610|NCT01704430|Randomized trial|randomized trial
1272611|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
1272612|NCT01704404|Chronic Bronchitis|chronic bronchitis
1272613|NCT01704404|Emphysema|emphysema
1272614|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1272615|NCT01704404|COPD|copd
1272616|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
1272617|NCT01704352|CBT-I|cbt-i
1272618|NCT01704339|End stage renal failure|end stage renal failure
1272619|NCT01704339|Neuropathic pain|neuropathic pain
1272620|NCT01704339|Critical digital ischaemia|critical digital ischaemia
1272621|NCT01704326|Deuce|deuce
1272622|NCT01704326|Journey Deuce|journey deuce
1272623|NCT01704326|Knee pain|knee pain
1272624|NCT01704326|Osteoarthritis|osteoarthritis
1272625|NCT01704326|Bicompartmental|bicompartmental
1272626|NCT01704326|Femoral|femoral
1272627|NCT01704326|Medial|medial
1272628|NCT01704313|Vascular access|vascular access
1272629|NCT01704313|Haemodialysis|haemodialysis
1272630|NCT01704313|Suturing technique|suturing technique
1272631|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
1272632|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
1272757|NCT01703832|stress|stress
1272633|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
1272634|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
1272635|NCT01704300|Heart failure|heart failure
1272636|NCT01704300|Ischaemic stroke|ischaemic stroke
1272735|NCT01703988|SMN|smn
1272637|NCT01704300|Peripheral arterial disease|peripheral arterial disease
1272638|NCT01704300|Stable angina|stable angina
1272639|NCT01704300|Unheralded coronary death|unheralded coronary death
1272640|NCT01704300|Unstable angina|unstable angina
1604258|NCT00378638|breast|breast
1272641|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
1272642|NCT01704300|Transient Ischemic Attack|transient ischemic attack
1272643|NCT01704287|PD-1|pd-1
1272644|NCT01704287|PD1|pd1
1272645|NCT01704287|PD-L1|pd-l1
1272646|NCT01704287|PDL1|pdl1
1272647|NCT01704274|biochemical|biochemical
1272648|NCT01704274|recurrence|recurrence
1272649|NCT01704274|prostate|prostate
1272650|NCT01704274|cancer|cancer
1272651|NCT01704274|active|active
1272652|NCT01704274|surveillence|surveillence
1272653|NCT01704248|eye drops self-instillation|eye drops self-instillation
1272654|NCT01704235|screening|screening
1272655|NCT01704222|Children|children
1272656|NCT01704222|nursery|nursery
1272657|NCT01704222|CMV|cmv
1272658|NCT01704222|Infection|infection
1272659|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
1272660|NCT01704183|heart rate variability|heart rate variability
1272661|NCT01704183|fingolimod|fingolimod
1272662|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
1272663|NCT01704157|Osteoarthritis|osteoarthritis
1272664|NCT01704157|knee|knee
1272665|NCT01704157|chronic pain|chronic pain
1272666|NCT01704144|Efavirenz|efavirenz
1272667|NCT01704144|rifampin|rifampin
1272668|NCT01704144|Pharmacokinetics|pharmacokinetics
1272669|NCT01704144|Drug-drug interactions|drug-drug interactions
1272670|NCT01704144|Drug-gene interactions|drug-gene interactions
1272671|NCT01704144|Children|children
1272672|NCT01704131|Levosimendan|levosimendan
1272673|NCT01704131|Children|children
1272674|NCT01704131|Pharmacokinetics|pharmacokinetics
1272675|NCT01704118|I-gel|i-gel
1272676|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
1272677|NCT01704118|small infants|small infants
1272678|NCT01704118|neonates|neonates
1272679|NCT01704105|Chlorine water treatment|chlorine water treatment
1272680|NCT01704105|Point-of-use water treatment|point-of-use water treatment
1272681|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
1272682|NCT01704105|Handwashing with soap|handwashing with soap
1272683|NCT01704105|Hand hygiene|hand hygiene
1272684|NCT01704105|Latrines|latrines
1272685|NCT01704105|Water|water
1272686|NCT01704105|Sanitation|sanitation
1272687|NCT01704105|Handwashing|handwashing
1272688|NCT01704105|Breast Feeding|breast feeding
1272689|NCT01704105|Complementary Feeding|complementary feeding
1272690|NCT01704105|Micronutrients|micronutrients
1272691|NCT01704105|Malnutrition|malnutrition
1272692|NCT01704105|Nutrition Disorders|nutrition disorders
1272693|NCT01704105|Diarrhea|diarrhea
1272694|NCT01704105|Child Development|child development
1272695|NCT01704105|Child potties|child potties
1272696|NCT01704105|Point-of-use fortification|point-of-use fortification
1272697|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
1272698|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
1272699|NCT01704105|Environmental enteropathy|environmental enteropathy
1272700|NCT01704105|Tropical enteropathy|tropical enteropathy
1272701|NCT01704105|Gut function|gut function
1272702|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
1272703|NCT01704105|Soil transmitted helminths|soil transmitted helminths
1272704|NCT01704105|Intestinal protozoans|intestinal protozoans
1272705|NCT01704105|Antibody response|antibody response
1272706|NCT01704079|Parathyroid Diseases|parathyroid diseases
1272707|NCT01704079|Renal Insufficiency|renal insufficiency
1272708|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
1272709|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1272710|NCT01704079|Vitamin D|vitamin d
1272711|NCT01704079|Hyperparathyroidism|hyperparathyroidism
1272712|NCT01704079|Kidney Diseases|kidney diseases
1272713|NCT01704079|Kidney Failure|kidney failure
1272714|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
1272715|NCT01704066|ARDS|ards
1272716|NCT01704066|Chest radiograph|chest radiograph
1272717|NCT01704066|Berlin Definition|berlin definition
1272718|NCT01704066|Inter-observer agreement|inter-observer agreement
1272719|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
1272720|NCT01704053|Dabigatran|dabigatran
1272721|NCT01704053|Rivaroxaban|rivaroxaban
1272722|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
1272723|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
1272724|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
1272725|NCT01704040|CNTO 3157|cnto 3157
1272726|NCT01704040|Rhinovirus|rhinovirus
1272727|NCT01704027|Localized|localized
1272728|NCT01704027|High risk|high risk
1272729|NCT01704014|occurrence of|occurrence of
1272730|NCT01704001|ART-123|art-123
1272731|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
1272732|NCT01704001|Pharmacokinetics|pharmacokinetics
1272733|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
1272736|NCT01703988|SMNRx|smnrx
1272737|NCT01703988|ISIS-SMNRx|isis-smnrx
1272738|NCT01703988|ISIS 396443|isis 396443
1604259|NCT00378638|cancer|cancer
1272739|NCT01703975|Simulation efficiency|simulation efficiency
1272740|NCT01703975|Collaborative learning|collaborative learning
1272741|NCT01703962|Glioma|glioma
1272742|NCT01703962|IDH1|idh1
1272743|NCT01703962|Spectroscopy|spectroscopy
1272744|NCT01703962|Plasma|plasma
1272745|NCT01703936|economic intervention|economic intervention
1272746|NCT01703936|ex-combatant|ex-combatant
1272747|NCT01703936|agriculture|agriculture
1272748|NCT01703936|life skills|life skills
1272749|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
1272750|NCT01703910|Adult patients|adult patients
1272751|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
1272752|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
1272753|NCT01703884|Malria diagnosis|malria diagnosis
1272754|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
1272755|NCT01703884|ANC services improvement|anc services improvement
1272756|NCT01703832|acute stress reaction|acute stress reaction
1272758|NCT01703832|stress perception|stress perception
1272759|NCT01703832|physiological stress response|physiological stress response
1272760|NCT01703832|Neurexan|neurexan
1272761|NCT01703819|acute stress reaction|acute stress reaction
1272762|NCT01703819|stress|stress
1272763|NCT01703819|stress perception|stress perception
1272764|NCT01703819|physiological stress response|physiological stress response
1272765|NCT01703819|Neurexan|neurexan
1272766|NCT01703806|Mitral regurgitation|mitral regurgitation
1272767|NCT01703806|Mitral valve repair|mitral valve repair
1272768|NCT01703806|Watchful waiting|watchful waiting
1272769|NCT01703767|patient satisfaction|patient satisfaction
1272770|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
1272771|NCT01703767|Desert Storm Veteran|desert storm veteran
1272772|NCT01703754|Genetically Modified Organism|genetically modified organism
1272773|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
1272774|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
1272775|NCT01703754|Breast Cancer|breast cancer
1272776|NCT01703754|Palifosfamide|palifosfamide
1272777|NCT01703754|INXN1001|inxn1001
1272778|NCT01703754|INXN2001|inxn2001
1272779|NCT01703754|Adenoviral vector|adenoviral vector
1272780|NCT01703715|Hydration|hydration
1272781|NCT01703715|Elderly patients|elderly patients
1272782|NCT01703715|Age 65 years and over|age 65 years and over
1272783|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
1272784|NCT01703689|Quality indicators|quality indicators
1272785|NCT01703689|quality of care|quality of care
1272786|NCT01703689|nursing home|nursing home
1272787|NCT01703689|long-term care unit|long-term care unit
1272788|NCT01703689|nursing home organisation|nursing home organisation
1272789|NCT01703689|nursing home structure|nursing home structure
1272790|NCT01703689|disability|disability
1272791|NCT01703689|dependence|dependence
1272792|NCT01703689|functional decline|functional decline
1272793|NCT01703689|functional impairment|functional impairment
1272794|NCT01703689|older adults|older adults
1272795|NCT01703689|elderly|elderly
1272796|NCT01703689|audit and feedback|audit and feedback
1272797|NCT01703689|cooperative work|cooperative work
1272798|NCT01703689|geriatrician|geriatrician
1272799|NCT01703689|medication|medication
1272800|NCT01703689|hospitalisation|hospitalisation
1272801|NCT01703689|comorbidity|comorbidity
1272802|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
1272803|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
1272804|NCT01703676|Gonadal status|gonadal status
1272805|NCT01703676|Gene expression|gene expression
1272806|NCT01703676|Methylation|methylation
1272807|NCT01703663|Stroke|stroke
1272808|NCT01703663|Sleep Apnea|sleep apnea
1272810|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
1272811|NCT01703650|RECIST|recist
1272812|NCT01703650|perfusion|perfusion
1272813|NCT01703637|Sitagliptin|sitagliptin
1272814|NCT01703637|Vildagliptin|vildagliptin
1272815|NCT01703637|Saxagliptin|saxagliptin
1272816|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1272817|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
1272818|NCT01703624|glycopyrrolate|glycopyrrolate
1272819|NCT01703624|oral inhalation|oral inhalation
1272820|NCT01703624|COPD|copd
1272821|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1272822|NCT01703624|lung function|lung function
1272823|NCT01703624|pharmacokinetics|pharmacokinetics
1272824|NCT01703624|tolerability|tolerability
1272825|NCT01703624|safety|safety
1272826|NCT01703624|cross-over|cross-over
1272827|NCT01703624|single-dose|single-dose
1272828|NCT01703624|dose-ranging|dose-ranging
1272829|NCT01703611|Nutrition|nutrition
1272830|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
1272831|NCT01703611|Diabetes Mellitus|diabetes mellitus
1272832|NCT01703611|Nutrition outcomes|nutrition outcomes
1272833|NCT01703611|Evidence Based Guidelines|evidence based guidelines
1272834|NCT01703598|Parkinson's disease|parkinson's disease
1272835|NCT01703598|Deep Brain Stimulation|deep brain stimulation
1272836|NCT01703585|genomic analysis|genomic analysis
1272837|NCT01703585|genome|genome
1272838|NCT01703585|tumor|tumor
1272839|NCT01703585|tissue|tissue
1272840|NCT01703585|archival|archival
1272841|NCT01703585|biopsy|biopsy
1272842|NCT01703585|core needle|core needle
1272843|NCT01703585|fine needle|fine needle
1272844|NCT01703585|DNA|dna
1272845|NCT01703585|gene|gene
1272846|NCT01703585|expression|expression
1272847|NCT01703585|sequencing|sequencing
1272848|NCT01703572|Phase 1|phase 1
1272849|NCT01703572|Dose escalation|dose escalation
1272850|NCT01703572|relapsed or refractory|relapsed or refractory
1272851|NCT01703572|lymphoid malignancies|lymphoid malignancies
1272852|NCT01703559|Glare|glare
1272853|NCT01703559|Starburst|starburst
1272854|NCT01703559|Halos|halos
1272855|NCT01703559|Reduced contrast sensitivity|reduced contrast sensitivity
1272856|NCT01703546|Morbid Obesity|morbid obesity
1272857|NCT01703546|Weight Loss Surgery|weight loss surgery
1272858|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
1272859|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
1272860|NCT01703546|Imbrication|imbrication
1272861|NCT01703533|Autism|autism
1272862|NCT01703533|Rett's Syndrome|rett's syndrome
1272863|NCT01703533|Rett Disorder|rett disorder
1272864|NCT01703533|Rett's Disorder|rett's disorder
1272865|NCT01703533|Ataxia|ataxia
1272866|NCT01703520|Males breast cancer|males breast cancer
1272867|NCT01703520|Finasteride|finasteride
1272868|NCT01703520|PROSCAR®|proscar®
1272869|NCT01703520|PROPECIA®|propecia®
1272870|NCT01703494|C. difficile|c. difficile
1272871|NCT01703494|fecal transplant|fecal transplant
1272872|NCT01703494|stool transplant|stool transplant
1272873|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
1272874|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
1272875|NCT01703494|FMT|fmt
1272876|NCT01703481|Tumor|tumor
1272877|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
1272878|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1272879|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
1272880|NCT01703481|JNJ-42756493|jnj-42756493
1272881|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
1272882|NCT01703429|Multiple Sclerosis|multiple sclerosis
1272884|NCT01703429|Complementary and Alternative|complementary and alternative
1272885|NCT01703429|CAM|cam
1272886|NCT01703416|COPD|copd
1272888|NCT01703416|CDLM questionnaire|cdlm questionnaire
1272889|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
1272890|NCT01703403|physical therapy|physical therapy
1272891|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
1272892|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
1272894|NCT01703390|ERCC-1|ercc-1
1272895|NCT01703390|ERCC1|ercc1
1272896|NCT01703390|AGMT|agmt
1272897|NCT01703364|CLL|cll
1272898|NCT01703364|Lenalidomide|lenalidomide
1272899|NCT01703364|Revlimid|revlimid
1272900|NCT01703364|AGMT|agmt
1272901|NCT01703364|T cell|t cell
1272902|NCT01703351|pain control, VATS|pain control, vats
1272903|NCT01703338|assessment model|assessment model
1272904|NCT01703338|biomechanical changes|biomechanical changes
1272905|NCT01703338|functional activities|functional activities
1272906|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1272907|NCT01703338|causal relationship|causal relationship
1272908|NCT01703338|core muscles activation pattern|core muscles activation pattern
1272909|NCT01703338|pathological changes|pathological changes
1272910|NCT01703338|early rehabilitation|early rehabilitation
1272911|NCT01703338|core stability exercise|core stability exercise
1272912|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
1272913|NCT01703325|Psoriatic nails|psoriatic nails
1272914|NCT01703325|Triamcinolone injection|triamcinolone injection
1272915|NCT01703325|clobetasol propionate|clobetasol propionate
1272916|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
1272917|NCT01703299|imipenem|imipenem
1272918|NCT01703299|ertapenem|ertapenem
1272919|NCT01703299|resistance|resistance
1272920|NCT01703299|commensal flora|commensal flora
1272921|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
1272922|NCT01703260|Drug therapy|drug therapy
1272923|NCT01703247|Arrhythmias|arrhythmias
1272924|NCT01703247|Ablation|ablation
1272925|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
1272926|NCT01703195|Vaginal Cancer|vaginal cancer
1272927|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
1272928|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
1272929|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
1272930|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
1272931|NCT01703195|DWMR|dwmr
1368773|NCT01297699|CAS|cas
1272932|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
1272933|NCT01703195|MRI|mri
1272934|NCT01703195|Tumor involvement|tumor involvement
1272935|NCT01703195|Response to radiation therapy|response to radiation therapy
1272936|NCT01703195|XRT|xrt
1272937|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
1272938|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
1272939|NCT01703182|leg amputation|leg amputation
1272940|NCT01703182|wound healing failure|wound healing failure
1272941|NCT01703182|amputation revision|amputation revision
1272942|NCT01703169|severe aplastic anemia|severe aplastic anemia
1272943|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
1272944|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
1272945|NCT01703169|bleeding|bleeding
1272946|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
1272947|NCT01703130|ISPB|ispb
1272948|NCT01703130|Brachial Plexus Block|brachial plexus block
1272949|NCT01703130|Anesthesia|anesthesia
1272950|NCT01703130|Pain Management|pain management
1272951|NCT01703130|Surgery|surgery
1272952|NCT01703117|Alzheimer's Disease|alzheimer's disease
1272953|NCT01703117|Dementia|dementia
1272954|NCT01703104|Sorghum bicolor|sorghum bicolor
1272955|NCT01703104|sickle cell anaemia|sickle cell anaemia
1272956|NCT01703104|haematological parameters|haematological parameters
1272957|NCT01703065|Prostate cancer|prostate cancer
1272958|NCT01703065|Bone metastases|bone metastases
1272959|NCT01703039|Major Depression|major depression
1272960|NCT01703039|Major Depressive Disorder|major depressive disorder
1272961|NCT01703039|Depression|depression
1272962|NCT01703039|Riluzole|riluzole
1272963|NCT01703039|Glutamate|glutamate
1272964|NCT01703039|Sertraline|sertraline
1272965|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
1272966|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
1272967|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
1272968|NCT01702974|HIV|hiv
1272969|NCT01702974|cholecalciferol|cholecalciferol
1272970|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
1272971|NCT01702974|antimicrobial peptides|antimicrobial peptides
1272972|NCT01702974|immune response|immune response
1272973|NCT01702974|inflammation|inflammation
1273076|NCT01702506|fasted|fasted
1273077|NCT01702506|antacid|antacid
1272984|NCT01702935|Stem Cells|stem cells
1272985|NCT01702922|Stress|stress
1272986|NCT01702922|Marriage|marriage
1272987|NCT01702922|Dyadic Coping|dyadic coping
1272988|NCT01702922|Mother|mother
1272989|NCT01702922|Father|father
1272990|NCT01702909|Metastatic Renal Cell|metastatic renal cell
1272991|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
1272992|NCT01702896|Metastatic Melanoma|metastatic melanoma
1272993|NCT01702883|prescriptions|prescriptions
1272994|NCT01702883|hypertension|hypertension
1272995|NCT01702883|high cholesterol|high cholesterol
1272996|NCT01702883|diabetes|diabetes
1272997|NCT01702883|depression|depression
1272998|NCT01702883|adherence|adherence
1272999|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
1273000|NCT01702857|Dengue|dengue
1273001|NCT01702857|Dengue fever|dengue fever
1273002|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1273003|NCT01702857|Flavivirus|flavivirus
1273004|NCT01702844|Nab paclitaxel|nab paclitaxel
1273005|NCT01702844|Abraxane|abraxane
1273006|NCT01702844|First Line|first line
1273007|NCT01702844|Non small cell lung cancer|non small cell lung cancer
1273008|NCT01702844|NSCLC|nsclc
1273009|NCT01702844|Phase II|phase ii
1273010|NCT01702844|Non-Randomized|non-randomized
1273011|NCT01702844|Elderly|elderly
1273012|NCT01702844|Lineberger|lineberger
1273013|NCT01702844|UNC|unc
1273014|NCT01702844|LCCC 1210|lccc 1210
1273015|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
1273016|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1273017|NCT01702818|HSDD|hsdd
1273018|NCT01702818|Cortisol|cortisol
1273019|NCT01702818|DHEA|dhea
1273020|NCT01702818|Stress Hormones|stress hormones
1273021|NCT01702818|Sexual Desire|sexual desire
1273022|NCT01702818|Mood|mood
1273023|NCT01702818|Sexual Function|sexual function
1273024|NCT01702818|Childhood Maltreatment|childhood maltreatment
1273025|NCT01702818|Childhood Abuse|childhood abuse
1273026|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
1273027|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1273028|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1273029|NCT01702805|Transfusions|transfusions
1273030|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
1273031|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
1273032|NCT01702779|Lung ultrasound|lung ultrasound
1273033|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
1273034|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
1273035|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
1273036|NCT01702740|Lupus erythematosus|lupus erythematosus
1273037|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
1273038|NCT01702740|Sirukumab|sirukumab
1273039|NCT01702727|Amblyopia|amblyopia
1273040|NCT01702727|I-BiT TM|i-bit tm
1273041|NCT01702727|Interactive games|interactive games
1273042|NCT01702727|Binocular|binocular
1273043|NCT01702675|Safety|safety
1273044|NCT01702675|Pharmacokinetics|pharmacokinetics
1273045|NCT01702675|Tolerability|tolerability
1273046|NCT01702675|Healthy men|healthy men
1273047|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
1273048|NCT01702636|ICH|ich
1273049|NCT01702636|Stroke|stroke
1273050|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
1273051|NCT01702636|Brain Diseases|brain diseases
1273052|NCT01702636|Central Nervous System Diseases|central nervous system diseases
1273053|NCT01702636|Nervous System Diseases|nervous system diseases
1273054|NCT01702636|Vascular Diseases|vascular diseases
1273055|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
1273056|NCT01702636|Tranexamic Acid|tranexamic acid
1273057|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
1273058|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
1273059|NCT01702636|Pharmacologic Actions|pharmacologic actions
1273060|NCT01702636|Cardiovascular Agents|cardiovascular agents
1273061|NCT01702636|Therapeutic Uses|therapeutic uses
1273062|NCT01702636|Hematologic Agents|hematologic agents
1273063|NCT01702636|Hemostatics|hemostatics
1273064|NCT01702636|Contrast Media|contrast media
1273065|NCT01702636|Angiography|angiography
1273066|NCT01702636|Cerebral Angiography|cerebral angiography
1273067|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
1273068|NCT01702584|stent|stent
1273069|NCT01702584|intracranial aneurysm|intracranial aneurysm
1273070|NCT01702584|embolization|embolization
1273071|NCT01702584|adverse event|adverse event
1273072|NCT01702532|provoked craving|provoked craving
1273073|NCT01702506|Dacomitinib|dacomitinib
1273074|NCT01702506|PF-00299804|pf-00299804
1273075|NCT01702506|fed|fed
1273078|NCT01702506|relative Bioavailability|relative bioavailability
1273080|NCT01702493|Modified Release|modified release
1273081|NCT01702493|Bioavailability|bioavailability
1273082|NCT01702493|Crossover|crossover
1273083|NCT01702480|Consumer Healthcare|consumer healthcare
1273084|NCT01702480|Ketones|ketones
1273085|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
1273086|NCT01702480|Age related cognitive decline|age related cognitive decline
1273087|NCT01702480|GSK Nutrition|gsk nutrition
1273088|NCT01702467|Lp-PLA2|lp-pla2
1273089|NCT01702467|Alzheimer's disease|alzheimer's disease
1273090|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
1273091|NCT01702454|Influenza|influenza
1273092|NCT01702454|Children|children
1273093|NCT01702454|Safety|safety
1273094|NCT01702454|Immunogenicity|immunogenicity
1273095|NCT01702428|Safety|safety
1273096|NCT01702428|Consistency study|consistency study
1273097|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
1273098|NCT01702428|Healthy children|healthy children
1273099|NCT01702428|Immunogenicity|immunogenicity
1273100|NCT01702415|Cystic fibrosis|cystic fibrosis
1273101|NCT01702415|Bone density|bone density
1273102|NCT01702402|intervention|intervention
1273103|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
1273104|NCT01702389|Pain|pain
1273105|NCT01702389|Postoperative pain|postoperative pain
1273106|NCT01702389|Hyperalgesia|hyperalgesia
1273107|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
1273108|NCT01702350|Healthy Subjects|healthy subjects
1273109|NCT01702350|Relative Bioavailability|relative bioavailability
1273110|NCT01702350|Pharmacokinetics|pharmacokinetics
1273111|NCT01702350|Elderly Subjects|elderly subjects
1273112|NCT01702337|Gardasil|gardasil
1273113|NCT01702337|Prevalence-model|prevalence-model
1273114|NCT01702337|Cervarix|cervarix
1273115|NCT01702337|economic|economic
1273116|NCT01702337|health|health
1273117|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
1273118|NCT01702324|Plaque|plaque
1273119|NCT01702324|Topical|topical
1273120|NCT01702324|Treatment|treatment
1273121|NCT01702311|Diabetes|diabetes
1273122|NCT01702311|Point of care testing|point of care testing
1273123|NCT01702311|Hypoglycemia|hypoglycemia
1273124|NCT01702311|Basal bolus insulin|basal bolus insulin
1273125|NCT01702285|Advanced Solid Tumors|advanced solid tumors
1273126|NCT01702285|EGFR|egfr
1273127|NCT01702285|HDAC|hdac
1273128|NCT01702285|Her2|her2
1273129|NCT01702285|Open-Label|open-label
1273130|NCT01702285|Dose-Escalation|dose-escalation
1273131|NCT01702246|sickle cell disease|sickle cell disease
1273132|NCT01702246|statins|statins
1273133|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
1273134|NCT01702246|inflammation|inflammation
1273135|NCT01702246|biomarkers|biomarkers
1273136|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
1273137|NCT01702220|Geriatric|geriatric
1273138|NCT01702207|Prograf®|prograf®
1273139|NCT01702207|Advagraf®|advagraf®
1273140|NCT01702207|tacrolimus|tacrolimus
1273141|NCT01702207|kidney transplant|kidney transplant
1273142|NCT01702207|renal transplant|renal transplant
1273143|NCT01702207|cardiovascular risk|cardiovascular risk
1273144|NCT01702207|Framingham Risk|framingham risk
1273145|NCT01702207|Reynolds Risk|reynolds risk
1273146|NCT01702207|immunosuppression|immunosuppression
1273147|NCT01702194|OIC|oic
1273148|NCT01702194|Opioid Induced Constipation|opioid induced constipation
1273149|NCT01702194|Constipation|constipation
1273150|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
1273151|NCT01702168|PTSD|ptsd
1273152|NCT01702168|EBT|ebt
1273153|NCT01702168|EST|est
1273154|NCT01702168|Community|community
1273155|NCT01702168|Latino|latino
1273156|NCT01702142|Addiction Treatment|addiction treatment
1273157|NCT01702129|EGFR|egfr
1273158|NCT01702129|liposomes|liposomes
1273159|NCT01702129|immunoliposomes|immunoliposomes
1273160|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
1273161|NCT01702116|Standard APR|standard apr
1273162|NCT01702116|Extralevator APR|extralevator apr
1273163|NCT01702090|HIV-1|hiv-1
1273164|NCT01702090|TMC114|tmc114
1273165|NCT01702090|Darunavir|darunavir
1273166|NCT01702090|PREZISTA|prezista
1273167|NCT01702090|Ritonavir|ritonavir
1273168|NCT01702090|Antiretrovirals|antiretrovirals
1273169|NCT01702090|Early access|early access
1273170|NCT01702090|Early treatment|early treatment
1273171|NCT01702090|Treatment naive|treatment naive
1273172|NCT01702077|neurofeedback|neurofeedback
1273173|NCT01702077|biofeedback|biofeedback
1273174|NCT01702077|real-time fMRI|real-time fmri
1273175|NCT01702077|rt-fMRI|rt-fmri
1273176|NCT01702077|functional connectivity|functional connectivity
1273177|NCT01702077|fMRI|fmri
1273178|NCT01702064|CML|cml
1273179|NCT01702064|CP-CML|cp-cml
1273180|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
1273181|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
1273182|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
1273183|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
1273184|NCT01702051|Pancreas|pancreas
1273185|NCT01702051|Pancreatectomy|pancreatectomy
1273186|NCT01702025|Hypoxia|hypoxia
1273187|NCT01702025|Altitude|altitude
1273188|NCT01702025|Exercise|exercise
1273189|NCT01702012|Diabetes-Obesity|diabetes-obesity
1273190|NCT01701999|Botulism Vaccine|botulism vaccine
1273191|NCT01701986|Lymphoma|lymphoma
1273192|NCT01701986|Aggressive lymphomas|aggressive lymphomas
1273193|NCT01701986|Allogeneic stem-cell transplant|allogeneic stem-cell transplant
1273194|NCT01701986|alloSCT|allosct
1273195|NCT01701986|Refractory B-cell|refractory b-cell
1273196|NCT01701986|T-cell|t-cell
1273197|NCT01701986|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1273198|NCT01701986|Hodgkin's lymphoma|hodgkin's lymphoma
1273199|NCT01701986|Gemcitabine|gemcitabine
1273200|NCT01701986|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1273201|NCT01701986|Gemzar|gemzar
1273202|NCT01701986|Clofarabine|clofarabine
1273203|NCT01701986|Clofarex|clofarex
1273204|NCT01701986|Clolar|clolar
1273205|NCT01701986|Busulfan|busulfan
1273206|NCT01701986|Busulfex|busulfex
1273207|NCT01701986|Myleran|myleran
1273208|NCT01701986|Anti-Thymocyte Globulin|anti-thymocyte globulin
1273209|NCT01701986|ATG|atg
1273210|NCT01701986|Thymoglobulin|thymoglobulin
1273211|NCT01701986|Rituximab|rituximab
1273212|NCT01701986|Rituxan|rituxan
1273213|NCT01701986|Filgrastim|filgrastim
1273214|NCT01701986|G-CSF|g-csf
1273215|NCT01701986|Neupogen|neupogen
1273216|NCT01701986|Tacrolimus|tacrolimus
1273217|NCT01701986|Prograf|prograf
1273218|NCT01701986|Mycophenolate Mofetil|mycophenolate mofetil
1273219|NCT01701986|MMF|mmf
1273220|NCT01701986|CellCept|cellcept
1273221|NCT01701973|obesity|obesity
1273222|NCT01701973|growth hormone|growth hormone
1273223|NCT01701947|Factor XI deficiency|factor xi deficiency
1273224|NCT01701947|EAP|eap
1273225|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
1273226|NCT01701947|surgery|surgery
1273227|NCT01701947|delivery|delivery
1273228|NCT01701947|Child birth|child birth
1273229|NCT01701934|COPD|copd
1273230|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
1273231|NCT01701934|Body composition|body composition
1273232|NCT01701934|Triglycerides|triglycerides
1273233|NCT01701934|Cholesterol|cholesterol
1273234|NCT01701921|cardiac surgery|cardiac surgery
1273235|NCT01701921|pregabalin|pregabalin
1273236|NCT01701921|postoperative pain|postoperative pain
1273237|NCT01701908|PPCs|ppcs
1273238|NCT01701908|abdominal surgery|abdominal surgery
1273239|NCT01701908|postoperative infections|postoperative infections
1273240|NCT01701908|postoperative residual curarization|postoperative residual curarization
1273241|NCT01701908|tracheal re-intubation|tracheal re-intubation
1273242|NCT01701908|mortality|mortality
1273243|NCT01701908|ICU stay|icu stay
1273244|NCT01701895|Complera|complera
1273245|NCT01701895|short-term|short-term
1273246|NCT01701895|long-term|long-term
1369060|NCT01296516|GDM|gdm
1273247|NCT01701895|compliance|compliance
1273248|NCT01701895|caloric|caloric
1273249|NCT01701895|intake|intake
1273250|NCT01701895|HIV|hiv
1273251|NCT01701895|positive|positive
1273252|NCT01701895|women|women
1273253|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1273254|NCT01701856|natalizumab|natalizumab
1273255|NCT01701856|de-escalation|de-escalation
1273256|NCT01701856|interferon beta-1b|interferon beta-1b
1273257|NCT01701830|omentin-1|omentin-1
1273258|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
1273259|NCT01701830|kidney disease|kidney disease
1273260|NCT01701817|Atrial Fibrillation|atrial fibrillation
1273261|NCT01701817|Irregular heart beat|irregular heart beat
1273262|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
1273263|NCT01701791|Depression|depression
1273264|NCT01701791|Primary care|primary care
1273265|NCT01701791|Computerized decision support system|computerized decision support system
1273266|NCT01701791|General practitioner|general practitioner
1273267|NCT01701778|Dexmedetomidine|dexmedetomidine
1273268|NCT01701778|Postoperative pain reaction|postoperative pain reaction
1273269|NCT01701778|anesthesia|anesthesia
1273270|NCT01701778|children|children
1273271|NCT01701765|Severe mental disorders|severe mental disorders
1273272|NCT01701765|Discharge|discharge
1273273|NCT01701765|Outcome evaluation|outcome evaluation
1273274|NCT01701752|Influenza A|influenza a
1273275|NCT01701726|Essential Hypertension|essential hypertension
1273276|NCT01701726|Acupuncture|acupuncture
1273277|NCT01701726|Specificity|specificity
1273278|NCT01701726|Acupoints effect|acupoints effect
1273279|NCT01701726|randomized controlled trials|randomized controlled trials
1273280|NCT01701713|TDCS|tdcs
1273281|NCT01701713|STROKE|stroke
1273282|NCT01701713|APHASIA|aphasia
1273283|NCT01701713|NAMING|naming
1273284|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
1273285|NCT01701687|Cirrhosis|cirrhosis
1273286|NCT01701687|Alcoholic liver disease|alcoholic liver disease
1273287|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
1273288|NCT01701687|Hazardous alcohol|hazardous alcohol
1273289|NCT01701674|skin cancer|skin cancer
1273290|NCT01701661|venous surgery|venous surgery
1273291|NCT01701661|compression therapy|compression therapy
1273292|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
1273293|NCT01701635|Disclosure|disclosure
1273294|NCT01701635|HIV-infected children|hiv-infected children
1273295|NCT01701635|Resource-limited settings|resource-limited settings
1273296|NCT01701622|Blood Pressure|blood pressure
1273297|NCT01701622|Gout|gout
1273298|NCT01701622|allopurinol|allopurinol
1273299|NCT01701622|febuxostat|febuxostat
1273300|NCT01701622|uric acid|uric acid
1273301|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
1273302|NCT01701609|adolescents|adolescents
1273303|NCT01701609|cognition|cognition
1273304|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
1273305|NCT01701596|Rotational atherectomy|rotational atherectomy
1273306|NCT01701596|Coronary dissection|coronary dissection
1273307|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
1273308|NCT01701596|Calcification|calcification
1273309|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
1273310|NCT01701583|CIU|ciu
1273311|NCT01701583|Urticaria|urticaria
1273312|NCT01701583|Chronic Hives|chronic hives
1273313|NCT01701583|Xolair|xolair
1273314|NCT01701570|Type 2 Diabetes|type 2 diabetes
1273315|NCT01701570|Exercise|exercise
1273316|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
1273317|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
1273318|NCT01701518|Ozurdex|ozurdex
1273319|NCT01701518|Dexamethasone|dexamethasone
1273320|NCT01701518|Epiretinal membrane|epiretinal membrane
1273321|NCT01701518|Macular edema|macular edema
1273322|NCT01701505|operative|operative
1273323|NCT01701505|dental procedure|dental procedure
1273324|NCT01701492|pediatric|pediatric
1273325|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1273326|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1273327|NCT01701479|Neuroblastoma|neuroblastoma
1273328|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
1273329|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
1273330|NCT01701479|ch14.18/CHO|ch14.18/cho
1273331|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
1273332|NCT01701466|Patients|patients
1273333|NCT01701466|with|with
1273334|NCT01701453|duration of DAPT|duration of dapt
1273335|NCT01701427|Hyperalgesia|hyperalgesia
1273336|NCT01701427|Persistent pain|persistent pain
1273337|NCT01701427|deep pain|deep pain
1273338|NCT01701427|electrical stimulation|electrical stimulation
1273339|NCT01701427|groin hernia|groin hernia
1273340|NCT01701414|Femur|femur
1273341|NCT01701414|Hip|hip
1273342|NCT01701414|Fracture|fracture
1273343|NCT01701414|Femoral neck|femoral neck
1273344|NCT01701414|Femoral head|femoral head
1273345|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1273346|NCT01701401|HCV|hcv
1273347|NCT01701401|Sustained Virologic Response|sustained virologic response
1273348|NCT01701401|Direct Acting Antiviral|direct acting antiviral
1273349|NCT01701401|Combination Therapy|combination therapy
1273350|NCT01701401|GS-7977|gs-7977
1273351|NCT01701401|GS-5885|gs-5885
1273352|NCT01701401|Ribavirin|ribavirin
1273353|NCT01701401|Open Label|open label
1273354|NCT01701401|Sofosbuvir|sofosbuvir
1273355|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
1273356|NCT01701401|Hepatitis|hepatitis
1273357|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
1273358|NCT01701401|Hepatitis C|hepatitis c
1273359|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
1273360|NCT01701401|Liver Diseases|liver diseases
1273361|NCT01701401|Digestive System Diseases|digestive system diseases
1273362|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
1273363|NCT01701401|Virus Diseases|virus diseases
1273364|NCT01701401|Enterovirus Infections|enterovirus infections
1273365|NCT01701401|Picornaviridae Infections|picornaviridae infections
1273366|NCT01701401|RNA Virus Infections|rna virus infections
1273367|NCT01701401|Flaviviridae Infections|flaviviridae infections
1273368|NCT01701401|Antiviral Agents|antiviral agents
1273369|NCT01701401|Anti-Infective Agents|anti-infective agents
1273370|NCT01701401|Therapeutic Uses|therapeutic uses
1273371|NCT01701401|Pharmacologic Actions|pharmacologic actions
1273372|NCT01701401|Antimetabolites|antimetabolites
1273373|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1273374|NCT01701388|Ekso|ekso
1273375|NCT01701388|Exoskeleton|exoskeleton
1273376|NCT01701388|Spinal Cord Injury|spinal cord injury
1273377|NCT01701388|Motor Complete Incomplete|motor complete incomplete
1273378|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
1273379|NCT01701349|ATC|atc
1273380|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
1273381|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
1273382|NCT01701349|Thyroid Cancer|thyroid cancer
1273383|NCT01701349|Head and Neck Tumors|head and neck tumors
1273384|NCT01701336|Hepatitis|hepatitis
1273385|NCT01701336|Hepatitis C|hepatitis c
1273386|NCT01701336|HCV|hcv
1273387|NCT01701336|vaccine|vaccine
1273388|NCT01701336|adenovirus|adenovirus
1273389|NCT01701336|MVA|mva
1273390|NCT01701336|T cells|t cells
1273391|NCT01701336|ELISpot|elispot
1273392|NCT01701310|Adenocarcinoma|adenocarcinoma
1273393|NCT01701310|Anemia|anemia
1273394|NCT01701310|Blood Transfusion|blood transfusion
1273395|NCT01701310|Colorectal surgery|colorectal surgery
1273396|NCT01701310|Preoperative care|preoperative care
1273397|NCT01701310|Perioperative care|perioperative care
1273398|NCT01701310|Postoperative care|postoperative care
1273399|NCT01701310|Iron|iron
1273400|NCT01701310|Hematinics|hematinics
1273401|NCT01701310|Hepcidin|hepcidin
1273402|NCT01701310|Quality of life|quality of life
1273403|NCT01701310|Postoperative complications|postoperative complications
1273404|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
1273405|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1273406|NCT01701284|Cancer Survivors|cancer survivors
1273407|NCT01701284|Depression|depression
1273408|NCT01701284|Anxiety|anxiety
1273409|NCT01701271|Baldness|baldness
1273410|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
1273411|NCT01701271|Alopecia|alopecia
1273412|NCT01701258|Depression|depression
1273413|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
1273414|NCT01701258|Dopamine|dopamine
1273415|NCT01701258|MRI|mri
1273416|NCT01701258|PET|pet
1273417|NCT01701258|ERP|erp
1273418|NCT01701258|Stress|stress
1273419|NCT01701258|Reward|reward
1273420|NCT01701258|Childhood trauma|childhood trauma
1273421|NCT01701258|Amisulpride|amisulpride
1273422|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
1273423|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
1273424|NCT01701245|nVNS|nvns
1273425|NCT01701245|VNS|vns
1273426|NCT01701245|cluster headache|cluster headache
1273427|NCT01701245|chronic|chronic
1273428|NCT01701245|non invasive|non invasive
1273429|NCT01701245|gammacore|gammacore
1273430|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
1273431|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
1273432|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
1273433|NCT01701219|MRSA bacteremia|mrsa bacteremia
1273434|NCT01701219|Blood|blood
1273435|NCT01701219|Adult|adult
1273436|NCT01701219|Infections|infections
1273437|NCT01701219|Blood Culture|blood culture
1273438|NCT01701206|HIV|hiv
1273439|NCT01701206|social networking|social networking
1273440|NCT01701206|at-risk populations|at-risk populations
1273441|NCT01701206|sexual risk behaviors|sexual risk behaviors
1273442|NCT01701180|Male Volunteers|male volunteers
1273443|NCT01701154|Pompe respiratory|pompe respiratory
1273444|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
1273445|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1273446|NCT01701141|reward|reward
1273447|NCT01701141|stress|stress
1273448|NCT01701141|learning|learning
1273449|NCT01701141|Major Depressive Disorder|major depressive disorder
1273450|NCT01701141|Anhedonia|anhedonia
1273451|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
1273452|NCT01701115|Interscalene Block|interscalene block
1273453|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
1273454|NCT01701076|2nd line treatment|2nd line treatment
1273455|NCT01701050|circulating tumor cells|circulating tumor cells
1273456|NCT01701050|CTC|ctc
1273457|NCT01701050|metastatic breast cancer|metastatic breast cancer
1273458|NCT01701050|endocrine therapy|endocrine therapy
1273459|NCT01701050|hormone therapy|hormone therapy
1273460|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
1273461|NCT01701024|Acne|acne
1273462|NCT01701011|coping|coping
1273463|NCT01701011|intervention|intervention
1273464|NCT01701011|waiting-period|waiting-period
1273465|NCT01700985|psoriasis|psoriasis
1273466|NCT01700985|plaque psoriasis|plaque psoriasis
1273467|NCT01700985|122-0551|122-0551
1273468|NCT01700985|steroid|steroid
1273469|NCT01700959|Melatonin|melatonin
1273470|NCT01700959|Neurocognitive impairment|neurocognitive impairment
1273471|NCT01700959|Sleep disturbance|sleep disturbance
1273472|NCT01700959|Childhood cancer survivors|childhood cancer survivors
1273473|NCT01700946|leukemia|leukemia
1273474|NCT01700946|lymphoma|lymphoma
1273475|NCT01700946|Non-Hodgkins|non-hodgkins
1273476|NCT01700933|Exercise therapy|exercise therapy
1273477|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
1273478|NCT01700920|Stem Cell|stem cell
1273479|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
1273480|NCT01700920|Femoral Head|femoral head
1273481|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1273482|NCT01700907|elderly patients|elderly patients
1273483|NCT01700907|long surgery|long surgery
1273484|NCT01700894|Physical Activity|physical activity
1273485|NCT01700894|African American|african american
1273486|NCT01700894|Adherence|adherence
1273487|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
1273488|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1273591|NCT01700491|Analgesia|analgesia
1273489|NCT01700868|Diet, Vegetarian|diet, vegetarian
1273490|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
1273491|NCT01700868|Glycemic Index|glycemic index
1273492|NCT01700855|Electroacupuncture|electroacupuncture
1273493|NCT01700855|Analgesia|analgesia
1273494|NCT01700855|Anesthesia|anesthesia
1273495|NCT01700855|Nasal septoplasty|nasal septoplasty
1273496|NCT01700855|Mammaplasty|mammaplasty
1273497|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
1273498|NCT01700829|Ketamine|ketamine
1273499|NCT01700829|Midazolam|midazolam
1273500|NCT01700829|Major Depressive Disorder|major depressive disorder
1273501|NCT01700829|Suicidal ideation|suicidal ideation
1273502|NCT01700829|Suicide|suicide
1273503|NCT01700829|Depression|depression
1273504|NCT01700829|Treatment|treatment
1273505|NCT01700829|Ketamine Treatment|ketamine treatment
1273506|NCT01700816|Delirium|delirium
1273507|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1273508|NCT01700816|Bone marrow transplantation|bone marrow transplantation
1273509|NCT01700816|Bright Light Therapy|bright light therapy
1273510|NCT01700803|Betadine|betadine
1273511|NCT01700803|Povidine Iodine|povidine iodine
1273512|NCT01700803|Hand scrubbing|hand scrubbing
1273513|NCT01700803|Cesarean section wound infections|cesarean section wound infections
1273514|NCT01700803|post cesarean section|post cesarean section
1273515|NCT01700790|HIV|hiv
1273516|NCT01700790|AIDS|aids
1273517|NCT01700790|Tuberculosis|tuberculosis
1273518|NCT01700790|Rifampin|rifampin
1273519|NCT01700790|Lopinavir|lopinavir
1273520|NCT01700790|Pharmacokinetic|pharmacokinetic
1273521|NCT01700777|bimanual training|bimanual training
1273522|NCT01700777|lower limb|lower limb
1273523|NCT01700777|intensive rehabilitation|intensive rehabilitation
1273524|NCT01700777|regular rehabilitation|regular rehabilitation
1273525|NCT01700777|hemiplegia|hemiplegia
1273526|NCT01700725|Gulf War Illness|gulf war illness
1273527|NCT01700725|xylitol|xylitol
1273528|NCT01700725|nasal irrigation|nasal irrigation
1273529|NCT01700725|Desert Storm|desert storm
1273530|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
1273531|NCT01700725|neti pot|neti pot
1273532|NCT01700725|cytokines|cytokines
1273533|NCT01700725|nasal mucus|nasal mucus
1273534|NCT01700725|inflammatory mediator|inflammatory mediator
1273535|NCT01700725|lactoferrin|lactoferrin
1273536|NCT01700725|lysozyme|lysozyme
1273537|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
1273538|NCT01700699|thyroid cancer|thyroid cancer
1273539|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1273540|NCT01700699|BRAF|braf
1273541|NCT01700699|Sorafenib|sorafenib
1273542|NCT01700699|Pazopanib|pazopanib
1273543|NCT01700699|Sunitinib|sunitinib
1369442|NCT01295034|HIV|hiv
1273544|NCT01700699|Cabozantinib|cabozantinib
1273545|NCT01700673|maintenance treatment|maintenance treatment
1273546|NCT01700673|stem cell transplant|stem cell transplant
1273547|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
1273548|NCT01700647|Larynx cancer|larynx cancer
1273549|NCT01700647|Volatile organic compounds|volatile organic compounds
1273550|NCT01700647|Diagnosis|diagnosis
1273551|NCT01700647|Bronchoscopy|bronchoscopy
1273552|NCT01700647|Cancer staging|cancer staging
1273553|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
1273554|NCT01700621|rotavirus|rotavirus
1273555|NCT01700582|lung cancer|lung cancer
1273556|NCT01700582|biomarkers|biomarkers
1273557|NCT01700582|EGFR|egfr
1273558|NCT01700582|KRAS|kras
1273559|NCT01700582|ALK|alk
1273560|NCT01700582|HER2|her2
1273561|NCT01700582|PI3K|pi3k
1273562|NCT01700582|BRAF|braf
1273563|NCT01700569|high-grade|high-grade
1273564|NCT01700569|glioma|glioma
1273565|NCT01700569|epigenetic|epigenetic
1273566|NCT01700556|Alzheimer Disease|alzheimer disease
1273567|NCT01700556|Family Caregiver|family caregiver
1273568|NCT01700556|Caregiver Burden|caregiver burden
1273569|NCT01700556|Home Care Services|home care services
1273570|NCT01700556|Assistive Technologies|assistive technologies
1273571|NCT01700543|Stemless shoulder implant|stemless shoulder implant
1273572|NCT01700543|Osteoarthritis|osteoarthritis
1273573|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
1273574|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
1273575|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
1273576|NCT01700543|Prospective|prospective
1273577|NCT01700543|Multi-center|multi-center
1273578|NCT01700543|Europe|europe
1273579|NCT01700543|Non-Controlled|non-controlled
1273580|NCT01700543|Good Bone Stock|good bone stock
1273581|NCT01700530|mitochondria|mitochondria
1273582|NCT01700530|fitness|fitness
1273583|NCT01700530|statins|statins
1273584|NCT01700530|cholesterol|cholesterol
1273585|NCT01700530|metabolic syndrome|metabolic syndrome
1273586|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
1273587|NCT01700504|Axillary drainage volume|axillary drainage volume
1273588|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
1273589|NCT01700491|Paravertebral Catheter|paravertebral catheter
1273590|NCT01700491|Epidural Catheter|epidural catheter
1273592|NCT01700491|Hypotension|hypotension
1273593|NCT01700491|Analgesia,Epidural|analgesia,epidural
1273594|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
1273595|NCT01700478|Myomectomy|myomectomy
1273596|NCT01700465|Hemodialysis|hemodialysis
1273597|NCT01700465|Hemodynamics|hemodynamics
1273598|NCT01700452|Lung cancer|lung cancer
1273599|NCT01700452|Pulmonary nodules|pulmonary nodules
1273600|NCT01700452|FISH Test|fish test
1273601|NCT01700439|Aortic valve|aortic valve
1273602|NCT01700439|Heart valve|heart valve
1273603|NCT01700439|Tissue valve|tissue valve
1273604|NCT01700439|Bioprosthesis|bioprosthesis
1273605|NCT01700439|Valve disorder|valve disorder
1273606|NCT01700439|Valve disease|valve disease
1273607|NCT01700439|Cardiac surgery|cardiac surgery
1273608|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
1273609|NCT01700439|Aortic valve stenosis|aortic valve stenosis
1273610|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
1273611|NCT01700439|Bovine pericardium|bovine pericardium
1273612|NCT01700426|Iron Deficiency|iron deficiency
1273613|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
1273614|NCT01700413|acute|acute
1273615|NCT01700413|myeloid|myeloid
1273616|NCT01700413|leukemia|leukemia
1273617|NCT01700413|CETLAM|cetlam
1273618|NCT01700413|Idarubicin|idarubicin
1273619|NCT01700400|Lung Cancer|lung cancer
1273620|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
1273621|NCT01700400|Advanced Lung Cancer|advanced lung cancer
1273622|NCT01700387|Migraine|migraine
1273623|NCT01700387|Chronic Migraine|chronic migraine
1273624|NCT01700387|Cognitive Efficiency|cognitive efficiency
1273625|NCT01700387|Pilot Study|pilot study
1273626|NCT01700387|Long Term Effect|long term effect
1273627|NCT01700374|pregnancy|pregnancy
1273628|NCT01700374|stress, psychological|stress, psychological
1273629|NCT01700374|stress, physiological|stress, physiological
1273630|NCT01700374|maternal-fetal relations|maternal-fetal relations
1273631|NCT01700361|sexual arousal|sexual arousal
1273632|NCT01700361|pelvic floor sEMG|pelvic floor semg
1273633|NCT01700348|moderate gingivitis|moderate gingivitis
1273634|NCT01700322|Coronary artery disease|coronary artery disease
1273635|NCT01700322|coronary stenting|coronary stenting
1273636|NCT01700322|platelet aggregation|platelet aggregation
1273637|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
1273763|NCT01699620|Dermatome technique|dermatome technique
1273638|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
1273639|NCT01700257|Lung cancer screening|lung cancer screening
1273640|NCT01700257|Smokers or former smokers|smokers or former smokers
1273641|NCT01700257|Family history of lung cancer|family history of lung cancer
1273642|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
1273643|NCT01700218|telemonitoring|telemonitoring
1273644|NCT01700205|Formula Feeding|formula feeding
1273645|NCT01700205|Mother|mother
1273646|NCT01700205|Moms|moms
1273647|NCT01700205|Infants|infants
1273648|NCT01700205|Babies|babies
1273649|NCT01700205|Baby|baby
1273650|NCT01700205|growth|growth
1273651|NCT01700205|energy balance|energy balance
1273652|NCT01700166|Autologous|autologous
1273653|NCT01700166|Cord Blood|cord blood
1273654|NCT01700166|Stem Cells|stem cells
1273655|NCT01700166|Pediatric stroke|pediatric stroke
1273656|NCT01700166|Children with ischemic stroke|children with ischemic stroke
1273657|NCT01700166|Cerebral Palsy|cerebral palsy
1273658|NCT01700166|Perinatal AIS|perinatal ais
1273659|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
1273660|NCT01700153|cerebral palsy|cerebral palsy
1273661|NCT01700153|ICF|icf
1273662|NCT01700127|immune response|immune response
1273663|NCT01700127|infants|infants
1273664|NCT01700127|rotavirus vaccine|rotavirus vaccine
1273665|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
1273666|NCT01700114|Dermatology|dermatology
1273667|NCT01700114|Skin Cancer|skin cancer
1273668|NCT01700114|Melanoma|melanoma
1273669|NCT01700114|MelaFind|melafind
1273670|NCT01700088|hypoxemia|hypoxemia
1273671|NCT01700088|Post Pulmonary Resection|post pulmonary resection
1273672|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
1273673|NCT01700062|medium-calorie|medium-calorie
1273674|NCT01700062|standard calorie|standard calorie
1273675|NCT01700062|parenteral nutrition|parenteral nutrition
1273676|NCT01700049|advanced BCC|advanced bcc
1273677|NCT01700049|high risk|high risk
1273678|NCT01700049|locally advanced|locally advanced
1273679|NCT01700023|acute heart failure|acute heart failure
1273680|NCT01700010|Urothelial|urothelial
1273681|NCT01700010|Bladder|bladder
1273682|NCT01700010|Cancer|cancer
1273683|NCT01699997|Schizophrenia|schizophrenia
1273684|NCT01699997|Oxytocin|oxytocin
1273685|NCT01699997|RCT|rct
1273686|NCT01699984|Cognitive impairment.|cognitive impairment.
1273687|NCT01699984|Geriatrics.|geriatrics.
1273688|NCT01699984|Hospital admission.|hospital admission.
1273689|NCT01699984|Hospital discharge.|hospital discharge.
1273690|NCT01699958|Problem solving therapy|problem solving therapy
1273691|NCT01699958|Behavior change|behavior change
1273692|NCT01699945|Verbal autopsies|verbal autopsies
1273693|NCT01699945|Maternal deaths|maternal deaths
1273694|NCT01699945|Still births|still births
1273695|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
1273696|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
1273697|NCT01699919|postoperative pain|postoperative pain
1273698|NCT01699906|Obesity|obesity
1273699|NCT01699880|tracheal intubation|tracheal intubation
1273700|NCT01699880|preoxygenation|preoxygenation
1273701|NCT01699880|desaturation|desaturation
1273702|NCT01699880|hypoxemia|hypoxemia
1273703|NCT01699880|oxygen therapy|oxygen therapy
1273704|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
1273705|NCT01699867|lumpectomy|lumpectomy
1273706|NCT01699867|breast cancer|breast cancer
1273707|NCT01699867|optical coherence tomography|optical coherence tomography
1273708|NCT01699867|tumor margin|tumor margin
1273709|NCT01699867|imaging|imaging
1273710|NCT01699828|buspirone|buspirone
1273711|NCT01699828|smoking cessation|smoking cessation
1273712|NCT01699828|dopamine|dopamine
1273713|NCT01699828|PET imaging|pet imaging
1273714|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
1273715|NCT01699815|acetaminophen|acetaminophen
1273716|NCT01699815|timing|timing
1273717|NCT01699815|arthroplasty|arthroplasty
1273718|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
1273719|NCT01699789|Community Engagement|community engagement
1273720|NCT01699789|Implementation|implementation
1273721|NCT01699789|Community Based Participatory Research|community based participatory research
1273722|NCT01699789|Quality Improvement|quality improvement
1273723|NCT01699789|Evidence Based Practice|evidence based practice
1273724|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
1273725|NCT01699776|Digoxin|digoxin
1273726|NCT01699776|Ivabradine|ivabradine
1273727|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
1273728|NCT01699750|contact lenses|contact lenses
1273729|NCT01699750|contact lens solution|contact lens solution
1273730|NCT01699750|myopia|myopia
1273731|NCT01699750|astigmatism|astigmatism
1273732|NCT01699737|Diabetes|diabetes
1273733|NCT01699724|JZoloft|jzoloft
1273734|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
1273736|NCT01699724|bioequivalence|bioequivalence
1273737|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
1273738|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1369683|NCT01294176|OCT|oct
1273739|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
1273740|NCT01699685|NVA|nva
1273741|NCT01699685|QAB|qab
1273742|NCT01699672|Patient education|patient education
1273743|NCT01699672|information|information
1273744|NCT01699672|communication|communication
1273745|NCT01699659|Allergic Rhinitis|allergic rhinitis
1273746|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
1273747|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
1273748|NCT01699646|CTG|ctg
1274355|NCT01696734|Phone calls|phone calls
1273749|NCT01699646|cardiotocography|cardiotocography
1273750|NCT01699646|STAN|stan
1273751|NCT01699646|ST-Analysis|st-analysis
1273752|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
1273753|NCT01699646|operative delivery|operative delivery
1273754|NCT01699633|Drug-drug interactions|drug-drug interactions
1273755|NCT01699633|Drug-gene interactions|drug-gene interactions
1273756|NCT01699633|Nevirapine|nevirapine
1273757|NCT01699633|Rifampicin|rifampicin
1273758|NCT01699633|children|children
1273759|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
1273760|NCT01699620|Soft tissue healing|soft tissue healing
1273761|NCT01699620|Implant stability|implant stability
1273762|NCT01699620|Linear incision|linear incision
1273764|NCT01699620|Hearing Aids|hearing aids
1273765|NCT01699620|Implants, Artificial|implants, artificial
1273766|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
1273767|NCT01699607|Cigarette Smokers|cigarette smokers
1273768|NCT01699607|Healthy Non Smokers|healthy non smokers
1273769|NCT01699607|Amphetamine|amphetamine
1273770|NCT01699607|PET|pet
1273771|NCT01699607|Controls|controls
1273772|NCT01699594|asthma|asthma
1273773|NCT01699594|allergies|allergies
1273774|NCT01699594|mannitol|mannitol
1273775|NCT01699594|methacholine|methacholine
1273776|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
1273777|NCT01699581|Multiple Myeloma|multiple myeloma
1273778|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1273779|NCT01699568|dental implant stability|dental implant stability
1273780|NCT01699568|dental implant surface treatment|dental implant surface treatment
1273781|NCT01699568|resonance frequence analysis|resonance frequence analysis
1273782|NCT01699555|Multiple sclerosis|multiple sclerosis
1273783|NCT01699555|GNbAC1|gnbac1
1273784|NCT01699555|Monoclonal antibody|monoclonal antibody
1273785|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
1273786|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
1273883|NCT01699165|double blind|double blind
1273787|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
1273788|NCT01699503|Dementia|dementia
1273789|NCT01699503|Alzheimer's Disease|alzheimer's disease
1273790|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
1273791|NCT01699503|Screening|screening
1273792|NCT01699490|Major Depressive Disorder|major depressive disorder
1273793|NCT01699490|Antidepressants|antidepressants
1273794|NCT01699490|Insulin|insulin
1273795|NCT01699490|Fluoxetine|fluoxetine
1273797|NCT01699477|focused ultrasound|focused ultrasound
1273798|NCT01699477|functional brain disorders|functional brain disorders
1273799|NCT01699477|neuropathic pain|neuropathic pain
1273800|NCT01699477|movement disorders|movement disorders
1273801|NCT01699464|Glaucoma|glaucoma
1273802|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
1273803|NCT01699438|Inflammation|inflammation
1273804|NCT01699438|Mesalazine|mesalazine
1273805|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
1273806|NCT01699425|Suburethral sling.|suburethral sling.
1273807|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
1273808|NCT01699425|Ajust.|ajust.
1273809|NCT01699425|Transobturator tape.|transobturator tape.
1273810|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
1273811|NCT01699412|Graft vs Host Disease|graft vs host disease
1273812|NCT01699412|Oral Manifestations|oral manifestations
1273813|NCT01699399|colonoscopy|colonoscopy
1273814|NCT01699399|pain|pain
1273815|NCT01699399|sedation|sedation
1273816|NCT01699399|water|water
1273817|NCT01699360|Kidney Transplantation|kidney transplantation
1273818|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
1273819|NCT01699360|Hydrocortisone|hydrocortisone
1273820|NCT01699360|Cortisone|cortisone
1273821|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
1273822|NCT01699334|Whiplash injuries|whiplash injuries
1273823|NCT01699334|patient education|patient education
1273824|NCT01699334|illness perceptions|illness perceptions
1273825|NCT01699334|RCT|rct
1273826|NCT01699334|motor vehicle accidents|motor vehicle accidents
1273827|NCT01699321|physical activity|physical activity
1273828|NCT01699321|barbershop|barbershop
1273829|NCT01699321|cancer prevention|cancer prevention
1273830|NCT01699321|exercise|exercise
1273831|NCT01699321|men's health|men's health
1273832|NCT01699321|African American men|african american men
1273833|NCT01699308|Traumatic Brain Injury|traumatic brain injury
1273834|NCT01699308|Growth Hormone|growth hormone
1273835|NCT01699308|Neuroimaging|neuroimaging
1273836|NCT01699295|academic achievement|academic achievement
1273837|NCT01699295|elementary school|elementary school
1273838|NCT01699295|physical activity|physical activity
1273839|NCT01699295|exercise|exercise
1273840|NCT01699282|oral anticoagulant|oral anticoagulant
1273841|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
1273842|NCT01699269|High grade brain tumor|high grade brain tumor
1273843|NCT01699269|Glioma|glioma
1273844|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
1273845|NCT01699269|Brain Cancer|brain cancer
1273846|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
1273847|NCT01699269|High order diffusion tensor|high order diffusion tensor
1273848|NCT01699269|Imaging guided biopsy|imaging guided biopsy
1273849|NCT01699269|Histopathologic evaluation|histopathologic evaluation
1273850|NCT01699269|Infiltration percentage|infiltration percentage
1273851|NCT01699256|General Practice|general practice
1273852|NCT01699256|Low Back Pain|low back pain
1273853|NCT01699256|Guideline|guideline
1273854|NCT01699256|Health Plan Implementation|health plan implementation
1273855|NCT01699256|Referral and Consultation|referral and consultation
1273856|NCT01699243|pregnancy|pregnancy
1273857|NCT01699243|labor|labor
1273858|NCT01699243|epidural|epidural
1273859|NCT01699243|fetal intervention|fetal intervention
1273860|NCT01699230|Elective cardiac surgery|elective cardiac surgery
1273861|NCT01699230|with sternotomy and|with sternotomy and
1273862|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
1273863|NCT01699230|for coronary artery|for coronary artery
1273864|NCT01699230|bypass graft.|bypass graft.
1273865|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
1273866|NCT01699217|Philadelphia positive|philadelphia positive
1273867|NCT01699217|BCR-ABL positive|bcr-abl positive
1273868|NCT01699204|Air pollution|air pollution
1273869|NCT01699204|Diesel exhaust|diesel exhaust
1273870|NCT01699204|Airway responsiveness|airway responsiveness
1273871|NCT01699204|Asthma|asthma
1273872|NCT01699204|Anti-oxidant|anti-oxidant
1273873|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
1273874|NCT01699191|Celiac Desease|celiac desease
1273875|NCT01699191|Probiotic|probiotic
1273876|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
1273877|NCT01699191|Bifidobacterium breve|bifidobacterium breve
1273878|NCT01699191|Lactobacillus casei|lactobacillus casei
1273879|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
1273880|NCT01699165|rhinitis|rhinitis
1273881|NCT01699165|allergic|allergic
1273882|NCT01699165|seasonal|seasonal
1273886|NCT01699165|randomised|randomised
1273888|NCT01699165|crossover|crossover
1273889|NCT01699165|clinical|clinical
1273890|NCT01699165|nasal|nasal
1273891|NCT01699165|filter|filter
1273892|NCT01699165|controlled|controlled
1273893|NCT01699165|trial|trial
1273894|NCT01699165|hayfever|hayfever
1273895|NCT01699165|hay|hay
1273896|NCT01699165|fever|fever
1273897|NCT01699165|efficacy|efficacy
1273898|NCT01699165|safety|safety
1273899|NCT01699165|prevention|prevention
1273900|NCT01699165|adult|adult
1273901|NCT01699165|grass|grass
1273902|NCT01699165|pollen|pollen
1273903|NCT01699165|symptom|symptom
1273904|NCT01699165|Total nasal symptom score|total nasal symptom score
1273905|NCT01699165|acoustic rhinometry|acoustic rhinometry
1273906|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1273907|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1273908|NCT01699139|supine position|supine position
1273909|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
1273910|NCT01699126|CPAP|cpap
1273911|NCT01699126|Endothelium dysfunction|endothelium dysfunction
1273912|NCT01699126|Hypertension|hypertension
1273913|NCT01699113|YF476|yf476
1273914|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
1273915|NCT01699113|gastric pH|gastric ph
1273916|NCT01699113|gastrin|gastrin
1273917|NCT01699113|rabeprazole|rabeprazole
1273918|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
1273919|NCT01699113|gastric function|gastric function
1273920|NCT01699113|healthy subjects|healthy subjects
1273921|NCT01699100|offloading|offloading
1273922|NCT01699100|plantar pressure|plantar pressure
1273923|NCT01699100|insole|insole
1273924|NCT01699100|foot ulcer|foot ulcer
1273928|NCT01699074|Korean White Ginseng|korean white ginseng
1273929|NCT01699074|Type 2 diabetes|type 2 diabetes
1273930|NCT01699074|Metabolic syndrome|metabolic syndrome
1273931|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
1273932|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
1273933|NCT01699035|stroke|stroke
1273934|NCT01699035|work|work
1273935|NCT01699035|vocational rehabilitation|vocational rehabilitation
1273936|NCT01699022|Contraceptive|contraceptive
1273937|NCT01699022|Injectable|injectable
1273938|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
1273939|NCT01698996|abscess|abscess
1273940|NCT01698996|packing|packing
1273941|NCT01698996|emergency medicine|emergency medicine
1273942|NCT01698996|wound care|wound care
1273943|NCT01698996|incision and drainage|incision and drainage
1273944|NCT01698970|Probiotic|probiotic
1273945|NCT01698970|capsules|capsules
1273946|NCT01698970|Crohn's disease|crohn's disease
1273947|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
1273948|NCT01698957|Pregnant women|pregnant women
1273949|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
1273950|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
1274052|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
1274356|NCT01696734|Domperidone|domperidone
1273951|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
1273952|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
1273953|NCT01698866|Low grade lymphoma|low grade lymphoma
1273954|NCT01698866|follicular lymphoma|follicular lymphoma
1273955|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
1273956|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
1273957|NCT01698840|Vitamin D|vitamin d
1273958|NCT01698840|Transitional Formula|transitional formula
1273959|NCT01698827|gastrostomy|gastrostomy
1273960|NCT01698827|tube|tube
1273961|NCT01698827|endoscopic|endoscopic
1273962|NCT01698827|replacement|replacement
1273963|NCT01698827|tube rupture|tube rupture
1273964|NCT01698827|durability|durability
1273965|NCT01698827|tube loss|tube loss
1273966|NCT01698827|balloon rupture|balloon rupture
1273967|NCT01698814|ocular safety|ocular safety
1273968|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
1273969|NCT01698801|Lenalidomide|lenalidomide
1273970|NCT01698801|dexamethasone|dexamethasone
1273971|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1273972|NCT01698788|diabetic macular edema|diabetic macular edema
1273973|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
1273974|NCT01698788|ozurdex|ozurdex
1273975|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
1273976|NCT01698762|Osteoarthritis|osteoarthritis
1273977|NCT01698762|OA|oa
1273978|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
1273979|NCT01698762|RA|ra
1273980|NCT01698762|Osteoporosis|osteoporosis
1273981|NCT01698762|OP|op
1273982|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
1273983|NCT01698762|MM-PtDAs|mm-ptdas
1273984|NCT01698762|DVD|dvd
1273985|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
1273986|NCT01698762|CERSG|cersg
1273987|NCT01698762|Booklet|booklet
1273988|NCT01698762|Questionnaires|questionnaires
1273989|NCT01698762|Surveys|surveys
1273990|NCT01698749|Ozurdex|ozurdex
1273991|NCT01698749|Diabetic macular edema|diabetic macular edema
1273992|NCT01698749|Central macular thickness|central macular thickness
1273993|NCT01698736|ABO isoagglutinins|abo isoagglutinins
1273994|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
1273995|NCT01698736|immunoadsorption|immunoadsorption
1273996|NCT01698736|membrane filtration|membrane filtration
1273997|NCT01698736|plasmapheresis|plasmapheresis
1273998|NCT01698723|ACLF|aclf
1273999|NCT01698723|HEV|hev
1274000|NCT01698723|Ribavirin|ribavirin
1274001|NCT01698710|Premalignant|premalignant
1274002|NCT01698710|Malignant|malignant
1274003|NCT01698684|ED|ed
1274004|NCT01698645|quality of life|quality of life
1274005|NCT01698645|PecFent|pecfent
1274006|NCT01698645|Lazanda|lazanda
1274007|NCT01698645|fentanyl|fentanyl
1274008|NCT01698645|intranasal|intranasal
1274009|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
1274010|NCT01698632|Adnexal masses|adnexal masses
1274011|NCT01698632|Ovarian cysts|ovarian cysts
1274012|NCT01698632|Ovarian tumors|ovarian tumors
1274013|NCT01698606|childhood obesity|childhood obesity
1274014|NCT01698606|multidisciplinary|multidisciplinary
1274015|NCT01698606|preschool children|preschool children
1274016|NCT01698606|community-based|community-based
1274017|NCT01698606|lifestyle intervention|lifestyle intervention
1274018|NCT01698606|family-centered|family-centered
1274019|NCT01698593|Bupivacaine|bupivacaine
1274020|NCT01698593|digital nerve block|digital nerve block
1274021|NCT01698593|epinephrine|epinephrine
1274022|NCT01698593|duration of action|duration of action
1274023|NCT01698593|pain|pain
1274024|NCT01698593|touch|touch
1274025|NCT01698593|pressure|pressure
1274026|NCT01698593|temperature|temperature
1274027|NCT01698580|accidental falls|accidental falls
1274028|NCT01698580|aged|aged
1274029|NCT01698580|aged, 80 and over|aged, 80 and over
1274030|NCT01698580|prevention and control|prevention and control
1274031|NCT01698567|Infants|infants
1274032|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
1274033|NCT01698567|anticoaglution|anticoaglution
1274034|NCT01698541|Renal|renal
1604260|NCT00378638|metastases|metastases
1274035|NCT01698541|Transplantation|transplantation
1274036|NCT01698541|Elderly|elderly
1274037|NCT01698528|Diabetes|diabetes
1274038|NCT01698528|diabetes technologies|diabetes technologies
1274039|NCT01698528|telemedicine|telemedicine
1274040|NCT01698502|Incretin|incretin
1274041|NCT01698502|Training|training
1274042|NCT01698502|Glucagon like peptide|glucagon like peptide
1274043|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
1274044|NCT01698502|Gut|gut
1274045|NCT01698502|Exercise|exercise
1274046|NCT01698502|Insulin|insulin
1274047|NCT01698502|Focus:|focus:
1274048|NCT01698502|Gut hormone|gut hormone
1274049|NCT01698502|adaptations|adaptations
1274050|NCT01698476|pulmonary TB|pulmonary tb
1274051|NCT01698476|cholecalciferol|cholecalciferol
1274354|NCT01696734|Surveys|surveys
1274053|NCT01698476|antimicrobial peptides|antimicrobial peptides
1274054|NCT01698476|immune response|immune response
1274055|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
1274056|NCT01698450|FUS|fus
1274057|NCT01698450|focused ultrasound|focused ultrasound
1274058|NCT01698450|functional brain disorder|functional brain disorder
1274059|NCT01698450|neuropathic pain|neuropathic pain
1274060|NCT01698450|movement disorders|movement disorders
1274061|NCT01698450|malignant brain tumors|malignant brain tumors
1274062|NCT01698437|FUS|fus
1274063|NCT01698437|focused ultrasound|focused ultrasound
1274064|NCT01698437|functional brain disorders|functional brain disorders
1274065|NCT01698437|neuropathic pain|neuropathic pain
1274066|NCT01698437|movement disorders|movement disorders
1274067|NCT01698437|malignant of brain tumors|malignant of brain tumors
1274068|NCT01698411|hypertension|hypertension
1274069|NCT01698411|sleep|sleep
1274070|NCT01698411|insomnia|insomnia
1274071|NCT01698372|Cardiac surgery.|cardiac surgery.
1274072|NCT01698372|Wound healing.|wound healing.
1274073|NCT01698372|Leg wound infection.|leg wound infection.
1274074|NCT01698372|Wound care.|wound care.
1274075|NCT01698346|Pertussis|pertussis
1274076|NCT01698346|Infants|infants
1274077|NCT01698346|Vaccination|vaccination
1274078|NCT01698346|Pregnancy|pregnancy
1274079|NCT01698333|122-0551|122-0551
1274080|NCT01698333|steroid|steroid
1274081|NCT01698333|HPA|hpa
1274082|NCT01698307|Crohn's Disease|crohn's disease
1274083|NCT01698307|Deep Remission|deep remission
1274084|NCT01698307|Complications|complications
1274085|NCT01698294|gut microbiome|gut microbiome
1274086|NCT01698294|hormones|hormones
1274087|NCT01698294|women|women
1274088|NCT01698294|race|race
1274089|NCT01698294|phytoestrogens|phytoestrogens
1274090|NCT01698255|Depression|depression
1274091|NCT01698255|Geriatrics|geriatrics
1274092|NCT01698242|Heart failure|heart failure
1274093|NCT01698242|Self-Management|self-management
1274094|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
1274095|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
1274096|NCT01698229|Lumbar puncture|lumbar puncture
1274097|NCT01698229|Spinal tap|spinal tap
1274098|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
1274099|NCT01698229|Batten disease|batten disease
1274100|NCT01698216|Paliperidone|paliperidone
1274101|NCT01698216|Palmitate|palmitate
1274102|NCT01698216|switching|switching
1274103|NCT01698216|schizophrenia|schizophrenia
1274104|NCT01698216|subjective well-being|subjective well-being
1274105|NCT01698177|Influenza|influenza
1274107|NCT01698177|Vaccination|vaccination
1274108|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
1274109|NCT01698164|lipid profiles|lipid profiles
1274110|NCT01698164|coronary heart disease|coronary heart disease
1274111|NCT01698164|menopausal syndrome|menopausal syndrome
1274112|NCT01698164|MMSE|mmse
1274113|NCT01698164|MENQOL|menqol
1274114|NCT01698164|HAD|had
1274115|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1274116|NCT01698151|COPD|copd
1274117|NCT01698138|Spinal cord injury|spinal cord injury
1274118|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
1274119|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
1274120|NCT01698138|Prevention|prevention
1274121|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
1274122|NCT01698125|Delirium|delirium
1274123|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
1274124|NCT01698125|Abdominal surgery|abdominal surgery
1274125|NCT01698125|Tilt-test|tilt-test
1274126|NCT01698086|Multiple Sclerosis|multiple sclerosis
1274127|NCT01698086|Balance|balance
1274128|NCT01698086|Fatigue|fatigue
1274129|NCT01698086|Eye movement|eye movement
1274130|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
1274131|NCT01698073|American Indian|american indian
1274132|NCT01698073|Group-randomized trial|group-randomized trial
1274133|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
1274134|NCT01698047|Depressive symptoms|depressive symptoms
1274135|NCT01698047|sub-threshold depression|sub-threshold depression
1274136|NCT01698047|resiliency|resiliency
1604462|NCT00377858|diabetes|diabetes
1274137|NCT01698047|Health Promotion|health promotion
1274138|NCT01698047|minority health|minority health
1274139|NCT01698034|volunteering|volunteering
1274140|NCT01698034|cardiovascular health|cardiovascular health
1274264|NCT01697189|sleepiness|sleepiness
1274141|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
1274142|NCT01698021|Troponin|troponin
1274143|NCT01698021|Acute coronary syndrome|acute coronary syndrome
1274144|NCT01698021|myocardial infarction|myocardial infarction
1274145|NCT01698021|Unstable angina|unstable angina
1274146|NCT01697995|right ventricle|right ventricle
1274147|NCT01697995|radiotracer uptake|radiotracer uptake
1274148|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
1274149|NCT01697995|balanced ischemia|balanced ischemia
1274150|NCT01697982|pilot study|pilot study
1274151|NCT01697982|psychosocial intervention|psychosocial intervention
1274152|NCT01697982|advanced cancer|advanced cancer
1274153|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
1274154|NCT01697969|Pataday|pataday
1274155|NCT01697969|Olopatadine|olopatadine
1274156|NCT01697956|Pediatric Subjects|pediatric subjects
1274157|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
1274158|NCT01697943|Total Gastrectomy|total gastrectomy
1274159|NCT01697943|Reconstruction|reconstruction
1274160|NCT01697930|PET Imaging|pet imaging
1274161|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
1274162|NCT01697930|12-168|12-168
1274163|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
1274164|NCT01697917|Total Gastrectomy|total gastrectomy
1274165|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
1274166|NCT01697891|Radiation Treatment|radiation treatment
1274167|NCT01697891|Head and Neck Cancer|head and neck cancer
1274168|NCT01697891|Dysphagia|dysphagia
1274169|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
1274170|NCT01697878|obesity|obesity
1274171|NCT01697878|respiratory function|respiratory function
1274172|NCT01697878|weight loss surgery|weight loss surgery
1274173|NCT01697865|Reverse total shoulder|reverse total shoulder
1274174|NCT01697852|vector control|vector control
1274175|NCT01697852|LLIN|llin
1274176|NCT01697852|IRS|irs
1274177|NCT01697826|Clindamycin|clindamycin
1274178|NCT01697826|Clotrimazole|clotrimazole
1274179|NCT01697826|Vaginal formulation|vaginal formulation
1274180|NCT01697826|Bacterial vaginosis|bacterial vaginosis
1274181|NCT01697826|Candidiasis|candidiasis
1274182|NCT01697826|Trichomoniasis|trichomoniasis
1274183|NCT01697826|Mixed vaginitis|mixed vaginitis
1274184|NCT01697826|Infective vaginitis|infective vaginitis
1274185|NCT01697787|Treatment, diagnosis|treatment, diagnosis
1274186|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
1274187|NCT01697722|Primary care|primary care
1274188|NCT01697722|Asthma management|asthma management
1274189|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
1274190|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
1274191|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
1274192|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
1274193|NCT01697709|cannabis|cannabis
1274194|NCT01697709|marijuana|marijuana
1274195|NCT01697709|pharmacotherapy|pharmacotherapy
1274196|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
1274197|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
1274198|NCT01697566|Gynecology|gynecology
1274199|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
1274201|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
1274202|NCT01697566|Post-menopausal|post-menopausal
1274203|NCT01697566|Hyperinsulinemia|hyperinsulinemia
1274204|NCT01697566|Metformin|metformin
1274205|NCT01697566|Placebo|placebo
1274206|NCT01697566|Sugar pill|sugar pill
1274207|NCT01697566|Lifestyle intervention|lifestyle intervention
1274208|NCT01697566|Diet|diet
1274209|NCT01697566|Exercise|exercise
1274210|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
1274211|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
1274212|NCT01697397|IBS|ibs
1274213|NCT01697397|Gastrointestinal pain|gastrointestinal pain
1274214|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
1274215|NCT01697384|prostate cancer, PSA|prostate cancer, psa
1274216|NCT01697358|FBSS|fbss
1274217|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
1274218|NCT01697358|SCS|scs
1274219|NCT01697358|RCT|rct
1274220|NCT01697358|back pain|back pain
1274221|NCT01697345|Vaginal Testosterone|vaginal testosterone
1274222|NCT01697345|Vaginal atrophy|vaginal atrophy
1274223|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
1274224|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
1274225|NCT01697332|COPD|copd
1274226|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
1274227|NCT01697319|MPS IVA Type A|mps iva type a
1274228|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1274229|NCT01697319|MPS IVA|mps iva
1274230|NCT01697319|Morquio A Syndrome|morquio a syndrome
1604463|NCT00377858|type 2|type 2
1274231|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
1274233|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1274234|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
1274235|NCT01697319|sulfatase|sulfatase
1274236|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
1274237|NCT01697319|GALNS|galns
1274238|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
1274239|NCT01697319|ERT|ert
1274240|NCT01697319|MOR-006|mor-006
1274241|NCT01697319|CPET|cpet
1274242|NCT01697319|Limited ambulation|limited ambulation
1274243|NCT01697319|Grip/ Pinch|grip/ pinch
1274244|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
1274245|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
1274246|NCT01697280|Routine EPI vaccine|routine epi vaccine
1274247|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
1274248|NCT01697267|vasculitis|vasculitis
1274249|NCT01697267|ANCA vasculitis|anca vasculitis
1274250|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
1274251|NCT01697267|granulomatosis|granulomatosis
1274252|NCT01697267|Wegener's|wegener's
1274253|NCT01697267|AAV|aav
1274254|NCT01697267|vasculitides|vasculitides
1274255|NCT01697241|Exercise Therapy|exercise therapy
1274256|NCT01697241|Education|education
1274257|NCT01697241|Osteoarthritis|osteoarthritis
1274258|NCT01697241|Hip|hip
1274259|NCT01697241|Hip replacement|hip replacement
1274260|NCT01697228|Diabetes|diabetes
1274261|NCT01697228|Vitamin D|vitamin d
1274262|NCT01697228|Proinflammatory markers|proinflammatory markers
1274263|NCT01697189|professional drivers|professional drivers
1274266|NCT01697189|safe driving|safe driving
1274267|NCT01697189|training|training
1274268|NCT01697163|De Novo Resistance|de novo resistance
1274269|NCT01697163|Iressa|iressa
1274270|NCT01697163|EGFR mutation|egfr mutation
1274271|NCT01697163|lung cancer|lung cancer
1274272|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
1274273|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
1274274|NCT01697124|Physical activity|physical activity
1274275|NCT01697124|children|children
1274276|NCT01697124|Head Start|head start
1274277|NCT01697124|SPARK-EC|spark-ec
1274278|NCT01697111|YAZ|yaz
1274279|NCT01697111|Flexible regimen|flexible regimen
1274280|NCT01697111|Drospirenone|drospirenone
1274281|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
1274282|NCT01697111|Endometriosis|endometriosis
1274283|NCT01697111|Dienogest|dienogest
1274284|NCT01697111|Japanese Patients|japanese patients
1274285|NCT01697098|Dexamethasone|dexamethasone
1274286|NCT01697098|preterm labour|preterm labour
1274287|NCT01697098|respiratory distress|respiratory distress
1274288|NCT01697085|sea buckthorn|sea buckthorn
1274289|NCT01697085|mucous membrane|mucous membrane
1274290|NCT01697085|dryness|dryness
1274291|NCT01697085|metabolic syndrome|metabolic syndrome
1274292|NCT01697085|vaginal atrophy|vaginal atrophy
1274293|NCT01697072|Gastric Cancer|gastric cancer
1274294|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
1274295|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
1274296|NCT01697072|GEJ Cancer|gej cancer
1274297|NCT01697059|appendicitis|appendicitis
1274298|NCT01697046|peri-exposure|peri-exposure
1274299|NCT01697046|chemoprophylaxis|chemoprophylaxis
1274300|NCT01696942|Crohn's disease|crohn's disease
1274301|NCT01696942|certolizumab|certolizumab
1274302|NCT01696942|mesalamine|mesalamine
1274303|NCT01696942|recurrence|recurrence
1274304|NCT01696929|tocilizumab|tocilizumab
1274305|NCT01696929|safety|safety
1274306|NCT01696929|tolerability|tolerability
1274307|NCT01696929|efficacy|efficacy
1274308|NCT01696929|schizophrenia|schizophrenia
1274309|NCT01696929|improvement|improvement
1274310|NCT01696929|cognition|cognition
1274311|NCT01696929|psychotic symptoms|psychotic symptoms
1274312|NCT01696929|baseline IL-6 levels|baseline il-6 levels
1274313|NCT01696916|COPD|copd
1274314|NCT01696916|carbon dioxide|carbon dioxide
1274315|NCT01696916|6-minute walking test|6-minute walking test
1274316|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
1274317|NCT01696903|Pancreatic texture|pancreatic texture
1274318|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
1274319|NCT01696903|Pancreatic consistency|pancreatic consistency
1274320|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
1274321|NCT01696890|chronic heart failure|chronic heart failure
1274322|NCT01696890|telemonitoring|telemonitoring
1274323|NCT01696890|first line practitioners|first line practitioners
1274324|NCT01696890|integrated approach|integrated approach
1274325|NCT01696890|efficacy|efficacy
1274326|NCT01696838|Crohn's disease|crohn's disease
1274327|NCT01696838|acupuncture|acupuncture
1274328|NCT01696838|moxibustion|moxibustion
1274329|NCT01696838|fMRI|fmri
1274330|NCT01696838|Gut|gut
1274331|NCT01696812|electrodeposition|electrodeposition
1274332|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
1274333|NCT01696812|Deep Brain Stimulation|deep brain stimulation
1274334|NCT01696812|Parkinson Disease|parkinson disease
1274335|NCT01696773|tomato|tomato
1274336|NCT01696773|tangerine tomato|tangerine tomato
1274337|NCT01696773|carotenoids|carotenoids
1274338|NCT01696773|lycopene|lycopene
1274339|NCT01696773|flavonoids|flavonoids
1274340|NCT01696747|gastroparesis|gastroparesis
1274341|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
1274342|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
1274343|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
1274344|NCT01696734|Gastrointestinal diseases|gastrointestinal diseases
1274345|NCT01696734|GI|gi
1274346|NCT01696734|Compassionate use|compassionate use
1274347|NCT01696734|GI motility disorders|gi motility disorders
1274348|NCT01696734|GI disorders|gi disorders
1274349|NCT01696734|Gastroparesis|gastroparesis
1274350|NCT01696734|Gastroesophageal reflux disease|gastroesophageal reflux disease
1274351|NCT01696734|GERD|gerd
1274352|NCT01696734|Chronic nausea and vomiting|chronic nausea and vomiting
1274353|NCT01696734|Questionnaires|questionnaires
1274357|NCT01696721|Proton Therapy|proton therapy
1274358|NCT01696721|Pediatrics|pediatrics
1274359|NCT01696721|Radiation Oncology|radiation oncology
1274360|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
1274361|NCT01696682|anastomotic leakage|anastomotic leakage
1274362|NCT01696682|gastric conduit|gastric conduit
1274363|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
1274364|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
1274365|NCT01696669|Gemcitabine|gemcitabine
1274366|NCT01696669|Docetaxel|docetaxel
1274367|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
1274368|NCT01696656|Antibiotics|antibiotics
1274369|NCT01696656|Vitamins|vitamins
1274370|NCT01696656|Minerals|minerals
1274371|NCT01696656|Intestinal insufficiency|intestinal insufficiency
1274372|NCT01696656|Short Bowel syndrome|short bowel syndrome
1274373|NCT01696656|Adjuvant therapy|adjuvant therapy
1274374|NCT01696656|Antacids|antacids
1274375|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
1274376|NCT01696656|Micronutrients|micronutrients
1274377|NCT01696643|Opioid|opioid
1274378|NCT01696643|Constipation|constipation
1274379|NCT01696643|Chronic|chronic
1274380|NCT01696643|Pain|pain
1274381|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
1274382|NCT01696604|safety|safety
1274383|NCT01696604|pharmacokinetics|pharmacokinetics
1274384|NCT01696604|FTIH|ftih
1274385|NCT01696604|SARM|sarm
1274386|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
1274387|NCT01696578|PTSD|ptsd
1274388|NCT01696578|Depression|depression
1274389|NCT01696578|Anxiety|anxiety
1274390|NCT01696578|Chronic pain|chronic pain
1274391|NCT01696578|Anger|anger
1274392|NCT01696578|Heart rate variability|heart rate variability
1274393|NCT01696578|Disability|disability
1274394|NCT01696565|myelosuppression|myelosuppression
1274395|NCT01696565|chemotherapy|chemotherapy
1274396|NCT01696565|Astragalus membranaceus|astragalus membranaceus
1274397|NCT01696565|hematopoietic response|hematopoietic response
1274398|NCT01696552|Gonarthritis|gonarthritis
1274399|NCT01696552|TKR|tkr
1274400|NCT01696552|Conventional|conventional
1274401|NCT01696552|Positioning Guides|positioning guides
1274402|NCT01696552|PSPG|pspg
1274403|NCT01696552|CT Perth|ct perth
1274404|NCT01696539|Prostate Cancer|prostate cancer
1274405|NCT01696526|vitamin D|vitamin d
1274406|NCT01696526|bioeffiency|bioeffiency
1274407|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
1274408|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
1274409|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
1274410|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
1274411|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
1274412|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1274413|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1274414|NCT01696487|NAFLD|nafld
1274415|NCT01696487|NASH|nash
1274416|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
1274417|NCT01696474|Bortezomib|bortezomib
1274418|NCT01696474|blood-transfusion|blood-transfusion
1274419|NCT01696448|Appetite Suppression|appetite suppression
1274420|NCT01696448|CAR-191|car-191
1274421|NCT01696435|Depression|depression
1274422|NCT01696435|Depressive Symptoms|depressive symptoms
1274423|NCT01696435|Mood|mood
1274424|NCT01696435|Geriatric|geriatric
1274425|NCT01696435|Prevention|prevention
1274426|NCT01696422|Dengue|dengue
1274427|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
1274428|NCT01696422|Healthy adults|healthy adults
1274429|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
1274430|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
1274431|NCT01696383|Glaucoma|glaucoma
1274432|NCT01696383|Ocular hypertension|ocular hypertension
1274433|NCT01696383|DuoTrav|duotrav
1274434|NCT01696383|Prostaglandin analogue|prostaglandin analogue
1274435|NCT01696383|Beta-blocker|beta-blocker
1274436|NCT01696370|Trimetazidine|trimetazidine
1274437|NCT01696357|Asthma|asthma
1274438|NCT01696357|Adolescents|adolescents
1274439|NCT01696357|Self-monitoring|self-monitoring
1274440|NCT01696357|Quality of life|quality of life
1274441|NCT01696357|Biomedical device|biomedical device
1274442|NCT01696357|Symptom monitoring|symptom monitoring
1274443|NCT01696357|Self-management|self-management
1274444|NCT01696344|LSPAF|lspaf
1274445|NCT01696344|AF termination|af termination
1274446|NCT01696344|PVAI|pvai
1274447|NCT01696344|nonPV triggers|nonpv triggers
1274448|NCT01696344|Long-standing persistent|long-standing persistent
1274449|NCT01696305|Thyroid disease|thyroid disease
1274450|NCT01696305|Hyalobarrier|hyalobarrier
1274451|NCT01696305|Thyroidectomy|thyroidectomy
1274452|NCT01696305|anti-adhesive effect|anti-adhesive effect
1274453|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
1274454|NCT01696240|Exercise Capacity|exercise capacity
1274455|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
1274456|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
1274457|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
1274458|NCT01696227|Nissle 1917|nissle 1917
1274459|NCT01696227|Probiotic|probiotic
1274460|NCT01696227|Uropathogen|uropathogen
1274461|NCT01696214|asthma,smokers|asthma,smokers
1274462|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
1274463|NCT01696188|Interscalene|interscalene
1274464|NCT01696188|nerve block|nerve block
1274465|NCT01696188|nerve catheter|nerve catheter
1274466|NCT01696188|in-plane|in-plane
1274467|NCT01696188|out-of-plane|out-of-plane
1274468|NCT01696188|anterolateral approach|anterolateral approach
1274469|NCT01696188|posterior approach|posterior approach
1274470|NCT01696188|shoulder surgery|shoulder surgery
1274471|NCT01696175|ScvO2|scvo2
1274472|NCT01696175|venous|venous
1274473|NCT01696175|oxymetry|oxymetry
1274474|NCT01696175|lactate|lactate
1274475|NCT01696175|children|children
1274476|NCT01696175|PICU|picu
1274477|NCT01696175|Admission parameters of shock|admission parameters of shock
1274478|NCT01696162|Knee pain|knee pain
1274479|NCT01696162|Anterior knee pain|anterior knee pain
1274480|NCT01696162|Patellofemoral|patellofemoral
1274481|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
1274482|NCT01696162|Runners knee|runners knee
1274483|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
1274484|NCT01696136|Ablation|ablation
1274485|NCT01696136|Multi-electrode catheter|multi-electrode catheter
1274486|NCT01696136|Single-tip catheter|single-tip catheter
1274487|NCT01696136|Holter|holter
1274488|NCT01696123|Alzheimer disease|alzheimer disease
1274489|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
1274491|NCT01696123|NeuroAiD|neuroaid
1274492|NCT01696123|neuroprotection|neuroprotection
1274493|NCT01696123|neuroregeneration|neuroregeneration
1274494|NCT01696110|Bivalirudin|bivalirudin
1274495|NCT01696110|Acute myocardial infarction|acute myocardial infarction
1274496|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1274497|NCT01696084|AML|aml
1274498|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
1274499|NCT01696084|high risk AML|high risk aml
1274500|NCT01696084|secondary AML|secondary aml
1274501|NCT01696084|AML in elderly|aml in elderly
1274502|NCT01696032|Ovarian Cancer|ovarian cancer
1274503|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
1274504|NCT01696019|cognition|cognition
1274505|NCT01696019|Tai Chi|tai chi
1274506|NCT01696019|physical exercise|physical exercise
1274507|NCT01696019|mental exercise|mental exercise
1274508|NCT01696019|intervention trial|intervention trial
1274509|NCT01696019|prevention|prevention
1274510|NCT01696019|dementia|dementia
1274511|NCT01696019|Alzheimer disease|alzheimer disease
1274512|NCT01696019|mild cognitive impairment|mild cognitive impairment
1274513|NCT01696006|perfusion computed tomography|perfusion computed tomography
1274514|NCT01696006|coronary artery disease|coronary artery disease
1274515|NCT01695993|Nausea|nausea
1274516|NCT01695993|Quality of life|quality of life
1274517|NCT01695993|Chemotherapy|chemotherapy
1274518|NCT01695993|Expectancy|expectancy
1274519|NCT01695980|adenotonsillectomy|adenotonsillectomy
1274520|NCT01695967|nasal obstruction|nasal obstruction
1274521|NCT01695954|HIV|hiv
1274522|NCT01695954|Hyperlipidemia|hyperlipidemia
1274523|NCT01695954|Pharmacokinetics|pharmacokinetics
1274524|NCT01695954|Statins|statins
1274525|NCT01695954|Darunavir|darunavir
1274526|NCT01695954|Efavirenz|efavirenz
1274527|NCT01695954|Pitavastatin|pitavastatin
1274528|NCT01695928|Velocity|velocity
1274529|NCT01695928|Location|location
1274530|NCT01695928|Periodontal status|periodontal status
1274531|NCT01695915|constipation|constipation
1274532|NCT01695915|children|children
1274533|NCT01695915|healthy|healthy
1274534|NCT01695915|rectal diameter|rectal diameter
1274535|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
1274536|NCT01695863|Movi pre|movi pre
1274537|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
1274538|NCT01695850|Randomized controlled trial|randomized controlled trial
1274539|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
1274540|NCT01695850|Constipation/drug therapy|constipation/drug therapy
1274541|NCT01695837|Diet counseling|diet counseling
1274542|NCT01695837|primary care|primary care
1274543|NCT01695824|catheter ablation|catheter ablation
1274544|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
1274545|NCT01695798|poliomyelitis|poliomyelitis
1274546|NCT01695798|oral polio vaccine|oral polio vaccine
1274547|NCT01695798|OPV|opv
1274548|NCT01695798|seroconversion|seroconversion
1274549|NCT01695798|mucosal immunity|mucosal immunity
1274550|NCT01695798|malnutrition|malnutrition
1274551|NCT01695798|IPV|ipv
1274552|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
1274553|NCT01695798|Pakistan|pakistan
1274554|NCT01695759|Anemia Secondary|anemia secondary
1274555|NCT01695759|Chronic Kidney Disease|chronic kidney disease
1274556|NCT01695720|Knee Injuries|knee injuries
1274557|NCT01695720|Meniscus Injuries|meniscus injuries
1274558|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
1274559|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
1274560|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
1274561|NCT01695707|atopic dermatitis|atopic dermatitis
1274562|NCT01695707|eczema|eczema
1274563|NCT01695681|Quality of life|quality of life
1274564|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
1274565|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
1274566|NCT01695681|Prospective Studies|prospective studies
1274567|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
1274568|NCT01695668|dry eyes|dry eyes
1274569|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
1274570|NCT01695668|Restasis|restasis
1274571|NCT01695668|Lotemax|lotemax
1274572|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
1274573|NCT01695603|Brain injury|brain injury
1274574|NCT01695603|Controlled ventilation|controlled ventilation
1274575|NCT01695603|Intellivent|intellivent
1274576|NCT01695603|Capnia control|capnia control
1274577|NCT01695590|Myeloma|myeloma
1274578|NCT01695590|PRLX93936|prlx93936
1274579|NCT01695577|Traumatic brain injury|traumatic brain injury
1274580|NCT01695577|Dizziness|dizziness
1274581|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
1274582|NCT01695577|Balance rehabilitation|balance rehabilitation
1274583|NCT01695564|atrial enlargement|atrial enlargement
1274584|NCT01695564|left atrial appendage|left atrial appendage
1274585|NCT01695551|Radiofrequency ablation|radiofrequency ablation
1274586|NCT01695551|fast heart rhythm|fast heart rhythm
1274587|NCT01695551|ventricle|ventricle
1274588|NCT01695551|catheter ablation|catheter ablation
1274589|NCT01695551|ablation|ablation
1274590|NCT01695538|Yoga|yoga
1274591|NCT01695538|atrial tachycardia|atrial tachycardia
1274592|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
1274593|NCT01695525|Yoga|yoga
1274594|NCT01695486|BIS|bis
1274595|NCT01695486|Comfort|comfort
1274596|NCT01695486|open muscle biopsy|open muscle biopsy
1274597|NCT01695473|Prostate cancer|prostate cancer
1274598|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
1274599|NCT01695473|Radical prostatectomy|radical prostatectomy
1274600|NCT01695473|BKM120|bkm120
1274601|NCT01695460|Migraine|migraine
1274602|NCT01695460|Vitamin D|vitamin d
1274603|NCT01695434|multiple sclerosis|multiple sclerosis
1274604|NCT01695434|MRI|mri
1274605|NCT01695434|Copaxone|copaxone
1274606|NCT01695434|healthy controls|healthy controls
1274607|NCT01695434|glatiramer acetate|glatiramer acetate
1274608|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1274609|NCT01695421|Oxygen Consumption|oxygen consumption
1274610|NCT01695421|Heart Failure|heart failure
1274611|NCT01695408|Drug Treatment|drug treatment
1274612|NCT01695408|Treatment pathways|treatment pathways
1274613|NCT01695408|Clinical routine|clinical routine
1274614|NCT01695408|Registry|registry
1274615|NCT01695408|Outcomes|outcomes
1274616|NCT01695408|Survival|survival
1274617|NCT01695408|Patient-related outcomes|patient-related outcomes
1274618|NCT01695408|Quality of life|quality of life
1274619|NCT01695408|Steroids|steroids
1274620|NCT01695408|Azathioprine|azathioprine
1274621|NCT01695408|N-Acetylcysteine|n-acetylcysteine
1274622|NCT01695408|Pirfenidone|pirfenidone
1274623|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
1274624|NCT01695408|Nintedanib|nintedanib
1274625|NCT01695408|multicenter|multicenter
1274626|NCT01695408|Germany|germany
1274627|NCT01695408|Safety|safety
1274628|NCT01695408|Adverse event|adverse event
1274629|NCT01695395|intellectual disability|intellectual disability
1274630|NCT01695395|mental disorder|mental disorder
1604464|NCT00377845|self test|self test
1274631|NCT01695395|dual diagnosis|dual diagnosis
1274632|NCT01695395|provision|provision
1274633|NCT01695395|needs assessment|needs assessment
1274634|NCT01695395|quality of life|quality of life
1274635|NCT01695382|Cancer|cancer
1274636|NCT01695382|Palliative Care|palliative care
1274637|NCT01695382|Patient Navigation|patient navigation
1274638|NCT01695356|Melasma|melasma
1274639|NCT01695356|sunscreens|sunscreens
1274640|NCT01695356|visible light|visible light
1274641|NCT01695356|ultraviolet light|ultraviolet light
1274642|NCT01695343|Cystic Fibrosis|cystic fibrosis
1274643|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
1274644|NCT01695343|CF|cf
1274645|NCT01695330|Multiple Myeloma|multiple myeloma
1274646|NCT01695330|Relapsed|relapsed
1274647|NCT01695330|Refractory|refractory
1274648|NCT01695330|Bortezomib|bortezomib
1274649|NCT01695330|Subcutaneous|subcutaneous
1274650|NCT01695330|Oncotherapeutics|oncotherapeutics
1274651|NCT01695317|Migraine|migraine
1274652|NCT01695317|Preventive medication|preventive medication
1274653|NCT01695304|Cryptosporidiosis|cryptosporidiosis
1274654|NCT01695304|Waterborne disease|waterborne disease
1274655|NCT01695304|Diarrheal disease|diarrheal disease
1274656|NCT01695304|Ceramic water filters|ceramic water filters
1274657|NCT01695304|infants|infants
1274658|NCT01695304|young children|young children
1274659|NCT01695304|drinking water|drinking water
1274660|NCT01695304|Kenya|kenya
1274661|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
1274662|NCT01695278|motivational interviewing|motivational interviewing
1274663|NCT01695278|telephone counseling|telephone counseling
1274664|NCT01695278|medical education|medical education
1274665|NCT01695278|diabetes self management|diabetes self management
1274666|NCT01695265|Airflow Obstruction|airflow obstruction
1274667|NCT01695226|Celecoxib|celecoxib
1274668|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
1274669|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
1274670|NCT01695213|uncemented hip|uncemented hip
1274671|NCT01695213|bone remodeling|bone remodeling
1274672|NCT01695213|DEXA|dexa
1274673|NCT01695213|clinical evaluation|clinical evaluation
1274674|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
1274675|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1274676|NCT01695174|Xifaxan|xifaxan
1274677|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
1274678|NCT01695161|Fabry disease|fabry disease
1274679|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
1274680|NCT01695148|micronutrients|micronutrients
1274681|NCT01695148|vitamin A|vitamin a
1274682|NCT01695148|serum retinol|serum retinol
1274683|NCT01695148|dark adaptation|dark adaptation
1274684|NCT01695135|Prostate neoplasms|prostate neoplasms
1274685|NCT01695135|Prostate cancer|prostate cancer
1274686|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
1274687|NCT01695135|Abiraterone acetate|abiraterone acetate
1274688|NCT01695135|JNJ-212082|jnj-212082
1274689|NCT01695122|Head and Neck Cancer|head and neck cancer
1274690|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
1274691|NCT01695122|Oral cavity cancer|oral cavity cancer
1274692|NCT01695122|Chemoradiation|chemoradiation
1274693|NCT01695122|valproic acid|valproic acid
1274694|NCT01695122|histone deacetylase|histone deacetylase
1274695|NCT01695109|GLP1|glp1
1274696|NCT01695109|obesity|obesity
1274697|NCT01695109|fMRI|fmri
1274698|NCT01695109|ghrelin|ghrelin
1274699|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
1274700|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
1274701|NCT01695083|Liver inflammation|liver inflammation
1274702|NCT01695083|Morbid obesity|morbid obesity
1274703|NCT01695083|Non invasive tests|non invasive tests
1274704|NCT01695031|Urban adolescents|urban adolescents
1274705|NCT01695031|Acute asthma|acute asthma
1274706|NCT01695031|Emergency department|emergency department
1274707|NCT01695031|Computer tailoring|computer tailoring
1274708|NCT01695031|Web-based intervention|web-based intervention
1274709|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
1274710|NCT01695018|p16 methylation|p16 methylation
1274711|NCT01695018|diagnostic reagents|diagnostic reagents
1274712|NCT01695018|early diagnosis|early diagnosis
1274713|NCT01694992|Stroke|stroke
1274714|NCT01694992|Early Ambulation|early ambulation
1274715|NCT01694992|Rehabilitation|rehabilitation
1274716|NCT01694992|Physical Therapy|physical therapy
1274717|NCT01694992|Randomized controlled trial|randomized controlled trial
1274718|NCT01694979|Pelvic floor|pelvic floor
1274719|NCT01694979|Rehabilitation|rehabilitation
1274720|NCT01694979|Respiration|respiration
1274721|NCT01694979|Urinary incontinence|urinary incontinence
1274722|NCT01694953|MNGIE|mngie
1274723|NCT01694953|Mitochondrial|mitochondrial
1274724|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
1274725|NCT01694940|mitochondrial disorders|mitochondrial disorders
1274726|NCT01694940|Mito Disease|mito disease
1274727|NCT01694940|Mitochondria|mitochondria
1604465|NCT00377845|PAP smear|pap smear
1274728|NCT01694940|Mitochondrial disease|mitochondrial disease
1274729|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
1274730|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
1274731|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
1274732|NCT01694940|Leigh Syndrome|leigh syndrome
1274733|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
1274734|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
1274735|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
1274736|NCT01694940|Pearson|pearson
1274737|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
1274738|NCT01694940|Barth Syndrome|barth syndrome
1274739|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
1274740|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
1274741|NCT01694940|DAD|dad
1274742|NCT01694940|Diabetes and Deafness|diabetes and deafness
1274743|NCT01694940|Encephalopathy|encephalopathy
1274744|NCT01694940|Encephalomyopathy|encephalomyopathy
1274745|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
1274746|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
1274747|NCT01694940|Leukoencephalopathy|leukoencephalopathy
1274748|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
1274749|NCT01694940|Complex I Deficiency|complex i deficiency
1274750|NCT01694940|Complex II Deficiency|complex ii deficiency
1274751|NCT01694940|Complex III Deficiency|complex iii deficiency
1274752|NCT01694940|Complex IV Deficiency|complex iv deficiency
1274753|NCT01694940|Complex V Deficiency|complex v deficiency
1274754|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
1274755|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
1274756|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
1274757|NCT01694927|Spinal cord injury|spinal cord injury
1274758|NCT01694914|Corneal Transplantation|corneal transplantation
1274759|NCT01694914|corneal organ culture medium|corneal organ culture medium
1274760|NCT01694914|free animal compound medium|free animal compound medium
1274761|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
1274762|NCT01694875|cervix cancer|cervix cancer
1274763|NCT01694875|HPV|hpv
1274764|NCT01694875|APTIMA|aptima
1274765|NCT01694862|quasi experimental|quasi experimental
1274766|NCT01694862|evaluation|evaluation
1274767|NCT01694862|intervention|intervention
1274768|NCT01694862|service integration|service integration
1274769|NCT01694862|cost analysis|cost analysis
1274770|NCT01694862|HIV|hiv
1274771|NCT01694862|FP|fp
1274772|NCT01694862|PNC|pnc
1274773|NCT01694862|Sub-Saharan Africa|sub-saharan africa
1274774|NCT01694849|PPARs|ppars
1274775|NCT01694849|NASH|nash
1274776|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1274777|NCT01694849|Liver Diseases|liver diseases
1274778|NCT01694849|Fibrosis|fibrosis
1274779|NCT01694836|Allergic rhinitis|allergic rhinitis
1274780|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1274781|NCT01694836|Allergy induced asthma|allergy induced asthma
1274782|NCT01694836|Birch (Betula alba)|birch (betula alba)
1274783|NCT01694836|Hayfever|hayfever
1274784|NCT01694836|Immunotherapy|immunotherapy
1274785|NCT01694823|Cartilage repair|cartilage repair
1274786|NCT01694823|Cartilage defects|cartilage defects
1274787|NCT01694823|cell sheet|cell sheet
1274788|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
1274789|NCT01694810|acne vulgaris|acne vulgaris
1274790|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
1274791|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
1274792|NCT01694745|Newborns|newborns
1274793|NCT01694745|Premature|premature
1274794|NCT01694745|Pain|pain
1274795|NCT01694745|Pain assessment|pain assessment
1274796|NCT01694745|Endotracheal Intubation|endotracheal intubation
1274797|NCT01694745|Analgesia|analgesia
1274798|NCT01694745|Sedation|sedation
1274799|NCT01694745|Longterm effects of pain|longterm effects of pain
1274800|NCT01694745|Epidemiology|epidemiology
1274801|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1274802|NCT01694732|Varenicline|varenicline
1274803|NCT01694732|Smoking cessation|smoking cessation
1274804|NCT01694719|Depression|depression
1274805|NCT01694719|Major Depressive Disorder|major depressive disorder
1274806|NCT01694719|Behavioral Activation|behavioral activation
1274807|NCT01694719|Cognitive Training|cognitive training
1274808|NCT01694680|AMD|amd
1274809|NCT01694680|Lutein|lutein
1274810|NCT01694680|Visual function|visual function
1274811|NCT01694680|Early signs of AMD|early signs of amd
1274812|NCT01694680|AREDS-category 2|areds-category 2
1274813|NCT01694641|time lapse monitoring|time lapse monitoring
1274814|NCT01694641|blastocyst|blastocyst
1274815|NCT01694641|single embryo transfer|single embryo transfer
1274816|NCT01694641|clinical pregnancy|clinical pregnancy
1274817|NCT01694641|implantation rate|implantation rate
1274818|NCT01694615|Lung Transplantation|lung transplantation
1274819|NCT01694615|Acute Rejection|acute rejection
1274820|NCT01694602|Cachexia|cachexia
1274821|NCT01694602|Sarcopenia|sarcopenia
1274822|NCT01694602|De Novo|de novo
1274823|NCT01694602|Deuterated|deuterated
1274824|NCT01694589|pancreatic cancer|pancreatic cancer
1274825|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
1274826|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
1274827|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
1274828|NCT01694563|Atrial Fibrillation|atrial fibrillation
1274829|NCT01694550|pacemaker|pacemaker
1274830|NCT01694550|ICD / CRTD|icd / crtd
1274831|NCT01694550|corrected QT-interval|corrected qt-interval
1274832|NCT01694537|lumbrokinase|lumbrokinase
1274833|NCT01694537|fibrinolytic|fibrinolytic
1274834|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
1274835|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
1274836|NCT01694537|platelet aggregation|platelet aggregation
1274837|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1274838|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
1274839|NCT01694459|angioplasty|angioplasty
1274840|NCT01694459|heparin|heparin
1274841|NCT01694459|trial|trial
1274842|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
1274843|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
1274844|NCT01694446|Pancreatic clamp|pancreatic clamp
1274845|NCT01694407|Prevention|prevention
1274846|NCT01694394|atrial fibrillation|atrial fibrillation
1274847|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
1274848|NCT01694394|left atrial enlargement|left atrial enlargement
1274849|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
1274850|NCT01694394|cardiovascular risk|cardiovascular risk
1274851|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
1274852|NCT01694381|TS01|ts01
1274853|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
1274854|NCT01694381|M5|m5
1274855|NCT01694381|C1 inhibitor|c1 inhibitor
1274856|NCT01694381|Safety|safety
1274857|NCT01694381|Stroke|stroke
1274858|NCT01694381|Tolerability|tolerability
1274859|NCT01694381|Ischemia|ischemia
1274860|NCT01694381|Cerebral Infarction|cerebral infarction
1274861|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
1274862|NCT01694381|Vascular Diseases|vascular diseases
1274863|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
1274864|NCT01694381|Brain Infarction|brain infarction
1274865|NCT01694381|Brain Ischemia|brain ischemia
1274866|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
1274867|NCT01694381|Thrombolytic Agents|thrombolytic agents
1274868|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1274869|NCT01694381|Pharmacologic Actions|pharmacologic actions
1274870|NCT01694381|Cardiovascular Agents|cardiovascular agents
1274871|NCT01694381|Therapeutic Uses|therapeutic uses
1274872|NCT01694381|Hematologic Agents|hematologic agents
1274873|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
1274874|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
1274875|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
1274876|NCT01694329|Immunization|immunization
1274877|NCT01694329|Otitis media|otitis media
1274878|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
1274879|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
1274880|NCT01694277|GIST|gist
1274881|NCT01694277|non-resectable|non-resectable
1274882|NCT01694277|metastatic|metastatic
1274883|NCT01694277|second line treatment|second line treatment
1274884|NCT01694277|resistance to imatinib|resistance to imatinib
1274885|NCT01694264|HBV surface antigen|hbv surface antigen
1274886|NCT01694264|Anti-HBc positive|anti-hbc positive
1274887|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
1274888|NCT01694264|Reactivation|reactivation
1274889|NCT01694251|mitral valve area|mitral valve area
1274890|NCT01694251|pressure half time|pressure half time
1274891|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
1274892|NCT01694251|computed tomography|computed tomography
1274893|NCT01694238|Colostomy|colostomy
1274894|NCT01694238|Surgical technique|surgical technique
1274895|NCT01694225|Breast cancer|breast cancer
1274896|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
1274897|NCT01694212|Macular edema|macular edema
1274898|NCT01694212|Cataract|cataract
1274899|NCT01694212|Diabetic retinopathy|diabetic retinopathy
1274900|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
1274901|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
1274902|NCT01694199|Pain|pain
1274903|NCT01694199|Postsurgical|postsurgical
1274904|NCT01694199|Opioids|opioids
1274905|NCT01694199|Pain relief|pain relief
1274906|NCT01694199|Medical device|medical device
1274907|NCT01694199|Endorphins|endorphins
1274908|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
1604466|NCT00377845|tampon test|tampon test
1274909|NCT01694160|kidney transplant patients|kidney transplant patients
1274910|NCT01694160|Albuminuria|albuminuria
1274911|NCT01694147|relationship|relationship
1274912|NCT01694147|endothelial injury|endothelial injury
1274913|NCT01694147|vascular permeability|vascular permeability
1274914|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
1274915|NCT01694134|Discopathy|discopathy
1274916|NCT01694134|Modic I|modic i
1274917|NCT01694134|Corticoids|corticoids
1274918|NCT01694134|Local Anaesthetic|local anaesthetic
1274919|NCT01694134|Intradiscal injection|intradiscal injection
1274920|NCT01694121|HIV prevention|hiv prevention
1274921|NCT01694121|African American men|african american men
1274922|NCT01694121|evaluation study|evaluation study
1274923|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
1274924|NCT01694082|brief intervention|brief intervention
1274925|NCT01694082|web-based interventions|web-based interventions
1274926|NCT01694082|computer-based interventions|computer-based interventions
1274927|NCT01694082|harm reduction|harm reduction
1274928|NCT01694082|young adult|young adult
1274929|NCT01694082|college student|college student
1274930|NCT01694069|piperacillin|piperacillin
1274931|NCT01694069|tazobactam|tazobactam
1274932|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
1274933|NCT01694069|cystic fibrosis|cystic fibrosis
1274934|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
1274935|NCT01694069|continuous infusion|continuous infusion
1274936|NCT01694069|beta lactam|beta lactam
1274937|NCT01694030|Attachment security priming|attachment security priming
1274938|NCT01694030|depressed mood|depressed mood
1274939|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
1274940|NCT01694004|Nutrient absorption|nutrient absorption
1274941|NCT01694004|Duodenal feeding tube|duodenal feeding tube
1274942|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
1274943|NCT01693978|PTSD|ptsd
1274944|NCT01693978|Prolonged Exposure|prolonged exposure
1274945|NCT01693978|Comorbidity|comorbidity
1274946|NCT01693978|Treatment|treatment
1274947|NCT01693978|Methadone Maintenance|methadone maintenance
1274948|NCT01693978|Substance Use Disorder|substance use disorder
1274949|NCT01693939|Lasik|lasik
1274950|NCT01693939|Myopia|myopia
1274951|NCT01693939|Femtosecond Laser|femtosecond laser
1274952|NCT01693926|Obesity|obesity
1274953|NCT01693926|Children|children
1274954|NCT01693926|Physical activity|physical activity
1274955|NCT01693926|Stress|stress
1274956|NCT01693926|Snacking|snacking
1274957|NCT01693900|joint replacement|joint replacement
1274958|NCT01693900|total hip replacement|total hip replacement
1274959|NCT01693900|regional pain block|regional pain block
1274960|NCT01693900|ultrasound guidance|ultrasound guidance
1274961|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
1274962|NCT01693887|IFI|ifi
1274963|NCT01693887|empirical therapy|empirical therapy
1274964|NCT01693887|preemptive therapy|preemptive therapy
1274965|NCT01693887|Itraconazole|itraconazole
1274966|NCT01693874|anxiety|anxiety
1274967|NCT01693874|depression|depression
1274968|NCT01693874|cognition|cognition
1274969|NCT01693874|MBSR|mbsr
1274970|NCT01693874|mindfulness|mindfulness
1274971|NCT01693874|stress|stress
1274972|NCT01693874|elderly|elderly
1274973|NCT01693861|Colorectal|colorectal
1274974|NCT01693861|Cancer|cancer
1274975|NCT01693861|Metastatic|metastatic
1275076|NCT01693484|Calcaneus|calcaneus
1274976|NCT01693861|Chronotherapy|chronotherapy
1274977|NCT01693861|Urine|urine
1274978|NCT01693861|Nucleosides|nucleosides
1274979|NCT01693861|Chemotherapy|chemotherapy
1274980|NCT01693861|Treated with chemotherapy|treated with chemotherapy
1274981|NCT01693848|Colorectal|colorectal
1274982|NCT01693848|Cancer|cancer
1274983|NCT01693848|Metastatic|metastatic
1274984|NCT01693848|Control|control
1274985|NCT01693848|Urine|urine
1274986|NCT01693848|Nucleosides|nucleosides
1274987|NCT01693848|Surgery|surgery
1274988|NCT01693848|General anesthesia|general anesthesia
1274989|NCT01693848|Scheduled for surgery|scheduled for surgery
1274990|NCT01693835|Colorectal|colorectal
1274991|NCT01693835|Cancer|cancer
1274992|NCT01693835|Metastatic|metastatic
1274993|NCT01693835|Healthy|healthy
1274994|NCT01693835|Control|control
1274995|NCT01693835|Circadian|circadian
1274996|NCT01693835|Urine|urine
1274997|NCT01693835|Nucleosides|nucleosides
1274998|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1274999|NCT01693822|predominant clear cell histology|predominant clear cell histology
1275000|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
1275001|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
1275002|NCT01693809|Caffeine|caffeine
1275003|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
1275004|NCT01693809|dizziness|dizziness
1275005|NCT01693809|vertigo|vertigo
1275006|NCT01693809|tinnitus|tinnitus
1275007|NCT01693770|Bone Metastasis|bone metastasis
1275008|NCT01693770|Pain Palliation|pain palliation
1275009|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
1275010|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
1275011|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
1275012|NCT01693757|Hop test|hop test
1275013|NCT01693757|Return to sports|return to sports
1275014|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
1275015|NCT01693731|Breast cancer|breast cancer
1275016|NCT01693731|Periodontal Diseases|periodontal diseases
1275017|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
1275018|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
1275019|NCT01693718|cancer|cancer
1275020|NCT01693718|advanced|advanced
1275021|NCT01693718|oral cavity|oral cavity
1275022|NCT01693718|larynx|larynx
1275023|NCT01693705|Tracheostomy|tracheostomy
1275024|NCT01693692|Fibromyalgia|fibromyalgia
1275025|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
1275026|NCT01693666|Pregnancy|pregnancy
1275027|NCT01693666|Obesity|obesity
1275028|NCT01693666|Weight gain|weight gain
1275029|NCT01693666|Obstetric complications|obstetric complications
1275030|NCT01693666|Lifestyle intervention|lifestyle intervention
1275031|NCT01693653|Behcet's syndrome|behcet's syndrome
1275032|NCT01693653|oral ulcers|oral ulcers
1275033|NCT01693640|Behcet's|behcet's
1275034|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
1275035|NCT01693601|Myelofibrosis|myelofibrosis
1275036|NCT01693601|Panobinostat|panobinostat
1275037|NCT01693601|Ruxolitinib|ruxolitinib
1275038|NCT01693588|Pain|pain
1275039|NCT01693588|Postoperative Pain|postoperative pain
1275040|NCT01693588|Surgical Pain|surgical pain
1275041|NCT01693588|Neurosurgical Pain|neurosurgical pain
1275042|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
1275043|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
1275044|NCT01693562|Advanced solid tumors|advanced solid tumors
1275045|NCT01693549|HER-2 negative|her-2 negative
1275046|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
1275047|NCT01693536|Elderly|elderly
1275048|NCT01693536|Sodium reduction|sodium reduction
1275049|NCT01693536|Fitness increase|fitness increase
1275050|NCT01693536|Primary Care|primary care
1275051|NCT01693523|Pancreatic Cancer|pancreatic cancer
1275052|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1275053|NCT01693523|Locally advanced|locally advanced
1275054|NCT01693523|Metastatic disease|metastatic disease
1275055|NCT01693523|Symptom reduction|symptom reduction
1275056|NCT01693523|Minocycline|minocycline
1275057|NCT01693523|Dynacin|dynacin
1275058|NCT01693523|Minocin|minocin
1275059|NCT01693523|Minocin PAC|minocin pac
1275060|NCT01693523|Myrac|myrac
1275061|NCT01693523|Solodyn|solodyn
1275062|NCT01693523|Placebo|placebo
1275063|NCT01693523|Sugar Pill|sugar pill
1275064|NCT01693523|Questionnaires|questionnaires
1275065|NCT01693523|Surveys|surveys
1275066|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
1275067|NCT01693510|Obesity|obesity
1275068|NCT01693510|Type 2 diabetes|type 2 diabetes
1275069|NCT01693510|Elevated fats in the blood|elevated fats in the blood
1275070|NCT01693510|High blood pressure|high blood pressure
1275071|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
1275072|NCT01693497|PTSD|ptsd
1275073|NCT01693497|psychotherapy|psychotherapy
1275074|NCT01693497|randomized trial|randomized trial
1275075|NCT01693497|gestalt|gestalt
1275077|NCT01693484|Fracture|fracture
1275078|NCT01693484|Indocyanine Green|indocyanine green
1275079|NCT01693484|Angiography|angiography
1275080|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
1275082|NCT01693471|SF-36|sf-36
1275083|NCT01693471|HRQOL|hrqol
1275084|NCT01693458|HIV|hiv
1275085|NCT01693458|prevention|prevention
1275086|NCT01693458|HIV-positive|hiv-positive
1275087|NCT01693458|education|education
1275088|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
1275089|NCT01693445|Oxaliplatin|oxaliplatin
1275090|NCT01693445|Irinotecan|irinotecan
1275091|NCT01693445|S-1|s-1
1275092|NCT01693432|Esophageal neoplasms|esophageal neoplasms
1275093|NCT01693432|Docetaxel|docetaxel
1275094|NCT01693432|S-1|s-1
1275095|NCT01693419|pancreas neoplasm|pancreas neoplasm
1275096|NCT01693419|gemcitabine|gemcitabine
1275097|NCT01693419|erlotinib|erlotinib
1275098|NCT01693419|S-1|s-1
1275099|NCT01693406|human milk|human milk
1275100|NCT01693406|infant growth|infant growth
1275101|NCT01693406|obesity|obesity
1275102|NCT01693406|diabetes|diabetes
1275103|NCT01693406|breastfeeding|breastfeeding
1275104|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
1275105|NCT01693393|Cyclosporine|cyclosporine
1275106|NCT01693380|Influenza|influenza
1275107|NCT01693380|Vaccination|vaccination
1275108|NCT01693380|Vaccines|vaccines
1275109|NCT01693380|Schoolchildren|schoolchildren
1275110|NCT01693380|Effectiveness|effectiveness
1275111|NCT01693380|Intervention studies|intervention studies
1275112|NCT01693380|Adolescents|adolescents
1275113|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
1275114|NCT01693367|Femoral fracture|femoral fracture
1275115|NCT01693367|Periprosthetic fracture|periprosthetic fracture
1275116|NCT01693367|Fracture fixation, internal|fracture fixation, internal
1275117|NCT01693367|Distal femur fractures|distal femur fractures
1275118|NCT01693367|Dynamic Locking Screw|dynamic locking screw
1275119|NCT01693367|WOMAC|womac
1275120|NCT01693354|dialysis|dialysis
1275121|NCT01693354|mortality|mortality
1275122|NCT01693354|cardiovascular stability|cardiovascular stability
1275123|NCT01693354|inflammation|inflammation
1275124|NCT01693354|quality of life|quality of life
1275125|NCT01693341|Chronic stroke patients|chronic stroke patients
1275126|NCT01693341|Stroke rehabilitation|stroke rehabilitation
1275127|NCT01693341|Caregiver|caregiver
1275128|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
1275129|NCT01693328|quality of life|quality of life
1275130|NCT01693328|PecFent|pecfent
1275131|NCT01693328|Lazanda|lazanda
1275132|NCT01693328|fentanyl|fentanyl
1275133|NCT01693328|intranasal|intranasal
1275134|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
1275135|NCT01693302|Blood Glucose|blood glucose
1275136|NCT01693302|Meal insulin|meal insulin
1275137|NCT01693289|Metformin|metformin
1275138|NCT01693289|letrozole|letrozole
1275139|NCT01693289|ovarian drilling|ovarian drilling
1275140|NCT01693289|clomiphene resistance|clomiphene resistance
1275141|NCT01693289|polycystic ovary.|polycystic ovary.
1275142|NCT01693276|pancreatic cancer|pancreatic cancer
1275143|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
1275144|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
1275243|NCT01692834|Sandimmun|sandimmun
1275145|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
1275146|NCT01693263|dialysis|dialysis
1275147|NCT01693250|technology|technology
1275148|NCT01693250|healthy weight management|healthy weight management
1275149|NCT01693250|primary care setting|primary care setting
1275150|NCT01693224|Tests, Diagnostic|tests, diagnostic
1275151|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
1275152|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
1275153|NCT01693224|TB|tb
1275154|NCT01693224|Tuberculosis|tuberculosis
1275155|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1275156|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
1275157|NCT01693224|Lipoarabinomannan|lipoarabinomannan
1275158|NCT01693211|femtosecond laser|femtosecond laser
1275159|NCT01693211|cataract|cataract
1275160|NCT01693211|control study|control study
1275161|NCT01693211|prospective|prospective
1275162|NCT01693198|allergy|allergy
1275163|NCT01693198|cyanobacteria|cyanobacteria
1275164|NCT01693198|sweet water swimming|sweet water swimming
1275165|NCT01693185|colonoscopy|colonoscopy
1275166|NCT01693185|remifentanil|remifentanil
1275167|NCT01693185|midazolam|midazolam
1275168|NCT01693185|meperidine|meperidine
1275169|NCT01693172|exercise|exercise
1275170|NCT01693172|neoplasm|neoplasm
1275171|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
1275172|NCT01693159|Radioimmunotherapy|radioimmunotherapy
1275173|NCT01693159|Head and neck cancer|head and neck cancer
1275174|NCT01693146|Oxygen|oxygen
1275175|NCT01693146|High Flow|high flow
1275176|NCT01693146|COPD|copd
1275177|NCT01693146|Hypercapnia|hypercapnia
1275178|NCT01693120|ablation|ablation
1275179|NCT01693120|atrial fibrillation|atrial fibrillation
1275180|NCT01693120|Radio frequency|radio frequency
1275181|NCT01693107|Atrial Fibrillation|atrial fibrillation
1275182|NCT01693107|Catheter Ablation|catheter ablation
1275183|NCT01693107|Electrophysiology|electrophysiology
1275184|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
1275185|NCT01693081|Parkinson's disease|parkinson's disease
1275186|NCT01693081|inhaled apomorphine|inhaled apomorphine
1275187|NCT01693081|"convert off to on"|"convert off to on"
1275188|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
1275189|NCT01693068|Dacarbazine|dacarbazine
1275190|NCT01693068|Pimasertib|pimasertib
1275191|NCT01693068|N-Ras|n-ras
1275192|NCT01693055|orbital Computed Tomography|orbital computed tomography
1275193|NCT01693055|baggy eyelids|baggy eyelids
1275194|NCT01693055|orbital fat prolapse|orbital fat prolapse
1275195|NCT01693055|UltheraTM|ultheratm
1275196|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
1275197|NCT01693042|heart failure|heart failure
1275198|NCT01693042|old myocardial infarction|old myocardial infarction
1275199|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
1275200|NCT01693042|chronic|chronic
1275201|NCT01693042|ischemic|ischemic
1275202|NCT01693029|erythropoietin alfa|erythropoietin alfa
1275203|NCT01693029|CKD 5d|ckd 5d
1275204|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
1275205|NCT01693003|COPD|copd
1275206|NCT01692990|Appetite|appetite
1275207|NCT01692990|Fish oil|fish oil
1275208|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
1275209|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
1275210|NCT01692912|Randomized|randomized
1275211|NCT01692912|Single blind|single blind
1275212|NCT01692912|Treat to target|treat to target
1275213|NCT01692899|Retention Rates|retention rates
1275214|NCT01692899|of Adalimumab|of adalimumab
1275215|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
1275216|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
1275217|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
1275218|NCT01692899|in Daily Practice.|in daily practice.
1275219|NCT01692899|TNF inhibitors|tnf inhibitors
1275220|NCT01692899|biotherapy|biotherapy
1275221|NCT01692899|retrospective study|retrospective study
1275222|NCT01692886|13vPnC|13vpnc
1275223|NCT01692886|7vPnC|7vpnc
1275224|NCT01692886|Healthy subjects|healthy subjects
1275225|NCT01692886|China|china
1275226|NCT01692873|pancreatic tumor|pancreatic tumor
1275227|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
1275228|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
1275229|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
1275230|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
1275231|NCT01692847|patient deterioration|patient deterioration
1275232|NCT01692847|rapid response teams|rapid response teams
1275233|NCT01692847|acute care teams|acute care teams
1275234|NCT01692847|early warning scoring|early warning scoring
1275235|NCT01692834|bioequivalence|bioequivalence
1275236|NCT01692834|pharmacokinetics|pharmacokinetics
1275237|NCT01692834|tolerability|tolerability
1275238|NCT01692834|safety|safety
1275239|NCT01692834|ciclosporin|ciclosporin
1275240|NCT01692834|cyclosporine|cyclosporine
1275241|NCT01692834|cyclosporine A|cyclosporine a
1275242|NCT01692834|Sandimmune|sandimmune
1275244|NCT01692834|CicloMulsion|ciclomulsion
1275245|NCT01692834|NeuroSTAT|neurostat
1275246|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
1275247|NCT01692821|retinal blood flow|retinal blood flow
1275248|NCT01692821|hyperoxia|hyperoxia
1275249|NCT01692821|hypoxia|hypoxia
1275250|NCT01692808|Crohn|crohn
1275251|NCT01692808|vitamin D|vitamin d
1275252|NCT01692808|remission|remission
1275253|NCT01692808|inflammation|inflammation
1275254|NCT01692808|tolerance|tolerance
1275255|NCT01692795|Myocardial infarction|myocardial infarction
1275256|NCT01692795|Antiplatelets|antiplatelets
1275257|NCT01692795|Lipid lowering agents|lipid lowering agents
1275258|NCT01692795|ACE inhibitors|ace inhibitors
1275259|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
1275260|NCT01692795|Beta blockers|beta blockers
1275261|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
1275262|NCT01692782|ADHD|adhd
1275263|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1275264|NCT01692769|Trauma|trauma
1275265|NCT01692769|Pediatric|pediatric
1275266|NCT01692769|Intravenous Fluid|intravenous fluid
1275267|NCT01692769|Normal Saline|normal saline
1275268|NCT01692769|Ringer's Lactate|ringer's lactate
1275269|NCT01692743|Telemedicine|telemedicine
1275270|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
1275271|NCT01692743|Crohn's disease|crohn's disease
1275272|NCT01692743|Ulcerative colitis|ulcerative colitis
1275273|NCT01692743|Quality of life|quality of life
1275274|NCT01692743|Health care utilization|health care utilization
1275275|NCT01692730|Smoking Cessation|smoking cessation
1275276|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
1275277|NCT01692691|Melanoma Metastatic|melanoma metastatic
1275278|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
1275279|NCT01692678|Sarcoma|sarcoma
1275280|NCT01692678|L-sarcoma|l-sarcoma
1275281|NCT01692678|Liposarcoma|liposarcoma
1275282|NCT01692678|Leiomyosarcoma|leiomyosarcoma
1275283|NCT01692678|Trabectedin|trabectedin
1275284|NCT01692678|Dacarbazine|dacarbazine
1275285|NCT01692678|Yondelis|yondelis
1275286|NCT01692678|Chinese patients|chinese patients
1275287|NCT01692678|Overall survival|overall survival
1275288|NCT01692678|Pharmacokinetics|pharmacokinetics
1275289|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
1275290|NCT01692665|keratometric value|keratometric value
1275291|NCT01692665|ocular aberration|ocular aberration
1275292|NCT01692626|Cetuximab rash|cetuximab rash
1275293|NCT01692626|Erbitux rash|erbitux rash
1275294|NCT01692626|Rash|rash
1275295|NCT01692626|Pimecrolimus|pimecrolimus
1275296|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
1275297|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
1275298|NCT01692600|head and neck cancer patients|head and neck cancer patients
1275299|NCT01692600|optical coherence tomography|optical coherence tomography
1275300|NCT01692600|subsurface imaging|subsurface imaging
1275301|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
1275302|NCT01692600|vascular imaging|vascular imaging
1275303|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
1275304|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
1275306|NCT01692587|protein|protein
1275307|NCT01692587|prostate|prostate
1275308|NCT01692574|depression and obesity treatment|depression and obesity treatment
1275309|NCT01692561|Dysautonomia|dysautonomia
1275310|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
1275311|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
1275312|NCT01692509|Non invasive ventilation|non invasive ventilation
1275313|NCT01692509|Respiratory failure|respiratory failure
1275314|NCT01692509|Respiratory comfort|respiratory comfort
1275315|NCT01692496|Advanced|advanced
1275316|NCT01692496|Metastatic|metastatic
1275317|NCT01692496|Liposarcoma|liposarcoma
1275318|NCT01692496|Pazopanib|pazopanib
1275319|NCT01692483|Prostate neoplasms|prostate neoplasms
1275320|NCT01692483|Prostate cancer|prostate cancer
1275321|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
1275322|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
1275323|NCT01692483|Abiraterone acetate|abiraterone acetate
1275324|NCT01692483|Taxane|taxane
1275325|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
1275326|NCT01692470|HIV-1|hiv-1
1275327|NCT01692470|Anti-retroviral naive|anti-retroviral naive
1275328|NCT01692470|ARV|arv
1275329|NCT01692470|Filipino patients|filipino patients
1275330|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
1275331|NCT01692470|Edurant|edurant
1275332|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
1275333|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
1275334|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
1275335|NCT01692457|Arthritis|arthritis
1275336|NCT01692457|Spondylitis|spondylitis
1275337|NCT01692457|Joint pain|joint pain
1275338|NCT01692457|CNTO148|cnto148
1275339|NCT01692457|Golimumab|golimumab
1275340|NCT01692457|Simponi|simponi
1275341|NCT01692457|Filipino|filipino
1275342|NCT01692457|Post-Marketing|post-marketing
1275343|NCT01692457|Surveillance|surveillance
1275344|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1275345|NCT01692444|Fibrosis|fibrosis
1275346|NCT01692444|Fibroblast|fibroblast
1275347|NCT01692444|Lung attenuation|lung attenuation
1275348|NCT01692444|Pletysmography|pletysmography
1275349|NCT01692418|Anaemia|anaemia
1275350|NCT01692418|Blood transfusion|blood transfusion
1275351|NCT01692418|Surgery|surgery
1275352|NCT01692418|Iron|iron
1275353|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
1275354|NCT01692392|Pectus carinatum|pectus carinatum
1275355|NCT01692392|Quality of life|quality of life
1275356|NCT01692392|Pain, postoperative|pain, postoperative
1275357|NCT01692392|Somatosensory disorders|somatosensory disorders
1275358|NCT01692379|Acute ischemic stroke|acute ischemic stroke
1275359|NCT01692379|endovascular treatment|endovascular treatment
1275360|NCT01692379|clinical trial|clinical trial
1275361|NCT01692353|Flow mediated dilation|flow mediated dilation
1275362|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
1275363|NCT01692353|Ankle-brachial index|ankle-brachial index
1275364|NCT01692353|Smokeless tobacco|smokeless tobacco
1275365|NCT01692353|Biological markers|biological markers
1275366|NCT01692353|Nicotine|nicotine
1275367|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
1275368|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
1275369|NCT01692353|Aromatic amines|aromatic amines
1275370|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
1275371|NCT01692353|Cholesterol|cholesterol
1275372|NCT01692353|Blood lipids|blood lipids
1275373|NCT01692353|Oxidative stress|oxidative stress
1275379|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
1275380|NCT01692327|Control (20)|control (20)
1275381|NCT01692314|Endothelial function|endothelial function
1275382|NCT01692314|Microvascular reactivity|microvascular reactivity
1275383|NCT01692314|Obesity|obesity
1275384|NCT01692314|Adolescents|adolescents
1275385|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
1275512|NCT01691716|Tendoactive|tendoactive
1275386|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
1275387|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
1275388|NCT01692262|prostate cancer,|prostate cancer,
1275389|NCT01692262|progressive disease,|progressive disease,
1275390|NCT01692262|advanced disease.|advanced disease.
1275391|NCT01692249|chronic shoulder pain|chronic shoulder pain
1275392|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
1275393|NCT01692249|sap therapy|sap therapy
1275394|NCT01692249|balneotherapy|balneotherapy
1275400|NCT01692223|Personal genomics|personal genomics
1275401|NCT01692223|Genome Sequencing Results|genome sequencing results
1275402|NCT01692223|12-167|12-167
1275403|NCT01692210|Breast Cancer|breast cancer
1275404|NCT01692210|Dexmedetomidine|dexmedetomidine
1275405|NCT01692210|Unilateral mastectomy|unilateral mastectomy
1275406|NCT01692210|Blood sample collections|blood sample collections
1275407|NCT01692210|Immune system|immune system
1275408|NCT01692210|White blood cell levels|white blood cell levels
1275409|NCT01692197|Leukemia|leukemia
1275410|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
1275411|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
1275412|NCT01692197|AML|aml
1275413|NCT01692197|Relapsed or Refractory|relapsed or refractory
1275414|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
1275415|NCT01692197|HRMDS|hrmds
1275416|NCT01692197|E7070|e7070
1275417|NCT01692197|Idarubicin|idarubicin
1275418|NCT01692197|Idamycin|idamycin
1275419|NCT01692197|Cytarabine|cytarabine
1275420|NCT01692197|ARA-C|ara-c
1275421|NCT01692197|Cytosar|cytosar
1275422|NCT01692197|DepoCyt|depocyt
1275423|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1275424|NCT01692197|Dexamethasone|dexamethasone
1275425|NCT01692197|Decadron|decadron
1275426|NCT01692184|AVL-292|avl-292
1275427|NCT01692184|Safety|safety
1275428|NCT01692184|Pharmacokinetics|pharmacokinetics
1275429|NCT01692184|Pharmacodynamics|pharmacodynamics
1275430|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
1275431|NCT01692171|Subjects|subjects
1275432|NCT01692158|subjects|subjects
1275433|NCT01692145|Dry eye syndromes|dry eye syndromes
1275434|NCT01692145|Corneal diseases|corneal diseases
1275435|NCT01692145|Conjunctival diseases|conjunctival diseases
1275436|NCT01692132|Chronic Constipation|chronic constipation
1275437|NCT01692132|Prucalopride|prucalopride
1275438|NCT01692132|Post Marketing Surveillance|post marketing surveillance
1275439|NCT01692119|chronic heart failure|chronic heart failure
1275440|NCT01692119|medication adherence|medication adherence
1275441|NCT01692119|pharmacy|pharmacy
1275442|NCT01692119|interdisciplinary care|interdisciplinary care
1275443|NCT01692119|randomized controlled trial|randomized controlled trial
1275444|NCT01692119|mortality|mortality
1275445|NCT01692119|hospitalization|hospitalization
1275643|NCT01691209|efficacy|efficacy
1275446|NCT01692106|Heller myotomy|heller myotomy
1275447|NCT01692093|SCORAD|scorad
1275448|NCT01692093|Atopic dermatits|atopic dermatits
1275449|NCT01692093|Skin health|skin health
1275450|NCT01692067|Rape|rape
1275451|NCT01692067|Women|women
1275452|NCT01692067|Military|military
1275453|NCT01692067|Veterans|veterans
1275454|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
1275455|NCT01692067|Traumatic Brain Injury|traumatic brain injury
1275456|NCT01692041|asthma|asthma
1275457|NCT01692041|children|children
1275458|NCT01692028|vitamin D|vitamin d
1275459|NCT01692028|Associational study|associational study
1275460|NCT01691976|Mild cognitive impairment|mild cognitive impairment
1275461|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
1275462|NCT01691963|Epiglottis|epiglottis
1275463|NCT01691963|Intubation|intubation
1275464|NCT01691963|Laryngoscopy|laryngoscopy
1275465|NCT01691950|Trauma|trauma
1275466|NCT01691950|Limb reconstruction|limb reconstruction
1275467|NCT01691950|Amputation|amputation
1275468|NCT01691950|Functional outcome|functional outcome
1275469|NCT01691950|Sensing|sensing
1275470|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
1275471|NCT01691937|Postoperative pain|postoperative pain
1275472|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
1275473|NCT01691937|Patient controlled analgesia|patient controlled analgesia
1275474|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
1275475|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
1275477|NCT01691911|Vascular disease|vascular disease
1275478|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
1275479|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
1275480|NCT01691911|Carotid endartrectomy|carotid endartrectomy
1275481|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
1275482|NCT01691911|Major lower limb amputation|major lower limb amputation
1275483|NCT01691859|extension study|extension study
1275484|NCT01691859|Severe refractory asthma|severe refractory asthma
1275485|NCT01691859|safety|safety
1275486|NCT01691859|SB-240563|sb-240563
1275487|NCT01691859|mepolizumab|mepolizumab
1275488|NCT01691859|eosinophils|eosinophils
1275489|NCT01691833|Vitamin D|vitamin d
1275490|NCT01691833|nonunion|nonunion
1275491|NCT01691833|long bone fracture|long bone fracture
1275492|NCT01691833|hypovitaminosis D|hypovitaminosis d
1275493|NCT01691820|Adolescent females|adolescent females
1275494|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
1275495|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1275496|NCT01691807|drug-drug interaction|drug-drug interaction
1275497|NCT01691807|ofatumumab|ofatumumab
1275498|NCT01691807|bendamustine|bendamustine
1275499|NCT01691781|Hyperparathyroidism|hyperparathyroidism
1275500|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1275501|NCT01691781|ACE inhibitors|ace inhibitors
1275502|NCT01691768|microbicides|microbicides
1275503|NCT01691768|women|women
1275504|NCT01691768|HIV prevention|hiv prevention
1275505|NCT01691768|PrEP|prep
1275506|NCT01691768|Tenofovir gel|tenofovir gel
1605441|NCT00374920|mixed|mixed
1275507|NCT01691742|Postoperative constipation|postoperative constipation
1275508|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
1275509|NCT01691742|MiraLax|miralax
1275510|NCT01691742|Docusate Sodium|docusate sodium
1275511|NCT01691716|Achilles tendinopathy|achilles tendinopathy
1275513|NCT01691716|Eccentric training|eccentric training
1275514|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
1275515|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
1275516|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
1275517|NCT01691664|Esophageal Cancer|esophageal cancer
1275518|NCT01691664|DC-CIK|dc-cik
1275519|NCT01691664|immunotherapy|immunotherapy
1275520|NCT01691664|cellular therapy|cellular therapy
1275521|NCT01691664|radiation therapy|radiation therapy
1275522|NCT01691651|Keratoconus|keratoconus
1275523|NCT01691651|Tetanus toxin|tetanus toxin
1275524|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
1275525|NCT01691625|DC-CIK|dc-cik
1275526|NCT01691625|Immunotherapy|immunotherapy
1275527|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
1275528|NCT01691599|Infection|infection
1275529|NCT01691599|Open tibia fractures|open tibia fractures
1275530|NCT01691599|Closed tibia fractures|closed tibia fractures
1275531|NCT01691599|Wound infection|wound infection
1275532|NCT01691586|implantable defibrillators|implantable defibrillators
1275533|NCT01691586|remote patient monitoring|remote patient monitoring
1275534|NCT01691586|patient-reported outcomes|patient-reported outcomes
1275535|NCT01691586|cost-effectiveness|cost-effectiveness
1275536|NCT01691573|ablation|ablation
1275537|NCT01691573|procedure|procedure
1275538|NCT01691573|pediatric|pediatric
1275539|NCT01691573|european|european
1275540|NCT01691573|cardiac|cardiac
1275541|NCT01691573|arrhythmias|arrhythmias
1275542|NCT01691573|registry|registry
1275543|NCT01691573|observational|observational
1275544|NCT01691573|prospective|prospective
1275545|NCT01691573|catheter|catheter
1275546|NCT01691573|cryoablation|cryoablation
1275547|NCT01691573|atrioventricular|atrioventricular
1275548|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
1275549|NCT01691547|pharmacokinetics|pharmacokinetics
1275550|NCT01691547|pharmacodynamics|pharmacodynamics
1275551|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
1275552|NCT01691547|healthy subjects|healthy subjects
1275553|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
1275554|NCT01691534|Tuberculosis|tuberculosis
1275555|NCT01691534|EBA|eba
1275556|NCT01691534|PA824|pa824
1275557|NCT01691534|pretomanid|pretomanid
1275558|NCT01691534|TMC207|tmc207
1275559|NCT01691521|safety|safety
1275560|NCT01691521|SB-240563|sb-240563
1275561|NCT01691521|efficacy|efficacy
1275562|NCT01691521|placebo|placebo
1275563|NCT01691521|eosinophils|eosinophils
1275564|NCT01691521|mepolizumab|mepolizumab
1275565|NCT01691521|Severe refractory asthma|severe refractory asthma
1275566|NCT01691508|Safety|safety
1275567|NCT01691508|Steroid Reduction|steroid reduction
1275568|NCT01691508|Efficacy|efficacy
1275569|NCT01691508|SB-240563|sb-240563
1275570|NCT01691508|Eosinophils|eosinophils
1275571|NCT01691508|Quality of Life|quality of life
1275572|NCT01691508|Mepolizumab|mepolizumab
1275573|NCT01691508|Severe Refractory Asthma|severe refractory asthma
1275574|NCT01691495|Physician Adherence|physician adherence
1275575|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
1275576|NCT01691495|Fondaparinux|fondaparinux
1275577|NCT01691469|Bioequivalence|bioequivalence
1275578|NCT01691469|Montelukast Sodium|montelukast sodium
1275579|NCT01691469|crossover|crossover
1275580|NCT01691456|Bioequivalence|bioequivalence
1275581|NCT01691456|Montelukast Sodium|montelukast sodium
1275582|NCT01691456|crossover|crossover
1275583|NCT01691404|Flavonoids|flavonoids
1275584|NCT01691404|Quercetin|quercetin
1275585|NCT01691404|Epicatechin|epicatechin
1275586|NCT01691404|Vascular function|vascular function
1275587|NCT01691404|Blood pressure|blood pressure
1275588|NCT01691404|Endothelial function|endothelial function
1275589|NCT01691391|Advanced CRC|advanced crc
1275590|NCT01691378|Veterans|veterans
1275591|NCT01691378|Window to Hope|window to hope
1275592|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
1275593|NCT01691378|Traumatic Brain Injury|traumatic brain injury
1275594|NCT01691378|Hopelessness|hopelessness
1275595|NCT01691378|Suicide|suicide
1275596|NCT01691365|Antioxidant|antioxidant
1275597|NCT01691365|vitamins|vitamins
1275598|NCT01691365|Diet|diet
1275599|NCT01691352|Wound infection|wound infection
1275600|NCT01691352|Ostomy reversal|ostomy reversal
1275601|NCT01691339|Influenza|influenza
1275602|NCT01691339|Influenza virus vaccine|influenza virus vaccine
1275603|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
1275604|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
1275605|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1333177|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
1275606|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
1275607|NCT01691326|Influenza|influenza
1275608|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
1275609|NCT01691326|Influenza virus vaccine|influenza virus vaccine
1275610|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1275611|NCT01691313|vanoxerine|vanoxerine
1275612|NCT01691313|atrial fibrillation|atrial fibrillation
1275613|NCT01691313|atrial flutter|atrial flutter
1275614|NCT01691313|a-fib|a-fib
1275615|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
1275616|NCT01691300|Multiple myeloma|multiple myeloma
1275617|NCT01691300|Pretreatment staging|pretreatment staging
1275618|NCT01691300|Response assessment|response assessment
1275619|NCT01691287|Type 1 Diabetes|type 1 diabetes
1275620|NCT01691287|Metabolic Control|metabolic control
1275621|NCT01691287|Quality of Life|quality of life
1275622|NCT01691274|Epilepsy|epilepsy
1275623|NCT01691274|Phase 1|phase 1
1275624|NCT01691274|Multiple Dose|multiple dose
1275625|NCT01691274|Safety|safety
1275626|NCT01691274|Pharmacokinetics|pharmacokinetics
1275627|NCT01691274|Toleration|toleration
1275628|NCT01691248|Clostridium difficile|clostridium difficile
1275629|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
1275630|NCT01691248|Prophylaxis|prophylaxis
1275631|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1275632|NCT01691235|SIMpill|simpill
1275633|NCT01691235|HCV|hcv
1275634|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
1275635|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
1275636|NCT01691222|Intensive Care Unit|intensive care unit
1275637|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
1275638|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
1275639|NCT01691222|weaning failure|weaning failure
1275640|NCT01691209|Phoenix|phoenix
1275641|NCT01691209|Hydrocortison|hydrocortison
1275642|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
1275644|NCT01691209|safety|safety
1275645|NCT01691196|Obesity|obesity
1275646|NCT01691196|Peritoneal dialysis|peritoneal dialysis
1275647|NCT01691196|Inflammation|inflammation
1275648|NCT01691196|Macrophages|macrophages
1275649|NCT01691196|Innate immunity|innate immunity
1275650|NCT01691183|Hertel|hertel
1275651|NCT01691183|exophthalmometer|exophthalmometer
1275652|NCT01691183|proptosis|proptosis
1275653|NCT01691183|eye disease|eye disease
1275654|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
1275655|NCT01691170|Stretching|stretching
1275656|NCT01691170|Strengthening|strengthening
1275657|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
1275658|NCT01691157|Rotator cuff|rotator cuff
1275659|NCT01691157|Exercise|exercise
1275660|NCT01691157|Physiotherapy|physiotherapy
1275661|NCT01691144|cancer|cancer
1275662|NCT01691144|gynecological|gynecological
1275663|NCT01691144|expectations|expectations
1275664|NCT01691144|satisfaction|satisfaction
1275665|NCT01691144|cooperation|cooperation
1275666|NCT01691131|Physical activity in daily life|physical activity in daily life
1275667|NCT01691131|Balance|balance
1275668|NCT01691131|COPD|copd
1275669|NCT01691131|Exercise training|exercise training
1275670|NCT01691118|Hypertension|hypertension
1275775|NCT01690559|Ciprofloxacin|ciprofloxacin
1275671|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
1275672|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
1275673|NCT01691105|Tobacco Use Cessation|tobacco use cessation
1275674|NCT01691105|Smoking Cessation|smoking cessation
1275675|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
1275676|NCT01691105|Hospitalized Smokers|hospitalized smokers
1275677|NCT01691092|Depression|depression
1275678|NCT01691092|Ketamine|ketamine
1275679|NCT01691092|PET|pet
1275680|NCT01691092|PTSD|ptsd
1275681|NCT01691053|End stage renal disease|end stage renal disease
1275682|NCT01691053|Hemodialysis|hemodialysis
1275683|NCT01691053|Spironolactone|spironolactone
1275684|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
1275685|NCT01691040|Hepcidin|hepcidin
1275686|NCT01691040|Iron|iron
1275687|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
1275688|NCT01691040|Anemia|anemia
1275689|NCT01691040|Cancer|cancer
1275690|NCT01691040|Interleukin-6|interleukin-6
1275691|NCT01691040|Iron restriction|iron restriction
1275692|NCT01691040|Lymphoma|lymphoma
1275693|NCT01691040|CLL|cll
1275694|NCT01691040|Multiple Myeloma|multiple myeloma
1275695|NCT01691040|Hodgkin|hodgkin
1275696|NCT01691040|anti-hepcidin|anti-hepcidin
1275697|NCT01691027|scotoma, central|scotoma, central
1275698|NCT01691027|visual motor coordination|visual motor coordination
1275699|NCT01690988|Delirium|delirium
1275700|NCT01690988|ketamine|ketamine
1275701|NCT01690988|surgery|surgery
1275702|NCT01690988|neurological complications|neurological complications
1333178|NCT01444170|isometric strength|isometric strength
1275703|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
1275704|NCT01690949|inflammation|inflammation
1275705|NCT01690949|COPD|copd
1275706|NCT01690949|respiratory disease|respiratory disease
1275707|NCT01690949|healthy volunteers|healthy volunteers
1275708|NCT01690936|Almonds|almonds
1275709|NCT01690936|Body weight|body weight
1275710|NCT01690936|Snacking|snacking
1275711|NCT01690910|Ventilator|ventilator
1275712|NCT01690910|Mobility Limitations|mobility limitations
1275713|NCT01690910|Critical Care|critical care
1275714|NCT01690910|Rifton Gait Trainer|rifton gait trainer
1275715|NCT01690897|Female sexual desire|female sexual desire
1275716|NCT01690897|Psychoeducational intervention|psychoeducational intervention
1275717|NCT01690897|Mindfulness|mindfulness
1275718|NCT01690884|Adenosine|adenosine
1275719|NCT01690884|Ticagrelor|ticagrelor
1275720|NCT01690884|Microdialysis|microdialysis
1275721|NCT01690871|Malignant PEComa|malignant pecoma
1275722|NCT01690871|Angiomyolipoma|angiomyolipoma
1275723|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
1275724|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
1275725|NCT01690858|Foetal loss|foetal loss
1275726|NCT01690858|complement|complement
1275727|NCT01690858|antiangiogenic factors|antiangiogenic factors
1275728|NCT01690858|Repeated fetal losses|repeated fetal losses
1275729|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
1275730|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1275731|NCT01690819|Acute Brain Injury|acute brain injury
1275732|NCT01690793|ASTHMA|asthma
1275733|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
1275734|NCT01690780|fracture|fracture
1275735|NCT01690780|pediatric|pediatric
1275736|NCT01690780|oral morphine|oral morphine
1275737|NCT01690780|ibuprofen|ibuprofen
1275738|NCT01690767|Urethral catheterization|urethral catheterization
1275739|NCT01690767|Lidocaine|lidocaine
1275740|NCT01690754|SMS|sms
1275741|NCT01690754|tuberculosis|tuberculosis
1275742|NCT01690754|impact evaluation|impact evaluation
1275743|NCT01690741|Cancer|cancer
1275744|NCT01690741|Malignancy|malignancy
1276054|NCT01689389|Xeroquel|xeroquel
1275745|NCT01690741|Solid tumors|solid tumors
1275746|NCT01690728|Obesity|obesity
1275747|NCT01690728|Gastric bypass|gastric bypass
1275748|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
1275749|NCT01690715|Thrombosis|thrombosis
1275750|NCT01690715|Portal Vein Invasion|portal vein invasion
1275751|NCT01690702|breast cancer|breast cancer
1275752|NCT01690702|tailored|tailored
1275753|NCT01690702|high-risk|high-risk
1275754|NCT01690676|FMD|fmd
1275755|NCT01690676|epicatechin|epicatechin
1275756|NCT01690676|apple polyphenol|apple polyphenol
1275757|NCT01690676|borderline hypertension|borderline hypertension
1275758|NCT01690650|Preterm|preterm
1275759|NCT01690650|Newborn|newborn
1275760|NCT01690650|Neonate|neonate
1275761|NCT01690650|Cerebral oxygenation|cerebral oxygenation
1275762|NCT01690650|Oxygen|oxygen
1275763|NCT01690637|Oseltamivir|oseltamivir
1275764|NCT01690637|Tamiflu|tamiflu
1275765|NCT01690611|Balance Training|balance training
1275766|NCT01690611|Walking|walking
1275767|NCT01690611|Falls|falls
1275768|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
1275769|NCT01690598|BRCA mutation|brca mutation
1275770|NCT01690598|Platinum resistant|platinum resistant
1275771|NCT01690598|Platinum sensitive|platinum sensitive
1275772|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
1275773|NCT01690572|drug eluting balloon|drug eluting balloon
1275774|NCT01690572|constrictive remodeling|constrictive remodeling
1275776|NCT01690559|sepsis|sepsis
1275777|NCT01690559|infection|infection
1275778|NCT01690559|pneumonia|pneumonia
1275779|NCT01690559|peritonitis|peritonitis
1275780|NCT01690559|cholecystitis|cholecystitis
1275781|NCT01690559|cholangitis|cholangitis
1275782|NCT01690559|anthrax|anthrax
1275783|NCT01690546|Opioid Addiction|opioid addiction
1275784|NCT01690546|Addiction|addiction
1275785|NCT01690546|Drug Dependence|drug dependence
1275786|NCT01690533|Avelox|avelox
1275787|NCT01690533|Laryngopharyngitis|laryngopharyngitis
1275788|NCT01690533|Tonsillitis|tonsillitis
1275789|NCT01690533|Bronchitis acute|bronchitis acute
1275790|NCT01690533|Pneumonia|pneumonia
1275791|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
1275792|NCT01690507|demethylating agent|demethylating agent
1275793|NCT01690507|immunogenicity|immunogenicity
1275794|NCT01690494|STI|sti
1275795|NCT01690494|sexually transmitted infection|sexually transmitted infection
1275796|NCT01690494|HIV|hiv
1275797|NCT01690494|criminal justice|criminal justice
1275798|NCT01690494|probation|probation
1275799|NCT01690494|couples|couples
1275800|NCT01690494|drug use|drug use
1275801|NCT01690442|HIV|hiv
1275802|NCT01690442|AIDS|aids
1275803|NCT01690442|Prevention|prevention
1275804|NCT01690429|Arousal detection|arousal detection
1275805|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
1275806|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
1275807|NCT01690429|Daytime sleepiness|daytime sleepiness
1275808|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
1275809|NCT01690377|Dendritic Cells|dendritic cells
1275810|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
1275811|NCT01690364|General Anesthesia|general anesthesia
1275812|NCT01690364|Neurosurgery|neurosurgery
1275813|NCT01690364|Cisatracurium|cisatracurium
1275814|NCT01690364|Vecuronium|vecuronium
1275815|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
1275816|NCT01690338|airway extubation|airway extubation
1275817|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
1275818|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
1275819|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1275820|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
1275821|NCT01690325|Bevacizumab|bevacizumab
1275822|NCT01690325|PET|pet
1275823|NCT01690312|Humans|humans
1275824|NCT01690312|Cardiovascular Disease|cardiovascular disease
1275825|NCT01690312|Statins|statins
1275826|NCT01690312|Fish Oil|fish oil
1275827|NCT01690312|DHA|dha
1275828|NCT01690312|EPA|epa
1275829|NCT01690312|High-DHA|high-dha
1275830|NCT01690312|Triglycerides|triglycerides
1275831|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
1275832|NCT01690312|Lipoproteins|lipoproteins
1275833|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
1275834|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
1275835|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
1275836|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
1275837|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
1275838|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
1275839|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
1275840|NCT01690312|Homocysteine|homocysteine
1275841|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
1275842|NCT01690312|Apolipoprotein B|apolipoprotein b
1275843|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
1275844|NCT01690312|Glucose|glucose
1275845|NCT01690312|Insulin|insulin
1275846|NCT01690312|Fasted|fasted
1275847|NCT01690312|Post-Prandial|post-prandial
1275848|NCT01690299|Psoriasis|psoriasis
1275849|NCT01690299|arthritis|arthritis
1275850|NCT01690299|psoriatic|psoriatic
1275851|NCT01690299|palmoplantar|palmoplantar
1275852|NCT01690299|scalp|scalp
1275853|NCT01690299|psoriasis pill|psoriasis pill
1275854|NCT01690299|psoriasis tablet|psoriasis tablet
1275855|NCT01690299|plaque psoriasis|plaque psoriasis
1275856|NCT01690299|plaque type psoriasis|plaque type psoriasis
1275857|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
1275858|NCT01690299|psoriatic arthritis|psoriatic arthritis
1275859|NCT01690286|Healthy|healthy
1275860|NCT01690286|Ketoconazole|ketoconazole
1275861|NCT01690286|JNJ-38518168|jnj-38518168
1275862|NCT01690286|Pharmacokinetics|pharmacokinetics
1275863|NCT01690273|exercise|exercise
1275864|NCT01690273|mobility|mobility
1275865|NCT01690273|strengthening|strengthening
1275866|NCT01690273|physiotherapy|physiotherapy
1275867|NCT01690260|Bone|bone
1275868|NCT01690260|Morphogenetic|morphogenetic
1275869|NCT01690260|Protein|protein
1275870|NCT01690260|Ilizarow|ilizarow
1275871|NCT01690260|Autologous|autologous
1275872|NCT01690260|Osteoarthritis|osteoarthritis
1275873|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
1275874|NCT01690247|liver transplantation|liver transplantation
1275875|NCT01690247|clinical trial|clinical trial
1275876|NCT01690247|rejection|rejection
1275877|NCT01690234|Low back pain|low back pain
1275878|NCT01690234|Return to work|return to work
1275879|NCT01690234|Sickness absence|sickness absence
1275880|NCT01690234|Rehabilitation|rehabilitation
1275881|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
1275882|NCT01690221|Anal|anal
1275883|NCT01690221|Fissure|fissure
1275884|NCT01690221|Pain|pain
1275885|NCT01690208|Diabetes|diabetes
1275886|NCT01690208|Structure Care|structure care
1275887|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
1275888|NCT01690182|MRI|mri
1275889|NCT01690182|gastric volumes|gastric volumes
1275890|NCT01690182|satiety|satiety
1275891|NCT01690156|In-plane|in-plane
1275892|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
1275893|NCT01690156|Probe position|probe position
1275894|NCT01690156|Needle visualization|needle visualization
1275895|NCT01690130|nicotine|nicotine
1275896|NCT01690130|craving|craving
1275897|NCT01690130|smoking|smoking
1275899|NCT01690130|prefrontal cortex|prefrontal cortex
1275900|NCT01690117|family caregiver|family caregiver
1275901|NCT01690117|dementia|dementia
1275902|NCT01690117|intervention|intervention
1275903|NCT01690117|implementation|implementation
1275904|NCT01690104|rifampicin|rifampicin
1275905|NCT01690104|pregnane X receptor|pregnane x receptor
1275906|NCT01690104|blood pressure|blood pressure
1275907|NCT01690091|chronic heart failure|chronic heart failure
1275908|NCT01690091|type 2 diabetes|type 2 diabetes
1275909|NCT01690091|metformin|metformin
1275910|NCT01690091|insulin resistance|insulin resistance
1275911|NCT01690078|Airway modeling|airway modeling
1275912|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
1275913|NCT01690078|Micrognathia|micrognathia
1275914|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
1275915|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
1275916|NCT01690065|myeloid blastic phase|myeloid blastic phase
1275917|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
1275918|NCT01690065|nilotinib|nilotinib
1275919|NCT01690052|dry mouth|dry mouth
1275920|NCT01690039|renal tubular acidosis|renal tubular acidosis
1275921|NCT01690039|V-ATPase|v-atpase
1275922|NCT01690039|kidney stones|kidney stones
1275923|NCT01689974|Metastatic Melanoma|metastatic melanoma
1275924|NCT01689974|Radiation Therapy|radiation therapy
1275925|NCT01689974|Immunology|immunology
1275926|NCT01689974|Abscopal|abscopal
1275927|NCT01689961|Nutrition|nutrition
1275928|NCT01689961|Physical activity|physical activity
1275929|NCT01689961|Gestational weight gain|gestational weight gain
1275930|NCT01689961|Pregnancy outcomes|pregnancy outcomes
1275931|NCT01689961|Birth|birth
1275932|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
1275933|NCT01689935|Acne vulgaris|acne vulgaris
1275934|NCT01689935|Photodynamic Therapy|photodynamic therapy
1275935|NCT01689935|Side-effects|side-effects
1275936|NCT01689935|Pain|pain
1275937|NCT01689909|Insomnia|insomnia
1275938|NCT01689909|Depression|depression
1275939|NCT01689909|Suicidal ideation|suicidal ideation
1275940|NCT01689909|Zolpidem CR|zolpidem cr
1275941|NCT01689909|Placebo|placebo
1275942|NCT01689896|Hypogonadism|hypogonadism
1275943|NCT01689896|Low testosterone|low testosterone
1275944|NCT01689896|Pain|pain
1275945|NCT01689883|stroke|stroke
1275946|NCT01689883|electrical stimulation|electrical stimulation
1275947|NCT01689870|OX40|ox40
1275948|NCT01689870|Anti-OX40|anti-ox40
1275949|NCT01689870|Ipilimumab|ipilimumab
1275950|NCT01689870|Melanoma|melanoma
1275951|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
1275952|NCT01689844|controlled high blood pressure|controlled high blood pressure
1275953|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
1275954|NCT01689805|Atopic dermatitis|atopic dermatitis
1275955|NCT01689805|Filaggrin|filaggrin
1275956|NCT01689779|vitamin D|vitamin d
1275957|NCT01689779|surgery|surgery
1275958|NCT01689779|acute stress|acute stress
1275959|NCT01689766|Renal Cell|renal cell
1275960|NCT01689753|Renal dialyse|renal dialyse
1275961|NCT01689753|Catheter, indwelling|catheter, indwelling
1275962|NCT01689753|Catheter-related infection|catheter-related infection
1275963|NCT01689740|MDMA|mdma
1275964|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
1275965|NCT01689740|PTSD|ptsd
1275966|NCT01689740|Israel|israel
1275967|NCT01689740|psychotherapy|psychotherapy
1275968|NCT01689727|Pituitary Tumors|pituitary tumors
1275969|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
1275970|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
1275971|NCT01689701|Erosive Gastritis|erosive gastritis
1275972|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
1275973|NCT01689675|musculoskeletal|musculoskeletal
1275974|NCT01689675|pain|pain
1275975|NCT01689675|pain management|pain management
1275976|NCT01689675|computer based intervention|computer based intervention
1275977|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1275978|NCT01689649|Epilepsy|epilepsy
1275979|NCT01689649|Seizures|seizures
1275980|NCT01689649|Topiramate|topiramate
1275981|NCT01689649|Anti-epileptic drug|anti-epileptic drug
1275982|NCT01689649|Nervous disorder|nervous disorder
1275983|NCT01689636|Ovarian Cancer|ovarian cancer
1275984|NCT01689623|Healthy participants|healthy participants
1275985|NCT01689623|TMC435|tmc435
1275986|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1275987|NCT01689623|Atorvastatin|atorvastatin
1275988|NCT01689623|Simvastatin|simvastatin
1275989|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
1275990|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
1275991|NCT01689610|Abraxane|abraxane
1275992|NCT01689610|Nabucco|nabucco
1275993|NCT01689610|safety|safety
1275994|NCT01689610|breast cancer|breast cancer
1275995|NCT01689610|daily routine|daily routine
1275996|NCT01689610|peripheral neuropathy|peripheral neuropathy
1275997|NCT01689610|iOMEDICO|iomedico
1275998|NCT01689584|BRCA1|brca1
1275999|NCT01689584|BRCA2|brca2
1276000|NCT01689584|VUS|vus
1276001|NCT01689584|co-segregation|co-segregation
1276002|NCT01689584|genetic counseling|genetic counseling
1276003|NCT01689584|PALB2|palb2
1276004|NCT01689571|PDE4 inhibitor|pde4 inhibitor
1276005|NCT01689571|Allergen Challenge|allergen challenge
1276006|NCT01689571|Asthma|asthma
1276007|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
1276009|NCT01689545|drug abuse|drug abuse
1276010|NCT01689545|social stigma|social stigma
1276011|NCT01689545|Vietnam|vietnam
1276012|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
1276013|NCT01689532|Sirukumab|sirukumab
1276014|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
1276015|NCT01689519|Zelboraf|zelboraf
1276016|NCT01689519|vemurafenib|vemurafenib
1276017|NCT01689519|RG7204|rg7204
1276018|NCT01689519|PLX4032|plx4032
1276019|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
1276020|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
1276021|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
1276022|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
1276023|NCT01689519|RO5185426|ro5185426
1276024|NCT01689519|metastatic melanoma|metastatic melanoma
1276025|NCT01689519|BRAF positive melanoma|braf positive melanoma
1276026|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
1276027|NCT01689519|advanced melanoma|advanced melanoma
1276028|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
1276029|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
1276030|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
1276031|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
1276032|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
1276033|NCT01689519|GDC-0973|gdc-0973
1276034|NCT01689519|XL518|xl518
1276035|NCT01689519|melanoma|melanoma
1276036|NCT01689480|Muscular Dystrophy|muscular dystrophy
1276037|NCT01689480|Facioscapulohumeral|facioscapulohumeral
1276038|NCT01689480|Physical training|physical training
1276039|NCT01689480|Exercise|exercise
1276040|NCT01689454|IVF|ivf
1276041|NCT01689454|embryo culture|embryo culture
1276042|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
1276043|NCT01689454|Ongoing implantation rate|ongoing implantation rate
1276044|NCT01689454|Miscarriage|miscarriage
1276045|NCT01689428|IVF|ivf
1276046|NCT01689428|Embryo culture|embryo culture
1276047|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
1276048|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
1276049|NCT01689428|Miscarriage|miscarriage
1276050|NCT01689415|Renal nerve denervation|renal nerve denervation
1276051|NCT01689389|Schizophrenia|schizophrenia
1276052|NCT01689389|Bipolar episodes|bipolar episodes
1276053|NCT01689389|France|france
1276055|NCT01689389|Real-life|real-life
1276056|NCT01689363|hyaluronidase|hyaluronidase
1276057|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
1276058|NCT01689363|allergic reaction|allergic reaction
1276059|NCT01689363|intradermal skin testing|intradermal skin testing
1276060|NCT01689350|Cyclophosphamide|cyclophosphamide
1276061|NCT01689350|genotype-based therapy|genotype-based therapy
1276062|NCT01689350|prospective study|prospective study
1276063|NCT01689337|Microfracture surgery|microfracture surgery
1276064|NCT01689337|Cartilage repair|cartilage repair
1276065|NCT01689337|Knee surgery|knee surgery
1276066|NCT01689324|Pertussis|pertussis
1276067|NCT01689324|Tetanus|tetanus
1276068|NCT01689324|Diphtheria|diphtheria
1276069|NCT01689324|Acellular pertussis|acellular pertussis
1276070|NCT01689324|ADACEL®|adacel®
1276071|NCT01689324|Tdap vaccine|tdap vaccine
1276072|NCT01689311|Uterine contraction|uterine contraction
1276073|NCT01689311|Dose response|dose response
1276074|NCT01689311|Non-laboring|non-laboring
1276075|NCT01689311|Laboring|laboring
1276076|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
1276077|NCT01689311|Oxytocin|oxytocin
1276078|NCT01689311|Ergonovine|ergonovine
1276079|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
1276080|NCT01689311|Misoprostol|misoprostol
1276387|NCT01687829|Surgery|surgery
1276087|NCT01689285|pharmacokinetics|pharmacokinetics
1276088|NCT01689285|valacyclovir|valacyclovir
1276089|NCT01689285|paediatric formulation|paediatric formulation
1276090|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
1276091|NCT01689246|Alzheimer's Disease|alzheimer's disease
1276092|NCT01689246|Alzheimer Disease|alzheimer disease
1276093|NCT01689246|TRx0237|trx0237
1276094|NCT01689246|AD|ad
1276095|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
1276096|NCT01689246|Dementia|dementia
1276097|NCT01689246|Brain Diseases|brain diseases
1276098|NCT01689233|Alzheimer's Disease|alzheimer's disease
1276099|NCT01689233|Alzheimer Disease|alzheimer disease
1276100|NCT01689233|TRx0237|trx0237
1276101|NCT01689233|AD|ad
1276102|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
1276103|NCT01689233|Dementia|dementia
1276104|NCT01689233|Brain Diseases|brain diseases
1276105|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
1276106|NCT01689155|Meningitis|meningitis
1276107|NCT01689155|Meningococcal Infection|meningococcal infection
1276108|NCT01689155|Menactra®|menactra®
1276109|NCT01689103|Alcohol use disorders|alcohol use disorders
1276110|NCT01689103|Treatment|treatment
1276111|NCT01689103|Outpatient|outpatient
1276112|NCT01689103|Therapeutic alliance|therapeutic alliance
1276113|NCT01689051|Type 2 diabetes|type 2 diabetes
1276114|NCT01689051|Blod pressure|blod pressure
1276115|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
1276116|NCT01689051|Human physiology|human physiology
1276117|NCT01689051|Blood flow|blood flow
1276118|NCT01688999|Kidney Cancer|kidney cancer
1276119|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1276120|NCT01688999|Bladder Cancer|bladder cancer
1276121|NCT01688986|Complex Disease|complex disease
1276122|NCT01688986|DNA Biorepository|dna biorepository
1276123|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
1276124|NCT01688986|Genetics|genetics
1276125|NCT01688986|Environmental Factors|environmental factors
1276126|NCT01688947|Pain|pain
1276127|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
1276128|NCT01688934|Pain|pain
1276129|NCT01688934|Osteoarthritis|osteoarthritis
1276130|NCT01688934|Knee|knee
1276131|NCT01688921|Injections, Jet|injections, jet
1276132|NCT01688921|Influenza Vaccines|influenza vaccines
1276133|NCT01688908|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1276134|NCT01688908|Endoscopic Screening|endoscopic screening
1276135|NCT01688908|Efficacy|efficacy
1276136|NCT01688908|Cost-utility|cost-utility
1276137|NCT01688908|High risk region|high risk region
1276138|NCT01688908|China|china
1276139|NCT01688895|erythropoietic|erythropoietic
1276140|NCT01688895|protoporphyria|protoporphyria
1276141|NCT01688895|cutaneous|cutaneous
1276142|NCT01688895|porphyria|porphyria
1276143|NCT01688882|bullous pemphigoid|bullous pemphigoid
1276144|NCT01688882|QGE031|qge031
1276145|NCT01688869|brain concussion|brain concussion
1276146|NCT01688856|hand|hand
1276147|NCT01688856|arm|arm
1276148|NCT01688856|stroke|stroke
1276149|NCT01688856|hemiplegia|hemiplegia
1276150|NCT01688856|electrical stimulation|electrical stimulation
1276151|NCT01688856|recovery|recovery
1276152|NCT01688856|rehabilitation|rehabilitation
1276153|NCT01688843|bradycardia|bradycardia
1276154|NCT01688843|sinus node dysfunction|sinus node dysfunction
1276155|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
1276156|NCT01688817|Colonoscopy|colonoscopy
1276157|NCT01688817|Early Detection of Cancer|early detection of cancer
1276158|NCT01688817|Patient Selection|patient selection
1276159|NCT01688817|Patient Participation|patient participation
1276160|NCT01688817|Physicians, Primary Care|physicians, primary care
1276161|NCT01688817|Conscious Sedation|conscious sedation
1276162|NCT01688804|Sedentary behavior|sedentary behavior
1276163|NCT01688804|Physical activity|physical activity
1276164|NCT01688804|Obesity|obesity
1276165|NCT01688804|Mobile health|mobile health
1276166|NCT01688804|Smartphone|smartphone
1276167|NCT01688778|Type 2 diabetes|type 2 diabetes
1276168|NCT01688778|Quality of life|quality of life
1276169|NCT01688778|Lifestyle intervention|lifestyle intervention
1276170|NCT01688778|Telemedicine|telemedicine
1276171|NCT01688778|Videoconference|videoconference
1276172|NCT01688765|Schizophrenia|schizophrenia
1276173|NCT01688765|Schizoaffective disorder|schizoaffective disorder
1276174|NCT01688765|Bipolar disorder|bipolar disorder
1276175|NCT01688739|Migraine|migraine
1276182|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1276183|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
1276184|NCT01688700|Nimotuzumab|nimotuzumab
1276185|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
1276186|NCT01688648|dexmedetomidine|dexmedetomidine
1276187|NCT01688648|lidocaine|lidocaine
1276188|NCT01688648|myocardial injury|myocardial injury
1276189|NCT01688648|arrhythmia|arrhythmia
1276190|NCT01688648|blood electrolyte balance|blood electrolyte balance
1276191|NCT01688635|Volunteers|volunteers
1276192|NCT01688596|Local|local
1276193|NCT01688596|Anesthesia|anesthesia
1276194|NCT01688596|Pain|pain
1276195|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
1276196|NCT01688596|Trocar site|trocar site
1276197|NCT01688596|Port site|port site
1276198|NCT01688583|Chronic pain|chronic pain
1276199|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
1276200|NCT01688583|Fentanyl matrix|fentanyl matrix
1276201|NCT01688583|Transdermal system|transdermal system
1276202|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
1276203|NCT01688570|motor impairment|motor impairment
1276204|NCT01688557|narrow band imaging|narrow band imaging
1276205|NCT01688557|dual focus|dual focus
1276206|NCT01688557|responsive insertion technique|responsive insertion technique
1276207|NCT01688557|scope guide|scope guide
1276208|NCT01688557|colonoscopy|colonoscopy
1276209|NCT01688557|colorectal cancer screening|colorectal cancer screening
1276210|NCT01688544|Ilaprazole|ilaprazole
1276211|NCT01688544|Intragastric pH|intragastric ph
1276212|NCT01688544|Serum Gastrin|serum gastrin
1276213|NCT01688544|Pharmacokinetics|pharmacokinetics
1276214|NCT01688518|Evaluation|evaluation
1276215|NCT01688518|Depth and Duration|depth and duration
1276216|NCT01688518|Anesthesia|anesthesia
1276217|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
1276218|NCT01688505|cognitive impairment|cognitive impairment
1276219|NCT01688505|Blood pressure variability|blood pressure variability
1276220|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
1276221|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
1276222|NCT01688492|PREDNISONE|prednisone
1276223|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
1276224|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
1276225|NCT01688492|12-120|12-120
1276226|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
1276227|NCT01688479|breast cancer|breast cancer
1276228|NCT01688466|Immune Modulatory|immune modulatory
1276229|NCT01688466|Systemic Absorption|systemic absorption
1276230|NCT01688466|Oral Agent|oral agent
1276231|NCT01688453|overweight/obesity|overweight/obesity
1276232|NCT01688453|adolescence|adolescence
1276233|NCT01688453|care management|care management
1276234|NCT01688440|Endotracheal Cares|endotracheal cares
1276235|NCT01688440|Neonate|neonate
1276236|NCT01688440|TAC's|tac's
1276237|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
1276238|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
1276239|NCT01688440|Oral Cares|oral cares
1276240|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
1276241|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
1276242|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
1276243|NCT01688401|angiography|angiography
1276244|NCT01688388|Breast Cancer|breast cancer
1276245|NCT01688388|Carcinoma|carcinoma
1276246|NCT01688388|Radiotherapy|radiotherapy
1276247|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
1276248|NCT01688388|IORT|iort
1276249|NCT01688375|obstructive jaundice|obstructive jaundice
1276250|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
1276251|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
1276252|NCT01688362|Rotator Cuff Tear|rotator cuff tear
1276253|NCT01688362|Platelet Rich Plasma|platelet rich plasma
1276254|NCT01688362|Corticosteroid|corticosteroid
1276255|NCT01688362|Ultrasound|ultrasound
1276256|NCT01688349|Glucocorticoids|glucocorticoids
1276257|NCT01688349|adipose tissue|adipose tissue
1276258|NCT01688349|Cushing|cushing
1276259|NCT01688349|lipodystrophy|lipodystrophy
1276260|NCT01688349|11 beta-HSD1|11 beta-hsd1
1276261|NCT01688336|Pancreatic|pancreatic
1276262|NCT01688336|Phase II|phase ii
1276263|NCT01688336|FOLFIRINOX|folfirinox
1276264|NCT01688336|Unresectable|unresectable
1276265|NCT01688336|Regimen|regimen
1276266|NCT01688336|First-line|first-line
1276267|NCT01688336|Resectable|resectable
1276268|NCT01688336|Borderline|borderline
1276269|NCT01688336|Oxaliplatin|oxaliplatin
1276270|NCT01688336|Leucovorin|leucovorin
1276271|NCT01688336|Irinotecan|irinotecan
1276273|NCT01688336|Lineberger|lineberger
1276274|NCT01688336|University of North Carolina|university of north carolina
1276275|NCT01688323|Geriatrics|geriatrics
1276276|NCT01688323|Oncology|oncology
1276277|NCT01688323|Biological Markers|biological markers
1276278|NCT01688323|Survey Instruments|survey instruments
1276279|NCT01688323|p16|p16
1276280|NCT01688323|Geriatric Oncology|geriatric oncology
1276281|NCT01688323|Biological Markers of Aging|biological markers of aging
1276282|NCT01688323|Symptom Assessment|symptom assessment
1276283|NCT01688323|Cancer|cancer
1276284|NCT01688323|Older Persons|older persons
1276285|NCT01688323|Head and Neck Cancer|head and neck cancer
1276286|NCT01688310|Gomco clamp instrument|gomco clamp instrument
1276287|NCT01688310|Tissue adhesive|tissue adhesive
1276288|NCT01688310|Open surgical circumcision|open surgical circumcision
1276289|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
1276290|NCT01688297|Influenza|influenza
1276291|NCT01688297|H1N1|h1n1
1276292|NCT01688297|flu|flu
1276293|NCT01688297|seasonal|seasonal
1276294|NCT01688284|uterine natural killer cells|uterine natural killer cells
1276295|NCT01688284|recurrent miscarriages|recurrent miscarriages
1276296|NCT01688284|alloimmunity|alloimmunity
1276297|NCT01688271|simulation|simulation
1276298|NCT01688271|ultrasound|ultrasound
1276299|NCT01688271|perineural infusion|perineural infusion
1276300|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
1276301|NCT01688245|young adults|young adults
1276302|NCT01688245|alcohol consumption|alcohol consumption
1276303|NCT01688245|mobile health|mobile health
1276304|NCT01688245|text message|text message
1276305|NCT01688232|colorectal cancer|colorectal cancer
1276306|NCT01688232|tumor resection|tumor resection
1276307|NCT01688232|immunoscore|immunoscore
1276308|NCT01688232|lymphocytic density|lymphocytic density
1276309|NCT01688232|CD3|cd3
1276310|NCT01688232|CD8|cd8
1276311|NCT01688232|CD45RO|cd45ro
1276312|NCT01688232|biopsy|biopsy
1276313|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
1276314|NCT01688232|relapse|relapse
1276315|NCT01688232|immunohistochemistry|immunohistochemistry
1276316|NCT01688232|image analysis software|image analysis software
1276317|NCT01688219|SAPHO syndrome|sapho syndrome
1276318|NCT01688219|Innate immunity|innate immunity
1276319|NCT01688219|TNF alpha|tnf alpha
1276320|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
1276321|NCT01688219|Propionibacterium acnes|propionibacterium acnes
1276322|NCT01688219|Interleukin-8|interleukin-8
1276323|NCT01688180|bronchiectasis|bronchiectasis
1276324|NCT01688180|depression|depression
1276325|NCT01688180|anxiety|anxiety
1276327|NCT01688167|Male circumcision|male circumcision
1276328|NCT01688167|Sexual risk reduction|sexual risk reduction
1276329|NCT01688167|Stages of change|stages of change
1276330|NCT01688141|CKD|ckd
1276331|NCT01688128|Mild cognitive impairment|mild cognitive impairment
1276332|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
1276333|NCT01688128|Cognitive therapy|cognitive therapy
1276334|NCT01688128|Spaced retrieval Training|spaced retrieval training
1276335|NCT01688128|Alzheimer's disease|alzheimer's disease
1276336|NCT01688128|Memory enhancement|memory enhancement
1276337|NCT01688128|U-healthcare|u-healthcare
1276338|NCT01688089|volunteer|volunteer
1276339|NCT01688089|study|study
1276340|NCT01688063|Skin Elasticity|skin elasticity
1276341|NCT01688063|Scar Elasticity|scar elasticity
1276342|NCT01688063|Cutometer|cutometer
1276343|NCT01688063|Dermal Torque Meter|dermal torque meter
1276344|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
1276345|NCT01688050|Transection|transection
1276346|NCT01688050|Endovascular graft|endovascular graft
1276347|NCT01688024|mitomycin C|mitomycin c
1276348|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
1276349|NCT01688011|MDS|mds
1276350|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
1276351|NCT01688011|AML|aml
1276352|NCT01688011|Registry|registry
1276353|NCT01688011|Connect®|connect®
1276354|NCT01687972|cesarean section|cesarean section
1276355|NCT01687972|insorb staples|insorb staples
1276356|NCT01687972|absorbable staples|absorbable staples
1276357|NCT01687972|transverse skin incision|transverse skin incision
1276358|NCT01687959|cholelithiasis|cholelithiasis
1276359|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1276360|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
1276361|NCT01687959|choledocholithiasis|choledocholithiasis
1276362|NCT01687946|Biology of Fibrosis|biology of fibrosis
1276363|NCT01687933|Labor pain|labor pain
1276364|NCT01687933|Virtual reality|virtual reality
1276365|NCT01687933|the first stage of labor|the first stage of labor
1276366|NCT01687933|Pain relief|pain relief
1276367|NCT01687933|Simulator|simulator
1276368|NCT01687920|Cardiac disorders|cardiac disorders
1276369|NCT01687907|fear of childbirth|fear of childbirth
1276370|NCT01687907|outcome of delivery|outcome of delivery
1276371|NCT01687907|music|music
1276372|NCT01687907|mother-baby relationship|mother-baby relationship
1276373|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
1276374|NCT01687894|beach chair position|beach chair position
1276375|NCT01687894|hemodynamic|hemodynamic
1276376|NCT01687894|jugular venous oximetry|jugular venous oximetry
1276377|NCT01687881|Chiropractic|chiropractic
1276378|NCT01687881|Manipulative therapy|manipulative therapy
1276379|NCT01687881|Cervicogenic headache|cervicogenic headache
1276380|NCT01687855|Obstructive Sleep|obstructive sleep
1276381|NCT01687855|Apnoea|apnoea
1276382|NCT01687855|tongue|tongue
1276383|NCT01687855|alteration|alteration
1276384|NCT01687829|Macular Holes|macular holes
1276385|NCT01687829|Internal limiting membrane|internal limiting membrane
1276386|NCT01687829|peeling|peeling
1276388|NCT01687816|Influenza-Like-Illness|influenza-like-illness
1276389|NCT01687816|nasal swabs|nasal swabs
1276390|NCT01687816|Detection of influenza|detection of influenza
1276391|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
1276392|NCT01687803|Obesity|obesity
1276393|NCT01687803|Sedentary lifestyle|sedentary lifestyle
1276394|NCT01687803|Body weight|body weight
1276395|NCT01687803|Physical fitness|physical fitness
1276396|NCT01687790|molecular breast imaging|molecular breast imaging
1276397|NCT01687790|breast disease|breast disease
1276398|NCT01687790|breast biopsy|breast biopsy
1276399|NCT01687777|Supraspinatus tendon|supraspinatus tendon
1276400|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
1276401|NCT01687777|OrthADAPT|orthadapt
1276402|NCT01687777|Rotator cuff|rotator cuff
1276403|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
1276404|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
1276405|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
1276406|NCT01687751|feasibility studies|feasibility studies
1276407|NCT01687751|conscious sedation/|conscious sedation/
1276408|NCT01687751|dexmedetomidine/|dexmedetomidine/
1276409|NCT01687751|midazolam/|midazolam/
1276410|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
1276411|NCT01687751|palliative care/|palliative care/
1276412|NCT01687751|terminal care/|terminal care/
1276413|NCT01687751|terminally ill/|terminally ill/
1276414|NCT01687751|neoplasms/|neoplasms/
1276415|NCT01687751|treatment outcome|treatment outcome
1276416|NCT01687751|Precedex|precedex
1276417|NCT01687751|"end of life"|"end of life"
1276418|NCT01687751|Dying|dying
1276419|NCT01687751|Advanced cancer|advanced cancer
1276420|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
1276421|NCT01687738|non small cell lung cancer|non small cell lung cancer
1276422|NCT01687738|health disparities|health disparities
1276423|NCT01687712|IVF|ivf
1276424|NCT01687712|In vitro fertilization|in vitro fertilization
1276425|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
1276426|NCT01687712|Follitropin|follitropin
1276427|NCT01687712|AFOLIA|afolia
1276428|NCT01687712|Finox|finox
1276429|NCT01687699|cardiovascular event|cardiovascular event
1276430|NCT01687699|hemodialysis|hemodialysis
1276431|NCT01687699|spironolactone|spironolactone
1276432|NCT01687673|Advanced HCC|advanced hcc
1276433|NCT01687673|Temsirolimus|temsirolimus
1276434|NCT01687673|TORISEL|torisel
1276435|NCT01687673|Sorafenib|sorafenib
1276436|NCT01687660|acupuncture|acupuncture
1276437|NCT01687660|migraine prophylaxis|migraine prophylaxis
1276438|NCT01687647|Lung cancer screening|lung cancer screening
1276439|NCT01687647|Asbestos exposed workers|asbestos exposed workers
1276440|NCT01687647|Sputum analysis|sputum analysis
1276441|NCT01687647|Automated cytometry|automated cytometry
1276442|NCT01687647|Predictive biomarkers|predictive biomarkers
1276443|NCT01687634|pregnancy|pregnancy
1276444|NCT01687634|home healthcare visits|home healthcare visits
1276445|NCT01687634|breast feeding|breast feeding
1276446|NCT01687634|nutrition|nutrition
1276447|NCT01687634|community health workers|community health workers
1276448|NCT01687621|Omphalitis|omphalitis
1276449|NCT01687621|Neonate|neonate
1276450|NCT01687621|Zambia|zambia
1276451|NCT01687621|Neonatal mortality|neonatal mortality
1276452|NCT01687621|Umbilical cord infection|umbilical cord infection
1276453|NCT01687608|Hemophilia B|hemophilia b
1276454|NCT01687608|factor IX deficiency|factor ix deficiency
1276455|NCT01687608|gene therapy|gene therapy
1276456|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
1276457|NCT01687595|genital herpes|genital herpes
1276458|NCT01687582|type 2 diabetes|type 2 diabetes
1276459|NCT01687582|psoriasis|psoriasis
1276460|NCT01687582|exenatide|exenatide
1276461|NCT01687582|liraglutide|liraglutide
1276462|NCT01687569|Glycaemic Response|glycaemic response
1276463|NCT01687556|EGCG|egcg
1276464|NCT01687556|green tea|green tea
1276465|NCT01687543|Clostridium difficile|clostridium difficile
1276466|NCT01687543|WBC|wbc
1276467|NCT01687543|CRP|crp
1276468|NCT01687543|Lactate|lactate
1276469|NCT01687543|Urea|urea
1276470|NCT01687543|Creatinine|creatinine
1276471|NCT01687517|sarcoidosis|sarcoidosis
1276472|NCT01687517|healthy volunteers|healthy volunteers
1276473|NCT01687504|pharmacokinetics|pharmacokinetics
1276474|NCT01687504|children|children
1276475|NCT01687504|HIV|hiv
1276476|NCT01687504|Tuberculosis|tuberculosis
1276477|NCT01687504|Pharmacogenetics|pharmacogenetics
1276478|NCT01687491|Enoxaparin|enoxaparin
1276479|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
1276480|NCT01687491|Factor X|factor x
1276481|NCT01687465|glaucoma|glaucoma
1276482|NCT01687465|laser|laser
1276483|NCT01687465|SLT|slt
1276484|NCT01687465|ALT|alt
1276485|NCT01687374|proximal humeral fracture|proximal humeral fracture
1276486|NCT01687335|chemotherapy|chemotherapy
1276487|NCT01687322|quality of life|quality of life
1276488|NCT01687322|functioning|functioning
1276489|NCT01687296|PEF|pef
1276490|NCT01687296|inhaled|inhaled
1276491|NCT01687296|Fluticasone Propionate|fluticasone propionate
1276492|NCT01687296|safety|safety
1276493|NCT01687296|prednisone|prednisone
1276494|NCT01687296|acute exacerbation|acute exacerbation
1276495|NCT01687296|asthma|asthma
1276496|NCT01687296|efficacy|efficacy
1276497|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
1276498|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
1276499|NCT01687283|efficacy|efficacy
1276500|NCT01687283|severe persistent asthma|severe persistent asthma
1276501|NCT01687283|pharmacokinetics|pharmacokinetics
1276502|NCT01687283|safety|safety
1276503|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
1276504|NCT01687244|rAd-IFN|rad-ifn
1276505|NCT01687244|Syn3|syn3
1276506|NCT01687244|Intravesical|intravesical
1276507|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1276508|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
1276509|NCT01687244|Interferon alpha2b|interferon alpha2b
1276510|NCT01687244|INSTILADRIN|instiladrin
1276511|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
1276512|NCT01687192|Seroconversion|seroconversion
1276513|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
1276514|NCT01687192|HPV vaccination|hpv vaccination
1276515|NCT01687192|Immunogenicity|immunogenicity
1276516|NCT01687179|LAM|lam
1276517|NCT01687179|TSC|tsc
1276518|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
1276519|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1276520|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
1276521|NCT01687166|Heart Disease|heart disease
1276522|NCT01687166|Cardiovascular Disease|cardiovascular disease
1276523|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
1276524|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
1276525|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
1276526|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
1276652|NCT01686633|vilanterol|vilanterol
1276527|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
1276528|NCT01687153|dementia|dementia
1276529|NCT01687153|biomarkers|biomarkers
1276530|NCT01687153|amyloid|amyloid
1276531|NCT01687153|neuroimaging|neuroimaging
1276532|NCT01687153|cognition disorder|cognition disorder
1276533|NCT01687153|tau|tau
1276534|NCT01687127|folic acid|folic acid
1276535|NCT01687127|folate|folate
1276536|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
1276537|NCT01687127|supplements|supplements
1276538|NCT01687127|women|women
1276539|NCT01687127|one-carbon metabolism|one-carbon metabolism
1276540|NCT01687127|methionine|methionine
1276541|NCT01687127|DNA methylation|dna methylation
1276542|NCT01687127|in vivo kinetics|in vivo kinetics
1276543|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
1276544|NCT01687101|acute migraine|acute migraine
1276545|NCT01687101|acute migraine treatment|acute migraine treatment
1276546|NCT01687101|topical treatment|topical treatment
1276547|NCT01687075|coronary angioplasty|coronary angioplasty
1276548|NCT01687075|de novo lesion|de novo lesion
1276549|NCT01687062|NaFeEDTA|nafeedta
1276550|NCT01687062|phytate|phytate
1276551|NCT01687062|injera|injera
1276552|NCT01687062|iron absorption|iron absorption
1276553|NCT01687049|nonmetastatic|nonmetastatic
1276554|NCT01687049|localized|localized
1276555|NCT01687049|prostate|prostate
1276556|NCT01687049|active surveillance|active surveillance
1276557|NCT01687036|Atrial fibrillation|atrial fibrillation
1276558|NCT01687036|Cryoablation|cryoablation
1276559|NCT01687023|Tai Chi|tai chi
1276560|NCT01687023|Wearable sensors|wearable sensors
1276561|NCT01687023|Movement|movement
1276562|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
1276563|NCT01686997|Bariatric surgery|bariatric surgery
1276564|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1276565|NCT01686958|Prostate Cancer|prostate cancer
1276566|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
1276567|NCT01686958|MRI-guided|mri-guided
1276568|NCT01686958|Minimally invasive|minimally invasive
1276569|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
1276570|NCT01686932|vildagliptin|vildagliptin
1276571|NCT01686932|sitagliptin|sitagliptin
1276572|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
1276573|NCT01686932|glycemic fluctuations|glycemic fluctuations
1276574|NCT01686932|MAGE|mage
1276575|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
1276576|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
1276577|NCT01686919|Gastric bypass|gastric bypass
1276578|NCT01686919|Questionnaires|questionnaires
1276579|NCT01686919|Diet|diet
1276580|NCT01686919|Milk|milk
1276581|NCT01686906|Keratoconus|keratoconus
1276582|NCT01686906|Bowman layer|bowman layer
1276583|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
1276584|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
1276585|NCT01686880|Liver Cirrhosis|liver cirrhosis
1276586|NCT01686880|radioembolization|radioembolization
1276587|NCT01686880|SIRT|sirt
1276588|NCT01686880|TARE|tare
1276589|NCT01686880|Sirspheres|sirspheres
1276590|NCT01686880|neoadjuvant|neoadjuvant
1276591|NCT01686880|liver cancer|liver cancer
1276592|NCT01686867|improved cookstove|improved cookstove
1276593|NCT01686867|ventilated cookstove|ventilated cookstove
1276594|NCT01686867|behavior change|behavior change
1276595|NCT01686867|adoption|adoption
1276596|NCT01686867|indoor air pollution|indoor air pollution
1276597|NCT01686867|DLCO|dlco
1276598|NCT01686867|spirometry|spirometry
1276599|NCT01686867|biomass fuel|biomass fuel
1276600|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
1276601|NCT01686854|obesity treatment|obesity treatment
1276602|NCT01686841|Lipolysis|lipolysis
1276603|NCT01686841|Cryolipolysis|cryolipolysis
1276604|NCT01686841|Fat Reduction|fat reduction
1276605|NCT01686828|insulin|insulin
1276606|NCT01686828|androgens|androgens
1276607|NCT01686828|insulin resistance|insulin resistance
1276608|NCT01686828|testosterone|testosterone
1276609|NCT01686828|estradiol|estradiol
1276610|NCT01686828|obesity|obesity
1276611|NCT01686815|metabolic side effects|metabolic side effects
1276612|NCT01686815|atypical antipsychotics|atypical antipsychotics
1276613|NCT01686815|FSIVGTT|fsivgtt
1276614|NCT01686802|oral morphine|oral morphine
1276615|NCT01686802|ibuprofen|ibuprofen
1276616|NCT01686802|post-operative pain|post-operative pain
1606397|NCT00371384|back pain|back pain
1276617|NCT01686776|Plasma albumine|plasma albumine
1276618|NCT01686776|Plasma volume|plasma volume
1276619|NCT01686776|Transcapillary escape rate|transcapillary escape rate
1276620|NCT01686776|Inflammation|inflammation
1276621|NCT01686776|Circulation|circulation
1276622|NCT01686750|HIV|hiv
1276623|NCT01686750|injection drug use|injection drug use
1276624|NCT01686750|men who have sex with men|men who have sex with men
1276625|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
1276626|NCT01686750|risk reduction|risk reduction
1276627|NCT01686750|sexually transmitted infections|sexually transmitted infections
1276628|NCT01686750|community viral load|community viral load
1276629|NCT01686750|antiretroviral therapy|antiretroviral therapy
1276630|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1276631|NCT01686724|Psychosocial Intervention|psychosocial intervention
1276632|NCT01686724|Behavioral Intervention|behavioral intervention
1276633|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
1276634|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
1276635|NCT01686685|ASD|asd
1276636|NCT01686685|autism|autism
1276637|NCT01686685|prematurity|prematurity
1276638|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
1276639|NCT01686685|CXCR4|cxcr4
1276640|NCT01686685|Language delay|language delay
1276641|NCT01686685|Cognitive delay|cognitive delay
1276642|NCT01686672|Cystic Fibrosis|cystic fibrosis
1276643|NCT01686672|Behavioral Intervention|behavioral intervention
1276644|NCT01686672|Children|children
1276645|NCT01686659|Transfusion|transfusion
1276646|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
1276647|NCT01686659|SpHb|sphb
1276648|NCT01686646|alertness|alertness
1276649|NCT01686633|asthma|asthma
1276650|NCT01686633|pharmacogenetics|pharmacogenetics
1276651|NCT01686633|adult|adult
1276653|NCT01686633|adolescents|adolescents
1276654|NCT01686633|fluticasone furoate|fluticasone furoate
1276655|NCT01686620|Mealtime insulin|mealtime insulin
1276656|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
1276657|NCT01686620|Prandial insulin|prandial insulin
1276658|NCT01686607|Hepatic toxicity|hepatic toxicity
1276659|NCT01686607|Renal toxicity|renal toxicity
1276660|NCT01686607|Micafungin|micafungin
1276661|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
1276662|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
1276663|NCT01686594|Mycosis fungoides|mycosis fungoides
1276664|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
1276665|NCT01686594|Photochemotherapy|photochemotherapy
1276666|NCT01686594|Maintenance treatment|maintenance treatment
1276667|NCT01686594|Immune function|immune function
1276668|NCT01686542|atrial fibrillation|atrial fibrillation
1276669|NCT01686529|Pterygium|pterygium
1276670|NCT01686529|bevacizumab|bevacizumab
1276671|NCT01686529|autoconjunctival graft|autoconjunctival graft
1276672|NCT01686516|age|age
1276673|NCT01686516|microstructure|microstructure
1276674|NCT01686516|diffusion MRI|diffusion mri
1276675|NCT01686490|AICD|aicd
1276676|NCT01686490|focus groups|focus groups
1276677|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
1276678|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
1276679|NCT01686464|magnetic|magnetic
1276680|NCT01686464|oxygen|oxygen
1276681|NCT01686464|Bell's Palsy|bell's palsy
1276682|NCT01686464|acupuncture|acupuncture
1276683|NCT01686438|cost effectiveness|cost effectiveness
1276684|NCT01686438|patient satisfaction|patient satisfaction
1276685|NCT01686425|Cholestasis|cholestasis
1276686|NCT01686425|Malignancy|malignancy
1276687|NCT01686425|ERCP|ercp
1276688|NCT01686425|PTC|ptc
1276689|NCT01686425|EUS-BD|eus-bd
1276690|NCT01686412|Breast Cancer|breast cancer
1276691|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
1276692|NCT01686399|Sustainable diet|sustainable diet
1276693|NCT01686399|Health promotion|health promotion
1276694|NCT01686399|Obesity|obesity
1276695|NCT01686386|Relapsed|relapsed
1276696|NCT01686386|Multiple Myeloma|multiple myeloma
1276697|NCT01686386|Lenalidomide|lenalidomide
1276698|NCT01686386|Bendamustine|bendamustine
1276699|NCT01686373|Aphasia|aphasia
1276700|NCT01686373|Brain|brain
1276701|NCT01686373|Stimulation|stimulation
1276702|NCT01686373|Communication|communication
1276703|NCT01686373|Stoke|stoke
1276704|NCT01686373|Post|post
1276705|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
1276706|NCT01686373|Treatment|treatment
1276707|NCT01686373|tDCS|tdcs
1276708|NCT01686373|Fridriksson|fridriksson
1276709|NCT01686347|epidural analgesia|epidural analgesia
1276710|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
1276711|NCT01686347|ropivacaine|ropivacaine
1276712|NCT01686347|sufentanil|sufentanil
1276713|NCT01686334|in complete remission|in complete remission
1276714|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
1276715|NCT01686321|elderly patients|elderly patients
1276716|NCT01686321|bendamustine|bendamustine
1276717|NCT01686308|cataract|cataract
1276718|NCT01686308|circadian rhythm|circadian rhythm
1276719|NCT01686308|pupillometry|pupillometry
1276720|NCT01686308|blue light transmission|blue light transmission
1276721|NCT01686308|questionnaire|questionnaire
1276722|NCT01686308|sleep|sleep
1276723|NCT01686295|androgenetic alopecia|androgenetic alopecia
1276724|NCT01686295|Baldness|baldness
1276725|NCT01686282|Blood pressure|blood pressure
1276726|NCT01686282|Arterial Stiffness|arterial stiffness
1276727|NCT01686282|Blueberry Supplementation|blueberry supplementation
1276728|NCT01686282|Aortic Blood Pressure|aortic blood pressure
1276729|NCT01686282|Hypertension|hypertension
1276730|NCT01686282|Postmenopausal|postmenopausal
1276731|NCT01686282|Pulse Wave Velocity|pulse wave velocity
1276732|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
1276733|NCT01686269|coronary artery bypass|coronary artery bypass
1276734|NCT01686256|Ovarian Cancer|ovarian cancer
1276735|NCT01686256|Endometrial Cancer|endometrial cancer
1276736|NCT01686243|epidural|epidural
1276737|NCT01686230|acupuncture|acupuncture
1276738|NCT01686230|Angina|angina
1276739|NCT01686230|Stable Angina Pectoris|stable angina pectoris
1276740|NCT01686217|ASP015K Extended Release|asp015k extended release
1276741|NCT01686217|ASP015K Immediate Release|asp015k immediate release
1276742|NCT01686217|Food Effect|food effect
1276743|NCT01686217|Healthy Volunteers|healthy volunteers
1276744|NCT01686204|Yogurt|yogurt
1276745|NCT01686204|Intestine|intestine
1276746|NCT01686204|Inflammation|inflammation
1276747|NCT01686204|Obese|obese
1276748|NCT01686191|heart transplantation|heart transplantation
1276749|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
1276750|NCT01686191|pharmacogenomics|pharmacogenomics
1276751|NCT01686191|cyclosporine|cyclosporine
1276752|NCT01686191|tacrolimus|tacrolimus
1276753|NCT01686178|Smoking|smoking
1276754|NCT01686178|Smoking Cessation|smoking cessation
1276755|NCT01686178|Tobacco Use Cessation|tobacco use cessation
1276756|NCT01686178|Social Networks|social networks
1276757|NCT01686178|Social Control, Informal|social control, informal
1276758|NCT01686139|Diabetic mellitus|diabetic mellitus
1276759|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
1276760|NCT01686139|Ischemic Limb|ischemic limb
1276761|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
1276762|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
1276763|NCT01686126|Gynecological Cancer|gynecological cancer
1276764|NCT01686113|Taste|taste
1276765|NCT01686113|Fat Taste|fat taste
1276766|NCT01686113|Threshold Testing|threshold testing
1276767|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
1276768|NCT01686100|Saphenous vein grafts|saphenous vein grafts
1276769|NCT01686074|Motor control|motor control
1276770|NCT01686074|walking|walking
1276771|NCT01686074|physical activity|physical activity
1276772|NCT01686074|Muscle activity|muscle activity
1276773|NCT01686022|Grass|grass
1276774|NCT01686022|Major allergen|major allergen
1276775|NCT01686022|cross-reactivity|cross-reactivity
1276776|NCT01686009|pain|pain
1276777|NCT01686009|analgesia|analgesia
1276778|NCT01686009|ketamine|ketamine
1276779|NCT01686009|intranasal|intranasal
1276780|NCT01686009|emergency|emergency
1276781|NCT01685996|tobacco|tobacco
1276782|NCT01685996|smoking cessation|smoking cessation
1276783|NCT01685996|nicotine|nicotine
1276784|NCT01685996|cigarettes|cigarettes
1276785|NCT01685996|nicotine withdrawal|nicotine withdrawal
1276786|NCT01685983|Prostate Cancer|prostate cancer
1276787|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
1276788|NCT01685983|Prostate specific antigen|prostate specific antigen
1276789|NCT01685983|Abiraterone acetate|abiraterone acetate
1276790|NCT01685983|JNJ-212082|jnj-212082
1276791|NCT01685983|Abiraterone|abiraterone
1276792|NCT01685983|Prednisolone|prednisolone
1276793|NCT01685983|Androgen Deprivation|androgen deprivation
1276794|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
1276795|NCT01685970|Bowel preparation|bowel preparation
1276796|NCT01685970|colonoscopy|colonoscopy
1276797|NCT01685970|polyethylene glycol|polyethylene glycol
1276798|NCT01685970|picosulfate|picosulfate
1276799|NCT01685957|Weight loss|weight loss
1276800|NCT01685957|Dietary intervention|dietary intervention
1276801|NCT01685957|Self-help book|self-help book
1276802|NCT01685957|Cooking|cooking
1276803|NCT01685957|Dietitian|dietitian
1276804|NCT01685957|Dietary therapy|dietary therapy
1276805|NCT01685931|Schizophrenia|schizophrenia
1276806|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
1276807|NCT01685931|Oral Antipsychotics|oral antipsychotics
1276808|NCT01685931|Invega Sustenna|invega sustenna
1276809|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
1276810|NCT01685918|aged|aged
1276811|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
1276812|NCT01685879|postprandial glycemic response|postprandial glycemic response
1276813|NCT01685879|postprandial insulin response|postprandial insulin response
1276814|NCT01685879|rice|rice
1276815|NCT01685879|appetite|appetite
1276816|NCT01685879|hunger|hunger
1276817|NCT01685866|anesthesia|anesthesia
1276818|NCT01685866|venous access|venous access
1276819|NCT01685840|Heart Failure|heart failure
1276820|NCT01685814|multiple myeloma|multiple myeloma
1276821|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
1276822|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
1276823|NCT01685814|lenalidomide|lenalidomide
1276824|NCT01685814|bortezomib|bortezomib
1276825|NCT01685775|Gallbladder|gallbladder
1276826|NCT01685775|cholecystectomy|cholecystectomy
1276827|NCT01685775|NOTES|notes
1276828|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
1276829|NCT01685775|gallstone|gallstone
1276830|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
1276831|NCT01685762|Uterus|uterus
1276832|NCT01685762|Pilot|pilot
1276833|NCT01685762|Metformin|metformin
1276834|NCT01685723|Cancer patients|cancer patients
1276835|NCT01685723|Smoking cessation|smoking cessation
1276836|NCT01685723|Risk communication|risk communication
1276837|NCT01685710|Arteriovenous fistula|arteriovenous fistula
1276838|NCT01685710|Patency|patency
1276839|NCT01685710|GTN patch|gtn patch
1276840|NCT01685684|Low back pain|low back pain
1276841|NCT01685684|Chronic back pain|chronic back pain
1276842|NCT01685684|Back pain|back pain
1276843|NCT01685684|Opioid|opioid
1276844|NCT01685684|Oxycodone|oxycodone
1276845|NCT01685684|DETERx|deterx
1276846|NCT01685684|Chronic pain|chronic pain
1276847|NCT01685684|Chronic low back pain|chronic low back pain
1276848|NCT01685684|CLBP|clbp
1276849|NCT01685684|Xtampza|xtampza
1276850|NCT01685671|CKD-11101|ckd-11101
1276851|NCT01685671|NESP|nesp
1276852|NCT01685671|Darbepoetin alfa|darbepoetin alfa
1276853|NCT01685671|Anemia|anemia
1276854|NCT01685671|subcutaneous|subcutaneous
1276855|NCT01685671|Pharmacokinetics|pharmacokinetics
1276856|NCT01685671|Phase 1|phase 1
1276857|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
1276858|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
1276859|NCT01685632|colorectal cancer|colorectal cancer
1276860|NCT01685632|ovarian cancer|ovarian cancer
1276861|NCT01685619|AML|aml
1276862|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
1276863|NCT01685619|MDS|mds
1276864|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
1276865|NCT01685619|Prognostic|prognostic
1276866|NCT01685619|Economic|economic
1276867|NCT01685606|Leukemia|leukemia
1276868|NCT01685606|Lymphoma|lymphoma
1276869|NCT01685606|Mantle cell|mantle cell
1276870|NCT01685606|DLBCL|dlbcl
1276871|NCT01685606|DLBC|dlbc
1276872|NCT01685606|Diffuse large B cell|diffuse large b cell
1276873|NCT01685606|T cell|t cell
1276874|NCT01685606|AML|aml
1276875|NCT01685606|ALL|all
1276876|NCT01685593|abdominal binder|abdominal binder
1276877|NCT01685580|primary lung cancer|primary lung cancer
1276878|NCT01685580|lobectomy|lobectomy
1276879|NCT01685580|pneumonectomy|pneumonectomy
1276880|NCT01685580|non-invasive ventilation|non-invasive ventilation
1276881|NCT01685567|carotid artery disease|carotid artery disease
1276882|NCT01685567|reverse flow|reverse flow
1276883|NCT01685554|perfusion|perfusion
1276884|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
1276885|NCT01685554|hypothermia|hypothermia
1276886|NCT01685554|cerebral oxygenation|cerebral oxygenation
1276887|NCT01685528|Anxiety|anxiety
1276888|NCT01685528|Depression|depression
1276889|NCT01685528|Geriatric|geriatric
1276890|NCT01685528|Veteran|veteran
1276891|NCT01685502|Glucobay OD|glucobay od
1276892|NCT01685502|Diabetes Mellitus|diabetes mellitus
1276893|NCT01685489|Prostate|prostate
1276894|NCT01685489|Neoplasm|neoplasm
1276895|NCT01685489|Adenocarcinoma|adenocarcinoma
1276896|NCT01685489|Cancer|cancer
1276897|NCT01685489|Metastatic|metastatic
1276898|NCT01685489|Castrate resistant|castrate resistant
1276899|NCT01685489|Docetaxel|docetaxel
1276900|NCT01685489|PSK|psk
1276901|NCT01685489|Krestin|krestin
1276902|NCT01685489|Trametes versicolor|trametes versicolor
1276903|NCT01685489|Safety|safety
1276904|NCT01685489|Maximum tolerated dose|maximum tolerated dose
1276905|NCT01685489|Mushroom|mushroom
1276906|NCT01685489|Natural|natural
1276907|NCT01685489|Immunotherapy|immunotherapy
1276908|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
1276909|NCT01685476|non invasive method|non invasive method
1276910|NCT01685476|indirect monitoring|indirect monitoring
1276911|NCT01685476|intracranial pressure|intracranial pressure
1276912|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
1276913|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
1276914|NCT01685450|non invasive method|non invasive method
1276915|NCT01685450|indirect measurement|indirect measurement
1276916|NCT01685450|intracranial pressure|intracranial pressure
1276917|NCT01685450|adults|adults
1276918|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
1276919|NCT01685424|Etoricoxib|etoricoxib
1276920|NCT01685424|ARCOXIA|arcoxia
1276921|NCT01685424|Osteoarthritis|osteoarthritis
1276922|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
1276923|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
1276924|NCT01685424|Gout|gout
1276925|NCT01685424|Arthritis|arthritis
1276926|NCT01685385|Dyspnoea|dyspnoea
1276927|NCT01685385|BNP|bnp
1276928|NCT01685385|Chronic heart failure|chronic heart failure
1276929|NCT01685385|congestive heart failure|congestive heart failure
1276930|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
1276931|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
1276932|NCT01685333|subject|subject
1276933|NCT01685320|Force|force
1276934|NCT01685320|Pressure|pressure
1276935|NCT01685320|Intubation|intubation
1276936|NCT01685320|laryngoscopy|laryngoscopy
1276937|NCT01685307|ileal digestibility|ileal digestibility
1276938|NCT01685307|metabolism|metabolism
1276939|NCT01685307|stable isotopes|stable isotopes
1276940|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1276941|NCT01685294|Suicidality|suicidality
1276942|NCT01685294|Incarcerated Populations|incarcerated populations
1276943|NCT01685294|Prisons|prisons
1276944|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
1276945|NCT01685281|ADHD , Inattention|adhd , inattention
1276946|NCT01685268|Prostate Cancer|prostate cancer
1276947|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
1276948|NCT01685255|PPC FTC|ppc ftc
1276949|NCT01685255|increasing CA 125|increasing ca 125
1276950|NCT01685216|VPRIV|vpriv
1276951|NCT01685216|velaglucerase alfa|velaglucerase alfa
1276952|NCT01685203|Hepatitis C Virus|hepatitis c virus
1276953|NCT01685203|Ribavirin-Free|ribavirin-free
1276954|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
1276955|NCT01685203|Hepatitis C|hepatitis c
1276956|NCT01685203|Interferon-Free|interferon-free
1276957|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
1276958|NCT01685203|Compensated cirrhosis|compensated cirrhosis
1276959|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
1276960|NCT01685203|Paritaprevir|paritaprevir
1276961|NCT01685203|Ombitasvir|ombitasvir
1276962|NCT01685203|Ritonavir|ritonavir
1276963|NCT01685203|Ribavirin|ribavirin
1276964|NCT01685177|Morbid obesity|morbid obesity
1276965|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
1276966|NCT01685177|Duodenal Switch|duodenal switch
1276967|NCT01685177|SADI-S|sadi-s
1276968|NCT01685164|nulliparous|nulliparous
1276969|NCT01685164|IUD|iud
1276970|NCT01685164|IUS|ius
1276971|NCT01685164|insertion|insertion
1276972|NCT01685164|expulsion|expulsion
1276973|NCT01685151|Drug therapy|drug therapy
1276974|NCT01685138|Non-Small Cell Lung Cancer, ALK, LDK378|non-small cell lung cancer, alk, ldk378
1276975|NCT01685112|adults|adults
1276976|NCT01685112|ECMO|ecmo
1276977|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
1276978|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
1276979|NCT01685073|marijuana|marijuana
1276980|NCT01685073|cannabis|cannabis
1276981|NCT01685073|treatment|treatment
1276982|NCT01685073|insomnia|insomnia
1276983|NCT01685073|relapse|relapse
1276984|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
1276985|NCT01685060|NSCLC|nsclc
1276986|NCT01685060|ALK|alk
1276987|NCT01685060|LDK378|ldk378
1276988|NCT01685060|Ceritinib|ceritinib
1276989|NCT01685047|Coronary Artery Disease|coronary artery disease
1276990|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
1276991|NCT01685047|ST Segment Changes|st segment changes
1276992|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
1276993|NCT01685034|Environmental allergens|environmental allergens
1277096|NCT01684605|Phase 1|phase 1
1276994|NCT01685034|Allergy immunotherapy|allergy immunotherapy
1276995|NCT01685034|Tolerance|tolerance
1276996|NCT01685034|Allergic rhinitis|allergic rhinitis
1276997|NCT01685034|Asthma|asthma
1276998|NCT01685034|Seasonal variation|seasonal variation
1276999|NCT01685021|B-ALL|b-all
1277000|NCT01685021|CD19|cd19
1277001|NCT01685021|MOR208|mor208
1277002|NCT01685021|MOR00208|mor00208
1277003|NCT01685021|Xmab5574|xmab5574
1277004|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
1277005|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
1277006|NCT01685008|NHL|nhl
1277007|NCT01685008|CD19|cd19
1277008|NCT01685008|MOR208|mor208
1277009|NCT01685008|MOR00208|mor00208
1277010|NCT01685008|Xmab5574|xmab5574
1277011|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
1277012|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
1277013|NCT01684982|Primary PCI|primary pci
1277014|NCT01684982|Drug Eluting Stent|drug eluting stent
1277015|NCT01684969|Nausea|nausea
1277016|NCT01684969|vomiting|vomiting
1277017|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
1277018|NCT01684969|palliative care|palliative care
1277019|NCT01684956|intradermal|intradermal
1277020|NCT01684956|pharmacokinetics|pharmacokinetics
1277021|NCT01684956|microneedle|microneedle
1277022|NCT01684956|insulin|insulin
1277023|NCT01684956|glucagon|glucagon
1277024|NCT01684943|Pharmacokinetics|pharmacokinetics
1277025|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
1277026|NCT01684930|Vascular Diseases|vascular diseases
1277027|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
1277028|NCT01684930|Exercise|exercise
1277029|NCT01684930|Functional Capacity|functional capacity
1277030|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
1277031|NCT01684839|Painful digital neuroma|painful digital neuroma
1277032|NCT01684839|nerve defect|nerve defect
1277033|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
1277034|NCT01684839|digital nerve|digital nerve
1277035|NCT01684839|pedicled nerve flap|pedicled nerve flap
1277036|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
1277037|NCT01684826|X-rays|x-rays
1277038|NCT01684826|Image processing|image processing
1277039|NCT01684826|Cardiovascular procedure|cardiovascular procedure
1277040|NCT01684813|Diabetes mellitus.|diabetes mellitus.
1277041|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
1277042|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
1277043|NCT01684787|chronic hepatitis C|chronic hepatitis c
1277044|NCT01684787|normal ALT|normal alt
1277045|NCT01684787|HIV/HCV patients|hiv/hcv patients
1277046|NCT01684761|Multicenter Study|multicenter study
1277047|NCT01684761|Randomized Controlled Trial|randomized controlled trial
1277048|NCT01684761|Individualized Medicine|individualized medicine
1277049|NCT01684761|Immunotherapy|immunotherapy
1277050|NCT01684761|Myelin Proteins|myelin proteins
1277051|NCT01684761|Biological Agents|biological agents
1277052|NCT01684748|angiotensin II|angiotensin ii
1277053|NCT01684748|obesity|obesity
1277054|NCT01684748|diabetes|diabetes
1277055|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
1277056|NCT01684722|vitamin D3|vitamin d3
1277057|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
1277058|NCT01684722|fish oil|fish oil
1277059|NCT01684722|diabetes|diabetes
1277060|NCT01684722|kidney disease|kidney disease
1277061|NCT01684722|albuminuria|albuminuria
1277062|NCT01684722|urine albumin excretion|urine albumin excretion
1277063|NCT01684722|glomerular filtration rate|glomerular filtration rate
1277064|NCT01684722|diabetic kidney disease|diabetic kidney disease
1277065|NCT01684709|Type 2 Diabetes|type 2 diabetes
1277066|NCT01684709|Informal Caregivers|informal caregivers
1277067|NCT01684709|Self Care|self care
1277068|NCT01684709|Quality of Life|quality of life
1277069|NCT01684709|Health Information Technology|health information technology
1277070|NCT01684696|Lung cancer|lung cancer
1277071|NCT01684696|stigma|stigma
1277072|NCT01684696|virtual intervention|virtual intervention
1277073|NCT01684696|mHealth|mhealth
1277074|NCT01684683|Bronchiectasis|bronchiectasis
1277075|NCT01684683|Theophylline|theophylline
1277076|NCT01684683|Therapeutic Uses|therapeutic uses
1277077|NCT01684683|HDAC|hdac
1277078|NCT01684683|HAT|hat
1277079|NCT01684683|Random placebo study|random placebo study
1277080|NCT01684657|Stuttering|stuttering
1277081|NCT01684644|ADHD|adhd
1277082|NCT01684644|Parent Training|parent training
1277083|NCT01684644|RCT|rct
1277084|NCT01684644|Preschool|preschool
1277085|NCT01684618|Preterm|preterm
1277086|NCT01684618|Neonate|neonate
1277087|NCT01684618|Newborn|newborn
1277088|NCT01684618|Cerebral oxygenation|cerebral oxygenation
1277089|NCT01684618|CPAP|cpap
1277090|NCT01684605|CKD-11101|ckd-11101
1277091|NCT01684605|NESP|nesp
1277092|NCT01684605|Darbepoetin alfa|darbepoetin alfa
1277093|NCT01684605|Anemia|anemia
1277094|NCT01684605|intravenous|intravenous
1277095|NCT01684605|Pharmacokinetics|pharmacokinetics
1277097|NCT01684592|smoking cessation|smoking cessation
1277098|NCT01684592|relapse prevention|relapse prevention
1277099|NCT01684592|pregnancy|pregnancy
1277100|NCT01684592|postpartum|postpartum
1277101|NCT01684579|Breast Cancer|breast cancer
1277102|NCT01684579|African-American Women|african-american women
1277103|NCT01684579|Aerobic Exercise|aerobic exercise
1277104|NCT01684553|Eating speed|eating speed
1277105|NCT01684553|energy intake|energy intake
1277106|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
1277107|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
1277108|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
1277109|NCT01684514|colitis, ulcerative|colitis, ulcerative
1277110|NCT01684501|prosthesis|prosthesis
1277111|NCT01684501|amputees|amputees
1277112|NCT01684501|gait|gait
1277113|NCT01684488|Depression/therapy;|depression/therapy;
1277114|NCT01684488|Developing Countries;|developing countries;
1277115|NCT01684488|Interpersonal Relations;|interpersonal relations;
1277116|NCT01684488|Life Change Events;|life change events;
1277117|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
1277118|NCT01684488|Resilience, Psychological;|resilience, psychological;
1277119|NCT01684488|Sierra Leone;|sierra leone;
1277120|NCT01684488|Survivors/psychology;|survivors/psychology;
1277121|NCT01684488|Social Adjustment;|social adjustment;
1277122|NCT01684488|Social Behavior;|social behavior;
1277123|NCT01684488|War|war
1277124|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
1277125|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
1277126|NCT01684462|Albumin|albumin
1277127|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
1277128|NCT01684449|Gemcitabine|gemcitabine
1277129|NCT01684449|Rapamycin|rapamycin
1277130|NCT01684449|Sirolimus|sirolimus
1277131|NCT01684449|mTOR inhibitor|mtor inhibitor
1277132|NCT01684449|Molecular biomarkers|molecular biomarkers
1277133|NCT01684410|Cystic Fibrosis|cystic fibrosis
1277134|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
1277135|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
1277136|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1277137|NCT01684384|COPD|copd
1277138|NCT01684384|Exacerbation|exacerbation
1277139|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
1277140|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
1277141|NCT01684384|HRCT scan|hrct scan
1277142|NCT01684384|Patient Reported Outcome|patient reported outcome
1277143|NCT01684384|PRO|pro
1277144|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
1277145|NCT01684384|CFD|cfd
1277146|NCT01684384|Lung function parameters|lung function parameters
1277147|NCT01684371|Osteoarthritis|osteoarthritis
1277148|NCT01684371|Osteoarthritic pain|osteoarthritic pain
1277149|NCT01684371|Arthritic pain|arthritic pain
1277150|NCT01684371|Arthritis|arthritis
1277151|NCT01684371|joint inflammation|joint inflammation
1277152|NCT01684371|Arthralgia|arthralgia
1277153|NCT01684358|Prostate-specific antigen|prostate-specific antigen
1277154|NCT01684358|Contraceptive implant|contraceptive implant
1277155|NCT01684358|Biological marker|biological marker
1277156|NCT01684358|Condoms|condoms
1277157|NCT01684358|Women|women
1277158|NCT01684345|Uveitis|uveitis
1277159|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
1277160|NCT01684345|Intermediate Uveitis|intermediate uveitis
1277161|NCT01684345|Posterior Uveitis|posterior uveitis
1277162|NCT01684345|Panuveitis|panuveitis
1277163|NCT01684332|Antioxidant|antioxidant
1277164|NCT01684332|glucose metabolism|glucose metabolism
1277165|NCT01684332|jam|jam
1277166|NCT01684332|polyphenols|polyphenols
1277167|NCT01684332|postprandial|postprandial
1277168|NCT01684332|strawberry|strawberry
1277169|NCT01684319|Constipation|constipation
1277170|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
1277171|NCT01684319|Colics|colics
1277172|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
1277173|NCT01684293|Cocaine|cocaine
1277174|NCT01684293|Cognitive Impairment|cognitive impairment
1277175|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
1277176|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
1277177|NCT01684267|Stroke|stroke
1277178|NCT01684267|Gait|gait
1277179|NCT01684267|Rehabilitation|rehabilitation
1277180|NCT01684254|Cerebral Palsy|cerebral palsy
1277181|NCT01684254|Home monitoring|home monitoring
1277182|NCT01684254|Gait|gait
1277183|NCT01684254|Sensorized Shoe|sensorized shoe
1277184|NCT01684241|Biontech|biontech
1277185|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
1277186|NCT01684241|Biontech RNA|biontech rna
1277187|NCT01684241|MERIT|merit
1277188|NCT01684241|RNA|rna
1277189|NCT01684241|Immuno Therapy|immuno therapy
1277190|NCT01684241|RB_0001-01|rb_0001-01
1277191|NCT01684241|Ribological|ribological
1277192|NCT01684241|Melanoma|melanoma
1277193|NCT01684241|RBL001|rbl001
1277194|NCT01684241|RBL002|rbl002
1277195|NCT01684241|cancer vaccine|cancer vaccine
1277196|NCT01684228|End stage renal disease|end stage renal disease
1277197|NCT01684228|hemodialysis|hemodialysis
1277198|NCT01684228|breath test|breath test
1277199|NCT01684228|volatile organic compound|volatile organic compound
1277200|NCT01684228|dialysis adequacy|dialysis adequacy
1277201|NCT01684215|Phase 1/2|phase 1/2
1277202|NCT01684215|PD-0332991|pd-0332991
1277203|NCT01684215|palbociclib|palbociclib
1277204|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
1277205|NCT01684215|Japanese|japanese
1277206|NCT01684215|solid tumors|solid tumors
1277207|NCT01684215|breast cancer|breast cancer
1277208|NCT01684215|A5481010|a5481010
1277209|NCT01684176|Stroke|stroke
1277210|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
1277211|NCT01684176|Medication adherence|medication adherence
1277212|NCT01684176|Motivational interviewing|motivational interviewing
1277213|NCT01684176|Stroke prevention|stroke prevention
1277214|NCT01684163|depression|depression
1277215|NCT01684163|MDD|mdd
1277216|NCT01684163|GLYX-13|glyx-13
1277217|NCT01684163|HDRS-17|hdrs-17
1277218|NCT01684163|HAMD-17|hamd-17
1277219|NCT01684150|Leukemia|leukemia
1277220|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
1277221|NCT01684150|Epizyme|epizyme
1277222|NCT01684150|Phase 1|phase 1
1277223|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
1277224|NCT01684137|Food supplements|food supplements
1277225|NCT01684137|Asthma bronchiale|asthma bronchiale
1277226|NCT01684124|oxygen|oxygen
1277227|NCT01684124|critical illness|critical illness
1277228|NCT01684124|mechanical ventilation|mechanical ventilation
1277229|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
1277230|NCT01684111|NSCLC Stage IV|nsclc stage iv
1277231|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
1277232|NCT01684098|head and neck cancer|head and neck cancer
1277233|NCT01684098|pancreas cancer|pancreas cancer
1277234|NCT01684098|bladder cancer|bladder cancer
1277235|NCT01684098|testicular cancer|testicular cancer
1277236|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
1277237|NCT01684072|varicella vaccine|varicella vaccine
1277238|NCT01684072|gelatin|gelatin
1277239|NCT01684046|multi-purpose solution|multi-purpose solution
1277240|NCT01684046|silicone hydrogel|silicone hydrogel
1277241|NCT01684046|contact lenses|contact lenses
1277242|NCT01684046|comfort|comfort
1277243|NCT01684046|Opti-Free|opti-free
1277244|NCT01684046|RevitaLens|revitalens
1277245|NCT01684033|multi-purpose solution|multi-purpose solution
1277246|NCT01684033|silicone hydrogel|silicone hydrogel
1277247|NCT01684033|contact lenses|contact lenses
1277248|NCT01684033|comfort|comfort
1277249|NCT01684033|Opti-Free|opti-free
1277250|NCT01684033|Biotrue|biotrue
1277251|NCT01684020|rhinoplasty|rhinoplasty
1277252|NCT01684020|external rhinoplasty|external rhinoplasty
1277253|NCT01684020|open rhinoplasty|open rhinoplasty
1277254|NCT01684020|nose job|nose job
1277255|NCT01684007|Intraocular lens|intraocular lens
1277256|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
1277257|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
1277258|NCT01683994|Small Molecules|small molecules
1277259|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1277260|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1277261|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
1277262|NCT01683981|Exercise Capacity|exercise capacity
1277263|NCT01683981|Quality of Life|quality of life
1277264|NCT01683955|Tranexamic Acid|tranexamic acid
1277265|NCT01683955|Blood transfusion|blood transfusion
1277266|NCT01683955|Total hip arthroplasty|total hip arthroplasty
1277267|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
1277268|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
1277269|NCT01683929|Obesity|obesity
1277270|NCT01683929|Overweight|overweight
1277271|NCT01683929|Sugar consumption|sugar consumption
1277272|NCT01683929|Metabolic syndrome|metabolic syndrome
1277273|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
1277274|NCT01683916|spinal cord injury|spinal cord injury
1277275|NCT01683916|stress hormone|stress hormone
1277276|NCT01683916|surgery|surgery
1277277|NCT01683916|bispectral index value|bispectral index value
1277278|NCT01683916|volatile anesthetic|volatile anesthetic
1277279|NCT01683903|heart failure|heart failure
1277280|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
1277281|NCT01683903|myocardial infarction|myocardial infarction
1277282|NCT01683890|Bladder symptoms|bladder symptoms
1277283|NCT01683890|Sexual function|sexual function
1277284|NCT01683890|Quality of life|quality of life
1277285|NCT01683890|Simple hysterectomy|simple hysterectomy
1277286|NCT01683851|pediatric|pediatric
1277287|NCT01683851|conscious sedation|conscious sedation
1277288|NCT01683851|mouthpiece|mouthpiece
1277289|NCT01683851|airway|airway
1277290|NCT01683851|isolite system|isolite system
1277291|NCT01683838|spinal cord injury|spinal cord injury
1277292|NCT01683838|muscle spasticity|muscle spasticity
1277293|NCT01683825|Amyloidosis|amyloidosis
1277294|NCT01683825|Cardiac|cardiac
1277295|NCT01683825|Heart|heart
1277296|NCT01683825|Imaging|imaging
1277297|NCT01683825|Diagnosis|diagnosis
1277298|NCT01683799|Osteoarthritis|osteoarthritis
1277299|NCT01683799|Insomnia|insomnia
1277300|NCT01683799|Chronic pain|chronic pain
1277301|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
1277302|NCT01683799|Inflammation|inflammation
1277303|NCT01683799|Inflammatory cytokines|inflammatory cytokines
1277304|NCT01683773|Tuberculosis|tuberculosis
1277305|NCT01683773|Phase I|phase i
1277306|NCT01683773|MVA85A|mva85a
1277307|NCT01683773|AERAS-402|aeras-402
1277308|NCT01683760|Fluconazole|fluconazole
1277309|NCT01683747|sepsis|sepsis
1277310|NCT01683747|shock|shock
1277311|NCT01683747|placebo controlled|placebo controlled
1277312|NCT01683747|double blinded|double blinded
1277313|NCT01683747|interventional|interventional
1277314|NCT01683708|sepsis|sepsis
1277315|NCT01683708|jaundice|jaundice
1277316|NCT01683708|symbiotic|symbiotic
1277317|NCT01683708|translocation|translocation
1277318|NCT01683708|abdominal collection|abdominal collection
1277319|NCT01683708|morbidity|morbidity
1277320|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
1277321|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
1277322|NCT01683682|NSCLC Stage IV|nsclc stage iv
1277324|NCT01683669|ARDS|ards
1277325|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
1277326|NCT01683656|HIV|hiv
1277327|NCT01683656|Atherosclerosis|atherosclerosis
1277328|NCT01683656|Niacin/laropiprant|niacin/laropiprant
1277329|NCT01683656|HDL|hdl
1277330|NCT01683630|Influenza|influenza
1277331|NCT01683630|Influenza type A|influenza type a
1277332|NCT01683630|Influenza type B|influenza type b
1277333|NCT01683630|hospitalization|hospitalization
1277334|NCT01683630|Manitoba|manitoba
1277335|NCT01683630|Canada|canada
1277336|NCT01683617|Psychological stress|psychological stress
1277337|NCT01683591|Acute stroke|acute stroke
1277338|NCT01683591|Dysphagia|dysphagia
1277339|NCT01683591|High-resolution manometry|high-resolution manometry
1277340|NCT01683578|mechanical ventilation|mechanical ventilation
1277341|NCT01683578|lung function|lung function
1277342|NCT01683578|abdominal surgery, open|abdominal surgery, open
1277343|NCT01683578|systemic inflammation|systemic inflammation
1277344|NCT01683552|ITCH|itch
1277345|NCT01683539|Schizophrenia|schizophrenia
1277346|NCT01683539|Chronic Mental Disorder|chronic mental disorder
1277347|NCT01683539|Employment|employment
1277348|NCT01683539|Cognitive remediation|cognitive remediation
1277349|NCT01683539|Vocational rehabilitation|vocational rehabilitation
1277350|NCT01683539|Brain-derived Neurotrophic Factor (BDNF)|brain-derived neurotrophic factor (bdnf)
1277351|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
1277352|NCT01683526|Direct laryngoscopy|direct laryngoscopy
1277353|NCT01683526|Video laryngoscopy|video laryngoscopy
1277354|NCT01683526|Glidescope|glidescope
1277355|NCT01683526|Critical Care|critical care
1277356|NCT01683513|OHSS|ohss
1277357|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
1277358|NCT01683513|good quality embryo's|good quality embryo's
1277359|NCT01683513|pregnancy|pregnancy
1277360|NCT01683474|aortic valve stenosis|aortic valve stenosis
1277361|NCT01683474|Calcification|calcification
1277362|NCT01683474|TAVI|tavi
1277363|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
1277364|NCT01683461|HIV|hiv
1277365|NCT01683461|AIDS|aids
1277366|NCT01683448|Perioperative medications|perioperative medications
1277367|NCT01683448|cardiac surgery|cardiac surgery
1277368|NCT01683448|outcomes|outcomes
1277369|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
1277370|NCT01683396|Osteoarthritis|osteoarthritis
1277371|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
1277372|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1277373|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
1277374|NCT01683383|Whole body cooling|whole body cooling
1277375|NCT01683383|Transport cooling|transport cooling
1277376|NCT01683357|Liver Metastases|liver metastases
1277377|NCT01683357|Surgery|surgery
1277378|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
1277379|NCT01683331|Kidney transplant|kidney transplant
1277380|NCT01683331|New onset diabetes|new onset diabetes
1277381|NCT01683331|Prevention|prevention
1277382|NCT01683331|Insulin|insulin
1277383|NCT01683305|biomarker,|biomarker,
1277384|NCT01683305|NAF|naf
1277385|NCT01683305|Subjects|subjects
1277386|NCT01683292|apomorphine|apomorphine
1277387|NCT01683292|inhaled|inhaled
1277388|NCT01683292|motor fluctuations|motor fluctuations
1277389|NCT01683279|pediatric|pediatric
1277390|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1277391|NCT01683279|CD19|cd19
1277392|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
1277393|NCT01683240|cholangiography|cholangiography
1277394|NCT01683240|cholangioscopy|cholangioscopy
1277395|NCT01683240|mother-baby|mother-baby
1277396|NCT01683240|cholangioscope|cholangioscope
1277397|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
1277398|NCT01683240|short access cholangioscopy|short access cholangioscopy
1277399|NCT01683240|ERCP|ercp
1277400|NCT01683240|gallstone therapy|gallstone therapy
1277401|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
1277402|NCT01683201|Total hip replacement|total hip replacement
1277403|NCT01683201|Functional exercise class|functional exercise class
1277404|NCT01683201|Randomised controlled trial|randomised controlled trial
1277405|NCT01683188|melanoma|melanoma
1277406|NCT01683188|skin cancer|skin cancer
1277407|NCT01683188|Stage IV|stage iv
1277408|NCT01683175|Erlotinib|erlotinib
1277409|NCT01683175|adjuvant therapy|adjuvant therapy
1277410|NCT01683175|radical operation|radical operation
1277411|NCT01683175|IIIA NSCLC|iiia nsclc
1277412|NCT01683175|EGFR mutation|egfr mutation
1277413|NCT01683162|parenteral nutrition|parenteral nutrition
1277414|NCT01683162|lipid emulsion|lipid emulsion
1277415|NCT01683162|olive oil|olive oil
1277416|NCT01683162|liver function|liver function
1277417|NCT01683162|fatty acid|fatty acid
1277418|NCT01683162|clinical outcomes|clinical outcomes
1277419|NCT01683149|Refractory|refractory
1277420|NCT01683149|Relapsed|relapsed
1277421|NCT01683149|Recurrent|recurrent
1277422|NCT01683149|Pediatric|pediatric
1277423|NCT01683149|Malignancy|malignancy
1277424|NCT01683123|Allogeneic HSCT|allogeneic hsct
1277425|NCT01683123|Busulfan|busulfan
1277426|NCT01683123|Fludarabina|fludarabina
1277427|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1277428|NCT01683084|AAA|aaa
1277429|NCT01683084|telmisartan|telmisartan
1277430|NCT01683071|Total knee arthroplasty|total knee arthroplasty
1277431|NCT01683071|Analgesia|analgesia
1277432|NCT01683071|Pain management|pain management
1277433|NCT01683058|Schizophrenia|schizophrenia
1277434|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
1277435|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
1277436|NCT01683045|atrial fibrillation|atrial fibrillation
1277437|NCT01683045|heart palpitations|heart palpitations
1277438|NCT01683045|irregular heart beat|irregular heart beat
1277439|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
1277440|NCT01683045|radiofrequency energy|radiofrequency energy
1277441|NCT01683045|TCRF energy|tcrf energy
1277442|NCT01683045|RF energy|rf energy
1277443|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
1277444|NCT01683045|concomitant heart surgery|concomitant heart surgery
1277445|NCT01683045|surgical ablation|surgical ablation
1277446|NCT01683019|Depression|depression
1277447|NCT01683019|magnetic field|magnetic field
1277448|NCT01683019|alpha frequency|alpha frequency
1277449|NCT01683019|EEG|eeg
1277450|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
1277451|NCT01682993|corneal cross linking|corneal cross linking
1277452|NCT01682993|topography guided excimer laser|topography guided excimer laser
1277453|NCT01682993|Keratoconus|keratoconus
1277454|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
1277455|NCT01682993|Post Excimer ectasia|post excimer ectasia
1277456|NCT01682980|Osteoarthritis|osteoarthritis
1277457|NCT01682980|Pain|pain
1277458|NCT01682980|Exercise|exercise
1277459|NCT01682980|Function|function
1277460|NCT01682980|Cartilage quality|cartilage quality
1277461|NCT01682967|Parturients|parturients
1277462|NCT01682967|Analgesia, epidural|analgesia, epidural
1277463|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
1277464|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
1277465|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
1277466|NCT01682928|Oligohydramnios|oligohydramnios
1277467|NCT01682928|Hydrotherapy|hydrotherapy
1277468|NCT01682928|Pregnancy|pregnancy
1277469|NCT01682915|ADHD|adhd
1277470|NCT01682915|endophenotype|endophenotype
1277471|NCT01682915|executive function|executive function
1277472|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
1277473|NCT01682915|resting-state fMRI|resting-state fmri
1277474|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
1277475|NCT01682915|DAT1|dat1
1277476|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
1277477|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
1277478|NCT01682850|COPD|copd
1277479|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1277480|NCT01682850|lung cancer|lung cancer
1277481|NCT01682850|emphysema|emphysema
1277482|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
1277483|NCT01682824|Central Nervous System|central nervous system
1277484|NCT01682824|CNS|cns
1277485|NCT01682824|CNS tumor|cns tumor
1277486|NCT01682824|Adolescent or Young Adult|adolescent or young adult
1277487|NCT01682824|AYA|aya
1277488|NCT01682824|Survivors|survivors
1277489|NCT01682824|Eating Questionnaire-Ecological Momentary Assessment|eating questionnaire-ecological momentary assessment
1277490|NCT01682824|EQ-EMA|eq-ema
1277491|NCT01682824|Cognitive restraint|cognitive restraint
1277492|NCT01682824|CR|cr
1277493|NCT01682824|Uncontrollable eating|uncontrollable eating
1277494|NCT01682824|UE|ue
1277495|NCT01682824|Three Factor Eating Questionnaire-R18v2|three factor eating questionnaire-r18v2
1277496|NCT01682824|TFEQ-R18v2|tfeq-r18v2
1277497|NCT01682824|Web-based questionnaire|web-based questionnaire
1277498|NCT01682824|Multifactor Screener|multifactor screener
1277499|NCT01682785|Major depressive disorder|major depressive disorder
1277500|NCT01682785|Metabolic syndrome|metabolic syndrome
1277501|NCT01682785|Thyroid dysfunction|thyroid dysfunction
1277502|NCT01682785|incidence|incidence
1277503|NCT01682772|Olaparib|olaparib
1277504|NCT01682772|Adenocarcinoma|adenocarcinoma
1277505|NCT01682772|Prostate|prostate
1277506|NCT01682759|diabetes|diabetes
1277507|NCT01682746|Brain Tumor|brain tumor
1277508|NCT01682746|Photodynamic Therapy|photodynamic therapy
1277509|NCT01682746|Photochemotherapy|photochemotherapy
1277510|NCT01682746|Astrocytoma|astrocytoma
1277511|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
1277512|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
1277513|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
1277514|NCT01682746|Glioblastoma|glioblastoma
1277515|NCT01682746|GBM|gbm
1277516|NCT01682746|Chordoma|chordoma
1277517|NCT01682746|Germinoma|germinoma
1277518|NCT01682746|Germ Cell Tumor|germ cell tumor
1277519|NCT01682746|Non-germinaoma|non-germinaoma
1277520|NCT01682746|CNS Lymphoma|cns lymphoma
1277521|NCT01682746|Craniopharyngioma|craniopharyngioma
1277522|NCT01682746|Brain Stem Glioma|brain stem glioma
1277523|NCT01682746|Ependymoma|ependymoma
1277524|NCT01682746|Mixed Glioma|mixed glioma
1277525|NCT01682746|Optic Nerve Glioma|optic nerve glioma
1277526|NCT01682746|Subependymoma|subependymoma
1277527|NCT01682746|Medulloblastoma|medulloblastoma
1277528|NCT01682746|Meningioma|meningioma
1277529|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
1277530|NCT01682746|Oligodendroglioma|oligodendroglioma
1277531|NCT01682746|Pituitary Tumors|pituitary tumors
1277532|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
1277533|NCT01682746|PNET|pnet
1277534|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
1277535|NCT01682746|DNET|dnet
1277536|NCT01682733|Obesity|obesity
1277537|NCT01682733|Weight loss|weight loss
1277538|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
1277539|NCT01682733|BMI 30-40|bmi 30-40
1277540|NCT01682720|HCV|hcv
1277541|NCT01682720|Genotype 2|genotype 2
1277542|NCT01682720|Genotype 3|genotype 3
1277543|NCT01682707|intubation|intubation
1277544|NCT01682707|coronary disease|coronary disease
1277545|NCT01682707|hemodynamic response|hemodynamic response
1277546|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
1277547|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
1277548|NCT01682681|Epilepsy|epilepsy
1277549|NCT01682681|Topiramate|topiramate
1277550|NCT01682681|Topmax|topmax
1277551|NCT01682668|parkinson's disease|parkinson's disease
1277552|NCT01682668|subthalamic nucleus|subthalamic nucleus
1277553|NCT01682668|akinesia|akinesia
1277554|NCT01682668|gait initiation|gait initiation
1277555|NCT01682668|neuronal activity|neuronal activity
1277556|NCT01682668|before STN stimulation|before stn stimulation
1277557|NCT01682668|with STN stimulation|with stn stimulation
1277558|NCT01682668|functional MRI|functional mri
1277559|NCT01682642|endometriosis|endometriosis
1277560|NCT01682642|pregnancy|pregnancy
1277561|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
1277562|NCT01682642|peritoneal implants|peritoneal implants
1277563|NCT01682642|embryo quality|embryo quality
1277564|NCT01682629|Pediatric|pediatric
1277565|NCT01682629|Cardiac|cardiac
1277566|NCT01682629|Arrest|arrest
1277567|NCT01682629|Simulation|simulation
1277568|NCT01682629|Debriefing|debriefing
1277569|NCT01682629|Realism|realism
1277570|NCT01682616|Safety|safety
1277571|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1277572|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1277573|NCT01682616|Rituximab|rituximab
1277574|NCT01682616|Tolerability|tolerability
1277575|NCT01682616|Pharmacokinetics|pharmacokinetics
1277576|NCT01682616|ABT-199|abt-199
1277577|NCT01682616|Cancer|cancer
1277578|NCT01682616|Preliminary|preliminary
1277579|NCT01682616|Efficacy|efficacy
1277580|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
1277581|NCT01682616|Venetoclax|venetoclax
1277582|NCT01682603|Nerve growth factor|nerve growth factor
1277583|NCT01682603|P2X3 receptor|p2x3 receptor
1277584|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
1277585|NCT01682603|Bladder function|bladder function
1277586|NCT01682603|Glomerular filtration rate|glomerular filtration rate
1277587|NCT01682603|Detrusor overactivity|detrusor overactivity
1277588|NCT01682603|Spinal cord injury|spinal cord injury
1277589|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
1277590|NCT01682577|Perindopril|perindopril
1277591|NCT01682577|Perindoprilat|perindoprilat
1277592|NCT01682577|Bioequivalence|bioequivalence
1277593|NCT01682577|Pharmacokinetic|pharmacokinetic
1277594|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
1277595|NCT01682564|Candemore|candemore
1277596|NCT01682564|Atacand|atacand
1277597|NCT01682564|Candesartan cilexetil|candesartan cilexetil
1277598|NCT01682564|Primary Hypertension|primary hypertension
1277599|NCT01682564|Congestive Hypertension|congestive hypertension
1277600|NCT01682551|High altitude illness|high altitude illness
1277601|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
1277602|NCT01682551|Chinese Medicine|chinese medicine
1277603|NCT01682551|High altitude medicine|high altitude medicine
1277604|NCT01682551|Mountain trekking|mountain trekking
1277605|NCT01682538|Orfadin|orfadin
1277606|NCT01682538|Nitisinone|nitisinone
1277607|NCT01682538|Bioequivalence|bioequivalence
1277608|NCT01682538|Bioavailability|bioavailability
1277609|NCT01682525|Fertility preservation|fertility preservation
1277610|NCT01682525|Ovarian Tissue|ovarian tissue
1277611|NCT01682525|Cryopreservation|cryopreservation
1277612|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
1374565|NCT01273376|MDD|mdd
1277613|NCT01682499|neuropathy|neuropathy
1277614|NCT01682499|taxane|taxane
1277615|NCT01682499|paclitaxel|paclitaxel
1277616|NCT01682499|calcium|calcium
1277617|NCT01682499|magnesium|magnesium
1277618|NCT01682499|prevention|prevention
1277619|NCT01682486|Medical device|medical device
1277620|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
1277621|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
1277622|NCT01682486|Tolerability|tolerability
1277623|NCT01682486|Safety|safety
1277624|NCT01682486|Performance|performance
1277625|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
1277626|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
1277627|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
1277628|NCT01682473|PI3K inhibitor|pi3k inhibitor
1277629|NCT01682473|clinical trial|clinical trial
1277630|NCT01682447|COPD|copd
1277631|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
1277632|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
1277633|NCT01682447|Quality of life|quality of life
1277634|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
1277635|NCT01682408|R406,|r406,
1277636|NCT01682408|Fostamatinib,|fostamatinib,
1277637|NCT01682408|Phase I,|phase i,
1277638|NCT01682408|Healthy Subjects,|healthy subjects,
1277639|NCT01682408|Pharmacokinetics,|pharmacokinetics,
1277640|NCT01682408|Fed/Fasted|fed/fasted
1277641|NCT01682395|Intestinal volvulus|intestinal volvulus
1277642|NCT01682395|Colon, sigmoid|colon, sigmoid
1277643|NCT01682395|Anastomosis, surgical|anastomosis, surgical
1277644|NCT01682395|Anastomotic leak|anastomotic leak
1277645|NCT01682395|Malawi|malawi
1277646|NCT01682395|Developing Country|developing country
1277647|NCT01682382|age-related macular degeneration|age-related macular degeneration
1277648|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
1277649|NCT01682382|genetics|genetics
1277650|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
1277651|NCT01682356|heart failure|heart failure
1277652|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
1277653|NCT01682356|oxygen consumption|oxygen consumption
1277654|NCT01682356|exercise tolerance|exercise tolerance
1277655|NCT01682317|eating frequency|eating frequency
1277656|NCT01682304|preeclampsia|preeclampsia
1277657|NCT01682304|hypertension|hypertension
1277658|NCT01682304|blood pressure|blood pressure
1277659|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
1277660|NCT01682304|chronic hypertension|chronic hypertension
1277661|NCT01682291|Prehypertension|prehypertension
1277662|NCT01682291|Life-style modifications|life-style modifications
1277663|NCT01682291|Dietary supplementation|dietary supplementation
1277664|NCT01682278|Health complaints|health complaints
1277665|NCT01682278|Amalgam|amalgam
1277666|NCT01682278|Mercury|mercury
1277667|NCT01682278|Plasma|plasma
1277668|NCT01682278|Cytokine|cytokine
1277669|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1277670|NCT01682226|CYCLOSPORINE|cyclosporine
1277671|NCT01682226|FLUDARABINE|fludarabine
1277672|NCT01682226|G-CSF|g-csf
1277673|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
1277674|NCT01682226|Cord Blood Transplantation|cord blood transplantation
1277675|NCT01682226|CliniMACS|clinimacs
1277676|NCT01682226|12-153|12-153
1277677|NCT01682213|Dabrafenib|dabrafenib
1277678|NCT01682213|(GSK2118436)|(gsk2118436)
1277679|NCT01682213|BRAFV600E/K|brafv600e/k
1277680|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
1277681|NCT01682213|12-124|12-124
1277682|NCT01682200|moderate|moderate
1277683|NCT01682200|facial acne|facial acne
1277684|NCT01682200|acne vulgaris|acne vulgaris
1277685|NCT01682161|Schizophrenia|schizophrenia
1277686|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
1277687|NCT01682161|Invega Sustenna|invega sustenna
1277688|NCT01682161|Antipsychotics|antipsychotics
1277689|NCT01682161|Atypical antipsychotics|atypical antipsychotics
1277690|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
1277691|NCT01682122|Blood Pressure|blood pressure
1277692|NCT01682122|Pediatrics|pediatrics
1277693|NCT01682122|Infant, Newborn|infant, newborn
1277694|NCT01682122|Cardiology|cardiology
1277695|NCT01682109|prophylaxis|prophylaxis
1277696|NCT01682109|herpes zoster|herpes zoster
1277697|NCT01682109|herpes simplex|herpes simplex
1277698|NCT01682109|valacyclovir|valacyclovir
1277699|NCT01682109|palatability|palatability
1277700|NCT01682109|paediatric|paediatric
1277701|NCT01682096|Chest pain|chest pain
1277702|NCT01682096|Emergency room|emergency room
1277703|NCT01682096|Acute coronary syndrome|acute coronary syndrome
1277704|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
1277705|NCT01682096|Stress echocardiography|stress echocardiography
1277706|NCT01682083|MEK inhibitor|mek inhibitor
1277707|NCT01682083|trametinib|trametinib
1277708|NCT01682083|Oncology|oncology
1277709|NCT01682083|adjuvant melanoma|adjuvant melanoma
1277710|NCT01682083|dabrafenib|dabrafenib
1277711|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
1277712|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
1277713|NCT01682083|BRAF inhibitor|braf inhibitor
1277714|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
1277715|NCT01682070|Dose range finding|dose range finding
1277716|NCT01682070|Dose tolerability|dose tolerability
1277717|NCT01682070|grass pollen|grass pollen
1277718|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
1277719|NCT01682070|Safety|safety
1277720|NCT01682070|Immunogenicity|immunogenicity
1277721|NCT01682057|High Blood Pressure|high blood pressure
1277722|NCT01682057|Hypertension|hypertension
1277723|NCT01682057|Resistant Hypertension|resistant hypertension
1277724|NCT01682018|emphysema|emphysema
1277725|NCT01682018|lung transplantation|lung transplantation
1277726|NCT01682005|Cost|cost
1277727|NCT01682005|Children|children
1277728|NCT01682005|Rotavirus|rotavirus
1277729|NCT01682005|Rotavirus vaccination|rotavirus vaccination
1277730|NCT01682005|Clinical|clinical
1277731|NCT01681992|Safety|safety
1277732|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
1277733|NCT01681992|Immunogenicity|immunogenicity
1277734|NCT01681979|fluticasone propionate|fluticasone propionate
1277735|NCT01681979|asthma|asthma
1277736|NCT01681979|pregnancy|pregnancy
1277737|NCT01681979|major congenital malformations|major congenital malformations
1277738|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
1277739|NCT01681914|adult HIV positive patients|adult hiv positive patients
1277740|NCT01681875|Biomarkers of exposure|biomarkers of exposure
1277741|NCT01681875|Compensatory smoking|compensatory smoking
1277742|NCT01681875|Nicotine dependence|nicotine dependence
1277743|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
1277744|NCT01681875|Tobacco withdrawal|tobacco withdrawal
1277745|NCT01681862|Hypertension|hypertension
1277746|NCT01681862|African American|african american
1277747|NCT01681862|Personal Health Record|personal health record
1277748|NCT01681862|Faith-based Organizations|faith-based organizations
1277749|NCT01681849|PTSD|ptsd
1277750|NCT01681849|childhood abuse|childhood abuse
1277751|NCT01681823|Prostate Cancer|prostate cancer
1277752|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
1277753|NCT01681823|Prostate Specific Antigen|prostate specific antigen
1277754|NCT01681823|Modified Citrus Pectin|modified citrus pectin
1277755|NCT01681823|PectaSol-C|pectasol-c
1277756|NCT01681823|Biochemical Relapse|biochemical relapse
1277757|NCT01681797|fluorescent angiography|fluorescent angiography
1277758|NCT01681797|reconstructive surgery|reconstructive surgery
1277759|NCT01681797|perforator flap|perforator flap
1277760|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
1277761|NCT01681784|biomarkers|biomarkers
1277762|NCT01681784|urodynamic studies|urodynamic studies
1277763|NCT01681758|cardiac surgery|cardiac surgery
1277764|NCT01681758|Pulse pressure variation|pulse pressure variation
1277765|NCT01681758|intravenous fluids|intravenous fluids
1277766|NCT01681732|Asthma|asthma
1277767|NCT01681732|child|child
1277768|NCT01681732|pediatric|pediatric
1277769|NCT01681719|VO2|vo2
1277770|NCT01681719|VCO2|vco2
1277771|NCT01681719|VE/VO2|ve/vo2
1277772|NCT01681719|heart rate|heart rate
1277773|NCT01681706|HIV|hiv
1277774|NCT01681706|Indicator disease|indicator disease
1277775|NCT01681654|Head/Neck Cancer|head/neck cancer
1277776|NCT01681654|Exercise|exercise
1277777|NCT01681654|Progressive Strength Training|progressive strength training
1277778|NCT01681654|Quality of Life|quality of life
1277779|NCT01681654|Cancer|cancer
1277780|NCT01681654|Randomized Controlled Trial|randomized controlled trial
1277781|NCT01681654|Nutrition|nutrition
1277782|NCT01681654|Lifestyle Intervention|lifestyle intervention
1277783|NCT01681641|Patients|patients
1277784|NCT01681641|Nursing|nursing
1277785|NCT01681641|Parkinsons disease|parkinsons disease
1277786|NCT01681641|Deep Brain Stimulation|deep brain stimulation
1277787|NCT01681641|Spouses|spouses
1277788|NCT01681628|Thought Field Therapy.|thought field therapy.
1277789|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
1277790|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
1277791|NCT01681628|Uganda|uganda
1277792|NCT01681628|Ugandan therapists.|ugandan therapists.
1277793|NCT01681628|Community treatment.|community treatment.
1277794|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
1277795|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
1277796|NCT01681602|Alzheimer Disease|alzheimer disease
1277797|NCT01681602|Exercise|exercise
1277798|NCT01681602|Cognition|cognition
1277799|NCT01681602|Quality of life|quality of life
1277800|NCT01681602|Cardiovascular fitness|cardiovascular fitness
1277801|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
1277802|NCT01681602|Physical fitness|physical fitness
1277803|NCT01681589|TBI|tbi
1277804|NCT01681589|Traumatic Brain Injury|traumatic brain injury
1277805|NCT01681589|Rehabilitation|rehabilitation
1277806|NCT01681589|Therapy|therapy
1333179|NCT01444170|range of motion|range of motion
1277807|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
1277808|NCT01681537|Relapsed|relapsed
1277809|NCT01681537|Refractory|refractory
1277810|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
1277811|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
1277812|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
1277813|NCT01681524|Coronary Artery Disease|coronary artery disease
1277814|NCT01681524|Myocardia Ischemia|myocardia ischemia
1277815|NCT01681524|Coronary Disease|coronary disease
1277816|NCT01681524|Heart Diseases|heart diseases
1277817|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
1277818|NCT01681524|Arteriosclerosis|arteriosclerosis
1277819|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
1277820|NCT01681524|Vascular Diseases|vascular diseases
1277821|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
1277822|NCT01681511|CAUTI|cauti
1277823|NCT01681498|pregnant|pregnant
1277824|NCT01681498|fetal ecg|fetal ecg
1277825|NCT01681498|ecg|ecg
1277826|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
1277827|NCT01681485|Non small cell lung cancer|non small cell lung cancer
1277828|NCT01681485|Surgery|surgery
1277829|NCT01681485|Chemotherapy|chemotherapy
1277830|NCT01681485|Radiation therapy|radiation therapy
1277831|NCT01681472|Colon cancer|colon cancer
1277832|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
1277833|NCT01681472|Rectal Neoplasms|rectal neoplasms
1277834|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
1277835|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
1277836|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1277837|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
1277838|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
1277839|NCT01681472|Therapeutic Uses|therapeutic uses
1277840|NCT01681472|Pharmacokinetics|pharmacokinetics
1277841|NCT01681472|Pharmacodynamics|pharmacodynamics
1277842|NCT01681459|Free fatty acid|free fatty acid
1277843|NCT01681459|Triglyceride|triglyceride
1277844|NCT01681459|Gastric emptying|gastric emptying
1277845|NCT01681459|Satiety hormones|satiety hormones
1277846|NCT01681459|Appetite|appetite
1277847|NCT01681459|Severe obesity|severe obesity
1277848|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
1277849|NCT01681446|interferon-alpha|interferon-alpha
1277850|NCT01681446|miR-26|mir-26
1277851|NCT01681433|OGX-427|ogx-427
1277852|NCT01681433|Abiraterone Acetate|abiraterone acetate
1277853|NCT01681420|HIV counseling|hiv counseling
1277854|NCT01681420|Blood donor HIV testing|blood donor hiv testing
1277855|NCT01681420|Brazil|brazil
1277856|NCT01681420|Blood banks|blood banks
1277857|NCT01681420|Blood donors|blood donors
1277858|NCT01681407|Depression|depression
1277859|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1277860|NCT01681407|MicroRNAs|micrornas
1277861|NCT01681407|Proteome|proteome
1277862|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
1277863|NCT01681368|Response Biomarkers|response biomarkers
1277864|NCT01681368|Progression-Free Survival|progression-free survival
1277865|NCT01681368|Pharmacokinetics|pharmacokinetics
1277866|NCT01681368|Pharmacodynamics|pharmacodynamics
1277867|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
1277868|NCT01681355|Infant formula|infant formula
1277869|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
1277870|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
1277871|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
1278074|NCT01680471|midazolam|midazolam
1277872|NCT01681329|Interpretation modification training|interpretation modification training
1277873|NCT01681329|Randomized clinical trial|randomized clinical trial
1277874|NCT01681329|Adults|adults
1277875|NCT01681316|Chronic Stable Angina|chronic stable angina
1277876|NCT01681316|Randomized Controlled Trial|randomized controlled trial
1277877|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
1277878|NCT01681264|Pain|pain
1277879|NCT01681264|Pain Management|pain management
1277880|NCT01681264|Back pain|back pain
1277881|NCT01681264|Neck pain|neck pain
1277882|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
1277883|NCT01681238|goal-directed therapy|goal-directed therapy
1277884|NCT01681238|elderly|elderly
1277885|NCT01681238|high-risk surgery|high-risk surgery
1277886|NCT01681225|ARDS|ards
1277887|NCT01681225|mechanical ventilation|mechanical ventilation
1277888|NCT01681225|ALI|ali
1277889|NCT01681225|esophageal pressure|esophageal pressure
1277890|NCT01681199|statin|statin
1277891|NCT01681199|atherosclerosis|atherosclerosis
1277892|NCT01681199|Coronary heart disease|coronary heart disease
1277893|NCT01681199|OPN|opn
1277894|NCT01681199|OPG|opg
1277895|NCT01681173|Nutritional support|nutritional support
1277896|NCT01681173|Diet therapy|diet therapy
1277897|NCT01681173|Diabetes prevention|diabetes prevention
1277898|NCT01681173|Insoluble fiber|insoluble fiber
1277899|NCT01681173|Healthy life style|healthy life style
1277900|NCT01681173|Weight loss|weight loss
1277901|NCT01681160|MAGGOT THERAPY|maggot therapy
1277902|NCT01681160|DIABETIC FOOT|diabetic foot
1277903|NCT01681160|NURSING CARE|nursing care
1277904|NCT01681160|DRESSING|dressing
1277905|NCT01681147|Gestational Diabetes|gestational diabetes
1277906|NCT01681147|postpartum|postpartum
1277907|NCT01681147|nutrition|nutrition
1277908|NCT01681147|exercise|exercise
1277909|NCT01681134|tacrolimus|tacrolimus
1277910|NCT01681134|Advagraf®|advagraf®
1277911|NCT01681134|Prograf®|prograf®
1277912|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
1277913|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
1277914|NCT01681134|Pharmacokinetics|pharmacokinetics
1277915|NCT01681134|Pharmacodynamics|pharmacodynamics
1277916|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
1277917|NCT01681095|Cardiovascular Agents|cardiovascular agents
1277918|NCT01681095|Therapeutic Uses|therapeutic uses
1277919|NCT01681095|Pharmacologic Actions|pharmacologic actions
1277920|NCT01681095|Mannitol|mannitol
1277921|NCT01681095|Cardiac Surgery|cardiac surgery
1277922|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
1277923|NCT01681095|HTK solution|htk solution
1277924|NCT01681095|Myocardial protection|myocardial protection
1277925|NCT01681095|Coronary Artery Disease|coronary artery disease
1277926|NCT01681095|Myocardial Ischemia|myocardial ischemia
1277927|NCT01681095|Coronary Disease|coronary disease
1277928|NCT01681095|Heart Diseases|heart diseases
1277929|NCT01681056|autosuggestion|autosuggestion
1277930|NCT01681056|quality of life|quality of life
1277931|NCT01681056|geriatric|geriatric
1277932|NCT01681056|serum cortisol|serum cortisol
1277933|NCT01681056|Interferon gamma|interferon gamma
1277934|NCT01681056|interleukin-2|interleukin-2
1277935|NCT01681056|interleukin-6|interleukin-6
1277936|NCT01681056|neuroplasticity|neuroplasticity
1277937|NCT01681043|Sleep|sleep
1277938|NCT01681017|Perinatal Mortality|perinatal mortality
1277939|NCT01681017|Asphyxia|asphyxia
1277940|NCT01681017|Stillbirth|stillbirth
1277941|NCT01681017|Neonatal Death|neonatal death
1277942|NCT01681017|Resuscitation|resuscitation
1277943|NCT01681017|Helping Babies Breathe|helping babies breathe
1277944|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
1277945|NCT01681004|si joint|si joint
1277946|NCT01681004|si joint pain|si joint pain
1277947|NCT01681004|si joint injury|si joint injury
1277948|NCT01681004|si joint treatment|si joint treatment
1277949|NCT01681004|si joint injections|si joint injections
1277950|NCT01681004|si joint inflammation|si joint inflammation
1277951|NCT01681004|si joint problems|si joint problems
1277952|NCT01681004|si joint symptoms|si joint symptoms
1277953|NCT01681004|hypermobile si joint|hypermobile si joint
1277954|NCT01681004|si joint arthritis|si joint arthritis
1277955|NCT01681004|si joint pain treatment|si joint pain treatment
1277956|NCT01681004|inflamed si joint|inflamed si joint
1277957|NCT01681004|si joint sclerosis|si joint sclerosis
1277958|NCT01681004|locked si joint|locked si joint
1277959|NCT01681004|si joint injuries|si joint injuries
1277960|NCT01681004|si joint disease|si joint disease
1277961|NCT01681004|si joint infection|si joint infection
1277962|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
1277963|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
1277964|NCT01680965|Graft vs. Host Disease|graft vs. host disease
1277965|NCT01680965|GVHD|gvhd
1277966|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
1277967|NCT01680965|Allogeneic Transplant|allogeneic transplant
1277968|NCT01680965|Ofatumumab|ofatumumab
1277969|NCT01680952|RECORD study|record study
1277970|NCT01680939|Pediatrics|pediatrics
1277971|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
1277972|NCT01680939|Adenotonsillectomy|adenotonsillectomy
1277973|NCT01680939|Analgesia|analgesia
1277974|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
1277975|NCT01680926|insulin|insulin
1277976|NCT01680926|hbA1c|hba1c
1277977|NCT01680926|body weight|body weight
1277978|NCT01680900|menopause|menopause
1277979|NCT01680900|hot flashes|hot flashes
1277980|NCT01680900|vilazodone|vilazodone
1277981|NCT01680887|Cocaine dependence|cocaine dependence
1277982|NCT01680874|Clostridium difficile|clostridium difficile
1277983|NCT01680874|Diarrhea|diarrhea
1277984|NCT01680874|Infection|infection
1277985|NCT01680874|Lactobacilli|lactobacilli
1277986|NCT01680874|Bifidobacteria|bifidobacteria
1277987|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
1277992|NCT01680861|Kidney transplant patients|kidney transplant patients
1277994|NCT01680848|Caries diagnosis,|caries diagnosis,
1277995|NCT01680848|Caries treatment,|caries treatment,
1277996|NCT01680848|Caries risk,|caries risk,
1277997|NCT01680848|Practice pattern,|practice pattern,
1277998|NCT01680848|Clinical epidemiology,|clinical epidemiology,
1277999|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
1278000|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
1278001|NCT01680809|Venous insufficiency|venous insufficiency
1606493|NCT00370968|Children|children
1375010|NCT01271790|HCV|hcv
1278002|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
1278003|NCT01680809|Compression stockings|compression stockings
1278004|NCT01680809|Compression stocking compliance|compression stocking compliance
1278005|NCT01680796|Multiple Myeloma|multiple myeloma
1278006|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
1278007|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
1278012|NCT01680770|shock|shock
1278013|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
1278014|NCT01680770|critical care|critical care
1278015|NCT01680757|Left Atrial Appendage|left atrial appendage
1278016|NCT01680757|LARIAT|lariat
1278017|NCT01680757|atrial fibrillation|atrial fibrillation
1278018|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
1278019|NCT01680744|Transplantation|transplantation
1278020|NCT01680744|Terminal creatinine|terminal creatinine
1278021|NCT01680744|Renal function|renal function
1278023|NCT01680731|Pelvic floor injury|pelvic floor injury
1278024|NCT01680731|Levator ani muscle|levator ani muscle
1278025|NCT01680718|oxytocin|oxytocin
1278026|NCT01680718|vasopressin|vasopressin
1278027|NCT01680718|intranasal administration|intranasal administration
1278028|NCT01680718|healthy sample|healthy sample
1278029|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
1278030|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
1278031|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
1278032|NCT01680705|Frequency|frequency
1278033|NCT01680705|Postoperative|postoperative
1278034|NCT01680705|High Volume|high volume
1278035|NCT01680705|Randomized Control Trial|randomized control trial
1278036|NCT01680705|Single Blinded|single blinded
1278037|NCT01680705|Prospective Study|prospective study
1278038|NCT01680705|Quality of Life|quality of life
1278039|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
1278040|NCT01680692|Analgesia TKA|analgesia tka
1278041|NCT01680692|Total knee arthroplasty|total knee arthroplasty
1278042|NCT01680692|Continuous femoral catheter|continuous femoral catheter
1278043|NCT01680692|Continuous tibial catheter|continuous tibial catheter
1278044|NCT01680692|Single shot sciatic|single shot sciatic
1278045|NCT01680679|Influenza|influenza
1278046|NCT01680679|India|india
1278047|NCT01680679|Children|children
1278048|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
1278049|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
1278050|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
1278051|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
1278052|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
1278053|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
1278054|NCT01680640|NAFLD|nafld
1278055|NCT01680640|synbiotic|synbiotic
1278056|NCT01680640|gut microbiota|gut microbiota
1278057|NCT01680640|intervention|intervention
1278058|NCT01680640|RCT|rct
1278059|NCT01680640|biomarkers|biomarkers
1278060|NCT01680588|Alzheimer|alzheimer
1278061|NCT01680575|Neutropenia|neutropenia
1278062|NCT01680575|Paclitaxel|paclitaxel
1278063|NCT01680575|Carboplatin|carboplatin
1278064|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
1278065|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
1278066|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
1278067|NCT01680523|cervical cancer|cervical cancer
1278068|NCT01680523|bulky early-stage|bulky early-stage
1278069|NCT01680523|locally advanced|locally advanced
1278070|NCT01680523|radical hysterectomy|radical hysterectomy
1278071|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
1278072|NCT01680484|non-stress test|non-stress test
1278073|NCT01680471|emergence agitation|emergence agitation
1278075|NCT01680471|sevoflurane|sevoflurane
1278076|NCT01680471|strabismus|strabismus
1278077|NCT01680458|antifungal treatment|antifungal treatment
1278078|NCT01680458|prophylaxis|prophylaxis
1278079|NCT01680458|administration|administration
1278080|NCT01680458|Japanese|japanese
1278081|NCT01680458|infants|infants
1278082|NCT01680458|fluconazole|fluconazole
1278083|NCT01680458|Diflucan|diflucan
1278084|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
1278085|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
1278086|NCT01680432|constipation|constipation
1278087|NCT01680432|probiotics|probiotics
1278088|NCT01680432|bifidobacterium|bifidobacterium
1278089|NCT01680432|cheese|cheese
1278090|NCT01680419|Veterans|veterans
1278091|NCT01680419|Reintegration|reintegration
1278092|NCT01680419|Resilience|resilience
1278093|NCT01680419|Marital|marital
1278094|NCT01680419|Spouse|spouse
1278095|NCT01680419|Behavioral intervention|behavioral intervention
1278096|NCT01680419|PTSD|ptsd
1278097|NCT01680419|Integrative therapies|integrative therapies
1278098|NCT01680419|Complementary therapies|complementary therapies
1278099|NCT01680419|Massage|massage
1278100|NCT01680419|Meditation|meditation
1278101|NCT01680419|Mindfulness|mindfulness
1278102|NCT01680419|Compassion|compassion
1278103|NCT01680419|Mental health|mental health
1278104|NCT01680406|Plasmodium vivax|plasmodium vivax
1278105|NCT01680406|malaria|malaria
1278106|NCT01680406|Ethiopia|ethiopia
1278107|NCT01680406|Sub-Saharan Africa|sub-saharan africa
1278108|NCT01680406|primaquine|primaquine
1278109|NCT01680406|artemether lumefantrine|artemether lumefantrine
1278110|NCT01680406|chloroquine|chloroquine
1278111|NCT01680380|sleep apnea|sleep apnea
1278112|NCT01680380|snoring|snoring
1278113|NCT01680315|Satiety,|satiety,
1278114|NCT01680315|satiation,|satiation,
1278115|NCT01680315|anticipation,|anticipation,
1278116|NCT01680315|food intake|food intake
1278117|NCT01680302|Atrial fibrillation|atrial fibrillation
1278118|NCT01680302|Prevention|prevention
1278119|NCT01680302|Exercise|exercise
1278120|NCT01680289|Dentin bonding agents|dentin bonding agents
1278121|NCT01680289|Composite restorations|composite restorations
1278122|NCT01680289|Dental restoration failure|dental restoration failure
1278123|NCT01680276|intellectual disability|intellectual disability
1278124|NCT01680276|developmental disability|developmental disability
1278125|NCT01680276|challenging behaviour|challenging behaviour
1278126|NCT01680276|behavioural intervention|behavioural intervention
1278127|NCT01680276|training|training
1278128|NCT01680263|Kinesiotaping|kinesiotaping
1278129|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
1278130|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
1278131|NCT01680263|physical therapy|physical therapy
1278132|NCT01680250|Total liver volume|total liver volume
1278133|NCT01680250|Liver cyst|liver cyst
1278134|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
1278135|NCT01680237|exposure in-vivo|exposure in-vivo
1278136|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
1278137|NCT01680224|Obesity|obesity
1278138|NCT01680224|Weight Gain|weight gain
1278139|NCT01680224|Dissonance|dissonance
1278140|NCT01680224|College,University Students|college,university students
1278141|NCT01680224|Eating Disorders|eating disorders
1278142|NCT01680224|Obesity Prevention|obesity prevention
1278143|NCT01680224|Selective Prevention|selective prevention
1278144|NCT01680224|Effectiveness|effectiveness
1278145|NCT01680211|Blood Sugar,|blood sugar,
1278146|NCT01680211|Lipoproteins,|lipoproteins,
1278147|NCT01680211|Salacia,|salacia,
1278148|NCT01680211|Sesame,|sesame,
1278149|NCT01680211|Prediabetes,|prediabetes,
1278150|NCT01680211|Hyperlipidemia,|hyperlipidemia,
1278151|NCT01680211|Herbal supplement|herbal supplement
1278152|NCT01680198|Vitamin D|vitamin d
1278153|NCT01680198|Paracalcitol|paracalcitol
1278154|NCT01680198|Chronic kidney disease|chronic kidney disease
1278155|NCT01680198|Endothelial dysfunction|endothelial dysfunction
1278156|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
1278157|NCT01680185|Hyperglycemia|hyperglycemia
1278158|NCT01680185|NODAT|nodat
1278159|NCT01680185|Insulin pump|insulin pump
1278160|NCT01680185|Semiclosed loop|semiclosed loop
1278161|NCT01680172|cancer|cancer
1278162|NCT01680172|depression|depression
1278163|NCT01680172|anxiety|anxiety
1278164|NCT01680172|palliative care|palliative care
1278165|NCT01680159|Infliximab|infliximab
1278166|NCT01680159|REMICADE|remicade
1278167|NCT01680159|TA-650|ta-650
1278168|NCT01680159|psoriasis|psoriasis
1278169|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
1278170|NCT01680094|HIV Infection|hiv infection
1278171|NCT01680094|Panobinostat|panobinostat
1278172|NCT01680094|Lentivirus Infections|lentivirus infections
1278173|NCT01680094|Retroviridae Infections|retroviridae infections
1278174|NCT01680094|RNA Virus Infections|rna virus infections
1278175|NCT01680094|Virus Diseases|virus diseases
1278176|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1278268|NCT01679535|Child nutrition disorders|child nutrition disorders
1278177|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
1278178|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1278179|NCT01680094|Immune System Diseases|immune system diseases
1278180|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1278181|NCT01680094|Therapeutic Uses|therapeutic uses
1278182|NCT01680068|Macular hole|macular hole
1278277|NCT01679470|lung|lung
1278183|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
1278184|NCT01680068|Macular surgery|macular surgery
1278185|NCT01680068|Air tamponade|air tamponade
1278186|NCT01680042|inflammatory halo|inflammatory halo
1278187|NCT01680042|VAS|vas
1278188|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
1278189|NCT01679964|HIV infection|hiv infection
1278190|NCT01679964|Raltegravir|raltegravir
1278191|NCT01679964|Adverse event|adverse event
1278192|NCT01679964|Life quality|life quality
1278193|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
1278194|NCT01679951|Swollen and tender joints|swollen and tender joints
1278195|NCT01679951|Methotrexate|methotrexate
1278196|NCT01679951|Immunology|immunology
1606494|NCT00370968|India|india
1278197|NCT01679951|Dose range finding study|dose range finding study
1278198|NCT01679938|obesity prevention|obesity prevention
1278199|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
1278200|NCT01679938|preschool-aged children|preschool-aged children
1278201|NCT01679925|Early puberty|early puberty
1278202|NCT01679925|Psychosocial impact|psychosocial impact
1278203|NCT01679925|Qualitative assessment|qualitative assessment
1278204|NCT01679912|Hereditary angioedema|hereditary angioedema
1278205|NCT01679912|Emergency Medical Service|emergency medical service
1278206|NCT01679912|Health care coast|health care coast
1278207|NCT01679912|Telephone|telephone
1278208|NCT01679899|diabetes|diabetes
1278209|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
1278210|NCT01679899|osteopenia|osteopenia
1278211|NCT01679899|osteoporosis|osteoporosis
1278212|NCT01679899|glycemic variability|glycemic variability
1278213|NCT01679899|bone markers|bone markers
1278214|NCT01679899|osteocalcin|osteocalcin
1278215|NCT01679899|NTX|ntx
1278216|NCT01679899|CTX|ctx
1278217|NCT01679899|BALP|balp
1278218|NCT01679886|Position emission tomography;|position emission tomography;
1278219|NCT01679886|Rubidium;|rubidium;
1278220|NCT01679886|Women;|women;
1278221|NCT01679886|Overweighted patients|overweighted patients
1278222|NCT01679873|confidence|confidence
1278223|NCT01679873|funding sources|funding sources
1278224|NCT01679873|conflicts of interests|conflicts of interests
1278225|NCT01679873|general practitioner|general practitioner
1278226|NCT01679847|Elemene|elemene
1278227|NCT01679847|pharmacokinetics|pharmacokinetics
1278228|NCT01679847|Blood-brain barrier|blood-brain barrier
1278229|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
1278230|NCT01679821|Dental prosthesis.|dental prosthesis.
1278231|NCT01679821|Dental students|dental students
1278232|NCT01679808|copd|copd
1278233|NCT01679808|airway obstruction|airway obstruction
1278234|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
1278235|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
1278236|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
1278237|NCT01679756|Colorectal cancer|colorectal cancer
1278238|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
1278239|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
1278240|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
1278241|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
1278242|NCT01679743|Monoclonal Antibody|monoclonal antibody
1278243|NCT01679743|18FLT|18flt
1278244|NCT01679743|Surgery|surgery
1278245|NCT01679717|Osteoarthritis|osteoarthritis
1278246|NCT01679717|CMC1-joint|cmc1-joint
1278247|NCT01679717|Postoperative therapy|postoperative therapy
1278248|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
1278249|NCT01679717|Occupational therapy|occupational therapy
1278250|NCT01679652|Essential hypertension|essential hypertension
1278251|NCT01679652|Nitric oxide|nitric oxide
1278252|NCT01679652|Nebivolol|nebivolol
1278253|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
1278254|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
1278255|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
1278256|NCT01679626|AP-rima distances|ap-rima distances
1278257|NCT01679626|Glottic area|glottic area
1278258|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
1278259|NCT01679600|Rehabilitation|rehabilitation
1278260|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
1278261|NCT01679600|Aerobic Capacity|aerobic capacity
1278262|NCT01679600|Exercise Testing|exercise testing
1278263|NCT01679574|PCO|pco
1278264|NCT01679561|implantation failure|implantation failure
1278265|NCT01679561|recurrent abortion|recurrent abortion
1278266|NCT01679561|intralipid|intralipid
1278267|NCT01679535|Infant nutrition disorder|infant nutrition disorder
1278269|NCT01679535|Malnutrition|malnutrition
1278270|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
1278271|NCT01679522|endometrial cancer|endometrial cancer
1278272|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
1278273|NCT01679522|single-port|single-port
1278274|NCT01679522|four-port|four-port
1278275|NCT01679496|LDL-cholesterol|ldl-cholesterol
1278276|NCT01679470|cancer|cancer
1278278|NCT01679470|laser|laser
1278279|NCT01679470|ablation|ablation
1278280|NCT01679470|airway obstruction|airway obstruction
1278281|NCT01679444|MRS|mrs
1278282|NCT01679444|Heavy dose drinkers|heavy dose drinkers
1278283|NCT01679444|Alcohol|alcohol
1278284|NCT01679444|NIAAA|niaaa
1278285|NCT01679431|Aortic Stenosis|aortic stenosis
1278286|NCT01679431|Obesity, Abdominal|obesity, abdominal
1278287|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
1278288|NCT01679431|Insulin Resistance|insulin resistance
1278289|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
1278290|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
1606495|NCT00370968|Hospital|hospital
1278291|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
1278292|NCT01679418|PONV|ponv
1278293|NCT01679418|thyroid|thyroid
1278294|NCT01679418|surgery|surgery
1278295|NCT01679418|nausea and vomiting|nausea and vomiting
1278296|NCT01679418|postoperative|postoperative
1278297|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
1278298|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
1278299|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
1278300|NCT01679379|Cesarean Section|cesarean section
1278301|NCT01679379|Obese Women|obese women
1278302|NCT01679379|Surgical Site Infection|surgical site infection
1278303|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
1278304|NCT01679340|Gastric cancer|gastric cancer
1278305|NCT01679340|D2 surgery|d2 surgery
1278307|NCT01679340|Oxaliplatin|oxaliplatin
1278308|NCT01679340|cisplatin|cisplatin
1278309|NCT01679314|COPD|copd
1278310|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
1278311|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
1278312|NCT01679314|nVNS|nvns
1278313|NCT01679314|VNS|vns
1278314|NCT01679314|non invasive|non invasive
1278315|NCT01679314|gammacore|gammacore
1278316|NCT01679301|oxygen|oxygen
1278317|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
1278318|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1278319|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
1278320|NCT01679288|Cardiovascular risk|cardiovascular risk
1278321|NCT01679288|Primary Health Care|primary health care
1278322|NCT01679275|Heart Defects, congenital|heart defects, congenital
1278323|NCT01679275|Patient Monitoring|patient monitoring
1278324|NCT01679275|Infant, Newborn|infant, newborn
1278325|NCT01679275|Physiology|physiology
1278326|NCT01679249|extracellular fluid volume|extracellular fluid volume
1278327|NCT01679249|hypotension|hypotension
1278328|NCT01679249|hemodialysis|hemodialysis
1278329|NCT01679236|Smoking|smoking
1278330|NCT01679236|Smoking cessation|smoking cessation
1278331|NCT01679236|Nicotine|nicotine
1278332|NCT01679236|Tobacco|tobacco
1278333|NCT01679236|Mindfulness|mindfulness
1278334|NCT01679236|Meditation|meditation
1278335|NCT01679236|MBSR|mbsr
1278336|NCT01679236|Mindfulness Training|mindfulness training
1278337|NCT01679236|Behavioral Intervention|behavioral intervention
1278338|NCT01679236|Alcohol|alcohol
1278339|NCT01679236|Young Adults|young adults
1278340|NCT01679223|Breast reconstruction|breast reconstruction
1278341|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
1278342|NCT01679223|neoangiogenesis|neoangiogenesis
1278343|NCT01679223|collagen deposition|collagen deposition
1278344|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1278345|NCT01679197|NAFLD|nafld
1278346|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1278347|NCT01679197|NASH|nash
1278348|NCT01679197|Lipodystrophy|lipodystrophy
1278349|NCT01679197|Leptin|leptin
1278350|NCT01679197|Metreleptin|metreleptin
1278351|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
1278352|NCT01679197|Diabetes mellitus|diabetes mellitus
1278353|NCT01679171|Elderly|elderly
1278354|NCT01679171|Intensive care unit|intensive care unit
1278355|NCT01679171|Outcome|outcome
1278356|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
1278357|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
1278358|NCT01679145|Reward- based learning|reward- based learning
1278359|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
1278360|NCT01679145|Functional imaging|functional imaging
1278361|NCT01679145|Relapse risk|relapse risk
1278362|NCT01679132|Hypertension|hypertension
1278363|NCT01679132|High Blood Pressure|high blood pressure
1278364|NCT01679132|Blood Pressure|blood pressure
1278365|NCT01679132|Cardiovascular Disease|cardiovascular disease
1278366|NCT01679132|Resistant Hypertension|resistant hypertension
1278367|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
1278368|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
1278369|NCT01679119|Gemcitabine|gemcitabine
1278370|NCT01679119|Rituximab|rituximab
1278371|NCT01679119|Cyclophosphamide|cyclophosphamide
1278372|NCT01679119|Vincristine|vincristine
1278373|NCT01679119|Prednisolone|prednisolone
1278374|NCT01679106|renal transplant|renal transplant
1278375|NCT01679106|flank incision|flank incision
1278376|NCT01679093|postoperative analgesia|postoperative analgesia
1278377|NCT01679093|paracetamol|paracetamol
1278378|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
1278379|NCT01679093|ondansetron|ondansetron
1278380|NCT01679093|PainMatcher|painmatcher
1278381|NCT01679080|Drug therapy|drug therapy
1278382|NCT01679080|Adult|adult
1278383|NCT01679067|HIV|hiv
1278384|NCT01679067|GALT|galt
1278385|NCT01679054|Neoplasm|neoplasm
1278386|NCT01679054|Gastric Cancer|gastric cancer
1278387|NCT01679054|Cost|cost
1278388|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
1278389|NCT01679015|Burning|burning
1278390|NCT01679015|Dryness|dryness
1278391|NCT01679015|Itching|itching
1278392|NCT01679015|Blurry Vision|blurry vision
1278393|NCT01679002|Epilepsy|epilepsy
1278394|NCT01679002|Oxcarbazepine|oxcarbazepine
1278395|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
1278396|NCT01679002|BIA 2-093|bia 2-093
1278397|NCT01678989|Bipolar disorder|bipolar disorder
1278398|NCT01678989|Children|children
1278399|NCT01678989|Cranial MRI|cranial mri
1278400|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
1278401|NCT01678976|Epilepsy|epilepsy
1278402|NCT01678976|Oxcarbazepine|oxcarbazepine
1278403|NCT01678963|Neovascular AMD|neovascular amd
1278404|NCT01678963|Wet AMD|wet amd
1278405|NCT01678963|AMD|amd
1278406|NCT01678963|Age related macular degeneration|age related macular degeneration
1278407|NCT01678950|Cardiac output monitoring|cardiac output monitoring
1278408|NCT01678950|Echocardiography|echocardiography
1278409|NCT01678950|Pulse contour system|pulse contour system
1278410|NCT01678937|Immunosuppression|immunosuppression
1278411|NCT01678911|Pelvic Pain|pelvic pain
1278412|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
1278413|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
1278414|NCT01678911|IBS|ibs
1278415|NCT01678911|Ulcerative Colitis|ulcerative colitis
1278416|NCT01678911|UC|uc
1278417|NCT01678911|Interstitial Cystitis|interstitial cystitis
1278418|NCT01678911|IC|ic
1278419|NCT01678911|Prostatitis|prostatitis
1278420|NCT01678911|Pain|pain
1278421|NCT01678898|Fabry disease|fabry disease
1278422|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
1278423|NCT01678898|Metabolic storage disease|metabolic storage disease
1278424|NCT01678859|infertility|infertility
1278425|NCT01678859|cervical|cervical
1278426|NCT01678859|mucus|mucus
1278427|NCT01678859|sperm|sperm
1278428|NCT01678859|interaction|interaction
1278429|NCT01678846|corporal punishment|corporal punishment
1278430|NCT01678846|violence|violence
1278431|NCT01678846|education|education
1278432|NCT01678846|depression|depression
1278433|NCT01678846|anxiety|anxiety
1278434|NCT01678846|conduct disorder|conduct disorder
1278435|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
1278436|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
1278437|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
1278438|NCT01678781|Abdominal pain|abdominal pain
1278439|NCT01678781|Diarrhea|diarrhea
1278440|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
1278441|NCT01678781|Constipation|constipation
1278442|NCT01678781|Pinaverium bromide|pinaverium bromide
1278443|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
1278444|NCT01678781|Bloating|bloating
1278445|NCT01678781|Quality of life|quality of life
1278446|NCT01678755|schizophrenia|schizophrenia
1278447|NCT01678742|Diet|diet
1278448|NCT01678742|Incretins|incretins
1278449|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
1278450|NCT01678742|Fish Proteins|fish proteins
1278451|NCT01678729|refractive surgery|refractive surgery
1278452|NCT01678729|pupil|pupil
1278453|NCT01678729|Pupil size|pupil size
1278454|NCT01678716|Anemia|anemia
1278455|NCT01678716|Breastfeeding|breastfeeding
1278456|NCT01678716|Complementary feeding|complementary feeding
1278457|NCT01678716|Stunting|stunting
1278458|NCT01678716|Wasting|wasting
1278459|NCT01678716|Underweight|underweight
1278460|NCT01678716|Micronutrient powder|micronutrient powder
1278461|NCT01678716|Behavior change counseling|behavior change counseling
1278462|NCT01678716|Frontline health worker|frontline health worker
1278463|NCT01678703|late abortion|late abortion
1278464|NCT01678703|laminaria|laminaria
1278465|NCT01678703|Misoprostol|misoprostol
1278466|NCT01678703|Cervical preparation|cervical preparation
1278467|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
1278468|NCT01678677|immunogenicity|immunogenicity
1278469|NCT01678677|reactogenicity|reactogenicity
1278470|NCT01678677|safety|safety
1278471|NCT01678664|cancer|cancer
1278472|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
1278473|NCT01678664|gastrointestinal tract|gastrointestinal tract
1278474|NCT01678664|metastases|metastases
1278475|NCT01678664|liver|liver
1278476|NCT01678664|hepatic|hepatic
1278477|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
1278478|NCT01678638|inguinal hernia|inguinal hernia
1278479|NCT01678638|premature infants|premature infants
1278480|NCT01678638|anesthesia safety|anesthesia safety
1278481|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
1278482|NCT01678638|preterm infants|preterm infants
1278483|NCT01678638|neonatal prematurity|neonatal prematurity
1278684|NCT01677845|Radiation|radiation
1278484|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
1278485|NCT01678625|Train-of-four|train-of-four
1278486|NCT01678625|Acceleromyography|acceleromyography
1278487|NCT01678625|Electromyography|electromyography
1278488|NCT01678612|Copper|copper
1278489|NCT01678612|Health-Acquired Infections|health-acquired infections
1278490|NCT01678612|Bacterial Load|bacterial load
1278491|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
1278492|NCT01678599|Chagas Disease|chagas disease
1278493|NCT01678599|PCR|pcr
1278494|NCT01678599|diagnosis|diagnosis
1278495|NCT01678586|Pain|pain
1278496|NCT01678586|Pain management|pain management
1278497|NCT01678573|Healthy|healthy
1278498|NCT01678573|Pharmacokinetics|pharmacokinetics
1278499|NCT01678573|Abiraterone acetate|abiraterone acetate
1278500|NCT01678573|Abiraterone|abiraterone
1278501|NCT01678573|JNJ-212082|jnj-212082
1278502|NCT01678573|Zytiga|zytiga
1278503|NCT01678573|Chinese|chinese
1278504|NCT01678573|Fasted|fasted
1278505|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
1278506|NCT01678547|Stroke|stroke
1278507|NCT01678547|Robot|robot
1278508|NCT01678547|Treatment|treatment
1278509|NCT01678547|Rehabilitation|rehabilitation
1278510|NCT01678534|Cerebral infarction|cerebral infarction
1278511|NCT01678534|Cellular therapy|cellular therapy
1278512|NCT01678521|Hypercholesterolemia|hypercholesterolemia
1278513|NCT01678521|LDL-apheresis|ldl-apheresis
1278514|NCT01678521|Coronary artery disease|coronary artery disease
1278515|NCT01678521|PTX3|ptx3
1278516|NCT01678521|CRP|crp
1278517|NCT01678521|IL6|il6
1278518|NCT01678521|IL10|il10
1278519|NCT01678482|Acne, LED, blue light|acne, led, blue light
1278520|NCT01678456|Atrial Fibrillation|atrial fibrillation
1278521|NCT01678456|Critical Event Committee|critical event committee
1278522|NCT01678456|Serious adverse events|serious adverse events
1278523|NCT01678456|Thromboembolic complications|thromboembolic complications
1278524|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
1278525|NCT01678456|Bleeding complications|bleeding complications
1278526|NCT01678456|Acute heart failure|acute heart failure
1278527|NCT01678456|Syncope|syncope
1278528|NCT01678456|Resuscitation|resuscitation
1278529|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
1278530|NCT01678430|Less fit|less fit
1278531|NCT01678430|CD20 antibody|cd20 antibody
1278532|NCT01678430|Ofatumumab|ofatumumab
1278533|NCT01678430|Chlorambucil|chlorambucil
1278534|NCT01678430|Bendamustine|bendamustine
1278535|NCT01678378|Adolescent|adolescent
1278536|NCT01678378|Intervention|intervention
1278537|NCT01678378|Female|female
1278538|NCT01678378|Male|male
1278539|NCT01678378|Interpersonal Relations|interpersonal relations
1278540|NCT01678378|School Health Services|school health services
1278541|NCT01678378|Community-Based Participatory Research|community-based participatory research
1278542|NCT01678378|Randomized Controlled Trial|randomized controlled trial
1278543|NCT01678378|Health Care Provider|health care provider
1278544|NCT01678378|Training Program|training program
1278545|NCT01678378|Harm Reduction|harm reduction
1278546|NCT01678378|Prevention|prevention
1278547|NCT01678378|Reproductive Coercion|reproductive coercion
1278548|NCT01678378|Tech-Based Abuse|tech-based abuse
1278549|NCT01678378|Social Environment|social environment
1278550|NCT01678378|Sexual Partners|sexual partners
1278551|NCT01678365|complicated appendicitis|complicated appendicitis
1278552|NCT01678365|Children|children
1278553|NCT01678365|conservative therapy|conservative therapy
1278554|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
1278555|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
1278556|NCT01678352|Glioma|glioma
1278557|NCT01678352|Vaccine|vaccine
1278558|NCT01678352|Immunotherapy|immunotherapy
1278559|NCT01678352|WHO Grade II|who grade ii
1278560|NCT01678339|ACS|acs
1278561|NCT01678339|AMI|ami
1278562|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
1278563|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1278564|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1278565|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
1278566|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
1278567|NCT01678300|Ulcerative Colitis|ulcerative colitis
1278568|NCT01678287|ASP1941|asp1941
1278569|NCT01678274|Turner Syndrome|turner syndrome
1278570|NCT01678274|Aortic Aneurysm|aortic aneurysm
1278571|NCT01678274|Ischemic heart disease|ischemic heart disease
1278572|NCT01678274|Hypertension|hypertension
1278573|NCT01678274|Congenital Heart Defect|congenital heart defect
1278574|NCT01678274|Pulse Wave Velocity|pulse wave velocity
1278575|NCT01678274|Augmentation Index|augmentation index
1278576|NCT01678274|Central Blood Pressure|central blood pressure
1278577|NCT01678274|Agatston Score|agatston score
1278578|NCT01678274|Segment involvement score|segment involvement score
1278579|NCT01678261|Sex chromosome|sex chromosome
1278580|NCT01678261|Turner Syndrome|turner syndrome
1278581|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
1278582|NCT01678261|Triple X Syndrome|triple x syndrome
1278583|NCT01678261|47 XYY syndrome|47 xyy syndrome
1278584|NCT01678261|Aortic Aneurysm|aortic aneurysm
1278585|NCT01678261|Epigenetics|epigenetics
1278586|NCT01678261|Transcriptome|transcriptome
1278587|NCT01678261|non-coding RNA|non-coding rna
1278588|NCT01678235|diabetes|diabetes
1278589|NCT01678235|insulin pump|insulin pump
1278590|NCT01678235|glulisine|glulisine
1278591|NCT01678235|aspart|aspart
1278592|NCT01678235|glycemic index|glycemic index
1278593|NCT01678222|Lymphocyte|lymphocyte
1278594|NCT01678222|Cyclooxygenase 2|cyclooxygenase 2
1278595|NCT01678222|Eicosanoid|eicosanoid
1278596|NCT01678222|Prostaglandin|prostaglandin
1278597|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1278598|NCT01678209|Stimulant|stimulant
1278599|NCT01678209|Non-stimulant|non-stimulant
1278600|NCT01678209|Drug|drug
1278601|NCT01678209|Methylphenidate|methylphenidate
1278602|NCT01678209|Atomoxetine|atomoxetine
1278603|NCT01678209|Strattera|strattera
1278604|NCT01678209|Concerta|concerta
1278605|NCT01678209|MACRO|macro
1278606|NCT01678209|Medication|medication
1278607|NCT01678209|Treatment|treatment
1278608|NCT01678209|Youth|youth
1278609|NCT01678209|Adolescent|adolescent
1278610|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1278611|NCT01678209|Brain scan|brain scan
1278612|NCT01678209|Imaging|imaging
1278613|NCT01678209|Response inhibition|response inhibition
1278614|NCT01678209|Inattentive|inattentive
1278615|NCT01678209|Hyperactive|hyperactive
1278616|NCT01678209|Combined|combined
1278617|NCT01678209|Medication Treatment|medication treatment
1278618|NCT01678209|Brain Imaging|brain imaging
1278619|NCT01678196|Family Members|family members
1278620|NCT01678196|Community Outreach|community outreach
1278621|NCT01678196|Internet|internet
1278622|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
1278623|NCT01678170|diagnosis|diagnosis
1278624|NCT01678157|Esophageal Hernia|esophageal hernia
1278625|NCT01678157|Hernia, Esophageal|hernia, esophageal
1278626|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
1278627|NCT01678157|Hiatal Hernia|hiatal hernia
1278628|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
1278629|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
1278630|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
1278631|NCT01678144|mitral valve|mitral valve
1278632|NCT01678144|mitral surgery|mitral surgery
1278633|NCT01678144|mitral repair|mitral repair
1278634|NCT01678144|mitral annuloplasty|mitral annuloplasty
1278635|NCT01678118|Patient Navigation|patient navigation
1278636|NCT01678118|Tobacco dependent|tobacco dependent
1278637|NCT01678118|smoking|smoking
1278638|NCT01678118|Cessation|cessation
1278639|NCT01678118|11-028|11-028
1278640|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
1278641|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
1278642|NCT01678105|Salivary Gland Cancers|salivary gland cancers
1278643|NCT01678105|ACC|acc
1278644|NCT01678105|Dovitinib|dovitinib
1278645|NCT01678105|TKI258|tki258
1278646|NCT01678105|RTK Inhibitor|rtk inhibitor
1278647|NCT01678079|Pregnancy|pregnancy
1278648|NCT01678079|Micronutrient Powder|micronutrient powder
1278649|NCT01678079|Calcium|calcium
1278650|NCT01678079|Iron|iron
1278651|NCT01678079|Bangladesh|bangladesh
1278652|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
1278653|NCT01678066|Pediatrics.|pediatrics.
1278654|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
1278655|NCT01678040|Ventricular Volume|ventricular volume
1278656|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
1278657|NCT01678040|Echocardiogram|echocardiogram
1278658|NCT01678027|Stomach neoplasm|stomach neoplasm
1278659|NCT01678027|Helicobacter pylori|helicobacter pylori
1278660|NCT01678014|Anorexia|anorexia
1278661|NCT01678014|DBS|dbs
1278662|NCT01678014|Capsulotomy|capsulotomy
1278663|NCT01678014|Signs and Symptoms|signs and symptoms
1278664|NCT01678001|plantar fascia|plantar fascia
1278665|NCT01678001|plantar fascitis|plantar fascitis
1278666|NCT01678001|botulinum toxin|botulinum toxin
1278667|NCT01678001|Xeomin|xeomin
1278668|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
1278669|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
1278670|NCT01677988|RADIATION THERAPY|radiation therapy
1278671|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
1278672|NCT01677962|Poly ICLC|poly iclc
1278673|NCT01677962|dendritic cells|dendritic cells
1278674|NCT01677936|diabetes|diabetes
1278675|NCT01677936|blood pressure|blood pressure
1278676|NCT01677936|lipid|lipid
1278677|NCT01677936|waist circumference|waist circumference
1278678|NCT01677936|BMI|bmi
1278679|NCT01677923|weight|weight
1278680|NCT01677923|body mass index|body mass index
1278681|NCT01677923|lipid profile|lipid profile
1278682|NCT01677923|glucose profile|glucose profile
1278683|NCT01677845|Localized Prostate Cancer|localized prostate cancer
1278685|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
1278686|NCT01677741|Children and Adolescents|children and adolescents
1278687|NCT01677741|BRAF|braf
1278688|NCT01677741|dabrafenib|dabrafenib
1278689|NCT01677741|dose escalation|dose escalation
1278690|NCT01677741|BRF116013|brf116013
1278691|NCT01677741|V600-mutation positive|v600-mutation positive
1278692|NCT01677741|BRF|brf
1278693|NCT01677728|colorectal liver metastases|colorectal liver metastases
1278694|NCT01677728|chemotherapy|chemotherapy
1278695|NCT01677728|cetuximab|cetuximab
1278696|NCT01677728|bevacizumab|bevacizumab
1278697|NCT01677689|oral temperature|oral temperature
1278698|NCT01677689|respiratory symptom|respiratory symptom
1278699|NCT01677689|cough|cough
1278700|NCT01677689|nasal obstruction|nasal obstruction
1278701|NCT01677689|sore throat|sore throat
1278702|NCT01677689|fever|fever
1278703|NCT01677676|Influenza A|influenza a
1278704|NCT01677663|autism|autism
1278705|NCT01677663|clinical phenotypes|clinical phenotypes
1278706|NCT01677663|neuropsychology|neuropsychology
1278707|NCT01677663|imaging endophenotypes|imaging endophenotypes
1278708|NCT01677663|family-based cohort|family-based cohort
1278709|NCT01677663|knoutout mice|knoutout mice
1278710|NCT01677650|Spinal Fusion|spinal fusion
1278711|NCT01677650|Opioid Analgesia|opioid analgesia
1278712|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
1278713|NCT01677624|Hypervascular tumor|hypervascular tumor
1278714|NCT01677624|arteriovenous malformation|arteriovenous malformation
1278715|NCT01677624|arterial embolization|arterial embolization
1278716|NCT01677611|Resveratrol|resveratrol
1278717|NCT01677611|SIRT1|sirt1
1278718|NCT01677611|AMPK|ampk
1278719|NCT01677598|Plaque Psoriasis|plaque psoriasis
1278720|NCT01677598|Ustekinumab|ustekinumab
1278721|NCT01677598|CNTO 1275|cnto 1275
1278722|NCT01677598|Asia-Pacific|asia-pacific
1278723|NCT01677546|diabetes|diabetes
1278724|NCT01677546|insulin pump|insulin pump
1278725|NCT01677546|bolus calculator|bolus calculator
1278726|NCT01677546|Contour Link|contour link
1278727|NCT01677533|Panel management|panel management
1278728|NCT01677533|Clinical microsystems|clinical microsystems
1278729|NCT01677533|Hypertension management|hypertension management
1278730|NCT01677533|Smoking cessation|smoking cessation
1278731|NCT01677533|Continuing medical education|continuing medical education
1278732|NCT01677533|Quality improvement,|quality improvement,
1278733|NCT01677533|Population health|population health
1278734|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
1278735|NCT01677520|viable ADSCs|viable adscs
1278736|NCT01677520|apoptosis|apoptosis
1278737|NCT01677520|necrosis|necrosis
1278738|NCT01677520|cryopreservation|cryopreservation
1278739|NCT01677507|glaucoma|glaucoma
1278740|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
1278741|NCT01677507|intraocular pressure|intraocular pressure
1278742|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
1278743|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
1278744|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
1278745|NCT01677455|ganetespib|ganetespib
1278746|NCT01677455|STA 9090|sta 9090
1278747|NCT01677442|nonintubated|nonintubated
1278748|NCT01677442|anaesthesia|anaesthesia
1278749|NCT01677442|VATS|vats
1278750|NCT01677429|panic disorder|panic disorder
1278751|NCT01677429|balance impairment|balance impairment
1278752|NCT01677429|virtual reality|virtual reality
1278753|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
1278754|NCT01677416|Ultrasonography|ultrasonography
1278755|NCT01677416|Synovitis|synovitis
1278756|NCT01677416|Foot joints|foot joints
1278757|NCT01677403|Bronchiectasis|bronchiectasis
1278758|NCT01677403|Tobramycin|tobramycin
1278759|NCT01677403|nebulised|nebulised
1278760|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
1278761|NCT01677390|monomethylauristatin F|monomethylauristatin f
1278762|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
1278763|NCT01677390|Antigens, CD70|antigens, cd70
1278764|NCT01677390|Drug Therapy|drug therapy
1278765|NCT01677377|Schizophrenia|schizophrenia
1278766|NCT01677377|Schizophrenic|schizophrenic
1278767|NCT01677377|Schizophrenias|schizophrenias
1278768|NCT01677364|induction of labour|induction of labour
1278769|NCT01677364|heart disease patients|heart disease patients
1278770|NCT01677351|clonidine|clonidine
1278771|NCT01677351|cataract surgery|cataract surgery
1278772|NCT01677351|arrythmia|arrythmia
1278773|NCT01677351|anesthesic medication|anesthesic medication
1278774|NCT01677286|AL Amyloidosis|al amyloidosis
1278775|NCT01677286|Primary Amyloidosis|primary amyloidosis
1278776|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
1278777|NCT01677286|Familial Amyloidosis|familial amyloidosis
1278778|NCT01677286|SSA Amyloidosis|ssa amyloidosis
1278779|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
1278780|NCT01677286|AA Amyloidosis|aa amyloidosis
1278781|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
1278782|NCT01677286|Localized Amyloidosis|localized amyloidosis
1278783|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
1278784|NCT01677273|Respiratory chambers|respiratory chambers
1278785|NCT01677273|Energy expenditure|energy expenditure
1278786|NCT01677273|Appetite|appetite
1278787|NCT01677273|Dairy proteins|dairy proteins
1278788|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
1278789|NCT01677273|Obesity|obesity
1278790|NCT01677260|Biguanide|biguanide
1278791|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
1278792|NCT01677260|bioavailability|bioavailability
1278793|NCT01677260|bioequivalence|bioequivalence
1278794|NCT01677260|metformin|metformin
1278795|NCT01677260|pharmacokinetics|pharmacokinetics
1278796|NCT01677247|sulphonylurea|sulphonylurea
1278797|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
1278798|NCT01677247|bioavailability|bioavailability
1278799|NCT01677247|bioequivalence|bioequivalence
1278800|NCT01677247|glimepiride|glimepiride
1278801|NCT01677247|pharmacokinetics|pharmacokinetics
1278802|NCT01677234|Blood pressure|blood pressure
1278804|NCT01677221|inflammatory acne|inflammatory acne
1278805|NCT01677221|intense pulsed light|intense pulsed light
1278806|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
1278807|NCT01677208|Randomized Controlled Trial|randomized controlled trial
1278808|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
1278809|NCT01677195|Mycotoxins|mycotoxins
1278810|NCT01677195|Aflatoxin|aflatoxin
1278811|NCT01677195|Fumonisin|fumonisin
1278812|NCT01677195|Aflatoxicosis|aflatoxicosis
1278813|NCT01677195|Dietary|dietary
1278814|NCT01677195|Cancer|cancer
1278815|NCT01677182|Drug therapy|drug therapy
1278816|NCT01677156|ASGES|asges
1278817|NCT01677156|Corus CAD|corus cad
1278818|NCT01677156|Age/Sex/Gene Expression Score|age/sex/gene expression score
1278819|NCT01677156|Gene Expression|gene expression
1278820|NCT01677156|GES|ges
1278821|NCT01677156|CAD|cad
1278822|NCT01677156|CVD|cvd
1278823|NCT01677156|CHD|chd
1278824|NCT01677156|Precision Medicine|precision medicine
1278825|NCT01677156|Clinical Utility|clinical utility
1278826|NCT01677156|Registry|registry
1278827|NCT01677156|Coronary Artery Disease|coronary artery disease
1278828|NCT01677156|Angina Pectoris|angina pectoris
1278829|NCT01677156|Chest Pain|chest pain
1278830|NCT01677156|Cardiovascular Disease|cardiovascular disease
1278831|NCT01677156|Coronary Heart Disease|coronary heart disease
1278832|NCT01677156|PRESET|preset
1278833|NCT01677143|Local anesthetic|local anesthetic
1278834|NCT01677143|Preemptive analgesia|preemptive analgesia
1278835|NCT01677143|Postoperative pain|postoperative pain
1278836|NCT01677143|Laparoscopy|laparoscopy
1278837|NCT01677143|Gynecological surgery|gynecological surgery
1278838|NCT01677143|Day-case surgery|day-case surgery
1278839|NCT01677130|Clinical efficacy|clinical efficacy
1278840|NCT01677130|safety|safety
1278841|NCT01677130|of HFOV treatment|of hfov treatment
1278842|NCT01677130|of patients|of patients
1278843|NCT01677104|GLP-1|glp-1
1278844|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
1278845|NCT01677104|microcirculation|microcirculation
1278846|NCT01677104|Exenatide|exenatide
1278847|NCT01677104|Liraglutide|liraglutide
1278848|NCT01677104|Linagliptin|linagliptin
1278849|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
1278850|NCT01677078|Major depressive disorder|major depressive disorder
1278851|NCT01677078|rTMS|rtms
1278852|NCT01677078|Neuronavigation|neuronavigation
1278853|NCT01677065|Bioavailability|bioavailability
1278854|NCT01677065|Oxycodone|oxycodone
1278855|NCT01677065|Healthy Volunteers|healthy volunteers
1278856|NCT01677039|Bioavailability|bioavailability
1278857|NCT01677039|oxycodone|oxycodone
1278858|NCT01677039|ethanol interaction|ethanol interaction
1278859|NCT01677039|healthy volunteers|healthy volunteers
1278860|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
1278861|NCT01677000|bone infection|bone infection
1278862|NCT01677000|staphylococcus aureus|staphylococcus aureus
1278863|NCT01677000|registry|registry
1278864|NCT01676987|Asthma|asthma
1278865|NCT01676987|Budesonide|budesonide
1278866|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
1278867|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
1278868|NCT01676974|Enterobacteriaceae|enterobacteriaceae
1278869|NCT01676974|ESBL|esbl
1278870|NCT01676974|Carbapenemase|carbapenemase
1278871|NCT01676974|Travel|travel
1278872|NCT01676948|SJIA|sjia
1278873|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
1278874|NCT01676948|children|children
1278875|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
1278876|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
1278877|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
1278878|NCT01676909|self-management|self-management
1278879|NCT01676896|children|children
1278880|NCT01676896|asthma|asthma
1278881|NCT01676896|quality of life|quality of life
1278882|NCT01676896|self-management|self-management
1278883|NCT01676883|Body constitution|body constitution
1278884|NCT01676883|Anthropometry|anthropometry
1278885|NCT01676883|Electric impedance|electric impedance
1278886|NCT01676870|exercise training|exercise training
1278887|NCT01676870|exercise therapy|exercise therapy
1279382|NCT01674621|Osteo|osteo
1278888|NCT01676870|physical fitness|physical fitness
1278889|NCT01676870|risk factors|risk factors
1278890|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
1278891|NCT01676844|Phosphorus|phosphorus
1278892|NCT01676844|Phosphate|phosphate
1278893|NCT01676844|Hypophosphataemia|hypophosphataemia
1278894|NCT01676844|Osteopenia|osteopenia
1278895|NCT01676844|Prematurity|prematurity
1278896|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
1278897|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
1278898|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
1278899|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
1278900|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
1278901|NCT01676792|condyloma acuminate|condyloma acuminate
1278902|NCT01676792|ano-genital warts|ano-genital warts
1278903|NCT01676792|genital warts|genital warts
1278904|NCT01676792|cutaneous condyloma|cutaneous condyloma
1278905|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
1278906|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
1278907|NCT01676792|VIN|vin
1278908|NCT01676792|EGW|egw
1278909|NCT01676779|melanoma|melanoma
1278910|NCT01676779|no evidence of disease|no evidence of disease
1278911|NCT01676779|resection|resection
1278912|NCT01676779|macro-metastases|macro-metastases
1278913|NCT01676766|Stargardt Disease|stargardt disease
1278914|NCT01676766|Macular degeneration|macular degeneration
1278915|NCT01676766|Retinal dystrophy|retinal dystrophy
1278916|NCT01676740|hematinic therapy|hematinic therapy
1278917|NCT01676740|blood transfusion|blood transfusion
1278918|NCT01676740|joint replacement|joint replacement
1278919|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
1278920|NCT01676727|Heart Valve Diseases|heart valve diseases
1278921|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
1278922|NCT01676714|Dovitinib|dovitinib
1278923|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
1278924|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
1278925|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
1278926|NCT01676688|deficiency|deficiency
1278927|NCT01676688|Alfalastin|alfalastin
1278928|NCT01676688|safety|safety
1278929|NCT01676675|whole virus|whole virus
1278930|NCT01676675|inactivated|inactivated
1278931|NCT01676675|influenza|influenza
1278932|NCT01676675|H5N1 vaccine|h5n1 vaccine
1278933|NCT01676675|safety|safety
1278934|NCT01676675|immunogenicity|immunogenicity
1278935|NCT01676662|Urinary Incontinence|urinary incontinence
1278936|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
1278937|NCT01676662|Urination Disorders|urination disorders
1278938|NCT01676662|Urologic Diseases|urologic diseases
1278939|NCT01676662|Urological Manifestations|urological manifestations
1278940|NCT01676662|Signs and Symptoms|signs and symptoms
1278941|NCT01676636|Pregnancy|pregnancy
1278942|NCT01676636|Calcium|calcium
1278943|NCT01676636|Supplements|supplements
1278944|NCT01676623|Child nutrition|child nutrition
1278945|NCT01676623|Stunting|stunting
1278946|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
1278947|NCT01676623|Complementary feeding|complementary feeding
1278948|NCT01676623|Social franchise|social franchise
1278949|NCT01676623|Mass media|mass media
1278950|NCT01676623|Counseling|counseling
1278951|NCT01676623|Facility-based|facility-based
1278952|NCT01676610|Pulse Oximetry|pulse oximetry
1278953|NCT01676610|Pediatrics|pediatrics
1278954|NCT01676610|Pakistan|pakistan
1278955|NCT01676610|Hypoxemia|hypoxemia
1278956|NCT01676610|Neonatal Sepsis|neonatal sepsis
1278957|NCT01676610|Pneumonia|pneumonia
1278958|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
1278959|NCT01676558|radioimmunotherapy|radioimmunotherapy
1278960|NCT01676558|131I-rituximab|131i-rituximab
1278961|NCT01676532|School Board Health Center|school board health center
1278962|NCT01676532|Pediatrics|pediatrics
1278963|NCT01676506|Wet AMD|wet amd
1278964|NCT01676506|genetic polymorphisms|genetic polymorphisms
1278965|NCT01676506|Ranibizumab|ranibizumab
1278966|NCT01676480|Prostate cancer|prostate cancer
1278968|NCT01676480|Endurance training|endurance training
1278969|NCT01676454|Vasopressin|vasopressin
1278970|NCT01676454|Trauma|trauma
1278971|NCT01676454|Injury|injury
1278972|NCT01676441|spinal cord injury|spinal cord injury
1278973|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
1278974|NCT01676428|Kidney|kidney
1278975|NCT01676428|Renal|renal
1278976|NCT01676428|Radiotherapy|radiotherapy
1278977|NCT01676428|Stereotactic|stereotactic
1278978|NCT01676428|Cancer|cancer
1278979|NCT01676415|Sinus disease|sinus disease
1278980|NCT01676415|Sinonasal complaints|sinonasal complaints
1278981|NCT01676415|Chronic sinusitis|chronic sinusitis
1278982|NCT01676415|Nasal polyps|nasal polyps
1278983|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
1278984|NCT01676415|Glucocorticoids|glucocorticoids
1278985|NCT01676415|Prednisone|prednisone
1278986|NCT01676415|Topical mometasone|topical mometasone
1278987|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
1278988|NCT01676402|Influenza A (H1)|influenza a (h1)
1278989|NCT01676402|Influenza A (H3)|influenza a (h3)
1278990|NCT01676402|Influenza B|influenza b
1278991|NCT01676402|DNA Vaccine|dna vaccine
1278992|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
1278993|NCT01676402|Healthy Adults|healthy adults
1278994|NCT01676402|Intradermal (ID)|intradermal (id)
1278995|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
1278996|NCT01676376|CABG|cabg
1278997|NCT01676376|SVG|svg
1278998|NCT01676376|nitinol mesh|nitinol mesh
1278999|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
1279000|NCT01676363|diflunisal|diflunisal
1279001|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
1279002|NCT01676363|antiviral agents|antiviral agents
1279003|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
1279004|NCT01676337|Text messaging|text messaging
1279005|NCT01676337|Clinic appointment attendance|clinic appointment attendance
1279006|NCT01676337|Emergency department|emergency department
1279007|NCT01676337|Primary care|primary care
1279008|NCT01676324|Fecal Calprotectin|fecal calprotectin
1279009|NCT01676311|cognition|cognition
1279010|NCT01676311|seizures|seizures
1279011|NCT01676311|electroencephalography|electroencephalography
1279012|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
1279013|NCT01676311|huperzine|huperzine
1279014|NCT01676311|chinese club moss|chinese club moss
1279015|NCT01676298|Cyp2C19|cyp2c19
1279016|NCT01676298|Genotyping|genotyping
1279017|NCT01676298|Spartan|spartan
1279018|NCT01676298|Reproducibility|reproducibility
1279019|NCT01676285|Cirrhosis|cirrhosis
1279020|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
1279021|NCT01676285|cardiac remodeling|cardiac remodeling
1279022|NCT01676285|cardiomyopathy|cardiomyopathy
1279023|NCT01676285|metoprolol succinate|metoprolol succinate
1279024|NCT01676285|betablockers|betablockers
1279025|NCT01676259|siRNA|sirna
1279026|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
1279027|NCT01676259|Cancer|cancer
1279028|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1279029|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
1279030|NCT01676259|Solid tumor|solid tumor
1279031|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
1279032|NCT01676207|coronary collateral circulation|coronary collateral circulation
1279033|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
1279034|NCT01676207|coronary artery disease|coronary artery disease
1279035|NCT01676207|coronary circulation|coronary circulation
1279036|NCT01676207|internal mammary artery|internal mammary artery
1279037|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
1279038|NCT01676194|Liver transplantation|liver transplantation
1279039|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
1279040|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1279041|NCT01676181|Children|children
1279042|NCT01676181|Polysomnography|polysomnography
1279043|NCT01676181|Surgery|surgery
1279044|NCT01676181|Coblation|coblation
1279045|NCT01676181|Tonsils|tonsils
1279046|NCT01676181|Tonsillectomy|tonsillectomy
1279047|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
1279048|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
1279049|NCT01676129|nocipoint|nocipoint
1279050|NCT01676129|physical therapy|physical therapy
1279051|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
1279052|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
1279053|NCT01676077|LGMD2B|lgmd2b
1279054|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
1279055|NCT01676077|Dysferlin|dysferlin
1279056|NCT01676077|Dysferlinopathy|dysferlinopathy
1279057|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
1279058|NCT01676077|Muscular Dystrophy|muscular dystrophy
1279059|NCT01676064|intraocular pressure|intraocular pressure
1279060|NCT01676064|perioperative fluid|perioperative fluid
1279061|NCT01676064|trendelenburg position|trendelenburg position
1279062|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1279063|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
1279064|NCT01676025|pheochromocytoma|pheochromocytoma
1279065|NCT01676025|aldosteronism|aldosteronism
1279066|NCT01676025|cushing's syndrome|cushing's syndrome
1279067|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
1279068|NCT01676025|Conn's syndrome|conn's syndrome
1279069|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1279070|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
1279071|NCT01675999|colon cancer|colon cancer
1279072|NCT01675973|Ranolazine|ranolazine
1279073|NCT01675973|renal impairment|renal impairment
1279074|NCT01675960|chronic irritability|chronic irritability
1279075|NCT01675960|chronic pain|chronic pain
1279076|NCT01675960|Neurologically impaired|neurologically impaired
1279077|NCT01675960|gabapentin|gabapentin
1279078|NCT01675921|Asthma|asthma
1279079|NCT01675921|Facebook|facebook
1279080|NCT01675921|teenagers|teenagers
1279081|NCT01675921|ACT|act
1606496|NCT00370968|Zinc|zinc
1279082|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
1279083|NCT01675895|İntrathecal|intrathecal
1279084|NCT01675895|Lidocaine|lidocaine
1279085|NCT01675895|TUR-P|tur-p
1279086|NCT01675882|Food allergy|food allergy
1279087|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
1279088|NCT01675882|Whole peanut extract|whole peanut extract
1279089|NCT01675882|Allergenic product|allergenic product
1279090|NCT01675882|Specific Immunotherapy|specific immunotherapy
1279091|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
1279092|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1279093|NCT01675869|Executive function|executive function
1279094|NCT01675869|Preschooler|preschooler
1279095|NCT01675869|Metacognition|metacognition
1279096|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
1279097|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
1279098|NCT01675843|Infertility|infertility
1279099|NCT01675843|PCOS|pcos
1279100|NCT01675843|IUI|iui
1279101|NCT01675817|heparin rebound|heparin rebound
1279102|NCT01675817|protamine|protamine
1279103|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
1279104|NCT01675817|cardiac surgery|cardiac surgery
1279105|NCT01675817|anti-Xa|anti-xa
1279106|NCT01675817|anti-IIa|anti-iia
1279107|NCT01675804|ADHD|adhd
1279108|NCT01675778|hydromorphone|hydromorphone
1279109|NCT01675778|acute pain|acute pain
1279110|NCT01675778|emergency department|emergency department
1279111|NCT01675765|Cancer|cancer
1279112|NCT01675765|Cancer vaccine|cancer vaccine
1279113|NCT01675765|Listeria monocytogenes|listeria monocytogenes
1279114|NCT01675765|Listeria-based vaccines|listeria-based vaccines
1279115|NCT01675765|Pemetrexed|pemetrexed
1279116|NCT01675765|Cisplatin|cisplatin
1279117|NCT01675765|T regulatory cells|t regulatory cells
1279118|NCT01675765|Mesothelin|mesothelin
1279119|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1279120|NCT01675765|Chemotherapy|chemotherapy
1279121|NCT01675765|Standard of care|standard of care
1279122|NCT01675765|Naive|naive
1279123|NCT01675765|Front-line|front-line
1279124|NCT01675765|Immunotherapy|immunotherapy
1279125|NCT01675765|MPM|mpm
1279126|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
1279127|NCT01675739|colonoscopy|colonoscopy
1279128|NCT01675739|bowel preparation|bowel preparation
1279129|NCT01675739|short message service|short message service
1279130|NCT01675713|Lifestyle|lifestyle
1279131|NCT01675713|Physical activity|physical activity
1279132|NCT01675700|Myofascial pain|myofascial pain
1279133|NCT01675700|Trigger point|trigger point
1279134|NCT01675700|Nitroglycerin|nitroglycerin
1279135|NCT01675687|dietary habits and obesity|dietary habits and obesity
1279136|NCT01675687|exercise habits and obesity|exercise habits and obesity
1279137|NCT01675687|cognition and obesity|cognition and obesity
1279138|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
1279139|NCT01675674|Prevalence|prevalence
1279140|NCT01675674|Pediatric|pediatric
1279141|NCT01675674|Rheumatology|rheumatology
1279142|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
1279143|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1279144|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
1279145|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
1279146|NCT01675648|Opiate dependent|opiate dependent
1279147|NCT01675648|inpatient detoxification|inpatient detoxification
1279148|NCT01675622|Cancer Pain|cancer pain
1279149|NCT01675596|Aortic Stenosis|aortic stenosis
1279150|NCT01675596|Transfemoral|transfemoral
1279151|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
1279152|NCT01675583|Diabetic Wounds|diabetic wounds
1279153|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
1279154|NCT01675583|Laser Speckle Imaging|laser speckle imaging
1279155|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
1279156|NCT01675570|RX-10045|rx-10045
1279157|NCT01675570|Dry Eye Disease|dry eye disease
1279158|NCT01675557|chronic kidney disease|chronic kidney disease
1279159|NCT01675544|Heart failure|heart failure
1279160|NCT01675531|Targin|targin
1279284|NCT01674985|chemotherapy|chemotherapy
1279161|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
1279162|NCT01675518|Plasma concentration|plasma concentration
1279163|NCT01675518|ASP7991|asp7991
1279164|NCT01675518|food effect|food effect
1279165|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
1279166|NCT01675492|Astigmatism|astigmatism
1279167|NCT01675492|refractive|refractive
1279168|NCT01675492|error|error
1279169|NCT01675492|LASIK|lasik
1279170|NCT01675479|refractive|refractive
1279171|NCT01675479|errors|errors
1279172|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
1279173|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
1279174|NCT01675466|appendicitis|appendicitis
1279175|NCT01675466|appendicectomy|appendicectomy
1279176|NCT01675466|appendectomy|appendectomy
1279177|NCT01675466|surgery|surgery
1279178|NCT01675466|laparoscopy|laparoscopy
1279179|NCT01675466|antibiotics|antibiotics
1607062|NCT00368862|Depression|depression
1279180|NCT01675466|randomised controlled trial|randomised controlled trial
1279181|NCT01675466|randomized controlled trial|randomized controlled trial
1279182|NCT01675466|controlled clinical trial|controlled clinical trial
1279183|NCT01675466|randomised|randomised
1279184|NCT01675466|placebo|placebo
1279185|NCT01675453|Organ dysfunction|organ dysfunction
1279186|NCT01675453|Hypertonic solution|hypertonic solution
1279187|NCT01675453|Extravascular water|extravascular water
1279188|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
1279189|NCT01675414|ASD|asd
1279190|NCT01675414|autism|autism
1279191|NCT01675414|gastrointestinal|gastrointestinal
1279192|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
1279193|NCT01675401|Body Weight|body weight
1279194|NCT01675401|Obesity|obesity
1279195|NCT01675401|Weight Loss|weight loss
1279196|NCT01675401|Vascular Function Markers|vascular function markers
1279197|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
1279198|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
1279199|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
1279200|NCT01675388|Neuroimaging|neuroimaging
1279201|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
1279202|NCT01675362|Kidney calculi|kidney calculi
1279203|NCT01675362|Renal protection|renal protection
1279204|NCT01675362|Antioxidants|antioxidants
1279205|NCT01675362|Calcium channel blockers|calcium channel blockers
1279206|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
1279207|NCT01675349|Standardization|standardization
1279208|NCT01675349|Immunotherapy|immunotherapy
1279209|NCT01675349|Skin prick test|skin prick test
1279210|NCT01675323|Restless Legs Syndrome|restless legs syndrome
1279211|NCT01675323|RLS|rls
1279212|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
1279213|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
1279214|NCT01675284|Avian Influenza|avian influenza
1279215|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
1279216|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
1279217|NCT01675284|Phase I|phase i
1279218|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
1279219|NCT01675271|gestational diabetes|gestational diabetes
1279220|NCT01675271|inflammation|inflammation
1279221|NCT01675271|autonomic nervous system|autonomic nervous system
1279222|NCT01675245|Multiple Myeloma|multiple myeloma
1279223|NCT01675245|Cancer|cancer
1279224|NCT01675245|Velcade|velcade
1279225|NCT01675245|Bortezomib|bortezomib
1279226|NCT01675245|Chinese patients|chinese patients
1279227|NCT01675232|Atopic dermatitis|atopic dermatitis
1279228|NCT01675232|Topical corticosteroid|topical corticosteroid
1279229|NCT01675232|Pediatric|pediatric
1279230|NCT01675232|Eczema|eczema
1279231|NCT01675219|bladder cancer|bladder cancer
1279232|NCT01675219|recurrence|recurrence
1279233|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
1279234|NCT01675219|PDD|pdd
1279235|NCT01675219|cost analysis|cost analysis
1279236|NCT01675206|Vascular calcification|vascular calcification
1279237|NCT01675206|Hemodialysis|hemodialysis
1279238|NCT01675206|Matrix Gla Protein|matrix gla protein
1279239|NCT01675206|Vitamin K2|vitamin k2
1279240|NCT01675193|Amblyopia|amblyopia
1279241|NCT01675193|Vision-Screening|vision-screening
1279242|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress
1279243|NCT01675167|CLBP|clbp
1279244|NCT01675167|Chronic Low Back Pain|chronic low back pain
1279245|NCT01675167|Chronic Pain|chronic pain
1279246|NCT01675167|Back Pain|back pain
1279247|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
1279248|NCT01675141|NK Cell Function|nk cell function
1279249|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
1279250|NCT01675141|T Cell Activity|t cell activity
1279251|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
1279252|NCT01675141|Extended Dosing|extended dosing
1279253|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
1279254|NCT01675128|Refractory|refractory
1279255|NCT01675128|Oncogene|oncogene
1279256|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
1279257|NCT01675128|Safety|safety
1279258|NCT01675115|Ischemic stroke|ischemic stroke
1279259|NCT01675115|Traditional Chinese Medication|traditional chinese medication
1279260|NCT01675115|Aspirin|aspirin
1279261|NCT01675102|del 17p|del 17p
1279262|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1279263|NCT01675102|cll|cll
1279264|NCT01675102|mutation|mutation
1279265|NCT01675102|p53|p53
1279266|NCT01675089|bone disease|bone disease
1279267|NCT01675089|kidney transplantation|kidney transplantation
1279268|NCT01675089|bisphosphonates|bisphosphonates
1279269|NCT01675076|Hematoma|hematoma
1279270|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
1279271|NCT01675076|Device surgery|device surgery
1376641|NCT01264679|CKD|ckd
1279272|NCT01675037|hypothalamic|hypothalamic
1279273|NCT01675037|pituitary,|pituitary,
1279274|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
1279275|NCT01675037|hydrocephalus|hydrocephalus
1279276|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
1279277|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
1279278|NCT01674998|RBD|rbd
1279279|NCT01674998|Dream|dream
1279280|NCT01674998|Dreams|dreams
1279281|NCT01674985|Decitabine|decitabine
1279282|NCT01674985|microtransplantation|microtransplantation
1279283|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
1279285|NCT01674972|NAFLD|nafld
1279286|NCT01674972|NASH|nash
1279287|NCT01674972|GLP-1|glp-1
1279288|NCT01674959|gastric cancer|gastric cancer
1279289|NCT01674959|radiation|radiation
1279290|NCT01674959|chemotherapy|chemotherapy
1279291|NCT01674946|GI-physiology|gi-physiology
1279292|NCT01674946|CDCA|cdca
1279293|NCT01674946|bile acids|bile acids
1279294|NCT01674946|TGR5|tgr5
1279295|NCT01674946|satiation peptides|satiation peptides
1279296|NCT01674933|dental|dental
1279297|NCT01674933|prevention|prevention
1279298|NCT01674933|caries|caries
1279299|NCT01674933|oral|oral
1279300|NCT01674933|children|children
1279301|NCT01674920|Pediatric obesity|pediatric obesity
1279302|NCT01674920|resiliency|resiliency
1279303|NCT01674920|physical activity|physical activity
1279304|NCT01674920|dietary patterns|dietary patterns
1279305|NCT01674920|children|children
1279306|NCT01674881|Mindfulness|mindfulness
1279307|NCT01674881|breast cancer|breast cancer
1279308|NCT01674881|chronic pain|chronic pain
1279309|NCT01674881|mediators|mediators
1279310|NCT01674881|distress|distress
1279311|NCT01674881|Breast cancer survivors|breast cancer survivors
1279312|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
1279313|NCT01674881|Potential mediators and moderators|potential mediators and moderators
1279314|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
1279315|NCT01674868|stroke|stroke
1279316|NCT01674868|recovery|recovery
1279317|NCT01674868|fluoxetine|fluoxetine
1279318|NCT01674868|aphasia|aphasia
1279319|NCT01674868|neglect|neglect
1279320|NCT01674868|motor|motor
1279321|NCT01674855|PEG-G-CSF|peg-g-csf
1279322|NCT01674842|Triple negative|triple negative
1279323|NCT01674842|Stage II|stage ii
1279324|NCT01674842|Stage III|stage iii
1279325|NCT01674803|drug-eluting stent|drug-eluting stent
1279326|NCT01674803|zotarolimus|zotarolimus
1279327|NCT01674803|everolimus|everolimus
1279328|NCT01674803|sirolimus|sirolimus
1279329|NCT01674803|all comers population|all comers population
1279330|NCT01674803|target vessel failure|target vessel failure
1279331|NCT01674803|coronary artery disease|coronary artery disease
1279332|NCT01674803|durable polymer|durable polymer
1279333|NCT01674803|biodegradable polymer|biodegradable polymer
1279334|NCT01674777|ASP1941|asp1941
1279335|NCT01674777|Food effect|food effect
1279336|NCT01674777|Pharmacokinetics|pharmacokinetics
1279337|NCT01674751|pre-ordering|pre-ordering
1279338|NCT01674751|healthy eating|healthy eating
1279339|NCT01674751|mindfulness|mindfulness
1279340|NCT01674751|incentives|incentives
1279341|NCT01674751|employees|employees
1279342|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
1279343|NCT01674738|NSCLC Stage IV|nsclc stage iv
1279344|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
1279345|NCT01674725|Hepatitis C virus|hepatitis c virus
1279346|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
1279347|NCT01674725|Hepatitis C|hepatitis c
1279348|NCT01674725|Interferon-Free|interferon-free
1279349|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
1279350|NCT01674725|Ombitasvir|ombitasvir
1279351|NCT01674725|Ribavirin|ribavirin
1279352|NCT01674725|Viekira PAK|viekira pak
1279353|NCT01674725|Dasabuvir|dasabuvir
1279354|NCT01674725|Paritaprevir|paritaprevir
1279355|NCT01674712|Fibrates|fibrates
1279356|NCT01674712|Dyslipidemia|dyslipidemia
1279357|NCT01674686|Vasospasm|vasospasm
1279358|NCT01674686|Sarpogrelate|sarpogrelate
1279359|NCT01674686|Statin|statin
1279360|NCT01674673|panic disorder|panic disorder
1279361|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
1279362|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
1279363|NCT01674660|hemodialysis|hemodialysis
1279364|NCT01674660|blood pressure variability|blood pressure variability
1279365|NCT01674660|volume status|volume status
1279366|NCT01674647|rivaroxaban|rivaroxaban
1279367|NCT01674647|oral anticoagulant|oral anticoagulant
1279368|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
1279369|NCT01674647|cardioversion|cardioversion
1279370|NCT01674647|stroke|stroke
1279371|NCT01674647|transient ischemic attack|transient ischemic attack
1279372|NCT01674647|thromboembolism|thromboembolism
1279373|NCT01674647|cardiovascular event|cardiovascular event
1279374|NCT01674634|XIAFLEX|xiaflex
1279375|NCT01674634|XIAPEX|xiapex
1279376|NCT01674634|Dupuytren's disease|dupuytren's disease
1279377|NCT01674634|contracture|contracture
1279378|NCT01674621|BA058|ba058
1279379|NCT01674621|Abaloparatide-SC|abaloparatide-sc
1279380|NCT01674621|abaloparatide|abaloparatide
1279381|NCT01674621|Abaloparatide-TD|abaloparatide-td
1279383|NCT01674621|Osteoporosis|osteoporosis
1279384|NCT01674621|Transdermal|transdermal
1279385|NCT01674621|Patch|patch
1279386|NCT01674608|intensive care|intensive care
1279387|NCT01674608|mobilization|mobilization
1279388|NCT01674608|rehabilitation|rehabilitation
1279389|NCT01674608|critical care|critical care
1279390|NCT01674595|Olea sensitization|olea sensitization
1279391|NCT01674582|Glioma|glioma
1279392|NCT01674582|Brain tumors|brain tumors
1279393|NCT01674582|Brain metastases|brain metastases
1279394|NCT01674582|MRI|mri
1279395|NCT01674582|Cognitive measurement|cognitive measurement
1279396|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
1279397|NCT01674582|DW-MRI|dw-mri
1279398|NCT01674582|P-MRI|p-mri
1279399|NCT01674582|MRS|mrs
1279400|NCT01674569|VEGF|vegf
1279401|NCT01674569|PDGF|pdgf
1279402|NCT01674569|AMD|amd
1279403|NCT01674556|pancreatic|pancreatic
1279404|NCT01674556|cancer|cancer
1279405|NCT01674556|adenocarcinoma|adenocarcinoma
1279406|NCT01674556|Ultrasound|ultrasound
1279407|NCT01674556|CEUS|ceus
1279408|NCT01674543|Physical exercise|physical exercise
1279409|NCT01674543|Schizophrenia|schizophrenia
1279410|NCT01674543|symptoms|symptoms
1279411|NCT01674543|IGF-1|igf-1
1279412|NCT01674517|Bioequivalence|bioequivalence
1279413|NCT01674517|Montelukast Sodium|montelukast sodium
1279414|NCT01674517|crossover|crossover
1279415|NCT01674504|Bioequivalence|bioequivalence
1279416|NCT01674504|Montelukast Sodium|montelukast sodium
1279417|NCT01674504|crossover|crossover
1279418|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
1279419|NCT01674478|enteral fat|enteral fat
1279420|NCT01674465|Kidney fibrosis|kidney fibrosis
1279421|NCT01674465|Kidney hypoxia|kidney hypoxia
1279422|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
1279423|NCT01674452|Stroke|stroke
1279424|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
1279425|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
1279426|NCT01674439|Cell therapy|cell therapy
1279427|NCT01674439|Autologous fat transfer|autologous fat transfer
1279428|NCT01674439|Tissue engineering|tissue engineering
1279429|NCT01674439|Craniofacial microsomia|craniofacial microsomia
1279430|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
1279431|NCT01674426|stress induced anovulation|stress induced anovulation
1279432|NCT01674413|Crohn's Disease|crohn's disease
1279433|NCT01674413|Crohn's|crohn's
1279434|NCT01674413|Crohns|crohns
1279435|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
1279437|NCT01674413|Humira|humira
1279438|NCT01674413|Adalimumab|adalimumab
1279439|NCT01674413|Adalimumab injection|adalimumab injection
1279440|NCT01674413|Higgins|higgins
1279441|NCT01674413|Calprotectin|calprotectin
1279442|NCT01674413|biomarkers|biomarkers
1279443|NCT01674413|Gastroenterology|gastroenterology
1279444|NCT01674413|University of Michigan|university of michigan
1279445|NCT01674413|U of M|u of m
1279446|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
1279447|NCT01674387|neck pain|neck pain
1279448|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
1279449|NCT01674387|Acupuncture Therapy|acupuncture therapy
1279450|NCT01674387|Electroacupuncture|electroacupuncture
1279451|NCT01674387|Meridians|meridians
1279452|NCT01674348|Diabetes Mellitus|diabetes mellitus
1279453|NCT01674335|Fibromyalgia|fibromyalgia
1279454|NCT01674335|Chronic pain|chronic pain
1279455|NCT01674335|Chronic fatigue|chronic fatigue
1279456|NCT01674335|Activity pacing|activity pacing
1279457|NCT01674335|Operant learning|operant learning
1279458|NCT01674335|Energy conservation|energy conservation
1279459|NCT01674335|Treatment|treatment
1279460|NCT01674335|Intervention|intervention
1279461|NCT01674335|Biopsychosocial factors|biopsychosocial factors
1279462|NCT01674335|Coping|coping
1279463|NCT01674335|Mood|mood
1279464|NCT01674335|Quality of life|quality of life
1279465|NCT01674322|Healthy participants|healthy participants
1279466|NCT01674322|Ibrutinib|ibrutinib
1279467|NCT01674322|PCI-32765|pci-32765
1279468|NCT01674322|B-cell malignancies|b-cell malignancies
1279469|NCT01674322|CYP3A4|cyp3a4
1279470|NCT01674296|Body Weight/physiology*|body weight/physiology*
1279471|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
1279472|NCT01674296|Diet*/trends|diet*/trends
1279473|NCT01674296|Exercise/physiology*|exercise/physiology*
1279474|NCT01674296|Female|female
1279475|NCT01674296|Humans|humans
1279476|NCT01674296|Longitudinal Studies|longitudinal studies
1279477|NCT01674296|Middle Aged|middle aged
1279478|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
1279479|NCT01674296|Seasons*|seasons*
1279480|NCT01674296|Time Factors|time factors
1279481|NCT01674257|Atherosclerosis|atherosclerosis
1279482|NCT01674257|Stroke|stroke
1279483|NCT01674257|Positron-emission tomography|positron-emission tomography
1279484|NCT01674257|Ferumoxytol|ferumoxytol
1279485|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
1279486|NCT01674257|Genetics|genetics
1279487|NCT01674257|Calcification|calcification
1279488|NCT01674257|Inflammation|inflammation
1279489|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
1279490|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
1279491|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
1279492|NCT01674179|Fibromyalgia|fibromyalgia
1279493|NCT01674179|qEEG|qeeg
1279494|NCT01674179|Sleep|sleep
1279495|NCT01674179|Pain|pain
1279496|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
1279497|NCT01674153|Toxin removal|toxin removal
1279498|NCT01674153|Hemodiafiltration|hemodiafiltration
1279499|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
1279500|NCT01674153|Cardiac output|cardiac output
1279501|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1279502|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
1279503|NCT01674140|stage IA breast cancer|stage ia breast cancer
1279504|NCT01674140|stage IB breast cancer|stage ib breast cancer
1279505|NCT01674140|stage II breast cancer|stage ii breast cancer
1279506|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
1279507|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
1279508|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
1279509|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1279510|NCT01674140|male breast cancer|male breast cancer
1279511|NCT01674114|Cesarean Section|cesarean section
1279512|NCT01674114|Anesthetics, Local|anesthetics, local
1279513|NCT01674101|Lower extremity malignancy|lower extremity malignancy
1279514|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
1279515|NCT01674088|breath testing|breath testing
1279516|NCT01674088|carbon-13|carbon-13
1279517|NCT01674075|safety|safety
1279518|NCT01674075|J-Tip Delivery System|j-tip delivery system
1279519|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
1279520|NCT01674049|nutrition|nutrition
1279521|NCT01674049|nutrient|nutrient
1279522|NCT01674049|timing|timing
1279523|NCT01674049|diabetes|diabetes
1279524|NCT01674049|family history|family history
1279525|NCT01674049|dairy|dairy
1279526|NCT01673971|hemangioma|hemangioma
1279527|NCT01673958|Eccentric exercise|eccentric exercise
1279528|NCT01673958|Aging|aging
1279529|NCT01673958|Heart failure|heart failure
1279530|NCT01673958|Muscle strength loss|muscle strength loss
1279531|NCT01673958|Sarcopenia|sarcopenia
1279532|NCT01673945|EUS-FNA, Forward viewing EUS scope, accuracy, Curvilinear EUS scope|eus-fna, forward viewing eus scope, accuracy, curvilinear eus scope
1279533|NCT01673932|stroke|stroke
1279534|NCT01673932|chronic stroke|chronic stroke
1279535|NCT01673932|ischemic stroke|ischemic stroke
1279536|NCT01673932|umbilical cord blood|umbilical cord blood
1279537|NCT01673932|mononuclear cell|mononuclear cell
1279538|NCT01673932|transplant|transplant
1279539|NCT01673906|positron-emission tomography|positron-emission tomography
1279540|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
1279541|NCT01673906|endosonography|endosonography
1279542|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
1279543|NCT01673906|biopsy, fine needle|biopsy, fine needle
1279544|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
1279545|NCT01673893|ClearWay|clearway
1279546|NCT01673893|Glycoprotein|glycoprotein
1279547|NCT01673893|Primary Coronary Intervention|primary coronary intervention
1279548|NCT01673893|Abciximab|abciximab
1279549|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1279550|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
1279551|NCT01673893|STEMI|stemi
1279552|NCT01673893|NSTEMI|nstemi
1279553|NCT01673893|Medicare|medicare
1279554|NCT01673893|Medicaid|medicaid
1279555|NCT01673893|Registry|registry
1279556|NCT01673893|catheterization|catheterization
1279557|NCT01673893|readmission|readmission
1279558|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
1279559|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
1279560|NCT01673841|bypass grafting|bypass grafting
1279561|NCT01673828|Brain Injuries|brain injuries
1279562|NCT01673828|Pregnanolone|pregnanolone
1279563|NCT01673828|Epilepsy|epilepsy
1279564|NCT01673815|optic disk|optic disk
1279565|NCT01673815|fundoscopy|fundoscopy
1279566|NCT01673815|pediatric|pediatric
1279567|NCT01673815|clinical examination|clinical examination
1279568|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
1279569|NCT01673789|Stem Cell Educator|stem cell educator
1279570|NCT01673789|Cord blood stem cells|cord blood stem cells
1279571|NCT01673789|Immune modulation|immune modulation
1279572|NCT01673789|Alopecia Areata|alopecia areata
1607572|NCT00366613|Cataract|cataract
1279573|NCT01673776|Proximal femoral fracture|proximal femoral fracture
1279574|NCT01673776|multimodal intervention|multimodal intervention
1607466|NCT00367224|tolerance|tolerance
1279575|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
1279576|NCT01673776|hemodynamic intervention|hemodynamic intervention
1279577|NCT01673776|outcome|outcome
1279578|NCT01673763|ERCP|ercp
1279579|NCT01673763|endoscopy|endoscopy
1279580|NCT01673763|pancreatitis|pancreatitis
1279581|NCT01673750|Adolescents|adolescents
1279582|NCT01673750|Body Image|body image
1279583|NCT01673698|obesity|obesity
1279584|NCT01673698|weight loss|weight loss
1279585|NCT01673685|COPD|copd
1279586|NCT01673685|Oxygen cylinder|oxygen cylinder
1279587|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
1279588|NCT01673685|Battery powered delivery device|battery powered delivery device
1279589|NCT01673685|mobility|mobility
1279590|NCT01673685|dyspnoea|dyspnoea
1279591|NCT01673685|Quality of Life|quality of life
1279592|NCT01673685|Cost effectiveness|cost effectiveness
1279593|NCT01673646|SOM230, Pasireotide, acromegaly, Phase II|som230, pasireotide, acromegaly, phase ii
1279594|NCT01673594|ADHD|adhd
1279595|NCT01673594|Naltrexone|naltrexone
1279596|NCT01673594|SODAS MPH|sodas mph
1279597|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
1279598|NCT01673594|Substance Abuse|substance abuse
1279599|NCT01673594|Adults|adults
1279600|NCT01673581|Low Risk|low risk
1279601|NCT01673555|GSK1278863|gsk1278863
1279602|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
1279603|NCT01673529|Pruritus|pruritus
1279604|NCT01673529|TRPV1|trpv1
1279605|NCT01673529|Cowhage|cowhage
1279606|NCT01673529|Atopic Dermatitis|atopic dermatitis
1279607|NCT01673529|Capsaicin|capsaicin
1279608|NCT01673529|Itch|itch
1279609|NCT01673529|Histamine|histamine
1279610|NCT01673529|healthy volunteers|healthy volunteers
1279611|NCT01673529|SB705498|sb705498
1279612|NCT01673529|Clinical|clinical
1279613|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
1279614|NCT01673516|Impedance cardiography|impedance cardiography
1279615|NCT01673503|Myopia|myopia
1279616|NCT01673503|refractive surgery|refractive surgery
1279617|NCT01673503|all femtosecond laser|all femtosecond laser
1279618|NCT01673503|ReLEx flex|relex flex
1279619|NCT01673503|ReLEx smile|relex smile
1279620|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1279621|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
1279622|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
1279623|NCT01673464|mTBI|mtbi
1279624|NCT01673464|Concussion|concussion
1279625|NCT01673451|insomnia|insomnia
1279626|NCT01673438|solid tumor|solid tumor
1279627|NCT01673438|aldoxorubicin|aldoxorubicin
1279628|NCT01673438|phase 1|phase 1
1279629|NCT01673438|INNO-206|inno-206
1279630|NCT01673438|doxorubicin|doxorubicin
1279631|NCT01673425|Influenza|influenza
1279632|NCT01673425|Influenza Vaccines|influenza vaccines
1279633|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
1279634|NCT01673425|Immunity, Mucosal|immunity, mucosal
1279635|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
1279636|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
1279637|NCT01673399|atosiban|atosiban
1279638|NCT01673399|pregnancy|pregnancy
1279639|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
1279640|NCT01673386|renal cell carcinoma|renal cell carcinoma
1279641|NCT01673386|subject preference|subject preference
1279642|NCT01673386|quality of life|quality of life
1279643|NCT01673373|Renal Artery Stenosis|renal artery stenosis
1279644|NCT01673373|Renal Artery Obstruction|renal artery obstruction
1279645|NCT01673373|Renovascular Hypertension|renovascular hypertension
1279646|NCT01673373|Resistant Hypertension|resistant hypertension
1279647|NCT01673373|Renal Revascularization|renal revascularization
1279648|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
1279649|NCT01673373|ARAS (Atherosclerotic Renal Artery Stenosis)|aras (atherosclerotic renal artery stenosis)
1279650|NCT01673373|RAS (Renal Artery Stenosis)|ras (renal artery stenosis)
1279651|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
1279652|NCT01673373|Hypertension|hypertension
1279653|NCT01673373|systolic blood pressure|systolic blood pressure
1279654|NCT01673373|blood pressure|blood pressure
1279655|NCT01673360|vaginal repair|vaginal repair
1279656|NCT01673360|urinary slings|urinary slings
1279657|NCT01673360|POP|pop
1279658|NCT01673360|SUI|sui
1279659|NCT01673360|prolapse|prolapse
1279660|NCT01673360|incontinence|incontinence
1279661|NCT01673347|allograft|allograft
1279662|NCT01673347|great toe|great toe
1279663|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
1279664|NCT01673321|Yogurt|yogurt
1279665|NCT01673321|Milk|milk
1279666|NCT01673321|Protein|protein
1279667|NCT01673321|Food intake|food intake
1279668|NCT01673321|Appetite|appetite
1279669|NCT01673321|Glucose|glucose
1279670|NCT01673321|Insulin|insulin
1279671|NCT01673295|Lupus Nephritis|lupus nephritis
1279672|NCT01673295|Rituximab|rituximab
1279673|NCT01673282|Lacosamide|lacosamide
1279674|NCT01673282|Vimpat|vimpat
1279675|NCT01673282|Focal Epilepsy|focal epilepsy
1279676|NCT01673282|Drug Load|drug load
1279678|NCT01673282|SP1065|sp1065
1279679|NCT01673269|ERCP|ercp
1279680|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
1279681|NCT01673269|Choledocholithiasis|choledocholithiasis
1279682|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
1279683|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
1279684|NCT01673243|Smoking cessation|smoking cessation
1279685|NCT01673243|Household smoking bans|household smoking bans
1279686|NCT01673243|Cancer|cancer
1279687|NCT01673243|Sickle cell disease|sickle cell disease
1279688|NCT01673204|surrogate marker,|surrogate marker,
1279689|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
1279690|NCT01673204|diabetic nephropathy|diabetic nephropathy
1279691|NCT01673178|Type 2 diabetes|type 2 diabetes
1279692|NCT01673178|safety|safety
1279693|NCT01673178|multiple dose|multiple dose
1279694|NCT01673178|intravenous|intravenous
1279695|NCT01673152|Obesity|obesity
1279696|NCT01673152|Overweight|overweight
1279697|NCT01673152|Satiety|satiety
1279698|NCT01673152|Oligofructose|oligofructose
1279699|NCT01673152|Prebiotic|prebiotic
1279700|NCT01673139|Atrial fibrillation|atrial fibrillation
1279701|NCT01673139|Exercise|exercise
1279702|NCT01673126|vegetative state|vegetative state
1279703|NCT01673126|minimally conscious state|minimally conscious state
1279704|NCT01673126|disorders of consciousness|disorders of consciousness
1279705|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
1279706|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
1279707|NCT01673100|physical activity|physical activity
1279708|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
1279709|NCT01673100|heart disease|heart disease
1279710|NCT01673087|stress biology|stress biology
1279711|NCT01673087|cortisol|cortisol
1279712|NCT01673087|adrenocorticotropin|adrenocorticotropin
1279713|NCT01673087|salivary biomarkers|salivary biomarkers
1279714|NCT01673061|Abscess|abscess
1279715|NCT01673061|Boils|boils
1279716|NCT01673061|Anesthetics, Local|anesthetics, local
1279717|NCT01673061|Lidocaine|lidocaine
1279718|NCT01673061|Vapocoolant|vapocoolant
1279719|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
1279720|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
1279721|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
1279722|NCT01673048|biomechanical testing|biomechanical testing
1279723|NCT01673048|fracture|fracture
1279724|NCT01673048|femur|femur
1279725|NCT01673048|treatment|treatment
1279726|NCT01673048|children|children
1279727|NCT01673048|adolescents|adolescents
1279728|NCT01673009|Gleevec|gleevec
1279729|NCT01672996|Use in Abdominal|use in abdominal
1279730|NCT01672996|Contrast Enhanced|contrast enhanced
1279731|NCT01672996|Computed Tomography|computed tomography
1279732|NCT01672996|Optimize concentration|optimize concentration
1279733|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
1279734|NCT01672983|Japanese|japanese
1279735|NCT01672983|Hepatitis C|hepatitis c
1279736|NCT01672983|Genotype 2|genotype 2
1279737|NCT01672983|Genotype 1b|genotype 1b
1279738|NCT01672983|paritaprevir|paritaprevir
1279739|NCT01672983|ombitasvir|ombitasvir
1279740|NCT01672983|ritonavir|ritonavir
1279741|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
1279742|NCT01672944|Biological specimen banks|biological specimen banks
1279743|NCT01672944|Health education|health education
1279744|NCT01672944|Tissue banks|tissue banks
1279745|NCT01672944|Health care survey|health care survey
1279746|NCT01672944|Tissue|tissue
1279747|NCT01672918|PET/CT|pet/ct
1279748|NCT01672918|Lymphoma|lymphoma
1279749|NCT01672918|Lymphadenopathy|lymphadenopathy
1279750|NCT01672918|ALPS|alps
1279751|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
1279752|NCT01672905|stage I prostate cancer|stage i prostate cancer
1279753|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
1279754|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
1279755|NCT01672905|stage III prostate cancer|stage iii prostate cancer
1279756|NCT01672892|gastrointestinal complications|gastrointestinal complications
1279757|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
1279758|NCT01672892|radiation toxicity|radiation toxicity
1279759|NCT01672892|urinary complications|urinary complications
1279760|NCT01672892|urinary tract toxicity|urinary tract toxicity
1279761|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1279762|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1279763|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
1279764|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
1279765|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
1279766|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
1279767|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
1279768|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
1279769|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
1279770|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
1279771|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
1279772|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
1279773|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
1279774|NCT01672879|NASH|nash
1279775|NCT01672879|cirrhosis|cirrhosis
1279776|NCT01672879|Compensated Liver disease|compensated liver disease
1279777|NCT01672879|Monoclonal antibody|monoclonal antibody
1279778|NCT01672879|LOXL2|loxl2
1279779|NCT01672879|Simtuzumab|simtuzumab
1279780|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1279781|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
1279783|NCT01672879|NAFLD|nafld
1279784|NCT01672879|MRE|mre
1279785|NCT01672879|Liver biopsy|liver biopsy
1279786|NCT01672866|NASH|nash
1279787|NCT01672866|non cirrhotic|non cirrhotic
1279788|NCT01672866|Monoclonal antibody|monoclonal antibody
1279789|NCT01672866|LOXL2|loxl2
1279790|NCT01672866|Simtuzumab|simtuzumab
1279791|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1279792|NCT01672866|NAFLD|nafld
1279793|NCT01672866|Liver biopsy|liver biopsy
1279794|NCT01672866|MRE|mre
1279795|NCT01672853|PSC|psc
1279796|NCT01672853|Sclerosis|sclerosis
1279797|NCT01672853|Monoclonal antibody|monoclonal antibody
1279798|NCT01672853|LOXL2|loxl2
1279799|NCT01672853|Simtuzumab|simtuzumab
1279800|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
1279801|NCT01672853|Liver fibrosis|liver fibrosis
1279802|NCT01672853|Liver disease|liver disease
1279803|NCT01672853|MRCP|mrcp
1279804|NCT01672853|MRE|mre
1279805|NCT01672853|Liver biopsy|liver biopsy
1279806|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
1279807|NCT01672840|cocoa consumption|cocoa consumption
1279808|NCT01672840|Blood pressure|blood pressure
1279809|NCT01672840|Endothelial function|endothelial function
1279810|NCT01672840|arterial stiffness|arterial stiffness
1279811|NCT01672827|Alzheimer's Disease|alzheimer's disease
1279812|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
1279813|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
1279814|NCT01672827|PET Images|pet images
1279815|NCT01672814|Keratoconus|keratoconus
1279816|NCT01672814|Collagen Crosslinking|collagen crosslinking
1279817|NCT01672814|Riboflavin|riboflavin
1279818|NCT01672814|Microwave|microwave
1279819|NCT01672814|Keraflex|keraflex
1279820|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
1279821|NCT01672775|AGS-16C3F|ags-16c3f
1279822|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
1279823|NCT01672762|diabetes mellitus|diabetes mellitus
1279824|NCT01672762|serum Insulin|serum insulin
1279825|NCT01672762|blood glucose|blood glucose
1279826|NCT01672762|glucose excretion|glucose excretion
1279827|NCT01672762|hypoglycemic agents|hypoglycemic agents
1279828|NCT01672762|ipragliflozin|ipragliflozin
1279829|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
1279830|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
1279831|NCT01672749|Early onset|early onset
1279832|NCT01672749|Growth guidance|growth guidance
1279833|NCT01672749|Growing rod|growing rod
1279834|NCT01672749|Trolley|trolley
1279835|NCT01672749|Dual growing rod technique|dual growing rod technique
1279836|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
1279837|NCT01672723|opioids|opioids
1279838|NCT01672723|social connection|social connection
1279839|NCT01672710|Hubbard detoxification|hubbard detoxification
1279840|NCT01672710|Exercise|exercise
1279841|NCT01672710|Sauna therapy|sauna therapy
1279842|NCT01672710|Niacin|niacin
1279843|NCT01672697|anal incontinence|anal incontinence
1279844|NCT01672697|genital trauma|genital trauma
1279845|NCT01672697|physical therapy|physical therapy
1279846|NCT01672697|anal manometry|anal manometry
1279847|NCT01672684|quality of life|quality of life
1279848|NCT01672658|TBI,|tbi,
1279849|NCT01672658|vestibular|vestibular
1279850|NCT01672645|Smoking cessation|smoking cessation
1279851|NCT01672645|vaccine|vaccine
1279852|NCT01672645|Phase 1|phase 1
1279853|NCT01672619|craniosynostoses|craniosynostoses
1279854|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
1279855|NCT01672619|craniotomy|craniotomy
1279856|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
1279857|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
1279858|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
1279859|NCT01672580|social networks|social networks
1279860|NCT01672580|nutrition|nutrition
1279861|NCT01672580|vitamins|vitamins
1279862|NCT01672580|chlorine|chlorine
1279863|NCT01672567|Coronary Artery Disease|coronary artery disease
1279864|NCT01672567|Egg Consumption|egg consumption
1279865|NCT01672567|Endothelial Function|endothelial function
1279866|NCT01672554|Schizophrenia|schizophrenia
1279867|NCT01672554|Anxiety disorder|anxiety disorder
1279868|NCT01672541|dating violence|dating violence
1279869|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
1279870|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
1279871|NCT01672528|PROMs|proms
1279872|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
1279873|NCT01672528|Cardiac ablation|cardiac ablation
1279874|NCT01672502|sleep|sleep
1279875|NCT01672502|firefighter|firefighter
1279876|NCT01672502|fire|fire
1279877|NCT01672502|apnea|apnea
1279878|NCT01672502|insomnia|insomnia
1279879|NCT01672502|shift|shift
1279880|NCT01672502|narcolepsy|narcolepsy
1279881|NCT01672502|restless leg|restless leg
1279882|NCT01672502|rls|rls
1279883|NCT01672502|fatigue|fatigue
1279884|NCT01672502|Optalert|optalert
1279885|NCT01672502|actigraph|actigraph
1279886|NCT01672502|actigraphy|actigraphy
1279887|NCT01672502|actiwatch|actiwatch
1279888|NCT01672502|safety|safety
1279889|NCT01672502|sleepiness|sleepiness
1279890|NCT01672502|sleepy|sleepy
1279891|NCT01672502|work|work
1279892|NCT01672502|hours|hours
1279893|NCT01672502|FEMA|fema
1279894|NCT01672502|drowsy|drowsy
1279895|NCT01672489|Drowsy|drowsy
1279896|NCT01672489|Drive|drive
1279897|NCT01672489|Driving|driving
1279898|NCT01672489|Shift Work Disorder|shift work disorder
1279899|NCT01672489|SWD|swd
1279900|NCT01672489|EEG|eeg
1279901|NCT01672489|ECG|ecg
1279902|NCT01672489|Actiwatch|actiwatch
1279903|NCT01672489|Diary|diary
1279904|NCT01672489|Bioharness|bioharness
1279905|NCT01672489|Q-Sensor|q-sensor
1279906|NCT01672489|Q Sensor|q sensor
1279907|NCT01672489|Liberty Mutual|liberty mutual
1279908|NCT01672489|sleep|sleep
1279909|NCT01672489|impaired|impaired
1279910|NCT01672489|Optalert|optalert
1279911|NCT01672489|tracker|tracker
1279912|NCT01672489|vehicle|vehicle
1279913|NCT01672489|questionnaire|questionnaire
1279914|NCT01672489|survey|survey
1279915|NCT01672476|Fimasartan|fimasartan
1279916|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
1279917|NCT01672437|Birth and parent preparation|birth and parent preparation
1279918|NCT01672437|Parenting stress|parenting stress
1279919|NCT01672437|Depression|depression
1279920|NCT01672437|self-efficacy|self-efficacy
1279921|NCT01672437|social network and support|social network and support
1279922|NCT01672424|NPO|npo
1279923|NCT01672424|Gastric Emptying|gastric emptying
1279924|NCT01672424|Ice Chips|ice chips
1279925|NCT01672424|Protein Drink|protein drink
1279926|NCT01672424|Ultrasound|ultrasound
1279927|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
1279928|NCT01672398|CarePartner|carepartner
1279929|NCT01672398|informal caregiver|informal caregiver
1279930|NCT01672398|interactive voice response|interactive voice response
1279931|NCT01672398|transition|transition
1279932|NCT01672398|post-discharge|post-discharge
1279933|NCT01672398|chronic illness|chronic illness
1279934|NCT01672398|readmission|readmission
1279935|NCT01672398|self-care|self-care
1279936|NCT01672385|CarePartner|carepartner
1279937|NCT01672385|informal caregiver|informal caregiver
1279938|NCT01672385|interactive voice response|interactive voice response
1279939|NCT01672385|transition|transition
1279940|NCT01672385|post-discharge|post-discharge
1279941|NCT01672385|chronic illness|chronic illness
1279942|NCT01672385|readmission|readmission
1279943|NCT01672385|self-care|self-care
1279944|NCT01672359|cognitive functioning|cognitive functioning
1279945|NCT01672359|immune function|immune function
1279946|NCT01672359|cytokines|cytokines
1279947|NCT01672359|growth factors|growth factors
1279948|NCT01672359|quality of life|quality of life
1279949|NCT01672359|dietary supplementation|dietary supplementation
1279950|NCT01672359|Ginkgo biloba|ginkgo biloba
1279951|NCT01672359|Improvement of cognitive function|improvement of cognitive function
1279952|NCT01672346|PAF|paf
1279953|NCT01672320|Robotic|robotic
1279954|NCT01672320|Arthroplasty|arthroplasty
1279955|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
1279956|NCT01672320|Cup Positioning|cup positioning
1279957|NCT01672320|Outcomes|outcomes
1279958|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
1279959|NCT01672307|thinning eyebrows|thinning eyebrows
1279960|NCT01672307|minoxidil|minoxidil
1279961|NCT01672307|placebo|placebo
1279962|NCT01672307|randomized|randomized
1279963|NCT01672294|caregiver|caregiver
1279964|NCT01672294|end of life|end of life
1279965|NCT01672294|self-disclosure|self-disclosure
1279966|NCT01672268|cardiac computed tomography|cardiac computed tomography
1279967|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
1279968|NCT01672268|safety and efficacy|safety and efficacy
1279969|NCT01672255|exercise|exercise
1279970|NCT01672255|diabetes|diabetes
1279971|NCT01672255|SSRIs|ssris
1279972|NCT01672216|Exercise Therapy|exercise therapy
1279973|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
1279974|NCT01672216|Adult|adult
1279975|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
1279976|NCT01672216|EMG - Biofeedback|emg - biofeedback
1279977|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
1279978|NCT01672216|Augmented biofeedback|augmented biofeedback
1279979|NCT01672177|Geriatrics|geriatrics
1279980|NCT01672177|Aged|aged
1279981|NCT01672177|Aging|aging
1279982|NCT01672177|Chronic disease|chronic disease
1279983|NCT01672177|Self management|self management
1279984|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
1279985|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
1279986|NCT01672151|rapamycin|rapamycin
1279987|NCT01672151|regulatory T cells|regulatory t cells
1279988|NCT01672138|PVAI|pvai
1279989|NCT01672138|CFAE|cfae
1279990|NCT01672138|NPAF|npaf
1279991|NCT01672112|analgesic efficacy|analgesic efficacy
1279992|NCT01672112|oral codeine|oral codeine
1279993|NCT01672112|oral oxycodone|oral oxycodone
1279994|NCT01672112|postcraniotomy|postcraniotomy
1279995|NCT01672099|vitamin K2|vitamin k2
1279996|NCT01672099|menaquinone-7|menaquinone-7
1279997|NCT01672099|vascular health|vascular health
1279998|NCT01672073|pressure|pressure
1279999|NCT01672073|waveform|waveform
1280000|NCT01672073|arterial|arterial
1280001|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
1280002|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
1280003|NCT01672047|The intact PTH level|the intact pth level
1280004|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
1280005|NCT01672047|The microalbuminuria level|the microalbuminuria level
1280006|NCT01672021|Breast Cancer|breast cancer
1280007|NCT01672021|MRI PET-CT|mri pet-ct
1280009|NCT01671995|Heart failure|heart failure
1280010|NCT01671995|Quality of life|quality of life
1280011|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
1280012|NCT01671956|IBD|ibd
1280013|NCT01671956|UC|uc
1280014|NCT01671956|Colitis|colitis
1280015|NCT01671956|Ulcerative Colitis|ulcerative colitis
1280016|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
1280017|NCT01671917|Total knee arthroplasty|total knee arthroplasty
1280018|NCT01671917|Total knee replacement|total knee replacement
1280019|NCT01671917|Knee osteoarthritis|knee osteoarthritis
1280020|NCT01671917|Education|education
1280021|NCT01671917|Exercise|exercise
1280022|NCT01671917|Handicap|handicap
1280023|NCT01671917|Function|function
1280024|NCT01671917|Cost-effectiveness|cost-effectiveness
1280025|NCT01671917|Cost-utility|cost-utility
1280026|NCT01671917|Quality of life|quality of life
1280027|NCT01671891|rectal cancer|rectal cancer
1280028|NCT01671891|circulating tumor cells|circulating tumor cells
1280029|NCT01671891|predict responses|predict responses
1280030|NCT01671865|FSHD|fshd
1280031|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
1280032|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1280033|NCT01671826|Multiple Myeloma|multiple myeloma
1280034|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1280035|NCT01671826|Elderly Patients|elderly patients
1280036|NCT01671813|positive|positive
1280037|NCT01671813|diffuse|diffuse
1280038|NCT01671813|B-Cell|b-cell
1280039|NCT01671813|elderly|elderly
1280040|NCT01671813|EBV|ebv
1280041|NCT01671813|DLBCL|dlbcl
1280042|NCT01671813|malignant|malignant
1280043|NCT01671813|pilot|pilot
1280044|NCT01671800|Hyperhidrosis|hyperhidrosis
1280045|NCT01671800|Botulinum Toxin|botulinum toxin
1280046|NCT01671800|Amputation|amputation
1280047|NCT01671800|Phantom limb pain|phantom limb pain
1280048|NCT01671787|Hepatitis B|hepatitis b
1280049|NCT01671787|HBV|hbv
1280050|NCT01671787|GS-7340|gs-7340
1280051|NCT01671787|TDF|tdf
1280052|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1280053|NCT01671787|Gilead|gilead
1280054|NCT01671787|Viread|viread
1280055|NCT01671761|Healthy|healthy
1280056|NCT01671761|Control|control
1280057|NCT01671748|Venous Leg Ulcer|venous leg ulcer
1280058|NCT01671748|Varicose Ulcer|varicose ulcer
1280059|NCT01671748|Chronic ulcer|chronic ulcer
1280060|NCT01671748|Chronic wound|chronic wound
1280061|NCT01671748|Ultrasound therapy|ultrasound therapy
1280062|NCT01671748|MIST device|mist device
1280063|NCT01671748|Wound healing|wound healing
1280064|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
1280065|NCT01671735|prevention|prevention
1280066|NCT01671735|diabetes|diabetes
1280067|NCT01671722|Bioequivalence|bioequivalence
1280068|NCT01671722|Montelukast Sodium|montelukast sodium
1280069|NCT01671722|crossover|crossover
1280070|NCT01671709|Bioequivalence|bioequivalence
1280071|NCT01671709|Montelukast Sodium|montelukast sodium
1280072|NCT01671709|crossover|crossover
1280073|NCT01671683|rectal cancer|rectal cancer
1280074|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1280075|NCT01671683|Capecitabine|capecitabine
1280076|NCT01671670|Functional dyspepsia|functional dyspepsia
1280077|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
1280078|NCT01671657|In vitro fertilization|in vitro fertilization
1280079|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
1280080|NCT01671657|Time-lapse image recording|time-lapse image recording
1280081|NCT01671657|Image analysis software|image analysis software
1280082|NCT01671644|In vitro fertilization|in vitro fertilization
1280083|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
1280084|NCT01671644|Time-lapse image recording|time-lapse image recording
1280085|NCT01671644|Image analysis software|image analysis software
1280086|NCT01671618|Aortic dissection|aortic dissection
1280087|NCT01671618|Aortic dilation|aortic dilation
1280088|NCT01671618|Aortic Aneurysm|aortic aneurysm
1280089|NCT01671618|ultrasound|ultrasound
1280090|NCT01671618|point-of-care|point-of-care
1280091|NCT01671618|echocardiography|echocardiography
1280092|NCT01671592|Cancer|cancer
1280093|NCT01671592|colorectal|colorectal
1280094|NCT01671592|tumor|tumor
1280095|NCT01671592|neoplasms|neoplasms
1280096|NCT01671592|carcinoma|carcinoma
1280097|NCT01671592|vaccine|vaccine
1280098|NCT01671566|Congenital Heart defect|congenital heart defect
1280099|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
1280100|NCT01671566|Rehabilitation|rehabilitation
1280101|NCT01671566|Quality of life|quality of life
1280102|NCT01671566|Behaviour|behaviour
1280103|NCT01671540|COPD|copd
1280104|NCT01671540|IPV|ipv
1280105|NCT01671527|Deep Brain Stimulation|deep brain stimulation
1280106|NCT01671527|DBS|dbs
1280107|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1280108|NCT01671527|TMS|tms
1280109|NCT01671527|Cervical Dystonia|cervical dystonia
1280110|NCT01671527|Dystonia|dystonia
1280111|NCT01671527|Control|control
1280112|NCT01671527|Healthy|healthy
1280113|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
1280114|NCT01671514|skeletal muscle|skeletal muscle
1280115|NCT01671514|epicatechin|epicatechin
1280116|NCT01671501|HIV|hiv
1280117|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1280118|NCT01671501|Alcoholism|alcoholism
1280119|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
1280120|NCT01671501|Substance-Related Disorders|substance-related disorders
1280121|NCT01671501|Intervention Studies|intervention studies
1280122|NCT01671501|Primary Health Care|primary health care
1280123|NCT01671501|therapy|therapy
1280124|NCT01671501|prevention & control|prevention & control
1280125|NCT01671488|Anal Cancer|anal cancer
1280126|NCT01671488|Mitomycin|mitomycin
1280127|NCT01671488|5-Fluorouracil|5-fluorouracil
1280128|NCT01671488|5-FU|5-fu
1280129|NCT01671488|IMRT|imrt
1280130|NCT01671488|ADXS11-001|adxs11-001
1280131|NCT01671475|Altered Mental Status|altered mental status
1280132|NCT01671475|Non-convulsive seizure|non-convulsive seizure
1280133|NCT01671475|Electroencephalography|electroencephalography
1280134|NCT01671462|HPV|hpv
1280135|NCT01671462|Cervical Cancer|cervical cancer
1280136|NCT01671462|Cervical Neoplasms|cervical neoplasms
1280137|NCT01671449|Gastric cancer|gastric cancer
1280138|NCT01671449|S-1|s-1
1280139|NCT01671449|Cisplatin|cisplatin
1280140|NCT01671449|Oxaliplatin|oxaliplatin
1280141|NCT01671436|Depression|depression
1280142|NCT01671436|Guided Imagery|guided imagery
1280143|NCT01671436|Psychotherapy|psychotherapy
1280144|NCT01671436|Meditation|meditation
1280145|NCT01671423|Cellulitis|cellulitis
1280146|NCT01671423|Skin infection|skin infection
1280147|NCT01671423|Prednisone|prednisone
1280148|NCT01671423|Steroid|steroid
1280149|NCT01671423|Anti-inflammatory|anti-inflammatory
1280150|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1280151|NCT01671410|buprenorphine|buprenorphine
1280152|NCT01671410|morphine|morphine
1280153|NCT01671410|benzodiazepine|benzodiazepine
1280154|NCT01671397|Obesity|obesity
1280155|NCT01671397|weight loss|weight loss
1280156|NCT01671397|sleep hygiene|sleep hygiene
1280157|NCT01671397|diet|diet
1280158|NCT01671397|exercise|exercise
1280159|NCT01671384|Valproate|valproate
1280160|NCT01671384|levocarnitine|levocarnitine
1280161|NCT01671384|SMA|sma
1280162|NCT01671384|physiotherapy|physiotherapy
1280163|NCT01671384|placebo|placebo
1280164|NCT01671371|syncope|syncope
1280165|NCT01671371|point of care|point of care
1280166|NCT01671371|ultrasound|ultrasound
1280167|NCT01671371|echocardiography|echocardiography
1280168|NCT01671358|MRSA|mrsa
1280169|NCT01671358|Contamination|contamination
1280170|NCT01671358|Isolation|isolation
1280171|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
1280172|NCT01671332|Second line|second line
1280173|NCT01671332|Third line|third line
1280174|NCT01671319|breast cancer|breast cancer
1280175|NCT01671319|female|female
1280176|NCT01671319|women|women
1280177|NCT01671319|adjuvant|adjuvant
1280178|NCT01671306|Coronary collaterals|coronary collaterals
1280179|NCT01671306|diabetes mellitus|diabetes mellitus
1280180|NCT01671306|monocyte subsets|monocyte subsets
1280181|NCT01671280|pneumonia|pneumonia
1280182|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
1280183|NCT01671280|Zithromax|zithromax
1280184|NCT01671280|Zithromac|zithromac
1280185|NCT01671280|Japanese|japanese
1280186|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1280187|NCT01671228|dialysis|dialysis
1280188|NCT01671228|chronic kidney failure|chronic kidney failure
1280189|NCT01671228|informed choice|informed choice
1280190|NCT01671228|patient decision making|patient decision making
1280191|NCT01671228|decision aid|decision aid
1280192|NCT01671215|endometrium|endometrium
1280193|NCT01671215|myometrium|myometrium
1280194|NCT01671215|fibroids|fibroids
1280195|NCT01671215|uterine malformations|uterine malformations
1280196|NCT01671176|Wide diameter implant|wide diameter implant
1280197|NCT01671176|ISQ|isq
1280198|NCT01671176|Ponto|ponto
1280199|NCT01671176|Bone anchored implant|bone anchored implant
1280200|NCT01671163|Cancer|cancer
1280201|NCT01671163|Radiation therapy|radiation therapy
1280202|NCT01671163|Fiducial markers|fiducial markers
1280203|NCT01671150|inflammation|inflammation
1280204|NCT01671150|depression|depression
1280205|NCT01671150|social cognition|social cognition
1280206|NCT01671150|neural activity|neural activity
1280207|NCT01671137|Lactobacillus GG|lactobacillus gg
1280208|NCT01671137|Functional Abdominal Pain|functional abdominal pain
1280209|NCT01671137|Children|children
1280210|NCT01671137|Acute|acute
1280211|NCT01671137|Gastroenteritis|gastroenteritis
1280212|NCT01671124|TG|tg
1280213|NCT01671124|TC|tc
1280214|NCT01671124|HDL|hdl
1280215|NCT01671124|LDL|ldl
1280216|NCT01671124|Albumin|albumin
1280217|NCT01671124|Hemoglobin|hemoglobin
1280218|NCT01671124|Hematocrit|hematocrit
1280219|NCT01671124|Uric acid|uric acid
1280220|NCT01671124|Sodium|sodium
1280221|NCT01671124|Potassium|potassium
1280222|NCT01671124|Calcium|calcium
1280223|NCT01671098|nitric oxide|nitric oxide
1280224|NCT01671098|sinuplasty|sinuplasty
1280225|NCT01671072|Chondrocyte cells|chondrocyte cells
1280226|NCT01671072|Osteoarthritis|osteoarthritis
1280227|NCT01671072|Gene therapy|gene therapy
1280228|NCT01671033|Panic disorder|panic disorder
1280229|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
1280230|NCT01671033|Internet|internet
1280231|NCT01671020|fimasartan|fimasartan
1280232|NCT01671020|absolute bioavailability|absolute bioavailability
1280233|NCT01670994|cancer|cancer
1280234|NCT01670994|immunotherapy|immunotherapy
1280235|NCT01670994|immunochemotherapy|immunochemotherapy
1280236|NCT01670994|targeted|targeted
1280237|NCT01670994|metastatic|metastatic
1280238|NCT01670994|interleukin-2|interleukin-2
1280239|NCT01670994|antitumor|antitumor
1280240|NCT01670994|TCR|tcr
1280241|NCT01670994|T-cell receptor|t-cell receptor
1280242|NCT01670994|p53|p53
1280243|NCT01670994|p53 gene|p53 gene
1280244|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
1280245|NCT01670994|HLA-A2 positive|hla-a2 positive
1280246|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
1280247|NCT01670994|HLA complex|hla complex
1280248|NCT01670994|multiple myeloma|multiple myeloma
1280249|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
1280250|NCT01670994|refractory|refractory
1280251|NCT01670994|relapsed|relapsed
1280252|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
1280253|NCT01670981|Heart failure|heart failure
1280254|NCT01670981|ixCELL|ixcell
1280255|NCT01670981|ixCELL DCM|ixcell dcm
1280256|NCT01670981|IDCM|idcm
1280257|NCT01670981|DCM|dcm
1280258|NCT01670981|stem cells|stem cells
1280259|NCT01670981|MSC|msc
1280260|NCT01670981|cell therapy|cell therapy
1280261|NCT01670955|Anemia|anemia
1280262|NCT01670955|preoperative|preoperative
1280263|NCT01670955|gynecological patients|gynecological patients
1280264|NCT01670955|Sorghum bicolor|sorghum bicolor
1280265|NCT01670955|Packed Cells Volume|packed cells volume
1280266|NCT01670942|pneumothorax|pneumothorax
1280267|NCT01670942|trauma|trauma
1280268|NCT01670942|commercial air travel|commercial air travel
1280269|NCT01670929|recurrent miscarriages|recurrent miscarriages
1280270|NCT01670929|progesterone|progesterone
1280271|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
1280272|NCT01670916|Probiotics|probiotics
1280273|NCT01670916|Preterm|preterm
1280274|NCT01670916|Infant|infant
1280275|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
1280276|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
1280277|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
1280278|NCT01670851|eLAPE,|elape,
1280279|NCT01670851|perineum,|perineum,
1280280|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
1280281|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
1280282|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
1280283|NCT01670825|Occipital neuralgia|occipital neuralgia
1280284|NCT01670825|corticosteroid injection|corticosteroid injection
1280285|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
1280286|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1280287|NCT01670812|ultra-high risk|ultra-high risk
1280288|NCT01670812|fresh frozen plasma|fresh frozen plasma
1280289|NCT01670812|methylprednisolone|methylprednisolone
1280290|NCT01670812|rituximab|rituximab
1280291|NCT01670799|Ketorolac|ketorolac
1280292|NCT01670799|Bioavailability|bioavailability
1280293|NCT01670799|Pain|pain
1280294|NCT01670760|Deep Tissue Temperature|deep tissue temperature
1280295|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
1280296|NCT01670760|Thermometry|thermometry
1280297|NCT01670760|Core Temperature|core temperature
1280298|NCT01670708|Substance Use|substance use
1280299|NCT01670708|Illicit Drug Use|illicit drug use
1280300|NCT01670708|Criminal Behavior|criminal behavior
1280301|NCT01670695|IgG4-related disease|igg4-related disease
1280302|NCT01670695|IgG4-RD|igg4-rd
1280303|NCT01670682|Stage III|stage iii
1280304|NCT01670643|AMD|amd
1280305|NCT01670643|vision rehabilitation|vision rehabilitation
1280306|NCT01670643|video camera magnifier|video camera magnifier
1280307|NCT01670643|IVI|ivi
1280308|NCT01670643|DASS|dass
1280309|NCT01670630|speculum|speculum
1280310|NCT01670630|vagina|vagina
1280311|NCT01670630|cervix|cervix
1280312|NCT01670630|examination|examination
1280313|NCT01670578|P.R.P.|p.r.p.
1280314|NCT01670578|viscosupplementation|viscosupplementation
1280315|NCT01670578|double-blind randomized|double-blind randomized
1280316|NCT01670578|intra-articular injections|intra-articular injections
1280317|NCT01670578|knee degenerative pathology|knee degenerative pathology
1280318|NCT01670578|early osteoarthritis|early osteoarthritis
1280319|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
1280320|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
1280321|NCT01670539|Lung Cancer|lung cancer
1280322|NCT01670539|Telemonitoring|telemonitoring
1280323|NCT01670539|Rural|rural
1280324|NCT01670539|Nursing|nursing
1280325|NCT01670526|Traumatic Brain Injury|traumatic brain injury
1280326|NCT01670526|Cognitive Impairment|cognitive impairment
1280327|NCT01670526|Rivastigmine|rivastigmine
1280328|NCT01670526|Pharmacologic Actions|pharmacologic actions
1280330|NCT01670526|Memory|memory
1280331|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
1280332|NCT01670526|Cognition|cognition
1280333|NCT01670526|Head Trauma|head trauma
1280334|NCT01670513|Psoriasis|psoriasis
1280335|NCT01670500|germline mutation|germline mutation
1280336|NCT01670500|BRCA1 mutation|brca1 mutation
1280337|NCT01670500|BRCA2 mutation|brca2 mutation
1280338|NCT01670487|Vapocoolant|vapocoolant
1280339|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
1280340|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
1280341|NCT01670474|Thrombolysis|thrombolysis
1280342|NCT01670474|rt-PA|rt-pa
1280343|NCT01670474|Thrombosis|thrombosis
1280344|NCT01670474|Lifespan|lifespan
1280345|NCT01670474|Blood flow rate|blood flow rate
1280346|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
1280347|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
1280348|NCT01670448|Postoperative pain|postoperative pain
1280349|NCT01670448|Chronic pain prevention|chronic pain prevention
1280350|NCT01670448|Regional anesthesia|regional anesthesia
1280351|NCT01670448|Mastectomy|mastectomy
1280352|NCT01670435|Ciprofloxacin|ciprofloxacin
1280353|NCT01670435|sepsis|sepsis
1280354|NCT01670435|infection|infection
1280355|NCT01670435|pneumonia|pneumonia
1280356|NCT01670435|peritonitis|peritonitis
1280357|NCT01670435|cholecystitis|cholecystitis
1280358|NCT01670435|cholangitis|cholangitis
1280359|NCT01670435|anthrax|anthrax
1280360|NCT01670422|CSOJ|csoj
1280361|NCT01670422|recurrence|recurrence
1280362|NCT01670422|life-threatening complications|life-threatening complications
1280363|NCT01670422|risk factors|risk factors
1280364|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1280365|NCT01670409|SMART|smart
1280366|NCT01670409|IMRT|imrt
1280367|NCT01670409|Chemotherapy|chemotherapy
1280368|NCT01670396|coronary stent implant|coronary stent implant
1280369|NCT01670396|polymorphism|polymorphism
1280370|NCT01670396|G protein|g protein
1280371|NCT01670396|drug-eluting stent|drug-eluting stent
1280372|NCT01670396|restenosis|restenosis
1280373|NCT01670383|Cardiac Arrest|cardiac arrest
1280374|NCT01670383|Sepsis|sepsis
1280375|NCT01670383|Biological Markers|biological markers
1280376|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
1280377|NCT01670383|Antioxidants|antioxidants
1280378|NCT01670370|Rituximab|rituximab
1280379|NCT01670370|Gemcitabine|gemcitabine
1280380|NCT01670370|Oxaliplatin|oxaliplatin
1280381|NCT01670370|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1280382|NCT01670357|Dry Eye Syndrome|dry eye syndrome
1280383|NCT01670318|Chronic total occlusion|chronic total occlusion
1280384|NCT01670318|Bifurcation lesion|bifurcation lesion
1280385|NCT01670318|Left main trunk lesion|left main trunk lesion
1280386|NCT01670318|Small vessel disease|small vessel disease
1280387|NCT01670318|Multi vessel disease|multi vessel disease
1280388|NCT01670292|Low Back Pain|low back pain
1280389|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1280390|NCT01670266|ONO-9054|ono-9054
1280391|NCT01670266|ocular hypertension|ocular hypertension
1280392|NCT01670266|OHT|oht
1280393|NCT01670266|Open angle-glaucoma|open angle-glaucoma
1280394|NCT01670266|OAG|oag
1280395|NCT01670266|Glaucoma|glaucoma
1280396|NCT01670266|Eye diseases|eye diseases
1280397|NCT01670240|IPAA|ipaa
1280398|NCT01670240|Pouchitis|pouchitis
1280399|NCT01670240|Ulcerative colitis|ulcerative colitis
1280400|NCT01670240|Pouch|pouch
1280401|NCT01670240|Adalimumab|adalimumab
1280402|NCT01670240|Humira|humira
1280605|NCT01669278|flexible|flexible
1280403|NCT01670227|EARLY CHILDHOOD|early childhood
1280404|NCT01670227|UNIVERSAL PREVENTION|universal prevention
1280405|NCT01670214|RM|rm
1280406|NCT01670214|R-CM|r-cm
1280407|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
1280408|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
1280409|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
1280410|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
1280411|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
1280412|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
1280413|NCT01670162|Wet macular degeneration|wet macular degeneration
1280414|NCT01670162|Macular degeneration|macular degeneration
1280415|NCT01670149|Clostridium difficile|clostridium difficile
1280416|NCT01670149|Diarrhoea|diarrhoea
1280417|NCT01670149|Rifaximin|rifaximin
1280418|NCT01670136|sildenafil|sildenafil
1280419|NCT01670136|preterm infants|preterm infants
1280420|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
1280421|NCT01670123|Mobile phone|mobile phone
1280422|NCT01670123|electronic intervention|electronic intervention
1280423|NCT01670123|behavioral intervention|behavioral intervention
1280424|NCT01670123|telehealth|telehealth
1280425|NCT01670123|bipolar disorder|bipolar disorder
1280426|NCT01670110|Polycystic Liver Disease|polycystic liver disease
1280427|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1280428|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
1280429|NCT01670110|Somatostatin analogs|somatostatin analogs
1280430|NCT01670110|Pasireotide LAR|pasireotide lar
1280431|NCT01670110|SOM230|som230
1280432|NCT01670097|Advanced Cancers|advanced cancers
1280433|NCT01670097|Hematologic Disorder|hematologic disorder
1280434|NCT01670097|Solid Tumors|solid tumors
1280435|NCT01670097|Dyspnea|dyspnea
1280436|NCT01670097|Difficulty breathing|difficulty breathing
1280437|NCT01670097|Shortness of breath|shortness of breath
1280438|NCT01670097|Dexamethasone|dexamethasone
1280439|NCT01670097|Decadron|decadron
1280440|NCT01670097|Placebo|placebo
1280441|NCT01670097|Sugar pill|sugar pill
1280442|NCT01670097|Questionnaires|questionnaires
1280443|NCT01670097|Surveys|surveys
1280444|NCT01670097|Spirometer|spirometer
1280445|NCT01670097|Phone calls|phone calls
1280446|NCT01670071|Schizophrenia|schizophrenia
1280447|NCT01670071|Paliperidone|paliperidone
1280448|NCT01670071|Risperidone|risperidone
1280449|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
1280450|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
1280451|NCT01670019|Depression|depression
1280452|NCT01670019|Antidepressant|antidepressant
1280453|NCT01670019|Antipsychotic|antipsychotic
1280454|NCT01669993|Outcomes|outcomes
1280455|NCT01669993|Quality improvement|quality improvement
1280456|NCT01669993|Patient Safety|patient safety
1280457|NCT01669993|PACU|pacu
1280458|NCT01669993|Complications|complications
1280459|NCT01669993|Adverse events|adverse events
1280460|NCT01669993|Respiratory arrest|respiratory arrest
1280461|NCT01669993|Pain|pain
1280462|NCT01669993|PONV|ponv
1280463|NCT01669993|Age|age
1280464|NCT01669993|Neonate|neonate
1280465|NCT01669993|Infant|infant
1280466|NCT01669993|Child|child
1280467|NCT01669993|Ambulatory|ambulatory
1280468|NCT01669993|Inpatient|inpatient
1280469|NCT01669993|General Anesthesia|general anesthesia
1280470|NCT01669993|Otolaryngology|otolaryngology
1280471|NCT01669993|Tonsillectomy|tonsillectomy
1280472|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
1280473|NCT01669980|Infections|infections
1280474|NCT01669980|Pediatrics|pediatrics
1280475|NCT01669980|Teflaro|teflaro
1280476|NCT01669980|Ceftriaxone|ceftriaxone
1280477|NCT01669980|cephalosporin|cephalosporin
1280478|NCT01669980|Vancomycin|vancomycin
1280479|NCT01669980|Clindamycin|clindamycin
1280480|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
1280481|NCT01669980|Linezolid|linezolid
1280482|NCT01669980|MRSA|mrsa
1280483|NCT01669980|pneumonia|pneumonia
1280484|NCT01669954|HIV|hiv
1280485|NCT01669954|Bone mineral density|bone mineral density
1280486|NCT01669954|Osteoporosis|osteoporosis
1280487|NCT01669954|Vitamin D|vitamin d
1280488|NCT01669954|Fractures|fractures
1280489|NCT01669941|Pregnancy|pregnancy
1280490|NCT01669941|Plasmodium|plasmodium
1280491|NCT01669941|Malaria|malaria
1280492|NCT01669941|Prevention|prevention
1280493|NCT01669941|Kenya|kenya
1280494|NCT01669941|Piperaquine|piperaquine
1280495|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
1280496|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
1280497|NCT01669876|Randomized|randomized
1280498|NCT01669876|Double-Blind|double-blind
1280499|NCT01669876|Dietary Supplements|dietary supplements
1280501|NCT01669850|Chronic kidney disease|chronic kidney disease
1280502|NCT01669850|Arteriovenous fistula|arteriovenous fistula
1280503|NCT01669850|Surgical anastomosis|surgical anastomosis
1280504|NCT01669850|Complications|complications
1280505|NCT01669850|Patency|patency
1280506|NCT01669850|Dialysis access|dialysis access
1280507|NCT01669837|Inguinal hernia|inguinal hernia
1280508|NCT01669837|Laparoscopy|laparoscopy
1280509|NCT01669837|Surgical tissue glue|surgical tissue glue
1280510|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
1280511|NCT01669811|Japanese,|japanese,
1280512|NCT01669811|Nexium,|nexium,
1280513|NCT01669811|twice daily,|twice daily,
1280514|NCT01669811|oral administration|oral administration
1280515|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
1280516|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
1280517|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
1280518|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
1280519|NCT01669746|Male Pattern Baldness|male pattern baldness
1280520|NCT01669746|Female Pattern Baldness|female pattern baldness
1280521|NCT01669746|Hair Loss|hair loss
1280522|NCT01669746|Baldness|baldness
1280523|NCT01669733|Breast Surgery|breast surgery
1280524|NCT01669733|Breast Biopsy|breast biopsy
1280525|NCT01669733|Music Therapy|music therapy
1280526|NCT01669720|Metastatic|metastatic
1280527|NCT01669720|Colorectal|colorectal
1280528|NCT01669720|Colorectal Cancer|colorectal cancer
1280529|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
1280530|NCT01669707|Endostar|endostar
1280531|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
1280532|NCT01669707|Continued Pumping into vein|continued pumping into vein
1280533|NCT01669707|Gemcitabine|gemcitabine
1280534|NCT01669707|Carboplatin|carboplatin
1280535|NCT01669694|Pelvic Pain|pelvic pain
1280536|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
1280537|NCT01669694|Biomarkers|biomarkers
1280538|NCT01669681|Severe asthma|severe asthma
1280539|NCT01669681|Medical economic|medical economic
1280540|NCT01669681|care|care
1280541|NCT01669681|Cost efficiency|cost efficiency
1280542|NCT01669681|CPAM|cpam
1280543|NCT01669681|EQ5D|eq5d
1280544|NCT01669642|ketamine sedation|ketamine sedation
1280545|NCT01669642|pediatric|pediatric
1280546|NCT01669642|abscess drainage|abscess drainage
1280547|NCT01669642|fracture reduction|fracture reduction
1280548|NCT01669616|Type 2 Diabetes|type 2 diabetes
1280549|NCT01669616|Adults 18 years and older|adults 18 years and older
1280550|NCT01669603|Common cold|common cold
1280551|NCT01669577|predictors|predictors
1280552|NCT01669577|trauma|trauma
1280553|NCT01669577|mortality|mortality
1280554|NCT01669564|Quality of Life|quality of life
1280555|NCT01669564|Tobacco Use Cessation|tobacco use cessation
1280556|NCT01669564|Physical Activity|physical activity
1280557|NCT01669538|Galantamine|galantamine
1280558|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
1280559|NCT01669538|Nicotine Tartrate|nicotine tartrate
1280560|NCT01669538|Nicotine dependence|nicotine dependence
1280561|NCT01669538|Tobacco Dependence|tobacco dependence
1280562|NCT01669512|Malaria vaccine|malaria vaccine
1280563|NCT01669512|Matrix M|matrix m
1280564|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
1280565|NCT01669486|Pain|pain
1280566|NCT01669486|ICU|icu
1280567|NCT01669486|Mechanical ventilation|mechanical ventilation
1280568|NCT01669486|CPOT|cpot
1280569|NCT01669486|BPS|bps
1280570|NCT01669473|Diabetes|diabetes
1280571|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
1280572|NCT01669434|Perioperative Period|perioperative period
1280573|NCT01669421|Alpha 1|alpha 1
1280574|NCT01669408|ischemic stroke|ischemic stroke
1280575|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
1280576|NCT01669408|prehospital cooling|prehospital cooling
1280577|NCT01669408|induction of cooling|induction of cooling
1280578|NCT01669408|ambulance|ambulance
1280579|NCT01669408|emergency room|emergency room
1280580|NCT01669408|cold infusions|cold infusions
1280581|NCT01669408|hypothermia|hypothermia
1280582|NCT01669408|normothermia|normothermia
1280583|NCT01669395|Severe heart failure|severe heart failure
1280584|NCT01669395|Homebased rehabilitation|homebased rehabilitation
1280585|NCT01669395|Physical exercise|physical exercise
1280586|NCT01669395|Activities of daily living|activities of daily living
1280587|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
1280588|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
1280589|NCT01669369|Lithium Carbonate|lithium carbonate
1280590|NCT01669369|Chemotherapy|chemotherapy
1280591|NCT01669369|prognosis|prognosis
1280592|NCT01669356|malnutrition|malnutrition
1280593|NCT01669356|parenteral supplement|parenteral supplement
1280594|NCT01669356|rest metabolic rate|rest metabolic rate
1280595|NCT01669356|postoperative complications|postoperative complications
1280596|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
1280597|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
1280598|NCT01669330|Fundoplication|fundoplication
1280599|NCT01669330|Surgical Procedures|surgical procedures
1280600|NCT01669317|Cherry Juice Pilot|cherry juice pilot
1280601|NCT01669304|migraine variant|migraine variant
1280602|NCT01669304|chronic dizziness|chronic dizziness
1280603|NCT01669304|pharmacologic dissection|pharmacologic dissection
1280606|NCT01669278|endoscopy|endoscopy
1280607|NCT01669278|otolaryngology|otolaryngology
1280608|NCT01669278|office|office
1280609|NCT01669265|Breast cancer|breast cancer
1280610|NCT01669265|OSNA|osna
1280611|NCT01669265|sentinel lymph node|sentinel lymph node
1280612|NCT01669252|Breast cancer|breast cancer
1280613|NCT01669252|Eribulin|eribulin
1280614|NCT01669252|Neoadjuvant|neoadjuvant
1280615|NCT01669252|PAM50|pam50
1280616|NCT01669252|Triple-negative|triple-negative
1280617|NCT01669252|Luminal A|luminal a
1280618|NCT01669252|Luminal B|luminal b
1280619|NCT01669239|Breast Cancer|breast cancer
1280620|NCT01669239|HER2 positive|her2 positive
1280621|NCT01669239|Neoadjuvant|neoadjuvant
1280622|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
1280623|NCT01669239|Paclitaxel|paclitaxel
1280624|NCT01669239|Trastuzumab|trastuzumab
1280625|NCT01669239|Pertuzumab|pertuzumab
1280626|NCT01669239|Safety|safety
1280627|NCT01669226|Ovarian Cancer|ovarian cancer
1280628|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1280629|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
1280630|NCT01669213|hypotension|hypotension
1280631|NCT01669213|spinal anesthesia|spinal anesthesia
1280632|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1280633|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
1280634|NCT01669161|Upper|upper
1280635|NCT01669161|Limb|limb
1280636|NCT01669161|Deficits|deficits
1280637|NCT01669161|Rehabilitation|rehabilitation
1280638|NCT01669161|VNS|vns
1280639|NCT01669148|breast cancer|breast cancer
1280640|NCT01669148|imaging|imaging
1280641|NCT01669135|cerebral oximetry|cerebral oximetry
1280642|NCT01669135|cesarean delivery|cesarean delivery
1280643|NCT01669109|Yoga|yoga
1280644|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
1280645|NCT01669109|Quality of Life|quality of life
1280646|NCT01669109|Randomized Controlled Trial|randomized controlled trial
1280647|NCT01669096|adults|adults
1280648|NCT01669096|healthy|healthy
1280649|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
1280650|NCT01669096|mRNA expression|mrna expression
1280651|NCT01669096|HIV negative|hiv negative
1280652|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
1280653|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
1280654|NCT01669070|bioavailability|bioavailability
1280655|NCT01669070|Fluticasone Furoate|fluticasone furoate
1280656|NCT01669070|pharmacokinetics|pharmacokinetics
1280657|NCT01669070|dose proportionality|dose proportionality
1280658|NCT01669057|Congenital heart disease|congenital heart disease
1280659|NCT01669057|DNA variation|dna variation
1280660|NCT01669057|methylation|methylation
1280661|NCT01669057|risk factors|risk factors
1280662|NCT01669057|supplements|supplements
1280663|NCT01669031|automated perimetry|automated perimetry
1280664|NCT01669031|visual fields|visual fields
1280665|NCT01669031|reliability|reliability
1280666|NCT01669031|vision tests/standards|vision tests/standards
1280667|NCT01669031|randomized controlled trial|randomized controlled trial
1280668|NCT01669031|false positive reactions|false positive reactions
1280669|NCT01669031|false negative reactions|false negative reactions
1280670|NCT01669031|fixation, ocular|fixation, ocular
1280671|NCT01669031|mean deviation|mean deviation
1280672|NCT01669031|variability|variability
1280673|NCT01669031|program|program
1280674|NCT01669031|software|software
1280675|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
1280676|NCT01669031|visual field tests/methods|visual field tests/methods
1280677|NCT01669031|aged|aged
1280678|NCT01669031|humans|humans
1280679|NCT01669031|female|female
1280680|NCT01669031|male|male
1280681|NCT01669031|prospective studies|prospective studies
1280682|NCT01669031|reproducibility of results|reproducibility of results
1280683|NCT01669005|neutropenia|neutropenia
1280684|NCT01669005|multiplex PCR|multiplex pcr
1280685|NCT01669005|infection|infection
1280686|NCT01668992|Parenting|parenting
1280687|NCT01668992|Discipline|discipline
1280688|NCT01668992|Family interventions|family interventions
1280689|NCT01668992|Thailand|thailand
1280690|NCT01668992|Migration|migration
1280691|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
1280692|NCT01668953|Tennis Elbow|tennis elbow
1280693|NCT01668953|Platelet Rich Plasma|platelet rich plasma
1280694|NCT01668953|Whole Blood|whole blood
1280695|NCT01668953|Tendon Fenestration|tendon fenestration
1280696|NCT01668940|Morning Sickness|morning sickness
1280697|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
1280698|NCT01668940|Pregnancy|pregnancy
1280699|NCT01668940|Obstetrics|obstetrics
1280700|NCT01668914|Breast Cancer|breast cancer
1280701|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
1280702|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1280703|NCT01668914|Internal Mammary|internal mammary
1280704|NCT01668901|warfarin|warfarin
1280705|NCT01668901|aspirin|aspirin
1280706|NCT01668875|head down postural drainage|head down postural drainage
1280707|NCT01668849|Plant exosomes|plant exosomes
1280708|NCT01668849|Grape exosomes|grape exosomes
1280709|NCT01668849|Grape extract|grape extract
1280908|NCT01668030|Facial|facial
1280710|NCT01668849|Oral mucositis|oral mucositis
1280711|NCT01668849|Head and Neck Cancer|head and neck cancer
1280712|NCT01668849|Immune response|immune response
1280713|NCT01668836|sirtuin|sirtuin
1280714|NCT01668836|atherosclerosis|atherosclerosis
1280715|NCT01668836|longevity|longevity
1280716|NCT01668836|calorie restriction|calorie restriction
1280717|NCT01668836|resveratrol|resveratrol
1280718|NCT01668836|vascular reactivity|vascular reactivity
1280719|NCT01668810|prescription|prescription
1280720|NCT01668810|schizophrenia|schizophrenia
1280721|NCT01668810|depression|depression
1280722|NCT01668810|bipolar disorder|bipolar disorder
1280723|NCT01668771|Self-Affirmation|self-affirmation
1280725|NCT01668771|Alcohol|alcohol
1280726|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
1280727|NCT01668758|Traumatic Brain Injury|traumatic brain injury
1280728|NCT01668745|Child mortality|child mortality
1280729|NCT01668745|Measles vaccine|measles vaccine
1280730|NCT01668745|Non-specific effects|non-specific effects
1280731|NCT01668693|Endometrial receptivity|endometrial receptivity
1280732|NCT01668693|recurrent implantation failure|recurrent implantation failure
1280733|NCT01668693|predictor tool|predictor tool
1280734|NCT01668693|ERA|era
1280735|NCT01668693|customized microarray|customized microarray
1280736|NCT01668693|personalized embryo transfer|personalized embryo transfer
1280737|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
1280738|NCT01668680|Anti-Angiogenic|anti-angiogenic
1280739|NCT01668680|Maintenance Treatment|maintenance treatment
1280740|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
1280741|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
1280742|NCT01668667|Horizant|horizant
1280743|NCT01668654|Epilepsy|epilepsy
1280744|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
1280745|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
1280746|NCT01668654|Open-label extension study|open-label extension study
1280747|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
1280748|NCT01668628|quality of life|quality of life
1280749|NCT01668628|depression|depression
1280750|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
1280751|NCT01668628|hydrational status|hydrational status
1280752|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
1280753|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
1280754|NCT01668615|regulory T cells|regulory t cells
1280755|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
1280756|NCT01668576|Lung transplantation|lung transplantation
1280757|NCT01668563|Aneurysm|aneurysm
1280758|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
1280759|NCT01668563|Vascular Diseases|vascular diseases
1280760|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
1280761|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
1280762|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
1280763|NCT01668563|Brain Diseases|brain diseases
1280764|NCT01668563|Central Nervous System Diseases|central nervous system diseases
1280765|NCT01668563|Nervous System Diseases|nervous system diseases
1280766|NCT01668550|Phase I|phase i
1280767|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
1280768|NCT01668550|Solid Tumours|solid tumours
1280769|NCT01668550|Cancer|cancer
1280770|NCT01668511|Immunogenicity|immunogenicity
1280771|NCT01668511|Safety|safety
1280772|NCT01668511|Tolerability|tolerability
1280773|NCT01668511|Osteoarthritis|osteoarthritis
1280774|NCT01668511|Pharmacokinetics|pharmacokinetics
1280775|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
1280776|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
1280777|NCT01668498|Panitumumab|panitumumab
1280778|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
1280779|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
1280780|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
1280781|NCT01668472|Pregnant|pregnant
1280782|NCT01668472|leaking fluid|leaking fluid
1280783|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
1280784|NCT01668459|Bladder cancer|bladder cancer
1280785|NCT01668459|Cancer|cancer
1280786|NCT01668459|Oncology|oncology
1280787|NCT01668459|Cabazitaxel|cabazitaxel
1280788|NCT01668446|Sildenafil|sildenafil
1280789|NCT01668446|Endometrial thickness|endometrial thickness
1280790|NCT01668446|Frozen embryo transfer|frozen embryo transfer
1280791|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
1280792|NCT01668446|endometrial pattern|endometrial pattern
1378532|NCT01256203|PDT|pdt
1280793|NCT01668446|Implantation rate|implantation rate
1280794|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
1280795|NCT01668433|G6PD|g6pd
1280796|NCT01668433|Primaquine|primaquine
1280797|NCT01668433|Methylene blue|methylene blue
1280798|NCT01668420|thermal stimulation|thermal stimulation
1280799|NCT01668420|lower extremity|lower extremity
1280800|NCT01668420|temperature|temperature
1280801|NCT01668420|efficacy|efficacy
1280802|NCT01668407|Parkinson's disease|parkinson's disease
1280803|NCT01668407|PSP|psp
1280804|NCT01668407|Robot|robot
1280805|NCT01668407|Gait rehabilitation|gait rehabilitation
1280806|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
1280807|NCT01668381|Catheter Ablation|catheter ablation
1280808|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
1280809|NCT01668381|IL-10|il-10
1280810|NCT01668381|TGF-β|tgf-β
1280811|NCT01668381|IFN-γ|ifn-γ
1280812|NCT01668368|ARDS|ards
1280813|NCT01668368|Esophageal pressure|esophageal pressure
1280814|NCT01668368|pleural pressure|pleural pressure
1280815|NCT01668368|pulmonary compliance|pulmonary compliance
1280816|NCT01668355|Delivery of Healthcare|delivery of healthcare
1280817|NCT01668355|Health Services Research|health services research
1280818|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
1280819|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
1280820|NCT01668355|Primary Care|primary care
1280821|NCT01668355|Quality Improvement|quality improvement
1280822|NCT01668355|Psychotic Disorders|psychotic disorders
1280823|NCT01668355|Medical Home|medical home
1280824|NCT01668355|Psychiatry|psychiatry
1280825|NCT01668355|Patient Care Management|patient care management
1280826|NCT01668355|Nursing Care Management|nursing care management
1280827|NCT01668355|Treatment Costs|treatment costs
1280828|NCT01668329|Septic shock|septic shock
1280829|NCT01668329|Inflammatory process|inflammatory process
1280830|NCT01668329|Cytokines|cytokines
1280831|NCT01668329|Hormonal response|hormonal response
1280832|NCT01668329|Oxydative stress|oxydative stress
1280833|NCT01668316|Overweight|overweight
1280834|NCT01668316|Obese|obese
1280835|NCT01668316|Postpartum|postpartum
1280836|NCT01668316|Weight loss|weight loss
1280837|NCT01668316|Inflammation|inflammation
1280838|NCT01668316|Obesity|obesity
1280839|NCT01668316|Cardiovascular|cardiovascular
1280840|NCT01668303|juvenile drug court|juvenile drug court
1280841|NCT01668303|adolescents|adolescents
1280842|NCT01668303|substance abuse|substance abuse
1280843|NCT01668303|delinquency|delinquency
1280844|NCT01668303|family therapy|family therapy
1280845|NCT01668303|multidimensional family therapy|multidimensional family therapy
1280846|NCT01668290|Coronary Artery Disease|coronary artery disease
1280847|NCT01668290|Stress Echocardiography|stress echocardiography
1280848|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
1280849|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
1280850|NCT01668290|outcomes|outcomes
1280851|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
1280852|NCT01668277|Pediatrics|pediatrics
1280853|NCT01668277|Hypertonic Saline|hypertonic saline
1280854|NCT01668264|Pediatrics|pediatrics
1280855|NCT01668264|Congenital Heart Disease|congenital heart disease
1280856|NCT01668264|Diastolic Function|diastolic function
1280857|NCT01668264|Echocardiograph|echocardiograph
1280859|NCT01668251|Turner syndrome|turner syndrome
1280860|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
1280861|NCT01668238|Thyroid tumor|thyroid tumor
1280862|NCT01668238|Breast tumor|breast tumor
1280863|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
1280864|NCT01668238|Tumor Diagnosis|tumor diagnosis
1280865|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
1280866|NCT01668186|PBD|pbd
1280867|NCT01668186|Zellweger spectrum|zellweger spectrum
1280868|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
1280869|NCT01668186|RCDP|rcdp
1280870|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
1280871|NCT01668173|AUY922|auy922
1280872|NCT01668173|12-076|12-076
1280873|NCT01668160|clinical outcomes|clinical outcomes
1280874|NCT01668160|radiographic outcomes|radiographic outcomes
1280875|NCT01668160|total hip arthroplasty|total hip arthroplasty
1280876|NCT01668160|survivorship|survivorship
1280877|NCT01668147|PET Imaging|pet imaging
1280878|NCT01668147|Efavirenz|efavirenz
1280879|NCT01668147|Ritonavir|ritonavir
1280880|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
1280881|NCT01668147|Healthy volunteers|healthy volunteers
1280882|NCT01668108|carcinoma|carcinoma
1280883|NCT01668108|breast cancer|breast cancer
1280884|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
1280885|NCT01668108|ovarial cancer|ovarial cancer
1280886|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
1280887|NCT01668108|treatment cycles|treatment cycles
1280888|NCT01668108|Paclitaxel|paclitaxel
1280889|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
1280890|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
1280891|NCT01668108|Packaging Sizes|packaging sizes
1280892|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
1280894|NCT01668069|vomiting|vomiting
1280895|NCT01668069|pregnancy|pregnancy
1280896|NCT01668069|ondansetron|ondansetron
1280897|NCT01668069|doxylamine|doxylamine
1280898|NCT01668069|vitamin B6|vitamin b6
1280899|NCT01668069|pyridoxine|pyridoxine
1280900|NCT01668056|in vitro fertilization|in vitro fertilization
1280901|NCT01668056|ovarian stimulation|ovarian stimulation
1280902|NCT01668056|follicular waves|follicular waves
1280903|NCT01668056|luteal phase|luteal phase
1280904|NCT01668043|HIV-1|hiv-1
1280905|NCT01668043|CD4|cd4
1280906|NCT01668043|antibody|antibody
1280907|NCT01668043|immunotherapy|immunotherapy
1280909|NCT01668030|Partial thickness|partial thickness
1280910|NCT01668017|Advanced solid tumors|advanced solid tumors
1280911|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
1280912|NCT01668017|cancer, liver|cancer, liver
1280913|NCT01667991|Colonization|colonization
1280914|NCT01667991|infection|infection
1280915|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
1280916|NCT01667991|guideline|guideline
1280917|NCT01667978|contraception|contraception
1280918|NCT01667978|mini pill|mini pill
1280919|NCT01667978|norethindrone|norethindrone
1280920|NCT01667978|atazanavir|atazanavir
1280921|NCT01667978|ritonavir|ritonavir
1280922|NCT01667978|norvir|norvir
1280923|NCT01667978|reyataz|reyataz
1280924|NCT01667978|pregnancy prevent|pregnancy prevent
1280925|NCT01667978|birth control|birth control
1280926|NCT01667978|HIV|hiv
1280927|NCT01667978|AIDS|aids
1280928|NCT01667978|antiviral|antiviral
1280929|NCT01667978|antiretroviral|antiretroviral
1280930|NCT01667965|palliative radiation|palliative radiation
1280931|NCT01667965|12-172|12-172
1280932|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
1280933|NCT01667952|Blood sample|blood sample
1280934|NCT01667952|Salvia sample|salvia sample
1280935|NCT01667952|12-145|12-145
1280936|NCT01667939|adequacy|adequacy
1280937|NCT01667939|diet|diet
1280938|NCT01667939|pregnancy|pregnancy
1280939|NCT01667913|Hip Fracture|hip fracture
1280940|NCT01667913|6-minutes walking test|6-minutes walking test
1280941|NCT01667913|Reliability|reliability
1280942|NCT01667887|Far Cortical Locking|far cortical locking
1280943|NCT01667887|Distal Femur Fracture|distal femur fracture
1280944|NCT01667887|Locking Plate|locking plate
1280945|NCT01667887|MotionLoc|motionloc
1280946|NCT01667887|Fracture Fixation|fracture fixation
1280947|NCT01667874|Randomized controlled trial|randomized controlled trial
1280948|NCT01667874|early joint infection|early joint infection
1280949|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
1280950|NCT01667861|Glaucoma|glaucoma
1280951|NCT01667861|Wind instruments|wind instruments
1280952|NCT01667848|pain|pain
1280953|NCT01667835|yoga|yoga
1280954|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
1280955|NCT01667796|Multiple sclerosis|multiple sclerosis
1280956|NCT01667796|Healthy controls|healthy controls
1280957|NCT01667796|Pharmacokinetics|pharmacokinetics
1280958|NCT01667796|Vitamin D|vitamin d
1280959|NCT01667783|Obesity|obesity
1280960|NCT01667783|Diabetes|diabetes
1280961|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
1280962|NCT01667757|drug eluting stent|drug eluting stent
1280963|NCT01667757|intravascular ultrasound|intravascular ultrasound
1280964|NCT01667757|fractional flow reserve|fractional flow reserve
1280965|NCT01667744|Angina|angina
1280966|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
1280967|NCT01667744|Emotional Distress|emotional distress
1280968|NCT01667744|Citalopram|citalopram
1280969|NCT01667744|Health Care Utilization|health care utilization
1280970|NCT01667731|Hepatitis C|hepatitis c
1280971|NCT01667731|Chronic|chronic
1280972|NCT01667731|HCV|hcv
1280973|NCT01667731|HIV|hiv
1280974|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
1280975|NCT01667731|Co-Infected|co-infected
1280976|NCT01667718|eradication|eradication
1280977|NCT01667718|helicobacter pylori|helicobacter pylori
1280978|NCT01667718|bismuth|bismuth
1280979|NCT01667705|Stress|stress
1280980|NCT01667705|Anxiety|anxiety
1280981|NCT01667705|Skyceiling|skyceiling
1280982|NCT01667705|Nature|nature
1280983|NCT01667692|H-pylori|h-pylori
1280984|NCT01667692|eradication|eradication
1280985|NCT01667692|azithromycin|azithromycin
1280986|NCT01667692|clarithromycin|clarithromycin
1280987|NCT01667679|Migraine|migraine
1280988|NCT01667679|Headaches|headaches
1280989|NCT01667679|Sumatriptan|sumatriptan
1280990|NCT01667666|trauma|trauma
1280991|NCT01667666|acute lung injury|acute lung injury
1280992|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
1280993|NCT01667640|Brain metastases|brain metastases
1280994|NCT01667640|radiation|radiation
1280995|NCT01667640|sector|sector
1280996|NCT01667640|singular|singular
1280997|NCT01667640|solitary|solitary
1280998|NCT01667640|neurocognition|neurocognition
1281000|NCT01667627|Probiotic|probiotic
1281001|NCT01667627|hs-CRP|hs-crp
1281002|NCT01667627|Cholinergic status|cholinergic status
1281003|NCT01667627|Micro-inflammation|micro-inflammation
1281004|NCT01667601|mindfulness-based program|mindfulness-based program
1281005|NCT01667601|Psychoeducation|psychoeducation
1281006|NCT01667601|schizophrenia|schizophrenia
1281007|NCT01667601|Chinese|chinese
1281008|NCT01667601|outpatients|outpatients
1281009|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1281010|NCT01667588|Pediatrics|pediatrics
1281011|NCT01667588|Sleep Disorders|sleep disorders
1281012|NCT01667549|Breastfeeding|breastfeeding
1281013|NCT01667549|Flavor learning|flavor learning
1281014|NCT01667549|Mother|mother
1281015|NCT01667549|Moms|moms
1281016|NCT01667549|Infants|infants
1281017|NCT01667549|Babies|babies
1281018|NCT01667549|Baby|baby
1281019|NCT01667549|Food Habits|food habits
1281020|NCT01667549|Fruits|fruits
1281021|NCT01667549|Vegetables|vegetables
1281022|NCT01667536|PROSTATE CANCER|prostate cancer
1281023|NCT01667536|HIGH-RISK|high-risk
1281024|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
1281025|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
1281026|NCT01667523|capsaicin|capsaicin
1281027|NCT01667523|cinnamaldehyde|cinnamaldehyde
1281028|NCT01667510|Prehypertension|prehypertension
1281029|NCT01667510|anti oxidation|anti oxidation
1281030|NCT01667510|lycopene|lycopene
1281031|NCT01667497|Cognitive fatigue|cognitive fatigue
1281032|NCT01667497|multiple sclerosis|multiple sclerosis
1281033|NCT01667484|Cognitive Impairment|cognitive impairment
1281034|NCT01667484|Multiple Sclerosis|multiple sclerosis
1281035|NCT01667484|Processing Speed|processing speed
1281036|NCT01667484|Treatment|treatment
1281037|NCT01667445|total knee arthroplasty|total knee arthroplasty
1281038|NCT01667445|epimorph|epimorph
1281039|NCT01667445|analgesia|analgesia
1281040|NCT01667406|kisspeptin|kisspeptin
1281041|NCT01667406|infertility|infertility
1281042|NCT01667406|in vitro fertilisation|in vitro fertilisation
1281043|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
1281045|NCT01667341|Herpes|herpes
1281046|NCT01667341|genital infection|genital infection
1281047|NCT01667341|vaccine|vaccine
1281048|NCT01667328|Anxiety|anxiety
1281049|NCT01667328|Presurgical anxiety|presurgical anxiety
1281050|NCT01667328|Breast Cancer|breast cancer
1281051|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
1281052|NCT01667302|Radiotherapy|radiotherapy
1281053|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
1281054|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
1281055|NCT01667289|Methotrexate|methotrexate
1281056|NCT01667289|Radiotherapy|radiotherapy
1281057|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
1281058|NCT01667276|AE adverse event|ae adverse event
1281059|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1281060|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1281061|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
1281062|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1281063|NCT01667276|DCF data collection forms|dcf data collection forms
1281064|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
1281065|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1281066|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1281067|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1281068|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
1281069|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
1281070|NCT01667276|IRB Institutional Review Board|irb institutional review board
1281071|NCT01667276|IU international units|iu international units
1281072|NCT01667276|mg milligram(s)|mg milligram(s)
1281073|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1281074|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
1281075|NCT01667276|SAE serious adverse event|sae serious adverse event
1281076|NCT01667276|µg microgram|µg microgram
1281077|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
1281078|NCT01667276|WB Western Blot|wb western blot
1281079|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
1281080|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
1281081|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
1281082|NCT01667263|refractory|refractory
1281083|NCT01667263|danazol|danazol
1281084|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
1281085|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
1281086|NCT01667250|nVNS|nvns
1281087|NCT01667250|VNS|vns
1281088|NCT01667250|chronic migraine|chronic migraine
1281089|NCT01667250|migraine|migraine
1281090|NCT01667250|non invasive|non invasive
1281091|NCT01667250|gammacore|gammacore
1281092|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
1281093|NCT01667237|Lung cancer|lung cancer
1281094|NCT01667237|Lung resection surgery|lung resection surgery
1281095|NCT01667237|Home-based|home-based
1281096|NCT01667224|Actiponin|actiponin
1281097|NCT01667224|Obesity|obesity
1281098|NCT01667224|Abdominal fat|abdominal fat
1281099|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
1281100|NCT01667185|pediatric|pediatric
1281101|NCT01667185|diabetes mellitus|diabetes mellitus
1281102|NCT01667159|Depression|depression
1281103|NCT01667159|Alcohol Use|alcohol use
1281104|NCT01667159|Outpatient Therapy|outpatient therapy
1281105|NCT01667133|Leukemia|leukemia
1281106|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
1281107|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1281108|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
1281109|NCT01667133|Neoplasms|neoplasms
1281110|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
1281111|NCT01667133|Lymphatic Diseases|lymphatic diseases
1281112|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
1281113|NCT01667133|Immune System Diseases|immune system diseases
1281114|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
1281115|NCT01667133|Bone Marrow Diseases|bone marrow diseases
1281116|NCT01667133|Hematologic Diseases|hematologic diseases
1281117|NCT01667120|Ketorolac|ketorolac
1281118|NCT01667120|postoperative pain|postoperative pain
1281119|NCT01667120|bleeding events|bleeding events
1281120|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
1281121|NCT01667094|Continuous infusion|continuous infusion
1281122|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
1281123|NCT01667068|Cardiac Diseases|cardiac diseases
1281124|NCT01667068|HIV-Infection|hiv-infection
1281125|NCT01667068|AIDS|aids
1281126|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
1281127|NCT01667068|Cardiovascular Medication|cardiovascular medication
1281128|NCT01667068|Risk Factors|risk factors
1281129|NCT01667068|coronary heart disease|coronary heart disease
1281130|NCT01667068|heart failure|heart failure
1281131|NCT01667068|metabolic syndrome|metabolic syndrome
1281132|NCT01667055|drug allergy|drug allergy
1281133|NCT01667055|drug hypersensitivity|drug hypersensitivity
1281134|NCT01667055|beta-lactam allergy|beta-lactam allergy
1281135|NCT01667055|penicillin allergy|penicillin allergy
1281136|NCT01667055|adverse drug reaction|adverse drug reaction
1281137|NCT01667042|Scleroderma Lung|scleroderma lung
1281138|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
1281139|NCT01667042|Microaspiration|microaspiration
1281140|NCT01667042|Cough|cough
1281141|NCT01667016|International|international
1281142|NCT01667016|Multicenter|multicenter
1281143|NCT01667016|Observational registry|observational registry
1281144|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1281145|NCT01667016|Stenting|stenting
1281146|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1281147|NCT01667016|Coronary revascularization|coronary revascularization
1281148|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
1281149|NCT01667016|STEMI|stemi
1281150|NCT01667016|NSTEMI|nstemi
1281151|NCT01667016|Ischemia|ischemia
1281152|NCT01667016|Angina|angina
1281153|NCT01667016|Subgroups|subgroups
1281154|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
1281155|NCT01667016|Diabetes|diabetes
1281156|NCT01667016|Small Vessels|small vessels
1281157|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1281158|NCT01667003|International|international
1281159|NCT01667003|Multicenter|multicenter
1281160|NCT01667003|Observational registry|observational registry
1281161|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1281162|NCT01667003|Stenting|stenting
1281163|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1281164|NCT01667003|Coronary revascularization|coronary revascularization
1281165|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
1281166|NCT01667003|STEMI|stemi
1281167|NCT01667003|NSTEMI|nstemi
1281168|NCT01667003|Ischemia|ischemia
1281169|NCT01667003|Angina|angina
1281170|NCT01667003|Subgroups|subgroups
1281171|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
1281172|NCT01667003|Diabetes|diabetes
1281173|NCT01667003|Small Vessels|small vessels
1281174|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
1281176|NCT01666990|CD4|cd4
1281177|NCT01666990|immune over-activation|immune over-activation
1281178|NCT01666964|Traumatic brain injury|traumatic brain injury
1281179|NCT01666964|hypopituitarism|hypopituitarism
1281180|NCT01666938|Diabetes Mellitus|diabetes mellitus
1281181|NCT01666938|Telephone|telephone
1281182|NCT01666938|Physical activity|physical activity
1281183|NCT01666912|adolescence|adolescence
1281184|NCT01666912|contraception|contraception
1281185|NCT01666912|postpartum|postpartum
1281186|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
1281187|NCT01666873|osteoarthritis|osteoarthritis
1281188|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
1281189|NCT01666847|Umbilical Cord Milking|umbilical cord milking
1281190|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
1281191|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
1281192|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
1281193|NCT01666782|Influenza vaccine|influenza vaccine
1281194|NCT01666782|Oncology|oncology
1281195|NCT01666782|Chemotherapy|chemotherapy
1281196|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1281197|NCT01666769|ECMO|ecmo
1281198|NCT01666769|Extracorporeal life support|extracorporeal life support
1281199|NCT01666769|Micafungin|micafungin
1281200|NCT01666769|Mycamine|mycamine
1281201|NCT01666769|Pharmacokinetics|pharmacokinetics
1281202|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
1281203|NCT01666743|Lung|lung
1281204|NCT01666743|Adult|adult
1281205|NCT01666743|Infections|infections
1281206|NCT01666691|Obese|obese
1281207|NCT01666691|Obesity|obesity
1281208|NCT01666691|Overweight|overweight
1281209|NCT01666691|Weight loss|weight loss
1281306|NCT01666223|Bile acid|bile acid
1281210|NCT01666691|Weight reduction|weight reduction
1281211|NCT01666691|Beloranib|beloranib
1281212|NCT01666678|Bioequivalence|bioequivalence
1281213|NCT01666665|Burn|burn
1281214|NCT01666652|Dengue|dengue
1281215|NCT01666652|Dengue fever|dengue fever
1281216|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1281217|NCT01666652|Flavivirus|flavivirus
1281218|NCT01666626|crohn's disease|crohn's disease
1281219|NCT01666626|ultrasound|ultrasound
1281220|NCT01666626|intestinal fibrosis|intestinal fibrosis
1281221|NCT01666626|shear wave imaging|shear wave imaging
1281222|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
1281223|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
1281224|NCT01666613|Bioavailability|bioavailability
1281225|NCT01666613|AUC|auc
1281226|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
1281227|NCT01666548|complications of HUS|complications of hus
1281228|NCT01666548|renal replacement treatment|renal replacement treatment
1281229|NCT01666548|renal function outcome|renal function outcome
1281230|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
1281231|NCT01666548|psychological adjustment|psychological adjustment
1281232|NCT01666548|quality of life|quality of life
1281233|NCT01666535|Influenza vaccine|influenza vaccine
1281234|NCT01666535|Immune response|immune response
1281235|NCT01666535|Remicade (infliximab)|remicade (infliximab)
1281236|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
1281237|NCT01666522|sarcopenia|sarcopenia
1281238|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
1281239|NCT01666522|older adults|older adults
1281240|NCT01666522|vitamin D supplementation|vitamin d supplementation
1281241|NCT01666522|physical activity|physical activity
1281242|NCT01666496|Adolescent|adolescent
1281243|NCT01666496|risk|risk
1281244|NCT01666496|HIV|hiv
1281245|NCT01666496|video games|video games
1281246|NCT01666483|hysterectomy|hysterectomy
1281247|NCT01666483|single-port|single-port
1281248|NCT01666483|micro-laparoscopy|micro-laparoscopy
1281249|NCT01666470|Quality of life|quality of life
1281250|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
1281251|NCT01666457|Infant Oral Feeding|infant oral feeding
1281252|NCT01666457|Infant Growth|infant growth
1281253|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
1281254|NCT01666457|Preterm infant growth|preterm infant growth
1281255|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
1281256|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
1281257|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1281258|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1281259|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1281260|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1281261|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1281262|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1281263|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1281264|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1281265|NCT01666444|Brenner tumor|brenner tumor
1281266|NCT01666405|Fecal Incontinence|fecal incontinence
1281267|NCT01666405|Bowel Incontinence|bowel incontinence
1281268|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
1281269|NCT01666392|Fish oil|fish oil
1281270|NCT01666392|Muscle mass|muscle mass
1281271|NCT01666392|Muscle strength|muscle strength
1281272|NCT01666392|Older adults|older adults
1281273|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
1281274|NCT01666392|Skeletal muscle mass|skeletal muscle mass
1281275|NCT01666392|Upper body strength|upper body strength
1281276|NCT01666392|Lower body strength|lower body strength
1281277|NCT01666379|Hallux valgus|hallux valgus
1281278|NCT01666379|Forefoot|forefoot
1281279|NCT01666379|transdermal fentanyl|transdermal fentanyl
1281280|NCT01666340|Exercise|exercise
1281281|NCT01666340|Elderly|elderly
1281282|NCT01666340|Mortality|mortality
1281283|NCT01666340|Morbidity|morbidity
1281284|NCT01666340|Prognosis|prognosis
1281285|NCT01666340|Longevity|longevity
1281286|NCT01666327|Crohn's Disease|crohn's disease
1281287|NCT01666327|Ulcerative Colitis|ulcerative colitis
1281288|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
1281289|NCT01666314|CRPC,|crpc,
1281290|NCT01666314|orteronel,|orteronel,
1281291|NCT01666314|TAK-700|tak-700
1281292|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
1281293|NCT01666301|Hemoglobin|hemoglobin
1281294|NCT01666301|Reticulocytes|reticulocytes
1281295|NCT01666301|Variability|variability
1281296|NCT01666262|FLU|flu
1281297|NCT01666262|H1N1|h1n1
1281298|NCT01666262|GPO|gpo
1281299|NCT01666262|PLAIV|plaiv
1281300|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
1281301|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
1281302|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
1281303|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1281304|NCT01666223|Type 2 diabetes|type 2 diabetes
1281305|NCT01666223|GLP-1|glp-1
1281307|NCT01666223|TGR-5|tgr-5
1281308|NCT01666197|Acute Joint Pain|acute joint pain
1281309|NCT01666184|Biomarkers study|biomarkers study
1281310|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1281914|NCT01663324|Tinnitus|tinnitus
1281311|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1281312|NCT01666171|stage IB breast cancer|stage ib breast cancer
1281313|NCT01666171|stage II breast cancer|stage ii breast cancer
1281314|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
1281315|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
1281316|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
1281317|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
1281318|NCT01666145|Hepatoma|hepatoma
1281319|NCT01666145|Liver Cancer, Adult|liver cancer, adult
1281320|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
1281321|NCT01666132|LVEF < 40%|lvef < 40%
1281322|NCT01666119|Opioid dependence|opioid dependence
1281323|NCT01666119|Suboxone|suboxone
1281324|NCT01666119|addiction|addiction
1281325|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
1281326|NCT01666119|oral transmucosal|oral transmucosal
1281327|NCT01666093|peripheral artery disease|peripheral artery disease
1281328|NCT01666093|endovascular procedure|endovascular procedure
1281329|NCT01666093|non-healing ulcer|non-healing ulcer
1281330|NCT01666080|second stem cell transplant|second stem cell transplant
1281331|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
1281332|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1281333|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
1281334|NCT01666067|insulin resistance|insulin resistance
1281335|NCT01666054|Weaning|weaning
1281336|NCT01666054|mechanical ventilation|mechanical ventilation
1281337|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
1281338|NCT01666041|insulin resistance|insulin resistance
1281339|NCT01666028|Type 1 Diabetes|type 1 diabetes
1281340|NCT01666028|Closed Loop glucose control|closed loop glucose control
1281341|NCT01666028|Artificial Pancreas|artificial pancreas
1281342|NCT01666028|CSII|csii
1281343|NCT01666028|CGM|cgm
1281344|NCT01666015|pediatric|pediatric
1281345|NCT01666015|exercise|exercise
1281346|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1281347|NCT01666015|cancer|cancer
1281348|NCT01666015|quality of life|quality of life
1281349|NCT01666015|immune system|immune system
1281350|NCT01666015|physical activity levels|physical activity levels
1281351|NCT01665937|liver cancer|liver cancer
1281352|NCT01665937|advanced liver cancer|advanced liver cancer
1281353|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
1281354|NCT01665911|Caries|caries
1281355|NCT01665898|cold biopsy forceps|cold biopsy forceps
1281356|NCT01665898|cold snare biopsy|cold snare biopsy
1281357|NCT01665885|hypothermia|hypothermia
1281358|NCT01665885|induction of hypothermia|induction of hypothermia
1281359|NCT01665885|non invasive cooling|non invasive cooling
1281360|NCT01665885|external cooling|external cooling
1281361|NCT01665885|surface cooling|surface cooling
1281362|NCT01665885|endovascular cooling|endovascular cooling
1281363|NCT01665885|cooling catheter|cooling catheter
1281364|NCT01665885|stroke|stroke
1281365|NCT01665885|shivering|shivering
1281366|NCT01665885|neuro monitoring|neuro monitoring
1281367|NCT01665885|coagulation|coagulation
1281368|NCT01665872|Mothers|mothers
1281369|NCT01665872|Depression|depression
1281370|NCT01665872|Stress|stress
1281371|NCT01665872|Trauma|trauma
1281372|NCT01665872|Public Housing|public housing
1281373|NCT01665859|readmission|readmission
1281374|NCT01665859|recurrence|recurrence
1281375|NCT01665859|umbilical|umbilical
1281376|NCT01665859|epigastric|epigastric
1281377|NCT01665859|hernia|hernia
1281378|NCT01665859|outcome|outcome
1281379|NCT01665859|morbidity|morbidity
1281380|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
1281381|NCT01665846|MRI|mri
1281382|NCT01665846|Ferumoxytol|ferumoxytol
1281383|NCT01665833|Angina|angina
1281384|NCT01665833|SYNTAX|syntax
1281385|NCT01665833|Coronary|coronary
1281386|NCT01665833|PCI|pci
1281387|NCT01665833|CABG|cabg
1281388|NCT01665820|chest|chest
1281389|NCT01665820|pathology|pathology
1281390|NCT01665807|influenza|influenza
1281391|NCT01665807|vaccine|vaccine
1281392|NCT01665807|administration|administration
1281393|NCT01665781|Hemoglobin|hemoglobin
1281394|NCT01665781|Erythropoietin|erythropoietin
1281395|NCT01665781|Acute Mountain sickness|acute mountain sickness
1281396|NCT01665742|Obesity|obesity
1281397|NCT01665742|Chronic inflammation|chronic inflammation
1281398|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
1281399|NCT01665742|Genetic susceptibility|genetic susceptibility
1281400|NCT01665729|etiology|etiology
1281401|NCT01665729|pathogenesis|pathogenesis
1281402|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
1281403|NCT01665729|types|types
1281404|NCT01665729|intervention|intervention
1281405|NCT01665703|[18F]|[18f]
1281506|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
1281406|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
1281407|NCT01665703|FDG-PET-MRI|fdg-pet-mri
1281408|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
1281409|NCT01665703|Pilot Study|pilot study
1281410|NCT01665703|LCCC 1213|lccc 1213
1281411|NCT01665703|UNC Lineberger|unc lineberger
1281412|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
1281413|NCT01665690|expedited partner therapy|expedited partner therapy
1281414|NCT01665690|partner notification|partner notification
1281415|NCT01665690|gonorrhea|gonorrhea
1281416|NCT01665690|chlamydia|chlamydia
1281417|NCT01665677|Graft vs Host Disease|graft vs host disease
1281418|NCT01665677|GVHD|gvhd
1281419|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1281420|NCT01665677|HSCT|hsct
1281421|NCT01665677|Atorvastatin|atorvastatin
1281422|NCT01665664|Indirect calorimetry|indirect calorimetry
1281423|NCT01665664|hypocaloric feeding|hypocaloric feeding
1281424|NCT01665638|Healthy|healthy
1281425|NCT01665638|Clearance|clearance
1281426|NCT01665638|Canagliflozin|canagliflozin
1281427|NCT01665638|JNJ-28431754|jnj-28431754
1281428|NCT01665638|Placebo|placebo
1281429|NCT01665638|Somatostatin|somatostatin
1281430|NCT01665638|C-peptide|c-peptide
1281431|NCT01665625|Pancreatic cancer|pancreatic cancer
1281432|NCT01665625|Intra-arterial infusion|intra-arterial infusion
1281433|NCT01665625|Gemcitabine|gemcitabine
1281434|NCT01665612|Contact lens|contact lens
1281435|NCT01665612|Care solution|care solution
1281436|NCT01665612|MPDS|mpds
1281437|NCT01665612|comfort|comfort
1281438|NCT01665586|dexmedetomidine|dexmedetomidine
1281439|NCT01665586|sedation in elderly patient|sedation in elderly patient
1281440|NCT01665586|spinal anesthesia|spinal anesthesia
1281441|NCT01665573|Fear Conditioning|fear conditioning
1281442|NCT01665573|Cannabinoids|cannabinoids
1281443|NCT01665573|Fear Response|fear response
1281444|NCT01665560|smoking|smoking
1281445|NCT01665560|fMRI|fmri
1281446|NCT01665560|odors|odors
1281447|NCT01665560|taste|taste
1281448|NCT01665547|clomiphene resistant|clomiphene resistant
1281449|NCT01665547|pcos|pcos
1281450|NCT01665547|induction of ovulation|induction of ovulation
1281451|NCT01665547|l-carnitine|l-carnitine
1281452|NCT01665534|hypertension|hypertension
1281453|NCT01665534|inflammation|inflammation
1281454|NCT01665534|salt intake|salt intake
1281455|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
1281456|NCT01665521|Chest pain|chest pain
1281457|NCT01665521|Risk Stratification|risk stratification
1281458|NCT01665521|HEART Pathway|heart pathway
1281459|NCT01665521|Emergency Department|emergency department
1281460|NCT01665508|angina|angina
1281461|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
1281462|NCT01665508|metabolomics|metabolomics
1281463|NCT01665508|nebivolol|nebivolol
1281464|NCT01665495|pericardial effusion|pericardial effusion
1281465|NCT01665495|cardiac tamponade|cardiac tamponade
1281466|NCT01665495|pericardiocentesis|pericardiocentesis
1281467|NCT01665495|pericardial drainage|pericardial drainage
1281468|NCT01665495|prevention|prevention
1281469|NCT01665482|Inflammation|inflammation
1281470|NCT01665482|Insulin sensitivity|insulin sensitivity
1281471|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1281472|NCT01665482|C-peptide|c-peptide
1281473|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
1281474|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
1281475|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
1281476|NCT01665469|anti oxidation|anti oxidation
1281477|NCT01665469|lycopene|lycopene
1281478|NCT01665469|Ox-LDL|ox-ldl
1281479|NCT01665456|complications|complications
1281480|NCT01665417|Icotinib|icotinib
1281481|NCT01665417|EGFR positive mutation|egfr positive mutation
1607773|NCT00365781|Antisense|antisense
1281482|NCT01665417|First-line treatment|first-line treatment
1281483|NCT01665417|Maintenance treatment|maintenance treatment
1281484|NCT01665378|prepregnancy|prepregnancy
1281485|NCT01665378|micronutrient|micronutrient
1281486|NCT01665378|supplementation|supplementation
1281487|NCT01665378|maternal|maternal
1281488|NCT01665378|child|child
1281489|NCT01665378|health|health
1281490|NCT01665365|Myocardial infarction|myocardial infarction
1281491|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
1281492|NCT01665365|Clinical outcome|clinical outcome
1281493|NCT01665339|preload|preload
1281494|NCT01665339|anthropometric measures|anthropometric measures
1281495|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
1281496|NCT01665326|Pompe disease|pompe disease
1281497|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
1281498|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
1281499|NCT01665326|CRIM Status|crim status
1281500|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
1281501|NCT01665326|Alglucosidase alfa|alglucosidase alfa
1281502|NCT01665326|Myozyme|myozyme
1281503|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
1281504|NCT01665326|Immune Tolerance Induction|immune tolerance induction
1281505|NCT01665313|attention|attention
1281507|NCT01665300|Trastuzumab|trastuzumab
1281508|NCT01665287|Cerebral Oximetry|cerebral oximetry
1281509|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
1281510|NCT01665287|Fullterm|fullterm
1281511|NCT01665287|Infant|infant
1281512|NCT01665274|xelox|xelox
1281513|NCT01665274|advanced gastric cancer|advanced gastric cancer
1281517|NCT01665261|Screening|screening
1281518|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
1281519|NCT01665248|Acute coronary syndrome|acute coronary syndrome
1281520|NCT01665248|Stable Angina|stable angina
1281521|NCT01665196|IgG4-related disease|igg4-related disease
1281522|NCT01665196|IgG4-RD|igg4-rd
1281523|NCT01665196|18F-FDG|18f-fdg
1281524|NCT01665196|PET/CT|pet/ct
1281525|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
1281526|NCT01665183|arginine|arginine
1281527|NCT01665183|arginine deiminase|arginine deiminase
1281528|NCT01665170|Pascoflair|pascoflair
1281529|NCT01665170|tsst|tsst
1281530|NCT01665170|passiflora incarnata|passiflora incarnata
1281531|NCT01665170|non smoking male|non smoking male
1281532|NCT01665170|and female volunteers|and female volunteers
1281533|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
1281534|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1281535|NCT01665118|Radio frequency|radio frequency
1281536|NCT01665118|thigh|thigh
1281537|NCT01665118|circumference|circumference
1281538|NCT01665118|reduction|reduction
1281539|NCT01665105|Pulse Rate Variability|pulse rate variability
1281540|NCT01665105|Skin Blood Flow|skin blood flow
1281541|NCT01665105|Skin Temperature|skin temperature
1281542|NCT01665105|Electroacupuncture|electroacupuncture
1281543|NCT01665105|Zusanli|zusanli
1281544|NCT01665105|Yanglingquan|yanglingquan
1281545|NCT01665079|anaesthetics iv|anaesthetics iv
1281546|NCT01665079|propofol|propofol
1281547|NCT01665079|pharmacokinetics|pharmacokinetics
1281548|NCT01665079|pharmacodynamic|pharmacodynamic
1281549|NCT01665053|Drug-Eluting Stents|drug-eluting stents
1281550|NCT01665040|neurostimulation|neurostimulation
1281551|NCT01665040|spinal cord stimulation|spinal cord stimulation
1281552|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
1281553|NCT01665027|caesarean section,|caesarean section,
1281554|NCT01665027|vacuum,|vacuum,
1281555|NCT01665027|fetal head extraction,|fetal head extraction,
1281556|NCT01665027|maternal complication,|maternal complication,
1281557|NCT01665027|fetal complication|fetal complication
1281558|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1281559|NCT01665014|total marrow irradiation|total marrow irradiation
1281560|NCT01665014|melphalan|melphalan
1281561|NCT01665014|multiple myeloma|multiple myeloma
1281562|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1281563|NCT01665001|Induction|induction
1281564|NCT01665001|Consolidation|consolidation
1281565|NCT01665001|Minimal residual disease|minimal residual disease
1281566|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1281567|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
1281568|NCT01664975|RR;PFS;OS|rr;pfs;os
1281569|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
1281570|NCT01664936|131I therapy|131i therapy
1281571|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
1281573|NCT01664936|Lymphoma|lymphoma
1281574|NCT01664936|Leukemia|leukemia
1281575|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
1281579|NCT01664910|Lymphoma|lymphoma
1281580|NCT01664910|CD22 Positive-Lymphoid Malignancies|cd22 positive-lymphoid malignancies
1281581|NCT01664910|Leukemia|leukemia
1281582|NCT01664910|Allogeneic stem cell transplant|allogeneic stem cell transplant
1281583|NCT01664910|CMC-544|cmc-544
1281584|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin
1281585|NCT01664910|Fludarabine|fludarabine
1281586|NCT01664910|Fludarabine Phosphate|fludarabine phosphate
1281587|NCT01664910|Fludara|fludara
1281588|NCT01664910|Bendamustine|bendamustine
1281589|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride
1281590|NCT01664910|Bendamustine HCL|bendamustine hcl
1281591|NCT01664910|CEP-18083|cep-18083
1281592|NCT01664910|SDX105|sdx105
1281593|NCT01664910|Treanda|treanda
1281594|NCT01664910|G-CSF|g-csf
1281595|NCT01664910|Filgrastim|filgrastim
1281596|NCT01664910|Neupogen|neupogen
1281597|NCT01664910|Methotrexate|methotrexate
1281598|NCT01664910|Rituximab|rituximab
1281599|NCT01664910|Rituxan|rituxan
1281600|NCT01664910|Thymoglobulin|thymoglobulin
1281601|NCT01664910|ATG|atg
1281602|NCT01664910|Antithymocyte Globulin|antithymocyte globulin
1281603|NCT01664910|Tacrolimus|tacrolimus
1281604|NCT01664910|Prograf|prograf
1281605|NCT01664897|Leukemia|leukemia
1281606|NCT01664897|Acute myeloid leukemia|acute myeloid leukemia
1281607|NCT01664897|AML|aml
1281608|NCT01664897|refractory|refractory
1281609|NCT01664897|relapsed|relapsed
1281610|NCT01664897|Erlotinib|erlotinib
1281611|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride
1281612|NCT01664897|OSI-774|osi-774
1281613|NCT01664897|CP358774|cp358774
1281614|NCT01664897|Tarceva|tarceva
1281615|NCT01664884|INTERNALIZED STIGMA|internalized stigma
1281616|NCT01664884|INSIGHT|insight
1281617|NCT01664884|SOCIAL ADEQUACY|social adequacy
1281618|NCT01664884|BIPOLAR DISORDER|bipolar disorder
1281619|NCT01664884|SCHIZOPHRENIA|schizophrenia
1281620|NCT01664858|Coronary Heart Disease|coronary heart disease
1281621|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
1281622|NCT01664858|Angina|angina
1281623|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1281624|NCT01664845|hepatitis c|hepatitis c
1281625|NCT01664845|metformin|metformin
1281626|NCT01664845|pegylated interferon|pegylated interferon
1281627|NCT01664832|Premature Infants|premature infants
1281628|NCT01664832|snychronized ventilation|snychronized ventilation
1281629|NCT01664832|non-invasive ventilation|non-invasive ventilation
1281630|NCT01664832|RDS|rds
1281631|NCT01664806|Electrosurgery|electrosurgery
1281632|NCT01664806|Radiofrequency energy|radiofrequency energy
1281633|NCT01664806|Monopolar instruments|monopolar instruments
1281634|NCT01664806|Capacitive coupling|capacitive coupling
1281635|NCT01664806|Thermal injury|thermal injury
1281636|NCT01664806|Surgical complications|surgical complications
1281637|NCT01664793|influenza|influenza
1281638|NCT01664793|vaccination|vaccination
1281639|NCT01664793|strategies|strategies
1281640|NCT01664793|children/adolescents|children/adolescents
1281641|NCT01664780|standard|standard
1281642|NCT01664780|values|values
1281643|NCT01664780|share|share
1281644|NCT01664780|wave velocity|wave velocity
1281645|NCT01664780|in ARFI imaging|in arfi imaging
1281646|NCT01664767|COPD|copd
1281647|NCT01664767|Thermal water|thermal water
1281648|NCT01664767|Oxidative stress|oxidative stress
1281649|NCT01664767|Inflammation|inflammation
1281650|NCT01664741|Nicotine dependence|nicotine dependence
1281651|NCT01664741|cigarette|cigarette
1281652|NCT01664741|smoking|smoking
1281653|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
1281654|NCT01664741|positron emission tomography|positron emission tomography
1281655|NCT01664728|Prostate neoplasms|prostate neoplasms
1281656|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
1281657|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
1281658|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
1281659|NCT01664728|Abiraterone acetate|abiraterone acetate
1281660|NCT01664728|CB7630|cb7630
1281661|NCT01664715|Overweight|overweight
1281662|NCT01664715|Obesity|obesity
1281663|NCT01664715|Exercise|exercise
1281664|NCT01664715|Weight Loss|weight loss
1281665|NCT01664702|Dairy|dairy
1281666|NCT01664702|obesity|obesity
1281667|NCT01664676|liraglutide|liraglutide
1281668|NCT01664676|victoza|victoza
1281669|NCT01664676|GLP-1|glp-1
1281670|NCT01664676|kidney|kidney
1281671|NCT01664676|diabetes|diabetes
1281672|NCT01664676|renal|renal
1281673|NCT01664676|diabetic nephropathy|diabetic nephropathy
1281674|NCT01664663|Radiotherapy|radiotherapy
1281675|NCT01664663|Dose escalation|dose escalation
1281676|NCT01664663|Normal tissue constraints|normal tissue constraints
1281677|NCT01664663|Locally advanced disease|locally advanced disease
1281678|NCT01664663|Good performance status|good performance status
1281679|NCT01664650|menopause|menopause
1281680|NCT01664650|pre-diabetes|pre-diabetes
1281681|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
1281682|NCT01664637|delayed gastric emptying|delayed gastric emptying
1281683|NCT01664637|gastroparesis|gastroparesis
1281684|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
1281685|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
1281686|NCT01664624|Drug Therapy|drug therapy
1333180|NCT01444170|self report symptoms|self report symptoms
1281687|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
1281688|NCT01664611|Remodeling|remodeling
1281689|NCT01664611|Heart Failure|heart failure
1281690|NCT01664611|Myocardial Infarction|myocardial infarction
1281691|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
1281692|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
1281693|NCT01664585|headache|headache
1281694|NCT01664585|women|women
1281695|NCT01664585|exercise|exercise
1281696|NCT01664585|fear avoidance|fear avoidance
1281697|NCT01664585|physical activity|physical activity
1281698|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
1281699|NCT01664559|intrauterine device|intrauterine device
1281700|NCT01664559|ketorolac|ketorolac
1281702|NCT01664559|mirena|mirena
1281703|NCT01664559|paragard|paragard
1281704|NCT01664559|pain control|pain control
1281705|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
1281706|NCT01664520|Dexmedetomidine|dexmedetomidine
1281707|NCT01664520|Autoregulation|autoregulation
1281708|NCT01664520|Intracranial pressure|intracranial pressure
1281709|NCT01664520|Cerebral oxygenation|cerebral oxygenation
1281710|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
1281711|NCT01664273|electroporation|electroporation
1281712|NCT01664273|gen electrotransfer|gen electrotransfer
1281713|NCT01664273|muscle|muscle
1281714|NCT01664273|plasmid AMEP|plasmid amep
1282120|NCT01662453|sudep|sudep
1281715|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
1281716|NCT01664260|N-acetylcysteine|n-acetylcysteine
1281717|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
1281718|NCT01664234|infants with cleft palate|infants with cleft palate
1281719|NCT01664234|Pierre Robin|pierre robin
1281720|NCT01664234|Treacher Collins|treacher collins
1281721|NCT01664234|trisomy 21|trisomy 21
1281722|NCT01664221|subject|subject
1281723|NCT01664195|subjects|subjects
1281724|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1281725|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
1281726|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
1281727|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
1281728|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
1281729|NCT01664156|Cold hypersensitivity|cold hypersensitivity
1281730|NCT01664156|Korean red ginseng|korean red ginseng
1281731|NCT01664156|Infrared thermography|infrared thermography
1281732|NCT01664156|Cold stress test|cold stress test
1281733|NCT01664156|Distal-dorsal difference|distal-dorsal difference
1281734|NCT01664091|tissue expander|tissue expander
1281735|NCT01664091|acellular dermal matrix|acellular dermal matrix
1281736|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1281737|NCT01664065|Patient Safety|patient safety
1281738|NCT01664065|Tolerability|tolerability
1281739|NCT01664065|Pharmacokinetics|pharmacokinetics
1281740|NCT01664039|Glaucoma|glaucoma
1281741|NCT01664039|Ocular hypertension|ocular hypertension
1281742|NCT01664000|Tumors|tumors
1281743|NCT01664000|carcinoma|carcinoma
1281744|NCT01664000|apoptosis|apoptosis
1281745|NCT01664000|p53|p53
1281746|NCT01664000|p21|p21
1281747|NCT01664000|Caspase3|caspase3
1281748|NCT01664000|PARP|parp
1281749|NCT01664000|MDM2|mdm2
1281750|NCT01664000|PUMA|puma
1281751|NCT01663974|Bipolar Disorders|bipolar disorders
1281752|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
1281753|NCT01663974|Acute depressive episode|acute depressive episode
1281754|NCT01663974|Symptomatic remission|symptomatic remission
1281755|NCT01663974|Functioning remission|functioning remission
1281756|NCT01663961|Phase I|phase i
1281757|NCT01663961|Pharmacokinetics|pharmacokinetics
1281758|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
1281759|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
1281760|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
1281761|NCT01663961|Open-label|open-label
1281762|NCT01663961|Steady-state|steady-state
1281763|NCT01663961|subjects|subjects
1281764|NCT01663948|Plastic bronchitis|plastic bronchitis
1281765|NCT01663948|PB|pb
1281766|NCT01663935|levodopa|levodopa
1281767|NCT01663935|Albinism|albinism
1281768|NCT01663935|dopamine|dopamine
1281769|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
1281770|NCT01663935|vision|vision
1281771|NCT01663935|retina function|retina function
1281772|NCT01663909|Pain|pain
1281773|NCT01663909|Scoliosis|scoliosis
1281774|NCT01663909|Rehabilitation|rehabilitation
1281775|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
1281776|NCT01663909|Adolescents|adolescents
1281777|NCT01663883|Blood flow autoregulation|blood flow autoregulation
1281778|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
1281779|NCT01663883|isometric exercise|isometric exercise
1281780|NCT01663883|Autoregulation|autoregulation
1281781|NCT01663883|ocular physiology|ocular physiology
1281782|NCT01663870|Cancer Prevention|cancer prevention
1281783|NCT01663870|Breast cancer survivors|breast cancer survivors
1281784|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
1281785|NCT01663870|eHealth technology|ehealth technology
1281786|NCT01663870|Internet|internet
1281787|NCT01663870|HealthATM website|healthatm website
1281788|NCT01663870|Questionnaire|questionnaire
1281789|NCT01663870|Clinic stakeholders|clinic stakeholders
1281790|NCT01663870|Clinic nurses|clinic nurses
1281791|NCT01663870|Physicians|physicians
1281792|NCT01663870|Case managers|case managers
1281793|NCT01663870|Oncology patient navigators|oncology patient navigators
1281794|NCT01663870|Audio recorded interviews|audio recorded interviews
1281795|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
1281796|NCT01663844|Internet treatment|internet treatment
1281797|NCT01663844|Self-help treatment|self-help treatment
1281798|NCT01663844|Insomnia|insomnia
1281799|NCT01663844|Depression|depression
1281800|NCT01663844|ICBT|icbt
1281801|NCT01663844|CBT-i|cbt-i
1281802|NCT01663844|CBT-d|cbt-d
1281803|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
1281804|NCT01663831|Anopheles|anopheles
1281805|NCT01663831|Topical repellent|topical repellent
1281806|NCT01663831|Early biting vector|early biting vector
1281807|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
1281808|NCT01663831|Cambodia|cambodia
1281809|NCT01663805|Extended Criteria Donor|extended criteria donor
1281810|NCT01663805|Delayed Graft Function|delayed graft function
1281811|NCT01663805|DGF|dgf
1281812|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
1281813|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
1281814|NCT01663805|history of systemic hypertension|history of systemic hypertension
1281915|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
1281815|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
1281816|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
1281817|NCT01663792|urokinase receptor|urokinase receptor
1281818|NCT01663792|protein expression|protein expression
1281819|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
1281820|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
1281821|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
1281822|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
1281823|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
1281824|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
1281825|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
1281826|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
1281827|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
1281828|NCT01663753|Positron emission tomography|positron emission tomography
1281829|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
1281830|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
1281831|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
1281832|NCT01663753|Sensitivity|sensitivity
1281833|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1281834|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
1281836|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
1281837|NCT01663701|Sepsis|sepsis
1281838|NCT01663701|Severe sepsis|severe sepsis
1281839|NCT01663701|Tuberculosis|tuberculosis
1281840|NCT01663701|Bundle|bundle
1281841|NCT01663701|Zambia|zambia
1281842|NCT01663675|Down syndrome|down syndrome
1281843|NCT01663649|Depression|depression
1281844|NCT01663649|Online-Therapy|online-therapy
1281845|NCT01663649|Deprexis|deprexis
1281846|NCT01663649|Self-help|self-help
1281847|NCT01663636|vaccines|vaccines
1281849|NCT01663636|mobile phones|mobile phones
1281850|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
1281851|NCT01663623|anti-MPO|anti-mpo
1281852|NCT01663623|WG|wg
1281853|NCT01663623|Belimumab|belimumab
1281854|NCT01663623|GPA|gpa
1281855|NCT01663623|anti-proteinase 3|anti-proteinase 3
1281856|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
1281857|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
1281858|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
1281859|NCT01663623|Vasculitis|vasculitis
1281860|NCT01663623|Autoimmune Diseases|autoimmune diseases
1281861|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
1281862|NCT01663623|anti-PR3|anti-pr3
1281863|NCT01663623|ANCA|anca
1281864|NCT01663623|MPA|mpa
1281865|NCT01663623|Systemic Vasculitis|systemic vasculitis
1281866|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
1281867|NCT01663584|Carrier Screening|carrier screening
1281868|NCT01663584|Genetic Testing|genetic testing
1281869|NCT01663558|anal dysplasia|anal dysplasia
1281870|NCT01663558|HPV|hpv
1281871|NCT01663558|HIV|hiv
1281872|NCT01663558|MSM|msm
1281873|NCT01663545|Epilepsy|epilepsy
1281874|NCT01663545|Epileptic Focus|epileptic focus
1281875|NCT01663545|Inflammation|inflammation
1281876|NCT01663545|P-Glycoprotein|p-glycoprotein
1281877|NCT01663545|PET Imaging|pet imaging
1281878|NCT01663532|Schizophrenia|schizophrenia
1281879|NCT01663519|Diabetic foot|diabetic foot
1281880|NCT01663519|Offloading|offloading
1281881|NCT01663519|Prevention|prevention
1281882|NCT01663519|Orthotics|orthotics
1281883|NCT01663467|tinnitus|tinnitus
1281884|NCT01663467|smartphone|smartphone
1281886|NCT01663441|Chemotherapy|chemotherapy
1281887|NCT01663441|Thrombocytopenia|thrombocytopenia
1281888|NCT01663441|Interleukin-11|interleukin-11
1281889|NCT01663441|Platelet|platelet
1281890|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
1281891|NCT01663428|brachial plexus|brachial plexus
1281892|NCT01663428|splint|splint
1281893|NCT01663415|MDV3100|mdv3100
1281894|NCT01663415|prostate|prostate
1281895|NCT01663415|cancer|cancer
1281896|NCT01663415|enzalutamide|enzalutamide
1281897|NCT01663389|mass balance|mass balance
1281898|NCT01663389|radiolabel|radiolabel
1281899|NCT01663389|oral|oral
1281900|NCT01663389|IV|iv
1281901|NCT01663389|GSK1322322|gsk1322322
1281902|NCT01663389|healthy volunteer|healthy volunteer
1281903|NCT01663389|antibiotic|antibiotic
1281904|NCT01663363|refractive|refractive
1281905|NCT01663363|LASIK|lasik
1281906|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
1281907|NCT01663337|PTSD|ptsd
1281908|NCT01663337|Alcohol Abuse|alcohol abuse
1281909|NCT01663337|Alcohol Dependance|alcohol dependance
1281910|NCT01663337|Alcoholism|alcoholism
1281911|NCT01663337|Comorbid|comorbid
1281912|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
1281913|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
1281916|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
1281917|NCT01663324|rTMS|rtms
1281918|NCT01663324|hearing disorders|hearing disorders
1281919|NCT01663311|rTMS|rtms
1281920|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1281921|NCT01663311|chronic tinnitus|chronic tinnitus
1281922|NCT01663311|subjective tinnitus|subjective tinnitus
1281923|NCT01663311|double cone coil|double cone coil
1281924|NCT01663298|DNA methylation|dna methylation
1281925|NCT01663298|FGF2|fgf2
1281926|NCT01663298|Wound healing|wound healing
1281927|NCT01663298|Smoking|smoking
1281928|NCT01663298|Diabetes|diabetes
1281929|NCT01663298|Implant|implant
1281930|NCT01663285|Urothelial|urothelial
1281931|NCT01663285|Bladder|bladder
1281932|NCT01663285|Cancer|cancer
1281933|NCT01663272|oncology|oncology
1281934|NCT01663272|pancrease|pancrease
1281935|NCT01663233|Essential hypertension|essential hypertension
1281936|NCT01663233|High blood pressure|high blood pressure
1281937|NCT01663220|type 2 diabetes|type 2 diabetes
1281938|NCT01663220|beta cell function|beta cell function
1281939|NCT01663220|meal tolerance test|meal tolerance test
1281940|NCT01663220|maximum stimulation test|maximum stimulation test
1281941|NCT01663220|method standardization|method standardization
1281942|NCT01663220|insulin secretion|insulin secretion
1281943|NCT01663220|prediabetes|prediabetes
1281944|NCT01663220|insulin sensitivity|insulin sensitivity
1281945|NCT01663207|type 2 diabetes|type 2 diabetes
1281946|NCT01663207|beta cell function|beta cell function
1281947|NCT01663207|meal tolerance test|meal tolerance test
1281948|NCT01663207|maximum stimulation test|maximum stimulation test
1281949|NCT01663207|method standardization|method standardization
1281950|NCT01663207|insulin secretion|insulin secretion
1281951|NCT01663207|prediabetes|prediabetes
1281952|NCT01663207|insulin sensitivity|insulin sensitivity
1281953|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
1281954|NCT01663168|HIV|hiv
1281955|NCT01663168|Tuberculosis|tuberculosis
1281956|NCT01663168|Rifabutin|rifabutin
1281957|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
1281958|NCT01663168|EARNEST trial|earnest trial
1281959|NCT01663168|Randomized Controlled Trial|randomized controlled trial
1281960|NCT01663168|Pilot Projects|pilot projects
1281961|NCT01663168|Second-line ART|second-line art
1281962|NCT01663168|Drug Toxicity|drug toxicity
1281963|NCT01663168|Pharmacokinetics|pharmacokinetics
1281964|NCT01663168|Drug Interactions|drug interactions
1281965|NCT01663155|lung cancer|lung cancer
1281966|NCT01663155|chest x-ray|chest x-ray
1281967|NCT01663155|CT scan|ct scan
1281968|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
1281969|NCT01663155|screening|screening
1281970|NCT01663155|smokers|smokers
1281971|NCT01663142|Crohn's disease|crohn's disease
1281972|NCT01663142|gastrointestinal tract|gastrointestinal tract
1281973|NCT01663129|Children|children
1281974|NCT01663129|Osteoporosis|osteoporosis
1281975|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
1281976|NCT01663129|Chronic Illness|chronic illness
1281977|NCT01663129|Glucocorticoids|glucocorticoids
1281978|NCT01663129|Bone Fragility|bone fragility
1281979|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
1281980|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
1281981|NCT01663103|Interleukin-1|interleukin-1
1281982|NCT01663103|Endothelium, Vascular|endothelium, vascular
1281983|NCT01663103|Vascular Stiffness|vascular stiffness
1281984|NCT01663103|Oxidative Stress|oxidative stress
1281985|NCT01663103|Inflammation|inflammation
1281986|NCT01663103|Endothelial cells|endothelial cells
1281987|NCT01663090|Newly diagnosed|newly diagnosed
1281988|NCT01663077|Clozapine|clozapine
1281989|NCT01663077|Schizophrenia|schizophrenia
1281990|NCT01663077|Remissia|remissia
1281991|NCT01663077|polymorphism|polymorphism
1281992|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
1281993|NCT01663064|Endovascular|endovascular
1281994|NCT01663064|Fenestration|fenestration
1281995|NCT01663064|Juxtarenal|juxtarenal
1281996|NCT01663064|Off-the-shelf|off-the-shelf
1281997|NCT01663064|Pararenal|pararenal
1281998|NCT01663038|Clopidogrel|clopidogrel
1281999|NCT01663038|Aspirin|aspirin
1282000|NCT01663038|Combination|combination
1282001|NCT01663038|Pharmacokinetics|pharmacokinetics
1282002|NCT01663038|Phase 1|phase 1
1282003|NCT01663025|Randomised controlled trial|randomised controlled trial
1282004|NCT01663025|Pain|pain
1282005|NCT01663025|Anxiety|anxiety
1282006|NCT01663025|Ambulatory surgery|ambulatory surgery
1282007|NCT01663025|Hand massage|hand massage
1282008|NCT01663025|Local anaesthetic|local anaesthetic
1282009|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
1282010|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
1282011|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
1282012|NCT01662973|Serum Bilirubin|serum bilirubin
1282013|NCT01662960|stroke|stroke
1282014|NCT01662960|hemiparesis|hemiparesis
1282015|NCT01662960|arm movement|arm movement
1282016|NCT01662960|sensory functioning|sensory functioning
1282017|NCT01662947|blood pressure|blood pressure
1282018|NCT01662934|dysmenorrhea|dysmenorrhea
1282019|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1282020|NCT01662934|heat therapy|heat therapy
1282021|NCT01662921|bolus treatment|bolus treatment
1282022|NCT01662895|Brain hemorrhage|brain hemorrhage
1282023|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
1282024|NCT01662895|Deferoxamine|deferoxamine
1282025|NCT01662895|Hi-DEF Trial|hi-def trial
1282026|NCT01662856|Vascular Surgery|vascular surgery
1282027|NCT01662856|Fibrin Sealant|fibrin sealant
1282028|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
1282029|NCT01662843|Dyspnea|dyspnea
1282030|NCT01662843|Ultrasonography|ultrasonography
1282031|NCT01662843|Emergencies|emergencies
1282032|NCT01662843|Critical Care|critical care
1282033|NCT01662830|Obesity|obesity
1282034|NCT01662830|Meal replacements|meal replacements
1282035|NCT01662804|INTERLEUKIN 2|interleukin 2
1282036|NCT01662804|MAB 3F8|mab 3f8
1282037|NCT01662804|GD2-positive tumor|gd2-positive tumor
1282038|NCT01662804|12-116|12-116
1282039|NCT01662791|Parkinson's Disease|parkinson's disease
1282040|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
1282041|NCT01662791|Weight Loss|weight loss
1282042|NCT01662791|Gastrointestinal|gastrointestinal
1282043|NCT01662791|Rifaximin|rifaximin
1282044|NCT01662778|Monodisperse aerosols|monodisperse aerosols
1282045|NCT01662778|Asthmatics|asthmatics
1282046|NCT01662778|Pharmacokinetics|pharmacokinetics
1282047|NCT01662778|AMP Challenge|amp challenge
1282048|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
1282049|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
1282050|NCT01662765|Treatment|treatment
1282051|NCT01662765|Surgery|surgery
1282052|NCT01662765|Conservative|conservative
1282053|NCT01662765|Investigational treatment|investigational treatment
1282054|NCT01662765|After care|after care
1282055|NCT01662752|Early colonic cancer|early colonic cancer
1282056|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
1282057|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
1282058|NCT01662752|Near infrared imaging|near infrared imaging
1282059|NCT01662752|Indocyanine green|indocyanine green
1282060|NCT01662752|Laparoscopic|laparoscopic
1282061|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
1282062|NCT01662739|Stomach|stomach
1282063|NCT01662739|Epidemiology|epidemiology
1282064|NCT01662739|Risk Factor|risk factor
1282065|NCT01662739|Biomolecular Features|biomolecular features
1282066|NCT01662713|skin cancer|skin cancer
1282067|NCT01662713|optical imaging|optical imaging
1282068|NCT01662713|optical coherence tomography|optical coherence tomography
1282069|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
1282070|NCT01662700|P. vivax infection|p. vivax infection
1282071|NCT01662700|Artesunate|artesunate
1282072|NCT01662700|Chloroquine|chloroquine
1282073|NCT01662700|Primaquine|primaquine
1282074|NCT01662661|Healthy participants|healthy participants
1282075|NCT01662661|Hepatitis C|hepatitis c
1282076|NCT01662661|Relative bioavailability|relative bioavailability
1282077|NCT01662661|Bioavailability|bioavailability
1282078|NCT01662661|Pharmacokinetics|pharmacokinetics
1282079|NCT01662661|JNJ-47910382|jnj-47910382
1282080|NCT01662648|Schizophrenia|schizophrenia
1282081|NCT01662648|Paliperidone|paliperidone
1282082|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
1282083|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
1282084|NCT01662635|Diagnosis,|diagnosis,
1282085|NCT01662635|Adenocarcinoma,|adenocarcinoma,
1282087|NCT01662635|FISH,|fish,
1282088|NCT01662635|IHC|ihc
1282089|NCT01662635|RT-qPCR|rt-qpcr
1282090|NCT01662622|anaesthesia|anaesthesia
1282091|NCT01662622|middle aged|middle aged
1282092|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
1282093|NCT01662622|sevoflurane|sevoflurane
1282094|NCT01662622|isoelectric EEG|isoelectric eeg
1282095|NCT01662609|pancreas|pancreas
1282096|NCT01662609|high-risk|high-risk
1282097|NCT01662596|Risk factors,|risk factors,
1282098|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
1282099|NCT01662596|fetal malformations|fetal malformations
1282100|NCT01662583|Influenza|influenza
1282101|NCT01662583|text message|text message
1282102|NCT01662583|vaccination|vaccination
1282103|NCT01662570|Pediatric Obesity|pediatric obesity
1282104|NCT01662570|Child Overweight|child overweight
1282105|NCT01662557|Pediatric Obesity|pediatric obesity
1282106|NCT01662544|Infants|infants
1282107|NCT01662544|Bronchiolitis|bronchiolitis
1282108|NCT01662544|Hypoxia|hypoxia
1282109|NCT01662544|Emergency Department|emergency department
1282110|NCT01662544|Length of Stay|length of stay
1282111|NCT01662544|Pediatrics|pediatrics
1282112|NCT01662466|testosterone|testosterone
1282113|NCT01662466|DHEA|dhea
1282114|NCT01662466|IVF|ivf
1282115|NCT01662466|egg quality|egg quality
1282116|NCT01662466|pregnancy rates|pregnancy rates
1282117|NCT01662453|epilepsy|epilepsy
1282118|NCT01662453|seizures|seizures
1282119|NCT01662453|mortality|mortality
1282121|NCT01662453|risk factors|risk factors
1282122|NCT01662440|Rabies|rabies
1282123|NCT01662440|JE|je
1282124|NCT01662440|accelerated schedule|accelerated schedule
1282125|NCT01662427|Quality of life|quality of life
1282126|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
1282127|NCT01662401|children|children
1282128|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
1282129|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
1282130|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
1282131|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
1282132|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
1282133|NCT01662362|Chagas Disease|chagas disease
1282134|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
1282135|NCT01662362|American trypanosomiasis|american trypanosomiasis
1282136|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
1282137|NCT01662362|kissing bugs|kissing bugs
1282138|NCT01662362|reduviid bugs|reduviid bugs
1282139|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
1282140|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
1282141|NCT01662310|Schizophrenia|schizophrenia
1282142|NCT01662310|Paliperidone|paliperidone
1282143|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
1282144|NCT01662297|Quetiapine|quetiapine
1282145|NCT01662297|Trazodone|trazodone
1282146|NCT01662297|Insomnia|insomnia
1282147|NCT01662297|Dual Diagnosis|dual diagnosis
1282148|NCT01662271|obesity|obesity
1282149|NCT01662271|adiposity|adiposity
1282150|NCT01662271|psychosocial|psychosocial
1282151|NCT01662271|healthcare|healthcare
1282152|NCT01662271|co-morbidities|co-morbidities
1282153|NCT01662271|youth with extreme obesity|youth with extreme obesity
1282154|NCT01662271|weight loss|weight loss
1282155|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
1282156|NCT01662258|Targeted strategy|targeted strategy
1282157|NCT01662258|Empiric therapy|empiric therapy
1282158|NCT01662232|Green tea|green tea
1282159|NCT01662232|EGCG|egcg
1282160|NCT01662232|Cardiovascular diseases|cardiovascular diseases
1282161|NCT01662232|Endothelial function|endothelial function
1282162|NCT01662232|Flow-mediated dilation|flow-mediated dilation
1282163|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
1282164|NCT01662219|quality of recovery|quality of recovery
1282165|NCT01662206|adults|adults
1282166|NCT01662206|probiotics|probiotics
1282167|NCT01662206|immune function|immune function
1282168|NCT01662206|microbiota|microbiota
1282169|NCT01662206|digestive health|digestive health
1282170|NCT01662193|Cholecalciferol|cholecalciferol
1282171|NCT01662193|Calciol|calciol
1282172|NCT01662193|vitamin D3|vitamin d3
1282173|NCT01662193|Diabetes Mellitus|diabetes mellitus
1282174|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
1282175|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
1282176|NCT01662193|ergocalciferol|ergocalciferol
1282177|NCT01662193|calcium|calcium
1282178|NCT01662193|adipicytokines|adipicytokines
1282179|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
1282180|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
1282181|NCT01662141|Cardiac output|cardiac output
1282182|NCT01662141|Perivascular Probe|perivascular probe
1282183|NCT01662128|Breast Cancer|breast cancer
1282184|NCT01662115|ILEUS|ileus
1282185|NCT01662089|Female pattern hair loss|female pattern hair loss
1282186|NCT01662076|Cancer|cancer
1282187|NCT01662076|Fatigue|fatigue
1282188|NCT01662076|Chemotherapy|chemotherapy
1282189|NCT01662076|Pediatrics|pediatrics
1282190|NCT01662076|Homeopathy|homeopathy
1282191|NCT01662050|MCL|mcl
1282192|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
1282193|NCT01662050|Older|older
1282194|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
1282195|NCT01662037|Heart defects, Congenital|heart defects, congenital
1282196|NCT01662037|Receptors, endothelin|receptors, endothelin
1282197|NCT01662037|Bosentan|bosentan
1282198|NCT01662024|Obesity|obesity
1282199|NCT01662024|BMI|bmi
1282200|NCT01662024|Weight loss|weight loss
1282201|NCT01662024|Gastric restriction|gastric restriction
1282202|NCT01662024|Bariatrics|bariatrics
1282203|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
1282204|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1282205|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
1282206|NCT01662011|pressure support ventilation|pressure support ventilation
1282207|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1282208|NCT01661998|Spinal Deformity|spinal deformity
1282209|NCT01661998|Treatment Outcomes|treatment outcomes
1282210|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
1282211|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
1282212|NCT01661985|Treatment|treatment
1282213|NCT01661985|Antibiotic resistance|antibiotic resistance
1282214|NCT01661972|colorectal cancer|colorectal cancer
1282215|NCT01661972|all solid tumors|all solid tumors
1282216|NCT01661972|metastatic|metastatic
1282217|NCT01661972|refractory|refractory
1282314|NCT01661569|stress|stress
1282218|NCT01661972|advanced solid tumors|advanced solid tumors
1282219|NCT01661959|Scoliosis|scoliosis
1282220|NCT01661959|Multi-center Database Registry|multi-center database registry
1282221|NCT01661959|Spinal Deformity|spinal deformity
1282222|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1282223|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
1282224|NCT01661946|macular edema|macular edema
1282225|NCT01661946|diabetic retinopathy|diabetic retinopathy
1282226|NCT01661933|celiac disease|celiac disease
1282227|NCT01661933|hookworm|hookworm
1282228|NCT01661933|probiotic|probiotic
1282229|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
1282230|NCT01661920|Treatment duration|treatment duration
1282231|NCT01661907|Elderly|elderly
1282232|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
1282233|NCT01661907|Postoperative period|postoperative period
1282234|NCT01661907|Delirium|delirium
1282235|NCT01661907|Postoperative complications|postoperative complications
1282236|NCT01661881|Newly diagnosed|newly diagnosed
1282237|NCT01661868|BRCA1 mutation|brca1 mutation
1282238|NCT01661868|BRCA2 mutation|brca2 mutation
1282239|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
1282240|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
1282241|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
1282242|NCT01661842|serum albumin|serum albumin
1282243|NCT01661842|serum Tbil|serum tbil
1282244|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
1282245|NCT01661816|breast cancer|breast cancer
1282246|NCT01661816|everyday issues|everyday issues
1282247|NCT01661816|couple|couple
1282248|NCT01661803|bupivacaine|bupivacaine
1282249|NCT01661803|clonidine|clonidine
1282250|NCT01661803|pediatric spinal|pediatric spinal
1282251|NCT01661803|efficacy|efficacy
1282252|NCT01661803|duration|duration
1282253|NCT01661803|quality|quality
1282254|NCT01661803|side effects|side effects
1282255|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
1282256|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
1282257|NCT01661790|Bevacizumab;|bevacizumab;
1282258|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
1282259|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
1282260|NCT01661790|intrapleural administration|intrapleural administration
1282261|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
1282262|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
1282263|NCT01661777|Diuretic|diuretic
1282264|NCT01661777|Low salt diet|low salt diet
1282265|NCT01661777|Myringotomy|myringotomy
1282266|NCT01661777|Pressure equalization tube|pressure equalization tube
1282267|NCT01661777|Ear tube|ear tube
1282268|NCT01661777|Ear fullness|ear fullness
1282269|NCT01661777|Ear pressure|ear pressure
1282270|NCT01661777|Allergy|allergy
1282271|NCT01661777|Nasal steroid|nasal steroid
1282272|NCT01661777|Antihistamine|antihistamine
1282273|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
1282274|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
1282275|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
1333181|NCT01444170|mechanical pain threshold|mechanical pain threshold
1282276|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
1282277|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
1282278|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
1282279|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
1282280|NCT01661686|esophageal cancer|esophageal cancer
1282281|NCT01661686|esophageal stenosis|esophageal stenosis
1282282|NCT01661686|stent|stent
1282283|NCT01661686|endoscopy|endoscopy
1282284|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
1282285|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1282286|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
1282287|NCT01661621|Antimuscarinics|antimuscarinics
1282288|NCT01661621|α-blockers|α-blockers
1282289|NCT01661608|Gastric Restriction|gastric restriction
1282290|NCT01661595|Fatigue|fatigue
1282291|NCT01661595|Fatigability|fatigability
1282292|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
1282293|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
1282294|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
1282295|NCT01661595|NO-cGMP|no-cgmp
1282296|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
1282297|NCT01661595|Sildenafil|sildenafil
1282298|NCT01661595|Tadalafil|tadalafil
1282299|NCT01661595|Isotope|isotope
1282300|NCT01661595|Infusion|infusion
1282301|NCT01661595|Anabolism|anabolism
1282302|NCT01661595|Upregulation|upregulation
1282303|NCT01661595|Accelerometer|accelerometer
1282304|NCT01661595|Placebo|placebo
1282305|NCT01661595|Nitrosylation|nitrosylation
1282306|NCT01661582|Air Pollution|air pollution
1282307|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
1282308|NCT01661582|Coronary Blood Flow|coronary blood flow
1282309|NCT01661582|Diesel Exhaust|diesel exhaust
1282310|NCT01661582|Troponin|troponin
1282311|NCT01661582|Electrocardiography|electrocardiography
1282312|NCT01661569|Mindfulness|mindfulness
1282313|NCT01661569|meditation|meditation
1282315|NCT01661569|well-being|well-being
1282316|NCT01661569|work stress|work stress
1282317|NCT01661569|blood pressure|blood pressure
1282318|NCT01661569|cortisol|cortisol
1282319|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
1282320|NCT01661530|asthma|asthma
1282321|NCT01661530|pregnancy|pregnancy
1282322|NCT01661530|diet|diet
1282323|NCT01661530|vitamin E|vitamin e
1282324|NCT01661517|substance use treatment|substance use treatment
1282325|NCT01661439|Recurrent miscarriages|recurrent miscarriages
1282326|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
1282328|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
1282329|NCT01661426|Adults|adults
1282330|NCT01661426|Weight loss|weight loss
1282331|NCT01661426|Diet|diet
1282332|NCT01661426|Insulin Resistance|insulin resistance
1282333|NCT01661426|Fatty acid composition|fatty acid composition
1282334|NCT01661413|Acute Leukemia|acute leukemia
1282335|NCT01661413|Pediatrics|pediatrics
1282336|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
1282337|NCT01661413|Chemotherapy|chemotherapy
1282338|NCT01661413|Nausea|nausea
1282339|NCT01661413|Vomiting|vomiting
1282340|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
1282341|NCT01661387|Adrenal insufficiency|adrenal insufficiency
1282342|NCT01661387|DuoCort|duocort
1282343|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
1282344|NCT01661387|Modified release|modified release
1282345|NCT01661387|Hydrocortisone|hydrocortisone
1282346|NCT01661361|vancomycin|vancomycin
1282347|NCT01661361|levels|levels
1282348|NCT01661361|central venous port device|central venous port device
1282349|NCT01661361|peripherally obtained levels|peripherally obtained levels
1282350|NCT01661361|dose adjustments|dose adjustments
1282351|NCT01661361|TDM|tdm
1282352|NCT01661348|Cesarian section|cesarian section
1282353|NCT01661348|Pregnancy|pregnancy
1282354|NCT01661348|Incision management|incision management
1282355|NCT01661335|Nausea|nausea
1282356|NCT01661335|Vomiting|vomiting
1282357|NCT01661335|Children|children
1282358|NCT01661335|Aprepitant|aprepitant
1282359|NCT01661335|Emend®|emend®
1282360|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
1282361|NCT01661322|TIA|tia
1282362|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
1282363|NCT01661309|Methylcobalamin|methylcobalamin
1282364|NCT01661309|Cardiovascular disease|cardiovascular disease
1282365|NCT01661309|Plasma total homocysteine|plasma total homocysteine
1282366|NCT01661309|Vegetarians|vegetarians
1282367|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
1282368|NCT01661283|MPNST|mpnst
1282369|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
1282370|NCT01661283|RAD001|rad001
1282371|NCT01661283|Everolimus|everolimus
1282372|NCT01661283|Bevacizumab|bevacizumab
1282373|NCT01661283|Sarcoma|sarcoma
1282374|NCT01661283|Avastin|avastin
1282375|NCT01661283|mTOR inhibitor|mtor inhibitor
1282376|NCT01661257|Crohn's disease|crohn's disease
1282377|NCT01661257|Infliximab|infliximab
1282378|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
1282379|NCT01661231|Vascular intervention|vascular intervention
1282380|NCT01661231|Endovascular|endovascular
1282381|NCT01661231|Peripheral stent|peripheral stent
1282382|NCT01661218|catheters|catheters
1282383|NCT01661218|Central Venous|central venous
1282384|NCT01661218|complications|complications
1282385|NCT01661218|cancer|cancer
1282386|NCT01661205|Persistent AF|persistent af
1282387|NCT01661205|Longstanding Persistent AF|longstanding persistent af
1282388|NCT01661205|Ablation|ablation
1282389|NCT01661205|catheter ablation|catheter ablation
1282390|NCT01661192|Type 1 Diabetes|type 1 diabetes
1282391|NCT01661192|newly diagnosed|newly diagnosed
1282392|NCT01661192|Beta cell preservation|beta cell preservation
1282393|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
1282394|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
1282395|NCT01661179|Vandetanib|vandetanib
1282396|NCT01661166|Male adult subjects|male adult subjects
1282397|NCT01661166|aged 30-90 years|aged 30-90 years
1282398|NCT01661166|RARP|rarp
1282399|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
1282400|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
1282401|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
1282402|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
1282403|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
1282404|NCT01661101|Myocardial injury|myocardial injury
1282405|NCT01661101|noncardiac surgery|noncardiac surgery
1282406|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
1282407|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
1282408|NCT01661088|Concurrent|concurrent
1282409|NCT01661088|IMRT|imrt
1282798|NCT01659021|GS-1101|gs-1101
1282410|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
1282411|NCT01661075|mTBI|mtbi
1282412|NCT01661075|concussion|concussion
1282413|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
1282414|NCT01661075|athlete|athlete
1282415|NCT01661075|college|college
1282416|NCT01661075|football|football
1282417|NCT01661075|soccer|soccer
1282418|NCT01661036|Cognitive Testing|cognitive testing
1282419|NCT01661036|Survey|survey
1282420|NCT01661036|Interview|interview
1282421|NCT01661023|Breast Cancer|breast cancer
1282422|NCT01661023|Epidemiology|epidemiology
1282423|NCT01661010|Infertility|infertility
1282424|NCT01661010|Male Factor Infertility|male factor infertility
1282425|NCT01661010|Female Factor Infertility|female factor infertility
1282426|NCT01661010|Unexplained Infertility|unexplained infertility
1282427|NCT01661010|Sex Chromosome|sex chromosome
1282428|NCT01661010|Klinefelter Syndrome|klinefelter syndrome
1282429|NCT01661010|Turner's Syndrome|turner's syndrome
1282430|NCT01661010|XXY|xxy
1282431|NCT01661010|Y Chromosome Deletion|y chromosome deletion
1282432|NCT01661010|Aneuploidy|aneuploidy
1282433|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
1282434|NCT01660997|Induction Combination Therapy|induction combination therapy
1282435|NCT01660997|Maintenance Strategy|maintenance strategy
1282436|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
1282437|NCT01660997|Precursor Disease|precursor disease
1282438|NCT01660984|Thyroid Tumor|thyroid tumor
1282439|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
1282440|NCT01660984|Pheochromocytoma|pheochromocytoma
1282441|NCT01660984|RET Mutations|ret mutations
1282442|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
1282443|NCT01660958|Early Child Development|early child development
1282444|NCT01660958|Infant Growth|infant growth
1282445|NCT01660958|Iron Deficiency|iron deficiency
1282446|NCT01660945|statins, insulin resistance|statins, insulin resistance
1282447|NCT01660932|insulin resistance|insulin resistance
1282448|NCT01660919|insulin resistance|insulin resistance
1282449|NCT01660893|operative|operative
1282450|NCT01660893|dental procedure|dental procedure
1282451|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
1282452|NCT01660854|Plasmodium|plasmodium
1282453|NCT01660854|falciparum|falciparum
1282454|NCT01660854|malaria|malaria
1282455|NCT01660854|heterologous|heterologous
1282456|NCT01660854|immunity|immunity
1282457|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
1282458|NCT01660841|central nervous system|central nervous system
1282459|NCT01660841|contrast media|contrast media
1282460|NCT01660841|gadobutrol|gadobutrol
1282461|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
1282462|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
1282463|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
1282464|NCT01660789|Obesity|obesity
1282465|NCT01660789|Diabetes|diabetes
1282466|NCT01660789|Physical activity|physical activity
1282467|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1282468|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
1282469|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
1282470|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
1282471|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1282472|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
1282473|NCT01660737|Hay fever|hay fever
1282474|NCT01660737|Pascallerg|pascallerg
1282475|NCT01660711|neoadjuvant|neoadjuvant
1282476|NCT01660711|chemotherapy|chemotherapy
1282477|NCT01660711|resectable|resectable
1282478|NCT01660711|adjuvant|adjuvant
1282479|NCT01660711|pancreas|pancreas
1282481|NCT01660711|adenocarcinoma|adenocarcinoma
1282482|NCT01660711|surgery|surgery
1282483|NCT01660685|Weight loss|weight loss
1282484|NCT01660685|Web-based|web-based
1282485|NCT01660685|Journaling|journaling
1282486|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
1282487|NCT01660659|Indoor air pollution|indoor air pollution
1282488|NCT01660659|pneumococcal carriage|pneumococcal carriage
1282489|NCT01660646|Tuberculosis case finding|tuberculosis case finding
1282490|NCT01660633|Multiple Myeloma|multiple myeloma
1282491|NCT01660633|High-Dose Melphalan|high-dose melphalan
1282492|NCT01660633|Propylene Glycol-Free|propylene glycol-free
1282493|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1282494|NCT01660633|Captisol|captisol
1282495|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
1282496|NCT01660594|coronary disease|coronary disease
1282497|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
1282498|NCT01660594|calcium|calcium
1282499|NCT01660594|exercise test|exercise test
1282500|NCT01660581|CD133+|cd133+
1282501|NCT01660581|stem cells|stem cells
1282502|NCT01660581|Coronary Artery Disease|coronary artery disease
1282503|NCT01660581|Stable Angina Pectoris|stable angina pectoris
1282504|NCT01660555|Microbiota|microbiota
1282505|NCT01660555|HITChip|hitchip
1282506|NCT01660555|biopsies|biopsies
1282507|NCT01660555|colon|colon
1282508|NCT01660555|protected biopsies|protected biopsies
1282601|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
1282509|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
1282510|NCT01660529|of care regimen|of care regimen
1282511|NCT01660516|Camellia sinensis|camellia sinensis
1282512|NCT01660516|flavonoids|flavonoids
1282513|NCT01660516|cardiovascular risk|cardiovascular risk
1282514|NCT01660516|flow mediated dilation|flow mediated dilation
1282515|NCT01660503|Calcium absorption|calcium absorption
1282516|NCT01660503|Osteoporosis|osteoporosis
1282517|NCT01660503|Bone Health|bone health
1282518|NCT01660503|Adolescent|adolescent
1282519|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
1282520|NCT01660490|Intraoperative Care|intraoperative care
1282521|NCT01660490|Femoral Fractures|femoral fractures
1282522|NCT01660490|Femoral Neck Fractures|femoral neck fractures
1282523|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
1282524|NCT01660490|Fracture Fixation Internal|fracture fixation internal
1282525|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
1282526|NCT01660490|Fractures Bone|fractures bone
1282527|NCT01660477|Isavuconazole|isavuconazole
1282528|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
1282529|NCT01660477|Healthy Volunteers|healthy volunteers
1282530|NCT01660477|BAL8557|bal8557
1282531|NCT01660477|Kaletra ®|kaletra ®
1282532|NCT01660464|Program evaluation|program evaluation
1282533|NCT01660464|ADHD|adhd
1282534|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
1282535|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
1282536|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
1282537|NCT01660438|Stress urinary incontinence|stress urinary incontinence
1282538|NCT01660438|Suburethral sling|suburethral sling
1282539|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
1282540|NCT01660425|parenting enhancement training|parenting enhancement training
1282541|NCT01660425|guided self-help|guided self-help
1282542|NCT01660425|methylphenidate|methylphenidate
1282543|NCT01660412|Pain|pain
1282544|NCT01660412|Alkalinization|alkalinization
1282545|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
1282546|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
1282547|NCT01660399|salvage chemotherapy|salvage chemotherapy
1282548|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
1282549|NCT01660399|Boanmycin|boanmycin
1282550|NCT01660386|Type 2 Diabetes|type 2 diabetes
1282551|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
1282552|NCT01660386|Sulfonylurea|sulfonylurea
1282553|NCT01660386|beta cell function|beta cell function
1282554|NCT01660373|ticagrelor|ticagrelor
1282555|NCT01660373|tirofiban|tirofiban
1282556|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
1282557|NCT01660373|P2Y12 blockers|p2y12 blockers
1282558|NCT01660373|acute coronary syndrome|acute coronary syndrome
1282559|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
1282560|NCT01660334|Systemic Mycosis|systemic mycosis
1282561|NCT01660334|Scedosporium infection|scedosporium infection
1282562|NCT01660334|Scedosporisis|scedosporisis
1282563|NCT01660334|Japanese|japanese
1282564|NCT01660334|voriconazole|voriconazole
1282565|NCT01660334|VFEND|vfend
1282566|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
1282567|NCT01660321|Pediculosis capitis|pediculosis capitis
1282568|NCT01660321|Head Lice|head lice
1282569|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
1282570|NCT01660295|Severe renal insufficiency|severe renal insufficiency
1282571|NCT01660243|Pruritus|pruritus
1282572|NCT01660243|Renal dialysis|renal dialysis
1282573|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
1282574|NCT01660243|Sleep Disorders|sleep disorders
1282575|NCT01660243|Quality of Life|quality of life
1282576|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
1282577|NCT01660217|atopic dermatitis|atopic dermatitis
1282578|NCT01660217|eczema action plan|eczema action plan
1282579|NCT01660217|patient education|patient education
1282580|NCT01660217|written handout|written handout
1282581|NCT01660217|investigator's global assessment|investigator's global assessment
1282582|NCT01660217|randomized controlled trial|randomized controlled trial
1282583|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
1282584|NCT01660191|LDL, HDL|ldl, hdl
1282585|NCT01660178|newborns|newborns
1282586|NCT01660178|intensive care unit|intensive care unit
1282587|NCT01660178|early stimulation|early stimulation
1282588|NCT01660165|Nutritional status|nutritional status
1282589|NCT01660165|Mental Health|mental health
1282590|NCT01660165|Omega-3|omega-3
1282591|NCT01660165|Pregnancy|pregnancy
1282592|NCT01660165|Postpartum depression|postpartum depression
1282593|NCT01660152|male erectile disorder|male erectile disorder
1282594|NCT01660152|prostate cancer|prostate cancer
1282595|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
1282596|NCT01660126|Aged|aged
1282597|NCT01660126|Cardiovascular disease|cardiovascular disease
1282598|NCT01660126|Levothyroxine|levothyroxine
1282799|NCT01659021|CAL-101|cal-101
1282599|NCT01660126|Randomised controlled trial|randomised controlled trial
1282600|NCT01660126|Quality of life|quality of life
1283104|NCT01657513|psoriasis|psoriasis
1282602|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
1282603|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
1282604|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
1282605|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
1282606|NCT01660087|Confocal Endoscopy|confocal endoscopy
1282607|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
1282608|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
1282609|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
1282610|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
1282611|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
1282612|NCT01660061|International normalized ratio|international normalized ratio
1282613|NCT01660061|Chromogenic factor X|chromogenic factor x
1282614|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
1282615|NCT01660022|Healthy|healthy
1282616|NCT01660022|Volunteers|volunteers
1282617|NCT01660009|Endothelial Function|endothelial function
1282618|NCT01660009|Hypoglycemia|hypoglycemia
1282619|NCT01660009|Mitochondria|mitochondria
1282620|NCT01659996|Meningitis|meningitis
1282621|NCT01659996|Meningococcal Infection|meningococcal infection
1282622|NCT01659996|Diphtheria|diphtheria
1282623|NCT01659996|Pertussis|pertussis
1282624|NCT01659996|Menactra®|menactra®
1282625|NCT01659996|Pentacel®|pentacel®
1282626|NCT01659983|complicated appendicitis|complicated appendicitis
1282627|NCT01659983|wound closure|wound closure
1282628|NCT01659983|infection|infection
1282629|NCT01659957|Alcoholism|alcoholism
1282630|NCT01659957|Couples|couples
1282631|NCT01659944|Drug-drug interaction|drug-drug interaction
1282632|NCT01659879|Parents|parents
1282633|NCT01659879|Caregivers|caregivers
1282634|NCT01659879|Anxiety|anxiety
1282635|NCT01659879|Consumer satisfaction|consumer satisfaction
1282636|NCT01659866|Infection|infection
1282637|NCT01659866|Antibiotic resistance|antibiotic resistance
1282638|NCT01659866|Prostate biopsy|prostate biopsy
1282639|NCT01659840|laser,|laser,
1282640|NCT01659840|quality of life,|quality of life,
1282641|NCT01659840|orofacial pain|orofacial pain
1282642|NCT01659814|Major Depressive Disorder|major depressive disorder
1282643|NCT01659814|Anhedonia|anhedonia
1282644|NCT01659814|Dopamine|dopamine
1282645|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
1282646|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
1282647|NCT01659814|Reward|reward
1282648|NCT01659801|cataract|cataract
1282649|NCT01659801|cataract surgery|cataract surgery
1282650|NCT01659801|intaocular lens|intaocular lens
1282651|NCT01659801|toric lens|toric lens
1282652|NCT01659788|Advanced Reproductive Age|advanced reproductive age
1333182|NCT01444144|Ankle|ankle
1282653|NCT01659788|poor ovarian response|poor ovarian response
1282654|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
1282655|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
1282656|NCT01659788|Coenzyme Q10|coenzyme q10
1282657|NCT01659788|Electron transfer chain|electron transfer chain
1282658|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
1282659|NCT01659762|Crohn's disease|crohn's disease
1282660|NCT01659749|Genetics|genetics
1282661|NCT01659749|Metabolic|metabolic
1282662|NCT01659749|Nutrition|nutrition
1282663|NCT01659749|Maternal PKU|maternal pku
1282664|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
1282665|NCT01659723|Radio therapy|radio therapy
1282666|NCT01659723|STRI|stri
1282667|NCT01659723|Urinary bladder|urinary bladder
1282668|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
1282669|NCT01659697|lifestyle|lifestyle
1282670|NCT01659697|diabetes prevention|diabetes prevention
1282672|NCT01659697|physical activity|physical activity
1282673|NCT01659684|congenital CMV infection|congenital cmv infection
1282674|NCT01659684|standard immunoglobulins|standard immunoglobulins
1282675|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
1282676|NCT01659684|IgG CMV avidity index|igg cmv avidity index
1282677|NCT01659684|Cytomegalovirus|cytomegalovirus
1282678|NCT01659658|MLN9708|mln9708
1282679|NCT01659658|Amyloidosis|amyloidosis
1282680|NCT01659658|Light Chain|light chain
1282681|NCT01659658|IXAZOMIB|ixazomib
1282682|NCT01659658|Tourmaline AL1|tourmaline al1
1282683|NCT01659658|Drug Therapy|drug therapy
1282684|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
1282685|NCT01659606|bone marrow failure|bone marrow failure
1282686|NCT01659606|aplastic anemia|aplastic anemia
1282687|NCT01659606|bone marrow transplantation|bone marrow transplantation
1282688|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
1282689|NCT01659606|campath|campath
1282690|NCT01659606|fludarabine|fludarabine
1282691|NCT01659606|telomere|telomere
1282692|NCT01659593|cognitive disorders|cognitive disorders
1282693|NCT01659593|multiple sclerosis|multiple sclerosis
1282694|NCT01659593|neuropsychology|neuropsychology
1282695|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
1282800|NCT01659021|Ofatumumab|ofatumumab
1282696|NCT01659554|Primary peritoneal|primary peritoneal
1282697|NCT01659541|spinal cord injury|spinal cord injury
1282698|NCT01659541|paralysis|paralysis
1283313|NCT01656642|PD-L1|pd-l1
1282700|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
1282701|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
1282702|NCT01659528|Penis|penis
1282703|NCT01659528|Micropenis|micropenis
1282704|NCT01659528|Nomograms|nomograms
1282705|NCT01659528|Ultrasound|ultrasound
1282706|NCT01659528|Fetus|fetus
1282707|NCT01659502|Patients|patients
1282708|NCT01659489|adnexal torsion|adnexal torsion
1282709|NCT01659489|laparoscopy|laparoscopy
1282710|NCT01659476|methacholine|methacholine
1282711|NCT01659476|deep inspiration|deep inspiration
1282712|NCT01659476|bronchoprotective effect|bronchoprotective effect
1282713|NCT01659476|bronchodilating effect|bronchodilating effect
1282714|NCT01659463|CARIES INFILTRATION|caries infiltration
1282715|NCT01659463|CARIES LESION|caries lesion
1282716|NCT01659463|INFILTRANT|infiltrant
1282717|NCT01659450|overweight|overweight
1282718|NCT01659450|obesity|obesity
1282719|NCT01659450|low energy dense|low energy dense
1282720|NCT01659437|M. ulcerans|m. ulcerans
1282721|NCT01659437|Buruli ulcer|buruli ulcer
1282722|NCT01659437|drug trial|drug trial
1282723|NCT01659437|clarithromycin|clarithromycin
1282724|NCT01659424|Rectal cancer|rectal cancer
1282725|NCT01659411|Congenital Heart Disease|congenital heart disease
1282726|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1282727|NCT01659398|Alzheimer's Disease|alzheimer's disease
1282728|NCT01659398|cerebral blood flow|cerebral blood flow
1282729|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
1282730|NCT01659398|blood viscosity|blood viscosity
1282731|NCT01659372|temporomandibular disorder|temporomandibular disorder
1282732|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
1282733|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
1282734|NCT01659307|Acute Lung Injury|acute lung injury
1282735|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1282736|NCT01659307|Aspirin|aspirin
1282737|NCT01659294|Type 2 diabetes|type 2 diabetes
1282738|NCT01659294|outcomes|outcomes
1282739|NCT01659294|case management|case management
1282740|NCT01659281|Artesunate|artesunate
1282741|NCT01659281|Mefloquine|mefloquine
1282742|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
1282743|NCT01659281|Thailand|thailand
1282744|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
1282745|NCT01659268|teaching|teaching
1282746|NCT01659268|patient simulation|patient simulation
1282747|NCT01659268|laryngeal masks|laryngeal masks
1282748|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
1282749|NCT01659268|teaching strategies|teaching strategies
1282750|NCT01659268|simulation|simulation
1282751|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
1282752|NCT01659242|Ultrasound|ultrasound
1282753|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
1282754|NCT01659229|knee osteoarthritis|knee osteoarthritis
1282755|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
1282756|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
1282757|NCT01659216|long-term efficacy|long-term efficacy
1282758|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
1282759|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
1282760|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
1282761|NCT01659164|Group Treatment|group treatment
1282762|NCT01659164|ADHD|adhd
1282763|NCT01659151|metastatic|metastatic
1282764|NCT01659151|melanoma|melanoma
1282765|NCT01659151|cell transfer|cell transfer
1282767|NCT01659151|T-cell|t-cell
1282768|NCT01659151|immunotherapy|immunotherapy
1282769|NCT01659151|antibodies|antibodies
1282770|NCT01659151|lymphocytes|lymphocytes
1282771|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
1282772|NCT01659099|DLBCL|dlbcl
1282773|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
1282774|NCT01659099|Diagnosis|diagnosis
1282775|NCT01659099|18 to 60 years|18 to 60 years
1282776|NCT01659099|Lymphoma|lymphoma
1282777|NCT01659086|Influenza|influenza
1282778|NCT01659086|Immunogenicity|immunogenicity
1282779|NCT01659086|H9N2|h9n2
1282780|NCT01659086|Safety|safety
1282781|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
1282782|NCT01659073|Functional Imaging|functional imaging
1282783|NCT01659060|Cacao|cacao
1282784|NCT01659060|Chocolate|chocolate
1282785|NCT01659060|Theobromine|theobromine
1282786|NCT01659060|Flavonoids|flavonoids
1282787|NCT01659060|Pregnant women|pregnant women
1282788|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
1282789|NCT01659060|Pre-eclampsia|pre-eclampsia
1282790|NCT01659060|Epicatechin|epicatechin
1282791|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1282792|NCT01659047|CLL|cll
1282793|NCT01659047|CAL-101|cal-101
1282794|NCT01659047|Ofatumumab|ofatumumab
1282795|NCT01659034|Anti-platelet therapy|anti-platelet therapy
1282796|NCT01659021|CLL|cll
1282797|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1283314|NCT01656642|PD-1|pd-1
1282801|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
1282802|NCT01658995|Implanon|implanon
1282803|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
1282804|NCT01658995|Nexplanon|nexplanon
1282805|NCT01658995|Contraception|contraception
1282806|NCT01658995|Irregular Bleeding|irregular bleeding
1282807|NCT01658995|Menometrorrhagia|menometrorrhagia
1282808|NCT01658956|GCSF|gcsf
1282809|NCT01658956|Chemotherapy|chemotherapy
1282810|NCT01658956|Breast cancer|breast cancer
1282811|NCT01658956|Prophylaxis|prophylaxis
1282812|NCT01658917|Tissue Acquisition|tissue acquisition
1282813|NCT01658904|Autologous Transplant|autologous transplant
1282814|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
1282815|NCT01658904|Melphalan|melphalan
1282816|NCT01658904|Filgrastim|filgrastim
1282817|NCT01658839|pediatric glaucoma|pediatric glaucoma
1282818|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
1282819|NCT01658839|travoprost|travoprost
1282820|NCT01658826|AIC316|aic316
1282821|NCT01658826|Viral shedding|viral shedding
1282822|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
1282823|NCT01658813|Metastatic Kidney|metastatic kidney
1282824|NCT01658813|Metastatic Lung|metastatic lung
1282825|NCT01658800|H5N1 Influenza|h5n1 influenza
1282826|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
1282827|NCT01658787|Aorta|aorta
1282828|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
1282829|NCT01658761|vitrectomy|vitrectomy
1282830|NCT01658761|internal limiting membrane|internal limiting membrane
1282831|NCT01658761|Retrospective, case control study|retrospective, case control study
1282832|NCT01658748|Pilot Study|pilot study
1282833|NCT01658748|Longitudinal Study|longitudinal study
1282834|NCT01658748|Amygdaloid Body|amygdaloid body
1282835|NCT01658748|Insula of Reil|insula of reil
1282836|NCT01658748|Cortex, prefrontal|cortex, prefrontal
1282837|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
1282838|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
1282839|NCT01658748|Combat Stress Disorder|combat stress disorder
1282840|NCT01658748|Social Adjustments|social adjustments
1282841|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
1282842|NCT01658735|Chronic low back pain|chronic low back pain
1282843|NCT01658735|Electrotherapy|electrotherapy
1282844|NCT01658735|H-Wave|h-wave
1282845|NCT01658735|H wave|h wave
1282846|NCT01658735|TENS|tens
1282847|NCT01658735|Trial|trial
1282848|NCT01658683|Coronary Artery Disease|coronary artery disease
1282849|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
1282850|NCT01658683|Exercise Maintenance|exercise maintenance
1282851|NCT01658683|Facilitator|facilitator
1282852|NCT01658683|Managed Home Exercise|managed home exercise
1282853|NCT01658683|Community Based Exercise|community based exercise
1282854|NCT01658670|Heart failure|heart failure
1282855|NCT01658670|exercise|exercise
1282856|NCT01658670|adherence|adherence
1282857|NCT01658670|quality of life|quality of life
1282858|NCT01658644|Patient satisfaction|patient satisfaction
1282859|NCT01658644|Memory recall|memory recall
1282860|NCT01658644|Patient-clinician communication|patient-clinician communication
1282861|NCT01658644|health communication|health communication
1282862|NCT01658644|clinical care team recall|clinical care team recall
1282863|NCT01658644|hospital quality of care|hospital quality of care
1282864|NCT01658618|Venous leg ulcer|venous leg ulcer
1282865|NCT01658618|ulcer|ulcer
1282866|NCT01658618|venous stasis|venous stasis
1282867|NCT01658618|compression|compression
1282868|NCT01658618|venous|venous
1282869|NCT01658618|venous stasis ulcer|venous stasis ulcer
1282870|NCT01658618|vlu|vlu
1282871|NCT01658618|hp802-247-09-029|hp802-247-09-029
1282872|NCT01658605|GSK1605786|gsk1605786
1282873|NCT01658605|ulcerative colitis|ulcerative colitis
1282874|NCT01658605|CCR9 antagonist|ccr9 antagonist
1282875|NCT01658605|proof of concept|proof of concept
1282876|NCT01658592|Alcohol Addiction;|alcohol addiction;
1282877|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
1282878|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
1282879|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
1282880|NCT01658553|solid tumors|solid tumors
1282881|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
1282882|NCT01658540|long SFA lesions disease|long sfa lesions disease
1282883|NCT01658527|metastatic|metastatic
1282884|NCT01658527|prostate cancer|prostate cancer
1282885|NCT01658488|Iron deficiency anemia|iron deficiency anemia
1282886|NCT01658488|rice|rice
1282887|NCT01658475|IgG titer|igg titer
1282888|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
1282889|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
1282890|NCT01658462|Docetaxel|docetaxel
1282891|NCT01658462|Nintedanib|nintedanib
1282892|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
1282893|NCT01658436|BEZ235|bez235
1282894|NCT01658436|pNET|pnet
1282895|NCT01658423|pubic hair|pubic hair
1282896|NCT01658423|sprint velocity|sprint velocity
1282897|NCT01658423|vertical jump height|vertical jump height
1282898|NCT01658423|body composition|body composition
1282899|NCT01658423|maximal voluntary torque|maximal voluntary torque
1282900|NCT01658410|Coronary artery disease|coronary artery disease
1282901|NCT01658410|bypass grafting|bypass grafting
1282902|NCT01658397|Healthy subjects|healthy subjects
1282903|NCT01658397|Fasting|fasting
1282904|NCT01658397|Weight loss|weight loss
1282905|NCT01658371|HIV|hiv
1282906|NCT01658358|ErbB receptor|erbb receptor
1282907|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1282908|NCT01658358|Anthracycline|anthracycline
1282909|NCT01658345|aortic stenosis|aortic stenosis
1282910|NCT01658345|asymptomatic|asymptomatic
1282911|NCT01658345|microvascular dysfunction|microvascular dysfunction
1282912|NCT01658345|Cardiac MRI|cardiac mri
1282913|NCT01658332|lung cancer|lung cancer
1282914|NCT01658332|circulating tumor cells|circulating tumor cells
1282915|NCT01658332|prospective|prospective
1282916|NCT01658332|monocentrique trial|monocentrique trial
1282917|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
1282918|NCT01658306|random-controlled|random-controlled
1282919|NCT01658306|double blind|double blind
1282920|NCT01658306|RIPC|ripc
1282921|NCT01658293|stroke|stroke
1282922|NCT01658293|follow up|follow up
1282923|NCT01658293|upper limb|upper limb
1282924|NCT01658293|rehabilitation|rehabilitation
1282925|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
1282926|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
1282927|NCT01658280|sensitivity|sensitivity
1282928|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
1282929|NCT01658254|Clinical trials|clinical trials
1282930|NCT01658254|Basic results|basic results
1282931|NCT01658254|Registry|registry
1282932|NCT01658228|Depression|depression
1282933|NCT01658228|Dysthymia|dysthymia
1282934|NCT01658228|Cognitive Impairment|cognitive impairment
1282935|NCT01658228|Cognitive Decline|cognitive decline
1282936|NCT01658228|Memory|memory
1282937|NCT01658215|Smoking cessation|smoking cessation
1282938|NCT01658215|Nicotine|nicotine
1282939|NCT01658215|Tobacco Use Disorder|tobacco use disorder
1282940|NCT01658215|Central Nervous System Agents|central nervous system agents
1282941|NCT01658202|Smoking cessation|smoking cessation
1282942|NCT01658202|Nicotine|nicotine
1282943|NCT01658202|Tobacco Use Disorder|tobacco use disorder
1282944|NCT01658202|Central Nervous System Agents|central nervous system agents
1282945|NCT01658176|Estrogen receptor positive|estrogen receptor positive
1282946|NCT01658176|Her-2 negative|her-2 negative
1333183|NCT01444144|Fracture|fracture
1282947|NCT01658176|advanced breast cancer|advanced breast cancer
1282948|NCT01658176|Breast Cancer|breast cancer
1282949|NCT01658163|abdominoplasty,|abdominoplasty,
1282950|NCT01658163|skin closure, dressings|skin closure, dressings
1282951|NCT01658150|Cognition|cognition
1282952|NCT01658150|Schizophrenia|schizophrenia
1282953|NCT01658150|Schizoaffective disorder|schizoaffective disorder
1282954|NCT01658137|diet|diet
1282955|NCT01658137|dietary pattern|dietary pattern
1282956|NCT01658137|gene|gene
1282957|NCT01658137|gene expression|gene expression
1282958|NCT01658137|epigenomics|epigenomics
1282959|NCT01658137|diet-gene interaction|diet-gene interaction
1282960|NCT01658137|inflammation|inflammation
1282961|NCT01658137|9p21|9p21
1282962|NCT01658137|fruits|fruits
1282963|NCT01658137|vegetables|vegetables
1282964|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
1282965|NCT01658111|Stroke|stroke
1282966|NCT01658111|Robots|robots
1282967|NCT01658111|EEG|eeg
1282968|NCT01658111|EMG|emg
1282969|NCT01658098|postpartum|postpartum
1282970|NCT01658098|depression|depression
1282971|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
1282972|NCT01658098|mexican population|mexican population
1282973|NCT01658085|Thyroidectomy|thyroidectomy
1282974|NCT01658085|Multinodular goiter|multinodular goiter
1282975|NCT01658085|Harmonic Focus|harmonic focus
1282976|NCT01658085|budget impact|budget impact
1282977|NCT01658085|Harmonic scalpel|harmonic scalpel
1282978|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
1282979|NCT01658072|Total Hip Replacement|total hip replacement
1282980|NCT01658046|COPD|copd
1282981|NCT01658046|exercise|exercise
1282982|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1282983|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
1282984|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
1282985|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
1282986|NCT01658020|Acute Exacerbation|acute exacerbation
1282987|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
1282988|NCT01658020|Zabofloxacin|zabofloxacin
1282989|NCT01658020|Moxifloxacin|moxifloxacin
1282990|NCT01657994|cerebral palsy|cerebral palsy
1282991|NCT01657994|gait training|gait training
1282992|NCT01657994|robotic|robotic
1282993|NCT01657994|functional electrical stimulation|functional electrical stimulation
1282994|NCT01657981|Pharmacokinetics|pharmacokinetics
1282995|NCT01657981|Phase 1|phase 1
1282996|NCT01657981|14C-labeled|14c-labeled
1282997|NCT01657968|Acute tonsillitis|acute tonsillitis
1282998|NCT01657968|Procalcitonin|procalcitonin
1282999|NCT01657968|Streptococcal antigen test|streptococcal antigen test
1283000|NCT01657968|Centor Criteria|centor criteria
1283001|NCT01657968|Infection marker|infection marker
1283002|NCT01657942|MRgFUS|mrgfus
1283003|NCT01657942|Prostate|prostate
1283004|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
1283005|NCT01657942|Focal Prostate treatment|focal prostate treatment
1283006|NCT01657942|InSightec|insightec
1283007|NCT01657942|ExAblate|exablate
1283008|NCT01657942|Non-invasive|non-invasive
1283009|NCT01657942|Prostate cancer|prostate cancer
1283010|NCT01657942|Gleason 7|gleason 7
1283011|NCT01657929|Influenza|influenza
1283012|NCT01657929|Avian|avian
1283013|NCT01657929|H5N1|h5n1
1283014|NCT01657929|H5-VLP|h5-vlp
1283015|NCT01657929|GLA|gla
1283016|NCT01657929|GLA-AF|gla-af
1283017|NCT01657916|mid-urethral sling|mid-urethral sling
1283018|NCT01657916|Align urethral support system|align urethral support system
1283019|NCT01657916|tension free vaginal tape|tension free vaginal tape
1283020|NCT01657916|cough stress test|cough stress test
1283021|NCT01657916|pelvic exam|pelvic exam
1283022|NCT01657916|PFDI-20|pfdi-20
1283023|NCT01657916|PFIQ|pfiq
1283024|NCT01657916|SSQ|ssq
1283025|NCT01657916|Urinary retention|urinary retention
1283026|NCT01657916|mesh erosion|mesh erosion
1283027|NCT01657916|urodynamics|urodynamics
1283028|NCT01657890|isavuconazole|isavuconazole
1283029|NCT01657890|BAL8557|bal8557
1283030|NCT01657864|Aseptic Meningitis|aseptic meningitis
1283031|NCT01657864|Epidemiology|epidemiology
1283032|NCT01657864|Bipolar Disorder|bipolar disorder
1283033|NCT01657864|Lamotrigine|lamotrigine
1283034|NCT01657864|Epilepsy|epilepsy
1283035|NCT01657838|Isavuconazole|isavuconazole
1283036|NCT01657838|Ketoconazole|ketoconazole
1283037|NCT01657838|Healthy Volunteers|healthy volunteers
1283038|NCT01657838|BAL8557|bal8557
1283039|NCT01657838|BAL4815|bal4815
1283040|NCT01657825|isavuconazole|isavuconazole
1283041|NCT01657825|warfarin|warfarin
1283042|NCT01657825|Healthy Volunteers|healthy volunteers
1283043|NCT01657825|BAL8557|bal8557
1283044|NCT01657825|Coumadin|coumadin
1283045|NCT01657812|dexmedetomidine|dexmedetomidine
1283046|NCT01657812|Epidural Anesthesia|epidural anesthesia
1283047|NCT01657812|stress response|stress response
1283048|NCT01657812|anesthesia recovery|anesthesia recovery
1283049|NCT01657786|ondanstron|ondanstron
1283050|NCT01657786|gene polymorphism|gene polymorphism
1283051|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
1283052|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
1283053|NCT01657760|craving|craving
1283054|NCT01657760|dopamine|dopamine
1283055|NCT01657760|citalopram|citalopram
1283056|NCT01657760|ssri|ssri
1283057|NCT01657747|Ovarian carcinoma|ovarian carcinoma
1283058|NCT01657747|Staging|staging
1283059|NCT01657747|Early treatment follow-up|early treatment follow-up
1283060|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
1283061|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
1283062|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
1283063|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
1283064|NCT01657695|HCC|hcc
1283065|NCT01657695|Computed tomography|computed tomography
1283066|NCT01657695|Gene expression|gene expression
1283067|NCT01657695|Fractional growth|fractional growth
1283068|NCT01657682|FLT3|flt3
1283069|NCT01657682|Crenolanib|crenolanib
1283070|NCT01657682|Acute|acute
1283071|NCT01657682|Myeloid|myeloid
1283073|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
1283074|NCT01657643|Health related quality of life|health related quality of life
1283075|NCT01657643|Functional Status|functional status
1283076|NCT01657630|Insulin Pump Therapy|insulin pump therapy
1283077|NCT01657630|Type 1 Diabetes|type 1 diabetes
1283078|NCT01657630|Treatment Satisfaction|treatment satisfaction
1283079|NCT01657604|CML|cml
1283080|NCT01657604|Tasigna|tasigna
1283081|NCT01657604|Nilotinib|nilotinib
1283082|NCT01657604|Interferon|interferon
1283083|NCT01657591|skin cancer|skin cancer
1283084|NCT01657591|unresectable|unresectable
1283085|NCT01657591|BRAF|braf
1283086|NCT01657578|neonates|neonates
1283087|NCT01657578|reflux disease|reflux disease
1283088|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
1283089|NCT01657565|LOS|los
1283090|NCT01657565|Ileus|ileus
1283091|NCT01657565|Fever|fever
1283092|NCT01657565|reoperation|reoperation
1283093|NCT01657552|Drug interaction|drug interaction
1283094|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
1283095|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
1283096|NCT01657552|Pharmacokinetics|pharmacokinetics
1283097|NCT01657552|Thrombocytopenia|thrombocytopenia
1283098|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
1283099|NCT01657526|Healthy adults|healthy adults
1283100|NCT01657526|Safety|safety
1283101|NCT01657526|Reactogenicity|reactogenicity
1283102|NCT01657526|Immunogenicity|immunogenicity
1283103|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
1283105|NCT01657513|treatment failure|treatment failure
1283106|NCT01657513|tnf-alfa|tnf-alfa
1283107|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
1283108|NCT01657487|COPD|copd
1283109|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
1283110|NCT01657487|high dose|high dose
1283111|NCT01657448|Symptom of Dysuria|symptom of dysuria
1283112|NCT01657435|Total hip replacement|total hip replacement
1283113|NCT01657435|Total hip arthroplasty|total hip arthroplasty
1283114|NCT01657435|Hip joint replacement|hip joint replacement
1283115|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
1283116|NCT01657422|Nutrition|nutrition
1283117|NCT01657422|Physical Activity|physical activity
1283118|NCT01657422|Adolescents|adolescents
1283119|NCT01657409|botulinum toxin|botulinum toxin
1283120|NCT01657409|detrusor overactivity|detrusor overactivity
1283121|NCT01657396|Oral Care|oral care
1283122|NCT01657396|Oral Hygiene|oral hygiene
1283123|NCT01657396|Intensive Care|intensive care
1283124|NCT01657396|Mechanical Ventilation|mechanical ventilation
1283125|NCT01657396|Chlorhexidine|chlorhexidine
1283126|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
1283127|NCT01657331|Hodgkin Disease|hodgkin disease
1283128|NCT01657331|Hodgkin's Disease|hodgkin's disease
1283129|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1283130|NCT01657331|ALCL|alcl
1283131|NCT01657331|SGN+Benda|sgn+benda
1283132|NCT01657331|Bendamustine|bendamustine
1283133|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
1283134|NCT01657318|diabetic foot|diabetic foot
1283135|NCT01657318|leg ulcer|leg ulcer
1283136|NCT01657305|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
1283137|NCT01657305|Split-thickness skin graft|split-thickness skin graft
1283138|NCT01657305|STSG|stsg
1283139|NCT01657305|Wound healing|wound healing
1283140|NCT01657305|Skin grafting|skin grafting
1283141|NCT01657305|Superficial wound|superficial wound
1283142|NCT01657305|Partial-thickness wound|partial-thickness wound
1283143|NCT01657305|Time to wound closure|time to wound closure
1283144|NCT01657292|Wound healing|wound healing
1283145|NCT01657292|Burn wound|burn wound
1283146|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
1283147|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
1283148|NCT01657292|Time to wound closure|time to wound closure
1283149|NCT01657279|stroke|stroke
1283150|NCT01657279|risk score|risk score
1283151|NCT01657279|iScore|iscore
1283152|NCT01657279|outcomes|outcomes
1283153|NCT01657279|mortality|mortality
1283154|NCT01657279|disability|disability
1283155|NCT01657279|institutionalization|institutionalization
1283156|NCT01657227|diabetes|diabetes
1283157|NCT01657227|self-management|self-management
1283158|NCT01657227|lifestyle|lifestyle
1283159|NCT01657227|diet|diet
1283160|NCT01657227|physical exercise|physical exercise
1283161|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
1283162|NCT01657188|Heart failure, congestive|heart failure, congestive
1283163|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
1283164|NCT01657188|Adaptive servoventilation|adaptive servoventilation
1283165|NCT01657188|Prognosis|prognosis
1283166|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
1283167|NCT01657175|Cancer|cancer
1283168|NCT01657175|long-term follow-up|long-term follow-up
1283169|NCT01657175|quality of life|quality of life
1283170|NCT01657175|Surgery|surgery
1283171|NCT01657175|Nursing|nursing
1283172|NCT01657162|BA058|ba058
1283173|NCT01657162|Abaloparatide-SC|abaloparatide-sc
1283174|NCT01657162|abaloparatide|abaloparatide
1283175|NCT01657162|ACTIVExtend|activextend
1283176|NCT01657162|osteoporosis|osteoporosis
1283177|NCT01657162|fracture|fracture
1283178|NCT01657162|bone loss|bone loss
1283179|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
1283180|NCT01657136|ivabradine|ivabradine
1283181|NCT01657136|beta blockers|beta blockers
1283182|NCT01657123|exercise capacity|exercise capacity
1283183|NCT01657123|Addison's disease|addison's disease
1283184|NCT01657110|acne|acne
1283185|NCT01657110|inflamed lesions|inflamed lesions
1283186|NCT01657110|non-inflamed lesions|non-inflamed lesions
1283187|NCT01657110|complementary medicine|complementary medicine
1283188|NCT01657110|essential oil|essential oil
1283189|NCT01657058|soluble fiber|soluble fiber
1283190|NCT01657058|second meal effect|second meal effect
1283191|NCT01657058|glycemia|glycemia
1283192|NCT01657058|satiety|satiety
1283193|NCT01657058|Individuals|individuals
1283194|NCT01657045|Cicatrix|cicatrix
1283195|NCT01657045|Wound healing|wound healing
1283196|NCT01657032|diarrhea|diarrhea
1283197|NCT01657032|probiotics|probiotics
1283198|NCT01657032|diosmectite|diosmectite
1283199|NCT01657006|Heart rate variability|heart rate variability
1283200|NCT01657006|ischemic heart disease|ischemic heart disease
1283201|NCT01657006|myocardial ischemia|myocardial ischemia
1283202|NCT01656993|Aspirin|aspirin
1283203|NCT01656993|ASA|asa
1283204|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
1283205|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
1283206|NCT01656993|shunt|shunt
1283207|NCT01656993|TEG|teg
1283217|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
1283218|NCT01656967|Blind Intubation|blind intubation
1283219|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
1283220|NCT01656954|stroke volume|stroke volume
1283221|NCT01656954|cardiac output|cardiac output
1283222|NCT01656954|pulse pressure variance|pulse pressure variance
1283223|NCT01656954|stroke volume variance|stroke volume variance
1283224|NCT01656954|passive leg raise|passive leg raise
1283225|NCT01656954|fluid challenge|fluid challenge
1283226|NCT01656954|central venous pressure|central venous pressure
1283233|NCT01656915|inflammation|inflammation
1283234|NCT01656915|response|response
1283235|NCT01656915|resilience|resilience
1283236|NCT01656915|cytokines|cytokines
1283237|NCT01656915|pre-diabetes|pre-diabetes
1283238|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
1283239|NCT01656902|NOVOCART 3D plus|novocart 3d plus
1283240|NCT01656902|knee joint pain|knee joint pain
1283241|NCT01656902|safety|safety
1283242|NCT01656902|efficacy|efficacy
1283243|NCT01656902|treatment|treatment
1283244|NCT01656902|TETEC|tetec
1283245|NCT01656902|cartilage|cartilage
1283246|NCT01656902|ACT|act
1283247|NCT01656902|cartilage repair|cartilage repair
1283248|NCT01656902|tissue|tissue
1283249|NCT01656902|MOCART|mocart
1283250|NCT01656889|Venous leg ulcer|venous leg ulcer
1283251|NCT01656889|ulcer|ulcer
1283252|NCT01656889|venous stasis|venous stasis
1283253|NCT01656889|compression|compression
1283254|NCT01656889|venous|venous
1283255|NCT01656889|venous stasis ulcer|venous stasis ulcer
1283256|NCT01656889|vlu|vlu
1283257|NCT01656876|Comparative effectiveness research|comparative effectiveness research
1283258|NCT01656876|Mirror therapy|mirror therapy
1283259|NCT01656876|Stroke rehabilitation|stroke rehabilitation
1283260|NCT01656876|Clinical evaluation|clinical evaluation
1283261|NCT01656876|Kinematic analysis|kinematic analysis
1283262|NCT01656876|Mesh glove|mesh glove
1283263|NCT01656876|Combined therapy|combined therapy
1283264|NCT01656863|Dehydration|dehydration
1283265|NCT01656850|hyperglycemia|hyperglycemia
1283266|NCT01656850|hyperinsulinemia|hyperinsulinemia
1283267|NCT01656837|Substance Abuse|substance abuse
1283268|NCT01656837|Child Maltreatment|child maltreatment
1283269|NCT01656837|Multisystemic Therapy|multisystemic therapy
1283270|NCT01656837|Child Trauma|child trauma
1283271|NCT01656824|Bv8/PK-2|bv8/pk-2
1283272|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
1283273|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
1283274|NCT01656824|Angiogenesis|angiogenesis
1283275|NCT01656824|Pancreatic Cancer|pancreatic cancer
1283276|NCT01656785|stroke|stroke
1283277|NCT01656785|cerebrovascular disease|cerebrovascular disease
1283278|NCT01656785|angiogenesis imaging|angiogenesis imaging
1283279|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
1283280|NCT01656785|PET/CT|pet/ct
1283281|NCT01656772|magnetic navigation|magnetic navigation
1283282|NCT01656772|robotic control|robotic control
1283283|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
1283284|NCT01656759|Blood Loss|blood loss
1283285|NCT01656759|Hemoglobin|hemoglobin
1283286|NCT01656759|Hematocrit|hematocrit
1283287|NCT01656759|Blood Transfusions|blood transfusions
1283288|NCT01656746|Colorectal Disease|colorectal disease
1283289|NCT01656746|SILS|sils
1283290|NCT01656746|colorectal surgery|colorectal surgery
1283291|NCT01656733|Smoking Cessation|smoking cessation
1283292|NCT01656733|Pregnancy|pregnancy
1283293|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
1283294|NCT01656733|Placebo Inhaler|placebo inhaler
1283295|NCT01656733|Nicotine Inhaler|nicotine inhaler
1283296|NCT01656720|Faecal Incontinence|faecal incontinence
1283297|NCT01656720|Suppository|suppository
1283298|NCT01656720|Wexner score|wexner score
1283299|NCT01656707|Adolescents|adolescents
1283300|NCT01656707|Substance Use Disorders|substance use disorders
1283301|NCT01656694|Osteoarthritis|osteoarthritis
1283302|NCT01656694|Knee|knee
1283303|NCT01656694|Replacement|replacement
1283304|NCT01656694|Unicompartmental|unicompartmental
1283305|NCT01656694|DePuy|depuy
1283306|NCT01656694|Sigma HP|sigma hp
1283307|NCT01656668|Chronic|chronic
1283308|NCT01656668|Acute|acute
1283309|NCT01656668|Persistent|persistent
1283310|NCT01656668|Longterm|longterm
1283311|NCT01656668|Cough|cough
1283312|NCT01656655|ptsd, parenting|ptsd, parenting
1283315|NCT01656642|PDL1|pdl1
1283316|NCT01656642|antiPD-L1|antipd-l1
1283317|NCT01656642|MPDL3280A|mpdl3280a
1283318|NCT01656642|Melanoma|melanoma
1283319|NCT01656642|BRAF|braf
1283320|NCT01656642|MPDL320A|mpdl320a
1283321|NCT01656616|Pharmacoeconomics|pharmacoeconomics
1283322|NCT01656616|Cost effectiveness|cost effectiveness
1283323|NCT01656616|Cyanide|cyanide
1283324|NCT01656616|Fire|fire
1283325|NCT01656616|Emergency Medical Services|emergency medical services
1283326|NCT01656616|Smoke Inhalation|smoke inhalation
1283327|NCT01656603|cord blood|cord blood
1283328|NCT01656603|transplantation|transplantation
1283329|NCT01656603|stem cells|stem cells
1283330|NCT01656603|adverse event|adverse event
1283331|NCT01656590|Pompe disease|pompe disease
1283332|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
1283333|NCT01656577|CRF1 antagonist|crf1 antagonist
1283334|NCT01656577|Stress|stress
1283335|NCT01656577|Eating Behavior|eating behavior
1283336|NCT01656577|Food Craving|food craving
1283337|NCT01656564|HIV|hiv
1283338|NCT01656564|Pediatric|pediatric
1283339|NCT01656564|ART|art
1283340|NCT01656564|Longitudinal|longitudinal
1283341|NCT01656564|Outcomes|outcomes
1283342|NCT01656551|elderly|elderly
1283343|NCT01656551|chemotherapy|chemotherapy
1283344|NCT01656512|ALL|all
1283345|NCT01656512|zoledronic acid|zoledronic acid
1283346|NCT01656512|Osteoporosis|osteoporosis
1283347|NCT01656486|Pancreas|pancreas
1283348|NCT01656486|Pancreatic fistula|pancreatic fistula
1283349|NCT01656486|Stereotactic radiation|stereotactic radiation
1283350|NCT01656473|Concurrent Disorders|concurrent disorders
1283351|NCT01656473|Adolescents|adolescents
1283352|NCT01656473|Motivational Interviewing|motivational interviewing
1283353|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
1283354|NCT01656473|Caregiver Burden|caregiver burden
1283355|NCT01656460|Lung Cancer|lung cancer
1283356|NCT01656447|Scleroderma|scleroderma
1283357|NCT01656447|Scleroderma Registry|scleroderma registry
1283358|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
1283359|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
1283360|NCT01656382|ABLC|ablc
1283361|NCT01656382|cryptococcosis|cryptococcosis
1283362|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
1283363|NCT01656356|Avian Flu|avian flu
1283364|NCT01656356|H5N2|h5n2
1283365|NCT01656330|Healthy|healthy
1283366|NCT01656330|Rivaroxaban|rivaroxaban
1283367|NCT01656330|JNJ-39039039|jnj-39039039
1283368|NCT01656330|BAY59-7939|bay59-7939
1283369|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
1283370|NCT01656317|SAH|sah
1283371|NCT01656317|Early rehabilitation|early rehabilitation
1283372|NCT01656317|Mobilisation|mobilisation
1283373|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
1283374|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
1283375|NCT01656278|Disease Progression|disease progression
1333184|NCT01444144|Elderly|elderly
1283376|NCT01656278|Longitudinal Studies|longitudinal studies
1283377|NCT01656278|Prospective Studies|prospective studies
1283378|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
1283379|NCT01656278|Remission Induction|remission induction
1283380|NCT01656278|Synovitis/immunology|synovitis/immunology
1283381|NCT01656278|Synovitis/pathology|synovitis/pathology
1283382|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
1283383|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
1283384|NCT01656252|Acute Leukemia|acute leukemia
1283385|NCT01656252|Complete Remission|complete remission
1283386|NCT01656252|Consolidation|consolidation
1283387|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
1283388|NCT01656252|Cytarabine|cytarabine
1283389|NCT01656252|Eltrombopag|eltrombopag
1283390|NCT01656252|Leukemia|leukemia
1283391|NCT01656252|Thrombocytopenia|thrombocytopenia
1283392|NCT01656252|Thrombopoietin|thrombopoietin
1283393|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
1283394|NCT01656226|Actinic Keratosis|actinic keratosis
1283395|NCT01656226|AK|ak
1283396|NCT01656213|Stroke|stroke
1283397|NCT01656213|End Stage Renal Disease|end stage renal disease
1283398|NCT01656213|Recovery|recovery
1283399|NCT01656213|Haemodialysis|haemodialysis
1283400|NCT01656200|Japanese encephalitis|japanese encephalitis
1283401|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
1283402|NCT01656200|T lymphocyte|t lymphocyte
1283403|NCT01656200|Immune response|immune response
1283404|NCT01656187|memantine|memantine
1283405|NCT01656187|cognition|cognition
1283406|NCT01656187|corticosteroid|corticosteroid
1283407|NCT01656187|prednisone|prednisone
1283408|NCT01656187|memory|memory
1283409|NCT01656187|hippocampus|hippocampus
1283410|NCT01656148|Multiple sclerosis|multiple sclerosis
1283411|NCT01656148|Walking disablility|walking disablility
1283412|NCT01656148|Mobility|mobility
1283413|NCT01656148|Six Spot Step Test|six spot step test
1283414|NCT01656148|Outcome measures|outcome measures
1283415|NCT01656148|Fampridine-SR|fampridine-sr
1283416|NCT01656148|Fampyra|fampyra
1283417|NCT01656135|gold standard treatment|gold standard treatment
1283418|NCT01656135|immune monitoring|immune monitoring
1283419|NCT01656135|acute rejection|acute rejection
1283420|NCT01656135|graft rejection|graft rejection
1283421|NCT01656135|living-donor|living-donor
1283422|NCT01656135|renal transplantation|renal transplantation
1283423|NCT01656135|kidney transplantation|kidney transplantation
1283424|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
1283425|NCT01656122|abacavir|abacavir
1283426|NCT01656122|lamuvidine|lamuvidine
1283427|NCT01656122|HIV-infected children|hiv-infected children
1283428|NCT01656109|pharmacokinetics|pharmacokinetics
1283429|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
1283430|NCT01656109|HIV-infected children|hiv-infected children
1283431|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
1283432|NCT01656083|Varenicline|varenicline
1283433|NCT01656083|The compliance|the compliance
1283434|NCT01656083|The abstinence rate|the abstinence rate
1283435|NCT01656070|HIV|hiv
1283436|NCT01656070|children|children
1283437|NCT01656070|adolescents|adolescents
1283438|NCT01656070|Vitamin D|vitamin d
1283439|NCT01656070|immunity|immunity
1283440|NCT01656070|T cell phenotype|t cell phenotype
1283441|NCT01656057|Bile acids|bile acids
1283442|NCT01656057|Gall bladder emptying|gall bladder emptying
1283443|NCT01656057|Human|human
1283444|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
1283445|NCT01656057|GLP-1|glp-1
1283446|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1283447|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1283448|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1283449|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1283450|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1283451|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1283452|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
1283453|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1283454|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1283455|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1283456|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1283457|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1283458|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1283459|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1283460|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1283461|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1283462|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1381855|NCT01241214|SAR|sar
1283463|NCT01656018|Healthy|healthy
1283464|NCT01656018|TMC278|tmc278
1283465|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
1283466|NCT01656018|HIV-1|hiv-1
1283467|NCT01656018|Pharmacokinetics|pharmacokinetics
1283468|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
1283469|NCT01656005|COPD|copd
1283470|NCT01656005|Beta blockers|beta blockers
1283471|NCT01656005|Cardioselective|cardioselective
1283472|NCT01656005|Non-cardioselective|non-cardioselective
1283473|NCT01656005|Impulse oscillometry|impulse oscillometry
1283474|NCT01655992|capecitabine|capecitabine
1283475|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
1283476|NCT01655966|chronic hepatitis c|chronic hepatitis c
1283477|NCT01655966|hcv|hcv
1283478|NCT01655966|vitamin d|vitamin d
1283479|NCT01655927|Neoplasms|neoplasms
1283480|NCT01655927|Tranexamic Acid|tranexamic acid
1283481|NCT01655927|Brain Tumors|brain tumors
1283482|NCT01655901|Active video games|active video games
1283483|NCT01655901|Food intake|food intake
1283484|NCT01655901|Energy balance|energy balance
1283485|NCT01655901|Adolescents|adolescents
1283486|NCT01655888|Tremelimumab|tremelimumab
1283487|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
1283488|NCT01655888|malignant mesothelioma|malignant mesothelioma
1283489|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
1283490|NCT01655823|Pain|pain
1283491|NCT01655823|Puffer fish|puffer fish
1283492|NCT01655823|Tetrodotoxin|tetrodotoxin
1283493|NCT01655823|TTX|ttx
1283494|NCT01655823|Neuropathy|neuropathy
1283495|NCT01655823|Chemotherapy|chemotherapy
1283496|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
1283497|NCT01655797|insomnia|insomnia
1283498|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
1283499|NCT01655797|primary care|primary care
1283500|NCT01655784|aneurysm|aneurysm
1283501|NCT01655784|intracranial aneurysm|intracranial aneurysm
1283502|NCT01655784|cerebral aneurysm|cerebral aneurysm
1283503|NCT01655784|intracranial embolization|intracranial embolization
1283504|NCT01655784|aneurysm embolization|aneurysm embolization
1283505|NCT01655784|intracranial coil|intracranial coil
1283506|NCT01655784|eighteen coils|eighteen coils
1283507|NCT01655784|bare platinum coils|bare platinum coils
1283508|NCT01655784|GDC Coil|gdc coil
1283509|NCT01655784|Target Coil|target coil
1283510|NCT01655771|Opioid induced constipation|opioid induced constipation
1283511|NCT01655771|Constipation|constipation
1283512|NCT01655758|glaucoma|glaucoma
1283513|NCT01655758|24-hour IOP|24-hour iop
1283514|NCT01655758|outflow drugs|outflow drugs
1283515|NCT01655758|inflow drugs|inflow drugs
1283516|NCT01655745|[18F]|[18f]
1283517|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
1283518|NCT01655745|FDG-PET-MRI|fdg-pet-mri
1283519|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
1283520|NCT01655745|Pilot Study|pilot study
1283521|NCT01655745|LCCC 1209|lccc 1209
1283522|NCT01655745|UNC Lineberger|unc lineberger
1283523|NCT01655745|MDCT|mdct
1283524|NCT01655732|Pregnancy|pregnancy
1283525|NCT01655706|major depression|major depression
1283526|NCT01655706|major depressive disorder|major depressive disorder
1283527|NCT01655706|biomarkers|biomarkers
1283528|NCT01655706|escitalopram|escitalopram
1283529|NCT01655706|aripiprazole|aripiprazole
1283530|NCT01655706|MDD|mdd
1283531|NCT01655706|neuroimaging|neuroimaging
1283532|NCT01655706|proteomic|proteomic
1283533|NCT01655706|genomics|genomics
1283534|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
1283535|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
1283536|NCT01655680|Schizophrenia|schizophrenia
1283537|NCT01655667|Diagnosis|diagnosis
1283538|NCT01655667|Primary Care|primary care
1283539|NCT01655667|Comorbidities|comorbidities
1283540|NCT01655667|Healthcare utilisation|healthcare utilisation
1283541|NCT01655654|Hypertension|hypertension
1283542|NCT01655654|Acute hospital staff|acute hospital staff
1283543|NCT01655654|Exercise|exercise
1283544|NCT01655654|Diet|diet
1283545|NCT01655641|Blood transfusion|blood transfusion
1283546|NCT01655641|Bleeding|bleeding
1283547|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
1283548|NCT01655641|Tranexamic Acid|tranexamic acid
1283549|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1283550|NCT01655628|metastasis|metastasis
1283551|NCT01655628|gemcitabine|gemcitabine
1283552|NCT01655628|CIK cells|cik cells
1283553|NCT01655615|Adolescent cognitive development|adolescent cognitive development
1283554|NCT01655615|mental disorders|mental disorders
1283555|NCT01655615|Mood disorders|mood disorders
1283556|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
1283557|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
1283558|NCT01655615|Substance related disorders|substance related disorders
1283559|NCT01655602|Trichophytic closure|trichophytic closure
1381971|NCT01240694|SLE|sle
1283560|NCT01655602|hair transplantation|hair transplantation
1283561|NCT01655602|donor site|donor site
1283562|NCT01655602|Androgenetic alopecia|androgenetic alopecia
1283563|NCT01655576|drainage|drainage
1283564|NCT01655576|pregnancy|pregnancy
1283565|NCT01655576|active management|active management
1283566|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
1283567|NCT01655563|Transplant|transplant
1283568|NCT01655563|Pediatrics|pediatrics
1283569|NCT01655563|Tacrolimus|tacrolimus
1283570|NCT01655563|Prograf|prograf
1283571|NCT01655537|fibromyalgia|fibromyalgia
1283572|NCT01655537|cognitive dysfunction|cognitive dysfunction
1283573|NCT01655524|Regadenoson|regadenoson
1283574|NCT01655524|Aminophylline|aminophylline
1283575|NCT01655524|ASSUAGE|assuage
1283576|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
1283577|NCT01655511|Pharmacokinetic|pharmacokinetic
1283578|NCT01655511|pharmacodynamic|pharmacodynamic
1283579|NCT01655498|fecal incontinence|fecal incontinence
1283580|NCT01655498|bowel control|bowel control
1283581|NCT01655485|child anxiety|child anxiety
1283582|NCT01655485|challenging behaviors|challenging behaviors
1283583|NCT01655485|time|time
1283584|NCT01655485|Parent anxiety|parent anxiety
1283585|NCT01655472|schizophrenia|schizophrenia
1283586|NCT01655472|imaging|imaging
1283587|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
1283588|NCT01655446|Comparative effectiveness research|comparative effectiveness research
1283589|NCT01655446|Robotic rehabilitation|robotic rehabilitation
1283590|NCT01655446|Mirror therapy|mirror therapy
1283591|NCT01655446|Functional electrical therapy|functional electrical therapy
1283592|NCT01655446|Combined therapy|combined therapy
1283593|NCT01655446|Stroke rehabilitation|stroke rehabilitation
1283594|NCT01655446|Translational science|translational science
1283595|NCT01655433|ST-elevation MI|st-elevation mi
1283596|NCT01655433|Hypothermia|hypothermia
1283597|NCT01655420|Myopia|myopia
1283598|NCT01655420|Hyperopia|hyperopia
1283599|NCT01655420|Astigmatism|astigmatism
1283600|NCT01655420|Patient-reported outcomes|patient-reported outcomes
1283601|NCT01655420|Patient satisfaction|patient satisfaction
1283602|NCT01655420|Refractive Error|refractive error
1283603|NCT01655420|Emmetropia|emmetropia
1283604|NCT01655420|Dry eyes|dry eyes
1283605|NCT01655420|Glare|glare
1283606|NCT01655420|Halos|halos
1283607|NCT01655420|Patient expectations|patient expectations
1283608|NCT01655407|Split-thickness Autograft|split-thickness autograft
1283609|NCT01655407|Engraftment|engraftment
1283610|NCT01655407|Wound Closure|wound closure
1283611|NCT01655407|Engineered Skin Substitute|engineered skin substitute
1283612|NCT01655407|ESS-W|ess-w
1283613|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
1283614|NCT01655407|Burn|burn
1283615|NCT01655342|pulpotomy|pulpotomy
1283616|NCT01655342|primary teeth|primary teeth
1283617|NCT01655342|Biodentine®|biodentine®
1283618|NCT01655342|formocresol|formocresol
1283619|NCT01655329|Image Processing|image processing
1283620|NCT01655329|tubes|tubes
1283621|NCT01655329|lines|lines
1283622|NCT01655329|catheters|catheters
1283623|NCT01655329|wires|wires
1283624|NCT01655329|Bedside|bedside
1283625|NCT01655329|chest|chest
1283626|NCT01655329|radiographs|radiographs
1283627|NCT01655264|Stroke|stroke
1283628|NCT01655264|Tele-health|tele-health
1283629|NCT01655264|Rehabilitation|rehabilitation
1283630|NCT01655264|Intervention|intervention
1283631|NCT01655264|Gesture recognition system|gesture recognition system
1283632|NCT01655251|children|children
1283633|NCT01655251|fever|fever
1283634|NCT01655251|emergency department|emergency department
1283635|NCT01655225|Advanced Breast Cancer|advanced breast cancer
1283636|NCT01655225|Advanced Lung Cancer|advanced lung cancer
1283637|NCT01655225|Mesothelioma|mesothelioma
1283638|NCT01655225|Lymphoma|lymphoma
1283639|NCT01655212|Cytomegalovirus|cytomegalovirus
1283640|NCT01655212|Congenital infection|congenital infection
1283641|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
1283642|NCT01655212|Randomized controlled trial|randomized controlled trial
1283643|NCT01655212|Valganciclovir|valganciclovir
1283644|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1283645|NCT01655199|Lung function|lung function
1283646|NCT01655199|Exertional dyspnea|exertional dyspnea
1283647|NCT01655199|Exercise capacity|exercise capacity
1283648|NCT01655199|Pulmonary function|pulmonary function
1283649|NCT01655199|Pleural pressures|pleural pressures
1283650|NCT01655186|Chronic Kidney Disease|chronic kidney disease
1283651|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1283652|NCT01655173|Asperger syndrome|asperger syndrome
1283653|NCT01655173|Autistic disorder|autistic disorder
1283654|NCT01655173|Adult|adult
1283655|NCT01655173|Psychotherapy|psychotherapy
1283656|NCT01655160|Stroke rehabilitation|stroke rehabilitation
1283657|NCT01655160|Mirror therapy|mirror therapy
1283658|NCT01655160|Functional performance|functional performance
1283659|NCT01655160|Kinematic analysis|kinematic analysis
1382115|NCT01240161|FLT|flt
1283660|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
1283661|NCT01655160|Motor recovery|motor recovery
1283662|NCT01655147|Healthy|healthy
1283663|NCT01655147|Pharmacokinetics|pharmacokinetics
1283664|NCT01655147|Abiraterone acetate|abiraterone acetate
1283665|NCT01655147|Abiraterone|abiraterone
1283666|NCT01655147|JNJ-589485|jnj-589485
1283667|NCT01655147|JNJ-212082|jnj-212082
1283668|NCT01655147|Zytiga|zytiga
1283669|NCT01655147|Rifampicin|rifampicin
1283670|NCT01655147|Rifadin|rifadin
1283671|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
1283672|NCT01655134|Heart Failure|heart failure
1283673|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
1283674|NCT01655134|Biomarkers|biomarkers
1283675|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
1283676|NCT01655108|Mesotherapy|mesotherapy
1283677|NCT01655108|Minoxidil|minoxidil
1283678|NCT01655108|Trichogram|trichogram
1283679|NCT01655095|Colon capsule|colon capsule
1283680|NCT01655095|Picosalax|picosalax
1283681|NCT01655095|PEG|peg
1283682|NCT01655095|Prucalopride|prucalopride
1283683|NCT01655082|Smoking cessation|smoking cessation
1283684|NCT01655082|Nicotine|nicotine
1283685|NCT01655082|Tobacco Use Disorder|tobacco use disorder
1283686|NCT01655082|Central Nervous System Agents|central nervous system agents
1283687|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
1283688|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
1283689|NCT01655069|Phase 3|phase 3
1283690|NCT01655069|Pediatric|pediatric
1283691|NCT01655056|Pharmacokinetics|pharmacokinetics
1283692|NCT01655056|Pharmacodynamics|pharmacodynamics
1283693|NCT01655056|Phase 1|phase 1
1283694|NCT01655056|YM150|ym150
1283695|NCT01655056|Dose-escalating|dose-escalating
1283696|NCT01655056|Ethnicity|ethnicity
1283697|NCT01655056|Caucasian|caucasian
1283698|NCT01655056|Japanese|japanese
1283699|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
1283700|NCT01655043|regadenoson|regadenoson
1283701|NCT01655017|Obesity|obesity
1283702|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
1283703|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
1283704|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
1283705|NCT01655017|non invasive device|non invasive device
1283706|NCT01655017|Bariatric surgery|bariatric surgery
1283707|NCT01655004|hormone receptor positive|hormone receptor positive
1283708|NCT01655004|breast cancer|breast cancer
1283710|NCT01654939|hepatitis C|hepatitis c
1283805|NCT01654406|Cesarian scar|cesarian scar
1283711|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
1283712|NCT01654913|hemoglobin determination|hemoglobin determination
1283713|NCT01654913|oxygen|oxygen
1283714|NCT01654887|Comparative Effectiveness|comparative effectiveness
1283715|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
1283716|NCT01654887|Pneumonia|pneumonia
1283717|NCT01654887|Emergency Department|emergency department
1283718|NCT01654848|liver transplantation|liver transplantation
1283719|NCT01654848|thrombocytes|thrombocytes
1283720|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1283721|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
1283722|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
1283723|NCT01654822|HPV|hpv
1283724|NCT01654822|cervix|cervix
1283725|NCT01654796|Depression|depression
1283726|NCT01654796|Treatment Resistant Depression|treatment resistant depression
1283727|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
1283728|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
1283729|NCT01654770|consecutive|consecutive
1283730|NCT01654770|patients|patients
1283731|NCT01654731|PBC|pbc
1283732|NCT01654731|Bezafibrate|bezafibrate
1283733|NCT01654692|metastatic melanoma|metastatic melanoma
1283734|NCT01654692|Ipilimumab|ipilimumab
1283735|NCT01654679|wound infection|wound infection
1283736|NCT01654679|surgery|surgery
1283737|NCT01654679|surgical wound infection rate|surgical wound infection rate
1283738|NCT01654679|wound healing|wound healing
1283739|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
1283740|NCT01654666|Stroke secondary prevention|stroke secondary prevention
1283741|NCT01654666|Carotid artery stenting|carotid artery stenting
1283742|NCT01654666|Carotid stenosis|carotid stenosis
1283743|NCT01654666|Inflammation|inflammation
1283744|NCT01654653|Heart disease|heart disease
1283745|NCT01654653|cardiac surgery|cardiac surgery
1283746|NCT01654653|CABG|cabg
1283747|NCT01654653|Totilac|totilac
1283748|NCT01654653|Voluven|voluven
1283749|NCT01654653|6% HES|6% hes
1283750|NCT01654640|schizophrenia|schizophrenia
1283751|NCT01654640|obesity|obesity
1283752|NCT01654640|clozapine|clozapine
1283753|NCT01654640|metformin|metformin
1283754|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
1283755|NCT01654627|Dental Implants|dental implants
1283756|NCT01654627|Membrane, Synthetic|membrane, synthetic
1283757|NCT01654614|Keratoconus match index|keratoconus match index
1283758|NCT01654614|keratoconus probability index|keratoconus probability index
1283759|NCT01654614|ocular response analyzer|ocular response analyzer
1283760|NCT01654614|Pentacam|pentacam
1283761|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
1283762|NCT01654601|Schizophrenia|schizophrenia
1283763|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
1283764|NCT01654575|Methotrexate|methotrexate
1283765|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
1283766|NCT01654575|Synovitis|synovitis
1283767|NCT01654575|Pain reduction|pain reduction
1283768|NCT01654575|Function scores|function scores
1283769|NCT01654549|Steatohepatitis,|steatohepatitis,
1283770|NCT01654549|Helicobacter pylori,|helicobacter pylori,
1283771|NCT01654549|Insulin resistance,|insulin resistance,
1283772|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
1283773|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
1283774|NCT01654536|PAR|par
1283775|NCT01654523|Trichotillomania|trichotillomania
1283776|NCT01654497|Brain|brain
1283777|NCT01654497|Glioma|glioma
1283778|NCT01654497|glioblastoma|glioblastoma
1283779|NCT01654497|metastases|metastases
1283780|NCT01654497|cancer|cancer
1283781|NCT01654497|ETS2101|ets2101
1283782|NCT01654497|leptomeningeal|leptomeningeal
1283783|NCT01654497|astrocytoma|astrocytoma
1283784|NCT01654497|oligodendroglioma|oligodendroglioma
1283785|NCT01654497|meningioma|meningioma
1283786|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
1283787|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
1283788|NCT01654471|Korean version|korean version
1283789|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
1283790|NCT01654458|Psychotherapy, Group|psychotherapy, group
1283791|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
1283792|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
1283793|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
1283794|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
1283795|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
1283796|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
1283797|NCT01654458|Uterine Neoplasms|uterine neoplasms
1283798|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
1283799|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
1283800|NCT01654445|Minor stroke|minor stroke
1283801|NCT01654419|sliding jig|sliding jig
1283802|NCT01654419|Class II malocclusion|class ii malocclusion
1283803|NCT01654419|Distalization mechanics|distalization mechanics
1283804|NCT01654419|Intermaxillary elastics|intermaxillary elastics
1284809|NCT01649713|influenza|influenza
1283806|NCT01654406|Fractional CO2 laser|fractional co2 laser
1283807|NCT01654393|Triage nurse|triage nurse
1283808|NCT01654393|Ottawa ankle rules|ottawa ankle rules
1283809|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
1283810|NCT01654328|contrast media|contrast media
1283811|NCT01654328|kidney injury|kidney injury
1283812|NCT01654328|hydration|hydration
1283813|NCT01654315|RTP Only Group|rtp only group
1283814|NCT01654315|Myomo Only Group|myomo only group
1283815|NCT01654315|Myom0 + RTP Group|myom0 + rtp group
1283816|NCT01654289|respiratory tract infections|respiratory tract infections
1283817|NCT01654289|common cold|common cold
1283818|NCT01654289|exercise|exercise
1283819|NCT01654289|influenza|influenza
1283820|NCT01654289|meditation|meditation
1283821|NCT01654263|13-valent|13-valent
1283822|NCT01654263|23-valent|23-valent
1283823|NCT01654263|elderly|elderly
1283824|NCT01654263|parent protocol|parent protocol
1283825|NCT01654263|Pneumococcal infections|pneumococcal infections
1283826|NCT01654263|vaccine|vaccine
1283827|NCT01654250|ADHD|adhd
1283828|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
1283829|NCT01654237|work|work
1283830|NCT01654237|WMSD|wmsd
1283831|NCT01654237|prevalence|prevalence
1283832|NCT01654237|occupational risks|occupational risks
1283833|NCT01654237|industry|industry
1283834|NCT01654237|questionnaires|questionnaires
1283835|NCT01654237|musculoskeletal pain|musculoskeletal pain
1283836|NCT01654237|lifestyle|lifestyle
1283837|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
1283838|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
1283839|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
1283840|NCT01654172|Diabetes|diabetes
1283841|NCT01654172|peripheral neuropathy|peripheral neuropathy
1283842|NCT01654172|Cocoa flavanols|cocoa flavanols
1283843|NCT01654159|intraocular lenses|intraocular lenses
1283844|NCT01654159|evaluation|evaluation
1283845|NCT01654159|cataract|cataract
1283846|NCT01654146|Ovarian cancer|ovarian cancer
1283847|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
1283848|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
1283849|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
1283850|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
1283851|NCT01654146|Randomised controlled trial|randomised controlled trial
1283852|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
1283853|NCT01654120|insulin|insulin
1283854|NCT01654120|Type II Diabetes|type ii diabetes
1283855|NCT01654120|liraglutide|liraglutide
1283856|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
1283857|NCT01654107|tobacco|tobacco
1283858|NCT01654107|smoking cessation|smoking cessation
1283859|NCT01654107|nicotine dependence|nicotine dependence
1283860|NCT01654081|Lung Cancer|lung cancer
1283861|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
1283862|NCT01654081|ISG15|isg15
1283863|NCT01654081|IRINOTECAN|irinotecan
1283864|NCT01654068|Female Breast Cancer|female breast cancer
1283865|NCT01654068|Kidney Cancer|kidney cancer
1283866|NCT01654068|Lung Cancer|lung cancer
1283867|NCT01654068|Prostate Cancer|prostate cancer
1283868|NCT01654068|Vertebral metastasis|vertebral metastasis
1283869|NCT01654055|Morphine|morphine
1283870|NCT01654055|Adverse events|adverse events
1283871|NCT01654055|Predictive factors|predictive factors
1283872|NCT01654042|anticoagulation|anticoagulation
1283873|NCT01654042|warfarin|warfarin
1283874|NCT01654042|monitoring|monitoring
1283875|NCT01654042|bleeding|bleeding
1283876|NCT01654042|thromboembolism|thromboembolism
1283877|NCT01654029|Stroke|stroke
1283878|NCT01654029|Communication impairments|communication impairments
1283879|NCT01654029|Nurse-patient communication|nurse-patient communication
1283880|NCT01654029|Patient-centred care|patient-centred care
1283881|NCT01654016|varicose veins|varicose veins
1283882|NCT01654016|inflammation|inflammation
1283883|NCT01654003|Goal-directed therapy|goal-directed therapy
1283884|NCT01654003|severe sepsis|severe sepsis
1283885|NCT01654003|emergency surgery|emergency surgery
1283886|NCT01654003|vasopressor|vasopressor
1283887|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
1283888|NCT01653977|Hypovolemic shock|hypovolemic shock
1283889|NCT01653977|trauma|trauma
1283890|NCT01653977|emergency|emergency
1283891|NCT01653977|surgery|surgery
1283893|NCT01653977|Picco|picco
1283894|NCT01653964|suspicious|suspicious
1283895|NCT01653964|lesion|lesion
1283896|NCT01653964|breast|breast
1283897|NCT01653964|cancer|cancer
1283898|NCT01653964|screening|screening
1283899|NCT01653964|mammogram|mammogram
1283900|NCT01653964|negative|negative
1283901|NCT01653938|CHF|chf
1283902|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
1283903|NCT01653925|Low grade prostate cancer|low grade prostate cancer
1283904|NCT01653912|cancer|cancer
1283905|NCT01653912|ovarian|ovarian
1283906|NCT01653912|platinum-resistant|platinum-resistant
1283907|NCT01653899|Type I Diabetes|type i diabetes
1283908|NCT01653886|Palatability|palatability
1283909|NCT01653886|Taste|taste
1283910|NCT01653873|fracture|fracture
1283911|NCT01653873|vertebral column|vertebral column
1283912|NCT01653873|osteoporosis|osteoporosis
1283913|NCT01653873|predictor|predictor
1283914|NCT01653873|vertebroplasty|vertebroplasty
1283915|NCT01653860|Behavior therapy|behavior therapy
1283916|NCT01653860|Group therapy|group therapy
1283917|NCT01653847|transplant|transplant
1283918|NCT01653847|kidney|kidney
1283919|NCT01653847|renal disease|renal disease
1283920|NCT01653834|lymphopenia|lymphopenia
1283921|NCT01653821|carotid body|carotid body
1283922|NCT01653821|heart failure|heart failure
1283923|NCT01653821|chemoreceptor|chemoreceptor
1283924|NCT01653821|hypersensitivity|hypersensitivity
1283925|NCT01653808|CKD dialysis|ckd dialysis
1283926|NCT01653808|hemodialysis|hemodialysis
1283927|NCT01653808|hemodiafiltration|hemodiafiltration
1283928|NCT01653808|Elisio dialyzer|elisio dialyzer
1283929|NCT01653808|efficacy|efficacy
1283930|NCT01653808|biocompatibility|biocompatibility
1283931|NCT01653782|LPB|lpb
1283932|NCT01653782|RCT|rct
1283933|NCT01653782|Intervention study|intervention study
1283934|NCT01653782|Cost effectiveness|cost effectiveness
1283935|NCT01653782|Yoga|yoga
1283936|NCT01653782|evidence based|evidence based
1283937|NCT01653782|advice to stay active|advice to stay active
1283938|NCT01653782|exercise training|exercise training
1283939|NCT01653769|CoSeal|coseal
1283940|NCT01653769|Surgical bleeding|surgical bleeding
1283941|NCT01653769|hemostasis|hemostasis
1283942|NCT01653769|Aortic anastamoses|aortic anastamoses
1283943|NCT01653769|bleeding|bleeding
1283944|NCT01653769|Cardiac surgery|cardiac surgery
1283945|NCT01653769|Aneurysms|aneurysms
1283946|NCT01653769|Aortic Dissection|aortic dissection
1283947|NCT01653756|Asthma|asthma
1283948|NCT01653756|Allergen Challenge|allergen challenge
1283949|NCT01653743|Japanese|japanese
1283950|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
1283951|NCT01653730|6-minute walk test|6-minute walk test
1283952|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
1283953|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
1283954|NCT01653730|long term oxygen therapy|long term oxygen therapy
1283955|NCT01653717|Advanced Cancers|advanced cancers
1283956|NCT01653717|Leukemia|leukemia
1283957|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1283958|NCT01653717|B-CLL|b-cll
1283959|NCT01653717|CD19 positivity|cd19 positivity
1283960|NCT01653717|CD19-specific T cells|cd19-specific t cells
1283961|NCT01653717|T-Cell Infusion|t-cell infusion
1283962|NCT01653717|Gene Transfer|gene transfer
1283963|NCT01653717|Leukapheresis|leukapheresis
1283964|NCT01653717|Fludarabine|fludarabine
1283965|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
1283966|NCT01653717|Fludara|fludara
1283967|NCT01653717|Cyclophosphamide|cyclophosphamide
1283968|NCT01653717|Cytoxan|cytoxan
1283969|NCT01653717|Neosar|neosar
1283970|NCT01653691|Pediatric|pediatric
1283971|NCT01653691|Burns|burns
1283972|NCT01653691|Scars|scars
1283973|NCT01653691|Pulse Dye laser|pulse dye laser
1283974|NCT01653678|vitamin D-3|vitamin d-3
1283975|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
1283976|NCT01653678|fish oil|fish oil
1283977|NCT01653678|hypertension|hypertension
1283978|NCT01653678|blood pressure|blood pressure
1283979|NCT01653652|grass pollen|grass pollen
1283980|NCT01653652|allergic rhinitis|allergic rhinitis
1283981|NCT01653652|TNSS|tnss
1283982|NCT01653652|miniRQLQ|minirqlq
1283983|NCT01653639|BAY14-2222|bay14-2222
1283984|NCT01653639|Pharmacokinetics|pharmacokinetics
1283985|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1283986|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1283987|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1283988|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1283989|NCT01653600|peripheral arterial disease|peripheral arterial disease
1283990|NCT01653600|atherosclerosis|atherosclerosis
1283991|NCT01653600|nitinol|nitinol
1283992|NCT01653600|stents|stents
1283993|NCT01653587|Transradial Approach|transradial approach
1283994|NCT01653587|Transfemoral Approach|transfemoral approach
1283995|NCT01653587|Vascular Closure Device|vascular closure device
1283996|NCT01653574|Famitinib Malate|famitinib malate
1283997|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
1283998|NCT01653574|HER-2 negative|her-2 negative
1283999|NCT01653561|Metastatic breast cancer|metastatic breast cancer
1284000|NCT01653561|Apatinib|apatinib
1284001|NCT01653561|non-triple-negative|non-triple-negative
1284002|NCT01653548|emotion dysregulation|emotion dysregulation
1284003|NCT01653548|borderline personality disorder|borderline personality disorder
1284004|NCT01653548|anxiety|anxiety
1284005|NCT01653548|depression|depression
1284006|NCT01653548|negative emotions|negative emotions
1284007|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
1284810|NCT01649713|vaccine|vaccine
1284008|NCT01653548|psychological distress|psychological distress
1284009|NCT01653548|emotion regulation problems|emotion regulation problems
1284010|NCT01653535|Prevention|prevention
1284011|NCT01653535|Health Service Use|health service use
1284012|NCT01653535|Behavioral Intervention|behavioral intervention
1284013|NCT01653535|Conduct Problems|conduct problems
1284014|NCT01653535|Anti-Social Behavior|anti-social behavior
1284015|NCT01653509|cold sore|cold sore
1284016|NCT01653496|Gastric cancer|gastric cancer
1284607|NCT01650662|Reperfusion|reperfusion
1284017|NCT01653496|Perioperative care|perioperative care
1284018|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
1284019|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
1284020|NCT01653496|Fast track surgery|fast track surgery
1284021|NCT01653496|Gastrectomy|gastrectomy
1284022|NCT01653483|Asthma|asthma
1284023|NCT01653483|Umeclidinium|umeclidinium
1284024|NCT01653483|Adolescent|adolescent
1284025|NCT01653483|Pharmacokinetics|pharmacokinetics
1284026|NCT01653457|Fibromyalgia|fibromyalgia
1284027|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1284028|NCT01653457|Memantine|memantine
1284029|NCT01653457|electroencephalic cordance|electroencephalic cordance
1284030|NCT01653405|anticoagulants|anticoagulants
1284031|NCT01653405|pharmacists|pharmacists
1284032|NCT01653405|quality improvement|quality improvement
1284033|NCT01653405|quality of health care|quality of health care
1284034|NCT01653392|Maternal Mortality|maternal mortality
1284035|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
1284036|NCT01653392|Eclampsia|eclampsia
1284037|NCT01653392|Pre-Eclampsia|pre-eclampsia
1284038|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
1284039|NCT01653392|Diabetes, Gestational|diabetes, gestational
1284040|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
1284041|NCT01653392|Hydatidiform Mole|hydatidiform mole
1284042|NCT01653392|Fetal death|fetal death
1284043|NCT01653392|Live birth|live birth
1284044|NCT01653392|Still birth|still birth
1284045|NCT01653392|Premature Birth|premature birth
1284046|NCT01653392|Sex ratio|sex ratio
1284047|NCT01653392|Birth weight|birth weight
1284048|NCT01653366|Breast Cancer|breast cancer
1284049|NCT01653353|nursing home|nursing home
1284050|NCT01653353|vitamin D supplements|vitamin d supplements
1284051|NCT01653353|calcium supplements|calcium supplements
1284052|NCT01653353|guideline adherence|guideline adherence
1284053|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
1284054|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
1284055|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
1284056|NCT01653327|mucositis|mucositis
1284057|NCT01653327|head and neck|head and neck
1284058|NCT01653327|cancer|cancer
1284059|NCT01653327|radiation therapy|radiation therapy
1284060|NCT01653327|chemoradiation|chemoradiation
1284061|NCT01653327|oral|oral
1284062|NCT01653327|pain|pain
1284063|NCT01653275|Mediterranean Diet|mediterranean diet
1284064|NCT01653275|Bone turnover|bone turnover
1284065|NCT01653275|postmenopausal women|postmenopausal women
1284066|NCT01653262|Brivaracetam|brivaracetam
1284067|NCT01653262|Levetiracetam|levetiracetam
1284068|NCT01653262|Epilepsy|epilepsy
1284069|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
1284070|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
1284071|NCT01653249|vaccine|vaccine
1284072|NCT01653249|treatment|treatment
1284073|NCT01653210|Insulin Pump|insulin pump
1284074|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
1284075|NCT01653210|Premenopausal women|premenopausal women
1284076|NCT01653184|AMD|amd
1284077|NCT01653184|Vision loss|vision loss
1284078|NCT01653184|omega-3|omega-3
1284079|NCT01653184|supplement|supplement
1284080|NCT01653184|age related macular degeneration|age related macular degeneration
1284081|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
1284082|NCT01653158|non-hematologic cancer|non-hematologic cancer
1284083|NCT01653158|advanced solid tumors|advanced solid tumors
1284084|NCT01653158|prostrate cancer|prostrate cancer
1284085|NCT01653145|Appetite|appetite
1284086|NCT01653145|Satiety|satiety
1284087|NCT01653132|PD|pd
1284088|NCT01653119|Acute coronary syndrome|acute coronary syndrome
1284089|NCT01653119|Diabetes mellitus|diabetes mellitus
1284090|NCT01653119|Statins|statins
1284091|NCT01653119|High loading dose|high loading dose
1284092|NCT01653119|Recurrent events|recurrent events
1284093|NCT01653106|cryotherapy|cryotherapy
1284094|NCT01653106|Melphalan|melphalan
1284095|NCT01653106|Mucositis|mucositis
1284096|NCT01653080|Solid Tumor|solid tumor
1284097|NCT01653080|Eye|eye
1284098|NCT01653080|Orbit|orbit
1284099|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
1284100|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1284101|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
1284102|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
1284103|NCT01653067|NHL|nhl
1284104|NCT01653067|aNHL|anhl
1284105|NCT01653067|Temsirolimus|temsirolimus
1284106|NCT01653067|Torisel|torisel
1284107|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
1284203|NCT01652469|protein signature|protein signature
1284108|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
1284109|NCT01653067|aggressive NHL|aggressive nhl
1284110|NCT01653067|B-NHL|b-nhl
1284111|NCT01653067|aggressive B-NHL|aggressive b-nhl
1284112|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
1284113|NCT01653002|Lung cancer|lung cancer
1284114|NCT01653002|EBUS-TBNA|ebus-tbna
1284115|NCT01653002|Epigenetics|epigenetics
1284116|NCT01653002|shox2 protein, human|shox2 protein, human
1284117|NCT01652989|weight loss|weight loss
1284118|NCT01652989|weight loss maintenance|weight loss maintenance
1284119|NCT01652989|community based participatory research|community based participatory research
1284120|NCT01652989|overweight|overweight
1284121|NCT01652976|Metastatic|metastatic
1284122|NCT01652976|Pancreatic Cancer|pancreatic cancer
1284123|NCT01652976|Adenocarcinoma|adenocarcinoma
1284124|NCT01652950|Physical activity|physical activity
1284125|NCT01652950|health-insured|health-insured
1284126|NCT01652950|Financial Incentives|financial incentives
1284127|NCT01652950|Benefits design|benefits design
1284128|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
1284129|NCT01652937|DMARD-IR|dmard-ir
1284130|NCT01652924|mechanical ventilation|mechanical ventilation
1284131|NCT01652924|manual ventilation|manual ventilation
1284132|NCT01652911|Islet Transplantation|islet transplantation
1284133|NCT01652911|Cell Pouch|cell pouch
1284134|NCT01652898|PK|pk
1284135|NCT01652885|atopic dermatitis|atopic dermatitis
1284136|NCT01652872|anemia|anemia
1284137|NCT01652872|chronic kidney disease|chronic kidney disease
1284138|NCT01652872|kidney disease|kidney disease
1284139|NCT01652872|renal failure|renal failure
1284140|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
1284141|NCT01652820|LUNG|lung
1284142|NCT01652820|DOCETAXEL|docetaxel
1284143|NCT01652820|GEMCITABINE|gemcitabine
1284144|NCT01652820|CARBOPLATIN|carboplatin
1284145|NCT01652820|RADIOTHERAPY|radiotherapy
1284146|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
1284147|NCT01652781|azacitidine|azacitidine
1284148|NCT01652781|dosing schedule|dosing schedule
1284149|NCT01652768|Malignant Brain Tumors|malignant brain tumors
1284150|NCT01652768|Malignant Glioma|malignant glioma
1284151|NCT01652768|High-grade Gliomas|high-grade gliomas
1284152|NCT01652768|Oncology|oncology
1284153|NCT01652768|Cancer|cancer
1284154|NCT01652768|Patient Caregiver|patient caregiver
1284155|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
1284156|NCT01652768|Palliative Care Intervention|palliative care intervention
1284157|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
1284158|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
1284159|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
1284160|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
1284161|NCT01652677|stroke rehabilitation|stroke rehabilitation
1284162|NCT01652651|Learning Disorders|learning disorders
1284163|NCT01652638|subjects|subjects
1284164|NCT01652625|Yunnan Baiyao|yunnan baiyao
1284165|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
1284166|NCT01652625|clinical trial|clinical trial
1284167|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
1284168|NCT01652599|Eltrombopag|eltrombopag
1284169|NCT01652599|Dexamethasone|dexamethasone
1284170|NCT01652599|High-dose|high-dose
1284171|NCT01652599|ITP|itp
1284172|NCT01652586|cardiac ablation|cardiac ablation
1284173|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
1284174|NCT01652573|calcitonin|calcitonin
1284175|NCT01652573|FGF twenty three|fgf twenty three
1284176|NCT01652560|bevacizumab|bevacizumab
1284177|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1284178|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
1284179|NCT01652547|Melanoma|melanoma
1284180|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
1284181|NCT01652547|Metastatic skin cancer|metastatic skin cancer
1284182|NCT01652534|Freezing of gait|freezing of gait
1284183|NCT01652534|gait dysfunction|gait dysfunction
1284184|NCT01652521|lung compliance|lung compliance
1284185|NCT01652521|pleural effusion|pleural effusion
1284186|NCT01652521|esophageal pressure|esophageal pressure
1284187|NCT01652508|smoking cessation|smoking cessation
1284188|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
1284189|NCT01652508|primary care setting|primary care setting
1284190|NCT01652508|randomised controlled trial|randomised controlled trial
1284191|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
1284192|NCT01652495|corticosteroids|corticosteroids
1284193|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
1284194|NCT01652495|methylprednisolone|methylprednisolone
1284195|NCT01652495|triamcinolone|triamcinolone
1284196|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
1284197|NCT01652469|squamous cell|squamous cell
1284198|NCT01652469|NSCLC|nsclc
1284199|NCT01652469|TKI|tki
1284200|NCT01652469|Erlotinib|erlotinib
1284201|NCT01652469|Docetaxel|docetaxel
1284202|NCT01652469|VeriStrat|veristrat
1284204|NCT01652456|addiction support|addiction support
1284205|NCT01652456|addiction specialist|addiction specialist
1284206|NCT01652456|lung cancer|lung cancer
1284207|NCT01652456|head and neck cancer|head and neck cancer
1284208|NCT01652443|OEF/OIF Veterans|oef/oif veterans
1284209|NCT01652443|Relationships|relationships
1284210|NCT01652430|PTSD|ptsd
1284211|NCT01652430|Suicidal ideation|suicidal ideation
1284212|NCT01652430|Cognitive processes|cognitive processes
1284213|NCT01652417|Methylprednisolone|methylprednisolone
1284214|NCT01652417|prednisone|prednisone
1284215|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
1284216|NCT01652404|ICU|icu
1284217|NCT01652404|sepsis|sepsis
1284218|NCT01652404|antibiotic therapy|antibiotic therapy
1284219|NCT01652404|procalcitonin|procalcitonin
1284220|NCT01652378|cocaine addiction|cocaine addiction
1284221|NCT01652378|neuroimaging|neuroimaging
1284222|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1284223|NCT01652365|Malaria Diagnosis|malaria diagnosis
1284224|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
1284225|NCT01652365|RDTs|rdts
1284226|NCT01652365|Private Sector|private sector
1284227|NCT01652365|Retail Sector|retail sector
1284228|NCT01652365|Drug Shops|drug shops
1284229|NCT01652352|Disabled|disabled
1284230|NCT01652352|Disability|disability
1284231|NCT01652352|Power wheelchair|power wheelchair
1284232|NCT01652352|Wheelchair|wheelchair
1284233|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
1284234|NCT01652352|WMRA|wmra
1284235|NCT01652352|Assistive|assistive
1284236|NCT01652352|Assistive robot|assistive robot
1284237|NCT01652352|Assistive robotics|assistive robotics
1284238|NCT01652352|Rehabilitation robot|rehabilitation robot
1284239|NCT01652352|Rehabilitation engineering|rehabilitation engineering
1284240|NCT01652352|Rehabilitation robotics|rehabilitation robotics
1284241|NCT01652300|Oral health|oral health
1284242|NCT01652300|education|education
1284243|NCT01652300|knowledge|knowledge
1284244|NCT01652300|attitude|attitude
1284245|NCT01652300|performance|performance
1284246|NCT01652274|Child Passenger Safety|child passenger safety
1284247|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
1284248|NCT01652274|Neonatology|neonatology
1284249|NCT01652274|Newborn|newborn
1284250|NCT01652261|advanced stage|advanced stage
1284251|NCT01652248|Heart failure|heart failure
1284252|NCT01652248|Pacemaker|pacemaker
1284253|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
1284254|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
1284255|NCT01652235|Endovascular|endovascular
1284256|NCT01652235|Fenestration|fenestration
1284257|NCT01652235|Juxtarenal|juxtarenal
1284258|NCT01652235|Off-the-shelf|off-the-shelf
1284259|NCT01652235|Pararenal|pararenal
1284260|NCT01652222|Alzheimer|alzheimer
1284261|NCT01652222|caregiver|caregiver
1284262|NCT01652222|dementia|dementia
1284263|NCT01652222|social support|social support
1284264|NCT01652222|Montessori|montessori
1284265|NCT01652222|Therapeutic game|therapeutic game
1284266|NCT01652196|colorectal cancer|colorectal cancer
1284267|NCT01652196|rectal cancer|rectal cancer
1284268|NCT01652196|FOLFOX|folfox
1284269|NCT01652196|Aflibercept|aflibercept
1284270|NCT01652183|Intravenous paracetamol|intravenous paracetamol
1284271|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
1284272|NCT01652183|urologic surgery|urologic surgery
1284273|NCT01652157|prospective|prospective
1284274|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
1284275|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
1284276|NCT01652157|observational|observational
1284277|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
1284278|NCT01652131|general anesthesia|general anesthesia
1284279|NCT01652131|volume kinetics|volume kinetics
1284280|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1284281|NCT01652118|clarithromycin|clarithromycin
1284282|NCT01652118|preterm babies|preterm babies
1284283|NCT01652105|Gastric bypass|gastric bypass
1284284|NCT01652105|Preoperative diet|preoperative diet
1284285|NCT01652105|Prodimed|prodimed
1284286|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
1284287|NCT01652092|histiocytic disorder|histiocytic disorder
1284288|NCT01652079|Epithelial|epithelial
1284289|NCT01652079|Primary|primary
1284290|NCT01652053|InterCushion|intercushion
1284291|NCT01652040|Spinal Cord Injury|spinal cord injury
1284292|NCT01652040|Rehabilitation|rehabilitation
1284293|NCT01652040|Electrical Stimulation|electrical stimulation
1284294|NCT01652040|Testosterone|testosterone
1284295|NCT01652040|Body Composition|body composition
1284296|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
1284297|NCT01652040|Ectopic Adiposity|ectopic adiposity
1284298|NCT01652027|FVIII inhibitors|fviii inhibitors
1284299|NCT01652014|Transplantation|transplantation
1284300|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1284301|NCT01652001|Xerostomia|xerostomia
1284302|NCT01652001|Antidepressant agents|antidepressant agents
1284303|NCT01652001|Antihypertensive agents|antihypertensive agents
1284304|NCT01651988|ketamine|ketamine
1284305|NCT01651988|propofol anesthesia|propofol anesthesia
1284306|NCT01651975|Dysphagia|dysphagia
1284307|NCT01651975|Thickening liquid|thickening liquid
1284308|NCT01651975|Thickening agent|thickening agent
1284309|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
1284310|NCT01651975|Aspiration|aspiration
1284311|NCT01651975|History of dysphagia|history of dysphagia
1284312|NCT01651975|DSS|dss
1284313|NCT01651975|Age > 18|age > 18
1284314|NCT01651975|comprehensive DSS|comprehensive dss
1284315|NCT01651975|informed consent|informed consent
1284316|NCT01651962|Labor Pain|labor pain
1284317|NCT01651962|Analgesia, Epidural|analgesia, epidural
1284318|NCT01651923|subjects|subjects
1284319|NCT01651910|Cancer Pain|cancer pain
1284320|NCT01651910|Breakthrough Pain|breakthrough pain
1284321|NCT01651910|Unmet Needs|unmet needs
1284322|NCT01651910|Supportive care needs|supportive care needs
1284323|NCT01651897|delirium|delirium
1284324|NCT01651897|emergency department|emergency department
1284325|NCT01651897|natural course|natural course
1284326|NCT01651897|outcomes|outcomes
1284327|NCT01651897|elderly|elderly
1284328|NCT01651884|Stroke|stroke
1284329|NCT01651884|Anomia|anomia
1284330|NCT01651871|Agents, anti allergic|agents, anti allergic
1284331|NCT01651871|Nasal congestion|nasal congestion
1284332|NCT01651871|Sneezing|sneezing
1284333|NCT01651871|Nasal discharge|nasal discharge
1284334|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
1284335|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
1284336|NCT01651832|Health Services Accessibility|health services accessibility
1284337|NCT01651832|Humans|humans
1284338|NCT01651832|Supportive Care Needs|supportive care needs
1284339|NCT01651832|Psychooncology|psychooncology
1284340|NCT01651832|Rural Population|rural population
1284341|NCT01651832|Primary Health Care/*methods|primary health care/*methods
1284342|NCT01651832|Treatment Outcome|treatment outcome
1284343|NCT01651832|Socioeconomic Factors|socioeconomic factors
1284344|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
1284345|NCT01651832|Quality of Life|quality of life
1284346|NCT01651832|Adult|adult
1284347|NCT01651832|Aged|aged
1284348|NCT01651832|Aged, 80 and over|aged, 80 and over
1284349|NCT01651819|HTLV-1|htlv-1
1284350|NCT01651819|neurogenic bladder|neurogenic bladder
1284351|NCT01651819|physical therapy|physical therapy
1284352|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
1284353|NCT01651806|Blood loss|blood loss
1284354|NCT01651806|transfusion rates|transfusion rates
1284355|NCT01651806|complications|complications
1284356|NCT01651793|cacao|cacao
1284357|NCT01651793|theobromine|theobromine
1284358|NCT01651793|flavanols|flavanols
1284359|NCT01651793|caffeine|caffeine
1284360|NCT01651793|sustained attention|sustained attention
1284361|NCT01651793|vigilance|vigilance
1284362|NCT01651793|vigor|vigor
1284363|NCT01651793|vitality|vitality
1284364|NCT01651793|energy|energy
1284365|NCT01651793|fatigue|fatigue
1284366|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
1284367|NCT01651780|Aortic valve replacement|aortic valve replacement
1284368|NCT01651780|Severe aortic stenosis|severe aortic stenosis
1284369|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
1284370|NCT01651767|JNJ-47910382|jnj-47910382
1284371|NCT01651767|Pharmacokinetics|pharmacokinetics
1284372|NCT01651767|Caucasian genotype-1|caucasian genotype-1
1284373|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
1284374|NCT01651741|Intestinal Microbiota|intestinal microbiota
1284375|NCT01651741|Probiotics|probiotics
1284376|NCT01651741|Seaweed|seaweed
1284377|NCT01651741|Healthy Subject|healthy subject
1284378|NCT01651728|Simvastatin|simvastatin
1284379|NCT01651728|Pneumonia|pneumonia
1284380|NCT01651728|Elderly|elderly
1284381|NCT01651728|TNF-α|tnf-α
1284382|NCT01651728|IFN-ϒ|ifn-ϒ
1284383|NCT01651728|PAI-1|pai-1
1284384|NCT01651728|CRP|crp
1284385|NCT01651702|Arrhythmia|arrhythmia
1284386|NCT01651702|Electroanatomical mapping|electroanatomical mapping
1284387|NCT01651689|Scalp biopsy|scalp biopsy
1284388|NCT01651689|Hair count|hair count
1284389|NCT01651689|Vertical section|vertical section
1284390|NCT01651689|Horizontal section|horizontal section
1284391|NCT01651689|Thais|thais
1284392|NCT01651676|VQ11 questionnaire|vq11 questionnaire
1284393|NCT01651676|COPD|copd
1284394|NCT01651676|LBD|lbd
1284395|NCT01651663|Influenza|influenza
1284396|NCT01651650|Asthma|asthma
1284397|NCT01651650|PIF|pif
1284398|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
1284399|NCT01651637|Complications of prematurity|complications of prematurity
1284400|NCT01651624|Colorectal Cancer|colorectal cancer
1284401|NCT01651624|Screening|screening
1284402|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
1284403|NCT01651624|CT Colonography|ct colonography
1284404|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
1284405|NCT01651624|Colonoscopy|colonoscopy
1284406|NCT01651611|Tobacco Cessation|tobacco cessation
1284407|NCT01651611|Public Housing|public housing
1284911|NCT01649180|Axitinib|axitinib
1284408|NCT01651611|Community Health Workers|community health workers
1284409|NCT01651611|Motivational Interviewing|motivational interviewing
1284410|NCT01651611|Patient centered|patient centered
1284411|NCT01651611|Low-income|low-income
1284412|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
1284413|NCT01651611|Social Epidemiology|social epidemiology
1284414|NCT01651611|Smoking cessation predictors|smoking cessation predictors
1284415|NCT01651611|Behavioral Intervention|behavioral intervention
1284416|NCT01651611|Non-pharmacologic|non-pharmacologic
1284417|NCT01651585|viral disease|viral disease
1284418|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
1284419|NCT01651585|is the first cause|is the first cause
1284420|NCT01651585|of congenital|of congenital
1284421|NCT01651585|neurological handicap|neurological handicap
1284422|NCT01651585|of infectious origin.|of infectious origin.
1284423|NCT01651572|Postoperative residual curarization|postoperative residual curarization
1284424|NCT01651572|Residual neuromuscular block|residual neuromuscular block
1284425|NCT01651572|Complications|complications
1284426|NCT01651572|Postoperative|postoperative
1284427|NCT01651572|Neuromuscular function|neuromuscular function
1284428|NCT01651572|Neuromuscular block|neuromuscular block
1284429|NCT01651559|modified PASI|modified pasi
1284430|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
1284431|NCT01651559|Dead Sea Minerals|dead sea minerals
1284432|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
1284433|NCT01651559|Skin wash samples|skin wash samples
1284434|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
1284435|NCT01651546|acceptance|acceptance
1284436|NCT01651546|test|test
1284437|NCT01651533|Mental practice group|mental practice group
1284438|NCT01651533|Active control group|active control group
1284439|NCT01651520|Neurodegeneration|neurodegeneration
1284440|NCT01651520|Disability|disability
1284441|NCT01651520|Cognition|cognition
1284442|NCT01651520|Prognosis|prognosis
1284443|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
1284444|NCT01651494|DAS181|das181
1284445|NCT01651494|Influenza|influenza
1284446|NCT01651494|inhalation|inhalation
1284447|NCT01651494|inpatient clinic|inpatient clinic
1284448|NCT01651494|Multi-Dose|multi-dose
1284449|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
1284450|NCT01651481|Rhinitis|rhinitis
1284451|NCT01651468|mild bleeding disorder|mild bleeding disorder
1284452|NCT01651455|Cystic Fibrosis|cystic fibrosis
1284453|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1284454|NCT01651429|Sleep Deprivation|sleep deprivation
1284455|NCT01651416|Home management of malaria|home management of malaria
1284456|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
1284457|NCT01651403|Hepatitis|hepatitis
1284458|NCT01651403|Hepatitis B|hepatitis b
1284459|NCT01651403|HBV|hbv
1284460|NCT01651390|Restenosis|restenosis
1284461|NCT01651390|Drug coated balloon|drug coated balloon
1284462|NCT01651390|Drug eluting stent|drug eluting stent
1284463|NCT01651390|Paclitaxel|paclitaxel
1284464|NCT01651390|Sirolimus|sirolimus
1284465|NCT01651377|Pramipexole|pramipexole
1284466|NCT01651377|Mirapex|mirapex
1284467|NCT01651377|Cocaine|cocaine
1284468|NCT01651364|Cocaine|cocaine
1284469|NCT01651364|Cabergoline|cabergoline
1284470|NCT01651351|for this study|for this study
1284471|NCT01651351|volunteers|volunteers
1284472|NCT01651351|Focus|focus
1284473|NCT01651351|Condition:|condition:
1284474|NCT01651338|Acupuncture|acupuncture
1284475|NCT01651338|quality of life|quality of life
1284476|NCT01651325|Isavuconazole|isavuconazole
1284477|NCT01651325|dextromethorphan|dextromethorphan
1284478|NCT01651325|dextrorphan|dextrorphan
1284479|NCT01651325|DXM|dxm
1284480|NCT01651325|Healthy Volunteers|healthy volunteers
1284481|NCT01651325|BAL4815|bal4815
1284482|NCT01651312|Radioactivity|radioactivity
1284483|NCT01651312|Excretion rate|excretion rate
1284484|NCT01651312|Human subjects|human subjects
1284485|NCT01651312|Pharmacokinetics|pharmacokinetics
1284486|NCT01651312|YM178|ym178
1284487|NCT01651312|Radio-labeled|radio-labeled
1284488|NCT01651312|Phase 1|phase 1
1284489|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
1284490|NCT01651286|General anesthesia|general anesthesia
1284491|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
1284492|NCT01651286|Masks|masks
1284493|NCT01651247|Toddlers|toddlers
1284494|NCT01651247|Retrospective|retrospective
1284495|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
1284496|NCT01651247|Infants|infants
1284497|NCT01651247|Laboratory evaluations|laboratory evaluations
1284498|NCT01651247|IPV|ipv
1284499|NCT01651221|gustatory response|gustatory response
1284500|NCT01651221|olfactory response|olfactory response
1284501|NCT01651208|Coronary stents|coronary stents
1284502|NCT01651208|Medication adherence|medication adherence
1284503|NCT01651208|Antiplatelet medications|antiplatelet medications
1284504|NCT01651208|Motivational Interviewing|motivational interviewing
1284505|NCT01651182|Blood transfusion|blood transfusion
1284506|NCT01651182|Blood loss|blood loss
1284507|NCT01651182|Postoperative complications|postoperative complications
1284508|NCT01651182|Outcome|outcome
1284509|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
1284510|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
1284511|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
1284512|NCT01651130|pregnancy|pregnancy
1284513|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
1284514|NCT01651130|Cesarean delivery|cesarean delivery
1284515|NCT01651130|carbetocin|carbetocin
1284516|NCT01651117|Diabetes Mellitus|diabetes mellitus
1284517|NCT01651117|Mentors|mentors
1284518|NCT01651117|Glucose control|glucose control
1284519|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1284520|NCT01651117|Randomized Controlled Trial|randomized controlled trial
1284521|NCT01651117|Veterans|veterans
1284522|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
1284523|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
1284524|NCT01651078|Progression|progression
1284525|NCT01651078|Radiation Necrosis|radiation necrosis
1284526|NCT01651078|Quality of Life|quality of life
1284527|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
1284528|NCT01651039|Panobinostat|panobinostat
1284529|NCT01651039|Lenalidomide|lenalidomide
1284530|NCT01651039|Dexamethasone|dexamethasone
1284531|NCT01651000|Parathyroid Diseases|parathyroid diseases
1284532|NCT01651000|Renal Insufficiency|renal insufficiency
1284533|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
1284534|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1284535|NCT01651000|Vitamin D|vitamin d
1284536|NCT01651000|Hyperparathyroidism|hyperparathyroidism
1284537|NCT01651000|Kidney Diseases|kidney diseases
1284538|NCT01651000|Kidney Failure|kidney failure
1284539|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
1284540|NCT01650987|carcinoma|carcinoma
1284542|NCT01650987|Not metastatic|not metastatic
1284543|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
1284544|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
1284545|NCT01650948|age-related macular degeneration|age-related macular degeneration
1284546|NCT01650948|AMD|amd
1284547|NCT01650935|Nephrolithiasis|nephrolithiasis
1284548|NCT01650935|Recurrent stone former|recurrent stone former
1284549|NCT01650935|DASH|dash
1284550|NCT01650935|Urine oxalate|urine oxalate
1284551|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
1284552|NCT01650896|Delirium|delirium
1284553|NCT01650896|Dementia|dementia
1284554|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
1284555|NCT01650883|Vitamin D3|vitamin d3
1284556|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
1284557|NCT01650870|Cathartics|cathartics
1284558|NCT01650870|Laxatives|laxatives
1284559|NCT01650870|Lactulose|lactulose
1284560|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
1284561|NCT01650870|Therapeutic Uses|therapeutic uses
1284562|NCT01650870|Pharmacologic Actions|pharmacologic actions
1284563|NCT01650857|Pulmonary hypertension|pulmonary hypertension
1284564|NCT01650857|Rehabilitation|rehabilitation
1284565|NCT01650857|Exercise capacity|exercise capacity
1284566|NCT01650857|Body composition|body composition
1284567|NCT01650857|Health related Quality of Life|health related quality of life
1284568|NCT01650831|Helicobacter Pylori|helicobacter pylori
1284569|NCT01650831|13C Urea Breath Test|13c urea breath test
1284570|NCT01650831|BreathID|breathid
1284571|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1284572|NCT01650818|Aerobic training|aerobic training
1284573|NCT01650818|Peak oxygen consumption|peak oxygen consumption
1284574|NCT01650818|Quality of life|quality of life
1284575|NCT01650805|Leukemia|leukemia
1284576|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
1284577|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1284578|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
1284579|NCT01650805|Neoplasms|neoplasms
1284580|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
1284581|NCT01650805|Lymphatic Diseases|lymphatic diseases
1284582|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
1284583|NCT01650805|Immune System Diseases|immune system diseases
1284584|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
1284585|NCT01650805|Bone Marrow Diseases|bone marrow diseases
1284586|NCT01650805|Hematologic Diseases|hematologic diseases
1284587|NCT01650792|Chagas disease|chagas disease
1284588|NCT01650792|Heart failure|heart failure
1284590|NCT01650792|Dementia|dementia
1284591|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
1284592|NCT01650779|a-GAL|a-gal
1284593|NCT01650779|Fabry|fabry
1284594|NCT01650779|GL-3|gl-3
1284595|NCT01650779|Fabrazyme|fabrazyme
1284596|NCT01650701|follicular lymphoma|follicular lymphoma
1284597|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
1284598|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
1284599|NCT01650701|rituximab treatment|rituximab treatment
1284701|NCT01650285|Radical prostatectomy|radical prostatectomy
1284600|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
1284601|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
1284602|NCT01650675|pregnancy|pregnancy
1284603|NCT01650675|screening|screening
1284604|NCT01650675|motivation|motivation
1284605|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
1284606|NCT01650662|Cyclosporine A|cyclosporine a
1284608|NCT01650662|Clinical Trial|clinical trial
1284609|NCT01650649|lofexidine|lofexidine
1284610|NCT01650649|methadone|methadone
1284611|NCT01650649|interaction|interaction
1284612|NCT01650649|pharmacodynamic|pharmacodynamic
1284613|NCT01650649|ECG|ecg
1284614|NCT01650649|QTc|qtc
1284615|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
1284616|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
1284617|NCT01650636|Symptoms|symptoms
1284618|NCT01650636|Neuroimmune processes|neuroimmune processes
1284619|NCT01650636|Psychosocial|psychosocial
1284620|NCT01650623|Parkinson´s Disease|parkinson´s disease
1284621|NCT01650623|Rehabilitation|rehabilitation
1284622|NCT01650623|Cognition|cognition
1284623|NCT01650610|Parkinson´s Disease|parkinson´s disease
1284624|NCT01650610|Rehabilitation|rehabilitation
1284625|NCT01650610|Cognition|cognition
1284626|NCT01650597|Healthy volunteers|healthy volunteers
1284627|NCT01650597|Pharmacokinetics|pharmacokinetics
1284628|NCT01650597|Free fatty amides|free fatty amides
1284629|NCT01650558|Malaria|malaria
1284630|NCT01650558|HIV|hiv
1284631|NCT01650558|Prophylaxis|prophylaxis
1284632|NCT01650558|Antiretroviral therapy|antiretroviral therapy
1284633|NCT01650545|case-control study|case-control study
1284634|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
1284635|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1284636|NCT01650545|Lung Transplantation|lung transplantation
1284637|NCT01650545|Lung function|lung function
1284638|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
1284639|NCT01650506|Triple Negative|triple negative
1284640|NCT01650506|Basal-like|basal-like
1284641|NCT01650493|remineralization|remineralization
1284642|NCT01650493|demineralzation|demineralzation
1284643|NCT01650493|in situ|in situ
1284644|NCT01650493|dentrifice|dentrifice
1284645|NCT01650480|COPD|copd
1284646|NCT01650480|holistic|holistic
1284647|NCT01650480|pilot|pilot
1284648|NCT01650480|intervention|intervention
1284649|NCT01650467|abl polymorphisms|abl polymorphisms
1284650|NCT01650454|Alzheimer|alzheimer
1284651|NCT01650454|Sleep|sleep
1284652|NCT01650454|Somnolence|somnolence
1284653|NCT01650441|Asthma|asthma
1284654|NCT01650441|NEXThaler®|nexthaler®
1284655|NCT01650441|Formoterol|formoterol
1284656|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
1284657|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
1284658|NCT01650441|Functional Imaging|functional imaging
1284659|NCT01650441|Central and Peripheral Airways|central and peripheral airways
1284660|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
1284661|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
1284662|NCT01650428|Rectal Cancer|rectal cancer
1284663|NCT01650428|Bevacizumab|bevacizumab
1284664|NCT01650428|Neoadjuvant|neoadjuvant
1284665|NCT01650428|Chemotherapy|chemotherapy
1284666|NCT01650428|Randomised|randomised
1284667|NCT01650415|Cerebral Palsy|cerebral palsy
1284668|NCT01650415|Erythropoietin|erythropoietin
1284669|NCT01650415|Rehabilitation|rehabilitation
1284670|NCT01650402|Hypertension, systolic|hypertension, systolic
1284671|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
1284672|NCT01650402|Cerebrovascular disease|cerebrovascular disease
1284673|NCT01650389|Tuberculosis|tuberculosis
1284674|NCT01650389|HIV|hiv
1284675|NCT01650389|BCG|bcg
1284676|NCT01650389|Infant|infant
1284677|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
1284678|NCT01650376|Cancer of the Ovary|cancer of the ovary
1284679|NCT01650376|Ovarian Cancer|ovarian cancer
1284680|NCT01650376|Uterine Neoplasms|uterine neoplasms
1284681|NCT01650376|Cancer of the Uterus|cancer of the uterus
1284682|NCT01650376|Uterine Cancer|uterine cancer
1284683|NCT01650376|Olaparib|olaparib
1284684|NCT01650376|AZD2281|azd2281
1284685|NCT01650376|Carboplatin|carboplatin
1284686|NCT01650376|Paclitaxel|paclitaxel
1284687|NCT01650376|Relapsed|relapsed
1284688|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
1284689|NCT01650363|Post operative recovery|post operative recovery
1284690|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
1284691|NCT01650350|Melanoma|melanoma
1284692|NCT01650350|Prostate Cancer|prostate cancer
1284693|NCT01650350|Renal Cancer|renal cancer
1284694|NCT01650324|DBPR108|dbpr108
1284695|NCT01650324|DPP4|dpp4
1284696|NCT01650324|Diabetes|diabetes
1284697|NCT01650324|GLP-1|glp-1
1284698|NCT01650324|Incretins|incretins
1284699|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
1284700|NCT01650285|Prostate Cancer|prostate cancer
1284808|NCT01649713|Fluval AB|fluval ab
1284702|NCT01650207|electroacupuncture|electroacupuncture
1284703|NCT01650207|TENS|tens
1284704|NCT01650207|shoulder disorder|shoulder disorder
1284705|NCT01650207|hemiplegia|hemiplegia
1284706|NCT01650194|abiraterone acetate|abiraterone acetate
1284707|NCT01650194|prednisone|prednisone
1284708|NCT01650194|enzalutamide|enzalutamide
1284709|NCT01650194|cancer|cancer
1284710|NCT01650194|prostate|prostate
1284711|NCT01650194|MDV3100|mdv3100
1284712|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
1284713|NCT01650168|NOMAC-E2|nomac-e2
1284714|NCT01650168|Nomegestrol acetate|nomegestrol acetate
1284715|NCT01650168|Estradiol|estradiol
1284716|NCT01650168|Levonorgestrel|levonorgestrel
1284717|NCT01650168|Safety|safety
1284718|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
1284719|NCT01650142|Phenotype|phenotype
1284720|NCT01650142|Modifiers|modifiers
1284721|NCT01650116|hypovolemia|hypovolemia
1284722|NCT01650116|renal hypoperfusion|renal hypoperfusion
1284723|NCT01650116|liver transplantation|liver transplantation
1284724|NCT01650116|sodium|sodium
1284725|NCT01650116|chloride|chloride
1284726|NCT01650116|PuCO2|puco2
1284727|NCT01650116|ScvO2|scvo2
1284728|NCT01650116|PiCCO|picco
1284729|NCT01650116|O2-delivery|o2-delivery
1284730|NCT01650116|hemodynamic indexes|hemodynamic indexes
1284731|NCT01650103|hypovolemia|hypovolemia
1284732|NCT01650103|renal hypoperfusion|renal hypoperfusion
1284733|NCT01650103|major surgery|major surgery
1284734|NCT01650103|sodium|sodium
1284735|NCT01650103|potassium|potassium
1284736|NCT01650103|chloride|chloride
1284737|NCT01650103|ScvO2|scvo2
1284738|NCT01650103|hemodynamic indexes|hemodynamic indexes
1284739|NCT01650090|Pulmonary relapse|pulmonary relapse
1284740|NCT01650090|Osteosarcoma|osteosarcoma
1284741|NCT01650090|Lung metastases|lung metastases
1284742|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
1284743|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
1284744|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
1284745|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
1284746|NCT01650077|Yondelis|yondelis
1284747|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
1284748|NCT01650077|CHOI criteria|choi criteria
1284749|NCT01650064|Hip fracture|hip fracture
1284750|NCT01650064|Mortality|mortality
1284751|NCT01650038|faecal transplantation|faecal transplantation
1284752|NCT01650038|ulcerative colitis|ulcerative colitis
1284753|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
1284754|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
1284755|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
1284757|NCT01649986|Hyperlipidemia|hyperlipidemia
1284758|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
1284759|NCT01649960|Aging|aging
1284760|NCT01649960|Biomarkers|biomarkers
1284761|NCT01649960|CAD|cad
1284762|NCT01649947|Lung cancer|lung cancer
1284763|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
1284764|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1284765|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1284766|NCT01649934|Appointments and Schedules|appointments and schedules
1284767|NCT01649921|Sepsis|sepsis
1284768|NCT01649921|SIRS|sirs
1284769|NCT01649921|Septic shock|septic shock
1284770|NCT01649921|Immunoparalysis|immunoparalysis
1284771|NCT01649921|Interferon-gamma|interferon-gamma
1284772|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
1284773|NCT01649895|internet|internet
1284774|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
1284775|NCT01649895|D-Cycloserine|d-cycloserine
1284776|NCT01649882|endotracheal tube position|endotracheal tube position
1284777|NCT01649882|intubation|intubation
1284778|NCT01649869|CMV|cmv
1284779|NCT01649869|Cytomegalovirus|cytomegalovirus
1284780|NCT01649869|Hearing Loss|hearing loss
1284781|NCT01649869|Infants|infants
1284782|NCT01649869|Valganciclovir|valganciclovir
1284783|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
1284784|NCT01649843|Esophageal Achalasia|esophageal achalasia
1284785|NCT01649830|low-grade glioma|low-grade glioma
1284786|NCT01649830|radiotherapy|radiotherapy
1284787|NCT01649830|chemotherapy|chemotherapy
1284788|NCT01649765|SLE Flare Index|sle flare index
1284789|NCT01649765|SRI|sri
1284790|NCT01649765|belimumab|belimumab
1284791|NCT01649765|efficacy|efficacy
1284792|NCT01649765|safety|safety
1284793|NCT01649765|B lymphocyte|b lymphocyte
1284794|NCT01649765|BLyS|blys
1284795|NCT01649765|SELENA SLEDAI|selena sledai
1284796|NCT01649765|BILAG|bilag
1284797|NCT01649765|Lupus|lupus
1284798|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1284799|NCT01649765|PGA|pga
1284800|NCT01649765|Pharmacokinetics|pharmacokinetics
1284801|NCT01649765|placebo|placebo
1284802|NCT01649765|PRINTO|printo
1284803|NCT01649752|Stem cells|stem cells
1284804|NCT01649752|Uterine cavity|uterine cavity
1284805|NCT01649752|Implantation|implantation
1284806|NCT01649752|ICSI|icsi
1284807|NCT01649739|PAH|pah
1284811|NCT01649713|immunization|immunization
1284812|NCT01649713|infections|infections
1284813|NCT01649661|MRI|mri
1284814|NCT01649661|12-125|12-125
1284815|NCT01649661|premenopausal women|premenopausal women
1284816|NCT01649661|postmenopausal women|postmenopausal women
1284817|NCT01649661|questionnaire|questionnaire
1284818|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1284819|NCT01649648|Autologous cord blood|autologous cord blood
1284820|NCT01649622|Leukemia|leukemia
1284821|NCT01649622|Lymphoma|lymphoma
1284822|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
1284823|NCT01649622|ALL|all
1284824|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
1284825|NCT01649622|Bendamustine|bendamustine
1284826|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
1284827|NCT01649622|Bendamustine HCL|bendamustine hcl
1284828|NCT01649622|CEP-18083|cep-18083
1284829|NCT01649622|SDX-105|sdx-105
1284830|NCT01649622|Treanda|treanda
1284831|NCT01649609|BK Viremia|bk viremia
1284832|NCT01649609|BK Nephropathy|bk nephropathy
1284833|NCT01649609|mTOR inhibitor|mtor inhibitor
1284834|NCT01649609|renal transplant|renal transplant
1284835|NCT01649557|Schizophrenia|schizophrenia
1284836|NCT01649544|Mitral valvulopathy|mitral valvulopathy
1284837|NCT01649544|Atrial Fibrillation|atrial fibrillation
1284838|NCT01649544|Amiodarone|amiodarone
1284839|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1284840|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
1284841|NCT01649544|Ultrasound Technique|ultrasound technique
1284842|NCT01649492|diclofenac|diclofenac
1284844|NCT01649492|bromelain|bromelain
1284845|NCT01649492|pineapple juice|pineapple juice
1284846|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
1284847|NCT01649479|Thrombophilia|thrombophilia
1284848|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
1284849|NCT01649453|Neoplasms|neoplasms
1284850|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
1284851|NCT01649453|Neoplastic Processes|neoplastic processes
1284852|NCT01649453|Pathologic Processes|pathologic processes
1284853|NCT01649440|Metabolomics|metabolomics
1284854|NCT01649440|serum|serum
1284855|NCT01649440|sepsis|sepsis
1284856|NCT01649440|biomarkers|biomarkers
1284857|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
1284858|NCT01649427|Tacroliums|tacroliums
1284859|NCT01649427|GFR|gfr
1284860|NCT01649427|kdney|kdney
1284861|NCT01649401|nebulizer|nebulizer
1284862|NCT01649401|PARI LC Spring SP|pari lc spring sp
1284863|NCT01649388|Kidney transplant|kidney transplant
1284864|NCT01649388|Delayed tolerance|delayed tolerance
1284865|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
1284866|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
1284867|NCT01649375|AS|as
1284868|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
1284869|NCT01649375|Inflammatory back pain|inflammatory back pain
1284870|NCT01649375|Secukinumab|secukinumab
1284871|NCT01649375|Prefilled syringe (PFS)|prefilled syringe (pfs)
1284872|NCT01649375|Subcutaneous injection|subcutaneous injection
1284873|NCT01649375|AIN457|ain457
1284874|NCT01649375|AIN457F|ain457f
1284875|NCT01649375|AIN457F2310|ain457f2310
1284876|NCT01649362|preterm infant|preterm infant
1284877|NCT01649362|feeding difficulties|feeding difficulties
1284878|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
1284879|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1284880|NCT01649310|Muscle strenght|muscle strenght
1284881|NCT01649310|Aged|aged
1284882|NCT01649245|Chronic hepatitis C|chronic hepatitis c
1284883|NCT01649245|Egyptian patients|egyptian patients
1284884|NCT01649245|pegylated interferon|pegylated interferon
1284885|NCT01649245|Ribavirin|ribavirin
1284886|NCT01649245|Reiferon retard|reiferon retard
1284887|NCT01649232|tdcs|tdcs
1284888|NCT01649232|tms|tms
1284889|NCT01649232|qeeg|qeeg
1284890|NCT01649232|neuroplasticity|neuroplasticity
1284891|NCT01649232|brain networks|brain networks
1284892|NCT01649232|add|add
1284893|NCT01649232|adhs|adhs
1284894|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
1284895|NCT01649206|Thyroid Nodule|thyroid nodule
1284896|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
1284897|NCT01649206|Pressure symptoms|pressure symptoms
1284898|NCT01649206|Hyperthyroidism|hyperthyroidism
1284899|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
1284900|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
1284901|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
1284902|NCT01649193|[C08]|[c08]
1284903|NCT01649193|[C08.381]|[c08.381]
1284904|NCT01649180|RCC|rcc
1284905|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
1284906|NCT01649180|ccRCC|ccrcc
1284907|NCT01649180|Metastatic RCC|metastatic rcc
1284908|NCT01649180|Recurrent RCC|recurrent rcc
1284909|NCT01649180|Kidney Cancer|kidney cancer
1284910|NCT01649180|Kidney Neoplasms|kidney neoplasms
1284912|NCT01649180|AG-013736|ag-013736
1284913|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
1284914|NCT01649180|TKI|tki
1284915|NCT01649167|body mass index|body mass index
1284916|NCT01649167|gestational diabetes|gestational diabetes
1284917|NCT01649167|leptin|leptin
1284918|NCT01649167|obesity|obesity
1284919|NCT01649167|pregnancy.|pregnancy.
1284920|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
1285121|NCT01648101|Asian Subjects|asian subjects
1284921|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
1284922|NCT01649141|trauma|trauma
1284923|NCT01649141|child abuse|child abuse
1284924|NCT01649128|preeclampsia|preeclampsia
1284925|NCT01649115|obesity|obesity
1284926|NCT01649115|overweight|overweight
1284927|NCT01649115|childhood obesity|childhood obesity
1284928|NCT01649115|prevention|prevention
1284929|NCT01649115|Z score|z score
1284930|NCT01649115|weight for length|weight for length
1284931|NCT01649115|WFL|wfl
1284932|NCT01649115|body mass index|body mass index
1284933|NCT01649115|BMI|bmi
1284934|NCT01649115|prenatal|prenatal
1284935|NCT01649115|maternal|maternal
1284936|NCT01649115|nutrition education|nutrition education
1284937|NCT01649115|health education|health education
1284938|NCT01649115|health literacy|health literacy
1284939|NCT01649115|health numeracy|health numeracy
1284940|NCT01649115|passport|passport
1284941|NCT01649115|healthy lifestyles|healthy lifestyles
1284942|NCT01649115|growth|growth
1284943|NCT01649115|growth chart|growth chart
1284944|NCT01649102|Chronic hemodialysis|chronic hemodialysis
1284945|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
1284946|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
1284947|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
1284948|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
1284949|NCT01649063|Uterine contraction;|uterine contraction;
1284950|NCT01649063|Shape; Frequency;|shape; frequency;
1284951|NCT01649063|First stage labor;|first stage labor;
1284952|NCT01649063|Fall|fall
1284953|NCT01649063|Rise ratio.|rise ratio.
1284954|NCT01649050|Spasticity|spasticity
1284955|NCT01649050|Multiple Sclerosis|multiple sclerosis
1284956|NCT01649024|Tremelimumab|tremelimumab
1284957|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
1284958|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
1284959|NCT01649011|Oswestry Disability Index|oswestry disability index
1284960|NCT01649011|ODI|odi
1284961|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
1284962|NCT01649011|RMDQ|rmdq
1284963|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
1284964|NCT01648998|Fludrocortisone|fludrocortisone
1284965|NCT01648998|Information Processing|information processing
1284966|NCT01648998|Cognition|cognition
1284967|NCT01648998|Depression|depression
1284968|NCT01648946|Strategies of transfusion|strategies of transfusion
1284969|NCT01648946|Red blood cells|red blood cells
1284970|NCT01648946|Liberal|liberal
1284971|NCT01648946|Restrictive|restrictive
1284972|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
1284973|NCT01648933|sarcoidosis|sarcoidosis
1284974|NCT01648933|heart|heart
1284975|NCT01648933|Rubidium|rubidium
1284976|NCT01648933|PET|pet
1284977|NCT01648920|Asthma|asthma
1284978|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
1284979|NCT01648907|DESIR|desir
1284980|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
1284981|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
1284982|NCT01648907|BACK PAIN|back pain
1284983|NCT01648894|Rectal cancer|rectal cancer
1284984|NCT01648894|radiochemotherapy|radiochemotherapy
1284985|NCT01648894|complete pathological response|complete pathological response
1284986|NCT01648868|TMSAutism|tmsautism
1284987|NCT01648868|Eye-tracking|eye-tracking
1284988|NCT01648868|Social perception|social perception
1284989|NCT01648868|Social cognition|social cognition
1284990|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
1284991|NCT01648855|Preeclampsia|preeclampsia
1284992|NCT01648855|Developing lung|developing lung
1284993|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1284994|NCT01648842|Preeclampsia|preeclampsia
1284995|NCT01648842|Vitamin D deficiency|vitamin d deficiency
1284996|NCT01648842|Pregnancy|pregnancy
1284997|NCT01648842|First trimester|first trimester
1284998|NCT01648777|Pneumonia|pneumonia
1284999|NCT01648777|Postoperative infection|postoperative infection
1285000|NCT01648777|Cardiac surgery|cardiac surgery
1285001|NCT01648777|Multiperforated catheter|multiperforated catheter
1285002|NCT01648777|Analgesia|analgesia
1285003|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
1285004|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
1285005|NCT01648751|Vaginal estrogen|vaginal estrogen
1285006|NCT01648751|Placebo|placebo
1285007|NCT01648738|Subacute low back pain|subacute low back pain
1285008|NCT01648738|Chronic low back pain|chronic low back pain
1285009|NCT01648738|Low back pain|low back pain
1285010|NCT01648738|Disability|disability
1285011|NCT01648738|Education|education
1285012|NCT01648738|Exercise|exercise
1285013|NCT01648738|Spa therapy|spa therapy
1285014|NCT01648738|Physiotherapy|physiotherapy
1285015|NCT01648738|Multidisciplinary|multidisciplinary
1285016|NCT01648738|Cost-effectiveness|cost-effectiveness
1285017|NCT01648738|Sick leave|sick leave
1285018|NCT01648725|Hypnosis|hypnosis
1285019|NCT01648725|Anesthesia|anesthesia
1285020|NCT01648725|Propofol|propofol
1285021|NCT01648725|Closed-loop|closed-loop
1285122|NCT01648101|Adjunctive Therapy|adjunctive therapy
1285022|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
1285023|NCT01648699|Pain|pain
1285024|NCT01648699|Cancer|cancer
1285025|NCT01648699|Osmotic Release Oral System|osmotic release oral system
1285026|NCT01648699|OROS Hydromorphone|oros hydromorphone
1285027|NCT01648699|Jurnista|jurnista
1285028|NCT01648686|Alendronate|alendronate
1285029|NCT01648686|Dental extraction|dental extraction
1285030|NCT01648686|Bone healing|bone healing
1285031|NCT01648686|postmenopausal women|postmenopausal women
1285032|NCT01648686|dental radiography|dental radiography
1285033|NCT01648673|Coronary Artery Disease|coronary artery disease
1285034|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
1285035|NCT01648634|Nebivolol|nebivolol
1285036|NCT01648634|beta-blockade treatment|beta-blockade treatment
1285037|NCT01648621|COPD|copd
1285038|NCT01648621|case management|case management
1285039|NCT01648595|Fentanyl|fentanyl
1285040|NCT01648595|analgesia|analgesia
1285041|NCT01648595|duration of the active phase|duration of the active phase
1285042|NCT01648595|pain severity|pain severity
1608586|NCT00363051|Carcinoma|carcinoma
1285043|NCT01648556|Purpura thrombopenic|purpura thrombopenic
1285044|NCT01648556|Medullary cytogenetics|medullary cytogenetics
1285045|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
1285046|NCT01648556|bone marrow biopsy|bone marrow biopsy
1285047|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
1285048|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
1285049|NCT01648504|Colonoscopy|colonoscopy
1285050|NCT01648504|Screening colonoscopy|screening colonoscopy
1285051|NCT01648504|Electronic education|electronic education
1285052|NCT01648504|Ipad|ipad
1285053|NCT01648504|Patient education|patient education
1285054|NCT01648478|IRAP|irap
1285055|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
1285056|NCT01648465|metastatic|metastatic
1285057|NCT01648465|unresectable|unresectable
1285058|NCT01648465|well or moderately differentiated|well or moderately differentiated
1285059|NCT01648465|advanced|advanced
1285060|NCT01648452|Achromatopsia|achromatopsia
1285061|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
1285062|NCT01648452|CNTF|cntf
1285063|NCT01648322|Breast Cancer|breast cancer
1285064|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
1285065|NCT01648322|Neulasta|neulasta
1285066|NCT01648322|efficacy and safety|efficacy and safety
1285067|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
1285068|NCT01648322|pegfilgrastim|pegfilgrastim
1285069|NCT01648309|aortic stenosis|aortic stenosis
1285070|NCT01648309|TAVI|tavi
1285071|NCT01648309|neuropsychological|neuropsychological
1285072|NCT01648309|cognitive|cognitive
1285073|NCT01648309|candidates for TAVI|candidates for tavi
1285074|NCT01648296|Heart Failure|heart failure
1285075|NCT01648296|Obesity|obesity
1285076|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1285077|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
1285078|NCT01648283|methadone polymorphisms|methadone polymorphisms
1285079|NCT01648270|buprenorphine concentration-effect (miosis) relationship|buprenorphine concentration-effect (miosis) relationship
1285080|NCT01648257|healthy subjects|healthy subjects
1285081|NCT01648257|relative bioavailability|relative bioavailability
1285082|NCT01648257|HIV|hiv
1285083|NCT01648257|GSK1265744|gsk1265744
1285084|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
1285085|NCT01648231|Healthy Volunteer|healthy volunteer
1285086|NCT01648218|glucocorticoid|glucocorticoid
1285087|NCT01648218|diabetes mellitus|diabetes mellitus
1285088|NCT01648218|post-transplant|post-transplant
1285089|NCT01648218|insulin|insulin
1285090|NCT01648205|ranolazine|ranolazine
1285091|NCT01648205|clinical trial|clinical trial
1285092|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
1285093|NCT01648166|trace|trace
1285094|NCT01648166|element|element
1285095|NCT01648166|lung|lung
1285096|NCT01648166|cancer|cancer
1285097|NCT01648166|Appalachia|appalachia
1285098|NCT01648153|Efficacy|efficacy
1285099|NCT01648153|Obese|obese
1285100|NCT01648153|T2DM|t2dm
1285101|NCT01648153|IL-18|il-18
1285102|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
1285103|NCT01648140|Genotype 4|genotype 4
1285104|NCT01648140|GSK2336805|gsk2336805
1285105|NCT01648140|pegylated interferon|pegylated interferon
1285106|NCT01648140|telaprevir|telaprevir
1285107|NCT01648140|Genotype 1|genotype 1
1285108|NCT01648140|chronic hepatitis C|chronic hepatitis c
1285109|NCT01648140|ribavirin|ribavirin
1285110|NCT01648140|NS5A inhibitor|ns5a inhibitor
1285111|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
1285112|NCT01648127|Ceftaroline|ceftaroline
1285113|NCT01648127|Pharmacokinetics|pharmacokinetics
1285114|NCT01648127|Obesity|obesity
1285115|NCT01648114|breastfeeding|breastfeeding
1285116|NCT01648114|pregnancy|pregnancy
1285117|NCT01648114|antenatal|antenatal
1285118|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
1285119|NCT01648114|education|education
1285120|NCT01648101|Retigabine IR|retigabine ir
1285123|NCT01648101|Efficacy|efficacy
1285124|NCT01648101|Drug-Resistant|drug-resistant
1285125|NCT01648101|Safety & tolerability|safety & tolerability
1285126|NCT01648101|Partial-Onset Seizures|partial-onset seizures
1285127|NCT01648101|Epilepsy|epilepsy
1285128|NCT01648088|staphylococcus aureus|staphylococcus aureus
1285129|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
1285130|NCT01648075|caries|caries
1285131|NCT01648075|probiotics|probiotics
1285132|NCT01648075|lactobacilli|lactobacilli
1285133|NCT01648062|Sleep|sleep
1285134|NCT01648062|self-regulation|self-regulation
1285135|NCT01648062|Implementation intentions|implementation intentions
1285136|NCT01648062|intervention|intervention
1285137|NCT01648062|mental simulation|mental simulation
1285138|NCT01648023|LC Bead|lc bead
1285139|NCT01648023|Irinotecan|irinotecan
1285140|NCT01648023|ONCOZENE BEAD|oncozene bead
1285141|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1608682|NCT00362492|TKR|tkr
1285142|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
1285143|NCT01648010|Intravesical instillation|intravesical instillation
1285144|NCT01648010|Mitomycin C|mitomycin c
1285145|NCT01648010|Hydrogel|hydrogel
1285146|NCT01648010|Reverse thermal gelation|reverse thermal gelation
1285147|NCT01648010|Drug retention|drug retention
1285148|NCT01648010|radical cystectomy|radical cystectomy
1285149|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
1285150|NCT01647997|hyperlactatemia|hyperlactatemia
1285151|NCT01647997|muscle lactate|muscle lactate
1285152|NCT01647984|Arrhythmias|arrhythmias
1285153|NCT01647984|Life quality|life quality
1285154|NCT01647971|Lymphoma|lymphoma
1285155|NCT01647971|Rituxan|rituxan
1285156|NCT01647971|Relapsed|relapsed
1285157|NCT01647971|Refractory|refractory
1285158|NCT01647958|TEMPO|tempo
1285159|NCT01647958|TIF|tif
1285160|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
1285161|NCT01647958|EsophyX System|esophyx system
1285162|NCT01647958|refractory symptoms|refractory symptoms
1285163|NCT01647958|proton pump inhibitors|proton pump inhibitors
1285164|NCT01647958|EndoGastric Solutions|endogastric solutions
1285165|NCT01647958|EGS|egs
1285166|NCT01647958|Acid Reflux|acid reflux
1285167|NCT01647958|Heartburn|heartburn
1285168|NCT01647958|Regurgitation|regurgitation
1285169|NCT01647945|PAH WHO group 1|pah who group 1
1285170|NCT01647932|Heart Failure|heart failure
1285171|NCT01647932|Diuretics|diuretics
1285172|NCT01647932|Diuretic resistance|diuretic resistance
1285173|NCT01647919|Cognition|cognition
1285174|NCT01647919|Attention|attention
1285175|NCT01647919|Memory|memory
1285176|NCT01647919|Mood|mood
1285177|NCT01647867|Met fragments expression|met fragments expression
1285178|NCT01647854|emergency medical service|emergency medical service
1285179|NCT01647854|telemedicine|telemedicine
1285180|NCT01647854|teleconsultation|teleconsultation
1285181|NCT01647854|safety|safety
1285182|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
1285183|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
1285184|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
1285185|NCT01647802|standing devices|standing devices
1285186|NCT01647802|transfer devices|transfer devices
1285187|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
1285188|NCT01647776|Colon Neoplasia|colon neoplasia
1285189|NCT01647776|Colorectal carcinoma|colorectal carcinoma
1285190|NCT01647776|colon cancer|colon cancer
1285191|NCT01647776|colon polyp|colon polyp
1285192|NCT01647776|colonoscopy|colonoscopy
1285193|NCT01647776|sDNA test|sdna test
1285194|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
1285195|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
1285196|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
1285197|NCT01647763|Hemorrhoids|hemorrhoids
1285198|NCT01647737|Xerostomia|xerostomia
1285199|NCT01647737|Sjogren syndrome|sjogren syndrome
1285200|NCT01647737|dry mouth|dry mouth
1285201|NCT01647724|cervical cancer|cervical cancer
1285202|NCT01647724|prevention|prevention
1285203|NCT01647724|screening|screening
1285204|NCT01647698|Parkinson Disease|parkinson disease
1285205|NCT01647698|near transfer|near transfer
1285206|NCT01647698|far transfer|far transfer
1285207|NCT01647698|working memory|working memory
1285208|NCT01647698|fluid intelligence|fluid intelligence
1285209|NCT01647698|cognitive training|cognitive training
1285210|NCT01647698|dual n-back|dual n-back
1285211|NCT01647685|Vesselwall inflammation|vesselwall inflammation
1285212|NCT01647685|liposomal prednisolone|liposomal prednisolone
1285213|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
1285214|NCT01647659|pharmacokinetics|pharmacokinetics
1285215|NCT01647659|powder for oral solution|powder for oral solution
1285216|NCT01647659|Solid Tumors|solid tumors
1285217|NCT01647659|pediatric formulation|pediatric formulation
1285218|NCT01647646|asthma|asthma
1285219|NCT01647646|SMART|smart
1285220|NCT01647646|fixed dose|fixed dose
1285221|NCT01647633|rhinitis|rhinitis
1285222|NCT01647633|stuffy nose|stuffy nose
1285223|NCT01647633|congestion|congestion
1285224|NCT01647633|Sneezing|sneezing
1285225|NCT01647607|Breast Cancer|breast cancer
1285226|NCT01647607|Young Women|young women
1285227|NCT01647607|Fertility|fertility
1285228|NCT01647607|Physical Activity|physical activity
1285229|NCT01647607|Survivorship|survivorship
1285230|NCT01647594|Breast cancer|breast cancer
1285231|NCT01647594|Young women|young women
1285232|NCT01647594|Fertility|fertility
1285233|NCT01647594|Physical activity|physical activity
1285234|NCT01647594|Survivorship|survivorship
1285235|NCT01647581|hemoclip|hemoclip
1285236|NCT01647581|colonoscopy|colonoscopy
1285237|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
1285238|NCT01647555|Cetuximab|cetuximab
1285239|NCT01647555|radiotherapy|radiotherapy
1285240|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
1608882|NCT00361699|recurrence|recurrence
1285241|NCT01647542|Drug therapy|drug therapy
1285242|NCT01647529|Cytomegalovirus|cytomegalovirus
1285243|NCT01647529|uveitis|uveitis
1285244|NCT01647529|endotheliitis|endotheliitis
1285245|NCT01647529|ganciclovir|ganciclovir
1285246|NCT01647503|parathyroid gland|parathyroid gland
1285247|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
1285248|NCT01647503|proteins|proteins
1285249|NCT01647477|non treated cancer|non treated cancer
1285250|NCT01647477|oral cavity|oral cavity
1285251|NCT01647477|oropharynx|oropharynx
1285252|NCT01647477|hypopharynx|hypopharynx
1285253|NCT01647477|larynx|larynx
1285254|NCT01647477|first consultation|first consultation
1285255|NCT01647438|South Asians|south asians
1285256|NCT01647438|Diabetes|diabetes
1285257|NCT01647438|Physical Activity|physical activity
1285258|NCT01647438|Coronary Heart Disease|coronary heart disease
1285259|NCT01647438|Lifestyle|lifestyle
1285260|NCT01647425|head and neck cancer|head and neck cancer
1285261|NCT01647425|lung cancer|lung cancer
1285262|NCT01647425|tobacco use disorder|tobacco use disorder
1285263|NCT01647425|alcoholism|alcoholism
1285264|NCT01647412|Crohn's disease|crohn's disease
1285265|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
1285266|NCT01647412|Growth Hormone|growth hormone
1285267|NCT01647412|Nutraceuticals|nutraceuticals
1285268|NCT01647399|Obesity|obesity
1285269|NCT01647399|Asthma|asthma
1285270|NCT01647399|Vitamin D|vitamin d
1285271|NCT01647399|Allergy|allergy
1285272|NCT01647399|Genetic|genetic
1285273|NCT01647399|Childhood|childhood
1285274|NCT01647399|Pediatric|pediatric
1285275|NCT01647399|cohort|cohort
1285276|NCT01647399|observational|observational
1285277|NCT01647399|prospective|prospective
1285278|NCT01647399|molecular|molecular
1285279|NCT01647373|retinal detachment|retinal detachment
1285280|NCT01647373|scleral buckle|scleral buckle
1285281|NCT01647373|silicone sponge|silicone sponge
1285282|NCT01647373|axial length|axial length
1285283|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
1285284|NCT01647373|retina currently attached|retina currently attached
1285285|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
1285286|NCT01647360|Metrorrhagia|metrorrhagia
1285287|NCT01647360|Menorrhagia|menorrhagia
1285288|NCT01647347|bacteria|bacteria
1285289|NCT01647347|bacteremia|bacteremia
1285290|NCT01647347|PVP-iodine|pvp-iodine
1285291|NCT01647347|periodontitis|periodontitis
1285292|NCT01647321|SPMS|spms
1285293|NCT01647295|visual exploration|visual exploration
1285294|NCT01647295|pupil size|pupil size
1285295|NCT01647295|social interactions|social interactions
1285296|NCT01647295|faces|faces
1285297|NCT01647295|human motion|human motion
1285298|NCT01647256|Bioavailability|bioavailability
1285299|NCT01647256|Fed|fed
1285300|NCT01647256|Fasting|fasting
1285301|NCT01647243|Knee osteoarthritis|knee osteoarthritis
1285302|NCT01647243|Total knee arthroplasty|total knee arthroplasty
1285303|NCT01647243|Preoperative training|preoperative training
1285304|NCT01647243|Strength training|strength training
1285305|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
1285306|NCT01647230|Cerebral oximetry|cerebral oximetry
1285307|NCT01647230|Blood pressure|blood pressure
1285308|NCT01647230|Heart rate|heart rate
1285309|NCT01647230|Cognitive Symptom|cognitive symptom
1285310|NCT01647217|Blepharitis|blepharitis
1285311|NCT01647217|Demodex|demodex
1285312|NCT01647217|Mites|mites
1285313|NCT01647217|Tea Tree oil|tea tree oil
1285314|NCT01647217|Terpinen|terpinen
1285315|NCT01647204|Nutrition|nutrition
1285316|NCT01647204|older|older
1285317|NCT01647204|hospital|hospital
1285318|NCT01647204|volunteer|volunteer
1285319|NCT01647191|HCV，|hcv，
1285320|NCT01647191|drug users，|drug users，
1285321|NCT01647191|intervention|intervention
1285624|NCT01645748|S-1|s-1
1285322|NCT01647165|Maintenance Strategy|maintenance strategy
1285323|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
1285324|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
1285325|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
1285326|NCT01647165|Novel Therapy|novel therapy
1285327|NCT01647152|Uveitis|uveitis
1285328|NCT01647152|Ustekinumab|ustekinumab
1285329|NCT01647152|IL 12/23|il 12/23
1285330|NCT01647152|Stelara|stelara
1285331|NCT01646866|autism|autism
1285332|NCT01646866|siblings|siblings
1285333|NCT01646866|genetic test|genetic test
1285334|NCT01646866|screening|screening
1285335|NCT01646840|PF-04958242|pf-04958242
1285336|NCT01646840|bioequivalence|bioequivalence
1285337|NCT01646840|pharmacokinetics|pharmacokinetics
1285338|NCT01646840|Schizophrenia|schizophrenia
1285339|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
1285340|NCT01646814|Healthy volunteer|healthy volunteer
1285341|NCT01646814|comparison of incidence of|comparison of incidence of
1285342|NCT01646814|treatment groups.|treatment groups.
1285343|NCT01646775|opioid|opioid
1285344|NCT01646775|malignancy|malignancy
1285345|NCT01646775|epidural|epidural
1285346|NCT01646749|Energy intake|energy intake
1285347|NCT01646749|Beef protein|beef protein
1285348|NCT01646749|Satiety|satiety
1285349|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
1285350|NCT01646736|Lupus Nephritis|lupus nephritis
1285351|NCT01646736|Cyclophosphamide|cyclophosphamide
1285352|NCT01646736|Tripterygium|tripterygium
1285353|NCT01646710|Tool|tool
1285354|NCT01646710|FBR|fbr
1285355|NCT01646710|Advocacy|advocacy
1285356|NCT01646710|Development of a tool|development of a tool
1285357|NCT01646710|advocacy materials|advocacy materials
1285358|NCT01646697|pancreatic cancer|pancreatic cancer
1285359|NCT01646697|adenocarcinoma|adenocarcinoma
1285360|NCT01646697|pancreatic resection|pancreatic resection
1285361|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
1285362|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
1285363|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
1285364|NCT01646645|Stem Cell Transplantation|stem cell transplantation
1285365|NCT01646645|12-086|12-086
1285366|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
1285367|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1285368|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
1285369|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
1285370|NCT01646619|Cooling|cooling
1285371|NCT01646606|Bronchiolitis|bronchiolitis
1285372|NCT01646606|Length of stay|length of stay
1285373|NCT01646606|Pilot Projects|pilot projects
1285374|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
1285375|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
1285376|NCT01646567|psoriasis|psoriasis
1285377|NCT01646554|Liver metastases|liver metastases
1285378|NCT01646554|Colorectal Cancer|colorectal cancer
1285379|NCT01646554|KRAS mutated|kras mutated
1285380|NCT01646554|FOLFOX|folfox
1285381|NCT01646554|Aflibercept|aflibercept
1285382|NCT01646554|Randomized|randomized
1285383|NCT01646554|Phase II-III|phase ii-iii
1285384|NCT01646554|Perioperative treatment|perioperative treatment
1285385|NCT01646554|Adjuvant|adjuvant
1285386|NCT01646554|Neo-adjuvant|neo-adjuvant
1285387|NCT01646554|Surgery|surgery
1285388|NCT01646554|Progression Free Survival|progression free survival
1285389|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
1285390|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
1285391|NCT01646515|systolic heart failure|systolic heart failure
1285392|NCT01646515|udenafil|udenafil
1285393|NCT01646515|exercise capacity|exercise capacity
1285394|NCT01646502|chronic wound|chronic wound
1285395|NCT01646502|treatment|treatment
1285396|NCT01646502|biofilms|biofilms
1285397|NCT01646502|venous insufficiency|venous insufficiency
1285398|NCT01646502|Esp|esp
1285399|NCT01646489|Antisense|antisense
1285400|NCT01646489|miR-122 antagonist|mir-122 antagonist
1285401|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
1285402|NCT01646489|Hepatitis C|hepatitis c
1285403|NCT01646463|mindfulness|mindfulness
1285404|NCT01646463|stress|stress
1285405|NCT01646463|coping|coping
1285406|NCT01646463|emotion|emotion
1285407|NCT01646463|depression|depression
1285408|NCT01646463|group medical visits|group medical visits
1285409|NCT01646463|prenatal healthcare|prenatal healthcare
1285410|NCT01646463|preterm birth|preterm birth
1285411|NCT01646463|birth weight|birth weight
1285412|NCT01646463|postpartum depression|postpartum depression
1285413|NCT01646463|cortisol|cortisol
1285414|NCT01646463|neuroendocrine function|neuroendocrine function
1285415|NCT01646463|blood pressure|blood pressure
1285416|NCT01646463|health disparities|health disparities
1285417|NCT01646450|NSCLC|nsclc
1285418|NCT01646450|EGFR Mutation|egfr mutation
1285419|NCT01646450|Elder patients|elder patients
1285420|NCT01646424|COPD,|copd,
1285625|NCT01645735|Infections|infections
1285421|NCT01646424|Patient satisfaction,|patient satisfaction,
1285422|NCT01646424|fix combination,|fix combination,
1285423|NCT01646424|NIS Turkey,|nis turkey,
1285424|NCT01646424|turbuhaler,|turbuhaler,
1285425|NCT01646424|FSI-10|fsi-10
1285426|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
1285427|NCT01646411|Lyme|lyme
1285428|NCT01646411|Toxoplasma|toxoplasma
1285429|NCT01646411|Rubella|rubella
1285430|NCT01646411|Rubeola IgM|rubeola igm
1285431|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
1285432|NCT01646411|Ebv IgM|ebv igm
1285433|NCT01646411|Herpes|herpes
1285434|NCT01646411|Babesia|babesia
1285435|NCT01646411|Measles|measles
1285436|NCT01646411|Tetanus|tetanus
1285437|NCT01646411|Mumps|mumps
1285438|NCT01646411|Mycoplasma|mycoplasma
1285439|NCT01646411|Legionella|legionella
1285440|NCT01646411|Giardia|giardia
1285441|NCT01646411|Syphilis|syphilis
1285442|NCT01646411|Bordetella Pertussis|bordetella pertussis
1285443|NCT01646411|H Pylori|h pylori
1285444|NCT01646411|Antibody Titre|antibody titre
1285445|NCT01646411|Elevated IgG|elevated igg
1285446|NCT01646411|Abnormal IgM|abnormal igm
1384371|NCT01230567|BCC|bcc
1285447|NCT01646411|SLE|sle
1285448|NCT01646398|13VPNC|13vpnc
1285449|NCT01646398|23VPS|23vps
1285450|NCT01646385|observational|observational
1285451|NCT01646385|non-interventional|non-interventional
1285452|NCT01646385|cohort|cohort
1285453|NCT01646385|retrospective|retrospective
1285454|NCT01646385|register|register
1285455|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
1285456|NCT01646372|Medical Education|medical education
1285457|NCT01646372|Cognitive Aid|cognitive aid
1285458|NCT01646372|Crisis Resource Management|crisis resource management
1285459|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
1285460|NCT01646372|Skills Retention|skills retention
1285461|NCT01646346|Breast Cancer|breast cancer
1285462|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
1285463|NCT01646333|Parkinson Disease|parkinson disease
1285464|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
1285465|NCT01646333|Cognition|cognition
1285466|NCT01646333|Executive Function|executive function
1285467|NCT01646333|Learning|learning
1285469|NCT01646333|Problem Solving|problem solving
1285470|NCT01646294|Pharmacokinetics|pharmacokinetics
1285471|NCT01646294|Phase I|phase i
1285472|NCT01646294|YM178|ym178
1285473|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
1285474|NCT01646294|Immediate release (IR)|immediate release (ir)
1285475|NCT01646294|Fasted conditions|fasted conditions
1285476|NCT01646294|Fed conditions|fed conditions
1285477|NCT01646281|Atrial fibrillation|atrial fibrillation
1285478|NCT01646281|Vernakalant|vernakalant
1285479|NCT01646281|Flecainide|flecainide
1285480|NCT01646281|Echocardiography|echocardiography
1285481|NCT01646268|Rotigotine|rotigotine
1285482|NCT01646268|Neupro phase 3|neupro phase 3
1285483|NCT01646268|Early phase|early phase
1285484|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
1285485|NCT01646255|Rotigotine|rotigotine
1285486|NCT01646255|Neupro phase 3|neupro phase 3
1285487|NCT01646255|Advanced-stage|advanced-stage
1285488|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
1285489|NCT01646229|Hemoperfusion|hemoperfusion
1285490|NCT01646229|Polymyxin-B|polymyxin-b
1285491|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
1285492|NCT01646229|Sepsis|sepsis
1285493|NCT01646229|Endotoxin|endotoxin
1285494|NCT01646216|stroke|stroke
1285495|NCT01646216|treadmill|treadmill
1285496|NCT01646216|walking|walking
1285497|NCT01646216|hemiparesis|hemiparesis
1285498|NCT01646216|training|training
1285499|NCT01646203|Advanced Solid Tumors|advanced solid tumors
1285500|NCT01646190|Fast-track|fast-track
1285501|NCT01646190|multimodal perioperative care|multimodal perioperative care
1285502|NCT01646190|enhanced recovery|enhanced recovery
1285503|NCT01646190|colorectal surgery|colorectal surgery
1285504|NCT01646190|elderly patients|elderly patients
1285505|NCT01646190|seniors|seniors
1285506|NCT01646164|Dill seed|dill seed
1285507|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
1285508|NCT01646164|Active phase of labor|active phase of labor
1285509|NCT01646138|H1N1|h1n1
1285510|NCT01646138|Influenza|influenza
1285511|NCT01646138|Human|human
1285512|NCT01646138|Challenge Study|challenge study
1285513|NCT01646138|Healthy Volunteer|healthy volunteer
1285514|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1285515|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
1285516|NCT01646125|lung cancer|lung cancer
1285517|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
1285518|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
1285519|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
1285520|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
1285521|NCT01646125|Non small cell lung cancer|non small cell lung cancer
1285522|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
1285523|NCT01646125|NSCLC|nsclc
1285524|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
1285525|NCT01646125|Large cell lung cancer|large cell lung cancer
1285526|NCT01646125|HSP90|hsp90
1285527|NCT01646125|AUY922|auy922
1285528|NCT01646125|Pemetrexed|pemetrexed
1285529|NCT01646125|Docetaxel|docetaxel
1285530|NCT01646125|EGFR TKI|egfr tki
1285531|NCT01646125|EGFR mutations|egfr mutations
1285532|NCT01646112|Uncertainty|uncertainty
1285533|NCT01646112|HNPCC|hnpcc
1285534|NCT01646112|Lynch Syndrome|lynch syndrome
1285535|NCT01646112|Genetic Tests|genetic tests
1285536|NCT01646099|Kidney transplant|kidney transplant
1285537|NCT01646099|Renal transplant|renal transplant
1285538|NCT01646099|Sun protection|sun protection
1285539|NCT01646099|Skin cancer|skin cancer
1285540|NCT01646086|Weight Loss|weight loss
1285541|NCT01646086|Self-Weighing|self-weighing
1285542|NCT01646086|Weight Tracking|weight tracking
1285543|NCT01646073|Plaque Psoriasis|plaque psoriasis
1285544|NCT01646073|Psoriasis|psoriasis
1285545|NCT01646073|Placebo Controlled|placebo controlled
1285546|NCT01646073|Skin Disease|skin disease
1285547|NCT01646073|Double Blind|double blind
1285549|NCT01646060|loss|loss
1285550|NCT01646060|healthy|healthy
1285551|NCT01646060|volume|volume
1285552|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
1285553|NCT01646047|diabetes|diabetes
1285554|NCT01646047|diabetic retinopathy|diabetic retinopathy
1285555|NCT01646047|nutritional supplements|nutritional supplements
1285556|NCT01646047|visual function|visual function
1285557|NCT01646047|macular pigment|macular pigment
1285558|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
1285559|NCT01646047|contrast sensitivity|contrast sensitivity
1285560|NCT01646047|color vision|color vision
1285561|NCT01646047|optical coherence tomography|optical coherence tomography
1285562|NCT01646034|oligo metastatic|oligo metastatic
1285563|NCT01646034|HRD deficiency|hrd deficiency
1285564|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
1285565|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
1285566|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
1285567|NCT01646021|Ibrutinib|ibrutinib
1285568|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1285569|NCT01646021|Temsirolimus|temsirolimus
1285570|NCT01645956|obesity|obesity
1285571|NCT01645956|exercise|exercise
1285572|NCT01645956|energy intake|energy intake
1285573|NCT01645956|physical activity|physical activity
1285574|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
1285575|NCT01645943|Comorbidities|comorbidities
1285576|NCT01645930|Relapsed multiple myeloma,|relapsed multiple myeloma,
1285577|NCT01645930|Refractory multiple myeloma,|refractory multiple myeloma,
1285578|NCT01645930|MLN9708,|mln9708,
1285579|NCT01645930|Proteasome inhibitor|proteasome inhibitor
1285580|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1285581|NCT01645904|Hereditary Diseases|hereditary diseases
1285582|NCT01645904|Genetic|genetic
1285583|NCT01645904|Lynch syndrome|lynch syndrome
1285584|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
1285585|NCT01645904|Social media|social media
1285586|NCT01645904|Internet-based program|internet-based program
1285587|NCT01645904|Questionnaire|questionnaire
1285588|NCT01645904|Survey|survey
1285589|NCT01645904|My Family Garden website|my family garden website
1285590|NCT01645904|Interview|interview
1285591|NCT01645904|Focus group|focus group
1285592|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
1285593|NCT01645904|WAMMI|wammi
1285594|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
1285595|NCT01645878|Primiparous Mothers|primiparous mothers
1285596|NCT01645878|self-efficacy,|self-efficacy,
1285597|NCT01645878|hands off,|hands off,
1285598|NCT01645878|hands on ,|hands on ,
1285599|NCT01645878|social cognitive theory|social cognitive theory
1285600|NCT01645865|HIV|hiv
1285601|NCT01645865|AIDS|aids
1285602|NCT01645865|PMTCT|pmtct
1285603|NCT01645865|Mobile Phone|mobile phone
1285604|NCT01645865|SMS|sms
1285605|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
1285606|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
1285607|NCT01645839|Depocyte|depocyte
1285608|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
1285609|NCT01645800|COPD|copd
1285610|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
1285611|NCT01645787|4-aminopyridine|4-aminopyridine
1285612|NCT01645787|dalfampridine|dalfampridine
1285613|NCT01645787|Ampyra|ampyra
1285614|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
1285615|NCT01645774|injection duration|injection duration
1285616|NCT01645774|bruising pain|bruising pain
1285617|NCT01645774|decrease pain|decrease pain
1285618|NCT01645774|decrease bruising|decrease bruising
1285619|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
1285620|NCT01645761|Peptic ulcer|peptic ulcer
1285621|NCT01645748|head and neck cancer|head and neck cancer
1285622|NCT01645748|docetaxel|docetaxel
1285623|NCT01645748|cisplatin|cisplatin
1285626|NCT01645735|Teflaro|teflaro
1285627|NCT01645735|cephalosporin|cephalosporin
1285628|NCT01645735|Ceftaroline|ceftaroline
1285629|NCT01645735|antibiotics|antibiotics
1285630|NCT01645735|pneumonia|pneumonia
1285631|NCT01645722|Fat Grafts|fat grafts
1285736|NCT01645007|Galilee|galilee
1285632|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1285633|NCT01645722|Wounded warriors|wounded warriors
1285634|NCT01645722|Amputation pain|amputation pain
1285635|NCT01645696|Diabetes|diabetes
1285636|NCT01645696|Type 1 Diabetes|type 1 diabetes
1285637|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
1285638|NCT01645696|Blood glucose|blood glucose
1285639|NCT01645696|Blood glucose sensor|blood glucose sensor
1285640|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
1285641|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1285642|NCT01645566|stress|stress
1285643|NCT01645566|intervention|intervention
1384602|NCT01229579|OPV|opv
1285644|NCT01645475|enuresis|enuresis
1285645|NCT01645449|Bioequivalence|bioequivalence
1285646|NCT01645449|Atorvastatin calcium|atorvastatin calcium
1285647|NCT01645449|crossover|crossover
1285648|NCT01645436|randomized controlled trial|randomized controlled trial
1285649|NCT01645436|in-hospital exercise|in-hospital exercise
1285650|NCT01645436|children|children
1285651|NCT01645436|cancer|cancer
1285652|NCT01645423|Bioequivalence|bioequivalence
1285653|NCT01645423|Atorvastatin calcium|atorvastatin calcium
1285654|NCT01645423|crossover|crossover
1285655|NCT01645410|Bioequivalence|bioequivalence
1285656|NCT01645410|Atorvastatin calcium|atorvastatin calcium
1285657|NCT01645410|crossover|crossover
1285658|NCT01645397|Asthma|asthma
1285659|NCT01645397|Deep inhalation|deep inhalation
1285660|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
1285661|NCT01645384|Bioequivalence|bioequivalence
1285662|NCT01645384|Atorvastatin calcium|atorvastatin calcium
1285663|NCT01645384|crossover|crossover
1285664|NCT01645371|opioid-induced constipation|opioid-induced constipation
1285665|NCT01645358|COPD|copd
1285666|NCT01645358|NIV|niv
1285667|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
1285668|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
1285669|NCT01645345|wrinkles|wrinkles
1285670|NCT01645345|acne scars|acne scars
1285671|NCT01645332|DLBS3233|dlbs3233
1285672|NCT01645332|new onset|new onset
1285673|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
1285674|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
1285675|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
1285676|NCT01645280|Ustekinumab|ustekinumab
1285677|NCT01645280|STELARA|stelara
1285678|NCT01645280|CNTO 1959|cnto 1959
1285679|NCT01645254|healthy volunteers|healthy volunteers
1285680|NCT01645254|pharmacokinetics|pharmacokinetics
1285681|NCT01645254|malaria|malaria
1285682|NCT01645254|Argemone mexicana|argemone mexicana
1285683|NCT01645241|Ovarian stimulation|ovarian stimulation
1285684|NCT01645241|Luteal phase|luteal phase
1285685|NCT01645241|Egg donors|egg donors
1285686|NCT01645241|Fertility preservation|fertility preservation
1285687|NCT01645202|Aortic stenosis|aortic stenosis
1285688|NCT01645202|TAVI|tavi
1285689|NCT01645202|Device success|device success
1285690|NCT01645202|Aortic regurgitation|aortic regurgitation
1285691|NCT01645189|Hunter syndrome|hunter syndrome
1285692|NCT01645189|idursulfase-beta|idursulfase-beta
1285693|NCT01645189|Hunterase|hunterase
1285694|NCT01645189|GC1111|gc1111
1285695|NCT01645176|OA|oa
1285696|NCT01645176|Knee|knee
1285697|NCT01645163|mHealth|mhealth
1285698|NCT01645163|Complementary feeding|complementary feeding
1285699|NCT01645163|ICDS|icds
1285700|NCT01645150|physical activity|physical activity
1285701|NCT01645150|exercise|exercise
1285702|NCT01645150|training|training
1285703|NCT01645150|fatigue|fatigue
1285704|NCT01645150|cancer|cancer
1285705|NCT01645150|TKI|tki
1285706|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1285707|NCT01645137|prematurity|prematurity
1285708|NCT01645137|OMT|omt
1285709|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
1285710|NCT01645137|neonates|neonates
1285711|NCT01645137|length of stay|length of stay
1285712|NCT01645124|Polycythemia|polycythemia
1285713|NCT01645124|Hematocrit|hematocrit
1285714|NCT01645124|Thrombosis|thrombosis
1285715|NCT01645085|R406|r406
1285716|NCT01645085|Fostamatinib|fostamatinib
1285717|NCT01645085|Phase I|phase i
1285718|NCT01645085|Healthy Subjects|healthy subjects
1285719|NCT01645085|Pharmacokinetics|pharmacokinetics
1285720|NCT01645085|Bioequivalence|bioequivalence
1285721|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
1285722|NCT01645072|Dietary therapy|dietary therapy
1285723|NCT01645072|ketogenic diet|ketogenic diet
1285724|NCT01645072|childhood epilepsy|childhood epilepsy
1285725|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
1285726|NCT01645033|computer|computer
1285727|NCT01645020|absorbable mesh|absorbable mesh
1285728|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
1285729|NCT01645020|Prolift|prolift
1285730|NCT01645020|Prolift + M|prolift + m
1285731|NCT01645020|mesh related complications|mesh related complications
1285732|NCT01645007|Hepatitis B|hepatitis b
1285733|NCT01645007|Prevalence|prevalence
1285734|NCT01645007|HBsAg|hbsag
1285735|NCT01645007|Vaccination|vaccination
1285737|NCT01644968|metastatic carcinoma|metastatic carcinoma
1285738|NCT01644968|lymphoma|lymphoma
1285739|NCT01644968|sarcoma|sarcoma
1285740|NCT01644968|anti-OX40|anti-ox40
1285741|NCT01644955|Gliomas|gliomas
1285742|NCT01644955|Carboplatin|carboplatin
1285743|NCT01644942|Obese|obese
1285744|NCT01644942|insulin sensitive|insulin sensitive
1285745|NCT01644942|insulin resistant|insulin resistant
1285746|NCT01644942|myotubes|myotubes
1285747|NCT01644942|lipid accumulation|lipid accumulation
1285748|NCT01644929|hemiparesis|hemiparesis
1285749|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
1285750|NCT01644929|ischemic stroke|ischemic stroke
1285751|NCT01644929|subacute|subacute
1285752|NCT01644929|rehabilitation|rehabilitation
1285753|NCT01644929|physiotherapy|physiotherapy
1285754|NCT01644929|ergotherapy|ergotherapy
1285755|NCT01644916|COPD|copd
1285756|NCT01644916|Integrated care|integrated care
1285757|NCT01644916|IPCL|ipcl
1285758|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
1285759|NCT01644851|veterans|veterans
1285760|NCT01644851|neuropsychology|neuropsychology
1285761|NCT01644851|neuroimaging|neuroimaging
1285762|NCT01644851|attention|attention
1285763|NCT01644851|working memory|working memory
1285764|NCT01644851|inhibition|inhibition
1285765|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
1285766|NCT01644851|trauma|trauma
1285767|NCT01644851|stress|stress
1285768|NCT01644851|anxiety|anxiety
1285769|NCT01644851|emotion|emotion
1285770|NCT01644851|prefrontal cortex|prefrontal cortex
1285771|NCT01644838|Hyoscine,|hyoscine,
1285772|NCT01644838|Promethazine,|promethazine,
1285773|NCT01644838|The first stage of labor,|the first stage of labor,
1285774|NCT01644838|Labor pain|labor pain
1285775|NCT01644825|platinum resistant|platinum resistant
1285776|NCT01644825|platinum refractory|platinum refractory
1285777|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1285778|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1285779|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1285780|NCT01644786|head and neck|head and neck
1285781|NCT01644786|HNSCC|hnscc
1285782|NCT01644786|orophaynx|orophaynx
1285783|NCT01644786|hypopharynx|hypopharynx
1285784|NCT01644786|larynx|larynx
1285785|NCT01644786|nasopharynx|nasopharynx
1285786|NCT01644786|oral cavity|oral cavity
1285787|NCT01644786|prospective study|prospective study
1285788|NCT01644786|predictive models for HNSCC|predictive models for hnscc
1285789|NCT01644786|genomic analyses|genomic analyses
1285790|NCT01644786|outcome prediction|outcome prediction
1285791|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
1285792|NCT01644760|normality|normality
1285793|NCT01644747|Resistant Depression|resistant depression
1285794|NCT01644747|Moods disorders|moods disorders
1285795|NCT01644747|Unipolar depression|unipolar depression
1285796|NCT01644747|Bipolar disorder|bipolar disorder
1285797|NCT01644747|tDCS|tdcs
1285798|NCT01644721|Child mortality|child mortality
1285799|NCT01644721|Measles vaccine|measles vaccine
1285800|NCT01644721|Non-specific effects|non-specific effects
1285801|NCT01644708|Obesity|obesity
1285802|NCT01644708|Overweight|overweight
1285803|NCT01644708|Individual empowerment|individual empowerment
1285804|NCT01644708|Physical parameters|physical parameters
1285805|NCT01644708|Self esteem|self esteem
1285806|NCT01644695|BARS|bars
1285807|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
1285808|NCT01644695|Hernia|hernia
1285809|NCT01644695|Incisional|incisional
1285810|NCT01644695|Recurrent|recurrent
1285811|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
1285812|NCT01644695|abdominal wall defect|abdominal wall defect
1285813|NCT01644695|mesh|mesh
1285814|NCT01644695|component separation|component separation
1285815|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
1285816|NCT01644682|insecticide|insecticide
1285817|NCT01644682|wall lining|wall lining
1285818|NCT01644682|KO TAB123|ko tab123
1285819|NCT01644682|Household|household
1285820|NCT01644682|Kala-azar endemic area|kala-azar endemic area
1285821|NCT01644656|portal hypertension|portal hypertension
1285822|NCT01644656|cirrhosis|cirrhosis
1285823|NCT01644656|ARFI|arfi
1285824|NCT01644656|diagnostic study|diagnostic study
1285825|NCT01644643|Ceftazidime,|ceftazidime,
1285826|NCT01644643|avibactam,|avibactam,
1285827|NCT01644643|metronidazone,|metronidazone,
1285828|NCT01644643|Anti-Infectives|anti-infectives
1285829|NCT01644604|Hypertension|hypertension
1285830|NCT01644604|Vascular Diseases|vascular diseases
1285831|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
1285832|NCT01644604|Renal denervation|renal denervation
1285833|NCT01644591|Melanoma|melanoma
1285834|NCT01644591|Malignant melanoma|malignant melanoma
1285835|NCT01644591|Brain Metastases|brain metastases
1285836|NCT01644591|Stereotactic Radiosurgery|stereotactic radiosurgery
1285838|NCT01644591|XRT|xrt
1285839|NCT01644591|Questionnaires|questionnaires
1285840|NCT01644591|Surveys|surveys
1285841|NCT01644578|MRI|mri
1285842|NCT01644578|real-time imaging|real-time imaging
1285843|NCT01644578|workflow|workflow
1285844|NCT01644552|aniridia|aniridia
1285845|NCT01644552|positive angle kappa|positive angle kappa
1285846|NCT01644539|Satiation|satiation
1285847|NCT01644539|Brain activation|brain activation
1285848|NCT01644539|Gut peptides|gut peptides
1285849|NCT01644526|dialysis|dialysis
1285850|NCT01644526|vascular access|vascular access
1285851|NCT01644526|arteriovenous grafts|arteriovenous grafts
1384861|NCT01228188|PPV|ppv
1285852|NCT01644526|valve system|valve system
1285853|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
1285854|NCT01644513|Choroidal Neovascular|choroidal neovascular
1285855|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
1285856|NCT01644409|OAB|oab
1285857|NCT01644409|Overactive bladder|overactive bladder
1285858|NCT01644409|Urgency|urgency
1285859|NCT01644409|Incontinence|incontinence
1285860|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
1285861|NCT01644383|meaning of life|meaning of life
1285862|NCT01644383|logotherapy|logotherapy
1285863|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
1285864|NCT01644383|adherence|adherence
1285865|NCT01644370|HIV-infected children|hiv-infected children
1285866|NCT01644370|T cell response|t cell response
1285867|NCT01644370|asthma|asthma
1285868|NCT01644292|Mobility Impairment|mobility impairment
1285869|NCT01644292|Manual Wheelchair|manual wheelchair
1285870|NCT01644292|Older Adults|older adults
1285871|NCT01644279|aging|aging
1285872|NCT01644279|sarcopenia|sarcopenia
1285873|NCT01644279|mitochondria|mitochondria
1285874|NCT01644279|skeletal muscle|skeletal muscle
1285875|NCT01644279|apoptosis|apoptosis
1285876|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1285877|NCT01644253|CLL|cll
1285878|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
1285879|NCT01644253|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1285880|NCT01644253|PTCL|ptcl
1285881|NCT01644227|Hip surgery|hip surgery
1285882|NCT01644227|dual mobility cup|dual mobility cup
1285883|NCT01644227|dislocation|dislocation
1285884|NCT01644227|total hip arthroplasty|total hip arthroplasty
1285885|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
1285886|NCT01644214|Pessary|pessary
1285887|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
1285888|NCT01644162|Disease Exacerbation|disease exacerbation
1285889|NCT01644162|Respiratory Failure|respiratory failure
1285890|NCT01644149|Jet Injector|jet injector
1285891|NCT01644149|Stratis®|stratis®
1285892|NCT01644149|PharmaJet|pharmajet
1285893|NCT01644149|Jet Injection|jet injection
1285894|NCT01644123|Spasticity|spasticity
1285895|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
1285896|NCT01644097|Quality of Life|quality of life
1285897|NCT01644084|albumin|albumin
1285898|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
1285899|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
1285900|NCT01644071|violent video games|violent video games
1285901|NCT01644071|serotonergic system|serotonergic system
1285902|NCT01644058|immediate-loading|immediate-loading
1285903|NCT01644058|patient-based outcomes|patient-based outcomes
1285904|NCT01644045|Asthma|asthma
1285905|NCT01644045|COPD|copd
1285906|NCT01644045|emergency medical service|emergency medical service
1285907|NCT01644045|teleconsultation|teleconsultation
1285908|NCT01644045|telemedicine|telemedicine
1285909|NCT01644032|telemedicine|telemedicine
1285910|NCT01644032|teleconsultation|teleconsultation
1285911|NCT01644032|analgesia|analgesia
1285912|NCT01644032|emergency|emergency
1285913|NCT01644032|prehospital|prehospital
1285914|NCT01644019|stroke|stroke
1285915|NCT01644019|teleconsultation|teleconsultation
1285916|NCT01644019|telemedicine|telemedicine
1285917|NCT01644019|emergency medical service|emergency medical service
1285918|NCT01644006|acute coronary syndrome|acute coronary syndrome
1285919|NCT01644006|telemedicine|telemedicine
1285920|NCT01644006|teleconsultation|teleconsultation
1285921|NCT01644006|emergency medical service|emergency medical service
1285922|NCT01643993|IVF|ivf
1285923|NCT01643993|embryo|embryo
1285924|NCT01643967|Ozone|ozone
1285925|NCT01643967|Sunflower oil|sunflower oil
1285926|NCT01643967|diabetes Mellitus|diabetes mellitus
1285927|NCT01643954|prostatectomy|prostatectomy
1285928|NCT01643954|surgery|surgery
1285929|NCT01643954|prostate cancer|prostate cancer
1285930|NCT01643941|Staphylococcus aureus|staphylococcus aureus
1285931|NCT01643941|vaccine|vaccine
1285932|NCT01643941|Staphylococcal infection|staphylococcal infection
1285933|NCT01643928|extension trial|extension trial
1285934|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
1285935|NCT01643928|rituximab|rituximab
1285936|NCT01643915|Audiovisual distraction|audiovisual distraction
1285937|NCT01643915|Pediatric dentistry|pediatric dentistry
1285938|NCT01643902|Stroke|stroke
1285939|NCT01643902|Wake up|wake up
1285940|NCT01643902|IV tPA|iv tpa
1285941|NCT01643902|Thrombolytic|thrombolytic
1285942|NCT01643889|Healthy|healthy
1285943|NCT01643889|Domperidone|domperidone
1285944|NCT01643889|Cardiac Repolarization|cardiac repolarization
1285945|NCT01643876|Denture stomatitis|denture stomatitis
1285946|NCT01643876|Denture Plaque|denture plaque
1285947|NCT01643876|Oral Candidiasis|oral candidiasis
1285948|NCT01643876|Oral Hygiene|oral hygiene
1285949|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
1285950|NCT01643850|PVNS|pvns
1285951|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
1285952|NCT01643850|GCCTS|gccts
1285953|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
1285954|NCT01643850|GCTS|gcts
1285955|NCT01643850|MCS110|mcs110
1285956|NCT01643837|Mastalgia|mastalgia
1285957|NCT01643837|Breast Pain|breast pain
1285958|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1285959|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1285960|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
1285961|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
1285962|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
1285963|NCT01643733|Angioplasty|angioplasty
1285964|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
1285965|NCT01643707|Bradycardia|bradycardia
1285966|NCT01643616|Sciatic Nerve|sciatic nerve
1285967|NCT01643616|Ultrasound|ultrasound
1285968|NCT01643616|Anesthesia, Regional|anesthesia, regional
1285969|NCT01643616|Orthopedic Surgery|orthopedic surgery
1285970|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1285971|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1285972|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1285973|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1285974|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1286799|NCT01640418|higher risk patients|higher risk patients
1285975|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1285976|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1285977|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1285978|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1285979|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1285980|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1285981|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1285982|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1285983|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1285984|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1285985|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1285986|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1285987|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1285988|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1285989|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1285990|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1285991|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1285992|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1285993|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1285994|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1285995|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1285996|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1285997|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1285998|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1285999|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1286000|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1286001|NCT01643603|intraocular lymphoma|intraocular lymphoma
1286002|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1286003|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1286004|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1286005|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1286006|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1286151|NCT01643395|conservative treatment|conservative treatment
1286007|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1286008|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1286009|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1286010|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1286011|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1286012|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1286013|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1286014|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1286015|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1286016|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1286017|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1286018|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1286019|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1286020|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1286021|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1286022|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1286023|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1286024|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1286025|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1286026|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1286027|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1286028|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1286029|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1286030|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1286031|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1286032|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1286033|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1286034|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1286035|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1286036|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1286037|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1286038|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
1286039|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1286040|NCT01643603|small intestine lymphoma|small intestine lymphoma
1286041|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1286042|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1286043|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1286044|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1286045|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1286046|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1286047|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1286048|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1286049|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1286050|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1286051|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1286052|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1286053|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1286054|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1286055|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1286056|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1286057|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1286058|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
1286059|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
1286060|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1286061|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1286062|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1286063|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
1286064|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
1286065|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1286066|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1286067|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1286068|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1286069|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1286152|NCT01643382|diabetes|diabetes
1286070|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1286071|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1286072|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1286461|NCT01641796|Topical|topical
1286073|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1286074|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1286075|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1286076|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1286077|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1286078|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1286079|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1286080|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1286081|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
1286082|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
1286083|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1286084|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1286085|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1286086|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1286087|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1286088|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1286089|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1286090|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1286091|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1286092|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1286093|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1286094|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1286095|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1286096|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1286097|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1286098|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1286099|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
1286100|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
1286101|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1286102|NCT01643603|testicular lymphoma|testicular lymphoma
1286103|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
1286104|NCT01643577|Idiopathic|idiopathic
1286105|NCT01643577|gastroparesis|gastroparesis
1286106|NCT01643577|delayed gastric emptying|delayed gastric emptying
1286108|NCT01643577|vomiting|vomiting
1286109|NCT01643577|abdominal pain|abdominal pain
1286110|NCT01643577|bloating|bloating
1286111|NCT01643564|Transplant|transplant
1286112|NCT01643564|Cytokines|cytokines
1286113|NCT01643564|Graft Dysfunction|graft dysfunction
1286114|NCT01643551|Heart Failure|heart failure
1286115|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
1286116|NCT01643551|Reperfusion Injury|reperfusion injury
1286117|NCT01643551|Neuron Specific Enolase|neuron specific enolase
1286118|NCT01643538|physical activity|physical activity
1286119|NCT01643538|adults age 65 and older|adults age 65 and older
1286120|NCT01643538|financial incentives|financial incentives
1286121|NCT01643525|Ischemic Stroke|ischemic stroke
1286122|NCT01643486|peritoneal dialysis|peritoneal dialysis
1286123|NCT01643486|phosphate|phosphate
1286124|NCT01643486|iTouch|itouch
1286125|NCT01643473|Hypertension|hypertension
1286126|NCT01643473|Latinos|latinos
1286127|NCT01643473|Medication Adherence|medication adherence
1286128|NCT01643473|Blood Pressure Control|blood pressure control
1286129|NCT01643473|Patient-centered|patient-centered
1286130|NCT01643473|Black|black
1286131|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
1286132|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
1286133|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
1286134|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
1286135|NCT01643447|Ulinastatin|ulinastatin
1286136|NCT01643447|Hepatic Failure|hepatic failure
1286137|NCT01643434|Resistant Hypertension|resistant hypertension
1286138|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1286139|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1286140|NCT01643408|Erwinaze|erwinaze
1286141|NCT01643408|asparaginase|asparaginase
1286142|NCT01643408|Eusa Pharma|eusa pharma
1286143|NCT01643408|Pharmacokinetic study|pharmacokinetic study
1286144|NCT01643408|NSAA|nsaa
1286145|NCT01643395|Trauma|trauma
1286146|NCT01643395|vertebral|vertebral
1286147|NCT01643395|compression fracture|compression fracture
1286148|NCT01643395|spinal|spinal
1286149|NCT01643395|acute|acute
1286150|NCT01643395|vertebroplasty|vertebroplasty
1286454|NCT01641809|HIV -1|hiv -1
1286153|NCT01643382|kidney transplant|kidney transplant
1286154|NCT01643382|end stage renal disease|end stage renal disease
1286155|NCT01643382|delayed draft function|delayed draft function
1286156|NCT01643369|meditation|meditation
1286157|NCT01643369|compassion|compassion
1286158|NCT01643369|inflammation|inflammation
1286159|NCT01643369|immune system|immune system
1286160|NCT01643356|weight|weight
1286161|NCT01643356|pregnancy|pregnancy
1286162|NCT01643356|behavioral intervention|behavioral intervention
1286163|NCT01643356|obesity|obesity
1286164|NCT01643343|autism spectrum disorders|autism spectrum disorders
1286165|NCT01643343|autism|autism
1286166|NCT01643343|joint attention|joint attention
1286167|NCT01643343|imitation|imitation
1286168|NCT01643343|fluency|fluency
1286169|NCT01643330|Cardiomegaly|cardiomegaly
1286170|NCT01643330|Heart Diseases|heart diseases
1286171|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
1286172|NCT01643304|Menorrhagia|menorrhagia
1286173|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
1286174|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
1286175|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
1286176|NCT01643252|Corneal Ectasia|corneal ectasia
1286177|NCT01643252|Refractive surgery|refractive surgery
1286178|NCT01643252|Cross-Linking|cross-linking
1286179|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
1286180|NCT01643239|Children with cerebral palsy|children with cerebral palsy
1286181|NCT01643239|Kinematic analysis|kinematic analysis
1286182|NCT01643239|Group therapy|group therapy
1286183|NCT01643200|Erectile Dysfunction|erectile dysfunction
1286184|NCT01643200|Male|male
1286185|NCT01643200|Zotarolimus|zotarolimus
1286186|NCT01643200|Stent|stent
1286187|NCT01643200|Stenosis|stenosis
1286188|NCT01643200|Erection|erection
1286189|NCT01643200|PDE5 Inhibitors|pde5 inhibitors
1286190|NCT01643148|biomarker|biomarker
1286192|NCT01643148|breast cancer|breast cancer
1286193|NCT01643148|CA-15-3|ca-15-3
1286194|NCT01643148|leptin|leptin
1286195|NCT01643135|tranexamic acid|tranexamic acid
1286196|NCT01643135|bleeding|bleeding
1286197|NCT01643135|blood transfusion|blood transfusion
1286198|NCT01643135|spine surgery|spine surgery
1286199|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
1286200|NCT01643109|Cerebral Palsy|cerebral palsy
1286201|NCT01643109|Hemiplegia|hemiplegia
1286202|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
1286203|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
1286204|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
1286205|NCT01643070|Rectal cancer|rectal cancer
1286206|NCT01643070|Liver metastases|liver metastases
1286207|NCT01643070|Capecitabine|capecitabine
1286208|NCT01643070|Oxaliplatin|oxaliplatin
1286209|NCT01643057|Apnea|apnea
1286210|NCT01643057|Prematurity|prematurity
1286211|NCT01643057|Biomarkers|biomarkers
1286212|NCT01643057|Stochastic Resonance|stochastic resonance
1286213|NCT01643057|Neonatal|neonatal
1286214|NCT01643044|pregnancy|pregnancy
1286215|NCT01643044|screening|screening
1286216|NCT01643044|motivation|motivation
1286217|NCT01643031|Diabetes|diabetes
1286218|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
1286219|NCT01643031|Platelet function tests|platelet function tests
1286220|NCT01643018|cystic echinococcosis|cystic echinococcosis
1286221|NCT01643018|liver cyst hydatique|liver cyst hydatique
1286222|NCT01643018|treatment|treatment
1286223|NCT01643018|surgery|surgery
1286224|NCT01643018|laparoscopy|laparoscopy
1286225|NCT01643005|HIV|hiv
1286226|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
1286227|NCT01642992|Drug-eluting stent|drug-eluting stent
1286228|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1286229|NCT01642979|Anemia|anemia
1286230|NCT01642979|Hematologic Diseases|hematologic diseases
1286231|NCT01642979|bone marrow failure|bone marrow failure
1286232|NCT01642979|Immunologic Factors|immunologic factors
1286233|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
1286234|NCT01642979|Levamisole|levamisole
1286235|NCT01642979|cyclosporine A|cyclosporine a
1286236|NCT01642966|ticagrelor|ticagrelor
1286237|NCT01642966|doppler echocardiography|doppler echocardiography
1286238|NCT01642953|Gastric cancer surgery|gastric cancer surgery
1286239|NCT01642953|Early oral feeding|early oral feeding
1286240|NCT01642953|Fast track surgery|fast track surgery
1286241|NCT01642927|LVAD|lvad
1286242|NCT01642927|IABP|iabp
1286243|NCT01642927|Heart Failure|heart failure
1286244|NCT01642927|Thrombosis|thrombosis
1286245|NCT01642927|Hemorrhage|hemorrhage
1286246|NCT01642914|Chronic Constipation|chronic constipation
1286247|NCT01642914|Abdominal Bloating|abdominal bloating
1286248|NCT01642914|Linaclotide|linaclotide
1286249|NCT01642901|spinal cord injury|spinal cord injury
1286250|NCT01642901|bone mineral density|bone mineral density
1286251|NCT01642875|Periampullary tumor|periampullary tumor
1286252|NCT01642875|Chronic pancreatitis|chronic pancreatitis
1286253|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
1286254|NCT01642875|Oral Nutrition|oral nutrition
1286255|NCT01642875|Enteral Nutrition|enteral nutrition
1286256|NCT01642849|high protein diet|high protein diet
1286257|NCT01642849|high carbohydrate diet|high carbohydrate diet
1286258|NCT01642849|weight loss|weight loss
1286259|NCT01642849|oxidative stress|oxidative stress
1286260|NCT01642849|inflammation|inflammation
1286261|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
1286262|NCT01642823|retinoblastoma|retinoblastoma
1286263|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
1286264|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
1286265|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
1286266|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
1286267|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
1286268|NCT01642797|gastric carcinoma|gastric carcinoma
1286269|NCT01642784|STEMI|stemi
1286270|NCT01642784|NSTEMI|nstemi
1286271|NCT01642784|revascularization|revascularization
1286272|NCT01642784|stents|stents
1286273|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
1286274|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
1286275|NCT01642771|Docetaxel|docetaxel
1286276|NCT01642771|Capecitabine|capecitabine
1286277|NCT01642771|Epirubicin|epirubicin
1286278|NCT01642771|Cyclophosphamide|cyclophosphamide
1286279|NCT01642771|Fluorouracil|fluorouracil
1286280|NCT01642758|Thalassemia intermedia|thalassemia intermedia
1286281|NCT01642758|Fetal hemoglobin|fetal hemoglobin
1286282|NCT01642758|Hemoglobin|hemoglobin
1286283|NCT01642732|Prostate|prostate
1286284|NCT01642732|Cancer|cancer
1286285|NCT01642732|Everolimus|everolimus
1286286|NCT01642732|Radiation|radiation
1286287|NCT01642719|Sleep disturbance|sleep disturbance
1286288|NCT01642719|Aging|aging
1286289|NCT01642719|Sleep restriction|sleep restriction
1286290|NCT01642719|Health status|health status
1286291|NCT01642719|Glucose tolerance|glucose tolerance
1286292|NCT01642719|Inflammation|inflammation
1286293|NCT01642706|Regulatory B cells|regulatory b cells
1286294|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
1286295|NCT01642706|Biomarker|biomarker
1286296|NCT01642693|root resorption|root resorption
1286297|NCT01642693|low-power laser|low-power laser
1286298|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
1286299|NCT01642693|pulp changes|pulp changes
1286300|NCT01642680|Physical activity program|physical activity program
1286301|NCT01642680|Chemotherapy|chemotherapy
1286302|NCT01642680|Metabolic syndrome|metabolic syndrome
1286303|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
1286304|NCT01642680|low physical activity level|low physical activity level
1286305|NCT01642628|Mirror|mirror
1286306|NCT01642628|Body Image|body image
1286307|NCT01642628|Mastectomy|mastectomy
1286308|NCT01642615|Drug therapy|drug therapy
1286309|NCT01642602|Drug Therapy|drug therapy
1286310|NCT01642589|Meningitis|meningitis
1286311|NCT01642589|Meningococcal disease|meningococcal disease
1286312|NCT01642589|Menactra®|menactra®
1286313|NCT01642589|Adacel®|adacel®
1286314|NCT01642576|obesity|obesity
1286315|NCT01642576|men|men
1286316|NCT01642576|sexual function|sexual function
1286317|NCT01642576|urinary tract symptoms|urinary tract symptoms
1286318|NCT01642576|endothelial function|endothelial function
1286319|NCT01642576|inflammation|inflammation
1286320|NCT01642576|quality of life|quality of life
1286321|NCT01642563|Platelet transfusion|platelet transfusion
1286322|NCT01642563|Leukemia|leukemia
1286323|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
1286324|NCT01642563|Chemotherapy|chemotherapy
1286325|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
1286326|NCT01642550|Anorexia nervosa|anorexia nervosa
1286327|NCT01642550|Anorexia|anorexia
1286328|NCT01642550|Eating disorders|eating disorders
1286329|NCT01642524|resuscitation|resuscitation
1286330|NCT01642511|Breast Cancer|breast cancer
1286331|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1286332|NCT01642511|Internal Mammary|internal mammary
1286333|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
1286334|NCT01642498|High Blood Pressure|high blood pressure
1286335|NCT01642498|Hypertension|hypertension
1286336|NCT01642498|Resistant Hypertension|resistant hypertension
1286337|NCT01642485|Insulin clamp|insulin clamp
1286338|NCT01642485|Glucose clamp|glucose clamp
1286339|NCT01642485|Moxifloxacin|moxifloxacin
1286340|NCT01642485|Fed|fed
1286341|NCT01642485|Fasted|fasted
1286342|NCT01642485|QT/QTC interval|qt/qtc interval
1286343|NCT01642485|TQT|tqt
1286344|NCT01642485|ECG|ecg
1286345|NCT01642485|Meal effects|meal effects
1286346|NCT01642485|C Peptide|c peptide
1286347|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
1286348|NCT01642485|TQT bridging|tqt bridging
1286349|NCT01642485|FDA standard breakfast|fda standard breakfast
1286350|NCT01642485|Adaptive study design|adaptive study design
1286351|NCT01642459|arteriovenous fistula|arteriovenous fistula
1286352|NCT01642459|hemodialysis|hemodialysis
1286353|NCT01642459|aneurysm|aneurysm
1286354|NCT01642459|vascular stenosis|vascular stenosis
1286355|NCT01642459|cannulation|cannulation
1286356|NCT01642446|precise hepatectomy|precise hepatectomy
1286357|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
1286358|NCT01642446|cirrhotic|cirrhotic
1608883|NCT00361699|pravastatin|pravastatin
1286359|NCT01642446|portal hypertension|portal hypertension
1286360|NCT01642446|safety|safety
1286462|NCT01641796|Treatment|treatment
1286361|NCT01642446|combined interventional treatment|combined interventional treatment
1286362|NCT01642394|Diabetes Mellitus|diabetes mellitus
1286363|NCT01642394|Chronic Disease|chronic disease
1286364|NCT01642394|Education|education
1286365|NCT01642394|Primary Care|primary care
1286366|NCT01642394|Self care|self care
1286367|NCT01642394|Self Management|self management
1286368|NCT01642381|Drinking|drinking
1286369|NCT01642381|Alcohol Problems|alcohol problems
1286370|NCT01642381|Alcoholism|alcoholism
1286371|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
1286372|NCT01642381|Controlled Drinking|controlled drinking
1286373|NCT01642381|Reduced Drinking|reduced drinking
1286374|NCT01642381|Heavy Drinking|heavy drinking
1286375|NCT01642381|Problematic Drinking|problematic drinking
1286376|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
1286377|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
1286378|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
1286379|NCT01642368|Cognitive response|cognitive response
1286380|NCT01642368|Physical performance|physical performance
1286381|NCT01642329|Myocardial Infarction|myocardial infarction
1286382|NCT01642329|Angina, Unstable|angina, unstable
1286383|NCT01642316|washback, reading comprehension|washback, reading comprehension
1286384|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
1286385|NCT01642277|Overactive Bladder|overactive bladder
1286386|NCT01642277|OAB|oab
1286387|NCT01642277|Urinary Tract Infection|urinary tract infection
1286388|NCT01642277|UTI|uti
1286389|NCT01642277|Microbiome|microbiome
1286390|NCT01642277|Bacteria|bacteria
1286391|NCT01642277|Solifenacin|solifenacin
1286392|NCT01642277|16S rRNA sequence|16s rrna sequence
1286393|NCT01642264|Tobacco Cessation|tobacco cessation
1286394|NCT01642264|Continuing Education|continuing education
1286395|NCT01642264|Pediatric|pediatric
1286396|NCT01642264|Respiratory Therapist|respiratory therapist
1286397|NCT01642264|Nurse|nurse
1286398|NCT01642238|Antiplatelet|antiplatelet
1286399|NCT01642238|ticagrelor|ticagrelor
1286400|NCT01642238|clopidogrel|clopidogrel
1286401|NCT01642238|bivalirudin|bivalirudin
1286402|NCT01642238|thrombosis|thrombosis
1286403|NCT01642212|EoE|eoe
1286404|NCT01642199|obesity|obesity
1286405|NCT01642199|weight loss|weight loss
1286406|NCT01642199|lay health coach|lay health coach
1286407|NCT01642199|peer coach|peer coach
1286408|NCT01642199|mentor coach|mentor coach
1286409|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
1286410|NCT01642186|LETROZOLE|letrozole
1286411|NCT01642186|LUPRON DEPOT|lupron depot
1286412|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
1286413|NCT01642186|11-211|11-211
1286414|NCT01642147|Cerebral blood flow|cerebral blood flow
1286415|NCT01642147|Transcranial Doppler|transcranial doppler
1286416|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
1286417|NCT01642134|Antiplatelet|antiplatelet
1286418|NCT01642134|Anticoagulation|anticoagulation
1286419|NCT01642056|Fibroblasts|fibroblasts
1286420|NCT01642056|Mitochondria|mitochondria
1286421|NCT01642056|Energy|energy
1286422|NCT01642056|Redox|redox
1286423|NCT01642056|Metabolic Disease|metabolic disease
1286424|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
1286425|NCT01642043|trochanteric bursitis|trochanteric bursitis
1286426|NCT01642043|lateral hip pain|lateral hip pain
1286427|NCT01642030|Quantitative sensory testing|quantitative sensory testing
1286428|NCT01642030|Cold pressor test|cold pressor test
1286429|NCT01642030|Opioid dependence|opioid dependence
1286430|NCT01642030|Methadone maintenance|methadone maintenance
1286431|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
1286432|NCT01642030|Abuse liability|abuse liability
1286433|NCT01642030|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
1286434|NCT01642030|Temporal Summation|temporal summation
1286435|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
1286436|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
1286437|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
1286438|NCT01641900|sleep|sleep
1286439|NCT01641900|memory|memory
1286440|NCT01641900|schizophrenia|schizophrenia
1286441|NCT01641900|eszopiclone|eszopiclone
1286442|NCT01641887|GERD|gerd
1286443|NCT01641887|Heartburn|heartburn
1286444|NCT01641887|Decision Aid|decision aid
1286445|NCT01641874|Knee|knee
1286446|NCT01641874|Osteoarthritis|osteoarthritis
1286447|NCT01641874|McKenzie system|mckenzie system
1286448|NCT01641874|Exercise|exercise
1286449|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
1286450|NCT01641874|Directional preference|directional preference
1286451|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
1286452|NCT01641861|Papacarie®|papacarie®
1286453|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
1286455|NCT01641809|GSK1265744|gsk1265744
1286456|NCT01641809|maintenance phase|maintenance phase
1286457|NCT01641809|dose selection|dose selection
1286458|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1286460|NCT01641796|Lesion|lesion
1286463|NCT01641796|Cream|cream
1286464|NCT01641796|Expanded Access|expanded access
1286465|NCT01641783|advanced|advanced
1286466|NCT01641783|paclitaxel|paclitaxel
1286467|NCT01641783|capecitabine|capecitabine
1286468|NCT01641783|first line therapy|first line therapy
1286469|NCT01641757|hemodialysis|hemodialysis
1286470|NCT01641757|periodontitis|periodontitis
1286471|NCT01641744|Parent Child Relationship|parent child relationship
1286472|NCT01641744|Maltreatment|maltreatment
1286473|NCT01641744|Risk Behaviors|risk behaviors
1286474|NCT01641744|Social and Emotional Development|social and emotional development
1286475|NCT01641744|Violence and Abuse|violence and abuse
1286476|NCT01641744|Policy|policy
1286477|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
1286478|NCT01641731|oral tolerance induction|oral tolerance induction
1286479|NCT01641718|Hernia, Inguinal|hernia, inguinal
1286480|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
1286481|NCT01641705|respiratory mechanics|respiratory mechanics
1286482|NCT01641705|time of disease|time of disease
1286483|NCT01641692|Asthma|asthma
1286484|NCT01641692|Pharmacokinetics|pharmacokinetics
1286485|NCT01641692|GSK573719|gsk573719
1286486|NCT01641692|Adults|adults
1286487|NCT01641692|Pharmacogenetics|pharmacogenetics
1286488|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
1286489|NCT01641679|I124-PET/CT|i124-pet/ct
1286490|NCT01641679|FDG-PET/CT|fdg-pet/ct
1286491|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
1286492|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
1286493|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
1286494|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
1286495|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
1286496|NCT01641640|HCV|hcv
1286497|NCT01641640|Sustained Virologic Response|sustained virologic response
1286498|NCT01641640|Direct Acting Antiviral|direct acting antiviral
1286499|NCT01641640|Combination Therapy|combination therapy
1286500|NCT01641640|Treatment-Naïve|treatment-naïve
1286501|NCT01641640|GS-7977|gs-7977
1286502|NCT01641640|Ribavirin|ribavirin
1286503|NCT01641640|RBV|rbv
1286504|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
1286505|NCT01641640|PEG|peg
1286506|NCT01641627|knee arthritis|knee arthritis
1286507|NCT01641627|muscle atrophy|muscle atrophy
1286508|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
1286509|NCT01641627|vibrations|vibrations
1286510|NCT01641614|Mitral valve|mitral valve
1286511|NCT01641614|valve replacement|valve replacement
1286512|NCT01641614|arrested heart|arrested heart
1286513|NCT01641614|beating heart|beating heart
1286514|NCT01641601|Induction of labor|induction of labor
1286515|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
1286516|NCT01641588|cognitive executive function|cognitive executive function
1286517|NCT01641588|posture|posture
1286518|NCT01641588|cognitive performance|cognitive performance
1286519|NCT01641588|heart rate|heart rate
1286520|NCT01641588|eeg|eeg
1286521|NCT01641575|CO-1.01|co-1.01
1286522|NCT01641575|CO-101|co-101
1286523|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
1286524|NCT01641575|hENT1|hent1
1286525|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
1286526|NCT01641575|solid tumor|solid tumor
1286527|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
1286528|NCT01641575|NSCLC|nsclc
1286529|NCT01641575|lung cancer|lung cancer
1286530|NCT01641562|BREAST CANCER,|breast cancer,
1286531|NCT01641562|TAXANES,|taxanes,
1286532|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
1286533|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
1286534|NCT01641562|PREDICTIVE MODELS|predictive models
1286535|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
1286536|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
1286537|NCT01641549|Emergency surgery|emergency surgery
1286538|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
1286539|NCT01641536|Virus Diseases|virus diseases
1286540|NCT01641536|DNA Virus Infections|dna virus infections
1286541|NCT01641536|Hepatitis B|hepatitis b
1286542|NCT01641536|Liver|liver
1286543|NCT01641536|Chronic Disease|chronic disease
1286544|NCT01641536|HBV|hbv
1286545|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
1286546|NCT01641523|Hydroxyapatite|hydroxyapatite
1286547|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
1286548|NCT01641523|Autologous Bone|autologous bone
1286549|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
1286550|NCT01641510|high platelet reactivity|high platelet reactivity
1286551|NCT01641510|clopidogrel|clopidogrel
1286552|NCT01641510|prasugrel|prasugrel
1286553|NCT01641497|endometrial cancer|endometrial cancer
1286554|NCT01641497|IMRT|imrt
1286555|NCT01641497|age over 70|age over 70
1286556|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1286557|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
1286558|NCT01641471|Pain|pain
1286559|NCT01641471|Function|function
1286560|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
1286561|NCT01641458|Genotyping|genotyping
1286562|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
1286563|NCT01641458|Toxicity|toxicity
1286564|NCT01641458|5-fluorouracil|5-fluorouracil
1286565|NCT01641458|Capecitabine|capecitabine
1286566|NCT01641419|Pain|pain
1286567|NCT01641419|Ropivacaine|ropivacaine
1286568|NCT01641419|sciatic block|sciatic block
1286569|NCT01641419|dexamethasone|dexamethasone
1286570|NCT01641406|NAC Protocol|nac protocol
1286571|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
1286572|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
1286573|NCT01641406|NAC CCAM 1101|nac ccam 1101
1286574|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1286575|NCT01641393|Cystic Fibrosis|cystic fibrosis
1286576|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
1286577|NCT01641380|Depoprovera|depoprovera
1286578|NCT01641380|Contraception|contraception
1286579|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
1286580|NCT01641380|Pregnancy Prevention|pregnancy prevention
1286581|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
1286582|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
1286583|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
1286584|NCT01641341|Stool test|stool test
1286585|NCT01641341|Rome III|rome iii
1286586|NCT01641341|Practice-based research|practice-based research
1286587|NCT01641341|treatable parasite|treatable parasite
1286588|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
1286589|NCT01641341|Bowel dysbiosis|bowel dysbiosis
1286590|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
1286591|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
1286593|NCT01641328|Meditation|meditation
1286594|NCT01641328|Mindfulness|mindfulness
1286595|NCT01641328|Cognitive Activation|cognitive activation
1286596|NCT01641328|Cognitive Training|cognitive training
1286597|NCT01641328|Tai Chi|tai chi
1286598|NCT01641315|rabies|rabies
1286599|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
1286600|NCT01641289|Falciparum malaria|falciparum malaria
1286601|NCT01641289|Paracetamol|paracetamol
1286602|NCT01641289|Renal function|renal function
1286603|NCT01641289|Oxidative stress|oxidative stress
1286604|NCT01641276|biofeedback response|biofeedback response
1286605|NCT01641263|Depression Prevention|depression prevention
1286606|NCT01641263|Sleep Disturbances|sleep disturbances
1286607|NCT01641263|Inflammatory Markers|inflammatory markers
1286608|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
1286609|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
1286610|NCT01641224|Pinaverium|pinaverium
1286611|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
1286612|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
1286613|NCT01641198|Dental implants, bone healing, fixed dental prostheses, implant surface|dental implants, bone healing, fixed dental prostheses, implant surface
1286614|NCT01641185|prostate|prostate
1286615|NCT01641185|IPI|ipi
1286616|NCT01641185|hypofractionation|hypofractionation
1286617|NCT01641185|carbon ions|carbon ions
1286618|NCT01641185|proton|proton
1286619|NCT01641172|taste|taste
1286620|NCT01641172|smell|smell
1286621|NCT01641172|cancer|cancer
1286622|NCT01641172|nutrition|nutrition
1286623|NCT01641159|Cocaine|cocaine
1286624|NCT01641159|Crack|crack
1286625|NCT01641159|Buspirone|buspirone
1286626|NCT01641159|Relapse Prevention|relapse prevention
1286627|NCT01641146|HIV risk reduction|hiv risk reduction
1286628|NCT01641146|Stress reduction|stress reduction
1286629|NCT01641146|Trauma reduction|trauma reduction
1286630|NCT01641146|PTSD|ptsd
1286631|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1286632|NCT01641133|Synflorix™|synflorix™
1286633|NCT01641133|Prevenar 13™|prevenar 13™
1286634|NCT01641133|Pneumococcal diseases|pneumococcal diseases
1286635|NCT01641120|Multiple Sclerosis|multiple sclerosis
1286636|NCT01641120|Intramuscular Injections|intramuscular injections
1286637|NCT01641120|Relapsing Remitting|relapsing remitting
1286638|NCT01641107|Ph+|ph+
1286639|NCT01641107|BCR-ABL+|bcr-abl+
1286640|NCT01641107|ALL|all
1286641|NCT01641107|Ponatinib|ponatinib
1286642|NCT01641107|stem cell transplantation|stem cell transplantation
1286643|NCT01641094|Hepatitis C|hepatitis c
1286644|NCT01641094|Liver|liver
1286645|NCT01641094|Immunology|immunology
1286646|NCT01641094|Genotype 1|genotype 1
1286647|NCT01641094|Treatment|treatment
1286648|NCT01641094|Chronic|chronic
1286649|NCT01641094|RNA Virus Infections|rna virus infections
1286650|NCT01641094|Ribavirin|ribavirin
1286651|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
1286652|NCT01641094|Protease Inhibitors|protease inhibitors
1286653|NCT01641094|Telaprevir|telaprevir
1286654|NCT01641068|Memory|memory
1286655|NCT01641068|Attention|attention
1286656|NCT01641068|Chemo-brain|chemo-brain
1286657|NCT01641068|Survivor|survivor
1286658|NCT01641068|Treatment|treatment
1286659|NCT01641042|Meningococcal vaccines|meningococcal vaccines
1286660|NCT01641042|Vaccines, conjugate|vaccines, conjugate
1286661|NCT01641042|Neisseria meningitidis|neisseria meningitidis
1286662|NCT01641042|Immunocompromised patient|immunocompromised patient
1286663|NCT01641016|short cycle therapy|short cycle therapy
1286664|NCT01641016|young people|young people
1286666|NCT01641003|cancer stem cells|cancer stem cells
1286667|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
1286668|NCT01640977|Open PLIF|open plif
1286669|NCT01640977|MAS PLIF|mas plif
1286670|NCT01640977|Lumbar spine|lumbar spine
1286671|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
1286672|NCT01640951|Psoriasis|psoriasis
1286673|NCT01640951|Plaque|plaque
1286674|NCT01640951|Inflammatory skin disease|inflammatory skin disease
1286675|NCT01640951|Scaly patches|scaly patches
1286676|NCT01640951|AIN457|ain457
1286677|NCT01640951|Secukinumab|secukinumab
1286678|NCT01640951|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
1286679|NCT01640925|nosocomial infection|nosocomial infection
1286680|NCT01640925|hospital acquired infection|hospital acquired infection
1286681|NCT01640925|chlorhexidine|chlorhexidine
1286682|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
1286683|NCT01640925|catheter-related infections|catheter-related infections
1286684|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
1286685|NCT01640925|surgical site infection|surgical site infection
1286686|NCT01640912|Scar|scar
1286687|NCT01640912|Scar prevention|scar prevention
1286688|NCT01640912|Fibrosis|fibrosis
1286689|NCT01640899|Orthotic Devices|orthotic devices
1286690|NCT01640899|Activities of Daily Living|activities of daily living
1286691|NCT01640899|Pain Measurement|pain measurement
1286692|NCT01640899|Lower Extremity|lower extremity
1286693|NCT01640899|Foot|foot
1286694|NCT01640899|Personal Satisfaction|personal satisfaction
1286695|NCT01640886|Staphylococcus aureus|staphylococcus aureus
1286696|NCT01640886|methicillin resistant|methicillin resistant
1286697|NCT01640886|MRSA|mrsa
1286698|NCT01640886|MSSA|mssa
1286699|NCT01640886|Blood Culture|blood culture
1286700|NCT01640886|Diagnostic|diagnostic
1286701|NCT01640873|Type 2 Diabetes|type 2 diabetes
1286702|NCT01640860|docetaxel|docetaxel
1286703|NCT01640860|cisplatin|cisplatin
1286704|NCT01640860|combined modality therapy|combined modality therapy
1286705|NCT01640847|Painful bone metastases|painful bone metastases
1286706|NCT01640847|Bone Cancer|bone cancer
1286707|NCT01640847|Bone Cancer Pain|bone cancer pain
1286708|NCT01640847|Patients with|patients with
1286709|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
1286710|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1286711|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1286712|NCT01640769|Cardiomyopathy|cardiomyopathy
1286713|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1286714|NCT01640756|Glaucoma Implant|glaucoma implant
1286715|NCT01640756|Trabeculectomy|trabeculectomy
1286716|NCT01640756|POAG|poag
1286717|NCT01640743|Kidney transplantation|kidney transplantation
1286718|NCT01640743|Regulatory T cells|regulatory t cells
1286719|NCT01640743|Tolerance|tolerance
1286720|NCT01640743|Tacrolimus|tacrolimus
1286721|NCT01640743|Rejection|rejection
1286722|NCT01640691|pandemic influenza|pandemic influenza
1286723|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
1286724|NCT01640691|Influenza|influenza
1286725|NCT01640691|Orthomyxoviruses|orthomyxoviruses
1286726|NCT01640691|A/H5N1|a/h5n1
1286727|NCT01640665|histologically|histologically
1286728|NCT01640665|unresectable|unresectable
1286729|NCT01640665|metastatic|metastatic
1286730|NCT01640665|Phase 1|phase 1
1286731|NCT01640665|Breast Cancer|breast cancer
1286732|NCT01640665|GI Tumors|gi tumors
1286733|NCT01640665|Sorafenib|sorafenib
1286734|NCT01640665|Capecitabine|capecitabine
1286735|NCT01640639|left ventricular function|left ventricular function
1286736|NCT01640626|Health Education|health education
1286737|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
1286738|NCT01640626|Ascaris|ascaris
1286739|NCT01640626|Trichuris|trichuris
1286740|NCT01640626|Hookworm|hookworm
1286741|NCT01640626|Prevention and control|prevention and control
1286742|NCT01640613|carotid endarterectomy|carotid endarterectomy
1286743|NCT01640613|regional anaesthesia|regional anaesthesia
1286744|NCT01640613|ultrasound guided block|ultrasound guided block
1286745|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
1333185|NCT01444144|At-risk Population|at-risk population
1286746|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
1286747|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
1286748|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
1286749|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
1286850|NCT01640314|Adults|adults
1286750|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1286751|NCT01640574|Vivax|vivax
1286752|NCT01640574|Chloroquine|chloroquine
1286753|NCT01640574|Primaquine|primaquine
1286754|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
1286755|NCT01640561|HIV affected|hiv affected
1286756|NCT01640561|Child Neurodevelopment|child neurodevelopment
1286757|NCT01640561|Low and Middle Income Country|low and middle income country
1286758|NCT01640535|PAR|par
1286759|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
1286760|NCT01640522|Cholangio carcinoma|cholangio carcinoma
1286761|NCT01640522|Primary Liver Cancer|primary liver cancer
1286762|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
1286763|NCT01640522|Gallbladder Cancer|gallbladder cancer
1286764|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
1286765|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
1286766|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
1286767|NCT01640496|Ulcerative Colitis|ulcerative colitis
1286768|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
1286769|NCT01640496|IBD|ibd
1286770|NCT01640496|Vitamin D|vitamin d
1286771|NCT01640470|assistive technology|assistive technology
1286772|NCT01640470|environmental modification|environmental modification
1286773|NCT01640470|caregiver|caregiver
1286774|NCT01640470|client-centred|client-centred
1286775|NCT01640457|degenerative disc|degenerative disc
1286776|NCT01640457|herniated disc|herniated disc
1286777|NCT01640457|sequestrectomy|sequestrectomy
1286778|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
1286779|NCT01640457|nucleotomy|nucleotomy
1286780|NCT01640457|safety|safety
1286781|NCT01640457|efficacy|efficacy
1286782|NCT01640457|treatment|treatment
1286783|NCT01640457|lumbar spine|lumbar spine
1286784|NCT01640457|low back pain|low back pain
1286785|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
1286786|NCT01640457|black disc|black disc
1286787|NCT01640457|NOVOCART|novocart
1286788|NCT01640444|colorectal carcinoma|colorectal carcinoma
1286789|NCT01640444|BRAF and PIK3K|braf and pik3k
1286790|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
1286791|NCT01640444|circulating tumor cells|circulating tumor cells
1286792|NCT01640431|lumbar disc herniation|lumbar disc herniation
1286793|NCT01640431|clinical trial|clinical trial
1286794|NCT01640431|exercise therapy|exercise therapy
1286795|NCT01640431|TENS|tens
1286796|NCT01640418|pressure ulcer|pressure ulcer
1286797|NCT01640418|dressing|dressing
1286798|NCT01640418|prevention|prevention
1286800|NCT01640405|colorectal cancer|colorectal cancer
1286801|NCT01640405|FOLFOX|folfox
1286802|NCT01640405|Bevacizumab|bevacizumab
1286803|NCT01640405|FOLFOXIRI|folfoxiri
1286804|NCT01640405|circulating tumor cell|circulating tumor cell
1286805|NCT01640392|Gay men|gay men
1286806|NCT01640392|African American males|african american males
1286807|NCT01640392|Unprotected anal sex|unprotected anal sex
1286808|NCT01640392|HIV risk|hiv risk
1286809|NCT01640392|behavioral intervention|behavioral intervention
1286810|NCT01640392|group-level intervention|group-level intervention
1286811|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
1286812|NCT01640379|Community Health Nursing|community health nursing
1286813|NCT01640379|Text Messaging|text messaging
1286814|NCT01640379|mobile health (mhealth)|mobile health (mhealth)
1286815|NCT01640379|Adolescents|adolescents
1286816|NCT01640366|surgical incision|surgical incision
1286817|NCT01640366|reduction mammoplasty|reduction mammoplasty
1286818|NCT01640366|healing complications|healing complications
1286819|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
1286820|NCT01640353|si joint|si joint
1286821|NCT01640353|si joint pain|si joint pain
1286822|NCT01640353|si joint injury|si joint injury
1286823|NCT01640353|si joint treatment|si joint treatment
1286824|NCT01640353|si joint injections|si joint injections
1286825|NCT01640353|si joint inflammation|si joint inflammation
1286826|NCT01640353|si joint problems|si joint problems
1286827|NCT01640353|si joint symptoms|si joint symptoms
1286828|NCT01640353|hypermobile si joint|hypermobile si joint
1286829|NCT01640353|si joint arthritis|si joint arthritis
1286830|NCT01640353|si joint pain treatment|si joint pain treatment
1286831|NCT01640353|inflamed si joint|inflamed si joint
1286832|NCT01640353|si joint sclerosis|si joint sclerosis
1286833|NCT01640353|locked si joint|locked si joint
1286834|NCT01640353|si joint injuries|si joint injuries
1286835|NCT01640353|si joint disease|si joint disease
1286836|NCT01640353|si joint infection|si joint infection
1286837|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
1286838|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
1286839|NCT01640340|ondansetron|ondansetron
1286840|NCT01640340|palonosetron|palonosetron
1286841|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
1286843|NCT01640327|Interpandemic influenza|interpandemic influenza
1286844|NCT01640327|Adult|adult
1286845|NCT01640327|Elderly|elderly
1286846|NCT01640327|Safety|safety
1286847|NCT01640327|Tolerability|tolerability
1286848|NCT01640327|Immunology|immunology
1286849|NCT01640314|Influenza|influenza
1286851|NCT01640314|Elderly|elderly
1286852|NCT01640314|Immunology|immunology
1286853|NCT01640314|Safety|safety
1286854|NCT01640288|COPD|copd
1286855|NCT01640288|Pulmonary Function Testing|pulmonary function testing
1286856|NCT01640288|MRI|mri
1286857|NCT01640288|Normal Lung Function|normal lung function
1286858|NCT01640288|Current Smoker|current smoker
1286859|NCT01640288|Non Smoker|non smoker
1286860|NCT01640288|Ex Smoker|ex smoker
1286861|NCT01640275|General Anesthesia|general anesthesia
1286862|NCT01640275|Alzheimers Disease|alzheimers disease
1286863|NCT01640275|Cognitive decline|cognitive decline
1286864|NCT01640262|prostate biopsy|prostate biopsy
1286865|NCT01640262|prostate cancer|prostate cancer
1286866|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
1286867|NCT01640262|Neoplasm Staging|neoplasm staging
1286868|NCT01640236|Ocular flare|ocular flare
1286869|NCT01640197|Cognitive performance|cognitive performance
1286870|NCT01640197|Cerebral blood flow|cerebral blood flow
1286871|NCT01640197|Subjective sleep|subjective sleep
1286872|NCT01640197|Subjective mood|subjective mood
1286873|NCT01640197|Subjective health|subjective health
1286874|NCT01640184|hyperparathyroidism|hyperparathyroidism
1286875|NCT01640184|vitamin D|vitamin d
1286876|NCT01640184|ultrasonic ablation|ultrasonic ablation
1286877|NCT01640184|surgery|surgery
1286878|NCT01640171|anesthesia|anesthesia
1286879|NCT01640171|pain|pain
1286880|NCT01640171|intravitreal|intravitreal
1286881|NCT01640171|anti-vegf|anti-vegf
1286882|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
1286883|NCT01640158|Cognitive remediation|cognitive remediation
1286884|NCT01640158|computer|computer
1286885|NCT01640119|metabolic acidosis|metabolic acidosis
1286886|NCT01640119|renal death|renal death
1286887|NCT01640106|Language|language
1286888|NCT01640106|Fatty acids|fatty acids
1286889|NCT01640106|Nutrition|nutrition
1286890|NCT01640106|Developmental delay|developmental delay
1286891|NCT01640093|Healthy participants|healthy participants
1286892|NCT01640093|Bioavailability|bioavailability
1286893|NCT01640093|Pharmacokinetics|pharmacokinetics
1286894|NCT01640093|Abiraterone acetate|abiraterone acetate
1286895|NCT01640093|Abiraterone|abiraterone
1286896|NCT01640080|Major depressive disorder|major depressive disorder
1286897|NCT01640080|Treatment resistant depression|treatment resistant depression
1286898|NCT01640080|Depression|depression
1286899|NCT01640080|Esketamine|esketamine
1286900|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1286901|NCT01640067|motor neuron disease|motor neuron disease
1286902|NCT01640067|stem cells|stem cells
1286903|NCT01640067|safety|safety
1286904|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
1286905|NCT01640067|Survival analysis|survival analysis
1286906|NCT01640067|Changes in quality of life scales|changes in quality of life scales
1286907|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
1286908|NCT01640015|Blood pressure|blood pressure
1286909|NCT01640015|eating episode|eating episode
1286910|NCT01640015|eating frequency|eating frequency
1286911|NCT01640015|insulin sensitivity|insulin sensitivity
1286912|NCT01640002|overactive bladder|overactive bladder
1286913|NCT01640002|HTLV-1|htlv-1
1286914|NCT01640002|Propantheline|propantheline
1286915|NCT01640002|anticholinergic|anticholinergic
1286916|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
1286917|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
1286918|NCT01639950|Self-Report|self-report
1286919|NCT01639950|Survey Scale|survey scale
1286920|NCT01639950|Validate|validate
1286921|NCT01639950|Pain Severity|pain severity
1286922|NCT01639950|Reliability|reliability
1286923|NCT01639937|Cardiac MRI|cardiac mri
1286924|NCT01639937|Congestive Heart Failure|congestive heart failure
1286925|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
1286926|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
1286927|NCT01639924|Small Bowel Disease|small bowel disease
1286928|NCT01639924|Digestive Disease|digestive disease
1286929|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
1286930|NCT01639924|Lower GI Disease|lower gi disease
1286931|NCT01639911|malignant solid tumor|malignant solid tumor
1286932|NCT01639911|advanced non-hematologic|advanced non-hematologic
1286933|NCT01639898|POEMS|poems
1286934|NCT01639898|VEGF|vegf
1286935|NCT01639898|Free light|free light
1286936|NCT01639898|lenalidomide|lenalidomide
1286937|NCT01639898|dexamethasone|dexamethasone
1286938|NCT01639885|p53 overexpression|p53 overexpression
1286939|NCT01639885|platinum-resistant|platinum-resistant
1286940|NCT01639872|Schizophrenia|schizophrenia
1286941|NCT01639872|Cannabis Abuse|cannabis abuse
1286942|NCT01639872|Cannabis Dependence|cannabis dependence
1286943|NCT01639872|Dual Diagnosis|dual diagnosis
1286944|NCT01639872|Clozapine|clozapine
1286945|NCT01639872|Risperidone|risperidone
1286946|NCT01639859|prostate cancer|prostate cancer
1286947|NCT01639859|elastography|elastography
1286948|NCT01639859|elasticity|elasticity
1286949|NCT01639820|Cervical cancer|cervical cancer
1286950|NCT01639820|early stage carcinoma|early stage carcinoma
1286951|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
1287042|NCT01639339|Antibodies|antibodies
1286952|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
1286953|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
1286954|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
1286955|NCT01639820|medico economic impact|medico economic impact
1286956|NCT01639820|quality of life|quality of life
1286957|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
1286958|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
1286959|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
1286960|NCT01639794|Solifenacin|solifenacin
1286961|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
1286962|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
1286963|NCT01639794|Storage Symptom improvement|storage symptom improvement
1286964|NCT01639781|flavanols|flavanols
1286965|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
1286966|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
1286967|NCT01639768|Dose range finding|dose range finding
1286968|NCT01639768|Dose tolerability|dose tolerability
1286969|NCT01639768|Birch pollen|birch pollen
1286970|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
1286971|NCT01639768|Safety|safety
1286972|NCT01639768|Immunogenicity|immunogenicity
1286973|NCT01639729|pharmacokinetics|pharmacokinetics
1286974|NCT01639729|area under curve|area under curve
1286975|NCT01639729|time to maximum concentration|time to maximum concentration
1286976|NCT01639716|Survey, interleukin status|survey, interleukin status
1286977|NCT01639703|CT perfusion|ct perfusion
1286978|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
1286979|NCT01639703|Xenetix|xenetix
1286980|NCT01639703|Contrast agent|contrast agent
1286981|NCT01639690|BUSULFAN|busulfan
1286982|NCT01639690|G-CSF|g-csf
1286983|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
1286984|NCT01639690|Blood transfusion|blood transfusion
1286985|NCT01639690|10-164|10-164
1286986|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
1286987|NCT01639677|Obesity|obesity
1286988|NCT01639677|weight loss|weight loss
1286989|NCT01639677|surgery|surgery
1286990|NCT01639677|gastric bypass|gastric bypass
1286991|NCT01639677|VBG|vbg
1286992|NCT01639651|Physical Therapy|physical therapy
1286993|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
1286994|NCT01639651|Joint Mobilization|joint mobilization
1286995|NCT01639651|Posterior capsule|posterior capsule
1286996|NCT01639651|Capsular contracture|capsular contracture
1286997|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
1286998|NCT01639612|Stem Cell|stem cell
1286999|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
1287000|NCT01639599|non-smoker|non-smoker
1287001|NCT01639599|female|female
1287002|NCT01639599|IV PCA|iv pca
1287003|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
1287004|NCT01639573|Patients with Scleroderma|patients with scleroderma
1287005|NCT01639560|smoking|smoking
1287006|NCT01639560|tobacco dependence|tobacco dependence
1287007|NCT01639560|nicotine dependence|nicotine dependence
1287008|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
1287009|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
1287010|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
1287011|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
1287012|NCT01639534|peripheral blood|peripheral blood
1287013|NCT01639508|Lung|lung
1287014|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
1287015|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
1287016|NCT01639508|RET Fusion Positive|ret fusion positive
1287017|NCT01639508|12-097|12-097
1287018|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
1287019|NCT01639495|Drug refractory|drug refractory
1287020|NCT01639495|Atrial fibrillation|atrial fibrillation
1287021|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
1287022|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
1287023|NCT01639469|Parkinson Disease|parkinson disease
1287024|NCT01639469|Quality of Life|quality of life
1287025|NCT01639469|Exercise Therapy|exercise therapy
1287026|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
1287027|NCT01639443|quality improvement|quality improvement
1386472|NCT01220817|psa|psa
1287028|NCT01639443|Organization and Administration|organization and administration
1287029|NCT01639443|Costs and cost analysis|costs and cost analysis
1287030|NCT01639443|Patient satisfaction|patient satisfaction
1287031|NCT01639443|Health plan implementation|health plan implementation
1287032|NCT01639404|Cerebral Palsy|cerebral palsy
1287033|NCT01639404|Umbilical Cord Blood|umbilical cord blood
1287034|NCT01639404|Rehabilitation|rehabilitation
1288120|NCT01633996|Acupuncture|acupuncture
1287035|NCT01639365|Ventricular tachycardia|ventricular tachycardia
1287036|NCT01639365|Catheter ablation|catheter ablation
1287037|NCT01639365|Tissue contact|tissue contact
1287038|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
1287040|NCT01639352|SOM230|som230
1287041|NCT01639352|Pasireotide LAR|pasireotide lar
1287043|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
1287044|NCT01639339|Autoimmune Disease|autoimmune disease
1287045|NCT01639339|Glomerulonephritis|glomerulonephritis
1287046|NCT01639339|Belimumab|belimumab
1287047|NCT01639339|Lupus|lupus
1287048|NCT01639339|Nephritis|nephritis
1287049|NCT01639339|Kidney Diseases|kidney diseases
1287050|NCT01639339|SLE|sle
1287051|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1287052|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
1287053|NCT01639300|GNbAC1|gnbac1
1287054|NCT01639300|Monoclonal antibody|monoclonal antibody
1287055|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
1287056|NCT01639261|steroid-refractory|steroid-refractory
1287057|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
1287058|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1287059|NCT01639261|interferon gamma|interferon gamma
1287060|NCT01639248|Breast Cancer|breast cancer
1287061|NCT01639235|Secondhand Smoke|secondhand smoke
1287062|NCT01639235|Flight Attendants|flight attendants
1287063|NCT01639235|Lung function|lung function
1287064|NCT01639235|Cardiac function|cardiac function
1287065|NCT01639235|Reproductive health|reproductive health
1287066|NCT01639222|Drug therapy|drug therapy
1287067|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
1287068|NCT01639209|Retinal detachment|retinal detachment
1287069|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
1287070|NCT01639209|Vitrectomy|vitrectomy
1287071|NCT01639196|Chronic pain|chronic pain
1287072|NCT01639196|Psychological adjustment|psychological adjustment
1287073|NCT01639196|Writing|writing
1287074|NCT01639196|Brief intervention|brief intervention
1287075|NCT01639196|Online|online
1287076|NCT01639196|Internet interventions|internet interventions
1287077|NCT01639183|oral inflammation|oral inflammation
1287078|NCT01639183|systemic inflammation|systemic inflammation
1287079|NCT01639183|compliance|compliance
1287080|NCT01639183|power toothbrushing|power toothbrushing
1287081|NCT01639183|nursing home residents|nursing home residents
1287082|NCT01639170|Pneumoperitoneum|pneumoperitoneum
1287083|NCT01639170|Free air|free air
1287084|NCT01639170|Surgery|surgery
1287085|NCT01639170|Perforation|perforation
1287086|NCT01639170|Radiograph|radiograph
1287087|NCT01639144|Infection|infection
1287088|NCT01639144|delayed wound healing|delayed wound healing
1287089|NCT01639144|platelet-rich plasma|platelet-rich plasma
1287090|NCT01639131|Gemcitabine|gemcitabine
1287091|NCT01639131|Docetaxel|docetaxel
1287092|NCT01639131|Filgrastim|filgrastim
1287093|NCT01639131|Pegfilgrastim|pegfilgrastim
1287094|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
1287095|NCT01639118|umbilical hernia repair|umbilical hernia repair
1287096|NCT01639118|epigastric hernia repair|epigastric hernia repair
1287097|NCT01639118|C-Qur V-patch|c-qur v-patch
1287098|NCT01639118|Size tailored repair|size tailored repair
1287099|NCT01639118|preperitoneal repair|preperitoneal repair
1287100|NCT01639118|abdominal hernia|abdominal hernia
1287101|NCT01639118|dual sided mesh|dual sided mesh
1287102|NCT01639092|Resistance of Entecavir|resistance of entecavir
1287103|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
1287104|NCT01639079|smoking cessation|smoking cessation
1287105|NCT01639079|Latino smoking cessation|latino smoking cessation
1287106|NCT01639066|Resistance of Adefovir|resistance of adefovir
1287107|NCT01639053|Breast Augmentation|breast augmentation
1287108|NCT01639053|Breast Reconstruction|breast reconstruction
1287109|NCT01639053|Breast Revision|breast revision
1287110|NCT01639053|Silicone breast implants|silicone breast implants
1287111|NCT01639001|Crizotinib|crizotinib
1287112|NCT01639001|ALK positive|alk positive
1287113|NCT01639001|ALK|alk
1287114|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
1287115|NCT01639001|NSCLC|nsclc
1287116|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
1287117|NCT01639001|Frontline|frontline
1287118|NCT01639001|1L|1l
1287119|NCT01639001|Previously Untreated|previously untreated
1287120|NCT01639001|East Asian|east asian
1287121|NCT01639001|Non-Squamous|non-squamous
1287122|NCT01638962|Exercise Therapy|exercise therapy
1287123|NCT01638962|Gait|gait
1287124|NCT01638962|Joint load|joint load
1287125|NCT01638962|Knee Joint|knee joint
1287126|NCT01638962|Middle Aged|middle aged
1287127|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
1287128|NCT01638962|Pain Management|pain management
1287129|NCT01638949|Alzheimer's disease|alzheimer's disease
1287131|NCT01638949|genetic|genetic
1287132|NCT01638949|AV45-PET|av45-pet
1287133|NCT01638936|Combination|combination
1287138|NCT01638923|Oral contraceptive|oral contraceptive
1287139|NCT01638923|Estradiol valerate|estradiol valerate
1287140|NCT01638923|Dienogest|dienogest
1287141|NCT01638910|Efficacy|efficacy
1287142|NCT01638910|Safety|safety
1287143|NCT01638910|oral contraception|oral contraception
1287144|NCT01638910|estradiol valerate|estradiol valerate
1287145|NCT01638910|dienogest|dienogest
1287146|NCT01638897|ICD|icd
1287147|NCT01638897|CRTD|crtd
1287148|NCT01638897|DF4|df4
1287149|NCT01638884|Prospective Memory|prospective memory
1287150|NCT01638884|Healthy Aging|healthy aging
1287151|NCT01638884|Alzheimer Disease|alzheimer disease
1287152|NCT01638884|Brain Imaging|brain imaging
1287153|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
1287154|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
1287155|NCT01638806|Myocardial infarction|myocardial infarction
1287156|NCT01638806|Angioplasty|angioplasty
1287157|NCT01638806|Prehospital emergency care|prehospital emergency care
1287158|NCT01638806|Biological markers|biological markers
1287159|NCT01638806|Troponin|troponin
1287160|NCT01638806|Point-of-Care systems|point-of-care systems
1287161|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
1287162|NCT01638767|NuvaRing|nuvaring
1287163|NCT01638767|Marvelon|marvelon
1287164|NCT01638767|In vitro fertilization|in vitro fertilization
1287165|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
1287166|NCT01638715|Biologic therapies|biologic therapies
1287167|NCT01638715|Biomarker|biomarker
1287168|NCT01638715|Mode of Action|mode of action
1287169|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
1287170|NCT01638702|Catheters, Indwelling|catheters, indwelling
1287171|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
1287172|NCT01638676|Unresectable melanoma|unresectable melanoma
1287173|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
1287174|NCT01638663|Tolvaptan|tolvaptan
1287175|NCT01638663|L-NMMA|l-nmma
1287176|NCT01638663|Healthy subjects|healthy subjects
1287177|NCT01638663|Nephrology|nephrology
1287178|NCT01638663|Cardiology|cardiology
1287179|NCT01638624|Propofol|propofol
1287180|NCT01638624|antioxidant capacity|antioxidant capacity
1287181|NCT01638624|total knee arthroplasty|total knee arthroplasty
1287182|NCT01638624|Propofol,antioxidant|propofol,antioxidant
1287183|NCT01638611|Healthy male volunteers|healthy male volunteers
1287184|NCT01638572|Neuroblastoma|neuroblastoma
1287185|NCT01638572|B4GALNT3|b4galnt3
1287186|NCT01638572|Prognosis|prognosis
1287191|NCT01638520|Immune Therapy|immune therapy
1287192|NCT01638520|Interleukin 4|interleukin 4
1287193|NCT01638520|monoclonal antibody|monoclonal antibody
1287194|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1287195|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1287196|NCT01638507|Coronary Artery Disease|coronary artery disease
1287197|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1287198|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1287199|NCT01638507|STENT THROMBOSIS|stent thrombosis
1287200|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1287201|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
1287202|NCT01638494|dietary counseling|dietary counseling
1287203|NCT01638494|pediatrics|pediatrics
1287204|NCT01638494|allergy|allergy
1287205|NCT01638494|bone metabolism|bone metabolism
1287206|NCT01638468|Pulmonary Embolism|pulmonary embolism
1287207|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
1287208|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
1287209|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
1287210|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
1287211|NCT01638442|Male subjects, healthy|male subjects, healthy
1287212|NCT01638403|narcolepsy|narcolepsy
1287213|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
1287214|NCT01638403|cataplexy|cataplexy
1287215|NCT01638377|Back on Track|back on track
1287216|NCT01638377|convicted drinking drivers|convicted drinking drivers
1287217|NCT01638377|naltrexone|naltrexone
1287218|NCT01638377|alcohol dependence|alcohol dependence
1287219|NCT01638351|Diabetes mellitus|diabetes mellitus
1287220|NCT01638351|Resistance exercise|resistance exercise
1287221|NCT01638351|Elderly|elderly
1287222|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
1287223|NCT01638351|Metabolomics|metabolomics
1287224|NCT01638338|Alcohol|alcohol
1287225|NCT01638338|Risky drinking|risky drinking
1287226|NCT01638338|Web site|web site
1386785|NCT01219595|UTI|uti
1287227|NCT01638338|Primary Care|primary care
1287228|NCT01638338|General Practice|general practice
1287229|NCT01638338|Local Community|local community
1287230|NCT01638338|Mayors|mayors
1287231|NCT01638312|HIV, fructose|hiv, fructose
1287232|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1287233|NCT01638299|Artificial Pancreas|artificial pancreas
1287234|NCT01638273|Pregabalin, GLARS|pregabalin, glars
1287235|NCT01638260|NEAT|neat
1287236|NCT01638260|liraglutide|liraglutide
1287237|NCT01638260|glycemic control|glycemic control
1287238|NCT01638247|Male breast cancer|male breast cancer
1287239|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
1287240|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
1287241|NCT01638234|atopic dermatitis|atopic dermatitis
1287242|NCT01638234|eczema|eczema
1287243|NCT01638182|phylloquinone,|phylloquinone,
1287244|NCT01638182|menaquinone-7|menaquinone-7
1287245|NCT01638182|vitamin K-status|vitamin k-status
1287246|NCT01638182|efficacy|efficacy
1287247|NCT01638156|Aortic stenosis|aortic stenosis
1287248|NCT01638143|vitamin K2|vitamin k2
1287249|NCT01638143|menaquinone-7|menaquinone-7
1287250|NCT01638143|bioavailability|bioavailability
1287251|NCT01638091|Narrow band imaging|narrow band imaging
1287252|NCT01638091|Screening colonoscopy|screening colonoscopy
1287253|NCT01638091|Histology|histology
1287254|NCT01638078|coronary restenosis|coronary restenosis
1287255|NCT01638065|vein identification|vein identification
1287256|NCT01638065|vascular access|vascular access
1287257|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
1287258|NCT01638052|Cochlear Implant|cochlear implant
1287259|NCT01638052|Mastoidectomy|mastoidectomy
1287260|NCT01638052|Cholesteatoma|cholesteatoma
1287261|NCT01638052|Pediatrics|pediatrics
1287262|NCT01638052|Clonidine|clonidine
1287263|NCT01638052|Bupivacaine|bupivacaine
1287264|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
1287265|NCT01638052|Regional Anesthesia|regional anesthesia
1287266|NCT01638026|Gnrh agonist|gnrh agonist
1287267|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
1287268|NCT01638013|ASP015K|asp015k
1287269|NCT01638000|Vesitrim|vesitrim
1287270|NCT01638000|Frequency|frequency
1287271|NCT01638000|Urgency|urgency
1287272|NCT01638000|Urgency incontinence|urgency incontinence
1287273|NCT01638000|Urinary incontinence|urinary incontinence
1287274|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
1287275|NCT01638000|Micturition|micturition
1287276|NCT01638000|Mirabegron|mirabegron
1287277|NCT01638000|YM178|ym178
1287278|NCT01638000|Vesicare|vesicare
1287279|NCT01638000|Solifenacin|solifenacin
1287280|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
1287281|NCT01637987|Vein visualization|vein visualization
1287282|NCT01637987|Transillumination|transillumination
1287283|NCT01637987|Near infrared light|near infrared light
1287284|NCT01637948|Chinese medicine|chinese medicine
1287285|NCT01637948|gingivitis|gingivitis
1287286|NCT01637948|cytokine|cytokine
1287287|NCT01637948|microbial|microbial
1287288|NCT01637935|Drug therapy|drug therapy
1287289|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
1287290|NCT01637883|benzydamine HCl|benzydamine hcl
1287291|NCT01637883|endotracheal tube|endotracheal tube
1287292|NCT01637883|postoperative sore throat|postoperative sore throat
1287293|NCT01637870|Cesarean delivery|cesarean delivery
1287294|NCT01637870|Postpartum infection|postpartum infection
1287295|NCT01637870|Wound complications|wound complications
1287296|NCT01637870|Wound seroma|wound seroma
1287297|NCT01637870|Wound separation|wound separation
1287298|NCT01637870|Wound infection|wound infection
1287299|NCT01637870|Negative pressure|negative pressure
1287300|NCT01637857|foof hypersensitivity|foof hypersensitivity
1287301|NCT01637857|anal fissures|anal fissures
1287302|NCT01637857|ano-rectal manometry|ano-rectal manometry
1287303|NCT01637844|Pregnant women|pregnant women
1287304|NCT01637844|HBsAg positive|hbsag positive
1287305|NCT01637844|HBeAg positive|hbeag positive
1287306|NCT01637844|Telbivudine|telbivudine
1287307|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
1287308|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1287309|NCT01637818|Inguinal hernia repair|inguinal hernia repair
1287310|NCT01637818|long-term follow-up|long-term follow-up
1287311|NCT01637818|Surgical technique|surgical technique
1287312|NCT01637792|peritoneal dialysis|peritoneal dialysis
1287313|NCT01637792|dose|dose
1287314|NCT01637792|residual kidney function|residual kidney function
1287315|NCT01637792|technique survival|technique survival
1287316|NCT01637792|patient survival|patient survival
1287317|NCT01637792|peritonitis|peritonitis
1287318|NCT01637779|randomized controlled trial|randomized controlled trial
1287319|NCT01637779|parent education|parent education
1287320|NCT01637779|pain management|pain management
1287321|NCT01637779|infant|infant
1287322|NCT01637779|immunization|immunization
1287323|NCT01637766|Spinal Metastases|spinal metastases
1287324|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
1287325|NCT01637766|Cord Compression|cord compression
1287326|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
1287327|NCT01637766|Spinal Tumors|spinal tumors
1287328|NCT01637740|myopia|myopia
1287329|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
1287330|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
1288702|NCT01631188|Pacing|pacing
1287331|NCT01637740|ocular optical components|ocular optical components
1287332|NCT01637740|cataract|cataract
1287333|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
1287334|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
1287335|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
1287336|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
1287337|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
1287338|NCT01637688|cow milk allergy|cow milk allergy
1287339|NCT01637688|amino acid formula|amino acid formula
1287340|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
1287341|NCT01637675|pulmonary hypertension|pulmonary hypertension
1287342|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
1287343|NCT01637636|rifampin,|rifampin,
1287344|NCT01637636|ketoconazole,|ketoconazole,
1287345|NCT01637636|CYP3A4,|cyp3a4,
1287346|NCT01637636|tasimelteon,|tasimelteon,
1287347|NCT01637636|VEC-162|vec-162
1287348|NCT01637636|Pharmacokinetics|pharmacokinetics
1287349|NCT01637623|Hypertension|hypertension
1287350|NCT01637623|High Blood Pressure|high blood pressure
1287351|NCT01637623|Sleep Apnea|sleep apnea
1287352|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
1287353|NCT01637623|OSA|osa
1287354|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
1287355|NCT01637610|AmniSure|amnisure
1287356|NCT01637610|preterm|preterm
1287357|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
1287358|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
1287359|NCT01637571|GERD|gerd
1287360|NCT01637571|NCCP|nccp
1287361|NCT01637571|chest pain|chest pain
1287362|NCT01637571|reflux|reflux
1287363|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
1287364|NCT01637545|facial bones|facial bones
1287365|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
1287366|NCT01637545|fractures|fractures
1287367|NCT01637545|reduction|reduction
1287368|NCT01637519|kidney stones|kidney stones
1287369|NCT01637519|ureteral stones|ureteral stones
1287370|NCT01637519|stent|stent
1287371|NCT01637506|urine|urine
1287372|NCT01637506|stool|stool
1287373|NCT01637506|kidney stones|kidney stones
1287374|NCT01637493|Pegylation|pegylation
1287375|NCT01637493|G-CSF|g-csf
1287376|NCT01637493|Pharmacokinetics|pharmacokinetics
1287377|NCT01637493|Pharmacodynamics|pharmacodynamics
1287378|NCT01637467|critical illness|critical illness
1287379|NCT01637467|myopathy|myopathy
1287380|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
1287381|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
1287382|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
1287383|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
1287384|NCT01637441|coelioscopic|coelioscopic
1287385|NCT01637441|prosthetic surgery|prosthetic surgery
1287386|NCT01637441|vaginal approach|vaginal approach
1287387|NCT01637441|Randomized study|randomized study
1287388|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
1287389|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
1287390|NCT01637441|Stage II|stage ii
1287391|NCT01637441|Clavien Dindo|clavien dindo
1287392|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
1287393|NCT01637415|prediction|prediction
1287394|NCT01637415|severity|severity
1287395|NCT01637415|alcohol use disorder|alcohol use disorder
1287396|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
1287397|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
1287398|NCT01637415|delirium tremens|delirium tremens
1287399|NCT01637415|PAWSS|pawss
1287400|NCT01637402|CRPC|crpc
1287401|NCT01637402|prostate|prostate
1287402|NCT01637402|cancer|cancer
1287403|NCT01637376|Lung neoplasms|lung neoplasms
1287404|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
1287405|NCT01637376|Non small cell lung cancer|non small cell lung cancer
1287406|NCT01637376|Large cell carcinoma|large cell carcinoma
1287407|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
1287408|NCT01637376|adenocarcinoma|adenocarcinoma
1287409|NCT01637363|Psychoeducation|psychoeducation
1287410|NCT01637363|Stress|stress
1287411|NCT01637363|Sickness absence|sickness absence
1287412|NCT01637363|Psychiatric symptoms|psychiatric symptoms
1287413|NCT01637363|Locus of control|locus of control
1287414|NCT01637363|Self reported health|self reported health
1287415|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
1287416|NCT01637324|nPEP|npep
1287417|NCT01637324|STIs|stis
1287418|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
1287419|NCT01637324|hyperlipidemia|hyperlipidemia
1287420|NCT01637324|diabetes|diabetes
1287421|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
1287422|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
1287423|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
1287424|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
1287425|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
1287426|NCT01637311|Heller myotomy|heller myotomy
1287427|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
1287428|NCT01637298|Histological HGAIN|histological hgain
1287429|NCT01637298|detected biomarkers|detected biomarkers
1287430|NCT01637298|MSM population|msm population
1287431|NCT01637298|HPV subtypes|hpv subtypes
1287432|NCT01637298|AIN study|ain study
1287433|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
1287434|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
1287435|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
1287436|NCT01637272|Dumping syndrome|dumping syndrome
1287437|NCT01637272|SOM230|som230
1287438|NCT01637272|pasireotide LAR|pasireotide lar
1287439|NCT01637259|proteinuria|proteinuria
1287441|NCT01637233|HIV-1 infection|hiv-1 infection
1287442|NCT01637233|neurocognitive function|neurocognitive function
1287443|NCT01637233|switch study|switch study
1287444|NCT01637220|Anaphylaxis|anaphylaxis
1287445|NCT01637220|Neutrophils|neutrophils
1287446|NCT01637220|Platelet activating factor|platelet activating factor
1287447|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
1287448|NCT01637168|Disorders of cognitive function|disorders of cognitive function
1287449|NCT01637155|Cholecalciferol|cholecalciferol
1287450|NCT01637129|Childhood stroke|childhood stroke
1287451|NCT01637129|Perinatal stroke|perinatal stroke
1287452|NCT01637129|Pediatric stroke|pediatric stroke
1287453|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
1287454|NCT01637129|Children who have hemiparesis|children who have hemiparesis
1287455|NCT01637103|Cancer|cancer
1287456|NCT01637103|Depression|depression
1287457|NCT01637103|Anxiety|anxiety
1287458|NCT01637103|Fatigue|fatigue
1287459|NCT01637103|Sleep|sleep
1287460|NCT01637103|Quality of life|quality of life
1287461|NCT01637103|Cognitive therapy|cognitive therapy
1287462|NCT01637103|Bright light therapy|bright light therapy
1287463|NCT01637064|Myositis|myositis
1287464|NCT01637064|Acthar treatment|acthar treatment
1287465|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
1287466|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
1287467|NCT01637012|ALEX|alex
1287468|NCT01637012|coronary stent|coronary stent
1287469|NCT01637012|cobalt-chromium|cobalt-chromium
1287470|NCT01637012|sirolimus|sirolimus
1287471|NCT01637012|OCT|oct
1287472|NCT01636999|Sedara|sedara
1287473|NCT01636999|Nitrous Oxide|nitrous oxide
1287474|NCT01636999|Butorphanol|butorphanol
1287475|NCT01636999|Visual Analog Scale|visual analog scale
1287476|NCT01636986|myopia|myopia
1287477|NCT01636986|contact lenses|contact lenses
1287478|NCT01636986|dry eyes|dry eyes
1287479|NCT01636986|comfort|comfort
1287480|NCT01636986|replacement|replacement
1287481|NCT01636973|Lung cancer|lung cancer
1287482|NCT01636947|chemotherapy|chemotherapy
1287483|NCT01636947|nausea|nausea
1287484|NCT01636947|vomiting|vomiting
1287485|NCT01636947|emetogenic|emetogenic
1287486|NCT01636947|cancer|cancer
1287487|NCT01636947|antiemetics|antiemetics
1287488|NCT01636947|tumor|tumor
1287489|NCT01636934|Lung Cancer|lung cancer
1287490|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
1287491|NCT01636934|NSCLC|nsclc
1287492|NCT01636934|Symptom Burden|symptom burden
1287493|NCT01636934|Chemoradiation|chemoradiation
1287494|NCT01636934|CXRT|cxrt
1287495|NCT01636934|Minocycline|minocycline
1287496|NCT01636934|Dynacin|dynacin
1287497|NCT01636934|Minocin|minocin
1287498|NCT01636934|Minocin PAC|minocin pac
1287499|NCT01636934|Myrac|myrac
1287500|NCT01636934|Solodyn|solodyn
1287501|NCT01636934|Placebo|placebo
1287502|NCT01636934|Sugar Pill|sugar pill
1287503|NCT01636934|Questionnaires|questionnaires
1287504|NCT01636934|Surveys|surveys
1287505|NCT01636921|Non-Small Cell Lung Cancer|non-small cell lung cancer
1287506|NCT01636921|Lung Cancer|lung cancer
1287507|NCT01636921|NSCLC|nsclc
1287508|NCT01636921|Radiation Therapy|radiation therapy
1287509|NCT01636921|Sorafenib|sorafenib
1287510|NCT01636921|BAY 43-9006|bay 43-9006
1287511|NCT01636921|Thoracic Radiation|thoracic radiation
1287512|NCT01636895|malaria|malaria
1287513|NCT01636895|pregnancy|pregnancy
1287514|NCT01636895|prevention|prevention
1287515|NCT01636895|treatment|treatment
1287516|NCT01636895|molecular markers|molecular markers
1287517|NCT01636882|Melanoma|melanoma
1287518|NCT01636882|CALM|calm
1287519|NCT01636869|bupivacaine level|bupivacaine level
1287520|NCT01636869|periarticular block|periarticular block
1287521|NCT01636869|total knee arthroplasty|total knee arthroplasty
1287522|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
1287523|NCT01636830|Toothbrushing|toothbrushing
1287524|NCT01636830|gingival recession|gingival recession
1287525|NCT01636804|Quicksite|quicksite
1287526|NCT01636804|Quickflex|quickflex
1287527|NCT01636804|St. Jude Medical|st. jude medical
1287528|NCT01636778|Thrombocytopenia|thrombocytopenia
1287529|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
1287530|NCT01636739|Intussusceptions|intussusceptions
1287531|NCT01636739|Special Drug Use Investigation|special drug use investigation
1287532|NCT01636739|Rotavirus|rotavirus
1287533|NCT01636726|COPD|copd
1287534|NCT01636726|AMI|ami
1287535|NCT01636726|Asthma|asthma
1287536|NCT01636726|LABAs|labas
1287537|NCT01636700|Tramadol infiltration|tramadol infiltration
1287538|NCT01636700|Analgesic effect|analgesic effect
1287539|NCT01636700|Serum IL-6|serum il-6
1287540|NCT01636687|Psoriasis|psoriasis
1287541|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
1287542|NCT01636674|positron emission tomography|positron emission tomography
1287543|NCT01636674|computed tomography|computed tomography
1287544|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
1287545|NCT01636674|colon cancer|colon cancer
1287546|NCT01636674|cancer|cancer
1287547|NCT01636674|staging|staging
1287548|NCT01636674|imaging|imaging
1287549|NCT01636648|Aortic Valve Replacement|aortic valve replacement
1287550|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
1287551|NCT01636622|Advanced Cancers|advanced cancers
1287552|NCT01636622|Advanced Malignancy|advanced malignancy
1287553|NCT01636622|BRAF Mutation|braf mutation
1287554|NCT01636622|Advanced solid tumor|advanced solid tumor
1287555|NCT01636622|Lymphoma|lymphoma
1287556|NCT01636622|Vemurafenib|vemurafenib
1287557|NCT01636622|PLX4032|plx4032
1287558|NCT01636622|RO5185426|ro5185426
1287559|NCT01636622|Carboplatin|carboplatin
1287560|NCT01636622|Paraplatin|paraplatin
1287561|NCT01636622|Paclitaxel|paclitaxel
1287562|NCT01636622|Taxol|taxol
1287563|NCT01636609|Leukemia|leukemia
1287564|NCT01636609|Acute Myeloid Leukemia|acute myeloid leukemia
1287565|NCT01636609|AML|aml
1287566|NCT01636609|Myelodysplastic Syndromes|myelodysplastic syndromes
1287567|NCT01636609|MDS|mds
1287568|NCT01636609|Relapsed|relapsed
1287569|NCT01636609|Refractory|refractory
1287570|NCT01636609|Cytarabine|cytarabine
1287571|NCT01636609|ARA-C|ara-c
1287572|NCT01636609|Cytosar|cytosar
1287573|NCT01636609|DepoCyt|depocyt
1287574|NCT01636609|Cytosine Arabinosine|cytosine arabinosine
1287575|NCT01636609|5-Azacytidine|5-azacytidine
1287576|NCT01636609|Azacitidine|azacitidine
1287577|NCT01636609|5-aza|5-aza
1287578|NCT01636609|Vidaza|vidaza
1287579|NCT01636609|5-AZC|5-azc
1287580|NCT01636609|AZA-CR|aza-cr
1287581|NCT01636609|Ladakamycin|ladakamycin
1287582|NCT01636609|NSC-102816|nsc-102816
1287583|NCT01636609|Tosedostat|tosedostat
1287584|NCT01636596|Alzheimer's Disease|alzheimer's disease
1287585|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
1287586|NCT01636596|Insulin|insulin
1287587|NCT01636596|Pulsatile|pulsatile
1287588|NCT01636583|zinc|zinc
1287589|NCT01636583|absorption|absorption
1287590|NCT01636583|bio-availability|bio-availability
1287591|NCT01636583|aqueous zinc|aqueous zinc
1287592|NCT01636583|zinc deficiency|zinc deficiency
1287593|NCT01636583|zinc fortification|zinc fortification
1287594|NCT01636570|Vitamin D|vitamin d
1287595|NCT01636570|Cholecalciferol|cholecalciferol
1287596|NCT01636570|Heart Failure|heart failure
1287597|NCT01636570|Congestive heart failure|congestive heart failure
1287598|NCT01636570|Cardiomyopathy|cardiomyopathy
1287599|NCT01636570|Strength|strength
1287600|NCT01636570|Parathyroid Hormone|parathyroid hormone
1287601|NCT01636570|Calcium|calcium
1287602|NCT01636570|Quality of Life|quality of life
1287603|NCT01636570|C reactive protein|c reactive protein
1287604|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1287605|NCT01636570|Prognosis|prognosis
1287606|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
1287607|NCT01636557|sirukumab|sirukumab
1287608|NCT01636557|CNTO 136|cnto 136
1287609|NCT01636557|CYP450 enzyme|cyp450 enzyme
1287610|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
1287611|NCT01636466|Chronic allograft failure|chronic allograft failure
1287612|NCT01636466|Kidney Transplantation|kidney transplantation
1287613|NCT01636453|wide-neck|wide-neck
1287614|NCT01636453|saccular|saccular
1287615|NCT01636453|intracranial aneurysms|intracranial aneurysms
1287616|NCT01636453|ICA|ica
1287617|NCT01636453|Stent assisted coiling|stent assisted coiling
1287618|NCT01636453|Liberty Stent|liberty stent
1287619|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
1287620|NCT01636427|myocardial infarction|myocardial infarction
1287621|NCT01636427|coronary angiography|coronary angiography
1287622|NCT01636427|STEMI|stemi
1287623|NCT01636427|NSTEMI|nstemi
1287624|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
1287625|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
1287626|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
1287627|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1287628|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
1287629|NCT01636388|Cellular Therapy|cellular therapy
1287630|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
1287631|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
1287632|NCT01636362|Mepitel Ag|mepitel ag
1287633|NCT01636362|Silver dressing|silver dressing
1287634|NCT01636349|Type 2 diabetes|type 2 diabetes
1287635|NCT01636349|hypertension|hypertension
1287636|NCT01636349|obesity|obesity
1287637|NCT01636349|metabolic syndrome|metabolic syndrome
1287638|NCT01636297|Parkinson's disease|parkinson's disease
1287639|NCT01636297|Exercise|exercise
1287640|NCT01636284|Liver Cancer|liver cancer
1287641|NCT01636284|HCC|hcc
1287642|NCT01636284|first line HCC|first line hcc
1287643|NCT01636284|Pexa-Vec|pexa-vec
1287644|NCT01636284|JX-594|jx-594
1287645|NCT01636271|CV Risk|cv risk
1287646|NCT01636271|Cardiovascular Disease|cardiovascular disease
1287647|NCT01636271|Atherosclerosis|atherosclerosis
1287648|NCT01636271|Acute coronary syndrome|acute coronary syndrome
1287649|NCT01636258|Prediabetes|prediabetes
1287650|NCT01636258|Overweight|overweight
1287651|NCT01636258|African American|african american
1287652|NCT01636258|Women|women
1287653|NCT01636258|Cooking|cooking
1287654|NCT01636258|Nutrition|nutrition
1287655|NCT01636258|Exercise|exercise
1287656|NCT01636258|Stress Management|stress management
1287657|NCT01636245|71 vaccine|71 vaccine
1287658|NCT01636245|HFMD|hfmd
1287659|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
1287660|NCT01636245|immunogenicity|immunogenicity
1287661|NCT01636232|Vitamin D|vitamin d
1287662|NCT01636232|infection|infection
1287663|NCT01636232|disease severity|disease severity
1287664|NCT01636232|mortality|mortality
1287665|NCT01636232|critically ill|critically ill
1287666|NCT01636232|sepsis|sepsis
1287667|NCT01636219|Spirometry,|spirometry,
1287668|NCT01636219|Cough|cough
1287669|NCT01636193|Rotavirus|rotavirus
1287670|NCT01636193|Rotarix|rotarix
1287671|NCT01636193|Drug Use Investigation|drug use investigation
1287672|NCT01636193|Safety|safety
1287673|NCT01636180|STEMI|stemi
1287674|NCT01636180|NSTEMI|nstemi
1287675|NCT01636180|clopidogrel|clopidogrel
1287676|NCT01636180|Areplex|areplex
1287677|NCT01636180|REL-0609|rel-0609
1287678|NCT01636154|fire-heat syndrome|fire-heat syndrome
1287679|NCT01636154|blood stasis syndrome|blood stasis syndrome
1287680|NCT01636154|method of clearing heat|method of clearing heat
1287681|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
1287682|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
1287683|NCT01636141|Safety|safety
1287684|NCT01636141|Tolerability|tolerability
1287685|NCT01636141|Pharmacokinetics|pharmacokinetics
1287686|NCT01636141|Dose escalation|dose escalation
1287687|NCT01636141|Randomized|randomized
1287688|NCT01636141|Healthy volunteers|healthy volunteers
1287689|NCT01636141|Topical|topical
1287690|NCT01636141|OLT1177|olt1177
1287691|NCT01636141|Olatec|olatec
1287692|NCT01636141|Pain|pain
1287693|NCT01636141|Inflammation|inflammation
1287694|NCT01636128|Urinary|urinary
1287695|NCT01636128|biomarkers|biomarkers
1287696|NCT01636128|DFMO|dfmo
1287697|NCT01636128|sulindac|sulindac
1287698|NCT01636102|Influenza|influenza
1287699|NCT01636102|Adults|adults
1287700|NCT01636102|Elderly|elderly
1287701|NCT01636102|Immunology|immunology
1287702|NCT01636102|Safety|safety
1287703|NCT01636089|intensive care unit|intensive care unit
1287704|NCT01636076|COPD|copd
1287705|NCT01636063|Induced Abortion|induced abortion
1287706|NCT01636063|Abortion Techniques|abortion techniques
1287707|NCT01636063|Mifepristone|mifepristone
1287708|NCT01636063|Misoprostol|misoprostol
1287709|NCT01636063|Initial Cervical Dilation|initial cervical dilation
1287710|NCT01636050|squat exercise|squat exercise
1287711|NCT01636037|schizophrenia|schizophrenia
1287712|NCT01636037|negative symptoms|negative symptoms
1287713|NCT01636037|deficit syndrome|deficit syndrome
1287714|NCT01636037|SANS|sans
1287715|NCT01636037|Sinemet|sinemet
1287716|NCT01636037|L-dopa|l-dopa
1287717|NCT01636037|levodopa|levodopa
1287718|NCT01636037|carbidopa|carbidopa
1287719|NCT01636037|augmentation|augmentation
1387346|NCT01217060|XRT|xrt
1287720|NCT01636037|antipsychotics|antipsychotics
1287721|NCT01636024|Phase 1,|phase 1,
1287722|NCT01636024|healthy volunteers,|healthy volunteers,
1287723|NCT01636024|safety,|safety,
1287724|NCT01636024|tolerability,|tolerability,
1287725|NCT01636024|pharmacokinetics,|pharmacokinetics,
1287726|NCT01636024|pharmacodynamics,|pharmacodynamics,
1287727|NCT01636024|single ascending dose study,|single ascending dose study,
1287728|NCT01636024|multiple|multiple
1287729|NCT01636011|Parkinson's Disease|parkinson's disease
1287730|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1287731|NCT01636011|Speech|speech
1287732|NCT01636011|Pulmonary Function|pulmonary function
1287733|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
1287734|NCT01635998|renal catheter ablation|renal catheter ablation
1287735|NCT01635998|hypertension|hypertension
1287736|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
1287737|NCT01635972|Isavuconazole|isavuconazole
1287738|NCT01635972|Bupropion|bupropion
1287739|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
1287740|NCT01635972|Healthy Volunteers|healthy volunteers
1287741|NCT01635972|BAL8557|bal8557
1287742|NCT01635972|BAL4815|bal4815
1287743|NCT01635972|BAL8728|bal8728
1287744|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
1287745|NCT01635946|Isavuconazole|isavuconazole
1287746|NCT01635946|Atorvastatin|atorvastatin
1287747|NCT01635946|Healthy Volunteers|healthy volunteers
1287748|NCT01635946|BAL8557|bal8557
1287749|NCT01635946|BAL4815|bal4815
1287750|NCT01635946|BAL8728|bal8728
1287751|NCT01635933|contact lenses|contact lenses
1287752|NCT01635933|color contact lenses|color contact lenses
1287753|NCT01635933|myopia|myopia
1287754|NCT01635920|contact lenses|contact lenses
1287755|NCT01635920|color contact lenses|color contact lenses
1287756|NCT01635920|myopia|myopia
1287757|NCT01635894|female pelvic floor condition|female pelvic floor condition
1287758|NCT01635894|pelvic floor training|pelvic floor training
1287759|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
1287760|NCT01635894|practice nurse|practice nurse
1287761|NCT01635894|nurse specialist|nurse specialist
1287762|NCT01635842|Patient|patient
1287763|NCT01635842|information leaflet|information leaflet
1287764|NCT01635842|informed consent|informed consent
1287765|NCT01635842|awareness|awareness
1287766|NCT01635829|Healthy participants|healthy participants
1287767|NCT01635829|Hepatitis C virus|hepatitis c virus
1287768|NCT01635829|Telaprevir|telaprevir
1287769|NCT01635829|Phenytoin|phenytoin
1287770|NCT01635829|Carbamazepine|carbamazepine
1287771|NCT01635829|HCV|hcv
1287772|NCT01635829|Interaction|interaction
1287773|NCT01635816|Immunogenicity|immunogenicity
1287774|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
1287775|NCT01635816|Bangladesh|bangladesh
1287776|NCT01635803|bevacizumab|bevacizumab
1287777|NCT01635803|ranibizumab|ranibizumab
1287778|NCT01635803|retinal vein occlusions|retinal vein occlusions
1287779|NCT01635803|randomized clinical trial|randomized clinical trial
1287780|NCT01635803|Macular edema|macular edema
1287781|NCT01635790|bevacizumab|bevacizumab
1287782|NCT01635790|ranibizumab|ranibizumab
1287783|NCT01635790|diabetic macular edema|diabetic macular edema
1287784|NCT01635790|randomized clinical trial|randomized clinical trial
1287785|NCT01635777|PKDL|pkdl
1287786|NCT01635777|miltefosine|miltefosine
1287787|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
1287788|NCT01635764|open-label|open-label
1287789|NCT01635764|acne inversa|acne inversa
1287790|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
1287791|NCT01635764|adalimumab|adalimumab
1287792|NCT01635764|HS|hs
1287793|NCT01635764|acne|acne
1287794|NCT01635764|tumor necrosis factor|tumor necrosis factor
1287795|NCT01635764|abscess|abscess
1287796|NCT01635764|inflammatory nodule|inflammatory nodule
1287797|NCT01635751|Pregabalin|pregabalin
1287798|NCT01635751|GLARS|glars
1287799|NCT01635738|Probiotics|probiotics
1287800|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
1287801|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
1287802|NCT01635738|Atopic dermatitis|atopic dermatitis
1287803|NCT01635738|Asthma|asthma
1287804|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
1287805|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
1287806|NCT01635738|efficacy and safety|efficacy and safety
1287807|NCT01635725|colonoscopy|colonoscopy
1287808|NCT01635725|bowel cleanliness|bowel cleanliness
1287809|NCT01635725|bowel rating scale|bowel rating scale
1287810|NCT01635712|Hematological Malignancy|hematological malignancy
1287811|NCT01635712|Hsp90|hsp90
1287812|NCT01635699|DNA oxidation|dna oxidation
1287813|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
1287814|NCT01635699|lipid peroxidation|lipid peroxidation
1287815|NCT01635699|oxidative stresses|oxidative stresses
1287816|NCT01635673|Exercise|exercise
1287817|NCT01635673|Latino|latino
1287818|NCT01635673|Hispanic|hispanic
1287819|NCT01635673|Boys|boys
1287820|NCT01635660|Out-of-hospital|out-of-hospital
1287821|NCT01635660|airway management|airway management
1287822|NCT01635660|intubation|intubation
1287823|NCT01635660|video laryngoscope|video laryngoscope
1287824|NCT01635634|Fibromyalgia|fibromyalgia
1287825|NCT01635634|Cupping|cupping
1287826|NCT01635621|Olokizumab|olokizumab
1287827|NCT01635621|OKZ|okz
1287828|NCT01635621|CDP6038|cdp6038
1287829|NCT01635621|Crohn's Disease|crohn's disease
1287830|NCT01635621|CDAI|cdai
1287831|NCT01635621|IBDQ|ibdq
1287832|NCT01635608|Pharmacokinetics|pharmacokinetics
1287833|NCT01635608|Talinolol|talinolol
1287834|NCT01635608|Amoxicillin|amoxicillin
1287835|NCT01635608|Acetaminophen|acetaminophen
1288703|NCT01631188|Wire|wire
1287836|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
1287837|NCT01635582|Hand exercises|hand exercises
1287838|NCT01635582|Hand function|hand function
1287839|NCT01635582|Computer based exercises|computer based exercises
1287840|NCT01635582|Therapeutic gaming|therapeutic gaming
1287841|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
1287842|NCT01635569|Pediatric|pediatric
1287843|NCT01635569|Group-based|group-based
1287844|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
1287845|NCT01635556|borderline personality disorder|borderline personality disorder
1287846|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
1287847|NCT01635556|psychological treatment|psychological treatment
1287848|NCT01635517|Diuretics|diuretics
1287849|NCT01635517|Vasopressins|vasopressins
1287850|NCT01635517|Sodium|sodium
1287851|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
1287852|NCT01635504|masseter hypertrophy|masseter hypertrophy
1287853|NCT01635504|parotid enlargement|parotid enlargement
1287854|NCT01635504|botulinum toxin|botulinum toxin
1287855|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
1287856|NCT01635491|Transit time|transit time
1287857|NCT01635426|Aspirin|aspirin
1287858|NCT01635426|Clopidogrel|clopidogrel
1287859|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
1287860|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
1287861|NCT01635400|Irinotecan|irinotecan
1287862|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
1287863|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
1287864|NCT01635348|gait speed|gait speed
1287865|NCT01635348|cognitive processing speed|cognitive processing speed
1287866|NCT01635335|HIV prevention|hiv prevention
1287867|NCT01635335|adolescents|adolescents
1287868|NCT01635335|Latinos|latinos
1287869|NCT01635335|Hispanics|hispanics
1287870|NCT01635335|family|family
1287871|NCT01635335|health promotion|health promotion
1287872|NCT01635335|disease prevention|disease prevention
1287873|NCT01635335|family communication|family communication
1287874|NCT01635335|parental supervision|parental supervision
1287875|NCT01635322|deformity|deformity
1287876|NCT01635322|adult|adult
1287877|NCT01635322|lumbar|lumbar
1287878|NCT01635322|thoraco-lumbar|thoraco-lumbar
1287879|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
1287880|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
1287881|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
1287882|NCT01635257|ultrasound|ultrasound
1287883|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
1287884|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
1287885|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
1287886|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
1287887|NCT01635244|Left ventricular remodeling|left ventricular remodeling
1287888|NCT01635231|Nephrology|nephrology
1287889|NCT01635231|sodium-channels|sodium-channels
1287890|NCT01635231|water-channels|water-channels
1287891|NCT01635231|BCM|bcm
1287892|NCT01635231|central blood pressure|central blood pressure
1287893|NCT01635218|Depression|depression
1287894|NCT01635218|Perimenopause|perimenopause
1287895|NCT01635218|Postmenopause|postmenopause
1287896|NCT01635218|Homeopathy|homeopathy
1287897|NCT01635205|Paraspinous block|paraspinous block
1287898|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
1287899|NCT01635192|renin|renin
1287900|NCT01635192|angiotensin|angiotensin
1287901|NCT01635192|probiotic|probiotic
1287902|NCT01635192|glucose absorption|glucose absorption
1287903|NCT01635192|intestinal|intestinal
1287904|NCT01635179|Videolaryngoscopy|videolaryngoscopy
1287905|NCT01635179|Bronchial Aspiration|bronchial aspiration
1287906|NCT01635179|Hypoxia|hypoxia
1287907|NCT01635166|Arthroplasty|arthroplasty
1287908|NCT01635166|Replacement|replacement
1287909|NCT01635166|Hip|hip
1287910|NCT01635166|Cementless|cementless
1287911|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
1287912|NCT01635153|HIV|hiv
1287913|NCT01635153|Tuberculosis|tuberculosis
1287914|NCT01635153|Nutrition|nutrition
1287915|NCT01635140|DIPG|dipg
1287916|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1287917|NCT01635140|Radiotherapy|radiotherapy
1287918|NCT01635140|Median survival|median survival
1333268|NCT01443767|Pulse Contour Analysis|pulse contour analysis
1287919|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
1287920|NCT01635088|Asthma|asthma
1287921|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
1287922|NCT01635075|psychiatric|psychiatric
1287923|NCT01635075|comorbidity|comorbidity
1287924|NCT01635075|craving|craving
1287925|NCT01635075|tobacco|tobacco
1287926|NCT01635049|in vitro fertilization|in vitro fertilization
1287927|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
1287928|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
1287929|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
1287930|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
1287931|NCT01635049|prediction of blastocysts|prediction of blastocysts
1287932|NCT01635049|infertility|infertility
1287933|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
1287934|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
1287935|NCT01635036|in vitro fertilization|in vitro fertilization
1287936|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
1287937|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
1287938|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
1287939|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
1287940|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
1287941|NCT01635036|infertility|infertility
1287942|NCT01635036|male factor female factor|male factor female factor
1287943|NCT01635036|embryo viability|embryo viability
1287945|NCT01635023|healthy volunteers|healthy volunteers
1287946|NCT01635023|AZD6244|azd6244
1287947|NCT01635023|pharmacokinetics|pharmacokinetics
1287948|NCT01635023|AUC|auc
1287949|NCT01635023|Cmax|cmax
1287950|NCT01635023|tmax|tmax
1287951|NCT01635023|AUC(0-t)|auc(0-t)
1287952|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
1287953|NCT01635010|inflammation|inflammation
1287954|NCT01635010|oxidative stress|oxidative stress
1287955|NCT01635010|arterial stiffness|arterial stiffness
1287956|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
1287957|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
1287958|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
1287959|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
1287960|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
1287961|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
1287962|NCT01634971|Anastomotic leakage|anastomotic leakage
1287963|NCT01634958|Allergic Rhinitis|allergic rhinitis
1287964|NCT01634958|Hayfever|hayfever
1287965|NCT01634958|Immunotherapy|immunotherapy
1287966|NCT01634958|Dose-Finding-Study|dose-finding-study
1287967|NCT01634945|anemia|anemia
1287968|NCT01634945|malaria|malaria
1287969|NCT01634945|malnutrition|malnutrition
1287970|NCT01634945|iron fortification|iron fortification
1287971|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
1287972|NCT01634945|subsaharan africa|subsaharan africa
1287973|NCT01634945|ivory coast|ivory coast
1287974|NCT01634945|young children|young children
1287975|NCT01634932|Iron deficiency|iron deficiency
1287976|NCT01634932|Biofortification|biofortification
1287977|NCT01634932|Pearl Millet|pearl millet
1287978|NCT01634932|Benin|benin
1287979|NCT01634919|Chronic hepatitis C|chronic hepatitis c
1287980|NCT01634919|Liver fibrosis|liver fibrosis
1287981|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
1287982|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
1287983|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
1287984|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
1287985|NCT01634880|Panitumumab|panitumumab
1287986|NCT01634880|Postoperative|postoperative
1287987|NCT01634880|Radiotherapy|radiotherapy
1287988|NCT01634841|walnuts|walnuts
1287989|NCT01634841|age related cognitive decline|age related cognitive decline
1287990|NCT01634841|age related macular degeneration|age related macular degeneration
1287991|NCT01634841|healthy elderly subjects|healthy elderly subjects
1287992|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
1287993|NCT01634802|Electronic Medical Record|electronic medical record
1287994|NCT01634802|Resource constrained countries|resource constrained countries
1287995|NCT01634802|HIV|hiv
1287996|NCT01634789|bioavailability|bioavailability
1287997|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
1287998|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
1287999|NCT01634750|HIBM|hibm
1288000|NCT01634750|GNE Myopathy|gne myopathy
1288001|NCT01634737|shellfish|shellfish
1288002|NCT01634737|tropomyosin|tropomyosin
1288003|NCT01634737|mites|mites
1288004|NCT01634737|food allergy|food allergy
1288005|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
1387689|NCT01215630|Veins|veins
1288006|NCT01634724|OHSS|ohss
1288007|NCT01634724|E2|e2
1288008|NCT01634724|VEGF|vegf
1288009|NCT01634711|ACL|acl
1288010|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
1288011|NCT01634711|Ligament|ligament
1288012|NCT01634711|Resorbable polymer|resorbable polymer
1288013|NCT01634711|Knee ligament|knee ligament
1288014|NCT01634698|chronic liver disease|chronic liver disease
1288015|NCT01634698|cirrhosis|cirrhosis
1288016|NCT01634698|vitamin A|vitamin a
1288017|NCT01634698|RDR test|rdr test
1288018|NCT01634698|retinol-binding protein|retinol-binding protein
1288019|NCT01634685|Rectal cancer|rectal cancer
1288020|NCT01634685|Bavituximab|bavituximab
1288021|NCT01634685|Capecitabine|capecitabine
1288022|NCT01634685|Radiation Therapy|radiation therapy
1288023|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1288024|NCT01634672|peritoneal dialysis|peritoneal dialysis
1288025|NCT01634672|hemodialysis|hemodialysis
1288026|NCT01634659|contact lenses|contact lenses
1288027|NCT01634659|myopia|myopia
1288028|NCT01634646|Observational study|observational study
1288029|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
1288030|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1288031|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
1288032|NCT01634620|Chronic Bronchitis|chronic bronchitis
1288033|NCT01634620|Chronic Emphysema|chronic emphysema
1288034|NCT01634620|Asthma|asthma
1288035|NCT01634607|osteopenia|osteopenia
1288036|NCT01634607|vitamin D deficiency|vitamin d deficiency
1288037|NCT01634607|HIV-infected patients|hiv-infected patients
1288038|NCT01634607|bone health|bone health
1288039|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
1288137|NCT01633944|Back Pain|back pain
1288040|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
1288041|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
1288042|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
1288043|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1288044|NCT01634516|Diet|diet
1288045|NCT01634516|Pregnant|pregnant
1288046|NCT01634503|3+3 design|3+3 design
1288047|NCT01634503|Phase 1|phase 1
1288048|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1288049|NCT01634503|Adult|adult
1288050|NCT01634503|Safety|safety
1288051|NCT01634503|Dose Finding|dose finding
1288052|NCT01634490|cow's milk allergy|cow's milk allergy
1288053|NCT01634490|formulas|formulas
1288054|NCT01634490|probiotics|probiotics
1288055|NCT01634477|morbidity|morbidity
1288056|NCT01634477|mortality|mortality
1288057|NCT01634477|HIV-infected patients|hiv-infected patients
1288058|NCT01634477|prospective cohort study|prospective cohort study
1288059|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
1288060|NCT01634477|opportunistic infections|opportunistic infections
1288061|NCT01634477|Non HIV-related illness|non hiv-related illness
1288062|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
1288063|NCT01634477|HIV negative patients|hiv negative patients
1288064|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
1288065|NCT01634451|Sedation|sedation
1288066|NCT01634451|Quality|quality
1288067|NCT01634438|coronary angiography|coronary angiography
1288068|NCT01634425|NSTEMI|nstemi
1288069|NCT01634425|Point of Care Biomarkers|point of care biomarkers
1288070|NCT01634334|Secondhand smoke|secondhand smoke
1288071|NCT01634295|CKD-828|ckd-828
1288072|NCT01634295|Hypertension|hypertension
1288073|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
1288074|NCT01634295|S-Amlodipine|s-amlodipine
1288075|NCT01634295|Telmisartan|telmisartan
1288076|NCT01634269|Valvular Heart Disease|valvular heart disease
1288077|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
1288078|NCT01634269|Aortic Valve Replacement|aortic valve replacement
1288079|NCT01634243|SPM 962|spm 962
1288080|NCT01634243|rotigotine|rotigotine
1288081|NCT01634243|Parkinson's disease|parkinson's disease
1288082|NCT01634204|weight reduction|weight reduction
1288083|NCT01634204|web-based intervention|web-based intervention
1288084|NCT01634204|cost-effective|cost-effective
1288085|NCT01634204|overweight|overweight
1288086|NCT01634204|obesity|obesity
1288087|NCT01634204|cardiovascular risk|cardiovascular risk
1288088|NCT01634191|Apremilast|apremilast
1288089|NCT01634191|pharmacokinetic|pharmacokinetic
1288090|NCT01634191|safety|safety
1288091|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
1288092|NCT01634178|Apremilast,|apremilast,
1288093|NCT01634178|pharmacokinetic|pharmacokinetic
1288094|NCT01634178|safety|safety
1288095|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
1288096|NCT01634126|Colon|colon
1288097|NCT01634126|Rectal|rectal
1288098|NCT01634126|Cancer|cancer
1288099|NCT01634126|Screening|screening
1288101|NCT01634126|Fecal|fecal
1333269|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
1288102|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
1288103|NCT01634048|high protein diet|high protein diet
1288104|NCT01634048|meal replacements|meal replacements
1288105|NCT01634048|low calorie diet|low calorie diet
1288106|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
1288107|NCT01634035|glycated hemoglobin|glycated hemoglobin
1288108|NCT01634035|mean plasma glucose|mean plasma glucose
1288109|NCT01634022|Acupuncture|acupuncture
1288110|NCT01634022|Antidepressant|antidepressant
1288111|NCT01634022|Monotherapy|monotherapy
1288112|NCT01634022|Depression|depression
1288113|NCT01634022|Alternative treatments|alternative treatments
1288114|NCT01634009|Severe acute malnutrition|severe acute malnutrition
1288115|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
1288116|NCT01634009|Soy protein|soy protein
1288117|NCT01634009|Community based management|community based management
1288118|NCT01634009|Efficacy|efficacy
1288119|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
1288121|NCT01633996|Antidepressant|antidepressant
1288122|NCT01633996|Augmentation|augmentation
1288123|NCT01633996|Depression|depression
1288124|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
1288125|NCT01633983|Methotrexate|methotrexate
1288126|NCT01633957|anticoagulation|anticoagulation
1288127|NCT01633957|bleeding|bleeding
1288128|NCT01633957|CYP2C9|cyp2c9
1288129|NCT01633957|CYP4F2|cyp4f2
1288130|NCT01633957|VKORC1|vkorc1
1288131|NCT01633957|warfarin dosing|warfarin dosing
1288132|NCT01633957|Heart Valve Diseases|heart valve diseases
1288133|NCT01633957|pharmacogenomics|pharmacogenomics
1288134|NCT01633944|CLBP|clbp
1288135|NCT01633944|Chronic Low Back Pain|chronic low back pain
1288136|NCT01633944|Chronic Pain|chronic pain
1288138|NCT01633918|intervention|intervention
1288139|NCT01633918|health education|health education
1288140|NCT01633918|physical activity|physical activity
1288141|NCT01633918|sedentary behavior|sedentary behavior
1288142|NCT01633918|health promotion|health promotion
1288143|NCT01633918|evaluation|evaluation
1288144|NCT01633918|RE-AIM|re-aim
1288145|NCT01633905|alcohol-dependence|alcohol-dependence
1288146|NCT01633905|event-related potentials|event-related potentials
1288147|NCT01633905|emotion|emotion
1288148|NCT01633905|crossmodal|crossmodal
1288149|NCT01633905|peripheral processing|peripheral processing
1288150|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
1288151|NCT01633892|Battle-injured (BI)|battle-injured (bi)
1288152|NCT01633892|Facial Trauma|facial trauma
1288153|NCT01633892|Fat Grafts|fat grafts
1288154|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1288155|NCT01633892|Wounded warriors|wounded warriors
1288156|NCT01633892|Adipose Tissue|adipose tissue
1288157|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
1288158|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
1288159|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
1288160|NCT01633853|vitamin D2|vitamin d2
1288161|NCT01633853|parathyroid hormone|parathyroid hormone
1288162|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
1288163|NCT01633840|food allergy|food allergy
1288164|NCT01633840|food hypersensitivity|food hypersensitivity
1288165|NCT01633840|triangle test|triangle test
1288166|NCT01633840|validated recipes|validated recipes
1288167|NCT01633814|Physiological Processes|physiological processes
1288168|NCT01633814|Exercise|exercise
1288169|NCT01633814|Hormone replacement therapy|hormone replacement therapy
1288170|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
1288171|NCT01633775|trabeculectomy|trabeculectomy
1288172|NCT01633775|ahmed valve implant|ahmed valve implant
1288173|NCT01633749|Influenza|influenza
1288174|NCT01633749|Vaccine|vaccine
1288175|NCT01633749|CHMP criteria|chmp criteria
1288176|NCT01633736|single blinded|single blinded
1288177|NCT01633736|randomised|randomised
1288178|NCT01633736|controlled|controlled
1288179|NCT01633736|physiotherapy|physiotherapy
1288180|NCT01633736|children|children
1288181|NCT01633736|cerebral palsy|cerebral palsy
1288182|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
1288183|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
1288184|NCT01633710|Diabetes|diabetes
1288185|NCT01633710|Photoplethysmography|photoplethysmography
1288186|NCT01633697|emphysema|emphysema
1288187|NCT01633697|chronic bronchitis|chronic bronchitis
1288188|NCT01633684|diabetes mellitus|diabetes mellitus
1288189|NCT01633684|bone|bone
1288190|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
1288191|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
1288192|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
1288193|NCT01633658|vitamin D|vitamin d
1288194|NCT01633632|Smoking cessation|smoking cessation
1288196|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
1288197|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
1288198|NCT01633606|severity of illness|severity of illness
1288199|NCT01633606|scoring|scoring
1288200|NCT01633606|medium care|medium care
1288201|NCT01633606|intensive care|intensive care
1288202|NCT01633606|staffing|staffing
1288203|NCT01633580|ICSI|icsi
1288204|NCT01633580|GnRH antagonist|gnrh antagonist
1288205|NCT01633580|corifollitropin alfa|corifollitropin alfa
1288206|NCT01633567|Smoking Cessation|smoking cessation
1288207|NCT01633567|Cigarette Smoking|cigarette smoking
1288208|NCT01633567|Tobacco|tobacco
1288209|NCT01633567|LGBT|lgbt
1288210|NCT01633567|LGBTQ|lgbtq
1288211|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
1288212|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
1288213|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
1288214|NCT01633515|Cryotherapy|cryotherapy
1288215|NCT01633515|Cryosurgery|cryosurgery
1288216|NCT01633476|CMV|cmv
1288221|NCT01633437|tyramine|tyramine
1288223|NCT01633437|cheese effect|cheese effect
1288224|NCT01633437|depression|depression
1288225|NCT01633398|Heart Failure|heart failure
1288226|NCT01633398|HF|hf
1288227|NCT01633385|bronchial inflammation|bronchial inflammation
1288228|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
1288229|NCT01633385|Sputum|sputum
1288230|NCT01633385|Blood|blood
1288231|NCT01633385|Inflammation|inflammation
1288232|NCT01633385|adaptive immune system|adaptive immune system
1288233|NCT01633385|innate immune system|innate immune system
1288234|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
1288235|NCT01633372|PMF|pmf
1288236|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
1288237|NCT01633372|PPV-MF|ppv-mf
1288238|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
1288239|NCT01633372|PET-MF|pet-mf
1288240|NCT01633333|Colonoscopy|colonoscopy
1288241|NCT01633333|Colorectal cancer|colorectal cancer
1288242|NCT01633333|Colorectal adenomas|colorectal adenomas
1288243|NCT01633333|Pain|pain
1288244|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
1288245|NCT01633307|education|education
1288246|NCT01633307|intravenous infusion|intravenous infusion
1288247|NCT01633294|premature rupture of membranes|premature rupture of membranes
1288248|NCT01633294|term pregnancy|term pregnancy
1288249|NCT01633294|chorioamnionitis|chorioamnionitis
1288250|NCT01633294|endometritis|endometritis
1288251|NCT01633294|neonatal sepsis|neonatal sepsis
1288252|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
1288253|NCT01633281|peripheral neuropathy|peripheral neuropathy
1288254|NCT01633281|acupuncture|acupuncture
1288255|NCT01633281|Bortezomib|bortezomib
1288256|NCT01633281|Thalidomide|thalidomide
1288257|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1288258|NCT01633268|Traumatic Brain Injury|traumatic brain injury
1288259|NCT01633255|Anti-Angiogenic|anti-angiogenic
1288260|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
1288261|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
1288262|NCT01633242|MRI|mri
1288263|NCT01633242|Muscular Dystrophy|muscular dystrophy
1288264|NCT01633242|Cardiac|cardiac
1288265|NCT01633242|Myocardium|myocardium
1288266|NCT01633242|Intramyocardial fat|intramyocardial fat
1288273|NCT01633216|poliovirus,|poliovirus,
1288274|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
1288275|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
1288276|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
1288277|NCT01633203|gastric cancer|gastric cancer
1288278|NCT01633203|combination chemotherapy|combination chemotherapy
1288279|NCT01633203|HER-2 gene|her-2 gene
1288280|NCT01633203|quality of life|quality of life
1288281|NCT01633190|Surveillance|surveillance
1288282|NCT01633190|Rotavirus|rotavirus
1288283|NCT01633190|Gastroenteritis|gastroenteritis
1288284|NCT01633177|vitamin D|vitamin d
1288285|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
1288286|NCT01633177|Type 2 diabetes|type 2 diabetes
1288287|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
1288288|NCT01633177|Insulin sensitivity|insulin sensitivity
1288289|NCT01633177|Beta-cell function|beta-cell function
1288290|NCT01633164|Spinal Cord Injury|spinal cord injury
1288291|NCT01633164|Self-Efficacy|self-efficacy
1288292|NCT01633164|Life Satisfaction|life satisfaction
1288293|NCT01633164|Community Participation|community participation
1288294|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
1288295|NCT01633138|substance abuse treatment|substance abuse treatment
1288296|NCT01633125|Group music therapy|group music therapy
1288297|NCT01633125|prisoners|prisoners
1288298|NCT01633125|Anxiety|anxiety
1288299|NCT01633125|Depression|depression
1288300|NCT01633125|Self-esteem|self-esteem
1288301|NCT01633099|decitabine|decitabine
1288302|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
1288303|NCT01633099|elderly patient|elderly patient
1288304|NCT01633060|BKM120|bkm120
1288305|NCT01633060|fulvestrant|fulvestrant
1288306|NCT01633060|breast cancer|breast cancer
1288307|NCT01633060|metastatic|metastatic
1288308|NCT01633060|locally advanced|locally advanced
1288309|NCT01633060|AI treated|ai treated
1288310|NCT01633060|mTOR inhibitor|mtor inhibitor
1288311|NCT01633060|PI3K|pi3k
1288312|NCT01633060|PIK3CA|pik3ca
1288313|NCT01633060|PTEN|pten
1288314|NCT01633060|HER2-|her2-
1288316|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
1288317|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
1288318|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
1288319|NCT01633034|back pain|back pain
1288320|NCT01633034|spine surgery|spine surgery
1288321|NCT01633021|Family Study|family study
1288322|NCT01633021|Social Networks|social networks
1288323|NCT01633021|Diabetes|diabetes
1288324|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
1288325|NCT01633008|Quality of Life|quality of life
1288326|NCT01633008|Pain-Related Coping|pain-related coping
1288327|NCT01633008|Pain-Related Anxiety|pain-related anxiety
1288328|NCT01633008|Depression|depression
1288329|NCT01632982|opioid abuse|opioid abuse
1288330|NCT01632982|substance abuse|substance abuse
1288331|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
1288332|NCT01632982|mobile technology|mobile technology
1288333|NCT01632982|technology-based intervention|technology-based intervention
1288334|NCT01632982|behavioral intervention|behavioral intervention
1288335|NCT01632982|psychosocial treatment|psychosocial treatment
1288336|NCT01632969|12-136|12-136
1288337|NCT01632956|Support Groups|support groups
1288338|NCT01632956|Breast cancer|breast cancer
1288339|NCT01632956|Mandarin speaking|mandarin speaking
1288340|NCT01632956|12-105|12-105
1288341|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
1288342|NCT01632930|diagnosis|diagnosis
1288343|NCT01632930|prostate cancer|prostate cancer
1288344|NCT01632930|urine|urine
1288345|NCT01632930|medical economics|medical economics
1288346|NCT01632917|Healthy volunteers|healthy volunteers
1288347|NCT01632904|Polycythemia Vera|polycythemia vera
1288348|NCT01632904|PV|pv
1288349|NCT01632878|Secondary prevention post MI|secondary prevention post mi
1288350|NCT01632865|occlusion|occlusion
1288351|NCT01632865|recanalization|recanalization
1288352|NCT01632865|stenting|stenting
1288353|NCT01632839|PISQ-R|pisq-r
1288354|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
1288355|NCT01632826|Relapsed|relapsed
1288356|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
1288357|NCT01632826|pomalidomide|pomalidomide
1288358|NCT01632813|neurocognitive testing|neurocognitive testing
1288359|NCT01632813|critical illness|critical illness
1288360|NCT01632813|executive function|executive function
1288361|NCT01632813|intelligence|intelligence
1288362|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
1288363|NCT01632787|Anxiety|anxiety
1288364|NCT01632787|Binocular|binocular
1288365|NCT01632787|Chronic Headache|chronic headache
1288366|NCT01632787|Dizziness|dizziness
1288367|NCT01632787|Vertical Heterophoria|vertical heterophoria
1288368|NCT01632787|Vision Dysfunction|vision dysfunction
1288369|NCT01632761|anemia|anemia
1288370|NCT01632761|vitamin D3|vitamin d3
1288371|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
1288372|NCT01632761|fish oil|fish oil
1288373|NCT01632761|primary prevention|primary prevention
1288374|NCT01632735|Continuing Care|continuing care
1288375|NCT01632735|Youth Substance Abuse|youth substance abuse
1288376|NCT01632735|Recovery Support|recovery support
1288377|NCT01632735|Mobile Texting|mobile texting
1288378|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
1288379|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
1288380|NCT01632696|Biologics|biologics
1288381|NCT01632696|F(ab')2|f(ab')2
1288382|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
1288383|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
1288384|NCT01632696|Solid Tumors|solid tumors
1288385|NCT01632696|Tumor Imaging|tumor imaging
1288386|NCT01632683|difficult airway|difficult airway
1288387|NCT01632683|video laryngoscopy|video laryngoscopy
1288388|NCT01632670|music|music
1288389|NCT01632670|cardiac catheterization|cardiac catheterization
1288390|NCT01632670|endothelial function|endothelial function
1288391|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
1288392|NCT01632605|ADPKD|adpkd
1288393|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1288394|NCT01632605|Sirolimus|sirolimus
1288395|NCT01632605|Rapamune|rapamune
1288396|NCT01632605|Polycystic liver disease|polycystic liver disease
1288397|NCT01632605|Rapamycin|rapamycin
1288398|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
1288399|NCT01632605|m-TOR|m-tor
1288400|NCT01632605|m-TOR inhibition|m-tor inhibition
1288401|NCT01632553|Observation|observation
1288402|NCT01632553|Domestic Violence|domestic violence
1288403|NCT01632553|Partner Abuse|partner abuse
1288404|NCT01632553|Spousal Abuse|spousal abuse
1288405|NCT01632553|Battered Women|battered women
1288406|NCT01632553|Abused Women|abused women
1288407|NCT01632553|Cortisol|cortisol
1288408|NCT01632553|Mental Health|mental health
1288409|NCT01632553|Depression|depression
1288410|NCT01632553|Anxiety|anxiety
1288411|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
1288412|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
1288413|NCT01632527|Dry AMD with GA|dry amd with ga
1288414|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
1288704|NCT01631188|MICS|mics
1288415|NCT01632527|Stem Cell Transplantation|stem cell transplantation
1288416|NCT01632527|Stem Cell transplant|stem cell transplant
1288417|NCT01632527|Stem cells for AMD|stem cells for amd
1288418|NCT01632527|Human neural stem cells|human neural stem cells
1288419|NCT01632527|multipotent stem cells|multipotent stem cells
1288420|NCT01632527|Macular Degeneration|macular degeneration
1288421|NCT01632527|Dry AMD|dry amd
1288422|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
1288423|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
1288424|NCT01632514|hypocalcemia|hypocalcemia
1288425|NCT01632514|vitamin D deficiency|vitamin d deficiency
1288426|NCT01632514|cholecalciferol|cholecalciferol
1288427|NCT01632514|thyroidectomy|thyroidectomy
1288428|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
1288429|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
1288430|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
1288431|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
1288432|NCT01632475|Premature infants|premature infants
1288433|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1288434|NCT01632475|Lung injury|lung injury
1288435|NCT01632475|Lung diseases|lung diseases
1288436|NCT01632475|Hyperplasia|hyperplasia
1288437|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
1288438|NCT01632475|Respiratory lung diseases|respiratory lung diseases
1288439|NCT01632475|Pathologic Processes|pathologic processes
1288440|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
1288441|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
1288442|NCT01632462|Crohn's disease|crohn's disease
1288443|NCT01632462|VSL#3|vsl#3
1288444|NCT01632462|probiotics|probiotics
1288445|NCT01632462|metabolic profile|metabolic profile
1288446|NCT01632449|bioequivalence|bioequivalence
1288447|NCT01632436|Hepatic impairment|hepatic impairment
1288448|NCT01632436|Metastatic Cancer|metastatic cancer
1288449|NCT01632410|autonomic nerve system|autonomic nerve system
1288450|NCT01632410|post stroke|post stroke
1288451|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
1288452|NCT01632410|autonomic nervous system|autonomic nervous system
1288453|NCT01632397|PrEP|prep
1288455|NCT01632397|Adherence|adherence
1288456|NCT01632397|MSM|msm
1288457|NCT01632397|Men having sex with men|men having sex with men
1288458|NCT01632384|Smoker|smoker
1288459|NCT01632384|Non-Smoker|non-smoker
1288460|NCT01632384|Healthy|healthy
1288461|NCT01632384|Drug free|drug free
1288462|NCT01632384|MRI|mri
1288463|NCT01632371|In-stent Restenosis|in-stent restenosis
1288464|NCT01632371|Drug Eluting Stent|drug eluting stent
1288465|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
1288466|NCT01632371|Scoring Balloon|scoring balloon
1288467|NCT01632371|Cutting Balloon|cutting balloon
1288468|NCT01632371|Angiographic follow-up|angiographic follow-up
1288469|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1288470|NCT01632358|safety|safety
1288471|NCT01632358|tolerability|tolerability
1288472|NCT01632358|pharmacokinetics|pharmacokinetics
1288473|NCT01632280|Obesity|obesity
1288474|NCT01632280|Gastric Banding|gastric banding
1288475|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1288476|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
1288477|NCT01632241|African Continental Ancestry Group|african continental ancestry group
1288478|NCT01632241|Autoimmune Disease|autoimmune disease
1288479|NCT01632241|Antibodies|antibodies
1288480|NCT01632241|Minority Groups|minority groups
1288481|NCT01632241|Black Race|black race
1288482|NCT01632241|African Americans|african americans
1288483|NCT01632241|SLE|sle
1288484|NCT01632241|Belimumab|belimumab
1288485|NCT01632241|Lupus|lupus
1288486|NCT01632215|gabapentine|gabapentine
1288487|NCT01632215|postoperative pain|postoperative pain
1288488|NCT01632202|submucosal myomas|submucosal myomas
1288489|NCT01632202|intrauterine adhesions|intrauterine adhesions
1288490|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
1288491|NCT01632202|seprafilm|seprafilm
1288492|NCT01632189|Varenicline|varenicline
1288493|NCT01632189|PET imaging|pet imaging
1288494|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
1609325|NCT00360373|obesity|obesity
1288495|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
1288496|NCT01632176|dating abuse|dating abuse
1288497|NCT01632176|dating violence|dating violence
1288498|NCT01632176|domestic violence|domestic violence
1288499|NCT01632176|sexual violence|sexual violence
1288500|NCT01632176|sexual assault|sexual assault
1288501|NCT01632176|youth violence|youth violence
1288502|NCT01632176|underage alcohol use|underage alcohol use
1288503|NCT01632176|alcohol use|alcohol use
1288504|NCT01632098|psychosocial|psychosocial
1288505|NCT01632098|healthcare|healthcare
1288506|NCT01632098|co-morbidities|co-morbidities
1288507|NCT01632098|extremely obese adolescents|extremely obese adolescents
1288508|NCT01632059|ADMA|adma
1288509|NCT01632059|DDAH II|ddah ii
1288510|NCT01632059|SAPS|saps
1288511|NCT01632059|SOFA|sofa
1288512|NCT01632059|Sepsis|sepsis
1288513|NCT01632059|Procalcitonin|procalcitonin
1288514|NCT01632059|ICU|icu
1288515|NCT01632059|mortality|mortality
1288516|NCT01632059|length of stay|length of stay
1288517|NCT01632046|peritoneal dialysis|peritoneal dialysis
1288518|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
1288519|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
1288520|NCT01632046|ultrafiltration|ultrafiltration
1288521|NCT01632046|children|children
1288522|NCT01632033|Peripheral artery disease|peripheral artery disease
1288523|NCT01632033|claudication|claudication
1288524|NCT01632033|walking|walking
1288525|NCT01632033|questionnaire|questionnaire
1288526|NCT01632020|colorectal tumor|colorectal tumor
1288527|NCT01632020|colorectal cancer|colorectal cancer
1288528|NCT01632020|colorectal carcinoma|colorectal carcinoma
1288529|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
1288530|NCT01632020|Metformin|metformin
1288531|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
1288532|NCT01631955|Acute cystitis|acute cystitis
1288533|NCT01631955|Antibiotics|antibiotics
1288534|NCT01631955|Quality of life|quality of life
1288535|NCT01631929|Diabetes|diabetes
1288536|NCT01631929|Ketoacidosis|ketoacidosis
1288537|NCT01631929|Children|children
1288538|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
1288539|NCT01631916|children|children
1288540|NCT01631916|respiratory infections|respiratory infections
1288663|NCT01631474|antiandrogen|antiandrogen
1288541|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
1288542|NCT01631851|Autism|autism
1288543|NCT01631851|Irritability|irritability
1288544|NCT01631851|Disruptive Behavior|disruptive behavior
1288545|NCT01631851|Aggression|aggression
1288546|NCT01631851|Behavior Therapy|behavior therapy
1288547|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
1288548|NCT01631838|Tocotrienols|tocotrienols
1288549|NCT01631838|Platelet aggregation|platelet aggregation
1288550|NCT01631838|Metabolic syndrome|metabolic syndrome
1288551|NCT01631838|Platelet activation|platelet activation
1288552|NCT01631838|Thrombosis|thrombosis
1288553|NCT01631825|SPM 962|spm 962
1288554|NCT01631825|rotigotine|rotigotine
1288555|NCT01631825|Parkinson's disease|parkinson's disease
1288556|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
1288557|NCT01631812|SPM 962|spm 962
1288558|NCT01631812|rotigotine|rotigotine
1288559|NCT01631812|Parkinson's disease|parkinson's disease
1288560|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
1288561|NCT01631799|epidural anesthesia|epidural anesthesia
1288562|NCT01631799|femoral block|femoral block
1288563|NCT01631799|patient control analgesia|patient control analgesia
1288564|NCT01631786|Ovaries|ovaries
1288565|NCT01631786|Imaging|imaging
1288566|NCT01631786|Ultrasonography|ultrasonography
1288567|NCT01631786|Synchrotron|synchrotron
1288568|NCT01631786|Histology|histology
1288569|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
1288570|NCT01631773|Nasal polyp|nasal polyp
1288571|NCT01631760|Asthma|asthma
1288572|NCT01631760|Asthma Exacerbations|asthma exacerbations
1288573|NCT01631747|Pregnancy|pregnancy
1288574|NCT01631747|Weight gain|weight gain
1288575|NCT01631747|Obesity|obesity
1288576|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
1288577|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
1288578|NCT01631721|parenting practices|parenting practices
1288579|NCT01631721|sexual risk behavior|sexual risk behavior
1288580|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
1288581|NCT01631708|Moderate iron overload|moderate iron overload
1288582|NCT01631708|Serum ferritin|serum ferritin
1288583|NCT01631708|Treatment|treatment
1288584|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
1288585|NCT01631682|PTSD|ptsd
1288586|NCT01631682|Anxiety|anxiety
1288587|NCT01631682|Fear of spiders|fear of spiders
1288588|NCT01631682|Reconsolidation|reconsolidation
1288589|NCT01631682|Reconsolidation blockade|reconsolidation blockade
1288590|NCT01631669|Ossification|ossification
1288591|NCT01631669|Heterotopic Ossification|heterotopic ossification
1288592|NCT01631656|Rosacea, Laser, Finacea Gel, Azelaic Acid,|rosacea, laser, finacea gel, azelaic acid,
1288593|NCT01631643|Blood glucose monitor|blood glucose monitor
1288594|NCT01631643|Pattern management|pattern management
1288595|NCT01631643|Pattern guide|pattern guide
1288596|NCT01631643|Education|education
1288597|NCT01631630|Alcohol|alcohol
1288598|NCT01631630|Alcohol Dependence|alcohol dependence
1288599|NCT01631630|Alcohol Use|alcohol use
1288600|NCT01631630|Nicotine Dependence|nicotine dependence
1288601|NCT01631630|Nicotine|nicotine
1288602|NCT01631617|Investigator-Blinded|investigator-blinded
1288603|NCT01631617|Skin Biopsy|skin biopsy
1288604|NCT01631617|Randomized|randomized
1288605|NCT01631617|Antibiotics|antibiotics
1288606|NCT01631617|Topical|topical
1288607|NCT01631604|risk of falling|risk of falling
1288608|NCT01631604|gait patterns|gait patterns
1288609|NCT01631604|muscle activity|muscle activity
1288610|NCT01631604|fall prevention|fall prevention
1288611|NCT01631604|motor impairment|motor impairment
1288612|NCT01631578|mitochondrial injection|mitochondrial injection
1288613|NCT01631565|Palliative Care|palliative care
1288614|NCT01631565|Survival|survival
1288615|NCT01631565|Quality of life|quality of life
1288616|NCT01631552|Colorectal (CRC)|colorectal (crc)
1288617|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
1288618|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
1288619|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1288620|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1288621|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
1288622|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
1288623|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
1288624|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
1288625|NCT01631552|Pancreatic ductal adenocarcinoma (PDC)|pancreatic ductal adenocarcinoma (pdc)
1288626|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
1288627|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
1288628|NCT01631552|Bladder cancer|bladder cancer
1288629|NCT01631552|Endometrial Cancer|endometrial cancer
1288630|NCT01631552|Cervical Cancer|cervical cancer
1288631|NCT01631552|Breast cancer|breast cancer
1288632|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
1288633|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
1288634|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
1288635|NCT01631539|chemoembolization|chemoembolization
1288636|NCT01631539|DC Bead™|dc bead™
1288637|NCT01631539|Irinotecan|irinotecan
1288638|NCT01631539|Cetuximab|cetuximab
1288639|NCT01631539|5FU/LV|5fu/lv
1288640|NCT01631539|KRAS|kras
1288641|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
1288642|NCT01631526|Lung cancer|lung cancer
1288643|NCT01631526|vitamin D|vitamin d
1288644|NCT01631526|pharmacokinetics|pharmacokinetics
1288645|NCT01631513|Chronic Low Back Pain|chronic low back pain
1288646|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
1288647|NCT01631513|Oxycodone|oxycodone
1288648|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
1288649|NCT01631513|Tapentadol|tapentadol
1288650|NCT01631513|NUCYNTA ER|nucynta er
1288651|NCT01631500|Integrative medicine|integrative medicine
1288652|NCT01631500|Acupuncture|acupuncture
1288653|NCT01631500|Minor mental health problems|minor mental health problems
1288654|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
1288655|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
1288656|NCT01631487|Healthy|healthy
1288657|NCT01631487|JNJ-39439335|jnj-39439335
1288658|NCT01631487|Japanese|japanese
1288659|NCT01631487|Caucasian|caucasian
1288660|NCT01631487|Male|male
1288661|NCT01631474|Intrepid|intrepid
1288662|NCT01631474|acne|acne
1288664|NCT01631461|pain|pain
1288665|NCT01631461|breast feeding|breast feeding
1288666|NCT01631461|yeast|yeast
1288667|NCT01631461|candida albicance|candida albicance
1288668|NCT01631461|staphylococcus aureus|staphylococcus aureus
1288669|NCT01631461|Signs and symptoms|signs and symptoms
1288670|NCT01631448|Fibrin sealant|fibrin sealant
1288671|NCT01631448|renal transplantation|renal transplantation
1288672|NCT01631448|surgical complication|surgical complication
1288673|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
1288674|NCT01631409|clinical research|clinical research
1288675|NCT01631409|coronary heart disease|coronary heart disease
1288676|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
1288677|NCT01631409|ischemic heart disease|ischemic heart disease
1288678|NCT01631409|myocardial revascularization|myocardial revascularization
1288679|NCT01631409|observational research|observational research
1288680|NCT01631409|prospective research|prospective research
1288681|NCT01631396|Morbid obesity|morbid obesity
1288682|NCT01631396|Bariatric Surgery|bariatric surgery
1288683|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
1288684|NCT01631383|Cocaine Use|cocaine use
1288685|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
1288686|NCT01631305|Thyroxine|thyroxine
1288687|NCT01631305|Intensive care|intensive care
1288688|NCT01631279|NSCLC|nsclc
1288689|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
1288690|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
1288691|NCT01631279|solid tumors|solid tumors
1288692|NCT01631279|lung cancer|lung cancer
1288693|NCT01631240|Sodium|sodium
1288694|NCT01631240|Potassium|potassium
1288695|NCT01631240|Iodine|iodine
1288696|NCT01631240|Creatinine|creatinine
1288697|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
1288698|NCT01631201|Chlamydia|chlamydia
1288699|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
1288700|NCT01631188|Port Access Surgery|port access surgery
1288701|NCT01631188|Heart|heart
1288705|NCT01631188|Cardiac Bypass|cardiac bypass
1288706|NCT01631188|Epicardial pacing|epicardial pacing
1288707|NCT01631188|pacing catheter|pacing catheter
1288708|NCT01631188|pacing wire|pacing wire
1288709|NCT01631188|pacing swan|pacing swan
1288710|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
1288711|NCT01631188|Pulmonary Endovent|pulmonary endovent
1288712|NCT01631188|Catheter|catheter
1288713|NCT01631188|Aortic Valve Surgery|aortic valve surgery
1288714|NCT01631188|Edwards Lifesciences|edwards lifesciences
1288715|NCT01631175|sarcoma|sarcoma
1288716|NCT01631175|distress|distress
1288717|NCT01631175|tumor|tumor
1288718|NCT01631175|quality of life|quality of life
1288719|NCT01631175|cancer|cancer
1288720|NCT01631162|Asthma|asthma
1288721|NCT01631162|COPD|copd
1288722|NCT01631149|urology|urology
1288723|NCT01631149|muscle relaxation|muscle relaxation
1288724|NCT01631149|laparoscopy|laparoscopy
1288725|NCT01631149|anesthesia|anesthesia
1288726|NCT01631149|rocuronium|rocuronium
1288727|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
1288728|NCT01631136|IFCT|ifct
1288729|NCT01631136|Maintenance|maintenance
1288730|NCT01631136|Switch|switch
1288731|NCT01631123|Twins|twins
1288732|NCT01631123|High carbohydrat diet|high carbohydrat diet
1288733|NCT01631123|High fat diet|high fat diet
1288734|NCT01631123|Isocaloric|isocaloric
1288735|NCT01631123|Nutrigenomics|nutrigenomics
1288736|NCT01631110|Influenza|influenza
1288737|NCT01631110|Virus|virus
1288738|NCT01631110|Vaccination|vaccination
1288739|NCT01631110|Inflexal V|inflexal v
1288740|NCT01631084|Diabetes|diabetes
1288741|NCT01631084|Structured care|structured care
1288742|NCT01631071|Influenza|influenza
1288743|NCT01631071|Virus|virus
1288744|NCT01631071|Vaccination|vaccination
1288745|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
1288746|NCT01631058|kidney transplantation|kidney transplantation
1288747|NCT01631058|chronic renal failure|chronic renal failure
1288748|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
1288749|NCT01631058|elderly|elderly
1288750|NCT01631058|pharmacokinetic|pharmacokinetic
1288751|NCT01631058|tacrolimus|tacrolimus
1288752|NCT01631058|everolimus|everolimus
1288753|NCT01631058|mycophenolate sodium|mycophenolate sodium
1288754|NCT01631058|serious adverse events|serious adverse events
1288755|NCT01631058|biopsy|biopsy
1288756|NCT01631058|Cystatin C|cystatin c
1288757|NCT01631058|metabolic effects|metabolic effects
1288758|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
1288759|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
1288760|NCT01631045|Obesity|obesity
1288761|NCT01631032|Allergic rhinitis|allergic rhinitis
1288762|NCT01631032|Chinese herbal products|chinese herbal products
1288763|NCT01631032|Qi deficiency|qi deficiency
1288764|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1288765|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
1288766|NCT01631019|Mobile phone|mobile phone
1288767|NCT01631019|Biomarker|biomarker
1288768|NCT01631006|CPAP|cpap
1288769|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1288770|NCT01631006|Blood Pressure|blood pressure
1288771|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
1288772|NCT01630993|umbilical cord milking|umbilical cord milking
1288773|NCT01630993|umbilical cord stripping|umbilical cord stripping
1288774|NCT01630993|umbilical cord clamping|umbilical cord clamping
1288775|NCT01630993|placental transfusion|placental transfusion
1288776|NCT01630993|placental residual blood volume|placental residual blood volume
1288777|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
1288778|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1288779|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1288780|NCT01630980|Clinical practice guidelines|clinical practice guidelines
1288781|NCT01630980|Clinical trials|clinical trials
1288782|NCT01630980|Tree nuts|tree nuts
1288783|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
1288784|NCT01630980|Triglycerides|triglycerides
1288785|NCT01630980|Cholesterol|cholesterol
1288786|NCT01630980|Glycemic control|glycemic control
1288787|NCT01630980|Insulin resistance|insulin resistance
1288788|NCT01630980|Body weight|body weight
1288789|NCT01630980|Blood pressure|blood pressure
1288790|NCT01630967|castrate resistance|castrate resistance
1288791|NCT01630967|PSA progression|psa progression
1288792|NCT01630967|LHRH antagonism|lhrh antagonism
1288793|NCT01630954|Hydatidiform mole|hydatidiform mole
1288794|NCT01630954|Molar pregnancy|molar pregnancy
1288795|NCT01630954|H Mole|h mole
1288796|NCT01630954|GTN|gtn
1288797|NCT01630954|GTD|gtd
1288798|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
1288799|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
1288800|NCT01630941|DXA|dxa
1288801|NCT01630941|BMD|bmd
1288802|NCT01630941|PET|pet
1288803|NCT01630941|CT|ct
1288804|NCT01630941|Biochemical bone markers|biochemical bone markers
1288805|NCT01630928|Renal denervation|renal denervation
1288806|NCT01630928|Resistant Hypertension|resistant hypertension
1288807|NCT01630928|Cardiovascular disease|cardiovascular disease
1288808|NCT01630928|Diabetes|diabetes
1288809|NCT01630928|Quality of LIfe|quality of life
1288810|NCT01630889|Kidney|kidney
1288811|NCT01630889|ESRD|esrd
1288812|NCT01630889|End Stage Renal Disease|end stage renal disease
1288813|NCT01630889|Anemia|anemia
1288814|NCT01630889|Oral anemia treatment|oral anemia treatment
1288815|NCT01630889|Hemoglobin levels|hemoglobin levels
1288816|NCT01630889|Hemodialysis|hemodialysis
1288817|NCT01630889|CKD|ckd
1288818|NCT01630889|Chronic Kidney Disease|chronic kidney disease
1288819|NCT01630889|Peritoneal|peritoneal
1288820|NCT01630889|HD|hd
1288821|NCT01630889|PD|pd
1288822|NCT01630889|Hb|hb
1288823|NCT01630889|Erythropoietin|erythropoietin
1288824|NCT01630889|Blood count|blood count
1288825|NCT01630876|Epiretinal membrane|epiretinal membrane
1288826|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
1288827|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
1288828|NCT01630863|photodynamic therapy|photodynamic therapy
1288829|NCT01630863|safe and effective dose|safe and effective dose
1288830|NCT01630824|education program|education program
1288831|NCT01630824|kidney transplantation|kidney transplantation
1288832|NCT01630824|renal transplantation|renal transplantation
1288833|NCT01630824|evaluation|evaluation
1288834|NCT01630811|Adults|adults
1288835|NCT01630798|barrett's esophgus|barrett's esophgus
1288836|NCT01630798|High grade dysplasia|high grade dysplasia
1288837|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
1288838|NCT01630772|women with preeclampsia|women with preeclampsia
1288839|NCT01630772|physical therapy|physical therapy
1288840|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
1288841|NCT01630772|perinatal outcomes|perinatal outcomes
1288842|NCT01630759|Gestational diabetes|gestational diabetes
1288843|NCT01630759|telemonitoring|telemonitoring
1288844|NCT01630759|telehealth|telehealth
1288845|NCT01630759|feasibility study|feasibility study
1288846|NCT01630733|Metastatic|metastatic
1288847|NCT01630733|Stage IV|stage iv
1288848|NCT01630733|Advanced|advanced
1288849|NCT01630733|lung cancer|lung cancer
1288850|NCT01630720|ascorbic acid|ascorbic acid
1288851|NCT01630720|cholecalciferol|cholecalciferol
1288852|NCT01630720|vitamin C|vitamin c
1288853|NCT01630720|vitamin D|vitamin d
1288854|NCT01630720|hypovitaminosis|hypovitaminosis
1288855|NCT01630720|mood|mood
1288856|NCT01630720|distress|distress
1288857|NCT01630694|Difficult airway management|difficult airway management
1288858|NCT01630694|anesthesia|anesthesia
1288859|NCT01630694|difficult intubation|difficult intubation
1288860|NCT01630629|Lactation|lactation
1288861|NCT01630629|Weaning|weaning
1288862|NCT01630629|Bone Density|bone density
1288863|NCT01630629|Endocrine|endocrine
1288864|NCT01630629|Physiological Properties|physiological properties
1288865|NCT01630629|Bone Metabolism|bone metabolism
1288866|NCT01630590|Prostate Cancer|prostate cancer
1288867|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
1288868|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
1288869|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
1288870|NCT01630590|Cabozantinib|cabozantinib
1288871|NCT01630590|XL 184|xl 184
1288872|NCT01630590|Androgen Ablation|androgen ablation
1288873|NCT01630577|acute circulatory failure|acute circulatory failure
1288874|NCT01630577|hemodynamic stability|hemodynamic stability
1288875|NCT01630577|hypovolemia|hypovolemia
1288876|NCT01630564|Blood And Marrow Transplantation|blood and marrow transplantation
1288877|NCT01630564|Leukemia|leukemia
1288878|NCT01630564|Lymphoma|lymphoma
1288879|NCT01630564|Myeloproliferative Diseases|myeloproliferative diseases
1288880|NCT01630564|Relapsed hematological malignancies|relapsed hematological malignancies
1288881|NCT01630564|Post-Transplant Relapsed Patients|post-transplant relapsed patients
1288882|NCT01630564|Cord Blood Lymphocyte Infusion|cord blood lymphocyte infusion
1388842|NCT01210846|QTc|qtc
1288883|NCT01630564|Ex Vivo Expanded Donor Cord Blood T-Lymphocyte Infusion|ex vivo expanded donor cord blood t-lymphocyte infusion
1288884|NCT01630551|tears|tears
1288885|NCT01630551|dry eyes|dry eyes
1288886|NCT01630551|ocular surface disease|ocular surface disease
1288887|NCT01630538|Transplantation|transplantation
1288888|NCT01630525|Alzheimer's disease|alzheimer's disease
1288889|NCT01630525|neurodegenerative signs|neurodegenerative signs
1288890|NCT01630499|Cancer|cancer
1288891|NCT01630499|Breast cancer|breast cancer
1288892|NCT01630499|Breast cancer prevention|breast cancer prevention
1288893|NCT01630499|Breast cancer recurrence|breast cancer recurrence
1288894|NCT01630499|Weight loss|weight loss
1288895|NCT01630499|Weight management|weight management
1288896|NCT01630499|Overweight|overweight
1288897|NCT01630499|Obesity|obesity
1288898|NCT01630486|renal progression|renal progression
1288899|NCT01630486|mortality|mortality
1288900|NCT01630486|complications|complications
1288901|NCT01630486|risk factors|risk factors
1288902|NCT01630486|role of biochemical parameters|role of biochemical parameters
1288903|NCT01630486|genetic influence|genetic influence
1288904|NCT01630473|Tooth crowding|tooth crowding
1288905|NCT01630473|Teeth malpositions|teeth malpositions
1288906|NCT01630473|corticotomy|corticotomy
1288907|NCT01630473|orthodontics|orthodontics
1288908|NCT01630473|tooth movement|tooth movement
1288909|NCT01630473|periodontal parameters|periodontal parameters
1288910|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
1288911|NCT01630460|bone|bone
1288912|NCT01630460|hyperostosis|hyperostosis
1288913|NCT01630460|osteoblast|osteoblast
1288914|NCT01630460|osteoclast|osteoclast
1288915|NCT01630447|cherubism|cherubism
1288916|NCT01630447|bone|bone
1288917|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
1288918|NCT01630447|osteoblast|osteoblast
1288919|NCT01630447|osteoclast|osteoclast
1288920|NCT01630447|mandible|mandible
1288921|NCT01630447|maxilla|maxilla
1288922|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
1288923|NCT01630421|bone|bone
1288924|NCT01630421|osteoblast|osteoblast
1288925|NCT01630421|osteoclast|osteoclast
1288926|NCT01630421|skin|skin
1288927|NCT01630408|Preserved ejection fraction|preserved ejection fraction
1288928|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
1288929|NCT01630408|Activated vitamin D|activated vitamin d
1288930|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
1288931|NCT01630408|Hospitalizations|hospitalizations
1288932|NCT01630356|Secondhand Smoke|secondhand smoke
1288933|NCT01630356|Nicotine|nicotine
1289024|NCT01629693|astigmatism|astigmatism
1288934|NCT01630356|Indoor Air Pollution|indoor air pollution
1288935|NCT01630343|Geriatric hip fracture|geriatric hip fracture
1288936|NCT01630343|pain management|pain management
1288937|NCT01630304|telecommunications|telecommunications
1288938|NCT01630304|Africa|africa
1288939|NCT01630304|randomized controlled trial|randomized controlled trial
1288940|NCT01630278|Prematurity|prematurity
1288941|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
1288942|NCT01630278|ibuprofen|ibuprofen
1288943|NCT01630265|Discharge Instructions|discharge instructions
1288944|NCT01630265|Video Discharge Instructions|video discharge instructions
1288945|NCT01630265|Video|video
1288946|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
1288947|NCT01630265|ED Discharge|ed discharge
1288948|NCT01630226|BRCA1|brca1
1288949|NCT01630226|pathological complete response|pathological complete response
1288950|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1288951|NCT01630213|Vitamin D3|vitamin d3
1288952|NCT01630213|Left ventricular mass|left ventricular mass
1288953|NCT01630213|Echocardiography|echocardiography
1288954|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
1288955|NCT01630200|COPD|copd
1288956|NCT01630200|comorbidity|comorbidity
1288957|NCT01630200|arterial stiffness|arterial stiffness
1288958|NCT01630200|roflumilast|roflumilast
1288959|NCT01630187|Carbetocin|carbetocin
1288960|NCT01630187|Uterotonic drug|uterotonic drug
1288961|NCT01630187|elective cesarean section|elective cesarean section
1288962|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
1288963|NCT01630161|relapse|relapse
1288964|NCT01630161|prevention|prevention
1288965|NCT01630161|smoking|smoking
1288966|NCT01630161|habit|habit
1288967|NCT01630161|Forever Free|forever free
1288968|NCT01630148|Thromboprophylaxis|thromboprophylaxis
1288969|NCT01630148|Bemiparin|bemiparin
1288970|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
1288971|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
1288972|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
1288973|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
1288974|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
1288975|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
1288976|NCT01630070|Critical limb ischemia|critical limb ischemia
1288977|NCT01630070|Rest pain|rest pain
1288978|NCT01630070|Minor tissue loss|minor tissue loss
1288979|NCT01630070|Below the knee|below the knee
1288980|NCT01630031|atrial fibrillation|atrial fibrillation
1288981|NCT01630031|paroxysmal|paroxysmal
1288982|NCT01630031|contact force|contact force
1288983|NCT01630031|radiofrequency|radiofrequency
1288984|NCT01630031|catheter ablation|catheter ablation
1288985|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
1288986|NCT01630031|recurrence|recurrence
1288987|NCT01630031|follow-up|follow-up
1288988|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
1288989|NCT01630018|Belotecan|belotecan
1288990|NCT01630018|Topotecan|topotecan
1288991|NCT01629992|Vomiting|vomiting
1288992|NCT01629992|Nausea|nausea
1288993|NCT01629992|Postoperative pain|postoperative pain
1288994|NCT01629992|Feeling|feeling
1288995|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
1288996|NCT01629966|GAD|gad
1288997|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
1288998|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1288999|NCT01629940|XLHED|xlhed
1289000|NCT01629940|HED|hed
1289001|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
1289002|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
1289003|NCT01629927|HED|hed
1289004|NCT01629927|XLHED|xlhed
1289005|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1289006|NCT01629914|executive functioning|executive functioning
1289007|NCT01629914|mindfulness meditation|mindfulness meditation
1289008|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
1289009|NCT01629914|healthy|healthy
1289010|NCT01629901|Healthy volunteer|healthy volunteer
1289011|NCT01629888|Plant sterol|plant sterol
1289012|NCT01629888|Hypercholesterolemia|hypercholesterolemia
1289013|NCT01629888|dairy|dairy
1289014|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
1289015|NCT01629810|Relief of pain.|relief of pain.
1289016|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
1289017|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
1289018|NCT01629810|Dose response effect .|dose response effect .
1289019|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
1289020|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1289021|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1289022|NCT01629693|contact lenses|contact lenses
1289023|NCT01629693|myopia|myopia
1289025|NCT01629680|moxaverine|moxaverine
1289026|NCT01629680|ocular blood flow|ocular blood flow
1289027|NCT01629654|Poststroke fatigue|poststroke fatigue
1289028|NCT01629654|Health promotion|health promotion
1289029|NCT01629654|Patient education|patient education
1289030|NCT01629641|goniometry|goniometry
1289031|NCT01629641|outcome measures|outcome measures
1289032|NCT01629641|shoulder assessment|shoulder assessment
1289033|NCT01629628|Crohn Disease|crohn disease
1289034|NCT01629628|Colitis Granulomatous|colitis granulomatous
1289035|NCT01629628|Crohn's Disease|crohn's disease
1289036|NCT01629628|Enteritis Regional|enteritis regional
1289037|NCT01629628|Ileitis Regional|ileitis regional
1289038|NCT01629628|Ileitis Terminal|ileitis terminal
1289039|NCT01629628|Ileocolitis|ileocolitis
1289040|NCT01629615|breast cancer|breast cancer
1289041|NCT01629615|metastatic|metastatic
1289042|NCT01629615|triple negative breast cancer|triple negative breast cancer
1289043|NCT01629615|BKM120|bkm120
1289044|NCT01629615|SOLTI|solti
1289045|NCT01629615|PI3K inhibitor|pi3k inhibitor
1289046|NCT01629602|defect;|defect;
1289047|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
1289048|NCT01629602|proper digital nerve;|proper digital nerve;
1289049|NCT01629602|vascularized nerve graft|vascularized nerve graft
1289050|NCT01629589|Adacel® vaccine|adacel® vaccine
1289051|NCT01629589|Tetanus|tetanus
1289052|NCT01629589|Diphtheria|diphtheria
1289053|NCT01629589|whooping cough|whooping cough
1289054|NCT01629589|Pertussis|pertussis
1289055|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
1289056|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
1289057|NCT01629511|Leukemia|leukemia
1289058|NCT01629511|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1289059|NCT01629511|CLL|cll
1289060|NCT01629511|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1289061|NCT01629511|HCT|hct
1289062|NCT01629511|Methotrexate|methotrexate
1289063|NCT01629511|Filgrastim|filgrastim
1289064|NCT01629511|G-CSF|g-csf
1289065|NCT01629511|Neupogen|neupogen
1289066|NCT01629511|Tacrolimus|tacrolimus
1289067|NCT01629511|Prograf|prograf
1289068|NCT01629511|Busulfan|busulfan
1289069|NCT01629511|Busulfex|busulfex
1289070|NCT01629511|Myleran|myleran
1289071|NCT01629511|Clofarabine|clofarabine
1289072|NCT01629511|Clofarex|clofarex
1289073|NCT01629511|Clolar|clolar
1289074|NCT01629511|Gemcitabine|gemcitabine
1289075|NCT01629511|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1289076|NCT01629511|Gemzar|gemzar
1289077|NCT01629511|Thymoglobulin|thymoglobulin
1289078|NCT01629511|ATG|atg
1289079|NCT01629511|Antithymocyte Globulin|antithymocyte globulin
1289080|NCT01629498|Lung cancer|lung cancer
1289081|NCT01629498|Non-small cell lung cancer|non-small cell lung cancer
1289082|NCT01629498|NSCLC|nsclc
1289083|NCT01629498|Image-guided intensity-modulated scanning beam proton therapy|image-guided intensity-modulated scanning beam proton therapy
1289084|NCT01629498|IMPT|impt
1289085|NCT01629498|Simultaneous integrated boost|simultaneous integrated boost
1289086|NCT01629498|SIB|sib
1289087|NCT01629498|Gross tumor volume|gross tumor volume
1289088|NCT01629498|GTV|gtv
1289089|NCT01629498|Chemotherapy|chemotherapy
1289090|NCT01629498|Questionnaire|questionnaire
1289091|NCT01629498|Survey|survey
1289092|NCT01629485|Mastery Learning|mastery learning
1289093|NCT01629485|Surgical Education|surgical education
1289094|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
1289095|NCT01629485|Part vs Whole Task|part vs whole task
1289096|NCT01629485|Contextual Interference|contextual interference
1289097|NCT01629485|laparoscopy|laparoscopy
1289098|NCT01629485|training|training
1289099|NCT01629485|curriculum|curriculum
1289104|NCT01629459|strength|strength
1289105|NCT01629459|training|training
1289106|NCT01629459|barth syndrome|barth syndrome
1289107|NCT01629459|mitochondria|mitochondria
1289108|NCT01629459|amino acid|amino acid
1289109|NCT01629459|protein|protein
1289110|NCT01629446|Phase 1|phase 1
1289111|NCT01629446|Normal healthy volunteers|normal healthy volunteers
1289112|NCT01629446|Mass Balance|mass balance
1289113|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
1289114|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
1289115|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
1289116|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
1289117|NCT01629381|knee arthroscopy|knee arthroscopy
1289118|NCT01629381|venous thromboembolism|venous thromboembolism
1289119|NCT01629381|prevention|prevention
1289120|NCT01629355|Auditory Brainstem Response|auditory brainstem response
1289121|NCT01629355|ABR|abr
1289122|NCT01629355|SD-BERA|sd-bera
1289123|NCT01629329|Headache|headache
1289124|NCT01629329|prochlorperazine|prochlorperazine
1289125|NCT01629329|excedrin migraine|excedrin migraine
1289126|NCT01629329|treatment efficacy|treatment efficacy
1289127|NCT01629329|pain scores|pain scores
1289128|NCT01629316|HIV|hiv
1289129|NCT01629316|prisoners|prisoners
1289130|NCT01629316|test|test
1289131|NCT01629316|treat|treat
1289132|NCT01629316|link coordination|link coordination
1289133|NCT01629316|retain|retain
1289134|NCT01629316|behavioral|behavioral
1289135|NCT01629316|intervention|intervention
1289136|NCT01629316|text reminders|text reminders
1289137|NCT01629316|motivational interviewing|motivational interviewing
1289138|NCT01629316|medication adherence|medication adherence
1289139|NCT01629303|constipation|constipation
1289140|NCT01629303|sacral nerve modulation|sacral nerve modulation
1289141|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
1289142|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
1289143|NCT01629264|Cornea|cornea
1289144|NCT01629264|biomechanics|biomechanics
1289145|NCT01629264|pregnancy|pregnancy
1289146|NCT01629264|keratoconus|keratoconus
1289147|NCT01629264|refractive surgery|refractive surgery
1289148|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
1289149|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
1289150|NCT01629251|Meal insulin dosing|meal insulin dosing
1289151|NCT01629238|cardiovascular risk|cardiovascular risk
1289152|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
1289153|NCT01629238|general practitioners|general practitioners
1289154|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
1289155|NCT01629225|men and women|men and women
1289156|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
1289157|NCT01629186|CPR|cpr
1289158|NCT01629186|flexible bronchoscope|flexible bronchoscope
1289159|NCT01629186|resuscitation|resuscitation
1289160|NCT01629186|ventilation|ventilation
1289161|NCT01629173|plantar pressure|plantar pressure
1289162|NCT01629173|metatarsalgia|metatarsalgia
1289164|NCT01629147|Constipation|constipation
1289165|NCT01629108|Normative Data|normative data
1289166|NCT01629108|Vestibular|vestibular
1289167|NCT01629108|Auditory|auditory
1289168|NCT01629108|Healthy Volunteers|healthy volunteers
1289169|NCT01629108|Hearing|hearing
1289170|NCT01629095|Fatty Liver|fatty liver
1289171|NCT01629095|Liver Transplant|liver transplant
1289172|NCT01629095|Non-Alcoholic Steato-Hepatitis|non-alcoholic steato-hepatitis
1289173|NCT01629095|Steatosis|steatosis
1289174|NCT01629095|Cirrhosis|cirrhosis
1289175|NCT01629095|Cryptogenic Cirrhosis|cryptogenic cirrhosis
1289176|NCT01629095|Liver Failure|liver failure
1609435|NCT00359970|Loperamide|loperamide
1389218|NCT01209039|PET|pet
1289177|NCT01629095|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1289181|NCT01629069|stress|stress
1289182|NCT01629069|mindfulness|mindfulness
1289183|NCT01629069|coping|coping
1289184|NCT01629056|atrial fibrillation|atrial fibrillation
1289185|NCT01629056|ablation|ablation
1289186|NCT01629056|contact|contact
1289187|NCT01629043|Parkinson's|parkinson's
1289188|NCT01629043|Quality of Care|quality of care
1289189|NCT01629043|Improvement|improvement
1289190|NCT01629043|Mobility|mobility
1289191|NCT01629043|Cognition|cognition
1289192|NCT01629043|Caregiver burden|caregiver burden
1289193|NCT01629043|Center difference|center difference
1289194|NCT01629030|sternal wound infection|sternal wound infection
1289195|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
1289196|NCT01629030|risk factor|risk factor
1289197|NCT01629004|colorectal cancer|colorectal cancer
1289198|NCT01629004|screening|screening
1289199|NCT01629004|fecal occult blood testing|fecal occult blood testing
1289200|NCT01629004|mailed invitation|mailed invitation
1289201|NCT01628991|Behavioral Intervention Program|behavioral intervention program
1289202|NCT01628991|Vaginal Cones|vaginal cones
1289203|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
1289204|NCT01628991|treatment|treatment
1289205|NCT01628991|Women|women
1289206|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
1289207|NCT01628978|endotracheal intubation|endotracheal intubation
1289208|NCT01628978|endobronchial intubation|endobronchial intubation
1289209|NCT01628965|SPM 962|spm 962
1289210|NCT01628965|rotigotine|rotigotine
1289211|NCT01628965|Parkinson's disease|parkinson's disease
1289212|NCT01628965|monotherapy|monotherapy
1289213|NCT01628939|low back pain|low back pain
1289214|NCT01628939|facet joint pain|facet joint pain
1289215|NCT01628913|Pancreatic|pancreatic
1289216|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
1289217|NCT01628913|PNET|pnet
1289218|NCT01628913|BEZ235|bez235
1289219|NCT01628913|Everolimus|everolimus
1289220|NCT01628900|pyelonephritis|pyelonephritis
1289221|NCT01628900|Infection|infection
1289222|NCT01628900|Antibiotic treatment|antibiotic treatment
1289223|NCT01628887|Breast Cancer|breast cancer
1289224|NCT01628874|Lumbar Puncture|lumbar puncture
1289225|NCT01628874|J-Tip|j-tip
1289226|NCT01628874|Jet injection|jet injection
1289227|NCT01628874|Local Analgesia|local analgesia
1289228|NCT01628861|occupation|occupation
1289229|NCT01628861|work|work
1289230|NCT01628861|sitting|sitting
1289231|NCT01628861|sedentary behaviour|sedentary behaviour
1289232|NCT01628861|office worker|office worker
1289233|NCT01628861|adult|adult
1289234|NCT01628861|education|education
1289235|NCT01628861|point-of-choice prompt|point-of-choice prompt
1289236|NCT01628848|SPM 962|spm 962
1289237|NCT01628848|rotigotine|rotigotine
1289238|NCT01628848|Parkinson's disease|parkinson's disease
1289239|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
1289240|NCT01628835|overweight|overweight
1289241|NCT01628835|pregnancy|pregnancy
1289242|NCT01628835|diet counselling|diet counselling
1289243|NCT01628835|glycemic|glycemic
1289244|NCT01628822|Fibromyalgia|fibromyalgia
1289245|NCT01628822|Relaxation|relaxation
1289246|NCT01628822|Improving the quality of life|improving the quality of life
1289247|NCT01628809|MBSR|mbsr
1289248|NCT01628809|mindfulness|mindfulness
1289249|NCT01628809|stress|stress
1289250|NCT01628783|Depression|depression
1289251|NCT01628783|emotional processing|emotional processing
1289252|NCT01628783|fMRI|fmri
1289253|NCT01628783|autobiographic memory|autobiographic memory
1289254|NCT01628783|moderator of treatment response|moderator of treatment response
1289255|NCT01628783|mediator of treatment response|mediator of treatment response
1289256|NCT01628770|iron|iron
1289257|NCT01628770|monofer|monofer
1289258|NCT01628770|Pakistan|pakistan
1289259|NCT01628731|loop diuretics|loop diuretics
1289260|NCT01628731|fluid balance|fluid balance
1289261|NCT01628731|urine output|urine output
1289262|NCT01628731|acute renal dysfunction|acute renal dysfunction
1289263|NCT01628718|OEF/OIF|oef/oif
1289264|NCT01628718|Veterans|veterans
1289265|NCT01628718|Psychotherapy|psychotherapy
1289266|NCT01628718|PTSD|ptsd
1289267|NCT01628705|Green tea|green tea
1289268|NCT01628705|oxLDL|oxldl
1289269|NCT01628705|fat mass|fat mass
1289270|NCT01628679|provoked|provoked
1289271|NCT01628679|vulvar|vulvar
1289272|NCT01628679|vestibulodynia|vestibulodynia
1289273|NCT01628679|vestibulitis|vestibulitis
1289274|NCT01628666|Arrhythmia|arrhythmia
1289275|NCT01628666|Device Procedure|device procedure
1289276|NCT01628666|Antibiotics|antibiotics
1289277|NCT01628666|Infection|infection
1289278|NCT01628666|Cluster|cluster
1289279|NCT01628653|Mild cognitive impairment|mild cognitive impairment
1289280|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
1289281|NCT01628653|Cognitive therapy|cognitive therapy
1289282|NCT01628653|Spaced retrieval Training|spaced retrieval training
1289283|NCT01628653|Alzheimer's disease|alzheimer's disease
1389308|NCT01208701|L-NMMA|l-nmma
1289284|NCT01628653|Memory enhancement|memory enhancement
1289285|NCT01628653|U-healthcare|u-healthcare
1289286|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
1289287|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
1289288|NCT01628562|Remifentanil|remifentanil
1289289|NCT01628562|Esmolol|esmolol
1289290|NCT01628562|Intracranial surgery|intracranial surgery
1289291|NCT01628562|Heart rate|heart rate
1289292|NCT01628562|Blood pressure|blood pressure
1289293|NCT01628549|acne|acne
1289294|NCT01628536|Black Cohosh|black cohosh
1289295|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
1289296|NCT01628536|Breast Cancer|breast cancer
1289297|NCT01628523|Respiratory failure|respiratory failure
1289298|NCT01628523|Mechanical ventilation|mechanical ventilation
1289299|NCT01628523|Acute lung injury|acute lung injury
1289300|NCT01628510|preterm|preterm
1289301|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
1289302|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
1289303|NCT01628458|Pancreatic cancer|pancreatic cancer
1291906|NCT01617278|I Scan|i scan
1289304|NCT01628458|locally advanced|locally advanced
1289305|NCT01628458|irresectable|irresectable
1289306|NCT01628458|Radiofrequency|radiofrequency
1289308|NCT01628445|Diabetes|diabetes
1289309|NCT01628445|Insulin|insulin
1289310|NCT01628419|Health promotion|health promotion
1289311|NCT01628419|Intervention|intervention
1289312|NCT01628419|Workplace|workplace
1289313|NCT01628419|Exercise program|exercise program
1289314|NCT01628380|HIPEC|hipec
1289315|NCT01628380|Ovarian Cancer|ovarian cancer
1289316|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
1289317|NCT01628354|Choroidal neovascularization|choroidal neovascularization
1289318|NCT01628354|Lucentis|lucentis
1289319|NCT01628328|colonic stenting|colonic stenting
1289320|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
1289321|NCT01628328|circulating tumor cell|circulating tumor cell
1289322|NCT01628315|Multiple Sclerosis|multiple sclerosis
1289323|NCT01628315|ASA|asa
1289324|NCT01628315|MRI|mri
1289325|NCT01628315|Lesion activity|lesion activity
1289326|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
1289327|NCT01628289|diabetic retinopathy|diabetic retinopathy
1289328|NCT01628289|screening|screening
1289329|NCT01628289|co-payment|co-payment
1289330|NCT01628289|health service|health service
1289331|NCT01628276|Multiple Sclerosis|multiple sclerosis
1289332|NCT01628276|MRI Scans|mri scans
1289333|NCT01628263|PICU|picu
1289334|NCT01628263|Follow up|follow up
1289335|NCT01628263|PTSD|ptsd
1289336|NCT01628224|Task saturation|task saturation
1289337|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
1289338|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1289339|NCT01628211|second-look laparoscopy|second-look laparoscopy
1289340|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
1289341|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
1289342|NCT01628198|Hypertension|hypertension
1289343|NCT01628198|renal denervation|renal denervation
1289344|NCT01628198|renal ablation|renal ablation
1289345|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
1289346|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
1289347|NCT01628172|renal catheter ablation|renal catheter ablation
1289348|NCT01628172|hypertension|hypertension
1289349|NCT01628146|Presbyopia|presbyopia
1289350|NCT01628146|hyperopia|hyperopia
1289351|NCT01628146|Supracor|supracor
1289352|NCT01628146|contrast sensitivity|contrast sensitivity
1289353|NCT01628133|Transfusion|transfusion
1289354|NCT01628133|Neonate|neonate
1289355|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
1289356|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
1289357|NCT01628133|Packed Red Blood Cell|packed red blood cell
1289358|NCT01628120|Chronic renal failure|chronic renal failure
1289359|NCT01628120|Hemodialysis|hemodialysis
1289360|NCT01628107|Chronic renal failure|chronic renal failure
1289361|NCT01628107|hemodialysis|hemodialysis
1289362|NCT01628081|psoriasis|psoriasis
1289363|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
1289364|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
1289365|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
1289366|NCT01628055|IVIg|ivig
1289367|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
1289368|NCT01628055|Stroke|stroke
1289369|NCT01628055|CVA|cva
1289370|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
1289371|NCT01628029|Advanced Cancers|advanced cancers
1289372|NCT01628029|Metastatic|metastatic
1289373|NCT01628029|Locally advanced|locally advanced
1289374|NCT01628029|Sleep disturbance|sleep disturbance
1289375|NCT01628029|Sleep problems|sleep problems
1289376|NCT01628029|Litebook|litebook
1289377|NCT01628029|Melatonin|melatonin
1289378|NCT01628029|Methylphenidate|methylphenidate
1289379|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
1289380|NCT01628029|Ritalin|ritalin
1289381|NCT01628029|Concerta|concerta
1289382|NCT01628029|Placebo|placebo
1289383|NCT01628029|Supportive counseling|supportive counseling
1289384|NCT01628029|Questionnaires|questionnaires
1289385|NCT01628029|Study Diaries|study diaries
1289386|NCT01628016|depression|depression
1289387|NCT01628016|attention|attention
1289388|NCT01628016|training|training
1289389|NCT01628016|modification|modification
1289390|NCT01628003|Traumatic Brain Injury|traumatic brain injury
1289391|NCT01628003|long-term outcome|long-term outcome
1289392|NCT01628003|Brain Reserves|brain reserves
1289393|NCT01628003|Cognitive Reserves|cognitive reserves
1289394|NCT01628003|Emotional Reserves|emotional reserves
1289395|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
1289396|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
1289397|NCT01627990|G-CSF|g-csf
1289398|NCT01627990|Solid tumour|solid tumour
1289399|NCT01627990|Malignant haematological tumour|malignant haematological tumour
1289400|NCT01627977|chromovitrectomy|chromovitrectomy
1289401|NCT01627977|epiretinal membrane|epiretinal membrane
1289402|NCT01627964|Heart Wall Motion Function|heart wall motion function
1289403|NCT01627951|Plasmodium falciparum|plasmodium falciparum
1289404|NCT01627951|malaria|malaria
1289405|NCT01627938|Multiple Sclerosis|multiple sclerosis
1289407|NCT01627938|Mitoxantrone|mitoxantrone
1289408|NCT01627938|Dexrazoxane|dexrazoxane
1289409|NCT01627938|Cardioxane|cardioxane
1289410|NCT01627938|cardiotoxicity|cardiotoxicity
1289411|NCT01627938|cardiac toxicity|cardiac toxicity
1289412|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
1289413|NCT01627938|cardiac MRI|cardiac mri
1289414|NCT01627938|cranial MRI|cranial mri
1289415|NCT01627938|LVEF|lvef
1289416|NCT01627938|neurological outcome|neurological outcome
1289417|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
1289418|NCT01627925|upper airway obstruction|upper airway obstruction
1289419|NCT01627925|mask ventilation|mask ventilation
1289420|NCT01627912|wine|wine
1289421|NCT01627912|inflammation|inflammation
1289422|NCT01627912|oxidative stress|oxidative stress
1289423|NCT01627912|randomized control trial|randomized control trial
1289424|NCT01627912|postprandial intervention|postprandial intervention
1289425|NCT01627912|platelet aggregation|platelet aggregation
1289426|NCT01627912|haemostasis|haemostasis
1289427|NCT01627912|robola|robola
1289428|NCT01627912|cabernet sauvignon|cabernet sauvignon
1289429|NCT01627912|alcohol|alcohol
1289430|NCT01627912|PAF metabolism|paf metabolism
1289431|NCT01627899|Blood glucose monitor|blood glucose monitor
1289432|NCT01627899|Pattern management|pattern management
1289433|NCT01627899|Pattern guide|pattern guide
1289434|NCT01627899|Education|education
1289435|NCT01627886|Bioequivalence|bioequivalence
1289436|NCT01627886|Ibandronate Sodium|ibandronate sodium
1289437|NCT01627886|crossover|crossover
1289438|NCT01627873|Major abdominal surgery|major abdominal surgery
1289439|NCT01627873|analgesic method|analgesic method
1289440|NCT01627873|Fentanyl|fentanyl
1289441|NCT01627873|Remifentanyl|remifentanyl
1289442|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
1289443|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
1289444|NCT01627860|Epilepsy|epilepsy
1289445|NCT01627860|Topiramate|topiramate
1289446|NCT01627860|Neuro-surgical patients|neuro-surgical patients
1289447|NCT01627860|Nervous disorder|nervous disorder
1289448|NCT01627860|Seizures|seizures
1289449|NCT01627847|Bioequivalence|bioequivalence
1289450|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
1289451|NCT01627847|crossover|crossover
1289452|NCT01627834|Bioequivalence|bioequivalence
1289453|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
1289454|NCT01627834|crossover|crossover
1289455|NCT01627821|Heart Failure|heart failure
1289456|NCT01627808|intraoperative monitoring|intraoperative monitoring
1289457|NCT01627808|fluid management|fluid management
1289458|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
1289459|NCT01627795|Cancer|cancer
1289460|NCT01627795|Anti cancer agents|anti cancer agents
1289461|NCT01627782|Major depressive disorder|major depressive disorder
1289462|NCT01627782|Treatment-resistant depression|treatment-resistant depression
1289463|NCT01627782|Ketamine|ketamine
1289464|NCT01627769|scars|scars
1289465|NCT01627769|blisters|blisters
1289466|NCT01627769|second degree burns|second degree burns
1289467|NCT01627769|cryosurgery|cryosurgery
1289468|NCT01627769|keloid scars|keloid scars
1289469|NCT01627769|hypertrophic scars|hypertrophic scars
1289470|NCT01627756|Thoracic Surgery|thoracic surgery
1289471|NCT01627756|Endotoxins|endotoxins
1289472|NCT01627756|Respiration, Artificial|respiration, artificial
1289473|NCT01627756|Immune System|immune system
1289474|NCT01627743|CDLM|cdlm
1289475|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
1289476|NCT01627743|COPD|copd
1289477|NCT01627743|GOLD group C and D|gold group c and d
1289478|NCT01627717|maraviroc|maraviroc
1289479|NCT01627717|boceprevir|boceprevir
1289480|NCT01627717|HIV|hiv
1289481|NCT01627717|HCV|hcv
1289482|NCT01627717|drug interaction|drug interaction
1289483|NCT01627717|pharmacokinetics|pharmacokinetics
1289484|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
1289485|NCT01627704|breast cancer|breast cancer
1289486|NCT01627704|metastatic|metastatic
1289487|NCT01627704|prediction of response|prediction of response
1289488|NCT01627704|hormone therapy|hormone therapy
1289489|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
1289490|NCT01627665|dabigatran|dabigatran
1289491|NCT01627665|rivaroxaban|rivaroxaban
1289492|NCT01627665|PKC|pkc
1289493|NCT01627665|PKD|pkd
1289494|NCT01627665|p-glycoprotein|p-glycoprotein
1289495|NCT01627665|polymorphism|polymorphism
1289496|NCT01627652|hypoxia|hypoxia
1289497|NCT01627626|xerostomia|xerostomia
1289498|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
1289499|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
1289500|NCT01627600|stroke|stroke
1289501|NCT01627600|myocardial infarction|myocardial infarction
1289502|NCT01627600|cardiovascular health|cardiovascular health
1289503|NCT01627600|population study|population study
1289504|NCT01627587|preterm labor|preterm labor
1289505|NCT01627574|Pregnancy|pregnancy
1289506|NCT01627574|STI prevention|sti prevention
1289507|NCT01627574|adolescents|adolescents
1289508|NCT01627574|probation|probation
1289509|NCT01627561|Immune response|immune response
1289510|NCT01627561|Human papillomavirus|human papillomavirus
1289511|NCT01627561|HPV vaccine|hpv vaccine
1289512|NCT01627561|Safety|safety
1289513|NCT01627548|PTSD|ptsd
1289514|NCT01627548|Couples|couples
1289515|NCT01627548|Combat Veteran|combat veteran
1289516|NCT01627548|Warfighter|warfighter
1289517|NCT01627548|OEF|oef
1289518|NCT01627548|OIF|oif
1289519|NCT01627548|OND|ond
1289520|NCT01627548|Structured Approach Therapy|structured approach therapy
1289521|NCT01627548|Trauma|trauma
1289522|NCT01627535|Brain Tumor|brain tumor
1289523|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
1289524|NCT01627509|hypoglycemia|hypoglycemia
1289525|NCT01627509|insulin regimen|insulin regimen
1289526|NCT01627509|basal bolus therapy|basal bolus therapy
1289527|NCT01627509|modern premixed insulin|modern premixed insulin
1289528|NCT01627509|diabetes control|diabetes control
1289529|NCT01627496|malnutrition|malnutrition
1289530|NCT01627496|elderly care|elderly care
1289531|NCT01627496|quality of life|quality of life
1289532|NCT01627496|hospital|hospital
1289533|NCT01627483|elderly|elderly
1289534|NCT01627483|hip fracture|hip fracture
1289535|NCT01627483|osteoporosis|osteoporosis
1289536|NCT01627483|fall risk|fall risk
1289537|NCT01627483|medication review|medication review
1289538|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
1289539|NCT01627470|emergency|emergency
1289540|NCT01627470|intensive care|intensive care
1289541|NCT01627457|Coronary Artery Disease|coronary artery disease
1289542|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
1289664|NCT01626872|Risperidone|risperidone
1289543|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
1289544|NCT01627457|Homely Rehabilitation|homely rehabilitation
1289545|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
1289546|NCT01627444|Acupuncture|acupuncture
1289547|NCT01627444|Anxiety|anxiety
1289548|NCT01627444|Human Milk|human milk
1289549|NCT01627444|Very low birth weight infants|very low birth weight infants
1289550|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
1289552|NCT01627431|Peripheral revascularization|peripheral revascularization
1289553|NCT01627431|Antiplatelet therapy|antiplatelet therapy
1289554|NCT01627431|Residual platelet activity|residual platelet activity
1289555|NCT01627418|COPD|copd
1289556|NCT01627418|CORD|cord
1289557|NCT01627418|COAD|coad
1289558|NCT01627379|nonresectable|nonresectable
1289559|NCT01627379|advanced|advanced
1289560|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
1289561|NCT01627379|Panitumumab|panitumumab
1289562|NCT01627353|Hysterectomy|hysterectomy
1289563|NCT01627353|Pain Prevention|pain prevention
1289564|NCT01627353|Wound Infiltration|wound infiltration
1289565|NCT01627340|hepatitis B|hepatitis b
1289566|NCT01627340|adults|adults
1289567|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
1289568|NCT01627340|Engerix™-B|engerix™-b
1289569|NCT01627327|Cardiovascular event|cardiovascular event
1289570|NCT01627327|Cardiovascular disease|cardiovascular disease
1289571|NCT01627275|Naive T Cell Depletion|naive t cell depletion
1289572|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
1289573|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1289574|NCT01627262|diverticular disease|diverticular disease
1289575|NCT01627262|colonic diverticulosis|colonic diverticulosis
1289576|NCT01627262|mesalamine|mesalamine
1289577|NCT01627262|placebo|placebo
1289578|NCT01627262|randomized|randomized
1289579|NCT01627249|Diabetic Macular Edema|diabetic macular edema
1289580|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1289581|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
1289582|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
1289583|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
1289584|NCT01627210|Diabetes Mellitus|diabetes mellitus
1289585|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
1289586|NCT01627197|intraarterial chemotherapy|intraarterial chemotherapy
1289587|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
1289588|NCT01627145|derusor overactivity|derusor overactivity
1289589|NCT01627145|urodynamic studies|urodynamic studies
1289590|NCT01627145|bladder oversensitivity|bladder oversensitivity
1289591|NCT01627119|CTGF|ctgf
1289592|NCT01627119|Peritoneal metastasis|peritoneal metastasis
1289593|NCT01627093|Head and Neck Cancer|head and neck cancer
1289594|NCT01627093|Head and Neck Malignancies|head and neck malignancies
1289595|NCT01627093|Chart Review|chart review
1289596|NCT01627093|Proton Radiation Therapy|proton radiation therapy
1289597|NCT01627080|Esophagus|esophagus
1289598|NCT01627080|Esophageal Cancer|esophageal cancer
1289599|NCT01627080|Radiation therapy|radiation therapy
1289600|NCT01627080|RT|rt
1289601|NCT01627080|Chemotherapy|chemotherapy
1289602|NCT01627080|Mid thoracic tumor|mid thoracic tumor
1289603|NCT01627080|Distal esophageal tumor|distal esophageal tumor
1289604|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
1289605|NCT01627080|Cardiac biomarkers|cardiac biomarkers
1289606|NCT01627067|Breast Cancer|breast cancer
1289607|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
1289608|NCT01627067|Hormone-sensitive|hormone-sensitive
1289609|NCT01627067|Postmenopausal|postmenopausal
1289610|NCT01627067|Body Mass Index|body mass index
1289611|NCT01627067|BMI|bmi
1289612|NCT01627067|Everolimus|everolimus
1289613|NCT01627067|Afinitor|afinitor
1289614|NCT01627067|RAD001|rad001
1289615|NCT01627067|Exemestane|exemestane
1289616|NCT01627067|Aromasin|aromasin
1289617|NCT01627067|Metformin|metformin
1289618|NCT01627028|Thai traditional massage|thai traditional massage
1289619|NCT01627028|Bone formation|bone formation
1289620|NCT01627028|Bone resorption|bone resorption
1289621|NCT01627015|Fully formula fed|fully formula fed
1289622|NCT01627002|Phase 1|phase 1
1289623|NCT01627002|First in Human|first in human
1289624|NCT01627002|Healthy Volunteers|healthy volunteers
1289625|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
1289626|NCT01626976|safety|safety
1289627|NCT01626976|tolerability|tolerability
1289628|NCT01626976|pharmacokinetics|pharmacokinetics
1289629|NCT01626976|oral|oral
1289630|NCT01626976|single ascending dose|single ascending dose
1289631|NCT01626976|placebo-controlled|placebo-controlled
1289632|NCT01626976|healthy subjects|healthy subjects
1289633|NCT01626963|single-port access|single-port access
1289634|NCT01626963|laparoscopic surgery|laparoscopic surgery
1289635|NCT01626963|surgical trauma|surgical trauma
1289636|NCT01626950|Breast cancer|breast cancer
1289737|NCT01626417|Robotics|robotics
1289637|NCT01626950|living conditions|living conditions
1289638|NCT01626950|social fragility|social fragility
1289639|NCT01626937|Acute respiratory failure|acute respiratory failure
1289640|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1289641|NCT01626937|Non invasive ventilation|non invasive ventilation
1289642|NCT01626937|Out of hospital|out of hospital
1289643|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
1289644|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
1289645|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
1289646|NCT01626924|Antenatal asphyxia|antenatal asphyxia
1289647|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
1289648|NCT01626924|birth asphyxia|birth asphyxia
1289649|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
1289650|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
1289651|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
1289652|NCT01626911|low molecular weight heparin|low molecular weight heparin
1289653|NCT01626885|Schizophrenia|schizophrenia
1289654|NCT01626885|Antipsychotic Agents|antipsychotic agents
1289655|NCT01626885|Mental Disorder|mental disorder
1289656|NCT01626885|Psychotropic Drugs|psychotropic drugs
1289657|NCT01626885|Dopamine Agents|dopamine agents
1289658|NCT01626885|Central Nervous System Agents|central nervous system agents
1289659|NCT01626872|Schizophrenia|schizophrenia
1289660|NCT01626872|Antipsychotic Agents|antipsychotic agents
1289661|NCT01626872|Mental Disorder|mental disorder
1289662|NCT01626872|Psychotropic Drugs|psychotropic drugs
1289663|NCT01626872|Dopamine Agents|dopamine agents
1289665|NCT01626872|Central Nervous System Agents|central nervous system agents
1289666|NCT01626859|Schizophrenia|schizophrenia
1289667|NCT01626859|Antipsychotic Agents|antipsychotic agents
1289668|NCT01626859|Mental Disorder|mental disorder
1289669|NCT01626859|Psychotropic Drugs|psychotropic drugs
1289670|NCT01626859|Dopamine Agents|dopamine agents
1289671|NCT01626859|Central Nervous System Agents|central nervous system agents
1289672|NCT01626846|Neurofibromatosis|neurofibromatosis
1289673|NCT01626833|anorexia nervosa|anorexia nervosa
1289674|NCT01626833|GH|gh
1289675|NCT01626833|Growth velocity|growth velocity
1289676|NCT01626820|Immunogenicity|immunogenicity
1289677|NCT01626820|Influenza|influenza
1289678|NCT01626820|Safety|safety
1289679|NCT01626820|Adults|adults
1289680|NCT01626820|Fluviral|fluviral
1289681|NCT01626807|Safe Routes to School|safe routes to school
1289682|NCT01626807|Walking School Bus|walking school bus
1289683|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1289684|NCT01626807|Physical Activity|physical activity
1289685|NCT01626807|Obesity|obesity
1289686|NCT01626807|Overweight|overweight
1289687|NCT01626755|Phantom limb pain|phantom limb pain
1289688|NCT01626755|Chronic pain|chronic pain
1289689|NCT01626755|Amputation|amputation
1289690|NCT01626755|Peripheral vascular disease|peripheral vascular disease
1289691|NCT01626729|Food Labeling|food labeling
1289692|NCT01626677|Umbilical Cord Blood|umbilical cord blood
1289693|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
1289694|NCT01626677|Cartilage injury|cartilage injury
1289695|NCT01626677|Osteoarthritis|osteoarthritis
1289696|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
1289697|NCT01626651|Healthy|healthy
1289698|NCT01626651|Ketoconazole|ketoconazole
1289699|NCT01626651|Ibrutinib|ibrutinib
1289998|NCT01625377|liver transplantation,|liver transplantation,
1289700|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
1289701|NCT01626625|nonunion|nonunion
1289702|NCT01626625|stem cells|stem cells
1289703|NCT01626625|autograft|autograft
1289704|NCT01626625|hydroxyapatite|hydroxyapatite
1289705|NCT01626599|ECG|ecg
1289706|NCT01626599|Accelerometer|accelerometer
1289707|NCT01626599|Device|device
1289708|NCT01626586|Youth|youth
1289709|NCT01626586|Family|family
1289710|NCT01626586|Group Therapy|group therapy
1289711|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1289712|NCT01626586|Self-Management|self-management
1289713|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
1289714|NCT01626573|RA|ra
1289715|NCT01626573|Active|active
1289716|NCT01626547|symptomatic anameia|symptomatic anameia
1289717|NCT01626508|breast milk|breast milk
1289718|NCT01626508|breast-milk bank|breast-milk bank
1289719|NCT01626508|plasma profile|plasma profile
1289720|NCT01626508|essential fatty acids|essential fatty acids
1289721|NCT01626495|Biological: CART19|biological: cart19
1289722|NCT01626443|PCOS|pcos
1289723|NCT01626443|Metabolic disorders|metabolic disorders
1289724|NCT01626443|Ovarian functionality|ovarian functionality
1289725|NCT01626443|Myo-inositol|myo-inositol
1289726|NCT01626443|D-chiro-inositol|d-chiro-inositol
1289727|NCT01626430|Gamma delta TRF|gamma delta trf
1289728|NCT01626430|Insulin sensitivity|insulin sensitivity
1289729|NCT01626430|Postprandial lipaemia|postprandial lipaemia
1289730|NCT01626430|Inflammatory markers|inflammatory markers
1289731|NCT01626430|NF-κB|nf-κb
1289732|NCT01626417|Stroke|stroke
1289733|NCT01626417|Tibion|tibion
1289734|NCT01626417|Bionics|bionics
1289735|NCT01626417|Rehab|rehab
1289736|NCT01626417|Therapy|therapy
1289738|NCT01626417|Intention|intention
1289739|NCT01626404|Thoratec Corporation|thoratec corporation
1289740|NCT01626391|Alzheimer's Disease|alzheimer's disease
1289741|NCT01626391|TRx0237|trx0237
1289742|NCT01626391|Safety Study|safety study
1289743|NCT01626391|AD|ad
1289744|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
1289745|NCT01626378|bvFTD|bvftd
1289746|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
1289747|NCT01626365|double-lumen tube|double-lumen tube
1289748|NCT01626365|intubation|intubation
1289749|NCT01626365|thermosoftening|thermosoftening
1289750|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1289751|NCT01626352|Ofatumumab|ofatumumab
1289752|NCT01626352|Bendamustine|bendamustine
1289753|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
1289754|NCT01626339|retinal vessels|retinal vessels
1289755|NCT01626326|smoking|smoking
1289756|NCT01626326|smoking cessation|smoking cessation
1289757|NCT01626326|mobile app|mobile app
1289758|NCT01626313|Veteran families|veteran families
1289759|NCT01626313|OEF|oef
1289760|NCT01626313|OIF|oif
1289761|NCT01626313|OND|ond
1289762|NCT01626313|Resiliency|resiliency
1289763|NCT01626313|Psycho educational training|psycho educational training
1289764|NCT01626313|Stress|stress
1289765|NCT01626313|Military|military
1289766|NCT01626287|perineal|perineal
1289767|NCT01626287|postpartum|postpartum
1289768|NCT01626287|pain|pain
1289769|NCT01626287|treatment|treatment
1289770|NCT01626287|ice and black tea|ice and black tea
1289771|NCT01626287|maternal satisfaction|maternal satisfaction
1289772|NCT01626274|Polysomnography|polysomnography
1289773|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
1289774|NCT01626274|In-ear sensor system|in-ear sensor system
1289775|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
1289776|NCT01626274|High wearing comfort|high wearing comfort
1289777|NCT01626248|Immunological|immunological
1289778|NCT01626248|biomarkers|biomarkers
1289779|NCT01626248|observational|observational
1289780|NCT01626248|RRMS|rrms
1289781|NCT01626248|Relapsing|relapsing
1289782|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
1289783|NCT01626235|pain control|pain control
1289784|NCT01626235|fractures|fractures
1289785|NCT01626235|sprains|sprains
1289786|NCT01626235|strains|strains
1289787|NCT01626235|dysmenorrhea|dysmenorrhea
1289788|NCT01626235|kidney stones|kidney stones
1289789|NCT01626235|gouty arthritis|gouty arthritis
1289790|NCT01626235|opioids|opioids
1289791|NCT01626235|NSDAIDs|nsdaids
1289792|NCT01626235|Emergency Department|emergency department
1289793|NCT01626235|patient reported outcomes|patient reported outcomes
1289794|NCT01626222|Postmenopausal|postmenopausal
1289795|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
1289796|NCT01626222|HER2 negative|her2 negative
1289797|NCT01626222|Locally Advanced|locally advanced
1289798|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
1289799|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
1289800|NCT01626222|Exemestane|exemestane
1289801|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
1289802|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1290505|NCT01623219|veterans|veterans
1289803|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1289804|NCT01626144|Exemestane|exemestane
1289805|NCT01626144|Metabolism|metabolism
1289806|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
1289807|NCT01626144|Breast cancer|breast cancer
1289808|NCT01626131|combat disorders|combat disorders
1289809|NCT01626131|exercise therapy|exercise therapy
1289810|NCT01626105|Hemophilia A|hemophilia a
1289811|NCT01626105|Factor VIII|factor viii
1289812|NCT01626105|Inhibitors|inhibitors
1289813|NCT01626105|Immunogenicity|immunogenicity
1289814|NCT01626105|Pharmacogenetics|pharmacogenetics
1289815|NCT01626105|Mutation|mutation
1289816|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
1289817|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
1289818|NCT01626092|bone marrow transplantation|bone marrow transplantation
1289819|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
1289820|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
1289821|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1289822|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
1289823|NCT01626092|Wolman's disease|wolman's disease
1289824|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
1289825|NCT01626092|Tay Sachs disease|tay sachs disease
1289826|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
1289827|NCT01626092|Sandhoff disease|sandhoff disease
1289828|NCT01626092|inherited metabolic|inherited metabolic
1289829|NCT01626092|I-cell disease|i-cell disease
1289830|NCT01626092|mucolipidosis II|mucolipidosis ii
1289831|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
1289832|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
1289833|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
1290332|NCT01624103|Lidocaine|lidocaine
1289834|NCT01626079|Functional MR|functional mr
1289835|NCT01626079|MitraClip|mitraclip
1289836|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
1289837|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1289838|NCT01626079|COAPT CAS|coapt cas
1289839|NCT01626079|COAPT Continued Access Study|coapt continued access study
1289840|NCT01626079|MitraClip NT|mitraclip nt
1289841|NCT01626053|psychological|psychological
1289842|NCT01626053|intervention|intervention
1289843|NCT01626053|stages of change|stages of change
1289844|NCT01626053|motivational interviewing|motivational interviewing
1289845|NCT01626053|coping skills|coping skills
1289846|NCT01626053|HbA1C|hba1c
1289847|NCT01626053|psychological testing|psychological testing
1289848|NCT01626053|integrated care|integrated care
1289849|NCT01626053|behavioral health|behavioral health
1289850|NCT01626027|Coronary Heart Disease|coronary heart disease
1289851|NCT01626027|Depression|depression
1289852|NCT01626027|Health Care Services|health care services
1289853|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
1289854|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
1289855|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
1289856|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
1289857|NCT01626014|fallopian tube cancer|fallopian tube cancer
1289858|NCT01626001|Esophagus Cancer|esophagus cancer
1289859|NCT01626001|Lung Cancer|lung cancer
1289860|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
1289861|NCT01626001|4D CT|4d ct
1289862|NCT01625975|Growth modulation|growth modulation
1289863|NCT01625975|Eight plate|eight plate
1289864|NCT01625975|Leg length discrepancy|leg length discrepancy
1289865|NCT01625975|Varus/valgus deformities|varus/valgus deformities
1289866|NCT01625975|Pediatric|pediatric
1289867|NCT01625962|PTSD|ptsd
1289868|NCT01625962|mTBI|mtbi
1289869|NCT01625962|mild TBI|mild tbi
1289870|NCT01625962|extracranial injury|extracranial injury
1289871|NCT01625962|ECI|eci
1289872|NCT01625962|Brain Indices|brain indices
1289873|NCT01625949|myocardial infarction|myocardial infarction
1289874|NCT01625936|metastatic|metastatic
1289875|NCT01625936|locally advanced|locally advanced
1289876|NCT01625936|unresectable|unresectable
1289877|NCT01625923|Gastroparesis|gastroparesis
1289878|NCT01625923|Idiopathic|idiopathic
1289879|NCT01625923|Olanzapine|olanzapine
1289880|NCT01625910|Childhood obesity treatment|childhood obesity treatment
1289881|NCT01625910|Motivational interviewing|motivational interviewing
1289882|NCT01625897|Schizophrenia|schizophrenia
1289883|NCT01625897|Antipsychotic Agents|antipsychotic agents
1289884|NCT01625897|Mental Disorder|mental disorder
1289885|NCT01625897|Psychotropic Drugs|psychotropic drugs
1289886|NCT01625897|Dopamine Agents|dopamine agents
1289887|NCT01625897|Risperidone|risperidone
1289888|NCT01625897|Central Nervous System Agents|central nervous system agents
1289889|NCT01625884|Statin|statin
1289890|NCT01625884|Hypercholesterolemia|hypercholesterolemia
1289891|NCT01625871|malaria|malaria
1289892|NCT01625871|vivax|vivax
1289893|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
1289894|NCT01625871|Sudan|sudan
1289895|NCT01625858|LMA Supreme|lma supreme
1289896|NCT01625845|Major Depressive Disorder|major depressive disorder
1289897|NCT01625845|Depression|depression
1289898|NCT01625845|Depressive Symptoms|depressive symptoms
1290811|NCT01621737|oxytocin|oxytocin
1289899|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1289900|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1289901|NCT01625845|Heart Disease|heart disease
1289902|NCT01625845|Endothelial Function|endothelial function
1289903|NCT01625845|Inflammation|inflammation
1289904|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
1289905|NCT01625832|collateral flow index|collateral flow index
1289906|NCT01625832|collateral circulation|collateral circulation
1289907|NCT01625832|coronary artery occlusion|coronary artery occlusion
1289908|NCT01625819|Tai Chi|tai chi
1289909|NCT01625793|Hepatitis C|hepatitis c
1289910|NCT01625793|interferon|interferon
1289911|NCT01625793|stress|stress
1289912|NCT01625793|social behavior|social behavior
1289913|NCT01625767|Nicotine|nicotine
1289914|NCT01625767|Smoking|smoking
1289915|NCT01625767|Adolescent|adolescent
1289916|NCT01625767|Tobacco|tobacco
1289917|NCT01625754|Ceramides|ceramides
1289918|NCT01625754|Lipids|lipids
1289919|NCT01625728|Voice|voice
1289920|NCT01625728|aerodynamics|aerodynamics
1289921|NCT01625728|acoustics|acoustics
1289922|NCT01625715|peanut allergy|peanut allergy
1289923|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
1289924|NCT01625689|Influenza vaccines|influenza vaccines
1289925|NCT01625689|Influenza, Human|influenza, human
1289926|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
1289927|NCT01625676|Aphasia|aphasia
1289928|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
1289929|NCT01625663|barth syndrome|barth syndrome
1289930|NCT01625663|heart failure|heart failure
1289931|NCT01625663|mitochondria|mitochondria
1289932|NCT01625663|metabolism|metabolism
1289933|NCT01625663|amino acid|amino acid
1289934|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
1289935|NCT01625650|Registry|registry
1289936|NCT01625650|RA|ra
1289937|NCT01625650|Biologic|biologic
1289938|NCT01625650|Medications|medications
1289939|NCT01625650|Rheumatology|rheumatology
1289940|NCT01625637|Nicotine|nicotine
1289941|NCT01625637|Smoking|smoking
1289942|NCT01625637|Adolescent|adolescent
1289943|NCT01625637|Tobacco|tobacco
1289944|NCT01625611|Alcohol|alcohol
1289945|NCT01625611|Drinking|drinking
1289946|NCT01625611|Drinkers|drinkers
1289947|NCT01625611|Alcohol Drinking|alcohol drinking
1289948|NCT01625611|Naltrexone|naltrexone
1289949|NCT01625611|Alcohol Dependence|alcohol dependence
1289950|NCT01625611|Alcohol Abuse|alcohol abuse
1289951|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
1289952|NCT01625611|Ethanol|ethanol
1289953|NCT01625611|Alcoholism|alcoholism
1289954|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
1289955|NCT01625598|diabetic macular edema|diabetic macular edema
1289956|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1289957|NCT01625598|ophthalmologists|ophthalmologists
1289958|NCT01625598|dilated eye exam|dilated eye exam
1289959|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
1289960|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
1289961|NCT01625572|general anaesthesia|general anaesthesia
1289962|NCT01625572|epidural catheter|epidural catheter
1289963|NCT01625572|intravenous pain therapy|intravenous pain therapy
1289964|NCT01625546|Major Depressive Disorder|major depressive disorder
1289965|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
1289966|NCT01625533|Coronary Angiography|coronary angiography
1390182|NCT01204801|Surgery|surgery
1289967|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
1289968|NCT01625533|Contrast media|contrast media
1289969|NCT01625533|Radiation|radiation
1289970|NCT01625520|Progressive metastatic|progressive metastatic
1289971|NCT01625520|postoperative persistent|postoperative persistent
1289972|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
1289973|NCT01625468|Smoke-free homes|smoke-free homes
1289974|NCT01625468|Smoke-free home bans|smoke-free home bans
1289975|NCT01625455|Sezary Syndrome|sezary syndrome
1289976|NCT01625455|Pruritus|pruritus
1289977|NCT01625455|Aprepitant|aprepitant
1289978|NCT01625455|Neurokinin-1|neurokinin-1
1289979|NCT01625442|Metabolic syndrome|metabolic syndrome
1289980|NCT01625442|hypercholesterolemia|hypercholesterolemia
1289981|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
1289982|NCT01625442|hyperglycemia|hyperglycemia
1289983|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
1289984|NCT01625416|Depression|depression
1289985|NCT01625416|Suicide|suicide
1289986|NCT01625416|Traumatic Brain Injury|traumatic brain injury
1289987|NCT01625416|Alcohol Use|alcohol use
1289988|NCT01625416|Drug Use|drug use
1289989|NCT01625416|Information Technology|information technology
1289990|NCT01625403|Recombinant BNP|recombinant bnp
1289991|NCT01625403|Diuretics|diuretics
1289992|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
1289993|NCT01625403|Acute renal injury|acute renal injury
1289994|NCT01625403|Heart function|heart function
1289995|NCT01625403|Renal function|renal function
1289996|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
1289997|NCT01625377|Everolimus,|everolimus,
1289999|NCT01625377|early introduction,|early introduction,
1290000|NCT01625377|renal function|renal function
1290001|NCT01625364|Health Education|health education
1290002|NCT01625364|Health Counseling|health counseling
1290003|NCT01625364|Patient Education|patient education
1290004|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1290005|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1290006|NCT01625338|HCV|hcv
1290007|NCT01625338|Sustained Virologic Response|sustained virologic response
1290008|NCT01625338|Direct Acting Antiviral|direct acting antiviral
1290009|NCT01625338|Combination Therapy|combination therapy
1290010|NCT01625338|GS-7977|gs-7977
1290011|NCT01625338|Ribavirin|ribavirin
1290012|NCT01625338|Open Label|open label
1290013|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
1290014|NCT01625299|intestinal permeability|intestinal permeability
1290015|NCT01625299|diet|diet
1290016|NCT01625299|gluten|gluten
1290017|NCT01625299|dairy|dairy
1290018|NCT01625286|advanced breast cancer,|advanced breast cancer,
1290019|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
1290020|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
1290021|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
1290022|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
1290023|NCT01625286|AKT inhibitor|akt inhibitor
1290024|NCT01625273|F19|f19
1290025|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
1290026|NCT01625260|cancer|cancer
1290027|NCT01625260|immunotherapy|immunotherapy
1290028|NCT01625260|targeted|targeted
1290029|NCT01625260|non-muscle invasive|non-muscle invasive
1290030|NCT01625260|interleukin-2|interleukin-2
1290031|NCT01625260|antitumor|antitumor
1290032|NCT01625260|TCR|tcr
1290033|NCT01625260|T-cell receptor|t-cell receptor
1290034|NCT01625260|p53|p53
1290035|NCT01625260|p53 gene|p53 gene
1290036|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
1290037|NCT01625260|urothelial cancer|urothelial cancer
1290038|NCT01625260|bladder cancer|bladder cancer
1290039|NCT01625260|HLA-A2 positive|hla-a2 positive
1290040|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
1290041|NCT01625260|HLA complex|hla complex
1290042|NCT01625260|refractory|refractory
1290043|NCT01625260|relapsed|relapsed
1290044|NCT01625260|BCG|bcg
1290045|NCT01625260|multi-focal|multi-focal
1290046|NCT01625260|carcinoma in situ|carcinoma in situ
1290047|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
1290048|NCT01625260|gemcitabine|gemcitabine
1290049|NCT01625234|Cancer|cancer
1290050|NCT01625234|Tumors|tumors
1290051|NCT01625234|ALK|alk
1290052|NCT01625234|NSCLC|nsclc
1290053|NCT01625234|Advanced Malignancies|advanced malignancies
1290054|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1290055|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
1290056|NCT01625221|FENIX|fenix
1290057|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
1290058|NCT01625169|Pharmacokinetics|pharmacokinetics
1290059|NCT01625169|HIV|hiv
1290060|NCT01625169|Breast milk|breast milk
1290061|NCT01625130|sulforaphane|sulforaphane
1290062|NCT01625130|ozone|ozone
1290063|NCT01625130|airway inflammation|airway inflammation
1290064|NCT01625130|broccoli sprouts|broccoli sprouts
1290065|NCT01625130|NRF2|nrf2
1290066|NCT01625130|controls|controls
1290067|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
1290068|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
1290069|NCT01625117|Appetitive Aggression|appetitive aggression
1290070|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
1290071|NCT01625104|Myocardial Infarction|myocardial infarction
1290072|NCT01625104|Time to Treatment|time to treatment
1290073|NCT01625104|Door to Balloon Time|door to balloon time
1290074|NCT01625091|HIV|hiv
1290075|NCT01625091|women|women
1290076|NCT01625091|drinking|drinking
1290077|NCT01625091|Naltrexone|naltrexone
1290078|NCT01625078|Baska Mask|baska mask
1290079|NCT01625078|Supraglottic airway device|supraglottic airway device
1290080|NCT01625078|Children|children
1290081|NCT01625078|Pediatric|pediatric
1290082|NCT01625065|medication compliance|medication compliance
1290083|NCT01625065|adherence|adherence
1290084|NCT01625065|toxicological analyzes|toxicological analyzes
1290085|NCT01625065|GC-MS|gc-ms
1290086|NCT01625065|HPLC|hplc
1290087|NCT01625065|pain patients|pain patients
1290088|NCT01625065|opioid misuse|opioid misuse
1290089|NCT01625065|patients with current pain|patients with current pain
1290090|NCT01625052|mask size|mask size
1290091|NCT01625052|Baska mask|baska mask
1290092|NCT01625052|supraglottic airway|supraglottic airway
1290093|NCT01625052|airway management|airway management
1290094|NCT01625039|Occupational health|occupational health
1290095|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
1290096|NCT01625039|physiotherapy|physiotherapy
1290097|NCT01625039|physical activity|physical activity
1290098|NCT01625026|Morbidly obesity|morbidly obesity
1290099|NCT01625026|Gastric bypass|gastric bypass
1290100|NCT01625026|Cholecystolithiasis|cholecystolithiasis
1290101|NCT01625013|osteoarthritis|osteoarthritis
1290102|NCT01625013|viscosupplementation|viscosupplementation
1290103|NCT01625013|Active|active
1290104|NCT01625013|Knee|knee
1290105|NCT01625013|Synvisc-One|synvisc-one
1290106|NCT01625000|Schizophrenia|schizophrenia
1290107|NCT01625000|Antipsychotic Agents|antipsychotic agents
1290108|NCT01625000|Acute Schizophrenia|acute schizophrenia
1290109|NCT01625000|Mental Disorder|mental disorder
1290110|NCT01625000|Psychotropic Drugs|psychotropic drugs
1290111|NCT01625000|Dopamine Agents|dopamine agents
1290112|NCT01625000|Risperidone|risperidone
1290113|NCT01625000|Central Nervous System Agents|central nervous system agents
1290114|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
1290115|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
1290116|NCT01624987|Appetitive Aggression|appetitive aggression
1290117|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
1290118|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
1290119|NCT01624961|Malaria challenge|malaria challenge
1290120|NCT01624961|Plasmodium falciparum|plasmodium falciparum
1290121|NCT01624961|PfSPZ Challenge|pfspz challenge
1290122|NCT01624948|BK virus|bk virus
1290123|NCT01624948|Kidney Transplantation|kidney transplantation
1290124|NCT01624948|Immunologic Monitoring|immunologic monitoring
1290125|NCT01624935|PTSD|ptsd
1290126|NCT01624935|earthquake|earthquake
1290127|NCT01624935|disaster|disaster
1290128|NCT01624935|global mental health|global mental health
1290129|NCT01624935|disaster mental health|disaster mental health
1290130|NCT01624935|depression|depression
1290131|NCT01624870|Aortic Valve Stenonis|aortic valve stenonis
1290132|NCT01624870|Valvular Heart Disease|valvular heart disease
1290133|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
1290134|NCT01624844|ultrasound|ultrasound
1290135|NCT01624831|Psychosis|psychosis
1290136|NCT01624831|schizophrenia|schizophrenia
1290137|NCT01624831|schizoaffective disorder|schizoaffective disorder
1290138|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
1290139|NCT01624831|Major depression with psychotic features|major depression with psychotic features
1290140|NCT01624831|Psychosis NOS|psychosis nos
1290141|NCT01624831|Social Cognition|social cognition
1290142|NCT01624818|coping|coping
1290143|NCT01624818|physical activity|physical activity
1290144|NCT01624818|psychosocial|psychosocial
1290145|NCT01624818|children|children
1290146|NCT01624818|heart disease|heart disease
1290147|NCT01624818|habilitation|habilitation
1290148|NCT01624805|Leukemia|leukemia
1290149|NCT01624805|Aplastic Anemia|aplastic anemia
1290151|NCT01624805|Low/Int-1 Risk Myelodysplastic Syndrome|low/int-1 risk myelodysplastic syndrome
1290152|NCT01624805|MDS|mds
1290153|NCT01624805|hATG|hatg
1290154|NCT01624805|Horse Antithymocyte Globulin|horse antithymocyte globulin
1290155|NCT01624805|ATG|atg
1290156|NCT01624805|Antithymocyte Globulin|antithymocyte globulin
1290157|NCT01624805|Thymoglobulin|thymoglobulin
1290158|NCT01624805|Cyclosporine|cyclosporine
1290159|NCT01624805|Sandimmune|sandimmune
1290160|NCT01624805|CYA|cya
1290161|NCT01624805|Cyclosporin A|cyclosporin a
1290162|NCT01624805|Methylprednisone|methylprednisone
1290163|NCT01624805|Methylprednisolone|methylprednisolone
1290164|NCT01624805|Depo-Medrol|depo-medrol
1290165|NCT01624805|Medrol|medrol
1290166|NCT01624805|Solu-Medrol|solu-medrol
1290167|NCT01624805|pegfilgrastim|pegfilgrastim
1290168|NCT01624805|Neulasta|neulasta
1290169|NCT01624805|PEG-G-CSF|peg-g-csf
1290170|NCT01624805|Filgrastim|filgrastim
1290171|NCT01624805|C-CSF|c-csf
1290172|NCT01624805|Neupogen|neupogen
1290173|NCT01624792|Protein metabolism|protein metabolism
1290174|NCT01624792|casein protein|casein protein
1290175|NCT01624792|EPA|epa
1290176|NCT01624792|Fish oil|fish oil
1290177|NCT01624779|autologous adipose tissue|autologous adipose tissue
1290178|NCT01624766|Advanced Cancers|advanced cancers
1290179|NCT01624766|Advanced Malignancies|advanced malignancies
1290180|NCT01624766|Metastatic Cancers|metastatic cancers
1290181|NCT01624766|Everolimus|everolimus
1290182|NCT01624766|Afinitor|afinitor
1290183|NCT01624766|RAD001|rad001
1290184|NCT01624766|Anakinra|anakinra
1290185|NCT01624766|Kineret|kineret
1290186|NCT01624766|Denosumab|denosumab
1290187|NCT01624766|AMG 162|amg 162
1290188|NCT01624753|interstitial lung disease|interstitial lung disease
1290189|NCT01624753|interstitial pneumonia|interstitial pneumonia
1290190|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1290191|NCT01624727|Coronary heart disease|coronary heart disease
1290192|NCT01624727|metabolic syndrome|metabolic syndrome
1290193|NCT01624727|CT angiography|ct angiography
1290194|NCT01624714|Treatment Refractory|treatment refractory
1290195|NCT01624701|Cord blood|cord blood
1290196|NCT01624701|unrelated donor|unrelated donor
1290197|NCT01624701|allogeneic|allogeneic
1290198|NCT01624701|cell dose|cell dose
1290199|NCT01624688|Tattoo|tattoo
1290200|NCT01624688|Tattoo Removal|tattoo removal
1290201|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
1290202|NCT01624675|Risperidone (R064766)|risperidone (r064766)
1290203|NCT01624675|Children|children
1290204|NCT01624675|Adolescents|adolescents
1290205|NCT01624675|Irritability|irritability
1290206|NCT01624675|Autistic disorder|autistic disorder
1290207|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
1290208|NCT01624649|Developmental disorder|developmental disorder
1290209|NCT01624649|Atomoxetine|atomoxetine
1290210|NCT01624649|Methylphenidate|methylphenidate
1290211|NCT01624649|Psychiatric disorder|psychiatric disorder
1290213|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
1290214|NCT01624636|Wet AMD|wet amd
1290215|NCT01624636|Neovascular AMD|neovascular amd
1290216|NCT01624623|radiation|radiation
1290217|NCT01624623|Calypso|calypso
1290218|NCT01624623|prostatectomy|prostatectomy
1290219|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
1290220|NCT01624610|Diarrhea|diarrhea
1290221|NCT01624610|abdominal pain|abdominal pain
1290222|NCT01624610|diet|diet
1290223|NCT01624610|nutrition|nutrition
1290224|NCT01624597|Road traffic safety|road traffic safety
1290225|NCT01624584|child|child
1290226|NCT01624584|anxiety|anxiety
1290227|NCT01624584|CBT|cbt
1290228|NCT01624558|malignant hyperthermia|malignant hyperthermia
1290229|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
1290230|NCT01624545|burr hole trepanation|burr hole trepanation
1290231|NCT01624545|radiologic follow-up|radiologic follow-up
1290232|NCT01624545|outcome|outcome
1290233|NCT01624545|recurrence|recurrence
1290234|NCT01624532|Anthrax vaccine|anthrax vaccine
1290235|NCT01624519|Arterial Lactate|arterial lactate
1290236|NCT01624519|Central Venous Lactate|central venous lactate
1290237|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
1290238|NCT01624506|GERD|gerd
1290239|NCT01624506|Fundoplication|fundoplication
1290240|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
1290241|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
1290242|NCT01624493|BNC105P|bnc105p
1290243|NCT01624493|Partially platinum sensitive|partially platinum sensitive
1290244|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
1290245|NCT01624467|Advanced Solid Tumors|advanced solid tumors
1290246|NCT01624454|colonoscopy|colonoscopy
1290247|NCT01624454|bowel cleansing|bowel cleansing
1290248|NCT01624428|Tobacco|tobacco
1290249|NCT01624428|Adolescent|adolescent
1290250|NCT01624428|Nicotine|nicotine
1290251|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
1290252|NCT01624428|Varenicline|varenicline
1290253|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
1290254|NCT01624389|Alzheimer's disease|alzheimer's disease
1290255|NCT01624376|non-invasive management|non-invasive management
1290256|NCT01624376|Fistula|fistula
1290257|NCT01624376|Crohn's Disease|crohn's disease
1290258|NCT01624376|local administration|local administration
1290259|NCT01624376|non-invasive|non-invasive
1290260|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
1290261|NCT01624350|Anorectal Fistulas|anorectal fistulas
1290262|NCT01624337|Plasmodium falciparum|plasmodium falciparum
1290263|NCT01624337|Plasmodium vivax|plasmodium vivax
1290264|NCT01624324|aminoglycoside|aminoglycoside
1290265|NCT01624324|KIM-1|kim-1
1290266|NCT01624324|DPOAE|dpoae
1290267|NCT01624324|nephrotoxicity|nephrotoxicity
1290268|NCT01624324|ototoxicity|ototoxicity
1290269|NCT01624311|High ammonia level|high ammonia level
1290270|NCT01624311|Hyperammonemia|hyperammonemia
1290271|NCT01624311|Poor suck|poor suck
1290272|NCT01624311|Lethargy|lethargy
1290273|NCT01624311|Coma|coma
1290274|NCT01624311|Encephalopathy|encephalopathy
1290275|NCT01624311|Seizures|seizures
1290276|NCT01624311|Brain edema|brain edema
1290277|NCT01624311|Urea Cycle Disorder|urea cycle disorder
1290278|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
1290279|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
1290280|NCT01624311|Citrullinemia|citrullinemia
1290281|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
1290282|NCT01624311|Organic Acidemia|organic acidemia
1290283|NCT01624311|Propionic Aciduria|propionic aciduria
1290284|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
1290285|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
1290286|NCT01624298|Randomized controlled trial|randomized controlled trial
1290287|NCT01624298|Traumatized youth|traumatized youth
1290288|NCT01624298|HIV risk|hiv risk
1290289|NCT01624272|Physical Therapy|physical therapy
1290290|NCT01624272|Respiratory Muscle Training|respiratory muscle training
1290291|NCT01624272|Elderly|elderly
1290292|NCT01624220|Spinal tumor|spinal tumor
1290293|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
1290294|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
1290295|NCT01624220|Breast cancer|breast cancer
1290296|NCT01624220|Prostate cancer|prostate cancer
1290297|NCT01624220|Renal cell cancer|renal cell cancer
1290298|NCT01624220|Melanoma|melanoma
1290299|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
1290300|NCT01624220|Sarcoma|sarcoma
1290301|NCT01624220|Thyroid cancer|thyroid cancer
1290302|NCT01624220|Head and neck primary cancer|head and neck primary cancer
1290303|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
1290304|NCT01624220|Fiducial markers|fiducial markers
1290305|NCT01624220|Gold seed markers|gold seed markers
1290306|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
1290307|NCT01624220|Spinal SBRT|spinal sbrt
1290308|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
1290309|NCT01624207|Atorva|atorva
1290310|NCT01624207|generic|generic
1290311|NCT01624207|atorvastatin|atorvastatin
1290312|NCT01624207|hypercholesterolemia|hypercholesterolemia
1290313|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
1290314|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
1290315|NCT01624181|microbiological investigation|microbiological investigation
1290316|NCT01624181|intensive care|intensive care
1290317|NCT01624168|anxiety|anxiety
1290318|NCT01624168|sleep quality|sleep quality
1290319|NCT01624168|tai chi chuan|tai chi chuan
1290320|NCT01624168|young adults|young adults
1290321|NCT01624155|teratogens|teratogens
1290322|NCT01624155|contraception|contraception
1290323|NCT01624155|electronic medical record|electronic medical record
1290324|NCT01624142|Hypercholesterolemia|hypercholesterolemia
1290325|NCT01624142|Elevated Cholesterol|elevated cholesterol
1290326|NCT01624142|High Cholesterol|high cholesterol
1290327|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1290328|NCT01624142|PCSK9 mutations|pcsk9 mutations
1290329|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
1290330|NCT01624103|Arm Injuries|arm injuries
1290331|NCT01624103|Wounds and Injuries|wounds and injuries
1290333|NCT01624103|Levobupivacaine|levobupivacaine
1290334|NCT01624103|Bupivacaine|bupivacaine
1290335|NCT01624103|Anesthetics|anesthetics
1290336|NCT01624103|Central Nervous System Depressants|central nervous system depressants
1290337|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
1290338|NCT01624090|Cancer Stem Cell|cancer stem cell
1290339|NCT01624090|Thoracic Malignancies|thoracic malignancies
1290340|NCT01624090|Mythramycin Treatment|mythramycin treatment
1290341|NCT01624090|Lung Tumors|lung tumors
1290342|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
1290343|NCT01624077|Regulatory T cells|regulatory t cells
1290344|NCT01624077|Liver Transplantation|liver transplantation
1290345|NCT01624077|Rejection|rejection
1290346|NCT01624077|Tolerance|tolerance
1290347|NCT01624077|Cell tolerance|cell tolerance
1290348|NCT01624077|Survival|survival
1290349|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
1290350|NCT01624064|Uncertain aetiology|uncertain aetiology
1290351|NCT01624064|ACEI|acei
1290352|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
1290353|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
1290354|NCT01624051|lean body mass|lean body mass
1290355|NCT01624051|sarcopenia|sarcopenia
1290356|NCT01624038|Hydroxyurea|hydroxyurea
1290357|NCT01624038|Erythropoitin therapy|erythropoitin therapy
1290358|NCT01624038|Thalassemia intermedia|thalassemia intermedia
1290359|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
1290360|NCT01624012|NIV NAVA|niv nava
1290361|NCT01624012|non-invasive ventilation|non-invasive ventilation
1290362|NCT01623973|hemiparetic|hemiparetic
1290363|NCT01623973|cognitive|cognitive
1290364|NCT01623973|balance|balance
1290365|NCT01623960|severe haemophilia|severe haemophilia
1290366|NCT01623960|quality of life|quality of life
1290367|NCT01623947|glutamine|glutamine
1290368|NCT01623947|cycling performance|cycling performance
1290369|NCT01623947|mental function|mental function
1290370|NCT01623934|Gestational diabetes|gestational diabetes
1290371|NCT01623934|Adiponectin|adiponectin
1290372|NCT01623934|Leptin|leptin
1290373|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
1290374|NCT01623934|Insulin resistance|insulin resistance
1290375|NCT01623921|Lung|lung
1290376|NCT01623921|Contusion|contusion
1290377|NCT01623921|Injury|injury
1290378|NCT01623921|Cyclooxygenase|cyclooxygenase
1290379|NCT01623921|Statin|statin
1290380|NCT01623908|Breast neoplasms|breast neoplasms
1290381|NCT01623908|Zoledronate|zoledronate
1290382|NCT01623908|Bone loss|bone loss
1290383|NCT01623882|Diabetes Mellitus|diabetes mellitus
1290384|NCT01623882|Wounds|wounds
1290385|NCT01623882|Ulcers|ulcers
1290386|NCT01623843|FAI|fai
1290387|NCT01623843|randomized|randomized
1290388|NCT01623843|hip arthroscopy|hip arthroscopy
1290389|NCT01623843|lavage|lavage
1290390|NCT01623843|osteochondroplasty|osteochondroplasty
1290391|NCT01623830|reconsolidation|reconsolidation
1290392|NCT01623830|fear of flying|fear of flying
1290393|NCT01623830|virtual reality|virtual reality
1290394|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
1290395|NCT01623804|Ultrasound therapy|ultrasound therapy
1290396|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
1290397|NCT01623804|Nonsurgical|nonsurgical
1291211|NCT01619878|plasmodium|plasmodium
1290398|NCT01623791|Pre-eclampsia|pre-eclampsia
1290399|NCT01623791|Proteinuria|proteinuria
1290400|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
1290401|NCT01623791|Dipstick proteinuria|dipstick proteinuria
1290402|NCT01623791|Severity of disease|severity of disease
1290403|NCT01623778|HBeAg seroconversion|hbeag seroconversion
1290404|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
1290405|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
1290406|NCT01623778|Optimal therapy|optimal therapy
1290407|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
1290408|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
1290409|NCT01623739|Dental implants|dental implants
1290410|NCT01623739|Esthetic score|esthetic score
1290411|NCT01623739|Immediate implants|immediate implants
1290412|NCT01623739|Early placement|early placement
1290413|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1290414|NCT01623726|Schizophrenia|schizophrenia
1290415|NCT01623713|schizophrenia|schizophrenia
1290416|NCT01623713|iloperidone|iloperidone
1290417|NCT01623713|Risperidone|risperidone
1290418|NCT01623713|Efficacy|efficacy
1290419|NCT01623713|Safety|safety
1290420|NCT01623700|clopidogrel|clopidogrel
1290421|NCT01623700|aspirin|aspirin
1290422|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
1290423|NCT01623700|coronary stenting|coronary stenting
1290424|NCT01623700|antiplatelet|antiplatelet
1290425|NCT01623687|total hip arthroplasty|total hip arthroplasty
1290426|NCT01623687|bone metabolism|bone metabolism
1290427|NCT01623687|mineralisation|mineralisation
1290428|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
1290429|NCT01623661|Nephrology|nephrology
1290430|NCT01623661|chronic kidney disease|chronic kidney disease
1291258|NCT01619761|Fludarabine|fludarabine
1290431|NCT01623661|sodium-channels|sodium-channels
1290432|NCT01623661|water-channels|water-channels
1290433|NCT01623661|BCM|bcm
1290434|NCT01623648|whey protein|whey protein
1290435|NCT01623648|hunger|hunger
1290436|NCT01623609|Phase 1|phase 1
1290437|NCT01623609|Healthy volunteers|healthy volunteers
1290438|NCT01623609|Naloxegol|naloxegol
1290439|NCT01623609|Bioequivalence|bioequivalence
1290440|NCT01623583|lidocaine|lidocaine
1290441|NCT01623583|tetracaine|tetracaine
1290442|NCT01623583|Renal dialysis|renal dialysis
1290443|NCT01623570|Luteinizing Hormone|luteinizing hormone
1290444|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1290445|NCT01623570|Ovulation Induction|ovulation induction
1290446|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
1290447|NCT01623557|Malaria|malaria
1290448|NCT01623557|Vaccine|vaccine
1290449|NCT01623557|Plasmodium|plasmodium
1290450|NCT01623557|falciparum|falciparum
1290451|NCT01623544|Asthma|asthma
1290452|NCT01623544|Comparative Effectiveness|comparative effectiveness
1290453|NCT01623544|Symbicort|symbicort
1290454|NCT01623531|Fibrinogen|fibrinogen
1290455|NCT01623531|cardiac surgery|cardiac surgery
1290456|NCT01623531|high risk|high risk
1290457|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
1290458|NCT01623531|bleeding|bleeding
1609436|NCT00359970|Treatment|treatment
1290459|NCT01623531|blood transfusion|blood transfusion
1290460|NCT01623505|Smoking Cessation|smoking cessation
1290461|NCT01623505|Psychiatric Illness|psychiatric illness
1290462|NCT01623505|Pharmacotherapy|pharmacotherapy
1290463|NCT01623492|Eisenmenger|eisenmenger
1290464|NCT01623466|PK and Safety|pk and safety
1290465|NCT01623453|crohn's disease|crohn's disease
1290466|NCT01623453|fistula|fistula
1290467|NCT01623453|complex|complex
1290468|NCT01623427|pediatric|pediatric
1290469|NCT01623427|laparoscopy|laparoscopy
1290470|NCT01623427|vacuum|vacuum
1290471|NCT01623427|dressing|dressing
1290472|NCT01623362|Dentifrices|dentifrices
1290473|NCT01623362|Dental Caries|dental caries
1290474|NCT01623362|Fluorides|fluorides
1290475|NCT01623362|Nails|nails
1290476|NCT01623362|pH|ph
1290477|NCT01623349|Recurrent|recurrent
1290478|NCT01623349|High Grade|high grade
1290479|NCT01623349|Serous|serous
1290480|NCT01623349|Triple Negative|triple negative
1290481|NCT01623336|HEPATITIS|hepatitis
1290482|NCT01623336|HEPATITIS C|hepatitis c
1290483|NCT01623336|PEGINTERFERON|peginterferon
1290484|NCT01623336|BIOEQUIVALENCE|bioequivalence
1290485|NCT01623336|TREATMENT|treatment
1290486|NCT01623297|Laparoscopy|laparoscopy
1290487|NCT01623297|Surgery|surgery
1290488|NCT01623297|Acute Phase Reaction|acute phase reaction
1290489|NCT01623297|Aged|aged
1290490|NCT01623297|Aged 80 and over|aged 80 and over
1290491|NCT01623297|Confusion|confusion
1290492|NCT01623297|Inflammation|inflammation
1290493|NCT01623297|Delirium|delirium
1290494|NCT01623284|aphasia|aphasia
1290495|NCT01623284|apraxia of speech|apraxia of speech
1290496|NCT01623284|language|language
1290497|NCT01623271|CRPS I|crps i
1290498|NCT01623232|vaccine|vaccine
1290499|NCT01623232|influenzavirus A|influenzavirus a
1290500|NCT01623232|influenzavirus B|influenzavirus b
1290501|NCT01623232|adjuvant|adjuvant
1290502|NCT01623219|PTSD|ptsd
1290503|NCT01623219|trauma|trauma
1290504|NCT01623219|combat trauma|combat trauma
1290506|NCT01623219|telemedicine|telemedicine
1290507|NCT01623219|prolonged exposure|prolonged exposure
1290508|NCT01623193|Cardioplegia|cardioplegia
1290509|NCT01623193|Blood transfusion|blood transfusion
1290510|NCT01623193|Cardiac function|cardiac function
1290511|NCT01623193|Myocardial edema|myocardial edema
1290512|NCT01623193|Coronary artery disease|coronary artery disease
1290513|NCT01623193|Valve disease|valve disease
1290514|NCT01623180|DES|des
1290515|NCT01623180|coronary stent|coronary stent
1290516|NCT01623180|bare metal stent|bare metal stent
1290517|NCT01623180|high bleeding|high bleeding
1290518|NCT01623180|MI|mi
1290519|NCT01623180|angina|angina
1290520|NCT01623167|T-cells|t-cells
1290521|NCT01623167|Immunosuppression|immunosuppression
1290522|NCT01623167|Hematopoesis|hematopoesis
1290523|NCT01623167|Autoimmunity|autoimmunity
1290524|NCT01623167|Thrombocytopenia|thrombocytopenia
1290525|NCT01623154|Helicobacter pylori|helicobacter pylori
1290526|NCT01623141|CRPS|crps
1290527|NCT01623141|TPBS|tpbs
1290528|NCT01623141|Pressure pain thresholds|pressure pain thresholds
1290529|NCT01623141|limb pain of other origin|limb pain of other origin
1290530|NCT01623128|Breastfeeding initiation|breastfeeding initiation
1290531|NCT01623128|Breastfeeding duration|breastfeeding duration
1290532|NCT01623128|WIC|wic
1290533|NCT01623128|Video education|video education
1290534|NCT01623128|Breastfeeding rates|breastfeeding rates
1290535|NCT01623115|PCSK9|pcsk9
1290536|NCT01623102|Bevacizumab|bevacizumab
1290537|NCT01623102|gemcitabine|gemcitabine
1290538|NCT01623102|cisplatin|cisplatin
1290539|NCT01623102|EGFR wild-type|egfr wild-type
1290540|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
1290541|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
1290542|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
1290543|NCT01623076|Transverse Myelitis|transverse myelitis
1290544|NCT01623076|Optic Neuritis|optic neuritis
1290545|NCT01623076|Biorepository|biorepository
1290546|NCT01623063|endometrium|endometrium
1290547|NCT01623063|infertility|infertility
1290548|NCT01623063|uterus|uterus
1290549|NCT01623063|histeroscopy|histeroscopy
1290550|NCT01623037|Lipolysis|lipolysis
1290551|NCT01623037|Cryolipolysis|cryolipolysis
1290552|NCT01623037|Fat Reduction|fat reduction
1290553|NCT01623011|Shoulder|shoulder
1290554|NCT01623011|Sub-acromial|sub-acromial
1290555|NCT01623011|Rotator Cuff|rotator cuff
1290556|NCT01623011|Impingement|impingement
1290557|NCT01622998|Pharmacotherapy|pharmacotherapy
1290558|NCT01622998|Titration|titration
1290559|NCT01622998|Smoking Cessation|smoking cessation
1290560|NCT01622959|emergency departement|emergency departement
1290561|NCT01622959|acute pain|acute pain
1290562|NCT01622959|acupuncture|acupuncture
1290563|NCT01622959|morphine|morphine
1290564|NCT01622946|total hip arthroplasty|total hip arthroplasty
1290565|NCT01622946|tranexamic acid|tranexamic acid
1290566|NCT01622946|postoperative blood loss|postoperative blood loss
1290567|NCT01622933|melanoma|melanoma
1290568|NCT01622933|recurrent|recurrent
1290569|NCT01622933|metastatic|metastatic
1290570|NCT01622920|enamel erosion|enamel erosion
1290571|NCT01622920|ultrasound|ultrasound
1290572|NCT01622920|reproducibility|reproducibility
1290573|NCT01622920|human central incisor|human central incisor
1290574|NCT01622920|reliability|reliability
1290575|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
1290576|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
1290577|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
1290578|NCT01622894|Alzheimer genetics|alzheimer genetics
1290579|NCT01622855|Rape|rape
1290580|NCT01622855|Secondary prevention|secondary prevention
1290581|NCT01622855|Intervention|intervention
1290582|NCT01622842|Impedance|impedance
1290583|NCT01622842|Electrical|electrical
1290584|NCT01622842|Tissue|tissue
1290585|NCT01622842|Excitation frequency|excitation frequency
1290586|NCT01622842|arterial distension|arterial distension
1290587|NCT01622842|distension wave form|distension wave form
1290588|NCT01622777|Rosuvastatin|rosuvastatin
1290589|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
1290590|NCT01622777|Nerve conduction|nerve conduction
1290591|NCT01622777|Oxidative stress|oxidative stress
1290592|NCT01622777|Nerve growth factor|nerve growth factor
1290593|NCT01622764|RO5323441|ro5323441
1290594|NCT01622764|bevacizumab|bevacizumab
1290595|NCT01622764|PET imaging|pet imaging
1290596|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
1290597|NCT01622751|REM sleep|rem sleep
1290598|NCT01622751|Adiponectin|adiponectin
1290599|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
1290600|NCT01622725|ventral hernia|ventral hernia
1290601|NCT01622712|inguinal hernia|inguinal hernia
1290602|NCT01622699|Jaundice|jaundice
1290603|NCT01622699|Neonatal Jaundice|neonatal jaundice
1290604|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
1290605|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
1290606|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
1290607|NCT01622699|jaundice meter|jaundice meter
1291602|NCT01618591|diarrhea|diarrhea
1290608|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
1290609|NCT01622699|Newborn|newborn
1290610|NCT01622686|Prescription Labels|prescription labels
1290611|NCT01622686|Low Health Literacy|low health literacy
1290612|NCT01622686|Limited English Proficiency|limited english proficiency
1290613|NCT01622686|Spanish|spanish
1290614|NCT01622660|URETER|ureter
1290615|NCT01622660|URINARY BLADDER|urinary bladder
1290616|NCT01622660|renal pelvis|renal pelvis
1290617|NCT01622660|GEMCITABINE|gemcitabine
1290618|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
1290619|NCT01622660|11-191|11-191
1290620|NCT01622647|NCPAP|ncpap
1290621|NCT01622634|cardiovascular disease|cardiovascular disease
1290622|NCT01622634|diabetes mellitus|diabetes mellitus
1290623|NCT01622621|Lung|lung
1290624|NCT01622621|Cancer|cancer
1290625|NCT01622608|Adolescent vaccination|adolescent vaccination
1290626|NCT01622608|Immunization rates|immunization rates
1290627|NCT01622608|Informational kiosk|informational kiosk
1290628|NCT01622608|Tailored health messaging|tailored health messaging
1290629|NCT01622608|Barriers to vaccination|barriers to vaccination
1290630|NCT01622608|Attitudes|attitudes
1290631|NCT01622608|Intentions|intentions
1290632|NCT01622595|Aspergillosis|aspergillosis
1290633|NCT01622595|Candidemia|candidemia
1290634|NCT01622595|Candidiasis|candidiasis
1290635|NCT01622595|C. Difficile|c. difficile
1290636|NCT01622595|cytomegalovirus|cytomegalovirus
1290637|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
1290638|NCT01622595|Influenza|influenza
1290639|NCT01622595|CONS|cons
1290640|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
1290641|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
1291343|NCT01619566|Biopsy|biopsy
1290642|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
1290643|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1290644|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1290645|NCT01622556|Hodgkin's Disease|hodgkin's disease
1290646|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
1290647|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
1290648|NCT01622504|Intranasal|intranasal
1290649|NCT01622504|nasal spray|nasal spray
1290650|NCT01622504|opioid|opioid
1290651|NCT01622504|overdose|overdose
1290652|NCT01622491|H1N1|h1n1
1290653|NCT01622491|pandemic|pandemic
1290654|NCT01622491|influenza|influenza
1290655|NCT01622491|pneumonia|pneumonia
1290656|NCT01622491|vaccine|vaccine
1290657|NCT01622491|effectiveness|effectiveness
1290658|NCT01622491|Manitoba|manitoba
1290659|NCT01622491|Canada|canada
1290660|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
1290661|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1290662|NCT01622478|breast cancer|breast cancer
1290663|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
1290664|NCT01622478|positive axillary lymph node|positive axillary lymph node
1290665|NCT01622478|negative conversion|negative conversion
1290666|NCT01622465|Hip arthroplasty|hip arthroplasty
1290667|NCT01622465|Aged|aged
1290668|NCT01622465|Rehabilitation|rehabilitation
1290669|NCT01622465|Exercise therapy|exercise therapy
1290670|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1290671|NCT01622452|Cognitive decline|cognitive decline
1290672|NCT01622452|Valve surgery|valve surgery
1290673|NCT01622452|Cardiac surgery|cardiac surgery
1290674|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
1290675|NCT01622452|Brain Morphometry|brain morphometry
1290676|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
1290677|NCT01622439|Lymphoma|lymphoma
1290678|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1290679|NCT01622439|Valproate|valproate
1290680|NCT01622439|R-CHOP|r-chop
1290681|NCT01622439|CD 20|cd 20
1290682|NCT01622413|lumbar spine|lumbar spine
1290683|NCT01622413|herniated disc|herniated disc
1290684|NCT01622413|slipped disc|slipped disc
1290685|NCT01622413|disc herniation|disc herniation
1290686|NCT01622413|discectomy|discectomy
1290687|NCT01622413|nucleotomy|nucleotomy
1290688|NCT01622413|disc surgery|disc surgery
1290689|NCT01622413|endoscopy|endoscopy
1290690|NCT01622413|spine|spine
1290691|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
1290692|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
1290693|NCT01622387|Arteries|arteries
1290694|NCT01622387|Veins|veins
1290695|NCT01622387|Conduits|conduits
1290696|NCT01622374|Music|music
1290697|NCT01622374|dental anxiety|dental anxiety
1290698|NCT01622374|"music for the mind"|"music for the mind"
1290699|NCT01622374|mozart|mozart
1290700|NCT01622374|iranian traditional music|iranian traditional music
1290701|NCT01622361|Neoadjuvant|neoadjuvant
1290702|NCT01622361|endocrine therapy|endocrine therapy
1290703|NCT01622361|premenopausal|premenopausal
1290704|NCT01622361|hormone responsive|hormone responsive
1290705|NCT01622361|HER2 negative|her2 negative
1290706|NCT01622361|lymph node positive|lymph node positive
1290707|NCT01622348|Psoriasis|psoriasis
1290708|NCT01622348|Plaque Psoriasis|plaque psoriasis
1291803|NCT01617824|Metabolism|metabolism
1290709|NCT01622309|Oxidative Stress|oxidative stress
1290710|NCT01622309|Obesity|obesity
1290711|NCT01622309|Solanum melongena|solanum melongena
1290712|NCT01622218|Medical clown|medical clown
1290713|NCT01622192|Probing|probing
1290714|NCT01622192|manual probe|manual probe
1290715|NCT01622192|automated probe|automated probe
1290716|NCT01622192|Periodontal disease|periodontal disease
1290717|NCT01622179|surgery|surgery
1290718|NCT01622179|suture method|suture method
1290719|NCT01622179|blood supply|blood supply
1290720|NCT01622140|T-SPOT.TB|t-spot.tb
1290721|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
1290722|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
1290723|NCT01622140|Tuberculin skin test|tuberculin skin test
1290724|NCT01622140|Discordance|discordance
1290725|NCT01622140|Predictive value|predictive value
1290726|NCT01622140|Tuberculosis disease development|tuberculosis disease development
1290727|NCT01622114|Obesity|obesity
1290728|NCT01622114|Weight reduction|weight reduction
1290729|NCT01622114|premenopausal Women|premenopausal women
1290730|NCT01622114|Menstrual cycle|menstrual cycle
1290731|NCT01622114|quality of life|quality of life
1290732|NCT01622114|food cravings|food cravings
1290733|NCT01622101|Energy expenditure|energy expenditure
1290734|NCT01622101|Appetite|appetite
1290735|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
1290736|NCT01622101|blood pressure|blood pressure
1290737|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
1290738|NCT01622062|Rabies|rabies
1290739|NCT01622062|Verorab®|verorab®
1290740|NCT01622062|Favirab®|favirab®
1290741|NCT01622036|Malnutrition|malnutrition
1290742|NCT01622036|pre-cachexia|pre-cachexia
1290743|NCT01622036|cancer|cancer
1290744|NCT01622036|cachexia|cachexia
1290745|NCT01622036|MNA|mna
1290746|NCT01622036|weight loss|weight loss
1290747|NCT01622023|insemination|insemination
1290748|NCT01622023|donor sperm|donor sperm
1290749|NCT01622023|natural cycle|natural cycle
1290750|NCT01622010|Heart Failure|heart failure
1290751|NCT01622010|Patient Education as Topic|patient education as topic
1290752|NCT01622010|Physical Therapy Specialty|physical therapy specialty
1290753|NCT01621997|peritoneal dialysis|peritoneal dialysis
1290754|NCT01621997|retraining|retraining
1290755|NCT01621997|peritonitis|peritonitis
1290756|NCT01621984|Cerebral palsy|cerebral palsy
1290757|NCT01621984|brain injury|brain injury
1290758|NCT01621984|spinal cord injuries|spinal cord injuries
1290759|NCT01621984|muscular disease|muscular disease
1290760|NCT01621971|inhaled milrinone|inhaled milrinone
1290761|NCT01621971|pulmonary hypertension|pulmonary hypertension
1290762|NCT01621971|mitral regurgitation|mitral regurgitation
1290763|NCT01621971|mitral valve surgery|mitral valve surgery
1290764|NCT01621958|balance loss|balance loss
1290765|NCT01621958|dynamic stability|dynamic stability
1609437|NCT00359970|Antibiotic|antibiotic
1290766|NCT01621958|motor learning|motor learning
1290767|NCT01621958|plasticity|plasticity
1290768|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
1290769|NCT01621945|Serum bactericidal activity|serum bactericidal activity
1290770|NCT01621945|OMV vaccine|omv vaccine
1290771|NCT01621932|Anterior approach|anterior approach
1290772|NCT01621906|Breast|breast
1290773|NCT01621906|brain metastases|brain metastases
1290774|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
1290775|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
1290776|NCT01621906|MR Imaging|mr imaging
1290777|NCT01621906|12-039|12-039
1290778|NCT01621893|bone marrow edema|bone marrow edema
1290779|NCT01621893|bone marrow defects|bone marrow defects
1290780|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
1290781|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1290782|NCT01621880|Bevacizumab|bevacizumab
1290783|NCT01621880|Methylprednisolone|methylprednisolone
1290784|NCT01621867|Cystic fibrosis|cystic fibrosis
1290785|NCT01621867|Gene therapy|gene therapy
1290786|NCT01621867|CFTR gene|cftr gene
1290787|NCT01621867|Gene expression|gene expression
1290788|NCT01621867|Non-viral|non-viral
1290789|NCT01621867|Multi dose|multi dose
1290790|NCT01621854|cancer|cancer
1290791|NCT01621854|nucleoside analogue|nucleoside analogue
1290792|NCT01621854|advanced solid tumours|advanced solid tumours
1290793|NCT01621828|pre-operative anxiety|pre-operative anxiety
1290794|NCT01621828|multimedia information|multimedia information
1290795|NCT01621828|operating theatre|operating theatre
1290796|NCT01621815|ADHD|adhd
1290797|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1290798|NCT01621815|Conduct|conduct
1290799|NCT01621815|Depression|depression
1290800|NCT01621815|Anxiety|anxiety
1290801|NCT01621815|PDD|pdd
1290802|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
1290803|NCT01621802|Safety|safety
1290804|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
1290805|NCT01621802|Immunogenicity|immunogenicity
1290806|NCT01621789|lutein|lutein
1290807|NCT01621789|zeaxanthin|zeaxanthin
1290808|NCT01621789|trypan blue|trypan blue
1290809|NCT01621789|dye|dye
1290810|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
1290817|NCT01621711|Substance Dependence|substance dependence
1290818|NCT01621711|Substance, addiction|substance, addiction
1290819|NCT01621711|Alcohol Abuse|alcohol abuse
1290820|NCT01621711|prevention and control|prevention and control
1290821|NCT01621711|preventative health services|preventative health services
1290822|NCT01621711|patient centered care|patient centered care
1290823|NCT01621698|VATS|vats
1290824|NCT01621698|Paravertebral blocks.|paravertebral blocks.
1290825|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
1290826|NCT01621698|Analgesia.|analgesia.
1290827|NCT01621685|Capsaicin|capsaicin
1290828|NCT01621685|Cough|cough
1290829|NCT01621685|Cough reflex|cough reflex
1290830|NCT01621685|Inhalation agents|inhalation agents
1290831|NCT01621685|Inhalation challenge|inhalation challenge
1290832|NCT01621685|TRPV1 receptor|trpv1 receptor
1290833|NCT01621672|Revlimid|revlimid
1290834|NCT01621672|progression free|progression free
1290835|NCT01621672|Lenalidomide|lenalidomide
1290836|NCT01621659|multidisciplinary team|multidisciplinary team
1290837|NCT01621659|exercise|exercise
1290838|NCT01621659|nutrition|nutrition
1290839|NCT01621659|cardiology|cardiology
1290840|NCT01621659|physiotherapy|physiotherapy
1290841|NCT01621659|imaging|imaging
1290842|NCT01621646|lutein|lutein
1290843|NCT01621646|eggs|eggs
1290844|NCT01621646|mild cognitive impairment|mild cognitive impairment
1290845|NCT01621646|elderly|elderly
1290846|NCT01621633|hepatic impairment|hepatic impairment
1290852|NCT01621594|Cardiac|cardiac
1290853|NCT01621594|Computed Tomography|computed tomography
1290854|NCT01621594|Radiation Reduction|radiation reduction
1290855|NCT01621594|Iterative Reconstruction|iterative reconstruction
1290856|NCT01621581|Gene Therapy|gene therapy
1290857|NCT01621581|Parkinson's Disease|parkinson's disease
1290858|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
1290859|NCT01621581|Viral Vector|viral vector
1290860|NCT01621568|VEGF|vegf
1290861|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
1290862|NCT01621568|Targeted Agent|targeted agent
1290863|NCT01621555|shoulder surgery|shoulder surgery
1290864|NCT01621555|Pain sensitivity|pain sensitivity
1290865|NCT01621555|Rowe score|rowe score
1290866|NCT01621555|Constant Score|constant score
1290867|NCT01621555|Surgical Outcome|surgical outcome
1290868|NCT01621555|Postoperative pain|postoperative pain
1290869|NCT01621542|Cancer|cancer
1290870|NCT01621542|Vaccine|vaccine
1290871|NCT01621542|Oncology|oncology
1290872|NCT01621542|Malignancies|malignancies
1290873|NCT01621542|Wilms' Tumor|wilms' tumor
1290874|NCT01621542|WT1|wt1
1290875|NCT01621542|Ovarian|ovarian
1290876|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
1290877|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
1290878|NCT01621529|Positron-Emission Tomography|positron-emission tomography
1290879|NCT01621529|PET Scan|pet scan
1290880|NCT01621529|FDG|fdg
1290881|NCT01621529|SUV|suv
1290882|NCT01621529|Invasive Breast cancer|invasive breast cancer
1290883|NCT01621529|Surgery compare|surgery compare
1290884|NCT01621529|Tumor measurement|tumor measurement
1290885|NCT01621516|Beta-cell function|beta-cell function
1290886|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
1290887|NCT01621516|Donor pancreas|donor pancreas
1290888|NCT01621516|Diabetes|diabetes
1290889|NCT01621516|Long-term immunesuppression|long-term immunesuppression
1290890|NCT01621477|Hematologic malignancy|hematologic malignancy
1290891|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
1290892|NCT01621464|Neuromediated syncope|neuromediated syncope
1290893|NCT01621464|Tilt test|tilt test
1290894|NCT01621464|Pacemaker|pacemaker
1290895|NCT01621464|CLS sensor|cls sensor
1290896|NCT01621438|coronary artery|coronary artery
1290897|NCT01621438|atherosclerosis|atherosclerosis
1290898|NCT01621438|angina pectoris|angina pectoris
1290899|NCT01621425|breast cancer|breast cancer
1290900|NCT01621425|prostate carcinoma|prostate carcinoma
1290901|NCT01621425|docetaxel|docetaxel
1290902|NCT01621425|lean body mass|lean body mass
1290903|NCT01621425|Body Surface Area|body surface area
1290904|NCT01621425|body weight|body weight
1290905|NCT01621425|dexascan|dexascan
1290906|NCT01621412|Medication Adherence|medication adherence
1290907|NCT01621412|HIV infection|hiv infection
1290908|NCT01621412|Disclosure|disclosure
1290909|NCT01621373|neonatology|neonatology
1290910|NCT01621373|intratracheal intubation|intratracheal intubation
1290911|NCT01621373|propofol|propofol
1290912|NCT01621360|Randomized controlled trial|randomized controlled trial
1290913|NCT01621360|Intention to treat|intention to treat
1290914|NCT01621347|HIV|hiv
1290915|NCT01621347|Pregnancy|pregnancy
1290916|NCT01621347|Postpartum|postpartum
1290917|NCT01621347|Women|women
1290918|NCT01621347|Medication Adherence|medication adherence
1290919|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
1290920|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
1290921|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
1290922|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
1290923|NCT01621282|journal club|journal club
1290924|NCT01621269|Multiple Sclerosis|multiple sclerosis
1290925|NCT01621269|MS|ms
1290926|NCT01621269|Fingolimod|fingolimod
1290927|NCT01621269|Gilenya|gilenya
1290928|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
1290929|NCT01621269|NAb|nab
1290930|NCT01621243|necuparanib|necuparanib
1290931|NCT01621243|gemcitabine|gemcitabine
1290932|NCT01621243|heparin|heparin
1290933|NCT01621243|low molecular weight heparin|low molecular weight heparin
1290934|NCT01621243|nab-Paclitaxel|nab-paclitaxel
1290935|NCT01621230|Bupivacaine|bupivacaine
1290936|NCT01621230|Fentanyl|fentanyl
1290937|NCT01621230|Epidural|epidural
1290938|NCT01621230|Second Stage of Labor|second stage of labor
1290939|NCT01621230|Randomized Controlled Trial|randomized controlled trial
1290940|NCT01621217|Anal cancer|anal cancer
1290941|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
1290942|NCT01621217|Cetuximab|cetuximab
1290943|NCT01621217|5-fluoruracil|5-fluoruracil
1290944|NCT01621217|Mitomycin C|mitomycin c
1290945|NCT01621217|Radiotherapy|radiotherapy
1290946|NCT01621204|Thrombocytopenia|thrombocytopenia
1290947|NCT01621204|ITP|itp
1290948|NCT01621204|Platelets|platelets
1290949|NCT01621204|Bleeding|bleeding
1290950|NCT01621204|Immune|immune
1290951|NCT01621204|Eltrombopag|eltrombopag
1290952|NCT01621204|IVIG|ivig
1290953|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
1290954|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
1290955|NCT01621165|drug intervention|drug intervention
1290956|NCT01621165|add-on study|add-on study
1290957|NCT01621165|prazosin|prazosin
1291344|NCT01619566|Predictive|predictive
1290958|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
1290959|NCT01621152|Acute renal failure|acute renal failure
1290960|NCT01621152|acute kidney injury|acute kidney injury
1290961|NCT01621152|electronic surveillance|electronic surveillance
1290962|NCT01621152|AKI|aki
1290963|NCT01621152|sniffer|sniffer
1290964|NCT01621152|AKIN|akin
1290965|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
1290966|NCT01621126|Shoulder instability|shoulder instability
1290967|NCT01621126|Latarjet procedure|latarjet procedure
1290968|NCT01621126|Nerve injury|nerve injury
1290969|NCT01621113|Spinal Cord Injuries|spinal cord injuries
1290970|NCT01621113|4-Aminopyridine|4-aminopyridine
1290971|NCT01621113|Physical Therapy Modalities|physical therapy modalities
1290972|NCT01621113|Randomized Controlled Trial|randomized controlled trial
1290973|NCT01621113|Rehabilitation|rehabilitation
1290974|NCT01621113|Walking|walking
1290975|NCT01621100|Cancer pain|cancer pain
1290976|NCT01621100|OROS|oros
1290977|NCT01621100|Osmotic release oral system|osmotic release oral system
1290978|NCT01621100|Hydromorphone|hydromorphone
1391491|NCT01199939|HIV|hiv
1290979|NCT01621100|Painkiller|painkiller
1290980|NCT01621100|Opioid analgesic|opioid analgesic
1290981|NCT01621100|Korean patients|korean patients
1290982|NCT01621061|high altitude illness|high altitude illness
1290983|NCT01621061|pulmonary hypertension|pulmonary hypertension
1290984|NCT01621061|sleep apnea|sleep apnea
1290985|NCT01621061|hypoxia|hypoxia
1290986|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
1290987|NCT01621048|Radiotherapy|radiotherapy
1290988|NCT01621048|Xerostomia|xerostomia
1290989|NCT01621048|Deglutition Disorders|deglutition disorders
1290990|NCT01621022|smoking cessation|smoking cessation
1290991|NCT01621022|tobacco dependence|tobacco dependence
1290992|NCT01621009|smoking cessation medications|smoking cessation medications
1290993|NCT01621009|smoking cessation counseling|smoking cessation counseling
1290994|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
1290995|NCT01620983|arthroplasty|arthroplasty
1290996|NCT01620983|pain|pain
1290997|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
1290998|NCT01620970|Metastatic disease|metastatic disease
1290999|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
1291000|NCT01620970|Angiogenesis|angiogenesis
1291001|NCT01620970|PF03446962|pf03446962
1291002|NCT01620970|Transforming growth factor beta|transforming growth factor beta
1291003|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
1291004|NCT01620970|Monoclonal Antibody|monoclonal antibody
1291005|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
1291006|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
1291007|NCT01620970|Measurable disease|measurable disease
1291008|NCT01620957|Default-mode network|default-mode network
1291009|NCT01620957|Difussion tensor imaging|difussion tensor imaging
1291010|NCT01620957|Cortical thickness|cortical thickness
1291011|NCT01620957|Coma|coma
1291012|NCT01620957|Vegetative state|vegetative state
1291013|NCT01620957|Minimally conscious state|minimally conscious state
1291014|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
1291015|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
1291016|NCT01620892|partial knee replacement|partial knee replacement
1291017|NCT01620866|EMDR|emdr
1291018|NCT01620866|bipolar disorder|bipolar disorder
1291019|NCT01620866|trauma|trauma
1291020|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
1291021|NCT01620866|PTSD|ptsd
1291022|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1291023|NCT01620853|ALK probe|alk probe
1291024|NCT01620853|FISH|fish
1291025|NCT01620853|Chromosomal aberrations|chromosomal aberrations
1291026|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
1291027|NCT01620827|follow up|follow up
1291028|NCT01620827|cell phone|cell phone
1291029|NCT01620827|hospital landline|hospital landline
1291030|NCT01620814|misoprostol|misoprostol
1291031|NCT01620814|dinoprostone|dinoprostone
1291032|NCT01620814|cervical ripening|cervical ripening
1291033|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
1291034|NCT01620801|AAV|aav
1291035|NCT01620801|AAV8|aav8
1291036|NCT01620801|Adeno-associated virus|adeno-associated virus
1291037|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
1291038|NCT01620801|Hemophilia|hemophilia
1291039|NCT01620801|Hemophilia B|hemophilia b
1291040|NCT01620801|Severe hemophilia B|severe hemophilia b
1291041|NCT01620801|Factor IX deficiency|factor ix deficiency
1291042|NCT01620801|Factor IX|factor ix
1291043|NCT01620801|FIX|fix
1291044|NCT01620762|Cat allergy|cat allergy
1291045|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
1291046|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
1291047|NCT01620736|Raltegravir|raltegravir
1291048|NCT01620736|HTLV|htlv
1291049|NCT01620736|Integrase|integrase
1291050|NCT01620723|Breastfeeding|breastfeeding
1291051|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
1291052|NCT01620710|prostatectomy|prostatectomy
1291053|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
1291054|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
1291055|NCT01620632|altered gastric anatomy|altered gastric anatomy
1291056|NCT01620619|Shoulder|shoulder
1291057|NCT01620619|Bankart|bankart
1291058|NCT01620619|Anterior Instability|anterior instability
1291059|NCT01620619|Rotator Cuff|rotator cuff
1291061|NCT01620606|RAP|rap
1291062|NCT01620606|Abdominal Pain|abdominal pain
1291063|NCT01620606|IBS|ibs
1291064|NCT01620593|Prostate Cancer|prostate cancer
1291065|NCT01620593|Metformin|metformin
1291066|NCT01620593|Castration therapy|castration therapy
1291067|NCT01620580|sleep disturbance|sleep disturbance
1291068|NCT01620580|tiredness|tiredness
1291069|NCT01620580|itching & numbness|itching & numbness
1291070|NCT01620567|lutein|lutein
1291071|NCT01620567|avocados|avocados
1291072|NCT01620567|chickpeas|chickpeas
1291073|NCT01620567|potatoes|potatoes
1291074|NCT01620567|elderly|elderly
1291075|NCT01620554|Sleep disorder|sleep disorder
1291076|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
1291077|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
1291078|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
1291079|NCT01620528|Endometriosis associated pain|endometriosis associated pain
1291080|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
1291081|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
1291082|NCT01620528|Elagolix|elagolix
1291083|NCT01620515|Prostate|prostate
1291084|NCT01620515|Prostate Cancer|prostate cancer
1291085|NCT01620515|Localized Prostate Cancer|localized prostate cancer
1291086|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
1291087|NCT01620515|Focal Therapy|focal therapy
1291088|NCT01620515|NX-1207|nx-1207
1291089|NCT01620411|Active Duty|active duty
1291090|NCT01620411|Comprehensive Medical Management|comprehensive medical management
1291091|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
1291092|NCT01620411|Veteran|veteran
1291093|NCT01620411|sustained|sustained
1291094|NCT01620411|military|military
1291095|NCT01620398|cardiovascular diseases|cardiovascular diseases
1291096|NCT01620398|secondary prevention|secondary prevention
1291097|NCT01620398|diet|diet
1291098|NCT01620385|Cochlear implants|cochlear implants
1291099|NCT01620359|Breast cancer|breast cancer
1291100|NCT01620359|Breast tumor|breast tumor
1291101|NCT01620359|stage 1 disease|stage 1 disease
1291102|NCT01620359|T1 M0 N0|t1 m0 n0
1291103|NCT01620346|advanced maternal age|advanced maternal age
1291104|NCT01620346|infertility|infertility
1291105|NCT01620346|IMSI|imsi
1291106|NCT01620346|ICSI|icsi
1291107|NCT01620346|implantation|implantation
1291108|NCT01620320|Left main coronary artery|left main coronary artery
1291109|NCT01620320|Coronary artery disease|coronary artery disease
1291110|NCT01620320|Stress echography|stress echography
1291111|NCT01620320|Intrastent stenosis|intrastent stenosis
1291112|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
1291113|NCT01620294|surgical site infection|surgical site infection
1291905|NCT01617278|Colonoscopy|colonoscopy
1291114|NCT01620294|elective colorectal surgery|elective colorectal surgery
1291115|NCT01620294|level of surgical site infection|level of surgical site infection
1291116|NCT01620294|complication of surgical site infection|complication of surgical site infection
1291117|NCT01620294|type of changed bandage|type of changed bandage
1291118|NCT01620294|frequency of bandage changing|frequency of bandage changing
1291119|NCT01620281|Back Pain|back pain
1291120|NCT01620268|leflunomide|leflunomide
1291121|NCT01620268|orotic acid|orotic acid
1291122|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
1291123|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
1291124|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
1291125|NCT01620268|Renal Allograft Rejection|renal allograft rejection
1291126|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
1291127|NCT01620242|cabazitaxel|cabazitaxel
1291128|NCT01620203|Premature infants|premature infants
1291129|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
1291130|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
1291131|NCT01620203|Cerebral oxygenation|cerebral oxygenation
1291132|NCT01620203|Brain function|brain function
1291133|NCT01620203|Cerebral perfusion|cerebral perfusion
1291134|NCT01620177|Cannabis|cannabis
1291135|NCT01620177|Marijuana|marijuana
1291136|NCT01620177|Marihuana|marihuana
1291138|NCT01620177|Driving|driving
1291139|NCT01620164|three-dimensional vision|three-dimensional vision
1291140|NCT01620164|Parkinson|parkinson
1291141|NCT01620151|Post-operative pain|post-operative pain
1291142|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
1291143|NCT01620151|PTH|pth
1291144|NCT01620151|RLN complication|rln complication
1291145|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
1291146|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
1291147|NCT01620138|Prolactinomas|prolactinomas
1291148|NCT01620138|Cabergoline|cabergoline
1291149|NCT01620138|Pasireotide|pasireotide
1291150|NCT01620138|somatostatin receptors|somatostatin receptors
1291151|NCT01620138|Dopamine receptors|dopamine receptors
1291152|NCT01620125|Lactobacillus|lactobacillus
1291153|NCT01620125|Gut microbiota|gut microbiota
1291154|NCT01620125|Diabetes mellitus|diabetes mellitus
1291155|NCT01620112|brachial plexus|brachial plexus
1291156|NCT01620112|lidocaine|lidocaine
1291157|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
1291158|NCT01620112|orthopedic procedure|orthopedic procedure
1291159|NCT01620099|Asthma|asthma
1291160|NCT01620099|Cigarette smoke|cigarette smoke
1291161|NCT01620099|Small airways|small airways
1291162|NCT01620099|Lung function|lung function
1291163|NCT01620099|Asthma control|asthma control
1291164|NCT01620086|Schizophrenia|schizophrenia
1291165|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
1291166|NCT01620086|Phantom sound perception|phantom sound perception
1291167|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1291168|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
1291169|NCT01620073|Male partner|male partner
1291170|NCT01620073|HIV counseling and testing|hiv counseling and testing
1291171|NCT01620073|Home based|home based
1291172|NCT01620073|Pregnancy|pregnancy
1291173|NCT01620060|Schizophrenia|schizophrenia
1291174|NCT01620060|autism|autism
1291175|NCT01620060|bipolar|bipolar
1291176|NCT01620060|Lurasidone|lurasidone
1291177|NCT01620060|Latuda|latuda
1291178|NCT01620047|Regional Anesthesia|regional anesthesia
1291179|NCT01620047|Post-operative pain management|post-operative pain management
1291180|NCT01620047|Femoral Nerve Block|femoral nerve block
1291181|NCT01620047|Total Knee Replacement|total knee replacement
1291182|NCT01620021|wearable sensors|wearable sensors
1291183|NCT01620021|kinematics|kinematics
1291184|NCT01620021|gait|gait
1291185|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
1291186|NCT01620008|Myelin content|myelin content
1291187|NCT01620008|Ferritin|ferritin
1291188|NCT01619995|urge incontinence|urge incontinence
1291189|NCT01619956|dental implants|dental implants
1291190|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
1291191|NCT01619956|survival rate|survival rate
1291192|NCT01619956|sinus grafting|sinus grafting
1291193|NCT01619956|bone remodeling|bone remodeling
1291195|NCT01619956|radiographic analysis|radiographic analysis
1291196|NCT01619943|Minor head injury|minor head injury
1291197|NCT01619943|CT scan|ct scan
1291198|NCT01619943|Canadian CT Head Rules|canadian ct head rules
1291199|NCT01619943|The New Orleans Criteria|the new orleans criteria
1291200|NCT01619930|Depression|depression
1291201|NCT01619930|Behavioral activation|behavioral activation
1291202|NCT01619917|burn|burn
1291203|NCT01619917|scar|scar
1291204|NCT01619917|laser|laser
1291205|NCT01619917|fractional|fractional
1291206|NCT01619917|vascular|vascular
1291207|NCT01619904|Pancreas Transplantation|pancreas transplantation
1291208|NCT01619904|Goal-directed therapy|goal-directed therapy
1291209|NCT01619904|Outcomes|outcomes
1291210|NCT01619904|Immunometric|immunometric
1291212|NCT01619878|P. falciparum|p. falciparum
1291214|NCT01619878|infant|infant
1291215|NCT01619878|neonate|neonate
1291216|NCT01619865|GA-68|ga-68
1291217|NCT01619865|Gallium 68|gallium 68
1291218|NCT01619865|GA-68 PET|ga-68 pet
1291219|NCT01619852|Surgery|surgery
1291220|NCT01619852|Breast|breast
1291221|NCT01619852|Pain|pain
1291222|NCT01619852|Chronic Pain|chronic pain
1291223|NCT01619852|Lidocaine|lidocaine
1291224|NCT01619852|Anesthesia|anesthesia
1291225|NCT01619852|Gynecologic|gynecologic
1291226|NCT01619852|Urologic|urologic
1291227|NCT01619839|Nektar|nektar
1291228|NCT01619839|NKTR-181|nktr-181
1291229|NCT01619826|physical activity|physical activity
1291230|NCT01619826|fitness|fitness
1291231|NCT01619826|brain health|brain health
1291232|NCT01619826|cognition|cognition
1291233|NCT01619826|scholastic achievement|scholastic achievement
1291234|NCT01619826|preadolescent children|preadolescent children
1291235|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
1291236|NCT01619800|Pacemaker|pacemaker
1291237|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
1291238|NCT01619774|Melanoma|melanoma
1291239|NCT01619774|Metastatic melanoma|metastatic melanoma
1291240|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
1291241|NCT01619774|Advanced melanoma|advanced melanoma
1291242|NCT01619774|GSK2118436|gsk2118436
1291243|NCT01619774|GSK1120212|gsk1120212
1291244|NCT01619761|Leukemia|leukemia
1291245|NCT01619761|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1291246|NCT01619761|CLL|cll
1291247|NCT01619761|Cord blood|cord blood
1291248|NCT01619761|CB|cb
1291249|NCT01619761|Umbilical cord blood|umbilical cord blood
1291250|NCT01619761|UCB|ucb
1291251|NCT01619761|Natural killer cells|natural killer cells
1291252|NCT01619761|NK|nk
1291253|NCT01619761|Graft versus host disease|graft versus host disease
1291254|NCT01619761|GVHD|gvhd
1291255|NCT01619761|Lenalidomide|lenalidomide
1291256|NCT01619761|CC-5013|cc-5013
1291257|NCT01619761|Revlimid|revlimid
1291259|NCT01619761|Fludarabine Phosphate|fludarabine phosphate
1291260|NCT01619761|Fludara|fludara
1291261|NCT01619761|Melphalan|melphalan
1291262|NCT01619761|Alkeran|alkeran
1291263|NCT01619761|Rituximab|rituximab
1291264|NCT01619761|Rituxan|rituxan
1291265|NCT01619735|Kidney Calculi|kidney calculi
1291266|NCT01619735|Kidney Stones|kidney stones
1291267|NCT01619735|Nephrolithiasis|nephrolithiasis
1291268|NCT01619735|Renal Stones|renal stones
1291269|NCT01619722|PKU|pku
1291270|NCT01619722|Osteoporosis|osteoporosis
1291271|NCT01619722|HMP|hmp
1291272|NCT01619722|Life quality|life quality
1291273|NCT01619722|Neuropsychological|neuropsychological
1291274|NCT01619722|Nutritial evaluation|nutritial evaluation
1291275|NCT01619722|Phenylketonuria|phenylketonuria
1291276|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
1291277|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
1291278|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
1291279|NCT01619709|Amyloid imaging|amyloid imaging
1291280|NCT01619709|18F-AV-45|18f-av-45
1291281|NCT01619696|chemotherapy|chemotherapy
1291282|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
1291283|NCT01619696|proctectomy|proctectomy
1291284|NCT01619696|Fmiso TEP|fmiso tep
1291285|NCT01619696|MRI|mri
1291286|NCT01619657|Cystic Fibrosis|cystic fibrosis
1291287|NCT01619657|Hypertonic Saline|hypertonic saline
1291288|NCT01619657|Infant|infant
1291289|NCT01619657|Newborn|newborn
1291290|NCT01619657|Prevention|prevention
1291291|NCT01619644|RTS|rts
1291292|NCT01619644|Rubinstein Taybi|rubinstein taybi
1291293|NCT01619644|explorative phase 2|explorative phase 2
1291294|NCT01619644|clinical approach|clinical approach
1291295|NCT01619644|biological approach|biological approach
1291296|NCT01619644|motor skills|motor skills
1291297|NCT01619631|Depression|depression
1291298|NCT01619631|Tai Chi|tai chi
1291299|NCT01619631|Alternative medicine|alternative medicine
1291300|NCT01619631|Mind body medicine|mind body medicine
1291301|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1291302|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1291303|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1291304|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
1291305|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
1291306|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
1291307|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1291308|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
1291309|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
1291310|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
1291311|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1291312|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1291313|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1291314|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1291315|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
1291316|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
1291317|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
1291318|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1291319|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
1291320|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
1291321|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
1291322|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
1291323|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
1291324|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
1291325|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
1291326|NCT01619605|tryptases|tryptases
1291327|NCT01619605|anaphylaxis|anaphylaxis
1291328|NCT01619605|shrimp allergy|shrimp allergy
1291329|NCT01619592|patients|patients
1291330|NCT01619592|adaptable|adaptable
1291331|NCT01619592|insulin|insulin
1291332|NCT01619592|schemes|schemes
1291333|NCT01619579|Fibromyalgia|fibromyalgia
1291334|NCT01619579|Pain|pain
1291335|NCT01619579|Non-Invasive|non-invasive
1291336|NCT01619579|Arthritis|arthritis
1291337|NCT01619579|Rheumatoid Disease|rheumatoid disease
1291338|NCT01619566|Fibromyalgia|fibromyalgia
1291339|NCT01619566|Duloxetine|duloxetine
1291340|NCT01619566|Cymbalta|cymbalta
1291341|NCT01619566|Pain|pain
1291342|NCT01619566|Peripheral Nerve|peripheral nerve
1291345|NCT01619553|keloid|keloid
1291346|NCT01619553|fibrosis|fibrosis
1291347|NCT01619553|wound healing|wound healing
1291348|NCT01619553|scar|scar
1291349|NCT01619540|COPD|copd
1291350|NCT01619540|Left Ventricular Failure|left ventricular failure
1291351|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
1291352|NCT01619527|Healthy participants|healthy participants
1291353|NCT01619527|Darunavir|darunavir
1291354|NCT01619527|Cobicistat|cobicistat
1291355|NCT01619527|Bioequivalence|bioequivalence
1291356|NCT01619527|Fixed dose combination|fixed dose combination
1291357|NCT01619527|Pharmacokinetics|pharmacokinetics
1291358|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
1291359|NCT01619527|Protease inhibitor|protease inhibitor
1291360|NCT01619488|Lap-Band|lap-band
1291361|NCT01619488|morbid obesity|morbid obesity
1291362|NCT01619488|adolescents|adolescents
1291363|NCT01619475|Living Donor|living donor
1291364|NCT01619475|Liver Transplantation|liver transplantation
1291365|NCT01619475|Quality of Life|quality of life
1291366|NCT01619475|Biosamples|biosamples
1291367|NCT01619475|Liver Recipient|liver recipient
1291368|NCT01619462|pneumococcal|pneumococcal
1291369|NCT01619462|vaccine|vaccine
1291370|NCT01619462|papua new guinea|papua new guinea
1291371|NCT01619449|Acute Kidney Injury|acute kidney injury
1291372|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1291373|NCT01619449|Liver Transplant|liver transplant
1291374|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
1291375|NCT01619423|stage IV|stage iv
1291376|NCT01619423|FOLFOX6|folfox6
1291377|NCT01619423|Chemotherapy|chemotherapy
1291378|NCT01619423|PledOx|pledox
1291379|NCT01619423|Mangafodipir|mangafodipir
1291380|NCT01619423|Febrile neutropenia|febrile neutropenia
1291381|NCT01619423|Oxidative stress|oxidative stress
1291382|NCT01619423|Antioxidant|antioxidant
1291383|NCT01619423|neutropenia|neutropenia
1291384|NCT01619423|neuropathy|neuropathy
1291385|NCT01619397|Condom|condom
1291386|NCT01619397|Medical Device|medical device
1291387|NCT01619384|posttraumatic stress|posttraumatic stress
1291388|NCT01619384|irritable bowel|irritable bowel
1291389|NCT01619371|breast pump|breast pump
1291390|NCT01619371|engorgement|engorgement
1291391|NCT01619371|lactation|lactation
1291392|NCT01619332|Healthy volunteers,|healthy volunteers,
1291393|NCT01619332|Diabetes|diabetes
1291394|NCT01619332|Glucose|glucose
1291395|NCT01619332|Pharmacokinetics|pharmacokinetics
1291396|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
1291397|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
1291398|NCT01619293|CCT|cct
1291399|NCT01619293|brain|brain
1291400|NCT01619293|trauma|trauma
1291401|NCT01619293|injury|injury
1291402|NCT01619280|Acute Lung Injury|acute lung injury
1291403|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1291404|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
1291405|NCT01619280|adult|adult
1291406|NCT01619280|Safety|safety
1291407|NCT01619280|Dose Finding|dose finding
1291408|NCT01619280|Phase 1|phase 1
1291409|NCT01619280|3 + 3 design|3 + 3 design
1291410|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
1291411|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
1291412|NCT01619280|nitric oxide|nitric oxide
1291413|NCT01619280|lung injury|lung injury
1291414|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
1291415|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
1291416|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
1291417|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
1291418|NCT01619254|Anaemia|anaemia
1291419|NCT01619254|School-aged children|school-aged children
1291420|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
1291421|NCT01619241|lung cancer|lung cancer
1291422|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
1291423|NCT01619228|premature infant|premature infant
1291424|NCT01619228|neonate|neonate
1291425|NCT01619228|skin maturation|skin maturation
1291426|NCT01619228|stratum corneum maturation|stratum corneum maturation
1291427|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
1291428|NCT01619228|sunflower oil|sunflower oil
1291429|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
1291430|NCT01619228|skin acidity|skin acidity
1291431|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
1291432|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
1291433|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
1291434|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
1291435|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
1291436|NCT01619202|accident prevention|accident prevention
1291437|NCT01619202|Adolescent|adolescent
1291438|NCT01619202|examination, automobile driver|examination, automobile driver
1291439|NCT01619202|Driving simulator|driving simulator
1291440|NCT01619202|Young drivers|young drivers
1291441|NCT01619202|Driving education|driving education
1291442|NCT01619189|Cell therapy|cell therapy
1291443|NCT01619189|Limbal deficiency|limbal deficiency
1291444|NCT01619189|Limbal stem cell|limbal stem cell
1291445|NCT01619189|Transplantation|transplantation
1291446|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
1291448|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
1291449|NCT01619163|Prednisolone,|prednisolone,
1291450|NCT01619163|pain,|pain,
1291451|NCT01619163|inflammation,|inflammation,
1291452|NCT01619163|mobility|mobility
1291453|NCT01619163|Function|function
1291454|NCT01619150|knee|knee
1291455|NCT01619150|osteoarthritis|osteoarthritis
1291456|NCT01619150|central sensitization|central sensitization
1291457|NCT01619150|mechanical detection|mechanical detection
1291458|NCT01619150|pain threshold|pain threshold
1291459|NCT01619150|quantitative sensory testing|quantitative sensory testing
1291460|NCT01619150|pain biomarkers|pain biomarkers
1291461|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
1291462|NCT01619150|etoricoxib.|etoricoxib.
1291463|NCT01619137|ununion wound|ununion wound
1291464|NCT01619137|soap|soap
1291465|NCT01619137|irrigation|irrigation
1291466|NCT01619137|Povidone-iodine|povidone-iodine
1291467|NCT01619137|normal salin|normal salin
1291468|NCT01619124|osteonecrosis|osteonecrosis
1291469|NCT01619124|children|children
1291470|NCT01619124|pediatric|pediatric
1291471|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
1291472|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
1291473|NCT01619111|metastatic breast cancer|metastatic breast cancer
1291474|NCT01619111|circulating tumor cells|circulating tumor cells
1291475|NCT01619111|lapatinib|lapatinib
1291476|NCT01619098|Hospital readmission|hospital readmission
1291477|NCT01619098|Care transition|care transition
1291478|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
1291479|NCT01619098|Community health worker|community health worker
1291480|NCT01619098|Patient Navigatgor|patient navigatgor
1291481|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
1291482|NCT01619072|treatment|treatment
1291483|NCT01619072|misoprostol|misoprostol
1291484|NCT01619072|home births|home births
1291485|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
1291486|NCT01619033|Renal impairment|renal impairment
1291487|NCT01619020|Healthy|healthy
1291488|NCT01619020|Colon|colon
1291489|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
1291490|NCT01619007|Thromboembolism|thromboembolism
1291491|NCT01619007|Venous Thromboembolism|venous thromboembolism
1291492|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
1291493|NCT01619007|Vascular Diseases|vascular diseases
1291494|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
1291495|NCT01619007|Thrombosis|thrombosis
1291496|NCT01618994|Robotic Simulator|robotic simulator
1291497|NCT01618994|EBL|ebl
1291498|NCT01618994|Robotic Surgeons|robotic surgeons
1291499|NCT01618994|Intuitive Surgical|intuitive surgical
1291500|NCT01618994|simulation modules|simulation modules
1291501|NCT01618994|benchmarks|benchmarks
1291502|NCT01618994|Morristown Protocol|morristown protocol
1291503|NCT01618994|Study Surgeons|study surgeons
1291504|NCT01618994|Control Surgeons|control surgeons
1291505|NCT01618994|Expert Surgeons|expert surgeons
1291506|NCT01618994|dual-console daVinci system|dual-console davinci system
1291507|NCT01618994|blinded skill assessment|blinded skill assessment
1291508|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1291509|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
1291510|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
1291511|NCT01618981|pacemaker|pacemaker
1291512|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
1291513|NCT01618929|Food allergy|food allergy
1291514|NCT01618929|Asthma|asthma
1291515|NCT01618929|Children|children
1291516|NCT01618929|Montelukast|montelukast
1291517|NCT01618929|Inflammation|inflammation
1291518|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
1291519|NCT01618903|Oral tablets|oral tablets
1291520|NCT01618903|Bioequivalence|bioequivalence
1291521|NCT01618903|Pharmacokinetics|pharmacokinetics
1291522|NCT01618903|Safety|safety
1291523|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
1291524|NCT01618890|Prevention|prevention
1291525|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
1291526|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
1291527|NCT01618890|Betablocker therapy|betablocker therapy
1291528|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
1291529|NCT01618877|Multiple dose|multiple dose
1291530|NCT01618877|Safety|safety
1291531|NCT01618877|Pharmacokinetics|pharmacokinetics
1291532|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
1291533|NCT01618851|prostate cancer|prostate cancer
1291534|NCT01618838|prostate cancer|prostate cancer
1291535|NCT01618812|Artificial bone graft|artificial bone graft
1291536|NCT01618812|Hydroxyapatite|hydroxyapatite
1291537|NCT01618812|Children|children
1291538|NCT01618812|Osteotomy|osteotomy
1291539|NCT01618812|Pes plano valgus|pes plano valgus
1291540|NCT01618812|Flatfeet|flatfeet
1291541|NCT01618786|Falls|falls
1291542|NCT01618786|Fall injuries|fall injuries
1291543|NCT01618786|Bone fracture|bone fracture
1291544|NCT01618786|Hip fracture|hip fracture
1291545|NCT01618786|Skull fracture|skull fracture
1291546|NCT01618786|Wounds|wounds
1291547|NCT01618786|Closed head injury|closed head injury
1291548|NCT01618786|Traumatic brain injury|traumatic brain injury
1291549|NCT01618786|Concussion|concussion
1291550|NCT01618786|Spinal cord injury|spinal cord injury
1291551|NCT01618786|Trauma|trauma
1291552|NCT01618786|Older adults|older adults
1291553|NCT01618786|Long-term care|long-term care
1291554|NCT01618786|Compliant flooring|compliant flooring
1291555|NCT01618786|Safety floors|safety floors
1291556|NCT01618786|Balance|balance
1291557|NCT01618786|Injury biomechanics|injury biomechanics
1291558|NCT01618786|Biomedical engineering|biomedical engineering
1291559|NCT01618786|Environmental hazards|environmental hazards
1291560|NCT01618786|Environmental interventions|environmental interventions
1291561|NCT01618786|Fall prevention|fall prevention
1291562|NCT01618786|Gerontology|gerontology
1291563|NCT01618773|acne|acne
1291564|NCT01618773|Epiduo|epiduo
1291565|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
1291566|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
1291567|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
1291568|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
1291569|NCT01618721|Interstitial lung disease;|interstitial lung disease;
1291570|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
1291571|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
1291572|NCT01618695|Partial-onset Seizures|partial-onset seizures
1291573|NCT01618695|partial seizures|partial seizures
1291574|NCT01618695|seizure|seizure
1291575|NCT01618695|epilepsy|epilepsy
1291576|NCT01618682|hand transplant|hand transplant
1291577|NCT01618682|hand replant|hand replant
1291578|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1291579|NCT01618669|regadenoson|regadenoson
1291580|NCT01618669|pharmacologic stress|pharmacologic stress
1291581|NCT01618643|Barrett's|barrett's
1291582|NCT01618643|High grade dysplasia|high grade dysplasia
1291583|NCT01618643|HGD|hgd
1291584|NCT01618643|IMC|imc
1291585|NCT01618643|Intramucosal cancer|intramucosal cancer
1291586|NCT01618643|Acetic acid|acetic acid
1291587|NCT01618643|Chromoendoscopy|chromoendoscopy
1291588|NCT01618630|burn injury|burn injury
1291589|NCT01618630|children|children
1291590|NCT01618630|nutrition|nutrition
1291591|NCT01618630|lipid metabolism|lipid metabolism
1291592|NCT01618630|insulin sensitivity|insulin sensitivity
1291593|NCT01618630|amino acids|amino acids
1291594|NCT01618630|stable isotopes|stable isotopes
1291595|NCT01618617|Constipation|constipation
1291596|NCT01618617|Probiotic|probiotic
1291597|NCT01618617|Randomized Controlled Trial|randomized controlled trial
1291598|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
1291599|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
1291600|NCT01618604|duration|duration
1291601|NCT01618604|correlation|correlation
1291603|NCT01618591|travelers' diarrhea|travelers' diarrhea
1291604|NCT01618591|watery diarrhea|watery diarrhea
1291605|NCT01618591|enteric illness|enteric illness
1291606|NCT01618591|dysentery|dysentery
1291607|NCT01618591|gastrointestinal|gastrointestinal
1291608|NCT01618578|rubber hand illusion|rubber hand illusion
1291609|NCT01618578|CRPS|crps
1291610|NCT01618578|body image|body image
1291611|NCT01618578|body ownership|body ownership
1291612|NCT01618565|shoulder dystocia|shoulder dystocia
1291613|NCT01618565|training|training
1291614|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
1291615|NCT01618552|Chronic disease|chronic disease
1291616|NCT01618552|Cluster randomization|cluster randomization
1291617|NCT01618552|Comorbidity|comorbidity
1291618|NCT01618552|Depression|depression
1291619|NCT01618552|Diabetes|diabetes
1291620|NCT01618552|Medical history taking|medical history taking
1291621|NCT01618552|Office visits|office visits
1291622|NCT01618552|Patient acceptance of health care|patient acceptance of health care
1291623|NCT01618552|Patient compliance|patient compliance
1291624|NCT01618552|Patient simulation|patient simulation
1291625|NCT01618552|Physician patient relations|physician patient relations
1291626|NCT01618552|Primary health care|primary health care
1291627|NCT01618552|Randomized controlled trials|randomized controlled trials
1291628|NCT01618552|Self care|self care
1291629|NCT01618552|Self efficacy|self efficacy
1291630|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
1291631|NCT01618526|Dietary fibers|dietary fibers
1291632|NCT01618526|Butyrate|butyrate
1291633|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
1291634|NCT01618526|Colon|colon
1291635|NCT01618526|Metabolic Syndrome|metabolic syndrome
1291636|NCT01618513|Acromegaly|acromegaly
1291637|NCT01618513|Somatostatin analogs|somatostatin analogs
1291638|NCT01618513|Treatment|treatment
1291639|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1291640|NCT01618500|Neuropsychological Test|neuropsychological test
1291641|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
1291642|NCT01618500|Neuropsychological assessment|neuropsychological assessment
1291643|NCT01618487|tennis elbow|tennis elbow
1291644|NCT01618487|lateral epicondylitis|lateral epicondylitis
1291645|NCT01618474|gastric cancer|gastric cancer
1291646|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
1291647|NCT01618461|Prescription drug information|prescription drug information
1291648|NCT01618461|Medication management|medication management
1291649|NCT01618435|Fusion surgery|fusion surgery
1291650|NCT01618435|Degenerative olisthesis|degenerative olisthesis
1291651|NCT01618435|i-FACTOR|i-factor
1291652|NCT01618435|ODI|odi
1291653|NCT01618435|Spinal stenosis|spinal stenosis
1291654|NCT01618422|DOTS plus|dots plus
1291655|NCT01618422|DOTS|dots
1291656|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
1291657|NCT01618409|PictureRx|picturerx
1291658|NCT01618409|Health Literacy|health literacy
1291659|NCT01618409|Limited English Proficiency|limited english proficiency
1291660|NCT01618409|Latinos|latinos
1291661|NCT01618409|Spanish|spanish
1291662|NCT01618396|Microcirculation|microcirculation
1291663|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
1291664|NCT01618396|Propofol,|propofol,
1291665|NCT01618396|Midazolam|midazolam
1291666|NCT01618383|Parkinson's disease|parkinson's disease
1291667|NCT01618383|gut|gut
1291668|NCT01618383|colon|colon
1291669|NCT01618383|biopsies|biopsies
1291670|NCT01618383|LRRK2|lrrk2
1291671|NCT01618370|Radium 223|radium 223
1291672|NCT01618370|Alpharadin|alpharadin
1291673|NCT01618370|Prostate Cancer|prostate cancer
1291674|NCT01618370|Bone metastases|bone metastases
1291675|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
1291676|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
1291677|NCT01618357|Veliparib|veliparib
1291678|NCT01618357|ABT-888|abt-888
1291679|NCT01618357|Radiation|radiation
1291680|NCT01618357|POPI|popi
1291681|NCT01618344|neoplasms|neoplasms
1291682|NCT01618344|adolescent|adolescent
1291683|NCT01618344|young adult|young adult
1291684|NCT01618344|medication adherence|medication adherence
1291685|NCT01618331|FSHD|fshd
1291686|NCT01618331|Endurance exercise|endurance exercise
1291687|NCT01618331|Protein supplementation|protein supplementation
1291688|NCT01618331|Placebo RCT|placebo rct
1291689|NCT01618318|Asthma|asthma
1291690|NCT01618318|Allergy|allergy
1291691|NCT01618318|Diagnosis|diagnosis
1291692|NCT01618318|Correlation study|correlation study
1291693|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
1291694|NCT01618292|constipation|constipation
1291695|NCT01618292|bowel dysfunction|bowel dysfunction
1291696|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1291697|NCT01618292|CRADI-8|cradi-8
1291698|NCT01618292|CRAIQ-7|craiq-7
1291699|NCT01618292|splinting with defecation|splinting with defecation
1291700|NCT01618292|excessive straining|excessive straining
1291701|NCT01618292|bowel movements|bowel movements
1291702|NCT01618292|fecal incontinence|fecal incontinence
1291703|NCT01618292|bowel symptoms|bowel symptoms
1291704|NCT01618279|tryptase|tryptase
1291705|NCT01618279|coronary|coronary
1291706|NCT01618279|stemi|stemi
1291707|NCT01618279|nstemi|nstemi
1291708|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
1291709|NCT01618253|TACE|tace
1291710|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
1291711|NCT01618253|Sorafenib|sorafenib
1291712|NCT01618253|Nexavar|nexavar
1291713|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
1291714|NCT01618253|Radiation Therapy|radiation therapy
1291715|NCT01618253|Radiotherapy|radiotherapy
1291716|NCT01618253|Radiation|radiation
1291717|NCT01618240|FEES|fees
1291718|NCT01618240|PAS|pas
1291719|NCT01618240|VPSR|vpsr
1291720|NCT01618240|MRC|mrc
1291721|NCT01618201|Inflammation|inflammation
1291722|NCT01618201|Migraine|migraine
1291723|NCT01618201|Headache|headache
1291724|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
1291725|NCT01618175|Home oxygen therapy|home oxygen therapy
1291726|NCT01618175|Home Nursing|home nursing
1291727|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1291728|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
1291729|NCT01618149|osteoarthritis|osteoarthritis
1291730|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
1291731|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1291732|NCT01618136|PARP inhibitors|parp inhibitors
1291733|NCT01618136|Malignant Solid Tumour|malignant solid tumour
1291734|NCT01618136|ovarian cancer|ovarian cancer
1291735|NCT01618136|triple negative breast cancer|triple negative breast cancer
1291736|NCT01618136|advanced melanoma|advanced melanoma
1291737|NCT01618123|Endothelial function|endothelial function
1291738|NCT01618123|Coronary disease|coronary disease
1291739|NCT01618123|Atherosclerosis|atherosclerosis
1291740|NCT01618123|Chest pain|chest pain
1291741|NCT01618110|ADHD|adhd
1291742|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1291743|NCT01618110|TMS|tms
1291744|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1291745|NCT01618097|Osteoarthritis|osteoarthritis
1291746|NCT01618097|Decision Aids|decision aids
1291747|NCT01618097|Health Literacy|health literacy
1291748|NCT01618084|hipreplacement|hipreplacement
1291749|NCT01618084|uncemented|uncemented
1291750|NCT01618084|migration|migration
1291751|NCT01618084|boneremodeling|boneremodeling
1291752|NCT01618071|n-3 PUFA|n-3 pufa
1609842|NCT00358410|Barostat|barostat
1291753|NCT01618071|Endothelial cells|endothelial cells
1291754|NCT01618071|Nitric oxide|nitric oxide
1291755|NCT01618071|Oxidative stress|oxidative stress
1291756|NCT01618071|Blood pressure|blood pressure
1291757|NCT01618071|Vasodilation|vasodilation
1291758|NCT01618071|Lipemia|lipemia
1291759|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
1291760|NCT01618058|HIV Infections|hiv infections
1291761|NCT01618058|Anti-HIV Agents|anti-hiv agents
1291762|NCT01618058|HIV-1|hiv-1
1291763|NCT01618045|Diabetes|diabetes
1291764|NCT01618045|FPP|fpp
1291765|NCT01618045|fermented papaya preparation|fermented papaya preparation
1291766|NCT01618019|n-3 PUFA|n-3 pufa
1291767|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
1291768|NCT01618019|inflammation|inflammation
1291769|NCT01618019|eicosanoids|eicosanoids
1291770|NCT01618019|bone turnover markers|bone turnover markers
1291771|NCT01617993|in vitro fertilization|in vitro fertilization
1291772|NCT01617993|assisted reproduction|assisted reproduction
1291773|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
1291774|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
1291775|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
1291776|NCT01617993|prediction of blastocysts|prediction of blastocysts
1291777|NCT01617993|infertility|infertility
1291778|NCT01617993|Genital Diseases, Male|genital diseases, male
1291779|NCT01617993|Genital Diseases, Female|genital diseases, female
1291780|NCT01617980|Hypoxia imaging|hypoxia imaging
1291781|NCT01617980|FMISO-PET|fmiso-pet
1291782|NCT01617980|functional MRI|functional mri
1291783|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
1291784|NCT01617967|RNAi therapeutic|rnai therapeutic
1291785|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
1291786|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
1291787|NCT01617902|cardiac|cardiac
1291788|NCT01617902|surgery|surgery
1291789|NCT01617902|aorta|aorta
1291790|NCT01617902|prognosis|prognosis
1291791|NCT01617876|Stomach Neoplasms|stomach neoplasms
1291792|NCT01617876|early gastric cancer|early gastric cancer
1291793|NCT01617876|magnifying endoscopy|magnifying endoscopy
1291794|NCT01617876|narrow band imaging|narrow band imaging
1291795|NCT01617876|acetic acid|acetic acid
1291796|NCT01617876|indigocarmine|indigocarmine
1291797|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
1291798|NCT01617837|P6 acupressure|p6 acupressure
1291799|NCT01617837|Craniotomy.|craniotomy.
1291800|NCT01617824|Diabetes|diabetes
1291801|NCT01617824|Kidney|kidney
1291802|NCT01617824|Inflammation|inflammation
1291804|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
1291805|NCT01617746|Asthma|asthma
1291806|NCT01617746|Endothelin|endothelin
1291807|NCT01617746|Airway hyperreactivity|airway hyperreactivity
1291808|NCT01617720|mitral|mitral
1291809|NCT01617720|valve|valve
1291810|NCT01617720|annuloplasty|annuloplasty
1291811|NCT01617720|mitral regurgitation|mitral regurgitation
1291812|NCT01617707|sedation|sedation
1291813|NCT01617707|endoscopy|endoscopy
1291814|NCT01617707|midazolam|midazolam
1291815|NCT01617707|propofol|propofol
1291816|NCT01617707|chronic alcoholics|chronic alcoholics
1291817|NCT01617694|dexmedetomidine|dexmedetomidine
1291818|NCT01617694|remifentanil|remifentanil
1291819|NCT01617694|target-controlled infusion|target-controlled infusion
1291820|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
1291821|NCT01617668|Breast cancer,|breast cancer,
1291822|NCT01617668|LCL161,|lcl161,
1291823|NCT01617668|paclitaxel,|paclitaxel,
1291824|NCT01617668|neoadjuvant,|neoadjuvant,
1291825|NCT01617668|triple negative breast cancer|triple negative breast cancer
1291826|NCT01617642|Porphyria|porphyria
1291827|NCT01617642|Inflammation|inflammation
1291828|NCT01617642|Diet|diet
1291829|NCT01617642|Iron status|iron status
1291830|NCT01617629|Cvac|cvac
1291831|NCT01617603|diabetes type 2|diabetes type 2
1291832|NCT01617603|insulin resistance|insulin resistance
1291833|NCT01617603|glycaemic control|glycaemic control
1291834|NCT01617603|Endothelial function|endothelial function
1291835|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
1291837|NCT01617590|Leflunomide|leflunomide
1291838|NCT01617590|Methotrexate|methotrexate
1291839|NCT01617577|G-CSF|g-csf
1291840|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
1291841|NCT01617577|Filgrastim|filgrastim
1291842|NCT01617564|medical abortion|medical abortion
1291843|NCT01617564|second trimester|second trimester
1291844|NCT01617564|para cervical blockage|para cervical blockage
1291845|NCT01617564|pain management|pain management
1291846|NCT01617551|Essential hypertension|essential hypertension
1291847|NCT01617551|Nitric oxide|nitric oxide
1291848|NCT01617551|Renal denervation|renal denervation
1291849|NCT01617551|Sodium|sodium
1291850|NCT01617551|GFR|gfr
1291851|NCT01617538|atherosclerosis|atherosclerosis
1291852|NCT01617538|stenosis|stenosis
1291853|NCT01617538|statin therapy|statin therapy
1291854|NCT01617538|Signs and Symptoms|signs and symptoms
1392563|NCT01195246|HBV|hbv
1291855|NCT01617538|Circulatory; Change|circulatory; change
1291856|NCT01617499|physical activity|physical activity
1291857|NCT01617499|pedometer|pedometer
1291858|NCT01617499|worksite|worksite
1291859|NCT01617499|wellness|wellness
1291860|NCT01617499|cardiovascular|cardiovascular
1291861|NCT01617499|lifestyle program|lifestyle program
1291862|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
1291863|NCT01617460|aripiprazole|aripiprazole
1291864|NCT01617460|Long-term safety study|long-term safety study
1291865|NCT01617460|children and adolescents|children and adolescents
1291866|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
1291867|NCT01617447|Aripiprazole|aripiprazole
1291868|NCT01617447|Double-blind|double-blind
1291869|NCT01617447|Randomized|randomized
1291870|NCT01617447|children and adolescents|children and adolescents
1291871|NCT01617421|Yoga|yoga
1291872|NCT01617421|Arthritis|arthritis
1291873|NCT01617408|Theta Burst Stimulation|theta burst stimulation
1291874|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1291875|NCT01617408|Visual Cortex|visual cortex
1291876|NCT01617408|Visual Processing|visual processing
1291877|NCT01617395|Multiple Sclerosis|multiple sclerosis
1291878|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1291879|NCT01617382|HIPEC|hipec
1291880|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
1291881|NCT01617356|TMD|tmd
1291882|NCT01617356|temporomandibular|temporomandibular
1291883|NCT01617356|dextrose|dextrose
1291884|NCT01617356|prolotherapy|prolotherapy
1291885|NCT01617330|Particulate matter|particulate matter
1291886|NCT01617330|Air pollution|air pollution
1291887|NCT01617330|Diesel exhaust|diesel exhaust
1291888|NCT01617330|Allergic rhinitis|allergic rhinitis
1291889|NCT01617317|H1N1 2009|h1n1 2009
1291890|NCT01617317|hyperimmune IVIG|hyperimmune ivig
1291891|NCT01617317|mortality|mortality
1291892|NCT01617317|length of stay|length of stay
1291893|NCT01617317|viral load|viral load
1291894|NCT01617317|cytokine|cytokine
1291895|NCT01617304|advanced glycation end products|advanced glycation end products
1291896|NCT01617304|insulin sensitivity|insulin sensitivity
1291897|NCT01617304|obesity|obesity
1291898|NCT01617304|inflammation|inflammation
1291899|NCT01617304|metabolomics|metabolomics
1291900|NCT01617304|appetite|appetite
1291901|NCT01617304|CVD|cvd
1291902|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
1291903|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
1291904|NCT01617291|Cardiac arrest|cardiac arrest
1291907|NCT01617278|High definition white light|high definition white light
1291908|NCT01617278|Adenomas|adenomas
1291909|NCT01617265|intensive care|intensive care
1291910|NCT01617265|mechanical ventilation|mechanical ventilation
1291911|NCT01617265|sedatives|sedatives
1291912|NCT01617265|morphinics|morphinics
1291913|NCT01617265|oversedation|oversedation
1291914|NCT01617265|mortality|mortality
1291915|NCT01617265|midazolam|midazolam
1291916|NCT01617265|propofol|propofol
1291917|NCT01617265|pain|pain
1291918|NCT01617265|agitation|agitation
1291919|NCT01617252|Cardiac surgery|cardiac surgery
1291920|NCT01617252|Acute respiratory failure|acute respiratory failure
1291921|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
1291922|NCT01617239|Influenza|influenza
1291923|NCT01617239|Vaccination|vaccination
1291924|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
1291925|NCT01617213|Multiple Myeloma|multiple myeloma
1291926|NCT01617174|prostate|prostate
1291927|NCT01617174|pain assessment|pain assessment
1291928|NCT01617174|12-110|12-110
1291929|NCT01617161|Low Risk|low risk
1291930|NCT01617161|Intermediate Risk|intermediate risk
1291931|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
1291932|NCT01617148|Aflibercept|aflibercept
1291933|NCT01617135|Parkinson's disease|parkinson's disease
1291934|NCT01617135|Motor fluctuations|motor fluctuations
1291935|NCT01617135|levodopa|levodopa
1291936|NCT01617135|inhaled drugs|inhaled drugs
1291937|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
1291938|NCT01617122|PID|pid
1291939|NCT01617122|PIDD|pidd
1291940|NCT01617122|antibody deficiency|antibody deficiency
1291941|NCT01617122|CVID|cvid
1291942|NCT01617122|recurrent infections|recurrent infections
1291943|NCT01617109|Vitamin D|vitamin d
1291944|NCT01617109|Calcium|calcium
1291945|NCT01617109|Parathyroid hormone|parathyroid hormone
1291946|NCT01617109|Bone|bone
1291947|NCT01617109|Bone formation|bone formation
1291948|NCT01617109|Bone resorption|bone resorption
1291949|NCT01617109|Micronutrients|micronutrients
1291950|NCT01617109|Trace Elements|trace elements
1291951|NCT01617096|HIV Infections|hiv infections
1291952|NCT01617096|Anti-HIV agents|anti-hiv agents
1291953|NCT01617096|HIV-1|hiv-1
1291954|NCT01617083|PANS|pans
1291955|NCT01617083|PANDAS|pandas
1291956|NCT01617083|OCD|ocd
1291957|NCT01617083|Tics|tics
1291958|NCT01617083|Azithromycin|azithromycin
1291959|NCT01617083|Antibiotic Treatment|antibiotic treatment
1291960|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
1291961|NCT01617070|Kuvan|kuvan
1291962|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
1291963|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
1291964|NCT01617070|Serotonin|serotonin
1291965|NCT01617070|Dopamine|dopamine
1291966|NCT01617070|Melatonin|melatonin
1291967|NCT01617057|otosclerosis|otosclerosis
1291968|NCT01617057|inner ear|inner ear
1291969|NCT01617057|tiludronic acid|tiludronic acid
1291970|NCT01617044|Iron|iron
1291971|NCT01617044|Deficiency|deficiency
1291972|NCT01617044|Restless|restless
1291973|NCT01617044|Leg|leg
1291974|NCT01617031|aspirin|aspirin
1291975|NCT01617031|diabetes mellitus|diabetes mellitus
1291976|NCT01617031|coronary artery disease|coronary artery disease
1291977|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
1291978|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
1291979|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
1291980|NCT01616966|hoarseness|hoarseness
1291981|NCT01616966|sore throat|sore throat
1291982|NCT01616966|vocal cord injuries|vocal cord injuries
1291983|NCT01616953|dental implants|dental implants
1291984|NCT01616940|HIV/AIDS|hiv/aids
1291985|NCT01616940|Peer support|peer support
1291986|NCT01616927|ADPKD|adpkd
1291987|NCT01616927|lanreotide|lanreotide
1291988|NCT01616927|polycystic kidney|polycystic kidney
1291989|NCT01616927|polycystic liver|polycystic liver
1291990|NCT01616914|delirium|delirium
1291991|NCT01616914|outcome|outcome
1291992|NCT01616901|Obese|obese
1291993|NCT01616901|Intensive Care|intensive care
1291994|NCT01616901|Respiratory weaning|respiratory weaning
1291995|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
1291996|NCT01616901|Work of breathing|work of breathing
1291997|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
1291998|NCT01616888|in stent restenosis|in stent restenosis
1291999|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
1292000|NCT01616888|angioplasty|angioplasty
1292001|NCT01616875|Bladder cancer|bladder cancer
1292002|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
1292003|NCT01616875|Urothelial cancer|urothelial cancer
1292004|NCT01616875|Cisplatin|cisplatin
1292005|NCT01616875|Cabazitaxel|cabazitaxel
1292006|NCT01616875|Chemotherapy|chemotherapy
1292007|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
1292008|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
1292009|NCT01616862|cystic fibrosis|cystic fibrosis
1292010|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
1292011|NCT01616810|urinary tract|urinary tract
1292012|NCT01616784|Adult|adult
1292013|NCT01616784|Diabetes Mellitus|diabetes mellitus
1292014|NCT01616784|Type 1|type 1
1292015|NCT01616784|Humans|humans
1292016|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
1292017|NCT01616784|Administration and Dosage|administration and dosage
1292018|NCT01616784|Insulin|insulin
1292019|NCT01616784|Self Care|self care
1292020|NCT01616784|Health Education|health education
1292021|NCT01616784|Insulin Infusion Systems|insulin infusion systems
1292022|NCT01616784|Randomised controlled trial|randomised controlled trial
1292023|NCT01616784|Patient Education as Topic|patient education as topic
1292024|NCT01616784|Hemoglobin A|hemoglobin a
1292025|NCT01616784|Glycosylated|glycosylated
1292026|NCT01616771|laryngoscopes|laryngoscopes
1292027|NCT01616745|NTM Lung disease|ntm lung disease
1292028|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
1292029|NCT01616693|rotavirus|rotavirus
1292030|NCT01616693|polio|polio
1292031|NCT01616693|zinc supplement|zinc supplement
1292032|NCT01616693|probiotic supplement|probiotic supplement
1292033|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
1292034|NCT01616667|Controlled Clinical Trial|controlled clinical trial
1292035|NCT01616667|Operative Surgical Procedures|operative surgical procedures
1292036|NCT01616667|Treatment Outcome|treatment outcome
1292037|NCT01616667|Pain Measurement|pain measurement
1292038|NCT01616667|Quality of Life|quality of life
1292039|NCT01616667|Questionnaires/standards|questionnaires/standards
1292040|NCT01616667|Activities of Daily Living|activities of daily living
1292041|NCT01616667|Biomechanics|biomechanics
1292042|NCT01616667|Gait*|gait*
1292043|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
1292044|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
1292045|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
1292046|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
1292047|NCT01616641|bite force|bite force
1292048|NCT01616641|grip strenght|grip strenght
1292049|NCT01616641|oral health|oral health
1292050|NCT01616641|quality of life|quality of life
1292051|NCT01616628|Incentives|incentives
1292052|NCT01616628|Fruit|fruit
1292053|NCT01616628|Vegetables|vegetables
1292054|NCT01616602|patients|patients
1292055|NCT01616602|presenting|presenting
1292056|NCT01616602|elective|elective
1292057|NCT01616602|colonoscopy.|colonoscopy.
1292058|NCT01616589|Fragile X syndrome|fragile x syndrome
1292059|NCT01616589|Fragile X full mutation|fragile x full mutation
1292060|NCT01616589|Fragile X premutation|fragile x premutation
1292061|NCT01616589|Fragile X intermediate|fragile x intermediate
1292062|NCT01616589|CGG repeat length|cgg repeat length
1292063|NCT01616576|cochlear implant|cochlear implant
1292064|NCT01616576|adults|adults
1292065|NCT01616576|HiResolution™|hiresolution™
1292066|NCT01616576|Fidelity 120™|fidelity 120™
1292067|NCT01616576|listening benefits|listening benefits
1292068|NCT01616576|noise|noise
1292069|NCT01616576|cochlear implant benefit|cochlear implant benefit
1292070|NCT01616563|central obesity|central obesity
1292071|NCT01616563|abdominal obesity|abdominal obesity
1292072|NCT01616563|hypertension|hypertension
1292073|NCT01616563|cardiovascular disease|cardiovascular disease
1292074|NCT01616563|high cholesterol|high cholesterol
1292075|NCT01616563|high triglycerides|high triglycerides
1292076|NCT01616563|insulin resistance|insulin resistance
1292077|NCT01616563|diabetes mellitus|diabetes mellitus
1292078|NCT01616550|analgesia|analgesia
1292079|NCT01616550|thoracic surgery|thoracic surgery
1292080|NCT01616537|solid tumors|solid tumors
1292081|NCT01616537|hematological malignancy|hematological malignancy
1292082|NCT01616472|hypertension|hypertension
1292083|NCT01616472|avascular necrosis|avascular necrosis
1292084|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
1292085|NCT01616472|osteoporosis|osteoporosis
1292086|NCT01616472|Steroid|steroid
1292087|NCT01616472|diabetes|diabetes
1292088|NCT01616472|cataracts|cataracts
1292089|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
1292090|NCT01616459|Haemophilus influenzae|haemophilus influenzae
1292091|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
1292092|NCT01616459|Infants|infants
1292093|NCT01616459|Safety|safety
1292094|NCT01616459|Immunogenicity|immunogenicity
1292095|NCT01616446|cyclosporin|cyclosporin
1292096|NCT01616446|nephrotic syndrome|nephrotic syndrome
1292097|NCT01616446|pharmacokinetics|pharmacokinetics
1292098|NCT01616446|children|children
1292099|NCT01616433|Arthritis|arthritis
1292100|NCT01616433|Preventive Behaviors|preventive behaviors
1292101|NCT01616420|prevention|prevention
1292102|NCT01616420|treatment|treatment
1292103|NCT01616420|cost-effectiveness|cost-effectiveness
1292104|NCT01616420|assisted partner notification services|assisted partner notification services
1292105|NCT01616420|Kenya|kenya
1292106|NCT01616420|linkage to HIV care|linkage to hiv care
1292107|NCT01616420|case-finding|case-finding
1292108|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
1292109|NCT01616355|denture, complete;|denture, complete;
1292216|NCT01615809|IFI|ifi
1292110|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
1292111|NCT01616355|disinfection;|disinfection;
1292112|NCT01616355|surface roughness;|surface roughness;
1292113|NCT01616355|color stability.|color stability.
1292114|NCT01616329|alloimmunization|alloimmunization
1292116|NCT01616329|clinicalfactors|clinicalfactors
1292117|NCT01616329|Risk|risk
1292118|NCT01616303|ovarian|ovarian
1292119|NCT01616303|cancer|cancer
1292120|NCT01616303|neoplasm|neoplasm
1292121|NCT01616303|adenocarcinoma|adenocarcinoma
1292122|NCT01616303|CA125|ca125
1292123|NCT01616290|peripheral artery disease|peripheral artery disease
1292124|NCT01616290|PAD|pad
1292125|NCT01616290|claudication|claudication
1292126|NCT01616290|angioplasty|angioplasty
1292127|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1292128|NCT01616290|PTA|pta
1292129|NCT01616290|superficial femoral artery|superficial femoral artery
1292130|NCT01616290|SFA|sfa
1292131|NCT01616290|popliteal artery|popliteal artery
1292132|NCT01616290|PA|pa
1292133|NCT01616290|PRT-201|prt-201
1292134|NCT01616290|restenosis|restenosis
1292135|NCT01616290|vonapanitase|vonapanitase
1292136|NCT01616264|Tuberculosis|tuberculosis
1292137|NCT01616264|Pleural Effusion|pleural effusion
1292138|NCT01616264|Computed Tomography|computed tomography
1292139|NCT01616251|Protein sources|protein sources
1292140|NCT01616251|Appetite|appetite
1292141|NCT01616251|Dietary fibers|dietary fibers
1292142|NCT01616251|Meat|meat
1292143|NCT01616251|Egg|egg
1292144|NCT01616251|Legumes|legumes
1292145|NCT01616225|Infertility|infertility
1292146|NCT01616225|Poor Responder|poor responder
1292147|NCT01616225|In Vitro Fertilization|in vitro fertilization
1292148|NCT01616225|Growth Hormone|growth hormone
1292149|NCT01616212|Teens|teens
1292150|NCT01616212|Parenting|parenting
1292151|NCT01616212|Substance Abuse|substance abuse
1292152|NCT01616212|Treatment Efficacy|treatment efficacy
1292153|NCT01616199|PX-866|px-866
1292154|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
1292155|NCT01616199|Advanced melanoma|advanced melanoma
1292156|NCT01616199|BRAF inhibitor|braf inhibitor
1292157|NCT01616199|Vemurafenib|vemurafenib
1292158|NCT01616199|Zelboraf|zelboraf
1292159|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
1609843|NCT00358410|Stomach|stomach
1292160|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
1292161|NCT01616173|Nerve Block|nerve block
1292162|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
1292163|NCT01616160|Nasal polyps|nasal polyps
1292164|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
1292165|NCT01616134|overweight,|overweight,
1292166|NCT01616134|ginseng|ginseng
1292167|NCT01616108|strabismus|strabismus
1292168|NCT01616108|diplopia|diplopia
1292169|NCT01616095|Growth hormone deficiency|growth hormone deficiency
1292170|NCT01616095|hrGH therapy|hrgh therapy
1292171|NCT01616095|metabolic health|metabolic health
1292172|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
1292173|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
1292174|NCT01616095|adipokines|adipokines
1292175|NCT01616082|fatty acid oxidation|fatty acid oxidation
1292176|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
1292177|NCT01616069|CABG|cabg
1292178|NCT01616069|Echocardiography|echocardiography
1292179|NCT01616069|Heart Failure|heart failure
1292180|NCT01616069|Heart Function|heart function
1292181|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
1292183|NCT01616043|scar quality|scar quality
1292184|NCT01616030|Hip fractures|hip fractures
1292185|NCT01616030|Strength training|strength training
1292186|NCT01616017|Cardiac output|cardiac output
1292187|NCT01616017|ultrasound dilution|ultrasound dilution
1292188|NCT01616017|thermodilution|thermodilution
1292189|NCT01615965|prostate cancer|prostate cancer
1292190|NCT01615965|lymph node|lymph node
1292191|NCT01615965|micrometastasis|micrometastasis
1292192|NCT01615952|Supraclavicular Block|supraclavicular block
1292193|NCT01615939|Sciatic Nerve Block|sciatic nerve block
1292194|NCT01615939|Continuous Nerve Block|continuous nerve block
1292195|NCT01615926|dyspnea|dyspnea
1292196|NCT01615926|shortness of breath|shortness of breath
1292197|NCT01615926|respiratory rate|respiratory rate
1292198|NCT01615926|orthopnea|orthopnea
1292199|NCT01615913|onychomycosis|onychomycosis
1292200|NCT01615913|terbinafine|terbinafine
1292201|NCT01615913|ketoconazole|ketoconazole
1292202|NCT01615913|transdermal topical therapy|transdermal topical therapy
1292203|NCT01615900|Renal graft|renal graft
1292204|NCT01615900|Teleconsultation|teleconsultation
1292205|NCT01615900|Kidney transplant failure score|kidney transplant failure score
1292206|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
1292207|NCT01615848|diet|diet
1292208|NCT01615848|mediterranean diet|mediterranean diet
1292209|NCT01615848|high protein diet|high protein diet
1292210|NCT01615822|Malaria|malaria
1292211|NCT01615822|PK|pk
1292212|NCT01615822|OZ439|oz439
1292213|NCT01615822|Mefloquine|mefloquine
1292214|NCT01615822|Healthy Volunteers|healthy volunteers
1292215|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1292217|NCT01615809|Leukaemia|leukaemia
1292218|NCT01615809|Leukemia|leukemia
1292219|NCT01615809|Pediatric|pediatric
1292220|NCT01615809|Paediatrics|paediatrics
1292221|NCT01615809|Amphotericin B|amphotericin b
1292222|NCT01615809|Aspergillosis|aspergillosis
1292223|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
1292224|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
1292225|NCT01615809|Antifungal agents|antifungal agents
1292226|NCT01615809|Fungal infections|fungal infections
1292227|NCT01615809|Invasive Fungal Infection|invasive fungal infection
1292228|NCT01615796|GSK2140944|gsk2140944
1292229|NCT01615796|antibiotics|antibiotics
1292230|NCT01615796|first time in human|first time in human
1292231|NCT01615796|pharmacokinetics|pharmacokinetics
1292232|NCT01615796|intravenous|intravenous
1292233|NCT01615796|safety|safety
1292234|NCT01615796|absolute bioavailability|absolute bioavailability
1292235|NCT01615796|Bacterial Type II|bacterial type ii
1292236|NCT01615796|tolerability|tolerability
1292237|NCT01615796|infection|infection
1292238|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1292239|NCT01615783|Costs|costs
1292240|NCT01615783|Resource utilization|resource utilization
1292241|NCT01615783|Medicaid|medicaid
1292242|NCT01615757|AML|aml
1292243|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
1292244|NCT01615757|Cytarabine dose|cytarabine dose
1292245|NCT01615757|Ara-c dose|ara-c dose
1292246|NCT01615757|Consolidation|consolidation
1292247|NCT01615744|calcaneal fractures|calcaneal fractures
1292248|NCT01615744|surgical treatment|surgical treatment
1292249|NCT01615744|conservative treatment|conservative treatment
1292250|NCT01615744|VAS scoring|vas scoring
1292251|NCT01615744|SF-36|sf-36
1292252|NCT01615744|AOFAS|aofas
1292253|NCT01615744|Olerud-Molander score|olerud-molander score
1292254|NCT01615744|outcome|outcome
1292255|NCT01615731|Mifepristone|mifepristone
1292256|NCT01615731|Induced Abortion|induced abortion
1292257|NCT01615731|Dilation and Evacuation|dilation and evacuation
1292258|NCT01615731|Cervical preparation|cervical preparation
1292259|NCT01615731|Osmotic dilators|osmotic dilators
1292260|NCT01615718|noninvasive stimulation|noninvasive stimulation
1292261|NCT01615718|motor function|motor function
1292262|NCT01615718|transcranial stimulation|transcranial stimulation
1292263|NCT01615718|transcranial ultrasound|transcranial ultrasound
1292264|NCT01615718|brain stimulation|brain stimulation
1292265|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
1292266|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
1292267|NCT01615705|Biomarkers|biomarkers
1292268|NCT01615705|Markers of Inflammation|markers of inflammation
1292269|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
1292270|NCT01615705|Coagulation Activation|coagulation activation
1292271|NCT01615692|Elastic Stockings|elastic stockings
1292272|NCT01615692|Stockings, Compression|stockings, compression
1292273|NCT01615692|Randomized Controlled Trials|randomized controlled trials
1292274|NCT01615692|Quality of Life|quality of life
1292275|NCT01615679|Non-interventional study|non-interventional study
1292276|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1292277|NCT01615679|ADHD|adhd
1292278|NCT01615666|Alzheimer's disease|alzheimer's disease
1292279|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
1292280|NCT01615666|Frontotemporal dementia|frontotemporal dementia
1292281|NCT01615666|fMRI|fmri
1292282|NCT01615666|functional neuroimaging|functional neuroimaging
1292283|NCT01615666|Memory|memory
1292284|NCT01615653|Pancreatic cancer|pancreatic cancer
1292285|NCT01615653|Pancreas cancer|pancreas cancer
1292286|NCT01615653|Pain|pain
1292287|NCT01615653|Celiac Plexus|celiac plexus
1292288|NCT01615653|Neurolysis|neurolysis
1292289|NCT01615640|Osteosarcoma|osteosarcoma
1292290|NCT01615640|Response of chemotherapy|response of chemotherapy
1292291|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
1292292|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
1292293|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
1292294|NCT01615614|Rilpivirine|rilpivirine
1292295|NCT01615614|Rifabutin|rifabutin
1292296|NCT01615614|Pharmacokinetics|pharmacokinetics
1292297|NCT01615614|Healthy participants|healthy participants
1292298|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
1292300|NCT01615601|HIV-1|hiv-1
1292301|NCT01615601|HIV type 1|hiv type 1
1292302|NCT01615601|Darunavir|darunavir
1292303|NCT01615601|PREZISTA|prezista
1292304|NCT01615601|Etravirine|etravirine
1292305|NCT01615601|INTELENCE|intelence
1292306|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
1292307|NCT01615601|HIV-SDM|hiv-sdm
1292308|NCT01615601|Antiretroviral therapy|antiretroviral therapy
1292309|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
1292310|NCT01615588|manuka honey|manuka honey
1292311|NCT01615588|glycaemic index|glycaemic index
1292312|NCT01615588|blood glucose control|blood glucose control
1292313|NCT01615588|individuals|individuals
1292314|NCT01615588|current disease|current disease
1292315|NCT01615588|medication use|medication use
1292316|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
1292317|NCT01615562|PCOS|pcos
1292318|NCT01615562|Infertility|infertility
1292319|NCT01615549|Cholecystectomy|cholecystectomy
1292320|NCT01615549|Virtual reality device|virtual reality device
1292321|NCT01615549|Training|training
1292322|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
1292323|NCT01615536|canine fossa trephine|canine fossa trephine
1292324|NCT01615536|canine fossa puncture|canine fossa puncture
1292325|NCT01615523|Executive functions|executive functions
1292326|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
1292327|NCT01615497|computer assisted instruction|computer assisted instruction
1292328|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
1292329|NCT01615497|educational resource design and development|educational resource design and development
1292330|NCT01615484|Lung Transplant|lung transplant
1292331|NCT01615484|Emphysema|emphysema
1292332|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1292333|NCT01615484|Cystic Fibrosis|cystic fibrosis
1292334|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
1292335|NCT01615484|Bronchiectasis|bronchiectasis
1292336|NCT01615484|Sarcoidosis|sarcoidosis
1292337|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
1292338|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1292339|NCT01615471|Obesity|obesity
1292340|NCT01615471|Lifestyle Intervention|lifestyle intervention
1292341|NCT01615471|Group treatment|group treatment
1292342|NCT01615471|Internet Intervention|internet intervention
1292343|NCT01615458|Care Management|care management
1292344|NCT01615458|Implementation|implementation
1292345|NCT01615458|Intervention|intervention
1292346|NCT01615458|Mood Disorders|mood disorders
1292347|NCT01615380|smoking cessation|smoking cessation
1292348|NCT01615380|Aerobic Exercise|aerobic exercise
1292349|NCT01615380|Women|women
1292350|NCT01615380|YMCA|ymca
1292351|NCT01615367|Bipolar disorder|bipolar disorder
1292352|NCT01615367|Nutrition|nutrition
1292353|NCT01615367|Exercise|exercise
1292354|NCT01615367|Symptoms|symptoms
1292355|NCT01615367|Functioning|functioning
1292356|NCT01615341|Kidney transplantation|kidney transplantation
1292357|NCT01615341|Subclinical Viral Infection|subclinical viral infection
1292358|NCT01615341|Renal Allograft Injury|renal allograft injury
1292452|NCT01614938|Locally advanced|locally advanced
1292359|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
1292360|NCT01615328|bone graft substitute|bone graft substitute
1292361|NCT01615328|PEEK cage|peek cage
1292362|NCT01615328|hydroxyapatite|hydroxyapatite
1292363|NCT01615328|demineralized bone matrix|demineralized bone matrix
1292364|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
1292365|NCT01615328|Bonion|bonion
1292366|NCT01615328|Cervios ChronOs|cervios chronos
1292367|NCT01615315|aspirin|aspirin
1292368|NCT01615315|screening|screening
1292369|NCT01615315|microscopic hematuria|microscopic hematuria
1292370|NCT01615302|Rectal Fistula|rectal fistula
1292371|NCT01615302|Peri-anal Fistula|peri-anal fistula
1292372|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
1292373|NCT01615302|Mucosa advancement flap|mucosa advancement flap
1292374|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
1292375|NCT01615276|Ageing|ageing
1292376|NCT01615276|Protein ingestion|protein ingestion
1292377|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
1292378|NCT01615263|One lung ventilation|one lung ventilation
1292379|NCT01615263|Bronchial blocker|bronchial blocker
1292380|NCT01615263|Lung collapse|lung collapse
1292381|NCT01615263|Double lumen tube|double lumen tube
1292382|NCT01615224|missed abortion|missed abortion
1292383|NCT01615224|miscarriage|miscarriage
1292384|NCT01615211|Abortion|abortion
1292385|NCT01615211|medical abortion|medical abortion
1292386|NCT01615211|termination of pregnancy|termination of pregnancy
1292387|NCT01615211|Mifepristone|mifepristone
1292388|NCT01615211|misoprostol|misoprostol
1292389|NCT01615211|letrozole|letrozole
1292390|NCT01615211|trilostane|trilostane
1292391|NCT01615211|femara|femara
1292392|NCT01615211|Modrenal|modrenal
1292393|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
1292394|NCT01615185|schizophrenia|schizophrenia
1292395|NCT01615185|amisulpride|amisulpride
1292396|NCT01615185|sulpiride|sulpiride
1292397|NCT01615185|antipsychotic combination|antipsychotic combination
1292398|NCT01615159|Sodium|sodium
1292399|NCT01615159|Diet|diet
1292400|NCT01615159|Urinary sodium excretion|urinary sodium excretion
1292401|NCT01615159|Feeding study|feeding study
1292402|NCT01615159|Diet maintenance|diet maintenance
1292403|NCT01615146|Myelodysplasia|myelodysplasia
1292404|NCT01615146|Leukemia|leukemia
1292405|NCT01615146|Thrombocytopenia|thrombocytopenia
1292406|NCT01615146|Platelet|platelet
1292407|NCT01615146|transfusions|transfusions
1292408|NCT01615146|Outpatient|outpatient
1292409|NCT01615081|Malt extract|malt extract
1292410|NCT01615081|carbohydrate|carbohydrate
1292411|NCT01615081|glucose response|glucose response
1292412|NCT01615081|insulin response|insulin response
1292413|NCT01615081|Appetite|appetite
1292812|NCT01613196|FDG-TEP|fdg-tep
1292414|NCT01615081|Appetite regulating hormones|appetite regulating hormones
1292415|NCT01615055|Chemotherapy|chemotherapy
1292416|NCT01615055|Cognitive|cognitive
1292417|NCT01615055|Prozac|prozac
1292418|NCT01615055|Fluoxetine|fluoxetine
1292419|NCT01615055|FDG|fdg
1292420|NCT01615055|PET|pet
1292421|NCT01615042|Acute Leukemia|acute leukemia
1292422|NCT01615042|Bone Marrow Transplant|bone marrow transplant
1292423|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
1292424|NCT01615029|Multiple Myeloma|multiple myeloma
1292425|NCT01615029|Daratumumab|daratumumab
1292426|NCT01615029|Lenalidomide|lenalidomide
1292427|NCT01615029|Dexamethasone|dexamethasone
1292428|NCT01615029|Dose-escalation|dose-escalation
1292429|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
1292430|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
1292431|NCT01615016|Preterm infant|preterm infant
1292432|NCT01615016|Surfactant application|surfactant application
1292433|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
1292434|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
1292435|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
1292436|NCT01615003|MicroRNA|microrna
1292437|NCT01615003|coronary heart disease|coronary heart disease
1292438|NCT01615003|unstable angina|unstable angina
1292439|NCT01615003|blood stasis syndrome|blood stasis syndrome
1292440|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
1292441|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
1292442|NCT01614977|corticosteroids|corticosteroids
1292443|NCT01614977|children|children
1292444|NCT01614977|lymphadeniti|lymphadeniti
1292445|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
1292446|NCT01614964|Plasmodium falciparum|plasmodium falciparum
1292447|NCT01614964|pharmacokinetics|pharmacokinetics
1292448|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
1292449|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
1292450|NCT01614964|QT (QTc) interval|qt (qtc) interval
1292451|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1292453|NCT01614938|Cetuximab|cetuximab
1292454|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
1292455|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
1292456|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
1292457|NCT01614873|Breathing Pattern|breathing pattern
1292458|NCT01614873|Mechanical Ventilation|mechanical ventilation
1292459|NCT01614873|Pressure support ventilation|pressure support ventilation
1292460|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1292461|NCT01614860|Aldosterone|aldosterone
1292462|NCT01614860|Echocardiography|echocardiography
1292463|NCT01614860|Neurohormones|neurohormones
1292464|NCT01614847|dry eye|dry eye
1292465|NCT01614847|artificial tears|artificial tears
1292466|NCT01614847|tear osmolarity|tear osmolarity
1292467|NCT01614847|residence time|residence time
1292468|NCT01614834|urticaria|urticaria
1292469|NCT01614834|disease control|disease control
1292470|NCT01614834|severity|severity
1292471|NCT01614834|test|test
1292472|NCT01614821|Relapsed|relapsed
1292473|NCT01614821|Refractory|refractory
1292474|NCT01614743|Rosacea|rosacea
1292475|NCT01614730|EMS|ems
1292476|NCT01614730|Modified Device|modified device
1292477|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
1292478|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1292479|NCT01614704|Breast cancer|breast cancer
1292480|NCT01614704|Fertility|fertility
1292481|NCT01614678|myopia|myopia
1292482|NCT01614665|Transplant|transplant
1292483|NCT01614665|Prograf|prograf
1292484|NCT01614665|Heart|heart
1292485|NCT01614665|Advagraf|advagraf
1292486|NCT01614665|Tacrolimus|tacrolimus
1292487|NCT01614665|Immunosuppression|immunosuppression
1292488|NCT01614665|Kidney|kidney
1292489|NCT01614665|Liver|liver
1292490|NCT01614665|Pharmacokinetic|pharmacokinetic
1292491|NCT01614665|Pediatric|pediatric
1292492|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
1292493|NCT01614639|Acupuncture|acupuncture
1292494|NCT01614639|fMRI|fmri
1292495|NCT01614639|CLBP|clbp
1292496|NCT01614639|Pain|pain
1292497|NCT01614639|Low Back Pain|low back pain
1292498|NCT01614639|Back Pain|back pain
1292499|NCT01614626|HIV|hiv
1292500|NCT01614626|Alcohol Use|alcohol use
1292501|NCT01614626|Microbial Translocation|microbial translocation
1292502|NCT01614626|Inflammation|inflammation
1292503|NCT01614626|Altered Coagulation|altered coagulation
1292504|NCT01614626|Russia|russia
1292505|NCT01614600|contact lens|contact lens
1292506|NCT01614600|dry eye syndrome|dry eye syndrome
1292507|NCT01614600|symptomatic|symptomatic
1292508|NCT01614600|daily disposable|daily disposable
1292509|NCT01614600|myopia|myopia
1292510|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
1292813|NCT01613196|cohorts|cohorts
1292511|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
1292512|NCT01614587|genetic predisposition|genetic predisposition
1292513|NCT01614587|SNP microarray analysis|snp microarray analysis
1292514|NCT01614587|pelvic floor|pelvic floor
1292515|NCT01614587|genetic factors|genetic factors
1292516|NCT01614587|adequate prolapse repair|adequate prolapse repair
1292517|NCT01614587|polymorphisms|polymorphisms
1292518|NCT01614587|surgical failure|surgical failure
1292519|NCT01614587|reoperation|reoperation
1292520|NCT01614587|DNA|dna
1292521|NCT01614587|buccal swabs|buccal swabs
1292522|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
1292523|NCT01614587|duplex real-time PCR|duplex real-time pcr
1292524|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
1292525|NCT01614587|next-generation sequencing|next-generation sequencing
1292526|NCT01614561|Hypercholesterolemia|hypercholesterolemia
1292527|NCT01614561|Lipid lowering drugs|lipid lowering drugs
1292528|NCT01614561|Cholesterol level in blood|cholesterol level in blood
1292529|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
1292530|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
1292531|NCT01614548|Prostate Cancer|prostate cancer
1292532|NCT01614548|Disease Management|disease management
1292533|NCT01614548|Rural|rural
1292534|NCT01614548|Urban|urban
1292535|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
1292536|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
1292537|NCT01614522|Gastric cancer|gastric cancer
1292538|NCT01614522|HER-1|her-1
1292539|NCT01614522|HER-2|her-2
1292540|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
1292541|NCT01614509|bevacizumab|bevacizumab
1292542|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
1292543|NCT01614483|Vitamin A deficiency|vitamin a deficiency
1609844|NCT00358397|Solid Tumor|solid tumor
1292544|NCT01614483|Biofortification|biofortification
1292545|NCT01614483|Cassava|cassava
1292546|NCT01614483|B-carotene|b-carotene
1292547|NCT01614483|School children|school children
1292548|NCT01614483|Kenya|kenya
1292549|NCT01614431|renal function|renal function
1292755|NCT01613521|11-174|11-174
1292550|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
1292551|NCT01614431|Cystinosis patients|cystinosis patients
1292553|NCT01614392|Resistance Exercise|resistance exercise
1292554|NCT01614392|Physical Activity|physical activity
1292555|NCT01614392|Mobility disability|mobility disability
1292556|NCT01614392|Physical function|physical function
1292557|NCT01614392|Muscle Strength|muscle strength
1292558|NCT01614392|Older Adults|older adults
1292559|NCT01614392|Mobility-Limited|mobility-limited
1292560|NCT01614392|Peak power and strength|peak power and strength
1292561|NCT01614366|amlodipine|amlodipine
1292562|NCT01614366|DMTA07|dmta07
1292563|NCT01614366|hypertension|hypertension
1292564|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
1292565|NCT01614353|Older Adults|older adults
1292566|NCT01614353|New Prescription|new prescription
1292567|NCT01614340|Home care|home care
1292568|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
1292569|NCT01614340|Physical Therapy|physical therapy
1292570|NCT01614340|Pain|pain
1292571|NCT01614340|Older Adults|older adults
1292572|NCT01614327|Diabetes Type One|diabetes type one
1292573|NCT01614327|Diabetes Type Two|diabetes type two
1292574|NCT01614327|PreDiabetes|prediabetes
1292575|NCT01614327|Retinal Screening|retinal screening
1292576|NCT01614327|RiskAnalyzer|riskanalyzer
1292577|NCT01614327|Retinal Imaging|retinal imaging
1292578|NCT01614327|Algorithm|algorithm
1292579|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
1292580|NCT01614327|Microaneurysms|microaneurysms
1292581|NCT01614327|Neovascularization|neovascularization
1292582|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
1292583|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
1292584|NCT01614301|advanced Melanoma|advanced melanoma
1292585|NCT01614288|HTO|hto
1292586|NCT01614288|Arthroscopy|arthroscopy
1292587|NCT01614288|Quality-of-Life|quality-of-life
1292588|NCT01614288|Gait Analysis|gait analysis
1292589|NCT01614275|Autism|autism
1292590|NCT01614275|Early Intervention|early intervention
1292591|NCT01614275|Parent Training|parent training
1292592|NCT01614275|EIBI|eibi
1292593|NCT01614275|Applied Behavior Analysis|applied behavior analysis
1292594|NCT01614249|Omega-3|omega-3
1292595|NCT01614249|EPA|epa
1292596|NCT01614249|Depression|depression
1292597|NCT01614249|HIV infected|hiv infected
1292598|NCT01614249|Pregnant women|pregnant women
1292599|NCT01614236|pregabalin|pregabalin
1292600|NCT01614236|analgesia|analgesia
1292601|NCT01614236|postoperative pain|postoperative pain
1292602|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
1292603|NCT01614223|Plantar fasciitis|plantar fasciitis
1292604|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
1292605|NCT01614197|Relapse|relapse
1292606|NCT01614197|Lymphoblastic|lymphoblastic
1292607|NCT01614197|Leukemia|leukemia
1292608|NCT01614197|Refractory|refractory
1292609|NCT01614197|Temsirolimus|temsirolimus
1292610|NCT01614197|Acute|acute
1292611|NCT01614197|Childhood|childhood
1292612|NCT01614197|Pediatric|pediatric
1292614|NCT01614197|NHL|nhl
1292615|NCT01614197|LL|ll
1292616|NCT01614197|PTL|ptl
1292617|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
1292618|NCT01614171|OPPG|oppg
1292619|NCT01614171|growth hormone|growth hormone
1292620|NCT01614171|osteoporosis|osteoporosis
1292621|NCT01614158|N-AION|n-aion
1292622|NCT01614158|perimetry|perimetry
1292623|NCT01614158|visual field loss|visual field loss
1292624|NCT01614158|Mean Defect|mean defect
1292625|NCT01614158|Total Loss Volume|total loss volume
1292626|NCT01614158|D-BCVA|d-bcva
1292627|NCT01614158|RAPD|rapd
1292628|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
1292629|NCT01614158|optic nerve head|optic nerve head
1292630|NCT01614132|medulloblastoma|medulloblastoma
1292631|NCT01614132|CNS|cns
1292632|NCT01614132|malignant neoplasm|malignant neoplasm
1292633|NCT01614132|NOA|noa
1292634|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
1292635|NCT01614132|Vincristin|vincristin
1292636|NCT01614132|CCNU|ccnu
1292637|NCT01614132|Cisplatin|cisplatin
1292638|NCT01614119|Cerebral|cerebral
1292639|NCT01614119|Oxygenation|oxygenation
1292640|NCT01614119|Performance|performance
1292641|NCT01614119|Exercise|exercise
1292642|NCT01614106|HIV/AIDS|hiv/aids
1292643|NCT01614106|Drug Users|drug users
1292644|NCT01614106|Crack-Cocaine Use|crack-cocaine use
1292645|NCT01614106|HIV Primary Care|hiv primary care
1292646|NCT01614093|Schizophrenia|schizophrenia
1292647|NCT01614093|Appetite|appetite
1292648|NCT01614093|Oxytocin|oxytocin
1292649|NCT01614080|Stroke|stroke
1292650|NCT01614080|Ischemic stroke|ischemic stroke
1292651|NCT01614080|thrombolysis|thrombolysis
1292652|NCT01614080|toxicity of t-PA|toxicity of t-pa
1292653|NCT01614067|DOR|dor
1292654|NCT01614067|Infertility|infertility
1292655|NCT01614067|IVF|ivf
1292656|NCT01614067|ART|art
1292657|NCT01614067|GnRHa|gnrha
1292658|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
1292659|NCT01614067|Ganirelix|ganirelix
1292660|NCT01614054|Smoking cessation|smoking cessation
1292661|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
1292662|NCT01614054|NRT|nrt
1292663|NCT01614054|Inpatient|inpatient
1292664|NCT01614054|General Medicine|general medicine
1292665|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
1292666|NCT01614015|Recording|recording
1292667|NCT01614015|Supervision|supervision
1292668|NCT01614015|Observation|observation
1292669|NCT01614002|carcinoma|carcinoma
1292670|NCT01614002|breast cancer|breast cancer
1292671|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
1292672|NCT01614002|prostata cancer|prostata cancer
1292673|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1292674|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
1292675|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
1292676|NCT01614002|treatment cycles|treatment cycles
1292677|NCT01614002|Docetaxel|docetaxel
1292678|NCT01614002|Doce onkovis|doce onkovis
1292679|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
1292680|NCT01614002|Packaging Sizes|packaging sizes
1292681|NCT01613989|Hip arthroplasty|hip arthroplasty
1292682|NCT01613989|navigation|navigation
1292683|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
1292684|NCT01613976|MDS|mds
1292685|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1292686|NCT01613976|CMML|cmml
1292687|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
1292688|NCT01613976|AML|aml
1292689|NCT01613976|Panobinostat|panobinostat
1292690|NCT01613976|LBH589|lbh589
1292691|NCT01613976|5-Aza|5-aza
1292692|NCT01613976|Azacitidine|azacitidine
1292693|NCT01613963|Uveitis|uveitis
1292694|NCT01613963|Scleritis|scleritis
1292695|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
1292696|NCT01613937|Latinas|latinas
1292697|NCT01613937|Gestational Diabetes|gestational diabetes
1292698|NCT01613937|Prevention|prevention
1292699|NCT01613911|Epilepsy|epilepsy
1292700|NCT01613911|Invasive monitoring|invasive monitoring
1292701|NCT01613911|Human sensory perception|human sensory perception
1292702|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
1292703|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
1292704|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
1292705|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
1292706|NCT01613833|Osteoarthritis|osteoarthritis
1292707|NCT01613833|plasma and synovium|plasma and synovium
1292708|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
1292709|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
1292710|NCT01613794|Deep vein thrombosis|deep vein thrombosis
1292711|NCT01613794|Pulmonary embolism|pulmonary embolism
1292712|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
1292713|NCT01613794|Pharmacologic actions|pharmacologic actions
1292714|NCT01613781|hemifacial spasm|hemifacial spasm
1292715|NCT01613781|microvascular decompression|microvascular decompression
1292716|NCT01613781|neuromuscular blockade|neuromuscular blockade
1292717|NCT01613781|electromyography|electromyography
1292718|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
1292719|NCT01613729|Dyslipidemia|dyslipidemia
1292720|NCT01613729|Rosuvastatin|rosuvastatin
1292721|NCT01613729|Efficacy|efficacy
1292722|NCT01613729|Safety|safety
1292723|NCT01613716|Diabetes|diabetes
1292724|NCT01613716|Macular Edema|macular edema
1292725|NCT01613716|Epiretinal Membrane|epiretinal membrane
1292726|NCT01613716|Vitrectomy|vitrectomy
1292727|NCT01613703|ONO-2952|ono-2952
1292728|NCT01613703|Healthy adult subjects|healthy adult subjects
1292729|NCT01613703|single doe|single doe
1292730|NCT01613703|PET study|pet study
1292731|NCT01613703|Safety|safety
1292732|NCT01613703|Tolerability|tolerability
1292733|NCT01613690|Renal impairment|renal impairment
1292734|NCT01613690|NVA237|nva237
1292735|NCT01613690|Pharmacokinetics|pharmacokinetics
1292736|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
1292737|NCT01613664|obesity|obesity
1292738|NCT01613664|surgical management|surgical management
1292739|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
1292740|NCT01613638|congenital malformation|congenital malformation
1292741|NCT01613638|pollutants|pollutants
1292742|NCT01613586|Interstitial Cystitis|interstitial cystitis
1292743|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
1292744|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
1292746|NCT01613573|pegylated Somatropin|pegylated somatropin
1292747|NCT01613573|PEG-GH|peg-gh
1292748|NCT01613573|Phase 1 study|phase 1 study
1292749|NCT01613573|Pharmacokinetics|pharmacokinetics
1292750|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
1292751|NCT01613534|argon plasma coagulation|argon plasma coagulation
1292752|NCT01613534|sucralfate|sucralfate
1292753|NCT01613521|DCE-MRI|dce-mri
1292754|NCT01613521|18F-FMISO PET|18f-fmiso pet
1292756|NCT01613495|obesity|obesity
1292757|NCT01613469|fluorouracil|fluorouracil
1292758|NCT01613469|leucovorin|leucovorin
1292759|NCT01613469|radiotherapy|radiotherapy
1292760|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
1292761|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
1292762|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
1292763|NCT01613404|Chronic kidney disease|chronic kidney disease
1292764|NCT01613404|Hemodialysis|hemodialysis
1292765|NCT01613404|Eprex|eprex
1292766|NCT01613404|Aranesp|aranesp
1292767|NCT01613404|ESA|esa
1292768|NCT01613404|Anemia|anemia
1292769|NCT01613391|Visfatin|visfatin
1292770|NCT01613391|Resistin|resistin
1292771|NCT01613391|Apelin|apelin
1292772|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
1292773|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
1292774|NCT01613391|morbid obesity|morbid obesity
1292775|NCT01613352|Early breast cancer surgery|early breast cancer surgery
1292776|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
1292777|NCT01613352|Ambulatory surgery|ambulatory surgery
1292778|NCT01613339|stroke|stroke
1292779|NCT01613339|postural control|postural control
1292780|NCT01613339|body awareness therapy|body awareness therapy
1292781|NCT01613326|COPD|copd
1292782|NCT01613313|Lipoma|lipoma
1292783|NCT01613313|Fatty Tumor|fatty tumor
1292784|NCT01613300|hodgkin|hodgkin
1292785|NCT01613300|disease|disease
1292786|NCT01613300|ofatumumab|ofatumumab
1292787|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
1292788|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1292789|NCT01613287|TheraSorb|therasorb
1292790|NCT01613287|immunoadsorption|immunoadsorption
1292791|NCT01613274|colon resection|colon resection
1292792|NCT01613261|TAK-733,|tak-733,
1292793|NCT01613261|alisertib,|alisertib,
1292794|NCT01613261|MLN8237,|mln8237,
1292795|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
1292796|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
1292797|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
1292798|NCT01613235|ischemia|ischemia
1292799|NCT01613235|vasospasm|vasospasm
1292800|NCT01613235|CT|ct
1292801|NCT01613235|perfusion|perfusion
1292802|NCT01613235|induced hypertension|induced hypertension
1292803|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
1292804|NCT01613209|Hypertension|hypertension
1292805|NCT01613209|ABPM|abpm
1292806|NCT01613209|office blood pressure|office blood pressure
1292807|NCT01613209|olmesartan|olmesartan
1292808|NCT01613209|amlodipine|amlodipine
1292809|NCT01613209|fixed combination|fixed combination
1292810|NCT01613209|time of intake|time of intake
1292811|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
1292814|NCT01613170|Overactive Bladder|overactive bladder
1292815|NCT01613170|Vaginal Estrogen|vaginal estrogen
1292816|NCT01613170|Anticholinergics|anticholinergics
1292817|NCT01613170|Antimuscarinics|antimuscarinics
1292818|NCT01613157|pharmacokinetics|pharmacokinetics
1292819|NCT01613157|HIV infected women|hiv infected women
1292820|NCT01613118|Primary FSGS|primary fsgs
1292821|NCT01613118|Nephrotic syndrome|nephrotic syndrome
1292822|NCT01613118|Steroid Resistant|steroid resistant
1292823|NCT01613105|Diabetes Mellitus|diabetes mellitus
1292824|NCT01613105|Type-2|type-2
1292825|NCT01613105|Acarbose|acarbose
1292826|NCT01613105|Drug Therapy|drug therapy
1292827|NCT01613105|Combination|combination
1292828|NCT01613092|Arrhythmia|arrhythmia
1292829|NCT01613092|Device Procedure|device procedure
1292830|NCT01613092|High risk patients|high risk patients
1292831|NCT01613092|Antibiotics|antibiotics
1292832|NCT01613092|Infection|infection
1292833|NCT01613092|Cluster|cluster
1292834|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
1292835|NCT01613079|Methotrexate|methotrexate
1292836|NCT01613079|Tripterygium|tripterygium
1292837|NCT01613066|Haematological malignancies|haematological malignancies
1292838|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
1292839|NCT01613066|Intrabone|intrabone
1292840|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
1292841|NCT01613014|Alcohol|alcohol
1292842|NCT01613014|Alcohol Dependence|alcohol dependence
1292843|NCT01613014|Alcohol Abuse|alcohol abuse
1292844|NCT01613014|Alcohol Use Disorders|alcohol use disorders
1292845|NCT01613014|Alcoholism|alcoholism
1292846|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1292847|NCT01612988|relapse|relapse
1292848|NCT01612988|Bendamustine|bendamustine
1292849|NCT01612988|Ofatumumab|ofatumumab
1292850|NCT01612988|Méthylprednisolone|méthylprednisolone
1292851|NCT01612975|Chest tubes|chest tubes
1292852|NCT01612975|Length of stay|length of stay
1292853|NCT01612975|Pleural effusion|pleural effusion
1292854|NCT01612975|Lung resection|lung resection
1292855|NCT01612975|Post-operative|post-operative
1292856|NCT01612975|Lung cancer|lung cancer
1292857|NCT01612949|endotracheal intubation|endotracheal intubation
1292858|NCT01612949|facial structure|facial structure
1292859|NCT01612949|Mallampati score|mallampati score
1292860|NCT01612949|computerized facial analysis|computerized facial analysis
1292861|NCT01612936|Asthma|asthma
1292862|NCT01612936|Allergic|allergic
1292863|NCT01612936|Inflammation|inflammation
1292864|NCT01612936|Constriction|constriction
1292865|NCT01612936|Airway|airway
1292866|NCT01612936|Challenge|challenge
1292867|NCT01612936|Chemokines|chemokines
1292868|NCT01612923|abortion|abortion
1292869|NCT01612923|medical abortion|medical abortion
1292870|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1292871|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
1292872|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1292873|NCT01612910|recurrent breast cancer|recurrent breast cancer
1292874|NCT01612910|stage II breast cancer|stage ii breast cancer
1292875|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
1292876|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
1292877|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
1292878|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
1292879|NCT01612897|autism|autism
1292880|NCT01612897|well child care|well child care
1292881|NCT01612897|screening|screening
1292882|NCT01612897|computer|computer
1292883|NCT01612897|reminders|reminders
1292884|NCT01612871|Breast cancer,|breast cancer,
1292885|NCT01612871|hormonotherapy,|hormonotherapy,
1292886|NCT01612871|miRNAs,|mirnas,
1292887|NCT01612871|biomarkers|biomarkers
1292888|NCT01612871|hormone therapy|hormone therapy
1292889|NCT01612858|Lipodystrophy|lipodystrophy
1292890|NCT01612858|Insulin resistance|insulin resistance
1292891|NCT01612858|HIV infection|hiv infection
1292892|NCT01612845|rotator cuff|rotator cuff
1292893|NCT01612845|shoulder|shoulder
1292894|NCT01612845|platelet rich plasma|platelet rich plasma
1292895|NCT01612845|fibrin|fibrin
1292896|NCT01612793|COPD|copd
1292897|NCT01612780|Sinusitis|sinusitis
1292898|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
1292899|NCT01612767|de novo coronary lesions|de novo coronary lesions
1292900|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
1292901|NCT01612767|coronary arteries|coronary arteries
1292902|NCT01612754|Reduction of noise pollution|reduction of noise pollution
1292903|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
1292904|NCT01612754|Stress|stress
1292905|NCT01612754|Sound Ears (TM)|sound ears (tm)
1292906|NCT01612754|Error|error
1292907|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
1292908|NCT01612741|Acarbose|acarbose
1292909|NCT01612741|Drug Therapy|drug therapy
1292910|NCT01612741|Combination|combination
1292911|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
1292912|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
1293114|NCT01611727|cisplatin|cisplatin
1292913|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
1292914|NCT01612702|postoperative pain|postoperative pain
1292915|NCT01612689|Accelerometer|accelerometer
1292916|NCT01612689|EMU|emu
1292917|NCT01612689|Ambulatory|ambulatory
1292918|NCT01612689|ECG|ecg
1292919|NCT01612689|Heart rate|heart rate
1292920|NCT01612663|Knee pain|knee pain
1292921|NCT01612663|Acupuncture|acupuncture
1292922|NCT01612663|Sham acupuncture|sham acupuncture
1292923|NCT01612650|breast cancer|breast cancer
1292924|NCT01612650|surveillance|surveillance
1292925|NCT01612650|diagnosis|diagnosis
1292926|NCT01612650|2D mammography|2d mammography
1292927|NCT01612650|3D mammography|3d mammography
1292928|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
1292929|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
1292930|NCT01612637|Prolapse symptoms|prolapse symptoms
1292931|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
1292932|NCT01612637|Ultrasonography|ultrasonography
1292933|NCT01612637|Predictors|predictors
1292934|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
1292935|NCT01612520|telenursing|telenursing
1292936|NCT01612520|RCT|rct
1292937|NCT01612520|economic analysis|economic analysis
1292938|NCT01612507|Phase 1|phase 1
1292939|NCT01612507|healthy volunteers|healthy volunteers
1292940|NCT01612507|Parallel Group Study|parallel group study
1292941|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
1292942|NCT01612507|safety|safety
1292943|NCT01612507|Cmax|cmax
1292944|NCT01612507|tmax|tmax
1292945|NCT01612507|AUC|auc
1292946|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
1292947|NCT01612481|lung metastasis|lung metastasis
1292948|NCT01612481|surveillance|surveillance
1292949|NCT01612468|Diabetes|diabetes
1292950|NCT01612468|Liraglutide|liraglutide
1292951|NCT01612468|Hypoglycaemia|hypoglycaemia
1292952|NCT01612468|Hyperglycaemia|hyperglycaemia
1292953|NCT01612468|CIMT|cimt
1292954|NCT01612468|PWV|pwv
1292955|NCT01612468|Food preference|food preference
1292956|NCT01612468|Blood pressure|blood pressure
1292957|NCT01612455|HIV|hiv
1292958|NCT01612455|drug addiction|drug addiction
1292959|NCT01612455|Russia|russia
1292960|NCT01612455|case management|case management
1293058|NCT01611961|Neoplasms|neoplasms
1292961|NCT01612442|complementary feeding|complementary feeding
1292962|NCT01612442|mothers|mothers
1292963|NCT01612442|6-24 months children|6-24 months children
1292964|NCT01612442|community health volunteers|community health volunteers
1292965|NCT01612442|nutrition education|nutrition education
1292966|NCT01612442|agricultural education|agricultural education
1292967|NCT01612429|Carbamylation|carbamylation
1292968|NCT01612429|Albumin|albumin
1292969|NCT01612429|Protein structure|protein structure
1292970|NCT01612429|Kidney disease|kidney disease
1292971|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
1292972|NCT01612403|zinc binding protein|zinc binding protein
1292973|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
1292974|NCT01612377|Moderate to Severe|moderate to severe
1292975|NCT01612364|CRPS I|crps i
1292976|NCT01612351|Head and neck cancer|head and neck cancer
1292977|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
1292978|NCT01612351|Phase II|phase ii
1292979|NCT01612351|Transoral Surgery|transoral surgery
1292980|NCT01612351|Induction Chemotherapy|induction chemotherapy
1292981|NCT01612351|Carboplatin|carboplatin
1292982|NCT01612351|Paclitaxel|paclitaxel
1292983|NCT01612351|Lapatinib|lapatinib
1292984|NCT01612338|breast cancer|breast cancer
1292985|NCT01612338|young age of onset|young age of onset
1292986|NCT01612338|family history|family history
1292987|NCT01612338|screening interventions|screening interventions
1292988|NCT01612338|family support|family support
1292989|NCT01612325|liver tumors|liver tumors
1292990|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
1292991|NCT01612312|thrombectomy|thrombectomy
1292992|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
1292993|NCT01612312|microvascular obstruction|microvascular obstruction
1292994|NCT01612286|Recombinant human endostatin|recombinant human endostatin
1292995|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1292996|NCT01612286|chemotherapy|chemotherapy
1292997|NCT01612273|Vasospastic syndrome|vasospastic syndrome
1292998|NCT01612273|Vascular dysregulation|vascular dysregulation
1292999|NCT01612260|heart failure|heart failure
1293000|NCT01612260|ventricular premature complex|ventricular premature complex
1293001|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
1293002|NCT01612247|Breast Cancer|breast cancer
1293003|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
1293004|NCT01612234|humans|humans
1293005|NCT01612234|lean|lean
1293006|NCT01612234|obese|obese
1293007|NCT01612234|saturated fat|saturated fat
1293008|NCT01612234|monounsaturated fat|monounsaturated fat
1293009|NCT01612234|insulin sensitivity|insulin sensitivity
1293010|NCT01612234|inflammation|inflammation
1293011|NCT01612234|oxidant stress|oxidant stress
1293012|NCT01612195|anal fistula|anal fistula
1293013|NCT01612195|anal continence|anal continence
1293113|NCT01611727|metastatic disease|metastatic disease
1293014|NCT01612195|health-related quality of life|health-related quality of life
1293015|NCT01612182|end-stage renal disease|end-stage renal disease
1293016|NCT01612182|renal replacement therapy|renal replacement therapy
1293017|NCT01612169|HIV patients|hiv patients
1293018|NCT01612169|Hospitalized patients|hospitalized patients
1293019|NCT01612169|Substance Users|substance users
1293020|NCT01612169|Drug Users|drug users
1293021|NCT01612156|Urodynamic testing|urodynamic testing
1293022|NCT01612156|pelvic floor examination|pelvic floor examination
1293023|NCT01612156|Lidocaine gel|lidocaine gel
1293024|NCT01612156|Surgical lubricant|surgical lubricant
1293025|NCT01612156|Pain|pain
1293026|NCT01612156|Embarrassment|embarrassment
1293027|NCT01612117|renal failure|renal failure
1293028|NCT01612117|cardiology|cardiology
1293029|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
1293030|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
1293031|NCT01612104|Anxiety symptoms|anxiety symptoms
1293032|NCT01612104|Depressive symptoms|depressive symptoms
1293033|NCT01612104|Externalizing behavior|externalizing behavior
1293034|NCT01612104|Reduced quality of life|reduced quality of life
1293035|NCT01612091|Expert System|expert system
1293036|NCT01612091|Intensive Care|intensive care
1293037|NCT01612091|Telemedicine|telemedicine
1293038|NCT01612091|Equipment Design|equipment design
1293039|NCT01612065|Office hysteroscopy|office hysteroscopy
1293040|NCT01612065|Cervical priming|cervical priming
1293041|NCT01612065|Misoprostol|misoprostol
1293042|NCT01612052|Vascular Surgery|vascular surgery
1293043|NCT01612039|ulcerative colitis|ulcerative colitis
1293044|NCT01612013|N-acetylcysteine|n-acetylcysteine
1293045|NCT01612013|angiography|angiography
1293046|NCT01612013|contrast medium|contrast medium
1293047|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
1293048|NCT01612013|sodium bicarbonate|sodium bicarbonate
1293049|NCT01612000|Influenza|influenza
1293050|NCT01611974|CMV|cmv
1293051|NCT01611974|cytomegalovirus|cytomegalovirus
1293052|NCT01611974|resistant|resistant
1293053|NCT01611974|refractory|refractory
1293054|NCT01611974|transplant|transplant
1293055|NCT01611974|treatment|treatment
1293056|NCT01611961|Docetaxel|docetaxel
1293057|NCT01611961|Lipid Microsphere|lipid microsphere
1293059|NCT01611961|Antineoplastic Agents|antineoplastic agents
1293060|NCT01611961|Pharmacologic Actions|pharmacologic actions
1293061|NCT01611961|Therapeutic Uses|therapeutic uses
1293062|NCT01611935|trauma|trauma
1293063|NCT01611935|shock|shock
1293064|NCT01611935|vasopressin|vasopressin
1293065|NCT01611935|blood transfusion|blood transfusion
1293066|NCT01611922|eye|eye
1293067|NCT01611922|eyelid|eyelid
1293068|NCT01611922|contact lenses|contact lenses
1293069|NCT01611922|dry eye disease|dry eye disease
1293070|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
1293071|NCT01611909|topical therapy|topical therapy
1293072|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
1293073|NCT01611896|Graves' disease|graves' disease
1293074|NCT01611896|Selenium|selenium
1293075|NCT01611896|Quality of Life|quality of life
1293076|NCT01611896|ThyPRO|thypro
1293077|NCT01611896|Autoimmunity|autoimmunity
1293078|NCT01611870|COPD|copd
1293079|NCT01611857|Advanced solid tumors|advanced solid tumors
1293080|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
1293081|NCT01611857|c-Met Inhibitor|c-met inhibitor
1293082|NCT01611857|Tivantinib|tivantinib
1293083|NCT01611857|FOLFOX|folfox
1293084|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
1293085|NCT01611844|tuberculosis skin test|tuberculosis skin test
1293086|NCT01611844|BD micro-needle|bd micro-needle
1293087|NCT01611844|medical device|medical device
1293088|NCT01611844|spectroscopy|spectroscopy
1293089|NCT01611831|fibromyalgia|fibromyalgia
1293090|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
1293091|NCT01611831|randomized controlled trial|randomized controlled trial
1293092|NCT01611818|Depression|depression
1293093|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
1293094|NCT01611818|Randomized-controlled trial|randomized-controlled trial
1293095|NCT01611792|Stabilization exercise|stabilization exercise
1293096|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
1293097|NCT01611792|Physical therapy|physical therapy
1293098|NCT01611792|Rehabilitation|rehabilitation
1293099|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
1293100|NCT01611779|tongue suspension|tongue suspension
1293101|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
1293102|NCT01611766|Ovarian Cancer|ovarian cancer
1293103|NCT01611766|surgery|surgery
1293104|NCT01611766|recurrence|recurrence
1293105|NCT01611753|Shock, Septic|shock, septic
1293106|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
1293107|NCT01611753|Ischemia|ischemia
1293108|NCT01611740|Preterm infant|preterm infant
1293109|NCT01611740|Bacterial infection|bacterial infection
1293110|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
1293111|NCT01611727|BRCA1|brca1
1293112|NCT01611727|survival|survival
1293115|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
1293116|NCT01611714|Imaging|imaging
1293117|NCT01611714|Emergency|emergency
1293118|NCT01611714|Headache|headache
1293119|NCT01611675|Metastatic|metastatic
1293120|NCT01611675|Unresectable|unresectable
1293121|NCT01611675|Clearly progressive|clearly progressive
1293122|NCT01611675|BRAF mutation|braf mutation
1293123|NCT01611649|infant formula|infant formula
1293124|NCT01611649|dairy lipids|dairy lipids
1293125|NCT01611649|omega-3|omega-3
1293126|NCT01611636|allergy|allergy
1293127|NCT01611636|autoimmune diseases|autoimmune diseases
1293128|NCT01611636|rheumatic diseases|rheumatic diseases
1293129|NCT01611623|Solid tumor malignancy|solid tumor malignancy
1293130|NCT01611623|Hsp90|hsp90
1293131|NCT01611610|outcome measures|outcome measures
1293132|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
1293133|NCT01611597|accelerometry|accelerometry
1293134|NCT01611597|neuromuscular disease|neuromuscular disease
1293135|NCT01611584|ALA|ala
1293136|NCT01611584|Florescence|florescence
1293137|NCT01611584|Lung cancer|lung cancer
1293138|NCT01611571|osteoporosis|osteoporosis
1293139|NCT01611571|male|male
1293140|NCT01611545|Pharmacogenomics|pharmacogenomics
1293141|NCT01611545|Pharmacogenetics|pharmacogenetics
1293142|NCT01611545|Clopidogrel|clopidogrel
1293143|NCT01611545|Plavix|plavix
1293144|NCT01611532|Acute pancreatitis|acute pancreatitis
1293145|NCT01611532|Intraabdominal pressure|intraabdominal pressure
1293146|NCT01611532|Critical illness|critical illness
1293147|NCT01611519|urinary bladder|urinary bladder
1293148|NCT01611519|urinary catheterization|urinary catheterization
1293149|NCT01611519|epidural analgesia|epidural analgesia
1293150|NCT01611519|catheters, indwelling|catheters, indwelling
1293151|NCT01611493|Dental Implants|dental implants
1293152|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
1293153|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
1293154|NCT01611493|randomised Clinical Trials|randomised clinical trials
1293155|NCT01611493|Humans|humans
1293156|NCT01611467|CC-223|cc-223
1293157|NCT01611467|safety|safety
1293158|NCT01611467|tolerability|tolerability
1293159|NCT01611467|pharmacokinetic|pharmacokinetic
1293284|NCT01610947|Adalimumab|adalimumab
1293160|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
1293161|NCT01611467|FE (Food Effect)|fe (food effect)
1293162|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
1293163|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
1293164|NCT01611441|Biomarkers|biomarkers
1293165|NCT01611428|Ipragliflozin|ipragliflozin
1293166|NCT01611428|Healthy|healthy
1293167|NCT01611428|Absolute Bioavailability|absolute bioavailability
1293168|NCT01611428|Pharmacokinetics|pharmacokinetics
1293169|NCT01611415|Phase 1|phase 1
1293170|NCT01611415|Ipragliflozin|ipragliflozin
1293171|NCT01611415|Furosemide|furosemide
1293172|NCT01611415|Pharmacokinetics|pharmacokinetics
1293173|NCT01611415|Pharmacodynamics|pharmacodynamics
1293174|NCT01611402|Tuberculosis|tuberculosis
1293175|NCT01611402|HIV Infection|hiv infection
1293176|NCT01611402|Transcriptional Signature|transcriptional signature
1293177|NCT01611402|IRIS|iris
1293178|NCT01611376|impedance cardiography|impedance cardiography
1293179|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
1293180|NCT01611376|cardiac output|cardiac output
1293181|NCT01611363|Ipragliflozin|ipragliflozin
1293182|NCT01611363|Phase 1|phase 1
1293183|NCT01611363|Healthy|healthy
1293184|NCT01611363|Diabetes Mellitus|diabetes mellitus
1293185|NCT01611363|Pharmacokinetics|pharmacokinetics
1293186|NCT01611363|Pharmacodynamics|pharmacodynamics
1293187|NCT01611350|Indoor Air Pollution|indoor air pollution
1293188|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
1293189|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
1293190|NCT01611337|schizophrenia, insight|schizophrenia, insight
1293191|NCT01611324|Varicose Veins|varicose veins
1293192|NCT01611324|Phlebectomy|phlebectomy
1293193|NCT01611324|Local Anesthesia|local anesthesia
1293194|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
1293195|NCT01611298|malignant diseases|malignant diseases
1293196|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1293197|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
1293198|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
1293199|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
1293200|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
1293201|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
1293202|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
1293203|NCT01611298|non-malignant disease|non-malignant disease
1293204|NCT01611285|UPHOLD|uphold
1293205|NCT01611285|robotic surgery|robotic surgery
1293206|NCT01611285|decision analysis|decision analysis
1293207|NCT01611285|FDA|fda
1293208|NCT01611285|decision node|decision node
1293209|NCT01611285|outcome node|outcome node
1293210|NCT01611272|Unstable angina|unstable angina
1293211|NCT01611259|MALT Lymphoma|malt lymphoma
1293212|NCT01611259|Lenalidomide|lenalidomide
1293213|NCT01611259|Rituximab|rituximab
1293214|NCT01611259|AGMT|agmt
1293226|NCT01611207|health services research,|health services research,
1293228|NCT01611194|HBO2|hbo2
1293229|NCT01611194|HBOT|hbot
1293230|NCT01611194|mTBI|mtbi
1293231|NCT01611194|Brain injury|brain injury
1293232|NCT01611194|PCS|pcs
1293233|NCT01611194|PTSD|ptsd
1293234|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
1293235|NCT01611181|Iron supplementation|iron supplementation
1293236|NCT01611181|Iron deficiency|iron deficiency
1293237|NCT01611181|Hip arthroplasty|hip arthroplasty
1293238|NCT01611181|Knee arthroplasty|knee arthroplasty
1293239|NCT01611142|Monoclonal antibody|monoclonal antibody
1293240|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1293241|NCT01611142|cancer|cancer
1293242|NCT01611142|hematologic malignancy|hematologic malignancy
1293243|NCT01611129|Disability Evaluation|disability evaluation
1293244|NCT01611103|Cognitive Enhancement|cognitive enhancement
1293245|NCT01611103|tDCS|tdcs
1293246|NCT01611103|stimulation|stimulation
1293247|NCT01611103|elderly|elderly
1293248|NCT01611103|older adults|older adults
1293259|NCT01611064|Hand|hand
1293260|NCT01611064|Surgery|surgery
1293261|NCT01611064|Tourniquet|tourniquet
1293262|NCT01611064|Pain|pain
1293263|NCT01611064|Oxygen|oxygen
1293264|NCT01611051|breast cancer|breast cancer
1293265|NCT01611051|neutropenia|neutropenia
1293266|NCT01611051|febrile neutropenia|febrile neutropenia
1293267|NCT01611012|Asthma|asthma
1293268|NCT01611012|Inflammation|inflammation
1293269|NCT01611012|Phenotype|phenotype
1293270|NCT01611012|Sputum|sputum
1293271|NCT01610986|Fructose|fructose
1293272|NCT01610986|Exercise|exercise
1293273|NCT01610986|Lactic acid|lactic acid
1293274|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
1293275|NCT01610973|Fuch's dystrophy|fuch's dystrophy
1293276|NCT01610973|Corneal graft|corneal graft
1293277|NCT01610960|Non invasive ventilation|non invasive ventilation
1293278|NCT01610960|Helmet|helmet
1293279|NCT01610960|NEXT Helmet|next helmet
1293280|NCT01610960|Work of breathing|work of breathing
1293281|NCT01610960|Intensive care|intensive care
1293282|NCT01610947|Spondyloarthritis|spondyloarthritis
1293283|NCT01610947|Anti-TNF|anti-tnf
1293285|NCT01610947|Etanercept|etanercept
1293286|NCT01610947|Infliximab|infliximab
1293287|NCT01610934|MODY|mody
1293288|NCT01610934|Monogenic diabetes|monogenic diabetes
1293289|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
1293290|NCT01610934|MODY3|mody3
1293291|NCT01610921|asthma|asthma
1293292|NCT01610921|small airways disease|small airways disease
1293293|NCT01610921|inflammation|inflammation
1293294|NCT01610921|provocation|provocation
1293295|NCT01610921|adenosine|adenosine
1293296|NCT01610908|Adolescent|adolescent
1293297|NCT01610908|Idiopathic|idiopathic
1293298|NCT01610908|Scoliosis|scoliosis
1293299|NCT01610908|Schroth|schroth
1293300|NCT01610908|Exercises|exercises
1293301|NCT01610908|Conservative treatment|conservative treatment
1293302|NCT01610895|Colonoscopy|colonoscopy
1293303|NCT01610895|low fibre diet|low fibre diet
1293304|NCT01610895|clear fluids|clear fluids
1293305|NCT01610895|Bowel Preparation|bowel preparation
1293306|NCT01610869|Recurrence|recurrence
1293307|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
1293308|NCT01610869|Ovarian Diseases|ovarian diseases
1293309|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
1293310|NCT01610869|Neoplasms|neoplasms
1293311|NCT01610869|Carcinoma|carcinoma
1293312|NCT01610869|Neoplasms by site|neoplasms by site
1293313|NCT01610856|bowel preparation|bowel preparation
1293314|NCT01610856|bowel purgative|bowel purgative
1293315|NCT01610856|bowel cleansing|bowel cleansing
1293316|NCT01610856|colonoscopy|colonoscopy
1293317|NCT01610843|Sarcoidosis|sarcoidosis
1293318|NCT01610843|WISE|wise
1293319|NCT01610843|Sarcoid Study|sarcoid study
1293320|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
1293321|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
1293322|NCT01610830|adults|adults
1293323|NCT01610830|children|children
1293324|NCT01610830|pronostic factors|pronostic factors
1293325|NCT01610817|Patient information and active participation|patient information and active participation
1293326|NCT01610817|Patient safety|patient safety
1293327|NCT01610817|Health education|health education
1293328|NCT01610817|Adverse drug event|adverse drug event
1293329|NCT01610817|Primary care|primary care
1293330|NCT01610817|Antihypertensive drugs|antihypertensive drugs
1293331|NCT01610765|HSV|hsv
1293332|NCT01610765|pharmacokinetics|pharmacokinetics
1293333|NCT01610765|herpes|herpes
1293334|NCT01610765|neonates|neonates
1293335|NCT01610752|Pregnancy|pregnancy
1293336|NCT01610752|Gestational weight gain|gestational weight gain
1293337|NCT01610726|colon|colon
1293338|NCT01610726|rectum|rectum
1293339|NCT01610726|recovery|recovery
1293340|NCT01610726|surgery|surgery
1293341|NCT01610674|Diabetes mellitus|diabetes mellitus
1293342|NCT01610674|Surgery|surgery
1293343|NCT01610674|Implementation|implementation
1293344|NCT01610674|Quality of care|quality of care
1293345|NCT01610674|Quality indicators|quality indicators
1293346|NCT01610661|carbohydrate|carbohydrate
1293347|NCT01610661|inflammation|inflammation
1293348|NCT01610661|glucose homeostasis|glucose homeostasis
1293349|NCT01610661|gene expression|gene expression
1293350|NCT01610648|OSA|osa
1293351|NCT01610648|metabolic syndrome|metabolic syndrome
1293352|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
1293353|NCT01610648|Oxygen desaturation index|oxygen desaturation index
1293354|NCT01610635|RCT|rct
1293355|NCT01610635|blood donation frequency|blood donation frequency
1293356|NCT01610635|quality of life|quality of life
1293357|NCT01610635|iron deficiency|iron deficiency
1293358|NCT01610622|Cardiac Output|cardiac output
1293359|NCT01610622|Blood volumes|blood volumes
1293360|NCT01610622|Neonates|neonates
1293361|NCT01610609|Statin treatment|statin treatment
1293362|NCT01610609|Cardiovascular disease|cardiovascular disease
1293363|NCT01610609|High cholesterol|high cholesterol
1293364|NCT01610609|Care management|care management
1293365|NCT01610596|Psoriasis|psoriasis
1293366|NCT01610596|Skin Diseases|skin diseases
1293367|NCT01610596|Halobetasol|halobetasol
1293368|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
1293369|NCT01610596|Therapeutic Uses|therapeutic uses
1293370|NCT01610596|Pharmacologic Actions|pharmacologic actions
1293371|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
1609845|NCT00358397|Clostridial|clostridial
1293372|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
1293373|NCT01610583|Genetic Literacy|genetic literacy
1293374|NCT01610583|Latino|latino
1293375|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
1293376|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
1293377|NCT01610570|Radiographic Response|radiographic response
1293378|NCT01610570|Time to Progression|time to progression
1293379|NCT01610570|Bone Tumors|bone tumors
1293380|NCT01610557|Diabetic Macular Edema|diabetic macular edema
1293381|NCT01610557|Ranibizumab|ranibizumab
1293382|NCT01610557|Bevacizumab|bevacizumab
1293383|NCT01610544|Thymoma|thymoma
1293384|NCT01610544|Insulin Growth Factor|insulin growth factor
1293385|NCT01610544|Cell Proliferation|cell proliferation
1293386|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
1293387|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
1293388|NCT01610531|Cohort|cohort
1293389|NCT01610531|Melanoma|melanoma
1293390|NCT01610531|targeted screening|targeted screening
1293391|NCT01610531|risks function|risks function
1293392|NCT01610531|cost effectiveness|cost effectiveness
1293393|NCT01610518|postprandial blood glucose|postprandial blood glucose
1293394|NCT01610518|dietary fiber|dietary fiber
1293395|NCT01610518|beta-glucan|beta-glucan
1293396|NCT01610505|Knee Osteoarthritis|knee osteoarthritis
1293397|NCT01610505|Knee pain|knee pain
1293398|NCT01610505|Arthritis|arthritis
1293399|NCT01610505|KineSpring|kinespring
1293400|NCT01610505|High Tibial Osteotomy|high tibial osteotomy
1293401|NCT01610492|IMGN|imgn
1293402|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
1293403|NCT01610492|pharmacokinetics|pharmacokinetics
1293404|NCT01610492|belimumab|belimumab
1293405|NCT01610492|Benlysta|benlysta
1293406|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
1293407|NCT01610492|safety|safety
1293408|NCT01610492|GSK1550188|gsk1550188
1293409|NCT01610492|Lymphostat-B|lymphostat-b
1293410|NCT01610492|membrane attack complex|membrane attack complex
1293411|NCT01610466|Education|education
1293412|NCT01610466|Simulation|simulation
1293413|NCT01610466|Technical skills training|technical skills training
1293414|NCT01610466|Laparoscopy|laparoscopy
1293415|NCT01610466|Bariatric Surgery|bariatric surgery
1293416|NCT01610453|prolonged labor|prolonged labor
1293417|NCT01610453|cesarean section|cesarean section
1293418|NCT01610453|duration of labor|duration of labor
1293419|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
1293420|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
1293421|NCT01610427|CMI|cmi
1293422|NCT01610427|HIV|hiv
1293423|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
1293424|NCT01610414|Observer-blind|observer-blind
1293425|NCT01610414|Efficacy|efficacy
1293426|NCT01610414|Immunogenicity|immunogenicity
1293427|NCT01610414|Vaccination|vaccination
1293428|NCT01610414|Safety|safety
1293429|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
1293430|NCT01610414|Herpes Zoster|herpes zoster
1293431|NCT01610388|healthy subjects|healthy subjects
1293432|NCT01610388|double-blind|double-blind
1293433|NCT01610388|FTIH|ftih
1293434|NCT01610388|dose-escalation|dose-escalation
1293435|NCT01610388|absolute bioavailability|absolute bioavailability
1293436|NCT01610388|GSK1322322|gsk1322322
1293437|NCT01610388|BAL|bal
1293438|NCT01610375|Endometrial cancer|endometrial cancer
1293439|NCT01610362|rabies|rabies
1293440|NCT01610362|immunoglobulin|immunoglobulin
1293441|NCT01610362|dosage|dosage
1293442|NCT01610336|EGFR|egfr
1293443|NCT01610336|c-MET|c-met
1293444|NCT01610336|Lung cancer|lung cancer
1293445|NCT01610336|Gefitinib|gefitinib
1293446|NCT01610336|Erlotinib|erlotinib
1293447|NCT01610323|Pregnancy|pregnancy
1293448|NCT01610323|Obesity|obesity
1293449|NCT01610323|Physical activity|physical activity
1293450|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
1293451|NCT01610323|Muscular Fitness|muscular fitness
1293452|NCT01610323|Weight gain|weight gain
1293453|NCT01610323|Fetal growth|fetal growth
1293455|NCT01610310|PEG|peg
1293456|NCT01610310|Inteferon|inteferon
1293457|NCT01610310|PK|pk
1293458|NCT01610310|Subcutaneous|subcutaneous
1293459|NCT01610310|PEGylated|pegylated
1293460|NCT01610310|Autoinjector|autoinjector
1293461|NCT01610310|Injectable|injectable
1293462|NCT01610310|MS|ms
1293463|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
1293464|NCT01610284|Breast cancer|breast cancer
1293465|NCT01610284|Hormone receptor positive|hormone receptor positive
1293466|NCT01610284|HER2-negative|her2-negative
1293467|NCT01610284|Metastatic|metastatic
1293468|NCT01610284|Locally advanced|locally advanced
1293469|NCT01610284|PI3K|pi3k
1293470|NCT01610284|Fulvestrant|fulvestrant
1293471|NCT01610284|Refractory|refractory
1293472|NCT01610284|Aromatase inhibitor|aromatase inhibitor
1293473|NCT01610271|Prevention|prevention
1293474|NCT01610271|Surgical Site Infection|surgical site infection
1293475|NCT01610271|Air Barrier System|air barrier system
1293476|NCT01610271|Implant Infection|implant infection
1293477|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
1293478|NCT01610245|Influenza|influenza
1293479|NCT01610232|Infrared LED|infrared led
1293480|NCT01610232|Treadmill Training|treadmill training
1293481|NCT01610232|Strength Muscle|strength muscle
1293482|NCT01610232|Fatigue Muscle|fatigue muscle
1293483|NCT01610232|Aerobic Capacity|aerobic capacity
1293484|NCT01610232|Cellulite|cellulite
1293485|NCT01610232|Osteoporosis|osteoporosis
1293486|NCT01610206|recurrent|recurrent
1293487|NCT01610206|persistent|persistent
1293488|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
1293489|NCT01610193|Abdominal pain|abdominal pain
1293490|NCT01610193|Acute appendicitis|acute appendicitis
1293491|NCT01610193|Alvarado score|alvarado score
1293492|NCT01610193|Appendectomy|appendectomy
1293493|NCT01610193|Sensitivity and specificity|sensitivity and specificity
1293494|NCT01610180|Eltrombopag|eltrombopag
1293496|NCT01610180|LPD|lpd
1293497|NCT01610180|leukemia|leukemia
1293498|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
1293499|NCT01610154|glucagon|glucagon
1293500|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
1293501|NCT01610141|warfarin metabolism|warfarin metabolism
1293502|NCT01610141|pharmacogenetics|pharmacogenetics
1293503|NCT01610141|CYP2C9|cyp2c9
1293504|NCT01610141|genotyping|genotyping
1293505|NCT01610141|VKORC1|vkorc1
1293506|NCT01610141|CYP4F2|cyp4f2
1293507|NCT01610141|anticoagulation|anticoagulation
1293508|NCT01610141|atrial fibrillation|atrial fibrillation
1293509|NCT01610141|deep vein thrombosis|deep vein thrombosis
1293510|NCT01610141|pulmonary embolism|pulmonary embolism
1293511|NCT01610141|Artificial Heart Valve|artificial heart valve
1293512|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
1293513|NCT01610115|Pregnancy|pregnancy
1293514|NCT01610102|clinical follow-up|clinical follow-up
1293515|NCT01610102|up to 7 years|up to 7 years
1293516|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
1293517|NCT01610089|citrullinemia|citrullinemia
1293518|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
1293519|NCT01610089|nitric oxide|nitric oxide
1293520|NCT01610089|urea|urea
1293521|NCT01610076|Code Status|code status
1293522|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
1293523|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
1293524|NCT01610076|CPR|cpr
1293525|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1293526|NCT01610076|video|video
1293527|NCT01610076|advanced directives|advanced directives
1293528|NCT01610063|Algorithm|algorithm
1293529|NCT01610063|Depression|depression
1293530|NCT01610063|Assurex|assurex
1293531|NCT01610063|GeneSight|genesight
1293532|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
1293533|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1293534|NCT01610037|COPD|copd
1293535|NCT01610037|QVA149|qva149
1293536|NCT01610037|QAB149|qab149
1293537|NCT01610037|NVA237|nva237
1293538|NCT01610037|Indacaterol maleate|indacaterol maleate
1293539|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
1293540|NCT01610011|Schizophrenia|schizophrenia
1293541|NCT01610011|Psychotic Disorders|psychotic disorders
1293542|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
1293543|NCT01610011|Glycine augmentation|glycine augmentation
1293544|NCT01610011|Glycine|glycine
1293545|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
1293546|NCT01610011|Glycine Bioavailability|glycine bioavailability
1293547|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1293548|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
1293549|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
1293550|NCT01609998|Influenza A (H1)|influenza a (h1)
1293551|NCT01609998|Influenza A (H3)|influenza a (h3)
1293552|NCT01609998|Influenza B|influenza b
1293553|NCT01609998|DNA Vaccine|dna vaccine
1293554|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
1293555|NCT01609998|Healthy Adolescents|healthy adolescents
1293556|NCT01609998|Healthy Children|healthy children
1293557|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
1293558|NCT01609972|Back pain|back pain
1293559|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
1293560|NCT01609959|Hypertension|hypertension
1293561|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
1293562|NCT01609959|Azilsartan|azilsartan
1293563|NCT01609959|Valsartan|valsartan
1293564|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
1293565|NCT01609933|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1293566|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
1293567|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
1293568|NCT01609933|HCV|hcv
1293569|NCT01609920|MRI|mri
1293570|NCT01609920|lymph node metastases|lymph node metastases
1293571|NCT01609920|breast cancer|breast cancer
1293572|NCT01609920|gadofosveset|gadofosveset
1293573|NCT01609907|Drug interaction|drug interaction
1293574|NCT01609907|YH14700|yh14700
1293575|NCT01609907|Rosuvastatin|rosuvastatin
1293576|NCT01609907|Valsartan|valsartan
1293577|NCT01609907|Yuhan|yuhan
1293578|NCT01609894|Postnatal development|postnatal development
1293579|NCT01609894|Breast milk fortification|breast milk fortification
1293580|NCT01609894|Composition of breast milk|composition of breast milk
1293581|NCT01609881|Inflammation|inflammation
1293582|NCT01609868|premature infant feeding protein|premature infant feeding protein
1293583|NCT01609855|Adenoma Detection Rate|adenoma detection rate
1293584|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
1293585|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
1293586|NCT01609842|adherence|adherence
1293587|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1293588|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1293819|NCT01609192|hydroxyurea|hydroxyurea
1293589|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1293590|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1293591|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1293592|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1293593|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1293594|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1293595|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1293596|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1293597|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1293598|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1293599|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1293600|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1293601|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1293602|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1293603|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1293604|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1293605|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1293606|NCT01609816|intraocular lymphoma|intraocular lymphoma
1293607|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1293749|NCT01609556|FOLR solid tumors|folr solid tumors
1293608|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1293609|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1293610|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1293611|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1293612|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1293613|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1293614|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1293615|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1293616|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1293617|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1293618|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1293619|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1293620|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1293621|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1293622|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1293623|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1293624|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1293625|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1293626|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1293627|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1293628|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1293629|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1293630|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1293631|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1293632|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1333270|NCT01443767|Partial Liver Resection|partial liver resection
1293633|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1293634|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1293635|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1293636|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1293637|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1293638|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1293639|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
1293640|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
1293641|NCT01609816|small intestine lymphoma|small intestine lymphoma
1293642|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1293643|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1293644|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1293645|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1293646|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1293647|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1294217|NCT01607632|depression|depression
1293648|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1293649|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1293650|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1293651|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1293652|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1293653|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1293654|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1293655|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1293656|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1293657|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
1293658|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1293659|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
1293660|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
1293661|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1293662|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1293663|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1293664|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
1293665|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
1293666|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
1293667|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1293668|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1293669|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1294159|NCT01607879|Geriatric|geriatric
1293750|NCT01609530|verruca vulgaris|verruca vulgaris
1293670|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1293671|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1293672|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1293673|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1293674|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1293675|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1293676|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1293677|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1293678|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1293679|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1293680|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1293681|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
1293682|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1293683|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
1293684|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
1293685|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1293686|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1293687|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1293688|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1293689|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1293690|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1293691|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1293692|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1293693|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1293694|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1293695|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1293696|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1293697|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1293698|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1293699|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1293700|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
1293701|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
1293702|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1293703|NCT01609816|testicular lymphoma|testicular lymphoma
1293704|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
1293705|NCT01609751|probiotic|probiotic
1293706|NCT01609751|lactobacillus|lactobacillus
1293707|NCT01609751|colonic diseases|colonic diseases
1293708|NCT01609751|dietary fibre|dietary fibre
1293709|NCT01609738|Cardiac pacing|cardiac pacing
1293710|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
1293711|NCT01609738|Feasibility and safety|feasibility and safety
1293712|NCT01609738|Lead stability|lead stability
1293713|NCT01609738|Hemodynamics|hemodynamics
1293714|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
1293715|NCT01609738|Pacing for heart failure|pacing for heart failure
1293716|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
1293717|NCT01609725|Coronary artery disease|coronary artery disease
1293718|NCT01609725|C reactive protein|c reactive protein
1293719|NCT01609725|Periodontitis|periodontitis
1293720|NCT01609725|Periodontal therapy|periodontal therapy
1293721|NCT01609725|Flow-mediated dilation|flow-mediated dilation
1293722|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
1293723|NCT01609712|Visual Analog Scale|visual analog scale
1293724|NCT01609712|Oswestry Disability Index|oswestry disability index
1293725|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
1293726|NCT01609699|body circumference|body circumference
1293727|NCT01609699|Non-Invasive Reduction|non-invasive reduction
1293728|NCT01609686|cardiac surgery|cardiac surgery
1293729|NCT01609686|renal dysfunction|renal dysfunction
1293730|NCT01609686|pharmacokinetics|pharmacokinetics
1293731|NCT01609686|tranexamic acid|tranexamic acid
1293732|NCT01609673|Immunosuppression|immunosuppression
1293733|NCT01609673|Chronic Kidney Disease|chronic kidney disease
1293734|NCT01609673|Renal Transplant|renal transplant
1293735|NCT01609660|probiotics|probiotics
1293736|NCT01609660|cytokine|cytokine
1293737|NCT01609660|short chain fatty acids|short chain fatty acids
1293738|NCT01609660|complications|complications
1293739|NCT01609660|colorectal surgery|colorectal surgery
1293740|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
1293741|NCT01609634|Healthy|healthy
1293742|NCT01609634|Term infants|term infants
1293743|NCT01609634|Growth|growth
1293744|NCT01609634|Body composition|body composition
1293745|NCT01609595|Thalassemia|thalassemia
1293746|NCT01609595|Anemia|anemia
1293747|NCT01609595|Fetal hemoglobin|fetal hemoglobin
1293748|NCT01609582|Drug therapy|drug therapy
1293751|NCT01609530|hands|hands
1293752|NCT01609530|feet|feet
1293753|NCT01609530|Nd:YAG|nd:yag
1293754|NCT01609530|laser|laser
1293755|NCT01609530|cryotherapy|cryotherapy
1293756|NCT01609517|Spinal anesthesia|spinal anesthesia
1293757|NCT01609517|determinant|determinant
1293758|NCT01609517|duration|duration
1293759|NCT01609504|Rectal cancer|rectal cancer
1293760|NCT01609504|Radiochemotherapy|radiochemotherapy
1293761|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
1293762|NCT01609504|Laparoscopic Resection|laparoscopic resection
1293763|NCT01609478|asthma|asthma
1293765|NCT01609465|stable angina|stable angina
1293766|NCT01609465|STEMI|stemi
1293767|NCT01609465|NSTEMI|nstemi
1293768|NCT01609465|CVD|cvd
1293769|NCT01609465|secondary prevention|secondary prevention
1293770|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1293771|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1293772|NCT01609452|Chronic ITP|chronic itp
1293773|NCT01609439|Permanent|permanent
1293774|NCT01609439|temporary|temporary
1293775|NCT01609439|hypocalcemia|hypocalcemia
1293776|NCT01609426|Proteinuria|proteinuria
1293777|NCT01609426|idiopathic|idiopathic
1293778|NCT01609426|nephrotic syndrome|nephrotic syndrome
1293779|NCT01609426|herpesvirus|herpesvirus
1293780|NCT01609426|epidemiology|epidemiology
1293781|NCT01609426|immune response|immune response
1293782|NCT01609426|interferon|interferon
1293783|NCT01609426|steroid dependency|steroid dependency
1293784|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
1293785|NCT01609387|Vitamine|vitamine
1293786|NCT01609387|mineral|mineral
1293787|NCT01609387|obese patients|obese patients
1293788|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
1293789|NCT01609374|Spinal Kinetics|spinal kinetics
1293790|NCT01609374|artificial cervical disc|artificial cervical disc
1293791|NCT01609374|cervical radiculopathy|cervical radiculopathy
1293792|NCT01609374|ACDF|acdf
1293793|NCT01609374|neck pain|neck pain
1293794|NCT01609374|cervical spine|cervical spine
1293795|NCT01609374|degenerative disc disease|degenerative disc disease
1293796|NCT01609361|Rehabilitation program|rehabilitation program
1293797|NCT01609361|Fast track surgery|fast track surgery
1293798|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
1293799|NCT01609361|Colorectal cancer|colorectal cancer
1293800|NCT01609361|Morbidity|morbidity
1293801|NCT01609348|Depression|depression
1293802|NCT01609348|Alzheimer's Disease|alzheimer's disease
1293803|NCT01609322|fear of falling|fear of falling
1293804|NCT01609322|agoraphobia|agoraphobia
1293805|NCT01609309|Stomach Neoplasms|stomach neoplasms
1293806|NCT01609309|Laparoscopy|laparoscopy
1293807|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
1293808|NCT01609296|Drug coated balloon|drug coated balloon
1293809|NCT01609296|Superficial Femoral Artery|superficial femoral artery
1293810|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
1293811|NCT01609296|Atherosclerosis|atherosclerosis
1293812|NCT01609244|Sleep apnea|sleep apnea
1293813|NCT01609244|central sleep apnea|central sleep apnea
1293815|NCT01609244|servoventilation|servoventilation
1293816|NCT01609244|CPAP|cpap
1293817|NCT01609192|sickle-cell anemia|sickle-cell anemia
1293818|NCT01609192|spermatogenesis|spermatogenesis
1293820|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
1293821|NCT01609166|capecitabine|capecitabine
1293822|NCT01609166|allopurinol|allopurinol
1293823|NCT01609153|schizophrenia|schizophrenia
1293824|NCT01609153|amisulpride|amisulpride
1293825|NCT01609153|olanzapine|olanzapine
1293826|NCT01609153|polypharmacy|polypharmacy
1293827|NCT01609140|Hyperlipidemia|hyperlipidemia
1293828|NCT01609140|Dyslipidemia|dyslipidemia
1293829|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
1293830|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
1293831|NCT01609114|different part in human|different part in human
1293832|NCT01609101|Videolaryngoscopy|videolaryngoscopy
1293833|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
1293834|NCT01609101|Trauma|trauma
1293835|NCT01609088|endothelium|endothelium
1293836|NCT01609088|diabetes mellitus|diabetes mellitus
1293837|NCT01609088|oxidative stress|oxidative stress
1293838|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
1293839|NCT01609062|MPS IVA Type A|mps iva type a
1293840|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1293841|NCT01609062|MPS IVA|mps iva
1293842|NCT01609062|Morquio A Syndrome|morquio a syndrome
1293843|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
1293844|NCT01609062|LSD|lsd
1293845|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1293846|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
1293847|NCT01609062|sulfatase|sulfatase
1293848|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
1293849|NCT01609062|GALNS|galns
1293850|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
1293851|NCT01609062|ERT|ert
1293852|NCT01609062|MOR-008|mor-008
1293853|NCT01609062|CPET|cpet
1293854|NCT01609062|MST|mst
1293855|NCT01609062|muscle strength test|muscle strength test
1293856|NCT01609062|physiological effect|physiological effect
1293857|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
1293858|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
1293859|NCT01608984|myocardial injury|myocardial injury
1293860|NCT01608971|Protamine|protamine
1293861|NCT01608971|heparin level|heparin level
1293862|NCT01608971|haemostasis|haemostasis
1293863|NCT01608971|thromboelastometry|thromboelastometry
1293864|NCT01608971|cardiac surgery|cardiac surgery
1293865|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
1293866|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
1293867|NCT01608958|Oxytocin|oxytocin
1293868|NCT01608958|Third stage of labor|third stage of labor
1293869|NCT01608958|Hemoglobin|hemoglobin
1293870|NCT01608958|Prevention|prevention
1293871|NCT01608958|Intravenous|intravenous
1293872|NCT01608958|Intramuscular|intramuscular
1293873|NCT01608945|steroid|steroid
1293874|NCT01608945|liver function|liver function
1293875|NCT01608945|prognosis|prognosis
1293876|NCT01608906|venous thrombosis|venous thrombosis
1293877|NCT01608906|heparin|heparin
1293878|NCT01608906|pulmonary embolism|pulmonary embolism
1293879|NCT01608906|ICU|icu
1293880|NCT01608867|Phase 1|phase 1
1293881|NCT01608867|dose escalation|dose escalation
1293882|NCT01608867|histologically confirmed|histologically confirmed
1293883|NCT01608867|malignancy|malignancy
1293884|NCT01608867|metastatic|metastatic
1293885|NCT01608854|surgical site infection|surgical site infection
1293886|NCT01608854|spinal surgery|spinal surgery
1293887|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
1293888|NCT01608854|postoperative spinal drains|postoperative spinal drains
1293889|NCT01608815|Salmonella infections|salmonella infections
1293890|NCT01608815|Typhoid fever|typhoid fever
1293891|NCT01608815|Bacterial infections|bacterial infections
1293892|NCT01608815|Typhoid vaccine|typhoid vaccine
1293893|NCT01608802|HIV|hiv
1293894|NCT01608802|Antiretroviral therapy|antiretroviral therapy
1293895|NCT01608802|Palliative care|palliative care
1293896|NCT01608802|Pain|pain
1293897|NCT01608789|Male sling|male sling
1293898|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
1293899|NCT01608789|Urination Disorders|urination disorders
1293900|NCT01608789|Urologic Diseases|urologic diseases
1293901|NCT01608724|Type 2 DM|type 2 dm
1293902|NCT01608711|Gemcitabine|gemcitabine
1293903|NCT01608711|ASP6182|asp6182
1293904|NCT01608711|AGS-1C4D4|ags-1c4d4
1293905|NCT01608711|Pancreatic Cancer|pancreatic cancer
1293906|NCT01608698|chlormadinone acetate|chlormadinone acetate
1293907|NCT01608698|drospirenone|drospirenone
1293908|NCT01608698|contraceptive pills|contraceptive pills
1293909|NCT01608685|Tuberculosis|tuberculosis
1293910|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
1293911|NCT01608685|Immunosuppression|immunosuppression
1293912|NCT01608685|Renal transplant recipient|renal transplant recipient
1293913|NCT01608646|S-1|s-1
1293914|NCT01608646|Oxaliplatin|oxaliplatin
1293915|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
1293916|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
1293917|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1293918|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1293919|NCT01608620|Clinical practice guidelines|clinical practice guidelines
1293920|NCT01608620|Clinical trials|clinical trials
1293921|NCT01608620|Dietary sugars|dietary sugars
1293922|NCT01608620|Fructose|fructose
1293923|NCT01608620|High fructose corn syrup|high fructose corn syrup
1293924|NCT01608620|Fruit|fruit
1293925|NCT01608620|Isocaloric|isocaloric
1293926|NCT01608620|Hypercaloric|hypercaloric
1293927|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
1293928|NCT01608620|Triglycerides|triglycerides
1293929|NCT01608620|Cholesterol|cholesterol
1293930|NCT01608620|Glycemic control|glycemic control
1293931|NCT01608620|Insulin resistance|insulin resistance
1293932|NCT01608620|Body weight|body weight
1293933|NCT01608620|Uric acid|uric acid
1293934|NCT01608620|Blood pressure|blood pressure
1293935|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
1293936|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1293937|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1293938|NCT01608607|Clinical practice guidelines|clinical practice guidelines
1293939|NCT01608607|Clinical trials|clinical trials
1293940|NCT01608607|Dietary sugars|dietary sugars
1293941|NCT01608607|Fructose|fructose
1293942|NCT01608607|High fructose corn syrup|high fructose corn syrup
1293943|NCT01608607|sucrose|sucrose
1293944|NCT01608607|Isocaloric|isocaloric
1293945|NCT01608607|Hypercaloric|hypercaloric
1293946|NCT01608607|Glycemic control|glycemic control
1293947|NCT01608607|Insulin resistance|insulin resistance
1293948|NCT01608607|Body weight|body weight
1293949|NCT01608607|body mass index|body mass index
1293950|NCT01608607|waist circumference|waist circumference
1293951|NCT01608581|prevention|prevention
1293952|NCT01608581|burn|burn
1293953|NCT01608581|adult|adult
1293954|NCT01608581|health promotion|health promotion
1293955|NCT01608581|evaluation|evaluation
1293956|NCT01608581|media|media
1293957|NCT01608568|Sutures|sutures
1293958|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
1293959|NCT01608568|Sacrocolpopexy|sacrocolpopexy
1293960|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
1293961|NCT01608555|cystic fibrosis|cystic fibrosis
1293962|NCT01608555|bacterial load|bacterial load
1293963|NCT01608555|inhaled tobramycin|inhaled tobramycin
1293964|NCT01608542|fostamatinib|fostamatinib
1293965|NCT01608542|FosD|fosd
1293966|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
1293967|NCT01608542|Phase 1|phase 1
1293968|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
1293969|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
1293970|NCT01608529|oronasal breathing|oronasal breathing
1293971|NCT01608529|nasal breathing.|nasal breathing.
1293972|NCT01608516|PET/CT|pet/ct
1293973|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
1293974|NCT01608516|18F-FDG|18f-fdg
1293976|NCT01608516|US ultrasound|us ultrasound
1293977|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
1293978|NCT01608516|endarterectomy|endarterectomy
1293979|NCT01608503|subclavian vein|subclavian vein
1293980|NCT01608503|ultrasound|ultrasound
1293981|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
1293982|NCT01608490|COPD|copd
1293983|NCT01608490|RePneu|repneu
1293984|NCT01608477|Heart transplantation|heart transplantation
1293985|NCT01608477|Medication adherence|medication adherence
1293986|NCT01608477|Behavior system factor|behavior system factor
1293987|NCT01608464|Randomized trial,|randomized trial,
1293988|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
1293989|NCT01608464|Multicenter study|multicenter study
1333271|NCT01443741|FIT Therapy|fit therapy
1293990|NCT01608438|Body-machine interface|body-machine interface
1293991|NCT01608438|Customization|customization
1293992|NCT01608438|Upper-body motion|upper-body motion
1293993|NCT01608438|Motor learning|motor learning
1293994|NCT01608438|Assistive Devices|assistive devices
1293995|NCT01608438|Wheelchair|wheelchair
1293996|NCT01608438|Computer keyboard|computer keyboard
1293997|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
1293998|NCT01608425|ulcer monitoring|ulcer monitoring
1293999|NCT01608425|telemedicine consultations|telemedicine consultations
1294000|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
1294001|NCT01608412|renal transplantation|renal transplantation
1294002|NCT01608412|everolimus|everolimus
1294003|NCT01608412|tacrolimus|tacrolimus
1294004|NCT01608412|molecular evaluation|molecular evaluation
1294005|NCT01608399|major depressive disorder|major depressive disorder
1294006|NCT01608399|psychotherapy|psychotherapy
1294007|NCT01608399|metacognitive therapy|metacognitive therapy
1294008|NCT01608386|Anterior approach|anterior approach
1294009|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
1294010|NCT01608386|hepatic resection|hepatic resection
1294011|NCT01608373|Pain|pain
1294012|NCT01608373|Lidocaine|lidocaine
1294013|NCT01608373|Intravenous|intravenous
1294014|NCT01608373|Intraperitoneum|intraperitoneum
1294015|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1294016|NCT01608360|Pain|pain
1294017|NCT01608360|Lidocaine|lidocaine
1294018|NCT01608360|Intravenous|intravenous
1294019|NCT01608360|Thyroidectomy|thyroidectomy
1294020|NCT01608347|LMWH|lmwh
1294021|NCT01608347|enoxaparin|enoxaparin
1294022|NCT01608347|recurrent miscarriage|recurrent miscarriage
1294023|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
1294024|NCT01608321|Chronic Pain|chronic pain
1294025|NCT01608321|Gulf War Illness|gulf war illness
1294026|NCT01608321|Gulf War Syndrome|gulf war syndrome
1294027|NCT01608321|Fibromyalgia|fibromyalgia
1294028|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1294029|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1294030|NCT01608321|Veterans|veterans
1294031|NCT01608308|Chronic Sinusitis|chronic sinusitis
1294032|NCT01608308|Pain Relief|pain relief
1294284|NCT01607255|adenoma detection|adenoma detection
1294033|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
1294034|NCT01608308|IV Acetaminophen|iv acetaminophen
1294035|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1294036|NCT01608308|FESS|fess
1294037|NCT01608295|depressed|depressed
1294038|NCT01608295|geriatric|geriatric
1294039|NCT01608295|older adults|older adults
1294040|NCT01608295|antidepressants|antidepressants
1294041|NCT01608295|depression|depression
1294042|NCT01608295|anxious|anxious
1294043|NCT01608295|major depressive disorder|major depressive disorder
1294044|NCT01608295|MDD|mdd
1294045|NCT01608282|Osteoarthritis|osteoarthritis
1294046|NCT01608282|Arthritis|arthritis
1294047|NCT01608282|Knee|knee
1294048|NCT01608282|Exercise|exercise
1294049|NCT01608282|Physical Activity|physical activity
1294050|NCT01608282|Web-based|web-based
1294051|NCT01608256|mild cognitive impairment|mild cognitive impairment
1294052|NCT01608256|Automobile Driving|automobile driving
1294053|NCT01608256|cognitive aspects|cognitive aspects
1294054|NCT01608217|Behavioural disturbances|behavioural disturbances
1294055|NCT01608217|Pain|pain
1294056|NCT01608217|Dementia|dementia
1294057|NCT01608217|Alzheimer's dementia|alzheimer's dementia
1294058|NCT01608217|Vascular dementia|vascular dementia
1294060|NCT01608217|Cannabis|cannabis
1294061|NCT01608204|Pharmacokinetics|pharmacokinetics
1294062|NCT01608204|Busulfan|busulfan
1294063|NCT01608204|Polymorphism|polymorphism
1294064|NCT01608204|GST|gst
1294065|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
1294066|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
1294067|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
1294068|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
1294069|NCT01608178|GABA|gaba
1294070|NCT01608178|Epilepsy|epilepsy
1294071|NCT01608165|Small renal cancer mass|small renal cancer mass
1294072|NCT01608152|Leukemia|leukemia
1294073|NCT01608152|Lymphoma|lymphoma
1294074|NCT01608152|Game mechanics|game mechanics
1294075|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
1294076|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1294077|NCT01608152|HSCT|hsct
1294078|NCT01608152|Internet-based|internet-based
1294079|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
1294080|NCT01608152|Questionnaires|questionnaires
1294081|NCT01608152|Focus groups|focus groups
1294082|NCT01608152|Interviews|interviews
1294083|NCT01608139|Advanced Cancers|advanced cancers
1294084|NCT01608139|Advanced Solid Tumors|advanced solid tumors
1294085|NCT01608139|Curcumin|curcumin
1294086|NCT01608139|Sorafenib|sorafenib
1294087|NCT01608139|Nexavar|nexavar
1294088|NCT01608139|Bay 43-9006|bay 43-9006
1294089|NCT01608139|Vorinostat|vorinostat
1294090|NCT01608139|SAHA|saha
1294091|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1294092|NCT01608139|MSK-390|msk-390
1294093|NCT01608139|Zolinza|zolinza
1294094|NCT01608126|Ultrasound|ultrasound
1294095|NCT01608126|Cervical Plexus|cervical plexus
1294096|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
1294097|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
1294098|NCT01608126|Atherectomy|atherectomy
1294099|NCT01608113|neovascular AMD|neovascular amd
1294100|NCT01608113|Optical coherence tomography|optical coherence tomography
1294101|NCT01608113|reading acuity|reading acuity
1294102|NCT01608113|contrast sensitivity|contrast sensitivity
1294103|NCT01608074|BRCA1|brca1
1294104|NCT01608074|BRCA2|brca2
1294105|NCT01608074|Prophylactic surgery|prophylactic surgery
1294106|NCT01608074|Salpingectomy|salpingectomy
1294107|NCT01608074|Fimbriectomy|fimbriectomy
1294108|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
1294109|NCT01608048|In-vitro Fertilization|in-vitro fertilization
1294110|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
1294111|NCT01608035|sciatic catheter|sciatic catheter
1294112|NCT01608035|stump catheter|stump catheter
1294113|NCT01608035|below knee amputation|below knee amputation
1294114|NCT01608009|platinum resistant|platinum resistant
1294115|NCT01608009|ovarian cancer|ovarian cancer
1294116|NCT01607996|Epidural anesthesia|epidural anesthesia
1294218|NCT01607619|CRP|crp
1294117|NCT01607996|pancreatic perfusion|pancreatic perfusion
1294118|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
1294119|NCT01607983|nitric oxide|nitric oxide
1294120|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
1294121|NCT01607983|congenital heart disease|congenital heart disease
1294122|NCT01607970|Oxytocin|oxytocin
1294123|NCT01607970|Startle|startle
1294124|NCT01607970|moral dilemma|moral dilemma
1294125|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
1294126|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
1294127|NCT01607931|Exercise|exercise
1294128|NCT01607931|Physical activity|physical activity
1294129|NCT01607931|Type 2 diabetes|type 2 diabetes
1294130|NCT01607931|Obesity|obesity
1294131|NCT01607931|Incretin effect|incretin effect
1294132|NCT01607931|GLP-1|glp-1
1294133|NCT01607931|GIP|gip
1294134|NCT01607931|Insulin secretion|insulin secretion
1294135|NCT01607931|Glucagon|glucagon
1294136|NCT01607931|Beta-cell function|beta-cell function
1294137|NCT01607931|Disposition Index|disposition index
1294138|NCT01607918|H pylori, eradication|h pylori, eradication
1294139|NCT01607905|Selinexor|selinexor
1294140|NCT01607905|KPT-330|kpt-330
1294141|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
1294142|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
1294143|NCT01607905|Adenocarcinoma|adenocarcinoma
1294144|NCT01607905|Melanoma|melanoma
1294145|NCT01607892|Selinexor|selinexor
1294146|NCT01607892|KPT-330|kpt-330
1294147|NCT01607892|Multiple Myeloma|multiple myeloma
1294148|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
1294149|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1294150|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
1294151|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1294152|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1294153|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
1294154|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1294155|NCT01607879|Prostate Cancer|prostate cancer
1294156|NCT01607879|Men|men
1294157|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
1294158|NCT01607879|Elderly|elderly
1294160|NCT01607879|Nutritional supplementation|nutritional supplementation
1294161|NCT01607840|Schizophrenia|schizophrenia
1294162|NCT01607840|Cognitive Improvement|cognitive improvement
1294163|NCT01607840|tDCS|tdcs
1294164|NCT01607840|stimulation|stimulation
1294165|NCT01607827|polypectomy|polypectomy
1294166|NCT01607827|colonoscopy|colonoscopy
1294167|NCT01607827|polyp miss rate|polyp miss rate
1294168|NCT01607827|surveillance|surveillance
1294169|NCT01607827|colorectal cancer|colorectal cancer
1294170|NCT01607814|cirrhosis|cirrhosis
1294171|NCT01607814|oxidative stress|oxidative stress
1294172|NCT01607814|NADPH oxidase|nadph oxidase
1294173|NCT01607814|isoprostanes|isoprostanes
1294174|NCT01607814|PUFA balance|pufa balance
1294175|NCT01607814|platelet activation|platelet activation
1294176|NCT01607814|coagulation abnormalities|coagulation abnormalities
1294177|NCT01607801|umbilical hernia repair|umbilical hernia repair
1294178|NCT01607801|recurrence|recurrence
1294179|NCT01607801|choice of suture|choice of suture
1294180|NCT01607801|mesh|mesh
1294181|NCT01607801|mesh/non-mesh|mesh/non-mesh
1294182|NCT01607788|Selection criteria|selection criteria
1294183|NCT01607788|Liver transplantation|liver transplantation
1294184|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
1294185|NCT01607762|Healthy|healthy
1294186|NCT01607762|Antipsychotics|antipsychotics
1294187|NCT01607762|Aripiprazole|aripiprazole
1294188|NCT01607762|Paliperidone|paliperidone
1294189|NCT01607762|Risperidone|risperidone
1294190|NCT01607762|Quetiapine|quetiapine
1294191|NCT01607762|Olanzapine|olanzapine
1294192|NCT01607749|Asthma Control|asthma control
1294193|NCT01607749|Quality of life|quality of life
1294194|NCT01607749|Children|children
1294195|NCT01607749|Asthma education|asthma education
1294196|NCT01607736|falls|falls
1294197|NCT01607736|walking|walking
1294198|NCT01607736|healthy older individuals|healthy older individuals
1294199|NCT01607736|virtual gait training|virtual gait training
1294200|NCT01607723|Sleep pattern|sleep pattern
1294201|NCT01607723|Mechanical ventilation|mechanical ventilation
1294202|NCT01607723|weaning|weaning
1294203|NCT01607723|Intensive Care|intensive care
1294204|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
1294205|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
1294206|NCT01607710|fMRI|fmri
1294207|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
1294208|NCT01607697|Parkinson's Disease|parkinson's disease
1294209|NCT01607671|Ischemic|ischemic
1294210|NCT01607671|Optic Neuropathy|optic neuropathy
1294211|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
1294212|NCT01607671|NAION|naion
1294213|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
1294214|NCT01607671|Intraocular Pressure|intraocular pressure
1294215|NCT01607658|Testosterone|testosterone
1294216|NCT01607632|posttraumatic stress|posttraumatic stress
1294219|NCT01607593|Retrospective|retrospective
1294220|NCT01607593|Sertraline|sertraline
1294221|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
1294222|NCT01607554|Lung|lung
1294223|NCT01607554|non small cell|non small cell
1294224|NCT01607554|NSCLC|nsclc
1294225|NCT01607554|Irinotecan|irinotecan
1294226|NCT01607541|HIV/AIDS|hiv/aids
1294227|NCT01607541|vulnerable populations|vulnerable populations
1294228|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
1294229|NCT01607541|peer-driven intervention|peer-driven intervention
1294230|NCT01607541|tailored intervention|tailored intervention
1294231|NCT01607541|African-American|african-american
1294232|NCT01607541|Latino/Hispanic|latino/hispanic
1294233|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
1294234|NCT01607515|Pulmonary hypertension|pulmonary hypertension
1294235|NCT01607515|Cardiac index|cardiac index
1294236|NCT01607515|impedance cardiography|impedance cardiography
1294237|NCT01607502|Pulmonary hypertension|pulmonary hypertension
1294238|NCT01607502|database|database
1294239|NCT01607502|biomarker|biomarker
1294240|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
1294241|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
1294242|NCT01607463|pain|pain
1294243|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1294244|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
1294245|NCT01607450|lean healthy control|lean healthy control
1294246|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
1294247|NCT01607424|schizophrenia|schizophrenia
1294248|NCT01607398|Japan|japan
1294249|NCT01607398|COPD|copd
1294250|NCT01607398|CAT|cat
1294251|NCT01607398|placebo|placebo
1294252|NCT01607398|serum|serum
1294253|NCT01607398|Adoair250|adoair250
1294254|NCT01607398|anti-inflammatory|anti-inflammatory
1294255|NCT01607398|sputum|sputum
1294256|NCT01607385|pharmacokinetic|pharmacokinetic
1294257|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
1294258|NCT01607385|GSK2330672|gsk2330672
1294259|NCT01607385|pharmacodynamic|pharmacodynamic
1294260|NCT01607385|GSK1614235|gsk1614235
1294261|NCT01607385|dose escalation|dose escalation
1294262|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
1294263|NCT01607359|atrial fibrillation|atrial fibrillation
1294264|NCT01607359|catheter ablation|catheter ablation
1294265|NCT01607359|dabigatran|dabigatran
1294266|NCT01607359|warfarin|warfarin
1294267|NCT01607359|oral anticoagulation|oral anticoagulation
1294268|NCT01607346|Urinary Retention|urinary retention
1294269|NCT01607333|Antiepileptics|antiepileptics
1294270|NCT01607333|suicidality|suicidality
1294271|NCT01607320|PCOS|pcos
1294272|NCT01607320|Infertility|infertility
1294273|NCT01607320|Anovulation|anovulation
1294274|NCT01607307|daikenchuto|daikenchuto
1294275|NCT01607307|postoperative ileus|postoperative ileus
1294276|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
1294277|NCT01607281|anatomical landmark|anatomical landmark
1294278|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
1294279|NCT01607268|autonomic failure|autonomic failure
1294280|NCT01607268|mangenetic resonance|mangenetic resonance
1294281|NCT01607268|neurochemistry|neurochemistry
1294282|NCT01607268|neurotransmitter|neurotransmitter
1294283|NCT01607268|glutamate|glutamate
1294285|NCT01607255|screening colonoscopy|screening colonoscopy
1294286|NCT01607255|water exchange method|water exchange method
1294287|NCT01607255|chromoendoscopy|chromoendoscopy
1294288|NCT01607242|total thyroidectomy|total thyroidectomy
1294289|NCT01607242|voice handicap index|voice handicap index
1294290|NCT01607242|swallowing disorders|swallowing disorders
1294291|NCT01607242|thyroid surgery|thyroid surgery
1294292|NCT01607242|voice disorders|voice disorders
1294293|NCT01607229|multi-frequency|multi-frequency
1294294|NCT01607229|bioelectrical impedance|bioelectrical impedance
1294295|NCT01607229|body composition|body composition
1294296|NCT01607229|hydration|hydration
1294297|NCT01607216|Prematurity|prematurity
1294298|NCT01607216|Respiratory Illness|respiratory illness
1294299|NCT01607216|Lung Function|lung function
1294300|NCT01607216|Lung Disease|lung disease
1294301|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
1294302|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
1294303|NCT01607203|good quality embryo's|good quality embryo's
1294304|NCT01607203|implantation|implantation
1294305|NCT01607203|pregnancy|pregnancy
1294306|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
1294307|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
1294308|NCT01607164|Mood management|mood management
1294309|NCT01607164|self-help|self-help
1294310|NCT01607164|depression|depression
1294311|NCT01607164|prevention|prevention
1294312|NCT01607164|cognitive behavioral|cognitive behavioral
1294313|NCT01607151|hypothermia|hypothermia
1294314|NCT01607151|normothermia|normothermia
1294315|NCT01607151|hyperthermia|hyperthermia
1294316|NCT01607138|laryngectomy|laryngectomy
1294317|NCT01607138|swallowing disturbances|swallowing disturbances
1294318|NCT01607138|speech disturbances|speech disturbances
1294319|NCT01607138|speech intelligibility|speech intelligibility
1294320|NCT01607138|voice prothesis|voice prothesis
1294321|NCT01607112|Influenza|influenza
1294322|NCT01607112|Healthy|healthy
1294323|NCT01607112|Immunogenicity|immunogenicity
1294324|NCT01607112|Elderly|elderly
1294325|NCT01607112|Safety|safety
1294326|NCT01607112|Adults|adults
1294327|NCT01607099|colonoscopy|colonoscopy
1294328|NCT01607099|bowel cleansing|bowel cleansing
1294329|NCT01607099|bowel cleanness|bowel cleanness
1294330|NCT01607099|efficiency|efficiency
1294331|NCT01607099|compatibility|compatibility
1294332|NCT01607086|Lamotrigine|lamotrigine
1294333|NCT01607086|placebo|placebo
1294334|NCT01607086|properties|properties
1294335|NCT01607086|characteristics|characteristics
1294336|NCT01607073|Dravet|dravet
1294337|NCT01607073|seizures|seizures
1294338|NCT01607073|verapamil|verapamil
1294339|NCT01607060|Critically ill patients|critically ill patients
1294340|NCT01607060|intestinal failure|intestinal failure
1294341|NCT01607047|leptospirosis|leptospirosis
1294342|NCT01607047|qPCR|qpcr
1294343|NCT01607047|cohort|cohort
1294344|NCT01607047|french west indies|french west indies
1294345|NCT01607047|blood sample collection|blood sample collection
1294346|NCT01607047|pronostic|pronostic
1294347|NCT01607047|diagnosis|diagnosis
1294348|NCT01607021|Chronic hepatitis C|chronic hepatitis c
1294349|NCT01607021|interleukin 28|interleukin 28
1294350|NCT01607021|Children|children
1294351|NCT01606995|Stroke|stroke
1294352|NCT01606995|Embolism|embolism
1294353|NCT01606995|Atrial fibrillation|atrial fibrillation
1294354|NCT01606982|prostate|prostate
1294355|NCT01606982|MDV3100|mdv3100
1294356|NCT01606982|cancer|cancer
1294357|NCT01606969|Dexmedetomidine|dexmedetomidine
1294358|NCT01606969|epinephrine|epinephrine
1294359|NCT01606969|lidocaine|lidocaine
1294360|NCT01606969|scalp infiltration|scalp infiltration
1294361|NCT01606969|craniotomy|craniotomy
1294362|NCT01606943|Aortic dissection|aortic dissection
1294363|NCT01606943|Risk factor|risk factor
1294364|NCT01606943|Feature|feature
1294365|NCT01606943|Management|management
1294366|NCT01606943|Outcome|outcome
1294367|NCT01606930|Patient Satisfaction|patient satisfaction
1294368|NCT01606930|Patient Doctor Communication|patient doctor communication
1294369|NCT01606930|Shared Decision Making|shared decision making
1294370|NCT01606930|Patient Activation|patient activation
1294371|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
1294372|NCT01606891|community home visiting parents|community home visiting parents
1294373|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
1294374|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
1294375|NCT01606852|sedation|sedation
1294376|NCT01606852|mechanical ventilation|mechanical ventilation
1294377|NCT01606852|anxiety|anxiety
1294378|NCT01606852|respiratory failure|respiratory failure
1294379|NCT01606826|Severe|severe
1294380|NCT01606787|Kidney|kidney
1294381|NCT01606787|MANNITOL|mannitol
1294382|NCT01606787|PLACEBO|placebo
1294383|NCT01606787|Partial Nephrectomy|partial nephrectomy
1294384|NCT01606787|12-079|12-079
1294385|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
1610126|NCT00357409|MRS|mrs
1294386|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
1294387|NCT01606761|Sirukumab|sirukumab
1294388|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
1294389|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1294390|NCT01606748|Solid Cancers|solid cancers
1294391|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
1294392|NCT01606748|NSCLC|nsclc
1294393|NCT01606748|Breast Cancer|breast cancer
1294394|NCT01606735|cataract surgery|cataract surgery
1294395|NCT01606735|ocular inflammation|ocular inflammation
1294396|NCT01606722|Antiretroviral therapy|antiretroviral therapy
1294397|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
1294398|NCT01606722|Resistance|resistance
1294399|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
1294400|NCT01606709|GnRHa trigger|gnrha trigger
1294401|NCT01606709|endometrial gene profile|endometrial gene profile
1294402|NCT01606709|quality of life|quality of life
1294403|NCT01606696|CAD|cad
1294404|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
1294405|NCT01606696|fitness|fitness
1294406|NCT01606683|Acidified milk|acidified milk
1294407|NCT01606683|Beta-palmitate|beta-palmitate
1294408|NCT01606683|Bifidobacteria|bifidobacteria
1294409|NCT01606683|Breastfeeding|breastfeeding
1294410|NCT01606683|Infant formula|infant formula
1294411|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
1294412|NCT01606683|Growth|growth
1294413|NCT01606683|Infants|infants
1294414|NCT01606683|Metabolomics|metabolomics
1294415|NCT01606683|Prebiotics|prebiotics
1294416|NCT01606670|Rotigotine|rotigotine
1294417|NCT01606670|Neupro®|neupro®
1294418|NCT01606657|I&D|i&d
1294419|NCT01606657|Abscess|abscess
1294420|NCT01606657|Irrigation|irrigation
1294421|NCT01606657|Cutaneous Abscess|cutaneous abscess
1294422|NCT01606644|radiation sequelae|radiation sequelae
1294423|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
1294424|NCT01606631|severe sepsis|severe sepsis
1294425|NCT01606631|toxic shock|toxic shock
1294426|NCT01606618|Self-esteem|self-esteem
1294427|NCT01606618|Spina Bifida|spina bifida
1294428|NCT01606618|Spinal cord injury|spinal cord injury
1294429|NCT01606605|Lymphoma|lymphoma
1294430|NCT01606605|Prognosis|prognosis
1294431|NCT01606605|Relapse|relapse
1294432|NCT01606605|Gene|gene
1294433|NCT01606605|microRNA|microrna
1294434|NCT01606579|Leukemia|leukemia
1294435|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
1294436|NCT01606579|AML|aml
1294437|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
1294438|NCT01606579|CML|cml
1294439|NCT01606579|MDS|mds
1294440|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
1294441|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
1294442|NCT01606579|MPN|mpn
1294443|NCT01606566|Recurrent|recurrent
1294444|NCT01606566|Head and Neck|head and neck
1294445|NCT01606566|Neoplasms|neoplasms
1294446|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
1294447|NCT01606566|Amphinex|amphinex
1294448|NCT01606566|Cancer|cancer
1294449|NCT01606566|Photodynamic therapy|photodynamic therapy
1294450|NCT01606566|Chemotherapy|chemotherapy
1294451|NCT01606566|Bleomycin|bleomycin
1294452|NCT01606553|chronic heart failure|chronic heart failure
1294453|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
1294454|NCT01606553|inspiratory muscle training|inspiratory muscle training
1294455|NCT01606540|Colles fracture|colles fracture
1294456|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
1294457|NCT01606540|Bone healing|bone healing
1294458|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
1294459|NCT01606527|hypoxia|hypoxia
1294460|NCT01606527|high altitude headache|high altitude headache
1294461|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
1294462|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1294463|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
1294464|NCT01606488|POCD|pocd
1294465|NCT01606488|Alzheimer's disease|alzheimer's disease
1294466|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
1294467|NCT01606475|Islet transplant|islet transplant
1294468|NCT01606475|Diabetes Mellitus|diabetes mellitus
1294469|NCT01606475|Hypoglycemia|hypoglycemia
1294470|NCT01606462|oxytocin|oxytocin
1294471|NCT01606462|social cognition|social cognition
1294472|NCT01606462|fMRI|fmri
1294473|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
1294474|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
1294475|NCT01606449|Hiatal Hernia|hiatal hernia
1294476|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
1294477|NCT01606358|Ovarian Cancer|ovarian cancer
1294478|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
1294479|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
1294480|NCT01606345|UTUC|utuc
1294481|NCT01606345|Kidney|kidney
1294482|NCT01606345|Cancer|cancer
1294483|NCT01606345|Renal|renal
1294484|NCT01606319|Asthma|asthma
1294485|NCT01606319|Wheezing|wheezing
1294486|NCT01606319|Ibuprofen|ibuprofen
1294487|NCT01606319|Acetaminophen|acetaminophen
1294488|NCT01606319|exacerbations|exacerbations
1294489|NCT01606319|pain|pain
1294490|NCT01606319|fever|fever
1294491|NCT01606306|Asthma|asthma
1294492|NCT01606306|Wheezing|wheezing
1294493|NCT01606306|Fluticasone|fluticasone
1294494|NCT01606306|Montelukast|montelukast
1294495|NCT01606306|Preschool-age|preschool-age
1294496|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
1294497|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
1294498|NCT01606293|Online surveys|online surveys
1294499|NCT01606293|Electronic surveys|electronic surveys
1294500|NCT01606293|Questionnaires|questionnaires
1294501|NCT01606293|Facebook|facebook
1294502|NCT01606293|Social networking support groups|social networking support groups
1294503|NCT01606280|Amyloidosis|amyloidosis
1294504|NCT01606267|Integrated Community Case Management|integrated community case management
1294505|NCT01606267|Pneumonia|pneumonia
1294506|NCT01606267|Ethiopia|ethiopia
1294507|NCT01606254|Schizophrenia|schizophrenia
1294508|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
1294509|NCT01606254|JNS010|jns010
1294510|NCT01606228|Schizophrenia|schizophrenia
1294511|NCT01606228|Paliperidone ER|paliperidone er
1294512|NCT01606228|Treatment naive patients|treatment naive patients
1294513|NCT01606228|Newly diagnosed patients|newly diagnosed patients
1294514|NCT01606215|multiple sclerosis|multiple sclerosis
1294515|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
1294516|NCT01606215|bone marrow|bone marrow
1294517|NCT01606215|rapidly evolving|rapidly evolving
1294518|NCT01606150|neonate|neonate
1294519|NCT01606150|late preterm|late preterm
1294520|NCT01606150|lumbar puncture|lumbar puncture
1294521|NCT01606150|analgesia|analgesia
1294522|NCT01606150|pain|pain
1294523|NCT01606150|lidocaine|lidocaine
1294524|NCT01606098|Surgery|surgery
1294525|NCT01606098|Chemotherapy|chemotherapy
1294526|NCT01606085|Diabetes|diabetes
1294527|NCT01606085|Heart Failure|heart failure
1294528|NCT01606085|Quality of Life|quality of life
1294529|NCT01606085|Self Care|self care
1294530|NCT01606072|DDAVP|ddavp
1294531|NCT01606033|stress|stress
1294532|NCT01606033|Life quality|life quality
1294533|NCT01606033|adjustment strategy|adjustment strategy
1294534|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
1294535|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
1294536|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
1294537|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
1294538|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1294539|NCT01606020|male, healthy volunteers|male, healthy volunteers
1294540|NCT01605981|Nilotinib|nilotinib
1294541|NCT01605981|CML patients|cml patients
1294542|NCT01605981|accelerated phase|accelerated phase
1294543|NCT01605968|Obstetrics|obstetrics
1294544|NCT01605968|Gynecology|gynecology
1294545|NCT01605968|Wound healing|wound healing
1294546|NCT01605955|SPO2|spo2
1294547|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
1294548|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
1294549|NCT01605929|Humans|humans
1294550|NCT01605929|Nerve Block/methods|nerve block/methods
1294551|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
1294552|NCT01605929|Catheters, Indwelling|catheters, indwelling
1294553|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
1294554|NCT01605929|Analgesia/methods|analgesia/methods
1294752|NCT01605110|healing|healing
1294555|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
1294556|NCT01605916|Cancer,|cancer,
1294557|NCT01605916|Tumour,|tumour,
1294558|NCT01605916|Metastatic,|metastatic,
1294559|NCT01605916|Lung cancer,|lung cancer,
1294560|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
1294561|NCT01605903|Tonsillectomy|tonsillectomy
1294562|NCT01605903|adenoidectomy|adenoidectomy
1294563|NCT01605903|bleeding|bleeding
1294564|NCT01605903|bleeding rates|bleeding rates
1294565|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
1294566|NCT01605890|HIV-2|hiv-2
1294567|NCT01605877|Cataracts|cataracts
1294568|NCT01605877|Intraocular lens|intraocular lens
1294569|NCT01605877|Multifocal|multifocal
1294570|NCT01605877|Presbyopia|presbyopia
1294571|NCT01605864|pneumonia|pneumonia
1294572|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
1294574|NCT01605864|CABP|cabp
1294575|NCT01605864|bacterial pneumonia|bacterial pneumonia
1294576|NCT01605851|PFO|pfo
1294577|NCT01605851|closure|closure
1294578|NCT01605838|TBI|tbi
1294579|NCT01605812|IOL;|iol;
1294580|NCT01605812|capsule；|capsule；
1294581|NCT01605812|PCO;|pco;
1294582|NCT01605812|OCT|oct
1294583|NCT01605799|PTSD|ptsd
1294584|NCT01605799|Mental Health|mental health
1294585|NCT01605799|War|war
1294586|NCT01605799|Veterans|veterans
1294587|NCT01605786|Malaria|malaria
1294588|NCT01605786|Plasmodium falciparum|plasmodium falciparum
1294589|NCT01605786|vaccine|vaccine
1294590|NCT01605786|ADCI|adci
1294591|NCT01605786|sporozoite challenge|sporozoite challenge
1294592|NCT01605786|pre-erythrocytic|pre-erythrocytic
1294593|NCT01605786|erythrocytic|erythrocytic
1294594|NCT01605760|immunotherapy|immunotherapy
1294595|NCT01605760|elderly|elderly
1294596|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
1294597|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
1294598|NCT01605734|sorafenib|sorafenib
1294599|NCT01605721|Everolimus|everolimus
1294600|NCT01605721|XIENCE PRIME|xience prime
1294601|NCT01605721|Drug eluting stent|drug eluting stent
1294602|NCT01605708|Itching|itching
1294603|NCT01605695|reference range|reference range
1294604|NCT01605695|plasma|plasma
1294605|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
1294606|NCT01605695|iNOS|inos
1294607|NCT01605695|healthy adults|healthy adults
1294608|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
1294609|NCT01605682|adults|adults
1294610|NCT01605669|Auscultation|auscultation
1294611|NCT01605669|Aortic stenosis|aortic stenosis
1294612|NCT01605669|computer assisted auscultation|computer assisted auscultation
1294613|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
1294614|NCT01605656|Cancer Prevention|cancer prevention
1294615|NCT01605656|Cervix|cervix
1294616|NCT01605656|Questionnaires|questionnaires
1294617|NCT01605656|Focus groups|focus groups
1294618|NCT01605656|Surveys|surveys
1294619|NCT01605656|Interviews|interviews
1294620|NCT01605643|cancer|cancer
1294621|NCT01605643|tobacco use|tobacco use
1294622|NCT01605643|pregnancy|pregnancy
1294623|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
1294624|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
1294625|NCT01605591|bending type|bending type
1294626|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
1294627|NCT01605552|Depression|depression
1294628|NCT01605552|Depressive Symptoms|depressive symptoms
1294629|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1294630|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1294631|NCT01605552|Heart Disease|heart disease
1294632|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
1294634|NCT01605474|foley catheter|foley catheter
1294635|NCT01605474|foley bulb|foley bulb
1294636|NCT01605474|induction of labor|induction of labor
1294637|NCT01605474|labor|labor
1294638|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
1294639|NCT01605448|Alzheimer's disease|alzheimer's disease
1294640|NCT01605448|Meditation|meditation
1294641|NCT01605448|Default Mode Network|default mode network
1294642|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
1294643|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1294644|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1294645|NCT01605422|Clinical practice guidelines|clinical practice guidelines
1294646|NCT01605422|Clinical trials|clinical trials
1294647|NCT01605422|Dietary pulses|dietary pulses
1294648|NCT01605422|legumes|legumes
1294649|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
1294650|NCT01605422|glycemic index|glycemic index
1294651|NCT01605422|postprandial glycemia|postprandial glycemia
1294652|NCT01605422|insulin resistance|insulin resistance
1294653|NCT01605422|body weight|body weight
1294654|NCT01605422|appetite|appetite
1294655|NCT01605422|food intake regulation|food intake regulation
1294656|NCT01605422|satiety|satiety
1294657|NCT01605422|satiation|satiation
1294658|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
1294659|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
1294660|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
1294661|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
1294662|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
1294663|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
1294664|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
1294665|NCT01605383|Bone marrow|bone marrow
1294666|NCT01605383|Tissue engineering|tissue engineering
1294667|NCT01605383|Bone Diseases|bone diseases
1294668|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
1294669|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
1294670|NCT01605357|Brain Injuries|brain injuries
1294671|NCT01605357|Hematoma, subdural|hematoma, subdural
1294672|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
1294673|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
1294674|NCT01605357|Hypernatremia|hypernatremia
1294675|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
1294676|NCT01605357|Head Injuries, closed|head injuries, closed
1294677|NCT01605357|Intracranial pressure|intracranial pressure
1294678|NCT01605357|Brain edema|brain edema
1294679|NCT01605357|Critical care|critical care
1294680|NCT01605357|Brain Diseases|brain diseases
1396157|NCT01180738|balance|balance
1294681|NCT01605357|Central Nervous System Diseases|central nervous system diseases
1294682|NCT01605357|Nervous System Diseases|nervous system diseases
1294683|NCT01605357|Wounds and Injuries|wounds and injuries
1294684|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
1294685|NCT01605357|Pharmacologic Actions|pharmacologic actions
1294686|NCT01605344|Advanced colon cancer|advanced colon cancer
1294687|NCT01605344|Advanced rectal cancer|advanced rectal cancer
1294688|NCT01605344|Metastatic colon cancer|metastatic colon cancer
1294689|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
1294690|NCT01605344|Lipitor|lipitor
1294691|NCT01605344|Atorvastatin|atorvastatin
1294692|NCT01605344|FOLFIRI|folfiri
1294693|NCT01605331|Adults|adults
1294694|NCT01605331|GH deficiency|gh deficiency
1294695|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
1294696|NCT01605318|colon cancer|colon cancer
1294697|NCT01605318|rectal cancer|rectal cancer
1294698|NCT01605318|previously treated|previously treated
1294699|NCT01605292|Transradial catheterization|transradial catheterization
1294700|NCT01605292|Ultrasound|ultrasound
1294701|NCT01605292|Radial artery|radial artery
1294702|NCT01605279|Low superior vena cava flow|low superior vena cava flow
1294703|NCT01605279|Functional echocardiography|functional echocardiography
1294704|NCT01605266|pediatric|pediatric
1294705|NCT01605266|kidney disease|kidney disease
1294706|NCT01605266|minimal change disease|minimal change disease
1294707|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1294708|NCT01605266|nephrotic syndrome|nephrotic syndrome
1294709|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
1294710|NCT01605253|sleep disturbance|sleep disturbance
1294711|NCT01605253|insomnia|insomnia
1294712|NCT01605253|cytokines|cytokines
1294713|NCT01605253|anxiety|anxiety
1294714|NCT01605253|traumatic event|traumatic event
1294715|NCT01605253|memory|memory
1294716|NCT01605240|Fracture pain|fracture pain
1294717|NCT01605240|Fracture reduction|fracture reduction
1294718|NCT01605240|Analgesia|analgesia
1294719|NCT01605240|Acetaminophen|acetaminophen
1294720|NCT01605240|Ibuprofen|ibuprofen
1294721|NCT01605240|Codeine|codeine
1294722|NCT01605240|Pediatric|pediatric
1294723|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
1294724|NCT01605227|prostate cancer|prostate cancer
1294725|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
1294726|NCT01605227|bone pain|bone pain
1294727|NCT01605227|CRPC|crpc
1294728|NCT01605214|Extravascular Lung Water|extravascular lung water
1294729|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
1294730|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
1294731|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
1294732|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
1294733|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
1294734|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
1294735|NCT01605149|Diabetes|diabetes
1294736|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
1294737|NCT01605136|EPP|epp
1294738|NCT01605136|Afamelanotide|afamelanotide
1294739|NCT01605123|endothelial function|endothelial function
1294740|NCT01605123|children|children
1294741|NCT01605123|obesity|obesity
1294742|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
1294743|NCT01605123|carotid intima media thickness|carotid intima media thickness
1294744|NCT01605123|blood pressure|blood pressure
1294745|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
1294746|NCT01605110|blepharoplasty|blepharoplasty
1294747|NCT01605110|hyperbaric|hyperbaric
1294748|NCT01605110|oxygen|oxygen
1294749|NCT01605110|ecchymosis|ecchymosis
1294750|NCT01605110|edema|edema
1294751|NCT01605110|wound|wound
1294753|NCT01605097|prostate neoplasms|prostate neoplasms
1294754|NCT01605097|interstitial radiation|interstitial radiation
1294755|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
1294756|NCT01605097|dose escalation|dose escalation
1294757|NCT01605071|menopause|menopause
1294758|NCT01605071|estrogen|estrogen
1294759|NCT01605071|insulin sensitivity|insulin sensitivity
1294760|NCT01605071|estrogen receptors|estrogen receptors
1294761|NCT01605045|Cardiac catheterization|cardiac catheterization
1294762|NCT01605045|Radiation|radiation
1294763|NCT01605019|Ventricular Assist Devices|ventricular assist devices
1294764|NCT01605019|Heart assist pumps|heart assist pumps
1294765|NCT01605019|heart pumps|heart pumps
1294766|NCT01605019|sealant agents|sealant agents
1294767|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1294768|NCT01605006|ALS|als
1294769|NCT01605006|motor neuron disease|motor neuron disease
1294770|NCT01605006|diaphragm|diaphragm
1294771|NCT01605006|diaphragm pacing|diaphragm pacing
1294772|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
1294773|NCT01605006|phrenic pacing|phrenic pacing
1294774|NCT01605006|phrenic nerve|phrenic nerve
1294775|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
1294776|NCT01605006|NeuRx DPS|neurx dps
1294777|NCT01605006|DPS|dps
1294778|NCT01605006|chronic hypoventilation|chronic hypoventilation
1294779|NCT01605006|respiration|respiration
1294780|NCT01605006|ventilation|ventilation
1294781|NCT01605006|breathing|breathing
1294782|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
1294783|NCT01605006|HDE|hde
1294784|NCT01605006|post-approval study|post-approval study
1294785|NCT01604993|Dietary Nitrates|dietary nitrates
1294786|NCT01604993|Arterial Stiffness|arterial stiffness
1294787|NCT01604993|Vascular|vascular
1294788|NCT01604993|Blood pressure|blood pressure
1294789|NCT01604954|Food labeling|food labeling
1294790|NCT01604928|Overactive Bladder|overactive bladder
1294791|NCT01604928|YM178|ym178
1294792|NCT01604928|Mirabegron|mirabegron
1294793|NCT01604928|Frequency|frequency
1294794|NCT01604928|Urinary urge incontinence|urinary urge incontinence
1294795|NCT01604928|Urgency|urgency
1294796|NCT01604928|Urinary incontinence|urinary incontinence
1294797|NCT01604928|Micturition|micturition
1294798|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
1294799|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
1294800|NCT01604876|Parkinson's disease|parkinson's disease
1294801|NCT01604876|depression|depression
1294802|NCT01604876|light therapy|light therapy
1294803|NCT01604876|sleeping problems|sleeping problems
1294804|NCT01604863|Solid Tumors|solid tumors
1294805|NCT01604863|Cancer|cancer
1294806|NCT01604863|Lung Cancer|lung cancer
1294807|NCT01604863|Prostate Cancer|prostate cancer
1294808|NCT01604863|Mesothelioma|mesothelioma
1294809|NCT01604863|Small Cell lung Cancer|small cell lung cancer
1294810|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1294811|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1294812|NCT01604850|HCV|hcv
1294813|NCT01604850|Sustained Virologic Response|sustained virologic response
1294814|NCT01604850|Direct Acting Antiviral|direct acting antiviral
1294815|NCT01604850|Combination Therapy|combination therapy
1294816|NCT01604850|Treatment Experienced|treatment experienced
1294817|NCT01604850|GS-7977|gs-7977
1294818|NCT01604850|Ribavirin|ribavirin
1294819|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
1294820|NCT01604837|pelvic malignancy|pelvic malignancy
1294821|NCT01604837|chronic pelvic pain|chronic pelvic pain
1294822|NCT01604798|proteomics|proteomics
1294823|NCT01604798|serum peptides|serum peptides
1294824|NCT01604798|colorectal cancer|colorectal cancer
1294825|NCT01604798|MALDI-TOF MS|maldi-tof ms
1294826|NCT01604785|Migraine Headache|migraine headache
1294827|NCT01604785|Pediatric|pediatric
1294828|NCT01604759|Mouth Neoplasms|mouth neoplasms
1294829|NCT01604759|Mouth Diseases|mouth diseases
1294830|NCT01604733|Multi-Center Survey|multi-center survey
1294831|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
1294832|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
1294833|NCT01604720|sample size|sample size
1294834|NCT01604720|liver disease|liver disease
1294835|NCT01604707|stress|stress
1294836|NCT01604707|anxiety|anxiety
1294837|NCT01604707|depression|depression
1294838|NCT01604707|quality of life|quality of life
1294839|NCT01604694|Abdominoplasty|abdominoplasty
1294840|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
1294841|NCT01604694|levobupivacaine|levobupivacaine
1294842|NCT01604694|Placebo|placebo
1294843|NCT01604681|Linseed Oil|linseed oil
1294844|NCT01604681|Oxidative Stress|oxidative stress
1294845|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
1294846|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
1294847|NCT01604655|Chest pain|chest pain
1294848|NCT01604655|shortness of breath|shortness of breath
1294849|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
1294850|NCT01604655|stress testing|stress testing
1294851|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
1294852|NCT01604629|Spondylarthropathies|spondylarthropathies
1294853|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
1294854|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
1294855|NCT01604590|Glioblastoma|glioblastoma
1294856|NCT01604590|Imaging Biomarkers|imaging biomarkers
1294857|NCT01604590|Bevacizumab|bevacizumab
1294858|NCT01604590|MRI|mri
1294859|NCT01604577|health literacy|health literacy
1294860|NCT01604577|health numeracy|health numeracy
1294861|NCT01604564|Registry|registry
1294862|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
1294863|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
1294864|NCT01604564|IPAA|ipaa
1294865|NCT01604512|Brain tumor|brain tumor
1294866|NCT01604512|MRI Perfusion|mri perfusion
1294867|NCT01604512|FDG PET/CT|fdg pet/ct
1294868|NCT01604512|12-067|12-067
1294869|NCT01604499|Healthy eating|healthy eating
1294870|NCT01604499|Incentives|incentives
1294871|NCT01604499|Feedback|feedback
1294872|NCT01604486|Myocardial infarction|myocardial infarction
1294873|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
1294874|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1294875|NCT01604486|General Practice Research Database|general practice research database
1294876|NCT01604486|Hospital Episode Statistics|hospital episode statistics
1294877|NCT01604486|Office for National Statistics|office for national statistics
1294878|NCT01604473|Chronic Kidney Disease|chronic kidney disease
1294879|NCT01604473|CKD|ckd
1294880|NCT01604473|ESRD|esrd
1294881|NCT01604473|AV Fistula|av fistula
1294882|NCT01604473|Arterio-venous fistula|arterio-venous fistula
1294883|NCT01604473|hemodialysis|hemodialysis
1294884|NCT01604460|Hypothermia|hypothermia
1294885|NCT01604460|Newborn|newborn
1294886|NCT01604460|Plastic bag|plastic bag
1294887|NCT01604460|Resuscitation|resuscitation
1294888|NCT01604447|Hypothermia|hypothermia
1294889|NCT01604447|Newborn|newborn
1294890|NCT01604447|Incubator|incubator
1294891|NCT01604447|Plastic bag|plastic bag
1294892|NCT01604447|Normothermia|normothermia
1294893|NCT01604434|Hypothermia|hypothermia
1294894|NCT01604434|Low birth Weight|low birth weight
1294895|NCT01604434|Newborn|newborn
1294896|NCT01604434|Incubator|incubator
1294897|NCT01604434|Plastic bag|plastic bag
1294898|NCT01604421|Hypothermia|hypothermia
1294899|NCT01604421|Low birth weight|low birth weight
1294900|NCT01604421|Newborn|newborn
1294901|NCT01604421|Plastic bag|plastic bag
1294902|NCT01604421|Thermoregulation|thermoregulation
1294903|NCT01604395|GHD|ghd
1294904|NCT01604395|TS|ts
1294905|NCT01604395|CRF|crf
1294906|NCT01604395|SGA|sga
1294907|NCT01604395|ISS|iss
1294908|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
1294909|NCT01604369|Atrial flutter|atrial flutter
1294910|NCT01604369|Cryoablation|cryoablation
1294911|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
1294912|NCT01604369|Visual analogue scale|visual analogue scale
1294913|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
1294914|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
1294915|NCT01604343|Sirukumab|sirukumab
1294916|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
1294917|NCT01604330|High dose baclofen|high dose baclofen
1294918|NCT01604330|Alcoholism|alcoholism
1294919|NCT01604330|Abstinence|abstinence
1294920|NCT01604330|Low risk consumption|low risk consumption
1294921|NCT01604330|Craving|craving
1294922|NCT01604317|Hypothermia|hypothermia
1294923|NCT01604317|Low birth Weight|low birth weight
1294924|NCT01604317|Newborn|newborn
1294925|NCT01604317|Resuscitation|resuscitation
1294926|NCT01604317|Plastic bag|plastic bag
1294927|NCT01604304|stone|stone
1294928|NCT01604304|calculi|calculi
1294929|NCT01604304|kidney|kidney
1294930|NCT01604304|renal treatment|renal treatment
1294931|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
1294932|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
1294933|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
1294934|NCT01604278|Indacaterol|indacaterol
1294935|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
1294936|NCT01604278|COPD|copd
1294937|NCT01604278|bronchodilation|bronchodilation
1294938|NCT01604239|Osteoarthritis|osteoarthritis
1294939|NCT01604239|Shinbaro|shinbaro
1294940|NCT01604239|Herbal drug|herbal drug
1294941|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
1294942|NCT01604226|Bispectral index monitoring|bispectral index monitoring
1294943|NCT01604226|propofol|propofol
1294944|NCT01604226|remifentanil|remifentanil
1294945|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
1294946|NCT01604213|vildagliptin|vildagliptin
1294947|NCT01604213|metformin|metformin
1294948|NCT01604213|atherosclerosis|atherosclerosis
1294949|NCT01604213|inflammation|inflammation
1294950|NCT01604213|interleukin-6|interleukin-6
1294951|NCT01604213|TNF|tnf
1294952|NCT01604213|atherothrombosis|atherothrombosis
1294953|NCT01604213|adiponectin|adiponectin
1294954|NCT01604213|MMP-9|mmp-9
1294956|NCT01604200|hypertension|hypertension
1294957|NCT01604200|dentistry|dentistry
1294958|NCT01604200|blood pressure|blood pressure
1294959|NCT01604200|measurement|measurement
1294960|NCT01604200|screening|screening
1294961|NCT01604200|qualitative research|qualitative research
1294962|NCT01604187|sublingual fentanyl|sublingual fentanyl
1294963|NCT01604187|pain in coloscopy|pain in coloscopy
1294964|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
1294965|NCT01604174|knee|knee
1294966|NCT01604174|osteoarthritis|osteoarthritis
1294967|NCT01604174|arthroplasty|arthroplasty
1294968|NCT01604174|rehabilitation|rehabilitation
1294969|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
1294970|NCT01604135|Collagen crosslinking|collagen crosslinking
1294971|NCT01604135|Keratoconus|keratoconus
1294972|NCT01604122|Survey|survey
1294973|NCT01604122|burden of illness|burden of illness
1294974|NCT01604122|caregivers|caregivers
1294975|NCT01604122|TTR-FAP|ttr-fap
1294976|NCT01604122|TTR-CM|ttr-cm
1294977|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
1294978|NCT01604122|observational|observational
1294979|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
1294980|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
1294981|NCT01604109|Preventive Dentistry|preventive dentistry
1294982|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
1294983|NCT01604109|Remineralization|remineralization
1294984|NCT01604109|Clinical trial|clinical trial
1294985|NCT01604096|Information|information
1294986|NCT01604096|campaign|campaign
1294987|NCT01604096|antibiotics|antibiotics
1294988|NCT01604096|bacterial resistance|bacterial resistance
1294989|NCT01604096|primary care|primary care
1294990|NCT01604083|transfusion|transfusion
1294991|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
1294992|NCT01604083|Transfusion Practice|transfusion practice
1294993|NCT01604083|Transfusion habits|transfusion habits
1294994|NCT01604083|Outcome|outcome
1294995|NCT01604083|elective surgery|elective surgery
1294996|NCT01604083|ETPOS|etpos
1294997|NCT01604083|ESA|esa
1294998|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
1294999|NCT01604070|Hammertoe deformity|hammertoe deformity
1295000|NCT01604070|podiatry|podiatry
1295001|NCT01604031|B-CLL|b-cll
1295002|NCT01604031|vaccine|vaccine
1295003|NCT01604031|Lenalidomide|lenalidomide
1295004|NCT01604031|CTL|ctl
1295005|NCT01604018|Cat Allergy|cat allergy
1295006|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
1295007|NCT01604005|Mesothelioma|mesothelioma
1295008|NCT01604005|radiotherapy|radiotherapy
1295009|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
1295010|NCT01603992|Cannabis|cannabis
1295011|NCT01603992|Craving|craving
1295012|NCT01603992|Questionnaire|questionnaire
1295013|NCT01603992|Non-Treatment|non-treatment
1295014|NCT01603992|Drug Use|drug use
1295015|NCT01603979|AV203|av203
1295016|NCT01603979|Solid Tumors|solid tumors
1295017|NCT01603979|ERBB3|erbb3
1295018|NCT01603979|Monoclonal Antibody|monoclonal antibody
1295019|NCT01603979|HER3|her3
1295020|NCT01603966|platelet|platelet
1295021|NCT01603966|aggregation|aggregation
1295022|NCT01603966|aspirin|aspirin
1295023|NCT01603966|inhibition|inhibition
1295024|NCT01603966|reactivity|reactivity
1295025|NCT01603940|Hypertension|hypertension
1295026|NCT01603940|Diabetes Mellitus|diabetes mellitus
1295027|NCT01603940|Vascular stiffness|vascular stiffness
1295028|NCT01603940|Endothelial function|endothelial function
1295029|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
1295030|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
1295031|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
1295032|NCT01603888|children with heart disease|children with heart disease
1295033|NCT01603888|infants|infants
1295034|NCT01603888|healthy newborns|healthy newborns
1295035|NCT01603875|CPRV|cprv
1295036|NCT01603875|SPEEDA|speeda
1295037|NCT01603875|intradermal|intradermal
1295038|NCT01603875|pre-exposure|pre-exposure
1295039|NCT01603875|booster|booster
1295040|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1295041|NCT01603849|Lung Cancer|lung cancer
1295042|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
1295171|NCT01603303|Internet based website|internet based website
1295043|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
1295044|NCT01603836|Lumbar spine|lumbar spine
1295045|NCT01603836|Posterolateral fusion|posterolateral fusion
1295046|NCT01603836|Allograft|allograft
1295047|NCT01603836|Bone marrow concentrate|bone marrow concentrate
1295048|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
1295049|NCT01603836|Fusion rate|fusion rate
1295050|NCT01603784|exercise|exercise
1295051|NCT01603784|cognition|cognition
1295052|NCT01603784|memory|memory
1295053|NCT01603784|adult|adult
1295054|NCT01603771|Adult|adult
1295055|NCT01603771|Exercise|exercise
1295056|NCT01603771|Cognition|cognition
1295058|NCT01603758|Cholesterol|cholesterol
1295059|NCT01603758|Spectrometry, mass|spectrometry, mass
1295060|NCT01603758|Deuterium|deuterium
1295061|NCT01603758|Kinetics|kinetics
1295062|NCT01603758|Cholesterol absorption|cholesterol absorption
1295063|NCT01603758|Coronary Heart Disease|coronary heart disease
1295064|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
1295065|NCT01603719|infant formula|infant formula
1295066|NCT01603719|prebiotics|prebiotics
1295067|NCT01603719|beta-palmitate|beta-palmitate
1295068|NCT01603719|stool flora|stool flora
1295069|NCT01603719|bifidogenic|bifidogenic
1295070|NCT01603563|Stepped Care|stepped care
1295071|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
1295072|NCT01603563|Preschool children|preschool children
1295073|NCT01603550|energy restriction|energy restriction
1295074|NCT01603550|sleep deprivation|sleep deprivation
1295075|NCT01603550|cognitive performance|cognitive performance
1295076|NCT01603550|brain function|brain function
1610127|NCT00357409|Blind|blind
1295077|NCT01603537|Traumatic injuries|traumatic injuries
1295078|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
1295079|NCT01603537|Traffic accidents|traffic accidents
1295080|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
1295081|NCT01603524|Primary Care|primary care
1295082|NCT01603511|rewarming|rewarming
1295083|NCT01603511|core cooling|core cooling
1295084|NCT01603511|afterdrop|afterdrop
1295085|NCT01603511|pre-hospital treatment|pre-hospital treatment
1295086|NCT01603511|hypothermia|hypothermia
1295087|NCT01603498|pain measurement,|pain measurement,
1295088|NCT01603498|edema,|edema,
1295089|NCT01603498|trismus|trismus
1295090|NCT01603407|prednisone|prednisone
1295091|NCT01603407|deflazacort|deflazacort
1295092|NCT01603407|muscular dystrophy|muscular dystrophy
1295093|NCT01603407|neuromuscular disease|neuromuscular disease
1295094|NCT01603407|multi-center|multi-center
1295095|NCT01603823|vitrectomy|vitrectomy
1295096|NCT01603823|cataract|cataract
1295097|NCT01603823|macular edema|macular edema
1295098|NCT01603810|Basal cell carcinoma|basal cell carcinoma
1295099|NCT01603810|Optical Coherence Tomography|optical coherence tomography
1295100|NCT01603797|internetdelivered CBT|internetdelivered cbt
1295101|NCT01603797|chronic pain|chronic pain
1295102|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
1295103|NCT01603797|mindfulness|mindfulness
1295104|NCT01603797|guided self help|guided self help
1295105|NCT01603745|PCOS|pcos
1295106|NCT01603706|Heart failure|heart failure
1295107|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1295108|NCT01603706|CRT|crt
1295109|NCT01603706|Radial strain echocardiography|radial strain echocardiography
1295110|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
1295111|NCT01603693|Guided bone regeneration|guided bone regeneration
1295112|NCT01603693|Bio Oss|bio oss
1295113|NCT01603693|BondBone|bondbone
1295114|NCT01603693|computerized tomography|computerized tomography
1295115|NCT01603693|histological examination|histological examination
1295116|NCT01603680|Ultrasonography|ultrasonography
1295117|NCT01603680|Block nerve|block nerve
1295118|NCT01603680|Anaesthesia|anaesthesia
1295119|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
1295120|NCT01603654|Colon preparation|colon preparation
1295121|NCT01603654|Colonoscopy|colonoscopy
1295122|NCT01603654|Polyethylene glycol|polyethylene glycol
1295123|NCT01603654|Sodium Picosulphate|sodium picosulphate
1295124|NCT01603589|coronary artery disease|coronary artery disease
1295125|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
1295126|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
1295127|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
1295128|NCT01603485|Bioavailability|bioavailability
1295129|NCT01603485|Pharmacokinetics|pharmacokinetics
1295130|NCT01603485|Lersivirine|lersivirine
1295131|NCT01603485|Modified-release|modified-release
1295132|NCT01603472|pediatric|pediatric
1295133|NCT01603472|parenteral nutrition|parenteral nutrition
1295134|NCT01603472|bone disease|bone disease
1295135|NCT01603472|long-term PN|long-term pn
1295136|NCT01603446|pediatric|pediatric
1295137|NCT01603446|MELAS|melas
1295138|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
1295139|NCT01603420|prostate|prostate
1295140|NCT01603420|cancer|cancer
1295141|NCT01603420|radiation|radiation
1295142|NCT01603420|proton|proton
1295143|NCT01603420|chemotherapy|chemotherapy
1295144|NCT01603420|high risk|high risk
1295145|NCT01603368|Probiotics|probiotics
1295146|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
1295147|NCT01603368|Prematures|prematures
1295148|NCT01603368|Enteral feeding|enteral feeding
1295149|NCT01603368|Motility|motility
1295150|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
1295151|NCT01603368|Sepsis|sepsis
1295152|NCT01603368|Weight|weight
1295153|NCT01603355|JIA|jia
1295154|NCT01603329|medication adherence|medication adherence
1295155|NCT01603329|diabetes|diabetes
1295156|NCT01603329|hypertension|hypertension
1295157|NCT01603329|cholesterol|cholesterol
1295158|NCT01603329|statins|statins
1295159|NCT01603316|Food pantry|food pantry
1295160|NCT01603316|Food voucher|food voucher
1295161|NCT01603316|Grocery delivery|grocery delivery
1295162|NCT01603316|12-099|12-099
1295163|NCT01603303|Breast Cancer|breast cancer
1295164|NCT01603303|Localized breast cancer|localized breast cancer
1295165|NCT01603303|Postmenopausal women|postmenopausal women
1295166|NCT01603303|Aromatase inhibitor|aromatase inhibitor
1295167|NCT01603303|AI|ai
1295168|NCT01603303|Questionnaires|questionnaires
1295169|NCT01603303|Surveys|surveys
1295170|NCT01603303|Luvena|luvena
1295172|NCT01603303|Phone counseling|phone counseling
1295173|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
1295174|NCT01603303|Hyalo-Gyn|hyalo-gyn
1295175|NCT01603290|Acute leukemia,|acute leukemia,
1295176|NCT01603290|Chemotherapy,|chemotherapy,
1295177|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
1295178|NCT01603290|Physical Fitness|physical fitness
1295180|NCT01603277|GM-CSF|gm-csf
1295181|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
1295182|NCT01603264|Bioequivalence|bioequivalence
1295183|NCT01603264|Biosimilarity|biosimilarity
1295184|NCT01603264|Similarity|similarity
1295185|NCT01603264|PK|pk
1295186|NCT01603264|Phase I|phase i
1295187|NCT01603264|Trastuzumab|trastuzumab
1295188|NCT01603264|Healthy Male Volunteers|healthy male volunteers
1295189|NCT01603264|Single-dose|single-dose
1295190|NCT01603264|HER-2|her-2
1295191|NCT01603264|Oncology|oncology
1295192|NCT01603251|transmission|transmission
1295193|NCT01603251|anopheles|anopheles
1295194|NCT01603225|Autism|autism
1295195|NCT01603225|tDCS|tdcs
1295196|NCT01603212|Melanoma|melanoma
1295197|NCT01603212|Metastatic melanoma|metastatic melanoma
1295198|NCT01603212|Advanced melanoma|advanced melanoma
1295199|NCT01603212|Vemurafenib|vemurafenib
1295200|NCT01603212|PLX4032|plx4032
1295201|NCT01603212|RO5185426|ro5185426
1295202|NCT01603212|IL-2|il-2
1295203|NCT01603212|Interleukin-2|interleukin-2
1295204|NCT01603212|Aldesleukin|aldesleukin
1295205|NCT01603212|Proleukin|proleukin
1295206|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
1295207|NCT01603212|Intron A|intron a
1295208|NCT01603160|Sickle Cell Disease|sickle cell disease
1295209|NCT01603160|Emergency Department|emergency department
1295210|NCT01603160|Quality Improvement|quality improvement
1295211|NCT01603147|methamphetamine|methamphetamine
1295212|NCT01603147|monoclonal antibody|monoclonal antibody
1295213|NCT01603121|lisofylline|lisofylline
1295214|NCT01603108|Liver Transplant Recipient|liver transplant recipient
1295215|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
1295216|NCT01603095|Achondroplasia|achondroplasia
1295217|NCT01603095|dwarfism|dwarfism
1295218|NCT01603069|Parkinson's disease|parkinson's disease
1295219|NCT01603069|Safety|safety
1295220|NCT01603069|Tolerability|tolerability
1295221|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
1295222|NCT01603043|Geographic Atrophy|geographic atrophy
1295223|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
1295224|NCT01603043|Intravitreal injection|intravitreal injection
1295225|NCT01603030|Moxifloxacin|moxifloxacin
1295226|NCT01603030|Prednisolone|prednisolone
1295227|NCT01603030|LASIK|lasik
1295228|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
1295229|NCT01603017|Osteoarthrosis|osteoarthrosis
1295230|NCT01603017|Osteoarthritis|osteoarthritis
1295231|NCT01603004|MRI|mri
1295232|NCT01603004|CT|ct
1295233|NCT01603004|12-058|12-058
1295234|NCT01602991|Obesity|obesity
1295235|NCT01602991|Endoscopy|endoscopy
1295236|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
1295237|NCT01602991|Bariatric Surgery|bariatric surgery
1295238|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
1295239|NCT01602965|obesity|obesity
1295240|NCT01602965|counselling|counselling
1295241|NCT01602965|weight loss|weight loss
1295242|NCT01602952|Radotinib|radotinib
1295243|NCT01602952|CML-CP, AP|cml-cp, ap
1295244|NCT01602939|Mast cell|mast cell
1295245|NCT01602939|Mastocytosis|mastocytosis
1295246|NCT01602939|Mast cell disease|mast cell disease
1295247|NCT01602926|hallux valgus|hallux valgus
1295248|NCT01602913|Pravastatin|pravastatin
1295249|NCT01602913|Adverse Events|adverse events
1295250|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
1295251|NCT01602913|Incidence|incidence
1295252|NCT01602913|Paroxetine|paroxetine
1295253|NCT01602887|BA/BE|ba/be
1295254|NCT01602887|PK|pk
1295255|NCT01602887|PD-0332991|pd-0332991
1295256|NCT01602887|PF-05089326|pf-05089326
1295257|NCT01602887|Breast Cancer|breast cancer
1295258|NCT01602874|children|children
1295259|NCT01602874|pediatry|pediatry
1295260|NCT01602874|pneumonia|pneumonia
1295261|NCT01602874|intra-abdominal|intra-abdominal
1295262|NCT01602874|infection|infection
1295263|NCT01602861|Fibrosis|fibrosis
1295264|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
1295265|NCT01602861|kidney transplant|kidney transplant
1295266|NCT01602861|chronic rejection|chronic rejection
1295267|NCT01602848|Medicaid|medicaid
1295268|NCT01602848|frequent users|frequent users
1295269|NCT01602848|heavy users|heavy users
1295270|NCT01602848|high risk|high risk
1295271|NCT01602848|high cost|high cost
1295272|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
1295273|NCT01602835|Alport syndrome|alport syndrome
1295274|NCT01602835|proteinuria|proteinuria
1295275|NCT01602835|glomerular disease|glomerular disease
1295276|NCT01602835|hereditary nephropathy|hereditary nephropathy
1295277|NCT01602835|nephropathy|nephropathy
1295278|NCT01602822|HIV Prevention|hiv prevention
1295279|NCT01602822|NPEP|npep
1295280|NCT01602822|PEP|pep
1295281|NCT01602809|Perfusion|perfusion
1295282|NCT01602809|Microvessels|microvessels
1295283|NCT01602809|Ultrasound|ultrasound
1295284|NCT01602809|Sickle Cell Disease|sickle cell disease
1295285|NCT01602783|Radical Prostatectomy|radical prostatectomy
1295286|NCT01602770|Oral contraceptives|oral contraceptives
1295287|NCT01602770|Adverse events|adverse events
1396898|NCT01177410|IBS|ibs
1295288|NCT01602770|Safety profile|safety profile
1295289|NCT01602770|Contraceptive Agents|contraceptive agents
1295290|NCT01602744|STOPP screening tool|stopp screening tool
1295291|NCT01602744|START screening tool|start screening tool
1295292|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
1295293|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
1295294|NCT01602731|medication adherence|medication adherence
1295295|NCT01602718|physical activity|physical activity
1295296|NCT01602718|physical performance|physical performance
1295297|NCT01602718|ESRD|esrd
1295298|NCT01602718|home dialysis|home dialysis
1295299|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
1295300|NCT01602705|Medication errors|medication errors
1295301|NCT01602705|Medication review|medication review
1295302|NCT01602705|Inappropriate medication|inappropriate medication
1295303|NCT01602705|Randomised controlled trial|randomised controlled trial
1295304|NCT01602705|Primary Health Care|primary health care
1295305|NCT01602705|Family Practice|family practice
1295306|NCT01602692|Pain, postoperative|pain, postoperative
1295307|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1295308|NCT01602692|Patient Readmission|patient readmission
1295309|NCT01602692|Time to Discharge|time to discharge
1295310|NCT01602640|sedation|sedation
1295311|NCT01602640|critical care|critical care
1295312|NCT01602640|morphine|morphine
1295313|NCT01602640|fentanyl|fentanyl
1295314|NCT01602640|analgesic based sedation|analgesic based sedation
1295315|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
1295316|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
1295317|NCT01602562|Herpes simplex infection|herpes simplex infection
1295318|NCT01602562|valaciclovir|valaciclovir
1295319|NCT01602562|herpes simplex virus|herpes simplex virus
1295320|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1295321|NCT01602536|twitter|twitter
1295322|NCT01602536|quit smoking|quit smoking
1295323|NCT01602536|smoking cessation|smoking cessation
1295324|NCT01602536|social media|social media
1295325|NCT01602536|peer support|peer support
1295326|NCT01602523|Emphysema|emphysema
1295327|NCT01602523|COPD|copd
1295328|NCT01602523|Sleep|sleep
1295329|NCT01602497|Borderline personality disorder|borderline personality disorder
1295330|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1295331|NCT01602471|Endarterectomy|endarterectomy
1295332|NCT01602471|K5-C200|k5-c200
1295333|NCT01602471|RGD-K5|rgd-k5
1295334|NCT01602471|angiogenesis|angiogenesis
1295335|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
1295336|NCT01602458|Preventative Scar Management|preventative scar management
1295337|NCT01602458|Skin Grafts|skin grafts
1295338|NCT01602458|Silicone Therapy|silicone therapy
1295339|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
1295340|NCT01602445|Venous Thrombosis|venous thrombosis
1295341|NCT01602445|Coagulation factors|coagulation factors
1295342|NCT01602445|Cancer|cancer
1295343|NCT01602445|Blood|blood
1295344|NCT01602432|Venous Thrombosis|venous thrombosis
1295345|NCT01602432|Cancer|cancer
1295346|NCT01602432|Coagulation factors|coagulation factors
1295347|NCT01602432|Blood|blood
1295348|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
1295349|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
1295350|NCT01602380|endocrine|endocrine
1295351|NCT01602380|no hormone therapy|no hormone therapy
1295352|NCT01602380|hormone|hormone
1295353|NCT01602380|breast|breast
1295354|NCT01602380|cancer|cancer
1295355|NCT01602380|neoplasm|neoplasm
1295356|NCT01602380|metastatic|metastatic
1295357|NCT01602380|tumour|tumour
1295358|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
1295359|NCT01602354|Gram negative|gram negative
1295360|NCT01602354|Septic Shock|septic shock
1295361|NCT01602354|EAA|eaa
1295362|NCT01602341|atopic dermatitis|atopic dermatitis
1295363|NCT01602328|Acute Kidney Injury|acute kidney injury
1295364|NCT01602328|Acute renal failure|acute renal failure
1295365|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
1295366|NCT01602328|Allogeneic stem cells|allogeneic stem cells
1295367|NCT01602315|BYL719|byl719
1295368|NCT01602315|PI3K inhibitor|pi3k inhibitor
1295369|NCT01602315|PIK3CA|pik3ca
1295370|NCT01602315|cetuximab|cetuximab
1295371|NCT01602315|EGFR|egfr
1295372|NCT01602315|HNSCC|hnscc
1295373|NCT01602315|RM HNSCC|rm hnscc
1295374|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
1295375|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
1295376|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
1295377|NCT01602315|swallowing dysfunction|swallowing dysfunction
1295378|NCT01602315|G-tube|g-tube
1295379|NCT01602315|alpelisib|alpelisib
1295380|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
1295381|NCT01602302|ultrasound|ultrasound
1295382|NCT01602302|remission|remission
1295383|NCT01602302|biological DMARD|biological dmard
1295384|NCT01602276|Parkinson's disease|parkinson's disease
1295385|NCT01602276|Lewy body dementia|lewy body dementia
1295386|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
1295387|NCT01602276|Subcortical Dementia|subcortical dementia
1295388|NCT01602276|Huntington's Disease|huntington's disease
1295389|NCT01602263|Normal cognitive function|normal cognitive function
1295390|NCT01602263|Aphasia|aphasia
1295391|NCT01602263|Autism|autism
1295392|NCT01602263|Schizophrenia|schizophrenia
1295393|NCT01602250|Anesthetics, local|anesthetics, local
1295394|NCT01602250|Toxicity|toxicity
1295395|NCT01602250|Adverse effects|adverse effects
1295396|NCT01602211|stem cell transplant|stem cell transplant
1295397|NCT01602211|cancer survivors|cancer survivors
1295398|NCT01602211|internet|internet
1295399|NCT01602211|social media|social media
1295400|NCT01602211|distress|distress
1295401|NCT01602211|health care adherence|health care adherence
1295402|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
1295403|NCT01602185|ketamine|ketamine
1295404|NCT01602185|memantine|memantine
1295405|NCT01602185|dextromethorphan|dextromethorphan
1295406|NCT01602185|Neuropathic pain|neuropathic pain
1295407|NCT01602172|alcohol consumption|alcohol consumption
1295408|NCT01602172|inpatients|inpatients
1295409|NCT01602172|risk reduction behavior|risk reduction behavior
1295410|NCT01602172|counseling|counseling
1295411|NCT01602172|nurses|nurses
1295412|NCT01602172|brief intervention|brief intervention
1295413|NCT01602159|Claudication|claudication
1295415|NCT01602159|Open Bypass|open bypass
1295416|NCT01602159|Angioplasty|angioplasty
1295417|NCT01602159|Stenting|stenting
1295418|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
1295419|NCT01602133|venous puncture|venous puncture
1295420|NCT01602133|seldinger technique|seldinger technique
1295421|NCT01602133|ultrasound guidance|ultrasound guidance
1295422|NCT01602107|Stress|stress
1295423|NCT01602107|Urinary|urinary
1295424|NCT01602107|Incontinence|incontinence
1295425|NCT01602107|Pelvic|pelvic
1295426|NCT01602107|Physiotherapy|physiotherapy
1295427|NCT01602094|measles|measles
1295428|NCT01602094|antibody|antibody
1295429|NCT01602094|prevalence|prevalence
1295430|NCT01602094|predictors|predictors
1295431|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
1295432|NCT01602094|Measles antibody levels|measles antibody levels
1295537|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
1295433|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
1295434|NCT01602081|Anal fistula|anal fistula
1295435|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
1295436|NCT01602081|LIFT|lift
1295437|NCT01602081|Tissue graft|tissue graft
1295438|NCT01602068|Iontophoresis|iontophoresis
1295439|NCT01602068|Cataract Surgery|cataract surgery
1295440|NCT01602068|Ophthalmology|ophthalmology
1295441|NCT01602068|Posterior Chamber Intraocular Lens Implant|posterior chamber intraocular lens implant
1295442|NCT01602042|essential tremor|essential tremor
1295443|NCT01602042|motion sensors|motion sensors
1295444|NCT01602042|tremor|tremor
1295445|NCT01602029|Anti inflammatory|anti inflammatory
1295446|NCT01602029|Schizophrenia|schizophrenia
1295447|NCT01602029|Simvastatin|simvastatin
1295448|NCT01602029|Ondansetron|ondansetron
1295449|NCT01602016|ASD|asd
1295450|NCT01602016|PDD-NOS|pdd-nos
1295451|NCT01601977|COPD|copd
1295452|NCT01601977|Respiratory failure|respiratory failure
1295453|NCT01601977|NIV|niv
1295454|NCT01601977|OSA|osa
1295455|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
1295456|NCT01601951|Osteoarthritis|osteoarthritis
1295457|NCT01601951|Stem Cell Injections|stem cell injections
1295458|NCT01601951|Bone Marrow|bone marrow
1295459|NCT01601951|Autologous|autologous
1295460|NCT01601938|Sepsis|sepsis
1295461|NCT01601938|Shock, Septic|shock, septic
1295462|NCT01601938|Selenium|selenium
1295463|NCT01601938|Survival|survival
1295464|NCT01601912|Whiplash Injuries|whiplash injuries
1295465|NCT01601912|Chronic Pain|chronic pain
1295466|NCT01601912|Exercise|exercise
1295467|NCT01601912|Cognition|cognition
1295468|NCT01601899|trial|trial
1295469|NCT01601899|stavudine|stavudine
1295470|NCT01601899|tenofovir|tenofovir
1295471|NCT01601899|mitochondria|mitochondria
1295472|NCT01601899|insulin resistance|insulin resistance
1295473|NCT01601899|lipids|lipids
1295474|NCT01601899|HOMA|homa
1295475|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
1295476|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
1295477|NCT01601886|Historical Cohort Studies|historical cohort studies
1295478|NCT01601886|Clinical Trial|clinical trial
1295479|NCT01601873|Arteriovenous graft|arteriovenous graft
1295480|NCT01601873|Propaten|propaten
1295481|NCT01601873|Heparin-bonded|heparin-bonded
1295482|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
1295483|NCT01601873|Surgical|surgical
1610664|NCT00355576|Celecoxib|celecoxib
1295484|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
1295485|NCT01601860|Labor|labor
1295486|NCT01601860|vaginal delivery|vaginal delivery
1295487|NCT01601860|pain|pain
1295488|NCT01601834|Phase 1|phase 1
1295489|NCT01601834|Single Dose|single dose
1295490|NCT01601834|Pharmacokinetics|pharmacokinetics
1295491|NCT01601834|Safety|safety
1295492|NCT01601834|Toleration|toleration
1295493|NCT01601795|Cardioprotection|cardioprotection
1295494|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
1295495|NCT01601769|Colposcopy|colposcopy
1295496|NCT01601769|Exocolposcopy|exocolposcopy
1295497|NCT01601769|Leep|leep
1295498|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
1295499|NCT01601756|navigation|navigation
1295500|NCT01601756|joint line|joint line
1295501|NCT01601743|Cocaine|cocaine
1295502|NCT01601743|Exercise|exercise
1295503|NCT01601730|Cocaine|cocaine
1295504|NCT01601730|Modafinil|modafinil
1295505|NCT01601730|Escitalopram|escitalopram
1295506|NCT01601717|RTI-336|rti-336
1295507|NCT01601717|Methamphetamine|methamphetamine
1295508|NCT01601704|Body Weight|body weight
1295509|NCT01601704|Bupropion|bupropion
1295510|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
1295511|NCT01601704|Diabetes Mellitus|diabetes mellitus
1295512|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1295513|NCT01601704|Endocrine System Diseases|endocrine system diseases
1295514|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
1295515|NCT01601704|Heart Diseases|heart diseases
1295516|NCT01601704|Metabolic Diseases|metabolic diseases
1295517|NCT01601704|Narcotic Antagonists|narcotic antagonists
1295518|NCT01601704|Naltrexone|naltrexone
1295519|NCT01601704|Nutrition Disorders|nutrition disorders
1295520|NCT01601704|Obesity|obesity
1295521|NCT01601704|Overnutrition|overnutrition
1295522|NCT01601704|Overweight|overweight
1295523|NCT01601691|prostate cancer|prostate cancer
1295524|NCT01601691|brachytherapy|brachytherapy
1295525|NCT01601691|spacer|spacer
1295526|NCT01601691|side effect|side effect
1295527|NCT01601678|Achalasia|achalasia
1295528|NCT01601678|Heller Myotomy|heller myotomy
1295529|NCT01601678|Dysphagia|dysphagia
1295530|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
1295531|NCT01601665|Intraocular lens|intraocular lens
1295532|NCT01601665|Cataracts|cataracts
1295533|NCT01601665|Astigmatism|astigmatism
1295534|NCT01601665|Toric|toric
1295535|NCT01601652|cholestasis|cholestasis
1295536|NCT01601652|PNAC|pnac
1295538|NCT01601652|PNALD|pnald
1295539|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
1295540|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
1295541|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
1295542|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
1295543|NCT01601639|GAVE|gave
1295544|NCT01601587|Introductory Seminar|introductory seminar
1295545|NCT01601587|Waiting list|waiting list
1295546|NCT01601587|Community Mental Health Centre|community mental health centre
1295547|NCT01601574|Type 2 diabetes|type 2 diabetes
1295548|NCT01601574|HbA1c|hba1c
1295549|NCT01601574|Overweight|overweight
1295550|NCT01601574|Obesity|obesity
1295551|NCT01601561|Insulin|insulin
1295552|NCT01601561|Protein metabolism|protein metabolism
1295553|NCT01601561|Stress response|stress response
1295554|NCT01601483|AMD|amd
1295555|NCT01601483|Dry AMD|dry amd
1295556|NCT01601483|Nonexudative AMD|nonexudative amd
1295557|NCT01601483|MC-1101|mc-1101
1295558|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
1295559|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
1295560|NCT01601431|Screening colonoscopy|screening colonoscopy
1295561|NCT01601418|YF476|yf476
1295562|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
1295563|NCT01601418|pentagastrin|pentagastrin
1295564|NCT01601418|gastric acid|gastric acid
1295565|NCT01601418|healthy subjects|healthy subjects
1295566|NCT01601405|YF476|yf476
1295567|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
1295568|NCT01601405|gastrin|gastrin
1295569|NCT01601405|gastric aspiration|gastric aspiration
1295570|NCT01601405|healthy subjects|healthy subjects
1295571|NCT01601392|Ischemic stroke|ischemic stroke
1295572|NCT01601392|direct current stimulation|direct current stimulation
1295573|NCT01601392|motor threshold|motor threshold
1295574|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
1295575|NCT01601392|Barthel index scale|barthel index scale
1295576|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
1295577|NCT01601379|Observational|observational
1295578|NCT01601379|GERD|gerd
1295579|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1295580|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
1295581|NCT01601379|Heartburn|heartburn
1295582|NCT01601366|Adenomyosis|adenomyosis
1610665|NCT00355576|Creatine|creatine
1295583|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
1295584|NCT01601366|Dysmenorrhea|dysmenorrhea
1295585|NCT01601366|Oral contraceptives|oral contraceptives
1295586|NCT01601366|Uterus|uterus
1295587|NCT01601353|Erectile Dysfunction|erectile dysfunction
1295588|NCT01601327|hypogonadism|hypogonadism
1295589|NCT01601327|treatment|treatment
1295590|NCT01601327|testis volume|testis volume
1295591|NCT01601301|Limb|limb
1295592|NCT01601301|Lengthening|lengthening
1295593|NCT01601301|PRECICE|precice
1295594|NCT01601301|Ellipse|ellipse
1295595|NCT01601301|Technologies|technologies
1295596|NCT01601301|Distraction|distraction
1295597|NCT01601301|Osteogenesis|osteogenesis
1295598|NCT01601301|Femur|femur
1295599|NCT01601301|Tibia|tibia
1295600|NCT01601301|Intramedullary|intramedullary
1295601|NCT01601301|Nail|nail
1295602|NCT01601301|Device|device
1295603|NCT01601301|Medical|medical
1295604|NCT01601301|Orthopedic|orthopedic
1295605|NCT01601301|Implant|implant
1295606|NCT01601288|obstructive lung disease|obstructive lung disease
1295607|NCT01601288|restrictive lung disease|restrictive lung disease
1295608|NCT01601288|cough|cough
1295609|NCT01601288|dyspnea|dyspnea
1295610|NCT01601275|tuberculosis|tuberculosis
1295611|NCT01601262|ED|ed
1295612|NCT01601262|LI-ESWT|li-eswt
1295613|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
1295614|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
1295615|NCT01601236|Acthar|acthar
1295616|NCT01601236|diabetic nephropathy|diabetic nephropathy
1295617|NCT01601236|proteinuria|proteinuria
1295618|NCT01601236|nephrotic syndrome|nephrotic syndrome
1295619|NCT01601223|Ventilatory Management|ventilatory management
1295620|NCT01601223|Mechanical Ventilation|mechanical ventilation
1295621|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
1295622|NCT01601223|Intra-operative complications|intra-operative complications
1295623|NCT01601223|General Anesthesia|general anesthesia
1295624|NCT01601223|Surgery|surgery
1295625|NCT01601223|LAS VEGAS|las vegas
1295626|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
1295627|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
1295628|NCT01601197|immunization|immunization
1295629|NCT01601197|pain management|pain management
1295630|NCT01601197|infants|infants
1295631|NCT01601197|tactile stimulation|tactile stimulation
1295632|NCT01601184|medulloblastoma|medulloblastoma
1295633|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
1295634|NCT01601184|vismodegib|vismodegib
1295635|NCT01601171|GnRH deficiency|gnrh deficiency
1295636|NCT01601171|hypogonadism|hypogonadism
1295637|NCT01601171|anosmia|anosmia
1295638|NCT01601171|infertility|infertility
1295639|NCT01601171|cleft lip|cleft lip
1295640|NCT01601171|cleft palate|cleft palate
1295641|NCT01601171|cryptorchidism|cryptorchidism
1295642|NCT01601171|microphallus|microphallus
1295643|NCT01601158|Global developmental delay|global developmental delay
1295644|NCT01601158|Umbilical cord blood|umbilical cord blood
1295645|NCT01601158|Rehabilitation|rehabilitation
1295646|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
1295647|NCT01601145|schoolchildren|schoolchildren
1295648|NCT01601145|dental caries|dental caries
1295649|NCT01601145|Gingivatis|gingivatis
1295650|NCT01601132|pharmacokinetics|pharmacokinetics
1295651|NCT01601132|colchicine|colchicine
1295652|NCT01601132|theophylline|theophylline
1295653|NCT01601119|Multiple Sclerosis|multiple sclerosis
1295654|NCT01601119|Patient reported outcome|patient reported outcome
1295655|NCT01601119|Patient reported experience|patient reported experience
1295656|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
1295657|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
1295658|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
1295659|NCT01601093|Phase Ⅱ|phase ⅱ
1295660|NCT01601080|Adherence|adherence
1295661|NCT01601080|Multiple Sclerosis|multiple sclerosis
1295662|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
1295663|NCT01601067|psychotherapy|psychotherapy
1295664|NCT01601067|alcoholism|alcoholism
1295665|NCT01601054|spine|spine
1295666|NCT01601054|deformity|deformity
1295667|NCT01601054|instrumentation|instrumentation
1295668|NCT01601054|ALIF|alif
1295669|NCT01601041|Urinary Tract Infection|urinary tract infection
1295670|NCT01601041|Bacteriuria|bacteriuria
1295671|NCT01601041|Pyuria|pyuria
1295672|NCT01601041|Prostatitis|prostatitis
1295673|NCT01601041|Intermittent Catheterization|intermittent catheterization
1295674|NCT01601041|Spinal Cord Injuries|spinal cord injuries
1295675|NCT01601041|Residual Urine|residual urine
1295676|NCT01601028|Autoimmune Diseases|autoimmune diseases
1295677|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
1295678|NCT01601028|Hydroxychloroquine|hydroxychloroquine
1295679|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
1295680|NCT01601002|Mirtazapine|mirtazapine
1295681|NCT01600989|shock septic|shock septic
1295682|NCT01600989|monocytes|monocytes
1295683|NCT01600989|lymphocytes|lymphocytes
1295684|NCT01600989|mitochondria|mitochondria
1295685|NCT01600989|interleukins|interleukins
1295686|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
1295687|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
1295688|NCT01600976|Hepatic impairment|hepatic impairment
1295689|NCT01600976|Hepatitis C|hepatitis c
1295690|NCT01600976|Telaprevir|telaprevir
1295691|NCT01600976|VX-950|vx-950
1295692|NCT01600976|Pharmacokinetics|pharmacokinetics
1295693|NCT01600976|Safety|safety
1295694|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
1295695|NCT01600976|Child-Pugh score|child-pugh score
1295696|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
1295697|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
1295698|NCT01600963|TMC207|tmc207
1295699|NCT01600963|Background regimen|background regimen
1295700|NCT01600937|diabetes mellitus|diabetes mellitus
1295701|NCT01600937|diabetes education|diabetes education
1295702|NCT01600937|behavioral therapy|behavioral therapy
1295703|NCT01600937|behavior modification|behavior modification
1295704|NCT01600937|physical activity|physical activity
1295705|NCT01600937|supervised exercise|supervised exercise
1295706|NCT01600937|physical fitness|physical fitness
1295707|NCT01600937|HbA1c|hba1c
1295708|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
1295709|NCT01600937|quality of life|quality of life
1295710|NCT01600924|diabetes mellitus|diabetes mellitus
1295711|NCT01600924|muscle strength|muscle strength
1295712|NCT01600924|bone strength|bone strength
1295713|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
1295714|NCT01600924|diabetic complications|diabetic complications
1295715|NCT01600911|metabolomics|metabolomics
1295716|NCT01600911|nutri-metabolomics|nutri-metabolomics
1295717|NCT01600911|plant food|plant food
1295718|NCT01600911|blood pressure|blood pressure
1295719|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
1295720|NCT01600898|follow up study|follow up study
1295721|NCT01600885|Guanfacine|guanfacine
1295722|NCT01600885|Ketamine|ketamine
1295723|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1295724|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
1295725|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
1295726|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
1295727|NCT01600885|Memory, Short-Term|memory, short-term
1295728|NCT01600885|Schizophrenia|schizophrenia
1295729|NCT01600872|EDCs|edcs
1295730|NCT01600872|PCOS|pcos
1295731|NCT01600872|TAS|tas
1295732|NCT01600872|TOS|tos
1295733|NCT01600872|ROS|ros
1295826|NCT01600469|NMDA|nmda
1295827|NCT01600456|PTSD|ptsd
1295734|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
1295735|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
1295736|NCT01600846|pharmacokinetics|pharmacokinetics
1295737|NCT01600846|Pharmacogenomics|pharmacogenomics
1295738|NCT01600846|genetics|genetics
1295739|NCT01600846|pharmacy|pharmacy
1295740|NCT01600846|drug response|drug response
1295741|NCT01600833|PCOS|pcos
1295742|NCT01600833|Ferritin|ferritin
1295743|NCT01600833|Homocysteine|homocysteine
1295744|NCT01600833|Insulin Resistance|insulin resistance
1295745|NCT01600833|Metabolic Syndrome|metabolic syndrome
1295746|NCT01600820|Plant sterol|plant sterol
1295747|NCT01600820|Hypercholesterolemia|hypercholesterolemia
1295748|NCT01600820|diet|diet
1295749|NCT01600820|dairy|dairy
1295750|NCT01600820|LDL-C|ldl-c
1295751|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
1295752|NCT01600807|Metastatic|metastatic
1295753|NCT01600807|Pancreas|pancreas
1295754|NCT01600807|Cancer|cancer
1295755|NCT01600807|Adenocarcinoma|adenocarcinoma
1295756|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
1295757|NCT01600794|androgens|androgens
1295758|NCT01600794|ovary function|ovary function
1295759|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
1295760|NCT01600781|Improve the nutritional status|improve the nutritional status
1295761|NCT01600781|QOL|qol
1295762|NCT01600781|children|children
1295763|NCT01600781|enhance immune response|enhance immune response
1295764|NCT01600781|induction chemotherapy|induction chemotherapy
1295765|NCT01600781|fewer side effects|fewer side effects
1295766|NCT01600768|focus of study|focus of study
1295767|NCT01600755|Cell Therapy|cell therapy
1295768|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
1295769|NCT01600755|Muscle-derived Cell|muscle-derived cell
1295770|NCT01600755|Anal Incontinence|anal incontinence
1295771|NCT01600755|Rectal Diseases|rectal diseases
1295772|NCT01600755|Intestinal Diseases|intestinal diseases
1295773|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
1295774|NCT01600755|Urinary Incontinence|urinary incontinence
1295775|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
1610666|NCT00355576|Minocycline|minocycline
1295776|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
1295777|NCT01600703|Pancreatic clamp|pancreatic clamp
1295778|NCT01600703|DPPIV inhibitor|dppiv inhibitor
1295779|NCT01600690|Stem cells|stem cells
1295780|NCT01600690|Regeneration|regeneration
1295781|NCT01600690|Inflammation|inflammation
1295782|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
1295783|NCT01600664|Type 1 diabetes|type 1 diabetes
1295784|NCT01600664|"My Diabetic friend"|"my diabetic friend"
1295785|NCT01600664|interactive computer game|interactive computer game
1295786|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
1295787|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
1295788|NCT01600651|Recruitment Maneuver|recruitment maneuver
1295789|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1295790|NCT01600651|Alveolar epithelium|alveolar epithelium
1295791|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
1295792|NCT01600651|Mechanical ventilation|mechanical ventilation
1295793|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
1295794|NCT01600638|Lipolysis|lipolysis
1295795|NCT01600638|Cryolipolysis|cryolipolysis
1295796|NCT01600638|Fat Reduction|fat reduction
1295797|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
1295798|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
1295799|NCT01600625|minocycline|minocycline
1295800|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
1295801|NCT01600586|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
1295802|NCT01600586|Music therapy|music therapy
1295803|NCT01600586|Premature infant|premature infant
1295804|NCT01600586|Oral feeds|oral feeds
1295805|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
1295806|NCT01600586|Suck rate|suck rate
1295807|NCT01600586|Suck efficiency|suck efficiency
1295808|NCT01600586|Contingent music|contingent music
1295809|NCT01600586|Mother's voice|mother's voice
1295810|NCT01600573|ovarian cancer|ovarian cancer
1295811|NCT01600534|gestational diabetes|gestational diabetes
1295812|NCT01600508|stoma care|stoma care
1295813|NCT01600508|videoconference|videoconference
1295815|NCT01600508|quality of life|quality of life
1295816|NCT01600495|pain|pain
1295817|NCT01600495|electric stimulation|electric stimulation
1295818|NCT01600495|nervous|nervous
1295819|NCT01600495|transcutaneous|transcutaneous
1295820|NCT01600495|humanized childbirth|humanized childbirth
1295821|NCT01600482|Hemostasis.|hemostasis.
1295822|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
1295823|NCT01600482|Closure Device|closure device
1295824|NCT01600469|Alzheimer's disease|alzheimer's disease
1295825|NCT01600469|mild cognitive impairment|mild cognitive impairment
1295828|NCT01600456|Antidepressants|antidepressants
1295829|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
1295830|NCT01600430|Vitamin D|vitamin d
1295831|NCT01600430|Newborn|newborn
1295832|NCT01600430|Preterm|preterm
1295833|NCT01600430|Supplementation|supplementation
1295834|NCT01600430|Respiratory|respiratory
1295835|NCT01600417|low back pain|low back pain
1295836|NCT01600417|spine|spine
1295837|NCT01600417|lumbar spine|lumbar spine
1295838|NCT01600417|lumbar instability|lumbar instability
1295839|NCT01600417|radiology|radiology
1295840|NCT01600417|functional radiology|functional radiology
1295841|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
1295842|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
1295843|NCT01600404|Spinal Cord Injuries|spinal cord injuries
1295844|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
1295845|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
1295846|NCT01600404|Overactive Detrusor|overactive detrusor
1295847|NCT01600391|Stroke|stroke
1295848|NCT01600391|Visual cues|visual cues
1295849|NCT01600391|Gait rehabilitation|gait rehabilitation
1295850|NCT01600391|Walking adaptability|walking adaptability
1295851|NCT01600391|Turning|turning
1295852|NCT01600391|Overground walking|overground walking
1295853|NCT01600391|Treadmill training|treadmill training
1295854|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
1295855|NCT01600378|interstitial lung disease|interstitial lung disease
1295856|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1295857|NCT01600365|Conjunctivitis|conjunctivitis
1295858|NCT01600365|adenovirus.|adenovirus.
1295859|NCT01600352|interstitial lung disease|interstitial lung disease
1295860|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1295861|NCT01600313|rice bran oil|rice bran oil
1295862|NCT01600313|diet|diet
1295863|NCT01600313|cardiovascular disease|cardiovascular disease
1295864|NCT01600313|low density lipoprotein|low density lipoprotein
1295865|NCT01600313|total cholesterol|total cholesterol
1295866|NCT01600300|Age-related macular degeneration|age-related macular degeneration
1295867|NCT01600300|electrical stimulation|electrical stimulation
1295868|NCT01600300|randomized|randomized
1295869|NCT01600300|double blind|double blind
1295870|NCT01600287|bispectral index|bispectral index
1295871|NCT01600287|propofol|propofol
1295872|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
1295873|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
1295874|NCT01600261|without eye disease|without eye disease
1295875|NCT01600248|Chronic Pain|chronic pain
1295876|NCT01600248|Military|military
1295877|NCT01600248|Veteran|veteran
1295878|NCT01600248|Online|online
1295879|NCT01600248|Acceptance|acceptance
1295880|NCT01600235|Stroke, ischemic|stroke, ischemic
1295881|NCT01600235|Progression|progression
1295882|NCT01600235|Induced-hypertension|induced-hypertension
1295883|NCT01600235|Phenylephrine|phenylephrine
1295884|NCT01600209|Cancer|cancer
1295885|NCT01600209|Colorectal Cancer|colorectal cancer
1295886|NCT01600209|Neoplasm|neoplasm
1295887|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
1295888|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
1295889|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1295890|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
1295891|NCT01600209|Neoplasms by Site|neoplasms by site
1295892|NCT01600209|Neoplasms|neoplasms
1295893|NCT01600209|Digestive System Diseases|digestive system diseases
1295894|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
1295895|NCT01600209|Colonic Diseases|colonic diseases
1295896|NCT01600209|Intestinal Diseases|intestinal diseases
1295897|NCT01600209|Rectal Diseases|rectal diseases
1295898|NCT01600196|Hepatectomy|hepatectomy
1295899|NCT01600196|Thrombectomy|thrombectomy
1295900|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
1295901|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
1295903|NCT01600183|metatarsus|metatarsus
1295904|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
1295905|NCT01600170|HIV|hiv
1295906|NCT01600170|monocytes|monocytes
1295907|NCT01600170|CD16+|cd16+
1295908|NCT01600170|statins|statins
1295909|NCT01600170|mcp1|mcp1
1295910|NCT01600170|inflammation|inflammation
1295911|NCT01600144|data mammography|data mammography
1295912|NCT01600118|tooth mobility|tooth mobility
1295913|NCT01600118|periodontal status|periodontal status
1295914|NCT01600118|irregularity index|irregularity index
1295915|NCT01600118|pulpal blood flow|pulpal blood flow
1295916|NCT01600105|liver fibrosis|liver fibrosis
1295917|NCT01600105|liver cirrhosis|liver cirrhosis
1295918|NCT01600105|chronic hepatitis|chronic hepatitis
1295919|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
1295920|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
1295921|NCT01600079|herpes zoster|herpes zoster
1295922|NCT01600079|shingles|shingles
1295923|NCT01600079|Varicella-zoster virus|varicella-zoster virus
1295924|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
1295925|NCT01600079|Herpesviridae Infections|herpesviridae infections
1295926|NCT01600079|DNA Virus Infections|dna virus infections
1296029|NCT01599689|Delirium|delirium
1295927|NCT01600079|Virus Diseases|virus diseases
1295928|NCT01600053|Chronic|chronic
1295929|NCT01600053|Lymphocytic|lymphocytic
1295930|NCT01600053|Leukemia|leukemia
1295931|NCT01600040|metastatic|metastatic
1295932|NCT01600027|Fascia iliaca block|fascia iliaca block
1295933|NCT01600027|dexmetomidine|dexmetomidine
1295934|NCT01600027|fracture femur|fracture femur
1295935|NCT01600027|α2 agonist|α2 agonist
1295936|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
1295937|NCT01600001|Constipation|constipation
1295938|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
1295939|NCT01599975|HAND|hand
1295940|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
1295941|NCT01599975|Methylphenidate|methylphenidate
1295942|NCT01599975|HIV Dementia|hiv dementia
1295943|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
1295944|NCT01599949|Ibrutinib|ibrutinib
1295945|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
1295946|NCT01599949|Rituximab|rituximab
1295947|NCT01599949|Bortezomib|bortezomib
1295948|NCT01599936|scorpion sting|scorpion sting
1295949|NCT01599936|envenomation|envenomation
1295950|NCT01599936|Anascorp|anascorp
1295951|NCT01599923|scorpion|scorpion
1295952|NCT01599923|envenomation|envenomation
1295953|NCT01599923|Alacramyn|alacramyn
1295954|NCT01599910|Scribes|scribes
1295955|NCT01599910|Physician Productivity|physician productivity
1295956|NCT01599910|Electronic Documentation|electronic documentation
1295957|NCT01599897|Tuberculosis|tuberculosis
1295958|NCT01599897|TB|tb
1295959|NCT01599897|Pulmonary|pulmonary
1295960|NCT01599897|Vaccine|vaccine
1295961|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1295962|NCT01599884|Chronic bronchitis|chronic bronchitis
1295963|NCT01599884|N-acetylcysteine|n-acetylcysteine
1295964|NCT01599871|COPD|copd
1295965|NCT01599858|YF476|yf476
1295966|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
1295967|NCT01599858|gastric pH|gastric ph
1295968|NCT01599858|healthy subjects|healthy subjects
1295969|NCT01599858|omeprazole|omeprazole
1295970|NCT01599845|Lung|lung
1295971|NCT01599845|Alveoli|alveoli
1295972|NCT01599845|Nanoparticles|nanoparticles
1295973|NCT01599845|Particulate matter|particulate matter
1295974|NCT01599845|Exhaled breath condensate|exhaled breath condensate
1295975|NCT01599845|Induced sputum|induced sputum
1295976|NCT01599845|Forced expiratory volume|forced expiratory volume
1295977|NCT01599845|Force vital capacity|force vital capacity
1295978|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
1295979|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
1295980|NCT01599793|CRPC|crpc
1295981|NCT01599793|cabozantinib|cabozantinib
1295982|NCT01599793|XL184|xl184
1295983|NCT01599780|preterm|preterm
1295984|NCT01599780|premature|premature
1295985|NCT01599780|prematurity|prematurity
1295986|NCT01599780|children|children
1295987|NCT01599780|child|child
1295988|NCT01599780|kid|kid
1295989|NCT01599780|toddler|toddler
1295990|NCT01599780|infant|infant
1295991|NCT01599780|baby|baby
1295992|NCT01599780|language|language
1295993|NCT01599780|development|development
1295994|NCT01599780|skills|skills
1295995|NCT01599780|listening|listening
1295996|NCT01599780|talking|talking
1295997|NCT01599780|communication|communication
1295998|NCT01599780|speech|speech
1295999|NCT01599780|processing|processing
1296000|NCT01599767|transcranial stimulation|transcranial stimulation
1296001|NCT01599767|direct current|direct current
1296002|NCT01599754|renal cell carcinoma|renal cell carcinoma
1296003|NCT01599754|axitinib|axitinib
1296004|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1296005|NCT01599741|X-rays|x-rays
1296006|NCT01599741|Endovascular angiography|endovascular angiography
1296007|NCT01599741|Image processing|image processing
1296008|NCT01599728|Urocortin 2|urocortin 2
1296009|NCT01599728|Urocortin 3|urocortin 3
1296010|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
1296011|NCT01599728|Heart failure|heart failure
1296012|NCT01599728|Endothelium|endothelium
1296013|NCT01599728|Substance P|substance p
1296014|NCT01599715|Urinary Incontinence|urinary incontinence
1296015|NCT01599715|Weak bladder|weak bladder
1296016|NCT01599715|Frequent urination|frequent urination
1296017|NCT01599715|Overactive bladder|overactive bladder
1296018|NCT01599715|Urine leakage|urine leakage
1296019|NCT01599715|Stress incontinence|stress incontinence
1296020|NCT01599715|Urge Incontinence|urge incontinence
1296021|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
1296022|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
1296023|NCT01599715|Kegel exercises|kegel exercises
1296024|NCT01599715|Self-Care|self-care
1296025|NCT01599702|IBD|ibd
1296026|NCT01599702|IDA|ida
1296027|NCT01599702|Subjects|subjects
1296028|NCT01599702|diagnosis|diagnosis
1296030|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1296031|NCT01599689|Confusion|confusion
1296032|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
1296033|NCT01599689|Neurologic Manifestations|neurologic manifestations
1296034|NCT01599689|Nervous System Diseases|nervous system diseases
1296035|NCT01599689|Signs and Symptoms|signs and symptoms
1296036|NCT01599689|Mental Disorders|mental disorders
1296037|NCT01599689|Cardiac Surgery|cardiac surgery
1296038|NCT01599689|Mirrors|mirrors
1296039|NCT01599676|Citrulline|citrulline
1296040|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
1296041|NCT01599676|amino acids|amino acids
1296042|NCT01599676|muscle strength|muscle strength
1296043|NCT01599676|resistance training|resistance training
1296044|NCT01599663|Pain management|pain management
1296045|NCT01599663|Pain assessment|pain assessment
1296046|NCT01599663|Intensive care unit|intensive care unit
1296047|NCT01599663|Adult|adult
1296048|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
1296049|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
1296050|NCT01599637|CIU|ciu
1296051|NCT01599637|Xolair|xolair
1296052|NCT01599637|IGE025|ige025
1296053|NCT01599637|FcεRI|fcεri
1296054|NCT01599637|IgE|ige
1296055|NCT01599624|Resilience|resilience
1296056|NCT01599624|Perceived stress|perceived stress
1296057|NCT01599624|PTSD symptoms|ptsd symptoms
1296058|NCT01599624|Depression|depression
1296059|NCT01599624|Anxiety|anxiety
1296060|NCT01599624|Sleep quality|sleep quality
1296061|NCT01599624|United States Navy service members|united states navy service members
1296062|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
1296063|NCT01599611|Follow-up|follow-up
1296064|NCT01599611|Motor development|motor development
1296065|NCT01599611|Hearing|hearing
1296066|NCT01599611|Executive function|executive function
1296067|NCT01599598|perceived stress|perceived stress
1296068|NCT01599598|depression|depression
1296069|NCT01599598|anxiety|anxiety
1610667|NCT00355576|Combination|combination
1296070|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
1296071|NCT01599598|military|military
1296072|NCT01599598|school|school
1296073|NCT01599598|training environment|training environment
1296074|NCT01599598|heart rate variability|heart rate variability
1296075|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
1296076|NCT01599598|psychophysiological coherence|psychophysiological coherence
1296077|NCT01599598|coherence advantage|coherence advantage
1296078|NCT01599598|stress reduction|stress reduction
1296079|NCT01599598|stress regulation|stress regulation
1296080|NCT01599598|independent duty corpsmen|independent duty corpsmen
1296081|NCT01599585|Depression|depression
1296082|NCT01599585|Behavioral Activation|behavioral activation
1296083|NCT01599585|Tele-medicine|tele-medicine
1296084|NCT01599572|zinc supplementation|zinc supplementation
1296085|NCT01599572|serum zinc concentration|serum zinc concentration
1296086|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
1296087|NCT01599559|previously|previously
1296088|NCT01599559|untreated|untreated
1296089|NCT01599546|Preterm|preterm
1296090|NCT01599546|Full term|full term
1296091|NCT01599546|Reading|reading
1296092|NCT01599546|Dyslexia|dyslexia
1296093|NCT01599546|Brain|brain
1296094|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
1296095|NCT01599520|cancer|cancer
1296096|NCT01599520|stress|stress
1296097|NCT01599520|stress management|stress management
1296098|NCT01599520|Latinas|latinas
1296099|NCT01599520|Hispanics|hispanics
1296100|NCT01599507|Anemia|anemia
1296101|NCT01599507|Renal|renal
1296102|NCT01599481|Common mental illness|common mental illness
1296103|NCT01599481|Supported Employment|supported employment
1296104|NCT01599481|Anxiety|anxiety
1296105|NCT01599481|Depression|depression
1296106|NCT01599481|Sickness absence|sickness absence
1296107|NCT01599468|post partum hemorrhage|post partum hemorrhage
1296108|NCT01599468|transfusion|transfusion
1296109|NCT01599468|tranexamic acid|tranexamic acid
1296110|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
1296111|NCT01599455|blood pressure|blood pressure
1296112|NCT01599455|heart rate|heart rate
1296113|NCT01599455|baseline|baseline
1296114|NCT01599429|AML / LMA|aml / lma
1296115|NCT01599416|Oral Probiotics|oral probiotics
1296116|NCT01599416|HPV DNA Index Test|hpv dna index test
1296117|NCT01599416|Vaginal infection|vaginal infection
1296118|NCT01599403|Rib Fracture|rib fracture
1296119|NCT01599403|Intercostal Nerve Block|intercostal nerve block
1296120|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
1296121|NCT01599390|United States|united states
1296122|NCT01599390|Burden of Disease|burden of disease
1296123|NCT01599390|Influenza|influenza
1296124|NCT01599364|HIV infection|hiv infection
1296125|NCT01599364|Atazanavir|atazanavir
1296126|NCT01599364|Lamivudine|lamivudine
1296127|NCT01599364|Ritonavir|ritonavir
1296128|NCT01599364|virological suppression|virological suppression
1296129|NCT01599364|non-inferiority|non-inferiority
1296130|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
1296131|NCT01599351|Radiation exposure|radiation exposure
1296132|NCT01599351|ERCP|ercp
1296133|NCT01599338|Liraglutide|liraglutide
1296134|NCT01599338|GLP-1 analogue|glp-1 analogue
1296135|NCT01599338|Food preference|food preference
1296136|NCT01599338|Gustative perception|gustative perception
1296137|NCT01599338|Liking|liking
1296138|NCT01599338|wanting|wanting
1296139|NCT01599338|T2DM|t2dm
1296140|NCT01599338|body mass composition|body mass composition
1296141|NCT01599338|leptin|leptin
1296142|NCT01599338|ghrelin|ghrelin
1296143|NCT01599312|Videolaryngoscopy|videolaryngoscopy
1296144|NCT01599312|Forces|forces
1296145|NCT01599312|Teeth|teeth
1296146|NCT01599299|ultrasound|ultrasound
1296147|NCT01599299|left and right jugular vein|left and right jugular vein
1296148|NCT01599299|comparison|comparison
1296149|NCT01599286|Hyperammonia|hyperammonia
1296150|NCT01599286|Propionic Acidemia (PA)|propionic acidemia (pa)
1296151|NCT01599286|Methylmalonic Acidemia (MMA)|methylmalonic acidemia (mma)
1296152|NCT01599286|Late-Onset CPS1 Deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
1296153|NCT01599286|Late-Onset Ornithine Transcarbamylase Deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
1296154|NCT01599286|Carbaglu|carbaglu
1296155|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1296156|NCT01599273|triamcinolone|triamcinolone
1296157|NCT01599273|retraction|retraction
1296158|NCT01599273|swelling|swelling
1296159|NCT01599247|Suicide|suicide
1296160|NCT01599247|Optimism|optimism
1296161|NCT01599247|Hopelessness|hopelessness
1296162|NCT01599221|Femoral fractures|femoral fractures
1296163|NCT01599221|Nail|nail
1296164|NCT01599221|Implant|implant
1296165|NCT01599221|Elderly|elderly
1296166|NCT01599221|Orthopaedics|orthopaedics
1296167|NCT01599195|carotid stenosis|carotid stenosis
1296168|NCT01599195|femoral artery ischemia|femoral artery ischemia
1296169|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
1296170|NCT01599195|carotid murmur|carotid murmur
1296171|NCT01599169|Burnout syndrome|burnout syndrome
1296172|NCT01599169|Depression work-related|depression work-related
1296173|NCT01599169|Food supplement|food supplement
1296174|NCT01599156|Chronic constipation|chronic constipation
1296175|NCT01599156|Reflexology|reflexology
1296176|NCT01599156|Complementary medicine|complementary medicine
1296177|NCT01599143|Mindfulness|mindfulness
1296178|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
1296179|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
1296180|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
1296181|NCT01599130|Hepatitis B|hepatitis b
1296182|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
1296183|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1296184|NCT01599117|Diastolic Heart Failure|diastolic heart failure
1296185|NCT01599117|Exercise Capacity|exercise capacity
1296186|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
1296187|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
1296188|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
1296189|NCT01599104|Essential hypertension|essential hypertension
1296190|NCT01599104|LCZ696|lcz696
1296191|NCT01599091|Fibroblasts|fibroblasts
1296192|NCT01599091|Periodontal ligament|periodontal ligament
1296193|NCT01599091|Gingiva|gingiva
1296194|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
1296195|NCT01599091|Chronic periodontitis|chronic periodontitis
1296196|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
1296197|NCT01599078|Restenosis|restenosis
1296198|NCT01599078|Angioplasty|angioplasty
1296199|NCT01599078|Stent|stent
1296200|NCT01599078|Atherectomy|atherectomy
1296201|NCT01599078|Femoral Artery|femoral artery
1296202|NCT01599078|Popliteal Artery|popliteal artery
1296203|NCT01599078|Paclitaxel|paclitaxel
1296205|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
1296206|NCT01599065|electrocautery|electrocautery
1296207|NCT01599052|Social Cognition|social cognition
1296208|NCT01599052|Theory of Mind|theory of mind
1296209|NCT01599052|Emotion Recognition|emotion recognition
1296210|NCT01599052|Social competence|social competence
1296211|NCT01599052|Brain Tumour|brain tumour
1296212|NCT01599039|early diagnostics|early diagnostics
1296213|NCT01599039|lymphedema|lymphedema
1296214|NCT01599039|breast cancer|breast cancer
1296215|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
1296216|NCT01599039|measuring methods|measuring methods
1296217|NCT01599039|inverse water volumetry|inverse water volumetry
1296218|NCT01599039|prevention|prevention
1296219|NCT01599026|cardiology|cardiology
1296220|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
1296221|NCT01599013|urothelial carcinoma|urothelial carcinoma
1296222|NCT01599013|bladder cancer|bladder cancer
1296223|NCT01599013|vinflunine|vinflunine
1296224|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
1296225|NCT01599013|advanced or metastatic|advanced or metastatic
1296226|NCT01599013|unfit|unfit
1296227|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
1296228|NCT01599013|renal impairment|renal impairment
1296229|NCT01599013|renal insufficiency|renal insufficiency
1296230|NCT01599013|urologic neoplasms|urologic neoplasms
1296231|NCT01599013|urogenital neoplasm|urogenital neoplasm
1296232|NCT01599013|urinary neoplasms|urinary neoplasms
1296233|NCT01599013|cisplatin|cisplatin
1296234|NCT01599013|tubulin inhibitors|tubulin inhibitors
1296235|NCT01599000|malaria|malaria
1296236|NCT01599000|Plasmodium|plasmodium
1296237|NCT01599000|Papua New Guinea|papua new guinea
1296238|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
1296239|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
1296240|NCT01598987|Everolimus|everolimus
1296241|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
1296242|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
1296243|NCT01598987|Renal function|renal function
1296244|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
1296245|NCT01598987|Liver transplant|liver transplant
1296246|NCT01598974|Lower Back Pain|lower back pain
1296247|NCT01598974|Acupuncture|acupuncture
1296248|NCT01598948|hypercholesterolemia|hypercholesterolemia
1296249|NCT01598948|apheresis|apheresis
1296250|NCT01598948|coronary heart disease|coronary heart disease
1296251|NCT01598948|cerebrovascular disease|cerebrovascular disease
1296252|NCT01598948|peripheral arterial disease|peripheral arterial disease
1296253|NCT01598922|Depression|depression
1296254|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
1296255|NCT01598922|fMRI|fmri
1296256|NCT01598922|Neuroimaging|neuroimaging
1296257|NCT01598909|blepharoplasty|blepharoplasty
1296258|NCT01598909|arnica|arnica
1296259|NCT01598909|homeopathy|homeopathy
1296260|NCT01598896|Cannabis Dependence|cannabis dependence
1398139|NCT01172509|TMS|tms
1296261|NCT01598896|Marijuana Dependence|marijuana dependence
1296262|NCT01598896|Cannabis Use Disorders|cannabis use disorders
1296263|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
1296264|NCT01598896|Dronabinol|dronabinol
1296265|NCT01598896|Clonidine|clonidine
1296266|NCT01598896|Schizophrenia|schizophrenia
1296267|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
1296268|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
1296269|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
1296270|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
1296271|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
1296272|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
1296273|NCT01598831|sepsis|sepsis
1296274|NCT01598818|Vision Nearsighted|vision nearsighted
1296275|NCT01598818|Vision Farsighted|vision farsighted
1296276|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
1296277|NCT01598779|genital warts|genital warts
1296278|NCT01598779|HPV types|hpv types
1296279|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
1296280|NCT01598779|Skin Diseases, Viral|skin diseases, viral
1296281|NCT01598779|Tumor Virus Infections|tumor virus infections
1296282|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
1296283|NCT01598779|Skin Diseases|skin diseases
1296284|NCT01598779|Papillomavirus Infections|papillomavirus infections
1296285|NCT01598779|DNA Virus Infections|dna virus infections
1296286|NCT01598779|Virus Diseases|virus diseases
1296287|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1296288|NCT01598727|parathyroid surgery|parathyroid surgery
1296289|NCT01598701|Acetaminophen|acetaminophen
1296290|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
1296291|NCT01598701|Opioid Requirement|opioid requirement
1296292|NCT01598701|Pain|pain
1296293|NCT01598701|Post-Operative Pain|post-operative pain
1296294|NCT01598701|Craniotomy|craniotomy
1296295|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
1296296|NCT01598688|Bone marrow transplantation|bone marrow transplantation
1296297|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1296298|NCT01598688|Medication management|medication management
1296299|NCT01598688|Nursing care|nursing care
1296300|NCT01598675|stroke|stroke
1296301|NCT01598675|Gait|gait
1296302|NCT01598675|walking|walking
1296303|NCT01598662|IUD placement|iud placement
1296304|NCT01598662|contraception|contraception
1296305|NCT01598662|postpartum|postpartum
1296306|NCT01598662|intrauterine device|intrauterine device
1296307|NCT01598662|expulsion|expulsion
1296308|NCT01598649|Dietary protein|dietary protein
1296309|NCT01598649|Lupin protein|lupin protein
1296310|NCT01598649|Cholesterol metabolism|cholesterol metabolism
1296311|NCT01598649|Protein metabolism|protein metabolism
1296312|NCT01598649|Hypercholesterolemia|hypercholesterolemia
1296313|NCT01598649|Protein-enriched foods|protein-enriched foods
1296314|NCT01598584|Mirtazapine|mirtazapine
1296315|NCT01598584|gemcitabine|gemcitabine
1296316|NCT01598584|placebo|placebo
1296317|NCT01598584|RCT|rct
1296318|NCT01598584|pancreatic cancer|pancreatic cancer
1296319|NCT01598571|Phase 1|phase 1
1296320|NCT01598571|Healthy male volunteers|healthy male volunteers
1296321|NCT01598571|pharmacokinetics|pharmacokinetics
1296322|NCT01598571|fostamatinib|fostamatinib
1296323|NCT01598571|Bioavailability|bioavailability
1296324|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
1296325|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
1296326|NCT01598571|t1/2λz|t1/2λz
1296327|NCT01598571|tmax|tmax
1296328|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
1296329|NCT01598532|mild TBI|mild tbi
1296330|NCT01598532|mTBI|mtbi
1296331|NCT01598519|school-based|school-based
1296332|NCT01598519|adolescent suicide|adolescent suicide
1296333|NCT01598519|intervention|intervention
1296334|NCT01598519|screening|screening
1296335|NCT01598493|Burns|burns
1296336|NCT01598493|Wound Healing|wound healing
1296337|NCT01598480|Burns|burns
1296338|NCT01598480|Wound Healing|wound healing
1296339|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
1296340|NCT01598467|POP|pop
1296341|NCT01598467|sacrocolpopexy|sacrocolpopexy
1296342|NCT01598467|sacrohysteropexy|sacrohysteropexy
1296343|NCT01598467|promontofixation|promontofixation
1296344|NCT01598467|colpopexy|colpopexy
1296345|NCT01598467|robotic surgery|robotic surgery
1296346|NCT01598467|surgical complications|surgical complications
1296347|NCT01598467|mesh|mesh
1296348|NCT01598467|prolapse repair|prolapse repair
1296349|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
1296350|NCT01598428|age related cataract|age related cataract
1296351|NCT01598428|phacoemulsification|phacoemulsification
1296352|NCT01598428|anterior capsule polishing|anterior capsule polishing
1296353|NCT01598428|optical coherence tomography|optical coherence tomography
1296354|NCT01598428|anterior chamber depth|anterior chamber depth
1296355|NCT01598402|LAHNC|lahnc
1296849|NCT01596426|CINV|cinv
1296356|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
1296357|NCT01598376|entropion|entropion
1296358|NCT01598376|suture|suture
1296359|NCT01598376|granuloma|granuloma
1296360|NCT01598376|tissue reaction|tissue reaction
1296361|NCT01598350|Gait|gait
1296362|NCT01598350|Orthoses|orthoses
1296363|NCT01598350|Down syndrome|down syndrome
1296364|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
1296365|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1296366|NCT01598324|depression|depression
1296367|NCT01598324|escitalopram|escitalopram
1296368|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1296369|NCT01598324|treatment-resistant depression|treatment-resistant depression
1296370|NCT01598324|ziprasidone|ziprasidone
1296371|NCT01598311|CDAD|cdad
1296372|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
1296373|NCT01598311|CDI|cdi
1296374|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
1296375|NCT01598311|Diarrhea|diarrhea
1296376|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1296377|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1296378|NCT01598298|stage IA breast cancer|stage ia breast cancer
1296379|NCT01598298|stage IB breast cancer|stage ib breast cancer
1296380|NCT01598298|stage II breast cancer|stage ii breast cancer
1296381|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
1296382|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
1296383|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
1296384|NCT01598298|pain|pain
1296385|NCT01598298|musculoskeletal complications|musculoskeletal complications
1296386|NCT01598285|Genome-Wide|genome-wide
1296387|NCT01598285|GWAS|gwas
1296388|NCT01598285|microRNA|microrna
1296389|NCT01598285|miRNA|mirna
1296390|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
1296391|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
1296392|NCT01598272|Ginseng|ginseng
1296393|NCT01598272|Cordyceps|cordyceps
1296394|NCT01598272|Pomegranate|pomegranate
1296395|NCT01598272|Red Orange|red orange
1296396|NCT01598272|Grape Seed|grape seed
1296397|NCT01598272|Broccoli Seed|broccoli seed
1296398|NCT01598246|Extubation failures|extubation failures
1296399|NCT01598246|Sedation|sedation
1296400|NCT01598220|schizophrenia|schizophrenia
1296401|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
1296402|NCT01598220|cognition|cognition
1296403|NCT01598220|quality of life|quality of life
1296404|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
1296405|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
1296406|NCT01598194|reverse bevel design|reverse bevel design
1296407|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
1296408|NCT01598194|EUS|eus
1296409|NCT01598194|guided|guided
1296410|NCT01598194|fine needle aspiration|fine needle aspiration
1296411|NCT01598194|FNA|fna
1296412|NCT01598168|rivaroxaban|rivaroxaban
1296413|NCT01598168|treatment|treatment
1296414|NCT01598168|venous thromboembolism|venous thromboembolism
1296415|NCT01598168|arterial thromboembolism|arterial thromboembolism
1296416|NCT01598168|thrombocytopenia|thrombocytopenia
1296417|NCT01598155|dental biofilm|dental biofilm
1296418|NCT01598155|periodontitis|periodontitis
1296419|NCT01598155|maintenance|maintenance
1296518|NCT01597674|gastrin|gastrin
1296420|NCT01598155|randomized clinical trial|randomized clinical trial
1296421|NCT01598155|biomarkers|biomarkers
1296422|NCT01598155|bacterias|bacterias
1296423|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
1296547|NCT01597622|B cell|b cell
1296424|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
1296425|NCT01598142|Guidewires|guidewires
1296426|NCT01598142|Cannulation|cannulation
1296427|NCT01598142|Single-operator|single-operator
1296428|NCT01598142|C-Hook|c-hook
1296429|NCT01598129|Phase I|phase i
1296430|NCT01598129|Dose escalation|dose escalation
1296431|NCT01598129|oncolytic virus|oncolytic virus
1296432|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
1296433|NCT01598103|spinal cord lesions|spinal cord lesions
1296434|NCT01598103|spinal cord injury|spinal cord injury
1296435|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
1296436|NCT01598077|Breast cancer|breast cancer
1296437|NCT01598077|Gastric cancer|gastric cancer
1296438|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1296439|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1296440|NCT01598051|Xarelto|xarelto
1296441|NCT01598051|SPAF|spaf
1296442|NCT01598051|QOL|qol
1296443|NCT01598038|cancer|cancer
1296444|NCT01598038|renal|renal
1296445|NCT01598038|Afinitor|afinitor
1296446|NCT01598038|pharmacokinetics|pharmacokinetics
1296447|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
1296448|NCT01598025|FLUDARABINE|fludarabine
1296449|NCT01598025|THI0TEPA|thi0tepa
1296450|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
1296451|NCT01598025|12-053|12-053
1296452|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
1296453|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
1296454|NCT01597986|isavuconazole|isavuconazole
1296455|NCT01597986|ethinyl estradiol|ethinyl estradiol
1296456|NCT01597986|norethindrone|norethindrone
1296457|NCT01597986|contraceptive|contraceptive
1296458|NCT01597986|Healthy Volunteers|healthy volunteers
1296459|NCT01597986|BAL8557|bal8557
1296460|NCT01597986|BAL4815|bal4815
1296461|NCT01597934|Chronic hepatitis B|chronic hepatitis b
1296462|NCT01597934|Partial virologic response|partial virologic response
1296463|NCT01597934|YMDD mutation|ymdd mutation
1296464|NCT01597921|Breast conserving surgery|breast conserving surgery
1296465|NCT01597921|Radiation dermatitis|radiation dermatitis
1296466|NCT01597908|BRAF inhibitor|braf inhibitor
1296467|NCT01597908|Metastatic Melanoma|metastatic melanoma
1296468|NCT01597908|Cancer|cancer
1296469|NCT01597908|MEK inhibitor|mek inhibitor
1296470|NCT01597895|maraviroc|maraviroc
1296471|NCT01597895|boceprevir|boceprevir
1296472|NCT01597895|telaprevir|telaprevir
1296473|NCT01597895|drug interaction|drug interaction
1296474|NCT01597895|pharmacokinetics|pharmacokinetics
1296476|NCT01597882|case management|case management
1296477|NCT01597882|long term conditions|long term conditions
1296478|NCT01597882|aged sixty five and over|aged sixty five and over
1296479|NCT01597843|education|education
1296480|NCT01597843|self care|self care
1296481|NCT01597843|peer group|peer group
1296482|NCT01597843|Computers|computers
1296483|NCT01597843|Attitude to computers|attitude to computers
1296484|NCT01597830|knee|knee
1296485|NCT01597830|osteoarthritis|osteoarthritis
1296486|NCT01597830|loading|loading
1296487|NCT01597817|Atopic dermatitis|atopic dermatitis
1296488|NCT01597817|Eczema|eczema
1296489|NCT01597817|Textiles|textiles
1296490|NCT01597791|Urinary Retention|urinary retention
1296491|NCT01597791|Urinary Catheter|urinary catheter
1296492|NCT01597791|Bacteriuria|bacteriuria
1296493|NCT01597778|Haplo identical transplant|haplo identical transplant
1296494|NCT01597778|Cord blood transplant|cord blood transplant
1296495|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
1296496|NCT01597778|Lymphoma|lymphoma
1296497|NCT01597778|Leukemia|leukemia
1296498|NCT01597765|Thalassemia|thalassemia
1296499|NCT01597765|Oxidative stress|oxidative stress
1296500|NCT01597765|antioxidant cocktail|antioxidant cocktail
1296501|NCT01597752|Immunotherapy|immunotherapy
1296502|NCT01597752|Skin prick test|skin prick test
1296503|NCT01597752|Standardization|standardization
1296504|NCT01597752|Blomia tropicalis|blomia tropicalis
1296505|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
1296506|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
1296507|NCT01597726|Abortion, Induced|abortion, induced
1296508|NCT01597726|Laminaria|laminaria
1296509|NCT01597726|Misoprostol|misoprostol
1296510|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
1296511|NCT01597687|pertussis infection|pertussis infection
1296512|NCT01597687|Prevalence|prevalence
1296513|NCT01597687|health economic burden|health economic burden
1296514|NCT01597687|prolonged cough|prolonged cough
1296515|NCT01597674|YF476|yf476
1296516|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
1296517|NCT01597674|gastric pH|gastric ph
1296519|NCT01597674|healthy subjects|healthy subjects
1296520|NCT01597661|first trimester|first trimester
1296521|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
1296522|NCT01597661|Bupropion|bupropion
1296523|NCT01597661|cardiovascular malformation|cardiovascular malformation
1296524|NCT01597661|antidepressants|antidepressants
1296525|NCT01597661|pregnancy|pregnancy
1296526|NCT01597661|cardiovascular defect|cardiovascular defect
1296527|NCT01597661|congenital malformation|congenital malformation
1296528|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
1296529|NCT01597635|rhACE2|rhace2
1296530|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1296531|NCT01597635|Acute Lung Injury|acute lung injury
1296532|NCT01597635|GSK2586881|gsk2586881
1296533|NCT01597635|critical care|critical care
1296534|NCT01597622|SELENA|selena
1296535|NCT01597622|belimumab|belimumab
1296536|NCT01597622|Lupus|lupus
1296537|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
1296538|NCT01597622|PGA|pga
1296539|NCT01597622|BLys|blys
1296540|NCT01597622|SLE Flare Index|sle flare index
1296541|NCT01597622|continuation|continuation
1296542|NCT01597622|phase III|phase iii
1296543|NCT01597622|BILAG|bilag
1296544|NCT01597622|extension|extension
1296545|NCT01597622|efficacy|efficacy
1296546|NCT01597622|SRI|sri
1296548|NCT01597622|SLEDAI|sledai
1296549|NCT01597622|safety|safety
1296550|NCT01597622|Asia|asia
1296551|NCT01597622|B lymphocyte|b lymphocyte
1296552|NCT01597557|Atrial Fibrillation|atrial fibrillation
1296553|NCT01597557|Electrical Cardioversion|electrical cardioversion
1296554|NCT01597557|Magnesium Sulfate|magnesium sulfate
1296555|NCT01597544|Voiding dysfunction|voiding dysfunction
1296556|NCT01597544|bladder catheter|bladder catheter
1296557|NCT01597544|prolapse surgery|prolapse surgery
1296558|NCT01597544|patient satisfaction|patient satisfaction
1296559|NCT01597531|Liraglutide|liraglutide
1296560|NCT01597531|Orlistat|orlistat
1296561|NCT01597518|Riluzole|riluzole
1296562|NCT01597518|spinal cord injury|spinal cord injury
1296563|NCT01597518|treatment|treatment
1296564|NCT01597505|CDAD|cdad
1296565|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
1296566|NCT01597505|CDI|cdi
1296567|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
1296568|NCT01597505|Diarrhea|diarrhea
1296569|NCT01597492|Antibodies|antibodies
1296570|NCT01597492|Vaccines|vaccines
1296571|NCT01597492|SLE|sle
1296572|NCT01597492|Immune System Diseases|immune system diseases
1296573|NCT01597492|Biological Therapy|biological therapy
1296574|NCT01597492|Autoimmune Diseases|autoimmune diseases
1296575|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
1296576|NCT01597492|Lupus|lupus
1296577|NCT01597492|Immunoglobulins|immunoglobulins
1296578|NCT01597492|Vaccination|vaccination
1296579|NCT01597492|Belimumab|belimumab
1296580|NCT01597492|Biological Agents|biological agents
1296581|NCT01597492|Immunization|immunization
1296582|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
1296583|NCT01597453|Young ischemic stroke|young ischemic stroke
1296584|NCT01597453|Families|families
1296585|NCT01597453|Long-term follow-up|long-term follow-up
1296586|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
1296587|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
1296588|NCT01597440|Carbaglu NCG|carbaglu ncg
1296589|NCT01597440|Hyperammonia|hyperammonia
1296590|NCT01597427|Clonidine|clonidine
1296591|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
1296592|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
1296593|NCT01597401|Antisickling Agents|antisickling agents
1296594|NCT01597388|Estrogen receptor positive|estrogen receptor positive
1296595|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
1296596|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
1296597|NCT01597375|Aspirin|aspirin
1296598|NCT01597375|Prasugrel|prasugrel
1296599|NCT01597375|Asthma|asthma
1296600|NCT01597375|AERD|aerd
1296601|NCT01597375|Aspirin challenge|aspirin challenge
1296602|NCT01597375|Aspirin desensitization|aspirin desensitization
1296603|NCT01597375|Aspirin induced asthma|aspirin induced asthma
1296604|NCT01597362|laparoscopy|laparoscopy
1296605|NCT01597362|trocars|trocars
1296606|NCT01597362|veress|veress
1296607|NCT01597362|open|open
1296608|NCT01597362|direct|direct
1296609|NCT01597336|abscess|abscess
1296610|NCT01597336|tPA|tpa
1296611|NCT01597323|Wrinkle Reduction|wrinkle reduction
1296612|NCT01597323|Skin Resurfacing|skin resurfacing
1296613|NCT01597323|Skin Texture Improvement|skin texture improvement
1296614|NCT01597284|Oral therapies|oral therapies
1296615|NCT01597284|Cancer|cancer
1296616|NCT01597284|cognitive function|cognitive function
1296617|NCT01597284|compliance|compliance
1296618|NCT01597258|Safety|safety
1296911|NCT01596166|childhood|childhood
1296619|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
1296620|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
1296621|NCT01597232|Transfusion trigger|transfusion trigger
1296622|NCT01597232|Hemoglobin level|hemoglobin level
1296623|NCT01597219|Haploidentical transplant|haploidentical transplant
1296624|NCT01597219|Haematological malignancy|haematological malignancy
1296625|NCT01597219|Myeloablative|myeloablative
1296626|NCT01597219|Reduced intensity|reduced intensity
1296627|NCT01597206|randomized controlled trial|randomized controlled trial
1296628|NCT01597206|intervention|intervention
1296629|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
1296630|NCT01597206|patient satisfaction|patient satisfaction
1296631|NCT01597206|sequential sampling|sequential sampling
1296632|NCT01597193|enzalutamide|enzalutamide
1296633|NCT01597193|MDV3100|mdv3100
1296634|NCT01597193|breast cancer|breast cancer
1296635|NCT01597180|contraception|contraception
1296636|NCT01597180|HIV|hiv
1296637|NCT01597180|pharmacokinetics|pharmacokinetics
1296638|NCT01597180|pharmacodynamics|pharmacodynamics
1296639|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
1296640|NCT01597167|magnesium sulfate|magnesium sulfate
1296641|NCT01597154|Adolescent|adolescent
1296642|NCT01597154|Type 2 Diabetes|type 2 diabetes
1296643|NCT01597154|Peer mentorship|peer mentorship
1296644|NCT01597141|Prodromal|prodromal
1296645|NCT01597141|Schizophrenia|schizophrenia
1296646|NCT01597141|Psychosis|psychosis
1296647|NCT01597141|Family psychoeducation|family psychoeducation
1296648|NCT01597141|Assertive community treatment|assertive community treatment
1296649|NCT01597141|Supported employment|supported employment
1296650|NCT01597141|Supported education|supported education
1296651|NCT01597128|Hernia|hernia
1296652|NCT01597128|human tissue|human tissue
1296653|NCT01597128|mesh|mesh
1296654|NCT01597115|duplex study|duplex study
1296655|NCT01597115|hemodialysis access|hemodialysis access
1296656|NCT01597115|maturation rate|maturation rate
1296657|NCT01597115|endovascular intervention|endovascular intervention
1296658|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
1296659|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
1296660|NCT01597102|liver failure|liver failure
1296661|NCT01597102|liver transplantation|liver transplantation
1296662|NCT01597089|Specificity|specificity
1296663|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
1296664|NCT01597089|Film Array Assay|film array assay
1296665|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
1296666|NCT01597089|Sensitivity|sensitivity
1296667|NCT01597076|Morinda citrifolia|morinda citrifolia
1296668|NCT01597076|noni|noni
1296669|NCT01597076|advanced glycation end products|advanced glycation end products
1296670|NCT01597076|oxidative stress|oxidative stress
1296671|NCT01597076|quality of life|quality of life
1296672|NCT01597076|metabolic syndrome|metabolic syndrome
1296673|NCT01597076|safety|safety
1296674|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
1296675|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
1296676|NCT01597037|Aphasia|aphasia
1296677|NCT01597037|Speech Rehabilitation|speech rehabilitation
1296678|NCT01597024|appetite|appetite
1296679|NCT01597024|food|food
1296680|NCT01597024|gut|gut
1296681|NCT01597024|brain|brain
1296682|NCT01597024|satiety|satiety
1296683|NCT01597024|hunger|hunger
1296684|NCT01597024|gut hormones|gut hormones
1296685|NCT01597011|Hernia, Inguinal|hernia, inguinal
1296686|NCT01597011|Hernia repair|hernia repair
1296687|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
1296688|NCT01597011|Tisseel|tisseel
1296689|NCT01597011|Tissucol|tissucol
1296690|NCT01597011|Recurrence|recurrence
1296691|NCT01597011|Chronic Pain|chronic pain
1296692|NCT01597011|Dysejaculation|dysejaculation
1296693|NCT01596998|anesthesia, conduction|anesthesia, conduction
1296694|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
1296695|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
1296696|NCT01596998|Ultrasonography|ultrasonography
1296697|NCT01596985|Endometrioma|endometrioma
1296698|NCT01596985|Endometriosis|endometriosis
1296699|NCT01596985|Cystectomy|cystectomy
1296700|NCT01596985|Ablation|ablation
1296701|NCT01596985|Plasma energy|plasma energy
1296702|NCT01596959|atrial flutter|atrial flutter
1296703|NCT01596959|ablation|ablation
1296704|NCT01596959|irrigation|irrigation
1296705|NCT01596959|contact|contact
1296706|NCT01596959|ECI|eci
1296707|NCT01596946|contact tracing|contact tracing
1296708|NCT01596946|home sampling|home sampling
1296709|NCT01596946|cluster randomisation|cluster randomisation
1296710|NCT01596933|head and neck cancer|head and neck cancer
1296711|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
1296712|NCT01596933|echium oil|echium oil
1296713|NCT01596933|weight loss|weight loss
1296714|NCT01596933|cancer cachexia|cancer cachexia
1296715|NCT01596933|body composition|body composition
1296716|NCT01596933|biomarker|biomarker
1296717|NCT01596933|quality of life|quality of life
1296718|NCT01596920|Chronic DFUs|chronic dfus
1296719|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
1296720|NCT01596907|resting energy expenditure|resting energy expenditure
1296721|NCT01596907|fat free mass|fat free mass
1296722|NCT01596907|lean body mass|lean body mass
1296723|NCT01596907|bariatric surgery|bariatric surgery
1296724|NCT01596907|morbid obesity|morbid obesity
1296725|NCT01596907|ephedrine|ephedrine
1296726|NCT01596907|caffeine|caffeine
1296727|NCT01596907|Low metabolic rate|low metabolic rate
1296728|NCT01596907|Low lean body mass|low lean body mass
1296729|NCT01596907|Weight loss rate|weight loss rate
1296730|NCT01596894|Pediatric|pediatric
1296731|NCT01596894|Crohn's disease|crohn's disease
1296732|NCT01596894|Azithromycin|azithromycin
1296733|NCT01596894|Metronidazole|metronidazole
1296734|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
1296735|NCT01596881|Multiple sclerosis|multiple sclerosis
1296736|NCT01596881|Blood flow|blood flow
1296737|NCT01596881|Optical Coherence Tomography|optical coherence tomography
1296738|NCT01596881|Imaging|imaging
1296739|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
1296740|NCT01596868|treatment|treatment
1296741|NCT01596868|Northwest China|northwest china
1296742|NCT01596855|Anemia|anemia
1296743|NCT01596855|Renal|renal
1296744|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
1296745|NCT01596842|vitamin D|vitamin d
1296746|NCT01596842|ergocalciferol|ergocalciferol
1296747|NCT01596842|hemodialysis|hemodialysis
1296748|NCT01596829|antibiotic|antibiotic
1296749|NCT01596829|probiotic|probiotic
1296750|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
1296751|NCT01596829|faecal microbiota|faecal microbiota
1296752|NCT01596816|prostate cancer|prostate cancer
1296753|NCT01596803|FSHD|fshd
1296754|NCT01596803|Antioxidants|antioxidants
1296755|NCT01596803|Oxidative stress|oxidative stress
1296756|NCT01596803|Muscle function|muscle function
1296757|NCT01596803|Quality of life|quality of life
1296758|NCT01596803|Activity|activity
1296759|NCT01596803|(FSHD;4q35)|(fshd;4q35)
1296760|NCT01596790|Bevacizumab|bevacizumab
1296761|NCT01596790|Circulating tumor cells|circulating tumor cells
1296762|NCT01596790|Treatment efficiency|treatment efficiency
1296763|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
1296764|NCT01596777|Methylnaltrexone|methylnaltrexone
1296765|NCT01596777|oro-cecal transit time|oro-cecal transit time
1296766|NCT01596777|whole gut transit time|whole gut transit time
1296767|NCT01596777|Pharmacokinetics|pharmacokinetics
1296768|NCT01596764|whole-gut transit time|whole-gut transit time
1296769|NCT01596764|oro-cecal transit time|oro-cecal transit time
1296770|NCT01596764|colon transit time|colon transit time
1296771|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
1296772|NCT01596764|pharmacokinetics|pharmacokinetics
1296773|NCT01596764|Methylnaltrexone|methylnaltrexone
1296774|NCT01596764|Naloxone|naloxone
1296775|NCT01596751|metastatic|metastatic
1296776|NCT01596751|breast|breast
1296777|NCT01596751|cancer|cancer
1296778|NCT01596751|triple|triple
1296779|NCT01596751|negative|negative
1296780|NCT01596751|PLX|plx
1296781|NCT01596751|Eribulin|eribulin
1296782|NCT01596738|Coronary Artery Disease|coronary artery disease
1296783|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
1296784|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1296785|NCT01596738|Tranexamic Acid|tranexamic acid
1296786|NCT01596712|Allergy,|allergy,
1296787|NCT01596712|Asthma,|asthma,
1296788|NCT01596712|Atopic dermatitis,|atopic dermatitis,
1296789|NCT01596712|Japanese,|japanese,
1296790|NCT01596712|QGE031,|qge031,
1296791|NCT01596712|IgE|ige
1296792|NCT01596699|conditioning|conditioning
1296793|NCT01596699|allogeneic|allogeneic
1296794|NCT01596699|hematopoietic|hematopoietic
1296795|NCT01596699|cell|cell
1296796|NCT01596699|transplantation|transplantation
1296797|NCT01596699|HCT|hct
1296798|NCT01596660|Tap block|tap block
1296799|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
1296800|NCT01596660|pain|pain
1296922|NCT01596140|solid tumor|solid tumor
1296923|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
1296801|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
1296802|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
1296803|NCT01596621|CEP-18083|cep-18083
1296804|NCT01596621|Treanda®|treanda®
1296805|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1296806|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
1296807|NCT01596608|Treatment resistance|treatment resistance
1296808|NCT01596608|Open-label trial|open-label trial
1296809|NCT01596608|Treatment resistant depression|treatment resistant depression
1296810|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
1296811|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
1296812|NCT01596595|ICD|icd
1296813|NCT01596595|CRT-D|crt-d
1296814|NCT01596595|Defibrillation lead|defibrillation lead
1296815|NCT01596582|Colorectal cancer screening|colorectal cancer screening
1296816|NCT01596582|Shared decision-making|shared decision-making
1296817|NCT01596582|Patient preferences|patient preferences
1296818|NCT01596582|Risk assessment|risk assessment
1296819|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
1296820|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
1296821|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
1296822|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1296823|NCT01596569|Combined Treatment|combined treatment
1296824|NCT01596556|smoking|smoking
1296825|NCT01596556|exercise|exercise
1296826|NCT01596556|heat tolerance|heat tolerance
1296827|NCT01596556|heat stroke|heat stroke
1296828|NCT01596543|sleep|sleep
1296829|NCT01596543|HTT|htt
1296830|NCT01596543|heat illness|heat illness
1296831|NCT01596530|Breast Neoplasm|breast neoplasm
1296832|NCT01596530|Breast Cancer|breast cancer
1296833|NCT01596530|Breast Tumour|breast tumour
1296834|NCT01596530|Cancer of Breast|cancer of breast
1296835|NCT01596530|Cancer of the Breast|cancer of the breast
1296836|NCT01596491|peripheral nerve injury|peripheral nerve injury
1296837|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
1296838|NCT01596491|PNI|pni
1296839|NCT01596491|PHN|phn
1296840|NCT01596491|Capsaicin|capsaicin
1296841|NCT01596491|QST|qst
1296842|NCT01596491|quantitative sensory testing|quantitative sensory testing
1398968|NCT01169324|DBS|dbs
1296843|NCT01596491|sensory profile|sensory profile
1296844|NCT01596491|neuropathic pain|neuropathic pain
1296845|NCT01596478|Gambling|gambling
1296846|NCT01596478|Pathological Gambling|pathological gambling
1296847|NCT01596439|Healthy women|healthy women
1296848|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
1296850|NCT01596413|CINV|cinv
1296851|NCT01596400|CINV|cinv
1296852|NCT01596387|anaesthetics iv|anaesthetics iv
1296853|NCT01596387|propofol|propofol
1296854|NCT01596387|pharmacokinetics|pharmacokinetics
1296855|NCT01596387|pharmacodynamic|pharmacodynamic
1296856|NCT01596348|Exercise|exercise
1296857|NCT01596348|Barriers|barriers
1296858|NCT01596348|Benefits|benefits
1296859|NCT01596348|Preferences|preferences
1296860|NCT01596348|Stages of change|stages of change
1296861|NCT01596335|Infliximab|infliximab
1296862|NCT01596335|REMICADE|remicade
1296863|NCT01596335|TA-650|ta-650
1296864|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
1296865|NCT01596335|Kawasaki disease|kawasaki disease
1296866|NCT01596335|IVIG|ivig
1296867|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
1296868|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
1296869|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
1296870|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
1296871|NCT01596309|cardiovascular risk|cardiovascular risk
1296872|NCT01596309|Elderly population|elderly population
1296873|NCT01596309|cocoa extract|cocoa extract
1296874|NCT01596309|overweight and obesity|overweight and obesity
1296875|NCT01596309|Glycemic profile|glycemic profile
1296876|NCT01596309|lipid profile|lipid profile
1296877|NCT01596309|antioxidant status|antioxidant status
1296878|NCT01596309|inflammatory state|inflammatory state
1296879|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
1296880|NCT01596296|labor induction|labor induction
1296881|NCT01596296|transcervical foley catheter|transcervical foley catheter
1296882|NCT01596296|dinoprostone|dinoprostone
1296883|NCT01596296|parous women|parous women
1296884|NCT01596283|Perioperative Fluid Management|perioperative fluid management
1296885|NCT01596283|liver resection|liver resection
1296886|NCT01596283|12-056|12-056
1296887|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
1296888|NCT01596257|Acute Leukemia|acute leukemia
1296889|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
1296890|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
1296891|NCT01596257|Hodgkins Disease|hodgkins disease
1296892|NCT01596257|Multiple Myeloma|multiple myeloma
1296893|NCT01596257|12-016|12-016
1296894|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1296895|NCT01596244|Disease management|disease management
1296896|NCT01596244|Chronic disease|chronic disease
1296897|NCT01596244|Prevention and control|prevention and control
1296898|NCT01596244|Education|education
1296899|NCT01596231|Alcohol consumption|alcohol consumption
1296900|NCT01596231|Kudzu extract|kudzu extract
1296901|NCT01596218|Steroid Refractory|steroid refractory
1296902|NCT01596218|Acute|acute
1296903|NCT01596205|cognitive therapy|cognitive therapy
1296904|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
1296905|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
1296906|NCT01596179|treatment adherence|treatment adherence
1296907|NCT01596179|fatigue|fatigue
1296908|NCT01596179|symptom management|symptom management
1296909|NCT01596166|migraine|migraine
1296910|NCT01596166|pediatric|pediatric
1296912|NCT01596166|emergency department|emergency department
1296913|NCT01596166|ketorolac|ketorolac
1296914|NCT01596166|metoclopramide|metoclopramide
1296915|NCT01596166|intravenous|intravenous
1296916|NCT01596140|Vemurafenib|vemurafenib
1296917|NCT01596140|Everolimus|everolimus
1296918|NCT01596140|Afinitor|afinitor
1296919|NCT01596140|RAD001|rad001
1296920|NCT01596140|temsirolimus|temsirolimus
1296921|NCT01596140|BRAF gene mutation|braf gene mutation
1296924|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
1296925|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
1296926|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
1296927|NCT01596127|Rituximab|rituximab
1296928|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
1296929|NCT01596127|CNS|cns
1296930|NCT01596127|Leptomeningeal disease|leptomeningeal disease
1296931|NCT01596127|LMD|lmd
1296932|NCT01596127|central nervous system disease|central nervous system disease
1296933|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
1296934|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
1296935|NCT01596127|CNS leukemia|cns leukemia
1296936|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
1296937|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
1296938|NCT01596127|CSF|csf
1296939|NCT01596127|lumbar puncture|lumbar puncture
1296940|NCT01596127|LP|lp
1296941|NCT01596114|TKI|tki
1296942|NCT01596114|CML|cml
1296943|NCT01596114|Stopping|stopping
1296944|NCT01596114|chronic phase|chronic phase
1296945|NCT01596114|in remission|in remission
1296946|NCT01596088|Extravasation|extravasation
1296947|NCT01596088|Anthracyclines|anthracyclines
1296948|NCT01596075|Cannabidiol|cannabidiol
1296949|NCT01596075|GVHD|gvhd
1296950|NCT01596075|Allogeneic transplantation|allogeneic transplantation
1296951|NCT01596062|Basiliximab|basiliximab
1296952|NCT01596062|renal transplantation|renal transplantation
1296953|NCT01596062|CNI-free|cni-free
1296954|NCT01596062|everolimus|everolimus
1296955|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
1296956|NCT01596036|referral|referral
1296957|NCT01596036|enrollment|enrollment
1296958|NCT01596036|timing|timing
1296959|NCT01596023|COPD|copd
1296960|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
1296961|NCT01595984|kidney|kidney
1296962|NCT01595984|transplantation|transplantation
1296963|NCT01595984|graft|graft
1296964|NCT01595984|creatinin|creatinin
1296965|NCT01595971|Asthma|asthma
1296966|NCT01595971|Continuing education|continuing education
1296967|NCT01595971|Primary health care|primary health care
1296968|NCT01595958|Cardiac arrest|cardiac arrest
1296969|NCT01595958|heart arrest|heart arrest
1296970|NCT01595958|cyclosporine A|cyclosporine a
1296971|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
1296972|NCT01595958|protective agent|protective agent
1296973|NCT01595958|multiple organ failure|multiple organ failure
1296974|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
1296975|NCT01595958|mitochondria|mitochondria
1296976|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
1296977|NCT01595958|cardioprotection|cardioprotection
1296978|NCT01595958|ischemia reperfusion|ischemia reperfusion
1296979|NCT01595958|postconditioning|postconditioning
1296980|NCT01595945|Caloric restriction|caloric restriction
1296981|NCT01595945|Obesity|obesity
1296982|NCT01595945|Gastric bypass|gastric bypass
1296983|NCT01595945|Resting metabolic rate|resting metabolic rate
1296984|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1296985|NCT01595932|bloating|bloating
1296986|NCT01595932|abdominal distension|abdominal distension
1296987|NCT01595932|flatulence|flatulence
1296988|NCT01595932|α-Galactosidase|α-galactosidase
1296989|NCT01595906|Helmet|helmet
1296990|NCT01595906|Heat Tolerance Test|heat tolerance test
1296991|NCT01595906|ventilation System|ventilation system
1296992|NCT01595893|Polymorphic light eruption|polymorphic light eruption
1296993|NCT01595893|Vitamin D3|vitamin d3
1296994|NCT01595893|Photo provocation|photo provocation
1296995|NCT01595893|Immune function|immune function
1296996|NCT01595867|abuse liability|abuse liability
1296997|NCT01595867|abuse potential|abuse potential
1296998|NCT01595867|morphine|morphine
1296999|NCT01595867|intranasal administration|intranasal administration
1297000|NCT01595867|snorting|snorting
1297001|NCT01595867|opioid abuse|opioid abuse
1297002|NCT01595867|pharmacodynamic|pharmacodynamic
1297003|NCT01595867|recreational drug use|recreational drug use
1297004|NCT01595841|hemodialysis|hemodialysis
1297005|NCT01595841|stenosis|stenosis
1297006|NCT01595841|angioplasty|angioplasty
1297007|NCT01595841|sirolimus|sirolimus
1297008|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
1297009|NCT01595802|Cerebral vasospasm|cerebral vasospasm
1297010|NCT01595789|Coronary Artery Disease|coronary artery disease
1297011|NCT01595789|Diabetes Mellitus|diabetes mellitus
1297012|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
1297013|NCT01595789|Beta-cell function|beta-cell function
1297014|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
1297015|NCT01595763|Deep vein thrombosis|deep vein thrombosis
1297016|NCT01595763|Primary care|primary care
1297017|NCT01595763|Diagnosis|diagnosis
1297018|NCT01595763|Clinical model|clinical model
1297019|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
1297020|NCT01595750|Chronic bronchitis|chronic bronchitis
1297021|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
1297022|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
1297023|NCT01595724|Non-interventional study|non-interventional study
1297024|NCT01595724|Endometriosis,|endometriosis,
1297025|NCT01595724|Quality of life|quality of life
1297026|NCT01595698|Physical exercise|physical exercise
1297027|NCT01595698|IGF-1|igf-1
1297028|NCT01595698|Schizophrenia|schizophrenia
1297029|NCT01595698|neuroplasticity|neuroplasticity
1297030|NCT01595685|HBeAg-positive|hbeag-positive
1297031|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
1297032|NCT01595672|organ failure|organ failure
1297033|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1297034|NCT01595672|systemic complications|systemic complications
1297035|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
1297036|NCT01595672|blood purification|blood purification
1297037|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
1297038|NCT01595659|Risk|risk
1297039|NCT01595659|Young drivers|young drivers
1297040|NCT01595659|Alcohol|alcohol
1297041|NCT01595659|Passengers|passengers
1297042|NCT01595659|Gender|gender
1297043|NCT01595646|Memory|memory
1297044|NCT01595646|Intranasal insulin|intranasal insulin
1297045|NCT01595646|Alzheimer's disease|alzheimer's disease
1297046|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
1297047|NCT01595633|nucleoside analogue|nucleoside analogue
1297048|NCT01595633|adefovir|adefovir
1297049|NCT01595633|tenofovir|tenofovir
1297050|NCT01595633|hepatitis B|hepatitis b
1297051|NCT01595620|Cannabis|cannabis
1297052|NCT01595620|THC|thc
1297053|NCT01595620|Pain|pain
1297054|NCT01595594|Periodontal Diseases|periodontal diseases
1297055|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1297056|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
1297057|NCT01595581|Testosterone|testosterone
1297058|NCT01595581|ACL Reconstruction|acl reconstruction
1297059|NCT01595581|Clinical outcomes|clinical outcomes
1297060|NCT01595581|Lean mass|lean mass
1297061|NCT01595581|Strength|strength
1297062|NCT01595581|Muscle atrophy|muscle atrophy
1297063|NCT01595568|Adolescents|adolescents
1297064|NCT01595568|Dual Diagnosis|dual diagnosis
1297065|NCT01595568|Mental Disorders|mental disorders
1297066|NCT01595568|Substance Use Problems|substance use problems
1297067|NCT01595568|Prevention|prevention
1297068|NCT01595555|stress|stress
1297069|NCT01595555|relaxation|relaxation
1297070|NCT01595555|mindfulness|mindfulness
1297071|NCT01595555|web-based|web-based
1297072|NCT01595555|online|online
1297073|NCT01595555|social media|social media
1297074|NCT01595555|discussion board|discussion board
1297075|NCT01595529|antibiotic therapy|antibiotic therapy
1297076|NCT01595529|antimicrobial resistance|antimicrobial resistance
1297077|NCT01595529|children|children
1297078|NCT01595529|E.coli|e.coli
1297079|NCT01595529|K.pneumoniae|k.pneumoniae
1297080|NCT01595529|parent study|parent study
1297081|NCT01595529|SCOUT Study|scout study
1297082|NCT01595529|spectrum stool bacteria|spectrum stool bacteria
1297083|NCT01595529|stool culture|stool culture
1297084|NCT01595529|urinary tract infections|urinary tract infections
1297085|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
1297086|NCT01595451|Acupuncture|acupuncture
1297087|NCT01595451|Back Pain|back pain
1297088|NCT01595451|Lower Back Pain|lower back pain
1297089|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
1297090|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
1297091|NCT01595451|Effects of Acupuncture|effects of acupuncture
1297092|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
1297093|NCT01595425|Bioequivalence,|bioequivalence,
1297094|NCT01595425|pharmacokinetics,|pharmacokinetics,
1297095|NCT01595425|safety,|safety,
1297096|NCT01595425|esomeprazole,|esomeprazole,
1297097|NCT01595425|Japanese,|japanese,
1297098|NCT01595425|healthy subject,|healthy subject,
1297099|NCT01595425|homo-EM|homo-em
1297100|NCT01595412|Laparoscopic surgery|laparoscopic surgery
1297101|NCT01595412|Colorectal Surgery|colorectal surgery
1297102|NCT01595412|Quality of Life|quality of life
1297103|NCT01595412|Rectal Prolapse|rectal prolapse
1297104|NCT01595412|Anorectal Physiology|anorectal physiology
1297105|NCT01595399|bradycardia|bradycardia
1297106|NCT01595399|hypoxemia|hypoxemia
1297107|NCT01595399|intubation|intubation
1297108|NCT01595399|premedication|premedication
1297109|NCT01595373|Ghrelin|ghrelin
1297110|NCT01595373|Microdialysis|microdialysis
1297111|NCT01595373|Controls|controls
1297112|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
1297113|NCT01595360|TT-173|tt-173
1297114|NCT01595360|Topical Hemostatics|topical hemostatics
1297115|NCT01595360|Hemostasis|hemostasis
1297116|NCT01595347|Pressure Ulcer|pressure ulcer
1297117|NCT01595347|Primary Prevention|primary prevention
1297118|NCT01595347|Fatty Acids|fatty acids
1297119|NCT01595347|Vegetable Fats|vegetable fats
1297120|NCT01595347|Olive oil|olive oil
1297121|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
1297122|NCT01595334|IVF-ET|ivf-et
1297123|NCT01595334|ICSI|icsi
1297124|NCT01595334|Gonadotrophins|gonadotrophins
1297125|NCT01595334|rFSH|rfsh
1297126|NCT01595334|rLH|rlh
1297127|NCT01595334|Cetrorelix|cetrorelix
1297128|NCT01595334|Leuprolide acetate|leuprolide acetate
1297129|NCT01595321|Adjuvant therapy|adjuvant therapy
1297130|NCT01595321|Immunotherapy|immunotherapy
1297131|NCT01595321|Cytoxan|cytoxan
1610668|NCT00355576|Selection|selection
1297132|NCT01595321|Cyclophosphamide|cyclophosphamide
1297133|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
1297134|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
1297135|NCT01595321|SBRT|sbrt
1297136|NCT01595321|FOLFIRINOX|folfirinox
1297137|NCT01595308|Male infertility|male infertility
1297138|NCT01595295|CMML|cmml
1297139|NCT01595295|MDS|mds
1297140|NCT01595295|AML|aml
1297141|NCT01595295|registry|registry
1297142|NCT01595295|Vidaza|vidaza
1297143|NCT01595282|pain|pain
1297144|NCT01595282|suction curettage|suction curettage
1297145|NCT01595269|Diabetes|diabetes
1297146|NCT01595269|eHealth|ehealth
1297147|NCT01595269|Type 2 Diabetes|type 2 diabetes
1297148|NCT01595269|Education|education
1297149|NCT01595269|Calgary Health Region|calgary health region
1297150|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
1297151|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
1297152|NCT01595243|Needs|needs
1297153|NCT01595243|Telephone consultation|telephone consultation
1297154|NCT01595230|Internal Hernias|internal hernias
1297155|NCT01595230|Clips|clips
1297156|NCT01595230|Gastric Bypass|gastric bypass
1297157|NCT01595230|Avoid|avoid
1297158|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
1297159|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
1297160|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
1297161|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
1297162|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
1297163|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
1297164|NCT01595178|smoking|smoking
1297165|NCT01595178|drinking|drinking
1297166|NCT01595178|SBIRT|sbirt
1297167|NCT01595178|BNI|bni
1297168|NCT01595178|counseling intervention|counseling intervention
1297169|NCT01595178|emergency department|emergency department
1297170|NCT01595178|adults|adults
1297171|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1297172|NCT01595165|ultrasound|ultrasound
1297173|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
1297174|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
1297175|NCT01595100|Waist circumference|waist circumference
1297176|NCT01595100|Visceral adipose tissue|visceral adipose tissue
1297177|NCT01595100|Intra-abdominal fat|intra-abdominal fat
1297178|NCT01595100|Pediatrics|pediatrics
1297179|NCT01595087|CRPC|crpc
1297180|NCT01595035|Day surgery|day surgery
1297181|NCT01595035|Orthopedic surgery|orthopedic surgery
1297182|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
1297183|NCT01594996|Seroquel XR|seroquel xr
1297184|NCT01594996|Quetiapine XR|quetiapine xr
1297185|NCT01594996|Drug utilization|drug utilization
1297186|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
1297187|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
1297188|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
1297189|NCT01594957|LCQ908,|lcq908,
1297190|NCT01594957|Hepatic Impairment,|hepatic impairment,
1297191|NCT01594957|Pharmacokinetics|pharmacokinetics
1297192|NCT01594931|malaria|malaria
1297193|NCT01594931|antimalarial|antimalarial
1297194|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
1297195|NCT01594918|metastatic|metastatic
1297196|NCT01594918|CRPC|crpc
1297197|NCT01594918|prostate|prostate
1297198|NCT01594918|CAMP|camp
1297199|NCT01594905|To explore|to explore
1297200|NCT01594905|adequate management|adequate management
1297201|NCT01594905|CHB|chb
1297202|NCT01594905|Multidrug resistance|multidrug resistance
1297203|NCT01594892|Spinal metastases|spinal metastases
1297204|NCT01594892|Vertebral metastases|vertebral metastases
1297205|NCT01594892|Radiosurgery|radiosurgery
1297206|NCT01594892|Radiotherapy|radiotherapy
1297207|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
1297208|NCT01594892|Pain|pain
1297209|NCT01594879|Endometrial cancer|endometrial cancer
1297210|NCT01594879|LNG-IUS|lng-ius
1297211|NCT01594879|oral MPA|oral mpa
1297212|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
1297213|NCT01594853|exercise|exercise
1297214|NCT01594853|women|women
1297215|NCT01594853|training|training
1297216|NCT01594853|rehabilitation|rehabilitation
1297217|NCT01594853|leukodystrophy|leukodystrophy
1297218|NCT01594840|language development|language development
1297219|NCT01594840|parental interaction|parental interaction
1297220|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1297221|NCT01594827|Vancomycin|vancomycin
1297222|NCT01594814|AVNRT|avnrt
1297223|NCT01594814|AVRT|avrt
1297224|NCT01594814|WPW|wpw
1297225|NCT01594801|DM|dm
1297226|NCT01594801|insulin|insulin
1297227|NCT01594801|injections|injections
1297228|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
1297229|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
1297230|NCT01594684|restenosis|restenosis
1297232|NCT01594684|drug eltuing balloon|drug eltuing balloon
1297233|NCT01594684|peripheral arterial disease|peripheral arterial disease
1297234|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
1297235|NCT01594671|tranexamic acid|tranexamic acid
1297236|NCT01594671|topical|topical
1297237|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
1297238|NCT01594632|AE adverse event|ae adverse event
1297239|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1297240|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1297241|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
1297339|NCT01594411|Chest Pain|chest pain
1297242|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1297243|NCT01594632|DCF data collection forms|dcf data collection forms
1297244|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
1297245|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1297246|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1297247|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1297248|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
1297249|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
1297250|NCT01594632|IRB Institutional Review Board|irb institutional review board
1297251|NCT01594632|IU International units|iu international units
1297252|NCT01594632|mg milligram(s)|mg milligram(s)
1297253|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1297254|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
1297255|NCT01594632|SAE serious adverse event|sae serious adverse event
1297256|NCT01594632|µg microgram|µg microgram
1297257|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
1297258|NCT01594632|WB Western Blot|wb western blot
1297259|NCT01594619|Phase 1|phase 1
1297260|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
1297261|NCT01594619|Drug-drug interaction|drug-drug interaction
1297262|NCT01594619|Pharmacokinetics|pharmacokinetics
1297263|NCT01594619|Naloxegol|naloxegol
1297264|NCT01594606|Animal-assisted intervention|animal-assisted intervention
1297265|NCT01594606|adjudicated adolescents|adjudicated adolescents
1297266|NCT01594606|empathy|empathy
1297267|NCT01594593|prostate cancer|prostate cancer
1297268|NCT01594593|behavioral|behavioral
1297269|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
1297270|NCT01594593|distress|distress
1297271|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
1297272|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1297273|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1297274|NCT01594567|Clinical practice guidelines|clinical practice guidelines
1297275|NCT01594567|Clinical trials|clinical trials
1297276|NCT01594567|Dietary pulses|dietary pulses
1297277|NCT01594567|legumes|legumes
1297278|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
1297279|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
1297280|NCT01594567|Triglycerides|triglycerides
1297281|NCT01594567|Cholesterol|cholesterol
1297282|NCT01594567|Glycemic control|glycemic control
1297283|NCT01594567|Insulin resistance|insulin resistance
1297284|NCT01594567|Body weight|body weight
1297285|NCT01594567|Uric acid|uric acid
1297286|NCT01594567|Blood pressure|blood pressure
1297287|NCT01594554|HCV viral genotypes|hcv viral genotypes
1297288|NCT01594554|host genotypes|host genotypes
1297289|NCT01594554|IL28B|il28b
1297290|NCT01594554|Outcome|outcome
1297291|NCT01594554|Follow-Up|follow-up
1297292|NCT01594554|ITPA|itpa
1297293|NCT01594554|RNA|rna
1297294|NCT01594554|China|china
1297295|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
1297296|NCT01594541|dementia|dementia
1297297|NCT01594541|depression|depression
1297298|NCT01594541|vitamin B12|vitamin b12
1297299|NCT01594541|mild cognitive impairment|mild cognitive impairment
1297300|NCT01594541|alzheimer's|alzheimer's
1297301|NCT01594528|schizophrenia|schizophrenia
1297302|NCT01594528|major depression|major depression
1297303|NCT01594528|pain|pain
1297304|NCT01594528|behavior|behavior
1297305|NCT01594502|prostate cancer|prostate cancer
1297306|NCT01594502|dutasteride|dutasteride
1297307|NCT01594476|Postpartum|postpartum
1297308|NCT01594476|Contraception|contraception
1297309|NCT01594476|Intrauterine device|intrauterine device
1297310|NCT01594476|Intrauterine system|intrauterine system
1297311|NCT01594476|Mirena|mirena
1297312|NCT01594476|Paragard|paragard
1297313|NCT01594476|Uterine involution|uterine involution
1297314|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
1297315|NCT01594463|Screening|screening
1297316|NCT01594463|Ultrasound|ultrasound
1297317|NCT01594463|Perinatal morbidity|perinatal morbidity
1297318|NCT01594463|Maternal complications|maternal complications
1297319|NCT01594450|incisional ventral hernia|incisional ventral hernia
1297320|NCT01594450|infected field|infected field
1297321|NCT01594450|biological mesh|biological mesh
1399491|NCT01167335|CNS|cns
1297322|NCT01594437|Cytomegalovirus|cytomegalovirus
1297323|NCT01594437|Monoclonal antibody|monoclonal antibody
1297324|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
1297325|NCT01594424|Kidney Transplantation|kidney transplantation
1297326|NCT01594411|Corus CAD|corus cad
1297327|NCT01594411|ASGES|asges
1297328|NCT01594411|Age/Sex/Gene Expression Score|age/sex/gene expression score
1297329|NCT01594411|Gene Expression|gene expression
1297330|NCT01594411|GES|ges
1297331|NCT01594411|CAD|cad
1297332|NCT01594411|CVD|cvd
1297333|NCT01594411|CHD|chd
1297334|NCT01594411|Clinical Utility|clinical utility
1297335|NCT01594411|Precision Medicine|precision medicine
1297336|NCT01594411|Primary care|primary care
1297337|NCT01594411|Coronary Artery Disease|coronary artery disease
1297338|NCT01594411|Angina Pectoris|angina pectoris
1297340|NCT01594411|Cardiovascular Disease|cardiovascular disease
1297341|NCT01594411|Coronary Heart Disease|coronary heart disease
1297342|NCT01594411|IMPACT|impact
1297343|NCT01594411|IMPACT-PCP|impact-pcp
1297344|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
1297345|NCT01594398|lung diseases|lung diseases
1297346|NCT01594398|lung neoplasms|lung neoplasms
1297347|NCT01594398|Respiratory|respiratory
1297348|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1297349|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
1297350|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
1297351|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
1297352|NCT01594398|Neoplasms by Site|neoplasms by site
1297353|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
1297354|NCT01594398|Erlotinib|erlotinib
1297355|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
1297356|NCT01594398|Breast Neoplasms|breast neoplasms
1297357|NCT01594398|Neoplasms|neoplasms
1297358|NCT01594398|Breast Diseases|breast diseases
1297359|NCT01594398|Exemestane|exemestane
1297360|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
1297361|NCT01594385|Open Abdomen|open abdomen
1297362|NCT01594385|Damage Control|damage control
1297363|NCT01594385|Trauma|trauma
1297364|NCT01594385|Wound healing|wound healing
1297365|NCT01594385|Gun shot wounds|gun shot wounds
1297366|NCT01594385|Stab wounds|stab wounds
1297367|NCT01594385|Automobile accidents|automobile accidents
1297368|NCT01594385|Wounds and Injury|wounds and injury
1297369|NCT01594372|Uterine Prolapse|uterine prolapse
1297370|NCT01594372|Laparoscopy|laparoscopy
1297371|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
1297372|NCT01594359|Ferritin|ferritin
1297373|NCT01594346|Vitamin E|vitamin e
1297374|NCT01594346|alpha-tocopherol|alpha-tocopherol
1297375|NCT01594346|cognitive decline|cognitive decline
1297376|NCT01594346|Down syndrome|down syndrome
1297377|NCT01594346|Aging|aging
1297378|NCT01594346|Dementia|dementia
1297379|NCT01594333|Myocardial Infarction|myocardial infarction
1297380|NCT01594333|Stroke|stroke
1297381|NCT01594333|Cardiovascular death|cardiovascular death
1297382|NCT01594333|Type 2 Diabetes|type 2 diabetes
1297383|NCT01594333|Metabolic Syndrome|metabolic syndrome
1297384|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
1297385|NCT01594333|Atherothrombosis|atherothrombosis
1297386|NCT01594307|BP|bp
1297387|NCT01594294|CLEAR CARE®|clear care®
1297388|NCT01594294|AOSEPT® Plus|aosept® plus
1297389|NCT01594294|ReNu MultiPlus®|renu multiplus®
1297390|NCT01594294|silicone hydrogel|silicone hydrogel
1297391|NCT01594294|hydrogel|hydrogel
1297392|NCT01594294|ACUVUE® 2®|acuvue® 2®
1297393|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
1297394|NCT01594294|eyelid response|eyelid response
1297395|NCT01594294|wettability|wettability
1297396|NCT01594294|contamination|contamination
1297397|NCT01594294|contact lenses|contact lenses
1297398|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
1297399|NCT01594281|Ranibizumab|ranibizumab
1297400|NCT01594268|kidney transplant|kidney transplant
1297401|NCT01594268|Certican|certican
1297402|NCT01594255|Healthy volunteer|healthy volunteer
1297403|NCT01594255|QT intervals|qt intervals
1297404|NCT01594255|ECG|ecg
1297405|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
1297904|NCT01592266|PET|pet
1297406|NCT01594242|multiple myeloma|multiple myeloma
1297407|NCT01594242|bortezomib|bortezomib
1297408|NCT01594242|proteasome inhibitor|proteasome inhibitor
1297409|NCT01594229|Pharmacokinetics|pharmacokinetics
1297410|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
1297411|NCT01594229|Safety|safety
1297412|NCT01594229|Bendamustine|bendamustine
1297413|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1297414|NCT01594229|Rituximab|rituximab
1297415|NCT01594229|ABT-199|abt-199
1297416|NCT01594229|Cancer|cancer
1297417|NCT01594229|Preliminary Efficacy|preliminary efficacy
1297418|NCT01594216|Postmenopausal female|postmenopausal female
1297419|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
1297420|NCT01594203|Pazopanib|pazopanib
1297421|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
1297422|NCT01594177|DAFNE|dafne
1297423|NCT01594177|GBG 70|gbg 70
1297425|NCT01594177|German Breast Group|german breast group
1297426|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
1297427|NCT01594177|Afatinib|afatinib
1297428|NCT01594177|neo-adjuvant|neo-adjuvant
1297429|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
1297430|NCT01594177|BIBW 2992|bibw 2992
1297431|NCT01594177|1200.159|1200.159
1297432|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
1297433|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
1297434|NCT01594164|upper airway|upper airway
1297435|NCT01594164|geometry|geometry
1297436|NCT01594151|asthma|asthma
1297437|NCT01594151|controlled|controlled
1297438|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
1297439|NCT01594151|upper airway|upper airway
1297440|NCT01594151|paediatric|paediatric
1297441|NCT01594112|Remote monitoring|remote monitoring
1297442|NCT01594112|Home monitoring|home monitoring
1297443|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
1297444|NCT01594112|Shock|shock
1297445|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
1297446|NCT01594112|Corrective actions|corrective actions
1297447|NCT01594112|ID recurrences|id recurrences
1297448|NCT01594112|Medical reaction time|medical reaction time
1297449|NCT01594099|cervical cancer|cervical cancer
1297450|NCT01594099|elderly women|elderly women
1297451|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
1297452|NCT01594086|green tea|green tea
1297453|NCT01594086|aging|aging
1297454|NCT01594086|atherosclerosis|atherosclerosis
1297455|NCT01594086|homocysteine|homocysteine
1297456|NCT01594086|cognitive impairment|cognitive impairment
1297457|NCT01594073|implantable defibrillator|implantable defibrillator
1297458|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
1297459|NCT01594073|cardiac death|cardiac death
1297460|NCT01594047|hyperalgesia|hyperalgesia
1297461|NCT01594047|Patient controlled analgesia|patient controlled analgesia
1297462|NCT01594047|morphine|morphine
1297463|NCT01594047|methadone|methadone
1297464|NCT01594047|ketamine|ketamine
1297465|NCT01594021|propofol|propofol
1297466|NCT01594021|anesthesia, induction|anesthesia, induction
1297467|NCT01594021|hypotension|hypotension
1297468|NCT01594021|cardiac output|cardiac output
1297469|NCT01594008|Toll like receptors|toll like receptors
1297470|NCT01594008|Inflammation|inflammation
1297471|NCT01594008|Anthocyanins|anthocyanins
1297472|NCT01594008|Blueberries|blueberries
1297473|NCT01593995|Erlotinib|erlotinib
1297474|NCT01593995|Skin side effect|skin side effect
1297475|NCT01593995|EGF ointment|egf ointment
1297476|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1297477|NCT01593982|Cocaine Dependence|cocaine dependence
1297478|NCT01593982|Cocaine Addicts|cocaine addicts
1297479|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1297480|NCT01593982|Cognitive Function|cognitive function
1297481|NCT01593969|Essential Fatty Acid|essential fatty acid
1297482|NCT01593969|Seed oil|seed oil
1297483|NCT01593969|Fish oil|fish oil
1297484|NCT01593969|Dietary deficiency|dietary deficiency
1297485|NCT01593943|contraception|contraception
1297486|NCT01593943|india|india
1297487|NCT01593943|rural|rural
1297488|NCT01593930|Pulp Anesthesia|pulp anesthesia
1297489|NCT01593930|Articaine|articaine
1297490|NCT01593930|Lidocaine|lidocaine
1297491|NCT01593917|Aortic valve|aortic valve
1297492|NCT01593917|Heart valve|heart valve
1297493|NCT01593917|Tissue valve|tissue valve
1297494|NCT01593917|Bioprosthesis|bioprosthesis
1297495|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
1297496|NCT01593891|IVUS, CCSVI|ivus, ccsvi
1297497|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1297498|NCT01593865|Mammary Artery Grafts|mammary artery grafts
1297499|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
1297500|NCT01593865|Clinical Outcomes|clinical outcomes
1297501|NCT01593852|X-rays|x-rays
1297502|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
1297503|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
1297504|NCT01593852|Catheter Ablation|catheter ablation
1297505|NCT01593813|Pronator quadratus|pronator quadratus
1297905|NCT01592266|bone marrow|bone marrow
1297506|NCT01593813|distal radius fracture|distal radius fracture
1297507|NCT01593813|volar plating|volar plating
1297508|NCT01593800|Probiotics|probiotics
1297509|NCT01593800|Lactose|lactose
1297510|NCT01593787|Hypertension|hypertension
1297511|NCT01593787|Renal dysfunction|renal dysfunction
1297512|NCT01593787|LCZ696|lcz696
1297513|NCT01593774|Melatonin|melatonin
1297514|NCT01593774|Olanzapine|olanzapine
1297515|NCT01593774|Metabolic side effects|metabolic side effects
1297516|NCT01593774|Psychosis|psychosis
1297517|NCT01593774|Hyperlipidemia|hyperlipidemia
1297518|NCT01593774|Hyperglycemia|hyperglycemia
1297519|NCT01593774|Weight gain|weight gain
1297520|NCT01593774|Diabetes|diabetes
1297521|NCT01593761|cABSSSI|cabsssi
1297522|NCT01593761|MRSA|mrsa
1297523|NCT01593748|Sarcoma|sarcoma
1399732|NCT01166334|Web|web
1297524|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
1297525|NCT01593722|Loa loa|loa loa
1297526|NCT01593722|Immune Response|immune response
1297527|NCT01593722|Therapy|therapy
1297528|NCT01593709|Healthy Volunteers|healthy volunteers
1297529|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
1297530|NCT01593696|B Cell Lymphoma|b cell lymphoma
1297531|NCT01593696|ALL|all
1297532|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
1297533|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
1297534|NCT01593683|Oncology service|oncology service
1297535|NCT01593683|Nursing staff|nursing staff
1297536|NCT01593683|Psychosocial intervention|psychosocial intervention
1297537|NCT01593683|Coping skills|coping skills
1297538|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
1297539|NCT01593670|natural killer cells|natural killer cells
1297540|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
1297541|NCT01593644|slow bolus and low doses|slow bolus and low doses
1297542|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
1297543|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
1297544|NCT01593644|Patients|patients
1297545|NCT01593644|stable|stable
1297546|NCT01593631|lactose malabsorption|lactose malabsorption
1297547|NCT01593631|lactose intolerance|lactose intolerance
1297548|NCT01593631|lactose digestion|lactose digestion
1297549|NCT01593631|lactose maldigestion|lactose maldigestion
1297550|NCT01593631|acid lactase|acid lactase
1297551|NCT01593631|yoghurt bacteria|yoghurt bacteria
1297552|NCT01593618|cancer survivor|cancer survivor
1297553|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
1297554|NCT01593605|supplements|supplements
1297555|NCT01593592|Helicobacter pylori|helicobacter pylori
1297556|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
1297557|NCT01593592|dyspeptic patients|dyspeptic patients
1297558|NCT01593592|eradication|eradication
1297559|NCT01593579|melanoma|melanoma
1297560|NCT01593579|autonomic failure|autonomic failure
1297561|NCT01593579|hypotension|hypotension
1297562|NCT01593579|akt therapy|akt therapy
1297563|NCT01593566|femoral nerve block|femoral nerve block
1297564|NCT01593553|Screening|screening
1297565|NCT01593553|Stroke prevention|stroke prevention
1297566|NCT01593553|Cost effectiveness|cost effectiveness
1297567|NCT01593527|Frequent flares|frequent flares
1297568|NCT01593527|Frequent attacks|frequent attacks
1297569|NCT01593527|gout|gout
1297570|NCT01593527|gouty arthritis|gouty arthritis
1297571|NCT01593527|Chronic kidney disease|chronic kidney disease
1297572|NCT01593527|renal impairment|renal impairment
1297573|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
1297574|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
1297575|NCT01593514|Vaccines|vaccines
1297576|NCT01593514|Meningitis|meningitis
1297577|NCT01593514|Meningococcal|meningococcal
1297578|NCT01593501|vitamin D|vitamin d
1297579|NCT01593501|cholecalciferol|cholecalciferol
1297580|NCT01593501|bone mineral density|bone mineral density
1297581|NCT01593501|Magnesium deficiency|magnesium deficiency
1297582|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
1297583|NCT01593488|recurrent|recurrent
1297584|NCT01593488|CNS disease|cns disease
1297585|NCT01593488|intrathecal therapy|intrathecal therapy
1297586|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
1297587|NCT01593410|Efficacy/Safety|efficacy/safety
1297588|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
1297589|NCT01593410|Chinese Subjects|chinese subjects
1297590|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1297591|NCT01593397|Obesity|obesity
1297592|NCT01593397|Insulin Resistance|insulin resistance
1297593|NCT01593384|Breast Cancer|breast cancer
1297594|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
1297595|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
1297596|NCT01593371|Adipokines|adipokines
1297597|NCT01593371|leptin|leptin
1297598|NCT01593371|chemerin|chemerin
1297599|NCT01593371|omentin|omentin
1297600|NCT01593371|metformin|metformin
1297601|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
1297602|NCT01593358|CCSVI|ccsvi
1297603|NCT01593345|Elderly|elderly
1297604|NCT01593345|mobility limitations|mobility limitations
1297605|NCT01593345|self-management|self-management
1297606|NCT01593345|exercise|exercise
1297607|NCT01593332|Rituximab|rituximab
1297608|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
1297609|NCT01593332|Biologics|biologics
1297610|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
1297611|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
1297612|NCT01593332|DAS28|das28
1297613|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
1297614|NCT01593293|Elderly patients|elderly patients
1297615|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
1297616|NCT01593293|Pemetrexed|pemetrexed
1297617|NCT01593293|Carboplatin|carboplatin
1297618|NCT01593280|anesthesia|anesthesia
1297619|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
1297620|NCT01593280|pain, postoperative|pain, postoperative
1297621|NCT01593280|surgery, cesarean section|surgery, cesarean section
1297622|NCT01593280|quality of recovery|quality of recovery
1297623|NCT01593267|intracranial aneurysm|intracranial aneurysm
1297624|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
1297625|NCT01593267|randomized trial|randomized trial
1297626|NCT01593267|coil embolization|coil embolization
1297627|NCT01593267|clip occlusion|clip occlusion
1297628|NCT01593267|vascular disorders|vascular disorders
1297629|NCT01593241|Seminoma IIA/B|seminoma iia/b
1297630|NCT01593241|Carboplatin|carboplatin
1297632|NCT01593215|genetics|genetics
1297633|NCT01593215|type 2 diabetes|type 2 diabetes
1297634|NCT01593215|insulin secretion|insulin secretion
1297635|NCT01593189|developmental disabilities|developmental disabilities
1297636|NCT01593189|school readiness|school readiness
1297637|NCT01593189|literacy|literacy
1297638|NCT01593189|social emotional skills|social emotional skills
1297639|NCT01593189|self regulation|self regulation
1297640|NCT01593189|caregiver involvement|caregiver involvement
1297641|NCT01593176|Femur|femur
1297642|NCT01593176|Fracture|fracture
1297643|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
1297644|NCT01593163|Functional echocardiography|functional echocardiography
1297645|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
1297646|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
1297647|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
1297648|NCT01593150|Atrial Fibrillation|atrial fibrillation
1297649|NCT01593150|TEE|tee
1297650|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
1297651|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
1297652|NCT01593111|Allergies|allergies
1297653|NCT01593111|Asthma|asthma
1297654|NCT01593111|Environmental|environmental
1297655|NCT01593111|NYC|nyc
1297656|NCT01593111|Manhattan|manhattan
1297657|NCT01593111|Harlem|harlem
1297658|NCT01593111|Bronx|bronx
1297659|NCT01593111|Brooklyn|brooklyn
1297660|NCT01593111|Breathing|breathing
1297661|NCT01593111|eNO|eno
1297662|NCT01593111|IgE|ige
1297663|NCT01593111|Allergens|allergens
1297664|NCT01593111|Cockroach|cockroach
1297665|NCT01593111|Dust mites|dust mites
1297666|NCT01593111|Pets|pets
1297667|NCT01593098|siblings|siblings
1297668|NCT01593098|advanced neoplasm|advanced neoplasm
1297669|NCT01593098|mRNA|mrna
1297670|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
1297671|NCT01593085|palliative cares|palliative cares
1297672|NCT01593085|cancer|cancer
1297673|NCT01593085|suicide risk|suicide risk
1297674|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
1297675|NCT01593072|Ebola Virus|ebola virus
1297676|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
1297677|NCT01593072|EHF|ehf
1297678|NCT01593059|International|international
1297679|NCT01593059|Multicenter|multicenter
1297680|NCT01593059|Observational registry|observational registry
1297681|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1297682|NCT01593059|Stenting|stenting
1297683|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1297684|NCT01593059|Coronary revascularization|coronary revascularization
1297685|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
1297686|NCT01593059|STEMI|stemi
1297687|NCT01593059|NSTEMI|nstemi
1297688|NCT01593059|Ischemia|ischemia
1297689|NCT01593059|Angina|angina
1297690|NCT01593059|Subgroups|subgroups
1297691|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
1297692|NCT01593059|Diabetes|diabetes
1297693|NCT01593059|Small Vessels|small vessels
1297694|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1297695|NCT01593046|GSK1265744 LAP|gsk1265744 lap
1297696|NCT01593046|integrase inhibitor|integrase inhibitor
1297697|NCT01593046|healthy subjects|healthy subjects
1297698|NCT01593046|TMC278 LA|tmc278 la
1297699|NCT01593046|GSK1265744LAP|gsk1265744lap
1297700|NCT01593046|long acting retroviral|long acting retroviral
1297701|NCT01593046|HIV-1 infection|hiv-1 infection
1297702|NCT01593020|Breast cancer|breast cancer
1297906|NCT01592266|AML|aml
1297703|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
1297704|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
1297705|NCT01593020|Paclitaxel|paclitaxel
1297706|NCT01593020|Taxol|taxol
1297707|NCT01593020|Eribulin|eribulin
1297708|NCT01593020|E7389|e7389
1297709|NCT01593020|5-Fluorouracil|5-fluorouracil
1297710|NCT01593020|5-FU|5-fu
1297711|NCT01593020|Adrucil|adrucil
1297712|NCT01593020|Efudex|efudex
1297713|NCT01593020|Epirubicin|epirubicin
1297714|NCT01593020|Ellence|ellence
1297715|NCT01593020|Cyclophosphamide|cyclophosphamide
1297717|NCT01593020|Neosar|neosar
1297718|NCT01593020|Doxorubicin|doxorubicin
1297719|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
1297720|NCT01593020|Adriamycin PFS|adriamycin pfs
1297721|NCT01593020|Adriamycin RDF|adriamycin rdf
1297722|NCT01593020|Adriamycin|adriamycin
1297723|NCT01593020|Rubex|rubex
1297724|NCT01593007|Heart failure|heart failure
1297725|NCT01593007|respiratory muscles|respiratory muscles
1297726|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
1297727|NCT01592994|HIV|hiv
1297728|NCT01592994|condom use|condom use
1297729|NCT01592994|India|india
1297730|NCT01592994|women|women
1297731|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
1297732|NCT01592981|bortezomib|bortezomib
1297733|NCT01592981|cyclophosphamide|cyclophosphamide
1297734|NCT01592981|rituximab|rituximab
1297735|NCT01592968|Brain Neoplasms|brain neoplasms
1297736|NCT01592968|Non-melanoma brain metastases|non-melanoma brain metastases
1297737|NCT01592968|Stereotactic radiosurgery|stereotactic radiosurgery
1297738|NCT01592968|SRS|srs
1297739|NCT01592968|Whole brain radiation therapy|whole brain radiation therapy
1297740|NCT01592968|WBRT|wbrt
1297741|NCT01592955|Glaucoma|glaucoma
1297742|NCT01592955|Cyclocoagulation|cyclocoagulation
1297743|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
1297744|NCT01592942|inguinal hernia|inguinal hernia
1297745|NCT01592942|mesh fixation|mesh fixation
1297746|NCT01592942|glue|glue
1297747|NCT01592942|Lichtenstein|lichtenstein
1297748|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
1297749|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
1297750|NCT01592929|MRI|mri
1297751|NCT01592929|Pharyngometry|pharyngometry
1297752|NCT01592929|Upper Airway|upper airway
1297753|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
1297754|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
1297755|NCT01592929|CBCT|cbct
1297756|NCT01592929|Computed Tomography|computed tomography
1297757|NCT01592929|CT|ct
1297758|NCT01592916|Fibromyalgia|fibromyalgia
1297759|NCT01592916|Pain|pain
1297760|NCT01592916|Women|women
1297761|NCT01592916|Exercise|exercise
1297762|NCT01592916|IGF1|igf1
1297763|NCT01592903|Uterine fibroids|uterine fibroids
1297764|NCT01592903|somatic stem cell|somatic stem cell
1297765|NCT01592903|Side Population|side population
1297766|NCT01592877|UWB|uwb
1297767|NCT01592877|non-contact|non-contact
1297768|NCT01592877|patient monitor|patient monitor
1297769|NCT01592838|Belgium|belgium
1297770|NCT01592838|Quality of hospital care|quality of hospital care
1297771|NCT01592838|Rotavirus vaccination|rotavirus vaccination
1297772|NCT01592825|Breast Cancer|breast cancer
1297773|NCT01592825|Prognostic factor|prognostic factor
1297774|NCT01592825|uPA/PA-1|upa/pa-1
1297775|NCT01592825|cohort|cohort
1297776|NCT01592799|Influenza|influenza
1297777|NCT01592799|Children|children
1297778|NCT01592799|Hospitalizations|hospitalizations
1297779|NCT01592799|Spain|spain
1297780|NCT01592799|Burden|burden
1297781|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1297782|NCT01592786|Autism|autism
1297783|NCT01592786|Autistic Disorder|autistic disorder
1297784|NCT01592786|Asperger's Disorder|asperger's disorder
1297785|NCT01592786|Asperger's|asperger's
1297786|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
1297787|NCT01592786|Memantine|memantine
1297788|NCT01592786|Pediatric Disorder|pediatric disorder
1297789|NCT01592773|Autistic Disorder|autistic disorder
1297790|NCT01592773|Asperger's Disorder|asperger's disorder
1297791|NCT01592773|Asperger's|asperger's
1297792|NCT01592773|Pediatric Autism|pediatric autism
1297793|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
1297794|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
1297795|NCT01592760|air-Q SP|air-q sp
1297796|NCT01592760|air-Q|air-q
1297797|NCT01592760|i-gel|i-gel
1297798|NCT01592760|supraglottic airway device|supraglottic airway device
1297799|NCT01592760|laryngeal mask airway|laryngeal mask airway
1297800|NCT01592747|Asperger's|asperger's
1297801|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
1297802|NCT01592747|Memantine|memantine
1297803|NCT01592747|Pervasive Child Development Disorder|pervasive child development disorder
1297804|NCT01592747|Pediatric Disorder|pediatric disorder
1297805|NCT01592747|Randomized Controlled Trial|randomized controlled trial
1297806|NCT01592734|chronic constipation|chronic constipation
1297807|NCT01592734|faecal impaction|faecal impaction
1297808|NCT01592734|PEG-only laxative|peg-only laxative
1297809|NCT01592721|Carcinoma|carcinoma
1297810|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
1297811|NCT01592721|Head and neck neoplasms|head and neck neoplasms
1297812|NCT01592721|Cetuximab|cetuximab
1297813|NCT01592708|orthognathic surgery|orthognathic surgery
1297814|NCT01592708|maxillary osteotomy|maxillary osteotomy
1297815|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
1297816|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
1297817|NCT01592708|anesthesia|anesthesia
1297818|NCT01592695|Nicotine dependence|nicotine dependence
1297819|NCT01592695|Smoking cessation|smoking cessation
1297820|NCT01592695|Telehealth|telehealth
1297821|NCT01592695|Alcohol use|alcohol use
1297822|NCT01592695|Depression|depression
1297823|NCT01592695|Body weight|body weight
1297824|NCT01592682|tobacco|tobacco
1297825|NCT01592682|secondhand smoke|secondhand smoke
1297826|NCT01592682|Chinese|chinese
1297827|NCT01592682|NNAL|nnal
1297828|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
1297829|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1297830|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
1297831|NCT01592656|Computed Tomography scan|computed tomography scan
1297832|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
1297833|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
1297834|NCT01592656|Arterial Blood Gas|arterial blood gas
1297835|NCT01592656|Hypercapnic|hypercapnic
1297836|NCT01592656|Health Related Quality of Life|health related quality of life
1297837|NCT01592656|Lung compliance|lung compliance
1297838|NCT01592643|Corneal shield|corneal shield
1297839|NCT01592643|PRK|prk
1297840|NCT01592643|Myopia|myopia
1297841|NCT01592643|Pain|pain
1297842|NCT01592643|Vision|vision
1297843|NCT01592617|cancer vaccine|cancer vaccine
1297844|NCT01592617|HLA-A*24:02|hla-a*24:02
1297845|NCT01592617|lung cancer|lung cancer
1297846|NCT01592617|CTL|ctl
1297847|NCT01592604|fracture|fracture
1297848|NCT01592604|fifth metatarsal|fifth metatarsal
1297849|NCT01592604|functioanl outcome|functioanl outcome
1297850|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
1297851|NCT01592578|liver cirrhosis|liver cirrhosis
1297852|NCT01592578|portal hypertension|portal hypertension
1297853|NCT01592552|Alzheimer's Disease|alzheimer's disease
1297854|NCT01592552|Multiple Sclerosis|multiple sclerosis
1297855|NCT01592552|Parkinson's Disease|parkinson's disease
1297856|NCT01592552|Huntington's Disease|huntington's disease
1297857|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1297858|NCT01592539|Type 1 Diabetes|type 1 diabetes
1297859|NCT01592539|Bone|bone
1297860|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
1297861|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
1297862|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
1297863|NCT01592500|GHD|ghd
1297864|NCT01592500|r-hGH|r-hgh
1297865|NCT01592500|Long-acting|long-acting
1297866|NCT01592474|Multiple Sclerosis|multiple sclerosis
1297867|NCT01592474|Avonex|avonex
1297868|NCT01592474|Brain atrophy|brain atrophy
1297869|NCT01592474|MRI|mri
1297870|NCT01592474|Interferon-beta 1a|interferon-beta 1a
1297871|NCT01592474|IFN Beta 1-a|ifn beta 1-a
1297872|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
1297873|NCT01592474|CIS|cis
1297874|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
1297875|NCT01592461|Opioid dependence|opioid dependence
1297876|NCT01592461|Suboxone|suboxone
1297877|NCT01592461|Methadone|methadone
1297878|NCT01592448|Acetaminophen|acetaminophen
1297879|NCT01592448|Patient Safety|patient safety
1297880|NCT01592448|Health Literacy|health literacy
1297881|NCT01592422|Small cell lung cancer|small cell lung cancer
1297882|NCT01592422|Maintenance therapy|maintenance therapy
1297883|NCT01592422|Immunotherapy|immunotherapy
1297884|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
1297885|NCT01592409|cannabis impaired driving|cannabis impaired driving
1297886|NCT01592409|driving simulation|driving simulation
1297887|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
1297888|NCT01592409|residual effects of cannabis|residual effects of cannabis
1297889|NCT01592409|young drivers|young drivers
1297890|NCT01592396|Tralokinumab|tralokinumab
1297891|NCT01592396|CAT-354|cat-354
1297892|NCT01592396|Asthma|asthma
1297893|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
1297894|NCT01592357|gait speed|gait speed
1297895|NCT01592357|mind body exercise|mind body exercise
1297896|NCT01592357|tai chi|tai chi
1297897|NCT01592357|cardiac disease|cardiac disease
1297898|NCT01592357|frail elderly|frail elderly
1297899|NCT01592344|Chronic pain|chronic pain
1297900|NCT01592344|peripheral nerve|peripheral nerve
1297901|NCT01592344|neuralgia|neuralgia
1297902|NCT01592344|somatosensory nervous system|somatosensory nervous system
1297903|NCT01592266|FLT|flt
1297907|NCT01592240|PF-04950615|pf-04950615
1297908|NCT01592240|RN316|rn316
1297909|NCT01592227|healthy volunteer|healthy volunteer
1297910|NCT01592227|pharmacokinetics|pharmacokinetics
1297911|NCT01592227|paracetamol|paracetamol
1297912|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
1297913|NCT01592201|Schizophrenia|schizophrenia
1297914|NCT01592201|Paliperidone ER|paliperidone er
1297915|NCT01592201|Antipsychotics|antipsychotics
1297916|NCT01592201|Mental disorder|mental disorder
1297917|NCT01592201|Comparative study|comparative study
1297918|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
1297919|NCT01592149|Appetite|appetite
1297920|NCT01592136|Ponatinib|ponatinib
1297921|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1297922|NCT01592123|anxiety|anxiety
1297923|NCT01592123|septal surgery|septal surgery
1297924|NCT01592123|septum deviation|septum deviation
1297925|NCT01592123|sleep|sleep
1297926|NCT01592110|Schizophrenia|schizophrenia
1297927|NCT01592097|Multiple Sclerosis|multiple sclerosis
1297928|NCT01592097|MS|ms
1297929|NCT01592097|Autoimmune|autoimmune
1297930|NCT01592084|lipid lowering therapy|lipid lowering therapy
1297931|NCT01592084|survival|survival
1297932|NCT01592084|ALSFRS|alsfrs
1297933|NCT01592084|age|age
1297934|NCT01592084|BMI|bmi
1297935|NCT01592084|weight|weight
1297936|NCT01592071|food sensitivity|food sensitivity
1297937|NCT01592071|IgG|igg
1297938|NCT01592071|obesity|obesity
1297939|NCT01592071|overweight|overweight
1297940|NCT01592071|body composition|body composition
1297941|NCT01592071|reactive foods|reactive foods
1297942|NCT01592058|weight change|weight change
1297943|NCT01592058|contraception|contraception
1297944|NCT01592058|birth control|birth control
1297945|NCT01592058|progestin|progestin
1297946|NCT01592058|progestin only|progestin only
1297947|NCT01592058|weight gain|weight gain
1297949|NCT01592058|Depo Provera|depo provera
1297950|NCT01592058|DMPA|dmpa
1297951|NCT01592058|IUD|iud
1297952|NCT01592058|IUC|iuc
1297953|NCT01592058|Mirena|mirena
1297954|NCT01592058|Paragard|paragard
1297955|NCT01592058|Implanon|implanon
1297956|NCT01592058|implant|implant
1297957|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
1297958|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
1297959|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
1297960|NCT01592006|hepatitis C virus|hepatitis c virus
1297961|NCT01592006|liver transplant recipient|liver transplant recipient
1297962|NCT01591993|Sensitive skin|sensitive skin
1297963|NCT01591993|Lactic acid test|lactic acid test
1297964|NCT01591993|Transepidermal water loss|transepidermal water loss
1297965|NCT01591993|Colorimetry|colorimetry
1297966|NCT01591993|Capacitance|capacitance
1297967|NCT01591980|post-craniotomy pain|post-craniotomy pain
1297968|NCT01591980|pregabalin|pregabalin
1297969|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
1297970|NCT01591980|Craniotomy|craniotomy
1297971|NCT01591967|Chiropractic|chiropractic
1297972|NCT01591967|Blood pressure|blood pressure
1297973|NCT01591967|Pulse Rate|pulse rate
1297974|NCT01591967|Thoracic|thoracic
1297975|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
1297976|NCT01591928|Pediatrics|pediatrics
1297977|NCT01591928|Congenital heart disease|congenital heart disease
1297978|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
1297979|NCT01591928|Intestinal malrotation|intestinal malrotation
1297980|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
1297981|NCT01591876|exercise|exercise
1297982|NCT01591876|kidney disease|kidney disease
1297983|NCT01591876|vascular function|vascular function
1297984|NCT01591876|haemodialysis|haemodialysis
1297985|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1297986|NCT01591863|CDAD|cdad
1297987|NCT01591863|Pediatric|pediatric
1297988|NCT01591798|Rectal cancer|rectal cancer
1297989|NCT01591798|Robotic surgery|robotic surgery
1297990|NCT01591798|Laparoscopic surgery|laparoscopic surgery
1297991|NCT01591785|Hand|hand
1297992|NCT01591785|Foot|foot
1297993|NCT01591785|Eczema|eczema
1297994|NCT01591785|Atopic Dermatitis|atopic dermatitis
1297995|NCT01591772|FALLOPIAN TUBE|fallopian tube
1297996|NCT01591772|OVARY|ovary
1297997|NCT01591772|PERITONEUM|peritoneum
1297998|NCT01591772|Quality of Life|quality of life
1297999|NCT01591772|structural MRI|structural mri
1298000|NCT01591772|functional MRI|functional mri
1298001|NCT01591772|neuropsychological assessment|neuropsychological assessment
1298002|NCT01591772|12-075|12-075
1298003|NCT01591759|citicoline|citicoline
1298004|NCT01591759|cognitive function|cognitive function
1298005|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
1298006|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1298007|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
1298008|NCT01591746|Mastectomy|mastectomy
1298009|NCT01591746|Mammaplasty|mammaplasty
1298010|NCT01591746|Breast reconstruction|breast reconstruction
1298011|NCT01591746|Tissue expansion|tissue expansion
1298012|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
1298013|NCT01591746|Quality of Life|quality of life
1298014|NCT01591746|Acellular dermal matrix|acellular dermal matrix
1610669|NCT00355576|ALS|als
1298015|NCT01591733|Borderline resectable|borderline resectable
1298016|NCT01591707|autism spectrum disorders|autism spectrum disorders
1298017|NCT01591707|school|school
1298018|NCT01591707|language|language
1298019|NCT01591707|social|social
1298020|NCT01591694|child trauma|child trauma
1298021|NCT01591694|maltreatment|maltreatment
1298022|NCT01591694|physical abuse|physical abuse
1298023|NCT01591694|sexual abuse|sexual abuse
1298024|NCT01591694|emotional abuse|emotional abuse
1298025|NCT01591694|abandonment|abandonment
1298026|NCT01591694|domestic violence|domestic violence
1298027|NCT01591694|community violence|community violence
1298028|NCT01591681|Type 1 Diabetes|type 1 diabetes
1298029|NCT01591681|Hypoglycemia|hypoglycemia
1298030|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
1298031|NCT01591681|Pump Suspension|pump suspension
1298032|NCT01591668|Hepatitis|hepatitis
1298033|NCT01591668|Hepatitis C|hepatitis c
1298034|NCT01591668|Chronic HCV|chronic hcv
1298035|NCT01591668|HCV|hcv
1298036|NCT01591668|Treatment Naive|treatment naive
1298037|NCT01591668|Gilead|gilead
1298038|NCT01591668|GS-9620|gs-9620
1298039|NCT01591642|physical activity|physical activity
1298040|NCT01591642|functional fitness|functional fitness
1298041|NCT01591642|quality of life|quality of life
1298042|NCT01591629|Cannabis|cannabis
1298043|NCT01591629|Marijuana|marijuana
1298055|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
1298056|NCT01591590|ADC|adc
1298057|NCT01591590|Metabolic Progression Index|metabolic progression index
1298058|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
1298059|NCT01591564|severe mood dysregulation|severe mood dysregulation
1298060|NCT01591538|Prevalence|prevalence
1298061|NCT01591538|MDRGNB|mdrgnb
1298062|NCT01591538|Acquisition|acquisition
1298063|NCT01591538|Middle stay|middle stay
1298064|NCT01591538|Endemic area|endemic area
1298065|NCT01591525|Type II Diabetes|type ii diabetes
1298066|NCT01591525|Minorities|minorities
1298067|NCT01591525|Diabetes Mellitus|diabetes mellitus
1298068|NCT01591525|Community based screening|community based screening
1298069|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
1298070|NCT01591512|SCLC|sclc
1298071|NCT01591512|Lung Cancer|lung cancer
1298072|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
1298073|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
1298074|NCT01591486|ASA users|asa users
1298075|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
1298076|NCT01591486|cohorts|cohorts
1298077|NCT01591473|Influenza|influenza
1298078|NCT01591473|Ampligen|ampligen
1298079|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
1298080|NCT01591473|Rintatolimod|rintatolimod
1298081|NCT01591473|FluMist|flumist
1298082|NCT01591408|EEG biofeedback|eeg biofeedback
1298083|NCT01591408|neurofeedback|neurofeedback
1298084|NCT01591408|therapy|therapy
1298085|NCT01591408|adjunct|adjunct
1298086|NCT01591395|inguinal hernia|inguinal hernia
1298087|NCT01591395|laparoscopy|laparoscopy
1298088|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
1298089|NCT01591382|Ketamine|ketamine
1298090|NCT01591382|Postoperative pain|postoperative pain
1298091|NCT01591382|Opioid dependent patients|opioid dependent patients
1298092|NCT01591382|Acute pain control|acute pain control
1298096|NCT01591343|Specific immunotherapy|specific immunotherapy
1298097|NCT01591343|Allergic rhinitis|allergic rhinitis
1298098|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1298099|NCT01591343|Asthma|asthma
1298100|NCT01591304|Ulthera® System|ulthera® system
1298101|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
1298102|NCT01591304|Ulthera, Inc.|ulthera, inc.
1298103|NCT01591291|alcohol dependence|alcohol dependence
1298104|NCT01591291|alcohol addiction|alcohol addiction
1298107|NCT01591252|HIV|hiv
1298108|NCT01591252|Bone mineral density|bone mineral density
1298109|NCT01591252|bone turnover|bone turnover
1298110|NCT01591252|fracture|fracture
1298111|NCT01591252|inflammation|inflammation
1298112|NCT01591239|Adolescent|adolescent
1298113|NCT01591239|Parent|parent
1298114|NCT01591239|Substance Abuse|substance abuse
1298115|NCT01591239|Parent Training|parent training
1298116|NCT01591239|Addiction|addiction
1298117|NCT01591239|Family Intervention|family intervention
1298118|NCT01591239|Brief Intervention|brief intervention
1298119|NCT01591239|Home Intervention|home intervention
1298120|NCT01591226|caffeine|caffeine
1298121|NCT01591226|sodium citrate|sodium citrate
1298122|NCT01591226|exercise performance|exercise performance
1298123|NCT01591226|wheelchair athletes|wheelchair athletes
1298124|NCT01591226|1500m|1500m
1298125|NCT01591213|Cancer education|cancer education
1298126|NCT01591213|Prevention education|prevention education
1298127|NCT01591213|Volunteers|volunteers
1298128|NCT01591200|Alcoholic|alcoholic
1298129|NCT01591200|Liver|liver
1298130|NCT01591200|Cirrhosis|cirrhosis
1298131|NCT01591200|Stem|stem
1298132|NCT01591200|Cells|cells
1298133|NCT01591187|Text messaging|text messaging
1298134|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
1298135|NCT01591174|Functional Dyspepsia|functional dyspepsia
1298136|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
1298137|NCT01591174|ghrelin|ghrelin
1298138|NCT01591174|C-13 acetate|c-13 acetate
1298139|NCT01591148|Pharmacokinetics|pharmacokinetics
1298140|NCT01591148|Pharmacodynamics|pharmacodynamics
1298141|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1298142|NCT01591135|chemoradiotherapy|chemoradiotherapy
1298149|NCT01591096|Childhood|childhood
1298150|NCT01591096|Thrombolysis|thrombolysis
1298151|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
1298152|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
1298154|NCT01591057|vegetables|vegetables
1298155|NCT01591057|biomarkers|biomarkers
1298156|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
1298157|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
1298158|NCT01591031|laryngeal injuries|laryngeal injuries
1298159|NCT01591031|vocal cord injuries|vocal cord injuries
1298160|NCT01591031|hoarseness|hoarseness
1298161|NCT01591031|sore throat|sore throat
1298162|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
1298163|NCT01591005|sonolysis|sonolysis
1298164|NCT01591005|carotid|carotid
1298165|NCT01591005|endarterectomy|endarterectomy
1298166|NCT01591005|stenting|stenting
1298167|NCT01590992|Somatoform disorder|somatoform disorder
1298168|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
1298169|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
1298170|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
1298171|NCT01590992|globus sensation|globus sensation
1298172|NCT01590992|globus pharynges|globus pharynges
1298173|NCT01590992|globus hystericus|globus hystericus
1298174|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
1298175|NCT01590979|Ranolazine|ranolazine
1298176|NCT01590979|CABG|cabg
1298177|NCT01590979|valve repair/replacement|valve repair/replacement
1298178|NCT01590979|Cardiac Surgery|cardiac surgery
1298179|NCT01590966|spondyloarthritis|spondyloarthritis
1298180|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
1298181|NCT01590927|pelvic floor|pelvic floor
1298182|NCT01590927|ultrasonography|ultrasonography
1298183|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
1298184|NCT01590914|Gastric banding,|gastric banding,
1298185|NCT01590914|fMRI,|fmri,
1298186|NCT01590914|food cues|food cues
1298187|NCT01590901|Pharmacokinetics|pharmacokinetics
1298188|NCT01590901|Probucol|probucol
1298189|NCT01590901|healthy male subjects|healthy male subjects
1298190|NCT01590875|atrial fibrillation|atrial fibrillation
1298191|NCT01590875|ablation|ablation
1298192|NCT01590875|pulmonary veins|pulmonary veins
1298193|NCT01590875|adenosine|adenosine
1298194|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
1298195|NCT01590862|Major Depressive Disorder|major depressive disorder
1298196|NCT01590862|Deep Brain Stimulation|deep brain stimulation
1298197|NCT01590849|contraceptive agents|contraceptive agents
1298198|NCT01590849|autonomic nervous system|autonomic nervous system
1298199|NCT01590849|blood pressure|blood pressure
1298200|NCT01590849|risk|risk
1298201|NCT01590823|pharmacokinetics|pharmacokinetics
1298202|NCT01590784|Depression|depression
1298203|NCT01590784|Schizophrenia|schizophrenia
1298204|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
1298205|NCT01590745|Ultrasound therapy|ultrasound therapy
1298206|NCT01590745|Nerve Conduction studies|nerve conduction studies
1298207|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
1298208|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
1298209|NCT01590745|Canterbury CTS scale|canterbury cts scale
1298210|NCT01590732|Lymphoma|lymphoma
1298211|NCT01590732|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1298212|NCT01590732|PTCL|ptcl
1298213|NCT01590732|Relapsed or refractory T-Cell Lymphoma|relapsed or refractory t-cell lymphoma
1298214|NCT01590732|TCL|tcl
1298215|NCT01590732|Peripheral TCL-NOS|peripheral tcl-nos
1298216|NCT01590732|Angioimmunoblastic TCL|angioimmunoblastic tcl
1298217|NCT01590732|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1298218|NCT01590732|Hepatosplenic TCL|hepatosplenic tcl
1298219|NCT01590732|Enteropathy-associated TCL|enteropathy-associated tcl
1298220|NCT01590732|Romidepsin|romidepsin
1298221|NCT01590732|Istodax|istodax
1298222|NCT01590732|Depsipeptide|depsipeptide
1298223|NCT01590732|FK228|fk228
1298224|NCT01590732|Etoposide|etoposide
1298225|NCT01590732|VePesid|vepesid
1298226|NCT01590732|Carboplatin|carboplatin
1298227|NCT01590732|Paraplatin|paraplatin
1298228|NCT01590732|Mesna|mesna
1298229|NCT01590732|Mesnex|mesnex
1298230|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
1298231|NCT01590706|Aged|aged
1298232|NCT01590706|Middle Aged|middle aged
1298233|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
1298234|NCT01590706|Heart Rate Control|heart rate control
1298235|NCT01590706|Biomarkers|biomarkers
1298236|NCT01590693|Gait|gait
1298237|NCT01590667|Fat excretion|fat excretion
1298238|NCT01590654|Hepatitis|hepatitis
1298239|NCT01590654|Hepatitis B|hepatitis b
1298240|NCT01590654|Hepatitis B Virus|hepatitis b virus
1298241|NCT01590654|HBV|hbv
1298242|NCT01590654|GS-9620|gs-9620
1298243|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
1298244|NCT01590641|Hepatitis|hepatitis
1298245|NCT01590641|Hepatitis B|hepatitis b
1298246|NCT01590641|Hepatitis B Virus|hepatitis b virus
1298248|NCT01590641|GS-9620|gs-9620
1298249|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
1298250|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
1298251|NCT01590628|Genetic disorder|genetic disorder
1298252|NCT01590615|Hepatitis|hepatitis
1298253|NCT01590615|Hepatitis B|hepatitis b
1298254|NCT01590615|HBV|hbv
1298255|NCT01590615|OLT|olt
1298256|NCT01590615|MELD|meld
1298257|NCT01590615|Renal Safety|renal safety
1298258|NCT01590615|Liver Transplant|liver transplant
1298259|NCT01590602|Huntington's Disease|huntington's disease
1298260|NCT01590602|European Huntington's Disease Network|european huntington's disease network
1298261|NCT01590602|Juvenile HD|juvenile hd
1298262|NCT01590602|EHDN|ehdn
1298263|NCT01590602|REGISTRY|registry
1298264|NCT01590589|Huntington Disease|huntington disease
1298265|NCT01590589|European HD Network|european hd network
1298266|NCT01590589|Cohort|cohort
1298267|NCT01590589|REGISTRY|registry
1298268|NCT01590589|EHDN|ehdn
1298269|NCT01590576|women|women
1298270|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
1298271|NCT01590550|Anticoagulation|anticoagulation
1298272|NCT01590537|non-interventional|non-interventional
1298273|NCT01590537|Mirena|mirena
1298274|NCT01590537|Contraception|contraception
1298275|NCT01590537|Russian Federation|russian federation
1298276|NCT01590524|Parent|parent
1298277|NCT01590524|childhood cancer|childhood cancer
1298278|NCT01590524|Complementary and Alternative|complementary and alternative
1298279|NCT01590511|mini fluid challenge|mini fluid challenge
1298280|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
1298281|NCT01590498|Adenocarcinoma|adenocarcinoma
1298282|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
1298283|NCT01590498|Carcinoma|carcinoma
1298284|NCT01590498|Prostatic Diseases|prostatic diseases
1298285|NCT01590485|pain|pain
1298286|NCT01590485|root canal therapy|root canal therapy
1298287|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
1298288|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
1298289|NCT01590472|GWAS|gwas
1298290|NCT01590472|Asbestos|asbestos
1298291|NCT01590446|Achondroplasia|achondroplasia
1298292|NCT01590433|Obesity|obesity
1298293|NCT01590433|Overweight|overweight
1298294|NCT01590433|Exenatide|exenatide
1298295|NCT01590433|Diet|diet
1298296|NCT01590433|Women|women
1298297|NCT01590420|OSA|osa
1298298|NCT01590420|Sleep|sleep
1298299|NCT01590420|CPAP|cpap
1298300|NCT01590420|Cost|cost
1298301|NCT01590394|obstruction|obstruction
1298302|NCT01590394|bile duct|bile duct
1298303|NCT01590394|malignant|malignant
1298304|NCT01590342|Pulmonary embolism|pulmonary embolism
1298305|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
1298306|NCT01590342|Prognosis|prognosis
1298307|NCT01590342|Inflammation|inflammation
1298308|NCT01590329|Skin surgery|skin surgery
1298309|NCT01590329|Micrografting|micrografting
1298310|NCT01590329|Hypo-pigmentation|hypo-pigmentation
1298311|NCT01590316|Brain Injuries|brain injuries
1298312|NCT01590316|Infant, Premature|infant, premature
1298313|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1298314|NCT01590316|Randomized Controlled Trial|randomized controlled trial
1298315|NCT01590303|severe sepsis|severe sepsis
1298316|NCT01590264|tinnitus|tinnitus
1298317|NCT01590264|bimodal stimulation|bimodal stimulation
1298318|NCT01590264|rTMS|rtms
1298319|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1298320|NCT01590251|Pain|pain
1298321|NCT01590251|Addiction|addiction
1298322|NCT01590251|Buprenorphine|buprenorphine
1298323|NCT01590251|Counseling|counseling
1298324|NCT01590251|Methadone|methadone
1298325|NCT01590251|Yoga|yoga
1298326|NCT01590238|alopecia|alopecia
1298327|NCT01590186|Pain|pain
1298328|NCT01590186|Front foot|front foot
1298329|NCT01590186|Flat foot|flat foot
1298330|NCT01590186|Metatarsalgia|metatarsalgia
1298331|NCT01590173|Low molecular weight heparin|low molecular weight heparin
1298332|NCT01590173|Prednisolone|prednisolone
1298333|NCT01590173|Glucocorticoids|glucocorticoids
1298334|NCT01590173|Recurrent implantation failure|recurrent implantation failure
1298335|NCT01590173|Pregnancy rate|pregnancy rate
1298336|NCT01590134|volunteers|volunteers
1298337|NCT01590134|Pilot study|pilot study
1298338|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
1298434|NCT01589900|colorectal cancer|colorectal cancer
1298339|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
1610959|NCT00354562|NSCLC|nsclc
1298340|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
1298341|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
1298342|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1298344|NCT01590108|Apelin|apelin
1298345|NCT01590108|APJ receptor|apj receptor
1298346|NCT01590095|Chlorine water treatment|chlorine water treatment
1298347|NCT01590095|Point-of-use water treatment|point-of-use water treatment
1298348|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
1298349|NCT01590095|Hand washing with soap|hand washing with soap
1298350|NCT01590095|Hand hygiene|hand hygiene
1298351|NCT01590095|Latrines|latrines
1298352|NCT01590095|Child potties|child potties
1298353|NCT01590095|Point-of-use fortification|point-of-use fortification
1298354|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
1298355|NCT01590095|Environmental enteropathy|environmental enteropathy
1298356|NCT01590095|Tropical enteropathy|tropical enteropathy
1298357|NCT01590095|Gut function|gut function
1298358|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
1298359|NCT01590095|Soil transmitted helminths|soil transmitted helminths
1298360|NCT01590095|Intestinal protozoans|intestinal protozoans
1298361|NCT01590095|Antibody response|antibody response
1298363|NCT01590095|Sanitation|sanitation
1298364|NCT01590095|Hand washing|hand washing
1298365|NCT01590095|Breast Feeding|breast feeding
1298366|NCT01590095|Complementary Feeding|complementary feeding
1298367|NCT01590095|Micronutrients|micronutrients
1298368|NCT01590095|Malnutrition|malnutrition
1298369|NCT01590095|Nutrition Disorders|nutrition disorders
1298370|NCT01590095|Diarrhea|diarrhea
1298371|NCT01590095|Child Development|child development
1298372|NCT01590082|Melanoma|melanoma
1298373|NCT01590082|Metastatic Melanoma|metastatic melanoma
1298374|NCT01590082|Advanced melanoma|advanced melanoma
1298375|NCT01590082|Doxycycline|doxycycline
1298376|NCT01590082|Ipilimumab|ipilimumab
1298377|NCT01590082|Yervoy|yervoy
1298378|NCT01590082|MDX010|mdx010
1298379|NCT01590082|BMS-734016|bms-734016
1298380|NCT01590082|Temozolomide|temozolomide
1298381|NCT01590082|Temodar|temodar
1298382|NCT01590069|Sarcoma|sarcoma
1298383|NCT01590069|Solid Tumors|solid tumors
1298384|NCT01590069|Pulmonary Metastases|pulmonary metastases
1298385|NCT01590069|Lung metastases|lung metastases
1298386|NCT01590069|Osteosarcomas|osteosarcomas
1298387|NCT01590069|Ewing sarcoma|ewing sarcoma
1298388|NCT01590069|IL-2|il-2
1298389|NCT01590069|Interleukin-2|interleukin-2
1298390|NCT01590069|Aldesleukin|aldesleukin
1298391|NCT01590069|Proleukin|proleukin
1298392|NCT01590069|Aerosol IL-2|aerosol il-2
1298393|NCT01590069|Spirometry|spirometry
1298394|NCT01590069|Nebulizer|nebulizer
1298395|NCT01590069|Pulse oximeter|pulse oximeter
1298396|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
1298397|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
1298398|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
1298399|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
1298400|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
1298401|NCT01590017|stage III cervical cancer|stage iii cervical cancer
1298402|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
1298403|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
1298404|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1298405|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1298406|NCT01590017|HIV infection|hiv infection
1298407|NCT01590004|LumbarCool system|lumbarcool system
1298408|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
1298409|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
1298410|NCT01589991|toothpastes|toothpastes
1298411|NCT01589991|bioavailability|bioavailability
1298412|NCT01589991|sodium fluoride|sodium fluoride
1298413|NCT01589991|monofluorphosphate|monofluorphosphate
1298414|NCT01589991|low-fluoride|low-fluoride
1298415|NCT01589978|drug-eluting stent|drug-eluting stent
1298416|NCT01589978|DES|des
1298417|NCT01589978|atherosclerosis|atherosclerosis
1298418|NCT01589978|everolimus|everolimus
1298419|NCT01589965|HIV/AIDS|hiv/aids
1298420|NCT01589965|STIs|stis
1298421|NCT01589965|Lottery|lottery
1298422|NCT01589952|Pegalyted interferon|pegalyted interferon
1298423|NCT01589952|Entecavir|entecavir
1298424|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
1298425|NCT01589939|radiation therapy|radiation therapy
1298426|NCT01589939|Calypso|calypso
1298427|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
1298428|NCT01589913|Heart Failure|heart failure
1298429|NCT01589913|Anxiety|anxiety
1298430|NCT01589913|Depression|depression
1298431|NCT01589913|Quality of Life|quality of life
1298432|NCT01589913|Remote Care|remote care
1298433|NCT01589913|Prevention|prevention
1298435|NCT01589900|invasion|invasion
1298436|NCT01589900|metastasis|metastasis
1298437|NCT01589900|IHC|ihc
1298438|NCT01589874|hepcidin|hepcidin
1298439|NCT01589874|anemia|anemia
1298440|NCT01589874|acute inflammation|acute inflammation
1298441|NCT01589874|IL-6|il-6
1298442|NCT01589874|cytokines|cytokines
1298443|NCT01589848|vWD|vwd
1298444|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
1298445|NCT01589809|Nervous System Diseases|nervous system diseases
1298446|NCT01589796|anesthesia|anesthesia
1298447|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
1298448|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
1298449|NCT01589796|pain, postoperative|pain, postoperative
1298450|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
1298451|NCT01589783|Pregnancy|pregnancy
1298452|NCT01589783|Vitamin D|vitamin d
1298453|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
1298454|NCT01589770|inflammation|inflammation
1298455|NCT01589757|"glycaemic index"|"glycaemic index"
1298456|NCT01589757|"glycemic index"|"glycemic index"
1298457|NCT01589757|hyperglycaemia|hyperglycaemia
1298458|NCT01589757|hyperglycemia|hyperglycemia
1298459|NCT01589757|pregnancy|pregnancy
1298460|NCT01589757|"dietary intervention"|"dietary intervention"
1298461|NCT01589757|"education evaluation"|"education evaluation"
1298462|NCT01589757|antioxidant|antioxidant
1298463|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
1298464|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
1298465|NCT01589757|"Breast Milk"|"breast milk"
1298466|NCT01589744|medical device|medical device
1298467|NCT01589731|Allergenicity|allergenicity
1298468|NCT01589731|Cow's milk allergy|cow's milk allergy
1298469|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
1298470|NCT01589731|Polymerization|polymerization
1298471|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1298472|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
1298473|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
1298474|NCT01589705|Uric acid|uric acid
1298475|NCT01589705|polycystic kidney disease|polycystic kidney disease
1298476|NCT01589692|WRIST|wrist
1298477|NCT01589692|Distal Radius Fracture|distal radius fracture
1298478|NCT01589692|DRF|drf
1298479|NCT01589692|elderly|elderly
1298480|NCT01589692|internal fixation|internal fixation
1298481|NCT01589692|VLPS|vlps
1298482|NCT01589692|External Fixation|external fixation
1298483|NCT01589692|Multi center randomized trial|multi center randomized trial
1298484|NCT01589666|Entegrion|entegrion
1298485|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
1298486|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
1298487|NCT01589666|Transfusion|transfusion
1298488|NCT01589666|Resuscitation|resuscitation
1298489|NCT01589666|Hemorrhage|hemorrhage
1298490|NCT01589666|Coagulopathy|coagulopathy
1298491|NCT01589627|distal radius fracture|distal radius fracture
1298492|NCT01589627|wrist contracture|wrist contracture
1298493|NCT01589627|dynasplint|dynasplint
1298494|NCT01589601|Congestive Heart Failure|congestive heart failure
1298495|NCT01589601|Heart Failure|heart failure
1298496|NCT01589601|Palliative Care|palliative care
1298497|NCT01589601|Palliative Medicine|palliative medicine
1298498|NCT01589588|acute treatment|acute treatment
1298499|NCT01589575|Intensive Care Unit|intensive care unit
1298500|NCT01589549|Acute graft versus host disease|acute graft versus host disease
1298501|NCT01589549|Bone marrow transplantation|bone marrow transplantation
1298502|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
1298503|NCT01589536|psychocardiological|psychocardiological
1298504|NCT01589536|interval intervention|interval intervention
1298505|NCT01589536|disability pension|disability pension
1298506|NCT01589536|risk profile|risk profile
1298507|NCT01589536|mental comorbidity|mental comorbidity
1298508|NCT01589484|Tomography|tomography
1298509|NCT01589484|Urinary Lithiasis|urinary lithiasis
1298510|NCT01589484|Kidney Calculi|kidney calculi
1298511|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
1298512|NCT01589471|Botulinum toxin A|botulinum toxin a
1298513|NCT01589471|Quality of life|quality of life
1298514|NCT01589471|Incontinence|incontinence
1298515|NCT01589471|Rectal cancer|rectal cancer
1298516|NCT01589471|Anorectal manometry|anorectal manometry
1298517|NCT01589458|toothpastes|toothpastes
1298518|NCT01589458|saliva|saliva
1298519|NCT01589458|dental caries|dental caries
1298520|NCT01589458|fluoride|fluoride
1298521|NCT01589445|Bangladesh|bangladesh
1298522|NCT01589445|T2DM|t2dm
1298523|NCT01589445|Pioglitazone|pioglitazone
1298524|NCT01589445|Metformin|metformin
1298525|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
1298526|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
1298527|NCT01589419|DLT|dlt
1298528|NCT01589419|radiation|radiation
1298529|NCT01589419|veliparib|veliparib
1610960|NCT00354562|ABT-751|abt-751
1298530|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
1298531|NCT01589419|ABT-888|abt-888
1298532|NCT01589419|capecitabine|capecitabine
1298533|NCT01589419|MTD|mtd
1298534|NCT01589419|PARP|parp
1298535|NCT01589406|Gynaecological Cancer|gynaecological cancer
1298536|NCT01589406|Quality of Life|quality of life
1298537|NCT01589406|Sexuality|sexuality
1298538|NCT01589393|Trauma|trauma
1298539|NCT01589393|Thromboprophylaxis|thromboprophylaxis
1298540|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
1298541|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
1298542|NCT01589380|Aortic stenosis|aortic stenosis
1298543|NCT01589380|Exercise performance|exercise performance
1298544|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
1298545|NCT01589380|fimasartan|fimasartan
1298546|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
1298547|NCT01589367|metformin|metformin
1298548|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
1298549|NCT01589328|pancreatic cancer|pancreatic cancer
1298550|NCT01589328|biliary tract cancer|biliary tract cancer
1298551|NCT01589328|cancer pain|cancer pain
1298552|NCT01589328|depression|depression
1298553|NCT01589315|ECT|ect
1298554|NCT01589315|FEAST|feast
1298555|NCT01589315|brain stimulation|brain stimulation
1298556|NCT01589315|depression|depression
1298557|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1298558|NCT01589302|CLL|cll
1298559|NCT01589302|SLL|sll
1298560|NCT01589302|B-PLL|b-pll
1298561|NCT01589289|Diagnostic research|diagnostic research
1298562|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
1298563|NCT01589289|Neurological disorders|neurological disorders
1298564|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
1298565|NCT01589289|Developing countries|developing countries
1298566|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1298567|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
1298568|NCT01589263|BPH|bph
1298569|NCT01589263|LUTS|luts
1298570|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
1298571|NCT01589237|LCQ908|lcq908
1298572|NCT01589211|smoking|smoking
1298573|NCT01589211|cessation|cessation
1298574|NCT01589211|intervention|intervention
1298575|NCT01589211|brief|brief
1298576|NCT01589198|Asthma|asthma
1298577|NCT01589185|Pneumonia|pneumonia
1298578|NCT01589185|Monoclonal antibody|monoclonal antibody
1298579|NCT01589185|Staphylococcus aureus|staphylococcus aureus
1298580|NCT01589146|colon-rectal cancer|colon-rectal cancer
1298581|NCT01589146|heparin|heparin
1298582|NCT01589146|prophylaxis|prophylaxis
1298583|NCT01589146|laparoscopy|laparoscopy
1298584|NCT01589133|Irregular antibody screening|irregular antibody screening
1298585|NCT01589120|CHF|chf
1298586|NCT01589120|video decision aid|video decision aid
1298587|NCT01589094|CISPLATIN|cisplatin
1298588|NCT01589094|GEMCITABINE|gemcitabine
1298589|NCT01589094|GM-CSF|gm-csf
1298590|NCT01589094|radical cystectomy|radical cystectomy
1298591|NCT01589094|12-071|12-071
1298592|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
1298593|NCT01588964|HIPEC|hipec
1298594|NCT01588964|ovarian cancer|ovarian cancer
1298595|NCT01588964|recurrence|recurrence
1298596|NCT01588938|radiation therapy|radiation therapy
1298597|NCT01588938|Calypso|calypso
1298598|NCT01588925|Cochlear implantation|cochlear implantation
1298599|NCT01588925|Dexamethasone|dexamethasone
1298600|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
1298601|NCT01588912|chronic hepatitis B|chronic hepatitis b
1298602|NCT01588912|HBeAg positive|hbeag positive
1298603|NCT01588912|telbivudine|telbivudine
1298604|NCT01588912|tenofovir|tenofovir
1298605|NCT01588912|entecavir|entecavir
1298606|NCT01588912|roadmap|roadmap
1298607|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
1298608|NCT01588899|Fibroids|fibroids
1298609|NCT01588899|HIFU|hifu
1298610|NCT01588899|Ablation|ablation
1298611|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
1298612|NCT01588886|Proton pump inhibitors|proton pump inhibitors
1298613|NCT01588886|Pneumonia|pneumonia
1298614|NCT01588886|Retrospective cohort study|retrospective cohort study
1298615|NCT01588873|Oral contraceptive pill|oral contraceptive pill
1298616|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
1298617|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
1298618|NCT01588847|perioperative immunoediting|perioperative immunoediting
1298619|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
1298620|NCT01588847|lymph node dissection|lymph node dissection
1298621|NCT01588821|Metastatic|metastatic
1298622|NCT01588821|Refractory|refractory
1298623|NCT01588821|Relapsed|relapsed
1298624|NCT01588808|Immobilization|immobilization
1298625|NCT01588808|Protein supplementation|protein supplementation
1298626|NCT01588795|Diabetic nephropathy|diabetic nephropathy
1298627|NCT01588795|renal denervation|renal denervation
1298628|NCT01588795|nephroprotection|nephroprotection
1298629|NCT01588795|Renal failure|renal failure
1298630|NCT01588795|Renal injury|renal injury
1298631|NCT01588795|End stage renal disease|end stage renal disease
1298632|NCT01588782|Healthy volunteers|healthy volunteers
1298633|NCT01588782|Pharmacology|pharmacology
1298634|NCT01588782|Pharmacokinetics|pharmacokinetics
1298635|NCT01588782|Pharmacodynamics|pharmacodynamics
1298636|NCT01588782|Drug-drug interactions|drug-drug interactions
1298638|NCT01588782|Abiraterone acetate|abiraterone acetate
1298639|NCT01588782|JNJ-589485|jnj-589485
1298640|NCT01588782|JNJ-212082|jnj-212082
1298641|NCT01588782|Ketoconazole|ketoconazole
1298642|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
1298643|NCT01588769|Brain cancer|brain cancer
1298644|NCT01588769|Immunotherapy|immunotherapy
1298645|NCT01588769|Cell based therapy|cell based therapy
1298646|NCT01588769|Autologous cell based therapy|autologous cell based therapy
1298647|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
1298648|NCT01588769|Cytotoxic T cells|cytotoxic t cells
1298649|NCT01588769|Natural Killer cells|natural killer cells
1298650|NCT01588756|Chronic kidney disease|chronic kidney disease
1298651|NCT01588756|GFR|gfr
1298652|NCT01588756|Inulin|inulin
1298653|NCT01588756|51Cr-EDTA|51cr-edta
1298654|NCT01588756|ASDKP-NH2|asdkp-nh2
1298655|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
1298656|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
1298657|NCT01588730|PF|pf
1298658|NCT01588730|Dynasplint|dynasplint
1298659|NCT01588730|ADFD|adfd
1298660|NCT01588730|AFD|afd
1298661|NCT01588730|Plantar Fasciitis|plantar fasciitis
1298662|NCT01588730|plantar Fasciopathy|plantar fasciopathy
1298663|NCT01588717|Hyperhydrosis|hyperhydrosis
1298664|NCT01588717|Excessive Sweating|excessive sweating
1298665|NCT01588717|Sweating|sweating
1298666|NCT01588717|Depression|depression
1298667|NCT01588717|Antidepressant|antidepressant
1298668|NCT01588704|lung cancer|lung cancer
1298669|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
1298670|NCT01588704|bevacizumab|bevacizumab
1298671|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
1298672|NCT01588704|surgical resection rate|surgical resection rate
1298673|NCT01588704|safety|safety
1298674|NCT01588704|feasibility|feasibility
1298675|NCT01588691|Traumatic Brain Injury|traumatic brain injury
1298676|NCT01588678|endometrial|endometrial
1298677|NCT01588678|prostate|prostate
1298678|NCT01588678|breast|breast
1298679|NCT01588678|gastric|gastric
1298680|NCT01588678|cervical|cervical
1298681|NCT01588678|ovarian|ovarian
1298682|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
1298683|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
1298684|NCT01588678|squamous cell NSCLC|squamous cell nsclc
1298685|NCT01588678|renal cell carcinoma|renal cell carcinoma
1298686|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
1298687|NCT01588665|pregnancy|pregnancy
1298688|NCT01588665|stable isotopes|stable isotopes
1298689|NCT01588665|red blood cell catabolism|red blood cell catabolism
1298690|NCT01588639|Recombinant human insulin|recombinant human insulin
1298691|NCT01588639|T2DM|t2dm
1298692|NCT01588639|Safety|safety
1298693|NCT01588639|Efficacy|efficacy
1298694|NCT01588626|Healthy volunteer|healthy volunteer
1298695|NCT01588626|Japanese males|japanese males
1298696|NCT01588626|PK study|pk study
1298697|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
1298698|NCT01588548|Advanced solid malignancies|advanced solid malignancies
1298699|NCT01588548|Malignant lymphoma|malignant lymphoma
1298700|NCT01588535|pain|pain
1298701|NCT01588535|pain measurement|pain measurement
1298702|NCT01588535|ear, middle|ear, middle
1298703|NCT01588535|otitis media|otitis media
1298704|NCT01588522|alopecia|alopecia
1298705|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
1298706|NCT01588496|hypercholesterolemia|hypercholesterolemia
1298707|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
1298708|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
1298709|NCT01588470|diastolic function|diastolic function
1298710|NCT01588470|mitochondria|mitochondria
1298711|NCT01588470|pioglitazone|pioglitazone
1298712|NCT01588470|pericardial fat|pericardial fat
1298713|NCT01588444|tooth extraction|tooth extraction
1298714|NCT01588444|bone grafting|bone grafting
1298715|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
1298716|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1298717|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
1298718|NCT01588418|Diabetes|diabetes
1298719|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1298720|NCT01588405|UT-15C SR|ut-15c sr
1298721|NCT01588405|PAH|pah
1298722|NCT01588392|Physical activity|physical activity
1298723|NCT01588392|preschoolers|preschoolers
1298724|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
1298725|NCT01588314|Fabry disease|fabry disease
1298726|NCT01588314|neuropathic pain|neuropathic pain
1298727|NCT01588314|gabapentin|gabapentin
1298728|NCT01588301|Cervical Cancer Screening|cervical cancer screening
1298729|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1298730|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
1298731|NCT01588301|Cervical Smear|cervical smear
1298732|NCT01588288|Diagnosis|diagnosis
1298733|NCT01588288|Galectin 3|galectin 3
1298734|NCT01588288|Puncture|puncture
1298735|NCT01588288|Goiter, nodular|goiter, nodular
1298736|NCT01588288|Surgery|surgery
1298737|NCT01588275|cost-effectiveness|cost-effectiveness
1298738|NCT01588275|effectiveness|effectiveness
1298739|NCT01588275|treatment|treatment
1298740|NCT01588275|CPAP|cpap
1298741|NCT01588275|MRA|mra
1298742|NCT01588275|compliance|compliance
1298743|NCT01588210|caries|caries
1298744|NCT01588210|sealant|sealant
1298745|NCT01588210|fluoride|fluoride
1298746|NCT01588210|prevention|prevention
1298747|NCT01588210|community dentistry|community dentistry
1298748|NCT01588197|Pain|pain
1298749|NCT01588197|fMRI|fmri
1298750|NCT01588197|real time|real time
1298751|NCT01588171|Deep vein thrombosis|deep vein thrombosis
1298752|NCT01588171|Pulmonary embolism|pulmonary embolism
1298753|NCT01588171|Low molecular weight heparin|low molecular weight heparin
1298754|NCT01588171|Enoxaparin|enoxaparin
1298755|NCT01588171|Bemiparin|bemiparin
1298756|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
1298757|NCT01588158|Tylenol|tylenol
1298758|NCT01588158|Vicodin|vicodin
1298759|NCT01588158|pain|pain
1298760|NCT01588145|NSCLC|nsclc
1298761|NCT01588145|HM61713|hm61713
1298762|NCT01588145|EGFR-TKI|egfr-tki
1298763|NCT01588145|Phase II|phase ii
1298764|NCT01588145|olmutinib|olmutinib
1298765|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
1298766|NCT01587976|Health related quality of life|health related quality of life
1298767|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
1298768|NCT01587976|surveillance|surveillance
1298769|NCT01587963|hypovolemic or septic|hypovolemic or septic
1298770|NCT01587950|dentinal sensitivity|dentinal sensitivity
1298771|NCT01587950|potassium nitrate|potassium nitrate
1298772|NCT01587950|dental pain|dental pain
1298773|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
1298774|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
1298775|NCT01587937|Antibiotic resistance.|antibiotic resistance.
1298776|NCT01587924|Renal Impairment|renal impairment
1298777|NCT01587924|Anemia|anemia
1298778|NCT01587924|pharmacokinetics|pharmacokinetics
1298779|NCT01587924|hemodialysis|hemodialysis
1298780|NCT01587924|Chronic kidney disease|chronic kidney disease
1298781|NCT01587924|GSK1278863|gsk1278863
1298782|NCT01587924|hemoglobin|hemoglobin
1298783|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1298784|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
1298785|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
1298786|NCT01587924|Dialysis, Renal|dialysis, renal
1298787|NCT01587911|Satiety|satiety
1298788|NCT01587911|Food intake regulation|food intake regulation
1298789|NCT01587911|Appetite regulation|appetite regulation
1298790|NCT01587911|Dairy Protein|dairy protein
1298791|NCT01587898|Anemia|anemia
1298792|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
1298793|NCT01587898|Hemoglobin|hemoglobin
1298794|NCT01587898|Chronic kidney disease|chronic kidney disease
1298795|NCT01587898|pharmacokinetics|pharmacokinetics
1298796|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
1298797|NCT01587898|GSK1278863|gsk1278863
1298798|NCT01587885|Frequent Heartburn|frequent heartburn
1298799|NCT01587885|Omeprazole|omeprazole
1298800|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
1298801|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
1298802|NCT01587885|Therapeutic Uses|therapeutic uses
1298803|NCT01587885|Pharmacologic Actions|pharmacologic actions
1298804|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
1298805|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1298806|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
1298807|NCT01587872|Colonoscopy|colonoscopy
1298808|NCT01587872|Colorectal cancer|colorectal cancer
1298809|NCT01587872|Screening colonoscopy|screening colonoscopy
1298810|NCT01587859|esophagus|esophagus
1298811|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
1298812|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
1298813|NCT01587859|esophageal surgery|esophageal surgery
1298814|NCT01587859|minimally invasive surgery|minimally invasive surgery
1298815|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
1298816|NCT01587833|Benzodiazepines|benzodiazepines
1298817|NCT01587833|hip/femur fracture|hip/femur fracture
1298818|NCT01587820|cisplatin|cisplatin
1298819|NCT01587820|RADPLAT|radplat
1298820|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
1298821|NCT01587820|head and neck cancer|head and neck cancer
1298822|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
1610961|NCT00354562|docetaxel|docetaxel
1298823|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1298824|NCT01587794|thickness of retinal layer|thickness of retinal layer
1298825|NCT01587794|outer nuclear layer|outer nuclear layer
1298826|NCT01587794|photoreceptor layer|photoreceptor layer
1298827|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
1298828|NCT01587768|Acute liver injury|acute liver injury
1298829|NCT01587768|antibiotics|antibiotics
1298830|NCT01587742|Calcium channel blockers|calcium channel blockers
1298831|NCT01587742|cancer|cancer
1298832|NCT01587729|Hip/femur fracture|hip/femur fracture
1298833|NCT01587729|antidepressants|antidepressants
1298834|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
1298835|NCT01587703|BRD3|brd3
1298836|NCT01587703|GSK525762|gsk525762
1298837|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
1298838|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
1298839|NCT01587703|BRD4|brd4
1298840|NCT01587703|BET inhibitor|bet inhibitor
1298841|NCT01587703|bromodomains|bromodomains
1298842|NCT01587703|NMC|nmc
1298843|NCT01587703|Colorectal C ancer|colorectal c ancer
1298844|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
1298845|NCT01587703|Multiple Myeloma|multiple myeloma
1298846|NCT01587703|Neuroblastoma|neuroblastoma
1298847|NCT01587703|Oncology|oncology
1298848|NCT01587677|Tuberculosis|tuberculosis
1298849|NCT01587664|Swallowing disorders|swallowing disorders
1298850|NCT01587664|Aspiration|aspiration
1298851|NCT01587651|CAD|cad
1298852|NCT01587651|prasugrel|prasugrel
1298853|NCT01587651|ticagrelor|ticagrelor
1298854|NCT01587651|antiplatelet|antiplatelet
1298855|NCT01587651|thienopyridine|thienopyridine
1298856|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
1298857|NCT01587638|new-onset diabetes|new-onset diabetes
1298858|NCT01587638|carvedilol|carvedilol
1298859|NCT01587638|claims analysis|claims analysis
1298860|NCT01587638|beta-blocker|beta-blocker
1298861|NCT01587638|Diabetes Mellitus|diabetes mellitus
1298862|NCT01587625|Delayed labour|delayed labour
1298863|NCT01587625|dystocia|dystocia
1298864|NCT01587625|oxytocin augmentation|oxytocin augmentation
1298865|NCT01587625|primiparous women|primiparous women
1298866|NCT01587625|childbirth|childbirth
1298867|NCT01587625|childbirth experience|childbirth experience
1298868|NCT01587625|progress|progress
1298869|NCT01587612|Pain|pain
1298870|NCT01587612|Foot|foot
1298871|NCT01587599|pharmaceutical care|pharmaceutical care
1298872|NCT01587599|drug-related problems|drug-related problems
1298873|NCT01587599|elderly|elderly
1298874|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
1298875|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
1298876|NCT01587586|Interferon-alpha|interferon-alpha
1298877|NCT01587586|Hepatitis C Virus|hepatitis c virus
1298878|NCT01587573|salivary biomarkers|salivary biomarkers
1298879|NCT01587560|Shoulder|shoulder
1298880|NCT01587560|Arthroplasty|arthroplasty
1298881|NCT01587560|Pyrocarbon|pyrocarbon
1298882|NCT01587560|Randomized controlled trial|randomized controlled trial
1298883|NCT01587560|Shoulder resurfacing|shoulder resurfacing
1298884|NCT01587547|ART|art
1298885|NCT01587547|IVF|ivf
1298886|NCT01587547|ICSI|icsi
1298887|NCT01587547|embryo selection|embryo selection
1298888|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
1298889|NCT01587521|Metabolic syndrome|metabolic syndrome
1298890|NCT01587521|Prevalence|prevalence
1298891|NCT01587521|Quality of life|quality of life
1298892|NCT01587521|Depression|depression
1298893|NCT01587521|Antipsychotics|antipsychotics
1298894|NCT01587482|Superficial femoral artery|superficial femoral artery
1298895|NCT01587482|endovascular|endovascular
1298896|NCT01587482|Drug eluting balloon|drug eluting balloon
1298897|NCT01587482|Paclitaxel|paclitaxel
1298898|NCT01587456|Osteoporosis|osteoporosis
1298899|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
1298900|NCT01587430|anthracyclines|anthracyclines
1298901|NCT01587430|high dose cytarabine|high dose cytarabine
1298902|NCT01587430|maintenance|maintenance
1298903|NCT01587404|Atrial Fibrillation|atrial fibrillation
1298904|NCT01587404|Electrogram|electrogram
1298905|NCT01587404|Ablation|ablation
1298906|NCT01587404|Contact Force|contact force
1298907|NCT01587378|miscarriage|miscarriage
1298908|NCT01587378|preterm birth|preterm birth
1298909|NCT01587378|prevention|prevention
1298910|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
1298911|NCT01587313|hydralazine|hydralazine
1298912|NCT01587313|isosorbide|isosorbide
1298913|NCT01587313|bidil|bidil
1298914|NCT01587313|volunteers|volunteers
1298915|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
1298916|NCT01587287|Anterior corneal power|anterior corneal power
1298917|NCT01587287|Placido topographer|placido topographer
1298918|NCT01587287|Scheimpﬂug|scheimpﬂug
1298919|NCT01587287|Precision|precision
1298920|NCT01587287|Agreement|agreement
1298921|NCT01587274|low back pain|low back pain
1298922|NCT01587261|Burns|burns
1298923|NCT01587261|Vitamin C|vitamin c
1298924|NCT01587261|Thermal Injury|thermal injury
1298925|NCT01587261|Fluid Resuscitation|fluid resuscitation
1298926|NCT01587248|Breast cancer,|breast cancer,
1298927|NCT01587248|Harmonic scalpel,|harmonic scalpel,
1298928|NCT01587248|Electrocautery,|electrocautery,
1298929|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
1298930|NCT01587248|Randomized Controlled Trial|randomized controlled trial
1298931|NCT01587209|decompression|decompression
1298932|NCT01587209|intravascular bubbles|intravascular bubbles
1298933|NCT01587209|neutrophil activation|neutrophil activation
1298934|NCT01587196|prescription opiates/medications|prescription opiates/medications
1298935|NCT01587196|vivitrol|vivitrol
1298936|NCT01587196|brain imaging|brain imaging
1298937|NCT01587183|Running|running
1298938|NCT01587183|Blood pressure|blood pressure
1298939|NCT01587170|spasticity|spasticity
1298940|NCT01587170|spinal cord injury|spinal cord injury
1298941|NCT01587170|zolmitriptan|zolmitriptan
1298943|NCT01587131|Universal Influenza|universal influenza
1298944|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
1298945|NCT01587131|Senior|senior
1298946|NCT01587131|Electroporation|electroporation
1298947|NCT01587131|H1|h1
1298948|NCT01587131|Influenza|influenza
1298949|NCT01587131|FVH1|fvh1
1298950|NCT01587118|PTSD|ptsd
1298951|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
1298952|NCT01587118|Asenapine|asenapine
1298953|NCT01587118|Adjunctive|adjunctive
1298954|NCT01587118|antidepressant|antidepressant
1298955|NCT01587118|neuroleptic|neuroleptic
1298956|NCT01587092|walking|walking
1298957|NCT01587092|physical activity|physical activity
1298958|NCT01587092|sedentary behavior|sedentary behavior
1298959|NCT01587092|workplace|workplace
1298960|NCT01587079|COPD|copd
1298961|NCT01587027|Altitude Sickness|altitude sickness
1298962|NCT01587027|High Altitude Sickness|high altitude sickness
1298963|NCT01587001|Sarcoidosis|sarcoidosis
1298964|NCT01587001|oxidative stress|oxidative stress
1298965|NCT01587001|anti-oxidant|anti-oxidant
1298966|NCT01586988|HIV|hiv
1298967|NCT01586988|Parenting|parenting
1298968|NCT01586988|self-care|self-care
1298969|NCT01586988|disclosure|disclosure
1298970|NCT01586988|medication adherence|medication adherence
1298971|NCT01586988|mother|mother
1298972|NCT01586988|child|child
1298973|NCT01586988|adolescent|adolescent
1298974|NCT01586962|paracetamol|paracetamol
1298975|NCT01586962|pseudoephedrine|pseudoephedrine
1298976|NCT01586962|syrup|syrup
1298977|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
1298978|NCT01586949|well-being|well-being
1298979|NCT01586949|web-based intervention|web-based intervention
1298980|NCT01586949|social networks|social networks
1298981|NCT01586923|Anemia|anemia
1298982|NCT01586923|Transfusion|transfusion
1298983|NCT01586923|RBC storage age|rbc storage age
1298984|NCT01586923|Tissue oxygenation|tissue oxygenation
1298985|NCT01586923|Malaria|malaria
1298986|NCT01586897|health information technology|health information technology
1298987|NCT01586897|primary care|primary care
1298988|NCT01586897|visit-independent|visit-independent
1298989|NCT01586897|medication monitoring|medication monitoring
1298990|NCT01586884|LV Pacing|lv pacing
1298991|NCT01586884|LV Lead Placement|lv lead placement
1298992|NCT01586884|LV Pacing Site|lv pacing site
1298993|NCT01586884|CRT Device Placement|crt device placement
1298994|NCT01586871|MPS I|mps i
1298995|NCT01586871|MPS II|mps ii
1298996|NCT01586871|MPS VI|mps vi
1298997|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
1298998|NCT01586858|Vasculitis|vasculitis
1298999|NCT01586858|ANCA|anca
1299000|NCT01586858|Rituximab|rituximab
1299001|NCT01586858|Small vessel vasculitis|small vessel vasculitis
1299002|NCT01586845|Randomized Controlled Trials|randomized controlled trials
1299003|NCT01586845|Immunosuppression|immunosuppression
1299004|NCT01586845|Adult|adult
1299005|NCT01586845|Kidney Transplantation|kidney transplantation
1299006|NCT01586845|Treatment Outcome|treatment outcome
1299007|NCT01586832|Hospital Supplies|hospital supplies
1299008|NCT01586832|Stocking of Supplies|stocking of supplies
1299009|NCT01586806|Dexamethasone|dexamethasone
1299010|NCT01586806|Glucocorticoids|glucocorticoids
1299011|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
1299012|NCT01586806|Therapeutic Uses|therapeutic uses
1299013|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1299014|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
1299015|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
1299016|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
1299017|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
1299018|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1299019|NCT01586793|Bipolar depression|bipolar depression
1299020|NCT01586793|Randomized trial|randomized trial
1299021|NCT01586793|rTMS|rtms
1299022|NCT01586793|Neuromodulation|neuromodulation
1299023|NCT01586780|Whey protein|whey protein
1299024|NCT01586780|Soy protein|soy protein
1299025|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
1299026|NCT01586780|Incretins|incretins
1299027|NCT01586780|Glycaemia|glycaemia
1299028|NCT01586780|Insulinaemia|insulinaemia
1299029|NCT01586767|Nasal cavity|nasal cavity
1299030|NCT01586767|Salivary gland tumors|salivary gland tumors
1299031|NCT01586767|Hard palate|hard palate
1299032|NCT01586767|Sinus|sinus
1299033|NCT01586767|Soft Palate|soft palate
1299034|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
1299035|NCT01586754|metabolic syndrome|metabolic syndrome
1299036|NCT01586754|obesity|obesity
1299037|NCT01586754|endothelial damage|endothelial damage
1299038|NCT01586754|homocysteine|homocysteine
1299039|NCT01586754|microalbumin|microalbumin
1299040|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
1299041|NCT01586728|Cystic fibrosis|cystic fibrosis
1299042|NCT01586728|oxygen therapy|oxygen therapy
1299043|NCT01586728|sleep|sleep
1299044|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
1299045|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
1299046|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
1299047|NCT01586689|Oxford House|oxford house
1299048|NCT01586689|recovery|recovery
1299049|NCT01586689|substance abuse|substance abuse
1299050|NCT01586689|alcohol abuse|alcohol abuse
1299051|NCT01586689|addiction|addiction
1299052|NCT01586676|supervision|supervision
1299053|NCT01586676|motivational interviewing|motivational interviewing
1299054|NCT01586676|substance abuse|substance abuse
1299055|NCT01586676|dissemination|dissemination
1299056|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
1299057|NCT01586663|Hand|hand
1299058|NCT01586663|Range of motion|range of motion
1299059|NCT01586663|Splint|splint
1299060|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
1299061|NCT01586650|aerobic exercise|aerobic exercise
1299062|NCT01586637|Fibromyalgia|fibromyalgia
1299063|NCT01586637|Art Therapy|art therapy
1299064|NCT01586637|Pain|pain
1299065|NCT01586637|Quality of life|quality of life
1299066|NCT01586637|Body Image|body image
1299067|NCT01586624|Phase I|phase i
1299068|NCT01586624|Drug evaluation|drug evaluation
1299069|NCT01586624|Oncology|oncology
1299070|NCT01586624|Vandetanib|vandetanib
1299071|NCT01586624|Selumetinib|selumetinib
1299072|NCT01586624|Dose escalation|dose escalation
1299073|NCT01586624|Clinical trial|clinical trial
1299074|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
1299075|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
1299076|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
1299077|NCT01586624|Non small cell lung cancer|non small cell lung cancer
1299078|NCT01586598|Mandibular Nerve|mandibular nerve
1299079|NCT01586598|Orthognathic Surgery|orthognathic surgery
1299080|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
1299081|NCT01586598|Sensory Retraining|sensory retraining
1299082|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
1299083|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
1299084|NCT01586572|Poliovaccine|poliovaccine
1299085|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
1299086|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
1299087|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
1299088|NCT01586546|Mind-body|mind-body
1299089|NCT01586546|Psychosocial|psychosocial
1299090|NCT01586546|Meditation|meditation
1299091|NCT01586546|Breathing Exercises|breathing exercises
1299092|NCT01586546|Guided Imagery|guided imagery
1299093|NCT01586546|Visualization|visualization
1299094|NCT01586533|ulcerative colitis|ulcerative colitis
1299096|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
1299097|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
1299098|NCT01586533|Zoenasa|zoenasa
1299099|NCT01586533|mesalamine|mesalamine
1299100|NCT01586533|mesalazine|mesalazine
1299101|NCT01586533|5-ASA|5-asa
1299102|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
1299103|NCT01586533|N-acetylcysteine|n-acetylcysteine
1299104|NCT01586533|acetylcysteine|acetylcysteine
1299105|NCT01586533|NAC|nac
1299106|NCT01586533|enema|enema
1299107|NCT01586533|rectal gel|rectal gel
1299108|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
1299109|NCT01586507|Pain|pain
1299110|NCT01586507|ULTRAM ER|ultram er
1299111|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
1299112|NCT01586507|Adolescents|adolescents
1299113|NCT01586494|Pain|pain
1299114|NCT01586494|ULTRAM ER|ultram er
1299115|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
1299116|NCT01586494|Children|children
1299117|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
1299118|NCT01586481|Off loading|off loading
1299119|NCT01586481|Compliance|compliance
1299120|NCT01586481|Healing duration|healing duration
1299121|NCT01586481|Amputation rate|amputation rate
1299122|NCT01586455|umbilical cord blood|umbilical cord blood
1299123|NCT01586455|stem cell transplantation|stem cell transplantation
1299124|NCT01586455|placental stem cell|placental stem cell
1299125|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
1299126|NCT01586455|marrow failure|marrow failure
1299127|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
1299128|NCT01586455|AML|aml
1299129|NCT01586455|ALL|all
1299130|NCT01586455|MDS|mds
1299223|NCT01586052|Erythropoietin|erythropoietin
1299224|NCT01586052|Rehabilitation|rehabilitation
1299131|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
1299132|NCT01586416|Colonic neoplasms|colonic neoplasms
1299133|NCT01586416|Older adults|older adults
1299134|NCT01586416|Psychosocial Intervention|psychosocial intervention
1299135|NCT01586416|Chemotherapy adherence|chemotherapy adherence
1299136|NCT01586403|Melanoma|melanoma
1299137|NCT01586403|Gene Therapy|gene therapy
1299138|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
1299139|NCT01586403|IL-2|il-2
1299140|NCT01586390|Ankle Sprain|ankle sprain
1299141|NCT01586390|Ankle Distortion|ankle distortion
1299142|NCT01586390|Functional treatment|functional treatment
1299143|NCT01586390|Brace treatment|brace treatment
1299144|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
1299145|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
1299146|NCT01586377|Vascular Occlusion Test|vascular occlusion test
1299147|NCT01586364|Menopausal symptoms|menopausal symptoms
1299148|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
1299149|NCT01586364|Vaginal atrophy|vaginal atrophy
1299150|NCT01586364|Urogenital atrophy|urogenital atrophy
1299151|NCT01586351|Rotator cuff tears|rotator cuff tears
1299152|NCT01586351|ACP|acp
1299153|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
1299154|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
1299155|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
1299156|NCT01586325|JNJ-47910382|jnj-47910382
1299157|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
1299158|NCT01586312|Knee degenerative disease|knee degenerative disease
1299159|NCT01586312|osteoarthritis|osteoarthritis
1299160|NCT01586312|gonarthrosis|gonarthrosis
1299161|NCT01586312|stem cell|stem cell
1299162|NCT01586312|cellular therapy|cellular therapy
1299163|NCT01586312|regenerative therapy|regenerative therapy
1299164|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
1299165|NCT01586312|Bone marrow|bone marrow
1299166|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
1299167|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
1299168|NCT01586299|pleuropneumonia children|pleuropneumonia children
1299169|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
1299170|NCT01586299|pleural effusion|pleural effusion
1299171|NCT01586299|severe pneumonia|severe pneumonia
1299172|NCT01586286|Levator Myalgia|levator myalgia
1299173|NCT01586286|Pelvic Pain|pelvic pain
1299174|NCT01586286|Vaginismus|vaginismus
1299175|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
1299176|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
1299177|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
1299178|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
1299179|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
1299180|NCT01586234|DSAEK|dsaek
1299181|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
1299182|NCT01586221|Rehabilitation|rehabilitation
1299183|NCT01586221|Fingers|fingers
1299184|NCT01586221|Grasp|grasp
1299185|NCT01586221|Strength|strength
1299186|NCT01586221|Brain Function|brain function
1299187|NCT01586221|Physiopathology|physiopathology
1299188|NCT01586221|Functional Laterality|functional laterality
1299189|NCT01586221|Psychomotor Performance|psychomotor performance
1299190|NCT01586221|Biomechanis|biomechanis
1299191|NCT01586221|Touch|touch
1299192|NCT01586221|Music Therapy|music therapy
1299193|NCT01586221|Weight-Bearing|weight-bearing
1299194|NCT01586208|refractory status epilepticus|refractory status epilepticus
1299195|NCT01586208|valproic acid|valproic acid
1299196|NCT01586208|phenytoin|phenytoin
1299197|NCT01586208|benzodiazepines|benzodiazepines
1299198|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
1299199|NCT01586182|poor prognosis|poor prognosis
1299200|NCT01586169|Albendazole|albendazole
1299201|NCT01586169|Ivermectin|ivermectin
1299202|NCT01586169|Azithromycin|azithromycin
1299203|NCT01586169|Lymphatic filariasis|lymphatic filariasis
1299204|NCT01586169|Trachoma|trachoma
1299205|NCT01586169|Safety|safety
1299206|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
1299207|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
1299208|NCT01586143|Pain.|pain.
1299209|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
1299210|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
1299211|NCT01586130|Exercise|exercise
1299212|NCT01586130|Isokinetic|isokinetic
1299213|NCT01586130|Muscle strength|muscle strength
1299214|NCT01586130|Rehabilitation|rehabilitation
1299215|NCT01586117|rectal cancer|rectal cancer
1299216|NCT01586117|amifostine|amifostine
1299217|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
1299218|NCT01586065|type 1 diabetes|type 1 diabetes
1299219|NCT01586065|adolescents|adolescents
1299220|NCT01586065|poor control|poor control
1299222|NCT01586052|Cerebral Palsy|cerebral palsy
1299225|NCT01586039|Melatonin|melatonin
1299226|NCT01586039|Sleep|sleep
1299227|NCT01586039|Light|light
1299228|NCT01586039|Alertness|alertness
1299229|NCT01586039|Circadian Rhythms|circadian rhythms
1299230|NCT01586026|Ports|ports
1299231|NCT01586026|Catheters|catheters
1299232|NCT01586026|Distal Valved Catheters|distal valved catheters
1299233|NCT01586026|Maintenance Flush|maintenance flush
1299234|NCT01586026|subjects|subjects
1299235|NCT01586026|routine maintenance flushes|routine maintenance flushes
1299236|NCT01586013|propofol|propofol
1299237|NCT01586013|pharmacodynamic|pharmacodynamic
1299238|NCT01586013|age|age
1299239|NCT01586013|ke0|ke0
1299240|NCT01586000|vaginal ring|vaginal ring
1299241|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
1299242|NCT01585974|TKI|tki
1299243|NCT01585974|Turkey|turkey
1299244|NCT01585974|Observational|observational
1299245|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
1299246|NCT01585961|Atrial fibrillation|atrial fibrillation
1299247|NCT01585961|Observational|observational
1299248|NCT01585961|Acute procedural outcomes|acute procedural outcomes
1299249|NCT01585961|Ablation|ablation
1299250|NCT01585961|Drug refractory|drug refractory
1299251|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
1299252|NCT01585961|Symptomatic|symptomatic
1299253|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
1299254|NCT01585935|Parenteral Nutrition|parenteral nutrition
1299255|NCT01585935|Fish Oils|fish oils
1299256|NCT01585935|Cholestasis|cholestasis
1299257|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
1299258|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
1299259|NCT01585896|Hoarding|hoarding
1299260|NCT01585896|Compulsive Hoarding|compulsive hoarding
1299261|NCT01585896|Self-Help|self-help
1299262|NCT01585883|Lung cancer|lung cancer
1299263|NCT01585883|Breathlessness|breathlessness
1299264|NCT01585883|Self-management|self-management
1299265|NCT01585870|Safety|safety
1299266|NCT01585870|Tolerability|tolerability
1299267|NCT01585870|Pharmacokinetics|pharmacokinetics
1299268|NCT01585870|Clinical benefit|clinical benefit
1299269|NCT01585870|Sorafenib|sorafenib
1299270|NCT01585870|Eribulin|eribulin
1299271|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
1299272|NCT01585844|sleep apnea|sleep apnea
1299273|NCT01585844|pregnancy|pregnancy
1299274|NCT01585844|obesity|obesity
1299275|NCT01585831|Klinefelter syndrome|klinefelter syndrome
1299276|NCT01585831|XXY syndrome|xxy syndrome
1299277|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
1299278|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
1299279|NCT01585818|Glycemic Index|glycemic index
1299280|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1299281|NCT01585818|Diet|diet
1299282|NCT01585818|Glucose Variability|glucose variability
1299283|NCT01585818|Metabolic Response|metabolic response
1299284|NCT01585818|Glucose Response|glucose response
1299285|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
1299286|NCT01585753|cardiovascular function|cardiovascular function
1299287|NCT01585753|maraviroc|maraviroc
1299288|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
1299289|NCT01585740|Neonatal acidosis|neonatal acidosis
1299290|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
1299291|NCT01585740|Base excess|base excess
1299292|NCT01585740|Metabolic acidosis|metabolic acidosis
1299293|NCT01585740|Caesarean section|caesarean section
1299294|NCT01585740|Normal saline|normal saline
1299295|NCT01585740|Ringer's Lactate|ringer's lactate
1299296|NCT01585740|Postoperative morbidity|postoperative morbidity
1299297|NCT01585727|Rectal cancer|rectal cancer
1299298|NCT01585727|total mesorectal excision|total mesorectal excision
1299299|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
1299300|NCT01585727|neurostimulation|neurostimulation
1299301|NCT01585727|urogenital function|urogenital function
1299302|NCT01585727|quality of life|quality of life
1299303|NCT01585701|Phase I|phase i
1299304|NCT01585701|Oncology|oncology
1299305|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
1299306|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
1299307|NCT01585701|Clinical Trial|clinical trial
1299308|NCT01585701|Multiple protein kinases|multiple protein kinases
1299309|NCT01585688|NHL|nhl
1299310|NCT01585688|CLL|cll
1299311|NCT01585675|Lung Cancer|lung cancer
1299312|NCT01585662|EUS|eus
1299313|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
1299314|NCT01585662|drainage|drainage
1299315|NCT01585636|SQ109|sq109
1299316|NCT01585636|Tuberculosis|tuberculosis
1299317|NCT01585610|smoking|smoking
1299318|NCT01585610|smoking cessation|smoking cessation
1299319|NCT01585610|disabled persons|disabled persons
1299320|NCT01585610|behavioral research|behavioral research
1299321|NCT01585597|Ischemic Stoke|ischemic stoke
1299322|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
1299323|NCT01585597|Reperfusion Injury|reperfusion injury
1299324|NCT01585597|Mild hypothermia|mild hypothermia
1299325|NCT01585584|Boceprevir|boceprevir
1299326|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
1299327|NCT01585571|Balance|balance
1299328|NCT01585571|Posture|posture
1299329|NCT01585571|Virtual Environment|virtual environment
1299330|NCT01585571|Cerebral Palsy|cerebral palsy
1299331|NCT01585571|Adults|adults
1299332|NCT01585558|Menopausal symptoms|menopausal symptoms
1299333|NCT01585558|Urogenital atrophy|urogenital atrophy
1299334|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
1299335|NCT01585558|Vaginal atrophy|vaginal atrophy
1299336|NCT01585545|CT|ct
1299337|NCT01585545|PET CT|pet ct
1299338|NCT01585545|MRI|mri
1299339|NCT01585545|cancer genomics|cancer genomics
1299340|NCT01585545|Radiomics|radiomics
1299341|NCT01585545|Radiogenomics|radiogenomics
1299342|NCT01585532|Tuberculosis|tuberculosis
1299343|NCT01585532|Urine|urine
1299344|NCT01585532|Nucleic acid|nucleic acid
1299345|NCT01585532|Alere|alere
1299346|NCT01585532|Borstel|borstel
1299347|NCT01585519|High Epicatechin Apples|high epicatechin apples
1299348|NCT01585519|Low Epicatechin Apples|low epicatechin apples
1299349|NCT01585519|Apple Extract|apple extract
1299350|NCT01585519|Apple Granules|apple granules
1299351|NCT01585519|Blood Pressure|blood pressure
1299352|NCT01585519|Cholesterol|cholesterol
1299353|NCT01585493|Lifestyle|lifestyle
1299354|NCT01585493|Smoking|smoking
1299355|NCT01585493|Dietary|dietary
1299356|NCT01585493|Exercise|exercise
1299357|NCT01585480|Obesity|obesity
1299358|NCT01585480|Weight Gain Prevention|weight gain prevention
1299359|NCT01585480|Workplace|workplace
1299360|NCT01585480|Intervention|intervention
1299361|NCT01585480|Diet|diet
1299362|NCT01585480|Exercise|exercise
1299363|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
1299364|NCT01585467|Shoulder Dislocation|shoulder dislocation
1299365|NCT01585467|Shoulder Pain|shoulder pain
1299366|NCT01585467|Shoulder Deformity|shoulder deformity
1299367|NCT01585454|Pregnancy|pregnancy
1299368|NCT01585454|Diabetes Mellitus|diabetes mellitus
1299369|NCT01585454|Weight Gain|weight gain
1299370|NCT01585454|Diabetes|diabetes
1299371|NCT01585441|Finasteride|finasteride
1299372|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
1299373|NCT01585428|Immunotherapy|immunotherapy
1299374|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
1299375|NCT01585428|Cervical Cancer|cervical cancer
1299376|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
1299377|NCT01585428|HPV Infection|hpv infection
1299378|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1299379|NCT01585415|Immunotherapy|immunotherapy
1299380|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
1299381|NCT01585415|B Raf Inhibitor|b raf inhibitor
1299382|NCT01585402|NT5E|nt5e
1299383|NCT01585402|Biphosphonates|biphosphonates
1299384|NCT01585402|Vascular Calcifications|vascular calcifications
1299385|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
1299386|NCT01585402|Inherited Disease|inherited disease
1299387|NCT01585389|adult brain tumor|adult brain tumor
1299388|NCT01585389|childhood brain tumor|childhood brain tumor
1299389|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1299390|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1299391|NCT01585350|melanoma|melanoma
1299392|NCT01585350|peptide vaccine|peptide vaccine
1299393|NCT01585350|polyICLC|polyiclc
1299394|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
1299395|NCT01585350|immunotherapy|immunotherapy
1299396|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
1299397|NCT01585311|tachycardia|tachycardia
1299398|NCT01585311|Outcome|outcome
1299399|NCT01585298|Multiple Sclerosis|multiple sclerosis
1299400|NCT01585298|MS|ms
1299401|NCT01585298|Fingolimod|fingolimod
1299402|NCT01585298|Gilenya|gilenya
1299403|NCT01585298|ECG|ecg
1299404|NCT01585298|Bradyarrythmia|bradyarrythmia
1299405|NCT01585298|conduction abnormalities|conduction abnormalities
1299406|NCT01585298|first dose observation|first dose observation
1299407|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
1299408|NCT01585285|Left internal mammary artery|left internal mammary artery
1299409|NCT01585285|Composite grafting|composite grafting
1299410|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
1299411|NCT01585285|Graft patency assessment|graft patency assessment
1299412|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
1299413|NCT01585259|anti-platelet;|anti-platelet;
1299414|NCT01585259|safety;|safety;
1299415|NCT01585259|efficacy|efficacy
1299416|NCT01585246|Prostate Cancer|prostate cancer
1299417|NCT01585246|Radiation Therapy|radiation therapy
1299418|NCT01585246|Quality of Life|quality of life
1299419|NCT01585246|Symptom Management|symptom management
1299420|NCT01585233|Moderate Psoriasis|moderate psoriasis
1299421|NCT01585233|Severe Psoriasis|severe psoriasis
1299422|NCT01585233|Skin disease|skin disease
1299423|NCT01585233|ASKP1240|askp1240
1299424|NCT01585233|CD40 antigen|cd40 antigen
1299425|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
1299426|NCT01585220|WSRS|wsrs
1299427|NCT01585220|GAIS|gais
1299428|NCT01585220|HA filler|ha filler
1299429|NCT01585220|filler|filler
1299430|NCT01585207|Tourette's Disorder|tourette's disorder
1299431|NCT01585207|vigabatrin|vigabatrin
1299432|NCT01585194|Melanoma|melanoma
1299433|NCT01585194|History of Uveal Melanoma|history of uveal melanoma
1299434|NCT01585194|Metastatic|metastatic
1299435|NCT01585194|Ipilimumab|ipilimumab
1299436|NCT01585194|Yervoy|yervoy
1299437|NCT01585194|BMS-734016|bms-734016
1299438|NCT01585194|MDX010|mdx010
1299439|NCT01585194|Nivolumab|nivolumab
1299440|NCT01585194|BMS-936558|bms-936558
1299441|NCT01585194|Opdivo|opdivo
1299442|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
1299443|NCT01585168|Reward Circuitry|reward circuitry
1299444|NCT01585168|Impulsivity|impulsivity
1299445|NCT01585168|Family History of Alcoholism|family history of alcoholism
1299446|NCT01585168|NMDA/DA Interactions|nmda/da interactions
1299447|NCT01585155|Infliximab|infliximab
1299448|NCT01585155|REMICADE|remicade
1299449|NCT01585155|TA-650|ta-650
1299450|NCT01585090|Ankle positions|ankle positions
1299451|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
1299452|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
1299453|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
1299454|NCT01585077|Plasmodium vivax|plasmodium vivax
1299455|NCT01585077|Malaria|malaria
1299456|NCT01585077|Challenge|challenge
1299457|NCT01585077|Anopheles albimanus|anopheles albimanus
1299458|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1299459|NCT01585064|Anti-TNF therapy|anti-tnf therapy
1299460|NCT01585064|Adalimumab|adalimumab
1299461|NCT01585064|Disease activity|disease activity
1299462|NCT01585064|Treating to target|treating to target
1299463|NCT01585051|vitamin D|vitamin d
1299464|NCT01585051|blood pressure|blood pressure
1299465|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
1299466|NCT01585051|blood glucose|blood glucose
1299467|NCT01585051|HbA1c|hba1c
1299468|NCT01585038|endothelium|endothelium
1299469|NCT01585038|inflammation|inflammation
1299470|NCT01585038|oxidative stress|oxidative stress
1299471|NCT01585038|HIV-1|hiv-1
1299472|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
1299473|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
1299474|NCT01585025|Chronic diarrhoea|chronic diarrhoea
1299475|NCT01585025|Obeticholic acid|obeticholic acid
1299476|NCT01585025|SeHCAT|sehcat
1299477|NCT01585025|FXR|fxr
1299478|NCT01585025|FGF19|fgf19
1299479|NCT01585012|Cervical cap insemination|cervical cap insemination
1299480|NCT01585012|Collection condom|collection condom
1299481|NCT01585012|Instructions for Use|instructions for use
1299482|NCT01585012|Safety during intercourse|safety during intercourse
1299483|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
1299484|NCT01585012|slip|slip
1299485|NCT01585012|break|break
1299486|NCT01585012|ease of conversion|ease of conversion
1299487|NCT01585012|adequate sample collection|adequate sample collection
1299488|NCT01584947|Oral pain|oral pain
1299489|NCT01584947|Local anesthetic|local anesthetic
1299490|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
1299491|NCT01584934|fatigue|fatigue
1299492|NCT01584934|sleep quality|sleep quality
1299493|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
1299494|NCT01584921|Erythropoietin|erythropoietin
1299495|NCT01584921|Glomerular filtration rate|glomerular filtration rate
1299496|NCT01584921|Tubular reabsorption|tubular reabsorption
1299497|NCT01584921|Renal function|renal function
1299498|NCT01584921|Renal perfusion|renal perfusion
1299499|NCT01584908|kidney transplant recipients|kidney transplant recipients
1299500|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
1299501|NCT01584882|Tobacco|tobacco
1299502|NCT01584882|Behavioral|behavioral
1299503|NCT01584882|Dental hygienist|dental hygienist
1299504|NCT01584882|Dentist|dentist
1299505|NCT01584882|Smoking|smoking
1299506|NCT01584882|Electronic health record|electronic health record
1299507|NCT01584869|GI-bleeding|gi-bleeding
1299508|NCT01584869|capsule endoscopy|capsule endoscopy
1299509|NCT01584843|Neuromuscular Agents|neuromuscular agents
1299510|NCT01584843|Strabismus|strabismus
1299511|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
1299512|NCT01584830|Regorafenib|regorafenib
1299513|NCT01584830|Colorectal|colorectal
1299514|NCT01584830|Metastatic|metastatic
1299515|NCT01584817|colonoscopy|colonoscopy
1299516|NCT01584817|bowel preparation|bowel preparation
1299517|NCT01584817|education|education
1299518|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
1299519|NCT01584804|Cough variant asthma|cough variant asthma
1299520|NCT01584804|Placebo|placebo
1299521|NCT01584791|CAD|cad
1299522|NCT01584791|PCI|pci
1299523|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
1299524|NCT01584778|Behçet's disease|behçet's disease
1299525|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
1299526|NCT01584778|Eosinophils|eosinophils
1299527|NCT01584765|liver injury|liver injury
1299528|NCT01584765|Rechallenge|rechallenge
1299529|NCT01584765|Kaiser Permanente California|kaiser permanente california
1299530|NCT01584739|Safety|safety
1299531|NCT01584739|tolerability|tolerability
1299532|NCT01584739|healthy|healthy
1299533|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
1299534|NCT01584739|pharmacokinetic|pharmacokinetic
1299535|NCT01584739|pharmacodynamic|pharmacodynamic
1299536|NCT01584739|inhaled|inhaled
1299537|NCT01584726|magnesium|magnesium
1299538|NCT01584726|nebulization|nebulization
1299539|NCT01584726|asthma|asthma
1299540|NCT01584726|sulfate|sulfate
1299541|NCT01584726|children|children
1299542|NCT01584726|pediatric|pediatric
1299543|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
1299544|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
1299545|NCT01584700|NYHA class III or IV|nyha class iii or iv
1299546|NCT01584700|Maximal medical therapy|maximal medical therapy
1299547|NCT01584700|Not eligible for CRT|not eligible for crt
1299548|NCT01584687|asthma|asthma
1299549|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
1299550|NCT01584687|mRNA expression|mrna expression
1299551|NCT01584687|biomarker|biomarker
1299552|NCT01584687|real time PCR|real time pcr
1299553|NCT01584687|ACT|act
1299554|NCT01584687|ACQ|acq
1299555|NCT01584648|Randomized study|randomized study
1299556|NCT01584648|combination therapy|combination therapy
1299557|NCT01584648|BRAF inhibitor|braf inhibitor
1299558|NCT01584648|GSK1120212|gsk1120212
1299559|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
1299560|NCT01584648|trametinib|trametinib
1299561|NCT01584648|GSK2118436|gsk2118436
1299562|NCT01584648|MEK inhibitor|mek inhibitor
1299563|NCT01584648|Phase III|phase iii
1299564|NCT01584648|dabrafenib|dabrafenib
1299565|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
1299566|NCT01584609|ischemic stroke|ischemic stroke
1299567|NCT01584609|large vessel occlusion|large vessel occlusion
1299568|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
1299569|NCT01584609|revascularization|revascularization
1299570|NCT01584609|Penumbra System|penumbra system
1299571|NCT01584609|Separator 3D|separator 3d
1299572|NCT01584596|physical activity|physical activity
1299573|NCT01584596|dietary|dietary
1299574|NCT01584596|adults|adults
1299575|NCT01584596|pedometer|pedometer
1299576|NCT01584596|education|education
1299577|NCT01584583|BP|bp
1299578|NCT01584570|dexmedetomidine|dexmedetomidine
1299579|NCT01584570|heart rate variability|heart rate variability
1299580|NCT01584570|QTc interval|qtc interval
1299581|NCT01584544|rectal neoplasms|rectal neoplasms
1299582|NCT01584544|aged|aged
1299583|NCT01584544|chemoradiotherapy|chemoradiotherapy
1299584|NCT01584544|clinical trials, phase I|clinical trials, phase i
1299585|NCT01584544|capecitabine|capecitabine
1299586|NCT01584531|rigosertib sodium|rigosertib sodium
1299587|NCT01584531|rigosertib|rigosertib
1299588|NCT01584531|ON 01910.Na|on 01910.na
1299589|NCT01584531|oral rigosertib|oral rigosertib
1299590|NCT01584505|COPD|copd
1299591|NCT01584479|periodontitis|periodontitis
1299592|NCT01584466|Schizophrenia|schizophrenia
1299593|NCT01584466|Substance Abuse|substance abuse
1299594|NCT01584427|Dietary fibers|dietary fibers
1299595|NCT01584427|Resistent Starch|resistent starch
1299596|NCT01584427|Arabinoxylans|arabinoxylans
1299597|NCT01584427|Postprandial lipaemia|postprandial lipaemia
1299598|NCT01584427|Insulin sensitivity|insulin sensitivity
1299599|NCT01584427|Body composition|body composition
1299600|NCT01584427|Gene expression|gene expression
1299601|NCT01584427|Metabolic rate|metabolic rate
1299602|NCT01584427|Blood pressure|blood pressure
1299603|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
1299604|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
1299605|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
1299606|NCT01584401|Body temperature|body temperature
1299607|NCT01584401|Thermometers|thermometers
1299608|NCT01584401|Non invasive|non invasive
1299609|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
1299610|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
1610962|NCT00354562|Taxotere|taxotere
1299611|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
1299612|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
1299613|NCT01584388|Lacrimal glands|lacrimal glands
1299614|NCT01584388|Orbital pseudotumor|orbital pseudotumor
1299615|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
1299616|NCT01584388|Lymphadenopathy|lymphadenopathy
1299617|NCT01584388|Pachymeningitis|pachymeningitis
1299618|NCT01584388|Aorta|aorta
1299619|NCT01584388|Peri-aortitis|peri-aortitis
1299620|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
1299621|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
1299622|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
1299623|NCT01584375|Preterm infant|preterm infant
1299624|NCT01584375|Midline head position|midline head position
1299825|NCT01583608|Angioplasty|angioplasty
1299625|NCT01584375|Lateral head Position|lateral head position
1299626|NCT01584362|Taenia solium|taenia solium
1299627|NCT01584362|neurocysticercosis|neurocysticercosis
1299628|NCT01584362|oxfendazole|oxfendazole
1299629|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
1299630|NCT01584362|safety|safety
1299631|NCT01584362|pharmacokinetics|pharmacokinetics
1299632|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
1299729|NCT01584024|Preventive therapy|preventive therapy
1299633|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
1299634|NCT01584323|pomgranate|pomgranate
1299635|NCT01584323|oxidative stress|oxidative stress
1299636|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
1299637|NCT01584310|Nutritional assessment|nutritional assessment
1299638|NCT01584310|children|children
1299639|NCT01584310|malnutrition|malnutrition
1299640|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
1299642|NCT01584284|Genelux Corporation|genelux corporation
1299643|NCT01584284|GL-ONC1|gl-onc1
1299644|NCT01584284|Vaccinia|vaccinia
1299645|NCT01584284|Vaccinia Virus|vaccinia virus
1299646|NCT01584284|Oncolytic virus|oncolytic virus
1299647|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
1299648|NCT01584284|Head and Neck Cancer|head and neck cancer
1299649|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
1299650|NCT01584271|AOE|aoe
1299651|NCT01584271|Ear Comfort|ear comfort
1299652|NCT01584271|Dex Otic|dex otic
1299653|NCT01584271|Otidin|otidin
1299654|NCT01584258|Prostate cancer|prostate cancer
1299655|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
1299656|NCT01584258|Early stage prostate cancer|early stage prostate cancer
1299657|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
1299658|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
1299659|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
1299660|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
1299661|NCT01584206|Sitosterolemia|sitosterolemia
1299662|NCT01584206|Ezetimibe|ezetimibe
1299663|NCT01584206|Plant sterol|plant sterol
1299664|NCT01584206|Cholesterol|cholesterol
1299665|NCT01584193|central venous access port|central venous access port
1299666|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
1299667|NCT01584193|suclavian vein|suclavian vein
1299668|NCT01584193|cephalic vein|cephalic vein
1299669|NCT01584180|hypothermia|hypothermia
1299670|NCT01584180|induction of hypothermia|induction of hypothermia
1299671|NCT01584180|cold infusion|cold infusion
1299672|NCT01584180|local neck cooling|local neck cooling
1299673|NCT01584180|external cooling|external cooling
1299674|NCT01584180|surface cooling|surface cooling
1299675|NCT01584180|non invasive cooling|non invasive cooling
1299676|NCT01584180|stroke|stroke
1299677|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
1299678|NCT01584180|cerebrovascular disease|cerebrovascular disease
1299679|NCT01584180|neuro intensive care|neuro intensive care
1299680|NCT01584167|hypothermia|hypothermia
1299681|NCT01584167|induction of hypothermia|induction of hypothermia
1299682|NCT01584167|cold infusion|cold infusion
1299683|NCT01584167|whole-body cooling|whole-body cooling
1299684|NCT01584167|external cooling|external cooling
1299685|NCT01584167|surface cooling|surface cooling
1299686|NCT01584167|non invasive cooling|non invasive cooling
1299687|NCT01584167|stroke|stroke
1299688|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
1299689|NCT01584167|cerebrovascular disease|cerebrovascular disease
1299690|NCT01584167|neuro intensive care|neuro intensive care
1299691|NCT01584141|Leukemia|leukemia
1299692|NCT01584141|Lymphoma|lymphoma
1299693|NCT01584141|Occupational Epidemiology|occupational epidemiology
1299694|NCT01584141|Molecular Epidemiology|molecular epidemiology
1299695|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
1299696|NCT01584115|Cancer.|cancer.
1299697|NCT01584115|Melanoma.|melanoma.
1299698|NCT01584115|Ovarian cancer.|ovarian cancer.
1299699|NCT01584115|Lung cancer.|lung cancer.
1299700|NCT01584115|NY-ESO-1.|ny-eso-1.
1299701|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
1299702|NCT01584115|Tumor antigen.|tumor antigen.
1299703|NCT01584115|Bordetella pertussis.|bordetella pertussis.
1299704|NCT01584102|Randomized controlled trial|randomized controlled trial
1299705|NCT01584102|obesity|obesity
1299706|NCT01584102|community-based participatory research|community-based participatory research
1299707|NCT01584102|minority health|minority health
1299708|NCT01584102|rural health|rural health
1299709|NCT01584102|health promotion|health promotion
1299710|NCT01584076|Amblyopia|amblyopia
1299711|NCT01584076|Donepezil|donepezil
1299712|NCT01584063|Mexican Americans|mexican americans
1299713|NCT01584063|Pregnancy|pregnancy
1299714|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
1299715|NCT01584063|Prevention|prevention
1299716|NCT01584063|Community health workers|community health workers
1299717|NCT01584063|Community based participatory research|community based participatory research
1299718|NCT01584063|Behavioral Intervention|behavioral intervention
1299719|NCT01584063|Lifestyle Intervention|lifestyle intervention
1299720|NCT01584037|Adenovirus|adenovirus
1299721|NCT01584037|Adenovirus Type 4|adenovirus type 4
1299722|NCT01584037|Adenovirus Type 7|adenovirus type 7
1299723|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
1299724|NCT01584024|Dental caries|dental caries
1299725|NCT01584024|Proximal surfaces|proximal surfaces
1299726|NCT01584024|Posterior teeth|posterior teeth
1299727|NCT01584024|Carious lesions|carious lesions
1299728|NCT01584024|Tooth diseases|tooth diseases
1299730|NCT01584011|Taste|taste
1299731|NCT01584011|Chorda tympani nerve|chorda tympani nerve
1299732|NCT01583998|Major Depressive Disorder|major depressive disorder
1299734|NCT01583998|Depression|depression
1299735|NCT01583998|Measurement Based Care|measurement based care
1299736|NCT01583998|MBC|mbc
1299737|NCT01583998|electronic health records|electronic health records
1299738|NCT01583998|EHR|ehr
1299739|NCT01583998|electronic medical records|electronic medical records
1299740|NCT01583998|EMR|emr
1299741|NCT01583985|opioid analgesics|opioid analgesics
1299742|NCT01583985|chronic pain|chronic pain
1299743|NCT01583985|musculoskeletal pain|musculoskeletal pain
1299744|NCT01583972|Vitamin A deficiency|vitamin a deficiency
1299745|NCT01583972|Vitamin A|vitamin a
1299746|NCT01583972|retinyl palmitate|retinyl palmitate
1299747|NCT01583972|malnutrition|malnutrition
1299748|NCT01583972|vaccine|vaccine
1299749|NCT01583972|vaccination|vaccination
1299750|NCT01583972|BCG|bcg
1299751|NCT01583972|tuberculosis|tuberculosis
1299752|NCT01583972|polio virus|polio virus
1299753|NCT01583972|tetanus toxoid|tetanus toxoid
1299754|NCT01583972|hepatitis B virus|hepatitis b virus
1299755|NCT01583972|thymus|thymus
1299756|NCT01583972|T lymphocyte|t lymphocyte
1299757|NCT01583972|B lymphocyte|b lymphocyte
1299758|NCT01583972|antibody|antibody
1299759|NCT01583972|bacterial translocation|bacterial translocation
1299760|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
1299761|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
1299762|NCT01583959|folic acid|folic acid
1299763|NCT01583959|methotrexate|methotrexate
1299764|NCT01583946|subjective well-being|subjective well-being
1299765|NCT01583946|life transitions|life transitions
1299766|NCT01583946|health-related quality of life|health-related quality of life
1299767|NCT01583946|health|health
1299768|NCT01583946|healthcare costs|healthcare costs
1299769|NCT01583933|Dental stability|dental stability
1299770|NCT01583933|Occlusal stability|occlusal stability
1299771|NCT01583933|Retainers|retainers
1299772|NCT01583920|prostatic neoplasms|prostatic neoplasms
1299773|NCT01583920|brachytherapy|brachytherapy
1299774|NCT01583920|salvage therapy|salvage therapy
1299775|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
1299776|NCT01583907|cow's milk allergy|cow's milk allergy
1299777|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
1299778|NCT01583855|Remote catheter ablation|remote catheter ablation
1299779|NCT01583855|Atrial fibrillation|atrial fibrillation
1299780|NCT01583842|neuroblastoma|neuroblastoma
1299781|NCT01583842|imaging|imaging
1299782|NCT01583842|124I-MIBG|124i-mibg
1299783|NCT01583842|131I-MIBG|131i-mibg
1299784|NCT01583842|PET/CT|pet/ct
1299785|NCT01583829|ADHD|adhd
1299786|NCT01583829|neurofeedback|neurofeedback
1299787|NCT01583829|biofeedback|biofeedback
1299788|NCT01583829|computer attention training|computer attention training
1299789|NCT01583816|Actinic Keratosis|actinic keratosis
1299790|NCT01583816|Resiquimod|resiquimod
1299791|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1299792|NCT01583790|Bariatric surgery|bariatric surgery
1299793|NCT01583790|Morbid Obesity|morbid obesity
1299794|NCT01583777|Belinostat|belinostat
1299795|NCT01583751|pilonidal sinus|pilonidal sinus
1299796|NCT01583751|new technique|new technique
1299797|NCT01583751|videoendoscopic|videoendoscopic
1299798|NCT01583725|Obesity|obesity
1299799|NCT01583725|Bariatric surgery|bariatric surgery
1299800|NCT01583725|Weight loss|weight loss
1299801|NCT01583725|fMRI|fmri
1299802|NCT01583725|gut peptides|gut peptides
1299803|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
1299804|NCT01583712|Small bowel imaging|small bowel imaging
1299805|NCT01583712|Graft-versus-host disease|graft-versus-host disease
1299806|NCT01583712|HSCT|hsct
1299807|NCT01583699|MALT-lymphoma|malt-lymphoma
1299808|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
1299809|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
1299810|NCT01583686|Metastatic Cancer|metastatic cancer
1299811|NCT01583686|Immunotherapy|immunotherapy
1299812|NCT01583686|Gene Therapy|gene therapy
1299813|NCT01583686|Mesothelioma|mesothelioma
1299814|NCT01583686|Pancreatic Cancer|pancreatic cancer
1299815|NCT01583660|NSAIDs|nsaids
1299816|NCT01583660|Anti-inflammatory|anti-inflammatory
1299817|NCT01583660|elderly hip fracture|elderly hip fracture
1299818|NCT01583660|mortality|mortality
1299819|NCT01583608|Drug eluting stent|drug eluting stent
1299820|NCT01583608|Bioabsorbable|bioabsorbable
1299821|NCT01583608|Bioresorbable|bioresorbable
1299822|NCT01583608|Coronary Stent|coronary stent
1299823|NCT01583608|Scaffold|scaffold
1299824|NCT01583608|Stents|stents
1299826|NCT01583608|Coronary Artery Disease|coronary artery disease
1299827|NCT01583608|Stentthrombosis|stentthrombosis
1299828|NCT01583595|Chronic Lung Disease|chronic lung disease
1299829|NCT01583595|Exercise|exercise
1299830|NCT01583595|Self-efficacy|self-efficacy
1299831|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
1299832|NCT01583582|peptide concentrate|peptide concentrate
1299833|NCT01583582|Coldwater Shrimp|coldwater shrimp
1299834|NCT01583582|antihypertensive effect|antihypertensive effect
1299835|NCT01583582|mild hypertension|mild hypertension
1299836|NCT01583582|moderate hypertension|moderate hypertension
1299837|NCT01583582|blood pressure|blood pressure
1299838|NCT01583569|Complex Dynamic Systems|complex dynamic systems
1299839|NCT01583569|Biomarkers|biomarkers
1299840|NCT01583569|Mood Disorders|mood disorders
1299841|NCT01583556|Adult|adult
1299842|NCT01583556|English speaking|english speaking
1299843|NCT01583556|Fractures|fractures
1299844|NCT01583556|Excellent prognosis|excellent prognosis
1299845|NCT01583556|Upper Extremity|upper extremity
1299846|NCT01583543|Recurrent|recurrent
1299847|NCT01583543|Metastatic|metastatic
1299848|NCT01583530|Belimumab|belimumab
1299849|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
1299850|NCT01583530|Drug Administration Routes|drug administration routes
1299851|NCT01583530|Injections|injections
1299852|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1299853|NCT01583530|Lupus|lupus
1299854|NCT01583530|SLE|sle
1299855|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
1299856|NCT01583530|Antibodies|antibodies
1299857|NCT01583530|Autoimmune Disease|autoimmune disease
1299858|NCT01583530|Biological Therapy|biological therapy
1299859|NCT01583530|Immune System Diseases|immune system diseases
1299860|NCT01583530|Pharmacokinetics|pharmacokinetics
1299861|NCT01583530|Biological Availability|biological availability
1299862|NCT01583517|Acute pancreatitis|acute pancreatitis
1299863|NCT01583517|ERCP|ercp
1299864|NCT01583517|Sphincterotomy|sphincterotomy
1299865|NCT01583517|Manometry|manometry
1299866|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
1299867|NCT01583504|Achilles|achilles
1299868|NCT01583504|Tendinopathy|tendinopathy
1299869|NCT01583504|Tendonitis|tendonitis
1299870|NCT01583504|Injection|injection
1299871|NCT01583491|platelet rich fibrin|platelet rich fibrin
1299872|NCT01583491|mandibular third molar|mandibular third molar
1299873|NCT01583491|periodontal problem|periodontal problem
1299874|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
1299875|NCT01583478|wrinkles|wrinkles
1299876|NCT01583478|glabellar|glabellar
1299877|NCT01583478|rhytids|rhytids
1299878|NCT01583478|frown|frown
1299879|NCT01583478|lines|lines
1299880|NCT01583465|randomized controlled trial|randomized controlled trial
1299881|NCT01583465|Blood loss, surgical|blood loss, surgical
1299882|NCT01583465|Blood loss, postoperative|blood loss, postoperative
1299883|NCT01583465|Wound healing|wound healing
1299884|NCT01583452|Post operative ileus|post operative ileus
1299885|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
1299886|NCT01583452|Chewing gum|chewing gum
1299887|NCT01583439|HIV Infections|hiv infections
1299888|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1299889|NCT01583439|Anti-HIV Agents|anti-hiv agents
1299890|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1299891|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1299892|NCT01583439|Immune System Diseases|immune system diseases
1299893|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
1299894|NCT01583439|Antiviral Agents|antiviral agents
1299895|NCT01583426|GeparSepto|geparsepto
1299896|NCT01583426|GBG 69|gbg 69
1299897|NCT01583426|GBG|gbg
1299898|NCT01583426|German Breast Group|german breast group
1299899|NCT01583426|neo-adjuvant|neo-adjuvant
1299900|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
1299901|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
1299902|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
1299903|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
1611053|NCT00354263|Monotherapy|monotherapy
1299904|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
1299905|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
1299906|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
1299907|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
1299908|NCT01583400|Depressive Disorder, Major|depressive disorder, major
1299909|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
1299910|NCT01583400|Dysthymic Disorder|dysthymic disorder
1299911|NCT01583387|healthy adults|healthy adults
1299912|NCT01583387|urinary adducts|urinary adducts
1299913|NCT01583387|water intake|water intake
1299914|NCT01583374|spondylitis|spondylitis
1299915|NCT01583374|spondyloarthritis|spondyloarthritis
1299916|NCT01583374|Spondyloarthropathy|spondyloarthropathy
1299917|NCT01583374|Oral preparation|oral preparation
1299918|NCT01583361|two arms|two arms
1299919|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
1299920|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
1299921|NCT01583361|disease free survival|disease free survival
1299922|NCT01583348|transvaginal|transvaginal
1299923|NCT01583348|NOTES|notes
1299924|NCT01583348|cholecystectomy|cholecystectomy
1299925|NCT01583348|cholangiography|cholangiography
1299926|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
1299927|NCT01583335|Overweight|overweight
1299928|NCT01583335|Obesity|obesity
1299929|NCT01583335|Predisposition|predisposition
1299930|NCT01583335|Prevention|prevention
1299931|NCT01583335|Diet|diet
1299932|NCT01583335|Physical activity|physical activity
1299933|NCT01583335|Sleep|sleep
1299934|NCT01583335|Family stress|family stress
1299935|NCT01583322|ovarian cancer|ovarian cancer
1299936|NCT01583322|debulking surgery|debulking surgery
1299937|NCT01583322|interval debulking|interval debulking
1299938|NCT01583322|vargatef|vargatef
1299939|NCT01583322|nintedanib|nintedanib
1299940|NCT01583322|maintenance|maintenance
1299941|NCT01583322|first line|first line
1299942|NCT01583322|paclitaxel|paclitaxel
1299943|NCT01583322|carboplatin|carboplatin
1299944|NCT01583309|blood pressure|blood pressure
1299945|NCT01583309|cardiovascular instability|cardiovascular instability
1299946|NCT01583309|symptomatic hypotension|symptomatic hypotension
1299947|NCT01583309|online hemofiltration|online hemofiltration
1299948|NCT01583309|online hemodiafiltration|online hemodiafiltration
1299949|NCT01583283|Multiple Myeloma|multiple myeloma
1299950|NCT01583283|Relapsed|relapsed
1299951|NCT01583283|Refractory|refractory
1299952|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
1299953|NCT01583283|Lenalidomide|lenalidomide
1299954|NCT01583283|Revlimid|revlimid
1299955|NCT01583283|Dexamethasone|dexamethasone
1299956|NCT01583270|Arabinxylan|arabinxylan
1299957|NCT01583270|Rye kernels|rye kernels
1299958|NCT01583270|whole grain|whole grain
1299959|NCT01583270|Dietary fibre|dietary fibre
1299960|NCT01583270|Metabolic syndrome|metabolic syndrome
1299961|NCT01583270|Glycemic response|glycemic response
1299962|NCT01583270|Colon fermentation|colon fermentation
1299963|NCT01583270|Second meal effekt|second meal effekt
1299964|NCT01583270|Satiety|satiety
1299965|NCT01583218|Phase III|phase iii
1299967|NCT01583205|Coping Effectiveness Training|coping effectiveness training
1299968|NCT01583205|Distress|distress
1299969|NCT01583205|Care Giver|care giver
1299970|NCT01583192|infection|infection
1299971|NCT01583192|skin preparation|skin preparation
1299972|NCT01583192|fore-foot surgery|fore-foot surgery
1299973|NCT01583192|chloride-hexidine|chloride-hexidine
1299974|NCT01583192|povidine-jodine|povidine-jodine
1299975|NCT01583192|alcohol|alcohol
1299976|NCT01583179|nerve block|nerve block
1299977|NCT01583179|outpatient surgery|outpatient surgery
1299978|NCT01583140|physical activity|physical activity
1299979|NCT01583140|Latinas|latinas
1299980|NCT01583127|Problem Behavior|problem behavior
1299981|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
1299982|NCT01583114|heart failure|heart failure
1299983|NCT01583114|genetics|genetics
1299984|NCT01583114|mutation carrier|mutation carrier
1299985|NCT01583114|ACE treatment|ace treatment
1299986|NCT01583114|preclinical|preclinical
1299987|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
1299988|NCT01583088|Diaphragm|diaphragm
1299989|NCT01583088|Mechanical ventilation|mechanical ventilation
1299990|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
1299991|NCT01583088|Respiratory insufficiency|respiratory insufficiency
1299992|NCT01583062|Surgical Wound Infection|surgical wound infection
1299993|NCT01583062|Facial Injuries|facial injuries
1299994|NCT01583062|Orbital Fractures|orbital fractures
1299995|NCT01583062|Zygomatic Fractures|zygomatic fractures
1299996|NCT01583062|Mandibular Fractures|mandibular fractures
1299997|NCT01583062|Jaw Injuries|jaw injuries
1299998|NCT01583023|bipolar disorder|bipolar disorder
1299999|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
1300000|NCT01583023|bupropion|bupropion
1300001|NCT01583023|lithium a/o Epival|lithium a/o epival
1333272|NCT01443741|Diabetes mellitus|diabetes mellitus
1300002|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
1300003|NCT01582997|BRAF|braf
1300004|NCT01582997|Advance solid tumors|advance solid tumors
1300005|NCT01582984|consent|consent
1300006|NCT01582984|Patient Understanding|patient understanding
1300007|NCT01582984|Knee Arthroplasty|knee arthroplasty
1300008|NCT01582971|Breast Cancer|breast cancer
1300009|NCT01582971|Reflexology|reflexology
1300010|NCT01582971|Complementary|complementary
1300011|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1300012|NCT01582958|Pulmonary Function Tests|pulmonary function tests
1300013|NCT01582958|Biochemical Alterations|biochemical alterations
1300014|NCT01582945|Treatment resistant|treatment resistant
1300015|NCT01582945|suicidal ideation|suicidal ideation
1300016|NCT01582945|major depressive disorder|major depressive disorder
1300017|NCT01582932|plaque psoriasis|plaque psoriasis
1300018|NCT01582932|pediatric|pediatric
1300019|NCT01582932|mild|mild
1300020|NCT01582932|moderate|moderate
1300021|NCT01582919|dementia|dementia
1300022|NCT01582919|Alzheimer's Disease|alzheimer's disease
1300023|NCT01582919|diagnostic|diagnostic
1300024|NCT01582919|biomarkers|biomarkers
1300025|NCT01582919|neuroimaging|neuroimaging
1300026|NCT01582919|PET|pet
1300027|NCT01582919|MRI|mri
1300028|NCT01582919|mild cognitive impairment|mild cognitive impairment
1300029|NCT01582893|inflammation|inflammation
1300030|NCT01582893|dialysis|dialysis
1300031|NCT01582880|Keratoprosthesis|keratoprosthesis
1300032|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
1300033|NCT01582867|Hemodiafiltration|hemodiafiltration
1300034|NCT01582867|Hemodialysis|hemodialysis
1300035|NCT01582867|Sodium|sodium
1300036|NCT01582867|Artis|artis
1300037|NCT01582867|renal failure|renal failure
1300038|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
1300039|NCT01582854|Stroke|stroke
1300040|NCT01582854|Actovegin|actovegin
1300041|NCT01582854|Cognition disorders|cognition disorders
1300042|NCT01582841|Colon Cancer|colon cancer
1300043|NCT01582841|Lynch Syndrome|lynch syndrome
1300044|NCT01582841|Genetic Screening|genetic screening
1300045|NCT01582828|atrial|atrial
1300046|NCT01582828|fibrillation|fibrillation
1300047|NCT01582828|pvi|pvi
1300048|NCT01582828|vats|vats
1300049|NCT01582828|ablation|ablation
1300050|NCT01582828|hybrid|hybrid
1300051|NCT01582815|Major Depressive Disorder|major depressive disorder
1300052|NCT01582815|Depression|depression
1300053|NCT01582815|Anxiety symptoms|anxiety symptoms
1300054|NCT01582815|JNJ-40411813|jnj-40411813
1300055|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
1300056|NCT01582763|Polyneuropathy|polyneuropathy
1300057|NCT01582763|Autoimmune Diseases|autoimmune diseases
1300058|NCT01582763|Immune System Diseases|immune system diseases
1300059|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
1300060|NCT01582763|Outcome|outcome
1300061|NCT01582763|Quality of life|quality of life
1300062|NCT01582763|Disability|disability
1300063|NCT01582763|Prognostic Determinants|prognostic determinants
1300064|NCT01582763|Treatment|treatment
1300065|NCT01582763|Immunoglobulins|immunoglobulins
1300066|NCT01582763|Prognosis|prognosis
1300067|NCT01582763|Infections|infections
1300068|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
1300069|NCT01582763|Genetic polymorphisms|genetic polymorphisms
1300070|NCT01582763|Electrophysiology|electrophysiology
1300071|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
1300072|NCT01582763|Serum|serum
1300073|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
1300074|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
1300075|NCT01582737|Xarelto|xarelto
1300076|NCT01582737|SPAF|spaf
1300077|NCT01582724|Menstrual pain|menstrual pain
1300078|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
1300079|NCT01582724|Self-care acupressure|self-care acupressure
1300080|NCT01582711|LTBI|ltbi
1300081|NCT01582711|LTB|ltb
1300082|NCT01582711|Latent TB|latent tb
1300083|NCT01582711|TB infection|tb infection
1300084|NCT01582685|Breast Cancer|breast cancer
1300085|NCT01582685|Obesity|obesity
1300086|NCT01582685|Exercise|exercise
1300087|NCT01582685|Angiogenesis|angiogenesis
1300088|NCT01582672|RCC|rcc
1300089|NCT01582672|Kidney Cancer|kidney cancer
1300090|NCT01582659|constipation|constipation
1300091|NCT01582659|children|children
1300092|NCT01582659|outpatient|outpatient
1300093|NCT01582633|vaccine|vaccine
1300094|NCT01582633|influenza|influenza
1300095|NCT01582633|needle free jet injector|needle free jet injector
1300096|NCT01582633|Intradermal|intradermal
1300097|NCT01582633|sparing dose|sparing dose
1300098|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
1300099|NCT01582620|Telemedicine|telemedicine
1300100|NCT01582620|remote consultation|remote consultation
1300101|NCT01582620|rural|rural
1300102|NCT01582620|thrombolysis therapy|thrombolysis therapy
1300103|NCT01582620|plasminogen activators|plasminogen activators
1300104|NCT01582620|stroke care|stroke care
1300105|NCT01582620|stroke management|stroke management
1300106|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
1300107|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
1300108|NCT01582581|mental health|mental health
1300109|NCT01582581|depression|depression
1300110|NCT01582581|behavioral health|behavioral health
1300111|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
1300112|NCT01582581|CBT|cbt
1300113|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
1300114|NCT01582555|mucolysis|mucolysis
1300115|NCT01582555|QOL|qol
1300116|NCT01582555|endoscopy|endoscopy
1300117|NCT01582555|sinus surgery|sinus surgery
1300118|NCT01582529|Developmental Outcomes|developmental outcomes
1300119|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
1300120|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1300121|NCT01582529|Congenital Heart Disease|congenital heart disease
1300122|NCT01582516|brain tumor|brain tumor
1300123|NCT01582516|virotherapy|virotherapy
1300124|NCT01582516|glioblastoma|glioblastoma
1300125|NCT01582516|replication competent adenovirus|replication competent adenovirus
1300126|NCT01582490|Mammoplasty|mammoplasty
1300127|NCT01582490|Postoperative pain|postoperative pain
1300128|NCT01582490|Analgesia|analgesia
1300129|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
1300130|NCT01582464|Protective Headwear|protective headwear
1300131|NCT01582464|Social Marketing|social marketing
1300132|NCT01582464|Theory of Planned Behavior|theory of planned behavior
1300133|NCT01582425|isavuconazole|isavuconazole
1300134|NCT01582425|methadone|methadone
1300135|NCT01582425|Healthy Volunteers|healthy volunteers
1300136|NCT01582425|BAL8557|bal8557
1300137|NCT01582412|Isavuconazole|isavuconazole
1300138|NCT01582412|Digoxin|digoxin
1300139|NCT01582412|Healthy Volunteers|healthy volunteers
1300140|NCT01582412|BAL8557|bal8557
1300141|NCT01582399|Healthy Volunteers|healthy volunteers
1300142|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
1300143|NCT01582399|Co-stimulation blockade|co-stimulation blockade
1300144|NCT01582399|CD40 antigen|cd40 antigen
1300145|NCT01582399|Anti-CD40|anti-cd40
1300146|NCT01582399|ASKP1240|askp1240
1300147|NCT01582360|critical illness|critical illness
1300148|NCT01582360|pharmacokinetics|pharmacokinetics
1300149|NCT01582360|CRRT|crrt
1300150|NCT01582360|CVVH|cvvh
1300151|NCT01582360|CVVHD|cvvhd
1300152|NCT01582360|CVVHDF|cvvhdf
1300153|NCT01582360|antiinfectives|antiinfectives
1300154|NCT01582360|antibiotics|antibiotics
1300155|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
1300156|NCT01582360|bacterial killing|bacterial killing
1300157|NCT01582360|pharmacodynamics|pharmacodynamics
1300158|NCT01582360|PK/PD index|pk/pd index
1300159|NCT01582347|Opioid dependence|opioid dependence
1300160|NCT01582334|Growth disorders|growth disorders
1300161|NCT01582334|Saizen|saizen
1300162|NCT01582334|Easypod|easypod
1300163|NCT01582334|Growth hormone|growth hormone
1300164|NCT01582334|Pediatric subject|pediatric subject
1300165|NCT01582321|vascular ultrasound|vascular ultrasound
1300166|NCT01582321|flow cytometry|flow cytometry
1300167|NCT01582321|platelet aggregation|platelet aggregation
1300168|NCT01582295|Bone disease|bone disease
1300169|NCT01582282|Type II NIDDM|type ii niddm
1300170|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
1300171|NCT01582243|vildagliptin|vildagliptin
1300172|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
1300173|NCT01582230|Vildagliptin|vildagliptin
1300174|NCT01582217|Bleeding|bleeding
1300175|NCT01582217|Risk Score|risk score
1300176|NCT01582217|Outcomes|outcomes
1300177|NCT01582217|Prasugrel|prasugrel
1300178|NCT01582204|clear cell carcinoma|clear cell carcinoma
1300179|NCT01582204|Kidney|kidney
1300180|NCT01582204|MAB-124I-CG250|mab-124i-cg250
1300181|NCT01582204|PET scan|pet scan
1300182|NCT01582204|CT scan|ct scan
1300183|NCT01582204|sunitinib|sunitinib
1300184|NCT01582204|pazopanib|pazopanib
1300185|NCT01582204|11-134|11-134
1300186|NCT01582191|Advanced Cancers|advanced cancers
1300187|NCT01582191|Advanced solid cancer|advanced solid cancer
1300188|NCT01582191|Metastatic cancer|metastatic cancer
1300189|NCT01582191|Vandetanib|vandetanib
1300190|NCT01582191|ZD 6474|zd 6474
1300191|NCT01582191|Zactima|zactima
1300192|NCT01582191|Caprelsa|caprelsa
1300193|NCT01582191|Everolimus|everolimus
1300194|NCT01582191|Afinitor|afinitor
1300195|NCT01582191|RAD001|rad001
1300196|NCT01582191|Multi-kinase Inhibitor|multi-kinase inhibitor
1300197|NCT01582178|colonoscopy|colonoscopy
1300198|NCT01582178|warm water immersion|warm water immersion
1300199|NCT01582178|cool water immersion|cool water immersion
1300200|NCT01582152|Brain Neoplasms|brain neoplasms
1300201|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
1300202|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
1300203|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
1300204|NCT01582152|GBM|gbm
1300205|NCT01582152|Gliosarcoma|gliosarcoma
1300206|NCT01582152|TPI287|tpi287
1300207|NCT01582152|Bevacizumab|bevacizumab
1300208|NCT01582152|Avastin|avastin
1300209|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
1300210|NCT01582152|rhuMAb-VEGF|rhumab-vegf
1300211|NCT01582139|Artificial Pancreas Project|artificial pancreas project
1300212|NCT01582139|AP Platform|ap platform
1300213|NCT01582139|Insulin Pump|insulin pump
1300214|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
1300215|NCT01582139|Closed-Loop Control|closed-loop control
1300216|NCT01582139|Control-to-Range|control-to-range
1300217|NCT01582126|multiple sclerosis|multiple sclerosis
1300218|NCT01582126|physical therapy|physical therapy
1300219|NCT01582126|postural control|postural control
1300220|NCT01582087|acute hepatic failure|acute hepatic failure
1300221|NCT01582087|chronic hepatic failure|chronic hepatic failure
1300222|NCT01582087|coma|coma
1300223|NCT01582074|Ultrasound Tomography|ultrasound tomography
1300224|NCT01582074|Tamoxifen|tamoxifen
1300225|NCT01582074|Breast Cancer|breast cancer
1300226|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
1300227|NCT01582074|Breast Density|breast density
1300228|NCT01582061|Cushing's disease|cushing's disease
1300229|NCT01582061|Hormone disorder|hormone disorder
1300230|NCT01582061|Cortisol|cortisol
1300333|NCT01581567|Samples|samples
1300231|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
1300232|NCT01582061|Pituitary tumor|pituitary tumor
1300233|NCT01582061|SOM230|som230
1300234|NCT01582061|adult|adult
1300235|NCT01582035|Hepatitis C|hepatitis c
1300236|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
1300237|NCT01582035|TMC647055|tmc647055
1300238|NCT01582035|telaprevir|telaprevir
1300239|NCT01581996|Chronic renal failure|chronic renal failure
1300443|NCT01581086|COPD|copd
1300240|NCT01581996|End-stage renal disease|end-stage renal disease
1300241|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
1300242|NCT01581996|Serum phosphorus|serum phosphorus
1300243|NCT01581996|Hyperphosphatemia|hyperphosphatemia
1300244|NCT01581996|Phosphate binders|phosphate binders
1300245|NCT01581996|Phosphate|phosphate
1300246|NCT01581970|head and neck cancer|head and neck cancer
1300247|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
1300248|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
1300249|NCT01581944|myomectomy|myomectomy
1300250|NCT01581944|GnRH|gnrh
1300251|NCT01581944|blood loss|blood loss
1300252|NCT01581905|Hysterectomy|hysterectomy
1300253|NCT01581905|Laparoscopy|laparoscopy
1300254|NCT01581905|Robotics|robotics
1300255|NCT01581892|bone nonunion|bone nonunion
1300256|NCT01581892|bone marrow|bone marrow
1300257|NCT01581892|mononuclear|mononuclear
1300258|NCT01581892|fracture|fracture
1300259|NCT01581879|Bioequivalence|bioequivalence
1300260|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
1300261|NCT01581879|crossover|crossover
1300262|NCT01581866|Bioequivalence|bioequivalence
1300263|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
1300264|NCT01581866|crossover|crossover
1300265|NCT01581853|HIV|hiv
1300266|NCT01581853|AIDS|aids
1300267|NCT01581853|MONOTHERAPY|monotherapy
1300268|NCT01581853|PILOT|pilot
1300269|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
1300270|NCT01581840|anus|anus
1300271|NCT01581840|carcinoma|carcinoma
1300272|NCT01581840|panitumumab|panitumumab
1300273|NCT01581840|mitomycine|mitomycine
1300274|NCT01581840|5Fu|5fu
1300275|NCT01581840|radiotherapy|radiotherapy
1300276|NCT01581827|Heart Failure|heart failure
1300277|NCT01581827|BNP|bnp
1300278|NCT01581827|NT-proBNP|nt-probnp
1300279|NCT01581814|PCOS|pcos
1300280|NCT01581801|gastric bypass|gastric bypass
1300281|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
1300282|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
1300283|NCT01581788|Bioequivalence|bioequivalence
1300284|NCT01581788|Divalproex Sodium|divalproex sodium
1300285|NCT01581788|Crossover|crossover
1300286|NCT01581775|Bioequivalence|bioequivalence
1300287|NCT01581775|Divalproex Sodium|divalproex sodium
1300288|NCT01581775|Crossover|crossover
1300289|NCT01581762|EUS, FNA|eus, fna
1300290|NCT01581749|low risk prostate cancer|low risk prostate cancer
1300291|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
1300292|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
1300293|NCT01581736|insulin resistance|insulin resistance
1300294|NCT01581736|mitochondria|mitochondria
1300295|NCT01581723|urinary bladder tumor|urinary bladder tumor
1300296|NCT01581723|monopolar TURBT|monopolar turbt
1300297|NCT01581723|bipolar TURBT|bipolar turbt
1300298|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
1300299|NCT01581710|Bronchodilator response|bronchodilator response
1300300|NCT01581697|oat|oat
1300301|NCT01581697|cholesterol|cholesterol
1300302|NCT01581697|children|children
1300303|NCT01581697|adolescent|adolescent
1300304|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
1300305|NCT01581645|Parkinson's disease|parkinson's disease
1300306|NCT01581645|Parkinsonism|parkinsonism
1300307|NCT01581645|Gait problems|gait problems
1300308|NCT01581645|Freezing gait|freezing gait
1300309|NCT01581632|atherosclerosis|atherosclerosis
1611145|NCT00353899|Pediatric|pediatric
1403133|NCT01151657|IBS|ibs
1300310|NCT01581632|endothelial dysfunction|endothelial dysfunction
1300311|NCT01581632|coronary vasospasm|coronary vasospasm
1300312|NCT01581619|Early Invasive N0|early invasive n0
1300313|NCT01581619|Non-Invasive|non-invasive
1300314|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
1300315|NCT01581606|Teleophthalmology|teleophthalmology
1300316|NCT01581606|Screening|screening
1300317|NCT01581606|Diagnosis|diagnosis
1300318|NCT01581606|Timing|timing
1300319|NCT01581606|Treatment|treatment
1300320|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
1300321|NCT01581593|PID|pid
1300322|NCT01581593|Agammaglobulinemia|agammaglobulinemia
1300323|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
1300324|NCT01581593|Antibody deficiency|antibody deficiency
1300325|NCT01581580|Parkinson's Disease|parkinson's disease
1300326|NCT01581580|Deep Brain Stimulation|deep brain stimulation
1300327|NCT01581580|Neurophysiology|neurophysiology
1300328|NCT01581580|Movement Disorder|movement disorder
1300329|NCT01581580|Essential Tremor|essential tremor
1300330|NCT01581580|Parkinson Disease|parkinson disease
1300331|NCT01581567|Storage|storage
1300332|NCT01581567|Repository|repository
1300334|NCT01581567|Data|data
1300335|NCT01581554|Hepatitis B|hepatitis b
1300336|NCT01581554|Treatment|treatment
1300337|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
1300338|NCT01581541|Targeted Therapy|targeted therapy
1300339|NCT01581541|Solid Tumors|solid tumors
1300340|NCT01581541|Lymphoma|lymphoma
1300341|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1300342|NCT01581541|Solid Tumor|solid tumor
1300444|NCT01581086|Pulmonary disease|pulmonary disease
1300343|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1300344|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1300345|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1300346|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1300347|NCT01581502|Anticoagulation|anticoagulation
1300348|NCT01581502|Recurrent stroke|recurrent stroke
1300349|NCT01581502|Bleeding|bleeding
1300350|NCT01581489|Cord clamping|cord clamping
1300351|NCT01581489|iron deficiency|iron deficiency
1300352|NCT01581489|Neurodevelopment|neurodevelopment
1300353|NCT01581476|Adolescence|adolescence
1300354|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
1300355|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
1300356|NCT01581437|atrial fibrillation|atrial fibrillation
1300357|NCT01581437|cardiac ablation|cardiac ablation
1300358|NCT01581424|Fabry disease|fabry disease
1300359|NCT01581424|kidney function|kidney function
1300360|NCT01581424|kidney structure morphometry|kidney structure morphometry
1300361|NCT01581424|Fabry kidney disease|fabry kidney disease
1300362|NCT01581424|Podocytes|podocytes
1300363|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
1300364|NCT01581411|macular edema|macular edema
1300365|NCT01581411|vision loss|vision loss
1300366|NCT01581411|rtelative afferent papillary defect|rtelative afferent papillary defect
1300367|NCT01581398|Peginterferon|peginterferon
1300368|NCT01581398|Pegasys|pegasys
1300369|NCT01581398|Sustained virus response|sustained virus response
1300370|NCT01581398|HCV|hcv
1300371|NCT01581385|atherosclerosis|atherosclerosis
1300372|NCT01581385|carotid artery|carotid artery
1300373|NCT01581385|carotid endarterectomy|carotid endarterectomy
1300374|NCT01581359|Endometriosis|endometriosis
1300375|NCT01581359|GnRH treatment|gnrh treatment
1300376|NCT01581359|Infertility|infertility
1300377|NCT01581359|IVF|ivf
1300378|NCT01581346|NSCLC|nsclc
1300379|NCT01581346|exercise intervention|exercise intervention
1300380|NCT01581346|quality of life|quality of life
1300381|NCT01581333|febrile neutropenia|febrile neutropenia
1300382|NCT01581333|antimicrobial treatment|antimicrobial treatment
1300383|NCT01581333|procalcitonin|procalcitonin
1300384|NCT01581307|liver|liver
1300385|NCT01581307|pancreas|pancreas
1300386|NCT01581307|chemotherapy|chemotherapy
1300387|NCT01581307|radiotherapy|radiotherapy
1300388|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
1300389|NCT01581294|Psoriatic arthritis|psoriatic arthritis
1300390|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
1300391|NCT01581294|Spondyloarthritis|spondyloarthritis
1300392|NCT01581281|Pediatric|pediatric
1300393|NCT01581281|Children|children
1300394|NCT01581281|Adolescent|adolescent
1300395|NCT01581281|Headache|headache
1300396|NCT01581281|Migraine|migraine
1300397|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
1300398|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
1300399|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
1300400|NCT01581255|biomarkers|biomarkers
1300401|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
1300402|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
1300403|NCT01581242|oral administration|oral administration
1300404|NCT01581242|male subjects|male subjects
1300405|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
1300406|NCT01581216|Fatigue|fatigue
1300407|NCT01581216|Palliative Care|palliative care
1300408|NCT01581216|Exercise|exercise
1300409|NCT01581190|Bananas|bananas
1300410|NCT01581190|Exercise|exercise
1300411|NCT01581190|Metabolomics|metabolomics
1300412|NCT01581190|Oxidative stress|oxidative stress
1300413|NCT01581190|Inflammation|inflammation
1300414|NCT01581190|Immune function|immune function
1300415|NCT01581177|asthma|asthma
1300416|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
1300417|NCT01581177|mild asthma|mild asthma
1300418|NCT01581177|moderate asthma|moderate asthma
1300419|NCT01581177|persistent asthma|persistent asthma
1300420|NCT01581164|blood|blood
1300421|NCT01581164|hematopoietic|hematopoietic
1300422|NCT01581164|stem|stem
1300423|NCT01581164|cell|cell
1300424|NCT01581164|transplant|transplant
1300425|NCT01581164|vaccine|vaccine
1300426|NCT01581164|vaccination|vaccination
1300427|NCT01581164|recovery|recovery
1300428|NCT01581164|immune|immune
1300429|NCT01581164|system|system
1300430|NCT01581151|retinal vein occlusion|retinal vein occlusion
1300431|NCT01581151|ozurdex|ozurdex
1300432|NCT01581151|lucentis|lucentis
1300433|NCT01581151|BCVA|bcva
1300434|NCT01581151|foveal thickness|foveal thickness
1300435|NCT01581125|Inpatients|inpatients
1300436|NCT01581125|Health Normalcy|health normalcy
1300437|NCT01581125|circadian rhythm|circadian rhythm
1300438|NCT01581099|Atherosclerosis|atherosclerosis
1300439|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
1300440|NCT01581099|Calorie restriction|calorie restriction
1300441|NCT01581099|Bariatric Surgery|bariatric surgery
1300442|NCT01581086|HIV|hiv
1300447|NCT01581073|hemoglobin|hemoglobin
1300448|NCT01581073|non-diabetes|non-diabetes
1300449|NCT01581073|CKD|ckd
1300450|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
1300451|NCT01581047|amoxicillin|amoxicillin
1300452|NCT01581047|clavulanic acid|clavulanic acid
1300453|NCT01581047|cefuroxime|cefuroxime
1300454|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
1300455|NCT01581034|endothelial function|endothelial function
1300456|NCT01581034|biomarkers|biomarkers
1300457|NCT01581034|autonomic nervous system|autonomic nervous system
1300458|NCT01581034|coronary artery disease|coronary artery disease
1300459|NCT01581021|randomized|randomized
1300460|NCT01581021|controlled|controlled
1300461|NCT01581021|hooks|hooks
1300462|NCT01581021|screws|screws
1300463|NCT01581008|palliative care|palliative care
1300464|NCT01581008|heart failure|heart failure
1300465|NCT01581008|delivery of health care|delivery of health care
1300466|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
1300469|NCT01580969|glioma|glioma
1300470|NCT01580956|Acute respiratory failure|acute respiratory failure
1300471|NCT01580956|Critical illness|critical illness
1300472|NCT01580956|Mechanical ventilation|mechanical ventilation
1300473|NCT01580956|Ventilation weaning|ventilation weaning
1300474|NCT01580956|Intensive Care Unit|intensive care unit
1300475|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
1300476|NCT01580956|PSV|psv
1300477|NCT01580943|Chlorhexidine|chlorhexidine
1300478|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
1300479|NCT01580943|Mouth rinse|mouth rinse
1300480|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
1300481|NCT01580943|Self Efficacy|self efficacy
1300482|NCT01580943|Taste Sweet|taste sweet
1300483|NCT01580943|Side Effects|side effects
1300484|NCT01580930|physical inactivity|physical inactivity
1300485|NCT01580930|exercise training|exercise training
1300486|NCT01580930|sedentary time|sedentary time
1300487|NCT01580930|habitual physical activity|habitual physical activity
1300488|NCT01580917|laser doppler anemometry|laser doppler anemometry
1300489|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
1300490|NCT01580917|diabetic foot complications|diabetic foot complications
1300491|NCT01580917|ulcer genesis|ulcer genesis
1300492|NCT01580904|Pharmaceutical Care|pharmaceutical care
1300493|NCT01580904|Diabetics patients|diabetics patients
1300494|NCT01580904|Clinical trial|clinical trial
1300495|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
1300496|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
1300497|NCT01580891|Tinea Pedis|tinea pedis
1300498|NCT01580891|Efficacy and safety|efficacy and safety
1300499|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
1300500|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
1300501|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
1300502|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
1300503|NCT01580865|Lupus nephritis|lupus nephritis
1300504|NCT01580865|Tacrolimus|tacrolimus
1300505|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
1300506|NCT01580865|Complete remission|complete remission
1300507|NCT01580839|ischemic stroke|ischemic stroke
1300508|NCT01580839|ischemic penumbra|ischemic penumbra
1300509|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
1300510|NCT01580839|MRI|mri
1300511|NCT01580839|diffusion imaging|diffusion imaging
1300512|NCT01580839|DWI|dwi
1300513|NCT01580839|perfusion imaging|perfusion imaging
1300514|NCT01580839|PWI|pwi
1300515|NCT01580839|thrombolysis|thrombolysis
1300516|NCT01580839|alteplase|alteplase
1300517|NCT01580839|tPA|tpa
1300518|NCT01580839|EPITHET|epithet
1300519|NCT01580826|pasteurization|pasteurization
1300520|NCT01580826|human milk|human milk
1300521|NCT01580826|very low birth weight infants|very low birth weight infants
1300522|NCT01580813|diabetes|diabetes
1300523|NCT01580813|exercise|exercise
1300524|NCT01580813|cardiovascular|cardiovascular
1300525|NCT01580813|heart|heart
1300526|NCT01580813|insulin sensitivity|insulin sensitivity
1300527|NCT01580787|Parkinson´s disease|parkinson´s disease
1300528|NCT01580787|Postural Balance|postural balance
1300529|NCT01580787|virtual reality|virtual reality
1300530|NCT01580735|NSCLC|nsclc
1300531|NCT01580735|c-MET|c-met
1300532|NCT01580735|EGFR mutation-positive|egfr mutation-positive
1300533|NCT01580735|gefitinib|gefitinib
1300534|NCT01580735|erlotinib|erlotinib
1300535|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
1300536|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
1300537|NCT01580709|stricture|stricture
1300538|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
1300539|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1300540|NCT01580709|bile duct|bile duct
1300541|NCT01580709|ERCP|ercp
1300542|NCT01580696|Folate binding protein|folate binding protein
1300543|NCT01580696|E39 vaccine|e39 vaccine
1300544|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
1300545|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
1300546|NCT01580683|Atrial Fibrillation|atrial fibrillation
1300547|NCT01580683|Ascorbic Acid|ascorbic acid
1300548|NCT01580683|Thoracic Surgery|thoracic surgery
1300549|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
1300550|NCT01580683|Cardiac Surgery|cardiac surgery
1300551|NCT01580683|Vitamin C|vitamin c
1300552|NCT01580683|Postoperative Complications|postoperative complications
1300553|NCT01580683|Antioxidants|antioxidants
1300554|NCT01580683|Inflammation|inflammation
1300555|NCT01580670|Infliximab|infliximab
1300556|NCT01580670|REMICADE|remicade
1300557|NCT01580670|TA-650|ta-650
1300558|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
1300559|NCT01580657|HIV|hiv
1300560|NCT01580657|Prevention|prevention
1300561|NCT01580657|Methods|methods
1300562|NCT01580657|Assessment reactivity|assessment reactivity
1300563|NCT01580657|South Africa|south africa
1300564|NCT01580657|Youth|youth
1300565|NCT01580631|Narrow band imaging|narrow band imaging
1300566|NCT01580631|Barrett's esophagus|barrett's esophagus
1300567|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
1300568|NCT01580618|pleural effusion|pleural effusion
1300569|NCT01580618|malignancy|malignancy
1300570|NCT01580618|loculated|loculated
1300571|NCT01580579|Radiation pneumonitis|radiation pneumonitis
1300572|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
1300573|NCT01580579|Respiratory function tests|respiratory function tests
1300574|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
1300575|NCT01580566|Kidney function|kidney function
1300576|NCT01580566|bio-markers|bio-markers
1300577|NCT01580553|Heart failure|heart failure
1300578|NCT01580553|L-carnitine|l-carnitine
1300579|NCT01580553|injection|injection
1300580|NCT01580553|safety|safety
1300581|NCT01580553|efficacy|efficacy
1300582|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
1300583|NCT01580527|parenteral nutrition|parenteral nutrition
1300584|NCT01580527|enteral nutrition|enteral nutrition
1300585|NCT01580527|postoperative complications|postoperative complications
1300586|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
1300587|NCT01580514|myocardial infarction|myocardial infarction
1300588|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
1300589|NCT01580514|exenatide|exenatide
1300590|NCT01580514|reperfusion injury|reperfusion injury
1300591|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
1300592|NCT01580475|glycemic control,|glycemic control,
1300593|NCT01580475|exercise training,|exercise training,
1300594|NCT01580475|detraining,|detraining,
1300595|NCT01580475|retraining,|retraining,
1300596|NCT01580475|body composition,|body composition,
1300597|NCT01580475|strength and fitness|strength and fitness
1300598|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
1300599|NCT01580462|children|children
1300600|NCT01580462|adolescent|adolescent
1300601|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
1300602|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
1300603|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
1300604|NCT01580423|dyspnea|dyspnea
1300605|NCT01580397|Pancreatic cancer|pancreatic cancer
1300606|NCT01580397|INNO-206|inno-206
1300607|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
1300608|NCT01580358|cancer|cancer
1300609|NCT01580358|radiotherapy|radiotherapy
1300610|NCT01580358|chemotherapy|chemotherapy
1300611|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
1300612|NCT01580358|Safety|safety
1300613|NCT01580345|DHA|dha
1300614|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
1300615|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
1300616|NCT01580345|Pregnancy|pregnancy
1300617|NCT01580345|Newborn outcome|newborn outcome
1300618|NCT01580345|Supplementation|supplementation
1300619|NCT01580345|Birth size|birth size
1300620|NCT01580345|gestational age|gestational age
1300621|NCT01580345|India|india
1300622|NCT01580345|Randomized controlled trial|randomized controlled trial
1300623|NCT01580345|RCT|rct
1300624|NCT01580332|biomarkers|biomarkers
1300625|NCT01580332|lung cancer|lung cancer
1300626|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
1300627|NCT01580332|SPN|spn
1300628|NCT01580332|breath analysis|breath analysis
1300629|NCT01580332|VOC|voc
1300630|NCT01580332|volatile organic compounds|volatile organic compounds
1300631|NCT01580332|sputum|sputum
1300632|NCT01580332|auto-antibodies|auto-antibodies
1300633|NCT01580319|obesity|obesity
1300634|NCT01580319|cholesterol|cholesterol
1300635|NCT01580319|cholesterol, LDL|cholesterol, ldl
1300636|NCT01580319|cholesterol, HDL|cholesterol, hdl
1300637|NCT01580319|blood glucose|blood glucose
1300935|NCT01579032|CKD,|ckd,
1300638|NCT01580319|Triglyceride|triglyceride
1300639|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
1300640|NCT01580319|blood pressure|blood pressure
1300641|NCT01580319|physical activity|physical activity
1300642|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
1300643|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
1300644|NCT01580280|Cervicogenic|cervicogenic
1300645|NCT01580280|Headache|headache
1300646|NCT01580280|Neck Pain|neck pain
1300647|NCT01580280|Manipulation|manipulation
1300648|NCT01580280|Mobilization|mobilization
1300649|NCT01580280|Exercise|exercise
1300650|NCT01580267|Anemia in trauma|anemia in trauma
1300651|NCT01580254|Latanoprost|latanoprost
1300652|NCT01580254|IOP|iop
1300653|NCT01580215|Valves|valves
1300654|NCT01580215|Endobronchial|endobronchial
1300655|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
1300656|NCT01580215|Pulmonx|pulmonx
1300657|NCT01580215|Zephyr|zephyr
1300658|NCT01580215|Chartis|chartis
1300659|NCT01580215|Emphysema|emphysema
1300660|NCT01580215|COPD|copd
1300661|NCT01580202|malignancy|malignancy
1300662|NCT01580202|hepatitis B|hepatitis b
1300663|NCT01580202|lamivudine|lamivudine
1300664|NCT01580202|entecavir|entecavir
1300665|NCT01580202|prophylaxis|prophylaxis
1300666|NCT01580189|Lean tissue|lean tissue
1300667|NCT01580189|Strength condition|strength condition
1300668|NCT01580189|Protein|protein
1300669|NCT01580189|Amino Acid|amino acid
1300670|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
1300671|NCT01580163|community|community
1300672|NCT01580150|Berries|berries
1300673|NCT01580150|Starch|starch
1300674|NCT01580150|Sucrose|sucrose
1300675|NCT01580150|Glucose|glucose
1300676|NCT01580150|Insulin|insulin
1300677|NCT01580150|Postprandial|postprandial
1300678|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
1300679|NCT01580137|common cold|common cold
1300680|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
1300681|NCT01580137|adult|adult
1300682|NCT01580137|conscript|conscript
1300683|NCT01580111|Blood|blood
1300684|NCT01580111|Storage|storage
1300685|NCT01580111|Age|age
1300686|NCT01580111|Transfusion|transfusion
1300687|NCT01580111|Lactic acidosis|lactic acidosis
1300688|NCT01580085|Sleep disordered breathing|sleep disordered breathing
1300689|NCT01580085|gender|gender
1300690|NCT01580085|hypercoagulability|hypercoagulability
1300691|NCT01580046|Chronic Kidney Disease|chronic kidney disease
1300692|NCT01580046|Coronary Angiography|coronary angiography
1300693|NCT01580046|Contrast Media|contrast media
1300694|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
1300695|NCT01580046|Serum Creatinine|serum creatinine
1300696|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
1300697|NCT01580046|Iodixanol|iodixanol
1300698|NCT01580046|Iopromide|iopromide
1300699|NCT01580033|immunogenicity|immunogenicity
1300700|NCT01580033|safety|safety
1300701|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
1300702|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
1300703|NCT01580020|Macular Degeneration|macular degeneration
1300704|NCT01580020|Macular Edema|macular edema
1300705|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
1300706|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
1300707|NCT01580020|Signs and Symptoms|signs and symptoms
1300708|NCT01580020|Retinal Degeneration|retinal degeneration
1300709|NCT01580020|Retinal Diseases|retinal diseases
1300710|NCT01580020|Eye Diseases|eye diseases
1333273|NCT01443741|Insulin pump|insulin pump
1300711|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
1300712|NCT01580020|Dexamethasone acetate|dexamethasone acetate
1300713|NCT01580020|Dexamethasone|dexamethasone
1300714|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
1300715|NCT01580020|BB 1101|bb 1101
1300716|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
1300717|NCT01580020|Therapeutic Uses|therapeutic uses
1300718|NCT01580020|Vision, Low|vision, low
1300719|NCT01580020|Signs|signs
1300720|NCT01580020|Vision Disorders|vision disorders
1300721|NCT01580007|tuberculosis|tuberculosis
1300722|NCT01580007|phenylbutyrate|phenylbutyrate
1300723|NCT01580007|vitamin D|vitamin d
1300724|NCT01580007|cathelicidin|cathelicidin
1300725|NCT01580007|antimicrobial peptide|antimicrobial peptide
1300726|NCT01580007|in adults|in adults
1300727|NCT01579994|adenocarcinoma|adenocarcinoma
1300728|NCT01579994|Lung|lung
1300729|NCT01579994|Metastatic|metastatic
1300730|NCT01579994|Crizotinib|crizotinib
1300731|NCT01579994|Ganetespib|ganetespib
1300732|NCT01579994|STA-9090|sta-9090
1300733|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
1300734|NCT01579994|12-015|12-015
1300735|NCT01579981|RYGB|rygb
1300736|NCT01579981|Bariatric Surgery|bariatric surgery
1300737|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
1300738|NCT01579942|EEG|eeg
1300739|NCT01579942|Biomarker|biomarker
1300740|NCT01579942|Major Depressive Disorder|major depressive disorder
1300741|NCT01579942|Healthy Control|healthy control
1300742|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
1300743|NCT01579929|CISPLATIN|cisplatin
1300744|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
1300745|NCT01579929|LDE-225|lde-225
1300746|NCT01579929|STAR|star
1301038|NCT01578525|elderly|elderly
1300747|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
1300748|NCT01579929|11-206|11-206
1300749|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
1300750|NCT01579903|Hemophilia A|hemophilia a
1300751|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
1300752|NCT01579903|ReFacto AF|refacto af
1300753|NCT01579903|dual-chamber syringe|dual-chamber syringe
1300754|NCT01579903|bioavailability|bioavailability
1300755|NCT01579877|Xerostomia|xerostomia
1300756|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
1300757|NCT01579877|Yin-Deficiency|yin-deficiency
1300758|NCT01579877|Visual analogue scale|visual analogue scale
1300759|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
1300760|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
1300761|NCT01579786|post operative pain|post operative pain
1300762|NCT01579786|acupuncture|acupuncture
1300763|NCT01579760|radiation|radiation
1300764|NCT01579760|retinopathy|retinopathy
1300765|NCT01579760|macular edema|macular edema
1300766|NCT01579760|anti-VEGF|anti-vegf
1300767|NCT01579760|VEGF-Trap|vegf-trap
1300768|NCT01579760|aflibercept|aflibercept
1300769|NCT01579747|nerve stimulation|nerve stimulation
1300770|NCT01579747|ultrasound|ultrasound
1300771|NCT01579747|sciatic nerve block|sciatic nerve block
1300772|NCT01579747|popliteal block|popliteal block
1300773|NCT01579747|obese|obese
1300774|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
1300775|NCT01579708|Diet|diet
1300776|NCT01579708|Physical activity|physical activity
1300777|NCT01579708|Knowledge|knowledge
1300778|NCT01579708|Attitudes|attitudes
1300779|NCT01579708|Habits|habits
1300780|NCT01579708|Lifestyle|lifestyle
1300781|NCT01579708|School-based|school-based
1300782|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
1300783|NCT01579682|Eating Disorder|eating disorder
1300784|NCT01579682|Anorexia Nervosa|anorexia nervosa
1300785|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
1300786|NCT01579682|Maudsley|maudsley
1300787|NCT01579682|Family-Based Therapy|family-based therapy
1300788|NCT01579682|FBT|fbt
1300789|NCT01579682|Family Therapy|family therapy
1300790|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
1300791|NCT01579669|Primary Care Services|primary care services
1300792|NCT01579669|Patient-Provider Communication|patient-provider communication
1300793|NCT01579669|Adults|adults
1300794|NCT01579643|cornea|cornea
1300795|NCT01579643|opacity|opacity
1300796|NCT01579643|congenital|congenital
1300797|NCT01579630|NSCLC|nsclc
1300798|NCT01579630|Nonsquamous|nonsquamous
1300799|NCT01579630|Maintenance therapy|maintenance therapy
1300800|NCT01579617|pregnancy|pregnancy
1300801|NCT01579617|STI|sti
1300802|NCT01579617|STD|std
1300803|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
1300804|NCT01579604|Nerve transfer|nerve transfer
1300805|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
1300806|NCT01579565|cataract|cataract
1300807|NCT01579565|lens replacement|lens replacement
1300808|NCT01579552|Questionnaires|questionnaires
1300809|NCT01579552|telephone counseling session|telephone counseling session
1300810|NCT01579552|10-104|10-104
1300811|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
1300812|NCT01579539|Methylprednisolone|methylprednisolone
1300813|NCT01579539|Dry Eye Syndrome|dry eye syndrome
1300814|NCT01579539|Tear Film|tear film
1300815|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1300816|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
1300817|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1300818|NCT01579513|System Inflammatory Response|system inflammatory response
1300819|NCT01579513|inflammation|inflammation
1300820|NCT01579513|Methylprednisolone|methylprednisolone
1300821|NCT01579513|Neonates|neonates
1300822|NCT01579513|Steroid|steroid
1300823|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
1300824|NCT01579513|Children|children
1300825|NCT01579513|Infants|infants
1300826|NCT01579513|Pediatrics|pediatrics
1300827|NCT01579513|Glucocorticoid|glucocorticoid
1300828|NCT01579513|Heart Disease|heart disease
1300829|NCT01579513|Heart Defects, Congenital|heart defects, congenital
1300830|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
1300831|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
1300832|NCT01579513|Corticosteroid|corticosteroid
1300833|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
1300834|NCT01579513|Hormones|hormones
1300835|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
1300836|NCT01579513|Randomized Clinical Trial|randomized clinical trial
1300837|NCT01579487|Lipolysis|lipolysis
1300838|NCT01579487|Cryolipolysis|cryolipolysis
1300839|NCT01579487|Fat Reduction|fat reduction
1300840|NCT01579461|Pharmacokinetics|pharmacokinetics
1300841|NCT01579461|mirabegron|mirabegron
1300842|NCT01579461|hepatic impairment|hepatic impairment
1300843|NCT01579461|Phase 1|phase 1
1300844|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
1300845|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
1300846|NCT01579448|safety and immunogenicity|safety and immunogenicity
1300847|NCT01579435|essential tremor|essential tremor
1300848|NCT01579435|primary motor cortex|primary motor cortex
1300849|NCT01579435|cerebellum|cerebellum
1300850|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
1300851|NCT01579435|electrophysiology|electrophysiology
1300852|NCT01579422|schizophrenia|schizophrenia
1300853|NCT01579422|treatment|treatment
1300854|NCT01579422|social cognition|social cognition
1300855|NCT01579409|Nutrition|nutrition
1300856|NCT01579409|Arterial stiffness|arterial stiffness
1300857|NCT01579409|Endothelial dysfunction|endothelial dysfunction
1300858|NCT01579409|Microcirculation|microcirculation
1300859|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
1300860|NCT01579396|septeX|septex
1300861|NCT01579396|high cut-off|high cut-off
1300862|NCT01579396|Thoracic Surgery|thoracic surgery
1300863|NCT01579396|Renal Replacement Therapy|renal replacement therapy
1300864|NCT01579383|Migraine Disorders|migraine disorders
1300865|NCT01579383|Phase 1|phase 1
1300866|NCT01579383|ALD403|ald403
1300867|NCT01579370|healthcare associated infections|healthcare associated infections
1300868|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
1300869|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
1300870|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
1300871|NCT01579370|clostridium difficile|clostridium difficile
1300872|NCT01579370|acinetobacter|acinetobacter
1300873|NCT01579357|colorectal carcinoma|colorectal carcinoma
1300874|NCT01579357|K-ras wild type|k-ras wild type
1300875|NCT01579357|Capecitabine|capecitabine
1300876|NCT01579357|Cetuximab|cetuximab
1300877|NCT01579357|Oxaliplatin|oxaliplatin
1300878|NCT01579357|Pharmacokinetics|pharmacokinetics
1300879|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
1300880|NCT01579357|plasma disposition|plasma disposition
1300881|NCT01579357|metabolic activation|metabolic activation
1300882|NCT01579357|CCB|ccb
1300883|NCT01579357|OxPt|oxpt
1300884|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
1300885|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
1300886|NCT01579344|radiation effects|radiation effects
1300887|NCT01579331|IOP|iop
1300888|NCT01579331|Tonometry|tonometry
1300889|NCT01579331|Pascal|pascal
1300890|NCT01579331|Goldmann|goldmann
1300891|NCT01579331|DCT|dct
1300892|NCT01579331|Dynamic Contour|dynamic contour
1300893|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
1300894|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
1300895|NCT01579266|Writer's Cramp|writer's cramp
1300896|NCT01579266|Focal Hand Dystonia|focal hand dystonia
1300897|NCT01579266|Writer Cramp|writer cramp
1300898|NCT01579266|Dystonia|dystonia
1300899|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
1300900|NCT01579253|Radiotherapy|radiotherapy
1300901|NCT01579253|PET-MRI|pet-mri
1300902|NCT01579253|FET-PET|fet-pet
1300903|NCT01579240|physical activity|physical activity
1300904|NCT01579240|older adults|older adults
1300905|NCT01579240|Internet|internet
1300906|NCT01579240|sedentary|sedentary
1300907|NCT01579240|multi-week|multi-week
1300908|NCT01579240|internet intervention|internet intervention
1300909|NCT01579227|Healthy participants|healthy participants
1300911|NCT01579214|Africa south of the sahara|africa south of the sahara
1300912|NCT01579214|Knowledge of results|knowledge of results
1300913|NCT01579214|Communication barriers|communication barriers
1300914|NCT01579214|Cellular Phones|cellular phones
1300915|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
1300916|NCT01579201|Uterine Atony|uterine atony
1300917|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
1300918|NCT01579201|Cesarean Section|cesarean section
1300919|NCT01579201|Carbetocin|carbetocin
1300920|NCT01579188|NSCLC|nsclc
1300921|NCT01579162|Hepatitis|hepatitis
1300922|NCT01579162|Fatty Liver|fatty liver
1300923|NCT01579123|Laser atherectomy|laser atherectomy
1300924|NCT01579123|Critical Limb Ischemia|critical limb ischemia
1300925|NCT01579123|Angioplasty|angioplasty
1300926|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
1300927|NCT01579110|hemolytic anemia|hemolytic anemia
1300928|NCT01579110|Levamisole|levamisole
1300929|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
1300930|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
1300931|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
1300932|NCT01579097|oral/enteral not possible|oral/enteral not possible
1300933|NCT01579058|aortic stenosis|aortic stenosis
1300934|NCT01579058|beta-blocker|beta-blocker
1300936|NCT01578980|Artificial Pancreas|artificial pancreas
1300937|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1300938|NCT01578980|Control-to-Range|control-to-range
1300939|NCT01578980|Closed-Loop Control|closed-loop control
1300940|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
1300941|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
1300942|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
1300943|NCT01578954|Leukemia|leukemia
1300944|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
1300945|NCT01578941|menstrual migraine|menstrual migraine
1300946|NCT01578941|migraine|migraine
1300947|NCT01578941|treximet|treximet
1300948|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
1300949|NCT01578928|renal|renal
1300950|NCT01578928|impairment|impairment
1300951|NCT01578928|endstage renal disease|endstage renal disease
1300952|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
1300953|NCT01578902|Radiotherapy|radiotherapy
1300954|NCT01578902|Hypofractionation|hypofractionation
1300955|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
1300956|NCT01578876|coronary artery disease|coronary artery disease
1300957|NCT01578876|angina pectoris|angina pectoris
1300958|NCT01578876|myocardial ischemia|myocardial ischemia
1300959|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
1300960|NCT01578863|Childhood obesity|childhood obesity
1300961|NCT01578863|Adolescence|adolescence
1300962|NCT01578863|Predictors|predictors
1300963|NCT01578863|Success|success
1300964|NCT01578863|Intervention program|intervention program
1300965|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
1300966|NCT01578850|etanercept|etanercept
1300967|NCT01578850|methotrexate|methotrexate
1300968|NCT01578850|DMARDs|dmards
1300969|NCT01578824|Rickets|rickets
1300970|NCT01578824|Vitamin D|vitamin d
1300971|NCT01578824|airway hyperreactivity|airway hyperreactivity
1300972|NCT01578824|Exhaled breath condensate|exhaled breath condensate
1300973|NCT01578772|HIV|hiv
1300974|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
1300975|NCT01578772|Telmisartan|telmisartan
1300976|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
1300977|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
1300978|NCT01578759|ovarian function tests|ovarian function tests
1300979|NCT01578746|Coxarthrosis|coxarthrosis
1300980|NCT01578746|Hip arthroplasty|hip arthroplasty
1300981|NCT01578746|Anterior approach|anterior approach
1300982|NCT01578746|Direct lateral approach|direct lateral approach
1300983|NCT01578746|Hardinge approach|hardinge approach
1300984|NCT01578746|Smith-Petersen approach|smith-petersen approach
1300985|NCT01578746|Osteoarthrosis|osteoarthrosis
1300986|NCT01578733|protein requirement|protein requirement
1300987|NCT01578733|female elderly|female elderly
1300988|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
1300989|NCT01578707|Chronic|chronic
1300990|NCT01578707|SLL|sll
1300991|NCT01578707|CLL|cll
1300992|NCT01578707|Ofatumumab|ofatumumab
1300993|NCT01578707|ibrutinib|ibrutinib
1300994|NCT01578707|RESONATE|resonate
1300995|NCT01578707|Phase III|phase iii
1300996|NCT01578707|Leukemia|leukemia
1300997|NCT01578707|Lymphoma|lymphoma
1300998|NCT01578681|bronchiectasis|bronchiectasis
1300999|NCT01578681|respiratory therapy|respiratory therapy
1301000|NCT01578681|airway clearance|airway clearance
1301001|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
1301002|NCT01578668|brain metastases|brain metastases
1301003|NCT01578668|erlotinib|erlotinib
1301004|NCT01578668|pemetrexed|pemetrexed
1301005|NCT01578655|custirsen sodium|custirsen sodium
1301006|NCT01578655|prostate cancer|prostate cancer
1301007|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
1301008|NCT01578655|overall survival|overall survival
1301009|NCT01578642|GERD|gerd
1301010|NCT01578642|LES Pressure|les pressure
1301011|NCT01578642|Electrical Stimulation|electrical stimulation
1301012|NCT01578629|stroke|stroke
1301013|NCT01578629|ischemia|ischemia
1301014|NCT01578629|TIA|tia
1301015|NCT01578616|Coronary artery disease|coronary artery disease
1301016|NCT01578616|Endothelial function|endothelial function
1301017|NCT01578616|Optical coherence tomography|optical coherence tomography
1301018|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
1301019|NCT01578603|prevention & control|prevention & control
1301020|NCT01578603|Xylitol|xylitol
1301021|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
1301022|NCT01578603|Streptococcus mutans|streptococcus mutans
1301023|NCT01578603|saliva|saliva
1301024|NCT01578603|dental plaque|dental plaque
1301025|NCT01578603|gingivitis|gingivitis
1301026|NCT01578577|Medication Therapy Management|medication therapy management
1301027|NCT01578577|Hypertension|hypertension
1301028|NCT01578577|Health Literacy|health literacy
1301029|NCT01578577|Medication Reconciliation|medication reconciliation
1301030|NCT01578577|Medication Adherence|medication adherence
1301031|NCT01578564|Cancer|cancer
1301032|NCT01578564|Ovarian Cancer|ovarian cancer
1301033|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
1301133|NCT01578148|Neckache|neckache
1301034|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1301035|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
1301036|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
1301037|NCT01578525|medication safety|medication safety
1301039|NCT01578525|pharmaceutical care|pharmaceutical care
1301040|NCT01578525|hospital readmission|hospital readmission
1301041|NCT01578525|drug-related readmission|drug-related readmission
1301042|NCT01578525|Health Services for the Aged|health services for the aged
1301043|NCT01578499|brentuximab vedotin|brentuximab vedotin
1301044|NCT01578499|ALCANZA|alcanza
1301045|NCT01578486|Schizophrenia|schizophrenia
1301046|NCT01578486|Cognition|cognition
1301047|NCT01578486|Metabolism|metabolism
1301048|NCT01578486|Antipsychotics|antipsychotics
1301049|NCT01578486|Psychopathology|psychopathology
1301050|NCT01578473|low testosterone|low testosterone
1301051|NCT01578473|penile curvature|penile curvature
1301052|NCT01578460|Pregnancy|pregnancy
1301053|NCT01578460|Gestational Diabetes|gestational diabetes
1301054|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1301055|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
1301056|NCT01578460|Glucose|glucose
1301057|NCT01578447|injectable contraception|injectable contraception
1301058|NCT01578447|acceptability|acceptability
1301059|NCT01578447|intramuscular|intramuscular
1301060|NCT01578447|subcutaneous|subcutaneous
1301061|NCT01578434|Nutritional Rickets|nutritional rickets
1301062|NCT01578434|Calcium|calcium
1301063|NCT01578434|Vitamin D|vitamin d
1301064|NCT01578408|Femoral neck fractures|femoral neck fractures
1301065|NCT01578408|Uncemented|uncemented
1301066|NCT01578408|Hydroxyapatite|hydroxyapatite
1301067|NCT01578408|Coated|coated
1301068|NCT01578408|Femoral|femoral
1301069|NCT01578408|Stems|stems
1301070|NCT01578408|Hip fractures|hip fractures
1301071|NCT01578408|THA|tha
1301072|NCT01578408|THR|thr
1301073|NCT01578408|Cemented|cemented
1301074|NCT01578408|Fat embolism|fat embolism
1301075|NCT01578408|Cognition|cognition
1301076|NCT01578408|Inflammatory response|inflammatory response
1301077|NCT01578408|Mobilization|mobilization
1301078|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
1301079|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
1301080|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
1301081|NCT01578382|Hypertension|hypertension
1301082|NCT01578382|Diabetes|diabetes
1301083|NCT01578382|Medial calcinosis|medial calcinosis
1301084|NCT01578382|Wound healing|wound healing
1301085|NCT01578369|Urinary incontinence|urinary incontinence
1301086|NCT01578369|Pregnancy|pregnancy
1301087|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
1301088|NCT01578356|Prostate cancer|prostate cancer
1301089|NCT01578343|fludarabine|fludarabine
1301090|NCT01578343|mitoxantrone|mitoxantrone
1301091|NCT01578343|dexamethasone|dexamethasone
1301092|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
1301093|NCT01578343|FND regimen|fnd regimen
1301094|NCT01578343|vorinostat|vorinostat
1301095|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
1333274|NCT01443741|Pediatric|pediatric
1301096|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1301097|NCT01578330|Fingolimod|fingolimod
1301098|NCT01578330|FTY720|fty720
1301099|NCT01578317|H5N1 Vaccine|h5n1 vaccine
1301100|NCT01578317|H5N1 Immunization|h5n1 immunization
1301101|NCT01578317|AS03 Adjuvant|as03 adjuvant
1301102|NCT01578317|Biologic Sample Collection|biologic sample collection
1301103|NCT01578317|Laboratory Research Specimens|laboratory research specimens
1301104|NCT01578317|Healthy Volunteer|healthy volunteer
1301105|NCT01578317|HV|hv
1301106|NCT01578304|Overactive bladder|overactive bladder
1301107|NCT01578291|Play therapy|play therapy
1301108|NCT01578291|Urinary tract infections|urinary tract infections
1301109|NCT01578291|Children|children
1301110|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
1301111|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
1301112|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
1301113|NCT01578226|Cirrhosis|cirrhosis
1301114|NCT01578226|Ascites|ascites
1301115|NCT01578226|Decompensation|decompensation
1301116|NCT01578226|Bacterial infection|bacterial infection
1301117|NCT01578226|Sepsis|sepsis
1301118|NCT01578226|Procalcitonin|procalcitonin
1301119|NCT01578226|PCT|pct
1301120|NCT01578200|CKD-MBD|ckd-mbd
1301121|NCT01578200|phosphate-binder|phosphate-binder
1301122|NCT01578200|vascular calcification|vascular calcification
1301123|NCT01578200|mortality|mortality
1301124|NCT01578200|dialysis|dialysis
1301125|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
1301126|NCT01578187|hair reduction|hair reduction
1301127|NCT01578187|hair removal|hair removal
1301128|NCT01578187|hair clearance|hair clearance
1301129|NCT01578148|Cervical pain|cervical pain
1301130|NCT01578148|Cervicalgia,|cervicalgia,
1301131|NCT01578148|Cervicodynia|cervicodynia
1301132|NCT01578148|Neck ache|neck ache
1301134|NCT01578148|Shoulder pain|shoulder pain
1301135|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
1301136|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
1301137|NCT01578122|prevention|prevention
1301138|NCT01578122|deep vein thrombosis|deep vein thrombosis
1301139|NCT01578122|elastic compression stockings|elastic compression stockings
1301140|NCT01578122|compliance|compliance
1301141|NCT01578122|quality of life|quality of life
1301142|NCT01578096|Type 2 Diabetes|type 2 diabetes
1301143|NCT01578083|Chemotherapy|chemotherapy
1301144|NCT01578083|Breast Cancer|breast cancer
1301145|NCT01578083|Cognitive Impairment|cognitive impairment
1301146|NCT01578083|Chemo brain|chemo brain
1301147|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
1301148|NCT01578057|alcohol|alcohol
1301149|NCT01578044|Anti-coagulation|anti-coagulation
1301150|NCT01578031|Sleep Apnea|sleep apnea
1301151|NCT01578031|Obesity|obesity
1301152|NCT01578018|lung cancer|lung cancer
1301153|NCT01578018|smoking|smoking
1301154|NCT01578005|acute coronary syndrome|acute coronary syndrome
1301155|NCT01578005|IVUS|ivus
1301156|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
1301157|NCT01577992|subjective pain|subjective pain
1301158|NCT01577992|Multiple System Atrophy|multiple system atrophy
1301159|NCT01577979|Vaccination|vaccination
1301160|NCT01577979|Medical Home|medical home
1301161|NCT01577979|Adolescents|adolescents
1301162|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
1301163|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
1301164|NCT01577953|Asthma|asthma
1301165|NCT01577953|Patients with asthma|patients with asthma
1301166|NCT01577953|Phase 1b|phase 1b
1301167|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
1301168|NCT01577953|Oral inhalation|oral inhalation
1301169|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
1301170|NCT01577940|postoperative pain|postoperative pain
1301171|NCT01577940|Postoperative pain management|postoperative pain management
1301172|NCT01577927|weaning|weaning
1301173|NCT01577927|severe chronic diseases|severe chronic diseases
1301174|NCT01577927|UTIR|utir
1301175|NCT01577901|Pregnancy|pregnancy
1301176|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
1301177|NCT01577862|COLISTIN|colistin
1301178|NCT01577862|RIFAMPICIN|rifampicin
1301179|NCT01577862|THERAPY|therapy
1301180|NCT01577862|RESISTANCE|resistance
1301181|NCT01577836|Radical prostatectomie|radical prostatectomie
1301182|NCT01577836|Robotic assistance|robotic assistance
1301183|NCT01577836|Laparotomy|laparotomy
1301184|NCT01577810|NIRS|nirs
1301185|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
1301186|NCT01577810|heart failure|heart failure
1301187|NCT01577810|cardiac output|cardiac output
1301188|NCT01577810|outpatient|outpatient
1301189|NCT01577810|pediatric|pediatric
1301190|NCT01577797|Methamphetamine|methamphetamine
1301191|NCT01577797|Drug Abuse|drug abuse
1301192|NCT01577797|Substance Abuse|substance abuse
1301193|NCT01577797|Amphetamine|amphetamine
1301194|NCT01577797|Dependence|dependence
1301195|NCT01577797|Addiction|addiction
1301196|NCT01577797|Craving|craving
1301197|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
1301198|NCT01577797|Text Messaging|text messaging
1301199|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
1301200|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
1301201|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
1301202|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1301203|NCT01577771|Immunogenicity|immunogenicity
1301204|NCT01577771|Reactogenicity|reactogenicity
1301205|NCT01577758|Phase 1,|phase 1,
1301206|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
1301207|NCT01577758|MLN0264,|mln0264,
1301208|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
1301209|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
1301210|NCT01577745|Cancer|cancer
1301211|NCT01577732|booster|booster
1301212|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
1301213|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
1301214|NCT01577732|Vietnamese toddlers|vietnamese toddlers
1301215|NCT01577719|Cardiovascular|cardiovascular
1301216|NCT01577719|Prevention|prevention
1301217|NCT01577719|Ethnicity|ethnicity
1301218|NCT01577719|Culture|culture
1301219|NCT01577719|Internet|internet
1301220|NCT01577719|Text Message|text message
1301221|NCT01577706|GABA|gaba
1301222|NCT01577706|glutamate|glutamate
1301223|NCT01577706|glutamine|glutamine
1301224|NCT01577706|spectroscopy|spectroscopy
1301225|NCT01577706|brain|brain
1301226|NCT01577706|imaging|imaging
1301227|NCT01577706|alprazolam|alprazolam
1301228|NCT01577706|dextroamphetamine|dextroamphetamine
1301229|NCT01577706|placebo|placebo
1301230|NCT01577693|dutasteride|dutasteride
1301231|NCT01577693|cross over study|cross over study
1301232|NCT01577693|bioavailability|bioavailability
1301233|NCT01577680|healthy subjects|healthy subjects
1301234|NCT01577680|pharmacokinetics|pharmacokinetics
1301235|NCT01577680|vilanterol|vilanterol
1301236|NCT01577680|tolerability|tolerability
1301237|NCT01577680|safety|safety
1301238|NCT01577680|hepatic impairment|hepatic impairment
1301239|NCT01577680|GW642444|gw642444
1301240|NCT01577680|GSK573719|gsk573719
1301241|NCT01577667|automation|automation
1301242|NCT01577667|closed loop|closed loop
1301243|NCT01577667|oxygenation|oxygenation
1301244|NCT01577667|ventilation|ventilation
1301245|NCT01577654|adenocarcinoma|adenocarcinoma
1301246|NCT01577654|squamous|squamous
1301247|NCT01577654|adenosquamous|adenosquamous
1301248|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
1301249|NCT01577654|EC145|ec145
1301250|NCT01577654|EC20|ec20
1301251|NCT01577654|Vintafolide|vintafolide
1301252|NCT01577654|Etarfolatide|etarfolatide
1301253|NCT01577628|Dermatitis|dermatitis
1301254|NCT01577628|Eczema|eczema
1301255|NCT01577628|Skin diseases|skin diseases
1301256|NCT01577628|Skin barrier|skin barrier
1301257|NCT01577628|Prevention|prevention
1301258|NCT01577628|Infant|infant
1301259|NCT01577628|Moisturizer|moisturizer
1301260|NCT01577628|Emollient|emollient
1301261|NCT01577628|Asthma|asthma
1301262|NCT01577628|Food allergy|food allergy
1301263|NCT01577628|Allergic rhinitis|allergic rhinitis
1301264|NCT01577615|Preterm Infant|preterm infant
1301265|NCT01577615|Neurobehavioral|neurobehavioral
1301266|NCT01577615|Development|development
1301267|NCT01577602|Medication reconciliation|medication reconciliation
1301268|NCT01577602|Self report|self report
1301269|NCT01577602|Electronic medical record medication list|electronic medical record medication list
1301270|NCT01577589|Phase 1|phase 1
1301271|NCT01577589|healthy volunteers|healthy volunteers
1301272|NCT01577589|cross-over study|cross-over study
1301273|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
1301274|NCT01577589|various infusion volumes|various infusion volumes
1301275|NCT01577589|local tolerability|local tolerability
1301276|NCT01577589|Cmax|cmax
1301277|NCT01577589|tmax|tmax
1301279|NCT01577576|Athletes|athletes
1301280|NCT01577576|Sedentary volunteers|sedentary volunteers
1301281|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
1301282|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1301283|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
1301284|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
1301285|NCT01577563|NSAIDs|nsaids
1301286|NCT01577550|ABBV-066|abbv-066
1301287|NCT01577550|BI 655066|bi 655066
1301288|NCT01577550|risankizumab|risankizumab
1301289|NCT01577537|SPL7013|spl7013
1301290|NCT01577537|VivaGel|vivagel
1301291|NCT01577537|bacterial vaginosis|bacterial vaginosis
1301293|NCT01577511|invasive potential|invasive potential
1301294|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
1301295|NCT01577498|Skeletal age|skeletal age
1301296|NCT01577498|Chronological age|chronological age
1301297|NCT01577498|Adolescent|adolescent
1301298|NCT01577472|female infertility|female infertility
1301299|NCT01577472|poor ovarian response|poor ovarian response
1301300|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1301302|NCT01577472|Antagonist protocol|antagonist protocol
1301303|NCT01577446|CRT|crt
1301304|NCT01577446|heart failure|heart failure
1301305|NCT01577446|narrow QRS|narrow qrs
1301306|NCT01577446|dyssynchrony|dyssynchrony
1301307|NCT01577433|HeartMate II|heartmate ii
1301308|NCT01577433|heart-assist device|heart-assist device
1301309|NCT01577433|left ventricular assist device|left ventricular assist device
1301310|NCT01577433|driveline infection|driveline infection
1301311|NCT01577433|LVAD|lvad
1301312|NCT01577433|HMII LVAS driveline|hmii lvas driveline
1301313|NCT01577433|silicone portion|silicone portion
1301314|NCT01577433|Thoratec Corporation|thoratec corporation
1301315|NCT01577420|Reflexology|reflexology
1301316|NCT01577420|Breast Cancer|breast cancer
1301317|NCT01577420|Complementary|complementary
1301318|NCT01577407|Dyspnea|dyspnea
1301319|NCT01577407|Pain|pain
1301320|NCT01577394|Alzheimer disease|alzheimer disease
1301321|NCT01577394|Lewy Body Disease|lewy body disease
1301322|NCT01577394|Cognitive Disorders|cognitive disorders
1301323|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
1301324|NCT01577394|Differential diagnosis|differential diagnosis
1301325|NCT01577394|Eye movement|eye movement
1301326|NCT01577381|Phase 2|phase 2
1301327|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
1301328|NCT01577381|Geographic Atrophy|geographic atrophy
1301329|NCT01577381|RN6G|rn6g
1301330|NCT01577368|Pseudomonas|pseudomonas
1301331|NCT01577368|Piperacillin|piperacillin
1301332|NCT01577368|Beta-lactams|beta-lactams
1301333|NCT01577368|Continuous infusion|continuous infusion
1301334|NCT01577368|Intermittent infusion|intermittent infusion
1301335|NCT01577368|Pharmacokinetics|pharmacokinetics
1301336|NCT01577329|meditation|meditation
1301337|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1301338|NCT01577329|Mindfulness|mindfulness
1301339|NCT01577329|Anxiety|anxiety
1301437|NCT01576809|Paracetamol|paracetamol
1301340|NCT01577329|Breathing Patterns|breathing patterns
1301341|NCT01577316|vaccination|vaccination
1301342|NCT01577316|Influenza|influenza
1301343|NCT01577316|Immunogenicity|immunogenicity
1301344|NCT01577316|Safety|safety
1301345|NCT01577303|social phobia|social phobia
1301346|NCT01577303|social anxiety|social anxiety
1301347|NCT01577303|cognitive bias modification|cognitive bias modification
1301348|NCT01577290|Anxiety|anxiety
1301349|NCT01577290|Depression|depression
1301350|NCT01577290|Insomnia|insomnia
1301351|NCT01577290|Mindfulness|mindfulness
1301352|NCT01577290|Internet|internet
1301353|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
1301354|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
1301355|NCT01577277|Learning|learning
1301356|NCT01577277|Attention|attention
1301357|NCT01577277|Nutritional Status|nutritional status
1301358|NCT01577277|Nutrition Assessments|nutrition assessments
1301359|NCT01577277|Body Weight|body weight
1301360|NCT01577277|Physical Activity|physical activity
1301361|NCT01577277|Sleep|sleep
1301362|NCT01577277|Child Nutrition Sciences|child nutrition sciences
1301363|NCT01577264|Certolizumab Pegol|certolizumab pegol
1301364|NCT01577264|Cimzia|cimzia
1301365|NCT01577238|SPL7013|spl7013
1301366|NCT01577238|VivaGel|vivagel
1301367|NCT01577238|bacterial vaginosis|bacterial vaginosis
1301368|NCT01577238|BV|bv
1301369|NCT01577225|Clean surgery|clean surgery
1301370|NCT01577212|stage III NSCLC|stage iii nsclc
1301371|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
1301372|NCT01577212|individualized dose-escalation|individualized dose-escalation
1301373|NCT01577199|IVF|ivf
1301374|NCT01577199|poor responder|poor responder
1301375|NCT01577199|low ovarian reserve|low ovarian reserve
1301376|NCT01577199|ART|art
1301377|NCT01577199|ovarian stimulation|ovarian stimulation
1301378|NCT01577199|IVF protocols|ivf protocols
1301379|NCT01577186|Schizophrenia|schizophrenia
1301380|NCT01577186|Paliperidone Extended Release|paliperidone extended release
1301381|NCT01577160|Schizophrenia|schizophrenia
1301382|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
1301383|NCT01577147|pregnancy|pregnancy
1301384|NCT01577134|multimorbidity|multimorbidity
1301385|NCT01577134|autonomy|autonomy
1301386|NCT01577134|older adults|older adults
1301387|NCT01577134|physical activity|physical activity
1301388|NCT01577134|intervention|intervention
1301389|NCT01577134|behavior change|behavior change
1301390|NCT01577121|Preterm labor|preterm labor
1301391|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
1301392|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
1301393|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
1301394|NCT01577095|electroacupuncture|electroacupuncture
1301395|NCT01577095|rosiglitazone|rosiglitazone
1301396|NCT01577095|plasma glucose|plasma glucose
1301397|NCT01577095|insulin resistance|insulin resistance
1301398|NCT01577095|free fatty acid|free fatty acid
1333275|NCT01443728|sickle cell disease|sickle cell disease
1301399|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
1301400|NCT01577069|Hepatitis C|hepatitis c
1301401|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
1301402|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
1301403|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
1301404|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
1301405|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
1301406|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
1301407|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
1301408|NCT01577056|Fish oil treatment|fish oil treatment
1301409|NCT01577056|Cardiovascular disease|cardiovascular disease
1301410|NCT01577043|acute diarrhea|acute diarrhea
1301411|NCT01577043|Racecadotril|racecadotril
1301412|NCT01577043|children|children
1301413|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
1301414|NCT01576978|LUMBAR BACK pain|lumbar back pain
1301415|NCT01576978|PELVIC PAIN|pelvic pain
1301416|NCT01576978|PREGNANCY|pregnancy
1301417|NCT01576978|HATHA YOGA|hatha yoga
1301418|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
1301419|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
1301420|NCT01576926|Deglutition Disorders|deglutition disorders
1301421|NCT01576913|exercise testing|exercise testing
1301422|NCT01576913|music|music
1301423|NCT01576913|VO2 max|vo2 max
1301424|NCT01576900|behavior therapy|behavior therapy
1301425|NCT01576900|nocturia|nocturia
1301426|NCT01576900|polyuria|polyuria
1301427|NCT01576874|nicotine dependence|nicotine dependence
1301428|NCT01576874|hormones|hormones
1301429|NCT01576848|muscle metabolism|muscle metabolism
1301430|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
1301431|NCT01576848|protein synthesis|protein synthesis
1301432|NCT01576848|insulin|insulin
1301433|NCT01576848|perfusion|perfusion
1301434|NCT01576835|Non-contrast|non-contrast
1301435|NCT01576822|Detoxification|detoxification
1301436|NCT01576822|Sauna|sauna
1301438|NCT01576809|acetaminophen|acetaminophen
1301439|NCT01576809|phenylephrine|phenylephrine
1301440|NCT01576809|guaifenesin|guaifenesin
1301441|NCT01576809|syrup|syrup
1301442|NCT01576809|URTI|urti
1301443|NCT01576809|productive cough|productive cough
1301444|NCT01576796|Radiotherapy|radiotherapy
1301445|NCT01576796|Fmiso|fmiso
1301446|NCT01576796|FDG PETSCAN|fdg petscan
1301447|NCT01576796|FMISO PETSCAN|fmiso petscan
1301448|NCT01576796|complement dose|complement dose
1301449|NCT01576796|lung cancer|lung cancer
1301450|NCT01576796|NSCLC|nsclc
1301451|NCT01576796|hypoxic lesion|hypoxic lesion
1301452|NCT01576770|propofol|propofol
1301453|NCT01576770|Pain|pain
1301454|NCT01576770|Synera Patch|synera patch
1301455|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
1301456|NCT01576757|Stem cell therapy|stem cell therapy
1301457|NCT01576744|HE4|he4
1301458|NCT01576744|IVF|ivf
1301459|NCT01576744|Biomarker|biomarker
1301460|NCT01576744|Ovarian cancer|ovarian cancer
1301461|NCT01576744|Infertility|infertility
1301462|NCT01576731|HIV Infection|hiv infection
1301463|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
1301464|NCT01576718|Dose ranging|dose ranging
1301465|NCT01576718|Fluticasone Propionate|fluticasone propionate
1301466|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
1301467|NCT01576718|High Dose ICS|high dose ics
1301468|NCT01576718|Asthma|asthma
1301469|NCT01576705|Down syndrome|down syndrome
1301470|NCT01576705|Young children|young children
1301471|NCT01576705|Psychomotor development|psychomotor development
1301472|NCT01576705|Thyroid hormone|thyroid hormone
1301473|NCT01576705|Folinic acid|folinic acid
1301474|NCT01576705|Psychometric tests|psychometric tests
1301475|NCT01576705|GMDS|gmds
1301476|NCT01576705|Griffiths|griffiths
1301477|NCT01576705|Genetic factors|genetic factors
1301478|NCT01576705|Biochemical factors|biochemical factors
1301479|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
1301480|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
1301481|NCT01576692|natural killer cells|natural killer cells
1301482|NCT01576679|intra-abdominal|intra-abdominal
1301483|NCT01576679|abscess|abscess
1301484|NCT01576679|tPA|tpa
1301485|NCT01576679|alteplase|alteplase
1301486|NCT01576679|cathflo|cathflo
1301487|NCT01576666|Dose escalation|dose escalation
1301488|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
1301489|NCT01576666|MTD|mtd
1301490|NCT01576666|Safety Expansion|safety expansion
1301491|NCT01576666|Safety|safety
1301492|NCT01576666|Preliminary Efficacy|preliminary efficacy
1301493|NCT01576666|Objective Response Rate|objective response rate
1301494|NCT01576666|Early progression rate|early progression rate
1301495|NCT01576666|PI3K activation|pi3k activation
1301496|NCT01576666|Combination Treatment|combination treatment
1301497|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
1404619|NCT01145573|bone|bone
1301498|NCT01576666|Smoothened inhibitor|smoothened inhibitor
1301499|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
1301500|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
1301501|NCT01576666|Advanced solid tumors|advanced solid tumors
1301502|NCT01576666|metastatic breast cancer|metastatic breast cancer
1301503|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
1301504|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
1301505|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1301506|NCT01576666|gastric cancer|gastric cancer
1301507|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
1301508|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
1301509|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
1301510|NCT01576653|IFI|ifi
1301511|NCT01576640|Nicotine Dependence|nicotine dependence
1301512|NCT01576640|Smoking Cessation|smoking cessation
1301513|NCT01576640|Relapse Prevention|relapse prevention
1301514|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
1301515|NCT01576640|Schizophrenia|schizophrenia
1301516|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
1301517|NCT01576601|pediatrics|pediatrics
1301518|NCT01576601|acute pain|acute pain
1301519|NCT01576601|neurosurgery|neurosurgery
1301520|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
1301521|NCT01576601|postoperative management|postoperative management
1301522|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
1301523|NCT01576575|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if CYP3A is involved.|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if cyp3a is involved.
1301524|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1301525|NCT01576562|Ventricular Assist Device|ventricular assist device
1301526|NCT01576536|Myocardial infarction|myocardial infarction
1301527|NCT01576536|Platelet aggregation|platelet aggregation
1301528|NCT01576536|cold pressor test|cold pressor test
1301529|NCT01576536|Genetics|genetics
1301530|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
1301531|NCT01576471|T. suis ova|t. suis ova
1301532|NCT01576471|Trichuris suis ova|trichuris suis ova
1301533|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
1301534|NCT01576471|TRUST-I|trust-i
1301535|NCT01576471|TRUSTI|trusti
1301536|NCT01576471|TRUST-1|trust-1
1301537|NCT01576471|TRUST1|trust1
1301538|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
1301539|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
1301540|NCT01576458|pregnancy|pregnancy
1301541|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
1301542|NCT01576445|function|function
1301543|NCT01576432|Pain|pain
1301544|NCT01576432|Breastfeeding|breastfeeding
1301545|NCT01576432|Heel prick|heel prick
1301546|NCT01576432|Sucrose|sucrose
1301547|NCT01576432|Skin-to-skin contact|skin-to-skin contact
1301548|NCT01576432|Newborn|newborn
1301549|NCT01576419|PG201|pg201
1301550|NCT01576419|Non-inferiority|non-inferiority
1301551|NCT01576419|100mm pain VAS|100mm pain vas
1301552|NCT01576406|crizotinib|crizotinib
1301553|NCT01576406|xalkori|xalkori
1301554|NCT01576406|PF-02341066|pf-02341066
1301555|NCT01576406|hepatic impairment|hepatic impairment
1301556|NCT01576406|pharmacokinetics|pharmacokinetics
1301557|NCT01576406|advanced cancer|advanced cancer
1301558|NCT01576393|substance abuse|substance abuse
1301559|NCT01576393|treatment|treatment
1301560|NCT01576393|families|families
1301561|NCT01576380|Solid tumors|solid tumors
1301562|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
1301563|NCT01576380|Gastric Cancer|gastric cancer
1301564|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
1301565|NCT01576380|VEGF|vegf
1301566|NCT01576380|FGFR|fgfr
1301567|NCT01576380|Neoplasms|neoplasms
1301568|NCT01576380|Gastric Neoplasms|gastric neoplasms
1301569|NCT01576380|Cancer|cancer
1301570|NCT01576380|Carcinoma|carcinoma
1301571|NCT01576380|Gastric Diseases|gastric diseases
1301572|NCT01576380|Female Genital Diseases|female genital diseases
1301574|NCT01576380|Oral Administration|oral administration
1301575|NCT01576380|Capsules|capsules
1301576|NCT01576380|TKI258|tki258
1301577|NCT01576380|TKI-258|tki-258
1301578|NCT01576380|TKI 258|tki 258
1301579|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
1301580|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
1301581|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
1301582|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
1301583|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
1301584|NCT01576367|CIAS-1 gene|cias-1 gene
1301585|NCT01576367|NALP-3|nalp-3
1301586|NCT01576367|NLRP3|nlrp3
1301587|NCT01576367|ACZ885|acz885
1301588|NCT01576367|canakinumab|canakinumab
1301589|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
1301590|NCT01576367|autosomal dominant|autosomal dominant
1301591|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
1301592|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
1301593|NCT01576354|Multiple Sclerosis|multiple sclerosis
1301594|NCT01576354|walking function|walking function
1301595|NCT01576354|fampridine|fampridine
1301596|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
1301597|NCT01576315|cystic fibrosis|cystic fibrosis
1301598|NCT01576315|Aspergillus|aspergillus
1301599|NCT01576315|itraconazole|itraconazole
1301600|NCT01576315|voriconazole|voriconazole
1301601|NCT01576302|Rumination|rumination
1301602|NCT01576289|Esophagus|esophagus
1301603|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
1301604|NCT01576289|Reflux esophagitis|reflux esophagitis
1301605|NCT01576289|Barrett's esophagus|barrett's esophagus
1301606|NCT01576289|Stomach|stomach
1301607|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
1301608|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
1301609|NCT01576289|Proton pump inhibitor|proton pump inhibitor
1301610|NCT01576289|Duodenum|duodenum
1301611|NCT01576289|Duodenal bulb|duodenal bulb
1301612|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
1301613|NCT01576263|Anaesthesia|anaesthesia
1301614|NCT01576263|Infiltration|infiltration
1301615|NCT01576263|Blood transfusion|blood transfusion
1301616|NCT01576263|Autologous|autologous
1301617|NCT01576263|Arthroplasty|arthroplasty
1301618|NCT01576263|Replacement|replacement
1301619|NCT01576263|Ropivacaine|ropivacaine
1301620|NCT01576237|hemovigilance|hemovigilance
1301621|NCT01576237|hemapheresis|hemapheresis
1301622|NCT01576237|donor vigilance|donor vigilance
1301623|NCT01576237|plasmapheresis|plasmapheresis
1301624|NCT01576237|platelet apheresis|platelet apheresis
1301625|NCT01576237|leukapheresis|leukapheresis
1301626|NCT01576237|stem cell apheresis|stem cell apheresis
1301627|NCT01576237|granulocyte apheresis|granulocyte apheresis
1301628|NCT01576237|monocyte apheresis|monocyte apheresis
1301629|NCT01576237|red cell apheresis|red cell apheresis
1301630|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
1301631|NCT01576224|Early mobilization|early mobilization
1301632|NCT01576224|DASH|dash
1301633|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
1301634|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
1301635|NCT01576159|Biochemical Marker|biochemical marker
1301636|NCT01576159|Fitness Exercises|fitness exercises
1301637|NCT01576159|Impact|impact
1301638|NCT01576159|Articular Cartilage|articular cartilage
1301639|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
1301640|NCT01576146|Renal Dialysis|renal dialysis
1301641|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1301642|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
1301643|NCT01576146|Parathyroid hormone|parathyroid hormone
1301644|NCT01576133|Quality of Life|quality of life
1301645|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
1301646|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
1301647|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
1301648|NCT01576107|Different cancer entities|different cancer entities
1301649|NCT01576094|congenital heart disease|congenital heart disease
1301650|NCT01576081|bone density|bone density
1301651|NCT01576081|weight bearing|weight bearing
1301652|NCT01576081|muscle atrophy|muscle atrophy
1301653|NCT01576081|vascular degeneration|vascular degeneration
1301654|NCT01576081|gravitational loading|gravitational loading
1301655|NCT01576081|muscular unloading|muscular unloading
1301656|NCT01576068|COPD|copd
1301657|NCT01576068|Pharmacy|pharmacy
1301658|NCT01576068|Spirometry|spirometry
1301659|NCT01576068|Case finding|case finding
1301660|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
1301661|NCT01576055|Superficial Femoral Artery|superficial femoral artery
1301662|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
1301663|NCT01576055|PAD|pad
1301664|NCT01576055|SFA|sfa
1301665|NCT01576055|PPA|ppa
1301666|NCT01576055|Stent|stent
1301667|NCT01576055|Gore|gore
1301668|NCT01576055|Bare Metal Stent|bare metal stent
1301669|NCT01576055|LifeStent|lifestent
1301670|NCT01576055|atherosclerosis|atherosclerosis
1301671|NCT01576055|Heparin|heparin
1301672|NCT01576055|claudication|claudication
1301673|NCT01576055|leg pain|leg pain
1301674|NCT01576042|Ischemic heart disease|ischemic heart disease
1301675|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1301676|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
1301677|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
1301678|NCT01576016|bradycardia|bradycardia
1301679|NCT01576016|MRI scans|mri scans
1611369|NCT00353106|Survey|survey
1301680|NCT01576003|Short Bowel Syndrome|short bowel syndrome
1301681|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
1301682|NCT01576003|Atresia|atresia
1301683|NCT01576003|Parenteral Nutrition|parenteral nutrition
1301684|NCT01576003|Biological Markers|biological markers
1301685|NCT01576003|Growth|growth
1301686|NCT01575990|Colon cancer screening|colon cancer screening
1301687|NCT01575990|Decision support interventions|decision support interventions
1301688|NCT01575990|Health status|health status
1301689|NCT01575990|Patient-centered care|patient-centered care
1301690|NCT01575990|Age|age
1301691|NCT01575990|Randomized controlled trial|randomized controlled trial
1301692|NCT01575990|Double blind|double blind
1301693|NCT01575990|UNC|unc
1301694|NCT01575938|HIV infection|hiv infection
1301695|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
1301696|NCT01575925|renal impairment|renal impairment
1301697|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
1301698|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
1301699|NCT01575925|Pomalidomide|pomalidomide
1301700|NCT01575925|dexamethasone|dexamethasone
1301701|NCT01575925|RRMM|rrmm
1301702|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
1301703|NCT01575925|hemodialysis|hemodialysis
1301704|NCT01575925|dialysis|dialysis
1301705|NCT01575925|POM|pom
1301706|NCT01575925|Pomalyst|pomalyst
1301707|NCT01575925|MM|mm
1301708|NCT01575925|severe renal impairment|severe renal impairment
1301709|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
1301710|NCT01575925|Creatinine less than 30|creatinine less than 30
1301711|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
1301712|NCT01575912|Schizophrenia|schizophrenia
1301713|NCT01575912|Major depression|major depression
1301714|NCT01575912|Pain|pain
1301715|NCT01575912|Past pain experience|past pain experience
1301716|NCT01575899|Helicobacter pylori|helicobacter pylori
1301717|NCT01575899|Levofloxacin|levofloxacin
1301718|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
1301719|NCT01575899|Rabeprazole|rabeprazole
1301720|NCT01575899|Eastern Taiwan|eastern taiwan
1301721|NCT01575886|clinician patient communication|clinician patient communication
1301722|NCT01575886|smoking cessation|smoking cessation
1301723|NCT01575886|weight management|weight management
1301724|NCT01575886|primary care|primary care
1301725|NCT01575886|health behavior change advice|health behavior change advice
1301726|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
1301727|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
1301728|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
1301729|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
1301730|NCT01575847|Acetaminophen|acetaminophen
1301731|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
1301732|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
1301733|NCT01575821|children, cough, honey|children, cough, honey
1301734|NCT01575808|Symptomatic PAD|symptomatic pad
1301735|NCT01575808|Stenosis|stenosis
1301736|NCT01575808|Occlusion|occlusion
1301737|NCT01575795|Ticagrelor|ticagrelor
1301738|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
1301739|NCT01575795|Platelet reactivity|platelet reactivity
1301740|NCT01575782|small cell lung cancer|small cell lung cancer
1301741|NCT01575782|stage I-III|stage i-iii
1301742|NCT01575782|chloroquine|chloroquine
1301743|NCT01575782|Phase I|phase i
1301744|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
1301745|NCT01575717|Vitamin D|vitamin d
1301746|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
1301747|NCT01575717|liver neoplasms|liver neoplasms
1301748|NCT01575717|liver transplantation|liver transplantation
1301749|NCT01575704|Exercise|exercise
1301750|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
1301751|NCT01575704|Children|children
1301752|NCT01575691|Combination Chemotherapy|combination chemotherapy
1301753|NCT01575691|MDS|mds
1301754|NCT01575691|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1301755|NCT01575691|AML|aml
1301756|NCT01575691|Acute myelogenous leukemia|acute myelogenous leukemia
1301757|NCT01575691|valproic acid|valproic acid
1301758|NCT01575691|VPA|vpa
1301759|NCT01575691|Depakene|depakene
1301760|NCT01575691|5-azacytidine|5-azacytidine
1301761|NCT01575691|5-aza|5-aza
1301762|NCT01575691|Azacitidine|azacitidine
1301763|NCT01575691|5-AZC|5-azc
1301764|NCT01575691|Vidaza|vidaza
1301765|NCT01575691|AZA-CR|aza-cr
1301766|NCT01575691|Ladakamycin|ladakamycin
1301767|NCT01575691|NSC-102816|nsc-102816
1301768|NCT01575691|All-trans retinoic acid|all-trans retinoic acid
1301769|NCT01575691|ATRA|atra
1301770|NCT01575691|Tretinoin|tretinoin
1301771|NCT01575691|Vesanoid|vesanoid
1301772|NCT01575678|enuresis|enuresis
1301773|NCT01575678|melatonin|melatonin
1301774|NCT01575678|circadian rhythm|circadian rhythm
1301775|NCT01575678|children|children
1301776|NCT01575678|blood pressure|blood pressure
1301777|NCT01575678|urine production|urine production
1301778|NCT01575678|activity|activity
1301779|NCT01575678|sleep|sleep
1301780|NCT01575665|Hyperventilation|hyperventilation
1301781|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
1301782|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
1301783|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
1301784|NCT01575665|Respiratory Acidosis|respiratory acidosis
1301785|NCT01575652|peritoneal dialysis|peritoneal dialysis
1301786|NCT01575652|protein losses|protein losses
1301787|NCT01575613|malaria|malaria
1301788|NCT01575613|heterogeneity|heterogeneity
1301789|NCT01575613|transmission|transmission
1301790|NCT01575613|elimination|elimination
1301791|NCT01575587|Pharmacology|pharmacology
1301792|NCT01575587|Pharmacokinetics|pharmacokinetics
1301793|NCT01575587|Pharmacodynamics|pharmacodynamics
1301794|NCT01575587|Abiraterone acetate|abiraterone acetate
1301795|NCT01575587|Food intake|food intake
1301796|NCT01575587|Caucasion|caucasion
1301797|NCT01575587|Japanese|japanese
1301798|NCT01575587|Healthy|healthy
1301799|NCT01575561|Lurasidone|lurasidone
1301800|NCT01575561|Latuda|latuda
1301801|NCT01575561|Bipolar Disorder|bipolar disorder
1301802|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1301803|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
1301804|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1301805|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1301806|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1301807|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1301808|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1301809|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1301810|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1301811|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1301812|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1301813|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1301814|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1301815|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1301816|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1301913|NCT01574924|Coping|coping
1301817|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1301818|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1301819|NCT01575496|Tinnitus|tinnitus
1301820|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
1301821|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
1301822|NCT01575470|Traumatic Brain Injury|traumatic brain injury
1301823|NCT01575470|TBI|tbi
1301824|NCT01575470|stem cells|stem cells
1301825|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
1301826|NCT01575444|Pap test|pap test
1301827|NCT01575444|HPV testing|hpv testing
1301828|NCT01575444|cervical cancer|cervical cancer
1301829|NCT01575431|coronary artery disease|coronary artery disease
1301830|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
1301831|NCT01575392|creatinine|creatinine
1301832|NCT01575392|chronic kidney disease|chronic kidney disease
1301833|NCT01575392|creatinine clearance|creatinine clearance
1301834|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
1301835|NCT01575340|inflammatory markers|inflammatory markers
1301836|NCT01575340|colorectal cancer|colorectal cancer
1301837|NCT01575340|cytokines|cytokines
1301838|NCT01575340|fish oil|fish oil
1301839|NCT01575314|stapling device|stapling device
1301840|NCT01575314|lobectomy|lobectomy
1301841|NCT01575314|cost utility|cost utility
1301842|NCT01575301|GLP-1R agonist|glp-1r agonist
1301843|NCT01575301|biomarker|biomarker
1301844|NCT01575288|arterial function|arterial function
1301845|NCT01575288|cardiovascular|cardiovascular
1301846|NCT01575288|aging|aging
1301847|NCT01575288|endothelial function|endothelial function
1301848|NCT01575288|arterial stiffness|arterial stiffness
1301849|NCT01575288|vascular function|vascular function
1301850|NCT01575288|Trehalose|trehalose
1301851|NCT01575262|behaviour change|behaviour change
1301852|NCT01575262|incentives|incentives
1301853|NCT01575262|nudging|nudging
1301854|NCT01575262|physical activity|physical activity
1301855|NCT01575262|self-monitoring|self-monitoring
1301856|NCT01575249|progression|progression
1301857|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
1301858|NCT01575249|asymptomatic|asymptomatic
1405110|NCT01143493|HV|hv
1301859|NCT01575249|symptomatic|symptomatic
1301860|NCT01575223|saline irrigation|saline irrigation
1301861|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
1301862|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
1301863|NCT01575223|high volume saline irrigation|high volume saline irrigation
1301864|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
1301865|NCT01575184|common carotid artery|common carotid artery
1301866|NCT01575184|infants|infants
1301867|NCT01575132|Parkinson's Disease|parkinson's disease
1301868|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
1301869|NCT01575132|Study, Follow-Up|study, follow-up
1301870|NCT01575132|Adverse Effects|adverse effects
1301871|NCT01575119|Cigarette smoker|cigarette smoker
1301872|NCT01575119|Elective surgery|elective surgery
1301873|NCT01575093|Healthy volunteers|healthy volunteers
1301874|NCT01575067|BP|bp
1301875|NCT01575041|sodium|sodium
1301876|NCT01575041|salt|salt
1301877|NCT01575041|potassium|potassium
1301878|NCT01575041|blood pressure|blood pressure
1301879|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
1301880|NCT01575041|endothelial function|endothelial function
1301881|NCT01575041|renal function|renal function
1301882|NCT01575041|controlled feeding study|controlled feeding study
1301883|NCT01575041|dietary intervention|dietary intervention
1301884|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
1301885|NCT01575028|TAP block|tap block
1301886|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
1301887|NCT01575028|Appendectomy|appendectomy
1301888|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
1301889|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
1301890|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
1301891|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
1301892|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
1301893|NCT01575015|Efficacy|efficacy
1301894|NCT01575002|transcranial stimulation|transcranial stimulation
1301895|NCT01575002|direct current stimulation|direct current stimulation
1301896|NCT01574989|direct current stimulation|direct current stimulation
1301897|NCT01574989|magnetic stimulation|magnetic stimulation
1301898|NCT01574989|transcranial stimulation|transcranial stimulation
1301899|NCT01574976|ADHD|adhd
1301900|NCT01574976|probabilistic|probabilistic
1301901|NCT01574976|choice|choice
1301902|NCT01574976|feedback|feedback
1301903|NCT01574976|practice|practice
1301904|NCT01574963|Coronary artery disease|coronary artery disease
1301905|NCT01574963|OPG|opg
1301906|NCT01574963|RANKL|rankl
1301907|NCT01574963|bone disease|bone disease
1301908|NCT01574950|Delirium|delirium
1301909|NCT01574937|Castration Resistant|castration resistant
1301910|NCT01574937|Post Chemotherapy|post chemotherapy
1301911|NCT01574924|Personality change|personality change
1301912|NCT01574924|Perfectionism|perfectionism
1301914|NCT01574924|Medical Specialty|medical specialty
1301915|NCT01574924|Medical Residency|medical residency
1301916|NCT01574911|volumetry 3D|volumetry 3d
1301917|NCT01574911|Displacement of water|displacement of water
1301918|NCT01574911|lymphoedema|lymphoedema
1301919|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
1301920|NCT01574898|Smoking cessation|smoking cessation
1301921|NCT01574898|Nicotine|nicotine
1301922|NCT01574898|Tobacco Use Disorder|tobacco use disorder
1301923|NCT01574898|Central Nervous System Agents|central nervous system agents
1301924|NCT01574885|sleep apnea|sleep apnea
1301925|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
1301926|NCT01574885|salt|salt
1301927|NCT01574885|sodium chloride|sodium chloride
1301928|NCT01574872|psoriasis|psoriasis
1301929|NCT01574872|salt|salt
1301930|NCT01574872|sodium chloride|sodium chloride
1301931|NCT01574859|central hypothyroidism|central hypothyroidism
1301932|NCT01574859|hypopituitarism|hypopituitarism
1301933|NCT01574859|levothyroxine replacement|levothyroxine replacement
1301934|NCT01574859|lipids|lipids
1301935|NCT01574859|body composition|body composition
1301936|NCT01574820|prediabetes|prediabetes
1301937|NCT01574820|coronary artery disease|coronary artery disease
1301938|NCT01574820|insulin resistance|insulin resistance
1301939|NCT01574820|glucose intolerance|glucose intolerance
1301940|NCT01574807|mepivacaine|mepivacaine
1301941|NCT01574807|lidocaine|lidocaine
1301942|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
1301943|NCT01574807|pulpal anesthesia|pulpal anesthesia
1301944|NCT01574807|pain of injection|pain of injection
1301945|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
1301946|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
1301947|NCT01574781|Down syndrome|down syndrome
1301948|NCT01574781|Trisomy 13|trisomy 13
1301949|NCT01574781|Trisomy 18|trisomy 18
1301950|NCT01574781|Microdeletions|microdeletions
1301951|NCT01574781|Pregnancy|pregnancy
1301952|NCT01574781|Non-invasive|non-invasive
1301953|NCT01574755|gastric inlet patches|gastric inlet patches
1301954|NCT01574755|argon plasma coagulation|argon plasma coagulation
1301955|NCT01574755|globus sensations|globus sensations
1301956|NCT01574729|p53 gene therapy|p53 gene therapy
1301957|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
1301958|NCT01574729|post-surgery|post-surgery
1301959|NCT01574729|chemotherapy|chemotherapy
1301960|NCT01574703|smoking cessation|smoking cessation
1301961|NCT01574703|psychiatric disease|psychiatric disease
1301962|NCT01574703|cardiovascular events|cardiovascular events
1301963|NCT01574690|central venous pressure|central venous pressure
1301964|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
1301965|NCT01574690|non-invasive monitor|non-invasive monitor
1301966|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
1301967|NCT01574690|heart failure (HF)|heart failure (hf)
1301968|NCT01574677|Colorectal cancer|colorectal cancer
1301969|NCT01574677|fecal immunochemical test|fecal immunochemical test
1301970|NCT01574677|Septin 9|septin 9
1301971|NCT01574677|screening|screening
1301972|NCT01574651|QVA149|qva149
1301973|NCT01574651|Health related quality of life|health related quality of life
1301974|NCT01574651|Formoterol|formoterol
1301975|NCT01574651|Tiotropium|tiotropium
1301976|NCT01574651|COPD|copd
1301977|NCT01574612|Xerese|xerese
1301978|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
1301979|NCT01574612|herpes labialis|herpes labialis
1301980|NCT01574612|pediatric|pediatric
1301981|NCT01574599|Stroke|stroke
1301982|NCT01574599|weakness|weakness
1301983|NCT01574599|rehabilitation|rehabilitation
1301984|NCT01574599|chronic stroke|chronic stroke
1301985|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
1301986|NCT01574573|Obesity|obesity
1301987|NCT01574573|GERD|gerd
1301988|NCT01574573|Weight loss|weight loss
1301989|NCT01574560|smoke-free|smoke-free
1301990|NCT01574560|tobacco exposure|tobacco exposure
1301991|NCT01574560|biomarker feedback|biomarker feedback
1301992|NCT01574560|nicotine|nicotine
1301993|NCT01574560|cotinine|cotinine
1301994|NCT01574560|secondhand smoke|secondhand smoke
1301995|NCT01574547|Cat Scratch Colon.|cat scratch colon.
1301996|NCT01574547|Mucosal tears.|mucosal tears.
1301997|NCT01574547|Mucosal erosion.|mucosal erosion.
1301998|NCT01574547|Colonoscopy.|colonoscopy.
1301999|NCT01574508|efficacy|efficacy
1302000|NCT01574508|safety|safety
1302001|NCT01574508|intensive insulin therapy|intensive insulin therapy
1302002|NCT01574495|stroke|stroke
1302003|NCT01574495|error augmentation|error augmentation
1302004|NCT01574495|arm recovery|arm recovery
1302005|NCT01574495|massed practice|massed practice
1302006|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
1302107|NCT01574092|Brainstem gliomas|brainstem gliomas
1302007|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
1302008|NCT01574443|Epilepsy|epilepsy
1302009|NCT01574417|Plant stanols|plant stanols
1302010|NCT01574417|Gene expression profile|gene expression profile
1302011|NCT01574417|Microbiota|microbiota
1302012|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
1302013|NCT01574378|Abdominoplasty|abdominoplasty
1302014|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
1302015|NCT01574352|Children|children
1302016|NCT01574352|Overweight|overweight
1302017|NCT01574352|Obesity|obesity
1302019|NCT01574352|Physical activity|physical activity
1302020|NCT01574352|Cognitive function|cognitive function
1302021|NCT01574352|Intervention study|intervention study
1302022|NCT01574352|Randomized controlled trial|randomized controlled trial
1302023|NCT01574352|Day camp|day camp
1302024|NCT01574352|Risk factors|risk factors
1302025|NCT01574339|GERD|gerd
1302026|NCT01574339|LES Pressure|les pressure
1302027|NCT01574339|Electrical Stimulation|electrical stimulation
1302028|NCT01574326|Chronic Kidney Disease|chronic kidney disease
1302029|NCT01574326|Pediatric|pediatric
1302030|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
1302031|NCT01574326|Hyperphosphatemia|hyperphosphatemia
1302032|NCT01574313|stellate ganglion block.|stellate ganglion block.
1302033|NCT01574313|Meniere's disease.|meniere's disease.
1302034|NCT01574313|electrocochleography.|electrocochleography.
1302035|NCT01574313|vertigo.|vertigo.
1302036|NCT01574313|hearing impairment.|hearing impairment.
1302037|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
1302038|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1302039|NCT01574300|M1A or B NSCLC|m1a or b nsclc
1302040|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
1302041|NCT01574261|Cardiovascular risk|cardiovascular risk
1302042|NCT01574261|Metabolic Syndrome|metabolic syndrome
1302043|NCT01574248|ACE inhibitor|ace inhibitor
1302044|NCT01574248|Angioedema|angioedema
1302045|NCT01574248|Bradykinin|bradykinin
1302046|NCT01574248|Swelling|swelling
1302047|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
1302048|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
1302049|NCT01574222|Lung Neoplasms|lung neoplasms
1302050|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1302051|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
1302052|NCT01574222|Neoplasms by Site|neoplasms by site
1302053|NCT01574222|Neoplasms|neoplasms
1302054|NCT01574222|Lung Diseases|lung diseases
1302055|NCT01574209|Celiac disease|celiac disease
1302056|NCT01574209|IBS|ibs
1302057|NCT01574209|Intestinal barrier|intestinal barrier
1302058|NCT01574209|Intestinal permeability|intestinal permeability
1302059|NCT01574209|GI peptides|gi peptides
1302060|NCT01574196|Childhood cancer|childhood cancer
1302061|NCT01574196|Cancer|cancer
1302062|NCT01574196|Sequels|sequels
1302063|NCT01574196|Complications|complications
1302064|NCT01574196|Chemotherapy|chemotherapy
1302065|NCT01574196|Radiotherapy|radiotherapy
1302066|NCT01574196|Surgery|surgery
1302067|NCT01574196|Autonomic nervous system|autonomic nervous system
1302068|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
1302069|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
1302070|NCT01574183|Marijuana|marijuana
1302071|NCT01574183|Vilazodone|vilazodone
1302072|NCT01574183|Contingency management|contingency management
1302073|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
1302074|NCT01574170|Breast cancer,|breast cancer,
1302075|NCT01574170|Third line metastatic|third line metastatic
1302076|NCT01574170|Chemotherapy,|chemotherapy,
1302077|NCT01574170|Overall survival,|overall survival,
1302078|NCT01574170|Quality of life.|quality of life.
1302079|NCT01574144|Heart Failure|heart failure
1302080|NCT01574131|Burn|burn
1302081|NCT01574131|Fenofibrate|fenofibrate
1302082|NCT01574131|PPAR alpha agonist|ppar alpha agonist
1302083|NCT01574131|insulin sensitivity|insulin sensitivity
1302084|NCT01574131|mitochondrial|mitochondrial
1302085|NCT01574118|PTSD|ptsd
1302086|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
1302087|NCT01574118|Exposure Therapy|exposure therapy
1302088|NCT01574118|Prolonged Exposure|prolonged exposure
1302089|NCT01574118|Fear Memory Retrieval|fear memory retrieval
1302090|NCT01574118|Compound extinction|compound extinction
1302091|NCT01574118|Deepened extinction|deepened extinction
1302092|NCT01574118|Psychotherapy|psychotherapy
1302093|NCT01574105|Heparin Dose|heparin dose
1302094|NCT01574105|Heparin Resistance|heparin resistance
1302095|NCT01574105|Chest Tube Losses|chest tube losses
1302096|NCT01574105|Transfusion Events|transfusion events
1302097|NCT01574092|Pediatric|pediatric
1302098|NCT01574092|Pediatrics|pediatrics
1302099|NCT01574092|Gliomas|gliomas
1302100|NCT01574092|Glioma|glioma
1302101|NCT01574092|Brain tumor|brain tumor
1302102|NCT01574092|Brain cancer|brain cancer
1302103|NCT01574092|Cisplatin|cisplatin
1302104|NCT01574092|Cisplatino|cisplatino
1302105|NCT01574092|Irinotecan|irinotecan
1302106|NCT01574092|Brain stem tumor|brain stem tumor
1302108|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
1302109|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
1302110|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
1302111|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
1302112|NCT01574066|Diagnosis|diagnosis
1302113|NCT01574066|Emergency medicine|emergency medicine
1302114|NCT01574066|Chest CT-scan|chest ct-scan
1302115|NCT01574053|Huntington's Disease|huntington's disease
1302116|NCT01574053|Huntington Disease|huntington disease
1302117|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
1302118|NCT01574053|Registry|registry
1302119|NCT01574053|Cohort|cohort
1302120|NCT01574053|CHDI|chdi
1302121|NCT01574040|Lifestyle|lifestyle
1302122|NCT01574040|Lifestyle modification|lifestyle modification
1302123|NCT01574040|Behavior|behavior
1302124|NCT01574040|Primary prevention|primary prevention
1302125|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
1302126|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
1302127|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
1302128|NCT01574014|Anxiety Disorder|anxiety disorder
1302129|NCT01574014|Phobic Disorders|phobic disorders
1302130|NCT01574001|ischemic stroke|ischemic stroke
1302131|NCT01574001|smoking cessation|smoking cessation
1302132|NCT01574001|antismoking interventions|antismoking interventions
1302133|NCT01573988|Nutrition|nutrition
1302134|NCT01573988|Eating frequency|eating frequency
1302135|NCT01573988|Food intake|food intake
1302136|NCT01573988|Eating behavior|eating behavior
1302137|NCT01573988|Satiety|satiety
1302138|NCT01573988|Ghrelin|ghrelin
1302139|NCT01573975|Helicobacter pylori|helicobacter pylori
1302140|NCT01573975|antibiotic resistance|antibiotic resistance
1302141|NCT01573975|sequential therapy|sequential therapy
1302142|NCT01573975|Taiwan|taiwan
1302143|NCT01573962|Kidney Renal|kidney renal
1302144|NCT01573949|Heart Failure|heart failure
1302145|NCT01573949|Diabetes|diabetes
1302146|NCT01573949|Pre-diabetes|pre-diabetes
1611370|NCT00353106|Caregiver|caregiver
1405491|NCT01141933|QOL|qol
1302147|NCT01573949|Early type II diabetes|early type ii diabetes
1302148|NCT01573949|Metformin|metformin
1302149|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
1302150|NCT01573936|acquired brain injury|acquired brain injury
1302151|NCT01573936|health-related quality of life|health-related quality of life
1302152|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
1302153|NCT01573936|rehabilitation|rehabilitation
1302154|NCT01573936|spinal cord injury|spinal cord injury
1302155|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
1302156|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
1302157|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
1302158|NCT01573910|Anti-infective|anti-infective
1302159|NCT01573910|Antibiotics|antibiotics
1302160|NCT01573897|Diabetes|diabetes
1302161|NCT01573897|Sleep apnea|sleep apnea
1302162|NCT01573897|Diabetic foot|diabetic foot
1302163|NCT01573897|Microcirculation|microcirculation
1302164|NCT01573858|Infertility|infertility
1302165|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
1302166|NCT01573858|Clomiphene citrate|clomiphene citrate
1302167|NCT01573858|Acupuncture|acupuncture
1302168|NCT01573845|child|child
1302169|NCT01573845|communication|communication
1302170|NCT01573845|diet|diet
1302171|NCT01573845|food|food
1302172|NCT01573845|health communication|health communication
1302173|NCT01573845|nutrition|nutrition
1302174|NCT01573845|parents|parents
1302175|NCT01573845|primary schools|primary schools
1302176|NCT01573845|school age population|school age population
1302177|NCT01573845|school health|school health
1302178|NCT01573819|repeat dose|repeat dose
1302179|NCT01573819|PDE4|pde4
1302180|NCT01573819|healthy volunteers|healthy volunteers
1302181|NCT01573819|GSK356278|gsk356278
1302182|NCT01573806|sepsis|sepsis
1302183|NCT01573806|septic shock|septic shock
1302184|NCT01573806|children|children
1302185|NCT01573806|incretins|incretins
1302186|NCT01573806|exenatide|exenatide
1302187|NCT01573806|pharmacokinetics|pharmacokinetics
1302188|NCT01573806|pharmacodynamics|pharmacodynamics
1302189|NCT01573806|glucose homeostasis|glucose homeostasis
1302190|NCT01573806|inflammation|inflammation
1302191|NCT01573806|cytokines|cytokines
1302192|NCT01573806|health-related quality of life|health-related quality of life
1302193|NCT01573806|functional status|functional status
1302194|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
1302195|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
1302196|NCT01573728|Depression|depression
1302197|NCT01573728|Biomarkers|biomarkers
1302198|NCT01573728|Exercise|exercise
1302199|NCT01573702|Non small cell lung cancer|non small cell lung cancer
1302200|NCT01573702|EGFR mutant|egfr mutant
1302201|NCT01573702|Phase II|phase ii
1302202|NCT01573702|erlotinib|erlotinib
1302203|NCT01573702|tarceva|tarceva
1302204|NCT01573702|cyberknife|cyberknife
1302205|NCT01573702|Lineberger|lineberger
1302206|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
1302207|NCT01573676|bariatric surgery|bariatric surgery
1302208|NCT01573676|sleep apnea|sleep apnea
1302209|NCT01573676|overweight|overweight
1302210|NCT01573663|Ambroxol|ambroxol
1302211|NCT01573663|Levodropropizine|levodropropizine
1302212|NCT01573663|Drug-drug interaction|drug-drug interaction
1302213|NCT01573637|schizophrenia|schizophrenia
1302214|NCT01573637|negative schizophrenia|negative schizophrenia
1302215|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
1302216|NCT01573637|schizophrenia in women|schizophrenia in women
1302217|NCT01573637|ralixifene|ralixifene
1302218|NCT01573637|raloxifen|raloxifen
1302219|NCT01573637|raloxifeno|raloxifeno
1302220|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
1302221|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
1302222|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
1302223|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
1302224|NCT01573624|Fluticasone Furoate|fluticasone furoate
1302225|NCT01573624|Vilanterol|vilanterol
1302226|NCT01573624|Adults|adults
1302227|NCT01573624|GSK573719|gsk573719
1302228|NCT01573624|Asthma|asthma
1302229|NCT01573611|mild cognitive impairment|mild cognitive impairment
1302230|NCT01573611|dementia|dementia
1302231|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
1302232|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
1302233|NCT01573611|cerebral metabolism|cerebral metabolism
1302234|NCT01573611|dietary supplement|dietary supplement
1302235|NCT01573598|Major Depressive Disorder|major depressive disorder
1302236|NCT01573598|Depression|depression
1302237|NCT01573585|Physical Therapy|physical therapy
1302238|NCT01573585|Exercise therapy|exercise therapy
1302239|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
1302240|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
1302241|NCT01573533|Glomerulosclerosis|glomerulosclerosis
1302242|NCT01573533|Proteinuria|proteinuria
1302243|NCT01573533|Rituximab|rituximab
1302244|NCT01573520|compliance|compliance
1302245|NCT01573520|dialysis|dialysis
1302246|NCT01573520|hyperparathyroidism|hyperparathyroidism
1302247|NCT01573507|traumatic brain injury|traumatic brain injury
1302248|NCT01573507|lactate|lactate
1302249|NCT01573507|brain metabolism|brain metabolism
1302250|NCT01573507|cerebral microdialysis|cerebral microdialysis
1302251|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
1302252|NCT01573507|transcranial doppler|transcranial doppler
1302253|NCT01573494|Cancer|cancer
1302254|NCT01573494|Melanoma|melanoma
1302255|NCT01573494|Circulating Tumor Cells|circulating tumor cells
1302256|NCT01573481|WEANING|weaning
1302257|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
1302258|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
1302259|NCT01573481|SLEEP|sleep
1302260|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
1302261|NCT01573442|hot flashes|hot flashes
1302262|NCT01573442|musculoskeletal complications|musculoskeletal complications
1302263|NCT01573442|sexual dysfunction|sexual dysfunction
1302264|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1302265|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1302266|NCT01573442|arthralgia|arthralgia
1302267|NCT01573442|stage IA breast cancer|stage ia breast cancer
1302268|NCT01573442|stage IB breast cancer|stage ib breast cancer
1302269|NCT01573442|stage II breast cancer|stage ii breast cancer
1302270|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
1302271|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
1302272|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
1302273|NCT01573429|Biologic Sample Collection|biologic sample collection
1302274|NCT01573429|Metabolism|metabolism
1302275|NCT01573429|Healthy Volunteer|healthy volunteer
1302277|NCT01573416|Alcohol|alcohol
1302278|NCT01573416|Abuse|abuse
1302279|NCT01573416|Drugs|drugs
1302280|NCT01573416|Brief intervention|brief intervention
1302281|NCT01573416|ASSIST|assist
1302282|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
1302283|NCT01573403|DLBS2411|dlbs2411
1302284|NCT01573403|gastric pH|gastric ph
1302285|NCT01573390|Non-invasive|non-invasive
1302286|NCT01573390|tissue-oxygenation|tissue-oxygenation
1302287|NCT01573390|hyperspectral|hyperspectral
1302288|NCT01573390|CWC imaging system|cwc imaging system
1302289|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
1302290|NCT01573377|insulin resistance|insulin resistance
1302291|NCT01573364|Distal Airways|distal airways
1302292|NCT01573364|Hyperinflation|hyperinflation
1302293|NCT01573364|Reversibility|reversibility
1302294|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
1302295|NCT01573338|Drug therapy, combination|drug therapy, combination
1302296|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
1302297|NCT01573338|Etoposide|etoposide
1302298|NCT01573338|Cisplatin|cisplatin
1302299|NCT01573338|Carboplatin|carboplatin
1302300|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
1302301|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
1302302|NCT01573325|Depression|depression
1302303|NCT01573325|Poor social support|poor social support
1302304|NCT01573325|Liver disease symptoms|liver disease symptoms
1302305|NCT01573325|Health releated quality of life|health releated quality of life
1302306|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
1302307|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
1302308|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
1302309|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
1302310|NCT01573286|malnutrition|malnutrition
1302311|NCT01573286|post surgical syndromes|post surgical syndromes
1302312|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
1302313|NCT01573286|intestinal atresia|intestinal atresia
1302314|NCT01573286|gastroschisis|gastroschisis
1302315|NCT01573273|cocaine|cocaine
1302316|NCT01573273|substance abuse|substance abuse
1302317|NCT01573273|drug abuse|drug abuse
1302318|NCT01573273|cocaine dependence|cocaine dependence
1302319|NCT01573273|drug addiction|drug addiction
1302320|NCT01573260|Parkinson's Disease|parkinson's disease
1302321|NCT01573260|Tango|tango
1302322|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
1302323|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
1302324|NCT01573247|FLT3 inhibitor|flt3 inhibitor
1302325|NCT01573247|kinase inhibitor|kinase inhibitor
1302326|NCT01573234|MySkin patch|myskin patch
1302327|NCT01573234|Hydrogel bandage|hydrogel bandage
1302328|NCT01573234|Occlusive dressing|occlusive dressing
1302329|NCT01573208|Knee osteoarthritis|knee osteoarthritis
1302330|NCT01573195|deescalation|deescalation
1302331|NCT01573195|best practice alert|best practice alert
1302332|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
1302333|NCT01573182|Zostavax|zostavax
1302334|NCT01573182|Herpes Zoster|herpes zoster
1302335|NCT01573182|VZV vaccination|vzv vaccination
1302336|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
1302337|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
1302338|NCT01573169|venous thromboembolism|venous thromboembolism
1302339|NCT01573169|prevention|prevention
1302340|NCT01573156|renal cancer|renal cancer
1302341|NCT01573156|photodynamic therapy|photodynamic therapy
1302342|NCT01573156|wst 11|wst 11
1302343|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
1302344|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1302345|NCT01573143|Rosuvastatin|rosuvastatin
1302346|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
1302347|NCT01573130|Depression|depression
1302348|NCT01573130|Physical exercise|physical exercise
1302349|NCT01573130|Internet|internet
1302350|NCT01573117|hypothermia|hypothermia
1302351|NCT01573117|induction of hypothermia|induction of hypothermia
1302352|NCT01573117|cold infusion|cold infusion
1302353|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
1302354|NCT01573117|stroke|stroke
1302355|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
1302356|NCT01573117|cerebrovascular disease|cerebrovascular disease
1302357|NCT01573117|neuro intensive care|neuro intensive care
1302358|NCT01573104|Diagnosis|diagnosis
1302359|NCT01573104|Acute Kidney Injury|acute kidney injury
1302360|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
1302361|NCT01573091|Heart failure|heart failure
1302362|NCT01573078|Crohn's disease|crohn's disease
1302363|NCT01573078|IBS|ibs
1302364|NCT01573078|Dissociation|dissociation
1302365|NCT01573078|Emotional processing|emotional processing
1302366|NCT01573065|alcohol consumption|alcohol consumption
1302367|NCT01573065|sexual risk behaviors|sexual risk behaviors
1302368|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
1302369|NCT01573039|Kidney transplantation|kidney transplantation
1302370|NCT01573039|PCR quantitative|pcr quantitative
1302371|NCT01573039|cytomegalovirus|cytomegalovirus
1302372|NCT01573039|antigenemia|antigenemia
1302373|NCT01573026|Dental Implants|dental implants
1302374|NCT01573026|Dental Implantation|dental implantation
1302375|NCT01573026|Osseointegration|osseointegration
1302376|NCT01573013|iron deficiency|iron deficiency
1302377|NCT01573013|Lead poisoning|lead poisoning
1302378|NCT01573013|cognitive development|cognitive development
1302379|NCT01573013|motor activity|motor activity
1302380|NCT01573000|Bexxar|bexxar
1302381|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1302382|NCT01573000|Tositumomab|tositumomab
1302383|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
1302384|NCT01573000|Radioimmunotherapy|radioimmunotherapy
1302385|NCT01573000|Iodine I-131|iodine i-131
1302386|NCT01573000|Iodine-131|iodine-131
1302387|NCT01572987|Barrett's Esophagus|barrett's esophagus
1302388|NCT01572987|Esophageal neoplasms|esophageal neoplasms
1302389|NCT01572987|Radiofrequency ablation|radiofrequency ablation
1302390|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
1302391|NCT01572974|Barrett's esophagus|barrett's esophagus
1302392|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
1302393|NCT01572974|Quality of life|quality of life
1302394|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
1302395|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
1302396|NCT01572922|Sickle cell disease|sickle cell disease
1302397|NCT01572922|Thalassemia|thalassemia
1302398|NCT01572922|Hemochromatosis|hemochromatosis
1302399|NCT01572922|Cancer|cancer
1302400|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
1302401|NCT01572909|Primary PCI|primary pci
1302402|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
1302403|NCT01572896|adoloescent|adoloescent
1302404|NCT01572896|internet self-management|internet self-management
1302405|NCT01572896|managing JIA|managing jia
1302406|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
1302407|NCT01572870|Chit1|chit1
1302408|NCT01572870|Cystic Fibrosis|cystic fibrosis
1302409|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
1302410|NCT01572870|Aspergillus|aspergillus
1302411|NCT01572857|multiple myeloma|multiple myeloma
1302412|NCT01572857|Proteinuria|proteinuria
1302413|NCT01572857|Albuminuria|albuminuria
1302414|NCT01572857|Urinary FLC|urinary flc
1302415|NCT01572857|Urine creatinine|urine creatinine
1302416|NCT01572844|Dermatomyositis|dermatomyositis
1302417|NCT01572844|Superficial calcinosis|superficial calcinosis
1302418|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
1302419|NCT01572844|Sodium thiosulfate|sodium thiosulfate
1302420|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
1302421|NCT01572831|procalcitonin|procalcitonin
1302422|NCT01572831|infection|infection
1302423|NCT01572831|critical care|critical care
1302424|NCT01572818|Phlebotomy|phlebotomy
1611475|NCT00352729|ACell|acell
1302425|NCT01572818|Insulin Resistance|insulin resistance
1302426|NCT01572818|Iron Overload|iron overload
1302427|NCT01572805|Post partum haemorrhage|post partum haemorrhage
1302428|NCT01572805|Cesarean|cesarean
1302429|NCT01572805|Pain|pain
1302430|NCT01572792|COPD|copd
1302431|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1302432|NCT01572792|Chronic Bronchitis|chronic bronchitis
1302433|NCT01572792|Emphysema|emphysema
1302434|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
1302435|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
1302436|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1302437|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1302438|NCT01572779|dorsavi|dorsavi
1302439|NCT01572779|vimove|vimove
1302440|NCT01572779|biofeedback|biofeedback
1302441|NCT01572779|objective movement data|objective movement data
1302442|NCT01572779|back pain|back pain
1302443|NCT01572766|Osteoporosis|osteoporosis
1302444|NCT01572766|Pharmacist|pharmacist
1302445|NCT01572766|Behavior Change|behavior change
1302446|NCT01572766|FRAX|frax
1302447|NCT01572766|Osteopenia|osteopenia
1302448|NCT01572727|BKM120|bkm120
1302449|NCT01572727|paclitaxel|paclitaxel
1302450|NCT01572727|breast cancer|breast cancer
1302451|NCT01572727|metastatic|metastatic
1302452|NCT01572727|locally advanced|locally advanced
1302453|NCT01572727|PI3K|pi3k
1302454|NCT01572727|PIK3CA|pik3ca
1302455|NCT01572727|PTEN|pten
1302456|NCT01572714|Exercise|exercise
1302457|NCT01572714|Self Care|self care
1302458|NCT01572714|Fatigue|fatigue
1302459|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
1302460|NCT01572675|Longitudinal|longitudinal
1302461|NCT01572675|Observational|observational
1302462|NCT01572662|Leukemia|leukemia
1302463|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
1302464|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
1302465|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
1302466|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1302467|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
1302468|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1302469|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
1302470|NCT01572662|Multiple myeloma|multiple myeloma
1302471|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
1302472|NCT01572662|MDS|mds
1302473|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
1302474|NCT01572662|Fludarabine phosphate|fludarabine phosphate
1302475|NCT01572662|Fludara|fludara
1302476|NCT01572662|Busulfan|busulfan
1302477|NCT01572662|Busulfex|busulfex
1302478|NCT01572662|Myleran|myleran
1302479|NCT01572662|Tacrolimus|tacrolimus
1302480|NCT01572662|Prograf|prograf
1302481|NCT01572662|Methotrexate|methotrexate
1302482|NCT01572662|G-CSF|g-csf
1302483|NCT01572662|Filgrastim|filgrastim
1302484|NCT01572662|Neupogen|neupogen
1302485|NCT01572662|Stem cell transplant|stem cell transplant
1302486|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
1302487|NCT01572636|Hurler Syndrome|hurler syndrome
1302690|NCT01571752|Drug Abuse|drug abuse
1302488|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
1302489|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
1302490|NCT01572597|Helicobacter pylori|helicobacter pylori
1302491|NCT01572597|antibiotic resistance|antibiotic resistance
1302492|NCT01572597|N-acetylcystein|n-acetylcystein
1302493|NCT01572597|biofilm|biofilm
1302997|NCT01570569|Volunteers|volunteers
1302497|NCT01572584|Chest sonography|chest sonography
1302498|NCT01572571|Emergency ultrasound|emergency ultrasound
1302499|NCT01572571|Focused ultrasound|focused ultrasound
1302500|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
1302501|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
1302502|NCT01572558|Appendectomy|appendectomy
1302503|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
1302504|NCT01572545|bone turnover|bone turnover
1302505|NCT01572545|denosumab|denosumab
1302506|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
1302507|NCT01572545|sclerostin|sclerostin
1302508|NCT01572545|zolendronic acid|zolendronic acid
1302509|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
1302510|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
1302511|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
1302512|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
1302513|NCT01572519|JNJ-40346527|jnj-40346527
1302514|NCT01572519|Dose-escalation|dose-escalation
1302515|NCT01572519|Pharmacokinetics|pharmacokinetics
1302516|NCT01572506|Anemia|anemia
1302517|NCT01572506|Elderly|elderly
1302518|NCT01572506|Mechanisms|mechanisms
1302519|NCT01572506|Red Cell Survival|red cell survival
1302520|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
1302521|NCT01572493|Cytokine Therapy|cytokine therapy
1302522|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
1302523|NCT01572493|Immunotherapy|immunotherapy
1302524|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
1302525|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
1302526|NCT01572480|Combination Therapy|combination therapy
1302527|NCT01572480|Anti-Myeloma Activity|anti-myeloma activity
1302528|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
1302529|NCT01572480|SMM|smm
1302530|NCT01572467|Leydig cell tumor|leydig cell tumor
1302531|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
1302532|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1302533|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1302534|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
1302535|NCT01572454|hypokalemia|hypokalemia
1302536|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
1302537|NCT01572454|dexmedetomidine|dexmedetomidine
1302538|NCT01572454|remifentanil|remifentanil
1302542|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
1302543|NCT01572402|Diet|diet
1302544|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
1302545|NCT01572402|Insulin secretion|insulin secretion
1302546|NCT01572402|Oxidative stress|oxidative stress
1302547|NCT01572402|Plasma lipids|plasma lipids
1302548|NCT01572402|Postprandial|postprandial
1302549|NCT01572402|Type 2 diabetes|type 2 diabetes
1302550|NCT01572389|Diabetes Mellitus|diabetes mellitus
1302551|NCT01572389|Depression|depression
1302552|NCT01572389|Affective Symptoms|affective symptoms
1302553|NCT01572389|Self Care|self care
1302554|NCT01572389|Telemedicine|telemedicine
1302555|NCT01572389|Psychotherapy|psychotherapy
1302556|NCT01572376|Pressure ulcers|pressure ulcers
1302557|NCT01572376|Chronic wounds|chronic wounds
1302558|NCT01572376|Spinal cord injury patients|spinal cord injury patients
1302559|NCT01572376|Bone marrow|bone marrow
1302560|NCT01572376|Mononuclear|mononuclear
1302561|NCT01572376|Debridement|debridement
1302562|NCT01572363|Fontan|fontan
1302563|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1302564|NCT01572363|Sildenafil|sildenafil
1302565|NCT01572337|NIV|niv
1302566|NCT01572337|acute respiratory failure|acute respiratory failure
1302567|NCT01572337|hypoxia|hypoxia
1302568|NCT01572337|hypercapnia|hypercapnia
1302569|NCT01572337|non-invasive ventilation|non-invasive ventilation
1302570|NCT01572337|hospital ward|hospital ward
1302571|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
1302572|NCT01572324|gallbladder cancer|gallbladder cancer
1302573|NCT01572324|Infusions|infusions
1302574|NCT01572324|Intra-Arterial|intra-arterial
1302575|NCT01572311|Aerobic exercise|aerobic exercise
1302576|NCT01572311|Cognition|cognition
1302577|NCT01572311|Dual Task|dual task
1302578|NCT01572311|Gait Training|gait training
1302579|NCT01572311|Group-based exercise|group-based exercise
1302580|NCT01572311|Older adults|older adults
1302581|NCT01572285|Hemiplegic|hemiplegic
1302582|NCT01572285|Shoulder Pain|shoulder pain
1302583|NCT01572285|Transforaminal|transforaminal
1302584|NCT01572285|Treatment|treatment
1302585|NCT01572285|Interventional|interventional
1302586|NCT01572272|Distal Capnography|distal capnography
1302587|NCT01572272|CO2|co2
1302588|NCT01572272|neonates|neonates
1302589|NCT01572272|conventional ventilation|conventional ventilation
1302590|NCT01572246|electrosurgery|electrosurgery
1304279|NCT01565057|protein|protein
1302591|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
1302592|NCT01572246|Surgical procedures, operative|surgical procedures, operative
1302593|NCT01572246|Defibrillators|defibrillators
1302594|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
1302595|NCT01572220|Hospitalized patients|hospitalized patients
1302596|NCT01572207|Multiple Sclerosis|multiple sclerosis
1302597|NCT01572207|Exercise|exercise
1302598|NCT01572207|Physical activity|physical activity
1302599|NCT01572207|Quality of life|quality of life
1302600|NCT01572194|CF|cf
1302601|NCT01572168|Fatigue|fatigue
1302602|NCT01572142|Parkinson disease|parkinson disease
1302603|NCT01572142|smell|smell
1302604|NCT01572142|cognitive|cognitive
1302605|NCT01572116|sufentanil|sufentanil
1302606|NCT01572116|irreversible pulpitis|irreversible pulpitis
1302607|NCT01572116|intra ligament injection|intra ligament injection
1302608|NCT01572090|Body mass index|body mass index
1302609|NCT01572090|Body fat|body fat
1302610|NCT01572090|Obesity|obesity
1302611|NCT01572090|Bariatric surgery|bariatric surgery
1302612|NCT01572090|Conventional dietary treatment|conventional dietary treatment
1302613|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1302614|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
1302615|NCT01572090|Inflammation|inflammation
1302616|NCT01572090|Adipokines|adipokines
1302617|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
1302618|NCT01572090|Comorbidity improvement|comorbidity improvement
1302619|NCT01572090|Energy intake|energy intake
1302620|NCT01572090|Energy expenditure|energy expenditure
1302621|NCT01572090|Physical activity|physical activity
1302622|NCT01572064|MRI|mri
1302623|NCT01572064|liver biopsy|liver biopsy
1302624|NCT01572064|serological markers|serological markers
1302625|NCT01572051|osteoarthritis|osteoarthritis
1302626|NCT01572051|knee osteoarthritis|knee osteoarthritis
1302627|NCT01572051|education|education
1302628|NCT01572012|Pharmacokinetics|pharmacokinetics
1302630|NCT01572012|Healthy Volunteers|healthy volunteers
1302631|NCT01572012|tolerability|tolerability
1302632|NCT01571999|pharmacokinetics|pharmacokinetics
1302633|NCT01571999|GW642444|gw642444
1302634|NCT01571999|GSK573719|gsk573719
1302635|NCT01571999|vilanterol|vilanterol
1302636|NCT01571999|renal impairment|renal impairment
1302637|NCT01571999|safety|safety
1302638|NCT01571999|COPD|copd
1302639|NCT01571986|NIV|niv
1302640|NCT01571986|acute respiratory failure|acute respiratory failure
1302641|NCT01571986|hypoxia|hypoxia
1302642|NCT01571986|hypercapnia|hypercapnia
1302643|NCT01571986|non-invasive ventilation|non-invasive ventilation
1302644|NCT01571986|hospital ward|hospital ward
1302645|NCT01571973|pharmaceutical care|pharmaceutical care
1302646|NCT01571973|depression|depression
1302647|NCT01571973|compliance|compliance
1302648|NCT01571973|pharmacist's intervention|pharmacist's intervention
1302649|NCT01571973|Dáder|dáder
1302650|NCT01571947|Insulinaemia|insulinaemia
1302651|NCT01571947|inflammatory markers|inflammatory markers
1302652|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
1302653|NCT01571947|SFA|sfa
1302654|NCT01571947|dietary fats|dietary fats
1302655|NCT01571947|carbohydrate|carbohydrate
1302656|NCT01571947|insulin sensitivity|insulin sensitivity
1302657|NCT01571934|Hemophilia A|hemophilia a
1302658|NCT01571908|rocuronium|rocuronium
1302659|NCT01571908|succinylcholine|succinylcholine
1302660|NCT01571908|magnesiumsulphate|magnesiumsulphate
1302661|NCT01571908|intubation conditions|intubation conditions
1302662|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
1302663|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
1302664|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
1302665|NCT01571856|Acute Diarrhea|acute diarrhea
1302666|NCT01571856|Zinc|zinc
1302667|NCT01571856|Children|children
1302668|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
1302669|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
1302670|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
1302671|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
1302672|NCT01571830|food allergy|food allergy
1302673|NCT01571830|nutrient intake|nutrient intake
1302674|NCT01571830|growth|growth
1302675|NCT01571817|Insulin Dependent|insulin dependent
1302676|NCT01571804|Anesthesia|anesthesia
1302677|NCT01571804|pregabalin|pregabalin
1302678|NCT01571804|sevoflurane|sevoflurane
1302679|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1302680|NCT01571791|Ketorolac|ketorolac
1302681|NCT01571791|lidocaine|lidocaine
1302682|NCT01571791|valvular hear diseases|valvular hear diseases
1302683|NCT01571791|cesarean section|cesarean section
1302684|NCT01571778|Hand Hygiene|hand hygiene
1302685|NCT01571778|Non-sterile Glove Use|non-sterile glove use
1302686|NCT01571765|maternal|maternal
1302687|NCT01571765|newborn|newborn
1302688|NCT01571765|child|child
1302689|NCT01571752|Drug Abuse/Dependence|drug abuse/dependence
1302691|NCT01571752|Drug Dependence|drug dependence
1302692|NCT01571739|Biomarker|biomarker
1302693|NCT01571739|Latent Tuberculosis|latent tuberculosis
1302694|NCT01571739|IGRA|igra
1302695|NCT01571739|Isoniazid|isoniazid
1302696|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
1302697|NCT01571739|Tuberculosis|tuberculosis
1302698|NCT01571739|TB|tb
1302699|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
1302700|NCT01571726|Serum M-Protein|serum m-protein
1302701|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
1302702|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
1302703|NCT01571726|Multiple Myeloma|multiple myeloma
1302704|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
1302705|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
1302706|NCT01571687|expedition|expedition
1302707|NCT01571687|hypoxia|hypoxia
1302708|NCT01571687|blood coagulation disorders|blood coagulation disorders
1302709|NCT01571687|cell-derived microparticles|cell-derived microparticles
1302710|NCT01571687|oxidative stress|oxidative stress
1302711|NCT01571687|N-Acetylcystein|n-acetylcystein
1302712|NCT01571687|vitamins|vitamins
1302713|NCT01571674|Cervical|cervical
1302714|NCT01571674|Clinical Prediction Rule|clinical prediction rule
1302715|NCT01571674|Exercise|exercise
1302716|NCT01571674|Manipulation|manipulation
1302717|NCT01571674|Manual therapy|manual therapy
1302718|NCT01571674|Mobilization|mobilization
1302719|NCT01571674|Physical Therapy|physical therapy
1302720|NCT01571674|Prognosis|prognosis
1302721|NCT01571674|Shoulder pain|shoulder pain
1302722|NCT01571674|Thoracic|thoracic
1302723|NCT01571661|KGT-1142|kgt-1142
1302724|NCT01571661|safety|safety
1302725|NCT01571661|pharmacokinetics|pharmacokinetics
1302726|NCT01571661|single-dose escalation|single-dose escalation
1302727|NCT01571661|tolerability|tolerability
1302728|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
1302729|NCT01571622|Whey protein|whey protein
1302730|NCT01571622|type 2 diabetes|type 2 diabetes
1302731|NCT01571596|XLH|xlh
1302732|NCT01571583|Chronic HCV infection|chronic hcv infection
1302733|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
1302734|NCT01571583|Liver transplantation|liver transplantation
1302735|NCT01571583|Hepatitis C|hepatitis c
1302736|NCT01571583|Hep C|hep c
1302737|NCT01571583|HCV|hcv
1302738|NCT01571583|Telaprevir|telaprevir
1302739|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
1302740|NCT01571583|Ribavirin|ribavirin
1302741|NCT01571570|Healthy volunteers|healthy volunteers
1302742|NCT01571570|Food effect|food effect
1302743|NCT01571570|Capsule|capsule
1302744|NCT01571570|Formulations|formulations
1302745|NCT01571570|Liquid formulation|liquid formulation
1302746|NCT01571570|Concept K|concept k
1302747|NCT01571570|Concept L|concept l
1302748|NCT01571570|Oral suspension|oral suspension
1302749|NCT01571570|Oral solution|oral solution
1302750|NCT01571570|TMC435HPC1002|tmc435hpc1002
1302751|NCT01571570|TMC435|tmc435
1302752|NCT01571570|HPC|hpc
1302753|NCT01571518|G-CSF|g-csf
1302754|NCT01571518|neutropenia|neutropenia
1302755|NCT01571518|TAC|tac
1302756|NCT01571505|Oral vaccines|oral vaccines
1302757|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
1302758|NCT01571505|Tropical Enteropathy|tropical enteropathy
1302759|NCT01571492|Postoperative Pain|postoperative pain
1302760|NCT01571492|Nerve block|nerve block
1302761|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
1302762|NCT01571492|Postoperative analgesia|postoperative analgesia
1302763|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
1302764|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
1302765|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1302766|NCT01571479|mini-instrument|mini-instrument
1302767|NCT01571466|HIV Seronegativity|hiv seronegativity
1302768|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
1302769|NCT01571453|MDD|mdd
1302770|NCT01571440|Bone|bone
1302771|NCT01571440|adolescents|adolescents
1302772|NCT01571440|fiber|fiber
1302773|NCT01571440|healthy|healthy
1302774|NCT01571440|boys|boys
1302775|NCT01571440|girls|girls
1302776|NCT01571440|camp|camp
1302777|NCT01571440|calcium|calcium
1302778|NCT01571427|Behavioral intervention|behavioral intervention
1302779|NCT01571427|Social engagement|social engagement
1302780|NCT01571427|Conversational engagement|conversational engagement
1302781|NCT01571427|Social network|social network
1302782|NCT01571427|Cognitive Reserve|cognitive reserve
1302783|NCT01571427|Alzheimer's disease|alzheimer's disease
1302784|NCT01571401|Kidney cancer survivors|kidney cancer survivors
1302785|NCT01571401|Randomized Controlled Trial|randomized controlled trial
1302786|NCT01571401|Physical Activity|physical activity
1302787|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
1302788|NCT01571401|Quality of life|quality of life
1302789|NCT01571388|dacomitinib|dacomitinib
1302790|NCT01571388|PF-00299804|pf-00299804
1302791|NCT01571388|hepatic impairment|hepatic impairment
1302792|NCT01571388|pharmacokinetics|pharmacokinetics
1302793|NCT01571375|Traumatic Brain Injury|traumatic brain injury
1302794|NCT01571375|HEMS|hems
1302795|NCT01571375|Out-of-hospital|out-of-hospital
1302796|NCT01571375|Finland|finland
1302797|NCT01571362|oxycodone|oxycodone
1302798|NCT01571362|naltrexone|naltrexone
1302799|NCT01571362|chronic pain|chronic pain
1302800|NCT01571362|low back pain|low back pain
1302801|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
1302802|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1302803|NCT01571349|coagulation status|coagulation status
1302804|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
1302805|NCT01571297|Diabetes Mellitus|diabetes mellitus
1302806|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
1302807|NCT01571297|Gastroparesis|gastroparesis
1302808|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
1302809|NCT01571271|biliary|biliary
1302810|NCT01571271|lithotripsy|lithotripsy
1302811|NCT01571271|gall stones|gall stones
1302812|NCT01571271|bile duct|bile duct
1302813|NCT01571271|Biliary stones|biliary stones
1302814|NCT01571258|SMS|sms
1302815|NCT01571258|Obesity|obesity
1302816|NCT01571258|Text Messaging|text messaging
1302817|NCT01571258|Intervention|intervention
1302818|NCT01571258|Mobile Phone|mobile phone
1302819|NCT01571245|Heart rate variability|heart rate variability
1302820|NCT01571245|Attentional Bias|attentional bias
1302821|NCT01571232|Macular Edema|macular edema
1302822|NCT01571232|DME|dme
1302823|NCT01571232|PDR|pdr
1302824|NCT01571232|NPDR|npdr
1302825|NCT01571232|Ozurdex|ozurdex
1302826|NCT01571232|Dexamethasone|dexamethasone
1302827|NCT01571232|Avastin|avastin
1302828|NCT01571232|Bevacizumab|bevacizumab
1302829|NCT01571219|RA|ra
1302830|NCT01571219|Biosimilar|biosimilar
1406346|NCT01138358|dyspnea|dyspnea
1302831|NCT01571206|AS|as
1302832|NCT01571206|Biosimilar|biosimilar
1302833|NCT01571180|Obesity|obesity
1302834|NCT01571180|Gastric bypass|gastric bypass
1302835|NCT01571180|Medication|medication
1302836|NCT01571180|Medication counseling|medication counseling
1302837|NCT01571180|Dietary pattern|dietary pattern
1302838|NCT01571180|Follow-up of patients|follow-up of patients
1302839|NCT01571167|Methamphetamine|methamphetamine
1302840|NCT01571167|Chantix|chantix
1302841|NCT01571167|Varenicline|varenicline
1302842|NCT01571141|HPV|hpv
1302843|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
1302844|NCT01571141|intraepithelial lesions|intraepithelial lesions
1302845|NCT01571141|regression rate|regression rate
1302846|NCT01571128|HIV|hiv
1302847|NCT01571128|Prevention & Control|prevention & control
1302848|NCT01571128|Intervention Studies|intervention studies
1302849|NCT01571128|Adolescent|adolescent
1302850|NCT01571128|Gender|gender
1302851|NCT01571128|Combination prevention|combination prevention
1302852|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
1302853|NCT01571128|Cash Transfer|cash transfer
1302854|NCT01571128|Medical Male Circumcision|medical male circumcision
1302855|NCT01571128|HIV Testing|hiv testing
1302856|NCT01571128|Mobile Health|mobile health
1302857|NCT01571115|insomnia|insomnia
1302858|NCT01571115|resistance physical exercise|resistance physical exercise
1302859|NCT01571115|stretching|stretching
1302860|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
1302861|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
1302862|NCT01571089|emotion regulation|emotion regulation
1302863|NCT01571089|emotion dysregulation|emotion dysregulation
1302864|NCT01571089|anxiety disorders|anxiety disorders
1302865|NCT01571089|skills training|skills training
1302866|NCT01571076|PGS|pgs
1302867|NCT01571076|CGH|cgh
1302868|NCT01571076|Aneuploidy|aneuploidy
1302869|NCT01571076|Advanced maternal age|advanced maternal age
1302870|NCT01571076|Male factor|male factor
1302871|NCT01571050|toothpastes|toothpastes
1302872|NCT01571050|dental fluorosis|dental fluorosis
1302873|NCT01571050|fluoride|fluoride
1302874|NCT01571050|bioavailability|bioavailability
1302875|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
1302876|NCT01571024|FOLFOX6|folfox6
1302877|NCT01571024|BKM120|bkm120
1302878|NCT01571024|Advanced Solid Tumors|advanced solid tumors
1302879|NCT01571024|Metastatic|metastatic
1302880|NCT01571024|Colorectal Cancer|colorectal cancer
1302881|NCT01571024|Pancreatic Cancer|pancreatic cancer
1302882|NCT01571011|Adolescent|adolescent
1302883|NCT01571011|Randomized Trial|randomized trial
1302884|NCT01571011|Internet|internet
1302885|NCT01571011|Depressive Disorder|depressive disorder
1302886|NCT01571011|Primary Care|primary care
1302887|NCT01571011|Prevention|prevention
1302888|NCT01570985|shoulder capsulitis|shoulder capsulitis
1302889|NCT01570985|frozen shoulder|frozen shoulder
1302890|NCT01570985|adhesive capsulitis|adhesive capsulitis
1302891|NCT01570985|distension|distension
1302892|NCT01570985|corticosteroid injection|corticosteroid injection
1302893|NCT01570985|intraarticular injection|intraarticular injection
1302894|NCT01570972|schizophrenia|schizophrenia
1302895|NCT01570972|schizoaffective disorder|schizoaffective disorder
1302896|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
1302897|NCT01570972|major depression with psychotic features|major depression with psychotic features
1304280|NCT01565057|layering|layering
1302898|NCT01570972|recent-onset psychosis|recent-onset psychosis
1302899|NCT01570972|first-episode psychosis|first-episode psychosis
1302900|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
1302901|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
1302902|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
1302903|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
1302904|NCT01570920|Activity limitations|activity limitations
1302905|NCT01570920|restriction of participation|restriction of participation
1302906|NCT01570920|chronic stroke survival|chronic stroke survival
1302907|NCT01570920|physical activity|physical activity
1302908|NCT01570920|walking|walking
1302909|NCT01570881|postoperative delirium|postoperative delirium
1302910|NCT01570881|melatonin|melatonin
1302911|NCT01570881|sevoflurane|sevoflurane
1302912|NCT01570868|Leukemia|leukemia
1302913|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
1302914|NCT01570868|CML|cml
1302915|NCT01570868|Chronic Phase|chronic phase
1302916|NCT01570868|Cytogenetic response|cytogenetic response
1302917|NCT01570868|CCyR|ccyr
1302918|NCT01570868|Major molecular response|major molecular response
1302919|NCT01570868|MMR|mmr
1302920|NCT01570868|Complete molecular response|complete molecular response
1302921|NCT01570868|CMR|cmr
1302922|NCT01570868|Ponatinib|ponatinib
1302923|NCT01570868|AP24534|ap24534
1302924|NCT01570855|Lung cancer|lung cancer
1302925|NCT01570855|chemosensitivity|chemosensitivity
1302926|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
1302927|NCT01570842|GERD|gerd
1406451|NCT01138046|ErbB2|erbb2
1302928|NCT01570842|Barrett's esophagus|barrett's esophagus
1302929|NCT01570816|stroke|stroke
1302930|NCT01570816|partial paralysis|partial paralysis
1302931|NCT01570816|gait correction|gait correction
1302932|NCT01570816|functional electrical stimulation|functional electrical stimulation
1302933|NCT01570816|paraplegia|paraplegia
1302934|NCT01570816|tetraplegia|tetraplegia
1302935|NCT01570816|spinal cord injury|spinal cord injury
1302936|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
1302937|NCT01570803|atherosclerosis,|atherosclerosis,
1302938|NCT01570803|nitinol,|nitinol,
1302939|NCT01570803|stents|stents
1302940|NCT01570777|Resistant hypertension|resistant hypertension
1302941|NCT01570777|Renal denervation|renal denervation
1302942|NCT01570777|Standardized medication regimen|standardized medication regimen
1302943|NCT01570777|Endovascular|endovascular
1302944|NCT01570777|Primary hypertension|primary hypertension
1302945|NCT01570777|Cardiovascular diseases|cardiovascular diseases
1302946|NCT01570777|Vascular diseases|vascular diseases
1302947|NCT01570764|Systemic sclerosis|systemic sclerosis
1302948|NCT01570764|Interstitial lung disease|interstitial lung disease
1302949|NCT01570764|Worsening|worsening
1302950|NCT01570764|Cyclophosphamide|cyclophosphamide
1302951|NCT01570764|Intravenous|intravenous
1302952|NCT01570738|sleep disorders|sleep disorders
1302953|NCT01570738|sleep apnea|sleep apnea
1302954|NCT01570738|ambulatory device|ambulatory device
1302955|NCT01570738|polysomnography|polysomnography
1302956|NCT01570738|WatchPAT|watchpat
1302957|NCT01570725|Immersive virtual reality|immersive virtual reality
1302958|NCT01570725|e-health|e-health
1302959|NCT01570725|surgery|surgery
1302960|NCT01570725|anxiety|anxiety
1302961|NCT01570725|relaxation|relaxation
1302962|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
1302963|NCT01570699|Cross-sectional observational study|cross-sectional observational study
1302964|NCT01570699|COMT polymorphism|comt polymorphism
1302965|NCT01570699|Opiate-users|opiate-users
1302966|NCT01570699|Opiate dependence|opiate dependence
1302967|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
1302968|NCT01570673|quality of life|quality of life
1302969|NCT01570673|urinary bladder|urinary bladder
1302970|NCT01570673|symptoms|symptoms
1302971|NCT01570673|children|children
1302972|NCT01570634|Clostridium difficile|clostridium difficile
1302973|NCT01570634|infection|infection
1302974|NCT01570634|diarrhea|diarrhea
1302975|NCT01570634|cramping|cramping
1302976|NCT01570621|achalasia|achalasia
1302977|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
1302978|NCT01570621|LES pressure|les pressure
1302979|NCT01570621|postoperative complication|postoperative complication
1302980|NCT01570621|symptom relief|symptom relief
1302981|NCT01570621|esophageal barium|esophageal barium
1302982|NCT01570608|Ranibizumab|ranibizumab
1302983|NCT01570608|Bevacizumab|bevacizumab
1302984|NCT01570608|Verteporfin|verteporfin
1302985|NCT01570608|age-related macular degeneration|age-related macular degeneration
1302986|NCT01570595|Tobacco Use Cessation|tobacco use cessation
1302987|NCT01570595|Tobacco Cessation|tobacco cessation
1302988|NCT01570595|Tobacco Use Disorder|tobacco use disorder
1302989|NCT01570595|Tobacco Dependence|tobacco dependence
1302990|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
1302991|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
1302992|NCT01570582|recurrent ovarian|recurrent ovarian
1302994|NCT01570582|GOG performance|gog performance
1302995|NCT01570582|Hematologic g|hematologic g
1302996|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
1302998|NCT01570556|Hemodialysis|hemodialysis
1302999|NCT01570556|Inflammation|inflammation
1303000|NCT01570556|Bacteriuria|bacteriuria
1303001|NCT01570556|Interleukin 6|interleukin 6
1303002|NCT01570556|C reactive protein|c reactive protein
1303003|NCT01570543|implants|implants
1303004|NCT01570543|knee implants|knee implants
1303005|NCT01570543|hip implants|hip implants
1303006|NCT01570543|metallic implants|metallic implants
1303007|NCT01570504|Strongyloidiasis|strongyloidiasis
1303008|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
1303009|NCT01570504|Ivermectin|ivermectin
1303010|NCT01570465|AML|aml
1303011|NCT01570465|adult|adult
1303012|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
1303013|NCT01570452|matrilysin|matrilysin
1303014|NCT01570452|MMP-7|mmp-7
1303015|NCT01570452|colorectal cancer|colorectal cancer
1303016|NCT01570452|adenoma|adenoma
1303017|NCT01570452|lymph nodes|lymph nodes
1303018|NCT01570426|Bipolar disorder|bipolar disorder
1303019|NCT01570426|Mood disorders|mood disorders
1303020|NCT01570426|ADHD|adhd
1303021|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1303022|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
1303023|NCT01570426|Anxiety disorders|anxiety disorders
1303024|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
1303025|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
1303026|NCT01570426|Mental disorders|mental disorders
1303027|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
1303028|NCT01570426|affective neuroscience|affective neuroscience
1303029|NCT01570426|emotion|emotion
1303031|NCT01570426|fMRI|fmri
1303032|NCT01570426|neurocognitive tasks|neurocognitive tasks
1303033|NCT01570426|imaging|imaging
1303034|NCT01570426|Healthy controls|healthy controls
1303035|NCT01570426|typical development|typical development
1303036|NCT01570400|social phobia|social phobia
1303037|NCT01570400|social anxiety|social anxiety
1303038|NCT01570400|cognitive bias modification|cognitive bias modification
1303039|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
1303040|NCT01570374|Internet|internet
1303041|NCT01570374|Anxiety|anxiety
1303042|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
1303043|NCT01570361|Atrial Fibrillation|atrial fibrillation
1303044|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
1303045|NCT01570361|Heart Diseases|heart diseases
1303046|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
1303047|NCT01570361|Pathologic Processes|pathologic processes
1303048|NCT01570348|Crohn's Disease|crohn's disease
1303049|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1303050|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
1303051|NCT01570335|SBAR,|sbar,
1303052|NCT01570335|SAQ,|saq,
1303053|NCT01570335|Team Resource Management|team resource management
1303054|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
1303055|NCT01570309|vitamin D,|vitamin d,
1303056|NCT01570309|vitamin D deficiency|vitamin d deficiency
1303057|NCT01570309|coronary artery disease|coronary artery disease
1303058|NCT01570309|ergocalciferol|ergocalciferol
1303059|NCT01570309|endothelial function|endothelial function
1303060|NCT01570309|adhesion molecules|adhesion molecules
1303061|NCT01570309|inflammation|inflammation
1303062|NCT01570309|IL-12|il-12
1303063|NCT01570309|interferon-gamma|interferon-gamma
1303064|NCT01570309|CXCL-10|cxcl-10
1303065|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
1303066|NCT01570309|endothelial dysfunction|endothelial dysfunction
1303067|NCT01570309|cytokines|cytokines
1303068|NCT01570309|chemokines|chemokines
1303069|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1303070|NCT01570296|tumors harbor molecular|tumors harbor molecular
1303071|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
1303072|NCT01570296|known to overexpress EGFR|known to overexpress egfr
1303073|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
1303074|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1303075|NCT01570283|Cytomegalovirus|cytomegalovirus
1303076|NCT01570283|CMV|cmv
1303077|NCT01570283|adenovirus|adenovirus
1303078|NCT01570283|Epstein-Barr virus|epstein-barr virus
1303079|NCT01570283|EBV|ebv
1303080|NCT01570283|Human polyomavirus type I|human polyomavirus type i
1303081|NCT01570283|BK virus|bk virus
1303082|NCT01570283|Human herpesvirus 6|human herpesvirus 6
1303083|NCT01570283|HHV6|hhv6
1303084|NCT01570270|Hypercholesterolemia|hypercholesterolemia
1303085|NCT01570270|Endocannabinoids|endocannabinoids
1303086|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
1303087|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
1303088|NCT01570257|overdrainage|overdrainage
1303089|NCT01570257|subdural effusion|subdural effusion
1303090|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
1303091|NCT01570231|octogenarian|octogenarian
1303193|NCT01569724|bexarotene|bexarotene
1303092|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
1303093|NCT01570231|stroke recurrence|stroke recurrence
1303094|NCT01570218|breast cancer|breast cancer
1303095|NCT01570218|gynecological cancer|gynecological cancer
1303096|NCT01570218|radiotherapy|radiotherapy
1303097|NCT01570218|fatigue|fatigue
1303098|NCT01570218|musicotherapy|musicotherapy
1303099|NCT01570192|gram negative pathogens|gram negative pathogens
1303100|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
1303101|NCT01570192|Acinetobacter|acinetobacter
1303102|NCT01570192|HCAP|hcap
1303103|NCT01570192|VABP|vabp
1303104|NCT01570192|HABP|habp
1303105|NCT01570179|bariatric surgery|bariatric surgery
1303106|NCT01570179|residual paralysis|residual paralysis
1303107|NCT01570179|surgical conditions|surgical conditions
1303108|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
1303109|NCT01570166|RFA|rfa
1303110|NCT01570166|HR|hr
1303111|NCT01570127|Individualized Acupuncture|individualized acupuncture
1303112|NCT01570127|Standardized Acupuncture|standardized acupuncture
1303113|NCT01570127|Low Back Pain|low back pain
1303114|NCT01570127|Randomized Controlled Trial|randomized controlled trial
1303115|NCT01570114|Covered metallic stent|covered metallic stent
1303116|NCT01570114|colon|colon
1303117|NCT01570114|benign stricture|benign stricture
1303118|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
1303119|NCT01570075|RFA|rfa
1303120|NCT01570075|HR|hr
1303121|NCT01570062|Inflammation|inflammation
1303122|NCT01570062|Pathologic Processes|pathologic processes
1303123|NCT01570049|Single arm|single arm
1303124|NCT01570049|Open label|open label
1303125|NCT01570049|Bendamustine HCl|bendamustine hcl
1303126|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
1303127|NCT01570036|stage I breast cancer|stage i breast cancer
1303128|NCT01570036|stage II breast cancer|stage ii breast cancer
1303129|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
1303130|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
1303131|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
1303132|NCT01570036|male breast cancer|male breast cancer
1303133|NCT01570023|Deglutition|deglutition
1303134|NCT01570023|Exercise|exercise
1303135|NCT01569997|Dementia|dementia
1303136|NCT01569997|emergency hospitalization|emergency hospitalization
1303137|NCT01569997|nursing home|nursing home
1303138|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
1303139|NCT01569997|cognitive decline|cognitive decline
1303140|NCT01569997|disability|disability
1303141|NCT01569997|residents|residents
1303142|NCT01569997|facilities|facilities
1303143|NCT01569997|long term care unit|long term care unit
1303144|NCT01569997|health policy|health policy
1303145|NCT01569997|general practitioner|general practitioner
1303146|NCT01569997|prevention|prevention
1303147|NCT01569984|Colorectal|colorectal
1303148|NCT01569971|Transition Program|transition program
1303149|NCT01569971|Perspectives|perspectives
1303150|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
1303151|NCT01569919|Phase II|phase ii
1303152|NCT01569919|Single arm|single arm
1303153|NCT01569919|Vaccine|vaccine
1303154|NCT01569906|Atopic Dermatitis|atopic dermatitis
1303155|NCT01569893|Telemonitoring|telemonitoring
1303156|NCT01569893|Telemedicine|telemedicine
1303157|NCT01569893|Diabetes mellitus|diabetes mellitus
1303158|NCT01569880|Blood gas response|blood gas response
1303159|NCT01569880|Exercise|exercise
1303160|NCT01569880|Gas exchange|gas exchange
1303161|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
1303162|NCT01569880|Pulmonary function|pulmonary function
1303163|NCT01569828|LCZ696|lcz696
1303164|NCT01569828|pharmacokinetics|pharmacokinetics
1303165|NCT01569815|Renal Impairment,|renal impairment,
1303166|NCT01569815|LCZ696|lcz696
1303167|NCT01569802|breast cancer screening|breast cancer screening
1303168|NCT01569802|tomosynthesis|tomosynthesis
1303169|NCT01569802|FFDM|ffdm
1303170|NCT01569789|cytokines|cytokines
1303171|NCT01569789|inflammation|inflammation
1303172|NCT01569789|vagus nerve|vagus nerve
1303173|NCT01569789|TNF|tnf
1303174|NCT01569776|Cow milk allergy|cow milk allergy
1303175|NCT01569776|CMA|cma
1303176|NCT01569763|endometrial ablation|endometrial ablation
1303177|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
1303178|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1303179|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
1303180|NCT01569750|Follicular lymphoma|follicular lymphoma
1303181|NCT01569750|Ibrutinib|ibrutinib
1303182|NCT01569750|R-CHOP|r-chop
1303183|NCT01569750|Rituximab|rituximab
1303184|NCT01569750|Cyclophosphamide|cyclophosphamide
1303185|NCT01569750|Doxorubicin|doxorubicin
1303186|NCT01569750|Vincristine|vincristine
1303187|NCT01569750|Prednisone|prednisone
1303188|NCT01569737|ella|ella
1303189|NCT01569737|ulipristal acetate|ulipristal acetate
1303190|NCT01569737|pregnancy|pregnancy
1303191|NCT01569737|emergency contraception|emergency contraception
1303192|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
1303194|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
1303195|NCT01569711|deep brain stimulation|deep brain stimulation
1303196|NCT01569698|pediatric|pediatric
1303197|NCT01569698|acute renal failure|acute renal failure
1303198|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
1303199|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
1303200|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
1303201|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
1303203|NCT01569685|Traumatic Stress|traumatic stress
1303204|NCT01569685|Depressions|depressions
1303205|NCT01569685|Refugees|refugees
1303206|NCT01569672|Navigator|navigator
1303207|NCT01569659|Schizophrenia|schizophrenia
1303208|NCT01569659|Refractory|refractory
1303209|NCT01569659|Treatment resistant|treatment resistant
1303210|NCT01569659|Lurasidone|lurasidone
1303211|NCT01569646|monocytes|monocytes
1303212|NCT01569646|culprit vessels|culprit vessels
1303213|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
1303214|NCT01569620|CRC|crc
1303215|NCT01569620|Screening Colonoscopy|screening colonoscopy
1303216|NCT01569620|Hispanics|hispanics
1303217|NCT01569620|Latinos|latinos
1303218|NCT01569607|Neurophysiology|neurophysiology
1303219|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1303220|NCT01569607|Neurology|neurology
1303221|NCT01569607|Stroke|stroke
1303222|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
1303223|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
1303224|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
1303225|NCT01569581|Inactivated Vaccine|inactivated vaccine
1303226|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
1303227|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
1303228|NCT01569581|Efficacy|efficacy
1303229|NCT01569568|Neuroimaging|neuroimaging
1303230|NCT01569568|MRI|mri
1303231|NCT01569568|Urea cycle|urea cycle
1303232|NCT01569568|hyperammonemia|hyperammonemia
1303233|NCT01569568|cognitive function|cognitive function
1303234|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
1303235|NCT01569516|Alzheimer's Disease|alzheimer's disease
1303236|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
1303237|NCT01569503|Crohn's Disease|crohn's disease
1303238|NCT01569503|VNS|vns
1303239|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
1303240|NCT01569503|inflammation|inflammation
1303241|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
1303242|NCT01569503|TNF|tnf
1303243|NCT01569464|Rotigotine|rotigotine
1303244|NCT01569464|Restless Legs Syndrome|restless legs syndrome
1303245|NCT01569464|Neupro®|neupro®
1303246|NCT01569451|Multiple Sclerosis|multiple sclerosis
1303247|NCT01569451|Glatiramer Acetate|glatiramer acetate
1303248|NCT01569451|Rituximab|rituximab
1303249|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1303250|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1303251|NCT01569425|PCOS|pcos
1303252|NCT01569399|Alcohol dependance|alcohol dependance
1303253|NCT01569399|rTMS|rtms
1303254|NCT01569399|craving|craving
1303255|NCT01569399|alcohol consumption|alcohol consumption
1303256|NCT01569386|pulse wave velocity|pulse wave velocity
1303257|NCT01569386|low intensity physical activity|low intensity physical activity
1303258|NCT01569386|hemiplegia|hemiplegia
1303259|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
1303260|NCT01569373|Graft versus Host Disease|graft versus host disease
1303261|NCT01569373|GVHD|gvhd
1303262|NCT01569360|Spinal cord injury|spinal cord injury
1303263|NCT01569360|Tetraplegia|tetraplegia
1303264|NCT01569360|Paraplegia|paraplegia
1303265|NCT01569360|Respiratory function|respiratory function
1303266|NCT01569360|Corset|corset
1303267|NCT01569347|Cocaine|cocaine
1303268|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
1303269|NCT01569347|Genetic|genetic
1303270|NCT01569347|Clinical|clinical
1303271|NCT01569347|Biological|biological
1303272|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
1303273|NCT01569308|Cardiac output|cardiac output
1303274|NCT01569308|Pulse pressure variation|pulse pressure variation
1303275|NCT01569308|Fluid responsiveness|fluid responsiveness
1303276|NCT01569308|Low tidal volume|low tidal volume
1303277|NCT01569295|Zydelig|zydelig
1303278|NCT01569295|CLL|cll
1303279|NCT01569295|CAL 101|cal 101
1303280|NCT01569295|CAL-101|cal-101
1303281|NCT01569295|GS 1101|gs 1101
1303282|NCT01569295|GS-1101|gs-1101
1303283|NCT01569295|PI3K|pi3k
1303284|NCT01569295|Rituxan|rituxan
1303285|NCT01569295|Rituximab|rituximab
1303286|NCT01569295|Bendamustine|bendamustine
1303287|NCT01569295|Leukemia|leukemia
1303288|NCT01569295|idelalisib|idelalisib
1303289|NCT01569282|Surgical bypass|surgical bypass
1303290|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
1303291|NCT01569282|Gastrojejunostomy|gastrojejunostomy
1303292|NCT01569282|Biliary stent|biliary stent
1303293|NCT01569282|Enteral stent|enteral stent
1303294|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
1303295|NCT01569269|cancer|cancer
1303296|NCT01569269|psychological distress|psychological distress
1303297|NCT01569269|mindfulness|mindfulness
1303298|NCT01569269|complementary and alternative|complementary and alternative
1303299|NCT01569243|Diabetes mellitus|diabetes mellitus
1303300|NCT01569243|Text messaging|text messaging
1303301|NCT01569243|Physical activity|physical activity
1303302|NCT01569230|Knee osteoarthritis|knee osteoarthritis
1303303|NCT01569230|acupuncture|acupuncture
1303304|NCT01569230|sham acupuncture|sham acupuncture
1303305|NCT01569217|Diaphragm|diaphragm
1303306|NCT01569217|Abdomen|abdomen
1303307|NCT01569217|Breathing pattern|breathing pattern
1303308|NCT01569217|dyspnea|dyspnea
1303309|NCT01569191|Ocular allergy|ocular allergy
1303310|NCT01569191|Tear supplement|tear supplement
1303311|NCT01569191|Cold compress|cold compress
1303312|NCT01569178|stem cells|stem cells
1303313|NCT01569178|acute myocardial infarction|acute myocardial infarction
1303314|NCT01569178|heart failure|heart failure
1303315|NCT01569178|heart attack|heart attack
1303316|NCT01569178|bone marrow|bone marrow
1303317|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
1303318|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
1303319|NCT01569178|Left ventricular function improvement|left ventricular function improvement
1303320|NCT01569178|mortality|mortality
1303321|NCT01569165|Acidogenicity|acidogenicity
1303322|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
1303323|NCT01569165|dental plaque|dental plaque
1303324|NCT01569165|water rinsing|water rinsing
1303325|NCT01569139|Validation|validation
1303326|NCT01569139|Concordance|concordance
1303327|NCT01569139|Myocardial infarction|myocardial infarction
1303328|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1303329|NCT01569139|General Practice Research Database|general practice research database
1303330|NCT01569139|Hospital Episode Statistics|hospital episode statistics
1303331|NCT01569139|ONS mortality|ons mortality
1303332|NCT01569113|ella|ella
1303333|NCT01569113|ellaOne|ellaone
1303334|NCT01569113|quickstart|quickstart
1303335|NCT01569113|contraception|contraception
1303336|NCT01569113|combined oral pill|combined oral pill
1303337|NCT01569113|microgynon|microgynon
1303338|NCT01569087|empegfilgrastim|empegfilgrastim
1303339|NCT01569087|pegylated filgrastim|pegylated filgrastim
1303340|NCT01569087|neutropenia|neutropenia
1303341|NCT01569087|febrile neutropenia|febrile neutropenia
1303342|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
1303343|NCT01569087|breast cancer|breast cancer
1303344|NCT01569087|docetaxel|docetaxel
1303345|NCT01569087|doxorubicin|doxorubicin
1303346|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
1303347|NCT01569061|overactive bladder|overactive bladder
1303348|NCT01569061|laser therapy|laser therapy
1303349|NCT01569061|urinary incontinence|urinary incontinence
1303350|NCT01569061|urinary urgency|urinary urgency
1303351|NCT01569035|oligohudramnios|oligohudramnios
1303352|NCT01569035|oral anti coagulant|oral anti coagulant
1303353|NCT01569035|Dopplar ultrasound|dopplar ultrasound
1303354|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
1303355|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
1303356|NCT01569022|oral appliance|oral appliance
1303357|NCT01569009|Bronchiectasis|bronchiectasis
1303358|NCT01569009|Physical activity|physical activity
1303359|NCT01569009|Activity monitor|activity monitor
1303360|NCT01569009|Pedometer|pedometer
1303361|NCT01568996|atypical nevi|atypical nevi
1303362|NCT01568996|melanoma|melanoma
1303363|NCT01568996|sulforaphane|sulforaphane
1303364|NCT01568996|broccoli|broccoli
1303365|NCT01568996|lesions|lesions
1303366|NCT01568996|STAT1|stat1
1303367|NCT01568996|STAT3|stat3
1303368|NCT01568970|rehabilitation|rehabilitation
1303369|NCT01568970|return to work|return to work
1303370|NCT01568970|sick leave|sick leave
1303371|NCT01568957|Gait|gait
1303372|NCT01568957|Dual-task|dual-task
1303373|NCT01568957|Obstacle avoidance|obstacle avoidance
1303374|NCT01568957|Attention allocation|attention allocation
1303375|NCT01568944|periodontal|periodontal
1303376|NCT01568944|disease|disease
1303377|NCT01568944|dendritic|dendritic
1303378|NCT01568944|cells|cells
1303379|NCT01568944|antibiotics|antibiotics
1303380|NCT01568931|thrombectomy|thrombectomy
1303381|NCT01568905|smoker|smoker
1303382|NCT01568905|smoking|smoking
1303383|NCT01568905|nicotine levels|nicotine levels
1303384|NCT01568905|tobacco|tobacco
1303385|NCT01568905|nicotine|nicotine
1303386|NCT01568892|ART-experienced|art-experienced
1303387|NCT01568892|GSK1349572|gsk1349572
1303388|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
1303389|NCT01568892|Dolutegravir|dolutegravir
1303390|NCT01568879|Recurrent gout|recurrent gout
1303391|NCT01568879|Tophaceous gout|tophaceous gout
1303392|NCT01568879|Gout flares|gout flares
1303393|NCT01568879|Arthritis|arthritis
1303394|NCT01568879|Joint Diseases|joint diseases
1303395|NCT01568879|Rheumatic Diseases|rheumatic diseases
1303396|NCT01568866|multiple myeloma|multiple myeloma
1303397|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
1303398|NCT01568840|Physical Therapy Modalities|physical therapy modalities
1303399|NCT01568840|Posture|posture
1303400|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
1303401|NCT01568840|Dyskinesias|dyskinesias
1303402|NCT01568840|Neck pain|neck pain
1303403|NCT01568814|colonoscopy|colonoscopy
1303404|NCT01568814|bowel preparation|bowel preparation
1303405|NCT01568814|polyethylene glycol|polyethylene glycol
1303406|NCT01568814|low residue meal|low residue meal
1303407|NCT01568801|Integrated Services|integrated services
1303408|NCT01568801|Health Services for the Elderly|health services for the elderly
1303409|NCT01568801|Community Services|community services
1303410|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
1303411|NCT01568775|End Stage Renal Disease|end stage renal disease
1303412|NCT01568775|Dialysis|dialysis
1303413|NCT01568775|aliskiren|aliskiren
1303414|NCT01568775|SPP100A|spp100a
1303415|NCT01568762|Asthma|asthma
1303416|NCT01568762|VAK694|vak694
1303417|NCT01568762|QAX576|qax576
1303418|NCT01568762|QBX258|qbx258
1303419|NCT01568762|pharmacokinetics|pharmacokinetics
1303421|NCT01568749|Analgesia|analgesia
1303422|NCT01568749|Paracetamol|paracetamol
1303423|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
1303424|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
1303425|NCT01568723|Barrett's esophagus|barrett's esophagus
1303426|NCT01568723|high grade dysplasia|high grade dysplasia
1303427|NCT01568723|ablation|ablation
1303428|NCT01568723|radiofrequency ablation|radiofrequency ablation
1303429|NCT01568723|esophageal cancer|esophageal cancer
1303430|NCT01568710|Blood Flow|blood flow
1303431|NCT01568710|Endothelium|endothelium
1303432|NCT01568710|Nitric Oxide|nitric oxide
1303433|NCT01568710|Oximetry|oximetry
1303434|NCT01568710|Laser Doppler|laser doppler
1303435|NCT01568710|Sickle Cell Disease|sickle cell disease
1303436|NCT01568697|Oral Microbiome|oral microbiome
1303437|NCT01568697|Periodontitis|periodontitis
1303438|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
1303439|NCT01568697|Oral Infection|oral infection
1303440|NCT01568697|Immune Disorder|immune disorder
1303441|NCT01568697|Periodontal Disease|periodontal disease
1303442|NCT01568697|Gum Disease|gum disease
1303443|NCT01568697|Healthy Volunteer|healthy volunteer
1303444|NCT01568697|HV|hv
1303445|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1303446|NCT01568684|Depression|depression
1303447|NCT01568684|Depression Treatment|depression treatment
1303448|NCT01568684|Major Depression|major depression
1303449|NCT01568684|Unipolar Depression|unipolar depression
1303450|NCT01568671|Adult|adult
1303451|NCT01568671|Body Fat Distribution|body fat distribution
1303452|NCT01568671|Healthy|healthy
1303453|NCT01568671|Metabolic Rate|metabolic rate
1303454|NCT01568671|Thermophysiology|thermophysiology
1303455|NCT01568671|Brown Fat|brown fat
1303456|NCT01568671|Healthy Volunteer|healthy volunteer
1303457|NCT01568671|HV|hv
1303458|NCT01568658|Hereditary Myopathies|hereditary myopathies
1303459|NCT01568658|Neuropathology|neuropathology
1303460|NCT01568658|Muscular Dystrophy|muscular dystrophy
1303461|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
1303462|NCT01568658|Inherited Neuropathy|inherited neuropathy
1303463|NCT01568658|Inherited Myopathy|inherited myopathy
1303464|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
1303465|NCT01568658|Healthy Volunteer|healthy volunteer
1303466|NCT01568658|HV|hv
1303467|NCT01568645|Sickle Cell Anemia|sickle cell anemia
1303468|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1303469|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
1303470|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
1303471|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
1303472|NCT01568645|Sickle Cell Disease|sickle cell disease
1303473|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
1303474|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
1303475|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
1303476|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
1303477|NCT01568632|Safety|safety
1303478|NCT01568632|Solid Tumor|solid tumor
1303479|NCT01568632|Lymphoma|lymphoma
1303480|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
1303481|NCT01568619|cardiac output|cardiac output
1303482|NCT01568606|Heart Failure|heart failure
1303483|NCT01568606|Obesity|obesity
1303484|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1303485|NCT01568580|Hemophilia A|hemophilia a
1303486|NCT01568580|Factor VIII|factor viii
1303487|NCT01568580|Recombinant|recombinant
1303488|NCT01568567|safety|safety
1303489|NCT01568567|tolerance|tolerance
1303490|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
1303491|NCT01568541|children|children
1303492|NCT01568541|dentifrice|dentifrice
1303493|NCT01568541|fluoride|fluoride
1303494|NCT01568541|dental fluorosis|dental fluorosis
1303495|NCT01568515|HPV vaccine|hpv vaccine
1304281|NCT01565044|Stroke|stroke
1303496|NCT01568515|Vaccine adherence|vaccine adherence
1303497|NCT01568515|Vaccine utilization|vaccine utilization
1303498|NCT01568515|Electronic Messaging|electronic messaging
1303499|NCT01568502|dobutamine stress|dobutamine stress
1303500|NCT01568502|inducible ischemia|inducible ischemia
1303501|NCT01568502|CAD|cad
1303502|NCT01568476|Regional anesthesia|regional anesthesia
1303503|NCT01568476|Sciatic nerve block|sciatic nerve block
1303504|NCT01568476|foot surgery|foot surgery
1303505|NCT01568476|ankle surgery|ankle surgery
1303506|NCT01568476|Interneural local anesthetic|interneural local anesthetic
1303507|NCT01568463|Inter-scalene Block|inter-scalene block
1303508|NCT01568463|Regional Anesthesia|regional anesthesia
1303509|NCT01568463|shoulder surgeries|shoulder surgeries
1303510|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
1303511|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
1303512|NCT01568437|TAP block|tap block
1303513|NCT01568424|Heart Failure|heart failure
1303514|NCT01568424|Right Ventricular Failure|right ventricular failure
1303515|NCT01568424|Levitronix|levitronix
1303516|NCT01568424|Thoratec Corporation|thoratec corporation
1303517|NCT01568411|None - normal volunteers|none - normal volunteers
1303518|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
1303519|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
1303520|NCT01568372|pediatric|pediatric
1303521|NCT01568372|tonsillectomy|tonsillectomy
1303522|NCT01568372|pain management|pain management
1303523|NCT01568372|nurse follow-up|nurse follow-up
1303524|NCT01568346|Newly diagnosed|newly diagnosed
1303525|NCT01568346|Early stage|early stage
1303526|NCT01568333|Decitabine|decitabine
1303527|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
1303528|NCT01568320|Aorta|aorta
1303529|NCT01568320|Thoracic|thoracic
1303530|NCT01568320|Aortic dissection|aortic dissection
1303531|NCT01568320|Rupture|rupture
1303532|NCT01568320|Type B|type b
1303533|NCT01568320|DeBakey type III|debakey type iii
1303534|NCT01568320|Endovascular|endovascular
1303535|NCT01568307|Major depressive disorder|major depressive disorder
1303536|NCT01568307|Serotonin transporter|serotonin transporter
1303537|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
1303538|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
1303539|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
1303540|NCT01568281|Bioequivalence|bioequivalence
1303541|NCT01568281|pharmacokinetics|pharmacokinetics
1303542|NCT01568281|safety|safety
1303543|NCT01568281|anastrozole|anastrozole
1303544|NCT01568281|Arimidex|arimidex
1303545|NCT01568281|Japanese|japanese
1303546|NCT01568281|healthy subject|healthy subject
1303547|NCT01568268|palonosetron|palonosetron
1303548|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
1303549|NCT01568255|myopathic symptoms|myopathic symptoms
1303550|NCT01568242|Cataract|cataract
1303551|NCT01568242|Phacoemulsification|phacoemulsification
1303552|NCT01568242|Temperature|temperature
1303553|NCT01568242|Vitreous|vitreous
1303554|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
1303555|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
1303556|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
1303557|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
1303558|NCT01568177|MCD|mcd
1303559|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
1303560|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
1303561|NCT01568164|Ventricular Remodeling|ventricular remodeling
1303562|NCT01568164|Dor|dor
1303563|NCT01568151|Colorectal Cancer|colorectal cancer
1303564|NCT01568151|Screening|screening
1303565|NCT01568151|Education|education
1303566|NCT01568151|Testing|testing
1303567|NCT01568138|Ventricular Remodeling|ventricular remodeling
1303568|NCT01568112|BG00012|bg00012
1303569|NCT01568112|gastrointestinal events|gastrointestinal events
1303570|NCT01568112|flushing events|flushing events
1303571|NCT01568112|dose titration|dose titration
1303572|NCT01568112|pre-medication|pre-medication
1303573|NCT01568112|aspirin|aspirin
1303574|NCT01568073|Parkinson|parkinson
1303575|NCT01568073|PD|pd
1303576|NCT01568073|Wearing-off|wearing-off
1303577|NCT01568073|Levodopa/DDCI|levodopa/ddci
1303578|NCT01568060|Safety|safety
1303579|NCT01568060|Infanrix-IPV|infanrix-ipv
1303580|NCT01568060|Post-marketing surveillance|post-marketing surveillance
1303581|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
1303582|NCT01568047|Parkinson Disease|parkinson disease
1303583|NCT01568047|BIA 9-1067|bia 9-1067
1303584|NCT01568034|Parkinson's Disease|parkinson's disease
1303585|NCT01568034|BIA 9-1067|bia 9-1067
1303586|NCT01567995|eczematous|eczematous
1303587|NCT01567995|dermatitis|dermatitis
1303588|NCT01567982|tDCS|tdcs
1303589|NCT01567982|brain stimulation|brain stimulation
1303590|NCT01567982|addiction|addiction
1303591|NCT01567982|substance dependence|substance dependence
1303592|NCT01567982|craving|craving
1303593|NCT01567982|cognition|cognition
1304282|NCT01565044|hemiplegia|hemiplegia
1303594|NCT01567969|mental health services|mental health services
1303595|NCT01567969|child behavior disorders|child behavior disorders
1303596|NCT01567969|child psychiatry|child psychiatry
1303597|NCT01567956|Ulcerative colitis|ulcerative colitis
1303598|NCT01567943|alcohol abuse|alcohol abuse
1303599|NCT01567943|drug abuse|drug abuse
1303600|NCT01567943|schizophrenia|schizophrenia
1303601|NCT01567943|bipolar disorder|bipolar disorder
1303602|NCT01567943|major depressive disorder|major depressive disorder
1303603|NCT01567943|contingency management|contingency management
1303604|NCT01567943|psychosocial treatment|psychosocial treatment
1303605|NCT01567930|Temsirolimus|temsirolimus
1303606|NCT01567930|HCC|hcc
1303607|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1303608|NCT01567917|Venous thromboembolism|venous thromboembolism
1303609|NCT01567917|Colorectal cancer|colorectal cancer
1303610|NCT01567917|Postoperative period|postoperative period
1303611|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
1303612|NCT01567904|thrombosis|thrombosis
1303613|NCT01567904|Central Venous Line|central venous line
1303614|NCT01567904|CVL|cvl
1611476|NCT00352729|Donor Site|donor site
1303615|NCT01567891|Ovarian Cancer|ovarian cancer
1303616|NCT01567891|Cell Therapy|cell therapy
1303617|NCT01567891|T Cell Therapy|t cell therapy
1303618|NCT01567891|NY-ESO-1|ny-eso-1
1303619|NCT01567891|Immuno-oncology|immuno-oncology
1303620|NCT01567891|Metastatic|metastatic
1303621|NCT01567891|Previously treated|previously treated
1303622|NCT01567891|T Cell Receptor|t cell receptor
1303623|NCT01567878|ultrasound|ultrasound
1303624|NCT01567878|MASEI index|masei index
1303625|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
1303626|NCT01567878|enthesis ultrasound|enthesis ultrasound
1303627|NCT01567878|articular ultrasound|articular ultrasound
1303628|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
1303629|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
1303630|NCT01567852|orientation|orientation
1303631|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
1303632|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
1303633|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
1303634|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
1303635|NCT01567826|YELLO|yello
1303636|NCT01567826|Atorvastatin|atorvastatin
1303637|NCT01567826|Simvastatin|simvastatin
1303638|NCT01567826|Rosuvastatin|rosuvastatin
1303639|NCT01567826|lipid therapy|lipid therapy
1303640|NCT01567826|Statin therapy|statin therapy
1303641|NCT01567826|Coronary artery disease|coronary artery disease
1303642|NCT01567826|CHD|chd
1303643|NCT01567813|Warts|warts
1303644|NCT01567813|Papillomavirus infections|papillomavirus infections
1303645|NCT01567813|DNA virus infections|dna virus infections
1303646|NCT01567813|Virus diseases|virus diseases
1303647|NCT01567813|Skin diseases, viral|skin diseases, viral
1303648|NCT01567813|Tumor virus infections|tumor virus infections
1303649|NCT01567813|Skin diseases, infectious|skin diseases, infectious
1303650|NCT01567813|Skin diseases|skin diseases
1303651|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
1303652|NCT01567787|Proton Radiation Therapy|proton radiation therapy
1303653|NCT01567787|Spinal tumors|spinal tumors
1303654|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
1303655|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
1303656|NCT01567774|Coronary artery disease|coronary artery disease
1303657|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
1303658|NCT01567774|atorvastatin|atorvastatin
1303659|NCT01567774|rosuvastatin|rosuvastatin
1303660|NCT01567761|IOP|iop
1303661|NCT01567748|CABG|cabg
1303662|NCT01567748|Coronary Artery Bypass|coronary artery bypass
1303663|NCT01567748|Central Aortic Pressure|central aortic pressure
1303664|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
1303665|NCT01567735|Hepatitis C|hepatitis c
1303666|NCT01567735|TMC435HPC3011|tmc435hpc3011
1303667|NCT01567735|TMC435|tmc435
1303668|NCT01567722|HIV infection|hiv infection
1303669|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
1303670|NCT01567722|anal cancer|anal cancer
1303671|NCT01567722|cervical cancer|cervical cancer
1303672|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
1303673|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1303674|NCT01567696|Revision,|revision,
1303675|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
1303676|NCT01567683|of Limtop and vehicle|of limtop and vehicle
1303677|NCT01567657|Sedation in TEE|sedation in tee
1303678|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
1303679|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
1303680|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1303681|NCT01567644|Myocardial Ischemia|myocardial ischemia
1303682|NCT01567644|Refractory Angina|refractory angina
1303683|NCT01567631|Classical Procedure|classical procedure
1303684|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
1303685|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
1303686|NCT01567631|Minimal invasive surgery|minimal invasive surgery
1303687|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
1303688|NCT01567618|Docetaxel|docetaxel
1303689|NCT01567618|Fluorouracil|fluorouracil
1303690|NCT01567618|First line therapy|first line therapy
1303691|NCT01567618|Gastric cancer|gastric cancer
1303692|NCT01567605|spinal cord injury|spinal cord injury
1303693|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
1303694|NCT01567605|blood pressure|blood pressure
1303695|NCT01567605|bowel care management|bowel care management
1303696|NCT01567605|defecation|defecation
1303697|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1303698|NCT01567592|Myocardial Ischemia|myocardial ischemia
1303699|NCT01567592|Refractory Angina|refractory angina
1303700|NCT01567579|congenital heart defects|congenital heart defects
1303701|NCT01567566|home based daily exercise program|home based daily exercise program
1303702|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
1611657|NCT00352235|a-GalCer|a-galcer
1407354|NCT01135368|GERD|gerd
1303703|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
1303704|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
1303705|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
1303706|NCT01567553|early clinical deficit|early clinical deficit
1303707|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
1303708|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
1303709|NCT01567540|Interferon protein 10|interferon protein 10
1303710|NCT01567540|Chemokine gradients|chemokine gradients
1303711|NCT01567540|Sitagliptin|sitagliptin
1303712|NCT01567527|Aripiprazole|aripiprazole
1303713|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
1303714|NCT01567527|Bipolar|bipolar
1303715|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
1303716|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
1303717|NCT01567488|Advanced|advanced
1303718|NCT01567488|Non functioning|non functioning
1303719|NCT01567488|Well differentiated|well differentiated
1303720|NCT01567462|bladder cancer|bladder cancer
1303721|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
1303722|NCT01567423|Malaria|malaria
1303723|NCT01567423|Plasmodium falciparum|plasmodium falciparum
1303724|NCT01567423|Children|children
1303725|NCT01567423|Efficacy|efficacy
1303726|NCT01567423|Uncomplicated malaria|uncomplicated malaria
1303727|NCT01567410|e-learning|e-learning
1303728|NCT01567410|education|education
1303729|NCT01567384|cancer|cancer
1303730|NCT01567384|neoplasms|neoplasms
1303731|NCT01567384|tumors|tumors
1303732|NCT01567345|Pain|pain
1303733|NCT01567345|cancer|cancer
1303734|NCT01567345|Intrathecal|intrathecal
1303735|NCT01567345|analgesia|analgesia
1303736|NCT01567345|Morphine|morphine
1303737|NCT01567345|Implantable pump|implantable pump
1303738|NCT01567319|Sensitization|sensitization
1303739|NCT01567319|Skin Prick Test|skin prick test
1303740|NCT01567319|Standardization|standardization
1303741|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
1303742|NCT01567306|Allergy|allergy
1303743|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1303744|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
1303745|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
1303746|NCT01567267|Evidence-based Medicine|evidence-based medicine
1303747|NCT01567267|Good Scientific Practice|good scientific practice
1303748|NCT01567267|Problem-based Learning|problem-based learning
1303749|NCT01567267|Critical health literacy|critical health literacy
1303750|NCT01567267|Educational intervention|educational intervention
1303751|NCT01567254|guided imaginary|guided imaginary
1303752|NCT01567241|clinical hypnosis|clinical hypnosis
1303753|NCT01567241|relaxation music|relaxation music
1303754|NCT01567241|reproduction techniques|reproduction techniques
1303755|NCT01567241|insemination|insemination
1303756|NCT01567241|embryo transfer|embryo transfer
1303757|NCT01567241|pregnancy rate|pregnancy rate
1303758|NCT01567228|obesity|obesity
1303759|NCT01567228|overweight|overweight
1303760|NCT01567228|dental caries|dental caries
1303761|NCT01567228|school problems|school problems
1303762|NCT01567228|school failure|school failure
1303763|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
1303764|NCT01567228|Needing dental preventive services|needing dental preventive services
1303765|NCT01567228|Needing academic support for school problems|needing academic support for school problems
1303766|NCT01567215|granuloma umbilical|granuloma umbilical
1303767|NCT01567202|Brain tumor|brain tumor
1303768|NCT01567202|Glioma|glioma
1303769|NCT01567202|Glioblastoma|glioblastoma
1303770|NCT01567202|Tumor stem cells|tumor stem cells
1303771|NCT01567202|Immunotherapy|immunotherapy
1303772|NCT01567202|Vaccine|vaccine
1303773|NCT01567189|Exercise therapy|exercise therapy
1303774|NCT01567189|cost effectiveness|cost effectiveness
1303775|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
1303776|NCT01567189|home-based exercise|home-based exercise
1303777|NCT01567176|Sirtuins|sirtuins
1303778|NCT01567176|Aging|aging
1303779|NCT01567176|Metabolic disease|metabolic disease
1303780|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1303781|NCT01567124|Schizophrenia|schizophrenia
1303782|NCT01567124|Moxonidine|moxonidine
1303783|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
1303784|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
1303785|NCT01567111|Primary aldosteronism|primary aldosteronism
1303786|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
1303787|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
1303788|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
1303789|NCT01567072|NSAID|nsaid
1303790|NCT01567072|bone fracture|bone fracture
1303791|NCT01567072|heal|heal
1303792|NCT01567033|Diabetes|diabetes
1303793|NCT01567033|Obesity|obesity
1303794|NCT01567033|Home visiting|home visiting
1303795|NCT01567020|Central Auditory Processing|central auditory processing
1303796|NCT01567020|Traumatic Brain Injury|traumatic brain injury
1303797|NCT01567020|Hearing Loss|hearing loss
1303798|NCT01567007|pedometer|pedometer
1303799|NCT01567007|physical activity|physical activity
1303800|NCT01567007|workplace|workplace
1303801|NCT01566994|smoking cessation|smoking cessation
1303802|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
1303803|NCT01566981|eHealth solution|ehealth solution
1303804|NCT01566981|Health Information Technology|health information technology
1303805|NCT01566981|quality of life|quality of life
1303806|NCT01566981|family medicine|family medicine
1303807|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
1303808|NCT01566981|primary care|primary care
1303809|NCT01566968|COPD|copd
1303810|NCT01566968|Asthma|asthma
1303811|NCT01566968|Healthy volunteers|healthy volunteers
1303812|NCT01566968|Chronic cough|chronic cough
1303813|NCT01566968|Smokers|smokers
1303814|NCT01566968|Cough challenge|cough challenge
1303815|NCT01566968|Cough challenge testing.|cough challenge testing.
1303816|NCT01566955|transgastric|transgastric
1303817|NCT01566955|NOTES|notes
1303818|NCT01566955|Gastrotomy|gastrotomy
1303819|NCT01566955|BRCA 1/2|brca 1/2
1303820|NCT01566942|FOLFIRI|folfiri
1303821|NCT01566942|FOLFOX|folfox
1303822|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
1303823|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
1303824|NCT01566929|Obesity|obesity
1303825|NCT01566929|In vitro fertilization|in vitro fertilization
1303826|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
1303827|NCT01566929|Obstetric outcome|obstetric outcome
1303828|NCT01566929|Weight reduction|weight reduction
1303829|NCT01566903|arterial stenosis|arterial stenosis
1303830|NCT01566903|arteriovenous malformations|arteriovenous malformations
1303831|NCT01566903|Post-treatment follow-up|post-treatment follow-up
1303832|NCT01566890|sickle cell|sickle cell
1303833|NCT01566890|sickle cell crisis|sickle cell crisis
1303834|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
1303835|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
1303836|NCT01566890|vaso-occlusion|vaso-occlusion
1303837|NCT01566890|sickle cell anemia|sickle cell anemia
1303838|NCT01566890|sickle cell disease|sickle cell disease
1303839|NCT01566890|genetic diseases|genetic diseases
1303840|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
1303841|NCT01566890|Lexiscan|lexiscan
1303842|NCT01566890|Regadenoson|regadenoson
1303843|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
1303844|NCT01566890|Hydroxyurea|hydroxyurea
1303845|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
1303846|NCT01566877|Marburg Virus|marburg virus
1303847|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
1303848|NCT01566864|hypertension|hypertension
1303849|NCT01566864|disparities|disparities
1303850|NCT01566864|care management|care management
1303851|NCT01566864|provider education|provider education
1303852|NCT01566864|audit and feedback|audit and feedback
1303853|NCT01566864|Omron|omron
1303854|NCT01566864|African Americans|african americans
1303855|NCT01566864|organizational change|organizational change
1303856|NCT01566864|implementation research|implementation research
1303857|NCT01566838|Visual analog pain score|visual analog pain score
1303858|NCT01566838|Length of stay|length of stay
1303859|NCT01566838|Hospital Cost|hospital cost
1303860|NCT01566838|Subpleural pain catheter|subpleural pain catheter
1303861|NCT01566838|Bupivacaine|bupivacaine
1303862|NCT01566825|amitriptyline|amitriptyline
1303863|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
1303864|NCT01566812|Breast Feeding|breast feeding
1303865|NCT01566812|Cardiovascular Risk|cardiovascular risk
1303866|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
1303867|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1303868|NCT01566799|Metformin|metformin
1303869|NCT01566799|Pathologic Complete Response|pathologic complete response
1303870|NCT01566773|COPD|copd
1303871|NCT01566760|food effect|food effect
1303872|NCT01566760|bioavailability|bioavailability
1304275|NCT01565070|Pain|pain
1303873|NCT01566760|pharmacokinetics|pharmacokinetics
1303874|NCT01566760|fesoterodine|fesoterodine
1303875|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
1303876|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
1303877|NCT01566734|Surgical Wound Infection|surgical wound infection
1303878|NCT01566734|cefazolin|cefazolin
1303879|NCT01566734|Cesarean Section|cesarean section
1303880|NCT01566708|Acute Tinnitus|acute tinnitus
1303881|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
1303882|NCT01566708|Music Therapy|music therapy
1303883|NCT01566708|fMRI|fmri
1303884|NCT01566708|Therapy Evaluation|therapy evaluation
1303885|NCT01566682|Lung Lesion|lung lesion
1303886|NCT01566682|Lung Mass|lung mass
1303887|NCT01566682|Lung Nodule|lung nodule
1303888|NCT01566682|Lung Cancer|lung cancer
1303889|NCT01566682|Low-Dose CT|low-dose ct
1303890|NCT01566682|CT|ct
1303891|NCT01566682|Diagnostic|diagnostic
1303892|NCT01566682|Evaluation|evaluation
1303893|NCT01566682|Bioconductance|bioconductance
1303894|NCT01566682|ProLung|prolung
1303895|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
1303896|NCT01566669|Morphine|morphine
1303897|NCT01566669|Analgesia|analgesia
1303898|NCT01566669|patient-controlled|patient-controlled
1303899|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
1303900|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1303901|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
1303902|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
1303903|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
1303904|NCT01566656|Lymphoid malignancies|lymphoid malignancies
1303905|NCT01566643|Helicobacter pylori|helicobacter pylori
1303906|NCT01566643|antibiotic resistance|antibiotic resistance
1303907|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
1303908|NCT01566630|human recombinant RLX030|human recombinant rlx030
1303909|NCT01566630|Pre-eclampsia|pre-eclampsia
1303910|NCT01566630|hemodynamics|hemodynamics
1303911|NCT01566630|Pharmacokinetics|pharmacokinetics
1303912|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1303913|NCT01566604|NVA237|nva237
1303914|NCT01566591|Bipolar Depression|bipolar depression
1303915|NCT01566552|AMBISOME|ambisome
1303916|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
1303917|NCT01566552|SINGLE DOSE|single dose
1303918|NCT01566539|Social cooperation|social cooperation
1303919|NCT01566539|Oxytocin|oxytocin
1303920|NCT01566539|Vasopressin|vasopressin
1303921|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
1303922|NCT01566539|Empathy|empathy
1303923|NCT01566539|fMRI|fmri
1303924|NCT01566513|Peer Support|peer support
1303925|NCT01566513|Cost Effectiveness|cost effectiveness
1303926|NCT01566513|Reducing Hospital use|reducing hospital use
1303927|NCT01566513|Serious Mental Illness|serious mental illness
1303928|NCT01566500|Epilepsy|epilepsy
1303929|NCT01566500|Medication Adherence|medication adherence
1303930|NCT01566487|Bioequivalence|bioequivalence
1303931|NCT01566487|Quetiapine fumarate|quetiapine fumarate
1303932|NCT01566487|crossover|crossover
1303933|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
1303934|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
1303935|NCT01566461|Peripheral Artery Disease|peripheral artery disease
1303936|NCT01566461|Experimental|experimental
1303937|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
1303938|NCT01566448|Ketamine|ketamine
1303939|NCT01566448|Mucositis|mucositis
1303940|NCT01566448|Oral ketamine rinse|oral ketamine rinse
1303941|NCT01566409|Constipation|constipation
1303942|NCT01566409|Maintenance treatment|maintenance treatment
1303943|NCT01566409|Ultrasound of rectum|ultrasound of rectum
1303944|NCT01566396|Fractional,|fractional,
1303945|NCT01566396|RF,|rf,
1303946|NCT01566396|Wrinkles|wrinkles
1303947|NCT01566396|Safety|safety
1303948|NCT01566396|Efficacy|efficacy
1303949|NCT01566396|treatment|treatment
1303950|NCT01566370|alcoholism|alcoholism
1303951|NCT01566370|alcohol use disorder|alcohol use disorder
1303952|NCT01566370|alcohol dependence|alcohol dependence
1303953|NCT01566370|alcohol abuse|alcohol abuse
1303954|NCT01566370|bipolar|bipolar
1303955|NCT01566370|anticonvulsant|anticonvulsant
1303956|NCT01566370|zonisamide|zonisamide
1303957|NCT01566357|dental erosion|dental erosion
1303958|NCT01566357|enamel|enamel
1303959|NCT01566357|dentin|dentin
1303960|NCT01566344|Premature Ventricular Complex|premature ventricular complex
1303961|NCT01566344|Cardiomyopathy|cardiomyopathy
1303962|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
1303963|NCT01566344|Catheter Ablation|catheter ablation
1303964|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
1303965|NCT01566344|Randomized Clinical Trial|randomized clinical trial
1303966|NCT01566331|Safe Delivery|safe delivery
1303967|NCT01566331|reduction of pain|reduction of pain
1303968|NCT01566331|reduction stage of labor|reduction stage of labor
1303969|NCT01566318|Depression|depression
1303970|NCT01566318|Anxiety|anxiety
1303971|NCT01566318|Geriatric mental health|geriatric mental health
1303972|NCT01566279|solid tumors|solid tumors
1303973|NCT01566279|all comers|all comers
1303974|NCT01566279|everolimus|everolimus
1303975|NCT01566279|biomarker|biomarker
1303976|NCT01566279|next generation sequencing|next generation sequencing
1303977|NCT01566266|gut flora|gut flora
1303978|NCT01566266|antibiotics|antibiotics
1303979|NCT01566266|lipid metabolism|lipid metabolism
1303980|NCT01566266|LDL cholesterol|ldl cholesterol
1303981|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
1303982|NCT01566240|cervical cancer|cervical cancer
1303983|NCT01566240|Chemotherapy|chemotherapy
1303984|NCT01566240|Paclitaxel|paclitaxel
1303985|NCT01566240|Carboplatin|carboplatin
1303986|NCT01566240|Cisplatin|cisplatin
1303987|NCT01566240|Radiotherapy|radiotherapy
1303988|NCT01566240|Chemoradiation|chemoradiation
1303989|NCT01566240|Brachytherapy|brachytherapy
1303990|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
1611743|NCT00352053|HIV|hiv
1303991|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
1303992|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
1303993|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
1303994|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
1303995|NCT01566227|overdenture|overdenture
1303996|NCT01566227|implant|implant
1303997|NCT01566227|edentulism|edentulism
1303998|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
1303999|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
1304000|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
1304001|NCT01566201|Arterial stiffness|arterial stiffness
1304002|NCT01566201|Endothelial function|endothelial function
1304003|NCT01566201|Left ventricular function|left ventricular function
1304004|NCT01566201|Apoptosis|apoptosis
1304005|NCT01566201|Nitrooxidative stress|nitrooxidative stress
1304006|NCT01566175|Neovasc Reducer|neovasc reducer
1304007|NCT01566175|Coronary Sinus|coronary sinus
1304008|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
1304009|NCT01566175|angina class 3-4|angina class 3-4
1304010|NCT01566162|Lurasidone|lurasidone
1304011|NCT01566162|Latuda|latuda
1304012|NCT01566162|Schizophrenia|schizophrenia
1304013|NCT01566136|hip fracture patients|hip fracture patients
1304014|NCT01566136|cognitive impairment|cognitive impairment
1304015|NCT01566136|rehabilitation model of care|rehabilitation model of care
1304016|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
1304017|NCT01566123|IMRT|imrt
1304018|NCT01566123|IORT|iort
1304019|NCT01566110|pediatric|pediatric
1304020|NCT01566110|dietary treatment|dietary treatment
1304021|NCT01566110|celiac disease|celiac disease
1304022|NCT01566110|T1D|t1d
1304023|NCT01566097|Cluster randomized trial|cluster randomized trial
1304024|NCT01566097|Decision aids|decision aids
1304025|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
1304026|NCT01566058|Post partum|post partum
1304027|NCT01566058|mother-child relationships|mother-child relationships
1304028|NCT01566045|Prostate Cancer|prostate cancer
1304029|NCT01566045|Biopsy|biopsy
1304030|NCT01566032|pulmonary air leak|pulmonary air leak
1304031|NCT01566032|Thopaz|thopaz
1304032|NCT01566032|analog|analog
1304033|NCT01566032|digital|digital
1304034|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
1304035|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
1304036|NCT01566006|proteinuria|proteinuria
1304037|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
1304038|NCT01565980|Lung cancer|lung cancer
1304039|NCT01565980|mindfulness therapy|mindfulness therapy
1304040|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
1304041|NCT01565967|AutoLog|autolog
1304042|NCT01565967|Post market release|post market release
1304043|NCT01565967|Non-interventional|non-interventional
1304044|NCT01565954|Sickle Cell Disease|sickle cell disease
1304045|NCT01565954|Respiration Disorders|respiration disorders
1304046|NCT01565954|Polysomnography|polysomnography
1304047|NCT01565941|Cardiovascular|cardiovascular
1304048|NCT01565941|Respiratory|respiratory
1304049|NCT01565941|Failure|failure
1304050|NCT01565941|Heart|heart
1304051|NCT01565941|Lung|lung
1304052|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
1304053|NCT01565941|Tight glycemic control|tight glycemic control
1304054|NCT01565941|Subcutaneous|subcutaneous
1304055|NCT01565941|Insulin|insulin
1304056|NCT01565941|Algorithm|algorithm
1304057|NCT01565928|Prostate cancer|prostate cancer
1304058|NCT01565928|docetaxel|docetaxel
1304059|NCT01565928|MDV3100|mdv3100
1304060|NCT01565928|enzalutamide|enzalutamide
1304061|NCT01565928|Xtandi|xtandi
1304062|NCT01565902|BAF312|baf312
1304063|NCT01565902|Pharmacokinetics|pharmacokinetics
1304064|NCT01565902|Hepatic impairment|hepatic impairment
1304065|NCT01565876|weight bearing|weight bearing
1304066|NCT01565876|physiological load|physiological load
1304067|NCT01565863|Perceived Disability|perceived disability
1304068|NCT01565863|Mental Wellness|mental wellness
1304069|NCT01565863|Employment|employment
1304070|NCT01565863|Social Integration and Engagement|social integration and engagement
1304071|NCT01565863|Goal Achievement|goal achievement
1304072|NCT01565850|HIV-1|hiv-1
1304073|NCT01565850|HIV|hiv
1304074|NCT01565850|Treatment-Naive|treatment-naive
1304075|NCT01565837|Melanoma|melanoma
1304076|NCT01565837|Malignant Melanoma|malignant melanoma
1304077|NCT01565837|Metastatic|metastatic
1304078|NCT01565837|Oligometastatic|oligometastatic
1304079|NCT01565837|Radiosurgery|radiosurgery
1304080|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
1304081|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
1304082|NCT01565837|Ipilimumab|ipilimumab
1304083|NCT01565837|Yervoy|yervoy
1304084|NCT01565837|MDX-010|mdx-010
1304085|NCT01565837|Circulating Tumor Cells|circulating tumor cells
1304086|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
1304087|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
1304088|NCT01565798|colonization|colonization
1304089|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
1304090|NCT01565785|Child parent home self-management|child parent home self-management
1304091|NCT01565772|Lung cancer|lung cancer
1304092|NCT01565772|Stage III|stage iii
1304093|NCT01565759|Gene expression|gene expression
1304094|NCT01565759|Lithium|lithium
1304095|NCT01565759|Healthy volunteers|healthy volunteers
1304096|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
1304097|NCT01565746|BAY88-8223|bay88-8223
1304098|NCT01565746|radium-223 dichloride|radium-223 dichloride
1304099|NCT01565746|prostate cancer|prostate cancer
1304100|NCT01565720|Isavuconazole|isavuconazole
1304101|NCT01565720|Healthy Volunteers|healthy volunteers
1304102|NCT01565720|BAL8557|bal8557
1304103|NCT01565707|Pediatric|pediatric
1304104|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
1304105|NCT01565707|Phase 3|phase 3
1304106|NCT01565707|Pharmacokinetics|pharmacokinetics
1304107|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
1304108|NCT01565694|Cognitive Function|cognitive function
1304109|NCT01565694|Phase 3|phase 3
1304110|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
1304111|NCT01565694|Pharmacokinetics|pharmacokinetics
1304112|NCT01565694|Ocular Accommodation|ocular accommodation
1304113|NCT01565694|Urodynamics|urodynamics
1304114|NCT01565681|Healthy Volunteers|healthy volunteers
1304115|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
1304116|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
1304117|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
1304118|NCT01565668|AC220|ac220
1304119|NCT01565668|Relapse|relapse
1304120|NCT01565668|Refractory|refractory
1304121|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
1304122|NCT01565655|ASP015K|asp015k
1304123|NCT01565642|Dementia, decision making|dementia, decision making
1304124|NCT01565629|Autism|autism
1304125|NCT01565629|Asperger's Syndrome|asperger's syndrome
1304126|NCT01565629|Treatment|treatment
1304127|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
1304128|NCT01565629|Anxiety|anxiety
1304129|NCT01565629|Children|children
1304130|NCT01565629|Therapy|therapy
1304131|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
1304132|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
1304133|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
1304134|NCT01565616|Bone Marrow Transplant|bone marrow transplant
1304135|NCT01565616|Hematologic Diseases|hematologic diseases
1304136|NCT01565616|Genetic Diseases|genetic diseases
1304137|NCT01565616|Anemia|anemia
1304138|NCT01565616|Hemolytic|hemolytic
1304139|NCT01565616|Congenital|congenital
1304140|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
1304141|NCT01565616|HLA|hla
1304142|NCT01565603|Hypoxia|hypoxia
1304143|NCT01565603|Exercise|exercise
1304144|NCT01565603|Sleep|sleep
1304145|NCT01565603|Brain|brain
1304146|NCT01565603|Neuromuscular function|neuromuscular function
1304147|NCT01565603|Heart|heart
1304148|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
1304149|NCT01565590|dexmedetomidine|dexmedetomidine
1304150|NCT01565590|cytokines|cytokines
1304151|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
1304152|NCT01565577|Serum bactericidal activity|serum bactericidal activity
1304153|NCT01565577|Menbvac|menbvac
1304154|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
1304155|NCT01565564|intervention|intervention
1304156|NCT01565564|shared care|shared care
1304157|NCT01565564|pregnancy outcome|pregnancy outcome
1304158|NCT01565564|macrosomia|macrosomia
1304159|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
1304160|NCT01565551|Traumatic Brain Injury|traumatic brain injury
1304161|NCT01565551|Common Data Elements|common data elements
1304162|NCT01565551|Prognostic Models|prognostic models
1304163|NCT01565551|Neuroimaging|neuroimaging
1304164|NCT01565551|Biomarkers|biomarkers
1304165|NCT01565551|Genetic Variants|genetic variants
1304166|NCT01565551|Concussion|concussion
1304167|NCT01565551|Psychological Health|psychological health
1304168|NCT01565538|Cancer|cancer
1304169|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
1304170|NCT01565538|Adenocarcinoma|adenocarcinoma
1304171|NCT01565538|EGFR gene mutation|egfr gene mutation
1304172|NCT01565538|Chemotherapy|chemotherapy
1304173|NCT01565538|Pemetrexed|pemetrexed
1304174|NCT01565538|Erlotinib|erlotinib
1304175|NCT01565525|well child visit|well child visit
1304176|NCT01565525|anticipatory guidance|anticipatory guidance
1304177|NCT01565525|obesity prevention|obesity prevention
1304178|NCT01565525|infant feeding|infant feeding
1304179|NCT01565512|randomized trial|randomized trial
1304180|NCT01565512|robotic prostatectomy|robotic prostatectomy
1304181|NCT01565512|prostate cancer|prostate cancer
1304182|NCT01565512|foley catheter discomfort|foley catheter discomfort
1304183|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
1304184|NCT01565486|operation time|operation time
1304185|NCT01565486|complication rate|complication rate
1304186|NCT01565486|costs|costs
1304187|NCT01565486|admission time|admission time
1304190|NCT01565473|non-motor symptoms|non-motor symptoms
1304191|NCT01565460|pancreas|pancreas
1304192|NCT01565460|biliary|biliary
1304193|NCT01565460|stricture|stricture
1304194|NCT01565421|Cancer|cancer
1304195|NCT01565421|Neoplasms|neoplasms
1304196|NCT01565421|Solid Tumor|solid tumor
1304197|NCT01565421|Ovarian Cancer|ovarian cancer
1304198|NCT01565421|Solid Malignancies|solid malignancies
1304199|NCT01565395|ALS|als
1304200|NCT01565395|PD|pd
1304201|NCT01565382|Amyloid imaging|amyloid imaging
1304202|NCT01565382|Positron Emission Tomography|positron emission tomography
1304203|NCT01565382|18F-AV-45|18f-av-45
1304204|NCT01565382|florbetapir F 18|florbetapir f 18
1304205|NCT01565382|Diagnostic imaging|diagnostic imaging
1304206|NCT01565369|Amyloid imaging|amyloid imaging
1304207|NCT01565369|Positron Emission Tomography|positron emission tomography
1304208|NCT01565369|18F-AV-45|18f-av-45
1304209|NCT01565369|florbetapir F 18|florbetapir f 18
1304210|NCT01565369|Diagnostic imaging|diagnostic imaging
1304211|NCT01565356|Amyloid imaging|amyloid imaging
1304212|NCT01565356|Positron Emission Tomography|positron emission tomography
1304213|NCT01565356|18F-AV-45|18f-av-45
1304214|NCT01565356|florbetapir F 18|florbetapir f 18
1304215|NCT01565356|Diagnostic imaging|diagnostic imaging
1304216|NCT01565343|Amyloid imaging|amyloid imaging
1304217|NCT01565343|Positron Emission Tomography|positron emission tomography
1304218|NCT01565343|18F-AV-45|18f-av-45
1304219|NCT01565343|florbetapir F 18|florbetapir f 18
1304220|NCT01565343|Diagnostic imaging|diagnostic imaging
1304221|NCT01565330|Amyloid imaging|amyloid imaging
1304222|NCT01565330|Positron Emission Tomography|positron emission tomography
1304223|NCT01565330|18F-AV-45|18f-av-45
1304224|NCT01565330|florbetapir F 18|florbetapir f 18
1304225|NCT01565330|Diagnostic imaging|diagnostic imaging
1304226|NCT01565304|Teen pregnancy|teen pregnancy
1304227|NCT01565304|Sexually transmitted infections|sexually transmitted infections
1304228|NCT01565304|Sexual risk behaviors|sexual risk behaviors
1304229|NCT01565291|Amyloid imaging|amyloid imaging
1304230|NCT01565291|Positron Emission Tomography|positron emission tomography
1304231|NCT01565291|18F-AV-45|18f-av-45
1304232|NCT01565291|florbetapir F 18|florbetapir f 18
1304233|NCT01565291|Diagnostic imaging|diagnostic imaging
1304234|NCT01565278|Parenteral nutrition|parenteral nutrition
1304235|NCT01565278|fish oil|fish oil
1304236|NCT01565278|liver disease|liver disease
1304237|NCT01565278|Omegaven|omegaven
1304238|NCT01565278|hepatic|hepatic
1304239|NCT01565278|liver biopsy|liver biopsy
1304240|NCT01565278|bilirubin|bilirubin
1304241|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
1304242|NCT01565265|GnRH antagonist|gnrh antagonist
1304243|NCT01565265|GnRH agonist|gnrh agonist
1304244|NCT01565265|assisted reproduction|assisted reproduction
1304245|NCT01565265|FSH|fsh
1304246|NCT01565265|LH|lh
1304247|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
1304248|NCT01565239|Warfarin|warfarin
1304249|NCT01565239|Monitoring|monitoring
1304250|NCT01565239|prothrombin time|prothrombin time
1304251|NCT01565239|Fiix prothrombin time|fiix prothrombin time
1304252|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
1304253|NCT01565239|new test|new test
1304254|NCT01565226|Capnography|capnography
1304255|NCT01565226|CO2|co2
1304256|NCT01565226|neonates|neonates
1304257|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
1304258|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
1304259|NCT01565213|group therapy|group therapy
1304260|NCT01565200|HER2|her2
1304261|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
1304262|NCT01565187|Hand Transplantation|hand transplantation
1304263|NCT01565174|cannabis|cannabis
1304264|NCT01565174|THC|thc
1304265|NCT01565174|COMT|comt
1304266|NCT01565174|psychosis|psychosis
1304267|NCT01565174|D2|d2
1304268|NCT01565161|Obesity|obesity
1304269|NCT01565161|Overweight|overweight
1304270|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
1304271|NCT01565109|NESC|nesc
1304272|NCT01565109|NEOADJUVANT|neoadjuvant
1304273|NCT01565109|GASTRIC|gastric
1304274|NCT01565070|Osteoarthritis|osteoarthritis
1304276|NCT01565070|Quality of life|quality of life
1304277|NCT01565057|emulsion|emulsion
1304278|NCT01565057|emptying|emptying
1304283|NCT01565044|automatic pilot|automatic pilot
1304284|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
1304285|NCT01565031|Asthma|asthma
1304286|NCT01565018|Rotigotine|rotigotine
1304287|NCT01565018|Neupro®|neupro®
1304288|NCT01565018|Transdermal Patch|transdermal patch
1304289|NCT01565018|Bioequivalence|bioequivalence
1304290|NCT01565005|MCPH|mcph
1304291|NCT01565005|FANCONI ANEMIA|fanconi anemia
1304292|NCT01564992|Parkinson's disease|parkinson's disease
1304293|NCT01564992|Pharmacogenetics|pharmacogenetics
1304294|NCT01564992|Genetics|genetics
1304295|NCT01564979|botulinum toxin|botulinum toxin
1304296|NCT01564979|facial nerve|facial nerve
1304297|NCT01564979|hemifacial spasm|hemifacial spasm
1304298|NCT01564979|tears|tears
1304299|NCT01564966|transplantation|transplantation
1304300|NCT01564966|inflammation|inflammation
1304301|NCT01564966|endothelial dysfunction|endothelial dysfunction
1304302|NCT01564953|vitamin D|vitamin d
1304303|NCT01564953|calcium|calcium
1304304|NCT01564953|magnesium|magnesium
1304305|NCT01564953|COPD|copd
1304307|NCT01564940|Cervical cap insemination|cervical cap insemination
1304308|NCT01564940|Usability Study|usability study
1304309|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
1304310|NCT01564927|BP HR HRV|bp hr hrv
1304311|NCT01564875|Simvast CR|simvast cr
1304312|NCT01564875|Zocor|zocor
1304313|NCT01564862|Drug Therapy|drug therapy
1304314|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
1304315|NCT01564849|Sinusitis|sinusitis
1304316|NCT01564849|rhinitis|rhinitis
1304317|NCT01564849|nasal polyps|nasal polyps
1304318|NCT01564823|Crohn´s disease|crohn´s disease
1304319|NCT01564823|Metronidazole|metronidazole
1304320|NCT01564823|Azathioprine|azathioprine
1304321|NCT01564823|Adalimumab|adalimumab
1304322|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
1304323|NCT01564810|liver metastasis|liver metastasis
1304324|NCT01564810|colorectal cancer|colorectal cancer
1304325|NCT01564810|cetuximab|cetuximab
1304326|NCT01564810|chemotherapy|chemotherapy
1304327|NCT01564797|Diabetes|diabetes
1304328|NCT01564797|haemoglobin A1C|haemoglobin a1c
1304329|NCT01564797|Hispanic|hispanic
1304330|NCT01564797|Behavioural Intervention|behavioural intervention
1304331|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
1304332|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
1304333|NCT01564758|non-interventional|non-interventional
1304334|NCT01564758|non-comparative|non-comparative
1304335|NCT01564758|open-label study|open-label study
1304336|NCT01564758|safety|safety
1304337|NCT01564758|Linezolid|linezolid
1304338|NCT01564758|gram positive infections|gram positive infections
1304339|NCT01564758|Filipino|filipino
1304340|NCT01564732|morbid obesity|morbid obesity
1304341|NCT01564732|gastric band|gastric band
1304342|NCT01564719|clergy|clergy
1304343|NCT01564719|weight loss|weight loss
1304344|NCT01564719|holistic|holistic
1304345|NCT01564719|stress|stress
1304346|NCT01564719|spiritual|spiritual
1304347|NCT01564706|Amyloid imaging|amyloid imaging
1304348|NCT01564706|Positron Emission Tomography|positron emission tomography
1304349|NCT01564706|18F-AV-45|18f-av-45
1304350|NCT01564706|florbetapir F 18|florbetapir f 18
1304351|NCT01564706|Diagnostic imaging|diagnostic imaging
1304352|NCT01564693|anorexia|anorexia
1304353|NCT01564693|cancer|cancer
1304354|NCT01564693|hypothalamus|hypothalamus
1304355|NCT01564693|inflammation|inflammation
1304356|NCT01564680|Lower abdominal surgery|lower abdominal surgery
1304357|NCT01564680|Paracetamol|paracetamol
1304358|NCT01564680|Lornoxicam|lornoxicam
1304359|NCT01564680|Morphine|morphine
1304360|NCT01564667|PTSD|ptsd
1304361|NCT01564667|Posttraumatic Stress|posttraumatic stress
1304362|NCT01564667|Post Traumatic Stress|post traumatic stress
1304363|NCT01564667|Attention Bias|attention bias
1304364|NCT01564667|Threat Bias|threat bias
1304365|NCT01564667|Combat|combat
1304366|NCT01564667|Warzone|warzone
1304367|NCT01564641|knee|knee
1304368|NCT01564641|osteoarthritis|osteoarthritis
1304369|NCT01564641|bicompartmental|bicompartmental
1304370|NCT01564641|arthroplasty|arthroplasty
1304371|NCT01564641|joint diseases|joint diseases
1304372|NCT01564628|CAD|cad
1304373|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
1304374|NCT01564615|Umbilical venous catheter|umbilical venous catheter
1304375|NCT01564615|Silver|silver
1304376|NCT01564615|Preterm infants|preterm infants
1304377|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
1304378|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
1304379|NCT01564576|Laparoscopic surgery|laparoscopic surgery
1304380|NCT01564576|Anesthesiology|anesthesiology
1304381|NCT01564576|Neuromuscular blockade|neuromuscular blockade
1304382|NCT01564550|Type 2 diabetes|type 2 diabetes
1304383|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
1304384|NCT01564550|VLDL1|vldl1
1304385|NCT01564550|VLDL2|vldl2
1304696|NCT01563094|Lactation|lactation
1304386|NCT01564550|hyperinsulinemia|hyperinsulinemia
1304387|NCT01564550|diet|diet
1304388|NCT01564537|Drug therapy|drug therapy
1304389|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
1304390|NCT01564524|Facial Trauma|facial trauma
1304391|NCT01564524|Fat Grafts|fat grafts
1304392|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1304393|NCT01564524|Wounded warriors|wounded warriors
1304394|NCT01564511|Multiple Sclerosis|multiple sclerosis
1304395|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
1304396|NCT01564511|Fatigue|fatigue
1304397|NCT01564511|Gait disorder|gait disorder
1304398|NCT01564498|anthocyanins|anthocyanins
1304399|NCT01564498|antioxidant|antioxidant
1304400|NCT01564498|polyphenols|polyphenols
1304401|NCT01564498|bioavailability|bioavailability
1304402|NCT01564498|cholesterol|cholesterol
1304403|NCT01564498|insulin sensitivity|insulin sensitivity
1304404|NCT01564498|glucose tolerance|glucose tolerance
1304405|NCT01564498|atherosclerosis|atherosclerosis
1304406|NCT01564498|metabolic syndrome|metabolic syndrome
1304407|NCT01564446|medication|medication
1304408|NCT01564446|discharge|discharge
1304409|NCT01564446|adherence|adherence
1304410|NCT01564446|compliance|compliance
1304411|NCT01564446|secure message|secure message
1304412|NCT01564433|robotics|robotics
1304413|NCT01564433|rehabilitation|rehabilitation
1304414|NCT01564433|gait|gait
1304415|NCT01564433|cerebral palsy|cerebral palsy
1304416|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
1304417|NCT01564420|intrathecal morphine|intrathecal morphine
1304418|NCT01564420|postoperative analgesia|postoperative analgesia
1304419|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
1304420|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
1304421|NCT01564407|Restrictive scar contracture|restrictive scar contracture
1304422|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
1304423|NCT01564407|Burn Scar|burn scar
1304424|NCT01564407|Burn Scar contractures|burn scar contractures
1304425|NCT01564407|Scar|scar
1304426|NCT01564394|qigong|qigong
1304427|NCT01564394|mindfulness meditation|mindfulness meditation
1304428|NCT01564394|fatigue|fatigue
1304429|NCT01564394|prostate cancer|prostate cancer
1304430|NCT01564381|Cardiovascular disease|cardiovascular disease
1304431|NCT01564368|stage II breast cancer|stage ii breast cancer
1304432|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
1304433|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
1304434|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
1304435|NCT01564368|stage IV breast cancer|stage iv breast cancer
1304436|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
1304437|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
1304438|NCT01564342|wound irrigation|wound irrigation
1304439|NCT01564342|tap water irrigation|tap water irrigation
1304440|NCT01564342|wound infection|wound infection
1304441|NCT01564342|wound irrigation solution|wound irrigation solution
1304442|NCT01564329|endostar|endostar
1304443|NCT01564329|CT Perfusion|ct perfusion
1304444|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
1304445|NCT01564303|Carnitine|carnitine
1304446|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
1304447|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
1304448|NCT01564290|acute diarrhea|acute diarrhea
1304449|NCT01564290|probiotics|probiotics
1304450|NCT01564290|children|children
1304451|NCT01564264|Uterine Neoplasms|uterine neoplasms
1304452|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1304453|NCT01564238|calcium retention|calcium retention
1304454|NCT01564238|sodium retention|sodium retention
1304455|NCT01564225|XLHED|xlhed
1304456|NCT01564212|heat loss|heat loss
1304457|NCT01564212|laminar airflow|laminar airflow
1304458|NCT01564212|operating rooms|operating rooms
1304459|NCT01564160|Fish Oil|fish oil
1304460|NCT01564160|EPA|epa
1304461|NCT01564160|DHA|dha
1304462|NCT01564160|Omega-Score|omega-score
1304463|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
1304464|NCT01564160|Green-Lipped Mussel|green-lipped mussel
1304465|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
1304466|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
1304467|NCT01564134|response vaccination|response vaccination
1304468|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
1304469|NCT01564108|Non-infectious uveitis|non-infectious uveitis
1304470|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
1304471|NCT01564108|Lucentis|lucentis
1304472|NCT01564108|LIMO|limo
1304473|NCT01564095|Liver transplantation|liver transplantation
1304474|NCT01564095|EDC|edc
1304475|NCT01564095|IRI|iri
1304476|NCT01564095|graft survival|graft survival
1304477|NCT01564095|graft function|graft function
1304478|NCT01564095|graft preconditioning|graft preconditioning
1304479|NCT01564095|Tacrolimus rinse|tacrolimus rinse
1304480|NCT01564095|randomised multicenter trial|randomised multicenter trial
1304481|NCT01564082|endotracheal intubation|endotracheal intubation
1304482|NCT01564082|GlideScope|glidescope
1304483|NCT01564069|Chronic pain|chronic pain
1304484|NCT01564069|Intrathecal pain management|intrathecal pain management
1304485|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
1304490|NCT01564030|Gastric contents|gastric contents
1304491|NCT01564030|Ultrasound|ultrasound
1304492|NCT01564017|Allergy|allergy
1304493|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1304494|NCT01564017|Immunotherapy|immunotherapy
1304495|NCT01564017|D. pteronyssinus|d. pteronyssinus
1304496|NCT01564017|house dust allergy|house dust allergy
1304497|NCT01564004|breech presentation at term|breech presentation at term
1304498|NCT01564004|pregnancy|pregnancy
1304499|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
1304500|NCT01564004|clinical hypnosis|clinical hypnosis
1304501|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
1304502|NCT01563991|surgery|surgery
1304503|NCT01563991|fluid|fluid
1304504|NCT01563991|morbidity|morbidity
1304505|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
1304506|NCT01563965|Preoperative fasting|preoperative fasting
1304507|NCT01563965|Acute phase proteins|acute phase proteins
1304508|NCT01563965|Carbohydrates|carbohydrates
1304509|NCT01563965|Protein hydrolizate|protein hydrolizate
1304510|NCT01563965|Inflammatory response|inflammatory response
1304511|NCT01563965|Surgery|surgery
1304512|NCT01563939|Labour analgesia|labour analgesia
1304513|NCT01563939|Pregnancy|pregnancy
1304514|NCT01563939|IVPCA|ivpca
1304520|NCT01563900|fatigue|fatigue
1304521|NCT01563900|multiple sclerosis|multiple sclerosis
1304522|NCT01563900|sleep apnea|sleep apnea
1304523|NCT01563900|CPAP|cpap
1304524|NCT01563887|Type 1 Diabetes|type 1 diabetes
1304525|NCT01563887|Hypoglycemia|hypoglycemia
1304526|NCT01563887|Driving|driving
1304527|NCT01563887|Driving safety|driving safety
1304528|NCT01563887|Internet|internet
1304530|NCT01563887|Treatment|treatment
1304531|NCT01563887|Intervention|intervention
1304532|NCT01563874|Antibodies|antibodies
1304533|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
1304534|NCT01563874|Epigenetics|epigenetics
1304535|NCT01563874|Acetylation|acetylation
1304536|NCT01563874|Methylation|methylation
1304537|NCT01563874|Lymphoma|lymphoma
1304538|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1304539|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1304540|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1304541|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1304542|NCT01563835|Termination of pregnancy|termination of pregnancy
1304543|NCT01563835|Epidural|epidural
1304544|NCT01563835|IV PCA|iv pca
1304545|NCT01563822|Follicular Fluid|follicular fluid
1304546|NCT01563822|uterine cavity|uterine cavity
1304547|NCT01563822|Implantation rates|implantation rates
1304548|NCT01563822|ICSI|icsi
1304549|NCT01563796|bladder cancer|bladder cancer
1304550|NCT01563796|TCC|tcc
1304551|NCT01563796|urine|urine
1304552|NCT01563796|protein ELISA|protein elisa
1304553|NCT01563783|Fibroids|fibroids
1304554|NCT01563783|Myomas|myomas
1304555|NCT01563783|leiomyomata|leiomyomata
1304556|NCT01563783|menorrhagia|menorrhagia
1304557|NCT01563783|Acessa Procedure|acessa procedure
1304558|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
1304559|NCT01563783|RFA|rfa
1304560|NCT01563770|Hyperlipidemia|hyperlipidemia
1304561|NCT01563770|Hypertension|hypertension
1304562|NCT01563770|Vasodilation|vasodilation
1304563|NCT01563770|Oxidative stress|oxidative stress
1304564|NCT01563770|Inflammation|inflammation
1304565|NCT01563770|Hemostasis|hemostasis
1304566|NCT01563770|Hemorheology|hemorheology
1304567|NCT01563770|Cardiovascular diseases|cardiovascular diseases
1304568|NCT01563770|Cardiovascular agents|cardiovascular agents
1304569|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
1304570|NCT01563770|Danshen|danshen
1304571|NCT01563770|Danshen root extract|danshen root extract
1304572|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1304573|NCT01563770|Therapeutic Uses|therapeutic uses
1304574|NCT01563744|colonoscopy|colonoscopy
1304575|NCT01563744|bowel preparation|bowel preparation
1304576|NCT01563744|tolerability|tolerability
1304577|NCT01563744|EGD-assisted|egd-assisted
1304578|NCT01563731|Blood pressure medicines|blood pressure medicines
1304579|NCT01563731|Lipid lowering medicines|lipid lowering medicines
1304580|NCT01563731|Hypertension|hypertension
1304581|NCT01563731|Stroke|stroke
1304582|NCT01563731|Dementia|dementia
1304583|NCT01563731|Heart attack|heart attack
1304584|NCT01563731|Heart failure|heart failure
1304585|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
1304586|NCT01563705|GSD III|gsd iii
1304587|NCT01563705|glycogen storage disease|glycogen storage disease
1304589|NCT01563692|Immune response|immune response
1304590|NCT01563679|cancer|cancer
1304591|NCT01563679|locoregional therapies|locoregional therapies
1304592|NCT01563679|RFA|rfa
1304593|NCT01563679|Cryoablation|cryoablation
1304594|NCT01563679|Microwave ablation|microwave ablation
1304595|NCT01563679|chemical ablation|chemical ablation
1304596|NCT01563679|Irreversible electroporation|irreversible electroporation
1304597|NCT01563653|predicting surgical success|predicting surgical success
1304598|NCT01563653|simple diagnostic test device|simple diagnostic test device
1304599|NCT01563640|dengue|dengue
1304600|NCT01563588|breast cancer|breast cancer
1304601|NCT01563588|chemotherapy|chemotherapy
1304602|NCT01563588|first line treatment|first line treatment
1304603|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
1304604|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
1304605|NCT01563575|Recognition Process|recognition process
1304606|NCT01563575|Health Promotion|health promotion
1304607|NCT01563575|HPH|hph
1304608|NCT01563575|WHO|who
1304609|NCT01563575|Hospitals|hospitals
1304610|NCT01563575|Health Services|health services
1304611|NCT01563575|Health Gain|health gain
1304612|NCT01563575|Service Delivery|service delivery
1304613|NCT01563575|Quality Management|quality management
1304614|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
1304615|NCT01563510|Hepatolithiasis|hepatolithiasis
1304616|NCT01563510|Minimal invasive surgery|minimal invasive surgery
1304617|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
1304618|NCT01563510|Choledochoscope|choledochoscope
1304619|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
1304620|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
1304621|NCT01563484|Liver function|liver function
1304622|NCT01563484|Renal function|renal function
1304623|NCT01563432|crossover|crossover
1304624|NCT01563432|pharmacokinetic|pharmacokinetic
1304625|NCT01563432|hyperuricemia|hyperuricemia
1304626|NCT01563432|gout|gout
1304627|NCT01563419|Insulin|insulin
1304628|NCT01563419|Diabetes|diabetes
1304629|NCT01563419|Low vision|low vision
1304630|NCT01563406|Needleless connectors|needleless connectors
1304631|NCT01563406|catheter hubs|catheter hubs
1304632|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
1304633|NCT01563393|children|children
1304634|NCT01563393|malnutrition|malnutrition
1304635|NCT01563380|total knee arthroplasty|total knee arthroplasty
1304636|NCT01563380|osteoarthritis|osteoarthritis
1304637|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
1304638|NCT01563380|complications|complications
1304639|NCT01563380|blood loss|blood loss
1304640|NCT01563380|Pain|pain
1304641|NCT01563380|functional outcome|functional outcome
1304642|NCT01563367|Anaemia|anaemia
1304643|NCT01563367|Cardiac surgery|cardiac surgery
1304644|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
1304645|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
1304646|NCT01563315|Community-Acquired Infections|community-acquired infections
1304647|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
1304648|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
1304649|NCT01563315|Prognosis|prognosis
1304650|NCT01563315|Prospective Studies|prospective studies
1304651|NCT01563302|Advanced Cancers|advanced cancers
1304652|NCT01563302|DLBCL|dlbcl
1304653|NCT01563302|Advanced Lymphoma|advanced lymphoma
1304654|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
1304655|NCT01563276|PSP|psp
1304656|NCT01563276|Falls|falls
1304657|NCT01563276|Gait|gait
1304658|NCT01563276|Balance|balance
1304659|NCT01563276|Parkinson's Disease|parkinson's disease
1304660|NCT01563276|PD|pd
1304661|NCT01563263|IC43|ic43
1304662|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1304663|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
1304664|NCT01563263|ICU patients|icu patients
1304665|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
1304666|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
1304667|NCT01563250|point of care testing|point of care testing
1304668|NCT01563224|GABA-B|gaba-b
1304669|NCT01563211|breast cancer therapy|breast cancer therapy
1304670|NCT01563211|toxicity|toxicity
1304671|NCT01563211|side effect profile|side effect profile
1304672|NCT01563198|MRI departments and facilities|mri departments and facilities
1304673|NCT01563198|Noncompletion of MRI|noncompletion of mri
1304674|NCT01563185|JIA|jia
1304675|NCT01563185|ibuprofen|ibuprofen
1304676|NCT01563185|famotidine|famotidine
1304677|NCT01563185|pediatrics|pediatrics
1304678|NCT01563185|for > 1 month|for > 1 month
1304679|NCT01563159|Belgium|belgium
1304680|NCT01563159|hospitals|hospitals
1304681|NCT01563159|Rotavirus|rotavirus
1304682|NCT01563146|Rotavirus|rotavirus
1304683|NCT01563146|hospitals|hospitals
1304684|NCT01563146|Belgium|belgium
1304685|NCT01563133|endomicroscopy|endomicroscopy
1304686|NCT01563133|needle-based|needle-based
1304687|NCT01563133|pancreatic|pancreatic
1304688|NCT01563133|cyst|cyst
1304689|NCT01563133|mass|mass
1304690|NCT01563133|EUSFNA|eusfna
1304691|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
1304692|NCT01563107|Tachycardia|tachycardia
1304693|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
1304694|NCT01563107|Sodium|sodium
1304695|NCT01563094|Bone Density|bone density
1304697|NCT01563094|Bone Turnover Markers|bone turnover markers
1304698|NCT01563081|Allergic rhinitis|allergic rhinitis
1304699|NCT01563081|Pediatric|pediatric
1304700|NCT01563081|Pruritus|pruritus
1304701|NCT01563081|Levocetirizine|levocetirizine
1304702|NCT01563068|plaque psoriasis|plaque psoriasis
1304703|NCT01563068|pediatric|pediatric
1304704|NCT01563068|adolescent|adolescent
1304705|NCT01563042|immunogenicity|immunogenicity
1304706|NCT01563042|GSK2434735|gsk2434735
1304707|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
1304709|NCT01563042|biospecific antibody|biospecific antibody
1304710|NCT01563016|schizophrenia|schizophrenia
1304711|NCT01563016|Psychotic Disorders|psychotic disorders
1304712|NCT01563016|Psychoses|psychoses
1304713|NCT01563003|Autism|autism
1304714|NCT01563003|Asperger's Syndrome|asperger's syndrome
1304715|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
1304716|NCT01563003|Treatment|treatment
1304717|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
1304718|NCT01563003|Anxiety|anxiety
1304719|NCT01563003|Children|children
1304720|NCT01563003|Therapy|therapy
1304721|NCT01562951|Crohn's disease|crohn's disease
1304722|NCT01562951|mucosal inflammation|mucosal inflammation
1304723|NCT01562951|lesions|lesions
1304724|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
1304725|NCT01562912|radiofrequency|radiofrequency
1304726|NCT01562912|ablation|ablation
1304727|NCT01562912|atrial fibrillation|atrial fibrillation
1304728|NCT01562912|PVAC|pvac
1304729|NCT01562899|MEK162|mek162
1304730|NCT01562899|AMG 479|amg 479
1304731|NCT01562899|Ganitumab|ganitumab
1304732|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
1304733|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1304734|NCT01562899|melanoma|melanoma
1304735|NCT01562899|KRAS|kras
1304736|NCT01562899|BRAF|braf
1304737|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
1304738|NCT01562873|pSTAT3+|pstat3+
1304739|NCT01562860|median nerve|median nerve
1304740|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
1304741|NCT01562860|Pronator Teres Release|pronator teres release
1304742|NCT01562782|Elevated triglycerides|elevated triglycerides
1304743|NCT01562782|Diabetes Mellitus|diabetes mellitus
1304744|NCT01562782|Dyslipidemia|dyslipidemia
1304745|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
1304746|NCT01562782|Body Weight|body weight
1304747|NCT01562730|Coronary Artery Disease|coronary artery disease
1304748|NCT01562730|Myocardial Ischemia|myocardial ischemia
1304749|NCT01562730|Coronary Disease|coronary disease
1304750|NCT01562730|Heart Diseases|heart diseases
1304751|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
1304752|NCT01562730|Arteriosclerosis|arteriosclerosis
1304753|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
1304754|NCT01562730|Vascular Diseases|vascular diseases
1304755|NCT01562730|iECG|iecg
1304756|NCT01562730|12 leads ECG|12 leads ecg
1304757|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
1304758|NCT01562691|nasal packing|nasal packing
1304759|NCT01562691|nasal airway|nasal airway
1304760|NCT01562691|septoplasty|septoplasty
1304761|NCT01562691|oxygen saturation|oxygen saturation
1304762|NCT01562691|postoperative pain|postoperative pain
1304763|NCT01562678|fMRI|fmri
1304764|NCT01562678|Liraglutide|liraglutide
1304765|NCT01562678|diabetes|diabetes
1304766|NCT01562678|GLP-1|glp-1
1304767|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
1304768|NCT01562639|maintenance therapy,|maintenance therapy,
1304769|NCT01562639|repeatedly recurring,|repeatedly recurring,
1304770|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
1304771|NCT01562639|Nexium|nexium
1304772|NCT01562613|Stroke|stroke
1304773|NCT01562613|Hypertension|hypertension
1304774|NCT01562600|NSAIDs|nsaids
1304775|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
1304776|NCT01562600|Nexium|nexium
1304777|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
1304778|NCT01562535|pulled elbow|pulled elbow
1304779|NCT01562535|nursemaid elbow|nursemaid elbow
1304780|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1304781|NCT01562509|Quality of health care|quality of health care
1304782|NCT01562509|Oncology Service Hospital|oncology service hospital
1304783|NCT01562509|Patient-centredness|patient-centredness
1304784|NCT01562509|PROMs|proms
1304785|NCT01562496|Parkinson's disease|parkinson's disease
1304786|NCT01562496|Neuroprotective|neuroprotective
1304787|NCT01562496|Intensive exercise|intensive exercise
1304788|NCT01562483|postsurgical pain|postsurgical pain
1304789|NCT01562483|abdominal pain|abdominal pain
1304790|NCT01562483|visceral pain|visceral pain
1304791|NCT01562483|chronic pain|chronic pain
1304792|NCT01562470|cellulite|cellulite
1304793|NCT01562470|reduction|reduction
1304794|NCT01562470|cream|cream
1304795|NCT01562470|thighs|thighs
1304796|NCT01562470|women|women
1304797|NCT01562444|Long term immunogenicity study|long term immunogenicity study
1304798|NCT01562418|Ergonomics|ergonomics
1304799|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
1304800|NCT01562418|kinematics|kinematics
1304801|NCT01562405|Relapsed|relapsed
1304802|NCT01562405|Refractory|refractory
1304803|NCT01562392|dietary prevention|dietary prevention
1304804|NCT01562392|cognitive performance|cognitive performance
1304805|NCT01562392|metabolic syndrome|metabolic syndrome
1304806|NCT01562392|colonic fermentation|colonic fermentation
1304807|NCT01562392|sub clinical inflammation|sub clinical inflammation
1611744|NCT00352053|HIV-1|hiv-1
1304808|NCT01562392|cognition and metabolism|cognition and metabolism
1304809|NCT01562379|complementary food supplements|complementary food supplements
1304810|NCT01562379|stunting|stunting
1304812|NCT01562379|growth|growth
1304813|NCT01562379|Bangladesh|bangladesh
1304814|NCT01562379|infant feeding|infant feeding
1304815|NCT01562366|Iliotibial Band Release|iliotibial band release
1304816|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
1304817|NCT01562366|Micro debridement|micro debridement
1304818|NCT01562353|Opioid Dependence|opioid dependence
1304819|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
1304820|NCT01562340|Hemodialysis|hemodialysis
1304821|NCT01562340|End stage renal disease|end stage renal disease
1304822|NCT01562340|Oxidative stress|oxidative stress
1304823|NCT01562340|Inflammation|inflammation
1304824|NCT01562340|Endothelial dysfunction|endothelial dysfunction
1304825|NCT01562340|Cardiovascular disease|cardiovascular disease
1304826|NCT01562340|Antioxidants|antioxidants
1304827|NCT01562340|Flavonoids|flavonoids
1304828|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
1304829|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1304830|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1304831|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1304832|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1304833|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1304834|NCT01562301|carboplatin|carboplatin
1304835|NCT01562301|Paraplatin|paraplatin
1304836|NCT01562301|docetaxel|docetaxel
1304837|NCT01562301|Taxotere|taxotere
1304838|NCT01562301|Anvirzel|anvirzel
1304839|NCT01562301|nerium oleander|nerium oleander
1304840|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1304841|NCT01562301|NSCLC|nsclc
1304842|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
1304843|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
1304844|NCT01562288|stage IA breast cancer|stage ia breast cancer
1304845|NCT01562288|stage IB breast cancer|stage ib breast cancer
1304846|NCT01562288|stage II breast cancer|stage ii breast cancer
1304847|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
1304848|NCT01562275|GDC0973|gdc0973
1304849|NCT01562275|MEK|mek
1304850|NCT01562275|MEK inhibitor|mek inhibitor
1304851|NCT01562275|GDC0068|gdc0068
1304852|NCT01562275|Akt|akt
1304853|NCT01562275|Akt inhibitor|akt inhibitor
1304854|NCT01562262|Apnea|apnea
1304855|NCT01562262|PVT|pvt
1304856|NCT01562262|Reaction Time|reaction time
1304857|NCT01562249|clinical evaluation|clinical evaluation
1304858|NCT01562249|controlled clinical trial|controlled clinical trial
1304859|NCT01562249|electromyography|electromyography
1304860|NCT01562249|exercise program|exercise program
1304861|NCT01562249|motor control|motor control
1304862|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
1304863|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
1304864|NCT01562223|stage III prostate cancer|stage iii prostate cancer
1304865|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
1304866|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1304867|NCT01562210|NSCLC|nsclc
1304868|NCT01562210|Olaparib|olaparib
1304869|NCT01562210|CCRT|ccrt
1304870|NCT01562197|axitinib|axitinib
1304871|NCT01562197|glioblastoma|glioblastoma
1304872|NCT01562197|recurrent|recurrent
1304873|NCT01562171|Overweight|overweight
1304874|NCT01562171|Obese|obese
1304875|NCT01562171|Obesity|obesity
1304876|NCT01562171|Cholesterol|cholesterol
1304877|NCT01562171|Hypercholesterolemia|hypercholesterolemia
1304878|NCT01562171|LDL-Cholesterol|ldl-cholesterol
1304879|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
1304880|NCT01562132|cryptococcus|cryptococcus
1304881|NCT01562132|HIV|hiv
1304882|NCT01562119|Burns|burns
1304883|NCT01562119|Wound repair|wound repair
1304884|NCT01562119|Skin substitutes|skin substitutes
1304885|NCT01562106|Cancer of Endometrium|cancer of endometrium
1304886|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
1304984|NCT01561638|Pulsed|pulsed
1304887|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
1304888|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
1304889|NCT01562106|Endometrium Cancer|endometrium cancer
1304890|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
1304891|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
1304892|NCT01562093|Spirometry|spirometry
1305199|NCT01560793|Vaccines|vaccines
1304893|NCT01562093|Administration, Intranasal|administration, intranasal
1304894|NCT01562093|Nasal blockage|nasal blockage
1304895|NCT01562093|Nasal sprays|nasal sprays
1304896|NCT01562080|hyperlipidemia|hyperlipidemia
1304897|NCT01562080|metabolic syndrome|metabolic syndrome
1304898|NCT01562080|yeast red|yeast red
1304899|NCT01562080|berberine|berberine
1304900|NCT01562080|policosanol|policosanol
1304901|NCT01562080|astaxanthin|astaxanthin
1611745|NCT00352053|AIDS Virus|aids virus
1304902|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
1304903|NCT01562041|Cardiovascular disease|cardiovascular disease
1304904|NCT01562041|Exercise Treadmill Test|exercise treadmill test
1304905|NCT01562041|Ranolazine|ranolazine
1304906|NCT01562041|Angina|angina
1304907|NCT01562041|Myocardial ischemia|myocardial ischemia
1304908|NCT01562028|non small cell lung cancer|non small cell lung cancer
1304909|NCT01562028|advanced|advanced
1304910|NCT01562028|non-squamous|non-squamous
1304911|NCT01562028|EGFR|egfr
1304912|NCT01562028|mutations|mutations
1304913|NCT01562002|limbus|limbus
1304914|NCT01562002|cornea|cornea
1304915|NCT01562002|insufficiency syndrome|insufficiency syndrome
1304916|NCT01562002|stem cell transplant|stem cell transplant
1304917|NCT01561963|Apremilast|apremilast
1304918|NCT01561963|drug interaction|drug interaction
1304919|NCT01561963|pharmacokinetics|pharmacokinetics
1304920|NCT01561911|Clinical Trial|clinical trial
1304921|NCT01561911|Phase I|phase i
1304922|NCT01561911|Antibodies|antibodies
1304923|NCT01561911|Monoclonal|monoclonal
1304924|NCT01561898|Schizophrenia|schizophrenia
1304925|NCT01561898|JNS007ER|jns007er
1304926|NCT01561898|Paliperidone extended-release|paliperidone extended-release
1304927|NCT01561885|Clinical Pathways|clinical pathways
1304928|NCT01561885|Length of Stay|length of stay
1304929|NCT01561885|Patient-Centered Care|patient-centered care
1304930|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
1304931|NCT01561859|Early Course Schizophrenia|early course schizophrenia
1304932|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
1304933|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
1304934|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
1304935|NCT01561846|LDL-cholesterol|ldl-cholesterol
1304936|NCT01561846|Endocannabinoids|endocannabinoids
1304937|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
1304938|NCT01561820|mild cognitive impairment|mild cognitive impairment
1304939|NCT01561820|cognitive disorders|cognitive disorders
1304940|NCT01561820|exercise|exercise
1304941|NCT01561794|Ciprofloxacin|ciprofloxacin
1304942|NCT01561794|Bacterial pneumonia|bacterial pneumonia
1304943|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
1304944|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
1304945|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
1304946|NCT01561794|400 mg BID/TID|400 mg bid/tid
1304947|NCT01561781|Phase 1|phase 1
1304948|NCT01561781|healthy volunteers|healthy volunteers
1304949|NCT01561781|pharmacokinetics|pharmacokinetics
1304950|NCT01561781|vandetanib|vandetanib
1304951|NCT01561781|digoxin|digoxin
1304952|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
1304953|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
1304954|NCT01561729|nasogastric tube|nasogastric tube
1304955|NCT01561729|orogastric tube|orogastric tube
1304956|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
1304957|NCT01561729|suction tube|suction tube
1304958|NCT01561729|RightBio Metrics|rightbio metrics
1304959|NCT01561729|RightLevel|rightlevel
1304960|NCT01561729|RightSpot Infant|rightspot infant
1304961|NCT01561729|NG Tube|ng tube
1304963|NCT01561729|Gastric Acidity|gastric acidity
1304964|NCT01561716|video games|video games
1304965|NCT01561716|energy expenditure|energy expenditure
1304966|NCT01561716|physical activity|physical activity
1304967|NCT01561716|exercise physiology|exercise physiology
1304968|NCT01561703|Healthcare utilization|healthcare utilization
1304969|NCT01561703|Tonsillectomy|tonsillectomy
1304970|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
1304971|NCT01561703|Antibiotics|antibiotics
1304972|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
1304973|NCT01561677|syndrome survival|syndrome survival
1304974|NCT01561677|ischemic stroke|ischemic stroke
1304975|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
1304976|NCT01561677|handicap|handicap
1304977|NCT01561664|obesity|obesity
1304978|NCT01561664|insulin resistance|insulin resistance
1304979|NCT01561651|cardiac surgery|cardiac surgery
1304980|NCT01561651|left atrial appendage|left atrial appendage
1304981|NCT01561651|atrial fibrillation|atrial fibrillation
1304982|NCT01561651|stroke|stroke
1304983|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
1304985|NCT01561638|radiofrequency|radiofrequency
1304986|NCT01561638|single-dose|single-dose
1304987|NCT01561638|shoulder pain|shoulder pain
1304988|NCT01561638|Pain lasts more than one month|pain lasts more than one month
1304989|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
1304990|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
1304991|NCT01561625|COPD|copd
1304992|NCT01561625|exercise training|exercise training
1304993|NCT01561612|Breastfeeding|breastfeeding
1304994|NCT01561612|Child Health|child health
1304995|NCT01561612|Obesity|obesity
1304996|NCT01561612|Blood Pressure|blood pressure
1304998|NCT01561612|Cognitive Development|cognitive development
1304999|NCT01561612|Behavior|behavior
1305000|NCT01561612|Eczema|eczema
1305001|NCT01561612|Lung Function|lung function
1305002|NCT01561612|Spirometry|spirometry
1305003|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
1305004|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
1305005|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
1305006|NCT01561599|Kidney transplantation|kidney transplantation
1305007|NCT01561586|Cervical cancer|cervical cancer
1305008|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
1305009|NCT01561586|Cisplatin|cisplatin
1305010|NCT01561573|Point of Care Ultrasound|point of care ultrasound
1305011|NCT01561573|Emergency Ultrasound|emergency ultrasound
1305012|NCT01561573|Colles Fracture|colles fracture
1305013|NCT01561573|Fracture Reduction|fracture reduction
1305014|NCT01561573|Bedside Ultrasound|bedside ultrasound
1305015|NCT01561560|DAILIES TOTAL1|dailies total1
1305016|NCT01561560|contact lenses|contact lenses
1305017|NCT01561560|myopia|myopia
1305018|NCT01561547|pain|pain
1305019|NCT01561547|preterm neonate|preterm neonate
1305020|NCT01561547|sucrose|sucrose
1305021|NCT01561547|kangaroo mother care|kangaroo mother care
1305022|NCT01561534|fibula flap|fibula flap
1305023|NCT01561534|oral implants|oral implants
1305024|NCT01561534|computer-guided|computer-guided
1305025|NCT01561508|diabetes mellitus|diabetes mellitus
1305026|NCT01561508|children|children
1305027|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
1305028|NCT01561482|Prostate carcinoma|prostate carcinoma
1305029|NCT01561482|Prostate cancer|prostate cancer
1305030|NCT01561482|Prostate Specific Antigen|prostate specific antigen
1305031|NCT01561482|PSA|psa
1305032|NCT01561482|Metformin|metformin
1305033|NCT01561482|Simvastatin|simvastatin
1305034|NCT01561482|Radiation therapy|radiation therapy
1305035|NCT01561482|Prostatectomy|prostatectomy
1305036|NCT01561469|Linezolid|linezolid
1305037|NCT01561469|Vancomycin|vancomycin
1305038|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1305039|NCT01561469|Respiratory Tract Infections|respiratory tract infections
1305040|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
1305041|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
1305042|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
1305043|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
1305044|NCT01561456|docetaxel|docetaxel
1305045|NCT01561456|AXL1717|axl1717
1305046|NCT01561456|NSCLC|nsclc
1305047|NCT01561456|SCC|scc
1305048|NCT01561456|AC|ac
1305049|NCT01561443|Breast cancer,|breast cancer,
1305050|NCT01561443|hormone positive,|hormone positive,
1305051|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
1305052|NCT01561326|cervical cancer|cervical cancer
1305053|NCT01561326|follow-up|follow-up
1305054|NCT01561326|Pap test|pap test
1305055|NCT01561326|Medical management|medical management
1305056|NCT01561326|Colposcopy|colposcopy
1305057|NCT01561313|On label Humira users|on label humira users
1305058|NCT01561313|Pain|pain
1305059|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
1305060|NCT01561300|Black tea|black tea
1305061|NCT01561300|Flow Mediated Dilation|flow mediated dilation
1305062|NCT01561300|Vascular function|vascular function
1305063|NCT01561300|India|india
1305064|NCT01561261|fasciotomy|fasciotomy
1305065|NCT01561261|ACS|acs
1305066|NCT01561248|EHEC|ehec
1305067|NCT01561248|O104:H4|o104:h4
1305068|NCT01561248|German|german
1305069|NCT01561248|outbreak|outbreak
1305070|NCT01561248|polyethylene glycol|polyethylene glycol
1305071|NCT01561248|Bowel lavage|bowel lavage
1305072|NCT01561235|Protein|protein
1305073|NCT01561235|Appetite|appetite
1305074|NCT01561235|Satiety|satiety
1305075|NCT01561235|Energi intake|energi intake
1305076|NCT01561235|Appetite regulating hormones|appetite regulating hormones
1305077|NCT01561235|Dose-response|dose-response
1305078|NCT01561222|calcitrol|calcitrol
1305079|NCT01561222|Bone mineral density|bone mineral density
1305080|NCT01561222|Osteoprotegin|osteoprotegin
1305081|NCT01561222|Vascular calcification|vascular calcification
1305082|NCT01561209|amitryptiline|amitryptiline
1305083|NCT01561209|Chronic pain|chronic pain
1305084|NCT01561209|Neck pain|neck pain
1305085|NCT01561196|arteria cannulation|arteria cannulation
1305086|NCT01561196|Ultrasound|ultrasound
1305087|NCT01561196|pain|pain
1305088|NCT01561196|complications|complications
1305089|NCT01561183|Vital pulp therapy|vital pulp therapy
1305090|NCT01561183|Pulp cap|pulp cap
1305091|NCT01561183|pulpotomy|pulpotomy
1305092|NCT01561183|calcium enriched mixture|calcium enriched mixture
1305093|NCT01561183|CEM cement|cem cement
1305094|NCT01561183|Endodontic|endodontic
1305095|NCT01561170|Electromagnetic|electromagnetic
1305096|NCT01561170|Field therapy|field therapy
1305097|NCT01561170|Chronically venous ulcer|chronically venous ulcer
1305098|NCT01561170|Venous insufficiens|venous insufficiens
1305099|NCT01561157|porphyria|porphyria
1305100|NCT01561157|acute intermittent|acute intermittent
1305101|NCT01561157|coproporphyria|coproporphyria
1305102|NCT01561157|variegate|variegate
1305103|NCT01561157|erythropoietic|erythropoietic
1305104|NCT01561157|protoporphyria|protoporphyria
1305105|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
1305106|NCT01561157|cutanea tarda|cutanea tarda
1305107|NCT01561157|AIP|aip
1305108|NCT01561157|HCP|hcp
1305109|NCT01561157|VP|vp
1305110|NCT01561157|ADP|adp
1305111|NCT01561157|ALAD|alad
1305112|NCT01561157|PCT|pct
1305113|NCT01561157|HEP|hep
1305114|NCT01561157|CEP|cep
1305115|NCT01561157|EPP|epp
1305116|NCT01561157|XLP|xlp
1305117|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
1305118|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
1305119|NCT01561144|Heart Disease|heart disease
1305120|NCT01561131|Obesity|obesity
1305121|NCT01561131|Protein intake|protein intake
1305122|NCT01561131|Calcium intake|calcium intake
1305123|NCT01561131|Weight loss|weight loss
1305124|NCT01561131|Weight maintenance|weight maintenance
1305125|NCT01561131|Blood lipid profile|blood lipid profile
1305126|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
1305127|NCT01561118|hemodialysis|hemodialysis
1305128|NCT01561118|dialysis efficacy|dialysis efficacy
1305129|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
1305130|NCT01561118|exercise capacity|exercise capacity
1305131|NCT01561118|children and adolescents|children and adolescents
1305132|NCT01561092|Stroke|stroke
1305133|NCT01561092|RCT|rct
1305134|NCT01561092|SSRI|ssri
1305135|NCT01561092|Outcome|outcome
1305136|NCT01561079|Buprenorphine|buprenorphine
1305137|NCT01561079|Methadone|methadone
1305138|NCT01561079|Fetal neurobehavior|fetal neurobehavior
1305139|NCT01561079|Infant neurobehavior|infant neurobehavior
1305140|NCT01561066|Fibrin glue|fibrin glue
1305141|NCT01561066|Platelet|platelet
1305142|NCT01561066|Autologous derivation|autologous derivation
1305143|NCT01561066|Prospective randomized trial|prospective randomized trial
1305144|NCT01561066|Fistulas|fistulas
1305145|NCT01561053|Alzheimer's disease|alzheimer's disease
1305146|NCT01561053|AB peptide|ab peptide
1305147|NCT01561053|Albumin|albumin
1305148|NCT01561053|Intravenous immune globulin|intravenous immune globulin
1305149|NCT01561053|IGIV|igiv
1305150|NCT01561040|Dry Eye syndrome|dry eye syndrome
1305151|NCT01561040|tear film deficiency|tear film deficiency
1305152|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
1305153|NCT01561040|Omega three supplements|omega three supplements
1305154|NCT01560988|Asthma|asthma
1305155|NCT01560988|Borage|borage
1305156|NCT01560988|Echium|echium
1305157|NCT01560988|Botanical|botanical
1305158|NCT01560949|Pancreatic Cancer|pancreatic cancer
1305159|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
1305160|NCT01560949|High Risk Resectable|high risk resectable
1305161|NCT01560949|Borderline Resectable|borderline resectable
1305162|NCT01560949|Chemotherapy|chemotherapy
1305163|NCT01560949|Chemoradiation therapy|chemoradiation therapy
1305164|NCT01560949|Oxaliplatin|oxaliplatin
1305165|NCT01560949|Eloxatin|eloxatin
1305166|NCT01560949|Irinotecan|irinotecan
1305167|NCT01560949|CPT-11|cpt-11
1305168|NCT01560949|Camptosar|camptosar
1305169|NCT01560949|5-FU|5-fu
1305170|NCT01560949|5-Fluorouracil|5-fluorouracil
1305171|NCT01560949|Adrucil|adrucil
1305172|NCT01560949|Efudex|efudex
1305173|NCT01560949|Gemcitabine|gemcitabine
1305174|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1305175|NCT01560949|Gemzar|gemzar
1305176|NCT01560949|Radiation Therapy|radiation therapy
1305177|NCT01560949|XRT|xrt
1305178|NCT01560949|RT|rt
1305179|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
1305180|NCT01560936|bacterial contamination|bacterial contamination
1305181|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
1305182|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
1305183|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
1305184|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
1305185|NCT01560910|GERD|gerd
1305186|NCT01560910|NERD|nerd
1305187|NCT01560871|Heart failure|heart failure
1305188|NCT01560871|inspiratory muscle training|inspiratory muscle training
1305189|NCT01560871|physical activity|physical activity
1305190|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
1305191|NCT01560845|portal hypertension|portal hypertension
1305192|NCT01560845|surgery|surgery
1305193|NCT01560845|liver cirrhosis|liver cirrhosis
1305194|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
1305195|NCT01560806|hypertension|hypertension
1305196|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
1305197|NCT01560806|lifestyle|lifestyle
1305198|NCT01560793|Influenza|influenza
1305200|NCT01560793|H5N1|h5n1
1305201|NCT01560780|Coronary Artery Bypass|coronary artery bypass
1305202|NCT01560780|thrombosis|thrombosis
1305203|NCT01560780|prasugrel|prasugrel
1305204|NCT01560767|Pain relief|pain relief
1305205|NCT01560767|Arthroplasty|arthroplasty
1305206|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
1305207|NCT01560754|Randomized|randomized
1305208|NCT01560754|Placebo-controlled|placebo-controlled
1305209|NCT01560754|Double-blind|double-blind
1305210|NCT01560754|Multi-center|multi-center
1305211|NCT01560754|Disease-modifying potential|disease-modifying potential
1305212|NCT01560754|transdermal nicotine|transdermal nicotine
1305213|NCT01560741|Chronic respiratory failure|chronic respiratory failure
1305214|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
1305215|NCT01560741|Home-care|home-care
1305216|NCT01560741|Telemedicine|telemedicine
1305217|NCT01560741|COPD|copd
1305218|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
1305219|NCT01560728|Major Depressive Disorder|major depressive disorder
1305220|NCT01560728|Dysthymia|dysthymia
1305221|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
1305222|NCT01560728|Social Phobia|social phobia
1305223|NCT01560728|Panic Disorder|panic disorder
1305224|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
1305225|NCT01560715|stem cell|stem cell
1305226|NCT01560715|bone marrow|bone marrow
1305227|NCT01560715|retinal dysprophy|retinal dysprophy
1305228|NCT01560702|autologous blood|autologous blood
1305229|NCT01560702|epinephrine|epinephrine
1305230|NCT01560702|endoscopy|endoscopy
1305231|NCT01560702|ulcer|ulcer
1305232|NCT01560702|hemostasis|hemostasis
1305233|NCT01560689|bone marrow transplantation|bone marrow transplantation
1305234|NCT01560689|obstructive lung disease|obstructive lung disease
1305235|NCT01560689|bronchodilators|bronchodilators
1305236|NCT01560689|inhaled steroids|inhaled steroids
1305237|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
1305238|NCT01560676|Internet|internet
1305239|NCT01560676|School based|school based
1305240|NCT01560676|Obesity Prevention Program|obesity prevention program
1305241|NCT01560676|Adolescents|adolescents
1305242|NCT01560663|Breast Cancer|breast cancer
1305243|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
1305244|NCT01560663|Triple negative|triple negative
1305245|NCT01560663|predictor of response|predictor of response
1305246|NCT01560663|predictor of resistance|predictor of resistance
1305247|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1305248|NCT01560650|CRRT|crrt
1305249|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
1305250|NCT01560650|Intensity|intensity
1305251|NCT01560637|PAH|pah
1305252|NCT01560637|PH|ph
1305253|NCT01560637|FREEDOM|freedom
1305254|NCT01560637|6 minute walk test|6 minute walk test
1305255|NCT01560637|treprostinil|treprostinil
1305256|NCT01560637|open label|open label
1305257|NCT01560624|PAH|pah
1305258|NCT01560624|PH|ph
1305259|NCT01560624|Clinical Worsening|clinical worsening
1305260|NCT01560624|Freedom|freedom
1305261|NCT01560624|Freedom-Ev|freedom-ev
1305262|NCT01560624|Treprostinil|treprostinil
1305263|NCT01560624|UT-15C|ut-15c
1305264|NCT01560624|6 Minute walk test|6 minute walk test
1305265|NCT01560598|GERD|gerd
1305266|NCT01560598|reflux esophagitis|reflux esophagitis
1305267|NCT01560598|adipokine|adipokine
1305268|NCT01560598|especially|especially
1305269|NCT01560598|endoscopically proven|endoscopically proven
1305270|NCT01560585|Isotretinoin|isotretinoin
1305271|NCT01560585|Alzheimer's disease|alzheimer's disease
1305272|NCT01560585|Dementia|dementia
1305273|NCT01560585|Retinoid|retinoid
1305274|NCT01560572|kidney transplantation|kidney transplantation
1305275|NCT01560572|immunosuppression|immunosuppression
1305276|NCT01560572|steroids|steroids
1305277|NCT01560572|tacrolimus OD|tacrolimus od
1305278|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
1305279|NCT01560559|endoscopic myotomy|endoscopic myotomy
1305280|NCT01560559|high resolution manometry|high resolution manometry
1305281|NCT01560520|acute ischemic stroke|acute ischemic stroke
1305282|NCT01560520|accelerometer|accelerometer
1305283|NCT01560481|metformin glycinate|metformin glycinate
1305284|NCT01560481|pharmacokinetics|pharmacokinetics
1305285|NCT01560481|pharmacodynamics|pharmacodynamics
1305286|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
1305287|NCT01560468|Liver Transplantation|liver transplantation
1305288|NCT01560455|stent|stent
1305289|NCT01560455|bifurcation|bifurcation
1305290|NCT01560455|coronary|coronary
1305291|NCT01560442|Analgesics, opioids|analgesics, opioids
1305292|NCT01560442|Opiate substitution treatment|opiate substitution treatment
1305293|NCT01560442|Methadone|methadone
1305294|NCT01560442|Buprenorphine|buprenorphine
1305295|NCT01560442|Hyperalgesia|hyperalgesia
1305296|NCT01560442|Pupil|pupil
1305297|NCT01560442|Pain|pain
1305298|NCT01560442|Psychophysics|psychophysics
1305299|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
1305300|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
1305301|NCT01560429|Epidural Anesthesia|epidural anesthesia
1612041|NCT00350987|COLD|cold
1305302|NCT01560429|administration schedules, drug|administration schedules, drug
1305303|NCT01560416|Metastatic|metastatic
1305304|NCT01560416|HR positive|hr positive
1305305|NCT01560416|ER positive|er positive
1305306|NCT01560403|Short bowel syndrome|short bowel syndrome
1305307|NCT01560403|Parenteral nutrition|parenteral nutrition
1305308|NCT01560403|PN|pn
1305309|NCT01560403|HPN|hpn
1305310|NCT01560403|TPN|tpn
1305311|NCT01560403|SBS|sbs
1305312|NCT01560390|Sedation|sedation
1305313|NCT01560390|ICU|icu
1305314|NCT01560390|Ketamine|ketamine
1305315|NCT01560390|Confusion|confusion
1305316|NCT01560390|Hyperalgesia|hyperalgesia
1305317|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
1305318|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
1305319|NCT01560377|Colectomy|colectomy
1305320|NCT01560377|Rectal cancer|rectal cancer
1305321|NCT01560377|Colon cancer|colon cancer
1305322|NCT01560377|Crohn's Disease|crohn's disease
1305323|NCT01560377|Polyp|polyp
1305324|NCT01560377|Procidentia|procidentia
1305325|NCT01560377|Diverticulitis|diverticulitis
1305326|NCT01560364|Renal replacement therapy|renal replacement therapy
1305327|NCT01560364|Hemofilter clotting|hemofilter clotting
1305328|NCT01560364|Clotting risk factor|clotting risk factor
1305329|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
1305330|NCT01560351|Pathological gambling|pathological gambling
1305331|NCT01560351|craving|craving
1305332|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
1305333|NCT01560351|craving cues|craving cues
1305334|NCT01560338|Pharmacokinetics|pharmacokinetics
1305335|NCT01560338|Midazolam|midazolam
1305336|NCT01560338|Morphine|morphine
1305337|NCT01560338|Cardiac Arrest|cardiac arrest
1305338|NCT01560338|Hypothermia|hypothermia
1305339|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
1305340|NCT01560312|Renal denervation|renal denervation
1305341|NCT01560312|Resistant hypertension|resistant hypertension
1305342|NCT01560312|Spironolactone|spironolactone
1305343|NCT01560312|Long-term Outcome|long-term outcome
1305344|NCT01560299|hyperthyroidism|hyperthyroidism
1305345|NCT01560299|radio-iodine|radio-iodine
1305346|NCT01560299|I-131|i-131
1305347|NCT01560299|methimazole|methimazole
1305348|NCT01560299|graves disease|graves disease
1305349|NCT01560286|PKU|pku
1305350|NCT01560286|Injections|injections
1305351|NCT01560286|PEG-PAL|peg-pal
1305352|NCT01560286|PAL|pal
1305353|NCT01560247|Stroke|stroke
1305354|NCT01560247|Ischemic Stroke|ischemic stroke
1305355|NCT01560247|Revascularization|revascularization
1305356|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
1305357|NCT01560247|Neurothrombectomy|neurothrombectomy
1305358|NCT01560234|Safety|safety
1305359|NCT01560234|tolerability|tolerability
1305360|NCT01560234|healthy|healthy
1305361|NCT01560234|pharmacokinetic|pharmacokinetic
1305362|NCT01560234|pharmacodynamic|pharmacodynamic
1305363|NCT01560234|inhaled|inhaled
1305364|NCT01560208|infectious keratitis|infectious keratitis
1305365|NCT01560208|infective keratitis|infective keratitis
1305366|NCT01560208|prospective multicentre study|prospective multicentre study
1305367|NCT01560208|Asia|asia
1305368|NCT01560195|neutropenia|neutropenia
1305369|NCT01560195|febrile neutropenia|febrile neutropenia
1305370|NCT01560195|chemotherapy|chemotherapy
1305371|NCT01560182|Lentiviral vector|lentiviral vector
1305372|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1305373|NCT01560182|Gene Therapy|gene therapy
1305374|NCT01560169|Celiac Disease|celiac disease
1305375|NCT01560169|Coeliac Disease|coeliac disease
1305376|NCT01560169|Celiac Sprue|celiac sprue
1305377|NCT01560169|Keilakia Disease|keilakia disease
1305378|NCT01560117|AGMT|agmt
1305379|NCT01560117|NHL|nhl
1305380|NCT01560104|Randomized|randomized
1305381|NCT01560104|metastatic|metastatic
1305382|NCT01560104|ABT-888|abt-888
1305383|NCT01560104|paclitaxel|paclitaxel
1305384|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
1305385|NCT01560104|PARP|parp
1305386|NCT01560104|veliparib|veliparib
1305387|NCT01560104|progression free survival|progression free survival
1305388|NCT01560104|carboplatin|carboplatin
1305389|NCT01560091|clearance rate|clearance rate
1305390|NCT01560078|Tuberculosis|tuberculosis
1305391|NCT01560078|Pleural effusion|pleural effusion
1305392|NCT01560078|Category 3|category 3
1305393|NCT01560052|end stage kidney disease|end stage kidney disease
1305394|NCT01560052|IgA nephropathy|iga nephropathy
1305395|NCT01560039|Neuropathic pain|neuropathic pain
1305396|NCT01560039|neurostimulation|neurostimulation
1305397|NCT01560026|ovarian preservation|ovarian preservation
1305398|NCT01560013|Alcohol|alcohol
1305399|NCT01560013|naltrexone|naltrexone
1305400|NCT01560013|cue reactivity|cue reactivity
1305401|NCT01560013|PET|pet
1305402|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
1305403|NCT01559987|plaque removal methods|plaque removal methods
1305404|NCT01559987|oral hygiene devices|oral hygiene devices
1306002|NCT01557517|Oral Rinse|oral rinse
1305405|NCT01559974|Peripheral arterial disease|peripheral arterial disease
1409387|NCT01126814|aml|aml
1305406|NCT01559974|PAOD|paod
1305407|NCT01559974|Vitamin D|vitamin d
1305408|NCT01559974|Walking impairment|walking impairment
1305409|NCT01559961|bladder|bladder
1305410|NCT01559961|cystitis|cystitis
1305411|NCT01559961|frequency|frequency
1305412|NCT01559961|nocturia|nocturia
1305413|NCT01559961|pain|pain
1305414|NCT01559961|urgency|urgency
1305415|NCT01559948|Low back pain|low back pain
1305416|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
1305417|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
1305418|NCT01559948|Pelvic compression belt|pelvic compression belt
1305419|NCT01559948|Deep abdominal muscles|deep abdominal muscles
1305420|NCT01559935|Multiple Myeloma|multiple myeloma
1305421|NCT01559922|Acne|acne
1305422|NCT01559909|Lower limb loss|lower limb loss
1305423|NCT01559909|Leg amputation|leg amputation
1305424|NCT01559909|walking study|walking study
1305425|NCT01559909|socket technology|socket technology
1305426|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
1305427|NCT01559883|cancer|cancer
1305428|NCT01559883|thrombosis|thrombosis
1305429|NCT01559883|pulmonary embolism|pulmonary embolism
1305430|NCT01559883|anticoagulation|anticoagulation
1305431|NCT01559883|low molecular weight heparin|low molecular weight heparin
1305432|NCT01559870|cardiac surgery|cardiac surgery
1305433|NCT01559870|cytokine|cytokine
1305434|NCT01559870|clinical scoring system|clinical scoring system
1305435|NCT01559870|risk factor|risk factor
1305436|NCT01559857|Depression|depression
1305437|NCT01559857|Insulin resistance|insulin resistance
1305438|NCT01559857|Mood disorder|mood disorder
1305439|NCT01559844|Hepatitis|hepatitis
1305440|NCT01559844|Chronic|chronic
1305441|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
1305443|NCT01559844|transplant|transplant
1305444|NCT01559831|Japanese Encephalitis|japanese encephalitis
1305445|NCT01559831|IXIARO|ixiaro
1305446|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
1305447|NCT01559805|HIV|hiv
1305448|NCT01559805|Viral Load|viral load
1305449|NCT01559805|Risk|risk
1305450|NCT01559805|Patient Compliance|patient compliance
1305451|NCT01559805|Homosexuality, Male|homosexuality, male
1305452|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
1305453|NCT01559779|Obesity|obesity
1305454|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1305455|NCT01559779|Incretin hormones|incretin hormones
1305456|NCT01559779|Beta cell function|beta cell function
1305457|NCT01559766|Vitamin A|vitamin a
1305458|NCT01559766|Dietary requirement|dietary requirement
1305459|NCT01559766|Dietary records|dietary records
1305460|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
1305461|NCT01559766|Chinese children|chinese children
1305462|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
1305463|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
1305464|NCT01559753|Antibiotic|antibiotic
1305465|NCT01559753|treatment|treatment
1305466|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
1305467|NCT01559753|duration|duration
1305468|NCT01559740|regional anesthesia|regional anesthesia
1305469|NCT01559740|children|children
1305470|NCT01559740|postoperative pain relief|postoperative pain relief
1305471|NCT01559727|heart failure|heart failure
1305472|NCT01559727|diuresis|diuresis
1305473|NCT01559727|prednisone|prednisone
1305474|NCT01559714|Troponin|troponin
1305475|NCT01559714|Exercise|exercise
1305476|NCT01559714|MRI|mri
1305477|NCT01559701|Safety|safety
1305478|NCT01559701|PF-00345439|pf-00345439
1305479|NCT01559701|Remoxy|remoxy
1305480|NCT01559701|PTI-821|pti-821
1305481|NCT01559675|Corticosteroids|corticosteroids
1305482|NCT01559675|perioperative|perioperative
1305483|NCT01559675|colorectal surgery|colorectal surgery
1305484|NCT01559662|chewing gum|chewing gum
1305485|NCT01559662|ileus|ileus
1305486|NCT01559662|gastrointestinal function|gastrointestinal function
1305487|NCT01559662|colorectal surgery|colorectal surgery
1305488|NCT01559662|abdominal surgery|abdominal surgery
1305489|NCT01559649|Stroke|stroke
1305490|NCT01559649|Deglutition|deglutition
1305491|NCT01559649|Deglutition Disorders|deglutition disorders
1305492|NCT01559649|Nurse Screening|nurse screening
1305493|NCT01559636|seroconversion|seroconversion
1305494|NCT01559636|oral polio vaccine|oral polio vaccine
1305495|NCT01559636|OPV|opv
1305496|NCT01559636|poliomyelitis|poliomyelitis
1305497|NCT01559636|diarrhea|diarrhea
1305498|NCT01559636|seroimmunity|seroimmunity
1305499|NCT01559610|cardiac surgery|cardiac surgery
1305500|NCT01559610|orientation|orientation
1305501|NCT01559610|nursing|nursing
1305502|NCT01559597|controlled temperature chain|controlled temperature chain
1305503|NCT01559597|outside the cold chain|outside the cold chain
1305504|NCT01559597|vaccination|vaccination
1305505|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
1305506|NCT01559584|Alopecia|alopecia
1305507|NCT01559584|Areata|areata
1305508|NCT01559584|Phototherapy|phototherapy
1305509|NCT01559584|Phototoxic|phototoxic
1306003|NCT01557517|Clobetasol|clobetasol
1305510|NCT01559584|Ultraviolet A|ultraviolet a
1305511|NCT01559584|Randomized controlled trial|randomized controlled trial
1305512|NCT01559584|Interferon gamma|interferon gamma
1305513|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
1305514|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
1305515|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
1305516|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
1305517|NCT01559545|Metronidazole|metronidazole
1305518|NCT01559545|CDAD|cdad
1305519|NCT01559532|Deep vein thrombosis|deep vein thrombosis
1305520|NCT01559532|Thromboembolism|thromboembolism
1305521|NCT01559532|Tourniquet|tourniquet
1305522|NCT01559532|Knee prosthesis.|knee prosthesis.
1305523|NCT01559519|TIPS|tips
1305524|NCT01559519|albumin|albumin
1305525|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
1305526|NCT01559519|hyponatremia|hyponatremia
1305527|NCT01559519|hypovolemia|hypovolemia
1305528|NCT01559519|cirrhosis|cirrhosis
1305529|NCT01559506|CFU|cfu
1305530|NCT01559506|surgery site|surgery site
1305531|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
1305532|NCT01559480|Endometriosis|endometriosis
1305533|NCT01559480|Desogestrel|desogestrel
1305534|NCT01559480|Placebo|placebo
1305535|NCT01559467|Myocardial infarction|myocardial infarction
1305536|NCT01559467|Randomized Controlled Trial|randomized controlled trial
1305537|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
1305538|NCT01559467|Coronary Angiography|coronary angiography
1305539|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
1305540|NCT01559467|Mortality|mortality
1305541|NCT01559467|Complications|complications
1305542|NCT01559467|Quality of Life|quality of life
1305543|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
1305544|NCT01559454|chronic pain|chronic pain
1305545|NCT01559454|opioid dependence|opioid dependence
1305546|NCT01559454|methadone|methadone
1305547|NCT01559454|buprenorphine|buprenorphine
1305548|NCT01559454|substance use disorder|substance use disorder
1305549|NCT01559441|beetroot juice|beetroot juice
1305550|NCT01559441|nitrate|nitrate
1305551|NCT01559441|vascular activity|vascular activity
1305552|NCT01559441|postprandial state|postprandial state
1305553|NCT01559428|Plant sterols|plant sterols
1305554|NCT01559428|Plant stanols|plant stanols
1305555|NCT01559428|Oxyphytosterols|oxyphytosterols
1305556|NCT01559428|Cardiovascular Disease|cardiovascular disease
1305557|NCT01559415|Adipocytes|adipocytes
1305558|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
1305559|NCT01559389|Vesicare|vesicare
1305560|NCT01559389|Urinary Incontinence|urinary incontinence
1305561|NCT01559389|Sexual function|sexual function
1305562|NCT01559350|OPCAB|opcab
1305563|NCT01559337|defect|defect
1305564|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
1305565|NCT01559337|proper digital nerve|proper digital nerve
1305566|NCT01559337|nerve transfer|nerve transfer
1305567|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
1305568|NCT01559311|Bradycardia|bradycardia
1305569|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1305570|NCT01559298|Antithrombotic treatment|antithrombotic treatment
1305571|NCT01559298|Clopidogrel|clopidogrel
1305572|NCT01559298|Aspirin|aspirin
1305573|NCT01559298|Myocardial Infarction|myocardial infarction
1305574|NCT01559298|Ischemic stroke|ischemic stroke
1305575|NCT01559298|Major bleeding|major bleeding
1305576|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
1305577|NCT01559285|epidural administration|epidural administration
1305578|NCT01559285|stroke volume variability|stroke volume variability
1305579|NCT01559272|Schizophrenia|schizophrenia
1305580|NCT01559272|Paliperidone palmitate|paliperidone palmitate
1305581|NCT01559272|R092670|r092670
1305582|NCT01559272|Paliperidone|paliperidone
1305583|NCT01559272|3-month formulation|3-month formulation
1305584|NCT01559272|Pharmacokinetics|pharmacokinetics
1305585|NCT01559259|ibuprofen|ibuprofen
1305586|NCT01559259|acetaminophen|acetaminophen
1305587|NCT01559259|pain|pain
1305588|NCT01559259|molar extraction|molar extraction
1305589|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
1305590|NCT01559246|Holter Monitoring|holter monitoring
1305591|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
1305592|NCT01559246|Event monitoring|event monitoring
1305593|NCT01559246|Observational|observational
1305594|NCT01559207|nucleosome|nucleosome
1305595|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
1305596|NCT01559207|free DNA|free dna
1305597|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
1305598|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
1305599|NCT01559181|Pregnancy and programing|pregnancy and programing
1305600|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
1305701|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
1305601|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
1305602|NCT01559155|proteasomes|proteasomes
1305603|NCT01559155|proteasome concentration|proteasome concentration
1306209|NCT01556607|RSV|rsv
1305604|NCT01559155|disease activity|disease activity
1305605|NCT01559155|proteolytic activity|proteolytic activity
1305606|NCT01559155|autoantibodies|autoantibodies
1305607|NCT01559155|proteasome autoantibody|proteasome autoantibody
1305608|NCT01559142|Crohn Disease|crohn disease
1305609|NCT01559142|infliximab|infliximab
1305610|NCT01559142|azathioprine|azathioprine
1305611|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
1305612|NCT01559103|Phase I|phase i
1305613|NCT01559103|Biologic|biologic
1305614|NCT01559090|Japan|japan
1305615|NCT01559090|Phase2|phase2
1305616|NCT01559090|Safety|safety
1305617|NCT01559090|Tolerability|tolerability
1305618|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
1305619|NCT01559090|SLE, MEDI-546|sle, medi-546
1305620|NCT01559077|ATTR|attr
1305621|NCT01559051|COPD|copd
1305622|NCT01559051|Pulmonary|pulmonary
1305623|NCT01559051|Lungs|lungs
1305624|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
1305625|NCT01559025|Type 1 diabetes|type 1 diabetes
1305626|NCT01559025|Vildagliptin|vildagliptin
1305627|NCT01559025|Galvus|galvus
1305628|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
1305629|NCT01559012|treatment|treatment
1305630|NCT01559012|transdermal clonidine|transdermal clonidine
1305631|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
1305632|NCT01558986|surgical site infection|surgical site infection
1305633|NCT01558986|modified radical mastectomy|modified radical mastectomy
1305634|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
1305635|NCT01558960|Retinoblastoma|retinoblastoma
1305636|NCT01558947|gastric cancer|gastric cancer
1305637|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
1305638|NCT01558934|lofexidine|lofexidine
1305639|NCT01558934|methadone|methadone
1305640|NCT01558934|interaction|interaction
1305641|NCT01558934|pharmacodynamic|pharmacodynamic
1305642|NCT01558934|ECG|ecg
1305643|NCT01558934|QTc|qtc
1305644|NCT01558921|rectal cancer|rectal cancer
1305645|NCT01558921|radiotherapy|radiotherapy
1305646|NCT01558921|chemotherapy|chemotherapy
1305647|NCT01558921|5x5|5x5
1305648|NCT01558921|capecitbine|capecitbine
1305649|NCT01558921|oxaliplatin|oxaliplatin
1305650|NCT01558921|CAPOX|capox
1305651|NCT01558921|FOLFOX|folfox
1305652|NCT01558921|folinic acid|folinic acid
1305653|NCT01558921|fluorouracil|fluorouracil
1305654|NCT01558908|critical limb ischemia|critical limb ischemia
1305655|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
1305656|NCT01558895|liver cirrhosis|liver cirrhosis
1305657|NCT01558895|refractory ascites|refractory ascites
1305658|NCT01558882|Essure|essure
1305659|NCT01558882|Change in uterine cytokines|change in uterine cytokines
1305660|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
1305661|NCT01558882|cytokine|cytokine
1305662|NCT01558882|natural killer cell|natural killer cell
1305663|NCT01558856|refractory overactive bladder|refractory overactive bladder
1305664|NCT01558856|neuromodulation|neuromodulation
1305665|NCT01558856|sacral nerves|sacral nerves
1305666|NCT01558843|Sodium Management|sodium management
1305667|NCT01558843|Neurointensive Care|neurointensive care
1305668|NCT01558843|Hyponatremia|hyponatremia
1305669|NCT01558830|amiodarone|amiodarone
1305670|NCT01558830|ranolazine|ranolazine
1305671|NCT01558830|safety|safety
1305672|NCT01558830|arrhythmia|arrhythmia
1305673|NCT01558817|CPR|cpr
1305674|NCT01558817|Palliative|palliative
1305675|NCT01558817|Outcome|outcome
1305676|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
1305677|NCT01558804|Streptococcus|streptococcus
1305678|NCT01558791|PTSD|ptsd
1305679|NCT01558791|patient education handout|patient education handout
1305680|NCT01558765|Rehabilitation|rehabilitation
1305681|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
1305682|NCT01558765|Exercise training|exercise training
1305683|NCT01558765|Psycho-educational care|psycho-educational care
1305684|NCT01558752|Total hip replacement|total hip replacement
1305685|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
1305686|NCT01558739|Ruxolitinib|ruxolitinib
1305687|NCT01558739|INC424|inc424
1305688|NCT01558739|myelofibrosis|myelofibrosis
1305689|NCT01558739|PMF|pmf
1305690|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
1305691|NCT01558739|PPV MF|ppv mf
1305692|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1305693|NCT01558739|PET-MF|pet-mf
1305694|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
1305695|NCT01558739|Polycythemia|polycythemia
1305696|NCT01558739|Thrombocythemia|thrombocythemia
1305697|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
1305698|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
1305699|NCT01558739|Bone Marrow Diseases|bone marrow diseases
1305700|NCT01558739|Haematologic Diseases|haematologic diseases
1305702|NCT01558739|Blood Platelet Disorders|blood platelet disorders
1612139|NCT00350584|Mindfulness|mindfulness
1305703|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
1305704|NCT01558726|Case Management|case management
1305705|NCT01558726|Crack abuse/dependents|crack abuse/dependents
1305706|NCT01558726|Evaluation|evaluation
1305707|NCT01558726|Inpatient|inpatient
1305708|NCT01558726|ASI|asi
1305709|NCT01558726|Treatment retention|treatment retention
1305710|NCT01558726|Abstinence|abstinence
1305711|NCT01558713|parturient|parturient
1305712|NCT01558700|osteoarthritis|osteoarthritis
1305713|NCT01558700|pain|pain
1305714|NCT01558700|brain|brain
1305715|NCT01558700|gray matter|gray matter
1305716|NCT01558687|Oncology|oncology
1305717|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
1305718|NCT01558687|temolozomide|temolozomide
1305719|NCT01558687|radiotherapy|radiotherapy
1305720|NCT01558687|dynamic MRI|dynamic mri
1305721|NCT01558687|Positron emission tomography|positron emission tomography
1305722|NCT01558687|[18]FET tracer|[18]fet tracer
1305723|NCT01558687|cilengitide|cilengitide
1305724|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
1305725|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
1305726|NCT01558661|recurrent|recurrent
1305727|NCT01558661|metastatic|metastatic
1305728|NCT01558661|12-004|12-004
1305729|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
1305730|NCT01558648|Open Esophagectomy|open esophagectomy
1305731|NCT01558648|Quality of Life|quality of life
1305732|NCT01558648|12-003|12-003
1305733|NCT01558635|Atrial Fibrillation|atrial fibrillation
1305734|NCT01558635|Surgical ablation|surgical ablation
1305735|NCT01558635|Maze procedure|maze procedure
1305736|NCT01558635|AF|af
1305737|NCT01558622|postoperative analgesia|postoperative analgesia
1305738|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
1305739|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
1305740|NCT01558622|pethidine|pethidine
1305741|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
1305742|NCT01558583|Colon|colon
1305743|NCT01558583|Prostate|prostate
1305744|NCT01558583|Cancer|cancer
1305745|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
1305746|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
1305747|NCT01558544|Fertility preservation|fertility preservation
1305748|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
1305749|NCT01558531|peripheral arterial disease|peripheral arterial disease
1305750|NCT01558531|drug-eluting balloon|drug-eluting balloon
1305751|NCT01558531|restenosis|restenosis
1305752|NCT01558518|Handheld echocardiography|handheld echocardiography
1305753|NCT01558518|V-scan|v-scan
1305754|NCT01558518|Handheld ultrasound|handheld ultrasound
1305755|NCT01558518|Portable ultrasound|portable ultrasound
1305756|NCT01558505|critical limb ischemia|critical limb ischemia
1305757|NCT01558505|drug-eluting balloon|drug-eluting balloon
1305758|NCT01558505|restenosis|restenosis
1305759|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
1305760|NCT01558492|CRPC|crpc
1305761|NCT01558479|Parkinson's Disease|parkinson's disease
1305762|NCT01558479|Genetics|genetics
1305763|NCT01558479|Family Research|family research
1305764|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
1305765|NCT01558466|newborn|newborn
1305766|NCT01558466|INO|ino
1305767|NCT01558466|Sildenafil|sildenafil
1305768|NCT01558466|PPHN|pphn
1305769|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
1305770|NCT01558440|severe malnutrition|severe malnutrition
1305771|NCT01558440|infant formula|infant formula
1305772|NCT01558440|F-100|f-100
1305773|NCT01558414|Cholecystectomy|cholecystectomy
1305774|NCT01558414|Minimally invasive surgery|minimally invasive surgery
1305775|NCT01558414|Laparoscopic surgery|laparoscopic surgery
1305776|NCT01558414|Single incision surgery|single incision surgery
1305777|NCT01558401|physical activity|physical activity
1305778|NCT01558401|elderly|elderly
1305779|NCT01558401|women|women
1305780|NCT01558401|efficiency|efficiency
1305781|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
1305782|NCT01558362|single photon emission tomography|single photon emission tomography
1305783|NCT01558362|Coronary artery disease|coronary artery disease
1305784|NCT01558362|gamma camera imaging|gamma camera imaging
1305785|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
1305786|NCT01558362|cyclotron|cyclotron
1305787|NCT01558349|Epispot|epispot
1305788|NCT01558349|CellSearch|cellsearch
1305789|NCT01558349|Circulating melanoma cells|circulating melanoma cells
1305790|NCT01558349|circulating cells|circulating cells
1305791|NCT01558336|Schistosoma haematobium|schistosoma haematobium
1305792|NCT01558336|schoolchildren|schoolchildren
1305793|NCT01558336|Central Sudan|central sudan
1305794|NCT01558336|Praziquantel|praziquantel
1305795|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
1305796|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
1305797|NCT01558284|Neu-P11|neu-p11
1305798|NCT01558284|Melatonin|melatonin
1305799|NCT01558284|D-IBS|d-ibs
1305800|NCT01558271|GLP-1|glp-1
1305897|NCT01557855|CAD|cad
1305801|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
1305900|NCT01557855|Precision Medicine|precision medicine
1305802|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
1305803|NCT01558232|Stroke|stroke
1305804|NCT01558232|Tibion|tibion
1305805|NCT01558232|Bionics|bionics
1305806|NCT01558232|Rehab|rehab
1305807|NCT01558232|Therapy|therapy
1305808|NCT01558232|Robotics|robotics
1305809|NCT01558232|Intention|intention
1305810|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
1305811|NCT01558206|PTE|pte
1305812|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
1305813|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
1305814|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
1305815|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
1305816|NCT01558193|Aggression DHA|aggression dha
1305817|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
1305818|NCT01558193|Impulsivity|impulsivity
1305819|NCT01558193|Minerals|minerals
1305820|NCT01558193|Vitamins|vitamins
1305821|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
1305822|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1305823|NCT01558154|depression|depression
1305824|NCT01558154|Chinese herb|chinese herb
1305825|NCT01558154|acupuncture|acupuncture
1305826|NCT01558154|Psychotherapy|psychotherapy
1305827|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
1305828|NCT01558141|IVF stimulation.|ivf stimulation.
1305829|NCT01558141|Poor responders.|poor responders.
1305830|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
1305831|NCT01558115|Columbia University|columbia university
1305832|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
1305833|NCT01558115|Low bone density|low bone density
1305834|NCT01558115|Denosumab|denosumab
1305835|NCT01558115|Prolia|prolia
1305836|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
1305837|NCT01558076|Sickle cell anemia|sickle cell anemia
1305838|NCT01558076|exercise testing|exercise testing
1305839|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
1305840|NCT01558063|Ketamine|ketamine
1305841|NCT01558063|Major Depressive Disorder|major depressive disorder
1305842|NCT01558063|Treatment|treatment
1305843|NCT01558063|Depression|depression
1305844|NCT01558037|transplant|transplant
1305845|NCT01558037|solid organ transplant|solid organ transplant
1305846|NCT01558037|kidney transplant|kidney transplant
1305847|NCT01558037|liver transplant|liver transplant
1305848|NCT01558037|pancreas transplant|pancreas transplant
1305849|NCT01558037|heart transplant|heart transplant
1305851|NCT01558037|Cytomegalovirus|cytomegalovirus
1305852|NCT01558024|compression stockings|compression stockings
1305853|NCT01558024|physiopathology|physiopathology
1305854|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
1305855|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
1305856|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
1305857|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
1305858|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
1305859|NCT01558011|predict the efficacy|predict the efficacy
1305860|NCT01557998|Test and linkage to care|test and linkage to care
1305861|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
1305862|NCT01557998|Prevention with positives|prevention with positives
1305863|NCT01557998|ART adherence|art adherence
1305864|NCT01557998|point of care CD4 counts|point of care cd4 counts
1305865|NCT01557998|Peer case management|peer case management
1305866|NCT01557998|Conditional cash transfer|conditional cash transfer
1305867|NCT01557985|children|children
1305868|NCT01557985|regional anesthesia|regional anesthesia
1305869|NCT01557985|postoperative pain management|postoperative pain management
1305870|NCT01557985|local anesthetic solution|local anesthetic solution
1305871|NCT01557985|toxicity|toxicity
1305872|NCT01557933|ECT|ect
1305873|NCT01557933|Bipolar Disorder|bipolar disorder
1305874|NCT01557920|apnea|apnea
1305875|NCT01557920|airway collapsibility|airway collapsibility
1305876|NCT01557920|healthy|healthy
1305877|NCT01557920|hypercapnia|hypercapnia
1305878|NCT01557920|general anesthesia|general anesthesia
1305879|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
1305880|NCT01557920|aspiration|aspiration
1305881|NCT01557907|Diabetes|diabetes
1305882|NCT01557907|Diabetes Mellitus|diabetes mellitus
1305883|NCT01557907|Type 1 diabetes|type 1 diabetes
1305884|NCT01557907|Insulin Pump users|insulin pump users
1305885|NCT01557907|Intradermal insulin|intradermal insulin
1305886|NCT01557894|Social anxiety disorders|social anxiety disorders
1305887|NCT01557894|Social phobia|social phobia
1305888|NCT01557894|Anxiety sensitivity|anxiety sensitivity
1305889|NCT01557894|Irrational thinking|irrational thinking
1305890|NCT01557894|Guided self-help|guided self-help
1305891|NCT01557894|Internet-delivered treatment|internet-delivered treatment
1305892|NCT01557855|Corus CAD|corus cad
1305893|NCT01557855|ASGES|asges
1305894|NCT01557855|Age/Sex/Gene Expression Score|age/sex/gene expression score
1305895|NCT01557855|Gene Expression|gene expression
1305896|NCT01557855|GES|ges
1305898|NCT01557855|CVD|cvd
1305899|NCT01557855|CHD|chd
1305901|NCT01557855|Clinical Utility|clinical utility
1305902|NCT01557855|Registry|registry
1305903|NCT01557855|Coronary Artery Disease|coronary artery disease
1305904|NCT01557855|Coronary Heart Disease|coronary heart disease
1305905|NCT01557855|Cardiovascular Disease|cardiovascular disease
1305906|NCT01557855|Angina Pectoris|angina pectoris
1305907|NCT01557855|Chest Pain|chest pain
1305908|NCT01557855|Registry I|registry i
1305909|NCT01557855|Registry-I|registry-i
1305910|NCT01557842|Ischemic|ischemic
1305911|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
1305912|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
1305913|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
1305914|NCT01557842|Ablation|ablation
1305915|NCT01557842|Electrophysiology|electrophysiology
1305916|NCT01557829|spondylolisthesis|spondylolisthesis
1305917|NCT01557829|disc degeneration|disc degeneration
1305918|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
1305919|NCT01557829|randomized controlled trial|randomized controlled trial
1305920|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
1305921|NCT01557816|osteoarthritis|osteoarthritis
1305922|NCT01557816|knee|knee
1305923|NCT01557816|Naproxen|naproxen
1305924|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
1305925|NCT01557803|Biomarkers|biomarkers
1305926|NCT01557803|HIV|hiv
1305927|NCT01557803|ART|art
1305928|NCT01557803|predictive factors|predictive factors
1305929|NCT01557803|epidemiological pattern|epidemiological pattern
1305930|NCT01557803|Gabon|gabon
1305931|NCT01557790|Adult male|adult male
1305932|NCT01557790|18 years or older|18 years or older
1305933|NCT01557790|clinical diagnosis|clinical diagnosis
1305934|NCT01557751|Total knee arthroplasty|total knee arthroplasty
1305935|NCT01557751|Total knee replacement|total knee replacement
1305936|NCT01557751|Genetics of pain|genetics of pain
1305937|NCT01557738|Exercise|exercise
1305938|NCT01557738|Blood Flow|blood flow
1305939|NCT01557738|Nitric Oxide|nitric oxide
1305940|NCT01557738|Aging|aging
1305941|NCT01557738|Antioxidant|antioxidant
1305942|NCT01557738|Flavanol|flavanol
1305943|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
1305944|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
1305945|NCT01557725|Knee Replacement, Total|knee replacement, total
1305946|NCT01557725|Hip Replacement, Total|hip replacement, total
1305947|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
1305948|NCT01557725|prophylaxis|prophylaxis
1305949|NCT01557725|Enhanced recovery|enhanced recovery
1305950|NCT01557686|Cancer Related fatigue|cancer related fatigue
1305951|NCT01557686|Quality of Life|quality of life
1305952|NCT01557686|Psychosocial Intervention|psychosocial intervention
1305953|NCT01557686|Rehabilitation|rehabilitation
1305954|NCT01557686|Physical Fitness|physical fitness
1305955|NCT01557686|Physical Activity|physical activity
1305956|NCT01557686|Exercise Therapy|exercise therapy
1305957|NCT01557686|Exercise|exercise
1305958|NCT01557686|Hematologic|hematologic
1305959|NCT01557686|Hematological|hematological
1305960|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1305961|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
1305962|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1305963|NCT01557686|Acute Leukemia|acute leukemia
1305964|NCT01557673|Nasogastric|nasogastric
1305965|NCT01557673|Small bowel water|small bowel water
1305966|NCT01557673|Diarrhoea|diarrhoea
1305967|NCT01557673|Mesenteric blood flow|mesenteric blood flow
1305968|NCT01557673|Enteral feeding|enteral feeding
1305969|NCT01557621|Immunization reminder/recall|immunization reminder/recall
1305970|NCT01557621|Reminder/Recall systems|reminder/recall systems
1305971|NCT01557621|Population based Recall|population based recall
1305972|NCT01557621|Practice based Recall|practice based recall
1305973|NCT01557608|cancer|cancer
1305974|NCT01557608|chemotherapy|chemotherapy
1305975|NCT01557608|photon stimulation|photon stimulation
1305976|NCT01557608|neuropathy|neuropathy
1305977|NCT01557608|pain|pain
1305978|NCT01557582|IPAH|ipah
1305979|NCT01557582|HPAH|hpah
1305980|NCT01557582|APAH CTD|apah ctd
1305981|NCT01557582|APAH HIV|apah hiv
1305982|NCT01557582|APAH PoPH|apah poph
1305983|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
1305984|NCT01557582|APAH CHD repaired|apah chd repaired
1305985|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
1305986|NCT01557569|methamphetamine|methamphetamine
1305987|NCT01557569|addiction|addiction
1305988|NCT01557569|relapse|relapse
1305989|NCT01557569|atomoxetine|atomoxetine
1305990|NCT01557556|CRH Antagonist|crh antagonist
1305991|NCT01557556|Nicotine|nicotine
1305992|NCT01557556|Nicotine Dependence|nicotine dependence
1305993|NCT01557556|Smoking|smoking
1305994|NCT01557556|Stress|stress
1305995|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1305996|NCT01557543|Coronary Artery Disease|coronary artery disease
1333276|NCT01443728|acute chest syndrome|acute chest syndrome
1305997|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
1305998|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
1305999|NCT01557517|cGVHD|cgvhd
1306000|NCT01557517|Oral cGVHD|oral cgvhd
1306001|NCT01557517|Topical|topical
1306004|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
1306005|NCT01557517|GVHD|gvhd
1306006|NCT01557491|Alopecia|alopecia
1306007|NCT01557491|Coronal Incision|coronal incision
1306008|NCT01557491|Scar Quality|scar quality
1306009|NCT01557478|breast cancer|breast cancer
1306010|NCT01557478|melatonin|melatonin
1306011|NCT01557478|adjuvant therapy|adjuvant therapy
1306012|NCT01557478|quality of life|quality of life
1306013|NCT01557478|pain|pain
1306014|NCT01557478|sleep|sleep
1306015|NCT01557478|survival|survival
1306016|NCT01557478|adverse events|adverse events
1306017|NCT01557452|JIA|jia
1306018|NCT01557426|skin|skin
1306019|NCT01557426|soft tissue|soft tissue
1306020|NCT01557426|infection|infection
1306021|NCT01557426|cellulitis|cellulitis
1306022|NCT01557426|abscess|abscess
1306023|NCT01557413|Humerus|humerus
1306024|NCT01557413|fracture|fracture
1306025|NCT01557413|nail|nail
1306026|NCT01557413|plate|plate
1306027|NCT01557413|tuberosity|tuberosity
1306028|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
1306029|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
1306030|NCT01557400|Nonsense mutation|nonsense mutation
1306031|NCT01557400|Premature stop codon|premature stop codon
1306032|NCT01557400|DMD|dmd
1306033|NCT01557400|BMD|bmd
1306034|NCT01557400|nmDBMD|nmdbmd
1306035|NCT01557400|DBMD|dbmd
1306036|NCT01557400|Ataluren|ataluren
1306037|NCT01557400|PTC124|ptc124
1306038|NCT01557387|Pseudopolyp|pseudopolyp
1306039|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
1306040|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
1306041|NCT01557374|Disease activity|disease activity
1306042|NCT01557374|Remission|remission
1306043|NCT01557374|Lowest Effective DOse|lowest effective dose
1306044|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
1306045|NCT01557374|ACR-EULAR 2010|acr-eular 2010
1306046|NCT01557361|renal replacement therapy|renal replacement therapy
1306047|NCT01557361|dialysis|dialysis
1306048|NCT01557361|acute kidney injury|acute kidney injury
1306049|NCT01557361|hemodialysis|hemodialysis
1306050|NCT01557361|critical illness|critical illness
1306051|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
1306052|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
1306053|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1306054|NCT01557309|age|age
1306055|NCT01557309|early rotator cuff repair|early rotator cuff repair
1306056|NCT01557296|Diet|diet
1306057|NCT01557296|Dietary treatment|dietary treatment
1306058|NCT01557296|Particle size|particle size
1306059|NCT01557296|Gastroparesis|gastroparesis
1306060|NCT01557296|Diabetes Mellitus|diabetes mellitus
1306061|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
1306062|NCT01557257|ALO-02|alo-02
1306063|NCT01557257|OxyContin|oxycontin
1306064|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1306065|NCT01557244|neurogenic bladder|neurogenic bladder
1306066|NCT01557244|neuropathic bladder|neuropathic bladder
1306067|NCT01557244|neurologic disease|neurologic disease
1306068|NCT01557244|fesoterodine|fesoterodine
1306070|NCT01557231|osteoarthritis|osteoarthritis
1306071|NCT01557231|pain|pain
1306072|NCT01557231|variability|variability
1306073|NCT01557231|activity|activity
1306074|NCT01557231|treatment|treatment
1306075|NCT01557218|Dietary variety|dietary variety
1306076|NCT01557218|Vegetable intake|vegetable intake
1306077|NCT01557218|Fruit intake|fruit intake
1306078|NCT01557205|optical coherence tomography|optical coherence tomography
1306079|NCT01557205|cell imaging|cell imaging
1306080|NCT01557192|Depression|depression
1306081|NCT01557192|Bipolar Depression|bipolar depression
1306082|NCT01557192|LFMS|lfms
1306083|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
1306084|NCT01557166|OSA|osa
1306085|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
1306086|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
1306087|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
1306088|NCT01557140|Beta-blockers,|beta-blockers,
1306089|NCT01557140|Enalapril,|enalapril,
1306090|NCT01557140|Carvedilol,|carvedilol,
1306091|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
1306092|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
1306093|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
1306094|NCT01557140|Chemokines|chemokines
1306095|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
1306096|NCT01557127|Sorafenib|sorafenib
1306097|NCT01557127|Dosing|dosing
1333277|NCT01443728|respiratory complications|respiratory complications
1410268|NCT01123161|tPA|tpa
1306098|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
1306099|NCT01557088|coronary artery disease|coronary artery disease
1306100|NCT01557088|coronary artery spasm|coronary artery spasm
1306101|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
1306102|NCT01557075|High dose statin|high dose statin
1306103|NCT01557062|Fibromyalgia|fibromyalgia
1306104|NCT01557062|Hydrotherapy|hydrotherapy
1306105|NCT01557062|Sleep|sleep
1306106|NCT01557062|Pain|pain
1306107|NCT01557062|Body Temperature|body temperature
1306108|NCT01557049|chronic low back pain|chronic low back pain
1306109|NCT01557049|Postural global reeducation|postural global reeducation
1306110|NCT01557049|randomized|randomized
1306111|NCT01557049|physical rehabilitation|physical rehabilitation
1306112|NCT01557036|Brain Aneurysm|brain aneurysm
1306113|NCT01556997|Hypertension|hypertension
1306114|NCT01556997|Essential Hypertension|essential hypertension
1306115|NCT01556984|diabetic foot|diabetic foot
1306116|NCT01556984|digital subtraction angiography|digital subtraction angiography
1306117|NCT01556984|endothelial function|endothelial function
1306118|NCT01556984|Patients with diabetes|patients with diabetes
1306119|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
1306120|NCT01556984|Endothelial function are determined|endothelial function are determined
1306121|NCT01556945|P. falciparum|p. falciparum
1306122|NCT01556945|vaccine|vaccine
1306123|NCT01556945|healthy volunteers|healthy volunteers
1306124|NCT01556919|GERD|gerd
1306125|NCT01556919|Esophagitis|esophagitis
1306126|NCT01556893|Flap Creation|flap creation
1306127|NCT01556893|Femtosecond Laser|femtosecond laser
1306128|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
1306129|NCT01556880|Drivers|drivers
1306130|NCT01556880|Chinese|chinese
1306131|NCT01556880|Short Message Service|short message service
1306132|NCT01556880|Cellular Phone|cellular phone
1306133|NCT01556867|Umbilical cord care|umbilical cord care
1306134|NCT01556867|dry cord care|dry cord care
1306135|NCT01556867|antiseptic|antiseptic
1306136|NCT01556867|Omphalitis|omphalitis
1306137|NCT01556867|umbilical cord drop|umbilical cord drop
1306138|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
1306139|NCT01556854|ginkgo leaves|ginkgo leaves
1306140|NCT01556854|butylphthalide|butylphthalide
1306141|NCT01556854|edaravone|edaravone
1306142|NCT01556854|citicoline|citicoline
1306143|NCT01556854|cerebrolysin|cerebrolysin
1306144|NCT01556854|piracetam|piracetam
1306145|NCT01556854|Neuroprotectants|neuroprotectants
1306146|NCT01556841|Randomised|randomised
1306147|NCT01556841|Controlled|controlled
1306148|NCT01556841|Trovax|trovax
1306149|NCT01556841|MVA-5T4|mva-5t4
1306151|NCT01556841|Immunotherapy|immunotherapy
1306152|NCT01556841|Relapsed|relapsed
1306153|NCT01556841|Asymptomatic|asymptomatic
1306154|NCT01556841|Epithelial|epithelial
1306155|NCT01556841|Ovarian|ovarian
1306156|NCT01556841|Fallopian|fallopian
1306157|NCT01556841|Peritoneal|peritoneal
1306158|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
1306159|NCT01556815|Sorafenib|sorafenib
1306160|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
1306161|NCT01556815|HBV|hbv
1306162|NCT01556802|stroke|stroke
1306163|NCT01556802|sequelaes|sequelaes
1306164|NCT01556802|minocicline|minocicline
1306165|NCT01556789|ONT-10|ont-10
1306166|NCT01556789|MUC1|muc1
1306167|NCT01556789|Vaccine|vaccine
1306168|NCT01556789|Phase 1|phase 1
1306169|NCT01556789|Solid Tumors|solid tumors
1306170|NCT01556789|Dose escalation|dose escalation
1306171|NCT01556776|CLL|cll
1306172|NCT01556776|High Risk|high risk
1306173|NCT01556776|Maintenance|maintenance
1306174|NCT01556763|Schizophrenia|schizophrenia
1306175|NCT01556763|Schizoaffective|schizoaffective
1306176|NCT01556763|CNS|cns
1306177|NCT01556737|isoflavone|isoflavone
1306178|NCT01556737|supplement|supplement
1306179|NCT01556737|daidzein|daidzein
1306180|NCT01556737|genistein|genistein
1306181|NCT01556737|gene expression|gene expression
1306182|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
1306183|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
1306184|NCT01556724|Postoperative pain|postoperative pain
1306185|NCT01556724|Total hip replacement|total hip replacement
1306186|NCT01556711|Head Injury|head injury
1306187|NCT01556711|Head Trauma|head trauma
1306188|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1306189|NCT01556711|Emergency Department|emergency department
1306190|NCT01556698|Acne Vulgaris|acne vulgaris
1306191|NCT01556698|Acne|acne
1306192|NCT01556672|small bowel lesions|small bowel lesions
1306193|NCT01556672|Crohn's Disease|crohn's disease
1306194|NCT01556672|Plaque psoriasis|plaque psoriasis
1306195|NCT01556672|adalimumab|adalimumab
1306196|NCT01556672|capsule endoscopy|capsule endoscopy
1306197|NCT01556659|Left ventricular thrombus|left ventricular thrombus
1306198|NCT01556659|Acute myocardial infarction|acute myocardial infarction
1306199|NCT01556659|Anticoagulation|anticoagulation
1306200|NCT01556646|Cirrhosis|cirrhosis
1306201|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
1306202|NCT01556646|Hyponatremia|hyponatremia
1306203|NCT01556646|Brain MRI|brain mri
1306204|NCT01556646|Health-related quality of life|health-related quality of life
1306205|NCT01556646|cognitive function|cognitive function
1306206|NCT01556620|PtiO2|ptio2
1306207|NCT01556620|NIRS|nirs
1306208|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
1306210|NCT01556594|Hypoglycemia|hypoglycemia
1306211|NCT01556594|Diabetes mellitus|diabetes mellitus
1306212|NCT01556581|back pain|back pain
1306213|NCT01556581|primary care|primary care
1306214|NCT01556581|physical therapy|physical therapy
1306215|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
1306216|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
1306217|NCT01556555|Spyglass|spyglass
1306218|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
1306219|NCT01556542|peripheral arterial disease|peripheral arterial disease
1306220|NCT01556542|drug-eluting balloon|drug-eluting balloon
1306221|NCT01556542|restenosis|restenosis
1306222|NCT01556477|MDS|mds
1306223|NCT01556477|AML|aml
1306224|NCT01556477|Azacitidine|azacitidine
1306225|NCT01556477|Lenalidomide|lenalidomide
1306226|NCT01556477|del5q|del5q
1306227|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
1306228|NCT01556464|CPAP|cpap
1306229|NCT01556425|opioid use disorder|opioid use disorder
1306230|NCT01556425|treatment|treatment
1306231|NCT01556425|heroin|heroin
1306232|NCT01556425|extended-release naltrexone|extended-release naltrexone
1306233|NCT01556425|incentives|incentives
1306234|NCT01556425|cotningency management|cotningency management
1306235|NCT01556425|employment-based reinforcement|employment-based reinforcement
1306236|NCT01556425|therapeutic workplace|therapeutic workplace
1306237|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
1306238|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
1306239|NCT01556412|EUS|eus
1306240|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
1306241|NCT01556399|Duodenal adenoma|duodenal adenoma
1306242|NCT01556399|Ampullary adenoma|ampullary adenoma
1306243|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1306244|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
1306245|NCT01556373|acute systemic inflammation|acute systemic inflammation
1306246|NCT01556373|arterial stiffness|arterial stiffness
1306247|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
1306248|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
1306249|NCT01556360|Iron overload|iron overload
1306250|NCT01556360|C282 homozygosity|c282 homozygosity
1306251|NCT01556347|alloantibody|alloantibody
1306252|NCT01556347|immunologic|immunologic
1306253|NCT01556347|memory|memory
1306254|NCT01556347|heart|heart
1306255|NCT01556347|transplant|transplant
1306256|NCT01556347|desensitization|desensitization
1306257|NCT01556334|premature ruptured membranes|premature ruptured membranes
1306258|NCT01556334|azithromycin|azithromycin
1306259|NCT01556334|erythromycin|erythromycin
1306260|NCT01556334|latency|latency
1306261|NCT01556334|antibiotics|antibiotics
1306262|NCT01556321|Obesity|obesity
1306263|NCT01556321|Body weight|body weight
1306264|NCT01556321|Gut flora|gut flora
1306265|NCT01556321|Fat absorption|fat absorption
1306266|NCT01556308|Dowling Meara|dowling meara
1306267|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
1306268|NCT01556308|inflammation|inflammation
1306269|NCT01556295|Nurses|nurses
1306270|NCT01556295|Low back pain|low back pain
1306271|NCT01556295|Gesture behavior|gesture behavior
1306272|NCT01556295|Knowlegde|knowlegde
1306273|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
1306274|NCT01556282|portal vein thrombosis|portal vein thrombosis
1306275|NCT01556282|HCC|hcc
1306276|NCT01556243|stage IA breast cancer|stage ia breast cancer
1306277|NCT01556243|stage IB breast cancer|stage ib breast cancer
1306278|NCT01556243|stage II breast cancer|stage ii breast cancer
1306279|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1306280|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1306281|NCT01556230|pituitary gland|pituitary gland
1306282|NCT01556230|pituitary adenoma|pituitary adenoma
1306283|NCT01556230|pituitary tumor|pituitary tumor
1306284|NCT01556230|hypophysis|hypophysis
1306285|NCT01556230|endocrine|endocrine
1306286|NCT01556230|neuroendocrine|neuroendocrine
1306287|NCT01556230|hormone|hormone
1306288|NCT01556217|Healthy volunteers|healthy volunteers
1306289|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
1306290|NCT01556217|Pharmacokinetics|pharmacokinetics
1306291|NCT01556217|Central brain penetrance|central brain penetrance
1306292|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
1306293|NCT01556204|Endometriosis|endometriosis
1306294|NCT01556191|lung cancer|lung cancer
1306295|NCT01556191|women|women
1306296|NCT01556178|Hydrocephalus|hydrocephalus
1306297|NCT01556178|Survivin|survivin
1410523|NCT01121952|ROM|rom
1306298|NCT01556178|miRNA|mirna
1306299|NCT01556165|Rasagiline|rasagiline
1306300|NCT01556165|Azilect|azilect
1306301|NCT01556165|Parkinson´s Disease|parkinson´s disease
1306302|NCT01556165|Motor fluctuations|motor fluctuations
1306303|NCT01556139|Endurance|endurance
1306304|NCT01556139|exercise training|exercise training
1306305|NCT01556139|6-min walking test|6-min walking test
1306306|NCT01556126|Coronary artery disease|coronary artery disease
1306307|NCT01556126|Drug Eluting Stent|drug eluting stent
1306308|NCT01556126|All comers patients|all comers patients
1306309|NCT01556113|fatty liver|fatty liver
1306310|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
1306311|NCT01556113|elevated liver enzymes|elevated liver enzymes
1306312|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
1306314|NCT01556087|distress tolerance|distress tolerance
1306315|NCT01556087|buprenorphine|buprenorphine
1306316|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
1306317|NCT01556074|PTSD|ptsd
1306318|NCT01556074|Insomnia|insomnia
1306319|NCT01556074|Sleep|sleep
1306320|NCT01556074|Yoga|yoga
1306321|NCT01556074|Meditation|meditation
1306322|NCT01556074|Mental Health|mental health
1306323|NCT01556074|Sleep Quality|sleep quality
1306324|NCT01556074|Actigraphy|actigraphy
1306325|NCT01556074|Sleep Diaries|sleep diaries
1306326|NCT01556074|Autonomic|autonomic
1306327|NCT01556074|Social Health|social health
1306328|NCT01556074|Interoception|interoception
1306329|NCT01556074|Attention Regulation|attention regulation
1306330|NCT01556074|Emotion Regulation|emotion regulation
1306331|NCT01556061|Laryngoscopy|laryngoscopy
1306332|NCT01556061|Airway Management|airway management
1306333|NCT01556061|Intubation|intubation
1306334|NCT01556048|Behavior therapy|behavior therapy
1306335|NCT01556048|Bereavement|bereavement
1306336|NCT01556048|Complicated grief|complicated grief
1306337|NCT01556048|Depression|depression
1306338|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
1306339|NCT01556035|oncodermatology|oncodermatology
1306340|NCT01556035|hematology|hematology
1306341|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
1306342|NCT01556035|lenalidomide|lenalidomide
1306343|NCT01556022|Ischemic heart disease|ischemic heart disease
1306344|NCT01556022|Coronary artery disease|coronary artery disease
1306345|NCT01556022|Chronic heart failure|chronic heart failure
1306346|NCT01556022|Cardiovascular disease|cardiovascular disease
1306347|NCT01556022|Adult stem cells|adult stem cells
1306348|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
1306349|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
1306350|NCT01556009|Photodynamic Therapy|photodynamic therapy
1306351|NCT01555996|older|older
1306352|NCT01555996|delirium|delirium
1306353|NCT01555996|cognitive status|cognitive status
1306354|NCT01555996|occupational therapy|occupational therapy
1306355|NCT01555996|critically ill patients|critically ill patients
1306356|NCT01555983|cannabis|cannabis
1306357|NCT01555983|central neuropathic pain|central neuropathic pain
1306358|NCT01555983|analgesia|analgesia
1306359|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
1306360|NCT01555970|Treatment|treatment
1306361|NCT01555970|Glutamate|glutamate
1306362|NCT01555970|N-Acetylcysteine|n-acetylcysteine
1306363|NCT01555918|Pharmacokinetics|pharmacokinetics
1306364|NCT01555918|Healthy volunteers|healthy volunteers
1306365|NCT01555918|Isavuconazole|isavuconazole
1306366|NCT01555918|BAL4815|bal4815
1306367|NCT01555918|BAL8728|bal8728
1306368|NCT01555918|BAL8557|bal8557
1306369|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
1306370|NCT01555892|EBV|ebv
1306371|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
1306372|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1306373|NCT01555892|Lymphoma Relapse|lymphoma relapse
1306374|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
1306375|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
1306376|NCT01555892|LMP|lmp
1306377|NCT01555892|BARF1|barf1
1306378|NCT01555892|EBNA1|ebna1
1306379|NCT01555879|Retrospective|retrospective
1306380|NCT01555879|Database|database
1306381|NCT01555879|Data warehouse|data warehouse
1306382|NCT01555879|Data mining|data mining
1306383|NCT01555879|Collaborative effectiveness|collaborative effectiveness
1306384|NCT01555879|Comparative effectiveness|comparative effectiveness
1306385|NCT01555879|Outcome based medicine|outcome based medicine
1306386|NCT01555879|Evidence based medicine|evidence based medicine
1306387|NCT01555866|isavuconazole|isavuconazole
1306388|NCT01555866|BAL4815|bal4815
1306389|NCT01555866|BAL8557|bal8557
1306390|NCT01555866|BAL8728|bal8728
1306391|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
1306392|NCT01555840|Gastroscopy|gastroscopy
1306393|NCT01555827|Retina|retina
1306394|NCT01555827|ALzheimer's disease|alzheimer's disease
1306395|NCT01555827|neurodegenerative signs|neurodegenerative signs
1306396|NCT01555814|dopamine|dopamine
1306397|NCT01555814|first episode|first episode
1306398|NCT01555814|reward|reward
1306399|NCT01555814|cognition|cognition
1306400|NCT01555814|MRI|mri
1306401|NCT01555814|fMRI|fmri
1306402|NCT01555814|PPI|ppi
1306403|NCT01555814|P300|p300
1306404|NCT01555814|P50 gating|p50 gating
1306405|NCT01555814|endophenotypes|endophenotypes
1306406|NCT01555801|esophageal cancer|esophageal cancer
1306407|NCT01555801|early cancer|early cancer
1306408|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
1306409|NCT01555801|stage|stage
1306410|NCT01555788|type 1 diabetes,|type 1 diabetes,
1306411|NCT01555788|diaport,|diaport,
1306412|NCT01555788|artificial pancreas,|artificial pancreas,
1306413|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
1306414|NCT01555788|ap system,|ap system,
1306415|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
1306416|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
1306417|NCT01555775|nutritional recovery|nutritional recovery
1306418|NCT01555775|nutritional supplement|nutritional supplement
1306419|NCT01555775|natural food|natural food
1306420|NCT01555736|allergic rhinitis|allergic rhinitis
1306421|NCT01555736|perennial immunotherapy|perennial immunotherapy
1306422|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
1306423|NCT01555697|Schizophrenia|schizophrenia
1306424|NCT01555697|prepulse inhibition|prepulse inhibition
1306425|NCT01555697|neurocognition|neurocognition
1306426|NCT01555697|working memory|working memory
1306427|NCT01555697|memantine|memantine
1306428|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
1306430|NCT01555684|CCSVI|ccsvi
1306431|NCT01555671|labor,|labor,
1306432|NCT01555671|meperidine,|meperidine,
1306433|NCT01555671|active phase,|active phase,
1306434|NCT01555671|duration of labor|duration of labor
1306435|NCT01555658|Long Lesions|long lesions
1306436|NCT01555658|Stent Implantation|stent implantation
1306437|NCT01555645|Breast cancer|breast cancer
1306438|NCT01555645|Stress management|stress management
1306439|NCT01555645|Stepped care|stepped care
1306440|NCT01555645|Randomized|randomized
1306441|NCT01555619|Left heart pacing lead|left heart pacing lead
1306442|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1306443|NCT01555619|Heart Failure|heart failure
1306444|NCT01555619|Quadripolar pacing|quadripolar pacing
1306445|NCT01555606|Psoriasis|psoriasis
1306446|NCT01555606|Patient-reported outcome|patient-reported outcome
1306447|NCT01555606|Quality of Life|quality of life
1306448|NCT01555593|COPD|copd
1306449|NCT01555593|FeNO|feno
1306450|NCT01555593|Bronchial inflammation|bronchial inflammation
1306451|NCT01555593|Small airways|small airways
1306452|NCT01555593|Decubitus|decubitus
1306453|NCT01555580|myasthenia gravis|myasthenia gravis
1306454|NCT01555580|autoimmune|autoimmune
1306455|NCT01555580|GM-CSF|gm-csf
1306456|NCT01555567|ACL|acl
1306457|NCT01555567|muscle|muscle
1306458|NCT01555567|quadriceps|quadriceps
1306459|NCT01555567|strength|strength
1306460|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
1306461|NCT01555554|Propranolol|propranolol
1306462|NCT01555554|surgery|surgery
1306463|NCT01555554|anesthesia|anesthesia
1306464|NCT01555541|relapsed|relapsed
1306465|NCT01555541|refractory|refractory
1306466|NCT01555541|DLBCL|dlbcl
1306467|NCT01555541|lymphoma|lymphoma
1306468|NCT01555541|B-cell|b-cell
1306469|NCT01555541|diffuse|diffuse
1306470|NCT01555528|Growth disorders|growth disorders
1306471|NCT01555528|Saizen|saizen
1306472|NCT01555528|Easypod|easypod
1306473|NCT01555528|Growth hormone|growth hormone
1306474|NCT01555528|Pediatric subject|pediatric subject
1306475|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
1306476|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
1306477|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
1306478|NCT01555489|Neoplasms by Site|neoplasms by site
1306479|NCT01555489|Neoplasms|neoplasms
1306480|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
1306481|NCT01555489|Digestive System Diseases|digestive system diseases
1306482|NCT01555489|Pancreatic Diseases|pancreatic diseases
1306483|NCT01555489|Endocrine System Diseases|endocrine system diseases
1306484|NCT01555489|Ascorbic Acid|ascorbic acid
1306485|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
1306486|NCT01555489|Vitamin C|vitamin c
1306487|NCT01555489|Antioxidants|antioxidants
1306488|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1306489|NCT01555489|Pharmacologic Actions|pharmacologic actions
1306490|NCT01555489|Protective Agents|protective agents
1306491|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
1306492|NCT01555489|Micronutrients|micronutrients
1306493|NCT01555489|Growth Substances|growth substances
1306494|NCT01555489|Erlotinib|erlotinib
1306495|NCT01555489|Integrative Medicine|integrative medicine
1306496|NCT01555489|Alternative Medicine|alternative medicine
1306497|NCT01555489|Complementary Medicine|complementary medicine
1306498|NCT01555476|Pharmacokinetics|pharmacokinetics
1306499|NCT01555463|Rosacea|rosacea
1306500|NCT01555450|Colorectal cancer screening|colorectal cancer screening
1306501|NCT01555450|Social inequalities|social inequalities
1306502|NCT01555450|Patient Navigator|patient navigator
1306503|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
1306504|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
1306505|NCT01555437|C-reactive protein|c-reactive protein
1306506|NCT01555437|serum albumin|serum albumin
1306507|NCT01555437|hemoglobin|hemoglobin
1306508|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
1306509|NCT01555424|Institutionalized seniors|institutionalized seniors
1306510|NCT01555424|SF-36 survey|sf-36 survey
1306511|NCT01555424|Winter|winter
1306512|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
1306513|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
1306514|NCT01555411|Biomarkers|biomarkers
1306515|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
1306516|NCT01555398|Fenofibric acid|fenofibric acid
1306517|NCT01555398|HIP0901|hip0901
1306518|NCT01555398|food effect|food effect
1306519|NCT01555385|Mental workload|mental workload
1306520|NCT01555385|Multitasking|multitasking
1306521|NCT01555385|Protein|protein
1306522|NCT01555385|Tryptophan|tryptophan
1306523|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
1306524|NCT01555372|Study Protocol|study protocol
1306525|NCT01555372|Fracture Fixation|fracture fixation
1306526|NCT01555346|Down syndrome|down syndrome
1306527|NCT01555346|fetal aneuploidy|fetal aneuploidy
1306528|NCT01555346|trisomy|trisomy
1306529|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
1306530|NCT01555307|total hip arthroplasty|total hip arthroplasty
1306531|NCT01555307|total knee arthroplasty|total knee arthroplasty
1306532|NCT01555307|balance exercises|balance exercises
1306533|NCT01555307|force plate|force plate
1306534|NCT01555307|berg balance scale|berg balance scale
1306535|NCT01555307|timed up and go test|timed up and go test
1306536|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
1306537|NCT01555294|non-invasive measurements|non-invasive measurements
1306538|NCT01555294|intima-media thickness|intima-media thickness
1306539|NCT01555294|flow-mediated dilation|flow-mediated dilation
1306540|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
1306541|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
1306542|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
1306543|NCT01555294|general population|general population
1306544|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
1306545|NCT01555281|Multiple Myeloma|multiple myeloma
1306546|NCT01555281|Kahler Disease|kahler disease
1306547|NCT01555281|Lenalidomide|lenalidomide
1306548|NCT01555281|Revlimid|revlimid
1306549|NCT01555281|Nelfinavir|nelfinavir
1306550|NCT01555281|Viracept|viracept
1306551|NCT01555281|Dexamethasone|dexamethasone
1306552|NCT01555255|malaria|malaria
1306553|NCT01555255|pregnancy|pregnancy
1306554|NCT01555255|placental malaria|placental malaria
1306555|NCT01555255|malaria in pregnancy|malaria in pregnancy
1306556|NCT01555255|birth weight|birth weight
1306557|NCT01555255|anemia|anemia
1306558|NCT01555242|Advanced Cancer|advanced cancer
1306559|NCT01555242|Lymphoma|lymphoma
1306560|NCT01555242|Refractory|refractory
1306561|NCT01555229|Secretion drainage|secretion drainage
1306562|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
1306563|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
1306564|NCT01555216|Forefoot surgery|forefoot surgery
1306565|NCT01555190|myo-inositol|myo-inositol
1306566|NCT01555190|folic acid|folic acid
1306567|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
1306568|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
1306569|NCT01555177|Optical coherence tomography|optical coherence tomography
1306570|NCT01555151|Asthma|asthma
1306571|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1306572|NCT01555138|Indacaterol|indacaterol
1306573|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
1306574|NCT01555125|Psoriasis|psoriasis
1306575|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
1306576|NCT01555086|Lymphadenectomy|lymphadenectomy
1306577|NCT01555086|Prostate cancer|prostate cancer
1306578|NCT01555060|hemoglobin recovery|hemoglobin recovery
1306579|NCT01555060|iron recovery|iron recovery
1306580|NCT01555060|iron supplements|iron supplements
1306581|NCT01555034|obesity|obesity
1306582|NCT01555034|movement therapy|movement therapy
1306583|NCT01555034|exercise|exercise
1306584|NCT01555034|behaviour|behaviour
1306585|NCT01554995|LCB01-0371|lcb01-0371
1306586|NCT01554982|Participation Limited|participation limited
1306587|NCT01554982|Long Term|long term
1306588|NCT01554982|Safety Extension|safety extension
1306589|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
1306590|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
1306591|NCT01554956|Plasminogen|plasminogen
1306592|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
1306593|NCT01554943|CMF|cmf
1306594|NCT01554943|HEC|hec
1306595|NCT01554943|EC|ec
1306596|NCT01554943|node positive|node positive
1306597|NCT01554943|breast cancer|breast cancer
1306598|NCT01554930|HFMD|hfmd
1306599|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
1306600|NCT01554930|Xiyanping|xiyanping
1306601|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
1306602|NCT01554917|Iguratimod|iguratimod
1306603|NCT01554904|Sleep Study|sleep study
1306604|NCT01554904|Snoring|snoring
1306605|NCT01554904|Sleep Apnea|sleep apnea
1306606|NCT01554904|Muscle Laxity|muscle laxity
1306607|NCT01554904|Oral Appliance|oral appliance
1306608|NCT01554904|Facial Muscles|facial muscles
1306609|NCT01554904|Neck Muscles|neck muscles
1306610|NCT01554904|Upper Airway|upper airway
1306611|NCT01554904|Muscle Strength|muscle strength
1306612|NCT01554904|Dynamic Resistance|dynamic resistance
1306613|NCT01554904|Oral Exercise|oral exercise
1306614|NCT01554904|Facial Toning|facial toning
1306615|NCT01554904|Facial Muscle Strength|facial muscle strength
1306616|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
1306617|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
1306618|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
1306619|NCT01554891|military personnel|military personnel
1306620|NCT01554891|classification|classification
1306621|NCT01554891|diagnosis|diagnosis
1306622|NCT01554891|instrumentation|instrumentation
1306623|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
1306624|NCT01554865|obesity|obesity
1306625|NCT01554865|men|men
1306626|NCT01554865|sexual function|sexual function
1306627|NCT01554865|urinary tract symptoms|urinary tract symptoms
1306628|NCT01554865|endothelial function|endothelial function
1306629|NCT01554865|inflammation|inflammation
1306630|NCT01554865|quality of life|quality of life
1306631|NCT01554852|myeloma|myeloma
1306632|NCT01554852|lenalidomide|lenalidomide
1306633|NCT01554852|Revlimid|revlimid
1306634|NCT01554852|cyclophosphamide|cyclophosphamide
1306635|NCT01554852|dexamethasone|dexamethasone
1306636|NCT01554852|bortezomib|bortezomib
1306637|NCT01554852|Velcade|velcade
1306638|NCT01554852|vorinostat|vorinostat
1306639|NCT01554852|Zolinza|zolinza
1306640|NCT01554852|stem cell|stem cell
1306641|NCT01554852|carfilzomib|carfilzomib
1306642|NCT01554852|Kyprolis|kyprolis
1306643|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
1306644|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
1306645|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
1306646|NCT01554800|LCAT|lcat
1306647|NCT01554800|rhLCAT|rhlcat
1306648|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
1306649|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
1306650|NCT01554800|Cholesterol|cholesterol
1306651|NCT01554800|Cholesterol ester|cholesterol ester
1306652|NCT01554800|LCAT Deficiency|lcat deficiency
1306653|NCT01554787|After stroke with fatigue|after stroke with fatigue
1306654|NCT01554774|COPD|copd
1306655|NCT01554774|PVR|pvr
1306656|NCT01554761|astigmatism|astigmatism
1306657|NCT01554761|pseudophakia|pseudophakia
1306658|NCT01554748|total joint arthroplasty|total joint arthroplasty
1306659|NCT01554748|thumb|thumb
1306660|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
1306661|NCT01554748|osteoarthritis|osteoarthritis
1306662|NCT01554735|obesity|obesity
1306663|NCT01554735|men|men
1306664|NCT01554735|sexual function|sexual function
1306665|NCT01554735|urinary tract symptoms|urinary tract symptoms
1306666|NCT01554735|endothelial function|endothelial function
1306667|NCT01554735|inflammation|inflammation
1306668|NCT01554735|quality of life|quality of life
1306669|NCT01554722|Ultrasound guidance|ultrasound guidance
1306670|NCT01554722|Femoral nerve block|femoral nerve block
1306671|NCT01554722|Needle placement|needle placement
1306672|NCT01554722|Intraneural needle insertion|intraneural needle insertion
1306673|NCT01554709|bypass|bypass
1306674|NCT01554709|cannula|cannula
1306675|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
1306676|NCT01554696|ASP015K|asp015k
1306677|NCT01554683|Alzheimer's Disease|alzheimer's disease
1306678|NCT01554683|Seizures|seizures
1306679|NCT01554683|Memory|memory
1306680|NCT01554683|Executive|executive
1306681|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
1306682|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
1306683|NCT01554670|Tendon debridement|tendon debridement
1306684|NCT01554670|Shoulder surgery|shoulder surgery
1306685|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
1306686|NCT01554644|Cleansing|cleansing
1306687|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
1306688|NCT01554644|Diabetic Patients|diabetic patients
1306689|NCT01554631|Bioequivalence|bioequivalence
1306690|NCT01554631|Acarbose|acarbose
1306691|NCT01554631|ODT|odt
1306692|NCT01554618|exenatide|exenatide
1306693|NCT01554618|type 2 diabetes|type 2 diabetes
1306694|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
1306695|NCT01554592|Heart Failure|heart failure
1306696|NCT01554592|Statin withdrawal|statin withdrawal
1306697|NCT01554566|honey|honey
1306698|NCT01554566|diabetes|diabetes
1306699|NCT01554566|lipids|lipids
1306700|NCT01554566|c-peptide|c-peptide
1306701|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
1306702|NCT01554553|Posterior crural repair|posterior crural repair
1306703|NCT01554540|Treprostinil|treprostinil
1306704|NCT01554540|Scleroderma|scleroderma
1306705|NCT01554540|Iontophoresis|iontophoresis
1306706|NCT01554527|polysomnography|polysomnography
1306708|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
1306709|NCT01554527|tonsillectomy|tonsillectomy
1306710|NCT01554527|neuropsychological tests|neuropsychological tests
1306711|NCT01554527|cognition|cognition
1306712|NCT01554527|sleepiness|sleepiness
1306713|NCT01554527|behavior|behavior
1306714|NCT01554514|ADAMTS13|adamts13
1306715|NCT01554514|Rituximab|rituximab
1306716|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
1306717|NCT01554514|TTP|ttp
1306718|NCT01554514|Plasma exchange|plasma exchange
1306719|NCT01554501|stress|stress
1306720|NCT01554501|self-control|self-control
1306721|NCT01554501|emotion regulation|emotion regulation
1306722|NCT01554501|health|health
1306723|NCT01554488|asthma|asthma
1306724|NCT01554488|COPD|copd
1306725|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
1306726|NCT01554475|herbal drugs|herbal drugs
1306727|NCT01554475|dietary supplements|dietary supplements
1306728|NCT01554475|drug interactions|drug interactions
1306729|NCT01554462|Attention|attention
1306730|NCT01554462|Cognitive control|cognitive control
1306731|NCT01554462|ADHD|adhd
1306732|NCT01554462|Healthy|healthy
1306733|NCT01554462|EPA|epa
1306734|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
1306735|NCT01554462|DHA|dha
1306736|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
1306737|NCT01554462|PUFA|pufa
1306738|NCT01554462|Omega-3|omega-3
1306739|NCT01554449|Stroke|stroke
1306740|NCT01554449|Upper arm|upper arm
1306741|NCT01554449|Rehabilitation|rehabilitation
1306742|NCT01554449|Motor function|motor function
1306743|NCT01554449|Video games|video games
1306744|NCT01554449|Virtual reality|virtual reality
1306745|NCT01554449|Occupational Therapy|occupational therapy
1306746|NCT01554449|Functional MRI|functional mri
1306747|NCT01554436|Smoking|smoking
1306748|NCT01554436|Neuropsychology|neuropsychology
1306749|NCT01554436|Abstinence|abstinence
1306750|NCT01554436|Prognosis|prognosis
1306751|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
1306752|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
1306753|NCT01554410|Cervical|cervical
1306754|NCT01554410|Carcinoma|carcinoma
1306755|NCT01554410|Gemcitabine|gemcitabine
1306756|NCT01554410|Gemzar|gemzar
1306757|NCT01554410|Cisplatin|cisplatin
1306758|NCT01554410|IMRT|imrt
1306759|NCT01554410|Radiation|radiation
1306760|NCT01554410|External Beam|external beam
1306761|NCT01554410|Brachytherapy|brachytherapy
1306762|NCT01554397|Cervical|cervical
1306763|NCT01554397|Carcinoma|carcinoma
1306764|NCT01554397|Cisplatin|cisplatin
1306765|NCT01554397|IMRT|imrt
1306766|NCT01554397|Radiation|radiation
1306767|NCT01554397|INTERTECC|intertecc
1306768|NCT01554397|International|international
1306769|NCT01554397|External Beam|external beam
1306770|NCT01554397|Brachytherapy|brachytherapy
1306771|NCT01554397|LDR|ldr
1306772|NCT01554397|HDR|hdr
1306773|NCT01554397|IGRT|igrt
1306774|NCT01554397|CBCT|cbct
1306775|NCT01554384|Tuberculosis|tuberculosis
1306776|NCT01554384|diagnosis|diagnosis
1306777|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
1306778|NCT01554384|point-of-treatment|point-of-treatment
1306779|NCT01554384|randomized controlled trial|randomized controlled trial
1306780|NCT01554371|Solid tumor|solid tumor
1306781|NCT01554371|Metastatic breast cancer|metastatic breast cancer
1306782|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
1306783|NCT01554371|Neuropathy|neuropathy
1306784|NCT01554371|Eribulin|eribulin
1306785|NCT01554371|Cyclophosphamide|cyclophosphamide
1306786|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
1306787|NCT01554358|Lifestyle intervention|lifestyle intervention
1306788|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
1306789|NCT01554332|Neuropathic pain|neuropathic pain
1306790|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
1306791|NCT01554319|Asthma|asthma
1306792|NCT01554319|Healthy subjects|healthy subjects
1306793|NCT01554319|Phase 1|phase 1
1306794|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
1306795|NCT01554319|Oral inhalation|oral inhalation
1306796|NCT01554280|Stricture|stricture
1306797|NCT01554280|Dysphagia|dysphagia
1306798|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
1306799|NCT01554267|Breast reconstruction|breast reconstruction
1306800|NCT01554267|Indocyanine Green Dye|indocyanine green dye
1306801|NCT01554254|Cord blood transplant|cord blood transplant
1306802|NCT01554254|hematological malignancy|hematological malignancy
1306803|NCT01554254|inherited metabolic disease|inherited metabolic disease
1306804|NCT01554254|Mucositis|mucositis
1306805|NCT01554254|Neutrophil engraftment|neutrophil engraftment
1306806|NCT01554254|Platelet recovery|platelet recovery
1306807|NCT01554254|Immune reconstitution|immune reconstitution
1306808|NCT01554241|vitamin D3|vitamin d3
1306809|NCT01554241|D3|d3
1306810|NCT01554241|cholecalciferol|cholecalciferol
1306811|NCT01554241|25-OH vitamin D|25-oh vitamin d
1306812|NCT01554241|elderly|elderly
1306813|NCT01554241|nursing home resident|nursing home resident
1306814|NCT01554215|parenting|parenting
1306815|NCT01554215|child behavior|child behavior
1306816|NCT01554215|attachment|attachment
1306817|NCT01554202|Alzheimer's disease|alzheimer's disease
1306818|NCT01554202|MCI|mci
1306819|NCT01554202|genetic|genetic
1306820|NCT01554202|AV45-PET|av45-pet
1306821|NCT01554176|Current depressive episode|current depressive episode
1306822|NCT01554176|moderate to severe|moderate to severe
1306823|NCT01554163|Osteoarthritis|osteoarthritis
1306824|NCT01554163|Celecoxib|celecoxib
1306825|NCT01554163|Etoricoxib|etoricoxib
1306826|NCT01554150|Primary Health Care|primary health care
1306827|NCT01554150|Mental Health|mental health
1306828|NCT01554150|Cognitive Therapy|cognitive therapy
1306829|NCT01554124|Meningitis|meningitis
1306830|NCT01554124|Neonates|neonates
1306831|NCT01554124|Meropenem|meropenem
1306832|NCT01554111|Bowel Evacuants|bowel evacuants
1306833|NCT01554111|Purgatives|purgatives
1306834|NCT01554098|Polyp detection|polyp detection
1306835|NCT01554098|Supine|supine
1306836|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
1306837|NCT01554098|Patient position|patient position
1306838|NCT01554098|Dynamic position change|dynamic position change
1306839|NCT01554072|home-based|home-based
1306840|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
1306841|NCT01554072|COPD|copd
1306842|NCT01554059|Rectal cancer|rectal cancer
1306843|NCT01554059|Adenocarcinoma|adenocarcinoma
1306844|NCT01554059|Bevacizumab|bevacizumab
1306845|NCT01554059|Chemoradiation|chemoradiation
1306846|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1306847|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
1306848|NCT01554033|European Huntington's Disease Network|european huntington's disease network
1306849|NCT01554033|Huntington patients in KOREA|huntington patients in korea
1306850|NCT01554020|Blood glucose|blood glucose
1306851|NCT01554020|Insulin sensitivity|insulin sensitivity
1306852|NCT01554020|Oral glucose tolerance|oral glucose tolerance
1306853|NCT01554007|Crohn's disease|crohn's disease
1306854|NCT01553981|Interstitial lung disease|interstitial lung disease
1306855|NCT01553981|Scleroderma|scleroderma
1306856|NCT01553955|PRP,|prp,
1306857|NCT01553955|Platelet|platelet
1306858|NCT01553955|Manual|manual
1306859|NCT01553942|NSCLC|nsclc
1306860|NCT01553929|MCI|mci
1306861|NCT01553903|Hormonal therapy|hormonal therapy
1306862|NCT01553903|Breast Cancer|breast cancer
1306863|NCT01553903|AEBS|aebs
1306864|NCT01553903|Oxysterols|oxysterols
1306865|NCT01553890|SSc= scleroderma|ssc= scleroderma
1306866|NCT01553890|ICF+ informed consent form|icf+ informed consent form
1306867|NCT01553890|age 18 to 85|age 18 to 85
1306868|NCT01553890|healthy|healthy
1306869|NCT01553838|prostate biopsy|prostate biopsy
1306870|NCT01553838|MRI guided biopsy|mri guided biopsy
1306871|NCT01553838|TRUS guided biopsy|trus guided biopsy
1306872|NCT01553812|forced oscillation technique|forced oscillation technique
1306873|NCT01553812|COPD|copd
1306874|NCT01553812|elderly|elderly
1306875|NCT01553812|airway resistance|airway resistance
1306876|NCT01553812|airtrapping|airtrapping
1306877|NCT01553786|T-cell lymphoma|t-cell lymphoma
1306878|NCT01553786|CHOp|chop
1306879|NCT01553786|lenalidomide|lenalidomide
1306880|NCT01553773|Hyaluroic acid|hyaluroic acid
1306881|NCT01553773|Estradiol|estradiol
1306882|NCT01553773|Isoflavone|isoflavone
1306883|NCT01553773|Skin|skin
1306884|NCT01553773|Postmenopause|postmenopause
1306885|NCT01553760|Cataract|cataract
1306886|NCT01553760|TRI-MICS|tri-mics
1306887|NCT01553760|ACM|acm
1306888|NCT01553760|MICS|mics
1306889|NCT01553760|phacoemulsification|phacoemulsification
1306890|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
1306891|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
1306892|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
1306893|NCT01553747|Colonic diseases|colonic diseases
1306894|NCT01553747|Colonic diseases, functional|colonic diseases, functional
1306895|NCT01553747|Digestive system disease|digestive system disease
1306896|NCT01553747|Gastrointestinal disease|gastrointestinal disease
1306897|NCT01553747|Intestinal disease|intestinal disease
1306898|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
1306899|NCT01553747|Diarrhea|diarrhea
1306900|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
1306901|NCT01553734|QT prolongation|qt prolongation
1306902|NCT01553734|Azithromycin|azithromycin
1306903|NCT01553734|macrolide|macrolide
1306904|NCT01553734|pneumonia|pneumonia
1306905|NCT01553734|ECG changes|ecg changes
1411268|NCT01118767|web|web
1306906|NCT01553708|Wound healing|wound healing
1306907|NCT01553708|Epithelialization|epithelialization
1306908|NCT01553708|Safety|safety
1306909|NCT01553695|Touble|touble
1306910|NCT01553695|deficit|deficit
1306911|NCT01553695|attention|attention
1306912|NCT01553695|hyperactivity|hyperactivity
1306913|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
1306914|NCT01553682|HIV|hiv
1306915|NCT01553682|STDs|stds
1306916|NCT01553682|African American Females|african american females
1306917|NCT01553682|Alcohol|alcohol
1306918|NCT01553656|Advanced cancer|advanced cancer
1306919|NCT01553656|Metastatic|metastatic
1306920|NCT01553656|NSCLC|nsclc
1306921|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
1306922|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
1306923|NCT01553630|Fractures|fractures
1306924|NCT01553630|distal femur fractures|distal femur fractures
1307218|NCT01552486|protrusion|protrusion
1306925|NCT01553630|distal tibial fracures|distal tibial fracures
1306926|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
1306927|NCT01553604|bandages|bandages
1306928|NCT01553604|skin colonization|skin colonization
1306929|NCT01553604|surgical site infection|surgical site infection
1306930|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
1306931|NCT01553604|dressing wear time|dressing wear time
1306932|NCT01553591|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
1306933|NCT01553591|Irritable bowel syndrome|irritable bowel syndrome
1306934|NCT01553591|Diarrhea Predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
1306935|NCT01553591|Colonic diseases|colonic diseases
1306936|NCT01553591|Colonic diseases, functional|colonic diseases, functional
1306937|NCT01553591|Digestive system disease|digestive system disease
1306938|NCT01553591|Gastrointestinal disease|gastrointestinal disease
1306939|NCT01553591|Intestinal disease|intestinal disease
1306940|NCT01553591|Colonic pseudo-obstruction|colonic pseudo-obstruction
1306941|NCT01553591|Diarrhea|diarrhea
1306942|NCT01553591|Signs and symptoms, Digestive|signs and symptoms, digestive
1306943|NCT01553565|10 mm in diameter|10 mm in diameter
1306944|NCT01553565|antithrombotic agents|antithrombotic agents
1306945|NCT01553552|Schistosoma haematobium|schistosoma haematobium
1306946|NCT01553552|schistosoma mansoni|schistosoma mansoni
1306947|NCT01553552|Anemia|anemia
1306948|NCT01553552|Underweight|underweight
1306949|NCT01553552|stunting|stunting
1306950|NCT01553552|Blastocystis|blastocystis
1306951|NCT01553526|International|international
1306952|NCT01553526|Multicenter|multicenter
1306953|NCT01553526|Observational registry|observational registry
1306954|NCT01553526|All-comers open label registry|all-comers open label registry
1306955|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
1306956|NCT01553526|Stenting|stenting
1306957|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
1306958|NCT01553526|Coronary revascularization|coronary revascularization
1306959|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
1306960|NCT01553526|STEMI|stemi
1306961|NCT01553526|NSTEMI|nstemi
1306962|NCT01553526|Ischemia|ischemia
1306963|NCT01553526|Angina|angina
1306964|NCT01553526|Subgroups|subgroups
1306965|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
1306966|NCT01553526|Diabetes|diabetes
1306967|NCT01553526|Small Vessels|small vessels
1306968|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1306969|NCT01553513|PET|pet
1306970|NCT01553513|Coronary Artery Disease|coronary artery disease
1306971|NCT01553513|Inflammation|inflammation
1306972|NCT01553513|Plaque|plaque
1306973|NCT01553513|Atherosclerosis|atherosclerosis
1306974|NCT01553500|NAFLD|nafld
1306975|NCT01553500|insulin resistance|insulin resistance
1306976|NCT01553500|children|children
1306977|NCT01553487|vibration|vibration
1306978|NCT01553487|muscle strength|muscle strength
1306979|NCT01553487|bone loss|bone loss
1306980|NCT01553487|immobilization|immobilization
1306981|NCT01553487|fracture|fracture
1306982|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1306983|NCT01553474|Eye Diseases|eye diseases
1306984|NCT01553461|Transplant|transplant
1306985|NCT01553461|Umbilical Cord Blood|umbilical cord blood
1306986|NCT01553461|Graft Rejection|graft rejection
1306987|NCT01553461|Graft Versus Host Disease|graft versus host disease
1306988|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
1306989|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
1306990|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
1306991|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1306992|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
1306993|NCT01553435|Dextromethorphan|dextromethorphan
1306994|NCT01553435|Morphine|morphine
1306995|NCT01553435|Fentanyl|fentanyl
1306996|NCT01553435|Opioid|opioid
1306997|NCT01553435|analgesia|analgesia
1306998|NCT01553435|Efficacy|efficacy
1306999|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
1307000|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
1307001|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
1307002|NCT01553409|Hypertension|hypertension
1307003|NCT01553409|Ferritin|ferritin
1307004|NCT01553409|Phlebotomy|phlebotomy
1307005|NCT01553409|Blood donation|blood donation
1307006|NCT01553383|OSA|osa
1307007|NCT01553357|Plasma cell leukemia|plasma cell leukemia
1307008|NCT01553357|Lenalidomide|lenalidomide
1307009|NCT01553357|Dexamethasone|dexamethasone
1307010|NCT01553357|Multiple myeloma|multiple myeloma
1307011|NCT01553357|Bortezomib|bortezomib
1307012|NCT01553357|Stem cell transplantation|stem cell transplantation
1307013|NCT01553344|sclerostin|sclerostin
1307014|NCT01553344|osteomalacia|osteomalacia
1307015|NCT01553344|vitamin D deficiency|vitamin d deficiency
1307016|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1307017|NCT01553318|Fibromyalgia|fibromyalgia
1307018|NCT01553318|FMS|fms
1307113|NCT01552993|pain|pain
1307019|NCT01553305|exercise programme|exercise programme
1307219|NCT01552473|TBI|tbi
1307020|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
1307021|NCT01553292|Preterm infants|preterm infants
1307022|NCT01553292|Vascular catheter|vascular catheter
1307023|NCT01553292|Surfactant|surfactant
1307024|NCT01553292|CPAP|cpap
1307025|NCT01553292|ECALMIST|ecalmist
1307026|NCT01553266|Diabetes Mellitus|diabetes mellitus
1307027|NCT01553266|diabetes care|diabetes care
1307028|NCT01553266|diabetes self-management education|diabetes self-management education
1307029|NCT01553266|primary care physicians|primary care physicians
1307030|NCT01553266|interprofessional collaboration|interprofessional collaboration
1307031|NCT01553266|diabetes education programs|diabetes education programs
1307032|NCT01553266|qualitative|qualitative
1307033|NCT01553266|quantitative|quantitative
1307034|NCT01553266|implementation|implementation
1307035|NCT01553266|evaluation|evaluation
1307036|NCT01553266|health services|health services
1307037|NCT01553266|coordinated care|coordinated care
1307038|NCT01553266|integrated care|integrated care
1307039|NCT01553266|patient care processes|patient care processes
1307040|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
1307041|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
1307042|NCT01553253|Visceral Pain|visceral pain
1307043|NCT01553253|Referred pain|referred pain
1307044|NCT01553253|Somatic pain|somatic pain
1307045|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
1307047|NCT01553240|functional MRI|functional mri
1307048|NCT01553240|Supplementary motor cortex|supplementary motor cortex
1307049|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
1307050|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
1307051|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
1307052|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
1307053|NCT01553227|BiPAP ventilation|bipap ventilation
1307054|NCT01553214|Healthy Volunteers|healthy volunteers
1307055|NCT01553214|Granulocyte Transfusion|granulocyte transfusion
1307056|NCT01553214|Granulocytapheresis|granulocytapheresis
1307057|NCT01553214|Leukapheresis|leukapheresis
1307058|NCT01553214|Cytokine Stimulation|cytokine stimulation
1307059|NCT01553214|Healthy Volunteer|healthy volunteer
1307060|NCT01553214|HV|hv
1307061|NCT01553201|Quality of Life|quality of life
1307062|NCT01553201|Endometriosis|endometriosis
1307063|NCT01553201|Botulinum Toxin A|botulinum toxin a
1307064|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
1307065|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
1307066|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
1307067|NCT01553188|Ang 1|ang 1
1307068|NCT01553188|Ang 2|ang 2
1307069|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
1307070|NCT01553188|Small Molecule|small molecule
1307071|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1307072|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1307073|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1307074|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1307075|NCT01553136|alcohol-related disorders|alcohol-related disorders
1307076|NCT01553136|Cholinergic Drugs|cholinergic drugs
1307077|NCT01553136|varenicline|varenicline
1307078|NCT01553136|Chantix|chantix
1307079|NCT01553123|Leiomyomas|leiomyomas
1307080|NCT01553110|Cold|cold
1307081|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
1307082|NCT01553110|Allergic Rhinitis|allergic rhinitis
1307083|NCT01553097|Breast Cancer|breast cancer
1307210|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
1307084|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
1307085|NCT01553097|Quality of Life|quality of life
1307086|NCT01553097|Cytokines|cytokines
1307087|NCT01553084|Smoking Cessation|smoking cessation
1307088|NCT01553084|Smoking|smoking
1307089|NCT01553084|Nicotine|nicotine
1307090|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
1307091|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
1307092|NCT01553058|Psoriasis|psoriasis
1307093|NCT01553058|Cardiovascular Disease|cardiovascular disease
1307094|NCT01553058|FDG/PET-CT|fdg/pet-ct
1307095|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
1307096|NCT01553058|Vascular Inflammation|vascular inflammation
1307097|NCT01553058|Lipid Biomarkers|lipid biomarkers
1307098|NCT01553045|symptom burden|symptom burden
1307099|NCT01553045|atrial fibrillation|atrial fibrillation
1307100|NCT01553045|biomarkers|biomarkers
1307101|NCT01553045|intracardiac pressures|intracardiac pressures
1307102|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
1307103|NCT01553032|Erbitux®|erbitux®
1307104|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
1307105|NCT01553019|Proton radiation|proton radiation
1307106|NCT01553019|Chemotherapy|chemotherapy
1307107|NCT01553019|Pancreatic cancer|pancreatic cancer
1307108|NCT01553019|Postoperative|postoperative
1307109|NCT01553006|rhinosinusitis|rhinosinusitis
1307110|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
1307111|NCT01552993|prematurity|prematurity
1307112|NCT01552993|retinopathy|retinopathy
1307114|NCT01552993|acetaminophen|acetaminophen
1307115|NCT01552980|Gastric cancer|gastric cancer
1307116|NCT01552980|Adenocarcinoma|adenocarcinoma
1307117|NCT01552980|SOX|sox
1307118|NCT01552967|Colorectal cancer|colorectal cancer
1307119|NCT01552967|Adenocarcinoma|adenocarcinoma
1307120|NCT01552967|XELOX|xelox
1307121|NCT01552954|hypertension|hypertension
1307122|NCT01552954|Chronic kidney disease|chronic kidney disease
1307123|NCT01552954|albuminuria|albuminuria
1307124|NCT01552954|low salt diet|low salt diet
1307125|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
1307126|NCT01552941|Vagus Nerve|vagus nerve
1307127|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
1307128|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
1307129|NCT01552941|Implantable Medical Device|implantable medical device
1307130|NCT01552915|ADHD|adhd
1307131|NCT01552902|ADHD|adhd
1307132|NCT01552863|pharmacokinetics|pharmacokinetics
1307133|NCT01552863|bioavailability|bioavailability
1307134|NCT01552863|oxycodone.|oxycodone.
1307135|NCT01552850|pharmacokinetics|pharmacokinetics
1307136|NCT01552850|relative bioavailability|relative bioavailability
1307137|NCT01552850|oxycodone|oxycodone
1307138|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
1307139|NCT01552837|quetiapine|quetiapine
1307140|NCT01552837|Bipolar Disorder|bipolar disorder
1307141|NCT01552837|hippocampus|hippocampus
1307142|NCT01552837|Volume Brain Morphometry|volume brain morphometry
1307143|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1307144|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
1307145|NCT01552824|LUTO|luto
1307146|NCT01552824|posterior urethral valves|posterior urethral valves
1307147|NCT01552824|urethral atresia|urethral atresia
1307148|NCT01552772|Safety|safety
1307149|NCT01552772|Tolerability|tolerability
1307150|NCT01552772|Schizophrenia|schizophrenia
1307151|NCT01552772|Aripiprazole|aripiprazole
1307152|NCT01552759|Appetite Hormones|appetite hormones
1307153|NCT01552759|Binge Eating Disorder|binge eating disorder
1307154|NCT01552759|Obesity|obesity
1307155|NCT01552759|Cortisol|cortisol
1307156|NCT01552759|Stress|stress
1307157|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
1307158|NCT01552746|Persisting postoperative pain|persisting postoperative pain
1307159|NCT01552720|aorta|aorta
1307160|NCT01552720|dissection|dissection
1307161|NCT01552720|feature|feature
1307162|NCT01552707|Spondylolisthesis|spondylolisthesis
1307163|NCT01552707|Degenerative discopathy|degenerative discopathy
1307164|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
1307165|NCT01552707|Bone marrow|bone marrow
1307166|NCT01552707|Tissue engineering|tissue engineering
1307167|NCT01552707|Spinal fusion|spinal fusion
1307168|NCT01552694|cardiometabolic complications|cardiometabolic complications
1307169|NCT01552681|baminercept treatment|baminercept treatment
1307170|NCT01552668|Clostridium difficile infection|clostridium difficile infection
1307171|NCT01552668|fidaxomicin|fidaxomicin
1307172|NCT01552655|Dual-time PET/CT|dual-time pet/ct
1307173|NCT01552655|Breast cancer recurrence|breast cancer recurrence
1307174|NCT01552655|Bone scintigraphy|bone scintigraphy
1307175|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
1307176|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
1307177|NCT01552629|Atopic dermatitis|atopic dermatitis
1307178|NCT01552629|Atopic eczema|atopic eczema
1307179|NCT01552629|Skin Diseases|skin diseases
1307180|NCT01552629|QGE031|qge031
1307181|NCT01552603|glucose sensors|glucose sensors
1307182|NCT01552603|artificial pancreas|artificial pancreas
1307183|NCT01552603|Diabetes Mellitus|diabetes mellitus
1307184|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
1307185|NCT01552577|Concussion|concussion
1307186|NCT01552577|Brain Injury|brain injury
1307187|NCT01552577|TBI|tbi
1307188|NCT01552577|Military Personnel|military personnel
1307189|NCT01552577|Eye-tracking|eye-tracking
1307190|NCT01552577|Neurocognitive Function|neurocognitive function
1307191|NCT01552577|Assessment|assessment
1307192|NCT01552551|Falls|falls
1307193|NCT01552551|exercise|exercise
1307194|NCT01552551|safety|safety
1307195|NCT01552551|injury|injury
1307196|NCT01552551|Older adults|older adults
1307197|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
1307198|NCT01552538|Vagus Nerve|vagus nerve
1307199|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
1307200|NCT01552525|acute kidney injury|acute kidney injury
1307201|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
1307202|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
1307203|NCT01552525|l-arginine|l-arginine
1307204|NCT01552525|arterial stiffness|arterial stiffness
1307205|NCT01552525|augmentation index|augmentation index
1307206|NCT01552525|pulse wave velocity|pulse wave velocity
1307207|NCT01552512|Stunting|stunting
1307208|NCT01552512|Hidden Hunger|hidden hunger
1307209|NCT01552512|Diarrhea|diarrhea
1307211|NCT01552486|chiropractic|chiropractic
1307212|NCT01552486|manipulation|manipulation
1307213|NCT01552486|radiculopathy|radiculopathy
1307214|NCT01552486|sciatica|sciatica
1307215|NCT01552486|lumbar|lumbar
1307216|NCT01552486|disc|disc
1307217|NCT01552486|herniation|herniation
1307220|NCT01552473|Traumatic Brain Injury|traumatic brain injury
1307221|NCT01552473|combat related injury|combat related injury
1307222|NCT01552473|blast injury|blast injury
1307223|NCT01552473|concussion|concussion
1307224|NCT01552473|sleep problems|sleep problems
1307225|NCT01552473|attention problems|attention problems
1307226|NCT01552473|memory problems|memory problems
1307227|NCT01552473|headaches|headaches
1307228|NCT01552473|dizziness|dizziness
1307229|NCT01552473|OEF|oef
1307230|NCT01552473|OIF|oif
1307231|NCT01552473|Veterans|veterans
1307232|NCT01552473|Civilian|civilian
1307233|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
1307234|NCT01552460|Brain Imaging|brain imaging
1307235|NCT01552460|Genetics|genetics
1307236|NCT01552434|Advanced Cancers|advanced cancers
1307237|NCT01552434|Advanced Malignancy|advanced malignancy
1307238|NCT01552434|Metastatic cancer|metastatic cancer
1307239|NCT01552434|Temsirolimus|temsirolimus
1307240|NCT01552434|CCI-779|cci-779
1307241|NCT01552434|Torisel|torisel
1307242|NCT01552434|Bevacizumab|bevacizumab
1307243|NCT01552434|Avastin|avastin
1307244|NCT01552434|rhuMAb-VEGF|rhumab-vegf
1307245|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
1307246|NCT01552434|Cetuximab|cetuximab
1307247|NCT01552434|C225|c225
1307248|NCT01552434|Erbitux|erbitux
1307249|NCT01552434|IMC-C225|imc-c225
1307250|NCT01552434|Valproic Acid|valproic acid
1307251|NCT01552434|Depakene|depakene
1307252|NCT01552421|Cholecystectomy|cholecystectomy
1307253|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
1307254|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
1307255|NCT01552421|Postoperative outcome|postoperative outcome
1307256|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
1307257|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
1307258|NCT01552408|Macular Edema|macular edema
1307259|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
1307260|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
1307261|NCT01552382|vitamin D|vitamin d
1307262|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
1307263|NCT01552382|MACCE|macce
1307264|NCT01552382|mortality|mortality
1307265|NCT01552382|cardiac|cardiac
1307266|NCT01552382|cerebrovascular|cerebrovascular
1307267|NCT01552369|CMV|cmv
1307268|NCT01552369|cytomegalovirus infections|cytomegalovirus infections
1307269|NCT01552369|ganciclovir|ganciclovir
1307270|NCT01552369|liver transplant|liver transplant
1307271|NCT01552369|preemptive therapy|preemptive therapy
1307272|NCT01552369|prophylaxis|prophylaxis
1307273|NCT01552369|valganciclovir|valganciclovir
1307274|NCT01552330|Primaquine|primaquine
1307275|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
1307276|NCT01552317|chronic kidney disease|chronic kidney disease
1307277|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
1307278|NCT01552304|Oxygen therapy|oxygen therapy
1307279|NCT01552304|Surgery|surgery
1307280|NCT01552304|Anesthesia|anesthesia
1307281|NCT01552291|Malnourishment|malnourishment
1307282|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
1307283|NCT01552291|Immunocompetence|immunocompetence
1307284|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
1307285|NCT01552265|Alzheimer's Disease|alzheimer's disease
1307286|NCT01552252|POs-Ca|pos-ca
1307287|NCT01552252|calcium additives|calcium additives
1307288|NCT01552252|drink|drink
1307289|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
1307290|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
1307291|NCT01552239|Tomotherapy|tomotherapy
1307292|NCT01552239|Safety Margins|safety margins
1307293|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
1307294|NCT01552239|Brachytherapy|brachytherapy
1307295|NCT01552239|interstitial|interstitial
1307296|NCT01552200|Colorectal Cancer|colorectal cancer
1307297|NCT01552200|Polyp|polyp
1307298|NCT01552200|Adenoma|adenoma
1307299|NCT01552200|Detection Rate|detection rate
1307300|NCT01552200|Colonoscopy|colonoscopy
1307301|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
1307302|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
1307303|NCT01552200|G-Eye procedure|g-eye procedure
1307304|NCT01552200|G-Eye system|g-eye system
1307305|NCT01552187|cardiac surgery|cardiac surgery
1307306|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
1307307|NCT01552187|atrial fibrillation|atrial fibrillation
1307308|NCT01552187|pericardial effusion|pericardial effusion
1307309|NCT01552187|pleural effusion|pleural effusion
1307310|NCT01552187|prevention|prevention
1307311|NCT01552187|colchicine|colchicine
1307312|NCT01552174|MGD|mgd
1307313|NCT01552174|ocular surface pathologies|ocular surface pathologies
1307314|NCT01552161|Angiography|angiography
1307315|NCT01552161|Atherosclerosis|atherosclerosis
1307316|NCT01552161|Asthma|asthma
1307317|NCT01552161|Tryptase|tryptase
1307318|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
1307319|NCT01552135|titanium dioxide|titanium dioxide
1307320|NCT01552135|nanoparticles|nanoparticles
1307321|NCT01552135|skin|skin
1307322|NCT01552135|penetrate|penetrate
1307323|NCT01552109|symptomatic stable angina|symptomatic stable angina
1307324|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
1307325|NCT01552096|Anaesthesia|anaesthesia
1307326|NCT01552096|tonsillectomy|tonsillectomy
1307327|NCT01552096|inflammatory response|inflammatory response
1307328|NCT01552096|stress response|stress response
1307329|NCT01552096|tramadol|tramadol
1307330|NCT01552096|lidocaine|lidocaine
1307331|NCT01552083|sleep apnea|sleep apnea
1307332|NCT01552083|screening|screening
1307333|NCT01552083|community pharmacy|community pharmacy
1307334|NCT01552044|retina|retina
1307335|NCT01552031|COPD exacerbations|copd exacerbations
1307336|NCT01552031|FOT variability|fot variability
1307337|NCT01551992|Sutures|sutures
1307338|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
1307339|NCT01551992|Sacrocolpopexy|sacrocolpopexy
1307340|NCT01551992|Laparoscopy|laparoscopy
1307341|NCT01551979|Schizophrenia|schizophrenia
1307342|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1307343|NCT01551966|Esophageal varices|esophageal varices
1307344|NCT01551966|Portal hypertension in children|portal hypertension in children
1307345|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
1307346|NCT01551953|chronic bronchitis|chronic bronchitis
1307347|NCT01551953|emphysema|emphysema
1307348|NCT01551953|pulmonary|pulmonary
1307349|NCT01551953|COPD|copd
1307350|NCT01551940|Sialorrhea|sialorrhea
1307351|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1307352|NCT01551940|Botulinum toxin|botulinum toxin
1307353|NCT01551927|expectations|expectations
1307354|NCT01551914|Ultrasonic scissors|ultrasonic scissors
1307355|NCT01551914|thyroidectomy|thyroidectomy
1307356|NCT01551901|Back pain|back pain
1307357|NCT01551901|Spinal fusion|spinal fusion
1307358|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
1307359|NCT01551901|Lower back pain|lower back pain
1307360|NCT01551901|Fusion|fusion
1307361|NCT01551888|COPD|copd
1307362|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1307363|NCT01551888|Chronic Bronchitis|chronic bronchitis
1307364|NCT01551888|Emphysema|emphysema
1307365|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
1307366|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
1307367|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1307368|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1307369|NCT01551875|CIMT|cimt
1307370|NCT01551875|cardiovascular disease|cardiovascular disease
1307371|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
1307372|NCT01551862|lower body lift|lower body lift
1307373|NCT01551862|body contouring surgery|body contouring surgery
1307374|NCT01551862|massive weight loss|massive weight loss
1307375|NCT01551836|pharmacokinetics|pharmacokinetics
1307376|NCT01551836|paracetamol|paracetamol
1307377|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
1307378|NCT01551823|Influenza|influenza
1307379|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
1307380|NCT01551810|Influenza|influenza
1307381|NCT01551784|Statin treatment|statin treatment
1307382|NCT01551784|Cardiovascular disease|cardiovascular disease
1307383|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
1307384|NCT01551771|CCR3 antagonist|ccr3 antagonist
1307385|NCT01551758|Exacerbation|exacerbation
1307386|NCT01551758|Adult|adult
1307387|NCT01551758|COPD|copd
1307388|NCT01551758|Respiratory|respiratory
1307389|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
1333278|NCT01443728|vitamin D|vitamin d
1307390|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
1307391|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
1307392|NCT01551732|Anger|anger
1307393|NCT01551732|Aggression|aggression
1307394|NCT01551732|Biofeedback|biofeedback
1307395|NCT01551732|Videogame|videogame
1307396|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
1307397|NCT01551706|Total antioxidant capacity|total antioxidant capacity
1307398|NCT01551706|SOD|sod
1307399|NCT01551706|8-OHdG|8-ohdg
1307400|NCT01551706|8-isoprostane|8-isoprostane
1307401|NCT01551706|oxLDL|oxldl
1307402|NCT01551693|Stage III|stage iii
1307403|NCT01551693|Stage IV|stage iv
1307404|NCT01551693|Unresectable|unresectable
1307405|NCT01551693|Metastatic|metastatic
1307406|NCT01551667|S. aureus|s. aureus
1307407|NCT01551654|Pain|pain
1307408|NCT01551654|Colonoscopy|colonoscopy
1307409|NCT01551654|TENS|tens
1307410|NCT01551654|Acupuncture|acupuncture
1307411|NCT01551641|Esophageal Cancer|esophageal cancer
1307412|NCT01551641|Chemoradiotherapy|chemoradiotherapy
1307413|NCT01551641|VEGF|vegf
1307414|NCT01551641|Thalidomide|thalidomide
1307415|NCT01551615|Phase 1|phase 1
1307416|NCT01551615|healthy volunteers|healthy volunteers
1307417|NCT01551615|pharmacokinetics|pharmacokinetics
1307418|NCT01551615|vandetanib|vandetanib
1307419|NCT01551615|metformin|metformin
1307420|NCT01551615|AUC(0-t)|auc(0-t)
1307421|NCT01551615|t1/2|t1/2
1307422|NCT01551615|tmax|tmax
1307423|NCT01551615|CL/F|cl/f
1307424|NCT01551615|Vz/F|vz/f
1307425|NCT01551615|Cmax|cmax
1307426|NCT01551602|AK159|ak159
1307427|NCT01551602|teriparatide acetate|teriparatide acetate
1307428|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1307429|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1307430|NCT01551589|Clinical target volume|clinical target volume
1307431|NCT01551589|Safety|safety
1307432|NCT01551589|Prognosis|prognosis
1307433|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
1307434|NCT01551537|Healthy females|healthy females
1307435|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
1307436|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
1307437|NCT01551537|Sri Lanka|sri lanka
1307438|NCT01551537|Cervarix|cervarix
1307439|NCT01551524|Leukemia|leukemia
1307440|NCT01551524|Lymphoma|lymphoma
1307441|NCT01551524|C240588.448|c240588.448
1307442|NCT01551524|C115.378.400|c115.378.400
1307443|NCT01551511|chronic pancreatitis|chronic pancreatitis
1307444|NCT01551511|abdominal pain|abdominal pain
1307445|NCT01551511|visceral pain|visceral pain
1307446|NCT01551511|chronic pain|chronic pain
1307447|NCT01551498|Hashimoto Disease|hashimoto disease
1307448|NCT01551498|Thyroiditis|thyroiditis
1307449|NCT01551459|Uveal|uveal
1307450|NCT01551459|Melanoma|melanoma
1307451|NCT01551459|Metastatic|metastatic
1307452|NCT01551459|Sunitinib|sunitinib
1307453|NCT01551433|esophagectomy|esophagectomy
1307454|NCT01551433|ESOPHAGUS|esophagus
1307455|NCT01551433|Wipox instrument|wipox instrument
1307456|NCT01551433|Tissue Oxygenation|tissue oxygenation
1307457|NCT01551433|Anastomotic Leak|anastomotic leak
1307458|NCT01551433|11-192|11-192
1307459|NCT01551420|Amputation|amputation
1307460|NCT01551420|Prosthetic Design|prosthetic design
1307461|NCT01551420|Upper Extremity|upper extremity
1307462|NCT01551407|Hexvix|hexvix
1307463|NCT01551407|bladder cancer|bladder cancer
1307464|NCT01551407|cystoscopy|cystoscopy
1307465|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
1307466|NCT01551394|sepsis|sepsis
1307467|NCT01551394|neonates|neonates
1307468|NCT01551394|meropenem|meropenem
1307469|NCT01551381|Safety|safety
1307470|NCT01551381|Tolerability|tolerability
1307471|NCT01551381|Pharmacokinetics|pharmacokinetics
1307472|NCT01551381|Pharmacodynamics|pharmacodynamics
1307473|NCT01551368|male factor|male factor
1307474|NCT01551368|intrauterine insemination|intrauterine insemination
1307475|NCT01551368|LH surge|lh surge
1307476|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
1307477|NCT01551368|clomiphene citrate|clomiphene citrate
1307478|NCT01551368|letrozole|letrozole
1307479|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
1307480|NCT01551355|behavioral modification|behavioral modification
1307481|NCT01551355|health communication|health communication
1307482|NCT01551355|prevention|prevention
1307483|NCT01551342|bladder cancer|bladder cancer
1307484|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
1307485|NCT01551329|depression|depression
1307486|NCT01551329|alcohol|alcohol
1307487|NCT01551329|comorbidity|comorbidity
1307488|NCT01551329|ketamine|ketamine
1307489|NCT01551329|glutamate|glutamate
1307490|NCT01551329|NMDA|nmda
1307491|NCT01551316|safety|safety
1307492|NCT01551316|pharmacokinetics|pharmacokinetics
1307493|NCT01551316|spirometry|spirometry
1307494|NCT01551290|Ulcerative colitis|ulcerative colitis
1307495|NCT01551290|UC|uc
1307496|NCT01551290|Remicade|remicade
1307497|NCT01551290|Infliximab|infliximab
1307498|NCT01551290|Chinese patients|chinese patients
1307499|NCT01551290|Mayo score|mayo score
1307500|NCT01551290|Mucosal healing|mucosal healing
1307501|NCT01551290|Rectal bleeding|rectal bleeding
1307502|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
1307503|NCT01551290|IBD|ibd
1307504|NCT01551238|Energy expenditure|energy expenditure
1307505|NCT01551238|Sleep|sleep
1307506|NCT01551238|Protein|protein
1307507|NCT01551238|Carbohydrate|carbohydrate
1307508|NCT01551225|Randomized controlled trial|randomized controlled trial
1307509|NCT01551225|Escitalopram|escitalopram
1307510|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
1307511|NCT01551225|Panic disorder|panic disorder
1307512|NCT01551212|Liver transplantation|liver transplantation
1307513|NCT01551212|everolimus|everolimus
1307514|NCT01551212|kidney function|kidney function
1307515|NCT01551186|Probiotics|probiotics
1307516|NCT01551173|Dyslipidemias|dyslipidemias
1307517|NCT01551173|Fluvastatin sodium|fluvastatin sodium
1307518|NCT01551173|Chinese|chinese
1307519|NCT01551160|Non-technical skills|non-technical skills
1307520|NCT01551160|Crisis resource management|crisis resource management
1307521|NCT01551160|Medical Emergency Team|medical emergency team
1307522|NCT01551160|Rapid Response Team|rapid response team
1307523|NCT01551147|asthma|asthma
1307524|NCT01551147|ONO-6950|ono-6950
1307525|NCT01551147|asthma in adult patients|asthma in adult patients
1307526|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
1307527|NCT01551134|Fundoplication|fundoplication
1307528|NCT01551134|Randomized Controlled Trial|randomized controlled trial
1307529|NCT01551134|General Surgery|general surgery
1307530|NCT01551134|Child|child
1307531|NCT01551134|Laparoscopy|laparoscopy
1307532|NCT01551108|Children|children
1307533|NCT01551108|physical activity|physical activity
1307534|NCT01551095|PEGJ|pegj
1307535|NCT01551095|PEG-J|peg-j
1307536|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1307537|NCT01551095|feeding tube|feeding tube
1307538|NCT01551095|gastroparesis|gastroparesis
1307539|NCT01551095|acute pancreatitis|acute pancreatitis
1307540|NCT01551095|stroke|stroke
1307541|NCT01551095|respiratory failure|respiratory failure
1307542|NCT01551095|GERD|gerd
1307543|NCT01551095|balloon|balloon
1307544|NCT01551095|self-propelled|self-propelled
1307545|NCT01551043|adult patients|adult patients
1307546|NCT01551043|aged 18|aged 18
1307547|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
1307548|NCT01551043|after allogeneic SCT|after allogeneic sct
1307549|NCT01551030|KIDNEY|kidney
1307550|NCT01551030|URETER|ureter
1307551|NCT01551030|URINARY BLADDER|urinary bladder
1307552|NCT01551030|Buparlisib|buparlisib
1307553|NCT01551030|11-060|11-060
1307554|NCT01551017|total knee endoprostheses|total knee endoprostheses
1307555|NCT01551017|swelling|swelling
1307556|NCT01551017|mobilisation|mobilisation
1307557|NCT01551004|C. diff|c. diff
1307558|NCT01551004|C. difficile|c. difficile
1307559|NCT01551004|Clostridium difficile|clostridium difficile
1307560|NCT01551004|CRS3123|crs3123
1307561|NCT01550965|Quality of Life|quality of life
1307562|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
1307563|NCT01550965|Health Care Utilization|health care utilization
1307564|NCT01550939|Biometry of the Eye|biometry of the eye
1307565|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
1307566|NCT01550939|IOL|iol
1307567|NCT01550926|orlistat|orlistat
1307568|NCT01550926|overweight|overweight
1307569|NCT01550926|bioequivalence|bioequivalence
1307570|NCT01550913|Substance use|substance use
1307571|NCT01550913|perinatal depression|perinatal depression
1307572|NCT01550913|pregnant|pregnant
1307573|NCT01550900|Colorectum|colorectum
1307574|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
1307575|NCT01550900|Chemoprevention|chemoprevention
1307576|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
1307577|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
1307578|NCT01550900|Metformin ER|metformin er
1307579|NCT01550900|Extended Release|extended release
1307580|NCT01550900|Placebo|placebo
1307581|NCT01550900|Sugar pill|sugar pill
1307582|NCT01550874|Physical Activity|physical activity
1307583|NCT01550874|Epilepsy|epilepsy
1307584|NCT01550874|Children|children
1307585|NCT01550874|Motivation|motivation
1307586|NCT01550861|infertility|infertility
1307587|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
1307588|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
1307589|NCT01550861|natural cycle|natural cycle
1307590|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
1307591|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
1307592|NCT01550809|T1DM|t1dm
1307593|NCT01550809|CSII|csii
1307594|NCT01550809|CGM|cgm
1307595|NCT01550809|postprandial control|postprandial control
1307596|NCT01550809|glycemic variability|glycemic variability
1333186|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
1333187|NCT01444131|Smoking|smoking
1307597|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
1307598|NCT01550796|Tinnitus|tinnitus
1307599|NCT01550796|Brain Fitness Program|brain fitness program
1307600|NCT01550796|Posit Science|posit science
1307601|NCT01550796|D-cycloserine|d-cycloserine
1307602|NCT01550796|Cognitive Training|cognitive training
1307603|NCT01550783|Cervical cancer|cervical cancer
1307604|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1307605|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
1307606|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1307607|NCT01550783|Cervical|cervical
1307608|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
1307609|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1307610|NCT01550783|Human papillomavirus|human papillomavirus
1307611|NCT01550783|HPV|hpv
1307612|NCT01550744|Psoriasis|psoriasis
1307613|NCT01550744|Ustekinumab|ustekinumab
1307614|NCT01550744|STELARA|stelara
1307615|NCT01550744|Skin disease|skin disease
1307616|NCT01550744|Monoclonal|monoclonal
1307617|NCT01550731|advance care planning|advance care planning
1307618|NCT01550731|health communication|health communication
1307619|NCT01550731|aging|aging
1307620|NCT01550718|Aerobic Exercise|aerobic exercise
1307621|NCT01550718|Alzheimer's Disease|alzheimer's disease
1307622|NCT01550718|Burden and Stress|burden and stress
1307623|NCT01550718|Caregiving Issues|caregiving issues
1307624|NCT01550718|Quality of Life|quality of life
1307625|NCT01550718|Early Stage Memory Loss|early stage memory loss
1307626|NCT01550705|Protoporphyria|protoporphyria
1307627|NCT01550705|Porphyria|porphyria
1307628|NCT01550705|Porphyrins|porphyrins
1307629|NCT01550666|negative symptoms|negative symptoms
1307630|NCT01550653|Memory|memory
1307631|NCT01550653|GLP-1|glp-1
1307632|NCT01550653|Liraglutide|liraglutide
1307633|NCT01550653|energy output|energy output
1307634|NCT01550653|Memory facilitation|memory facilitation
1307635|NCT01550653|GLP-1 analogue|glp-1 analogue
1307636|NCT01550640|remifentanil|remifentanil
1307637|NCT01550640|Caesarean operation|caesarean operation
1307638|NCT01550640|general anaesthesia|general anaesthesia
1307639|NCT01550640|hypertension|hypertension
1307640|NCT01550640|newborn's adaptation|newborn's adaptation
1307641|NCT01550640|pharmacogenetics|pharmacogenetics
1307642|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
1307643|NCT01550614|Angina Pectoris|angina pectoris
1307644|NCT01550614|Myocardial Ischemia|myocardial ischemia
1307645|NCT01550614|Chest Pain|chest pain
1307646|NCT01550614|Coronary Artery Disease|coronary artery disease
1307647|NCT01550614|Heart Diseases|heart diseases
1307648|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
1307649|NCT01550614|Myocardial Perfusion|myocardial perfusion
1307650|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
1307651|NCT01550614|SPECT-MIBI|spect-mibi
1307652|NCT01550614|Anti-Anginal Medication|anti-anginal medication
1307653|NCT01550614|Quality of Life|quality of life
1307654|NCT01550601|morbid obesity|morbid obesity
1307655|NCT01550601|gastrectomy|gastrectomy
1307656|NCT01550601|gastrinaemia|gastrinaemia
1307657|NCT01550601|comorbidity|comorbidity
1307658|NCT01550601|gastric antrum|gastric antrum
1307659|NCT01550588|PFO|pfo
1307660|NCT01550588|Stroke|stroke
1307661|NCT01550549|Amyloid imaging|amyloid imaging
1307662|NCT01550549|Positron Emission Tomography|positron emission tomography
1307663|NCT01550549|18F-AV-45|18f-av-45
1307664|NCT01550549|florbetapir F 18|florbetapir f 18
1307665|NCT01550549|Diagnostic imaging|diagnostic imaging
1307666|NCT01550536|basal metabolic rate|basal metabolic rate
1307667|NCT01550536|resting energy expenditure|resting energy expenditure
1307668|NCT01550536|menopause|menopause
1307669|NCT01550536|physical activity|physical activity
1307670|NCT01550536|metabolic syndrome|metabolic syndrome
1307671|NCT01550523|Brain Tumor|brain tumor
1307672|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
1307673|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
1307674|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
1307675|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1307676|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
1307677|NCT01550510|Neoplasms by Site|neoplasms by site
1307678|NCT01550510|Neoplasms|neoplasms
1307679|NCT01550510|Digestive System Diseases|digestive system diseases
1307680|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
1307681|NCT01550510|Colonic Diseases|colonic diseases
1307682|NCT01550510|Intestinal Diseases|intestinal diseases
1307683|NCT01550510|Rectal Diseases|rectal diseases
1307684|NCT01550510|Ascorbic Acid|ascorbic acid
1307685|NCT01550510|Vitamins|vitamins
1307686|NCT01550510|Irinotecan|irinotecan
1307687|NCT01550510|Integrative Medicine|integrative medicine
1307688|NCT01550510|Complementary Medicine|complementary medicine
1307689|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
1307690|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1333279|NCT01443715|MDD|mdd
1307691|NCT01550510|Pharmacologic Actions|pharmacologic actions
1307692|NCT01550510|Protective Agents|protective agents
1307693|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
1307694|NCT01550510|Micronutrients|micronutrients
1307695|NCT01550510|Growth Substances|growth substances
1307696|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1307697|NCT01550510|Antineoplastic Agents|antineoplastic agents
1307698|NCT01550510|Therapeutic Uses|therapeutic uses
1307699|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
1307700|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
1307701|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
1307702|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
1307703|NCT01550497|back pain|back pain
1307704|NCT01550497|scoliosis|scoliosis
1307705|NCT01550497|home exercise program|home exercise program
1307706|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
1307707|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
1307708|NCT01550458|Human Volunteers|human volunteers
1307709|NCT01550458|Healthy Volunteers|healthy volunteers
1307710|NCT01550458|mibefradil|mibefradil
1307711|NCT01550458|Posicor®|posicor®
1307712|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
1307713|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
1307714|NCT01550419|Ischemic stroke|ischemic stroke
1307715|NCT01550419|Atorvastatin|atorvastatin
1307716|NCT01550419|Morbidity|morbidity
1307717|NCT01550419|Mortality|mortality
1307718|NCT01550406|Pancreatic fistula|pancreatic fistula
1307719|NCT01550406|distal Pancreatectomy|distal pancreatectomy
1307720|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
1307721|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
1307722|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1307723|NCT01550380|Endometrial cancer|endometrial cancer
1307725|NCT01550341|AIDS|aids
1307726|NCT01550341|Opiate Addiction|opiate addiction
1307727|NCT01550341|Drug Dependence|drug dependence
1307728|NCT01550341|Buprenorphine|buprenorphine
1307729|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
1307730|NCT01550315|POTS|pots
1307731|NCT01550315|endothelial function|endothelial function
1307732|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
1307733|NCT01550315|PAT protocol|pat protocol
1307734|NCT01550315|Calf blood flow|calf blood flow
1307735|NCT01550315|forearm mediated dilation|forearm mediated dilation
1307736|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
1307737|NCT01550302|Thoracic Surgery|thoracic surgery
1307738|NCT01550302|Thoracotomy|thoracotomy
1307739|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
1307740|NCT01550289|Dengue Fever|dengue fever
1307741|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1307742|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
1307743|NCT01550289|Dengue Virus|dengue virus
1307744|NCT01550289|Flavivirus|flavivirus
1307745|NCT01550276|Effectiveness|effectiveness
1307746|NCT01550276|Tension-type headache|tension-type headache
1307747|NCT01550276|Manual therapy|manual therapy
1307748|NCT01550263|Hip Preservation|hip preservation
1307749|NCT01550263|Hip Arthroscopy|hip arthroscopy
1307750|NCT01550263|Hip Pain|hip pain
1307751|NCT01550263|Psychological distress|psychological distress
1307752|NCT01550250|Breast cancer|breast cancer
1307753|NCT01550250|Arm lymphedema|arm lymphedema
1307754|NCT01550250|Compression therapy|compression therapy
1307755|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
1307756|NCT01550237|adverse effects|adverse effects
1307757|NCT01550237|position verification|position verification
1307758|NCT01550237|safety margins|safety margins
1307759|NCT01550198|newborn|newborn
1307760|NCT01550198|shock|shock
1307761|NCT01550198|hemodynamics|hemodynamics
1307762|NCT01550198|cardiac output|cardiac output
1307763|NCT01550198|blood pressure|blood pressure
1307764|NCT01550172|dementia caregivers|dementia caregivers
1307765|NCT01550172|caregivers|caregivers
1307766|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
1307767|NCT01550172|caregiver sleep|caregiver sleep
1307768|NCT01550172|heart disease risk|heart disease risk
1307769|NCT01550172|dementia|dementia
1307770|NCT01550172|Alzheimer's Disease|alzheimer's disease
1307771|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1307772|NCT01550159|Cardiac Surgery|cardiac surgery
1307773|NCT01550159|General Anesthesia|general anesthesia
1307774|NCT01550159|Neuropsychological Tests|neuropsychological tests
1307775|NCT01550146|Fractured neck of femur|fractured neck of femur
1307776|NCT01550146|Dexamethasone|dexamethasone
1307777|NCT01550133|Peptides|peptides
1307778|NCT01550133|Hormones|hormones
1307779|NCT01550133|Appetite|appetite
1307780|NCT01550133|Humans|humans
1307781|NCT01550133|Obese|obese
1307782|NCT01550133|Beverage|beverage
1307783|NCT01550133|Solid food|solid food
1307784|NCT01550133|cephalic phase|cephalic phase
1307785|NCT01550120|taste|taste
1307786|NCT01550120|fat|fat
1307787|NCT01550120|threshold|threshold
1307788|NCT01550120|sensitivity|sensitivity
1307789|NCT01550120|human|human
1307790|NCT01550107|Sarcopenia|sarcopenia
1307791|NCT01550107|Allopurinol|allopurinol
1307792|NCT01550107|Xanthine Oxidase|xanthine oxidase
1307793|NCT01550107|MR Spectroscopy|mr spectroscopy
1307794|NCT01550094|obese|obese
1307795|NCT01550094|regional anesthesia|regional anesthesia
1307796|NCT01550094|anesthesia|anesthesia
1307797|NCT01550094|anesthesiology|anesthesiology
1307798|NCT01550094|surgery|surgery
1307799|NCT01550094|foot|foot
1307800|NCT01550094|foot surgery|foot surgery
1307801|NCT01550094|ankle|ankle
1307802|NCT01550094|ankle surgery|ankle surgery
1307803|NCT01550094|orthopedics|orthopedics
1307804|NCT01550094|orthopedic surgery|orthopedic surgery
1307805|NCT01550094|sports medicine|sports medicine
1307806|NCT01550094|sports medicine surgery|sports medicine surgery
1307807|NCT01550094|Ochsner Hospital|ochsner hospital
1307808|NCT01550094|Ochsner Clinic|ochsner clinic
1307809|NCT01550094|New Orleans|new orleans
1307810|NCT01550094|Louisiana|louisiana
1307811|NCT01550094|Jefferson|jefferson
1307812|NCT01550094|Soberon|soberon
1307813|NCT01550081|exercise intensity|exercise intensity
1307814|NCT01550081|aerobic interval training|aerobic interval training
1307815|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
1307816|NCT01550081|group exercise|group exercise
1307817|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
1307818|NCT01550055|KRAS wild-type|kras wild-type
1307819|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
1307918|NCT01549626|Obesity|obesity
1307820|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
1307821|NCT01550055|Phase II/III|phase ii/iii
1307822|NCT01550029|Smoking|smoking
1307823|NCT01550029|Tobacco|tobacco
1307824|NCT01550029|Nicotine|nicotine
1307825|NCT01550029|Bipolar|bipolar
1307826|NCT01550016|dengue warning signs|dengue warning signs
1307827|NCT01550016|latin america|latin america
1307828|NCT01550016|south east asia|south east asia
1307829|NCT01550016|other febrile illnesses|other febrile illnesses
1307830|NCT01550016|dengue classification|dengue classification
1307831|NCT01550003|Cimzia|cimzia
1307832|NCT01550003|JIA|jia
1307833|NCT01550003|Polyarticular|polyarticular
1307834|NCT01550003|Oligoarticular|oligoarticular
1307835|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
1307836|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1307837|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
1307838|NCT01550003|Certolizumab Pegol|certolizumab pegol
1307839|NCT01550003|PASCAL|pascal
1307840|NCT01550003|CDP870|cdp870
1307841|NCT01549977|Drug Therapy|drug therapy
1307842|NCT01549964|Drug Therapy|drug therapy
1307967|NCT01549418|Rectal Diseases|rectal diseases
1307843|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
1307844|NCT01549938|Vitamin D|vitamin d
1307845|NCT01549938|Cholecalciferol|cholecalciferol
1307846|NCT01549938|Respiratory tract infection|respiratory tract infection
1307847|NCT01549912|Rotator Cuff Tears|rotator cuff tears
1307848|NCT01549912|Dislocation|dislocation
1307849|NCT01549912|Shoulder Dislocation|shoulder dislocation
1307850|NCT01549899|Insomnia|insomnia
1307851|NCT01549899|Cognitive|cognitive
1307852|NCT01549899|Behavioral|behavioral
1307853|NCT01549899|Therapy|therapy
1307854|NCT01549899|Internet|internet
1307855|NCT01549899|Depression|depression
1307856|NCT01549899|Substance Use|substance use
1307857|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
1307858|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1307859|NCT01549886|Zevalin|zevalin
1307860|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
1307861|NCT01549860|Venous Insufficiency|venous insufficiency
1307862|NCT01549860|Reflux|reflux
1307863|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
1307864|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
1307865|NCT01549847|Piracetam|piracetam
1307866|NCT01549847|L-Carnitine|l-carnitine
1307867|NCT01549808|ADL|adl
1307868|NCT01549808|activities of daily living|activities of daily living
1307869|NCT01549808|level of function|level of function
1307870|NCT01549795|Liver transplantation|liver transplantation
1307871|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
1307872|NCT01549782|Prebiotics|prebiotics
1307873|NCT01549782|Microbiota|microbiota
1307874|NCT01549782|Radiotherapy|radiotherapy
1307875|NCT01549782|Gynaecological Cancer|gynaecological cancer
1307876|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
1307877|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
1307878|NCT01549717|Early warning score|early warning score
1307879|NCT01549717|Physiological score|physiological score
1307880|NCT01549717|Track and trigger score|track and trigger score
1307881|NCT01549717|Scoring system|scoring system
1307882|NCT01549717|Physiological model|physiological model
1307883|NCT01549717|Monitoring|monitoring
1307884|NCT01549717|Patient monitoring|patient monitoring
1307885|NCT01549717|Wireless monitoring|wireless monitoring
1307886|NCT01549717|Wearable monitor|wearable monitor
1307887|NCT01549704|Total knee arthroplasty|total knee arthroplasty
1307888|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
1307889|NCT01549704|High pain responders|high pain responders
1307890|NCT01549704|US-guided nerve block|us-guided nerve block
1307891|NCT01549691|Premedication|premedication
1307892|NCT01549691|Benzodiazepine|benzodiazepine
1307893|NCT01549691|Anti-anxiety agents|anti-anxiety agents
1307894|NCT01549691|Anxiety|anxiety
1307895|NCT01549691|Surgery|surgery
1307896|NCT01549691|Adult|adult
1307897|NCT01549691|Human|human
1307898|NCT01549678|Plantar fasciitis|plantar fasciitis
1307899|NCT01549678|foot pain|foot pain
1307900|NCT01549678|insoles|insoles
1307901|NCT01549678|foot function|foot function
1307902|NCT01549678|electronic baropodometer|electronic baropodometer
1307903|NCT01549678|plantar pressure|plantar pressure
1307904|NCT01549678|gait analysis|gait analysis
1307905|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
1307906|NCT01549665|GVHD|gvhd
1307907|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1307908|NCT01549665|Stem Cell Transplantation|stem cell transplantation
1307909|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
1307910|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
1307911|NCT01549665|Unrelated Donors|unrelated donors
1307912|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
1307913|NCT01549639|Propofol|propofol
1307914|NCT01549639|Target controlled infusion|target controlled infusion
1307915|NCT01549639|General anaesthesia|general anaesthesia
1307916|NCT01549626|Flaxseed|flaxseed
1307917|NCT01549626|Women|women
1307919|NCT01549626|No smokers|no smokers
1307920|NCT01549574|crizotinib|crizotinib
1307921|NCT01549574|pharmacokinetics|pharmacokinetics
1307922|NCT01549574|esomeprazole|esomeprazole
1307923|NCT01549574|proton pump inhibitor|proton pump inhibitor
1307924|NCT01549574|drug drug interaction|drug drug interaction
1307925|NCT01549574|healthy volunteers|healthy volunteers
1307926|NCT01549561|behavior problems|behavior problems
1307927|NCT01549561|foster care|foster care
1307928|NCT01549561|parent training|parent training
1307929|NCT01549561|youth skills training|youth skills training
1307930|NCT01549548|CML|cml
1307931|NCT01549522|patients or caregivers|patients or caregivers
1307932|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
1307933|NCT01549496|HCV|hcv
1307934|NCT01549496|pharmacokinetics|pharmacokinetics
1307935|NCT01549496|boceprevir|boceprevir
1307936|NCT01549496|hypertension|hypertension
1307937|NCT01549496|amlodipine|amlodipine
1307938|NCT01549496|diltiazem|diltiazem
1307939|NCT01549483|asthma|asthma
1307940|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
1307941|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
1307942|NCT01549483|small airways|small airways
1307943|NCT01549457|latent tuberculosis|latent tuberculosis
1307944|NCT01549457|text message interventions|text message interventions
1307945|NCT01549457|medication adherence|medication adherence
1307946|NCT01549444|renin|renin
1307947|NCT01549444|aldosterone|aldosterone
1307948|NCT01549444|neonate|neonate
1307949|NCT01549431|Multiple Myeloma|multiple myeloma
1307950|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
1307951|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
1307952|NCT01549418|Polypectomy|polypectomy
1307953|NCT01549418|Large colorectal polyps|large colorectal polyps
1307954|NCT01549418|ASA|asa
1307955|NCT01549418|Aspirin|aspirin
1307956|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
1307957|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
1307958|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
1307959|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1307960|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
1307961|NCT01549418|Neoplasms by Site|neoplasms by site
1307962|NCT01549418|Neoplasms|neoplasms
1307963|NCT01549418|Digestive System Diseases|digestive system diseases
1307964|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
1307965|NCT01549418|Colonic Diseases|colonic diseases
1307966|NCT01549418|Intestinal Diseases|intestinal diseases
1307968|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
1307969|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
1307970|NCT01549392|mri spectroscopy|mri spectroscopy
1307971|NCT01549392|recurrent gliomas|recurrent gliomas
1307972|NCT01549379|Head and neck cancer|head and neck cancer
1307973|NCT01549379|Radiation|radiation
1307974|NCT01549379|Chemotherapy|chemotherapy
1307975|NCT01549379|Surgery|surgery
1307976|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
1307977|NCT01549340|Rhinitis|rhinitis
1307978|NCT01549340|Allergen immunotherapy|allergen immunotherapy
1307979|NCT01549327|Virtual Patient Navigation|virtual patient navigation
1307980|NCT01549327|Randomized Clinical Trial|randomized clinical trial
1307981|NCT01549327|Empowerment|empowerment
1307982|NCT01549327|Cost-Effectiveness|cost-effectiveness
1333280|NCT01443715|Dysthymia|dysthymia
1307983|NCT01549327|Cancer Information Preferences|cancer information preferences
1307984|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
1307985|NCT01549314|Cystic fibrosis|cystic fibrosis
1307986|NCT01549314|Ivacaftor|ivacaftor
1307987|NCT01549249|cone outer segment tips line|cone outer segment tips line
1307988|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
1307989|NCT01549249|optical coherence tomography|optical coherence tomography
1307990|NCT01549249|epiretinal membrane|epiretinal membrane
1307991|NCT01549236|Chagas Disease|chagas disease
1307992|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
1307993|NCT01549236|T.Cruzi|t.cruzi
1307994|NCT01549223|Uterine Atony|uterine atony
1307995|NCT01549223|Hypotension|hypotension
1307996|NCT01549223|Cesarean Delivery|cesarean delivery
1307997|NCT01549223|Hemorrhage|hemorrhage
1307998|NCT01549223|Phenylephrine|phenylephrine
1307999|NCT01549223|Ephedrine|ephedrine
1308000|NCT01549210|gout|gout
1308001|NCT01549210|gouty arthritis|gouty arthritis
1308002|NCT01549197|PTSD|ptsd
1308003|NCT01549184|secondary ITP|secondary itp
1308004|NCT01549184|hydroxychloroquine|hydroxychloroquine
1308005|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
1308006|NCT01549171|Human ART|human art
1308007|NCT01549171|Prostacyclin|prostacyclin
1308008|NCT01549171|Iloprost|iloprost
1308009|NCT01549171|Pregnancy|pregnancy
1308010|NCT01549158|loop diuretics|loop diuretics
1308011|NCT01549158|torasemide prolonged release|torasemide prolonged release
1308012|NCT01549158|torasemide immediate release|torasemide immediate release
1308013|NCT01549158|Sutril Neo|sutril neo
1308014|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
1308015|NCT01549145|Severe|severe
1308016|NCT01549145|Ongoing|ongoing
1308017|NCT01549145|Unilateral|unilateral
1308018|NCT01549145|present for more than 6 months|present for more than 6 months
1308019|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
1308020|NCT01549132|Retinal Oximetry|retinal oximetry
1308021|NCT01549132|Spectral imaging|spectral imaging
1308022|NCT01549132|Retinal Laser therapy|retinal laser therapy
1308023|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
1308024|NCT01549119|HIV-1|hiv-1
1308026|NCT01549119|immunotherapy|immunotherapy
1308027|NCT01549119|active immunotherapy|active immunotherapy
1308028|NCT01549119|vaccine|vaccine
1308029|NCT01549119|virulence|virulence
1308030|NCT01549119|innate immunity|innate immunity
1308031|NCT01549119|NK cells|nk cells
1308032|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
1308033|NCT01549093|Endostar|endostar
1308034|NCT01549093|Continued Pumping into|continued pumping into
1308035|NCT01549093|Gemcitabine|gemcitabine
1308036|NCT01549093|Carboplatin|carboplatin
1308037|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
1308038|NCT01549067|Advanced|advanced
1308039|NCT01549067|Colorectal Cancer|colorectal cancer
1308040|NCT01549067|Targeted chemotherapy|targeted chemotherapy
1308041|NCT01549067|Surgery|surgery
1308042|NCT01549067|Radiotherapy|radiotherapy
1308043|NCT01549041|schizophrenia|schizophrenia
1308044|NCT01549041|asenapine|asenapine
1308045|NCT01549041|Once daily|once daily
1308046|NCT01549041|twice daily|twice daily
1308047|NCT01549015|Urea Cycle Defects|urea cycle defects
1308048|NCT01549015|CPSD|cpsd
1308049|NCT01549015|OTCD|otcd
1308050|NCT01549015|ASSD|assd
1308051|NCT01549015|ASLD|asld
1308052|NCT01549002|Abscess|abscess
1308053|NCT01549002|Pain|pain
1308054|NCT01549002|Administration intranasal|administration intranasal
1308055|NCT01549002|Infusions intravenous|infusions intravenous
1308056|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
1308057|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
1308058|NCT01548963|Tight glycemia control|tight glycemia control
1308059|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
1308060|NCT01548963|Cardiac surgery patients|cardiac surgery patients
1308061|NCT01548950|Congenital heart disease|congenital heart disease
1308062|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
1308063|NCT01548950|Sildenafil|sildenafil
1308064|NCT01548950|Bosentan|bosentan
1308065|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
1308066|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
1308067|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
1308068|NCT01548872|HTk solution|htk solution
1308069|NCT01548872|Cardioplegia|cardioplegia
1308070|NCT01548872|myocardial protection|myocardial protection
1308071|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
1308072|NCT01548859|Myocardial protection|myocardial protection
1308073|NCT01548859|Myocardial injury|myocardial injury
1308074|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
1412677|NCT01113879|fMRI|fmri
1308075|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
1308076|NCT01548859|Troponin I|troponin i
1308077|NCT01548859|Sevoflurane|sevoflurane
1308078|NCT01548859|Midazolam|midazolam
1308079|NCT01548846|tomotherapy|tomotherapy
1308080|NCT01548846|xerostomy|xerostomy
1308081|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1308082|NCT01548833|Myopia|myopia
1308083|NCT01548833|Contact Lenses|contact lenses
1308084|NCT01548820|Hepatitis B virus|hepatitis b virus
1308085|NCT01548820|Lamivudine|lamivudine
1308086|NCT01548820|Resistance to treatment|resistance to treatment
1308087|NCT01548794|spinal anesthesia|spinal anesthesia
1308088|NCT01548794|bupivacaine|bupivacaine
1308089|NCT01548794|lidocaine|lidocaine
1308090|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
1308091|NCT01548794|recovery|recovery
1308092|NCT01548794|duration of anesthesia|duration of anesthesia
1308093|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
1308095|NCT01548781|strength|strength
1308096|NCT01548781|coordination|coordination
1308097|NCT01548781|physical therapy|physical therapy
1308098|NCT01548781|robotics|robotics
1308099|NCT01548781|stroke|stroke
1308100|NCT01548781|synergy|synergy
1308101|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
1308102|NCT01548768|Cardiovascular disease|cardiovascular disease
1308103|NCT01548768|Myocardium|myocardium
1308104|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
1308105|NCT01548768|ESCAPE|escape
1308106|NCT01548768|Co-morbidities|co-morbidities
1308107|NCT01548768|RHYTHM|rhythm
1308108|NCT01548755|Home monitoring|home monitoring
1308109|NCT01548755|cardiomessenger|cardiomessenger
1308110|NCT01548755|ICD|icd
1308111|NCT01548742|Meditation|meditation
1308112|NCT01548729|Cystic Fibrosis|cystic fibrosis
1308113|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
1308114|NCT01548729|Lung transplantation|lung transplantation
1308115|NCT01548729|Pancreatic islets|pancreatic islets
1308116|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
1308117|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
1308118|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
1308119|NCT01548703|antagonist|antagonist
1308120|NCT01548703|mGluR|mglur
1308121|NCT01548703|ketamine|ketamine
1308122|NCT01548703|BDNF|bdnf
1308123|NCT01548703|Depression|depression
1308124|NCT01548703|Major Depressive Disorder|major depressive disorder
1308125|NCT01548703|Treatment Resistant Depression|treatment resistant depression
1308126|NCT01548703|Mood Disorder|mood disorder
1308127|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
1308128|NCT01548690|ornithine|ornithine
1308129|NCT01548690|phenylacetate|phenylacetate
1308130|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
1308131|NCT01548690|acute liver failure|acute liver failure
1308132|NCT01548690|hepatitis B|hepatitis b
1308133|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
1308134|NCT01548690|drug-induced liver injury|drug-induced liver injury
1308135|NCT01548677|Circulating Tumour Cells|circulating tumour cells
1308136|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
1308137|NCT01548677|HER2 positive CTC|her2 positive ctc
1308138|NCT01548677|Trastuzumab|trastuzumab
1308139|NCT01548664|Total knee replacement|total knee replacement
1308140|NCT01548664|Outpatient|outpatient
1308141|NCT01548664|Randomized controlled trial|randomized controlled trial
1308142|NCT01548664|Video games|video games
1308143|NCT01548638|Tobacco|tobacco
1308144|NCT01548638|Smoking|smoking
1308145|NCT01548638|Galantamine|galantamine
1308146|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
1308147|NCT01548612|Schizophrenia|schizophrenia
1308148|NCT01548612|Nitric oxide|nitric oxide
1308149|NCT01548612|Sodium nitroprusside|sodium nitroprusside
1308150|NCT01548599|HIV|hiv
1308151|NCT01548599|Malnutrition|malnutrition
1308152|NCT01548599|Food Security|food security
1308153|NCT01548599|Kenya|kenya
1308154|NCT01548586|tDCS|tdcs
1308155|NCT01548586|Diaphragm|diaphragm
1308156|NCT01548586|Cortical Excitability|cortical excitability
1308157|NCT01548586|MEPs|meps
1308158|NCT01548586|TMS|tms
1308159|NCT01548573|multiple myeloma|multiple myeloma
1308160|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
1308161|NCT01548573|amyloidosis|amyloidosis
1308162|NCT01548573|bone marrow transplant|bone marrow transplant
1308163|NCT01548573|autologous|autologous
1308164|NCT01548560|HIV Infections|hiv infections
1308165|NCT01548560|Anti-HIV agents|anti-hiv agents
1308166|NCT01548560|HIV-1|hiv-1
1308167|NCT01548547|intravenous line|intravenous line
1308168|NCT01548547|simulation education|simulation education
1308169|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
1308170|NCT01548534|First-Line chemotherapy|first-line chemotherapy
1308171|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
1308172|NCT01548534|DHA|dha
1308173|NCT01548534|PUFA|pufa
1308174|NCT01548534|Dietary supplementation|dietary supplementation
1308175|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
1308176|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
1308177|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
1308178|NCT01548495|MDS|mds
1308179|NCT01548495|Autoantibodies|autoantibodies
1308180|NCT01548495|Erythropoietin|erythropoietin
1308181|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
1308182|NCT01548469|Mild periodontitis|mild periodontitis
1308183|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
1308184|NCT01548469|Geumjin Thermal Water|geumjin thermal water
1308185|NCT01548456|femur fracture|femur fracture
1308186|NCT01548456|internal fixation|internal fixation
1308187|NCT01548456|intramedullary nailing|intramedullary nailing
1308188|NCT01548443|Wound Healing|wound healing
1308189|NCT01548443|hydrocolloid|hydrocolloid
1308190|NCT01548443|Wound Dressing|wound dressing
1308191|NCT01548443|Medifoam H|medifoam h
1308192|NCT01548443|Duoderm THIN|duoderm thin
1308193|NCT01548443|Mild Acute Trauma|mild acute trauma
1308194|NCT01548417|Alcohol|alcohol
1308195|NCT01548417|Relapse|relapse
1308196|NCT01548378|HGF|hgf
1308197|NCT01548378|Gene|gene
1308198|NCT01548378|Critical Limb Ischemia|critical limb ischemia
1308199|NCT01548365|Nursing Services|nursing services
1308200|NCT01548365|Catheterization, Central Venous|catheterization, central venous
1308201|NCT01548365|Catheters Indwelling|catheters indwelling
1308202|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
1308203|NCT01548352|Syncope|syncope
1308204|NCT01548352|Unconsciousness|unconsciousness
1308205|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
1308206|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
1308703|NCT01546233|Lung cancer|lung cancer
1308207|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
1308208|NCT01548352|Sudden cardiac death|sudden cardiac death
1308209|NCT01548352|Syncopal episode|syncopal episode
1308210|NCT01548326|Vaccination Failure|vaccination failure
1308211|NCT01548326|Nonresponder|nonresponder
1308212|NCT01548326|Hepatitis B virus|hepatitis b virus
1308213|NCT01548326|Atorvastatin|atorvastatin
1308214|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
1308215|NCT01548313|human milk|human milk
1308216|NCT01548313|nutrition|nutrition
1308217|NCT01548313|breastfed child|breastfed child
1308218|NCT01548313|microbiota|microbiota
1308219|NCT01548313|fatty acids|fatty acids
1308220|NCT01548313|intestinal microbiota|intestinal microbiota
1308221|NCT01548313|probiotics|probiotics
1308222|NCT01548300|cardiometabolic disease|cardiometabolic disease
1308223|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
1308224|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
1308225|NCT01548287|Safety|safety
1308226|NCT01548287|Tolerability|tolerability
1308227|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
1308228|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
1308229|NCT01548222|type 2 diabetes|type 2 diabetes
1308230|NCT01548222|continuous glucose|continuous glucose
1308231|NCT01548222|basal insulin|basal insulin
1308232|NCT01548196|nephrolithotomy|nephrolithotomy
1308233|NCT01548170|Pharmacokinetic|pharmacokinetic
1308234|NCT01548170|Sunitinib|sunitinib
1308235|NCT01548170|Ketoconazol|ketoconazol
1308236|NCT01548170|interaction, Phase I|interaction, phase i
1308237|NCT01548157|HCP1007|hcp1007
1308238|NCT01548157|Rosuvastatin|rosuvastatin
1308239|NCT01548157|Omega-3|omega-3
1308240|NCT01548144|Advanced Cancers|advanced cancers
1308241|NCT01548144|Advanced Malignancies|advanced malignancies
1308242|NCT01548144|Crizotinib|crizotinib
1308243|NCT01548144|PF-02341066|pf-02341066
1308244|NCT01548144|Pazopanib|pazopanib
1308245|NCT01548144|Gw786034|gw786034
1308246|NCT01548144|Pemetrexed|pemetrexed
1308247|NCT01548144|LY231514|ly231514
1308248|NCT01548144|Alimta|alimta
1308249|NCT01548144|MTA|mta
1308250|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
1308251|NCT01548144|NSC-698037|nsc-698037
1308252|NCT01548131|fear of childbirth|fear of childbirth
1308253|NCT01548131|delivery mode|delivery mode
1308254|NCT01548131|delivery satisfaction|delivery satisfaction
1308255|NCT01548118|Human papillomavirus|human papillomavirus
1308256|NCT01548118|vaccine|vaccine
1308257|NCT01548118|cervical infection|cervical infection
1308258|NCT01548118|cervical cancer|cervical cancer
1308259|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
1308260|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
1308261|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
1308262|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
1308263|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
1308264|NCT01548079|fatty liver disease|fatty liver disease
1308265|NCT01548079|morbid obesity|morbid obesity
1308266|NCT01548079|bariatric surgery|bariatric surgery
1308267|NCT01548079|NAFLD|nafld
1308268|NCT01548053|Primary care|primary care
1308269|NCT01548053|Dementia|dementia
1308270|NCT01548053|Knowledge translation|knowledge translation
1308271|NCT01548053|Quality of care|quality of care
1308272|NCT01548053|Qualitative methods|qualitative methods
1308273|NCT01548053|Alzheimer's disease|alzheimer's disease
1308274|NCT01548040|NMES|nmes
1308275|NCT01548040|Muscle|muscle
1308276|NCT01548040|strength|strength
1308277|NCT01548040|TKA|tka
1308278|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
1308279|NCT01548027|TAP block|tap block
1308280|NCT01548027|postoperative analgesia|postoperative analgesia
1308281|NCT01548014|Crohn's disease|crohn's disease
1308282|NCT01548014|VSL #3|vsl #3
1308283|NCT01548014|infliximab|infliximab
1308284|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
1308285|NCT01548001|Iguratimod|iguratimod
1308286|NCT01548001|Methotrexate|methotrexate
1308287|NCT01547988|Aging|aging
1308288|NCT01547988|Falls|falls
1308289|NCT01547988|Balance Control|balance control
1308290|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
1308291|NCT01547988|Dual-Task|dual-task
1308292|NCT01547988|Self-reported function|self-reported function
1308293|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
1308294|NCT01547975|Retrospective analysis|retrospective analysis
1308295|NCT01547975|corneal transplantation|corneal transplantation
1308296|NCT01547949|pain|pain
1308297|NCT01547949|inflammation|inflammation
1308298|NCT01547949|muscle damage|muscle damage
1308299|NCT01547923|Colorectal Cancer|colorectal cancer
1308300|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
1308301|NCT01547923|Lethal toxicity|lethal toxicity
1308302|NCT01547923|Fluoropyrimidine|fluoropyrimidine
1308303|NCT01547910|fatty liver|fatty liver
1308304|NCT01547910|hepatitis|hepatitis
1308305|NCT01547910|insulin resistance|insulin resistance
1308306|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
1308307|NCT01547910|NAFLD, children|nafld, children
1308308|NCT01547884|Immune Responses|immune responses
1308309|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
1308310|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
1308311|NCT01547871|Natural History Study|natural history study
1308312|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
1308313|NCT01547871|Natural History|natural history
1308314|NCT01547858|Hematotoxicity|hematotoxicity
1308315|NCT01547858|Formaldehyde|formaldehyde
1308316|NCT01547858|Cross-Sectional Study|cross-sectional study
1308317|NCT01547858|Occupational Exposure|occupational exposure
1308318|NCT01547845|Disparities|disparities
1308319|NCT01547845|Patient Reported Outcomes|patient reported outcomes
1308320|NCT01547845|Symptoms|symptoms
1308321|NCT01547845|Symptom Surveillance|symptom surveillance
1308322|NCT01547832|Cholesterol|cholesterol
1308323|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
1308324|NCT01547832|Fat Metabolism|fat metabolism
1308325|NCT01547832|Insulin Resistance|insulin resistance
1308326|NCT01547832|PARK2 Mutations|park2 mutations
1308327|NCT01547819|TBI|tbi
1308328|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1308329|NCT01547819|PTSD|ptsd
1308330|NCT01547819|PET Imaging|pet imaging
1308331|NCT01547819|11C-Flumazenil|11c-flumazenil
1308332|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
1308333|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
1308334|NCT01547806|Mobilization|mobilization
1308335|NCT01547806|Apheresis|apheresis
1308336|NCT01547806|Plerixafor|plerixafor
1308337|NCT01547793|Hemolytic Severity|hemolytic severity
1308338|NCT01547793|Erythrocyte|erythrocyte
1308339|NCT01547793|Sickle Cell Disease|sickle cell disease
1308340|NCT01547793|SD|sd
1308341|NCT01547780|MRI|mri
1308342|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
1308343|NCT01547780|Inflammation|inflammation
1308344|NCT01547780|Microglial Activation|microglial activation
1308345|NCT01547780|Traumatic Brain Injury|traumatic brain injury
1308346|NCT01547780|TBI|tbi
1308347|NCT01547767|Metabolism|metabolism
1308348|NCT01547767|Muscle|muscle
1308349|NCT01547767|Mutation|mutation
1308350|NCT01547767|ISCU Myopathy|iscu myopathy
1308351|NCT01547767|Myopathy|myopathy
1308352|NCT01547754|Neuroinflammation|neuroinflammation
1308353|NCT01547754|HIV|hiv
1308354|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
1308355|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
1308356|NCT01547754|P-Glycoprotein|p-glycoprotein
1308357|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
1308358|NCT01547754|Healthy Volunteer|healthy volunteer
1308359|NCT01547754|HV|hv
1308360|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1308361|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1308362|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
1308363|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1333188|NCT01444131|Smoking cessation|smoking cessation
1308364|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1308365|NCT01547741|stage IA breast cancer|stage ia breast cancer
1308366|NCT01547741|stage IB breast cancer|stage ib breast cancer
1308367|NCT01547741|stage II breast cancer|stage ii breast cancer
1308368|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
1308369|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
1308370|NCT01547728|antithrombin|antithrombin
1308371|NCT01547728|Heparin Resistant|heparin resistant
1308372|NCT01547728|Cardiac Surgery|cardiac surgery
1308373|NCT01547715|Meningococcal,|meningococcal,
1308374|NCT01547715|ACWY,|acwy,
1308375|NCT01547715|bacterial meningitis,|bacterial meningitis,
1308376|NCT01547715|conjugate vaccine,|conjugate vaccine,
1308377|NCT01547715|healthy, children,|healthy, children,
1308378|NCT01547715|adolescents,|adolescents,
1308379|NCT01547715|adults,|adults,
1308380|NCT01547715|India|india
1308381|NCT01547702|ADHD|adhd
1308382|NCT01547702|attention|attention
1308383|NCT01547702|inattention|inattention
1308384|NCT01547702|hyperactivity|hyperactivity
1308385|NCT01547702|classroom intervention|classroom intervention
1308386|NCT01547702|teacher education|teacher education
1308387|NCT01547702|web-based intervention|web-based intervention
1308388|NCT01547663|pain scale|pain scale
1308389|NCT01547663|craniotomy|craniotomy
1308390|NCT01547637|Obturator nerve block|obturator nerve block
1308391|NCT01547637|Regional anesthesia|regional anesthesia
1308392|NCT01547637|TURBT|turbt
1308393|NCT01547624|Neck|neck
1308394|NCT01547624|Spine|spine
1308395|NCT01547624|Muscles|muscles
1308396|NCT01547624|Activity|activity
1308397|NCT01547624|Coordination|coordination
1308398|NCT01547611|Rehabilitation|rehabilitation
1308399|NCT01547611|Cervical Spine|cervical spine
1308400|NCT01547611|Radiculopathy|radiculopathy
1308401|NCT01547611|Disc|disc
1308402|NCT01547611|Surgery|surgery
1308403|NCT01547585|Cholesterol|cholesterol
1308404|NCT01547585|Cardiovascular disease|cardiovascular disease
1308405|NCT01547585|Soy|soy
1308406|NCT01547585|Dose-response|dose-response
1308407|NCT01547572|Video education|video education
1308409|NCT01547572|Reducing hospital stay|reducing hospital stay
1308410|NCT01547572|Improving patient satisfaction|improving patient satisfaction
1308411|NCT01547533|Chagas disease|chagas disease
1308413|NCT01547533|breastmilk|breastmilk
1308414|NCT01547533|postpartum period|postpartum period
1308415|NCT01547533|infants|infants
1308416|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
1308417|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
1308418|NCT01547533|parasitology|parasitology
1308419|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
1308420|NCT01547520|meperidine|meperidine
1308421|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1308422|NCT01547520|unsedated|unsedated
1308423|NCT01547520|minimal sedation|minimal sedation
1308424|NCT01547507|hemodynamics|hemodynamics
1308425|NCT01547507|respiratory|respiratory
1308426|NCT01547494|Migraines|migraines
1308427|NCT01547494|Diet, Vegetarian|diet, vegetarian
1308428|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
1308429|NCT01547494|Pain|pain
1308430|NCT01547468|hip fracture|hip fracture
1308431|NCT01547468|elderly|elderly
1308432|NCT01547468|delirium|delirium
1308433|NCT01547468|broken hip|broken hip
1308434|NCT01547468|hip|hip
1308435|NCT01547468|surgery|surgery
1308436|NCT01547468|orthopedic|orthopedic
1308437|NCT01547468|orthopedic surgery|orthopedic surgery
1308438|NCT01547468|pain|pain
1308439|NCT01547468|anesthesia|anesthesia
1308440|NCT01547468|Ochsner Clinic|ochsner clinic
1308441|NCT01547468|Ochsner Hospital|ochsner hospital
1308442|NCT01547468|Leslie Thomas MD|leslie thomas md
1308443|NCT01547468|New Orleans|new orleans
1308444|NCT01547468|Louisiana|louisiana
1308445|NCT01547455|Statin|statin
1308446|NCT01547455|kidney function|kidney function
1308447|NCT01547455|antiinflammatory effect|antiinflammatory effect
1308448|NCT01547442|aphakia|aphakia
1308449|NCT01547442|secondary intraocular lens|secondary intraocular lens
1308450|NCT01547442|congenital cataract|congenital cataract
1308451|NCT01547442|marfan syndrome|marfan syndrome
1308452|NCT01547442|pediatric cataract|pediatric cataract
1308453|NCT01547442|ectopia lentis|ectopia lentis
1308454|NCT01547442|subluxated lens|subluxated lens
1308455|NCT01547429|aphakia|aphakia
1308456|NCT01547429|secondary intraocular lens|secondary intraocular lens
1308457|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
1308458|NCT01547416|General anesthesia|general anesthesia
1308459|NCT01547416|Epidural Anesthesia|epidural anesthesia
1308460|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
1308463|NCT01547377|atherosclerosis|atherosclerosis
1308464|NCT01547377|zinc and selenium status|zinc and selenium status
1308465|NCT01547377|rosuvastatin|rosuvastatin
1308466|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
1308467|NCT01547377|inflammation biomarkers|inflammation biomarkers
1308468|NCT01547364|Caudal|caudal
1308469|NCT01547364|Epidural|epidural
1308470|NCT01547364|Dextrose|dextrose
1308471|NCT01547364|Analgesia|analgesia
1308472|NCT01547364|TRVP1|trvp1
1308473|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
1308474|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
1308475|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
1308476|NCT01547338|Breast|breast
1308477|NCT01547338|Reconstruction|reconstruction
1308478|NCT01547299|prostate cancer|prostate cancer
1308479|NCT01547299|prostatectomy|prostatectomy
1308480|NCT01547299|neoadjuvant|neoadjuvant
1308481|NCT01547286|Asthma|asthma
1308482|NCT01547286|Allergen Challenge|allergen challenge
1308483|NCT01547286|Cat allergen|cat allergen
1308484|NCT01547286|Dust mite allergen|dust mite allergen
1308485|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
1308486|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
1308487|NCT01547286|Nitrogen isotopes|nitrogen isotopes
1308488|NCT01547286|Blood flow|blood flow
1308489|NCT01547247|colonoscopy|colonoscopy
1308490|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
1308491|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
1308492|NCT01547234|Multiple Sclerosis|multiple sclerosis
1308493|NCT01547234|ambulation|ambulation
1308494|NCT01547234|manual function|manual function
1308495|NCT01547234|Fampridine|fampridine
1308496|NCT01547221|otomycosis|otomycosis
1308497|NCT01547221|3% boric acid|3% boric acid
1308498|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
1308499|NCT01547208|ICD shocks|icd shocks
1308500|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
1308501|NCT01547208|Timing of ablation|timing of ablation
1308502|NCT01547208|Electrical storm|electrical storm
1308503|NCT01547208|Arrhythmic storm|arrhythmic storm
1308504|NCT01547195|fibromyalgia|fibromyalgia
1308505|NCT01547195|swimming|swimming
1308506|NCT01547169|memory|memory
1308507|NCT01547169|intranasal insulin|intranasal insulin
1308508|NCT01547169|Alzheimer's disease|alzheimer's disease
1308509|NCT01547156|patient decision support|patient decision support
1308510|NCT01547156|telemonitoring|telemonitoring
1308511|NCT01547156|self-management|self-management
1308512|NCT01547156|remote patient monitoring|remote patient monitoring
1308513|NCT01547156|active assistance technology|active assistance technology
1308514|NCT01547156|selfcare|selfcare
1308515|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
1308516|NCT01547130|Colonoscopy|colonoscopy
1308517|NCT01547130|Yoga|yoga
1308518|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
1308519|NCT01547130|Bowel cleansing|bowel cleansing
1308520|NCT01547130|Large bowel preparation|large bowel preparation
1308521|NCT01547130|Cancer screening|cancer screening
1308522|NCT01547130|Colorectal cancer|colorectal cancer
1308523|NCT01547117|POTS|pots
1308524|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
1308525|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
1308526|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
1308527|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
1308528|NCT01547065|TEE and renal resistive index|tee and renal resistive index
1308529|NCT01547052|DBT, child, emotion regulation, behavior problems, residential care|dbt, child, emotion regulation, behavior problems, residential care
1308530|NCT01547039|Carotid endarterectomy|carotid endarterectomy
1308531|NCT01547039|Transcranial doppler|transcranial doppler
1308532|NCT01547039|Micro embolic signals|micro embolic signals
1308533|NCT01547039|Platelets|platelets
1308534|NCT01547039|Aspirin|aspirin
1308535|NCT01547026|schizophrenia|schizophrenia
1308536|NCT01547026|exercise|exercise
1308537|NCT01547026|sport|sport
1308538|NCT01547026|weight control|weight control
1308539|NCT01547026|fitness|fitness
1308540|NCT01547000|Tourette Syndrome|tourette syndrome
1308541|NCT01547000|Tourette Disorder|tourette disorder
1308542|NCT01547000|Tics|tics
1308543|NCT01547000|Motor tics|motor tics
1308544|NCT01547000|Vocal tics|vocal tics
1308545|NCT01547000|Intuniv|intuniv
1308546|NCT01547000|Guanfacine|guanfacine
1308547|NCT01547000|Medication|medication
1308548|NCT01547000|Drug|drug
1308549|NCT01547000|Placebo|placebo
1308550|NCT01547000|Child|child
1308551|NCT01547000|Children|children
1308552|NCT01547000|Adolescent|adolescent
1308553|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1308554|NCT01546987|stage I prostate cancer|stage i prostate cancer
1308555|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
1308556|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
1308557|NCT01546987|stage III prostate cancer|stage iii prostate cancer
1308558|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
1308559|NCT01546974|Mechanical Ventilation|mechanical ventilation
1308560|NCT01546974|Humidification system|humidification system
1308561|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
1308562|NCT01546961|Chloroquine|chloroquine
1308563|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
1308564|NCT01546948|Methadone|methadone
1308565|NCT01546948|Hydromorphone|hydromorphone
1308566|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
1308567|NCT01546948|Postoperative pain|postoperative pain
1308568|NCT01546935|Influenza|influenza
1308569|NCT01546935|Oseltamivir|oseltamivir
1308570|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
1308571|NCT01546922|Hydrocortisone|hydrocortisone
1308572|NCT01546922|Cognition|cognition
1308573|NCT01546922|Adrenal insufficiency|adrenal insufficiency
1308574|NCT01546922|Quality of Life|quality of life
1308575|NCT01546922|Common Somatic Complaints|common somatic complaints
1308576|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
1308577|NCT01546922|Somatosensation|somatosensation
1308578|NCT01546883|Atrial fibrillation|atrial fibrillation
1308579|NCT01546883|MRI|mri
1308580|NCT01546857|orthopedic pain|orthopedic pain
1308581|NCT01546844|SMS|sms
1308582|NCT01546844|text|text
1308583|NCT01546844|text messages|text messages
1308584|NCT01546844|text messaging|text messaging
1308585|NCT01546844|diabetes|diabetes
1308586|NCT01546844|diabetes mellitus|diabetes mellitus
1308587|NCT01546844|type II diabetes|type ii diabetes
1308588|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
1308589|NCT01546844|type 2 diabetes|type 2 diabetes
1308590|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
1308591|NCT01546844|Beacon|beacon
1308592|NCT01546818|HIV|hiv
1308593|NCT01546818|Vaccine|vaccine
1308594|NCT01546818|HIV-1 infections|hiv-1 infections
1308595|NCT01546805|Blepharospasm|blepharospasm
1308596|NCT01546805|Hemifacial spasm|hemifacial spasm
1308597|NCT01546805|Botox|botox
1308598|NCT01546805|Zinc|zinc
1308599|NCT01546792|exercise|exercise
1308600|NCT01546792|diet|diet
1308601|NCT01546792|lifestyle|lifestyle
1308602|NCT01546792|sleep apnoea|sleep apnoea
1308603|NCT01546792|obesity|obesity
1308604|NCT01546766|Diabetes|diabetes
1308605|NCT01546766|Pupillary response|pupillary response
1308606|NCT01546766|Retinal disorders|retinal disorders
1308701|NCT01546246|failed|failed
1308607|NCT01546766|Midperipheral ischemia|midperipheral ischemia
1309370|NCT01543672|lung|lung
1308608|NCT01546766|Fundus photography|fundus photography
1308609|NCT01546766|Optical coherence tomography|optical coherence tomography
1308610|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
1308611|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
1308612|NCT01546753|Oral immunotherapy|oral immunotherapy
1308613|NCT01546753|Food allergy|food allergy
1308614|NCT01546753|Walnut allergy|walnut allergy
1308615|NCT01546753|tree nut allergy|tree nut allergy
1308616|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
1308617|NCT01546727|Preschoolers|preschoolers
1308618|NCT01546727|Obesity|obesity
1308619|NCT01546727|Behavioral Treatment|behavioral treatment
1308620|NCT01546675|Amputation|amputation
1308621|NCT01546675|Prosthesis Design|prosthesis design
1308622|NCT01546675|Biomechanics|biomechanics
1308623|NCT01546662|Rhinitis|rhinitis
1308624|NCT01546636|Cerebral desaturation events|cerebral desaturation events
1308625|NCT01546636|Cerebral oximetry|cerebral oximetry
1308626|NCT01546636|Beach chair position|beach chair position
1308627|NCT01546610|Rheumatoid foot|rheumatoid foot
1308628|NCT01546610|foot pain|foot pain
1308629|NCT01546610|insoles|insoles
1308630|NCT01546610|foot function|foot function
1308631|NCT01546610|electronic baropodometer|electronic baropodometer
1308632|NCT01546610|plantar pressure|plantar pressure
1308633|NCT01546610|gait analysis|gait analysis
1308634|NCT01546597|Metformin|metformin
1308635|NCT01546597|Ranolazine|ranolazine
1308636|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1308637|NCT01546558|Metformin|metformin
1308638|NCT01546558|Ranolazine|ranolazine
1308639|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1308640|NCT01546532|Heart failure|heart failure
1308641|NCT01546532|RLX030|rlx030
1308642|NCT01546532|hemodynamics|hemodynamics
1308643|NCT01546532|cardiovascular diseases|cardiovascular diseases
1308644|NCT01546480|Chronic postoperative pain|chronic postoperative pain
1308645|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
1308646|NCT01546480|Inflammation|inflammation
1308647|NCT01546480|Interleukines|interleukines
1308648|NCT01546467|Schizophrenia|schizophrenia
1308649|NCT01546467|Schizoaffective disorder|schizoaffective disorder
1308650|NCT01546467|Psychosis|psychosis
1308651|NCT01546467|Early phase|early phase
1308652|NCT01546467|Cognitive remediation|cognitive remediation
1308653|NCT01546467|Functional outcome|functional outcome
1308654|NCT01546454|Premenopausal women|premenopausal women
1308655|NCT01546454|coronary heart disease|coronary heart disease
1308656|NCT01546454|menstrual cycle|menstrual cycle
1308657|NCT01546454|lipids|lipids
1308658|NCT01546441|primary care|primary care
1308659|NCT01546441|aging|aging
1308660|NCT01546441|interprofessional care|interprofessional care
1308661|NCT01546441|multimorbidity|multimorbidity
1308662|NCT01546428|c-MET|c-met
1308663|NCT01546428|Advanced solid tumor|advanced solid tumor
1308664|NCT01546415|Phase 4|phase 4
1308665|NCT01546415|Desferasirox|desferasirox
1308666|NCT01546415|Iron Overload|iron overload
1308667|NCT01546415|Aplastic Anemia|aplastic anemia
1308668|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
1308669|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
1308670|NCT01546337|anemia|anemia
1308671|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
1308672|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
1308673|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
1308674|NCT01546337|predictive markers|predictive markers
1308675|NCT01546324|Maternal Blood|maternal blood
1308676|NCT01546324|PGD|pgd
1308677|NCT01546324|PGS|pgs
1308678|NCT01546324|Natera|natera
1308679|NCT01546324|Gene Security Network|gene security network
1308680|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
1308681|NCT01546311|prosthetic socket|prosthetic socket
1308682|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
1308683|NCT01546311|instantaneous bladder|instantaneous bladder
1308684|NCT01546298|Contact Dermatitis|contact dermatitis
1308685|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
1308686|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
1308687|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
1308688|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
1308689|NCT01546272|Medico-economic evaluation|medico-economic evaluation
1308690|NCT01546272|Accidental exposure to blood|accidental exposure to blood
1308691|NCT01546259|colonoscopy|colonoscopy
1308692|NCT01546259|water|water
1308693|NCT01546259|female|female
1308694|NCT01546259|BMI|bmi
1308695|NCT01546259|unsedated|unsedated
1308696|NCT01546259|low BMI female patients|low bmi female patients
1308697|NCT01546259|Intubation|intubation
1308698|NCT01546246|colonoscopy|colonoscopy
1308699|NCT01546246|water|water
1308700|NCT01546246|incomplete|incomplete
1308702|NCT01546246|unsedated|unsedated
1308704|NCT01546233|Chemotherapy|chemotherapy
1308705|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
1308706|NCT01546233|Fatigue|fatigue
1308707|NCT01546220|colonoscopy|colonoscopy
1308708|NCT01546220|elder patient|elder patient
1308709|NCT01546220|water|water
1308710|NCT01546220|unsedated|unsedated
1308711|NCT01546207|ventricular tachycardia|ventricular tachycardia
1308712|NCT01546207|catheter ablation|catheter ablation
1308713|NCT01546207|VT|vt
1308714|NCT01546194|Informed consent|informed consent
1308715|NCT01546194|Perioperative period|perioperative period
1308716|NCT01546194|Morning of surgery|morning of surgery
1308717|NCT01546194|Anesthesiology|anesthesiology
1308718|NCT01546181|photoreceptors|photoreceptors
1308719|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
1308720|NCT01546181|adaptive optics|adaptive optics
1308721|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
1308722|NCT01546168|Esophageal Deviation|esophageal deviation
1308723|NCT01546168|AF|af
1308724|NCT01546116|adefovir|adefovir
1308725|NCT01546116|lamivudine|lamivudine
1308726|NCT01546116|entecavir resistance|entecavir resistance
1308727|NCT01546103|Vitamin D deficiency|vitamin d deficiency
1308728|NCT01546090|Alprazolam|alprazolam
1308729|NCT01546090|benzodiazepines|benzodiazepines
1308730|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
1308731|NCT01546090|irreversible pulpitis|irreversible pulpitis
1308732|NCT01546090|local anesthesia|local anesthesia
1308733|NCT01546064|Bile duct anastomosis|bile duct anastomosis
1308734|NCT01546064|Biliary complications|biliary complications
1308735|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
1308736|NCT01546051|antagonist|antagonist
1308737|NCT01546051|mGluR|mglur
1308738|NCT01546051|ketamine|ketamine
1308739|NCT01546051|BDNF|bdnf
1308740|NCT01546051|Depression|depression
1308741|NCT01546051|Major Depressive Disorder|major depressive disorder
1308742|NCT01546051|Mood Disorder|mood disorder
1308743|NCT01546051|Treatment Resistant Depression|treatment resistant depression
1308744|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
1308745|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
1308746|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
1308747|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
1308748|NCT01546038|Intensive chemotherapy|intensive chemotherapy
1308749|NCT01546038|LDAC|ldac
1308750|NCT01546038|glasdegib|glasdegib
1308751|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1308752|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
1308753|NCT01545999|Schizophrenia|schizophrenia
1308754|NCT01545999|Working Memory|working memory
1308755|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
1612338|NCT00349544|Disability|disability
1413546|NCT01110213|Aging|aging
1308756|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
1308757|NCT01545999|Cognition|cognition
1308758|NCT01545986|Joint Replacement|joint replacement
1308759|NCT01545986|Exercise|exercise
1308760|NCT01545986|Power training|power training
1308761|NCT01545947|Neoplasms|neoplasms
1308762|NCT01545947|Pulmonary|pulmonary
1308763|NCT01545947|Lung Cancer|lung cancer
1308764|NCT01545947|Cancer of the Lung|cancer of the lung
1308765|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
1308766|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
1308767|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
1308768|NCT01545934|Overweight|overweight
1308769|NCT01545934|Obese|obese
1308770|NCT01545934|Pregnancy|pregnancy
1308771|NCT01545934|Weight Gain|weight gain
1308772|NCT01545921|Quality Of Life|quality of life
1308773|NCT01545921|Cancer|cancer
1308774|NCT01545921|End of life|end of life
1308775|NCT01545921|palliative setting|palliative setting
1308776|NCT01545908|Fecal transplant|fecal transplant
1308777|NCT01545908|induction of remission|induction of remission
1308778|NCT01545908|active ulcerative colitis|active ulcerative colitis
1308779|NCT01545882|prostate|prostate
1308780|NCT01545882|hormone-resistant|hormone-resistant
1308781|NCT01545882|degarelix|degarelix
1308782|NCT01545882|firmagon|firmagon
1308783|NCT01545882|anti-androgens|anti-androgens
1308784|NCT01545882|total androgen blockade|total androgen blockade
1308785|NCT01545882|injection|injection
1308786|NCT01545869|carbon dioxide laser|carbon dioxide laser
1308787|NCT01545869|fractional resurfacing|fractional resurfacing
1308788|NCT01545869|freckles|freckles
1308789|NCT01545869|melanosis|melanosis
1308790|NCT01545856|Parkinson's Disease|parkinson's disease
1308791|NCT01545856|cardiovascular events|cardiovascular events
1308792|NCT01545856|Levodopa|levodopa
1308793|NCT01545843|depression|depression
1308794|NCT01545843|sleep|sleep
1308795|NCT01545843|treatment|treatment
1308796|NCT01545830|Metabolic syndrome|metabolic syndrome
1308797|NCT01545830|Insulin resistance|insulin resistance
1308798|NCT01545830|Vitamin D deficiency|vitamin d deficiency
1308799|NCT01545817|Renal cell carcinoma|renal cell carcinoma
1308800|NCT01545817|GW786034|gw786034
1308801|NCT01545817|Everolimus|everolimus
1308802|NCT01545817|Pazopanib|pazopanib
1308803|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
1308804|NCT01545778|Substance abuse detection|substance abuse detection
1308805|NCT01545778|Opioids abuse|opioids abuse
1308806|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
1308807|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
1308808|NCT01545765|Healthy volunteers|healthy volunteers
1308809|NCT01545752|elearning|elearning
1308810|NCT01545752|CD-based education|cd-based education
1308811|NCT01545739|Pacemaker therapy|pacemaker therapy
1308812|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
1308813|NCT01545726|Asthma|asthma
1308814|NCT01545726|Sputum eosinophilia|sputum eosinophilia
1308815|NCT01545726|CRTH2 receptor|crth2 receptor
1308816|NCT01545726|PGD2 antagonist|pgd2 antagonist
1308817|NCT01545713|renal|renal
1308818|NCT01545713|kidney|kidney
1308819|NCT01545713|transplant|transplant
1308820|NCT01545713|living donor|living donor
1308821|NCT01545700|dexamethasone|dexamethasone
1308822|NCT01545700|hyperglycemia|hyperglycemia
1308823|NCT01545700|gynecologic surgery|gynecologic surgery
1308824|NCT01545687|pain|pain
1308825|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
1308826|NCT01545687|weight changes|weight changes
1308827|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1308828|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1308829|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1308830|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1308831|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1308832|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1308833|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1308944|NCT01545479|ECA|eca
1308834|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1308835|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1308836|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1308837|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1308838|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1308839|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1308840|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1333189|NCT01444131|Pharmaceutical aids|pharmaceutical aids
1308841|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1308842|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1308843|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1308844|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1308845|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1308846|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1308847|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1308848|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1308849|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
1308850|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
1308851|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
1308852|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
1308853|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
1308854|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
1308855|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
1308856|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
1308857|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
1308858|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1308859|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1308860|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1308861|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1308862|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1308863|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1308864|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
1308865|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
1308965|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
1308866|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
1308867|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
1309371|NCT01543672|SBRT|sbrt
1308868|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
1308869|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
1308870|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1308871|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1308872|NCT01545674|Aneuploidy|aneuploidy
1308873|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
1308874|NCT01545674|Prenatal Blood Test|prenatal blood test
1308875|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
1308876|NCT01545674|Trisomy 13|trisomy 13
1308877|NCT01545674|Trisomy 18|trisomy 18
1308878|NCT01545674|Trisomy 21|trisomy 21
1308879|NCT01545674|Trisomy|trisomy
1308880|NCT01545674|Down Syndrome|down syndrome
1308881|NCT01545674|Turner Syndrome|turner syndrome
1308882|NCT01545674|Edwards Syndrome|edwards syndrome
1308883|NCT01545661|Tuberculosis|tuberculosis
1308884|NCT01545661|diagnosis|diagnosis
1308885|NCT01545661|sputum induction|sputum induction
1308886|NCT01545661|primary care|primary care
1308887|NCT01545648|breast|breast
1308888|NCT01545648|cancer|cancer
1308889|NCT01545648|early|early
1308890|NCT01545648|DTC|dtc
1308891|NCT01545648|disseminated|disseminated
1308892|NCT01545648|tumor|tumor
1308893|NCT01545648|cells|cells
1308894|NCT01545635|Major trauma|major trauma
1308895|NCT01545635|Injury Severity Score|injury severity score
1308896|NCT01545635|ISS > 15|iss > 15
1308897|NCT01545635|clinical signs|clinical signs
1308898|NCT01545635|risk of blood loss|risk of blood loss
1308899|NCT01545635|coagulopathy|coagulopathy
1308900|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
1308901|NCT01545635|ROTEM|rotem
1308902|NCT01545609|Text messaging|text messaging
1308903|NCT01545609|birth control|birth control
1308904|NCT01545609|adolescents|adolescents
1308905|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
1308906|NCT01545596|Decision Support Systems|decision support systems
1308907|NCT01545596|anesthesia outcomes|anesthesia outcomes
1308908|NCT01545557|Volume loss|volume loss
1308909|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
1308910|NCT01545544|Hepatitis C|hepatitis c
1308911|NCT01545531|glomerular filtration rate|glomerular filtration rate
1308912|NCT01545531|iohexol|iohexol
1308913|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
1308914|NCT01545531|kidney function|kidney function
1308915|NCT01545531|gold standard measure|gold standard measure
1308916|NCT01545531|cystatin C.|cystatin c.
1308917|NCT01545518|Refractory epilepsy|refractory epilepsy
1308918|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
1308919|NCT01545518|Autoimmune disorders|autoimmune disorders
1308920|NCT01545518|IVIG|ivig
1308921|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
1308922|NCT01545518|Autoantibodies|autoantibodies
1308923|NCT01545492|CHIPS|chips
1308924|NCT01545492|famine|famine
1308925|NCT01545492|reprogramming|reprogramming
1308926|NCT01545492|developmental|developmental
1308927|NCT01545492|blood|blood
1308928|NCT01545492|pressure|pressure
1308929|NCT01545492|randomised|randomised
1308930|NCT01545492|randomized|randomized
1308931|NCT01545492|hypertension|hypertension
1308932|NCT01545492|anthropometry|anthropometry
1308933|NCT01545492|measurement|measurement
1308934|NCT01545492|genetics|genetics
1308935|NCT01545492|epigenetics|epigenetics
1308936|NCT01545492|methylation|methylation
1308937|NCT01545492|cortisol|cortisol
1308938|NCT01545492|stress|stress
1308939|NCT01545492|DNA|dna
1308940|NCT01545492|growth|growth
1308941|NCT01545492|weight|weight
1308942|NCT01545492|length|length
1308943|NCT01545492|height|height
1308945|NCT01545479|BOLD-MRI|bold-mri
1308946|NCT01545479|kidney|kidney
1308947|NCT01545466|Migraines|migraines
1308948|NCT01545466|Behavioral|behavioral
1308949|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
1308950|NCT01545466|Mindfulness Meditation|mindfulness meditation
1308951|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1308952|NCT01545427|Scleroderma|scleroderma
1308953|NCT01545427|Randomized controled trial|randomized controled trial
1308954|NCT01545427|Pilot study|pilot study
1308955|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
1308956|NCT01545427|Biomarkers|biomarkers
1308957|NCT01545414|Self-help treatment|self-help treatment
1308958|NCT01545414|Internet treatment|internet treatment
1308959|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
1308960|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
1308961|NCT01545401|chronic disease management|chronic disease management
1308962|NCT01545401|Chronic Care Model|chronic care model
1308963|NCT01545401|multifaceted intervention|multifaceted intervention
1308964|NCT01545401|primary care|primary care
1308966|NCT01545401|hypertension|hypertension
1308967|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
1308968|NCT01545375|safety|safety
1309372|NCT01543672|MLD|mld
1308969|NCT01545375|immunogenicity|immunogenicity
1308970|NCT01545375|US|us
1308971|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
1308972|NCT01545375|efficacy|efficacy
1308973|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
1308974|NCT01545375|infants|infants
1308975|NCT01545349|LGG|lgg
1308976|NCT01545349|Immune response|immune response
1308977|NCT01545349|Influenza vaccine|influenza vaccine
1308978|NCT01545349|Elderly|elderly
1308979|NCT01545349|Healthy|healthy
1308980|NCT01545349|Microbiome|microbiome
1308981|NCT01545323|Netherton syndrome|netherton syndrome
1308982|NCT01545323|Gene therapy|gene therapy
1308983|NCT01545323|SPINK5|spink5
1308984|NCT01545297|dexmedetomidine|dexmedetomidine
1308985|NCT01545297|conscious sedation|conscious sedation
1308986|NCT01545297|awake craniotomy|awake craniotomy
1308987|NCT01545297|brain mapping|brain mapping
1308988|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
1308989|NCT01545284|acitretin|acitretin
1308990|NCT01545284|PGA|pga
1308991|NCT01545271|Xenon|xenon
1308992|NCT01545271|Hypothermia|hypothermia
1308993|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1308994|NCT01545271|Newborn|newborn
1308995|NCT01545271|Term|term
1308996|NCT01545271|Neuroprotection|neuroprotection
1308997|NCT01545271|Cooling|cooling
1308998|NCT01545271|HIE|hie
1308999|NCT01545245|atopic asthma|atopic asthma
1309000|NCT01545245|recurrent wheezing|recurrent wheezing
1309001|NCT01545245|preterm infants|preterm infants
1309002|NCT01545245|palivizumab|palivizumab
1309003|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
1309004|NCT01545245|RSV|rsv
1309005|NCT01545232|Massive Transfusion|massive transfusion
1309006|NCT01545232|Trauma|trauma
1309007|NCT01545232|Coagulopathy|coagulopathy
1309008|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
1309009|NCT01545232|Plasma|plasma
1309010|NCT01545232|Platelets|platelets
1309011|NCT01545232|Red Blood Cells|red blood cells
1309012|NCT01545232|Mortality|mortality
1309013|NCT01545232|Wounds and Injuries|wounds and injuries
1309014|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
1309015|NCT01545232|Shock|shock
1309016|NCT01545232|Pathologic Processes|pathologic processes
1309017|NCT01545232|Hemorrhage|hemorrhage
1309018|NCT01545232|Hemostatics|hemostatics
1309019|NCT01545232|Coagulation|coagulation
1333190|NCT01444105|Open angle glaucoma|open angle glaucoma
1309020|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
1309021|NCT01545232|Inflammation|inflammation
1309022|NCT01545193|Elderly|elderly
1309023|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
1309024|NCT01545180|Observatory|observatory
1309025|NCT01545180|Heart failure|heart failure
1309026|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
1309027|NCT01545180|HTPcap|htpcap
1309028|NCT01545167|African Americans|african americans
1309029|NCT01545167|pancreatitis|pancreatitis
1309030|NCT01545167|controls|controls
1309031|NCT01545141|metastatic|metastatic
1309032|NCT01545141|recurrent|recurrent
1309033|NCT01545141|peritoneal metastasis|peritoneal metastasis
1309034|NCT01545141|cytoreductive surgery|cytoreductive surgery
1309035|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
1309036|NCT01545141|HIPEC|hipec
1309037|NCT01545141|hepatic metastasis|hepatic metastasis
1309038|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
1309039|NCT01545141|vaccine|vaccine
1309040|NCT01545128|COPD|copd
1309041|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
1309042|NCT01545115|Children|children
1309043|NCT01545115|Immunity|immunity
1309044|NCT01545115|Sub-Saharan|sub-saharan
1309045|NCT01545115|Pertussis|pertussis
1309046|NCT01545115|Malaria|malaria
1309047|NCT01545115|Nutrition|nutrition
1309048|NCT01545115|antibodies|antibodies
1309049|NCT01545011|Inspiratory muscle training|inspiratory muscle training
1309050|NCT01545011|COPD|copd
1309051|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
1309052|NCT01545011|Dyspnea scale|dyspnea scale
1309053|NCT01544985|pediatrics|pediatrics
1309054|NCT01544985|emergency medicine|emergency medicine
1309055|NCT01544985|pain|pain
1309056|NCT01544985|bladder catheterization|bladder catheterization
1309057|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
1309058|NCT01544972|Paracetamol|paracetamol
1309059|NCT01544972|Ibuprofen|ibuprofen
1309060|NCT01544972|Serum levels|serum levels
1309061|NCT01544972|Preterm infant|preterm infant
1309062|NCT01544959|Narcotic|narcotic
1309063|NCT01544959|Opioid|opioid
1309064|NCT01544959|betablocking drug|betablocking drug
1309065|NCT01544959|postoperative pain|postoperative pain
1309066|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
1309067|NCT01544959|breast cancer|breast cancer
1309068|NCT01544959|hyperalgesia|hyperalgesia
1309069|NCT01544959|cancer recurrence|cancer recurrence
1309070|NCT01544959|anesthesia|anesthesia
1309071|NCT01544959|mastectomy|mastectomy
1309072|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
1309073|NCT01544959|acute postoperative pain|acute postoperative pain
1309373|NCT01543672|toxicity|toxicity
1309074|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
1309076|NCT01544959|ambulatory surgery|ambulatory surgery
1309077|NCT01544946|pediatrics|pediatrics
1309078|NCT01544946|emergency medicine|emergency medicine
1309079|NCT01544946|pain|pain
1309080|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
1309081|NCT01544933|spinal fractures|spinal fractures
1309082|NCT01544933|Thoracic vertebrae|thoracic vertebrae
1309083|NCT01544933|spinal canal|spinal canal
1309084|NCT01544933|kyphosis|kyphosis
1309085|NCT01544907|Drug Eluting Balloon|drug eluting balloon
1309086|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
1309087|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
1309088|NCT01544894|Compliance|compliance
1309089|NCT01544894|Bone mineral density|bone mineral density
1309090|NCT01544894|Bonemarkers|bonemarkers
1309091|NCT01544881|Pharmacokinetics|pharmacokinetics
1309092|NCT01544881|Pharmacodynamics|pharmacodynamics
1309093|NCT01544881|Hyperglycemia|hyperglycemia
1309094|NCT01544881|Insulin|insulin
1309095|NCT01544868|Total Energy Expenditure|total energy expenditure
1309096|NCT01544868|Protein Balance|protein balance
1309097|NCT01544868|Burns|burns
1309098|NCT01544855|Health young participants|health young participants
1309099|NCT01544842|Oral lichen planus|oral lichen planus
1309100|NCT01544842|Tacrolimus ointment|tacrolimus ointment
1309101|NCT01544842|Triamcinolone paste|triamcinolone paste
1309102|NCT01544829|theobromine|theobromine
1309103|NCT01544829|heart rate|heart rate
1309104|NCT01544829|blood lipids|blood lipids
1309105|NCT01544803|Randomized Controlled Trial|randomized controlled trial
1309106|NCT01544803|Alcohol|alcohol
1309107|NCT01544803|Internet|internet
1309108|NCT01544803|Screening|screening
1309109|NCT01544803|Brief intervention|brief intervention
1309110|NCT01544803|Personalized feedback|personalized feedback
1309111|NCT01544790|Esophageal carcinoma|esophageal carcinoma
1309112|NCT01544790|Esophageal cancer|esophageal cancer
1309113|NCT01544790|Robotic surgery|robotic surgery
1309114|NCT01544790|Esophagectomy|esophagectomy
1309115|NCT01544790|Minimally invasive|minimally invasive
1309116|NCT01544777|Aphakia|aphakia
1309117|NCT01544777|Cataract|cataract
1309118|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
1309119|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
1309120|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
1309121|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
1309122|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
1309123|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
1309124|NCT01544751|NAFLD|nafld
1309125|NCT01544751|metformin|metformin
1309126|NCT01544751|atorvastatin|atorvastatin
1309127|NCT01544751|metabolic syndrome|metabolic syndrome
1309128|NCT01544738|Parkinson Disease|parkinson disease
1309129|NCT01544738|sensory stimulation|sensory stimulation
1309130|NCT01544738|Bradykinesia|bradykinesia
1309131|NCT01544725|Procedural sedation|procedural sedation
1309132|NCT01544725|Ketamine-propofol|ketamine-propofol
1309133|NCT01544725|Ketamine|ketamine
1309134|NCT01544712|osteonecrosis|osteonecrosis
1309135|NCT01544712|cell-based therapy|cell-based therapy
1309136|NCT01544712|bone marrow|bone marrow
1309137|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
1309138|NCT01544712|hip|hip
1309139|NCT01544712|core decompression|core decompression
1309140|NCT01544699|stroke|stroke
1309141|NCT01544686|neutropenia|neutropenia
1309142|NCT01544686|cancer|cancer
1309143|NCT01544686|fever|fever
1309144|NCT01544686|central venous catheter|central venous catheter
1309145|NCT01544686|infection|infection
1309146|NCT01544660|spine and hip scan|spine and hip scan
1309147|NCT01544660|BMD|bmd
1309148|NCT01544647|Knee osteoarthritis|knee osteoarthritis
1309149|NCT01544647|spa therapy|spa therapy
1309150|NCT01544647|spa modalities|spa modalities
1309151|NCT01544634|Asthma|asthma
1309152|NCT01544634|Propranolol|propranolol
1309153|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
1309154|NCT01544634|Steroid sparing agent|steroid sparing agent
1309155|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
1309156|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
1309157|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
1309158|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
1309159|NCT01544595|scaly patches|scaly patches
1309160|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
1309161|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
1309162|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
1309163|NCT01544582|Pegylated Interferon|pegylated interferon
1309164|NCT01544582|boceprevir|boceprevir
1309165|NCT01544582|telaprevir|telaprevir
1309166|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1309167|NCT01544556|abdominoplasty|abdominoplasty
1309168|NCT01544543|COPD|copd
1309169|NCT01544530|Brain-death|brain-death
1309170|NCT01544530|organ donation|organ donation
1309171|NCT01544517|Helicobacter pylori|helicobacter pylori
1309172|NCT01544517|Concomitant therapy|concomitant therapy
1309173|NCT01544517|Sequential therapy|sequential therapy
1309174|NCT01544517|levofloxacin|levofloxacin
1309175|NCT01544504|Radiodermatitis|radiodermatitis
1309176|NCT01544504|Prevention|prevention
1309177|NCT01544504|Radiotherapy|radiotherapy
1309179|NCT01544504|Radiation Dermatitis|radiation dermatitis
1309180|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
1309181|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
1309182|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
1309183|NCT01544491|Renal function|renal function
1309184|NCT01544465|Parkinson's disease|parkinson's disease
1309185|NCT01544465|Sleep Quality|sleep quality
1309186|NCT01544465|Daytime sleepiness|daytime sleepiness
1309187|NCT01544465|physical therapy|physical therapy
1309188|NCT01544465|exercise|exercise
1309189|NCT01544452|MR|mr
1309190|NCT01544452|CT|ct
1309191|NCT01544452|ultrasonography|ultrasonography
1309192|NCT01544452|MR colonography|mr colonography
1309193|NCT01544452|MR rectum|mr rectum
1309194|NCT01544452|MR liver|mr liver
1309195|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
1309196|NCT01544439|Stress psychological|stress psychological
1309197|NCT01544439|Depression|depression
1309198|NCT01544439|Quality of Life|quality of life
1309199|NCT01544426|Office hysteroscopy,|office hysteroscopy,
1309200|NCT01544426|intrauterine insemination|intrauterine insemination
1309201|NCT01544426|endometrial scrap|endometrial scrap
1309202|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
1309203|NCT01544413|quality control study|quality control study
1309204|NCT01544413|early gastric cancer|early gastric cancer
1309205|NCT01544400|reverse anorexia,|reverse anorexia,
1309206|NCT01544400|anorexia athletics|anorexia athletics
1309207|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
1309208|NCT01544387|PPROM|pprom
1309209|NCT01544387|Pregnancy|pregnancy
1309210|NCT01544387|Bed rest.|bed rest.
1309211|NCT01544374|Breast Cancer|breast cancer
1309212|NCT01544374|Treatment Disparities|treatment disparities
1309213|NCT01544374|Tracking and Feedback|tracking and feedback
1309214|NCT01544374|Registry|registry
1414282|NCT01107054|QTC|qtc
1309215|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
1309216|NCT01544374|Adjuvant Treatment|adjuvant treatment
1309217|NCT01544374|Racial Disparities|racial disparities
1309218|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
1309219|NCT01544361|Healthy subjects|healthy subjects
1309220|NCT01544361|MEDI7814|medi7814
1309221|NCT01544361|FTiH|ftih
1309222|NCT01544348|Allergic|allergic
1309223|NCT01544348|Atopic Dermatitis|atopic dermatitis
1309224|NCT01544348|MEDI4212|medi4212
1309225|NCT01544322|solid tumors|solid tumors
1309226|NCT01544322|recurrent|recurrent
1309227|NCT01544322|advanced|advanced
1309228|NCT01544322|metastatic|metastatic
1309229|NCT01544322|refractory|refractory
1309230|NCT01544283|Shoulder Pain|shoulder pain
1309231|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
1309232|NCT01544270|milk protein|milk protein
1309233|NCT01544270|probiotics|probiotics
1309234|NCT01544270|stress|stress
1309235|NCT01544270|cortisol|cortisol
1309236|NCT01544270|heart beat|heart beat
1309237|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
1309238|NCT01544257|alternative medicine|alternative medicine
1309239|NCT01544257|complementary medicine|complementary medicine
1309240|NCT01544257|neonatology|neonatology
1309241|NCT01544257|neonatal care|neonatal care
1309242|NCT01544257|prematurity|prematurity
1309243|NCT01544257|allied health care|allied health care
1309244|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
1309245|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
1309246|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
1309247|NCT01544231|emergency room|emergency room
1309248|NCT01544218|Alcohol related disorders|alcohol related disorders
1309249|NCT01544192|Antioxidant|antioxidant
1309250|NCT01544192|α−tocopherol|α−tocopherol
1309251|NCT01544192|Vitamin E|vitamin e
1309252|NCT01544192|Gingko Biloba|gingko biloba
1309253|NCT01544192|Glaucoma|glaucoma
1309254|NCT01544192|Neuroprotection|neuroprotection
1309255|NCT01544192|Retina|retina
1309256|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
1309257|NCT01544179|Gefitinib|gefitinib
1309258|NCT01544179|Pemetrexed|pemetrexed
1309259|NCT01544179|Treatment Beyond Progression|treatment beyond progression
1309260|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
1309261|NCT01544153|Web based behavioral intervention|web based behavioral intervention
1309262|NCT01544153|Adherence|adherence
1309263|NCT01544153|Smoking cessation|smoking cessation
1309264|NCT01544153|Social network|social network
1309265|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
1309266|NCT01544153|Social support|social support
1309267|NCT01544140|Phase 1|phase 1
1309268|NCT01544140|healthy volunteers|healthy volunteers
1309269|NCT01544140|pharmacokinetics|pharmacokinetics
1309270|NCT01544140|vandetanib|vandetanib
1309271|NCT01544140|midazolam|midazolam
1309272|NCT01544127|Veterans|veterans
1309273|NCT01544127|Motivational Interviewing|motivational interviewing
1309274|NCT01544127|Inpatients|inpatients
1309275|NCT01544127|Suicide, Attempted|suicide, attempted
1309276|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
1309277|NCT01544101|Diet, Vegetarian|diet, vegetarian
1309278|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
1309279|NCT01544101|Pain|pain
1309280|NCT01544088|randomized controlled trial|randomized controlled trial
1309281|NCT01544088|PTSD|ptsd
1309282|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
1309283|NCT01544088|group treatment|group treatment
1309284|NCT01544062|Cardiac surgery|cardiac surgery
1309285|NCT01544062|Acute Pain|acute pain
1309286|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
1309287|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
1309288|NCT01544062|Patient Satisfaction|patient satisfaction
1309289|NCT01544049|fallopian tube removal|fallopian tube removal
1309290|NCT01544049|salpingectomy|salpingectomy
1309291|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
1309292|NCT01544036|AKI|aki
1309293|NCT01544036|contrast nephropathy|contrast nephropathy
1309294|NCT01544036|renal blood flow|renal blood flow
1309295|NCT01544023|breast reconstruction|breast reconstruction
1309296|NCT01544023|mesh|mesh
1309297|NCT01544023|implant reconstruction|implant reconstruction
1309298|NCT01544023|acellular dermal matrix|acellular dermal matrix
1309299|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
1309300|NCT01544023|TiLOOP Bra|tiloop bra
1309301|NCT01544023|TiLOOP|tiloop
1309302|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
1309303|NCT01544010|Transtheoretical Model|transtheoretical model
1309304|NCT01544010|Tailored Print Intervention|tailored print intervention
1309305|NCT01544010|Population-based|population-based
1309306|NCT01544010|Behavioral Intervention|behavioral intervention
1309307|NCT01543984|health care workers|health care workers
1309308|NCT01543984|tailored physical activity|tailored physical activity
1309309|NCT01543984|prevention|prevention
1309310|NCT01543984|spine|spine
1309311|NCT01543984|upper body|upper body
1309312|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
1309313|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
1309314|NCT01543971|CD34+ count|cd34+ count
1309315|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1309316|NCT01543945|Ambulatory|ambulatory
1309317|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
1309318|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
1309319|NCT01543932|antiplatelet effect|antiplatelet effect
1309320|NCT01543932|prasugrel|prasugrel
1309321|NCT01543932|clopidogrel|clopidogrel
1309322|NCT01543932|stable angina|stable angina
1309323|NCT01543893|neck pain|neck pain
1309324|NCT01543893|shoulder pain|shoulder pain
1309325|NCT01543893|resistance training|resistance training
1309326|NCT01543854|Heart failure|heart failure
1309327|NCT01543854|RLX030|rlx030
1309328|NCT01543854|Hemodynamics|hemodynamics
1309329|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
1309330|NCT01543841|advanced cancer|advanced cancer
1309331|NCT01543841|healthy|healthy
1309332|NCT01543841|blood sample|blood sample
1309333|NCT01543841|TEM|tem
1309334|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
1309335|NCT01543841|ANG1|ang1
1309336|NCT01543841|ANG2|ang2
1309337|NCT01543828|COPD|copd
1309338|NCT01543828|Indacatarol|indacatarol
1309339|NCT01543828|placebo|placebo
1309340|NCT01543828|crossover|crossover
1309341|NCT01543828|patient perception|patient perception
1309342|NCT01543815|Psychological Distress|psychological distress
1309343|NCT01543815|Depression|depression
1309344|NCT01543815|Anxiety|anxiety
1309345|NCT01543815|Well-Being Therapy|well-being therapy
1309346|NCT01543815|Heart Failure|heart failure
1309347|NCT01543815|Quality of Life|quality of life
1309348|NCT01543815|Adherence|adherence
1309349|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
1309350|NCT01543802|pazopanib|pazopanib
1309351|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
1309352|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
1309353|NCT01543802|preoperative therapy|preoperative therapy
1309354|NCT01543789|Umbilical Hernia|umbilical hernia
1309355|NCT01543763|metastatic|metastatic
1309356|NCT01543763|solid|solid
1309357|NCT01543763|sarcoma|sarcoma
1309358|NCT01543763|progression|progression
1309359|NCT01543750|episodic ataxia|episodic ataxia
1309360|NCT01543750|CACNA1A mutations|cacna1a mutations
1309361|NCT01543724|Lithium|lithium
1309362|NCT01543724|Bipolar disorder|bipolar disorder
1309363|NCT01543724|Multimodal Brain Imaging|multimodal brain imaging
1309364|NCT01543711|Breast cancer|breast cancer
1309365|NCT01543711|persistent pain|persistent pain
1309366|NCT01543711|neuropathic pain|neuropathic pain
1309367|NCT01543711|lymphedema|lymphedema
1309368|NCT01543698|Advanced solid tumor,|advanced solid tumor,
1309369|NCT01543698|BRAF V600 mutation|braf v600 mutation
1309374|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
1309375|NCT01543659|prostate|prostate
1309376|NCT01543659|Pet scan|pet scan
1309377|NCT01543659|11-126|11-126
1309378|NCT01543646|Hepatology|hepatology
1309379|NCT01543646|Liver Cirrhosis|liver cirrhosis
1309380|NCT01543646|Fatty Liver|fatty liver
1309381|NCT01543620|kidney safety|kidney safety
1309382|NCT01543620|biomarkers|biomarkers
1309383|NCT01543620|serum creatinine|serum creatinine
1309384|NCT01543620|BUN|bun
1309385|NCT01543620|cystic fibrosis|cystic fibrosis
1309386|NCT01543620|head and neck cancer|head and neck cancer
1309387|NCT01543620|renal injury|renal injury
1309388|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
1309389|NCT01543620|aminoglycoside|aminoglycoside
1309390|NCT01543620|cisplatin|cisplatin
1309391|NCT01543620|nephrotoxicity|nephrotoxicity
1309392|NCT01543620|biomarker qualification|biomarker qualification
1309393|NCT01543607|Bile duct|bile duct
1309394|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
1309395|NCT01543607|Bile duct stenosis|bile duct stenosis
1309396|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
1309397|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
1309398|NCT01543607|Radiofrequency ablation|radiofrequency ablation
1309399|NCT01543607|RFA|rfa
1309400|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
1309401|NCT01543607|EndoHPB|endohpb
1309402|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
1309403|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
1309404|NCT01543594|Biologic drugs|biologic drugs
1309405|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
1309406|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
1309407|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
1309408|NCT01543568|Age related Macular Degeneration|age related macular degeneration
1309409|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
1309410|NCT01543555|myocardial infarction|myocardial infarction
1309411|NCT01543555|statin|statin
1309412|NCT01543555|perioperative care|perioperative care
1333191|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
1309413|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
1309414|NCT01543555|anesthesiology|anesthesiology
1309415|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
1309416|NCT01543516|Asthma|asthma
1309417|NCT01543516|Sputum|sputum
1309418|NCT01543516|Blood|blood
1309419|NCT01543516|Inflammation|inflammation
1309420|NCT01543516|adaptive immune system|adaptive immune system
1309421|NCT01543516|innate immune system|innate immune system
1309422|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
1309423|NCT01543464|Survivin|survivin
1309424|NCT01543464|Montanide|montanide
1309425|NCT01543464|Imiquimod|imiquimod
1309426|NCT01543464|GMCSF|gmcsf
1309427|NCT01543438|ED utilization|ed utilization
1309428|NCT01543438|video education|video education
1309429|NCT01543438|mobile health|mobile health
1309430|NCT01543438|streaming media|streaming media
1309431|NCT01543438|underserved populations|underserved populations
1309432|NCT01543425|Neuropathic Pain|neuropathic pain
1309433|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
1309434|NCT01543425|Psychological state|psychological state
1309435|NCT01543412|FOLFIRI|folfiri
1309436|NCT01543412|Metastases|metastases
1309437|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1309438|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
1309439|NCT01543399|Tibolone|tibolone
1309440|NCT01543399|climacteric|climacteric
1309441|NCT01543399|Doppler|doppler
1309442|NCT01543399|hormone replacement therapy|hormone replacement therapy
1309443|NCT01543386|Polyphenol|polyphenol
1309444|NCT01543386|Curcumin|curcumin
1309445|NCT01543386|Endothelium, vascular|endothelium, vascular
1309446|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
1309447|NCT01543386|Smoking|smoking
1309448|NCT01543386|Transcriptome|transcriptome
1309449|NCT01543373|Coronary artery disease|coronary artery disease
1309450|NCT01543373|Optical Coherence Tomography|optical coherence tomography
1309451|NCT01543373|Tissue coverage|tissue coverage
1309452|NCT01543373|DES|des
1309453|NCT01543360|axillary vein|axillary vein
1309454|NCT01543360|sub clavian vein|sub clavian vein
1309455|NCT01543360|comparison of strategies|comparison of strategies
1309456|NCT01543347|UTI|uti
1309457|NCT01543347|ESBL|esbl
1309458|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
1309459|NCT01543334|intensive care|intensive care
1309460|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
1309461|NCT01543321|tetrabenazine|tetrabenazine
1309462|NCT01543321|movement disorders|movement disorders
1309463|NCT01543321|tardive disorders|tardive disorders
1309464|NCT01543295|Non-Treponemal|non-treponemal
1309465|NCT01543295|Treponemal|treponemal
1309466|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
1309467|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
1309468|NCT01543282|22 gauge|22 gauge
1309469|NCT01543282|25 gauge|25 gauge
1309470|NCT01543269|Obesity|obesity
1309471|NCT01543269|Lipid disorders|lipid disorders
1309960|NCT01541137|thoracotomy|thoracotomy
1309472|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
1309473|NCT01543243|postural balance|postural balance
1309474|NCT01543243|strength|strength
1309475|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
1309476|NCT01543217|COPD|copd
1309477|NCT01543204|plaque psoriasis|plaque psoriasis
1309478|NCT01543204|etanercept|etanercept
1309479|NCT01543204|adalimumab|adalimumab
1309480|NCT01543191|Lung Diseases|lung diseases
1309481|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
1309482|NCT01543191|Fibrosis|fibrosis
1309483|NCT01543178|IBS|ibs
1309484|NCT01543178|IBS-D|ibs-d
1309485|NCT01543178|IBS with diarrhea|ibs with diarrhea
1309486|NCT01543178|Diarrhea|diarrhea
1309487|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
1309488|NCT01543165|Renal colic|renal colic
1309489|NCT01543165|Analgesia|analgesia
1309490|NCT01543165|Nefopam|nefopam
1309491|NCT01543165|Ketorolac|ketorolac
1309492|NCT01543152|HIV|hiv
1309493|NCT01543152|autologous cell therapy|autologous cell therapy
1309494|NCT01543152|cyclophosphamide|cyclophosphamide
1309495|NCT01543139|Bipolar Depression|bipolar depression
1309496|NCT01543139|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1309497|NCT01543139|Cytidine-|cytidine-
1309498|NCT01543139|Creatine-|creatine-
1309499|NCT01543113|melanoma|melanoma
1309500|NCT01543113|white-caucasian population|white-caucasian population
1309501|NCT01543100|MGUS|mgus
1309502|NCT01543074|HDAC|hdac
1309503|NCT01543074|histone acetylation|histone acetylation
1309504|NCT01543074|broccoli sprout extract|broccoli sprout extract
1309505|NCT01543074|garlic oil|garlic oil
1309506|NCT01543074|PBMCs|pbmcs
1309507|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1309508|NCT01543048|Virological tests|virological tests
1309509|NCT01543048|CIN3|cin3
1309510|NCT01543048|Cervical cancer|cervical cancer
1309511|NCT01543048|Conization|conization
1309512|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
1309513|NCT01543035|HIV infection|hiv infection
1309514|NCT01543035|lipid lowering drugs|lipid lowering drugs
1309515|NCT01543035|etravirine|etravirine
1309517|NCT01543035|statin treatment|statin treatment
1309518|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
1309519|NCT01543009|child|child
1309520|NCT01543009|venipuncture|venipuncture
1309521|NCT01543009|pain|pain
1309522|NCT01542983|breast cancer|breast cancer
1309523|NCT01542983|bright light|bright light
1309524|NCT01542983|insomnia|insomnia
1309525|NCT01542983|fatigue|fatigue
1309526|NCT01542970|intervention|intervention
1309527|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
1309528|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
1309529|NCT01542970|pregnancy|pregnancy
1309530|NCT01542970|lactation|lactation
1309531|NCT01542970|allergic symptoms|allergic symptoms
1309532|NCT01542970|IgE associated disease|ige associated disease
1309533|NCT01542970|gastrointestinal function|gastrointestinal function
1309534|NCT01542957|Major Depressive Disorder|major depressive disorder
1309535|NCT01542957|Dysthymic Disorder|dysthymic disorder
1309536|NCT01542957|Depression|depression
1309537|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
1309538|NCT01542957|Personal Construct Theory|personal construct theory
1309539|NCT01542957|Repertory Grid Technique|repertory grid technique
1309540|NCT01542957|Cognitive Conflicts|cognitive conflicts
1309541|NCT01542957|Personal dilemmas|personal dilemmas
1309542|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
1309543|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
1309544|NCT01542944|Stem Cell Mobilization|stem cell mobilization
1309545|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1309546|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
1309547|NCT01542931|Induction chemotherapy|induction chemotherapy
1309548|NCT01542931|Surgery|surgery
1309549|NCT01542931|Radiotherapy|radiotherapy
1309550|NCT01542918|Recurrent|recurrent
1309551|NCT01542918|Refractory|refractory
1309552|NCT01542918|CNS|cns
1309553|NCT01542918|Intraocular|intraocular
1309554|NCT01542918|Lymphoma|lymphoma
1309555|NCT01542892|Sarcopenia|sarcopenia
1309556|NCT01542892|Nutrition|nutrition
1309557|NCT01542892|Vitamin D|vitamin d
1309558|NCT01542892|Exercise|exercise
1309559|NCT01542866|ranibizumab|ranibizumab
1309560|NCT01542866|Age related Macular Degeneration|age related macular degeneration
1309561|NCT01542866|AMD|amd
1309562|NCT01542866|Health Management Tool|health management tool
1309563|NCT01542866|HMT|hmt
1309564|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
1309565|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
1309566|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
1309567|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
1309568|NCT01542866|visual function self test|visual function self test
1309569|NCT01542840|surgery|surgery
1309570|NCT01542840|orthopedic surgery|orthopedic surgery
1309961|NCT01541137|pain|pain
1309571|NCT01542840|foot surgery|foot surgery
1309572|NCT01542840|leg surgery|leg surgery
1309573|NCT01542840|ankle surgery|ankle surgery
1309574|NCT01542840|leg|leg
1309575|NCT01542840|foot|foot
1309576|NCT01542840|ankle|ankle
1309577|NCT01542840|anesthesia|anesthesia
1309578|NCT01542840|local anesthesia|local anesthesia
1309579|NCT01542840|regional anesthesia|regional anesthesia
1309580|NCT01542840|Ochsner Clinic|ochsner clinic
1309581|NCT01542840|Ochsner Hospital|ochsner hospital
1309582|NCT01542840|New Orleans|new orleans
1309583|NCT01542840|Louisiana|louisiana
1309584|NCT01542840|Kristie Osteen, MD|kristie osteen, md
1309585|NCT01542827|neck pain|neck pain
1309586|NCT01542827|menthol|menthol
1309587|NCT01542814|Screening Mammogram|screening mammogram
1309588|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
1309589|NCT01542814|Benign|benign
1309590|NCT01542814|Malignant|malignant
1309591|NCT01542814|BI-RADS Categories|bi-rads categories
1309592|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
1309593|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1309594|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1309595|NCT01542788|HCV|hcv
1309596|NCT01542788|Sustained Virologic Response|sustained virologic response
1309597|NCT01542788|Direct Acting Antiviral|direct acting antiviral
1309598|NCT01542788|Combination Therapy|combination therapy
1309599|NCT01542788|Interferon intolerant|interferon intolerant
1309600|NCT01542788|Interferon ineligible|interferon ineligible
1309601|NCT01542788|GS-7977|gs-7977
1309602|NCT01542788|Ribavirin|ribavirin
1309603|NCT01542762|Deep venous thrombosis|deep venous thrombosis
1309604|NCT01542762|Pulmonary Embolism|pulmonary embolism
1309605|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
1309606|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
1309607|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
1309608|NCT01542723|Deep venous thrombosis|deep venous thrombosis
1309609|NCT01542723|Pulmonary Embolism|pulmonary embolism
1309610|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
1309611|NCT01542697|magnesium sulpahate|magnesium sulpahate
1309612|NCT01542697|postoperative analgesia|postoperative analgesia
1309613|NCT01542684|Leukemia|leukemia
1309614|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
1309615|NCT01542684|MDS|mds
1309616|NCT01542684|Azacytidine|azacytidine
1309617|NCT01542684|5-Azacytidine|5-azacytidine
1309618|NCT01542684|5-AZA|5-aza
1309619|NCT01542684|Vidaza|vidaza
1309620|NCT01542684|5-AZC|5-azc
1309621|NCT01542684|Aza-CR|aza-cr
1309622|NCT01542684|Ladakamycin|ladakamycin
1309623|NCT01542684|NSC-102816|nsc-102816
1309624|NCT01542684|GM-CSF|gm-csf
1309625|NCT01542684|Sargramostim|sargramostim
1309626|NCT01542684|Leukine|leukine
1309627|NCT01542671|lifestyle change|lifestyle change
1309628|NCT01542671|obesity treatment|obesity treatment
1309629|NCT01542671|physical activity|physical activity
1309630|NCT01542671|primary care|primary care
1309631|NCT01542671|quality of life|quality of life
1309632|NCT01542645|Fentanyl|fentanyl
1309633|NCT01542645|Methadone|methadone
1309634|NCT01542645|Thoracic Surgery|thoracic surgery
1309635|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
1309636|NCT01542606|PH|ph
1309637|NCT01542606|SCREENING|screening
1309638|NCT01542606|EARLY WARNING|early warning
1309639|NCT01542606|VAGINAL HEALTH|vaginal health
1309640|NCT01542606|VAGINAL SECRETION|vaginal secretion
1309641|NCT01542606|VAGINAL PH|vaginal ph
1309642|NCT01542580|Revision surgery|revision surgery
1309643|NCT01542567|Diclofenac|diclofenac
1309644|NCT01542567|BCG|bcg
1309645|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
1309646|NCT01542554|Diabetes mellitus|diabetes mellitus
1309647|NCT01542554|Chinese|chinese
1309648|NCT01542554|Glycaemic index|glycaemic index
1309649|NCT01542528|ADHD|adhd
1309650|NCT01542528|Executive function|executive function
1309651|NCT01542528|Inhibitory control|inhibitory control
1309652|NCT01542528|Computer games|computer games
1309653|NCT01542528|Sports activities|sports activities
1309654|NCT01542528|Good Behavior Game|good behavior game
1309655|NCT01542515|Allograft|allograft
1309656|NCT01542515|Arthroplasty|arthroplasty
1309657|NCT01542515|Basal Joint|basal joint
1309658|NCT01542515|carpometacarpal joint|carpometacarpal joint
1309659|NCT01542515|Thumb|thumb
1309660|NCT01542515|meniscus|meniscus
1309661|NCT01542515|osteoarthritis|osteoarthritis
1309662|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
1309663|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1309664|NCT01542502|Diastolic heart failure|diastolic heart failure
1309665|NCT01542502|Aerobic exercise performance|aerobic exercise performance
1309666|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
1309667|NCT01542398|community-based|community-based
1309668|NCT01542398|war-affected|war-affected
1309669|NCT01542398|psychosocial support|psychosocial support
1309670|NCT01542398|family-focused|family-focused
1309671|NCT01542398|psychological distress|psychological distress
1309672|NCT01542398|adolescents|adolescents
1309673|NCT01542398|Democratic Republic of Congo|democratic republic of congo
1309674|NCT01542398|family functioning|family functioning
1309675|NCT01542398|community functioning|community functioning
1309676|NCT01542398|daily functioning|daily functioning
1309677|NCT01542385|Delayed stenting|delayed stenting
1309678|NCT01542385|Deferred stenting|deferred stenting
1309679|NCT01542385|Late stenting|late stenting
1309680|NCT01542385|postponed stenting|postponed stenting
1309681|NCT01542385|Thrombectomy|thrombectomy
1309682|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
1309683|NCT01542385|PCI|pci
1309684|NCT01542385|Angioplasty|angioplasty
1309685|NCT01542385|STEMI|stemi
1309686|NCT01542385|acute myocardial infarction|acute myocardial infarction
1309687|NCT01542372|PTSD|ptsd
1309688|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
1309689|NCT01542372|Medication augmentation|medication augmentation
1309690|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
1309691|NCT01542372|Cambodian refugees|cambodian refugees
1309692|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
1309693|NCT01542359|Yoga, Hypertension|yoga, hypertension
1309694|NCT01542359|Blood Pressure|blood pressure
1309695|NCT01542359|Autonomic Nervous system|autonomic nervous system
1309696|NCT01542346|Wound closure|wound closure
1309697|NCT01542346|cosmetic outcome|cosmetic outcome
1309819|NCT01541761|Obesity|obesity
1309698|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1309699|NCT01542333|stage I Wilms tumor|stage i wilms tumor
1309700|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
1309701|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
1309702|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
1309703|NCT01542333|stage V Wilms tumor|stage v wilms tumor
1309704|NCT01542320|probiotic|probiotic
1309705|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
1309706|NCT01542320|healthy infants|healthy infants
1309707|NCT01542307|migraine|migraine
1309708|NCT01542307|oxygen therapy|oxygen therapy
1309709|NCT01542294|gastric cancer|gastric cancer
1309710|NCT01542294|S-1|s-1
1309711|NCT01542294|oxaliplatin|oxaliplatin
1309712|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
1309713|NCT01542281|liver resection|liver resection
1309714|NCT01542281|hepatectomy|hepatectomy
1309715|NCT01542281|pre-habilitation|pre-habilitation
1309716|NCT01542268|pentoxifylline|pentoxifylline
1309717|NCT01542268|tight junction signalling|tight junction signalling
1309718|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
1309719|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
1309720|NCT01542255|Metronomic Therapy|metronomic therapy
1309721|NCT01542255|Metastatic Melanoma|metastatic melanoma
1309722|NCT01542255|Vinblastine|vinblastine
1309723|NCT01542255|Cyclophosphamide|cyclophosphamide
1309724|NCT01542255|Dacarbazine|dacarbazine
1309725|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
1309726|NCT01542242|Prader Willi Syndrome|prader willi syndrome
1309727|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
1309728|NCT01542229|Severe Mental Illness|severe mental illness
1309729|NCT01542203|doxorubicin|doxorubicin
1309730|NCT01542203|cyclophosphamide|cyclophosphamide
1309731|NCT01542203|Breast Cancer|breast cancer
1309732|NCT01542203|BMI|bmi
1309733|NCT01542190|cataract surgery|cataract surgery
1309734|NCT01542190|cystoid macular edema|cystoid macular edema
1309735|NCT01542190|angiography|angiography
1309736|NCT01542177|hypoxia|hypoxia
1309737|NCT01542177|pancreas|pancreas
1309738|NCT01542177|cancer|cancer
1309739|NCT01542177|pancreatic cancer|pancreatic cancer
1309740|NCT01542177|18F-FAZA|18f-faza
1309741|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
1309742|NCT01542177|Positron Emission Tomography|positron emission tomography
1309743|NCT01542177|PET|pet
1309744|NCT01542164|Calcium intake|calcium intake
1309745|NCT01542164|Fat excretion|fat excretion
1309746|NCT01542164|Energy excretion|energy excretion
1309747|NCT01542164|Gut micro flora|gut micro flora
1309748|NCT01542151|Labor, induced|labor, induced
1309749|NCT01542151|Sleep|sleep
1309750|NCT01542151|Fatigue|fatigue
1309751|NCT01542151|Patient satisfaction|patient satisfaction
1309752|NCT01542151|Circadian rhythm|circadian rhythm
1309753|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
1309754|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
1309755|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
1309756|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
1309757|NCT01542112|Patient-Centered Care|patient-centered care
1309758|NCT01542112|Patient Satisfaction|patient satisfaction
1309759|NCT01542112|Interventional study|interventional study
1309760|NCT01542112|Patient Expectations|patient expectations
1309761|NCT01542112|Hospitalization|hospitalization
1309762|NCT01542086|intermediate pre-test|intermediate pre-test
1310651|NCT01538329|Amantadine|amantadine
1309763|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
1309764|NCT01542073|myocardial infarction|myocardial infarction
1309765|NCT01542073|angiogenesis|angiogenesis
1309962|NCT01541137|NSAID|nsaid
1309766|NCT01542073|integrin receptor imaging|integrin receptor imaging
1309767|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
1309768|NCT01542047|Metastatic|metastatic
1309769|NCT01542047|Solid tumors|solid tumors
1309770|NCT01542047|carboplatin|carboplatin
1309771|NCT01542047|Paraplatin|paraplatin
1309772|NCT01542047|Pazopanib|pazopanib
1309773|NCT01542047|Votrient|votrient
1309774|NCT01542047|Alkylating agent|alkylating agent
1309775|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1309776|NCT01542047|Metastatic disease|metastatic disease
1309777|NCT01542021|prostate|prostate
1309778|NCT01542021|Degarelix|degarelix
1309779|NCT01542021|injections|injections
1309780|NCT01542021|radical prostatectomy|radical prostatectomy
1309781|NCT01542021|11-182|11-182
1309782|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
1309783|NCT01541995|virtual autopsy|virtual autopsy
1309784|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
1309785|NCT01541969|Ear|ear
1309786|NCT01541969|Hearing|hearing
1309787|NCT01541956|type 2 diabetes;|type 2 diabetes;
1309788|NCT01541956|vildagliptin;|vildagliptin;
1309789|NCT01541956|metformin;|metformin;
1309790|NCT01541943|Atorvastatin|atorvastatin
1309791|NCT01541943|Losartan|losartan
1309792|NCT01541943|Essential Hypertension|essential hypertension
1309793|NCT01541943|Hyperlipidemia|hyperlipidemia
1309794|NCT01541904|Ocular Allergy.|ocular allergy.
1309795|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
1309796|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
1612428|NCT00349037|influenza|influenza
1309797|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
1309798|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
1309800|NCT01541891|Dry eye syndrome|dry eye syndrome
1309801|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
1309802|NCT01541852|Vascular Inflammation|vascular inflammation
1309803|NCT01541852|FDG PET-CT|fdg pet-ct
1309804|NCT01541852|COPD|copd
1309805|NCT01541852|Atherosclerosis|atherosclerosis
1309806|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
1309807|NCT01541839|Nasal septum|nasal septum
1309808|NCT01541839|Nasal surgical procedures|nasal surgical procedures
1309809|NCT01541826|aronia|aronia
1309810|NCT01541826|LDL cholesterol|ldl cholesterol
1309811|NCT01541826|polyphenols|polyphenols
1309812|NCT01541826|bioavailability|bioavailability
1309813|NCT01541826|oxidative stress|oxidative stress
1309814|NCT01541813|Rare iron overload|rare iron overload
1309815|NCT01541813|hepcidin|hepcidin
1309816|NCT01541774|Atherectomy|atherectomy
1309817|NCT01541774|Atherosclerosis|atherosclerosis
1309818|NCT01541774|Peripheral artery disease|peripheral artery disease
1309820|NCT01541761|Child|child
1309821|NCT01541761|Hispanic|hispanic
1309822|NCT01541761|Prevention|prevention
1309823|NCT01541761|Nutrition|nutrition
1309824|NCT01541761|Parenting|parenting
1309825|NCT01541735|Diabetes|diabetes
1309826|NCT01541735|Insulin|insulin
1309827|NCT01541735|Pantoprazole|pantoprazole
1309828|NCT01541722|Urea cycle disorders|urea cycle disorders
1309829|NCT01541709|This is a single-center|this is a single-center
1309830|NCT01541709|prospective|prospective
1309831|NCT01541709|single-arm|single-arm
1309832|NCT01541709|open-label phase II study|open-label phase ii study
1309833|NCT01541696|zinc|zinc
1309834|NCT01541696|zn|zn
1309835|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
1309836|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
1309837|NCT01541683|bowel cleansing|bowel cleansing
1309838|NCT01541683|Mentholyptus drops|mentholyptus drops
1309839|NCT01541683|Palatability|palatability
1309840|NCT01541657|Ankle Instability|ankle instability
1309841|NCT01541657|Sensorimotor Control|sensorimotor control
1309842|NCT01541657|Sensory|sensory
1309843|NCT01541657|Postural Control|postural control
1309844|NCT01541657|Balance|balance
1309845|NCT01541657|Gait|gait
1309846|NCT01541644|Acupuncture Therapy|acupuncture therapy
1309847|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
1309848|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
1309849|NCT01541631|Schistosoma mansoni|schistosoma mansoni
1309850|NCT01541631|Anemia|anemia
1309851|NCT01541631|Immune response|immune response
1309852|NCT01541631|Opportunistic infections|opportunistic infections
1309853|NCT01541631|Tanzania|tanzania
1309854|NCT01541618|MS|ms
1309855|NCT01541618|RRMS|rrms
1309856|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
1309857|NCT01541592|Insulin resistance|insulin resistance
1309858|NCT01541592|Endothelial dysfunction|endothelial dysfunction
1309859|NCT01541592|saturated fat|saturated fat
1309860|NCT01541592|monounsaturated fat|monounsaturated fat
1309861|NCT01541592|polyunsaturated fat|polyunsaturated fat
1309862|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
1309863|NCT01541566|arterial hypertension|arterial hypertension
1309864|NCT01541566|metabolic syndrome|metabolic syndrome
1309865|NCT01541566|home blood pressure|home blood pressure
1309866|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
1309867|NCT01541566|office blood pressure|office blood pressure
1309868|NCT01541566|telemedicine|telemedicine
1309869|NCT01541527|non neutralizing antibody|non neutralizing antibody
1309870|NCT01541527|Epitopic profile|epitopic profile
1309871|NCT01541527|Clinical relevance|clinical relevance
1309872|NCT01541501|Central Corneal Thickness|central corneal thickness
1309873|NCT01541501|Pachymetry|pachymetry
1309874|NCT01541462|mechanical ventilation|mechanical ventilation
1309875|NCT01541462|weaning|weaning
1309876|NCT01541462|pressure support|pressure support
1309877|NCT01541462|spontaneous breathing|spontaneous breathing
1309878|NCT01541462|Long-term acute care facility|long-term acute care facility
1309879|NCT01541462|mortality|mortality
1309880|NCT01541449|AMD|amd
1309881|NCT01541449|PLAQUENIL|plaquenil
1309882|NCT01541449|CNV|cnv
1309883|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
1309884|NCT01541436|Nociception|nociception
1309885|NCT01541436|Central Sensitization|central sensitization
1309886|NCT01541436|Peripheral Sensitization|peripheral sensitization
1309887|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
1309888|NCT01541397|Phenylketonuria|phenylketonuria
1309889|NCT01541397|Adults|adults
1309890|NCT01541397|Bone Mineral Density|bone mineral density
1309891|NCT01541384|Kidney transplant|kidney transplant
1309892|NCT01541384|Adherence|adherence
1309893|NCT01541384|Electronic pill bottles|electronic pill bottles
1309894|NCT01541371|Schizophrenia|schizophrenia
1415024|NCT01103843|P2Y12|p2y12
1309895|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
1309896|NCT01541332|relapsed refractory|relapsed refractory
1309897|NCT01541332|multiple myeloma|multiple myeloma
1309898|NCT01541332|pomalidomide|pomalidomide
1309899|NCT01541332|Doxil|doxil
1309900|NCT01541332|dexamethasone|dexamethasone
1309901|NCT01541332|Oncotherapeutics|oncotherapeutics
1309902|NCT01541319|Cardiac Surgery|cardiac surgery
1309903|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
1309904|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
1309905|NCT01541306|dwarfism|dwarfism
1309906|NCT01541306|growth|growth
1309907|NCT01541306|achondroplasia|achondroplasia
1309908|NCT01541306|hypochondroplasia|hypochondroplasia
1309909|NCT01541306|biomarker|biomarker
1309910|NCT01541293|Abortion, Induced|abortion, induced
1309911|NCT01541293|Laminaria|laminaria
1309912|NCT01541293|Pain management|pain management
1309913|NCT01541293|Cervical preparation|cervical preparation
1309914|NCT01541293|Dilation and Evacuation|dilation and evacuation
1309915|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
1309916|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
1309917|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
1309918|NCT01541267|aliskiren|aliskiren
1309919|NCT01541267|eplerenon|eplerenon
1309920|NCT01541267|telmisartan|telmisartan
1309921|NCT01541267|direct renin inhibitor|direct renin inhibitor
1309922|NCT01541267|ACE inhibitor|ace inhibitor
1309923|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
1309924|NCT01541267|proteinuria|proteinuria
1309925|NCT01541267|chronic kidney diseases|chronic kidney diseases
1309926|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1309927|NCT01541254|intracranial aneurysm|intracranial aneurysm
1309928|NCT01541254|wide-neck|wide-neck
1309929|NCT01541254|saccular|saccular
1309930|NCT01541254|endovascular treatment|endovascular treatment
1309931|NCT01541254|coil embolization|coil embolization
1309932|NCT01541254|stent|stent
1309933|NCT01541254|bare platinum|bare platinum
1309934|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
1309935|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
1309936|NCT01541228|actinic keratosis|actinic keratosis
1309937|NCT01541228|photodynamic therapy|photodynamic therapy
1309938|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
1309939|NCT01541202|chronic heart failure|chronic heart failure
1309940|NCT01541202|neuregulin|neuregulin
1309941|NCT01541202|mortality|mortality
1309942|NCT01541189|hypertension|hypertension
1309943|NCT01541189|valsartan|valsartan
1309944|NCT01541176|Corticotherapy|corticotherapy
1309945|NCT01541176|Fibrosis|fibrosis
1309946|NCT01541176|Numerical reading|numerical reading
1309947|NCT01541176|18-70 years|18-70 years
1309948|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
1309949|NCT01541176|first or second renal transplant|first or second renal transplant
1309950|NCT01541163|Ischemia|ischemia
1309951|NCT01541163|Brain Infarction|brain infarction
1309952|NCT01541163|Acute Stroke|acute stroke
1309953|NCT01541163|Heart Diseases|heart diseases
1309954|NCT01541163|Myocardial Infarction|myocardial infarction
1309955|NCT01541150|Pedophilia|pedophilia
1309956|NCT01541150|Impaired Decision making|impaired decision making
1309957|NCT01541150|Insight|insight
1309958|NCT01541150|Cognitive Distorsions|cognitive distorsions
1309959|NCT01541150|Impulsiveness|impulsiveness
1309963|NCT01541137|PCA|pca
1309964|NCT01541137|TEA|tea
1309965|NCT01541137|chronic|chronic
1309966|NCT01541124|cancer pain|cancer pain
1309967|NCT01541124|analgesia|analgesia
1309968|NCT01541124|morphine|morphine
1309969|NCT01541111|Cancer pain|cancer pain
1309970|NCT01541111|Magnesiun|magnesiun
1309971|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
1309972|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
1309973|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
1309974|NCT01541072|Lymphocyte subsets|lymphocyte subsets
1309975|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
1309976|NCT01541072|Induction chemotherapy|induction chemotherapy
1309977|NCT01541072|growth factor|growth factor
1309978|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
1309979|NCT01541072|Pegfilgrastim|pegfilgrastim
1309980|NCT01541072|Filgrastim|filgrastim
1309981|NCT01541059|Third molar extraction|third molar extraction
1309982|NCT01541059|local anesthesia|local anesthesia
1309983|NCT01541059|ropivacaine|ropivacaine
1309984|NCT01541046|pediatric|pediatric
1309985|NCT01541046|infantile colic|infantile colic
1309986|NCT01541046|probiotic treatment|probiotic treatment
1309987|NCT01541033|autism|autism
1309988|NCT01541033|children|children
1309989|NCT01541007|Prostate Cancer|prostate cancer
1309990|NCT01541007|Metastatic|metastatic
1309991|NCT01541007|Castration Resistant|castration resistant
1309992|NCT01540994|Neoplasms|neoplasms
1309993|NCT01540994|Urogenital neoplasm|urogenital neoplasm
1309994|NCT01540994|Genital neoplasms, male|genital neoplasms, male
1309995|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
1309996|NCT01540955|improve cognitive function|improve cognitive function
1309997|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
1309998|NCT01540942|Crohn's disease|crohn's disease
1309999|NCT01540942|Nutrition|nutrition
1310000|NCT01540942|Bowel resection|bowel resection
1310001|NCT01540942|Postoperative recurrence|postoperative recurrence
1310002|NCT01540942|complication|complication
1310003|NCT01540942|Active disease|active disease
1310004|NCT01540929|Smallpox|smallpox
1310005|NCT01540929|ACAM2000®|acam2000®
1310006|NCT01540929|Smallpox vaccine|smallpox vaccine
1310007|NCT01540916|acid-base equilibrium|acid-base equilibrium
1310008|NCT01540916|renal system|renal system
1310009|NCT01540916|urinary electrolytes|urinary electrolytes
1310010|NCT01540903|Malaria Challenge|malaria challenge
1310011|NCT01540903|Plasmodium falciparum|plasmodium falciparum
1310012|NCT01540903|PfSPZ Challenge|pfspz challenge
1310013|NCT01540903|Controlled|controlled
1310014|NCT01540903|human|human
1310015|NCT01540903|malaria infection|malaria infection
1310016|NCT01540864|Obesity|obesity
1310017|NCT01540864|Overweight|overweight
1310018|NCT01540864|Body Mass Index|body mass index
1310019|NCT01540851|Osteoarthritis|osteoarthritis
1310020|NCT01540851|Total Knee Replacement|total knee replacement
1310021|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
1310022|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
1310023|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
1310024|NCT01540851|Care Navigator|care navigator
1310025|NCT01540838|Bacterial meningitis|bacterial meningitis
1310026|NCT01540838|infusion|infusion
1310027|NCT01540838|bolus|bolus
1310028|NCT01540838|paracetamol|paracetamol
1310029|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1310030|NCT01540799|Migraine|migraine
1310031|NCT01540799|High disability migraine|high disability migraine
1310032|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
1310033|NCT01540799|Neuromodulation|neuromodulation
1310034|NCT01540799|Neurostimulation|neurostimulation
1310035|NCT01540799|Autonomic nervous system|autonomic nervous system
1310036|NCT01540786|OAB|oab
1310037|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
1310038|NCT01540773|growth hormone|growth hormone
1310039|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
1310040|NCT01540747|PCOS|pcos
1310041|NCT01540747|embryos quality|embryos quality
1310042|NCT01540747|oocytes quality|oocytes quality
1310043|NCT01540734|paracetamol|paracetamol
1310044|NCT01540734|pharmacokinetic|pharmacokinetic
1310045|NCT01540721|paracetamol|paracetamol
1310046|NCT01540721|pharmacokinetics|pharmacokinetics
1310047|NCT01540708|Asthma|asthma
1310048|NCT01540708|Respiratory|respiratory
1310049|NCT01540708|COPD|copd
1310050|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
1310051|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
1310147|NCT01540201|gas exchange|gas exchange
1310052|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
1310053|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
1310054|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
1310351|NCT01539239|POAG|poag
1310055|NCT01540669|constipation|constipation
1310056|NCT01540669|functional constipation|functional constipation
1310057|NCT01540669|polydextrose|polydextrose
1310058|NCT01540669|whole gut transit time|whole gut transit time
1310059|NCT01540656|Stress incontinence|stress incontinence
1310060|NCT01540656|Incontinence|incontinence
1310061|NCT01540656|prostate cancer|prostate cancer
1310062|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
1310063|NCT01540656|nerve stimulation|nerve stimulation
1310064|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
1310065|NCT01540643|iliac leg graft|iliac leg graft
1310066|NCT01540617|Low back pain|low back pain
1310067|NCT01540617|Proprioception|proprioception
1310068|NCT01540617|Postural control|postural control
1310069|NCT01540617|Spine|spine
1310070|NCT01540617|Variability|variability
1310071|NCT01540617|MRI|mri
1310072|NCT01540617|Vibration|vibration
1310073|NCT01540617|Brain|brain
1310074|NCT01540604|DMD|dmd
1310075|NCT01540604|BMD|bmd
1310076|NCT01540604|symptomatic carriers|symptomatic carriers
1310077|NCT01540591|repeated implantation failure|repeated implantation failure
1310078|NCT01540591|intralipid|intralipid
1310079|NCT01540552|lung cancer|lung cancer
1310080|NCT01540552|precancerous condition|precancerous condition
1310081|NCT01540552|lung nodules|lung nodules
1310082|NCT01540552|CT Scan|ct scan
1310083|NCT01540500|Pharmacokinetics|pharmacokinetics
1310084|NCT01540500|Drug Interaction|drug interaction
1310085|NCT01540474|Interference of malaria infection|interference of malaria infection
1310086|NCT01540461|HCC|hcc
1310087|NCT01540435|Colorectal cancer|colorectal cancer
1310088|NCT01540435|Liver metastases|liver metastases
1310089|NCT01540435|Perioperative treatment|perioperative treatment
1310090|NCT01540435|Liver resection|liver resection
1310091|NCT01540422|vein grafts|vein grafts
1310092|NCT01540422|coronary bypass|coronary bypass
1310093|NCT01540422|endoscopic harvest|endoscopic harvest
1310094|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
1310095|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
1310096|NCT01540396|Gestational Diabetes|gestational diabetes
1310097|NCT01540383|Communication|communication
1310098|NCT01540383|Language|language
1310099|NCT01540383|Treatment|treatment
1310100|NCT01540383|Intervention|intervention
1310101|NCT01540383|Therapy|therapy
1310102|NCT01540383|Efficacy|efficacy
1310103|NCT01540383|Maintenance|maintenance
1310104|NCT01540383|Recovery|recovery
1310105|NCT01540383|Outcome|outcome
1310106|NCT01540383|Rehabilitation|rehabilitation
1310107|NCT01540383|Treatment Intensity|treatment intensity
1310108|NCT01540383|Language Impairment|language impairment
1310109|NCT01540383|Intensive Language Therapy|intensive language therapy
1310110|NCT01540383|Functional Communication|functional communication
1310111|NCT01540383|Functional Improvement|functional improvement
1310112|NCT01540383|Evidence-Based Intervention|evidence-based intervention
1310113|NCT01540383|High-Frequency|high-frequency
1310114|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
1310115|NCT01540357|chronic tinnitus;|chronic tinnitus;
1310116|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
1310117|NCT01540344|cytoreductive surgery|cytoreductive surgery
1310118|NCT01540344|HIPEC|hipec
1310119|NCT01540344|colorectal cancer|colorectal cancer
1310120|NCT01540318|ultrasonography|ultrasonography
1310121|NCT01540318|Abdominal Injuries|abdominal injuries
1310122|NCT01540318|Trauma|trauma
1310123|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
1310124|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1310125|NCT01540305|Treatment|treatment
1310126|NCT01540292|Crohn's disease|crohn's disease
1310127|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
1310128|NCT01540292|Cell therapy|cell therapy
1310129|NCT01540292|Allogeneic|allogeneic
1310130|NCT01540292|Inflammatory disorders|inflammatory disorders
1310131|NCT01540292|Autoimmune disorders|autoimmune disorders
1310132|NCT01540266|physician-patient communication|physician-patient communication
1310133|NCT01540266|information structuring|information structuring
1310134|NCT01540266|emergency department|emergency department
1310135|NCT01540240|HIV treatment|hiv treatment
1310136|NCT01540240|zidovudine|zidovudine
1310137|NCT01540240|dose reduction|dose reduction
1310138|NCT01540240|anaemia|anaemia
1310139|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
1310140|NCT01540227|Syphilis|syphilis
1310141|NCT01540227|Penicillin|penicillin
1310142|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
1310143|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
1310144|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
1310145|NCT01540214|Urodynamics|urodynamics
1310146|NCT01540201|one lung ventilation|one lung ventilation
1310148|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
1310149|NCT01540188|Drug user|drug user
1310150|NCT01540188|Family member|family member
1310151|NCT01540188|Intervention|intervention
1310152|NCT01540188|Community|community
1310153|NCT01540188|Support|support
1310154|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
1310155|NCT01540175|Immune reconstitution|immune reconstitution
1310156|NCT01540162|preterm newborn|preterm newborn
1310157|NCT01540162|neonatology|neonatology
1310158|NCT01540162|EcN|ecn
1310159|NCT01540162|Nissle|nissle
1310160|NCT01540162|Mutaflor|mutaflor
1310161|NCT01540162|prophylaxis|prophylaxis
1310162|NCT01540162|infection|infection
1310163|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
1310164|NCT01540084|Cocktail sedation|cocktail sedation
1310165|NCT01540084|ERCP|ercp
1310166|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
1310167|NCT01540071|HRPC|hrpc
1310168|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
1310169|NCT01540071|CRPC|crpc
1310170|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
1310171|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
1310172|NCT01540045|Dysgeusia|dysgeusia
1310173|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
1310174|NCT01540045|Paclitaxel|paclitaxel
1310175|NCT01540045|Cisplatin|cisplatin
1310176|NCT01540019|anorexia|anorexia
1613387|NCT00345228|High myopia|high myopia
1310177|NCT01540019|Paullinia cupana|paullinia cupana
1310178|NCT01540019|loss of weight|loss of weight
1310179|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
1310180|NCT01539993|Liver metastases|liver metastases
1310181|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
1310182|NCT01539993|Percutaneous treatments|percutaneous treatments
1310183|NCT01539993|RFA|rfa
1310184|NCT01539993|TACE|tace
1310185|NCT01539993|DEB|deb
1310186|NCT01539980|Sericin scaffold|sericin scaffold
1310187|NCT01539980|Wound healing|wound healing
1310188|NCT01539980|Skin graft donor|skin graft donor
1310189|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1310190|NCT01539967|Obesity follow-up|obesity follow-up
1310191|NCT01539954|Alcohol related disorders|alcohol related disorders
1310192|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
1310193|NCT01539928|Dual time PET/CT|dual time pet/ct
1310194|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
1310195|NCT01539915|Psoriasis|psoriasis
1310196|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
1310197|NCT01539915|lesions|lesions
1310198|NCT01539915|TNF-alpha|tnf-alpha
1310199|NCT01539915|BCT194|bct194
1310200|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
1310201|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
1310202|NCT01539850|obesity|obesity
1310203|NCT01539850|gastric stimulation|gastric stimulation
1310204|NCT01539850|morbid obesity|morbid obesity
1310205|NCT01539837|Parkinson's disease|parkinson's disease
1310206|NCT01539837|Brain Iron|brain iron
1310207|NCT01539837|Iron chelation|iron chelation
1310208|NCT01539837|Oxidative stress|oxidative stress
1310209|NCT01539811|Foot Infections|foot infections
1310210|NCT01539811|Diabetes|diabetes
1310211|NCT01539811|Antibiotic|antibiotic
1310212|NCT01539798|Saline solution|saline solution
1310213|NCT01539798|Sodium Chloride|sodium chloride
1310214|NCT01539798|Hypoalbuminemia|hypoalbuminemia
1310215|NCT01539798|Weight Gain|weight gain
1310216|NCT01539785|HIPEC|hipec
1310217|NCT01539785|Hyperthermic|hyperthermic
1310218|NCT01539785|ovarian cancer|ovarian cancer
1310219|NCT01539785|recurrence|recurrence
1310220|NCT01539759|Postpartum Contraception|postpartum contraception
1310221|NCT01539759|Intrauterine Devices|intrauterine devices
1310222|NCT01539746|Aortic stenosis|aortic stenosis
1310223|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
1310224|NCT01539746|TAVI|tavi
1310225|NCT01539746|Predilation|predilation
1310226|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
1310227|NCT01539746|BAV|bav
1310228|NCT01539746|CoreValve|corevalve
1310229|NCT01539720|emergency contraception|emergency contraception
1310230|NCT01539720|Ella|ella
1310231|NCT01539720|Mirena IUD|mirena iud
1310232|NCT01539720|post-coital contraception|post-coital contraception
1310233|NCT01539720|Liletta IUD|liletta iud
1310234|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
1310235|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
1310236|NCT01539707|Pharmacokinetics|pharmacokinetics
1310237|NCT01539707|Phase 1|phase 1
1310238|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
1310239|NCT01539681|Cancer, Liver|cancer, liver
1310240|NCT01539681|Sorafenib|sorafenib
1310241|NCT01539681|Nexavar|nexavar
1310242|NCT01539668|Cervical Cancer|cervical cancer
1310243|NCT01539668|HPV|hpv
1310244|NCT01539668|Secondary prevention|secondary prevention
1310245|NCT01539655|Phase 1|phase 1
1310246|NCT01539655|healthy volunteers|healthy volunteers
1310247|NCT01539655|pharmacokinetics|pharmacokinetics
1310248|NCT01539655|vandetanib|vandetanib
1310249|NCT01539655|omeprazole|omeprazole
1310250|NCT01539655|ranitidine|ranitidine
1310251|NCT01539642|In patient, post operative pain|in patient, post operative pain
1310348|NCT01539252|double dialyzer|double dialyzer
1310349|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
1310350|NCT01539239|Glaucoma|glaucoma
1310252|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
1310253|NCT01539629|Heart failure|heart failure
1310254|NCT01539629|Autothreshold|autothreshold
1310255|NCT01539629|Pacing|pacing
1310256|NCT01539629|CRT-D recipients|crt-d recipients
1310257|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
1310258|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
1310259|NCT01539616|Dyslipidemia|dyslipidemia
1310260|NCT01539603|drug eluting balloon|drug eluting balloon
1310261|NCT01539603|bare metal stent|bare metal stent
1310262|NCT01539603|drug eluting stent|drug eluting stent
1310263|NCT01539603|coronary artery disease|coronary artery disease
1310264|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
1310265|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
1310266|NCT01539590|Myocardial Infarction|myocardial infarction
1614536|NCT00341211|AIDS|aids
1415518|NCT01101646|Safety|safety
1310267|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
1310268|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1310269|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
1310270|NCT01539538|are expected to require parenteral|are expected to require parenteral
1310271|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
1310272|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
1310273|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
1310274|NCT01539512|CLL|cll
1310275|NCT01539512|CAL-101|cal-101
1310276|NCT01539512|GS 1101|gs 1101
1310277|NCT01539512|PI3K|pi3k
1310278|NCT01539512|GS-US-312-0117|gs-us-312-0117
1310279|NCT01539512|idelalisib|idelalisib
1310280|NCT01539460|Axillary osmidrosis|axillary osmidrosis
1310281|NCT01539460|liposuction|liposuction
1310282|NCT01539460|minimally invasive surgery|minimally invasive surgery
1310283|NCT01539447|Hip arthroscopy|hip arthroscopy
1310284|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
1310285|NCT01539447|Heterotopic ossification|heterotopic ossification
1310286|NCT01539447|Heterotopic bone formation|heterotopic bone formation
1310287|NCT01539434|COPD|copd
1310288|NCT01539434|Behavioral intervention|behavioral intervention
1310289|NCT01539434|Physical capacity|physical capacity
1310290|NCT01539434|Physical activity|physical activity
1310291|NCT01539421|COPD|copd
1310292|NCT01539421|exercise endurance|exercise endurance
1310293|NCT01539395|Relapsing Remitting|relapsing remitting
1310294|NCT01539395|MS|ms
1310295|NCT01539382|cardiac surgery|cardiac surgery
1310296|NCT01539382|neurocognitive assessment|neurocognitive assessment
1310297|NCT01539382|neurocognitive function|neurocognitive function
1310298|NCT01539369|dietary intervention|dietary intervention
1310299|NCT01539369|dietary fibre|dietary fibre
1310300|NCT01539369|weight loss|weight loss
1310301|NCT01539369|weight maintenance|weight maintenance
1310302|NCT01539356|Hepcidin|hepcidin
1310303|NCT01539356|Preterm Infants|preterm infants
1310304|NCT01539356|Anemia|anemia
1310305|NCT01539356|Sepsis|sepsis
1310306|NCT01539356|Ferritin|ferritin
1310307|NCT01539343|Infection|infection
1310308|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
1310309|NCT01539343|CRBSI|crbsi
1310310|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
1310311|NCT01539343|ALT|alt
1310312|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
1310313|NCT01539343|CLABSI|clabsi
1310314|NCT01539343|Central Venous Catheter|central venous catheter
1310315|NCT01539343|CVC|cvc
1310316|NCT01539343|Quantitative blood cultures|quantitative blood cultures
1310317|NCT01539343|QBC|qbc
1310318|NCT01539330|voriconazole|voriconazole
1310319|NCT01539330|microdialysis|microdialysis
1310320|NCT01539330|sequence therapy|sequence therapy
1310321|NCT01539330|pharmacokinetics|pharmacokinetics
1310322|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
1310323|NCT01539317|Vulvodynia|vulvodynia
1310324|NCT01539317|Dyspareunia|dyspareunia
1310325|NCT01539317|Breast Cancer|breast cancer
1310326|NCT01539317|Menopause|menopause
1310327|NCT01539317|Vaginal dryness|vaginal dryness
1310328|NCT01539317|Painful intercourse|painful intercourse
1310329|NCT01539291|CLL|cll
1310330|NCT01539291|CAL-101|cal-101
1310331|NCT01539291|CAL 101|cal 101
1310332|NCT01539291|GS-1101|gs-1101
1310333|NCT01539291|GS 1101|gs 1101
1310334|NCT01539291|PI3K|pi3k
1310335|NCT01539291|Leukemia|leukemia
1310336|NCT01539291|GS-US-312-0116|gs-us-312-0116
1310337|NCT01539291|idelalisib|idelalisib
1310549|NCT01538485|Vitamin D|vitamin d
1310338|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
1310339|NCT01539278|Child|child
1310340|NCT01539278|Tonsillectomy|tonsillectomy
1310341|NCT01539278|Adenoidectomy|adenoidectomy
1310342|NCT01539265|urinary calculus|urinary calculus
1310343|NCT01539265|ureteral stones|ureteral stones
1310344|NCT01539265|medical expulsive therapy|medical expulsive therapy
1310345|NCT01539252|hemodialysis|hemodialysis
1310346|NCT01539252|adequacy|adequacy
1310347|NCT01539252|phosphate clearance|phosphate clearance
1310352|NCT01539239|Cataract|cataract
1310353|NCT01539226|HIV Infections|hiv infections
1310354|NCT01539226|Anti-HIV agents|anti-hiv agents
1310355|NCT01539226|HIV-1|hiv-1
1310356|NCT01539213|Psoriasis|psoriasis
1310357|NCT01539213|interstitial fluid|interstitial fluid
1310358|NCT01539213|open flow microperfusion|open flow microperfusion
1310359|NCT01539213|IL-17|il-17
1310360|NCT01539213|inflammatory skin disease|inflammatory skin disease
1310361|NCT01539213|scaly patches|scaly patches
1310362|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
1310363|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
1310364|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
1310365|NCT01539187|VizAblate|vizablate
1310366|NCT01539161|Chagas Disease|chagas disease
1310367|NCT01539161|Chagasic|chagasic
1310368|NCT01539161|Reveal XT|reveal xt
1310369|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
1310370|NCT01539161|ICM|icm
1310371|NCT01539148|Quality of Life|quality of life
1310372|NCT01539148|Qol|qol
1310373|NCT01539148|Questionnaire|questionnaire
1310374|NCT01539148|Survey|survey
1310375|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
1310376|NCT01539148|IPTLD|iptld
1310377|NCT01539148|Nutritional Therapy|nutritional therapy
1310378|NCT01539148|Chemotherapy|chemotherapy
1310379|NCT01539148|Cancer Treatment|cancer treatment
1310380|NCT01539148|Kotsanis Institute|kotsanis institute
1310381|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
1310382|NCT01539148|Liberty IRB|liberty irb
1310383|NCT01539148|Texas|texas
1310384|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
1310385|NCT01539122|osteoarthritis|osteoarthritis
1310386|NCT01539122|shoulder replacement|shoulder replacement
1310387|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
1310388|NCT01539109|Quadriplegia|quadriplegia
1310389|NCT01539109|Tetraplegia|tetraplegia
1310390|NCT01539109|SCI|sci
1310391|NCT01539109|Spinal Cord Disease|spinal cord disease
1310392|NCT01539109|Spinal Cord Injury|spinal cord injury
1310393|NCT01539109|iSCI|isci
1310394|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1310395|NCT01539109|tDCS|tdcs
1310396|NCT01539109|SCI recovery|sci recovery
1310397|NCT01539109|brain stimulation|brain stimulation
1310398|NCT01539109|rehabilitation|rehabilitation
1310399|NCT01539096|Stroke|stroke
1310400|NCT01539096|Rehabilitation|rehabilitation
1310401|NCT01539096|Paresis|paresis
1310402|NCT01539096|Paralysis|paralysis
1310403|NCT01539096|Recovery|recovery
1310404|NCT01539096|tDCS|tdcs
1310405|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1310406|NCT01539096|CIMT|cimt
1310407|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
1310408|NCT01539096|Stroke therapy|stroke therapy
1310409|NCT01539096|MRI|mri
1310410|NCT01539096|Hand|hand
1310411|NCT01539096|CVA|cva
1310412|NCT01539096|Cerebrovascular accident|cerebrovascular accident
1310413|NCT01539083|Multiple Myeloma|multiple myeloma
1310414|NCT01539083|Bortezomib|bortezomib
1310415|NCT01539083|VELCADE|velcade
1310416|NCT01539083|Consolidation therapy|consolidation therapy
1310417|NCT01539083|Subcutaneous|subcutaneous
1310418|NCT01539083|Thalidomide|thalidomide
1310419|NCT01539083|Prednisolone|prednisolone
1310420|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
1310421|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
1310422|NCT01539070|Nutritional intervention|nutritional intervention
1310423|NCT01539070|Childhood obesity|childhood obesity
1310424|NCT01539070|Physical activity|physical activity
1310425|NCT01539070|Feeding practices|feeding practices
1310426|NCT01539057|Liver|liver
1310427|NCT01539057|Surgery|surgery
1310428|NCT01539057|hemostasis|hemostasis
1310429|NCT01539057|coagulation|coagulation
1310430|NCT01539057|Fibrinogen|fibrinogen
1310431|NCT01539044|reversal|reversal
1310432|NCT01539044|muscle relaxant|muscle relaxant
1310433|NCT01539044|sugammadex|sugammadex
1310434|NCT01539031|Alzheimer Disease|alzheimer disease
1310435|NCT01539031|Dementia|dementia
1310436|NCT01539031|Delirium|delirium
1310437|NCT01539031|Amnestic|amnestic
1310438|NCT01539031|Cognitive Disorders|cognitive disorders
1310439|NCT01539031|Donepezil|donepezil
1310440|NCT01539031|Brain Diseases|brain diseases
1310441|NCT01539031|Central Nervous System Diseases|central nervous system diseases
1310442|NCT01539031|Nervous System Diseases|nervous system diseases
1310443|NCT01539031|Tauopathies|tauopathies
1310444|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
1310445|NCT01539031|Mental Disorders|mental disorders
1310446|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
1310447|NCT01539031|Enzy|enzy
1310448|NCT01539005|Recurrence|recurrence
1310449|NCT01539005|Tuberculosis|tuberculosis
1310450|NCT01538992|renal denervation|renal denervation
1310451|NCT01538992|heart failure|heart failure
1310452|NCT01538979|Grass pollen allergy|grass pollen allergy
1310453|NCT01538979|Immunotherapy|immunotherapy
1310454|NCT01538979|Recombinant vaccine|recombinant vaccine
1310455|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
1310456|NCT01538966|acromegaly|acromegaly
1310457|NCT01538966|pituitary|pituitary
1310458|NCT01538966|pegvisomant|pegvisomant
1310459|NCT01538966|somavert|somavert
1310460|NCT01538966|lanreotide|lanreotide
1310461|NCT01538966|octreotide|octreotide
1310462|NCT01538953|diarrhea|diarrhea
1310463|NCT01538953|handwashing|handwashing
1310464|NCT01538953|point-of-use water treatment|point-of-use water treatment
1310465|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
1310466|NCT01538940|Influenza|influenza
1310467|NCT01538940|Vaccine|vaccine
1310468|NCT01538940|Thailand|thailand
1310469|NCT01538927|fibrin sealant|fibrin sealant
1310470|NCT01538927|tissue adhesive|tissue adhesive
1310471|NCT01538927|wound healing|wound healing
1310472|NCT01538927|interleukin 1 beta|interleukin 1 beta
1310473|NCT01538927|interleukin 8|interleukin 8
1310474|NCT01538901|actinic keratoses|actinic keratoses
1310475|NCT01538901|organ transplant recipients|organ transplant recipients
1310476|NCT01538901|photodynamic therapy|photodynamic therapy
1310477|NCT01538901|imiquimod|imiquimod
1310478|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
1310479|NCT01538888|AGED|aged
1310481|NCT01538888|muscle strength|muscle strength
1310482|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
1310483|NCT01538875|Hydralazine|hydralazine
1310484|NCT01538875|Labetalol|labetalol
1310485|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
1310486|NCT01538810|CT imaging|ct imaging
1310487|NCT01538797|YF476|yf476
1310488|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
1310489|NCT01538797|gastric pH|gastric ph
1310490|NCT01538797|healthy subjects|healthy subjects
1310491|NCT01538797|ranitidine|ranitidine
1310492|NCT01538784|YF476|yf476
1310493|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
1310494|NCT01538784|gastric pH|gastric ph
1310495|NCT01538784|healthy subjects|healthy subjects
1310496|NCT01538771|Myocardial infarction|myocardial infarction
1310497|NCT01538771|Erythropoietin|erythropoietin
1310498|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
1310499|NCT01538758|calcifying tendinitis|calcifying tendinitis
1310500|NCT01538758|rotator cuff|rotator cuff
1310501|NCT01538745|Pain|pain
1310502|NCT01538745|Emergency Department|emergency department
1310503|NCT01538745|Morphine|morphine
1310504|NCT01538745|Ketamine|ketamine
1310505|NCT01538706|Hospital-based home care|hospital-based home care
1310506|NCT01538706|Pediatric oncology|pediatric oncology
1310507|NCT01538693|BDNF|bdnf
1310508|NCT01538693|serotonin|serotonin
1310509|NCT01538693|high-intensity|high-intensity
1310510|NCT01538693|exercise|exercise
1310511|NCT01538667|Lung|lung
1310512|NCT01538667|Scintigraphy|scintigraphy
1310513|NCT01538667|Pharmacokinetics|pharmacokinetics
1310514|NCT01538667|Inhalation|inhalation
1310515|NCT01538667|Ciprofloxacin|ciprofloxacin
1310516|NCT01538654|obesity|obesity
1310517|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
1310518|NCT01538654|Enteral nutrition|enteral nutrition
1310519|NCT01538654|Tube feeding|tube feeding
1310520|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
1310521|NCT01538654|Pulmonary function tests|pulmonary function tests
1310522|NCT01538654|body composition|body composition
1310523|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
1310524|NCT01538654|Body fat|body fat
1310525|NCT01538654|Handgripstregth|handgripstregth
1310526|NCT01538628|Prostate cancer|prostate cancer
1310527|NCT01538628|Spacer|spacer
1310528|NCT01538615|Family meals|family meals
1310529|NCT01538615|Home food environment|home food environment
1310530|NCT01538615|Electronic media|electronic media
1310531|NCT01538602|PCOS|pcos
1310532|NCT01538602|cardiovascular disorders|cardiovascular disorders
1310533|NCT01538563|ON 01910.Na|on 01910.na
1310534|NCT01538563|rigosertib sodium|rigosertib sodium
1310535|NCT01538563|rogosertib|rogosertib
1310536|NCT01538550|cancer|cancer
1310537|NCT01538550|colon|colon
1310538|NCT01538550|rectum|rectum
1310539|NCT01538550|adenoma|adenoma
1310540|NCT01538550|screening|screening
1310541|NCT01538550|iFOBT|ifobt
1310542|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
1310543|NCT01538550|randomized trial|randomized trial
1310544|NCT01538537|ON 01910.Na|on 01910.na
1310545|NCT01538537|rigosertib Sodium|rigosertib sodium
1310546|NCT01538537|rigosertib|rigosertib
1310547|NCT01538498|PCI|pci
1310548|NCT01538498|Ovarian cancer|ovarian cancer
1310550|NCT01538485|regulatory T cells|regulatory t cells
1310551|NCT01538485|GUT|gut
1310552|NCT01538472|Lymphoma|lymphoma
1310553|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
1310554|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
1310555|NCT01538472|Y Zevalin|y zevalin
1310556|NCT01538472|In Zevalin|in zevalin
1310557|NCT01538472|Rituxan|rituxan
1310558|NCT01538472|Rituximab|rituximab
1310559|NCT01538472|BCNU|bcnu
1310560|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
1310561|NCT01538472|Carmustine|carmustine
1310562|NCT01538472|BiCNU|bicnu
1310563|NCT01538472|VP-16|vp-16
1310564|NCT01538472|Ara-C|ara-c
1310565|NCT01538472|Cytarabine|cytarabine
1310566|NCT01538472|Cytosar|cytosar
1310567|NCT01538472|DepoCyt|depocyt
1310568|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1310569|NCT01538472|Melphalan|melphalan
1310570|NCT01538472|Alkeran|alkeran
1310571|NCT01538472|G-CSF|g-csf
1310572|NCT01538472|Filgrastim|filgrastim
1310573|NCT01538472|Neupogen|neupogen
1310574|NCT01538472|Stem cell infusion|stem cell infusion
1310575|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
1310576|NCT01538459|Blood Glucose|blood glucose
1310577|NCT01538459|Bupivacaine|bupivacaine
1310578|NCT01538459|Interscalene Nerve Block|interscalene nerve block
1310579|NCT01538459|Regional Anesthesia|regional anesthesia
1310580|NCT01538459|Pain Blockade|pain blockade
1310581|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
1310582|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
1310583|NCT01538459|Dexamethasone|dexamethasone
1310584|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
1310585|NCT01538459|Therapeutic Uses|therapeutic uses
1310586|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
1310587|NCT01538459|Glucocorticoids|glucocorticoids
1310588|NCT01538459|Anesthetics, Local|anesthetics, local
1310589|NCT01538459|Anesthetics|anesthetics
1310590|NCT01538459|Sensory System Agents|sensory system agents
1310591|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
1310592|NCT01538459|Anesthesiology|anesthesiology
1310593|NCT01538459|Injections|injections
1310595|NCT01538459|Analgesia/methods|analgesia/methods
1310596|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
1310597|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
1310598|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
1310599|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
1310600|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
1310601|NCT01538459|Drug Therapy, Combination|drug therapy, combination
1310602|NCT01538459|Female|female
1310603|NCT01538459|Humans|humans
1310604|NCT01538459|Male|male
1310605|NCT01538459|Nerve Block/methods|nerve block/methods
1310606|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
1310607|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
1310608|NCT01538459|Prospective Studies|prospective studies
1310609|NCT01538459|Time Factors|time factors
1310610|NCT01538446|Elderly|elderly
1310611|NCT01538446|Acute coronary syndrome|acute coronary syndrome
1310612|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
1310613|NCT01538446|Prasugrel|prasugrel
1310614|NCT01538446|Platelet function test|platelet function test
1310615|NCT01538433|diagnosis|diagnosis
1310616|NCT01538433|IgA nephropathy|iga nephropathy
1310617|NCT01538420|Safety|safety
1310618|NCT01538420|Tolerability|tolerability
1310619|NCT01538420|Pharmacokinetics|pharmacokinetics
1310620|NCT01538420|Pharmacodynamics|pharmacodynamics
1310621|NCT01538407|Strength training|strength training
1310622|NCT01538407|Biomechanics|biomechanics
1310623|NCT01538407|Quadriceps|quadriceps
1310624|NCT01538407|Gait|gait
1310625|NCT01538394|smoking cessation|smoking cessation
1310626|NCT01538394|abstinence|abstinence
1310627|NCT01538394|clinical trial|clinical trial
1310628|NCT01538394|varenicline|varenicline
1310629|NCT01538394|nicotine|nicotine
1310630|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
1310631|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
1310632|NCT01538381|Afatinib|afatinib
1310633|NCT01538368|MRCP|mrcp
1310634|NCT01538368|ERCP|ercp
1310636|NCT01538368|Image interpretation|image interpretation
1310637|NCT01538368|MRCP findings|mrcp findings
1310638|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
1310639|NCT01538355|multiple sclerosis|multiple sclerosis
1310640|NCT01538355|diet|diet
1310641|NCT01538355|prolonged fasting|prolonged fasting
1310642|NCT01538355|caloric restriction|caloric restriction
1310643|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
1310644|NCT01538355|health related quality of life|health related quality of life
1310645|NCT01538355|ketogenic diet|ketogenic diet
1310646|NCT01538355|neurodegeneration|neurodegeneration
1310647|NCT01538355|neuroinflammation|neuroinflammation
1310648|NCT01538329|Dyskinesia|dyskinesia
1310649|NCT01538329|L-DOPA|l-dopa
1310650|NCT01538329|Early introduced treatment|early introduced treatment
1310652|NCT01538316|Prostate cancer|prostate cancer
1310653|NCT01538316|dietary supplements|dietary supplements
1310654|NCT01538316|quercetin|quercetin
1310655|NCT01538316|genistein|genistein
1310656|NCT01538316|prostate-specific antigen|prostate-specific antigen
1310657|NCT01538316|oxidative Status|oxidative status
1310658|NCT01538303|STEMI|stemi
1310659|NCT01538303|absolute flow|absolute flow
1310660|NCT01538303|microvascular resistance|microvascular resistance
1310661|NCT01538290|Calibration|calibration
1310662|NCT01538290|Validation|validation
1310663|NCT01538290|Transfer function|transfer function
1310664|NCT01538290|SphygmoCor|sphygmocor
1310665|NCT01538290|Arteriograph|arteriograph
1310666|NCT01538277|contact force catheter|contact force catheter
1310667|NCT01538277|loop recorder|loop recorder
1310668|NCT01538251|ulcerative colitis|ulcerative colitis
1310669|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
1310670|NCT01538225|Spasticity|spasticity
1310671|NCT01538212|Alzheimer's disease|alzheimer's disease
1310672|NCT01538212|retrospective|retrospective
1310674|NCT01538199|Device study|device study
1310675|NCT01538199|Depression|depression
1310676|NCT01538199|Major Depression|major depression
1310677|NCT01538199|Major Depressive Disorder|major depressive disorder
1310678|NCT01538199|MDD|mdd
1310679|NCT01538199|Device for depression|device for depression
1310680|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
1310681|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
1310682|NCT01538199|Boston|boston
1310683|NCT01538186|Coronary intervention|coronary intervention
1310684|NCT01538186|PCI of the side branch|pci of the side branch
1310685|NCT01538173|surgical side infection|surgical side infection
1310686|NCT01538173|breast reduction|breast reduction
1310687|NCT01538173|reduction mammaplasty|reduction mammaplasty
1310688|NCT01538173|prospective trial|prospective trial
1310689|NCT01538173|microcirculation|microcirculation
1310690|NCT01538173|breast surgery|breast surgery
1310691|NCT01538160|recombinant factor VIIa|recombinant factor viia
1310692|NCT01538160|factor XI deficiency|factor xi deficiency
1310693|NCT01538147|Restless Leg Syndrome|restless leg syndrome
1310694|NCT01538147|Severe Preeclampsia|severe preeclampsia
1310695|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
1310696|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
1310697|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
1310698|NCT01538134|Fetal Growth Restriction|fetal growth restriction
1310699|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
1310700|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
1310701|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
1310702|NCT01538121|Severe Preeclampsia|severe preeclampsia
1310703|NCT01538082|Anxiety disorders|anxiety disorders
1310704|NCT01538082|Depressive disorders|depressive disorders
1310705|NCT01538082|Metabolic syndrome|metabolic syndrome
1310706|NCT01538082|Stress disorders|stress disorders
1310707|NCT01538082|Primary care|primary care
1310708|NCT01538069|Heart failure|heart failure
1310709|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
1310710|NCT01538069|Exercise|exercise
1310711|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
1310712|NCT01538056|AAA|aaa
1310713|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
1310714|NCT01538043|Cost-utility analysis|cost-utility analysis
1310715|NCT01538043|Osteoarthritis|osteoarthritis
1310716|NCT01538043|Spa therapy|spa therapy
1310717|NCT01538043|Randomized clinical trial|randomized clinical trial
1310718|NCT01538043|Mechanisms of action|mechanisms of action
1310719|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
1310720|NCT01538030|Cesarean section|cesarean section
1310721|NCT01538030|Perinatal mortality|perinatal mortality
1310722|NCT01538030|Neonatal sepsis|neonatal sepsis
1310723|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
1310724|NCT01538004|Blood pressure determination|blood pressure determination
1310725|NCT01538004|Primary health care|primary health care
1310726|NCT01538004|Office visits|office visits
1310727|NCT01538004|Reproducibility of results|reproducibility of results
1310728|NCT01537991|radiotherapy|radiotherapy
1310729|NCT01537991|non small cell lung cancer|non small cell lung cancer
1310730|NCT01537991|isotoxic|isotoxic
1310731|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
1310732|NCT01537965|hepatitis|hepatitis
1310733|NCT01537965|fibrosis|fibrosis
1310734|NCT01537965|elastography|elastography
1310735|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
1310736|NCT01537939|Physical Activity|physical activity
1310737|NCT01537939|Walking|walking
1310738|NCT01537939|Pedometer|pedometer
1310739|NCT01537939|Body Composition|body composition
1310740|NCT01537939|Aerobic Fitness|aerobic fitness
1310741|NCT01537926|HALT|halt
1310742|NCT01537926|HCM|hcm
1310743|NCT01537874|Secondhand smoke|secondhand smoke
1310744|NCT01537874|Pediatric disease|pediatric disease
1310745|NCT01537848|EUS|eus
1310746|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
1310747|NCT01537848|abdominal collection|abdominal collection
1310748|NCT01537848|post-operative|post-operative
1310749|NCT01537848|post-surgical|post-surgical
1310750|NCT01537835|healthcare|healthcare
1310751|NCT01537835|worker|worker
1310752|NCT01537835|uniforms|uniforms
1310753|NCT01537835|bacterial|bacterial
1310754|NCT01537835|contamination|contamination
1310755|NCT01537822|intrauterine polyps|intrauterine polyps
1310756|NCT01537822|myomas|myomas
1310757|NCT01537822|residual placental tissue|residual placental tissue
1310758|NCT01537809|Vitamin D|vitamin d
1310759|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
1310760|NCT01537809|Avitaminosis|avitaminosis
1310761|NCT01537809|Deficiency Diseases|deficiency diseases
1310762|NCT01537809|Blood lipids|blood lipids
1310763|NCT01537796|Obesity|obesity
1310764|NCT01537796|Exercise|exercise
1310765|NCT01537783|abscess|abscess
1310766|NCT01537770|Vertebroplasty|vertebroplasty
1310767|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
1310768|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
1310769|NCT01537744|expansion cohort|expansion cohort
1310770|NCT01537705|Medical food|medical food
1310771|NCT01537705|Neuropathy|neuropathy
1310772|NCT01537705|Diabetes|diabetes
1310773|NCT01537705|Neuropathic Pain|neuropathic pain
1310774|NCT01537679|Caregiver|caregiver
1310775|NCT01537679|meditation|meditation
1310776|NCT01537679|relaxation|relaxation
1310777|NCT01537679|stress|stress
1310778|NCT01537627|Motor activity|motor activity
1310779|NCT01537627|Exercise|exercise
1310780|NCT01537627|Rehabilitation|rehabilitation
1310781|NCT01537601|Posterior urethral valves|posterior urethral valves
1310782|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
1310783|NCT01537601|Circumcision|circumcision
1310784|NCT01537601|Antibioprophylaxis|antibioprophylaxis
1310785|NCT01537601|Impact on family|impact on family
1310786|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
1310787|NCT01537588|hamstring|hamstring
1310788|NCT01537588|semitendinosus|semitendinosus
1310789|NCT01537588|gracilis|gracilis
1310790|NCT01537588|graft|graft
1310791|NCT01537562|Copper IUD|copper iud
1310792|NCT01537562|LNG-IUS|lng-ius
1310793|NCT01537562|intrauterine contraception|intrauterine contraception
1310794|NCT01537562|medical abortion|medical abortion
1310795|NCT01537562|postabortion contraception|postabortion contraception
1310796|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
1310797|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
1310798|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
1310799|NCT01537549|antioxidant|antioxidant
1310800|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1310801|NCT01537549|neurodegeneration|neurodegeneration
1310802|NCT01537549|glutathione|glutathione
1310803|NCT01537536|Breast cancer|breast cancer
1310804|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1310805|NCT01537536|EndoTAG-1|endotag-1
1310806|NCT01537523|physical|physical
1310807|NCT01537523|psychological|psychological
1310808|NCT01537523|fracture hip|fracture hip
1310809|NCT01537497|Phase 1|phase 1
1310810|NCT01537497|Single Doses|single doses
1310811|NCT01537497|Pharmacodynamics|pharmacodynamics
1310812|NCT01537497|Healthy Volunteers|healthy volunteers
1310813|NCT01537484|massage|massage
1310814|NCT01537484|osteoarthritis|osteoarthritis
1310815|NCT01537484|light touch|light touch
1310816|NCT01537484|Swedish|swedish
1310817|NCT01537471|PPI|ppi
1310818|NCT01537471|Meclizine|meclizine
1310819|NCT01537471|Startle|startle
1310820|NCT01537471|Sensory processing|sensory processing
1310821|NCT01537471|antihistamines|antihistamines
1310822|NCT01537445|Diabetes Mellitus|diabetes mellitus
1310823|NCT01537445|Pancreas|pancreas
1310824|NCT01537445|Renal failure|renal failure
1310825|NCT01537445|Transplantation|transplantation
1310826|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
1310827|NCT01537432|Plaque|plaque
1310828|NCT01537432|Secukinumab|secukinumab
1310829|NCT01537432|AIN457A|ain457a
1310830|NCT01537432|PASI|pasi
1310831|NCT01537432|DLQI|dlqi
1310833|NCT01537419|Suicide|suicide
1310834|NCT01537419|Depression|depression
1310835|NCT01537419|Family Relationships|family relationships
1310836|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
1310837|NCT01537393|cornea|cornea
1310838|NCT01537393|transplant|transplant
1310839|NCT01537393|preservation|preservation
1310840|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
1310841|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
1310842|NCT01537367|HIV primary care|hiv primary care
1310843|NCT01537328|Total knee arthroplasty|total knee arthroplasty
1310844|NCT01537328|quadriceps|quadriceps
1310845|NCT01537328|muscle|muscle
1310846|NCT01537328|arthroplasty|arthroplasty
1310847|NCT01537328|joint diseases|joint diseases
1310848|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
1310849|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
1310850|NCT01537315|Cardiovascular Disease|cardiovascular disease
1310851|NCT01537315|Arteriosclerosis|arteriosclerosis
1310852|NCT01537302|Chronic Total Occlusion|chronic total occlusion
1310949|NCT01536769|Microbiota|microbiota
1310853|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
1310854|NCT01537302|Lumivascular|lumivascular
1310855|NCT01537289|Trauma|trauma
1310856|NCT01537289|Pneumothorax|pneumothorax
1310857|NCT01537276|hysterosalpingography|hysterosalpingography
1310858|NCT01537276|Fluoroscopy|fluoroscopy
1310859|NCT01537276|diagnostic accuracy|diagnostic accuracy
1310860|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
1310861|NCT01537263|SAB|sab
1310862|NCT01537263|SAH|sah
1310863|NCT01537263|Ultrasound|ultrasound
1310864|NCT01537263|Perfusion imaging|perfusion imaging
1310865|NCT01537250|CAP|cap
1310866|NCT01537237|Atrial Fibrillation|atrial fibrillation
1310867|NCT01537237|Catheter-based ablation|catheter-based ablation
1310868|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
1310869|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
1310870|NCT01537237|Rotational angiography|rotational angiography
1310871|NCT01537224|Electrophysiology|electrophysiology
1310872|NCT01537224|Subthalamic nucleus|subthalamic nucleus
1310873|NCT01537224|Parkinson|parkinson
1310874|NCT01537211|Dysvascular|dysvascular
1310875|NCT01537211|amputation|amputation
1310876|NCT01537211|above knee|above knee
1310877|NCT01537211|ambulation|ambulation
1310878|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
1310879|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
1310880|NCT01537172|3 part adaptive design|3 part adaptive design
1310881|NCT01537159|AML|aml
1310882|NCT01537146|unicompartmental|unicompartmental
1310883|NCT01537146|osteoarthritis|osteoarthritis
1310884|NCT01537146|varus|varus
1310885|NCT01537146|malalignment|malalignment
1310886|NCT01537146|opening wedge|opening wedge
1310887|NCT01537146|HTO|hto
1310888|NCT01537146|high|high
1310889|NCT01537146|tibia|tibia
1310890|NCT01537146|osteotomy|osteotomy
1310891|NCT01537094|low vitamin c|low vitamin c
1310892|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
1310893|NCT01537068|Dysthymic disorder|dysthymic disorder
1310894|NCT01537068|Dysthymia|dysthymia
1310895|NCT01537068|Chronic non-major depression|chronic non-major depression
1310896|NCT01537068|Non-major chronic depression|non-major chronic depression
1310897|NCT01537068|Chronic depressive disorder|chronic depressive disorder
1310898|NCT01537068|Antidepressant treatment|antidepressant treatment
1310899|NCT01537055|H pylori eradication|h pylori eradication
1310900|NCT01537042|Rotigotine|rotigotine
1310901|NCT01537042|Neupro|neupro
1310902|NCT01537042|Restless Legs Syndrome|restless legs syndrome
1310903|NCT01537042|RLS|rls
1310904|NCT01537042|End-Stage Renal Disease|end-stage renal disease
1310905|NCT01537029|Breast cancer|breast cancer
1310906|NCT01537029|Pharmacokinetics|pharmacokinetics
1310907|NCT01537029|Obesity|obesity
1310908|NCT01537029|Doxorubicin|doxorubicin
1310909|NCT01537029|Cyclophosphamide|cyclophosphamide
1310910|NCT01537029|Weight|weight
1310911|NCT01536977|quality of life|quality of life
1310912|NCT01536925|Behavioral Economics|behavioral economics
1310913|NCT01536925|Drug self administration|drug self administration
1310914|NCT01536925|Opioid|opioid
1310915|NCT01536912|HIV positive|hiv positive
1310916|NCT01536899|HIV positive|hiv positive
1310917|NCT01536899|Medical Marijuana|medical marijuana
1310918|NCT01536873|treatment experienced patients|treatment experienced patients
1310919|NCT01536873|Integrase resistance|integrase resistance
1310920|NCT01536834|Verruca|verruca
1310921|NCT01536834|Plantar Wart|plantar wart
1310922|NCT01536834|Medical Device|medical device
1310923|NCT01536834|Podiatry|podiatry
1310924|NCT01536834|Footcare|footcare
1310925|NCT01536821|Parkinson disease|parkinson disease
1310926|NCT01536821|Parkinson's Disease|parkinson's disease
1310927|NCT01536821|PD|pd
1310928|NCT01536821|LRRK2|lrrk2
1310929|NCT01536821|genetics|genetics
1310930|NCT01536821|genes|genes
1310931|NCT01536808|Diabetes mellitus|diabetes mellitus
1310932|NCT01536808|accelerated aging|accelerated aging
1310933|NCT01536808|cellular senescence|cellular senescence
1310934|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
1310935|NCT01536808|strain imaging|strain imaging
1310936|NCT01536808|strain rate imaging,|strain rate imaging,
1310937|NCT01536808|echocardiography|echocardiography
1310938|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
1310939|NCT01536782|head and neck cancer|head and neck cancer
1310940|NCT01536782|chemoradiation therapy|chemoradiation therapy
1310941|NCT01536782|bolus feeding|bolus feeding
1310942|NCT01536782|gravity feeding|gravity feeding
1310943|NCT01536782|pump feeding|pump feeding
1310944|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
1310945|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
1310946|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
1310947|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
1310948|NCT01536769|Metagenomic analysis|metagenomic analysis
1310950|NCT01536756|Depressive disorder|depressive disorder
1310951|NCT01536756|exercise|exercise
1310952|NCT01536756|pain|pain
1310953|NCT01536756|physical|physical
1310954|NCT01536756|psychological|psychological
1310955|NCT01536756|Chinese|chinese
1310956|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
1310957|NCT01536717|atrial septal defect|atrial septal defect
1310958|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
1310959|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
1310960|NCT01536717|open heart surgery|open heart surgery
1310961|NCT01536717|oxycodone consumption|oxycodone consumption
1310962|NCT01536717|articain|articain
1310963|NCT01536717|bupivacaine|bupivacaine
1310964|NCT01536717|pain after sternotomy|pain after sternotomy
1310965|NCT01536717|postoperative pain|postoperative pain
1310966|NCT01536717|wound infusion|wound infusion
1614537|NCT00341211|Cancer|cancer
1310967|NCT01536704|nicotine lozenge|nicotine lozenge
1310968|NCT01536704|nicotine|nicotine
1310969|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
1310970|NCT01536691|ramosetron|ramosetron
1310971|NCT01536691|ondansetron|ondansetron
1310972|NCT01536691|aprepitant|aprepitant
1310973|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
1310974|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
1310975|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
1310976|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
1310977|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
1310978|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
1310979|NCT01536561|Bexxar|bexxar
1310980|NCT01536548|hemodialysis|hemodialysis
1310981|NCT01536548|cannulation|cannulation
1310982|NCT01536548|AV-fistula|av-fistula
1310983|NCT01536548|buttonhole technique|buttonhole technique
1310984|NCT01536535|Ulcerative Colitis|ulcerative colitis
1310985|NCT01536535|mesalamine|mesalamine
1310986|NCT01536535|corticosteroids|corticosteroids
1310987|NCT01536535|PROTECT|protect
1310988|NCT01536522|Asthma|asthma
1310989|NCT01536522|Allergic Asthma|allergic asthma
1310990|NCT01536522|Non-allergic Asthma|non-allergic asthma
1310991|NCT01536496|trauma|trauma
1310992|NCT01536496|hemorrhagic shock|hemorrhagic shock
1310993|NCT01536496|thrombelastography|thrombelastography
1310994|NCT01536496|coagulopathy|coagulopathy
1310995|NCT01536496|transfusion|transfusion
1310996|NCT01536496|resuscitation|resuscitation
1310997|NCT01536483|Butyrate|butyrate
1310998|NCT01536483|Preterms|preterms
1310999|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
1311000|NCT01536483|Rectocolonic enemas|rectocolonic enemas
1311001|NCT01536483|Digestive maturation|digestive maturation
1311002|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
1311003|NCT01536483|ECUN|ecun
1311004|NCT01536483|Whole gut transit time|whole gut transit time
1311005|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
1311006|NCT01536470|Arterial pressure|arterial pressure
1311007|NCT01536470|Postoperative complications|postoperative complications
1311008|NCT01536470|Intraoperative fluids|intraoperative fluids
1311009|NCT01536470|Noradrenaline|noradrenaline
1311010|NCT01536457|asthma|asthma
1311011|NCT01536457|children|children
1311012|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
1311013|NCT01536457|retrospective|retrospective
1311014|NCT01536457|data analysis|data analysis
1311015|NCT01536444|Mohs surgery|mohs surgery
1311016|NCT01536444|Excisional skin surgery|excisional skin surgery
1311017|NCT01536444|Micrografting|micrografting
1311018|NCT01536431|Diabetes|diabetes
1311019|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
1311020|NCT01536418|active treatment|active treatment
1311021|NCT01536392|Cancer of the Cervix|cancer of the cervix
1311022|NCT01536392|Anti-emetic therapy|anti-emetic therapy
1311023|NCT01536392|Granisetron|granisetron
1311024|NCT01536392|Transdermal patch|transdermal patch
1311025|NCT01536392|Ondansetron|ondansetron
1311026|NCT01536392|Zofran|zofran
1311027|NCT01536392|Questionnaires|questionnaires
1311028|NCT01536392|Surveys|surveys
1311029|NCT01536392|Study Drug Diary|study drug diary
1311030|NCT01536379|Infection|infection
1311031|NCT01536379|Quality of Life|quality of life
1311032|NCT01536366|Parkinson Disease|parkinson disease
1311033|NCT01536366|BIA 9-1067|bia 9-1067
1311034|NCT01536340|post discharge adverse events|post discharge adverse events
1311035|NCT01536340|discontinuities in care|discontinuities in care
1311036|NCT01536340|medical injury|medical injury
1311037|NCT01536327|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1311038|NCT01536327|Demyelinating Diseases|demyelinating diseases
1311039|NCT01536314|Pre-emptive administration|pre-emptive administration
1311040|NCT01536314|Post-operative administration|post-operative administration
1311041|NCT01536314|Prophylaxis|prophylaxis
1311042|NCT01536314|Memantine|memantine
1311539|NCT01534247|Phase I|phase i
1311043|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
1311044|NCT01536314|Neuropathic pain|neuropathic pain
1311045|NCT01536301|oxycodone|oxycodone
1311046|NCT01536301|morphine|morphine
1311047|NCT01536301|hip replacement|hip replacement
1311048|NCT01536301|analgesia|analgesia
1311049|NCT01536301|post operative analgesia|post operative analgesia
1311050|NCT01536288|acute mountain sickness|acute mountain sickness
1311051|NCT01536288|AMS|ams
1311052|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
1311053|NCT01536288|mountaineering|mountaineering
1311054|NCT01536288|pulse oximetry|pulse oximetry
1311055|NCT01536288|oxygen saturation|oxygen saturation
1311056|NCT01536275|critical illness|critical illness
1311057|NCT01536275|children|children
1311058|NCT01536275|nutrition|nutrition
1311059|NCT01536275|metabolism|metabolism
1311060|NCT01536236|Diabetes|diabetes
1311061|NCT01536236|Polyneuropathy|polyneuropathy
1311062|NCT01536236|Spinal cord stimulation|spinal cord stimulation
1311063|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
1311064|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
1311315|NCT01535131|cleft palate|cleft palate
1311065|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
1311066|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1311067|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
1311068|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
1311069|NCT01536197|obesity|obesity
1311070|NCT01536197|gastric bypass|gastric bypass
1311071|NCT01536197|gastric banding|gastric banding
1311072|NCT01536197|sleeve gastrectomy|sleeve gastrectomy
1311073|NCT01536197|weight loss|weight loss
1311074|NCT01536197|taste perception|taste perception
1311075|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
1311076|NCT01536184|FASD|fasd
1311077|NCT01536171|runners|runners
1311078|NCT01536171|mid-foot strike|mid-foot strike
1311079|NCT01536171|fore foot strike|fore foot strike
1311080|NCT01536171|metabolic costs|metabolic costs
1311081|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
1311082|NCT01536171|shod running|shod running
1311083|NCT01536171|barefoot running|barefoot running
1311084|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
1311085|NCT01536158|Paracetamol|paracetamol
1311086|NCT01536158|Ibuprofen|ibuprofen
1311087|NCT01536158|Preterm infant|preterm infant
1311088|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
1311089|NCT01536145|CP-751871|cp-751871
1311090|NCT01536145|multiple myeloma|multiple myeloma
1311091|NCT01536132|Levosimendan|levosimendan
1311092|NCT01536132|chronic heart failure|chronic heart failure
1311093|NCT01536132|inotropic drug|inotropic drug
1311094|NCT01536119|Breastfeeding|breastfeeding
1311095|NCT01536119|Coparenting|coparenting
1311096|NCT01536119|Infant feeding|infant feeding
1311097|NCT01536119|Fathers' support|fathers' support
1311098|NCT01536119|Breastfeeding support|breastfeeding support
1311099|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
1311100|NCT01536119|clinical trial|clinical trial
1311101|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
1311102|NCT01536041|asthma|asthma
1311103|NCT01536041|Adult|adult
1311104|NCT01536015|Rotigotine|rotigotine
1311105|NCT01536015|Neupro®|neupro®
1311106|NCT01536015|Levodopa|levodopa
1311107|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
1311108|NCT01536002|Bariatric surgery|bariatric surgery
1311109|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
1311110|NCT01536002|Propofol|propofol
1311111|NCT01536002|Pharmacokinetics|pharmacokinetics
1311112|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
1311113|NCT01535989|CD22 positive|cd22 positive
1311114|NCT01535950|Age-related macular degeneration|age-related macular degeneration
1311115|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
1311116|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1311117|NCT01535950|wet AMD|wet amd
1311118|NCT01535950|Age-related|age-related
1311119|NCT01535950|Macular degeneration|macular degeneration
1311120|NCT01535950|Intravitreal|intravitreal
1311121|NCT01535950|Neovascular|neovascular
1311122|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
1311123|NCT01535924|relapsed|relapsed
1311124|NCT01535924|refractory|refractory
1311125|NCT01535911|ketogenic diet|ketogenic diet
1311126|NCT01535911|brain tumors|brain tumors
1311127|NCT01535898|MRI|mri
1311128|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
1311129|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
1311130|NCT01535898|Questionnaire|questionnaire
1311131|NCT01535898|12-033|12-033
1311132|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
1311133|NCT01535885|T-cell Depleted|t-cell depleted
1311134|NCT01535885|Allogeneic Transplant|allogeneic transplant
1311135|NCT01535885|Epstein Barr Virus|epstein barr virus
1311136|NCT01535885|Adenovirus|adenovirus
1311137|NCT01535885|Cytomegalovirus|cytomegalovirus
1311239|NCT01535469|retention-in-care|retention-in-care
1311240|NCT01535456|MDS|mds
1311138|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
1311139|NCT01535846|taste|taste
1311140|NCT01535846|mindful eating|mindful eating
1311141|NCT01535846|intuitive eating|intuitive eating
1311142|NCT01535846|attitude|attitude
1311143|NCT01535846|behavior|behavior
1311144|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
1311145|NCT01535833|Learning curve|learning curve
1311146|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
1311147|NCT01535833|Robotic Surgery|robotic surgery
1311148|NCT01535820|Healthy volunteers|healthy volunteers
1311149|NCT01535820|ORTHO EVRA|ortho evra
1311150|NCT01535820|Contraceptive hormones|contraceptive hormones
1311151|NCT01535820|Transdermal patch|transdermal patch
1311152|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
1311153|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
1311154|NCT01535820|JNJ-93964|jnj-93964
1311155|NCT01535820|JNJ-622206|jnj-622206
1311156|NCT01535807|Atrial Fibrillation|atrial fibrillation
1311157|NCT01535807|Cardiac surgery|cardiac surgery
1311158|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
1311159|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
1311160|NCT01535807|Heart surgery|heart surgery
1311161|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
1311162|NCT01535807|Myocardial Infarction|myocardial infarction
1311163|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
1311164|NCT01535794|HPV vaccine|hpv vaccine
1311165|NCT01535794|acceptability|acceptability
1311166|NCT01535794|males|males
1311167|NCT01535794|men who have sex with men|men who have sex with men
1311168|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
1311169|NCT01535781|tranexamic acid|tranexamic acid
1311170|NCT01535781|postoperative blood loss|postoperative blood loss
1311171|NCT01535781|blood loss|blood loss
1311172|NCT01535781|hidden blood loss|hidden blood loss
1311173|NCT01535781|blood transfusions|blood transfusions
1311174|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
1311175|NCT01535755|ventilator weaning|ventilator weaning
1311176|NCT01535742|laryngeal mask airway|laryngeal mask airway
1311177|NCT01535742|children|children
1311178|NCT01535742|tracheal intubation|tracheal intubation
1311179|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
1311180|NCT01535690|Laser|laser
1311181|NCT01535690|Clinical trial|clinical trial
1311182|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
1311183|NCT01535690|Periodontitis|periodontitis
1311184|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
1311185|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
1311186|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
1311187|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
1311188|NCT01535677|Phase 1|phase 1
1311189|NCT01535677|healthy volunteers|healthy volunteers
1311190|NCT01535677|cross-over study|cross-over study
1311191|NCT01535677|Bioavailability|bioavailability
1311192|NCT01535677|Bioequivalence|bioequivalence
1311193|NCT01535677|Cmax|cmax
1311194|NCT01535677|tmax|tmax
1311195|NCT01535677|AUC|auc
1311196|NCT01535677|AUC(0-t)|auc(0-t)
1311197|NCT01535677|λz|λz
1311198|NCT01535677|tlast|tlast
1311199|NCT01535664|Multiple Sclerosis|multiple sclerosis
1311200|NCT01535664|MS|ms
1311201|NCT01535625|Coronary artery disease|coronary artery disease
1311202|NCT01535625|Atherosclerosis|atherosclerosis
1311203|NCT01535625|CAD|cad
1311204|NCT01535599|Acute Otitis Externa|acute otitis externa
1311205|NCT01535586|CPAP|cpap
1311206|NCT01535586|MAD|mad
1311207|NCT01535586|sleep apnea|sleep apnea
1311208|NCT01535586|PTSD|ptsd
1311209|NCT01535573|Cocaine|cocaine
1311210|NCT01535573|citalopram|citalopram
1311211|NCT01535573|treatment|treatment
1311212|NCT01535573|serotonin|serotonin
1311213|NCT01535560|Acute otitis externa|acute otitis externa
1311214|NCT01535547|isavuconazole|isavuconazole
1311215|NCT01535547|tacrolimus|tacrolimus
1311216|NCT01535547|Healthy Volunteers|healthy volunteers
1311217|NCT01535547|BAL8557|bal8557
1311218|NCT01535534|sepsis|sepsis
1311219|NCT01535534|inflammation|inflammation
1311220|NCT01535534|diagnosis|diagnosis
1311221|NCT01535534|prognosis|prognosis
1311222|NCT01535534|survival|survival
1311223|NCT01535534|mortality|mortality
1311224|NCT01535495|beta-antagonist|beta-antagonist
1311225|NCT01535495|propranolol|propranolol
1311226|NCT01535495|diabetic retinopathy|diabetic retinopathy
1311227|NCT01535495|diabetes|diabetes
1311228|NCT01535495|angiogenesis|angiogenesis
1311229|NCT01535495|neovascularization|neovascularization
1311230|NCT01535482|Cognitive therapy|cognitive therapy
1311231|NCT01535482|Suicide|suicide
1311232|NCT01535482|Older men|older men
1311233|NCT01535482|suicide ideation|suicide ideation
1311234|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
1311235|NCT01535469|hiv|hiv
1311236|NCT01535469|aids|aids
1311237|NCT01535469|implementation science|implementation science
1311238|NCT01535469|stepped wedge design|stepped wedge design
1311241|NCT01535456|AML|aml
1311242|NCT01535456|5 azacitidine|5 azacitidine
1311243|NCT01535456|FLT PET|flt pet
1311244|NCT01535443|PRO-155|pro-155
1311245|NCT01535443|Ocular NSAIDs|ocular nsaids
1311246|NCT01535443|Safety and tolerability|safety and tolerability
1311247|NCT01535443|Ocular Inflammation|ocular inflammation
1311248|NCT01535443|Ocular Paint|ocular paint
1311249|NCT01535430|brain mapping|brain mapping
1311250|NCT01535430|brain tumor|brain tumor
1311251|NCT01535417|Osteoarthritis|osteoarthritis
1311252|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
1311253|NCT01535391|Nilotinib,|nilotinib,
1311254|NCT01535391|Philadelphia positive,|philadelphia positive,
1311255|NCT01535391|BCR-ABL+|bcr-abl+
1311256|NCT01535391|Early chronic phase|early chronic phase
1311257|NCT01535365|muscular sprain|muscular sprain
1311258|NCT01535365|acute back pain|acute back pain
1311259|NCT01535365|acute neck pain|acute neck pain
1311260|NCT01535365|heat treatment|heat treatment
1311261|NCT01535365|cold treatment|cold treatment
1311262|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
1311264|NCT01535339|Concussion|concussion
1311265|NCT01535326|colonoscopy|colonoscopy
1311266|NCT01535300|Ultrasound|ultrasound
1311267|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
1311268|NCT01535300|Endotracheal tube size|endotracheal tube size
1311269|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
1311270|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
1311271|NCT01535287|Dexmedetomidine|dexmedetomidine
1311272|NCT01535287|Emergence Agitation|emergence agitation
1311273|NCT01535287|Myringotomy|myringotomy
1311274|NCT01535287|Children|children
1311275|NCT01535287|General Anesthesia|general anesthesia
1311276|NCT01535274|Cerebral oxygenation|cerebral oxygenation
1311277|NCT01535274|Beach chair position|beach chair position
1311278|NCT01535274|General anesthetic technique|general anesthetic technique
1311279|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
1311280|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
1311281|NCT01535261|Ophthalmology|ophthalmology
1311282|NCT01535261|Ranibizumab|ranibizumab
1311283|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
1311284|NCT01535248|ERCP|ercp
1311285|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
1311286|NCT01535248|Air Embolus|air embolus
1311287|NCT01535248|ERCP associated air embolus|ercp associated air embolus
1311288|NCT01535235|HIV|hiv
1311289|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
1311290|NCT01535222|cardiac surgery|cardiac surgery
1311291|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
1311292|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
1311293|NCT01535222|haemostasis modulator|haemostasis modulator
1311294|NCT01535222|blood loss|blood loss
1311295|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
1311296|NCT01535222|CABG|cabg
1311297|NCT01535222|CPB|cpb
1311298|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
1311299|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
1311300|NCT01535209|Resection cavity|resection cavity
1311301|NCT01535196|vitamin D|vitamin d
1311302|NCT01535196|heart failure|heart failure
1311303|NCT01535183|irinotecan|irinotecan
1311304|NCT01535183|brain tumor|brain tumor
1311305|NCT01535183|pediatrics|pediatrics
1311306|NCT01535183|salvage therapy|salvage therapy
1311307|NCT01535183|chemotherapy|chemotherapy
1311308|NCT01535170|lactoferrin|lactoferrin
1311309|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
1311310|NCT01535170|antimicrobial activity|antimicrobial activity
1311311|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
1311312|NCT01535170|respiratory care center|respiratory care center
1311313|NCT01535157|Chemotherapy|chemotherapy
1311314|NCT01535131|otitis media|otitis media
1311316|NCT01535118|Allergies|allergies
1311317|NCT01535118|Immunotherapy|immunotherapy
1311318|NCT01535092|HCV recurrence|hcv recurrence
1311319|NCT01535092|HCV reinfection|hcv reinfection
1311320|NCT01535092|Liver transplantation|liver transplantation
1311321|NCT01535092|Legalon SIL|legalon sil
1311322|NCT01535092|silibinin|silibinin
1311323|NCT01535092|viral load|viral load
1311324|NCT01535079|sore throat pain|sore throat pain
1311325|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
1311326|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
1311327|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1311328|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1311329|NCT01535066|stage IA breast cancer|stage ia breast cancer
1311330|NCT01535066|stage IB breast cancer|stage ib breast cancer
1311331|NCT01535066|stage II breast cancer|stage ii breast cancer
1311332|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
1311333|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
1311334|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
1311335|NCT01535066|pain|pain
1311336|NCT01535040|cancer survivor|cancer survivor
1311337|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1311338|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1311339|NCT01535040|tobacco use disorder|tobacco use disorder
1311340|NCT01535040|stage IA breast cancer|stage ia breast cancer
1311341|NCT01535040|stage IB breast cancer|stage ib breast cancer
1311342|NCT01535040|stage II breast cancer|stage ii breast cancer
1311343|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
1311344|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
1311345|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
1311346|NCT01535040|stage I prostate cancer|stage i prostate cancer
1311347|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
1311348|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
1311349|NCT01535040|stage III prostate cancer|stage iii prostate cancer
1311350|NCT01535040|stage I colon cancer|stage i colon cancer
1311351|NCT01535040|stage IIA colon cancer|stage iia colon cancer
1311352|NCT01535040|stage IIB colon cancer|stage iib colon cancer
1311353|NCT01535040|stage IIC colon cancer|stage iic colon cancer
1311354|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
1311355|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
1311356|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
1311357|NCT01535040|stage I rectal cancer|stage i rectal cancer
1311358|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
1311359|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
1311360|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
1311361|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
1311362|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
1311363|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
1311364|NCT01535027|teriparatide|teriparatide
1311365|NCT01535027|alendronate|alendronate
1311366|NCT01535027|raloxifene|raloxifene
1311367|NCT01535027|bone mineral density|bone mineral density
1311368|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
1311369|NCT01535001|Treatment Outcome|treatment outcome
1311370|NCT01535001|Time Factors|time factors
1311371|NCT01535001|Rehabilitation|rehabilitation
1311372|NCT01535001|Combined Modality Therapy|combined modality therapy
1311373|NCT01535001|Middle Aged|middle aged
1311374|NCT01535001|Aged|aged
1311375|NCT01535001|Aged, 80 and over|aged, 80 and over
1311376|NCT01535001|Male|male
1311377|NCT01535001|Female|female
1311378|NCT01535001|Humans|humans
1311379|NCT01535001|Analysis of Variance|analysis of variance
1311380|NCT01534975|cardiac CT|cardiac ct
1311381|NCT01534975|enhancement|enhancement
1311382|NCT01534975|contrast|contrast
1311383|NCT01534975|safety|safety
1311384|NCT01534975|image quality|image quality
1311385|NCT01534962|Atrial Fibrillation|atrial fibrillation
1311386|NCT01534962|Ranolazine|ranolazine
1311387|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
1311388|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
1311389|NCT01534962|Cardiac Electroversion|cardiac electroversion
1311390|NCT01534962|Ranexa|ranexa
1311391|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
1311392|NCT01534936|schizophrenia|schizophrenia
1311393|NCT01534936|atypical antipsychotics|atypical antipsychotics
1311394|NCT01534936|depressive symptoms|depressive symptoms
1311395|NCT01534923|Doctor-Patient Communication|doctor-patient communication
1311396|NCT01534923|questionnaire|questionnaire
1311397|NCT01534923|survey|survey
1311398|NCT01534923|12-017|12-017
1311399|NCT01534910|garlic|garlic
1311400|NCT01534910|ct angiography|ct angiography
1311401|NCT01534910|atherosclerosis|atherosclerosis
1311402|NCT01534910|carotid IMT|carotid imt
1311403|NCT01534897|thyroid cancer|thyroid cancer
1311404|NCT01534897|Tall cell PTC|tall cell ptc
1311405|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
1311406|NCT01534897|metastatic|metastatic
1311407|NCT01534884|RA, Biosimilar|ra, biosimilar
1311408|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
1311409|NCT01534871|Exercise|exercise
1311410|NCT01534871|Systemic inflammation|systemic inflammation
1311411|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
1311412|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
1311413|NCT01534832|surgical smoke|surgical smoke
1311414|NCT01534832|laparoscopic surgery|laparoscopic surgery
1311415|NCT01534832|impaired vision|impaired vision
1311416|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
1311418|NCT01534819|Endograft|endograft
1311419|NCT01534819|interventional treatment of AAA|interventional treatment of aaa
1311420|NCT01534806|Migraine|migraine
1311421|NCT01534793|Quality assessment|quality assessment
1311422|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1311423|NCT01534793|Enucleation of the prostate|enucleation of the prostate
1311424|NCT01534793|LUMENIS|lumenis
1311425|NCT01534793|Laser|laser
1311426|NCT01534793|Learning Curve|learning curve
1311427|NCT01534728|Hepatitis C|hepatitis c
1311428|NCT01534728|CD8 epitopes|cd8 epitopes
1311429|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
1311430|NCT01534702|chemotherapy|chemotherapy
1311431|NCT01534702|clofarabine|clofarabine
1311432|NCT01534676|iron|iron
1311433|NCT01534676|transfusion|transfusion
1311434|NCT01534676|red blood cells|red blood cells
1311435|NCT01534676|sickle cell disease|sickle cell disease
1311436|NCT01534676|thalassemia|thalassemia
1311437|NCT01534676|blood donors|blood donors
1311438|NCT01534663|Heart Failure|heart failure
1311565|NCT01534104|DSI|dsi
1311439|NCT01534663|Skeletal Muscle Function|skeletal muscle function
1311440|NCT01534663|Metabolism|metabolism
1311441|NCT01534663|Inflammation|inflammation
1311442|NCT01534663|Glutamine|glutamine
1311443|NCT01534663|Fish oil|fish oil
1311444|NCT01534663|Muscle Function|muscle function
1311445|NCT01534650|motion sensors|motion sensors
1311447|NCT01534650|bradykinesia|bradykinesia
1311448|NCT01534650|gait|gait
1311449|NCT01534650|balance|balance
1311450|NCT01534650|dyskinesia|dyskinesia
1311451|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
1311452|NCT01534624|Addiction|addiction
1311453|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
1311454|NCT01534624|Dopamine Transporter|dopamine transporter
1311455|NCT01534598|DNA Methylation|dna methylation
1311456|NCT01534598|Advanced Cancer|advanced cancer
1311457|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
1311458|NCT01534598|Epigenetics|epigenetics
1311459|NCT01534598|Gene Re-Expression|gene re-expression
1311460|NCT01534598|Cancer|cancer
1311461|NCT01534598|Solid Tumor|solid tumor
1311462|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
1311463|NCT01534585|Icotinib|icotinib
1311464|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
1311465|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1311466|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
1311467|NCT01534546|DFS|dfs
1311468|NCT01534546|OS|os
1311469|NCT01534546|safety|safety
1311470|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
1311471|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
1311472|NCT01534533|early atherosclerosis|early atherosclerosis
1311473|NCT01534533|serum lutein|serum lutein
1311474|NCT01534533|serum lycopene|serum lycopene
1311475|NCT01534533|intima-media thickness|intima-media thickness
1311476|NCT01534533|arterial stiffness|arterial stiffness
1311477|NCT01534533|combined effect|combined effect
1311478|NCT01534520|Intrauterine Device|intrauterine device
1311479|NCT01534520|Pain|pain
1311480|NCT01534520|Lidocaine|lidocaine
1311481|NCT01534494|alcohol dependence|alcohol dependence
1311482|NCT01534494|psilocybin|psilocybin
1311483|NCT01534494|clinical trial|clinical trial
1311484|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
1311485|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
1311486|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1311487|NCT01534481|Prematurity|prematurity
1311488|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
1311489|NCT01534481|Donor Breast Milk|donor breast milk
1311490|NCT01534481|Preterm Formula|preterm formula
1311491|NCT01534455|German Breast Group|german breast group
1311492|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
1311493|NCT01534455|GBG|gbg
1311494|NCT01534455|GBG 64|gbg 64
1311495|NCT01534455|E-VITA|e-vita
1311496|NCT01534455|Breast Cancer|breast cancer
1311497|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
1311498|NCT01534455|Eribulin|eribulin
1311499|NCT01534455|Lapatinib|lapatinib
1311500|NCT01534455|Halaven|halaven
1311501|NCT01534455|Tyverb|tyverb
1311502|NCT01534429|pain|pain
1311503|NCT01534416|Paracervical Block|paracervical block
1311504|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
1311505|NCT01534416|Postoperative Pain|postoperative pain
1311506|NCT01534416|Bupivacaine|bupivacaine
1311507|NCT01534416|Hysterectomy|hysterectomy
1311508|NCT01534416|Myomectomy|myomectomy
1311509|NCT01534416|Randomized Trial|randomized trial
1311510|NCT01534403|Lupus|lupus
1311511|NCT01534403|Monoclonal antibody|monoclonal antibody
1311512|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
1311513|NCT01534403|Epratuzumab|epratuzumab
1311514|NCT01534390|microparticles|microparticles
1311515|NCT01534390|in-line microfilters|in-line microfilters
1311516|NCT01534390|systemic inflammation|systemic inflammation
1311517|NCT01534390|organ failure|organ failure
1311518|NCT01534390|critical illness|critical illness
1311519|NCT01534390|adult|adult
1311520|NCT01534377|Depression|depression
1311521|NCT01534377|Adolescents|adolescents
1311522|NCT01534364|acute renal failure|acute renal failure
1311523|NCT01534364|acute kidney injury|acute kidney injury
1311524|NCT01534364|diet|diet
1311525|NCT01534364|caloric restriction|caloric restriction
1311526|NCT01534364|cardiac surgery|cardiac surgery
1311527|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
1311528|NCT01534338|Sleep|sleep
1311529|NCT01534338|inflammation|inflammation
1311530|NCT01534338|mindfulness|mindfulness
1311531|NCT01534338|meditation|meditation
1311532|NCT01534338|randomized controlled trial|randomized controlled trial
1311533|NCT01534312|Glycopeptides|glycopeptides
1311534|NCT01534312|Dietary proteins|dietary proteins
1311535|NCT01534286|Prescription Medical Food|prescription medical food
1311536|NCT01534286|Theramine|theramine
1311537|NCT01534286|Knee surgery|knee surgery
1311538|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
1311540|NCT01534247|drug to drug|drug to drug
1311541|NCT01534247|CAZ-AVI|caz-avi
1311542|NCT01534247|Healthy volunteer|healthy volunteer
1311543|NCT01534247|pharmacokinetics|pharmacokinetics
1311544|NCT01534247|open label|open label
1311545|NCT01534247|metronidazole|metronidazole
1311546|NCT01534247|safety|safety
1311547|NCT01534234|CRT-D device|crt-d device
1311548|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
1311549|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
1311550|NCT01534234|sinus rhythm|sinus rhythm
1311551|NCT01534221|Ischemic Heart Disease|ischemic heart disease
1311552|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
1311553|NCT01534182|Fingolimod|fingolimod
1311554|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
1311555|NCT01534182|TSQM-9|tsqm-9
1311556|NCT01534169|Graves' disease|graves' disease
1311557|NCT01534169|Dexamethasone|dexamethasone
1311558|NCT01534169|Function of regulatory T cells|function of regulatory t cells
1311559|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
1311560|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
1311561|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
1311562|NCT01534130|Acupuncture|acupuncture
1311563|NCT01534104|fMRI|fmri
1311564|NCT01534104|DTI|dti
1311566|NCT01534104|tractography|tractography
1311567|NCT01534104|neurological/physical testing|neurological/physical testing
1311568|NCT01534104|Motor and Language Pathways|motor and language pathways
1311569|NCT01534104|resting state fMRI|resting state fmri
1311570|NCT01534104|12-008|12-008
1311571|NCT01534091|overweight|overweight
1311572|NCT01534091|obese|obese
1311573|NCT01534091|children|children
1311574|NCT01534091|exercise|exercise
1311575|NCT01534091|physical activity|physical activity
1311576|NCT01534091|pedometer|pedometer
1311577|NCT01534078|non-bulky|non-bulky
1311578|NCT01534078|limited stage|limited stage
1311579|NCT01534065|Hernia|hernia
1311580|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
1311581|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
1311582|NCT01534065|Spinal Diseases|spinal diseases
1311583|NCT01534065|Bone Diseases|bone diseases
1311584|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
1311585|NCT01534052|Prostate Cancer|prostate cancer
1311586|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
1311587|NCT01534052|MDV3100|mdv3100
1311588|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
1311589|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
1311590|NCT01534000|Cardiac CT|cardiac ct
1311591|NCT01534000|Ischemic heat disease|ischemic heat disease
1311592|NCT01534000|Stress test|stress test
1311593|NCT01533987|Male|male
1311594|NCT01533987|Overweight|overweight
1311595|NCT01533987|Juice Plus|juice plus
1311596|NCT01533961|neglected disease|neglected disease
1311597|NCT01533961|africa|africa
1311598|NCT01533961|new drug|new drug
1311599|NCT01533961|oral drug|oral drug
1311600|NCT01533961|parasite|parasite
1311601|NCT01533896|Obesity prevention|obesity prevention
1311602|NCT01533896|Primary care|primary care
1311603|NCT01533896|Education|education
1311604|NCT01533883|Mitral|mitral
1311605|NCT01533883|Valve|valve
1311606|NCT01533883|Annuloplasty|annuloplasty
1311607|NCT01533883|Transatrial|transatrial
1311608|NCT01533883|Transapical|transapical
1311609|NCT01533883|Transfemoral|transfemoral
1311610|NCT01533883|Mitral valve insufficiency|mitral valve insufficiency
1311611|NCT01533870|Phase 1|phase 1
1311612|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
1311613|NCT01533870|Drug-drug interaction|drug-drug interaction
1311614|NCT01533870|Pharmacokinetics|pharmacokinetics
1311615|NCT01533870|NKTR-118|nktr-118
1311616|NCT01533870|Bioavailability|bioavailability
1311617|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
1311618|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
1311619|NCT01533857|Black tea|black tea
1311620|NCT01533857|phenolic acids|phenolic acids
1311621|NCT01533844|CDAD|cdad
1311622|NCT01533844|Neonates|neonates
1311623|NCT01533844|Clostridium difficile|clostridium difficile
1311624|NCT01533818|Fast breathing|fast breathing
1311625|NCT01533818|Young infants|young infants
1311626|NCT01533818|Management|management
1311627|NCT01533818|Amoxicillin|amoxicillin
1311628|NCT01533818|Placebo|placebo
1311629|NCT01533805|Lumbago|lumbago
1311630|NCT01533805|Exercise therapy|exercise therapy
1311631|NCT01533805|Spine|spine
1311632|NCT01533792|Treatment|treatment
1311633|NCT01533792|pregnant women|pregnant women
1311634|NCT01533792|periodontitis|periodontitis
1311635|NCT01533792|dental scaling|dental scaling
1311636|NCT01533792|dental plaque|dental plaque
1311637|NCT01533779|children|children
1311638|NCT01533779|malignancy|malignancy
1311639|NCT01533779|neutrophil|neutrophil
1311640|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
1311641|NCT01533779|superoxide production|superoxide production
1311642|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
1311643|NCT01533779|chemotaxis|chemotaxis
1311644|NCT01533779|myeloperoxidase|myeloperoxidase
1311645|NCT01533779|immunosurveillance|immunosurveillance
1311646|NCT01533779|cancer cell lines|cancer cell lines
1311647|NCT01533753|hot flashes|hot flashes
1311648|NCT01533753|prostate cancer|prostate cancer
1311649|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
1311650|NCT01533727|NSCLC|nsclc
1311651|NCT01533727|adjuvant therapy|adjuvant therapy
1417172|NCT01095731|FDA|fda
1311652|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
1311653|NCT01533714|Monoclonal antibody|monoclonal antibody
1311654|NCT01533714|Interleukin-6|interleukin-6
1311655|NCT01533714|Olokizumab|olokizumab
1311656|NCT01533714|CDP6038|cdp6038
1311657|NCT01533701|Hypoxia|hypoxia
1311658|NCT01533701|Fetal blood sampling|fetal blood sampling
1311659|NCT01533701|Lactate|lactate
1311660|NCT01533701|pH|ph
1311661|NCT01533701|base deficit|base deficit
1311662|NCT01533701|angiogenic factors|angiogenic factors
1311663|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
1311664|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
1311665|NCT01533662|phenylephrine|phenylephrine
1311666|NCT01533662|hypotension|hypotension
1311667|NCT01533662|spinal anesthesia|spinal anesthesia
1311668|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
1311669|NCT01533649|Behavioral intervention|behavioral intervention
1311670|NCT01533649|Seizure self-efficacy|seizure self-efficacy
1311671|NCT01533649|Psychosocial outcomes|psychosocial outcomes
1311672|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
1311673|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
1311674|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
1311675|NCT01533610|Stellate ganglion|stellate ganglion
1311676|NCT01533610|cervical plexus|cervical plexus
1311677|NCT01533610|local anesthesia|local anesthesia
1311678|NCT01533610|anxiety|anxiety
1311679|NCT01533597|Overactive bladder|overactive bladder
1311680|NCT01533597|Solifenacin succinate|solifenacin succinate
1311681|NCT01533597|Tamsulosin|tamsulosin
1311682|NCT01533571|Guided Bone Regeneration|guided bone regeneration
1311683|NCT01533571|Dental Implant|dental implant
1311684|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
1311685|NCT01533571|Socket graft|socket graft
1311686|NCT01533558|caspofungin|caspofungin
1311687|NCT01533558|pharmacokinetics|pharmacokinetics
1311688|NCT01533558|invasive fungal infection|invasive fungal infection
1311689|NCT01533558|candidiasis|candidiasis
1311690|NCT01533558|aspergillosis|aspergillosis
1311691|NCT01533558|intensive care|intensive care
1311692|NCT01533545|Mepivacaine|mepivacaine
1311693|NCT01533545|Epinephrine|epinephrine
1311694|NCT01533545|Brachial plexus block|brachial plexus block
1311695|NCT01533545|Renal insufficiency|renal insufficiency
1311696|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
1311697|NCT01533519|Neuropeptide Y|neuropeptide y
1311698|NCT01533519|Intranasal Administration|intranasal administration
1311699|NCT01533519|PTSD|ptsd
1311700|NCT01533519|Trauma|trauma
1311701|NCT01533506|treatment with stiripentol|treatment with stiripentol
1311702|NCT01533493|ADHD|adhd
1311703|NCT01533493|Executive Function|executive function
1311704|NCT01533493|Namenda|namenda
1311705|NCT01533493|Concerta|concerta
1311706|NCT01533480|Adenovirus|adenovirus
1311707|NCT01533480|Conjunctivitis|conjunctivitis
1311708|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
1311709|NCT01533480|viral shedding|viral shedding
1311710|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
1311711|NCT01533480|bulbar injection|bulbar injection
1311712|NCT01533467|Delivery rupture|delivery rupture
1311713|NCT01533467|perineal protection device|perineal protection device
1311714|NCT01533467|reduce perineal tears|reduce perineal tears
1311715|NCT01533454|Obesity|obesity
1311716|NCT01533454|Weight loss|weight loss
1311717|NCT01533454|Incentives|incentives
1311718|NCT01533454|Motivation|motivation
1311719|NCT01533441|anticoagulant therapy|anticoagulant therapy
1311720|NCT01533441|INR|inr
1311721|NCT01533441|vitamin K2|vitamin k2
1311722|NCT01533441|vitamin K antagonist|vitamin k antagonist
1311723|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
1311724|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
1311725|NCT01533415|Anxiety|anxiety
1311726|NCT01533415|Anxiety Disorders|anxiety disorders
1311727|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
1311728|NCT01533402|Internet|internet
1311729|NCT01533402|Anxiety disorders|anxiety disorders
1311730|NCT01533402|Children|children
1311731|NCT01533376|Sturge Weber|sturge weber
1311732|NCT01533376|SWS|sws
1311733|NCT01533376|Timolol|timolol
1311734|NCT01533376|Port wine mark|port wine mark
1311735|NCT01533363|Hemorrhoids|hemorrhoids
1311736|NCT01533363|Surgery|surgery
1311737|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
1311738|NCT01533363|Milligan Morgan|milligan morgan
1311739|NCT01533350|Ultrasonography|ultrasonography
1311740|NCT01533350|late follicle phase|late follicle phase
1311741|NCT01533350|homogeneous endometrium|homogeneous endometrium
1311742|NCT01533350|receptivity|receptivity
1311743|NCT01533350|biochemical factor|biochemical factor
1311744|NCT01533350|ultrastructure|ultrastructure
1311745|NCT01533350|endometrial echo pattern|endometrial echo pattern
1311746|NCT01533337|dorsal digital free flap|dorsal digital free flap
1311747|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
1311748|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
1311749|NCT01533337|proper digital artery|proper digital artery
1311750|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
1311751|NCT01533324|S-1|s-1
1311752|NCT01533324|Leucovorin|leucovorin
1311753|NCT01533324|fluorouracil|fluorouracil
1311754|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
1311755|NCT01533311|prevalence|prevalence
1311756|NCT01533311|histology|histology
1311757|NCT01533285|Major depressive disorder|major depressive disorder
1311758|NCT01533285|MDD|mdd
1311759|NCT01533285|Psychiatry disorders|psychiatry disorders
1311760|NCT01533285|Psychosocial stressor|psychosocial stressor
1311761|NCT01533285|Psychosocial stress|psychosocial stress
1311762|NCT01533285|Typhoid vaccination|typhoid vaccination
1311763|NCT01533285|Typhoid vaccine|typhoid vaccine
1311764|NCT01533272|HIV infection|hiv infection
1311765|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
1311766|NCT01533259|HIV-1|hiv-1
1311767|NCT01533259|HIV|hiv
1311768|NCT01533259|Treatment Experienced|treatment experienced
1311769|NCT01533233|thoracoscopy|thoracoscopy
1311770|NCT01533233|lung cancer|lung cancer
1311771|NCT01533233|lobectomy|lobectomy
1311772|NCT01533233|epidural anesthesia|epidural anesthesia
1311773|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
1311774|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1311775|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1311776|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1311777|NCT01533155|Phase 1|phase 1
1311778|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
1311779|NCT01533155|Drug-drug interaction|drug-drug interaction
1311780|NCT01533155|Pharmacokinetics|pharmacokinetics
1311781|NCT01533155|NKTR-118|nktr-118
1311782|NCT01533142|lipids|lipids
1311783|NCT01533129|Hypogonadism|hypogonadism
1311784|NCT01533129|Endothelial dysfunction|endothelial dysfunction
1311785|NCT01533129|Inflammation|inflammation
1311786|NCT01533129|Insulin resistance|insulin resistance
1311787|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
1311788|NCT01533116|Parkinson Disease|parkinson disease
1311789|NCT01533116|BIA 9-1067|bia 9-1067
1311790|NCT01533077|Parkinson Disease|parkinson disease
1311791|NCT01533077|BIA 9-1067|bia 9-1067
1311792|NCT01533051|Chronic hepatitis B|chronic hepatitis b
1311793|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
1311794|NCT01533051|Antiviral treatment|antiviral treatment
1311795|NCT01533051|Korea|korea
1311796|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
1311797|NCT01533025|Achilles|achilles
1311798|NCT01533025|free tendon|free tendon
1311799|NCT01533025|bone-tendon|bone-tendon
1311800|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
1311801|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
1311802|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
1311803|NCT01532999|Meditation|meditation
1311804|NCT01532999|Present Centered Group Therapy|present centered group therapy
1311805|NCT01532999|mindfulness|mindfulness
1311806|NCT01532999|MBSR|mbsr
1311807|NCT01532999|complementary alternative medicine|complementary alternative medicine
1311808|NCT01532986|Quality of Health Care|quality of health care
1311809|NCT01532986|Nursing Care Management|nursing care management
1311810|NCT01532986|Care Coordination|care coordination
1311811|NCT01532986|Randomized Trials|randomized trials
1311812|NCT01532960|breast cancer|breast cancer
1311813|NCT01532960|peptide vaccine|peptide vaccine
1311814|NCT01532960|immunotherapy|immunotherapy
1311815|NCT01532934|substance use|substance use
1311816|NCT01532934|psychopathy|psychopathy
1311817|NCT01532934|motivational enhancement|motivational enhancement
1311818|NCT01532934|criminal recidivism|criminal recidivism
1311819|NCT01532908|Liver Transplantation|liver transplantation
1311820|NCT01532895|Pain|pain
1311821|NCT01532895|Cancer pain|cancer pain
1311822|NCT01532895|Hydromorphone|hydromorphone
1311823|NCT01532895|Hydromorphone OROS|hydromorphone oros
1311824|NCT01532895|Narcotic analgesics|narcotic analgesics
1311825|NCT01532895|Opioid-naive|opioid-naive
1311826|NCT01532856|multiple myeloma|multiple myeloma
1311827|NCT01532856|thalidomide|thalidomide
1311828|NCT01532856|comparative|comparative
1311829|NCT01532856|elderly|elderly
1311830|NCT01532843|Hepatitis B|hepatitis b
1311831|NCT01532843|sustained response|sustained response
1311832|NCT01532843|peginterferon|peginterferon
1311833|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
1311834|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
1311835|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
1311836|NCT01532830|nVNS|nvns
1311837|NCT01532830|VNS|vns
1311838|NCT01532830|migraine|migraine
1311839|NCT01532830|non invasive|non invasive
1311840|NCT01532830|gammacore|gammacore
1311841|NCT01532804|Unresectable metastases|unresectable metastases
1311842|NCT01532791|MELAS|melas
1417414|NCT01094860|CLL|cll
1311843|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
1311844|NCT01532791|mtDNA mutation|mtdna mutation
1311845|NCT01532791|mitochondrial DNA|mitochondrial dna
1311846|NCT01532791|mitochondria|mitochondria
1311847|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
1311848|NCT01532765|Internal limiting membrane|internal limiting membrane
1311849|NCT01532765|Indocyanine green dye|indocyanine green dye
1311850|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
1311851|NCT01532739|Aging|aging
1311852|NCT01532739|Memory|memory
1311853|NCT01532739|Executive Function|executive function
1311854|NCT01532739|Cognitive Intervention|cognitive intervention
1311855|NCT01532739|Memory Training|memory training
1311856|NCT01532739|Mental Health|mental health
1311857|NCT01532726|Partial-Onset Seizures|partial-onset seizures
1311858|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
1311859|NCT01532726|ESL|esl
1311860|NCT01532726|BIA 2-093|bia 2-093
1311861|NCT01532726|BIAL|bial
1311862|NCT01532661|TRAUMA|trauma
1311863|NCT01532661|HAEMORRHAGIC|haemorrhagic
1311864|NCT01532661|rVIIa|rviia
1311865|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
1311866|NCT01532661|bleeding|bleeding
1311867|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
1311868|NCT01532648|Ulcerative Colitis|ulcerative colitis
1311869|NCT01532635|hematologic malignancy|hematologic malignancy
1311870|NCT01532635|leukemia|leukemia
1311871|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1311872|NCT01532635|ALL|all
1311873|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
1311874|NCT01532635|AML|aml
1311875|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1311876|NCT01532635|CLL|cll
1311877|NCT01532635|lymphoma|lymphoma
1311878|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
1311879|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
1311880|NCT01532635|myeloma|myeloma
1311881|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
1311882|NCT01532635|TJU 2-step|tju 2-step
1311883|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1311884|NCT01532635|HSCT|hsct
1311885|NCT01532635|bone marrow transplant|bone marrow transplant
1311886|NCT01532635|Cyclophosphamide|cyclophosphamide
1311887|NCT01532635|MMF|mmf
1311888|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
1311889|NCT01532622|Blueberry|blueberry
1311890|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
1311891|NCT01532609|Behavioral intervention|behavioral intervention
1311892|NCT01532609|Service provider|service provider
1311893|NCT01532609|Drug use|drug use
1311894|NCT01532570|Behcet's disease|behcet's disease
1311895|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
1311896|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
1311897|NCT01532570|vascular Behcet's disease|vascular behcet's disease
1311898|NCT01532544|Severe pneumonia|severe pneumonia
1311899|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
1311900|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
1311901|NCT01532518|Feeding intolerance|feeding intolerance
1311902|NCT01532518|Infant|infant
1311903|NCT01532518|tachykinin antagonist|tachykinin antagonist
1311904|NCT01532518|Infant colic|infant colic
1311905|NCT01532518|Nepadutant|nepadutant
1311906|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
1311907|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
1311908|NCT01532505|Microcirculation|microcirculation
1311909|NCT01532505|Catecholamines|catecholamines
1311910|NCT01532505|Vasopressin|vasopressin
1311911|NCT01532492|Questionnaire|questionnaire
1311912|NCT01532492|WORC|worc
1311913|NCT01532492|Rotator cuff|rotator cuff
1311914|NCT01532492|Reliability|reliability
1311915|NCT01532492|Validity|validity
1311916|NCT01532492|Responsiveness|responsiveness
1311917|NCT01532479|Osteoradionecrosis|osteoradionecrosis
1311918|NCT01532479|Xerostomia|xerostomia
1311919|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
1311920|NCT01532401|Blood pressure|blood pressure
1311921|NCT01532388|Randomized Controlled Trial|randomized controlled trial
1311922|NCT01532388|Alcohol|alcohol
1311923|NCT01532388|Drugs|drugs
1311924|NCT01532388|Internet|internet
1311925|NCT01532388|Screening|screening
1311926|NCT01532388|Brief intervention|brief intervention
1311927|NCT01532375|Kochujang,|kochujang,
1311928|NCT01532375|visceral fat|visceral fat
1311929|NCT01532375|population|population
1311930|NCT01532349|chronic kidney disease|chronic kidney disease
1311931|NCT01532349|anemia|anemia
1311932|NCT01532336|adenovirus|adenovirus
1311933|NCT01532336|conjunctivitis|conjunctivitis
1311934|NCT01532336|pinkeye|pinkeye
1311935|NCT01532323|Oral disorders|oral disorders
1311936|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
1311937|NCT01532310|belimumab|belimumab
1311938|NCT01532310|pregnancy|pregnancy
1311939|NCT01532297|citrate dialysate|citrate dialysate
1311940|NCT01532297|dialysis|dialysis
1311941|NCT01532297|calcium|calcium
1311942|NCT01532284|aneuploid oocytes|aneuploid oocytes
1311943|NCT01532284|ICSI|icsi
1311944|NCT01532284|IVF|ivf
1311945|NCT01532284|Polar Body Biopsy|polar body biopsy
1311946|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
1311947|NCT01532271|mTBI|mtbi
1311948|NCT01532271|Concussion|concussion
1311949|NCT01532258|BMI|bmi
1311950|NCT01532258|Weight loss|weight loss
1311951|NCT01532258|Nutrition|nutrition
1311952|NCT01532258|Diet|diet
1311953|NCT01532258|Mediterranean diet|mediterranean diet
1311954|NCT01532258|Online program|online program
1311955|NCT01532258|web-based program|web-based program
1311956|NCT01532258|Oxidative stress|oxidative stress
1311957|NCT01532258|F2 isoprostanes|f2 isoprostanes
1311958|NCT01532232|PLACEBO|placebo
1311959|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
1311960|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
1311961|NCT01532232|Smoking Cessation|smoking cessation
1311962|NCT01532232|11-136|11-136
1311963|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
1311964|NCT01532206|inflammation|inflammation
1311965|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
1311966|NCT01532141|Parkinson Disease|parkinson disease
1311967|NCT01532141|BIA 9-1067|bia 9-1067
1311968|NCT01532128|Parkinson Disease|parkinson disease
1311969|NCT01532128|BIA 9-1067|bia 9-1067
1311970|NCT01532115|Parkinson Disease|parkinson disease
1311971|NCT01532115|BIA 9-1067|bia 9-1067
1311972|NCT01532102|Genital warts|genital warts
1311973|NCT01532102|Anogenital warts|anogenital warts
1311974|NCT01532102|HPV|hpv
1311975|NCT01532102|Human papillomavirus|human papillomavirus
1311976|NCT01532102|Antiviral|antiviral
1311977|NCT01532076|osteoporosis|osteoporosis
1311978|NCT01532076|prox. humeral fracture|prox. humeral fracture
1311979|NCT01532076|geriatric trauma|geriatric trauma
1311980|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
1311981|NCT01532063|Difficult intubation|difficult intubation
1311982|NCT01532063|Intensive care units|intensive care units
1311983|NCT01532063|Risk factors|risk factors
1311984|NCT01532063|Incidence|incidence
1311985|NCT01532063|Complications|complications
1311986|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
1311987|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
1311988|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
1311989|NCT01532050|OSAS|osas
1311990|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
1311991|NCT01532037|Randomised controlled trial|randomised controlled trial
1311992|NCT01532037|Multiple Sclerosis|multiple sclerosis
1311993|NCT01532037|Fatigue|fatigue
1311994|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
1311995|NCT01532037|Self Help|self help
1311996|NCT01532024|Optical Imaging|optical imaging
1311997|NCT01532024|Neutrophil|neutrophil
1311998|NCT01532024|Elastase|elastase
1311999|NCT01532024|Molecular Imaging|molecular imaging
1312000|NCT01532024|Acute Lung Injury|acute lung injury
1312001|NCT01532024|ARDS|ards
1312002|NCT01532011|Advanced Cancers|advanced cancers
1312003|NCT01532011|Solid Tumors|solid tumors
1312004|NCT01532011|Erlotinib|erlotinib
1312005|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
1312006|NCT01532011|OSI-774|osi-774
1312007|NCT01532011|Tarceva|tarceva
1312008|NCT01532011|Pralatrexate|pralatrexate
1312009|NCT01532011|Folotyn|folotyn
1312010|NCT01532011|PDX-010|pdx-010
1312011|NCT01531998|Myeloma|myeloma
1312012|NCT01531998|Multiple Myeloma|multiple myeloma
1312013|NCT01531998|MM|mm
1312014|NCT01531998|Newly diagnosed|newly diagnosed
1312015|NCT01531998|Lenalidomide|lenalidomide
1312016|NCT01531998|CC-5013|cc-5013
1312017|NCT01531998|Revlimid|revlimid
1312018|NCT01531998|Bortezomib|bortezomib
1312019|NCT01531998|Velcade|velcade
1312020|NCT01531998|LDP-341|ldp-341
1312021|NCT01531998|MLN341|mln341
1312022|NCT01531998|PS-341|ps-341
1312023|NCT01531998|Siltuximab|siltuximab
1312024|NCT01531998|CNTO 328|cnto 328
1312025|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
1312026|NCT01531998|Dexamethasone|dexamethasone
1312027|NCT01531998|Decadron|decadron
1312028|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
1312029|NCT01531998|MDASI-MM|mdasi-mm
1312030|NCT01531998|Questionnaires|questionnaires
1312031|NCT01531998|Surveys|surveys
1312032|NCT01531985|Congenital Heart Disease|congenital heart disease
1312033|NCT01531985|Acute Kidney Injury|acute kidney injury
1312034|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
1312035|NCT01531985|Biomarkers|biomarkers
1312036|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
1312037|NCT01531972|Healthy Volunteers|healthy volunteers
1312038|NCT01531972|Tomography|tomography
1312039|NCT01531959|Midodrine|midodrine
1312040|NCT01531959|Hypotension|hypotension
1312346|NCT01530672|Syphilis|syphilis
1312041|NCT01531959|Intensive care unit|intensive care unit
1312042|NCT01531959|IV vasopressors|iv vasopressors
1312043|NCT01531959|ICU discharge|icu discharge
1312044|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
1312045|NCT01531933|Prediabetic|prediabetic
1312046|NCT01531933|Primary prevention|primary prevention
1312047|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
1312048|NCT01531907|GLP2|glp2
1312049|NCT01531907|Obesity|obesity
1312050|NCT01531907|Premenopausal|premenopausal
1312051|NCT01531907|Bone|bone
1312052|NCT01531907|Formation|formation
1312053|NCT01531907|Resorption|resorption
1312054|NCT01531894|solid tumor|solid tumor
1312055|NCT01531894|GSK2110183|gsk2110183
1312056|NCT01531894|hematologic malignancy|hematologic malignancy
1312057|NCT01531894|AKT inhibitor|akt inhibitor
1312058|NCT01531894|cancer|cancer
1312059|NCT01531894|safety|safety
1312060|NCT01531868|Decision making|decision making
1312061|NCT01531868|Carotid stenosis|carotid stenosis
1312062|NCT01531855|T1DM, Exercise|t1dm, exercise
1312063|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
1312064|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
1312065|NCT01531842|injection|injection
1312066|NCT01531842|intravitreal injection|intravitreal injection
1312067|NCT01531842|bacterial resistance|bacterial resistance
1312068|NCT01531842|serial injection|serial injection
1312069|NCT01531842|serial intravitreal injections|serial intravitreal injections
1312071|NCT01531842|CRVO|crvo
1312072|NCT01531842|AMD|amd
1312073|NCT01531842|BRVO|brvo
1312074|NCT01531829|pulmonary embolism|pulmonary embolism
1312075|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
1312076|NCT01531829|Thrombolysis|thrombolysis
1312077|NCT01531829|Heparin|heparin
1312078|NCT01531816|Pediatrics,|pediatrics,
1312079|NCT01531816|Critically ill Children|critically ill children
1312080|NCT01531816|immobility|immobility
1312081|NCT01531790|Endostar|endostar
1312082|NCT01531790|Carboplatin|carboplatin
1312083|NCT01531790|Pemetrexed|pemetrexed
1312084|NCT01531790|NSCLC|nsclc
1312085|NCT01531790|Phase I|phase i
1312086|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
1312087|NCT01531764|Metastatic breast cancer|metastatic breast cancer
1312088|NCT01531764|intermediate HER2 expression|intermediate her2 expression
1312089|NCT01531764|Afatinib|afatinib
1312090|NCT01531751|HCO-HD|hco-hd
1312091|NCT01531751|survival|survival
1312092|NCT01531751|cardiac biomarkers|cardiac biomarkers
1312093|NCT01531751|AL amyloidosis|al amyloidosis
1312094|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
1312095|NCT01531738|Taste|taste
1312096|NCT01531738|bariatric surgery|bariatric surgery
1312097|NCT01531738|food preferences|food preferences
1312098|NCT01531738|reward|reward
1312099|NCT01531738|progressive ratio task|progressive ratio task
1312100|NCT01531725|Stents|stents
1312101|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
1312102|NCT01531712|borderline resectability|borderline resectability
1312103|NCT01531686|intraosseous vascular access|intraosseous vascular access
1312104|NCT01531686|CT examination|ct examination
1312105|NCT01531634|Borderline Personality Disorder|borderline personality disorder
1312106|NCT01531634|Women|women
1312107|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
1312108|NCT01531634|Recovery|recovery
1312109|NCT01531634|Hope Scale|hope scale
1312110|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
1312111|NCT01531608|melanoma|melanoma
1312112|NCT01531608|imaging|imaging
1312113|NCT01531608|sentinel node|sentinel node
1312114|NCT01531608|biopsy|biopsy
1312115|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
1312116|NCT01531582|Angelman|angelman
1312117|NCT01531582|Minocycline|minocycline
1312118|NCT01531582|cognitive|cognitive
1312119|NCT01531582|children|children
1312120|NCT01531582|tetracycline|tetracycline
1312121|NCT01531569|Flaxseed|flaxseed
1312122|NCT01531569|Lignans|lignans
1312123|NCT01531569|Pharmacokinetics|pharmacokinetics
1312124|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
1312125|NCT01531543|Laparostomy|laparostomy
1312126|NCT01531543|Severe peritonitis|severe peritonitis
1312127|NCT01531530|Shigella|shigella
1312128|NCT01531530|Vaccine|vaccine
1312129|NCT01531530|Mucosal immunity|mucosal immunity
1312130|NCT01531517|Pedyphar|pedyphar
1312131|NCT01531517|Ointment|ointment
1312132|NCT01531517|Healing|healing
1312133|NCT01531517|Diabetic|diabetic
1312134|NCT01531517|Foot Ulcer|foot ulcer
1312135|NCT01531504|hysterectomies|hysterectomies
1312136|NCT01531504|uterine manipulator|uterine manipulator
1312137|NCT01531491|Emergence|emergence
1312138|NCT01531491|Hypercapnia|hypercapnia
1312139|NCT01531491|Hypocapnia|hypocapnia
1312140|NCT01531491|Propofol|propofol
1312141|NCT01531478|Childhood cancer|childhood cancer
1312142|NCT01531478|Cancer|cancer
1312143|NCT01531478|Sequels|sequels
1312144|NCT01531478|Complications|complications
1312145|NCT01531478|Chemotherapy|chemotherapy
1312146|NCT01531478|Radiotherapy|radiotherapy
1312147|NCT01531478|Surgery|surgery
1312148|NCT01531465|Respiratory insufficiency|respiratory insufficiency
1312149|NCT01531465|Infants|infants
1312150|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
1312655|NCT01529476|Ofloxacin|ofloxacin
1312151|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
1312152|NCT01531452|Stomach Neoplasms|stomach neoplasms
1312153|NCT01531452|drug therapy|drug therapy
1312154|NCT01531452|oxaliplatin|oxaliplatin
1312155|NCT01531452|s1|s1
1312156|NCT01531439|Narcotic Antagonists|narcotic antagonists
1312157|NCT01531439|Naloxone infusion|naloxone infusion
1312158|NCT01531439|Postoperative pruritis|postoperative pruritis
1312159|NCT01531439|Patient controlled analgesia|patient controlled analgesia
1312160|NCT01531439|Pediatric|pediatric
1312161|NCT01531439|Children|children
1312162|NCT01531426|resuscitation|resuscitation
1312163|NCT01531426|hypothermia|hypothermia
1312164|NCT01531426|outcome|outcome
1312165|NCT01531387|Phase III|phase iii
1312166|NCT01531387|Sickle cell anemia|sickle cell anemia
1312167|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
1312168|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
1312169|NCT01531387|Pediatric patients|pediatric patients
1312170|NCT01531374|Valvular Heart Disease|valvular heart disease
1312171|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
1312172|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
1312173|NCT01531374|Extreme Risk|extreme risk
1312174|NCT01531374|High Risk|high risk
1312175|NCT01531374|Aortic Valve Replacement|aortic valve replacement
1312176|NCT01531361|Advanced Cancers|advanced cancers
1312177|NCT01531361|Advanced Malignancies|advanced malignancies
1312178|NCT01531361|Metastatic cancers|metastatic cancers
1312179|NCT01531361|Vemurafenib|vemurafenib
1312180|NCT01531361|PLX4032|plx4032
1312181|NCT01531361|R05185426|r05185426
1312182|NCT01531361|Sorafenib|sorafenib
1312183|NCT01531361|Nexavar|nexavar
1312184|NCT01531361|Bay 43-9006|bay 43-9006
1312185|NCT01531361|Crizotinib|crizotinib
1312186|NCT01531361|PF-02341066|pf-02341066
1312187|NCT01531361|Xalkori|xalkori
1312188|NCT01531361|Maximum tolerated dose|maximum tolerated dose
1312189|NCT01531361|MTD|mtd
1312190|NCT01531361|Dose limiting toxicity|dose limiting toxicity
1312191|NCT01531361|DLT|dlt
1312192|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
1312193|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
1312194|NCT01531348|Intravitreal injection|intravitreal injection
1312195|NCT01531335|adults|adults
1312196|NCT01531322|13vPnC|13vpnc
1312197|NCT01531322|Healthy subjects|healthy subjects
1312198|NCT01531322|China|china
1312199|NCT01531309|Liver impairment|liver impairment
1312200|NCT01531309|Major Depression Disorder|major depression disorder
1312201|NCT01531309|Sublingual tablet|sublingual tablet
1312202|NCT01531296|MRI|mri
1312203|NCT01531296|Lower Extremity Rotational|lower extremity rotational
1312204|NCT01531296|Femoral Version|femoral version
1312205|NCT01531296|Tibial Torsion|tibial torsion
1312206|NCT01531283|unacylated ghrelin|unacylated ghrelin
1312207|NCT01531283|beta cell function|beta cell function
1312208|NCT01531231|heart disease|heart disease
1312209|NCT01531231|unstable angina|unstable angina
1312210|NCT01531231|myocardial infarction|myocardial infarction
1312211|NCT01531231|behavioral|behavioral
1312212|NCT01531231|cardiovascular|cardiovascular
1312213|NCT01531231|emotions|emotions
1312214|NCT01531218|Campylobacter|campylobacter
1312215|NCT01531218|concisus|concisus
1312216|NCT01531218|diarrhea|diarrhea
1312217|NCT01531218|fever|fever
1312218|NCT01531218|abdominal pain|abdominal pain
1312219|NCT01531218|vomiting|vomiting
1312220|NCT01531205|recurrent|recurrent
1312221|NCT01531205|high risk|high risk
1312222|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
1312223|NCT01531192|Nystatin|nystatin
1312224|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
1312225|NCT01531192|Candida Colonization|candida colonization
1312226|NCT01531166|Chronic hepatitis B|chronic hepatitis b
1312227|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
1312228|NCT01531166|Korean|korean
1312229|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
1312230|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
1312231|NCT01531140|PEG|peg
1312232|NCT01531140|sennosides|sennosides
1312233|NCT01531140|children|children
1312234|NCT01531114|Diabetes mellitus|diabetes mellitus
1312235|NCT01531114|antiplatelet effect|antiplatelet effect
1312236|NCT01531114|prasugrel|prasugrel
1312237|NCT01531114|ticagrelor|ticagrelor
1312238|NCT01531114|STEMI|stemi
1312239|NCT01531114|Insulin|insulin
1312240|NCT01531101|Transference work|transference work
1312241|NCT01531101|Psychodynamic|psychodynamic
1312242|NCT01531101|Depression|depression
1312243|NCT01531101|Treatment|treatment
1312244|NCT01531101|Adolescent|adolescent
1312245|NCT01531088|Nursing Home|nursing home
1312246|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
1312347|NCT01530672|Combination|combination
1312247|NCT01531062|nigella sativa|nigella sativa
1312248|NCT01531062|dyslipidemia|dyslipidemia
1312249|NCT01531062|elderly|elderly
1312250|NCT01531049|smoking cessation|smoking cessation
1312251|NCT01531049|young adults|young adults
1312252|NCT01531049|motivational counselling|motivational counselling
1312253|NCT01531049|smoking|smoking
1312254|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
1312255|NCT01531049|therapy|therapy
1312256|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
1312257|NCT01531010|Neonate|neonate
1312258|NCT01531010|Premature|premature
1312259|NCT01531010|Pressure limited ventilation|pressure limited ventilation
1312260|NCT01531010|Volume ventilation|volume ventilation
1312261|NCT01530997|Human Papilloma Virus|human papilloma virus
1312262|NCT01530997|Oropharynx|oropharynx
1312263|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
1312264|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
1312265|NCT01530997|Radiation Therapy|radiation therapy
1312266|NCT01530997|Chemotherapy|chemotherapy
1312267|NCT01530997|p16|p16
1312268|NCT01530984|prostate cancer|prostate cancer
1312269|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
1312270|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
1312271|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
1312272|NCT01530984|systemic GM-CSF|systemic gm-csf
1312273|NCT01530984|Ipilimumab|ipilimumab
1312274|NCT01530971|oxygen|oxygen
1312275|NCT01530971|pregnancy|pregnancy
1312276|NCT01530971|caesarean section|caesarean section
1312277|NCT01530971|anesthetic techniques|anesthetic techniques
1312278|NCT01530958|CKD|ckd
1312279|NCT01530958|Automated Telephone Self Management|automated telephone self management
1312280|NCT01530958|Registry|registry
1312281|NCT01530958|CKD awareness|ckd awareness
1312282|NCT01530958|Self efficacy|self efficacy
1312283|NCT01530932|sepsis|sepsis
1312284|NCT01530932|tissue oxygenation|tissue oxygenation
1312285|NCT01530932|tissue perfusion|tissue perfusion
1312286|NCT01530932|immune reaction|immune reaction
1312287|NCT01530906|Eating disorders|eating disorders
1312288|NCT01530906|Bulimia|bulimia
1312289|NCT01530906|rTMS|rtms
1312290|NCT01530906|Treatment|treatment
1312291|NCT01530893|flavonoids|flavonoids
1312292|NCT01530893|vascular function|vascular function
1312293|NCT01530893|randomised controlled trial|randomised controlled trial
1312294|NCT01530893|placebo controlled|placebo controlled
1312295|NCT01530880|Fever reduction|fever reduction
1312296|NCT01530880|Fever burden|fever burden
1312297|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
1312298|NCT01530867|Dietary Supplements|dietary supplements
1312299|NCT01530867|Physician-patient communication|physician-patient communication
1312300|NCT01530867|Qualitative study|qualitative study
1312301|NCT01530867|Audio recorded office visits|audio recorded office visits
1312302|NCT01530854|sepsis|sepsis
1312303|NCT01530854|free fatty acids|free fatty acids
1312304|NCT01530854|emergency department|emergency department
1312305|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
1312306|NCT01530841|Home ventilation|home ventilation
1312307|NCT01530841|Respiratory insufficiency|respiratory insufficiency
1312308|NCT01530841|Neuromuscular|neuromuscular
1312309|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
1312310|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
1312311|NCT01530828|Premature Infants|premature infants
1312312|NCT01530828|Serial IRT|serial irt
1312313|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
1312314|NCT01530789|Telemedecine|telemedecine
1312315|NCT01530789|Telemedecine nurse|telemedecine nurse
1312316|NCT01530789|Delegation of tasks|delegation of tasks
1312317|NCT01530789|Type 1 diabetes|type 1 diabetes
1312318|NCT01530776|Pregnancy|pregnancy
1312319|NCT01530776|Postpartum|postpartum
1312320|NCT01530776|Weight Retention|weight retention
1312321|NCT01530776|Behavioral|behavioral
1312322|NCT01530776|Electronically-mediated|electronically-mediated
1312323|NCT01530763|Infections|infections
1312324|NCT01530763|Pediatrics|pediatrics
1312325|NCT01530763|Teflaro|teflaro
1312326|NCT01530763|cephalosporin|cephalosporin
1312327|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
1312328|NCT01530750|internal loop recorder|internal loop recorder
1312329|NCT01530750|risk factors|risk factors
1312330|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
1312331|NCT01530737|pediatric|pediatric
1312332|NCT01530737|Antithrombin|antithrombin
1312333|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
1312334|NCT01530737|cardiac surgery|cardiac surgery
1312335|NCT01530724|abdominal obesity|abdominal obesity
1312336|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
1312337|NCT01530698|melanoma|melanoma
1312338|NCT01530698|toll like receptor ligands|toll like receptor ligands
1312339|NCT01530698|mRNA electroporation|mrna electroporation
1312340|NCT01530698|vaccines|vaccines
1312341|NCT01530685|cinnamon|cinnamon
1312342|NCT01530685|chromium|chromium
1312343|NCT01530685|prediabete|prediabete
1312344|NCT01530685|overweight|overweight
1312349|NCT01530672|point-of-care|point-of-care
1312350|NCT01530672|MBIO|mbio
1312949|NCT01528358|VOT|vot
1312351|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
1312352|NCT01530659|Usher syndrome type 2|usher syndrome type 2
1312353|NCT01530659|Usher syndrome type 3|usher syndrome type 3
1312354|NCT01530659|Cone photoreceptor|cone photoreceptor
1312355|NCT01530659|Vision|vision
1312356|NCT01530659|Blind|blind
1312357|NCT01530646|obesity|obesity
1312358|NCT01530646|overweight|overweight
1312359|NCT01530646|muscle|muscle
1312360|NCT01530646|protein|protein
1312361|NCT01530646|muscle protein synthesis|muscle protein synthesis
1312362|NCT01530646|muscle protein breakdown|muscle protein breakdown
1312363|NCT01530646|whey|whey
1312364|NCT01530646|soy|soy
1312365|NCT01530646|caloric restriction|caloric restriction
1312366|NCT01530620|Antimuscarinics|antimuscarinics
1312367|NCT01530620|Neurogenic bladder|neurogenic bladder
1312368|NCT01530620|Propiverine|propiverine
1312369|NCT01530620|Urodynamics|urodynamics
1312370|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
1312371|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
1312372|NCT01530594|Untreated|untreated
1312373|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
1312374|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
1312375|NCT01530542|bioavailability|bioavailability
1312376|NCT01530542|food effect|food effect
1312377|NCT01530542|oxycodone|oxycodone
1312378|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
1312379|NCT01530529|PF-05180999|pf-05180999
1312380|NCT01530529|safety|safety
1312381|NCT01530529|pharmacokinetics|pharmacokinetics
1312382|NCT01530529|relative bioavailability|relative bioavailability
1312383|NCT01530529|Mental Disorders|mental disorders
1312384|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1312385|NCT01530529|Schizophrenia|schizophrenia
1312386|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
1312387|NCT01530503|biliary tract cancer|biliary tract cancer
1312388|NCT01530503|advanced disease|advanced disease
1312389|NCT01530503|chemotherapy|chemotherapy
1312390|NCT01530490|IVF|ivf
1312391|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
1312392|NCT01530490|cabergoline|cabergoline
1312393|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
1312394|NCT01530490|prevention|prevention
1312395|NCT01530477|Bone mineral density|bone mineral density
1312396|NCT01530477|weight|weight
1312397|NCT01530477|body composition|body composition
1312398|NCT01530477|DEXA|dexa
1312399|NCT01530477|DXA|dxa
1312400|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
1312401|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
1312402|NCT01530451|Nocturia|nocturia
1312403|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
1312404|NCT01530451|Desmopressin|desmopressin
1312405|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1312406|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
1312407|NCT01530425|low-income|low-income
1312408|NCT01530425|comparisons|comparisons
1312409|NCT01530412|Quality of Life|quality of life
1312410|NCT01530412|Free-living activity|free-living activity
1312411|NCT01530412|Exacerbation|exacerbation
1312412|NCT01530412|Rehabilitation|rehabilitation
1312413|NCT01530386|Lacosamide|lacosamide
1312414|NCT01530386|Vimpat|vimpat
1312415|NCT01530373|hot flashes|hot flashes
1312416|NCT01530373|breast cancer|breast cancer
1312417|NCT01530373|aromatase inhibitors|aromatase inhibitors
1312418|NCT01530373|solifenacin|solifenacin
1312419|NCT01530373|clonidine|clonidine
1312420|NCT01530373|quality of life|quality of life
1312421|NCT01530347|Glucose monitoring|glucose monitoring
1312422|NCT01530347|non-invasive glucometer|non-invasive glucometer
1312423|NCT01530347|Self glucose monitoring|self glucose monitoring
1312424|NCT01530321|cervicogenic headache|cervicogenic headache
1312425|NCT01530321|spinal manipulation|spinal manipulation
1312426|NCT01530321|chiropractic|chiropractic
1312427|NCT01530321|randomized controlled trial|randomized controlled trial
1312428|NCT01530321|dose-response|dose-response
1312429|NCT01530321|efficacy|efficacy
1312430|NCT01530308|Delirium|delirium
1312431|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
1312432|NCT01530269|intermediate|intermediate
1312433|NCT01530269|high|high
1312434|NCT01530269|risk|risk
1312435|NCT01530269|radiation|radiation
1312436|NCT01530269|therapy|therapy
1312437|NCT01530269|planning|planning
1312438|NCT01530269|surgical|surgical
1312439|NCT01530269|immunotherapy|immunotherapy
1312440|NCT01530269|chemotherapy|chemotherapy
1312441|NCT01530269|hormone|hormone
1312442|NCT01530256|allograph|allograph
1312443|NCT01530256|steroid refractory|steroid refractory
1312444|NCT01530230|cesarean section|cesarean section
1312445|NCT01530230|electrocardiography|electrocardiography
1312446|NCT01530230|heart|heart
1312447|NCT01530230|hypotension|hypotension
1312448|NCT01530230|ischemia|ischemia
1312449|NCT01530230|oxytocin|oxytocin
1312450|NCT01530230|preeclampsia|preeclampsia
1312451|NCT01530230|regional anesthesia|regional anesthesia
1312452|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
1312453|NCT01530217|Analgesics|analgesics
1312454|NCT01530217|Ibuprofen|ibuprofen
1312455|NCT01530217|Inflammation|inflammation
1312456|NCT01530217|Tooth Bleaching|tooth bleaching
1312457|NCT01530204|knee arthritis|knee arthritis
1312458|NCT01530204|knee osteoarthritis|knee osteoarthritis
1312459|NCT01530204|knee pain|knee pain
1312460|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
1312461|NCT01530204|physical therapy|physical therapy
1312462|NCT01530204|depression prevention|depression prevention
1312463|NCT01530191|depression|depression
1312464|NCT01530191|anxiety|anxiety
1312465|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
1312466|NCT01530191|POP|pop
1312467|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1312468|NCT01530165|IFG|ifg
1312469|NCT01530165|IGTT|igtt
1312470|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
1312471|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
1312472|NCT01530126|periodontitis|periodontitis
1312473|NCT01530113|Childhood sexual abuse|childhood sexual abuse
1312474|NCT01530113|Vaginismus|vaginismus
1312475|NCT01530113|Partial vaginismus|partial vaginismus
1312476|NCT01530113|Labor dystocia|labor dystocia
1312477|NCT01530113|Depression|depression
1312478|NCT01530100|Edema|edema
1312479|NCT01530100|Pain|pain
1312480|NCT01530100|Lower laser therapy|lower laser therapy
1312481|NCT01530100|orthognathics surgery|orthognathics surgery
1312482|NCT01530087|colostomy|colostomy
1312483|NCT01530087|ileostomy|ileostomy
1312484|NCT01530087|irritant dermatitis|irritant dermatitis
1312485|NCT01530087|two piece barrier|two piece barrier
1312486|NCT01530074|Mandibular nerve|mandibular nerve
1312487|NCT01530074|Mental nerve|mental nerve
1312488|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
1312489|NCT01530074|Local anesthesia|local anesthesia
1312490|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
1312491|NCT01530035|cardiac|cardiac
1312492|NCT01530035|vascular|vascular
1312493|NCT01530035|muscular|muscular
1312494|NCT01530035|adaptations|adaptations
1312495|NCT01530035|soccer training|soccer training
1312496|NCT01530035|strength training|strength training
1312497|NCT01530022|Lacosamide|lacosamide
1312498|NCT01530022|Vimpat|vimpat
1312499|NCT01530022|Cognition|cognition
1312500|NCT01530022|Mental Processes|mental processes
1312501|NCT01530022|Adverse Effects|adverse effects
1312502|NCT01530009|Antroduodenal manometry|antroduodenal manometry
1312503|NCT01530009|Child|child
1312504|NCT01530009|Adolescent|adolescent
1312505|NCT01530009|Amoxicillin|amoxicillin
1312506|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
1312507|NCT01529957|Volunteers|volunteers
1312508|NCT01529918|Diabetes|diabetes
1312509|NCT01529918|Self-screening|self-screening
1312510|NCT01529918|Web-based technology|web-based technology
1312511|NCT01529918|follow-up clinical care|follow-up clinical care
1312512|NCT01529918|randomized control trial|randomized control trial
1312513|NCT01529905|depression|depression
1312514|NCT01529905|mania|mania
1312515|NCT01529905|bipolar|bipolar
1312516|NCT01529905|outcome|outcome
1312517|NCT01529905|cognitive|cognitive
1312518|NCT01529879|edentulism|edentulism
1312519|NCT01529879|dental implants|dental implants
1312520|NCT01529879|clinical study|clinical study
1312521|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
1312522|NCT01529879|randomized|randomized
1312523|NCT01529879|crestal bone level|crestal bone level
1312524|NCT01529866|clinical study|clinical study
1312525|NCT01529866|edentulism|edentulism
1312526|NCT01529866|dental implants|dental implants
1312527|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
1312528|NCT01529866|randomized|randomized
1312529|NCT01529866|crestal bone level|crestal bone level
1312530|NCT01529866|immediate loading|immediate loading
1312531|NCT01529814|edentulism|edentulism
1312532|NCT01529814|dental implants|dental implants
1312533|NCT01529814|clinical study|clinical study
1312534|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
1312535|NCT01529814|randomized|randomized
1312536|NCT01529814|crestal bone level|crestal bone level
1312537|NCT01529814|early loading|early loading
1312538|NCT01529801|edentulism|edentulism
1312539|NCT01529801|dental implants|dental implants
1312540|NCT01529801|clinical study|clinical study
1312541|NCT01529801|randomized|randomized
1312542|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
1312543|NCT01529801|Crestal bone level|crestal bone level
1312544|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
1312545|NCT01529788|BotoxCosmetic|botoxcosmetic
1312546|NCT01529788|Dysport|dysport
1312547|NCT01529788|onabotulinum toxin|onabotulinum toxin
1312548|NCT01529788|wrinkles|wrinkles
1312549|NCT01529788|lateral orbital lines|lateral orbital lines
1312550|NCT01529775|partial edentulism|partial edentulism
1312551|NCT01529775|dental implants|dental implants
1312552|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
1312553|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
1312554|NCT01529775|Crestal bone level|crestal bone level
1312555|NCT01529775|randomized|randomized
1312556|NCT01529775|clinical study|clinical study
1312557|NCT01529762|edentulism|edentulism
1312558|NCT01529762|dental implants|dental implants
1312559|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
1312560|NCT01529762|randomized|randomized
1312561|NCT01529762|clinical study|clinical study
1312562|NCT01529762|partial edentulism|partial edentulism
1312563|NCT01529762|immediate loading|immediate loading
1312564|NCT01529762|crestal bone level|crestal bone level
1312565|NCT01529736|edentulism|edentulism
1312566|NCT01529736|dental implants|dental implants
1312567|NCT01529736|early loading|early loading
1312568|NCT01529736|crestal bone level|crestal bone level
1312569|NCT01529736|high torque insertion|high torque insertion
1312570|NCT01529736|low torque insertion|low torque insertion
1312571|NCT01529736|randomized|randomized
1312572|NCT01529736|Osseotite|osseotite
1312573|NCT01529736|clinical study|clinical study
1312574|NCT01529723|Stroke|stroke
1312575|NCT01529723|Dysphagia screening|dysphagia screening
1312576|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
1312577|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
1312579|NCT01529697|Inhaler use|inhaler use
1312580|NCT01529684|Cancer, solid tumors|cancer, solid tumors
1312581|NCT01529684|oncology patients|oncology patients
1312582|NCT01529684|OSI-906|osi-906
1312583|NCT01529684|mass balance|mass balance
1312584|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
1312585|NCT01529684|Metabolic profile of 906|metabolic profile of 906
1312586|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
1312587|NCT01529658|Renal function|renal function
1312588|NCT01529658|Renal hypothermia|renal hypothermia
1312589|NCT01529658|Nephrology|nephrology
1312590|NCT01529658|Nephrectomy|nephrectomy
1312591|NCT01529658|Renal tumor|renal tumor
1312592|NCT01529658|Urology|urology
1312593|NCT01529658|Kidney|kidney
1312594|NCT01529645|pertussis|pertussis
1312595|NCT01529645|booster vaccine|booster vaccine
1312596|NCT01529645|tetanus|tetanus
1312597|NCT01529645|diphtheria in adults|diphtheria in adults
1312598|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1312599|NCT01529632|COPD|copd
1312600|NCT01529632|QVA149|qva149
1312601|NCT01529632|QAB149|qab149
1312602|NCT01529632|NVA237|nva237
1312603|NCT01529632|indacaterol|indacaterol
1312604|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
1312605|NCT01529619|Rivastigmine|rivastigmine
1312606|NCT01529619|Alzheimer's disease|alzheimer's disease
1312607|NCT01529619|Transdermal patch|transdermal patch
1312608|NCT01529606|dental restoration|dental restoration
1312609|NCT01529606|dental caries|dental caries
1312610|NCT01529606|tooth cavity|tooth cavity
1312611|NCT01529593|Advanced Cancers|advanced cancers
1312612|NCT01529593|Metastatic cancer|metastatic cancer
1312613|NCT01529593|Tumor response|tumor response
1312614|NCT01529593|Dose limiting toxicity|dose limiting toxicity
1312615|NCT01529593|DLT|dlt
1312616|NCT01529593|Maximum tolerated dose|maximum tolerated dose
1312617|NCT01529593|MTD|mtd
1312618|NCT01529593|Temsirolimus|temsirolimus
1312619|NCT01529593|CCI-779|cci-779
1312620|NCT01529593|Torisel|torisel
1312621|NCT01529593|Metformin|metformin
1312622|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
1312623|NCT01529580|language|language
1312624|NCT01529580|intervention|intervention
1312625|NCT01529580|school-age|school-age
1312626|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
1312627|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1312628|NCT01529554|Infarct size|infarct size
1312629|NCT01529554|inflammation|inflammation
1312630|NCT01529554|everolimus|everolimus
1312631|NCT01529541|CWP-0403|cwp-0403
1312632|NCT01529541|Sitagliptin|sitagliptin
1312633|NCT01529541|Metformin|metformin
1312634|NCT01529541|type 2 DM|type 2 dm
1312635|NCT01529528|CWP-0403|cwp-0403
1312636|NCT01529528|type 2 DM|type 2 dm
1312637|NCT01529528|Efficacy|efficacy
1312638|NCT01529528|Safety|safety
1312639|NCT01529528|Phase 3|phase 3
1312640|NCT01529515|Schizophrenia|schizophrenia
1312641|NCT01529515|R092670|r092670
1312642|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
1312643|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
1312644|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
1312645|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
1312646|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
1312647|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
1418401|NCT01090700|HCV|hcv
1312648|NCT01529502|Hemoglobins|hemoglobins
1312649|NCT01529502|Nitric Oxide|nitric oxide
1312650|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
1312651|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1312652|NCT01529489|Physical training|physical training
1312653|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
1312654|NCT01529489|Heart rate kinetic|heart rate kinetic
1312656|NCT01529476|Levofloxacin|levofloxacin
1312657|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
1312658|NCT01529463|Congestive Heart Failure|congestive heart failure
1312659|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
1312660|NCT01529437|allergy|allergy
1312661|NCT01529437|immunology|immunology
1312662|NCT01529437|immune tolerance|immune tolerance
1312663|NCT01529437|immunotherapy|immunotherapy
1312664|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
1312665|NCT01529411|urothelium|urothelium
1312666|NCT01529411|transitional|transitional
1312667|NCT01529411|carcinoma|carcinoma
1312668|NCT01529411|cancer|cancer
1312669|NCT01529411|metastatic|metastatic
1312670|NCT01529411|tract|tract
1312671|NCT01529398|knee osteoarthritis|knee osteoarthritis
1312672|NCT01529398|exercise therapy|exercise therapy
1312673|NCT01529398|resistance training|resistance training
1312674|NCT01529398|proprioception|proprioception
1312675|NCT01529385|swollen leg|swollen leg
1312676|NCT01529385|diabetes|diabetes
1312677|NCT01529385|compression stockings|compression stockings
1312678|NCT01529385|edema|edema
1312679|NCT01529372|Hypertension|hypertension
1312680|NCT01529372|Blood pressure|blood pressure
1312681|NCT01529372|Renal denervation|renal denervation
1312682|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
1312683|NCT01529359|Probiotics|probiotics
1312684|NCT01529346|Postoperative dental pain|postoperative dental pain
1312685|NCT01529307|Biologic,|biologic,
1312686|NCT01529307|solid tumors,|solid tumors,
1312687|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
1312688|NCT01529307|caspase-8|caspase-8
1312689|NCT01529294|Hepatic impairment|hepatic impairment
1312690|NCT01529294|Iloperidone|iloperidone
1312691|NCT01529294|ILO522D|ilo522d
1312692|NCT01529294|Pharmacokinetics|pharmacokinetics
1312693|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
1312694|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
1312695|NCT01529268|Children|children
1312696|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
1312697|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
1312698|NCT01529216|DIAMOND System|diamond system
1312699|NCT01529216|T2DM|t2dm
1312700|NCT01529216|Randomized study|randomized study
1312701|NCT01529216|Electrical stimulation|electrical stimulation
1312702|NCT01529216|Fundus|fundus
1312703|NCT01529190|pregabalin|pregabalin
1312704|NCT01529190|postoperative pain control|postoperative pain control
1312705|NCT01529190|interleukin-6|interleukin-6
1312706|NCT01529190|acute pain|acute pain
1312707|NCT01529177|Metformin|metformin
1312708|NCT01529177|Insulin resistance|insulin resistance
1312709|NCT01529177|male infertility|male infertility
1312710|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
1312711|NCT01529177|Clomiphene citrate|clomiphene citrate
1312712|NCT01529177|Unexplained azoospermia|unexplained azoospermia
1312713|NCT01529164|endostatin|endostatin
1312714|NCT01529164|chemotherapy|chemotherapy
1312715|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
1312716|NCT01529164|colorectal cancer|colorectal cancer
1312717|NCT01529151|Dizziness|dizziness
1312718|NCT01529151|Vertigo|vertigo
1312719|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
1312720|NCT01529151|Labyrinthitis|labyrinthitis
1312721|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1312722|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
1312723|NCT01529138|Cancer|cancer
1312724|NCT01529112|Locally Advanced|locally advanced
1312725|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
1312726|NCT01529099|Osteoarthritis|osteoarthritis
1312727|NCT01529099|Knee|knee
1312728|NCT01529099|Knee replacement|knee replacement
1312729|NCT01529099|Knee implant|knee implant
1312730|NCT01529099|Knee arthroplasty|knee arthroplasty
1312731|NCT01529099|Unicompartmental|unicompartmental
1312732|NCT01529099|Primary|primary
1312733|NCT01529099|Partial|partial
1312734|NCT01529099|Patellofemoral|patellofemoral
1312735|NCT01529099|Medial|medial
1312736|NCT01529099|Lateral|lateral
1312737|NCT01529099|Bicompartmental|bicompartmental
1312738|NCT01529099|Cemented|cemented
1312739|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
1312740|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
1312741|NCT01529086|prostate cancer|prostate cancer
1312742|NCT01529086|dutasteride|dutasteride
1312743|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
1312745|NCT01529073|genotype 4 HCV|genotype 4 hcv
1312746|NCT01529073|pegylated interferon|pegylated interferon
1312747|NCT01529073|ribavirin|ribavirin
1312748|NCT01529073|nitazoxanide|nitazoxanide
1312749|NCT01529060|phenylbutyrate|phenylbutyrate
1312750|NCT01529060|MSUD|msud
1312751|NCT01529060|Buphenyl-TM|buphenyl-tm
1312752|NCT01529034|Epilepsy|epilepsy
1312753|NCT01529034|seizure clusters|seizure clusters
1312754|NCT01529034|acute repetitive seizures|acute repetitive seizures
1313153|NCT01527279|paroxysmal|paroxysmal
1312755|NCT01529034|rescue treatment|rescue treatment
1312756|NCT01529021|Pain management|pain management
1312757|NCT01529021|vaccination|vaccination
1312758|NCT01529021|immunization|immunization
1312759|NCT01529021|pediatric|pediatric
1312760|NCT01529021|robotics|robotics
1312761|NCT01529021|human-robot interaction|human-robot interaction
1312762|NCT01529008|Osteonecrosis|osteonecrosis
1312763|NCT01529008|Femoral Head|femoral head
1312764|NCT01529008|Hip|hip
1312765|NCT01529008|Orthopedics|orthopedics
1312766|NCT01529008|Bone|bone
1312767|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
1312768|NCT01528995|fecal incontinence|fecal incontinence
1312769|NCT01528995|anal incontinence|anal incontinence
1312770|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
1312771|NCT01528995|OASIS|oasis
1312772|NCT01528995|double incontinence|double incontinence
1312773|NCT01528995|urinary incontinence|urinary incontinence
1312774|NCT01528995|sexual function|sexual function
1312775|NCT01528995|sacral nerve modulation|sacral nerve modulation
1312776|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
1312777|NCT01528995|Interstim|interstim
1312778|NCT01528995|anal bulking injections|anal bulking injections
1312779|NCT01528995|Permacol|permacol
1312780|NCT01528969|oral microbiota|oral microbiota
1312781|NCT01528969|mutans streptococci|mutans streptococci
1312782|NCT01528969|xylitol|xylitol
1312783|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
1312784|NCT01528943|To evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery|to evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery
1312785|NCT01528930|Lung Diseases|lung diseases
1312786|NCT01528930|Anti-Infective Agents|anti-infective agents
1312787|NCT01528930|Therapeutic Uses|therapeutic uses
1312788|NCT01528930|Amikacin|amikacin
1312789|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
1312790|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
1312791|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
1312792|NCT01528917|Acid lipase disease|acid lipase disease
1312793|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1312794|NCT01528917|LAL Deficiency|lal deficiency
1312795|NCT01528917|LIPA Deficiency|lipa deficiency
1312796|NCT01528917|Wolman disease|wolman disease
1312797|NCT01528904|pregnancy|pregnancy
1312798|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
1312799|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
1312800|NCT01528904|antithyroid antibodies|antithyroid antibodies
1312801|NCT01528904|ultrasound parameters|ultrasound parameters
1312802|NCT01528891|tonsillectomy|tonsillectomy
1312803|NCT01528891|emergence agitation|emergence agitation
1312804|NCT01528878|Liver Cancer|liver cancer
1312805|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
1312806|NCT01528878|HCC|hcc
1312807|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
1312808|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
1312809|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
1312810|NCT01528878|mCRC|mcrc
1312811|NCT01528878|Liver Function|liver function
1312812|NCT01528878|Child-Pugh|child-pugh
1312813|NCT01528865|virus|virus
1312814|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
1312815|NCT01528865|Lymphoma|lymphoma
1312816|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
1312817|NCT01528852|neonatal Mortality|neonatal mortality
1312818|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
1312819|NCT01528852|cord infections|cord infections
1312820|NCT01528852|african settings|african settings
1312821|NCT01528852|clinical trials|clinical trials
1312822|NCT01528839|Bipolar disorder|bipolar disorder
1312823|NCT01528839|Bipolar depression|bipolar depression
1312824|NCT01528839|Thyroid abnormality|thyroid abnormality
1312825|NCT01528839|mood stabilizer|mood stabilizer
1312826|NCT01528839|antidepressants|antidepressants
1312827|NCT01528839|currently depressed|currently depressed
1312828|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
1312829|NCT01528826|vinorebine|vinorebine
1312830|NCT01528826|oxaliplatin|oxaliplatin
1312831|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
1312832|NCT01528813|Er:YAG|er:yag
1312833|NCT01528813|Amorolfine lacquer|amorolfine lacquer
1312834|NCT01528813|Dermatophytes|dermatophytes
1312835|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
1312836|NCT01528813|Drug delivery|drug delivery
1312837|NCT01528800|Vitamin K|vitamin k
1312838|NCT01528800|Chronic kidney disease|chronic kidney disease
1312839|NCT01528800|vascular calcification|vascular calcification
1312840|NCT01528800|hemodialysis|hemodialysis
1312841|NCT01528800|coronary artery calcification|coronary artery calcification
1312842|NCT01528787|Intraocular pressure|intraocular pressure
1312843|NCT01528787|visual field|visual field
1312844|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
1312845|NCT01528774|Melanoma|melanoma
1312846|NCT01528774|Circulating Tumor Cells|circulating tumor cells
1312847|NCT01528774|Prostate cancer|prostate cancer
1312848|NCT01528774|Sarcoma|sarcoma
1312849|NCT01528774|Renal Cancer|renal cancer
1312850|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
1312851|NCT01528774|Other solid tumor|other solid tumor
1312852|NCT01528761|physical activity|physical activity
1312853|NCT01528761|older adults|older adults
1312854|NCT01528761|physical function|physical function
1312855|NCT01528761|health-related quality of life|health-related quality of life
1312856|NCT01528761|prosocial behavior|prosocial behavior
1312857|NCT01528761|social cognitive theory|social cognitive theory
1312858|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
1312859|NCT01528722|Pain scores|pain scores
1312860|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
1312861|NCT01528722|Cholecystitis|cholecystitis
1312862|NCT01528709|Statin,|statin,
1312863|NCT01528709|CABG,|cabg,
1312864|NCT01528709|saphenous vein graft,|saphenous vein graft,
1312865|NCT01528709|graft occlusion,|graft occlusion,
1312866|NCT01528709|lipids|lipids
1312867|NCT01528696|Obesity|obesity
1312868|NCT01528696|Cesarean Section|cesarean section
1312869|NCT01528696|Wound care|wound care
1312870|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
1312871|NCT01528657|Ventricular pacing|ventricular pacing
1312872|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
1312873|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
1312874|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
1312875|NCT01528657|Long term AV|long term av
1312876|NCT01528644|iron|iron
1312877|NCT01528644|fortification|fortification
1312878|NCT01528644|alginate|alginate
1312879|NCT01528644|iron deficiency|iron deficiency
1312880|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
1312881|NCT01528618|treatment|treatment
1312882|NCT01528605|lutein|lutein
1312883|NCT01528605|zeaxanthin|zeaxanthin
1312884|NCT01528605|age-related macular degeneration|age-related macular degeneration
1312885|NCT01528605|supplementation|supplementation
1312886|NCT01528605|macular pigment optical density|macular pigment optical density
1312887|NCT01528605|visual function|visual function
1312888|NCT01528605|serum concentration|serum concentration
1312889|NCT01528579|Whiplash|whiplash
1312890|NCT01528579|Rehabilitation|rehabilitation
1312891|NCT01528579|Physiotherapy|physiotherapy
1312892|NCT01528579|Exercises|exercises
1312893|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
1312894|NCT01528566|Cognitive impairment|cognitive impairment
1312895|NCT01528566|Tai Chi|tai chi
1312896|NCT01528553|genu valgus|genu valgus
1312897|NCT01528553|lower limb|lower limb
1312898|NCT01528553|paediatric|paediatric
1312899|NCT01528553|epiphysiodesis|epiphysiodesis
1312900|NCT01528540|chronic pancreatitis|chronic pancreatitis
1312901|NCT01528540|pregabalin|pregabalin
1312902|NCT01528540|antioxidant|antioxidant
1312903|NCT01528514|Myocardial infarction|myocardial infarction
1312904|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
1312905|NCT01528514|Anti-oxidant|anti-oxidant
1312906|NCT01528514|Curcuminoids|curcuminoids
1312907|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
1312908|NCT01528475|Cardiac arrest|cardiac arrest
1312909|NCT01528462|Stroke|stroke
1312910|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
1312911|NCT01528462|Sleep Disorders|sleep disorders
1312912|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
1312913|NCT01528462|Restless Legs Syndrome|restless legs syndrome
1312914|NCT01528462|Chronobiology Disorders|chronobiology disorders
1312915|NCT01528449|babesia|babesia
1312916|NCT01528449|blood donation|blood donation
1312917|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
1312918|NCT01528436|Cerebral Palsy|cerebral palsy
1312919|NCT01528436|Umbilical Cord Blood|umbilical cord blood
1312920|NCT01528436|Rehabilitation|rehabilitation
1312921|NCT01528423|XtremeCT|xtremect
1312922|NCT01528423|Density|density
1312923|NCT01528423|pQCT|pqct
1312924|NCT01528423|Turnover|turnover
1312925|NCT01528423|Bone|bone
1312926|NCT01528423|short-term reproducibility|short-term reproducibility
1312927|NCT01528397|defect|defect
1312928|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
1312929|NCT01528397|proper digital nerve|proper digital nerve
1312930|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
1312931|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
1312932|NCT01528384|Arginine|arginine
1312933|NCT01528384|Arginine deiminase|arginine deiminase
1312934|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
1312935|NCT01528384|Phase 1|phase 1
1312936|NCT01528384|Pediatric|pediatric
1312937|NCT01528384|Failed other treatments|failed other treatments
1312938|NCT01528384|Pediatric patients|pediatric patients
1312939|NCT01528371|Intravenous sedation|intravenous sedation
1312940|NCT01528371|Midazolam|midazolam
1312941|NCT01528371|Dental treatment|dental treatment
1312942|NCT01528371|White-coat hypertension|white-coat hypertension
1312943|NCT01528371|STAI|stai
1312944|NCT01528371|Dental patients|dental patients
1312945|NCT01528371|Transient hypertension|transient hypertension
1312946|NCT01528358|sepsis|sepsis
1312947|NCT01528358|tissue oximetry|tissue oximetry
1312948|NCT01528358|NIRS|nirs
1312950|NCT01528345|Breast Cancer|breast cancer
1312951|NCT01528345|HER2-, HR+|her2-, hr+
1312952|NCT01528345|post-menopausal|post-menopausal
1312953|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
1312954|NCT01528332|Musculoskeletal pain|musculoskeletal pain
1312955|NCT01528332|Back pain|back pain
1312956|NCT01528332|Chronic pain|chronic pain
1312957|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
1312958|NCT01528319|Suture anchor|suture anchor
1312959|NCT01528319|Shoulder dislocation|shoulder dislocation
1312960|NCT01528306|HP802-247|hp802-247
1312961|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
1312962|NCT01528280|Shift work|shift work
1312963|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
1312964|NCT01528280|humoral response|humoral response
1312965|NCT01528280|cellular response|cellular response
1312966|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
1312967|NCT01528254|Type 2 Diabetes Mellitus,|type 2 diabetes mellitus,
1312968|NCT01528254|Vildagliptin,|vildagliptin,
1312969|NCT01528254|Elderly Patients|elderly patients
1312970|NCT01528241|ABP688|abp688
1312971|NCT01528241|Tracer|tracer
1312972|NCT01528241|Depression|depression
1312973|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
1312974|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
1312975|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
1312976|NCT01528163|Head and neck|head and neck
1312977|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
1312978|NCT01528163|Randomized|randomized
1312979|NCT01528163|palliative treatment|palliative treatment
1312980|NCT01528098|polyethylene glycol|polyethylene glycol
1312981|NCT01528098|bisacodyl|bisacodyl
1312982|NCT01528085|Philadelphia chromsome|philadelphia chromsome
1312983|NCT01528085|BCR-ABL|bcr-abl
1312985|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1312986|NCT01528085|Nilotinib|nilotinib
1312987|NCT01528085|Tasigna|tasigna
1312988|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
1312989|NCT01528072|Spondylolithesis|spondylolithesis
1312990|NCT01528072|pseudoarthrosis|pseudoarthrosis
1312991|NCT01528072|neurologic impairment|neurologic impairment
1312992|NCT01528072|failed fusion|failed fusion
1312993|NCT01528059|Diabetes|diabetes
1312994|NCT01528059|Gastric cancer|gastric cancer
1312995|NCT01528059|Gastric bypass|gastric bypass
1312996|NCT01528046|central nervous system (CNS)|central nervous system (cns)
1312997|NCT01528046|malignancy|malignancy
1312998|NCT01528046|relapsed|relapsed
1312999|NCT01528046|refractory|refractory
1313000|NCT01528046|pediatric|pediatric
1313001|NCT01528046|recurrent|recurrent
1313002|NCT01528033|surgical wound|surgical wound
1313003|NCT01528033|wound healing disorder|wound healing disorder
1313004|NCT01528033|Wound healing impairment|wound healing impairment
1313005|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
1313006|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
1313007|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
1313008|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
1313009|NCT01528007|Pathological gambling|pathological gambling
1313010|NCT01528007|Treatment intervention|treatment intervention
1313011|NCT01527994|Aprepitant|aprepitant
1313012|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
1313013|NCT01527981|Depression|depression
1313014|NCT01527981|Diabetes|diabetes
1313015|NCT01527981|Adherence|adherence
1313016|NCT01527981|Medication|medication
1313017|NCT01527981|Glucose|glucose
1313018|NCT01527981|Insulin|insulin
1313019|NCT01527955|Kelee|kelee
1313020|NCT01527955|Meditation|meditation
1313021|NCT01527955|Stress|stress
1313022|NCT01527955|Anxiety|anxiety
1313023|NCT01527955|Depression|depression
1313024|NCT01527955|Brain|brain
1313025|NCT01527955|Mind|mind
1313026|NCT01527942|Pain Management|pain management
1313027|NCT01527903|propofol|propofol
1313028|NCT01527903|midazolam|midazolam
1313029|NCT01527903|sedation|sedation
1313030|NCT01527903|ICU|icu
1313031|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
1313032|NCT01527890|IV PCA|iv pca
1313033|NCT01527877|BKM120|bkm120
1313034|NCT01527877|head and neck cancer|head and neck cancer
1313035|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
1313036|NCT01527864|NSCLC|nsclc
1313037|NCT01527851|Post-bariatric surgery|post-bariatric surgery
1313038|NCT01527851|Excess skin|excess skin
1313039|NCT01527851|Physical fitness|physical fitness
1313040|NCT01527851|Physical activity|physical activity
1313041|NCT01527851|Barriers to physical activity|barriers to physical activity
1313042|NCT01527851|Plastic surgery|plastic surgery
1313043|NCT01527851|Quality of life|quality of life
1313044|NCT01527851|Self-esteem|self-esteem
1313045|NCT01527838|Hematologic malignancies|hematologic malignancies
1313046|NCT01527799|Sickle cell anemia|sickle cell anemia
1313047|NCT01527799|Exercise testing|exercise testing
1313048|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
1313560|NCT01525446|Lung Cancer|lung cancer
1313049|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
1313050|NCT01527773|COPD|copd
1313051|NCT01527773|Cardiovascular disease|cardiovascular disease
1313052|NCT01527773|Phenotypes|phenotypes
1313053|NCT01527760|Essential Hypertension|essential hypertension
1313054|NCT01527760|Viscum album mother tincture|viscum album mother tincture
1313055|NCT01527760|one group pretest post-test study|one group pretest post-test study
1313056|NCT01527747|Type 2 Diabetes|type 2 diabetes
1313057|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
1313058|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
1313059|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
1313060|NCT01527734|Comparison study|comparison study
1313061|NCT01527721|keratoconus|keratoconus
1313062|NCT01527721|CxL|cxl
1313063|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
1313064|NCT01527695|Phase IIa|phase iia
1313065|NCT01527695|AZD3241|azd3241
1313066|NCT01527695|microglia activation|microglia activation
1313067|NCT01527695|safety|safety
1313068|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
1313069|NCT01527695|Parkinson patients|parkinson patients
1313070|NCT01527682|Intraocular pressure|intraocular pressure
1313071|NCT01527682|Latanoprost|latanoprost
1313072|NCT01527682|Dorzolamide|dorzolamide
1313073|NCT01527669|Red yeast rice|red yeast rice
1313074|NCT01527669|lovastatin|lovastatin
1313075|NCT01527669|Pharmacokinetics|pharmacokinetics
1313076|NCT01527578|Healthy children|healthy children
1313077|NCT01527578|Healthy adults|healthy adults
1313078|NCT01527578|individuals ages 7-60|individuals ages 7-60
1313079|NCT01527526|DMPA|dmpa
1313080|NCT01527526|insulin resistance|insulin resistance
1313081|NCT01527526|cardiovascular disease|cardiovascular disease
1313082|NCT01527526|BMI|bmi
1313083|NCT01527526|weight gain|weight gain
1313084|NCT01527526|thrombosis|thrombosis
1313085|NCT01527513|Partial Epilepsy|partial epilepsy
1313086|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
1313087|NCT01527513|Children|children
1313088|NCT01527500|AMD|amd
1313089|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
1313090|NCT01527500|geographic atrophy|geographic atrophy
1313091|NCT01527500|GA|ga
1313092|NCT01527500|Dry AMD|dry amd
1313093|NCT01527500|Blindness|blindness
1313094|NCT01527500|Drusen|drusen
1313095|NCT01527500|GA lesion|ga lesion
1313096|NCT01527487|breast cancer|breast cancer
1313097|NCT01527487|eribulin|eribulin
1313098|NCT01527487|Halaven|halaven
1313099|NCT01527487|taxotere|taxotere
1313100|NCT01527474|postpartum|postpartum
1313101|NCT01527474|postpartum depression|postpartum depression
1313102|NCT01527474|PPD|ppd
1313103|NCT01527474|escitalopram|escitalopram
1313104|NCT01527461|lung neoplasms|lung neoplasms
1313105|NCT01527461|dogs|dogs
1313106|NCT01527461|sweat|sweat
1313107|NCT01527461|smell|smell
1313108|NCT01527448|postpartum|postpartum
1313109|NCT01527448|postpartum depression|postpartum depression
1313110|NCT01527448|PPD|ppd
1313111|NCT01527448|quetiapine XR|quetiapine xr
1313112|NCT01527448|quetiapine|quetiapine
1313113|NCT01527448|seroquel|seroquel
1313114|NCT01527448|bipolar|bipolar
1313115|NCT01527448|bipolar disorder|bipolar disorder
1313116|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
1313117|NCT01527435|Best corrected visual acuity|best corrected visual acuity
1313118|NCT01527435|Slit lamp examination|slit lamp examination
1313119|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
1313120|NCT01527435|OCT assessment|oct assessment
1313121|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
1313122|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
1313123|NCT01527409|Exercise|exercise
1313124|NCT01527409|Diet|diet
1313125|NCT01527409|Posttraumatic growth|posttraumatic growth
1313126|NCT01527396|endometrial cancer|endometrial cancer
1313127|NCT01527396|lymph node metastasis|lymph node metastasis
1313128|NCT01527396|lymphadenectomy|lymphadenectomy
1313129|NCT01527396|risk criteria|risk criteria
1313130|NCT01527383|Shingles|shingles
1313131|NCT01527357|fibrin sealant|fibrin sealant
1313132|NCT01527357|thrombin|thrombin
1313133|NCT01527357|fibrinogen|fibrinogen
1313134|NCT01527357|hemostasis|hemostasis
1313135|NCT01527344|OCT|oct
1313136|NCT01527344|IVUS|ivus
1313138|NCT01527318|NLSDM|nlsdm
1313139|NCT01527318|Lipid accumulation|lipid accumulation
1313140|NCT01527305|Schizophrenia|schizophrenia
1313141|NCT01527305|Antipsychotics|antipsychotics
1313142|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
1313143|NCT01527305|Paliperidone|paliperidone
1313144|NCT01527305|Invega|invega
1313145|NCT01527305|Sustenna|sustenna
1313146|NCT01527305|Psychotic disorder|psychotic disorder
1313147|NCT01527305|Psychosis|psychosis
1313148|NCT01527292|Vertebral Metastasis|vertebral metastasis
1313149|NCT01527292|pain control|pain control
1313150|NCT01527292|VAP|vap
1313151|NCT01527292|SRT+VAP|srt+vap
1313152|NCT01527279|atrial fibrillation|atrial fibrillation
1313154|NCT01527279|cardioversion|cardioversion
1313155|NCT01527279|antazoline|antazoline
1313156|NCT01527266|carbohydrate|carbohydrate
1313157|NCT01527266|performance|performance
1313158|NCT01527266|cycling|cycling
1313159|NCT01527253|Cardiometabolic risk|cardiometabolic risk
1313160|NCT01527253|Metabolic syndrome|metabolic syndrome
1313161|NCT01527253|Prebiotics|prebiotics
1313162|NCT01527253|Legumes|legumes
1313163|NCT01527253|Wholegrain cereal|wholegrain cereal
1313164|NCT01527253|Functional diet|functional diet
1313165|NCT01527253|Low glycemic index diet|low glycemic index diet
1313166|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
1313167|NCT01527240|Stroke|stroke
1313168|NCT01527240|CsA|csa
1313169|NCT01527240|NIHSS|nihss
1313170|NCT01527227|Children of mentally ill|children of mentally ill
1313171|NCT01527214|Lung cancer|lung cancer
1313172|NCT01527214|early detection|early detection
1313173|NCT01527214|CT scan|ct scan
1313174|NCT01527214|General Practice|general practice
1313175|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
1313176|NCT01527214|Clinical medical education|clinical medical education
1313177|NCT01527201|Arthroscopy|arthroscopy
1313178|NCT01527201|Debridement|debridement
1313179|NCT01527188|HDM|hdm
1313180|NCT01527188|allergic rhinitis|allergic rhinitis
1313181|NCT01527162|Cerebral palsy|cerebral palsy
1313182|NCT01527162|orthotics|orthotics
1313183|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
1313184|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
1313185|NCT01527110|zanamivir|zanamivir
1313186|NCT01527110|Seasonal Influenza|seasonal influenza
1313187|NCT01527110|H1N1|h1n1
1313188|NCT01527110|intravenous|intravenous
1313189|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
1313190|NCT01527110|Pandemic|pandemic
1313191|NCT01527110|Relenza|relenza
1313192|NCT01527110|Influenza B virus|influenza b virus
1313193|NCT01527110|Influenza A virus|influenza a virus
1313194|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
1313195|NCT01527097|Pharmacologic Actions|pharmacologic actions
1313196|NCT01527097|Endothelial Function|endothelial function
1313197|NCT01527097|Dermatology|dermatology
1313198|NCT01527097|Inflammatory Disease|inflammatory disease
1313199|NCT01527097|Skin Disease|skin disease
1313200|NCT01527058|lung cancer|lung cancer
1313201|NCT01527058|integrin receptor|integrin receptor
1313202|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
1313203|NCT01527058|PET/CT|pet/ct
1313204|NCT01527058|efficacy and safety|efficacy and safety
1313205|NCT01527032|amyloidosis|amyloidosis
1313206|NCT01527032|stem cell transplant|stem cell transplant
1313207|NCT01527019|Acute Cystitis|acute cystitis
1313208|NCT01526967|ostomy|ostomy
1313209|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
1313210|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
1313211|NCT01526928|cancer|cancer
1313212|NCT01526928|metastatic|metastatic
1313213|NCT01526928|locally advanced|locally advanced
1313214|NCT01526928|lung|lung
1313215|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
1313216|NCT01526928|NSCLC|nsclc
1313217|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
1313218|NCT01526928|EGFR|egfr
1313219|NCT01526928|T790M|t790m
1313220|NCT01526928|CO-1686|co-1686
1313221|NCT01526928|unresectable|unresectable
1313222|NCT01526928|recurrent|recurrent
1313223|NCT01526928|EGFR-directed therapy|egfr-directed therapy
1313224|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
1313225|NCT01526928|TIGER|tiger
1313226|NCT01526928|Rociletinib|rociletinib
1313227|NCT01526915|PRF|prf
1313228|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
1313229|NCT01526915|BISPHOSPHONATES|bisphosphonates
1313230|NCT01526902|contact lenses|contact lenses
1313231|NCT01526889|Non-infectious uveitis|non-infectious uveitis
1313232|NCT01526889|Panuveitis|panuveitis
1313233|NCT01526889|Vitreous haze|vitreous haze
1313234|NCT01526889|Visual acuity|visual acuity
1313235|NCT01526876|Intracranial Pressure|intracranial pressure
1313236|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
1313237|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
1313238|NCT01526863|Allergy|allergy
1313239|NCT01526863|Egg|egg
1313240|NCT01526850|cGVHD|cgvhd
1313241|NCT01526837|Brain tumor|brain tumor
1313242|NCT01526837|GBM|gbm
1313243|NCT01526837|Brain cancer|brain cancer
1313244|NCT01526811|Endurant|endurant
1313245|NCT01526811|Stent Graft|stent graft
1313246|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1313247|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
1313248|NCT01526798|chronic Inflammation|chronic inflammation
1313249|NCT01526798|EPO Resistance|epo resistance
1313250|NCT01526798|ESA Resistance|esa resistance
1313251|NCT01526798|high cut-off dialysis|high cut-off dialysis
1313252|NCT01526798|hemodialysis|hemodialysis
1313253|NCT01526772|Transnasal|transnasal
1313254|NCT01526772|Transoral|transoral
1313255|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
1313256|NCT01526772|Upper Endoscopy|upper endoscopy
1313257|NCT01526772|Obesity|obesity
1313258|NCT01526759|dietary fiber|dietary fiber
1313259|NCT01526759|energy intake|energy intake
1313260|NCT01526759|satiety|satiety
1313261|NCT01526759|physicochemical properties|physicochemical properties
1313262|NCT01526759|men and women|men and women
1313263|NCT01526759|Healthy adults|healthy adults
1313264|NCT01526746|End stage renal disease|end stage renal disease
1313265|NCT01526746|ESRD|esrd
1313266|NCT01526746|kidney disease|kidney disease
1313267|NCT01526746|renal impairment|renal impairment
1313268|NCT01526746|renal|renal
1313269|NCT01526733|Type 1 Diabetes|type 1 diabetes
1313270|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
1313271|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
1313272|NCT01526720|Beta cell function|beta cell function
1313273|NCT01526720|Insulin sensitivity|insulin sensitivity
1313274|NCT01526720|Genetics of diabetes|genetics of diabetes
1313275|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
1313276|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
1313277|NCT01526681|Sensory Nerve|sensory nerve
1313278|NCT01526681|Mixed Nerve|mixed nerve
1313279|NCT01526681|Motor Nerve|motor nerve
1313280|NCT01526668|Benign gynecological disease|benign gynecological disease
1313281|NCT01526668|Surgery|surgery
1313282|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
1313283|NCT01526668|Pain threshold|pain threshold
1313284|NCT01526668|Chronic pelvic pain|chronic pelvic pain
1313285|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
1313286|NCT01526668|[C13.351.500]|[c13.351.500]
1313287|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
1313288|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
1313289|NCT01526668|Postoperative Care|postoperative care
1313290|NCT01526655|Endometrial cancer|endometrial cancer
1313291|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
1313292|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
1313293|NCT01526655|Fast track program|fast track program
1313294|NCT01526629|ICD|icd
1313295|NCT01526629|Remote follow-up|remote follow-up
1313296|NCT01526616|PCOS|pcos
1313297|NCT01526616|metformin|metformin
1313298|NCT01526616|spironolactone|spironolactone
1313299|NCT01526616|metabolic syndrome|metabolic syndrome
1313300|NCT01526616|hyperandrogenism|hyperandrogenism
1313301|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1313302|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
1313303|NCT01526577|phase1|phase1
1313304|NCT01526577|healthy subjects|healthy subjects
1313305|NCT01526577|antiplatelet agent|antiplatelet agent
1313306|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
1313307|NCT01526551|Human Papillomavirus|human papillomavirus
1313308|NCT01526525|tramadol|tramadol
1313309|NCT01526525|ketamine|ketamine
1313310|NCT01526525|parecoxib|parecoxib
1313311|NCT01526525|paracetamol|paracetamol
1313312|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
1313313|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
1313314|NCT01526525|electronic pressure algometer|electronic pressure algometer
1313315|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
1313316|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
1313317|NCT01526512|Metronomic capecitabine|metronomic capecitabine
1313318|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
1313319|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
1313320|NCT01526499|metastatic breast cancer|metastatic breast cancer
1313321|NCT01526499|first line|first line
1313322|NCT01526499|docetaxel|docetaxel
1313323|NCT01526486|melanoma|melanoma
1313324|NCT01526486|urology|urology
1313325|NCT01526486|inguinal|inguinal
1313326|NCT01526486|lymph nodes|lymph nodes
1313327|NCT01526486|groin|groin
1313328|NCT01526486|lymphadenectomy|lymphadenectomy
1313329|NCT01526486|groin dissection|groin dissection
1313330|NCT01526486|skin cancer|skin cancer
1313331|NCT01526486|penile cancer|penile cancer
1313332|NCT01526486|urethral cancer|urethral cancer
1313333|NCT01526486|scrotal cancer|scrotal cancer
1614761|NCT00340639|Family|family
1313334|NCT01526486|Paget's disease|paget's disease
1313335|NCT01526473|Alphavirus|alphavirus
1313336|NCT01526473|Vaccine|vaccine
1313337|NCT01526473|Immunotherapy|immunotherapy
1313338|NCT01526473|HER2|her2
1313339|NCT01526460|Platelet|platelet
1313340|NCT01526460|Atorvastatin|atorvastatin
1313341|NCT01526460|Rosuvastatin|rosuvastatin
1313342|NCT01526460|Multiplate|multiplate
1313343|NCT01526460|reactivity|reactivity
1313344|NCT01526447|Neck Pain|neck pain
1313345|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
1313346|NCT01526447|Complementary Therapies|complementary therapies
1313347|NCT01526447|Randomized Controlled Trial|randomized controlled trial
1313348|NCT01526447|Sensory Thresholds|sensory thresholds
1313349|NCT01526447|Quality of Life|quality of life
1313350|NCT01526434|Cimzia|cimzia
1313351|NCT01526434|Non-interventional|non-interventional
1313352|NCT01526434|Multicenter|multicenter
1313353|NCT01526434|Postmarketing|postmarketing
1313354|NCT01526434|Local|local
1313355|NCT01526421|HIV|hiv
1313356|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
1313357|NCT01526408|Meniere's Disease|meniere's disease
1313358|NCT01526408|Vertigo|vertigo
1313359|NCT01526408|Hearing loss|hearing loss
1313360|NCT01526408|Tinnitus|tinnitus
1313361|NCT01526408|Anti-viral|anti-viral
1313362|NCT01526408|Famciclovir|famciclovir
1313363|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
1313364|NCT01526395|ECT|ect
1313365|NCT01526395|unmodified|unmodified
1313366|NCT01526395|anesthesia|anesthesia
1313367|NCT01526395|propofol|propofol
1313368|NCT01526382|septic shock|septic shock
1313369|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
1313370|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
1313371|NCT01526382|mortality|mortality
1313372|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
1313373|NCT01526356|Angiofibroma|angiofibroma
1313374|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
1313375|NCT01526356|Rapamycin|rapamycin
1313376|NCT01526356|Sirolimus|sirolimus
1313377|NCT01526356|mTOR|mtor
1313378|NCT01526343|Patients|patients
1313379|NCT01526330|Degenerative disc disease|degenerative disc disease
1313380|NCT01526330|YH14618|yh14618
1313381|NCT01526330|Penial 2000|penial 2000
1313382|NCT01526330|Penial 2K|penial 2k
1313383|NCT01526317|Drug interaction|drug interaction
1313384|NCT01526317|Rosuvastatin|rosuvastatin
1313385|NCT01526317|Metformin SR|metformin sr
1313386|NCT01526317|Pharmacokinetic|pharmacokinetic
1313387|NCT01526291|Myopia|myopia
1313388|NCT01526291|Hyperopia|hyperopia
1313389|NCT01526291|Astigmatism|astigmatism
1313390|NCT01526291|Patient-reported outcomes|patient-reported outcomes
1313391|NCT01526291|Patient satisfaction|patient satisfaction
1313392|NCT01526291|Refractive Error|refractive error
1313393|NCT01526291|Emmetropia|emmetropia
1313394|NCT01526291|Dry eyes|dry eyes
1313395|NCT01526291|glare|glare
1313396|NCT01526291|halos|halos
1313397|NCT01526291|patient expectations|patient expectations
1313398|NCT01526278|alendronate|alendronate
1313399|NCT01526278|Maxmarvil®|maxmarvil®
1313400|NCT01526265|Smoking Cessation|smoking cessation
1313401|NCT01526265|Work-site|work-site
1313402|NCT01526265|Incentives|incentives
1313403|NCT01526265|Health Behavior|health behavior
1313404|NCT01526265|Smoking|smoking
1313405|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
1313406|NCT01526252|database|database
1313407|NCT01526239|Colorectal cancer screening|colorectal cancer screening
1313408|NCT01526239|colon cancer screening|colon cancer screening
1313409|NCT01526239|colonoscopy|colonoscopy
1313410|NCT01526226|High flow nasal cannula|high flow nasal cannula
1313411|NCT01526226|Discomfort|discomfort
1313412|NCT01526200|CLM|clm
1313413|NCT01526187|Public Health and Epidemiology|public health and epidemiology
1313414|NCT01526187|Bacteriology|bacteriology
1313415|NCT01526187|Infectious and Tropical|infectious and tropical
1313416|NCT01526174|autoimmune|autoimmune
1313417|NCT01526174|hearing loss|hearing loss
1313418|NCT01526174|bilateral hearing loss|bilateral hearing loss
1313419|NCT01526174|steroid-dependent|steroid-dependent
1313420|NCT01526161|Asthma|asthma
1313421|NCT01526161|Children|children
1313422|NCT01526161|Therapy|therapy
1313423|NCT01526161|Fluticasone|fluticasone
1313424|NCT01526161|Salmeterol|salmeterol
1313425|NCT01526161|Montelukast|montelukast
1313426|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
1313427|NCT01526122|Clopidogrel|clopidogrel
1313428|NCT01526122|Aspirin|aspirin
1313429|NCT01526122|coadministration|coadministration
1313430|NCT01526109|elderly|elderly
1313431|NCT01526109|quality of life|quality of life
1313432|NCT01526109|functional capacity|functional capacity
1313433|NCT01526109|cognitive function|cognitive function
1313434|NCT01526109|physical exercise|physical exercise
1313435|NCT01526083|Male Healthy Volunteers|male healthy volunteers
1313436|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
1313437|NCT01526057|rituximab|rituximab
1313438|NCT01526057|methotrexate|methotrexate
1313439|NCT01526057|anti-TNF|anti-tnf
1313440|NCT01526044|hyperglycemia|hyperglycemia
1313441|NCT01526044|hypoglycemia|hypoglycemia
1313443|NCT01526044|critical illness|critical illness
1313444|NCT01526044|intensive insulin therapy|intensive insulin therapy
1313445|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
1313446|NCT01526044|CGM|cgm
1313447|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
1313448|NCT01526044|intensive care unit|intensive care unit
1313449|NCT01526044|Blood glucose|blood glucose
1313450|NCT01526031|frozen shoulder|frozen shoulder
1313451|NCT01526031|bee venom acupuncture|bee venom acupuncture
1313452|NCT01526018|Intake|intake
1313453|NCT01526018|Formula feeding|formula feeding
1313454|NCT01525992|Community Pharmacy Services|community pharmacy services
1313455|NCT01525992|Pharmacists|pharmacists
1313456|NCT01525992|Diabetes Mellitus|diabetes mellitus
1313457|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1313458|NCT01525992|Self Care|self care
1313561|NCT01525394|lymphomas|lymphomas
1313459|NCT01525992|Randomized Controlled Trial|randomized controlled trial
1313460|NCT01525979|Stroke rehabilitation|stroke rehabilitation
1313461|NCT01525979|Unilateral arm training|unilateral arm training
1313462|NCT01525979|Bilateral arm training|bilateral arm training
1313463|NCT01525979|Robot-assisted arm training|robot-assisted arm training
1313464|NCT01525979|Kinematic analysis|kinematic analysis
1313465|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
1313466|NCT01525979|Motor recovery|motor recovery
1313467|NCT01525979|Quality of life|quality of life
1313468|NCT01525953|esophageal cancer|esophageal cancer
1313469|NCT01525953|radiochemotherapy|radiochemotherapy
1313470|NCT01525953|prognosis|prognosis
1313471|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
1313472|NCT01525940|CT-colonography|ct-colonography
1313473|NCT01525940|Patients|patients
1313474|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
1313475|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
1313476|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
1313477|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
1313478|NCT01525914|prostate cancer|prostate cancer
1313479|NCT01525914|PSA kinetics|psa kinetics
1313480|NCT01525914|PSA doubling time|psa doubling time
1313481|NCT01525914|active surveillance|active surveillance
1313483|NCT01525901|IGF-1|igf-1
1313484|NCT01525901|Autism|autism
1313485|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
1313486|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
1313487|NCT01525875|calcification|calcification
1313488|NCT01525836|Purpura|purpura
1313489|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1313490|NCT01525797|Liver Transplant|liver transplant
1313491|NCT01525784|rtCGMS|rtcgms
1313492|NCT01525784|glycemic control|glycemic control
1313493|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
1313494|NCT01525784|youth|youth
1313495|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
1313496|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
1313497|NCT01525771|Cisplatin|cisplatin
1313498|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
1313499|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
1313500|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
1313501|NCT01525719|RAD001|rad001
1313502|NCT01525719|everolimus|everolimus
1313503|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
1313504|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
1313505|NCT01525706|Fine Needle Injection|fine needle injection
1313506|NCT01525706|Ethanol Ablation|ethanol ablation
1313507|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
1313508|NCT01525693|diabetes|diabetes
1313509|NCT01525693|diabetics|diabetics
1313510|NCT01525693|high glucose|high glucose
1313511|NCT01525693|Chinese patients|chinese patients
1313512|NCT01525680|PTSD|ptsd
1313513|NCT01525667|THA|tha
1313514|NCT01525667|Muscle injury|muscle injury
1313515|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
1313516|NCT01525654|peer support|peer support
1313517|NCT01525654|self-efficacy|self-efficacy
1313518|NCT01525654|medication adherence|medication adherence
1313519|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
1313520|NCT01525589|Breast cancer|breast cancer
1313521|NCT01525589|PM01183|pm01183
1313522|NCT01525589|lurbinectedin|lurbinectedin
1313523|NCT01525589|Pharma Mar|pharma mar
1313524|NCT01525576|booster program|booster program
1313525|NCT01525576|internet|internet
1313526|NCT01525576|cbt|cbt
1313527|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
1313528|NCT01525563|Duphaston Study|duphaston study
1313529|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
1313530|NCT01525550|adenoma islet cells|adenoma islet cells
1313531|NCT01525550|carcinoma islet cells|carcinoma islet cells
1313532|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
1313533|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
1313534|NCT01525550|sunitinib|sunitinib
1313535|NCT01525550|neoplasms|neoplasms
1313536|NCT01525550|carcinoma|carcinoma
1313537|NCT01525550|adenoma|adenoma
1313538|NCT01525537|Anesthesia General|anesthesia general
1313539|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
1313540|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
1313541|NCT01525524|tDCS|tdcs
1313542|NCT01525524|Major Depression|major depression
1313543|NCT01525524|Stroke|stroke
1313544|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
1313545|NCT01525498|Catheterization|catheterization
1313546|NCT01525498|Urinary tract infection|urinary tract infection
1313547|NCT01525498|Urinary retention|urinary retention
1313548|NCT01525472|obesity|obesity
1313549|NCT01525472|adipose tissue|adipose tissue
1313550|NCT01525472|angiogenesis|angiogenesis
1313551|NCT01525472|senecence|senecence
1313552|NCT01525459|Glioma|glioma
1313553|NCT01525459|PBMC subpopulations|pbmc subpopulations
1313554|NCT01525459|Gene expression|gene expression
1313555|NCT01525459|Metabolomics|metabolomics
1313556|NCT01525459|Immunological status|immunological status
1313557|NCT01525459|miRNA|mirna
1313558|NCT01525459|Proteomics|proteomics
1313559|NCT01525446|NSCLC|nsclc
1313562|NCT01525394|Refractory solid tumors|refractory solid tumors
1313563|NCT01525368|mild cognitive impairment|mild cognitive impairment
1313564|NCT01525368|Alzheimer's disease|alzheimer's disease
1313565|NCT01525368|cognitive intervention|cognitive intervention
1313566|NCT01525368|cognitive reserve|cognitive reserve
1313567|NCT01525355|EUS|eus
1313568|NCT01525355|ERCP|ercp
1313569|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
1313570|NCT01525355|Cholecystectomy|cholecystectomy
1313571|NCT01525355|Common Bile Duct Stones|common bile duct stones
1313572|NCT01525355|Strictures|strictures
1313573|NCT01525355|Stenosis|stenosis
1313574|NCT01525355|Duodenum|duodenum
1313575|NCT01525355|Dilated Bile duct|dilated bile duct
1313576|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
1313577|NCT01525329|Actinic Keratosis|actinic keratosis
1313578|NCT01525329|Photodynamic Therapy|photodynamic therapy
1313579|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
1313580|NCT01525316|Neonates|neonates
1313581|NCT01525316|Lactoferrin|lactoferrin
1313582|NCT01525316|Infections|infections
1313583|NCT01525316|Prevention|prevention
1313584|NCT01525316|Neurodevelopment|neurodevelopment
1313585|NCT01525303|headaches|headaches
1313586|NCT01525303|behavioral treatment|behavioral treatment
1313587|NCT01525303|physical activity|physical activity
1313588|NCT01525290|wake-up stroke|wake-up stroke
1313589|NCT01525290|thrombolysis|thrombolysis
1313590|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1313591|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
1313592|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
1313593|NCT01525264|Mammography|mammography
1313594|NCT01525251|primary caregiver|primary caregiver
1313595|NCT01525251|neuroblastoma|neuroblastoma
1313596|NCT01525251|support group|support group
1313597|NCT01525251|posttraumatic stress|posttraumatic stress
1313598|NCT01525251|uncertainty|uncertainty
1313599|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
1313600|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
1313601|NCT01525199|Lung cancer,|lung cancer,
1313602|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
1313603|NCT01525186|Weight|weight
1313604|NCT01525186|Food intakes|food intakes
1313605|NCT01525186|Feeding|feeding
1313606|NCT01525160|Clot structure|clot structure
1313607|NCT01525160|Haemostasis|haemostasis
1313608|NCT01525160|Gel point|gel point
1313609|NCT01525160|Fractal dimension|fractal dimension
1313610|NCT01525160|serum amyloid A|serum amyloid a
1313611|NCT01525160|C-reactive protein|c-reactive protein
1313612|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
1313613|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
1313614|NCT01525134|Tests, Diagnostic|tests, diagnostic
1313615|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
1313616|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
1313617|NCT01525134|TB|tb
1313618|NCT01525134|Tuberculosis|tuberculosis
1313619|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1313620|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
1313621|NCT01525134|Lipoarabinomannan|lipoarabinomannan
1313622|NCT01525121|mechanical ventilation|mechanical ventilation
1313623|NCT01525121|chest physiotherapy|chest physiotherapy
1313624|NCT01525121|critical care|critical care
1313625|NCT01525121|pneumonia|pneumonia
1313626|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
1313627|NCT01525108|Medication adherence|medication adherence
1313628|NCT01525108|Blood pressure|blood pressure
1313629|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
1313630|NCT01525108|Blood Pressure Determination|blood pressure determination
1313631|NCT01525108|Blood Pressure Monitors|blood pressure monitors
1313632|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1313633|NCT01525095|Candida|candida
1313634|NCT01525095|Diagnostic Assay|diagnostic assay
1313635|NCT01525095|Blood culture|blood culture
1313636|NCT01525095|Sepsis|sepsis
1313637|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
1313638|NCT01525056|rectal cancer|rectal cancer
1313639|NCT01525056|imaging|imaging
1313640|NCT01525056|PET|pet
1313641|NCT01525056|MRI|mri
1313642|NCT01525043|Epicondylitis|epicondylitis
1313643|NCT01525004|Solid organ transplant|solid organ transplant
1313644|NCT01525004|Flu vaccine|flu vaccine
1313645|NCT01524965|Locking Plate|locking plate
1313646|NCT01524965|Physiotherapy|physiotherapy
1313647|NCT01524926|Phase 2|phase 2
1313648|NCT01524926|Crizotinib|crizotinib
1313649|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1313650|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
1313651|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
1313755|NCT01524536|HES|hes
1313652|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
1313653|NCT01524926|Clear cell sarcoma|clear cell sarcoma
1313654|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
1313655|NCT01524874|vitamin d|vitamin d
1313656|NCT01524874|cholecalciferol|cholecalciferol
1313762|NCT01524510|AHI|ahi
1313657|NCT01524874|nutritional supplements|nutritional supplements
1313658|NCT01524874|hypovitaminosis d|hypovitaminosis d
1313659|NCT01524874|klotho|klotho
1313660|NCT01524874|toll like receptor 4|toll like receptor 4
1313661|NCT01524861|Tako-Tsubo|tako-tsubo
1313662|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
1313663|NCT01524861|MIBG|mibg
1313664|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
1313665|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
1313666|NCT01524848|Clinical trial|clinical trial
1313667|NCT01524848|Investigational drugs|investigational drugs
1313668|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1313669|NCT01524848|Pazopanib|pazopanib
1313670|NCT01524835|Tissue Donors|tissue donors
1313671|NCT01524835|Lung|lung
1313672|NCT01524835|Transplants|transplants
1313673|NCT01524835|Transplantation|transplantation
1313674|NCT01524822|Military|military
1313675|NCT01524822|Traumatic Brain Injury|traumatic brain injury
1313676|NCT01524822|Cognitive Testing|cognitive testing
1313677|NCT01524822|Neuroimaging|neuroimaging
1313678|NCT01524822|Brain Function|brain function
1313679|NCT01524796|Real-life|real-life
1313680|NCT01524796|non-interventional|non-interventional
1313681|NCT01524796|observational|observational
1313682|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
1313683|NCT01524796|Lyrica|lyrica
1313684|NCT01524796|pregabalin|pregabalin
1313685|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
1313686|NCT01524783|NET|net
1313687|NCT01524783|progressive|progressive
1313688|NCT01524783|advanced|advanced
1313689|NCT01524783|gastrointestinal|gastrointestinal
1313690|NCT01524783|GI or lung origin|gi or lung origin
1313691|NCT01524783|nonfunctional|nonfunctional
1313692|NCT01524783|everolimus|everolimus
1313693|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
1313694|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
1313695|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
1313696|NCT01524718|radiation|radiation
1313697|NCT01524718|time surgery|time surgery
1313698|NCT01524705|Pilot Study|pilot study
1313699|NCT01524705|Prospective Randomized Trial|prospective randomized trial
1313700|NCT01524705|Comparative Effectiveness|comparative effectiveness
1313701|NCT01524705|Glycemic Variability|glycemic variability
1313702|NCT01524705|insulin glargine|insulin glargine
1313703|NCT01524705|exenatide|exenatide
1313704|NCT01524705|basal insulin|basal insulin
1313705|NCT01524705|bolus insulin|bolus insulin
1313706|NCT01524679|chronic hepatitis B|chronic hepatitis b
1313707|NCT01524653|VTE|vte
1313708|NCT01524653|DVT|dvt
1313709|NCT01524653|Chemo|chemo
1313710|NCT01524653|Metastatic|metastatic
1313711|NCT01524653|Advanced|advanced
1313712|NCT01524653|Systemic therapy|systemic therapy
1313713|NCT01524653|statin|statin
1313714|NCT01524653|biomarkers|biomarkers
1313715|NCT01524640|oral cholera vaccine|oral cholera vaccine
1313716|NCT01524640|safety and immunogenicity|safety and immunogenicity
1313717|NCT01524640|bridging study|bridging study
1313718|NCT01524640|ethiopia|ethiopia
1313719|NCT01524627|Smokers|smokers
1313720|NCT01524627|fMRI|fmri
1313721|NCT01524627|varenicline|varenicline
1313722|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
1313723|NCT01524614|nasal mask|nasal mask
1313724|NCT01524614|upper airway obstruction|upper airway obstruction
1313725|NCT01524601|Immunosuppression|immunosuppression
1313726|NCT01524601|Everolimus|everolimus
1313727|NCT01524601|rosuvastatin|rosuvastatin
1313728|NCT01524601|fluvastatin|fluvastatin
1313729|NCT01524601|Lipid lowering|lipid lowering
1313730|NCT01524588|Genotype|genotype
1313731|NCT01524588|Phenotype|phenotype
1313732|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
1313733|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
1313734|NCT01524575|pancreatic cancer|pancreatic cancer
1313735|NCT01524575|ERCC1|ercc1
1313736|NCT01524575|oxaliplatin|oxaliplatin
1313737|NCT01524575|gemcitabine|gemcitabine
1313738|NCT01524562|Fibrosis|fibrosis
1313739|NCT01524562|Cirrhosis|cirrhosis
1313740|NCT01524562|Africa|africa
1313741|NCT01524562|Schistosomiasis|schistosomiasis
1313742|NCT01524562|Aflatoxin|aflatoxin
1313743|NCT01524562|Liver Disease|liver disease
1313744|NCT01524549|Cardiovascular|cardiovascular
1313745|NCT01524549|P450s|p450s
1313746|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
1313747|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
1313748|NCT01524549|Endothelial Cell Function|endothelial cell function
1313749|NCT01524549|Healthy Volunteer|healthy volunteer
1313750|NCT01524549|HV|hv
1313751|NCT01524536|Hypereosinophilia|hypereosinophilia
1313752|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1313753|NCT01524536|Corticosteroids|corticosteroids
1313754|NCT01524536|Therapy|therapy
1313756|NCT01524523|Gene Expression|gene expression
1313757|NCT01524523|Acute Pain|acute pain
1313758|NCT01524523|Nitric Oxide|nitric oxide
1313759|NCT01524523|Pain|pain
1313760|NCT01524523|Bone Marrow|bone marrow
1313761|NCT01524510|OSAS|osas
1313763|NCT01524510|MRA|mra
1313764|NCT01524510|CFD|cfd
1313765|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
1313766|NCT01524497|poor concentration|poor concentration
1313767|NCT01524497|loss of appetite|loss of appetite
1313768|NCT01524497|suicide|suicide
1313769|NCT01524484|Data quality|data quality
1313770|NCT01524484|Anesthesia|anesthesia
1313771|NCT01524484|Quality assurance|quality assurance
1313772|NCT01524471|Hypertensive LES|hypertensive les
1313773|NCT01524445|Bortezomib|bortezomib
1313774|NCT01524445|Velcade|velcade
1313775|NCT01524445|multiple myeloma|multiple myeloma
1313776|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
1313777|NCT01524432|Clotrimazole|clotrimazole
1313778|NCT01524432|Microcapsules|microcapsules
1313779|NCT01524419|spontaneous labor|spontaneous labor
1313780|NCT01524419|term|term
1313781|NCT01524419|surgical|surgical
1313782|NCT01524419|mechanical|mechanical
1313783|NCT01524419|fetal or maternal complications|fetal or maternal complications
1313784|NCT01524406|Muscle Atrophy|muscle atrophy
1313785|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
1313786|NCT01524393|Pregnancy|pregnancy
1313787|NCT01524393|Pulmonary Embolism|pulmonary embolism
1313788|NCT01524393|Venous Thromboembolism|venous thromboembolism
1313789|NCT01524380|Schizophrenia|schizophrenia
1313790|NCT01524380|clinical trial|clinical trial
1313791|NCT01524380|risperidone|risperidone
1313792|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
1313793|NCT01524380|antioxidant|antioxidant
1313794|NCT01524354|depth of anesthesia|depth of anesthesia
1313795|NCT01524354|valve surgery|valve surgery
1313796|NCT01524341|Acute malaria|acute malaria
1313797|NCT01524341|KAE609|kae609
1313798|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
1313799|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
1313800|NCT01524315|Thiamine|thiamine
1313801|NCT01524315|Vitamin B1|vitamin b1
1313802|NCT01524315|Thiamine Deficiency|thiamine deficiency
1313803|NCT01524315|Thiamine supplementation|thiamine supplementation
1313804|NCT01524315|Cardiac surgery|cardiac surgery
1313805|NCT01524315|Lactic Acid|lactic acid
1313806|NCT01524302|pneumonia|pneumonia
1313807|NCT01524302|ceftaroline|ceftaroline
1313808|NCT01524302|community-aquired|community-aquired
1313809|NCT01524250|Multiple Sclerosis|multiple sclerosis
1313810|NCT01524250|relapse|relapse
1313811|NCT01524250|demyelination|demyelination
1313812|NCT01524250|treatment|treatment
1313813|NCT01524250|corticosteroids|corticosteroids
1313814|NCT01524224|Metastases|metastases
1313815|NCT01524224|Neoplasm|neoplasm
1313816|NCT01524224|Advanced Cancer|advanced cancer
1313817|NCT01524224|Metastatic Cancer|metastatic cancer
1313818|NCT01524211|Aortic Aneurysms|aortic aneurysms
1313819|NCT01524185|childhood trauma|childhood trauma
1313820|NCT01524185|intergenerational trauma|intergenerational trauma
1313821|NCT01524185|child neglect|child neglect
1313822|NCT01524185|child maltreatment|child maltreatment
1313823|NCT01524185|mental health|mental health
1313824|NCT01524172|child trauma exposure|child trauma exposure
1313825|NCT01524172|mental health|mental health
1313826|NCT01524172|yoga|yoga
1313827|NCT01524172|mood regulation|mood regulation
1313828|NCT01524172|child maltreatment|child maltreatment
1313829|NCT01524159|cardiovascular disease|cardiovascular disease
1313830|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
1313831|NCT01524146|Biliary obstruction|biliary obstruction
1313832|NCT01524146|Stent obstruction|stent obstruction
1313833|NCT01524146|Biliary stricture|biliary stricture
1313834|NCT01524146|Photodynamic therapy|photodynamic therapy
1313835|NCT01524146|PDT|pdt
1313836|NCT01524146|Ablation|ablation
1313837|NCT01524133|combat-related PTSD|combat-related ptsd
1313838|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
1313839|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
1313840|NCT01524133|sertraline|sertraline
1313841|NCT01524133|military|military
1313842|NCT01524133|veterans|veterans
1313843|NCT01524133|VA hospital|va hospital
1313844|NCT01524133|mental illness|mental illness
1313845|NCT01524120|Mucosal healing|mucosal healing
1313846|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
1313847|NCT01524107|Maternal Complications|maternal complications
1313848|NCT01524107|Neonatal Complications|neonatal complications
1313849|NCT01524107|Cord Prolapse|cord prolapse
1313850|NCT01524107|Elective Caesarian Section|elective caesarian section
1313851|NCT01524107|Maternal Morbidity|maternal morbidity
1313852|NCT01524107|Neonatal Morbidity|neonatal morbidity
1313853|NCT01524094|colorectal cancer|colorectal cancer
1313854|NCT01524094|cytoreductive surgery|cytoreductive surgery
1313855|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1313856|NCT01524094|systemic chemotherapy|systemic chemotherapy
1314458|NCT01521377|LABA|laba
1313857|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
1313858|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
1313859|NCT01524081|emergent surgery|emergent surgery
1313860|NCT01524081|surgical site infection|surgical site infection
1313958|NCT01523639|steatosis|steatosis
1313861|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
1313862|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1313863|NCT01524068|IPF|ipf
1313864|NCT01524042|Satisfaction|satisfaction
1313865|NCT01524042|colonoscopy|colonoscopy
1313866|NCT01524042|double pants|double pants
1313867|NCT01524042|single pants|single pants
1313868|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
1313869|NCT01524029|Digital Mammography|digital mammography
1313870|NCT01524029|Breast cancer detection|breast cancer detection
1313871|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
1313872|NCT01524016|mesenchymal tumor|mesenchymal tumor
1313873|NCT01524016|Somatostatin receptor|somatostatin receptor
1313874|NCT01524016|68Ga-DOTATATE|68ga-dotatate
1313875|NCT01524016|PET/CT|pet/ct
1313876|NCT01524003|community based participatory research|community based participatory research
1313877|NCT01523977|ALL|all
1313878|NCT01523977|pediatric|pediatric
1313879|NCT01523977|relapse|relapse
1313880|NCT01523964|DMD|dmd
1313881|NCT01523964|EIM|eim
1313882|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1313883|NCT01523964|electrical impedance myography|electrical impedance myography
1313884|NCT01523951|topical local anaesthesia|topical local anaesthesia
1313885|NCT01523951|cooling|cooling
1313886|NCT01523951|capsaicin 8%|capsaicin 8%
1313887|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
1313888|NCT01523951|treatment pain|treatment pain
1313889|NCT01523925|Functional electrical therapy|functional electrical therapy
1313890|NCT01523925|Bilateral arm training|bilateral arm training
1313891|NCT01523925|Constraint induced therapy|constraint induced therapy
1313892|NCT01523925|Stroke rehabilitation|stroke rehabilitation
1313893|NCT01523925|Clinical evaluation|clinical evaluation
1313894|NCT01523925|Kinematic analysis|kinematic analysis
1313895|NCT01523912|radiofrequency ablation|radiofrequency ablation
1313896|NCT01523912|gastric dysplasia|gastric dysplasia
1313897|NCT01523912|gastric neoplasia|gastric neoplasia
1313898|NCT01523899|SSTI|ssti
1313899|NCT01523899|cutaneous abscess|cutaneous abscess
1313900|NCT01523899|boil|boil
1313901|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
1313902|NCT01523847|Cardiopathic|cardiopathic
1313903|NCT01523847|elderly|elderly
1313904|NCT01523847|Myocet|myocet
1313905|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1313906|NCT01523834|Panobinostat|panobinostat
1313907|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
1313908|NCT01523808|pancreatic cancer|pancreatic cancer
1313909|NCT01523808|asparaginase|asparaginase
1313910|NCT01523795|Energy intake|energy intake
1313911|NCT01523795|Video games|video games
1313912|NCT01523795|Television|television
1313913|NCT01523795|Physical activity|physical activity
1313914|NCT01523795|Obesity|obesity
1313915|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
1313916|NCT01523782|Elderly patient|elderly patient
1313917|NCT01523782|Asparaginase|asparaginase
1313918|NCT01523769|prematurity|prematurity
1313919|NCT01523769|umbilical cord milking|umbilical cord milking
1313920|NCT01523769|delayed cord clamping|delayed cord clamping
1313921|NCT01523769|neonatal transfusion|neonatal transfusion
1313922|NCT01523730|Schizophrenia|schizophrenia
1313923|NCT01523730|Nicotine|nicotine
1313924|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1313925|NCT01523730|Cognition|cognition
1313926|NCT01523730|EEG|eeg
1313927|NCT01523717|procalcitonin|procalcitonin
1313928|NCT01523717|decrease over 72 hours|decrease over 72 hours
1313929|NCT01523717|severe sepsis|severe sepsis
1313930|NCT01523717|septic shock|septic shock
1313931|NCT01523691|Healthy individuals|healthy individuals
1313932|NCT01523678|Ovarian Cancer|ovarian cancer
1313933|NCT01523678|Endometrial Cancer|endometrial cancer
1313934|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
1313935|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
1313936|NCT01523678|Paclitaxel|paclitaxel
1313937|NCT01523678|Carboplatin|carboplatin
1313938|NCT01523678|Neupogen|neupogen
1313939|NCT01523678|Filgrastim|filgrastim
1313940|NCT01523678|Ovarian Diseases|ovarian diseases
1313941|NCT01523678|Peritoneal Diseases|peritoneal diseases
1313942|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
1313943|NCT01523678|Endocrine System Diseases|endocrine system diseases
1313944|NCT01523678|Endometrial Diseases|endometrial diseases
1313945|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
1313946|NCT01523678|Neoplasms|neoplasms
1313947|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1313948|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
1313949|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
1313950|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
1313951|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
1313952|NCT01523678|Cervical Neoplasms|cervical neoplasms
1313953|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
1313954|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
1313955|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1313956|NCT01523678|Genital Diseases, Female|genital diseases, female
1313957|NCT01523639|liver injury|liver injury
1313959|NCT01523639|KRAS-Wild-Type|kras-wild-type
1313960|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
1313961|NCT01523639|metformin|metformin
1313962|NCT01523639|placebo|placebo
1313963|NCT01523639|chemotherapy|chemotherapy
1313964|NCT01523626|Trauma|trauma
1313965|NCT01523626|Injur*|injur*
1313966|NCT01523626|Emergen*|emergen*
1313967|NCT01523626|Computed Tomography|computed tomography
1313968|NCT01523626|Total body|total body
1313969|NCT01523626|TBCT|tbct
1313970|NCT01523626|Whole body|whole body
1313971|NCT01523626|WBCT|wbct
1313972|NCT01523626|Full body|full body
1313973|NCT01523626|Pan CT|pan ct
1313974|NCT01523613|Dental caries|dental caries
1313975|NCT01523613|Proximal surfaces|proximal surfaces
1313976|NCT01523613|Posterior teeth|posterior teeth
1313977|NCT01523613|Carious lesions|carious lesions
1313978|NCT01523613|Tooth diseases|tooth diseases
1313979|NCT01523613|Dental restorations|dental restorations
1313980|NCT01523613|Glass-ionomer|glass-ionomer
1313981|NCT01523600|whole body vibration|whole body vibration
1313982|NCT01523600|physical functioning|physical functioning
1313983|NCT01523600|falls|falls
1313984|NCT01523600|older people|older people
1313985|NCT01523600|prevention|prevention
1313986|NCT01523574|oxaliplatin|oxaliplatin
1313987|NCT01523574|vitamin e|vitamin e
1313988|NCT01523574|neuropathy|neuropathy
1313989|NCT01523574|peripheral|peripheral
1313990|NCT01523574|prophylaxis|prophylaxis
1313991|NCT01523561|dance|dance
1313992|NCT01523561|intervention|intervention
1313993|NCT01523561|adolescent|adolescent
1313994|NCT01523561|girls|girls
1313995|NCT01523548|Carbon Monoxide|carbon monoxide
1313996|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
1313997|NCT01523522|Fecal incontinence|fecal incontinence
1313998|NCT01523522|Myoblast|myoblast
1313999|NCT01523522|Surgery|surgery
1314000|NCT01523509|Dental Caries|dental caries
1314001|NCT01523509|Radiography, Dental|radiography, dental
1314002|NCT01523509|Contrast media|contrast media
1314003|NCT01523509|Tooth|tooth
1314004|NCT01523496|HIV|hiv
1314005|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
1314006|NCT01523483|preterm birth|preterm birth
1314007|NCT01523483|preterm labor|preterm labor
1314008|NCT01523483|progesterone|progesterone
1314009|NCT01523483|uterine electromyography|uterine electromyography
1314010|NCT01523483|cervical length|cervical length
1314011|NCT01523470|non-invasive ventilator|non-invasive ventilator
1314012|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
1314013|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
1314014|NCT01523457|FOLFIRINOX|folfirinox
1314015|NCT01523457|phase II|phase ii
1314016|NCT01523457|progression free survival|progression free survival
1314017|NCT01523444|Adolescents|adolescents
1314018|NCT01523444|Screening|screening
1314019|NCT01523444|Advice|advice
1314020|NCT01523444|Referral|referral
1314021|NCT01523431|Colorectal cancer|colorectal cancer
1314022|NCT01523431|Irinotecan|irinotecan
1314023|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
1314024|NCT01523431|Neutropenia|neutropenia
1314025|NCT01523431|diarrhea|diarrhea
1314026|NCT01523431|response|response
1314027|NCT01523431|pharmacokinetic|pharmacokinetic
1314028|NCT01523418|Xarelto|xarelto
1314029|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
1314030|NCT01523418|Orthopedic surgery|orthopedic surgery
1314031|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
1314032|NCT01523418|Observational study|observational study
1314033|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
1314034|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
1314035|NCT01523379|Causalgia|causalgia
1314036|NCT01523379|CRPS|crps
1314037|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
1314038|NCT01523379|Dynastat|dynastat
1314039|NCT01523379|Parecoxib|parecoxib
1314040|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
1314041|NCT01523353|Prehabilitation|prehabilitation
1314042|NCT01523353|Exercise|exercise
1314043|NCT01523353|Colorectal Cancer|colorectal cancer
1314044|NCT01523353|Surgery|surgery
1314045|NCT01523327|Uric acid|uric acid
1314046|NCT01523314|diabetic macular edema|diabetic macular edema
1314047|NCT01523314|intravitreal injection|intravitreal injection
1314048|NCT01523314|dexamethasone|dexamethasone
1314049|NCT01523314|Cyclodextrin|cyclodextrin
1314050|NCT01523314|eye drops|eye drops
1314051|NCT01523314|bevacizumab|bevacizumab
1314052|NCT01523314|macular laser|macular laser
1314053|NCT01523301|Rotigotine|rotigotine
1314054|NCT01523301|Neupro|neupro
1314055|NCT01523301|Depressive Symptom|depressive symptom
1314056|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1314057|NCT01523275|mitomycin-C|mitomycin-c
1314058|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
1314059|NCT01523275|subglottic stenosis|subglottic stenosis
1314060|NCT01523275|tracheal stenosis|tracheal stenosis
1314061|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
1314062|NCT01523262|preconditioning|preconditioning
1314063|NCT01523262|aortic aneurysm|aortic aneurysm
1314064|NCT01523249|3D ultrasonography|3d ultrasonography
1314065|NCT01523249|epidural|epidural
1314066|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
1314067|NCT01523249|neuraxial analgesia|neuraxial analgesia
1314068|NCT01523249|pregnant woman|pregnant woman
1314069|NCT01523249|parturients|parturients
1314070|NCT01523236|Allergic Rhinitis|allergic rhinitis
1314071|NCT01523236|Bioequivalence|bioequivalence
1314072|NCT01523210|spasticity|spasticity
1314073|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
1314074|NCT01523210|distribution|distribution
1314075|NCT01523210|botulinum toxin|botulinum toxin
1314076|NCT01523210|physiotherapy|physiotherapy
1314077|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
1314078|NCT01523197|COPD|copd
1314079|NCT01523197|overlap syndrome|overlap syndrome
1314080|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
1314081|NCT01523197|BiPAP ventilation|bipap ventilation
1314082|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
1314083|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
1314084|NCT01523184|Gastric Emptying|gastric emptying
1314085|NCT01523184|Colon Transit|colon transit
1314086|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
1314087|NCT01523184|gastrointestinal transit|gastrointestinal transit
1314088|NCT01523184|colonic transit|colonic transit
1314089|NCT01523158|Allergic Rhinitis|allergic rhinitis
1314090|NCT01523158|Immunotherapy|immunotherapy
1314091|NCT01523145|Atrial fibrillation|atrial fibrillation
1314092|NCT01523145|Radio Frequency Ablation|radio frequency ablation
1314093|NCT01523145|Rehabilitation|rehabilitation
1314094|NCT01523145|Physical capacity|physical capacity
1314095|NCT01523145|Quality of life|quality of life
1314096|NCT01523145|Integrated rehabilitation|integrated rehabilitation
1314097|NCT01523106|Crohn's disease|crohn's disease
1314098|NCT01523106|carnitine|carnitine
1314099|NCT01523067|Vasomera|vasomera
1314100|NCT01523067|PB1046|pb1046
1314101|NCT01523067|Hypertension|hypertension
1314102|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
1314103|NCT01523015|Adenocarcinoma|adenocarcinoma
1314104|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
1314105|NCT01523015|chemotherapy|chemotherapy
1314106|NCT01523015|chemoradiotherapy|chemoradiotherapy
1314107|NCT01523015|surgery|surgery
1314108|NCT01522989|Cancer|cancer
1314109|NCT01522989|Advanced|advanced
1314110|NCT01522989|Refractory|refractory
1314111|NCT01522950|hypertension|hypertension
1314112|NCT01522950|prevention|prevention
1314113|NCT01522950|endothelial function|endothelial function
1314114|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
1314115|NCT01522924|standardized patients|standardized patients
1314116|NCT01522924|dental students|dental students
1314117|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
1314118|NCT01522898|Heart Failure|heart failure
1314119|NCT01522898|Atrial Fibrillation|atrial fibrillation
1314120|NCT01522885|Chest tube|chest tube
1314121|NCT01522885|placement|placement
1314122|NCT01522885|mal positioning|mal positioning
1314123|NCT01522872|TH-302|th-302
1314124|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1314125|NCT01522872|Bortezomib|bortezomib
1314126|NCT01522872|Phase 1/2|phase 1/2
1314127|NCT01522872|Hypoxia|hypoxia
1314128|NCT01522872|Myeloma|myeloma
1314129|NCT01522872|Evofosfamide|evofosfamide
1314130|NCT01522872|Pomalidomide|pomalidomide
1314131|NCT01522872|Pimonidazole|pimonidazole
1314132|NCT01522859|COPD|copd
1314133|NCT01522859|Telehealth|telehealth
1314134|NCT01522859|health related quality of life|health related quality of life
1314135|NCT01522833|NSLCL|nslcl
1314136|NCT01522833|Erlotinib|erlotinib
1314137|NCT01522833|Tarceva|tarceva
1314138|NCT01522807|Phase 1|phase 1
1314139|NCT01522807|Single Doses|single doses
1314140|NCT01522807|Biocomparison|biocomparison
1314141|NCT01522807|Pharmacokinetics|pharmacokinetics
1314142|NCT01522807|Healthy Volunteers|healthy volunteers
1314143|NCT01522768|ESOPHAGUS|esophagus
1314144|NCT01522768|STOMACH|stomach
1314145|NCT01522768|Afatinib|afatinib
1314146|NCT01522768|paclitaxel|paclitaxel
1314147|NCT01522768|trastuzumab|trastuzumab
1314148|NCT01522768|11-166|11-166
1314149|NCT01522755|Pacing lead|pacing lead
1314150|NCT01522755|implant|implant
1314151|NCT01522755|pacemaker|pacemaker
1314152|NCT01522742|psoriasis|psoriasis
1314153|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
1314154|NCT01522742|atherosclerosis|atherosclerosis
1314155|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
1314156|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
1314157|NCT01522729|Muscle dysfunction|muscle dysfunction
1314158|NCT01522729|Exercise intolerance|exercise intolerance
1314159|NCT01522729|Muscle afferents|muscle afferents
1314160|NCT01522729|Ventilation|ventilation
1314161|NCT01522703|asthma|asthma
1314162|NCT01522703|allergic rhinitis|allergic rhinitis
1314163|NCT01522703|dietary interventions|dietary interventions
1314164|NCT01522703|mouse allergy|mouse allergy
1314165|NCT01522690|Accelerometer|accelerometer
1314166|NCT01522690|gait analysis|gait analysis
1314167|NCT01522690|Healthy subjects|healthy subjects
1314168|NCT01522677|tumor immunology|tumor immunology
1314169|NCT01522677|neoadjuvant|neoadjuvant
1314170|NCT01522677|colonoscopy|colonoscopy
1314171|NCT01522677|photosensitization|photosensitization
1314172|NCT01522651|Atrial Fibrillation|atrial fibrillation
1314173|NCT01522651|Ranolazine|ranolazine
1314174|NCT01522651|Dronedarone|dronedarone
1314175|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
1314176|NCT01522625|chronic hepatitis B|chronic hepatitis b
1314177|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
1314178|NCT01522625|antiviral therapy|antiviral therapy
1314179|NCT01522625|Tenofovir|tenofovir
1314180|NCT01522612|KRAS Wild Type|kras wild type
1314181|NCT01522612|Frail Elderly|frail elderly
1314182|NCT01522612|QLQ-C30|qlq-c30
1314183|NCT01522612|QLQ-ELD14|qlq-eld14
1314184|NCT01522612|CGA|cga
1314185|NCT01522612|EGFR|egfr
1314186|NCT01522612|Cetuximab|cetuximab
1314187|NCT01522612|5-FU|5-fu
1314188|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
1314189|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
1314190|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
1314191|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
1314192|NCT01522573|Pancreatic Cancer|pancreatic cancer
1314193|NCT01522573|Bile Duct Cancer|bile duct cancer
1314194|NCT01522573|Biliary Stricture|biliary stricture
1314195|NCT01522573|Biliary obstruction|biliary obstruction
1314196|NCT01522573|Stent obstruction|stent obstruction
1314197|NCT01522573|Proximal duct stricture|proximal duct stricture
1314198|NCT01522573|Distal duct stricture|distal duct stricture
1314199|NCT01522573|Ampullary Cancer|ampullary cancer
1314200|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
1314201|NCT01522573|Impacted stones|impacted stones
1314202|NCT01522573|Chronic pancreatitis|chronic pancreatitis
1314203|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
1314204|NCT01522573|Altered anatomy|altered anatomy
1314205|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
1314206|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1314207|NCT01522573|Multicenter|multicenter
1314208|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
1314209|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
1314210|NCT01522547|Pomalidomide|pomalidomide
1314211|NCT01522547|Sickle Cell Disease|sickle cell disease
1314212|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
1314213|NCT01522534|injuries|injuries
1314214|NCT01522534|pain|pain
1314215|NCT01522534|Block, Nerve|block, nerve
1314216|NCT01522534|morphine|morphine
1314217|NCT01522534|Prehospital Emergency Care|prehospital emergency care
1314218|NCT01522521|AK156|ak156
1314219|NCT01522508|Analgesia|analgesia
1314220|NCT01522508|Anesthetics|anesthetics
1314221|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1314222|NCT01522482|fatty acids|fatty acids
1314223|NCT01522482|cardiovascular disease|cardiovascular disease
1314224|NCT01522482|genotype|genotype
1314225|NCT01522482|apoE|apoe
1314226|NCT01522469|FLT3|flt3
1314227|NCT01522469|Crenolanib|crenolanib
1314228|NCT01522469|Acute|acute
1314229|NCT01522469|myeloid|myeloid
1314230|NCT01522469|leukemia|leukemia
1314231|NCT01522469|relapsed|relapsed
1314232|NCT01522469|refractory|refractory
1314233|NCT01522443|prostate cancer|prostate cancer
1314234|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
1314235|NCT01522443|bone pain|bone pain
1314236|NCT01522443|CRPC|crpc
1314237|NCT01522430|Resistant hypertension|resistant hypertension
1314238|NCT01522430|Renal denervation|renal denervation
1314239|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
1314240|NCT01522430|Renal function|renal function
1314241|NCT01522430|Simplicity catheter|simplicity catheter
1314242|NCT01522430|Sham procedure|sham procedure
1314243|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
1314244|NCT01522404|Memory Loss|memory loss
1314245|NCT01522404|Alzheimer's Disease|alzheimer's disease
1314246|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
1314247|NCT01522365|Dental implants|dental implants
1314248|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
1314249|NCT01522352|Bioprosthesis,|bioprosthesis,
1314250|NCT01522352|aortic valve replacement|aortic valve replacement
1314251|NCT01522352|Magna Ease|magna ease
1314252|NCT01522352|Mitroflow|mitroflow
1314253|NCT01522352|Trifecta|trifecta
1314254|NCT01522339|NICU|nicu
1314256|NCT01522339|Neonatal|neonatal
1314257|NCT01522339|Safety|safety
1314258|NCT01522339|Efficacy|efficacy
1314259|NCT01522339|Cincinnati|cincinnati
1314260|NCT01522326|Acute Mountain Sickness|acute mountain sickness
1314646|NCT01520623|Gut GVHD|gut gvhd
1314261|NCT01522326|High Altitude Headache|high altitude headache
1314262|NCT01522326|Lake Louise AMS Score|lake louise ams score
1314263|NCT01522326|Visual Analog Scale|visual analog scale
1314264|NCT01522326|Ibuprofen|ibuprofen
1314265|NCT01522326|Metoclopramide|metoclopramide
1314266|NCT01522326|Nepal|nepal
1314267|NCT01522300|Tomosynthesis|tomosynthesis
1314268|NCT01522300|breast cancer|breast cancer
1314269|NCT01522300|specificity|specificity
1314270|NCT01522300|sensitivity|sensitivity
1314271|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
1314272|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
1314273|NCT01522287|Computer Assisted Therapy|computer assisted therapy
1314274|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
1314275|NCT01522287|Cognitive Therapy|cognitive therapy
1314276|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
1314277|NCT01522248|influenza vaccine|influenza vaccine
1314278|NCT01522248|cytokines|cytokines
1314279|NCT01522248|chemokines|chemokines
1314280|NCT01522248|symptoms|symptoms
1314281|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
1314282|NCT01522235|Orthostatic hypotension|orthostatic hypotension
1314283|NCT01522235|Dysautonomia|dysautonomia
1314284|NCT01522235|Autonomic failure|autonomic failure
1314285|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
1314286|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
1314287|NCT01522222|CABG|cabg
1314288|NCT01522222|PEEP|peep
1314289|NCT01522209|CRLM|crlm
1314290|NCT01522209|Primovist MRI|primovist mri
1314291|NCT01522209|CEIOUS|ceious
1314292|NCT01522196|SCD|scd
1314293|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
1314294|NCT01522183|aHUS|ahus
1314295|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
1314296|NCT01522183|TMA|tma
1314297|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
1314298|NCT01522170|aHUS|ahus
1314299|NCT01522170|Eculizumab|eculizumab
1314300|NCT01522157|Diet|diet
1314301|NCT01522157|Low-carbohydrate|low-carbohydrate
1314302|NCT01522157|Postprandial|postprandial
1314303|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
1314304|NCT01522131|bioresorbable membrane|bioresorbable membrane
1314305|NCT01522118|Prostate Cancer|prostate cancer
1314306|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
1314307|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
1314308|NCT01522118|Non-invasive therapy|non-invasive therapy
1314309|NCT01522118|Focal Disease|focal disease
1314310|NCT01522105|Meningitis|meningitis
1314311|NCT01522105|Central Nervous System Infections|central nervous system infections
1314312|NCT01522105|Pediatrics|pediatrics
1314313|NCT01522105|Daptomycin|daptomycin
1314314|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
1314315|NCT01522105|Therapeutic Use|therapeutic use
1314316|NCT01522105|Pharmacologic Actions|pharmacologic actions
1314317|NCT01522092|Exacerbations|exacerbations
1314318|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
1314319|NCT01522079|heart rate variability|heart rate variability
1314320|NCT01522079|posture|posture
1314321|NCT01522079|air stacking|air stacking
1314322|NCT01522040|Asthma|asthma
1314323|NCT01522040|Magnesium|magnesium
1314324|NCT01522040|Adrenergic Receptor|adrenergic receptor
1314325|NCT01522014|Joint Replacement|joint replacement
1314326|NCT01522014|Health Related Quality of Life|health related quality of life
1314327|NCT01522014|Functional Outcomes|functional outcomes
1314328|NCT01522014|Revision Rate|revision rate
1314329|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
1314330|NCT01522001|Myocardial Ischemia|myocardial ischemia
1314331|NCT01522001|Shared Care|shared care
1314332|NCT01522001|Rehabilitation|rehabilitation
1314333|NCT01522001|Community|community
1314334|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
1314335|NCT01522001|Hospital|hospital
1314336|NCT01521988|Atrial flutter|atrial flutter
1314337|NCT01521988|Atrial fibrillation|atrial fibrillation
1314338|NCT01521988|Catheter ablation|catheter ablation
1314339|NCT01521975|HBV DNA|hbv dna
1314340|NCT01521975|LdT|ldt
1314341|NCT01521975|ADV|adv
1314342|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
1314343|NCT01521975|CHB|chb
1314344|NCT01521949|Prostate Cancer|prostate cancer
1314345|NCT01521949|Nutraceutical|nutraceutical
1314346|NCT01521949|Acai Juice|acai juice
1314347|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
1314348|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
1314349|NCT01521910|survival|survival
1314350|NCT01521910|protein restriction|protein restriction
1314351|NCT01521910|diabetic nephropathy|diabetic nephropathy
1314352|NCT01521910|type 1 diabetes|type 1 diabetes
1314353|NCT01521910|GFR|gfr
1314354|NCT01521910|ESRD|esrd
1314355|NCT01521910|progressive renal disease|progressive renal disease
1314356|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
1314357|NCT01521897|Prevenar|prevenar
1314358|NCT01521897|7-valent|7-valent
1315050|NCT01519037|renin|renin
1314359|NCT01521897|Special Use-result surveillance|special use-result surveillance
1314360|NCT01521871|Tissue glue|tissue glue
1314361|NCT01521871|Cyanoacrylate|cyanoacrylate
1314362|NCT01521871|Wound closure|wound closure
1314363|NCT01521871|Living donor nephrectomy|living donor nephrectomy
1314364|NCT01521871|Surgical wound closure|surgical wound closure
1314467|NCT01521364|drug-interaction|drug-interaction
1314365|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
1314366|NCT01521845|hs-CRP|hs-crp
1314367|NCT01521845|CKMB and troponin I|ckmb and troponin i
1314368|NCT01521819|AMD|amd
1314369|NCT01521819|V-Ped|v-ped
1314370|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
1314371|NCT01521819|Iray|iray
1314372|NCT01521819|radiation|radiation
1314373|NCT01521819|retina|retina
1314374|NCT01521819|macula|macula
1314375|NCT01521819|radiotherapy|radiotherapy
1314376|NCT01521806|insulin sensitivity|insulin sensitivity
1314377|NCT01521806|resistant starch|resistant starch
1314378|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
1314379|NCT01521780|MRI|mri
1314380|NCT01521780|pharmacogenomics|pharmacogenomics
1314381|NCT01521780|beta-catenin|beta-catenin
1314382|NCT01521767|pharmacokinetics|pharmacokinetics
1314383|NCT01521767|relative bioavailability|relative bioavailability
1314384|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
1314385|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
1314386|NCT01521741|Breast Cancer|breast cancer
1314387|NCT01521741|Lymphedema|lymphedema
1314388|NCT01521741|symptoms|symptoms
1314389|NCT01521728|ALS|als
1314390|NCT01521728|Exercise|exercise
1314391|NCT01521728|Resistance|resistance
1314392|NCT01521728|Endurance|endurance
1314393|NCT01521702|adenocarcinoma|adenocarcinoma
1314394|NCT01521702|pancreatic head|pancreatic head
1314395|NCT01521689|MRD negative CR|mrd negative cr
1314396|NCT01521676|breast cancer|breast cancer
1314397|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
1314398|NCT01521650|Probiotics|probiotics
1314399|NCT01521650|Anaesthesia|anaesthesia
1314400|NCT01521650|Intubation|intubation
1314401|NCT01521650|Pathogenic bacteria|pathogenic bacteria
1314402|NCT01521611|Radioimmunotherapy|radioimmunotherapy
1314403|NCT01521611|Transplant|transplant
1314404|NCT01521611|BMT|bmt
1314405|NCT01521611|yttrium|yttrium
1314406|NCT01521611|indium|indium
1314407|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1314408|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1314409|NCT01521572|bronchial reversibility,|bronchial reversibility,
1314410|NCT01521572|bronchodilator,|bronchodilator,
1314411|NCT01521572|respiratory impedance,|respiratory impedance,
1314412|NCT01521572|forced oscillation technique,|forced oscillation technique,
1314413|NCT01521572|plethysmography,|plethysmography,
1314414|NCT01521572|spirometry|spirometry
1314415|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
1314416|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
1314417|NCT01521546|cardiomyopathy|cardiomyopathy
1314418|NCT01521546|aldosterone antagonist|aldosterone antagonist
1314419|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
1314420|NCT01521533|NOX-A12|nox-a12
1314421|NCT01521533|Velcade|velcade
1314422|NCT01521533|Dexamethasone|dexamethasone
1314423|NCT01521533|Spiegelmer|spiegelmer
1314424|NCT01521533|Chemosensitization|chemosensitization
1314425|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
1314426|NCT01521533|CXCL12|cxcl12
1314427|NCT01521520|type 1 diabetes|type 1 diabetes
1314428|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
1314429|NCT01521520|insulitis|insulitis
1314430|NCT01521520|ferumoxytol|ferumoxytol
1314431|NCT01521494|Hemodialysis|hemodialysis
1314432|NCT01521494|Hyperphosphatemia|hyperphosphatemia
1314433|NCT01521468|Coronary artery disease|coronary artery disease
1314434|NCT01521468|Diagnostic accuracy|diagnostic accuracy
1314435|NCT01521468|CT coronary angiography|ct coronary angiography
1314436|NCT01521468|Positron emission tomography|positron emission tomography
1314437|NCT01521468|Single photon emission tomography|single photon emission tomography
1314438|NCT01521468|Noninvasive techniques|noninvasive techniques
1314439|NCT01521468|Cardiac catheterization|cardiac catheterization
1314440|NCT01521468|Fractional flow reserve|fractional flow reserve
1314441|NCT01521442|PTSD|ptsd
1314442|NCT01521442|Yoga|yoga
1314443|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
1314444|NCT01521416|Illness|illness
1314445|NCT01521416|Influenza|influenza
1314446|NCT01521416|Cost|cost
1314447|NCT01521416|UK|uk
1314448|NCT01521403|Blastocystis hominis|blastocystis hominis
1314449|NCT01521403|Metronidazole|metronidazole
1314450|NCT01521377|LAMA|lama
1314451|NCT01521377|Respiratory|respiratory
1314452|NCT01521377|COPD|copd
1314453|NCT01521377|Tolerability|tolerability
1314454|NCT01521377|Beta-2 Agonist|beta-2 agonist
1314455|NCT01521377|Safety|safety
1314456|NCT01521377|Pharmacokinetics|pharmacokinetics
1314457|NCT01521377|Pharmacodynamics|pharmacodynamics
1314459|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
1314460|NCT01521377|Healthy subjects|healthy subjects
1314461|NCT01521377|Moxifloxacin|moxifloxacin
1314462|NCT01521377|Anticholinergic|anticholinergic
1314463|NCT01521377|GW642444|gw642444
1314464|NCT01521377|GSK573719|gsk573719
1314465|NCT01521377|QTc|qtc
1314466|NCT01521364|pharmacokinetic|pharmacokinetic
1314468|NCT01521364|linezolid|linezolid
1314469|NCT01521364|clarithromycin|clarithromycin
1314470|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
1314471|NCT01521351|microwave radiometry|microwave radiometry
1314472|NCT01521351|cardiovascular events|cardiovascular events
1314473|NCT01521351|carotid artery disease|carotid artery disease
1314475|NCT01521351|myocardial infarction|myocardial infarction
1314476|NCT01521338|Cystic Fibrosis|cystic fibrosis
1314477|NCT01521338|G551D|g551d
1314478|NCT01521338|G551D Mutation|g551d mutation
1314479|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
1314480|NCT01521312|Saxagliptin|saxagliptin
1314481|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
1314482|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
1314483|NCT01521312|Arterial stiffness|arterial stiffness
1314484|NCT01521312|Endothelial function|endothelial function
1314485|NCT01521299|hydroxyurea|hydroxyurea
1314486|NCT01521299|S phase|s phase
1314487|NCT01521299|G2 phase|g2 phase
1314488|NCT01521299|pharmacokinetics|pharmacokinetics
1314489|NCT01521286|Spain|spain
1314490|NCT01521286|cost|cost
1314491|NCT01521286|complications|complications
1314492|NCT01521286|incidence|incidence
1314493|NCT01521286|adults|adults
1314494|NCT01521286|quality of life|quality of life
1314495|NCT01521286|Herpes Zoster|herpes zoster
1314496|NCT01521286|Surveillance|surveillance
1314497|NCT01521273|beans|beans
1314498|NCT01521273|biofortification|biofortification
1314499|NCT01521273|phytic acid|phytic acid
1314500|NCT01521273|iron|iron
1314501|NCT01521273|iron isotopes|iron isotopes
1314502|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
1314503|NCT01521260|dental implants|dental implants
1314504|NCT01521260|microbiology|microbiology
1314505|NCT01521260|chlorhexidine|chlorhexidine
1314506|NCT01521247|Asthma|asthma
1314507|NCT01521247|Transition program|transition program
1314508|NCT01521247|Pediatric|pediatric
1314509|NCT01521247|Adult|adult
1314510|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
1314511|NCT01521208|Chest compressions|chest compressions
1314512|NCT01521208|LUCAS device|lucas device
1314513|NCT01521195|pediatric|pediatric
1314514|NCT01521195|ECMO|ecmo
1314515|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
1314516|NCT01521195|VO2|vo2
1314517|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
1314518|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
1314519|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
1314520|NCT01521143|EOC|eoc
1314521|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
1314522|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
1314523|NCT01521117|donepezil|donepezil
1314524|NCT01521117|parkinson's disease|parkinson's disease
1314525|NCT01521117|balance|balance
1314526|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
1314527|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
1314528|NCT01521104|colorectal lesions|colorectal lesions
1314529|NCT01521104|predicting histology|predicting histology
1314530|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
1420769|NCT01081431|MDS|mds
1314531|NCT01521091|indigo carmine|indigo carmine
1314532|NCT01521091|acetic acid|acetic acid
1314533|NCT01521091|colorectal lesions|colorectal lesions
1314534|NCT01521091|predicting histology|predicting histology
1314535|NCT01521065|AMD|amd
1314536|NCT01521065|Wet AMD|wet amd
1314537|NCT01521039|aGVHD|agvhd
1314538|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
1314539|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1314540|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1314541|NCT01521039|MicroRNA Expression|microrna expression
1314542|NCT01521000|Breast Cancer|breast cancer
1314543|NCT01521000|Lymphedema|lymphedema
1314544|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
1314545|NCT01521000|Axillary Dissection|axillary dissection
1314546|NCT01520987|Parkinson Disease|parkinson disease
1314547|NCT01520987|BIA 9-1067|bia 9-1067
1314548|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
1314549|NCT01520948|Parkinson disease|parkinson disease
1314550|NCT01520948|Incontinence|incontinence
1314551|NCT01520935|Office of National Statistics|office of national statistics
1314552|NCT01520935|Burden of Disease|burden of disease
1314553|NCT01520935|Influenza|influenza
1314554|NCT01520935|Hospital Episode Statistics|hospital episode statistics
1314555|NCT01520935|General Practitioners Research Database|general practitioners research database
1314645|NCT01520623|Activation of complement system|activation of complement system
1314556|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
1314557|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1314558|NCT01520922|CLL|cll
1314559|NCT01520922|Cancer|cancer
1314560|NCT01520922|Lymphoid leukemia|lymphoid leukemia
1314561|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
1314562|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1314563|NCT01520909|pediatrics|pediatrics
1314564|NCT01520909|chronic ITP|chronic itp
1314565|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1314566|NCT01520909|eltrombopag|eltrombopag
1314567|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
1314568|NCT01520909|platelet disorder|platelet disorder
1314569|NCT01520909|thrombocytopenia|thrombocytopenia
1314570|NCT01520896|Phase 1|phase 1
1314571|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
1314572|NCT01520896|Drug-drug interaction|drug-drug interaction
1314573|NCT01520896|Pharmacokinetics|pharmacokinetics
1314574|NCT01520896|NKTR-118|nktr-118
1314575|NCT01520870|Dacomitinib|dacomitinib
1314576|NCT01520870|PF-299804|pf-299804
1314577|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
1314578|NCT01520870|EGFR|egfr
1314579|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
1314580|NCT01520857|TAPP|tapp
1314581|NCT01520857|Spinal Anesthesia|spinal anesthesia
1314582|NCT01520857|General Anesthesia|general anesthesia
1314583|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
1314584|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
1314585|NCT01520805|refractory|refractory
1314586|NCT01520805|relapsed|relapsed
1314587|NCT01520805|hypomethylating agents|hypomethylating agents
1314588|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
1314589|NCT01520792|Pain threshold|pain threshold
1314590|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
1314591|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
1314592|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
1314593|NCT01520766|glass fiber posts|glass fiber posts
1314594|NCT01520766|titanium posts|titanium posts
1314595|NCT01520766|postendodontic restoration|postendodontic restoration
1314596|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
1314597|NCT01520740|Gold Stage III|gold stage iii
1314598|NCT01520740|Gold Stage IV|gold stage iv
1314599|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1314600|NCT01520740|COPD|copd
1314601|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
1314602|NCT01520740|LVRS|lvrs
1314603|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1314604|NCT01520740|BLVR|blvr
1314605|NCT01520740|Upper Lobe Predominant|upper lobe predominant
1314606|NCT01520740|ULP|ulp
1314607|NCT01520740|Heterogeneous|heterogeneous
1314608|NCT01520740|Homogeneous|homogeneous
1314609|NCT01520727|BIA 9-1067|bia 9-1067
1314610|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
1314611|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
1314612|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
1314613|NCT01520714|Fraction|fraction
1314614|NCT01520701|head and neck cancer|head and neck cancer
1314615|NCT01520701|Hydrotac®|hydrotac®
1314616|NCT01520701|radiodermatitis|radiodermatitis
1314617|NCT01520701|algia|algia
1314618|NCT01520701|radiotherapy|radiotherapy
1314619|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
1314620|NCT01520675|chronic pancreatitis|chronic pancreatitis
1314621|NCT01520675|randomized controlled trial|randomized controlled trial
1314622|NCT01520675|endoscopic therapy|endoscopic therapy
1314623|NCT01520675|surgery|surgery
1314624|NCT01520675|ESWL|eswl
1314625|NCT01520662|patient-centered care|patient-centered care
1314626|NCT01520662|wellness|wellness
1314627|NCT01520662|preventive services|preventive services
1314628|NCT01520662|primary care|primary care
1314629|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
1314630|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
1314631|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
1314632|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
1314633|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
1314634|NCT01520649|Neurogenesis|neurogenesis
1314635|NCT01520649|hippocampal stem cells|hippocampal stem cells
1314636|NCT01520649|depression|depression
1314637|NCT01520649|stroke|stroke
1314638|NCT01520636|stroke|stroke
1314639|NCT01520636|early rehabilitation|early rehabilitation
1314640|NCT01520636|motor recovery|motor recovery
1314641|NCT01520636|functional recovery|functional recovery
1314642|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
1314643|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
1314644|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
1314647|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
1314648|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
1314649|NCT01520610|Myocardiopathies|myocardiopathies
1314650|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
1314651|NCT01520610|Gene|gene
1314652|NCT01520597|Multicentric|multicentric
1314653|NCT01520597|National|national
1314654|NCT01520597|Prospective on|prospective on
1314655|NCT01520597|Listeriosis|listeriosis
1314656|NCT01520597|Listeria|listeria
1314657|NCT01520571|Computer Assistance|computer assistance
1314658|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
1314659|NCT01520571|conventional|conventional
1314660|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
1314661|NCT01520558|High Risk Relapse|high risk relapse
1314662|NCT01520558|Complete Remission|complete remission
1314663|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
1314664|NCT01520545|Gablofen|gablofen
1314665|NCT01520545|baclofen injection|baclofen injection
1314666|NCT01520519|Leukemia|leukemia
1314667|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1314668|NCT01520519|CLL|cll
1314669|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1314670|NCT01520519|SLL|sll
1314671|NCT01520519|Rituximab|rituximab
1314672|NCT01520519|Rituxan|rituxan
1314673|NCT01520519|PCI-32765|pci-32765
1314674|NCT01520506|Hypertension|hypertension
1314675|NCT01520506|Kidney Diseases|kidney diseases
1314676|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
1314677|NCT01520506|Vascular Diseases|vascular diseases
1314678|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
1314679|NCT01520506|Urologic Diseases|urologic diseases
1314680|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
1314681|NCT01520506|Renal Insufficiency|renal insufficiency
1314682|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
1314683|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
1314684|NCT01520493|exercise induced blood flow|exercise induced blood flow
1314685|NCT01520480|survival after surgery|survival after surgery
1314686|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
1314687|NCT01520467|SRS|srs
1314688|NCT01520467|PWS|pws
1314689|NCT01520467|pathological adrenarche|pathological adrenarche
1314690|NCT01520467|aromatase inhibitor|aromatase inhibitor
1314691|NCT01520467|Children|children
1314692|NCT01520454|Leptin resistance|leptin resistance
1314693|NCT01520454|Free fatty acids|free fatty acids
1314694|NCT01520454|Lipotoxicity|lipotoxicity
1314695|NCT01520441|Botulinum Toxin|botulinum toxin
1314696|NCT01520441|Prostate Cancer|prostate cancer
1314697|NCT01520441|BPH|bph
1314698|NCT01520441|LUTS|luts
1314699|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
1314700|NCT01520389|cancer|cancer
1314701|NCT01520389|solid tumors|solid tumors
1314702|NCT01520389|oncology|oncology
1314703|NCT01520389|Phase I|phase i
1314704|NCT01520389|EGFR|egfr
1314705|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
1314706|NCT01520389|irinotecan|irinotecan
1314707|NCT01520363|Rett syndrome|rett syndrome
1314708|NCT01520363|RTT|rtt
1314709|NCT01520363|MECP2|mecp2
1314710|NCT01520363|dextromethorphan|dextromethorphan
1314711|NCT01520363|DM|dm
1314712|NCT01520311|Coronary Artery Disease|coronary artery disease
1314713|NCT01520311|Myocardial Ischemia|myocardial ischemia
1314714|NCT01520311|Coronary Disease|coronary disease
1314715|NCT01520311|Heart Diseases|heart diseases
1314716|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
1314717|NCT01520311|Arteriosclerosis|arteriosclerosis
1314718|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
1314719|NCT01520311|Vascular Diseases|vascular diseases
1314720|NCT01520311|CABG|cabg
1314721|NCT01520311|SVG|svg
1314722|NCT01520311|eSVS Mesh|esvs mesh
1314723|NCT01520311|Bypass Grafting|bypass grafting
1314724|NCT01520285|hypertension|hypertension
1314725|NCT01520285|Blood pressure decrease|blood pressure decrease
1314726|NCT01520285|efficacy|efficacy
1314727|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
1314728|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
1314729|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
1314730|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
1314731|NCT01520272|HP Vaccine|hp vaccine
1314732|NCT01520259|Gallbaldder|gallbaldder
1314733|NCT01520259|Gallstones|gallstones
1314734|NCT01520259|Inflammation|inflammation
1314735|NCT01520259|Cholecystectomy|cholecystectomy
1314736|NCT01520259|Cancer|cancer
1314737|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
1314738|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1314739|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1314740|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1314741|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
1314742|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1314743|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
1314744|NCT01520233|regional neuroblastoma|regional neuroblastoma
1314745|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
1314746|NCT01520194|genital warts|genital warts
1314747|NCT01520194|HPV|hpv
1314748|NCT01520194|psychosocial burden|psychosocial burden
1314749|NCT01520194|economic burden|economic burden
1314750|NCT01520194|female genital warts|female genital warts
1314751|NCT01520168|Incisional hernia|incisional hernia
1314752|NCT01520168|Mesh|mesh
1314753|NCT01520168|Surgery|surgery
1314754|NCT01520168|Composix Kugel|composix kugel
1314755|NCT01520168|IPOM technique|ipom technique
1314756|NCT01520155|lupus erythematosus|lupus erythematosus
1314757|NCT01520155|cardiovascular risk|cardiovascular risk
1314758|NCT01520142|Healthy participants|healthy participants
1314759|NCT01520142|Pharmacodynamic|pharmacodynamic
1314760|NCT01520142|Pharmacokinetics|pharmacokinetics
1314761|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
1314762|NCT01520142|Acute Inflammation|acute inflammation
1314763|NCT01520142|JNJ-26528398|jnj-26528398
1314764|NCT01520142|Anti-inflammatory|anti-inflammatory
1314765|NCT01520129|Bipolar Disorder|bipolar disorder
1314766|NCT01520129|Bipolar NOS|bipolar nos
1314767|NCT01520129|Bipolar Depression|bipolar depression
1314768|NCT01520103|Metastatic breast cancer|metastatic breast cancer
1314769|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
1314770|NCT01520103|Her2/new negative|her2/new negative
1314771|NCT01520103|HER2 negative|her2 negative
1314772|NCT01520090|contraception|contraception
1314773|NCT01520090|family planning|family planning
1314774|NCT01520090|egyptian|egyptian
1314775|NCT01520090|knowledge|knowledge
1314776|NCT01520077|alopecia areata|alopecia areata
1314777|NCT01520077|vytorin|vytorin
1314778|NCT01520077|statin|statin
1314779|NCT01520077|hair growth|hair growth
1314780|NCT01520064|Emphysema|emphysema
1314781|NCT01520064|GOLD Stage III|gold stage iii
1314782|NCT01520064|GOLD Stage IV|gold stage iv
1314783|NCT01520064|AeriSeal System|aeriseal system
1314784|NCT01520064|Homogeneous|homogeneous
1314785|NCT01520064|Heterogeneous|heterogeneous
1314786|NCT01520064|Upper Lobe Predominant|upper lobe predominant
1314787|NCT01520064|ULP|ulp
1314788|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1314789|NCT01520064|COPD|copd
1314790|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
1314791|NCT01520064|LVRS|lvrs
1314792|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1314793|NCT01520064|BLVR|blvr
1314794|NCT01520051|Asthma|asthma
1314795|NCT01520051|Viral|viral
1314796|NCT01520051|Infection|infection
1314797|NCT01520051|Inflammation|inflammation
1314798|NCT01520051|Mepolizumab|mepolizumab
1314799|NCT01520051|Eosinophilia|eosinophilia
1314800|NCT01520025|Radiopharmaceutical|radiopharmaceutical
1314801|NCT01520025|18FDG PET|18fdg pet
1314802|NCT01520025|CTA|cta
1314803|NCT01520025|Multi-modality imaging|multi-modality imaging
1314804|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
1314805|NCT01520025|Myocardial blood flow|myocardial blood flow
1314806|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
1314807|NCT01519999|Shared decision making|shared decision making
1314808|NCT01519999|Ambulatory Care|ambulatory care
1314809|NCT01519999|Patient-Centered Care|patient-centered care
1314810|NCT01519999|Community-wide intervention|community-wide intervention
1314811|NCT01519999|Intervention Study|intervention study
1314812|NCT01519999|Longitudinal Studies|longitudinal studies
1314813|NCT01519986|Vitamin D|vitamin d
1314814|NCT01519986|Cholecalciferol|cholecalciferol
1314815|NCT01519986|Supplementation|supplementation
1314816|NCT01519986|Dietary Supplements|dietary supplements
1314817|NCT01519986|Dietary Fats|dietary fats
1314818|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
1314819|NCT01519973|Diagnostic imaging|diagnostic imaging
1314820|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
1314821|NCT01519973|Positron emission tomography|positron emission tomography
1314822|NCT01519973|Computed tomography|computed tomography
1314823|NCT01519973|Attenuation|attenuation
1314824|NCT01519973|Resolution|resolution
1314825|NCT01519973|Scatter|scatter
1314826|NCT01519973|Radiopharmaceutical|radiopharmaceutical
1314827|NCT01519934|Ulthera® System|ulthera® system
1314828|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
1314829|NCT01519934|Ulthera, Inc.|ulthera, inc.
1314830|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1314831|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
1314832|NCT01519908|biomarkers|biomarkers
1314833|NCT01519908|response|response
1314834|NCT01519895|quality of life|quality of life
1314835|NCT01519895|anxiety|anxiety
1314836|NCT01519895|stress|stress
1314837|NCT01519895|carers|carers
1314838|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
1314839|NCT01519882|Rotigotine|rotigotine
1314840|NCT01519882|Neupro|neupro
1314841|NCT01519882|Polysomnography|polysomnography
1314842|NCT01519882|Sleep efficiency|sleep efficiency
1314843|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
1314844|NCT01519882|Sleep Disorder|sleep disorder
1314845|NCT01519869|peritoneal|peritoneal
1314846|NCT01519869|carcinoma|carcinoma
1314847|NCT01519869|ovarian|ovarian
1314848|NCT01519869|fallopian tube|fallopian tube
1314849|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1314850|NCT01519869|surgical debulking|surgical debulking
1314851|NCT01519856|open|open
1314852|NCT01519856|non-intervention|non-intervention
1314853|NCT01519856|observational|observational
1314854|NCT01519843|stroke|stroke
1314855|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
1314856|NCT01519830|Blood Donors|blood donors
1314857|NCT01519817|Vaccine Therapy|vaccine therapy
1314858|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
1314859|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
1314860|NCT01519817|Clinical Response|clinical response
1314861|NCT01519817|Immune Response|immune response
1314862|NCT01519817|Cancer|cancer
1314863|NCT01519817|Solid Tumor|solid tumor
1314864|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
1314865|NCT01519791|Methotrexate|methotrexate
1314866|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
1314867|NCT01519752|Tinea Pedis|tinea pedis
1314868|NCT01519713|Meningitis|meningitis
1314869|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
1314870|NCT01519713|Meningococcal Infections|meningococcal infections
1314871|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
1314872|NCT01519713|Menactra®|menactra®
1314873|NCT01519700|Filgrastim|filgrastim
1314874|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
1314875|NCT01519700|supportive care|supportive care
1314876|NCT01519700|breast cancer|breast cancer
1314877|NCT01519687|hyperuricemia|hyperuricemia
1314878|NCT01519687|gout|gout
1314879|NCT01519687|levotofisopam|levotofisopam
1314880|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
1314881|NCT01519661|Cystic fibrosis|cystic fibrosis
1314882|NCT01519661|Lung disease|lung disease
1314883|NCT01519661|Anti-bacterial agents|anti-bacterial agents
1314884|NCT01519648|Invasive fungal infection|invasive fungal infection
1314885|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
1314886|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1314887|NCT01519648|Antifungal stewardship|antifungal stewardship
1314888|NCT01519648|Neutropenia|neutropenia
1314889|NCT01519648|Hematological malignancies|hematological malignancies
1314890|NCT01519635|Kidney oxygenation|kidney oxygenation
1314891|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
1314892|NCT01519635|BOLD-IRM|bold-irm
1314893|NCT01519622|End of life decisions|end of life decisions
1314894|NCT01519622|Perception of illness|perception of illness
1314895|NCT01519609|Bowel prep|bowel prep
1314896|NCT01519609|Safety|safety
1314897|NCT01519609|Efficacy|efficacy
1314898|NCT01519583|walking|walking
1314899|NCT01519583|physical activity|physical activity
1314900|NCT01519583|sedentary behavior|sedentary behavior
1314901|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
1314902|NCT01519570|Electronic patient portal|electronic patient portal
1314903|NCT01519570|Electronic medical record|electronic medical record
1314904|NCT01519570|Primary care|primary care
1314905|NCT01519570|Immunizations|immunizations
1314906|NCT01519544|Sleep|sleep
1314907|NCT01519544|High Altitude|high altitude
1314908|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
1314909|NCT01519544|Acute Mountain Sickness|acute mountain sickness
1314910|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
1314911|NCT01519544|Periodic Breathing|periodic breathing
1314912|NCT01519544|Actigraphy|actigraphy
1314913|NCT01519544|Acetazolamide|acetazolamide
1314914|NCT01519544|Temazepam|temazepam
1314915|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
1314916|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
1314917|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
1314918|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
1314919|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1314920|NCT01519518|Unfractionated heparin|unfractionated heparin
1314921|NCT01519518|Bivalirudin|bivalirudin
1314922|NCT01519518|primary angioplasty|primary angioplasty
1314923|NCT01519505|Prevention|prevention
1314924|NCT01519505|Diabetes mellitus|diabetes mellitus
1314925|NCT01519505|Lifestyle changes|lifestyle changes
1314926|NCT01519505|Cardiovascular risk|cardiovascular risk
1314927|NCT01519505|Cost-effectiveness|cost-effectiveness
1314928|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
1314929|NCT01519479|Congestive Heart Failure|congestive heart failure
1314930|NCT01519479|Heart Failure|heart failure
1314931|NCT01519479|Palliative Care|palliative care
1314932|NCT01519479|Palliative Medicine|palliative medicine
1314933|NCT01519466|Diabetes|diabetes
1314934|NCT01519466|SMBG|smbg
1314935|NCT01519466|Insulin calculator|insulin calculator
1314936|NCT01519453|Asthma|asthma
1314937|NCT01519453|Preschool|preschool
1314938|NCT01519453|Health Disparities|health disparities
1314939|NCT01519453|Implementation|implementation
1314940|NCT01519440|unintended extension|unintended extension
1314941|NCT01519440|blunt|blunt
1314942|NCT01519440|sharp|sharp
1314943|NCT01519440|maternal blood loss|maternal blood loss
1314944|NCT01519401|PCOS|pcos
1314945|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
1314946|NCT01519401|androgens|androgens
1314947|NCT01519401|metabolism|metabolism
1314948|NCT01519388|Neuromuscular disorder|neuromuscular disorder
1314949|NCT01519388|Respiratory failure|respiratory failure
1314950|NCT01519388|Swallowing|swallowing
1314951|NCT01519388|Mechanical ventilation|mechanical ventilation
1314952|NCT01519375|Osteoarthritis|osteoarthritis
1314953|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
1314954|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
1314955|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
1314956|NCT01519362|leukocytopenia|leukocytopenia
1314957|NCT01519362|migration|migration
1314958|NCT01519362|complication|complication
1314959|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
1314960|NCT01519362|PAAG injection|paag injection
1314961|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
1314962|NCT01519349|BMD|bmd
1314963|NCT01519349|muscular dystrophy|muscular dystrophy
1314964|NCT01519349|inclusion body myositis|inclusion body myositis
1314965|NCT01519349|IBM|ibm
1314966|NCT01519349|Follistatin|follistatin
1314967|NCT01519310|choline metabolism|choline metabolism
1314968|NCT01519310|gut flora|gut flora
1314969|NCT01519310|phosphatidylcholine|phosphatidylcholine
1314970|NCT01519310|lecithin|lecithin
1314971|NCT01519297|Preeclampsia|preeclampsia
1314972|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
1314973|NCT01519284|Parkinson Disease|parkinson disease
1314974|NCT01519284|BIA 9-1067|bia 9-1067
1314975|NCT01519271|Parkinson's Disease|parkinson's disease
1314976|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
1314977|NCT01519271|Cognition|cognition
1314978|NCT01519271|Memory|memory
1314979|NCT01519271|Attention|attention
1314980|NCT01519271|Exelon|exelon
1314981|NCT01519271|Rivastigmine|rivastigmine
1314982|NCT01519258|ARDS|ards
1314983|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
1314984|NCT01519245|tranexamic acid|tranexamic acid
1314985|NCT01519245|antifibrinolytic|antifibrinolytic
1314986|NCT01519245|administration, topical|administration, topical
1314987|NCT01519245|operative blood salvage|operative blood salvage
1314988|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
1314989|NCT01519219|hepatic irradiation|hepatic irradiation
1314990|NCT01519219|IC-GREEN|ic-green
1314991|NCT01519206|Ulthera® System|ulthera® system
1314992|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
1314993|NCT01519206|Ulthera, Inc.|ulthera, inc.
1314994|NCT01519193|Aggressive Behavior|aggressive behavior
1314995|NCT01519193|Appetitive Aggression|appetitive aggression
1314996|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1314997|NCT01519180|gastroparesis|gastroparesis
1314998|NCT01519180|gastric emptying|gastric emptying
1314999|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
1315000|NCT01519154|deep sedation|deep sedation
1315001|NCT01519154|propofol|propofol
1315002|NCT01519154|ketamine|ketamine
1315003|NCT01519154|child|child
1315004|NCT01519154|preschool child|preschool child
1315005|NCT01519154|infant|infant
1315006|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
1315007|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
1315008|NCT01519141|Atherosclerosis|atherosclerosis
1315009|NCT01519141|Inflammation|inflammation
1315010|NCT01519141|Endothelial Function|endothelial function
1315011|NCT01519141|Thrombosis|thrombosis
1315012|NCT01519128|Healthy|healthy
1315013|NCT01519128|TMC278|tmc278
1315014|NCT01519128|TMC278IFD1001|tmc278ifd1001
1315015|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
1315016|NCT01519128|Pharmacokinetics|pharmacokinetics
1315017|NCT01519128|Digoxin|digoxin
1315018|NCT01519115|deep cervical flexors|deep cervical flexors
1315019|NCT01519115|spine stabilization|spine stabilization
1315020|NCT01519115|posture|posture
1315021|NCT01519115|function|function
1315022|NCT01519115|neck pain|neck pain
1315023|NCT01519089|chronic|chronic
1315024|NCT01519089|severe|severe
1315025|NCT01519089|moderate|moderate
1315026|NCT01519089|treatment|treatment
1315027|NCT01519089|safety|safety
1315028|NCT01519089|efficacy|efficacy
1315029|NCT01519089|CP-690|cp-690
1315030|NCT01519089|550|550
1315031|NCT01519089|Plaque psoriasis|plaque psoriasis
1315032|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
1315033|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
1315034|NCT01519089|tofacitinib|tofacitinib
1315035|NCT01519089|Xeljanz|xeljanz
1315036|NCT01519076|stroke|stroke
1315037|NCT01519063|Alcohol|alcohol
1315038|NCT01519063|Drinking|drinking
1315039|NCT01519063|Drinkers|drinkers
1315040|NCT01519063|Alcohol Drinking|alcohol drinking
1315041|NCT01519063|Memantine|memantine
1315042|NCT01519063|Naltrexone|naltrexone
1315043|NCT01519063|Alcohol Dependence|alcohol dependence
1315044|NCT01519063|Alcohol Abuse|alcohol abuse
1315045|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
1315046|NCT01519063|Ethanol|ethanol
1315047|NCT01519063|Alcoholism|alcoholism
1315048|NCT01519037|calcimimetic agent|calcimimetic agent
1315049|NCT01519037|RAAS|raas
1315051|NCT01519037|aldosterone|aldosterone
1315052|NCT01519024|hypertrophy|hypertrophy
1315053|NCT01519024|breast|breast
1315054|NCT01519024|postural balance|postural balance
1315055|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
1315056|NCT01519011|MDS|mds
1315057|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1315058|NCT01519011|CMML|cmml
1315059|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
1315060|NCT01519011|AML|aml
1315061|NCT01519011|Vidaza|vidaza
1315062|NCT01519011|oral azacitidine|oral azacitidine
1315063|NCT01519011|aza|aza
1315064|NCT01519011|oral aza|oral aza
1315065|NCT01519011|pharmacokinetics|pharmacokinetics
1315066|NCT01519011|hematology|hematology
1315067|NCT01519011|myeloid disease|myeloid disease
1315068|NCT01519011|PK|pk
1315069|NCT01518998|Fimasartan|fimasartan
1315070|NCT01518998|Amlodipine|amlodipine
1315071|NCT01518998|antihypertension|antihypertension
1315072|NCT01518972|Alcohol|alcohol
1315073|NCT01518972|Abuse|abuse
1315074|NCT01518972|Use|use
1315075|NCT01518972|Disorder|disorder
1315076|NCT01518972|Dependence|dependence
1315077|NCT01518972|Symptoms|symptoms
1315078|NCT01518972|Alcoholic|alcoholic
1315079|NCT01518972|Alcoholism|alcoholism
1315080|NCT01518972|Prazosin|prazosin
1315081|NCT01518972|Drug|drug
1315082|NCT01518972|Medicine|medicine
1315083|NCT01518972|Medication|medication
1315084|NCT01518972|Treatment|treatment
1315085|NCT01518972|Study|study
1315086|NCT01518972|Placebo|placebo
1315087|NCT01518972|Medical|medical
1315088|NCT01518972|Management|management
1315089|NCT01518972|Craving|craving
1315090|NCT01518972|Consumption|consumption
1315091|NCT01518972|Binge|binge
1315092|NCT01518972|Drinking|drinking
1315093|NCT01518972|Drink|drink
1315094|NCT01518972|Heavy|heavy
1315095|NCT01518972|PTSD|ptsd
1315096|NCT01518972|Trauma|trauma
1315097|NCT01518972|Post|post
1315098|NCT01518972|Posttraumatic|posttraumatic
1315099|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
1315100|NCT01518933|HCV recurrence|hcv recurrence
1315101|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
1315102|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
1315103|NCT01518920|PF-04958242|pf-04958242
1315104|NCT01518907|cellulite|cellulite
1315105|NCT01518907|Xiaflex|xiaflex
1315106|NCT01518894|PF-04958242|pf-04958242
1315107|NCT01518894|multiple dose|multiple dose
1315108|NCT01518894|Safety|safety
1315109|NCT01518894|schizophrenia|schizophrenia
1315110|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
1315111|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
1315112|NCT01518829|postablation syndrom|postablation syndrom
1315113|NCT01518829|procalcitonin|procalcitonin
1315114|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
1315115|NCT01518803|Obesity|obesity
1315116|NCT01518803|Adolescence|adolescence
1315117|NCT01518803|Lipid metabolism|lipid metabolism
1315118|NCT01518803|Mediterranean diet|mediterranean diet
1315119|NCT01518803|Chylomicron|chylomicron
1315120|NCT01518803|Macrophages|macrophages
1315121|NCT01518790|PEG 3350|peg 3350
1315122|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
1315123|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
1315124|NCT01518790|bowel preparation|bowel preparation
1315125|NCT01518790|miralax|miralax
1315126|NCT01518790|gatorade|gatorade
1315127|NCT01518790|cleanout efficacy|cleanout efficacy
1315128|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
1315129|NCT01518777|Coronary Artery Disease|coronary artery disease
1315130|NCT01518725|Muscle Power|muscle power
1315131|NCT01518725|Vitamin D|vitamin d
1315132|NCT01518725|Vitamins|vitamins
1315133|NCT01518725|Cholecalciferol|cholecalciferol
1315134|NCT01518712|Healthy Volunteers|healthy volunteers
1315135|NCT01518712|Bioequivalence|bioequivalence
1315136|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1315137|NCT01518712|Metformin IR|metformin ir
1315138|NCT01518686|Norm values|norm values
1315139|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
1315140|NCT01518686|isopters|isopters
1315141|NCT01518686|mathematical model|mathematical model
1315142|NCT01518686|luminance|luminance
1315143|NCT01518686|test-retest reliability|test-retest reliability
1315144|NCT01518686|deviation|deviation
1315145|NCT01518686|age dependance|age dependance
1315146|NCT01518686|different age groups|different age groups
1315147|NCT01518686|Healthy subjects|healthy subjects
1315148|NCT01518660|Resistance Training|resistance training
1315149|NCT01518660|Strength Training|strength training
1315150|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
1315151|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
1315152|NCT01518647|Functional somatic symptoms|functional somatic symptoms
1315153|NCT01518647|Functional somatic syndromes|functional somatic syndromes
1315154|NCT01518647|Treatment|treatment
1315247|NCT01518192|erythema migrans|erythema migrans
1315155|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
1315156|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
1315157|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
1315158|NCT01518634|Functional somatic symptoms|functional somatic symptoms
1315159|NCT01518634|Functional somatic syndromes|functional somatic syndromes
1315160|NCT01518634|Treatment|treatment
1315161|NCT01518634|Imipramine|imipramine
1315162|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
1315163|NCT01518608|Alfentanil|alfentanil
1315164|NCT01518608|Tracheal intubation|tracheal intubation
1315165|NCT01518608|Rapid sequence induction|rapid sequence induction
1315166|NCT01518595|patients|patients
1315167|NCT01518582|Cervicobrachial|cervicobrachial
1315168|NCT01518582|neuralgia|neuralgia
1315169|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
1315170|NCT01518569|ulinastatin|ulinastatin
1315171|NCT01518569|systemic inflammation|systemic inflammation
1315172|NCT01518569|cardiac surgery|cardiac surgery
1315173|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
1315174|NCT01518556|Idarubicin|idarubicin
1315175|NCT01518556|Remission Induction|remission induction
1315176|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
1315177|NCT01518556|Survival|survival
1315178|NCT01518543|arthrodesis|arthrodesis
1315179|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
1315180|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
1315181|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1315182|NCT01518517|relapse|relapse
1315183|NCT01518517|asparaginase|asparaginase
1315184|NCT01518504|Thoracic|thoracic
1315185|NCT01518504|Manipulation|manipulation
1315186|NCT01518504|Manual Therapy|manual therapy
1315187|NCT01518504|Mobilization|mobilization
1315188|NCT01518504|Shoulder|shoulder
1315189|NCT01518504|Range of Motion|range of motion
1315190|NCT01518452|working memory training, computerized|working memory training, computerized
1315191|NCT01518452|clinical assessment|clinical assessment
1315192|NCT01518452|quantitative EEG|quantitative eeg
1315193|NCT01518452|child, preschool|child, preschool
1315194|NCT01518439|neuromuscular|neuromuscular
1315195|NCT01518439|cough|cough
1315196|NCT01518439|restrictive|restrictive
1315197|NCT01518426|Brain computer interface|brain computer interface
1315198|NCT01518426|EEG recording|eeg recording
1315199|NCT01518426|Electrodes|electrodes
1315200|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
1315201|NCT01518400|Pediatric Cancer|pediatric cancer
1315202|NCT01518400|Cancer Late Effects|cancer late effects
1315203|NCT01518400|Cancer Survivor|cancer survivor
1315204|NCT01518400|Cancer Survivorship|cancer survivorship
1315205|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
1315206|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
1315208|NCT01518374|MCI|mci
1315209|NCT01518348|Patch Test|patch test
1315210|NCT01518348|Contact Dermatitis|contact dermatitis
1315211|NCT01518348|Allergy|allergy
1315212|NCT01518348|Children|children
1315213|NCT01518348|PREA|prea
1315214|NCT01518335|platelet rich plasma|platelet rich plasma
1315215|NCT01518335|ankle|ankle
1315216|NCT01518335|sprain|sprain
1315217|NCT01518335|injection|injection
1315218|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
1315219|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
1315220|NCT01518322|Asthma|asthma
1315221|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
1315222|NCT01518322|Respiratory Symptoms|respiratory symptoms
1315223|NCT01518322|NIOX MINO|niox mino
1315224|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
1315225|NCT01518322|Nitric Oxide|nitric oxide
1315226|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
1315227|NCT01518296|POPQ|popq
1315228|NCT01518296|Urodynamic test|urodynamic test
1315229|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
1315230|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
1315231|NCT01518283|Unfit patients.|unfit patients.
1315232|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
1315233|NCT01518244|Ocular hypertension|ocular hypertension
1315234|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
1315235|NCT01518231|stroke|stroke
1315236|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1315237|NCT01518218|Sickle cell disease|sickle cell disease
1315238|NCT01518218|laying-on-of-hands|laying-on-of-hands
1315239|NCT01518218|morbidity|morbidity
1315240|NCT01518218|mortality|mortality
1315241|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
1315242|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
1315243|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
1315244|NCT01518205|inflammatory markers|inflammatory markers
1315245|NCT01518205|type 2 diabetes|type 2 diabetes
1315246|NCT01518205|LDL-cholesterol|ldl-cholesterol
1315248|NCT01518192|doxycycline|doxycycline
1315249|NCT01518192|cefuroxime axetil|cefuroxime axetil
1315250|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
1315251|NCT01518192|background symptoms in general population|background symptoms in general population
1315252|NCT01518179|Colles' Fracture|colles' fracture
1316139|NCT01514409|Mood|mood
1315253|NCT01518179|Compression Bandages|compression bandages
1315254|NCT01518179|Occupational therapy|occupational therapy
1315255|NCT01518179|Rehabilitation|rehabilitation
1315256|NCT01518179|Smith's fracture|smith's fracture
1315257|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
1315258|NCT01518153|Lymphoma|lymphoma
1315259|NCT01518153|Myeloma|myeloma
1315260|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
1315261|NCT01518153|Leukemia|leukemia
1315262|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
1315263|NCT01518153|MDS|mds
1315264|NCT01518153|Hodgkin disease|hodgkin disease
1315265|NCT01518153|Multiple myeloma|multiple myeloma
1315266|NCT01518153|Fludarabine|fludarabine
1315267|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
1315268|NCT01518153|Fludara|fludara
1315269|NCT01518153|Melphalan|melphalan
1315270|NCT01518153|Alkeran|alkeran
1315271|NCT01518153|Tacrolimus|tacrolimus
1315272|NCT01518153|Prograf|prograf
1315273|NCT01518153|Methotrexate|methotrexate
1315274|NCT01518153|G-CSF|g-csf
1315275|NCT01518153|Filgrastim|filgrastim
1315276|NCT01518153|NeupogenTM|neupogentm
1315277|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
1315278|NCT01518153|DLI|dli
1315279|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1315280|NCT01518153|Graft-vs-host disease|graft-vs-host disease
1315281|NCT01518153|GvHD|gvhd
1315282|NCT01518153|T-lymphocytes|t-lymphocytes
1315283|NCT01518153|T-cells|t-cells
1315284|NCT01518153|Alemtuzumab|alemtuzumab
1315285|NCT01518153|CAMPATH-1H|campath-1h
1315286|NCT01518153|Campath|campath
1315287|NCT01518140|Advanced Cancers|advanced cancers
1315288|NCT01518140|Locally advanced|locally advanced
1315289|NCT01518140|Recurrent|recurrent
1315290|NCT01518140|Metastatic disease|metastatic disease
1315291|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
1315292|NCT01518140|Shortness of breath|shortness of breath
1315293|NCT01518140|Dyspnea|dyspnea
1315294|NCT01518140|VapoTherm|vapotherm
1315295|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
1315296|NCT01518140|BiPAP|bipap
1315297|NCT01518140|Non-rebreather mask|non-rebreather mask
1315298|NCT01518127|Macular Degeneration|macular degeneration
1315299|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1315300|NCT01518114|Exercise Training|exercise training
1315301|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
1315302|NCT01518114|Heart Failure|heart failure
1315303|NCT01518101|patient preference|patient preference
1315304|NCT01518101|vildagliptin|vildagliptin
1315305|NCT01518101|liraglutide|liraglutide
1615197|NCT00339339|Absorption|absorption
1315306|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1315307|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
1315308|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
1315309|NCT01518075|Intensive Care Unit|intensive care unit
1315310|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
1315311|NCT01518049|Psychometrics|psychometrics
1315312|NCT01518049|Biological Markers|biological markers
1315313|NCT01518023|diabetes mellitus|diabetes mellitus
1315314|NCT01518023|prediabetes|prediabetes
1315315|NCT01518023|fasting blood glucose|fasting blood glucose
1315316|NCT01518023|HbA1c|hba1c
1315317|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
1315318|NCT01518023|Cancer gastrectomy|cancer gastrectomy
1315319|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
1315320|NCT01518010|Brain injury|brain injury
1315321|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
1315322|NCT01518010|Video game|video game
1315323|NCT01517997|Drug coated balloons|drug coated balloons
1315324|NCT01517997|Drug eluting stents|drug eluting stents
1315325|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
1315326|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
1315327|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
1315328|NCT01517984|CNI withdrawal|cni withdrawal
1315329|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1315330|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1315331|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
1315332|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
1315333|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
1315334|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
1315335|NCT01517958|Lung Ultrasound|lung ultrasound
1315336|NCT01517958|Neonates|neonates
1315337|NCT01517945|Survivors|survivors
1315338|NCT01517945|Quality of Life|quality of life
1315339|NCT01517945|Questionnaire|questionnaire
1315340|NCT01517945|11-204|11-204
1315341|NCT01517919|peer support|peer support
1315342|NCT01517919|peer leader|peer leader
1315343|NCT01517919|community health worker|community health worker
1315344|NCT01517919|empowerment|empowerment
1315345|NCT01517919|self-management|self-management
1315346|NCT01517906|eating disorder behaviors|eating disorder behaviors
1315347|NCT01517906|well being|well being
1315348|NCT01517906|functional health|functional health
1315349|NCT01517893|vitiligo|vitiligo
1315350|NCT01517893|simvastatin|simvastatin
1315355|NCT01517867|preschool children behavior problems|preschool children behavior problems
1315357|NCT01517841|peritoneal dialysis|peritoneal dialysis
1315358|NCT01517841|modality choice|modality choice
1315359|NCT01517841|kidney disease|kidney disease
1315360|NCT01517828|Intubation|intubation
1315361|NCT01517828|Delivery room|delivery room
1315362|NCT01517828|Sedation|sedation
1315363|NCT01517828|Analgesia|analgesia
1315364|NCT01517815|Septic shock|septic shock
1315365|NCT01517815|overweight|overweight
1315366|NCT01517815|critically ill|critically ill
1315367|NCT01517815|pharmacokinetic|pharmacokinetic
1315368|NCT01517815|doripenem|doripenem
1315369|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
1315375|NCT01517789|Surgery|surgery
1315376|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
1315377|NCT01517789|visual event-related potential|visual event-related potential
1315378|NCT01517776|High grade glioma|high grade glioma
1315379|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
1315380|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
1315381|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1315382|NCT01517776|Relapse|relapse
1315383|NCT01517776|refractory tumour disease|refractory tumour disease
1315384|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
1315385|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
1315386|NCT01517763|Humidification|humidification
1315387|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
1315388|NCT01517763|ICON|icon
1315389|NCT01517763|ThermoSmart|thermosmart
1315390|NCT01517763|SensAwake|sensawake
1315391|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
1315392|NCT01517750|Humidification|humidification
1315393|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
1315394|NCT01517750|ICON|icon
1315395|NCT01517750|ThermoSmart|thermosmart
1315396|NCT01517724|MM|mm
1315397|NCT01517724|HDT|hdt
1315398|NCT01517724|ASCT|asct
1315399|NCT01517724|consolidation|consolidation
1315400|NCT01517724|bortezomib|bortezomib
1315401|NCT01517711|pharmacotherapy|pharmacotherapy
1315402|NCT01517711|combat disorders|combat disorders
1315403|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
1315404|NCT01517685|EPA|epa
1315405|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
1315406|NCT01517685|DHA|dha
1315407|NCT01517685|Omega 3 fat|omega 3 fat
1315408|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
1315409|NCT01517685|ALA|ala
1315410|NCT01517685|fish oil|fish oil
1315411|NCT01517685|flax seed oil|flax seed oil
1315412|NCT01517672|PTSD|ptsd
1315413|NCT01517672|domestic violence|domestic violence
1315414|NCT01517672|intimate partner violence|intimate partner violence
1315415|NCT01517672|functional MRI|functional mri
1315416|NCT01517672|neuroimaging|neuroimaging
1315417|NCT01517659|Lipolysis|lipolysis
1315418|NCT01517659|Cryolipolysis|cryolipolysis
1315419|NCT01517659|Fat Reduction|fat reduction
1315420|NCT01517646|Lipolysis|lipolysis
1315421|NCT01517646|Cryolipolysis|cryolipolysis
1315422|NCT01517646|Fat Reduction|fat reduction
1315423|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
1315424|NCT01517633|Urinary incontinence|urinary incontinence
1315425|NCT01517581|Brown adipose tissue|brown adipose tissue
1315426|NCT01517542|diet|diet
1315427|NCT01517542|DASH|dash
1315428|NCT01517542|Stroke|stroke
1315429|NCT01517542|Nutritional counseling|nutritional counseling
1315430|NCT01517529|Hepatitis C|hepatitis c
1315431|NCT01517529|HCV|hcv
1315432|NCT01517516|fMRI|fmri
1315433|NCT01517516|resting state|resting state
1315434|NCT01517516|structural MRI|structural mri
1315435|NCT01517516|functional MRI|functional mri
1315436|NCT01517477|Open angle|open angle
1315437|NCT01517477|Glaucoma|glaucoma
1315438|NCT01517477|surgery|surgery
1315439|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
1315440|NCT01517477|Ocular Hypertension|ocular hypertension
1315441|NCT01517477|Eye Diseases|eye diseases
1315442|NCT01517464|neoplasm|neoplasm
1315443|NCT01517464|bladder cancer|bladder cancer
1315444|NCT01517464|advances solid tumors|advances solid tumors
1315445|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
1315446|NCT01517399|Oncology|oncology
1315447|NCT01517399|pharmacokinetics|pharmacokinetics
1315448|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
1316349|NCT01513317|MDS|mds
1315449|NCT01517386|paravertebral space|paravertebral space
1315450|NCT01517386|needle placement|needle placement
1315451|NCT01517386|tissue identification|tissue identification
1315452|NCT01517386|regional|regional
1315453|NCT01517373|T2DM|t2dm
1315454|NCT01517373|PF-04937319|pf-04937319
1315455|NCT01517373|Phase 2|phase 2
1315456|NCT01517360|Schizophrenia|schizophrenia
1315457|NCT01517360|Social Cognition|social cognition
1315458|NCT01517360|Oxytocin|oxytocin
1315459|NCT01517347|IL2|il2
1315460|NCT01517347|relapse|relapse
1315461|NCT01517347|GVHD|gvhd
1315462|NCT01517347|survival|survival
1315463|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1315464|NCT01517347|MRD|mrd
1315465|NCT01517347|CR|cr
1315466|NCT01517308|HCV|hcv
1315467|NCT01517308|Hepatitis|hepatitis
1315468|NCT01517308|Genotype 2 or 3|genotype 2 or 3
1315469|NCT01517308|Pegylated Interferon|pegylated interferon
1315470|NCT01517308|Duration|duration
1315471|NCT01517295|Pharmacokinetics|pharmacokinetics
1315472|NCT01517295|Hydromorphone|hydromorphone
1315473|NCT01517295|Hydrocodone|hydrocodone
1315474|NCT01517295|APAP|apap
1315475|NCT01517269|Parent education|parent education
1315476|NCT01517256|Chronic pain|chronic pain
1315477|NCT01517256|Primary care|primary care
1315478|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
1315479|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
1315480|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1315481|NCT01517243|sunitinib|sunitinib
1315482|NCT01517243|alternating|alternating
1315483|NCT01517243|temsirolimus|temsirolimus
1315484|NCT01517230|Cluster-randomised trial|cluster-randomised trial
1315485|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
1315486|NCT01517230|Rural community radio|rural community radio
1315487|NCT01517230|Under-five child mortality|under-five child mortality
1315488|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
1315489|NCT01517230|Burkina Faso|burkina faso
1315490|NCT01517230|Health care seeking behavior|health care seeking behavior
1315491|NCT01517230|Childbirth|childbirth
1315492|NCT01517217|girdle|girdle
1315493|NCT01517217|laparotomy|laparotomy
1315494|NCT01517217|pulmonary function|pulmonary function
1315495|NCT01517217|postoperative pain|postoperative pain
1315496|NCT01517217|mobilisation|mobilisation
1315497|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
1315498|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
1315499|NCT01517204|Efficacy|efficacy
1315500|NCT01517204|Intubation complication|intubation complication
1315501|NCT01517191|Influenza|influenza
1315502|NCT01517191|Respiratory Infection|respiratory infection
1315503|NCT01517165|Opioid Dependence|opioid dependence
1315504|NCT01517165|Pioglitazone|pioglitazone
1315505|NCT01517165|Buprenorphine|buprenorphine
1315506|NCT01517152|Symptoms|symptoms
1315507|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
1315508|NCT01517152|Linguistic Validation|linguistic validation
1315509|NCT01517152|Toxicity|toxicity
1315510|NCT01517152|PRO-CTCAE|pro-ctcae
1315511|NCT01517152|Adverse Events|adverse events
1315512|NCT01517152|Translation|translation
1315513|NCT01517152|Questionnaire|questionnaire
1315514|NCT01517139|Diet and Nutrition|diet and nutrition
1315515|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
1315516|NCT01517139|In Utero Exposure|in utero exposure
1315517|NCT01517139|DNA Methylation|dna methylation
1315518|NCT01517139|Physical Activity|physical activity
1315519|NCT01517126|Youth Suicide|youth suicide
1315520|NCT01517126|Suicide Screening|suicide screening
1315521|NCT01517126|Developmental Delay|developmental delay
1315522|NCT01517126|Intellectual Disability|intellectual disability
1315523|NCT01517126|Assessment Instrument|assessment instrument
1315524|NCT01517126|Mental Retardation|mental retardation
1315525|NCT01517126|Suicidal Thoughts|suicidal thoughts
1315526|NCT01517126|Suicidal Behavior|suicidal behavior
1315527|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
1315528|NCT01517113|Hepatic|hepatic
1315529|NCT01517113|Adiposity|adiposity
1315530|NCT01517113|Cytokines|cytokines
1315531|NCT01517113|Muscle Mass|muscle mass
1315532|NCT01517113|Coronary Artery Disease|coronary artery disease
1315533|NCT01517113|Aging|aging
1315534|NCT01517113|Inflammation|inflammation
1315535|NCT01517100|Glucose|glucose
1315536|NCT01517100|Insulin Secretion|insulin secretion
1315537|NCT01517100|Insulin Action|insulin action
1315538|NCT01517100|Endocannabinoids|endocannabinoids
1315539|NCT01517100|Insulin|insulin
1315540|NCT01517100|Metabolism|metabolism
1315541|NCT01517087|Motor Function|motor function
1315542|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1315543|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1315544|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
1315545|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1315546|NCT01517087|Healthy Volunteer|healthy volunteer
1315547|NCT01517087|HV|hv
1315548|NCT01517074|Sirolimus|sirolimus
1315549|NCT01517074|Scleritis|scleritis
1315550|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
1315551|NCT01517061|Phantom Limb Pain|phantom limb pain
1315552|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
1315553|NCT01517061|Genetic Susceptibility|genetic susceptibility
1315554|NCT01517061|Amputation|amputation
1315555|NCT01517048|Body Composition|body composition
1315556|NCT01517048|Obesity|obesity
1315557|NCT01517048|Overweight|overweight
1315558|NCT01517048|Energy Homeostasis|energy homeostasis
1315559|NCT01517048|Nociception|nociception
1315560|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
1315561|NCT01517048|Genetic Disorder|genetic disorder
1315562|NCT01517048|Healthy Volunteer|healthy volunteer
1315563|NCT01517048|HV|hv
1315564|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1315565|NCT01517035|Stem Cell Transplant|stem cell transplant
1315566|NCT01517035|Transplant|transplant
1315567|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
1315568|NCT01517035|MDS|mds
1315569|NCT01517035|Leukemia|leukemia
1315570|NCT01517022|smoking cessation|smoking cessation
1315571|NCT01517022|early sputum smear conversion|early sputum smear conversion
1315572|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1315573|NCT01517009|D1extra-resection|d1extra-resection
1315574|NCT01516996|Neoadjuvant|neoadjuvant
1315575|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
1315576|NCT01516996|Nimotuzumab|nimotuzumab
1315577|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
1315578|NCT01516996|Hypopharynx cancer|hypopharynx cancer
1315579|NCT01516996|Randomized|randomized
1315580|NCT01516996|Multicenter|multicenter
1315581|NCT01516983|Safety|safety
1315582|NCT01516983|EGFR-TKI|egfr-tki
1315583|NCT01516983|NSCLC|nsclc
1315584|NCT01516983|Icotinib|icotinib
1315585|NCT01516983|WBRT|wbrt
1315586|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
1315587|NCT01516970|DRV/r|drv/r
1315588|NCT01516970|Occupational injury|occupational injury
1315589|NCT01516970|Non-occupational exposure|non-occupational exposure
1315590|NCT01516970|Prezista|prezista
1315591|NCT01516970|Darunavir/r|darunavir/r
1315592|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
1315593|NCT01516957|IL-17|il-17
1315594|NCT01516957|AMG 827|amg 827
1315595|NCT01516957|AMG827|amg827
1315596|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
1315597|NCT01516957|Spondylarthropathy|spondylarthropathy
1315598|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
1315599|NCT01516944|Capecitabine|capecitabine
1315600|NCT01516944|Oxaliplatin|oxaliplatin
1315601|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
1315602|NCT01516944|Gastric Cancer|gastric cancer
1315603|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1315604|NCT01516931|Depression|depression
1315605|NCT01516931|Venlafaxine|venlafaxine
1315606|NCT01516931|Relapse|relapse
1315607|NCT01516879|Cholesterol|cholesterol
1315608|NCT01516879|High Cholesterol|high cholesterol
1315609|NCT01516879|Elevated Cholesterol|elevated cholesterol
1315610|NCT01516879|Raised Cholesterol|raised cholesterol
1315611|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
1315612|NCT01516866|NaF PET/CT|naf pet/ct
1315613|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
1315614|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
1315615|NCT01516827|PTSD|ptsd
1315616|NCT01516827|Children and Adolescents|children and adolescents
1315617|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
1315618|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
1315619|NCT01516801|Prostate Cancer Screening|prostate cancer screening
1315620|NCT01516801|Pragmatic Trial|pragmatic trial
1315621|NCT01516801|Health Literacy|health literacy
1315622|NCT01516775|preoperative care|preoperative care
1315623|NCT01516775|preoperative period|preoperative period
1315624|NCT01516775|fasting|fasting
1315625|NCT01516762|Radium 223|radium 223
1315626|NCT01516762|Alpharadin|alpharadin
1315627|NCT01516762|Prostate Cancer|prostate cancer
1315628|NCT01516762|Bone metastases|bone metastases
1315629|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
1315630|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
1315631|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
1315632|NCT01516749|anakinra|anakinra
1315633|NCT01516736|Pegfilgrastim|pegfilgrastim
1315634|NCT01516736|G-CSF|g-csf
1315635|NCT01516736|neutropenia|neutropenia
1315636|NCT01516736|breast cancer|breast cancer
1315637|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
1315638|NCT01516723|drug-eluting stent|drug-eluting stent
1315639|NCT01516723|chronic total occlusion|chronic total occlusion
1315640|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
1315641|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
1315642|NCT01516710|Open liver resection|open liver resection
1315643|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
1315644|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
1315645|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
1315646|NCT01516697|cardiac output monitoring|cardiac output monitoring
1315647|NCT01516697|cesarean section|cesarean section
1315648|NCT01516697|spinal anesthesia|spinal anesthesia
1315649|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
1315650|NCT01516671|Cerebral vasospasm|cerebral vasospasm
1315651|NCT01516671|Neuroinflammation|neuroinflammation
1315652|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
1315653|NCT01516658|intracranial aneurysm|intracranial aneurysm
1315654|NCT01516658|endovascular therapy|endovascular therapy
1315655|NCT01516658|detachable coil|detachable coil
1315656|NCT01516658|recanalization|recanalization
1315657|NCT01516645|Squamous cell type tumor|squamous cell type tumor
1315658|NCT01516632|Cellular Phone|cellular phone
1315659|NCT01516632|Mobile Phone|mobile phone
1315660|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
1315661|NCT01516632|Technology|technology
1315662|NCT01516632|Smoking cessation|smoking cessation
1315663|NCT01516632|young adults|young adults
1315665|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
1315666|NCT01516606|MALT|malt
1315667|NCT01516606|refractory|refractory
1315668|NCT01516606|relapsed|relapsed
1315669|NCT01516606|extranodal|extranodal
1315670|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
1315671|NCT01516593|HIV|hiv
1315672|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
1315673|NCT01516593|intensive|intensive
1315674|NCT01516593|short term|short term
1315675|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
1315676|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
1315677|NCT01516554|Multiple Sclerosis|multiple sclerosis
1315678|NCT01516554|Fatigue|fatigue
1315679|NCT01516528|COPD|copd
1315680|NCT01516528|exacerbation|exacerbation
1315681|NCT01516528|comorbidities|comorbidities
1315682|NCT01516528|lung function|lung function
1315683|NCT01516528|burden|burden
1315684|NCT01516528|chronic bronchitis|chronic bronchitis
1315685|NCT01516528|emphysema|emphysema
1315686|NCT01516528|prevalence|prevalence
1315687|NCT01516528|cardiovascular disease|cardiovascular disease
1315688|NCT01516515|Actinic Keratosis|actinic keratosis
1315689|NCT01516515|AK|ak
1315690|NCT01516502|laser therapy|laser therapy
1315691|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
1315692|NCT01516502|acupoint|acupoint
1315693|NCT01516502|trigger point|trigger point
1315694|NCT01516502|range of motion|range of motion
1315695|NCT01516489|screening|screening
1315696|NCT01516489|colon cancer|colon cancer
1315697|NCT01516489|incentives|incentives
1315698|NCT01516489|behavioral economics|behavioral economics
1315699|NCT01516463|burn|burn
1315700|NCT01516463|partial thickness burn|partial thickness burn
1315701|NCT01516463|second degree burn|second degree burn
1315702|NCT01516463|minor burn|minor burn
1315703|NCT01516463|scar|scar
1315704|NCT01516463|Santyl|santyl
1315705|NCT01516463|Bacitracin|bacitracin
1315706|NCT01516463|outpatient burn center|outpatient burn center
1315707|NCT01516463|scar appearance|scar appearance
1315708|NCT01516463|Kansas City|kansas city
1315709|NCT01516463|University of Kansas Medical Center|university of kansas medical center
1315710|NCT01516463|KUMC|kumc
1315834|NCT01515904|body mass index|body mass index
1315711|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
1315712|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1315713|NCT01516424|Blonanserin|blonanserin
1315714|NCT01516411|Health Promotion|health promotion
1315715|NCT01516411|Physical Activity|physical activity
1315716|NCT01516411|Sedentary Time|sedentary time
1315717|NCT01516411|Smartphones|smartphones
1315718|NCT01516385|spinal cord injury|spinal cord injury
1315719|NCT01516385|biomarkers|biomarkers
1315720|NCT01516385|rehabilitation|rehabilitation
1315721|NCT01516385|functional independence|functional independence
1315722|NCT01516385|prognosis|prognosis
1315723|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
1315724|NCT01516346|Heart Failure|heart failure
1315725|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1315726|NCT01516346|Vasodilators|vasodilators
1315727|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
1315728|NCT01516346|Hydralazine|hydralazine
1315729|NCT01516346|wave reflections|wave reflections
1315730|NCT01516346|arterial stiffness|arterial stiffness
1315731|NCT01516346|hemodynamics|hemodynamics
1315732|NCT01516333|glycemic Index|glycemic index
1315733|NCT01516320|Type 2 Diabetes|type 2 diabetes
1315734|NCT01516320|Gastric Bypass|gastric bypass
1315735|NCT01516320|Laparoscopic Banding|laparoscopic banding
1315736|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
1315737|NCT01516294|AMD|amd
1315738|NCT01516294|PCV|pcv
1315739|NCT01516294|Iray|iray
1315740|NCT01516294|radiation|radiation
1315741|NCT01516294|retina|retina
1315742|NCT01516294|macula|macula
1315743|NCT01516294|radiotherapy|radiotherapy
1315744|NCT01516281|TBI|tbi
1315745|NCT01516281|PD|pd
1315746|NCT01516268|Cesarean Delivery|cesarean delivery
1315747|NCT01516268|TAP block|tap block
1315748|NCT01516268|sufentanyl|sufentanyl
1315846|NCT01515839|Football|football
1315749|NCT01516268|Narcotic dosages|narcotic dosages
1315750|NCT01516216|previously untreated|previously untreated
1315751|NCT01516203|AZD5847,dose-ranging,Mycobacterium tuberculosis,Rifafour,tuberculosis|azd5847,dose-ranging,mycobacterium tuberculosis,rifafour,tuberculosis
1315752|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
1315753|NCT01516177|Kidney Transplantation|kidney transplantation
1315754|NCT01516177|kidney transplant|kidney transplant
1315755|NCT01516177|renal transplant|renal transplant
1315756|NCT01516177|immunosuppression|immunosuppression
1315757|NCT01516164|Laryngoscopy|laryngoscopy
1315758|NCT01516164|Videolaryngoscopy|videolaryngoscopy
1315759|NCT01516164|Ease of Intubation|ease of intubation
1315760|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
1315761|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
1315762|NCT01516138|Cardiac surgery|cardiac surgery
1315763|NCT01516125|healthy adult|healthy adult
1315764|NCT01516125|genetic variation|genetic variation
1315765|NCT01516125|botanical oils|botanical oils
1315766|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
1315767|NCT01516125|fish oil|fish oil
1315768|NCT01516125|fat metabolism|fat metabolism
1315769|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
1315770|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
1315771|NCT01516099|Physical activity counselor|physical activity counselor
1315772|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
1315773|NCT01516099|General Practitioner|general practitioner
1315774|NCT01516099|Social-cultural Organization|social-cultural organization
1315775|NCT01516086|Controlled|controlled
1315776|NCT01516086|uncontrolled|uncontrolled
1315777|NCT01516073|partially controlled|partially controlled
1315778|NCT01516073|uncontrolled|uncontrolled
1315779|NCT01516047|Hepatic impairment|hepatic impairment
1315780|NCT01516047|Pharmacology|pharmacology
1315781|NCT01516047|Pharmacokinetics|pharmacokinetics
1315782|NCT01516047|Pharmacodynamics|pharmacodynamics
1315783|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
1315784|NCT01516047|JNJ-212082|jnj-212082
1315785|NCT01516034|Tattoo removal|tattoo removal
1315786|NCT01516034|ultrasound|ultrasound
1315787|NCT01516021|Fat ingestion|fat ingestion
1315788|NCT01516021|hypothalamus|hypothalamus
1315789|NCT01516021|insula|insula
1315790|NCT01516021|fMRI|fmri
1315791|NCT01516021|CBF|cbf
1315792|NCT01516008|Hallux Valgus|hallux valgus
1315793|NCT01516008|Bunionectomy|bunionectomy
1315794|NCT01516008|Bunion|bunion
1315795|NCT01516008|Acute pain|acute pain
1315796|NCT01516008|Tapentadol|tapentadol
1315797|NCT01516008|Tapentadol IR|tapentadol ir
1315798|NCT01515995|Magnesium sulfate|magnesium sulfate
1315799|NCT01515995|Childhood asthma|childhood asthma
1315800|NCT01515995|Emergency department|emergency department
1315801|NCT01515982|Alzheimer's disease|alzheimer's disease
1315802|NCT01515982|Aerobic exercise|aerobic exercise
1315803|NCT01515982|Physical training|physical training
1315804|NCT01515982|Cognitive function|cognitive function
1315805|NCT01515982|Functional capacity.|functional capacity.
1315806|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
1315807|NCT01515956|MPS IVA Type A|mps iva type a
1315808|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1315809|NCT01515956|MPS IVA|mps iva
1315810|NCT01515956|Morquio A Syndrome|morquio a syndrome
1315811|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
1315812|NCT01515956|LSD|lsd
1315813|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1315814|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
1315815|NCT01515956|sulfatase|sulfatase
1315816|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
1315817|NCT01515956|GALNS|galns
1315818|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
1315819|NCT01515956|ERT|ert
1315820|NCT01515943|Convergence insufficiency|convergence insufficiency
1315821|NCT01515930|Parenting|parenting
1315822|NCT01515930|Parental Monitoring|parental monitoring
1315823|NCT01515930|Diabetes|diabetes
1315824|NCT01515930|Care|care
1315825|NCT01515917|Veterans|veterans
1315826|NCT01515917|Traumatic Brain Injury|traumatic brain injury
1315827|NCT01515917|TBI|tbi
1315828|NCT01515917|Substance Abuse|substance abuse
1315829|NCT01515917|Substance Dependence|substance dependence
1315830|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
1315831|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
1315832|NCT01515904|obesity management|obesity management
1315833|NCT01515904|adolescents|adolescents
1315835|NCT01515904|treatment outcomes|treatment outcomes
1315836|NCT01515904|program evaluation|program evaluation
1315837|NCT01515891|Parkinson Disease|parkinson disease
1315838|NCT01515891|BIA 9-1067|bia 9-1067
1315839|NCT01515852|stress level|stress level
1315840|NCT01515852|stereotactic biopsy|stereotactic biopsy
1315841|NCT01515852|brain lesion|brain lesion
1315842|NCT01515852|general anesthesia|general anesthesia
1315843|NCT01515852|local anesthesia|local anesthesia
1315844|NCT01515839|SPECT|spect
1315845|NCT01515839|Imaging|imaging
1315847|NCT01515839|Traumatic brain injury|traumatic brain injury
1315848|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
1315849|NCT01515826|Cataract surgery|cataract surgery
1315850|NCT01515826|Topical therapy|topical therapy
1315851|NCT01515826|Prevention of inflammation|prevention of inflammation
1315852|NCT01515826|Inflammation of infection|inflammation of infection
1315853|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1315854|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1315855|NCT01515800|stage IA breast cancer|stage ia breast cancer
1315856|NCT01515800|stage IB breast cancer|stage ib breast cancer
1315857|NCT01515800|stage II breast cancer|stage ii breast cancer
1315858|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
1315859|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
1315860|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
1315861|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
1315862|NCT01515774|Parkinson's disease|parkinson's disease
1315863|NCT01515774|Pramipexole|pramipexole
1315864|NCT01515722|Medication Persistence|medication persistence
1315865|NCT01515722|Compliance|compliance
1315866|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
1315867|NCT01515709|Cohort Studies|cohort studies
1315868|NCT01515709|Longitudinal Studies|longitudinal studies
1315869|NCT01515696|VLBW infant|vlbw infant
1315870|NCT01515696|Meconium|meconium
1315871|NCT01515696|Enteral nutrition|enteral nutrition
1315872|NCT01515696|Meconium passage|meconium passage
1315873|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
1315874|NCT01515670|THA|tha
1315875|NCT01515670|TKA|tka
1315876|NCT01515670|Fast-track|fast-track
1315877|NCT01515670|Enhanced recovery|enhanced recovery
1315878|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
1315879|NCT01515670|postoperative morbidity|postoperative morbidity
1315880|NCT01515670|Arthroplasty|arthroplasty
1315881|NCT01515670|Replacement|replacement
1315882|NCT01515670|Hip|hip
1315883|NCT01515670|Knee|knee
1315884|NCT01515670|Morbidity|morbidity
1315885|NCT01515644|Healthy infants|healthy infants
1315886|NCT01515644|Infant formula|infant formula
1315887|NCT01515644|Prebiotics|prebiotics
1315888|NCT01515566|Advanced Cancer|advanced cancer
1315889|NCT01515566|Dyspnea|dyspnea
1315890|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
1315891|NCT01515566|Shortness of breath|shortness of breath
1315892|NCT01515566|Fentanyl|fentanyl
1315893|NCT01515566|Sublimaze|sublimaze
1315894|NCT01515566|Placebo|placebo
1315895|NCT01515566|Normal saline|normal saline
1315896|NCT01515566|NS|ns
1315897|NCT01515566|Questionnaires|questionnaires
1315898|NCT01515566|Surveys|surveys
1315899|NCT01515566|Walk test|walk test
1315900|NCT01515540|chronic back pain|chronic back pain
1315901|NCT01515540|placebo|placebo
1315902|NCT01515540|fmri|fmri
1315903|NCT01515540|brain imaging|brain imaging
1315904|NCT01515527|Leukemia|leukemia
1315905|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
1315907|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
1315908|NCT01515527|MDS|mds
1315909|NCT01515527|Cytarabine|cytarabine
1315910|NCT01515527|Ara-C|ara-c
1315911|NCT01515527|Cytosar|cytosar
1315912|NCT01515527|DepoCyt|depocyt
1315913|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1315914|NCT01515527|Decitabine|decitabine
1315915|NCT01515527|Dacogen|dacogen
1315916|NCT01515527|Cladribine|cladribine
1315917|NCT01515527|Leustatin|leustatin
1315918|NCT01515527|2-CdA|2-cda
1315919|NCT01515514|polyps|polyps
1315920|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
1315921|NCT01515514|associated neoplasia|associated neoplasia
1315922|NCT01515501|Constipation|constipation
1315923|NCT01515501|Hirschsprung Disease|hirschsprung disease
1315924|NCT01515488|Triage|triage
1315925|NCT01515488|Automated|automated
1315926|NCT01515488|Admitting|admitting
1315927|NCT01515488|Pediatric ED|pediatric ed
1315928|NCT01515475|Hyperopia|hyperopia
1315929|NCT01515475|Glasses|glasses
1315930|NCT01515462|Lentiviral vector|lentiviral vector
1315931|NCT01515462|Gene therapy|gene therapy
1315932|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1315933|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
1315934|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
1315935|NCT01515436|Epilepsy|epilepsy
1315936|NCT01515436|Seizures|seizures
1315937|NCT01515436|Music|music
1315938|NCT01515436|Mozart|mozart
1315939|NCT01515436|Beethoven|beethoven
1315940|NCT01515423|Schizophrenia|schizophrenia
1315941|NCT01515423|R092670|r092670
1315942|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
1316037|NCT01514838|urine glucose|urine glucose
1316038|NCT01514825|YM150|ym150
1315943|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
1315944|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
1315945|NCT01515410|Parkinson's disease|parkinson's disease
1315947|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
1315948|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
1315949|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
1315950|NCT01515345|stent thrombosis|stent thrombosis
1315951|NCT01515319|Obesity|obesity
1315952|NCT01515319|Peptide YY|peptide yy
1315953|NCT01515319|Food intake|food intake
1315954|NCT01515319|Safety|safety
1315955|NCT01515319|Pharmacokinetics|pharmacokinetics
1315956|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1315957|NCT01515280|chronic cough|chronic cough
1315958|NCT01515267|EF|ef
1315959|NCT01515267|EDV|edv
1315960|NCT01515267|ESV|esv
1315961|NCT01515267|Biplane|biplane
1315962|NCT01515267|Echocardiography|echocardiography
1315963|NCT01515254|Children|children
1315964|NCT01515254|Obesity Prevention|obesity prevention
1315965|NCT01515254|Child Overweight|child overweight
1315966|NCT01515254|Eating Behavior|eating behavior
1315967|NCT01515254|Energy Compensation|energy compensation
1315968|NCT01515254|Food Intake|food intake
1315969|NCT01515254|Parenting Behavior|parenting behavior
1315970|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1315971|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
1315972|NCT01515241|HDL mimetic|hdl mimetic
1315973|NCT01515241|ApoA-1|apoa-1
1315974|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
1315975|NCT01515215|Major Depression Disorder|major depression disorder
1315976|NCT01515215|Treatment Resistance|treatment resistance
1315977|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1315978|NCT01515150|diverticulitis|diverticulitis
1315979|NCT01515150|Out-patient management|out-patient management
1315980|NCT01515150|Antibiotics|antibiotics
1315981|NCT01515137|Head and Neck|head and neck
1315982|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
1315983|NCT01515124|Lymphedema|lymphedema
1315984|NCT01515124|Strength training intervention|strength training intervention
1315985|NCT01515124|Weight loss intervention|weight loss intervention
1315986|NCT01515124|Breast cancer recurrence|breast cancer recurrence
1315987|NCT01515124|Cost Effectiveness|cost effectiveness
1315988|NCT01515111|Non-communicable diseases|non-communicable diseases
1315989|NCT01515111|Preventive services|preventive services
1315990|NCT01515111|Medical education|medical education
1315991|NCT01515111|Guatemala|guatemala
1315992|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
1315993|NCT01515072|Brain death organ donors|brain death organ donors
1315994|NCT01515072|Delayed graft function|delayed graft function
1315995|NCT01515072|Donor management|donor management
1315996|NCT01515072|Pulsatile perfusion|pulsatile perfusion
1315997|NCT01515059|obesity|obesity
1315998|NCT01515059|diabetes|diabetes
1315999|NCT01515059|bariatric surgery|bariatric surgery
1316000|NCT01515059|gastric bypass|gastric bypass
1316001|NCT01515059|insulin|insulin
1316002|NCT01515059|glucose|glucose
1316003|NCT01515059|incretins|incretins
1316004|NCT01515059|leptin|leptin
1316005|NCT01515059|ghrelin|ghrelin
1316006|NCT01515046|Vitamins|vitamins
1316007|NCT01515046|Complementary medicine|complementary medicine
1316008|NCT01515046|Pancreatic cancer|pancreatic cancer
1316009|NCT01515046|Ascorbate|ascorbate
1316010|NCT01515046|Ascorbic Acid|ascorbic acid
1316011|NCT01515046|Antioxidants|antioxidants
1316012|NCT01515046|Gemcitabine|gemcitabine
1316013|NCT01515046|Pharmacologic actions|pharmacologic actions
1316014|NCT01515033|Coronary artery disease|coronary artery disease
1316015|NCT01515033|Exercise|exercise
1316016|NCT01515033|Ventilatory efficiency|ventilatory efficiency
1316017|NCT01515020|bacteremia|bacteremia
1316018|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
1316019|NCT01515020|nosocomial infection|nosocomial infection
1316020|NCT01515020|healthcare-associated infection|healthcare-associated infection
1316021|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
1316022|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
1316023|NCT01514981|Asthma|asthma
1316024|NCT01514942|PCOS|pcos
1316025|NCT01514942|Insulin resistance|insulin resistance
1316026|NCT01514942|Myo-inositol|myo-inositol
1316027|NCT01514942|D-chiro-inositol|d-chiro-inositol
1316028|NCT01514929|Thorough QT|thorough qt
1316029|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
1316030|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
1316031|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
1316032|NCT01514877|Icotinib|icotinib
1316033|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
1316034|NCT01514838|ASP1941|asp1941
1316035|NCT01514838|ipragliflozin|ipragliflozin
1316036|NCT01514838|plasma glucose|plasma glucose
1316039|NCT01514825|Plasma concentration|plasma concentration
1316040|NCT01514825|darexaban|darexaban
1316041|NCT01514825|Healthy elderly subject|healthy elderly subject
1316042|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
1316043|NCT01514812|YM150|ym150
1316044|NCT01514812|digoxin|digoxin
1316045|NCT01514812|drug-drug interaction|drug-drug interaction
1316046|NCT01514812|Plasma concentration|plasma concentration
1316047|NCT01514812|darexaban|darexaban
1316048|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
1316049|NCT01514799|gastric bypass|gastric bypass
1316050|NCT01514799|morbid obesity|morbid obesity
1316051|NCT01514799|gut function|gut function
1316052|NCT01514799|weight loss|weight loss
1316053|NCT01514786|Colorectal Cancer|colorectal cancer
1316054|NCT01514786|Screening|screening
1316055|NCT01514786|Prevention|prevention
1316056|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
1316057|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1316058|NCT01514773|systolic heart failure|systolic heart failure
1316059|NCT01514773|congestive heart failure|congestive heart failure
1316060|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
1316061|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
1316062|NCT01514773|ICD|icd
1316063|NCT01514773|ICD utilization|icd utilization
1316064|NCT01514773|ICD implantation|icd implantation
1316065|NCT01514773|defibrillator|defibrillator
1316066|NCT01514773|defibrillator therapy|defibrillator therapy
1316067|NCT01514773|sudden cardiac death|sudden cardiac death
1316068|NCT01514760|Adolescents|adolescents
1316069|NCT01514760|Mobile based applications|mobile based applications
1316070|NCT01514760|Asthma action plan|asthma action plan
1316071|NCT01514760|Self Efficacy|self efficacy
1316072|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
1316073|NCT01514734|Ocular hypertension|ocular hypertension
1316074|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
1316075|NCT01514721|Open-angle glaucoma|open-angle glaucoma
1316076|NCT01514721|Ocular hypertension|ocular hypertension
1316077|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
1316078|NCT01514708|Influenza|influenza
1316079|NCT01514708|Vaccination|vaccination
1316080|NCT01514708|Vaccine|vaccine
1316081|NCT01514708|Pregnancy|pregnancy
1316082|NCT01514695|endoscopy|endoscopy
1316083|NCT01514695|sedation|sedation
1316084|NCT01514695|opioid|opioid
1316085|NCT01514695|narcotic|narcotic
1316086|NCT01514682|schizophrenia|schizophrenia
1316087|NCT01514682|anti-inflammatory|anti-inflammatory
1316088|NCT01514682|salsalate|salsalate
1316089|NCT01514682|statins|statins
1316090|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
1316091|NCT01514643|tibial plateau fracture|tibial plateau fracture
1316092|NCT01514643|tibial plafond fracture|tibial plafond fracture
1422659|NCT01073800|stroke|stroke
1316093|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
1316094|NCT01514643|synovial fluid|synovial fluid
1316095|NCT01514643|blood serum|blood serum
1316096|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
1316097|NCT01514617|Leiomyoma|leiomyoma
1316098|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
1316099|NCT01514617|Perfusion MRI|perfusion mri
1316100|NCT01514617|Uterine artery embolization|uterine artery embolization
1316101|NCT01514617|Volumetric Response|volumetric response
1316102|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
1316103|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
1316104|NCT01514604|ultrasonography|ultrasonography
1316105|NCT01514604|education|education
1316106|NCT01514578|safety|safety
1316107|NCT01514578|tolerability|tolerability
1316108|NCT01514578|TRV130A|trv130a
1316109|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
1316110|NCT01514565|RB|rb
1316111|NCT01514565|PTEN|pten
1316112|NCT01514565|Chemotherapy|chemotherapy
1316113|NCT01514565|Neoadjuvant|neoadjuvant
1316114|NCT01514552|Functional food|functional food
1316115|NCT01514552|Strawberries|strawberries
1316116|NCT01514552|Gummies|gummies
1316117|NCT01514552|Smoker|smoker
1316118|NCT01514552|Nonsmoker|nonsmoker
1316119|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
1316120|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
1316121|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
1316122|NCT01514461|Fasting Triglycerides|fasting triglycerides
1316123|NCT01514448|Kidney cancer|kidney cancer
1316124|NCT01514448|mRCC|mrcc
1316125|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
1316126|NCT01514448|everolimus|everolimus
1316127|NCT01514448|sunitinib|sunitinib
1316128|NCT01514448|pazopanib|pazopanib
1316129|NCT01514435|depression|depression
1316130|NCT01514435|FDG-PET|fdg-pet
1316131|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
1316132|NCT01514435|glucose metabolism|glucose metabolism
1316133|NCT01514422|Bipolar disorder|bipolar disorder
1316134|NCT01514422|depression|depression
1316135|NCT01514422|minocycline|minocycline
1316136|NCT01514422|mood disorders|mood disorders
1316137|NCT01514422|bipolar depression|bipolar depression
1316138|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
1316140|NCT01514409|Emotional Processing|emotional processing
1316141|NCT01514409|Emotional Cognition|emotional cognition
1316142|NCT01514409|Nutritional Supplement|nutritional supplement
1316143|NCT01514409|Low mood|low mood
1316144|NCT01514396|Pediatric|pediatric
1316145|NCT01514396|Wounds|wounds
1316146|NCT01514383|wounds|wounds
1316147|NCT01514370|Multiple Sclerosis|multiple sclerosis
1316148|NCT01514370|Relapsing|relapsing
1316149|NCT01514370|Interferon beta 1a|interferon beta 1a
1316150|NCT01514370|Curcumin|curcumin
1316151|NCT01514344|OAL|oal
1316152|NCT01514344|MALT|malt
1316153|NCT01514344|conjunctiva|conjunctiva
1316154|NCT01514344|indolent|indolent
1316155|NCT01514344|CD20+|cd20+
1316156|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
1316157|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
1316158|NCT01514331|Mechanical ventilation|mechanical ventilation
1316159|NCT01514279|Overweight|overweight
1316160|NCT01514279|Obese|obese
1316161|NCT01514279|Over Nutrition|over nutrition
1316162|NCT01514279|Nutrition Disorders|nutrition disorders
1316163|NCT01514279|Body weight|body weight
1316164|NCT01514279|Signs and Symptoms|signs and symptoms
1316165|NCT01514266|proven diagnosis|proven diagnosis
1316166|NCT01514266|COPD|copd
1316167|NCT01514266|sputum|sputum
1316168|NCT01514253|glucose|glucose
1316169|NCT01514253|analgesic|analgesic
1316170|NCT01514253|newborns|newborns
1316171|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
1316172|NCT01514240|affecting ileum|affecting ileum
1316173|NCT01514240|ileocecal region|ileocecal region
1316174|NCT01514240|ascending colon|ascending colon
1316175|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
1316176|NCT01514214|ERCP|ercp
1316177|NCT01514214|biliary stricture|biliary stricture
1316178|NCT01514214|viaduct|viaduct
1316179|NCT01514214|cancer|cancer
1316180|NCT01514188|sarcoma|sarcoma
1316181|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
1316182|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
1316183|NCT01514175|Ketorolac|ketorolac
1316184|NCT01514175|Caldolor|caldolor
1316185|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
1316186|NCT01514162|Trifecta Valve|trifecta valve
1316187|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1316188|NCT01514149|T2DM|t2dm
1316189|NCT01514149|diabetes|diabetes
1316190|NCT01514149|ConjuChem|conjuchem
1316191|NCT01514149|GLP-1|glp-1
1316192|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
1316193|NCT01514149|exendin-4|exendin-4
1316194|NCT01514149|modified exendin-4|modified exendin-4
1316196|NCT01514123|Bevacizumab|bevacizumab
1316197|NCT01514123|VEGF-C|vegf-c
1316198|NCT01514123|First-In-Human|first-in-human
1316199|NCT01514123|Dose Escalation|dose escalation
1316200|NCT01514123|Advanced Solid Tumors|advanced solid tumors
1316201|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
1316202|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
1316203|NCT01514123|Pharmacologic Actions|pharmacologic actions
1316204|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
1316205|NCT01514123|Phase 1|phase 1
1316206|NCT01514123|Oncology|oncology
1316207|NCT01514123|Advanced malignancy|advanced malignancy
1316208|NCT01514097|emergency|emergency
1316209|NCT01514097|pediatric|pediatric
1316210|NCT01514097|fracture|fracture
1316211|NCT01514097|pain|pain
1316212|NCT01514084|laceration|laceration
1316213|NCT01514084|emergency|emergency
1316214|NCT01514084|cosmetic outcomes|cosmetic outcomes
1316215|NCT01514084|patient satisfaction|patient satisfaction
1316216|NCT01514084|suture|suture
1316217|NCT01514071|head injury|head injury
1316218|NCT01514071|CT|ct
1316219|NCT01514071|emergency|emergency
1316220|NCT01514071|radiation|radiation
1316221|NCT01514045|Quality of Life|quality of life
1316222|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
1316223|NCT01514019|effect of apple juice|effect of apple juice
1316224|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
1316225|NCT01514006|postoperative anemia|postoperative anemia
1316226|NCT01514006|functional outcomes|functional outcomes
1316227|NCT01513993|CHF|chf
1316228|NCT01513993|Telemonitoring|telemonitoring
1316229|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1316230|NCT01513980|Telemonitoring|telemonitoring
1316231|NCT01513967|Alzheimer,|alzheimer,
1316232|NCT01513967|dementia|dementia
1316233|NCT01513954|Infertility|infertility
1316234|NCT01513941|Chronic hepatitis C|chronic hepatitis c
1316235|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
1316236|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
1316237|NCT01513941|Telaprevir|telaprevir
1316238|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
1316239|NCT01513941|Ribavirin|ribavirin
1316240|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
1316241|NCT01513941|Hepatitis C|hepatitis c
1316242|NCT01513928|pharmacokinetics|pharmacokinetics
1316243|NCT01513928|relative bioavailability|relative bioavailability
1316244|NCT01513928|formulation comparison|formulation comparison
1316245|NCT01513915|parents|parents
1316246|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
1316247|NCT01513915|anxiety disorder|anxiety disorder
1316248|NCT01513915|children|children
1316249|NCT01513915|FRIENDS program|friends program
1316250|NCT01513902|Arthritis|arthritis
1316251|NCT01513902|Pediatric|pediatric
1316252|NCT01513902|Tofacitinib|tofacitinib
1316253|NCT01513902|JIA|jia
1316254|NCT01513850|Liver Transplantation|liver transplantation
1316255|NCT01513850|HBV|hbv
1316256|NCT01513850|HBV Recurrence|hbv recurrence
1316257|NCT01513850|HBsAg Positive|hbsag positive
1316258|NCT01513824|stress|stress
1316259|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
1316260|NCT01513824|acupressure|acupressure
1316261|NCT01513824|ischemic heart disease|ischemic heart disease
1316262|NCT01513811|bowel preparation|bowel preparation
1316263|NCT01513811|constipation|constipation
1316264|NCT01513811|polyethylene glycol|polyethylene glycol
1316265|NCT01513811|itopride|itopride
1316266|NCT01513798|Diet Therapy|diet therapy
1316267|NCT01513798|Exercise Therapy|exercise therapy
1316268|NCT01513798|Insulin Resistance|insulin resistance
1316269|NCT01513785|H. pylori|h. pylori
1316270|NCT01513785|Dual therapy|dual therapy
1316271|NCT01513785|Amoxicillin|amoxicillin
1316272|NCT01513785|Rabeprazole|rabeprazole
1316273|NCT01513759|Fibrinolysis|fibrinolysis
1316274|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
1316275|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
1316276|NCT01513759|recombinant t-PA|recombinant t-pa
1316277|NCT01513759|Activase|activase
1316278|NCT01513746|Type 1 Diabetes|type 1 diabetes
1316279|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1316280|NCT01513746|Eating Disorders|eating disorders
1316281|NCT01513746|Insulin Omission|insulin omission
1316282|NCT01513720|Bioequivalence|bioequivalence
1316283|NCT01513720|Lamotrigine|lamotrigine
1316284|NCT01513720|crossover|crossover
1316285|NCT01513707|kidney transplantation|kidney transplantation
1316286|NCT01513707|hemodialysis|hemodialysis
1316287|NCT01513707|peritoneal dialysis|peritoneal dialysis
1316288|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
1316289|NCT01513694|Stem Cells|stem cells
1316290|NCT01513694|Intervertebral disc disease|intervertebral disc disease
1316291|NCT01513681|Bioequivalence|bioequivalence
1316292|NCT01513681|Lamotrigine|lamotrigine
1316293|NCT01513681|crossover|crossover
1316294|NCT01513655|COPD|copd
1316295|NCT01513655|Home NIV|home niv
1316296|NCT01513655|NIV|niv
1316297|NCT01513642|physiotherapy|physiotherapy
1316298|NCT01513642|cardiac surgery|cardiac surgery
1316299|NCT01513642|breath Stacking|breath stacking
1316300|NCT01513629|Autism spectrum disorders|autism spectrum disorders
1316301|NCT01513629|structural connectivity|structural connectivity
1316302|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
1316303|NCT01513629|sibling|sibling
1316304|NCT01513629|endophenotype|endophenotype
1316305|NCT01513616|COPD|copd
1316306|NCT01513616|dyspnea|dyspnea
1316307|NCT01513616|exercise|exercise
1316308|NCT01513616|measurement|measurement
1316309|NCT01513616|respiratory physiology|respiratory physiology
1316310|NCT01513577|Lumbar fusion|lumbar fusion
1316311|NCT01513577|Pedicular screws|pedicular screws
1316312|NCT01513577|Minimal invasive technique|minimal invasive technique
1316313|NCT01513577|Randomized controlled trial|randomized controlled trial
1316314|NCT01513564|Disc disease|disc disease
1316315|NCT01513564|Spondylolisthesis|spondylolisthesis
1316316|NCT01513538|Pacemaker programming|pacemaker programming
1316317|NCT01513538|Bradyarrhythmia|bradyarrhythmia
1316318|NCT01513499|Eating behavior|eating behavior
1316319|NCT01513499|Appetite|appetite
1316320|NCT01513499|Oxytocin|oxytocin
1316321|NCT01513499|Neuropeptide|neuropeptide
1316322|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
1316323|NCT01513460|NVA 237,|nva 237,
1316324|NCT01513460|glycopyrronium,|glycopyrronium,
1316325|NCT01513460|COPD|copd
1316326|NCT01513447|sterile water injections|sterile water injections
1316327|NCT01513447|back labor|back labor
1316328|NCT01513421|Infected|infected
1316329|NCT01513421|Intra-abdominal|intra-abdominal
1316330|NCT01513421|Collection|collection
1316331|NCT01513421|Drainage|drainage
1316332|NCT01513421|Percutaneous|percutaneous
1316333|NCT01513408|breast cancer|breast cancer
1316334|NCT01513408|CD8+|cd8+
1316335|NCT01513408|Foxp3|foxp3
1316336|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1316337|NCT01513395|Cervical assessment|cervical assessment
1316338|NCT01513395|Focal myometrial contractions|focal myometrial contractions
1316339|NCT01513382|Pilonidal sinus|pilonidal sinus
1316340|NCT01513382|Methylene blue|methylene blue
1316341|NCT01513382|Histopathology|histopathology
1316342|NCT01513382|Surgery|surgery
1316343|NCT01513369|Diabetes|diabetes
1316344|NCT01513369|iron deficiency|iron deficiency
1316345|NCT01513356|breast|breast
1316346|NCT01513356|cancer|cancer
1316347|NCT01513356|BKM120|bkm120
1316348|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
1316350|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
1316351|NCT01513317|Siltuximab|siltuximab
1316352|NCT01513317|Anemic|anemic
1316353|NCT01513265|reduction polypharmacy|reduction polypharmacy
1316354|NCT01513265|clinical outcomes|clinical outcomes
1316355|NCT01513265|pharmaceutical care|pharmaceutical care
1316649|NCT01512225|preterm|preterm
1316356|NCT01513265|clinical pharmacy|clinical pharmacy
1316357|NCT01513265|geriatrics|geriatrics
1316358|NCT01513265|medication review|medication review
1316359|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
1316360|NCT01513252|Cognitive decline|cognitive decline
1316361|NCT01513252|prevention|prevention
1316362|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
1316363|NCT01513252|nutrition exercise|nutrition exercise
1316364|NCT01513252|cognitive training|cognitive training
1316365|NCT01513252|social activities|social activities
1316366|NCT01513252|frailty|frailty
1316367|NCT01513239|Clostridium difficile|clostridium difficile
1316368|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
1316369|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
1316370|NCT01513239|vancomycin|vancomycin
1316371|NCT01513239|metronidazole|metronidazole
1316372|NCT01513239|monoclonal antibody|monoclonal antibody
1316373|NCT01513226|cycled light|cycled light
1316374|NCT01513226|dim light|dim light
1316375|NCT01513226|circadian rhythm|circadian rhythm
1316376|NCT01513226|actigraphy, sleep|actigraphy, sleep
1316377|NCT01513226|premature infant|premature infant
1316378|NCT01513213|Arterial cannulation|arterial cannulation
1316379|NCT01513213|Blood gas|blood gas
1316380|NCT01513213|Carbon dioxide|carbon dioxide
1316381|NCT01513213|Arterial blood|arterial blood
1316382|NCT01513213|Oxygen|oxygen
1316383|NCT01513213|Oxygen fractions|oxygen fractions
1316384|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
1316385|NCT01513187|SOGUG|sogug
1316386|NCT01513187|Pazopanib|pazopanib
1316387|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
1316388|NCT01513174|GOAL|goal
1316389|NCT01513174|Lung|lung
1316390|NCT01513174|Non small cell lung cancer|non small cell lung cancer
1316391|NCT01513174|EGFR mutations|egfr mutations
1316392|NCT01513161|pruritus|pruritus
1316393|NCT01513135|HIV,|hiv,
1316394|NCT01513135|HAART-treated|haart-treated
1316395|NCT01513135|participants|participants
1316396|NCT01513135|Tat protein,|tat protein,
1316397|NCT01513135|Therapeutic immunization|therapeutic immunization
1316398|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
1316399|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
1316400|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
1316401|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
1316402|NCT01513096|colonoscopy|colonoscopy
1316403|NCT01513096|bowel preparation|bowel preparation
1316404|NCT01513096|PEG|peg
1316405|NCT01513096|Prokinetics|prokinetics
1316406|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
1316407|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
1316408|NCT01513070|Coronary Heart Disease|coronary heart disease
1316409|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
1316410|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
1316411|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
1316412|NCT01513070|Chinese Medicine|chinese medicine
1316413|NCT01513070|Angina Pectoris|angina pectoris
1316414|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
1316415|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
1316416|NCT01513070|Clinical Trial|clinical trial
1316417|NCT01513057|bioequivalence|bioequivalence
1316418|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
1316419|NCT01513057|crossover|crossover
1316420|NCT01513044|bioequivalence|bioequivalence
1316421|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
1316422|NCT01513044|crossover|crossover
1316423|NCT01513031|Atrial fibrillation|atrial fibrillation
1316424|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
1316425|NCT01513031|Medication adherence|medication adherence
1316426|NCT01513018|OLV|olv
1316427|NCT01513018|one lung ventilation|one lung ventilation
1316428|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1316429|NCT01513005|obesity management|obesity management
1316430|NCT01512966|Diabetic Macular Edema|diabetic macular edema
1316431|NCT01512966|DME|dme
1316432|NCT01512966|VEGF Trap-Eye|vegf trap-eye
1316433|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
1316434|NCT01512953|PPI|ppi
1316435|NCT01512953|clopidogrel|clopidogrel
1316436|NCT01512953|2C19|2c19
1316437|NCT01512953|Lansoprazole|lansoprazole
1316438|NCT01512940|obesity|obesity
1316439|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
1316440|NCT01512940|Percent Excess weight Loss|percent excess weight loss
1316441|NCT01512940|comorbidities|comorbidities
1316442|NCT01512940|BMI|bmi
1316443|NCT01512940|Bariatric Surgery|bariatric surgery
1316444|NCT01512927|electronic stethoscope|electronic stethoscope
1316445|NCT01512927|arteriovenous fistula|arteriovenous fistula
1316446|NCT01512927|hemodialysis,|hemodialysis,
1316447|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
1316448|NCT01512914|Postoperative pain|postoperative pain
1316449|NCT01512914|Nebulization|nebulization
1316450|NCT01512914|Ropivacaine|ropivacaine
1316451|NCT01512888|SCID|scid
1316452|NCT01512888|SCID-X1|scid-x1
1316650|NCT01512212|thyroid|thyroid
1316453|NCT01512888|X-linked SCID|x-linked scid
1316454|NCT01512888|immunodeficiency|immunodeficiency
1316455|NCT01512888|gene therapy|gene therapy
1316456|NCT01512875|Helicobacter pylori|helicobacter pylori
1316457|NCT01512875|water contamination|water contamination
1316458|NCT01512875|Lima, Peru|lima, peru
1316459|NCT01512862|Calcitriol|calcitriol
1316460|NCT01512862|Off-label|off-label
1316461|NCT01512849|TA-7284|ta-7284
1316462|NCT01512849|JNJ-28431754|jnj-28431754
1316463|NCT01512849|Canagliflozin|canagliflozin
1316464|NCT01512849|Renal Impairment|renal impairment
1316465|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
1316466|NCT01512836|COPD|copd
1316467|NCT01512836|Case management|case management
1316468|NCT01512836|CEA|cea
1316469|NCT01512836|Health economy|health economy
1316470|NCT01512836|Quality of Life|quality of life
1316471|NCT01512823|randomised controlled trial|randomised controlled trial
1316472|NCT01512823|educational intervention|educational intervention
1316473|NCT01512823|occupational therapy|occupational therapy
1316474|NCT01512810|Endometrial|endometrial
1316475|NCT01512810|Cancer|cancer
1316476|NCT01512810|Intraoperative Consultation|intraoperative consultation
1316477|NCT01512797|Januvia|januvia
1316478|NCT01512797|Sitagliptin|sitagliptin
1316479|NCT01512797|Diabetes|diabetes
1316480|NCT01512797|Gastric-Bypass|gastric-bypass
1316481|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
1316482|NCT01512784|HIV infection|hiv infection
1316483|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
1316484|NCT01512758|East Asian Patients|east asian patients
1316485|NCT01512758|Advanced solid tumors|advanced solid tumors
1316486|NCT01512758|Lymphomas|lymphomas
1316487|NCT01512758|MLN8237|mln8237
1316488|NCT01512758|Alisertib|alisertib
1316489|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
1316490|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
1316491|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
1316492|NCT01512706|Inactivated Vaccine|inactivated vaccine
1316493|NCT01512706|Human Diploid cell|human diploid cell
1316494|NCT01512706|Safety|safety
1316495|NCT01512706|Immunogenicity|immunogenicity
1316496|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
1316497|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
1316498|NCT01512680|Carbs counting|carbs counting
1316499|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
1316500|NCT01512680|Insulin pump|insulin pump
1316501|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
1316502|NCT01512654|diabetes|diabetes
1316503|NCT01512654|diadvisor|diadvisor
1316504|NCT01512654|type 1 diabetes|type 1 diabetes
1316505|NCT01512654|type 2 diabetes|type 2 diabetes
1316506|NCT01512654|glucose prediction|glucose prediction
1316507|NCT01512654|cgm prediction|cgm prediction
1316508|NCT01512654|algorithm|algorithm
1316509|NCT01512654|therapy advices|therapy advices
1316510|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
1316511|NCT01512615|Rehabilitation|rehabilitation
1316512|NCT01512615|Exercise training|exercise training
1316513|NCT01512615|Psycho-educational care|psycho-educational care
1316514|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
1316515|NCT01512602|Suicide prevention|suicide prevention
1316516|NCT01512602|Self-harm|self-harm
1316517|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
1316518|NCT01512602|DBT|dbt
1316519|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
1316520|NCT01512602|CAMS|cams
1316521|NCT01512589|Proton Beam Therapy|proton beam therapy
1316522|NCT01512589|PBT|pbt
1316523|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
1316524|NCT01512589|IMRT|imrt
1316525|NCT01512589|Esophageal cancer|esophageal cancer
1316526|NCT01512589|Adenocarcinoma|adenocarcinoma
1316527|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
1316528|NCT01512589|Cervical esophagus|cervical esophagus
1316529|NCT01512589|Thoracic esophagus|thoracic esophagus
1316530|NCT01512589|Gastroesophageal junction|gastroesophageal junction
1316531|NCT01512589|Cardia of stomach|cardia of stomach
1316532|NCT01512589|Questionnaires|questionnaires
1316533|NCT01512589|Surveys|surveys
1316534|NCT01512589|Symptom scores|symptom scores
1316535|NCT01512589|Quality of life|quality of life
1316536|NCT01512589|QOL|qol
1316537|NCT01512576|whiplash|whiplash
1316538|NCT01512576|chronic pain|chronic pain
1316539|NCT01512576|sensitization|sensitization
1316540|NCT01512576|treatment|treatment
1316541|NCT01512576|acupuncture|acupuncture
1316542|NCT01512576|relaxation|relaxation
1316543|NCT01512563|paclitaxel|paclitaxel
1316544|NCT01512563|drug eluting stent|drug eluting stent
1316545|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
1316546|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
1316547|NCT01512550|Hip anatomy|hip anatomy
1316548|NCT01512550|Hip biomechanics|hip biomechanics
1316549|NCT01512537|Vitamin D|vitamin d
1316550|NCT01512537|UVB|uvb
1316551|NCT01512537|Vitamin D supplementation|vitamin d supplementation
1316552|NCT01512524|Traumatic Brain Injury|traumatic brain injury
1316553|NCT01512524|Quality of Life (QoL)|quality of life (qol)
1316554|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
1316555|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1316556|NCT01512511|pneumoperitoneum|pneumoperitoneum
1316557|NCT01512511|nitrous oxide|nitrous oxide
1316558|NCT01512511|carbon dioxide|carbon dioxide
1316559|NCT01512498|VV GVHD|vv gvhd
1316560|NCT01512498|girls|girls
1316561|NCT01512498|adolescents|adolescents
1316562|NCT01512498|HSCT|hsct
1316563|NCT01512485|Bioequivalence|bioequivalence
1316564|NCT01512485|Clopidogrel|clopidogrel
1316565|NCT01512485|crossover|crossover
1316566|NCT01512472|localized prostate cancer|localized prostate cancer
1316567|NCT01512472|degarelix|degarelix
1316568|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
1316569|NCT01512459|Bioavailability|bioavailability
1316570|NCT01512459|Venlafaxine|venlafaxine
1316571|NCT01512459|two way crossover|two way crossover
1316572|NCT01512446|Osteoporosis|osteoporosis
1316573|NCT01512446|Osteoporotic fractures|osteoporotic fractures
1316574|NCT01512446|Bisphosphonate|bisphosphonate
1316575|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
1316576|NCT01512433|acupuncture|acupuncture
1316577|NCT01512433|methadone|methadone
1316578|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
1316579|NCT01512407|Randomised controlled trial|randomised controlled trial
1316580|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
1316581|NCT01512394|bowel preparation|bowel preparation
1316582|NCT01512381|heart failure|heart failure
1316583|NCT01512381|CRT|crt
1316584|NCT01512381|atrial fibrillation|atrial fibrillation
1316585|NCT01512381|AV junction ablation|av junction ablation
1316586|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
1316587|NCT01512368|Exercise|exercise
1316588|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
1316589|NCT01512368|Lipolysis|lipolysis
1316590|NCT01512368|Glucose|glucose
1316591|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
1316592|NCT01512368|Epinephrine|epinephrine
1316593|NCT01512342|pacing|pacing
1316594|NCT01512342|activity management|activity management
1316595|NCT01512342|relaxation|relaxation
1316596|NCT01512342|physiotherapy|physiotherapy
1316597|NCT01512342|occupational therapy|occupational therapy
1316598|NCT01512342|autonomic nervous system|autonomic nervous system
1316599|NCT01512329|neurology|neurology
1316600|NCT01512329|physiotherapy|physiotherapy
1316601|NCT01512329|physical therapy|physical therapy
1316602|NCT01512329|occupational therapy|occupational therapy
1316603|NCT01512329|stress management|stress management
1316604|NCT01512329|activity management|activity management
1316605|NCT01512329|treatment|treatment
1316606|NCT01512316|Fear|fear
1316607|NCT01512316|Cycloserine|cycloserine
1316608|NCT01512316|Conditioning|conditioning
1316609|NCT01512316|Functional neuroimaging|functional neuroimaging
1316610|NCT01512316|Anxiety disorders|anxiety disorders
1316611|NCT01512303|PTSD|ptsd
1316612|NCT01512303|Veterans' Health|veterans' health
1316613|NCT01512303|Meditation|meditation
1316614|NCT01512303|MRI, Functional|mri, functional
1316615|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
1316616|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
1316617|NCT01512290|Theta Burst frequency|theta burst frequency
1316618|NCT01512277|vaccines|vaccines
1316619|NCT01512277|safety|safety
1316620|NCT01512277|drug tolerance|drug tolerance
1316621|NCT01512277|immunogenic protein|immunogenic protein
1316622|NCT01512277|antibody response|antibody response
1316623|NCT01512277|cytokine|cytokine
1316624|NCT01512264|Aphasia|aphasia
1316625|NCT01512264|Stroke|stroke
1316626|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
1316627|NCT01512264|fMRI|fmri
1316628|NCT01512264|Language recovery after stroke|language recovery after stroke
1316629|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
1316630|NCT01512264|CIAT|ciat
1316631|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1316632|NCT01512264|rTMS|rtms
1316633|NCT01512251|BKM120|bkm120
1316634|NCT01512251|BRAF|braf
1316635|NCT01512251|Melanoma|melanoma
1316636|NCT01512251|PI3K|pi3k
1316637|NCT01512238|Medicine adherence|medicine adherence
1316638|NCT01512238|Drug substitution|drug substitution
1316639|NCT01512238|Herb-drug interaction|herb-drug interaction
1316640|NCT01512238|Herbal medicine|herbal medicine
1316641|NCT01512238|Dietary supplements|dietary supplements
1316642|NCT01512238|Over-the-counter products|over-the-counter products
1316643|NCT01512238|On-line prescription records|on-line prescription records
1316842|NCT01511471|Ticagrelor|ticagrelor
1316644|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
1316645|NCT01512238|Intentional non-adherence|intentional non-adherence
1316646|NCT01512238|Unintentional non-adherence|unintentional non-adherence
1316647|NCT01512225|breastmilk|breastmilk
1316648|NCT01512225|domperidone|domperidone
1316651|NCT01512212|fine|fine
1316652|NCT01512212|needle|needle
1316653|NCT01512212|aspiration|aspiration
1316654|NCT01512212|biopsy|biopsy
1316655|NCT01512212|new|new
1316656|NCT01512212|technique|technique
1316657|NCT01512199|U3-1287|u3-1287
1316658|NCT01512199|Trastuzumab|trastuzumab
1316659|NCT01512199|Paclitaxel|paclitaxel
1316660|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
1316661|NCT01512199|breast cancer|breast cancer
1316662|NCT01512199|metastatic|metastatic
1316663|NCT01512186|Clear cell renal cancer|clear cell renal cancer
1316664|NCT01512173|Propranolol gel|propranolol gel
1316665|NCT01512173|Hemangioma|hemangioma
1316666|NCT01512173|capillary neoplasm|capillary neoplasm
1316667|NCT01512173|vascular tissue|vascular tissue
1316668|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
1316669|NCT01512173|neoplasm|neoplasm
1316670|NCT01512173|therapeutic uses|therapeutic uses
1316671|NCT01512173|pharmacologic actions|pharmacologic actions
1316672|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
1316673|NCT01512173|adrenergic antagonist|adrenergic antagonist
1316674|NCT01512173|adrenergics agent|adrenergics agent
1316675|NCT01512173|neurotransmitter agent|neurotransmitter agent
1316676|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
1316677|NCT01512173|physiological effects of drugs|physiological effects of drugs
1316678|NCT01512160|Post-surgical dental pain|post-surgical dental pain
1316679|NCT01512147|SSEP measurements|ssep measurements
1316680|NCT01512147|MEP measurements|mep measurements
1316681|NCT01512147|Pediatric Patients|pediatric patients
1316682|NCT01512147|Neurosurgery|neurosurgery
1316683|NCT01512147|General Anesthesia|general anesthesia
1316684|NCT01512134|Obesity|obesity
1316685|NCT01512134|DBS|dbs
1316686|NCT01512082|Pain|pain
1316687|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
1316688|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
1316689|NCT01512082|Marathon|marathon
1316690|NCT01512069|randomized controlled trial|randomized controlled trial
1316691|NCT01512069|internet|internet
1316692|NCT01512069|diet|diet
1316693|NCT01512069|exercise|exercise
1316694|NCT01512069|health planning|health planning
1316695|NCT01512069|the TTM|the ttm
1316696|NCT01512056|Influenza vaccine|influenza vaccine
1316697|NCT01512056|dialysis|dialysis
1316698|NCT01512056|vaccine|vaccine
1316699|NCT01512056|Seroprotection|seroprotection
1316700|NCT01512056|Seroresponse|seroresponse
1316701|NCT01512056|Seroconversion|seroconversion
1316702|NCT01512056|Safety of the vaccine|safety of the vaccine
1316703|NCT01512043|Breathlessness|breathlessness
1316704|NCT01512043|Symptoms|symptoms
1316705|NCT01512043|Quality of life|quality of life
1316706|NCT01512017|skin lesions or defects|skin lesions or defects
1316707|NCT01512004|Overactive Bladder|overactive bladder
1316708|NCT01512004|urgent micturition|urgent micturition
1316709|NCT01512004|frequent micturition|frequent micturition
1316710|NCT01512004|urge urinary incontinence|urge urinary incontinence
1316711|NCT01511991|cardiac surgery|cardiac surgery
1316712|NCT01511991|sevoflurane|sevoflurane
1316713|NCT01511991|tissue Doppler|tissue doppler
1316714|NCT01511978|Lambert-Eaton|lambert-eaton
1316715|NCT01511978|Eaton-Lambert|eaton-lambert
1316716|NCT01511978|myasthenia|myasthenia
1316717|NCT01511978|myasthenic|myasthenic
1316718|NCT01511978|LEMS|lems
1316719|NCT01511978|LES|les
1316720|NCT01511978|DAP|dap
1316721|NCT01511978|diaminopyridine|diaminopyridine
1316722|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
1316723|NCT01511978|3,4-DAP|3,4-dap
1316724|NCT01511952|music therapy|music therapy
1316725|NCT01511952|entrainment|entrainment
1316726|NCT01511952|premature infants|premature infants
1316727|NCT01511952|live music intervention|live music intervention
1316728|NCT01511952|parent preferred lullabies|parent preferred lullabies
1316729|NCT01511939|Knee pain|knee pain
1316730|NCT01511939|Anticoagulant|anticoagulant
1316731|NCT01511939|Warfarin|warfarin
1316732|NCT01511939|Dabigatran|dabigatran
1316733|NCT01511939|Clopidogrel|clopidogrel
1316734|NCT01511939|Aspirin|aspirin
1316735|NCT01511939|Topical NSAID|topical nsaid
1316736|NCT01511939|Osteoarthritis|osteoarthritis
1316737|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
1316738|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
1316739|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
1316740|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
1316741|NCT01511887|PDA|pda
1316742|NCT01511887|Term newborns|term newborns
1316743|NCT01511887|Ibuprofen|ibuprofen
1316744|NCT01511874|ELIGARD|eligard
1316745|NCT01511874|Prostate cancer|prostate cancer
1316746|NCT01511848|Iron chelation|iron chelation
1316747|NCT01511848|Iron balance|iron balance
1316748|NCT01511848|Secondary iron overload|secondary iron overload
1316749|NCT01511848|deferoxamine|deferoxamine
1316750|NCT01511848|deferasirox|deferasirox
1316751|NCT01511848|Deferiprone|deferiprone
1316752|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
1316849|NCT01511458|Down Syndrome|down syndrome
1316753|NCT01511848|Patients with high iron stores|patients with high iron stores
1316754|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
1316755|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
1316756|NCT01511848|2- Sickle cell disease|2- sickle cell disease
1316757|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
1316758|NCT01511835|diabetes|diabetes
1316759|NCT01511835|pregnancy|pregnancy
1316760|NCT01511835|myo-inositol|myo-inositol
1316761|NCT01511822|PCOS|pcos
1316762|NCT01511822|Insulin resistance|insulin resistance
1316763|NCT01511822|Hyperandrogenism|hyperandrogenism
1316764|NCT01511822|Myo-inositol|myo-inositol
1316765|NCT01511809|HIV-1|hiv-1
1316766|NCT01511796|stroke|stroke
1316767|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
1316768|NCT01511770|Bioequivalence|bioequivalence
1316769|NCT01511770|Fluconazole|fluconazole
1316770|NCT01511770|Crossover|crossover
1316771|NCT01511757|Bioequivalence|bioequivalence
1316772|NCT01511757|Fluconazole|fluconazole
1316773|NCT01511757|Crossover|crossover
1316774|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
1316775|NCT01511731|Bioequivalence|bioequivalence
1316776|NCT01511731|famotidine|famotidine
1316777|NCT01511731|Crossover|crossover
1316778|NCT01511718|Bioequivalence|bioequivalence
1316779|NCT01511718|Ondansetron|ondansetron
1316780|NCT01511718|crossover|crossover
1316781|NCT01511705|Bioequivalence|bioequivalence
1316782|NCT01511705|Ondansetron|ondansetron
1316783|NCT01511705|crossover|crossover
1316784|NCT01511679|Alcohol abuse|alcohol abuse
1316785|NCT01511666|cardiac arrest|cardiac arrest
1316786|NCT01511666|mechanical chest compressions|mechanical chest compressions
1316787|NCT01511666|intraarrest cooling|intraarrest cooling
1316788|NCT01511666|ECLS|ecls
1316789|NCT01511653|screening colonoscopy|screening colonoscopy
1316790|NCT01511653|colon cancer early detection|colon cancer early detection
1316791|NCT01511653|rectal cancer early detection|rectal cancer early detection
1316792|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
1316793|NCT01511653|biomarker validation|biomarker validation
1316794|NCT01511640|marijuana|marijuana
1316795|NCT01511640|addiction|addiction
1316796|NCT01511640|treatment|treatment
1316797|NCT01511640|pharmacotherapy|pharmacotherapy
1316798|NCT01511640|cannabinoid|cannabinoid
1316799|NCT01511614|fMRI|fmri
1316800|NCT01511614|Nicotine Withdrawal|nicotine withdrawal
1316801|NCT01511601|Apheresis|apheresis
1316802|NCT01511601|Leukocytes|leukocytes
1316803|NCT01511601|Plasma|plasma
1316804|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
1316805|NCT01511601|Immunology|immunology
1316806|NCT01511588|Kallmann Syndrome|kallmann syndrome
1316807|NCT01511588|Delayed Puberty|delayed puberty
1316808|NCT01511588|GnRH Deficiency|gnrh deficiency
1316809|NCT01511588|Infertility|infertility
1316810|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1316811|NCT01511588|Amenorrhea|amenorrhea
1316812|NCT01511588|Hypogonadism|hypogonadism
1316813|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1316814|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1316815|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1316816|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1316817|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1316818|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1316819|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1316820|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1316821|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1316822|NCT01511523|Liver|liver
1316823|NCT01511523|Fatty|fatty
1316824|NCT01511523|Non Alcoholic|non alcoholic
1316825|NCT01511523|Vitamin E|vitamin e
1316826|NCT01511523|Silymarin|silymarin
1316827|NCT01511523|Carnitine|carnitine
1316828|NCT01511523|Supplement|supplement
1316829|NCT01511523|NAFLD|nafld
1316830|NCT01511510|PF-04958242|pf-04958242
1316831|NCT01511510|multiple dose|multiple dose
1316832|NCT01511510|safety|safety
1316833|NCT01511510|schizophrenia|schizophrenia
1316834|NCT01511497|Phase 1|phase 1
1316835|NCT01511497|PF-04427429|pf-04427429
1316836|NCT01511484|fruit|fruit
1316837|NCT01511484|vegetables|vegetables
1316838|NCT01511484|appearance|appearance
1316839|NCT01511484|skin color|skin color
1316840|NCT01511484|carotenoids|carotenoids
1316841|NCT01511484|diet|diet
1316843|NCT01511471|platelet reactivity|platelet reactivity
1316844|NCT01511471|clopidogrel|clopidogrel
1316845|NCT01511471|haemodialysis|haemodialysis
1316846|NCT01511458|Pregnancy|pregnancy
1316847|NCT01511458|Fetal aneuploidy|fetal aneuploidy
1316848|NCT01511458|Trisomy 21|trisomy 21
1317443|NCT01508715|subacromial|subacromial
1316850|NCT01511458|Prenatal screening|prenatal screening
1316851|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
1316852|NCT01511458|First trimester|first trimester
1316853|NCT01511458|Combined screening|combined screening
1316854|NCT01511458|Nuchal translucency|nuchal translucency
1316855|NCT01511458|PAPP-A|papp-a
1316856|NCT01511458|hCG|hcg
1316857|NCT01511458|cell free DNA|cell free dna
1316858|NCT01511458|cf DNA|cf dna
1316859|NCT01511458|DNA|dna
1316860|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
1316861|NCT01511458|Harmony Prenatal Test|harmony prenatal test
1316862|NCT01511445|Cervicobrachial pain|cervicobrachial pain
1316863|NCT01511445|radicular pain|radicular pain
1316864|NCT01511445|arm pain|arm pain
1316865|NCT01511445|myelopathy|myelopathy
1316866|NCT01511445|radiculitis|radiculitis
1316867|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
1316868|NCT01511432|Relative bioavailability|relative bioavailability
1316869|NCT01511432|telaprevir formulations|telaprevir formulations
1316870|NCT01511419|Influenza|influenza
1316871|NCT01511419|Vaccine|vaccine
1316872|NCT01511419|Pandemic|pandemic
1316873|NCT01511419|H7N3|h7n3
1316874|NCT01511406|Psychosis|psychosis
1316875|NCT01511406|Schizophrenia|schizophrenia
1316876|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
1316877|NCT01511406|Self esteem|self esteem
1316878|NCT01511406|Depression|depression
1316879|NCT01511393|GLP1|glp1
1316880|NCT01511393|Glucagon like peptide|glucagon like peptide
1316881|NCT01511393|liraglutide|liraglutide
1316882|NCT01511393|exenatide extended release|exenatide extended release
1316883|NCT01511393|albiglutide|albiglutide
1316884|NCT01511393|dulaglutide|dulaglutide
1316885|NCT01511380|juvenile|juvenile
1316886|NCT01511380|randomized trial|randomized trial
1316887|NCT01511380|substance abuse|substance abuse
1316888|NCT01511380|sexual risk|sexual risk
1316889|NCT01511380|contingency management|contingency management
1316890|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
1316891|NCT01511354|critically ill children|critically ill children
1316892|NCT01511354|ICU|icu
1316893|NCT01511354|24hr protein balance|24hr protein balance
1316894|NCT01511354|stable isotopes|stable isotopes
1316895|NCT01511354|fed state|fed state
1316896|NCT01511341|Telenursing|telenursing
1316897|NCT01511341|Children|children
1316898|NCT01511341|Chronic Illness|chronic illness
1316899|NCT01511341|Nursing|nursing
1316900|NCT01511328|HPV testing|hpv testing
1316901|NCT01511328|Primary screening|primary screening
1316902|NCT01511328|Cervical Cancer|cervical cancer
1316903|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
1316904|NCT01511289|Radotinib|radotinib
1316905|NCT01511289|CML-CP|cml-cp
1316906|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
1316907|NCT01511276|Breast cancer|breast cancer
1316908|NCT01511276|Sex hormones|sex hormones
1316909|NCT01511276|Physical activity|physical activity
1316910|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
1316911|NCT01511263|AL amyloidosis|al amyloidosis
1316912|NCT01511250|Normal healthy adults and children|normal healthy adults and children
1316913|NCT01511250|Safety and tolerability|safety and tolerability
1316914|NCT01511250|Active vaccine|active vaccine
1316915|NCT01511250|Placebo|placebo
1316916|NCT01511250|Dengue virus vaccine|dengue virus vaccine
1316917|NCT01511250|Immune response|immune response
1316918|NCT01511237|HIV-1 infection|hiv-1 infection
1316919|NCT01511237|Prophylaxis|prophylaxis
1316920|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
1316921|NCT01511237|Thailand|thailand
1316922|NCT01511237|Developing Countries|developing countries
1316923|NCT01511224|Bloodstream infections|bloodstream infections
1316924|NCT01511224|Acinetobacter|acinetobacter
1316925|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
1316926|NCT01511211|Dexamethasone|dexamethasone
1316927|NCT01511211|lower limb block|lower limb block
1316928|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
1316929|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
1316930|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
1316931|NCT01511211|ropivacaine|ropivacaine
1316932|NCT01511211|total knee arthroplasty|total knee arthroplasty
1316933|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
1316934|NCT01511146|oxaliplatin|oxaliplatin
1316935|NCT01511146|mitomycin|mitomycin
1316936|NCT01511146|gemcitabine|gemcitabine
1316937|NCT01511146|intrahepatic|intrahepatic
1316938|NCT01511146|liver metastasis|liver metastasis
1316939|NCT01511146|response in liver metastasis|response in liver metastasis
1317333|NCT01509365|clopidogrel|clopidogrel
1316940|NCT01511146|downsized to operation|downsized to operation
1316941|NCT01511133|Laboratory evaluations|laboratory evaluations
1316942|NCT01511133|infants|infants
1316943|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
1316944|NCT01511133|serologic response|serologic response
1317545|NCT01508299|skin test|skin test
1316945|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
1316946|NCT01511107|acute otitis media|acute otitis media
1316947|NCT01511107|ear infection|ear infection
1316948|NCT01511107|antimicrobial therapy|antimicrobial therapy
1316949|NCT01511107|antimicrobial resistance|antimicrobial resistance
1316950|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
1316951|NCT01511094|intraocular pressure,|intraocular pressure,
1316952|NCT01511094|open angle glaucoma|open angle glaucoma
1316953|NCT01511094|trabeculectomy|trabeculectomy
1316954|NCT01511094|Goniocurettage|goniocurettage
1316955|NCT01511094|Non-Filtering Surgery|non-filtering surgery
1316956|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
1316957|NCT01511081|NSCLC|nsclc
1316958|NCT01511081|Centrally-located|centrally-located
1316959|NCT01511081|Recurrent|recurrent
1316960|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
1316961|NCT01511081|Adenocarcinoma|adenocarcinoma
1316962|NCT01511081|Large cell carcinoma|large cell carcinoma
1316963|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
1316964|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
1316965|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1316966|NCT01511081|SBRT|sbrt
1316967|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
1316968|NCT01511081|SBPT|sbpt
1316969|NCT01511068|PAP|pap
1316970|NCT01511055|Ovarian Cancer|ovarian cancer
1316971|NCT01511016|lipid kinetics|lipid kinetics
1316972|NCT01511016|fat oxidation|fat oxidation
1316973|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
1316974|NCT01511003|Prograf|prograf
1316975|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1316976|NCT01511003|Tacrolimus|tacrolimus
1615198|NCT00339339|Systemic|systemic
1316977|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
1316978|NCT01510990|Gefitinib|gefitinib
1316979|NCT01510990|FDG-PET|fdg-pet
1316980|NCT01510977|colonoscopy|colonoscopy
1316981|NCT01510977|bowel preparation|bowel preparation
1316982|NCT01510964|Breast cancer|breast cancer
1316983|NCT01510964|Patient involvement|patient involvement
1316984|NCT01510964|Question prompt-sheet|question prompt-sheet
1316985|NCT01510964|Doctor-patient communication|doctor-patient communication
1316986|NCT01510964|RCT|rct
1316987|NCT01510951|AMGEN|amgen
1316988|NCT01510951|PSORIASIS|psoriasis
1316989|NCT01510951|SAFETY|safety
1316990|NCT01510938|Children|children
1316991|NCT01510938|Respiratory Tract Infections|respiratory tract infections
1316992|NCT01510938|Prevention|prevention
1316993|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
1316994|NCT01510873|Health-related quality of life|health-related quality of life
1316995|NCT01510873|Fatigue|fatigue
1316996|NCT01510873|pITO|pito
1316997|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
1316998|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
1316999|NCT01510834|CTI|cti
1317000|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
1317001|NCT01510834|PTSD|ptsd
1317002|NCT01510834|Smoking|smoking
1317003|NCT01510834|Anxiety|anxiety
1317004|NCT01510834|Depression|depression
1317005|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
1317006|NCT01510821|saphenous vein graft|saphenous vein graft
1317007|NCT01510821|endothelial function|endothelial function
1317008|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
1317009|NCT01510795|Kidney transplantation|kidney transplantation
1317010|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
1317011|NCT01510795|Spironolactone|spironolactone
1317012|NCT01510743|open heart surgery|open heart surgery
1317013|NCT01510743|lung surgery|lung surgery
1317014|NCT01510743|spine surgery|spine surgery
1317015|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
1317016|NCT01510730|gastric tumor|gastric tumor
1317017|NCT01510730|Helicobacter pylori|helicobacter pylori
1317018|NCT01510730|endoscopic resection|endoscopic resection
1317019|NCT01510730|metachronous neoplasms|metachronous neoplasms
1317020|NCT01510717|Intraocular Lens|intraocular lens
1317021|NCT01510717|Monofocal|monofocal
1317022|NCT01510717|Multifocal|multifocal
1317023|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
1317024|NCT01510691|vitroretinal surgery|vitroretinal surgery
1317025|NCT01510678|Diet Quality|diet quality
1317026|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
1317027|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
1317028|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
1317029|NCT01510652|Heart Failure,|heart failure,
1317030|NCT01510652|Left Ventricular Lead,|left ventricular lead,
1317031|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
1317032|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
1317033|NCT01510652|Intra and post operative related complications|intra and post operative related complications
1317034|NCT01510626|Multiple food allergies|multiple food allergies
1317035|NCT01510613|Pomalidomide|pomalidomide
1317036|NCT01510613|Dexamethasone|dexamethasone
1317037|NCT01510613|treatment|treatment
1317546|NCT01508299|raw food|raw food
1317038|NCT01510613|AL amyloidosis|al amyloidosis
1317039|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
1317040|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
1317041|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1317042|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
1317043|NCT01510600|regional neuroblastoma|regional neuroblastoma
1317044|NCT01510587|obesity|obesity
1317045|NCT01510587|prevention|prevention
1317046|NCT01510587|preteen|preteen
1317047|NCT01510587|nutrition|nutrition
1317048|NCT01510587|physical activity|physical activity
1317049|NCT01510587|body image|body image
1317050|NCT01510587|family dynamics|family dynamics
1317051|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
1317052|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
1317053|NCT01510561|pancreatic cancer|pancreatic cancer
1317054|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
1317055|NCT01510548|Disc prolapse|disc prolapse
1317056|NCT01510548|Pain|pain
1317057|NCT01510548|Disability|disability
1317058|NCT01510535|Osteoartritis|osteoartritis
1317059|NCT01510535|Knee|knee
1317060|NCT01510535|LBSA0103|lbsa0103
1317061|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
1317062|NCT01510522|Diabetes|diabetes
1317063|NCT01510522|Glucophage|glucophage
1317064|NCT01510522|Metformin|metformin
1317065|NCT01510522|sachets|sachets
1317066|NCT01510522|tablets|tablets
1317067|NCT01510509|Drug Eluting Stent|drug eluting stent
1317068|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
1317069|NCT01510496|Chronic pain|chronic pain
1317070|NCT01510496|genetic polymorphisms|genetic polymorphisms
1317071|NCT01510496|postoperative pain|postoperative pain
1317072|NCT01510483|obesity prevention|obesity prevention
1317073|NCT01510483|tobacco prevention|tobacco prevention
1317074|NCT01510483|nutrition|nutrition
1317075|NCT01510483|physical activity|physical activity
1317076|NCT01510483|sedentary activity|sedentary activity
1317077|NCT01510483|tobacco use|tobacco use
1317078|NCT01510483|tobacco exposure|tobacco exposure
1317079|NCT01510483|prevention|prevention
1317080|NCT01510483|clinician intervention|clinician intervention
1317081|NCT01510483|preteen|preteen
1317082|NCT01510483|adolescents|adolescents
1317083|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
1317084|NCT01510470|Marginal bone level|marginal bone level
1317085|NCT01510470|soft tissue|soft tissue
1317086|NCT01510470|soft tissue responds|soft tissue responds
1317087|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
1317088|NCT01510457|Degenerative Joint Disease|degenerative joint disease
1317089|NCT01510457|Chronic Pain|chronic pain
1317090|NCT01510457|Knee Pain|knee pain
1317091|NCT01510418|Hemophilia|hemophilia
1317092|NCT01510418|Spouse|spouse
1317093|NCT01510418|Significant Other|significant other
1317094|NCT01510418|Quality of Life|quality of life
1317095|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
1317096|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
1317097|NCT01510392|Optical coherence tomography|optical coherence tomography
1317098|NCT01510392|Glaucoma|glaucoma
1317099|NCT01510392|Macula|macula
1317100|NCT01510392|Keratoconus|keratoconus
1317101|NCT01510392|Screening|screening
1317102|NCT01510379|nausea|nausea
1317103|NCT01510379|vomiting|vomiting
1317104|NCT01510379|post-operative|post-operative
1317105|NCT01510379|foregut surgery|foregut surgery
1317106|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
1317107|NCT01510366|Sabin Strains|sabin strains
1317108|NCT01510366|poliomyelitis|poliomyelitis
1317109|NCT01510340|adherence|adherence
1317110|NCT01510340|HIV|hiv
1317111|NCT01510340|antiretroviral therapy|antiretroviral therapy
1317112|NCT01510340|tailored web intervention|tailored web intervention
1317113|NCT01510327|drug-eluting stents|drug-eluting stents
1317114|NCT01510327|DES|des
1317115|NCT01510327|atherosclerotic|atherosclerotic
1317116|NCT01510301|Self-report|self-report
1317117|NCT01510301|Self-management|self-management
1317118|NCT01510301|Hypertension|hypertension
1317119|NCT01510301|Adherence|adherence
1317120|NCT01510301|Cell phone|cell phone
1317121|NCT01510301|Drug treatment|drug treatment
1317122|NCT01510301|Medical Adherence|medical adherence
1317123|NCT01510288|GVAX|gvax
1317124|NCT01510288|Ipilimumab|ipilimumab
1317125|NCT01510288|prostate cancer|prostate cancer
1317126|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
1317127|NCT01510275|patients|patients
1317128|NCT01510275|pulmonary volume|pulmonary volume
1317129|NCT01510275|respiratory muscle performance|respiratory muscle performance
1317130|NCT01510262|Repeat STI patients|repeat sti patients
1317131|NCT01510262|HIV|hiv
1317132|NCT01510262|Cost effectiveness|cost effectiveness
1317133|NCT01510262|Resource scarce|resource scarce
1317134|NCT01510262|Urban clinics|urban clinics
1317135|NCT01510249|calcaneal spur|calcaneal spur
1317136|NCT01510249|shock wave therapy|shock wave therapy
1317137|NCT01510249|ultrasound therapy|ultrasound therapy
1317138|NCT01510236|Adolescence|adolescence
1317139|NCT01510236|Cancer|cancer
1317140|NCT01510236|Depression|depression
1317141|NCT01510236|Anxiety|anxiety
1317142|NCT01510236|Self-help via internet|self-help via internet
1317143|NCT01510223|Fats|fats
1317144|NCT01510223|Macronutrients|macronutrients
1317145|NCT01510223|appetite|appetite
1317146|NCT01510223|gastric emptying|gastric emptying
1317147|NCT01510223|Gastrointestinal transit|gastrointestinal transit
1317148|NCT01510210|Atrial Fibrillation|atrial fibrillation
1317149|NCT01510210|Arrhythmia|arrhythmia
1317150|NCT01510210|Rhythm control|rhythm control
1317151|NCT01510197|Atrial Fibrillation|atrial fibrillation
1317152|NCT01510197|Arrhythmia|arrhythmia
1317153|NCT01510197|Rhythm control|rhythm control
1317154|NCT01510171|platelet inhibitor|platelet inhibitor
1317155|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1317156|NCT01510171|stent|stent
1317157|NCT01510171|prasugrel|prasugrel
1317158|NCT01510171|ticagrelor|ticagrelor
1317159|NCT01510145|Glaucoma|glaucoma
1317160|NCT01510145|Open-angle glaucoma|open-angle glaucoma
1317161|NCT01510145|Ocular hypertension|ocular hypertension
1317162|NCT01510145|Hypertension|hypertension
1317163|NCT01510145|Eye Diseases|eye diseases
1317164|NCT01510145|Vascular Diseases|vascular diseases
1317165|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
1317166|NCT01510145|Travoprost|travoprost
1317167|NCT01510145|Antihypertensive Agents|antihypertensive agents
1317168|NCT01510145|Cardiovascular Agents|cardiovascular agents
1317169|NCT01510145|Therapeutic Uses|therapeutic uses
1317170|NCT01510145|Pharmacologic Actions|pharmacologic actions
1317172|NCT01510132|OHT|oht
1317173|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
1317174|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
1317175|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
1317176|NCT01510080|Delayed video-based supervision|delayed video-based supervision
1317177|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
1317178|NCT01510067|CLE|cle
1317179|NCT01510067|Lupus|lupus
1317180|NCT01510067|Lupus Erythematosus|lupus erythematosus
1317181|NCT01510054|miRNA in endometrium|mirna in endometrium
1317182|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1317183|NCT01510041|Physical therapy|physical therapy
1317184|NCT01510041|Dyspnea|dyspnea
1317185|NCT01510041|Inspiratory muscle training|inspiratory muscle training
1317186|NCT01510041|Activities of daily living|activities of daily living
1317187|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
1317188|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
1317189|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
1317190|NCT01510015|cannabis|cannabis
1317191|NCT01510015|psychostimulants|psychostimulants
1317192|NCT01510015|psychosis|psychosis
1317193|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
1317194|NCT01510002|central neck dissection|central neck dissection
1317195|NCT01510002|survival|survival
1317196|NCT01510002|locoregional control|locoregional control
1317197|NCT01510002|morbidity|morbidity
1317198|NCT01509989|Adherence|adherence
1317199|NCT01509989|Compliance|compliance
1317200|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
1317201|NCT01509989|Hydroxychloroquine|hydroxychloroquine
1317202|NCT01509989|Blood monitoring|blood monitoring
1317203|NCT01509989|Flares|flares
1317204|NCT01509976|Triclosan|triclosan
1317205|NCT01509976|Triclocarban|triclocarban
1317206|NCT01509976|Microbial flora|microbial flora
1317207|NCT01509976|Obesity|obesity
1317208|NCT01509963|MSKCC nomogram|mskcc nomogram
1317209|NCT01509963|Tenon score|tenon score
1317210|NCT01509963|metastatic SN|metastatic sn
1317211|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
1317212|NCT01509963|additional ALND|additional alnd
1317213|NCT01509937|end stage renal disease|end stage renal disease
1317214|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
1317215|NCT01509937|dry weight|dry weight
1317216|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
1317217|NCT01509937|body composition monitor|body composition monitor
1317218|NCT01509937|Fresenius BCM|fresenius bcm
1317219|NCT01509937|Ultrafiltration|ultrafiltration
1317220|NCT01509924|Walking capacity|walking capacity
1317221|NCT01509924|Mental Fatigue|mental fatigue
1317222|NCT01509924|Quality of Life|quality of life
1317223|NCT01509924|Cognition|cognition
1317224|NCT01509924|Motor activity|motor activity
1317225|NCT01509924|Exercise|exercise
1317226|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
1317227|NCT01509872|War-affected Children|war-affected children
1317228|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
1317229|NCT01509872|Psychosocial Distress|psychosocial distress
1317230|NCT01509859|proximal femur nail|proximal femur nail
1317232|NCT01509859|intertan|intertan
1317233|NCT01509859|weight bearing|weight bearing
1317656|NCT01507974|pregnancy|pregnancy
1317234|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
1317235|NCT01509859|femur neck fracture|femur neck fracture
1317236|NCT01509846|Shigella|shigella
1317237|NCT01509846|vaccine|vaccine
1317238|NCT01509846|shigellosis|shigellosis
1317239|NCT01509846|dysentery|dysentery
1317240|NCT01509846|whole cell|whole cell
1317241|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
1317242|NCT01509833|hCG low dose|hcg low dose
1317243|NCT01509833|Oocyte maturity|oocyte maturity
1317244|NCT01509833|poor respond|poor respond
1317245|NCT01509807|Ileostomy reversal|ileostomy reversal
1317246|NCT01509794|CME|cme
1317247|NCT01509794|Simulation|simulation
1317248|NCT01509794|Affective engagement|affective engagement
1317249|NCT01509794|Cognitive performance|cognitive performance
1317250|NCT01509781|simple mastectomy|simple mastectomy
1317251|NCT01509781|modified radical mastectomy|modified radical mastectomy
1317252|NCT01509781|wound care|wound care
1317253|NCT01509781|suction drain|suction drain
1317254|NCT01509781|adaptive suture|adaptive suture
1317255|NCT01509768|MPS IIIB|mps iiib
1317256|NCT01509729|Knee|knee
1317257|NCT01509729|Arthroscopy|arthroscopy
1317258|NCT01509729|Lidocaine patch|lidocaine patch
1317259|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
1317260|NCT01509716|Predialysis|predialysis
1317261|NCT01509703|COPD|copd
1317262|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
1317263|NCT01509703|tracheotomy stent|tracheotomy stent
1317264|NCT01509703|tracheotomy|tracheotomy
1317265|NCT01509690|Incident|incident
1317266|NCT01509690|Hemodialysis|hemodialysis
1317267|NCT01509677|Roflumilast|roflumilast
1317268|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1317269|NCT01509677|COPD|copd
1317270|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
1317271|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
1317272|NCT01509651|neuromuscular function|neuromuscular function
1317273|NCT01509638|Ileostomy reversal|ileostomy reversal
1317274|NCT01509625|Fulvestrant|fulvestrant
1317275|NCT01509625|Faslodex|faslodex
1317276|NCT01509612|cancer|cancer
1317277|NCT01509612|additive homeopathy|additive homeopathy
1317278|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
1317279|NCT01509599|Venous disease|venous disease
1317280|NCT01509599|Venous disorders|venous disorders
1317281|NCT01509599|Venous insufficiency|venous insufficiency
1317282|NCT01509599|Venous ulcers|venous ulcers
1317283|NCT01509599|Cryotherapy|cryotherapy
1317284|NCT01509586|smoking|smoking
1317285|NCT01509586|smoking cessation|smoking cessation
1317286|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
1317287|NCT01509573|prevention therapy|prevention therapy
1317288|NCT01509573|depressive symptoms|depressive symptoms
1317289|NCT01509573|anxiety|anxiety
1317290|NCT01509573|parenting|parenting
1317291|NCT01509573|family functioning|family functioning
1317292|NCT01509573|resilience, psychological|resilience, psychological
1317293|NCT01509573|Developing countries|developing countries
1317294|NCT01509573|Rwanda|rwanda
1317295|NCT01509573|HIV/AIDS|hiv/aids
1317296|NCT01509534|pacemaker|pacemaker
1317297|NCT01509534|implantable loop recorder|implantable loop recorder
1317298|NCT01509534|syncope|syncope
1317299|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1317300|NCT01509521|Fetal heartrate|fetal heartrate
1317301|NCT01509521|Ephedrine|ephedrine
1317302|NCT01509521|Phenylephrine|phenylephrine
1317303|NCT01509508|HIV|hiv
1317304|NCT01509508|Prevention|prevention
1317305|NCT01509508|Treatment|treatment
1317306|NCT01509508|South Africa|south africa
1317307|NCT01509495|Heart Failure|heart failure
1317308|NCT01509495|HF|hf
1317309|NCT01509482|insulin resistance|insulin resistance
1317310|NCT01509482|unexplained azoospermia|unexplained azoospermia
1317311|NCT01509482|unexplained oligospermia|unexplained oligospermia
1317312|NCT01509469|Ileal brake|ileal brake
1317313|NCT01509469|Casein|casein
1317314|NCT01509469|Sucrose|sucrose
1317315|NCT01509469|Ileal infusion|ileal infusion
1317316|NCT01509456|bone metabolism|bone metabolism
1317317|NCT01509456|potassium bicarbonate|potassium bicarbonate
1317318|NCT01509456|alkaline salt|alkaline salt
1317319|NCT01509456|acid base balance|acid base balance
1317320|NCT01509456|bed rest|bed rest
1317321|NCT01509443|Asthma|asthma
1317322|NCT01509443|Obesity|obesity
1317323|NCT01509443|Breathing exercise|breathing exercise
1317324|NCT01509417|pyloric stenosis|pyloric stenosis
1317325|NCT01509404|CMV|cmv
1317326|NCT01509404|cytomegalovirus|cytomegalovirus
1317327|NCT01509404|transplant|transplant
1317328|NCT01509378|ICD|icd
1317329|NCT01509378|ATP therapy|atp therapy
1317330|NCT01509378|Rescue Shock therapy|rescue shock therapy
1317331|NCT01509365|cardiovascular disease|cardiovascular disease
1317332|NCT01509365|maintenance dose|maintenance dose
1317334|NCT01509365|overweight|overweight
1317335|NCT01509365|antiplatelet agents|antiplatelet agents
1317336|NCT01509352|fundoplication|fundoplication
1317337|NCT01509352|gastric reflux|gastric reflux
1317338|NCT01509339|Vancomycin|vancomycin
1317339|NCT01509339|Inhalation|inhalation
1317340|NCT01509339|Nebulization|nebulization
1317341|NCT01509339|Pharmacokinetics|pharmacokinetics
1317342|NCT01509326|headache|headache
1317343|NCT01509326|chiropractic|chiropractic
1317344|NCT01509326|manipulation|manipulation
1317345|NCT01509326|acupressure|acupressure
1317346|NCT01509326|self-care|self-care
1317347|NCT01509313|endometrial polyps|endometrial polyps
1317348|NCT01509313|uterine polyps|uterine polyps
1317349|NCT01509313|morcellator|morcellator
1317350|NCT01509313|hysteroscopy|hysteroscopy
1317351|NCT01509300|TBI|tbi
1317352|NCT01509300|Fludarabine|fludarabine
1317353|NCT01509300|CD3 depletion|cd3 depletion
1317354|NCT01509300|Children and adolescents|children and adolescents
1317355|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1317356|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
1317357|NCT01509287|metabolic testing|metabolic testing
1317358|NCT01509287|genes|genes
1317359|NCT01509287|genetic|genetic
1317360|NCT01509274|Plantar fasciitis|plantar fasciitis
1317361|NCT01509274|Plasma|plasma
1317362|NCT01509274|PRP|prp
1317363|NCT01509274|Heel pain|heel pain
1317364|NCT01509261|Erosive Esophagitis|erosive esophagitis
1317365|NCT01509261|Ilaprazole|ilaprazole
1317366|NCT01509261|GERD|gerd
1317367|NCT01509248|Theophylline|theophylline
1317368|NCT01509235|cystic fibrosis|cystic fibrosis
1317369|NCT01509235|Lung function|lung function
1317370|NCT01509235|physical exercise|physical exercise
1317371|NCT01509222|Health promotion|health promotion
1317372|NCT01509222|Dietary Counseling|dietary counseling
1317374|NCT01509209|pseudoephedrine|pseudoephedrine
1317375|NCT01509209|levocetirizine|levocetirizine
1317376|NCT01509196|Fenofibric acid|fenofibric acid
1317377|NCT01509196|HIP0901|hip0901
1317378|NCT01509196|Lipidilsupra|lipidilsupra
1317379|NCT01509183|asthma|asthma
1317380|NCT01509183|healthcare utilization costs|healthcare utilization costs
1317381|NCT01509157|Type 1 diabetes|type 1 diabetes
1317382|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
1317383|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
1317384|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
1317385|NCT01509092|traumatic macular hole|traumatic macular hole
1317386|NCT01509092|vitrectomy|vitrectomy
1317387|NCT01509092|observation|observation
1317388|NCT01509066|vegetarian|vegetarian
1317389|NCT01509066|vegan|vegan
1317390|NCT01509066|low calorie|low calorie
1317391|NCT01509066|infertility|infertility
1317392|NCT01509066|PCOS|pcos
1317393|NCT01509053|Schizophrenia|schizophrenia
1317394|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
1317395|NCT01509027|hemodialysis|hemodialysis
1317396|NCT01509027|hyperphoshatemia|hyperphoshatemia
1317397|NCT01509027|compliance|compliance
1317398|NCT01509014|Statins|statins
1317399|NCT01509014|Adherence|adherence
1317400|NCT01509014|Pharmacists|pharmacists
1317401|NCT01509001|type 2 diabetes|type 2 diabetes
1317402|NCT01509001|metformin|metformin
1317403|NCT01509001|glimepiride|glimepiride
1317404|NCT01509001|glucose control|glucose control
1317405|NCT01509001|vascular reactivity|vascular reactivity
1317406|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
1317407|NCT01508988|ONO-9054|ono-9054
1317408|NCT01508988|adult healthy volunteers|adult healthy volunteers
1317409|NCT01508988|single dose|single dose
1317410|NCT01508988|phase 1|phase 1
1317411|NCT01508975|satiety|satiety
1317412|NCT01508975|obesity|obesity
1317413|NCT01508975|food intake|food intake
1317414|NCT01508962|Disease onset|disease onset
1317415|NCT01508962|Disease progression|disease progression
1317416|NCT01508884|intradermal|intradermal
1317417|NCT01508884|influenza|influenza
1317418|NCT01508884|vaccination|vaccination
1317419|NCT01508845|vitamin D|vitamin d
1317420|NCT01508845|vitamin D absorption|vitamin d absorption
1317421|NCT01508845|vitamin D deficiency|vitamin d deficiency
1317422|NCT01508819|Patients over 75|patients over 75
1317423|NCT01508819|acute pathology|acute pathology
1317424|NCT01508819|ICU admission|icu admission
1317425|NCT01508793|Sleep|sleep
1317426|NCT01508793|Obesity|obesity
1317427|NCT01508793|Children|children
1317428|NCT01508793|Eating behaviors|eating behaviors
1317429|NCT01508793|Activity|activity
1317430|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
1317431|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
1317432|NCT01508741|Insomnia|insomnia
1317433|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
1317434|NCT01508741|Irritability|irritability
1317435|NCT01508741|Moody|moody
1317436|NCT01508741|Moodiness|moodiness
1317437|NCT01508741|Coping Ability|coping ability
1317438|NCT01508741|Coping Behavior|coping behavior
1317439|NCT01508741|Stress|stress
1317440|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
1317441|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
1317442|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
1317444|NCT01508715|rotator cuff|rotator cuff
1317445|NCT01508715|impingement|impingement
1317446|NCT01508715|physical therapy|physical therapy
1317447|NCT01508715|eccentric exercise|eccentric exercise
1317448|NCT01508715|concentric exercise|concentric exercise
1317449|NCT01508702|Gout|gout
1317450|NCT01508689|Cereal bar|cereal bar
1317451|NCT01508689|Calcium-fortified|calcium-fortified
1317452|NCT01508689|Calcium intake|calcium intake
1317453|NCT01508676|neuropathic pain|neuropathic pain
1317454|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
1317455|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
1317456|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
1317457|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
1317458|NCT01508650|heart failure|heart failure
1317459|NCT01508637|air pollution|air pollution
1317460|NCT01508637|vasoconstriction|vasoconstriction
1317461|NCT01508637|blood pressure|blood pressure
1317462|NCT01508637|diesel exhaust|diesel exhaust
1317463|NCT01508624|Randomised controlled trial|randomised controlled trial
1317464|NCT01508624|Pain|pain
1317465|NCT01508624|Recovery|recovery
1317466|NCT01508624|Office based surgery|office based surgery
1317467|NCT01508611|dental caries|dental caries
1317468|NCT01508611|permanent teeth|permanent teeth
1317469|NCT01508611|silver diamine fluoride|silver diamine fluoride
1317470|NCT01508611|tooth eruption|tooth eruption
1317471|NCT01508598|Pediatric|pediatric
1317472|NCT01508598|Obesity|obesity
1317473|NCT01508598|Bariatric surgery|bariatric surgery
1317474|NCT01508598|Cardiovascular disease|cardiovascular disease
1317475|NCT01508585|Bariatric surgery|bariatric surgery
1317476|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
1317477|NCT01508585|Telephone based CBT|telephone based cbt
1317478|NCT01508585|Obesity|obesity
1317479|NCT01508572|breast cancer|breast cancer
1317480|NCT01508572|VEGF|vegf
1317481|NCT01508572|optical imaging|optical imaging
1317482|NCT01508559|HIV|hiv
1317483|NCT01508559|Neurocognitive|neurocognitive
1317484|NCT01508546|breast cancer|breast cancer
1317485|NCT01508546|axillary dissection|axillary dissection
1317486|NCT01508533|Disease burden|disease burden
1317487|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
1317488|NCT01508520|early gastric cancer|early gastric cancer
1317489|NCT01508520|stomach neoplasms|stomach neoplasms
1317490|NCT01508520|magnifying endoscopy|magnifying endoscopy
1317491|NCT01508520|narrow band imaging|narrow band imaging
1317492|NCT01508507|Oral|oral
1317493|NCT01508507|Cholera|cholera
1317494|NCT01508507|Vaccine|vaccine
1317495|NCT01508507|Herd|herd
1317496|NCT01508507|Risk|risk
1317497|NCT01508507|population|population
1317498|NCT01508507|Matched|matched
1317499|NCT01508507|Control|control
1317500|NCT01508507|Case|case
1317501|NCT01508507|Bias|bias
1317502|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
1317503|NCT01508481|Vitamin D|vitamin d
1317504|NCT01508481|Diabetes|diabetes
1317505|NCT01508481|pancreas beta cell function|pancreas beta cell function
1317506|NCT01508481|insulin resistance|insulin resistance
1317507|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
1317508|NCT01508468|Rituximab|rituximab
1317509|NCT01508468|membranous nephropathy|membranous nephropathy
1317510|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
1317511|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
1317512|NCT01508429|PPH|pph
1317513|NCT01508429|misoprostol|misoprostol
1317514|NCT01508429|home deliveries|home deliveries
1317515|NCT01508416|Multiple Myeloma|multiple myeloma
1317516|NCT01508416|Newly diagnosed|newly diagnosed
1317517|NCT01508416|Thrombin generation|thrombin generation
1317518|NCT01508416|TFPI|tfpi
1317519|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
1317520|NCT01508416|Protein S|protein s
1317521|NCT01508416|Thrombosis|thrombosis
1317522|NCT01508416|Chemotherapy|chemotherapy
1317523|NCT01508390|prostate|prostate
1317524|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
1317525|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
1317526|NCT01508377|cognitive restructuring|cognitive restructuring
1317527|NCT01508377|exposure|exposure
1317528|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
1317529|NCT01508351|Propofol|propofol
1317530|NCT01508351|Induction|induction
1317531|NCT01508351|Hypotension|hypotension
1317532|NCT01508351|General population|general population
1317533|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
1317534|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
1317535|NCT01508338|trained athletes|trained athletes
1317536|NCT01508325|Bisoprolol|bisoprolol
1317537|NCT01508325|Hypertension|hypertension
1317538|NCT01508325|Blood pressure|blood pressure
1317539|NCT01508325|Heart rate|heart rate
1317540|NCT01508312|CARBOPLATIN|carboplatin
1317541|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
1317542|NCT01508312|IFOSFAMIDE|ifosfamide
1317543|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
1317544|NCT01508312|11-142|11-142
1317547|NCT01508299|commercial extract|commercial extract
1317548|NCT01508286|telaprevir|telaprevir
1317549|NCT01508286|hepatitis C|hepatitis c
1317550|NCT01508286|early access program|early access program
1317551|NCT01508273|Breast Cancer|breast cancer
1317552|NCT01508273|Breast Cancer Survivors|breast cancer survivors
1317553|NCT01508273|High risk cancer survivors|high risk cancer survivors
1317554|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
1317555|NCT01508273|African American|african american
1317556|NCT01508273|AA|aa
1317557|NCT01508273|Hispanic|hispanic
1317558|NCT01508273|Non-Hispanic White|non-hispanic white
1317559|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
1317560|NCT01508273|Aerobic and resistance training|aerobic and resistance training
1317561|NCT01508273|Pedometer|pedometer
1317562|NCT01508273|Telephone Counseling Calls|telephone counseling calls
1317563|NCT01508273|Physical activity report|physical activity report
1317564|NCT01508273|PAR|par
1317565|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
1317566|NCT01508273|FACT-B|fact-b
1317567|NCT01508273|Health related quality of life|health related quality of life
1317568|NCT01508273|HRQOL|hrqol
1317569|NCT01508260|Leukemia|leukemia
1317570|NCT01508260|Aquapheresis|aquapheresis
1317571|NCT01508260|Ultrafiltration|ultrafiltration
1317572|NCT01508260|Aquadex pump|aquadex pump
1317573|NCT01508260|Severe Fluid Overload|severe fluid overload
1317574|NCT01508260|Diuretic therapy|diuretic therapy
1317575|NCT01508260|Dyspnea|dyspnea
1317576|NCT01508260|Orthopnea|orthopnea
1317577|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
1317578|NCT01508260|PND|pnd
1317579|NCT01508260|Peripheral edema|peripheral edema
1317580|NCT01508260|Rales|rales
1317581|NCT01508260|Jugular venous distension|jugular venous distension
1317582|NCT01508260|JVD|jvd
1317583|NCT01508260|Hypoxia|hypoxia
1317584|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
1317585|NCT01508260|Furosemide|furosemide
1317586|NCT01508260|Lasix|lasix
1317587|NCT01508247|efficacy|efficacy
1317588|NCT01508247|safety|safety
1317589|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
1317590|NCT01508247|EV71-associated diseases|ev71-associated diseases
1317591|NCT01508221|brain metastasis|brain metastasis
1317592|NCT01508208|Hypertension|hypertension
1317593|NCT01508208|24 hour urine protein|24 hour urine protein
1317594|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
1317595|NCT01508195|Healthy Volunteers|healthy volunteers
1317596|NCT01508195|Bioequivalence|bioequivalence
1317597|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1317598|NCT01508195|Metformin IR|metformin ir
1317599|NCT01508182|Healthy Volunteers|healthy volunteers
1317600|NCT01508182|Bioequivalence|bioequivalence
1317601|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1317602|NCT01508182|Metformin IR|metformin ir
1317603|NCT01508169|elderly|elderly
1317604|NCT01508169|balance|balance
1317605|NCT01508169|insole|insole
1317606|NCT01508169|foot orthosis|foot orthosis
1317607|NCT01508169|orthotics|orthotics
1317608|NCT01508156|Hepatitis C|hepatitis c
1317609|NCT01508156|HCV|hcv
1317610|NCT01508156|treatment-naive|treatment-naive
1317611|NCT01508143|Abortion|abortion
1317612|NCT01508143|Pregnancy|pregnancy
1317613|NCT01508143|Termination|termination
1317614|NCT01508143|Misoprostol|misoprostol
1317615|NCT01508117|GBM|gbm
1317616|NCT01508117|brain tumor|brain tumor
1317617|NCT01508104|solid tumor|solid tumor
1317618|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
1317619|NCT01508104|GBM|gbm
1317620|NCT01508104|brain tumor|brain tumor
1317621|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
1317622|NCT01508091|Obesity|obesity
1317623|NCT01508091|ageing|ageing
1317624|NCT01508052|core temperature|core temperature
1317625|NCT01508052|sequential compression device|sequential compression device
1317626|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
1317627|NCT01508039|Intranasal|intranasal
1317628|NCT01508039|Chitin Micro-particles|chitin micro-particles
1317629|NCT01508039|Immunological Effects|immunological effects
1317630|NCT01508039|Nasal mucosa|nasal mucosa
1317631|NCT01508039|Cytokines|cytokines
1317632|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
1317633|NCT01508026|Stage 1|stage 1
1317634|NCT01508026|Stage 2|stage 2
1317635|NCT01508026|Hypertension|hypertension
1317636|NCT01508013|Melanoma|melanoma
1317637|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
1317638|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
1317639|NCT01508000|Liver metastases|liver metastases
1317648|NCT01508000|Adjuvant|adjuvant
1317649|NCT01508000|Neo-adjuvant|neo-adjuvant
1317650|NCT01508000|Surgery|surgery
1317651|NCT01508000|Progression Free Survival|progression free survival
1317652|NCT01507987|Externalized Conductors, visual lead an|externalized conductors, visual lead an
1317653|NCT01507974|preventive|preventive
1317654|NCT01507974|antibiotic treatment|antibiotic treatment
1317655|NCT01507974|urinary tract infection|urinary tract infection
1317657|NCT01507974|puerperium|puerperium
1317658|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
1317659|NCT01507948|Psychotherapy|psychotherapy
1317660|NCT01507948|non-medication treatment|non-medication treatment
1317661|NCT01507948|Prolonged Exposure|prolonged exposure
1317662|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1317663|NCT01507948|Anxiety Disorders|anxiety disorders
1317664|NCT01507948|emotion|emotion
1317665|NCT01507948|emotion regulation|emotion regulation
1317666|NCT01507948|functional MRI|functional mri
1317667|NCT01507948|Affective Symptoms|affective symptoms
1317668|NCT01507935|Healthy infants|healthy infants
1317669|NCT01507935|Infant formula|infant formula
1317670|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
1317671|NCT01507935|Colonisation Resistance|colonisation resistance
1317672|NCT01507935|Gut Microbiota|gut microbiota
1317673|NCT01507922|Fenoverine|fenoverine
1317674|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
1317675|NCT01507922|Abdominal pain|abdominal pain
1317676|NCT01507922|BSS|bss
1317677|NCT01507909|EEG|eeg
1317678|NCT01507909|related visual|related visual
1317679|NCT01507909|and verbal cues|and verbal cues
1317680|NCT01507883|Supervision|supervision
1317682|NCT01507883|Resulting|resulting
1317683|NCT01507870|body mass index|body mass index
1317684|NCT01507857|EV71 vaccine|ev71 vaccine
1317685|NCT01507857|HFMD|hfmd
1317686|NCT01507857|efficacy|efficacy
1317687|NCT01507857|EV71 associated disease|ev71 associated disease
1317688|NCT01507844|COPD|copd
1317689|NCT01507844|CPAP|cpap
1317690|NCT01507844|Sham|sham
1317691|NCT01507844|FEV1|fev1
1317692|NCT01507844|IC|ic
1317693|NCT01507844|RV/TLC|rv/tlc
1317694|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
1317695|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
1317696|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
1317697|NCT01507818|Non-invasive|non-invasive
1317698|NCT01507818|Non-thermal|non-thermal
1317699|NCT01507805|Electroacupuncture|electroacupuncture
1317700|NCT01507805|preconditioning|preconditioning
1317701|NCT01507805|Non-cardiac surgery|non-cardiac surgery
1317702|NCT01507805|Coronary heart disease|coronary heart disease
1317703|NCT01507792|Cough|cough
1317704|NCT01507792|Laryngismus|laryngismus
1317705|NCT01507792|Bronchial spasm|bronchial spasm
1317706|NCT01507792|Deficiency diseases|deficiency diseases
1317707|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
1317708|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
1317709|NCT01507766|enteral nutrition|enteral nutrition
1317710|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
1317711|NCT01507727|hyponatremia|hyponatremia
1317712|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
1317713|NCT01507727|Tolvaptan|tolvaptan
1317714|NCT01507714|Preventive|preventive
1317715|NCT01507714|tvt-o|tvt-o
1317716|NCT01507714|stress incontinence|stress incontinence
1317717|NCT01507701|adolescents|adolescents
1317718|NCT01507688|Stroke|stroke
1317719|NCT01507675|suicide|suicide
1317720|NCT01507675|psychometric properties|psychometric properties
1317721|NCT01507675|military|military
1317722|NCT01507675|veterans|veterans
1317723|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
1317724|NCT01507675|Acquired capability for suicide|acquired capability for suicide
1317725|NCT01507675|mental health|mental health
1317726|NCT01507675|Survey of Life Principles|survey of life principles
1317727|NCT01507675|Risk assessment|risk assessment
1317734|NCT01507649|postnatal depression|postnatal depression
1317735|NCT01507649|quality of life|quality of life
1317737|NCT01507636|occupational therapy|occupational therapy
1317738|NCT01507636|multiple sclerosis|multiple sclerosis
1317739|NCT01507636|manual dexterity|manual dexterity
1317740|NCT01507623|NAPS|naps
1317741|NCT01507623|Hypoxia|hypoxia
1317742|NCT01507623|Propofol|propofol
1317743|NCT01507623|capnography|capnography
1317744|NCT01507623|endoscopy|endoscopy
1317745|NCT01507623|Sedation|sedation
1317746|NCT01507610|sumatriptan|sumatriptan
1317747|NCT01507610|bioavailability|bioavailability
1317748|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
1317749|NCT01507597|Glucagon|glucagon
1317750|NCT01507597|Normal physiology|normal physiology
1317752|NCT01507597|T1DM|t1dm
1317753|NCT01507571|Incurable cancer|incurable cancer
1317754|NCT01507571|Palliative care|palliative care
1317755|NCT01507571|Dignity Therapy|dignity therapy
1317756|NCT01507571|Loss of dignity|loss of dignity
1317757|NCT01507571|Patient Dignity Intventory|patient dignity intventory
1317758|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
1317759|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
1317760|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
1317761|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
1317762|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
1317763|NCT01507545|mCRC|mcrc
1317764|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
1317765|NCT01507506|Glioblastoma|glioblastoma
1317766|NCT01507506|Radiotherapy|radiotherapy
1317767|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
1317768|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
1317769|NCT01507493|gene polymorphism|gene polymorphism
1317770|NCT01507493|SCN9A|scn9a
1317771|NCT01507493|pain perception|pain perception
1317772|NCT01507493|postoperative pain|postoperative pain
1317773|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
1317774|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
1317775|NCT01507480|Bevacizumab|bevacizumab
1317776|NCT01507467|Head and neck carcinoma|head and neck carcinoma
1317777|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
1317778|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
1317779|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1317780|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1317781|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1317782|NCT01507415|Cohort Studies|cohort studies
1317783|NCT01507415|Longitudinal Studies|longitudinal studies
1317784|NCT01507415|Patient Readmission|patient readmission
1317785|NCT01507415|Hospitalization|hospitalization
1317786|NCT01507415|Disability Evaluation|disability evaluation
1317787|NCT01507376|Ovulation induction|ovulation induction
1317788|NCT01507376|urinary|urinary
1317789|NCT01507376|hCG|hcg
1317790|NCT01507376|recombinant hCG|recombinant hcg
1317791|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
1317792|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
1317793|NCT01507350|impaired renal function|impaired renal function
1317794|NCT01507350|gastric band|gastric band
1317795|NCT01507350|GFR measurement|gfr measurement
1317796|NCT01507350|gastric bypass|gastric bypass
1317797|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
1317798|NCT01507298|Physical activity|physical activity
1317799|NCT01507298|Accelerometry|accelerometry
1317800|NCT01507298|Oesophageal pH|oesophageal ph
1317801|NCT01507298|Capsule endoscopy|capsule endoscopy
1317802|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
1317803|NCT01507246|open colectomy|open colectomy
1317804|NCT01507233|open colectomy|open colectomy
1317805|NCT01507233|colectomy|colectomy
1317806|NCT01507220|open colectomy|open colectomy
1317807|NCT01507207|Dysphagia|dysphagia
1317808|NCT01507207|aspiration|aspiration
1317809|NCT01507207|pediatric|pediatric
1317810|NCT01507207|injection laryngoplasty|injection laryngoplasty
1317811|NCT01507181|suicidal ideation|suicidal ideation
1317812|NCT01507181|major depression|major depression
1317813|NCT01507181|treatment resistant|treatment resistant
1317814|NCT01507181|ketamine|ketamine
1317815|NCT01507181|glutamate|glutamate
1317816|NCT01507155|Major|major
1317817|NCT01507155|Depressive|depressive
1317818|NCT01507155|Disorder|disorder
1317819|NCT01507155|Depression|depression
1317820|NCT01507155|MDD|mdd
1317821|NCT01507155|Treatment Resistant|treatment resistant
1317822|NCT01507155|Anxiety|anxiety
1317823|NCT01507155|GAD|gad
1317824|NCT01507142|saliva|saliva
1317825|NCT01507142|diagnostics|diagnostics
1317826|NCT01507142|HIV|hiv
1317827|NCT01507142|AIDS|aids
1317828|NCT01507129|dehydration|dehydration
1317829|NCT01507129|plasma|plasma
1317830|NCT01507129|osmolality|osmolality
1317831|NCT01507129|saliva|saliva
1317832|NCT01507129|urine|urine
1317833|NCT01507129|biomarkers|biomarkers
1317834|NCT01507129|hypertonic|hypertonic
1317835|NCT01507129|isotonic|isotonic
1317836|NCT01507129|hydration|hydration
1317837|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
1317838|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
1317839|NCT01507103|Mode of action|mode of action
1317840|NCT01507103|Neoplasms|neoplasms
1317841|NCT01507103|Neoplasms by Site|neoplasms by site
1317842|NCT01507103|Carcinomas|carcinomas
1317843|NCT01507103|Antineoplastic Agents|antineoplastic agents
1317844|NCT01507103|Neoadjuvant|neoadjuvant
1317845|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
1317846|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
1317847|NCT01507103|Immunologic Function|immunologic function
1317848|NCT01507103|Therapeutic Uses|therapeutic uses
1317849|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1317850|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
1317851|NCT01507077|Obese|obese
1317852|NCT01507077|Obesity|obesity
1317853|NCT01507077|Overweight|overweight
1317854|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
1317855|NCT01507064|sorafenib|sorafenib
1317856|NCT01507064|laser ablation|laser ablation
1317857|NCT01507051|Rivaroxaban|rivaroxaban
1317858|NCT01507051|Xa-Factors|xa-factors
1317859|NCT01507051|Warfarin|warfarin
1317860|NCT01507051|Thrombosis|thrombosis
1317861|NCT01507051|Embolism|embolism
1317862|NCT01507038|Diabetes Mellitus|diabetes mellitus
1317863|NCT01507038|YH14617|yh14617
1317864|NCT01507038|Exenatide|exenatide
1317865|NCT01507038|Yuhan|yuhan
1317866|NCT01507025|hinge position|hinge position
1317867|NCT01507025|dry eye|dry eye
1317868|NCT01507012|Berry phenolics|berry phenolics
1317869|NCT01507012|mood|mood
1317870|NCT01507012|cognition|cognition
1317871|NCT01507012|adults|adults
1317872|NCT01506999|Angina Pectoris|angina pectoris
1317873|NCT01506999|SNPs|snps
1317874|NCT01506999|Genetic|genetic
1317875|NCT01506999|Myocardial Infarction|myocardial infarction
1317876|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
1317877|NCT01506986|Ulcer bleeding|ulcer bleeding
1317878|NCT01506986|Aspirin|aspirin
1317879|NCT01506986|Helicobacter pylori|helicobacter pylori
1317880|NCT01506986|H. pylori|h. pylori
1317881|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
1317882|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
1317883|NCT01506947|Hemodialysis|hemodialysis
1317884|NCT01506947|Chronic kidney disease|chronic kidney disease
1317885|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
1317886|NCT01506921|racemic ketamine|racemic ketamine
1317887|NCT01506921|S-ketamine|s-ketamine
1317888|NCT01506921|Cerebral blood flow|cerebral blood flow
1317889|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
1317890|NCT01506921|arterial spin labeling|arterial spin labeling
1317891|NCT01506921|healthy volunteers|healthy volunteers
1317892|NCT01506908|craving|craving
1317893|NCT01506895|Diabetic Macular Edema|diabetic macular edema
1317894|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
1317895|NCT01506856|Fallopian tube cancer|fallopian tube cancer
1317896|NCT01506856|peritoneal cancer|peritoneal cancer
1317897|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
1317898|NCT01506856|Carboplatin|carboplatin
1317899|NCT01506856|Paclitaxel|paclitaxel
1317900|NCT01506843|IgA antibody|iga antibody
1317901|NCT01506843|IgE antibody|ige antibody
1317902|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
1317903|NCT01506843|Mite allergy|mite allergy
1317904|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
1317905|NCT01506843|Saliva|saliva
1317906|NCT01506830|Adhesives.|adhesives.
1317907|NCT01506830|Composites.|composites.
1317908|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
1317909|NCT01506830|Clinical performance.|clinical performance.
1317910|NCT01506830|Treatment|treatment
1317911|NCT01506817|fibromyalgia|fibromyalgia
1317912|NCT01506817|DCE-MRI|dce-mri
1317913|NCT01506817|neurogenic inflammation|neurogenic inflammation
1317914|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
1317915|NCT01506804|Shoulder|shoulder
1317916|NCT01506804|Impingement|impingement
1317917|NCT01506804|Ultrasound|ultrasound
1317918|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
1317919|NCT01506804|exercise|exercise
1317920|NCT01506791|Bioequivalence|bioequivalence
1317921|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
1317922|NCT01506791|crossover|crossover
1317923|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
1317924|NCT01506778|Likert Scala|likert scala
1317925|NCT01506778|Pipelle|pipelle
1317926|NCT01506778|Tenaculum|tenaculum
1317927|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
1317928|NCT01506765|Schizophrenia|schizophrenia
1317929|NCT01506765|glutathione|glutathione
1317930|NCT01506765|NAC|nac
1317931|NCT01506765|Neurological scales|neurological scales
1317932|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1317933|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
1317934|NCT01506765|fibroblasts|fibroblasts
1317935|NCT01506765|patients who receive NAC|patients who receive nac
1317936|NCT01506765|patients who receive placebo|patients who receive placebo
1317937|NCT01506752|Bioequivalence|bioequivalence
1317938|NCT01506752|Healthy Subjects|healthy subjects
1317939|NCT01506752|Donepezil|donepezil
1317940|NCT01506739|Bioequivalence|bioequivalence
1317941|NCT01506739|Healthy Subjects|healthy subjects
1317942|NCT01506739|Donepezil|donepezil
1317943|NCT01506726|anemia|anemia
1317944|NCT01506726|unexplained anemia|unexplained anemia
1317945|NCT01506726|elderly|elderly
1317946|NCT01506726|geriatric|geriatric
1317947|NCT01506726|older adults|older adults
1317949|NCT01506726|over 65|over 65
1317950|NCT01506726|salsalate|salsalate
1317951|NCT01506726|PACTTE|pactte
1317952|NCT01506726|pactee|pactee
1317953|NCT01506726|aging|aging
1317954|NCT01506726|aged|aged
1317955|NCT01506726|old|old
1317956|NCT01506726|older|older
1317957|NCT01506687|Colorectal cancer screening|colorectal cancer screening
1317958|NCT01506687|50 years or older|50 years or older
1317959|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
1317960|NCT01506661|vaccination|vaccination
1317961|NCT01506661|immune response|immune response
1317962|NCT01506661|varicella zoster|varicella zoster
1317963|NCT01506609|PARP|parp
1317964|NCT01506609|TMZ|tmz
1317965|NCT01506609|Temodal|temodal
1317966|NCT01506609|Carboplatin|carboplatin
1317967|NCT01506609|veliparib|veliparib
1317968|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
1317969|NCT01506609|Breast cancer|breast cancer
1318266|NCT01505621|Aging|aging
1317970|NCT01506609|Metastatic breast cancer|metastatic breast cancer
1317971|NCT01506609|temozolomide|temozolomide
1317972|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
1317973|NCT01506609|ABT-888|abt-888
1317974|NCT01506609|Paclitaxel|paclitaxel
1317975|NCT01506609|Recurrent breast cancer|recurrent breast cancer
1317976|NCT01506609|Temodar|temodar
1317977|NCT01506609|Locally recurrent|locally recurrent
1317978|NCT01506596|Liposarcoma|liposarcoma
1317979|NCT01506583|cough|cough
1317980|NCT01506583|myalgia|myalgia
1317981|NCT01506583|nasal obstruction|nasal obstruction
1317982|NCT01506583|sore throat|sore throat
1317983|NCT01506583|headache|headache
1317984|NCT01506583|fatigue|fatigue
1317985|NCT01506583|feverishness|feverishness
1317986|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
1317987|NCT01506557|vitamin D|vitamin d
1317988|NCT01506557|vitamin D deficiency|vitamin d deficiency
1317989|NCT01506557|breastfeeding|breastfeeding
1317990|NCT01506557|body composition|body composition
1317991|NCT01506557|bone mineral content|bone mineral content
1317992|NCT01506544|HU|hu
1317993|NCT01506544|Hydroxyurea|hydroxyurea
1317994|NCT01506544|Sickle cell|sickle cell
1317995|NCT01506544|Pediatric|pediatric
1317996|NCT01506531|gastroschisis|gastroschisis
1317997|NCT01506531|silo|silo
1317998|NCT01506531|primary closure|primary closure
1317999|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
1318000|NCT01506518|Ultrasound|ultrasound
1318001|NCT01506518|Imaging|imaging
1318002|NCT01506518|Acoustic Radiation Force|acoustic radiation force
1318003|NCT01506518|Double Push|double push
1318004|NCT01506505|Cardiovascular prevention|cardiovascular prevention
1318005|NCT01506505|Polypill|polypill
1318006|NCT01506505|Combination therapy|combination therapy
1318007|NCT01506492|Randomized controlled trial|randomized controlled trial
1318008|NCT01506492|Depression|depression
1318009|NCT01506492|Cancer|cancer
1318010|NCT01506492|Psychotherapy|psychotherapy
1318011|NCT01506492|Quality of life|quality of life
1318012|NCT01506479|Parkinson Disease|parkinson disease
1318013|NCT01506479|Basal Ganglia Disease|basal ganglia disease
1318014|NCT01506479|Central Nervous System Diseases|central nervous system diseases
1318015|NCT01506479|Nervous System Diseases|nervous system diseases
1318016|NCT01506479|Movement Disorders|movement disorders
1318017|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
1318018|NCT01506479|Brain Diseases|brain diseases
1318019|NCT01506466|chemotherapy|chemotherapy
1318020|NCT01506466|metabolism|metabolism
1318021|NCT01506466|weight|weight
1318022|NCT01506466|body composition|body composition
1318023|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1318024|NCT01506453|Neuropathy|neuropathy
1318025|NCT01506453|Neuropathic Pain|neuropathic pain
1318026|NCT01506453|Vincristine|vincristine
1318027|NCT01506453|TOTAL XVI Protocol|total xvi protocol
1318028|NCT01506427|Newly Diagnosed|newly diagnosed
1318029|NCT01506427|Head and Neck Cancer|head and neck cancer
1318030|NCT01506427|PET Imaging|pet imaging
1318031|NCT01506414|Purpura|purpura
1318032|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1318033|NCT01506401|ARDS|ards
1318034|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
1318035|NCT01506401|lung protective ventilation|lung protective ventilation
1318036|NCT01506401|high frequency oscillation|high frequency oscillation
1318037|NCT01506388|labour induction|labour induction
1318038|NCT01506388|Foley catheter|foley catheter
1318039|NCT01506388|misoprostol|misoprostol
1318040|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
1318041|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
1318042|NCT01506375|grass pollen|grass pollen
1318043|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
1318044|NCT01506362|Ulcerative Colitis|ulcerative colitis
1318045|NCT01506362|IBD|ibd
1318046|NCT01506349|celiac disease|celiac disease
1318047|NCT01506349|gluten|gluten
1318048|NCT01506349|fog|fog
1318049|NCT01506349|attention|attention
1318050|NCT01506336|GIST|gist
1318051|NCT01506336|resistant|resistant
1318052|NCT01506336|imatinib|imatinib
1318053|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
1318054|NCT01506323|Complementary Therapy|complementary therapy
1318055|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1318056|NCT01506323|Veterans Health|veterans health
1318057|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
1318058|NCT01506323|Mindfulness|mindfulness
1318059|NCT01506323|Spirituality|spirituality
1318060|NCT01506323|Meditation|meditation
1318061|NCT01506323|Mind-body therapy|mind-body therapy
1318062|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
1318063|NCT01506310|fasting glucose|fasting glucose
1318064|NCT01506310|insulin resistance|insulin resistance
1318065|NCT01506310|birth-weight|birth-weight
1318066|NCT01506310|Glucose values|glucose values
1318067|NCT01506310|Insulin concentrations|insulin concentrations
1318068|NCT01506310|Cesarean sections|cesarean sections
1318069|NCT01506297|obesity|obesity
1318070|NCT01506297|satiety|satiety
1318071|NCT01506297|body weight management|body weight management
1318072|NCT01506284|Forced oscillatory technique|forced oscillatory technique
1318073|NCT01506284|Laser interferometry|laser interferometry
1318074|NCT01506284|Intravenous anesthesia|intravenous anesthesia
1318075|NCT01506284|Mechanical ventilation|mechanical ventilation
1318076|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
1318077|NCT01506284|Airways mechanical properties|airways mechanical properties
1318078|NCT01506284|Respiratory system reactance|respiratory system reactance
1318079|NCT01506284|Oscillatory mechanics|oscillatory mechanics
1318080|NCT01506284|Atelectasis|atelectasis
1318081|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
1318082|NCT01506258|CD34+|cd34+
1318083|NCT01506258|perinatal hypoxia|perinatal hypoxia
1318084|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
1318085|NCT01506258|cord and placental blood|cord and placental blood
1318086|NCT01506258|cerebral palsy|cerebral palsy
1318087|NCT01506245|Obesity|obesity
1318088|NCT01506245|Children|children
1318089|NCT01506245|Behavior|behavior
1318090|NCT01506245|Family|family
1318091|NCT01506245|Exercise|exercise
1318092|NCT01506232|ADHD|adhd
1318093|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
1318094|NCT01506232|Autism|autism
1318095|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
1318097|NCT01506232|Brain Flow Analyses|brain flow analyses
1318098|NCT01506219|Randomized controlled trial|randomized controlled trial
1318099|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
1318100|NCT01506219|Activity of daily living|activity of daily living
1318101|NCT01506219|Quality of life|quality of life
1318102|NCT01506219|Healthcare utilization|healthcare utilization
1318103|NCT01506219|Community rehabilitation unit|community rehabilitation unit
1318104|NCT01506219|Medication adjustment|medication adjustment
1318105|NCT01506206|Deep Brain Stimulation|deep brain stimulation
1318106|NCT01506206|Impulsivity|impulsivity
1318107|NCT01506193|safety|safety
1318108|NCT01506193|healthy|healthy
1318109|NCT01506193|conjugated|conjugated
1318110|NCT01506193|immunogenicity|immunogenicity
1318111|NCT01506193|children|children
1318112|NCT01506193|MenC vaccine|menc vaccine
1318113|NCT01506193|MMRV vaccine|mmrv vaccine
1318114|NCT01506180|acute medical care|acute medical care
1318115|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
1318116|NCT01506180|Health Services for the Aged|health services for the aged
1318117|NCT01506180|Geriatric Assessment|geriatric assessment
1318118|NCT01506180|Geriatrics|geriatrics
1318119|NCT01506180|Aged|aged
1318120|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
1318121|NCT01506141|MPS II|mps ii
1318122|NCT01506141|MPS 2|mps 2
1318123|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
1318124|NCT01506141|mps symptoms|mps symptoms
1318125|NCT01506141|enlarged adenoids|enlarged adenoids
1318126|NCT01506141|elaprase|elaprase
1318127|NCT01506141|hunter's syndrome|hunter's syndrome
1318128|NCT01506141|MPS2|mps2
1318129|NCT01506141|hunters disease|hunters disease
1318130|NCT01506141|hunter's disease treatment|hunter's disease treatment
1318131|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
1318132|NCT01506141|iduronate sulfatase|iduronate sulfatase
1318133|NCT01506141|mps society|mps society
1318134|NCT01506141|MPSII|mpsii
1318135|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
1318136|NCT01506141|hunter's disease|hunter's disease
1318137|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
1318138|NCT01506141|mucopolysaccharides|mucopolysaccharides
1318139|NCT01506141|mps diagnosis|mps diagnosis
1318140|NCT01506141|chronic ear infection|chronic ear infection
1318141|NCT01506141|hunters syndrome|hunters syndrome
1318142|NCT01506141|ert treatment|ert treatment
1318143|NCT01506141|lysosomal storage disease|lysosomal storage disease
1318144|NCT01506141|hunter disease|hunter disease
1318145|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
1318146|NCT01506141|idursulfase|idursulfase
1318147|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
1318148|NCT01506128|HPV|hpv
1318149|NCT01506128|Menstrual blood|menstrual blood
1318150|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
1318151|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
1318152|NCT01506115|Obstructive jaundice|obstructive jaundice
1318153|NCT01506115|Photodynamic therapy|photodynamic therapy
1318154|NCT01506089|IVF|ivf
1318155|NCT01506089|infertility|infertility
1318156|NCT01506089|PGD|pgd
1318157|NCT01506089|embryo|embryo
1318158|NCT01506089|temperature|temperature
1318159|NCT01506089|incubator|incubator
1318160|NCT01506089|CCS|ccs
1318161|NCT01506089|culture|culture
1318162|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
1318163|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
1318164|NCT01506063|Bioequivalence|bioequivalence
1318165|NCT01506063|Levocetirizine|levocetirizine
1318166|NCT01506063|Crossover|crossover
1318167|NCT01506050|Bioequivalence|bioequivalence
1318168|NCT01506050|Desloratadine|desloratadine
1318169|NCT01506050|crossover|crossover
1318170|NCT01506037|Bioequivalence|bioequivalence
1318171|NCT01506037|Desloratadine|desloratadine
1318172|NCT01506037|crossover|crossover
1318173|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1318174|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
1318175|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
1318176|NCT01505985|Hip fracture|hip fracture
1318177|NCT01505985|SPPB|sppb
1318178|NCT01505985|Functional recovery|functional recovery
1318179|NCT01505972|screening colonoscopy|screening colonoscopy
1318180|NCT01505972|attendance|attendance
1318181|NCT01505972|response|response
1318182|NCT01505972|colorectal cancer|colorectal cancer
1318183|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1318185|NCT01505959|Sleep Apnea|sleep apnea
1318186|NCT01505959|Telemedicine|telemedicine
1318187|NCT01505959|CPAP compliance|cpap compliance
1318188|NCT01505946|Thrombin|thrombin
1318189|NCT01505946|Hemophilia|hemophilia
1318190|NCT01505946|Inhibitors|inhibitors
1318191|NCT01505946|Immunotolerance|immunotolerance
1318192|NCT01505946|Haemostatic|haemostatic
1318193|NCT01505946|FVIII|fviii
1318194|NCT01505946|Epitopes|epitopes
1318195|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
1318196|NCT01505933|upper|upper
1318197|NCT01505933|airway|airway
1318198|NCT01505933|dimensions|dimensions
1318199|NCT01505933|propofol|propofol
1318200|NCT01505933|dexmedetomidine|dexmedetomidine
1318201|NCT01505907|Pharmacokinetics|pharmacokinetics
1318202|NCT01505907|Safety|safety
1318203|NCT01505907|Healthy Males|healthy males
1318204|NCT01505868|Prostate Cancer|prostate cancer
1318205|NCT01505868|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1318206|NCT01505868|mCRPC|mcrpc
1318207|NCT01505868|Prior treatment with docetaxel|prior treatment with docetaxel
1318208|NCT01505868|Cabazitaxel|cabazitaxel
1318209|NCT01505868|Jevtana|jevtana
1318210|NCT01505868|Carboplatin|carboplatin
1318211|NCT01505868|Paraplatin|paraplatin
1318212|NCT01505868|Prednisone|prednisone
1318213|NCT01505855|Crohn's disease|crohn's disease
1318214|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
1318215|NCT01505842|Ulcerative colitis|ulcerative colitis
1318216|NCT01505842|Crohn's disease|crohn's disease
1318217|NCT01505842|Chromoendoscopy|chromoendoscopy
1318218|NCT01505842|Dysplasia|dysplasia
1318219|NCT01505842|Neoplasia|neoplasia
1318220|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
1318221|NCT01505816|Cataract|cataract
1318222|NCT01505816|Vision|vision
1318223|NCT01505816|Intraocular lens|intraocular lens
1318224|NCT01505816|Multifocal|multifocal
1318225|NCT01505816|Toric|toric
1318226|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
1318227|NCT01505803|Dietary supplements|dietary supplements
1318228|NCT01505803|Hyperglycemia|hyperglycemia
1318229|NCT01505803|Insulin resistance|insulin resistance
1318230|NCT01505803|Dyslipidemia|dyslipidemia
1318231|NCT01505803|Inflammation|inflammation
1318232|NCT01505803|Oxidative stress|oxidative stress
1318233|NCT01505803|Zinc|zinc
1318234|NCT01505803|Omega 3|omega 3
1318235|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
1318236|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
1318237|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
1318238|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
1318239|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
1318240|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
1318241|NCT01505764|Cachexia|cachexia
1318242|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
1318243|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
1318244|NCT01505725|Tobacco Craving|tobacco craving
1318245|NCT01505725|Behavior Genetics|behavior genetics
1318246|NCT01505725|Smoking|smoking
1318247|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1318248|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1318249|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1318250|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1318251|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1318252|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1318253|NCT01505673|Insulin|insulin
1318254|NCT01505673|Glucagon-like peptide|glucagon-like peptide
1318255|NCT01505673|Liraglutide|liraglutide
1318256|NCT01505673|Beta-Cell|beta-cell
1318257|NCT01505673|pancreatic steatosis|pancreatic steatosis
1318258|NCT01505673|hepatic steatosis|hepatic steatosis
1318259|NCT01505660|Adherence|adherence
1318260|NCT01505660|Depression|depression
1318261|NCT01505660|Care management|care management
1318262|NCT01505660|Stepped care|stepped care
1318263|NCT01505660|HIV|hiv
1318264|NCT01505660|Patient reported outcomes|patient reported outcomes
1318265|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
1318267|NCT01505621|Protein accumulation|protein accumulation
1318268|NCT01505621|Protein damage|protein damage
1318269|NCT01505569|autologous transplantation|autologous transplantation
1318270|NCT01505569|high risk solid tumor|high risk solid tumor
1318271|NCT01505569|relapsed solid tumor|relapsed solid tumor
1318272|NCT01505478|Sepsis|sepsis
1318273|NCT01505478|Clinical Prediction Rule|clinical prediction rule
1318274|NCT01505478|Clinical Informatics|clinical informatics
1318275|NCT01505478|Machine Learning|machine learning
1318276|NCT01505465|Total Knee Replacement|total knee replacement
1318277|NCT01505465|Pain|pain
1318278|NCT01505465|Confusion|confusion
1318279|NCT01505465|Sleep|sleep
1318280|NCT01505439|solifenacin|solifenacin
1318281|NCT01505439|bladder symptom|bladder symptom
1318282|NCT01505426|ASP1941|asp1941
1318283|NCT01505426|ipragliflozin|ipragliflozin
1318284|NCT01505426|metformin|metformin
1318285|NCT01505426|plasma glucose|plasma glucose
1318286|NCT01505426|urine glucose|urine glucose
1318287|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
1318288|NCT01505400|Molecular profiling|molecular profiling
1318289|NCT01505400|Advanced cancer|advanced cancer
1318290|NCT01505400|Breast cancer|breast cancer
1318291|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
1318292|NCT01505400|Colorectal cancer|colorectal cancer
1318293|NCT01505400|Genitourinary cancer|genitourinary cancer
1318294|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
1318295|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
1318296|NCT01505400|Gynecological cancers|gynecological cancers
1318297|NCT01505400|Phase I|phase i
1318298|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
1318299|NCT01505400|melanoma cancer|melanoma cancer
1318300|NCT01505400|rare cancer|rare cancer
1318301|NCT01505400|unknown primary cancer|unknown primary cancer
1318302|NCT01505387|Weight maintenance|weight maintenance
1318303|NCT01505387|Overweight|overweight
1318304|NCT01505387|Obese|obese
1318305|NCT01505387|Weight management|weight management
1318306|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
1318307|NCT01505374|Femoral Nerve Block|femoral nerve block
1318308|NCT01505374|Saphenous Nerve Block|saphenous nerve block
1318309|NCT01505361|probiotic|probiotic
1318310|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
1318311|NCT01505361|mastitis|mastitis
1318312|NCT01505361|prevention|prevention
1318313|NCT01505361|group B streptococci|group b streptococci
1318314|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
1318315|NCT01505348|feeding patterns|feeding patterns
1318316|NCT01505348|aerobic exercise|aerobic exercise
1318317|NCT01505348|osteoclasts|osteoclasts
1318318|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
1318319|NCT01505335|ultrasound|ultrasound
1318320|NCT01505335|digital radiography, dental|digital radiography, dental
1318321|NCT01505335|nerve injury|nerve injury
1318322|NCT01505322|daily activities|daily activities
1318323|NCT01505309|Aortic Diseases|aortic diseases
1318324|NCT01505309|Vascular Diseases|vascular diseases
1318325|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
1318326|NCT01505309|Treatment Outcome|treatment outcome
1318327|NCT01505309|Aorta Dissection|aorta dissection
1318328|NCT01505309|Aorta Aneurysm|aorta aneurysm
1318329|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
1318330|NCT01505309|Endovascular aortic repair|endovascular aortic repair
1318331|NCT01505296|Catheter ablation|catheter ablation
1318332|NCT01505257|Delirium|delirium
1318333|NCT01505257|Dementia|dementia
1318334|NCT01505257|Confusion Assessment Method|confusion assessment method
1318335|NCT01505231|Shock|shock
1318336|NCT01505231|norepinephrine|norepinephrine
1318337|NCT01505231|vasopressin|vasopressin
1318338|NCT01505231|cardiac surgery|cardiac surgery
1318339|NCT01505218|Sedation|sedation
1318340|NCT01505218|propofol|propofol
1318341|NCT01505218|patient-controlled|patient-controlled
1318342|NCT01505218|safety|safety
1318343|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
1318344|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
1318345|NCT01505179|HFPEF|hfpef
1318346|NCT01505179|Heart Failure|heart failure
1318347|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
1318348|NCT01505179|Preserved EF|preserved ef
1318349|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
1318350|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
1318351|NCT01505166|colorectal carcinoma|colorectal carcinoma
1318352|NCT01505166|colon cancer|colon cancer
1318353|NCT01505166|liver metastases|liver metastases
1318354|NCT01505153|Advanced cancer|advanced cancer
1318355|NCT01505153|Metastatic cancer|metastatic cancer
1318356|NCT01505153|solid tumors|solid tumors
1318357|NCT01505153|Melanoma|melanoma
1318358|NCT01505140|Andrology|andrology
1318359|NCT01505140|Fertility|fertility
1318360|NCT01505140|Reproduction|reproduction
1318362|NCT01505140|Nutritional Sciences|nutritional sciences
1318363|NCT01505140|Fatty Acids|fatty acids
1318364|NCT01505140|Antioxidants|antioxidants
1318365|NCT01505140|Body weight changes|body weight changes
1318366|NCT01505127|Drug Therapy|drug therapy
1318367|NCT01505114|HIV Prevention|hiv prevention
1318368|NCT01505114|PrEP|prep
1318369|NCT01505114|Maraviroc|maraviroc
1318370|NCT01505088|Iontophoresis|iontophoresis
1318371|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
1318372|NCT01505088|Ophthalmology|ophthalmology
1318373|NCT01505075|prostatic neoplasms|prostatic neoplasms
1318374|NCT01505075|radiotherapy|radiotherapy
1318375|NCT01505075|hypofractionated|hypofractionated
1617117|NCT00331136|ACT|act
1318376|NCT01505075|high risk prostate cancer|high risk prostate cancer
1318377|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
1318378|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
1318379|NCT01505049|immunology|immunology
1318380|NCT01505049|vaccination|vaccination
1318381|NCT01505049|human papillomavirus|human papillomavirus
1318382|NCT01505036|Diabetes Mellitus|diabetes mellitus
1318383|NCT01505036|smart-care|smart-care
1318384|NCT01505036|U-health care|u-health care
1318385|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
1318386|NCT01505010|Renal denervation|renal denervation
1318387|NCT01505010|Sympathetic nervous system|sympathetic nervous system
1318388|NCT01504997|DaVinci|davinci
1318389|NCT01504997|Robot assisted surgery|robot assisted surgery
1318390|NCT01504997|Gastrectomy|gastrectomy
1318391|NCT01504997|Safety|safety
1318392|NCT01504997|Gastric Cancer|gastric cancer
1318393|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
1318394|NCT01504984|Healthy volunteers|healthy volunteers
1318395|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
1318396|NCT01504984|Healthy male volunteers|healthy male volunteers
1318397|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
1318398|NCT01504971|Endoscopy;|endoscopy;
1318399|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
1318400|NCT01504971|Narrow band imaging;|narrow band imaging;
1318401|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
1318402|NCT01504971|White light imaging;|white light imaging;
1318403|NCT01504958|Alzheimer's disease|alzheimer's disease
1318404|NCT01504958|Cognitive Training|cognitive training
1318405|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1318406|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
1318407|NCT01504932|black raspberry lozenges|black raspberry lozenges
1318408|NCT01504932|Appalachian|appalachian
1318409|NCT01504932|Oral Cancer|oral cancer
1318410|NCT01504919|Psychosocial|psychosocial
1318411|NCT01504919|Behavioral intervention|behavioral intervention
1318412|NCT01504919|Nicotine patch|nicotine patch
1318413|NCT01504919|Latinos|latinos
1318414|NCT01504919|Mexican American|mexican american
1318415|NCT01504919|Motivation and Problem Solving|motivation and problem solving
1318416|NCT01504919|MAPS|maps
1318417|NCT01504919|Cancer risk reduction|cancer risk reduction
1318418|NCT01504919|Smoking cessation|smoking cessation
1318419|NCT01504919|Overweight/obese smokers|overweight/obese smokers
1318420|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
1318421|NCT01504919|Wellness program|wellness program
1318422|NCT01504919|Questionnaires|questionnaires
1318423|NCT01504919|Surveys|surveys
1318424|NCT01504919|Self-help materials|self-help materials
1318425|NCT01504919|Pamphlets|pamphlets
1318426|NCT01504906|Phase 1|phase 1
1318427|NCT01504906|Healthy male volunteers|healthy male volunteers
1318428|NCT01504906|pharmacokinetics|pharmacokinetics
1318429|NCT01504906|cyclosporine|cyclosporine
1318430|NCT01504906|ticagrelor|ticagrelor
1318431|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
1318432|NCT01504893|ventilation|ventilation
1318433|NCT01504893|PEEP|peep
1318434|NCT01504893|Acute Lung Injury|acute lung injury
1318435|NCT01504893|pneumonectomy|pneumonectomy
1318436|NCT01504893|ARDS|ards
1318437|NCT01504880|Mitral Regurgitation|mitral regurgitation
1318438|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
1318439|NCT01504880|Vena Contracta|vena contracta
1318440|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1318441|NCT01504867|Acute Lung Injury|acute lung injury
1318442|NCT01504867|ARDS|ards
1318443|NCT01504867|ALI|ali
1318444|NCT01504867|aspirin|aspirin
1318445|NCT01504867|prevention|prevention
1318446|NCT01504854|Alzheimer's disease|alzheimer's disease
1318447|NCT01504854|Dementia|dementia
1318448|NCT01504854|Brain diseases|brain diseases
1318449|NCT01504854|Resveratrol|resveratrol
1318450|NCT01504854|Memory problems|memory problems
1318451|NCT01504854|Mental disorders|mental disorders
1318452|NCT01504854|Cognitive disorders|cognitive disorders
1318453|NCT01504828|Energy Metabolism|energy metabolism
1318454|NCT01504828|Ageing|ageing
1318455|NCT01504828|left ventricle|left ventricle
1318456|NCT01504828|energetics|energetics
1318457|NCT01504828|function|function
1318458|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
1318459|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
1318460|NCT01504815|cisplatinum|cisplatinum
1318461|NCT01504802|Growth hormone|growth hormone
1318462|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
1318463|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
1318464|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
1318465|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
1318466|NCT01504802|leptin|leptin
1318467|NCT01504802|deoxypyridinoline|deoxypyridinoline
1318468|NCT01504802|growth velocity|growth velocity
1617324|NCT00330317|Letrozole|letrozole
1318469|NCT01504802|pharmacodynamic|pharmacodynamic
1318470|NCT01504802|biomarker|biomarker
1318471|NCT01504789|Breast Cancer|breast cancer
1318472|NCT01504789|Breast Cancer Survivors|breast cancer survivors
1318473|NCT01504789|Exercise|exercise
1318474|NCT01504789|Hispanic|hispanic
1318475|NCT01504789|Mexican-American|mexican-american
1318476|NCT01504789|Puerto Rican|puerto rican
1318477|NCT01504789|Culturally tailored exercise|culturally tailored exercise
1318478|NCT01504789|Fitness tests|fitness tests
1318479|NCT01504789|Questionnaires|questionnaires
1318480|NCT01504789|Surveys|surveys
1318481|NCT01504789|Culturally tailored written material|culturally tailored written material
1318483|NCT01504776|Lymphoma|lymphoma
1318484|NCT01504776|Panobinostat|panobinostat
1318485|NCT01504763|Massage|massage
1318486|NCT01504763|Chair massage|chair massage
1318487|NCT01504763|Relaxation|relaxation
1318488|NCT01504763|Nurses|nurses
1318489|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
1318490|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
1318491|NCT01504737|Exercise|exercise
1318492|NCT01504737|Physical Activity|physical activity
1318493|NCT01504737|Physiotherapy|physiotherapy
1318494|NCT01504737|Exercise test|exercise test
1318495|NCT01504737|Quality of Life|quality of life
1318496|NCT01504737|Aortic Valve Replacement|aortic valve replacement
1318497|NCT01504724|central macular thickness|central macular thickness
1318498|NCT01504698|Manipulative treatment|manipulative treatment
1318499|NCT01504698|Children|children
1318500|NCT01504698|Neck pain|neck pain
1318501|NCT01504698|Back pain|back pain
1318502|NCT01504698|Effect|effect
1318503|NCT01504698|Adolescence|adolescence
1318504|NCT01504698|Advise|advise
1318505|NCT01504698|Exercise|exercise
1318506|NCT01504685|Morbid obesity|morbid obesity
1318507|NCT01504685|Obesity surgery|obesity surgery
1318508|NCT01504685|Gastric bypass|gastric bypass
1318509|NCT01504685|Banded gastric bypass|banded gastric bypass
1318510|NCT01504672|Drug related problems|drug related problems
1318511|NCT01504659|bipolar disorder|bipolar disorder
1318512|NCT01504659|treatment resistance|treatment resistance
1318513|NCT01504659|depression|depression
1318514|NCT01504659|ketamine|ketamine
1318515|NCT01504659|intranasal|intranasal
1318516|NCT01504659|child|child
1318517|NCT01504646|Asthma|asthma
1318518|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
1318519|NCT01504646|lipids|lipids
1318520|NCT01504646|n-3 PUFA|n-3 pufa
1318521|NCT01504646|airway inflammation|airway inflammation
1318522|NCT01504646|Bronchoconstriction|bronchoconstriction
1318523|NCT01504633|cognitive function|cognitive function
1318524|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
1318525|NCT01504633|iron|iron
1318526|NCT01504633|nutrigenomics|nutrigenomics
1318527|NCT01504633|under-two year old children|under-two year old children
1318528|NCT01504633|Indonesia|indonesia
1318529|NCT01504620|diabetes mellitus|diabetes mellitus
1318530|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
1318531|NCT01504620|Accuracy|accuracy
1318532|NCT01504620|Intra-Assay precision|intra-assay precision
1318533|NCT01504620|Hematocrit interference|hematocrit interference
1318534|NCT01504607|corneal endothelium|corneal endothelium
1318535|NCT01504607|congenital cataract surgery|congenital cataract surgery
1318536|NCT01504607|IOL implantation|iol implantation
1318537|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
1318538|NCT01504594|Idiopathic|idiopathic
1318539|NCT01504594|Bone Marrow|bone marrow
1318540|NCT01504594|Stem Cells|stem cells
1318541|NCT01504594|CD34 +|cd34 +
1318542|NCT01504594|Autologous|autologous
1318543|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
1318544|NCT01504542|Immunotherapy|immunotherapy
1318545|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
1318546|NCT01504529|Non-Motor Symptoms|non-motor symptoms
1318547|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
1318548|NCT01504529|Local study|local study
1318549|NCT01504529|Spain|spain
1318550|NCT01504529|Observational study|observational study
1318551|NCT01504529|Non-interventional study|non-interventional study
1318552|NCT01504529|Retrospective study|retrospective study
1318553|NCT01504529|Post-marketing study|post-marketing study
1318554|NCT01504529|Multicenter study|multicenter study
1318555|NCT01504516|Bioequivalence|bioequivalence
1318556|NCT01504516|Donepezil|donepezil
1318557|NCT01504516|crossover|crossover
1318558|NCT01504503|Bioequivalence|bioequivalence
1318559|NCT01504503|Donepezil|donepezil
1318560|NCT01504503|crossover|crossover
1318561|NCT01504490|Advanced cancer|advanced cancer
1318562|NCT01504477|colorectal cancer|colorectal cancer
1318563|NCT01504477|relapsed|relapsed
1318564|NCT01504477|refractory|refractory
1318565|NCT01504477|Kras wild type|kras wild type
1318566|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
1318567|NCT01504451|Atrial fibrillation|atrial fibrillation
1318568|NCT01504451|Ablation|ablation
1318569|NCT01504451|Implantable loop recorder|implantable loop recorder
1318570|NCT01504412|Pain|pain
1318571|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1318572|NCT01504399|Pituitary surgery|pituitary surgery
1318573|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
1318574|NCT01504399|Anterior skull base surgery|anterior skull base surgery
1318575|NCT01504399|Endoscopic surgery|endoscopic surgery
1318576|NCT01504399|Patient survey|patient survey
1318577|NCT01504399|Nasal complications|nasal complications
1318578|NCT01504373|NAVA|nava
1318579|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
1318580|NCT01504373|lung injury|lung injury
1318581|NCT01504373|ventilation|ventilation
1318582|NCT01504373|lung volume distribution|lung volume distribution
1318583|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
1318584|NCT01504360|sarcoma|sarcoma
1318585|NCT01504360|radiation therapy|radiation therapy
1318586|NCT01504360|predictive essay|predictive essay
1318587|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
1318588|NCT01504321|PCOS|pcos
1318589|NCT01504321|sympathetic nervous system|sympathetic nervous system
1318590|NCT01504321|moxonidine|moxonidine
1318591|NCT01504308|uterine fibroids|uterine fibroids
1318592|NCT01504308|uterine leiomyomas|uterine leiomyomas
1318593|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
1318594|NCT01504308|focused ultrasound|focused ultrasound
1318595|NCT01504256|Adenocarcinoma|adenocarcinoma
1318596|NCT01504256|Esophagogastric Junction|esophagogastric junction
1318597|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
1318598|NCT01504256|Catumaxomab|catumaxomab
1318599|NCT01504256|AIO-STO-0110|aio-sto-0110
1318600|NCT01504243|CD163;|cd163;
1318601|NCT01504243|SNPs;|snps;
1318602|NCT01504243|prognosis;|prognosis;
1318603|NCT01504243|control（normal person）|control（normal person）
1318604|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
1318605|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
1318606|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
1318607|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
1318608|NCT01504204|adherence|adherence
1318609|NCT01504204|adapalene|adapalene
1318610|NCT01504204|benzoyl peroxide|benzoyl peroxide
1318611|NCT01504204|sample|sample
1318612|NCT01504204|topical treatment|topical treatment
1318613|NCT01504191|myocardial infarction|myocardial infarction
1318614|NCT01504191|depression|depression
1318615|NCT01504191|anxiety|anxiety
1318616|NCT01504191|Internet‐based CBT|internet‐based cbt
1318617|NCT01504191|genetic disposition|genetic disposition
1318618|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
1318619|NCT01504165|Renal impairment|renal impairment
1318620|NCT01504165|Pharmacokinetic|pharmacokinetic
1318621|NCT01504165|cilengitide|cilengitide
1318622|NCT01504165|subjects with mild|subjects with mild
1318717|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
1318718|NCT01503827|Neurocognitive function|neurocognitive function
1318623|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
1318624|NCT01504152|International travel|international travel
1318625|NCT01504152|cancer patients|cancer patients
1318626|NCT01504152|HSCT|hsct
1318627|NCT01504152|Quality of Life|quality of life
1318628|NCT01504152|questionnaire|questionnaire
1318629|NCT01504152|11-176|11-176
1318630|NCT01504126|Ovarian Cancer|ovarian cancer
1318631|NCT01504126|Primary peritoneal carcinoma|primary peritoneal carcinoma
1318632|NCT01504126|Fallopian tube cancer|fallopian tube cancer
1318633|NCT01504126|Invasive epithelial ovarian cancer|invasive epithelial ovarian cancer
1318634|NCT01504126|Serous adenocarcinoma|serous adenocarcinoma
1318635|NCT01504126|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
1318636|NCT01504126|Mucinous adenocarcinoma|mucinous adenocarcinoma
1318637|NCT01504126|Undifferentiated carcinoma|undifferentiated carcinoma
1318638|NCT01504126|Clear cell carcinoma|clear cell carcinoma
1318639|NCT01504126|Mixed epithelial carcinoma|mixed epithelial carcinoma
1318640|NCT01504126|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
1318641|NCT01504126|Primary Müllerian epithelial adenocarcinoma|primary müllerian epithelial adenocarcinoma
1318642|NCT01504126|Propranolol|propranolol
1318643|NCT01504126|Beta-blocker|beta-blocker
1318644|NCT01504113|Target therapy|target therapy
1318645|NCT01504113|Biologics|biologics
1318646|NCT01504113|Psoriasis|psoriasis
1318647|NCT01504113|Latent virus|latent virus
1318648|NCT01504113|Human papillomaviruses|human papillomaviruses
1318649|NCT01504113|Cytomegalovirus|cytomegalovirus
1318650|NCT01504113|Epstein-Barr virus|epstein-barr virus
1318651|NCT01504113|Tumor necrosis factor|tumor necrosis factor
1318652|NCT01504087|patient in critical care|patient in critical care
1318653|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
1318654|NCT01504074|multimodal imaging|multimodal imaging
1318656|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
1318657|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
1318658|NCT01504061|surgical|surgical
1318659|NCT01504061|scars|scars
1318660|NCT01504061|Mederma|mederma
1318661|NCT01504048|Microscopic colitis|microscopic colitis
1318662|NCT01504048|Intestinal Diseases|intestinal diseases
1318663|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
1318664|NCT01504035|Donor site pain|donor site pain
1318665|NCT01504035|Iliac crest|iliac crest
1318666|NCT01504035|Bone graft|bone graft
1318667|NCT01504035|Hemostatic putty|hemostatic putty
1318668|NCT01504035|lidocaine|lidocaine
1318669|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
1318670|NCT01504022|Hypertension|hypertension
1318671|NCT01504022|self-monitoring|self-monitoring
1318672|NCT01504022|internet|internet
1318673|NCT01504022|lifestyle modification|lifestyle modification
1318674|NCT01504009|Nervous System Disease|nervous system disease
1318675|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
1318676|NCT01504009|Motor Neuron Disease|motor neuron disease
1318677|NCT01504009|ALS|als
1318678|NCT01504009|Muscle training|muscle training
1318679|NCT01504009|Muscle atrophy|muscle atrophy
1318680|NCT01503996|dehydration|dehydration
1318681|NCT01503996|risk factor|risk factor
1318682|NCT01503996|glaucoma|glaucoma
1318683|NCT01503996|Controls|controls
1318684|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
1318685|NCT01503983|HER2-positive|her2-positive
1318686|NCT01503970|chondral lesions|chondral lesions
1318687|NCT01503970|knee|knee
1318688|NCT01503957|Allergic rhinitis|allergic rhinitis
1318689|NCT01503957|Allergen|allergen
1318690|NCT01503957|Allergy|allergy
1318691|NCT01503957|Dustmite|dustmite
1318692|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
1318693|NCT01503931|glutamate|glutamate
1318694|NCT01503918|Critical Illness|critical illness
1318695|NCT01503918|Critical Care|critical care
1318696|NCT01503918|Valganciclovir|valganciclovir
1318697|NCT01503918|Ganciclovir|ganciclovir
1318698|NCT01503918|Aciclovir|aciclovir
1318699|NCT01503918|Valaciclovir|valaciclovir
1318700|NCT01503918|Cytomegalovirus|cytomegalovirus
1318701|NCT01503905|breast cancer|breast cancer
1318702|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1318703|NCT01503905|amenorrhea|amenorrhea
1318704|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
1318705|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
1318706|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
1318707|NCT01503879|general anaesthesia|general anaesthesia
1318708|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
1318709|NCT01503879|DLCO|dlco
1318710|NCT01503879|SPB|spb
1318711|NCT01503853|Medical Costs|medical costs
1318712|NCT01503853|Health Care|health care
1318713|NCT01503853|Focus Groups|focus groups
1318714|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
1318715|NCT01503827|Brain metastases|brain metastases
1318716|NCT01503827|Melanoma|melanoma
1318719|NCT01503827|Quality of life|quality of life
1318720|NCT01503814|hypertension|hypertension
1318721|NCT01503814|primary care|primary care
1318722|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
1318723|NCT01503814|high cardiovascular risk|high cardiovascular risk
1318724|NCT01503814|diuretics|diuretics
1318725|NCT01503814|aspirin|aspirin
1318726|NCT01503814|smoking cessation|smoking cessation
1318727|NCT01503814|salt reduction|salt reduction
1318728|NCT01503814|Tibet|tibet
1318729|NCT01503801|Preterm neonates|preterm neonates
1318730|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1318731|NCT01503801|Chronic lung disease|chronic lung disease
1318732|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
1318733|NCT01503801|Respiratory therapy|respiratory therapy
1318734|NCT01503775|intracranial|intracranial
1318735|NCT01503775|ruptured|ruptured
1318736|NCT01503775|non-ruptured|non-ruptured
1318737|NCT01503775|aneurysms|aneurysms
1318738|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
1318739|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
1318740|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
1318741|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
1318742|NCT01503736|Kidney Diseases|kidney diseases
1318743|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
1318744|NCT01503736|Hyperphosphatemia|hyperphosphatemia
1318745|NCT01503736|Urologic Diseases|urologic diseases
1318746|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
1318747|NCT01503736|Renal Insufficiency|renal insufficiency
1318748|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
1318749|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
1318750|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
1318751|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
1318752|NCT01503697|Breast Cancer|breast cancer
1318753|NCT01503697|High Risk|high risk
1318755|NCT01503697|Angiogenesis|angiogenesis
1318756|NCT01503684|sepsis|sepsis
1318757|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
1318758|NCT01503671|inflammation|inflammation
1318759|NCT01503671|peritoneal dialysis|peritoneal dialysis
1318760|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
1318761|NCT01503658|Clopidogrel,|clopidogrel,
1318762|NCT01503658|Aspirin,|aspirin,
1318763|NCT01503658|Pharmacogenomics|pharmacogenomics
1318764|NCT01503645|kidney diseases|kidney diseases
1318765|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
1318766|NCT01503645|aristolochic acid|aristolochic acid
1318767|NCT01503645|polymorphism, genetic|polymorphism, genetic
1318768|NCT01503619|small cell lung cancer|small cell lung cancer
1318769|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
1318770|NCT01503606|antibiotics|antibiotics
1318771|NCT01503606|duration|duration
1318772|NCT01503606|cefazolin|cefazolin
1318773|NCT01503606|clarithromycin|clarithromycin
1318774|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1318775|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1318776|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1318777|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1318778|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1318779|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1318780|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
1318781|NCT01503528|arthroplasty|arthroplasty
1318782|NCT01503528|wound|wound
1318783|NCT01503528|catheter|catheter
1318784|NCT01503528|local|local
1318785|NCT01503528|anesthesia|anesthesia
1318786|NCT01503528|infiltration|infiltration
1318787|NCT01503528|Total Knee Arthroplasty|total knee arthroplasty
1318788|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
1318789|NCT01503502|chronce|chronce
1318790|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
1318791|NCT01503502|Flumatinib|flumatinib
1318792|NCT01503489|Switch.|switch.
1318793|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
1318794|NCT01503463|Congestive Heart Failure|congestive heart failure
1318795|NCT01503463|Telemedicine|telemedicine
1318796|NCT01503385|Celecoxib|celecoxib
1318797|NCT01503385|phase II|phase ii
1318798|NCT01503359|glutamic acid|glutamic acid
1318799|NCT01503359|sarcosine|sarcosine
1318800|NCT01503359|NMDA|nmda
1318801|NCT01503359|schizophrenia|schizophrenia
1318802|NCT01503346|Appetite Loss|appetite loss
1318803|NCT01503333|exercise|exercise
1318804|NCT01503333|adolescent|adolescent
1318805|NCT01503333|intervention|intervention
1318806|NCT01503333|female|female
1318807|NCT01503333|counseling|counseling
1318808|NCT01503320|To evaluate|to evaluate
1318809|NCT01503320|efficacy|efficacy
1318810|NCT01503320|enteral glutamine|enteral glutamine
1318811|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
1318812|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
1318813|NCT01503307|parenting|parenting
1318814|NCT01503307|internal working models|internal working models
1318815|NCT01503294|Temporal artery thermometer|temporal artery thermometer
1318816|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
1318817|NCT01503281|Children|children
1318818|NCT01503281|Physical activity|physical activity
1318819|NCT01503281|Home-based treatment|home-based treatment
1318820|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
1318821|NCT01503281|Percentage body fat|percentage body fat
1318822|NCT01503281|Waist circumference|waist circumference
1318823|NCT01503268|Atrial fibrillation|atrial fibrillation
1318824|NCT01503268|Ablation|ablation
1318825|NCT01503268|Percutaneous ablation|percutaneous ablation
1318826|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
1318827|NCT01503268|Implantable loop recorder|implantable loop recorder
1318828|NCT01503255|CBT|cbt
1318829|NCT01503255|alcohol|alcohol
1318830|NCT01503255|HIV|hiv
1318831|NCT01503255|Kenya|kenya
1318832|NCT01503255|paraprofessional|paraprofessional
1318954|NCT01502787|microneurography|microneurography
1318833|NCT01503216|randomized controlled trial|randomized controlled trial
1318834|NCT01503216|vitamin D|vitamin d
1318835|NCT01503216|bioavailability|bioavailability
1318836|NCT01503203|Older|older
1318837|NCT01503203|virtual systems|virtual systems
1318838|NCT01503203|low back pain|low back pain
1318839|NCT01503203|postural balance|postural balance
1318840|NCT01503190|Breast Cancer|breast cancer
1318841|NCT01503190|Young Women|young women
1318842|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
1318843|NCT01503190|Pregnancy|pregnancy
1318844|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
1318845|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
1318846|NCT01503164|Sleep Apnea|sleep apnea
1318847|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
1318848|NCT01503164|Insulin sensitivity|insulin sensitivity
1318849|NCT01503164|Glucose tolerance|glucose tolerance
1318850|NCT01503164|Type 2 diabetes|type 2 diabetes
1318851|NCT01503151|attention bias modification treatment|attention bias modification treatment
1318852|NCT01503151|interpretive bias modification|interpretive bias modification
1318853|NCT01503151|cognitive bias modification|cognitive bias modification
1318854|NCT01503151|attention training|attention training
1318855|NCT01503151|social anxiety|social anxiety
1318856|NCT01503138|Intimate Partner Violence|intimate partner violence
1318857|NCT01503138|Depressive Symptoms|depressive symptoms
1318858|NCT01503138|Intervention|intervention
1318859|NCT01503138|Randomized Controlled Trial|randomized controlled trial
1318860|NCT01503138|Mainland Chinese|mainland chinese
1318861|NCT01503138|Immigrants|immigrants
1318862|NCT01503138|Women|women
1318863|NCT01503125|GAN|gan
1318864|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
1318865|NCT01503125|Neuromuscular Disease|neuromuscular disease
1318866|NCT01503125|Natural History Study|natural history study
1318867|NCT01503125|Observational Study|observational study
1318868|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
1318869|NCT01503099|ITB|itb
1318870|NCT01503099|PTB|ptb
1318871|NCT01503099|CD|cd
1318872|NCT01503073|stroke|stroke
1318873|NCT01503060|pediatrics|pediatrics
1318874|NCT01503060|Pain|pain
1318875|NCT01503060|Immunization|immunization
1318876|NCT01503034|Pregnant women|pregnant women
1318877|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
1318878|NCT01503021|Chronic kidney disease|chronic kidney disease
1318879|NCT01503021|Chronic hemodialysis|chronic hemodialysis
1318880|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
1318881|NCT01502995|Assistive devices|assistive devices
1318882|NCT01502995|Freezing of gait|freezing of gait
1318883|NCT01502995|Gait disorders|gait disorders
1318884|NCT01502995|Gait hesitation|gait hesitation
1318885|NCT01502995|Gait ignition failure|gait ignition failure
1318886|NCT01502995|Laser light|laser light
1318887|NCT01502995|Parkinson's disease|parkinson's disease
1318888|NCT01502995|Rolling walker|rolling walker
1318889|NCT01502995|Visual Cue|visual cue
1318890|NCT01502995|Walker|walker
1318891|NCT01502982|DLBCL|dlbcl
1318892|NCT01502982|high risk|high risk
1318893|NCT01502982|young|young
1318894|NCT01502969|diarrhea|diarrhea
1318895|NCT01502969|fever|fever
1318896|NCT01502969|nausea|nausea
1318897|NCT01502969|vomit|vomit
1318898|NCT01502969|irritability|irritability
1318899|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
1318900|NCT01502956|Botox A®|botox a®
1318901|NCT01502956|Interstim® Device|interstim® device
1318902|NCT01502943|Complementary Therapies|complementary therapies
1318903|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
1318904|NCT01502943|Quality of life|quality of life
1318905|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
1318906|NCT01502943|SF-12|sf-12
1318907|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
1319003|NCT01502553|heart rate|heart rate
1318908|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
1318909|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
1318910|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
1318911|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
1318912|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
1318913|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
1318914|NCT01502943|clinical efficacy|clinical efficacy
1318915|NCT01502943|evaluative index|evaluative index
1318916|NCT01502917|Brain stem glioma|brain stem glioma
1318917|NCT01502917|CNS|cns
1318918|NCT01502917|MAB 124I-8H9|mab 124i-8h9
1318919|NCT01502917|infusion cannula|infusion cannula
1318920|NCT01502917|DIPG|dipg
1318921|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
1318922|NCT01502917|11-011|11-011
1318923|NCT01502904|SES vs BES|ses vs bes
1318924|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
1318925|NCT01502891|Decision Support Techniques|decision support techniques
1318926|NCT01502891|Decision Making|decision making
1318927|NCT01502878|Nut allergy|nut allergy
1318928|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
1617537|NCT00329381|Asthma|asthma
1318929|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
1318930|NCT01502878|Nut oral desensitization|nut oral desensitization
1318931|NCT01502852|OEF/OIF Veterans|oef/oif veterans
1318932|NCT01502852|Traumatic Brain Injury|traumatic brain injury
1318933|NCT01502852|Community Mental Health|community mental health
1318934|NCT01502826|Childhood obesity|childhood obesity
1318935|NCT01502826|Endothelial dysfunction|endothelial dysfunction
1318936|NCT01502826|Inflammation|inflammation
1318937|NCT01502826|Insulin resistance|insulin resistance
1318938|NCT01502813|Neuropsychological testing|neuropsychological testing
1318939|NCT01502813|Dietary supplements|dietary supplements
1318940|NCT01502800|Metastatic|metastatic
1318941|NCT01502800|Unresectable|unresectable
1318942|NCT01502800|Recurrent advanced|recurrent advanced
1318943|NCT01502787|hypertension|hypertension
1318944|NCT01502787|blood pressure|blood pressure
1318945|NCT01502787|blood pressure medications|blood pressure medications
1318946|NCT01502787|metoprolol|metoprolol
1318947|NCT01502787|nebivolol|nebivolol
1318948|NCT01502787|handgrip exercise|handgrip exercise
1318949|NCT01502787|lower body negative pressure|lower body negative pressure
1318950|NCT01502787|angiotensin II|angiotensin ii
1318951|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
1318952|NCT01502787|flow mediated dilation|flow mediated dilation
1318953|NCT01502787|nitric oxide|nitric oxide
1318955|NCT01502774|STEMI|stemi
1318956|NCT01502774|cyclosporine|cyclosporine
1318957|NCT01502774|reperfusion injury|reperfusion injury
1318958|NCT01502761|stroke|stroke
1318959|NCT01502761|Magnesium|magnesium
1318960|NCT01502761|endovascular|endovascular
1318961|NCT01502748|stroke|stroke
1318962|NCT01502748|Magnesium|magnesium
1318963|NCT01502748|Endovascular|endovascular
1318964|NCT01502735|dengue|dengue
1318965|NCT01502735|dengue fever|dengue fever
1318966|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
1318967|NCT01502709|Single blind|single blind
1318968|NCT01502709|Randomized|randomized
1318969|NCT01502709|Controlled clinical trial|controlled clinical trial
1318970|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
1318971|NCT01502696|Stage II|stage ii
1318972|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
1318973|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
1318974|NCT01502683|Stroke|stroke
1318975|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
1318976|NCT01502683|cerebral embolic events|cerebral embolic events
1318977|NCT01502670|Pulmonary nodules|pulmonary nodules
1318978|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
1318979|NCT01502657|ultrasonography|ultrasonography
1318980|NCT01502657|echography|echography
1318981|NCT01502657|critical care|critical care
1318982|NCT01502644|low back pain|low back pain
1318983|NCT01502644|opioids|opioids
1318984|NCT01502644|mood symptoms|mood symptoms
1318985|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
1318986|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
1318987|NCT01502605|5-ALA|5-ala
1318988|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
1318989|NCT01502605|Craniotomy|craniotomy
1318990|NCT01502605|Brain Tumor|brain tumor
1318991|NCT01502605|Surgical Resection|surgical resection
1318992|NCT01502605|Neurosurgery|neurosurgery
1318993|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
1318994|NCT01502592|Cryoablation|cryoablation
1318995|NCT01502592|Total mastectomy planned|total mastectomy planned
1318996|NCT01502592|11-202|11-202
1318997|NCT01502579|IgA nephropathy|iga nephropathy
1318998|NCT01502566|educational intervention|educational intervention
1318999|NCT01502566|dentals caries|dentals caries
1319000|NCT01502566|population|population
1319001|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
1319002|NCT01502553|blood pressure|blood pressure
1319004|NCT01502540|pain|pain
1319005|NCT01502540|craniotomy|craniotomy
1319006|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
1319007|NCT01502527|Femarelle|femarelle
1319009|NCT01502514|ischemia|ischemia
1319010|NCT01502514|Heart Failure|heart failure
1319011|NCT01502501|CHF|chf
1319012|NCT01502501|Heart Failure|heart failure
1319013|NCT01502501|Non-Ischemic|non-ischemic
1319014|NCT01502501|nonischemic|nonischemic
1319015|NCT01502501|nonischemia|nonischemia
1319016|NCT01502488|Autistic|autistic
1319017|NCT01502488|ASC therapy|asc therapy
1319018|NCT01502488|ADSC|adsc
1319019|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
1319020|NCT01502475|Veteran|veteran
1319021|NCT01502475|Attitudes|attitudes
1319022|NCT01502475|Beliefs|beliefs
1319023|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
1319024|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
1319025|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
1319026|NCT01502436|traumatic brain injury|traumatic brain injury
1319027|NCT01502436|Suicide Attempt|suicide attempt
1319028|NCT01502436|Veterans|veterans
1319029|NCT01502423|On label Humira users|on label humira users
1319030|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
1319031|NCT01502423|Pain|pain
1319032|NCT01502397|hepatitis B|hepatitis b
1319033|NCT01502397|anti-HBc|anti-hbc
1319034|NCT01502397|HBsAg|hbsag
1319035|NCT01502397|rituximab|rituximab
1319036|NCT01502397|occult HBV|occult hbv
1319037|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
1319038|NCT01502371|Asthma|asthma
1319039|NCT01502371|Children|children
1319040|NCT01502371|Persistent|persistent
1319041|NCT01502358|dengue|dengue
1319042|NCT01502358|dengue fever|dengue fever
1319043|NCT01502358|dengue disease|dengue disease
1319044|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
1319045|NCT01502358|Vaxfectin®|vaxfectin®
1319046|NCT01502345|HFRS|hfrs
1319047|NCT01502332|Mechanical ventilation|mechanical ventilation
1319048|NCT01502332|Open lung approach|open lung approach
1319049|NCT01502332|Blood gases|blood gases
1319050|NCT01502332|Cardiac surgery|cardiac surgery
1319051|NCT01502332|Pulmonary complications|pulmonary complications
1319052|NCT01502306|Smoking cessation|smoking cessation
1319053|NCT01502306|Telephone|telephone
1319054|NCT01502306|Self-help|self-help
1319055|NCT01502306|Smoking abstinence|smoking abstinence
1319056|NCT01502306|Incentives|incentives
1319057|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
1319058|NCT01502306|Medi-Cal|medi-cal
1319059|NCT01502306|Medicaid|medicaid
1319060|NCT01502280|extent of resection|extent of resection
1319061|NCT01502280|Glioma|glioma
1319062|NCT01502280|5-ALA|5-ala
1319063|NCT01502280|tumor fluorescence|tumor fluorescence
1319064|NCT01502280|confocal microscopy|confocal microscopy
1319065|NCT01502267|Waiting list|waiting list
1319066|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
1319067|NCT01502267|Desensitization|desensitization
1319068|NCT01502267|anti HLA antibody|anti hla antibody
1319069|NCT01502254|Informed consent|informed consent
1319070|NCT01502254|Cancer clinical trials|cancer clinical trials
1319071|NCT01502254|Patient information|patient information
1319072|NCT01502254|Knowledge|knowledge
1319073|NCT01502254|Questionnaire|questionnaire
1319074|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
1319075|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
1319076|NCT01502241|elderly|elderly
1319077|NCT01502241|brain tumors|brain tumors
1319078|NCT01502241|MGMT|mgmt
1319079|NCT01502241|chemotherapy|chemotherapy
1319080|NCT01502241|Newly diagnosed|newly diagnosed
1319081|NCT01502241|patients > 65 years|patients > 65 years
1319082|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
1319083|NCT01502202|never smoker|never smoker
1319084|NCT01502202|1st line treatment|1st line treatment
1319085|NCT01502202|Intercalation administration|intercalation administration
1319086|NCT01502202|Gefitinib|gefitinib
1319087|NCT01502202|never smokers|never smokers
1319088|NCT01502189|patient education as topic|patient education as topic
1319089|NCT01502189|representational approach|representational approach
1319090|NCT01502189|parents|parents
1319091|NCT01502189|childhood cancer|childhood cancer
1319092|NCT01502189|paediatric oncology|paediatric oncology
1319093|NCT01502189|nursing|nursing
1319094|NCT01502189|parents of children with cancer|parents of children with cancer
1319095|NCT01502189|Stress|stress
1319096|NCT01502189|Health Knowledge|health knowledge
1319097|NCT01502189|Attitudes|attitudes
1319098|NCT01502189|Practice|practice
1319099|NCT01502176|atrial fibrillation|atrial fibrillation
1319100|NCT01502176|registry|registry
1319101|NCT01502163|perioperative hypothermia|perioperative hypothermia
1319102|NCT01502163|prewarming|prewarming
1319103|NCT01502163|forced air warming|forced air warming
1319104|NCT01502163|insulation|insulation
1319105|NCT01502150|Pediatric Cancer|pediatric cancer
1319106|NCT01502150|Proton Radiation Therapy|proton radiation therapy
1319107|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
1319108|NCT01502150|PBT|pbt
1319109|NCT01502150|Data Collection|data collection
1319110|NCT01502150|Database|database
1319111|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
1319112|NCT01502150|Dosimetric data|dosimetric data
1319113|NCT01502150|Toxicity data|toxicity data
1319114|NCT01502111|decreased level of consciousness|decreased level of consciousness
1319115|NCT01502111|hypoxemia|hypoxemia
1319116|NCT01502111|ineffective ventilation|ineffective ventilation
1319117|NCT01502111|airway obstruction|airway obstruction
1319118|NCT01502111|combative or unresponsive|combative or unresponsive
1319119|NCT01502111|relief of pain or distress|relief of pain or distress
1319120|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
1319121|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
1319122|NCT01502072|Ribavirin|ribavirin
1319123|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
1319124|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
1319125|NCT01502072|RSV|rsv
1319126|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
1319127|NCT01502072|URI|uri
1319128|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
1319129|NCT01502072|LRI|lri
1319130|NCT01502072|pneumonia|pneumonia
1319131|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
1319132|NCT01502072|HSCT|hsct
1319133|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1319134|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
1319135|NCT01502059|Pilates|pilates
1319136|NCT01502059|Exercise|exercise
1319137|NCT01502059|Treatment|treatment
1319138|NCT01502059|Low back pain|low back pain
1319139|NCT01502059|Pain|pain
1319140|NCT01502059|Function|function
1319141|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
1319142|NCT01502033|Adolescent Depression|adolescent depression
1319143|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1319144|NCT01502020|actinic keratoses|actinic keratoses
1319145|NCT01502020|actinic keratosis|actinic keratosis
1319146|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
1319147|NCT01502020|imiquimod|imiquimod
1319148|NCT01502020|Zyclara|zyclara
1319149|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
1319150|NCT01502007|Activity Level|activity level
1319151|NCT01502007|Overweight|overweight
1319152|NCT01502007|Obesity|obesity
1319153|NCT01501994|Activity level|activity level
1319154|NCT01501994|Weight|weight
1319155|NCT01501994|Body Fat|body fat
1319156|NCT01501994|Well Being|well being
1319157|NCT01501981|heart failure|heart failure
1319158|NCT01501981|MR-proANP|mr-proanp
1319159|NCT01501981|MR-proADM|mr-proadm
1319160|NCT01501981|decompensation|decompensation
1319161|NCT01501981|Copeptin|copeptin
1319162|NCT01501981|CT-proET1|ct-proet1
1319163|NCT01501981|NT-proBNP|nt-probnp
1319164|NCT01501968|Colistin|colistin
1319165|NCT01501968|ascorbic acid|ascorbic acid
1319166|NCT01501968|renal toxicity|renal toxicity
1319167|NCT01501955|Osteoarthritis|osteoarthritis
1319168|NCT01501942|Asthma|asthma
1319169|NCT01501942|Allergen induced asthma|allergen induced asthma
1319170|NCT01501942|ATS Criteria (1)|ats criteria (1)
1319171|NCT01501929|hypertension|hypertension
1319172|NCT01501929|blood pressure|blood pressure
1319173|NCT01501929|blood pressure medications|blood pressure medications
1319174|NCT01501929|metoprolol|metoprolol
1319175|NCT01501929|nebivolol|nebivolol
1319176|NCT01501929|vascular oxidative stress|vascular oxidative stress
1319177|NCT01501929|nitric oxide|nitric oxide
1319178|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
1319179|NCT01501929|endothelium|endothelium
1319180|NCT01501929|endothelial dysfunction|endothelial dysfunction
1319181|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
1319182|NCT01501929|microvascular blood flow|microvascular blood flow
1319183|NCT01501929|flow mediated dilation|flow mediated dilation
1319184|NCT01501929|handgrip exercise|handgrip exercise
1319185|NCT01501929|endothelial cell collection|endothelial cell collection
1319186|NCT01501929|microbubbles|microbubbles
1319187|NCT01501929|Definity|definity
1319188|NCT01501890|Threatened Abortion|threatened abortion
1319189|NCT01501890|Progesterone|progesterone
1319190|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
1319191|NCT01501890|Pre-Eclampsia|pre-eclampsia
1319192|NCT01501890|Abruptio Placentae|abruptio placentae
1319193|NCT01501890|Fetal Growth Retardation|fetal growth retardation
1319194|NCT01501890|Premature Birth|premature birth
1319195|NCT01501877|Smoking|smoking
1319196|NCT01501877|Type 2 Diabetes|type 2 diabetes
1319197|NCT01501877|Smoking cessation|smoking cessation
1319198|NCT01501864|HIV prevention|hiv prevention
1319199|NCT01501864|HSV-2|hsv-2
1319200|NCT01501864|Schooling|schooling
1319201|NCT01501864|Kenya|kenya
1319202|NCT01501864|Orphans|orphans
1319203|NCT01501864|School support|school support
1319204|NCT01501799|acne|acne
1319205|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
1319206|NCT01501799|Epiduo|epiduo
1319207|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
1319208|NCT01501786|children|children
1319209|NCT01501786|sedation|sedation
1319210|NCT01501786|propofol|propofol
1319211|NCT01501786|ketamine|ketamine
1319212|NCT01501773|Acute ischemic stroke|acute ischemic stroke
1319213|NCT01501747|Placebo effect|placebo effect
1319214|NCT01501747|drug half life|drug half life
1319215|NCT01501747|pharmacokinetics|pharmacokinetics
1319216|NCT01501734|CHF|chf
1319217|NCT01501734|watch-pat|watch-pat
1319218|NCT01501734|embletta x|embletta x
1319219|NCT01501734|endothelial function|endothelial function
1319220|NCT01501721|prevention|prevention
1319221|NCT01501721|workers|workers
1319222|NCT01501721|clinical trials|clinical trials
1319223|NCT01501721|obesity|obesity
1319224|NCT01501708|caspofungin|caspofungin
1319225|NCT01501708|IFI|ifi
1319226|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1319227|NCT01501695|tic disorder|tic disorder
1319228|NCT01501695|pediatric|pediatric
1319229|NCT01501682|ventralex|ventralex
1618726|NCT00324688|Methadone|methadone
1319230|NCT01501682|ventral hernia|ventral hernia
1319231|NCT01501669|irinotecan|irinotecan
1319232|NCT01501669|capecitabine|capecitabine
1319233|NCT01501669|metastatic breast cancer|metastatic breast cancer
1319234|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
1319235|NCT01501643|Spirometry|spirometry
1319236|NCT01501643|Acute chest syndrome|acute chest syndrome
1319237|NCT01501643|Sickle cell disease|sickle cell disease
1319238|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
1319239|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
1319240|NCT01501630|Impact on patient management|impact on patient management
1319241|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
1319242|NCT01501617|Hair Loss|hair loss
1319243|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
1319244|NCT01501617|Baldness|baldness
1319245|NCT01501617|Male pattern baldness|male pattern baldness
1319246|NCT01501617|Male pattern hair loss|male pattern hair loss
1319247|NCT01501617|Hair Regrowth|hair regrowth
1319248|NCT01501617|Alopecia|alopecia
1319249|NCT01501617|Hair growth|hair growth
1319250|NCT01501617|Regrow Hair|regrow hair
1319251|NCT01501604|PIK3CA mutation|pik3ca mutation
1319252|NCT01501604|Advanced solid tumors|advanced solid tumors
1319253|NCT01501591|Placebo effect|placebo effect
1319254|NCT01501591|placebo drug interaction|placebo drug interaction
1319255|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
1319256|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
1319257|NCT01501578|Telomerase mutation|telomerase mutation
1319258|NCT01501565|Postoperative pain|postoperative pain
1319259|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
1319260|NCT01501565|Efficacy|efficacy
1319261|NCT01501565|Safety|safety
1319262|NCT01501565|Urology|urology
1319263|NCT01501552|Primary health care|primary health care
1319264|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
1319265|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
1319266|NCT01501539|Hypergranulation tissue|hypergranulation tissue
1319267|NCT01501539|Gastrostomy tube|gastrostomy tube
1319268|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
1319269|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
1319270|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
1319271|NCT01501539|Wound infection|wound infection
1319272|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
1319273|NCT01501526|herpes esophagitis|herpes esophagitis
1319274|NCT01501526|dysphagia|dysphagia
1319275|NCT01501526|vocal fold palsy|vocal fold palsy
1319276|NCT01501526|immunocompetent|immunocompetent
1319277|NCT01501526|husky voice|husky voice
1319278|NCT01501513|colonoscopy|colonoscopy
1319279|NCT01501513|bowel preparation|bowel preparation
1319280|NCT01501513|endoscopy|endoscopy
1319281|NCT01501500|botulinum toxin type A|botulinum toxin type a
1319282|NCT01501500|hallux valgus angle|hallux valgus angle
1319283|NCT01501500|foot function index|foot function index
1319284|NCT01501500|VAS pain scale|vas pain scale
1319285|NCT01501487|breast cancer|breast cancer
1319286|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
1319287|NCT01501474|Confocal|confocal
1319288|NCT01501474|malignant biliary stricture|malignant biliary stricture
1319289|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
1319290|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
1319291|NCT01501435|Safety|safety
1319292|NCT01501435|Pharmacokinetics|pharmacokinetics
1319293|NCT01501422|postmenopause|postmenopause
1319294|NCT01501422|sleep quality|sleep quality
1319295|NCT01501422|estrogen|estrogen
1319296|NCT01501422|objective sleep quality|objective sleep quality
1319297|NCT01501422|actigraph|actigraph
1319298|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
1319299|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
1319300|NCT01501409|dentifrice|dentifrice
1319301|NCT01501409|pain|pain
1319302|NCT01501370|Myeloma|myeloma
1319303|NCT01501370|Biochemical relapse|biochemical relapse
1319304|NCT01501357|caries|caries
1319305|NCT01501357|primary molars|primary molars
1319306|NCT01501357|plaque|plaque
1319307|NCT01501357|toothbrushing|toothbrushing
1319308|NCT01501344|osteoporosis|osteoporosis
1319309|NCT01501344|postmenopausal women|postmenopausal women
1319310|NCT01501344|bone remodelling|bone remodelling
1319311|NCT01501344|bone turnover markers|bone turnover markers
1319312|NCT01501331|Congestive Heart Failure|congestive heart failure
1319313|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1319314|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
1319315|NCT01501318|SBIRT|sbirt
1319316|NCT01501318|brief intervention|brief intervention
1319317|NCT01501318|alcohol|alcohol
1319318|NCT01501318|drug abuse|drug abuse
1319319|NCT01501305|influence|influence
1319320|NCT01501305|carob powder|carob powder
1319321|NCT01501305|probiotics|probiotics
1319322|NCT01501305|duration|duration
1319323|NCT01501279|pudendal nerve block|pudendal nerve block
1319324|NCT01501279|postoperative pain|postoperative pain
1319325|NCT01501279|bladder spasm|bladder spasm
1319326|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
1319327|NCT01501266|Faslodex|faslodex
1319328|NCT01501266|cohort|cohort
1319329|NCT01501253|CKD-828|ckd-828
1319330|NCT01501253|Hypertension|hypertension
1319331|NCT01501253|Primary Hypertension|primary hypertension
1319332|NCT01501253|S-Amlodipine|s-amlodipine
1319333|NCT01501253|Telmisartan|telmisartan
1319334|NCT01501253|Non-Responder|non-responder
1319335|NCT01501240|Magnetic resonance image|magnetic resonance image
1319336|NCT01501240|gadoxetic acid|gadoxetic acid
1319337|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
1319338|NCT01501240|liver cirrhosis|liver cirrhosis
1319339|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
1319340|NCT01501214|atosiban|atosiban
1319341|NCT01501214|in vitro fertilization|in vitro fertilization
1319342|NCT01501214|subfertility|subfertility
1319343|NCT01501201|Obesity|obesity
1319344|NCT01501201|Diabetes|diabetes
1319345|NCT01501201|Bariatric Surgery|bariatric surgery
1319346|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
1319347|NCT01501188|Kinesio Taping|kinesio taping
1319348|NCT01501188|Electromyography|electromyography
1319349|NCT01501188|Range of ankle motion|range of ankle motion
1319350|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
1319351|NCT01501175|Saint Etienne region|saint etienne region
1319352|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
1319353|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
1319354|NCT01501149|chemotherapy|chemotherapy
1319355|NCT01501149|clinical trial|clinical trial
1319356|NCT01501149|RR|rr
1319357|NCT01501149|PFS|pfs
1319358|NCT01501149|OS|os
1319359|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
1319360|NCT01501136|chemotherapy|chemotherapy
1319361|NCT01501136|clinical trial|clinical trial
1319362|NCT01501136|RR|rr
1319363|NCT01501136|PFS|pfs
1319364|NCT01501136|OS|os
1319365|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
1319366|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
1319367|NCT01501110|low T3 syndrome|low t3 syndrome
1319368|NCT01501110|deiodases|deiodases
1319369|NCT01501110|oxidative stress|oxidative stress
1319370|NCT01501110|ischemic heart disease|ischemic heart disease
1319371|NCT01501084|functional MRI|functional mri
1319372|NCT01501084|Structural MRI|structural mri
1319373|NCT01501084|obesity|obesity
1319374|NCT01501084|resting state networks|resting state networks
1319375|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
1319376|NCT01501071|Esophageal calibration|esophageal calibration
1319377|NCT01501071|Postoperative dysphagia|postoperative dysphagia
1319378|NCT01501045|TMS|tms
1319379|NCT01501045|CPM|cpm
1319380|NCT01501045|headache|headache
1319381|NCT01501045|migraine|migraine
1319382|NCT01501045|EEG|eeg
1319383|NCT01501045|psychophysics|psychophysics
1319384|NCT01501032|Diabetes Type 1|diabetes type 1
1319385|NCT01501032|Artificial Pancreas|artificial pancreas
1319386|NCT01501006|Physicians|physicians
1319387|NCT01500993|Rectal cancer|rectal cancer
1319388|NCT01500993|Chemoradiotherapy|chemoradiotherapy
1319389|NCT01500993|Capecitabine|capecitabine
1319390|NCT01500993|phase-III trial|phase-iii trial
1319391|NCT01500980|malaria|malaria
1319392|NCT01500980|challenge|challenge
1319393|NCT01500980|P. falciparum|p. falciparum
1319394|NCT01500980|prevention|prevention
1319395|NCT01500928|Insulin Pump|insulin pump
1319396|NCT01500928|Glycemic Control|glycemic control
1319397|NCT01500928|Type 1 Diabetes|type 1 diabetes
1319398|NCT01500915|AMD|amd
1319399|NCT01500915|ranibizumab|ranibizumab
1319400|NCT01500915|antiVEGF|antivegf
1319401|NCT01500915|regimen of injections|regimen of injections
1319402|NCT01500915|anti VEGF regimen|anti vegf regimen
1319403|NCT01500915|PRN|prn
1319404|NCT01500915|treat and extend|treat and extend
1319994|NCT01498380|TIVA|tiva
1319405|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1319406|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
1319407|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
1319408|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
1319409|NCT01500902|stent placement|stent placement
1319410|NCT01500902|balloon angioplasty|balloon angioplasty
1319411|NCT01500889|Anal fissure|anal fissure
1319412|NCT01500889|Advancement flap|advancement flap
1319413|NCT01500889|Internal sphincterotomy|internal sphincterotomy
1319414|NCT01500876|lung cancer|lung cancer
1319415|NCT01500863|endometrial receptivity|endometrial receptivity
1319416|NCT01500863|gene arrays|gene arrays
1319417|NCT01500863|agonist triggering|agonist triggering
1319418|NCT01500863|Endometrial gene expression|endometrial gene expression
1319419|NCT01500863|OHSS|ohss
1319420|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1319421|NCT01500850|NPH insulin|nph insulin
1319422|NCT01500850|Insulin Glargine|insulin glargine
1319423|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
1319424|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
1319425|NCT01500850|intact proinsulin|intact proinsulin
1319426|NCT01500850|cardiovascular risk|cardiovascular risk
1319726|NCT01499706|Telephone|telephone
1319427|NCT01500837|Staphylococcus aureus|staphylococcus aureus
1319428|NCT01500837|osteoarticular infection|osteoarticular infection
1319429|NCT01500837|clindamycin|clindamycin
1319430|NCT01500837|serum concentration|serum concentration
1319431|NCT01500837|orthopedic surgery|orthopedic surgery
1319432|NCT01500824|Crizotinib|crizotinib
1319433|NCT01500824|ALK|alk
1319434|NCT01500824|NSCLC|nsclc
1319435|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
1319436|NCT01500824|Asian|asian
1319437|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
1319438|NCT01500772|Hepatitis C|hepatitis c
1319439|NCT01500772|PI treatment failure|pi treatment failure
1319440|NCT01500759|chronic heart failure|chronic heart failure
1319441|NCT01500759|heart failure|heart failure
1319442|NCT01500759|hf|hf
1319443|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
1319444|NCT01500759|sdb|sdb
1319445|NCT01500759|nyha|nyha
1319446|NCT01500759|lvef|lvef
1319447|NCT01500759|cheyne stokes|cheyne stokes
1319448|NCT01500759|central sleep apnoea|central sleep apnoea
1319449|NCT01500759|sleep apnoea|sleep apnoea
1319450|NCT01500746|chronic wound treatment|chronic wound treatment
1319451|NCT01500746|pulse lavage|pulse lavage
1319452|NCT01500746|serial pulse lavage|serial pulse lavage
1319453|NCT01500746|wounds|wounds
1319454|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
1319455|NCT01500733|Treatment|treatment
1319456|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
1319457|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
1319458|NCT01500733|Leukemia|leukemia
1319459|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
1319460|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1319461|NCT01500733|CLL|cll
1319462|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
1319463|NCT01500733|SLL|sll
1319464|NCT01500668|Botox|botox
1319465|NCT01500668|catocholamine|catocholamine
1319466|NCT01500668|shock|shock
1319467|NCT01500668|vasomotor|vasomotor
1319468|NCT01500668|Vasopressin|vasopressin
1319469|NCT01500668|botulinum toxin|botulinum toxin
1319470|NCT01500655|burn|burn
1319471|NCT01500655|skin graft donor site|skin graft donor site
1319472|NCT01500655|analgesia for donor site|analgesia for donor site
1319473|NCT01500629|Allergic Rhinitis|allergic rhinitis
1319474|NCT01500629|Hayfever|hayfever
1319475|NCT01500629|Pollen Allergy|pollen allergy
1319476|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
1319477|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
1319478|NCT01500616|Hepatitis C|hepatitis c
1319479|NCT01500616|Severe Fibrosis|severe fibrosis
1319480|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
1319481|NCT01500616|VX-950HPC3005|vx-950hpc3005
1319482|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
1319483|NCT01500603|stress urinary incontinence|stress urinary incontinence
1319484|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
1319485|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
1319486|NCT01500590|Diabetes|diabetes
1319487|NCT01500590|hypertensive|hypertensive
1319488|NCT01500590|without albuminuria|without albuminuria
1319489|NCT01500577|Prevention|prevention
1319490|NCT01500577|Breast Cancer|breast cancer
1319491|NCT01500577|Proliferation|proliferation
1319492|NCT01500577|Breast Cancer Prevention|breast cancer prevention
1319493|NCT01500564|Stroke|stroke
1319494|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1319495|NCT01500564|motor function|motor function
1319496|NCT01500551|Arthritis|arthritis
1319497|NCT01500551|Pediatric|pediatric
1319498|NCT01500551|Tofacitinib|tofacitinib
1319499|NCT01500551|Long-term|long-term
1319500|NCT01500551|JIA|jia
1319501|NCT01500551|CP-690,550|cp-690,550
1319502|NCT01500551|Xeljanz|xeljanz
1319503|NCT01500538|Follicular lymphoma|follicular lymphoma
1319504|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
1319505|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
1319506|NCT01500538|thrombocytopenia|thrombocytopenia
1319507|NCT01500538|eltrombopag|eltrombopag
1319508|NCT01500538|vorinostat|vorinostat
1319509|NCT01500538|lymphoma|lymphoma
1319510|NCT01500525|asthma|asthma
1319511|NCT01500525|children|children
1319512|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
1319513|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
1319514|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1319515|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1319516|NCT01500447|Kallmann Syndrome|kallmann syndrome
1319517|NCT01500447|Delayed Puberty|delayed puberty
1319518|NCT01500447|Infertility|infertility
1319519|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
1319520|NCT01500447|Early Puberty|early puberty
1319521|NCT01500447|Late Puberty|late puberty
1319522|NCT01500447|Hypogonadism|hypogonadism
1319523|NCT01500447|Amenorrhea|amenorrhea
1319524|NCT01500447|Endocrine Diseases|endocrine diseases
1319525|NCT01500434|drug-eluting stents|drug-eluting stents
1319527|NCT01500434|atherosclerotic|atherosclerotic
1319528|NCT01500421|Hypothermia, Induced|hypothermia, induced
1319529|NCT01500395|Aortic Diseases|aortic diseases
1319530|NCT01500395|Vascular Diseases|vascular diseases
1319531|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
1319532|NCT01500395|Treatment Outcome|treatment outcome
1319533|NCT01500395|Aorta Dissection|aorta dissection
1319534|NCT01500395|Aorta Aneurysm|aorta aneurysm
1319535|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
1319536|NCT01500395|Endovascular aortic repair|endovascular aortic repair
1319537|NCT01500395|Hybrid operation|hybrid operation
1319538|NCT01500395|Debranching|debranching
1319539|NCT01500369|atrial fibrillation|atrial fibrillation
1319540|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
1319541|NCT01500356|cardiovascular disease|cardiovascular disease
1319542|NCT01500356|obesity|obesity
1319543|NCT01500356|exercise|exercise
1319544|NCT01500343|heart failure|heart failure
1319545|NCT01500343|probiotics|probiotics
1319546|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
1319547|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
1319548|NCT01500343|gut|gut
1319549|NCT01500343|inflammation|inflammation
1319550|NCT01500317|tapentadol|tapentadol
1319551|NCT01500317|oxycodone|oxycodone
1319552|NCT01500317|mu-opiate|mu-opiate
1319553|NCT01500317|stomach|stomach
1319554|NCT01500317|small intestine|small intestine
1319555|NCT01500317|colon|colon
1319556|NCT01500317|motility|motility
1319557|NCT01500317|nausea|nausea
1319558|NCT01500317|constipation|constipation
1319559|NCT01500304|Melanoma|melanoma
1319560|NCT01500304|Lymph Nodes|lymph nodes
1319561|NCT01500304|Lymph Node Dissection|lymph node dissection
1319562|NCT01500304|Minimally invasive|minimally invasive
1319563|NCT01500291|anesthesia stress|anesthesia stress
1319564|NCT01500278|Certolizumab Pegol|certolizumab pegol
1319565|NCT01500278|Cimzia|cimzia
1319566|NCT01500278|Adalimumab|adalimumab
1319567|NCT01500278|Humira|humira
1319568|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
1319569|NCT01500265|hepatitis B virus|hepatitis b virus
1319570|NCT01500265|early screening tools|early screening tools
1319571|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
1319572|NCT01500252|Total Knee Replacement|total knee replacement
1319573|NCT01500252|Patellar Resurfacing|patellar resurfacing
1319574|NCT01500252|Health Related Quality of Life|health related quality of life
1319575|NCT01500226|Rolapitant|rolapitant
1319576|NCT01500226|Nausea|nausea
1319577|NCT01500226|Vomiting|vomiting
1319578|NCT01500226|CINV|cinv
1319579|NCT01500226|Chemotherapy|chemotherapy
1319580|NCT01500213|Rolapitant|rolapitant
1319581|NCT01500213|Nausea|nausea
1319582|NCT01500213|Vomiting|vomiting
1319583|NCT01500213|CINV|cinv
1319584|NCT01500213|Chemotherapy|chemotherapy
1319585|NCT01500187|white spot lesions|white spot lesions
1319586|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
1319587|NCT01500187|fluoride varnish|fluoride varnish
1319588|NCT01500187|fluoride gel|fluoride gel
1319589|NCT01500174|skin|skin
1319590|NCT01500174|decubitus|decubitus
1319591|NCT01500174|pressure|pressure
1319592|NCT01500174|sore|sore
1319593|NCT01500174|spinal cord injury|spinal cord injury
1319594|NCT01500161|Leukemia|leukemia
1319595|NCT01500161|Lymphoma|lymphoma
1319596|NCT01500161|Myeloma|myeloma
1319597|NCT01500161|Aplastic Anemia|aplastic anemia
1319598|NCT01500161|Myelodysplasia|myelodysplasia
1319599|NCT01500161|AML|aml
1319600|NCT01500161|ALL|all
1319601|NCT01500161|CLL|cll
1319602|NCT01500161|CML|cml
1319603|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
1319604|NCT01500148|Mitral Valve Disease|mitral valve disease
1319605|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
1319606|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
1319607|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
1319608|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
1319609|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
1319610|NCT01500148|Mitral valve degeneration|mitral valve degeneration
1319611|NCT01500135|Vascular Surgery|vascular surgery
1319612|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
1319613|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
1319614|NCT01500109|cleft palate surgery|cleft palate surgery
1319615|NCT01500109|post-operative pain management|post-operative pain management
1319616|NCT01500109|Acetaminophen|acetaminophen
1319617|NCT01500096|Fatigue|fatigue
1319618|NCT01500096|HIV/AIDS|hiv/aids
1319619|NCT01500096|American ginseng|american ginseng
1319620|NCT01500096|Panax quinquefolius|panax quinquefolius
1319621|NCT01500096|Fatigue Severity Scale|fatigue severity scale
1319622|NCT01500096|CD4 count|cd4 count
1319623|NCT01500096|plasma HIV RNA|plasma hiv rna
1319624|NCT01500096|cytokines|cytokines
1319625|NCT01500096|IL-6|il-6
1319626|NCT01500096|sTNFR1|stnfr1
1319627|NCT01500096|sTNFR2|stnfr2
1319628|NCT01500083|iNHL|inhl
1319630|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
1319631|NCT01500070|Claudication|claudication
1319632|NCT01500070|Drug-Eluting Stent|drug-eluting stent
1319633|NCT01500070|BTK|btk
1319634|NCT01500070|Everolimus|everolimus
1319635|NCT01500070|CLI|cli
1319636|NCT01500057|enlarged prostate|enlarged prostate
1319637|NCT01500044|Radiculopathy|radiculopathy
1319638|NCT01500044|Rehabilitation|rehabilitation
1319639|NCT01500044|Mobilization|mobilization
1319640|NCT01500044|Exercise|exercise
1319641|NCT01500044|Physical Therapy|physical therapy
1319642|NCT01500018|Phase I|phase i
1319643|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
1319644|NCT01500018|abuse liability|abuse liability
1319645|NCT01500018|TC-5214|tc-5214
1319646|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
1319647|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
1319648|NCT01499992|Rotator cuff tear|rotator cuff tear
1319649|NCT01499992|Physiotherapy|physiotherapy
1319650|NCT01499992|aqua therapy|aqua therapy
1319651|NCT01499992|Therapy dosage|therapy dosage
1319652|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
1319653|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
1319654|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
1319655|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
1319656|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
1319657|NCT01499966|Plaster of Paris|plaster of paris
1319658|NCT01499966|Tubigrip|tubigrip
1319659|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
1319660|NCT01499953|thrombosis|thrombosis
1319661|NCT01499953|SVT|svt
1319662|NCT01499940|peripheral neuropathy|peripheral neuropathy
1319663|NCT01499940|vitamin D status|vitamin d status
1319664|NCT01499940|oxaliplatin|oxaliplatin
1319665|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
1319666|NCT01499914|vaccination H1N1|vaccination h1n1
1319667|NCT01499914|cystic fibrosis|cystic fibrosis
1319668|NCT01499901|deafness|deafness
1319669|NCT01499901|unilateral implantation|unilateral implantation
1319670|NCT01499901|bilateral|bilateral
1319671|NCT01499901|auditory perception|auditory perception
1319672|NCT01499888|Sickle Cell Disease|sickle cell disease
1319673|NCT01499888|Subtype Hgb SS|subtype hgb ss
1319674|NCT01499888|Subtype Hgb SC|subtype hgb sc
1319675|NCT01499888|Subtype Hgb SB|subtype hgb sb
1319676|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
1319677|NCT01499888|Prior Stroke|prior stroke
1319678|NCT01499888|Allogeneic|allogeneic
1319679|NCT01499888|Stem Cell Transplantation|stem cell transplantation
1319680|NCT01499888|Alemtuzumab|alemtuzumab
1319681|NCT01499888|Sirolimus|sirolimus
1319682|NCT01499888|Total Body Irradiation|total body irradiation
1319683|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
1319684|NCT01499875|Pharmacokinetic|pharmacokinetic
1319685|NCT01499875|Pharmacodynamic|pharmacodynamic
1319686|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
1319687|NCT01499875|Children|children
1319688|NCT01499862|Stroke|stroke
1319689|NCT01499862|Tibion|tibion
1319690|NCT01499862|Bionics|bionics
1319691|NCT01499862|Rehab|rehab
1319692|NCT01499862|Therapy|therapy
1319693|NCT01499862|Robotics|robotics
1319694|NCT01499862|Intention|intention
1319695|NCT01499849|Rolapitant|rolapitant
1319696|NCT01499849|Nausea|nausea
1319697|NCT01499849|Vomiting|vomiting
1319698|NCT01499849|CINV|cinv
1319699|NCT01499849|Chemotherapy|chemotherapy
1319700|NCT01499823|Permeability Map|permeability map
1319701|NCT01499823|High-Grade Glioma|high-grade glioma
1319702|NCT01499810|Hypertension|hypertension
1319703|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
1319704|NCT01499810|Renal Artery|renal artery
1319705|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
1319706|NCT01499797|frailty|frailty
1319707|NCT01499797|frail elders|frail elders
1319708|NCT01499797|multicomponent intervention|multicomponent intervention
1319709|NCT01499797|overall functioning|overall functioning
1319710|NCT01499797|cost-effectiveness|cost-effectiveness
1319711|NCT01499797|integrated care|integrated care
1319712|NCT01499797|primary care|primary care
1319713|NCT01499797|community dwelling|community dwelling
1319714|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
1319715|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
1319716|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
1319717|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
1619027|NCT00324038|Pain|pain
1319718|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
1319719|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
1319720|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
1319721|NCT01499719|Sinusitis|sinusitis
1319723|NCT01499719|Chronic|chronic
1319724|NCT01499719|Sinonasal|sinonasal
1319725|NCT01499706|Motivational Interviewing|motivational interviewing
1319727|NCT01499706|HIV|hiv
1319728|NCT01499706|AIDS|aids
1319729|NCT01499706|Older Adults|older adults
1319730|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
1319731|NCT01499693|gastric pH|gastric ph
1319732|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
1319733|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1319734|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
1319735|NCT01499667|safety|safety
1319736|NCT01499667|tolerability|tolerability
1319737|NCT01499667|health outcomes|health outcomes
1319738|NCT01499667|fingolimod|fingolimod
1319739|NCT01499667|disease control|disease control
1319740|NCT01499667|MRI|mri
1319741|NCT01499654|SPECT MPI|spect mpi
1319742|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
1319743|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
1319744|NCT01499641|discectomy|discectomy
1319745|NCT01499641|methylprednisolone|methylprednisolone
1319746|NCT01499641|randomized control trial|randomized control trial
1319747|NCT01499615|adverse events|adverse events
1319748|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
1319749|NCT01499615|early warning|early warning
1319750|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
1319751|NCT01499602|LNG-IUS,|lng-ius,
1319752|NCT01499602|Progestin|progestin
1319753|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
1319754|NCT01499589|turnover time|turnover time
1319755|NCT01499576|Mass Screening|mass screening
1319756|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1319757|NCT01499576|Stomach Neoplasms|stomach neoplasms
1319758|NCT01499576|Metaplasia|metaplasia
1319759|NCT01499576|Diagnosis|diagnosis
1319760|NCT01499576|Acetic acid|acetic acid
1319761|NCT01499576|Chromoendoscopy|chromoendoscopy
1319762|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
1319763|NCT01499550|COPD|copd
1319764|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
1319765|NCT01499524|ICP, GDM|icp, gdm
1319766|NCT01499511|Hypertension|hypertension
1319767|NCT01499511|Mortality|mortality
1319768|NCT01499511|Morbidity|morbidity
1319769|NCT01499511|Coronary Heart Disease|coronary heart disease
1319770|NCT01499511|Stroke|stroke
1319771|NCT01499511|Diabetes|diabetes
1319772|NCT01499498|Healthy volunteers|healthy volunteers
1319773|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1319774|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
1319775|NCT01499485|Alkalosis|alkalosis
1319776|NCT01499485|Respiration, Artificial|respiration, artificial
1319777|NCT01499485|Acetazolamide|acetazolamide
1319778|NCT01499485|Intensive care|intensive care
1319779|NCT01499485|Adult|adult
1319780|NCT01499459|liver cirrhosis|liver cirrhosis
1319781|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
1319782|NCT01499342|Stent|stent
1319783|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
1319784|NCT01499342|Peripheral arterial disease|peripheral arterial disease
1319785|NCT01499342|Superficial femoral artery|superficial femoral artery
1319786|NCT01499342|SFA|sfa
1319787|NCT01499329|Stent therapy|stent therapy
1319788|NCT01499316|Coronary artery disease|coronary artery disease
1319789|NCT01499316|Fractional flow reserve|fractional flow reserve
1319790|NCT01499303|lymphoma|lymphoma
1319791|NCT01499303|DLBCL|dlbcl
1319792|NCT01499303|fostamatinib|fostamatinib
1319793|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1319794|NCT01499290|Ceftazidime|ceftazidime
1319795|NCT01499290|Meropenem|meropenem
1319796|NCT01499290|Metronidazole|metronidazole
1319797|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
1319798|NCT01499290|Anti-Infective Agents|anti-infective agents
1319799|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
1319800|NCT01499290|Antiparasitic Agents|antiparasitic agents
1319801|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
1319802|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
1319803|NCT01499277|skin infection|skin infection
1319804|NCT01499277|ceftaroline|ceftaroline
1319805|NCT01499277|wound infection|wound infection
1319806|NCT01499277|cellulitis|cellulitis
1319807|NCT01499277|burn infection|burn infection
1319808|NCT01499277|bacterial infection|bacterial infection
1319809|NCT01499277|vancomycin|vancomycin
1319810|NCT01499264|MySkin patch|myskin patch
1319811|NCT01499251|glioblastoma|glioblastoma
1427352|NCT01054105|genes|genes
1319812|NCT01499238|Efficacy|efficacy
1319813|NCT01499238|safety|safety
1319814|NCT01499238|nasal SIMV|nasal simv
1319815|NCT01499238|nasal CPAP|nasal cpap
1319816|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
1319817|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1319818|NCT01499199|ART-naive|art-naive
1319819|NCT01499199|integrase inhibitor|integrase inhibitor
1319820|NCT01499199|dolutegravir|dolutegravir
1319821|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
1319822|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
1319823|NCT01499160|endocrine resistant|endocrine resistant
1319824|NCT01499160|everolimus|everolimus
1319825|NCT01499160|lapatinib|lapatinib
1319826|NCT01499160|letrozole|letrozole
1319827|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
1319828|NCT01499147|First remission|first remission
1319829|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
1319830|NCT01499147|Acute leukemia|acute leukemia
1319831|NCT01499147|Second remission|second remission
1319832|NCT01499147|Early relapse|early relapse
1319833|NCT01499147|Partial remission|partial remission
1319834|NCT01499147|Accelerated phase|accelerated phase
1319835|NCT01499147|Blast-crisis|blast-crisis
1319836|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
1319837|NCT01499147|Chronic phase|chronic phase
1319838|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
1319839|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
1319840|NCT01499147|Hodgkin's disease|hodgkin's disease
1319841|NCT01499147|Multiple myeloma.|multiple myeloma.
1319842|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1319843|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
1319844|NCT01499147|Polycythemia vera|polycythemia vera
1319845|NCT01499147|Myelofibrosis|myelofibrosis
1319846|NCT01499147|Severe aplastic anemia|severe aplastic anemia
1319847|NCT01499108|type 2 diabetes|type 2 diabetes
1319848|NCT01499108|hypertension|hypertension
1319849|NCT01499108|liraglutide|liraglutide
1319850|NCT01499108|kidney function|kidney function
1319851|NCT01499056|osteoarthritis|osteoarthritis
1319852|NCT01499056|hip joint|hip joint
1319853|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
1319854|NCT01499043|CRPC|crpc
1319855|NCT01499043|Prostate Cancer|prostate cancer
1319856|NCT01499043|Bone metastasis|bone metastasis
1319857|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
1319858|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
1319859|NCT01499004|tofacitinib|tofacitinib
1319860|NCT01499004|CP-690|cp-690
1319862|NCT01499004|relative bioavailability|relative bioavailability
1319863|NCT01499004|modified release|modified release
1319864|NCT01499004|Phase 1|phase 1
1319865|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
1319866|NCT01498991|Rehabilitation|rehabilitation
1319867|NCT01498991|AMES device|ames device
1319868|NCT01498991|Lower Extremity|lower extremity
1319869|NCT01498991|Gait|gait
1319870|NCT01498991|Paraplegia|paraplegia
1319871|NCT01498965|food allergy|food allergy
1319872|NCT01498965|eczema|eczema
1319873|NCT01498965|Vitamin D status|vitamin d status
1319874|NCT01498965|body composition|body composition
1319875|NCT01498965|obesity|obesity
1319876|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
1319877|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
1319878|NCT01498887|Multiple Sclerosis|multiple sclerosis
1319879|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1319880|NCT01498887|Fingolimod|fingolimod
1319881|NCT01498887|Early multiple sclerosis|early multiple sclerosis
1319882|NCT01498887|Naive patients|naive patients
1319883|NCT01498874|Acne|acne
1319884|NCT01498874|Acne Vulgaris|acne vulgaris
1319885|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
1319886|NCT01498835|Radiation therapy|radiation therapy
1319887|NCT01498835|Sunitinib|sunitinib
1319888|NCT01498822|Levetiracetam|levetiracetam
1319889|NCT01498822|Oxcarbazepine|oxcarbazepine
1319890|NCT01498822|treatment failure|treatment failure
1319891|NCT01498822|partial epilepsy|partial epilepsy
1319892|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
1319893|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
1319894|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1319895|NCT01498744|Incision and Drainage|incision and drainage
1319896|NCT01498744|Clindamycin|clindamycin
1319897|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1319898|NCT01498744|Skin Infection|skin infection
1319899|NCT01498731|Copeptin|copeptin
1319900|NCT01498731|Troponin|troponin
1319901|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
1319902|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
1319903|NCT01498731|Emergency Medicine|emergency medicine
1319904|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
1319905|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
1319906|NCT01498718|Influenza B|influenza b
1319907|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
1319908|NCT01498718|Healthy Adults|healthy adults
1319909|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
1319910|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
1319911|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
1319912|NCT01498705|Brain Diseases|brain diseases
1319913|NCT01498705|Central Nervous System Diseases|central nervous system diseases
1319914|NCT01498705|Nervous System Diseases|nervous system diseases
1319915|NCT01498705|Vascular Diseases|vascular diseases
1319916|NCT01498705|Procalcitonin Level|procalcitonin level
1319917|NCT01498692|drug-eluting stents|drug-eluting stents
1319918|NCT01498692|DES|des
1319919|NCT01498692|atherosclerotic|atherosclerotic
1319920|NCT01498640|XIAFLEX|xiaflex
1319921|NCT01498640|XIAPEX|xiapex
1319922|NCT01498640|Dupuytren's disease|dupuytren's disease
1319923|NCT01498640|contracture|contracture
1319924|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
1319925|NCT01498627|Cervarix|cervarix
1319926|NCT01498627|PGRx information system|pgrx information system
1319927|NCT01498614|Diabetes mellitus|diabetes mellitus
1319928|NCT01498614|depression|depression
1319929|NCT01498614|anxiety|anxiety
1319930|NCT01498614|negative self image|negative self image
1319931|NCT01498614|alexithymia|alexithymia
1319932|NCT01498614|metabolic control|metabolic control
1319933|NCT01498614|diabetes complications|diabetes complications
1319934|NCT01498601|oral hygiene|oral hygiene
1319935|NCT01498601|tracheostomy|tracheostomy
1319936|NCT01498601|deglutition disorders|deglutition disorders
1319937|NCT01498601|enteral nutrition|enteral nutrition
1319938|NCT01498601|brain injury|brain injury
1319939|NCT01498601|coma|coma
1319940|NCT01498588|Breast Neoplasms|breast neoplasms
1319941|NCT01498588|Breast Cancer|breast cancer
1319942|NCT01498588|Breast Tumors|breast tumors
1319943|NCT01498588|Cancer of the Breast|cancer of the breast
1319944|NCT01498588|Neoplasms, Breast|neoplasms, breast
1319945|NCT01498588|Tumors, Breast|tumors, breast
1319946|NCT01498575|Teen driving|teen driving
1319947|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
1319948|NCT01498575|Parent supervision|parent supervision
1319949|NCT01498549|Abstinent cocaine users|abstinent cocaine users
1319950|NCT01498549|cognitive testing|cognitive testing
1319951|NCT01498523|Camel milk|camel milk
1319952|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
1319953|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
1319954|NCT01498523|Glycaemic index|glycaemic index
1319955|NCT01498510|chronic pain|chronic pain
1319956|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
1319957|NCT01498510|web-based intervention|web-based intervention
1319958|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
1319959|NCT01498484|11-130|11-130
1319960|NCT01498458|German Breast Group|german breast group
1319961|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
1319962|NCT01498458|GBG|gbg
1319963|NCT01498458|GBG 62|gbg 62
1319964|NCT01498458|PazoX|pazox
1319965|NCT01498458|Breast Cancer|breast cancer
1319966|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
1319967|NCT01498458|Pazopanib|pazopanib
1319968|NCT01498458|Abraxane|abraxane
1319969|NCT01498458|Capecitabine|capecitabine
1319970|NCT01498458|Xeloda|xeloda
1319971|NCT01498445|Leukemia|leukemia
1319972|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
1319973|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
1319974|NCT01498445|CML|cml
1319975|NCT01498445|Accelerated phase|accelerated phase
1319976|NCT01498445|Blastic phase|blastic phase
1319977|NCT01498445|Dasatinib|dasatinib
1319978|NCT01498445|BMS-354825|bms-354825
1319979|NCT01498445|Sprycel|sprycel
1319980|NCT01498445|Decitabine|decitabine
1319981|NCT01498445|Dacogen|dacogen
1319982|NCT01498419|Tuberculosis|tuberculosis
1319983|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
1319984|NCT01498419|Colony Forming Units|colony forming units
1319985|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
1319986|NCT01498419|PA824|pa824
1319987|NCT01498419|pretomanid|pretomanid
1319988|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
1319989|NCT01498406|vitamin D|vitamin d
1319990|NCT01498406|quality of life|quality of life
1319991|NCT01498393|fungal nail|fungal nail
1319992|NCT01498380|Dexmedetomidine|dexmedetomidine
1319993|NCT01498380|Precedex|precedex
1319995|NCT01498380|Rapid bolus|rapid bolus
1319996|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1319997|NCT01498367|Telemedicine|telemedicine
1319998|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
1319999|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
1320000|NCT01498354|Rectal adenomas|rectal adenomas
1320001|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
1333192|NCT01444079|Liver transplantation|liver transplantation
1320002|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
1320003|NCT01498341|Hypoparathyroidism|hypoparathyroidism
1320004|NCT01498341|Epidemiology|epidemiology
1320005|NCT01498341|Prognosis|prognosis
1320006|NCT01498341|Symptoms|symptoms
1320007|NCT01498328|EGFRvIII|egfrviii
1320008|NCT01498328|Glioblastoma|glioblastoma
1320009|NCT01498328|Rindopepimut|rindopepimut
1320010|NCT01498328|CDX-110|cdx-110
1320011|NCT01498328|Small cell|small cell
1320012|NCT01498328|Giant cell|giant cell
1320013|NCT01498328|Brain Cancer|brain cancer
1320014|NCT01498328|Brain Tumor|brain tumor
1320015|NCT01498328|Gliosarcoma|gliosarcoma
1320016|NCT01498328|oligodendroglial|oligodendroglial
1320017|NCT01498328|radiotherapy|radiotherapy
1320018|NCT01498328|chemoradiation|chemoradiation
1320019|NCT01498328|Tumor|tumor
1320020|NCT01498328|Bevacizumab|bevacizumab
1320021|NCT01498328|Relapsed|relapsed
1320022|NCT01498328|Returned|returned
1320023|NCT01498328|Recurrent|recurrent
1320024|NCT01498328|EGFR variant III|egfr variant iii
1320025|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1320026|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
1320027|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
1320028|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
1320029|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
1320030|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1320031|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
1320032|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
1320033|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
1320034|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
1320035|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1320036|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1320037|NCT01498276|Family History|family history
1320038|NCT01498276|Family Health History|family health history
1320039|NCT01498276|Disease Risk Assessment|disease risk assessment
1320040|NCT01498263|Family Systems|family systems
1320041|NCT01498263|Caregiving|caregiving
1320042|NCT01498263|Alzheimer Disease|alzheimer disease
1320043|NCT01498263|Family History|family history
1320044|NCT01498263|Alzheimer's Disease|alzheimer's disease
1320045|NCT01498263|AD|ad
1320046|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
1320047|NCT01498224|Cataract surgery|cataract surgery
1320048|NCT01498211|volunteer|volunteer
1320049|NCT01498198|Rotator Cuff|rotator cuff
1320050|NCT01498198|WCB|wcb
1320051|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
1320052|NCT01498159|Diabetes Mellitus|diabetes mellitus
1320053|NCT01498159|Pharmacists|pharmacists
1320054|NCT01498159|Community Health Aides|community health aides
1320055|NCT01498146|cryptogenic stroke|cryptogenic stroke
1320056|NCT01498146|atrial fibrillation|atrial fibrillation
1320057|NCT01498146|longterm monitoring|longterm monitoring
1320058|NCT01498146|loop recorder|loop recorder
1320059|NCT01498133|Skin-to-skin contact|skin-to-skin contact
1320060|NCT01498133|Decolonization|decolonization
1320061|NCT01498133|MRSA|mrsa
1320062|NCT01498120|Rotigotine|rotigotine
1320063|NCT01498120|Restless Legs Syndrome|restless legs syndrome
1320064|NCT01498120|RLS|rls
1320065|NCT01498120|Long-term|long-term
1320066|NCT01498120|Adolescents|adolescents
1320067|NCT01498107|online intervention|online intervention
1320068|NCT01498107|computerized CBT|computerized cbt
1320069|NCT01498107|e-health|e-health
1320070|NCT01498094|Bronchiolitis|bronchiolitis
1320071|NCT01498094|High|high
1320072|NCT01498094|Flow|flow
1320073|NCT01498094|Oxygen|oxygen
1320074|NCT01498094|Therapy|therapy
1320075|NCT01498094|Nasal|nasal
1320076|NCT01498094|Cannulae|cannulae
1320077|NCT01498094|Prongs|prongs
1320078|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
1320079|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
1320080|NCT01498068|VX-950HPC3007|vx-950hpc3007
1320081|NCT01498068|VX-950|vx-950
1320082|NCT01498068|Hepatitis C|hepatitis c
1320083|NCT01498068|Telaprevir|telaprevir
1320084|NCT01498068|HCV|hcv
1320085|NCT01498055|lung cancer|lung cancer
1320086|NCT01498055|CIK cells|cik cells
1320087|NCT01498055|therapy|therapy
1320088|NCT01498029|Cartilage, Articular|cartilage, articular
1320089|NCT01498016|acute leukemia|acute leukemia
1320090|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1320091|NCT01498016|busulfan|busulfan
1320092|NCT01498003|coronary disease|coronary disease
1320093|NCT01498003|stents|stents
1320094|NCT01498003|thrombosis|thrombosis
1320095|NCT01498003|myocardial infarction|myocardial infarction
1320096|NCT01498003|prognosis|prognosis
1320097|NCT01497990|Burns|burns
1320098|NCT01497990|Ertapenem|ertapenem
1320099|NCT01497990|Pharmacokinetics|pharmacokinetics
1320100|NCT01497977|phytoestrogens|phytoestrogens
1320101|NCT01497977|postmenopause|postmenopause
1320102|NCT01497977|serum lipids|serum lipids
1320103|NCT01497925|Arginine deiminase|arginine deiminase
1320104|NCT01497925|Arginine|arginine
1320105|NCT01497925|Solid tumors|solid tumors
1320106|NCT01497925|Prostate cancer|prostate cancer
1320107|NCT01497925|Phase 1 study|phase 1 study
1320108|NCT01497899|HIV-1|hiv-1
1320109|NCT01497899|HIV|hiv
1320110|NCT01497899|Treatment-Naive|treatment-naive
1320111|NCT01497886|Stroke|stroke
1320112|NCT01497886|Children|children
1320113|NCT01497886|Hip Hop Stroke|hip hop stroke
1320114|NCT01497886|New York City|new york city
1320115|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
1320116|NCT01497873|Belotecan|belotecan
1320117|NCT01497873|Topotecan|topotecan
1320118|NCT01497860|pediatric|pediatric
1320119|NCT01497860|children|children
1320120|NCT01497860|glioma|glioma
1320121|NCT01497860|low-grade|low-grade
1320122|NCT01497860|vinorelbine|vinorelbine
1320123|NCT01497860|recurrent|recurrent
1320124|NCT01497860|progressive|progressive
1320125|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
1320126|NCT01497847|PI-IBS|pi-ibs
1320127|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
1320128|NCT01497821|Amgen|amgen
1320129|NCT01497821|Phase 1|phase 1
1320130|NCT01497821|First in Human|first in human
1320131|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
1320132|NCT01497821|Kidney Cancer|kidney cancer
1320133|NCT01497821|Clinical Trial|clinical trial
1320134|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
1320135|NCT01497821|Open-label|open-label
1320136|NCT01497821|Oncology|oncology
1320137|NCT01497808|previously untreated|previously untreated
1320138|NCT01497808|previously treated|previously treated
1320139|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
1320140|NCT01497808|nodal involvement|nodal involvement
1320141|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
1320142|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
1320143|NCT01497769|vaccine|vaccine
1320144|NCT01497769|immunogenicity|immunogenicity
1320145|NCT01497743|Scleroderma|scleroderma
1320146|NCT01497743|gastrointestinal|gastrointestinal
1320147|NCT01497743|bloating|bloating
1320148|NCT01497743|reflux|reflux
1320149|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
1320150|NCT01497704|Cancer|cancer
1320151|NCT01497704|Tumor|tumor
1320152|NCT01497704|Oncology|oncology
1320153|NCT01497704|Antiangiogenesis|antiangiogenesis
1320154|NCT01497691|Asthma|asthma
1320155|NCT01497691|Pediatrics|pediatrics
1320156|NCT01497691|BiPAP|bipap
1320157|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
1320158|NCT01497678|MTURR|mturr
1320159|NCT01497678|ECM|ecm
1320160|NCT01497678|Muscle Loss|muscle loss
1320161|NCT01497678|Tendon|tendon
1320162|NCT01497678|Tendon Repair|tendon repair
1320163|NCT01497678|Muscle Repair|muscle repair
1320164|NCT01497678|Soft Tissue Repair|soft tissue repair
1320165|NCT01497678|Scaffold|scaffold
1320166|NCT01497678|Extracellular Matrix|extracellular matrix
1320167|NCT01497665|GRN1005|grn1005
1320168|NCT01497665|ANG1005|ang1005
1320169|NCT01497665|LRP-1|lrp-1
1320170|NCT01497665|Targeted Therapy|targeted therapy
1320171|NCT01497665|Brain Tumor|brain tumor
1320172|NCT01497665|Blood Brain Barrier|blood brain barrier
1320173|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
1320174|NCT01497665|Brain Metastases|brain metastases
1320175|NCT01497665|Paclitaxel|paclitaxel
1320176|NCT01497665|Taxol|taxol
1320177|NCT01497665|NSCLC|nsclc
1320178|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
1320179|NCT01497652|Parkinson's Disease|parkinson's disease
1320180|NCT01497652|Cognition|cognition
1320181|NCT01497652|Rasagiline|rasagiline
1320182|NCT01497652|MoCA|moca
1320183|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
1320184|NCT01497639|dystonia|dystonia
1320185|NCT01497639|pallidal stimulation|pallidal stimulation
1320186|NCT01497639|deep brain stimulation|deep brain stimulation
1320187|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
1320188|NCT01497639|GPi|gpi
1320189|NCT01497639|interleaving stimulation|interleaving stimulation
1320190|NCT01497626|Advanced cancer|advanced cancer
1320191|NCT01497626|Solid tumor|solid tumor
1320192|NCT01497613|Socialization|socialization
1320193|NCT01497613|Well-being|well-being
1320194|NCT01497613|Quality of Life|quality of life
1320195|NCT01497613|Connectivity|connectivity
1320196|NCT01497548|Depression|depression
1320197|NCT01497548|cancer|cancer
1320198|NCT01497548|methylphenidate|methylphenidate
1320199|NCT01497548|pharmacotherapy|pharmacotherapy
1320200|NCT01497522|Vildagliptin|vildagliptin
1320201|NCT01497522|Type 2 diabetes|type 2 diabetes
1320202|NCT01497522|HbA1c|hba1c
1320203|NCT01497522|Fasting plasma glucose|fasting plasma glucose
1320204|NCT01497496|leukemia|leukemia
1320205|NCT01497496|lymphoma|lymphoma
1320206|NCT01497496|consolidative therapy|consolidative therapy
1320207|NCT01497496|combination regimen|combination regimen
1320208|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1320455|NCT01496456|Dental caries|dental caries
1320209|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1320210|NCT01497470|paclitaxel|paclitaxel
1320211|NCT01497470|carboplatin|carboplatin
1320212|NCT01497470|custirsen|custirsen
1320213|NCT01497470|drug-drug interaction|drug-drug interaction
1320214|NCT01497470|pharmacokinetics|pharmacokinetics
1320216|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1320217|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
1320218|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
1320219|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1320220|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1320221|NCT01497405|Gender-based Violence|gender-based violence
1320223|NCT01497405|Randomized Controlled Trial|randomized controlled trial
1320224|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
1320225|NCT01497405|Substance Abuse Detection|substance abuse detection
1320226|NCT01497405|Test, Treat and Retain|test, treat and retain
1320227|NCT01497379|Hereditary retinal|hereditary retinal
1320228|NCT01497379|degeneration outer|degeneration outer
1320229|NCT01497379|retinal layers|retinal layers
1320230|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
1320231|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
1320232|NCT01497379|blindness|blindness
1320233|NCT01497379|reading ability|reading ability
1320234|NCT01497379|retina implant|retina implant
1320235|NCT01497379|subretinal|subretinal
1320236|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
1320237|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
1320238|NCT01497353|Cord clamping|cord clamping
1320239|NCT01497353|newborn|newborn
1320240|NCT01497353|Skin contact|skin contact
1320241|NCT01497353|Placental transfusion|placental transfusion
1320242|NCT01497353|Delivery room|delivery room
1320243|NCT01497340|Cord clamping|cord clamping
1320244|NCT01497340|newborn|newborn
1320245|NCT01497340|Placental trasfusion|placental trasfusion
1320246|NCT01497340|Delivery room|delivery room
1320247|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
1320248|NCT01497327|HCV|hcv
1320249|NCT01497327|hepatic impairment|hepatic impairment
1320250|NCT01497314|healthy term infants|healthy term infants
1320251|NCT01497314|growth|growth
1320252|NCT01497314|infant formula|infant formula
1320253|NCT01497301|Diabetes|diabetes
1320254|NCT01497301|Group Visit|group visit
1320255|NCT01497301|Shared Medical Appointment|shared medical appointment
1320256|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
1320257|NCT01497288|Population PK|population pk
1320258|NCT01497262|Multiple Sclerosis|multiple sclerosis
1320259|NCT01497262|Relapsing-Remitting|relapsing-remitting
1320260|NCT01497249|Dietary Fiber|dietary fiber
1320261|NCT01497249|Blood glucose control|blood glucose control
1320262|NCT01497249|Fermentability|fermentability
1320263|NCT01497249|Tolerability|tolerability
1320264|NCT01497223|Phase II|phase ii
1320265|NCT01497223|Double-Blind|double-blind
1320266|NCT01497223|Placebo-Controlled|placebo-controlled
1320267|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
1320268|NCT01497223|Moderate to Severe|moderate to severe
1320269|NCT01497223|Acute|acute
1320270|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
1320271|NCT01497197|Reproduction Techniques|reproduction techniques
1320272|NCT01497197|Reproductive Medicine|reproductive medicine
1320273|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
1320274|NCT01497197|Pregnancy Rate|pregnancy rate
1320275|NCT01497197|Ovulation Induction|ovulation induction
1320276|NCT01497197|Ovarian Stimulation|ovarian stimulation
1320277|NCT01497197|Oocytes|oocytes
1320278|NCT01497197|Implantation|implantation
1320279|NCT01497184|Leukemia|leukemia
1320280|NCT01497184|Lymphoma|lymphoma
1320281|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
1320282|NCT01497184|DLI|dli
1320283|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1320284|NCT01497184|HSCT|hsct
1320285|NCT01497184|Bone marrow transplant|bone marrow transplant
1320286|NCT01497184|CD19-specific T cells|cd19-specific t cells
1320287|NCT01497184|T cell infusion|t cell infusion
1320288|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
1320289|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
1320290|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1320291|NCT01497184|ALL|all
1320292|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
1320293|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1320294|NCT01497184|NHL|nhl
1320295|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1320296|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
1320297|NCT01497184|Follicular lymphoma|follicular lymphoma
1333193|NCT01444079|Rejection|rejection
1320298|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
1320299|NCT01497171|Cystocele|cystocele
1320300|NCT01497171|Bladder prolapse|bladder prolapse
1320301|NCT01497171|Anterior prolapse|anterior prolapse
1320302|NCT01497171|Vaginal prolapse|vaginal prolapse
1320303|NCT01497171|Uterine prolapse|uterine prolapse
1320304|NCT01497171|Urinary incontinence|urinary incontinence
1320305|NCT01497158|tobacco cessation|tobacco cessation
1320306|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
1320307|NCT01497119|JNJ-39758979|jnj-39758979
1320308|NCT01497119|Japanese patients|japanese patients
1320309|NCT01497106|Insulin resistance|insulin resistance
1320310|NCT01497106|Abdominal obesity|abdominal obesity
1320311|NCT01497106|Calorie restriction|calorie restriction
1320312|NCT01497093|Myeloma|myeloma
1320313|NCT01497093|Multiple Myeloma|multiple myeloma
1320314|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
1320315|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1320316|NCT01497093|Refractory Myeloma|refractory myeloma
1320317|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
1320318|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
1320319|NCT01497093|Pomalidomide|pomalidomide
1320320|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
1320321|NCT01497080|distal radius fracture|distal radius fracture
1320322|NCT01497080|Condition|condition
1320323|NCT01497080|risk factors|risk factors
1320324|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
1320325|NCT01497080|optimal assessment approach|optimal assessment approach
1320326|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
1320327|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
1320328|NCT01497054|Preterm infant|preterm infant
1320329|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
1320331|NCT01496989|HIV|hiv
1320332|NCT01496989|AIDS|aids
1320333|NCT01496989|HIV vaccine|hiv vaccine
1320334|NCT01496989|HIV prevention|hiv prevention
1320335|NCT01496976|leukemia|leukemia
1320336|NCT01496976|lymphoma|lymphoma
1320337|NCT01496976|consolidative therapy|consolidative therapy
1320338|NCT01496976|combination regimen|combination regimen
1320339|NCT01496976|CLL|cll
1320340|NCT01496976|SLL|sll
1320341|NCT01496963|Thalassemia|thalassemia
1320342|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1320343|NCT01496950|migraine|migraine
1320344|NCT01496924|Dysphagia|dysphagia
1320345|NCT01496924|Intensive care units|intensive care units
1320346|NCT01496924|Deglutition disorders|deglutition disorders
1320347|NCT01496924|Rehabilitation|rehabilitation
1320348|NCT01496911|Diving|diving
1320349|NCT01496911|Drugs|drugs
1320350|NCT01496911|Antihistamines|antihistamines
1320351|NCT01496911|Performance|performance
1320352|NCT01496898|Microflora|microflora
1320353|NCT01496898|Vaginal|vaginal
1320354|NCT01496898|Cervical|cervical
1320355|NCT01496898|Uterine|uterine
1320356|NCT01496898|Inflammation|inflammation
1320357|NCT01496898|Cytokine|cytokine
1320358|NCT01496898|Intrauterine Device|intrauterine device
1320359|NCT01496898|Levonorgestrel|levonorgestrel
1320360|NCT01496885|stroke|stroke
1320361|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
1320362|NCT01496872|Newborn observational study|newborn observational study
1320363|NCT01496872|Somatic dysfunction|somatic dysfunction
1320364|NCT01496872|Cranial strain pattern|cranial strain pattern
1320365|NCT01496872|Osteopathy|osteopathy
1320366|NCT01496859|Baska mask|baska mask
1320367|NCT01496859|supraglottic airway|supraglottic airway
1320368|NCT01496859|airway management|airway management
1320369|NCT01496846|Articaine|articaine
1320370|NCT01496846|Lidocaine|lidocaine
1320371|NCT01496846|Anesthesia, Local|anesthesia, local
1320372|NCT01496846|Endodontics|endodontics
1320373|NCT01496846|Molar|molar
1320374|NCT01496846|Dental Pulp Diseases|dental pulp diseases
1320375|NCT01496833|Aortic Diseases|aortic diseases
1320376|NCT01496833|Vascular Diseases|vascular diseases
1320377|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
1320378|NCT01496833|Treatment Outcome|treatment outcome
1320379|NCT01496833|Aorta Dissection|aorta dissection
1320380|NCT01496833|Aorta Aneurysm|aorta aneurysm
1320381|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
1320382|NCT01496833|Endovascular aortic repair|endovascular aortic repair
1320383|NCT01496807|unresectable|unresectable
1320384|NCT01496807|stage 3|stage 3
1320385|NCT01496807|stage 4|stage 4
1320386|NCT01496807|autoimmune|autoimmune
1320387|NCT01496807|antibodies|antibodies
1320388|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
1320389|NCT01496781|metallic hemoclip|metallic hemoclip
1320390|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
1320391|NCT01496781|Colonic Polyps|colonic polyps
1320392|NCT01496729|Kidney transplantation|kidney transplantation
1320393|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
1320394|NCT01496716|Osteoarthritis|osteoarthritis
1320395|NCT01496716|obesity|obesity
1320396|NCT01496716|quality of life|quality of life
1320397|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
1320398|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
1320399|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
1320400|NCT01496690|Pregabalin|pregabalin
1320401|NCT01496677|volunteer|volunteer
1320402|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
1320403|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
1320404|NCT01496651|Left Main|left main
1320405|NCT01496638|PCI|pci
1320406|NCT01496638|Bifurcation lesion|bifurcation lesion
1320407|NCT01496625|Biological Specimens|biological specimens
1320408|NCT01496625|Retinal Disease|retinal disease
1320409|NCT01496625|Phenotype|phenotype
1320410|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
1320411|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1320412|NCT01496625|AMD|amd
1320413|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
1320414|NCT01496625|Healthy Volunteer|healthy volunteer
1320415|NCT01496625|HV|hv
1320416|NCT01496612|Epilepsy|epilepsy
1320417|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
1320418|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
1320419|NCT01496612|Seizures|seizures
1320420|NCT01496599|Brain Imaging|brain imaging
1320421|NCT01496599|Parkinson's Disease|parkinson's disease
1320422|NCT01496599|Parkinsonism|parkinsonism
1320423|NCT01496599|Parkinson Disease|parkinson disease
1320424|NCT01496599|PD|pd
1320425|NCT01496599|Healthy Volunteer|healthy volunteer
1320426|NCT01496599|HV|hv
1320427|NCT01496586|Fatigue|fatigue
1320428|NCT01496586|Traumatic Brain Injury|traumatic brain injury
1320429|NCT01496586|Motivational Incentive|motivational incentive
1320430|NCT01496586|TBI|tbi
1320431|NCT01496560|colonoscopy|colonoscopy
1320432|NCT01496560|pain|pain
1320433|NCT01496560|rectal balloon|rectal balloon
1320434|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
1320435|NCT01496547|intensive chemotherapy|intensive chemotherapy
1320436|NCT01496547|RIC regimen|ric regimen
1320437|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
1320438|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1320439|NCT01496534|advanced solid tumors|advanced solid tumors
1320440|NCT01496534|bladder cancer|bladder cancer
1320441|NCT01496534|gemcitabine|gemcitabine
1320442|NCT01496534|cisplatin|cisplatin
1320443|NCT01496534|carboplatin|carboplatin
1320444|NCT01496534|solid tumors|solid tumors
1320445|NCT01496521|Aspirin|aspirin
1320446|NCT01496521|polyphenols|polyphenols
1320447|NCT01496521|Chemoprevention|chemoprevention
1320448|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
1320449|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
1320450|NCT01496508|preterm infants|preterm infants
1320451|NCT01496508|neurodevelopment|neurodevelopment
1320452|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
1320453|NCT01496482|Dry eye Syndromes|dry eye syndromes
1320454|NCT01496469|Drug Therapy|drug therapy
1320456|NCT01496456|Proximal surfaces|proximal surfaces
1320457|NCT01496456|Posterior teeth|posterior teeth
1320458|NCT01496456|Carious lesions|carious lesions
1320459|NCT01496456|Tooth diseases|tooth diseases
1320460|NCT01496456|Preventive therapy|preventive therapy
1320461|NCT01496443|Drug Therapy|drug therapy
1320462|NCT01496430|Drug Therapy|drug therapy
1320463|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
1320464|NCT01496417|Kidney Transplantation|kidney transplantation
1320465|NCT01496417|Biopsy|biopsy
1320466|NCT01496417|Belatacept|belatacept
1320467|NCT01496404|Electrocautery|electrocautery
1320468|NCT01496391|imaging|imaging
1320469|NCT01496391|renal function|renal function
1320470|NCT01496391|I-123 OIH|i-123 oih
1320471|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
1320472|NCT01496378|Chronic Pain|chronic pain
1320473|NCT01496378|Abdominal Pain|abdominal pain
1320474|NCT01496378|Headache|headache
1320475|NCT01496378|Adolescents|adolescents
1320476|NCT01496378|Children|children
1320477|NCT01496378|Parents|parents
1320478|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
1320479|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
1320480|NCT01496352|Surgical site infection|surgical site infection
1320481|NCT01496352|Colorectal surgery|colorectal surgery
1320482|NCT01496326|Osteoarthritis|osteoarthritis
1320483|NCT01496326|knee pain|knee pain
1320484|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
1320485|NCT01496313|metastatic|metastatic
1320486|NCT01496313|thyroid cancer|thyroid cancer
1320487|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
1320488|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
1320489|NCT01496313|VEGFR|vegfr
1320490|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
1320491|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
1320492|NCT01496261|Clopidogrel|clopidogrel
1320493|NCT01496261|Aspirin|aspirin
1320494|NCT01496261|Combination|combination
1320495|NCT01496261|Pharmacokinetics|pharmacokinetics
1320497|NCT01496248|Major depressive disorder|major depressive disorder
1320498|NCT01496248|Residual symptoms|residual symptoms
1320499|NCT01496248|Korean red ginseng|korean red ginseng
1320500|NCT01496222|mild cognitive impairment|mild cognitive impairment
1320501|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
1320502|NCT01496209|Infarction|infarction
1320503|NCT01496209|Myocardial Infarction|myocardial infarction
1320504|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
1320505|NCT01496209|Heart Disease|heart disease
1320506|NCT01496209|Cardiovascular Disease|cardiovascular disease
1320507|NCT01496209|Chronic Ischemia|chronic ischemia
1320508|NCT01496196|hemoptisis|hemoptisis
1320509|NCT01496196|bleeding|bleeding
1320510|NCT01496196|tranexamic acid|tranexamic acid
1320511|NCT01496157|Primary Prostate Cancer|primary prostate cancer
1320512|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
1320513|NCT01496144|Manual therapy|manual therapy
1320514|NCT01496144|Active exercises|active exercises
1320515|NCT01496144|Pain|pain
1320516|NCT01496144|Disability|disability
1320517|NCT01496131|Tecemotide|tecemotide
1320518|NCT01496131|Prostate Cancer|prostate cancer
1320519|NCT01496131|Goserelin|goserelin
1320520|NCT01496131|Cyclophosphamide|cyclophosphamide
1320521|NCT01496131|Radiotherapy|radiotherapy
1320522|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1320523|NCT01496118|carfilzomib|carfilzomib
1320524|NCT01496118|panobinostat|panobinostat
1320525|NCT01496092|Keto Acid|keto acid
1320526|NCT01496092|Peritoneal dialysis|peritoneal dialysis
1320527|NCT01496092|Insulin resistance|insulin resistance
1320528|NCT01496079|Maternal immunization|maternal immunization
1320529|NCT01496079|Infant immunization|infant immunization
1320530|NCT01496079|Influenza vaccine|influenza vaccine
1320531|NCT01496079|Passive transfer of immunity|passive transfer of immunity
1320532|NCT01496053|Cytokine levels in blood|cytokine levels in blood
1320533|NCT01496053|Calprotectin in feces|calprotectin in feces
1320534|NCT01496053|Clinical symptom score.|clinical symptom score.
1320535|NCT01496027|cerebral oxygenation|cerebral oxygenation
1320536|NCT01496027|NIRS|nirs
1320537|NCT01496027|tissue oximeters|tissue oximeters
1320538|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
1320539|NCT01496027|newborn|newborn
1320540|NCT01496014|open fracture wounds|open fracture wounds
1320541|NCT01496014|infections|infections
1320542|NCT01496014|tibia fractures|tibia fractures
1320543|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
1320544|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
1320545|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
1320546|NCT01495988|Metastatic melanoma|metastatic melanoma
1320547|NCT01495988|BRAF-mutant|braf-mutant
1320548|NCT01495988|Stage IV melanoma|stage iv melanoma
1320549|NCT01495988|Vemurafenib|vemurafenib
1320550|NCT01495988|Bevacizumab|bevacizumab
1320551|NCT01495988|Cobimetinib|cobimetinib
1320552|NCT01495975|Diabetes Mellitus|diabetes mellitus
1320553|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1320554|NCT01495975|Hospitalization|hospitalization
1320555|NCT01495975|Patient Discharge|patient discharge
1320556|NCT01495962|Damage Control Laparotomy|damage control laparotomy
1320557|NCT01495962|Open Abdomen|open abdomen
1320558|NCT01495962|Botulinum Toxin A|botulinum toxin a
1320559|NCT01495962|Primary Fascial Closure|primary fascial closure
1320560|NCT01495949|etomidate|etomidate
1320561|NCT01495949|cortisol level|cortisol level
1320562|NCT01495949|inotrope|inotrope
1320563|NCT01495949|cardiac patients|cardiac patients
1320564|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
1320565|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
1320566|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
1320567|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
1320568|NCT01495936|Hypoxia|hypoxia
1320569|NCT01495923|low back pain|low back pain
1320570|NCT01495923|radiculopathy|radiculopathy
1320571|NCT01495923|injection|injection
1320572|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
1320573|NCT01495910|Androstenedione|androstenedione
1320574|NCT01495910|Abiraterone acetate|abiraterone acetate
1320575|NCT01495910|Pharmacokinetics|pharmacokinetics
1320576|NCT01495910|Pharmacodynamics|pharmacodynamics
1320577|NCT01495910|Dose-finding|dose-finding
1320578|NCT01495897|Dystonia|dystonia
1320579|NCT01495897|Cerebellar|cerebellar
1320580|NCT01495897|ocular movements|ocular movements
1320581|NCT01495897|DYT 11|dyt 11
1320582|NCT01495897|sensorimotor integration|sensorimotor integration
1320583|NCT01495858|Naproxen sodium|naproxen sodium
1320584|NCT01495858|Diphenhydramine|diphenhydramine
1320585|NCT01495845|pharmacogenomics|pharmacogenomics
1320586|NCT01495845|feasibility|feasibility
1320587|NCT01495845|community pharmacy|community pharmacy
1320588|NCT01495845|personalized medicine|personalized medicine
1320589|NCT01495845|clopidogrel|clopidogrel
1320591|NCT01495832|Adult Obesity|adult obesity
1320592|NCT01495832|Cardiometabolic health|cardiometabolic health
1320593|NCT01495832|Pulse Foods|pulse foods
1320594|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
1320595|NCT01495832|Cognitive Function|cognitive function
1320596|NCT01495819|Nicotine|nicotine
1320597|NCT01495819|smokers|smokers
1320598|NCT01495819|vitals associated with smoking|vitals associated with smoking
1320599|NCT01495806|functional dyspepsia|functional dyspepsia
1320600|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
1320601|NCT01495806|functional abdominal pain|functional abdominal pain
1320602|NCT01495793|Rotigotine|rotigotine
1320603|NCT01495793|Restless Legs Syndrome|restless legs syndrome
1320604|NCT01495793|RLS|rls
1320605|NCT01495793|Children|children
1320606|NCT01495793|Adolescents|adolescents
1320607|NCT01495780|Behavioral|behavioral
1320608|NCT01495780|Remote monitoring|remote monitoring
1320609|NCT01495767|childhood uveitis|childhood uveitis
1320610|NCT01495767|health-related quality of life|health-related quality of life
1320611|NCT01495767|gender|gender
1320612|NCT01495754|coffee|coffee
1320613|NCT01495754|overweight/obese|overweight/obese
1320614|NCT01495754|appetite|appetite
1320615|NCT01495754|energy intake|energy intake
1320616|NCT01495754|inflammation|inflammation
1320617|NCT01495754|glucose metabolism|glucose metabolism
1320618|NCT01495754|randomized controlled trial|randomized controlled trial
1320619|NCT01495741|Mania|mania
1320620|NCT01495741|Manic|manic
1320621|NCT01495741|Depressive|depressive
1320622|NCT01495741|Manic Depressive|manic depressive
1320623|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
1320624|NCT01495728|Neck Pain|neck pain
1320625|NCT01495728|Manipulation|manipulation
1320626|NCT01495702|HIV-1|hiv-1
1320627|NCT01495702|HIV|hiv
1320628|NCT01495702|Treatment Experienced|treatment experienced
1320629|NCT01495689|Smoking Cessation|smoking cessation
1320630|NCT01495689|respirology Out-patient setting|respirology out-patient setting
1320631|NCT01495689|SmartCard|smartcard
1320632|NCT01495676|Bladder cancer|bladder cancer
1320633|NCT01495676|Organ-conserving strategy|organ-conserving strategy
1320634|NCT01495676|Radiochemotherapy|radiochemotherapy
1320635|NCT01495676|non metastatic|non metastatic
1320636|NCT01495663|refractory|refractory
1320637|NCT01495663|relapsed|relapsed
1320638|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
1320639|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
1320640|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
1320641|NCT01495663|colorectal cancer|colorectal cancer
1320642|NCT01495663|esophageal cancer|esophageal cancer
1320643|NCT01495663|prostate cancer|prostate cancer
1320644|NCT01495663|ovarian cancer|ovarian cancer
1320645|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
1320646|NCT01495650|Cancer-related fatigue|cancer-related fatigue
1320647|NCT01495650|Therapeutic patient education|therapeutic patient education
1320648|NCT01495650|Physical Activity|physical activity
1320649|NCT01495650|Nutritional counselling|nutritional counselling
1320650|NCT01495650|Rehabilitation|rehabilitation
1320651|NCT01495637|pediatric|pediatric
1320652|NCT01495637|trauma|trauma
1320653|NCT01495637|critical|critical
1320654|NCT01495637|GM-CSF|gm-csf
1320655|NCT01495637|immune|immune
1320656|NCT01495624|rotator cuff repair|rotator cuff repair
1320657|NCT01495624|capsular shift|capsular shift
1320658|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
1320659|NCT01495624|subacromial decompression|subacromial decompression
1320660|NCT01495624|18 and 75 years|18 and 75 years
1320661|NCT01495611|postoperative,|postoperative,
1320662|NCT01495611|pediatric|pediatric
1320663|NCT01495611|pharmacogenetic|pharmacogenetic
1320664|NCT01495611|opioid|opioid
1320665|NCT01495611|morphine|morphine
1320666|NCT01495611|perioperative|perioperative
1320667|NCT01495611|respiratory depression|respiratory depression
1320668|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
1320669|NCT01495598|Immune Modulation|immune modulation
1320670|NCT01495598|CC-4047|cc-4047
1320671|NCT01495598|IMiD|imid
1320672|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
1320673|NCT01495585|Hepatitis|hepatitis
1320674|NCT01495585|Delta|delta
1320675|NCT01495585|Treatment|treatment
1320676|NCT01495585|Lonafarnib|lonafarnib
1320677|NCT01495585|Hepatitis D|hepatitis d
1320678|NCT01495572|Malignant Melanoma|malignant melanoma
1320679|NCT01495572|Immunotherapy|immunotherapy
1320680|NCT01495572|Cell Therapy|cell therapy
1320681|NCT01495572|HLA-A2 Positive|hla-a2 positive
1320682|NCT01495572|Skin Cancer|skin cancer
1320683|NCT01495546|total hip arthroplasty|total hip arthroplasty
1320684|NCT01495546|THA|tha
1320685|NCT01495546|prosthesis type Lepine|prosthesis type lepine
1320686|NCT01495520|Arrhythmias|arrhythmias
1320687|NCT01495520|palpitations|palpitations
1320688|NCT01495494|Nasal Strip|nasal strip
1320689|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
1320690|NCT01495481|SVT|svt
1320691|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
1320692|NCT01495481|Dexmedetomidine|dexmedetomidine
1320693|NCT01495481|Adenosine|adenosine
1320694|NCT01495468|pegylated somatropin|pegylated somatropin
1320695|NCT01495468|PEG-rhGH|peg-rhgh
1320696|NCT01495468|growth hormone|growth hormone
1320697|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
1320698|NCT01495468|phase III study|phase iii study
1320699|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
1320700|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
1320701|NCT01495429|central venous catheters|central venous catheters
1320702|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
1320703|NCT01495403|liver cirrhosis|liver cirrhosis
1320704|NCT01495403|muscle cramps|muscle cramps
1320705|NCT01495390|Biomarkers|biomarkers
1320706|NCT01495390|Biological Markers|biological markers
1320707|NCT01495390|Surrogate Markers|surrogate markers
1320708|NCT01495390|Clinical Markers|clinical markers
1320709|NCT01495390|Plasma|plasma
1320710|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
1320711|NCT01495390|DNA|dna
1320712|NCT01495390|Serum|serum
1320713|NCT01495390|RNA|rna
1320714|NCT01495377|swallowing difficulties|swallowing difficulties
1320715|NCT01495377|remifentanil|remifentanil
1320716|NCT01495377|pulmonary aspiration|pulmonary aspiration
1320717|NCT01495377|scintigraphy|scintigraphy
1320718|NCT01495364|STEMI|stemi
1320719|NCT01495325|Firefighter|firefighter
1320720|NCT01495325|Woodsmoke|woodsmoke
1320721|NCT01495325|Vascular function|vascular function
1320722|NCT01495325|Air Pollution|air pollution
1320723|NCT01495325|Endothelial function|endothelial function
1320724|NCT01495325|Thrombosis|thrombosis
1320725|NCT01495312|IOP fluctuations|iop fluctuations
1320726|NCT01495312|during two 24-hour periods|during two 24-hour periods
1320727|NCT01495299|relationship|relationship
1320728|NCT01495299|IOP fluctuations|iop fluctuations
1320729|NCT01495299|glaucoma|glaucoma
1320730|NCT01495299|cataract surgery|cataract surgery
1320731|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
1320732|NCT01495286|newborn infant|newborn infant
1320733|NCT01495286|acupuncture|acupuncture
1320734|NCT01495286|safety|safety
1320735|NCT01495286|pain|pain
1320736|NCT01495260|XALD|xald
1320737|NCT01495260|AMN|amn
1320738|NCT01495247|Locally advanced|locally advanced
1320739|NCT01495247|metastatic|metastatic
1320740|NCT01495247|breast cancer|breast cancer
1320741|NCT01495247|HER2 negative|her2 negative
1320742|NCT01495247|PI3K pathway|pi3k pathway
1320743|NCT01495247|paclitaxel|paclitaxel
1320744|NCT01495247|mTOR inhibitor|mtor inhibitor
1320745|NCT01495234|Spinal degeneration|spinal degeneration
1320746|NCT01495195|Acetylcholine|acetylcholine
1320747|NCT01495195|Cholinesterases|cholinesterases
1320748|NCT01495195|Cocaine|cocaine
1320749|NCT01495195|Self-Administration|self-administration
1320750|NCT01495182|Dietary fiber|dietary fiber
1320751|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
1320752|NCT01495182|Fecal weight|fecal weight
1320753|NCT01495169|Antipsychotic|antipsychotic
1320754|NCT01495169|Schizophrenia|schizophrenia
1320755|NCT01495169|Bipolar disorder|bipolar disorder
1320756|NCT01495169|Iloperidone|iloperidone
1320757|NCT01495143|Glucose|glucose
1320758|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
1320759|NCT01495143|Glycerol|glycerol
1320760|NCT01495143|Paraspinal muscle|paraspinal muscle
1320761|NCT01495143|Microdialysis|microdialysis
1320762|NCT01495117|surgical site infection|surgical site infection
1320763|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
1320764|NCT01495117|povidone iodine|povidone iodine
1320765|NCT01495091|coronary artery disease|coronary artery disease
1320766|NCT01495091|cardiovascular disease|cardiovascular disease
1320767|NCT01495091|exercise stress testing|exercise stress testing
1320768|NCT01495091|biomarkers|biomarkers
1320769|NCT01495091|NT-pro-BNP|nt-pro-bnp
1320770|NCT01495078|telemonitoring|telemonitoring
1320771|NCT01495078|heart failure|heart failure
1320772|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
1320773|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
1320774|NCT01495052|diabetes mellitus|diabetes mellitus
1320775|NCT01495052|RCT|rct
1320776|NCT01495026|Healthy male subjects|healthy male subjects
1320777|NCT01495026|North-East Asian ancestry|north-east asian ancestry
1320778|NCT01495026|Bioequivalence|bioequivalence
1320779|NCT01495026|Food effect|food effect
1320780|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
1320781|NCT01495026|Cross-over design|cross-over design
1320782|NCT01495026|Pilot bioequivalence|pilot bioequivalence
1320783|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
1320784|NCT01495013|non-inferiority|non-inferiority
1320785|NCT01495013|glimepiride|glimepiride
1320786|NCT01495013|LDL cholesterol|ldl cholesterol
1320787|NCT01495013|fixed dose combination|fixed dose combination
1320788|NCT01495013|atorvastatin|atorvastatin
1320789|NCT01495013|Diabetes Mellitus|diabetes mellitus
1320790|NCT01495000|India|india
1320791|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1320792|NCT01495000|bone mineral density|bone mineral density
1320793|NCT01495000|denosumab|denosumab
1320794|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1320795|NCT01494974|Glaucoma|glaucoma
1320796|NCT01494974|Pediatric|pediatric
1320797|NCT01494974|Ahmed|ahmed
1320798|NCT01494974|Congenital|congenital
1320799|NCT01494974|FP7|fp7
1320800|NCT01494974|FP8|fp8
1320801|NCT01494961|Partner HIV testing|partner hiv testing
1320802|NCT01494961|Couple HIV counseling|couple hiv counseling
1320803|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
1320804|NCT01494961|HIV incidence|hiv incidence
1320805|NCT01494961|Incidence of pregnancies|incidence of pregnancies
1320806|NCT01494961|Disclosure|disclosure
1320807|NCT01494961|Condom use|condom use
1320808|NCT01494922|Skin scarring|skin scarring
1320809|NCT01494922|cicatrix|cicatrix
1320810|NCT01494922|hypertrophic scar|hypertrophic scar
1320811|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
1320812|NCT01494909|protein digestion|protein digestion
1320813|NCT01494909|fat absorption|fat absorption
1320814|NCT01494909|gut function|gut function
1320815|NCT01494909|glucose absorption|glucose absorption
1320816|NCT01494909|CF|cf
1320817|NCT01494909|pancreatic intake|pancreatic intake
1320818|NCT01494909|feeding|feeding
1320819|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
1320820|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1320821|NCT01494896|COPD|copd
1320822|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1320823|NCT01494896|Tyvaso|tyvaso
1320824|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
1320825|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
1320826|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
1320827|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
1320828|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1320829|NCT01494883|lung cancer|lung cancer
1320830|NCT01494883|psychological distress|psychological distress
1320831|NCT01494883|caretakers|caretakers
1320832|NCT01494870|acute coronary syndrome|acute coronary syndrome
1320833|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
1320834|NCT01494870|left bundle branch block|left bundle branch block
1320835|NCT01494857|Ulcerative colitis|ulcerative colitis
1320836|NCT01494857|biological treatment|biological treatment
1320837|NCT01494857|anti-TNF|anti-tnf
1320838|NCT01494844|Patient Monitoring|patient monitoring
1320839|NCT01494844|Capnography|capnography
1320840|NCT01494844|Human Engineering|human engineering
1320841|NCT01494818|Contact lenses|contact lenses
1320842|NCT01494818|Contact lens solutions|contact lens solutions
1320843|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
1320844|NCT01494805|AAV|aav
1320845|NCT01494805|AMD|amd
1320846|NCT01494805|Wet AMD|wet amd
1320847|NCT01494805|Neovascular AMD|neovascular amd
1320848|NCT01494805|Gene Therapy|gene therapy
1320849|NCT01494805|Ocular|ocular
1320850|NCT01494805|Ocular Gene Therapy|ocular gene therapy
1320851|NCT01494805|Eye diseases|eye diseases
1320852|NCT01494805|Macular Degeneration|macular degeneration
1320853|NCT01494805|Retinal Degeneration|retinal degeneration
1320854|NCT01494805|Retinal Neovascularization|retinal neovascularization
1320855|NCT01494805|Wet Macular Degeneration|wet macular degeneration
1320856|NCT01494805|Retinal Diseases|retinal diseases
1320857|NCT01494779|children|children
1320858|NCT01494766|RLS|rls
1320859|NCT01494740|H1N1|h1n1
1320860|NCT01494740|Vaccine|vaccine
1320861|NCT01494740|Immunogenicity|immunogenicity
1320862|NCT01494740|Safety|safety
1320863|NCT01494740|infants|infants
1320864|NCT01494727|Safety|safety
1320865|NCT01494727|Pharmacokinetics|pharmacokinetics
1320866|NCT01494714|Healthy volunteers|healthy volunteers
1320867|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
1320868|NCT01494714|Skin irritation|skin irritation
1320869|NCT01494714|Skin photo irritation|skin photo irritation
1320870|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
1320871|NCT01494701|SMA|sma
1320872|NCT01494701|SMN|smn
1320873|NCT01494701|SMNRx|smnrx
1320874|NCT01494701|ISIS-SMNRx|isis-smnrx
1320875|NCT01494701|ISIS-SMN Rx|isis-smn rx
1320876|NCT01494701|ISIS 396443|isis 396443
1320877|NCT01494701|IONIS-SMNRx|ionis-smnrx
1320878|NCT01494701|IONIS-SMN Rx|ionis-smn rx
1320879|NCT01494701|Spinraza|spinraza
1320880|NCT01494675|procalcitonin|procalcitonin
1320881|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
1320882|NCT01494675|sepsis|sepsis
1320883|NCT01494662|HER2 Positive|her2 positive
1320884|NCT01494662|BrCa|brca
1320885|NCT01494649|dentinal|dentinal
1320886|NCT01494649|hypersensitivity|hypersensitivity
1320887|NCT01494636|Capsaicin Challenge|capsaicin challenge
1320888|NCT01494636|Pharmacodynamics|pharmacodynamics
1320889|NCT01494636|Safety|safety
1320890|NCT01494636|Pharmacokinetics|pharmacokinetics
1320891|NCT01494636|Oral GSK2339345|oral gsk2339345
1333194|NCT01444079|Tolerance|tolerance
1320892|NCT01494636|Tolerability|tolerability
1320893|NCT01494636|FTIH|ftih
1320894|NCT01494636|Chronic Cough|chronic cough
1320895|NCT01494623|working memory|working memory
1320896|NCT01494623|schizophrenia|schizophrenia
1320897|NCT01494623|cognition|cognition
1320898|NCT01494623|rTMS|rtms
1320899|NCT01494610|safety|safety
1320900|NCT01494610|replicated cross-over design|replicated cross-over design
1320901|NCT01494610|pharmacodynamics|pharmacodynamics
1320902|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
1320903|NCT01494610|capsule-based inhaler|capsule-based inhaler
1320904|NCT01494610|COPD|copd
1320905|NCT01494610|asthma|asthma
1320906|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
1320907|NCT01494610|bioavailability|bioavailability
1320908|NCT01494610|pharmacokinetics|pharmacokinetics
1320909|NCT01494597|Isavuconazole|isavuconazole
1320910|NCT01494597|Cyclosporine|cyclosporine
1320911|NCT01494597|Healthy Volunteers|healthy volunteers
1320912|NCT01494597|BAL8557|bal8557
1320913|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
1320914|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
1320915|NCT01494558|Overall survival|overall survival
1320916|NCT01494545|DAILIES TOTAL1|dailies total1
1320917|NCT01494545|Alcon|alcon
1320918|NCT01494545|contact lens|contact lens
1320919|NCT01494519|External ring fixation|external ring fixation
1320920|NCT01494519|internal fixation|internal fixation
1321110|NCT01493544|COPD|copd
1320921|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
1320922|NCT01494506|Pancreatic cancer|pancreatic cancer
1320923|NCT01494506|MM-398|mm-398
1320924|NCT01494506|PEP02|pep02
1320925|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
1320926|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
1320927|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
1320928|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
1320929|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
1320930|NCT01494480|ALS|als
1320931|NCT01494480|stem cell|stem cell
1320932|NCT01494467|PPR|ppr
1320933|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
1320934|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
1320935|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
1320936|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
1320937|NCT01494415|radiation therapy|radiation therapy
1320938|NCT01494415|chemotherapy|chemotherapy
1320939|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
1320940|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
1320941|NCT01494389|sepsis|sepsis
1320942|NCT01494389|immunoparalysis|immunoparalysis
1320943|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
1320944|NCT01494350|topical treatment|topical treatment
1320945|NCT01494350|Tunisia|tunisia
1320946|NCT01494337|LASER|laser
1320947|NCT01494337|BPH|bph
1320948|NCT01494337|Prostate surgery|prostate surgery
1320949|NCT01494337|HOLEP|holep
1320950|NCT01494337|Green light PVP|green light pvp
1320951|NCT01494324|Liver|liver
1320952|NCT01494324|Thermal Ablation|thermal ablation
1320953|NCT01494324|Dynamic CT|dynamic ct
1320954|NCT01494324|09-122|09-122
1320955|NCT01494311|Arterial catheter|arterial catheter
1320956|NCT01494311|arterial cannula|arterial cannula
1320957|NCT01494311|Rapydan|rapydan
1320958|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
1320959|NCT01494311|topical anaesthesia|topical anaesthesia
1320960|NCT01494298|Type 2 diabetes|type 2 diabetes
1320961|NCT01494298|African American|african american
1320962|NCT01494298|cholesterol|cholesterol
1320963|NCT01494298|lipoprotein|lipoprotein
1320964|NCT01494298|apolipoprotein|apolipoprotein
1320965|NCT01494285|Acne Vulgaris|acne vulgaris
1320966|NCT01494285|Topical|topical
1320967|NCT01494285|Foam|foam
1320968|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
1320969|NCT01494272|elective circumcision|elective circumcision
1320970|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
1320971|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
1320972|NCT01494259|pain control|pain control
1320973|NCT01494259|post mastectomy pain control|post mastectomy pain control
1320974|NCT01494246|Adult|adult
1320975|NCT01494246|computer-assisted instruction|computer-assisted instruction
1320976|NCT01494246|electronic mail|electronic mail
1320977|NCT01494246|program evaluation|program evaluation
1320978|NCT01494246|smoking cessation/methods|smoking cessation/methods
1320979|NCT01494246|continued abstinence|continued abstinence
1320980|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
1320981|NCT01494220|liver transplantation|liver transplantation
1320982|NCT01494220|independent factors|independent factors
1320983|NCT01494220|outcome|outcome
1320984|NCT01494220|Living donor liver transplantation|living donor liver transplantation
1320985|NCT01494207|worksite|worksite
1320986|NCT01494207|interventions|interventions
1619232|NCT00323258|Pharmacists|pharmacists
1320987|NCT01494207|motivational interviewing|motivational interviewing
1320988|NCT01494207|physical activity|physical activity
1320989|NCT01494194|Mold sensitized|mold sensitized
1320990|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
1320991|NCT01494181|vascular events|vascular events
1321186|NCT01493154|HPV|hpv
1320992|NCT01494168|Hypertension|hypertension
1320993|NCT01494168|Arterial stiffness|arterial stiffness
1320994|NCT01494168|Obesity|obesity
1320995|NCT01494168|Bariatric surgery|bariatric surgery
1320996|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
1320997|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
1320998|NCT01494142|Registry|registry
1320999|NCT01494142|Atopic Dermatitis|atopic dermatitis
1321000|NCT01494142|Eczema Herpeticum|eczema herpeticum
1321001|NCT01494142|GWAS|gwas
1321002|NCT01494142|Staphylococcus aureus|staphylococcus aureus
1321003|NCT01494116|Pediatrics|pediatrics
1321004|NCT01494116|Fluid|fluid
1321005|NCT01494116|Bolus|bolus
1321006|NCT01494116|Resuscitation|resuscitation
1321007|NCT01494116|Shock|shock
1321008|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1321009|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
1321010|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
1321011|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
1321012|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
1321013|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1321014|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
1321015|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
1321016|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
1321017|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
1321018|NCT01494090|Venous thromboembolism|venous thromboembolism
1321019|NCT01494090|Hip fracture|hip fracture
1321020|NCT01494090|Cardiovascular events|cardiovascular events
1321021|NCT01494090|Statin|statin
1321022|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
1321023|NCT01494077|Dilution|dilution
1321024|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
1321025|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
1321026|NCT01494025|Diabetes|diabetes
1321027|NCT01494025|Pre-diabetes|pre-diabetes
1321028|NCT01494025|Obese|obese
1321029|NCT01493999|Clopidogrel|clopidogrel
1321030|NCT01493999|prasugrel|prasugrel
1321032|NCT01493999|loading dose|loading dose
1321033|NCT01493999|maintenance dose|maintenance dose
1321034|NCT01493999|stent thrombosis|stent thrombosis
1321035|NCT01493999|platelet reactivity|platelet reactivity
1321036|NCT01493999|Coronary intervention|coronary intervention
1321037|NCT01493999|stent implantation|stent implantation
1321038|NCT01493986|Ropivacaine|ropivacaine
1321039|NCT01493986|Brachial plexus|brachial plexus
1321040|NCT01493973|Erythropoietin|erythropoietin
1321041|NCT01493973|EPO|epo
1321042|NCT01493973|Friedreich|friedreich
1321043|NCT01493973|Ataxia|ataxia
1321044|NCT01493973|Epoetin alfa|epoetin alfa
1321045|NCT01493973|VO2 max|vo2 max
1321046|NCT01493973|SARA|sara
1321047|NCT01493973|EQ-5D|eq-5d
1321048|NCT01493973|frataxin|frataxin
1321049|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
1321050|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
1321051|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
1321052|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
1321053|NCT01493960|Glucocorticoids|glucocorticoids
1321054|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
1321055|NCT01493960|Therapeutic uses|therapeutic uses
1321056|NCT01493934|metabolic syndrome|metabolic syndrome
1321057|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
1321058|NCT01493934|insulin resistance|insulin resistance
1321059|NCT01493934|Scintigraphy|scintigraphy
1321060|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
1321061|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
1321062|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
1321063|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
1321064|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
1321065|NCT01493908|Placebo effect;|placebo effect;
1321066|NCT01493908|Pain; Analgesic;|pain; analgesic;
1321067|NCT01493908|Electrical shock|electrical shock
1321068|NCT01493908|control in healthy volunteers|control in healthy volunteers
1321069|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
1321070|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
1321071|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
1321072|NCT01493830|neuroblastoma|neuroblastoma
1321073|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
1321074|NCT01493804|EEG|eeg
1321075|NCT01493804|Brain Connectivity|brain connectivity
1321076|NCT01493804|Healthy Volunteer|healthy volunteer
1321077|NCT01493804|HV|hv
1321078|NCT01493791|CDB-2914|cdb-2914
1620772|NCT00317213|Nicotine|nicotine
1321079|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
1321080|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
1321081|NCT01493700|heated circuit|heated circuit
1321082|NCT01493700|body temperature|body temperature
1321083|NCT01493674|folate|folate
1321084|NCT01493674|homocysteine|homocysteine
1321085|NCT01493674|cognitive function|cognitive function
1321086|NCT01493674|eating disorders|eating disorders
1321087|NCT01493674|depression.|depression.
1321088|NCT01493661|Sleep|sleep
1321089|NCT01493661|Polysomnography|polysomnography
1321090|NCT01493661|Reaction Time|reaction time
1321091|NCT01493661|Sleep Deprivation|sleep deprivation
1321092|NCT01493661|Psychophysiology|psychophysiology
1321093|NCT01493661|Chronic sleep restriction|chronic sleep restriction
1321094|NCT01493661|healthy|healthy
1321095|NCT01493661|without sleep complaints|without sleep complaints
1321096|NCT01493648|statins|statins
1321097|NCT01493648|side effects|side effects
1321098|NCT01493648|muscle|muscle
1321099|NCT01493648|vitamin D|vitamin d
1321100|NCT01493648|biopsy|biopsy
1321101|NCT01493648|strength|strength
1321102|NCT01493648|fatigue|fatigue
1321103|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
1321104|NCT01493596|Safety|safety
1321105|NCT01493596|Tolerability|tolerability
1321106|NCT01493583|severely obese|severely obese
1321107|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
1321108|NCT01493583|brain activity by fMRI|brain activity by fmri
1321109|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
1321111|NCT01493544|smokers|smokers
1321112|NCT01493544|primary care|primary care
1321113|NCT01493531|Gout|gout
1321114|NCT01493518|SAFETY|safety
1321115|NCT01493518|ADULT|adult
1321116|NCT01493518|PSORIASIS|psoriasis
1321117|NCT01493518|INFLAMMATION|inflammation
1321118|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
1321119|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
1321120|NCT01493466|proteomics,|proteomics,
1321121|NCT01493466|serum,|serum,
1321122|NCT01493466|sepsis,|sepsis,
1321123|NCT01493466|potential biomarkers,|potential biomarkers,
1321124|NCT01493466|dynamic changes|dynamic changes
1321125|NCT01493466|normal|normal
1321126|NCT01493440|atosiban|atosiban
1321127|NCT01493440|clinical pregnancy|clinical pregnancy
1321128|NCT01493440|implantation rate|implantation rate
1321129|NCT01493440|uterine contractility|uterine contractility
1321130|NCT01493440|IVF-ET|ivf-et
1321131|NCT01493427|Glaucoma|glaucoma
1321133|NCT01493427|OHT|oht
1321134|NCT01493414|Myelofibrosis|myelofibrosis
1321135|NCT01493414|Primary myelofibrosis|primary myelofibrosis
1321136|NCT01493414|PMF|pmf
1321137|NCT01493414|Post polycythemia myelofibrosis|post polycythemia myelofibrosis
1321138|NCT01493414|PPV MF|ppv mf
1321139|NCT01493414|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1321140|NCT01493414|PET-MF|pet-mf
1321141|NCT01493414|INC424|inc424
1321142|NCT01493414|Ruxolitinib|ruxolitinib
1321143|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
1321144|NCT01493362|Bulimia Nervosa|bulimia nervosa
1321145|NCT01493362|PET Imaging|pet imaging
1321146|NCT01493362|Dopamine|dopamine
1321147|NCT01493349|Colonic diverticula|colonic diverticula
1321148|NCT01493349|Diverticulitis|diverticulitis
1321149|NCT01493323|Psychic pain|psychic pain
1321150|NCT01493323|Social exclusion|social exclusion
1321151|NCT01493323|Mood disorders|mood disorders
1321152|NCT01493323|Suicide, attempted|suicide, attempted
1321153|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1321154|NCT01493323|Genetic|genetic
1321155|NCT01493323|Physic pain|physic pain
1321156|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
1321157|NCT01493284|aortic stenosis|aortic stenosis
1321158|NCT01493284|aortic valve stenosis|aortic valve stenosis
1321159|NCT01493284|valvular heart disease|valvular heart disease
1321160|NCT01493284|aortic valve replacement|aortic valve replacement
1321161|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1321162|NCT01493284|TAVI|tavi
1321163|NCT01493258|Diabetes|diabetes
1321164|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
1321165|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
1321166|NCT01493258|Informatics|informatics
1321167|NCT01493245|Chronic Pain|chronic pain
1321168|NCT01493245|JNS020QD|jns020qd
1321169|NCT01493245|Fentanyl|fentanyl
1321170|NCT01493245|Opioid analgesics|opioid analgesics
1321171|NCT01493232|Lingualized occlusion|lingualized occlusion
1321172|NCT01493232|Complete denture occlusion|complete denture occlusion
1321173|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
1321174|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
1321175|NCT01493219|Glioblastoma|glioblastoma
1321176|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
1321177|NCT01493219|Astrocytoma|astrocytoma
1321178|NCT01493219|Gliosarcoma|gliosarcoma
1321179|NCT01493219|Glioma WHO grade IV|glioma who grade iv
1321180|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
1321181|NCT01493167|cast|cast
1321182|NCT01493167|splint|splint
1321183|NCT01493167|circumferential casting|circumferential casting
1321184|NCT01493167|casting techniques|casting techniques
1321185|NCT01493167|fracture in extremity|fracture in extremity
1321187|NCT01493154|Head and Neck Cancer|head and neck cancer
1321188|NCT01493154|Vaccine|vaccine
1321189|NCT01493154|Immunotherapy|immunotherapy
1321190|NCT01493154|Cyclophosphamide|cyclophosphamide
1321191|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1321192|NCT01493141|MOMHR|momhr
1321194|NCT01493141|Osteoarthritis|osteoarthritis
1321195|NCT01493128|atrial fibrillation|atrial fibrillation
1321196|NCT01493128|atrial cells|atrial cells
1321197|NCT01493128|myocardial tissue|myocardial tissue
1321198|NCT01493128|t-tubules|t-tubules
1321199|NCT01493128|immunofluorescence|immunofluorescence
1321200|NCT01493102|septic shock|septic shock
1321201|NCT01493102|norepinephrine|norepinephrine
1321202|NCT01493102|vasopressin|vasopressin
1321203|NCT01493102|hypotension|hypotension
1321204|NCT01493076|ERCP|ercp
1321205|NCT01493076|Cannulation|cannulation
1321206|NCT01493076|Precut|precut
1321207|NCT01493076|Mini-spincterotome|mini-spincterotome
1321208|NCT01493063|preterm infant|preterm infant
1321209|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
1321210|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
1321211|NCT01493037|STEMI|stemi
1321212|NCT01493037|PICSO|picso
1321213|NCT01493037|Coronary Sinus|coronary sinus
1321422|NCT01492309|Pregnancy|pregnancy
1321214|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
1321215|NCT01492998|Hepatitis C virus|hepatitis c virus
1321216|NCT01492998|Biliary salts|biliary salts
1321217|NCT01492998|Farnesoid X receptor|farnesoid x receptor
1321218|NCT01492998|Guggulsterone|guggulsterone
1321219|NCT01492972|Prostate|prostate
1321220|NCT01492972|proton|proton
1321221|NCT01492972|radiation|radiation
1321222|NCT01492972|intermediate risk|intermediate risk
1321223|NCT01492946|Malnutrition|malnutrition
1321224|NCT01492946|Post-operative outcome|post-operative outcome
1321225|NCT01492946|Phase angle|phase angle
1321226|NCT01492946|MUST|must
1321227|NCT01492946|Clavien Dindo classification|clavien dindo classification
1321228|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
1321229|NCT01492933|Ethanol|ethanol
1321230|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1321231|NCT01492933|Spectroscopy|spectroscopy
1321232|NCT01492933|Alcohol Use|alcohol use
1321233|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
1321234|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
1321235|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
1321236|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
1321237|NCT01492881|vorinostat|vorinostat
1321238|NCT01492881|bortezomib|bortezomib
1321239|NCT01492881|doxil|doxil
1321240|NCT01492868|sinusitis|sinusitis
1321241|NCT01492868|upper respiratory infection|upper respiratory infection
1321242|NCT01492855|Meniscal lesions|meniscal lesions
1321243|NCT01492855|MRI|mri
1321244|NCT01492855|arthroscopic treatment|arthroscopic treatment
1321245|NCT01492829|HIV prevention|hiv prevention
1321246|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
1321247|NCT01492829|HIV knowledge|hiv knowledge
1321248|NCT01492829|relationship power|relationship power
1321249|NCT01492829|depression|depression
1321250|NCT01492829|coping|coping
1321251|NCT01492829|social support|social support
1321252|NCT01492829|internally displaced persons|internally displaced persons
1321253|NCT01492829|community health worker|community health worker
1321254|NCT01492829|HIV/STI educational video|hiv/sti educational video
1321255|NCT01492829|substance use|substance use
1321256|NCT01492829|women's health|women's health
1321257|NCT01492816|HIV prevention|hiv prevention
1321258|NCT01492816|HIV positive communities|hiv positive communities
1321259|NCT01492803|HIV infection|hiv infection
1321260|NCT01492803|Probiotics|probiotics
1321261|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
1321262|NCT01492764|Ablation|ablation
1321263|NCT01492764|Electrophysiology|electrophysiology
1321264|NCT01492764|Human|human
1321265|NCT01492764|Mapping|mapping
1321266|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
1321267|NCT01492751|Radiotherapy conformal|radiotherapy conformal
1321268|NCT01492751|brachytherapy|brachytherapy
1321269|NCT01492751|radical prostatectomy|radical prostatectomy
1321270|NCT01492751|Quality of life|quality of life
1321271|NCT01492751|biochemical relapse|biochemical relapse
1321272|NCT01492751|biochemical failure|biochemical failure
1321273|NCT01492751|survival|survival
1321274|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
1321275|NCT01492738|Acupuncture|acupuncture
1321276|NCT01492738|anxiety|anxiety
1321277|NCT01492738|memory|memory
1321278|NCT01492712|Propofol|propofol
1321279|NCT01492712|Pharmacokinetics|pharmacokinetics
1321280|NCT01492712|Pharmacodynamics|pharmacodynamics
1321281|NCT01492712|Infusion Pumps|infusion pumps
1321282|NCT01492699|PTSD|ptsd
1321283|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
1321284|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1321285|NCT01492673|Ewing's sarcoma|ewing's sarcoma
1321286|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1321287|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1321288|NCT01492673|TOPOTECAN|topotecan
1321289|NCT01492673|11-183|11-183
1321290|NCT01492673|POETIC|poetic
1321291|NCT01492660|Ultrasonography|ultrasonography
1321292|NCT01492660|nerve block|nerve block
1321293|NCT01492660|catheters|catheters
1321294|NCT01492660|needle|needle
1321295|NCT01492660|anesthesia|anesthesia
1321296|NCT01492647|Acne vulgaris|acne vulgaris
1321297|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
1321298|NCT01492647|Japanese patients|japanese patients
1321299|NCT01492647|Topical treatment|topical treatment
1321300|NCT01492634|bioimpedance|bioimpedance
1321301|NCT01492634|overhydration|overhydration
1321302|NCT01492634|dry weight|dry weight
1321303|NCT01492621|major depression|major depression
1321304|NCT01492621|DTI|dti
1321305|NCT01492621|inflammatory markers|inflammatory markers
1321306|NCT01492621|cognition|cognition
1321307|NCT01492608|magnesium sulphate|magnesium sulphate
1321308|NCT01492608|preterm birth|preterm birth
1321309|NCT01492608|cerebral palsy|cerebral palsy
1321310|NCT01492595|contact|contact
1321311|NCT01492556|Recurrent|recurrent
1321312|NCT01492556|Metastatic|metastatic
1321313|NCT01492556|Breast cancer|breast cancer
1321314|NCT01492543|Advanced|advanced
1321315|NCT01492543|Metastatic|metastatic
1321316|NCT01492543|Breast cancer|breast cancer
1321317|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
1321318|NCT01492530|HIV Prevention|hiv prevention
1321319|NCT01492530|Behavioral Intervention|behavioral intervention
1321320|NCT01492530|Condom use|condom use
1321321|NCT01492530|African American MSMW|african american msmw
1321322|NCT01492517|Controlled Human exposure study|controlled human exposure study
1321323|NCT01492517|Air Pollution|air pollution
1321324|NCT01492517|Gene expression|gene expression
1321325|NCT01492517|Epigenetic|epigenetic
1321326|NCT01492517|Cardiovascular|cardiovascular
1321327|NCT01492491|SUPRA-HFR|supra-hfr
1321328|NCT01492491|adsorpition|adsorpition
1321329|NCT01492491|vitamins|vitamins
1321330|NCT01492491|large toxins|large toxins
1321331|NCT01492465|Type 2 diabetes|type 2 diabetes
1321332|NCT01492452|guidelines for nursing|guidelines for nursing
1321333|NCT01492452|anxiety|anxiety
1321334|NCT01492452|cardiac surgery|cardiac surgery
1321335|NCT01492452|pediatrics|pediatrics
1321336|NCT01492439|Psychosis|psychosis
1321337|NCT01492439|Psychosis NOS|psychosis nos
1321338|NCT01492439|Schizophrenia|schizophrenia
1321339|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
1321340|NCT01492439|Bipolar Disorder|bipolar disorder
1321341|NCT01492426|Hepatitis C Virus|hepatitis c virus
1321342|NCT01492413|Overweight|overweight
1321343|NCT01492413|Obesity|obesity
1321344|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
1321345|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
1321346|NCT01492387|antibiotic therapy|antibiotic therapy
1321347|NCT01492387|Duration of therapy|duration of therapy
1321348|NCT01492361|Coronary Artery Disease|coronary artery disease
1321349|NCT01492361|Myocardial Ischemia|myocardial ischemia
1321350|NCT01492361|Coronary Disease|coronary disease
1321351|NCT01492361|Heart Diseases|heart diseases
1321352|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
1321353|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
1321354|NCT01492361|Arteriosclerosis|arteriosclerosis
1321355|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
1321356|NCT01492361|Vascular Diseases|vascular diseases
1321357|NCT01492361|Angina Pectoris|angina pectoris
1321358|NCT01492361|Chest Pain|chest pain
1321359|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
1321360|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
1321361|NCT01492361|Lipid Regulating Agents|lipid regulating agents
1321362|NCT01492361|hypertriglyceridemia|hypertriglyceridemia
1321363|NCT01492361|omega-3 fatty acids|omega-3 fatty acids
1321364|NCT01492361|statin|statin
1321365|NCT01492361|triglycerides|triglycerides
1321366|NCT01492361|EPA|epa
1321367|NCT01492361|docosahexaenoic acid|docosahexaenoic acid
1321368|NCT01492361|fish|fish
1321369|NCT01492361|fatty acids|fatty acids
1321370|NCT01492361|fibrates|fibrates
1321371|NCT01492361|niacin|niacin
1321372|NCT01492361|lipids|lipids
1321373|NCT01492361|lipoprotein|lipoprotein
1321374|NCT01492361|atorvastatin|atorvastatin
1321375|NCT01492361|Lovaza|lovaza
1321376|NCT01492361|simvastatin|simvastatin
1321377|NCT01492361|lovastatin|lovastatin
1321378|NCT01492361|pravastatin|pravastatin
1321379|NCT01492361|fluvastatin|fluvastatin
1321380|NCT01492361|rosuvastatin|rosuvastatin
1321381|NCT01492361|Trilipix|trilipix
1321382|NCT01492361|Vytorin|vytorin
1321383|NCT01492361|Simcor|simcor
1321384|NCT01492361|ezetimibe|ezetimibe
1321385|NCT01492361|Zetia|zetia
1321386|NCT01492361|ethyl-EPA|ethyl-epa
1321387|NCT01492361|ethyl icosapentate|ethyl icosapentate
1321388|NCT01492361|Crestor|crestor
1321389|NCT01492361|Zocor|zocor
1321390|NCT01492361|Lipitor|lipitor
1321391|NCT01492361|LDL|ldl
1321392|NCT01492361|HDL|hdl
1321393|NCT01492361|cholesterol|cholesterol
1321394|NCT01492361|dyslipidemia|dyslipidemia
1321395|NCT01492361|AMR101|amr101
1321901|NCT01490489|EG-VEGF|eg-vegf
1321396|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
1321397|NCT01492361|VASCEPA|vascepa
1321398|NCT01492361|icosapent ethyl|icosapent ethyl
1321399|NCT01492348|collaborative care|collaborative care
1321400|NCT01492348|PTSD|ptsd
1321401|NCT01492348|military|military
1321402|NCT01492348|Depression|depression
1321403|NCT01492348|primary care|primary care
1321404|NCT01492348|care management|care management
1321405|NCT01492348|stepped care|stepped care
1321406|NCT01492348|telehealth|telehealth
1321408|NCT01492348|OEF|oef
1321409|NCT01492348|preference-based treatment|preference-based treatment
1321410|NCT01492348|cost effectiveness|cost effectiveness
1321411|NCT01492348|web-based treatment|web-based treatment
1321412|NCT01492348|telephonic CBT|telephonic cbt
1321413|NCT01492348|evidence-based treatment|evidence-based treatment
1321414|NCT01492335|Cognitive decline|cognitive decline
1321415|NCT01492335|Cognitive impairment|cognitive impairment
1321416|NCT01492322|Smoker|smoker
1321417|NCT01492322|SPECT|spect
1321418|NCT01492322|Dopamine|dopamine
1321419|NCT01492322|Nicotine Sated condition|nicotine sated condition
1321420|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
1321421|NCT01492309|Major Depressive Disorder|major depressive disorder
1321423|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
1321424|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1321425|NCT01492283|NAFLD|nafld
1321426|NCT01492283|Incretin hormones|incretin hormones
1321427|NCT01492270|Prostate Cancer|prostate cancer
1321428|NCT01492270|Multi parametric MRI|multi parametric mri
1321429|NCT01492270|Prostate HistoScanning|prostate histoscanning
1321430|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
1321431|NCT01492257|shared decision making|shared decision making
1321432|NCT01492257|decision aids|decision aids
1321433|NCT01492257|total joint arthroplasty|total joint arthroplasty
1321434|NCT01492257|osteoarthritis|osteoarthritis
1321435|NCT01492244|Knee pain|knee pain
1321436|NCT01492244|map|map
1321437|NCT01492244|questionnaire|questionnaire
1321438|NCT01492244|survey|survey
1321439|NCT01492231|gastroenterology|gastroenterology
1321440|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
1321441|NCT01492231|Endosonography|endosonography
1321442|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1321443|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
1321444|NCT01492192|Angiogenesis|angiogenesis
1321445|NCT01492192|PET-CT|pet-ct
1321446|NCT01492192|Perfusion-CT|perfusion-ct
1321447|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
1321448|NCT01492179|Anesthetics: Local|anesthetics: local
1321449|NCT01492179|Postoperative: Pain|postoperative: pain
1321450|NCT01492179|Drugs: Morphine|drugs: morphine
1321451|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
1321452|NCT01492127|cirrhosis|cirrhosis
1321453|NCT01492127|proteasome|proteasome
1321454|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
1321455|NCT01492114|C-reactive protein|c-reactive protein
1321456|NCT01492114|Resveratrol|resveratrol
1321457|NCT01492114|Redox index|redox index
1321458|NCT01492088|Pediatric|pediatric
1321459|NCT01492088|Lymphoma|lymphoma
1321460|NCT01492088|Hodgkin|hodgkin
1321461|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
1321462|NCT01492088|Relapsed|relapsed
1321463|NCT01492088|Refractory|refractory
1321464|NCT01492088|Drug therapy|drug therapy
1321465|NCT01492075|Postoperative pain|postoperative pain
1321466|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
1321467|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
1321468|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
1321469|NCT01492062|artificial pancreas|artificial pancreas
1321470|NCT01492062|closed-loop|closed-loop
1321471|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
1321472|NCT01492049|Promoting Health Literacy|promoting health literacy
1321473|NCT01492049|Patient education program|patient education program
1321474|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
1321475|NCT01492049|CRCS|crcs
1321476|NCT01492049|Patient decision aid|patient decision aid
1321477|NCT01492049|PtDA|ptda
1321478|NCT01492049|Video|video
1321479|NCT01492049|Questionnaires|questionnaires
1321480|NCT01492049|Surveys|surveys
1321481|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
1321482|NCT01492036|RCR|rcr
1321483|NCT01492036|Gene transfer therapy|gene transfer therapy
1321484|NCT01492036|Registry|registry
1321485|NCT01492036|Medical information database|medical information database
1321486|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
1321487|NCT01492036|Blood draw|blood draw
1321488|NCT01492036|Computed tomography|computed tomography
1321489|NCT01492036|CT|ct
1321490|NCT01492036|Questionnaires|questionnaires
1321491|NCT01492036|Surveys|surveys
1321492|NCT01492036|Gene Transfer Research|gene transfer research
1321493|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
1321494|NCT01492036|NGVB|ngvb
1321495|NCT01492023|neuropsychological|neuropsychological
1321496|NCT01492023|rehabilitation|rehabilitation
1321497|NCT01492023|multiple sclerosis|multiple sclerosis
1321498|NCT01492023|RCT study|rct study
1321499|NCT01492010|skeletal muscle|skeletal muscle
1321500|NCT01492010|FSR|fsr
1321501|NCT01492010|resistance exercise|resistance exercise
1321502|NCT01492010|leucine|leucine
1321503|NCT01492010|protein|protein
1321504|NCT01491958|Leukemia|leukemia
1321505|NCT01491958|AML|aml
1321506|NCT01491958|ALL|all
1321507|NCT01491958|MDS|mds
1321508|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
1321509|NCT01491945|Renal stent|renal stent
1321510|NCT01491945|Juxtarenal|juxtarenal
1321511|NCT01491945|Pararenal|pararenal
1321512|NCT01491945|Endovascular|endovascular
1321513|NCT01491932|Parkinson Disease|parkinson disease
1321514|NCT01491932|L-dopa|l-dopa
1321515|NCT01491932|Levodopa|levodopa
1321516|NCT01491932|Dyskinesia|dyskinesia
1321517|NCT01491919|High Blood Pressure|high blood pressure
1321518|NCT01491919|Hypertension|hypertension
1321519|NCT01491919|Renal Transplantation|renal transplantation
1321520|NCT01491919|Kidney Transplantation|kidney transplantation
1321521|NCT01491893|GBM|gbm
1321522|NCT01491893|Brain Tumor|brain tumor
1321523|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
1321624|NCT01491555|EIM|eim
1321524|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
1321525|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
1321526|NCT01491880|telemedicine|telemedicine
1321527|NCT01491880|rural|rural
1321528|NCT01491880|Latinos|latinos
1321529|NCT01491880|children|children
1321530|NCT01491867|intraocular pressure|intraocular pressure
1321531|NCT01491854|Long-term|long-term
1321532|NCT01491854|safety|safety
1321533|NCT01491854|follow-up|follow-up
1321534|NCT01491854|growth hormone treatment|growth hormone treatment
1321535|NCT01491854|short children|short children
1321536|NCT01491854|Small for Gestational Age|small for gestational age
1321537|NCT01491854|Somatropin|somatropin
1321538|NCT01491828|Apnea|apnea
1321539|NCT01491828|Sleep apnea|sleep apnea
1321540|NCT01491828|Snoring|snoring
1321541|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
1321542|NCT01491828|Laynx stimulation|laynx stimulation
1321543|NCT01491802|COPD|copd
1321544|NCT01491802|Combination therapy|combination therapy
1321545|NCT01491802|Anticholinergic|anticholinergic
1321546|NCT01491802|Beta2-agonist|beta2-agonist
1321547|NCT01491802|Exercise|exercise
1321548|NCT01491802|Dyspnea|dyspnea
1321549|NCT01491802|Respiratory mechanics|respiratory mechanics
1321550|NCT01491789|spinal cord injury|spinal cord injury
1321551|NCT01491789|Virtual sailing|virtual sailing
1321552|NCT01491789|Vsail|vsail
1321553|NCT01491776|Group A Streptococcus|group a streptococcus
1321554|NCT01491776|Strep A|strep a
1321555|NCT01491776|Rapid Test|rapid test
1321556|NCT01491776|Pharyngitis|pharyngitis
1321557|NCT01491750|SURGERY|surgery
1321558|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
1321559|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
1321560|NCT01491750|GUIDED IMAGERY|guided imagery
1321561|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
1321562|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
1321563|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
1321564|NCT01491711|Skin diseases|skin diseases
1321565|NCT01491711|Connective tissue diseases|connective tissue diseases
1321566|NCT01491711|Treatment|treatment
1321567|NCT01491711|Drug therapy|drug therapy
1321568|NCT01491711|Efficacy|efficacy
1321569|NCT01491711|Photodynamic therapy|photodynamic therapy
1321570|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
1321571|NCT01491711|Aminolevulinic acid|aminolevulinic acid
1321572|NCT01491711|Methylaminolevulinate|methylaminolevulinate
1321573|NCT01491711|Pain measurement|pain measurement
1321574|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
1321575|NCT01491698|stomach|stomach
1321576|NCT01491698|surgery|surgery
1321577|NCT01491698|Total Gastrectomy|total gastrectomy
1321578|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
1321579|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
1321580|NCT01491698|Quality of Life|quality of life
1321581|NCT01491698|11-170|11-170
1321582|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1321583|NCT01491672|Second Line|second line
1321584|NCT01491672|Everolimus|everolimus
1321585|NCT01491672|RAD001|rad001
1321586|NCT01491646|pulmonary hypertension|pulmonary hypertension
1321587|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1321588|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
1321589|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
1321590|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
1321591|NCT01491633|Lung cancer|lung cancer
1321592|NCT01491633|NSCLC|nsclc
1321593|NCT01491633|Stage IIIB|stage iiib
1321594|NCT01491633|Stage IV|stage iv
1321595|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
1321596|NCT01491620|red dyschromia|red dyschromia
1321597|NCT01491620|brown dyschromia|brown dyschromia
1321598|NCT01491620|sun damage|sun damage
1321599|NCT01491620|neck|neck
1321600|NCT01491620|chest|chest
1321601|NCT01491620|dyschromia|dyschromia
1321602|NCT01491620|pigmentation disorders|pigmentation disorders
1321603|NCT01491620|erythema|erythema
1321604|NCT01491620|photosensitivity disorders|photosensitivity disorders
1321605|NCT01491620|sun exposure|sun exposure
1321606|NCT01491620|telangiectasia|telangiectasia
1321607|NCT01491620|hyperpigmentation|hyperpigmentation
1321608|NCT01491620|hypopigmentation|hypopigmentation
1321609|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
1321610|NCT01491607|toxin neutralization assay|toxin neutralization assay
1321611|NCT01491594|Metastatic sarcoma|metastatic sarcoma
1321612|NCT01491594|Bone sarcoma|bone sarcoma
1321613|NCT01491581|anthropometry|anthropometry
1321614|NCT01491581|zinc|zinc
1321615|NCT01491581|iodine|iodine
1321616|NCT01491581|vitamin D|vitamin d
1321617|NCT01491581|calcium|calcium
1321618|NCT01491581|school children|school children
1321619|NCT01491581|food supplement|food supplement
1321620|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
1321621|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1321623|NCT01491555|controls|controls
1321625|NCT01491555|QUS|qus
1321626|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
1321627|NCT01491529|Parkinson Disease|parkinson disease
1321628|NCT01491529|L-dopa|l-dopa
1321629|NCT01491529|Levodopa|levodopa
1321630|NCT01491529|Dyskinesia|dyskinesia
1321631|NCT01491529|Amantadine|amantadine
1321632|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
1321633|NCT01491503|montelukast|montelukast
1321634|NCT01491503|levocetirizine|levocetirizine
1321635|NCT01491503|interaction|interaction
1321636|NCT01491490|Schizophrenia|schizophrenia
1321637|NCT01491490|Functional psychosis|functional psychosis
1321638|NCT01491490|Schizophreniform|schizophreniform
1321639|NCT01491490|Acute psychosis|acute psychosis
1321640|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
1321641|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
1321642|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
1321643|NCT01491412|Schizophrenia|schizophrenia
1321644|NCT01491412|antipsychotics|antipsychotics
1321645|NCT01491412|real life treatment|real life treatment
1321646|NCT01491412|non-interventional|non-interventional
1321647|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
1321648|NCT01491373|Degenerative Disc Disease|degenerative disc disease
1321649|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
1321650|NCT01491360|Presbyopia|presbyopia
1321651|NCT01491360|sclera|sclera
1321652|NCT01491360|LaserACE|laserace
1321653|NCT01491347|BDNF|bdnf
1321654|NCT01491347|withdrawal|withdrawal
1321655|NCT01491347|alcohol|alcohol
1321656|NCT01491347|psychiatry|psychiatry
1321657|NCT01491334|POP|pop
1321658|NCT01491334|Pelvic Floor|pelvic floor
1321659|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
1321660|NCT01491321|chronic low back pain|chronic low back pain
1321661|NCT01491321|bee venom acupuncture|bee venom acupuncture
1321662|NCT01491295|Lamivudine|lamivudine
1321663|NCT01491295|adefovir add on treatment|adefovir add on treatment
1321664|NCT01491295|tenofovir|tenofovir
1321665|NCT01491295|chronic hepatitis B|chronic hepatitis b
1321666|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
1321667|NCT01491282|obesity|obesity
1321668|NCT01491282|energy metabolism|energy metabolism
1321669|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
1321670|NCT01491269|chronic pain|chronic pain
1321671|NCT01491269|internet delivered CBT|internet delivered cbt
1321672|NCT01491269|tertiary intervention|tertiary intervention
1321673|NCT01491269|mindfulness|mindfulness
1321674|NCT01491269|applied relaxation|applied relaxation
1321675|NCT01491269|guided self help|guided self help
1321676|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
1321677|NCT01491256|atorvastatin|atorvastatin
1321678|NCT01491256|drug-eluting stent|drug-eluting stent
1321679|NCT01491256|acute coronary syndrome|acute coronary syndrome
1321680|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
1321681|NCT01491230|cancer|cancer
1321682|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
1321683|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1321684|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1321685|NCT01491230|chemotaxis|chemotaxis
1321686|NCT01491230|superoxide production|superoxide production
1321687|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
1321688|NCT01491230|myeloperoxidase|myeloperoxidase
1321689|NCT01491217|Oraxol®|oraxol®
1321690|NCT01491217|oral paclitaxel|oral paclitaxel
1321691|NCT01491217|paclitaxel|paclitaxel
1321692|NCT01491217|HM30181A|hm30181a
1321693|NCT01491217|MTD|mtd
1321694|NCT01491217|DLT|dlt
1321695|NCT01491217|RD|rd
1321696|NCT01491191|surgical pain|surgical pain
1321697|NCT01491191|chronic pain|chronic pain
1321698|NCT01491191|prevention|prevention
1321699|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
1321700|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
1321701|NCT01491152|Cerebral Palsy|cerebral palsy
1321702|NCT01491152|Whole Body Vibration|whole body vibration
1321703|NCT01491152|Infant|infant
1321704|NCT01491152|Motor development|motor development
1321705|NCT01491152|Physiotherapy|physiotherapy
1321706|NCT01491139|Radiotherapy|radiotherapy
1321707|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
1321708|NCT01491139|Pharmacokinetics|pharmacokinetics
1321709|NCT01491139|Genetic Markers|genetic markers
1321710|NCT01491139|Cisplatin|cisplatin
1321711|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
1321712|NCT01491139|AZD 2281|azd 2281
1321713|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
1321714|NCT01491139|Head and Neck|head and neck
1321715|NCT01491139|Chemoradiotherapy|chemoradiotherapy
1321716|NCT01491139|SCC|scc
1321717|NCT01491126|Gastroscopy|gastroscopy
1321718|NCT01491126|Colonoscopy|colonoscopy
1321719|NCT01491126|Anesthesia|anesthesia
1321720|NCT01491126|Recovery|recovery
1321721|NCT01491113|Levetiracetam|levetiracetam
1321722|NCT01491113|Oral administration|oral administration
1321723|NCT01491113|Japanese|japanese
1321724|NCT01491113|Non-epileptic|non-epileptic
1321725|NCT01491113|Healthy|healthy
1321726|NCT01491113|Renal impaired subjects|renal impaired subjects
1321727|NCT01491100|Cognition|cognition
1321728|NCT01491100|Physical Activity|physical activity
1321729|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1321730|NCT01491087|Pentaxim®|pentaxim®
1321731|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
1321732|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
1321733|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
1321734|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
1321735|NCT01491087|Pentavac®|pentavac®
1321736|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
1321737|NCT01491061|ranolazine|ranolazine
1321738|NCT01491048|Hip osteoarthritis|hip osteoarthritis
1321739|NCT01491048|Physiotherapy|physiotherapy
1321740|NCT01491048|THA|tha
1321741|NCT01491035|Children|children
1321742|NCT01491035|Adolescents|adolescents
1321743|NCT01491035|Pharmacokinetic|pharmacokinetic
1321744|NCT01491035|Pharmacodynamic|pharmacodynamic
1321745|NCT01491022|parkinson's|parkinson's
1321746|NCT01491022|gait dysfunction|gait dysfunction
1321747|NCT01491022|ampyra|ampyra
1321748|NCT01491022|4-aminopyridine|4-aminopyridine
1321749|NCT01491009|Dexmedetomidine|dexmedetomidine
1321750|NCT01491009|midazolam|midazolam
1321751|NCT01491009|remifentanil|remifentanil
1321752|NCT01491009|mini-mental state examination|mini-mental state examination
1321753|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
1321754|NCT01491009|cystoscopy|cystoscopy
1321755|NCT01491009|sedation|sedation
1321756|NCT01490996|Curcumin|curcumin
1321757|NCT01490996|Colorectal cancer|colorectal cancer
1321758|NCT01490996|metastases|metastases
1321759|NCT01490996|FOLFOX|folfox
1321760|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
1321761|NCT01490983|Chronic Phase CML|chronic phase cml
1321762|NCT01490970|Sarcoma Database|sarcoma database
1321763|NCT01490957|HD|hd
1321764|NCT01490957|NHL|nhl
1321765|NCT01490931|acute pain|acute pain
1321766|NCT01490931|dental pain|dental pain
1321767|NCT01490931|intranasal ketorolac|intranasal ketorolac
1321768|NCT01490931|dental implant surgery|dental implant surgery
1321769|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
1321770|NCT01490918|Acarbose|acarbose
1321771|NCT01490918|ACADEMIC|academic
1321772|NCT01490905|Medical food|medical food
1321773|NCT01490905|Theramine|theramine
1321774|NCT01490905|Ibuprofen|ibuprofen
1321775|NCT01490905|Amino acids|amino acids
1321776|NCT01490905|Convenience Pack Kit|convenience pack kit
1321777|NCT01490892|breast abnormality|breast abnormality
1321778|NCT01490892|ultrasound imaging|ultrasound imaging
1321779|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
1620773|NCT00317213|Withdrawal|withdrawal
1321780|NCT01490892|subharmonic imaging|subharmonic imaging
1321781|NCT01490879|DFU|dfu
1321782|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
1321783|NCT01490879|Ulcers|ulcers
1321784|NCT01490879|Foot Ulcers|foot ulcers
1321785|NCT01490879|chronic wound|chronic wound
1321786|NCT01490879|wounds|wounds
1321787|NCT01490879|Nexagon|nexagon
1321788|NCT01490879|CoDa|coda
1321789|NCT01490866|Colorectal Cancer|colorectal cancer
1321790|NCT01490866|Axitinib|axitinib
1321791|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
1321792|NCT01490853|Ph pos CML|ph pos cml
1321793|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
1321794|NCT01490840|Fatigue|fatigue
1321795|NCT01490840|MS|ms
1321796|NCT01490840|Multiple Sclerosis|multiple sclerosis
1321797|NCT01490840|Exercise|exercise
1321798|NCT01490840|Physical activity|physical activity
1322400|NCT01488357|UNC|unc
1321799|NCT01490840|Physical training|physical training
1321800|NCT01490840|Fingolimod|fingolimod
1321801|NCT01490814|PAF|paf
1321802|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
1321803|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
1321804|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
1321805|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
1321806|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1321807|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1321808|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
1321809|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
1321810|NCT01490762|PK|pk
1321811|NCT01490762|PD|pd
1321812|NCT01490749|Esophageal Cancer|esophageal cancer
1321813|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
1321814|NCT01490736|Acne|acne
1321815|NCT01490736|Sebum gland disease|sebum gland disease
1321816|NCT01490723|Leukemia|leukemia
1321817|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1321818|NCT01490723|Lymphoma|lymphoma
1321819|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
1321820|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1321821|NCT01490723|Allogeneic transplantation|allogeneic transplantation
1321822|NCT01490723|Rituximab|rituximab
1321823|NCT01490723|Rituxan|rituxan
1321824|NCT01490723|In ibritumomab|in ibritumomab
1321825|NCT01490723|Y ibritumomab|y ibritumomab
1321826|NCT01490723|Zevalin|zevalin
1321827|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
1321828|NCT01490723|Fludara|fludara
1321829|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
1321830|NCT01490723|Bendamustine HCL|bendamustine hcl
1321831|NCT01490723|CEP-18083|cep-18083
1321832|NCT01490723|SDX-105|sdx-105
1321833|NCT01490723|Treanda|treanda
1321834|NCT01490723|Stem Cell Transplantation|stem cell transplantation
1321835|NCT01490723|Planar Scintigraphy|planar scintigraphy
1321836|NCT01490723|Spect Scan|spect scan
1321837|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
1321838|NCT01490723|CT Scan|ct scan
1321839|NCT01490723|Computed Tomography|computed tomography
1321840|NCT01490723|G-CSF|g-csf
1321841|NCT01490723|Filgrastim|filgrastim
1321842|NCT01490723|Neupogen|neupogen
1321843|NCT01490723|Thymoglobulin|thymoglobulin
1321844|NCT01490723|ATG|atg
1321845|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
1321846|NCT01490723|Methotrexate|methotrexate
1321847|NCT01490723|Mycophenolate|mycophenolate
1321848|NCT01490723|MMF|mmf
1321849|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
1321850|NCT01490723|CellCept|cellcept
1321851|NCT01490723|Tacrolimus|tacrolimus
1321852|NCT01490723|Prograf|prograf
1321853|NCT01490710|NAVA|nava
1321854|NCT01490710|Hemodynamic|hemodynamic
1321855|NCT01490710|Cardiac Index|cardiac index
1321856|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
1321857|NCT01490697|stress disorders|stress disorders
1321858|NCT01490697|posttraumatic|posttraumatic
1321859|NCT01490697|memory|memory
1321860|NCT01490697|mifepristone|mifepristone
1321861|NCT01490697|d-cycloserine|d-cycloserine
1321862|NCT01490697|psychophysiology|psychophysiology
1321863|NCT01490684|candidiasis|candidiasis
1321864|NCT01490684|critically ill|critically ill
1321865|NCT01490684|outcomes|outcomes
1321866|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
1321867|NCT01490645|QoL after ACS|qol after acs
1321868|NCT01490645|ASC Patients's needs|asc patients's needs
1321869|NCT01490632|Moderate|moderate
1321870|NCT01490632|Severe|severe
1321871|NCT01490632|Plaque|plaque
1321872|NCT01490632|Chronic|chronic
1321873|NCT01490619|Type 1 diabetes|type 1 diabetes
1321874|NCT01490619|Adolescent|adolescent
1321875|NCT01490619|Resilience|resilience
1321876|NCT01490619|Prevention|prevention
1321877|NCT01490619|Depression|depression
1321878|NCT01490593|Canadian|canadian
1321879|NCT01490593|Eye|eye
1321880|NCT01490593|Injury|injury
1321881|NCT01490593|Registry|registry
1321882|NCT01490580|Pain|pain
1321883|NCT01490580|Newborn|newborn
1321884|NCT01490580|Anaesthesia|anaesthesia
1321885|NCT01490580|opioids|opioids
1321886|NCT01490580|propofol|propofol
1321887|NCT01490580|neuromuscular blocker|neuromuscular blocker
1321888|NCT01490580|atropine|atropine
1321889|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
1321890|NCT01490554|Skin aging|skin aging
1321891|NCT01490554|fibroblasts|fibroblasts
1321892|NCT01490554|transplantation|transplantation
1321893|NCT01490554|autologous|autologous
1321894|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
1321895|NCT01490528|Pediatric IBD|pediatric ibd
1321896|NCT01490515|non-invasive,|non-invasive,
1321897|NCT01490515|metabolomics,|metabolomics,
1321898|NCT01490515|morphology,|morphology,
1321899|NCT01490515|embryo selection,|embryo selection,
1321900|NCT01490515|implantation rates|implantation rates
1321902|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
1321903|NCT01490489|Pre-eclampsia|pre-eclampsia
1321904|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
1321905|NCT01490489|prognosis|prognosis
1321906|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
1321907|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
1321908|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
1321909|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
1321910|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
1321911|NCT01490463|Treatment of|treatment of
1321912|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
1321913|NCT01490424|TREM-1;|trem-1;
1321914|NCT01490424|SNPs;|snps;
1321915|NCT01490424|prognosis|prognosis
1321916|NCT01490424|control（normal person）|control（normal person）
1321917|NCT01490411|Specific immunotherapy|specific immunotherapy
1321918|NCT01490411|SIT|sit
1321919|NCT01490411|SCIT|scit
1321920|NCT01490411|recombinant|recombinant
1321921|NCT01490398|Hypertension|hypertension
1321922|NCT01490398|Rosuvastatin|rosuvastatin
1321923|NCT01490398|Coronary flow reserve|coronary flow reserve
1322029|NCT01489969|Sleep maintenance|sleep maintenance
1321924|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
1321925|NCT01490359|randomized controlled trial|randomized controlled trial
1321926|NCT01490359|intervention studies|intervention studies
1321927|NCT01490359|South Africa|south africa
1321928|NCT01490359|men|men
1321929|NCT01490359|sexually behavior|sexually behavior
1321930|NCT01490359|social cognitive theory|social cognitive theory
1321931|NCT01490346|HIV 1|hiv 1
1321932|NCT01490346|Pharmacokinetics|pharmacokinetics
1321933|NCT01490346|Drug levels|drug levels
1321934|NCT01490346|Treatment naive|treatment naive
1321935|NCT01490320|Violence prevention|violence prevention
1321936|NCT01490320|Media|media
1321937|NCT01490320|Primary care|primary care
1321938|NCT01490320|Parenting|parenting
1321939|NCT01490307|parenting intervention|parenting intervention
1321940|NCT01490307|Family Check-Up|family check-up
1321941|NCT01490307|Anxiety Disorders|anxiety disorders
1321942|NCT01490307|Depression|depression
1321943|NCT01490307|Depressive Disorder|depressive disorder
1321944|NCT01490307|Conduct Disorder|conduct disorder
1321945|NCT01490307|Mental Disorders|mental disorders
1321946|NCT01490307|Behavioral Symptoms|behavioral symptoms
1321947|NCT01490307|Mood Disorders|mood disorders
1321948|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
1321949|NCT01490307|Substance-Related Disorders|substance-related disorders
1321950|NCT01490294|Cardiac MRI|cardiac mri
1321951|NCT01490294|gadobutrol|gadobutrol
1321952|NCT01490281|Fibromyalgia|fibromyalgia
1321953|NCT01490281|exercise|exercise
1321954|NCT01490281|physical activity|physical activity
1321955|NCT01490281|pain|pain
1321956|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
1321957|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
1321958|NCT01490268|Target-controlled infusion|target-controlled infusion
1321959|NCT01490268|Hydromorphone|hydromorphone
1321960|NCT01490268|Sufentanil|sufentanil
1321961|NCT01490268|after thoracotomy|after thoracotomy
1321962|NCT01490268|cardiac surgery|cardiac surgery
1321963|NCT01490255|platelet reactivity|platelet reactivity
1321964|NCT01490255|aspirin|aspirin
1321965|NCT01490255|clopidogrel|clopidogrel
1321966|NCT01490229|nutraceuticals|nutraceuticals
1321967|NCT01490229|statin|statin
1321968|NCT01490216|cocaine|cocaine
1321969|NCT01490216|lisdexamfetamine|lisdexamfetamine
1321970|NCT01490216|vyvanse|vyvanse
1321971|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
1321973|NCT01490203|Hepatectomy|hepatectomy
1321974|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
1321975|NCT01490203|Liver Function Tests|liver function tests
1321976|NCT01490177|Multiple food allergies|multiple food allergies
1321977|NCT01490151|Hormone|hormone
1321978|NCT01490151|Diabetes|diabetes
1321979|NCT01490151|Mellitus|mellitus
1321980|NCT01490151|Type 1|type 1
1321981|NCT01490151|Immune|immune
1321982|NCT01490151|Metabolic disorder|metabolic disorder
1321983|NCT01490138|β-D-Glucan test|β-d-glucan test
1321984|NCT01490138|IFI|ifi
1321985|NCT01490125|COPD|copd
1321986|NCT01490125|Dyspnea|dyspnea
1321987|NCT01490125|QVA149|qva149
1321988|NCT01490125|tiotropium|tiotropium
1321989|NCT01490073|Intrauterine device|intrauterine device
1321990|NCT01490073|Pain|pain
1321991|NCT01490073|Contraception|contraception
1321992|NCT01490073|Nitroglycerin|nitroglycerin
1321993|NCT01490073|Nitric oxide donor|nitric oxide donor
1321994|NCT01490073|Intrauterine device insertion|intrauterine device insertion
1321995|NCT01490060|cancer|cancer
1321996|NCT01490060|fosaprepitant|fosaprepitant
1321997|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
1321998|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
1321999|NCT01490060|CINV|cinv
1322000|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
1322001|NCT01490060|antiemetics|antiemetics
1322002|NCT01490060|adverse effect|adverse effect
1322003|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
1322004|NCT01490060|AI|ai
1322005|NCT01490060|AI and vincristine|ai and vincristine
1322006|NCT01490060|VAI|vai
1322007|NCT01490060|aprepitant|aprepitant
1322008|NCT01490060|prevention|prevention
1322009|NCT01490060|nausea|nausea
1322010|NCT01490060|vomiting|vomiting
1322011|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
1322012|NCT01490034|obesity|obesity
1322013|NCT01490034|energy intake|energy intake
1322014|NCT01490034|appetite|appetite
1322015|NCT01490034|food form|food form
1322016|NCT01490034|beverage|beverage
1322017|NCT01490034|learning|learning
1322018|NCT01490034|dietary compensation|dietary compensation
1322019|NCT01490021|Healthy young men|healthy young men
1322020|NCT01489995|Food effect|food effect
1322021|NCT01489995|GR181413A|gr181413a
1322022|NCT01489995|AT1001|at1001
1322023|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
1322024|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
1322025|NCT01489995|Pharmacokinetics|pharmacokinetics
1322026|NCT01489982|Parkinson's disease|parkinson's disease
1322027|NCT01489982|insomnia|insomnia
1322028|NCT01489969|sleep latency|sleep latency
1322327|NCT01488643|Obesity|obesity
1322030|NCT01489969|Sleep fragmentation|sleep fragmentation
1322031|NCT01489969|Polysomnography|polysomnography
1322032|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
1322033|NCT01489956|Immucothel|immucothel
1322034|NCT01489956|Native KLH|native klh
1322035|NCT01489956|Healthy volunteers|healthy volunteers
1322036|NCT01489956|Oral tolerance|oral tolerance
1322037|NCT01489956|Immunogenicity|immunogenicity
1322038|NCT01489956|Autoimmune diseases|autoimmune diseases
1322039|NCT01489930|Exercise|exercise
1322040|NCT01489930|Aging|aging
1322041|NCT01489930|Sarcopenia|sarcopenia
1322042|NCT01489930|Mitochondria|mitochondria
1322043|NCT01489917|radial artery occlusion|radial artery occlusion
1322044|NCT01489917|hemostasis|hemostasis
1322045|NCT01489917|coronary intervention|coronary intervention
1322046|NCT01489917|radial approach|radial approach
1322047|NCT01489904|drooling|drooling
1322048|NCT01489904|cerebral palsy|cerebral palsy
1322049|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
1322050|NCT01489891|Lidocaine|lidocaine
1322051|NCT01489891|Propofol|propofol
1322052|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
1322053|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
1322054|NCT01489878|Staphylococcus aureus|staphylococcus aureus
1322055|NCT01489878|Anti-bacterial agents|anti-bacterial agents
1322056|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
1322057|NCT01489878|Methicillin resistance|methicillin resistance
1322058|NCT01489878|Β-lactams|β-lactams
1322059|NCT01489878|Fluoroquinolones|fluoroquinolones
1322060|NCT01489878|Macrolides|macrolides
1322061|NCT01489878|Synergistin|synergistin
1322062|NCT01489878|General practitioners|general practitioners
1322063|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
1322064|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
1322065|NCT01489878|Community patients|community patients
1322066|NCT01489865|Pancreas cancer|pancreas cancer
1322067|NCT01489865|Veliparib|veliparib
1322068|NCT01489865|oxaliplatin|oxaliplatin
1322069|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
1322070|NCT01489852|GnRH antagonist|gnrh antagonist
1322071|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
1322072|NCT01489852|Ovarian stimulation|ovarian stimulation
1322073|NCT01489839|periodontal disease|periodontal disease
1322074|NCT01489839|biomarkers|biomarkers
1322075|NCT01489839|periodontal treatment|periodontal treatment
1322076|NCT01489839|clinical attachment level|clinical attachment level
1322077|NCT01489826|Cancer|cancer
1322078|NCT01489800|feeding|feeding
1322079|NCT01489800|complications|complications
1322080|NCT01489800|radical cystectomy|radical cystectomy
1322081|NCT01489787|Surgery|surgery
1322082|NCT01489787|Ultrasonic therapy|ultrasonic therapy
1322083|NCT01489787|Liver|liver
1322084|NCT01489761|long lesions|long lesions
1322085|NCT01489761|drug eluting stents|drug eluting stents
1322086|NCT01489735|GERD|gerd
1322087|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
1322088|NCT01489722|Leukemia|leukemia
1322089|NCT01489722|AML|aml
1322090|NCT01489722|AZD1208|azd1208
1322091|NCT01489709|overactive bladder|overactive bladder
1322092|NCT01489709|solifenacin|solifenacin
1322093|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
1322094|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
1322095|NCT01489709|satisfaction score|satisfaction score
1322096|NCT01489696|Pharmacokinetics|pharmacokinetics
1322097|NCT01489696|Mirabegron|mirabegron
1322098|NCT01489696|Tamsulosin|tamsulosin
1322099|NCT01489696|Phase 1|phase 1
1322100|NCT01489683|intubating conditions|intubating conditions
1322101|NCT01489683|propofol|propofol
1322102|NCT01489683|remifentanil|remifentanil
1322103|NCT01489683|topical lidocaine|topical lidocaine
1322104|NCT01489657|Obesity|obesity
1322105|NCT01489657|Bariatric Surgery|bariatric surgery
1322401|NCT01488357|Lineberger|lineberger
1322106|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
1322107|NCT01489657|Metabolite Profiling|metabolite profiling
1322108|NCT01489631|Epidural|epidural
1322109|NCT01489631|Local infiltration|local infiltration
1322110|NCT01489631|Knee|knee
1322111|NCT01489631|Arthroplasty|arthroplasty
1322112|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
1322113|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
1322114|NCT01489618|prime boost|prime boost
1322115|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
1322116|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
1322117|NCT01489553|Egg hypersensitivity|egg hypersensitivity
1322118|NCT01489553|egg allergy|egg allergy
1322119|NCT01489553|egg protein allergy|egg protein allergy
1322120|NCT01489540|Burn|burn
1322121|NCT01489540|Depth|depth
1322122|NCT01489540|Diagnosis|diagnosis
1322123|NCT01489540|Laser Doppler Imaging|laser doppler imaging
1322124|NCT01489527|Vaccine|vaccine
1322125|NCT01489527|Placebo|placebo
1322126|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
1322127|NCT01489527|HIV|hiv
1322128|NCT01489527|Human Immunodeficiency|human immunodeficiency
1322129|NCT01489527|Gardasil|gardasil
1322130|NCT01489527|HPV|hpv
1322131|NCT01489527|human papillomavirus|human papillomavirus
1322132|NCT01489514|peanut allergy|peanut allergy
1322133|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
1322134|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
1322135|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
1322136|NCT01489488|Relative bioavailability study|relative bioavailability study
1322137|NCT01489475|children|children
1322138|NCT01489475|congenital heart defects|congenital heart defects
1322139|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
1322140|NCT01489475|modified ultrafiltration|modified ultrafiltration
1322141|NCT01489475|angiopoietins|angiopoietins
1322142|NCT01489475|cytokines|cytokines
1322143|NCT01489462|Arthritis|arthritis
1322144|NCT01489462|Osteoarthritis|osteoarthritis
1322145|NCT01489462|Strength Training|strength training
1322146|NCT01489449|drug coated balloon|drug coated balloon
1322147|NCT01489449|NSTEMI|nstemi
1322148|NCT01489436|gallstone disease|gallstone disease
1322149|NCT01489436|cholecystectomy|cholecystectomy
1322150|NCT01489436|minimally invasive|minimally invasive
1322151|NCT01489436|surgical|surgical
1322152|NCT01489436|laparoscopic|laparoscopic
1322153|NCT01489436|single port|single port
1322154|NCT01489436|cytokine|cytokine
1322155|NCT01489423|stage IIIC melanoma|stage iiic melanoma
1322156|NCT01489423|stage IV melanoma|stage iv melanoma
1322157|NCT01489423|recurrent melanoma|recurrent melanoma
1322158|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
1322159|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
1322160|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
1322161|NCT01489384|DAS28|das28
1322162|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
1322163|NCT01489358|Antibody Response|antibody response
1322164|NCT01489358|Chikungunya Virus|chikungunya virus
1322165|NCT01489358|Immune Response|immune response
1322166|NCT01489358|Healthy Volunteer|healthy volunteer
1322167|NCT01489358|Humoral Inmunity|humoral inmunity
1322168|NCT01489358|Virus-like Particles|virus-like particles
1322169|NCT01489345|ONO-2952|ono-2952
1322170|NCT01489345|Healthy adult subjects|healthy adult subjects
1322171|NCT01489345|Multiple dose|multiple dose
1322172|NCT01489345|Safety|safety
1322173|NCT01489345|Tolerability|tolerability
1322174|NCT01489345|Pharmacokinetics|pharmacokinetics
1322175|NCT01489332|rectal cancer|rectal cancer
1322176|NCT01489332|capecitabine|capecitabine
1322177|NCT01489332|radiotherapy|radiotherapy
1322178|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
1322179|NCT01489319|inflammation|inflammation
1322180|NCT01489319|body composition|body composition
1322181|NCT01489319|hyperandrogenism|hyperandrogenism
1322182|NCT01489319|insulin resistance|insulin resistance
1322183|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
1322184|NCT01489306|RSV|rsv
1322185|NCT01489280|Temple Touch Pro|temple touch pro
1322186|NCT01489280|Medisim|medisim
1322187|NCT01489280|temperature|temperature
1322188|NCT01489280|surgery|surgery
1322189|NCT01489267|cerebellar ataxia|cerebellar ataxia
1322190|NCT01489267|hereditary disease|hereditary disease
1322191|NCT01489267|stem cell|stem cell
1322192|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
1322193|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
1322194|NCT01489254|glatiramer acetate,|glatiramer acetate,
1322195|NCT01489254|MRI,|mri,
1322196|NCT01489254|lesions,|lesions,
1322197|NCT01489254|MS relapse rate,|ms relapse rate,
1322198|NCT01489254|Copaxone|copaxone
1322199|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1322200|NCT01489241|Telemedicine|telemedicine
1322201|NCT01489228|Chagas Disease|chagas disease
1322202|NCT01489202|drug-eluting stent|drug-eluting stent
1322301|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
1322203|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
1322204|NCT01489176|Stress Echocardiography|stress echocardiography
1322205|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
1322206|NCT01489176|Regadenoson|regadenoson
1322207|NCT01489176|Optison|optison
1322208|NCT01489163|Gestational Diabetes|gestational diabetes
1322209|NCT01489163|Weight Loss|weight loss
1322210|NCT01489163|Physical Activity|physical activity
1322211|NCT01489163|Pregnancy|pregnancy
1322212|NCT01489163|Postpartum|postpartum
1322213|NCT01489163|Intervention|intervention
1322214|NCT01489150|Acute respiratory failure|acute respiratory failure
1322215|NCT01489150|Hypercapnia|hypercapnia
1322216|NCT01489150|Non invasive ventilation|non invasive ventilation
1322217|NCT01489150|End-tidal CO2|end-tidal co2
1322218|NCT01489124|Infection|infection
1322219|NCT01489124|Imipenem|imipenem
1322220|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1322221|NCT01489124|pharmacokinetic|pharmacokinetic
1322222|NCT01489124|pharmacodynamic|pharmacodynamic
1322223|NCT01489098|Body composition|body composition
1322224|NCT01489098|Protein Metabolism|protein metabolism
1322225|NCT01489085|ventilation|ventilation
1322226|NCT01489085|automated|automated
1322227|NCT01489033|Allergic rhinitis|allergic rhinitis
1322228|NCT01489033|Phleum pratense|phleum pratense
1322229|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
1322230|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
1322231|NCT01489020|Allergy|allergy
1322232|NCT01489020|Immunotherapy|immunotherapy
1322233|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
1322234|NCT01489020|D. pteronyssinus|d. pteronyssinus
1322235|NCT01489020|house dust allergy|house dust allergy
1322236|NCT01489007|vegetarian|vegetarian
1322237|NCT01489007|children|children
1322238|NCT01489007|iron|iron
1322239|NCT01489007|iron absorption|iron absorption
1322240|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
1322241|NCT01488981|Traumatic Brain Injury|traumatic brain injury
1322242|NCT01488981|TBI|tbi
1322243|NCT01488981|Arm Rehabilitation|arm rehabilitation
1322244|NCT01488981|electrical stimulation|electrical stimulation
1322245|NCT01488981|FES|fes
1322246|NCT01488968|high risk prostate cancer|high risk prostate cancer
1322247|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
1322248|NCT01488968|higher biological doses|higher biological doses
1322249|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
1322250|NCT01488968|Radiation Treatment|radiation treatment
1322251|NCT01488955|bacterial infection|bacterial infection
1322252|NCT01488942|HIV|hiv
1322253|NCT01488942|reinforcement|reinforcement
1322254|NCT01488942|medication adherence|medication adherence
1322255|NCT01488942|patient compliance|patient compliance
1322256|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
1322257|NCT01488916|Vitamin D|vitamin d
1322258|NCT01488916|Postprandial Glucose|postprandial glucose
1322259|NCT01488916|Type 2 Diabetes|type 2 diabetes
1322260|NCT01488903|genetic susceptibility|genetic susceptibility
1322261|NCT01488903|obesity|obesity
1322262|NCT01488903|body composition|body composition
1322263|NCT01488903|the metabolic syndrome|the metabolic syndrome
1322264|NCT01488903|women|women
1322265|NCT01488890|Dengue fever|dengue fever
1322266|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1322267|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
1322268|NCT01488890|Yellow Fever|yellow fever
1322269|NCT01488890|Flavivirus|flavivirus
1322270|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
1322271|NCT01488864|Hot flashes|hot flashes
1322272|NCT01488864|Vasomotor symptoms|vasomotor symptoms
1322273|NCT01488864|Menopause|menopause
1322274|NCT01488864|Applied Relaxation|applied relaxation
1322275|NCT01488864|Health Related Quality of Life|health related quality of life
1322276|NCT01488864|Salivary cortisol|salivary cortisol
1322277|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
1322278|NCT01488812|Hip-fracture|hip-fracture
1322279|NCT01488799|Anxiety|anxiety
1322280|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
1322281|NCT01488799|Motivational Interviewing|motivational interviewing
1322282|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
1322283|NCT01488799|Psychotherapy|psychotherapy
1322284|NCT01488786|Assistive Technology|assistive technology
1322285|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
1322286|NCT01488786|Sensory Substitution|sensory substitution
1322287|NCT01488773|asthma|asthma
1322288|NCT01488773|asthma control|asthma control
1322289|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
1322291|NCT01488773|leukotriene antagonist|leukotriene antagonist
1322292|NCT01488773|LTRA|ltra
1322293|NCT01488773|montelukast|montelukast
1322294|NCT01488773|fluticasone|fluticasone
1322295|NCT01488773|salmeterol|salmeterol
1322296|NCT01488773|observational study|observational study
1322297|NCT01488773|repeated measures|repeated measures
1322298|NCT01488773|retrospective|retrospective
1322299|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
1322300|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
1322302|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
1322303|NCT01488734|Vitamin D|vitamin d
1322304|NCT01488734|Mushroom|mushroom
1322305|NCT01488734|Cholecalciferol|cholecalciferol
1322306|NCT01488734|Prediabetes|prediabetes
1322307|NCT01488734|Metabolic Syndrome|metabolic syndrome
1322308|NCT01488708|Lupus|lupus
1322309|NCT01488708|SLE|sle
1322310|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
1322311|NCT01488708|Immune System Disease|immune system disease
1322312|NCT01488695|intubation|intubation
1322313|NCT01488695|double lumen tube|double lumen tube
1322314|NCT01488682|Head and neck cancer|head and neck cancer
1322315|NCT01488682|Neck dissection|neck dissection
1322316|NCT01488682|Harmonic scalpel|harmonic scalpel
1322317|NCT01488669|head and neck neoplasms|head and neck neoplasms
1322318|NCT01488669|neck dissection|neck dissection
1322319|NCT01488669|robotics|robotics
1322320|NCT01488656|Antioxidants|antioxidants
1322321|NCT01488656|Dietary supplements|dietary supplements
1322322|NCT01488656|Forced vital lung capacity|forced vital lung capacity
1322323|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
1322324|NCT01488656|Air pollution|air pollution
1322325|NCT01488643|Bronchospasm|bronchospasm
1322326|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
1322328|NCT01488630|substance abuse|substance abuse
1322329|NCT01488630|alcohol|alcohol
1322330|NCT01488630|drug|drug
1322331|NCT01488630|smoking|smoking
1322332|NCT01488630|HIV screening|hiv screening
1322333|NCT01488617|Surgery|surgery
1322334|NCT01488617|Psychosocial Factors|psychosocial factors
1322335|NCT01488617|Psychological Distress|psychological distress
1322336|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
1322337|NCT01488578|Overactive Bladder|overactive bladder
1322338|NCT01488578|Japanese|japanese
1322339|NCT01488578|Tolterodine|tolterodine
1322340|NCT01488578|Detrusitol|detrusitol
1322341|NCT01488578|Detrol|detrol
1322342|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
1322343|NCT01488552|pancreatic cancer|pancreatic cancer
1322344|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1322345|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
1322346|NCT01488552|pancreas|pancreas
1322347|NCT01488552|pancreatic|pancreatic
1322348|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1322349|NCT01488539|PTSD|ptsd
1322350|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
1322351|NCT01488539|Women|women
1322352|NCT01488539|Interpersonal violence|interpersonal violence
1322353|NCT01488539|psychological trauma|psychological trauma
1322354|NCT01488526|Hepatitis B|hepatitis b
1322355|NCT01488526|Vertical transmission|vertical transmission
1322356|NCT01488526|Pregnancy|pregnancy
1322357|NCT01488526|Antiviral treatment|antiviral treatment
1322358|NCT01488513|ABC294640|abc294640
1322359|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
1322360|NCT01488513|ABC-101|abc-101
1322361|NCT01488513|Medical University of South Carolina|medical university of south carolina
1322362|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
1322363|NCT01488500|Wood smoke|wood smoke
1322364|NCT01488500|inflammation|inflammation
1322365|NCT01488500|lung function|lung function
1322366|NCT01488500|arterial stiffness|arterial stiffness
1322367|NCT01488500|heart rate variability|heart rate variability
1322368|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
1322369|NCT01488487|HCC|hcc
1322370|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1322371|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
1322372|NCT01488487|Liver Cancer|liver cancer
1322373|NCT01488474|regional anesthesia|regional anesthesia
1322374|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
1322375|NCT01488474|diabetes|diabetes
1322376|NCT01488474|diabetic neuropathy|diabetic neuropathy
1322377|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
1322378|NCT01488461|Genetics|genetics
1322379|NCT01488461|Gene ATCAY|gene atcay
1322380|NCT01488461|Gene ABC7|gene abc7
1322381|NCT01488461|Cerebellar atrophy|cerebellar atrophy
1322382|NCT01488448|Hypertonic saline|hypertonic saline
1322383|NCT01488448|Bronchiolitis|bronchiolitis
1322384|NCT01488448|Infants|infants
1322385|NCT01488448|Wheezing|wheezing
1322386|NCT01488448|Nebulized|nebulized
1322387|NCT01488448|Bronchodilator|bronchodilator
1322388|NCT01488396|Cyclosporin|cyclosporin
1322389|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
1322390|NCT01488396|Dry eye|dry eye
1322391|NCT01488383|Hyperglycemia|hyperglycemia
1322392|NCT01488383|Diabetes|diabetes
1322393|NCT01488383|Blood glucose|blood glucose
1322394|NCT01488383|Hypertension|hypertension
1322395|NCT01488383|Anti hypertensive agents|anti hypertensive agents
1322396|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
1322397|NCT01488383|Anti hypertensive|anti hypertensive
1322398|NCT01488370|breathing tube placement|breathing tube placement
1322399|NCT01488357|Breast cancer|breast cancer
1322402|NCT01488357|Breast Reconstruction|breast reconstruction
1322403|NCT01488357|Mastectomy|mastectomy
1322404|NCT01488318|Cetuximab|cetuximab
1322405|NCT01488318|Dasatinib|dasatinib
1322406|NCT01488318|Squamous Cell|squamous cell
1322407|NCT01488318|Head and Neck|head and neck
1322408|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
1322409|NCT01488318|Recurrent|recurrent
1322410|NCT01488318|Metastatic|metastatic
1322411|NCT01488305|MNP|mnp
1322412|NCT01488305|AAMA program|aama program
1322413|NCT01488305|Nepal|nepal
1322414|NCT01488305|HFP|hfp
1322415|NCT01488305|IYCF|iycf
1322416|NCT01488305|BCC|bcc
1322417|NCT01488292|mental health|mental health
1322418|NCT01488292|social skills|social skills
1322419|NCT01488279|Pre-diabetes|pre-diabetes
1322420|NCT01488279|Impaired fasting glucose|impaired fasting glucose
1322421|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
1322422|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
1322423|NCT01488266|depression|depression
1322424|NCT01488266|depressive|depressive
1322425|NCT01488266|major|major
1322426|NCT01488266|aripiprazole|aripiprazole
1322427|NCT01488266|switching|switching
1322428|NCT01488266|augmentation|augmentation
1322429|NCT01488266|antidepressant|antidepressant
1322430|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1322431|NCT01488253|Graft vs Host disease|graft vs host disease
1322432|NCT01488253|Prevention|prevention
1322433|NCT01488253|Sirolimus|sirolimus
1322434|NCT01488253|Tacrolimus|tacrolimus
1322435|NCT01488240|burn|burn
1322436|NCT01488240|scar|scar
1322437|NCT01488240|laser|laser
1322438|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
1322439|NCT01488227|Vitamin D|vitamin d
1322440|NCT01488227|25(OH)D|25(oh)d
1322441|NCT01488227|athletes|athletes
1322442|NCT01488227|body composition|body composition
1322443|NCT01488227|inflammatory markers|inflammatory markers
1322444|NCT01488227|illness|illness
1322445|NCT01488227|injury|injury
1322446|NCT01488214|Systemic Sclerosis|systemic sclerosis
1322447|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
1322448|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
1322449|NCT01488201|Psoriasis|psoriasis
1322450|NCT01488188|Influenza vaccine|influenza vaccine
1322451|NCT01488188|nasal route|nasal route
1322452|NCT01488188|sublingual route|sublingual route
1322453|NCT01488188|immunogenicity|immunogenicity
1322454|NCT01488188|safety|safety
1322455|NCT01488175|TKA|tka
1322456|NCT01488175|RSA|rsa
1322457|NCT01488175|Tourniquet|tourniquet
1322458|NCT01488175|Arthroplasty|arthroplasty
1322459|NCT01488175|Knee|knee
1322460|NCT01488149|Fentanyl|fentanyl
1322461|NCT01488149|Bupivacaine|bupivacaine
1322462|NCT01488149|Nalbuphine|nalbuphine
1322463|NCT01488136|Type 1 diabetes|type 1 diabetes
1322464|NCT01488136|Hypoglycaemia|hypoglycaemia
1322465|NCT01488136|Diazoxide|diazoxide
1322466|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
1322467|NCT01488097|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
1322468|NCT01488097|Lysosomal Storage Disease|lysosomal storage disease
1322469|NCT01488097|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
1322470|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
1322471|NCT01488097|Acid lipase disease|acid lipase disease
1322472|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1620866|NCT00316810|Alemtuzumab|alemtuzumab
1322473|NCT01488097|LAL Deficiency|lal deficiency
1322474|NCT01488097|LIPA Deficiency|lipa deficiency
1322475|NCT01488097|Wolman disease|wolman disease
1322476|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
1322477|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
1322478|NCT01488084|Coronary artery disease|coronary artery disease
1322479|NCT01488071|Depression|depression
1322480|NCT01488071|Multimodal antidepressant|multimodal antidepressant
1322481|NCT01488045|Colonoscopy|colonoscopy
1322482|NCT01488045|Propofol|propofol
1322483|NCT01488045|Cancer Screening|cancer screening
1322484|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
1322485|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
1322486|NCT01488006|Total shoulder replacement|total shoulder replacement
1322487|NCT01488006|Osteoarthritis|osteoarthritis
1322488|NCT01488006|Multicenter study|multicenter study
1322489|NCT01487993|Obesity|obesity
1322490|NCT01487993|Children|children
1322491|NCT01487993|Adolescents|adolescents
1322492|NCT01487993|Metformin|metformin
1322493|NCT01487993|Insulin resistance|insulin resistance
1322494|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1322495|NCT01487967|ADHD|adhd
1322496|NCT01487967|Preferences|preferences
1322497|NCT01487967|Goals|goals
1322498|NCT01487967|Decision Making|decision making
1322499|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
1322500|NCT01487928|breastfed|breastfed
1322501|NCT01487928|human milk cream|human milk cream
1322502|NCT01487928|human milk fat|human milk fat
1322503|NCT01487928|caloric supplement|caloric supplement
1322504|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
1322505|NCT01487902|Chemotherapy-naive|chemotherapy-naive
1322506|NCT01487876|DNA vaccine|dna vaccine
1322507|NCT01487876|HBV|hbv
1322508|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
1322509|NCT01487876|T-cell|t-cell
1322510|NCT01487863|prostate cancer|prostate cancer
1322511|NCT01487863|prostate|prostate
1322512|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
1322513|NCT01487863|androgen-independent|androgen-independent
1322514|NCT01487863|androgen independent|androgen independent
1322515|NCT01487863|hormone insensitive|hormone insensitive
1322516|NCT01487863|hormone-insensitive|hormone-insensitive
1322517|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
1322518|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
1322519|NCT01487863|hormone-refractory|hormone-refractory
1322520|NCT01487863|hormone refractory|hormone refractory
1322521|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
1322522|NCT01487863|immune therapy|immune therapy
1322523|NCT01487863|immunotherapy|immunotherapy
1322524|NCT01487863|vaccine|vaccine
1322525|NCT01487863|dendritic cells|dendritic cells
1323604|NCT01483391|Depression|depression
1322526|NCT01487863|antigen-presenting cells|antigen-presenting cells
1322527|NCT01487863|antigen presenting cells|antigen presenting cells
1322528|NCT01487863|cancer vaccine|cancer vaccine
1322529|NCT01487863|therapeutic vaccine|therapeutic vaccine
1322530|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
1322531|NCT01487863|recombinant|recombinant
1322532|NCT01487863|biological|biological
1322533|NCT01487863|biopharmaceutical|biopharmaceutical
1322534|NCT01487863|biotechnology|biotechnology
1322535|NCT01487863|biotech|biotech
1322536|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
1322537|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
1322538|NCT01487863|castration-resistance|castration-resistance
1322539|NCT01487863|sipuleucel-T|sipuleucel-t
1322540|NCT01487863|abiraterone|abiraterone
1322541|NCT01487863|prednisone|prednisone
1322542|NCT01487863|sequence|sequence
1322543|NCT01487863|sequencing|sequencing
1322544|NCT01487850|wind instruments|wind instruments
1322545|NCT01487850|molds|molds
1322546|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
1322547|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
1322548|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
1322549|NCT01487850|musicians|musicians
1322550|NCT01487837|Fibrinogen|fibrinogen
1322551|NCT01487837|Blood coagulation disorders|blood coagulation disorders
1322552|NCT01487837|Postoperative bleeding|postoperative bleeding
1322553|NCT01487837|Transfusions|transfusions
1322554|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
1322555|NCT01487785|LDE225|lde225
1322556|NCT01487785|gemcitabine|gemcitabine
1322557|NCT01487785|locally advanced|locally advanced
1322558|NCT01487785|adenocarcinoma|adenocarcinoma
1322559|NCT01487746|APLA|apla
1322560|NCT01487746|APS|aps
1322561|NCT01487746|Stroke|stroke
1322562|NCT01487746|minor anti body|minor anti body
1322563|NCT01487746|major anti body|major anti body
1322564|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
1322565|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1333195|NCT01444040|Open angle glaucoma|open angle glaucoma
1322566|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1322567|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1322568|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1322569|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1322570|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1322571|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1322572|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1322573|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1322574|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1322575|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1322576|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1322577|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1322578|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1322579|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1322580|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1322581|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1322582|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
1322583|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
1322705|NCT01487330|aortic stenosis|aortic stenosis
1322584|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
1322585|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
1322586|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
1322587|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
1322588|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
1322589|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
1322590|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
1322591|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
1322592|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
1322593|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
1322594|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
1322595|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
1322596|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
1322597|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
1322598|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
1322599|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
1322600|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
1322601|NCT01487707|pregnancy|pregnancy
1322602|NCT01487707|maternal mortality|maternal mortality
1322603|NCT01487707|neonatal mortality|neonatal mortality
1322604|NCT01487707|community intervention|community intervention
1322605|NCT01487707|voluntary health worker|voluntary health worker
1322606|NCT01487707|safe birth kit|safe birth kit
1322607|NCT01487707|maternal child health|maternal child health
1322608|NCT01487694|back cohosh|back cohosh
1322609|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
1322610|NCT01487694|menopausal symptoms|menopausal symptoms
1322611|NCT01487694|hot flashes|hot flashes
1322612|NCT01487694|Kupperman index|kupperman index
1322613|NCT01487694|MENQOL|menqol
1322614|NCT01487668|chronic mental disorders|chronic mental disorders
1322615|NCT01487668|cardiovascular disease|cardiovascular disease
1322616|NCT01487668|behavior change|behavior change
1322617|NCT01487655|Open-angle glaucoma|open-angle glaucoma
1322618|NCT01487655|Low tension glaucoma|low tension glaucoma
1322619|NCT01487655|Color Doppler Imaging|color doppler imaging
1322620|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
1322621|NCT01487629|Macular Edema|macular edema
1322622|NCT01487629|Bevacizumab|bevacizumab
1322623|NCT01487629|Ranibizumab|ranibizumab
1322624|NCT01487616|Mullerian anomalies|mullerian anomalies
1322625|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
1322626|NCT01487616|Arcuate|arcuate
1322627|NCT01487616|Septate|septate
1322628|NCT01487616|Subseptate|subseptate
1322629|NCT01487616|Bicornuate|bicornuate
1322630|NCT01487616|Unicornuate|unicornuate
1322631|NCT01487616|Didelphys|didelphys
1322632|NCT01487616|T-shaped|t-shaped
1322633|NCT01487603|Patients|patients
1322634|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
1322635|NCT01487603|lymph nodes|lymph nodes
1322636|NCT01487590|pregnancy|pregnancy
1322637|NCT01487590|breech|breech
1322638|NCT01487590|acupuncture|acupuncture
1322639|NCT01487590|moxibustion|moxibustion
1322640|NCT01487590|version|version
1322641|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
1322642|NCT01487577|Graft versus host disease|graft versus host disease
1322643|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
1322644|NCT01487577|Pharmacokinetics|pharmacokinetics
1322645|NCT01487564|Healthy volunteers|healthy volunteers
1322646|NCT01487564|Pharmacokinetics|pharmacokinetics
1322647|NCT01487564|OROS Hydromorphone|oros hydromorphone
1322648|NCT01487564|Hydromorphone|hydromorphone
1322649|NCT01487564|Taiwan|taiwan
1322650|NCT01487564|UGT2B7 Gene|ugt2b7 gene
1322651|NCT01487551|Systemic sclerosis|systemic sclerosis
1322652|NCT01487551|Biomarkers|biomarkers
1322653|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
1322654|NCT01487525|partial blood flow restriction|partial blood flow restriction
1322655|NCT01487525|knee extensor strength|knee extensor strength
1322656|NCT01487512|Healthy Volunteers|healthy volunteers
1322657|NCT01487512|Dose Proportionality|dose proportionality
1322658|NCT01487512|Pharmacokinetics|pharmacokinetics
1322659|NCT01487512|OROS Hydromorphone|oros hydromorphone
1322660|NCT01487512|Hydromorphone|hydromorphone
1322661|NCT01487512|Taiwan|taiwan
1322662|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
1322663|NCT01487486|PCOS|pcos
1322664|NCT01487486|Follicular Fluid|follicular fluid
1322665|NCT01487486|Proteomics|proteomics
1322666|NCT01487486|Glyco-proteomics|glyco-proteomics
1322667|NCT01487473|Meditation|meditation
1322668|NCT01487473|Mindfulness|mindfulness
1322669|NCT01487473|Attention|attention
1322670|NCT01487473|Chronic Pain|chronic pain
1322671|NCT01487473|Depression|depression
1322672|NCT01487473|Anxiety|anxiety
1322673|NCT01487473|Stress|stress
1322674|NCT01487473|Acceptance|acceptance
1322675|NCT01487473|Pain intensity|pain intensity
1322676|NCT01487473|Pain disability|pain disability
1322677|NCT01487460|High cholesterol levels|high cholesterol levels
1322678|NCT01487460|Hyperlipidemia|hyperlipidemia
1322679|NCT01487460|High-density Lipoprotein|high-density lipoprotein
1322680|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
1322681|NCT01487460|Simvastatin|simvastatin
1322682|NCT01487434|Attendance|attendance
1322683|NCT01487434|Truancy|truancy
1322684|NCT01487434|Student engagement|student engagement
1322685|NCT01487434|Mentoring|mentoring
1322686|NCT01487434|Monitoring|monitoring
1322687|NCT01487434|Case management|case management
1322688|NCT01487395|Alzheimer|alzheimer
1322689|NCT01487395|Donepezil|donepezil
1322690|NCT01487395|biomarkers|biomarkers
1322691|NCT01487395|battery|battery
1322692|NCT01487395|cognition|cognition
1322693|NCT01487395|imaging|imaging
1322694|NCT01487395|neurophysiological|neurophysiological
1322695|NCT01487356|Colonoscopy|colonoscopy
1322696|NCT01487356|quality assurance|quality assurance
1322697|NCT01487356|withdrawal time|withdrawal time
1322698|NCT01487356|polyp detection rate|polyp detection rate
1322699|NCT01487343|Oral Chemotherapy|oral chemotherapy
1322700|NCT01487343|capecitabine|capecitabine
1322701|NCT01487343|questionnaire|questionnaire
1322702|NCT01487343|breast|breast
1322703|NCT01487343|gastric|gastric
1322704|NCT01487343|11-194|11-194
1322706|NCT01487330|aortic valve stenosis|aortic valve stenosis
1322707|NCT01487330|valvular heart disease|valvular heart disease
1322708|NCT01487330|aortic valve replacement|aortic valve replacement
1322709|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
1322711|NCT01487330|TAVR|tavr
1322712|NCT01487317|Delirium|delirium
1322713|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1322714|NCT01487317|Elderly|elderly
1322715|NCT01487317|Emergency department|emergency department
1322716|NCT01487291|Thrombophilia tests|thrombophilia tests
1322717|NCT01487291|Hypofibrinolysis|hypofibrinolysis
1322718|NCT01487291|Fibrinolysis|fibrinolysis
1322719|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
1322720|NCT01487278|prevention|prevention
1322721|NCT01487278|misoprostol|misoprostol
1322722|NCT01487278|Uniject|uniject
1322723|NCT01487278|oxytocin|oxytocin
1322724|NCT01487265|Erlotinib|erlotinib
1322725|NCT01487265|BKM120|bkm120
1322726|NCT01487265|NSCLC|nsclc
1322727|NCT01487226|Cervical cancer|cervical cancer
1322728|NCT01487213|Medical abortion|medical abortion
1322729|NCT01487213|Termination of pregnancy|termination of pregnancy
1322730|NCT01487213|Mifepristone|mifepristone
1322731|NCT01487213|Misoprostol|misoprostol
1322732|NCT01487213|Urine hCG|urine hcg
1322733|NCT01487213|Follow Up|follow up
1322734|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
1322735|NCT01487200|Osteoarthritis|osteoarthritis
1322736|NCT01487200|Knee|knee
1322737|NCT01487200|Steroid|steroid
1322738|NCT01487200|intra-articular|intra-articular
1322739|NCT01487200|injection|injection
1322740|NCT01487187|Cord-milking|cord-milking
1322741|NCT01487187|hemodynamic|hemodynamic
1322742|NCT01487187|preterm infants|preterm infants
1322743|NCT01487161|osteoarthritis|osteoarthritis
1322744|NCT01487161|knee|knee
1322745|NCT01487161|pain|pain
1322746|NCT01487161|corticosteroid|corticosteroid
1322747|NCT01487161|intra-articular|intra-articular
1322748|NCT01487161|injection|injection
1322749|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
1322750|NCT01487135|EVP-6124|evp-6124
1322751|NCT01487122|Diathermy|diathermy
1322752|NCT01487122|Neck Pain|neck pain
1322753|NCT01487109|Type 2 diabetes|type 2 diabetes
1322754|NCT01487109|chronic kidney disease|chronic kidney disease
1322755|NCT01487083|schizophrenia|schizophrenia
1322756|NCT01487083|LY2140023|ly2140023
1322757|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
1322758|NCT01487057|thyroid cancer|thyroid cancer
1322759|NCT01487057|dislipidemia|dislipidemia
1322760|NCT01487057|cardiovascular risk|cardiovascular risk
1322761|NCT01487044|DME|dme
1322762|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1322763|NCT01487031|multiple myeloma|multiple myeloma
1322764|NCT01487031|non-Hodgkin|non-hodgkin
1322765|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
1322766|NCT01487031|Music Therapy|music therapy
1322767|NCT01487031|Nausea|nausea
1322768|NCT01487031|Pain|pain
1322769|NCT01487018|Zygomatic Fractures|zygomatic fractures
1322770|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
1322771|NCT01487018|Facial Asymmetry|facial asymmetry
1322772|NCT01487005|ozone|ozone
1322773|NCT01487005|air pollution|air pollution
1322774|NCT01487005|vascular function|vascular function
1322775|NCT01487005|cardiac function|cardiac function
1322776|NCT01487005|inflammation|inflammation
1322777|NCT01486953|respiratory resistance|respiratory resistance
1322778|NCT01486953|lung compliance|lung compliance
1322779|NCT01486953|desflurane|desflurane
1322780|NCT01486953|sevoflurane|sevoflurane
1322781|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
1322782|NCT01486810|cocaine|cocaine
1322783|NCT01486810|lisdexamfetamine|lisdexamfetamine
1322784|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
1322785|NCT01486797|NOX-A12|nox-a12
1322786|NCT01486797|Bendamustine|bendamustine
1322787|NCT01486797|Rituximab|rituximab
1322788|NCT01486797|Spiegelmer|spiegelmer
1322789|NCT01486797|Chemosensitization|chemosensitization
1322790|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
1322791|NCT01486797|CXCL12|cxcl12
1322792|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
1322793|NCT01486784|non-M3 AML|non-m3 aml
1322794|NCT01486784|relapsed disease|relapsed disease
1322795|NCT01486784|primary refractory disease|primary refractory disease
1322796|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
1322797|NCT01486784|AML|aml
1322798|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1322799|NCT01486732|Cerebral Palsy|cerebral palsy
1322800|NCT01486732|Umbilical Cord Blood|umbilical cord blood
1322801|NCT01486732|FLT-PET|flt-pet
1322802|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
1322803|NCT01486719|dorsal branch|dorsal branch
1322804|NCT01486719|proper digital nerve|proper digital nerve
1322805|NCT01486719|palmar arterial arch|palmar arterial arch
1322806|NCT01486719|dorsal digital island flap|dorsal digital island flap
1322807|NCT01486706|Overactive Bladder|overactive bladder
1322808|NCT01486706|Gabapentin|gabapentin
1322809|NCT01486706|Quality of Life|quality of life
1322810|NCT01486706|Urodynamic|urodynamic
1322811|NCT01486706|safety|safety
1322812|NCT01486706|Efficacy|efficacy
1322813|NCT01486693|cytomegalovirus|cytomegalovirus
1322814|NCT01486693|uveitis|uveitis
1322815|NCT01486680|Gastric bypass|gastric bypass
1322816|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
1322817|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1322818|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
1322819|NCT01486680|Body composition analysis|body composition analysis
1322820|NCT01486667|focus of study instead|focus of study instead
1322821|NCT01486654|Cortical stimulation|cortical stimulation
1322822|NCT01486654|Ischemic Stroke|ischemic stroke
1322823|NCT01486654|Aphasia|aphasia
1322824|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
1322825|NCT01486641|femoral neck fracture|femoral neck fracture
1322826|NCT01486641|arthroplasty|arthroplasty
1322827|NCT01486641|surgical approach|surgical approach
1322828|NCT01486641|anterolateral|anterolateral
1322829|NCT01486641|posterolateral|posterolateral
1322830|NCT01486615|premedication|premedication
1322831|NCT01486615|premedicants|premedicants
1322832|NCT01486615|preoperative anxiety|preoperative anxiety
1322833|NCT01486615|melatonin|melatonin
1322834|NCT01486615|alprazolam|alprazolam
1322835|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1322836|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1322837|NCT01486589|emergency care|emergency care
1322838|NCT01486589|cardiac autonomic function|cardiac autonomic function
1322839|NCT01486589|deceleration capacity|deceleration capacity
1322840|NCT01486537|samples|samples
1322841|NCT01486537|children|children
1322842|NCT01486537|the age group 3-13 years|the age group 3-13 years
1322843|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
1322844|NCT01486524|predictive marker|predictive marker
1322845|NCT01486524|prospective-retrospective|prospective-retrospective
1322846|NCT01486524|propensity score|propensity score
1322847|NCT01486524|matched-patients trial|matched-patients trial
1322848|NCT01486511|Liver disease|liver disease
1322849|NCT01486511|Pulmonary embolism|pulmonary embolism
1322850|NCT01486511|Thrombophilia|thrombophilia
1322851|NCT01486511|Death|death
1322852|NCT01486485|renal replacement therapy|renal replacement therapy
1322853|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
1322854|NCT01486446|IEM|iem
1322855|NCT01486446|EM|em
1322856|NCT01486446|Erythromelalgia|erythromelalgia
1322857|NCT01486446|Erythermalgia|erythermalgia
1322858|NCT01486446|Red neuralgia|red neuralgia
1322859|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
1322860|NCT01486446|Vascular Disease|vascular disease
1322861|NCT01486446|Cardiovascular Disease|cardiovascular disease
1322862|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
1322863|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
1322864|NCT01486433|arachidonic acid|arachidonic acid
1322865|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
1322866|NCT01486433|simvastatin|simvastatin
1322867|NCT01486420|Quinell grade|quinell grade
1322868|NCT01486420|Open surgery|open surgery
1322869|NCT01486420|corticosteroid injections|corticosteroid injections
1322870|NCT01486420|randomized controlled trial|randomized controlled trial
1322871|NCT01486420|Trigger finger|trigger finger
1322872|NCT01486407|Airway management|airway management
1322873|NCT01486355|Mortality|mortality
1322874|NCT01486355|Morbidity|morbidity
1322875|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
1322876|NCT01486355|Growth|growth
1322877|NCT01486355|Measles infection|measles infection
1322878|NCT01486329|Pancreatic cancer|pancreatic cancer
1322879|NCT01486329|Cancer vaccine|cancer vaccine
1322880|NCT01486329|Gemcitabine|gemcitabine
1322881|NCT01486329|Inoperable|inoperable
1322882|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
1322883|NCT01486329|Locally advanced|locally advanced
1322884|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
1322885|NCT01486303|Skin Rejuvenation|skin rejuvenation
1322886|NCT01486303|Skin Aging|skin aging
1322887|NCT01486290|Intervention|intervention
1322888|NCT01486290|Cost Effective|cost effective
1322889|NCT01486290|Elderly|elderly
1322890|NCT01486290|Glycemic Control|glycemic control
1322891|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
1322892|NCT01486277|T-cell lymphoma|t-cell lymphoma
1322893|NCT01486277|Lymphoma|lymphoma
1322894|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1322895|NCT01486277|JNJ-26481585|jnj-26481585
1322896|NCT01486238|Diabetic Macular Edema|diabetic macular edema
1322897|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
1322898|NCT01486212|Oxidative markers|oxidative markers
1322899|NCT01486212|Inflammatory markers|inflammatory markers
1322900|NCT01486199|cystic fibrosis|cystic fibrosis
1322901|NCT01486199|mucociliary clearance|mucociliary clearance
1322902|NCT01486199|airway surface liquid|airway surface liquid
1322903|NCT01486199|nuclear medicine|nuclear medicine
1322904|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1322905|NCT01486186|Double-Blind Method|double-blind method
1322906|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
1322907|NCT01486186|Humans|humans
1322908|NCT01486186|Treatment Outcome|treatment outcome
1322909|NCT01486173|PUFA|pufa
1322910|NCT01486173|Iron|iron
1322911|NCT01486173|Neurological development|neurological development
1322912|NCT01486173|Premature infant|premature infant
1322913|NCT01486147|Food labeling|food labeling
1322914|NCT01486147|Nutrition|nutrition
1322915|NCT01486147|Memory|memory
1322916|NCT01486147|Diet|diet
1322917|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
1322918|NCT01486134|Radiofrequency ablation|radiofrequency ablation
1322919|NCT01486134|Multipolar mode|multipolar mode
1322920|NCT01486134|Recurrence|recurrence
1322921|NCT01486134|Cirrhosis|cirrhosis
1322922|NCT01486134|MR temperature monitoring|mr temperature monitoring
1322923|NCT01486134|large tumor|large tumor
1322924|NCT01486121|Surgery|surgery
1322925|NCT01486121|Critical illness|critical illness
1322926|NCT01486121|Mechanical ventilation|mechanical ventilation
1322927|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
1322928|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
1322929|NCT01486121|Analgesia|analgesia
1322930|NCT01486121|Treatment protocol|treatment protocol
1322931|NCT01486121|Nursing protocol|nursing protocol
1322932|NCT01486121|Outcome|outcome
1322933|NCT01486121|Pain|pain
1322934|NCT01486121|Neurological disorders|neurological disorders
1322935|NCT01486121|Delirium|delirium
1322936|NCT01486121|Muscular weakness|muscular weakness
1322937|NCT01486121|Psychological disorders|psychological disorders
1322938|NCT01486121|Anxiety|anxiety
1322939|NCT01486121|Depression|depression
1322940|NCT01486121|Stress disorders|stress disorders
1322941|NCT01486121|Post-Traumatic|post-traumatic
1322942|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
1322943|NCT01486082|OCA 10|oca 10
1322944|NCT01486082|Antibiogram|antibiogram
1322945|NCT01486082|Eradication|eradication
1322946|NCT01486069|Dentofacial Deformity|dentofacial deformity
1322947|NCT01486069|Orthognathic Surgery|orthognathic surgery
1322948|NCT01486069|Mandible|mandible
1322949|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
1322950|NCT01486056|epilepsy|epilepsy
1322951|NCT01486056|ECG|ecg
1322952|NCT01486056|device placement|device placement
1322953|NCT01486043|Induction chemotherapy|induction chemotherapy
1322954|NCT01486043|Transient hyperglycemia|transient hyperglycemia
1322955|NCT01486043|Metformin|metformin
1322956|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1322957|NCT01486043|Insulin resistance|insulin resistance
1322958|NCT01486043|Hyperglycemia|hyperglycemia
1322959|NCT01486043|Insulin|insulin
1322960|NCT01486030|Atherosclerosis|atherosclerosis
1322961|NCT01486030|Corus CAD|corus cad
1322962|NCT01486030|Age/Sex/Gene Expression Score|age/sex/gene expression score
1322963|NCT01486030|ASGES|asges
1322964|NCT01486030|Gene Expression|gene expression
1322965|NCT01486030|GES|ges
1322966|NCT01486030|CAD|cad
1322967|NCT01486030|CVD|cvd
1322968|NCT01486030|CHD|chd
1322969|NCT01486030|Precision Medicine|precision medicine
1322970|NCT01486030|Exercise Stress Test|exercise stress test
1322971|NCT01486030|Coronary Artery Disease|coronary artery disease
1322972|NCT01486030|Angina Pectoris|angina pectoris
1322973|NCT01486030|Chest Pain|chest pain
1322974|NCT01486030|Cardiovascular Disease|cardiovascular disease
1322975|NCT01486030|Coronary Heart Disease|coronary heart disease
1322976|NCT01486030|EXERCISE|exercise
1322978|NCT01486017|healthy subjects|healthy subjects
1322979|NCT01486017|bioavailability|bioavailability
1322980|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
1322981|NCT01486017|psoriasis|psoriasis
1322982|NCT01486017|transplantation|transplantation
1322983|NCT01486004|Hepatitis C Virus|hepatitis c virus
1322984|NCT01486004|TMC435|tmc435
1322985|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
1322986|NCT01486004|TMC435-C124|tmc435-c124
1322987|NCT01486004|HCV|hcv
1322988|NCT01486004|Hepatitis C|hepatitis c
1322989|NCT01486004|Hep C|hep c
1322990|NCT01486004|Healthy participants|healthy participants
1322991|NCT01485991|Hepatitis C|hepatitis c
1322992|NCT01485991|TMC435HPC3001|tmc435hpc3001
1322993|NCT01485991|TMC435|tmc435
1322994|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1322995|NCT01485991|HEP C|hep c
1322996|NCT01485991|Genotype 1|genotype 1
1322997|NCT01485991|Treatment experienced|treatment experienced
1322998|NCT01485991|Null responders|null responders
1322999|NCT01485991|Partial responders|partial responders
1323000|NCT01485978|Alport Syndrome|alport syndrome
1323805|NCT01482351|memory|memory
1323001|NCT01485978|chronic kidney disease|chronic kidney disease
1323002|NCT01485978|renal fibrosis|renal fibrosis
1323003|NCT01485978|nephroprotection|nephroprotection
1323004|NCT01485978|pediatric study|pediatric study
1323005|NCT01485965|Huntington Disease|huntington disease
1323006|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
1323007|NCT01485965|Brain Diseases|brain diseases
1323008|NCT01485965|Central Nervous System Diseases|central nervous system diseases
1323009|NCT01485965|Nervous System Diseases|nervous system diseases
1323010|NCT01485965|Dementia|dementia
1323011|NCT01485965|Chorea|chorea
1323012|NCT01485965|Dyskinesias|dyskinesias
1323013|NCT01485965|Movement Disorders|movement disorders
1323014|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
1323015|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
1323016|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
1323017|NCT01485965|Cognition Disorders|cognition disorders
1323018|NCT01485965|Mental Disorders|mental disorders
1323019|NCT01485952|Huntington Disease|huntington disease
1323020|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
1323021|NCT01485952|Brain Diseases|brain diseases
1323022|NCT01485952|Central Nervous System Diseases|central nervous system diseases
1323023|NCT01485952|Nervous System Diseases|nervous system diseases
1323024|NCT01485952|Dementia|dementia
1323025|NCT01485952|Chorea|chorea
1323026|NCT01485952|Dyskinesias|dyskinesias
1323027|NCT01485952|Movement Disorders|movement disorders
1323028|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
1323029|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
1323030|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
1323031|NCT01485952|Cognition Disorders|cognition disorders
1323032|NCT01485952|Mental Disorders|mental disorders
1323033|NCT01485939|lidocaine patch|lidocaine patch
1323034|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1323035|NCT01485913|Education|education
1323036|NCT01485913|Diabetes|diabetes
1323037|NCT01485913|Prevention complications|prevention complications
1323038|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
1323039|NCT01485887|Venlafaxine ER|venlafaxine er
1323040|NCT01485887|long-term extension|long-term extension
1323041|NCT01485887|Japan|japan
1323042|NCT01485874|BIBF 1120|bibf 1120
1323043|NCT01485835|Multiple Myeloma|multiple myeloma
1323044|NCT01485835|Bortezomib|bortezomib
1323045|NCT01485835|Velcade|velcade
1323046|NCT01485835|Ganetespib|ganetespib
1323047|NCT01485822|Glaucoma|glaucoma
1323048|NCT01485822|Travatan|travatan
1323049|NCT01485822|Trabeculectomy|trabeculectomy
1323050|NCT01485796|PIDD|pidd
1323051|NCT01485783|Hypertension|hypertension
1323052|NCT01485757|patients|patients
1323053|NCT01485744|metastatic|metastatic
1323054|NCT01485744|untreated|untreated
1323055|NCT01485744|advanced|advanced
1323056|NCT01485731|Cervical|cervical
1323057|NCT01485731|Cancer|cancer
1323058|NCT01485731|Uterine Cervix|uterine cervix
1323059|NCT01485731|Squamous Cell|squamous cell
1323060|NCT01485731|Adenocarcinoma|adenocarcinoma
1323061|NCT01485718|Obesity|obesity
1323062|NCT01485718|Overweight|overweight
1323063|NCT01485718|Weight loss|weight loss
1323064|NCT01485705|severe bacterial infection|severe bacterial infection
1323065|NCT01485692|Violence|violence
1323066|NCT01485692|Aggression|aggression
1323067|NCT01485692|Psychiatric emergencies|psychiatric emergencies
1323068|NCT01485692|Psychomotor agitation|psychomotor agitation
1323069|NCT01485692|Violent patient|violent patient
1323070|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
1323071|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
1323072|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
1323073|NCT01485679|pancreas|pancreas
1323074|NCT01485666|Thoratec|thoratec
1323075|NCT01485666|HeartMate II|heartmate ii
1323076|NCT01485666|heart-assist devices|heart-assist devices
1323077|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
1323078|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
1323079|NCT01485653|Brachial Plexus|brachial plexus
1323080|NCT01485653|Mepivacaine|mepivacaine
1323081|NCT01485653|Ultrasound|ultrasound
1323082|NCT01485653|Axillary|axillary
1323083|NCT01485653|Block|block
1323084|NCT01485640|Schizophrenia|schizophrenia
1323085|NCT01485640|bipolar disorder|bipolar disorder
1323086|NCT01485640|Lurasidone|lurasidone
1323087|NCT01485640|Latuda|latuda
1323088|NCT01485627|Cancer|cancer
1323089|NCT01485627|Communication|communication
1323090|NCT01485627|prognosis|prognosis
1323091|NCT01485575|Chromovitrectomy|chromovitrectomy
1323092|NCT01485575|Indocyanine green|indocyanine green
1323094|NCT01485575|Brilliant Blue G|brilliant blue g
1323095|NCT01485575|BBG|bbg
1323096|NCT01485575|Trypan blue|trypan blue
1323097|NCT01485575|TB|tb
1323098|NCT01485575|Internal limiting membrane|internal limiting membrane
1323099|NCT01485575|ILM|ilm
1323806|NCT01482351|function|function
1323100|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
1323101|NCT01485562|misoprostol|misoprostol
1323102|NCT01485562|treatment|treatment
1323103|NCT01485562|prophylaxis|prophylaxis
1323104|NCT01485562|home births|home births
1323105|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
1323106|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
1323107|NCT01485549|biological markers|biological markers
1323108|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
1323109|NCT01485549|plasma|plasma
1323110|NCT01485536|Lymphoma|lymphoma
1323111|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
1323112|NCT01485536|AUY922|auy922
1323113|NCT01485523|Allergic rhinitis|allergic rhinitis
1323114|NCT01485523|Nasal provocation test|nasal provocation test
1323115|NCT01485510|Maltreatment|maltreatment
1323116|NCT01485510|Infant Mental Health|infant mental health
1323117|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
1323118|NCT01485497|APNEA|apnea
1323119|NCT01485471|Middle Ear Infection|middle ear infection
1323120|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
1323121|NCT01485458|Cervical canal stenosis|cervical canal stenosis
1323122|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
1323123|NCT01485458|Surgery|surgery
1323124|NCT01485458|Decompression|decompression
1323125|NCT01485445|bioequivalence|bioequivalence
1323126|NCT01485445|pharmacokinetics|pharmacokinetics
1323127|NCT01485445|Fluticasone Furoate|fluticasone furoate
1323128|NCT01485445|Vilanterol|vilanterol
1323129|NCT01485432|Renal transplant surgery|renal transplant surgery
1323130|NCT01485432|hemodynamic management|hemodynamic management
1323131|NCT01485432|PiCCO|picco
1323132|NCT01485432|delayed graft function|delayed graft function
1323133|NCT01485419|Sex hormones|sex hormones
1323134|NCT01485419|Testosterone|testosterone
1323135|NCT01485419|Estradiol|estradiol
1323136|NCT01485406|Haemophilus influenzae|haemophilus influenzae
1323137|NCT01485406|Safety|safety
1323138|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
1323139|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
1323140|NCT01485406|Immunogenicity|immunogenicity
1323141|NCT01485406|Toddlers|toddlers
1323142|NCT01485380|Dexmedetomidine|dexmedetomidine
1323143|NCT01485380|Sleep|sleep
1323144|NCT01485380|MRI-PET|mri-pet
1323145|NCT01485380|EEG|eeg
1323146|NCT01485367|Senile Purpura|senile purpura
1323147|NCT01485367|Adapalene 0.3%|adapalene 0.3%
1323148|NCT01485354|Stroke|stroke
1323149|NCT01485354|Rehabilitation|rehabilitation
1323150|NCT01485341|gluten sensitivity|gluten sensitivity
1323151|NCT01485328|Dyspepsia|dyspepsia
1323152|NCT01485328|Flatulence|flatulence
1323153|NCT01485328|Aerophagia|aerophagia
1323154|NCT01485328|Constipation|constipation
1323155|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
1323156|NCT01485276|Parkinson's Disease|parkinson's disease
1323157|NCT01485276|Deep Brain Stimulation|deep brain stimulation
1323158|NCT01485276|Gait|gait
1323159|NCT01485276|Electrophysiology|electrophysiology
1323160|NCT01485276|Parkinson Disease|parkinson disease
1323161|NCT01485276|PD|pd
1323162|NCT01485263|Deep Brain Stimulation|deep brain stimulation
1323163|NCT01485263|OCD|ocd
1323164|NCT01485250|Healthy Volunteers|healthy volunteers
1323165|NCT01485250|Motivations|motivations
1323166|NCT01485250|Decision Making|decision making
1323167|NCT01485250|Motivation|motivation
1323168|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1323169|NCT01485224|Epistaxis|epistaxis
1323170|NCT01485224|Thalidomide|thalidomide
1323171|NCT01485211|progressive keratoconus|progressive keratoconus
1323172|NCT01485211|thin corneas|thin corneas
1323173|NCT01485211|cross-linking|cross-linking
1323174|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
1323175|NCT01485198|osteoarthritis|osteoarthritis
1323176|NCT01485198|knee|knee
1323177|NCT01485198|stem cell therapy|stem cell therapy
1323178|NCT01485198|bone marrow|bone marrow
1323179|NCT01485198|G-CSF|g-csf
1323180|NCT01485185|Donepezil|donepezil
1323181|NCT01485185|allodynia|allodynia
1323182|NCT01485185|Gabapentin|gabapentin
1323183|NCT01485185|Sural nerve stimulation|sural nerve stimulation
1323184|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
1323185|NCT01485159|prevalence|prevalence
1323186|NCT01485159|COPD|copd
1323187|NCT01485159|emphysema|emphysema
1323188|NCT01485159|co-morbidities|co-morbidities
1323189|NCT01485159|ischemic heart disease|ischemic heart disease
1323190|NCT01485159|chronic bronchitis|chronic bronchitis
1323191|NCT01485159|spirometry|spirometry
1323192|NCT01485159|burden|burden
1323193|NCT01485133|colonoscopy|colonoscopy
1323194|NCT01485133|water|water
1323195|NCT01485133|surgery|surgery
1323196|NCT01485133|unsedated|unsedated
1323197|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
1323198|NCT01485107|Ulthera® System|ulthera® system
1323199|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
1323200|NCT01485107|Ulthera, Inc.|ulthera, inc.
1323201|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1323202|NCT01485094|neuralgia|neuralgia
1323203|NCT01485094|postherpetic|postherpetic
1323204|NCT01485081|Bifurcation|bifurcation
1323205|NCT01485081|Drug-eluting balloon|drug-eluting balloon
1323206|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
1323207|NCT01485081|Angioplasty|angioplasty
1323208|NCT01485081|Coronary artery disease|coronary artery disease
1323209|NCT01485081|Coronary artery stenosis|coronary artery stenosis
1323210|NCT01485068|Restenosis|restenosis
1323211|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
1323212|NCT01485068|Angioplasty|angioplasty
1323213|NCT01485068|Coronary artery disease|coronary artery disease
1323214|NCT01485068|Coronary artery stenosis|coronary artery stenosis
1323215|NCT01485055|aGVHD|agvhd
1323216|NCT01485055|GVHD|gvhd
1323217|NCT01485055|Graft versus host disease|graft versus host disease
1323218|NCT01485055|Acute graft versus host disease|acute graft versus host disease
1323219|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
1323220|NCT01485055|Bone marrow transplant|bone marrow transplant
1323221|NCT01485055|BMT|bmt
1323222|NCT01485055|HSCT|hsct
1323223|NCT01485055|infliximab|infliximab
1323224|NCT01485055|basiliximab|basiliximab
1323225|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
1323226|NCT01485042|Phase 1|phase 1
1323227|NCT01485042|pazopanib|pazopanib
1323228|NCT01485042|TH-302|th-302
1323229|NCT01485042|advanced solid tumors|advanced solid tumors
1323230|NCT01485016|epilepsy|epilepsy
1323231|NCT01485016|ECG|ecg
1323232|NCT01485016|accelerometer|accelerometer
1323233|NCT01484990|Parkinson's Disease|parkinson's disease
1323234|NCT01484990|levodopa|levodopa
1323235|NCT01484990|carbidopa|carbidopa
1323236|NCT01484990|Duodopa|duodopa
1323237|NCT01484990|intestinal gel|intestinal gel
1323238|NCT01484977|Lacosamide|lacosamide
1323239|NCT01484977|Epilepsy|epilepsy
1323240|NCT01484977|Levetiracetam|levetiracetam
1323241|NCT01484977|Sodium Channel Blockers|sodium channel blockers
1323242|NCT01484964|ASP015K|asp015k
1323243|NCT01484964|healthy subjects|healthy subjects
1323244|NCT01484964|bioavailability|bioavailability
1323245|NCT01484964|food effect|food effect
1323246|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
1323247|NCT01484964|psoriasis|psoriasis
1323248|NCT01484964|transplantation|transplantation
1323249|NCT01484951|Open-angle glaucoma|open-angle glaucoma
1323250|NCT01484951|Ocular hypertension|ocular hypertension
1323251|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
1323252|NCT01484938|Soft contact lenses|soft contact lenses
1323253|NCT01484938|Multi-purpose solution|multi-purpose solution
1323254|NCT01484938|Corneal staining|corneal staining
1323255|NCT01484925|Barrett's esophagus|barrett's esophagus
1323256|NCT01484912|Green tea polyphenols|green tea polyphenols
1323257|NCT01484912|Chronic Stable Angina|chronic stable angina
1323258|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
1323259|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1323260|NCT01484899|smoking|smoking
1323261|NCT01484886|Hemoglobin|hemoglobin
1323262|NCT01484886|Congenital heart disease|congenital heart disease
1323263|NCT01484886|Cardiac surgery|cardiac surgery
1323264|NCT01484886|Red blood cell transfusion|red blood cell transfusion
1323265|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
1323266|NCT01484873|Exenatide|exenatide
1323267|NCT01484873|Byetta|byetta
1323268|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
1323269|NCT01484873|Obesity|obesity
1323270|NCT01484873|Craniopharyngioma|craniopharyngioma
1323271|NCT01484860|AUY922|auy922
1323272|NCT01484860|Pancreas|pancreas
1323273|NCT01484860|Pancreatic cancer|pancreatic cancer
1323274|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1323275|NCT01484860|Cancer of the pancreas|cancer of the pancreas
1323276|NCT01484860|Metastatic|metastatic
1323277|NCT01484860|Advanced|advanced
1323278|NCT01484860|Advanced disease|advanced disease
1323279|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
1323280|NCT01484847|advanced|advanced
1323281|NCT01484847|PF-00299804|pf-00299804
1323282|NCT01484847|head and neck|head and neck
1323283|NCT01484847|pharmacokinetic|pharmacokinetic
1323284|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
1323285|NCT01484847|gastrojejunostomy|gastrojejunostomy
1323286|NCT01484847|feeding tube|feeding tube
1323287|NCT01484834|Physical Activity|physical activity
1323288|NCT01484834|Occupational Health|occupational health
1323289|NCT01484834|Quality of Life|quality of life
1323290|NCT01484834|Health Promotion|health promotion
1323291|NCT01484821|Sarcopenia|sarcopenia
1323292|NCT01484821|ARFI|arfi
1323293|NCT01484821|DEXA|dexa
1323294|NCT01484821|Cancer|cancer
1323295|NCT01484808|PSA Density|psa density
1323296|NCT01484808|Prostate Cancer|prostate cancer
1323297|NCT01484808|Prostate Biopsy|prostate biopsy
1323298|NCT01484808|PSA|psa
1323299|NCT01484795|noninvasive ventilation|noninvasive ventilation
1323300|NCT01484795|autonomic nervous system|autonomic nervous system
1323301|NCT01484782|Hypertension|hypertension
1323302|NCT01484782|Telephone Care Management|telephone care management
1323303|NCT01484782|Blood pressure|blood pressure
1323304|NCT01484782|Medication adherence|medication adherence
1323305|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
1323306|NCT01484782|Cloud computing|cloud computing
1323307|NCT01484756|respiratory infection|respiratory infection
1323308|NCT01484756|independent elderly|independent elderly
1323309|NCT01484756|zinc|zinc
1323310|NCT01484756|vitamins|vitamins
1323311|NCT01484743|recurrence|recurrence
1323312|NCT01484743|readmission|readmission
1323313|NCT01484743|reoperation|reoperation
1323314|NCT01484743|mortality|mortality
1323315|NCT01484743|morbidity|morbidity
1323316|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
1323317|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1323318|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
1323319|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1323320|NCT01484678|Muscle|muscle
1323321|NCT01484665|PSA screening|psa screening
1323322|NCT01484665|Decision aids|decision aids
1323323|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
1323324|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
1323325|NCT01484652|Bunionectomy|bunionectomy
1323326|NCT01484639|transfusion|transfusion
1323327|NCT01484639|cardiac surgery|cardiac surgery
1323328|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
1323329|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
1323330|NCT01484626|Bendamustine|bendamustine
1323331|NCT01484626|Bortezomib|bortezomib
1323332|NCT01484626|Lenalidomide|lenalidomide
1323333|NCT01484626|Dexamethasone|dexamethasone
1323334|NCT01484626|Treanda|treanda
1323335|NCT01484626|Velcade|velcade
1323336|NCT01484626|Revlimid|revlimid
1323337|NCT01484613|Hear Failure|hear failure
1323338|NCT01484613|Cardiac resynchronization|cardiac resynchronization
1323339|NCT01484613|CRT-D|crt-d
1323340|NCT01484613|quadripolar|quadripolar
1323341|NCT01484600|Volunteers|volunteers
1323342|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
1323343|NCT01484587|Psoriasis|psoriasis
1323344|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
1323345|NCT01484587|CNTO 1959|cnto 1959
1323346|NCT01484587|Japanese participants|japanese participants
1323347|NCT01484574|Critical limb ischemia|critical limb ischemia
1323348|NCT01484574|Buerger's disease|buerger's disease
1323349|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
1323350|NCT01484561|Phase 1|phase 1
1323351|NCT01484522|Influenza|influenza
1323352|NCT01484522|Perinatal|perinatal
1323353|NCT01484522|immunogenicity|immunogenicity
1323354|NCT01484522|Monovalent vaccine|monovalent vaccine
1323355|NCT01484522|Children|children
1323356|NCT01484522|Youth|youth
1323357|NCT01484522|H1N1|h1n1
1323358|NCT01484522|Adolescent|adolescent
1323359|NCT01484522|Flu|flu
1323360|NCT01484509|walking impairment|walking impairment
1323361|NCT01484509|claudication|claudication
1323362|NCT01484509|treadmill|treadmill
1323363|NCT01484509|questionnaire|questionnaire
1323364|NCT01484496|Subcutaneous|subcutaneous
1323365|NCT01484496|Lupus|lupus
1323366|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
1323367|NCT01484496|SLE|sle
1323368|NCT01484496|Belimumab|belimumab
1323369|NCT01484496|Autoimmune Disease|autoimmune disease
1323370|NCT01484496|Antibodies|antibodies
1323371|NCT01484470|Stem cell transplantation|stem cell transplantation
1323372|NCT01484470|Stem Cell expansion|stem cell expansion
1323373|NCT01484470|Elderly|elderly
1323374|NCT01484457|Diabetes Mellitus|diabetes mellitus
1323375|NCT01484457|Closed Loop|closed loop
1323376|NCT01484457|Artificial Pancreas|artificial pancreas
1323377|NCT01484418|Chronic Low Back Pain|chronic low back pain
1323378|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
1323379|NCT01484418|Exposure|exposure
1323380|NCT01484418|Fear avoidance|fear avoidance
1323477|NCT01483898|critical limb ischemia|critical limb ischemia
1323381|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
1323382|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
1323383|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
1323384|NCT01484392|open angle glaucoma|open angle glaucoma
1323385|NCT01484392|compliance|compliance
1323386|NCT01484392|adherence|adherence
1323387|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
1323388|NCT01484379|multigland disease|multigland disease
1323389|NCT01484379|neck exploration|neck exploration
1323390|NCT01484379|elderly|elderly
1323391|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
1323392|NCT01484353|Diabetes|diabetes
1323393|NCT01484340|smoking|smoking
1323394|NCT01484340|administration, cutaneous|administration, cutaneous
1323395|NCT01484327|Heart Failure|heart failure
1323396|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
1323397|NCT01484327|LVEF|lvef
1323398|NCT01484314|Relapsed|relapsed
1323399|NCT01484301|Chronic pain|chronic pain
1323400|NCT01484301|Opioids|opioids
1323401|NCT01484301|Tolerability|tolerability
1323402|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
1323403|NCT01484275|Multiple myeloma|multiple myeloma
1323404|NCT01484275|Siltuximab|siltuximab
1323405|NCT01484249|embolic|embolic
1323406|NCT01484249|filters|filters
1323407|NCT01484249|brachiocephalic|brachiocephalic
1323408|NCT01484249|neurovasculature|neurovasculature
1323409|NCT01484249|debris|debris
1323410|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1323411|NCT01484223|Primary Health Care|primary health care
1323412|NCT01484223|Somatization symptoms|somatization symptoms
1323413|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
1323414|NCT01484223|Nursing intervention|nursing intervention
1323415|NCT01484197|Asthma|asthma
1323416|NCT01484197|Indacaterol|indacaterol
1323417|NCT01484197|QAB149|qab149
1323418|NCT01484184|Completely paralyzed|completely paralyzed
1323419|NCT01484184|Chronically injured|chronically injured
1323420|NCT01484184|Central Pattern Generator|central pattern generator
1323421|NCT01484184|Locomotion|locomotion
1323422|NCT01484184|Secondary complications|secondary complications
1323423|NCT01484184|Activity-based training|activity-based training
1323424|NCT01484184|Treadmill training|treadmill training
1323425|NCT01484184|Spinal cord injury|spinal cord injury
1323426|NCT01484184|Paraplegia|paraplegia
1323427|NCT01484184|Tetraplegia|tetraplegia
1323428|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
1323429|NCT01484171|idarubicin|idarubicin
1323430|NCT01484171|Microtransplantation|microtransplantation
1323431|NCT01484158|Myocardial Infarction|myocardial infarction
1323432|NCT01484145|Onychomycosis|onychomycosis
1323433|NCT01484145|Nail fungus|nail fungus
1323434|NCT01484145|Tinea Unguium|tinea unguium
1323435|NCT01484132|Dental Caries|dental caries
1323436|NCT01484132|Dental Restorative Materials|dental restorative materials
1323437|NCT01484132|Dental Composite|dental composite
1323438|NCT01484132|Bisphenol-A|bisphenol-a
1323439|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
1323440|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1323441|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
1323442|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
1323443|NCT01484093|PREDNISONE|prednisone
1323444|NCT01484093|RITUXIMAB|rituximab
1323445|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
1323446|NCT01484093|Iodine|iodine
1323447|NCT01484093|VINCRISTIN|vincristin
1323448|NCT01484093|Lymphoma|lymphoma
1323449|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
1323450|NCT01484093|Autologous Transplantation|autologous transplantation
1323451|NCT01484093|Untreated|untreated
1323452|NCT01484093|11-095|11-095
1323453|NCT01484067|Herpes Simplex Virus|herpes simplex virus
1323454|NCT01484041|Breast cancer|breast cancer
1323455|NCT01484041|postmenopausal|postmenopausal
1323456|NCT01484002|Hip replacement|hip replacement
1323457|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
1323458|NCT01484002|Oxidation|oxidation
1323459|NCT01484002|Crosslink density|crosslink density
1323460|NCT01484002|Outcome|outcome
1323461|NCT01483989|Dry Eye|dry eye
1323462|NCT01483989|Epithelial changes|epithelial changes
1323463|NCT01483950|Dyslipidemia|dyslipidemia
1323464|NCT01483950|Statins|statins
1323465|NCT01483950|Total Cholesterol|total cholesterol
1323466|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
1323467|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
1323468|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
1323469|NCT01483937|Physical Therapy|physical therapy
1323470|NCT01483937|Rehabilitation|rehabilitation
1323471|NCT01483937|Disequilibrium|disequilibrium
1323472|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
1323473|NCT01483937|Vestibular|vestibular
1323474|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
1323475|NCT01483937|Vibrotactile|vibrotactile
1323476|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
1323478|NCT01483898|REVIVE|revive
1323479|NCT01483898|peripheral vascular disease|peripheral vascular disease
1323480|NCT01483898|CLI|cli
1323481|NCT01483898|PAD|pad
1323482|NCT01483898|MSC|msc
1323483|NCT01483898|stem cells|stem cells
1323484|NCT01483898|cell therapy|cell therapy
1323485|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
1323486|NCT01483872|novel catheter lock solution|novel catheter lock solution
1323487|NCT01483846|Neuropathic Pain|neuropathic pain
1323488|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
1323489|NCT01483807|speech|speech
1323490|NCT01483807|speech therapy|speech therapy
1323491|NCT01483807|apraxia of speech|apraxia of speech
1323492|NCT01483794|genital warts|genital warts
1323493|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1323494|NCT01483781|Plasma Volume|plasma volume
1323495|NCT01483781|Canagliflozin|canagliflozin
1323496|NCT01483781|Metformin|metformin
1323497|NCT01483781|Hemoglobin A1c|hemoglobin a1c
1323498|NCT01483781|Hypertension|hypertension
1323499|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
1323500|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
1323501|NCT01483781|Pharmacodynamics|pharmacodynamics
1323502|NCT01483781|Pharmacokinetics|pharmacokinetics
1323503|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
1323504|NCT01483768|Obesity surgery|obesity surgery
1323505|NCT01483768|Iron deficiency|iron deficiency
1323506|NCT01483768|HEPCIDINE|hepcidine
1323507|NCT01483755|Myocardial infarction|myocardial infarction
1323508|NCT01483755|Postconditioning|postconditioning
1323509|NCT01483690|Relapse|relapse
1323510|NCT01483690|Lymphoblastic|lymphoblastic
1323511|NCT01483690|Leukemia|leukemia
1323512|NCT01483690|Decitabine|decitabine
1323513|NCT01483690|Vorinostat|vorinostat
1323514|NCT01483690|Refractory|refractory
1323515|NCT01483690|Acute|acute
1323516|NCT01483690|Childhood|childhood
1323517|NCT01483690|Pediatric|pediatric
1323518|NCT01483690|ALL|all
1323519|NCT01483677|Laparoscopy|laparoscopy
1323520|NCT01483677|video games|video games
1323521|NCT01483677|Nintendo Wii|nintendo wii
1323522|NCT01483677|Playstation|playstation
1323523|NCT01483664|patient outcomes|patient outcomes
1323524|NCT01483664|Survivorship|survivorship
1323525|NCT01483664|Communication Skills|communication skills
1323526|NCT01483664|Communication strategies|communication strategies
1323527|NCT01483664|Physicians communication|physicians communication
1323528|NCT01483664|11-180|11-180
1323529|NCT01483651|diabetes|diabetes
1323530|NCT01483651|glucagon|glucagon
1323531|NCT01483651|insulin|insulin
1323532|NCT01483651|dideuterated glucose|dideuterated glucose
1323533|NCT01483638|duration of disease response|duration of disease response
1323534|NCT01483638|axitinib|axitinib
1323535|NCT01483612|Body Weight|body weight
1323536|NCT01483612|Female|female
1323537|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
1323538|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
1323539|NCT01483612|Obesity/physiopathology|obesity/physiopathology
1323540|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
1323541|NCT01483612|Pregnancy|pregnancy
1323542|NCT01483612|Pregnancy Outcome|pregnancy outcome
1323543|NCT01483612|Weight Loss|weight loss
1323544|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
1323545|NCT01483599|Psoriasis|psoriasis
1323546|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
1323547|NCT01483599|CNTO 1959|cnto 1959
1323548|NCT01483599|adalimumab|adalimumab
1323549|NCT01483573|low back pain|low back pain
1323550|NCT01483573|straight leg raise|straight leg raise
1323551|NCT01483560|REMOVAL|removal
1323552|NCT01483560|metformin|metformin
1323553|NCT01483560|carotid IMT|carotid imt
1323554|NCT01483560|LDL Cholesterol|ldl cholesterol
1323555|NCT01483560|endothelial function|endothelial function
1323556|NCT01483560|retinopathy|retinopathy
1323557|NCT01483560|HbA1c|hba1c
1323558|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1323559|NCT01483534|Pulmonary|pulmonary
1323560|NCT01483534|Intervention|intervention
1323561|NCT01483534|Device|device
1323562|NCT01483534|Denervation|denervation
1323563|NCT01483534|Lung|lung
1323564|NCT01483534|Holaira, Inc.|holaira, inc.
1323565|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
1323566|NCT01483521|Randomized|randomized
1323567|NCT01483521|Home visitation|home visitation
1323568|NCT01483521|Externalizing disorder|externalizing disorder
1323569|NCT01483521|Parenting stress|parenting stress
1323570|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
1323571|NCT01483521|Positional defiant|positional defiant
1323572|NCT01483508|flavanols|flavanols
1323573|NCT01483508|procyanidins|procyanidins
1323574|NCT01483508|absorption|absorption
1323575|NCT01483508|cocoa polyphenols|cocoa polyphenols
1323576|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
1323577|NCT01483482|clavicle fractures|clavicle fractures
1323578|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
1323579|NCT01483482|conservative treatment|conservative treatment
1323580|NCT01483482|surgical treatment|surgical treatment
1323581|NCT01483482|functional outcome|functional outcome
1323582|NCT01483482|clinical assessment|clinical assessment
1323583|NCT01483482|adults|adults
1323584|NCT01483456|Accidental falls|accidental falls
1323585|NCT01483456|safety management|safety management
1323586|NCT01483456|aged|aged
1323587|NCT01483456|inpatient|inpatient
1323588|NCT01483456|stepped wedge design|stepped wedge design
1323589|NCT01483443|oophrectomy|oophrectomy
1323590|NCT01483443|survival|survival
1323591|NCT01483430|Blood pressure|blood pressure
1323592|NCT01483430|Korea red ginseng|korea red ginseng
1323593|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
1323594|NCT01483430|Pulse wave velocity|pulse wave velocity
1323595|NCT01483417|SILS|sils
1323596|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
1323597|NCT01483417|Cosmetic outcome|cosmetic outcome
1323598|NCT01483417|Pain|pain
1323599|NCT01483404|microcirculation|microcirculation
1323600|NCT01483404|caput femoris|caput femoris
1323601|NCT01483391|Bipolar disorder|bipolar disorder
1323602|NCT01483391|Major depressive disorder|major depressive disorder
1323603|NCT01483391|Mania|mania
1323605|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
1323606|NCT01483313|Anesthestics|anesthestics
1323607|NCT01483313|Minor surgery|minor surgery
1323608|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
1323609|NCT01483313|Cognitiion|cognitiion
1323610|NCT01483300|breast cancer|breast cancer
1323611|NCT01483300|gemcitabine|gemcitabine
1323612|NCT01483300|lobaplatin|lobaplatin
1323613|NCT01483300|cisplatin|cisplatin
1323614|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
1323615|NCT01483287|Bloating|bloating
1323616|NCT01483287|Distention|distention
1323617|NCT01483274|AML|aml
1323618|NCT01483274|vaccine|vaccine
1323619|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
1323620|NCT01483261|Sexually Exploited Girls|sexually exploited girls
1323621|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
1323622|NCT01483261|Psychosocial Distress|psychosocial distress
1323623|NCT01483248|Menstrual blood|menstrual blood
1323624|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
1323625|NCT01483248|Liver cirrhosis|liver cirrhosis
1323626|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
1323627|NCT01483235|prevention|prevention
1323628|NCT01483235|exercise capacity|exercise capacity
1323629|NCT01483222|Low Back Pain|low back pain
1323630|NCT01483222|Braces|braces
1323631|NCT01483222|Prevention|prevention
1323632|NCT01483209|Digital ischemia|digital ischemia
1323633|NCT01483209|Vasopressor|vasopressor
1323634|NCT01483183|Atrial fibrillation|atrial fibrillation
1323635|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
1323636|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
1323638|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
1323639|NCT01483144|Eflornithine|eflornithine
1323640|NCT01483144|Sulindac|sulindac
1323641|NCT01483118|PCOS|pcos
1323642|NCT01483118|Insulin resistance|insulin resistance
1323643|NCT01483118|Cinnamon extract|cinnamon extract
1323644|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
1323645|NCT01483118|Ovarian cysts|ovarian cysts
1323646|NCT01483105|VCUG|vcug
1323647|NCT01483105|Child|child
1323648|NCT01483105|Hypnosis|hypnosis
1323649|NCT01483105|Relaxation|relaxation
1323650|NCT01483105|Voiding cystourethrography|voiding cystourethrography
1323651|NCT01483079|donor human milk products|donor human milk products
1323652|NCT01483079|post-discharge|post-discharge
1323653|NCT01483079|growth|growth
1323654|NCT01483079|development|development
1323655|NCT01483053|Major depressive disorder|major depressive disorder
1323656|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
1323657|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
1323658|NCT01483053|Agomelatine|agomelatine
1323659|NCT01483053|Escitalopram|escitalopram
1323660|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
1323661|NCT01483040|PeerScope B System™|peerscope b system™
1323662|NCT01483014|Gastrointestinal,|gastrointestinal,
1323663|NCT01483014|stromal,|stromal,
1323664|NCT01483014|neoadjuvant,|neoadjuvant,
1323665|NCT01483014|imatinib,|imatinib,
1323666|NCT01483014|mesylate,|mesylate,
1323667|NCT01483014|pre-operatory|pre-operatory
1323668|NCT01483001|Cancer Stem Cells|cancer stem cells
1323669|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
1323670|NCT01483001|Cancer Treatment|cancer treatment
1323671|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
1323672|NCT01482975|tobacco|tobacco
1323673|NCT01482975|alcohol|alcohol
1323674|NCT01482975|diet|diet
1323675|NCT01482975|exercise|exercise
1323676|NCT01482962|Drug Therapy|drug therapy
1323677|NCT01482949|RCC|rcc
1323678|NCT01482949|Kidney Cancer|kidney cancer
1323679|NCT01482949|Renal Cancer|renal cancer
1323680|NCT01482949|Arcelis|arcelis
1323681|NCT01482923|Tobacco Use Assessment|tobacco use assessment
1323682|NCT01482923|smoke tobacco|smoke tobacco
1323683|NCT01482923|quit smoking|quit smoking
1323684|NCT01482923|tobacco cessation|tobacco cessation
1323685|NCT01482923|HIV/AIDS|hiv/aids
1323686|NCT01482923|Community-Based Service Organizations|community-based service organizations
1323687|NCT01482923|11-173|11-173
1323688|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
1323689|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
1323690|NCT01482897|Subjects|subjects
1323691|NCT01482897|evolving|evolving
1323692|NCT01482884|tralokinumab|tralokinumab
1323693|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
1323694|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
1323695|NCT01482871|Diabetic Macular Edema|diabetic macular edema
1323696|NCT01482832|Randomized trial|randomized trial
1323697|NCT01482832|Postpartum depression|postpartum depression
1323698|NCT01482832|Adolescent pregnancy|adolescent pregnancy
1323699|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
1323700|NCT01482806|Depression|depression
1323701|NCT01482806|Anxiety|anxiety
1323702|NCT01482806|Primary care|primary care
1323703|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
1323704|NCT01482806|Internet|internet
1323705|NCT01482806|Support groups|support groups
1323706|NCT01482806|Technology assisted|technology assisted
1323707|NCT01482741|Quality of Life|quality of life
1323708|NCT01482741|Focus groups|focus groups
1323709|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
1323710|NCT01482741|Risk of medical imaging|risk of medical imaging
1323711|NCT01482741|11-185|11-185
1323712|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
1323713|NCT01482715|platinum sensitive|platinum sensitive
1323714|NCT01482715|PARP Inhibitor|parp inhibitor
1323715|NCT01482715|Rucaparib|rucaparib
1323716|NCT01482715|CO-338|co-338
1323717|NCT01482715|PF 01367338|pf 01367338
1323718|NCT01482715|AG 14699|ag 14699
1323719|NCT01482715|BRCA1|brca1
1323720|NCT01482715|BRCA2|brca2
1323721|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
1323722|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
1323723|NCT01482715|gynecological cancer|gynecological cancer
1323724|NCT01482715|relapsed disease|relapsed disease
1323725|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
1323727|NCT01482702|breast cancer survivor|breast cancer survivor
1323728|NCT01482702|weight loss|weight loss
1323729|NCT01482702|postmenopausal|postmenopausal
1323730|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
1323731|NCT01482689|Bioavailability|bioavailability
1323732|NCT01482689|Vitamin D metabolism|vitamin d metabolism
1323733|NCT01482689|Bone turnover|bone turnover
1323734|NCT01482663|Hand eczema|hand eczema
1323735|NCT01482663|Hand dermatitis|hand dermatitis
1323736|NCT01482663|Chronic hand eczema|chronic hand eczema
1323737|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
1323738|NCT01482663|Contact dermatitis|contact dermatitis
1323739|NCT01482663|Skin disease|skin disease
1323740|NCT01482663|Self-management|self-management
1323741|NCT01482650|Baska mask|baska mask
1323742|NCT01482650|LMA|lma
1323743|NCT01482650|laryngeal mask airway|laryngeal mask airway
1323744|NCT01482650|supraglottic airway device|supraglottic airway device
1323745|NCT01482624|hyaluronan|hyaluronan
1323746|NCT01482624|hyaluronic acid|hyaluronic acid
1323747|NCT01482611|Hepatitis C Virus|hepatitis c virus
1323748|NCT01482611|JNJ-47910382|jnj-47910382
1323749|NCT01482611|47910382HPC1001|47910382hpc1001
1323750|NCT01482611|HCV|hcv
1323751|NCT01482611|Hepatitis C|hepatitis c
1323752|NCT01482611|Hep C|hep c
1323753|NCT01482611|Healthy participants|healthy participants
1323754|NCT01482611|Japanese|japanese
1323755|NCT01482611|Caucasians|caucasians
1323756|NCT01482598|Heart Failure|heart failure
1323757|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1323758|NCT01482598|Remote Care|remote care
1323759|NCT01482598|Disease Management|disease management
1323760|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
1323761|NCT01482585|prognosis|prognosis
1323762|NCT01482585|tumor aggressiveness|tumor aggressiveness
1323763|NCT01482585|imaging biomarker|imaging biomarker
1323764|NCT01482585|genetic biomarker|genetic biomarker
1323765|NCT01482572|biopsy|biopsy
1323766|NCT01482572|needle aspiration|needle aspiration
1323767|NCT01482572|mutational analysis|mutational analysis
1323768|NCT01482559|Dopamine|dopamine
1323769|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
1323770|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
1323771|NCT01482559|Neurodisability|neurodisability
1323772|NCT01482559|Infant|infant
1323773|NCT01482546|colonoscopy|colonoscopy
1323774|NCT01482546|trainees|trainees
1323775|NCT01482546|water|water
1323776|NCT01482546|adenoma detection rate|adenoma detection rate
1323777|NCT01482546|cecal intubation rate|cecal intubation rate
1323778|NCT01482494|Myopathies|myopathies
1323779|NCT01482494|Pompe disease|pompe disease
1323780|NCT01482494|Polymyositis|polymyositis
1323781|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
1323782|NCT01482481|Patient Care Planning|patient care planning
1323783|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1323784|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
1323785|NCT01482481|Primary Health Care|primary health care
1323786|NCT01482481|Spain|spain
1323787|NCT01482455|Insulin resistance|insulin resistance
1323788|NCT01482455|vascular impairment|vascular impairment
1323789|NCT01482455|diabetes|diabetes
1323790|NCT01482442|Liver, HCC|liver, hcc
1323791|NCT01482442|Liver, interventional procedures|liver, interventional procedures
1323792|NCT01482442|Liver, randomized studies|liver, randomized studies
1323793|NCT01482442|Liver, targeted therapy|liver, targeted therapy
1323794|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
1323795|NCT01482429|ventilator weaning|ventilator weaning
1323796|NCT01482429|protocol|protocol
1323797|NCT01482416|hormone replacement therapy|hormone replacement therapy
1323798|NCT01482416|Doppler velocimetry|doppler velocimetry
1323799|NCT01482416|Flow-mediated dilation|flow-mediated dilation
1323800|NCT01482416|menopause|menopause
1323801|NCT01482364|HOTMAN System|hotman system
1323802|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
1323803|NCT01482351|apnea|apnea
1323804|NCT01482351|cognition|cognition
1323807|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
1323808|NCT01482351|older adults|older adults
1323809|NCT01482351|Alzheimer's Disease|alzheimer's disease
1323810|NCT01482338|PMS|pms
1323811|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
1323812|NCT01482338|COC|coc
1323813|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
1323814|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
1323815|NCT01482299|second-line treatment|second-line treatment
1323816|NCT01482299|advanced gastric cancer|advanced gastric cancer
1323817|NCT01482286|Exercise|exercise
1323818|NCT01482286|Diet|diet
1323819|NCT01482286|Insulin resistance|insulin resistance
1323820|NCT01482286|Weight|weight
1323821|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
1323822|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
1323823|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
1323824|NCT01482273|Phlebographic scores|phlebographic scores
1323825|NCT01482273|Phlebography|phlebography
1323826|NCT01482273|Catheters|catheters
1323827|NCT01482234|physical activity|physical activity
1323828|NCT01482234|exercise|exercise
1323829|NCT01482234|walking|walking
1323830|NCT01482234|pedometers|pedometers
1323831|NCT01482234|goal setting|goal setting
1323832|NCT01482234|text messages|text messages
1323833|NCT01482234|motivation|motivation
1323834|NCT01482234|intrinsic motivation|intrinsic motivation
1323835|NCT01482234|extrinsic motivation|extrinsic motivation
1323836|NCT01482234|self determination theory|self determination theory
1323837|NCT01482234|prompts|prompts
1323838|NCT01482221|Major Depressive Disorder|major depressive disorder
1323839|NCT01482221|MDD|mdd
1324092|NCT01481324|Compliance|compliance
1323840|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
1323841|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
1323842|NCT01482208|Dehydration|dehydration
1323843|NCT01482208|Hydration|hydration
1323844|NCT01482208|Muscle composition|muscle composition
1323845|NCT01482208|Diarrhea|diarrhea
1323846|NCT01482208|Pediatrics|pediatrics
1323847|NCT01482208|Neonatology|neonatology
1323848|NCT01482208|Ultrasound|ultrasound
1323849|NCT01482195|Retinal Disease|retinal disease
1323850|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
1323851|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
1323852|NCT01482182|18F-FDG PET|18f-fdg pet
1323853|NCT01482182|Treatment response|treatment response
1323854|NCT01482182|Prognosis|prognosis
1323855|NCT01482169|Left heart catheterization|left heart catheterization
1323856|NCT01482169|Fractional flow reserve|fractional flow reserve
1323857|NCT01482169|Adenoscan®|adenoscan®
1323858|NCT01482169|Regadenoson|regadenoson
1323859|NCT01482156|Advanced solid tumors|advanced solid tumors
1323860|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
1323861|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
1323862|NCT01482156|Dose finding study|dose finding study
1323863|NCT01482156|mTOR|mtor
1323864|NCT01482156|Pl3K|pl3k
1323865|NCT01482156|BEZ235|bez235
1323866|NCT01482156|RAD001|rad001
1323867|NCT01482156|Everolimus|everolimus
1323868|NCT01482156|Afinitor®|afinitor®
1323869|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
1323870|NCT01482143|Fragile X Syndrome|fragile x syndrome
1323871|NCT01482143|pharmacokinetics|pharmacokinetics
1323872|NCT01482143|safety and tolerability|safety and tolerability
1323873|NCT01482130|Exercise|exercise
1323874|NCT01482130|osteoporosis|osteoporosis
1323875|NCT01482130|prevention|prevention
1323876|NCT01482117|CYP2C19|cyp2c19
1323877|NCT01482117|CYP3A5|cyp3a5
1323878|NCT01482117|Clopidogrel|clopidogrel
1323879|NCT01482117|Cilostazol|cilostazol
1323880|NCT01482117|Healthy|healthy
1323881|NCT01482104|Photochemotherapy|photochemotherapy
1323882|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
1323883|NCT01482091|fentanyl|fentanyl
1323884|NCT01482091|intranasal|intranasal
1323885|NCT01482091|sickle cell|sickle cell
1323886|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
1323887|NCT01482091|pain crisis|pain crisis
1323888|NCT01482091|pediatrics|pediatrics
1323889|NCT01482078|Magnesium Sulphate|magnesium sulphate
1323890|NCT01482078|Neuroprotection|neuroprotection
1323891|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
1323892|NCT01482078|Sedation|sedation
1323893|NCT01482078|Respiratory function|respiratory function
1323894|NCT01482078|Cesarean Section|cesarean section
1323895|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
1323896|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
1323897|NCT01482065|NAFLD|nafld
1323898|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
1323899|NCT01482065|CPAP|cpap
1323900|NCT01482065|CPAP Therapy|cpap therapy
1323901|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
1323902|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
1323903|NCT01482065|NASH|nash
1323904|NCT01482065|OSA|osa
1323905|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
1323906|NCT01482065|AHI|ahi
1323907|NCT01482052|Central Nervous System Infections|central nervous system infections
1323908|NCT01482052|Meningitis|meningitis
1323909|NCT01482052|toxoid|toxoid
1323910|NCT01482052|Meningococcal vaccine|meningococcal vaccine
1323911|NCT01482052|conjugate vaccines|conjugate vaccines
1323912|NCT01482039|short cervix|short cervix
1323913|NCT01482039|cervical shortening|cervical shortening
1323914|NCT01482039|preterm birth|preterm birth
1323915|NCT01482026|Epilepsy|epilepsy
1323916|NCT01482026|Attention deficit|attention deficit
1323917|NCT01482026|ADHD rating scale IV|adhd rating scale iv
1323918|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1323919|NCT01482000|Adult|adult
1323920|NCT01482000|therapeutic use|therapeutic use
1323921|NCT01482000|Humans|humans
1323922|NCT01482000|Treatment Outcome|treatment outcome
1323923|NCT01482000|daoyin therapy|daoyin therapy
1323924|NCT01481987|Microperimetry|microperimetry
1323925|NCT01481987|OCT|oct
1323926|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
1323927|NCT01481974|liver transplantation|liver transplantation
1323928|NCT01481974|treprostinil|treprostinil
1323929|NCT01481961|Alzheimer's disease|alzheimer's disease
1323930|NCT01481961|rTMS|rtms
1323931|NCT01481961|cognition|cognition
1323932|NCT01481948|physical activity|physical activity
1323933|NCT01481948|fruit and vegetable|fruit and vegetable
1323934|NCT01481948|water|water
1323935|NCT01481948|girls|girls
1323936|NCT01481948|African American|african american
1323937|NCT01481948|online|online
1323938|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
1323939|NCT01481935|Colonization|colonization
1323940|NCT01481935|Hospital cleaning|hospital cleaning
1323941|NCT01481935|Environmental cleaning|environmental cleaning
1323942|NCT01481935|Infection Control|infection control
1323943|NCT01481922|Lumbar puncture|lumbar puncture
1323944|NCT01481922|Flow rate|flow rate
1323945|NCT01481922|Backache|backache
1323946|NCT01481922|Pain|pain
1323947|NCT01481922|Undifferentiated headache|undifferentiated headache
1323948|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
1323949|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
1323950|NCT01481909|Assessment of life quality|assessment of life quality
1323951|NCT01481896|Hip replacement|hip replacement
1323952|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
1323953|NCT01481896|Osteolysis|osteolysis
1323954|NCT01481896|Metal ion levels|metal ion levels
1323955|NCT01481896|Outcome|outcome
1323956|NCT01481883|Schizophrenia|schizophrenia
1323957|NCT01481883|Mental Illness|mental illness
1323958|NCT01481883|SERM|serm
1323959|NCT01481883|Raloxifene|raloxifene
1323960|NCT01481870|renal cell carcinoma|renal cell carcinoma
1323961|NCT01481870|sorafenib|sorafenib
1323962|NCT01481870|sunitinib|sunitinib
1323963|NCT01481870|crossover|crossover
1323964|NCT01481844|sequential therapy|sequential therapy
1323965|NCT01481844|second line treatment|second line treatment
1323966|NCT01481844|H pylori|h pylori
1323967|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
1323968|NCT01481766|child development|child development
1323969|NCT01481766|screening|screening
1323970|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
1323971|NCT01481766|primary care pediatrics|primary care pediatrics
1323972|NCT01481766|prevention and health promotion|prevention and health promotion
1323973|NCT01481740|spinal induced hypotension|spinal induced hypotension
1323974|NCT01481740|nausea and vomiting|nausea and vomiting
1323975|NCT01481740|cesarean delivery|cesarean delivery
1323976|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
1323977|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
1323978|NCT01481714|Sodium picosulphate|sodium picosulphate
1323979|NCT01481714|Split-dose|split-dose
1323980|NCT01481714|Bowel cleansing|bowel cleansing
1323981|NCT01481714|colonoscopy|colonoscopy
1323982|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
1323983|NCT01481701|ovarian carcinoma|ovarian carcinoma
1323984|NCT01481701|Bordet|bordet
1323985|NCT01481701|relapse|relapse
1323986|NCT01481688|Dialysis adequacy|dialysis adequacy
1323987|NCT01481688|Urea clearance|urea clearance
1323988|NCT01481688|Phosphate clearance|phosphate clearance
1323989|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
1323990|NCT01481688|Intradialytic exercise|intradialytic exercise
1323991|NCT01481688|Haemodialysis patients|haemodialysis patients
1323992|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
1323993|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
1323994|NCT01481675|diabetes mellitus|diabetes mellitus
1323995|NCT01481675|weight loss|weight loss
1323996|NCT01481675|ghrelin|ghrelin
1323997|NCT01481675|PYY|pyy
1323998|NCT01481675|GLP-1|glp-1
1323999|NCT01481662|SUSAC's Syndrome|susac's syndrome
1324000|NCT01481662|encephalopathy|encephalopathy
1324001|NCT01481662|hearing loss|hearing loss
1324002|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
1324003|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
1324004|NCT01481649|hepatitis B|hepatitis b
1324005|NCT01481649|anti-HBc|anti-hbc
1324006|NCT01481649|HBsAg|hbsag
1324007|NCT01481649|HSCT|hsct
1324008|NCT01481649|recipients|recipients
1324009|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
1324010|NCT01481636|correlation|correlation
1324011|NCT01481636|AHI|ahi
1324012|NCT01481636|symptoms|symptoms
1324013|NCT01481636|mechanisms|mechanisms
1324014|NCT01481623|Diabetes|diabetes
1324015|NCT01481623|neonatal|neonatal
1324016|NCT01481623|consanguinity|consanguinity
1324017|NCT01481623|monogenic|monogenic
1324018|NCT01481623|metabolism|metabolism
1324019|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
1324020|NCT01481610|Arthralgia|arthralgia
1324021|NCT01481610|NSAID|nsaid
1324022|NCT01481610|Diclofenac|diclofenac
1324023|NCT01481610|Lumiracoxib|lumiracoxib
1324024|NCT01481610|Safety|safety
1324025|NCT01481597|deuteporfin|deuteporfin
1324026|NCT01481597|safety|safety
1324027|NCT01481597|tolerability|tolerability
1324028|NCT01481597|pharmacokinetics|pharmacokinetics
1324029|NCT01481597|healthy volunteers|healthy volunteers
1324030|NCT01481584|Dietary protein|dietary protein
1324031|NCT01481584|Canola protein|canola protein
1333196|NCT01444040|POAG|poag
1324032|NCT01481584|Protein metabolism|protein metabolism
1324033|NCT01481584|Protein-enriched drinks|protein-enriched drinks
1324034|NCT01481584|Nitrogen balance|nitrogen balance
1324035|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
1324036|NCT01481558|Apathy|apathy
1324037|NCT01481558|Alzheimer's Disease|alzheimer's disease
1324038|NCT01481558|Dementia|dementia
1324039|NCT01481545|locally advanced|locally advanced
1324040|NCT01481545|high risk|high risk
1324041|NCT01481545|preoperative therapy|preoperative therapy
1324042|NCT01481532|Antineoplastic agent|antineoplastic agent
1324043|NCT01481519|Conjunctivitis|conjunctivitis
1324044|NCT01481519|Ocular diseases|ocular diseases
1324045|NCT01481519|Artificial tears|artificial tears
1324046|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
1324047|NCT01481480|shoulder|shoulder
1324048|NCT01481480|rotator cuff|rotator cuff
1324049|NCT01481480|tendon transfer|tendon transfer
1324050|NCT01481480|arthroscopic repair|arthroscopic repair
1324051|NCT01481467|influenza vaccination|influenza vaccination
1324052|NCT01481467|intervention mapping|intervention mapping
1324053|NCT01481467|hospital care|hospital care
1324054|NCT01481467|respiratory infections|respiratory infections
1324055|NCT01481467|vaccination|vaccination
1324056|NCT01481454|Influenza|influenza
1324057|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
1324058|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1324059|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
1324060|NCT01481441|Prostate cancer|prostate cancer
1324061|NCT01481441|Quantification|quantification
1324062|NCT01481441|Prostate biopsies|prostate biopsies
1324063|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
1324064|NCT01481441|Microbubbles|microbubbles
1324065|NCT01481428|High risk behavior|high risk behavior
1324066|NCT01481428|Drug court clients|drug court clients
1324067|NCT01481428|Substance abuse|substance abuse
1324068|NCT01481428|HIV intervention|hiv intervention
1324069|NCT01481428|Treatment Court Clients|treatment court clients
1324070|NCT01481415|left atrial|left atrial
1324071|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
1324072|NCT01481415|left atrial function|left atrial function
1324073|NCT01481402|Heart failure|heart failure
1324074|NCT01481402|Liothyronine|liothyronine
1324075|NCT01481402|Low T3 syndrome|low t3 syndrome
1324076|NCT01481389|Blood lipids|blood lipids
1324077|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
1324269|NCT01480479|Giant cell|giant cell
1324078|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
1324079|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
1324080|NCT01481376|TAPP|tapp
1324081|NCT01481376|Inguinal hernia repair|inguinal hernia repair
1324082|NCT01481363|dementia|dementia
1324083|NCT01481363|communication|communication
1324084|NCT01481363|carers|carers
1324085|NCT01481363|caregivers|caregivers
1324086|NCT01481363|psychosocial support systems|psychosocial support systems
1324087|NCT01481363|education|education
1324088|NCT01481337|colon|colon
1324089|NCT01481337|endoscopy|endoscopy
1324090|NCT01481337|resection|resection
1324091|NCT01481324|Clubfoot|clubfoot
1324093|NCT01481324|Brace wear|brace wear
1324094|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
1324095|NCT01481285|Adults|adults
1324096|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
1324097|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
1324098|NCT01481259|Maintenance therapy|maintenance therapy
1324099|NCT01481259|Immunotherapy|immunotherapy
1324100|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
1324101|NCT01481259|Pemetrexed|pemetrexed
1324102|NCT01481246|neurorehabilitation|neurorehabilitation
1324103|NCT01481246|cognition|cognition
1324104|NCT01481246|aging|aging
1324105|NCT01481246|MCI|mci
1324106|NCT01481246|cognitive decline|cognitive decline
1324107|NCT01481233|oral colchicine|oral colchicine
1324108|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1324109|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
1324110|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
1324111|NCT01481220|azacitidine|azacitidine
1324112|NCT01481220|Eltrombopag|eltrombopag
1324113|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
1324114|NCT01481220|Thrombocytopenia|thrombocytopenia
1324115|NCT01481220|Transfusion dependency|transfusion dependency
1324116|NCT01481220|Safety study|safety study
1324117|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1324118|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
1324119|NCT01481194|Multiple Myeloma|multiple myeloma
1324120|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
1324121|NCT01481155|actinic keratosis|actinic keratosis
1324122|NCT01481155|field cancerisation|field cancerisation
1324123|NCT01481116|Drug Therapy|drug therapy
1324124|NCT01481103|Over the counter medication|over the counter medication
1324125|NCT01481103|Acupuncture|acupuncture
1324126|NCT01481090|Infertility|infertility
1324127|NCT01481090|acupuncture|acupuncture
1324128|NCT01481090|frozen embryos|frozen embryos
1324129|NCT01481090|endometrium|endometrium
1324130|NCT01481090|TCM|tcm
1324131|NCT01481064|Patient centredness|patient centredness
1324132|NCT01481064|Quality of life|quality of life
1324133|NCT01481064|Multifaceted approach|multifaceted approach
1324134|NCT01481064|Fertility care|fertility care
1324135|NCT01481038|early detection|early detection
1324136|NCT01481038|CRBSI|crbsi
1324137|NCT01481025|Climacteric|climacteric
1324138|NCT01481025|Depression|depression
1324139|NCT01481025|Herbal treatment|herbal treatment
1324140|NCT01481012|Heart transplantation|heart transplantation
1324141|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
1324142|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
1324143|NCT01480999|Laparotomy|laparotomy
1324144|NCT01480999|Open Surgery|open surgery
1324145|NCT01480999|Laparoscopy|laparoscopy
1324146|NCT01480999|Robotic surgery|robotic surgery
1324147|NCT01480960|lung transplantation|lung transplantation
1324148|NCT01480960|whole body vibration|whole body vibration
1324149|NCT01480960|exercise training|exercise training
1324150|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
1324151|NCT01480947|probiotics|probiotics
1324152|NCT01480947|pediatric|pediatric
1324153|NCT01480947|salmonella|salmonella
1324154|NCT01480947|rotavirus|rotavirus
1324155|NCT01480947|gastroenteritis|gastroenteritis
1324156|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
1324157|NCT01480921|heart failure|heart failure
1324158|NCT01480921|health related quality of life|health related quality of life
1324159|NCT01480921|exercise capacity|exercise capacity
1324160|NCT01480921|home based exercise training|home based exercise training
1324161|NCT01480921|supervised exercise training|supervised exercise training
1324162|NCT01480908|Right bundle branch block|right bundle branch block
1324163|NCT01480908|Ventricular septal defect|ventricular septal defect
1324164|NCT01480908|Echocardiography|echocardiography
1324165|NCT01480908|MRI|mri
1324166|NCT01480908|Exercise testing|exercise testing
1324167|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
1324168|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
1324169|NCT01480895|Glucose Intolerance|glucose intolerance
1324170|NCT01480895|Physical exercise|physical exercise
1324171|NCT01480895|Nutritional Habits|nutritional habits
1324172|NCT01480895|Dyslipidemia|dyslipidemia
1324173|NCT01480882|Manual percussion|manual percussion
1324270|NCT01480479|Gliosarcoma|gliosarcoma
1324174|NCT01480882|Mechanical percussion|mechanical percussion
1324175|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
1324176|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1324177|NCT01480882|Wet sputum weight|wet sputum weight
1324178|NCT01480882|Dry sputum weight|dry sputum weight
1324179|NCT01480869|Breast cancer|breast cancer
1324180|NCT01480869|Vitamin D supplementation|vitamin d supplementation
1324181|NCT01480869|in neoadjuvant|in neoadjuvant
1324182|NCT01480869|adjuvant setting|adjuvant setting
1324183|NCT01480843|simplification|simplification
1324184|NCT01480843|glargine|glargine
1324185|NCT01480843|elderly|elderly
1324186|NCT01480830|Quality|quality
1324187|NCT01480830|indicators|indicators
1324188|NCT01480804|Barriers|barriers
1324189|NCT01480804|Intervention|intervention
1324190|NCT01480804|Elderly|elderly
1324191|NCT01480804|glycemic control|glycemic control
1324192|NCT01480791|resistance arteries|resistance arteries
1324193|NCT01480791|endothelial dysfunction|endothelial dysfunction
1324194|NCT01480791|aortic stiffness|aortic stiffness
1324195|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
1324196|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
1324197|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
1324198|NCT01480713|HIV-1|hiv-1
1324199|NCT01480713|protease inhibitors|protease inhibitors
1324200|NCT01480713|integrase inhibitors|integrase inhibitors
1324201|NCT01480713|raltegravir|raltegravir
1324202|NCT01480713|viral replication|viral replication
1324203|NCT01480713|treatment intensification|treatment intensification
1324204|NCT01480713|viral pathogenesis|viral pathogenesis
1324205|NCT01480713|immune activation|immune activation
1324206|NCT01480700|eggs|eggs
1324207|NCT01480700|Optical Macular Pigment|optical macular pigment
1324208|NCT01480700|Age Macular Degeneration|age macular degeneration
1324209|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
1324210|NCT01480687|Hypertension|hypertension
1324211|NCT01480687|Endothelial dysfunction|endothelial dysfunction
1324212|NCT01480687|Vascular stiffness|vascular stiffness
1324213|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1324214|NCT01480661|Computed Tomography scan|computed tomography scan
1324215|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
1324216|NCT01480661|Roflumilast|roflumilast
1324217|NCT01480661|Health Related Quality of Life|health related quality of life
1324218|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
1324219|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
1324220|NCT01480622|healthy subjects|healthy subjects
1324221|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1324222|NCT01480622|hepatitis|hepatitis
1324223|NCT01480622|pharmacokinetics|pharmacokinetics
1324224|NCT01480583|GRN1005|grn1005
1324225|NCT01480583|ANG1005|ang1005
1324226|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
1324227|NCT01480583|LRP-1|lrp-1
1324228|NCT01480583|Targeted Therapy|targeted therapy
1324229|NCT01480583|Breast Cancer|breast cancer
1324230|NCT01480583|Brain Metastases|brain metastases
1324231|NCT01480583|Brain Tumor|brain tumor
1324232|NCT01480583|Blood Brain Barrier|blood brain barrier
1324233|NCT01480583|Trastuzumab|trastuzumab
1324234|NCT01480583|Herceptin|herceptin
1324235|NCT01480583|Paclitaxel|paclitaxel
1324236|NCT01480583|Taxol|taxol
1324237|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
1324238|NCT01480557|cataract|cataract
1324239|NCT01480557|phacoemulsification|phacoemulsification
1324240|NCT01480557|liquefaction|liquefaction
1324241|NCT01480557|torsional ip|torsional ip
1324242|NCT01480557|endothelial cell count|endothelial cell count
1324243|NCT01480557|central corneal edema|central corneal edema
1324244|NCT01480557|central corneal sensitivity|central corneal sensitivity
1324245|NCT01480544|Institutional Deliveries|institutional deliveries
1324246|NCT01480544|Maternal Health|maternal health
1324247|NCT01480544|Infant Health|infant health
1324248|NCT01480544|Private Medical Providers|private medical providers
1324249|NCT01480544|Provider Incentives|provider incentives
1324250|NCT01480544|Randomized Control Trial|randomized control trial
1324251|NCT01480531|aorta|aorta
1324252|NCT01480531|aneurysm|aneurysm
1324253|NCT01480531|dissection|dissection
1324254|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1324255|NCT01480505|Retinal detachment|retinal detachment
1324256|NCT01480505|high myopia|high myopia
1324257|NCT01480505|macular hole|macular hole
1324258|NCT01480505|axial length|axial length
1324259|NCT01480505|Scleral buckling|scleral buckling
1324260|NCT01480505|Vitrectomy|vitrectomy
1324261|NCT01480505|Visual acuity|visual acuity
1324262|NCT01480505|fundus examination results|fundus examination results
1324263|NCT01480492|HBV|hbv
1324264|NCT01480492|Immune|immune
1324265|NCT01480492|antiviral therapy|antiviral therapy
1324266|NCT01480479|EGFRvIII|egfrviii
1324267|NCT01480479|Glioblastoma|glioblastoma
1324268|NCT01480479|Small cell|small cell
1324271|NCT01480479|oligodendroglial|oligodendroglial
1324272|NCT01480479|Brain Cancer|brain cancer
1324273|NCT01480479|Brain Tumor|brain tumor
1324274|NCT01480479|radiotherapy|radiotherapy
1324275|NCT01480479|chemoradiation|chemoradiation
1324276|NCT01480479|Tumor|tumor
1324277|NCT01480479|temozolomide|temozolomide
1324278|NCT01480479|EGFR variant III|egfr variant iii
1324279|NCT01480466|Overweight|overweight
1324280|NCT01480466|Obesity|obesity
1324281|NCT01480466|Body mass index|body mass index
1324282|NCT01480466|Weight|weight
1324283|NCT01480466|Primary care|primary care
1324284|NCT01480453|Osteoarthritis|osteoarthritis
1324285|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
1324286|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
1324287|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
1324288|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
1324289|NCT01480453|Avascular necrosis|avascular necrosis
1324290|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
1324291|NCT01480440|Reverse TSA|reverse tsa
1324292|NCT01480440|Osteoarthritis|osteoarthritis
1324293|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
1324294|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
1324295|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
1324494|NCT01479595|Interleukin|interleukin
1324296|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
1324297|NCT01480440|Avascular necrosis|avascular necrosis
1324298|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
1324299|NCT01480440|Failed total shoulder arthroplasty (both glenoid and humeral components require revision|failed total shoulder arthroplasty (both glenoid and humeral components require revision
1324300|NCT01480427|Children aged 0-12 years|children aged 0-12 years
1324301|NCT01480427|IgE mediated food allergy|ige mediated food allergy
1324302|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
1324303|NCT01480401|Patients with stable heart failure|patients with stable heart failure
1324304|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
1324305|NCT01480388|Swollen and tender joints|swollen and tender joints
1324306|NCT01480388|Dose range finding study|dose range finding study
1324307|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
1324308|NCT01480375|prostate cancer detection|prostate cancer detection
1620867|NCT00316810|Tacrolimus|tacrolimus
1324309|NCT01480375|prostate biopsy|prostate biopsy
1324310|NCT01480375|3d navigation|3d navigation
1324311|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
1324312|NCT01480362|Diabetic foot wound|diabetic foot wound
1324313|NCT01480362|Amputation wound|amputation wound
1324314|NCT01480362|Chronic wound|chronic wound
1324315|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
1324316|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
1324317|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
1324318|NCT01480336|Arrhythmia|arrhythmia
1324319|NCT01480323|Malignant melanoma|malignant melanoma
1324320|NCT01480297|Pain|pain
1324321|NCT01480297|Neuropathy|neuropathy
1324322|NCT01480297|Diabetes type 1|diabetes type 1
1324323|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1324324|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
1324325|NCT01480271|Allergic Rhinitis|allergic rhinitis
1324326|NCT01480271|Healthy Volunteers|healthy volunteers
1324327|NCT01480271|Single Dose Escalation|single dose escalation
1324328|NCT01480271|TLR7 agonist|tlr7 agonist
1324329|NCT01480271|First Time in Human Study|first time in human study
1324330|NCT01480258|combination vaccine|combination vaccine
1324331|NCT01480258|diphtheria|diphtheria
1324332|NCT01480258|pertussis|pertussis
1324333|NCT01480258|tetanus|tetanus
1324334|NCT01480258|hepatitis B|hepatitis b
1324335|NCT01480258|Hep B|hep b
1324336|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
1324337|NCT01480258|Hib|hib
1324338|NCT01480258|polio|polio
1324339|NCT01480258|poliovirus|poliovirus
1324340|NCT01480245|968|968
1324341|NCT01480245|Duchenne|duchenne
1324342|NCT01480245|DMD|dmd
1324343|NCT01480245|drisapersen|drisapersen
1324344|NCT01480219|voriconazole|voriconazole
1324345|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
1324346|NCT01480219|confounding|confounding
1324347|NCT01480219|statistical adjustment|statistical adjustment
1324348|NCT01480219|risk adjustment|risk adjustment
1324349|NCT01480219|lung transplant|lung transplant
1324350|NCT01480219|heart/lung transplant|heart/lung transplant
1324351|NCT01480219|immunosuppression|immunosuppression
1324352|NCT01480193|Tinnitus|tinnitus
1324353|NCT01480167|VCF|vcf
1324354|NCT01480167|Osteoporosis|osteoporosis
1324355|NCT01480167|Minimally Invasive|minimally invasive
1324356|NCT01480167|Non-operative management|non-operative management
1324357|NCT01480167|Medical Management|medical management
1324358|NCT01480128|Single-port|single-port
1324359|NCT01480128|Laparoscopy|laparoscopy
1324360|NCT01480128|colectomy|colectomy
1324361|NCT01480128|Single port|single port
1324362|NCT01480128|colon cancer|colon cancer
1324363|NCT01480128|minimally invasive surgery|minimally invasive surgery
1324364|NCT01480115|antral follicle count|antral follicle count
1324365|NCT01480115|automated antral follicle count|automated antral follicle count
1324366|NCT01480115|ovarian reserve|ovarian reserve
1324367|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
1324368|NCT01480102|Paravertebral block|paravertebral block
1324369|NCT01480102|bupivacaine|bupivacaine
1324370|NCT01480089|Surgical Pain Management|surgical pain management
1324371|NCT01480089|Robotic surgery|robotic surgery
1324372|NCT01480089|Ropivacaine|ropivacaine
1324373|NCT01480076|Quality of Life|quality of life
1324374|NCT01480076|Multiple Sclerosis|multiple sclerosis
1324375|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
1324376|NCT01480050|adult glioblastoma|adult glioblastoma
1324377|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1324378|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
1324379|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1324380|NCT01480050|adult mixed glioma|adult mixed glioma
1324381|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
1324382|NCT01480024|healthy women|healthy women
1324383|NCT01480024|oocytes|oocytes
1324384|NCT01480024|in vitro fertilization|in vitro fertilization
1324385|NCT01480024|pregnancy|pregnancy
1324386|NCT01480024|childbearing-age|childbearing-age
1324387|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
1324388|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
1324389|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1324390|NCT01479998|smoking cessation|smoking cessation
1324391|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
1324392|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
1324393|NCT01479998|contingency management|contingency management
1324394|NCT01479972|Tuberculosis|tuberculosis
1324395|NCT01479972|Vaccine|vaccine
1324396|NCT01479972|Live vaccine|live vaccine
1324397|NCT01479972|rBCG|rbcg
1324398|NCT01479959|Tracheostomy|tracheostomy
1324399|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
1324400|NCT01479959|speech|speech
1324401|NCT01479959|respiratory failure|respiratory failure
1324402|NCT01479959|ventilation|ventilation
1324403|NCT01479959|neuromuscular disorders|neuromuscular disorders
1324404|NCT01479933|vitamin D|vitamin d
1324405|NCT01479933|cholecalciferol|cholecalciferol
1324406|NCT01479933|supplementation|supplementation
1324407|NCT01479933|prediabetic state|prediabetic state
1324408|NCT01479933|obesity|obesity
1324409|NCT01479933|glucose metabolism|glucose metabolism
1324410|NCT01479933|gene expression|gene expression
1324411|NCT01479933|transcriptomics|transcriptomics
1324412|NCT01479933|epigenomics|epigenomics
1324413|NCT01479933|immunological function|immunological function
1324414|NCT01479933|insulin sensitivity|insulin sensitivity
1324415|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
1324416|NCT01479920|Depressive Disorder|depressive disorder
1324417|NCT01479920|Depressive Symptoms|depressive symptoms
1324418|NCT01479920|Depressive Syndrome|depressive syndrome
1324419|NCT01479920|Emotional Depression|emotional depression
1324420|NCT01479881|Hepatitis C Virus|hepatitis c virus
1324421|NCT01479881|TMC435|tmc435
1324422|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
1324423|NCT01479881|TMC435-C120|tmc435-c120
1324424|NCT01479881|HCV|hcv
1324425|NCT01479881|Hepatitis C|hepatitis c
1324426|NCT01479881|Hep C|hep c
1324427|NCT01479881|Healthy participants|healthy participants
1324428|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
1324429|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
1324430|NCT01479868|HCV-1|hcv-1
1324431|NCT01479868|HIV-1|hiv-1
1324432|NCT01479868|TMC435|tmc435
1324433|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
1324434|NCT01479868|PegIFNα-2a|pegifnα-2a
1324435|NCT01479868|Pegasys|pegasys
1324436|NCT01479868|Ribavirin|ribavirin
1324437|NCT01479868|RBV|rbv
1324438|NCT01479868|Copegus|copegus
1324439|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1324440|NCT01479855|Alzheimers disease|alzheimers disease
1324441|NCT01479855|Vitamines|vitamines
1324442|NCT01479855|Nutrients|nutrients
1324443|NCT01479829|Bipolar depression|bipolar depression
1324444|NCT01479829|Celecoxib|celecoxib
1324445|NCT01479829|Escitalopram|escitalopram
1324446|NCT01479829|Inflammation|inflammation
1324447|NCT01479816|continence|continence
1324448|NCT01479816|index|index
1324449|NCT01479790|Visante AS-OCT|visante as-oct
1324450|NCT01479790|Cirrus AS-OCT|cirrus as-oct
1324451|NCT01479790|Thermography|thermography
1324452|NCT01479790|Tear evaporation|tear evaporation
1324453|NCT01479790|Tear evaporimetry|tear evaporimetry
1324454|NCT01479777|Spinal Cord Injury|spinal cord injury
1324455|NCT01479777|Functional electrical stimulation|functional electrical stimulation
1324456|NCT01479777|Rehabilitation|rehabilitation
1324457|NCT01479751|Rocuronium|rocuronium
1324458|NCT01479751|magnesium|magnesium
1324459|NCT01479751|priming|priming
1324460|NCT01479751|ketamine|ketamine
1324461|NCT01479751|intubation|intubation
1324462|NCT01479738|arthroplasty|arthroplasty
1324463|NCT01479738|graft|graft
1324464|NCT01479738|capitate|capitate
1324465|NCT01479738|artery|artery
1324466|NCT01479725|interstitial cystitis|interstitial cystitis
1324467|NCT01479712|Irrigation|irrigation
1324468|NCT01479712|Cesarean Section|cesarean section
1324469|NCT01479712|Nausea|nausea
1324470|NCT01479712|Infection|infection
1324471|NCT01479699|Olive leaf extract|olive leaf extract
1324472|NCT01479699|Polyphenols|polyphenols
1324473|NCT01479699|Vascular function|vascular function
1324474|NCT01479699|Bioavailability|bioavailability
1324475|NCT01479699|Cytokines|cytokines
1324476|NCT01479686|GLIOMA|glioma
1324477|NCT01479686|NEURONAVIGATION|neuronavigation
1324478|NCT01479686|INTERVENTIONAL MRI|interventional mri
1324479|NCT01479673|Enteral Nutrition|enteral nutrition
1324480|NCT01479673|Parenteral Nutrition|parenteral nutrition
1324481|NCT01479673|Indirect Calorimetry|indirect calorimetry
1324482|NCT01479673|Intravenous Feeding|intravenous feeding
1324483|NCT01479660|Probiotics|probiotics
1324484|NCT01479660|ulcerative colitis|ulcerative colitis
1324485|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
1324486|NCT01479634|HIV|hiv
1324487|NCT01479634|ART|art
1324488|NCT01479621|Dose Ranging|dose ranging
1324489|NCT01479621|Fluticasone Propionate|fluticasone propionate
1324490|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
1324491|NCT01479621|Non-steroidal|non-steroidal
1324492|NCT01479621|Asthma|asthma
1324493|NCT01479595|Asthma|asthma
1324495|NCT01479595|QBX258|qbx258
1324496|NCT01479595|QAX576|qax576
1324497|NCT01479595|VAK694|vak694
1324498|NCT01479582|Adult and Pediatric|adult and pediatric
1324499|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
1324500|NCT01479582|NMDP|nmdp
1324501|NCT01479582|Transplant|transplant
1324502|NCT01479582|Hematologic Malignancies|hematologic malignancies
1324503|NCT01479582|Leukemia|leukemia
1324504|NCT01479582|Multiple Myeloma|multiple myeloma
1324505|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1324506|NCT01479582|CML|cml
1324507|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1324508|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
1324509|NCT01479582|MDS|mds
1324510|NCT01479582|Thalassemia|thalassemia
1621088|NCT00315965|Diffusion|diffusion
1324511|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
1324512|NCT01479569|MRI Catheterization|mri catheterization
1324513|NCT01479569|Pericardiocentesis|pericardiocentesis
1324514|NCT01479569|MRI Safety|mri safety
1324515|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1324516|NCT01479556|Pregabalin|pregabalin
1324517|NCT01479556|Neuropathic pain|neuropathic pain
1324518|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
1324519|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
1324520|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
1324521|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
1324522|NCT01479543|Probiotic|probiotic
1324523|NCT01479543|Immunity|immunity
1324524|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
1324525|NCT01479530|Rasagiline|rasagiline
1324526|NCT01479530|Azilect|azilect
1324527|NCT01479530|Parkinson´s Disease|parkinson´s disease
1324528|NCT01479530|Motor fluctuations|motor fluctuations
1324529|NCT01479517|operative|operative
1324530|NCT01479517|dental procedure|dental procedure
1324531|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1324532|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1324533|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1324534|NCT01479504|Nedaplatin|nedaplatin
1324535|NCT01479491|Japan|japan
1324536|NCT01479491|Retrospective|retrospective
1324537|NCT01479491|Observational|observational
1324538|NCT01479491|Epidemiological study|epidemiological study
1324539|NCT01479491|Children aged < 12 months|children aged < 12 months
1324540|NCT01479491|Intussusception|intussusception
1324541|NCT01479465|GSI|gsi
1324542|NCT01479465|Gilead|gilead
1324543|NCT01479465|Gilead Sciences|gilead sciences
1324544|NCT01479465|GS-6624|gs-6624
1324545|NCT01479465|Colorectal Cancer|colorectal cancer
1324546|NCT01479465|KRAS|kras
1324547|NCT01479465|Oncology|oncology
1324548|NCT01479465|monoclonal antibody|monoclonal antibody
1324549|NCT01479452|obesity|obesity
1324550|NCT01479452|bariatric surgery|bariatric surgery
1324551|NCT01479452|weight loss|weight loss
1324552|NCT01479426|Erectile dysfunction|erectile dysfunction
1324553|NCT01479426|Korean Red Ginseng|korean red ginseng
1324554|NCT01479426|IIEF|iief
1324555|NCT01479426|MSHQ|mshq
1324556|NCT01479413|Schizophrenia|schizophrenia
1324557|NCT01479413|Oxidative stress|oxidative stress
1324558|NCT01479413|Mitochondria|mitochondria
1324559|NCT01479400|antipsychotic|antipsychotic
1324560|NCT01479400|schizophrenia|schizophrenia
1324561|NCT01479400|infant development|infant development
1324562|NCT01479387|Zevalin|zevalin
1324563|NCT01479387|CD20+|cd20+
1324564|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1324565|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
1324566|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
1324567|NCT01479374|Ocular Allergy|ocular allergy
1324568|NCT01479361|Atovaquone|atovaquone
1324569|NCT01479361|Drug Interaction|drug interaction
1324570|NCT01479361|Pharmacokinetics|pharmacokinetics
1324571|NCT01479361|Efavirenz|efavirenz
1324572|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
1324573|NCT01479361|HIV|hiv
1324574|NCT01479348|Imaging|imaging
1324575|NCT01479348|Radiopharmaceutical|radiopharmaceutical
1324576|NCT01479348|Safety|safety
1324577|NCT01479348|Dosimetry|dosimetry
1324578|NCT01479348|Drug Distribution|drug distribution
1324579|NCT01479348|Cancer|cancer
1324580|NCT01479322|Intima-media thickness|intima-media thickness
1324581|NCT01479322|Ghrelin|ghrelin
1324582|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
1324583|NCT01479309|Advanced Malignancies|advanced malignancies
1324584|NCT01479309|Solid Tumors|solid tumors
1324585|NCT01479309|Melanoma|melanoma
1324586|NCT01479309|Renal Cell Carcinoma|renal cell carcinoma
1324587|NCT01479309|Phase I Studies|phase i studies
1324588|NCT01479309|Sodium Stibogluconate|sodium stibogluconate
1324589|NCT01479309|Interferon Alpha-2b|interferon alpha-2b
1324590|NCT01479309|Intron A|intron a
1324591|NCT01479309|SSG|ssg
1324592|NCT01479283|Infection|infection
1324593|NCT01479283|Bone Neoplasms|bone neoplasms
1324594|NCT01479283|Prosthesis|prosthesis
1324595|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
1324596|NCT01479283|Randomized|randomized
1324597|NCT01479270|recovery|recovery
1324598|NCT01479270|postoperative|postoperative
1324599|NCT01479270|pain|pain
1324600|NCT01479270|laparoscopy|laparoscopy
1324601|NCT01479270|hysterectomy|hysterectomy
1324602|NCT01479270|ropivacaine|ropivacaine
1324603|NCT01479270|TAP block|tap block
1324604|NCT01479270|local anesthesia|local anesthesia
1324605|NCT01479257|Cancer|cancer
1324606|NCT01479257|Risk factors|risk factors
1324607|NCT01479257|Latinos|latinos
1324608|NCT01479257|Hispanic Americans|hispanic americans
1324609|NCT01479257|Hispanics|hispanics
1324610|NCT01479257|Latino resident|latino resident
1324611|NCT01479257|Houston metropolitan area|houston metropolitan area
1324612|NCT01479257|Spanish speaking|spanish speaking
1324613|NCT01479257|Cancer risk behaviors|cancer risk behaviors
1324614|NCT01479257|Questionnaires|questionnaires
1324615|NCT01479257|Surveys|surveys
1324616|NCT01479257|Accelerometer|accelerometer
1324617|NCT01479244|HER2|her2
1324618|NCT01479244|low or intermediate|low or intermediate
1324619|NCT01479244|breast cancer|breast cancer
1324620|NCT01479244|node-positive tumors|node-positive tumors
1324621|NCT01479231|GERD|gerd
1324622|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
1324623|NCT01479231|Proton pump inhibitor|proton pump inhibitor
1324624|NCT01479231|dysphagia|dysphagia
1324625|NCT01479205|specific immunotherapy|specific immunotherapy
1324626|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
1324627|NCT01479205|specific IgE|specific ige
1324628|NCT01479205|specific IgG|specific igg
1324629|NCT01479205|specific IgG4|specific igg4
1324630|NCT01479205|SIT|sit
1324631|NCT01479192|breast|breast
1324632|NCT01479192|cancer|cancer
1324633|NCT01479192|prevention|prevention
1324634|NCT01479192|fenretinide|fenretinide
1324635|NCT01479179|Breast Cancer|breast cancer
1324636|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
1324637|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
1324638|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
1324639|NCT01479179|AMG 479|amg 479
1324640|NCT01479179|Trastuzumab|trastuzumab
1324641|NCT01479179|Herceptin|herceptin
1324642|NCT01479166|cystic fibrosis|cystic fibrosis
1324643|NCT01479166|HRCT|hrct
1324644|NCT01479166|Sputum|sputum
1324645|NCT01479166|Blood|blood
1324646|NCT01479166|Inflammation|inflammation
1324647|NCT01479166|adaptive immune system|adaptive immune system
1324648|NCT01479166|innate immune system|innate immune system
1324649|NCT01479153|Central venous catheterization|central venous catheterization
1324650|NCT01479153|Major complications|major complications
1324651|NCT01479153|Internal Jugular|internal jugular
1324652|NCT01479153|Femoral|femoral
1324653|NCT01479153|Subclavian|subclavian
1324654|NCT01479140|myocardial infarction|myocardial infarction
1324655|NCT01479140|dissection|dissection
1324656|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
1324657|NCT01479140|coronary ectasia|coronary ectasia
1324658|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
1324659|NCT01479140|coronary vasculitis|coronary vasculitis
1324660|NCT01479140|coronary embolism|coronary embolism
1324661|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
1324662|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1324663|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
1324664|NCT01479127|Severe motor fluctuations|severe motor fluctuations
1324665|NCT01479127|Dyskinesia|dyskinesia
1324666|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
1324667|NCT01479088|Cinacalcet|cinacalcet
1324668|NCT01479088|PK|pk
1324669|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1324670|NCT01479088|Paediatric|paediatric
1324671|NCT01479088|Chronic Kidney Disease|chronic kidney disease
1324672|NCT01479088|Dialysis|dialysis
1324673|NCT01479075|central insulin|central insulin
1325083|NCT01477450|Oxygen|oxygen
1324674|NCT01479075|insulin resistance|insulin resistance
1324675|NCT01479075|energy metabolism|energy metabolism
1324676|NCT01479062|behavior change|behavior change
1324677|NCT01479062|pre-diabetes|pre-diabetes
1324678|NCT01479062|prevention|prevention
1324679|NCT01479062|diabetes prevention|diabetes prevention
1324680|NCT01479062|Hemoglobin A1c|hemoglobin a1c
1324681|NCT01479062|glucose|glucose
1324682|NCT01479062|physical activity|physical activity
1324683|NCT01479062|nutrition|nutrition
1324684|NCT01479062|email|email
1324685|NCT01479062|web|web
1324686|NCT01479062|obesity|obesity
1324687|NCT01479049|congenital heart disease|congenital heart disease
1324688|NCT01479049|cardiac surgery|cardiac surgery
1324689|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
1324690|NCT01479049|cardioplegia|cardioplegia
1324691|NCT01479036|breast cancer|breast cancer
1324692|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1324693|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
1324694|NCT01479036|docetaxel|docetaxel
1324695|NCT01479036|epirubicin|epirubicin
1324696|NCT01478984|NSTEMI|nstemi
1324697|NCT01478984|PCI|pci
1324698|NCT01478984|onestage|onestage
1324699|NCT01478984|multistaged|multistaged
1324700|NCT01478971|Anemia|anemia
1324804|NCT01478542|Vitamin D|vitamin d
1324701|NCT01478971|Chronic Renal Failure|chronic renal failure
1324702|NCT01478971|CRF|crf
1324703|NCT01478971|Chronic Kidney Disease|chronic kidney disease
1324704|NCT01478971|CKD|ckd
1324705|NCT01478971|Erythropoietin|erythropoietin
1324706|NCT01478971|Hematide|hematide
1324707|NCT01478971|Peginesatide|peginesatide
1324708|NCT01478971|Hemoglobin|hemoglobin
1324709|NCT01478971|Hgb|hgb
1324710|NCT01478971|Red Blood Cell|red blood cell
1324711|NCT01478971|Red Blood Cell Production|red blood cell production
1324712|NCT01478971|Dialysis|dialysis
1324713|NCT01478958|fatty acids|fatty acids
1324714|NCT01478958|cardiovascular disease|cardiovascular disease
1324715|NCT01478958|vascular function|vascular function
1324716|NCT01478958|microparticles|microparticles
1324717|NCT01478945|vitiligo|vitiligo
1324718|NCT01478945|early vitiligo|early vitiligo
1324719|NCT01478945|focal vitiligo|focal vitiligo
1324720|NCT01478932|dyspnea|dyspnea
1324721|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
1324722|NCT01478932|Heart failure|heart failure
1324723|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
1324724|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
1324725|NCT01478919|Local Residual Neoplasia|local residual neoplasia
1324726|NCT01478919|Colonoscopy|colonoscopy
1324727|NCT01478919|Therapy|therapy
1324728|NCT01478893|nicotine vaccine|nicotine vaccine
1324729|NCT01478893|smoking vaccine|smoking vaccine
1324730|NCT01478893|smoking cessation|smoking cessation
1324731|NCT01478893|SEL-068|sel-068
1324732|NCT01478867|celiac disease|celiac disease
1324733|NCT01478867|gluten-free diet|gluten-free diet
1324734|NCT01478867|gluten peptides|gluten peptides
1324735|NCT01478867|feces|feces
1324736|NCT01478841|insulin resistance|insulin resistance
1324737|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
1324738|NCT01478841|cardiovascular complications|cardiovascular complications
1324739|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
1324740|NCT01478841|oxidative stress|oxidative stress
1324741|NCT01478802|Mechanical Ventilation|mechanical ventilation
1324742|NCT01478802|High frequency oscillation|high frequency oscillation
1324743|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
1324744|NCT01478776|ASP|asp
1324745|NCT01478776|LCN2|lcn2
1324746|NCT01478776|RBP4|rbp4
1324747|NCT01478776|C5L2|c5l2
1324748|NCT01478763|PDRP|pdrp
1324749|NCT01478763|vitreous|vitreous
1324750|NCT01478763|protein|protein
1324751|NCT01478763|vitrectomy|vitrectomy
1324752|NCT01478750|obesity|obesity
1324753|NCT01478750|fat|fat
1324754|NCT01478750|appetite|appetite
1324755|NCT01478750|digestion|digestion
1324756|NCT01478737|PDRP|pdrp
1324757|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
1324758|NCT01478737|vitrectomy|vitrectomy
1324759|NCT01478698|peritoneal dialysis|peritoneal dialysis
1324760|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
1324761|NCT01478698|peritonitis|peritonitis
1324762|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
1324763|NCT01478672|Promotion health|promotion health
1324764|NCT01478659|Diet|diet
1324765|NCT01478659|Fiber|fiber
1324766|NCT01478659|Adult|adult
1324767|NCT01478659|Fructooligosaccharide|fructooligosaccharide
1324768|NCT01478646|breathing therapy|breathing therapy
1324769|NCT01478646|reflective breathing therapy|reflective breathing therapy
1324770|NCT01478646|COPD|copd
1324771|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1324772|NCT01478633|Alzheimer's disease|alzheimer's disease
1324773|NCT01478633|Dementia|dementia
1324774|NCT01478633|Galantamine|galantamine
1324775|NCT01478633|Donepezil|donepezil
1324776|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
1324777|NCT01478607|Qutenza|qutenza
1325085|NCT01477437|teens|teens
1324778|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
1324779|NCT01478594|Avastin|avastin
1324780|NCT01478594|bevacizumab|bevacizumab
1324781|NCT01478594|tivozanib|tivozanib
1324782|NCT01478594|mFOLFOX6|mfolfox6
1324783|NCT01478594|BATON-CRC|baton-crc
1324784|NCT01478594|AV951|av951
1324785|NCT01478594|ASP4130|asp4130
1324786|NCT01478581|PCI-32765|pci-32765
1324787|NCT01478581|Multiple Myeloma|multiple myeloma
1324788|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
1324789|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1324790|NCT01478568|Pharmacokinetics|pharmacokinetics
1324791|NCT01478568|Mirabegron|mirabegron
1324792|NCT01478568|Phase 1|phase 1
1324793|NCT01478555|Dry Eye|dry eye
1324794|NCT01478542|DLBCL|dlbcl
1324795|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
1324796|NCT01478542|Optimised Rituximab|optimised rituximab
1324797|NCT01478542|Toxicity|toxicity
1324798|NCT01478542|Elderly Patients|elderly patients
1324799|NCT01478542|FDG-PET|fdg-pet
1324800|NCT01478542|Bulky Disease|bulky disease
1324801|NCT01478542|Radiation|radiation
1324802|NCT01478542|age >60 years|age >60 years
1324803|NCT01478542|First line Therapy|first line therapy
1324805|NCT01478529|Pharmacokinetics|pharmacokinetics
1324806|NCT01478529|Mirabegron|mirabegron
1324807|NCT01478529|Phase 1|phase 1
1324808|NCT01478516|autologous plasmin|autologous plasmin
1324809|NCT01478516|macular edema|macular edema
1324810|NCT01478516|vitreous|vitreous
1324811|NCT01478503|Pharmacokinetics|pharmacokinetics
1324812|NCT01478503|Mirabegron|mirabegron
1324813|NCT01478503|Phase 1|phase 1
1324814|NCT01478503|Dose-Escalation|dose-escalation
1324815|NCT01478490|Pharmacokinetics,|pharmacokinetics,
1324816|NCT01478490|Mirabegron|mirabegron
1324817|NCT01478490|Metoprolol|metoprolol
1324818|NCT01478490|CYP2D6|cyp2d6
1324819|NCT01478490|Phase 1|phase 1
1324820|NCT01478477|Breast Cancer|breast cancer
1324821|NCT01478451|DOMS|doms
1324822|NCT01478438|Unifocal|unifocal
1324823|NCT01478438|20mm in diameter|20mm in diameter
1324824|NCT01478438|measures|measures
1324825|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
1324826|NCT01478425|Prevention|prevention
1324827|NCT01478425|Pollen|pollen
1324828|NCT01478425|Allergy|allergy
1324829|NCT01478425|Rhinitis|rhinitis
1324830|NCT01478412|Prostate cancer|prostate cancer
1324831|NCT01478412|Low risk|low risk
1324832|NCT01478412|Intermediate risk|intermediate risk
1324833|NCT01478412|T1|t1
1324834|NCT01478412|T2a|t2a
1324835|NCT01478412|T2b|t2b
1324836|NCT01478412|Gleason 6|gleason 6
1324837|NCT01478412|Gleason 7|gleason 7
1324838|NCT01478412|PSA 10|psa 10
1324839|NCT01478412|PSA 20|psa 20
1324840|NCT01478373|GIST|gist
1324841|NCT01478373|Dovitinib|dovitinib
1324842|NCT01478360|Asthma|asthma
1324843|NCT01478360|Secukinumab|secukinumab
1324844|NCT01478360|Therapeutic Uses|therapeutic uses
1324845|NCT01478360|Respiratory|respiratory
1324846|NCT01478360|Lung|lung
1324847|NCT01478360|Pulmonary|pulmonary
1324848|NCT01478360|inhaled|inhaled
1324849|NCT01478360|corticosteroids|corticosteroids
1324850|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
1324851|NCT01478334|High intensity exercise|high intensity exercise
1324852|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
1324853|NCT01478321|Information Not Provided|information not provided
1324854|NCT01478308|prostate|prostate
1324855|NCT01478308|castration resistant|castration resistant
1324856|NCT01478308|hormone resistant|hormone resistant
1324857|NCT01478308|CRPC|crpc
1324858|NCT01478295|Nursing intervention|nursing intervention
1324859|NCT01478295|Primary Health care|primary health care
1324860|NCT01478295|caregiver|caregiver
1324861|NCT01478295|strain|strain
1324862|NCT01478282|dabigatran|dabigatran
1324863|NCT01478282|rivaroxaban|rivaroxaban
1324864|NCT01478282|oral anticoagulants|oral anticoagulants
1324865|NCT01478282|coagulation|coagulation
1324866|NCT01478282|bleeding|bleeding
1324867|NCT01478282|plasma concentrates|plasma concentrates
1324868|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
1324869|NCT01478269|R-CHOP|r-chop
1324870|NCT01478256|blepharitis|blepharitis
1324871|NCT01478256|topical erythromycin|topical erythromycin
1324872|NCT01478256|topical besifloxocin|topical besifloxocin
1324873|NCT01478243|Keloid|keloid
1324874|NCT01478230|Pharmacokinetics|pharmacokinetics
1324875|NCT01478217|lung ultrasonography|lung ultrasonography
1324876|NCT01478217|pressure-volume loops|pressure-volume loops
1324877|NCT01478217|ARDS|ards
1324878|NCT01478204|Alzheimer's disease|alzheimer's disease
1324879|NCT01478204|Sleep quality|sleep quality
1324880|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
1324881|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
1324882|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
1324883|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
1325084|NCT01477450|oxygen concentrator|oxygen concentrator
1324884|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
1324885|NCT01478178|Glioma|glioma
1324886|NCT01478178|Glioblastoma|glioblastoma
1324887|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
1324889|NCT01478178|brain tumor|brain tumor
1324890|NCT01478178|brain cancer|brain cancer
1324891|NCT01478178|recurrent brain tumor|recurrent brain tumor
1324892|NCT01478178|recurrent brain cancer|recurrent brain cancer
1324893|NCT01478178|refractory brain tumor|refractory brain tumor
1324894|NCT01478178|refractory brain cancer|refractory brain cancer
1324895|NCT01478178|recurrent GBM|recurrent gbm
1324896|NCT01478178|refractory GBM|refractory gbm
1324897|NCT01478178|recurrent glioma|recurrent glioma
1324898|NCT01478178|refractory glioma|refractory glioma
1324899|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
1324900|NCT01478178|refractory glioblastoma|refractory glioblastoma
1324901|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1324902|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
1324903|NCT01478178|failed temodar|failed temodar
1324904|NCT01478178|failed temozolomide|failed temozolomide
1324905|NCT01478178|temodar refractory|temodar refractory
1324906|NCT01478178|temozolomide refractory|temozolomide refractory
1324907|NCT01478178|failed avastin|failed avastin
1324908|NCT01478178|avastin refractory|avastin refractory
1324909|NCT01478178|failed bevacizumab|failed bevacizumab
1324910|NCT01478178|bevacizumab refractory|bevacizumab refractory
1324911|NCT01478178|avastin failure|avastin failure
1324912|NCT01478178|bevacizumab failure|bevacizumab failure
1324913|NCT01478178|temodar failure|temodar failure
1324914|NCT01478178|temozolomide failure|temozolomide failure
1324915|NCT01478165|Palonosetron|palonosetron
1324916|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
1324917|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
1324918|NCT01478152|Asthma|asthma
1324919|NCT01478152|Ectoin|ectoin
1324920|NCT01478152|Ectoine|ectoine
1324921|NCT01478152|FeNO|feno
1324922|NCT01478152|Metacholin|metacholin
1324923|NCT01478152|sRaw|sraw
1324924|NCT01478139|anorectal fistula|anorectal fistula
1324925|NCT01478139|acellular dermal matrix|acellular dermal matrix
1324926|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
1324927|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
1324928|NCT01478139|complications of treatment|complications of treatment
1324929|NCT01478139|recurrence|recurrence
1324930|NCT01478113|Major Depressive Disorder|major depressive disorder
1324931|NCT01478113|Therapy|therapy
1324932|NCT01478113|Medication study|medication study
1324933|NCT01478113|Depression|depression
1324934|NCT01478113|Therapy study|therapy study
1324935|NCT01478100|Coronary artery disease|coronary artery disease
1324936|NCT01478100|CT|ct
1324937|NCT01478100|Computational flow dynamics|computational flow dynamics
1324938|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
1324939|NCT01478074|Relapsed leukemia|relapsed leukemia
1324940|NCT01478074|Refractory leukemia|refractory leukemia
1324941|NCT01478074|Natural Killer Cells|natural killer cells
1324942|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
1324943|NCT01478074|NK cell infusion|nk cell infusion
1324944|NCT01478074|Haploidentical|haploidentical
1324945|NCT01478074|KIR mismatch|kir mismatch
1324946|NCT01478074|Fludarabine|fludarabine
1324947|NCT01478074|Cytarabine|cytarabine
1324948|NCT01478074|Ara-C|ara-c
1324949|NCT01478074|ALT-801|alt-801
1324950|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1324951|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
1324952|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
1324953|NCT01478035|Randomized|randomized
1324954|NCT01478035|Placebo-controlled|placebo-controlled
1324955|NCT01478035|Double blind|double blind
1324956|NCT01478035|Patient 50 years or older|patient 50 years or older
1324957|NCT01478022|DMD|dmd
1324958|NCT01478022|Duchenne|duchenne
1324959|NCT01478022|Muscular Dystrophy|muscular dystrophy
1324960|NCT01477996|intravitreal therapy|intravitreal therapy
1324961|NCT01477996|pain scales|pain scales
1324962|NCT01477996|gauge|gauge
1324963|NCT01477996|Pain Scores|pain scores
1324964|NCT01477996|Visual Analog Scale|visual analog scale
1324965|NCT01477983|atrial fibrillation|atrial fibrillation
1324966|NCT01477983|catheter ablation|catheter ablation
1324967|NCT01477983|adenosine triphosphate|adenosine triphosphate
1324968|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
1324969|NCT01477970|GnRH antagonists|gnrh antagonists
1324970|NCT01477970|OHSS|ohss
1324971|NCT01477970|ovarian stimulation|ovarian stimulation
1324972|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
1324973|NCT01477957|Insulin sensitivity|insulin sensitivity
1324974|NCT01477957|insulin resistance|insulin resistance
1324975|NCT01477944|Statins pattern of use|statins pattern of use
1324976|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
1324977|NCT01477944|Statins|statins
1324978|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
1324979|NCT01477931|Wellbutrin XL|wellbutrin xl
1324980|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
1324981|NCT01477918|prevalence|prevalence
1324982|NCT01477918|Korea|korea
1324983|NCT01477905|priming|priming
1324984|NCT01477905|remifentanil|remifentanil
1324985|NCT01477905|target-controlled infusion|target-controlled infusion
1324986|NCT01477840|Misoprostol|misoprostol
1324987|NCT01477840|Oxytocin|oxytocin
1324988|NCT01477840|Cesarean Delivery|cesarean delivery
1324989|NCT01477840|Blood Loss|blood loss
1324990|NCT01477814|colorectal cancer|colorectal cancer
1324991|NCT01477814|screening|screening
1324992|NCT01477814|colonoscopy|colonoscopy
1324993|NCT01477814|fecal immunochemical test|fecal immunochemical test
1324994|NCT01477814|clinical guidelines|clinical guidelines
1324995|NCT01477788|pelvic mass|pelvic mass
1324996|NCT01477788|ovarian mass|ovarian mass
1324997|NCT01477788|ultrasound|ultrasound
1324998|NCT01477788|serum markers|serum markers
1324999|NCT01477788|ovarian malignancy|ovarian malignancy
1325000|NCT01477775|myocardial infarction|myocardial infarction
1325001|NCT01477775|coronary stent|coronary stent
1325002|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
1325003|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
1325004|NCT01477762|startle response|startle response
1325005|NCT01477762|fear conditioning|fear conditioning
1325006|NCT01477762|PTSD|ptsd
1325007|NCT01477749|prostate cancer|prostate cancer
1325008|NCT01477749|prostate|prostate
1325009|NCT01477749|immune therapy|immune therapy
1325010|NCT01477749|immunotherapy|immunotherapy
1325011|NCT01477749|vaccine|vaccine
1325012|NCT01477749|dendritic cells|dendritic cells
1325013|NCT01477749|antigen-presenting cells|antigen-presenting cells
1325014|NCT01477749|antigen presenting cells|antigen presenting cells
1325015|NCT01477749|cancer vaccine|cancer vaccine
1325016|NCT01477749|PSA|psa
1621293|NCT00315159|Cell|cell
1325017|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
1325018|NCT01477736|Neurogenic bladder|neurogenic bladder
1325019|NCT01477736|Urodynamic|urodynamic
1325020|NCT01477736|Quality of life|quality of life
1325021|NCT01477710|Mechanical ventilation|mechanical ventilation
1325022|NCT01477710|Tidal volume|tidal volume
1325023|NCT01477710|Respiratory rate|respiratory rate
1325024|NCT01477697|Trauma|trauma
1325025|NCT01477671|Dengue|dengue
1325026|NCT01477671|Dengue Fever|dengue fever
1325027|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1325028|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
1325029|NCT01477658|Pacemaker|pacemaker
1325030|NCT01477658|Cardiac pacing|cardiac pacing
1325031|NCT01477658|Children|children
1325032|NCT01477658|Heart failure|heart failure
1325033|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
1325034|NCT01477658|Echocardiography|echocardiography
1325035|NCT01477658|Quality of life|quality of life
1325036|NCT01477658|Six-minute walk test|six-minute walk test
1325037|NCT01477658|Young adults|young adults
1325038|NCT01477619|Pharmacokinetics|pharmacokinetics
1325039|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
1325040|NCT01477606|FLT3-ITD|flt3-itd
1325041|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
1325042|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
1325043|NCT01477554|Women|women
1325044|NCT01477554|Maternal morbidity|maternal morbidity
1325045|NCT01477554|Maternal mortality|maternal mortality
1325046|NCT01477554|Perinatal mortality|perinatal mortality
1325047|NCT01477554|Perinatal morbidity|perinatal morbidity
1325048|NCT01477554|Training|training
1325049|NCT01477554|Obstetric Emergency|obstetric emergency
1325050|NCT01477554|Medical team|medical team
1325051|NCT01477554|Simulation|simulation
1325052|NCT01477541|Prenatal care|prenatal care
1325053|NCT01477541|Maternal mortality|maternal mortality
1325054|NCT01477541|Perinatal mortality|perinatal mortality
1325055|NCT01477541|Perinatal|perinatal
1325056|NCT01477541|Puerperium|puerperium
1325057|NCT01477541|Puerperium care|puerperium care
1325058|NCT01477541|Midwives|midwives
1325059|NCT01477541|Midwife|midwife
1325060|NCT01477541|Obstetric|obstetric
1325061|NCT01477541|Nurse|nurse
1325062|NCT01477541|Integration|integration
1325063|NCT01477541|Alternative personnel|alternative personnel
1325064|NCT01477541|Skilled attendant|skilled attendant
1325065|NCT01477541|Birth attendant|birth attendant
1325066|NCT01477541|Delivery|delivery
1325067|NCT01477541|Delivery services|delivery services
1325068|NCT01477541|Best practices|best practices
1325069|NCT01477541|Rural|rural
1325070|NCT01477528|HeartMate II|heartmate ii
1325071|NCT01477528|Anticoagulation|anticoagulation
1325072|NCT01477528|Thoratec Corporation|thoratec corporation
1325073|NCT01477502|urinary tract infection|urinary tract infection
1325074|NCT01477502|spinal cord injury|spinal cord injury
1325075|NCT01477502|homeopathy|homeopathy
1325076|NCT01477502|prevention|prevention
1325077|NCT01477476|DKA|dka
1325078|NCT01477476|Diabetes|diabetes
1325079|NCT01477476|Type I Diabetes|type i diabetes
1325080|NCT01477463|quality of life|quality of life
1325081|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
1325082|NCT01477450|Altitude|altitude
1325086|NCT01477437|adolescents|adolescents
1325087|NCT01477437|Internet intervention|internet intervention
1325088|NCT01477437|Hemophilia|hemophilia
1325089|NCT01477424|Drug-drug interaction|drug-drug interaction
1325090|NCT01477424|Pharmacokinetics|pharmacokinetics
1325091|NCT01477424|PA21|pa21
1325092|NCT01477411|Drug-drug interaction|drug-drug interaction
1325093|NCT01477411|Pharmacokinetics|pharmacokinetics
1325094|NCT01477411|PA21|pa21
1325095|NCT01477385|dental caries|dental caries
1325096|NCT01477385|primary teeth|primary teeth
1325097|NCT01477385|permanent teeth|permanent teeth
1325098|NCT01477385|silver diamine fluoride|silver diamine fluoride
1325099|NCT01477372|Pregnancy|pregnancy
1325100|NCT01477372|Exercise|exercise
1325101|NCT01477372|Excessive weight gain|excessive weight gain
1325102|NCT01477372|Outcomes|outcomes
1325103|NCT01477372|Urinary incontinence|urinary incontinence
1325104|NCT01477359|Sarcoidosis|sarcoidosis
1325105|NCT01477333|Tyvaso|tyvaso
1325106|NCT01477333|UT-15C SR|ut-15c sr
1325107|NCT01477333|PAH|pah
1325108|NCT01477320|Enteral Nutrition|enteral nutrition
1325109|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
1325110|NCT01477320|Critically Ill Patients|critically ill patients
1325111|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
1325112|NCT01477320|Stress gastropathy|stress gastropathy
1325113|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
1325114|NCT01477320|Vital AF|vital af
1325115|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
1325116|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
1325117|NCT01477307|obesity|obesity
1325118|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1325119|NCT01477294|Total|total
1621294|NCT00315159|Carcinoma|carcinoma
1325120|NCT01477294|Intra and Extracellular Water|intra and extracellular water
1325121|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
1325122|NCT01477294|Body Composition|body composition
1325123|NCT01477294|Dilution Techniques|dilution techniques
1325124|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
1325125|NCT01477281|Daflon|daflon
1325126|NCT01477281|Venaflon|venaflon
1325127|NCT01477268|antidepressants|antidepressants
1325128|NCT01477268|depression|depression
1325129|NCT01477268|zoloft|zoloft
1325130|NCT01477268|psychiatry|psychiatry
1325131|NCT01477268|psychology|psychology
1325132|NCT01477255|daily assessment|daily assessment
1325133|NCT01477255|electronic diary|electronic diary
1325134|NCT01477255|coping strategies|coping strategies
1325135|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
1325136|NCT01477255|psychology|psychology
1325137|NCT01477242|vomiting|vomiting
1325138|NCT01477242|anti-emetics|anti-emetics
1325139|NCT01477242|ketamine|ketamine
1325140|NCT01477242|sedation|sedation
1325141|NCT01477229|Rectal cancer|rectal cancer
1325142|NCT01477229|Quality of Life|quality of life
1325143|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
1325144|NCT01477229|Anterior Resection|anterior resection
1325145|NCT01477229|Palliative cancer treatment|palliative cancer treatment
1325146|NCT01477229|Radio chemotherapy|radio chemotherapy
1325147|NCT01477216|Glycemic index|glycemic index
1325148|NCT01477216|Glycemic responses|glycemic responses
1325149|NCT01477216|Insulin responses|insulin responses
1325150|NCT01477216|Insulinemic index|insulinemic index
1325151|NCT01477216|Carbohydrates|carbohydrates
1325152|NCT01477216|Methodology|methodology
1325153|NCT01477216|Glucose metabolism|glucose metabolism
1325154|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
1325155|NCT01477164|Exercise|exercise
1325156|NCT01477164|Aging|aging
1325157|NCT01477164|Sarcopenia|sarcopenia
1325158|NCT01477164|Muscle function|muscle function
1325159|NCT01477151|isoflurane|isoflurane
1325160|NCT01477151|sevoflurane|sevoflurane
1325161|NCT01477151|troponin|troponin
1325162|NCT01477151|anesthesia|anesthesia
1325163|NCT01477151|cardioprotection|cardioprotection
1325164|NCT01477151|preconditioning|preconditioning
1325165|NCT01477151|cardiac surgery|cardiac surgery
1325166|NCT01477151|cardiac anesthesia|cardiac anesthesia
1325167|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
1325168|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
1325169|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1325170|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
1325172|NCT01477125|adhd|adhd
1325173|NCT01477125|adults|adults
1325174|NCT01477125|working memory|working memory
1325175|NCT01477125|training|training
1325176|NCT01477125|RCT|rct
1325177|NCT01477112|Type 2 diabetes|type 2 diabetes
1325178|NCT01477112|β-carotene|β-carotene
1325179|NCT01477112|Oxidative balance|oxidative balance
1325180|NCT01477112|Oxidants|oxidants
1325181|NCT01477112|Antioxidants|antioxidants
1325182|NCT01477086|Sarcopenia|sarcopenia
1325183|NCT01477086|Hip fracture|hip fracture
1325184|NCT01477086|Frailty|frailty
1325185|NCT01477073|in-vitro fertilization|in-vitro fertilization
1325186|NCT01477073|reproductive disorder|reproductive disorder
1325187|NCT01477034|Vitamin D deficiency|vitamin d deficiency
1325188|NCT01477034|Obesity|obesity
1325189|NCT01477034|Inflammation|inflammation
1325190|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
1325191|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
1325192|NCT01477034|Diabetes|diabetes
1325193|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
1325194|NCT01477034|Insulin resistance|insulin resistance
1325195|NCT01477034|Intestinal permeability|intestinal permeability
1325196|NCT01477008|Knee|knee
1325197|NCT01477008|Cartilage repair|cartilage repair
1325198|NCT01477008|Cartilage regeneration|cartilage regeneration
1325199|NCT01477008|Chondral|chondral
1325200|NCT01477008|Osteochondral|osteochondral
1325201|NCT01477008|Biphasic scaffold|biphasic scaffold
1325202|NCT01477008|Medical device|medical device
1325203|NCT01477008|Autologous|autologous
1325204|NCT01477008|Synthetic|synthetic
1325205|NCT01477008|Medial condyle|medial condyle
1325206|NCT01477008|Lateral condyle|lateral condyle
1325207|NCT01477008|Trochlea|trochlea
1325208|NCT01476995|Cardiovascular system|cardiovascular system
1325209|NCT01476995|gastrointestinal system|gastrointestinal system
1325210|NCT01476995|kidneys|kidneys
1325211|NCT01476995|liver|liver
1325212|NCT01476995|lungs|lungs
1325213|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
1325214|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
1325215|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
1325216|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
1325217|NCT01476930|migraine|migraine
1325218|NCT01476930|prophylactic treatment|prophylactic treatment
1325219|NCT01476930|cupping|cupping
1325220|NCT01476930|serkangabin|serkangabin
1325221|NCT01476904|Asthma|asthma
1325222|NCT01476904|Bronchial Asthma|bronchial asthma
1325223|NCT01476904|Shortness of breath|shortness of breath
1325224|NCT01476891|MBSR|mbsr
1325225|NCT01476891|Cancer|cancer
1325226|NCT01476891|Online|online
1325227|NCT01476891|Mindfulness Meditation|mindfulness meditation
1325228|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
1325229|NCT01476878|Radiosurgery|radiosurgery
1325230|NCT01476878|Frameless radiosurgery|frameless radiosurgery
1325231|NCT01476878|Accuracy|accuracy
1325232|NCT01476800|Drugs, Investigational|drugs, investigational
1325233|NCT01476800|pharmacokinetics|pharmacokinetics
1325234|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
1325235|NCT01476800|YM178|ym178
1325236|NCT01476800|Mirabegron|mirabegron
1325237|NCT01476787|Follicular lymphoma|follicular lymphoma
1325238|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
1325239|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
1325240|NCT01476787|rituximab treatment|rituximab treatment
1325241|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
1325242|NCT01476761|Surgical tissue resection|surgical tissue resection
1325243|NCT01476761|Tissue dissection|tissue dissection
1325244|NCT01476761|Tissue transection|tissue transection
1325245|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
1325246|NCT01476722|Silicone Hydrogel|silicone hydrogel
1325247|NCT01476722|Soft Contact Lenses|soft contact lenses
1325248|NCT01476722|Multi-Purpose Solution|multi-purpose solution
1325249|NCT01476709|Puncture; Instrument|puncture; instrument
1325250|NCT01476709|Optics and Photonics|optics and photonics
1325251|NCT01476709|Pain|pain
1325252|NCT01476696|Sickle cell disease|sickle cell disease
1325253|NCT01476696|pediatrics|pediatrics
1325254|NCT01476696|SCD|scd
1325255|NCT01476696|children|children
1325256|NCT01476696|child|child
1325257|NCT01476696|kids|kids
1325258|NCT01476696|pain crisis|pain crisis
1325259|NCT01476696|sickle cell anemia|sickle cell anemia
1325260|NCT01476696|sickle cell pain|sickle cell pain
1325261|NCT01476683|Antidiarrheals|antidiarrheals
1325262|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
1325263|NCT01476670|Cerebral blood flow|cerebral blood flow
1325264|NCT01476670|Cerebral autoregulation|cerebral autoregulation
1325265|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
1325266|NCT01476670|Transcranial Doppler|transcranial doppler
1325267|NCT01476657|Phase 1|phase 1
1325268|NCT01476644|Health related quality of life|health related quality of life
1325269|NCT01476644|Clinical measures of vision|clinical measures of vision
1325270|NCT01476618|Provider Perspectives|provider perspectives
1325271|NCT01476618|Barriers|barriers
1325272|NCT01476618|OIF/OEF Veterans|oif/oef veterans
1325273|NCT01476605|prolotherapy|prolotherapy
1325274|NCT01476605|Platelet rich plasma|platelet rich plasma
1325275|NCT01476605|tennis elbow|tennis elbow
1325276|NCT01476605|lateral epicondylosis|lateral epicondylosis
1325277|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
1325278|NCT01476579|Coronary CT|coronary ct
1325279|NCT01476579|Sensitivity|sensitivity
1325280|NCT01476579|Specificity|specificity
1325281|NCT01476579|Radiation|radiation
1325282|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
1325283|NCT01476579|Coronary angiography|coronary angiography
1325284|NCT01476566|aged|aged
1325285|NCT01476566|family practice|family practice
1325286|NCT01476553|gastric cancer|gastric cancer
1325287|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
1325288|NCT01476553|EIPL|eipl
1325289|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
1325290|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
1325291|NCT01476514|Hyperekplexia|hyperekplexia
1325292|NCT01476514|Pain modulation|pain modulation
1325293|NCT01476514|Glycine receptors|glycine receptors
1325294|NCT01476514|Hyperalgesia|hyperalgesia
1325295|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
1325296|NCT01476501|vitamin D|vitamin d
1325297|NCT01476501|bone health|bone health
1325298|NCT01476501|diabetes|diabetes
1325299|NCT01476501|nephropathy|nephropathy
1325300|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1325301|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
1325302|NCT01476462|Second cancer|second cancer
1325303|NCT01476462|Survival|survival
1325304|NCT01476449|Diabetic Macular Edema|diabetic macular edema
1325305|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
1325306|NCT01476449|DIabetic Eye Disease|diabetic eye disease
1325307|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
1325308|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
1325309|NCT01476397|full-term|full-term
1325310|NCT01476397|formula-fed infants|formula-fed infants
1325311|NCT01476384|Glucose|glucose
1325312|NCT01476384|insulin|insulin
1325313|NCT01476384|Glycocalyx|glycocalyx
1325314|NCT01476384|Muscle|muscle
1325315|NCT01476384|Vascularisation|vascularisation
1325316|NCT01476384|young|young
1325318|NCT01476371|Group treatment|group treatment
1325319|NCT01476371|Mindfulness|mindfulness
1325320|NCT01476371|Minor mental disorders|minor mental disorders
1325321|NCT01476371|Inflammation|inflammation
1325322|NCT01476332|eyes|eyes
1325323|NCT01476332|cis-urocanic acid|cis-urocanic acid
1325324|NCT01476332|safety|safety
1325325|NCT01476332|tolerability|tolerability
1325326|NCT01476332|pharmacokinetics|pharmacokinetics
1325327|NCT01476306|feasibility|feasibility
1325328|NCT01476306|effectiveness|effectiveness
1325329|NCT01476306|Parkinson disease care|parkinson disease care
1325330|NCT01476306|care via telemedicine|care via telemedicine
1325331|NCT01476293|Infiltration|infiltration
1325332|NCT01476293|Extravasation|extravasation
1325333|NCT01476293|Leaking|leaking
1325334|NCT01476293|PIV Infiltration|piv infiltration
1325335|NCT01476293|IV Infiltration|iv infiltration
1325336|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
1325337|NCT01476293|Optical Monitoring|optical monitoring
1325338|NCT01476280|antiemetics|antiemetics
1325339|NCT01476280|ramosetron|ramosetron
1325340|NCT01476280|palonosetron|palonosetron
1325341|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
1325342|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
1325343|NCT01476254|Laparoscopic surgery|laparoscopic surgery
1325344|NCT01476215|paracetamol|paracetamol
1325345|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
1325346|NCT01476189|pharmacokinetic|pharmacokinetic
1325347|NCT01476189|paracetamol|paracetamol
1325348|NCT01476189|Healthy volunteer|healthy volunteer
1325349|NCT01476189|steady state|steady state
1325350|NCT01476176|Bioequivalence|bioequivalence
1325351|NCT01476176|Pharmacokinetics|pharmacokinetics
1325352|NCT01476176|Healthy volunteers|healthy volunteers
1325353|NCT01476176|paracetamol|paracetamol
1325354|NCT01476176|caffeine|caffeine
1325355|NCT01476163|AT1001|at1001
1325356|NCT01476163|Lysosomal storage disease|lysosomal storage disease
1325357|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
1325358|NCT01476163|migalastat|migalastat
1325359|NCT01476163|Fabry disease|fabry disease
1325360|NCT01476163|Fabry|fabry
1325361|NCT01476163|Amicus|amicus
1325362|NCT01476137|oncology|oncology
1325363|NCT01476137|solid tumors|solid tumors
1325364|NCT01476137|multiple myeloma|multiple myeloma
1325365|NCT01476137|AKT inhibitor|akt inhibitor
1325366|NCT01476137|MEK inhibitor|mek inhibitor
1325367|NCT01476111|tumor antigens|tumor antigens
1325368|NCT01476111|observational|observational
1325369|NCT01476111|breast cancer|breast cancer
1325370|NCT01476111|biomarkers|biomarkers
1325371|NCT01476111|Neoadjuvant|neoadjuvant
1325372|NCT01476059|Treatment compliance|treatment compliance
1325373|NCT01476059|Pediatric|pediatric
1325374|NCT01476059|Asthma|asthma
1325375|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
1325376|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1325377|NCT01476033|Oxidative stress|oxidative stress
1325378|NCT01476033|inflammation|inflammation
1325379|NCT01476033|blood flow|blood flow
1325380|NCT01476020|Drug eluting stent|drug eluting stent
1325381|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
1325382|NCT01476020|bleeding|bleeding
1325383|NCT01476020|stent thrombosis|stent thrombosis
1325384|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
1325385|NCT01476007|primary health care|primary health care
1325386|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
1325387|NCT01475981|JTK-853|jtk-853
1325388|NCT01475981|single dose|single dose
1325389|NCT01475942|elderly|elderly
1325390|NCT01475942|probiotic|probiotic
1325391|NCT01475942|bowel function|bowel function
1325392|NCT01475942|pathogen|pathogen
1325393|NCT01475942|constipation|constipation
1325394|NCT01475942|diarrhoea|diarrhoea
1325395|NCT01475942|Subclinical levels|subclinical levels
1325396|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
1325397|NCT01475929|probiotic|probiotic
1325398|NCT01475916|Asthma|asthma
1325399|NCT01475916|Educational program|educational program
1325400|NCT01475916|Quality of life|quality of life
1325401|NCT01475916|School-aged children|school-aged children
1325402|NCT01475903|Obesity|obesity
1325403|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
1325404|NCT01475903|Nutritional impact|nutritional impact
1325405|NCT01475903|Vitamin deficiency|vitamin deficiency
1325406|NCT01475890|HIV/AIDS|hiv/aids
1325407|NCT01475890|Nutrition|nutrition
1325408|NCT01475877|bromfenac|bromfenac
1325409|NCT01475877|nepafenac|nepafenac
1325411|NCT01475877|epithelial healing,|epithelial healing,
1325412|NCT01475864|Choledocholithiasis|choledocholithiasis
1325413|NCT01475864|metal stents|metal stents
1325414|NCT01475864|biliary duct stent|biliary duct stent
1325415|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
1325416|NCT01475838|HIV-1|hiv-1
1325417|NCT01475838|HIV|hiv
1325418|NCT01475838|Treatment Experienced|treatment experienced
1325419|NCT01475812|COPD|copd
1325420|NCT01475812|activities of daily living|activities of daily living
1325421|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
1325422|NCT01475812|exercise|exercise
1325423|NCT01475786|nerve pain|nerve pain
1325424|NCT01475786|diabetic nerve pain|diabetic nerve pain
1325425|NCT01475786|throbbing|throbbing
1325426|NCT01475786|burning|burning
1325427|NCT01475786|painful feet|painful feet
1325428|NCT01475786|tingling|tingling
1325429|NCT01475786|numbness|numbness
1325430|NCT01475773|self-esteem|self-esteem
1325431|NCT01475773|personality|personality
1325432|NCT01475773|quality of life|quality of life
1325433|NCT01475773|malocclusion|malocclusion
1325434|NCT01475773|orthodontics|orthodontics
1325435|NCT01475760|chronic kidney disease|chronic kidney disease
1325436|NCT01475760|serum phosphorus|serum phosphorus
1325437|NCT01475760|salivary phosphorus|salivary phosphorus
1325438|NCT01475760|FGF23|fgf23
1325439|NCT01475734|glucose clamp|glucose clamp
1325440|NCT01475734|hypoglycemia|hypoglycemia
1325441|NCT01475721|ADVAIR|advair
1325442|NCT01475721|Asthma|asthma
1325443|NCT01475721|safety|safety
1325444|NCT01475721|FLOVENT|flovent
1325445|NCT01475708|Lyme borreliosis|lyme borreliosis
1325446|NCT01475708|Erythema migrans|erythema migrans
1325447|NCT01475708|Doxycycline|doxycycline
1325448|NCT01475708|Subjective symptoms|subjective symptoms
1325449|NCT01475708|Outcome|outcome
1325450|NCT01475695|Mass balance|mass balance
1325451|NCT01475695|intravenous|intravenous
1325452|NCT01475695|GSK2251052|gsk2251052
1325453|NCT01475695|Healthy volunteer|healthy volunteer
1325454|NCT01475695|Antimicrobial|antimicrobial
1325455|NCT01475695|Radiolabel|radiolabel
1325456|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
1325457|NCT01475682|cardiometabolic complications|cardiometabolic complications
1325458|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
1325459|NCT01475643|Pediatric cataract|pediatric cataract
1325460|NCT01475630|temporomandibular joint|temporomandibular joint
1325461|NCT01475630|rehabilitation medicine|rehabilitation medicine
1325462|NCT01475630|joint diseases|joint diseases
1325463|NCT01475630|physical therapy|physical therapy
1325464|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
1325465|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
1325466|NCT01475591|neck|neck
1325467|NCT01475591|shoulder|shoulder
1325468|NCT01475591|back-area|back-area
1325469|NCT01475591|risk|risk
1325470|NCT01475591|longlasting|longlasting
1325471|NCT01475591|pain syndrome|pain syndrome
1325472|NCT01475578|Vascular Dementia|vascular dementia
1325473|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
1325474|NCT01475565|insulin sensitivity|insulin sensitivity
1325475|NCT01475565|insulin resistance|insulin resistance
1325476|NCT01475565|gestational diabetes|gestational diabetes
1325477|NCT01475565|pregnancy|pregnancy
1325478|NCT01475565|estrogen|estrogen
1325479|NCT01475565|glucose intolerance|glucose intolerance
1325480|NCT01475565|obesity|obesity
1325481|NCT01475565|ovulatory disorder|ovulatory disorder
1325482|NCT01475565|racial differences|racial differences
1325483|NCT01475565|hyperandrogenism|hyperandrogenism
1325484|NCT01475552|platelet reactivity|platelet reactivity
1325485|NCT01475552|platelet function assay|platelet function assay
1325486|NCT01475552|abciximab|abciximab
1325487|NCT01475552|tailored therapy|tailored therapy
1325488|NCT01475539|Polio|polio
1325489|NCT01475539|Poliovirus|poliovirus
1325490|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
1325491|NCT01475539|IMOVAX Polio®|imovax polio®
1325492|NCT01475526|grocery store|grocery store
1325493|NCT01475526|nutrition|nutrition
1325494|NCT01475526|Latino|latino
1325495|NCT01475526|Hispanic|hispanic
1325496|NCT01475513|oral contraceptive|oral contraceptive
1325497|NCT01475513|birth control pill|birth control pill
1325498|NCT01475513|women|women
1325499|NCT01475513|healthy volunteer|healthy volunteer
1325500|NCT01475513|insulin sensitivity|insulin sensitivity
1325501|NCT01475513|insulin resistance|insulin resistance
1325502|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
1325503|NCT01475513|endothelial function|endothelial function
1325504|NCT01475513|estrogen metabolism|estrogen metabolism
1325505|NCT01475513|racial difference|racial difference
1325506|NCT01475513|glucose intolerance|glucose intolerance
1325507|NCT01475474|incontinence|incontinence
1325508|NCT01475474|bowel|bowel
1325509|NCT01475474|movement|movement
1325510|NCT01475474|fecal|fecal
1325511|NCT01475474|anal|anal
1325512|NCT01475474|diarrhea|diarrhea
1325513|NCT01475474|stool|stool
1325514|NCT01475474|rectal|rectal
1325515|NCT01475474|feces|feces
1325516|NCT01475474|uncontrolled|uncontrolled
1325517|NCT01475474|loose|loose
1325518|NCT01475474|leakage|leakage
1325519|NCT01475474|rectum|rectum
1325520|NCT01475474|BM|bm
1325521|NCT01475474|watery|watery
1325522|NCT01475474|urgent|urgent
1325523|NCT01475474|flatulence|flatulence
1325524|NCT01475474|gas|gas
1325525|NCT01475461|Phase 2|phase 2
1325526|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
1325527|NCT01475461|PF-04937319|pf-04937319
1325528|NCT01475448|biomechanics|biomechanics
1325529|NCT01475448|motor control|motor control
1325530|NCT01475448|movement|movement
1325531|NCT01475448|walking|walking
1325532|NCT01475448|running|running
1325533|NCT01475448|sedentarism|sedentarism
1325534|NCT01475448|joint moment|joint moment
1325535|NCT01475409|anti-TNF|anti-tnf
1325536|NCT01475409|tuberculosis|tuberculosis
1325537|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
1325538|NCT01475409|tuberculin skin test|tuberculin skin test
1325539|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
1325540|NCT01475409|spondyloarthritis|spondyloarthritis
1325541|NCT01475396|exercise|exercise
1325542|NCT01475396|physical activity|physical activity
1325543|NCT01475396|cognition|cognition
1325544|NCT01475396|brain|brain
1325545|NCT01475396|aging|aging
1325546|NCT01475396|BDNF|bdnf
1325547|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
1325548|NCT01475383|Safety and Efficacy|safety and efficacy
1325549|NCT01475383|Randomized|randomized
1325550|NCT01475383|Placebo Control|placebo control
1325551|NCT01475383|Cross-over|cross-over
1325552|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
1325553|NCT01475370|WT1|wt1
1325554|NCT01475357|congenital heart defects|congenital heart defects
1325555|NCT01475357|growth failure|growth failure
1325556|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
1325557|NCT01475331|pancreatic cyst|pancreatic cyst
1325558|NCT01475331|chemotherapy|chemotherapy
1325559|NCT01475331|ethanol|ethanol
1325560|NCT01475331|ablation|ablation
1325561|NCT01475318|complete abortion rate|complete abortion rate
1325562|NCT01475318|side effects|side effects
1325563|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
1325564|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1325565|NCT01475305|Healthy adults|healthy adults
1325566|NCT01475305|MEDI-557|medi-557
1325567|NCT01475305|Intranasal challenge|intranasal challenge
1325568|NCT01475305|Human model|human model
1325569|NCT01475292|COPD|copd
1325570|NCT01475279|Warfarin|warfarin
1325571|NCT01475279|Dantonic|dantonic
1325572|NCT01475279|Pharmacodynamics|pharmacodynamics
1325573|NCT01475279|Pharmacokinetics|pharmacokinetics
1325574|NCT01475279|Interaction|interaction
1325575|NCT01475266|Bladder Cancer|bladder cancer
1325576|NCT01475266|NMIBC|nmibc
1325577|NCT01475266|TURBT|turbt
1325578|NCT01475266|Apaziquone|apaziquone
1325579|NCT01475266|EOquin|eoquin
1325580|NCT01475266|Immediate instillation|immediate instillation
1325581|NCT01475240|HIV|hiv
1325582|NCT01475227|HIV|hiv
1325583|NCT01475227|Bilirubin|bilirubin
1325584|NCT01475214|potassium bicarbonate|potassium bicarbonate
1325585|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
1325586|NCT01475214|urinary nitrogen|urinary nitrogen
1325587|NCT01475214|net acid excretion|net acid excretion
1325588|NCT01475201|Type 2 diabetes|type 2 diabetes
1325589|NCT01475201|Hypertension|hypertension
1325590|NCT01475201|Primary Care|primary care
1325591|NCT01475201|Physical Activity|physical activity
1325592|NCT01475201|Behavioural Intervention|behavioural intervention
1325593|NCT01475201|Pedometer|pedometer
1325594|NCT01475201|Accelerometer|accelerometer
1325595|NCT01475201|Arterial Stiffness|arterial stiffness
1325596|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
1325597|NCT01475201|Vascular disease risk|vascular disease risk
1325598|NCT01475201|Vascular disease prevention|vascular disease prevention
1325599|NCT01475201|Intervention|intervention
1325600|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
1325601|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
1325602|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
1325603|NCT01475188|signal transduction|signal transduction
1325604|NCT01475188|histamine receptor|histamine receptor
1325605|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
1325606|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
1325607|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
1325608|NCT01475162|corticosteroids|corticosteroids
1325730|NCT01474655|epiretinal membrane|epiretinal membrane
1325609|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1325610|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
1325611|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
1325612|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
1325613|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
1325614|NCT01475123|Nicorandil|nicorandil
1325615|NCT01475123|Randomized control study|randomized control study
1325616|NCT01475123|Hemodialysis|hemodialysis
1325617|NCT01475123|Coronary Artery Disease|coronary artery disease
1325618|NCT01475110|Imatinib|imatinib
1325619|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
1325620|NCT01475110|Nilotinib|nilotinib
1325621|NCT01475110|Adult patients|adult patients
1325622|NCT01475110|Imatinib resistant|imatinib resistant
1325623|NCT01475097|AE - Adverse event|ae - adverse event
1325624|NCT01475097|Arteriography|arteriography
1325625|NCT01475097|IA - Intra-arterial|ia - intra-arterial
1325626|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
1325627|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
1325628|NCT01475097|Patient Comfort|patient comfort
1325629|NCT01475097|Body Image Disturbance|body image disturbance
1325630|NCT01475097|Patient|patient
1325631|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
1325632|NCT01475084|cryobiopsy|cryobiopsy
1325633|NCT01475084|pleural biopsy|pleural biopsy
1325634|NCT01475084|pleural effusion|pleural effusion
1325635|NCT01475084|safety|safety
1325636|NCT01475084|thoracoscopy|thoracoscopy
1325637|NCT01475045|COPD|copd
1325638|NCT01475032|Asthma|asthma
1325639|NCT01475032|children|children
1325640|NCT01475032|chronic treatment|chronic treatment
1325641|NCT01475019|Obesity|obesity
1325642|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
1325643|NCT01475019|Orlistat|orlistat
1325644|NCT01475019|Sibutramine|sibutramine
1325645|NCT01475019|Androgen levels|androgen levels
1325646|NCT01475019|Insulin resistance|insulin resistance
1325647|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
1325648|NCT01475006|EGFRvIII|egfrviii
1325649|NCT01475006|Glioma|glioma
1325650|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
1325651|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
1325652|NCT01475006|Antibody drug conjugate|antibody drug conjugate
1325653|NCT01475006|brain tumor|brain tumor
1325654|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
1325655|NCT01474980|Pregnancy|pregnancy
1325656|NCT01474980|Outcome|outcome
1325657|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
1325658|NCT01474967|lipid profile|lipid profile
1325659|NCT01474967|metformin|metformin
1325660|NCT01474954|HIV|hiv
1325661|NCT01474954|Antiretroviral Medication|antiretroviral medication
1325662|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
1325663|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
1325664|NCT01474928|Asthma|asthma
1325665|NCT01474928|Community-based participatory research|community-based participatory research
1325666|NCT01474928|Educational intervention|educational intervention
1325667|NCT01474928|Ethno-cultural community|ethno-cultural community
1325668|NCT01474928|Video recording|video recording
1325669|NCT01474928|Patient education handout|patient education handout
1325670|NCT01474915|Neurosurgery|neurosurgery
1325671|NCT01474902|pediatric|pediatric
1325672|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
1325673|NCT01474902|Enoxaparin|enoxaparin
1325674|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
1325675|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
1325676|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
1325677|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
1325678|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
1325679|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
1325680|NCT01474850|mechanical ventilation|mechanical ventilation
1325681|NCT01474850|pressure control ventilation|pressure control ventilation
1325682|NCT01474850|lung recruitment|lung recruitment
1325683|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
1325684|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
1325685|NCT01474850|chest wall volume variation|chest wall volume variation
1326189|NCT01472809|Zydus|zydus
1325686|NCT01474850|intravenous anesthesia|intravenous anesthesia
1325687|NCT01474837|depressive disorders|depressive disorders
1325688|NCT01474837|exercise therapy|exercise therapy
1325689|NCT01474824|Cardiac output|cardiac output
1325690|NCT01474824|Stroke volume|stroke volume
1325691|NCT01474811|Hepatitis|hepatitis
1325692|NCT01474811|Hepatitis C|hepatitis c
1325693|NCT01474811|HCV-TARGET|hcv-target
1325695|NCT01474811|Observational Study|observational study
1325696|NCT01474798|Acne Vulgaris|acne vulgaris
1325697|NCT01474785|Obesity|obesity
1325698|NCT01474785|Bariatric surgery|bariatric surgery
1325699|NCT01474785|Nashville, Tennessee|nashville, tennessee
1325700|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1325701|NCT01474772|Pain on Walking|pain on walking
1325702|NCT01474772|Pregabalin|pregabalin
1325703|NCT01474746|Fragile X Syndrome|fragile x syndrome
1325704|NCT01474746|Pediatrics|pediatrics
1325705|NCT01474746|sertraline|sertraline
1325706|NCT01474746|autism|autism
1325707|NCT01474733|resident education|resident education
1325708|NCT01474733|health literacy|health literacy
1325709|NCT01474733|curriculum|curriculum
1325710|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
1325711|NCT01474720|Lupus|lupus
1325712|NCT01474720|SLE|sle
1325713|NCT01474720|Zostavax|zostavax
1325714|NCT01474720|shingles|shingles
1325715|NCT01474707|COPD|copd
1325716|NCT01474707|Educational materials|educational materials
1325717|NCT01474707|Cultural background|cultural background
1325718|NCT01474707|Instructional videos|instructional videos
1325719|NCT01474707|Patient education handouts|patient education handouts
1325720|NCT01474707|Lung age|lung age
1325721|NCT01474694|prospective study|prospective study
1325722|NCT01474694|multicenter trial|multicenter trial
1325723|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
1325724|NCT01474694|CE marked|ce marked
1325725|NCT01474694|medical devices|medical devices
1325726|NCT01474694|catheter ablation|catheter ablation
1325727|NCT01474681|hematologic malignancies|hematologic malignancies
1325728|NCT01474681|leukemia|leukemia
1325729|NCT01474681|lymphoma|lymphoma
1325731|NCT01474655|visual acuity|visual acuity
1325732|NCT01474655|metamorphopsia|metamorphopsia
1325733|NCT01474655|thickness of retinal layers|thickness of retinal layers
1325734|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
1325735|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
1325736|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
1325737|NCT01474642|Capecitabine|capecitabine
1325738|NCT01474642|Cisplatin|cisplatin
1325739|NCT01474642|Genexol|genexol
1325740|NCT01474629|oxidative stress|oxidative stress
1325741|NCT01474629|inflammation|inflammation
1325742|NCT01474629|endotoxemia|endotoxemia
1325743|NCT01474629|strenuous exercise|strenuous exercise
1325744|NCT01474616|Aging|aging
1325745|NCT01474616|Health Services|health services
1325746|NCT01474616|Knowledge Translation|knowledge translation
1325747|NCT01474616|Long-Term Care Facilities|long-term care facilities
1325748|NCT01474616|Mobility|mobility
1325749|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
1325750|NCT01474603|observational study|observational study
1325751|NCT01474577|stress test|stress test
1325752|NCT01474577|cardiac issues|cardiac issues
1325753|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
1325754|NCT01474577|11-150|11-150
1325755|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
1325756|NCT01474564|Blood draw|blood draw
1325757|NCT01474564|pancreas|pancreas
1325758|NCT01474564|Tumorigenic Cells|tumorigenic cells
1325759|NCT01474564|11-141|11-141
1325760|NCT01474551|Vemurafenib|vemurafenib
1325761|NCT01474551|skin cancer|skin cancer
1325762|NCT01474551|Stage IV|stage iv
1325763|NCT01474551|advanced stage III|advanced stage iii
1325764|NCT01474551|11-091|11-091
1325765|NCT01474538|diabetes|diabetes
1325766|NCT01474538|type 2 diabetes|type 2 diabetes
1325767|NCT01474538|insulin pump|insulin pump
1325768|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1325769|NCT01474538|CSII|csii
1325770|NCT01474538|A1C|a1c
1325771|NCT01474486|thiamin|thiamin
1325772|NCT01474486|pyridoxine|pyridoxine
1325773|NCT01474486|vitamin D|vitamin d
1325774|NCT01474486|zinc|zinc
1325775|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
1325776|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
1325777|NCT01474486|nutritional injury|nutritional injury
1325778|NCT01474486|quality of life|quality of life
1325779|NCT01474473|CACIPLIQ20|cacipliq20
1325780|NCT01474473|Matrix Therapy|matrix therapy
1325781|NCT01474473|Diabetic foot|diabetic foot
1325782|NCT01474460|warfarin|warfarin
1325783|NCT01474460|phytonadione|phytonadione
1325784|NCT01474460|INR|inr
1325785|NCT01474447|low back pain|low back pain
1325786|NCT01474434|coronary artery disease,|coronary artery disease,
1325787|NCT01474434|LCQ908,|lcq908,
1325788|NCT01474434|hyperlipidemia,|hyperlipidemia,
1325789|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
1325790|NCT01474434|pradigastat|pradigastat
1325791|NCT01474421|Parkinson's disease|parkinson's disease
1325792|NCT01474421|Dyskinesia|dyskinesia
1325793|NCT01474421|Movement disorders|movement disorders
1325794|NCT01474421|L-dopa|l-dopa
1325795|NCT01474408|Coronary artery bypass|coronary artery bypass
1325796|NCT01474408|Exercise therapy|exercise therapy
1325797|NCT01474408|Revascularization (PCI)|revascularization (pci)
1325798|NCT01474395|schizophrenia|schizophrenia
1325799|NCT01474395|cognitive remediation|cognitive remediation
1325800|NCT01474395|NMDA|nmda
1325801|NCT01474382|OraVerse|oraverse
1325802|NCT01474382|Safety|safety
1325803|NCT01474382|Efficacy|efficacy
1325804|NCT01474382|Pediatric|pediatric
1325805|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
1325806|NCT01474369|Drug Therapy|drug therapy
1325807|NCT01474356|brachytherapy|brachytherapy
1325808|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
1325809|NCT01474356|cervical cancer|cervical cancer
1325810|NCT01474356|side effects|side effects
1325811|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
1325812|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
1325813|NCT01474343|Nervous System Diseases|nervous system diseases
1325814|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
1325815|NCT01474343|Metabolic Diseases|metabolic diseases
1325816|NCT01474343|Gene Therapy|gene therapy
1325817|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
1325818|NCT01474330|Pomalidomide|pomalidomide
1325819|NCT01474330|safety|safety
1325820|NCT01474330|tolerability|tolerability
1325821|NCT01474330|pharmacokinetics|pharmacokinetics
1325822|NCT01474304|craniotomy|craniotomy
1325823|NCT01474304|tumor resection|tumor resection
1325824|NCT01474304|aneurysm|aneurysm
1325825|NCT01474304|revascularization|revascularization
1325826|NCT01474304|opioid|opioid
1325827|NCT01474304|nausea|nausea
1325828|NCT01474304|vomiting|vomiting
1325829|NCT01474304|acetaminophen|acetaminophen
1325830|NCT01474265|smoking cessation|smoking cessation
1325831|NCT01474265|varenicline|varenicline
1325832|NCT01474265|sympathovagal balance|sympathovagal balance
1325833|NCT01474265|quit attempts|quit attempts
1325834|NCT01474265|MSNA|msna
1325835|NCT01474226|lysine|lysine
1325836|NCT01474226|rice|rice
1325837|NCT01474226|bioavailability|bioavailability
1325838|NCT01474213|dexmedetomidine|dexmedetomidine
1325839|NCT01474213|remifentanil|remifentanil
1325840|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
1325841|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
1325842|NCT01474213|difficult airway|difficult airway
1325843|NCT01474213|adult|adult
1325844|NCT01474200|Ultrafiltration|ultrafiltration
1325845|NCT01474200|Aquapheresis|aquapheresis
1325846|NCT01474200|Diuretics|diuretics
1325847|NCT01474200|Loop Diuretics|loop diuretics
1325848|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
1325849|NCT01474200|Gambro UF Solutions|gambro uf solutions
1325850|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1325851|NCT01474187|rectal cancer|rectal cancer
1325852|NCT01474187|phase I study|phase i study
1325853|NCT01474187|irinotecan|irinotecan
1325854|NCT01474148|paraplegia|paraplegia
1325855|NCT01474148|tetraplegia|tetraplegia
1325856|NCT01474148|Spinal cord injured|spinal cord injured
1325857|NCT01474148|FES|fes
1325858|NCT01474135|Glaucoma|glaucoma
1325859|NCT01474135|Ocular Hypertension|ocular hypertension
1325860|NCT01474122|digital ulcers|digital ulcers
1325861|NCT01474122|systemic sclerosis|systemic sclerosis
1325862|NCT01474109|systemic sclerosis|systemic sclerosis
1325863|NCT01474109|digital ulcers|digital ulcers
1325864|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
1325865|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
1325866|NCT01474083|pharmacokinetics|pharmacokinetics
1325867|NCT01474083|pharmacodynamics|pharmacodynamics
1325868|NCT01474070|Glaucoma|glaucoma
1325869|NCT01474070|Goldmann Tonometry|goldmann tonometry
1325870|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
1325871|NCT01474057|PTSD|ptsd
1325872|NCT01474057|combat trauma|combat trauma
1325873|NCT01474057|telemedicine|telemedicine
1325874|NCT01474057|primary care interventions|primary care interventions
1325875|NCT01474057|CBT|cbt
1325876|NCT01474057|self-managed treatment|self-managed treatment
1325877|NCT01474057|web-based intervention|web-based intervention
1325878|NCT01474057|internet treatment|internet treatment
1325879|NCT01474031|total hip arthroplasty|total hip arthroplasty
1325880|NCT01474031|biomechanics|biomechanics
1325881|NCT01474031|direct anterior approach|direct anterior approach
1325882|NCT01474005|laryngectomy|laryngectomy
1325883|NCT01474005|artificial larynx|artificial larynx
1325884|NCT01474005|breathing|breathing
1325885|NCT01474005|swallowing|swallowing
1325886|NCT01474005|upper airway|upper airway
1325887|NCT01473979|cardiac surgery|cardiac surgery
1325888|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
1325889|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
1325890|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
1325891|NCT01473927|Crohn disease|crohn disease
1325892|NCT01473927|Ficolin-2|ficolin-2
1325893|NCT01473927|C-Reactive Protein|c-reactive protein
1325894|NCT01473927|Calprotectin|calprotectin
1325895|NCT01473927|Inflammatory markers|inflammatory markers
1325896|NCT01473927|SES-CD|ses-cd
1325897|NCT01473901|BKM120|bkm120
1325898|NCT01473901|temozolomide|temozolomide
1325899|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
1325900|NCT01473901|GBM|gbm
1325901|NCT01473901|Newly diagnosed|newly diagnosed
1325902|NCT01473888|T89(Dantonic®)|t89(dantonic®)
1325903|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
1325904|NCT01473888|CYP450|cyp450
1325905|NCT01473875|LIPA|lipa
1325906|NCT01473875|Wolman Disease|wolman disease
1325907|NCT01473875|Wolman Phenotype|wolman phenotype
1325908|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
1325909|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
1325910|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
1325911|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
1325912|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
1435046|NCT01024036|MCD|mcd
1325913|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
1325914|NCT01473875|LAL Deficiency|lal deficiency
1325915|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
1325916|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
1325917|NCT01473875|Related Disorders:|related disorders:
1325918|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1325919|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1325920|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
1325921|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
1325922|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
1325923|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
1325924|NCT01473862|adolescent|adolescent
1325925|NCT01473862|bereavement|bereavement
1325926|NCT01473862|cancer|cancer
1325927|NCT01473862|coping skills|coping skills
1325928|NCT01473849|Cytomegalovirus|cytomegalovirus
1325929|NCT01473849|Liver transplantation|liver transplantation
1325930|NCT01473849|Hepatitis C virus|hepatitis c virus
1325931|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
1325932|NCT01473836|Metronidazole|metronidazole
1325933|NCT01473836|intra-abdominal infection|intra-abdominal infection
1325934|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
1325935|NCT01473836|anaerobe|anaerobe
1325936|NCT01473823|food allergy|food allergy
1325937|NCT01473823|eczema|eczema
1325938|NCT01473823|sensitisation|sensitisation
1325939|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
1325940|NCT01473823|prevention|prevention
1325941|NCT01473823|asthma|asthma
1325942|NCT01473810|HIV|hiv
1325943|NCT01473810|vaccination|vaccination
1325944|NCT01473810|T cells|t cells
1325945|NCT01473810|mucosal immunity|mucosal immunity
1325946|NCT01473810|safety|safety
1325947|NCT01473810|nasal administration|nasal administration
1325948|NCT01473810|DTH skin test|dth skin test
1325949|NCT01473771|Suicide|suicide
1325950|NCT01473771|Suicide, Attempted|suicide, attempted
1325951|NCT01473758|COPD|copd
1325952|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1325953|NCT01473758|Roflumilast|roflumilast
1325954|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
1325955|NCT01473732|CNI toxicity|cni toxicity
1325956|NCT01473732|CAI|cai
1325957|NCT01473719|alcohol use|alcohol use
1325958|NCT01473719|marijuana use|marijuana use
1325959|NCT01473719|STI|sti
1325960|NCT01473706|Malnutrition|malnutrition
1325961|NCT01473706|Nutrition status|nutrition status
1325962|NCT01473706|Elderly|elderly
1325963|NCT01473706|Nutrition screening|nutrition screening
1325964|NCT01473693|Quality of Life|quality of life
1325965|NCT01473693|Lung cancer|lung cancer
1325966|NCT01473693|MRI|mri
1325967|NCT01473693|Surgery|surgery
1325968|NCT01473693|induction chemotherapy|induction chemotherapy
1325969|NCT01473693|11-145|11-145
1325970|NCT01473680|minority breast cancer patients|minority breast cancer patients
1325971|NCT01473680|EEG|eeg
1325972|NCT01473680|Evaluation|evaluation
1325973|NCT01473680|Questionnaires|questionnaires
1325974|NCT01473680|11-139|11-139
1325975|NCT01473641|Etonogestrel|etonogestrel
1325976|NCT01473641|Contraceptive implant|contraceptive implant
1325977|NCT01473641|Safety|safety
1325978|NCT01473628|early stage follicular lymphoma|early stage follicular lymphoma
1325979|NCT01473628|indolent non-Hodgkin's lymphomas|indolent non-hodgkin's lymphomas
1325980|NCT01473628|Lymphoma|lymphoma
1325981|NCT01473628|Follicular Lymphoma|follicular lymphoma
1325982|NCT01473628|FL|fl
1325983|NCT01473628|Rituximab|rituximab
1325984|NCT01473628|Rituxan|rituxan
1325985|NCT01473628|Radiation|radiation
1325986|NCT01473628|Radiation Therapy|radiation therapy
1325987|NCT01473628|XRT|xrt
1325988|NCT01473576|type II diabetes|type ii diabetes
1325989|NCT01473576|protein synthesis|protein synthesis
1325990|NCT01473576|nitrate|nitrate
1325991|NCT01473576|elderly|elderly
1325992|NCT01473550|Mental Health|mental health
1325993|NCT01473550|Smart Technology|smart technology
1325994|NCT01473550|Mood disorder|mood disorder
1325995|NCT01473550|Psychotic disorder|psychotic disorder
1325996|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
1325997|NCT01473537|oral health|oral health
1325998|NCT01473537|cariostatic agents|cariostatic agents
1325999|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
1326000|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
1326001|NCT01473524|PBC|pbc
1326002|NCT01473524|Cirrhosis|cirrhosis
1326003|NCT01473524|Liver|liver
1326004|NCT01473511|Behavioural intervention|behavioural intervention
1326005|NCT01473511|Distance intervention|distance intervention
1326006|NCT01473511|Parenting intervention|parenting intervention
1326007|NCT01473498|Sepsis|sepsis
1326008|NCT01473498|Acute kidney injury|acute kidney injury
1326009|NCT01473498|Mean arterial pressure|mean arterial pressure
1326010|NCT01473498|Catecholamines|catecholamines
1326011|NCT01473498|Renal doppler|renal doppler
1326012|NCT01473485|Brain Tumor|brain tumor
1326013|NCT01473485|Glioma|glioma
1326014|NCT01473485|Brain Cancer|brain cancer
1326015|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
1326016|NCT01473472|Prophylaxis|prophylaxis
1326017|NCT01473472|HIV infection|hiv infection
1326018|NCT01473472|tenofovir|tenofovir
1326019|NCT01473472|emtricitabine|emtricitabine
1326020|NCT01473472|men who have sex with men|men who have sex with men
1326021|NCT01473459|best fertility protocol|best fertility protocol
1326022|NCT01473459|(BMI > 30)|(bmi > 30)
1326023|NCT01473459|women|women
1326024|NCT01473459|PCOS|pcos
1326025|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
1326026|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
1326027|NCT01473446|LiDCOrapid|lidcorapid
1326028|NCT01473446|Postoperative outcome|postoperative outcome
1326029|NCT01473446|Open abdominal surgery|open abdominal surgery
1326030|NCT01473433|Regenerative medicine|regenerative medicine
1326031|NCT01473433|Myocardial infarction|myocardial infarction
1326032|NCT01473394|Major depressive disorder|major depressive disorder
1326033|NCT01473394|Depression|depression
1326034|NCT01473381|Major Depressive Disorder|major depressive disorder
1326035|NCT01473381|Depression|depression
1326036|NCT01473368|human Gut Microbiota|human gut microbiota
1326037|NCT01473368|gut microbiota|gut microbiota
1326038|NCT01473368|gut microbiome|gut microbiome
1326039|NCT01473368|probiotic|probiotic
1326040|NCT01473368|antibiotic|antibiotic
1326041|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
1326042|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
1326043|NCT01473342|Healthy survivorship|healthy survivorship
1326044|NCT01473342|Smartphones|smartphones
1326045|NCT01473342|Treatment|treatment
1326046|NCT01473329|diabetes care|diabetes care
1326047|NCT01473329|diabetes education|diabetes education
1326048|NCT01473329|diabetes control|diabetes control
1326049|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
1326050|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1326051|NCT01473290|diarrhea|diarrhea
1326052|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1326053|NCT01473290|gastrointestinal complications|gastrointestinal complications
1326054|NCT01473290|fatigue|fatigue
1326055|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1326056|NCT01473290|cognitive/functional effects|cognitive/functional effects
1326057|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1326058|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
1326059|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
1326060|NCT01473277|Steroid|steroid
1326061|NCT01473277|Intra-articular injection|intra-articular injection
1326062|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
1326063|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
1326064|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
1326065|NCT01473264|CC10|cc10
1326066|NCT01473264|BPD|bpd
1326067|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1326068|NCT01473264|premature infants|premature infants
1326069|NCT01473264|neonates|neonates
1326070|NCT01473264|pulmonary inflammation|pulmonary inflammation
1326071|NCT01473264|lung function|lung function
1326072|NCT01473264|RDS|rds
1326073|NCT01473238|Desktop computer|desktop computer
1326074|NCT01473238|Mobile|mobile
1326075|NCT01473238|iPad|ipad
1326076|NCT01473238|Evaluation|evaluation
1326077|NCT01473238|User experience|user experience
1326078|NCT01473238|Benefits|benefits
1326079|NCT01473238|Cost analysis|cost analysis
1326080|NCT01473199|focal defect|focal defect
1326081|NCT01473199|focal lesion|focal lesion
1326082|NCT01473199|chondral lesion|chondral lesion
1326083|NCT01473199|osteochondral lesion|osteochondral lesion
1326084|NCT01473186|morbid obesity|morbid obesity
1326085|NCT01473186|endometrial pathology|endometrial pathology
1326086|NCT01473186|menstrual irregularities|menstrual irregularities
1326087|NCT01473173|Safety|safety
1326088|NCT01473173|Tolerability|tolerability
1326089|NCT01473173|Pharmacokinetics|pharmacokinetics
1326090|NCT01473173|Pharmacodynamics|pharmacodynamics
1326091|NCT01473147|GLP-1 analogue|glp-1 analogue
1326092|NCT01473147|CSII|csii
1326093|NCT01473147|insulin|insulin
1326094|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
1326095|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
1326096|NCT01473121|Registry|registry
1326097|NCT01473121|Turkey|turkey
1326098|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
1326099|NCT01473095|AKT|akt
1326100|NCT01473095|ARQ 092|arq 092
1326101|NCT01473095|Targeted therapy|targeted therapy
1326102|NCT01473095|Molecular therapy|molecular therapy
1326103|NCT01473095|Biomarker|biomarker
1326104|NCT01473095|Phase 1|phase 1
1326105|NCT01473095|Phase I|phase i
1326106|NCT01473095|Endometrial cancer|endometrial cancer
1326107|NCT01473095|Lymphoma|lymphoma
1326108|NCT01473095|AKT pathway|akt pathway
1326109|NCT01473095|AKT signaling|akt signaling
1326110|NCT01473095|AKT inhibitor|akt inhibitor
1326111|NCT01473095|AKT pan inhibitor|akt pan inhibitor
1326112|NCT01473095|AKT1|akt1
1326113|NCT01473095|AKT2|akt2
1326114|NCT01473095|AKT3|akt3
1326115|NCT01473095|AKT1 mutation|akt1 mutation
1326116|NCT01473095|AKT1-E17K|akt1-e17k
1326117|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
1326118|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
1326119|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
1326120|NCT01473095|AKT 3 amplification|akt 3 amplification
1326121|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
1326122|NCT01473095|mTOR inhibitor|mtor inhibitor
1326123|NCT01473095|PI3K inhibitor|pi3k inhibitor
1326124|NCT01473095|Clinical oncology|clinical oncology
1326125|NCT01473095|Tumor|tumor
1326126|NCT01473095|Tumour|tumour
1326127|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
1326128|NCT01473069|JTK-853|jtk-853
1326129|NCT01473069|Healthy subjects|healthy subjects
1326130|NCT01473056|Hepatitis C|hepatitis c
1326131|NCT01473056|JTK-853|jtk-853
1326132|NCT01473043|Axitinib|axitinib
1326133|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1326134|NCT01473030|Benign prostate|benign prostate
1326135|NCT01473030|serum DHT|serum dht
1326136|NCT01473030|Dutasteride|dutasteride
1326137|NCT01473030|PSA|psa
1326138|NCT01473030|Avodart|avodart
1326139|NCT01473004|Sir-spheres|sir-spheres
1326140|NCT01473004|Liver Metastases|liver metastases
1326141|NCT01473004|Selective internal radiation|selective internal radiation
1326142|NCT01473004|Yttrium-90|yttrium-90
1326143|NCT01473004|Uveal|uveal
1326144|NCT01473004|Melanoma|melanoma
1326145|NCT01473004|Ocular melanoma|ocular melanoma
1326146|NCT01472991|ADHD|adhd
1326147|NCT01472978|C. difficile|c. difficile
1326148|NCT01472965|central line|central line
1326149|NCT01472965|adolescents|adolescents
1326150|NCT01472965|children|children
1326151|NCT01472965|bloodstream infection|bloodstream infection
1326152|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
1326153|NCT01472965|catheter lock therapy|catheter lock therapy
1326154|NCT01472965|ethanol lock therapy|ethanol lock therapy
1326155|NCT01472952|sepsis|sepsis
1326156|NCT01472952|immune cells|immune cells
1326157|NCT01472952|immune reaction|immune reaction
1326158|NCT01472952|trauma|trauma
1326159|NCT01472952|Immune activation|immune activation
1326160|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
1326161|NCT01472926|stroke|stroke
1326162|NCT01472926|thrombolysis|thrombolysis
1326163|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
1326164|NCT01472926|CT perfusion|ct perfusion
1326165|NCT01472926|CT angiography|ct angiography
1326166|NCT01472926|brain imaging|brain imaging
1326167|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
1326168|NCT01472913|Fibrin sealant|fibrin sealant
1326169|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
1326170|NCT01472913|Blood loss|blood loss
1326171|NCT01472913|Postoperative pain|postoperative pain
1326172|NCT01472913|Complications|complications
1326173|NCT01472900|acne vulgaris|acne vulgaris
1326174|NCT01472874|Wilson Disease|wilson disease
1326175|NCT01472874|Trientine|trientine
1326176|NCT01472874|One Daily Dosage|one daily dosage
1326177|NCT01472861|coculture|coculture
1326178|NCT01472861|endometrial biopsy|endometrial biopsy
1326179|NCT01472861|IVF poor responders|ivf poor responders
1326180|NCT01472835|sedation|sedation
1326181|NCT01472835|sensitivity|sensitivity
1326182|NCT01472835|specificity|specificity
1326183|NCT01472835|validity|validity
1326184|NCT01472835|diagnostic injection|diagnostic injection
1326185|NCT01472822|Omija|omija
1326186|NCT01472822|knee osteoarthritis|knee osteoarthritis
1326187|NCT01472809|ZYGK1|zygk1
1326188|NCT01472809|Cadila|cadila
1326190|NCT01472809|ZRC|zrc
1326191|NCT01472809|Zydus Research Center|zydus research center
1326192|NCT01472809|Phase 1|phase 1
1326193|NCT01472809|Diabetes|diabetes
1326194|NCT01472796|African American|african american
1326195|NCT01472796|Vitamin D deficient|vitamin d deficient
1326196|NCT01472783|BRCA1 mutation|brca1 mutation
1326197|NCT01472783|BRCA2 mutation|brca2 mutation
1326198|NCT01472783|Ovarian cancer|ovarian cancer
1326199|NCT01472783|PARP inhibitor|parp inhibitor
1326200|NCT01472770|Colorectal cancer|colorectal cancer
1326201|NCT01472770|Metastatic|metastatic
1326202|NCT01472770|Treatment resistant|treatment resistant
1326203|NCT01472744|Executive function|executive function
1326204|NCT01472744|Aging|aging
1326205|NCT01472744|Physical activity|physical activity
1326206|NCT01472731|GC1008|gc1008
1326207|NCT01472731|PET imaging|pet imaging
1326208|NCT01472731|primary brain tumors|primary brain tumors
1326209|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
1326210|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
1326211|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
1326212|NCT01472692|Prehypertension|prehypertension
1326213|NCT01472692|Gout|gout
1326214|NCT01472692|Puls Wave Velocity|puls wave velocity
1326215|NCT01472692|Hypertension|hypertension
1326216|NCT01472692|24 hour blood pressure|24 hour blood pressure
1326217|NCT01472679|fat mass|fat mass
1326218|NCT01472679|fat free mass|fat free mass
1326219|NCT01472679|body mass index|body mass index
1326220|NCT01472666|Medium chain fatty acids|medium chain fatty acids
1326221|NCT01472666|Saturated fatty acids|saturated fatty acids
1326222|NCT01472666|Whey protein|whey protein
1326223|NCT01472666|Casein protein|casein protein
1326224|NCT01472666|Metabolic syndrome|metabolic syndrome
1326225|NCT01472666|Type 2 diabetes|type 2 diabetes
1326226|NCT01472666|Cardiovascular disease|cardiovascular disease
1326227|NCT01472666|Dairy products|dairy products
1326228|NCT01472666|Dietary intervention|dietary intervention
1326229|NCT01472653|Head and neck Cancer|head and neck cancer
1326230|NCT01472653|Radiochemotherapy|radiochemotherapy
1326231|NCT01472653|Radioimmunotherapy|radioimmunotherapy
1326232|NCT01472653|Skin rush|skin rush
1326233|NCT01472653|locoregional control|locoregional control
1326234|NCT01472653|Survival|survival
1326235|NCT01472653|Toxicity|toxicity
1326236|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
1326237|NCT01472627|MM|mm
1326238|NCT01472627|Bortezomib|bortezomib
1326239|NCT01472627|Velcade|velcade
1326240|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
1326241|NCT01472614|Add-on therapy|add-on therapy
1326242|NCT01472575|rotavirus|rotavirus
1326243|NCT01472575|gastroenteritis|gastroenteritis
1326244|NCT01472575|vaccination|vaccination
1326245|NCT01472575|hospitalisation|hospitalisation
1326246|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
1326247|NCT01472549|Preoperative|preoperative
1326248|NCT01472549|Antiseptics|antiseptics
1326249|NCT01472549|Comparative|comparative
1326250|NCT01472549|Cost|cost
1326251|NCT01472549|Effectiveness|effectiveness
1326252|NCT01472536|Influenza|influenza
1326253|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
1326254|NCT01472536|Sequestration|sequestration
1326255|NCT01472536|Social network|social network
1326256|NCT01472510|Diabetic|diabetic
1326257|NCT01472510|Macular|macular
1326258|NCT01472510|Edema|edema
1326259|NCT01472510|Ranibizumab|ranibizumab
1326260|NCT01472510|anti-VEGF|anti-vegf
1326261|NCT01472497|hypertension|hypertension
1326262|NCT01472497|insulin resistance|insulin resistance
1326263|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
1326264|NCT01472497|AGE|age
1326265|NCT01472497|inflammatory cytokine|inflammatory cytokine
1326266|NCT01472484|beans|beans
1326267|NCT01472484|lpa mutant|lpa mutant
1326268|NCT01472484|polyphenols|polyphenols
1326269|NCT01472484|phytic acid|phytic acid
1326270|NCT01472484|stable iron isotopes|stable iron isotopes
1326271|NCT01472471|Childhood Asthma|childhood asthma
1326272|NCT01472471|Oxidative stress|oxidative stress
1326273|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
1326274|NCT01472458|Cardiac arrest|cardiac arrest
1326275|NCT01472458|Hypothermia|hypothermia
1326276|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
1326277|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
1326278|NCT01472445|Vitamin D|vitamin d
1326279|NCT01472445|Obesity|obesity
1326280|NCT01472432|type 2 diabetes|type 2 diabetes
1326281|NCT01472432|healing|healing
1326282|NCT01472432|foot ulcers|foot ulcers
1326283|NCT01472432|vildagliptin|vildagliptin
1326284|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
1326285|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
1326286|NCT01472419|prognosis|prognosis
1326287|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
1326288|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
1326289|NCT01472393|creatine supplementation|creatine supplementation
1326290|NCT01472393|bone mass|bone mass
1326291|NCT01472393|postmenopausal women|postmenopausal women
1326292|NCT01472393|muscle function|muscle function
1326293|NCT01472393|bone markers|bone markers
1326295|NCT01472354|Hepatitis C|hepatitis c
1326296|NCT01472354|Decision-Making|decision-making
1326297|NCT01472354|chronic|chronic
1326298|NCT01472328|Oxidative stress|oxidative stress
1326299|NCT01472328|Insulin resistance|insulin resistance
1326300|NCT01472315|sleep apnea|sleep apnea
1326301|NCT01472315|women|women
1326302|NCT01472315|postmenopause|postmenopause
1326303|NCT01472315|hormone treatment|hormone treatment
1326304|NCT01472289|CLI|cli
1326305|NCT01472289|Peripheral arterial disease|peripheral arterial disease
1326306|NCT01472276|Behaviour change|behaviour change
1326307|NCT01472276|Weight loss|weight loss
1326308|NCT01472276|Cardiovascular risk|cardiovascular risk
1326309|NCT01472276|Diet|diet
1326310|NCT01472276|Physical activity|physical activity
1326311|NCT01472276|Overweight|overweight
1326312|NCT01472276|Obesity|obesity
1326313|NCT01472276|Internet|internet
1326314|NCT01472263|HTLV-1|htlv-1
1326315|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
1326316|NCT01472263|Immune System Diseases|immune system diseases
1326317|NCT01472263|Physical disability|physical disability
1326318|NCT01472263|pentoxifylline|pentoxifylline
1326319|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
1326320|NCT01472250|chemotherapy|chemotherapy
1326321|NCT01472250|quality of life|quality of life
1326322|NCT01472250|treatment expense|treatment expense
1326323|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
1326324|NCT01472224|Transcranial ultrasound|transcranial ultrasound
1326325|NCT01472224|Haematoma expansion|haematoma expansion
1326326|NCT01472198|GSI|gsi
1326327|NCT01472198|Gilead|gilead
1326328|NCT01472198|Gilead Sciences|gilead sciences
1326329|NCT01472198|Pancreatic Cancer|pancreatic cancer
1326330|NCT01472198|PC|pc
1326331|NCT01472198|Gemcitabine|gemcitabine
1326332|NCT01472198|Phase 2|phase 2
1326333|NCT01472198|Phase II|phase ii
1326334|NCT01472198|GS-6624|gs-6624
1326335|NCT01472198|Oncology|oncology
1326336|NCT01472198|Monoclonal Antibody|monoclonal antibody
1326337|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1326338|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
1326339|NCT01472172|cryobiopsy|cryobiopsy
1326340|NCT01472172|pleural biopsy|pleural biopsy
1326341|NCT01472172|pleural effusion|pleural effusion
1326342|NCT01472172|safety|safety
1326343|NCT01472172|thoracoscopy|thoracoscopy
1326344|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
1326345|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
1326346|NCT01472146|zolendronic acid|zolendronic acid
1326347|NCT01472133|Respiration Rate|respiration rate
1326348|NCT01472133|ECG|ecg
1326349|NCT01472133|Pulse oximetry|pulse oximetry
1326350|NCT01472133|Photoplethysmograph|photoplethysmograph
1326351|NCT01472133|PPG|ppg
1326352|NCT01472133|Physiology|physiology
1326353|NCT01472107|Pregnancy|pregnancy
1326354|NCT01472107|APL female patients|apl female patients
1326355|NCT01472068|Incontinence|incontinence
1326356|NCT01472068|NMES|nmes
1326357|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
1326358|NCT01472042|Traumatic Brain Injury|traumatic brain injury
1326359|NCT01472042|Sport Concussion|sport concussion
1326360|NCT01472042|Head Injury|head injury
1326361|NCT01472042|Sports Injury|sports injury
1326362|NCT01472029|Adenocarcinoma|adenocarcinoma
1326363|NCT01472029|Gastroesophageal junction|gastroesophageal junction
1326364|NCT01472029|Stomach|stomach
1326365|NCT01472029|HER2|her2
1326366|NCT01472016|c-Met overexpression|c-met overexpression
1326367|NCT01472016|MET amplification|met amplification
1326368|NCT01472016|Neoplasms|neoplasms
1326369|NCT01472016|h224G11|h224g11
1326370|NCT01471990|PACAP38|pacap38
1326371|NCT01471990|MMA|mma
1326372|NCT01471990|migraine|migraine
1326373|NCT01471990|angiography|angiography
1326374|NCT01471990|VIP|vip
1326375|NCT01471990|vasodilatation|vasodilatation
1326376|NCT01471912|Macular Holes|macular holes
1326377|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
1326378|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
1326379|NCT01471912|M-score|m-score
1326380|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
1326381|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
1326382|NCT01471873|variability|variability
1326383|NCT01471873|progressive keratoconus|progressive keratoconus
1326384|NCT01471873|corneal cross-linking|corneal cross-linking
1326385|NCT01471847|Locally advanced|locally advanced
1326386|NCT01471847|metastatic|metastatic
1326387|NCT01471847|breast cancer|breast cancer
1326388|NCT01471847|HER2 positive|her2 positive
1326389|NCT01471847|PI3K|pi3k
1326390|NCT01471847|mTOR|mtor
1326391|NCT01471847|trastuzumab|trastuzumab
1326392|NCT01471847|targeted therapy|targeted therapy
1326393|NCT01471847|LABC|labc
1326394|NCT01471847|MBC|mbc
1326395|NCT01471782|ALL|all
1326396|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
1326397|NCT01471782|Leukemia|leukemia
1326398|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
1326399|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
1326400|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
1326401|NCT01471782|Neoplasms|neoplasms
1326402|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
1326403|NCT01471782|Lymphatic Diseases|lymphatic diseases
1326404|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
1326405|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
1326406|NCT01471769|pediatric|pediatric
1326407|NCT01471769|pain|pain
1326408|NCT01471756|sessile neoplasms|sessile neoplasms
1326409|NCT01471756|flat neoplasms|flat neoplasms
1326410|NCT01471756|gastric cancer|gastric cancer
1326411|NCT01471743|nutrition|nutrition
1326412|NCT01471743|surgery|surgery
1326413|NCT01471743|immune|immune
1326414|NCT01471730|Transfusions|transfusions
1326415|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
1326416|NCT01471730|Fibrinogen|fibrinogen
1326417|NCT01471730|Prothrombin complex|prothrombin complex
1326419|NCT01471717|pharmacokinetics|pharmacokinetics
1326420|NCT01471717|INX08189|inx08189
1326421|NCT01471717|Victrelis|victrelis
1326422|NCT01471717|Inhibitex|inhibitex
1326423|NCT01471704|Pharmacokinetics|pharmacokinetics
1326424|NCT01471704|PK|pk
1326425|NCT01471704|INX08189|inx08189
1326426|NCT01471704|Verapamil|verapamil
1326427|NCT01471704|Inhibitex|inhibitex
1326428|NCT01471678|Cross-over design|cross-over design
1326429|NCT01471678|Pilot bioequivalence|pilot bioequivalence
1326430|NCT01471678|North east Asian ancestry|north east asian ancestry
1326431|NCT01471678|GI198745|gi198745
1326432|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
1326433|NCT01471678|healthy male subjects|healthy male subjects
1326434|NCT01471678|Bioequivalence|bioequivalence
1326435|NCT01471678|Dutasteride|dutasteride
1326436|NCT01471561|Osmolarity|osmolarity
1326437|NCT01471561|Cataract|cataract
1326438|NCT01471561|Dry Eye|dry eye
1326439|NCT01471548|tumor|tumor
1326440|NCT01471548|cancer|cancer
1326441|NCT01471548|phase1|phase1
1326442|NCT01471548|TKI258|tki258
1326443|NCT01471418|TMJ|tmj
1326444|NCT01471418|orofacial pain|orofacial pain
1326445|NCT01471418|synovitis|synovitis
1326446|NCT01471418|arthroscopy|arthroscopy
1326447|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
1326448|NCT01471379|IBS|ibs
1326449|NCT01471379|Savella|savella
1326450|NCT01471379|Milnacipran|milnacipran
1326451|NCT01471379|Abdominal Pain|abdominal pain
1326452|NCT01471366|Hyperlipidemias|hyperlipidemias
1326453|NCT01471366|Dyslipidemias|dyslipidemias
1326454|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
1326455|NCT01471366|Fish Oils|fish oils
1326456|NCT01471353|Metastatic|metastatic
1326457|NCT01471353|Colon Cancer|colon cancer
1326458|NCT01471353|Rectal Cancer|rectal cancer
1326459|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
1326460|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
1326461|NCT01471652|post viral infection|post viral infection
1326462|NCT01471652|fatigue|fatigue
1326463|NCT01471652|muscle pain|muscle pain
1326464|NCT01471652|unrefreshing sleep|unrefreshing sleep
1326465|NCT01471652|fuzzy thought|fuzzy thought
1326466|NCT01471652|poor memory|poor memory
1326467|NCT01471652|forgetfulness|forgetfulness
1326468|NCT01471639|18 years and older,|18 years and older,
1326469|NCT01471639|previously healthy|previously healthy
1326470|NCT01471639|men and nonpregnant women|men and nonpregnant women
1326471|NCT01471639|emergency department|emergency department
1326472|NCT01471626|sleep apnea|sleep apnea
1326473|NCT01471626|polysomnography|polysomnography
1326474|NCT01471626|telemedicine|telemedicine
1326475|NCT01471613|spinal cord injury|spinal cord injury
1326476|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
1326477|NCT01471613|cell transplant|cell transplant
1326478|NCT01471613|lithium carbonate|lithium carbonate
1326479|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1326480|NCT01471600|general anesthesia|general anesthesia
1326481|NCT01471535|chronic hepatitis B|chronic hepatitis b
1326482|NCT01471509|Glycemic Index|glycemic index
1326483|NCT01471509|LoBAG Diet|lobag diet
1326484|NCT01471509|Insulin|insulin
1326485|NCT01471509|Glucagon|glucagon
1326486|NCT01471496|duodenal ulcer|duodenal ulcer
1326487|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
1326488|NCT01471496|injection therapy|injection therapy
1326489|NCT01471483|Geriatric Assessment|geriatric assessment
1326490|NCT01471483|Quality of Life|quality of life
1326491|NCT01471483|11-164|11-164
1326492|NCT01471483|Fallopian Tubes|fallopian tubes
1326493|NCT01471470|Advanced gastric cancer|advanced gastric cancer
1326494|NCT01471470|Neoadjuvant|neoadjuvant
1326495|NCT01471470|Bevacizumab|bevacizumab
1326496|NCT01471457|bacterial|bacterial
1326497|NCT01471457|vaginosis|vaginosis
1326498|NCT01471457|pessary|pessary
1326499|NCT01471457|discharge|discharge
1326500|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
1326501|NCT01471444|Leukemia|leukemia
1326502|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1326503|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
1326504|NCT01471444|AML|aml
1326505|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
1326506|NCT01471444|MDS|mds
1326507|NCT01471444|Progression free survival|progression free survival
1326508|NCT01471444|Rate of engraftment|rate of engraftment
1326509|NCT01471444|Toxicity|toxicity
1326510|NCT01471444|Relapse rate|relapse rate
1326511|NCT01471444|Graft-vs-host disease|graft-vs-host disease
1326512|NCT01471444|GvHD|gvhd
1326513|NCT01471444|Progression-free survival|progression-free survival
1326514|NCT01471444|PFS|pfs
1326515|NCT01471444|Overall survival|overall survival
1326516|NCT01471444|OS|os
1326517|NCT01471444|Fludarabine|fludarabine
1621295|NCT00315159|Vulva|vulva
1326518|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
1326519|NCT01471444|Fludara|fludara
1326520|NCT01471444|Clofarabine|clofarabine
1326521|NCT01471444|Clofarex|clofarex
1326522|NCT01471444|Clolar|clolar
1326523|NCT01471444|Busulfan|busulfan
1326524|NCT01471444|Busulfex|busulfex
1326525|NCT01471444|Myleran|myleran
1326526|NCT01471444|Thymoglobulin|thymoglobulin
1326527|NCT01471444|ATG|atg
1326528|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
1326529|NCT01471444|Methotrexate|methotrexate
1326530|NCT01471444|Tacrolimus|tacrolimus
1326531|NCT01471444|Prograf|prograf
1326532|NCT01471392|Identigene|identigene
1326533|NCT01471392|STD Test|std test
1326534|NCT01471392|Chlamydia|chlamydia
1326535|NCT01471392|Gonorrhoeae|gonorrhoeae
1326536|NCT01471392|APTIMA|aptima
1326537|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
1326538|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
1326539|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
1326540|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
1326541|NCT01471288|Carum Carvi|carum carvi
1326542|NCT01471288|Normal controls|normal controls
1326543|NCT01471275|type 2 diabetes|type 2 diabetes
1326544|NCT01471275|obesity|obesity
1326545|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
1326546|NCT01471262|Complications|complications
1326547|NCT01471262|Mortality|mortality
1326548|NCT01471262|Liver|liver
1326549|NCT01471262|Failure|failure
1326550|NCT01471249|esophageal stenting|esophageal stenting
1326551|NCT01471249|palliative|palliative
1326552|NCT01471249|dysphagia|dysphagia
1326553|NCT01471236|cartilage|cartilage
1326554|NCT01471236|bone|bone
1326555|NCT01471184|Allergic Rhinitis|allergic rhinitis
1326556|NCT01471184|Conjunctivitis|conjunctivitis
1326557|NCT01471184|Bitop|bitop
1326558|NCT01471184|Eye|eye
1326559|NCT01471184|Eye Drops|eye drops
1326560|NCT01471184|Nasal Spray|nasal spray
1326561|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
1326562|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
1326563|NCT01471184|AUC|auc
1326564|NCT01471171|COPD|copd
1326565|NCT01471171|Antimuscarinic|antimuscarinic
1326566|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
1326567|NCT01471158|ocular hypertension|ocular hypertension
1326568|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
1326569|NCT01471145|opioid dependence|opioid dependence
1326570|NCT01471145|heroin dependence|heroin dependence
1326571|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
1326572|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1326573|NCT01471145|dopamine transporter|dopamine transporter
1326574|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
1326575|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
1326576|NCT01471119|atopic dermatitis|atopic dermatitis
1326577|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
1326578|NCT01471106|Breast Cancer|breast cancer
1326579|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
1326580|NCT01471106|Biomarker studies|biomarker studies
1326581|NCT01471106|Ki-67|ki-67
1326582|NCT01471106|Dasatinib|dasatinib
1326583|NCT01471106|BMS-354825|bms-354825
1326584|NCT01471106|Sprycel|sprycel
1326585|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
1326586|NCT01471080|radio-frequency ablation|radio-frequency ablation
1326587|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
1326588|NCT01471080|liver|liver
1326589|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
1326590|NCT01471067|Leukemia|leukemia
1326591|NCT01471067|Lymphoma|lymphoma
1326592|NCT01471067|Pediatrics|pediatrics
1326593|NCT01471067|Cord blood transplant|cord blood transplant
1326594|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
1326595|NCT01471067|Hematologic Malignancies|hematologic malignancies
1326596|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
1326597|NCT01471067|AML|aml
1326598|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
1326599|NCT01471067|MDS|mds
1326600|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
1326601|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
1326602|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
1326603|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1326604|NCT01471067|ALL|all
1326605|NCT01471067|complete remission|complete remission
1326606|NCT01471067|Philadelphia chromosome|philadelphia chromosome
1326607|NCT01471067|translocation 4;11|translocation 4;11
1326608|NCT01471067|Hypodiploidy|hypodiploidy
1326609|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
1326610|NCT01471067|CML|cml
1326611|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1326612|NCT01471067|NHL|nhl
1326613|NCT01471067|Hodgkin's Disease|hodgkin's disease
1326614|NCT01471067|HD|hd
1326615|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1326616|NCT01471067|CLL|cll
1326617|NCT01471067|Melphalan|melphalan
1326618|NCT01471067|Alkeran|alkeran
1326619|NCT01471067|Thiotepa|thiotepa
1326620|NCT01471067|Fludarabine|fludarabine
1326621|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
1326622|NCT01471067|Fludara|fludara
1326623|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
1326624|NCT01471067|MMF|mmf
1326625|NCT01471067|CellCept|cellcept
1326626|NCT01471067|Tacrolimus|tacrolimus
1326627|NCT01471067|Prograf|prograf
1326628|NCT01471067|Rituximab|rituximab
1326629|NCT01471067|Rituxan|rituxan
1326630|NCT01471067|ATG|atg
1326631|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
1326632|NCT01471067|Thymoglobulin|thymoglobulin
1326633|NCT01471054|Plaque radiotherapy|plaque radiotherapy
1326634|NCT01471054|Brachytherapy|brachytherapy
1326635|NCT01471054|Macular edema|macular edema
1326636|NCT01471054|Cystoid macular edema|cystoid macular edema
1326637|NCT01471054|Uveal melanoma|uveal melanoma
1326638|NCT01471054|Radiation maculopathy|radiation maculopathy
1326639|NCT01471054|Radiation retinopathy|radiation retinopathy
1326640|NCT01471054|Ozurdex|ozurdex
1326641|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
1326642|NCT01471041|End Stage Renal Disease|end stage renal disease
1326643|NCT01471041|Hemodialysis|hemodialysis
1326644|NCT01471041|AV fistula|av fistula
1326645|NCT01471041|Kidney failure|kidney failure
1326646|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
1326647|NCT01471028|alcoholic|alcoholic
1326648|NCT01471028|hepatitis|hepatitis
1326649|NCT01471028|liver|liver
1326650|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1326651|NCT01471015|Cooling Therapy|cooling therapy
1326652|NCT01471015|HIE|hie
1326653|NCT01470989|gouty arthritis|gouty arthritis
1326654|NCT01470976|Goal-directed therapy|goal-directed therapy
1326655|NCT01470976|Hemodynamic optimization|hemodynamic optimization
1326656|NCT01470976|Cardiac surgery|cardiac surgery
1326657|NCT01470963|Referral|referral
1326658|NCT01470963|Quality of Health Care|quality of health care
1326659|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
1326660|NCT01470950|Signalling Pathways|signalling pathways
1326661|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
1326662|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1326663|NCT01470924|relapse|relapse
1326664|NCT01470924|salvage|salvage
1326665|NCT01470924|prognostic|prognostic
1326666|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
1326667|NCT01470911|Asthma|asthma
1326668|NCT01470911|Healthy subjects|healthy subjects
1326669|NCT01470911|Phase 1|phase 1
1326670|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
1326671|NCT01470911|Oral inhalation|oral inhalation
1326672|NCT01470898|bispectral index monitoring|bispectral index monitoring
1326673|NCT01470898|extubation|extubation
1326674|NCT01470898|analgesia|analgesia
1326675|NCT01470898|abdominal surgery|abdominal surgery
1326676|NCT01470885|glucose|glucose
1326677|NCT01470885|prognosis|prognosis
1326678|NCT01470885|glycated hemoglobin|glycated hemoglobin
1326679|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
1326680|NCT01470859|initial treatment|initial treatment
1326681|NCT01470859|pramipexole|pramipexole
1326682|NCT01470859|Levodopa|levodopa
1326683|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
1326684|NCT01470846|epidural analgesia|epidural analgesia
1326685|NCT01470846|morphin analgesia|morphin analgesia
1326686|NCT01470846|laparotomy|laparotomy
1326687|NCT01470833|Achilles tendon|achilles tendon
1326688|NCT01470833|rupture|rupture
1326689|NCT01470833|non-operative|non-operative
1326690|NCT01470833|treatment|treatment
1326691|NCT01470820|Neonates|neonates
1326692|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
1326693|NCT01470820|Phototherapy|phototherapy
1326694|NCT01470820|Light irradiance|light irradiance
1326695|NCT01470820|Saturation point|saturation point
1326696|NCT01470807|Artificial Pancreas|artificial pancreas
1326697|NCT01470807|Insulin Pump|insulin pump
1326698|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
1326699|NCT01470807|Closed Loop|closed loop
1326700|NCT01470794|GBM|gbm
1326701|NCT01470794|HGG|hgg
1326702|NCT01470794|High grade glioma|high grade glioma
1326703|NCT01470794|Malignant glioma|malignant glioma
1326704|NCT01470794|Grade III glioma|grade iii glioma
1326705|NCT01470794|Grad IV glioma|grad iv glioma
1326706|NCT01470794|glioma|glioma
1326707|NCT01470794|glioblastoma|glioblastoma
1326708|NCT01470794|Grade IV astrocytoma|grade iv astrocytoma
1326709|NCT01470794|brain cancer|brain cancer
1326710|NCT01470794|recurrent glioblastoma|recurrent glioblastoma
1326711|NCT01470794|AA|aa
1326712|NCT01470794|AOD|aod
1326713|NCT01470794|anaplastic astrocytoma|anaplastic astrocytoma
1326714|NCT01470794|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1326715|NCT01470794|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1326716|NCT01470781|Bipolar Disorder|bipolar disorder
1326717|NCT01470781|Psychosis|psychosis
1326718|NCT01470781|Cognition|cognition
1326719|NCT01470781|Cognitive Remediation|cognitive remediation
1326720|NCT01470755|Pediatrics|pediatrics
1326721|NCT01470755|Bronchial wheeze|bronchial wheeze
1326722|NCT01470755|bronchodilator|bronchodilator
1326723|NCT01470755|lung function|lung function
1326724|NCT01470755|airway resistance|airway resistance
1326725|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
1326726|NCT01470716|EGFR mutation|egfr mutation
1326727|NCT01470716|NSCLC|nsclc
1326728|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
1326729|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
1326730|NCT01470703|Randomized controlled trial|randomized controlled trial
1326731|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
1326732|NCT01470703|Survival Rate|survival rate
1326733|NCT01470690|HVC infection|hvc infection
1326734|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
1326735|NCT01470690|proton pump inhibitor|proton pump inhibitor
1326736|NCT01470690|interaction|interaction
1326737|NCT01470690|pharmacokinetics|pharmacokinetics
1326738|NCT01470690|boceprevir|boceprevir
1326739|NCT01470690|omeprazole|omeprazole
1326740|NCT01470677|lymph cyst|lymph cyst
1326741|NCT01470677|lymphocele|lymphocele
1326742|NCT01470677|fibrin|fibrin
1326743|NCT01470677|collagen|collagen
1326744|NCT01470677|prevention|prevention
1326745|NCT01470677|cancer|cancer
1326746|NCT01470651|HCV+|hcv+
1326747|NCT01470651|HCV treatment|hcv treatment
1326748|NCT01470651|Fatigue|fatigue
1326749|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
1326750|NCT01470638|Flt3-L|flt3-l
1326751|NCT01470638|CSF|csf
1326752|NCT01470625|Dying|dying
1326753|NCT01470625|Patients|patients
1326754|NCT01470625|Hospice|hospice
1326755|NCT01470625|Liverpool Care Pathways|liverpool care pathways
1326756|NCT01470612|Ulcerative colitis|ulcerative colitis
1326757|NCT01470612|open-label|open-label
1326758|NCT01470612|long term treatment|long term treatment
1326759|NCT01470586|Colorectal cancer|colorectal cancer
1326760|NCT01470586|Surgical resection|surgical resection
1326761|NCT01470586|Oxidative Stress Markers|oxidative stress markers
1326762|NCT01470586|Controls|controls
1326763|NCT01470560|Mindfulness|mindfulness
1326764|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1326765|NCT01470560|Meditation|meditation
1326766|NCT01470560|Yoga|yoga
1326767|NCT01470547|Liver Cirrhosis|liver cirrhosis
1326768|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
1326769|NCT01470547|Cirrhosis Complications|cirrhosis complications
1326770|NCT01470547|Registry|registry
1326771|NCT01470547|Italian|italian
1326772|NCT01470534|Dietary supplement|dietary supplement
1326773|NCT01470534|Carbohydrate loading|carbohydrate loading
1326774|NCT01470534|Insulin resistance|insulin resistance
1326775|NCT01470534|Surgery|surgery
1326776|NCT01470521|Multiple sclerosis|multiple sclerosis
1326777|NCT01470521|Hookworm larvae|hookworm larvae
1326778|NCT01470521|Necator americanus|necator americanus
1326779|NCT01470521|Treg cells|treg cells
1326780|NCT01470508|Bulimia|bulimia
1326781|NCT01470508|Binge-Eating Disorder|binge-eating disorder
1326782|NCT01470508|Eating Disorders|eating disorders
1326783|NCT01470482|Total knee|total knee
1326784|NCT01470482|Tourniquet|tourniquet
1326785|NCT01470482|Blood loss|blood loss
1326786|NCT01470482|pain|pain
1326787|NCT01470482|range of motion|range of motion
1326788|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
1326789|NCT01470391|Femoral Nerve Block|femoral nerve block
1326790|NCT01470391|Postoperative Pain|postoperative pain
1326791|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
1326792|NCT01470378|Lymphedema|lymphedema
1326793|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
1326794|NCT01470378|Plastic Surgery|plastic surgery
1326795|NCT01470352|migraine|migraine
1326796|NCT01470352|pain|pain
1326797|NCT01470352|CPM|cpm
1326798|NCT01470352|offset analgesia|offset analgesia
1326799|NCT01470352|fMRI|fmri
1326800|NCT01470339|endogenous pain modulation|endogenous pain modulation
1326801|NCT01470339|migraine|migraine
1326802|NCT01470339|fMRI|fmri
1326803|NCT01470339|duloxetine|duloxetine
1326804|NCT01470339|preventive migraine treatment|preventive migraine treatment
1326805|NCT01470326|Osteoporosis|osteoporosis
1326806|NCT01470326|Post menopausal women|post menopausal women
1326807|NCT01470326|SERM|serm
1326808|NCT01470326|Japanese|japanese
1326809|NCT01470326|Viviant|viviant
1326810|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1326811|NCT01470326|Long term treatment|long term treatment
1326812|NCT01470313|Safety and tolerability|safety and tolerability
1326813|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
1326814|NCT01470313|efficacy|efficacy
1326815|NCT01470287|Infants,|infants,
1326816|NCT01470287|Immunogenicity,|immunogenicity,
1326817|NCT01470287|Safety|safety
1326818|NCT01470274|Blood volume|blood volume
1326819|NCT01470274|CO-rebreathing|co-rebreathing
1326820|NCT01470274|COPD|copd
1326822|NCT01470261|methylphenidate|methylphenidate
1326823|NCT01470261|ritalin|ritalin
1326824|NCT01470261|Attention Deficit Disorder|attention deficit disorder
1326825|NCT01470248|Lung Cancer|lung cancer
1326826|NCT01470248|Carcinoma, small cell|carcinoma, small cell
1326827|NCT01470248|Trisenox|trisenox
1326828|NCT01470248|Arsenic trioxide|arsenic trioxide
1326829|NCT01470248|phase II trial|phase ii trial
1326830|NCT01470235|screening|screening
1326831|NCT01470235|genetic|genetic
1326832|NCT01470235|cancer|cancer
1326833|NCT01470222|Worksite|worksite
1326834|NCT01470222|group weight loss|group weight loss
1326835|NCT01470222|behavioral components|behavioral components
1326836|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
1326837|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
1326838|NCT01470196|WM|wm
1326839|NCT01470196|untreated|untreated
1326840|NCT01470196|symptomatic|symptomatic
1326841|NCT01470183|Lupus Nephritis|lupus nephritis
1326842|NCT01470170|Sedative bronchoscope|sedative bronchoscope
1326843|NCT01470170|Alfentanil doses|alfentanil doses
1326844|NCT01470170|Propofol|propofol
1326845|NCT01470170|Targeted controlled infusion|targeted controlled infusion
1326846|NCT01470170|Hypoxemia|hypoxemia
1326847|NCT01470131|multiple myeloma|multiple myeloma
1326848|NCT01470131|relapse|relapse
1326849|NCT01470131|second line therapy|second line therapy
1326850|NCT01470131|bortezomib|bortezomib
1326851|NCT01470131|dexamethasone|dexamethasone
1326852|NCT01470105|questionnaire|questionnaire
1326853|NCT01470105|11-121|11-121
1326854|NCT01470092|Menopause|menopause
1326855|NCT01470092|Depression|depression
1326856|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
1326857|NCT01470066|interim PET/CT|interim pet/ct
1326858|NCT01470066|prognosis|prognosis
1326859|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
1326860|NCT01470053|mometasone furoate|mometasone furoate
1326861|NCT01470053|azelastine HCl|azelastine hcl
1326862|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
1326863|NCT01470040|traumatic brain injury|traumatic brain injury
1326864|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
1326865|NCT01470040|aspirin|aspirin
1326866|NCT01470040|antiplatelet therapy|antiplatelet therapy
1326867|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1326868|NCT01470027|N-acetylcysteine|n-acetylcysteine
1326869|NCT01470027|antioxidant|antioxidant
1326870|NCT01470027|glutathione|glutathione
1326871|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
1326872|NCT01470014|cardiac computed tomography|cardiac computed tomography
1326873|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
1326874|NCT01470014|echocardiography|echocardiography
1326875|NCT01469975|cancer|cancer
1326876|NCT01469975|relapse or refractory|relapse or refractory
1326877|NCT01469962|morbid obesity|morbid obesity
1326878|NCT01469962|bariatric surgery|bariatric surgery
1326879|NCT01469962|NASH|nash
1326880|NCT01469962|Liver fibrosis|liver fibrosis
1326881|NCT01469962|Fibrotest|fibrotest
1326882|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
1326883|NCT01469936|Fibromyalgia|fibromyalgia
1326884|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
1326885|NCT01469923|Phase 1|phase 1
1326886|NCT01469923|obese|obese
1326887|NCT01469923|healthy male volunteers|healthy male volunteers
1326888|NCT01469923|multiple doses|multiple doses
1326889|NCT01469923|dose escalation|dose escalation
1326890|NCT01469923|pharmacokinetics|pharmacokinetics
1326891|NCT01469923|pharmakodynamics|pharmakodynamics
1326892|NCT01469897|JIA|jia
1326893|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1326894|NCT01469897|Cost of Care|cost of care
1326895|NCT01469897|Quality of Life|quality of life
1326896|NCT01469897|QOL|qol
1326897|NCT01469884|Renal allograft recipients|renal allograft recipients
1326898|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
1326899|NCT01469884|Certican|certican
1326900|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
1326901|NCT01469871|Dressing|dressing
1326902|NCT01469871|Blisters|blisters
1326903|NCT01469871|Silicone|silicone
1326904|NCT01469845|hospital admissions|hospital admissions
1326905|NCT01469845|acute bronchiolitis|acute bronchiolitis
1326906|NCT01469845|under one year old|under one year old
1326907|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
1326908|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
1326909|NCT01469832|Retinal Diseases|retinal diseases
1326910|NCT01469832|Macular Degeneration|macular degeneration
1326911|NCT01469832|SMD|smd
1326912|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
1326913|NCT01469819|chronic constipation|chronic constipation
1326914|NCT01469819|constipation|constipation
1326915|NCT01469819|idiopathic constipation|idiopathic constipation
1326916|NCT01469819|SmartPill|smartpill
1326917|NCT01469819|Wireless Motility Capsule|wireless motility capsule
1326918|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
1621396|NCT00314834|prealbumin|prealbumin
1326919|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
1326920|NCT01469780|Pain|pain
1326921|NCT01469780|Health behavior change|health behavior change
1326922|NCT01469780|Coronary angioplasty|coronary angioplasty
1326923|NCT01469780|Cardiovascular disease|cardiovascular disease
1326924|NCT01469780|Outcomes|outcomes
1326925|NCT01469780|Morbidity|morbidity
1326926|NCT01469780|Mortality|mortality
1326927|NCT01469767|eczema|eczema
1326928|NCT01469767|itch|itch
1326929|NCT01469767|scratching|scratching
1326930|NCT01469767|actigraphy|actigraphy
1326931|NCT01469767|adherence|adherence
1326932|NCT01469754|lymphoma|lymphoma
1326933|NCT01469754|survivors|survivors
1327247|NCT01468441|ICSI|icsi
1326934|NCT01469754|posttraumatic growth|posttraumatic growth
1326935|NCT01469754|posttraumatic stress|posttraumatic stress
1326936|NCT01469754|longitudinal|longitudinal
1326937|NCT01469728|VATS|vats
1326938|NCT01469728|awake thoracic surgery|awake thoracic surgery
1326939|NCT01469728|pleurodesis|pleurodesis
1326940|NCT01469728|talc|talc
1326941|NCT01469728|TEA|tea
1326942|NCT01469728|epidural anesthesia|epidural anesthesia
1326943|NCT01469728|Video-Assisted|video-assisted
1326944|NCT01469728|Anesthesia Epidural|anesthesia epidural
1326945|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
1326946|NCT01469702|cat-scratch disease|cat-scratch disease
1326947|NCT01469702|Bartonella henselae|bartonella henselae
1326948|NCT01469702|corticosteroids|corticosteroids
1326949|NCT01469702|treatment|treatment
1326950|NCT01469689|People|people
1326951|NCT01469689|living|living
1326952|NCT01469689|community|community
1326953|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1326954|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
1326955|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
1326956|NCT01469676|Pulmonary Function|pulmonary function
1326957|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
1326958|NCT01469663|Borderline Personality Disorder|borderline personality disorder
1326959|NCT01469663|Major Depression|major depression
1326960|NCT01469663|Electroencephalogram|electroencephalogram
1326961|NCT01469663|N2|n2
1326962|NCT01469663|Error Related Negativity|error related negativity
1326963|NCT01469663|Emotional Processing|emotional processing
1326964|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
1326965|NCT01469650|vitamin D3|vitamin d3
1326966|NCT01469650|prematurity|prematurity
1326967|NCT01469650|parathyroid hormone|parathyroid hormone
1326968|NCT01469650|25(OH)D|25(oh)d
1326969|NCT01469650|NICU hospitalization|nicu hospitalization
1326970|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
1326971|NCT01469624|Pentoxifylline|pentoxifylline
1326972|NCT01469624|PCI|pci
1326973|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
1326974|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
1326975|NCT01469585|MMP expression|mmp expression
1326976|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
1326977|NCT01469572|Liver cancer|liver cancer
1326978|NCT01469572|Metastatic liver cancer|metastatic liver cancer
1326979|NCT01469559|Insulin|insulin
1326980|NCT01469559|Diabetic neuropathy|diabetic neuropathy
1326981|NCT01469559|Intranasal administration|intranasal administration
1326982|NCT01469559|Pilot project|pilot project
1326983|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1326984|NCT01469533|Spine|spine
1326985|NCT01469533|Manipulation|manipulation
1326986|NCT01469533|Pain Threshold|pain threshold
1326987|NCT01469533|Electromyography.|electromyography.
1326988|NCT01469520|HIV|hiv
1326989|NCT01469520|AIDS|aids
1326990|NCT01469520|Treatment|treatment
1326991|NCT01469494|DIEP flap|diep flap
1326992|NCT01469494|SIEA flap|siea flap
1326993|NCT01469494|breast reconstruction|breast reconstruction
1326994|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
1326995|NCT01469494|fat necrosis|fat necrosis
1326996|NCT01469494|flap loss|flap loss
1326997|NCT01469494|seroma rate|seroma rate
1326998|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
1326999|NCT01469494|Breast-Q|breast-q
1327126|NCT01468922|Solid Tumor|solid tumor
1327000|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
1327001|NCT01469481|diabetes mellitus|diabetes mellitus
1327002|NCT01469481|ADME|adme
1327003|NCT01469455|Local metastatic melanoma|local metastatic melanoma
1327004|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
1327005|NCT01469455|melanoma-in-transit|melanoma-in-transit
1327006|NCT01469442|Biliary fistula|biliary fistula
1327007|NCT01469442|prevention|prevention
1327008|NCT01469442|hepatectomy|hepatectomy
1327009|NCT01469442|external stent|external stent
1327010|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
1327011|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
1327012|NCT01469429|oral cancer|oral cancer
1327013|NCT01469416|rosuvastatin|rosuvastatin
1327014|NCT01469416|clopidogrel|clopidogrel
1327015|NCT01469416|pharmacokinetics|pharmacokinetics
1327016|NCT01469416|drug interaction|drug interaction
1327017|NCT01469416|healthy volunteer|healthy volunteer
1327018|NCT01469416|drug transporter|drug transporter
1327019|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
1327020|NCT01469403|Obesity|obesity
1327021|NCT01469403|Weight Loss|weight loss
1327022|NCT01469403|Arthroplasty|arthroplasty
1327023|NCT01469377|Major depressive disorder|major depressive disorder
1327024|NCT01469377|Depression|depression
1327025|NCT01469364|Lung Transplant|lung transplant
1327026|NCT01469364|Lung Transplant Recipient|lung transplant recipient
1327027|NCT01469351|Alzheimers disease|alzheimers disease
1327028|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1327029|NCT01469325|Depression|depression
1327808|NCT01466231|everolimus|everolimus
1327030|NCT01469325|left prefrontal|left prefrontal
1327031|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
1327032|NCT01469312|Diabetes|diabetes
1327033|NCT01469312|Glycemic Index|glycemic index
1327034|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
1327035|NCT01469286|delayed gastric emptying|delayed gastric emptying
1327036|NCT01469286|nausea|nausea
1327037|NCT01469286|vomiting|vomiting
1327038|NCT01469286|abdominal discomfort|abdominal discomfort
1327039|NCT01469273|Diarrhea|diarrhea
1327040|NCT01469273|EcN|ecn
1327041|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
1327042|NCT01469273|Gastrointestinal infection|gastrointestinal infection
1327043|NCT01469273|Infant|infant
1327044|NCT01469273|Newborn|newborn
1327045|NCT01469273|Probiotic drug|probiotic drug
1327046|NCT01469273|Prevention|prevention
1327047|NCT01469273|Prophylaxis|prophylaxis
1327048|NCT01469260|Overweight|overweight
1327049|NCT01469260|Obesity|obesity
1327050|NCT01469260|Pregnancy|pregnancy
1327051|NCT01469260|Weight gain|weight gain
1327052|NCT01469260|Pedometer|pedometer
1327053|NCT01469260|Exercise|exercise
1327054|NCT01469247|Brain cancer|brain cancer
1327055|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
1327056|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
1327057|NCT01469247|DIPG|dipg
1327058|NCT01469247|Reirradiation|reirradiation
1327059|NCT01469247|ReRT|rert
1327060|NCT01469247|Photon radiation therapy|photon radiation therapy
1327061|NCT01469247|XRT|xrt
1327062|NCT01469221|Bladder Cancer|bladder cancer
1327063|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
1327064|NCT01469221|NMIBC|nmibc
1327065|NCT01469221|Apaziquone|apaziquone
1327066|NCT01469221|EOquin|eoquin
1327067|NCT01469221|GU Cancer|gu cancer
1327068|NCT01469221|TURBT|turbt
1327069|NCT01469208|Gastroschisis|gastroschisis
1327070|NCT01469208|NICU inpatients|nicu inpatients
1327071|NCT01469208|Post surgical repair|post surgical repair
1327072|NCT01469208|Music Therapy|music therapy
1327073|NCT01469195|lead rectangle|lead rectangle
1327074|NCT01469195|radiation exposure|radiation exposure
1327075|NCT01469195|operators|operators
1327076|NCT01469195|radial approach|radial approach
1327077|NCT01469195|coronary procedures|coronary procedures
1327078|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
1327079|NCT01469182|Immunology|immunology
1327080|NCT01469169|Iloprost|iloprost
1327081|NCT01469169|Inhalation|inhalation
1327082|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
1327083|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
1327084|NCT01469169|Japanese Patients|japanese patients
1327085|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1327086|NCT01469156|choroidal neovascularization|choroidal neovascularization
1327087|NCT01469156|ranibizumab|ranibizumab
1327088|NCT01469156|Lucentis|lucentis
1327089|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
1327090|NCT01469117|Developmental disabilities|developmental disabilities
1327091|NCT01469117|Enteral Nutrition|enteral nutrition
1327092|NCT01469117|Tube feeding|tube feeding
1327093|NCT01469117|Nutrition support|nutrition support
1327094|NCT01469104|Diabetes|diabetes
1327095|NCT01469091|Acute admittance|acute admittance
1327096|NCT01469091|Current smoker|current smoker
1327097|NCT01469078|Chronic Kidney Disease|chronic kidney disease
1327098|NCT01469078|CKD stage 5|ckd stage 5
1327099|NCT01469078|Iron deficiency|iron deficiency
1327100|NCT01469065|inpatient|inpatient
1327101|NCT01469065|diabetes|diabetes
1327102|NCT01469065|phase 1|phase 1
1327103|NCT01469039|Alkermes|alkermes
1327104|NCT01469039|schizophrenia|schizophrenia
1327105|NCT01469039|ALKS 9072|alks 9072
1327106|NCT01469039|ALKS 9070|alks 9070
1327123|NCT01468922|Advanced Cancer|advanced cancer
1327124|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
1327125|NCT01468922|Cancer|cancer
1327127|NCT01468922|Sarcoma|sarcoma
1327128|NCT01468883|Breast Cancer|breast cancer
1327129|NCT01468883|Surgery|surgery
1327130|NCT01468883|Radiation|radiation
1327131|NCT01468857|Clinical Stress Markers|clinical stress markers
1327132|NCT01468857|Chronic Stress|chronic stress
1621500|NCT00314431|prematurity|prematurity
1327133|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1327134|NCT01468857|HSCT Caregivers|hsct caregivers
1327135|NCT01468857|Cancer Caregivers|cancer caregivers
1327136|NCT01468857|Stress|stress
1327137|NCT01468857|Family Caregivers|family caregivers
1327138|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
1327139|NCT01468844|Minocycline|minocycline
1327140|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
1327141|NCT01468844|CRVO|crvo
1327142|NCT01468831|Branch Retinal Vein Occlusion|branch retinal vein occlusion
1327143|NCT01468831|Minocycline|minocycline
1327144|NCT01468831|Macular Edema|macular edema
1327145|NCT01468831|Retinal Vein Occlusion|retinal vein occlusion
1327146|NCT01468831|BRVO|brvo
1327147|NCT01468818|Metastatic Melanoma|metastatic melanoma
1327148|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
1327149|NCT01468818|Skin Cancer|skin cancer
1327150|NCT01468805|Environmental Intervention|environmental intervention
1327151|NCT01468805|Indoor Allergens|indoor allergens
1327152|NCT01468805|Cockroach|cockroach
1327153|NCT01468805|Health Disparities|health disparities
1327154|NCT01468805|Multi-Center|multi-center
1327155|NCT01468805|Asthma|asthma
1327156|NCT01468805|Environment|environment
1327157|NCT01468792|systemic sclerosis|systemic sclerosis
1327158|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
1327159|NCT01468779|Periampullary cancer|periampullary cancer
1327160|NCT01468779|Surgery|surgery
1327161|NCT01468779|Dietary supplementation|dietary supplementation
1327162|NCT01468779|Nutritional assessment|nutritional assessment
1327163|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
1327164|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
1327165|NCT01468753|Vaginal Insemination|vaginal insemination
1327166|NCT01468727|dental caries|dental caries
1327167|NCT01468727|mutans streptococci|mutans streptococci
1327168|NCT01468727|lactobacilli|lactobacilli
1327169|NCT01468727|bacterial transmission|bacterial transmission
1327170|NCT01468727|bacterial colonization|bacterial colonization
1327171|NCT01468714|Drug Interaction|drug interaction
1327172|NCT01468714|pharmacokinetics|pharmacokinetics
1327173|NCT01468714|ketoconazole|ketoconazole
1327174|NCT01468714|CYP3A|cyp3a
1327175|NCT01468688|Imatinib mesylate|imatinib mesylate
1327176|NCT01468688|BKM120|bkm120
1327177|NCT01468688|GIST|gist
1327178|NCT01468649|Breast Cancer|breast cancer
1327179|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
1327180|NCT01468649|Intraoperative Imaging|intraoperative imaging
1327181|NCT01468636|Warts|warts
1327182|NCT01468636|HPV|hpv
1327183|NCT01468636|Zinc|zinc
1327184|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
1327185|NCT01468623|FOLFOX6|folfox6
1327186|NCT01468623|5-FU|5-fu
1327187|NCT01468623|First line|first line
1327188|NCT01468623|bevacizumab|bevacizumab
1327189|NCT01468610|depression|depression
1327190|NCT01468610|cognition|cognition
1327191|NCT01468610|occupational functioning|occupational functioning
1327192|NCT01468610|productivity|productivity
1327193|NCT01468610|neuropsychology|neuropsychology
1327194|NCT01468610|desvenlafaxine|desvenlafaxine
1327195|NCT01468610|antidepressants|antidepressants
1327196|NCT01468597|Emergent|emergent
1327197|NCT01468597|Cardiac surgery|cardiac surgery
1327198|NCT01468597|On-pump|on-pump
1327199|NCT01468597|Platelet function|platelet function
1327200|NCT01468584|Genotype 2|genotype 2
1327201|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
1327202|NCT01468571|Right-sided heart failure|right-sided heart failure
1327203|NCT01468571|Edema|edema
1327204|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
1327205|NCT01468545|Education|education
1327206|NCT01468545|Ventavis|ventavis
1327207|NCT01468545|Adherence|adherence
1327208|NCT01468545|PAH|pah
1327209|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
1328067|NCT01465243|phase IV|phase iv
1327210|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
1327211|NCT01468519|Erectile dysfunction|erectile dysfunction
1327212|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1327213|NCT01468519|CSII|csii
1327214|NCT01468519|insulin|insulin
1327215|NCT01468506|Chronic Kidney Disease|chronic kidney disease
1327216|NCT01468506|arteriovenous fistula|arteriovenous fistula
1327217|NCT01468493|FSGS|fsgs
1327218|NCT01468493|suPAR|supar
1327219|NCT01468480|direct pulp capping|direct pulp capping
1327220|NCT01468480|MTA|mta
1327221|NCT01468480|Single visit pulp cap|single visit pulp cap
1327222|NCT01468480|Multical|multical
1327223|NCT01468467|AC220|ac220
1327224|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1327225|NCT01468467|Transplantation|transplantation
1327226|NCT01468467|Stem Cell Transplantation|stem cell transplantation
1327227|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
1327228|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
1327229|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
1327230|NCT01468467|Kinase|kinase
1327231|NCT01468467|Kinase Inhibitor|kinase inhibitor
1327232|NCT01468467|Pharmacokinetics|pharmacokinetics
1327233|NCT01468467|ASP2689|asp2689
1327234|NCT01468467|quizartinib|quizartinib
1327235|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
1327236|NCT01468454|hyperinsulinism|hyperinsulinism
1327237|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
1327238|NCT01468454|CHI|chi
1327239|NCT01468454|PHHI|phhi
1327240|NCT01468454|Pancreatectomy|pancreatectomy
1327241|NCT01468454|18F-DOPA|18f-dopa
1327242|NCT01468454|PET/CT scan|pet/ct scan
1327243|NCT01468441|ovarian stimulation|ovarian stimulation
1327244|NCT01468441|GnRH agonist|gnrh agonist
1327245|NCT01468441|GnRH antagonist|gnrh antagonist
1327246|NCT01468441|hCG microdose|hcg microdose
1327248|NCT01468415|Methylprednisolone|methylprednisolone
1327249|NCT01468415|trans sacral block|trans sacral block
1327250|NCT01468415|phenol|phenol
1327251|NCT01468402|Leiomyoma|leiomyoma
1327252|NCT01468402|uterine artery embolization|uterine artery embolization
1327505|NCT01467284|Exercise|exercise
1327253|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
1327254|NCT01468389|Gastric Cancer|gastric cancer
1327255|NCT01468389|capecitabine|capecitabine
1327256|NCT01468389|maintenance treatment|maintenance treatment
1327257|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
1327258|NCT01468376|pre-diabetes|pre-diabetes
1327259|NCT01468363|Dry weight|dry weight
1327260|NCT01468363|Body composition monitor|body composition monitor
1327261|NCT01468363|Hemodialysis|hemodialysis
1327262|NCT01468363|Zonguldak|zonguldak
1327263|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
1327264|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
1327265|NCT01468337|Jakstat|jakstat
1327266|NCT01468337|Retinal Eye Disease|retinal eye disease
1327267|NCT01468337|Macular Eye Disease|macular eye disease
1327268|NCT01468337|CSC|csc
1327269|NCT01468324|Brain|brain
1327270|NCT01468324|Angiogenesis|angiogenesis
1327271|NCT01468324|Radiotherapy|radiotherapy
1327272|NCT01468324|Malignant|malignant
1327273|NCT01468324|Tumor|tumor
1327274|NCT01468324|Glioma|glioma
1327275|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
1327276|NCT01468324|Brain Tumor|brain tumor
1327277|NCT01468311|Immunotherapy|immunotherapy
1327278|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
1327279|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
1327280|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
1327281|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
1327282|NCT01468298|back pain|back pain
1327283|NCT01468298|physical therapy|physical therapy
1327284|NCT01468298|spine|spine
1327285|NCT01468298|rehabilitation|rehabilitation
1327286|NCT01468298|exercise|exercise
1327287|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
1327288|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
1327289|NCT01468246|Breast Cancer|breast cancer
1327290|NCT01468246|Cohort|cohort
1327291|NCT01468246|Young Women|young women
1327292|NCT01468246|Survivorship|survivorship
1327293|NCT01468246|Fertility|fertility
1327294|NCT01468233|placebo controlled|placebo controlled
1327295|NCT01468233|double blind|double blind
1327296|NCT01468233|adalimumab|adalimumab
1327297|NCT01468233|TNF|tnf
1327298|NCT01468233|psoriasis|psoriasis
1327299|NCT01468233|HS|hs
1327300|NCT01468233|PIONEER II|pioneer ii
1327301|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
1327302|NCT01468233|acne inversa|acne inversa
1327303|NCT01468233|boil|boil
1327304|NCT01468233|acne|acne
1327305|NCT01468220|tissue metabolism|tissue metabolism
1327306|NCT01468220|skeletal muscle|skeletal muscle
1327307|NCT01468220|adipose tissue|adipose tissue
1327308|NCT01468220|HIF|hif
1327309|NCT01468207|acne|acne
1327310|NCT01468207|psoriasis|psoriasis
1327311|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
1327312|NCT01468207|TNF|tnf
1327313|NCT01468207|HS|hs
1327314|NCT01468207|PIONEER I|pioneer i
1327315|NCT01468207|acne inversa|acne inversa
1327316|NCT01468207|boil|boil
1327317|NCT01468207|placebo controlled|placebo controlled
1327318|NCT01468207|Double blind|double blind
1327319|NCT01468207|adalimumab|adalimumab
1327320|NCT01468194|AMS|ams
1327321|NCT01468194|HAPE|hape
1327322|NCT01468194|high altitude|high altitude
1327323|NCT01468194|oxygen|oxygen
1327324|NCT01468194|saturation|saturation
1327325|NCT01468194|mountain|mountain
1327326|NCT01468194|climbing|climbing
1327327|NCT01468194|breathing|breathing
1327328|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
1327329|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
1327330|NCT01468181|Long-Term Safety|long-term safety
1327331|NCT01468181|GLP 1|glp 1
1327332|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
1327333|NCT01468155|PVA|pva
1436797|NCT01016522|ALS|als
1327334|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
1327335|NCT01468116|Type 2 diabetes|type 2 diabetes
1327336|NCT01468116|Gastric bypass surgery|gastric bypass surgery
1327337|NCT01468116|Obesity|obesity
1327338|NCT01468116|Mitochondrial function|mitochondrial function
1327339|NCT01468103|intraocular pressure|intraocular pressure
1327340|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
1327341|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
1327342|NCT01468090|Crohn's disease|crohn's disease
1327343|NCT01468090|Ulcerative colitis|ulcerative colitis
1327344|NCT01468090|Disease course|disease course
1327345|NCT01468090|Phenotype|phenotype
1327346|NCT01468090|Biological treatment|biological treatment
1327347|NCT01468064|Central Nervous System Diseases|central nervous system diseases
1327348|NCT01468064|Stroke|stroke
1327349|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
1327350|NCT01468064|Cerebral Infarction|cerebral infarction
1327351|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
1327352|NCT01468064|Stem Cell Transplantation|stem cell transplantation
1327353|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
1327354|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
1327355|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
1327356|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
1327357|NCT01468064|Adult Stem Cells|adult stem cells
1327358|NCT01468064|Cell Therapy|cell therapy
1327359|NCT01468051|predialysed|predialysed
1327360|NCT01468051|chronic|chronic
1327361|NCT01468051|renal failure patients|renal failure patients
1327362|NCT01468025|NSAIDs|nsaids
1327363|NCT01468025|Theramine|theramine
1327364|NCT01468025|naproxen|naproxen
1327365|NCT01468025|Low back pain|low back pain
1327366|NCT01468025|amino acids|amino acids
1327367|NCT01468025|CRP|crp
1327368|NCT01468025|Medical Food|medical food
1327369|NCT01468012|cocaine dependence|cocaine dependence
1327370|NCT01468012|levodopa|levodopa
1327371|NCT01468012|carbidopa|carbidopa
1327372|NCT01468012|entacapone|entacapone
1327373|NCT01467999|cannabis dependence|cannabis dependence
1327374|NCT01467999|marijuana dependence|marijuana dependence
1327375|NCT01467999|guanfacine|guanfacine
1327376|NCT01467986|neuroblastoma|neuroblastoma
1327377|NCT01467986|molecular targeted therapy|molecular targeted therapy
1327378|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
1327379|NCT01467986|mTOR Inhibitor|mtor inhibitor
1327506|NCT01467245|Thoracoscopy|thoracoscopy
1327380|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
1327381|NCT01467986|temozolomide|temozolomide
1327382|NCT01467986|irinotecan|irinotecan
1327383|NCT01467986|dasatinib|dasatinib
1327384|NCT01467986|rapamycin|rapamycin
1327385|NCT01467973|Heart Failure|heart failure
1327386|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
1327387|NCT01467973|Heart Failure, Systolic|heart failure, systolic
1327388|NCT01467973|Middle-East|middle-east
1327389|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
1327390|NCT01467869|abnormal semen|abnormal semen
1327391|NCT01467869|assisted conception|assisted conception
1327392|NCT01467856|Tetraplegia|tetraplegia
1327393|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
1327394|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1327395|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
1327396|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
1327397|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
1327398|NCT01467817|body mass|body mass
1327399|NCT01467817|abdominal fat|abdominal fat
1327400|NCT01467817|whole body lean mass|whole body lean mass
1327401|NCT01467817|insulin resistance|insulin resistance
1327402|NCT01467817|caloric intake|caloric intake
1327403|NCT01467817|expenditure|expenditure
1327404|NCT01467817|endurance|endurance
1327405|NCT01467817|Strength|strength
1327406|NCT01467817|TC:HDL ratio|tc:hdl ratio
1327407|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
1328068|NCT01465243|NSCLC|nsclc
1327408|NCT01467817|area under the TG response curve|area under the tg response curve
1327409|NCT01467817|feeding challenge|feeding challenge
1327410|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
1327411|NCT01467817|HRQoL|hrqol
1327412|NCT01467804|efficacy,|efficacy,
1327413|NCT01467804|safety,|safety,
1327414|NCT01467804|JWXYJN|jwxyjn
1327415|NCT01467791|ambrisentan|ambrisentan
1327416|NCT01467791|Bosentan|bosentan
1327417|NCT01467791|Iloprost|iloprost
1327418|NCT01467778|skin|skin
1327419|NCT01467752|reconstruction|reconstruction
1327420|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
1327421|NCT01467752|bone graft|bone graft
1327422|NCT01467752|MCP joint|mcp joint
1327423|NCT01467726|Alzheimer's disease|alzheimer's disease
1327424|NCT01467726|Elderly|elderly
1327425|NCT01467713|Drug Therapy|drug therapy
1327426|NCT01467700|Drug Therapy|drug therapy
1327427|NCT01467674|Diabetes mellitus|diabetes mellitus
1327428|NCT01467674|Chronic periodontitis|chronic periodontitis
1327429|NCT01467674|Malondialdehyde|malondialdehyde
1327430|NCT01467674|Glutathione peroxidase|glutathione peroxidase
1327431|NCT01467674|Paraoxonase|paraoxonase
1327432|NCT01467648|Infection|infection
1327433|NCT01467648|Doripenem|doripenem
1327434|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1327435|NCT01467648|pharmacokinetic|pharmacokinetic
1327436|NCT01467648|pharmacodynamic|pharmacodynamic
1327437|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
1327438|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
1327439|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
1327440|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
1327441|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
1327442|NCT01467622|chest tube drainage|chest tube drainage
1327443|NCT01467622|pulmonary air leak|pulmonary air leak
1327444|NCT01467622|lung resection|lung resection
1328108|NCT01465061|Psoriasis|psoriasis
1327445|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
1327446|NCT01467609|conventional colonoscopy|conventional colonoscopy
1327447|NCT01467609|ulcerative colitis|ulcerative colitis
1327448|NCT01467609|endoscopic manifestation|endoscopic manifestation
1327449|NCT01467609|colonoscopy|colonoscopy
1327450|NCT01467596|Ultrasound|ultrasound
1327451|NCT01467596|Brachial block|brachial block
1327452|NCT01467596|Levobupivacaine|levobupivacaine
1327453|NCT01467596|Minimum|minimum
1327454|NCT01467596|Volume|volume
1327455|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
1327456|NCT01467583|Fondaparinux|fondaparinux
1327457|NCT01467583|Renal Failure|renal failure
1327458|NCT01467583|Critically Ill|critically ill
1327459|NCT01467570|diarrhea|diarrhea
1327460|NCT01467557|adverse events|adverse events
1327461|NCT01467544|Tai Chi|tai chi
1327462|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
1327463|NCT01467518|methadone|methadone
1327464|NCT01467518|Opiate-dependent|opiate-dependent
1327465|NCT01467492|VX-950, Incivek|vx-950, incivek
1327466|NCT01467466|renal|renal
1327467|NCT01467466|cardiovascular|cardiovascular
1327468|NCT01467466|kidney|kidney
1327469|NCT01467466|heart|heart
1327470|NCT01467466|clinical trial|clinical trial
1327471|NCT01467466|double-blind|double-blind
1327472|NCT01467466|multi-site trial|multi-site trial
1327473|NCT01467466|randomized|randomized
1327474|NCT01467466|drug treatment|drug treatment
1327475|NCT01467466|IV solutions|iv solutions
1327476|NCT01467466|antioxidant|antioxidant
1327477|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
1327478|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
1327479|NCT01467362|xerosis|xerosis
1327480|NCT01467362|dry skin|dry skin
1327481|NCT01467362|dermatitis|dermatitis
1327482|NCT01467362|pruritus|pruritus
1327483|NCT01467362|eczema|eczema
1327484|NCT01467362|emollient|emollient
1327485|NCT01467362|corticosteroid|corticosteroid
1327486|NCT01467349|Raltegravir|raltegravir
1327487|NCT01467349|efficacy|efficacy
1327488|NCT01467349|safety|safety
1327489|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
1327490|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
1327491|NCT01467310|GSK1120212|gsk1120212
1327492|NCT01467310|TNBC|tnbc
1327493|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
1327494|NCT01467310|Surgical Resection|surgical resection
1327495|NCT01467297|Chronic bronchitis|chronic bronchitis
1327496|NCT01467297|exacerbations|exacerbations
1327497|NCT01467297|treatment|treatment
1327498|NCT01467297|ceftidoren|ceftidoren
1327499|NCT01467297|levofloxacin|levofloxacin
1327500|NCT01467297|inflammation|inflammation
1327501|NCT01467284|Obesity|obesity
1327502|NCT01467284|Workplace|workplace
1327503|NCT01467284|Intervention|intervention
1327504|NCT01467284|Diet|diet
1327507|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
1327508|NCT01467245|oesophageal atresia|oesophageal atresia
1327509|NCT01467245|hypercapnia|hypercapnia
1327510|NCT01467245|acidosis|acidosis
1327511|NCT01467245|cerebral oxygenation|cerebral oxygenation
1327512|NCT01467245|neonates|neonates
1327513|NCT01467219|early|early
1327514|NCT01467219|high risk|high risk
1327515|NCT01467206|Stroke|stroke
1327516|NCT01467206|Physiotherapy|physiotherapy
1327517|NCT01467206|Motor training|motor training
1327518|NCT01467206|Rehabilitation|rehabilitation
1327519|NCT01467180|septeX|septex
1327520|NCT01467180|CVVH|cvvh
1327521|NCT01467180|CVHD|cvhd
1327522|NCT01467180|myoglobin|myoglobin
1327523|NCT01467167|Anesthesia|anesthesia
1327524|NCT01467167|Smart Pilot View|smart pilot view
1327525|NCT01467167|Pain control|pain control
1327526|NCT01467167|Recovery|recovery
1327527|NCT01467128|Elderly|elderly
1327528|NCT01467128|Hospital|hospital
1327529|NCT01467128|Adverse Drug|adverse drug
1327530|NCT01467128|Pharmacist|pharmacist
1327531|NCT01467128|Prevention|prevention
1327532|NCT01467115|loco regionally advanced|loco regionally advanced
1327533|NCT01467115|head and neck cancer|head and neck cancer
1327534|NCT01467115|chemotherapy|chemotherapy
1327535|NCT01467115|radiation|radiation
1327536|NCT01467102|chronic post surgical pain|chronic post surgical pain
1327537|NCT01467102|Pain|pain
1327538|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
1327539|NCT01467102|predictive risk factors|predictive risk factors
1327540|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
1327541|NCT01467102|international level|international level
1327542|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
1327543|NCT01467102|Europe|europe
1327544|NCT01467102|observational|observational
1327545|NCT01467102|prospective|prospective
1327546|NCT01467089|Schizophrenia|schizophrenia
1327547|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
1327548|NCT01467089|Tardive dyskinesia|tardive dyskinesia
1327549|NCT01467089|Two Way Video Assessment|two way video assessment
1327550|NCT01467063|Type I Diabetes|type i diabetes
1327551|NCT01467063|Insulin Resistance|insulin resistance
1327552|NCT01467063|Glutamine|glutamine
1327553|NCT01467063|Amino Acids|amino acids
1327554|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
1327555|NCT01467063|Glutathione|glutathione
1327556|NCT01467063|Citrulline|citrulline
1327557|NCT01467063|Arginine|arginine
1327558|NCT01467063|Nitric Oxide|nitric oxide
1327559|NCT01467050|Adverse drug event|adverse drug event
1327560|NCT01467050|Adverse drug reaction|adverse drug reaction
1327561|NCT01467050|Inappropriate prescribing|inappropriate prescribing
1327562|NCT01467050|Elderly|elderly
1327563|NCT01467050|Hospital-acquired|hospital-acquired
1327564|NCT01467037|Rotavirus|rotavirus
1327565|NCT01467037|Gastroenteritis|gastroenteritis
1327566|NCT01467037|Vaccination|vaccination
1327567|NCT01467037|Pediatrics|pediatrics
1327568|NCT01467024|HTLV|htlv
1327569|NCT01467024|Confirmatory|confirmatory
1327570|NCT01467024|Supplemental|supplemental
1327571|NCT01467024|Blot|blot
1327572|NCT01467024|HTLV-I|htlv-i
1327573|NCT01467024|HTLV-II|htlv-ii
1327574|NCT01467011|Myfortic|myfortic
1327575|NCT01467011|Mycophenolic acid|mycophenolic acid
1327576|NCT01467011|Prograf|prograf
1327577|NCT01467011|Tacrolimus|tacrolimus
1327578|NCT01467011|Liver transplantation|liver transplantation
1327579|NCT01466972|Advanced|advanced
1327580|NCT01466972|Breast|breast
1327581|NCT01466972|Cancer|cancer
1327582|NCT01466972|Hormone Resistance|hormone resistance
1327583|NCT01466972|Pazopanib|pazopanib
1327584|NCT01466972|anastrozole|anastrozole
1327585|NCT01466972|arimidex|arimidex
1327586|NCT01466972|letrozole|letrozole
1327587|NCT01466972|femara|femara
1327588|NCT01466959|hemodialysis|hemodialysis
1327589|NCT01466959|dialysate|dialysate
1327590|NCT01466959|acetate based dialysate|acetate based dialysate
1327591|NCT01466959|citrasate dialysate|citrasate dialysate
1327592|NCT01466959|heparin anticoagulation|heparin anticoagulation
1327593|NCT01466959|hemodynamic stability|hemodynamic stability
1327594|NCT01466946|lung cancer|lung cancer
1327595|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
1327596|NCT01466946|interviews|interviews
1327597|NCT01466946|11-109|11-109
1327598|NCT01466933|parenting intervention|parenting intervention
1327599|NCT01466933|child development|child development
1327600|NCT01466933|low and middle income countries|low and middle income countries
1327601|NCT01466920|Total knee arthroplasty|total knee arthroplasty
1327602|NCT01466907|complication|complication
1327603|NCT01466907|depression|depression
1327604|NCT01466907|follow-up|follow-up
1327605|NCT01466907|intervention|intervention
1327606|NCT01466907|nurse-led|nurse-led
1327607|NCT01466907|outcome|outcome
1327608|NCT01466907|secondary prevention|secondary prevention
1327609|NCT01466907|stroke|stroke
1327610|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1327611|NCT01466894|NAFLD|nafld
1327612|NCT01466894|Fatty liver|fatty liver
1327613|NCT01466894|NASH|nash
1327614|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
1327615|NCT01466868|AKT|akt
1327616|NCT01466868|MK 2206|mk 2206
1327617|NCT01466868|objective response rate|objective response rate
1327618|NCT01466868|progression free survival|progression free survival
1327619|NCT01466868|overall survival|overall survival
1327620|NCT01466868|safety|safety
1327621|NCT01466855|Retinoblastoma|retinoblastoma
1327622|NCT01466829|sternotomy|sternotomy
1327623|NCT01466829|parathyroid hormone|parathyroid hormone
1327624|NCT01466829|bone healing|bone healing
1327625|NCT01466816|Lipid metabolism|lipid metabolism
1327626|NCT01466803|Buprenorphine|buprenorphine
1327627|NCT01466803|Vorikonazole|vorikonazole
1327628|NCT01466803|Interactions|interactions
1327629|NCT01466803|Pharmacokinetics|pharmacokinetics
1327630|NCT01466803|Pharmacodynamics|pharmacodynamics
1327631|NCT01466803|Voriconazole|voriconazole
1327632|NCT01466790|Hepatitis C|hepatitis c
1327633|NCT01466790|TMC435|tmc435
1327634|NCT01466790|PSI-7977|psi-7977
1327635|NCT01466790|GS7977|gs7977
1327636|NCT01466790|Ribavirin|ribavirin
1327638|NCT01466790|Hep C|hep c
1327639|NCT01466790|Genotype 1|genotype 1
1327640|NCT01466777|Endometrium cancer|endometrium cancer
1327641|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
1327642|NCT01466777|Traditional laparoscopy|traditional laparoscopy
1327643|NCT01466777|Laparoscopic surgery|laparoscopic surgery
1327644|NCT01466777|Treatment|treatment
1327645|NCT01466777|Operation time|operation time
1327646|NCT01466777|Bleeding|bleeding
1327647|NCT01466777|Complications|complications
1327648|NCT01466777|Conversions|conversions
1327649|NCT01466777|Pelvic lymph node|pelvic lymph node
1327650|NCT01466764|biomarkers|biomarkers
1327651|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
1327652|NCT01466738|Healthy volunteer|healthy volunteer
1327653|NCT01466738|Rhinovirus|rhinovirus
1327654|NCT01466738|Cold virus|cold virus
1327655|NCT01466738|HRV-16|hrv-16
1327656|NCT01466725|Lupus|lupus
1327657|NCT01466725|Discoid Lupus|discoid lupus
1327658|NCT01466725|DLE|dle
1327659|NCT01466725|Cutaneous Lupus|cutaneous lupus
1327660|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1327661|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
1327662|NCT01466686|Surgery|surgery
1327663|NCT01466686|Adjuvant Radiation|adjuvant radiation
1327664|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
1327665|NCT01466673|Acne Vulgaris|acne vulgaris
1327666|NCT01466673|Ethinyl estradiol|ethinyl estradiol
1327667|NCT01466673|Norgestimate|norgestimate
1327668|NCT01466673|Desogestrel|desogestrel
1327669|NCT01466673|Tricilest|tricilest
1327670|NCT01466673|Oilezz|oilezz
1327671|NCT01466647|NSCLC|nsclc
1327672|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
1327673|NCT01466621|heart failure|heart failure
1327674|NCT01466621|mortality|mortality
1327675|NCT01466608|OATP1B1|oatp1b1
1327676|NCT01466608|Rosuvastatin|rosuvastatin
1327677|NCT01466608|lipidomics|lipidomics
1327678|NCT01466608|pharmacodynamics|pharmacodynamics
1327679|NCT01466582|HIV-1-infection|hiv-1-infection
1327680|NCT01466582|comorbidity|comorbidity
1327681|NCT01466582|ageing|ageing
1327682|NCT01466569|Advanced Solid Tumor|advanced solid tumor
1327683|NCT01466569|Gastric Cancer|gastric cancer
1327684|NCT01466569|Oncology|oncology
1327685|NCT01466569|monoclonal Antibody|monoclonal antibody
1327686|NCT01466543|Vascular dementia|vascular dementia
1327687|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
1327688|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
1327689|NCT01466543|Udenafil|udenafil
1327690|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
1327691|NCT01466530|Cesarean delivery|cesarean delivery
1327692|NCT01466530|General anesthesia|general anesthesia
1327693|NCT01466517|Relative Bioavailability Study|relative bioavailability study
1327694|NCT01466517|Ibuprofen|ibuprofen
1327695|NCT01466517|Alivium|alivium
1327696|NCT01466504|P63|p63
1327697|NCT01466504|Sorafenib|sorafenib
1327698|NCT01466504|Regorafenib|regorafenib
1327699|NCT01466504|rash|rash
1327700|NCT01466504|skin toxicity|skin toxicity
1327701|NCT01466504|RCC|rcc
1327702|NCT01466504|HCC|hcc
1327703|NCT01466504|colorectal carcinoma|colorectal carcinoma
1327704|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
1327705|NCT01466465|Vitamin D|vitamin d
1327706|NCT01466465|SIT|sit
1327707|NCT01466465|Grass pollen|grass pollen
1327708|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1327709|NCT01466439|rTMS|rtms
1327710|NCT01466439|P50|p50
1327711|NCT01466439|inhibitory|inhibitory
1327712|NCT01466439|facilitatory|facilitatory
1327713|NCT01466439|physiological process|physiological process
1327714|NCT01466439|brain changes|brain changes
1327715|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
1327716|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
1327717|NCT01466426|Pulmonary embolism|pulmonary embolism
1327718|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
1327719|NCT01466400|health benefits of infant formula|health benefits of infant formula
1327720|NCT01466387|Adults|adults
1327721|NCT01466387|international travel vaccination|international travel vaccination
1327722|NCT01466387|Meningococcal disease|meningococcal disease
1327723|NCT01466387|meningococcal meningitis|meningococcal meningitis
1327724|NCT01466387|typhoid|typhoid
1327725|NCT01466387|yellow fever|yellow fever
1327726|NCT01466387|rabies|rabies
1327727|NCT01466387|Japanese encephalitis|japanese encephalitis
1327728|NCT01466361|Nicotine|nicotine
1327729|NCT01466361|Nicotine craving|nicotine craving
1327730|NCT01466348|Paracetomol|paracetomol
1327731|NCT01466348|Caffeine|caffeine
1327732|NCT01466348|Common cold|common cold
1327733|NCT01466322|Healthy volunteers|healthy volunteers
1327734|NCT01466322|GSK2018682|gsk2018682
1327735|NCT01466322|Pharmacokinetics|pharmacokinetics
1327736|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1327737|NCT01466322|Pharmacodynamics|pharmacodynamics
1327738|NCT01466309|AHI|ahi
1327739|NCT01466309|ESS|ess
1327740|NCT01466309|VAS|vas
1327741|NCT01466309|FOSQ|fosq
1327742|NCT01466309|SF-36|sf-36
1327743|NCT01466296|CERBRAL PALSY|cerbral palsy
1327744|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
1327745|NCT01466296|REHABILITATION|rehabilitation
1327746|NCT01466296|WALKING|walking
1327747|NCT01466296|PERUTURBATION|peruturbation
1327748|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
1327749|NCT01466270|fatigue|fatigue
1327750|NCT01466270|sleep disorders|sleep disorders
1327751|NCT01466270|depression|depression
1327752|NCT01466270|anxiety disorder|anxiety disorder
1327753|NCT01466270|cognitive/functional effects|cognitive/functional effects
1327754|NCT01466270|breast cancer|breast cancer
1327755|NCT01466270|cancer survivor|cancer survivor
1327756|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1327757|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1327758|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1327759|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1327760|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1327761|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1327762|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1327763|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1327764|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1327765|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1327766|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1327767|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1327768|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1327769|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
1327770|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
1327771|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
1327772|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
1327773|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
1327774|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
1327775|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
1327776|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
1327777|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
1327778|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
1327779|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
1327780|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
1327781|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1327782|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1327783|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1327784|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1327785|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1327786|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1327787|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1327788|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1327866|NCT01466010|osteoma, osteoid|osteoma, osteoid
1327789|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1327790|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1327791|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1327792|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1327793|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1327794|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
1333197|NCT01444040|Ocular hypertension|ocular hypertension
1327795|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
1327796|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
1327797|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
1327798|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
1327799|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
1327800|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
1327801|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
1327802|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
1327803|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
1327804|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
1327805|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
1327806|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1327807|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
1327809|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
1327810|NCT01466218|pulmonary disease|pulmonary disease
1327811|NCT01466218|cardiac disease|cardiac disease
1327812|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
1327813|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
1327814|NCT01466218|OSA|osa
1327815|NCT01466218|cardiovascular disease|cardiovascular disease
1327816|NCT01466218|CVD|cvd
1327817|NCT01466218|particulate matter|particulate matter
1327818|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
1327819|NCT01466205|cognitive impairment|cognitive impairment
1327820|NCT01466205|working memory|working memory
1327821|NCT01466192|Genotype 2|genotype 2
1327822|NCT01466179|B-ALL|b-all
1327823|NCT01466179|relapsed ALL|relapsed all
1327824|NCT01466179|refractory ALL|refractory all
1327825|NCT01466179|adult ALL|adult all
1327826|NCT01466179|Leukemia|leukemia
1327827|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
1327828|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
1327829|NCT01466179|Lymphatic diseases|lymphatic diseases
1327830|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
1327831|NCT01466179|bispecific antibody|bispecific antibody
1327832|NCT01466179|anti-CD19|anti-cd19
1327833|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
1327834|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
1327835|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
1327836|NCT01466140|Patient Satisfaction|patient satisfaction
1327837|NCT01466140|Request for help|request for help
1327838|NCT01466140|General practice|general practice
1327839|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
1327840|NCT01466114|multiple sclerosis|multiple sclerosis
1327841|NCT01466114|MS|ms
1327842|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1327843|NCT01466114|RRMS|rrms
1327844|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
1327845|NCT01466114|SPMS|spms
1327846|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
1327847|NCT01466114|estrogen|estrogen
1327848|NCT01466114|estriol|estriol
1327849|NCT01466101|Hysterectomy|hysterectomy
1327850|NCT01466101|Pain|pain
1327851|NCT01466101|Pregabalin|pregabalin
1327852|NCT01466088|Alzheimer's Disease|alzheimer's disease
1327853|NCT01466088|AD|ad
1327854|NCT01466088|Dementia|dementia
1327855|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
1327856|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
1327857|NCT01466062|Infant|infant
1327858|NCT01466062|Newborn|newborn
1327859|NCT01466062|Young children|young children
1327860|NCT01466049|Ovarian Cancer|ovarian cancer
1327861|NCT01466049|Adnexal Mass|adnexal mass
1327862|NCT01466049|Pelvic Mass|pelvic mass
1327863|NCT01466036|metastatic|metastatic
1327864|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
1327865|NCT01466023|impact on neonate|impact on neonate
1327867|NCT01466010|surgical procedures, operative|surgical procedures, operative
1327868|NCT01466010|bone neoplasms|bone neoplasms
1327869|NCT01465997|Lacosamide|lacosamide
1327870|NCT01465984|Paracetamol|paracetamol
1327871|NCT01465984|Morphine sulfates|morphine sulfates
1327872|NCT01465984|Acute pain|acute pain
1327873|NCT01465971|high|high
1327874|NCT01465971|altitude|altitude
1327875|NCT01465971|acute|acute
1327876|NCT01465971|mountain|mountain
1327877|NCT01465971|sickness|sickness
1327878|NCT01465971|sleep|sleep
1327879|NCT01465971|disorder|disorder
1327880|NCT01465971|periodic|periodic
1327881|NCT01465971|breathing|breathing
1327882|NCT01465971|hyperventilation|hyperventilation
1327883|NCT01465971|apnea|apnea
1327884|NCT01465945|TEM for rectal lesions|tem for rectal lesions
1327885|NCT01465945|Sutured defect|sutured defect
1327886|NCT01465945|Unsutured defect|unsutured defect
1327887|NCT01465932|Nursing staff|nursing staff
1327888|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
1327889|NCT01465919|depression|depression
1327890|NCT01465919|interferon|interferon
1327891|NCT01465919|chronic hepatitis C|chronic hepatitis c
1327892|NCT01465919|mirtazapine|mirtazapine
1327893|NCT01465906|COPD|copd
1327894|NCT01465893|vitamin d|vitamin d
1327895|NCT01465880|Smoking research study|smoking research study
1327896|NCT01465867|Selenium|selenium
1327897|NCT01465867|Pregnancy|pregnancy
1327898|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
1327899|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
1327900|NCT01465867|Miscarriage|miscarriage
1327901|NCT01465867|Pre-eclampsia|pre-eclampsia
1327902|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
1327903|NCT01465867|Infertility|infertility
1327904|NCT01465854|lung cancer|lung cancer
1327905|NCT01465854|smoking|smoking
1327906|NCT01465854|molecular epidemiology|molecular epidemiology
1327907|NCT01465854|genetic polymorphism|genetic polymorphism
1327908|NCT01465854|risk factors|risk factors
1327909|NCT01465854|never smokers|never smokers
1327910|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
1327911|NCT01465841|intracranial aneurysms|intracranial aneurysms
1327912|NCT01465841|Peripheral aneurysms|peripheral aneurysms
1327913|NCT01465841|acute treatment|acute treatment
1327914|NCT01465841|PC 400 System|pc 400 system
1327915|NCT01465841|packing density|packing density
1327916|NCT01465828|antiplatelet effect|antiplatelet effect
1327917|NCT01465828|prasugrel|prasugrel
1327918|NCT01465828|clopidogrel|clopidogrel
1327920|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
1327921|NCT01465802|advanced|advanced
1327922|NCT01465802|previously treated|previously treated
1327923|NCT01465776|SCC of the oral cavity|scc of the oral cavity
1327924|NCT01465776|black raspberries|black raspberries
1327925|NCT01465763|tofacitinib|tofacitinib
1327926|NCT01465763|CP-690|cp-690
1327927|NCT01465763|550|550
1327928|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
1327929|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
1327930|NCT01465763|Mayo score|mayo score
1327931|NCT01465737|epidemiology|epidemiology
1327932|NCT01465737|uterine cancer|uterine cancer
1327933|NCT01465737|Taiwan|taiwan
1327934|NCT01465724|Insulin resistance|insulin resistance
1327935|NCT01465724|Insulin sensitivity|insulin sensitivity
1327936|NCT01465724|HOMA-IR|homa-ir
1327937|NCT01465724|blood pressure|blood pressure
1327938|NCT01465724|Renal denervation|renal denervation
1327939|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
1327940|NCT01465724|renal ablation|renal ablation
1327941|NCT01465711|Peritonitis|peritonitis
1327942|NCT01465711|Sepsis|sepsis
1327943|NCT01465711|General Surgery|general surgery
1327944|NCT01465711|Intensive Care Units|intensive care units
1327945|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
1327946|NCT01465698|exercise|exercise
1327947|NCT01465698|counseling|counseling
1327948|NCT01465698|movement control|movement control
1327949|NCT01465698|fear avoidance|fear avoidance
1327950|NCT01465685|MDMA|mdma
1327951|NCT01465685|pharmacokinetics|pharmacokinetics
1327952|NCT01465685|pharmacodynamics|pharmacodynamics
1327953|NCT01465685|emotions|emotions
1327954|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
1327955|NCT01465685|Interaction study|interaction study
1327956|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
1327957|NCT01465672|copeptin|copeptin
1327958|NCT01465672|SIADH|siadh
1327959|NCT01465672|Diabetes insipidus|diabetes insipidus
1327960|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
1327961|NCT01465672|pituitary adenoma|pituitary adenoma
1327962|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
1327963|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
1327964|NCT01465646|levothyroxine|levothyroxine
1327965|NCT01465646|bioavailability|bioavailability
1327966|NCT01465633|bioavailability|bioavailability
1327967|NCT01465633|levothyroxine|levothyroxine
1327968|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
1327970|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
1327971|NCT01465607|Condom use|condom use
1327972|NCT01465594|Pain Measurement|pain measurement
1327973|NCT01465581|incontinence|incontinence
1327974|NCT01465581|dysfunctional voiding|dysfunctional voiding
1327975|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
1327976|NCT01465581|filum terminale|filum terminale
1327977|NCT01465581|spinal cord tethering|spinal cord tethering
1327978|NCT01465581|conus|conus
1327979|NCT01465568|osteoporosis|osteoporosis
1327980|NCT01465568|denosumab|denosumab
1327981|NCT01465568|RANKL|rankl
1327982|NCT01465568|glucocorticoids|glucocorticoids
1327983|NCT01465555|Clinical Alert|clinical alert
1327984|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
1327985|NCT01465555|Web-based|web-based
1327986|NCT01465555|Substance Abuse Treatment|substance abuse treatment
1327987|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
1327988|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
1327989|NCT01465542|N-acetylcysteine|n-acetylcysteine
1327990|NCT01465542|Liver Toxicity|liver toxicity
1327991|NCT01465503|bleeding|bleeding
1327992|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
1327993|NCT01465503|heparin|heparin
1327994|NCT01465503|bivalirudin|bivalirudin
1327995|NCT01465490|Monitoring|monitoring
1327996|NCT01465490|Feedback|feedback
1327997|NCT01465490|Substance Abuse Treatment|substance abuse treatment
1327998|NCT01465477|Fibromyalgia|fibromyalgia
1327999|NCT01465477|Influenza vaccination|influenza vaccination
1328000|NCT01465451|colorectal cancer|colorectal cancer
1328001|NCT01465451|curative resection|curative resection
1328002|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
1328003|NCT01465451|5-fluorouracil|5-fluorouracil
1328004|NCT01465451|chemotherapy|chemotherapy
1328005|NCT01465425|extracolonic findings|extracolonic findings
1328006|NCT01465425|ECFs|ecfs
1328007|NCT01465425|CT colonography|ct colonography
1328109|NCT01465061|Filipino|filipino
1328008|NCT01465425|computed tomography colonography|computed tomography colonography
1328009|NCT01465425|National CT Colonography Trial|national ct colonography trial
1328010|NCT01465425|ACRIN 6664|acrin 6664
1328011|NCT01465412|Parkinson disease|parkinson disease
1328012|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
1328013|NCT01465373|Donor Egg IVF|donor egg ivf
1328014|NCT01465360|Alzheimer's disease|alzheimer's disease
1328015|NCT01465360|AD|ad
1328016|NCT01465360|Non AD dementia|non ad dementia
1328017|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
1328018|NCT01465360|MCI|mci
1328019|NCT01465360|Vascular dementia|vascular dementia
1328020|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
1328021|NCT01465360|Primary progressive aphasia|primary progressive aphasia
1328022|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
1328023|NCT01465360|Mixed dementia|mixed dementia
1328024|NCT01465360|Blood signature|blood signature
1328025|NCT01465360|Diagnosis|diagnosis
1328026|NCT01465360|AclarusDx|aclarusdx
1328027|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
1328028|NCT01465360|Exonhit|exonhit
1328029|NCT01465347|Primary brain tumor|primary brain tumor
1328030|NCT01465347|Glioblastoma|glioblastoma
1328031|NCT01465347|Glioma|glioma
1328032|NCT01465347|GBM|gbm
1328033|NCT01465347|Radiation therapy|radiation therapy
1328035|NCT01465308|head and neck cancer|head and neck cancer
1328036|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
1328037|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
1328038|NCT01465308|RCT|rct
1328039|NCT01465308|symptom management|symptom management
1328040|NCT01465295|Scoliosis|scoliosis
1328041|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
1328042|NCT01465295|Scoliosis treatment|scoliosis treatment
1328043|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
1328044|NCT01465295|Vertebral stapling|vertebral stapling
1328045|NCT01465295|Spinal stapling|spinal stapling
1328046|NCT01465295|Non-fusion|non-fusion
1328047|NCT01465295|Spinal curvature|spinal curvature
1328048|NCT01465295|Curvature of the spine|curvature of the spine
1328049|NCT01465295|Spinal bracing alternative|spinal bracing alternative
1328050|NCT01465295|HemiBridge|hemibridge
1328051|NCT01465295|SpineForm|spineform
1328052|NCT01465295|Dr. Eric Wall|dr. eric wall
1328053|NCT01465295|Dr. George Thompson|dr. george thompson
1328054|NCT01465295|Spinal clip|spinal clip
1328055|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
1328056|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
1328057|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
1328058|NCT01465282|topical ointment|topical ointment
1328059|NCT01465269|TBI|tbi
1328060|NCT01465269|Social Competence|social competence
1328061|NCT01465256|Aspirin|aspirin
1328062|NCT01465256|Colon polypectomy|colon polypectomy
1328063|NCT01465256|Bleeding|bleeding
1328064|NCT01465243|Efficacy|efficacy
1328065|NCT01465243|Safety|safety
1328066|NCT01465243|EGFR-TKI|egfr-tki
1328069|NCT01465243|Dose escalation|dose escalation
1328070|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1328071|NCT01465230|maintenance therapy|maintenance therapy
1328072|NCT01465217|medication adherence|medication adherence
1328073|NCT01465217|African Americans|african americans
1328074|NCT01465204|Behavior Change|behavior change
1328075|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
1328076|NCT01465191|cesarean|cesarean
1328077|NCT01465191|postoperative|postoperative
1328078|NCT01465191|morphine|morphine
1328079|NCT01465191|genetics|genetics
1328080|NCT01465191|opioid|opioid
1328081|NCT01465178|hypovitaminosis D|hypovitaminosis d
1328082|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
1328083|NCT01465178|low vitamin D|low vitamin d
1328084|NCT01465165|Depression|depression
1328085|NCT01465165|Positron emission tomography|positron emission tomography
1328086|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1328087|NCT01465165|glucose metabolism|glucose metabolism
1328088|NCT01465165|ATP|atp
1328089|NCT01465165|phosphocreatine|phosphocreatine
1328090|NCT01465113|Barrett's Esophagus|barrett's esophagus
1328091|NCT01465113|Vitamin D3|vitamin d3
1328092|NCT01465113|cholecalciferol|cholecalciferol
1328093|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
1328094|NCT01465113|metformin|metformin
1328095|NCT01465100|phenylketonuria|phenylketonuria
1328096|NCT01465100|hepatocyte|hepatocyte
1328097|NCT01465087|Multiple Sclerosis|multiple sclerosis
1328098|NCT01465087|Breath|breath
1328099|NCT01465087|Diagnosis|diagnosis
1328100|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
1328101|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
1328102|NCT01465074|nicotine|nicotine
1328103|NCT01465074|memory|memory
1328104|NCT01465074|plasticity|plasticity
1328105|NCT01465074|TMS|tms
1328106|NCT01465074|Paired Associative Stimulation|paired associative stimulation
1328107|NCT01465061|Online social network|online social network
1328110|NCT01465048|Malaria|malaria
1328111|NCT01465048|Protozoan Infections|protozoan infections
1328112|NCT01465048|Parasitic Diseases|parasitic diseases
1328113|NCT01465048|Malaria Challenge|malaria challenge
1328114|NCT01465022|Breastfeeding rates|breastfeeding rates
1328115|NCT01465022|Contraceptive continuation|contraceptive continuation
1328116|NCT01465022|Birth control pills|birth control pills
1328117|NCT01465022|Lactation|lactation
1328118|NCT01465009|Sore Throat|sore throat
1328119|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
1328120|NCT01464996|bonded restorations|bonded restorations
1328121|NCT01464996|composites|composites
1328122|NCT01464996|adhesives|adhesives
1328123|NCT01464970|DIEP perfusion|diep perfusion
1328124|NCT01464970|Zone IV|zone iv
1328125|NCT01464970|Free Flap|free flap
1328126|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
1328127|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
1328128|NCT01464957|skin cancer prevention|skin cancer prevention
1328129|NCT01464957|precaution adoption process model|precaution adoption process model
1328130|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
1328131|NCT01464957|pediatric|pediatric
1328132|NCT01464957|behavioral intervention|behavioral intervention
1328133|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
1328134|NCT01464918|gastric cancer|gastric cancer
1328135|NCT01464918|colon cancer|colon cancer
1328136|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
1328137|NCT01464905|RRMS|rrms
1328138|NCT01464892|Imagery rescripting|imagery rescripting
1328139|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
1328140|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
1328141|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
1328142|NCT01464892|Childhood abuse|childhood abuse
1328143|NCT01464892|Childhood sexual abuse|childhood sexual abuse
1328144|NCT01464840|Pregnancy|pregnancy
1328145|NCT01464840|Cesarean section|cesarean section
1328146|NCT01464840|Antibiotic|antibiotic
1328147|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
1328148|NCT01464827|Hepatitis C|hepatitis c
1328149|NCT01464827|Interferon-Free|interferon-free
1328150|NCT01464827|HCV|hcv
1328151|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
1328152|NCT01464814|probiotic|probiotic
1328153|NCT01464814|fish oil|fish oil
1328154|NCT01464814|digestion|digestion
1328155|NCT01464814|viability|viability
1328156|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1328157|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1328158|NCT01464801|Resveratrol|resveratrol
1328159|NCT01464801|Human study|human study
1328160|NCT01464788|stroke|stroke
1328161|NCT01464788|Argatroban|argatroban
1328162|NCT01464788|thrombin-inhibition|thrombin-inhibition
1328163|NCT01464788|thrombolysis|thrombolysis
1328164|NCT01464788|anticoagulation|anticoagulation
1328165|NCT01464775|Endometriosis|endometriosis
1328166|NCT01464775|Laparoscopy|laparoscopy
1328167|NCT01464775|Narrow Band Imaging|narrow band imaging
1328168|NCT01464762|Tuberculosis|tuberculosis
1328169|NCT01464762|TMC207TBC3001|tmc207tbc3001
1328170|NCT01464762|TMC207|tmc207
1328171|NCT01464762|Early access|early access
1328172|NCT01464762|TB|tb
1328173|NCT01464762|Drug resistant|drug resistant
1328174|NCT01464762|Multi drug-resistant|multi drug-resistant
1328175|NCT01464762|Extensively drug-resistant|extensively drug-resistant
1328176|NCT01464749|multiple sclerosis|multiple sclerosis
1328177|NCT01464749|gait rehabilitation|gait rehabilitation
1328178|NCT01464736|aerobic exercise|aerobic exercise
1328179|NCT01464736|noninvasive ventilation|noninvasive ventilation
1328180|NCT01464736|functionality|functionality
1328181|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
1328182|NCT01464697|night sweats|night sweats
1328183|NCT01464697|sleep problems|sleep problems
1328184|NCT01464697|negative mood|negative mood
1328185|NCT01464697|anxiety|anxiety
1328186|NCT01464697|perimenopause|perimenopause
1328187|NCT01464697|progesterone|progesterone
1328188|NCT01464697|vasomotor symptoms|vasomotor symptoms
1328189|NCT01464697|premenopause|premenopause
1328190|NCT01464671|Coronary Artery Disease|coronary artery disease
1328191|NCT01464671|Stable Angina|stable angina
1328192|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
1328193|NCT01464658|panniculitis|panniculitis
1328194|NCT01464658|panniculectomy|panniculectomy
1328195|NCT01464632|medial knee replacement|medial knee replacement
1328196|NCT01464619|Parenting|parenting
1328197|NCT01464619|Early Child Development|early child development
1328198|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
1328199|NCT01464606|pediatric|pediatric
1328200|NCT01464606|lung cysts|lung cysts
1328201|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
1328202|NCT01464593|Colon Cancer|colon cancer
1328203|NCT01464593|Liver Cancer|liver cancer
1328204|NCT01464593|Liver Metastasis|liver metastasis
1328205|NCT01464593|Liver metastases|liver metastases
1328206|NCT01464567|Weaning|weaning
1328207|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1328208|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
1328209|NCT01464554|adolescents|adolescents
1328210|NCT01464554|alcohol|alcohol
1328211|NCT01464554|drugs|drugs
1328212|NCT01464554|delinquency|delinquency
1328213|NCT01464554|intervention|intervention
1328214|NCT01464541|Orbit|orbit
1328215|NCT01464541|Fracture|fracture
1328216|NCT01464541|measurement|measurement
1328217|NCT01464541|CT|ct
1328218|NCT01464541|intraoperative|intraoperative
1328219|NCT01464528|hysteroscopy|hysteroscopy
1328220|NCT01464528|postoperative complications|postoperative complications
1328221|NCT01464528|adhesions|adhesions
1328222|NCT01464528|hyaluronic gel|hyaluronic gel
1328223|NCT01464528|prevention|prevention
1328224|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
1328225|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
1328226|NCT01464502|Heart failure|heart failure
1328227|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1328228|NCT01464502|Acute haemodynamic response|acute haemodynamic response
1328229|NCT01464502|Responder|responder
1328230|NCT01464489|Intubation time|intubation time
1328231|NCT01464489|Atropine|atropine
1328232|NCT01464489|Propofol anesthesia|propofol anesthesia
1328233|NCT01464463|Depression|depression
1328234|NCT01464463|Exercise|exercise
1328235|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
1328236|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
1328237|NCT01464463|CBASP|cbasp
1328238|NCT01464450|Pharmacokinetics|pharmacokinetics
1328239|NCT01464450|Bioavailability|bioavailability
1328240|NCT01464450|Healthy Participants|healthy participants
1328241|NCT01464437|diabetes|diabetes
1328242|NCT01464437|mellitus|mellitus
1328243|NCT01464437|metformin|metformin
1328244|NCT01464424|Glaucoma|glaucoma
1328245|NCT01464424|Ocular Hypertension|ocular hypertension
1328246|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
1328247|NCT01464424|Intraocular Pressure|intraocular pressure
1328248|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
1328249|NCT01464411|chronic phase|chronic phase
1328250|NCT01464411|Phase II|phase ii
1328251|NCT01464411|dasatinib|dasatinib
1328252|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
1328253|NCT01464398|stress|stress
1328254|NCT01464398|mindfulness|mindfulness
1328255|NCT01464398|meditation|meditation
1328256|NCT01464398|health education|health education
1328257|NCT01464398|women|women
1328258|NCT01464398|overweight|overweight
1328259|NCT01464398|obesity|obesity
1328260|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
1328261|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
1328262|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
1328263|NCT01464346|diabetes|diabetes
1328264|NCT01464346|glucose sensor|glucose sensor
1328265|NCT01464346|CGM|cgm
1328266|NCT01464333|Crohn's Disease|crohn's disease
1328267|NCT01464320|Safety|safety
1328367|NCT01463904|diabetes|diabetes
1328268|NCT01464320|Type 2 diabetes|type 2 diabetes
1328269|NCT01464320|Kidney disease|kidney disease
1328270|NCT01464294|CAD/CAM|cad/cam
1328271|NCT01464294|crowns|crowns
1328272|NCT01464294|onlays|onlays
1328273|NCT01464294|composite block|composite block
1328274|NCT01464294|milled restorations|milled restorations
1328275|NCT01464281|nucleoside|nucleoside
1328276|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
1328277|NCT01464268|Keratoconus|keratoconus
1328278|NCT01464268|Corneal Ectasia|corneal ectasia
1328279|NCT01464268|Collagen Crosslinking|collagen crosslinking
1328280|NCT01464268|Riboflavin|riboflavin
1328281|NCT01464255|contact lenses|contact lenses
1328282|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1328283|NCT01464242|pentoxifylline|pentoxifylline
1328284|NCT01464242|immunomodulation|immunomodulation
1328285|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1328286|NCT01464216|Prostate cancer|prostate cancer
1328287|NCT01464216|FACBC PET|facbc pet
1328288|NCT01464216|Hypoxia imaging|hypoxia imaging
1328289|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
1328290|NCT01464203|multi-slice CT|multi-slice ct
1328291|NCT01464203|angina|angina
1328292|NCT01464203|cost-effectiveness|cost-effectiveness
1328293|NCT01464190|PA21|pa21
1328294|NCT01464190|Phosphate Binder|phosphate binder
1328295|NCT01464177|malignant glioma|malignant glioma
1328296|NCT01464177|glioblastoma|glioblastoma
1328297|NCT01464177|radiotherapy|radiotherapy
1328298|NCT01464177|randomized|randomized
1328299|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
1328300|NCT01464164|DBA|dba
1328301|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
1328302|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
1328303|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
1328304|NCT01464164|Aase Syndrome|aase syndrome
1328305|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
1328306|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
1328307|NCT01464164|BDA|bda
1328308|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
1328309|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
1328310|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
1328311|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
1328312|NCT01464164|pure red cell aplasia|pure red cell aplasia
1328313|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
1328314|NCT01464151|IBD|ibd
1328315|NCT01464151|colitis|colitis
1328316|NCT01464151|dysplasia|dysplasia
1328317|NCT01464151|colorectal cancer|colorectal cancer
1328318|NCT01464138|Malaria|malaria
1328319|NCT01464125|Malaria|malaria
1328320|NCT01464125|Plasmodium falciparum|plasmodium falciparum
1328321|NCT01464125|acute uncomplicated|acute uncomplicated
1328322|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
1328323|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
1328324|NCT01464112|JNJ 26481585|jnj 26481585
1328325|NCT01464112|VELCADE|velcade
1328326|NCT01464112|Bortezomib|bortezomib
1328327|NCT01464112|Dexamethasone|dexamethasone
1328328|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
1328329|NCT01464073|NIDDM|niddm
1328330|NCT01464073|obesity|obesity
1328331|NCT01464073|lifestyle intervention|lifestyle intervention
1328332|NCT01464073|physical exercise|physical exercise
1328333|NCT01464073|diet|diet
1328334|NCT01464073|LIPOXmax|lipoxmax
1328335|NCT01464073|FATmax|fatmax
1328336|NCT01464073|fat oxydation rate|fat oxydation rate
1328337|NCT01464060|Helicobacter pylori|helicobacter pylori
1328338|NCT01464060|Quadruple therapy|quadruple therapy
1328339|NCT01464060|Clarithromycin resistance|clarithromycin resistance
1328340|NCT01464021|Study|study
1328341|NCT01464021|prospective|prospective
1328342|NCT01464021|Rheumatoid|rheumatoid
1328343|NCT01464021|Observational study|observational study
1328344|NCT01464021|Arthritis|arthritis
1328345|NCT01464021|Adalimumab|adalimumab
1328346|NCT01463995|severe neurological diseases|severe neurological diseases
1328347|NCT01463995|neurological intensive care unit|neurological intensive care unit
1328348|NCT01463995|prediction|prediction
1328349|NCT01463995|long-term outcome|long-term outcome
1328350|NCT01463995|biomarkers|biomarkers
1328351|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
1328352|NCT01463982|Advanced solid cancer|advanced solid cancer
1328353|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
1328354|NCT01463956|Boceprevir|boceprevir
1328355|NCT01463956|HCV infection|hcv infection
1328356|NCT01463956|Antiviral therapy|antiviral therapy
1328357|NCT01463956|Liver transplantation|liver transplantation
1328358|NCT01463930|Total Knee Replacement|total knee replacement
1328359|NCT01463930|Expectations|expectations
1328360|NCT01463930|Audiovisual videodisc|audiovisual videodisc
1328361|NCT01463917|Coronary Artery Bypass|coronary artery bypass
1328362|NCT01463917|Off-Pump|off-pump
1328363|NCT01463917|Saline Solution|saline solution
1328364|NCT01463917|Hypertonic|hypertonic
1328365|NCT01463904|Morbid obesity|morbid obesity
1328366|NCT01463904|duodenal switch|duodenal switch
1328368|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
1328369|NCT01463904|remission of T2DM|remission of t2dm
1328370|NCT01463891|Eribulin Mesylate|eribulin mesylate
1328371|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
1328372|NCT01463878|glycemic control|glycemic control
1621704|NCT00313677|B3GNT1|b3gnt1
1328373|NCT01463878|glycemic variability|glycemic variability
1328374|NCT01463878|mean blood glucose level|mean blood glucose level
1328375|NCT01463852|vincristine|vincristine
1328376|NCT01463852|JNK|jnk
1328377|NCT01463852|phosphorylation|phosphorylation
1328378|NCT01463852|cll|cll
1328379|NCT01463852|vinca alkaloid|vinca alkaloid
1328380|NCT01463852|apoptosis|apoptosis
1328381|NCT01463839|sleep disorder|sleep disorder
1328382|NCT01463839|malocclusion|malocclusion
1328383|NCT01463839|children|children
1328384|NCT01463826|bruxism|bruxism
1328385|NCT01463826|children|children
1328386|NCT01463826|oral breathing|oral breathing
1328387|NCT01463826|dental caries|dental caries
1328388|NCT01463813|bone density conservation agents|bone density conservation agents
1328389|NCT01463813|cancer|cancer
1328390|NCT01463813|cardiovascular disease|cardiovascular disease
1328391|NCT01463813|cholecalciferol|cholecalciferol
1328392|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
1328393|NCT01463813|dietary supplements|dietary supplements
1328394|NCT01463813|primary prevention|primary prevention
1328395|NCT01463813|vitamin D|vitamin d
1328396|NCT01463800|Heart Defects, congenital|heart defects, congenital
1328397|NCT01463787|Infertility|infertility
1328398|NCT01463787|varicocelectomy|varicocelectomy
1328399|NCT01463787|microsurgery|microsurgery
1328400|NCT01463787|Chinese men|chinese men
1328401|NCT01463787|pregnancy rate|pregnancy rate
1328402|NCT01463774|Healthy Volunteers|healthy volunteers
1328403|NCT01463774|Bioequivalence|bioequivalence
1328404|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1328405|NCT01463774|Metformin|metformin
1328406|NCT01463761|High-level athlete|high-level athlete
1328407|NCT01463761|ANS activity|ans activity
1328408|NCT01463761|Overtraining|overtraining
1328409|NCT01463735|Cirrhotic patients|cirrhotic patients
1328410|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
1328411|NCT01463722|Lung maturity|lung maturity
1328412|NCT01463722|lamellar body|lamellar body
1328413|NCT01463709|basal cell carcinoma|basal cell carcinoma
1328414|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
1328415|NCT01463709|Electric Field|electric field
1328416|NCT01463709|Nanosecond pulse|nanosecond pulse
1328417|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
1328418|NCT01463670|BONE MARROW|bone marrow
1328419|NCT01463670|11-107|11-107
1328420|NCT01463657|Aging|aging
1328421|NCT01463644|Mepolizumab|mepolizumab
1328422|NCT01463644|COPD|copd
1328423|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
1328424|NCT01463644|exacerbation|exacerbation
1328425|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
1328426|NCT01463605|radiotherapy|radiotherapy
1328427|NCT01463605|targeted therapy|targeted therapy
1328428|NCT01463605|esophageal cancer|esophageal cancer
1328429|NCT01463605|older|older
1328430|NCT01463592|Renessans|renessans
1328431|NCT01463592|HCV|hcv
1328432|NCT01463579|Intensive Care Unit|intensive care unit
1328433|NCT01463579|Critical Illness|critical illness
1328434|NCT01463579|Rehabilitation|rehabilitation
1328435|NCT01463579|Exercise Programme|exercise programme
1328436|NCT01463566|arthritis|arthritis
1328437|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
1328438|NCT01463553|VATS|vats
1328439|NCT01463553|pleurodesis|pleurodesis
1328440|NCT01463553|recurrence rate|recurrence rate
1328441|NCT01463540|Enteral nutrition|enteral nutrition
1328442|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
1328443|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
1328444|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
1328445|NCT01463540|Surgical wound infection|surgical wound infection
1328446|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
1328447|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
1328448|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
1328449|NCT01463514|NIRS,|nirs,
1328450|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
1328451|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
1328452|NCT01463514|cerebral blood flow|cerebral blood flow
1328453|NCT01463501|Esophageal cancer|esophageal cancer
1328454|NCT01463501|Resectable|resectable
1328455|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1328456|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
1328457|NCT01463475|MSC|msc
1328458|NCT01463475|Allogeneic|allogeneic
1328459|NCT01463475|Bone marrow cells|bone marrow cells
1328460|NCT01463475|Healthy subject donors|healthy subject donors
1328461|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
1328462|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
1328463|NCT01463449|Obesity|obesity
1328464|NCT01463449|Soluble-CD163|soluble-cd163
1328465|NCT01463449|Macrophage|macrophage
1328466|NCT01463449|Inflammation|inflammation
1328467|NCT01463436|endothelial function|endothelial function
1328468|NCT01463436|postmenopausal|postmenopausal
1328469|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
1328470|NCT01463436|osteoporosis|osteoporosis
1328471|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
1328472|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1328473|NCT01463384|Neuroinflammation|neuroinflammation
1328474|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
1328475|NCT01463384|Alzheimer's Disease|alzheimer's disease
1328476|NCT01463384|Minocycline|minocycline
1328477|NCT01463371|Bronchiectasis|bronchiectasis
1328478|NCT01463371|Oxidative stress markers|oxidative stress markers
1328479|NCT01463371|Airway inflammation|airway inflammation
1328480|NCT01463358|Syncope|syncope
1328481|NCT01463358|Bifascicular block|bifascicular block
1328482|NCT01463358|Bradycardia pacing|bradycardia pacing
1328483|NCT01463345|Blood conservation|blood conservation
1328484|NCT01463345|Transfusion|transfusion
1328485|NCT01463345|Hemoglobin trigger|hemoglobin trigger
1328486|NCT01463345|Transfusion trigger|transfusion trigger
1328487|NCT01463345|Cardiac surgery|cardiac surgery
1328488|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
1328489|NCT01463332|Propofol|propofol
1328490|NCT01463332|Pain|pain
1328491|NCT01463332|Dexmedetomidine|dexmedetomidine
1328492|NCT01463319|colonoscopy|colonoscopy
1328493|NCT01463319|warm water method|warm water method
1328494|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
1328495|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
1328496|NCT01463306|safety|safety
1328497|NCT01463306|partial onset seizures|partial onset seizures
1328498|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
1328499|NCT01463306|pregabalin|pregabalin
1328500|NCT01463306|pediatric|pediatric
1328501|NCT01463306|adult|adult
1328502|NCT01463306|open-label|open-label
1328503|NCT01463306|long term|long term
1328504|NCT01463293|constipation|constipation
1328505|NCT01463293|probiotic|probiotic
1328506|NCT01463293|functional constipation|functional constipation
1328507|NCT01463293|IBS-C|ibs-c
1328508|NCT01463280|Platelets|platelets
1328509|NCT01463280|Inhibition|inhibition
1328510|NCT01463280|Lidocaine|lidocaine
1328511|NCT01463280|Thromboembolism|thromboembolism
1328512|NCT01463280|Prevention|prevention
1328513|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
1328514|NCT01463267|Heart Failure|heart failure
1328515|NCT01463254|Femplant|femplant
1328516|NCT01463254|AE adverse event|ae adverse event
1328517|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1328518|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1328519|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
1328520|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1328521|NCT01463254|DCF data collection forms|dcf data collection forms
1328522|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
1328523|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1328524|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1328525|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1328526|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
1328527|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
1328528|NCT01463254|IRB Institutional Review Board|irb institutional review board
1328529|NCT01463254|IU international units|iu international units
1328530|NCT01463254|mg milligram(s)|mg milligram(s)
1328531|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1328532|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
1328533|NCT01463254|SAE serious adverse event|sae serious adverse event
1328534|NCT01463254|µg microgram|µg microgram
1328535|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
1328536|NCT01463254|WB Western Blot|wb western blot
1328537|NCT01463228|Healthy Volunteers|healthy volunteers
1328538|NCT01463228|Bioequivalence|bioequivalence
1328539|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1328540|NCT01463228|Metformin IR|metformin ir
1328541|NCT01463215|Ambroxol|ambroxol
1328542|NCT01463215|Type I Gaucher Disease|type i gaucher disease
1328543|NCT01463202|Postpartum contraception|postpartum contraception
1328544|NCT01463202|Contraceptive continuation|contraceptive continuation
1328545|NCT01463202|Breastfeeding|breastfeeding
1328546|NCT01463202|Postpartum depression|postpartum depression
1328547|NCT01463202|Progestins|progestins
1328548|NCT01463189|arthritis|arthritis
1328549|NCT01463189|self management|self management
1328550|NCT01463176|Music Therapy|music therapy
1328551|NCT01463176|Child Psychology|child psychology
1328552|NCT01463176|Vaccination|vaccination
1328553|NCT01463163|Platelet reactivity|platelet reactivity
1328554|NCT01463163|Ticagrelor|ticagrelor
1328555|NCT01463163|Prasugrel|prasugrel
1328556|NCT01463150|Platelet reactivity|platelet reactivity
1328557|NCT01463150|Clopidogrel|clopidogrel
1328558|NCT01463150|Prasugrel|prasugrel
1328559|NCT01463137|social phobia|social phobia
1328560|NCT01463137|anxiety|anxiety
1328561|NCT01463124|School Nurse|school nurse
1328562|NCT01463124|Overweight|overweight
1328563|NCT01463124|Obesity|obesity
1328564|NCT01463124|Counseling|counseling
1328565|NCT01463124|Intervention|intervention
1328566|NCT01463124|Exercise|exercise
1328567|NCT01463111|Bipolar|bipolar
1328568|NCT01463111|Manic depression|manic depression
1328569|NCT01463111|Mood stabilizer|mood stabilizer
1328570|NCT01463111|Decision|decision
1328571|NCT01463111|Neuroeconomics|neuroeconomics
1328572|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
1328573|NCT01463059|Monoclonal Antibody|monoclonal antibody
1328574|NCT01463059|Interleukin-6|interleukin-6
1328575|NCT01463059|Olokizumab|olokizumab
1328576|NCT01463059|CDP6038|cdp6038
1328577|NCT01463046|leukemia|leukemia
1328579|NCT01463046|AMS|ams
1328580|NCT01463046|panobinostat|panobinostat
1328581|NCT01463046|cytarabine|cytarabine
1328582|NCT01463046|daunorubicin|daunorubicin
1328583|NCT01463046|HDAC|hdac
1328584|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
1328585|NCT01463033|Traumatic brain injury|traumatic brain injury
1328586|NCT01463033|Epilepsy prevention|epilepsy prevention
1328587|NCT01463033|Levetiracetam|levetiracetam
1328588|NCT01463020|Depression|depression
1328589|NCT01463020|Smartphone|smartphone
1328590|NCT01463020|Behavioural activation|behavioural activation
1328591|NCT01463020|Mindfulness|mindfulness
1328592|NCT01463007|invasive ductal cancer|invasive ductal cancer
1328593|NCT01463007|tubular breast cancer|tubular breast cancer
1328594|NCT01463007|breast cancer|breast cancer
1328595|NCT01463007|colloid|colloid
1328596|NCT01463007|ER positive|er positive
1328597|NCT01463007|radiation|radiation
1328598|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
1328599|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
1328600|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
1328601|NCT01462968|Thrombin generation|thrombin generation
1328602|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
1328603|NCT01462942|COPD|copd
1328604|NCT01462942|Bronchitis|bronchitis
1328605|NCT01462942|Chronic|chronic
1328606|NCT01462942|Emphysema|emphysema
1328607|NCT01462929|COPD|copd
1328608|NCT01462929|antimuscarinic|antimuscarinic
1328609|NCT01462916|honey|honey
1328610|NCT01462916|mucositis|mucositis
1328611|NCT01462916|bee products|bee products
1328612|NCT01462903|TIL|til
1328613|NCT01462903|NPC|npc
1328614|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
1328615|NCT01462903|immunotherapy|immunotherapy
1328616|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
1328617|NCT01462890|Bevacizumab|bevacizumab
1328618|NCT01462890|Paclitaxel|paclitaxel
1328619|NCT01462890|Carboplatin|carboplatin
1328620|NCT01462877|Lipid Regulating Agents|lipid regulating agents
1328621|NCT01462877|Drug Therapy|drug therapy
1328622|NCT01462877|cardiovascular diseases|cardiovascular diseases
1328623|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
1328624|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1328625|NCT01462877|fenofibrate|fenofibrate
1328626|NCT01462877|Dyslipidemias|dyslipidemias
1328627|NCT01462877|Combination|combination
1328628|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
1328629|NCT01462864|Lifestyle|lifestyle
1328630|NCT01462864|Structured Education|structured education
1328631|NCT01462864|Walking Activity|walking activity
1328632|NCT01462864|Exercise|exercise
1328633|NCT01462864|Overweight|overweight
1328634|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
1328635|NCT01462864|Diabetes Prevention|diabetes prevention
1328636|NCT01462851|healthy volunteer|healthy volunteer
1328637|NCT01462851|safety|safety
1328638|NCT01462851|pharmacokinetic|pharmacokinetic
1328639|NCT01462851|pharmacodynamic|pharmacodynamic
1328640|NCT01462838|advanced HPV-|advanced hpv-
1328641|NCT01462838|p16INK4a-positive|p16ink4a-positive
1328642|NCT01462838|cervical|cervical
1328643|NCT01462838|vulvar,|vulvar,
1328644|NCT01462838|vaginal|vaginal
1328645|NCT01462838|penile|penile
1328646|NCT01462838|anal|anal
1328647|NCT01462838|head|head
1328648|NCT01462838|neck|neck
1328649|NCT01462825|Inflammation|inflammation
1328650|NCT01462825|cytokines|cytokines
1328651|NCT01462825|chemotaxis|chemotaxis
1328652|NCT01462825|tomatoes|tomatoes
1328653|NCT01462825|cardiovascular disease|cardiovascular disease
1328654|NCT01462812|Migraine|migraine
1328655|NCT01462812|Headache|headache
1328656|NCT01462812|Sumatriptan|sumatriptan
1328657|NCT01462799|PBL|pbl
1328658|NCT01462799|patient education|patient education
1328659|NCT01462799|coronary heart disease|coronary heart disease
1328660|NCT01462799|empowerment|empowerment
1328661|NCT01462799|self-efficacy|self-efficacy
1328662|NCT01462799|self-care|self-care
1328663|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
1333198|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
1333199|NCT01444040|Naïve to treatment|naïve to treatment
1328664|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
1328665|NCT01462773|malignant|malignant
1328666|NCT01462773|melanoma|melanoma
1328667|NCT01462708|Parkinson Disease|parkinson disease
1328668|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
1328669|NCT01462682|focus group study|focus group study
1328670|NCT01462682|sleep deprivation|sleep deprivation
1328671|NCT01462682|surgery|surgery
1328672|NCT01462669|Ezogabine|ezogabine
1328673|NCT01462669|Pharmacokinetics|pharmacokinetics
1328674|NCT01462669|Retigabine|retigabine
1328675|NCT01462656|anti-epileptic drug|anti-epileptic drug
1328676|NCT01462656|ezogabine|ezogabine
1328677|NCT01462656|AED polytherapy|aed polytherapy
1328678|NCT01462656|epilepsy|epilepsy
1328679|NCT01462656|AED monotherapy|aed monotherapy
1328680|NCT01462656|retigabine|retigabine
1328681|NCT01462656|urinary retention|urinary retention
1328682|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
1328683|NCT01462643|topical|topical
1328684|NCT01462643|ointment|ointment
1328685|NCT01462591|wave reflection|wave reflection
1328686|NCT01462591|augmentation Index|augmentation index
1328687|NCT01462591|heart rate variability|heart rate variability
1328688|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
1328689|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
1328690|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
1328692|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
1328693|NCT01462578|MDS|mds
1328694|NCT01462565|flolan|flolan
1328695|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
1328696|NCT01462565|thermo stable formulation|thermo stable formulation
1328697|NCT01462565|epoprostenol sodium|epoprostenol sodium
1328698|NCT01462565|modified sterile diluent|modified sterile diluent
1328699|NCT01462552|liver function testing|liver function testing
1328700|NCT01462552|Breast cancer|breast cancer
1328701|NCT01462552|lapatanib|lapatanib
1328702|NCT01462513|Colon carcinoma|colon carcinoma
1328703|NCT01462513|Rectum carcinoma|rectum carcinoma
1328704|NCT01462513|Liver metastases|liver metastases
1328705|NCT01462500|Miltefosine|miltefosine
1328706|NCT01462500|pharmacokinetics|pharmacokinetics
1328707|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
1328708|NCT01462487|Pregnancy safety|pregnancy safety
1328709|NCT01462487|zanamivir|zanamivir
1328710|NCT01462487|influenza|influenza
1328711|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1328712|NCT01462461|Phantom Limb|phantom limb
1328713|NCT01462461|Amputation, Traumatic|amputation, traumatic
1328714|NCT01462461|Electromyography|electromyography
1328715|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
1328716|NCT01462448|Phantom Limb|phantom limb
1328717|NCT01462448|Genetic Variation|genetic variation
1328718|NCT01462448|DNA Sequence Analysis|dna sequence analysis
1328719|NCT01462448|Amputation, Traumatic|amputation, traumatic
1328720|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
1328721|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
1328722|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
1328723|NCT01462448|Inflammatory Antibody|inflammatory antibody
1328724|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
1328725|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
1328726|NCT01462422|Prevention|prevention
1328727|NCT01462422|Misoprostol|misoprostol
1328728|NCT01462422|Developing countries|developing countries
1328729|NCT01462422|Nurse midwife|nurse midwife
1328730|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
1328731|NCT01462409|humidification|humidification
1328732|NCT01462409|mask|mask
1328733|NCT01462409|heated tubing|heated tubing
1328734|NCT01462396|Neuroblastoma|neuroblastoma
1328735|NCT01462396|Relapsed|relapsed
1328736|NCT01462396|Refractory|refractory
1328737|NCT01462383|Advanced Cancer|advanced cancer
1328738|NCT01462383|Malignancy|malignancy
1328739|NCT01462383|Cardiac complications|cardiac complications
1328740|NCT01462383|Electrocardiograms|electrocardiograms
1328742|NCT01462383|Chart Review|chart review
1328743|NCT01462383|Data Review|data review
1328744|NCT01462383|Data Analysis|data analysis
1328745|NCT01462383|Phase I|phase i
1328746|NCT01462383|Clinical Research Study|clinical research study
1328747|NCT01462357|Human papillomavirus|human papillomavirus
1328748|NCT01462357|Safety|safety
1328749|NCT01462357|HPV vaccine|hpv vaccine
1328750|NCT01462357|Immune response|immune response
1328751|NCT01462344|pediatric|pediatric
1328752|NCT01462344|ADVAIR|advair
1328753|NCT01462344|FLOVENT|flovent
1328754|NCT01462344|asthma|asthma
1328755|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
1328756|NCT01462331|Human Consumption|human consumption
1328757|NCT01462331|Dose tolerance|dose tolerance
1328758|NCT01462331|Prebiotic|prebiotic
1328759|NCT01462331|Short chain fatty acids|short chain fatty acids
1328760|NCT01462331|Blood glucose|blood glucose
1328761|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
1328762|NCT01462318|Pre-filled syringe|pre-filled syringe
1328763|NCT01462318|Pharmacokinetic|pharmacokinetic
1328764|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
1328765|NCT01462318|immunogenicity|immunogenicity
1328766|NCT01462305|SAD|sad
1328767|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
1328768|NCT01462305|Winter Blues|winter blues
1328769|NCT01462305|Seasonal Depression|seasonal depression
1328770|NCT01462292|968|968
1328771|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1328772|NCT01462292|GSK2402968|gsk2402968
1328773|NCT01462292|DMD|dmd
1328774|NCT01462292|Duchenne|duchenne
1328775|NCT01462292|GSK|gsk
1328776|NCT01462279|acute respiratory failure|acute respiratory failure
1328777|NCT01462279|thiamine|thiamine
1328778|NCT01462279|oxygen consumption|oxygen consumption
1328779|NCT01462279|VO2|vo2
1328780|NCT01462253|Adult patients|adult patients
1328781|NCT01462253|Refractory|refractory
1328782|NCT01462253|Relapsed|relapsed
1328783|NCT01462253|clofarabine|clofarabine
1328784|NCT01462253|cyclophosphamide|cyclophosphamide
1328785|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
1328786|NCT01462253|ALL|all
1328787|NCT01462240|arthritis|arthritis
1328788|NCT01462227|Hypoglycemia|hypoglycemia
1328789|NCT01462227|Type 1 diabetes|type 1 diabetes
1328790|NCT01462201|focused ultrasound|focused ultrasound
1328791|NCT01462201|mechanical fat destruction|mechanical fat destruction
1328792|NCT01462201|Body Sculpting|body sculpting
1328793|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1328794|NCT01462188|Primary angioplasty|primary angioplasty
1328795|NCT01462188|stent|stent
1328796|NCT01462136|PK study|pk study
1328797|NCT01462097|Chronic kidney disease|chronic kidney disease
1328798|NCT01462097|Exercise|exercise
1328799|NCT01462097|Aerobic capacity|aerobic capacity
1328800|NCT01462097|Learning and memory|learning and memory
1328801|NCT01462097|Executive function|executive function
1328802|NCT01462097|Endothelial function|endothelial function
1328803|NCT01462084|sleeping|sleeping
1328804|NCT01462084|opioid medications|opioid medications
1328805|NCT01462084|positive airway pressure|positive airway pressure
1328806|NCT01462058|SPAQ|spaq
1328807|NCT01462058|Sigh-SAD|sigh-sad
1328808|NCT01462058|Hamilton 29|hamilton 29
1328809|NCT01462058|Vitamin D3|vitamin d3
1328810|NCT01462058|p25(OH)D|p25(oh)d
1328811|NCT01462045|Exercise|exercise
1328812|NCT01462045|Stress|stress
1328813|NCT01462045|PTSD|ptsd
1328814|NCT01462045|Mindfulness|mindfulness
1328815|NCT01462045|Breathing|breathing
1328816|NCT01462045|Cortisol|cortisol
1328817|NCT01462032|Preschool Children|preschool children
1328818|NCT01462032|ADHD|adhd
1328819|NCT01462032|Treatment|treatment
1328820|NCT01462032|Non-pharmacological|non-pharmacological
1328821|NCT01462019|nipple trauma|nipple trauma
1328822|NCT01462019|breast feeding|breast feeding
1328823|NCT01462019|phototherapy|phototherapy
1328824|NCT01462019|wound healing|wound healing
1328825|NCT01461993|vaccine|vaccine
1328826|NCT01461993|rLP2086|rlp2086
1328827|NCT01461993|Gardasil|gardasil
1328828|NCT01461993|HPV|hpv
1328829|NCT01461993|meningitis B|meningitis b
1328830|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
1328831|NCT01461993|adolescents|adolescents
1328832|NCT01461993|single-blind|single-blind
1328833|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
1328834|NCT01461980|vaccine|vaccine
1328835|NCT01461980|rLP2086|rlp2086
1328836|NCT01461980|MCV4|mcv4
1328837|NCT01461980|Tdap|tdap
1328838|NCT01461980|meningitis B|meningitis b
1328839|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
1328840|NCT01461980|adolescents|adolescents
1328841|NCT01461980|observer-blind|observer-blind
1328842|NCT01461941|Dermatitis|dermatitis
1328843|NCT01461941|Atopic|atopic
1328844|NCT01461915|Pancreatic Cancer|pancreatic cancer
1328845|NCT01461902|traumatic brain injury|traumatic brain injury
1328846|NCT01461902|brain injury|brain injury
1328847|NCT01461902|head injury|head injury
1328848|NCT01461902|vasospasm|vasospasm
1328849|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
1328850|NCT01461889|Blood Component Transfusion|blood component transfusion
1328851|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1328852|NCT01461889|Cirrhosis|cirrhosis
1328853|NCT01461889|Fresh frozen plasma|fresh frozen plasma
1328854|NCT01461837|sickle cell disease|sickle cell disease
1328855|NCT01461837|stem cell transplantation|stem cell transplantation
1328856|NCT01461837|haploidentical|haploidentical
1328857|NCT01461824|Birth Control|birth control
1328858|NCT01461824|Contraceptive Methods|contraceptive methods
1328859|NCT01461824|Female Contraception|female contraception
1328860|NCT01461824|Weight Gain|weight gain
1328861|NCT01461824|Bone Density|bone density
1328862|NCT01461811|toric|toric
1328863|NCT01461811|contact lenses|contact lenses
1328864|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
1328865|NCT01461811|astigmatism|astigmatism
1328866|NCT01461811|soft contact lenses|soft contact lenses
1333200|NCT01444014|YF476|yf476
1328867|NCT01461811|contact lens comfort|contact lens comfort
1328868|NCT01461798|plant stanols|plant stanols
1328869|NCT01461798|lipids|lipids
1328870|NCT01461798|cardiovascular disease|cardiovascular disease
1328871|NCT01461785|Platelet rich plasma|platelet rich plasma
1328872|NCT01461785|Dermal improvement|dermal improvement
1328873|NCT01461785|Graft survival|graft survival
1328874|NCT01461733|atrial fibrillation|atrial fibrillation
1328875|NCT01461733|amiodarone|amiodarone
1328876|NCT01461720|Bone marrow|bone marrow
1328877|NCT01461720|Autologous|autologous
1328878|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
1328879|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
1328880|NCT01461707|Cellular phone|cellular phone
1328881|NCT01461707|exercise|exercise
1328882|NCT01461707|pregnant women|pregnant women
1328883|NCT01461707|obesity|obesity
1328884|NCT01461707|overweight|overweight
1328885|NCT01461707|physical activity|physical activity
1328886|NCT01461694|Hirsutism|hirsutism
1328887|NCT01461694|Laser|laser
1328888|NCT01461694|Hair Reduction|hair reduction
1328889|NCT01461694|IPL|ipl
1328890|NCT01461694|Intense Pulsed Light|intense pulsed light
1328891|NCT01461681|Palliative care|palliative care
1328892|NCT01461681|Symptom management|symptom management
1328893|NCT01461681|Heart failure|heart failure
1328894|NCT01461668|MRSA|mrsa
1328895|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
1328896|NCT01461642|Asthma|asthma
1328897|NCT01461642|ICT Support|ict support
1328898|NCT01461642|ACT|act
1328899|NCT01461642|PEF|pef
1328900|NCT01461629|cognitive impairment|cognitive impairment
1328901|NCT01461629|cognitive function|cognitive function
1328902|NCT01461629|hospitalization|hospitalization
1328903|NCT01461629|self-management|self-management
1328904|NCT01461629|cardiac disease|cardiac disease
1328905|NCT01461629|heart failure|heart failure
1328906|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1328907|NCT01461603|critical illness|critical illness
1328908|NCT01461603|protein metabolism|protein metabolism
1328909|NCT01461603|pharmaconutrients|pharmaconutrients
1328910|NCT01461564|screening|screening
1328911|NCT01461564|colonoscopy|colonoscopy
1328912|NCT01461564|carbon dioxide|carbon dioxide
1328913|NCT01461564|air|air
1328914|NCT01461564|pain score|pain score
1328915|NCT01461564|complications|complications
1328916|NCT01461551|troponin I|troponin i
1328917|NCT01461551|creatine kinase mb|creatine kinase mb
1328918|NCT01461551|hospital days|hospital days
1328919|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
1328920|NCT01461551|intensive care unit days|intensive care unit days
1328921|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
1328922|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
1328923|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
1328924|NCT01461538|Solid Tumors|solid tumors
1328925|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
1328926|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
1328927|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
1328928|NCT01461538|Antigens, CD30|antigens, cd30
1328929|NCT01461538|Drug Therapy|drug therapy
1328930|NCT01461538|Hematologic Diseases|hematologic diseases
1328931|NCT01461538|Immunotherapy|immunotherapy
1328932|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
1328933|NCT01461525|Low Rectal Cancer|low rectal cancer
1328934|NCT01461525|Sphincter preservation|sphincter preservation
1328935|NCT01461525|Abdominoperineal resection|abdominoperineal resection
1328936|NCT01461525|Quality of life|quality of life
1328937|NCT01461525|Sexual function|sexual function
1328938|NCT01461525|Urinary function|urinary function
1328939|NCT01461525|Oncologic outcome|oncologic outcome
1328940|NCT01461499|Hypertension|hypertension
1328941|NCT01461499|Albuminuria|albuminuria
1328942|NCT01461499|Direct renin inhibitor|direct renin inhibitor
1328943|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
1328944|NCT01461499|Type 2 diabetes|type 2 diabetes
1328945|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
1328946|NCT01461486|Oral appliance|oral appliance
1328947|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
1328948|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
1328949|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1328950|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
1328951|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
1328952|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
1328953|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
1328954|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
1328955|NCT01461460|volunteer|volunteer
1328956|NCT01461434|atrial fibrillation|atrial fibrillation
1328957|NCT01461434|biomarkers|biomarkers
1328958|NCT01461434|stroke prevention|stroke prevention
1328959|NCT01461434|implantable loop recorder|implantable loop recorder
1328960|NCT01461421|Obesity|obesity
1328961|NCT01461421|Primary Care|primary care
1328962|NCT01461421|Behavior Modification|behavior modification
1328963|NCT01461408|HPV Vaccination|hpv vaccination
1328964|NCT01461408|Beauty Salons|beauty salons
1329362|NCT01459822|miRNA|mirna
1328968|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
1328969|NCT01461330|diabetes|diabetes
1328970|NCT01461330|exercise|exercise
1328971|NCT01461330|DASH diet|dash diet
1328972|NCT01461330|ABPM|abpm
1328973|NCT01461304|fatty acid oxidation|fatty acid oxidation
1328974|NCT01461304|triheptanoin|triheptanoin
1328975|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
1328976|NCT01461304|LCHADD|lchadd
1328977|NCT01461304|VLCADD|vlcadd
1328978|NCT01461304|CPT1|cpt1
1328979|NCT01461304|CPT2|cpt2
1328981|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
1328982|NCT01461304|GSD|gsd
1328983|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
1328984|NCT01461304|PC|pc
1328985|NCT01461304|ACAD9|acad9
1328986|NCT01461304|Barth|barth
1328987|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
1328988|NCT01461291|POAG|poag
1328989|NCT01461291|Trabecular meshwork|trabecular meshwork
1328990|NCT01461291|iStent inject|istent inject
1328991|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
1328992|NCT01461278|POAG|poag
1328993|NCT01461278|Cataract surgery|cataract surgery
1328994|NCT01461278|Suprachoroidal space|suprachoroidal space
1328995|NCT01461278|Suprachoroidal stent|suprachoroidal stent
1328996|NCT01461278|iStent supra|istent supra
1328997|NCT01461265|Painful bone metastases|painful bone metastases
1328998|NCT01461265|Bone metastases|bone metastases
1328999|NCT01461265|Metastatic bone tumors|metastatic bone tumors
1329000|NCT01461265|Metastatic bone pain|metastatic bone pain
1329001|NCT01461265|Cryoablation|cryoablation
1329002|NCT01461265|Cryotherapy|cryotherapy
1329003|NCT01461265|Cryosurgery|cryosurgery
1329004|NCT01461252|Painful bone metastases|painful bone metastases
1329005|NCT01461252|Bone metastases|bone metastases
1329006|NCT01461252|Metastatic bone tumors|metastatic bone tumors
1329007|NCT01461252|Metastatic bone pain|metastatic bone pain
1329008|NCT01461252|Cryoablation|cryoablation
1329009|NCT01461252|Cryotherapy|cryotherapy
1329010|NCT01461252|Cryosurgery|cryosurgery
1329011|NCT01461252|Radiation therapy|radiation therapy
1329012|NCT01461252|Radiotherapy|radiotherapy
1329013|NCT01461239|survival|survival
1329014|NCT01461239|debonding|debonding
1329015|NCT01461239|endodontic treated teeth|endodontic treated teeth
1329016|NCT01461226|overweight|overweight
1329017|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
1329018|NCT01461226|exercise training|exercise training
1329019|NCT01461226|endothelial function|endothelial function
1329020|NCT01461226|endothelium|endothelium
1329021|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
1329022|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
1329023|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
1329024|NCT01461187|Exercise|exercise
1329025|NCT01461187|Pregnancy|pregnancy
1329026|NCT01461187|Childbirth|childbirth
1329027|NCT01461187|Vaginal|vaginal
1329028|NCT01461187|Cesarean section|cesarean section
1329029|NCT01461174|Sleep deprivation|sleep deprivation
1329030|NCT01461174|Cognitive Functions|cognitive functions
1329031|NCT01461174|young male|young male
1329032|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
1329033|NCT01461109|Parkinson Disease|parkinson disease
1329034|NCT01461109|Alzheimer Disease|alzheimer disease
1329035|NCT01461109|[18F] CFPyPB|[18f] cfpypb
1329036|NCT01461109|GlyT1|glyt1
1329037|NCT01461083|Parkinson Disease|parkinson disease
1329038|NCT01461083|[18F]MPPF|[18f]mppf
1329042|NCT01461031|pain|pain
1329043|NCT01461031|orthognathic|orthognathic
1329044|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
1329045|NCT01461018|SCIG|scig
1329046|NCT01461018|Primary immunodeficiency|primary immunodeficiency
1329047|NCT01461018|PID|pid
1329048|NCT01461005|Spondylolisthesis|spondylolisthesis
1329049|NCT01461005|Neurologic impairment|neurologic impairment
1329050|NCT01461005|Kyphosis|kyphosis
1329051|NCT01461005|Pseudarthrosis|pseudarthrosis
1329052|NCT01460992|Pacemaker therapy|pacemaker therapy
1329053|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1329054|NCT01460992|EVIA/ENTOVIS|evia/entovis
1329055|NCT01460979|Ovarian Cancer|ovarian cancer
1329056|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
1329057|NCT01460979|Temsirolimus|temsirolimus
1329058|NCT01460966|Distal protection device|distal protection device
1329059|NCT01460966|Thrombus aspiration|thrombus aspiration
1329060|NCT01460966|Coronary Artery Disease|coronary artery disease
1329061|NCT01460966|Coronary Disease|coronary disease
1329062|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
1329063|NCT01460953|curriculum|curriculum
1329064|NCT01460953|training|training
1329065|NCT01460953|Medical student Knowledge|medical student knowledge
1329066|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
1329067|NCT01460940|panobinostat|panobinostat
1329068|NCT01460940|lenalidomide|lenalidomide
1329069|NCT01460914|ECP|ecp
1329070|NCT01460914|CTCL|ctcl
1329071|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
1329072|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1329073|NCT01460914|GVHD|gvhd
1329074|NCT01460914|Graft versus host disease|graft versus host disease
1329075|NCT01460901|Neuroblastoma|neuroblastoma
1329076|NCT01460901|Relapsed|relapsed
1329077|NCT01460901|Refractory|refractory
1329078|NCT01460875|high risk melanoma|high risk melanoma
1329079|NCT01460875|lymph node disease|lymph node disease
1329080|NCT01460862|Asthma|asthma
1329081|NCT01460862|Omalizumab|omalizumab
1329082|NCT01460849|Cystic fibrosis|cystic fibrosis
1329083|NCT01460836|Cystic fibrosis|cystic fibrosis
1329084|NCT01460823|Hearing loss|hearing loss
1329085|NCT01460823|Cochlear Implantation|cochlear implantation
1329086|NCT01460823|Image guided surgery|image guided surgery
1329087|NCT01460797|Glycemic index|glycemic index
1329088|NCT01460797|Caloric restriction|caloric restriction
1329089|NCT01460797|Energy intake|energy intake
1329090|NCT01460797|Glucose|glucose
1329091|NCT01460797|Lipid Metabolism|lipid metabolism
1329092|NCT01460797|Cholesterol|cholesterol
1329093|NCT01460797|HDL Cholesterol|hdl cholesterol
1329094|NCT01460797|LDL Cholesterol|ldl cholesterol
1329095|NCT01460797|Obesity|obesity
1329096|NCT01460797|Metformin|metformin
1329097|NCT01460784|Metabolic dysfunction|metabolic dysfunction
1329098|NCT01460784|Insulin resistance|insulin resistance
1329099|NCT01460784|Brown adipose tissue|brown adipose tissue
1329100|NCT01460784|Dyslipidemia|dyslipidemia
1329101|NCT01460771|childhood dystonia|childhood dystonia
1329102|NCT01460758|Depression|depression
1329103|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
1329104|NCT01460758|rTMS|rtms
1329105|NCT01460758|DLPFC|dlpfc
1329106|NCT01460758|medial frontal cortex|medial frontal cortex
1329107|NCT01460758|anterior cingulate complex|anterior cingulate complex
1329108|NCT01460745|Erbitux|erbitux
1329109|NCT01460745|CRC|crc
1329110|NCT01460745|mCRC|mcrc
1329111|NCT01460745|Liver|liver
1329112|NCT01460745|Metastases|metastases
1329113|NCT01460732|Hypertension|hypertension
1329114|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
1329115|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
1329116|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1329117|NCT01460706|Glioma|glioma
1329118|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
1329119|NCT01460706|PET/CT|pet/ct
1329120|NCT01460706|Somatostatin receptor|somatostatin receptor
1329121|NCT01460693|Leukemia|leukemia
1329122|NCT01460693|Myeloid|myeloid
1329123|NCT01460693|Chronic|chronic
1329124|NCT01460693|Chronic-Phase|chronic-phase
1329125|NCT01460693|CML|cml
1329126|NCT01460680|Fibromyalgia|fibromyalgia
1329127|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
1329128|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
1329129|NCT01460680|Magnesium|magnesium
1329130|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
1329131|NCT01460667|Post-Operative Pain|post-operative pain
1329132|NCT01460667|IV Acetaminophen|iv acetaminophen
1329133|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
1329134|NCT01460628|fatigue|fatigue
1329135|NCT01460628|menopausal symptoms|menopausal symptoms
1329136|NCT01460628|hot flashes|hot flashes
1329137|NCT01460628|Vasomotor symptoms|vasomotor symptoms
1329138|NCT01460628|perimenopause|perimenopause
1329139|NCT01460628|related Quality of life|related quality of life
1329140|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
1329141|NCT01460615|Postoperative complications|postoperative complications
1329142|NCT01460615|Delayed gastric emptying|delayed gastric emptying
1329143|NCT01460615|Leakage|leakage
1329144|NCT01460615|Fistula|fistula
1329145|NCT01460615|Acinar cell|acinar cell
1329146|NCT01460615|Risk patient|risk patient
1329147|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
1329148|NCT01460615|Whipple|whipple
1329149|NCT01460615|Cortisone|cortisone
1329150|NCT01460602|Lymphoma|lymphoma
1329151|NCT01460602|Follicular|follicular
1329152|NCT01460602|Marginal Zone|marginal zone
1329153|NCT01460602|Mantle Cell|mantle cell
1329154|NCT01460602|Velcade|velcade
1329155|NCT01460602|bortezomib|bortezomib
1329156|NCT01460602|Nipent|nipent
1329157|NCT01460602|pentastatin|pentastatin
1329158|NCT01460602|Rituxan|rituxan
1329159|NCT01460602|rituximab|rituximab
1329160|NCT01460602|Turturro|turturro
1329161|NCT01460602|Shreveport|shreveport
1329162|NCT01460589|colon cancer|colon cancer
1329163|NCT01460589|Chemotherapy|chemotherapy
1329164|NCT01460589|adjuvant|adjuvant
1329165|NCT01460576|prematurity|prematurity
1329166|NCT01460576|respiratory disease|respiratory disease
1329167|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1329168|NCT01460563|craniotomy|craniotomy
1329169|NCT01460563|sodium valproate|sodium valproate
1329170|NCT01460563|rocuronium|rocuronium
1329363|NCT01459783|Caregivers|caregivers
1329171|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
1329172|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
1329173|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
1329174|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
1329175|NCT01460550|morbidity|morbidity
1329176|NCT01460537|phase I|phase i
1329177|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
1329178|NCT01460537|gemcitabine|gemcitabine
1329179|NCT01460537|cisplatin|cisplatin
1329180|NCT01460537|maximum tolerated dose|maximum tolerated dose
1329181|NCT01460524|bronchiolitis|bronchiolitis
1329182|NCT01460524|saline|saline
1329183|NCT01460524|nebulization|nebulization
1329184|NCT01460524|hypertonic|hypertonic
1329185|NCT01460511|Mild bronchial asthma|mild bronchial asthma
1329186|NCT01460498|Leukemia|leukemia
1329187|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
1329188|NCT01460498|CML|cml
1329189|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
1329190|NCT01460498|CCyR|ccyr
1329191|NCT01460498|Minimal residual disease|minimal residual disease
1329192|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
1329193|NCT01460498|BCR/ABL-positive|bcr/abl-positive
1329194|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1329195|NCT01460498|TKI|tki
1329196|NCT01460498|Azacitidine|azacitidine
1329197|NCT01460498|5-Azacytidine|5-azacytidine
1329198|NCT01460498|5-AZA|5-aza
1329199|NCT01460498|Vidaza|vidaza
1329200|NCT01460498|5-AZC|5-azc
1329201|NCT01460498|AZA-CR|aza-cr
1329202|NCT01460498|Ladakamycin|ladakamycin
1329203|NCT01460498|NSC-102816|nsc-102816
1329204|NCT01460472|NSCLC|nsclc
1329205|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
1329206|NCT01460472|advanced lung cancer|advanced lung cancer
1329207|NCT01460472|therapeutic vaccine|therapeutic vaccine
1329208|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
1329209|NCT01460472|1E10|1e10
1329210|NCT01460459|diabetes|diabetes
1329211|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
1329212|NCT01460459|frequency|frequency
1329213|NCT01460433|HIV 1|hiv 1
1329214|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
1329215|NCT01460433|Treatment experienced|treatment experienced
1329216|NCT01460420|Allogeneic transplantation|allogeneic transplantation
1329217|NCT01460420|Hematologic malignancies|hematologic malignancies
1329218|NCT01460420|Multiple myeloma|multiple myeloma
1329219|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
1329220|NCT01460394|Healthy|healthy
1329221|NCT01460394|Control|control
1329222|NCT01460355|strabismus surgery|strabismus surgery
1329223|NCT01460355|botulinum toxin|botulinum toxin
1329224|NCT01460355|esotropia|esotropia
1329225|NCT01460355|exotropia|exotropia
1329226|NCT01460355|blepharoptosis|blepharoptosis
1329227|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
1329228|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
1329229|NCT01460342|Lower urinary tract|lower urinary tract
1329230|NCT01460329|intensive care units|intensive care units
1329231|NCT01460329|pediatric|pediatric
1329232|NCT01460329|cardiac index|cardiac index
1329233|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
1329234|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
1329235|NCT01460316|methylation|methylation
1329236|NCT01460316|genotype|genotype
1329237|NCT01460316|cobalamin|cobalamin
1329238|NCT01460316|folates|folates
1329239|NCT01460316|nutrition|nutrition
1329240|NCT01460303|Transurethral catheterization|transurethral catheterization
1329241|NCT01460303|Urinary retention|urinary retention
1329242|NCT01460303|Bladder dysfunction|bladder dysfunction
1329243|NCT01460303|Patient comfort|patient comfort
1329244|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
1329245|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
1329246|NCT01460303|Postoperative urinary retention|postoperative urinary retention
1329247|NCT01460277|hemiplegic|hemiplegic
1329248|NCT01460277|balance|balance
1329249|NCT01460277|hydrotherapy|hydrotherapy
1329250|NCT01460264|Prospective Cohort Study|prospective cohort study
1329251|NCT01460264|Respiratory Function Tests|respiratory function tests
1329252|NCT01460264|Computed Tomography|computed tomography
1329253|NCT01460264|Electrocardiography|electrocardiography
1329254|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
1329255|NCT01460251|type 1 diabetes|type 1 diabetes
1329256|NCT01460251|beta cell|beta cell
1329257|NCT01460251|immunomodulation|immunomodulation
1329258|NCT01460251|immunointervention|immunointervention
1329259|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
1329260|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1329261|NCT01460238|CLL|cll
1329262|NCT01460225|constipation|constipation
1329263|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
1329264|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
1329265|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
1329266|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
1329267|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
1329268|NCT01460212|major depressive disorder|major depressive disorder
1329269|NCT01460186|Germ line polymorphisms|germ line polymorphisms
1329270|NCT01460173|alertness test|alertness test
1329271|NCT01460173|sleepiness|sleepiness
1329272|NCT01460173|vigilance|vigilance
1329273|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
1329274|NCT01460147|Hemophilia|hemophilia
1329275|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
1329276|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
1329277|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1329278|NCT01460134|Burkett's lymphoma|burkett's lymphoma
1329279|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
1329280|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
1329281|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
1329282|NCT01460134|solid tumor|solid tumor
1329283|NCT01460134|metastatic melanoma|metastatic melanoma
1329284|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
1329285|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
1329286|NCT01460134|ovarian cancer|ovarian cancer
1329287|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
1329288|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
1329289|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
1329290|NCT01460121|Visual Vertigo|visual vertigo
1329291|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
1329292|NCT01460121|Motion and Space Discomfort|motion and space discomfort
1329294|NCT01460108|PLVR|plvr
1329295|NCT01460108|AeriSeal|aeriseal
1329296|NCT01460108|Treatment|treatment
1329297|NCT01460108|Device|device
1329298|NCT01460108|Breathing|breathing
1329299|NCT01460108|COPD|copd
1329300|NCT01460108|emphysema|emphysema
1329301|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
1329302|NCT01460108|heterogeneous|heterogeneous
1329303|NCT01460108|homogeneous|homogeneous
1329304|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1329305|NCT01460095|diabetes|diabetes
1329306|NCT01460095|translational research|translational research
1329307|NCT01460095|HbA1c|hba1c
1329308|NCT01460095|education|education
1329309|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1329310|NCT01460082|acute exacerbation|acute exacerbation
1329311|NCT01460082|endothelial dysfunction|endothelial dysfunction
1329312|NCT01460082|flow mediated dilation|flow mediated dilation
1329313|NCT01460082|systemic inflammation|systemic inflammation
1329314|NCT01460069|psoriasis|psoriasis
1329315|NCT01460069|liraglutide|liraglutide
1329316|NCT01460069|morbidity|morbidity
1329317|NCT01460069|PASI|pasi
1329318|NCT01460069|DLQI|dlqi
1329319|NCT01460056|peritoneal dialysis|peritoneal dialysis
1329320|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
1329321|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
1329322|NCT01460004|patellar tendinopathy|patellar tendinopathy
1329323|NCT01460004|jumper's knee|jumper's knee
1329324|NCT01459991|walnut|walnut
1329325|NCT01459991|mediterranean|mediterranean
1329326|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
1329327|NCT01459978|quality indicators|quality indicators
1329328|NCT01459978|obstetrics|obstetrics
1329329|NCT01459965|Jaundice|jaundice
1329330|NCT01459965|Biliary stents|biliary stents
1329331|NCT01459965|Palliation|palliation
1329332|NCT01459965|Quality of Life|quality of life
1329333|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
1329334|NCT01459952|occurences of flu|occurences of flu
1329335|NCT01459952|occurences of common cold|occurences of common cold
1329336|NCT01459939|Osteoarthritis|osteoarthritis
1329337|NCT01459926|Opioid induced constipation|opioid induced constipation
1329338|NCT01459926|OIC|oic
1329339|NCT01459926|Constipation|constipation
1329340|NCT01459926|Opioid side effects|opioid side effects
1329341|NCT01459926|Morphine induced constipation|morphine induced constipation
1329342|NCT01459926|Opioid therapy|opioid therapy
1329343|NCT01459913|VX-950|vx-950
1329344|NCT01459913|INCIVEK|incivek
1329345|NCT01459913|INCIVO|incivo
1329346|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
1329347|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
1329348|NCT01459874|Home Monitoring|home monitoring
1329349|NCT01459874|Remote monitoring|remote monitoring
1329350|NCT01459874|Telecardiology|telecardiology
1329351|NCT01459874|Organizational model|organizational model
1329352|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
1329353|NCT01459861|early ambulation|early ambulation
1329354|NCT01459861|knee arthroplasty|knee arthroplasty
1329355|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
1329356|NCT01459835|TV|tv
1329357|NCT01459835|Violence|violence
1329358|NCT01459835|DVDs|dvds
1329359|NCT01459835|Behavior|behavior
1329360|NCT01459835|Preschool children|preschool children
1329364|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
1329365|NCT01459783|Cost Effectiveness|cost effectiveness
1329366|NCT01459783|Patient Care Management|patient care management
1329367|NCT01459783|Social Work|social work
1329368|NCT01459770|glomerular filtration rate|glomerular filtration rate
1329369|NCT01459770|albuminuria|albuminuria
1329370|NCT01459770|medical therapy|medical therapy
1329371|NCT01459770|hospital discharge|hospital discharge
1329372|NCT01459770|hospital readmission|hospital readmission
1329373|NCT01459770|CKD complications|ckd complications
1329374|NCT01459770|CKD risk factors|ckd risk factors
1329375|NCT01459757|Retrospective|retrospective
1329376|NCT01459757|GIST|gist
1329377|NCT01459757|sunitinib|sunitinib
1329378|NCT01459757|mutational|mutational
1329379|NCT01459744|Heart failure|heart failure
1329380|NCT01459744|Palliative care|palliative care
1329381|NCT01459744|Communication|communication
1329382|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
1329383|NCT01459718|deferasirox|deferasirox
1329384|NCT01459718|β-thalassaemia|β-thalassaemia
1329385|NCT01459718|cardiac dysfunction|cardiac dysfunction
1329386|NCT01459705|Combat Disorders|combat disorders
1329387|NCT01459705|Exposure Therapy|exposure therapy
1329388|NCT01459705|Army Personnel|army personnel
1329389|NCT01459692|Seizures|seizures
1329390|NCT01459692|Epilepsy|epilepsy
1329391|NCT01459692|Auditory Stimulation|auditory stimulation
1329392|NCT01459692|Music|music
1329393|NCT01459666|Scar|scar
1329394|NCT01459666|Forehead|forehead
1329395|NCT01459666|Skin Cancer|skin cancer
1329396|NCT01459666|MOHS Surgery|mohs surgery
1329397|NCT01459666|Dermatology|dermatology
1329398|NCT01459653|Febrile neutropenia|febrile neutropenia
1329399|NCT01459653|cancer|cancer
1329400|NCT01459653|chemotherapy,|chemotherapy,
1329401|NCT01459653|primary prophylaxis|primary prophylaxis
1329402|NCT01459653|secondary prophylaxis|secondary prophylaxis
1329403|NCT01459653|filgrastim|filgrastim
1329404|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
1329405|NCT01459653|observational study|observational study
1329406|NCT01459653|noninterventional study|noninterventional study
1329407|NCT01459640|Osteoarthritis|osteoarthritis
1329408|NCT01459640|Bone marrow|bone marrow
1329409|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
1329410|NCT01459640|Autologous|autologous
1329411|NCT01459640|Mild osteoarthritis|mild osteoarthritis
1329412|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
1329413|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
1329414|NCT01459627|STEMI|stemi
1329415|NCT01459601|diabetes mellitus|diabetes mellitus
1329416|NCT01459601|FBS|fbs
1329417|NCT01459601|HbA1C|hba1c
1329418|NCT01459601|Cabergoline|cabergoline
1329419|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1329420|NCT01459575|antiretroviral therapy|antiretroviral therapy
1329421|NCT01459575|China|china
1329422|NCT01459549|hepatolithiasis|hepatolithiasis
1329423|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
1329424|NCT01459549|choledochojejunostomy|choledochojejunostomy
1329425|NCT01459536|Aging|aging
1329426|NCT01459523|Peripheral Nerve Block|peripheral nerve block
1329427|NCT01459523|Perineural Catheter|perineural catheter
1329428|NCT01459523|Orthopedic Surgery|orthopedic surgery
1329429|NCT01459523|Ultrasound|ultrasound
1329430|NCT01459510|Violence prevention|violence prevention
1329431|NCT01459510|Parenting|parenting
1329432|NCT01459510|Discipline|discipline
1329433|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
1329434|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
1329435|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
1329436|NCT01459458|intimate partner violence|intimate partner violence
1329437|NCT01459458|gender-based violence|gender-based violence
1329438|NCT01459458|domestic violence|domestic violence
1329439|NCT01459458|unintended pregnancy|unintended pregnancy
1329440|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
1329441|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
1329442|NCT01459445|endothelial dysfunction|endothelial dysfunction
1329443|NCT01459445|hsCRP|hscrp
1329444|NCT01459445|metformin|metformin
1329445|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
1329446|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
1329447|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
1329448|NCT01459406|MRI|mri
1329449|NCT01459406|gastrointestinal|gastrointestinal
1329450|NCT01459406|stomach|stomach
1329451|NCT01459406|small bowel|small bowel
1329452|NCT01459406|colon|colon
1329453|NCT01459406|glucose|glucose
1329454|NCT01459406|fructose|fructose
1329455|NCT01459406|fructan|fructan
1329456|NCT01459406|FODMAP|fodmap
1329457|NCT01459393|Actinic keratosis|actinic keratosis
1329458|NCT01459393|Photodynamic therapy|photodynamic therapy
1333201|NCT01444014|netazepide|netazepide
1439476|NCT01006005|HIV|hiv
1329459|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
1329460|NCT01459393|Cryotherapy|cryotherapy
1329461|NCT01459367|Drug Therapy|drug therapy
1329462|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
1329463|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
1329464|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
1329465|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
1329466|NCT01459328|rectal carcinoma|rectal carcinoma
1329467|NCT01459328|long course chemo-radiation|long course chemo-radiation
1329468|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
1329469|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
1329470|NCT01459315|Healthy|healthy
1329471|NCT01459315|Male|male
1329472|NCT01459315|GSK1349572|gsk1349572
1329473|NCT01459315|Dolutegravir|dolutegravir
1329475|NCT01459315|Integrase|integrase
1329476|NCT01459315|HIV|hiv
1329477|NCT01459302|FALS|fals
1329478|NCT01459302|ALS|als
1329479|NCT01459302|SALS|sals
1329480|NCT01459302|MND|mnd
1329481|NCT01459302|SOD1|sod1
1329482|NCT01459302|ALS GENES|als genes
1329483|NCT01459302|PLS|pls
1329484|NCT01459302|PMA|pma
1329485|NCT01459302|ALS/FTD|als/ftd
1329486|NCT01459302|FAMILIAL ALS|familial als
1329487|NCT01459302|SPORADIC ALS|sporadic als
1329488|NCT01459302|GENETICS|genetics
1329489|NCT01459302|FTD|ftd
1329490|NCT01459302|Miyoshi myopathy|miyoshi myopathy
1329491|NCT01459276|seasonal|seasonal
1329492|NCT01459276|prevention|prevention
1329493|NCT01459276|influenza|influenza
1329494|NCT01459276|infection|infection
1329495|NCT01459276|influenza vaccine|influenza vaccine
1329496|NCT01459276|vaccine|vaccine
1329497|NCT01459276|influenza in humans|influenza in humans
1329498|NCT01459263|GSV|gsv
1329499|NCT01459263|insufficiency|insufficiency
1329500|NCT01459263|ClariVein device|clarivein device
1329501|NCT01459263|safety|safety
1329502|NCT01459263|efficacy|efficacy
1329503|NCT01459263|QOL|qol
1329504|NCT01459250|AGO178C,|ago178c,
1329505|NCT01459250|renal impairment,|renal impairment,
1329506|NCT01459250|ESRD,|esrd,
1329507|NCT01459250|pharmacokinetics|pharmacokinetics
1329508|NCT01459237|Cushing's Disease|cushing's disease
1329509|NCT01459237|Microadenoma|microadenoma
1329510|NCT01459237|PET Imaging|pet imaging
1329511|NCT01459237|Cushing Disease Tumor|cushing disease tumor
1329512|NCT01459237|Pituitary Tumors|pituitary tumors
1329513|NCT01459211|CLL|cll
1329514|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
1329515|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
1329516|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
1329517|NCT01459185|S-1|s-1
1329518|NCT01459185|Feasibility study|feasibility study
1329519|NCT01459185|Surgery|surgery
1329520|NCT01459172|breast cancer prevention|breast cancer prevention
1329521|NCT01459159|Hematology|hematology
1329522|NCT01459159|MDS|mds
1329523|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
1329524|NCT01459159|Low risk MDS|low risk mds
1329525|NCT01459159|Int-1 risk MDS|int-1 risk mds
1329526|NCT01459159|Transfusion dependence|transfusion dependence
1329527|NCT01459159|Telintra|telintra
1329528|NCT01459159|ezatiostat|ezatiostat
1329529|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
1329530|NCT01459159|TLK199|tlk199
1329531|NCT01459159|Glutathione|glutathione
1329532|NCT01459159|Glutathione analog|glutathione analog
1329533|NCT01459159|Glutathione Transferase|glutathione transferase
1329534|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
1329535|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
1329536|NCT01459159|Apoptosis|apoptosis
1329537|NCT01459159|Differentiation|differentiation
1329538|NCT01459159|Enzyme inhibitor|enzyme inhibitor
1329539|NCT01459159|non-del (5q)|non-del (5q)
1329540|NCT01459159|non-deletion 5q|non-deletion 5q
1329541|NCT01459146|IPT|ipt
1329542|NCT01459146|malaria|malaria
1329543|NCT01459146|ACT|act
1329544|NCT01459146|schistosomiasis|schistosomiasis
1329545|NCT01459146|Hemoglobin|hemoglobin
1329546|NCT01459146|Anemia|anemia
1329547|NCT01459146|Sustained attention|sustained attention
1329548|NCT01459146|Recall|recall
1329549|NCT01459146|Schoolchildren|schoolchildren
1329550|NCT01459146|Kassena-Nankana|kassena-nankana
1329551|NCT01459133|investigational|investigational
1329552|NCT01459133|inhaled insulin product|inhaled insulin product
1329553|NCT01459120|Home-based HIV-testing|home-based hiv-testing
1329554|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
1329555|NCT01459120|Community based testing|community based testing
1329556|NCT01459120|HIV/AIDS|hiv/aids
1329557|NCT01459120|Lesotho|lesotho
1329558|NCT01459107|Hand Transplant|hand transplant
1329559|NCT01459107|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
1329560|NCT01459107|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
1329561|NCT01459107|Composite Tissue|composite tissue
1329562|NCT01459107|Amputation|amputation
1329563|NCT01459107|Upper limb|upper limb
1329564|NCT01459107|Immunosuppression|immunosuppression
1329565|NCT01459094|Healthy Volunteers|healthy volunteers
1329566|NCT01459094|Oral bioavailability|oral bioavailability
1329567|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1329568|NCT01459094|Metformin IR|metformin ir
1329569|NCT01459029|Schizophrenia|schizophrenia
1329570|NCT01459029|NMDA receptor|nmda receptor
1329571|NCT01459029|D-serine|d-serine
1329572|NCT01459029|Recent onset|recent onset
1329573|NCT01459029|Negative symptoms|negative symptoms
1329574|NCT01459029|Cognition|cognition
1329575|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
1329576|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
1329577|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
1329578|NCT01459016|Positron Emission Tomography|positron emission tomography
1329579|NCT01458977|Lípid-lowering effect|lípid-lowering effect
1329580|NCT01458977|Tenofovir|tenofovir
1329581|NCT01458977|Dyslipidemia|dyslipidemia
1329582|NCT01458964|Fibromyalgia|fibromyalgia
1329583|NCT01458951|Tofacitinib|tofacitinib
1329584|NCT01458951|CP-690|cp-690
1329585|NCT01458951|550|550
1329586|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
1329587|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
1329588|NCT01458951|Mayo score|mayo score
1329589|NCT01458925|Colorectal cancer|colorectal cancer
1329590|NCT01458925|Colonic polyps|colonic polyps
1329591|NCT01458899|Phase 1|phase 1
1329592|NCT01458899|healthy male|healthy male
1329593|NCT01458899|nonpregnant female|nonpregnant female
1329594|NCT01458899|volunteers|volunteers
1329595|NCT01458899|pharmacokinetics|pharmacokinetics
1329596|NCT01458899|TC 5214|tc 5214
1329597|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
1329598|NCT01458873|infiltration|infiltration
1329599|NCT01458873|extravasation|extravasation
1329600|NCT01458847|bladder cancer|bladder cancer
1329601|NCT01458847|cis-urocanic acid|cis-urocanic acid
1329602|NCT01458847|primary|primary
1329603|NCT01458847|recurrent|recurrent
1329604|NCT01458847|non-muscle|non-muscle
1329605|NCT01458834|Smoking|smoking
1329606|NCT01458834|Attentional bias|attentional bias
1329607|NCT01458834|Craving|craving
1329608|NCT01458821|Tinnitus|tinnitus
1329609|NCT01458808|salt|salt
1329610|NCT01458808|inflammation|inflammation
1329611|NCT01458808|hypervolemia|hypervolemia
1329612|NCT01458808|diet|diet
1329613|NCT01458782|Cartilage repair|cartilage repair
1329614|NCT01458782|Chondrocytes|chondrocytes
1329615|NCT01458782|Stemcells|stemcells
1329616|NCT01458756|liver transplant patients|liver transplant patients
1329617|NCT01458756|hepatic transplantation|hepatic transplantation
1329618|NCT01458743|pharmacokinetics|pharmacokinetics
1329619|NCT01458730|PCNSL|pcnsl
1329620|NCT01458730|Immunochemotherapy|immunochemotherapy
1329621|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
1329622|NCT01458730|Maintenance temozolomide|maintenance temozolomide
1329623|NCT01458717|pancreas|pancreas
1329624|NCT01458717|cancer|cancer
1329625|NCT01458717|borderline resectable|borderline resectable
1329626|NCT01458717|locally advanced|locally advanced
1329627|NCT01458717|resectability|resectability
1329628|NCT01458717|chemotherapy|chemotherapy
1329629|NCT01458717|radiation|radiation
1329630|NCT01458717|chemoradiation|chemoradiation
1329631|NCT01458717|neoadjuvant|neoadjuvant
1329632|NCT01458717|survival|survival
1329633|NCT01458717|prognosis|prognosis
1329634|NCT01458717|recurrence|recurrence
1329635|NCT01458717|response rate|response rate
1329636|NCT01458652|AST-120|ast-120
1329637|NCT01458652|HDF|hdf
1329638|NCT01458652|Replacement Volume described above|replacement volume described above
1329639|NCT01458639|Pulmonary embolism|pulmonary embolism
1329640|NCT01458639|PE|pe
1329641|NCT01458626|mirtazapine|mirtazapine
1329642|NCT01458626|paroxetine|paroxetine
1329643|NCT01458626|major depression|major depression
1329644|NCT01458626|early improvement|early improvement
1329645|NCT01458613|Mucopolysaccharidoses|mucopolysaccharidoses
1329646|NCT01458613|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
1329647|NCT01458613|Metabolism, Inborn Errors|metabolism, inborn errors
1329648|NCT01458613|Genetic Diseases, Inborn|genetic diseases, inborn
1329649|NCT01458613|Mucinoses|mucinoses
1329650|NCT01458613|Connective Tissue Diseases|connective tissue diseases
1329651|NCT01458613|Metabolic Diseases|metabolic diseases
1329652|NCT01458600|ophthalmopathy|ophthalmopathy
1329653|NCT01458600|prevention|prevention
1329654|NCT01458600|diclofenac|diclofenac
1329655|NCT01458587|Actinic keratosis|actinic keratosis
1329656|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
1329657|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
1329658|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
1329659|NCT01458574|ulcerative colitis|ulcerative colitis
1329660|NCT01458574|OCTAVE|octave
1329661|NCT01458574|CP-690|cp-690
1329662|NCT01458574|550|550
1329663|NCT01458574|tofacitinib|tofacitinib
1329664|NCT01458574|Xeljanz|xeljanz
1329665|NCT01458561|Hemostatic agent|hemostatic agent
1329666|NCT01458561|Liver surgery|liver surgery
1329667|NCT01458561|Hemostasis|hemostasis
1329668|NCT01458548|1st-line therapy|1st-line therapy
1329669|NCT01458548|single agent rituximab|single agent rituximab
1329670|NCT01458548|CHOP|chop
1329671|NCT01458548|PTLD|ptld
1329672|NCT01458535|Genotype 1|genotype 1
1329673|NCT01458535|Genotype 2|genotype 2
1329674|NCT01458535|Genotype 3|genotype 3
1329675|NCT01458535|Hepatitis C Virus|hepatitis c virus
1329676|NCT01458535|ABT-450/r|abt-450/r
1329677|NCT01458535|Ribavirin|ribavirin
1329678|NCT01458535|ABT-267|abt-267
1329679|NCT01458535|Ombitasvir|ombitasvir
1329680|NCT01458535|Paritaprevir|paritaprevir
1329681|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
1329682|NCT01458509|Quality of Life|quality of life
1329683|NCT01458509|patient outcomes|patient outcomes
1329684|NCT01458509|questionaires|questionaires
1329685|NCT01458509|11-101|11-101
1329686|NCT01458470|huntington|huntington
1329687|NCT01458470|huntingtin|huntingtin
1329688|NCT01458470|memantine|memantine
1329689|NCT01458470|ebixa|ebixa
1329690|NCT01458470|namenda|namenda
1329691|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
1329692|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
1329693|NCT01458444|Ventilation system|ventilation system
1329694|NCT01458431|cesarean section|cesarean section
1329695|NCT01458431|wound infusion|wound infusion
1329696|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
1329697|NCT01458431|Pain management|pain management
1329698|NCT01458418|Eosinophil|eosinophil
1329699|NCT01458418|Esophagitis|esophagitis
1329700|NCT01458405|Myocardial Infarction|myocardial infarction
1329701|NCT01458405|Heart Attack|heart attack
1329702|NCT01458405|Stem cell|stem cell
1329703|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
1329704|NCT01458405|Congestive heart failure|congestive heart failure
1329705|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1329706|NCT01458366|Lymphoma|lymphoma
1329707|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
1329708|NCT01458353|Right-sided colon cancer|right-sided colon cancer
1329709|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
1329710|NCT01458353|stapled anastomosis|stapled anastomosis
1329711|NCT01458353|handsewn anastomosis|handsewn anastomosis
1329712|NCT01458353|peritoneal contamination|peritoneal contamination
1329713|NCT01458353|microbiological spectrum|microbiological spectrum
1329714|NCT01458340|Adult ADHD|adult adhd
1329715|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1329716|NCT01458327|MDMA|mdma
1329717|NCT01458327|PTSD|ptsd
1329718|NCT01458327|psychotherapy|psychotherapy
1329719|NCT01458314|Physical exercise|physical exercise
1329720|NCT01458314|Rehabilitation|rehabilitation
1329721|NCT01458314|NIV|niv
1329722|NCT01458301|Drug Therapy|drug therapy
1329723|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1329724|NCT01458275|Ciclesonide|ciclesonide
1329725|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
1329726|NCT01458262|cerebral oxymetry|cerebral oxymetry
1329727|NCT01458262|systemic oxymetry|systemic oxymetry
1329728|NCT01458262|hepatic surgery|hepatic surgery
1329729|NCT01458262|liver transplantation|liver transplantation
1329730|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
1329731|NCT01458223|spine surgery|spine surgery
1329732|NCT01458223|postoperative infection|postoperative infection
1329733|NCT01458223|postoperative antibiotics|postoperative antibiotics
1329734|NCT01458197|Overactive Bladder|overactive bladder
1329735|NCT01458197|Tarafenacin|tarafenacin
1329736|NCT01458184|risk factors for complications|risk factors for complications
1329737|NCT01458184|precarious medical situations|precarious medical situations
1329738|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
1329739|NCT01458171|SCIG|scig
1329740|NCT01458171|Primary immunodeficiency|primary immunodeficiency
1329741|NCT01458171|PID|pid
1329742|NCT01458158|Gelatinases|gelatinases
1329743|NCT01458158|kidney disease|kidney disease
1329744|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
1329745|NCT01458132|subject follow-up|subject follow-up
1329746|NCT01458132|HIV infection|hiv infection
1329747|NCT01458132|registry|registry
1329748|NCT01458132|seizures|seizures
1329749|NCT01458132|GSK2248761|gsk2248761
1329750|NCT01458119|Fabry disease|fabry disease
1329751|NCT01458119|Lysosomal storage disease|lysosomal storage disease
1329752|NCT01458119|migalastat HCl|migalastat hcl
1329753|NCT01458119|AT1001|at1001
1329754|NCT01458080|ENABLE|enable
1329755|NCT01458080|invasive procedures|invasive procedures
1329756|NCT01458080|Thrombocytopenia|thrombocytopenia
1329757|NCT01458080|Thromboembolic events|thromboembolic events
1329758|NCT01458080|Eltrombopag|eltrombopag
1329759|NCT01458080|Hepatitis C|hepatitis c
1329760|NCT01458080|HCV|hcv
1329761|NCT01458054|pharmacokinetics|pharmacokinetics
1329762|NCT01458054|omeprazole|omeprazole
1329763|NCT01458054|ritonavir|ritonavir
1329764|NCT01458054|healthy subjects|healthy subjects
1329765|NCT01458054|drug interaction|drug interaction
1329766|NCT01458041|Critical limb ischaemia|critical limb ischaemia
1329767|NCT01458041|Iloprost|iloprost
1621705|NCT00313677|B3GALNT2|b3galnt2
1329768|NCT01458041|Quality of life|quality of life
1329769|NCT01458041|Visual analogue scale|visual analogue scale
1329770|NCT01458028|BAY85-3934|bay85-3934
1329771|NCT01458028|pharmacokinetics|pharmacokinetics
1329772|NCT01458028|age|age
1329773|NCT01458028|gender|gender
1329774|NCT01458015|QST|qst
1329775|NCT01458015|neuropathic pain|neuropathic pain
1329776|NCT01458015|tapentadol pr|tapentadol pr
1329777|NCT01458015|oxycodone|oxycodone
1329778|NCT01457989|retention rate|retention rate
1329779|NCT01457989|epilepsy|epilepsy
1329780|NCT01457989|responder rate|responder rate
1329781|NCT01457989|seizure freedom|seizure freedom
1329782|NCT01457989|discontinuation rate|discontinuation rate
1329783|NCT01457989|safety assessment|safety assessment
1329784|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
1329785|NCT01457989|open-label|open-label
1329786|NCT01457976|cancer|cancer
1329787|NCT01457976|obesity|obesity
1329788|NCT01457976|personal responsibility|personal responsibility
1329789|NCT01457950|denosumab|denosumab
1329790|NCT01457950|Republic of Korea|republic of korea
1329791|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1329792|NCT01457937|HCV|hcv
1329793|NCT01457937|Menopause|menopause
1329794|NCT01457937|Peg IFN|peg ifn
1329795|NCT01457937|Ribavirin|ribavirin
1329796|NCT01457937|Boceprevir|boceprevir
1329797|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1329798|NCT01457924|Ofatumumab|ofatumumab
1329799|NCT01457898|Cardiac surgery|cardiac surgery
1329800|NCT01457898|Non-invasive ventilation|non-invasive ventilation
1329801|NCT01457885|AML|aml
1329802|NCT01457872|Heroin addiction|heroin addiction
1329803|NCT01457872|Substance use disorders|substance use disorders
1329804|NCT01457872|Substitution treatment|substitution treatment
1329805|NCT01457872|Syringe exchange|syringe exchange
1329806|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
1329807|NCT01457846|gastric cancer|gastric cancer
1329808|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
1329809|NCT01457846|polysomy|polysomy
1329810|NCT01457846|amplification|amplification
1329811|NCT01457846|FGFR|fgfr
1329812|NCT01457820|Allopurinol|allopurinol
1329813|NCT01457820|Angina|angina
1329814|NCT01457820|Acute coronary syndrome|acute coronary syndrome
1329815|NCT01457807|Phase 1|phase 1
1329816|NCT01457807|Parkinson's disease|parkinson's disease
1329817|NCT01457807|pharmacodynamic|pharmacodynamic
1329818|NCT01457807|biomarkers|biomarkers
1329819|NCT01457807|pharmacokinetics|pharmacokinetics
1329820|NCT01457807|extended release formulation|extended release formulation
1329821|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
1329822|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
1329823|NCT01457794|Learning|learning
1329824|NCT01457794|Attention|attention
1329825|NCT01457794|Nutritional Status|nutritional status
1329826|NCT01457794|Nutrition Assessments|nutrition assessments
1329827|NCT01457794|Body Weight|body weight
1329828|NCT01457794|Physical Activity|physical activity
1329829|NCT01457794|Sleep|sleep
1329830|NCT01457794|Child Nutrition Sciences|child nutrition sciences
1329831|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
1329832|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
1329833|NCT01457781|pulmonary hypertension|pulmonary hypertension
1329834|NCT01457781|PAH|pah
1329835|NCT01457768|Hepatitis C|hepatitis c
1329836|NCT01457768|HCV|hcv
1329837|NCT01457768|Sustained Virologic Response|sustained virologic response
1329838|NCT01457768|Direct Acting Antiviral|direct acting antiviral
1329839|NCT01457768|Combination Therapy|combination therapy
1329840|NCT01457768|Tegobuvir|tegobuvir
1329841|NCT01457768|Registry|registry
1329842|NCT01457768|HCV RNA|hcv rna
1329843|NCT01457768|Treatment experienced|treatment experienced
1329844|NCT01457768|Treatment naive|treatment naive
1329845|NCT01457768|GS 9451|gs 9451
1329846|NCT01457768|GS 5885|gs 5885
1329847|NCT01457768|Sequence|sequence
1329848|NCT01457768|GS 5816|gs 5816
1329849|NCT01457768|GS 7977|gs 7977
1329850|NCT01457768|Sofosbuvir|sofosbuvir
1329851|NCT01457768|Sovaldi™|sovaldi™
1329852|NCT01457768|SOF|sof
1329853|NCT01457768|Ledipasvir|ledipasvir
1329854|NCT01457768|LDV|ldv
1329855|NCT01457755|Hepatitis C|hepatitis c
1329856|NCT01457755|HCV|hcv
1329857|NCT01457755|Sustained Virologic Response|sustained virologic response
1329858|NCT01457755|Direct Acting Antiviral|direct acting antiviral
1329859|NCT01457755|Combination Therapy|combination therapy
1329860|NCT01457755|Tegobuvir|tegobuvir
1329861|NCT01457755|Registry|registry
1329862|NCT01457755|HCV RNA|hcv rna
1329863|NCT01457755|Treatment experienced|treatment experienced
1329864|NCT01457755|Treatment naive|treatment naive
1329865|NCT01457755|GS 9451|gs 9451
1329866|NCT01457755|GS 5885|gs 5885
1329867|NCT01457755|GS 7977|gs 7977
1329868|NCT01457755|GS 5816|gs 5816
1329869|NCT01457755|Sofosbuvir|sofosbuvir
1329870|NCT01457755|Sovaldi™|sovaldi™
1329871|NCT01457755|SOF|sof
1329872|NCT01457755|Ledipasvir|ledipasvir
1329873|NCT01457755|LDV|ldv
1329874|NCT01457742|Osteoarthritis|osteoarthritis
1329875|NCT01457729|ergometer|ergometer
1329876|NCT01457729|training|training
1329877|NCT01457729|motivation|motivation
1329878|NCT01457729|telemonitoring|telemonitoring
1329879|NCT01457729|sleep apnea|sleep apnea
1329880|NCT01457716|Healthy volunteer study|healthy volunteer study
1329881|NCT01457703|LH pulsatility|lh pulsatility
1329883|NCT01457703|Reproduction|reproduction
1329884|NCT01457690|Vitamin E pegylated|vitamin e pegylated
1330970|NCT01452958|LPS|lps
1329885|NCT01457690|chylomicron retention|chylomicron retention
1329886|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
1329887|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
1329888|NCT01457651|Recruitment|recruitment
1329889|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
1329890|NCT01457651|Postoperative period|postoperative period
1329891|NCT01457638|nasal obstruction|nasal obstruction
1329892|NCT01457638|rhinoplasty|rhinoplasty
1329893|NCT01457638|turbinate surgery|turbinate surgery
1329894|NCT01457638|quality of life|quality of life
1329895|NCT01457638|acoustic rhinometry|acoustic rhinometry
1329896|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
1329897|NCT01457612|Insulin Resistant|insulin resistant
1329898|NCT01457612|Dietary Supplements|dietary supplements
1329899|NCT01457612|Nutrition|nutrition
1329900|NCT01457612|Antioxidant|antioxidant
1329901|NCT01457612|Inflammation|inflammation
1329902|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
1329903|NCT01457599|Feasibility, safety|feasibility, safety
1329904|NCT01457586|Heart Surgery|heart surgery
1329905|NCT01457586|Blood Transfusion|blood transfusion
1329906|NCT01457586|Postoperative Complications|postoperative complications
1329907|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
1329908|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
1329909|NCT01457547|HEXAVACTM|hexavactm
1329910|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
1329911|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
1329912|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
1329913|NCT01457521|pain|pain
1329914|NCT01457521|medical abortion|medical abortion
1329915|NCT01457508|combination vaccine|combination vaccine
1329916|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
1329917|NCT01457508|Hib|hib
1329918|NCT01457495|Infants|infants
1329919|NCT01457495|combined vaccine|combined vaccine
1329920|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
1329921|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
1329922|NCT01457495|safety|safety
1329923|NCT01457495|Immunogenicity|immunogenicity
1329924|NCT01457495|HBV|hbv
1329925|NCT01457482|Fear|fear
1329926|NCT01457482|Childbirth|childbirth
1329927|NCT01457482|Art therapy|art therapy
1330316|NCT01455753|Proximity|proximity
1329928|NCT01457482|Therapeutic conversations|therapeutic conversations
1329929|NCT01457482|W-DEQ|w-deq
1329930|NCT01457456|Mucopolysaccharidoses|mucopolysaccharidoses
1329931|NCT01457456|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
1329932|NCT01457456|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
1329933|NCT01457456|Metabolism, Inborn Errors|metabolism, inborn errors
1329934|NCT01457456|Genetic Diseases, Inborn|genetic diseases, inborn
1329935|NCT01457456|Lysosomal Storage Diseases|lysosomal storage diseases
1329936|NCT01457456|Connective Tissue Diseases|connective tissue diseases
1329937|NCT01457456|Metabolic Diseases|metabolic diseases
1329938|NCT01457456|Musculoskeletal Diseases|musculoskeletal diseases
1329939|NCT01457443|Glycogen Storage Disease|glycogen storage disease
1329940|NCT01457443|Glycogen Storage Disease Type II|glycogen storage disease type ii
1329941|NCT01457443|Metabolic Diseases|metabolic diseases
1329942|NCT01457443|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
1329943|NCT01457443|Metabolism, Inborn Errors|metabolism, inborn errors
1329944|NCT01457443|Genetic Diseases, Inborn|genetic diseases, inborn
1329945|NCT01457443|Lysosomal Storage Diseases, Nervous System|lysosomal storage diseases, nervous system
1329946|NCT01457417|Cancer|cancer
1329947|NCT01457417|Oncology|oncology
1329948|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
1329949|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
1329950|NCT01457404|addiction|addiction
1329951|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
1329952|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
1329953|NCT01457391|addiction|addiction
1329954|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
1329955|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
1329956|NCT01457378|healthy subjects|healthy subjects
1329957|NCT01457378|IBS|ibs
1329958|NCT01457378|HRQoL|hrqol
1329959|NCT01457378|questionnaires|questionnaires
1329960|NCT01457352|Baclofen, spasticity|baclofen, spasticity
1329961|NCT01457339|Schizophrenia|schizophrenia
1329962|NCT01457326|Immersion therapy|immersion therapy
1329963|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
1329964|NCT01457300|Rehabilitation outcome|rehabilitation outcome
1329965|NCT01457300|Aged|aged
1329966|NCT01457300|Aged, 80 and over|aged, 80 and over
1329967|NCT01457300|Activities of daily living|activities of daily living
1329968|NCT01457274|AMBULATORY CARE|ambulatory care
1329969|NCT01457274|AWARENESS AND RECALL|awareness and recall
1329970|NCT01457274|Propofol|propofol
1329971|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
1329972|NCT01457274|Colonoscopy|colonoscopy
1329973|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
1329974|NCT01457274|Procedural sedation|procedural sedation
1329975|NCT01457261|interstitial lung disease|interstitial lung disease
1329976|NCT01457261|drug deposition|drug deposition
1329977|NCT01457261|lung imaging|lung imaging
1329978|NCT01457261|respiratory|respiratory
1329979|NCT01457248|after aortic surgery|after aortic surgery
1329980|NCT01457235|Bipolar disorder|bipolar disorder
1329981|NCT01457235|Cognitive Remediation|cognitive remediation
1329982|NCT01457235|Cognition|cognition
1329983|NCT01457235|Cognitive function|cognitive function
1329984|NCT01457235|Mood disorders|mood disorders
1329985|NCT01457235|Affective disorders|affective disorders
1329986|NCT01457222|Mindfulness|mindfulness
1329987|NCT01457222|Stress|stress
1329988|NCT01457222|Cognition|cognition
1329989|NCT01457222|Psychological health|psychological health
1329990|NCT01457222|Primary prevention|primary prevention
1329991|NCT01457209|PCOS|pcos
1329992|NCT01457209|Insulin resistance|insulin resistance
1329993|NCT01457209|Acupuncture|acupuncture
1329994|NCT01457196|Cancer Genetics|cancer genetics
1329995|NCT01457183|pulsed lavage|pulsed lavage
1329996|NCT01457183|evaluate containment|evaluate containment
1329997|NCT01457183|evaluate tolerability|evaluate tolerability
1329998|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
1329999|NCT01457170|Heart Failure|heart failure
1330000|NCT01457170|Apelin|apelin
1330001|NCT01457170|Haemodynamics|haemodynamics
1330002|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
1330003|NCT01457170|cardiac output|cardiac output
1330004|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
1330005|NCT01457144|Rituximab|rituximab
1330006|NCT01457144|bendamustine|bendamustine
1330007|NCT01457144|Velcade|velcade
1330008|NCT01457144|Dexamethasone|dexamethasone
1330009|NCT01457131|Metastatic Cancer|metastatic cancer
1330010|NCT01457131|Immunotherapy|immunotherapy
1330011|NCT01457131|Gene Therapy|gene therapy
1330012|NCT01457131|Metastatic Melanoma|metastatic melanoma
1330013|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
1330014|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
1330015|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
1330016|NCT01457092|benign biliary strictures|benign biliary strictures
1330017|NCT01457092|chronic pancreatitis|chronic pancreatitis
1330018|NCT01457079|Keloid|keloid
1330019|NCT01457079|Radiation Therapy|radiation therapy
1330020|NCT01457079|Hypertrophic Scar|hypertrophic scar
1330021|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
1330022|NCT01457053|Myocardial blood flow|myocardial blood flow
1330023|NCT01457053|Coronary flow reserve|coronary flow reserve
1330024|NCT01457053|Ultrafiltration|ultrafiltration
1330025|NCT01457053|Diuretics|diuretics
1330026|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
1330027|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1330028|NCT01457027|Influenza|influenza
1330029|NCT01457027|Virus|virus
1330030|NCT01457027|Vaccination|vaccination
1330031|NCT01457027|Immunisation|immunisation
1330032|NCT01457014|chronic pain|chronic pain
1330033|NCT01457014|sleep disordered breathing|sleep disordered breathing
1330034|NCT01457014|Opioids|opioids
1330035|NCT01457001|chronic haemodialysis|chronic haemodialysis
1330036|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
1330037|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
1330038|NCT01456975|Aortic insufficiency|aortic insufficiency
1330039|NCT01456962|Immune reconstitution|immune reconstitution
1330040|NCT01456962|CD4+ T cells|cd4+ t cells
1330041|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
1330042|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
1330043|NCT01456949|Arrythmias|arrythmias
1330044|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
1330045|NCT01456949|Cardiac ablation|cardiac ablation
1330046|NCT01456949|Cryoablation|cryoablation
1330047|NCT01456936|smoking cessation|smoking cessation
1330048|NCT01456936|psychiatric disease|psychiatric disease
1330049|NCT01456923|DNA damaging agents|dna damaging agents
1330050|NCT01456910|Physical education|physical education
1330051|NCT01456910|People with mental disabilities|people with mental disabilities
1330052|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
1330053|NCT01456910|Performance Evaluation|performance evaluation
1330054|NCT01456910|Occupational health|occupational health
1330055|NCT01456884|Music therapy|music therapy
1330056|NCT01456884|Infants|infants
1330057|NCT01456884|Children|children
1330058|NCT01456884|Adolescents|adolescents
1330059|NCT01456884|pediatric|pediatric
1330060|NCT01456884|palliative care|palliative care
1330061|NCT01456884|neurological impairment|neurological impairment
1330062|NCT01456884|metabolic condition|metabolic condition
1330063|NCT01456884|pain management|pain management
1330064|NCT01456871|Mechanoreceptors|mechanoreceptors
1330065|NCT01456871|PIP joint|pip joint
1330066|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
1330067|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
1330068|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
1330069|NCT01456845|Plasma levels|plasma levels
1330070|NCT01456845|isoniazid|isoniazid
1330071|NCT01456845|rifampicin|rifampicin
1330072|NCT01456845|pyrazinamide|pyrazinamide
1330073|NCT01456845|hepatoxicity|hepatoxicity
1330074|NCT01456832|hyponatremia|hyponatremia
1330075|NCT01456832|renal transplant|renal transplant
1330076|NCT01456819|autologous|autologous
1330077|NCT01456819|bone marrow|bone marrow
1330078|NCT01456819|critical limb ischemia|critical limb ischemia
1330079|NCT01456819|efficacy|efficacy
1330080|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
1330081|NCT01456819|mononuclear cells|mononuclear cells
1330082|NCT01456806|T2DM|t2dm
1330083|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
1330084|NCT01456806|Metabolic control|metabolic control
1330085|NCT01456806|Well-being|well-being
1330086|NCT01456806|Cost|cost
1330087|NCT01456806|Cost-consequence|cost-consequence
1330088|NCT01456793|Pregnancy prevention|pregnancy prevention
1330089|NCT01456793|Pregnancy|pregnancy
1330090|NCT01456793|Birth|birth
1330091|NCT01456793|Contraceptive use|contraceptive use
1330092|NCT01456793|Adolescents|adolescents
1330093|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
1330094|NCT01456780|Blepharitis|blepharitis
1330095|NCT01456780|Dry Eye|dry eye
1330096|NCT01456780|Ocular Inflammation|ocular inflammation
1330097|NCT01456780|MGD|mgd
1330098|NCT01456780|Zylet|zylet
1330099|NCT01456780|Lotemax|lotemax
1330100|NCT01456780|Artificial Tear|artificial tear
1330101|NCT01456754|Insulin Metabolism|insulin metabolism
1330102|NCT01456754|Glucose Metabolism|glucose metabolism
1330103|NCT01456754|Substrate Partitioning|substrate partitioning
1330104|NCT01456754|Muscle Biopsies|muscle biopsies
1330105|NCT01456754|Feeding Frequency|feeding frequency
1330106|NCT01456754|Insulin|insulin
1330107|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
1330108|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
1330109|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
1330110|NCT01456741|lung cancer|lung cancer
1330111|NCT01456728|Helicobacter pylori|helicobacter pylori
1330112|NCT01456728|Progastria|progastria
1330113|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
1330114|NCT01456728|omeprazole|omeprazole
1330115|NCT01456728|triple therapy|triple therapy
1330116|NCT01456728|probiotic|probiotic
1330117|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
1330513|NCT01454843|Astigmatism|astigmatism
1330118|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
1330119|NCT01456715|Booster dose|booster dose
1330120|NCT01456702|SVV|svv
1330121|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
1330122|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
1330123|NCT01456689|Myeloma|myeloma
1330124|NCT01456689|Multiple Myeloma|multiple myeloma
1330125|NCT01456689|MM|mm
1330126|NCT01456676|LDE225|lde225
1330127|NCT01456676|nilotinib|nilotinib
1330128|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
1330129|NCT01456676|CML|cml
1330130|NCT01456676|Philadelphia positive|philadelphia positive
1330131|NCT01456676|Ph+|ph+
1330132|NCT01456676|resistant|resistant
1330133|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
1330134|NCT01456663|AFQ056|afq056
1330135|NCT01456663|Hepatic impairment|hepatic impairment
1330136|NCT01456663|Hepatic impaired|hepatic impaired
1330137|NCT01456650|Type 2 diabetes|type 2 diabetes
1330138|NCT01456650|ABCA1 alleles|abca1 alleles
1330139|NCT01456650|Glyburide|glyburide
1330140|NCT01456637|Insomnia|insomnia
1330141|NCT01456637|Intervention|intervention
1330142|NCT01456637|Self-help|self-help
1330143|NCT01456637|Internet|internet
1330144|NCT01456598|Stomach neoplasm|stomach neoplasm
1330145|NCT01456598|Laparoscopy|laparoscopy
1330146|NCT01456585|Histological documentation|histological documentation
1330147|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
1330148|NCT01456585|surgically eligible|surgically eligible
1330149|NCT01456585|tumor resection|tumor resection
1330150|NCT01456585|curative intent|curative intent
1330151|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
1330152|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
1330153|NCT01456572|ghrelin|ghrelin
1330154|NCT01456572|stomach|stomach
1330155|NCT01456572|small intestine|small intestine
1330156|NCT01456572|gastric emptying|gastric emptying
1330157|NCT01456559|Hypovolemia|hypovolemia
1330158|NCT01456559|Lower body negative pressure|lower body negative pressure
1330159|NCT01456559|Photoplethysmography|photoplethysmography
1330160|NCT01456546|CYP2C19*17|cyp2c19*17
1330161|NCT01456546|Pharmacokinetics|pharmacokinetics
1330162|NCT01456546|Pharmacodynamics|pharmacodynamics
1330163|NCT01456533|hyponatremia|hyponatremia
1330164|NCT01456533|hypernatremia|hypernatremia
1330165|NCT01456520|pharmacokinetics|pharmacokinetics
1330166|NCT01456520|bioequivalence|bioequivalence
1330167|NCT01456520|hydrocodone|hydrocodone
1330168|NCT01456520|acetaminophen|acetaminophen
1330169|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
1330170|NCT01456507|Food effect|food effect
1330171|NCT01456507|bioavailability|bioavailability
1330172|NCT01456507|oxycodone|oxycodone
1330173|NCT01456507|sequestered Naltrexone|sequestered naltrexone
1330274|NCT01456078|Liver metastases|liver metastases
1330174|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
1330175|NCT01456494|Obstructive Lung Disease|obstructive lung disease
1330176|NCT01456494|COPD|copd
1330177|NCT01456494|Asthma|asthma
1330178|NCT01456494|Inhaler|inhaler
1330179|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
1330180|NCT01456494|Education|education
1330181|NCT01456494|Hospital-based education|hospital-based education
1330182|NCT01456481|reflex fainting|reflex fainting
1330183|NCT01456481|vasovagal syncope|vasovagal syncope
1330184|NCT01456481|midodrine|midodrine
1330185|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
1330186|NCT01456468|Tretinoin|tretinoin
1330187|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
1330188|NCT01456455|Central nervous system|central nervous system
1330189|NCT01456455|pathological markers|pathological markers
1330190|NCT01456429|invasive staging|invasive staging
1330191|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
1330192|NCT01456429|endosonography|endosonography
1330193|NCT01456429|surgical staging|surgical staging
1330194|NCT01456429|lung cancer|lung cancer
1330195|NCT01456416|RRMS|rrms
1330196|NCT01456416|Multiple Sclerosis|multiple sclerosis
1330197|NCT01456416|Glatiramer Acetate|glatiramer acetate
1330198|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
1330199|NCT01456416|Psoriasis|psoriasis
1330200|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
1330201|NCT01456416|Vasculitis|vasculitis
1330202|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
1330203|NCT01456403|Carotid|carotid
1330204|NCT01456403|endarterectomy|endarterectomy
1330205|NCT01456403|vulnerable plaque|vulnerable plaque
1330206|NCT01456403|Ultrasound|ultrasound
1330207|NCT01456403|MRI|mri
1330208|NCT01456403|PET/CT|pet/ct
1330209|NCT01456390|Open angle glaucoma|open angle glaucoma
1330210|NCT01456390|Prior trabeculectomy|prior trabeculectomy
1330211|NCT01456377|lumbar stenosis|lumbar stenosis
1330212|NCT01456377|systemic corticosteroids|systemic corticosteroids
1330213|NCT01456377|outcome|outcome
1330214|NCT01456377|security|security
1330215|NCT01456364|clopidogrel low response|clopidogrel low response
1330216|NCT01456364|ticagrelor|ticagrelor
1330217|NCT01456364|prasugrel|prasugrel
1330218|NCT01456364|platelet aggregation|platelet aggregation
1330219|NCT01456351|Event free survival|event free survival
1330220|NCT01456351|Remission rates|remission rates
1330221|NCT01456351|Toxicity|toxicity
1330222|NCT01456351|Overall survival|overall survival
1330223|NCT01456351|Efficiency costs|efficiency costs
1330224|NCT01456351|Recurrent low grade|recurrent low grade
1330225|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
1330226|NCT01456338|addiction|addiction
1330227|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
1330228|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
1330229|NCT01456312|Entecavir|entecavir
1330230|NCT01456312|Response Guided Therapy|response guided therapy
1330231|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
1330232|NCT01456299|laryngeal mask airway|laryngeal mask airway
1330233|NCT01456299|insertion|insertion
1330234|NCT01456299|sevoflurane|sevoflurane
1330235|NCT01456299|remifentanil|remifentanil
1330236|NCT01456273|biopsychosocial model|biopsychosocial model
1330237|NCT01456273|biomedical model|biomedical model
1330238|NCT01456273|functional dyspepsia|functional dyspepsia
1330239|NCT01456260|Drug Therapy|drug therapy
1330240|NCT01456247|Drug Therapy|drug therapy
1330241|NCT01456221|Obesity|obesity
1330242|NCT01456221|Insulin resistance|insulin resistance
1330243|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
1330244|NCT01456195|Drug Therapy|drug therapy
1330245|NCT01456169|High Blood Pressure|high blood pressure
1330246|NCT01456169|Drug Therapy|drug therapy
1330247|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
1330248|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
1330249|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
1330250|NCT01456143|Neoplasia|neoplasia
1330251|NCT01456143|Optical imaging|optical imaging
1330252|NCT01456143|Head and Neck Cancer|head and neck cancer
1330253|NCT01456143|Oropharynx|oropharynx
1330254|NCT01456143|Larynx|larynx
1330255|NCT01456143|Oral Cavity|oral cavity
1330256|NCT01456117|Drug Therapy|drug therapy
1330257|NCT01456117|pharmacodynamics|pharmacodynamics
1440469|NCT01002066|RDT|rdt
1330258|NCT01456117|pharmacokinetics|pharmacokinetics
1330259|NCT01456104|vaccine|vaccine
1330260|NCT01456104|stage IIB|stage iib
1330261|NCT01456104|stage IIC|stage iic
1330262|NCT01456104|stage III|stage iii
1330263|NCT01456104|stage IV (MIa)|stage iv (mia)
1330264|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
1330265|NCT01456104|Immune Responses|immune responses
1330266|NCT01456104|10-229|10-229
1330267|NCT01456091|adolescent pregnancy|adolescent pregnancy
1330268|NCT01456091|adolescent birth|adolescent birth
1330269|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
1330270|NCT01456091|rapid repeat birth|rapid repeat birth
1330271|NCT01456091|youth development|youth development
1330272|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
1330273|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
1330275|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
1330276|NCT01456078|Safety|safety
1330277|NCT01456078|Kidney dosimetry|kidney dosimetry
1330278|NCT01456078|Dose escalation|dose escalation
1330279|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
1330280|NCT01456026|Diabetes|diabetes
1330281|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
1330282|NCT01456026|Endothelium|endothelium
1330283|NCT01456000|atrial fibrillation|atrial fibrillation
1330284|NCT01456000|AF|af
1330285|NCT01456000|PAF|paf
1330286|NCT01456000|PVI|pvi
1330287|NCT01456000|ablation|ablation
1330288|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1330289|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
1330290|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
1330291|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
1330292|NCT01455987|Knee|knee
1330293|NCT01455987|Osteochondral|osteochondral
1330294|NCT01455987|Outcome|outcome
1330295|NCT01455974|hypertension|hypertension
1330296|NCT01455974|arterial stiffness|arterial stiffness
1330297|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
1330298|NCT01455961|Real life setting|real life setting
1330299|NCT01455961|Bipolar Disorder|bipolar disorder
1330300|NCT01455961|Registry based Data Base Audit|registry based data base audit
1330301|NCT01455948|sinusitis|sinusitis
1330302|NCT01455948|chronic|chronic
1330303|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
1330304|NCT01455948|balloon sinuplasty|balloon sinuplasty
1330305|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
1330306|NCT01455792|Biopsy|biopsy
1330307|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
1330308|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
1330309|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
1330310|NCT01455779|Incontinence|incontinence
1330311|NCT01455779|SUI|sui
1330312|NCT01455779|Renessa|renessa
1330313|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
1330314|NCT01455766|extravascular lung water|extravascular lung water
1330315|NCT01455753|Influenza|influenza
1330317|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1330318|NCT01455740|HIV|hiv
1330319|NCT01455740|Commitment|commitment
1330320|NCT01455740|Financial Incentives|financial incentives
1330321|NCT01455727|Pharmaceutical care|pharmaceutical care
1330322|NCT01455727|Diabetes Mellitus|diabetes mellitus
1330323|NCT01455714|hypertenion|hypertenion
1330324|NCT01455714|exertional dyspnoea|exertional dyspnoea
1330325|NCT01455714|heart failure|heart failure
1330326|NCT01455714|biomarkers|biomarkers
1330327|NCT01455688|critically ill patients|critically ill patients
1330328|NCT01455688|HIV infection|hiv infection
1330329|NCT01455688|HAART|haart
1330330|NCT01455688|mortality|mortality
1330331|NCT01455675|cystic fibrosis|cystic fibrosis
1330332|NCT01455662|cardiac arrest|cardiac arrest
1330333|NCT01455649|Kidney|kidney
1330334|NCT01455649|Transplant|transplant
1330335|NCT01455649|Immunosuppression|immunosuppression
1330336|NCT01455649|Everolimus|everolimus
1330337|NCT01455649|Graft function|graft function
1330338|NCT01455636|pediatric|pediatric
1330339|NCT01455636|micronutrient powder|micronutrient powder
1330340|NCT01455636|hand hygiene|hand hygiene
1330341|NCT01455636|low birth weight|low birth weight
1330342|NCT01455636|infant feeding|infant feeding
1330343|NCT01455636|hand sanitizers|hand sanitizers
1330344|NCT01455623|CMT|cmt
1330345|NCT01455610|Computed tomography|computed tomography
1330346|NCT01455610|Contrast enhancement|contrast enhancement
1330347|NCT01455610|Pancreas|pancreas
1330348|NCT01455610|Cancer|cancer
1330349|NCT01455610|Resectability|resectability
1330350|NCT01455597|Postmenopausal Women|postmenopausal women
1330351|NCT01455597|Vaginal Dryness|vaginal dryness
1330352|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
1330353|NCT01455584|HM781-36B|hm781-36b
1330354|NCT01455558|Pharmacokinetics|pharmacokinetics
1330355|NCT01455545|Asthma|asthma
1330356|NCT01455545|Degree of Control|degree of control
1621706|NCT00313677|GTDC2|gtdc2
1330357|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
1330358|NCT01455545|Asthma Control Test|asthma control test
1330359|NCT01455519|Low Back Pain|low back pain
1330360|NCT01455519|Back Pain|back pain
1330361|NCT01455519|Chronic back pain|chronic back pain
1330362|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1330363|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1330364|NCT01455506|Bone Marrow Transplant|bone marrow transplant
1330365|NCT01455506|Stem Cell Transplant|stem cell transplant
1330366|NCT01455480|Second Degree Burn|second degree burn
1330367|NCT01455480|partial thickness burns|partial thickness burns
1330368|NCT01455467|Open angle glaucoma|open angle glaucoma
1330369|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
1330370|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
1330371|NCT01455441|GLP-1|glp-1
1330372|NCT01455441|Training|training
1330373|NCT01455441|Exercise|exercise
1330374|NCT01455441|Type 2 Diabetes|type 2 diabetes
1330375|NCT01455428|Pregabalin|pregabalin
1330376|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
1330377|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
1330378|NCT01455389|Lung Cancer|lung cancer
1330379|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
1330380|NCT01455389|NSCLC|nsclc
1330381|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
1330382|NCT01455389|DOTAP:Chol-fus1|dotap:chol-fus1
1330383|NCT01455389|DOTAP:Cholesterol-Fus1 Liposome Complex|dotap:cholesterol-fus1 liposome complex
1330384|NCT01455389|Erlotinib|erlotinib
1330385|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
1330386|NCT01455389|OSI-774|osi-774
1330387|NCT01455389|Tarceva|tarceva
1330388|NCT01455389|Dexamethasone|dexamethasone
1330389|NCT01455389|Decadron|decadron
1330390|NCT01455389|Diphenhydramine|diphenhydramine
1330391|NCT01455389|Benadryl|benadryl
1330392|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
1330393|NCT01455389|PK|pk
1330394|NCT01455376|brain injury|brain injury
1330395|NCT01455376|cognitive function|cognitive function
1330396|NCT01455376|sodium lactate|sodium lactate
1330397|NCT01455376|MMSE score|mmse score
1330398|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
1330399|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
1330400|NCT01455350|lidocaine|lidocaine
1330401|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
1330402|NCT01455324|prosthetic socket|prosthetic socket
1330403|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
1330404|NCT01455324|conformable socket liner|conformable socket liner
1330405|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
1330406|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
1330407|NCT01455311|gastrointestinal|gastrointestinal
1330408|NCT01455311|GI|gi
1330409|NCT01455311|EUS-FNA|eus-fna
1330410|NCT01455311|EchoBrush®|echobrush®
1330411|NCT01455311|cytology brush|cytology brush
1330412|NCT01455311|endoscopic|endoscopic
1330413|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
1330414|NCT01455298|liver injury|liver injury
1330514|NCT01454843|Aberrations|aberrations
1330415|NCT01455298|Transient Elastography|transient elastography
1330416|NCT01455298|FibroTest|fibrotest
1330417|NCT01455285|dysmenorrhea|dysmenorrhea
1330418|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
1330419|NCT01455285|analgesia|analgesia
1330420|NCT01455285|pain visual analog scale|pain visual analog scale
1330421|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
1330422|NCT01455259|AdCD40L|adcd40l
1330423|NCT01455259|Adenoviral vector|adenoviral vector
1330424|NCT01455259|CD40L|cd40l
1330425|NCT01455259|CD154|cd154
1330426|NCT01455259|malignant melanoma|malignant melanoma
1330427|NCT01455246|Cirrhosis|cirrhosis
1330428|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
1330429|NCT01455246|Ascites|ascites
1330430|NCT01455246|Daptomycin|daptomycin
1330431|NCT01455246|Meropenem|meropenem
1330432|NCT01455246|Ceftazidime|ceftazidime
1330433|NCT01455246|Nosocomial infection|nosocomial infection
1330434|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
1330435|NCT01455246|Sepsis|sepsis
1330436|NCT01455246|Albumin|albumin
1330437|NCT01455233|cornea|cornea
1330438|NCT01455233|ocular antibiotic|ocular antibiotic
1330439|NCT01455233|cataract surgery|cataract surgery
1330440|NCT01455220|Multiple Sclerosis|multiple sclerosis
1330441|NCT01455220|Sexual Dysfunction|sexual dysfunction
1330442|NCT01455220|Quality of Life|quality of life
1330443|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
1330444|NCT01455207|Positon Emission Tomography|positon emission tomography
1330445|NCT01455207|Behavior|behavior
1330446|NCT01455194|ciclesonide|ciclesonide
1330447|NCT01455194|asthma|asthma
1330448|NCT01455181|Hypoparathyroidism|hypoparathyroidism
1330449|NCT01455181|NPSP558|npsp558
1330450|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
1330451|NCT01455181|PTH 1-84|pth 1-84
1330452|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
1440708|NCT01000987|alcohol|alcohol
1330453|NCT01455168|capsular tension ring|capsular tension ring
1330454|NCT01455168|exfoliation syndrome|exfoliation syndrome
1330455|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
1330456|NCT01455155|stroke|stroke
1330457|NCT01455155|Art therapy|art therapy
1330458|NCT01455155|Music therapy|music therapy
1330459|NCT01455155|Creative therapy|creative therapy
1330460|NCT01455155|Efficacy|efficacy
1330461|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1330462|NCT01455129|COPD|copd
1330463|NCT01455129|COPD exacerbation|copd exacerbation
1330464|NCT01455129|treatment|treatment
1330465|NCT01455129|tiotropium|tiotropium
1330466|NCT01455129|anticholinergic|anticholinergic
1330467|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
1330468|NCT01455116|Sepsis|sepsis
1330469|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
1330470|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
1330471|NCT01455077|obesity|obesity
1330472|NCT01455077|sleep apnea|sleep apnea
1330473|NCT01455077|portable monitoring|portable monitoring
1330474|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
1330475|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
1330476|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
1330477|NCT01455012|Rotigotine|rotigotine
1330478|NCT01455012|Neupro|neupro
1330479|NCT01455012|RLS|rls
1330480|NCT01455012|Cardiovascular Risk|cardiovascular risk
1330481|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
1330482|NCT01454999|veteran|veteran
1330483|NCT01454999|smoking|smoking
1330484|NCT01454999|stage of change|stage of change
1330485|NCT01454999|cell phone|cell phone
1330486|NCT01454999|computerized tailored intervention|computerized tailored intervention
1330487|NCT01454986|Healthy subjects|healthy subjects
1330488|NCT01454973|type 2 diabetes|type 2 diabetes
1330489|NCT01454973|beta cell function|beta cell function
1330490|NCT01454973|meal tolerance test|meal tolerance test
1330491|NCT01454973|maximum stimulation test|maximum stimulation test
1330492|NCT01454973|method standardization|method standardization
1330493|NCT01454973|insulin secretion|insulin secretion
1330494|NCT01454960|Antibiotics|antibiotics
1330495|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
1330496|NCT01454960|Respiratory Tract Infections|respiratory tract infections
1330497|NCT01454960|Behavioral Research|behavioral research
1330498|NCT01454947|Antibiotics|antibiotics
1330499|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
1330500|NCT01454947|Respiratory Tract Infections|respiratory tract infections
1330501|NCT01454947|Behavioral Research|behavioral research
1330502|NCT01454921|HIV|hiv
1330503|NCT01454921|Adolescent Trials Network|adolescent trials network
1330504|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
1330505|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
1330506|NCT01454895|prevention|prevention
1330507|NCT01454895|farmers|farmers
1330508|NCT01454882|Direct calorimetry|direct calorimetry
1330509|NCT01454882|Indirect calorimetry|indirect calorimetry
1330510|NCT01454882|Energy Expenditure|energy expenditure
1330511|NCT01454869|heparin|heparin
1330512|NCT01454843|Myopia|myopia
1330515|NCT01454843|Wavefront|wavefront
1330516|NCT01454843|LASIK|lasik
1330517|NCT01454843|Wavefront LASIK|wavefront lasik
1330518|NCT01454830|Social support|social support
1330519|NCT01454830|Cognition|cognition
1330520|NCT01454830|Adaptation, psychological|adaptation, psychological
1330521|NCT01454830|Health behavior|health behavior
1330522|NCT01454830|Patient education|patient education
1330523|NCT01454817|Quality of Life|quality of life
1330524|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
1330525|NCT01454817|ICDs|icds
1330526|NCT01454804|Advanced Cancers|advanced cancers
1330527|NCT01454804|Solid Tumors|solid tumors
1330528|NCT01454804|Pazopanib|pazopanib
1330529|NCT01454804|GW786034|gw786034
1330530|NCT01454804|Lapatinib|lapatinib
1330531|NCT01454804|Tykerb|tykerb
1330532|NCT01454804|GW572016|gw572016
1330533|NCT01454804|Trastuzumab|trastuzumab
1330534|NCT01454804|Herceptin|herceptin
1330535|NCT01454791|multiple sclerosis|multiple sclerosis
1330536|NCT01454791|diclofenac|diclofenac
1330537|NCT01454791|subcutaneous injection|subcutaneous injection
1330538|NCT01454791|glatiramer acetate|glatiramer acetate
1330539|NCT01454791|Copaxone|copaxone
1330540|NCT01454778|restenosis|restenosis
1330541|NCT01454778|peripheral vascular disease|peripheral vascular disease
1330542|NCT01454778|lower extremity ischemia|lower extremity ischemia
1330543|NCT01454778|claudication|claudication
1330544|NCT01454752|malaria|malaria
1330545|NCT01454752|anaemia|anaemia
1330546|NCT01454752|cognition|cognition
1330547|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
1330548|NCT01454752|children|children
1330549|NCT01454752|schools|schools
1330550|NCT01454752|insecticide-treated nets|insecticide-treated nets
1330551|NCT01454739|rFVIIIFc|rfviiifc
1330552|NCT01454739|A-LONG Extension|a-long extension
1330553|NCT01454726|Dizziness|dizziness
1330554|NCT01454726|Meniere's disease|meniere's disease
1330555|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
1330556|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
1330557|NCT01454700|Albuminuria|albuminuria
1330558|NCT01454700|Late diabetes complications|late diabetes complications
1330559|NCT01454700|CSII|csii
1330560|NCT01454700|CGM|cgm
1330561|NCT01454700|Glycaemic control|glycaemic control
1330562|NCT01454661|Probiotics|probiotics
1330563|NCT01454661|Premature infant|premature infant
1330564|NCT01454661|Intestinal microbiota|intestinal microbiota
1330565|NCT01454661|Intestinal immunity|intestinal immunity
1330566|NCT01454661|Breastfeeding|breastfeeding
1330567|NCT01454648|Traumatic Brain Injury|traumatic brain injury
1330568|NCT01454648|EMS|ems
1330569|NCT01454648|Out-of-Hospital|out-of-hospital
1330570|NCT01454635|depression|depression
1330571|NCT01454635|treatment response|treatment response
1330572|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1330573|NCT01454622|Healthy Volunteers|healthy volunteers
1330574|NCT01454622|Bioequivalence|bioequivalence
1330872|NCT01453283|DNA Repair|dna repair
1330575|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1330576|NCT01454622|Metformin IR|metformin ir
1330577|NCT01454609|cervical plexus block|cervical plexus block
1330578|NCT01454609|thyroidectomy|thyroidectomy
1330579|NCT01454609|postoperative analgesia|postoperative analgesia
1330580|NCT01454596|Cell Therapy|cell therapy
1330581|NCT01454596|Gene Therapy|gene therapy
1330582|NCT01454596|Immunotherapy|immunotherapy
1330583|NCT01454596|Brain Cancer|brain cancer
1330584|NCT01454596|Glioma|glioma
1330585|NCT01454596|Glioblastoma|glioblastoma
1330586|NCT01454583|renin inhibitor|renin inhibitor
1330587|NCT01454583|ACE inhibitor|ace inhibitor
1330588|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
1330589|NCT01454583|RAS blockade|ras blockade
1330590|NCT01454570|exoskeleton walking system|exoskeleton walking system
1330591|NCT01454570|paraplegia|paraplegia
1330592|NCT01454570|paralysis|paralysis
1330593|NCT01454557|Acquired Brain Injury|acquired brain injury
1330594|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
1330595|NCT01454557|Auditory Stimuli|auditory stimuli
1330596|NCT01454557|Physical Activity|physical activity
1330597|NCT01454518|hip arthroscopy|hip arthroscopy
1330598|NCT01454518|post operative analgesia|post operative analgesia
1330599|NCT01454505|Healthy subjects|healthy subjects
1330600|NCT01454505|Nasal allergies|nasal allergies
1330601|NCT01454505|Allergies|allergies
1330602|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
1330603|NCT01454505|EEC|eec
1330604|NCT01454505|Ragweed|ragweed
1330605|NCT01454492|Allergy rhinitis|allergy rhinitis
1330606|NCT01454492|Geographic tongue|geographic tongue
1330607|NCT01454479|Lapatinib|lapatinib
1330608|NCT01454479|Ixabepilone|ixabepilone
1330609|NCT01454479|HER-2|her-2
1330610|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
1330611|NCT01454466|prevention|prevention
1330612|NCT01454466|retinal break|retinal break
1330613|NCT01454466|vitrectomy|vitrectomy
1330614|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
1330615|NCT01454453|amisulpride|amisulpride
1330616|NCT01454453|receptor occupancy|receptor occupancy
1330617|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
1330618|NCT01454440|Coronary artery disease|coronary artery disease
1330619|NCT01454440|Eptifibatide|eptifibatide
1330620|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
1330621|NCT01454440|stable coronary artery disease|stable coronary artery disease
1330622|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1330623|NCT01454440|DES|des
1330624|NCT01454375|Smoking|smoking
1330625|NCT01454362|nicotine|nicotine
1330626|NCT01454362|inhalator|inhalator
1330627|NCT01454362|electronic cigarette|electronic cigarette
1330628|NCT01454362|tobacco|tobacco
1330629|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
1330630|NCT01454349|BPH|bph
1330631|NCT01454349|Enlarged prostate|enlarged prostate
1330632|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1330633|NCT01454336|MSCs|mscs
1330634|NCT01454336|Pioglitazon|pioglitazon
1330635|NCT01454336|fibrosis|fibrosis
1330636|NCT01454336|liver|liver
1330637|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
1330638|NCT01454323|Cell therapy|cell therapy
1330639|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
1330640|NCT01454310|Skin substitutes|skin substitutes
1330641|NCT01454310|Split-thickness skin graft|split-thickness skin graft
1330642|NCT01454310|Burn wound|burn wound
1330643|NCT01454310|Scar formation|scar formation
1330644|NCT01454310|Skin quality|skin quality
1330645|NCT01454297|Myeloma|myeloma
1330646|NCT01454297|Multiple Myeloma|multiple myeloma
1330647|NCT01454297|Observational|observational
1330648|NCT01454297|Longitudinal|longitudinal
1621707|NCT00313677|TMEM5|tmem5
1330649|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
1330650|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
1330651|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
1330652|NCT01454245|39439335EDI1013|39439335edi1013
1330653|NCT01454245|Bioavailability|bioavailability
1330654|NCT01454245|Pharmacokinetics|pharmacokinetics
1330655|NCT01454232|Obesity|obesity
1330656|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
1330657|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
1330658|NCT01454232|gut microbiota|gut microbiota
1330659|NCT01454232|Bariatric surgery|bariatric surgery
1330660|NCT01454206|cannabis abuse|cannabis abuse
1330661|NCT01454206|alcohol abuse|alcohol abuse
1330662|NCT01454206|substance abuse|substance abuse
1330663|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
1330664|NCT01454167|vacum drains|vacum drains
1330665|NCT01454167|operational wounds|operational wounds
1330666|NCT01454167|infections|infections
1330667|NCT01454167|seroma|seroma
1330668|NCT01454167|acid base|acid base
1330669|NCT01454167|glucose|glucose
1330670|NCT01454167|lactate|lactate
1330671|NCT01454154|TBI|tbi
1330672|NCT01454154|Traumatic Brain Injury|traumatic brain injury
1330673|NCT01454141|Depressed mood|depressed mood
1330674|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
1330969|NCT01452958|Endotoxin|endotoxin
1330675|NCT01454128|heart failure|heart failure
1330676|NCT01454128|periodic breathing|periodic breathing
1330677|NCT01454128|aerobic fitness|aerobic fitness
1330678|NCT01454089|bladder|bladder
1330679|NCT01454089|urinary tract|urinary tract
1330680|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
1330681|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
1330682|NCT01454089|chemotherapy|chemotherapy
1330683|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
1330684|NCT01454076|AUC0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration|auc0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration
1330685|NCT01454063|cataract|cataract
1330686|NCT01454063|lens replacement|lens replacement
1330687|NCT01454050|ICD therapy|icd therapy
1330688|NCT01454050|RV/LV Capture Control|rv/lv capture control
1330689|NCT01454050|Safety and Efficacy|safety and efficacy
1330690|NCT01454011|hypogonadism|hypogonadism
1330691|NCT01454011|testosterone|testosterone
1330692|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
1330693|NCT01454011|hsCRP|hscrp
1330694|NCT01454011|HOMA-IR|homa-ir
1330695|NCT01453972|Exercise|exercise
1330696|NCT01453972|High-intensity|high-intensity
1330697|NCT01453972|Interval training|interval training
1330698|NCT01453959|hypertension|hypertension
1330699|NCT01453959|salt sensitivity|salt sensitivity
1330700|NCT01453959|fludrocortisone|fludrocortisone
1330701|NCT01453946|Crohn's Disease|crohn's disease
1330702|NCT01453933|Anti-HIV Agents|anti-hiv agents
1330703|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
1330704|NCT01453933|Antiviral Agents|antiviral agents
1330705|NCT01453933|Anti-Infective Agents|anti-infective agents
1330706|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
1330707|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
1330708|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
1330709|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
1330710|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
1330711|NCT01453881|Asthma|asthma
1330712|NCT01453881|pMDI|pmdi
1330713|NCT01453881|Beclomethasone|beclomethasone
1330714|NCT01453881|Formoterol|formoterol
1330715|NCT01453881|Efficacy|efficacy
1330716|NCT01453868|Multiple Sclerosis|multiple sclerosis
1330717|NCT01453868|non impact aerobics|non impact aerobics
1330718|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
1330719|NCT01453855|Ocular Hypertension|ocular hypertension
1330720|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
1330721|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
1330722|NCT01453842|Glucagon|glucagon
1330723|NCT01453842|Peptide PYY|peptide pyy
1330724|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
1330725|NCT01453816|Renal insufficiency|renal insufficiency
1330726|NCT01453816|kidney failure|kidney failure
1330727|NCT01453803|Liposuction|liposuction
1330728|NCT01453803|ADSC|adsc
1330729|NCT01453803|ASC|asc
1330730|NCT01453803|stem cell|stem cell
1330731|NCT01453803|Parkinson's Disease|parkinson's disease
1330732|NCT01453803|Parkinson's|parkinson's
1330733|NCT01453803|therapy|therapy
1330734|NCT01453790|depression|depression
1330735|NCT01453790|treatment|treatment
1330736|NCT01453790|motivation to seek follow up|motivation to seek follow up
1330737|NCT01453777|diffuse brain lesion|diffuse brain lesion
1330738|NCT01453751|Diabetes|diabetes
1330739|NCT01453751|Type 2 Diabetes|type 2 diabetes
1330740|NCT01453738|Osteoarthritis|osteoarthritis
1330741|NCT01453738|Knee|knee
1330742|NCT01453738|Stem cells|stem cells
1330743|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
1330744|NCT01453712|coronary artery disease|coronary artery disease
1621708|NCT00313677|Fukutin|fukutin
1330745|NCT01453712|coronary CT angiography|coronary ct angiography
1330746|NCT01453712|radiation dose|radiation dose
1330747|NCT01453712|iterative image reconstruction|iterative image reconstruction
1330748|NCT01453712|detection|detection
1330749|NCT01453699|Bereavement|bereavement
1330750|NCT01453699|early parental death|early parental death
1330751|NCT01453699|grief|grief
1330752|NCT01453699|affective disorders|affective disorders
1330753|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
1330754|NCT01453699|socioeconomic factors|socioeconomic factors
1330755|NCT01453699|suicide|suicide
1330756|NCT01453699|attempted suicide|attempted suicide
1330757|NCT01453699|antidepressive agents|antidepressive agents
1330758|NCT01453699|cardiovascular diseases|cardiovascular diseases
1330759|NCT01453699|quality of life|quality of life
1330760|NCT01453699|Long-term health effects|long-term health effects
1330761|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
1330762|NCT01453699|Psychosocial well-being|psychosocial well-being
1330763|NCT01453686|Alopecia Areata|alopecia areata
1330764|NCT01453686|Hydrocortisone|hydrocortisone
1330765|NCT01453686|Clobetasol Propionate|clobetasol propionate
1330766|NCT01453686|Randomized Controlled Trial|randomized controlled trial
1330767|NCT01453673|knee|knee
1330768|NCT01453673|Cruciate Ligament|cruciate ligament
1330769|NCT01453673|Meniscus|meniscus
1330770|NCT01453660|Endothelial Function|endothelial function
1330771|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
1330772|NCT01453660|11-140|11-140
1330773|NCT01453647|Fibromyalgia|fibromyalgia
1330774|NCT01453647|self-efficacy|self-efficacy
1330775|NCT01453647|fatigue|fatigue
1330776|NCT01453647|stress|stress
1330777|NCT01453647|cytokine|cytokine
1330778|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
1330779|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1330780|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
1330781|NCT01453621|prediction rules|prediction rules
1330782|NCT01453621|computerized clinical decision support|computerized clinical decision support
1330783|NCT01453621|traumatic brain injury|traumatic brain injury
1330784|NCT01453621|blunt head trauma|blunt head trauma
1330785|NCT01453595|Kidney|kidney
1330786|NCT01453595|renal cell carcinoma|renal cell carcinoma
1330787|NCT01453595|BEZ235|bez235
1330788|NCT01453595|11-080|11-080
1330789|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
1330790|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
1330791|NCT01453556|Laparoscopic surgery|laparoscopic surgery
1330792|NCT01453556|Right colectomy|right colectomy
1330793|NCT01453556|Mechanical anastomosis|mechanical anastomosis
1330794|NCT01453556|Post-operative ileum|post-operative ileum
1330795|NCT01453530|Recovery|recovery
1330796|NCT01453530|Street fitness|street fitness
1330797|NCT01453530|Sugammadex|sugammadex
1330798|NCT01453530|Alertness|alertness
1330799|NCT01453530|Ambulatory surgery|ambulatory surgery
1330800|NCT01453517|bariatric|bariatric
1330801|NCT01453517|obesity|obesity
1330802|NCT01453517|post-surgery|post-surgery
1330803|NCT01453517|intervention|intervention
1330804|NCT01453465|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1330805|NCT01453465|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1330806|NCT01453452|weight changes|weight changes
1330807|NCT01453452|fatigue|fatigue
1330808|NCT01453452|depression|depression
1330809|NCT01453452|anxiety disorder|anxiety disorder
1330810|NCT01453452|pain|pain
1330811|NCT01453452|cognitive/functional effects|cognitive/functional effects
1330812|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1330813|NCT01453452|cancer survivor|cancer survivor
1330814|NCT01453452|stage IA breast cancer|stage ia breast cancer
1330815|NCT01453452|stage IB breast cancer|stage ib breast cancer
1330816|NCT01453452|stage II breast cancer|stage ii breast cancer
1330817|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
1330818|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
1330819|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
1330820|NCT01453452|stage I colon cancer|stage i colon cancer
1330821|NCT01453452|stage IIA colon cancer|stage iia colon cancer
1330822|NCT01453452|stage IIB colon cancer|stage iib colon cancer
1330823|NCT01453452|stage IIC colon cancer|stage iic colon cancer
1330824|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
1330825|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
1330826|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
1330827|NCT01453452|stage I rectal cancer|stage i rectal cancer
1330828|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
1330829|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
1330830|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
1330831|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
1330832|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
1330833|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
1330834|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
1330835|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
1330836|NCT01453439|Body image|body image
1330837|NCT01453439|Appearance concerns|appearance concerns
1441196|NCT00999167|HE|he
1330838|NCT01453400|aspirin|aspirin
1330839|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
1330840|NCT01453400|pharyngitis|pharyngitis
1330841|NCT01453400|sore throat|sore throat
1330842|NCT01453387|MEK inhibitor|mek inhibitor
1330843|NCT01453387|Solid Tumor|solid tumor
1330844|NCT01453387|Phase I|phase i
1330845|NCT01453374|opioid dependence|opioid dependence
1330846|NCT01453374|VIVITROL|vivitrol
1330847|NCT01453374|criminal justice|criminal justice
1330848|NCT01453361|FANG|fang
1330849|NCT01453361|Melanoma|melanoma
1330850|NCT01453361|Vigil|vigil
1330851|NCT01453348|meningococcal|meningococcal
1330852|NCT01453348|conjugate|conjugate
1330853|NCT01453348|vaccine|vaccine
1330854|NCT01453348|adults|adults
1330855|NCT01453335|Veins|veins
1330856|NCT01453335|Catheter Segments|catheter segments
1330857|NCT01453335|Vascular Access|vascular access
1330858|NCT01453335|VeinViewer Vision|veinviewer vision
1330859|NCT01453322|Veins|veins
1330860|NCT01453322|Vascular Access|vascular access
1330861|NCT01453322|IV complications|iv complications
1330862|NCT01453322|VeinViewer Vision|veinviewer vision
1330863|NCT01453309|lumbar fusion|lumbar fusion
1330864|NCT01453309|transfusion|transfusion
1330865|NCT01453309|cell-saver|cell-saver
1330866|NCT01453309|cost-effectiveness|cost-effectiveness
1330867|NCT01453296|Asthma|asthma
1330868|NCT01453296|Tolerability|tolerability
1330869|NCT01453296|Safety|safety
1330870|NCT01453296|Pharmacokinetics|pharmacokinetics
1330871|NCT01453296|GW642444|gw642444
1330873|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
1330874|NCT01453283|Trabectedine|trabectedine
1330875|NCT01453283|Phase I|phase i
1330876|NCT01453283|Sarcoma|sarcoma
1330877|NCT01453283|Cytotoxic|cytotoxic
1330878|NCT01453283|Chemotherapy|chemotherapy
1330879|NCT01453283|Solid Tumor|solid tumor
1330880|NCT01453283|Malignant Tumor|malignant tumor
1330881|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
1330882|NCT01453283|Ewing Sarcoma|ewing sarcoma
1330883|NCT01453283|Neuroblastoma|neuroblastoma
1330884|NCT01453283|Wilm's Tumor|wilm's tumor
1330885|NCT01453283|Hepatic Tumor|hepatic tumor
1330886|NCT01453283|Brain Tumor|brain tumor
1330887|NCT01453270|Sepsis|sepsis
1330888|NCT01453270|Emergency medicine|emergency medicine
1330889|NCT01453270|Cardiac output|cardiac output
1330890|NCT01453270|Stroke volume|stroke volume
1330891|NCT01453270|Lactate|lactate
1330892|NCT01453257|Molecular Targets|molecular targets
1330893|NCT01453257|Personalize Treatment|personalize treatment
1330894|NCT01453257|Colon Cancer|colon cancer
1330895|NCT01453257|Complete Response Rate|complete response rate
1330896|NCT01453244|Chronic hepatitis C|chronic hepatitis c
1330897|NCT01453244|Pharmacogenomics|pharmacogenomics
1330898|NCT01453244|IL28B|il28b
1330899|NCT01453244|ITPA|itpa
1330900|NCT01453231|bariatric surgery|bariatric surgery
1330901|NCT01453231|plastic surgery|plastic surgery
1330902|NCT01453231|thigh|thigh
1330903|NCT01453231|obesity|obesity
1330904|NCT01453231|body image|body image
1330905|NCT01453231|quality of life|quality of life
1330906|NCT01453218|Renal insufficiency|renal insufficiency
1330907|NCT01453218|Liver transplant|liver transplant
1330908|NCT01453218|Acute rejection|acute rejection
1330909|NCT01453218|Infections|infections
1330910|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
1331006|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
1331007|NCT01452802|HeartMate II|heartmate ii
1331008|NCT01452802|heart-assist device|heart-assist device
1331712|NCT01449994|activator|activator
1330911|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
1330912|NCT01453192|Raltegravir|raltegravir
1330913|NCT01453192|Renal transplantation|renal transplantation
1330914|NCT01453192|HIV-1|hiv-1
1330915|NCT01453192|Acute renal graft rejection|acute renal graft rejection
1330916|NCT01453179|actinic keratosis|actinic keratosis
1330917|NCT01453179|invasive SCC|invasive scc
1330918|NCT01453179|in situ SCC|in situ scc
1330919|NCT01453179|histological classification|histological classification
1330920|NCT01453179|histological progression|histological progression
1330921|NCT01453179|clinical clearance|clinical clearance
1330922|NCT01453179|cryotherapy|cryotherapy
1330923|NCT01453153|pancreatic|pancreatic
1330924|NCT01453153|Cancer|cancer
1330925|NCT01453153|Stage IV|stage iv
1330926|NCT01453153|untreated|untreated
1330927|NCT01453127|dementia|dementia
1330928|NCT01453127|parkinsonism|parkinsonism
1330929|NCT01453127|mild cognitive impairment|mild cognitive impairment
1330930|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
1330931|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
1330932|NCT01453114|CBT|cbt
1330933|NCT01453114|relapse|relapse
1330934|NCT01453114|postpartum depression|postpartum depression
1330935|NCT01453114|depression recurrence|depression recurrence
1330936|NCT01453114|depression relapse|depression relapse
1330937|NCT01453101|Multiple Myeloma|multiple myeloma
1330938|NCT01453101|Transplant|transplant
1330939|NCT01453088|multiple myeloma|multiple myeloma
1330940|NCT01453088|transplant|transplant
1330941|NCT01453075|hepatitis C|hepatitis c
1330942|NCT01453075|herpes simplex type 2|herpes simplex type 2
1330943|NCT01453075|veterans|veterans
1330944|NCT01453062|Ofatumumab|ofatumumab
1330945|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1330946|NCT01453062|Arzerra|arzerra
1330947|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
1330948|NCT01453036|Peptic ulcer|peptic ulcer
1330949|NCT01453036|Helicobacter pylori|helicobacter pylori
1330950|NCT01453036|Clarithromycin|clarithromycin
1330951|NCT01453036|23S rRNA|23s rrna
1330952|NCT01453036|Resistance|resistance
1330953|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
1330954|NCT01453010|SaeboFlex|saeboflex
1330955|NCT01453010|Stroke rehabilitation|stroke rehabilitation
1330956|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
1330957|NCT01453010|Acute Stroke|acute stroke
1330958|NCT01452997|mosquito|mosquito
1330959|NCT01452997|allergy|allergy
1330960|NCT01452997|bite|bite
1330961|NCT01452997|ant-inflammatory|ant-inflammatory
1330962|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
1330963|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
1330964|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
1330965|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
1330966|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
1330967|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
1330968|NCT01452971|lung cancer|lung cancer
1330971|NCT01452958|TNF-α|tnf-α
1330972|NCT01452958|insulin resistance|insulin resistance
1330973|NCT01452958|metabolism|metabolism
1330974|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1330975|NCT01452932|Dyspnea|dyspnea
1330976|NCT01452932|Exercise test|exercise test
1330977|NCT01452932|Endurance training|endurance training
1330978|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
1330979|NCT01452906|Drug-drug interaction|drug-drug interaction
1330980|NCT01452906|Pharmacokinetics|pharmacokinetics
1330981|NCT01452906|PA21|pa21
1330982|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
1330983|NCT01452880|Remifentanil|remifentanil
1330984|NCT01452880|Lithotripsy|lithotripsy
1330985|NCT01452880|Conscious Sedation|conscious sedation
1330986|NCT01452867|Airway|airway
1330987|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
1330988|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
1330989|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
1330990|NCT01452854|LGG|lgg
1330991|NCT01452854|Temozolomide|temozolomide
1330992|NCT01452854|Temodar|temodar
1330993|NCT01452854|Ovarian Aging|ovarian aging
1330994|NCT01452854|Infertility|infertility
1330995|NCT01452854|Chemotherapy|chemotherapy
1330996|NCT01452841|grapefruit|grapefruit
1330997|NCT01452841|weight loss|weight loss
1330998|NCT01452841|blood pressure|blood pressure
1330999|NCT01452841|lipids|lipids
1331000|NCT01452841|inflammation|inflammation
1331001|NCT01452828|Renal Impairment|renal impairment
1331002|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
1331003|NCT01452815|delayed gastric emptying|delayed gastric emptying
1331004|NCT01452815|gastroparesis|gastroparesis
1331005|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
1331009|NCT01452802|medical management|medical management
1331010|NCT01452802|optimal medical management|optimal medical management
1331011|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
1331012|NCT01452802|Thoratec Corporation|thoratec corporation
1331013|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
1331014|NCT01452789|buprenorphine|buprenorphine
1331015|NCT01452789|morphine|morphine
1331016|NCT01452789|pharmacokinetics|pharmacokinetics
1331017|NCT01452776|Drug Therapy|drug therapy
1331018|NCT01452763|Drug Therapy|drug therapy
1331019|NCT01452750|Drug Therapy|drug therapy
1331020|NCT01452737|colonoscopy|colonoscopy
1331021|NCT01452737|bowel preparation|bowel preparation
1331022|NCT01452737|Golytely|golytely
1331023|NCT01452724|Drug Therapy|drug therapy
1331024|NCT01452711|Drug Therapy|drug therapy
1331025|NCT01452698|Drug Therapy|drug therapy
1331026|NCT01452685|Drug Therapy|drug therapy
1331027|NCT01452672|Breast cancer|breast cancer
1331028|NCT01452672|Radiotherapy|radiotherapy
1331029|NCT01452672|Post-mastectomy|post-mastectomy
1331030|NCT01452672|Molecular characterization|molecular characterization
1331031|NCT01452659|Drug Therapy|drug therapy
1331032|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
1331033|NCT01452646|risk-adapted therapy|risk-adapted therapy
1331034|NCT01452646|MRD-directed therapy|mrd-directed therapy
1331035|NCT01452646|young adults|young adults
1331036|NCT01452633|pain|pain
1331037|NCT01452633|laparoscopy|laparoscopy
1331038|NCT01452633|reduction|reduction
1331039|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
1331040|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
1331041|NCT01452607|Ebselen|ebselen
1331042|NCT01452581|Transfusion|transfusion
1331043|NCT01452581|Red blood cells|red blood cells
1331044|NCT01452581|Postoperative|postoperative
1331045|NCT01452581|Dizziness|dizziness
1331046|NCT01452581|Hip Arthroplasty|hip arthroplasty
1331047|NCT01452568|Thromboembolic complications|thromboembolic complications
1331048|NCT01452568|Bleeding complications|bleeding complications
1331049|NCT01452568|Haemorrhagic complications|haemorrhagic complications
1331050|NCT01452568|Anticoagulant therapy|anticoagulant therapy
1331051|NCT01452568|Aspirin|aspirin
1331052|NCT01452568|biological Aorta Valve|biological aorta valve
1331053|NCT01452555|HIV|hiv
1331054|NCT01452555|HIV Prevention|hiv prevention
1331055|NCT01452555|HIV testing|hiv testing
1331056|NCT01452555|HIV Rapid Test|hiv rapid test
1331057|NCT01452542|Genz-112638|genz-112638
1331058|NCT01452529|Pain|pain
1331059|NCT01452529|Opioid|opioid
1331060|NCT01452516|PLF|plf
1331061|NCT01452516|lumbar fusion|lumbar fusion
1331062|NCT01452516|bone graft|bone graft
1331063|NCT01452516|biologics|biologics
1331064|NCT01452503|AE adverse event|ae adverse event
1331065|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1331066|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1331067|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
1331068|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1331164|NCT01452204|impingement|impingement
1331069|NCT01452503|DCF data collection forms|dcf data collection forms
1331070|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
1331071|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1331072|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1331073|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1331074|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
1331075|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
1331076|NCT01452503|IRB Institutional Review Board|irb institutional review board
1331077|NCT01452503|IU International units|iu international units
1331078|NCT01452503|mg milligram(s)|mg milligram(s)
1331079|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1331080|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
1331081|NCT01452503|SAE serious adverse event|sae serious adverse event
1331082|NCT01452503|µg microgram|µg microgram
1331083|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
1331084|NCT01452503|WB Western Blot|wb western blot
1331085|NCT01452490|Onychomycosis|onychomycosis
1331086|NCT01452490|Toenail Fungus|toenail fungus
1331087|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
1331088|NCT01452477|Cryptotanshinone|cryptotanshinone
1331089|NCT01452464|observational|observational
1331090|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
1331091|NCT01452464|meningococcal meningitis|meningococcal meningitis
1331092|NCT01452464|meningococcal vaccines|meningococcal vaccines
1331094|NCT01452464|MenACYW-CRM|menacyw-crm
1331095|NCT01452464|post-marketing|post-marketing
1331096|NCT01452464|adolescents|adolescents
1331097|NCT01452438|observational|observational
1331098|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
1331099|NCT01452438|meningococcal meningitis|meningococcal meningitis
1331100|NCT01452438|meningococcal vaccines|meningococcal vaccines
1331101|NCT01452438|safety|safety
1331102|NCT01452438|MenACYW-CRM|menacyw-crm
1331510|NCT01450865|flupirtine|flupirtine
1331103|NCT01452438|post-marketing|post-marketing
1331104|NCT01452438|children|children
1331105|NCT01452425|Human volunteers|human volunteers
1331106|NCT01452412|Alkali|alkali
1331107|NCT01452412|Sodium bicarbonate|sodium bicarbonate
1331108|NCT01452412|Kidney disease|kidney disease
1331109|NCT01452412|Acidosis|acidosis
1331110|NCT01452386|Constipation|constipation
1331111|NCT01452386|Stimulation Treatment|stimulation treatment
1331112|NCT01452373|Hot flush(es)|hot flush(es)
1331113|NCT01452373|Hot flash(es)|hot flash(es)
1331114|NCT01452373|Vasomotor symptoms|vasomotor symptoms
1331115|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
1331116|NCT01452373|Prasterone|prasterone
1331117|NCT01452373|Acolbifene|acolbifene
1331118|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
1331119|NCT01452373|Antiestrogen|antiestrogen
1331120|NCT01452373|Menopause|menopause
1331121|NCT01452373|Postmenopausal women|postmenopausal women
1331122|NCT01452360|chronic kidney disease|chronic kidney disease
1331249|NCT01451866|Healthy People Programs|healthy people programs
1331123|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
1331124|NCT01452321|Postpartum Depression;|postpartum depression;
1331125|NCT01452321|Clinical Performance;|clinical performance;
1331126|NCT01452321|Cognitive Performance;|cognitive performance;
1621709|NCT00313677|DAG1|dag1
1331127|NCT01452321|Social Performance|social performance
1331128|NCT01452308|Gilead|gilead
1331129|NCT01452308|Gilead Sciences|gilead sciences
1331130|NCT01452308|GSI|gsi
1331131|NCT01452308|Liver Fibrosis|liver fibrosis
1331132|NCT01452308|Liver|liver
1331133|NCT01452308|Fibrosis|fibrosis
1331134|NCT01452295|liver|liver
1331135|NCT01452295|liver failure|liver failure
1331136|NCT01452295|acute liver failure|acute liver failure
1331137|NCT01452295|ELAD|elad
1331138|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
1331139|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
1331140|NCT01452282|Ankle Brachial Index|ankle brachial index
1331141|NCT01452282|Perioperative care|perioperative care
1331142|NCT01452282|General Surgery|general surgery
1331143|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
1331144|NCT01452282|Cardiovascular Complications|cardiovascular complications
1331145|NCT01452243|Vitamin D|vitamin d
1331146|NCT01452243|Calcium|calcium
1331147|NCT01452243|Elderly|elderly
1331148|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
1331149|NCT01452230|Severely obese|severely obese
1331150|NCT01452230|Bariatric surgery|bariatric surgery
1331151|NCT01452230|Physical activity|physical activity
1331152|NCT01452230|Physical fitness|physical fitness
1331153|NCT01452230|Comorbidities|comorbidities
1331154|NCT01452230|Quality of life|quality of life
1331155|NCT01452230|Surgical complications|surgical complications
1331156|NCT01452217|Pancreas|pancreas
1331157|NCT01452217|Chronic pancreatitis|chronic pancreatitis
1331158|NCT01452217|Perfusion|perfusion
1331159|NCT01452217|Blood flow|blood flow
1331160|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
1331161|NCT01452204|PEMF|pemf
1331162|NCT01452204|magneto|magneto
1331163|NCT01452204|shoulder|shoulder
1331165|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
1331166|NCT01452191|Community Health Services|community health services
1331167|NCT01452191|prevention & control|prevention & control
1331168|NCT01452191|Accidents, Home|accidents, home
1331169|NCT01452191|Child Health Services|child health services
1331170|NCT01452178|Cardiovascular diseases|cardiovascular diseases
1331171|NCT01452178|Glucometabolic disorders|glucometabolic disorders
1331172|NCT01452178|Type-D personality|type-d personality
1331173|NCT01452165|Cardiovascular diseases|cardiovascular diseases
1331174|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
1331175|NCT01452165|Echocardiography|echocardiography
1331176|NCT01452165|Prognosis|prognosis
1331177|NCT01452152|Pharmacogenomics|pharmacogenomics
1331178|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1331180|NCT01452139|Pharmacogenetics|pharmacogenetics
1331181|NCT01452139|Prasugrel|prasugrel
1331182|NCT01452139|Clopidogrel|clopidogrel
1331183|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
1331184|NCT01452113|Diabetes Mellitus|diabetes mellitus
1331185|NCT01452113|DPP-IV protein|dpp-iv protein
1331186|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
1331187|NCT01452113|autonomic neuropathy|autonomic neuropathy
1331188|NCT01452100|embolism|embolism
1331189|NCT01452100|cholesterol cristal|cholesterol cristal
1331190|NCT01452100|creatinine|creatinine
1331191|NCT01452100|renal insufficiency|renal insufficiency
1331192|NCT01452100|prednisone|prednisone
1331193|NCT01452100|systemic atheroembolism|systemic atheroembolism
1331194|NCT01452087|insulin sensitivity|insulin sensitivity
1331195|NCT01452087|exercise|exercise
1331196|NCT01452074|Insulin Sensitivity|insulin sensitivity
1331197|NCT01452074|Exercise Training|exercise training
1331198|NCT01452074|Weight Loss|weight loss
1331199|NCT01452074|Fat Metabolism|fat metabolism
1331200|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
1331201|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1331202|NCT01452061|Developmental Delay|developmental delay
1331203|NCT01452048|insulin sensitivity|insulin sensitivity
1331204|NCT01452048|fatty acid metabolism|fatty acid metabolism
1331205|NCT01452035|insulin sensitivity|insulin sensitivity
1331206|NCT01452035|fatty acid metabolism|fatty acid metabolism
1331207|NCT01452035|exercise|exercise
1331208|NCT01452022|inductigraft|inductigraft
1331209|NCT01452022|osteoinductive|osteoinductive
1331210|NCT01452022|synthetic bone graft|synthetic bone graft
1331211|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
1331212|NCT01452022|post market|post market
1331213|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
1331214|NCT01452009|open angle glaucoma|open angle glaucoma
1331215|NCT01452009|ocular hypertension|ocular hypertension
1331216|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
1331217|NCT01451983|Autism|autism
1331218|NCT01451983|PTEN|pten
1331219|NCT01451983|macrocephaly|macrocephaly
1331220|NCT01451970|high fat diet treatment|high fat diet treatment
1331221|NCT01451970|insulin sensitivity|insulin sensitivity
1331222|NCT01451957|exercise|exercise
1331223|NCT01451957|fatty acid metabolism|fatty acid metabolism
1331224|NCT01451957|insulin sensitivity|insulin sensitivity
1331225|NCT01451944|Asthma|asthma
1331226|NCT01451944|Home Health Nursing|home health nursing
1331227|NCT01451944|Patient education|patient education
1331228|NCT01451931|kidney stone|kidney stone
1331229|NCT01451931|urolithiasis|urolithiasis
1331230|NCT01451931|urinary tract infection|urinary tract infection
1331231|NCT01451931|ultrasound|ultrasound
1331232|NCT01451931|computed tomography|computed tomography
1331233|NCT01451931|safety|safety
1331234|NCT01451931|cost|cost
1331235|NCT01451931|accuracy|accuracy
1331236|NCT01451918|Dyslipidaemia|dyslipidaemia
1331237|NCT01451918|Insulin resistance|insulin resistance
1331238|NCT01451918|Type 2 Diabetes|type 2 diabetes
1331239|NCT01451892|Obesity|obesity
1331240|NCT01451892|dance|dance
1331241|NCT01451892|gait|gait
1331242|NCT01451892|balance|balance
1331243|NCT01451892|posture|posture
1331244|NCT01451892|dance therapy|dance therapy
1331245|NCT01451879|Pompe Disease|pompe disease
1331246|NCT01451879|Infusion Associated Reaction|infusion associated reaction
1331247|NCT01451879|Immune-modulation regimen|immune-modulation regimen
1331248|NCT01451866|resistance training|resistance training
1331250|NCT01451853|Lung Cancer|lung cancer
1331251|NCT01451853|Head and Neck Cancer|head and neck cancer
1331252|NCT01451853|Hearing Loss|hearing loss
1331253|NCT01451853|Ototoxicity|ototoxicity
1331254|NCT01451853|Tinnitus|tinnitus
1331255|NCT01451853|Deafness|deafness
1331256|NCT01451853|SPI-1005|spi-1005
1331257|NCT01451853|Cisplatin|cisplatin
1331258|NCT01451853|Carboplatin|carboplatin
1331259|NCT01451853|Ebselen|ebselen
1331260|NCT01451827|Kidney Disease|kidney disease
1331261|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
1331262|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1331263|NCT01451827|PKD|pkd
1331264|NCT01451827|ADPKD|adpkd
1331265|NCT01451814|smoking cessation|smoking cessation
1331266|NCT01451801|Hepatitis B|hepatitis b
1331267|NCT01451801|non responders|non responders
1331268|NCT01451801|cellular immune response|cellular immune response
1331269|NCT01451801|cytokines|cytokines
1331270|NCT01451801|predictors|predictors
1331271|NCT01451801|HBsAg|hbsag
1331272|NCT01451788|RCT|rct
1331273|NCT01451788|Gelatin matrix|gelatin matrix
1331274|NCT01451788|thrombin|thrombin
1331275|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
1331276|NCT01451788|Surgery|surgery
1331277|NCT01451762|pain|pain
1331278|NCT01451762|anesthesia|anesthesia
1331279|NCT01451762|surgery|surgery
1331280|NCT01451762|postoperative|postoperative
1331281|NCT01451749|Mild cognitive impairment|mild cognitive impairment
1331282|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
1331283|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
1331284|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
1331285|NCT01451736|oral risperidone|oral risperidone
1331286|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
1331287|NCT01451736|functional outcome|functional outcome
1331288|NCT01451723|Multiple Sclerosis|multiple sclerosis
1331289|NCT01451723|Polyphenon E|polyphenon e
1331290|NCT01451723|Green tea|green tea
1331291|NCT01451723|EGCG|egcg
1331292|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
1331293|NCT01451723|Placebo|placebo
1331294|NCT01451723|Randomized controlled trial|randomized controlled trial
1331295|NCT01451710|enough steroids|enough steroids
1331296|NCT01451710|MCD|mcd
1331297|NCT01451710|efficacy|efficacy
1331298|NCT01451684|pregnancy|pregnancy
1331299|NCT01451684|fetus|fetus
1331300|NCT01451684|euploid|euploid
1331301|NCT01451671|fetal|fetal
1331302|NCT01451671|aneuploidy|aneuploidy
1331303|NCT01451671|non-invasive|non-invasive
1331304|NCT01451671|prenatal|prenatal
1331305|NCT01451671|cell free DNA|cell free dna
1331306|NCT01451658|Variceal bleeding|variceal bleeding
1331709|NCT01449994|foot|foot
1331307|NCT01451658|portal hypertension|portal hypertension
1331308|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
1331309|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
1331310|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
1331311|NCT01451658|rebleeding|rebleeding
1331312|NCT01451645|Gout|gout
1331313|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
1331314|NCT01451632|Kras wild-type|kras wild-type
1331315|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
1331316|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
1331317|NCT01451632|Triple negative breast cancer|triple negative breast cancer
1331318|NCT01451632|EGFR|egfr
1331319|NCT01451632|ErbB3|erbb3
1331320|NCT01451632|MM-121|mm-121
1331321|NCT01451632|Cetuximab|cetuximab
1331322|NCT01451632|Irinotecan|irinotecan
1331323|NCT01451606|Chronic Pelvic Pain (CPP)|chronic pelvic pain (cpp)
1331324|NCT01451606|Pelvic Pain|pelvic pain
1331325|NCT01451593|Optic neuritis|optic neuritis
1331326|NCT01451593|Multiple sclerosis|multiple sclerosis
1331327|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
1331328|NCT01451593|Axonal loss|axonal loss
1331329|NCT01451593|Neuroprotection|neuroprotection
1331330|NCT01451593|Phenytoin|phenytoin
1331331|NCT01451593|MRI|mri
1331332|NCT01451593|Optical coherence tomography|optical coherence tomography
1331333|NCT01451593|Sodium Channel Blockers|sodium channel blockers
1331334|NCT01451580|Phase II|phase ii
1331335|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
1331336|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
1331337|NCT01451554|weight|weight
1331338|NCT01451554|body mass index|body mass index
1331339|NCT01451554|obesity|obesity
1331340|NCT01451554|portion control plate|portion control plate
1331341|NCT01451554|diet|diet
1331342|NCT01451554|exercise|exercise
1331343|NCT01451528|Umbilical Cord Blood|umbilical cord blood
1331344|NCT01451528|Allogeneic|allogeneic
1331345|NCT01451528|Traumatic Brain Injury|traumatic brain injury
1331346|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
1331347|NCT01451502|umbilical cord blood|umbilical cord blood
1331348|NCT01451489|FSGS|fsgs
1331349|NCT01451489|FK506|fk506
1331351|NCT01451476|Ageing|ageing
1331352|NCT01451463|Huntington's Disease|huntington's disease
1331353|NCT01451463|Chorea|chorea
1331354|NCT01451463|Gait|gait
1331355|NCT01451463|Balance|balance
1331356|NCT01451450|Peanut Allergy|peanut allergy
1331357|NCT01451411|Serum Sodium|serum sodium
1331358|NCT01451411|Euvolemia|euvolemia
1331359|NCT01451411|Hypervolemia|hypervolemia
1331360|NCT01451411|Vaprisol®|vaprisol®
1331361|NCT01451411|Conivaptan|conivaptan
1331362|NCT01451411|YM087|ym087
1331363|NCT01451372|Diabetes|diabetes
1331364|NCT01451372|CGM|cgm
1331365|NCT01451372|CSII|csii
1331366|NCT01451346|Pilot study|pilot study
1331367|NCT01451333|HIV|hiv
1331368|NCT01451333|Efavirenz|efavirenz
1331369|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
1331370|NCT01451333|Lumbar puncture|lumbar puncture
1331371|NCT01451333|Dose reduction|dose reduction
1331372|NCT01451320|Prosthetic valve|prosthetic valve
1331373|NCT01451320|thrombosis|thrombosis
1331375|NCT01451320|tPA|tpa
1331376|NCT01451320|TEE|tee
1331377|NCT01451307|Congenital abnormalities|congenital abnormalities
1331378|NCT01451307|Digestive system abnormalities|digestive system abnormalities
1331379|NCT01451307|Neonatal surgery|neonatal surgery
1331380|NCT01451307|Neonatal anesthesia|neonatal anesthesia
1331381|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
1331382|NCT01451294|Cerebral autoregulation|cerebral autoregulation
1331383|NCT01451281|Ultrasonography|ultrasonography
1331384|NCT01451281|Muscular Dystrophy|muscular dystrophy
1331385|NCT01451281|Neuromuscular Disease|neuromuscular disease
1331386|NCT01451281|Oligonucleotide|oligonucleotide
1331387|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1331388|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1331389|NCT01451281|DND|dnd
1331390|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
1331391|NCT01451268|High Risk MDS|high risk mds
1331392|NCT01451268|MDS|mds
1331393|NCT01451268|AML|aml
1331394|NCT01451255|pulsatility|pulsatility
1331395|NCT01451255|normal subjects|normal subjects
1331396|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
1331397|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
1331398|NCT01451242|Heart Rate Variability|heart rate variability
1331399|NCT01451242|Acquired Brain Injury|acquired brain injury
1331400|NCT01451242|Physical Activity|physical activity
1331401|NCT01451229|pharmacokinetics|pharmacokinetics
1331402|NCT01451229|pharmacodynamics|pharmacodynamics
1331403|NCT01451216|Acquired brain injury|acquired brain injury
1331404|NCT01451216|Balance control|balance control
1331405|NCT01451216|Functional reach|functional reach
1331406|NCT01451203|Cimzia|cimzia
1331407|NCT01451203|Early RA|early ra
1331408|NCT01451203|Certolizumab Pegol|certolizumab pegol
1331409|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
1331410|NCT01451190|Male Pattern Baldness|male pattern baldness
1331411|NCT01451190|Female Pattern Baldness|female pattern baldness
1331412|NCT01451190|Hair Loss|hair loss
1331413|NCT01451190|Baldness|baldness
1331414|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
1331415|NCT01451177|Male Pattern Baldness|male pattern baldness
1331416|NCT01451177|Female Pattern Baldness|female pattern baldness
1331417|NCT01451177|Hair Loss|hair loss
1331418|NCT01451177|Baldness|baldness
1331419|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
1331420|NCT01451151|Male Pattern Baldness|male pattern baldness
1331421|NCT01451151|Female Pattern Baldness|female pattern baldness
1331422|NCT01451151|Hair Loss|hair loss
1331423|NCT01451151|Baldness|baldness
1331424|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
1331425|NCT01451138|Male Pattern Baldness|male pattern baldness
1331426|NCT01451138|Female Pattern Baldness|female pattern baldness
1331427|NCT01451138|Hair Loss|hair loss
1331428|NCT01451138|Baldness|baldness
1331429|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
1331430|NCT01451125|Male Pattern Baldness|male pattern baldness
1331431|NCT01451125|Female Pattern Baldness|female pattern baldness
1331432|NCT01451125|Hair Loss Baldness|hair loss baldness
1331433|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
1331434|NCT01451112|Male Pattern Baldness|male pattern baldness
1331435|NCT01451112|Female Pattern Baldness|female pattern baldness
1331436|NCT01451112|Hair Loss|hair loss
1331437|NCT01451112|Baldness|baldness
1331438|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
1331439|NCT01451099|Male Pattern Baldness|male pattern baldness
1331440|NCT01451099|Female Pattern Baldness|female pattern baldness
1331441|NCT01451099|Hair Loss|hair loss
1331442|NCT01451099|Baldness|baldness
1331444|NCT01451086|Immunogenicity|immunogenicity
1331445|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
1331446|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
1331447|NCT01451073|Male Pattern Baldness|male pattern baldness
1331448|NCT01451073|Female Pattern Baldness|female pattern baldness
1331449|NCT01451073|Hair Loss|hair loss
1331450|NCT01451073|Baldness|baldness
1331451|NCT01451060|vasopressors|vasopressors
1331452|NCT01451060|cesarean anesthesia|cesarean anesthesia
1331453|NCT01451060|hypotension|hypotension
1331454|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
1331455|NCT01451047|Male Pattern Baldness|male pattern baldness
1331456|NCT01451047|Female Pattern Baldness|female pattern baldness
1331457|NCT01451047|Hair Loss|hair loss
1331458|NCT01451047|Baldness|baldness
1331459|NCT01451034|WHYX lesion|whyx lesion
1331460|NCT01451034|endoscopic resection|endoscopic resection
1331461|NCT01451034|complete resection|complete resection
1331462|NCT01451034|complete resection rate|complete resection rate
1331463|NCT01451034|endoscopic feature|endoscopic feature
1331464|NCT01451034|Average size discrepancy|average size discrepancy
1331465|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
1331466|NCT01451021|Male Pattern Baldness|male pattern baldness
1331467|NCT01451021|Female Pattern Baldness|female pattern baldness
1331468|NCT01451021|Hair Loss|hair loss
1331469|NCT01451021|Baldness|baldness
1331470|NCT01451008|Anastomosis|anastomosis
1331471|NCT01451008|Compression|compression
1331472|NCT01451008|Colon|colon
1331473|NCT01450995|Migraine|migraine
1331474|NCT01450995|Headache, Migraine|headache, migraine
1331475|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
1331476|NCT01450982|JNJ-38518168|jnj-38518168
1331477|NCT01450982|Methotrexate|methotrexate
1331478|NCT01450969|Operator Comfort Assessment|operator comfort assessment
1331479|NCT01450969|Radiation protection|radiation protection
1331480|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
1331481|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
1331482|NCT01450956|congenital heart diseases|congenital heart diseases
1331483|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
1331484|NCT01450956|Pediatric|pediatric
1331485|NCT01450956|sevoflurane|sevoflurane
1331486|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
1331487|NCT01450943|Chronic wounds|chronic wounds
1331488|NCT01450943|Chronic ulcers|chronic ulcers
1331489|NCT01450943|Oasis|oasis
1331490|NCT01450943|Dermagraft|dermagraft
1331491|NCT01450943|Adaptic|adaptic
1331492|NCT01450930|Adrenal insufficiency|adrenal insufficiency
1331493|NCT01450930|Addison's disease|addison's disease
1331494|NCT01450891|Alzheimer's disease|alzheimer's disease
1331495|NCT01450891|Diagnosis|diagnosis
1331496|NCT01450891|Costs|costs
1331497|NCT01450891|Benefits|benefits
1331498|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
1331499|NCT01450878|high dose of EPO|high dose of epo
1331500|NCT01450878|transplant kidney|transplant kidney
1331501|NCT01450878|cadaveric organ donor|cadaveric organ donor
1331502|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
1331503|NCT01450878|patient|patient
1331504|NCT01450878|kidney graft|kidney graft
1331505|NCT01450865|neuropathy|neuropathy
1331506|NCT01450865|axonal excitability|axonal excitability
1331507|NCT01450865|myelinated nerve|myelinated nerve
1331508|NCT01450865|human|human
1331509|NCT01450865|ectopic discharge|ectopic discharge
1331511|NCT01450852|Melanocortin Receptor|melanocortin receptor
1331512|NCT01450852|Monocyte|monocyte
1331513|NCT01450852|Resistance Training|resistance training
1331514|NCT01450852|Inflammation|inflammation
1331515|NCT01450852|Markers of Inflammation|markers of inflammation
1331516|NCT01450839|Transdermal Administration|transdermal administration
1331517|NCT01450839|Japanese|japanese
1331518|NCT01450839|elderly|elderly
1331519|NCT01450839|male|male
1331520|NCT01450839|volunteers|volunteers
1331521|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
1331522|NCT01450826|CINV|cinv
1331523|NCT01450826|Glioma|glioma
1331524|NCT01450826|Temozolomide|temozolomide
1331525|NCT01450826|Temodar|temodar
1331526|NCT01450826|Aprepitant|aprepitant
1331527|NCT01450826|Emend|emend
1331528|NCT01450826|Ondansetron|ondansetron
1331529|NCT01450826|Zofran|zofran
1331530|NCT01450826|Pro00031206|pro00031206
1331531|NCT01450826|Affronti|affronti
1331532|NCT01450826|Peters|peters
1331533|NCT01450826|Duke|duke
1331534|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
1331535|NCT01450800|urinary tract infection|urinary tract infection
1331536|NCT01450800|gynecologic surgery|gynecologic surgery
1331537|NCT01450800|post-operative complications|post-operative complications
1331538|NCT01450800|nitrofurantoin|nitrofurantoin
1331539|NCT01450787|dry eyes|dry eyes
1331540|NCT01450787|diabetes|diabetes
1331541|NCT01450748|sodium alginate|sodium alginate
1331542|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
1331543|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
1331544|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
1331545|NCT01450722|claudication|claudication
1331546|NCT01450722|chronic critical ischemia|chronic critical ischemia
1331547|NCT01450709|Probiotics|probiotics
1331548|NCT01450709|Kibow Biotics|kibow biotics
1331549|NCT01450709|Dialysis|dialysis
1331550|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
1331551|NCT01450670|Probiotics|probiotics
1331552|NCT01450670|Kibow Biotics|kibow biotics
1331553|NCT01450670|Dialysis|dialysis
1331554|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
1331555|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
1331556|NCT01450657|Probiotics|probiotics
1331557|NCT01450657|Kibow Biotics|kibow biotics
1331558|NCT01450657|Dialysis|dialysis
1331559|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
1331560|NCT01450644|Advanced|advanced
1331561|NCT01450644|Progressive|progressive
1331562|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
1331563|NCT01450644|Palliative Care|palliative care
1331564|NCT01450644|Randomised|randomised
1331565|NCT01450644|Controlled|controlled
1331566|NCT01450631|surgical site infection|surgical site infection
1331567|NCT01450631|nosocomial infection|nosocomial infection
1331768|NCT01449708|non-opioid|non-opioid
1331568|NCT01450631|post-operative complication|post-operative complication
1331569|NCT01450631|surgical incision risk|surgical incision risk
1331570|NCT01450631|surgical incision infection|surgical incision infection
1331571|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
1331572|NCT01450631|wound management|wound management
1331573|NCT01450631|cesarean section surgery|cesarean section surgery
1331574|NCT01450631|wound dehiscence|wound dehiscence
1331575|NCT01450631|wound infection|wound infection
1331576|NCT01450631|surgical closure|surgical closure
1331577|NCT01450631|wound disruption|wound disruption
1331578|NCT01450631|subcutaneous approximation|subcutaneous approximation
1331579|NCT01450631|wound separation|wound separation
1331580|NCT01450631|seroma|seroma
1331581|NCT01450631|hematoma|hematoma
1331582|NCT01450631|subcutaneous closure|subcutaneous closure
1331583|NCT01450631|obesity|obesity
1331584|NCT01450631|cesarean|cesarean
1331585|NCT01450631|incision|incision
1331586|NCT01450631|massive obesity|massive obesity
1331587|NCT01450631|obese|obese
1331588|NCT01450631|pregnancy|pregnancy
1331589|NCT01450631|cesarean delivery|cesarean delivery
1331590|NCT01450631|superobesity|superobesity
1331591|NCT01450631|wound complication|wound complication
1331592|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
1331593|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
1331594|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
1331595|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
1331596|NCT01450566|ureteral stent placement|ureteral stent placement
1331597|NCT01450566|Ureteral Calculi|ureteral calculi
1331598|NCT01450566|Renal Calculi|renal calculi
1331599|NCT01450553|Tissue Collection|tissue collection
1331600|NCT01450553|Lung Cancer|lung cancer
1331601|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
1331602|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
1331603|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
1331604|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
1331605|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
1331710|NCT01449994|pain|pain
1331711|NCT01449994|lower limb|lower limb
1331606|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
1331607|NCT01450423|Epilepsy|epilepsy
1331608|NCT01450423|Physical activity|physical activity
1331609|NCT01450423|Cardio exercise|cardio exercise
1331610|NCT01450423|Physical fitness|physical fitness
1331611|NCT01450423|Cognitive function|cognitive function
1331612|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
1331613|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
1331614|NCT01450384|protocol specific|protocol specific
1331615|NCT01450371|Autonomic Nervous System|autonomic nervous system
1331616|NCT01450371|Neuromodulation|neuromodulation
1331617|NCT01450371|Blood flow control|blood flow control
1331618|NCT01450371|Exercise|exercise
1331619|NCT01450358|Sepsis|sepsis
1331620|NCT01450358|Real time PCR|real time pcr
1331621|NCT01450358|Blood culture|blood culture
1331622|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
1331623|NCT01450358|Fungemia diagnosis|fungemia diagnosis
1331624|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
1621710|NCT00313677|POMK|pomk
1331625|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
1331626|NCT01450345|ASA I-II|asa i-ii
1331627|NCT01450345|Written consent|written consent
1331629|NCT01450332|arthroscopy|arthroscopy
1331630|NCT01450332|ligament|ligament
1331631|NCT01450332|rupture|rupture
1331632|NCT01450332|reconstruction|reconstruction
1331633|NCT01450332|ACLR|aclr
1331634|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
1331635|NCT01450319|K-RAS|k-ras
1331636|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
1331638|NCT01450319|Colorectal cancer|colorectal cancer
1331639|NCT01450293|Immune response|immune response
1331640|NCT01450267|Cystic Fibrosis|cystic fibrosis
1331641|NCT01450267|Glutathione|glutathione
1331642|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
1331643|NCT01450254|Gait Patterns|gait patterns
1331644|NCT01450254|Neuromuscular retraining|neuromuscular retraining
1331645|NCT01450241|Febrile neutropenia|febrile neutropenia
1331646|NCT01450241|Unexplained fever|unexplained fever
1331647|NCT01450241|Duration|duration
1331648|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
1331649|NCT01450228|primary insomnia|primary insomnia
1331650|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1331651|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
1331652|NCT01450202|Colonoscopy|colonoscopy
1331653|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
1331654|NCT01450202|Bowel insufflation|bowel insufflation
1331655|NCT01450202|Postprocedure pain|postprocedure pain
1331656|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
1331657|NCT01450189|Acute HIV|acute hiv
1331658|NCT01450189|Transmission Prevention|transmission prevention
1331659|NCT01450189|Randomized Pilot study|randomized pilot study
1331660|NCT01450176|eye|eye
1331661|NCT01450176|itching|itching
1331662|NCT01450176|allergies|allergies
1331663|NCT01450163|Neuropathic pain|neuropathic pain
1331664|NCT01450163|prevention|prevention
1331665|NCT01450163|prophylaxis|prophylaxis
1331666|NCT01450163|chemotherapy|chemotherapy
1331667|NCT01450163|neuropathy|neuropathy
1331668|NCT01450163|Oxaliplatin|oxaliplatin
1331669|NCT01450163|pregabalin|pregabalin
1331670|NCT01450150|Major Depression|major depression
1331671|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1331672|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
1331673|NCT01450150|tDCS|tdcs
1331674|NCT01450137|Giant Cell Arteritis|giant cell arteritis
1331675|NCT01450137|Tocilizumab|tocilizumab
1331676|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
1331677|NCT01450137|Glucocorticoids|glucocorticoids
1331678|NCT01450111|Lacosamide|lacosamide
1331679|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
1331680|NCT01450059|Microchimerism|microchimerism
1331681|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
1331682|NCT01450059|Gestation|gestation
1331683|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
1331684|NCT01450046|pancreas|pancreas
1331685|NCT01450046|gastrointestinal|gastrointestinal
1331686|NCT01450046|GI|gi
1331687|NCT01450046|prevention|prevention
1331688|NCT01450046|vitamin E|vitamin e
1331689|NCT01450033|kidney|kidney
1331690|NCT01450033|renal|renal
1331691|NCT01450033|transplant|transplant
1331692|NCT01450033|transplantation|transplantation
1331693|NCT01450033|adolescent|adolescent
1331694|NCT01450033|pediatric|pediatric
1331695|NCT01450033|mentor|mentor
1331696|NCT01450033|mentoring|mentoring
1331697|NCT01450033|medication|medication
1331698|NCT01450033|adherence|adherence
1331699|NCT01450033|immunosuppressant|immunosuppressant
1331700|NCT01450033|heart|heart
1331701|NCT01450033|liver|liver
1331702|NCT01450020|cancer survivor|cancer survivor
1331703|NCT01450007|Pain blockade|pain blockade
1331704|NCT01450007|Ropivacaine|ropivacaine
1331705|NCT01450007|Dexamethasone|dexamethasone
1331706|NCT01449994|knee|knee
1331707|NCT01449994|hip|hip
1331708|NCT01449994|ankle|ankle
1331713|NCT01449994|instrumental|instrumental
1331714|NCT01449994|chiropractic|chiropractic
1331715|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
1331716|NCT01449981|Adolescents|adolescents
1331717|NCT01449981|Alcohol Abuse|alcohol abuse
1331718|NCT01449981|Alcohol Dependence|alcohol dependence
1331719|NCT01449981|Drug Abuse|drug abuse
1331720|NCT01449981|Drug Dependence|drug dependence
1331721|NCT01449981|Substance Use Disorder|substance use disorder
1331722|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
1331723|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
1331724|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
1331725|NCT01449955|PTSD|ptsd
1331726|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1331727|NCT01449942|EBV|ebv
1331728|NCT01449942|LMP1|lmp1
1331729|NCT01449929|ritonavir|ritonavir
1331730|NCT01449929|HIV|hiv
1331731|NCT01449929|HAART|haart
1331732|NCT01449929|darunavir|darunavir
1331733|NCT01449929|antiretroviral|antiretroviral
1331734|NCT01449929|dolutegravir|dolutegravir
1331735|NCT01449929|GSK1349572|gsk1349572
1331736|NCT01449916|Sepsis|sepsis
1331737|NCT01449916|Severe Sepsis|severe sepsis
1331738|NCT01449916|Protocol|protocol
1331739|NCT01449916|Zambia|zambia
1331740|NCT01449890|follow up care|follow up care
1331741|NCT01449890|e-mail|e-mail
1331742|NCT01449890|effectiveness|effectiveness
1331743|NCT01449890|depressive disorders|depressive disorders
1331744|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
1331745|NCT01449877|Retinochoroiditis|retinochoroiditis
1331746|NCT01449877|Prophylaxis|prophylaxis
1331747|NCT01449864|upper GI malignancies|upper gi malignancies
1331748|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
1331749|NCT01449825|hepatic safety|hepatic safety
1331750|NCT01449825|prescriber compliance|prescriber compliance
1331751|NCT01449825|pazopanib|pazopanib
1331752|NCT01449825|epidemiology|epidemiology
1331753|NCT01449812|combination vaccine|combination vaccine
1331754|NCT01449812|booster vaccination|booster vaccination
1331755|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
1331756|NCT01449760|Ankle sprain|ankle sprain
1331757|NCT01449760|Balance|balance
1331758|NCT01449760|Gait|gait
1331759|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
1331760|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
1331761|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
1331762|NCT01449721|Sepsis|sepsis
1331763|NCT01449721|Multiple organ failure|multiple organ failure
1331764|NCT01449721|Resuscitation|resuscitation
1331765|NCT01449708|Bariatric Surgery|bariatric surgery
1331766|NCT01449708|TIVA|tiva
1331767|NCT01449708|PONV|ponv
1331769|NCT01449708|OSA|osa
1331770|NCT01449695|PAD|pad
1331771|NCT01449695|CVA|cva
1331772|NCT01449695|ACS|acs
1331773|NCT01449682|BRVO|brvo
1331774|NCT01449682|CRVO|crvo
1331775|NCT01449682|Macular Edema|macular edema
1331776|NCT01449682|Anti-VEGF|anti-vegf
1331777|NCT01449682|Ozurdex|ozurdex
1331778|NCT01449669|pharmacokinetics|pharmacokinetics
1331779|NCT01449669|cefazolin|cefazolin
1331780|NCT01449669|microdialysis sampling|microdialysis sampling
1331781|NCT01449669|interstitial fluid|interstitial fluid
1331782|NCT01449669|skeletal muscle|skeletal muscle
1331783|NCT01449669|plasma|plasma
1331784|NCT01449669|children|children
1331785|NCT01449643|Obesity|obesity
1331786|NCT01449643|Diaphragm|diaphragm
1331787|NCT01449643|Inspiratory muscular training|inspiratory muscular training
1331788|NCT01449617|Carotid stenosis|carotid stenosis
1331789|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
1331790|NCT01449617|Residual platelet reactivity|residual platelet reactivity
1331791|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
1331792|NCT01449604|SRS|srs
1331793|NCT01449604|SRT|srt
1331794|NCT01449604|vestibular schwannoma|vestibular schwannoma
1331795|NCT01449591|BFH772|bfh772
1331796|NCT01449591|rosacea|rosacea
1331797|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
1331798|NCT01449565|methamphetamine|methamphetamine
1331799|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
1331800|NCT01449565|HIV prevention|hiv prevention
1331801|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
1331802|NCT01449539|mobilize|mobilize
1331803|NCT01449539|stem cells|stem cells
1331804|NCT01449539|growth factor|growth factor
1331805|NCT01449526|contact lens|contact lens
1331806|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
1331807|NCT01449487|Experimental pain|experimental pain
1331808|NCT01449487|IBS|ibs
1331809|NCT01449487|Rectum|rectum
1331810|NCT01449448|pain relief|pain relief
1331811|NCT01449448|Hypermobility, Joint|hypermobility, joint
1331812|NCT01449448|increased strength|increased strength
1331813|NCT01449448|increased patient satisfaction|increased patient satisfaction
1331814|NCT01449435|Asthma|asthma
1331815|NCT01449435|children|children
1331816|NCT01449435|predictors of exacerbation|predictors of exacerbation
1331817|NCT01449435|Methacholine challenge|methacholine challenge
1331818|NCT01449435|Pulmonary function testing|pulmonary function testing
1331819|NCT01449409|Uncontrolled asthma|uncontrolled asthma
1331820|NCT01449409|Asthma risk|asthma risk
1331821|NCT01449409|Asthma impairment|asthma impairment
1331822|NCT01449409|Real time asthma outreach program|real time asthma outreach program
1331823|NCT01449396|acupuncture|acupuncture
1331824|NCT01449396|in vitro fertilization|in vitro fertilization
1331825|NCT01449396|embryo transfer|embryo transfer
1331826|NCT01449383|cross over|cross over
1331827|NCT01449383|dietary intervention|dietary intervention
1331828|NCT01449383|fibre|fibre
1331829|NCT01449383|red meat|red meat
1331830|NCT01449383|microbiota|microbiota
1331831|NCT01449370|INK1117|ink1117
1331832|NCT01449370|PIK3CA|pik3ca
1331833|NCT01449370|KINASE|kinase
1331834|NCT01449370|TUMOR|tumor
1331835|NCT01449370|CANCER|cancer
1331836|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
1331837|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
1331838|NCT01449357|NSCLC|nsclc
1331839|NCT01449357|Zalutumumab|zalutumumab
1331840|NCT01449357|Efficacy|efficacy
1331841|NCT01449357|Safety|safety
1331842|NCT01449344|relapsed|relapsed
1331843|NCT01449344|refractory|refractory
1331844|NCT01449318|Pain|pain
1331845|NCT01449318|quantitative sensory testing|quantitative sensory testing
1331846|NCT01449292|PLVR|plvr
1331847|NCT01449292|ELVR|elvr
1331848|NCT01449292|AeriSeal System|aeriseal system
1331849|NCT01449292|foam sealant|foam sealant
1331850|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
1331851|NCT01449292|ELS|els
1331852|NCT01449292|COPD|copd
1331853|NCT01449292|emphysema|emphysema
1331854|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
1331855|NCT01449292|heterogeneous|heterogeneous
1331856|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
1331857|NCT01449292|Lung Diseases|lung diseases
1331858|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1331859|NCT01449266|Dotarem|dotarem
1331860|NCT01449266|Dialyses|dialyses
1331861|NCT01449266|Dialysed|dialysed
1331862|NCT01449266|Safety|safety
1331863|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
1331864|NCT01449240|Hunter syndrome|hunter syndrome
1331865|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1331866|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
1331867|NCT01449240|Lumbar puncture|lumbar puncture
1331868|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1331869|NCT01449240|Pediatric|pediatric
1331870|NCT01449240|Adult|adult
1331871|NCT01449240|Biomarkers|biomarkers
1331872|NCT01449227|adhesive capsulitis|adhesive capsulitis
1331873|NCT01449227|hip|hip
1331874|NCT01449214|Thoracic epidural|thoracic epidural
1331875|NCT01449214|Epidural anesthesia|epidural anesthesia
1331876|NCT01449214|Ultrasound|ultrasound
1331877|NCT01449214|Palpation|palpation
1331878|NCT01449214|Thoracic spine|thoracic spine
1331879|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
1331880|NCT01449188|ondansetron|ondansetron
1331881|NCT01449188|moxifloxacin|moxifloxacin
1331882|NCT01449188|Zofran|zofran
1331883|NCT01449188|thorough QT study|thorough qt study
1331884|NCT01449188|IV|iv
1331885|NCT01449175|AeriSeal|aeriseal
1331886|NCT01449175|treatment|treatment
1331887|NCT01449175|device|device
1331888|NCT01449175|breathing|breathing
1331889|NCT01449175|COPD|copd
1331890|NCT01449175|emphysema|emphysema
1331891|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
1331892|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
1331893|NCT01449175|heterogeneous|heterogeneous
1331894|NCT01449175|homogeneous|homogeneous
1331895|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
1331896|NCT01449175|Lung Diseases|lung diseases
1331897|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1331898|NCT01449162|severe persistent asthma|severe persistent asthma
1331899|NCT01449162|patients treated with oral corticosteroids|patients treated with oral corticosteroids
1331900|NCT01449149|Age 18 or greater|age 18 or greater
1331901|NCT01449149|No prior radiation|no prior radiation
1331902|NCT01449136|Antibacterial agents|antibacterial agents
1331903|NCT01449136|Deciduous Teeth|deciduous teeth
1331904|NCT01449136|Clinical Trial|clinical trial
1331905|NCT01449123|Asthma|asthma
1331906|NCT01449123|mannitol challenge test|mannitol challenge test
1331907|NCT01449123|Sweden|sweden
1331908|NCT01449123|primary care|primary care
1331909|NCT01449110|Primary prevention|primary prevention
1331910|NCT01449110|Secondary prevention|secondary prevention
1331911|NCT01449110|Resveratrol|resveratrol
1331912|NCT01449110|Grape|grape
1331913|NCT01449110|Cardiovascular|cardiovascular
1331914|NCT01449110|Nutraceutical|nutraceutical
1331915|NCT01449110|Food complement|food complement
1331916|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
1331917|NCT01449097|human volunteers,|human volunteers,
1331918|NCT01449097|US-guided nerve block|us-guided nerve block
1331919|NCT01449097|femoral nerve block|femoral nerve block
1331920|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
1331921|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
1331922|NCT01449071|Lupus|lupus
1331923|NCT01449071|Monoclonal antibody|monoclonal antibody
1331924|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
1331925|NCT01449071|Epratuzumab|epratuzumab
1331926|NCT01449058|Advanced solid tumor,|advanced solid tumor,
1331927|NCT01449058|AML|aml
1331928|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
1331929|NCT01449058|dose escalation,|dose escalation,
1331930|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
1626174|NCT00297193|EBMT|ebmt
1331931|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
1331932|NCT01449058|MEK inhibitor,|mek inhibitor,
1331933|NCT01449058|BYL719,|byl719,
1331934|NCT01449058|MEK162|mek162
1331935|NCT01449045|IPTc|iptc
1331936|NCT01449045|Community Case Management|community case management
1331937|NCT01449045|Home Management for malaria|home management for malaria
1331938|NCT01449032|Patients|patients
1331939|NCT01449019|GLP-1|glp-1
1331940|NCT01449019|Exendin(9-39)|exendin(9-39)
1331941|NCT01449019|Insulin|insulin
1331942|NCT01449019|Glucagon|glucagon
1331943|NCT01449019|T2DM|t2dm
1331944|NCT01449019|incretin effect|incretin effect
1331945|NCT01449019|human physiology|human physiology
1331946|NCT01449006|HIV|hiv
1331947|NCT01449006|HAND|hand
1331948|NCT01449006|Maraviroc|maraviroc
1331949|NCT01449006|Neurocognitive|neurocognitive
1331950|NCT01449006|Neurology|neurology
1331951|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
1331952|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
1331953|NCT01448980|massage|massage
1331954|NCT01448980|stroke spasticity|stroke spasticity
1331955|NCT01448928|Zevalin|zevalin
1331956|NCT01448928|CD20+|cd20+
1331957|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1331958|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
1331959|NCT01448915|HIV|hiv
1331960|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
1331961|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1331962|NCT01448915|AIDS virus|aids virus
1331963|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
1331964|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
1331965|NCT01448915|Hepatitis C|hepatitis c
1331966|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
1331967|NCT01448915|Hepatitis C virus|hepatitis c virus
1331968|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
1331969|NCT01448915|Hepatitis C antigens|hepatitis c antigens
1331970|NCT01448902|Allergic rhinitis|allergic rhinitis
1331971|NCT01448902|CRTH2|crth2
1331972|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
1331973|NCT01448889|oxigen|oxigen
1331974|NCT01448889|coronary angiography|coronary angiography
1331975|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
1331976|NCT01448876|anorectal|anorectal
1331977|NCT01448876|cervicovaginal|cervicovaginal
1331978|NCT01448876|MSM|msm
1331979|NCT01448876|women|women
1331980|NCT01448876|treatment|treatment
1331981|NCT01448876|RNA|rna
1331982|NCT01448876|bacterial load|bacterial load
1331983|NCT01448876|sexual behaviour|sexual behaviour
1331984|NCT01448876|Azythromycin treated|azythromycin treated
1331985|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1331986|NCT01448850|MEDI8968|medi8968
1331987|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
1331988|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
1331989|NCT01448798|radical prostatectomy|radical prostatectomy
1331990|NCT01448798|robotic surgery|robotic surgery
1331991|NCT01448798|erectile dysfunction|erectile dysfunction
1331992|NCT01448798|continence|continence
1331993|NCT01448785|obesity|obesity
1331994|NCT01448785|gastric stimulation|gastric stimulation
1331995|NCT01448785|morbid obesity|morbid obesity
1331996|NCT01448772|Dronabinol|dronabinol
1331997|NCT01448772|fasting|fasting
1331998|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
1331999|NCT01448746|gastric cancer|gastric cancer
1332000|NCT01448746|VTE|vte
1332001|NCT01448746|incidence|incidence
1332002|NCT01448733|acne vulgaris|acne vulgaris
1332003|NCT01448720|Schizophrenia|schizophrenia
1332004|NCT01448720|Paliperidone palmitate|paliperidone palmitate
1332005|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
1332006|NCT01448707|Darunavir (DRV)|darunavir (drv)
1332007|NCT01448707|TMC114|tmc114
1332008|NCT01448707|Prezista|prezista
1332009|NCT01448707|HIV|hiv
1332010|NCT01448707|virologic response|virologic response
1332011|NCT01448707|neurocognitive function|neurocognitive function
1332012|NCT01448694|Hemorrhage|hemorrhage
1332013|NCT01448681|Intracranial Hypertension|intracranial hypertension
1332014|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
1332015|NCT01448668|pancreatic cancer|pancreatic cancer
1332016|NCT01448668|mistletoe|mistletoe
1332214|NCT01447823|Gastroscopy|gastroscopy
1332017|NCT01448668|supportive treatment|supportive treatment
1332018|NCT01448668|long-term study|long-term study
1332019|NCT01448668|non-interventional cohort study|non-interventional cohort study
1332020|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
1332021|NCT01448655|colorectal cancer|colorectal cancer
1332022|NCT01448655|mistletoe|mistletoe
1332023|NCT01448655|supportive treatment|supportive treatment
1332024|NCT01448655|long-term study|long-term study
1332025|NCT01448655|non-interventional cohort study|non-interventional cohort study
1332026|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
1332027|NCT01448603|Ragweed allergy|ragweed allergy
1332028|NCT01448603|ToleroMune ragweed|toleromune ragweed
1442676|NCT00993733|cost|cost
1332029|NCT01448603|immunotherapy|immunotherapy
1332030|NCT01448590|post dural puncture headache|post dural puncture headache
1332031|NCT01448590|accidental dural puncture|accidental dural puncture
1332032|NCT01448590|PDPH|pdph
1332033|NCT01448590|ADP|adp
1332034|NCT01448590|spinal catheter|spinal catheter
1332035|NCT01448590|epidural catheter|epidural catheter
1332036|NCT01448590|intrathecal catheter|intrathecal catheter
1332037|NCT01448590|dural puncture|dural puncture
1332038|NCT01448590|systemic review|systemic review
1332039|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1332040|NCT01448564|Fatigue|fatigue
1332041|NCT01448564|laser therapy|laser therapy
1332042|NCT01448551|Obesity|obesity
1332043|NCT01448551|Treatment|treatment
1332044|NCT01448551|Adolescents|adolescents
1332045|NCT01448551|Text Messages|text messages
1332046|NCT01448551|Mobile phones|mobile phones
1332047|NCT01448551|Multidisciplinary|multidisciplinary
1332048|NCT01448538|Medication Non-Adherence|medication non-adherence
1332049|NCT01448538|Medication Persistence|medication persistence
1332050|NCT01448538|wet macular degeneration|wet macular degeneration
1332051|NCT01448512|HIV|hiv
1332052|NCT01448512|Pregnancy|pregnancy
1332053|NCT01448512|Prevention|prevention
1332054|NCT01448512|Couples|couples
1332055|NCT01448499|schizophrenia|schizophrenia
1332056|NCT01448499|clozapine|clozapine
1332057|NCT01448499|amisulpride|amisulpride
1332058|NCT01448499|combination|combination
1332059|NCT01448499|treatment resistant|treatment resistant
1332060|NCT01448486|HIV|hiv
1332061|NCT01448486|HAND|hand
1332062|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
1332063|NCT01448486|Raltegravir|raltegravir
1332064|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
1332065|NCT01448486|Neuro-HAART|neuro-haart
1332066|NCT01448486|Neurocognitive|neurocognitive
1332067|NCT01448486|Neurology|neurology
1332068|NCT01448473|Head trauma|head trauma
1332069|NCT01448473|Children|children
1332070|NCT01448473|Radiography|radiography
1332071|NCT01448434|Osteoarthritis|osteoarthritis
1332072|NCT01448434|Knee|knee
1332073|NCT01448434|Stem cell|stem cell
1332074|NCT01448434|MSC|msc
1332075|NCT01448421|TAVR|tavr
1332076|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
1332077|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
1332078|NCT01448408|Anterior Segment Parameters|anterior segment parameters
1332079|NCT01448408|Diagnostic Capacity|diagnostic capacity
1332080|NCT01448395|Mass Balance|mass balance
1332081|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
1332082|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
1332083|NCT01448395|Mass Balance Recovery|mass balance recovery
1332084|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
1332085|NCT01448369|hot compress|hot compress
1332086|NCT01448369|eyelid warming|eyelid warming
1332087|NCT01448369|meibum|meibum
1332088|NCT01448356|Controlled adverse chamber|controlled adverse chamber
1332089|NCT01448356|tear film stability|tear film stability
1332090|NCT01448356|tear film evaporation|tear film evaporation
1332091|NCT01448356|tear film break up time|tear film break up time
1332092|NCT01448356|humidity|humidity
1332093|NCT01448356|temperature|temperature
1332094|NCT01448343|transfusion|transfusion
1332095|NCT01448343|potassium|potassium
1332096|NCT01448330|clopidogrel|clopidogrel
1332097|NCT01448330|aspinin|aspinin
1332098|NCT01448330|combination|combination
1332099|NCT01448291|Contraception|contraception
1332100|NCT01448291|Nuvaring|nuvaring
1332101|NCT01448291|Vaginal inflammation|vaginal inflammation
1332102|NCT01448291|Bacterial vaginosis|bacterial vaginosis
1332103|NCT01448291|Nugent score|nugent score
1332104|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
1332105|NCT01448278|Arthroscopy|arthroscopy
1332106|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
1332107|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1332108|NCT01448265|atrial fibrillation|atrial fibrillation
1332109|NCT01448265|catheter ablation|catheter ablation
1332110|NCT01448265|circular mapping catheter|circular mapping catheter
1332111|NCT01448265|cryoballoon|cryoballoon
1332112|NCT01448252|T cell vaccination|t cell vaccination
1332113|NCT01448252|Immunotherapy|immunotherapy
1332114|NCT01448252|Tolerance|tolerance
1332115|NCT01448252|safety|safety
1332116|NCT01448252|clinical efficacy|clinical efficacy
1332117|NCT01448213|DMEK|dmek
1332118|NCT01448213|Rejection|rejection
1332119|NCT01448213|Corticosteroid|corticosteroid
1332120|NCT01448200|hepatitis C|hepatitis c
1332121|NCT01448200|NS5A inhibitor|ns5a inhibitor
1332122|NCT01448200|Phase 1|phase 1
1332123|NCT01448200|genotype-1|genotype-1
1332124|NCT01448200|genotype-2|genotype-2
1332125|NCT01448200|genotype-3|genotype-3
1332126|NCT01448187|Lung cancer, France|lung cancer, france
1332127|NCT01448174|salusin-alpha|salusin-alpha
1332128|NCT01448174|atorvastatin|atorvastatin
1332129|NCT01448174|CD36|cd36
1332130|NCT01448174|Hemodialysis|hemodialysis
1332131|NCT01448161|Pediatric|pediatric
1332132|NCT01448161|Adult|adult
1332133|NCT01448161|ICU|icu
1332134|NCT01448148|Mild cognitive impairment|mild cognitive impairment
1332135|NCT01448122|Prevention of pigmentation|prevention of pigmentation
1332136|NCT01448109|Sepsis|sepsis
1332137|NCT01448109|Corticosteroid|corticosteroid
1332261|NCT01447667|Recurrence|recurrence
1332138|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
1332139|NCT01448096|rituximab|rituximab
1332140|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
1332141|NCT01448096|CNS recurrence|cns recurrence
1332142|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
1332143|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
1332144|NCT01448057|Paracetamol|paracetamol
1332145|NCT01448057|dimethindene maleate|dimethindene maleate
1332146|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
1332147|NCT01448057|cold and flu symptoms|cold and flu symptoms
1332148|NCT01448044|hepatitis C virus|hepatitis c virus
1332149|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
1332150|NCT01448031|Bioavailability|bioavailability
1332151|NCT01448031|Healthy Volunteers|healthy volunteers
1332152|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1332153|NCT01448005|Resuscitation|resuscitation
1332154|NCT01448005|Sudden Cardiac Death|sudden cardiac death
1332155|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
1332156|NCT01447992|Artificial Pancreas|artificial pancreas
1332157|NCT01447992|Insulin Pump|insulin pump
1332158|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
1332159|NCT01447992|Closed Loop|closed loop
1332160|NCT01447979|Artificial Pancreas|artificial pancreas
1332161|NCT01447979|Insulin Pump|insulin pump
1332162|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
1332163|NCT01447979|Closed Loop|closed loop
1332164|NCT01447966|OCD|ocd
1332165|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
1332166|NCT01447966|Child|child
1332167|NCT01447966|Pediatric|pediatric
1332168|NCT01447966|CBT|cbt
1332169|NCT01447966|Therapy|therapy
1332170|NCT01447966|ERP|erp
1332171|NCT01447966|Exposure Response Prevention|exposure response prevention
1332172|NCT01447966|Preschool|preschool
1332173|NCT01447966|Cognitive Behavioral|cognitive behavioral
1332174|NCT01447953|Activity|activity
1332175|NCT01447953|disability|disability
1332176|NCT01447953|life-role|life-role
1332177|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
1332178|NCT01447953|primary health care|primary health care
1332179|NCT01447953|persistent pain|persistent pain
1332180|NCT01447953|randomized controlled trial|randomized controlled trial
1332181|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
1332182|NCT01447940|Telemedicine|telemedicine
1332183|NCT01447940|Type 1 diabetes|type 1 diabetes
1332184|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
1332185|NCT01447940|ePortal Meos|eportal meos
1332186|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
1332187|NCT01447914|tivantinib|tivantinib
1332188|NCT01447914|multiple myeloma|multiple myeloma
1332189|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
1332190|NCT01447914|Hypercalcemia|hypercalcemia
1332191|NCT01447914|hematologic malignancy|hematologic malignancy
1332192|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
1332193|NCT01447914|cast nephropathy|cast nephropathy
1332194|NCT01447914|amyloidosis|amyloidosis
1332195|NCT01447914|osteolysis|osteolysis
1332196|NCT01447914|Renal insufficiency|renal insufficiency
1332197|NCT01447914|Anemia|anemia
1332198|NCT01447914|Bone lytic lesions|bone lytic lesions
1332199|NCT01447914|severe osteopenia|severe osteopenia
1332200|NCT01447914|pathologic fractures|pathologic fractures
1332201|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
1332202|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
1332203|NCT01447888|Spine surgery|spine surgery
1332204|NCT01447888|Chronic pain|chronic pain
1332205|NCT01447888|Opioid tolerant|opioid tolerant
1332206|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
1332207|NCT01447862|recent-onset|recent-onset
1332208|NCT01447849|Chronic Constipation|chronic constipation
1332209|NCT01447836|indocyanine green|indocyanine green
1332210|NCT01447836|sepsis|sepsis
1332211|NCT01447836|liver injury|liver injury
1332212|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
1332213|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
1332215|NCT01447823|phmetry|phmetry
1332216|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
1332217|NCT01447810|Pediatric|pediatric
1332218|NCT01447810|Hemiplegia|hemiplegia
1332219|NCT01447810|Brain Tumor|brain tumor
1332220|NCT01447810|Rehabilitation|rehabilitation
1332221|NCT01447797|Irbesartan|irbesartan
1332222|NCT01447797|Atorvastatin|atorvastatin
1332223|NCT01447797|combination|combination
1332224|NCT01447784|HDM allergy|hdm allergy
1332225|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
1332226|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
1332227|NCT01447784|Immunotherapy|immunotherapy
1332228|NCT01447784|ToleroMune HDM|toleromune hdm
1332229|NCT01447771|Decision making|decision making
1332230|NCT01447771|Decisional aide|decisional aide
1332231|NCT01447745|Visceral obesity|visceral obesity
1332232|NCT01447745|Cardiometabolic risk|cardiometabolic risk
1332233|NCT01447745|Atherosclerosis|atherosclerosis
1332234|NCT01447745|Ectopic fat|ectopic fat
1332235|NCT01447745|Carotid plaque|carotid plaque
1332236|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1332237|NCT01447745|Computed tomography (CT)|computed tomography (ct)
1332238|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
1332239|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
1332240|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
1332241|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
1332242|NCT01447706|Ovarian Cancer|ovarian cancer
1332243|NCT01447706|Platinum-resistant|platinum-resistant
1332244|NCT01447706|Platinum-refractory|platinum-refractory
1332245|NCT01447706|Fallopian tube cancer|fallopian tube cancer
1332246|NCT01447706|Peritoneal Cancer|peritoneal cancer
1332247|NCT01447706|Paclitaxel|paclitaxel
1332248|NCT01447706|ErbB3|erbb3
1332249|NCT01447706|Phase II|phase ii
1332250|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
1332251|NCT01447693|uremia|uremia
1332252|NCT01447693|pruritus|pruritus
1332253|NCT01447693|oliva-omega 3|oliva-omega 3
1332254|NCT01447680|HIV infection|hiv infection
1332255|NCT01447680|HCV infection|hcv infection
1332256|NCT01447680|SMARTube|smartube
1332257|NCT01447680|SMARTplasma|smartplasma
1332258|NCT01447667|Hepatic fibrosis|hepatic fibrosis
1332259|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
1332260|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
1332262|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1332263|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
1332264|NCT01447654|Hypertrophy|hypertrophy
1332265|NCT01447654|Losartan|losartan
1332266|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
1332267|NCT01447641|Cluster Headache|cluster headache
1332268|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
1332269|NCT01447641|Sleep|sleep
1332270|NCT01447641|Circadian Rhythms|circadian rhythms
1332372|NCT01447225|Gemcitabine|gemcitabine
1332271|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
1332272|NCT01447628|Iron deficiency|iron deficiency
1332273|NCT01447615|Orphaned children and youth|orphaned children and youth
1332274|NCT01447615|Economic empowerment|economic empowerment
1332275|NCT01447615|Uganda|uganda
1332276|NCT01447615|HIV/AIDS|hiv/aids
1332277|NCT01447615|Sub-Saharan Africa|sub-saharan africa
1332278|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1332279|NCT01447602|Dysthymia|dysthymia
1332280|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
1332281|NCT01447589|Radiosensitiser|radiosensitiser
1332282|NCT01447563|Bioequivalence|bioequivalence
1332283|NCT01447563|Bioavailability|bioavailability
1332284|NCT01447550|Bosentan|bosentan
1332285|NCT01447550|Buerguer disease|buerguer disease
1332286|NCT01447537|Cirrhosis|cirrhosis
1332287|NCT01447537|Exercise|exercise
1332288|NCT01447537|Relaxation|relaxation
1332289|NCT01447537|Muscle mass|muscle mass
1332290|NCT01447537|Effort tolerance|effort tolerance
1332291|NCT01447511|Drug Interactions|drug interactions
1332292|NCT01447511|Warfarin|warfarin
1332293|NCT01447511|Genetics|genetics
1332294|NCT01447511|CYP2C9|cyp2c9
1332295|NCT01447511|Healthy Volunteers|healthy volunteers
1332296|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
1332297|NCT01447485|nephrotic syndrome|nephrotic syndrome
1332298|NCT01447485|pharmacokinetics|pharmacokinetics
1332299|NCT01447472|MDMA,|mdma,
1332300|NCT01447472|pharmacokinetics,|pharmacokinetics,
1332301|NCT01447472|pharmacodynamics,|pharmacodynamics,
1332302|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
1332303|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
1332304|NCT01447472|dextromethorphan,|dextromethorphan,
1332305|NCT01447472|caffeine.|caffeine.
1332306|NCT01447459|Asthma|asthma
1332307|NCT01447459|Asthma Education|asthma education
1332308|NCT01447433|Calcium Carbonate|calcium carbonate
1332309|NCT01447433|Vitamin D|vitamin d
1332310|NCT01447433|Body weight|body weight
1332311|NCT01447433|Body fat|body fat
1332312|NCT01447433|Metabolic parameters|metabolic parameters
1332313|NCT01447433|Energy restriction|energy restriction
1332314|NCT01447433|Very-low calcium consumers|very-low calcium consumers
1332315|NCT01447433|Obesity|obesity
1332316|NCT01447433|Overweight|overweight
1332317|NCT01447407|Staphylococcal infections|staphylococcal infections
1332318|NCT01447407|Yeast infections|yeast infections
1332319|NCT01447407|Candidiasis|candidiasis
1332320|NCT01447368|chronic kidney disease|chronic kidney disease
1332321|NCT01447368|peritoneal dialysis|peritoneal dialysis
1332322|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
1332323|NCT01447368|parathyroidectomy|parathyroidectomy
1332324|NCT01447368|vascular calcification|vascular calcification
1332325|NCT01447368|cinacalcet|cinacalcet
1332326|NCT01447329|pain|pain
1332327|NCT01447329|acupuncture|acupuncture
1332328|NCT01447329|knee|knee
1332329|NCT01447329|debridement|debridement
1332330|NCT01447329|surgery|surgery
1332331|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
1332332|NCT01447316|body composition|body composition
1332333|NCT01447316|gait|gait
1332334|NCT01447316|quality of life|quality of life
1332335|NCT01447316|Patients|patients
1332336|NCT01447316|undergoing|undergoing
1332337|NCT01447316|bariatric surgery.|bariatric surgery.
1332338|NCT01447303|knee|knee
1332339|NCT01447303|osteoarthritis|osteoarthritis
1332340|NCT01447303|hyaluronic acid|hyaluronic acid
1332341|NCT01447303|viscosupplementation|viscosupplementation
1332342|NCT01447290|preeclampsia|preeclampsia
1332343|NCT01447290|protein|protein
1332344|NCT01447290|creatinine|creatinine
1332345|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
1332346|NCT01447277|ACL reconstruction|acl reconstruction
1332347|NCT01447277|Femoral Block|femoral block
1332348|NCT01447277|Sciatic Block|sciatic block
1332349|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
1332350|NCT01447264|Muscle strength|muscle strength
1332351|NCT01447264|Body composition|body composition
1332352|NCT01447264|Physical activity|physical activity
1332353|NCT01447264|Water exercises|water exercises
1332354|NCT01447264|Hydrotherapy|hydrotherapy
1332355|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
1332356|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
1332357|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
1332358|NCT01447251|DM2|dm2
1332359|NCT01447251|OSA|osa
1332360|NCT01447251|CPAP|cpap
1332361|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
1332362|NCT01447238|pancreatic cysts|pancreatic cysts
1332363|NCT01447238|EUS/FNA|eus/fna
1332364|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
1332365|NCT01447238|fiber optic imaging|fiber optic imaging
1332366|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
1332367|NCT01447225|Advanced-stage|advanced-stage
1332368|NCT01447225|Solid Tumors|solid tumors
1332369|NCT01447225|MM-121|mm-121
1332370|NCT01447225|Carboplatin|carboplatin
1332371|NCT01447225|Pemetrexed|pemetrexed
1332373|NCT01447225|Cabazitaxel|cabazitaxel
1332374|NCT01447225|ErbB3|erbb3
1332375|NCT01447225|Phase I|phase i
1332376|NCT01447225|Cancer|cancer
1332377|NCT01447212|Opioid Dependence|opioid dependence
1332378|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
1332379|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
1332380|NCT01447212|Hydromorphone|hydromorphone
1332381|NCT01447212|Diamorphine|diamorphine
1332382|NCT01447212|Diacetylmorphine|diacetylmorphine
1332383|NCT01447199|Bladder cancer|bladder cancer
1332384|NCT01447199|Colorectal cancer|colorectal cancer
1332385|NCT01447199|Endometrial cancer|endometrial cancer
1332386|NCT01447199|Kidney cancer|kidney cancer
1332387|NCT01447199|Skin cancer|skin cancer
1332388|NCT01447199|Uterus cancer|uterus cancer
1332389|NCT01447199|Molecular Predisposition|molecular predisposition
1332390|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
1332391|NCT01447199|HNPCC|hnpcc
1332392|NCT01447199|Molecular genetic testing|molecular genetic testing
1332393|NCT01447199|Gene mutations|gene mutations
1332394|NCT01447199|Mutation analyses|mutation analyses
1332395|NCT01447199|Genetic polymorphisms|genetic polymorphisms
1332396|NCT01447199|Family history of cancer|family history of cancer
1332397|NCT01447199|Early age of cancer onset|early age of cancer onset
1332398|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
1332399|NCT01447199|Spouses|spouses
1332400|NCT01447199|Questionnaires|questionnaires
1332401|NCT01447199|Blood sample|blood sample
1332402|NCT01447199|Saliva Sample|saliva sample
1332403|NCT01447186|Prostate cancer screening|prostate cancer screening
1332404|NCT01447186|Prostate Cancer|prostate cancer
1332405|NCT01447186|Patient Decision Aid|patient decision aid
1332406|NCT01447186|Spanish Speaking Men|spanish speaking men
1332407|NCT01447186|Spanish-language slide set|spanish-language slide set
1332408|NCT01447186|Focus group|focus group
1332409|NCT01447186|Interview|interview
1332410|NCT01447186|Survey|survey
1332411|NCT01447173|Asthma|asthma
1332412|NCT01447173|Pulmonary Function Test|pulmonary function test
1332413|NCT01447173|Vitamin D|vitamin d
1332414|NCT01447160|facet joint|facet joint
1332415|NCT01447160|back pain|back pain
1332416|NCT01447160|osteoarthritis|osteoarthritis
1332417|NCT01447160|infiltration|infiltration
1332418|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
1332419|NCT01447108|Tic Douloureux|tic douloureux
1332420|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
1332421|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
1332422|NCT01447095|vasospasm|vasospasm
1332423|NCT01447095|prostacyclin|prostacyclin
1332424|NCT01447082|atypical|atypical
1332425|NCT01447082|antipsychotics|antipsychotics
1332426|NCT01447082|quetiapine|quetiapine
1332427|NCT01447069|heart failure stage 3|heart failure stage 3
1332428|NCT01447069|beta 2 agonist|beta 2 agonist
1332429|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
1332430|NCT01447069|ejection fraction <35%|ejection fraction <35%
1332431|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
1332432|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1332433|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
1332434|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1332435|NCT01447056|Leiomyosarcoma|leiomyosarcoma
1332436|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
1332437|NCT01447043|retrospective studies|retrospective studies
1332438|NCT01447030|Biliary strictur|biliary strictur
1332439|NCT01447030|Hepatojejunostomy|hepatojejunostomy
1332440|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
1332441|NCT01446991|prostate neoplasm|prostate neoplasm
1332442|NCT01446991|brachytherapy|brachytherapy
1332443|NCT01446991|androgen ablation|androgen ablation
1332444|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
1332445|NCT01446991|prostate size reduction|prostate size reduction
1332446|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
1332447|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
1332448|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
1332449|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
1332450|NCT01446978|methotrexate|methotrexate
1332451|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
1332452|NCT01446965|myocardial infarction|myocardial infarction
1332453|NCT01446965|ventricular dysfunction|ventricular dysfunction
1332454|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
1332455|NCT01446965|death, sudden|death, sudden
1332457|NCT01446965|ventricular tachycardia|ventricular tachycardia
1332458|NCT01446965|ventricular fibrillation|ventricular fibrillation
1332459|NCT01446965|defibrillation, electric|defibrillation, electric
1332460|NCT01446965|cardioversion, electric|cardioversion, electric
1332461|NCT01446965|electric countershock|electric countershock
1332462|NCT01446965|defibrillators, external|defibrillators, external
1332463|NCT01446952|prevention|prevention
1332464|NCT01446952|pancreas|pancreas
1332465|NCT01446939|MRI|mri
1332466|NCT01446939|Parkinson's disease|parkinson's disease
1333064|NCT01444651|Obesity|obesity
1332467|NCT01446939|Essential tremor|essential tremor
1332468|NCT01446939|Ultrasonography|ultrasonography
1332469|NCT01446939|Diagnosis|diagnosis
1332470|NCT01446926|Pneumonia|pneumonia
1332471|NCT01446926|Pneumococcal Infections|pneumococcal infections
1332472|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
1332473|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
1332474|NCT01446913|Sleep Apnea|sleep apnea
1332475|NCT01446913|CPAP adherence|cpap adherence
1332476|NCT01446913|behavioral adherence|behavioral adherence
1332477|NCT01446913|stroke|stroke
1332478|NCT01446900|Rituximab|rituximab
1332479|NCT01446900|Cladribine|cladribine
1332480|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
1332481|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1332482|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
1332483|NCT01446887|total hip arthroplasty|total hip arthroplasty
1332484|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
1332485|NCT01446887|randomized study|randomized study
1332486|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
1332487|NCT01446861|Cystic fibrosis|cystic fibrosis
1332488|NCT01446861|Pancreas|pancreas
1332489|NCT01446861|Exocrine function|exocrine function
1332490|NCT01446861|Ultrasound|ultrasound
1332491|NCT01446861|Contrast ultrasound|contrast ultrasound
1332492|NCT01446848|iron deficiency|iron deficiency
1332493|NCT01446848|pulmonary hypertension|pulmonary hypertension
1332494|NCT01446848|iron supplements|iron supplements
1332495|NCT01446848|ferrous sulfate|ferrous sulfate
1332496|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
1332497|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
1332498|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
1332499|NCT01446822|obturator nerve|obturator nerve
1332500|NCT01446796|Ventricular assist device|ventricular assist device
1332501|NCT01446783|COL5A1|col5a1
1332502|NCT01446783|Collagen disorders|collagen disorders
1332503|NCT01446783|IGF-I|igf-i
1332504|NCT01446783|Collagen synthesis|collagen synthesis
1332505|NCT01446757|quality of life|quality of life
1332506|NCT01446757|feeling of security|feeling of security
1332507|NCT01446757|costs|costs
1332508|NCT01446757|multiprofessional team|multiprofessional team
1332509|NCT01446757|geriatric competence|geriatric competence
1332510|NCT01446731|Prostate cancer|prostate cancer
1332511|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
1332512|NCT01446718|Human Papillomavirus|human papillomavirus
1332513|NCT01446692|Major depressive disorder|major depressive disorder
1332514|NCT01446692|primary care|primary care
1332515|NCT01446692|real-world evidence|real-world evidence
1332516|NCT01446692|database|database
1332517|NCT01446679|Lipitor|lipitor
1332518|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
1332519|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
1332520|NCT01446666|surveillance|surveillance
1332521|NCT01446666|gadoxetic acid|gadoxetic acid
1332522|NCT01446666|MRI|mri
1332523|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
1332524|NCT01446653|FASDs|fasds
1332525|NCT01446653|AEP risk|aep risk
1332526|NCT01446653|binge drinking|binge drinking
1332527|NCT01446653|ineffective contraception|ineffective contraception
1332528|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
1332529|NCT01446627|metal staples|metal staples
1332530|NCT01446627|wound healing|wound healing
1332531|NCT01446627|cesarean section|cesarean section
1332532|NCT01446601|Apnea|apnea
1332533|NCT01446601|OSA|osa
1332534|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
1332535|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
1332536|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
1332537|NCT01446601|Sleep Disorders|sleep disorders
1332538|NCT01446601|Tongue|tongue
1332539|NCT01446536|Quality|quality
1332540|NCT01446536|Improvement|improvement
1332541|NCT01446523|endotoxins HE|endotoxins he
1332542|NCT01446510|VTE|vte
1332543|NCT01446510|DVT|dvt
1332544|NCT01446510|PE|pe
1332545|NCT01446510|Risk assessment|risk assessment
1332546|NCT01446510|risk score|risk score
1332547|NCT01446510|risk analysis|risk analysis
1332548|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
1332549|NCT01446497|Normal tension glaucoma|normal tension glaucoma
1332550|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
1332551|NCT01446497|Brimonidine|brimonidine
1332552|NCT01446497|Timolol|timolol
1332553|NCT01446497|Combination drugs|combination drugs
1332554|NCT01446484|Renal transplantation|renal transplantation
1332555|NCT01446484|Kidney transplantation|kidney transplantation
1332556|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
1332557|NCT01446484|T reg|t reg
1332558|NCT01446484|Campath|campath
1332559|NCT01446471|Bedside Ultrasound|bedside ultrasound
1332560|NCT01446471|Point of care ultrasound|point of care ultrasound
1332561|NCT01446471|cardiac arrest|cardiac arrest
1332562|NCT01446458|Cancer of Pancreas|cancer of pancreas
1332563|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
1332564|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
1332565|NCT01446458|Pancreas Cancer|pancreas cancer
1332566|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
1332567|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
1332568|NCT01446445|Cytomegalovirus|cytomegalovirus
1332569|NCT01446445|renal transplant|renal transplant
1332570|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
1332571|NCT01446419|chronic axial low back pain|chronic axial low back pain
1332572|NCT01446419|vertebrogenic pain|vertebrogenic pain
1332573|NCT01446419|Radio frequency ablation|radio frequency ablation
1332574|NCT01446406|Bipolar disorder|bipolar disorder
1332575|NCT01446406|Electronic daily monitoring|electronic daily monitoring
1332576|NCT01446406|Affective episodes|affective episodes
1332577|NCT01446354|Blood component transfusion|blood component transfusion
1332578|NCT01446354|Hypothermic|hypothermic
1332579|NCT01446341|Ankle sprain|ankle sprain
1332580|NCT01446341|Functional rehabilitation|functional rehabilitation
1332581|NCT01446341|Immobilization|immobilization
1332582|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
1332583|NCT01446328|Randomized Controlled Trial|randomized controlled trial
1332584|NCT01446328|Treatment Effectiveness|treatment effectiveness
1332585|NCT01446328|Translational Research|translational research
1332586|NCT01446315|asthma|asthma
1332587|NCT01446315|asthma care system|asthma care system
1332588|NCT01446315|effectiveness|effectiveness
1332589|NCT01446315|primary care|primary care
1332590|NCT01446315|practice based research network|practice based research network
1332591|NCT01446302|Dialysis|dialysis
1332592|NCT01446302|Protein-energy wasting|protein-energy wasting
1332593|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
1332594|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
1332595|NCT01446302|Inflammation|inflammation
1332596|NCT01446289|Group B streptococcus|group b streptococcus
1332597|NCT01446289|GBS|gbs
1332598|NCT01446289|Vaccine|vaccine
1332599|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
1332600|NCT01446276|Obesity|obesity
1332601|NCT01446276|Resveratrol|resveratrol
1332602|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1332603|NCT01446276|Insulin sensitivity|insulin sensitivity
1332604|NCT01446276|Lipid turnover|lipid turnover
1332605|NCT01446276|Liver fat content|liver fat content
1332606|NCT01446263|Radial access|radial access
1332607|NCT01446263|Femoral access|femoral access
1332608|NCT01446263|Coronary angiography|coronary angiography
1332609|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
1332610|NCT01446250|Chronic hepatitis C|chronic hepatitis c
1332611|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
1332612|NCT01446224|adverse events|adverse events
1332613|NCT01446224|pazopanib|pazopanib
1332614|NCT01446224|Torsades des Pointes|torsades des pointes
1332615|NCT01446224|renal cell carcinoma|renal cell carcinoma
1332616|NCT01446224|anti-VEGF agents|anti-vegf agents
1332617|NCT01446224|observational data|observational data
1332618|NCT01446224|cardiac ischemia|cardiac ischemia
1332619|NCT01446211|gusperimus|gusperimus
1332620|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
1332621|NCT01446211|relapse|relapse
1332622|NCT01446198|HPV|hpv
1332623|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
1332624|NCT01446185|Early Breast cancer|early breast cancer
1332625|NCT01446185|Gene Expression|gene expression
1332626|NCT01446185|Node-Negative|node-negative
1332627|NCT01446185|treatment options|treatment options
1332628|NCT01446185|Hormone receptor positive|hormone receptor positive
1332629|NCT01446172|Long term outcome|long term outcome
1332630|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
1332631|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
1332632|NCT01446146|PTSD Treatment|ptsd treatment
1332633|NCT01446146|Decision making|decision making
1332634|NCT01446146|Veterans|veterans
1332635|NCT01446133|Leukemia|leukemia
1332636|NCT01446133|Lymphoma|lymphoma
1332637|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1332638|NCT01446133|CLL|cll
1332639|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1332640|NCT01446133|SLL|sll
1332641|NCT01446133|Initial Treatment|initial treatment
1332642|NCT01446133|Subsequent Therapy|subsequent therapy
1332643|NCT01446133|Rituximab|rituximab
1332644|NCT01446133|Rituxan|rituxan
1332645|NCT01446133|Lenalidomide|lenalidomide
1332646|NCT01446133|CC-5013|cc-5013
1332647|NCT01446133|Revlimid|revlimid
1332648|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
1332649|NCT01446107|tooth decay|tooth decay
1332650|NCT01446107|fluoride|fluoride
1332651|NCT01446107|sealant|sealant
1332652|NCT01446107|prevention|prevention
1332653|NCT01446094|Coronary artery disease|coronary artery disease
1332654|NCT01446081|chemotherapy|chemotherapy
1332655|NCT01446081|exercise|exercise
1332656|NCT01446081|quality of life|quality of life
1332657|NCT01446081|cancer-related fatigue|cancer-related fatigue
1332658|NCT01446081|elderly|elderly
1333164|NCT01444261|anemia|anemia
1332659|NCT01446081|physical fitness|physical fitness
1332660|NCT01446055|Peripheral arterial disease|peripheral arterial disease
1332661|NCT01446055|Buerger's disease|buerger's disease
1332662|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
1332663|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
1332664|NCT01446055|chronic limb ischemia|chronic limb ischemia
1332665|NCT01446029|Telemonitoring|telemonitoring
1332666|NCT01446029|Chronic Kidney Disease|chronic kidney disease
1332667|NCT01446016|Breast Cancer|breast cancer
1332668|NCT01446016|Breast Tumors|breast tumors
1332669|NCT01446016|Cancer of Breast|cancer of breast
1332670|NCT01446016|Cancer of the Breast|cancer of the breast
1332671|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
1332672|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
1332673|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
1332674|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
1332675|NCT01446016|Neoplasms, Breast|neoplasms, breast
1332676|NCT01446016|Tumors, Breast|tumors, breast
1332677|NCT01446016|Taxotere|taxotere
1332678|NCT01446016|Chloroquine|chloroquine
1332679|NCT01446016|Paclitaxel|paclitaxel
1332680|NCT01446016|Taxol|taxol
1332681|NCT01446016|Ixabepilone|ixabepilone
1332682|NCT01446016|Abraxane|abraxane
1332683|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
1332684|NCT01446016|Advanced Breast Cancer|advanced breast cancer
1332685|NCT01446016|Anthracycline|anthracycline
1332686|NCT01445990|free tissue flaps|free tissue flaps
1332687|NCT01445990|lactic acid|lactic acid
1332688|NCT01445990|glucose|glucose
1332689|NCT01445990|thrombosis|thrombosis
1332690|NCT01445990|diagnostic test|diagnostic test
1332691|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
1332692|NCT01445977|Sonitus Medical|sonitus medical
1332693|NCT01445977|SoundBite|soundbite
1332694|NCT01445977|Single Sided Deafness|single sided deafness
1332695|NCT01445977|Conductive Hearing Loss|conductive hearing loss
1332696|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
1332697|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
1332698|NCT01445964|effect of apple juice|effect of apple juice
1332699|NCT01445886|Nail Psoriasis|nail psoriasis
1332700|NCT01445886|Indigo Naturalis|indigo naturalis
1332701|NCT01445886|Indirubin|indirubin
1332702|NCT01445886|Calcipotriol|calcipotriol
1332703|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
1332704|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
1332705|NCT01445873|sitaxentan sodium|sitaxentan sodium
1332706|NCT01445873|Thelin|thelin
1332707|NCT01445860|DDI|ddi
1332708|NCT01445860|pharmacokinetics|pharmacokinetics
1332709|NCT01445847|Laryngospasm|laryngospasm
1332710|NCT01445847|Lidocaine|lidocaine
1332711|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
1332712|NCT01445834|female|female
1332713|NCT01445834|stress urinary incontinence|stress urinary incontinence
1332714|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
1332715|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
1332716|NCT01445821|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1332717|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
1332718|NCT01445808|coronary heart disease|coronary heart disease
1332719|NCT01445808|physical activity|physical activity
1332720|NCT01445808|secondary prevention|secondary prevention
1332721|NCT01445795|Inhibitex|inhibitex
1332722|NCT01445795|Chronic Hepatitis|chronic hepatitis
1332723|NCT01445795|Hepatitis C Virus|hepatitis c virus
1332724|NCT01445782|Safety|safety
1332725|NCT01445782|tolerability|tolerability
1332726|NCT01445782|healthy|healthy
1332727|NCT01445782|inhaled|inhaled
1332728|NCT01445769|Myelofibrosis|myelofibrosis
1332729|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
1332730|NCT01445769|PMF|pmf
1332731|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1332732|NCT01445769|PPV-MF|ppv-mf
1332733|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1332734|NCT01445769|PET-MF|pet-mf
1332735|NCT01445769|Open label|open label
1332736|NCT01445769|Ruxolitinib|ruxolitinib
1332737|NCT01445769|18424|18424
1332738|NCT01445769|Jak inhibitor|jak inhibitor
1332739|NCT01445756|Intrauterine Device|intrauterine device
1332740|NCT01445743|Tdap Vaccine|tdap vaccine
1332741|NCT01445743|Pregnant woman|pregnant woman
1332742|NCT01445743|Pertussis|pertussis
1332743|NCT01445730|fructose|fructose
1332744|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
1332745|NCT01445730|postprandial lipids|postprandial lipids
1332746|NCT01445730|de novo lipogenesis|de novo lipogenesis
1332747|NCT01445730|stable isotopes|stable isotopes
1332748|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
1332749|NCT01445717|Group B|group b
1332750|NCT01445704|Weight loss|weight loss
1332751|NCT01445704|Probiotics|probiotics
1332752|NCT01445704|Gastric Bypass|gastric bypass
1332753|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
1332754|NCT01445691|Brain Cancer|brain cancer
1332755|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
1332756|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
1332757|NCT01445691|Brain Tumor, Primary|brain tumor, primary
1332758|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
1332759|NCT01445691|Brain Tumors|brain tumors
1332760|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
1332761|NCT01445691|Neoplasms, Brain|neoplasms, brain
1332762|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
1332763|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
1332764|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
1332765|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
1332766|NCT01445691|Gliomas|gliomas
1332767|NCT01445691|Glioblastoma|glioblastoma
1332768|NCT01445691|Surgery|surgery
1332769|NCT01445691|5-ALA|5-ala
1332770|NCT01445691|Aminolevulinic acid|aminolevulinic acid
1332771|NCT01445691|Fluorescence|fluorescence
1332772|NCT01445678|cIAI|ciai
1332773|NCT01445639|dexmedetomidine|dexmedetomidine
1332774|NCT01445639|sedation|sedation
1332775|NCT01445639|neurosurgery|neurosurgery
1332776|NCT01445639|postoperative care|postoperative care
1332777|NCT01445613|Carotid|carotid
1332778|NCT01445613|Stent|stent
1332779|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
1332780|NCT01445600|Impetigo|impetigo
1332781|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
1332782|NCT01445600|retapamulin|retapamulin
1332783|NCT01445587|bortezomib|bortezomib
1332784|NCT01445587|AKT inhibitor|akt inhibitor
1332785|NCT01445587|multiple myeloma|multiple myeloma
1332786|NCT01445587|GSK2110183|gsk2110183
1332787|NCT01445587|hematologic malignancies|hematologic malignancies
1332788|NCT01445561|Interleukin-2|interleukin-2
1332789|NCT01445561|IL-2|il-2
1332790|NCT01445561|Stem Cells|stem cells
1332791|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
1332792|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
1332793|NCT01445561|Healthy Volunteer|healthy volunteer
1332794|NCT01445561|HV|hv
1332795|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1332796|NCT01445548|Geographic Atrophy|geographic atrophy
1332797|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
1332798|NCT01445548|Sirolimus|sirolimus
1332799|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
1332800|NCT01445548|AMD|amd
1332801|NCT01445535|CD2 Positive|cd2 positive
1332802|NCT01445535|Toxicity|toxicity
1332803|NCT01445535|EBV Lymphoma|ebv lymphoma
1332804|NCT01445535|Chemotherapy Naive|chemotherapy naive
1332805|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
1332806|NCT01445535|Lymphoma|lymphoma
1332807|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
1332808|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
1332809|NCT01445522|PARP Inhibitor|parp inhibitor
1332810|NCT01445522|DNA Damage|dna damage
1332811|NCT01445522|Chemotherapy|chemotherapy
1332812|NCT01445522|Advanced Cancer|advanced cancer
1332813|NCT01445522|DNA Repair|dna repair
1332814|NCT01445509|Angiogenesis|angiogenesis
1332815|NCT01445509|VEGF|vegf
1332816|NCT01445509|SRC|src
1332817|NCT01445509|Targeted Therapy|targeted therapy
1332818|NCT01445509|Cancer|cancer
1332819|NCT01445509|Solid Tumor|solid tumor
1332820|NCT01445483|Cancer|cancer
1332821|NCT01445483|Radiation|radiation
1332822|NCT01445483|Brain|brain
1332823|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
1332824|NCT01445483|Metastasis|metastasis
1332825|NCT01445483|Brain Metastasis|brain metastasis
1332826|NCT01445444|Habit Reversal Training|habit reversal training
1332827|NCT01445444|Hair Pulling|hair pulling
1332828|NCT01445444|Children|children
1332829|NCT01445444|Trich|trich
1332830|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
1332831|NCT01445444|TTM|ttm
1332832|NCT01445444|psychotherapy|psychotherapy
1332833|NCT01445418|Genetic|genetic
1332834|NCT01445418|BRCA|brca
1332835|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
1332836|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
1332837|NCT01445418|Metastatic|metastatic
1332838|NCT01445418|Breast Cancer|breast cancer
1332839|NCT01445418|Ovarian Cancer|ovarian cancer
1332840|NCT01445405|Proteasome|proteasome
1332841|NCT01445405|Bortezomib|bortezomib
1332842|NCT01445405|NF-kappaB|nf-kappab
1332843|NCT01445405|Cetuximab|cetuximab
1332844|NCT01445405|Epidermal Growth Factor|epidermal growth factor
1332845|NCT01445405|Head and Neck Cancer|head and neck cancer
1332846|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
1332847|NCT01445405|Oral Cancer|oral cancer
1332848|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
1332849|NCT01445392|Monoclonal Antibody|monoclonal antibody
1332850|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
1332851|NCT01445392|Targeted Therapy|targeted therapy
1332852|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
1332853|NCT01445392|Mesothelioma|mesothelioma
1332854|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
1332855|NCT01445379|Solid Tumor|solid tumor
1332856|NCT01445379|Monoclonal Antibody|monoclonal antibody
1332857|NCT01445379|Pediatrics|pediatrics
1332858|NCT01445379|Pharmacokinetics|pharmacokinetics
1332859|NCT01445379|Immunotherapy|immunotherapy
1332860|NCT01445379|Sarcoma|sarcoma
1332861|NCT01445379|Lymphoma|lymphoma
1332862|NCT01445379|Neuroblastoma|neuroblastoma
1332863|NCT01445340|Topical Depsi|topical depsi
1332864|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1332865|NCT01445340|CTCL|ctcl
1332866|NCT01445340|Mycosis Fungoides|mycosis fungoides
1332867|NCT01445327|Blood|blood
1332868|NCT01445327|Urine|urine
1332869|NCT01445327|Stool|stool
1332870|NCT01445327|Tumor Marker|tumor marker
1332871|NCT01445327|Radiation Therapy|radiation therapy
1332872|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
1332873|NCT01445327|Esophageal Cancer|esophageal cancer
1332874|NCT01445327|Stomach|stomach
1332875|NCT01445327|Pancreatic Cancer|pancreatic cancer
1332876|NCT01445314|Stored Data|stored data
1332877|NCT01445314|Neurobehavioral|neurobehavioral
1332878|NCT01445314|Behavior|behavior
1332879|NCT01445314|Quality of Life|quality of life
1332880|NCT01445301|twice daily|twice daily
1332881|NCT01445301|once daily|once daily
1332882|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
1332883|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
1332884|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
1332885|NCT01445301|inflammatory lesion|inflammatory lesion
1332886|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
1332887|NCT01445301|acne vulgaris|acne vulgaris
1332888|NCT01445288|Neurotoxicity|neurotoxicity
1332889|NCT01445288|Brain Tumor|brain tumor
1332890|NCT01445288|Children|children
1332891|NCT01445288|Angiogenesis|angiogenesis
1332892|NCT01445288|Imaging|imaging
1332893|NCT01445288|Central Nervous System Tumor|central nervous system tumor
1332894|NCT01445288|CNS Tumor|cns tumor
1332895|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
1332896|NCT01445249|surgery orthopaedic|surgery orthopaedic
1332897|NCT01445236|Operational tolerance|operational tolerance
1332898|NCT01445236|Biomarkers|biomarkers
1332899|NCT01445236|Liver Transplantation|liver transplantation
1332900|NCT01445223|HIV|hiv
1332901|NCT01445223|Antiretroviral therapy|antiretroviral therapy
1332902|NCT01445223|efavirenz|efavirenz
1332903|NCT01445223|lopinavir|lopinavir
1332904|NCT01445223|atazanavir|atazanavir
1443747|NCT00990054|AML|aml
1332905|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
1332906|NCT01445210|Postoperative pain|postoperative pain
1332907|NCT01445210|Major ankle surgery|major ankle surgery
1332908|NCT01445210|Continuous nerve block|continuous nerve block
1332909|NCT01445210|Saphenous nerve|saphenous nerve
1332910|NCT01445210|Ropivacaine|ropivacaine
1332911|NCT01445171|Aortic Valve Replacement|aortic valve replacement
1332912|NCT01445158|ShopTalk|shoptalk
1332913|NCT01445158|Comprehension|comprehension
1332914|NCT01445158|Donors|donors
1332915|NCT01445158|Education|education
1332916|NCT01445158|Stem Cell Transplant|stem cell transplant
1332917|NCT01445158|Sibling Donor|sibling donor
1332918|NCT01445145|End-of-Life|end-of-life
1332919|NCT01445145|Advance Directive|advance directive
1332920|NCT01445145|Pediatric Cancer|pediatric cancer
1332921|NCT01445145|Adolescents|adolescents
1332922|NCT01445145|Young Adults|young adults
1332923|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
1332924|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1332925|NCT01445132|Refractory Tumor|refractory tumor
1332926|NCT01445132|Resection|resection
1332927|NCT01445132|B-Cell Malignancies|b-cell malignancies
1332928|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1332929|NCT01445132|BCL|bcl
1332930|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
1332931|NCT01445119|Brain|brain
1332932|NCT01445119|Tumor|tumor
1332933|NCT01445119|Radiation|radiation
1332934|NCT01445119|Antiangiogenesis|antiangiogenesis
1332935|NCT01445119|Chemotherapy|chemotherapy
1332936|NCT01445119|Brain Tumor|brain tumor
1332937|NCT01445119|Glioma|glioma
1332938|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
1332939|NCT01445106|Drug Repositioning|drug repositioning
1332940|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
1332941|NCT01445106|Targeted Therapy|targeted therapy
1332942|NCT01445106|Off - Label Drugs|off - label drugs
1332943|NCT01445106|Nelfinavir|nelfinavir
1332944|NCT01445106|Protease Inhibitor|protease inhibitor
1332945|NCT01445106|Solid Tumor|solid tumor
1332946|NCT01445106|Phase I|phase i
1332947|NCT01445106|Malignant Tumor|malignant tumor
1332948|NCT01445080|MTD|mtd
1332949|NCT01445080|Phase I/II|phase i/ii
1332950|NCT01445080|Pediatric|pediatric
1332951|NCT01445080|Solid Tumor|solid tumor
1332952|NCT01445080|Leukemia|leukemia
1332953|NCT01445080|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1332954|NCT01445080|CML|cml
1332955|NCT01445080|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1332956|NCT01445080|ALL|all
1332957|NCT01445080|Acute Myeloid Leukemia|acute myeloid leukemia
1332958|NCT01445080|AML|aml
1332959|NCT01445080|Juevenile Myelomoncytic Leukemia|juevenile myelomoncytic leukemia
1332960|NCT01445080|JMML|jmml
1332961|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
1332962|NCT01445054|PET|pet
1332963|NCT01445054|Optimal Scanning Strategy|optimal scanning strategy
1332964|NCT01445054|Breast Cancer|breast cancer
1332965|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1332966|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
1332967|NCT01445041|Newborn Infants|newborn infants
1332968|NCT01445015|adolescents|adolescents
1332969|NCT01445002|grass pollen allergy|grass pollen allergy
1332970|NCT01445002|immunotherapy|immunotherapy
1332971|NCT01445002|recombinant vaccine|recombinant vaccine
1332972|NCT01444989|"Sun spots"|"sun spots"
1332973|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
1332974|NCT01444976|age range of 18-83|age range of 18-83
1332975|NCT01444924|Pain control|pain control
1332976|NCT01444924|Gynecologic Oncology|gynecologic oncology
1332977|NCT01444924|Surgery|surgery
1332978|NCT01444911|Sexual Dysfunction|sexual dysfunction
1332979|NCT01444911|Gynecologic cancer|gynecologic cancer
1332980|NCT01444911|Cancer survivor|cancer survivor
1332981|NCT01444911|Vaginal dilator|vaginal dilator
1332982|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
1332983|NCT01444898|Obesity|obesity
1332984|NCT01444898|Weight|weight
1332985|NCT01444898|Exenatide|exenatide
1332986|NCT01444898|Byetta|byetta
1332987|NCT01444898|Pediatrics|pediatrics
1332988|NCT01444898|Adolescents|adolescents
1332989|NCT01444885|Variant angina|variant angina
1332990|NCT01444885|Cilostazol|cilostazol
1332991|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
1332992|NCT01444846|Hearing Loss|hearing loss
1332993|NCT01444846|Deafness|deafness
1332994|NCT01444846|SPI-1005|spi-1005
1332995|NCT01444846|Ebselen|ebselen
1332996|NCT01444833|hypertension|hypertension
1332997|NCT01444833|obesity|obesity
1332998|NCT01444833|metabolism|metabolism
1332999|NCT01444833|angiotensin|angiotensin
1333000|NCT01444820|radiation therapy|radiation therapy
1333001|NCT01444820|hypofractionation|hypofractionation
1333002|NCT01444820|hormonal therapy|hormonal therapy
1333003|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
1333004|NCT01444807|sorafenib|sorafenib
1333005|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1333006|NCT01444807|metastasectomy|metastasectomy
1333007|NCT01444794|Lower limb spasticity|lower limb spasticity
1333008|NCT01444781|Diphtheria|diphtheria
1333009|NCT01444781|Tetanus|tetanus
1333010|NCT01444781|Whooping Cough|whooping cough
1333011|NCT01444781|Hepatitis B|hepatitis b
1333012|NCT01444781|Poliomyelitis|poliomyelitis
1333013|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
1333014|NCT01444781|Invasive Hib infections|invasive hib infections
1333015|NCT01444768|Alert Systems, Medication|alert systems, medication
1333016|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
1333017|NCT01444768|CPOE|cpoe
1333018|NCT01444768|Medication Alert Systems|medication alert systems
1333019|NCT01444768|Medical Order Entry Systems|medical order entry systems
1333020|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
1333021|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1333022|NCT01444742|Leukemia|leukemia
1333023|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
1333024|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
1333025|NCT01444742|(MDS)|(mds)
1333026|NCT01444742|Relapsing|relapsing
1333027|NCT01444742|Refractory|refractory
1333028|NCT01444742|Clofarabine|clofarabine
1333029|NCT01444742|Clofarex|clofarex
1333030|NCT01444742|Clolar|clolar
1333031|NCT01444742|Cytarabine|cytarabine
1333032|NCT01444742|Ara-C|ara-c
1333033|NCT01444742|Cytosar|cytosar
1333034|NCT01444742|DepoCyt|depocyt
1333035|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1333036|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
1333037|NCT01444729|'xiapex'|'xiapex'
1333038|NCT01444729|'surgery'|'surgery'
1333039|NCT01444716|Advanced Cancers|advanced cancers
1333040|NCT01444716|Leukemia|leukemia
1333041|NCT01444716|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1333042|NCT01444716|CLL|cll
1333043|NCT01444716|Elderly|elderly
1333044|NCT01444716|Ofatumumab|ofatumumab
1333045|NCT01444716|Arzerra|arzerra
1333046|NCT01444703|Thoracic surgery|thoracic surgery
1333047|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
1333048|NCT01444703|intubation|intubation
1333049|NCT01444703|extubation|extubation
1333050|NCT01444703|sore throat|sore throat
1333051|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
1333052|NCT01444690|Antiretroviral therapy|antiretroviral therapy
1333053|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
1333054|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
1333055|NCT01444677|Safety|safety
1333056|NCT01444677|Tolerability|tolerability
1333057|NCT01444677|Pharmacokinetic|pharmacokinetic
1333058|NCT01444651|Tadalafil|tadalafil
1333059|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
1333060|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
1333061|NCT01444651|Pharmacologic Actions|pharmacologic actions
1333062|NCT01444651|Vasodilator Agents|vasodilator agents
1333063|NCT01444651|Cardiovascular Agents|cardiovascular agents
1333065|NCT01444651|Glycemic Traits|glycemic traits
1333066|NCT01444651|Insulin Resistance|insulin resistance
1333067|NCT01444651|Glucose Metabolism|glucose metabolism
1333068|NCT01444638|pregnancy|pregnancy
1333069|NCT01444638|Caesarian|caesarian
1333070|NCT01444638|section|section
1333071|NCT01444638|spinal|spinal
1333072|NCT01444625|UV radiation|uv radiation
1333073|NCT01444625|photoprotection|photoprotection
1333074|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
1333075|NCT01444612|cancer surgery|cancer surgery
1333076|NCT01444612|venous thromboembolism|venous thromboembolism
1333077|NCT01444612|hospitalization|hospitalization
1333078|NCT01444612|anticoagulants|anticoagulants
1333079|NCT01444612|costs and cost analysis|costs and cost analysis
1333080|NCT01444612|thromboprophylaxis|thromboprophylaxis
1333081|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
1333082|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
1333083|NCT01444599|fractional flow reserve|fractional flow reserve
1333084|NCT01444586|non-interventional|non-interventional
1333085|NCT01444586|Xarelto|xarelto
1333086|NCT01444586|knee replacement|knee replacement
1333087|NCT01444586|hip replecement|hip replecement
1333088|NCT01444586|Russia|russia
1333089|NCT01444573|Rate control|rate control
1333091|NCT01444547|esophageal cancer|esophageal cancer
1333092|NCT01444547|paclitaxel|paclitaxel
1333093|NCT01444547|cisplatin|cisplatin
1333094|NCT01444534|mobile phone application|mobile phone application
1333095|NCT01444534|diabetes type 1|diabetes type 1
1333096|NCT01444534|self-management|self-management
1333097|NCT01444534|telemedicin|telemedicin
1333098|NCT01444521|advanced gastric cancer|advanced gastric cancer
1333099|NCT01444521|irinotecan|irinotecan
1333100|NCT01444521|cisplatin|cisplatin
1333101|NCT01444495|rectal cancer|rectal cancer
1333102|NCT01444495|radiotherapy|radiotherapy
1333103|NCT01444495|overall survival|overall survival
1333104|NCT01444495|recurrence rate|recurrence rate
1333105|NCT01444495|downstaging|downstaging
1626175|NCT00297193|ECCO|ecco
1333281|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
1333282|NCT01443702|Kidney Calculi|kidney calculi
1333283|NCT01443702|Iranian traditional medicine|iranian traditional medicine
1333284|NCT01443702|Lapis judaicus|lapis judaicus
1333285|NCT01443689|Extensive Burn|extensive burn
1333286|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
1333287|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
1333288|NCT01443637|Coronary Artery Disease|coronary artery disease
1333290|NCT01443637|Atherosclerosis|atherosclerosis
1333291|NCT01443637|Myocardial Infarction|myocardial infarction
1333292|NCT01443637|MI|mi
1333293|NCT01443637|CONFIRM|confirm
1333294|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
1333295|NCT01443637|CCTA|ccta
1333296|NCT01443624|iron|iron
1333297|NCT01443624|critical illness|critical illness
1333298|NCT01443624|oxidative stress|oxidative stress
1333299|NCT01443611|Infants|infants
1333300|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
1333301|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
1333302|NCT01443585|Progressive Addition Lens|progressive addition lens
1333303|NCT01443585|Multifocal|multifocal
1333304|NCT01443585|Presbyopia|presbyopia
1333305|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
1333306|NCT01443559|Xenogenic|xenogenic
1333307|NCT01443546|oocyte donor|oocyte donor
1333308|NCT01443546|oocyte recipient|oocyte recipient
1333309|NCT01443546|ovulation trigger|ovulation trigger
1333310|NCT01443533|Contraception|contraception
1333311|NCT01443533|Contraception behavior|contraception behavior
1333312|NCT01443533|Postnatal care|postnatal care
1333313|NCT01443533|Health education|health education
1333314|NCT01443533|Randomized controlled trial|randomized controlled trial
1333315|NCT01443520|Pharmacokinetics|pharmacokinetics
1333316|NCT01443520|Pharmacodynamics|pharmacodynamics
1333317|NCT01443507|aerobic capacity|aerobic capacity
1333318|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
1333319|NCT01443507|aerobic endurance|aerobic endurance
1333320|NCT01443507|work economy|work economy
1333321|NCT01443507|lactate threshold|lactate threshold
1333322|NCT01443507|endurance training|endurance training
1333323|NCT01443507|exercise intensity|exercise intensity
1333324|NCT01443494|septic shock|septic shock
1333325|NCT01443494|microcirculation|microcirculation
1333326|NCT01443494|norepinephrine|norepinephrine
1333327|NCT01443494|fluid|fluid
1333328|NCT01443481|solid tumors|solid tumors
1333329|NCT01443481|hepatic impairment|hepatic impairment
1333330|NCT01443481|Child-Pugh classification|child-pugh classification
1333331|NCT01443481|pharmacokinetics|pharmacokinetics
1333332|NCT01443481|PK|pk
1333333|NCT01443481|RECIST 1.1|recist 1.1
1333334|NCT01443468|Tp53|tp53
1333335|NCT01443468|Cancer|cancer
1333336|NCT01443468|Hereditary|hereditary
1333337|NCT01443468|Genetic Testing|genetic testing
1333338|NCT01443468|Screening|screening
1333339|NCT01443468|Li-Fraumeni Syndrome|li-fraumeni syndrome
1333340|NCT01443468|LFS|lfs
1333341|NCT01443455|menopause|menopause
1333342|NCT01443455|sedentary|sedentary
1333343|NCT01443455|overweight|overweight
1333344|NCT01443442|Conjunctivitis|conjunctivitis
1333345|NCT01443442|Allergic|allergic
1333346|NCT01443442|Bepotastine besilate|bepotastine besilate
1333347|NCT01443442|Loteprednol etabonate|loteprednol etabonate
1333348|NCT01443429|TRK-100STP|trk-100stp
1333349|NCT01443429|PK|pk
1333350|NCT01443429|beraprost sodium|beraprost sodium
1333351|NCT01443429|Japanese males and females|japanese males and females
1333352|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
1333353|NCT01443429|renal impairment|renal impairment
1333354|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1333355|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
1333356|NCT01443416|vaccination|vaccination
1333357|NCT01443416|children|children
1333358|NCT01443403|Opioid Therapy|opioid therapy
1333359|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
1333360|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
1333361|NCT01443390|Whole genome sequencing|whole genome sequencing
1333362|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
1333363|NCT01443377|Neorec|neorec
1333364|NCT01443377|rectal cancer|rectal cancer
1333365|NCT01443377|KRAS|kras
1333366|NCT01443377|Panitumumab|panitumumab
1333368|NCT01443377|Radiochemotherapy|radiochemotherapy
1333369|NCT01443377|antibody|antibody
1333370|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
1333371|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
1333372|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
1333373|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
1333374|NCT01443364|Italy|italy
1333375|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
1333376|NCT01443351|ITP|itp
1333377|NCT01443351|romiplostim|romiplostim
1333378|NCT01443351|eltrombopag|eltrombopag
1333379|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
1333380|NCT01443351|long-term safety|long-term safety
1333381|NCT01443338|Triptergium wilfordii|triptergium wilfordii
1333382|NCT01443338|Acitretin|acitretin
1333383|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
1333384|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
1333385|NCT01443312|Beta globin gene|beta globin gene
1333386|NCT01443312|Alfa globin gene|alfa globin gene
1333387|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
1333388|NCT01443273|Newborns|newborns
1333389|NCT01443260|oncolytic virus|oncolytic virus
1333390|NCT01443260|oncolytic|oncolytic
1333391|NCT01443260|GL-ONC1|gl-onc1
1333392|NCT01443260|Vaccinia|vaccinia
1333393|NCT01443260|Vaccinia virus|vaccinia virus
1333394|NCT01443260|Genelux|genelux
1333395|NCT01443260|Genelux GmbH|genelux gmbh
1333396|NCT01443260|peritoneal|peritoneal
1333397|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
1333398|NCT01443260|cancer|cancer
1333399|NCT01443260|abdominal cancer|abdominal cancer
1333400|NCT01443260|imaging|imaging
1333401|NCT01443234|Depression|depression
1333402|NCT01443234|Cognitive Bias|cognitive bias
1333403|NCT01443234|Internet|internet
1333404|NCT01443221|mitiglinide|mitiglinide
1333405|NCT01443221|metformin|metformin
1333406|NCT01443221|Pharmacokinetics|pharmacokinetics
1333407|NCT01443221|Safety|safety
1333408|NCT01443208|pharmacokinetics|pharmacokinetics
1333409|NCT01443208|safety|safety
1333410|NCT01443208|desvenlafaxine|desvenlafaxine
1333411|NCT01443208|Korean healthy subjects|korean healthy subjects
1333412|NCT01443169|Pharmacokinetic|pharmacokinetic
1333413|NCT01443169|relative oral bioavailability|relative oral bioavailability
1333414|NCT01443169|pregabalin|pregabalin
1333415|NCT01443156|Diet|diet
1333416|NCT01443156|Sleep deficiency|sleep deficiency
1333417|NCT01443156|Cancer|cancer
1333418|NCT01443156|Obesity|obesity
1333419|NCT01443156|Diabetes|diabetes
1333420|NCT01443156|Shift work|shift work
1333421|NCT01443156|Work schedule|work schedule
1333422|NCT01443156|Cardiovascular disease|cardiovascular disease
1333423|NCT01443156|Body composition|body composition
1333424|NCT01443156|Body mass index|body mass index
1333425|NCT01443156|Body fat percentage|body fat percentage
1333426|NCT01443143|Diabetes|diabetes
1333427|NCT01443143|Obesity|obesity
1333428|NCT01443143|Glycemic|glycemic
1333429|NCT01443143|Portion-control|portion-control
1333430|NCT01443143|Commercial diet|commercial diet
1333431|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
1333432|NCT01443104|coronary artery disease|coronary artery disease
1333433|NCT01443104|drug-eluting stents|drug-eluting stents
1333434|NCT01443104|polymers|polymers
1333435|NCT01443091|very low birth weight infants|very low birth weight infants
1333436|NCT01443091|VLBW infants|vlbw infants
1333437|NCT01443091|colostrum|colostrum
1333438|NCT01443078|Carboplatin|carboplatin
1333439|NCT01443078|Cisplatin|cisplatin
1333440|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
1333441|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
1333442|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
1333443|NCT01443078|Stage IB-III|stage ib-iii
1333444|NCT01443078|non squamous|non squamous
1333445|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
1333446|NCT01443078|11-106|11-106
1333447|NCT01443065|Adenocarcinoma|adenocarcinoma
1333448|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
1333449|NCT01443065|First line treatment|first line treatment
1333450|NCT01443052|Gait stability|gait stability
1333451|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
1333452|NCT01443052|Walking|walking
1333453|NCT01443052|Elderly people|elderly people
1333454|NCT01443052|Stroke|stroke
1333455|NCT01443052|Fallers|fallers
1333456|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
1333457|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
1333458|NCT01443039|Obesity|obesity
1333459|NCT01443039|Drug Availability|drug availability
1333460|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
1333461|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
1333462|NCT01443026|Prostatic neoplasms|prostatic neoplasms
1333463|NCT01443026|Male urogenital disease|male urogenital disease
1333464|NCT01443026|Prostate|prostate
1333465|NCT01443013|Tolerance|tolerance
1333466|NCT01443013|Renal Transplantation|renal transplantation
1333467|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
1333468|NCT01443000|Observational study|observational study
1333469|NCT01443000|IOIS|iois
1333470|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
1333471|NCT01443000|Outcome|outcome
1333472|NCT01443000|Treatment|treatment
1333473|NCT01442987|Irbesartan|irbesartan
1333474|NCT01442987|Atorvastatin|atorvastatin
1333475|NCT01442987|Hypertension|hypertension
1333476|NCT01442987|Hyperlipidemia|hyperlipidemia
1333477|NCT01442974|nab-paclitaxel|nab-paclitaxel
1333478|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
1333479|NCT01442974|SPARC|sparc
1333480|NCT01442974|Pancreatic Cancer|pancreatic cancer
1333481|NCT01442961|pain, postoperative|pain, postoperative
1333482|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
1333483|NCT01442961|surgery, gynecological|surgery, gynecological
1333484|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
1333485|NCT01442935|Adenocarcinoma|adenocarcinoma
1333486|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
1333487|NCT01442935|First-line treatment|first-line treatment
1333488|NCT01442922|L3-L4|l3-l4
1333489|NCT01442922|L4-L5|l4-l5
1333490|NCT01442922|L5-S1|l5-s1
1333491|NCT01442922|Human Meniscus Allograft|human meniscus allograft
1333492|NCT01442922|Nucleus pulposus|nucleus pulposus
1333493|NCT01442922|Minimally invasive surgery|minimally invasive surgery
1333494|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
1333495|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
1333496|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
1333497|NCT01442909|lung cancer|lung cancer
1333498|NCT01442909|docetaxel|docetaxel
1333499|NCT01442909|pemetrexed|pemetrexed
1333500|NCT01442883|Treatment Resistant|treatment resistant
1333501|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
1333502|NCT01442857|Nerve Net|nerve net
1333503|NCT01442857|Brachial Plexus|brachial plexus
1333504|NCT01442857|Nerve block|nerve block
1333505|NCT01442844|Mohs|mohs
1333506|NCT01442844|Scalp|scalp
1333507|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
1333508|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
1333509|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
1333510|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1333511|NCT01442805|Psychophysiological Measures|psychophysiological measures
1333512|NCT01442805|Driving Phobia|driving phobia
1333513|NCT01442805|Flying Phobia|flying phobia
1333514|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
1333515|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1333516|NCT01442779|Interferon alpha|interferon alpha
1333517|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
1333518|NCT01442766|donepezil|donepezil
1333519|NCT01442766|motor|motor
1333520|NCT01442766|stroke|stroke
1333521|NCT01442753|Spanish speaking|spanish speaking
1333522|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1333523|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
1333524|NCT01442727|arsenical melanosis|arsenical melanosis
1333525|NCT01442727|arsenical melanoses|arsenical melanoses
1333526|NCT01442727|arsenical keratosis|arsenical keratosis
1333527|NCT01442727|arsenical keratoses|arsenical keratoses
1333528|NCT01442727|arsenical cancer|arsenical cancer
1333529|NCT01442727|arsenic cancers|arsenic cancers
1333530|NCT01442727|arsenic|arsenic
1333531|NCT01442727|arsenicosis|arsenicosis
1333532|NCT01442727|arsenic exposure|arsenic exposure
1333533|NCT01442727|arsenic toxicity|arsenic toxicity
1333534|NCT01442727|arsenic poisoning|arsenic poisoning
1333535|NCT01442727|drinking water|drinking water
1333536|NCT01442727|selenium|selenium
1333537|NCT01442727|selenite|selenite
1333538|NCT01442727|sodium selenite|sodium selenite
1333539|NCT01442675|Meningitis|meningitis
1333540|NCT01442675|Meningococcal Infection|meningococcal infection
1333541|NCT01442675|Menactra®|menactra®
1333542|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
1333543|NCT01442649|Adenocarcinoma|adenocarcinoma
1333544|NCT01442649|Metastatic|metastatic
1333545|NCT01442649|Second-line treatment|second-line treatment
1333546|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
1333547|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
1333548|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
1333549|NCT01442623|Balance|balance
1333550|NCT01442623|Virtual Reality|virtual reality
1333551|NCT01442623|Gait|gait
1333552|NCT01442623|Dizziness|dizziness
1333553|NCT01442610|Rasagiline|rasagiline
1333554|NCT01442610|Sleep disorder|sleep disorder
1333555|NCT01442610|Parkinson's disease|parkinson's disease
1333556|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
1333557|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
1333558|NCT01442597|computer assisted instruction|computer assisted instruction
1333559|NCT01442597|drug abuse therapy|drug abuse therapy
1333560|NCT01442597|educational resource design and development|educational resource design and development
1333561|NCT01442584|ovary|ovary
1333562|NCT01442584|cortex|cortex
1333563|NCT01442584|transplantation|transplantation
1333564|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
1333565|NCT01442558|relief|relief
1333566|NCT01442558|Intra-operative|intra-operative
1444354|NCT00987545|Keloids|keloids
1333567|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
1333568|NCT01442545|JNJ-39758979|jnj-39758979
1333569|NCT01442545|Methotrexate|methotrexate
1333570|NCT01442532|Healthy male volunteer|healthy male volunteer
1333571|NCT01442532|JNJ-38518168|jnj-38518168
1333572|NCT01442532|Midazolam|midazolam
1333573|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
1333676|NCT01442064|AMD|amd
1333574|NCT01442519|intravesical therapy|intravesical therapy
1333575|NCT01442519|BCG|bcg
1333576|NCT01442519|mitomycin|mitomycin
1333577|NCT01442519|electromotive drug administration|electromotive drug administration
1333578|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
1333579|NCT01442506|acetic acid|acetic acid
1333580|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
1333581|NCT01442493|Methadone Treatment|methadone treatment
1333582|NCT01442493|Opiate dependence|opiate dependence
1333583|NCT01442493|Services research|services research
1333584|NCT01442480|air pollution|air pollution
1333585|NCT01442480|fatty acid supplementation|fatty acid supplementation
1333586|NCT01442467|mitral annular calcification|mitral annular calcification
1333587|NCT01442467|MAC|mac
1333588|NCT01442467|left atrial pressure|left atrial pressure
1333589|NCT01442467|LAP|lap
1333590|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
1333591|NCT01442467|LVEDP|lvedp
1333592|NCT01442467|Echocardiogram|echocardiogram
1333593|NCT01442454|chronic pancreatitis|chronic pancreatitis
1333594|NCT01442441|chronic pancreatitis|chronic pancreatitis
1333595|NCT01442428|TB|tb
1333596|NCT01442428|AIDS|aids
1333597|NCT01442428|HIV|hiv
1333598|NCT01442428|IRIS|iris
1333599|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
1333600|NCT01442428|anti-inflammatory|anti-inflammatory
1333601|NCT01442428|treatment|treatment
1333602|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
1333603|NCT01442376|Palonosetron|palonosetron
1333604|NCT01442376|Ondansetron|ondansetron
1333605|NCT01442376|Pediatric|pediatric
1333606|NCT01442363|Crohn's disease|crohn's disease
1333607|NCT01442363|perianal|perianal
1333608|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
1333609|NCT01442363|fistula|fistula
1333610|NCT01442350|Fabry disease|fabry disease
1333611|NCT01442350|annexin 5|annexin 5
1333612|NCT01442350|miosin|miosin
1333613|NCT01442350|sarcoma|sarcoma
1333614|NCT01442350|alfa-galactosidase|alfa-galactosidase
1333615|NCT01442350|fibrosis|fibrosis
1333616|NCT01442350|apoptosis|apoptosis
1333617|NCT01442350|biomarkers|biomarkers
1333618|NCT01442350|NT-proBNP|nt-probnp
1333619|NCT01442337|de novo kidney transplant|de novo kidney transplant
1333620|NCT01442337|kidney transplant|kidney transplant
1333621|NCT01442337|ASP8597|asp8597
1333622|NCT01442337|diannexin|diannexin
1333623|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
1333624|NCT01442324|Laparotomic surgery|laparotomic surgery
1333625|NCT01442324|Laparoscopic surgery|laparoscopic surgery
1333626|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
1333627|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
1333628|NCT01442311|Hepatitis C Virus|hepatitis c virus
1333629|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
1333630|NCT01442311|Methadone|methadone
1333631|NCT01442311|Injection Drug User|injection drug user
1333632|NCT01442311|Adherence|adherence
1333633|NCT01442311|Directly Observed Treatment|directly observed treatment
1333634|NCT01442298|bloodless field|bloodless field
1333635|NCT01442298|cuff pressure|cuff pressure
1333636|NCT01442298|limb occlusion pressure|limb occlusion pressure
1333637|NCT01442259|Renal impairment,|renal impairment,
1333638|NCT01442259|pharmacokinetics,|pharmacokinetics,
1333639|NCT01442259|safety|safety
1333640|NCT01442246|Benefit of|benefit of
1333641|NCT01442246|adjuvant|adjuvant
1333642|NCT01442246|treatment|treatment
1333643|NCT01442246|prostatectomy|prostatectomy
1333644|NCT01442233|multiple sclerosis|multiple sclerosis
1333645|NCT01442233|plasma exchange|plasma exchange
1333646|NCT01442207|Premature Birth|premature birth
1333647|NCT01442207|Placenta Previa|placenta previa
1333648|NCT01442194|Multiple sclerosis|multiple sclerosis
1333649|NCT01442194|fingolimod|fingolimod
1333650|NCT01442194|observational study|observational study
1333651|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
1333652|NCT01442168|Plasmodium falciparum|plasmodium falciparum
1333653|NCT01442168|Antimalarial treatment|antimalarial treatment
1333654|NCT01442168|Sevuparin/DF02|sevuparin/df02
1333655|NCT01442168|Adjuvant therapy|adjuvant therapy
1333656|NCT01442168|Malanil|malanil
1333657|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
1333658|NCT01442168|Rosette formation|rosette formation
1333659|NCT01442168|Maximum tolerated dose|maximum tolerated dose
1333660|NCT01442155|Colorectal cancer|colorectal cancer
1333661|NCT01442155|Adjuvant setting|adjuvant setting
1333662|NCT01442155|Capecitabine|capecitabine
1333663|NCT01442155|Oxaliplatin|oxaliplatin
1333664|NCT01442142|obesity|obesity
1333665|NCT01442142|pediatric|pediatric
1333666|NCT01442142|childhood|childhood
1333667|NCT01442142|overweight|overweight
1333668|NCT01442129|Heart Failure|heart failure
1333669|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
1333670|NCT01442129|Heart Transplantation|heart transplantation
1333671|NCT01442129|Cardiomyopathy|cardiomyopathy
1333672|NCT01442129|Destination Therapy|destination therapy
1333673|NCT01442129|Cell Therapy|cell therapy
1333675|NCT01442064|Lucentis|lucentis
1333677|NCT01442064|Age-related macular degeneration|age-related macular degeneration
1333678|NCT01442064|RVO|rvo
1333679|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
1333680|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
1333681|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
1333682|NCT01442051|laparotomy|laparotomy
1333683|NCT01442051|11-149|11-149
1333684|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
1333685|NCT01442025|Crohn's Disease|crohn's disease
1333686|NCT01442025|IFX trough level|ifx trough level
1333687|NCT01442012|PONV|ponv
1333688|NCT01442012|ACUPUNCTURE|acupuncture
1333689|NCT01441999|Rigid rods|rigid rods
1333690|NCT01441999|less rigid rods|less rigid rods
1333691|NCT01441999|prevent kyphosis|prevent kyphosis
1333692|NCT01441999|long constructs|long constructs
1333693|NCT01441986|dextromethorphan|dextromethorphan
1333694|NCT01441986|amantadine|amantadine
1333695|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
1333696|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
1333697|NCT01441960|Succinylcholine|succinylcholine
1333698|NCT01441960|Rocuronium|rocuronium
1333699|NCT01441960|ECT|ect
1333700|NCT01441947|ER+|er+
1333701|NCT01441947|PR+|pr+
1333702|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
1333703|NCT01441947|metastatic|metastatic
1333704|NCT01441921|pistachio intake|pistachio intake
1333705|NCT01441921|insulin resistance|insulin resistance
1333706|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
1333707|NCT01441908|Cardiovascular|cardiovascular
1333708|NCT01441908|Multi-analyte|multi-analyte
1333709|NCT01441908|Statin|statin
1333710|NCT01441908|Dyslipidemia|dyslipidemia
1333711|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
1333712|NCT01441895|Femtosecond laser|femtosecond laser
1333713|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
1333714|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
1333715|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
1333716|NCT01441856|Open|open
1333717|NCT01441856|Laparoscopic|laparoscopic
1333718|NCT01441856|Hemihepatectomy|hemihepatectomy
1333719|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
1333720|NCT01441856|Functional recovery|functional recovery
1333721|NCT01441843|quality of life|quality of life
1333722|NCT01441843|lorazepam|lorazepam
1333723|NCT01441843|anxiety|anxiety
1333724|NCT01441843|premedication|premedication
1333725|NCT01441843|surgery|surgery
1333726|NCT01441843|Adult patients|adult patients
1333727|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
1333728|NCT01441843|Postoperative Period|postoperative period
1333729|NCT01441830|shoulder|shoulder
1333730|NCT01441830|subacromial|subacromial
1333731|NCT01441830|impingement|impingement
1333732|NCT01441830|tendinopathy|tendinopathy
1333733|NCT01441830|rESWT|reswt
1333734|NCT01441830|shock wave|shock wave
1333735|NCT01441830|ESWT|eswt
1333736|NCT01441830|RSWT|rswt
1333737|NCT01441791|PEEP|peep
1333738|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
1333739|NCT01441791|Recruitment maneuver|recruitment maneuver
1333740|NCT01441791|Open lung approach|open lung approach
1333741|NCT01441791|Post-operative complications|post-operative complications
1333742|NCT01441791|Open abdominal surgery|open abdominal surgery
1333743|NCT01441778|nasal irrigation|nasal irrigation
1333744|NCT01441778|allergic rhinitis|allergic rhinitis
1333745|NCT01441778|children|children
1333746|NCT01441765|Kidney|kidney
1333747|NCT01441765|Metastatic|metastatic
1333748|NCT01441765|Stage IV|stage iv
1333749|NCT01441726|Advanced dementia|advanced dementia
1333750|NCT01441726|Quality|quality
1333751|NCT01441726|Terminal care|terminal care
1333752|NCT01441713|Hormone treatment|hormone treatment
1333753|NCT01441713|castration|castration
1333754|NCT01441713|Orchiectomy|orchiectomy
1333755|NCT01441713|treatment frequency|treatment frequency
1333756|NCT01441713|treatment satisfaction|treatment satisfaction
1333757|NCT01441713|side effects|side effects
1333758|NCT01441700|Prone emergence|prone emergence
1333759|NCT01441700|supine emergence|supine emergence
1333760|NCT01441700|coughing|coughing
1333761|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
1333762|NCT01441700|lumbar surgery|lumbar surgery
1333763|NCT01441687|Health status unknown|health status unknown
1333764|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
1333765|NCT01441674|Occupational Therapy|occupational therapy
1333766|NCT01441661|Sunitinib|sunitinib
1333767|NCT01441661|kidney diseases|kidney diseases
1333768|NCT01441661|urogenital neoplasms|urogenital neoplasms
1333769|NCT01441661|kidney cancer|kidney cancer
1333770|NCT01441648|conjunctival injection|conjunctival injection
1333771|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
1333772|NCT01441648|pannus formation|pannus formation
1333773|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
1333774|NCT01441648|Schirmer test|schirmer test
1333775|NCT01441648|Impression cytology|impression cytology
1333776|NCT01441648|confocal microscopy|confocal microscopy
1333777|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
1333778|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
1333779|NCT01441635|Elagolix|elagolix
1333780|NCT01441635|Uterine Fibroids|uterine fibroids
1333781|NCT01441635|Elagolix sodium|elagolix sodium
1333782|NCT01441635|Leiomyomata|leiomyomata
1333783|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
1333784|NCT01441635|Menorrhagia|menorrhagia
1333785|NCT01441635|ABT-620|abt-620
1333786|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
1333787|NCT01441622|AL539|al539
1333788|NCT01441622|Home-monitoring|home-monitoring
1333789|NCT01441609|Th9 cells|th9 cells
1333790|NCT01441609|IL9|il9
1333791|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
1333792|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
1333793|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
1333794|NCT01441570|kidney|kidney
1333795|NCT01441570|transplant|transplant
1333796|NCT01441570|hypertension|hypertension
1333797|NCT01441570|nebivolol|nebivolol
1333798|NCT01441570|metoprolol|metoprolol
1333799|NCT01441570|bystolic|bystolic
1333800|NCT01441570|toprol|toprol
1333801|NCT01441557|mechanical ventilation|mechanical ventilation
1333802|NCT01441544|active video games|active video games
1333803|NCT01441544|Energy expenditure|energy expenditure
1333804|NCT01441531|narcotic use|narcotic use
1333805|NCT01441531|Other Acute Pain|other acute pain
1333806|NCT01441492|Distal pancreatectomy|distal pancreatectomy
1333807|NCT01441492|Pancreas resection|pancreas resection
1333808|NCT01441466|bronchiolitis|bronchiolitis
1333809|NCT01441466|RSV|rsv
1333810|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
1333811|NCT01441453|Cirrhosis|cirrhosis
1333812|NCT01441453|Liver resection|liver resection
1333813|NCT01441453|FibroScan|fibroscan
1333814|NCT01441440|venlafaxine ER|venlafaxine er
1333815|NCT01441440|Major depressive disorder|major depressive disorder
1333816|NCT01441440|Japan|japan
1333817|NCT01441440|placebo-controlled|placebo-controlled
1333818|NCT01441427|feeding intolerance|feeding intolerance
1333819|NCT01441427|recombinant growth factors|recombinant growth factors
1333820|NCT01441427|G-CSF|g-csf
1333821|NCT01441427|EPO|epo
1333822|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
1333823|NCT01441414|CVX-060|cvx-060
1333824|NCT01441414|PF-04856884|pf-04856884
1333825|NCT01441414|AG-013736|ag-013736
1333826|NCT01441414|axitinib|axitinib
1333827|NCT01441414|mRCC|mrcc
1333828|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
1333829|NCT01441414|second line|second line
1333830|NCT01441414|anti-angiogenic|anti-angiogenic
1333831|NCT01441414|Ang-2|ang-2
1333832|NCT01441401|Gabapentin|gabapentin
1333833|NCT01441401|Epilepsies|epilepsies
1333834|NCT01441401|safety|safety
1333835|NCT01441388|Phase 1b|phase 1b
1333836|NCT01441388|crizotinib|crizotinib
1333837|NCT01441388|sunitinib|sunitinib
1333838|NCT01441388|axitinib|axitinib
1333839|NCT01441388|sorafenib|sorafenib
1333840|NCT01441388|bevacizumab|bevacizumab
1333841|NCT01441388|cMET inhibitor|cmet inhibitor
1333842|NCT01441388|VEGF inhibitor|vegf inhibitor
1333843|NCT01441388|crizotinib combination|crizotinib combination
1333844|NCT01441375|Sickle cell anemia|sickle cell anemia
1333845|NCT01441362|during double-lumen|during double-lumen
1333846|NCT01441362|tube intubation|tube intubation
1333847|NCT01441349|Simvastatin|simvastatin
1333848|NCT01441349|SCLC|sclc
1333849|NCT01441349|Extensive Disease|extensive disease
1333850|NCT01441323|Obesity|obesity
1333851|NCT01441323|Type 2 Diabetes|type 2 diabetes
1333852|NCT01441323|Cardiovascular Risk|cardiovascular risk
1333853|NCT01441323|Cancer|cancer
1333854|NCT01441323|African American|african american
1333855|NCT01441323|Adolescents|adolescents
1333856|NCT01441323|Strength Training|strength training
1333857|NCT01441323|Nutrition|nutrition
1333858|NCT01441310|Gastric cancer|gastric cancer
1333859|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
1333860|NCT01441310|Dual method|dual method
1333861|NCT01441310|Recurrence|recurrence
1333862|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
1333863|NCT01441284|pramipexole|pramipexole
1333864|NCT01441284|essential tremor|essential tremor
1444750|NCT00986089|IUD|iud
1333865|NCT01441284|cross-over|cross-over
1333866|NCT01441245|acute heart failure|acute heart failure
1333867|NCT01441245|diuretics|diuretics
1333868|NCT01441245|BNP|bnp
1333869|NCT01441245|Renal function|renal function
1333870|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
1333871|NCT01441245|volume overload|volume overload
1333872|NCT01441206|rifampin|rifampin
1333873|NCT01441206|infants|infants
1333874|NCT01441193|HIV|hiv
1333875|NCT01441193|preventive vaccine|preventive vaccine
1333876|NCT01441193|Tat|tat
1333877|NCT01441193|Env|env
1333878|NCT01441180|Direct Acting Antiviral|direct acting antiviral
1333879|NCT01441180|Liver|liver
1333880|NCT01441180|Hepatitis C|hepatitis c
1333881|NCT01441180|HCV|hcv
1333882|NCT01441167|Healthy Subjects|healthy subjects
1333883|NCT01441167|Immunogenicity|immunogenicity
1333884|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
1333885|NCT01441167|Sporozoites|sporozoites
1333886|NCT01441167|Parasitemia|parasitemia
1333887|NCT01441167|Healthy Volunteer|healthy volunteer
1333888|NCT01441167|HV|hv
1333889|NCT01441154|Hypothyroidism|hypothyroidism
1333890|NCT01441154|Thyroid Cancer|thyroid cancer
1333891|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
1333892|NCT01441154|Energy Expenditure|energy expenditure
1333893|NCT01441154|Thyroid Hormone|thyroid hormone
1333894|NCT01441141|GCH1|gch1
1333895|NCT01441141|Pain Sensitivity|pain sensitivity
1333896|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
1333897|NCT01441141|Genetic Variation|genetic variation
1333898|NCT01441141|Sickle Cell Anemia|sickle cell anemia
1333899|NCT01441128|Lung Neoplasms|lung neoplasms
1333900|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
1333901|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1333902|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
1333903|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1333904|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
1333905|NCT01441128|NSCLC|nsclc
1333906|NCT01441115|Metastasis|metastasis
1333907|NCT01441115|Cancer|cancer
1333908|NCT01441115|Radiation Therapy|radiation therapy
1333909|NCT01441115|Locally Advanced|locally advanced
1333910|NCT01441115|Palliation|palliation
1333911|NCT01441115|Metastatic Cancer|metastatic cancer
1333912|NCT01441102|Diabetic Macular Edema|diabetic macular edema
1333913|NCT01441102|Microglia|microglia
1333914|NCT01441102|Dextromethorphan|dextromethorphan
1333915|NCT01441089|Pharmacogenetics|pharmacogenetics
1333916|NCT01441089|Pharmacokinetics|pharmacokinetics
1333917|NCT01441089|Pharmacodynamics|pharmacodynamics
1333918|NCT01441089|Clinical Outcome|clinical outcome
1333919|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
1333920|NCT01441089|Cancer|cancer
1333921|NCT01441076|Behcet's Disease|behcet's disease
1333922|NCT01441076|Aphthous Ulcer|aphthous ulcer
1333923|NCT01441076|Uveitis|uveitis
1333924|NCT01441076|IL-1|il-1
1333925|NCT01441076|Autoinflammation|autoinflammation
1333926|NCT01441076|BD|bd
1333927|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
1333928|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
1333929|NCT01441063|Tocilizumab|tocilizumab
1333930|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
1333931|NCT01441063|Interleukin-6|interleukin-6
1333932|NCT01441063|Castleman Disease|castleman disease
1333933|NCT01441037|Aplastic Anemia|aplastic anemia
1333934|NCT01441037|Androgen|androgen
1333935|NCT01441037|Telomeres|telomeres
1333936|NCT01441024|Immunocompromised|immunocompromised
1333937|NCT01441024|Respiratory Tract Disease|respiratory tract disease
1333938|NCT01441024|Viral Shedding|viral shedding
1333939|NCT01441024|Fever|fever
1333940|NCT01441024|Pharmacokinetics|pharmacokinetics
1333941|NCT01441024|Parainfluenza Infection|parainfluenza infection
1333942|NCT01441024|Flu|flu
1333943|NCT01441011|weight loss|weight loss
1333944|NCT01441011|breast cancer|breast cancer
1333945|NCT01441011|obesity|obesity
1333946|NCT01441011|overweight|overweight
1333947|NCT01441011|rural women|rural women
1333948|NCT01441011|community based|community based
1333949|NCT01441011|Secondary Prevention|secondary prevention
1333950|NCT01440985|Tooth Staining|tooth staining
1333951|NCT01440972|knee osteoarthritis|knee osteoarthritis
1333952|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
1333953|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
1333954|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
1333955|NCT01440972|quadriceps volume|quadriceps volume
1333956|NCT01440959|This is a single-center|this is a single-center
1333957|NCT01440959|prospective|prospective
1333958|NCT01440959|single-arm|single-arm
1333959|NCT01440959|open-label phase II study|open-label phase ii study
1333960|NCT01440933|sugammadex|sugammadex
1333961|NCT01440933|rocuronium|rocuronium
1333962|NCT01440933|magnesiumsulphate|magnesiumsulphate
1333963|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
1333964|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
1333966|NCT01440907|Health Information Technology|health information technology
1333967|NCT01440907|Health Records, Personal|health records, personal
1333968|NCT01440907|Hospital Information Systems|hospital information systems
1333969|NCT01440907|Patient Access to Records|patient access to records
1333970|NCT01440907|Medical Records|medical records
1333971|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
1333972|NCT01440894|weight|weight
1333973|NCT01440894|body fat|body fat
1333974|NCT01440894|total body water|total body water
1333975|NCT01440894|bone mass|bone mass
1333976|NCT01440894|muscle mass|muscle mass
1333977|NCT01440881|renal failure|renal failure
1333978|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
1334172|NCT01440218|Idiopathic diseases|idiopathic diseases
1333979|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
1333980|NCT01440868|Delivery Rooms|delivery rooms
1333981|NCT01440868|Resuscitation|resuscitation
1333982|NCT01440868|Premature Birth|premature birth
1333983|NCT01440868|Infant, Newborn|infant, newborn
1333984|NCT01440868|Respiration, Artificial|respiration, artificial
1333985|NCT01440855|Survivorship|survivorship
1333986|NCT01440855|cancer control|cancer control
1333987|NCT01440855|psychosocial interventions|psychosocial interventions
1333988|NCT01440855|Facing Forward|facing forward
1333989|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
1333990|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
1333991|NCT01440829|TIPS|tips
1333992|NCT01440829|Liver Cirrhosis|liver cirrhosis
1333993|NCT01440829|LOLA|lola
1333994|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
1333995|NCT01440829|Refractory Ascites|refractory ascites
1333996|NCT01440803|osteoporosis|osteoporosis
1333997|NCT01440803|premenopausal|premenopausal
1333998|NCT01440803|forteo|forteo
1333999|NCT01440803|idiopathic|idiopathic
1334000|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
1334001|NCT01440777|Insomnia|insomnia
1334002|NCT01440777|Sleep|sleep
1334003|NCT01440777|Stress|stress
1334004|NCT01440777|Online program|online program
1334005|NCT01440777|Web-based program|web-based program
1334006|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
1334007|NCT01440764|dyspnea|dyspnea
1334008|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
1334009|NCT01440751|ologen collagen matrix|ologen collagen matrix
1334010|NCT01440751|mitomycin-C|mitomycin-c
1334011|NCT01440751|trabeculectomy|trabeculectomy
1334012|NCT01440751|glaucoma|glaucoma
1334013|NCT01440751|filtering surgery|filtering surgery
1334014|NCT01440738|general population|general population
1334015|NCT01440725|muscle|muscle
1334016|NCT01440725|injuries|injuries
1334017|NCT01440725|platelet-rich plasma|platelet-rich plasma
1334018|NCT01440725|autologous|autologous
1334019|NCT01440725|haematoma|haematoma
1334020|NCT01440712|Gastrografin|gastrografin
1334021|NCT01440712|Postoperative ileus|postoperative ileus
1334022|NCT01440712|Colo-rectal surgery|colo-rectal surgery
1334023|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
1334024|NCT01440699|Crohn's fistula|crohn's fistula
1334025|NCT01440686|Pharmacokinetics|pharmacokinetics
1334026|NCT01440686|Pharmacodynamics|pharmacodynamics
1334027|NCT01440686|Safety|safety
1334028|NCT01440686|Male|male
1334029|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1334030|NCT01440647|Respiration, Artificial|respiration, artificial
1334031|NCT01440647|Infant, Premature|infant, premature
1334032|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1334033|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
1334034|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
1334035|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
1334036|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
1334037|NCT01440634|Peripheral arterial disease|peripheral arterial disease
1334038|NCT01440634|Community Medicine|community medicine
1334039|NCT01440634|Exercise Test|exercise test
1334040|NCT01440634|Exercise Therapy|exercise therapy
1334041|NCT01440621|Cancer related fatigue|cancer related fatigue
1334042|NCT01440621|Quality of life|quality of life
1334043|NCT01440621|Modafinil|modafinil
1334044|NCT01440621|Radiation therapy|radiation therapy
1334045|NCT01440621|Radiotherapy|radiotherapy
1334046|NCT01440582|Myeloma|myeloma
1334047|NCT01440582|Multiple Myeloma|multiple myeloma
1334048|NCT01440582|MM|mm
1334049|NCT01440582|Newly diagnosed|newly diagnosed
1334050|NCT01440582|Transplant eligible|transplant eligible
1334051|NCT01440582|Panobinostat|panobinostat
1334052|NCT01440582|LBH589B|lbh589b
1334053|NCT01440582|Bortezomib|bortezomib
1334054|NCT01440582|Velcade|velcade
1334055|NCT01440582|LDP-341|ldp-341
1334056|NCT01440582|MLN341|mln341
1334057|NCT01440582|PS-341|ps-341
1334058|NCT01440582|Lenalidomide|lenalidomide
1334059|NCT01440582|CC-5013|cc-5013
1334060|NCT01440582|Revlimid|revlimid
1334061|NCT01440582|Dexamethasone|dexamethasone
1334062|NCT01440582|Decadron|decadron
1334063|NCT01440582|Symptom questionnaire|symptom questionnaire
1334064|NCT01440582|Survey|survey
1334065|NCT01440569|HIV-1|hiv-1
1334066|NCT01440569|HIV|hiv
1334067|NCT01440569|Treatment Naïve|treatment naïve
1334068|NCT01440569|Treatment Experienced|treatment experienced
1334069|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1334070|NCT01440556|Multiple myeloma|multiple myeloma
1334071|NCT01440543|colonoscopy|colonoscopy
1334072|NCT01440543|water immersion|water immersion
1334073|NCT01440543|CO2 insufflation|co2 insufflation
1334074|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
1334075|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
1334587|NCT01438593|Cord Blood|cord blood
1334076|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
1334077|NCT01440530|Diabetes Internet Education|diabetes internet education
1334078|NCT01440530|Diabetes Education|diabetes education
1334079|NCT01440530|Diabetes Self-Care|diabetes self-care
1334080|NCT01440530|Diabetes Self-Management|diabetes self-management
1334081|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
1334082|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
1334083|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
1334084|NCT01440517|EKG - Echocardiography|ekg - echocardiography
1334085|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
1334086|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
1334087|NCT01440504|Cancer|cancer
1334088|NCT01440504|Ovarian|ovarian
1334089|NCT01440504|chemotherapy|chemotherapy
1334090|NCT01440504|BH3-mimetic|bh3-mimetic
1334091|NCT01440504|platin|platin
1334092|NCT01440504|ex-vivo|ex-vivo
1334093|NCT01440491|low back pain|low back pain
1334094|NCT01440491|exercise|exercise
1334095|NCT01440491|booklet|booklet
1334096|NCT01440465|chemotherapy|chemotherapy
1334097|NCT01440465|cancer|cancer
1334098|NCT01440465|nausea|nausea
1334099|NCT01440465|vomiting|vomiting
1334100|NCT01440452|TM|tm
1334101|NCT01440452|MS|ms
1334102|NCT01440452|Spinal Cord Injury|spinal cord injury
1334103|NCT01440452|Functional electrical stimulation|functional electrical stimulation
1334104|NCT01440452|Rehabilitation|rehabilitation
1334105|NCT01440452|Growth factors|growth factors
1334106|NCT01440452|Cytokines|cytokines
1334107|NCT01440439|insulin glargine|insulin glargine
1334108|NCT01440439|insulin detemir|insulin detemir
1334109|NCT01440439|hypoglycaemia|hypoglycaemia
1334110|NCT01440439|metabolism|metabolism
1334111|NCT01440439|Exercise|exercise
1334112|NCT01440426|gingival recession|gingival recession
1334113|NCT01440426|root coverage|root coverage
1334114|NCT01440426|periodontal surgery|periodontal surgery
1334115|NCT01440426|collagen matrix|collagen matrix
1334116|NCT01440426|mucograft|mucograft
1334117|NCT01440426|multiple exposed teeth|multiple exposed teeth
1334118|NCT01440413|anti-tumor immune response|anti-tumor immune response
1334119|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1334120|NCT01440413|relapse|relapse
1334121|NCT01440413|long term survival|long term survival
1334122|NCT01440413|histo-pathological response|histo-pathological response
1334123|NCT01440413|tumor cell death|tumor cell death
1334124|NCT01440413|tumor associated antigens|tumor associated antigens
1334125|NCT01440413|Calreticulin|calreticulin
1334126|NCT01440413|Localized breast cancer|localized breast cancer
1334127|NCT01440400|Ultrasound|ultrasound
1334128|NCT01440400|Spinal anesthesia|spinal anesthesia
1334129|NCT01440400|Cesarean section|cesarean section
1334130|NCT01440387|Influenza|influenza
1334131|NCT01440387|Phase III|phase iii
1334132|NCT01440387|Seasonal influenza|seasonal influenza
1334133|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1334134|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1334135|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
1334136|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
1334137|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
1334138|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
1334139|NCT01440348|Achilles allograft|achilles allograft
1334140|NCT01440348|cruciate ligament|cruciate ligament
1334141|NCT01440348|reconstruction|reconstruction
1334142|NCT01440335|Fenoterol|fenoterol
1334143|NCT01440335|Pharmacodynamics|pharmacodynamics
1334144|NCT01440335|Pharmacokinetics|pharmacokinetics
1334145|NCT01440335|Safety|safety
1334146|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
1334147|NCT01440322|Myopia|myopia
1334148|NCT01440322|Contact lenses|contact lenses
1334149|NCT01440309|biliary cirrhosis|biliary cirrhosis
1334150|NCT01440283|Neuroblastoma|neuroblastoma
1334151|NCT01440283|Radiation Therapy|radiation therapy
1334152|NCT01440270|Oral cancer|oral cancer
1334153|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
1334154|NCT01440270|Induction chemotherapy|induction chemotherapy
1334155|NCT01440270|Targeted chemotherapy|targeted chemotherapy
1334156|NCT01440270|Surgery|surgery
1334157|NCT01440270|Radiotherapy|radiotherapy
1334158|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
1334159|NCT01440244|mediastinoscopy|mediastinoscopy
1334160|NCT01440244|pleural evaluation|pleural evaluation
1334161|NCT01440244|pleural biopsy|pleural biopsy
1334162|NCT01440244|pleurodesis|pleurodesis
1334163|NCT01440231|Rheumatology|rheumatology
1334164|NCT01440231|Double-Blind|double-blind
1334165|NCT01440231|Placebo-Controlled|placebo-controlled
1334166|NCT01440231|Multidose|multidose
1334167|NCT01440231|Dose-Response|dose-response
1334168|NCT01440231|Phase II|phase ii
1334169|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
1334170|NCT01440231|SLE|sle
1334171|NCT01440231|Atacicept|atacicept
1335272|NCT01435733|Divorce|divorce
1334173|NCT01440218|family member of the affected individual|family member of the affected individual
1334174|NCT01440218|unknown etiology|unknown etiology
1334175|NCT01440205|Flu Shot|flu shot
1334176|NCT01440192|Sarcoidosis|sarcoidosis
1334177|NCT01440192|Stem cells|stem cells
1334178|NCT01440192|PDA001|pda001
1334179|NCT01440192|Celgene|celgene
1334180|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
1334181|NCT01440192|Cenplacel-L|cenplacel-l
1334182|NCT01440166|Human healthy volunteers|human healthy volunteers
1334183|NCT01440153|Dance|dance
1334184|NCT01440153|Injury|injury
1334185|NCT01440153|Physical condition|physical condition
1334186|NCT01440153|Exercise|exercise
1334187|NCT01440114|emergence agitation|emergence agitation
1334188|NCT01440114|pediatric patient|pediatric patient
1334189|NCT01440114|fentanyl|fentanyl
1334190|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
1334191|NCT01440114|severity of emergence agitation|severity of emergence agitation
1334192|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
1334193|NCT01440088|TH-302|th-302
1334194|NCT01440088|TH-CR-406|th-cr-406
1334195|NCT01440088|SARC021|sarc021
1334196|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
1334197|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
1334198|NCT01440088|Sarcoma|sarcoma
1334199|NCT01440088|Doxorubicin|doxorubicin
1334200|NCT01440088|Evofosfamide|evofosfamide
1334201|NCT01440075|Kawasaki disease|kawasaki disease
1334202|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
1334203|NCT01440036|carotid artery|carotid artery
1334204|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
1334205|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
1334206|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
1334207|NCT01440023|tic disorder|tic disorder
1334208|NCT01440023|tourette syndrome|tourette syndrome
1334209|NCT01440023|habit reversal|habit reversal
1334210|NCT01440023|response inhibition|response inhibition
1334211|NCT01440023|cognitive retraining|cognitive retraining
1334212|NCT01440010|IORT|iort
1334213|NCT01440010|Boost|boost
1334214|NCT01440010|Breast cancer|breast cancer
1334215|NCT01440010|Local recurrence|local recurrence
1334216|NCT01440010|Toxicity|toxicity
1334217|NCT01440010|LENT SOMA|lent soma
1334218|NCT01440010|TARGIT|targit
1334219|NCT01440010|Quality Control Registry|quality control registry
1334220|NCT01439997|Nocturnal polyuria|nocturnal polyuria
1334221|NCT01439984|PE|pe
1334222|NCT01439984|IELT|ielt
1334223|NCT01439984|DCIT|dcit
1334224|NCT01439971|Phase 1|phase 1
1334225|NCT01439971|Safety|safety
1334226|NCT01439971|Pharmacokinetic|pharmacokinetic
1334227|NCT01439971|Pharmacodynamic|pharmacodynamic
1334228|NCT01439958|Inhalation|inhalation
1334229|NCT01439958|Lung Transplantation|lung transplantation
1334230|NCT01439958|Cyclosporine|cyclosporine
1334231|NCT01439945|hot flashes|hot flashes
1334232|NCT01439945|cancer survivor|cancer survivor
1334233|NCT01439945|breast cancer|breast cancer
1334234|NCT01439932|plantar fasciitis|plantar fasciitis
1334235|NCT01439932|heel pain|heel pain
1334236|NCT01439932|manual treatment|manual treatment
1334237|NCT01439932|dorsi flexion|dorsi flexion
1334238|NCT01439906|Degenerative scoliosis|degenerative scoliosis
1334239|NCT01439906|Pain|pain
1334240|NCT01439906|Deformity correction|deformity correction
1334241|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
1334242|NCT01439893|Chronic heart failure|chronic heart failure
1334243|NCT01439893|rhNRG-1|rhnrg-1
1334244|NCT01439893|Cardiac remodeling|cardiac remodeling
1334245|NCT01439880|High cholesterol|high cholesterol
1334246|NCT01439880|Raised cholesterol|raised cholesterol
1334247|NCT01439880|Cholesterol|cholesterol
1334248|NCT01439880|Elevated Cholesterol|elevated cholesterol
1334249|NCT01439867|Dialysis|dialysis
1334250|NCT01439867|Sensipar|sensipar
1334251|NCT01439867|Mimpara|mimpara
1334252|NCT01439867|Hemodialysis|hemodialysis
1334253|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
1334254|NCT01439867|Renal|renal
1334255|NCT01439867|Parathyroid hormone|parathyroid hormone
1334256|NCT01439867|Pediatric|pediatric
1334257|NCT01439854|Insulin sensitivity|insulin sensitivity
1334258|NCT01439854|Mitochondrial function|mitochondrial function
1334259|NCT01439854|Glucose toxicity|glucose toxicity
1334260|NCT01439854|Glucosuria|glucosuria
1334262|NCT01439841|microbial translocation|microbial translocation
1334263|NCT01439841|immune activation|immune activation
1334264|NCT01439841|probiotics|probiotics
1334265|NCT01439828|Cannabis|cannabis
1334266|NCT01439828|N-Acetylcystein|n-acetylcystein
1334267|NCT01439828|Dependence|dependence
1334268|NCT01439828|Abuse|abuse
1334269|NCT01439828|Craving|craving
1334270|NCT01439828|Genetic|genetic
1334271|NCT01439802|Postpartum IUD|postpartum iud
1334272|NCT01439802|Cesarean Delivery|cesarean delivery
1334273|NCT01439802|6 months postpartum|6 months postpartum
1334274|NCT01439802|satisfaction|satisfaction
1335373|NCT01435278|Overweight|overweight
1334275|NCT01439789|Chronic Heart Failure|chronic heart failure
1334276|NCT01439789|rhNRG-1|rhnrg-1
1334277|NCT01439789|NT-proBNP|nt-probnp
1334278|NCT01439776|chronic hepatitis C|chronic hepatitis c
1334279|NCT01439776|SVR|svr
1334280|NCT01439776|Vit D|vit d
1334281|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
1334282|NCT01439776|Ribavirin|ribavirin
1334283|NCT01439763|Bullies|bullies
1334284|NCT01439763|Bully victims|bully victims
1334285|NCT01439763|Psychiatric symptoms|psychiatric symptoms
1334286|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
1334287|NCT01439750|lymphoma|lymphoma
1334288|NCT01439737|Asthma|asthma
1334289|NCT01439737|metabolomics|metabolomics
1334290|NCT01439737|exhaled breath condensate|exhaled breath condensate
1334291|NCT01439724|Oral mucositis|oral mucositis
1334292|NCT01439724|Low Level Laser Therapy|low level laser therapy
1334293|NCT01439724|Head and neck cancer|head and neck cancer
1334294|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1334295|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1334296|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
1334297|NCT01439698|Pancreatic Cancer|pancreatic cancer
1334298|NCT01439698|Bile Duct Cancer|bile duct cancer
1334299|NCT01439698|Biliary Stricture|biliary stricture
1334300|NCT01439698|Bile duct obstruction|bile duct obstruction
1334301|NCT01439698|ENDOHPB|endohpb
1334302|NCT01439698|Radio Frequency Ablation|radio frequency ablation
1334303|NCT01439698|RFA|rfa
1334304|NCT01439698|ERCP|ercp
1334305|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1334306|NCT01439698|Registry|registry
1334307|NCT01439698|Multicenter|multicenter
1334308|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
1334309|NCT01439685|PDT|pdt
1334310|NCT01439685|Photodynamic Therapy|photodynamic therapy
1334311|NCT01439685|Bile Duct|bile duct
1334312|NCT01439685|Bile Duct Obstruction|bile duct obstruction
1334313|NCT01439685|Jaundice|jaundice
1334314|NCT01439685|Biliary Stent|biliary stent
1334315|NCT01439685|ERCP|ercp
1334316|NCT01439685|Obstructive Jaundice|obstructive jaundice
1334317|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1334318|NCT01439659|Ovarian Cancer|ovarian cancer
1334319|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
1334320|NCT01439659|First clinical remission|first clinical remission
1334321|NCT01439659|Nutritional Supplements|nutritional supplements
1334322|NCT01439659|Juice Plus +|juice plus +
1334323|NCT01439659|Juice Plus + Complete|juice plus + complete
1334324|NCT01439659|Dietary counseling|dietary counseling
1334325|NCT01439646|empirical|empirical
1334326|NCT01439646|ICU|icu
1334327|NCT01439646|high risk patient|high risk patient
1334328|NCT01439633|Barrett's Esophagus|barrett's esophagus
1334329|NCT01439633|Esophagus|esophagus
1334330|NCT01439633|OCT|oct
1334331|NCT01439633|Imaging|imaging
1334332|NCT01439620|Biliary Stricture|biliary stricture
1334333|NCT01439620|OCT|oct
1334334|NCT01439620|Imaging|imaging
1334335|NCT01439607|Gaucher disease|gaucher disease
1334336|NCT01439594|Barrett's Esophagus|barrett's esophagus
1334337|NCT01439594|Esophagus|esophagus
1334338|NCT01439594|OCT|oct
1334339|NCT01439594|Imaging|imaging
1334340|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
1334341|NCT01439594|BARRX|barrx
1334342|NCT01439581|patients|patients
1334343|NCT01439581|susceptible to|susceptible to
1334344|NCT01439581|hospital|hospital
1334345|NCT01439581|acquired pressure|acquired pressure
1334346|NCT01439568|Cancer|cancer
1334347|NCT01439568|Lung|lung
1334348|NCT01439568|Metastasis|metastasis
1334349|NCT01439555|Early Alzheimer|early alzheimer
1334350|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
1334351|NCT01439555|Drug treatment|drug treatment
1334352|NCT01439555|Cerebral blood flow|cerebral blood flow
1334353|NCT01439555|Endothelial facilitation|endothelial facilitation
1334354|NCT01439555|Cognitive improvement|cognitive improvement
1334355|NCT01439542|High risk prostate cancer|high risk prostate cancer
1334356|NCT01439529|Cardiac|cardiac
1334357|NCT01439529|Resynchronization|resynchronization
1334358|NCT01439529|Therapy|therapy
1334359|NCT01439477|exercise|exercise
1334360|NCT01439477|healthy eating|healthy eating
1334361|NCT01439477|heart disease|heart disease
1334362|NCT01439477|prevention & control|prevention & control
1334363|NCT01439477|Middle aged|middle aged
1334364|NCT01439477|Women|women
1334365|NCT01439477|Health promotion|health promotion
1334366|NCT01439451|Balance control|balance control
1334367|NCT01439451|Aging|aging
1334368|NCT01439451|Balance reactions|balance reactions
1334369|NCT01439451|Perturbation|perturbation
1334370|NCT01439451|above seventy years old|above seventy years old
1334371|NCT01439425|psoriasis|psoriasis
1334372|NCT01439425|obesity|obesity
1334373|NCT01439425|body mass index|body mass index
1334374|NCT01439425|disease remission|disease remission
1334375|NCT01439425|diet|diet
1334376|NCT01439412|Low back pain|low back pain
1334377|NCT01439412|Acupuncture|acupuncture
1334378|NCT01439412|General practice|general practice
1334379|NCT01439399|postoperative pain|postoperative pain
1334380|NCT01439399|postoperative care|postoperative care
1334381|NCT01439399|intravenous lidocaine|intravenous lidocaine
1334382|NCT01439399|intravenous ketamine|intravenous ketamine
1334383|NCT01439399|morphine consumption|morphine consumption
1334384|NCT01439373|chronic hepatitis C|chronic hepatitis c
1334385|NCT01439373|NS5A inhibitor|ns5a inhibitor
1334386|NCT01439373|ribavirin|ribavirin
1334387|NCT01439373|pegylated interferon|pegylated interferon
1334388|NCT01439373|GSK2336805|gsk2336805
1334389|NCT01439360|Vaccine|vaccine
1334390|NCT01439360|Seasonal Flu|seasonal flu
1334391|NCT01439360|Efficacy|efficacy
1334392|NCT01439360|Children|children
1334393|NCT01439347|Marqibo|marqibo
1334394|NCT01439347|HALLMARQ|hallmarq
1334395|NCT01439347|leukemia|leukemia
1334396|NCT01439347|front-line|front-line
1334398|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1334399|NCT01439334|Brief|brief
1334400|NCT01439334|Online|online
1334401|NCT01439334|Image|image
1334402|NCT01439334|Interactive|interactive
1334403|NCT01439334|Young Adult|young adult
1334404|NCT01439334|Primary Care|primary care
1334405|NCT01439321|treatment satisfaction|treatment satisfaction
1334406|NCT01439321|romiplostim|romiplostim
1334407|NCT01439321|eltrombopag|eltrombopag
1334408|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
1334409|NCT01439308|NAR|nar
1334410|NCT01439308|Capsaicin challenge|capsaicin challenge
1334411|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
1334412|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1334413|NCT01439295|Redox status|redox status
1334414|NCT01439295|Necrotising entercolitis|necrotising entercolitis
1334415|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
1334416|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
1334417|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
1334418|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
1334419|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
1334420|NCT01439269|Separation stress|separation stress
1334421|NCT01439269|Family Nurture|family nurture
1334422|NCT01439269|Maternal Confidence|maternal confidence
1334423|NCT01439269|Maternal Competence|maternal competence
1334424|NCT01439269|Calming Cycle|calming cycle
1334425|NCT01439269|Kangaroo Care|kangaroo care
1334426|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
1334427|NCT01439269|Infant Psychological Development|infant psychological development
1334428|NCT01439269|Post-partum depression|post-partum depression
1334429|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
1334430|NCT01439243|Bioequivalence|bioequivalence
1334431|NCT01439243|Healthy Subjects|healthy subjects
1334432|NCT01439243|Donepezil|donepezil
1334433|NCT01439230|Bioequivalence|bioequivalence
1334434|NCT01439230|Healthy Subjects|healthy subjects
1334435|NCT01439230|Donepezil|donepezil
1334436|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1334437|NCT01439217|Survivor|survivor
1334438|NCT01439217|Sibling control|sibling control
1334439|NCT01439191|HER2-Overexpressed|her2-overexpressed
1334440|NCT01439165|Adacel vaccine|adacel vaccine
1334441|NCT01439165|Tetanus|tetanus
1334442|NCT01439165|Diphtheria|diphtheria
1334443|NCT01439165|whooping cough|whooping cough
1334444|NCT01439152|Oncology|oncology
1334445|NCT01439152|Solid tumors|solid tumors
1334446|NCT01439152|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
1334447|NCT01439152|Treatment Emergent Adverse Events|treatment emergent adverse events
1334448|NCT01439152|Mesothelin|mesothelin
1334449|NCT01439139|Osteoporosis|osteoporosis
1334450|NCT01439139|ultrasound|ultrasound
1334451|NCT01439139|sonometer|sonometer
1334452|NCT01439139|DXA|dxa
1334453|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1334454|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
1334455|NCT01439100|Parkinson's disease|parkinson's disease
1334456|NCT01439100|severe pain|severe pain
1334457|NCT01439100|OXN PR|oxn pr
1334458|NCT01439100|randomised|randomised
1334459|NCT01439087|Colonic Polyps|colonic polyps
1334460|NCT01439087|OCT|oct
1334461|NCT01439087|Imaging|imaging
1334462|NCT01439087|Colon|colon
1334463|NCT01439087|Polyp|polyp
1334464|NCT01439074|Burn injuries|burn injuries
1334465|NCT01439074|Mepilex Ag|mepilex ag
1334466|NCT01439074|SSD Ag|ssd ag
1334467|NCT01439074|Partial thickness|partial thickness
1334468|NCT01439061|Growth disorders|growth disorders
1334469|NCT01439061|Saizen|saizen
1334470|NCT01439061|Easypod|easypod
1334471|NCT01439061|Growth hormone|growth hormone
1334472|NCT01439061|Pediatric subject|pediatric subject
1334473|NCT01439048|Placenta|placenta
1334474|NCT01439048|Cord Blood|cord blood
1334475|NCT01439048|PAH|pah
1334476|NCT01439048|Environmental Markers|environmental markers
1334477|NCT01439048|Toll-Like Receptors|toll-like receptors
1334478|NCT01439035|Celiac Disease|celiac disease
1334479|NCT01439035|Duodenal|duodenal
1334480|NCT01439035|OCT|oct
1334481|NCT01439035|Imaging|imaging
1334482|NCT01439022|Parkinson's Disease|parkinson's disease
1334483|NCT01439022|Exercise|exercise
1335374|NCT01435278|Obesity|obesity
1334484|NCT01439022|Treatment Outcome|treatment outcome
1334485|NCT01439022|Patient Adherence|patient adherence
1334486|NCT01439009|Heart failure|heart failure
1334487|NCT01439009|Volume overload|volume overload
1334488|NCT01439009|Tolvaptan|tolvaptan
1334489|NCT01439009|loop diuretics|loop diuretics
1334490|NCT01438996|Typhoid fever|typhoid fever
1334491|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
1334492|NCT01438996|Vi polysaccharide|vi polysaccharide
1334493|NCT01438996|Immunogenicity|immunogenicity
1334494|NCT01438957|Dexmedetomidine|dexmedetomidine
1334495|NCT01438957|Sedation|sedation
1334496|NCT01438957|Non-intubation|non-intubation
1334497|NCT01438957|epidural anesthesia|epidural anesthesia
1334498|NCT01438957|spinal anesthesia|spinal anesthesia
1334499|NCT01438944|NRT|nrt
1334500|NCT01438944|Patch|patch
1334501|NCT01438944|smoking|smoking
1334502|NCT01438944|addiction|addiction
1334503|NCT01438931|Dexmedetomidine|dexmedetomidine
1334504|NCT01438931|Sedation|sedation
1334505|NCT01438931|Non-intubation|non-intubation
1334506|NCT01438931|local anesthesia|local anesthesia
1334507|NCT01438918|Knee|knee
1334508|NCT01438918|Osteoarthritis|osteoarthritis
1334509|NCT01438918|X-ray|x-ray
1334510|NCT01438918|Joint Space Narrowing|joint space narrowing
1334511|NCT01438905|Ankle Sprain|ankle sprain
1334512|NCT01438905|Chronic Ankle Instability|chronic ankle instability
1334513|NCT01438905|Ankle Mobilization|ankle mobilization
1334514|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
1334515|NCT01438905|Cortical Muscle Activation|cortical muscle activation
1334516|NCT01438905|Spinal Muscle Activation|spinal muscle activation
1334517|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
1334518|NCT01438892|therapy compliance|therapy compliance
1334519|NCT01438879|CSF|csf
1334520|NCT01438879|PCR|pcr
1334521|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
1334522|NCT01438879|CNS|cns
1334523|NCT01438866|Dental caries|dental caries
1334524|NCT01438866|Fissure sealant|fissure sealant
1334525|NCT01438866|Fluoride varnish|fluoride varnish
1334526|NCT01438866|Primary molar|primary molar
1334527|NCT01438853|Sepsis|sepsis
1334528|NCT01438853|Acute Lung Injury|acute lung injury
1334529|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1334530|NCT01438853|ALI/ARDS|ali/ards
1334531|NCT01438853|Lung Disease|lung disease
1334532|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
1334533|NCT01438788|Bethlem myopathy|bethlem myopathy
1334534|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
1334535|NCT01438788|Low protein diet|low protein diet
1334536|NCT01438788|Autophagy|autophagy
1334537|NCT01438788|Pilot clinical trial|pilot clinical trial
1334538|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
1334539|NCT01438775|BPH|bph
1334540|NCT01438775|Enlarged prostate|enlarged prostate
1334541|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
1334542|NCT01438775|LUTS|luts
1334543|NCT01438775|LUTS secondary to BPH|luts secondary to bph
1334544|NCT01438775|LUTS/BPH|luts/bph
1334545|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
1334546|NCT01438775|BPO|bpo
1334547|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
1334548|NCT01438775|BOO|boo
1334549|NCT01438762|Anterior Knee Pain|anterior knee pain
1334550|NCT01438736|Focus:|focus:
1334551|NCT01438736|preceding|preceding
1334552|NCT01438736|desogestrel predicts|desogestrel predicts
1334553|NCT01438736|pattern of following|pattern of following
1334554|NCT01438736|etonogestrel implant|etonogestrel implant
1334555|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
1334556|NCT01438723|CABG|cabg
1334557|NCT01438723|metformin|metformin
1334558|NCT01438723|Hs-troponin-I|hs-troponin-i
1334559|NCT01438697|sleep|sleep
1334560|NCT01438697|insomnia|insomnia
1334561|NCT01438697|internet|internet
1334562|NCT01438697|CBT|cbt
1334563|NCT01438684|chronic vegetative state|chronic vegetative state
1334564|NCT01438684|functional MRI|functional mri
1334565|NCT01438671|WiiFit|wiifit
1334566|NCT01438671|Standing Balance|standing balance
1334567|NCT01438671|Neurological Population|neurological population
1334568|NCT01438658|uveal melanoma|uveal melanoma
1334569|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
1334570|NCT01438645|Colonoscopy|colonoscopy
1334571|NCT01438645|Colon cancer screening|colon cancer screening
1334572|NCT01438632|Insulin action|insulin action
1334573|NCT01438632|Jet injector|jet injector
1334574|NCT01438632|Diabetes Mellitus|diabetes mellitus
1334575|NCT01438632|Pharmacodynamics|pharmacodynamics
1334576|NCT01438632|Pharmacokinetics|pharmacokinetics
1334577|NCT01438632|Insulin analogs|insulin analogs
1334578|NCT01438632|Insulin aspart|insulin aspart
1334579|NCT01438619|sodium|sodium
1334580|NCT01438619|blood pressure|blood pressure
1334581|NCT01438619|pulse wave velocity|pulse wave velocity
1334582|NCT01438619|random digit dialling|random digit dialling
1334583|NCT01438593|Stroke|stroke
1334584|NCT01438593|Brain disease|brain disease
1334585|NCT01438593|Ischemia|ischemia
1334586|NCT01438593|Cerebral infraction|cerebral infraction
1334588|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
1334589|NCT01438580|stroke|stroke
1334590|NCT01438580|warfarin|warfarin
1334591|NCT01438580|aspirin|aspirin
1334592|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
1334593|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
1334594|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
1334595|NCT01438567|Opioid related constipation|opioid related constipation
1334596|NCT01438541|No skin breakdown|no skin breakdown
1334597|NCT01438541|Prevention|prevention
1334598|NCT01438541|protection of the skin|protection of the skin
1334599|NCT01438528|Growth disorders|growth disorders
1334600|NCT01438528|Saizen|saizen
1334601|NCT01438528|Easypod|easypod
1334602|NCT01438528|Growth hormone|growth hormone
1334603|NCT01438528|Pediatric subject|pediatric subject
1334604|NCT01438515|MRSA|mrsa
1334605|NCT01438515|doxycycline|doxycycline
1334606|NCT01438515|rifampin|rifampin
1334607|NCT01438515|mupirocin|mupirocin
1334608|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
1334609|NCT01438515|decolonization|decolonization
1334610|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
1334611|NCT01438502|cardiac surgery|cardiac surgery
1334612|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
1334613|NCT01438489|MEDI-546|medi-546
1334614|NCT01438489|Anifrolumab|anifrolumab
1334615|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
1334616|NCT01438476|Liver Cancer|liver cancer
1334617|NCT01438476|Pancreatic Cancer|pancreatic cancer
1334618|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
1334619|NCT01438476|TEA|tea
1334620|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
1334621|NCT01438476|IVPCA|ivpca
1334622|NCT01438476|Pain control|pain control
1334623|NCT01438476|Quality of life|quality of life
1334624|NCT01438476|QOL|qol
1334625|NCT01438476|Surgical resection|surgical resection
1334626|NCT01438463|non-seasonal allergy|non-seasonal allergy
1334627|NCT01438463|house dust mite|house dust mite
1334628|NCT01438463|immunotherapy|immunotherapy
1334629|NCT01438463|dose response|dose response
1334630|NCT01438450|Thalidomide|thalidomide
1334631|NCT01438450|Capecitabine|capecitabine
1334632|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1334633|NCT01438450|Therapy|therapy
1334634|NCT01438450|Supportive care|supportive care
1334635|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
1334636|NCT01438437|Radiofrequency ablation|radiofrequency ablation
1334637|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
1334638|NCT01438437|Tumour response|tumour response
1334639|NCT01438411|Cholic Acid|cholic acid
1334640|NCT01438411|Inborn Error|inborn error
1334641|NCT01438411|Bile Acid Metabolism|bile acid metabolism
1334642|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
1334643|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
1334644|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
1334645|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
1334646|NCT01438385|Pancreatico-biliary|pancreatico-biliary
1334647|NCT01438385|Biliary|biliary
1334648|NCT01438385|Bile Duct|bile duct
1334649|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
1334650|NCT01438385|Esophageal disorder|esophageal disorder
1334651|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
1334652|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
1334653|NCT01438372|Children|children
1334654|NCT01438359|Drug-drug interaction|drug-drug interaction
1334655|NCT01438359|Pharmacokinetics|pharmacokinetics
1334656|NCT01438359|PA21|pa21
1334657|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
1334658|NCT01438346|Substance Abuse|substance abuse
1334659|NCT01438346|Substance Addiction|substance addiction
1334660|NCT01438346|Substance Dependence|substance dependence
1334661|NCT01438346|Treatment program|treatment program
1334662|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
1334663|NCT01438333|probiotics|probiotics
1334664|NCT01438333|lactobacillus brevis|lactobacillus brevis
1334665|NCT01438333|full mouth disinfection|full mouth disinfection
1334666|NCT01438320|Treatment naive|treatment naive
1334667|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
1334668|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
1334669|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
1334670|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
1334671|NCT01438307|P-glycoprotein|p-glycoprotein
1334672|NCT01438307|taxane|taxane
1334673|NCT01438307|Advanced NSCLC|advanced nsclc
1334674|NCT01438294|Asthma|asthma
1334675|NCT01438294|childhood|childhood
1334676|NCT01438294|exercise|exercise
1334677|NCT01438281|ocular pain|ocular pain
1334678|NCT01438281|dry eye|dry eye
1334679|NCT01438281|siRNA|sirna
1334680|NCT01438242|Major|major
1334681|NCT01438242|Depressive|depressive
1334682|NCT01438242|Disorder|disorder
1334683|NCT01438242|Depression|depression
1334684|NCT01438242|Treatment Resistant|treatment resistant
1334685|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
1334686|NCT01438229|Hypertension|hypertension
1334687|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
1334688|NCT01438216|Pharmacokinetics|pharmacokinetics
1334689|NCT01438216|Intensive Care|intensive care
1334690|NCT01438216|Candidemia|candidemia
1334691|NCT01438216|Invasive candidiasis|invasive candidiasis
1334692|NCT01438216|Anidulafungin|anidulafungin
1334693|NCT01438203|manipulation|manipulation
1334694|NCT01438203|mobilization|mobilization
1334695|NCT01438203|low back pain|low back pain
1334696|NCT01438203|treatment|treatment
1334697|NCT01438177|myeloma|myeloma
1334698|NCT01438177|multiple myeloma|multiple myeloma
1334699|NCT01438177|relapsed myeloma|relapsed myeloma
1334700|NCT01438177|refractory myeloma|refractory myeloma
1334701|NCT01438164|FDG-PET|fdg-pet
1334702|NCT01438164|cancer|cancer
1334703|NCT01438164|staging|staging
1334704|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
1334705|NCT01438151|Crohn's disease|crohn's disease
1334706|NCT01438151|Remicade|remicade
1334707|NCT01438151|infliximab|infliximab
1334708|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1334709|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1334710|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1334711|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1334712|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1334713|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1334714|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1334715|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1334716|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1334717|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1334718|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1334719|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1334720|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1334721|NCT01438112|cancer|cancer
1334722|NCT01438112|bladder cancer|bladder cancer
1334723|NCT01438112|transitional cell|transitional cell
1334724|NCT01438112|virus|virus
1334725|NCT01438112|oncolytic|oncolytic
1334726|NCT01438112|GM-CSF|gm-csf
1334727|NCT01438112|adenovirus|adenovirus
1334728|NCT01438112|intravesical|intravesical
1334729|NCT01438112|neoadjuvant|neoadjuvant
1334730|NCT01438112|cystectomy|cystectomy
1334731|NCT01438112|gene therapy|gene therapy
1334732|NCT01438112|oncolytic virus|oncolytic virus
1334733|NCT01438112|carcinoma in situ|carcinoma in situ
1334734|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
1334735|NCT01438099|epidural analgesia|epidural analgesia
1334736|NCT01438099|ultrasound|ultrasound
1334737|NCT01438099|labor analgesia|labor analgesia
1334738|NCT01438099|labor|labor
1334739|NCT01438086|Heart Failure|heart failure
1334740|NCT01438086|Myocardial Infarction|myocardial infarction
1334741|NCT01438047|Port Wine Stain|port wine stain
1334742|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1334743|NCT01438008|Sucrose|sucrose
1334744|NCT01438008|Pain|pain
1334745|NCT01437995|Asthma|asthma
1334746|NCT01437995|Step down therapy|step down therapy
1334747|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
1334748|NCT01437995|Long-acting beta agonists|long-acting beta agonists
1334749|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
1334750|NCT01437982|post-operative inflammation|post-operative inflammation
1334751|NCT01437982|conjunctivitis|conjunctivitis
1334753|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
1334754|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
1334755|NCT01437969|Possible association|possible association
1334756|NCT01437969|between severity|between severity
1334757|NCT01437969|IL28B genetic variants|il28b genetic variants
1334758|NCT01437969|patients|patients
1334759|NCT01437969|different HCV genotypes|different hcv genotypes
1334760|NCT01437956|Calcineurin|calcineurin
1334761|NCT01437956|Bronchiolitis|bronchiolitis
1334762|NCT01437956|Epithelial lung injury|epithelial lung injury
1334763|NCT01437956|Rhinovirus|rhinovirus
1334764|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
1334765|NCT01437956|Asthma|asthma
1334766|NCT01437943|Transplant|transplant
1334767|NCT01437943|Failure|failure
1334768|NCT01437943|Kidney|kidney
1334769|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
1334770|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
1334771|NCT01437930|human|human
1334772|NCT01437930|TAG|tag
1334773|NCT01437917|glycemic index|glycemic index
1334774|NCT01437904|Renal Calculi|renal calculi
1334775|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
1334776|NCT01437891|PTSD|ptsd
1334777|NCT01437891|Military veteran|military veteran
1334778|NCT01437891|Gulf War|gulf war
1334779|NCT01437891|Fibromyalgia|fibromyalgia
1334780|NCT01437891|Gulf War Syndrome|gulf war syndrome
1334781|NCT01437878|PH|ph
1334782|NCT01437878|COPD|copd
1334783|NCT01437865|MRI|mri
1334784|NCT01437865|lymph node metastases|lymph node metastases
1334785|NCT01437865|breast cancer|breast cancer
1334786|NCT01437865|gadofosveset|gadofosveset
1334787|NCT01437839|Food effect study|food effect study
1334788|NCT01437839|Pharmacokinetics|pharmacokinetics
1334789|NCT01437839|Apixaban|apixaban
1334790|NCT01437826|chemoprevention|chemoprevention
1334791|NCT01437826|colorectal cancer|colorectal cancer
1334792|NCT01437826|metachronous adenoma|metachronous adenoma
1334793|NCT01437826|randomized trial|randomized trial
1334794|NCT01437813|DM2|dm2
1334795|NCT01437813|glimepiride|glimepiride
1334796|NCT01437813|metformin extended release|metformin extended release
1334797|NCT01437800|DM2|dm2
1334798|NCT01437800|glimepiride|glimepiride
1334799|NCT01437800|metformin extended release|metformin extended release
1334800|NCT01437774|Acute ischemic stroke|acute ischemic stroke
1334801|NCT01437748|Small Airways|small airways
1334802|NCT01437748|Closing volume|closing volume
1334803|NCT01437748|Closing Capacity|closing capacity
1334804|NCT01437748|Tiotropium|tiotropium
1334805|NCT01437748|Indacaterol|indacaterol
1334806|NCT01437748|COPD|copd
1334807|NCT01437735|Asthma|asthma
1334808|NCT01437735|QAW039|qaw039
1334809|NCT01437722|BV|bv
1334810|NCT01437722|Bacterial vaginosis|bacterial vaginosis
1334811|NCT01437722|recurrent|recurrent
1334812|NCT01437722|SPL7013 Gel|spl7013 gel
1334813|NCT01437722|VivaGel|vivagel
1334814|NCT01437709|Bendamustine HCL|bendamustine hcl
1334815|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
1334816|NCT01437709|Immunotherapy|immunotherapy
1334817|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
1334818|NCT01437709|11-050|11-050
1334819|NCT01437696|Aging|aging
1334820|NCT01437696|Vitamin D|vitamin d
1334821|NCT01437696|Bone health|bone health
1334822|NCT01437696|Inflammation|inflammation
1334823|NCT01437696|Men|men
1334824|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
1334825|NCT01437683|Quality of life|quality of life
1334826|NCT01437683|Long term outcome|long term outcome
1334827|NCT01437683|Activities of Daily Living|activities of daily living
1334828|NCT01437683|Cognitive Deficiency|cognitive deficiency
1334829|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1334830|NCT01437644|Cerebral Palsy|cerebral palsy
1334831|NCT01437644|Hip displacement|hip displacement
1334832|NCT01437644|Hip surgery|hip surgery
1334833|NCT01437644|Post-operative pain|post-operative pain
1334834|NCT01437644|Botulinum Toxin|botulinum toxin
1334835|NCT01437631|colon polyp|colon polyp
1334836|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
1334837|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
1334838|NCT01437631|prophylactic clip application|prophylactic clip application
1334839|NCT01437605|Resected|resected
1334840|NCT01437605|Skin|skin
1334841|NCT01437605|Stage IV|stage iv
1334842|NCT01437579|interstitial cystitis|interstitial cystitis
1334843|NCT01437579|bladder pain syndrome|bladder pain syndrome
1334844|NCT01437579|intratrigonal injection|intratrigonal injection
1334845|NCT01437579|botulinum toxin|botulinum toxin
1334846|NCT01437553|IVUS|ivus
1334847|NCT01437553|iMAP|imap
1334848|NCT01437553|Catheterization|catheterization
1334849|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
1334850|NCT01437540|COPD|copd
1334851|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1334852|NCT01437540|Chronic Bronchitis|chronic bronchitis
1334853|NCT01437540|Emphysema|emphysema
1334854|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
1334855|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
1334856|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1334857|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1334858|NCT01437527|anorexia nervosa|anorexia nervosa
1334859|NCT01437527|CMME-TCA Unit|cmme-tca unit
1334860|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
1334861|NCT01437514|rectal cancer|rectal cancer
1334862|NCT01437514|Endosonography|endosonography
1334863|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
1334864|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
1334865|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
1334866|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
1334867|NCT01437514|total mesorectal excision|total mesorectal excision
1334868|NCT01437514|circumferential resection margin|circumferential resection margin
1334869|NCT01437514|local recurrence|local recurrence
1334870|NCT01437514|overall survival|overall survival
1334871|NCT01437514|metastasis|metastasis
1334872|NCT01437514|complication|complication
1334873|NCT01437501|glucoraphanin|glucoraphanin
1334874|NCT01437501|sulforaphane|sulforaphane
1334875|NCT01437501|pharmacokinetics|pharmacokinetics
1334876|NCT01437501|pharmacodynamics|pharmacodynamics
1334877|NCT01437501|broccoli sprout|broccoli sprout
1334878|NCT01437501|carcinogens, environment|carcinogens, environment
1334879|NCT01437488|Urothelial carcinoma|urothelial carcinoma
1334880|NCT01437488|Urothelial cancer|urothelial cancer
1334882|NCT01437475|HIV|hiv
1334883|NCT01437475|Immunization|immunization
1334884|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
1334885|NCT01437462|Pain, Postoperative|pain, postoperative
1334886|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
1334887|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
1334888|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
1334889|NCT01437449|Quality of Life|quality of life
1334890|NCT01437436|otitis media|otitis media
1334891|NCT01437436|obesity|obesity
1334892|NCT01437436|ventilation tube|ventilation tube
1334893|NCT01437423|Diphtheria|diphtheria
1334894|NCT01437423|Tetanus|tetanus
1334895|NCT01437423|Pertussis|pertussis
1334896|NCT01437423|Poliomyelitis|poliomyelitis
1334897|NCT01437423|TETRAXIM™|tetraxim™
1334898|NCT01437397|COPD|copd
1334899|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1334900|NCT01437397|Chronic Bronchitis|chronic bronchitis
1334901|NCT01437397|Emphysema|emphysema
1334902|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
1334903|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
1334904|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1334905|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1334906|NCT01437371|Heart failure|heart failure
1334907|NCT01437371|Aged and over 80|aged and over 80
1334908|NCT01437371|clinical trial|clinical trial
1334909|NCT01437371|quality of life|quality of life
1334910|NCT01437358|Epidural catheter|epidural catheter
1334911|NCT01437358|Epidural analgesia|epidural analgesia
1334912|NCT01437358|Intensive care unit|intensive care unit
1334913|NCT01437358|Safety|safety
1334914|NCT01437306|lofexidine|lofexidine
1334915|NCT01437306|food effect|food effect
1334916|NCT01437306|pharmacokinetics|pharmacokinetics
1334917|NCT01437306|healthy volunteer|healthy volunteer
1334918|NCT01437293|cocaine|cocaine
1334919|NCT01437280|Tumors|tumors
1334920|NCT01437280|Solid Tumors|solid tumors
1334921|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
1334922|NCT01437254|thyroidectomy|thyroidectomy
1334923|NCT01437241|HIV-infection|hiv-infection
1334924|NCT01437241|Etravirine|etravirine
1334925|NCT01437241|Treatment|treatment
1334926|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
1334927|NCT01437215|aneurysm|aneurysm
1334928|NCT01437215|renal stent|renal stent
1334929|NCT01437215|juxtarenal|juxtarenal
1334930|NCT01437215|pararenal|pararenal
1334931|NCT01437202|imatinib|imatinib
1334932|NCT01437202|drug resistance|drug resistance
1334933|NCT01437202|pharmacogenetics|pharmacogenetics
1334934|NCT01437189|Parkinson's disease|parkinson's disease
1334935|NCT01437189|depression|depression
1334936|NCT01437189|sertraline|sertraline
1334937|NCT01437189|intervention|intervention
1334938|NCT01437176|surgery|surgery
1334939|NCT01437176|fixation|fixation
1334940|NCT01437176|intramedullary nail|intramedullary nail
1334941|NCT01437150|surgery|surgery
1334942|NCT01437150|fixation|fixation
1334943|NCT01437150|bone plate|bone plate
1334944|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
1334945|NCT01437111|Osteoporosis|osteoporosis
1334946|NCT01437111|Postmenopausal|postmenopausal
1334947|NCT01437098|Valvular Heart Disease|valvular heart disease
1334948|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
1334949|NCT01437098|Aortic Valve Replacement|aortic valve replacement
1334950|NCT01437085|Needle deflection|needle deflection
1334951|NCT01437085|Prostate Deformation|prostate deformation
1334952|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
1334953|NCT01437085|Needles|needles
1334954|NCT01437046|Alcohol drinking|alcohol drinking
1334955|NCT01437046|Alcohol craving|alcohol craving
1334956|NCT01437033|Breath Tests|breath tests
1334957|NCT01437033|Human Volunteers|human volunteers
1334958|NCT01437033|Pilot Study|pilot study
1334959|NCT01437033|Breath Test|breath test
1334960|NCT01437020|IL-10|il-10
1334961|NCT01437020|Leishmaniasis|leishmaniasis
1334962|NCT01437020|Immunotherapy|immunotherapy
1334963|NCT01437007|SNALP|snalp
1334964|NCT01437007|Regional Therapy|regional therapy
1334965|NCT01437007|Stage IV Disease|stage iv disease
1334966|NCT01437007|Adenocarcinoma|adenocarcinoma
1334967|NCT01437007|Unresectable|unresectable
1334968|NCT01437007|Liver Metastases|liver metastases
1334969|NCT01437007|Colorectal Cancer|colorectal cancer
1334970|NCT01437007|Stomach Cancer|stomach cancer
1334971|NCT01437007|Gastric Cancer|gastric cancer
1334972|NCT01437007|Breast Cancer|breast cancer
1334973|NCT01437007|Ovarian Cancer|ovarian cancer
1334974|NCT01437007|Pancreatic Cancer|pancreatic cancer
1334975|NCT01437007|Liver Cancer|liver cancer
1334976|NCT01436994|thyrotoxic|thyrotoxic
1334977|NCT01436994|thyrotoxicosis|thyrotoxicosis
1334978|NCT01436994|paediatric|paediatric
1334979|NCT01436994|endocrinology|endocrinology
1334980|NCT01436994|block and replace|block and replace
1334981|NCT01436994|dose titration|dose titration
1334982|NCT01436994|carbimazole|carbimazole
1334983|NCT01436981|papaverine|papaverine
1334984|NCT01436981|pharmacokinetic|pharmacokinetic
1334985|NCT01436981|CABG|cabg
1334986|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
1334987|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
1334988|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
1334989|NCT01436929|silymarin|silymarin
1334990|NCT01436929|hepatotoxicity|hepatotoxicity
1334991|NCT01436929|tuberculosis|tuberculosis
1334992|NCT01436929|HREZ|hrez
1334993|NCT01436916|prediabetes|prediabetes
1334994|NCT01436916|oral cholecalciferol|oral cholecalciferol
1334995|NCT01436903|menorrhagia|menorrhagia
1334996|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
1334997|NCT01436903|endometrial ablation|endometrial ablation
1334998|NCT01436903|cavatermTM|cavatermtm
1334999|NCT01436903|probe|probe
1335000|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
1335001|NCT01436877|BPH|bph
1335002|NCT01436877|bladder neck obstruction|bladder neck obstruction
1335003|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
1335004|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
1335005|NCT01436864|)|)
1335006|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1335007|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1335008|NCT01436864|intravitreal injection|intravitreal injection
1335009|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
1335010|NCT01436864|central retinal thickness|central retinal thickness
1335011|NCT01436851|rhinitis|rhinitis
1335012|NCT01436851|allergy|allergy
1335013|NCT01436851|occupational|occupational
1335014|NCT01436851|storage mites|storage mites
1335015|NCT01436851|nasal lavage|nasal lavage
1335016|NCT01436851|challenge test|challenge test
1335017|NCT01436851|ECP|ecp
1335018|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
1335019|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1335147|NCT01436318|Respiratory|respiratory
1335020|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1335021|NCT01436825|Haemophilia A|haemophilia a
1335022|NCT01436825|Factor VIII|factor viii
1335023|NCT01436825|Pharmacokinetic|pharmacokinetic
1335024|NCT01436825|Computer Tool validation|computer tool validation
1335025|NCT01436812|cerebral oxymetry|cerebral oxymetry
1335026|NCT01436812|laparoscopy|laparoscopy
1335027|NCT01436812|PEEP|peep
1335028|NCT01436799|propofol|propofol
1335029|NCT01436799|desflurane|desflurane
1335030|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
1335031|NCT01436799|sitting|sitting
1335032|NCT01436786|cytokines|cytokines
1335033|NCT01436786|Guided imagery|guided imagery
1335034|NCT01436760|IBS|ibs
1335035|NCT01436747|Kidney transplantation|kidney transplantation
1335036|NCT01436747|Proteinuria|proteinuria
1335037|NCT01436747|Albuminuria|albuminuria
1335038|NCT01436747|Vitamin D|vitamin d
1335039|NCT01436747|Paricalcitol|paricalcitol
1335040|NCT01436721|Effectiveness|effectiveness
1335041|NCT01436721|Device success|device success
1335042|NCT01436721|Hepatectomy|hepatectomy
1335043|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
1335044|NCT01436708|urinary symptoms|urinary symptoms
1335045|NCT01436708|sexual function|sexual function
1335046|NCT01436695|seizure early detection|seizure early detection
1335047|NCT01436682|Nerve Blocks|nerve blocks
1335048|NCT01436656|BRAF mutant,|braf mutant,
1335049|NCT01436656|BRAF mutated,|braf mutated,
1335050|NCT01436656|melanoma,|melanoma,
1335051|NCT01436656|metastatic,|metastatic,
1335052|NCT01436656|advanced,|advanced,
1335053|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
1335054|NCT01436656|BRAF V600 mutation|braf v600 mutation
1335055|NCT01436643|Depression|depression
1335056|NCT01436643|Multiple Sclerosis|multiple sclerosis
1335057|NCT01436643|Fingolimod|fingolimod
1335058|NCT01436643|Venlafaxine|venlafaxine
1335059|NCT01436643|Fluoxetine|fluoxetine
1335060|NCT01436630|Exercise Tolerance|exercise tolerance
1335061|NCT01436630|Step Test|step test
1335062|NCT01436630|Stroke|stroke
1335063|NCT01436630|Walking|walking
1335064|NCT01436617|cancer|cancer
1335065|NCT01436617|colon|colon
1335066|NCT01436617|Head and neck|head and neck
1335067|NCT01436617|cetuximab|cetuximab
1335068|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
1335069|NCT01436604|cardiac MRI|cardiac mri
1335070|NCT01436604|Cancer|cancer
1335071|NCT01436604|Breast|breast
1335072|NCT01436604|Herceptin|herceptin
1335073|NCT01436604|LV dysfunction|lv dysfunction
1335074|NCT01436591|Cancer|cancer
1335075|NCT01436591|Breast|breast
1335076|NCT01436591|18FDG|18fdg
1335077|NCT01436591|Axillary|axillary
1335078|NCT01436591|Positron Emission Tomography|positron emission tomography
1335079|NCT01436552|MCI|mci
1335080|NCT01436552|Depression|depression
1335081|NCT01436552|Alzheimer|alzheimer
1335082|NCT01436552|Life events|life events
1335083|NCT01436526|Bioequivalence|bioequivalence
1335084|NCT01436513|bioequivalence|bioequivalence
1335085|NCT01436513|menometrorrhagia|menometrorrhagia
1335086|NCT01436513|climacteric disturbance|climacteric disturbance
1335087|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
1335088|NCT01436513|Estrogens Conjugated|estrogens conjugated
1335089|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
1335090|NCT01436500|HRS|hrs
1335091|NCT01436500|ifetroban|ifetroban
1335092|NCT01436487|ischemic stroke|ischemic stroke
1335093|NCT01436487|adult stem cells|adult stem cells
1335094|NCT01436474|Varenicline|varenicline
1335095|NCT01436474|Chantix|chantix
1335096|NCT01436474|Chronic Pain|chronic pain
1335097|NCT01436474|Opioid dependence|opioid dependence
1335098|NCT01436448|efficacy|efficacy
1335099|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
1335100|NCT01436448|glucose intolerance|glucose intolerance
1335101|NCT01436448|feasibility|feasibility
1335102|NCT01436448|compliance and safety|compliance and safety
1335103|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
1335104|NCT01436435|PAD|pad
1335105|NCT01436435|peripheral artery disease|peripheral artery disease
1335106|NCT01436435|atherectomy|atherectomy
1335107|NCT01436422|Dengue Virus|dengue virus
1335108|NCT01436422|Dengue Fever|dengue fever
1335109|NCT01436422|Dengue Vaccine|dengue vaccine
1335110|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1335111|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
1335112|NCT01436409|vaginal touch|vaginal touch
1335113|NCT01436409|deliveries assisted|deliveries assisted
1335114|NCT01436409|echography|echography
1335115|NCT01436409|assisted delivery|assisted delivery
1335116|NCT01436396|Dengue|dengue
1335117|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1335118|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
1335119|NCT01436396|Yellow Fever|yellow fever
1335120|NCT01436396|Stamaril®|stamaril®
1335121|NCT01436396|Flavivirus Infections|flavivirus infections
1335122|NCT01436383|high altitude|high altitude
1335123|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
1335124|NCT01436383|metabolomics|metabolomics
1335125|NCT01436383|oxidative stress|oxidative stress
1335126|NCT01436383|acute mountain sickness|acute mountain sickness
1335127|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
1335128|NCT01436357|AdCh3NSmut1|adch3nsmut1
1335129|NCT01436357|Hepatitis C|hepatitis c
1335130|NCT01436357|MVA-NSmut|mva-nsmut
1335131|NCT01436357|vaccine|vaccine
1335132|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
1335133|NCT01436344|electrocardiography|electrocardiography
1335134|NCT01436344|atrial electrogram|atrial electrogram
1335135|NCT01436344|atrial function, left|atrial function, left
1335136|NCT01436331|First episode psychosis|first episode psychosis
1335137|NCT01436331|Early Psychosis|early psychosis
1335138|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
1335139|NCT01436331|Psychosocial Intervention|psychosocial intervention
1335140|NCT01436331|Assertive Community treatment|assertive community treatment
1335141|NCT01436331|Family Intervention|family intervention
1335142|NCT01436331|Mental Disorders|mental disorders
1335143|NCT01436331|Psychotic Disorders|psychotic disorders
1567105|NCT00510068|neuroendocrine|neuroendocrine
1446309|NCT00980239|HAI|hai
1335144|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1335145|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
1335146|NCT01436318|Healthy Kids|healthy kids
1335148|NCT01436318|Volunteers|volunteers
1335149|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
1335150|NCT01436305|long-term graft function|long-term graft function
1335151|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
1335152|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
1335153|NCT01436305|corticosteroids|corticosteroids
1335154|NCT01436292|Hypoalbuminemia|hypoalbuminemia
1335155|NCT01436292|Burns|burns
1335156|NCT01436292|Albumin|albumin
1335157|NCT01436292|Organ dysfunction|organ dysfunction
1335158|NCT01436292|Outcome|outcome
1335159|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
1335258|NCT01435798|central neuropathic pain|central neuropathic pain
1335160|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
1335161|NCT01436240|PRO-CTCAE|pro-ctcae
1335162|NCT01436240|Native Spanish Speaking|native spanish speaking
1335163|NCT01436240|Spanish Translation|spanish translation
1335164|NCT01436240|Cognitive Interview|cognitive interview
1335165|NCT01436240|Questionnaire|questionnaire
1335166|NCT01436240|11-133|11-133
1335167|NCT01436240|Adverse Events|adverse events
1335168|NCT01436240|chemotherapy|chemotherapy
1335169|NCT01436240|radiation therapy|radiation therapy
1335170|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
1335171|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
1335172|NCT01436227|VHL|vhl
1335173|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
1335174|NCT01436227|Pazopanib|pazopanib
1335175|NCT01436227|GW786034|gw786034
1335176|NCT01436188|Biological Markers|biological markers
1335177|NCT01436188|Healthy Volunteer|healthy volunteer
1335178|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
1335179|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1335180|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1335181|NCT01436188|CSF proteins|csf proteins
1335182|NCT01436136|Cardiovascular disease|cardiovascular disease
1335183|NCT01436136|HIV|hiv
1335184|NCT01436136|Antiretroviral treatment|antiretroviral treatment
1335185|NCT01436136|team interventions|team interventions
1335186|NCT01436136|Framingham risk score|framingham risk score
1335187|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
1335188|NCT01436123|Nanoparticles|nanoparticles
1335189|NCT01436123|Stem cells|stem cells
1335190|NCT01436123|Atherosclerosis|atherosclerosis
1335191|NCT01436123|Bioengineering|bioengineering
1335192|NCT01436123|Biodegradable stenting|biodegradable stenting
1335193|NCT01436123|Repair disease|repair disease
1335194|NCT01436097|Healthy Eating|healthy eating
1335195|NCT01436097|Health Behavior|health behavior
1335196|NCT01436097|Incentive|incentive
1335197|NCT01436097|Work-site|work-site
1335198|NCT01436084|Leukemia|leukemia
1335199|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
1335200|NCT01436084|MDS|mds
1335201|NCT01436084|SB1518|sb1518
1335202|NCT01436058|side effect|side effect
1335203|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
1335204|NCT01436058|ankle|ankle
1335205|NCT01436058|osteoarthritis|osteoarthritis
1335206|NCT01436045|Memory|memory
1335207|NCT01436045|Insulin glulisine|insulin glulisine
1335208|NCT01436045|Alzheimer's Disease|alzheimer's disease
1335209|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
1335210|NCT01436019|Rheumatic diseases|rheumatic diseases
1335211|NCT01436019|Antibodies|antibodies
1335212|NCT01436019|Biological therapy|biological therapy
1335213|NCT01436006|MDCT|mdct
1335214|NCT01436006|radiation|radiation
1335215|NCT01436006|dose|dose
1335216|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
1335217|NCT01435980|type 2 diabetes|type 2 diabetes
1335218|NCT01435980|Gastric Bypass|gastric bypass
1335219|NCT01435980|GLP-1|glp-1
1335220|NCT01435980|adiponectin|adiponectin
1335221|NCT01435967|Rotarix™|rotarix™
1335222|NCT01435967|Observational|observational
1335223|NCT01435967|ecological|ecological
1335224|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
1335225|NCT01435954|surgery|surgery
1335226|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
1335227|NCT01435954|enlarged prostate|enlarged prostate
1335228|NCT01435954|acute urinary retention|acute urinary retention
1335229|NCT01435941|mailed survey|mailed survey
1335230|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
1335231|NCT01435941|migraine disorders|migraine disorders
1335232|NCT01435941|headache|headache
1335233|NCT01435928|Schizophrenia|schizophrenia
1335234|NCT01435928|Lurasidone|lurasidone
1335235|NCT01435928|Latuda|latuda
1335236|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
1335237|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
1335238|NCT01435902|asthma|asthma
1335239|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
1335240|NCT01435889|Children|children
1335241|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
1335242|NCT01435889|Pulmonary function tests|pulmonary function tests
1335243|NCT01435889|Computed tomography, lung|computed tomography, lung
1335244|NCT01435850|hip arthroplasty|hip arthroplasty
1335245|NCT01435850|primary stability|primary stability
1335246|NCT01435850|secondary stability|secondary stability
1335247|NCT01435850|EBRA|ebra
1335248|NCT01435837|Voice|voice
1335249|NCT01435837|aerodynamics|aerodynamics
1335250|NCT01435837|acoustics|acoustics
1335251|NCT01435824|healthy adult volunteers|healthy adult volunteers
1335252|NCT01435824|comparative bioavailability|comparative bioavailability
1335253|NCT01435824|amoxicillin|amoxicillin
1335254|NCT01435824|breast milk|breast milk
1335255|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
1335256|NCT01435811|Norovirus|norovirus
1335257|NCT01435798|chronic pain|chronic pain
1335857|NCT01433445|DACi|daci
1335259|NCT01435798|spinal cord injury|spinal cord injury
1335260|NCT01435798|dextromethorphan|dextromethorphan
1335261|NCT01435798|lidocaine|lidocaine
1335262|NCT01435798|combination therapy|combination therapy
1335263|NCT01435798|analgesia|analgesia
1335264|NCT01435785|PKPD|pkpd
1335265|NCT01435785|Propofol|propofol
1335266|NCT01435785|TCI|tci
1335267|NCT01435785|Elderly patients|elderly patients
1335268|NCT01435746|liver transplantation|liver transplantation
1335269|NCT01435746|intensive care|intensive care
1335270|NCT01435746|red blood cell transfusion|red blood cell transfusion
1335271|NCT01435733|ASD|asd
1335273|NCT01435720|Multiple myeloma|multiple myeloma
1335274|NCT01435720|B cell lymphoma|b cell lymphoma
1335275|NCT01435720|Hematologic disease|hematologic disease
1335276|NCT01435720|Blood protein disorder|blood protein disorder
1335277|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
1335278|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
1335279|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1335280|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
1335281|NCT01435720|B cell malignancy|b cell malignancy
1335282|NCT01435707|epidural steroid injection|epidural steroid injection
1335283|NCT01435707|triamcinolone|triamcinolone
1335284|NCT01435707|fasting blood glucose|fasting blood glucose
1335285|NCT01435707|diabetes mellitus|diabetes mellitus
1335286|NCT01435694|multiple sclerosis|multiple sclerosis
1335287|NCT01435694|gait rehabilitation|gait rehabilitation
1335288|NCT01435681|DYT-1|dyt-1
1335289|NCT01435681|DYT1|dyt1
1335290|NCT01435681|DYT 1|dyt 1
1335291|NCT01435681|dystonia|dystonia
1335292|NCT01435681|DBS|dbs
1335293|NCT01435681|deep brain stimulation|deep brain stimulation
1335294|NCT01435681|TMS|tms
1335295|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
1335296|NCT01435668|alcohol|alcohol
1335297|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
1335298|NCT01435668|emergency department (ED)|emergency department (ed)
1335299|NCT01435616|diabetes mellitus|diabetes mellitus
1335300|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
1335301|NCT01435616|insulin naive|insulin naive
1335302|NCT01435616|insulin treatment|insulin treatment
1335303|NCT01435603|Prevention & Control|prevention & control
1335304|NCT01435603|Hyperglycemia|hyperglycemia
1335305|NCT01435603|Obesity|obesity
1335306|NCT01435603|Diabetes Mellitus|diabetes mellitus
1335307|NCT01435603|Cost Benefit Analysis|cost benefit analysis
1335308|NCT01435577|Bunionectomy|bunionectomy
1335309|NCT01435577|Postsurgical Pain|postsurgical pain
1335310|NCT01435577|Acute Pain|acute pain
1335311|NCT01435564|Mobile phone|mobile phone
1335312|NCT01435564|Sedentary lifestyle|sedentary lifestyle
1335313|NCT01435564|Physical activity|physical activity
1335314|NCT01435564|Prevention|prevention
1335315|NCT01435564|Health Promotion|health promotion
1335316|NCT01435564|Exercise|exercise
1335317|NCT01435564|eHealth|ehealth
1335318|NCT01435564|Electronic diary|electronic diary
1335319|NCT01435551|Alzheimer|alzheimer
1335320|NCT01435551|Dementia|dementia
1335321|NCT01435538|interprofessional teamwork|interprofessional teamwork
1335322|NCT01435538|care pathways|care pathways
1335323|NCT01435538|team communication|team communication
1335324|NCT01435538|team coordination|team coordination
1335325|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
1335326|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
1335327|NCT01435525|triple therapy|triple therapy
1335328|NCT01435525|Helicobacter pylori|helicobacter pylori
1335329|NCT01435525|eradication|eradication
1335330|NCT01435525|Nexium|nexium
1335331|NCT01435512|PTSD|ptsd
1335332|NCT01435512|CBT|cbt
1335333|NCT01435512|Intimate Partner Violence|intimate partner violence
1335334|NCT01435512|Treatment|treatment
1335335|NCT01435499|immunotherapy|immunotherapy
1335336|NCT01435499|vaccine|vaccine
1335337|NCT01435499|GVAX|gvax
1335338|NCT01435499|GM-CSF|gm-csf
1335339|NCT01435486|caffeine|caffeine
1335340|NCT01435486|apnea|apnea
1335341|NCT01435486|bronchiolitis|bronchiolitis
1335342|NCT01435473|pediatrics|pediatrics
1335343|NCT01435473|thrombosis|thrombosis
1335344|NCT01435473|thromboembolic complications|thromboembolic complications
1335345|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
1335346|NCT01435460|ocular allergy|ocular allergy
1335347|NCT01435447|efficacy|efficacy
1335348|NCT01435447|safety|safety
1335349|NCT01435447|conditioning|conditioning
1335350|NCT01435447|fludarabine|fludarabine
1335351|NCT01435447|busulfan|busulfan
1335352|NCT01435447|cyclophosphamide|cyclophosphamide
1335353|NCT01435447|adult|adult
1335354|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
1335355|NCT01435408|STEMI|stemi
1335356|NCT01435408|Ischemic postconditioning|ischemic postconditioning
1335357|NCT01435408|Deferred stenting|deferred stenting
1335358|NCT01435408|Primary PCI|primary pci
1335359|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
1335955|NCT01433120|Prebiotic|prebiotic
1335360|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
1335361|NCT01435356|Immune System Diseases|immune system diseases
1335362|NCT01435356|Cystectomy|cystectomy
1335363|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
1335364|NCT01435356|Immunologic Factors|immunologic factors
1335365|NCT01435330|Safety|safety
1335366|NCT01435330|BVS857|bvs857
1335367|NCT01435330|insulin resistance|insulin resistance
1335368|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
1335369|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
1335370|NCT01435278|Weight maintenance|weight maintenance
1335371|NCT01435278|BMI|bmi
1335372|NCT01435278|Body weight|body weight
1335375|NCT01435278|Satiety|satiety
1335376|NCT01435265|Psoriasis|psoriasis
1335377|NCT01435265|Dermatology|dermatology
1335378|NCT01435265|Phase IV|phase iv
1335379|NCT01435265|Nurse Education|nurse education
1335380|NCT01435265|Adalimumab|adalimumab
1335381|NCT01435265|Humira|humira
1335382|NCT01435226|Hepatitis C|hepatitis c
1335383|NCT01435226|HCV|hcv
1335384|NCT01435226|Rapid Virologic Response|rapid virologic response
1335385|NCT01435226|Sustained Virologic Response|sustained virologic response
1335386|NCT01435226|Direct Acting Antiviral|direct acting antiviral
1335387|NCT01435226|Combination Therapy|combination therapy
1335388|NCT01435226|Tegobuvir|tegobuvir
1335389|NCT01435226|Treatment Experienced|treatment experienced
1335390|NCT01435226|HCV RNA|hcv rna
1335391|NCT01435226|Polymerase inhibitor|polymerase inhibitor
1335392|NCT01435226|Protease inhibitor|protease inhibitor
1335393|NCT01435226|Interferon intolerant|interferon intolerant
1335394|NCT01435226|Interferon ineligible|interferon ineligible
1335395|NCT01435226|GS-9190|gs-9190
1335396|NCT01435226|GS-9451|gs-9451
1335397|NCT01435226|GS-5885|gs-5885
1335398|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
1335399|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
1335400|NCT01435213|receptor occupancy|receptor occupancy
1335401|NCT01435213|positron emission tomography|positron emission tomography
1335402|NCT01435213|[11C]ORM-13070|[11c]orm-13070
1335403|NCT01435213|striatum|striatum
1335404|NCT01435213|brain|brain
1335405|NCT01435213|noradrenaline|noradrenaline
1335406|NCT01435213|norepinephrine|norepinephrine
1335407|NCT01435213|endogenous|endogenous
1335408|NCT01435213|binding|binding
1335409|NCT01435213|Validation studies|validation studies
1335410|NCT01435200|Intravenous iron|intravenous iron
1335411|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
1335412|NCT01435174|ranolazine|ranolazine
1335413|NCT01435174|end-stage renal disease|end-stage renal disease
1335414|NCT01435174|pharmacokinetics|pharmacokinetics
1335415|NCT01435174|cardiovascular disease|cardiovascular disease
1335416|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
1335417|NCT01435148|Deep Brain Stimulation|deep brain stimulation
1335418|NCT01435148|Treatment Resistant Depression|treatment resistant depression
1335419|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
1335420|NCT01435122|advanced|advanced
1335421|NCT01435122|unresectable|unresectable
1335422|NCT01435122|metastatic|metastatic
1335423|NCT01435122|cancerous tumors|cancerous tumors
1335424|NCT01435122|neuroendocrine|neuroendocrine
1335425|NCT01435122|digestive tract|digestive tract
1335426|NCT01435122|lungs|lungs
1335427|NCT01435122|renal|renal
1335428|NCT01435122|ovarian|ovarian
1335429|NCT01435122|thymic|thymic
1335430|NCT01435122|hepatic|hepatic
1335431|NCT01435109|Osteoarthritis|osteoarthritis
1335432|NCT01435109|Exercise|exercise
1335433|NCT01435109|Diet|diet
1335434|NCT01435109|Coping Skills|coping skills
1335435|NCT01435109|Education, Medical|education, medical
1335436|NCT01435083|Nocturia|nocturia
1335437|NCT01435070|Colles' fracture|colles' fracture
1335438|NCT01435070|Radius fracture|radius fracture
1335439|NCT01435070|grip strength|grip strength
1335440|NCT01435070|pinch strength|pinch strength
1335441|NCT01435070|range of movement|range of movement
1335442|NCT01435070|PRWE|prwe
1335443|NCT01435070|DASH|dash
1335444|NCT01435070|EQ-5D|eq-5d
1335445|NCT01435070|Kirschner wire|kirschner wire
1335446|NCT01435070|Volar locking plate|volar locking plate
1335447|NCT01435057|Abdominal Obesity|abdominal obesity
1335448|NCT01435057|training|training
1335449|NCT01435057|fat|fat
1335450|NCT01435057|insulin|insulin
1335451|NCT01435057|glucose|glucose
1335452|NCT01435057|diet|diet
1335453|NCT01435044|Hepatitis C|hepatitis c
1335454|NCT01435044|Chronic|chronic
1335455|NCT01435044|HCV|hcv
1335456|NCT01435031|Angioplasty|angioplasty
1335457|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
1335458|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
1335459|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1335460|NCT01435031|Coronary artery stenosis|coronary artery stenosis
1335461|NCT01435031|Total coronary occlusion|total coronary occlusion
1335462|NCT01435005|Prevention and control|prevention and control
1335463|NCT01435005|Exercise|exercise
1335956|NCT01433107|Tinea pedis|tinea pedis
1335464|NCT01435005|Sedentary lifestyle|sedentary lifestyle
1335465|NCT01435005|Biological markers|biological markers
1335466|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
1335467|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
1335468|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
1335469|NCT01434966|TENS Spine|tens spine
1335470|NCT01434966|TENS Knee|tens knee
1335471|NCT01434966|Knee Pain|knee pain
1335472|NCT01434966|Chronic Knee Pain|chronic knee pain
1335473|NCT01434953|Prehypertension|prehypertension
1335474|NCT01434953|Blood pressure screening|blood pressure screening
1335475|NCT01434953|White coat effect|white coat effect
1335476|NCT01434940|Alzheimer disease|alzheimer disease
1335477|NCT01434940|Depression|depression
1335478|NCT01434940|Differential diagnosis|differential diagnosis
1335479|NCT01434940|Eye movement|eye movement
1335480|NCT01434914|Ulcus cruris|ulcus cruris
1335481|NCT01434914|chronic wounds|chronic wounds
1335482|NCT01434914|octenisept®|octenisept®
1335483|NCT01434901|Diabetes|diabetes
1335484|NCT01434901|Blood Sugar|blood sugar
1335485|NCT01434901|Xenin-25|xenin-25
1335486|NCT01434901|GIP|gip
1335487|NCT01434901|Muscarinic|muscarinic
1335488|NCT01434888|pharmacokinetics|pharmacokinetics
1335489|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1335490|NCT01434849|infantile hemangioma|infantile hemangioma
1335491|NCT01434849|very low birth weight infants|very low birth weight infants
1335492|NCT01434849|premature infants|premature infants
1335493|NCT01434836|Anti-depressant effects|anti-depressant effects
1335494|NCT01434823|nocturnal staffing|nocturnal staffing
1335495|NCT01434823|intensivist staffing|intensivist staffing
1335496|NCT01434823|intensivist coverage|intensivist coverage
1335497|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
1335498|NCT01434823|ICU resource utilization|icu resource utilization
1335499|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
1335500|NCT01434823|Sleep Deprivation|sleep deprivation
1335501|NCT01434823|Inattention|inattention
1335502|NCT01434823|Work Hours|work hours
1335503|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
1335504|NCT01434797|Infection|infection
1335505|NCT01434797|Permanent central venous catheter|permanent central venous catheter
1335506|NCT01434797|Device Related|device related
1335507|NCT01434784|lung cancer|lung cancer
1335508|NCT01434784|quality of life|quality of life
1335509|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
1335510|NCT01434758|Culture yield|culture yield
1335511|NCT01434745|SLOS|slos
1335512|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
1335513|NCT01434745|Simvastatin|simvastatin
1335514|NCT01434732|Superior vena cava flow|superior vena cava flow
1335515|NCT01434732|umbilical cord milking|umbilical cord milking
1335516|NCT01434732|hemodynamics|hemodynamics
1335517|NCT01434732|systemic blood flow|systemic blood flow
1335518|NCT01434719|Streptococcus suis|streptococcus suis
1335519|NCT01434719|Sepsis|sepsis
1335520|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
1335521|NCT01434719|Pig disease|pig disease
1335522|NCT01434719|Epidemiology|epidemiology
1335523|NCT01434706|HIV|hiv
1335524|NCT01434706|acute infection|acute infection
1335525|NCT01434706|primary infection|primary infection
1335526|NCT01434706|seroconverters|seroconverters
1335527|NCT01434693|T. suis ova|t. suis ova
1335528|NCT01434693|Crohn's disease|crohn's disease
1335529|NCT01434680|Meningococcal disease|meningococcal disease
1335530|NCT01434680|vaccines|vaccines
1335531|NCT01434680|toddlers|toddlers
1335532|NCT01434680|prevention|prevention
1335533|NCT01434680|Meningitis|meningitis
1335534|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1335535|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
1335536|NCT01434667|APOE|apoe
1335537|NCT01434667|genetics|genetics
1335538|NCT01434667|risk assessment|risk assessment
1335539|NCT01434667|education|education
1335540|NCT01434667|genetic counseling|genetic counseling
1335541|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
1335542|NCT01434654|HAND|hand
1335543|NCT01434654|HIV|hiv
1335544|NCT01434654|Neurology|neurology
1335545|NCT01434654|Neurocognitive|neurocognitive
1335546|NCT01434654|Neuro-HAART|neuro-haart
1335547|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
1335548|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
1335549|NCT01434641|wide beam reconstruction|wide beam reconstruction
1335550|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
1335551|NCT01434628|Male Circumcision|male circumcision
1335552|NCT01434628|HIV Prevention|hiv prevention
1335553|NCT01434628|HIV Infections|hiv infections
1335554|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1335555|NCT01434615|Moderate to advanced|moderate to advanced
1335556|NCT01434615|patients|patients
1335557|NCT01434615|current consensus guidelines|current consensus guidelines
1335558|NCT01434602|Chemotherapy|chemotherapy
1335559|NCT01434602|Brain Tumor|brain tumor
1335560|NCT01434602|Glioblastoma|glioblastoma
1335561|NCT01434602|Anaplastic Glioma|anaplastic glioma
1335562|NCT01434589|internet addiction|internet addiction
1335563|NCT01434589|computer game addiction|computer game addiction
1335564|NCT01434589|STICA|stica
1335565|NCT01434589|short-term treatment|short-term treatment
1335566|NCT01434589|psychotherapy|psychotherapy
1335567|NCT01434589|internet and computer game addiction|internet and computer game addiction
1335568|NCT01434563|HIV|hiv
1335569|NCT01434563|neurocognitive disorder|neurocognitive disorder
1335570|NCT01434563|primary care|primary care
1335571|NCT01434563|HIV negative|hiv negative
1335572|NCT01434563|HAND|hand
1335573|NCT01434563|CNS|cns
1335574|NCT01434550|pancreas|pancreas
1335575|NCT01434550|pancreatic cancer|pancreatic cancer
1335576|NCT01434550|SBRT|sbrt
1335577|NCT01434550|stereotactic body radiation|stereotactic body radiation
1335578|NCT01434550|radiation therapy|radiation therapy
1335579|NCT01434550|unresectable|unresectable
1335580|NCT01434550|non-metastatic|non-metastatic
1335581|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
1335582|NCT01434550|TBRI|tbri
1335583|NCT01434537|pediatric anesthesia|pediatric anesthesia
1335584|NCT01434537|venepuncture|venepuncture
1335585|NCT01434537|peripheral venous access|peripheral venous access
1335586|NCT01434511|hemophilia A|hemophilia a
1335587|NCT01434511|haemophilia A|haemophilia a
1335588|NCT01434511|blood coagulation disorders|blood coagulation disorders
1335589|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
1335590|NCT01434511|coagulation protein disorder|coagulation protein disorder
1335591|NCT01434511|hematologic diseases|hematologic diseases
1335592|NCT01434511|congenital hemophilia A|congenital hemophilia a
1335593|NCT01434498|Hepatitis C|hepatitis c
1335594|NCT01434498|HCV|hcv
1335595|NCT01434498|Rapid Virologic Response|rapid virologic response
1335596|NCT01434498|Sustained Virologic Response|sustained virologic response
1335597|NCT01434498|Direct Acting Antiviral|direct acting antiviral
1335598|NCT01434498|Combination Therapy|combination therapy
1335599|NCT01434498|Tegobuvir|tegobuvir
1335600|NCT01434498|Treatment naïve|treatment naïve
1335601|NCT01434498|HCV RNA|hcv rna
1335602|NCT01434498|Polymerase inhibitor|polymerase inhibitor
1335603|NCT01434498|Protease inhibitor|protease inhibitor
1335604|NCT01434498|Interferon intolerant|interferon intolerant
1335605|NCT01434498|Interferon ineligible|interferon ineligible
1335606|NCT01434498|GS-9190|gs-9190
1335607|NCT01434498|GS-9451|gs-9451
1335608|NCT01434498|GS-5885|gs-5885
1335609|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
1335610|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
1335611|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
1335612|NCT01434420|triple negative breast cancer|triple negative breast cancer
1335613|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
1335614|NCT01434407|Satiety|satiety
1335615|NCT01434407|Obesity|obesity
1335616|NCT01434407|Inflammation|inflammation
1335617|NCT01434407|Insulin resistance|insulin resistance
1335618|NCT01434394|Oral cancer|oral cancer
1335619|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
1335620|NCT01434394|Induction chemotherapy|induction chemotherapy
1335621|NCT01434394|Targeted chemotherapy|targeted chemotherapy
1335622|NCT01434394|Surgery|surgery
1335623|NCT01434394|Radiotherapy|radiotherapy
1335624|NCT01434381|Recombinant|recombinant
1335625|NCT01434381|Proteins|proteins
1335626|NCT01434381|Antigen|antigen
1335627|NCT01434381|Membrane|membrane
1335628|NCT01434381|Assay|assay
1335629|NCT01434381|Malaria|malaria
1335630|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1335631|NCT01434368|Normal Development|normal development
1335632|NCT01434368|Puberty|puberty
1335633|NCT01434368|Brain Function|brain function
1335634|NCT01434368|Gonadal Steroids|gonadal steroids
1335635|NCT01434368|Brain Structure|brain structure
1335636|NCT01434368|Healthy Volunteer|healthy volunteer
1335637|NCT01434368|HV|hv
1335638|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1335639|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1335640|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1335641|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1335642|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1335643|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1335644|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
1335645|NCT01434342|tobacco use disorder|tobacco use disorder
1335646|NCT01434342|Breast Cancer|breast cancer
1335647|NCT01434342|Cervical Cancer|cervical cancer
1335648|NCT01434342|head & neck cancer|head & neck cancer
1335649|NCT01434342|Prostate Cancer|prostate cancer
1335650|NCT01434342|All histologies|all histologies
1335651|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1335652|NCT01434290|radiation toxicity|radiation toxicity
1335653|NCT01434290|sexual dysfunction|sexual dysfunction
1335654|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1336057|NCT01432665|HSDD|hsdd
1335655|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1335656|NCT01434290|stage I prostate cancer|stage i prostate cancer
1335657|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
1335658|NCT01434277|Preservative|preservative
1335659|NCT01434277|Eye Drops|eye drops
1335660|NCT01434264|rehabilitation|rehabilitation
1335661|NCT01434251|Hypotension|hypotension
1335662|NCT01434251|premature infants|premature infants
1335663|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
1335664|NCT01434238|infant feeding|infant feeding
1335665|NCT01434238|HIV|hiv
1335666|NCT01434238|growth|growth
1335667|NCT01434238|anemia|anemia
1335668|NCT01434225|Neonatal seizures|neonatal seizures
1335669|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
1335670|NCT01434225|Electroencephalography|electroencephalography
1335671|NCT01434225|Bumetanide|bumetanide
1335672|NCT01434212|HCV dynamics|hcv dynamics
1335673|NCT01434212|Mathematical model|mathematical model
1335674|NCT01434212|Interferon|interferon
1335675|NCT01434212|Predict|predict
1335676|NCT01434212|Hepatitis C Virus|hepatitis c virus
1335677|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
1335678|NCT01434199|colonoscopy|colonoscopy
1335679|NCT01434199|caecal intubation|caecal intubation
1335680|NCT01434173|Liver Diseases|liver diseases
1335681|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
1335682|NCT01434173|Fluoroquinolones|fluoroquinolones
1335683|NCT01434173|Amoxicillin|amoxicillin
1335684|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
1335685|NCT01434173|Clarithromycin|clarithromycin
1335686|NCT01434173|Doxycycline|doxycycline
1335687|NCT01434173|Cefuroxime|cefuroxime
1335688|NCT01434173|Case-Control Studies|case-control studies
1335689|NCT01434173|Retrospective Studies|retrospective studies
1335690|NCT01434173|Cohort Studies|cohort studies
1335691|NCT01434173|Epidemiologic Research Design|epidemiologic research design
1335692|NCT01434173|Epidemiologic Studies|epidemiologic studies
1335693|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
1335694|NCT01434173|United States|united states
1335695|NCT01434173|Human|human
1335696|NCT01434173|Insurance Claim Review|insurance claim review
1335697|NCT01434160|Intrauterine|intrauterine
1335698|NCT01434160|contraception|contraception
1335699|NCT01434160|adolescent|adolescent
1335700|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
1335701|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
1335702|NCT01434134|Anthracyclines|anthracyclines
1335703|NCT01434134|Trastuzumab|trastuzumab
1335704|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
1335705|NCT01434095|microperimetry|microperimetry
1335706|NCT01434095|fixation point|fixation point
1335707|NCT01434095|retinal sensitivity|retinal sensitivity
1335708|NCT01434095|photodynamic therapy|photodynamic therapy
1335709|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
1335710|NCT01434082|sleep|sleep
1335711|NCT01434082|school-age children|school-age children
1335712|NCT01434082|Children with and without arthritis|children with and without arthritis
1335713|NCT01434069|colon|colon
1335714|NCT01434069|rectum|rectum
1335715|NCT01434069|small bowel|small bowel
1335716|NCT01434069|pancreas|pancreas
1335717|NCT01434069|gastric|gastric
1335718|NCT01434069|esophageal|esophageal
1335719|NCT01434069|metastatic|metastatic
1335720|NCT01434069|unresectable|unresectable
1335721|NCT01434069|GI|gi
1335722|NCT01434069|combination therapy|combination therapy
1335723|NCT01434069|dose escalation|dose escalation
1335724|NCT01434069|solid tumor|solid tumor
1335725|NCT01434056|Liver disease|liver disease
1335726|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
1335727|NCT01434056|MELD|meld
1335728|NCT01434056|Liver transplantation|liver transplantation
1335729|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
1335730|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
1335731|NCT01434043|Quantitative perfusion|quantitative perfusion
1335732|NCT01434017|PONV|ponv
1335733|NCT01434017|Dexamethasone|dexamethasone
1335734|NCT01434017|Droperidol|droperidol
1335735|NCT01434017|Ondansetron|ondansetron
1335736|NCT01434017|Tonsillectomy|tonsillectomy
1335737|NCT01434004|prostate cancer|prostate cancer
1335738|NCT01433965|Bone marrow transplantation|bone marrow transplantation
1335739|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
1335740|NCT01433939|colonoscopy|colonoscopy
1335741|NCT01433939|position changes|position changes
1335742|NCT01433939|patient comfort|patient comfort
1335743|NCT01433926|Breast cancer.|breast cancer.
1335744|NCT01433926|Trastuzumab.|trastuzumab.
1335745|NCT01433926|Complete remission.|complete remission.
1335746|NCT01433900|glaucoma|glaucoma
1335747|NCT01433900|intraocular pressure|intraocular pressure
1335748|NCT01433900|ocular surface|ocular surface
1335749|NCT01433900|benzalkonium chloride|benzalkonium chloride
1335750|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
1335751|NCT01433887|ribavirin|ribavirin
1335752|NCT01433874|Shoulder pain|shoulder pain
1335753|NCT01433874|Upper abdominal pain|upper abdominal pain
1335754|NCT01433874|Laparoscopic surgery|laparoscopic surgery
1335755|NCT01433874|Abdominal fullness|abdominal fullness
1335756|NCT01433861|gastric cancer|gastric cancer
1335757|NCT01433861|proximal gastrectomy|proximal gastrectomy
1335758|NCT01433861|total gastrectomy|total gastrectomy
1335759|NCT01433861|laparoscopy|laparoscopy
1335760|NCT01433861|reflux esophagitis|reflux esophagitis
1335761|NCT01433861|double tract reconstruction|double tract reconstruction
1335762|NCT01433835|Cytomegalovirus|cytomegalovirus
1335763|NCT01433835|Antiviral|antiviral
1335764|NCT01433835|Safety|safety
1335765|NCT01433835|Healthy|healthy
1335766|NCT01433809|thyroid cancer|thyroid cancer
1335767|NCT01433809|thyroid neoplasm|thyroid neoplasm
1335768|NCT01433809|thyroid adenoma|thyroid adenoma
1335769|NCT01433796|antiretroviral therapy|antiretroviral therapy
1335770|NCT01433796|tuberculosis|tuberculosis
1335771|NCT01433796|health centres|health centres
1335772|NCT01433796|Ethiopia|ethiopia
1335773|NCT01433757|dystonia|dystonia
1335774|NCT01433757|DYT-1|dyt-1
1335775|NCT01433757|AMPICILLIN|ampicillin
1335776|NCT01433744|C-Reactive protein|c-reactive protein
1335777|NCT01433744|risk|risk
1335778|NCT01433731|CTCL|ctcl
1335779|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1335780|NCT01433718|Effectivness|effectivness
1335781|NCT01433718|Neuromuscular Training|neuromuscular training
1335782|NCT01433718|Resistance Training|resistance training
1335783|NCT01433718|Modification|modification
1335784|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
1335785|NCT01433718|Drop-Jump|drop-jump
1335786|NCT01433718|Knee Separation|knee separation
1335787|NCT01433718|Resistance training program|resistance training program
1335788|NCT01433705|heart|heart
1335789|NCT01433705|perfusion|perfusion
1335790|NCT01433705|glucose|glucose
1335791|NCT01433692|Addictions|addictions
1335792|NCT01433692|Adolescents|adolescents
1335793|NCT01433692|Primary Health Care|primary health care
1335794|NCT01433692|Brief Intervention|brief intervention
1335795|NCT01433679|Health Behavior|health behavior
1335796|NCT01433679|Exercise|exercise
1335797|NCT01433679|Adolescent Behavior|adolescent behavior
1335798|NCT01433679|Motivation|motivation
1335799|NCT01433679|Biological Markers|biological markers
1335800|NCT01433653|Comorbid|comorbid
1335801|NCT01433653|Complicated|complicated
1335802|NCT01433640|image on multi-modalities|image on multi-modalities
1335803|NCT01433640|visualize cancer lesions|visualize cancer lesions
1335804|NCT01433640|highly suspicious lesions|highly suspicious lesions
1335805|NCT01433627|acute coronary syndromes|acute coronary syndromes
1335806|NCT01433627|myocardial infarction|myocardial infarction
1335807|NCT01433627|access site|access site
1335808|NCT01433627|bivalirudin|bivalirudin
1335809|NCT01433627|bleedings|bleedings
1335810|NCT01433601|Adherence|adherence
1335811|NCT01433601|Peer support|peer support
1335812|NCT01433601|Treatment failure|treatment failure
1335813|NCT01433588|Managing infant pain|managing infant pain
1335814|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
1335815|NCT01433588|Preterm infants|preterm infants
1335816|NCT01433562|breast cancer|breast cancer
1335817|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
1335818|NCT01433562|Stage II/III|stage ii/iii
1335819|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
1335820|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
1335821|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
1335823|NCT01433523|AIT|ait
1335824|NCT01433523|asthma|asthma
1335825|NCT01433523|asthma exacerbation|asthma exacerbation
1335826|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
1335827|NCT01433510|Allergic|allergic
1335828|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
1335829|NCT01433510|Immunotherapy|immunotherapy
1335830|NCT01433497|multiple sclerosis|multiple sclerosis
1335831|NCT01433497|primary progressive|primary progressive
1335832|NCT01433497|relapse-free|relapse-free
1335833|NCT01433497|secondary progressive|secondary progressive
1335834|NCT01433484|cardiovascular disease|cardiovascular disease
1335835|NCT01433484|coronary heart disease|coronary heart disease
1335836|NCT01433484|obesity|obesity
1335837|NCT01433484|weight loss|weight loss
1335838|NCT01433484|genomics|genomics
1335839|NCT01433471|Ulcerative Colitis|ulcerative colitis
1335840|NCT01433471|Trichuris Suis Ova|trichuris suis ova
1335841|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
1335842|NCT01433471|Mucus|mucus
1335843|NCT01433458|Hepatic impairment|hepatic impairment
1335844|NCT01433458|healthy volunteers|healthy volunteers
1335845|NCT01433458|RLX030|rlx030
1335846|NCT01433458|pharmacokinetics|pharmacokinetics
1335847|NCT01433445|Myelofibrosis|myelofibrosis
1335848|NCT01433445|Panobinostat|panobinostat
1335849|NCT01433445|Ruxolitinib|ruxolitinib
1335850|NCT01433445|MF|mf
1335851|NCT01433445|PMF|pmf
1335852|NCT01433445|PPV|ppv
1335853|NCT01433445|PPV-MF|ppv-mf
1335854|NCT01433445|PET|pet
1335855|NCT01433445|PET-MF|pet-mf
1335856|NCT01433445|JAK2|jak2
1335858|NCT01433432|Crohn's Disease|crohn's disease
1335859|NCT01433419|Drug Therapy|drug therapy
1335860|NCT01433406|Drug Therapy|drug therapy
1335861|NCT01433393|Drug Therapy|drug therapy
1335862|NCT01433380|Phase 1|phase 1
1335863|NCT01433380|Single Doses|single doses
1335864|NCT01433380|Pharmacodynamics|pharmacodynamics
1335865|NCT01433380|Healthy Volunteers|healthy volunteers
1335866|NCT01433367|total disc replacement|total disc replacement
1335867|NCT01433367|cervical disc disease|cervical disc disease
1335868|NCT01433354|Fragile X Syndrome|fragile x syndrome
1335869|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
1335870|NCT01433354|Genetic Diseases|genetic diseases
1335871|NCT01433354|X-Linked|x-linked
1335872|NCT01433354|Escalante's syndrome|escalante's syndrome
1335873|NCT01433341|Normal young athletes|normal young athletes
1335874|NCT01433328|Remodulin|remodulin
1335875|NCT01433328|Treprostinil|treprostinil
1335876|NCT01433315|sleep deprivation|sleep deprivation
1335877|NCT01433315|sleep restriction|sleep restriction
1335878|NCT01433302|Breast cancer|breast cancer
1335879|NCT01433302|Genitourinary cancer|genitourinary cancer
1335880|NCT01433302|Gynecological cancer|gynecological cancer
1335881|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
1335882|NCT01433302|Melanoma|melanoma
1335883|NCT01433302|Sarcoma|sarcoma
1335884|NCT01433302|Inflammatory Response|inflammatory response
1335885|NCT01433302|Inflammatory proteins|inflammatory proteins
1335886|NCT01433302|Tissue Fibrosis|tissue fibrosis
1335887|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
1335888|NCT01433302|Punch biopsy|punch biopsy
1335889|NCT01433302|Lab collections|lab collections
1335890|NCT01433302|Th2 immune phenotype|th2 immune phenotype
1335891|NCT01433302|Lymphedema|lymphedema
1335892|NCT01433289|HIV|hiv
1335893|NCT01433289|safety|safety
1335894|NCT01433289|toxicity|toxicity
1335895|NCT01433289|pharmacokinetics|pharmacokinetics
1335896|NCT01433289|Polyphenon E|polyphenon e
1335897|NCT01433289|EGCG|egcg
1335898|NCT01433289|green tea|green tea
1335899|NCT01433289|CD4|cd4
1335900|NCT01433289|viral load|viral load
1335901|NCT01433276|Fluid resuscitation|fluid resuscitation
1335902|NCT01433276|hemorrhagic shock|hemorrhagic shock
1335903|NCT01433276|Totilac|totilac
1335904|NCT01433276|Ringer's|ringer's
1335905|NCT01433276|trauma|trauma
1335906|NCT01433263|Wasting syndrome|wasting syndrome
1335907|NCT01433263|emaciation|emaciation
1335908|NCT01433263|lung cancer|lung cancer
1335909|NCT01433263|adenocarcinoma|adenocarcinoma
1335910|NCT01433263|pancreatic cancer|pancreatic cancer
1335911|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
1335912|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
1335913|NCT01433250|interleukin-17,|interleukin-17,
1335914|NCT01433250|monoclonal human antibody|monoclonal human antibody
1335915|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1335916|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1335917|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1335918|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
1335919|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
1335920|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1335921|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1567106|NCT00510042|von Willebrand disease|von willebrand disease
1335922|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1335923|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1335924|NCT01433185|PMTCT|pmtct
1335925|NCT01433185|SMS|sms
1335926|NCT01433185|HIV Infections|hiv infections
1335927|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1335928|NCT01433185|Prevention & Control|prevention & control
1335929|NCT01433185|Patient Compliance|patient compliance
1335930|NCT01433185|Cellular Phone|cellular phone
1335931|NCT01433185|Randomized Controlled Trial|randomized controlled trial
1335932|NCT01433172|stage IV|stage iv
1335933|NCT01433172|adenocarcinoma|adenocarcinoma
1335934|NCT01433172|vaccine therapy|vaccine therapy
1335935|NCT01433172|immunology|immunology
1335936|NCT01433172|tumor vaccine|tumor vaccine
1335937|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
1335938|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
1335939|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
1335940|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
1335941|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
1335942|NCT01433159|Pressure Ulcers|pressure ulcers
1335943|NCT01433159|Spinal Cord Injury|spinal cord injury
1335944|NCT01433159|Healthpoint|healthpoint
1335945|NCT01433159|Xenaderm|xenaderm
1335946|NCT01433159|011-101|011-101
1335947|NCT01433146|Temperament|temperament
1335948|NCT01433146|Anxiety|anxiety
1335949|NCT01433146|Depression|depression
1335950|NCT01433146|Colorectal Cancer|colorectal cancer
1335951|NCT01433120|Obesity|obesity
1335952|NCT01433120|Insulin resistance|insulin resistance
1335953|NCT01433120|Microbiota|microbiota
1335954|NCT01433120|Probiotic|probiotic
1335957|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
1335958|NCT01433094|Adherence|adherence
1335959|NCT01433094|Psychoeducation|psychoeducation
1335960|NCT01433094|Pharmacotherapy|pharmacotherapy
1335961|NCT01433094|Schizophrenia|schizophrenia
1335962|NCT01433094|Family support|family support
1335963|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
1335964|NCT01433055|Schizophrenia|schizophrenia
1335965|NCT01433055|Cognitive Symptoms|cognitive symptoms
1335966|NCT01433055|Clozapine|clozapine
1335967|NCT01433042|small bowel disease|small bowel disease
1335968|NCT01433029|Surgical Procedure|surgical procedure
1335969|NCT01433029|Assessment|assessment
1335970|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
1335971|NCT01433029|Coronary artery bypass|coronary artery bypass
1335972|NCT01433029|CAB|cab
1335973|NCT01433029|Video recordings|video recordings
1335974|NCT01433029|Global rating scale|global rating scale
1335975|NCT01433029|GRS|grs
1335976|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
1335977|NCT01433029|Surgical trainees|surgical trainees
1335978|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
1335979|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
1335980|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
1335981|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
1335982|NCT01433003|plasma exchange|plasma exchange
1335983|NCT01433003|Improve treatment response|improve treatment response
1335984|NCT01433003|TTP/HUS|ttp/hus
1335985|NCT01432990|SCI|sci
1335986|NCT01432990|gait|gait
1335987|NCT01432990|rehabilitation|rehabilitation
1335988|NCT01432990|robotic|robotic
1335989|NCT01432964|Orbital Fractures|orbital fractures
1335990|NCT01432964|Fracture Fixation|fracture fixation
1335991|NCT01432964|Blow-out Fractures|blow-out fractures
1335992|NCT01432964|Surgical Mesh|surgical mesh
1335993|NCT01432964|Titanium|titanium
1335994|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
1335995|NCT01432925|Buruli ulcer|buruli ulcer
1335996|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
1335997|NCT01432925|Streptomycin|streptomycin
1335998|NCT01432925|Rifampicin|rifampicin
1335999|NCT01432925|Functional limitations|functional limitations
1336000|NCT01432925|surgery|surgery
1336001|NCT01432925|Bénin|bénin
1336002|NCT01432899|Neurophysiology|neurophysiology
1336003|NCT01432899|Hemidystonia|hemidystonia
1336004|NCT01432899|Childhood-onset|childhood-onset
1336005|NCT01432899|Motion Analysis|motion analysis
1336006|NCT01432899|Neuroimaging|neuroimaging
1336007|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
1336008|NCT01432899|Healthy Volunteer|healthy volunteer
1336009|NCT01432899|HV|hv
1336010|NCT01432886|Breast Cancer|breast cancer
1336011|NCT01432873|BMT|bmt
1336012|NCT01432873|HSCT|hsct
1336013|NCT01432860|Skin Self Examination|skin self examination
1336014|NCT01432847|Best Disease|best disease
1336015|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
1336016|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1336017|NCT01432847|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
1336018|NCT01432847|Retinal Degeneration|retinal degeneration
1336019|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
1336020|NCT01432847|AMD|amd
1336021|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
1336022|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
1336023|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
1336024|NCT01432834|LASIK|lasik
1336025|NCT01432834|PRK|prk
1336026|NCT01432821|Epilepsy,|epilepsy,
1336027|NCT01432821|dopamine|dopamine
1336028|NCT01432821|yawning,|yawning,
1336029|NCT01432821|blinking eyelids,|blinking eyelids,
1336030|NCT01432821|electroencephalography|electroencephalography
1336031|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
1336032|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
1336033|NCT01432795|medical compression therapy|medical compression therapy
1336034|NCT01432795|compression stocking|compression stocking
1336035|NCT01432795|gliding aid|gliding aid
1336036|NCT01432795|stocking butler|stocking butler
1336037|NCT01432795|adherence to treatment|adherence to treatment
1336038|NCT01432782|Weight loss|weight loss
1336039|NCT01432782|Dysphagia|dysphagia
1336040|NCT01432782|Esophageal hypermotility|esophageal hypermotility
1336041|NCT01432782|Chest Pain|chest pain
1336042|NCT01432769|enteral nutrition|enteral nutrition
1336043|NCT01432769|malnutrition|malnutrition
1336044|NCT01432769|cardiac surgery|cardiac surgery
1336045|NCT01432756|HIV|hiv
1336046|NCT01432743|3D mapping|3d mapping
1336047|NCT01432743|Image integration|image integration
1336048|NCT01432743|Atrial fibrillation|atrial fibrillation
1336049|NCT01432743|Catheter Ablation|catheter ablation
1336050|NCT01432704|MS|ms
1336051|NCT01432704|vitamin D|vitamin d
1336052|NCT01432704|environment|environment
1336053|NCT01432691|Hip-fracture|hip-fracture
1336054|NCT01432691|RSA|rsa
1336055|NCT01432678|vitamin D|vitamin d
1336056|NCT01432678|asthma|asthma
1336058|NCT01432639|Myocardial infarction|myocardial infarction
1336059|NCT01432639|Autonomic function|autonomic function
1336060|NCT01432639|Arterial Stiffness|arterial stiffness
1336061|NCT01432639|Endothelial function|endothelial function
1336062|NCT01432639|Inflammation|inflammation
1336063|NCT01432639|Rehabilitation program|rehabilitation program
1336064|NCT01432639|Exercise|exercise
1336065|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
1336066|NCT01432626|broken heart syndrome|broken heart syndrome
1336067|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
1336068|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
1336069|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
1336070|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
1336071|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
1336072|NCT01432613|Myositis|myositis
1336073|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
1336074|NCT01432613|Muscle biopsy|muscle biopsy
1336075|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
1336076|NCT01432600|Multiple Myeloma|multiple myeloma
1336077|NCT01432600|Relapsed|relapsed
1336078|NCT01432600|Refractory|refractory
1336079|NCT01432600|Corticosteroids|corticosteroids
1336080|NCT01432587|Amyloidosis|amyloidosis
1336081|NCT01432587|Transthyretin|transthyretin
1336082|NCT01432587|Neuropathies|neuropathies
1336083|NCT01432587|Diflunisal|diflunisal
1336084|NCT01432587|Familial|familial
1336085|NCT01432574|HPV|hpv
1336086|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
1336087|NCT01432561|Metabolic Diseases|metabolic diseases
1336088|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
1336089|NCT01432548|Ischemic|ischemic
1336090|NCT01432548|preconditioning|preconditioning
1336091|NCT01432548|liver|liver
1336092|NCT01432548|resection|resection
1336093|NCT01432522|Intranasal epinephrine|intranasal epinephrine
1336094|NCT01432522|Plasma epinephrine level|plasma epinephrine level
1336095|NCT01432509|Pre-diabetes|pre-diabetes
1336096|NCT01432509|Type 2 diabetes|type 2 diabetes
1336097|NCT01432509|Biomarkers|biomarkers
1336098|NCT01432509|Cohort|cohort
1336099|NCT01432509|Diabetes Risk Score|diabetes risk score
1336100|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1336101|NCT01432509|Glucose Intolerance|glucose intolerance
1336102|NCT01432509|Prediabetic State|prediabetic state
1336103|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
1336104|NCT01432509|Metabolic Diseases|metabolic diseases
1336105|NCT01432509|Endocrine System Diseases|endocrine system diseases
1336106|NCT01432509|Hyperglycemia|hyperglycemia
1336107|NCT01432496|Laparoscopic|laparoscopic
1336108|NCT01432496|Colectomy|colectomy
1336109|NCT01432496|Nebulization|nebulization
1336110|NCT01432496|Ropivacaine|ropivacaine
1336111|NCT01432483|Cancer|cancer
1336112|NCT01432483|ONTAK|ontak
1336113|NCT01432483|Denileukin diftitox|denileukin diftitox
1336114|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
1336115|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
1336116|NCT01432470|vaginal atrophy|vaginal atrophy
1336117|NCT01432444|Schizophrenia|schizophrenia
1336118|NCT01432418|rehabilitation|rehabilitation
1336119|NCT01432418|wheelchairs|wheelchairs
1336120|NCT01432418|safety|safety
1336121|NCT01432418|disability evaluation|disability evaluation
1336122|NCT01432418|motor skills|motor skills
1336123|NCT01432405|Diabetes|diabetes
1336124|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
1336125|NCT01432392|GERD questionnaire|gerd questionnaire
1336126|NCT01432392|primary care setting|primary care setting
1336127|NCT01432340|Influenza|influenza
1336128|NCT01432340|Influenza vaccine|influenza vaccine
1336129|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
1336130|NCT01432327|motor activity|motor activity
1336131|NCT01432327|randomized controlled trial|randomized controlled trial
1336132|NCT01432327|feedback|feedback
1336133|NCT01432314|patient's survival|patient's survival
1336134|NCT01432314|tumor response|tumor response
1336135|NCT01432314|safety|safety
1336136|NCT01432301|fluorouracil overdose|fluorouracil overdose
1336137|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
1336138|NCT01432301|capecitabine overdose|capecitabine overdose
1336139|NCT01432301|capecitabine toxicity|capecitabine toxicity
1336140|NCT01432275|Diabetes|diabetes
1336141|NCT01432275|SMBG|smbg
1336142|NCT01432275|Insulin calculator|insulin calculator
1336143|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
1336144|NCT01432249|pediatric psoriasis|pediatric psoriasis
1336145|NCT01432249|enbrel|enbrel
1336146|NCT01432249|safety|safety
1336147|NCT01432249|efficacy|efficacy
1336148|NCT01432236|Pregabalin|pregabalin
1336149|NCT01432236|Lyrica|lyrica
1336150|NCT01432236|depression|depression
1336151|NCT01432223|Trastuzumab|trastuzumab
1336152|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1336153|NCT01432223|Primary chemotherapy|primary chemotherapy
1336154|NCT01432210|post-prandial absorption|post-prandial absorption
1336155|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
1336156|NCT01432210|vitamin A|vitamin a
1336157|NCT01432210|avocado|avocado
1336158|NCT01432210|tomato|tomato
1336159|NCT01432210|carrot|carrot
1336160|NCT01432197|HRQOL|hrqol
1336161|NCT01432197|Occupational therapy|occupational therapy
1336162|NCT01432197|ADL intervention|adl intervention
1336163|NCT01432197|Cancer patients|cancer patients
1336164|NCT01432184|cerebral|cerebral
1336165|NCT01432184|hypoxia|hypoxia
1336166|NCT01432171|Brain cancer|brain cancer
1336167|NCT01432171|Central nervous system|central nervous system
1336168|NCT01432171|Seizure prophylaxis|seizure prophylaxis
1336169|NCT01432171|High-Grade Gliomas|high-grade gliomas
1336171|NCT01432171|Supratentorial high-grade glioma|supratentorial high-grade glioma
1336172|NCT01432171|Malignant glioma|malignant glioma
1336173|NCT01432171|Lacosamide|lacosamide
1336174|NCT01432171|Vimpat|vimpat
1336175|NCT01432171|Placebo|placebo
1336176|NCT01432171|Sugar pill|sugar pill
1336177|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
1336178|NCT01432145|BRCA defective|brca defective
1336179|NCT01432132|Head and Neck Cancer|head and neck cancer
1336180|NCT01432132|Body Image Adaptation|body image adaptation
1336181|NCT01432132|Post surgical body image|post surgical body image
1336182|NCT01432132|Audio-recorded interview|audio-recorded interview
1336183|NCT01432132|Questionnaire|questionnaire
1336184|NCT01432132|Survey|survey
1336185|NCT01432119|Advanced Cancers|advanced cancers
1336186|NCT01432119|Advanced Malignancies|advanced malignancies
1336187|NCT01432119|Liver Metastases|liver metastases
1336188|NCT01432119|SIR-Spheres|sir-spheres
1336189|NCT01432119|Selective internal radiation|selective internal radiation
1336190|NCT01432119|Yttrium-90|yttrium-90
1336191|NCT01432119|Cetuximab|cetuximab
1336192|NCT01432119|C225|c225
1336193|NCT01432119|Erbitux|erbitux
1336194|NCT01432119|Erlotinib|erlotinib
1336195|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
1336196|NCT01432119|Tarceva|tarceva
1336197|NCT01432119|OSI-774|osi-774
1336198|NCT01432106|Hypertension|hypertension
1336199|NCT01432106|Metabolic Syndrome|metabolic syndrome
1336200|NCT01432106|African American|african american
1336201|NCT01432093|liver transplant|liver transplant
1336202|NCT01432093|high blood sugars|high blood sugars
1336203|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
1336204|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
1336205|NCT01432093|post liver transplant|post liver transplant
1336206|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
1336207|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1336208|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
1336209|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
1336210|NCT01432080|Influenza virus A|influenza virus a
1336211|NCT01432080|Influenza virus B|influenza virus b
1336212|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
1336213|NCT01432067|cancer|cancer
1336214|NCT01432067|geriatry|geriatry
1336215|NCT01432067|curative care|curative care
1336216|NCT01432067|physical activity|physical activity
1336217|NCT01432054|Human Tissue Repository|human tissue repository
1336218|NCT01432041|Injury prevention|injury prevention
1336219|NCT01432041|smoke alarms|smoke alarms
1336220|NCT01432041|car seats|car seats
1336221|NCT01432015|aprepitant|aprepitant
1336222|NCT01432015|fosaprepitant|fosaprepitant
1336223|NCT01432015|gynecologic cancer|gynecologic cancer
1336224|NCT01432015|emesis|emesis
1336225|NCT01432002|breast carcinoma|breast carcinoma
1336227|NCT01432002|PET/CT|pet/ct
1336228|NCT01432002|PET/IRM|pet/irm
1336229|NCT01431950|fluticasone furoate|fluticasone furoate
1336230|NCT01431937|Pharmacodynamics|pharmacodynamics
1336231|NCT01431937|Pharmacokinetics|pharmacokinetics
1336232|NCT01431924|outcomes|outcomes
1336233|NCT01431924|observational|observational
1336234|NCT01431924|retrospective|retrospective
1336235|NCT01431924|database|database
1336236|NCT01431924|asthma|asthma
1336237|NCT01431898|HCV RNA|hcv rna
1336238|NCT01431898|Polymerase inhibitor|polymerase inhibitor
1336239|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
1336240|NCT01431898|GS-9669|gs-9669
1336241|NCT01431898|Hepatitis C|hepatitis c
1336242|NCT01431898|HCV|hcv
1336243|NCT01431885|fibronectin|fibronectin
1336244|NCT01431885|cervical length|cervical length
1336245|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
1336246|NCT01431859|pollen|pollen
1336247|NCT01431859|allergy|allergy
1336248|NCT01431859|food|food
1336249|NCT01431859|immunotherapy|immunotherapy
1336250|NCT01431833|Hepatic Impairment|hepatic impairment
1336251|NCT01431833|Matched control subjects|matched control subjects
1336252|NCT01431820|Onychomycosis|onychomycosis
1336253|NCT01431820|Toenail Fungus|toenail fungus
1336254|NCT01431820|luliconazole|luliconazole
1336255|NCT01431820|Antifungal|antifungal
1336256|NCT01431820|Topical|topical
1336257|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
1336258|NCT01431794|LDE225|lde225
1336259|NCT01431794|nab-paclitaxel|nab-paclitaxel
1336260|NCT01431794|abraxane|abraxane
1336261|NCT01431794|gemcitabine|gemcitabine
1336262|NCT01431794|neoadjuvant|neoadjuvant
1336263|NCT01431794|cytotoxic|cytotoxic
1336264|NCT01431794|hedgehog (Hh) inhibitors|hedgehog (hh) inhibitors
1336265|NCT01431794|stromal cells|stromal cells
1336266|NCT01431794|resectable PDA|resectable pda
1336267|NCT01431794|Pancreatic Diseases|pancreatic diseases
1336268|NCT01431794|Carcinoma|carcinoma
1336269|NCT01431768|Influenza|influenza
1336270|NCT01431768|Human|human
1336271|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
1336272|NCT01431768|RNA Virus Infections|rna virus infections
1336273|NCT01431768|Virus Diseases|virus diseases
1336274|NCT01431768|Respiratory Tract infections|respiratory tract infections
1336275|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
1336276|NCT01431742|buccal soluble film|buccal soluble film
1336277|NCT01431742|Pain|pain
1336278|NCT01431742|Back Pain|back pain
1336279|NCT01431742|Low Back Pain|low back pain
1336280|NCT01431742|Buprenorphine|buprenorphine
1336281|NCT01431742|Analgesics, Opioid|analgesics, opioid
1336282|NCT01431742|Analgesics|analgesics
1336283|NCT01431703|narrow band imaging|narrow band imaging
1336284|NCT01431703|learning curve|learning curve
1336285|NCT01431703|colorectal|colorectal
1336286|NCT01431703|differential diagnosis|differential diagnosis
1336287|NCT01431703|with colorectal lesion|with colorectal lesion
1336288|NCT01431703|NBI with magnification|nbi with magnification
1336289|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
1336290|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
1336291|NCT01431690|Warfarin|warfarin
1336292|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
1336293|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
1336294|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
1336295|NCT01431690|Epanova|epanova
1336296|NCT01431690|Lovaza|lovaza
1336297|NCT01431690|pharmacokinetics|pharmacokinetics
1336298|NCT01431690|low-fat meal|low-fat meal
1336299|NCT01431677|Muscle|muscle
1336300|NCT01431677|Biopsy|biopsy
1336301|NCT01431677|Energetics|energetics
1336302|NCT01431677|Sarcopenia|sarcopenia
1336303|NCT01431677|Frailty|frailty
1336304|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1336305|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1336306|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
1336307|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
1336308|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1336309|NCT01431651|Food and beverages|food and beverages
1336310|NCT01431651|Food|food
1336311|NCT01431651|Dietary supplements|dietary supplements
1336312|NCT01431638|Gout|gout
1336313|NCT01431638|arthritis|arthritis
1336314|NCT01431638|gout flare|gout flare
1336315|NCT01431638|acute gout|acute gout
1336316|NCT01431638|gouty|gouty
1336317|NCT01431638|rheumatic disease|rheumatic disease
1336318|NCT01431638|uric acid|uric acid
1336319|NCT01431638|podagra|podagra
1336320|NCT01431625|COPD|copd
1336321|NCT01431625|Exercise Training|exercise training
1336322|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
1336323|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
1336324|NCT01431612|Fluids, i.v.;|fluids, i.v.;
1336325|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
1336326|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
1336327|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
1336328|NCT01431586|JDTic|jdtic
1336329|NCT01431586|cocaine dependence|cocaine dependence
1336330|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
1336331|NCT01431573|Depression|depression
1336332|NCT01431560|ankle|ankle
1336333|NCT01431560|metallic|metallic
1336334|NCT01431560|biodegradable|biodegradable
1336335|NCT01431560|Freedom|freedom
1336336|NCT01431508|Hypertension|hypertension
1336337|NCT01431495|platelet agregation|platelet agregation
1336338|NCT01431495|clopidogrel|clopidogrel
1336339|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
1336340|NCT01431482|skin symptoms|skin symptoms
1336341|NCT01431456|Prevention|prevention
1336342|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
1336343|NCT01431443|Randomized double blind trial|randomized double blind trial
1336344|NCT01431443|Cocoa flavonoids|cocoa flavonoids
1336345|NCT01431443|Endothelial function|endothelial function
1336346|NCT01431443|Blood pressure|blood pressure
1336347|NCT01431443|Pregnant women|pregnant women
1336348|NCT01431443|Preeclampsia|preeclampsia
1336349|NCT01431443|Uterine artery flow|uterine artery flow
1336350|NCT01431443|Pulsatility index|pulsatility index
1336351|NCT01431430|Vitamine D|vitamine d
1336352|NCT01431430|renal transplantation|renal transplantation
1336353|NCT01431430|diabetes mellitus|diabetes mellitus
1336354|NCT01431430|cancer|cancer
1336355|NCT01431430|cardiovascular complications|cardiovascular complications
1336356|NCT01431417|Shoulder|shoulder
1336357|NCT01431417|Outcome treatment|outcome treatment
1336358|NCT01431417|Validation Studies as topic|validation studies as topic
1336359|NCT01431417|Biomechanics|biomechanics
1336360|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
1336361|NCT01431391|Immune therapy|immune therapy
1336362|NCT01431391|Cancer vaccine|cancer vaccine
1336363|NCT01431391|Therapeutic vaccine|therapeutic vaccine
1336364|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
1336365|NCT01431391|Vaccine|vaccine
1336366|NCT01431391|Dendritic cells|dendritic cells
1336368|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
1336369|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
1336370|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
1336371|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
1336372|NCT01431391|Neoplasms|neoplasms
1336373|NCT01431391|Prostatic Diseases|prostatic diseases
1336374|NCT01431391|Androgens|androgens
1336375|NCT01431391|Hormones|hormones
1336376|NCT01431391|Adenocarcinoma|adenocarcinoma
1336377|NCT01431391|Carcinoma|carcinoma
1336378|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1336379|NCT01431391|Immunology|immunology
1336380|NCT01431391|Hormone therapy|hormone therapy
1336381|NCT01431391|Immunotherapy|immunotherapy
1336382|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
1336383|NCT01431378|CT scan|ct scan
1336384|NCT01431378|CNS|cns
1336385|NCT01431378|Thorax|thorax
1336386|NCT01431378|Abdomen|abdomen
1336387|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
1336388|NCT01431378|suspected urolithiasis|suspected urolithiasis
1336389|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
1336390|NCT01431365|exercise|exercise
1336391|NCT01431365|topography|topography
1336392|NCT01431365|cravings|cravings
1336393|NCT01431365|smoking behaviour|smoking behaviour
1336394|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
1336395|NCT01431352|Randomized controlled trial|randomized controlled trial
1336396|NCT01431352|Chinese herbal medicine|chinese herbal medicine
1336397|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
1336398|NCT01431352|Letrozole|letrozole
1336399|NCT01431352|Live birth|live birth
1336400|NCT01431326|adenovirus|adenovirus
1336401|NCT01431326|anaesthetic|anaesthetic
1336402|NCT01431326|anesthesia|anesthesia
1336403|NCT01431326|anticoagulant|anticoagulant
1336404|NCT01431326|anti-epileptic|anti-epileptic
1336405|NCT01431326|anti-inflammatory|anti-inflammatory
1336406|NCT01431326|antimicrobial|antimicrobial
1336407|NCT01431326|anti-psychotic|anti-psychotic
1336408|NCT01431326|antiviral|antiviral
1336410|NCT01431326|anxiolysis|anxiolysis
1336411|NCT01431326|anxiolytic|anxiolytic
1336412|NCT01431326|autism|autism
1336413|NCT01431326|autistic disorder|autistic disorder
1336414|NCT01431326|benzodiazepine|benzodiazepine
1336415|NCT01431326|bipolar disorder|bipolar disorder
1336416|NCT01431326|convulsions|convulsions
1336417|NCT01431326|epilepsy|epilepsy
1336418|NCT01431326|headaches|headaches
1336419|NCT01431326|herpes simplex virus|herpes simplex virus
1336420|NCT01431326|herpes simplex virus (HSV)|herpes simplex virus (hsv)
1336421|NCT01431326|hypertension|hypertension
1336422|NCT01431326|infantile hemangioma|infantile hemangioma
1336423|NCT01431326|infection|infection
1336424|NCT01431326|inflammation|inflammation
1336425|NCT01431326|influenza|influenza
1336426|NCT01431326|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
1336427|NCT01431326|meningitis|meningitis
1336428|NCT01431326|migraines|migraines
1336429|NCT01431326|muscle spasms|muscle spasms
1336430|NCT01431326|pain|pain
1336431|NCT01431326|pneumonia|pneumonia
1336432|NCT01431326|prophylaxis|prophylaxis
1336433|NCT01431326|retinitis|retinitis
1336434|NCT01431326|schizophrenia|schizophrenia
1336435|NCT01431326|sedation|sedation
1336436|NCT01431326|sedative|sedative
1336437|NCT01431326|seizures|seizures
1336438|NCT01431326|septicemia|septicemia
1336439|NCT01431326|swelling|swelling
1336440|NCT01431326|thromboprophylaxis|thromboprophylaxis
1336441|NCT01431326|thrombosis|thrombosis
1336442|NCT01431326|urinary tract infection|urinary tract infection
1336443|NCT01431326|urinary tract infection (UTI)|urinary tract infection (uti)
1336444|NCT01431326|withdrawal|withdrawal
1336445|NCT01431326|empiric therapy|empiric therapy
1336446|NCT01431326|staphylococci|staphylococci
1336447|NCT01431313|pulmonary hypertension|pulmonary hypertension
1336448|NCT01431300|central veins|central veins
1336449|NCT01431300|thorax|thorax
1336450|NCT01431300|superior vena cava|superior vena cava
1336451|NCT01431300|Central vein imaging|central vein imaging
1336452|NCT01431261|Chronic neck pain|chronic neck pain
1336453|NCT01431261|Whiplash|whiplash
1336454|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
1336455|NCT01431261|Chronic Pain|chronic pain
1336456|NCT01431261|Neck exercises|neck exercises
1336457|NCT01431261|Training|training
1336458|NCT01431261|Pacing|pacing
1336459|NCT01431261|Patient Education|patient education
1336460|NCT01431261|Pain Management|pain management
1336461|NCT01431261|Whiplash Injuries|whiplash injuries
1336462|NCT01431261|Musculoskeletal|musculoskeletal
1336752|NCT01430182|Humans|humans
1336463|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
1336464|NCT01431248|Erythromycin|erythromycin
1336465|NCT01431248|Azithromycin|azithromycin
1336467|NCT01431235|SUD|sud
1336468|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
1336469|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
1336470|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
1336471|NCT01431222|inoperable|inoperable
1336472|NCT01431222|EuroSCORE|euroscore
1336473|NCT01431222|STS Risk Score|sts risk score
1336474|NCT01431222|MitraClip|mitraclip
1336475|NCT01431222|fluoroscopy|fluoroscopy
1336476|NCT01431222|echocardiography|echocardiography
1336477|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
1336478|NCT01431196|breast cancer|breast cancer
1336479|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1336480|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
1336481|NCT01431183|influenza|influenza
1336482|NCT01431183|vaccine|vaccine
1336483|NCT01431183|reminder / recall|reminder / recall
1336484|NCT01431183|immunization registry|immunization registry
1336485|NCT01431183|immunization information systems|immunization information systems
1336486|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
1336487|NCT01431157|Heart Failure|heart failure
1336488|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
1336489|NCT01431144|soft tissue thickness|soft tissue thickness
1336490|NCT01431144|dental implant|dental implant
1336491|NCT01431144|soft tissue recession|soft tissue recession
1336492|NCT01431144|implant exposure|implant exposure
1336493|NCT01431131|graft placement|graft placement
1336494|NCT01431131|bone resorption|bone resorption
1336495|NCT01431118|iron metabolism|iron metabolism
1336496|NCT01431118|hepcidin|hepcidin
1336497|NCT01431118|dragon boating|dragon boating
1336498|NCT01431118|sport-specific stress|sport-specific stress
1336499|NCT01431118|iron|iron
1336500|NCT01431118|anaemia|anaemia
1336501|NCT01431118|sport|sport
1336502|NCT01431105|Kawasaki disease|kawasaki disease
1336503|NCT01431079|HPV|hpv
1336504|NCT01431079|College men|college men
1336505|NCT01431079|HPV vaccine|hpv vaccine
1336506|NCT01431079|Health belief model|health belief model
1336507|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
1336508|NCT01431053|exemestane|exemestane
1336509|NCT01431053|aspirin|aspirin
1336510|NCT01431053|quality of life|quality of life
1336511|NCT01431040|Bowel Prep|bowel prep
1336512|NCT01431040|No bowel prep|no bowel prep
1336513|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
1336514|NCT01431027|Heart Failure|heart failure
1336515|NCT01431027|Diastolic Heart Failure|diastolic heart failure
1336516|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
1336517|NCT01431014|orthognathic surgery|orthognathic surgery
1336518|NCT01431014|steroid|steroid
1336519|NCT01431014|swelling|swelling
1336520|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
1336521|NCT01431001|Depression|depression
1336522|NCT01431001|MDD|mdd
1336523|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1336524|NCT01431001|Depressive Disorder|depressive disorder
1336525|NCT01431001|TMS|tms
1336526|NCT01430988|Head Injuries|head injuries
1336527|NCT01430988|Head Trauma|head trauma
1336528|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1336529|NCT01430988|Emergency Department|emergency department
1336530|NCT01430988|Accident & Emergency|accident & emergency
1336531|NCT01430975|Radiation Exposure|radiation exposure
1336532|NCT01430975|Rubidium 82|rubidium 82
1336533|NCT01430975|Strontium 82|strontium 82
1336534|NCT01430975|Strontium 85|strontium 85
1336535|NCT01430962|EBUS|ebus
1336536|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
1336537|NCT01430962|mediastinal masses|mediastinal masses
1336538|NCT01430962|anesthesia|anesthesia
1336539|NCT01430962|moderate sedation|moderate sedation
1336540|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1336541|NCT01430949|Catheter Ablation|catheter ablation
1336542|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
1336543|NCT01430949|Radio Frequency Ablation|radio frequency ablation
1336544|NCT01430936|Vascular Diseases|vascular diseases
1336545|NCT01430936|Hypertension|hypertension
1336546|NCT01430936|Chronic Kidney Disease|chronic kidney disease
1336547|NCT01430936|COPD|copd
1336548|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
1336549|NCT01430910|Phase 1|phase 1
1336550|NCT01430910|open label|open label
1336551|NCT01430910|ceftazidime|ceftazidime
1336552|NCT01430910|pharmacokinetics|pharmacokinetics
1336553|NCT01430910|urinary tract infection|urinary tract infection
1336554|NCT01430910|intra-abdominal infection|intra-abdominal infection
1336555|NCT01430897|d-TGA|d-tga
1336556|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
1336557|NCT01430897|systemic right ventricle|systemic right ventricle
1336558|NCT01430897|right ventricular failure|right ventricular failure
1336559|NCT01430897|Atrial switch procedure|atrial switch procedure
1336575|NCT01430832|Preterm|preterm
1336576|NCT01430832|Premature|premature
1336577|NCT01430832|VLBW|vlbw
1336578|NCT01430819|Influenza|influenza
1336579|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
1336580|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
1336581|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
1336582|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1336583|NCT01430780|Coronary artery disease|coronary artery disease
1336584|NCT01430780|nitrate|nitrate
1336585|NCT01430780|endothelium|endothelium
1336586|NCT01430767|adherence|adherence
1336587|NCT01430754|Blindness|blindness
1336588|NCT01430754|Eye Diseases|eye diseases
1336589|NCT01430754|Nap Disorders|nap disorders
1336590|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
1336591|NCT01430754|Sleep Disorders|sleep disorders
1336592|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
1336593|NCT01430754|Dyssomnias|dyssomnias
1336594|NCT01430754|Nervous System Diseases|nervous system diseases
1336600|NCT01430715|active video game|active video game
1336601|NCT01430715|video gaming|video gaming
1336602|NCT01430715|accelerometery|accelerometery
1336603|NCT01430715|MVPA|mvpa
1336604|NCT01430715|outdoor play|outdoor play
1336605|NCT01430715|children|children
1336606|NCT01430715|unstructured|unstructured
1336607|NCT01430715|energy expenditure|energy expenditure
1336608|NCT01430689|Influenza|influenza
1336609|NCT01430689|Pregnancy|pregnancy
1336610|NCT01430689|Neonates|neonates
1336611|NCT01430676|Incisional hernia|incisional hernia
1336612|NCT01430676|recurrence|recurrence
1336613|NCT01430676|longterm|longterm
1336614|NCT01430663|aspergillosis|aspergillosis
1336615|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
1336616|NCT01430663|galactomannan|galactomannan
1336617|NCT01430663|pcr|pcr
1336618|NCT01430663|hematological patients|hematological patients
1336619|NCT01430650|Oral estrogens|oral estrogens
1336620|NCT01430650|transdermal estrogens|transdermal estrogens
1336621|NCT01430650|endometrial priming|endometrial priming
1336622|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1336623|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1336624|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1336625|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1336626|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1336627|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1336628|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1336629|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1336630|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1336631|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1336632|NCT01430624|Rape|rape
1448136|NCT00973544|drains|drains
1336633|NCT01430624|Secondary prevention|secondary prevention
1336634|NCT01430624|Intervention|intervention
1336635|NCT01430611|Meningitis|meningitis
1336636|NCT01430611|Neisseria meningitidis|neisseria meningitidis
1336637|NCT01430611|Meningo A+C®|meningo a+c®
1336638|NCT01430611|Meng Ling Kang®|meng ling kang®
1336639|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
1336640|NCT01430585|Ki-67|ki-67
1336641|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
1336642|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
1336643|NCT01430572|Advanced Cancers|advanced cancers
1336644|NCT01430572|Solid Tumors|solid tumors
1336645|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
1336646|NCT01430572|Refractory to standard therapy|refractory to standard therapy
1336647|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
1336648|NCT01430572|Pazopanib|pazopanib
1336649|NCT01430572|GW786034|gw786034
1336650|NCT01430572|Everolimus|everolimus
1336651|NCT01430572|Afinitor|afinitor
1336653|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
1336753|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
1336654|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1336655|NCT01430533|dermal sensitization potential|dermal sensitization potential
1336656|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
1336657|NCT01430481|rosehip|rosehip
1336658|NCT01430481|osteoarthritis|osteoarthritis
1336659|NCT01430481|pain|pain
1336660|NCT01430481|knee|knee
1336661|NCT01430481|RCT|rct
1336662|NCT01430468|Glenoid component position|glenoid component position
1336663|NCT01430468|patient specific instruments|patient specific instruments
1336664|NCT01430455|Major Depressive Episode|major depressive episode
1336665|NCT01430455|Depression NOS|depression nos
1336666|NCT01430455|Bipolar Disorder|bipolar disorder
1336667|NCT01430455|Bipolar Disorder I|bipolar disorder i
1336668|NCT01430455|Bipolar Disorder II|bipolar disorder ii
1336669|NCT01430455|Bipolar Depression|bipolar depression
1336670|NCT01430455|Major Depression|major depression
1336671|NCT01430416|Uveal melanoma|uveal melanoma
1336672|NCT01430416|phase 1|phase 1
1336673|NCT01430416|AEB071|aeb071
1336674|NCT01430416|Metastatic|metastatic
1336675|NCT01430403|persistent allergic asthma|persistent allergic asthma
1336676|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
1336677|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
1336678|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
1336679|NCT01430403|placebo|placebo
1336680|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
1336681|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
1336682|NCT01430403|anti-IgE therapy|anti-ige therapy
1336683|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
1336684|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
1336685|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
1336686|NCT01430390|11-038|11-038
1336687|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
1336688|NCT01430377|procedure time|procedure time
1336689|NCT01430377|fluoroscopy time|fluoroscopy time
1336690|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
1336691|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
1336692|NCT01430364|sirolymus|sirolymus
1336693|NCT01430364|PTS|pts
1336694|NCT01430364|BiOSS Lym|bioss lym
1336695|NCT01430351|Brain cancer|brain cancer
1336696|NCT01430351|Central nervous system|central nervous system
1336697|NCT01430351|Glioblastoma Multiforme|glioblastoma multiforme
1336698|NCT01430351|GBM|gbm
1336699|NCT01430351|Post Radiation Therapy|post radiation therapy
1336700|NCT01430351|Post-RT|post-rt
1336701|NCT01430351|External beam radiotherapy|external beam radiotherapy
1336702|NCT01430351|XRT|xrt
1336703|NCT01430351|Supratentorial glioblastoma|supratentorial glioblastoma
1336704|NCT01430351|Gliosarcoma|gliosarcoma
1336705|NCT01430351|Grade IV astrocytoma|grade iv astrocytoma
1336706|NCT01430351|Temozolomide|temozolomide
1336707|NCT01430351|Temodar|temodar
1336708|NCT01430351|Memantine|memantine
1336709|NCT01430351|Namenda|namenda
1336710|NCT01430351|Mefloquine|mefloquine
1336711|NCT01430351|Apo-Mefloquine|apo-mefloquine
1336712|NCT01430351|Lariam|lariam
1336713|NCT01430351|Metformin|metformin
1336714|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
1336715|NCT01430312|dermal irritative potential|dermal irritative potential
1336716|NCT01430286|Caregivers|caregivers
1336717|NCT01430286|Alzheimer Disease|alzheimer disease
1336718|NCT01430286|Psychological stress|psychological stress
1336719|NCT01430286|Psychological adaptation|psychological adaptation
1336720|NCT01430286|Self-efficacy|self-efficacy
1336721|NCT01430286|Randomized controlled trial|randomized controlled trial
1336722|NCT01430273|Antiplatelet therapy|antiplatelet therapy
1336723|NCT01430273|Surgery|surgery
1448283|NCT00973011|GA|ga
1336724|NCT01430273|Bleeding|bleeding
1336725|NCT01430273|Platelet aggregation|platelet aggregation
1336726|NCT01430260|efficacy|efficacy
1336727|NCT01430260|ciclesonide|ciclesonide
1336728|NCT01430260|levocetirizine|levocetirizine
1336729|NCT01430260|allergic rhinitis|allergic rhinitis
1336730|NCT01430247|amblyopia|amblyopia
1336731|NCT01430247|amblyogenic factors|amblyogenic factors
1336732|NCT01430247|screening|screening
1336733|NCT01430247|preschool children|preschool children
1336734|NCT01430247|visual acuity|visual acuity
1336735|NCT01430247|prevalence|prevalence
1336736|NCT01430234|Chronic pancreatitis|chronic pancreatitis
1336737|NCT01430234|Exocrine insufficiency|exocrine insufficiency
1336738|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
1336739|NCT01430234|Self-administration|self-administration
1336740|NCT01430221|prediabetes|prediabetes
1336741|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
1336742|NCT01430221|mindfulness|mindfulness
1336743|NCT01430221|personalized health planning|personalized health planning
1336744|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
1336745|NCT01430208|endometrial pathology|endometrial pathology
1336746|NCT01430195|vitiligo|vitiligo
1336747|NCT01430195|depigmentation|depigmentation
1336748|NCT01430195|phototherapy|phototherapy
1336749|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
1336750|NCT01430182|Adult|adult
1336751|NCT01430182|Female|female
1336754|NCT01430182|Male|male
1336755|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
1336756|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
1336757|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
1336758|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
1336759|NCT01430182|Middle Aged|middle aged
1336760|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
1336761|NCT01430182|Pain Measurement/methods|pain measurement/methods
1336762|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
1336763|NCT01430182|Prospective Studies|prospective studies
1336764|NCT01430182|Double-Blind Method|double-blind method
1336765|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
1336766|NCT01430182|Young Adult|young adult
1336767|NCT01430182|Orthopedics|orthopedics
1336768|NCT01430169|Xiaflex|xiaflex
1336769|NCT01430169|Xiapex|xiapex
1336770|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
1336771|NCT01430156|Renal Transplantation|renal transplantation
1336772|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
1336773|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
1336774|NCT01430156|Heme arginate|heme arginate
1336775|NCT01430143|Exercise|exercise
1336776|NCT01430130|scar|scar
1336777|NCT01430130|incision|incision
1336778|NCT01430130|wound healing|wound healing
1336779|NCT01430130|scarring|scarring
1336780|NCT01430130|scar revision|scar revision
1336781|NCT01430117|Immunotherapy|immunotherapy
1336782|NCT01430117|Skin prick test|skin prick test
1336783|NCT01430117|Standardization|standardization
1336784|NCT01430117|Poa pratensis|poa pratensis
1336785|NCT01430078|ASP015K|asp015k
1336786|NCT01430078|Healthy subjects|healthy subjects
1336787|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
1336788|NCT01430065|transplant|transplant
1336789|NCT01430065|ASP015K|asp015k
1336790|NCT01430065|tacrolimus|tacrolimus
1336791|NCT01430065|Prograf|prograf
1336792|NCT01430065|healthy volunteers|healthy volunteers
1336793|NCT01430039|Crohn's disease|crohn's disease
1336794|NCT01430039|ulcerative colitis|ulcerative colitis
1336795|NCT01430039|Syndecan-1|syndecan-1
1336796|NCT01430026|chronic sinusitis|chronic sinusitis
1336797|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
1336798|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
1336799|NCT01429987|Constipation|constipation
1336800|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
1336801|NCT01429974|amniotic fluid|amniotic fluid
1336802|NCT01429974|post term pregnancies|post term pregnancies
1336803|NCT01429948|Stroke, Ischemic|stroke, ischemic
1336804|NCT01429948|Patent foramen ovale|patent foramen ovale
1336805|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
1336806|NCT01429948|Paradoxical embolism|paradoxical embolism
1336807|NCT01429948|Transcranial Doppler|transcranial doppler
1336808|NCT01429948|Silent cerebral infarct|silent cerebral infarct
1336809|NCT01429935|dental pain model|dental pain model
1336810|NCT01429935|Ginger powder|ginger powder
1336811|NCT01429935|CRP|crp
1336812|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
1336813|NCT01429909|T2*|t2*
1336814|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
1336815|NCT01429909|Parkinson's disease|parkinson's disease
1336816|NCT01429896|peanut allergy|peanut allergy
1336817|NCT01429896|food allergy|food allergy
1336818|NCT01429896|thresholds|thresholds
1336819|NCT01429896|anaphylaxis|anaphylaxis
1336820|NCT01429896|food labelling|food labelling
1336821|NCT01429896|food challenges|food challenges
1336822|NCT01429896|peanut challenges|peanut challenges
1336823|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
1336824|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
1336825|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
1336826|NCT01429844|Lung transplantation|lung transplantation
1336827|NCT01429844|Cyclosporine|cyclosporine
1336828|NCT01429844|Tacrolimus|tacrolimus
1336829|NCT01429844|Mycophenolate|mycophenolate
1336830|NCT01429844|Steroids|steroids
1336831|NCT01429844|Chronic rejection|chronic rejection
1336832|NCT01429844|Acute rejection|acute rejection
1336833|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
1336834|NCT01429818|Endothelial dysfunction|endothelial dysfunction
1336835|NCT01429818|Diabetes mellitus|diabetes mellitus
1336836|NCT01429818|glimepiride|glimepiride
1336837|NCT01429818|metformin|metformin
1336838|NCT01429805|Hip arthroscopy|hip arthroscopy
1336839|NCT01429779|General surgery|general surgery
1336840|NCT01429766|Breath holding times|breath holding times
1336841|NCT01429766|Phases of respiration|phases of respiration
1336842|NCT01429766|Radiotherapy|radiotherapy
1336843|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
1336844|NCT01429753|Heart failure|heart failure
1336845|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
1336846|NCT01429740|PF 05180999|pf 05180999
1336847|NCT01429740|safety|safety
1336848|NCT01429740|pharmacokinetics|pharmacokinetics
1336849|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
1336850|NCT01429727|SCAD|scad
1337147|NCT01428739|MRS|mrs
1336851|NCT01429727|coronary artery disease|coronary artery disease
1336852|NCT01429727|myocardial infarction|myocardial infarction
1336853|NCT01429727|coronary dissection|coronary dissection
1336854|NCT01429714|Elastic Compression Stockings|elastic compression stockings
1336855|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
1336856|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
1336857|NCT01429701|Dermatitis|dermatitis
1336858|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
1336859|NCT01429662|postmenopause|postmenopause
1336860|NCT01429662|hypertension|hypertension
1336861|NCT01429662|relaxation|relaxation
1336862|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
1336863|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
1336864|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
1336865|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
1336866|NCT01429636|perimenopause|perimenopause
1336867|NCT01429636|postmenopause|postmenopause
1336868|NCT01429636|vasomotor symptoms|vasomotor symptoms
1336869|NCT01429636|relaxation|relaxation
1336870|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
1336871|NCT01429623|Early Stage Dementia|early stage dementia
1336872|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
1336873|NCT01429623|Memory Impairment|memory impairment
1336874|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1336875|NCT01429610|rituximab|rituximab
1336876|NCT01429610|VPDL|vpdl
1336877|NCT01429610|CD20|cd20
1336878|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
1336879|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1336880|NCT01429597|Fabry Disease|fabry disease
1336881|NCT01429597|Fabry´s Disease|fabry´s disease
1336882|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
1336883|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1336884|NCT01429597|Stroke, Acute|stroke, acute
1336885|NCT01429597|Cerebral Stroke|cerebral stroke
1336886|NCT01429584|bupivacaine concentration|bupivacaine concentration
1336887|NCT01429584|interscalene nerve block|interscalene nerve block
1336888|NCT01429584|diaphragm function|diaphragm function
1336889|NCT01429584|diaphragm weakness|diaphragm weakness
1336890|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
1336891|NCT01429545|Tocolysis|tocolysis
1336892|NCT01429545|atosiban|atosiban
1336893|NCT01429545|nifedipine|nifedipine
1336894|NCT01429545|combination|combination
1336895|NCT01429532|Cataract|cataract
1336896|NCT01429519|chronic wound|chronic wound
1336897|NCT01429519|ulcerated wound|ulcerated wound
1336898|NCT01429519|venous insufficiency|venous insufficiency
1336899|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
1336900|NCT01429519|neuropathic wound|neuropathic wound
1336901|NCT01429519|diabetic ulcer|diabetic ulcer
1336902|NCT01429519|post- operative|post- operative
1336903|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
1336904|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
1336905|NCT01429506|Intensive medical management|intensive medical management
1336906|NCT01429480|Analgesia, postoperative|analgesia, postoperative
1336907|NCT01429467|Glucose Variability|glucose variability
1336908|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
1336909|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
1336910|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
1336911|NCT01429467|Erythropoietin|erythropoietin
1336912|NCT01429467|Cortisol|cortisol
1336913|NCT01429454|Prodromal|prodromal
1336914|NCT01429454|Schizophrenia|schizophrenia
1336915|NCT01429454|Psychosis|psychosis
1336916|NCT01429454|Omega|omega
1336917|NCT01429428|Cellulitis|cellulitis
1336918|NCT01429428|Skin ultra-sound images|skin ultra-sound images
1336919|NCT01429428|Treatment|treatment
1336920|NCT01429428|Infra-red light|infra-red light
1336921|NCT01429415|pediatric|pediatric
1336922|NCT01429415|Acute Asthma|acute asthma
1336923|NCT01429415|Inhaled Magnesium|inhaled magnesium
1336924|NCT01429402|Botulinum toxin A.|botulinum toxin a.
1336925|NCT01429402|Cleft lip scar|cleft lip scar
1336926|NCT01429389|Down syndrome|down syndrome
1336927|NCT01429389|fetal aneuploidy|fetal aneuploidy
1336928|NCT01429389|trisomy|trisomy
1336929|NCT01429389|noninvasive screening test|noninvasive screening test
1336930|NCT01429376|Chronic heart failure|chronic heart failure
1336931|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
1336932|NCT01429376|Restriction|restriction
1336933|NCT01429376|Airway obstruction|airway obstruction
1336934|NCT01429376|Diffusion impairment|diffusion impairment
1336935|NCT01429376|Pulmonary function tests|pulmonary function tests
1336936|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1336937|NCT01429376|Prevalence|prevalence
1336938|NCT01429376|Overdiagnosis|overdiagnosis
1336939|NCT01429376|Underdiagnosis|underdiagnosis
1336940|NCT01429376|Systemic inflammation|systemic inflammation
1336941|NCT01429376|Diagnostic Errors|diagnostic errors
1336942|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
1336944|NCT01429363|Case series|case series
1336945|NCT01429363|RCT|rct
1336946|NCT01429350|ischemic stroke|ischemic stroke
1336947|NCT01429350|acute intervention|acute intervention
1336948|NCT01429350|thrombolysis|thrombolysis
1336949|NCT01429350|rtPA|rtpa
1336950|NCT01429350|internal carotid artery|internal carotid artery
1336951|NCT01429350|middle cerebral artery|middle cerebral artery
1336952|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
1336953|NCT01429350|Penumbra System|penumbra system
1336954|NCT01429350|clot length|clot length
1336955|NCT01429350|mRS|mrs
1336956|NCT01429350|NIHSS|nihss
1336957|NCT01429337|Pharmacokinetics|pharmacokinetics
1336958|NCT01429337|Hepatic impaired patients|hepatic impaired patients
1336959|NCT01429337|Healthy volunteers|healthy volunteers
1336960|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
1336961|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
1336962|NCT01429324|neuromonitoring|neuromonitoring
1336963|NCT01429324|aortic arch surgery|aortic arch surgery
1336964|NCT01429311|Atopic Dermatitis|atopic dermatitis
1336965|NCT01429311|Eczema herpeticum|eczema herpeticum
1336966|NCT01429311|Interferon gamma|interferon gamma
1336967|NCT01429311|IFNγ|ifnγ
1336968|NCT01429298|Acute|acute
1336969|NCT01429298|Pain|pain
1336970|NCT01429298|Emergency Department|emergency department
1336971|NCT01429298|Hydromorphone|hydromorphone
1336972|NCT01429298|Protocol|protocol
1336973|NCT01429285|Pain|pain
1336974|NCT01429285|Hydromorphone|hydromorphone
1336975|NCT01429285|Acute|acute
1336976|NCT01429285|Emergency Department|emergency department
1336977|NCT01429272|Bipolar Disorder|bipolar disorder
1336978|NCT01429272|Minocycline|minocycline
1336979|NCT01429259|Cystic Fibrosis|cystic fibrosis
1336980|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
1336981|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
1336982|NCT01429246|Hypertension|hypertension
1336983|NCT01429246|Diet Therapy|diet therapy
1336984|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
1336985|NCT01429246|Tibet|tibet
1336986|NCT01429246|Aged|aged
1336987|NCT01429233|Observational|observational
1336988|NCT01429233|Colombia|colombia
1336989|NCT01429220|deep brain stimulation|deep brain stimulation
1336990|NCT01429220|monopolar review|monopolar review
1336991|NCT01429220|motion sensors|motion sensors
1336992|NCT01429220|tremor|tremor
1336993|NCT01429220|bradykinesia|bradykinesia
1336994|NCT01429207|levodopa|levodopa
1336995|NCT01429207|tremor|tremor
1336996|NCT01429207|bradykinesia|bradykinesia
1336997|NCT01429207|motion sensors|motion sensors
1336998|NCT01429194|Weight Loss|weight loss
1336999|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
1337000|NCT01429194|Gastric Plication|gastric plication
1337001|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
1337002|NCT01429155|End stage liver disease|end stage liver disease
1337003|NCT01429155|Living donor liver transplantation|living donor liver transplantation
1337004|NCT01429155|Hepatitis C|hepatitis c
1337005|NCT01429155|Interleukin 28B|interleukin 28b
1337006|NCT01429129|Smoking|smoking
1337007|NCT01429129|Nicotine|nicotine
1337008|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
1337009|NCT01429129|Nicotine Patch|nicotine patch
1337010|NCT01429129|Nicoderm|nicoderm
1337011|NCT01429129|Mass Distribution|mass distribution
1337012|NCT01429129|Tobacco Control|tobacco control
1337013|NCT01429129|Randomized Controlled Trial|randomized controlled trial
1337014|NCT01429116|Blindness|blindness
1337015|NCT01429116|Eye Diseases|eye diseases
1337016|NCT01429116|Nap Disorders|nap disorders
1337017|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
1337018|NCT01429116|Sleep Disorders|sleep disorders
1337019|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
1337020|NCT01429116|Dyssomnias|dyssomnias
1337021|NCT01429116|Nervous System Diseases|nervous system diseases
1337022|NCT01429090|Pharmacokinetics|pharmacokinetics
1337023|NCT01429090|Accommodation, Ocular|accommodation, ocular
1337024|NCT01429090|Reflex, Pupillary|reflex, pupillary
1337025|NCT01429090|Salivation|salivation
1337026|NCT01429077|Levodopa|levodopa
1337027|NCT01429077|Ischemic Stroke|ischemic stroke
1337028|NCT01429077|Aphasia|aphasia
1337029|NCT01429077|Speech Rehabilitation|speech rehabilitation
1337030|NCT01429051|Break through pain|break through pain
1337031|NCT01429051|BTP|btp
1337032|NCT01429051|Cancer|cancer
1337033|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
1337034|NCT01429051|INFS|infs
1337035|NCT01429051|cancer patients|cancer patients
1337036|NCT01429038|end-stage|end-stage
1337037|NCT01429038|liver diseases|liver diseases
1337038|NCT01429038|cirrhosis|cirrhosis
1337039|NCT01429038|cancer|cancer
1337040|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
1337041|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
1337042|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
1337043|NCT01429038|renal diseases|renal diseases
1337044|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1337045|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1337046|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1337047|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1337048|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1337049|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
1337050|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1337051|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1337052|NCT01429012|bone|bone
1337053|NCT01429012|nonunion fracture|nonunion fracture
1337054|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
1337055|NCT01429012|callus|callus
1337056|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
1337057|NCT01429012|cell therapy|cell therapy
1337058|NCT01429012|autologous|autologous
1337059|NCT01429012|indium|indium
1337060|NCT01429012|Pet-scan|pet-scan
1337061|NCT01428999|probiotics|probiotics
1337062|NCT01428999|gastrointestinal function|gastrointestinal function
1337063|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
1337064|NCT01428986|maraviroc|maraviroc
1337065|NCT01428986|osteoclasts|osteoclasts
1337066|NCT01428986|Receptors, CCR5|receptors, ccr5
1337067|NCT01428986|Chemokine CCL5|chemokine ccl5
1337068|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
1337069|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
1337070|NCT01428973|Prophylaxis|prophylaxis
1337071|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
1337072|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
1337073|NCT01428973|HLA-matched donor|hla-matched donor
1337074|NCT01428973|Progression free survival|progression free survival
1337075|NCT01428973|Overall survival|overall survival
1337076|NCT01428960|Palm mid fraction|palm mid fraction
1337077|NCT01428960|Shea butter|shea butter
1337078|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
1337079|NCT01428960|Cholesterol|cholesterol
1337080|NCT01428960|Postprandial lipemia,|postprandial lipemia,
1337081|NCT01428960|Inflammatory markers|inflammatory markers
1337082|NCT01428960|Satiety|satiety
1337083|NCT01428960|Gut hormone|gut hormone
1337084|NCT01428960|Insulin|insulin
1337085|NCT01428921|Long-term efficacy|long-term efficacy
1337086|NCT01428921|Education programme|education programme
1337087|NCT01428921|Adherence|adherence
1337088|NCT01428921|OSA|osa
1337089|NCT01428921|CPAP|cpap
1337090|NCT01428908|immunogenicity|immunogenicity
1337091|NCT01428908|safety|safety
1337092|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
1337093|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
1337094|NCT01428908|conjugate vaccine|conjugate vaccine
1337095|NCT01428895|Bone Metastases|bone metastases
1337096|NCT01428895|Femoral Metastases|femoral metastases
1337097|NCT01428882|Propofol|propofol
1337098|NCT01428882|Midazolam|midazolam
1337099|NCT01428882|Moderate sedation|moderate sedation
1337100|NCT01428882|Deep sedation|deep sedation
1337101|NCT01428882|Colonoscopy|colonoscopy
1337102|NCT01428869|Statins|statins
1337103|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
1337104|NCT01428869|dutasteride|dutasteride
1337105|NCT01428869|Prostate Cancer|prostate cancer
1337106|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
1337107|NCT01428869|prevention|prevention
1337108|NCT01428869|drug interactions|drug interactions
1337109|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
1337110|NCT01428843|Anemia|anemia
1337111|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
1337112|NCT01428843|Ferrisat perfusion|ferrisat perfusion
1337113|NCT01428830|fistula|fistula
1337114|NCT01428830|catheter|catheter
1337115|NCT01428830|surgery|surgery
1337116|NCT01428830|obstetrics|obstetrics
1337117|NCT01428830|gynecology|gynecology
1337118|NCT01428830|urology|urology
1337119|NCT01428817|pregnancy|pregnancy
1337120|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
1337121|NCT01428817|Cesarean delivery|cesarean delivery
1337122|NCT01428817|carbetocin|carbetocin
1337123|NCT01428804|Resistant Major Depression|resistant major depression
1337124|NCT01428804|Mood disorders|mood disorders
1337125|NCT01428804|tDCS|tdcs
1337126|NCT01428791|Geriatrics|geriatrics
1337127|NCT01428791|Older adults|older adults
1337128|NCT01428791|Health Disparities|health disparities
1337129|NCT01428791|Health Services for the Aged|health services for the aged
1337130|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
1337131|NCT01428791|Depressive symptoms|depressive symptoms
1337132|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
1337133|NCT01428791|Overweight|overweight
1337134|NCT01428791|Obesity|obesity
1337135|NCT01428791|Hypertension|hypertension
1337136|NCT01428791|Hyperglycemia|hyperglycemia
1337137|NCT01428791|Dyslipidemias|dyslipidemias
1337138|NCT01428778|Marathon running|marathon running
1337139|NCT01428778|Brain MRI|brain mri
1337140|NCT01428778|ECG recording|ecg recording
1337141|NCT01428778|Blood tests|blood tests
1337142|NCT01428752|colonoscopy|colonoscopy
1337143|NCT01428752|colorectal neoplasms|colorectal neoplasms
1337144|NCT01428752|screening|screening
1337145|NCT01428752|family history|family history
1337146|NCT01428739|cancer|cancer
1337148|NCT01428739|Treatment response|treatment response
1337149|NCT01428726|NT-KO-003|nt-ko-003
1337150|NCT01428726|RRMS|rrms
1337151|NCT01428726|efficacy|efficacy
1337152|NCT01428726|safety|safety
1337153|NCT01428726|Phase IIa|phase iia
1337154|NCT01428713|menorrhagia|menorrhagia
1337155|NCT01428713|oral contraceptives|oral contraceptives
1337156|NCT01428713|oral tranexamic acid|oral tranexamic acid
1337157|NCT01428687|Weight loss|weight loss
1337158|NCT01428687|Sleep duration|sleep duration
1337159|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
1337160|NCT01428674|Loving kindness meditation|loving kindness meditation
1337161|NCT01428674|Autonomic Nervous System|autonomic nervous system
1337162|NCT01428674|Heart rate variability|heart rate variability
1337163|NCT01428674|Respiratory rate|respiratory rate
1337164|NCT01428674|Relaxation|relaxation
1337165|NCT01428661|tasimelteon|tasimelteon
1337166|NCT01428661|Major Depressive Disorder|major depressive disorder
1337167|NCT01428661|MDD|mdd
1337168|NCT01428661|depression|depression
1337169|NCT01428648|Parkinson|parkinson
1337170|NCT01428648|ballroom dancing|ballroom dancing
1337171|NCT01428635|Leukemia|leukemia
1337172|NCT01428635|Thrombocytopenia|thrombocytopenia
1337173|NCT01428635|Tyrosine kinase therapy|tyrosine kinase therapy
1337174|NCT01428635|TKI|tki
1337175|NCT01428635|Chronic myeloid leukemia|chronic myeloid leukemia
1337176|NCT01428635|CML|cml
1337177|NCT01428635|Platelet count|platelet count
1337178|NCT01428635|Clonal evolution|clonal evolution
1337179|NCT01428635|Eltrombopag|eltrombopag
1337180|NCT01428635|Promacta|promacta
1337181|NCT01428635|Myelofibrosis|myelofibrosis
1337182|NCT01428635|MF|mf
1337183|NCT01428609|Amalgam|amalgam
1337184|NCT01428609|Mercury|mercury
1337185|NCT01428609|Endodontics|endodontics
1337186|NCT01428609|Apicoectomy|apicoectomy
1337187|NCT01428596|HIV-1|hiv-1
1337188|NCT01428596|therapeutic vaccine|therapeutic vaccine
1337189|NCT01428596|immunotherapy|immunotherapy
1337190|NCT01428596|AIDS|aids
1337191|NCT01428583|Chronic noncancer pain|chronic noncancer pain
1337192|NCT01428583|oxycodone|oxycodone
1337193|NCT01428583|naltrexone|naltrexone
1337194|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
1337195|NCT01428570|intubation|intubation
1337196|NCT01428557|Heart Failure|heart failure
1337197|NCT01428557|Epidemiology|epidemiology
1337198|NCT01428557|Evidence-Based Practice|evidence-based practice
1337199|NCT01428492|AKT Inhibitor|akt inhibitor
1337200|NCT01428492|hematologic malignancies|hematologic malignancies
1337201|NCT01428492|GSK2110183|gsk2110183
1337202|NCT01428492|bortezomib|bortezomib
1337203|NCT01428492|multiple myeloma|multiple myeloma
1337204|NCT01428492|dexamethasone|dexamethasone
1337205|NCT01428453|Alzheimer's disease|alzheimer's disease
1337206|NCT01428427|Gemcitabine|gemcitabine
1337207|NCT01428427|MEK inhibitor|mek inhibitor
1337208|NCT01428427|GSK1120212|gsk1120212
1337209|NCT01428414|HER2|her2
1337210|NCT01428414|Breast cancer|breast cancer
1337211|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1337212|NCT01428414|efficacy|efficacy
1337213|NCT01428414|safety|safety
1337214|NCT01428401|Complementary therapies|complementary therapies
1337215|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
1337216|NCT01428388|macular edema|macular edema
1337217|NCT01428388|vein occlusion|vein occlusion
1337218|NCT01428388|bevacizumab|bevacizumab
1337219|NCT01428388|ranibizumab|ranibizumab
1337220|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
1337221|NCT01428375|intravenous paracetamol|intravenous paracetamol
1337222|NCT01428375|intrapartum analgesia|intrapartum analgesia
1337223|NCT01428375|labor pain|labor pain
1337224|NCT01428375|intrapartum pains|intrapartum pains
1337225|NCT01428362|donepezil|donepezil
1337226|NCT01428362|VI-1121|vi-1121
1337227|NCT01428349|Incarcerated offenders|incarcerated offenders
1337228|NCT01428349|emotionally reactive|emotionally reactive
1337229|NCT01428349|emotionally stable|emotionally stable
1337230|NCT01428349|psychopathy|psychopathy
1337231|NCT01428310|dietary supplement|dietary supplement
1337232|NCT01428310|nutraceutical|nutraceutical
1337233|NCT01428297|Atopic dermatitis|atopic dermatitis
1337234|NCT01428297|Eczema|eczema
1337235|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
1337236|NCT01428297|Netherton syndrome|netherton syndrome
1337237|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
1337238|NCT01428297|BPR277|bpr277
1337239|NCT01428284|Healthy Volunteers|healthy volunteers
1337240|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1337241|NCT01428284|Pharmacokinetic|pharmacokinetic
1337242|NCT01428284|Probenecid|probenecid
1337243|NCT01428258|Diet therapy|diet therapy
1337244|NCT01428258|Low phenylalanine diet|low phenylalanine diet
1337245|NCT01428258|Attention|attention
1337246|NCT01428258|Executive function|executive function
1337247|NCT01428232|Breastfeeding|breastfeeding
1337248|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
1337249|NCT01428232|Well-child clinics|well-child clinics
1337250|NCT01428219|Prostate|prostate
1337251|NCT01428219|Cancer|cancer
1337252|NCT01428219|Metastatic|metastatic
1337253|NCT01428206|palliative care|palliative care
1337254|NCT01428206|nursing homes|nursing homes
1337255|NCT01428206|Liverpool care pathway|liverpool care pathway
1337256|NCT01428193|PCOS|pcos
1337257|NCT01428193|hyperandrogenemia|hyperandrogenemia
1337258|NCT01428180|preterm neonates|preterm neonates
1337259|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
1337260|NCT01428167|Thyroid cancer|thyroid cancer
1337261|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
1337262|NCT01428167|Thyroidectomy|thyroidectomy
1337263|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
1337264|NCT01428154|paediatric|paediatric
1337265|NCT01428154|dialysis|dialysis
1337266|NCT01428154|CKD|ckd
1337267|NCT01428154|pediatric|pediatric
1337268|NCT01428141|Cancer|cancer
1337269|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
1337270|NCT01428115|monoclonal|monoclonal
1337271|NCT01428115|anxiety|anxiety
1337272|NCT01428115|antibodies|antibodies
1337273|NCT01428115|adalimumab|adalimumab
1337274|NCT01428115|severe crohn's disease|severe crohn's disease
1337275|NCT01428115|quality of life|quality of life
1337276|NCT01428115|biological products|biological products
1337277|NCT01428102|Thromboelastography|thromboelastography
1337278|NCT01428102|TEG|teg
1337279|NCT01428102|Coagulation|coagulation
1337280|NCT01428102|RapidTEG|rapidteg
1337281|NCT01428102|Kaolin|kaolin
1337282|NCT01428089|hyperandrogenemia|hyperandrogenemia
1337283|NCT01428076|Varicose Veins|varicose veins
1337284|NCT01428076|SFJ Reflux|sfj reflux
1337285|NCT01428050|whipple|whipple
1337286|NCT01428050|hypertonic saline|hypertonic saline
1337287|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
1337288|NCT01428050|fluid restriction|fluid restriction
1337289|NCT01428050|resuscitation strategy|resuscitation strategy
1337290|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
1337291|NCT01428037|Cervical Ripening|cervical ripening
1337292|NCT01428037|Labor Induced|labor induced
1337293|NCT01428024|efficacy|efficacy
1337294|NCT01428024|safety|safety
1337295|NCT01428024|Restylane|restylane
1337296|NCT01428024|Lip products|lip products
1337297|NCT01428024|injection techniques|injection techniques
1337298|NCT01428011|Hypertension|hypertension
1337299|NCT01428011|Patient-Provider Communication|patient-provider communication
1337300|NCT01428011|Medication Adherence|medication adherence
1337301|NCT01428011|Race Concordance|race concordance
1337302|NCT01427998|diabetes|diabetes
1337303|NCT01427998|blood glucose|blood glucose
1337304|NCT01427998|olive leaf extract|olive leaf extract
1337305|NCT01427946|KRAS mutant|kras mutant
1337306|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
1337307|NCT01427946|NSCLC|nsclc
1337308|NCT01427933|Breast Cancer|breast cancer
1337309|NCT01427907|Serum phosphorus levels|serum phosphorus levels
1337310|NCT01427894|Prematurity|prematurity
1337311|NCT01427894|Music|music
1337312|NCT01427894|Kangaroo Care|kangaroo care
1337313|NCT01427894|Bonding Mother infant|bonding mother infant
1337314|NCT01427868|LB80380|lb80380
1337315|NCT01427868|bioequivalence|bioequivalence
1337316|NCT01427855|Dietary Protein|dietary protein
1337317|NCT01427855|Red Meat|red meat
1337318|NCT01427855|White Meat|white meat
1337319|NCT01427855|Vegetable Protein|vegetable protein
1337320|NCT01427855|Saturated Fat|saturated fat
1337321|NCT01427855|LDL Subclasses|ldl subclasses
1337322|NCT01427855|Cholesterol|cholesterol
1337323|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
1337324|NCT01427842|Trough concentration|trough concentration
1337325|NCT01427842|Vancomycin|vancomycin
1337326|NCT01427842|Pharmacokinetics|pharmacokinetics
1337327|NCT01427829|pilot|pilot
1337328|NCT01427829|randomized controlled trial|randomized controlled trial
1337329|NCT01427829|RCT|rct
1337330|NCT01427829|computer|computer
1337331|NCT01427829|screening|screening
1337332|NCT01427829|community heath center|community heath center
1337333|NCT01427829|psychosocial|psychosocial
1337334|NCT01427829|immigrant|immigrant
1337335|NCT01427816|Dry eye syndromes|dry eye syndromes
1337336|NCT01427816|Corneal diseases|corneal diseases
1337337|NCT01427816|Conjunctival diseases|conjunctival diseases
1337338|NCT01427803|Actual Use Trial|actual use trial
1337339|NCT01427764|Dentin sensitivity|dentin sensitivity
1337340|NCT01427764|Dental scaling|dental scaling
1337341|NCT01427764|Ultrasonic|ultrasonic
1337342|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
1337343|NCT01427725|Digestive System Diseases|digestive system diseases
1337344|NCT01427725|Therapeutic Uses|therapeutic uses
1337345|NCT01427725|Pancreatectomy|pancreatectomy
1337346|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
1337347|NCT01427725|Pancreatic Diseases|pancreatic diseases
1337348|NCT01427725|Pancrelipase|pancrelipase
1337349|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1337350|NCT01427712|Digestive System Diseases|digestive system diseases
1337351|NCT01427712|Cystic Fibrosis|cystic fibrosis
1337352|NCT01427712|Therapeutic Uses|therapeutic uses
1337353|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
1337354|NCT01427712|Pancreatic Diseases|pancreatic diseases
1337355|NCT01427712|Pancrelipase|pancrelipase
1337356|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1337357|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1337358|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
1337359|NCT01427673|Overlap Syndrome|overlap syndrome
1337360|NCT01427673|COPD|copd
1337361|NCT01427673|OSA|osa
1337362|NCT01427660|Diabetes|diabetes
1337363|NCT01427660|Decision Aid|decision aid
1337364|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
1337365|NCT01427660|Tailored health information|tailored health information
1337366|NCT01427660|Medication information|medication information
1337367|NCT01427647|Laparoscopy|laparoscopy
1337368|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
1337369|NCT01427634|Heart Failure|heart failure
1337370|NCT01427634|Ventricular Assist Device|ventricular assist device
1337371|NCT01427634|Palliative Care|palliative care
1337372|NCT01427595|hyperandrogenemia|hyperandrogenemia
1337373|NCT01427569|Diabetes|diabetes
1337374|NCT01427569|Chronic wound|chronic wound
1337375|NCT01427556|Food intake|food intake
1337376|NCT01427556|Breakfast eating|breakfast eating
1337377|NCT01427543|behavioral intervention|behavioral intervention
1337378|NCT01427543|HIV risk reduction|hiv risk reduction
1337379|NCT01427543|African Americans|african americans
1337380|NCT01427543|incarceration|incarceration
1337381|NCT01427543|bisexual|bisexual
1337382|NCT01427543|reduce risk behaviors|reduce risk behaviors
1337383|NCT01427530|brain activity|brain activity
1337384|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
1337385|NCT01427517|Parkinson's disease|parkinson's disease
1337386|NCT01427517|Gaucher's disease|gaucher's disease
1337387|NCT01427517|Control|control
1337388|NCT01427504|HCV|hcv
1337389|NCT01427504|HIV|hiv
1337390|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1337391|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
1337392|NCT01427478|Randomisation|randomisation
1337393|NCT01427478|Maintenance treatment|maintenance treatment
1337394|NCT01427478|Afatinib|afatinib
1337395|NCT01427465|Brief|brief
1337396|NCT01427465|Image|image
1337397|NCT01427465|Intervention|intervention
1337398|NCT01427465|Adolescents|adolescents
1337399|NCT01427465|School|school
1337400|NCT01427452|Live Donor|live donor
1337401|NCT01427452|Kidney Donation|kidney donation
1337402|NCT01427452|Living Donation|living donation
1337403|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
1337404|NCT01427452|Donor Nephrectomy|donor nephrectomy
1337405|NCT01427439|MDD|mdd
1337406|NCT01427439|Non-interventional study|non-interventional study
1337407|NCT01427439|Observational study|observational study
1337408|NCT01427426|Health|health
1337409|NCT01427426|Vitality|vitality
1337410|NCT01427426|Well-being|well-being
1337411|NCT01427426|Nutritional Supplement|nutritional supplement
1337412|NCT01427426|Phytonutrient|phytonutrient
1337413|NCT01427426|Greens|greens
1337414|NCT01427413|blastocoele fluid|blastocoele fluid
1337415|NCT01427413|mass spectrometry|mass spectrometry
1337416|NCT01427413|metabolomics|metabolomics
1337417|NCT01427400|Breast expander|breast expander
1337418|NCT01427400|Breast reconstruction|breast reconstruction
1337419|NCT01427400|Implants|implants
1337420|NCT01427400|Botox|botox
1337421|NCT01427387|ASP0456|asp0456
1337422|NCT01427387|Pharmacokinetics|pharmacokinetics
1337423|NCT01427387|safety|safety
1337424|NCT01427387|tolerability|tolerability
1337425|NCT01427387|food effect|food effect
1337426|NCT01427374|hemodialysis|hemodialysis
1337427|NCT01427374|peritoneal dialysis|peritoneal dialysis
1337428|NCT01427374|chronic kidney disease|chronic kidney disease
1337429|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
1337430|NCT01427374|cardiac imaging|cardiac imaging
1337431|NCT01427374|dialysis|dialysis
1337432|NCT01427374|parathyroid hormone|parathyroid hormone
1337433|NCT01427374|vitamin D|vitamin d
1337434|NCT01427374|coronary artery calcification|coronary artery calcification
1337435|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
1337436|NCT01427374|genetic predisposition|genetic predisposition
1337437|NCT01427374|biochemical markers|biochemical markers
1337438|NCT01427374|infection|infection
1337439|NCT01427374|pharmacogenomics|pharmacogenomics
1337440|NCT01427335|OHSS|ohss
1337441|NCT01427335|ICSI|icsi
1337442|NCT01427335|calcium injection|calcium injection
1337443|NCT01427322|lapatinib|lapatinib
1337444|NCT01427322|radiation therapy|radiation therapy
1337445|NCT01427322|metastases|metastases
1337446|NCT01427309|Influenza|influenza
1337447|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1337448|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
1337449|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
1337450|NCT01427309|Influenza vaccines|influenza vaccines
1337451|NCT01427296|Colon Cleansing|colon cleansing
1337452|NCT01427296|Bowel Prep|bowel prep
1337453|NCT01427296|Colonoscopy|colonoscopy
1337454|NCT01427283|Low back pain|low back pain
1337455|NCT01427283|Chronic pain|chronic pain
1337456|NCT01427283|Opioid|opioid
1337457|NCT01427283|Constipation|constipation
1337458|NCT01427283|Moderate to severe|moderate to severe
1337459|NCT01427270|Low back pain|low back pain
1337460|NCT01427270|Chronic pain|chronic pain
1337461|NCT01427270|Opioid|opioid
1337462|NCT01427270|Constipation|constipation
1337463|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
1337464|NCT01427244|HER2+|her2+
1337465|NCT01427244|Histologic confirmation|histologic confirmation
1337466|NCT01427244|measurable disease|measurable disease
1337467|NCT01427244|HER2 positive|her2 positive
1337468|NCT01427244|HER2 overexpression|her2 overexpression
1337469|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
1337470|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
1337471|NCT01427231|Cognitive performance|cognitive performance
1337472|NCT01427231|Attention|attention
1337473|NCT01427231|Memory|memory
1337474|NCT01427231|Glucose|glucose
1337475|NCT01427231|Sacharose|sacharose
1337476|NCT01427231|Elderly|elderly
1337477|NCT01427231|Memory complaints|memory complaints
1337478|NCT01427218|pharmacist|pharmacist
1337479|NCT01427218|medication therapy management|medication therapy management
1337480|NCT01427218|evidence based medicine|evidence based medicine
1337481|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1337482|NCT01427205|HNSCC|hnscc
1337483|NCT01427205|recurrent|recurrent
1337484|NCT01427205|metastatic|metastatic
1337485|NCT01427205|oral cavity|oral cavity
1337486|NCT01427205|Cetuximab|cetuximab
1337487|NCT01427205|C225|c225
1337488|NCT01427205|Erbitux|erbitux
1337489|NCT01427205|IMC-C225|imc-c225
1337490|NCT01427205|OSI-906|osi-906
1337491|NCT01427205|Placebo|placebo
1337492|NCT01427205|sugar pill|sugar pill
1337493|NCT01427205|oropharynx|oropharynx
1337494|NCT01427205|larynx|larynx
1337495|NCT01427205|hypopharynx|hypopharynx
1337496|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
1337497|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
1337498|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
1337499|NCT01427179|SCAD|scad
1337500|NCT01427166|Breast Cancer|breast cancer
1337501|NCT01427166|Cording|cording
1337502|NCT01427166|Lymphedema|lymphedema
1337503|NCT01427166|upper extremity cording|upper extremity cording
1337504|NCT01427166|following treatment|following treatment
1337505|NCT01427153|knee osteoarthritis|knee osteoarthritis
1337506|NCT01427153|physical therapy|physical therapy
1337507|NCT01427153|corticosteroid|corticosteroid
1337508|NCT01427153|treatment|treatment
1337509|NCT01427140|Liver fat|liver fat
1337510|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
1337511|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
1337512|NCT01427140|Weight gain|weight gain
1337513|NCT01427140|Overfeed|overfeed
1337514|NCT01427140|Dietary fatty acids|dietary fatty acids
1337515|NCT01427140|Palm oil|palm oil
1337516|NCT01427140|Sunflower oil|sunflower oil
1337517|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
1337518|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
1337519|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
1337520|NCT01427114|cyclophosphamide|cyclophosphamide
1337521|NCT01427114|vincristine|vincristine
1337522|NCT01427114|prednisolone|prednisolone
1337523|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
1337524|NCT01427101|Cytoreductive surgery|cytoreductive surgery
1337525|NCT01427101|Debulking surgery|debulking surgery
1337526|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1337527|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
1337528|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
1337529|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
1337530|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
1337531|NCT01427062|parkinson's disease|parkinson's disease
1337532|NCT01427062|balance|balance
1337533|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
1337534|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
1337535|NCT01427062|falls|falls
1337536|NCT01427049|renal denervation|renal denervation
1337537|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
1337538|NCT01427049|renal ablation|renal ablation
1337539|NCT01427049|resistant hypertension|resistant hypertension
1337540|NCT01427049|hypertension|hypertension
1337541|NCT01427049|renal oxygenation|renal oxygenation
1337542|NCT01427049|renal perfusion|renal perfusion
1337543|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
1337544|NCT01427023|APTIMA|aptima
1337545|NCT01427023|trichomonas|trichomonas
1337546|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
1337547|NCT01426997|Major Depressive Disorder|major depressive disorder
1337548|NCT01426997|Depression|depression
1337549|NCT01426971|Migraine|migraine
1337550|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1337551|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1337552|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1337553|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1337554|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1337555|NCT01426932|Vestibular Function Tests|vestibular function tests
1337556|NCT01426932|Caloric Test|caloric test
1337557|NCT01426932|Electronystagmography|electronystagmography
1337558|NCT01426932|Prediction|prediction
1337559|NCT01426919|Traumatic Brain Injury|traumatic brain injury
1337560|NCT01426919|Head Injury|head injury
1337561|NCT01426893|Respiratory disease|respiratory disease
1337562|NCT01426893|COPD|copd
1337563|NCT01426880|GBG|gbg
1337564|NCT01426880|German Breast Group|german breast group
1337565|NCT01426880|neo-adjuvant|neo-adjuvant
1337566|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
1337567|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
1337568|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
1337569|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
1337570|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
1337571|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
1337572|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
1337573|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
1337574|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
1337575|NCT01426867|Ocular Hypertension|ocular hypertension
1337576|NCT01426867|Intraocular Pressure|intraocular pressure
1337577|NCT01426867|Brinzolamide|brinzolamide
1337578|NCT01426867|Brimonidine|brimonidine
1337579|NCT01426854|Cataract Surgery|cataract surgery
1337580|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
1337581|NCT01426854|Anti-ocular Pain|anti-ocular pain
1337582|NCT01426841|Small cell lung cancer|small cell lung cancer
1337583|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
1337584|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
1337585|NCT01426828|adult|adult
1337586|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
1337587|NCT01426828|myeloma|myeloma
1337588|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
1337589|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
1337590|NCT01426802|metformin|metformin
1337591|NCT01426802|vildagliptin|vildagliptin
1337592|NCT01426802|T2DM|t2dm
1337593|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
1337594|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
1337595|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
1337596|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
1337597|NCT01426776|Heart valve disease|heart valve disease
1337598|NCT01426776|Central Sleep Apnea|central sleep apnea
1337599|NCT01426763|HAE|hae
1337600|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
1337601|NCT01426763|C1 INH|c1 inh
1337602|NCT01426763|Subcutaneous|subcutaneous
1337603|NCT01426763|hyaluronidase|hyaluronidase
1337604|NCT01426763|rHuPH20|rhuph20
1337605|NCT01426750|Nutritional support.|nutritional support.
1337606|NCT01426750|Cancer.|cancer.
1337607|NCT01426750|Malnutrition.|malnutrition.
1337608|NCT01426750|Child.|child.
1337609|NCT01426750|Adolescent|adolescent
1337610|NCT01426724|Vitamin D|vitamin d
1337611|NCT01426724|Chronic Kidney Disease|chronic kidney disease
1337612|NCT01426724|Hyperparathyroidism|hyperparathyroidism
1337613|NCT01426724|Renal Blood Flow|renal blood flow
1337614|NCT01426724|Proteinuria|proteinuria
1337615|NCT01426724|Inflammation|inflammation
1337616|NCT01426724|Renin Angiotensin System|renin angiotensin system
1337617|NCT01426698|delayed cord clamping|delayed cord clamping
1337618|NCT01426698|developmental delay|developmental delay
1337619|NCT01426685|sudden death|sudden death
1337620|NCT01426685|coronary artery disease|coronary artery disease
1337621|NCT01426685|diabetes|diabetes
1337622|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
1337623|NCT01426659|language|language
1337624|NCT01426659|constraints|constraints
1337625|NCT01426659|premature|premature
1337626|NCT01426659|phonology|phonology
1337627|NCT01426659|implied|implied
1337628|NCT01426659|early development (< 5 years)|early development (< 5 years)
1337629|NCT01426646|gastric cancer|gastric cancer
1337631|NCT01426646|cisplatin|cisplatin
1337632|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
1337633|NCT01426633|L-sarcomas|l-sarcomas
1337634|NCT01426620|NSCLC|nsclc
1337635|NCT01426620|blueberry|blueberry
1337636|NCT01426620|salvage therapy|salvage therapy
1337637|NCT01426620|docetaxel|docetaxel
1337638|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
1337639|NCT01426620|second-line|second-line
1337640|NCT01426620|polyphenol|polyphenol
1337641|NCT01426594|Observational|observational
1337642|NCT01426594|Colombia|colombia
1337643|NCT01426594|Metpure XL|metpure xl
1337644|NCT01426581|Asthma|asthma
1337645|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1337646|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1337647|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
1337648|NCT01426581|Self-management|self-management
1337649|NCT01426581|Health Literacy|health literacy
1337848|NCT01425658|bupivacaine|bupivacaine
1337653|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
1337654|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
1337655|NCT01426568|Psychological Stress|psychological stress
1337656|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
1337657|NCT01426555|Weakening of the bone structure|weakening of the bone structure
1337662|NCT01426516|Treatment Resistant|treatment resistant
1337663|NCT01426516|Depression|depression
1337664|NCT01426477|Ventral hernia|ventral hernia
1337665|NCT01426477|Abdominal wall hernia|abdominal wall hernia
1337666|NCT01426477|Incisional hernia|incisional hernia
1337667|NCT01426477|Biologic mesh|biologic mesh
1337668|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
1337669|NCT01426477|Veritas|veritas
1337670|NCT01426464|Glaucoma|glaucoma
1337671|NCT01426464|Xalatan|xalatan
1337672|NCT01426464|Transdermal|transdermal
1337673|NCT01426451|Dramatherapy|dramatherapy
1337674|NCT01426451|Group tutoring activities|group tutoring activities
1337675|NCT01426451|Impairment|impairment
1337676|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
1337677|NCT01426451|Learning difficulties|learning difficulties
1337678|NCT01426425|Cardiac cryoablation|cardiac cryoablation
1337679|NCT01426425|AVNRT|avnrt
1337680|NCT01426425|heart disease|heart disease
1337681|NCT01426425|tachycardia|tachycardia
1337682|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
1337683|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
1337685|NCT01426360|dentifrice|dentifrice
1337686|NCT01426360|potassium nitrate|potassium nitrate
1337687|NCT01426360|strontium chloride|strontium chloride
1337688|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
1337689|NCT01426347|Vitamin D deficiency|vitamin d deficiency
1337690|NCT01426347|Disability|disability
1337691|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
1337692|NCT01426321|Echocardiography|echocardiography
1337693|NCT01426321|Cardiac computed tomography|cardiac computed tomography
1337694|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
1337695|NCT01426282|Out-patient Compliance|out-patient compliance
1337696|NCT01426282|Nurse, Heath Education|nurse, heath education
1337697|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
1337698|NCT01426282|Treatment and Prevention|treatment and prevention
1337699|NCT01426256|vitamin D|vitamin d
1337700|NCT01426256|cholecalciferol|cholecalciferol
1337701|NCT01426256|cystic fibrosis|cystic fibrosis
1337702|NCT01426256|respiratory tract infection|respiratory tract infection
1337703|NCT01426256|immunity|immunity
1337704|NCT01426256|intervention studies|intervention studies
1337705|NCT01426256|inflammation|inflammation
1337706|NCT01426256|dietary supplements|dietary supplements
1337707|NCT01426256|alpha-Defensins|alpha-defensins
1337708|NCT01426256|Cytokines|cytokines
1337709|NCT01426256|mortality|mortality
1337710|NCT01426256|biological markers|biological markers
1337711|NCT01426256|Biomedical Research|biomedical research
1337712|NCT01426230|PHN|phn
1337713|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
1337714|NCT01426230|Shingles|shingles
1337715|NCT01426230|HZ roster|hz roster
1337716|NCT01426204|Hepatitis C|hepatitis c
1337717|NCT01426204|Retreatment|retreatment
1337718|NCT01426204|Failures|failures
1337719|NCT01426204|Infergen|infergen
1337720|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
1337721|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
1337722|NCT01426191|Phase IV clinical studies|phase iv clinical studies
1337723|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
1337724|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
1337725|NCT01426178|Respiration, Artificial|respiration, artificial
1337726|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
1337727|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1337728|NCT01426178|Non Invasive Ventilation|non invasive ventilation
1337729|NCT01426165|hypomagnesemia|hypomagnesemia
1337730|NCT01426165|magnesium|magnesium
1337731|NCT01426165|magnesium sulfate|magnesium sulfate
1337732|NCT01426152|IVF|ivf
1337733|NCT01426152|progesterone|progesterone
1337734|NCT01426152|ovulation induction|ovulation induction
1337735|NCT01426152|pregnancy rates|pregnancy rates
1337736|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
1337737|NCT01426126|urothelial carcinoma|urothelial carcinoma
1337738|NCT01426126|gemcitabine|gemcitabine
1337739|NCT01426126|platinum|platinum
1337740|NCT01426126|refractory|refractory
1337741|NCT01426126|salvage chemotherapy|salvage chemotherapy
1337742|NCT01426100|CKD-828|ckd-828
1337743|NCT01426100|Hypertension|hypertension
1337744|NCT01426100|Primary Hypertension|primary hypertension
1337745|NCT01426100|S-Amlodipine|s-amlodipine
1337746|NCT01426100|Telmisartan|telmisartan
1337747|NCT01426100|Amlodipine|amlodipine
1337748|NCT01426100|Non-Responder|non-responder
1337749|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
1337750|NCT01426061|Reflexology|reflexology
1337751|NCT01426061|Homeopathy|homeopathy
1337752|NCT01426061|Asthma|asthma
1337753|NCT01426061|Randomized controlled trial|randomized controlled trial
1337754|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
1337755|NCT01426022|alcohol|alcohol
1337756|NCT01426022|mood|mood
1337757|NCT01426022|postprandial|postprandial
1337758|NCT01426009|COPD|copd
1337759|NCT01425996|HCC|hcc
1337760|NCT01425996|PVTT|pvtt
1337761|NCT01425983|stress|stress
1337762|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
1337763|NCT01425983|dietary supplement|dietary supplement
1337764|NCT01425983|amino acid composition|amino acid composition
1337765|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
1337766|NCT01425970|Inhibitex|inhibitex
1337767|NCT01425970|Chronic Hepatitis|chronic hepatitis
1337768|NCT01425970|Hepatitis C Virus|hepatitis c virus
1337769|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
1337770|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
1337771|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
1337772|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
1337773|NCT01425944|Biomarkers|biomarkers
1337774|NCT01425944|DNA arrays|dna arrays
1337775|NCT01425944|brain vessel malformations|brain vessel malformations
1337776|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
1337777|NCT01425918|language|language
1337778|NCT01425918|social|social
1337779|NCT01425918|toddlers|toddlers
1337780|NCT01425905|Female|female
1337781|NCT01425905|Depression|depression
1337782|NCT01425905|Obesity|obesity
1337783|NCT01425905|Insulin Resistance|insulin resistance
1337784|NCT01425905|Adolescents|adolescents
1337785|NCT01425905|Overweight|overweight
1338083|NCT01424943|prevention|prevention
1337786|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
1337787|NCT01425905|Mood|mood
1337788|NCT01425892|Salivary Gland|salivary gland
1337789|NCT01425892|Pathogenesis|pathogenesis
1337790|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
1337791|NCT01425892|Sjogren Syndrome|sjogren syndrome
1337792|NCT01425866|Diabetes Mellitus|diabetes mellitus
1337793|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1337794|NCT01425866|Structured self-management education|structured self-management education
1337795|NCT01425866|Therapeutic patient education|therapeutic patient education
1337796|NCT01425866|Lifestyle changes|lifestyle changes
1337797|NCT01425866|Self-management Blood glucose|self-management blood glucose
1337798|NCT01425866|Empowerment|empowerment
1337799|NCT01425866|Adult learning|adult learning
1337800|NCT01425866|Socio-constructivism|socio-constructivism
1337801|NCT01425866|Health management network|health management network
1337802|NCT01425866|Reunion island|reunion island
1337803|NCT01425840|Lidocaine,|lidocaine,
1337804|NCT01425840|liposome encapsulation,|liposome encapsulation,
1337805|NCT01425840|topical anesthesia,|topical anesthesia,
1337806|NCT01425840|palatal mucosa|palatal mucosa
1337807|NCT01425827|duloxetine|duloxetine
1337808|NCT01425827|osteoarthritis|osteoarthritis
1337809|NCT01425827|pain|pain
1337810|NCT01425827|function|function
1337811|NCT01425814|COPD|copd
1337812|NCT01425801|COPD|copd
1337813|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
1337814|NCT01425775|SLE|sle
1337815|NCT01425775|disease activity markers|disease activity markers
1337816|NCT01425775|vitamin D|vitamin d
1337817|NCT01425749|melanoma|melanoma
1337818|NCT01425749|MAGE-A3|mage-a3
1337819|NCT01425749|immunotherapy|immunotherapy
1337820|NCT01425749|adjuvant|adjuvant
1337821|NCT01425749|skin cancer|skin cancer
1337822|NCT01425749|skin diseases|skin diseases
1337823|NCT01425749|immunology|immunology
1337824|NCT01425736|Nimotuzumab|nimotuzumab
1337825|NCT01425736|Chemotherapy|chemotherapy
1337826|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1337827|NCT01425723|B-LONG|b-long
1337828|NCT01425723|B-YOND|b-yond
1337829|NCT01425723|B-LONG Extension|b-long extension
1337830|NCT01425723|rFIXFc|rfixfc
1337831|NCT01425723|Severe Hemophilia B|severe hemophilia b
1337832|NCT01425710|Pheochromocytoma|pheochromocytoma
1337833|NCT01425710|Adrenalectomy|adrenalectomy
1337834|NCT01425710|Cardiac output|cardiac output
1337835|NCT01425710|Fluid managment|fluid managment
1337836|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
1337837|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
1337838|NCT01425697|Surgery site infections|surgery site infections
1337839|NCT01425684|MRI|mri
1337840|NCT01425684|Smoking|smoking
1337841|NCT01425684|Schizophrenia|schizophrenia
1337842|NCT01425671|Schizophrenia|schizophrenia
1337843|NCT01425671|Family|family
1337844|NCT01425671|Psychosis|psychosis
1337845|NCT01425658|Fentanyl|fentanyl
1337846|NCT01425658|clonidine|clonidine
1337847|NCT01425658|intrathcal|intrathcal
1337849|NCT01425645|gestational diabetes|gestational diabetes
1337850|NCT01425645|GDM|gdm
1337851|NCT01425645|prevention|prevention
1337852|NCT01425632|TAU-284|tau-284
1337853|NCT01425632|Bepotastine besilate|bepotastine besilate
1337854|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
1337855|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
1337856|NCT01425580|Congestive Heart Failure|congestive heart failure
1337857|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1337858|NCT01425580|GLP-1|glp-1
1337859|NCT01425580|Liraglutide|liraglutide
1337860|NCT01425567|cholestasis|cholestasis
1337861|NCT01425567|parenteral nutrition|parenteral nutrition
1337862|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
1337863|NCT01425515|hypertension|hypertension
1337864|NCT01425515|genomics|genomics
1337865|NCT01425502|High risk prescribing|high risk prescribing
1337866|NCT01425502|Primary care|primary care
1337867|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1337868|NCT01425502|Anti-platelet agents|anti-platelet agents
1337869|NCT01425502|Stepped wedge design|stepped wedge design
1337870|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
1337871|NCT01425502|United Kingdom|united kingdom
1337872|NCT01425489|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
1337873|NCT01425489|Hereditary Central Nervous System Demyelinating Diseases|hereditary central nervous system demyelinating diseases
1337874|NCT01425489|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
1337875|NCT01425489|Central Nervous System Diseases|central nervous system diseases
1337876|NCT01425489|Nervous System Diseases|nervous system diseases
1337877|NCT01425489|Sphingolipidoses|sphingolipidoses
1337878|NCT01425489|Leukoencephalopathies|leukoencephalopathies
1337879|NCT01425489|Demyelinating Diseases|demyelinating diseases
1337880|NCT01425489|Metabolism, Inborn Errors|metabolism, inborn errors
1337881|NCT01425489|Genetic Diseases, Inborn|genetic diseases, inborn
1337882|NCT01425489|Lipidoses|lipidoses
1337883|NCT01425489|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1337884|NCT01425489|Lysosomal Storage Diseases|lysosomal storage diseases
1337885|NCT01425489|Metabolic Diseases|metabolic diseases
1337886|NCT01425489|Lipid Metabolism DisordersLeukodystrophy, Globoid Cell|lipid metabolism disordersleukodystrophy, globoid cell
1337887|NCT01425476|breast|breast
1337888|NCT01425476|high risk women|high risk women
1337889|NCT01425476|biomarkers|biomarkers
1337890|NCT01425476|vitamin D|vitamin d
1337891|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
1337892|NCT01425463|Polyferose|polyferose
1337893|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
1337894|NCT01425463|Niferex|niferex
1337895|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
1337896|NCT01425437|Keloid|keloid
1337897|NCT01425424|Vitamin D|vitamin d
1337898|NCT01425424|Prediabetes|prediabetes
1337899|NCT01425424|Prehypertension|prehypertension
1337900|NCT01425411|hypertension|hypertension
1337901|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
1337902|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
1337903|NCT01425411|midwall mechanics|midwall mechanics
1337904|NCT01425411|tissue Doppler imaging|tissue doppler imaging
1337905|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
1337906|NCT01425385|liver failure|liver failure
1337907|NCT01425385|liver transplantation|liver transplantation
1337909|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1337910|NCT01425372|immune responses|immune responses
1337911|NCT01425372|primary immunisation|primary immunisation
1337912|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
1337913|NCT01425359|Chronic angina|chronic angina
1337914|NCT01425359|Angina pectoris|angina pectoris
1337915|NCT01425359|Coronary artery disease|coronary artery disease
1337916|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1337917|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
1337918|NCT01425333|Ovarian endometriomas|ovarian endometriomas
1337919|NCT01425333|Laparoscopy|laparoscopy
1337920|NCT01425333|Cystectomy|cystectomy
1337921|NCT01425333|Ablation|ablation
1337922|NCT01425307|Phase III|phase iii
1337923|NCT01425307|Sickle cell anemia|sickle cell anemia
1337924|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
1337925|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
1337926|NCT01425307|Pediatric patients|pediatric patients
1337927|NCT01425307|Chelation therapy|chelation therapy
1337928|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
1337929|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
1337930|NCT01425294|metastatic breast cancer|metastatic breast cancer
1337931|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
1337932|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
1337933|NCT01425281|Bioabsorbable|bioabsorbable
1337934|NCT01425281|Coronary scaffold|coronary scaffold
1337935|NCT01425281|Coronary Stent|coronary stent
1337936|NCT01425281|Everolimus|everolimus
1337937|NCT01425281|Drug eluting stents|drug eluting stents
1337938|NCT01425281|Angioplasty|angioplasty
1337939|NCT01425281|Coronary artery disease|coronary artery disease
1337940|NCT01425281|Total coronary occlusion|total coronary occlusion
1337941|NCT01425281|Coronary artery restenosis|coronary artery restenosis
1337942|NCT01425281|Stent thrombosis|stent thrombosis
1337943|NCT01425281|Myocardial ischemia|myocardial ischemia
1337944|NCT01425281|Coronary artery stenosis|coronary artery stenosis
1337945|NCT01425268|Tissue Expansion|tissue expansion
1337946|NCT01425268|Tissue Expander|tissue expander
1337947|NCT01425268|Breast Tissue Expansion|breast tissue expansion
1337948|NCT01425268|Breast Tissue Expander|breast tissue expander
1337949|NCT01425268|Breast Reconstruction|breast reconstruction
1337950|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
1337951|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
1337952|NCT01425255|Type 1 diabetes|type 1 diabetes
1337953|NCT01425255|Sleep quality|sleep quality
1337954|NCT01425255|Parents|parents
1337955|NCT01425242|inflammation|inflammation
1337956|NCT01425242|aneurysm|aneurysm
1337957|NCT01425242|hypertension|hypertension
1337958|NCT01425242|aliskiren|aliskiren
1337959|NCT01425229|steady state|steady state
1337960|NCT01425229|bosentan|bosentan
1337961|NCT01425229|clarithromycin|clarithromycin
1337962|NCT01425216|Keloid|keloid
1337963|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
1337964|NCT01425177|Retained CBD Stones|retained cbd stones
1337965|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
1337966|NCT01425164|hemodialysis|hemodialysis
1337967|NCT01425164|coronary heart disease|coronary heart disease
1337968|NCT01425164|angina|angina
1337969|NCT01425164|betablocker|betablocker
1337970|NCT01425164|carvedilol|carvedilol
1337971|NCT01425164|ivabradine|ivabradine
1337972|NCT01425138|psoriasis|psoriasis
1337973|NCT01425138|systematic review|systematic review
1337974|NCT01425138|meta-analyses|meta-analyses
1337975|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
1338283|NCT01424007|Women|women
1337976|NCT01425125|fractional urate excretion|fractional urate excretion
1337977|NCT01425112|trabeculectomy|trabeculectomy
1337978|NCT01425112|bevacizumab|bevacizumab
1337979|NCT01425112|anti-VEGF|anti-vegf
1337980|NCT01425112|Efficacy|efficacy
1337981|NCT01425086|Incubator,|incubator,
1337982|NCT01425086|hypothermia,|hypothermia,
1337983|NCT01425086|preterm,|preterm,
1337984|NCT01425086|low-birthweight infants,|low-birthweight infants,
1337985|NCT01425086|embrace device,|embrace device,
1337986|NCT01425086|phase change materials|phase change materials
1337987|NCT01425086|PCM|pcm
1337988|NCT01425073|HIV|hiv
1337989|NCT01425073|Co-Infections|co-infections
1337990|NCT01425073|Malaria|malaria
1337991|NCT01425073|Pneumonia|pneumonia
1337992|NCT01425073|Diarrhea|diarrhea
1337993|NCT01425060|Contraception|contraception
1337994|NCT01425060|Unintended pregnancy|unintended pregnancy
1337995|NCT01425060|HIV|hiv
1337996|NCT01425060|HIV Risk|hiv risk
1337997|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
1337998|NCT01425060|Women|women
1337999|NCT01425060|Pregnancy|pregnancy
1338000|NCT01425060|Neonatal Health|neonatal health
1338001|NCT01425060|Drug Use|drug use
1338002|NCT01425060|Drug Treatment|drug treatment
1338003|NCT01425060|Opioids|opioids
1338004|NCT01425047|mangosteen|mangosteen
1338005|NCT01425047|xanthones|xanthones
1338006|NCT01425047|dietary supplement|dietary supplement
1338007|NCT01425047|botanical supplement|botanical supplement
1338008|NCT01425047|bioavailability|bioavailability
1338009|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
1338010|NCT01425034|Cast|cast
1338011|NCT01425034|motion|motion
1338012|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
1338013|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
1338014|NCT01424995|trigger thumb|trigger thumb
1338015|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
1338016|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
1338017|NCT01424982|Leukemia|leukemia
1338018|NCT01424982|Ph-positive acute lymphoblastic leukemia|ph-positive acute lymphoblastic leukemia
1338020|NCT01424982|Philadelphia (Ph) chromosome|philadelphia (ph) chromosome
1338021|NCT01424982|BCR-ABL|bcr-abl
1338022|NCT01424982|Depo-Medrol|depo-medrol
1338023|NCT01424982|Medrol|medrol
1338024|NCT01424982|Solu-Medrol|solu-medrol
1338025|NCT01424982|Methylprednisolone|methylprednisolone
1338026|NCT01424982|Vincristine|vincristine
1338027|NCT01424982|Dexamethasone|dexamethasone
1338028|NCT01424982|Decadron|decadron
1338029|NCT01424982|Ponatinib|ponatinib
1338030|NCT01424982|G-CSF|g-csf
1338031|NCT01424982|Filgrastim|filgrastim
1338032|NCT01424982|NeupogenTM|neupogentm
1338033|NCT01424982|Cyclophosphamide|cyclophosphamide
1338034|NCT01424982|Cytoxan|cytoxan
1338035|NCT01424982|Neosar|neosar
1338036|NCT01424982|Doxorubicin|doxorubicin
1338037|NCT01424982|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1338038|NCT01424982|Adriamycin PFS|adriamycin pfs
1338039|NCT01424982|Adriamycin RDF|adriamycin rdf
1338040|NCT01424982|Adriamycin|adriamycin
1338041|NCT01424982|Rubex|rubex
1338042|NCT01424982|Rituximab|rituximab
1338043|NCT01424982|Rituxan|rituxan
1338044|NCT01424982|Mesna|mesna
1338045|NCT01424982|Mesnex|mesnex
1338046|NCT01424982|Cytarabine|cytarabine
1338047|NCT01424982|Ara-C|ara-c
1338048|NCT01424982|Cytosar|cytosar
1338049|NCT01424982|DepoCyt|depocyt
1338050|NCT01424982|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1338051|NCT01424982|Methotrexate|methotrexate
1338052|NCT01424982|Leucovorin|leucovorin
1338053|NCT01424982|Wellcovorin|wellcovorin
1338054|NCT01424982|Citrovorum|citrovorum
1338055|NCT01424982|Prednisone|prednisone
1338056|NCT01424982|NeulastaTM|neulastatm
1338057|NCT01424982|PEG-G-CSF|peg-g-csf
1338058|NCT01424969|rotator cuff repair|rotator cuff repair
1338059|NCT01424969|arthroscopic|arthroscopic
1338060|NCT01424969|platelet-rich plasma|platelet-rich plasma
1338061|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
1338062|NCT01424969|outcomes|outcomes
1338063|NCT01424969|tendon healing|tendon healing
1338064|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
1338065|NCT01424956|breast|breast
1338066|NCT01424956|breast cancer|breast cancer
1338067|NCT01424956|breast screening|breast screening
1338068|NCT01424956|breast cancer screening|breast cancer screening
1338069|NCT01424956|ultrasound|ultrasound
1338070|NCT01424956|ultrasonography|ultrasonography
1338071|NCT01424956|mammogram|mammogram
1338072|NCT01424956|mammography|mammography
1338073|NCT01424956|breast density|breast density
1338074|NCT01424956|dense breasts|dense breasts
1338075|NCT01424956|early detection|early detection
1338076|NCT01424956|somo v|somo v
1338077|NCT01424956|somo•v|somo•v
1338078|NCT01424956|U-Systems|u-systems
1338079|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
1338080|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
1338081|NCT01424956|Breast Neoplasms|breast neoplasms
1338082|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
1338084|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
1338085|NCT01424943|children|children
1338086|NCT01424943|disabilities|disabilities
1338087|NCT01424943|IDEA Part C|idea part c
1338088|NCT01424943|Stepping Stones Triple P|stepping stones triple p
1338089|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1338090|NCT01424930|CRPC|crpc
1338091|NCT01424930|Abiraterone Acetate|abiraterone acetate
1338092|NCT01424930|Prednisone|prednisone
1338093|NCT01424930|Food Safety|food safety
1338094|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
1338095|NCT01424904|Ergogenic aid|ergogenic aid
1338096|NCT01424904|Exercise endurance|exercise endurance
1338097|NCT01424904|High performance|high performance
1338098|NCT01424904|Time trial performance|time trial performance
1338099|NCT01424904|Glutathione|glutathione
1567107|NCT00510042|von Willebrand factor|von willebrand factor
1338100|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
1338101|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
1338102|NCT01424865|stage II breast cancer|stage ii breast cancer
1338103|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
1338104|NCT01424852|Probiotics|probiotics
1338106|NCT01424852|Oral flora|oral flora
1338107|NCT01424839|SIOP CNS GCT II|siop cns gct ii
1338108|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
1338109|NCT01424826|Healthy volunteers|healthy volunteers
1338110|NCT01424813|Asthma|asthma
1338111|NCT01424813|dry powder inhaler|dry powder inhaler
1338112|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
1338113|NCT01424813|SABA|saba
1338114|NCT01424813|bronchoconstriction|bronchoconstriction
1338115|NCT01424813|bronchodilation|bronchodilation
1338116|NCT01424813|bronchodilator|bronchodilator
1338117|NCT01424813|metered dose inhaler|metered dose inhaler
1338118|NCT01424774|Radiation Exposure|radiation exposure
1338119|NCT01424774|Rubidium 82|rubidium 82
1338120|NCT01424774|Strontium 82|strontium 82
1338121|NCT01424774|Strontium 85|strontium 85
1338122|NCT01424748|Noni juice|noni juice
1338123|NCT01424748|Safety|safety
1338124|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
1338125|NCT01424735|Pupillary Reaction|pupillary reaction
1338126|NCT01424735|Colour vision|colour vision
1338127|NCT01424735|Disc edema|disc edema
1338128|NCT01424722|ICD Indicated patients|icd indicated patients
1338129|NCT01424722|documented CAD|documented cad
1338130|NCT01424709|Chemotherapy|chemotherapy
1338131|NCT01424709|Individual therapy|individual therapy
1338132|NCT01424709|RRM1|rrm1
1338133|NCT01424709|BRCA1|brca1
1338134|NCT01424696|growth measures|growth measures
1338135|NCT01424696|nutritional status|nutritional status
1338136|NCT01424696|pulmonary infection|pulmonary infection
1338137|NCT01424696|inflammatory markers|inflammatory markers
1338138|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
1338139|NCT01424683|Qol|qol
1338140|NCT01424683|Quality of life|quality of life
1338141|NCT01424683|VAS|vas
1338446|NCT01423448|Depression|depression
1338142|NCT01424683|Visual Analogue Scale|visual analogue scale
1338143|NCT01424683|CABG|cabg
1338144|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
1338145|NCT01424683|Qol conversion|qol conversion
1338146|NCT01424683|post hoc HTA|post hoc hta
1338147|NCT01424670|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
1338148|NCT01424657|MRCP|mrcp
1338149|NCT01424657|ERCP|ercp
1338150|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
1338151|NCT01424657|EFFECTIVENESS|effectiveness
1338152|NCT01424644|meningitis|meningitis
1338153|NCT01424644|human papillomavirus|human papillomavirus
1338154|NCT01424644|tetanus|tetanus
1338155|NCT01424644|diptheria|diptheria
1338156|NCT01424644|pertussis|pertussis
1338157|NCT01424618|Donor eggs|donor eggs
1338158|NCT01424618|Donor oocytes|donor oocytes
1338159|NCT01424618|Pregnancy|pregnancy
1338160|NCT01424618|Embryo Implantation|embryo implantation
1338161|NCT01424618|Infertility|infertility
1338163|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
1338164|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
1338165|NCT01424605|direct laryngoscope|direct laryngoscope
1338166|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
1338167|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
1338168|NCT01424592|Polysomnography|polysomnography
1338169|NCT01424566|Cancer pain|cancer pain
1338170|NCT01424566|Opioid therapy|opioid therapy
1338171|NCT01424566|Inadequate analgesia|inadequate analgesia
1338172|NCT01424566|Optimized chronic opioid therapy|optimized chronic opioid therapy
1338173|NCT01424553|Low birthweight|low birthweight
1338174|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1338175|NCT01424553|Lung development|lung development
1338176|NCT01424553|Airway obstruction|airway obstruction
1338177|NCT01424553|Asthma|asthma
1338178|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
1338179|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
1338284|NCT01424007|Weight loss|weight loss
1338180|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
1338181|NCT01424501|HIV-negative|hiv-negative
1338182|NCT01424501|tuberculosis treatment|tuberculosis treatment
1338183|NCT01424488|sugammadex|sugammadex
1338184|NCT01424488|reversal|reversal
1338185|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
1338186|NCT01424462|healthy volunteers|healthy volunteers
1338187|NCT01424462|firategrast|firategrast
1338188|NCT01424462|Pharmacokinetics|pharmacokinetics
1338189|NCT01424462|modified release|modified release
1338190|NCT01424436|CSF sampling|csf sampling
1338191|NCT01424436|Alzheimer's disease|alzheimer's disease
1338192|NCT01424436|Amyloid beta levels|amyloid beta levels
1338193|NCT01424423|Safety|safety
1338194|NCT01424423|GSK1223249|gsk1223249
1338195|NCT01424423|Pharmacokinetics|pharmacokinetics
1450145|NCT00965354|flu|flu
1338196|NCT01424423|Single dose escalation|single dose escalation
1338197|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
1338198|NCT01424423|Multiple Sclerosis|multiple sclerosis
1338199|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
1338200|NCT01424384|healthy volunteers|healthy volunteers
1338201|NCT01424384|Anxiety Disorder|anxiety disorder
1338202|NCT01424384|neuropsychological tests|neuropsychological tests
1338203|NCT01424345|Kidney Transplantation|kidney transplantation
1338204|NCT01424345|Immunosuppression|immunosuppression
1338205|NCT01424345|Immune monitoring|immune monitoring
1338206|NCT01424332|Pharmacodynamics|pharmacodynamics
1338207|NCT01424332|pharmacokinetics|pharmacokinetics
1338208|NCT01424332|darexaban|darexaban
1338209|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
1338210|NCT01424332|darexaban glucuronide|darexaban glucuronide
1338211|NCT01424332|YM150|ym150
1338212|NCT01424332|YM-222714|ym-222714
1338213|NCT01424332|Phase 1|phase 1
1338214|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
1338215|NCT01424319|Proteinuria|proteinuria
1338216|NCT01424306|Inflammation|inflammation
1338217|NCT01424306|Intestinal permeability|intestinal permeability
1338218|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
1338219|NCT01424306|Cardiovascular disease|cardiovascular disease
1338220|NCT01424306|Obesity|obesity
1338221|NCT01424306|Sweetened beverages|sweetened beverages
1338222|NCT01424306|Sugar|sugar
1338223|NCT01424306|Fructose|fructose
1338224|NCT01424306|Glucose|glucose
1338225|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
1338226|NCT01424293|Rectal Cancer|rectal cancer
1338227|NCT01424293|Colon Cancer|colon cancer
1338228|NCT01424293|Diverticulitis|diverticulitis
1338229|NCT01424293|Anastamosis|anastamosis
1338230|NCT01424293|colectomy|colectomy
1338231|NCT01424293|low anterior resection|low anterior resection
1338232|NCT01424267|low profile|low profile
1338233|NCT01424267|endovascular graft|endovascular graft
1338234|NCT01424267|endovascular procedure|endovascular procedure
1338235|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
1338236|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
1338237|NCT01424241|Sandostatin LAR|sandostatin lar
1338238|NCT01424228|Long term|long term
1338241|NCT01424202|Post extubation failure|post extubation failure
1338242|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
1338243|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
1338244|NCT01424202|Weaning|weaning
1338247|NCT01424150|Postoperative fluid|postoperative fluid
1338248|NCT01424150|surgery|surgery
1338249|NCT01424150|anaesthesia|anaesthesia
1338250|NCT01424150|fluid|fluid
1338251|NCT01424150|mortality|mortality
1338252|NCT01424150|morbidity|morbidity
1338253|NCT01424111|Biomarkers|biomarkers
1338254|NCT01424111|Depression|depression
1338255|NCT01424111|Major Depressive Disorder|major depressive disorder
1338256|NCT01424111|Escitalopram|escitalopram
1338257|NCT01424072|stress psychological|stress psychological
1338258|NCT01424072|coping behavior|coping behavior
1338259|NCT01424059|fear|fear
1338260|NCT01424059|labor|labor
1338261|NCT01424059|induction|induction
1338262|NCT01424059|amniotomy|amniotomy
1338263|NCT01424059|WEDQ-B|wedq-b
1338264|NCT01424059|parous|parous
1338265|NCT01424059|cesarean section|cesarean section
1338266|NCT01424046|type 1 diabetes|type 1 diabetes
1338267|NCT01424046|basal insulin|basal insulin
1338268|NCT01424046|developing world|developing world
1338269|NCT01424046|comparative effectiveness|comparative effectiveness
1338270|NCT01424033|Interstitial lung disease|interstitial lung disease
1338271|NCT01424033|Connective tissue disease|connective tissue disease
1338272|NCT01424033|Scleroderma|scleroderma
1338273|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
1338274|NCT01424033|Sjogren's syndrome|sjogren's syndrome
1338275|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
1338276|NCT01424033|Dermatomyositis|dermatomyositis
1338277|NCT01424033|Polymyositis|polymyositis
1338278|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
1338279|NCT01424020|Questionnaire|questionnaire
1338280|NCT01424020|peripheral artery disease|peripheral artery disease
1338281|NCT01424020|execise|execise
1338282|NCT01424007|Obese|obese
1338285|NCT01424007|Exercise|exercise
1338286|NCT01424007|Physical activity|physical activity
1338287|NCT01424007|Diet|diet
1338288|NCT01424007|Female|female
1338289|NCT01423994|syncope|syncope
1338290|NCT01423994|fainting|fainting
1338291|NCT01423994|implantable loop recorder|implantable loop recorder
1338292|NCT01423994|pacemaker|pacemaker
1338293|NCT01423994|heart block|heart block
1338294|NCT01423994|bifascicular heart block|bifascicular heart block
1338295|NCT01423981|Keloid|keloid
1338296|NCT01423981|Scar|scar
1338297|NCT01423981|hypertrophic scar|hypertrophic scar
1338298|NCT01423981|familial keloid|familial keloid
1450252|NCT00964873|Synta|synta
1338299|NCT01423968|Sepsis|sepsis
1338300|NCT01423968|Inflammation|inflammation
1338301|NCT01423968|Lipopolysaccharide|lipopolysaccharide
1338302|NCT01423968|Muscle protein turnover|muscle protein turnover
1338303|NCT01423968|Insulin resistance|insulin resistance
1338304|NCT01423955|Erythropoietin|erythropoietin
1338305|NCT01423955|Erythropoetin|erythropoetin
1338306|NCT01423955|Cardiac surgery|cardiac surgery
1338307|NCT01423955|Ischemia|ischemia
1338308|NCT01423955|Reperfusion|reperfusion
1338309|NCT01423955|Renal function|renal function
1338310|NCT01423955|Cystatin C|cystatin c
1338311|NCT01423955|Creatinine|creatinine
1338312|NCT01423955|Safety|safety
1338313|NCT01423929|Oxygen|oxygen
1338314|NCT01423929|Myocardial infarction|myocardial infarction
1338315|NCT01423929|Ambulance|ambulance
1338316|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
1338317|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1338318|NCT01423916|Schizophrenia|schizophrenia
1338319|NCT01423916|QTc Interval|qtc interval
1338320|NCT01423903|Phase I|phase i
1338321|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
1338322|NCT01423903|solid tumors|solid tumors
1338323|NCT01423890|Breast Cancer|breast cancer
1338324|NCT01423890|Oncotype DX|oncotype dx
1338325|NCT01423890|Adjuvant! Online|adjuvant! online
1338326|NCT01423890|Decisional Conflict Scale|decisional conflict scale
1338327|NCT01423877|bariatric surgery|bariatric surgery
1338328|NCT01423877|diabetes|diabetes
1338329|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
1338330|NCT01423877|gastric bypass|gastric bypass
1338331|NCT01423877|gastric banding|gastric banding
1338332|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1338333|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
1338334|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1338335|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
1338336|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
1338337|NCT01423851|NS-018|ns-018
1338338|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1338339|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
1338445|NCT01423474|Hypofractionation|hypofractionation
1338340|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1338341|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1338342|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
1338343|NCT01423851|Bone Marrow Diseases|bone marrow diseases
1338344|NCT01423851|Hematologic Diseases|hematologic diseases
1338345|NCT01423851|Polycythemia Vera|polycythemia vera
1338346|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
1338347|NCT01423851|PMF|pmf
1338348|NCT01423851|post-PV MF|post-pv mf
1338349|NCT01423851|post-ET MF|post-et mf
1338350|NCT01423838|Overactive bladder|overactive bladder
1338351|NCT01423838|Solifenacin|solifenacin
1338352|NCT01423838|Oxybutynin|oxybutynin
1338353|NCT01423812|HIV|hiv
1338354|NCT01423812|treatment-experienced|treatment-experienced
1338355|NCT01423812|protease inhibitor|protease inhibitor
1338356|NCT01423812|adherence|adherence
1338357|NCT01423812|lipids|lipids
1338358|NCT01423799|Quality of life|quality of life
1338359|NCT01423799|Cancer|cancer
1338360|NCT01423799|Immunonutrition|immunonutrition
1338361|NCT01423760|Vaccine|vaccine
1338362|NCT01423760|Stimuvax|stimuvax
1338363|NCT01423760|Tecemotide|tecemotide
1338364|NCT01423760|L-BLP25|l-blp25
1338365|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
1338366|NCT01423760|Multiple Myeloma|multiple myeloma
1338367|NCT01423747|ALL|all
1338368|NCT01423747|HSCT|hsct
1338369|NCT01423747|children|children
1338370|NCT01423747|adolescents|adolescents
1338371|NCT01423734|ADRENAL GLAND|adrenal gland
1338372|NCT01423734|MRI|mri
1338373|NCT01423734|11-122|11-122
1338374|NCT01423708|Liver Transplantation|liver transplantation
1338375|NCT01423708|Graft Rejection|graft rejection
1338376|NCT01423708|Graft Survival|graft survival
1338377|NCT01423708|Transplantation Immunology|transplantation immunology
1338378|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
1338379|NCT01423708|Immunosuppression|immunosuppression
1338380|NCT01423708|Organ Transplantation|organ transplantation
1338381|NCT01423708|Host vs Graft Reaction|host vs graft reaction
1338382|NCT01423708|Gastroenterology|gastroenterology
1338383|NCT01423708|Hepatology|hepatology
1338384|NCT01423669|Psychotic Disorders|psychotic disorders
1338385|NCT01423643|HIV|hiv
1338386|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
1338387|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1338388|NCT01423643|AIDS Virus|aids virus
1338389|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
1338390|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
1338391|NCT01423643|Hepatitis C|hepatitis c
1338392|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
1338393|NCT01423643|Hepatitis C virus|hepatitis c virus
1338394|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
1338395|NCT01423643|Hepatitis C antigens|hepatitis c antigens
1338396|NCT01423630|fatty liver|fatty liver
1338397|NCT01423630|probiotics|probiotics
1338398|NCT01423630|Lactobacillus|lactobacillus
1338399|NCT01423630|fruit|fruit
1338400|NCT01423630|fibre|fibre
1338401|NCT01423630|dietary intervention|dietary intervention
1338402|NCT01423630|obesity|obesity
1338403|NCT01423617|overweight|overweight
1338404|NCT01423617|weight loss|weight loss
1338405|NCT01423617|body fat|body fat
1338406|NCT01423617|waist circumference|waist circumference
1338407|NCT01423617|satiety|satiety
1338408|NCT01423617|appetite|appetite
1338409|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
1338410|NCT01423591|Infliximab|infliximab
1338411|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
1338412|NCT01423591|refractory|refractory
1338413|NCT01423591|double blind|double blind
1338414|NCT01423591|placebo controlled|placebo controlled
1338415|NCT01423591|trial|trial
1338416|NCT01423578|craving|craving
1338417|NCT01423578|mood|mood
1338418|NCT01423578|cue reactivity|cue reactivity
1338419|NCT01423578|smoking behavior|smoking behavior
1338420|NCT01423578|quit smoking|quit smoking
1338421|NCT01423578|prevention|prevention
1338422|NCT01423578|Hatha yoga|hatha yoga
1338423|NCT01423578|cardiovascular exercise|cardiovascular exercise
1338424|NCT01423565|Deep Brain Stimulation|deep brain stimulation
1338425|NCT01423565|Parkinson's Disease|parkinson's disease
1338426|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
1338427|NCT01423565|Constant Current|constant current
1338428|NCT01423552|Heart transplantation|heart transplantation
1338429|NCT01423552|Immunosuppression|immunosuppression
1338430|NCT01423552|Pharmacokinetics|pharmacokinetics
1338431|NCT01423552|Pharmacogenetics|pharmacogenetics
1338432|NCT01423513|ankle tape|ankle tape
1338433|NCT01423513|Hoffmann reflex|hoffmann reflex
1338434|NCT01423513|Balance|balance
1338435|NCT01423500|ALL|all
1338436|NCT01423500|HSCT|hsct
1338437|NCT01423500|children|children
1338438|NCT01423500|adolescents|adolescents
1338439|NCT01423487|Metformin|metformin
1338440|NCT01423487|Risperidone|risperidone
1338441|NCT01423487|Prevention|prevention
1338442|NCT01423487|weight gain|weight gain
1338443|NCT01423487|Amenorrhea|amenorrhea
1338444|NCT01423474|Radiotherapy|radiotherapy
1338447|NCT01423448|mental health|mental health
1338448|NCT01423448|wellbeing|wellbeing
1338449|NCT01423448|online bulletin board|online bulletin board
1338450|NCT01423448|online support group|online support group
1338451|NCT01423435|TRK-100STP|trk-100stp
1338452|NCT01423435|PK|pk
1338453|NCT01423435|beraprost sodium|beraprost sodium
1338454|NCT01423422|Exercise stress test|exercise stress test
1338455|NCT01423422|Effort Angina|effort angina
1338456|NCT01423422|Exercise induced angina|exercise induced angina
1338457|NCT01423409|visual analog pain scale|visual analog pain scale
1338458|NCT01423409|Deaf persons|deaf persons
1338459|NCT01423409|clinical trial|clinical trial
1338460|NCT01423409|multicentric|multicentric
1338461|NCT01423396|Alzheimer's disease|alzheimer's disease
1338462|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
1338463|NCT01423383|Keloid|keloid
1338464|NCT01423370|Erectile Dysfunction|erectile dysfunction
1338465|NCT01423370|YHD1023|yhd1023
1338466|NCT01423370|YCD190|ycd190
1338467|NCT01423370|Cialis|cialis
1338468|NCT01423370|Yuhan|yuhan
1338469|NCT01423357|HIV prevention|hiv prevention
1338470|NCT01423357|condom distribution|condom distribution
1338471|NCT01423357|youth peer education|youth peer education
1338472|NCT01423357|high risk places|high risk places
1338473|NCT01423357|condom use|condom use
1338474|NCT01423357|prevention through increased condom use|prevention through increased condom use
1338475|NCT01423344|multiple myeloma|multiple myeloma
1338476|NCT01423344|Free light chains|free light chains
1338477|NCT01423331|Postpartum depression|postpartum depression
1338478|NCT01423331|maternal mental health|maternal mental health
1338479|NCT01423305|Asthma|asthma
1338480|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
1338481|NCT01423266|obesity and heart failure|obesity and heart failure
1338482|NCT01423266|Weight management in Heart failure|weight management in heart failure
1338483|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
1338484|NCT01423253|Depression|depression
1338485|NCT01423253|Lurasidone|lurasidone
1338486|NCT01423253|Latuda|latuda
1338487|NCT01423240|Depression|depression
1338488|NCT01423240|Lurasidone|lurasidone
1338489|NCT01423240|Latuda|latuda
1338490|NCT01423227|COPD|copd
1338491|NCT01423227|exercise|exercise
1338492|NCT01423227|rehabilitation|rehabilitation
1338493|NCT01423227|dyspnea|dyspnea
1338494|NCT01423227|quality of life|quality of life
1338495|NCT01423227|economic evaluation|economic evaluation
1338496|NCT01423214|rectal cancer|rectal cancer
1338497|NCT01423214|robot|robot
1338498|NCT01423214|laparoscopy|laparoscopy
1338499|NCT01423214|total mesorectal excision|total mesorectal excision
1338500|NCT01423214|robotic surgery|robotic surgery
1338501|NCT01423201|TIA|tia
1338502|NCT01423201|triage|triage
1338503|NCT01423201|Lp-PLA2|lp-pla2
1338504|NCT01423201|Proteomic|proteomic
1338505|NCT01423201|Genomic|genomic
1338506|NCT01423188|ApolipoproteinA1|apolipoproteina1
1338507|NCT01423188|HDL-C|hdl-c
1338508|NCT01423188|Atherosclerosis|atherosclerosis
1338509|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
1338510|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
1338511|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
1338512|NCT01423175|clofarabine|clofarabine
1338513|NCT01423162|Iron absorption|iron absorption
1338514|NCT01423162|Oats|oats
1338515|NCT01423162|fortified oat beverages|fortified oat beverages
1338516|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
1338517|NCT01423149|pathologic myopia|pathologic myopia
1338518|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
1338519|NCT01423123|Paclitaxel|paclitaxel
1338520|NCT01423123|Trastuzumab|trastuzumab
1338521|NCT01423123|Neratinib|neratinib
1338522|NCT01423123|Breast Cancer|breast cancer
1338523|NCT01423123|HER2-positive|her2-positive
1338524|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
1338525|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
1338526|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
1338527|NCT01423084|prevention, vaccination|prevention, vaccination
1338528|NCT01423084|adolescents|adolescents
1338529|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
1338530|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1338531|NCT01423071|Prevalence|prevalence
1338532|NCT01423071|Quality of life|quality of life
1338533|NCT01423045|Chronic kidney disease|chronic kidney disease
1338534|NCT01423045|Urine osmolarity|urine osmolarity
1338535|NCT01423045|Glomerular filtration rate|glomerular filtration rate
1338536|NCT01423032|relapsed|relapsed
1338537|NCT01423019|Weight Loss|weight loss
1338538|NCT01423019|Body Composition|body composition
1338539|NCT01423019|Fat Free Mass|fat free mass
1338540|NCT01423019|Bone Mineral Density|bone mineral density
1338541|NCT01423019|Adipose Tissue|adipose tissue
1338542|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
1338543|NCT01423019|Body Fat|body fat
1338544|NCT01423019|Eating and appetite control|eating and appetite control
1338545|NCT01423019|Basal Metabolic Rate|basal metabolic rate
1338546|NCT01423006|Pilot|pilot
1338547|NCT01423006|Ablation|ablation
1338548|NCT01423006|Low Risk|low risk
1338549|NCT01423006|Radio Frequency|radio frequency
1338551|NCT01423006|minimally invasive|minimally invasive
1338552|NCT01423006|prostate gland|prostate gland
1338553|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
1338554|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
1338555|NCT01422993|Strength|strength
1338556|NCT01422993|Balance|balance
1338557|NCT01422993|Training Program|training program
1338558|NCT01422993|Colon|colon
1338559|NCT01422993|Rectal|rectal
1338560|NCT01422980|dairy product|dairy product
1338561|NCT01422980|upper gastric discomfort|upper gastric discomfort
1338562|NCT01422980|adult|adult
1338563|NCT01422967|Osteoarthritis|osteoarthritis
1338564|NCT01422967|Sleep|sleep
1338565|NCT01422967|muscle strength|muscle strength
1338566|NCT01422967|balance|balance
1338567|NCT01422928|Radiotherapy|radiotherapy
1338568|NCT01422928|Acupuncture|acupuncture
1338569|NCT01422928|Immune System|immune system
1338570|NCT01422915|Sorbent|sorbent
1338571|NCT01422915|Resin|resin
1338572|NCT01422915|EPP|epp
1338573|NCT01422915|Cutaneous porphyria|cutaneous porphyria
1338574|NCT01422915|Adult|adult
1338575|NCT01422915|over age 21|over age 21
1338576|NCT01422915|without intercurrent illness|without intercurrent illness
1338577|NCT01422915|not pregnant|not pregnant
1338578|NCT01422915|willing to participate|willing to participate
1338579|NCT01422902|Schizophrenia|schizophrenia
1338580|NCT01422902|Cognitive deficits|cognitive deficits
1338581|NCT01422902|Cognitive remediation|cognitive remediation
1338582|NCT01422902|Software|software
1338583|NCT01422902|Brain Plasticity|brain plasticity
1338584|NCT01422889|Atherosclerosis|atherosclerosis
1338585|NCT01422889|Coronary Artery Disease|coronary artery disease
1338586|NCT01422863|weight loss|weight loss
1338587|NCT01422863|exercise|exercise
1338588|NCT01422863|diet|diet
1338589|NCT01422863|sleep apnea|sleep apnea
1338590|NCT01422863|aging|aging
1338591|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
1338592|NCT01422850|Immunotherapy|immunotherapy
1338593|NCT01422837|opioid|opioid
1338594|NCT01422837|dependence|dependence
1338595|NCT01422837|VIVITROL|vivitrol
1338596|NCT01422811|Public health|public health
1338597|NCT01422811|Policy|policy
1338598|NCT01422811|Training|training
1338599|NCT01422785|Acne Vulgaris|acne vulgaris
1338600|NCT01422720|Epilepsy|epilepsy
1338601|NCT01422720|ESL|esl
1338602|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
1338603|NCT01422720|BIAL|bial
1338604|NCT01422720|BIA|bia
1338605|NCT01422720|Partial-onset Seizures|partial-onset seizures
1338606|NCT01422694|Sacroiliitis|sacroiliitis
1338607|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
1338608|NCT01422694|Spondyloarthritis|spondyloarthritis
1338610|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
1338611|NCT01422681|COPD|copd
1338612|NCT01422668|Glycemic index|glycemic index
1338613|NCT01422668|Dates|dates
1338614|NCT01422668|Diabetes|diabetes
1338615|NCT01422668|Coffee|coffee
1338616|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
1338617|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
1338618|NCT01422616|Ischemic stroke|ischemic stroke
1338619|NCT01422616|High blood pressure|high blood pressure
1338620|NCT01422616|Thrombolysis|thrombolysis
1338621|NCT01422616|Antihypertensive drugs|antihypertensive drugs
1338622|NCT01422616|Disability|disability
1338623|NCT01422616|Clinical trial|clinical trial
1338624|NCT01422603|High risk|high risk
1338625|NCT01422603|AML|aml
1338626|NCT01422603|MDS|mds
1338627|NCT01422590|sitagliptin|sitagliptin
1338628|NCT01422590|mitiglinide|mitiglinide
1338629|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
1338630|NCT01422590|Pharmacodynamics|pharmacodynamics
1338631|NCT01422590|Safety|safety
1338632|NCT01422551|stress management intervention|stress management intervention
1338633|NCT01422551|breast cancer|breast cancer
1338634|NCT01422551|quality of life|quality of life
1338635|NCT01422551|psychosocial adaptation|psychosocial adaptation
1338636|NCT01422538|Ulthera® System|ulthera® system
1338637|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
1338638|NCT01422538|Ulthera, Inc.|ulthera, inc.
1338639|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1338640|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
1338641|NCT01422512|seasonal influenza|seasonal influenza
1338642|NCT01422512|vaccine|vaccine
1338643|NCT01422499|pediatric oncology|pediatric oncology
1338644|NCT01422499|relapsed solid tumor|relapsed solid tumor
1338645|NCT01422499|lymphoma|lymphoma
1338646|NCT01422499|leukemia|leukemia
1338647|NCT01422499|vorinostat|vorinostat
1338648|NCT01422486|Hematology|hematology
1338649|NCT01422486|MDS|mds
1338650|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
1338651|NCT01422486|Low risk MDS|low risk mds
1338652|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
1338653|NCT01422486|Int-1 risk MDS|int-1 risk mds
1338654|NCT01422486|Transfusion dependence|transfusion dependence
1338655|NCT01422486|Lenalidomide refractory|lenalidomide refractory
1338656|NCT01422486|Revlimid refractory|revlimid refractory
1338657|NCT01422486|Lenalidomide resistant|lenalidomide resistant
1338658|NCT01422486|Revlimid resistant|revlimid resistant
1338659|NCT01422486|Telintra|telintra
1338660|NCT01422486|ezatiostat|ezatiostat
1338661|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
1338662|NCT01422486|TLK199|tlk199
1338663|NCT01422486|Glutathione|glutathione
1338664|NCT01422486|Glutathione analog|glutathione analog
1338665|NCT01422486|Glutathione Transferase|glutathione transferase
1338666|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
1338667|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
1338668|NCT01422486|Apoptosis|apoptosis
1338669|NCT01422486|Differentiation|differentiation
1338670|NCT01422486|Enzyme inhibitor|enzyme inhibitor
1338671|NCT01422473|Hemorrhoids|hemorrhoids
1338672|NCT01422473|Rectal Diseases|rectal diseases
1338673|NCT01422473|Intestinal Diseases|intestinal diseases
1338674|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
1338675|NCT01422473|Digestive System Diseases|digestive system diseases
1338676|NCT01422460|Osteoarthritis|osteoarthritis
1338677|NCT01422460|PRP|prp
1338678|NCT01422460|PRGF|prgf
1338679|NCT01422447|mental health education|mental health education
1338680|NCT01422447|community-based|community-based
1338681|NCT01422434|A national|a national
1338682|NCT01422434|multi-centre|multi-centre
1338683|NCT01422434|prospective|prospective
1338684|NCT01422434|randomised|randomised
1338685|NCT01422434|double-blind|double-blind
1338686|NCT01422434|active-controlled|active-controlled
1338687|NCT01422434|3-arm|3-arm
1338688|NCT01422434|parallel group|parallel group
1338689|NCT01422434|4 week study|4 week study
1338690|NCT01422421|type 2 diabetes|type 2 diabetes
1338691|NCT01422421|coronary artery disease|coronary artery disease
1338692|NCT01422421|hypertension|hypertension
1338693|NCT01422421|dyslipidemia|dyslipidemia
1338694|NCT01422395|Vitrification|vitrification
1338695|NCT01422395|Egg Freezing|egg freezing
1338696|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
1338697|NCT01422382|Healthy Volunteers|healthy volunteers
1338698|NCT01422369|Healthy Volunteers|healthy volunteers
1338699|NCT01422356|cohort study|cohort study
1338700|NCT01422356|men who have sex with men|men who have sex with men
1338701|NCT01422343|peripheral arterial disease|peripheral arterial disease
1338702|NCT01422343|cell-derived microparticles|cell-derived microparticles
1338703|NCT01422343|immunity, innate|immunity, innate
1338704|NCT01422343|blood coagulation|blood coagulation
1338705|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
1338706|NCT01422330|TMC125IFD3002|tmc125ifd3002
1338707|NCT01422330|TMC125|tmc125
1338708|NCT01422330|Intelence|intelence
1338709|NCT01422330|HIV|hiv
1338710|NCT01422317|n-3 fatty acids|n-3 fatty acids
1338711|NCT01422317|randomized double-blind study|randomized double-blind study
1338712|NCT01422317|coronary events|coronary events
1338713|NCT01422317|serum lipids|serum lipids
1338714|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
1338715|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
1338716|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
1338717|NCT01422291|Low back pain|low back pain
1338718|NCT01422291|paracetamol|paracetamol
1338719|NCT01422291|dexketoprofen|dexketoprofen
1338720|NCT01422291|morphine|morphine
1338721|NCT01422252|Falls Elderly persons|falls elderly persons
1338722|NCT01422252|Isolated At risk for falls|isolated at risk for falls
1338723|NCT01422252|Fall detection device|fall detection device
1338724|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
1338725|NCT01422239|smoking|smoking
1338726|NCT01422239|treatment|treatment
1338727|NCT01422239|perceived risks|perceived risks
1338728|NCT01422226|IUD|iud
1338729|NCT01422226|contraception|contraception
1338730|NCT01422226|nulliparous|nulliparous
1338731|NCT01422226|women|women
1338732|NCT01422213|MDD|mdd
1338733|NCT01422213|Cognitive dysfunction|cognitive dysfunction
1338734|NCT01422200|DMD|dmd
1338735|NCT01422200|SMA|sma
1338736|NCT01422200|CMD|cmd
1338737|NCT01422200|flu vaccine|flu vaccine
1338738|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
1338739|NCT01422174|Primary prevention|primary prevention
1338740|NCT01422174|Latin America|latin america
1338741|NCT01422174|Sudden death|sudden death
1338742|NCT01422174|Myocardial infarction|myocardial infarction
1338743|NCT01422174|Ejection Fraction|ejection fraction
1338744|NCT01422174|ICD|icd
1338745|NCT01422161|Rehabilitation|rehabilitation
1338746|NCT01422161|Fingers|fingers
1338747|NCT01422161|Grasp|grasp
1338748|NCT01422161|Hand|hand
1338749|NCT01422161|Strength|strength
1338750|NCT01422161|Brain Infraction|brain infraction
1338751|NCT01422161|Pathology|pathology
1338752|NCT01422161|Physiopathology|physiopathology
1338753|NCT01422161|Functional Laterality|functional laterality
1338754|NCT01422161|Neuronal Plasticity|neuronal plasticity
1338755|NCT01422161|Psychomotor Performance|psychomotor performance
1338756|NCT01422161|Biomechanics|biomechanics
1338757|NCT01422161|Touch|touch
1338758|NCT01422161|Weight-Bearing|weight-bearing
1338759|NCT01422148|cardiac surgery|cardiac surgery
1338760|NCT01422148|atrial fibrillation|atrial fibrillation
1338761|NCT01422148|minocycline|minocycline
1338762|NCT01422148|amiodarone|amiodarone
1338763|NCT01422135|PK and safety|pk and safety
1338764|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
1338765|NCT01422122|vitamin D|vitamin d
1338766|NCT01422122|pregnancy|pregnancy
1338767|NCT01422122|periodontal health|periodontal health
1338768|NCT01422122|biomarkers|biomarkers
1338769|NCT01422109|YH14659|yh14659
1338770|NCT01422109|Aspirin|aspirin
1338771|NCT01422109|Clopidogrel|clopidogrel
1338772|NCT01422109|Yuhan|yuhan
1338773|NCT01422070|mortality|mortality
1338774|NCT01422070|intensive care|intensive care
1338775|NCT01422070|critical care|critical care
1338776|NCT01422070|intermediate care|intermediate care
1338777|NCT01422057|diabetes|diabetes
1338778|NCT01422057|coronary artery disease|coronary artery disease
1338779|NCT01422057|ischemic heart disease|ischemic heart disease
1338780|NCT01422057|autonomic function|autonomic function
1338781|NCT01422057|heart rate turbulence|heart rate turbulence
1338782|NCT01422057|deceleration capacity|deceleration capacity
1338783|NCT01422057|severe autonomic failure|severe autonomic failure
1338784|NCT01422044|aortic stenosis|aortic stenosis
1338785|NCT01422044|autonomic function|autonomic function
1338786|NCT01422031|Primary care|primary care
1338787|NCT01422031|Family doctor|family doctor
1338788|NCT01422031|Consultation|consultation
1338789|NCT01422031|utilization|utilization
1338790|NCT01422031|Non-drug managements|non-drug managements
1338791|NCT01422031|Patient enablement index|patient enablement index
1338792|NCT01422018|clinically significant macular edema|clinically significant macular edema
1338793|NCT01422018|diabetic macular edema|diabetic macular edema
1338794|NCT01422018|focal edema|focal edema
1338795|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
1338796|NCT01422018|hard exudates|hard exudates
1338797|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
1338798|NCT01422005|Rehabilitation|rehabilitation
1338799|NCT01422005|Fingers|fingers
1338800|NCT01422005|Grasp|grasp
1338801|NCT01422005|Hand|hand
1338802|NCT01422005|Strength|strength
1338803|NCT01422005|Brain Infraction|brain infraction
1338804|NCT01422005|Hand Function|hand function
1338805|NCT01422005|Post Stroke|post stroke
1338806|NCT01422005|Neural mechanisms|neural mechanisms
1338807|NCT01422005|Motor Control|motor control
1338808|NCT01422005|Motor Function|motor function
1338809|NCT01421992|randomized|randomized
1338810|NCT01421992|double-blind|double-blind
1338811|NCT01421992|crossover|crossover
1338812|NCT01421992|methylphenidate|methylphenidate
1338813|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
1338814|NCT01421966|chronic ulcers|chronic ulcers
1338815|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
1338816|NCT01421953|Positron Emission Tomography|positron emission tomography
1338817|NCT01421953|Computed Tomography|computed tomography
1338818|NCT01421953|Lung cancer|lung cancer
1338819|NCT01421940|Udenafil|udenafil
1338820|NCT01421940|rectal cancer|rectal cancer
1338821|NCT01421940|penile rehabilitation|penile rehabilitation
1338822|NCT01421940|total mesorectal excision|total mesorectal excision
1338823|NCT01421927|lenalidomide|lenalidomide
1338824|NCT01421914|Ultrasound|ultrasound
1338825|NCT01421914|Axillary block|axillary block
1338826|NCT01421914|Bupivacaine|bupivacaine
1338827|NCT01421914|Minimum|minimum
1338828|NCT01421914|Volume|volume
1338829|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
1338830|NCT01421901|Acute appendicitis|acute appendicitis
1338831|NCT01421901|Surgery|surgery
1338832|NCT01421901|Antibiotics|antibiotics
1338833|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
1338834|NCT01421901|resolutions of symptoms|resolutions of symptoms
1338835|NCT01421888|Immunity|immunity
1338836|NCT01421888|Urea Cycle Disorder|urea cycle disorder
1338837|NCT01421888|Nutrition|nutrition
1338838|NCT01421888|Vaccination|vaccination
1338839|NCT01421888|Influenza|influenza
1338840|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1338841|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1338842|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1338843|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1338844|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1338845|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1338846|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1338847|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1338848|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1338849|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1338850|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1338851|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1338852|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1338853|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1338854|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1338855|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
1338856|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1338857|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1338858|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1338859|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1338860|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1338861|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1338862|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1338863|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1338864|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1338865|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1338866|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1338867|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1338868|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1338869|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1338870|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1338871|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1338872|NCT01421849|single implant denture|single implant denture
1338873|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
1338874|NCT01421836|stent patency|stent patency
1338875|NCT01421836|EUS guided insertion|eus guided insertion
1338876|NCT01421836|ERCP guided insertion|ercp guided insertion
1338877|NCT01421823|Fecal Incontinence|fecal incontinence
1338878|NCT01421823|Alpha agonist|alpha agonist
1338879|NCT01421732|Dengue fever|dengue fever
1338880|NCT01421732|severe dengue fever|severe dengue fever
1338881|NCT01421732|NS1 detection assay|ns1 detection assay
1338882|NCT01421732|Prognosis|prognosis
1338883|NCT01421732|Diagnosis|diagnosis
1338884|NCT01421719|Parkinson's Disease|parkinson's disease
1338885|NCT01421719|Neurogenic Bladder|neurogenic bladder
1338886|NCT01421719|Urinary Incontinence|urinary incontinence
1338887|NCT01421719|botulinum toxin|botulinum toxin
1338888|NCT01421719|cystoscopy|cystoscopy
1338889|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
1338890|NCT01421706|clarithromycin|clarithromycin
1338891|NCT01421706|sibutramine|sibutramine
1338892|NCT01421706|clopidogrel|clopidogrel
1338893|NCT01421693|Gatifloxacin|gatifloxacin
1338894|NCT01421693|Ceftriaxone|ceftriaxone
1338895|NCT01421693|Enteric fever|enteric fever
1338896|NCT01421693|Typhoid fever|typhoid fever
1338897|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1338898|NCT01421667|Antigens, CD30|antigens, cd30
1338899|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
1338900|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
1338901|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1338902|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
1338903|NCT01421667|Drug Therapy|drug therapy
1338904|NCT01421667|Immunotherapy|immunotherapy
1338905|NCT01421667|Hematologic Diseases|hematologic diseases
1338906|NCT01421667|Lymphoma|lymphoma
1338907|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
1338908|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
1338909|NCT01421654|OSA|osa
1338910|NCT01421654|Sleep Apnea|sleep apnea
1338911|NCT01421654|PAP|pap
1338912|NCT01421654|positive airway pressure|positive airway pressure
1338913|NCT01421641|Tenaculum|tenaculum
1338914|NCT01421641|Pain|pain
1338915|NCT01421641|Lidocaine|lidocaine
1338916|NCT01421628|older adults|older adults
1338917|NCT01421628|exercise|exercise
1338918|NCT01421628|stretching|stretching
1338919|NCT01421628|mobility|mobility
1338920|NCT01421615|Bacterial vaginosis|bacterial vaginosis
1338921|NCT01421615|Probiotics|probiotics
1338922|NCT01421615|Lactobacilli|lactobacilli
1338923|NCT01421615|Pregnancy outcome|pregnancy outcome
1338924|NCT01421615|Randomized controlled trial|randomized controlled trial
1338925|NCT01421602|Inguinal Hernia|inguinal hernia
1338926|NCT01421602|Self-fixating mesh|self-fixating mesh
1338927|NCT01421602|Progrip|progrip
1338928|NCT01421602|Hernia Recurrence|hernia recurrence
1338929|NCT01421602|Mesh, Surgical|mesh, surgical
1338930|NCT01421602|Recurrence|recurrence
1338931|NCT01421589|Growth hormone|growth hormone
1338932|NCT01421589|GH|gh
1338933|NCT01421589|Obesity|obesity
1338934|NCT01421589|Mitochondrial function|mitochondrial function
1338935|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
1338936|NCT01421550|umbilical|umbilical
1338937|NCT01421550|hernia|hernia
1338938|NCT01421550|cirrhosis|cirrhosis
1338939|NCT01421550|ascites|ascites
1338940|NCT01421550|conservative|conservative
1338941|NCT01421550|surgery|surgery
1338942|NCT01421550|optimal management|optimal management
1338943|NCT01421537|Thromboprophylaxis|thromboprophylaxis
1338944|NCT01421537|enoxaparin|enoxaparin
1338945|NCT01421524|Neoplasm|neoplasm
1338946|NCT01421524|Malignancy|malignancy
1338947|NCT01421524|Carcinoma|carcinoma
1338948|NCT01421524|Lymphoma|lymphoma
1338949|NCT01421524|Multiple Myeloma|multiple myeloma
1338950|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
1338951|NCT01421524|Advanced Solid Tumors|advanced solid tumors
1338952|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
1338953|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
1338954|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1338955|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
1338956|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
1338957|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
1338958|NCT01421511|ABSSSI|absssi
1338959|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
1338960|NCT01421511|TR-701|tr-701
1338961|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
1338962|NCT01421498|Dry Eye|dry eye
1338963|NCT01421498|ophthalmic delivery|ophthalmic delivery
1338964|NCT01421472|Breast Cancer|breast cancer
1338965|NCT01421472|Neoadjuvant|neoadjuvant
1338966|NCT01421472|Her2 negative|her2 negative
1338967|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
1338968|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
1338969|NCT01421472|Triple Negative|triple negative
1338970|NCT01421472|MM-121|mm-121
1338971|NCT01421472|Paclitaxel|paclitaxel
1338972|NCT01421459|Diabetes|diabetes
1338973|NCT01421459|Type 2 Diabetes|type 2 diabetes
1338974|NCT01421446|Neuropsychology|neuropsychology
1338975|NCT01421433|Clonixin|clonixin
1338976|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1338977|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
1338978|NCT01421433|Lysine|lysine
1338979|NCT01421433|L-Lysine|l-lysine
1338980|NCT01421433|Lysine Acetate|lysine acetate
1338981|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
1338982|NCT01421433|Amitriptyline|amitriptyline
1338983|NCT01421420|Alzheimer's|alzheimer's
1338984|NCT01421420|Dementia|dementia
1338985|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
1338986|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
1338987|NCT01421407|End stage renal disease|end stage renal disease
1338988|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
1338989|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
1338990|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
1338991|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
1338992|NCT01421394|tractography|tractography
1338993|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
1338994|NCT01421381|idebenone|idebenone
1338995|NCT01421342|Mood Disorder|mood disorder
1338996|NCT01421342|Depression|depression
1338997|NCT01421342|Depressive Disorder|depressive disorder
1338998|NCT01421342|Depressive Disorder, Major|depressive disorder, major
1338999|NCT01421342|Bupropion|bupropion
1339000|NCT01421342|Aripiprazole|aripiprazole
1339001|NCT01421342|Remission|remission
1339002|NCT01421342|Relapse|relapse
1339003|NCT01421342|Cost-Effectiveness|cost-effectiveness
1339004|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
1339005|NCT01421342|Antidepressant|antidepressant
1339006|NCT01421342|Augmentation|augmentation
1339007|NCT01421342|Veterans|veterans
1339008|NCT01421342|Mental Health|mental health
1339009|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
1339010|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
1339011|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
1339012|NCT01421264|concussion|concussion
1339013|NCT01421264|gabapentin|gabapentin
1339014|NCT01421264|neurontin|neurontin
1339015|NCT01421264|insomnia|insomnia
1339016|NCT01421251|H1N1|h1n1
1339017|NCT01421251|Flu|flu
1339018|NCT01421251|Influenza|influenza
1339019|NCT01421251|Vaccine|vaccine
1339020|NCT01421251|Manitoba|manitoba
1339021|NCT01421251|Canada|canada
1339022|NCT01421251|Safety|safety
1339023|NCT01421238|Decision Making|decision making
1339024|NCT01421238|Premature infant|premature infant
1339025|NCT01421238|Informed consent|informed consent
1339026|NCT01421238|Prematurity|prematurity
1339028|NCT01421238|Negotiation Model|negotiation model
1339029|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
1339030|NCT01421225|Diabetes|diabetes
1339031|NCT01421225|Type 1 Diabetes|type 1 diabetes
1339032|NCT01421225|Artificial pancreas|artificial pancreas
1339033|NCT01421212|Liver Transplantation|liver transplantation
1339034|NCT01421212|Liver Disease|liver disease
1339035|NCT01421212|Hepatitis B|hepatitis b
1339036|NCT01421212|Hepatitis B Infection|hepatitis b infection
1339037|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
1339039|NCT01421199|Otitis Media with Effusion|otitis media with effusion
1339040|NCT01421199|Middle Ear Effusion|middle ear effusion
1339041|NCT01421186|Multiple Myeloma|multiple myeloma
1339042|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
1339043|NCT01421186|Lenalidomide|lenalidomide
1339044|NCT01421186|Pomalidomide|pomalidomide
1339045|NCT01421186|CD38|cd38
1339046|NCT01421173|Lymphoma|lymphoma
1339047|NCT01421173|Lymphoid malignancies|lymphoid malignancies
1339048|NCT01421173|Relapsed|relapsed
1339049|NCT01421173|Refractory|refractory
1339050|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
1339051|NCT01421173|Stem cell infusion|stem cell infusion
1339052|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
1339053|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1339054|NCT01421173|Vorinostat|vorinostat
1339055|NCT01421173|SAHA|saha
1339056|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1339057|NCT01421173|MSK-390|msk-390
1339058|NCT01421173|Zolinza|zolinza
1339059|NCT01421173|Busulfan|busulfan
1339060|NCT01421173|Busulfex|busulfex
1339061|NCT01421173|Myleran|myleran
1339062|NCT01421173|Gemcitabine|gemcitabine
1339063|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1339064|NCT01421173|Gemzar|gemzar
1339065|NCT01421173|Melphalan|melphalan
1339066|NCT01421173|Alkeran|alkeran
1339067|NCT01421173|Rituximab|rituximab
1339068|NCT01421173|Rituxan|rituxan
1339069|NCT01421173|Dexamethasone|dexamethasone
1339070|NCT01421173|Decadron|decadron
1339071|NCT01421173|G-CSF|g-csf
1339072|NCT01421173|Filgrastim|filgrastim
1339073|NCT01421173|NeupogenTM|neupogentm
1339074|NCT01421173|Palifermin|palifermin
1339075|NCT01421173|Kepivance|kepivance
1339076|NCT01421160|Chronic|chronic
1339077|NCT01421160|Inflammatory|inflammatory
1339078|NCT01421160|Joint|joint
1339079|NCT01421160|Pain|pain
1339080|NCT01421147|Diabetes|diabetes
1339081|NCT01421147|Type 1 Diabetes|type 1 diabetes
1339082|NCT01421147|Diabetes Mellitus|diabetes mellitus
1339083|NCT01421134|depression|depression
1339084|NCT01421134|Lurasidone|lurasidone
1339085|NCT01421134|Latuda|latuda
1339086|NCT01421108|oral health|oral health
1339087|NCT01421108|dental brushing|dental brushing
1339088|NCT01421108|dental flossing|dental flossing
1339089|NCT01421095|Fertility|fertility
1339090|NCT01421095|adolescent|adolescent
1339091|NCT01421095|young adult|young adult
1339092|NCT01421095|cancer survivors|cancer survivors
1339093|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
1339094|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
1339095|NCT01421082|Emphysema|emphysema
1339096|NCT01421082|coil|coil
1339097|NCT01421082|RePneu|repneu
1339098|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
1339099|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
1339100|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
1339101|NCT01421043|bioequivalence study|bioequivalence study
1339102|NCT01421043|triazolam|triazolam
1339103|NCT01421043|liquid oral drops|liquid oral drops
1339104|NCT01421043|tablet|tablet
1339105|NCT01421030|quality of life|quality of life
1339106|NCT01421030|congenital heart disease|congenital heart disease
1339107|NCT01421030|open heart surgery|open heart surgery
1339108|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
1339109|NCT01421030|costs|costs
1339110|NCT01421017|radiation therapy|radiation therapy
1339111|NCT01421017|combination therapy|combination therapy
1339112|NCT01421017|immunotherapy|immunotherapy
1339113|NCT01421017|immune response modifier|immune response modifier
1339114|NCT01421017|immunostimulatory|immunostimulatory
1339115|NCT01421017|immunomodulator|immunomodulator
1339116|NCT01421004|cancer|cancer
1339117|NCT01421004|tumors|tumors
1339118|NCT01421004|phase I|phase i
1339119|NCT01421004|crossover|crossover
1339120|NCT01421004|bioequivalence|bioequivalence
1339121|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
1339122|NCT01420965|Vaccine|vaccine
1339123|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
1339124|NCT01420965|Prostate Cancer|prostate cancer
1339125|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
1339126|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
1339127|NCT01420952|Brain|brain
1339129|NCT01420939|Brain|brain
1339130|NCT01420939|Traumatic Brain Injury|traumatic brain injury
1339131|NCT01420939|Biomarkers|biomarkers
1339132|NCT01420939|Healthy Volunteer|healthy volunteer
1339133|NCT01420939|HV|hv
1339134|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
1339135|NCT01420887|CPM|cpm
1339136|NCT01420887|elbow joint surgery|elbow joint surgery
1339137|NCT01420887|continuous passive motion|continuous passive motion
1339138|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
1339139|NCT01420861|castrate resistant|castrate resistant
1339140|NCT01420848|stress disorders|stress disorders
1339141|NCT01420848|anxiety disorders|anxiety disorders
1339143|NCT01420835|Quality of life|quality of life
1339144|NCT01420796|Parkinson's disease|parkinson's disease
1339145|NCT01420796|dysphagia|dysphagia
1339146|NCT01420796|swallowing treatment|swallowing treatment
1339147|NCT01420757|operation time|operation time
1339148|NCT01420757|length of hospital stay|length of hospital stay
1339149|NCT01420744|Endotracheal ventilation|endotracheal ventilation
1339150|NCT01420744|Bacterial pneumonia|bacterial pneumonia
1339151|NCT01420731|sexual life, back pain|sexual life, back pain
1339152|NCT01420718|partial pulpotomy|partial pulpotomy
1339153|NCT01420718|Cvek pulpotomy|cvek pulpotomy
1339154|NCT01420718|MTA|mta
1339155|NCT01420718|iRootBP|irootbp
1339156|NCT01420718|dentin bridge|dentin bridge
1339157|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
1339158|NCT01420705|DTP|dtp
1339159|NCT01420705|Vaccination|vaccination
1339160|NCT01420705|Allergy|allergy
1339161|NCT01420705|Atopy|atopy
1339162|NCT01420705|Guinea-Bissau|guinea-bissau
1339163|NCT01420692|Tip 2 DM|tip 2 dm
1339164|NCT01420692|Endothelium|endothelium
1339165|NCT01420692|Gliclazide|gliclazide
1339166|NCT01420692|Insulin detemir|insulin detemir
1339167|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
1339168|NCT01420679|Lymphoma|lymphoma
1339169|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1339170|NCT01420679|T-cell Lymphoma|t-cell lymphoma
1339171|NCT01420640|Fibromyalgia|fibromyalgia
1339172|NCT01420640|Tai Chi|tai chi
1339173|NCT01420640|mind-body exercise|mind-body exercise
1339174|NCT01420640|aerobic exercise|aerobic exercise
1339175|NCT01420640|exercise|exercise
1339176|NCT01420640|pain|pain
1339177|NCT01420614|radial access|radial access
1339178|NCT01420614|primary angioplasty|primary angioplasty
1339179|NCT01420614|trial|trial
1339180|NCT01420614|randomization|randomization
1339181|NCT01420614|outcome|outcome
1339182|NCT01420601|Torisel|torisel
1339183|NCT01420601|Long-term use|long-term use
1339184|NCT01420601|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1339185|NCT01420588|Oncologic Investigations|oncologic investigations
1339186|NCT01420588|Gastric Diseases|gastric diseases
1339187|NCT01420588|Gastric Cancer|gastric cancer
1451288|NCT00961311|PCI|pci
1339188|NCT01420588|Gastric Ulcer|gastric ulcer
1339189|NCT01420588|Breath Analysis|breath analysis
1339190|NCT01420588|Volatile Biomarkers|volatile biomarkers
1339191|NCT01420588|Nanosensors Array|nanosensors array
1339192|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
1339193|NCT01420588|GC-MS|gc-ms
1339194|NCT01420588|Breath Tests|breath tests
1339195|NCT01420575|Schizophrenia|schizophrenia
1339196|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
1339197|NCT01420575|Shared Decision|shared decision
1339198|NCT01420575|Decision Aid|decision aid
1339199|NCT01420575|Antipsychotic|antipsychotic
1339200|NCT01420575|Weight Gain|weight gain
1339201|NCT01420575|Olanzapine|olanzapine
1339202|NCT01420575|Lexapro|lexapro
1339203|NCT01420575|Perphenazine|perphenazine
1339204|NCT01420562|allogeneic HSCT|allogeneic hsct
1339205|NCT01420562|posaconazole|posaconazole
1339206|NCT01420562|prophylaxis|prophylaxis
1339207|NCT01420562|mucositis|mucositis
1339208|NCT01420562|pharmacokinetics|pharmacokinetics
1339209|NCT01420549|Hypercholesterolemia|hypercholesterolemia
1339210|NCT01420549|Dyslipidemia|dyslipidemia
1339211|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
1339212|NCT01420536|Canine Guidance|canine guidance
1339213|NCT01420536|Complete Denture|complete denture
1339214|NCT01420536|Denture Retention|denture retention
1339215|NCT01420536|Dental Occlusion|dental occlusion
1339216|NCT01420536|Edentulous|edentulous
1339217|NCT01420536|Edentulism|edentulism
1339218|NCT01420536|Mandibular movement|mandibular movement
1339219|NCT01420536|Mastication|mastication
1339220|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
1339221|NCT01420536|Patient Satisfaction|patient satisfaction
1339222|NCT01420523|HIV|hiv
1339223|NCT01420523|Lipohypertrophy|lipohypertrophy
1339224|NCT01420510|Patients satisfaction|patients satisfaction
1339225|NCT01420510|Side effects|side effects
1339226|NCT01420497|methylprednisolone|methylprednisolone
1339227|NCT01420497|intra articular infiltration|intra articular infiltration
1339228|NCT01420497|glycemia|glycemia
1339229|NCT01420497|epidural infiltration|epidural infiltration
1339230|NCT01420497|diabetes|diabetes
1339231|NCT01420484|CNAP|cnap
1339232|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
1339233|NCT01420484|IAP|iap
1339234|NCT01420484|blood pressure|blood pressure
1339235|NCT01420484|analgosedation|analgosedation
1339236|NCT01420484|high-risk patients|high-risk patients
1339237|NCT01420484|rapid-pacing|rapid-pacing
1339238|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
1339239|NCT01420471|Triamcinolone|triamcinolone
1339240|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
1339241|NCT01420458|bioequivalence|bioequivalence
1339242|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
1339243|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
1339244|NCT01420432|Transplantation|transplantation
1339245|NCT01420419|nipple pain|nipple pain
1339246|NCT01420419|breastfeeding|breastfeeding
1339247|NCT01420419|nipple damage|nipple damage
1339248|NCT01420419|lanolin|lanolin
1339249|NCT01420419|clinical trial|clinical trial
1339250|NCT01420406|lactation|lactation
1339251|NCT01420406|cryptoxanthin|cryptoxanthin
1339252|NCT01420406|beta-carotene|beta-carotene
1339253|NCT01420406|vitamin A|vitamin a
1339254|NCT01420393|Heart Failure|heart failure
1339255|NCT01420393|Atrial Fibrillation|atrial fibrillation
1339256|NCT01420393|Catheter Ablation|catheter ablation
1339257|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
1339258|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
1339259|NCT01420367|Paediatric|paediatric
1339260|NCT01420367|Simple|simple
1339261|NCT01420367|Non-perforated|non-perforated
1339262|NCT01420354|Metabolic stones|metabolic stones
1339263|NCT01420354|kidney stones|kidney stones
1339264|NCT01420354|renal calculi|renal calculi
1339265|NCT01420354|metabolic evaluation|metabolic evaluation
1339266|NCT01420341|Meliodosis|meliodosis
1339267|NCT01420341|Co-trimoxazole|co-trimoxazole
1339268|NCT01420341|Relapse|relapse
1339269|NCT01420315|vitamin D|vitamin d
1339270|NCT01420315|deficiency|deficiency
1339271|NCT01420315|alzheimer's disease|alzheimer's disease
1339272|NCT01420302|critical illness|critical illness
1339273|NCT01420302|intensive care|intensive care
1339274|NCT01420302|insulin|insulin
1339275|NCT01420302|glucose|glucose
1339276|NCT01420302|algorithm|algorithm
1339277|NCT01420302|blood glucose control|blood glucose control
1339278|NCT01420289|Ischemic ulcers|ischemic ulcers
1339279|NCT01420289|PAD|pad
1339280|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
1339281|NCT01420276|Female sexual function|female sexual function
1339282|NCT01420263|premature infant|premature infant
1339283|NCT01420263|feeding|feeding
1339284|NCT01420263|residuals|residuals
1339285|NCT01420263|fresh feeds|fresh feeds
1339286|NCT01420263|full feeds|full feeds
1339287|NCT01420263|digestive system|digestive system
1339288|NCT01420250|Prostate cancer|prostate cancer
1451411|NCT00960804|OA|oa
1339289|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1339290|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
1339291|NCT01420224|Air travel|air travel
1339292|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
1339293|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
1339294|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
1339295|NCT01420224|Pulmonary hypertension|pulmonary hypertension
1339296|NCT01420211|pharmacokinetics|pharmacokinetics
1339297|NCT01420211|MRI|mri
1339298|NCT01420211|liver|liver
1339299|NCT01420211|drug transporter|drug transporter
1339300|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
1339301|NCT01420198|Diabetes type 2|diabetes type 2
1339302|NCT01420198|Lifestyle intervention|lifestyle intervention
1339303|NCT01420198|QALY|qaly
1339304|NCT01420198|Ethnic group|ethnic group
1339305|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
1339306|NCT01420198|Impaired fasting glucose|impaired fasting glucose
1339307|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1339308|NCT01420185|stage II breast cancer|stage ii breast cancer
1339309|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
1339310|NCT01420159|Pain|pain
1339311|NCT01420159|Trauma|trauma
1339312|NCT01420159|Analgesia|analgesia
1339313|NCT01420133|Corticosteroids|corticosteroids
1339314|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
1339315|NCT01420133|Dermatological disease|dermatological disease
1339316|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
1339317|NCT01420133|3 Months|3 months
1339318|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
1339319|NCT01420107|Infant, Premature|infant, premature
1339320|NCT01420107|Delivery Rooms|delivery rooms
1339321|NCT01420107|Video Recording|video recording
1339322|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
1339323|NCT01420094|Drugs, Investigational|drugs, investigational
1339324|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
1339325|NCT01420094|Aspirin|aspirin
1339326|NCT01420094|dental pain|dental pain
1339327|NCT01420081|uterine neoplasms|uterine neoplasms
1339328|NCT01420081|endometrial|endometrial
1339329|NCT01420081|uterine|uterine
1339330|NCT01420081|cancer|cancer
1339331|NCT01420081|PI3K|pi3k
1339332|NCT01420081|mTOR|mtor
1339333|NCT01420081|PI3K/mTOR|pi3k/mtor
1339334|NCT01420081|recurrent|recurrent
1339335|NCT01420081|metastatic|metastatic
1339336|NCT01420068|Pediatric|pediatric
1339337|NCT01420068|hypertension|hypertension
1339338|NCT01420068|aliskiren|aliskiren
1339339|NCT01420055|Multiple sclerosis|multiple sclerosis
1339340|NCT01420055|Fingolimod|fingolimod
1339341|NCT01420055|Coping|coping
1339342|NCT01420055|Anxiety|anxiety
1339343|NCT01420055|France|france
1339344|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
1339345|NCT01420055|Active|active
1339346|NCT01420029|Low birth weight neonates|low birth weight neonates
1339347|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
1339348|NCT01420029|Thyroid dysfunction|thyroid dysfunction
1339349|NCT01420029|Extrauterine growth|extrauterine growth
1339350|NCT01420029|Plasticizers|plasticizers
1339351|NCT01420016|Cardiovascular risk|cardiovascular risk
1339352|NCT01420003|Allergen Challenge|allergen challenge
1339353|NCT01420003|B cell activation|b cell activation
1339354|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
1339355|NCT01419977|sickle cell disease|sickle cell disease
1339356|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
1339357|NCT01419977|anticoagulation|anticoagulation
1339358|NCT01419964|Vitiligo|vitiligo
1339359|NCT01419964|Macular depigmentation|macular depigmentation
1339360|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
1339361|NCT01419951|Behavioral treatment|behavioral treatment
1339362|NCT01419951|Preschool aged children|preschool aged children
1339363|NCT01419951|Obesity|obesity
1339364|NCT01419938|Light therapy|light therapy
1339365|NCT01419938|circadian rhythm|circadian rhythm
1339366|NCT01419938|CBT|cbt
1339367|NCT01419925|influenza vaccine|influenza vaccine
1339368|NCT01419925|peptide|peptide
1339369|NCT01419925|universal|universal
1339370|NCT01419925|prime|prime
1339371|NCT01419925|boost|boost
1339372|NCT01419925|TIV|tiv
1339373|NCT01419925|HAI|hai
1339374|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
1339375|NCT01419925|elderly|elderly
1339376|NCT01419899|Brief intervention|brief intervention
1339377|NCT01419899|Rapid testing|rapid testing
1339378|NCT01419873|Hyperglycaemia|hyperglycaemia
1339379|NCT01419873|Very low birthweight infants|very low birthweight infants
1339380|NCT01419873|Insulin|insulin
1339381|NCT01419860|Microcirculation|microcirculation
1339382|NCT01419860|Colon|colon
1339383|NCT01419860|Anastomosis|anastomosis
1339384|NCT01419860|ICG|icg
1339385|NCT01419860|Gastro surgery|gastro surgery
1339386|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
1339387|NCT01419834|CNS|cns
1451538|NCT00960349|S-1|s-1
1339388|NCT01419834|Brain|brain
1339389|NCT01419834|MAB 3F8|mab 3f8
1339390|NCT01419834|Hu3F8|hu3f8
1339391|NCT01419834|11-009|11-009
1339392|NCT01419821|Vitamin D|vitamin d
1339393|NCT01419821|Bone densitometry|bone densitometry
1339394|NCT01419821|Vitamin D supplementation|vitamin d supplementation
1339395|NCT01419821|Growth|growth
1339396|NCT01419808|Scaphoid|scaphoid
1339397|NCT01419808|Non-Union|non-union
1339398|NCT01419808|Proximal pole|proximal pole
1339399|NCT01419808|Bone Graft|bone graft
1339400|NCT01419808|Vascularized|vascularized
1339401|NCT01419808|Non-Vascularized|non-vascularized
1339402|NCT01419808|PREE|pree
1339403|NCT01419782|bone|bone
1339404|NCT01419782|osteocyte|osteocyte
1339405|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
1339406|NCT01419782|whole-body vibration|whole-body vibration
1339407|NCT01419782|sclerostin|sclerostin
1339408|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
1339409|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
1339410|NCT01419769|transluminal drainage|transluminal drainage
1339411|NCT01419769|minimally invasive|minimally invasive
1339412|NCT01419769|Nitinol stent|nitinol stent
1339413|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
1339414|NCT01419769|catheter based|catheter based
1339415|NCT01419743|Vitamin D deficiency|vitamin d deficiency
1339416|NCT01419743|Supplementation|supplementation
1339417|NCT01419743|Infertility|infertility
1339418|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
1339419|NCT01419717|cancer|cancer
1339420|NCT01419717|bone metastases|bone metastases
1339421|NCT01419717|breast cancer|breast cancer
1339422|NCT01419717|prostate cancer|prostate cancer
1339423|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
1339424|NCT01419704|chimerism|chimerism
1339425|NCT01419704|sickle cell|sickle cell
1339426|NCT01419704|thalassemia|thalassemia
1339427|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
1339428|NCT01419691|auranofin|auranofin
1339429|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1339430|NCT01419691|relapsed|relapsed
1339431|NCT01419691|refractory|refractory
1339432|NCT01419691|CLL|cll
1339433|NCT01419691|SLL|sll
1339434|NCT01419691|PLL|pll
1339435|NCT01419678|posaconazole|posaconazole
1339436|NCT01419678|PK blood sampling|pk blood sampling
1339437|NCT01419665|Follicular Lymphoma|follicular lymphoma
1339438|NCT01419665|Biosimilar|biosimilar
1339439|NCT01419665|GP13-301|gp13-301
1339440|NCT01419665|rituximab|rituximab
1339441|NCT01419665|Antibodies|antibodies
1339442|NCT01419665|CD20|cd20
1339443|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
1339444|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
1339538|NCT01419327|Fosrenol|fosrenol
1339445|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
1339446|NCT01419639|meningiomas|meningiomas
1339447|NCT01419639|ependymomas|ependymomas
1339448|NCT01419613|healthy lifestyle|healthy lifestyle
1339449|NCT01419613|physical activity|physical activity
1339450|NCT01419613|behavior|behavior
1339451|NCT01419613|motivational|motivational
1339452|NCT01419613|interview|interview
1339453|NCT01419613|breast cancer survivor|breast cancer survivor
1339454|NCT01419600|Phase 1|phase 1
1339455|NCT01419600|healthy volunteers|healthy volunteers
1339456|NCT01419600|safety|safety
1339457|NCT01419600|tolerability|tolerability
1339458|NCT01419600|pharmacokinetics|pharmacokinetics
1339459|NCT01419600|single ascending dose study|single ascending dose study
1339460|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1339461|NCT01419587|Non small cell lung cancer|non small cell lung cancer
1339462|NCT01419587|NSCLC|nsclc
1339463|NCT01419587|Ketogenic Diet|ketogenic diet
1339464|NCT01419587|radiotherapy|radiotherapy
1339465|NCT01419587|paclitaxel|paclitaxel
1339466|NCT01419587|carboplatin|carboplatin
1339467|NCT01419574|Carotid Artery Plaque|carotid artery plaque
1339468|NCT01419574|Contrast Agents|contrast agents
1339469|NCT01419574|Vasa Vasorum|vasa vasorum
1339470|NCT01419574|MRI|mri
1339471|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
1339472|NCT01419574|Solid Tumor|solid tumor
1339473|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
1339474|NCT01419561|KSHV|kshv
1339475|NCT01419561|KICS|kics
1339476|NCT01419561|HIV|hiv
1339477|NCT01419561|Cytokines|cytokines
1339478|NCT01419561|HHV-8|hhv-8
1339479|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
1339480|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
1339481|NCT01419548|ABT-888|abt-888
1339482|NCT01419548|Liver Dysfunction|liver dysfunction
1339483|NCT01419548|Kidney Dysfunction|kidney dysfunction
1339484|NCT01419548|PARP Inhibitor|parp inhibitor
1339485|NCT01419548|Pharmacokinetics|pharmacokinetics
1339486|NCT01419548|Cancer|cancer
1339487|NCT01419535|Metabolism|metabolism
1339488|NCT01419535|Cortisol|cortisol
1339489|NCT01419535|Hypercortisolism|hypercortisolism
1339490|NCT01419535|Glucose Intolerance|glucose intolerance
1339491|NCT01419522|Traumatic Brain Injury|traumatic brain injury
1339492|NCT01419522|Walking Impairment|walking impairment
1339581|NCT01419184|Antibiotics|antibiotics
1339493|NCT01419522|Gait Training|gait training
1339495|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1339496|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1339497|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1339498|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
1339499|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
1339500|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1339501|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1339502|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1339503|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1339504|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1339505|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1339506|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1339507|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1339508|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1339509|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1339510|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
1339511|NCT01419483|Pancreatic cancer|pancreatic cancer
1339512|NCT01419483|Ketogenic Diet|ketogenic diet
1339513|NCT01419483|radiotherapy|radiotherapy
1339514|NCT01419483|gemcitabine|gemcitabine
1339515|NCT01419457|Healthy|healthy
1339516|NCT01419457|hepatic impairment|hepatic impairment
1339517|NCT01419457|T-705a|t-705a
1339518|NCT01419457|Favipiravir|favipiravir
1339519|NCT01419444|Voice|voice
1339520|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
1339521|NCT01419444|Hyperfunction|hyperfunction
1339522|NCT01419444|Treatment|treatment
1339523|NCT01419431|Colon cancer|colon cancer
1339524|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
1339525|NCT01419418|Qualitative analysis|qualitative analysis
1339526|NCT01419418|Patients' perspective|patients' perspective
1339527|NCT01419405|analgesia|analgesia
1339528|NCT01419405|acute experimental pain|acute experimental pain
1339529|NCT01419405|cold pressor test|cold pressor test
1339530|NCT01419405|pregabalin|pregabalin
1339531|NCT01419405|remifentanil|remifentanil
1339532|NCT01419392|sildenafil citrate|sildenafil citrate
1339533|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
1339534|NCT01419392|nitric oxide|nitric oxide
1339535|NCT01419392|total antioxidant capacity|total antioxidant capacity
1339536|NCT01419379|COPD exacerbation rate|copd exacerbation rate
1339537|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
1339539|NCT01419327|Hyperphosphatemia|hyperphosphatemia
1339540|NCT01419327|Hemodialysis|hemodialysis
1339541|NCT01419314|Physical Therapy|physical therapy
1339542|NCT01419314|Splint|splint
1339543|NCT01419314|Sleep|sleep
1339544|NCT01419314|Pain|pain
1339545|NCT01419314|6 min walk|6 min walk
1339546|NCT01419314|forward reach|forward reach
1339547|NCT01419314|Function|function
1339548|NCT01419301|multiple sclerosis|multiple sclerosis
1339549|NCT01419301|glatiramer acetate|glatiramer acetate
1339550|NCT01419301|stress reduction|stress reduction
1339551|NCT01419301|medication adherence|medication adherence
1339552|NCT01419288|Amputees|amputees
1339553|NCT01419262|Vitamin D|vitamin d
1339554|NCT01419262|Randomized Controlled Trial|randomized controlled trial
1339555|NCT01419262|Child, Preschool|child, preschool
1339556|NCT01419262|Dietary Supplements|dietary supplements
1339557|NCT01419262|Respiratory Tract Infections|respiratory tract infections
1339558|NCT01419262|Asthma|asthma
1339559|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
1339560|NCT01419249|Turner syndrome|turner syndrome
1339561|NCT01419249|Pharmacogenetics|pharmacogenetics
1339562|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
1339563|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
1339564|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
1339565|NCT01419236|Sexual Dysfunction|sexual dysfunction
1339566|NCT01419236|Climax Dysfunction|climax dysfunction
1339567|NCT01419236|Erectile Dysfunction|erectile dysfunction
1339568|NCT01419236|Impotence|impotence
1339569|NCT01419236|Hypogonadism|hypogonadism
1339570|NCT01419236|Low testosterone|low testosterone
1339571|NCT01419236|Low t|low t
1339572|NCT01419223|Qualitative research|qualitative research
1339573|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1339574|NCT01419223|Refusal to Participate|refusal to participate
1339575|NCT01419210|Complementary Medicine|complementary medicine
1339576|NCT01419210|Traditional Medicine|traditional medicine
1567108|NCT00510042|national study|national study
1451794|NCT00959257|Asthma|asthma
1339577|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
1339578|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1339579|NCT01419184|Daptomycin|daptomycin
1339580|NCT01419184|Vancomycin|vancomycin
1339582|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
1339583|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1339584|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1339585|NCT01419145|cachexia|cachexia
1339586|NCT01419145|neoplasms|neoplasms
1339587|NCT01419145|complications|complications
1339588|NCT01419145|combined modality therapy|combined modality therapy
1339589|NCT01419145|exercise therapy|exercise therapy
1339590|NCT01419145|diet therapy|diet therapy
1339591|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
1339592|NCT01419132|furosemide|furosemide
1339593|NCT01419132|hypertonic saline solution|hypertonic saline solution
1339594|NCT01419132|troponin I|troponin i
1339595|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
1339596|NCT01419119|Cholecalciferol|cholecalciferol
1339597|NCT01419119|D3|d3
1339598|NCT01419119|Parathyroid Hormone|parathyroid hormone
1339599|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
1339600|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
1339601|NCT01419119|Vitamin D|vitamin d
1339602|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
1339603|NCT01419119|Pharmacologic treatment|pharmacologic treatment
1339604|NCT01419106|Hypotension|hypotension
1339605|NCT01419106|Emergency care|emergency care
1339606|NCT01419106|Point of care Ultrasound|point of care ultrasound
1339607|NCT01419106|Shock|shock
1339608|NCT01419093|Physical Activity|physical activity
1339609|NCT01419093|Exercise|exercise
1339610|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
1339611|NCT01419080|Quality of Life|quality of life
1339612|NCT01419080|Quality of Care|quality of care
1339613|NCT01419067|Proton Therapy|proton therapy
1339614|NCT01419067|Radical resection|radical resection
1339615|NCT01419041|renal impairment|renal impairment
1339616|NCT01419041|crizotinib|crizotinib
1339617|NCT01419041|pharmacokinetics|pharmacokinetics
1339618|NCT01419028|Hypophosphatasia|hypophosphatasia
1339619|NCT01419028|HPP|hpp
1339620|NCT01419028|Bone disease|bone disease
1339621|NCT01419028|Soft bones|soft bones
1339622|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
1339623|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
1339624|NCT01419028|Alkaline phosphatase|alkaline phosphatase
1339625|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1339626|NCT01419028|Rickets|rickets
1339627|NCT01419028|Osteomalacia|osteomalacia
1339628|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
1339629|NCT01419015|Cardiovascular Disease|cardiovascular disease
1339630|NCT01419015|Valvular Heart Disease|valvular heart disease
1339631|NCT01419015|Aortic Stenosis|aortic stenosis
1339632|NCT01419015|Heart Valve Therapy|heart valve therapy
1339633|NCT01419015|Transcatheter|transcatheter
1339634|NCT01419015|Transfemoral|transfemoral
1339635|NCT01419015|Efficacy endpoints|efficacy endpoints
1339636|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
1339637|NCT01419015|NYHA|nyha
1339638|NCT01419002|Pancreatic Cancer|pancreatic cancer
1339639|NCT01419002|Adenocarcinoma|adenocarcinoma
1339640|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
1339641|NCT01418976|physical therapy techniques|physical therapy techniques
1339642|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
1339643|NCT01418976|walking|walking
1339644|NCT01418976|gait|gait
1339645|NCT01418976|postural balance|postural balance
1339646|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
1339647|NCT01418937|HPV vaccine|hpv vaccine
1339648|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
1339649|NCT01418937|medically significant conditions|medically significant conditions
1339650|NCT01418937|cervical neoplasia|cervical neoplasia
1339651|NCT01418924|sclerostin|sclerostin
1339652|NCT01418924|estradiol|estradiol
1339653|NCT01418924|progesterone|progesterone
1339654|NCT01418924|testosteron|testosteron
1339655|NCT01418924|sex hormones|sex hormones
1339656|NCT01418898|Iron deficiency anemia|iron deficiency anemia
1339657|NCT01418898|iron|iron
1339658|NCT01418898|zinc|zinc
1339659|NCT01418898|vitamin A|vitamin a
1339660|NCT01418898|vitamin C|vitamin c
1339661|NCT01418898|oats|oats
1339662|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
1339663|NCT01418872|Obesity|obesity
1339664|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
1339665|NCT01418872|Paediatrics|paediatrics
1339666|NCT01418859|cervical cancer|cervical cancer
1339667|NCT01418859|postoperation|postoperation
1339668|NCT01418859|chemotherapy|chemotherapy
1339669|NCT01418859|radiotherapy|radiotherapy
1339670|NCT01418846|voriconazole|voriconazole
1451923|NCT00958685|ICU|icu
1339671|NCT01418846|saliva|saliva
1339672|NCT01418846|pharmacokinetics|pharmacokinetics
1339673|NCT01418833|voriconazole|voriconazole
1339674|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
1339675|NCT01418833|plasma levels|plasma levels
1339676|NCT01418833|dose adjustment|dose adjustment
1339677|NCT01418820|hemianopia|hemianopia
1339678|NCT01418820|visual field defect|visual field defect
1339679|NCT01418820|stroke|stroke
1339680|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
1339681|NCT01418820|alternating current stimulation|alternating current stimulation
1339682|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
1339683|NCT01418794|Drug eluting stent|drug eluting stent
1339684|NCT01418794|Diffused lesion|diffused lesion
1339685|NCT01418781|gout|gout
1339686|NCT01418781|cost|cost
1339687|NCT01418781|utilization|utilization
1339688|NCT01418768|COPD|copd
1339689|NCT01418768|CAT|cat
1339690|NCT01418768|Rehabilitation|rehabilitation
1339691|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
1339692|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
1339693|NCT01418755|Knee|knee
1339694|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
1339695|NCT01418755|Injection|injection
1339696|NCT01418742|skin toxicity|skin toxicity
1339697|NCT01418716|Disease Management|disease management
1339698|NCT01418716|Quality Improvement|quality improvement
1339699|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
1339700|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
1339701|NCT01418664|vitamin D|vitamin d
1339702|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
1339703|NCT01418664|Pakistan|pakistan
1339704|NCT01418638|Major Depressive Disorder|major depressive disorder
1339705|NCT01418638|Antidepressants|antidepressants
1339706|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
1339707|NCT01418560|renal artery|renal artery
1339708|NCT01418560|sympathetic nerves|sympathetic nerves
1339709|NCT01418560|modification|modification
1339710|NCT01418560|chronic renal failure|chronic renal failure
1339711|NCT01418521|Cardiac surgery|cardiac surgery
1339712|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
1339713|NCT01418521|Tetraspan|tetraspan
1339714|NCT01418521|Ringer-albumin|ringer-albumin
1339715|NCT01418469|COPD|copd
1339716|NCT01418469|protein metabolism|protein metabolism
1339717|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
1339718|NCT01418469|exercise|exercise
1339719|NCT01418469|protein feeding|protein feeding
1339720|NCT01418456|diabetes|diabetes
1339721|NCT01418456|antibiotics|antibiotics
1339722|NCT01418456|clean foot ulcers|clean foot ulcers
1339723|NCT01418404|Stroke|stroke
1339724|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
1339725|NCT01418404|Brain mapping|brain mapping
1339726|NCT01418404|Kinematics analysis|kinematics analysis
1339727|NCT01418391|minimal laparotomy|minimal laparotomy
1339728|NCT01418391|TAP block|tap block
1339729|NCT01418391|morphine consumption|morphine consumption
1339730|NCT01418391|post-operative analgesia|post-operative analgesia
1339731|NCT01418378|Sigma|sigma
1339732|NCT01418378|cruciate|cruciate
1339733|NCT01418378|retaining|retaining
1339734|NCT01418378|fixed|fixed
1339735|NCT01418378|primary|primary
1339736|NCT01418378|total|total
1339737|NCT01418378|knee|knee
1339738|NCT01418378|arthroplasty|arthroplasty
1339739|NCT01418378|cemented|cemented
1339740|NCT01418378|osteoarthritis|osteoarthritis
1339741|NCT01418352|Tourette's Disorder|tourette's disorder
1339742|NCT01418352|tic disorders|tic disorders
1339743|NCT01418339|Tourette's Disorder|tourette's disorder
1339744|NCT01418339|tic disorders|tic disorders
1339745|NCT01418326|Cancer - breast|cancer - breast
1339746|NCT01418326|colo-rectal|colo-rectal
1339747|NCT01418326|skin|skin
1339748|NCT01418313|Atherosclerosis|atherosclerosis
1339749|NCT01418313|Non-invasive imaging|non-invasive imaging
1339750|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
1339751|NCT01418313|MRI|mri
1339752|NCT01418313|Positron Emission Tomography|positron emission tomography
1339753|NCT01418313|PET/CT|pet/ct
1339754|NCT01418313|PET/MRI|pet/mri
1339755|NCT01418313|Inflammation|inflammation
1339756|NCT01418313|Neovascularization|neovascularization
1339757|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
1339758|NCT01418261|renal denervation|renal denervation
1339759|NCT01418248|cardiac catheterization|cardiac catheterization
1339760|NCT01418248|echocardiography|echocardiography
1339761|NCT01418235|HIV Infections|hiv infections
1339762|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1339763|NCT01418235|Lentivirus Infections|lentivirus infections
1339764|NCT01418235|Retroviridae Infections|retroviridae infections
1339765|NCT01418235|RNA Virus Infections|rna virus infections
1339766|NCT01418235|Virus Diseases|virus diseases
1567109|NCT00510042|bleeding disorder|bleeding disorder
1339767|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1339768|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
1339769|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1339770|NCT01418235|Immune System Diseases|immune system diseases
1339771|NCT01418235|Slow Virus Diseases|slow virus diseases
1339772|NCT01418209|Menopause|menopause
1339773|NCT01418209|Vasomotor|vasomotor
1339774|NCT01418209|Symptoms|symptoms
1339775|NCT01418209|Estradiol|estradiol
1339776|NCT01418209|Venlafaxine|venlafaxine
1339777|NCT01418196|TMAO|tmao
1339778|NCT01418196|Children|children
1339779|NCT01418196|Dietary choline|dietary choline
1339780|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
1339781|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
1339782|NCT01418183|Orthognathic surgery|orthognathic surgery
1339783|NCT01418183|Pain control|pain control
1339784|NCT01418183|Trigeminal nerve|trigeminal nerve
1339785|NCT01418183|Levobupivacaine|levobupivacaine
1339786|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
1339787|NCT01418170|myofascial trigger points|myofascial trigger points
1339788|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
1339789|NCT01418170|algometer|algometer
1339790|NCT01418170|pressure pain thresholds|pressure pain thresholds
1339791|NCT01418157|Acute mountain sickness|acute mountain sickness
1339792|NCT01418157|Rapid ascent|rapid ascent
1339793|NCT01418157|High altitude headache|high altitude headache
1339794|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
1339795|NCT01418131|Proctitis|proctitis
1339796|NCT01418131|resistant|resistant
1339797|NCT01418131|ulcerative colitis|ulcerative colitis
1339798|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
1339799|NCT01418118|noradrenaline|noradrenaline
1339800|NCT01418118|norepinephrine|norepinephrine
1339801|NCT01418118|epinephrine|epinephrine
1339802|NCT01418118|adrenaline|adrenaline
1339803|NCT01418118|dobutamine|dobutamine
1339804|NCT01418118|dopexamine|dopexamine
1339805|NCT01418118|inotrope|inotrope
1339806|NCT01418118|pressor|pressor
1339807|NCT01418118|sympathomimetic|sympathomimetic
1339808|NCT01418118|free flap|free flap
1339809|NCT01418118|transplantation|transplantation
1339810|NCT01418118|free tissue transfer|free tissue transfer
1339811|NCT01418118|microsurgery|microsurgery
1339812|NCT01418118|survival|survival
1339813|NCT01418105|spine injuries|spine injuries
1339814|NCT01418105|brain lesions|brain lesions
1339815|NCT01418105|dysphagia|dysphagia
1339816|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
1339817|NCT01418079|cerebral oxygenation|cerebral oxygenation
1339818|NCT01418027|NAFLD|nafld
1339819|NCT01418027|exercise|exercise
1339820|NCT01418027|hepatic triglycerides|hepatic triglycerides
1339821|NCT01418001|GEMCITABINE|gemcitabine
1339822|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
1339823|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
1339824|NCT01418001|11-104|11-104
1339825|NCT01417988|TB|tb
1339826|NCT01417975|exercise|exercise
1339827|NCT01417975|smoking satisfaction|smoking satisfaction
1339828|NCT01417975|topography|topography
1339829|NCT01417975|cravings|cravings
1339830|NCT01417962|Autopsy|autopsy
1339831|NCT01417962|MRI|mri
1339832|NCT01417962|Stillbirths|stillbirths
1339833|NCT01417962|Neonatal death|neonatal death
1339834|NCT01417962|Sudden Infant death|sudden infant death
1339835|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
1339836|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
1339837|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
1339838|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
1339839|NCT01417884|molecular cardiology|molecular cardiology
1339840|NCT01417884|molecular epidemiology|molecular epidemiology
1339841|NCT01417884|platelets|platelets
1339842|NCT01417884|cardiovascular disease|cardiovascular disease
1339843|NCT01417858|intra-ocular pressure|intra-ocular pressure
1339844|NCT01417858|iridectomy|iridectomy
1339845|NCT01417858|gonioscopy|gonioscopy
1339846|NCT01417858|ocular tonometry|ocular tonometry
1339847|NCT01417832|Dental caries|dental caries
1339848|NCT01417832|Proximal surfaces|proximal surfaces
1339849|NCT01417832|Preventive therapy|preventive therapy
1339850|NCT01417832|Dental radiography|dental radiography
1339851|NCT01417832|Treatment efficacy|treatment efficacy
1339852|NCT01417832|Young adults|young adults
1339853|NCT01417806|small cell lung cancer|small cell lung cancer
1339854|NCT01417806|somatostatin|somatostatin
1339855|NCT01417806|topotecan|topotecan
1339856|NCT01417793|Smoking cessation rate|smoking cessation rate
1339857|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
1339858|NCT01417767|Decitabine|decitabine
1339859|NCT01417767|homoharringtonine|homoharringtonine
1339860|NCT01417767|cytarabine|cytarabine
1339861|NCT01417767|G-CSF|g-csf
1339862|NCT01417754|toremifene|toremifene
1339863|NCT01417728|endomicroscopy|endomicroscopy
1339864|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
1339865|NCT01417728|mucosal healing|mucosal healing
1339866|NCT01417728|infliximab|infliximab
1339867|NCT01417689|glaucoma|glaucoma
1339868|NCT01417689|randomized controlled trial|randomized controlled trial
1339869|NCT01417689|eye drops|eye drops
1339870|NCT01417689|instillation|instillation
1339871|NCT01417689|compliance|compliance
1339872|NCT01417676|prostate cancer|prostate cancer
1339873|NCT01417676|locally advanced|locally advanced
1339874|NCT01417676|lymph node positive|lymph node positive
1339875|NCT01417676|radiation therapy|radiation therapy
1339876|NCT01417676|morbidity|morbidity
1339877|NCT01417676|early morbidity|early morbidity
1339878|NCT01417676|late morbidity|late morbidity
1339879|NCT01417663|Aging|aging
1339880|NCT01417663|Cardiovascular disease|cardiovascular disease
1339881|NCT01417663|Endothelial function|endothelial function
1339882|NCT01417663|Physical activity|physical activity
1339883|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
1339884|NCT01417663|AGE crosslink breakers|age crosslink breakers
1339885|NCT01417650|temporomandibular disorder|temporomandibular disorder
1339886|NCT01417650|laser therapy|laser therapy
1339887|NCT01417650|osteoarthritis|osteoarthritis
1339889|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
1339890|NCT01417637|low level laser therapy|low level laser therapy
1339891|NCT01417637|LLLT|lllt
1339892|NCT01417624|Heart Failure|heart failure
1339893|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
1339894|NCT01417611|screening colonoscopy|screening colonoscopy
1339895|NCT01417598|Balance|balance
1339896|NCT01417598|Gait|gait
1339897|NCT01417598|Physical activity|physical activity
1339898|NCT01417585|Activities of daily living|activities of daily living
1339899|NCT01417585|Caregiver burden|caregiver burden
1339900|NCT01417585|Client centered|client centered
1339901|NCT01417585|Life satisfaction|life satisfaction
1339902|NCT01417585|Participation|participation
1339903|NCT01417585|Patient satisfaction|patient satisfaction
1339904|NCT01417585|Rehabilitation|rehabilitation
1339905|NCT01417585|Self rated impact of stroke|self rated impact of stroke
1339906|NCT01417585|Stroke|stroke
1339907|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
1339908|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
1339909|NCT01417546|Immune Response|immune response
1339910|NCT01417546|Pharmacokinetics|pharmacokinetics
1339911|NCT01417546|Dose Escalation|dose escalation
1339912|NCT01417546|Cancer|cancer
1339913|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
1339914|NCT01417546|Solid Tumor|solid tumor
1339915|NCT01417533|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1339916|NCT01417533|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
1339917|NCT01417533|UDP-N-acetyglucosamine 2-epimerase (GNE)|udp-n-acetyglucosamine 2-epimerase (gne)
1339918|NCT01417533|Sialic Acid|sialic acid
1339919|NCT01417533|Muscular Dystrophy|muscular dystrophy
1339920|NCT01417533|HIBM|hibm
1339921|NCT01417520|Histiocytosis|histiocytosis
1339922|NCT01417520|Xanthomatosis|xanthomatosis
1339923|NCT01417520|Fibrosis|fibrosis
1339924|NCT01417520|Osteosclerosis|osteosclerosis
1339925|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
1339927|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
1339928|NCT01417494|stage IVA colon cancer|stage iva colon cancer
1339929|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
1339930|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1339931|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
1339932|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
1339933|NCT01417481|cystic fibrosis|cystic fibrosis
1339934|NCT01417481|glycine|glycine
1339935|NCT01417481|airway inflammation|airway inflammation
1339936|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
1339937|NCT01417468|Learning Styles|learning styles
1339938|NCT01417468|Learning Modes|learning modes
1339939|NCT01417468|Learning Modalities|learning modalities
1339940|NCT01417468|Multiple Intelligences|multiple intelligences
1339941|NCT01417468|Educational Intervention|educational intervention
1339942|NCT01417468|Instructional Design|instructional design
1339943|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
1339944|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
1339945|NCT01417455|Osteoclasts|osteoclasts
1339946|NCT01417455|TNF antagonists|tnf antagonists
1339947|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
1339948|NCT01417442|BRAF V600E|braf v600e
1339949|NCT01417442|poor prognosis|poor prognosis
1339950|NCT01417442|aggressive|aggressive
1339951|NCT01417429|galantamine|galantamine
1339952|NCT01417429|subjective nicotine|subjective nicotine
1339953|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
1339954|NCT01417429|nicotine|nicotine
1339955|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1339956|NCT01417364|Sarcopenia|sarcopenia
1339957|NCT01417364|Aging muscle|aging muscle
1339958|NCT01417364|Testosterone administration|testosterone administration
1339959|NCT01417364|Bone metabolism|bone metabolism
1339960|NCT01417351|pregnancy|pregnancy
1339961|NCT01417351|immune function|immune function
1339962|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
1339963|NCT01417338|Mortality|mortality
1339964|NCT01417338|Risk factors|risk factors
1339965|NCT01417312|Multiple sclerosis|multiple sclerosis
1339966|NCT01417312|Green tea extract|green tea extract
1339967|NCT01417312|Metabolism|metabolism
1339968|NCT01417299|chronic vegetative state|chronic vegetative state
1339969|NCT01417299|RPh201|rph201
1339970|NCT01417299|functional MRI|functional mri
1339971|NCT01417273|Multiple sclerosis|multiple sclerosis
1339972|NCT01417273|immune system|immune system
1339973|NCT01417273|vitamin A|vitamin a
1339974|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
1339975|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
1339976|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
1339977|NCT01417247|renal artery|renal artery
1339978|NCT01417247|sympathetic nerves|sympathetic nerves
1339979|NCT01417247|modification|modification
1339980|NCT01417247|metabolic syndrome|metabolic syndrome
1339981|NCT01417221|renal artery|renal artery
1339982|NCT01417221|sympathetic nerves|sympathetic nerves
1339983|NCT01417221|modification|modification
1339984|NCT01417221|essential hypertension|essential hypertension
1339985|NCT01417221|primary hypertension|primary hypertension
1339986|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
1339987|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
1339988|NCT01417143|dovitinib|dovitinib
1339989|NCT01417130|Naproxen|naproxen
1339990|NCT01417130|Celecoxib|celecoxib
1339991|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1339992|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
1339993|NCT01417117|Ischemic Stroke|ischemic stroke
1339994|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
1339995|NCT01417117|Neurologic Outcome|neurologic outcome
1339996|NCT01417104|plaque|plaque
1339997|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1339998|NCT01417104|high blood pressure|high blood pressure
1339999|NCT01417104|MI|mi
1340000|NCT01417104|heart attack|heart attack
1340001|NCT01417104|CVA|cva
1340002|NCT01417104|stroke|stroke
1340003|NCT01417104|PAD|pad
1340004|NCT01417091|Brittle bone disease|brittle bone disease
1340005|NCT01417091|inherited|inherited
1340006|NCT01417091|connective tissue disorder|connective tissue disorder
1340007|NCT01417091|fracture|fracture
1340008|NCT01417065|Cancer|cancer
1340009|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
1340010|NCT01417065|Torisel|torisel
1340011|NCT01417065|CCI-779|cci-779
1340012|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
1340013|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
1340014|NCT01417026|Oxytocin|oxytocin
1340015|NCT01417026|Clinical Trial|clinical trial
1340016|NCT01417026|Computer-based Intervention|computer-based intervention
1340017|NCT01417026|Social Perception|social perception
1340018|NCT01417026|Social Motivation|social motivation
1340019|NCT01417026|Social Cognition|social cognition
1340020|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
1340021|NCT01417000|Cancer|cancer
1340022|NCT01417000|Cancer vaccine|cancer vaccine
1340023|NCT01417000|Listeria monocytogenes|listeria monocytogenes
1340024|NCT01417000|Listeria-based vaccines|listeria-based vaccines
1340025|NCT01417000|GVAX|gvax
1340026|NCT01417000|Cyclophosphamide|cyclophosphamide
1340027|NCT01417000|Cytoxan|cytoxan
1340028|NCT01417000|T regulatory cells|t regulatory cells
1340029|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
1340030|NCT01417000|Immunotherapy|immunotherapy
1340031|NCT01417000|Mesothelin|mesothelin
1340322|NCT01415856|Torino II|torino ii
1340032|NCT01417000|Pancreatic cancer|pancreatic cancer
1340033|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
1340034|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1340035|NCT01416974|autologous T cells|autologous t cells
1340036|NCT01416974|Leukapheresis|leukapheresis
1340037|NCT01416974|11-048|11-048
1340038|NCT01416961|Squamous Cell|squamous cell
1340039|NCT01416961|Non-squamous cell|non-squamous cell
1340040|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
1340041|NCT01416935|Atrial Fibrillation|atrial fibrillation
1340042|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
1340043|NCT01416909|Medication-induced|medication-induced
1340044|NCT01416909|Constipation in Cancer|constipation in cancer
1340045|NCT01416896|End stage Renal Disease|end stage renal disease
1340046|NCT01416896|Hemodialysis|hemodialysis
1340047|NCT01416896|Oxidative Stress|oxidative stress
1340048|NCT01416896|Inflammation|inflammation
1340049|NCT01416883|oral mucosal absorption|oral mucosal absorption
1340050|NCT01416883|pharmacokinetics|pharmacokinetics
1340051|NCT01416883|safety|safety
1340052|NCT01416883|bicalutamide|bicalutamide
1340053|NCT01416883|Japanese|japanese
1340054|NCT01416883|healthy subject|healthy subject
1340055|NCT01416870|Bioequivalence|bioequivalence
1340056|NCT01416870|pharmacokinetics|pharmacokinetics
1340057|NCT01416870|safety|safety
1340058|NCT01416870|bicalutamide|bicalutamide
1340059|NCT01416870|Casodex|casodex
1340060|NCT01416870|Japanese|japanese
1340061|NCT01416870|healthy subject|healthy subject
1340062|NCT01416857|Medicare|medicare
1340063|NCT01416844|Metastatic melanoma|metastatic melanoma
1340064|NCT01416844|anti-OX40|anti-ox40
1340065|NCT01416844|Immunostimulatory|immunostimulatory
1340066|NCT01416831|metastatic melanoma|metastatic melanoma
1340067|NCT01416831|IL-2|il-2
1340068|NCT01416831|Interleukin 2|interleukin 2
1340069|NCT01416831|Radiation|radiation
1340070|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
1340071|NCT01416831|SBRT|sbrt
1340072|NCT01416831|Immunotherapy|immunotherapy
1340073|NCT01416818|Depression;|depression;
1340074|NCT01416818|Parkinson's disease;|parkinson's disease;
1340075|NCT01416818|antidepressant|antidepressant
1340076|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
1340077|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
1340079|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
1340080|NCT01416805|Social Phobia|social phobia
1340081|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
1340082|NCT01416805|Psychotherapy|psychotherapy
1340083|NCT01416805|Counseling|counseling
1340084|NCT01416805|Social Anxiety Disorder|social anxiety disorder
1340085|NCT01416779|Writing Intervention|writing intervention
1340086|NCT01416779|Bereaved Caregivers|bereaved caregivers
1340087|NCT01416779|Older Adults|older adults
1340088|NCT01416779|hope|hope
1340089|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
1340090|NCT01416766|Blood Pressure Monitors|blood pressure monitors
1340091|NCT01416766|Medical Informatics|medical informatics
1340092|NCT01416766|Disease Management|disease management
1340093|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
1340094|NCT01416753|hemodialysis|hemodialysis
1340095|NCT01416753|blood volume monitoring|blood volume monitoring
1340096|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
1340097|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
1340098|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
1340099|NCT01416727|Patient Simulation|patient simulation
1340100|NCT01416727|Education, Medical, Graduate|education, medical, graduate
1340101|NCT01416727|Internship and Residency|internship and residency
1340102|NCT01416727|Psychiatry|psychiatry
1340103|NCT01416701|COPD|copd
1340104|NCT01416701|Vitamin D|vitamin d
1340105|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
1340106|NCT01416688|therapy-related toxicity|therapy-related toxicity
1340107|NCT01416688|dermatologic complications|dermatologic complications
1340108|NCT01416688|stage I colon cancer|stage i colon cancer
1340109|NCT01416688|stage IIA colon cancer|stage iia colon cancer
1340110|NCT01416688|stage IIB colon cancer|stage iib colon cancer
1340111|NCT01416688|stage IIC colon cancer|stage iic colon cancer
1340112|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
1340113|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
1340114|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
1340115|NCT01416688|stage IVA colon cancer|stage iva colon cancer
1340116|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
1340117|NCT01416688|stage I rectal cancer|stage i rectal cancer
1340118|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
1340119|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
1340120|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
1340121|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
1340122|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
1340123|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
1340124|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
1340125|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
1340218|NCT01416259|QTc Prolongation|qtc prolongation
1340126|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1340127|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1340128|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1340129|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1340130|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1340131|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1340132|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1340133|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1340134|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
1340135|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
1340136|NCT01416688|recurrent colon cancer|recurrent colon cancer
1340137|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
1340138|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1340139|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1340140|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
1340141|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
1340142|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
1340143|NCT01416623|Advanced solid cancer|advanced solid cancer
1340144|NCT01416623|Henatinib|henatinib
1340145|NCT01416623|phase I|phase i
1340146|NCT01416597|Influenza|influenza
1340147|NCT01416597|Systematic review|systematic review
1340148|NCT01416597|Meta-analysis|meta-analysis
1340149|NCT01416597|Mismatched strains|mismatched strains
1340150|NCT01416597|Cross-protection|cross-protection
1340151|NCT01416571|H5N1|h5n1
1340152|NCT01416571|Influenza vaccine|influenza vaccine
1340153|NCT01416571|influenza infection|influenza infection
1340154|NCT01416571|GSK1557484A|gsk1557484a
1340155|NCT01416558|German Breast Group|german breast group
1340156|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
1340157|NCT01416558|GBG|gbg
1340158|NCT01416558|GBG 65|gbg 65
1340159|NCT01416558|Tiffany|tiffany
1340160|NCT01416558|Breast Cancer|breast cancer
1340161|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
1340162|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
1340163|NCT01416558|Abraxane|abraxane
1340164|NCT01416558|Taxane Failure|taxane failure
1340165|NCT01416545|Primary Prevention|primary prevention
1340166|NCT01416545|Cardiovascular disease|cardiovascular disease
1340167|NCT01416545|Child|child
1340168|NCT01416545|Behavior modification|behavior modification
1340169|NCT01416545|Activities, Educational|activities, educational
1340170|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
1340171|NCT01416532|Computed Tomography|computed tomography
1340172|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
1340173|NCT01416519|Cough|cough
1340174|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
1340175|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
1340176|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
1340177|NCT01416480|Theobromine|theobromine
1340178|NCT01416480|cough|cough
1340179|NCT01416480|acute bronchitis|acute bronchitis
1340180|NCT01416467|lysosomal storage disease|lysosomal storage disease
1340181|NCT01416467|AAV vector|aav vector
1340182|NCT01416467|gene transfer|gene transfer
1340183|NCT01416467|disease characterization|disease characterization
1340184|NCT01416441|Tourette's Disorder|tourette's disorder
1340185|NCT01416441|tic disorders|tic disorders
1340186|NCT01416428|multiple myeloma|multiple myeloma
1340187|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1340188|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
1340189|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
1340190|NCT01416415|Instructional Films and Videos|instructional films and videos
1340191|NCT01416402|Hyperuricemia|hyperuricemia
1340192|NCT01416402|gout|gout
1340193|NCT01416402|serum uric acid|serum uric acid
1340194|NCT01416389|Locally|locally
1340195|NCT01416389|Recurrent|recurrent
1340196|NCT01416389|Breast|breast
1340197|NCT01416389|Cancer|cancer
1340198|NCT01416363|firategrast|firategrast
1340199|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
1340200|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
1340201|NCT01416363|pharmacokinetics|pharmacokinetics
1340202|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
1340203|NCT01416363|healthy volunteers|healthy volunteers
1340204|NCT01416363|modified release|modified release
1340205|NCT01416324|pharmacodynamics|pharmacodynamics
1340206|NCT01416324|first time in human|first time in human
1340207|NCT01416324|pharmacokinetics|pharmacokinetics
1340208|NCT01416298|Acute Kidney Injury|acute kidney injury
1340209|NCT01416298|Critically ill children|critically ill children
1340210|NCT01416298|Biomarkers|biomarkers
1340211|NCT01416298|NGAL|ngal
1340212|NCT01416298|Fluid Overload|fluid overload
1340213|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
1340214|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
1340215|NCT01416285|CHF education|chf education
1340216|NCT01416285|self-care training|self-care training
1340217|NCT01416285|CHF center|chf center
1340219|NCT01416246|Stem cell Infusions|stem cell infusions
1340220|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
1340221|NCT01416246|11-105|11-105
1340222|NCT01416233|autologous|autologous
1340223|NCT01416233|fat|fat
1340224|NCT01416233|orbit|orbit
1340225|NCT01416233|atrophy|atrophy
1340226|NCT01416233|cannula|cannula
1340227|NCT01416220|depression|depression
1340228|NCT01416220|bipolar disorder|bipolar disorder
1340229|NCT01416220|manic depressive illness|manic depressive illness
1340230|NCT01416194|Osteoporosis|osteoporosis
1340231|NCT01416181|Natalizumab|natalizumab
1340232|NCT01416181|secondary|secondary
1340233|NCT01416181|multiple sclerosis|multiple sclerosis
1340234|NCT01416181|MS|ms
1340235|NCT01416181|SPMS|spms
1340236|NCT01416181|Tysabri|tysabri
1340237|NCT01416168|Colon|colon
1340238|NCT01416168|Geriatric|geriatric
1340239|NCT01416168|McCorkle Model|mccorkle model
1340240|NCT01416168|Questionnaire|questionnaire
1340241|NCT01416116|Tramadol|tramadol
1340242|NCT01416116|QUTENZA|qutenza
1340243|NCT01416116|Pre-treatment|pre-treatment
1340244|NCT01416116|Tolerability|tolerability
1340245|NCT01416090|syndactyly|syndactyly
1340246|NCT01416077|fluid|fluid
1340247|NCT01416077|goal-directed|goal-directed
1340248|NCT01416077|FloTrac|flotrac
1340249|NCT01416077|pulse contour analysis|pulse contour analysis
1340250|NCT01416077|postoperative complications|postoperative complications
1340251|NCT01416077|anesthesia|anesthesia
1340252|NCT01416077|esophagus|esophagus
1340253|NCT01416038|vaccine|vaccine
1340254|NCT01416038|immunotherapy|immunotherapy
1340255|NCT01416038|ovarian|ovarian
1340256|NCT01416038|fallopian tube|fallopian tube
1340257|NCT01416038|peritoneal|peritoneal
1340258|NCT01416038|cancer|cancer
1340259|NCT01416038|tumor|tumor
1340260|NCT01416038|Phase 1|phase 1
1340261|NCT01416038|Phase I|phase i
1340262|NCT01416038|combination therapy|combination therapy
1340263|NCT01416025|Voriconazole|voriconazole
1340264|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
1340265|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1340266|NCT01416025|Hematologic malignancy|hematologic malignancy
1340267|NCT01416025|Invasive mould infection|invasive mould infection
1340268|NCT01415999|anthracycline|anthracycline
1340269|NCT01415999|cardiac function|cardiac function
1340270|NCT01415999|echocardiography|echocardiography
1340271|NCT01415999|biomarkers|biomarkers
1340272|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
1340273|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
1340275|NCT01415986|HNSCC|hnscc
1340276|NCT01415973|beef|beef
1340277|NCT01415973|protein|protein
1340278|NCT01415973|synergy|synergy
1340279|NCT01415973|intact beef constituents|intact beef constituents
1340280|NCT01415973|protein constituent|protein constituent
1340281|NCT01415973|Nutrient Synergy|nutrient synergy
1340282|NCT01415960|Prostate Cancer|prostate cancer
1340283|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
1340284|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
1340285|NCT01415960|Pharmacokinetics|pharmacokinetics
1340286|NCT01415960|testosterone|testosterone
1340287|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
1340288|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
1340289|NCT01415960|prostate-specific antigen|prostate-specific antigen
1340290|NCT01415947|Heart disease|heart disease
1340291|NCT01415947|Device|device
1340292|NCT01415947|Mitral valve|mitral valve
1340293|NCT01415947|leaflet prolapse|leaflet prolapse
1340294|NCT01415947|Heart valve disease|heart valve disease
1340295|NCT01415947|Cardiovascular disease|cardiovascular disease
1340296|NCT01415947|Neochordae|neochordae
1340297|NCT01415921|heart failure|heart failure
1340298|NCT01415921|autonomic function|autonomic function
1340299|NCT01415921|sympathovagal balance|sympathovagal balance
1340300|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
1340301|NCT01415921|pharmacology|pharmacology
1340302|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
1340303|NCT01415908|lumbosacral spine|lumbosacral spine
1340304|NCT01415908|radiculopathy|radiculopathy
1340305|NCT01415908|degenerative instability|degenerative instability
1340306|NCT01415908|spondylolisthesis|spondylolisthesis
1340307|NCT01415908|retrolisthesis|retrolisthesis
1340308|NCT01415908|lateral listhesis|lateral listhesis
1340309|NCT01415908|spinal stenosis|spinal stenosis
1340310|NCT01415908|disc herniation|disc herniation
1340311|NCT01415908|INFUSE Bone Graft|infuse bone graft
1340312|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
1340313|NCT01415908|CAPSTONE Spinal System|capstone spinal system
1340314|NCT01415895|back pain|back pain
1340315|NCT01415895|cervical pain|cervical pain
1340316|NCT01415895|neuropathic pain|neuropathic pain
1340317|NCT01415895|radicular pain|radicular pain
1340318|NCT01415869|Ventricular Assist Device|ventricular assist device
1340319|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
1340320|NCT01415869|VAD|vad
1340321|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
1340329|NCT01415830|children|children
1340330|NCT01415817|Quality Improvement|quality improvement
1340331|NCT01415817|Adenoma Detection Rate|adenoma detection rate
1340332|NCT01415817|Polyp detection rate|polyp detection rate
1340333|NCT01415817|Colonoscopy|colonoscopy
1340334|NCT01415817|Training|training
1340335|NCT01415817|Colorectal cancer screening|colorectal cancer screening
1340336|NCT01415804|Dissection|dissection
1340337|NCT01415804|Aorta|aorta
1340338|NCT01415804|Surgery|surgery
1340339|NCT01415791|oral mucosal absorption|oral mucosal absorption
1340340|NCT01415791|pharmacokinetics|pharmacokinetics
1340341|NCT01415791|safety|safety
1340342|NCT01415791|bicalutamide|bicalutamide
1340343|NCT01415791|Japanese|japanese
1340344|NCT01415791|healthy subject|healthy subject
1340345|NCT01415778|Bioequivalence|bioequivalence
1340346|NCT01415778|pharmacokinetics|pharmacokinetics
1340347|NCT01415778|safety|safety
1340348|NCT01415778|bicalutamide|bicalutamide
1340349|NCT01415778|Casodex|casodex
1340350|NCT01415778|Japanese|japanese
1340351|NCT01415778|healthy subject|healthy subject
1340352|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
1340353|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
1340354|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
1340355|NCT01415765|Drug Resistance|drug resistance
1340356|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
1340357|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1340358|NCT01415765|Lymphoma|lymphoma
1340359|NCT01415752|neurotoxicity|neurotoxicity
1340360|NCT01415752|therapy-related toxicity|therapy-related toxicity
1340361|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1340362|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1340363|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1340364|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1340365|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1340366|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1340367|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1340368|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
1340369|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
1340370|NCT01415726|Cord blood stem cells|cord blood stem cells
1340371|NCT01415726|inflammation|inflammation
1340372|NCT01415726|type 2 diabetes|type 2 diabetes
1340373|NCT01415726|stem cell educator|stem cell educator
1340374|NCT01415726|autoimmunity|autoimmunity
1340375|NCT01415726|immune modulation|immune modulation
1340376|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
1340377|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
1340378|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
1340379|NCT01415700|feet orthosis|feet orthosis
1340380|NCT01415687|preoperative care|preoperative care
1340381|NCT01415687|colonoscopy|colonoscopy
1340382|NCT01415687|cathartics|cathartics
1340388|NCT01415648|with surgical indication|with surgical indication
1340389|NCT01415648|Cerebral oximetry|cerebral oximetry
1340390|NCT01415648|carotid endarterectomy|carotid endarterectomy
1340391|NCT01415648|MRI|mri
1340392|NCT01415648|ischemic lesion|ischemic lesion
1340393|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
1340394|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
1340395|NCT01415648|protein S-100B|protein s-100b
1340396|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
1340397|NCT01415622|plasma therapy|plasma therapy
1340398|NCT01415622|ulcus cruris|ulcus cruris
1340399|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
1340400|NCT01415609|Submucosal resection|submucosal resection
1340401|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
1340402|NCT01415570|racial disparities|racial disparities
1340403|NCT01415570|hemodialysis|hemodialysis
1340404|NCT01415570|survival paradoxes|survival paradoxes
1340405|NCT01415570|Stage 5|stage 5
1340406|NCT01415557|micronutrient|micronutrient
1340407|NCT01415557|healthy children|healthy children
1340408|NCT01415557|vitamins|vitamins
1340409|NCT01415557|minerals|minerals
1340410|NCT01415557|cognition|cognition
1340411|NCT01415557|physical performance|physical performance
1340412|NCT01415557|iron|iron
1340413|NCT01415557|Micronutrient status|micronutrient status
1340414|NCT01415557|Cognitive Performance|cognitive performance
1340415|NCT01415544|Diabetes|diabetes
1340416|NCT01415531|Stage 1|stage 1
1340417|NCT01415531|Stage 2|stage 2
1340418|NCT01415531|Hypertension|hypertension
1340419|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
1340420|NCT01415505|Stage 1|stage 1
1340421|NCT01415505|Stage 2|stage 2
1340422|NCT01415505|Hypertension|hypertension
1340423|NCT01415505|1 year open label safety study|1 year open label safety study
1340424|NCT01415492|Exercise|exercise
1340425|NCT01415492|Physical activity|physical activity
1340426|NCT01415492|Cigarette Smoking|cigarette smoking
1340427|NCT01415492|Smoking cessation|smoking cessation
1340428|NCT01415492|Multi Vitamin intake|multi vitamin intake
1340429|NCT01415492|Vegetable consumption|vegetable consumption
1340430|NCT01415492|Fruit consumption|fruit consumption
1340431|NCT01415492|Meat consumption|meat consumption
1340432|NCT01415479|Colon cancer|colon cancer
1340433|NCT01415479|Screening|screening
1340434|NCT01415479|Decision-making|decision-making
1340435|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
1340436|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
1340437|NCT01415453|RP|rp
1340438|NCT01415453|visual field loss|visual field loss
1340439|NCT01415453|Photoreceptor|photoreceptor
1340440|NCT01415453|Vision loss|vision loss
1340441|NCT01415453|retina|retina
1340442|NCT01415453|progressive vision loss|progressive vision loss
1340443|NCT01415453|ultrasound|ultrasound
1340444|NCT01415440|ADHD|adhd
1340445|NCT01415440|Vyvanse|vyvanse
1340446|NCT01415440|stimulant medication|stimulant medication
1340447|NCT01415440|ADD|add
1340448|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
1340449|NCT01415427|MPS IV Type A|mps iv type a
1340450|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1340451|NCT01415427|MPS IVA|mps iva
1340452|NCT01415427|Morquio A Syndrome|morquio a syndrome
1340453|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
1340454|NCT01415427|LSD|lsd
1340455|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1340456|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
1340457|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
1340458|NCT01415427|GALNS|galns
1340459|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
1340460|NCT01415427|ERT|ert
1340461|NCT01415414|Image quality|image quality
1340462|NCT01415414|CNR|cnr
1340463|NCT01415414|SNR|snr
1340464|NCT01415414|Abdominal|abdominal
1340465|NCT01415414|Pelvic|pelvic
1340466|NCT01415401|Glaucoma|glaucoma
1340467|NCT01415401|Ocular hypertension|ocular hypertension
1340468|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
1340469|NCT01415401|Open angle glaucoma|open angle glaucoma
1340470|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
1340471|NCT01415401|Pigmentary|pigmentary
1340472|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
1340673|NCT01414374|phytotherapy|phytotherapy
1340473|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
1340474|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
1340475|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
1340476|NCT01415362|electroencephalography|electroencephalography
1340477|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
1340478|NCT01415323|Psychomotor agitation|psychomotor agitation
1340479|NCT01415323|Suicide|suicide
1340480|NCT01415323|Violence|violence
1340481|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
1340482|NCT01415310|Quality register|quality register
1340483|NCT01415310|Quality improvement|quality improvement
1340484|NCT01415310|Quality control|quality control
1340485|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
1340486|NCT01415297|Phase 1|phase 1
1340487|NCT01415297|advanced solid tumors|advanced solid tumors
1340488|NCT01415284|Obstetric anesthesia|obstetric anesthesia
1340489|NCT01415284|Spinal anesthesia|spinal anesthesia
1340490|NCT01415284|Hypotension|hypotension
1340491|NCT01415284|Fluid therapy|fluid therapy
1340492|NCT01415284|Cesarean section|cesarean section
1340493|NCT01415284|phenylephrine|phenylephrine
1340494|NCT01415284|cardiac output|cardiac output
1340495|NCT01415271|diabetes|diabetes
1340496|NCT01415271|A1c|a1c
1340497|NCT01415271|internet|internet
1340498|NCT01415271|long term care|long term care
1340499|NCT01415258|cancer|cancer
1340500|NCT01415258|vulnerability|vulnerability
1340501|NCT01415258|frail|frail
1340502|NCT01415232|Obesity|obesity
1340503|NCT01415232|Ultrasound|ultrasound
1340504|NCT01415219|rehabilitation|rehabilitation
1340505|NCT01415219|exercise|exercise
1340506|NCT01415219|efficacy|efficacy
1340507|NCT01415219|functional status|functional status
1340508|NCT01415206|Behavioral changes|behavioral changes
1340509|NCT01415206|Multiple risks|multiple risks
1340510|NCT01415180|sepsis|sepsis
1340511|NCT01415180|health related quality of life|health related quality of life
1340512|NCT01415180|functional status|functional status
1340513|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
1340514|NCT01415180|organ dysfunction|organ dysfunction
1340515|NCT01415154|TMS|tms
1340516|NCT01415154|Major Depressive Disorder|major depressive disorder
1340517|NCT01415154|NeuroStar TMS|neurostar tms
1340518|NCT01415141|genotype 1|genotype 1
1340519|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
1340520|NCT01415141|telaprevir|telaprevir
1340521|NCT01415141|peginterferon|peginterferon
1340522|NCT01415141|ribavirin|ribavirin
1340523|NCT01415115|diabetes|diabetes
1340524|NCT01415115|hypertension|hypertension
1340525|NCT01415089|Cancer|cancer
1340526|NCT01415089|Quality of life|quality of life
1340527|NCT01415089|Family caregiver|family caregiver
1340528|NCT01415089|Stress and coping|stress and coping
1340529|NCT01415089|Web-based intervention|web-based intervention
1340530|NCT01415089|Communication|communication
1340531|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
1340533|NCT01415063|TACE|tace
1340534|NCT01415050|Osteoporosis|osteoporosis
1340535|NCT01415050|Menopause|menopause
1340536|NCT01415050|Raloxifane|raloxifane
1340537|NCT01415050|Alendronate|alendronate
1340538|NCT01415037|Annular Array Ultrasound|annular array ultrasound
1340539|NCT01415037|Ultrasound Exam|ultrasound exam
1340540|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
1340541|NCT01415037|PVD|pvd
1340542|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
1340543|NCT01415024|CRT|crt
1340544|NCT01415024|Dual LV|dual lv
1340545|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
1340546|NCT01415024|two leftventricular leads|two leftventricular leads
1340547|NCT01415024|Av VV optimization|av vv optimization
1340548|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
1340549|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
1340550|NCT01415011|EGFR Mutation|egfr mutation
1340551|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
1340552|NCT01415011|Poor performance status|poor performance status
1340553|NCT01415011|Elderly|elderly
1340554|NCT01414985|Batten Disease|batten disease
1340555|NCT01414972|Atherosclerosis|atherosclerosis
1340556|NCT01414972|Coronary Artery Disease|coronary artery disease
1340557|NCT01414972|Vitamin A|vitamin a
1340558|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1340559|NCT01414972|gene expression|gene expression
1340560|NCT01414959|intensive care patient|intensive care patient
1340561|NCT01414959|intubation|intubation
1340562|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
1340563|NCT01414920|Drug Therapy|drug therapy
1340564|NCT01414907|Drinking Behavior|drinking behavior
1340565|NCT01414907|Harm Reduction|harm reduction
1340566|NCT01414907|Tobacco Use Cessation|tobacco use cessation
1340567|NCT01414907|Smoking Cessation|smoking cessation
1340568|NCT01414907|Rehabilitation|rehabilitation
1340569|NCT01414907|Health Promotion|health promotion
1340570|NCT01414907|Nutrition Therapy|nutrition therapy
1340571|NCT01414907|Feeding Behavior|feeding behavior
1340572|NCT01414907|Exercise|exercise
1340573|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
1340574|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
1340575|NCT01414881|mipomersen|mipomersen
1340576|NCT01414868|Leukotriene|leukotriene
1340577|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
1340578|NCT01414868|bronchial provocation test|bronchial provocation test
1340579|NCT01414868|therapeutic outcome|therapeutic outcome
1340580|NCT01414829|Peptic disease|peptic disease
1340581|NCT01414829|Helicobacter pylori|helicobacter pylori
1340582|NCT01414829|Different methods|different methods
1340583|NCT01414816|Multiple Sclerosis|multiple sclerosis
1340584|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
1340585|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
1340586|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
1340587|NCT01414790|parotid tumor|parotid tumor
1340588|NCT01414790|total parotidectomy|total parotidectomy
1340589|NCT01414777|c-section|c-section
1340590|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
1340591|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
1340592|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
1340593|NCT01414751|Risk communication|risk communication
1340594|NCT01414751|Shared decision making|shared decision making
1340595|NCT01414751|Cardiovascular diseases|cardiovascular diseases
1340596|NCT01414751|Hypercholesterolemia|hypercholesterolemia
1340597|NCT01414751|Prevention|prevention
1340598|NCT01414725|Multiple Sclerosis|multiple sclerosis
1340599|NCT01414725|Mobility|mobility
1340600|NCT01414725|Balance|balance
1340601|NCT01414725|Core Stability|core stability
1340602|NCT01414725|Physiotherapy|physiotherapy
1340603|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
1340604|NCT01414699|dietary variety|dietary variety
1340605|NCT01414699|course sequence|course sequence
1340606|NCT01414699|preschool|preschool
1340607|NCT01414699|child feeding|child feeding
1340608|NCT01414673|IUI|iui
1340609|NCT01414673|HCG|hcg
1340610|NCT01414673|Spontaneous LH|spontaneous lh
1340611|NCT01414673|pregnancy|pregnancy
1340612|NCT01414660|interleukin 7|interleukin 7
1340613|NCT01414660|transplantation|transplantation
1340614|NCT01414660|liver|liver
1340615|NCT01414660|kidney|kidney
1340616|NCT01414660|islet|islet
1340617|NCT01414660|diabetes|diabetes
1340618|NCT01414647|Bilberry|bilberry
1340619|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
1340620|NCT01414647|Metabolic syndrome|metabolic syndrome
1340621|NCT01414647|Glucose metabolism|glucose metabolism
1340622|NCT01414647|Lipid metabolism|lipid metabolism
1340623|NCT01414647|Inflammation|inflammation
1340624|NCT01414647|Gene expression|gene expression
1340625|NCT01414621|CABG|cabg
1340626|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
1340627|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1340628|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
1340629|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
1340630|NCT01414582|tDCS|tdcs
1340631|NCT01414582|Stroke|stroke
1340632|NCT01414582|Functional MRI|functional mri
1340633|NCT01414582|Motor Learning|motor learning
1340634|NCT01414543|violence|violence
1340635|NCT01414517|Prebiotics|prebiotics
1340636|NCT01414517|Acute Intestinal Injury|acute intestinal injury
1340637|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
1340638|NCT01414504|pneumococcal,|pneumococcal,
1340639|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
1340640|NCT01414504|challenge dose,|challenge dose,
1340641|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
1340642|NCT01414504|Papua New Guinea|papua new guinea
1340643|NCT01414478|emesis|emesis
1340644|NCT01414478|nausea|nausea
1340645|NCT01414465|Fatty acids|fatty acids
1340646|NCT01414465|orlistat|orlistat
1340647|NCT01414465|lipase|lipase
1567110|NCT00510042|quality of life|quality of life
1340648|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
1340649|NCT01414465|Women|women
1340650|NCT01414465|18 to 45 years|18 to 45 years
1340651|NCT01414465|Premenopausal stage|premenopausal stage
1340652|NCT01414452|Myocardial Infarction|myocardial infarction
1340653|NCT01414452|Reperfusion injury|reperfusion injury
1340654|NCT01414452|Adiponectin|adiponectin
1340655|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
1340656|NCT01414413|HIV|hiv
1340657|NCT01414413|AIDS|aids
1340658|NCT01414413|Antiretroviral therapy|antiretroviral therapy
1340659|NCT01414413|Community-based study|community-based study
1340660|NCT01414413|Cluster-randomised trial|cluster-randomised trial
1340661|NCT01414413|HIV testing|hiv testing
1340662|NCT01414413|Africa|africa
1340663|NCT01414400|Bacteremia|bacteremia
1340664|NCT01414400|Spyglass|spyglass
1340665|NCT01414400|Cholangioscopy|cholangioscopy
1340666|NCT01414387|carotid stenosis|carotid stenosis
1340667|NCT01414387|cerebral embolization|cerebral embolization
1340668|NCT01414387|stents|stents
1340669|NCT01414387|stroke|stroke
1340670|NCT01414374|iron|iron
1340671|NCT01414374|anemia|anemia
1340672|NCT01414374|herbal medicine|herbal medicine
1340674|NCT01414374|Centella asiatica|centella asiatica
1340675|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
1340676|NCT01414361|Coronary artery stenosis|coronary artery stenosis
1340677|NCT01414361|Fractional flow reserve|fractional flow reserve
1340678|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
1340679|NCT01414348|participation|participation
1340680|NCT01414348|activities of daily living|activities of daily living
1340681|NCT01414348|brain injuries|brain injuries
1340682|NCT01414348|executive function|executive function
1340683|NCT01414335|amino acids|amino acids
1340684|NCT01414335|immune system|immune system
1340685|NCT01414335|vitamins|vitamins
1340686|NCT01414335|chronic infection|chronic infection
1340687|NCT01414335|common cold|common cold
1340688|NCT01414335|ear|ear
1340689|NCT01414335|nose|nose
1340690|NCT01414335|throat|throat
1340691|NCT01414309|Heart Failure|heart failure
1340692|NCT01414309|Central Sleep Apnea|central sleep apnea
1340693|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
1340694|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
1340695|NCT01414257|Rheumatrex|rheumatrex
1340696|NCT01414257|High Dose|high dose
1340697|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
1340698|NCT01414244|Glutamine|glutamine
1340699|NCT01414244|Intestinal Permeability|intestinal permeability
1340700|NCT01414231|AML|aml
1340701|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
1340702|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
1340703|NCT01414231|CR rate|cr rate
1340704|NCT01414231|patients <60 years|patients <60 years
1340705|NCT01414218|elderly|elderly
1340706|NCT01414218|humor|humor
1340707|NCT01414218|general well being|general well being
1340708|NCT01414218|psychological distress|psychological distress
1340709|NCT01414218|health quality of life|health quality of life
1340710|NCT01414179|nutrition|nutrition
1340711|NCT01414179|environnement|environnement
1340712|NCT01414179|cardiovascular pathology|cardiovascular pathology
1340713|NCT01414153|choroidal neovascularization|choroidal neovascularization
1340714|NCT01414153|age-related macular degeneration|age-related macular degeneration
1340715|NCT01414153|iSONEP|isonep
1340716|NCT01414153|sonepcizumab|sonepcizumab
1340717|NCT01414153|Lucentis|lucentis
1340718|NCT01414153|ranibizumab|ranibizumab
1340720|NCT01414153|bevacizumab|bevacizumab
1340721|NCT01414153|Eylea|eylea
1340722|NCT01414153|aflibercept|aflibercept
1340723|NCT01414140|Mirena, contraception|mirena, contraception
1340724|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
1340725|NCT01414114|Renal Dialysis|renal dialysis
1340726|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1340727|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
1340728|NCT01414114|Parathyroid hormone|parathyroid hormone
1340729|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
1340730|NCT01414088|Nephrology|nephrology
1340731|NCT01414088|ENaC|enac
1340732|NCT01414088|NCC|ncc
1340733|NCT01414088|NKCC|nkcc
1340734|NCT01414088|Sodium channels|sodium channels
1340735|NCT01414088|renal biomarkers|renal biomarkers
1340736|NCT01414075|Kidney|kidney
1340737|NCT01414075|ESRD|esrd
1340738|NCT01414075|Renal|renal
1340739|NCT01414075|End-Stage Renal Disease|end-stage renal disease
1340740|NCT01414075|Anemia|anemia
1340741|NCT01414075|Oral anemia treatment|oral anemia treatment
1340742|NCT01414075|Hemoglobin levels|hemoglobin levels
1340743|NCT01414075|Hemodialysis|hemodialysis
1340744|NCT01414075|Peritoneal|peritoneal
1340745|NCT01414075|HD|hd
1340746|NCT01414075|PD|pd
1340747|NCT01414075|Hb|hb
1340748|NCT01414075|Erythropoietin|erythropoietin
1340749|NCT01414075|Blood count|blood count
1340750|NCT01414062|Breast Cancer|breast cancer
1340751|NCT01414062|Healthy meals|healthy meals
1340752|NCT01414062|Cocinar|cocinar
1340753|NCT01414062|Dietary|dietary
1340754|NCT01414062|Dietary Intervention|dietary intervention
1340755|NCT01414062|fruits and vegetables|fruits and vegetables
1340756|NCT01414062|Cancer survivor|cancer survivor
1340757|NCT01414062|Nutrition|nutrition
1340758|NCT01414049|CABG|cabg
1340759|NCT01414049|Off-pump CABG|off-pump cabg
1340760|NCT01414049|Beating heart|beating heart
1340761|NCT01414049|Graft patency|graft patency
1340762|NCT01414049|Computed tomography angiography|computed tomography angiography
1340763|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
1340764|NCT01414036|cigarette smoking|cigarette smoking
1340765|NCT01414036|patient navigation|patient navigation
1340766|NCT01414036|primary care|primary care
1340767|NCT01414023|High OCI-R scores|high oci-r scores
1340768|NCT01414010|healthy volunteers|healthy volunteers
1340769|NCT01414010|gut microbiota|gut microbiota
1340770|NCT01414010|gut microbiome|gut microbiome
1340771|NCT01414010|prebiotic|prebiotic
1340772|NCT01414010|probiotic|probiotic
1340773|NCT01414010|antibiotic|antibiotic
1340774|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
1340775|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
1340776|NCT01413984|Trauma|trauma
1340777|NCT01413984|incarceration|incarceration
1340778|NCT01413984|treatment|treatment
1340779|NCT01413984|substance abuse|substance abuse
1340780|NCT01413958|Nasal Decongestants|nasal decongestants
1340781|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
1340782|NCT01413958|Rhinitis|rhinitis
1340783|NCT01413958|Nose Conditions|nose conditions
1340784|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
1340785|NCT01413958|Phenylephrine|phenylephrine
1340786|NCT01413945|Ileocecal valve|ileocecal valve
1340787|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
1340788|NCT01413945|small bowel bacteria|small bowel bacteria
1340789|NCT01413867|hemorrhoids|hemorrhoids
1340790|NCT01413867|circular staplers|circular staplers
1340791|NCT01413867|mucosal resection|mucosal resection
1340792|NCT01413867|hemostatic suture|hemostatic suture
1340793|NCT01413841|PCI|pci
1340794|NCT01413841|oxygen|oxygen
1340795|NCT01413828|breast cancer|breast cancer
1340796|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
1340797|NCT01413828|trastuzumab|trastuzumab
1340798|NCT01413828|anthracycline|anthracycline
1340799|NCT01413815|peri-operative|peri-operative
1340800|NCT01413815|cardiovascular risk|cardiovascular risk
1340801|NCT01413815|oral supplementation|oral supplementation
1340802|NCT01413815|amino acid L-arginine|amino acid l-arginine
1340803|NCT01413802|Thyroid surgery|thyroid surgery
1340804|NCT01413763|Actinic keratosis|actinic keratosis
1340805|NCT01413763|Atrial ectopy|atrial ectopy
1340806|NCT01413724|Administered analgesic therapy|administered analgesic therapy
1340807|NCT01413711|IS|is
1340808|NCT01413711|Pharmacokinetics|pharmacokinetics
1340809|NCT01413711|Area under the curve|area under the curve
1340810|NCT01413711|Maximum plasma concentration|maximum plasma concentration
1340811|NCT01413711|Time to maximum concentration|time to maximum concentration
1340812|NCT01413685|tacrolimus|tacrolimus
1340813|NCT01413685|calcineurin|calcineurin
1340814|NCT01413685|pharmacodynamic|pharmacodynamic
1340815|NCT01413685|TDM|tdm
1340816|NCT01413685|pharmacokinetics|pharmacokinetics
1340817|NCT01413672|ostomy|ostomy
1340818|NCT01413672|colostomy|colostomy
1340819|NCT01413672|ileostomy|ileostomy
1340820|NCT01413672|barrier|barrier
1340821|NCT01413672|irritation|irritation
1340822|NCT01413659|Colorectal surgery|colorectal surgery
1340823|NCT01413659|Surgical site infection|surgical site infection
1340824|NCT01413659|Symbiotic|symbiotic
1340825|NCT01413646|obesity|obesity
1340826|NCT01413646|walnuts|walnuts
1340827|NCT01413646|endothelial function|endothelial function
1340828|NCT01413620|Vitamin E|vitamin e
1340829|NCT01413620|Burn|burn
1340830|NCT01413620|Oxidation|oxidation
1340831|NCT01413620|Lung Dysfunction|lung dysfunction
1340832|NCT01413620|Fatty Liver|fatty liver
1340833|NCT01413620|Lipid Peroxidation|lipid peroxidation
1340834|NCT01413607|nephrectomy|nephrectomy
1340835|NCT01413607|self retaining sutures|self retaining sutures
1340836|NCT01413607|laparoscopy|laparoscopy
1340837|NCT01413594|cerebral palsy|cerebral palsy
1340838|NCT01413594|constraint-induced therapy|constraint-induced therapy
1340839|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
1340840|NCT01413594|CP|cp
1340841|NCT01413594|hemiplegia|hemiplegia
1340842|NCT01413594|hand|hand
1340843|NCT01413594|forced use|forced use
1340844|NCT01413594|motor control|motor control
1340845|NCT01413594|children|children
1340846|NCT01413594|HABIT|habit
1340847|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
1340848|NCT01413594|bilateral training|bilateral training
1340849|NCT01413594|bimanual training|bimanual training
1340850|NCT01413594|functional therapy|functional therapy
1340851|NCT01413594|physical therapy|physical therapy
1340852|NCT01413594|occupational therapy|occupational therapy
1340853|NCT01413594|intensive|intensive
1340854|NCT01413594|pediatric|pediatric
1340855|NCT01413594|development|development
1340856|NCT01413594|upper extremity|upper extremity
1340857|NCT01413594|hemiplegic|hemiplegic
1340858|NCT01413594|childhood stroke|childhood stroke
1340859|NCT01413581|rhBSSL|rhbssl
1340860|NCT01413581|preterm infants|preterm infants
1340861|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
1340862|NCT01413581|growth velocity|growth velocity
1340863|NCT01413581|Prevention of growth restriction|prevention of growth restriction
1340864|NCT01413555|blood culture|blood culture
1340865|NCT01413555|emergency department|emergency department
1340866|NCT01413555|quality improvement|quality improvement
1340867|NCT01413542|DPPIV inhibitors|dppiv inhibitors
1340868|NCT01413542|ACE inhibitors|ace inhibitors
1340869|NCT01413542|Bradykinin|bradykinin
1340870|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
1340871|NCT01413542|BNP|bnp
1340872|NCT01413542|diabetes|diabetes
1340873|NCT01413542|hypertension|hypertension
1340874|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
1340875|NCT01413516|Varenicline|varenicline
1340876|NCT01413516|Placebo|placebo
1340877|NCT01413516|Inpatient|inpatient
1340878|NCT01413503|Pheochromocytoma|pheochromocytoma
1340879|NCT01413503|Paraganglioma|paraganglioma
1340880|NCT01413503|MIBG|mibg
1340881|NCT01413503|131I-MIBG|131i-mibg
1340882|NCT01413503|Resistant|resistant
1340883|NCT01413503|Relapsed|relapsed
1340884|NCT01413503|Treatment|treatment
1340885|NCT01413503|UCSF|ucsf
1340886|NCT01413503|Pediatric|pediatric
1340887|NCT01413503|Adult|adult
1340888|NCT01413503|Oncology|oncology
1340889|NCT01413490|hepatitis C virus|hepatitis c virus
1340890|NCT01413490|Interferon|interferon
1340891|NCT01413490|rimantadine|rimantadine
1340892|NCT01413490|liver|liver
1340893|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
1340894|NCT01413477|Nickel allergy|nickel allergy
1340895|NCT01413477|Desensitization therapy|desensitization therapy
1340896|NCT01413464|Renal Transplant|renal transplant
1340897|NCT01413464|Venous Thrombosis|venous thrombosis
1340898|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
1340899|NCT01413464|Prophylaxis|prophylaxis
1340900|NCT01413464|Bleeding|bleeding
1340901|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
1340902|NCT01413451|Biodistribution|biodistribution
1340903|NCT01413451|Pharmacokinetics|pharmacokinetics
1340904|NCT01413451|HACA|haca
1340905|NCT01413451|Safety|safety
1340906|NCT01413451|Mesothelioma|mesothelioma
1340907|NCT01413451|Ovarian Cancer|ovarian cancer
1340908|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
1340909|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
1340910|NCT01413438|Bevacizumab|bevacizumab
1340911|NCT01413438|Quality of Life|quality of life
1340912|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
1340913|NCT01413438|Neurosurgery|neurosurgery
1340914|NCT01413438|Glioblastoma|glioblastoma
1340915|NCT01413438|GBM|gbm
1340916|NCT01413438|Brain Tumor|brain tumor
1340917|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1340918|NCT01413425|Cholesterol|cholesterol
1340919|NCT01413425|SLOS|slos
1340920|NCT01413412|Ventral Hernia|ventral hernia
1340921|NCT01413412|Postoperative Pain|postoperative pain
1340922|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
1340923|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
1340924|NCT01413412|Biodex|biodex
1340925|NCT01413386|paclitaxel|paclitaxel
1340926|NCT01413386|drug eluting stent|drug eluting stent
1340927|NCT01413373|cephalometry|cephalometry
1340928|NCT01413373|three-dimensional|three-dimensional
1340930|NCT01413373|lateral radiography|lateral radiography
1340931|NCT01413373|facial symmetry|facial symmetry
1340932|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
1340933|NCT01413334|Coronary artery disease|coronary artery disease
1340934|NCT01413334|CT|ct
1340935|NCT01413321|Brain Injuries|brain injuries
1340936|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
1340937|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1340938|NCT01413321|Cerebral Stroke|cerebral stroke
1340939|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
1340940|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
1340941|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
1340942|NCT01413321|hemiparesis|hemiparesis
1340943|NCT01413308|Fontan|fontan
1340944|NCT01413308|lung function test|lung function test
1340945|NCT01413308|nitric oxide production|nitric oxide production
1340946|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
1340947|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
1340948|NCT01413295|Dendritic Cells|dendritic cells
1340949|NCT01413282|Acute coronary syndrome|acute coronary syndrome
1340950|NCT01413269|breast cancer patients|breast cancer patients
1340951|NCT01413269|breast conservation surgery|breast conservation surgery
1340952|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
1340953|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
1340954|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
1340955|NCT01413230|vitamin D supplementation|vitamin d supplementation
1340956|NCT01413230|regulatory T cells|regulatory t cells
1340957|NCT01413230|Th17 cells|th17 cells
1340958|NCT01413204|TA-7284|ta-7284
1340959|NCT01413204|JNJ-28431754|jnj-28431754
1340960|NCT01413204|Canagliflozin|canagliflozin
1340961|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
1340962|NCT01413178|Myeloma|myeloma
1340963|NCT01413178|Multiple Myeloma|multiple myeloma
1340964|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
1340966|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
1340967|NCT01413178|Busulfan|busulfan
1340968|NCT01413178|Busulfex|busulfex
1340969|NCT01413178|Myleran|myleran
1340970|NCT01413178|Melphalan|melphalan
1340971|NCT01413178|Alkeran|alkeran
1340972|NCT01413178|G-CSF|g-csf
1340973|NCT01413178|Filgrastim|filgrastim
1340974|NCT01413178|NeupogenTM|neupogentm
1340975|NCT01413178|Questionnaire|questionnaire
1340976|NCT01413178|Survey|survey
1340977|NCT01413178|Quality of Life|quality of life
1340978|NCT01413178|QOL|qol
1340979|NCT01413152|men having sex with men|men having sex with men
1340980|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
1340981|NCT01413139|claudication|claudication
1340982|NCT01413139|rest pain|rest pain
1340983|NCT01413126|Peanut|peanut
1340984|NCT01413126|Blood glucose|blood glucose
1340985|NCT01413126|Insulin|insulin
1340986|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
1340987|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
1340988|NCT01413126|Peptide YY|peptide yy
1340989|NCT01413126|Cholecystokinin|cholecystokinin
1340990|NCT01413126|Appetitive|appetitive
1340991|NCT01413126|Food intake|food intake
1340992|NCT01413087|Pancreatic cancer|pancreatic cancer
1340993|NCT01413087|Gemcitabine|gemcitabine
1340994|NCT01413087|BC-819|bc-819
1340995|NCT01413087|Adenocarcinoma|adenocarcinoma
1340996|NCT01413087|Resectable|resectable
1340997|NCT01413087|H19 gene|h19 gene
1340998|NCT01413087|DTA-H19|dta-h19
1340999|NCT01413087|BioCancell|biocancell
1341000|NCT01413074|End Stage Renal Disease|end stage renal disease
1341001|NCT01413074|ESRD|esrd
1341002|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
1341003|NCT01413074|PD|pd
1341004|NCT01413074|Hemodialysis|hemodialysis
1341005|NCT01413074|HD|hd
1341006|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
1341007|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
1341008|NCT01413048|Essential Hypertension|essential hypertension
1341009|NCT01413048|Hypertension|hypertension
1341010|NCT01413035|Diabetes|diabetes
1341011|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
1341012|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
1341013|NCT01413035|Transplantation|transplantation
1341014|NCT01413009|delirium|delirium
1341015|NCT01413009|ICU|icu
1341016|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
1341017|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
1341018|NCT01413009|early mobility|early mobility
1341019|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
1341020|NCT01412970|volume responsiveness|volume responsiveness
1341021|NCT01412970|electrical impedance tomography|electrical impedance tomography
1341022|NCT01412957|Best Supportive Care|best supportive care
1341023|NCT01412957|Panitumumab|panitumumab
1341024|NCT01412957|Chemorefractory|chemorefractory
1341025|NCT01412957|Wild-type KRAS|wild-type kras
1341026|NCT01412957|Overall Survival|overall survival
1341027|NCT01412957|Phase 3|phase 3
1341028|NCT01412944|Psoriasis|psoriasis
1341029|NCT01412944|plaque|plaque
1341030|NCT01412944|inflammatory skin disease|inflammatory skin disease
1341031|NCT01412944|scaly patches|scaly patches
1341033|NCT01412944|secukinumab|secukinumab
1341034|NCT01412944|Moderate to severe|moderate to severe
1341035|NCT01412918|Tinnitus|tinnitus
1341036|NCT01412918|Inhibitor Device|inhibitor device
1341037|NCT01412918|SCN9 gene|scn9 gene
1341038|NCT01412918|Ringing in the ears|ringing in the ears
1341039|NCT01412918|Milwaukee|milwaukee
1341040|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
1341041|NCT01412905|screening|screening
1341042|NCT01412905|diabetic retinopathy|diabetic retinopathy
1341043|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
1341044|NCT01412892|Everolimus|everolimus
1341045|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
1341046|NCT01412892|Rapamycin|rapamycin
1341047|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1341048|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1341049|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1341050|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1341051|NCT01412866|schizophrenia|schizophrenia
1341052|NCT01412866|severe mental illness|severe mental illness
1453563|NCT00952380|VTE|vte
1341053|NCT01412866|nicotine|nicotine
1341054|NCT01412866|smoking|smoking
1341055|NCT01412866|motivation|motivation
1341056|NCT01412866|electronic decision support system|electronic decision support system
1341057|NCT01412866|motivational interviewing|motivational interviewing
1341058|NCT01412853|localized|localized
1341059|NCT01412840|Ureterolithiasis|ureterolithiasis
1341060|NCT01412840|Pain|pain
1341061|NCT01412840|Complementary|complementary
1341062|NCT01412840|RCT|rct
1341063|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
1341064|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
1341065|NCT01412827|rest/stress|rest/stress
1341066|NCT01412827|treadmill|treadmill
1341067|NCT01412827|persantine|persantine
1341068|NCT01412827|half-dose|half-dose
1341069|NCT01412827|radiotracer|radiotracer
1341070|NCT01412827|tetrofosmin|tetrofosmin
1341071|NCT01412827|Thallium|thallium
1341072|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
1341073|NCT01412827|diagnostic|diagnostic
1341074|NCT01412827|prognostic|prognostic
1341075|NCT01412814|Total knee arthroplasty|total knee arthroplasty
1341076|NCT01412814|Total knee replacement|total knee replacement
1341077|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
1341078|NCT01412814|Gait patterns|gait patterns
1341079|NCT01412814|Neuromuscular education|neuromuscular education
1341080|NCT01412801|Group B streptococcus|group b streptococcus
1341081|NCT01412801|GBS|gbs
1341082|NCT01412801|Vaccine|vaccine
1341083|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
1341084|NCT01412788|breast cancer|breast cancer
1341085|NCT01412788|Breast Conserving Surgery|breast conserving surgery
1341086|NCT01412788|Peri-areolar Incision|peri-areolar incision
1341087|NCT01412775|stress|stress
1341088|NCT01412775|burnout|burnout
1341089|NCT01412775|exhaustion|exhaustion
1341090|NCT01412762|Surgery|surgery
1341091|NCT01412762|interview|interview
1341092|NCT01412762|11-087|11-087
1341093|NCT01412749|registry|registry
1341094|NCT01412749|database|database
1341095|NCT01412749|eHNS|ehns
1341096|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
1341097|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
1341098|NCT01412749|TEST|test
1341099|NCT01412749|melanoma|melanoma
1341100|NCT01412749|head and neck surgery|head and neck surgery
1341101|NCT01412723|Iron Deficiency|iron deficiency
1341102|NCT01412723|Child, Preschool|child, preschool
1341103|NCT01412723|Dietary Iron|dietary iron
1341104|NCT01412723|Ferrous sulfate|ferrous sulfate
1341105|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
1341106|NCT01412710|Type 2 Diabetes|type 2 diabetes
1341107|NCT01412710|Cholecalciferol|cholecalciferol
1341108|NCT01412710|Vitamin D|vitamin d
1341109|NCT01412710|Insulin resistance|insulin resistance
1341110|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
1341111|NCT01412710|Minorities|minorities
1341112|NCT01412697|Rural youth|rural youth
1341113|NCT01412697|Theory-based intervention|theory-based intervention
1341114|NCT01412697|Randomized by schools|randomized by schools
1341115|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
1341116|NCT01412697|Health classes|health classes
1341117|NCT01412671|Nexavar|nexavar
1341118|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
1341119|NCT01412645|Obesity|obesity
1341120|NCT01412645|Inflammation|inflammation
1341121|NCT01412645|Metabolic Syndrome|metabolic syndrome
1341122|NCT01412645|Insulin sensitivity|insulin sensitivity
1341123|NCT01412645|Osteoporosis|osteoporosis
1341124|NCT01412645|Bone turnover|bone turnover
1341125|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
1341126|NCT01412645|Resveratrol|resveratrol
1341127|NCT01412619|Neurological Outcome|neurological outcome
1341128|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
1341129|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
1341130|NCT01412619|Central venous blood pressure|central venous blood pressure
1341131|NCT01412619|Cardiac output|cardiac output
1341132|NCT01412619|Serum Lactate|serum lactate
1341133|NCT01412619|Venous oxygen saturation|venous oxygen saturation
1341134|NCT01412619|Fluid balance|fluid balance
1341135|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
1341136|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
1341137|NCT01412567|Hepatitis B|hepatitis b
1341139|NCT01412567|Antenatal|antenatal
1341140|NCT01412567|Pregnancy|pregnancy
1341141|NCT01412567|Vertical transmission|vertical transmission
1341142|NCT01412567|Placenta|placenta
1341143|NCT01412567|HBV DNA|hbv dna
1341144|NCT01412554|Insulin resistance|insulin resistance
1341145|NCT01412554|Diabetes mellitus|diabetes mellitus
1341146|NCT01412554|Adipositas|adipositas
1341147|NCT01412541|Arms|arms
1341148|NCT01412541|Experimental|experimental
1341149|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
1341150|NCT01412541|Active Comparator|active comparator
1341151|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
1341152|NCT01412515|mTOR inhibitors|mtor inhibitors
1341153|NCT01412502|Tissue Donors|tissue donors
1341154|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
1341155|NCT01412502|Brain death|brain death
1341156|NCT01412502|Withdrawal of life support|withdrawal of life support
1341157|NCT01412489|Uterine synechiae|uterine synechiae
1341158|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
1341159|NCT01412489|Operative hysteroscopy|operative hysteroscopy
1341160|NCT01412489|submucous myoma|submucous myoma
1341161|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
1341162|NCT01412437|PKU|pku
1341163|NCT01412437|MRI|mri
1341164|NCT01412437|neurocognition|neurocognition
1341165|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
1341166|NCT01412424|acromegaly|acromegaly
1341167|NCT01412424|IGF-1|igf-1
1341168|NCT01412424|growth hormone|growth hormone
1341169|NCT01412424|Octreolin|octreolin
1341170|NCT01412424|octreotide|octreotide
1341171|NCT01412424|somatostatin analog|somatostatin analog
1341172|NCT01412411|Anemia|anemia
1341173|NCT01412411|Growth|growth
1341174|NCT01412411|Infants|infants
1341175|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
1341176|NCT01412398|Fosrenol|fosrenol
1341177|NCT01412398|Hyperphosphatemia|hyperphosphatemia
1341178|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
1341179|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
1341180|NCT01412372|Diarrhea|diarrhea
1341181|NCT01412372|Mesalamine|mesalamine
1341182|NCT01412372|Gastroenteritis|gastroenteritis
1341183|NCT01412372|abdominal pain|abdominal pain
1341184|NCT01412372|hypersensitivity|hypersensitivity
1341185|NCT01412359|TPN Cholestasis|tpn cholestasis
1341186|NCT01412346|human|human
1341187|NCT01412346|clinical trial|clinical trial
1341188|NCT01412346|dietary intervention study|dietary intervention study
1341189|NCT01412346|blood pressure|blood pressure
1341190|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
1341191|NCT01412346|nutritional biomarkers|nutritional biomarkers
1341192|NCT01412346|gene expression|gene expression
1341193|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
1341194|NCT01412307|Lenalidomide|lenalidomide
1341195|NCT01412307|Bendamustine|bendamustine
1341196|NCT01412307|Salvage therapy|salvage therapy
1341197|NCT01412307|Palliation|palliation
1341198|NCT01412294|gastric cancer|gastric cancer
1341199|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
1341200|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1341201|NCT01412294|capecitabine|capecitabine
1341202|NCT01412294|xp|xp
1341203|NCT01412281|Influenza|influenza
1341204|NCT01412281|Virus|virus
1341205|NCT01412281|Vaccination|vaccination
1341206|NCT01412281|Immunisation|immunisation
1341207|NCT01412268|Obesity|obesity
1341208|NCT01412268|Bariatric surgery|bariatric surgery
1341209|NCT01412268|Behavioral changes|behavioral changes
1341210|NCT01412268|Eating habits|eating habits
1341211|NCT01412268|Eating addiction|eating addiction
1341212|NCT01412242|Deep vein thrombosis|deep vein thrombosis
1341213|NCT01412242|Ultrasonography|ultrasonography
1341214|NCT01412242|Pulmonary embolism|pulmonary embolism
1341215|NCT01412242|D-dimer|d-dimer
1341216|NCT01412242|Pre-test probability|pre-test probability
1341217|NCT01412229|Head and neck cancer|head and neck cancer
1341218|NCT01412229|Phase II|phase ii
1341219|NCT01412229|Locally advanced|locally advanced
1341220|NCT01412229|Squamous Cell|squamous cell
1341221|NCT01412229|Carboplatin|carboplatin
1341222|NCT01412229|Nab-paclitaxel|nab-paclitaxel
1341223|NCT01412229|Abraxane|abraxane
1341224|NCT01412229|Cetuximab|cetuximab
1341225|NCT01412229|Induction|induction
1341226|NCT01412229|Chemotherapy|chemotherapy
1341227|NCT01412216|Sedentarism|sedentarism
1341228|NCT01412216|Physical inactivity|physical inactivity
1341229|NCT01412216|Fish oil|fish oil
1341230|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
1341231|NCT01412216|Endothelial dysfunction|endothelial dysfunction
1341232|NCT01412216|Insulin resistance|insulin resistance
1341233|NCT01412216|Metabolic syndrome|metabolic syndrome
1341234|NCT01412216|peripheral arterial disease|peripheral arterial disease
1341235|NCT01412203|Physical activity|physical activity
1341236|NCT01412203|Healthy weight|healthy weight
1341237|NCT01412203|Healthy eating|healthy eating
1341238|NCT01412203|Physical fitness|physical fitness
1341239|NCT01412203|Children|children
1341240|NCT01412203|School based|school based
1341241|NCT01412203|Community based|community based
1341242|NCT01412203|Obesity|obesity
1341243|NCT01412203|Health promotion|health promotion
1341244|NCT01412203|Socio-ecological|socio-ecological
1341245|NCT01412203|Environment based|environment based
1341246|NCT01412190|Skin rejuvenation|skin rejuvenation
1341247|NCT01412177|Meniere's Disease|meniere's disease
1341248|NCT01412177|Vertigo|vertigo
1341249|NCT01412177|Definitive vertigo|definitive vertigo
1341250|NCT01412177|Vertigo episodes|vertigo episodes
1341251|NCT01412177|Vertigo frequency|vertigo frequency
1341252|NCT01412177|Tinnitus|tinnitus
1341253|NCT01412177|Hearing loss|hearing loss
1341254|NCT01412177|Aural fullness|aural fullness
1341255|NCT01412164|DES|des
1341256|NCT01412164|CAD|cad
1341257|NCT01412164|FIREHAWK|firehawk
1341258|NCT01412164|MicroPort|microport
1341259|NCT01412164|PCI|pci
1341260|NCT01412151|Symptomatic|symptomatic
1341261|NCT01412151|Huntington's Disease|huntington's disease
1341262|NCT01412151|HD|hd
1341263|NCT01412125|Biomarkers|biomarkers
1341264|NCT01412125|Genetic polymorphism|genetic polymorphism
1341265|NCT01412125|Neuroimaging markers|neuroimaging markers
1341266|NCT01412125|Neuropsychology|neuropsychology
1341267|NCT01412099|Exercise|exercise
1341268|NCT01412099|Fast Foods|fast foods
1341269|NCT01412099|Fruits|fruits
1341270|NCT01412099|Vegetables|vegetables
1341271|NCT01412099|Beverages|beverages
1341272|NCT01412099|Non-traditional college students|non-traditional college students
1341273|NCT01412099|Motivational Interviewing|motivational interviewing
1341274|NCT01412099|Peer Counselors|peer counselors
1341275|NCT01412099|Cancer Prevention|cancer prevention
1341276|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
1341277|NCT01412060|Schizophrenia|schizophrenia
1341278|NCT01412060|Schizophrenic Disorder|schizophrenic disorder
1341279|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1341280|NCT01412047|PNH|pnh
1341281|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
1341282|NCT01412047|HAHA|haha
1341283|NCT01412047|Soliris|soliris
1341284|NCT01412047|eculizumab|eculizumab
1341285|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1341286|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
1341287|NCT01412034|HDL mimetic|hdl mimetic
1341288|NCT01412034|ApoA-1|apoa-1
1341289|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
1341290|NCT01412008|MRI|mri
1341291|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
1341292|NCT01412008|Botox|botox
1341293|NCT01412008|botulinum toxin|botulinum toxin
1341294|NCT01412008|neurological|neurological
1341295|NCT01412008|stroke|stroke
1341296|NCT01412008|spasticity|spasticity
1341297|NCT01412008|muscle stiffness|muscle stiffness
1341298|NCT01412008|diffusion|diffusion
1341299|NCT01412008|Weill Cornell|weill cornell
1341300|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
1341301|NCT01412008|O'Dell|o'dell
1341302|NCT01411995|intrauterine device|intrauterine device
1341303|NCT01411995|pain|pain
1341304|NCT01411995|lidocaine gel|lidocaine gel
1341305|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
1341306|NCT01411982|Nephrotic syndrome|nephrotic syndrome
1341307|NCT01411982|Thrombosis|thrombosis
1341308|NCT01411982|Platelets|platelets
1341309|NCT01411969|external nasal dilator strip|external nasal dilator strip
1341310|NCT01411969|nasal valve|nasal valve
1341311|NCT01411969|acoustic rhinometry|acoustic rhinometry
1341312|NCT01411956|Health Behavior Theory|health behavior theory
1341313|NCT01411956|Patient Education|patient education
1341314|NCT01411956|Hypertension|hypertension
1341315|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
1341316|NCT01411943|Epigenetics|epigenetics
1341317|NCT01411943|Inflammatory|inflammatory
1341318|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
1341319|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
1341320|NCT01411943|Pain|pain
1341321|NCT01411943|Fatigue|fatigue
1341322|NCT01411943|Sleep Disturbance|sleep disturbance
1341323|NCT01411943|Depression|depression
1341324|NCT01411943|Depressive Symptoms|depressive symptoms
1341325|NCT01411943|Anxiety|anxiety
1341326|NCT01411943|Breast Cancer|breast cancer
1341327|NCT01411930|Insulin resistance|insulin resistance
1341328|NCT01411930|Antipsychotics|antipsychotics
1341329|NCT01411930|Olanzapine|olanzapine
1341330|NCT01411930|Aripiprazole|aripiprazole
1341331|NCT01411917|surgical stomas|surgical stomas
1341332|NCT01411917|Nerve block|nerve block
1341333|NCT01411904|Leukemia|leukemia
1341334|NCT01411904|magnetic needle|magnetic needle
1341335|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
1341336|NCT01411904|CD34|cd34
1341337|NCT01411891|Arthroplasty|arthroplasty
1341338|NCT01411891|Infection Control|infection control
1341339|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
1341340|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
1341341|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
1341342|NCT01411865|Knowledge translation|knowledge translation
1341343|NCT01411865|Clinical practice guidelines|clinical practice guidelines
1341344|NCT01411865|Administrative databases|administrative databases
1341345|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
1341346|NCT01411852|trauma|trauma
1341347|NCT01411852|hemorrhagic shock|hemorrhagic shock
1341348|NCT01411839|Depression|depression
1341349|NCT01411839|Latinos|latinos
1341350|NCT01411839|Adherence|adherence
1341351|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1341352|NCT01411839|HIV/AIDS|hiv/aids
1341353|NCT01411826|Colon cancer screening|colon cancer screening
1341354|NCT01411787|Breast cancer|breast cancer
1341355|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1341356|NCT01411787|exercise|exercise
1341357|NCT01411787|Ki-67|ki-67
1341358|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
1341359|NCT01411774|OCD|ocd
1341360|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
1341361|NCT01411761|very low birth weight infants|very low birth weight infants
1341362|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
1341363|NCT01411722|Weaning outcome|weaning outcome
1341364|NCT01411722|NAVA|nava
1341365|NCT01411683|Cost estimates|cost estimates
1341366|NCT01411683|Complete Denture|complete denture
1341367|NCT01411683|Dental Economics|dental economics
1341368|NCT01411683|Dental Implants|dental implants
1341369|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
1341370|NCT01411683|Denture Retention|denture retention
1341371|NCT01411683|Edentulous|edentulous
1341372|NCT01411683|Edentulism|edentulism
1341373|NCT01411683|Mini dental implant|mini dental implant
1341374|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
1341375|NCT01411683|Overdenture|overdenture
1341376|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
1341377|NCT01411683|Quality of Health Care|quality of health care
1341378|NCT01411683|Quality of Life|quality of life
1341379|NCT01411683|Patient Satisfaction|patient satisfaction
1341380|NCT01411670|Human Protein C|human protein c
1341381|NCT01411670|Activated protein C|activated protein c
1341382|NCT01411670|Microcirculation|microcirculation
1341383|NCT01411670|Septic Shock|septic shock
1341384|NCT01411670|Sepsis|sepsis
1341385|NCT01411644|POF|pof
1341386|NCT01411644|IOF|iof
1341387|NCT01411644|Poor response|poor response
1341388|NCT01411644|early menopause|early menopause
1341389|NCT01411644|Primary amenorrhea|primary amenorrhea
1341390|NCT01411631|Polyphenols|polyphenols
1341391|NCT01411631|Cognition|cognition
1341392|NCT01411631|Cognitive function|cognitive function
1341393|NCT01411631|Driving performance|driving performance
1341394|NCT01411631|Stress|stress
1341395|NCT01411618|Antiplaque agents|antiplaque agents
1341396|NCT01411618|chemical plaque control|chemical plaque control
1341397|NCT01411618|oral hygiene|oral hygiene
1341398|NCT01411618|essential oils|essential oils
1341399|NCT01411618|alcohol|alcohol
1341400|NCT01411618|mouthwash|mouthwash
1341401|NCT01411605|Obesity|obesity
1341402|NCT01411605|Adolescent|adolescent
1341403|NCT01411605|Exercise training|exercise training
1341404|NCT01411605|Exercise tolerance|exercise tolerance
1341405|NCT01411592|All-Ceramic|all-ceramic
1341406|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
1341407|NCT01411592|Single Retainer|single retainer
1341408|NCT01411592|Randomized Clinical Trial|randomized clinical trial
1341409|NCT01411592|Resin Bond|resin bond
1341410|NCT01411592|Bonding System|bonding system
1341411|NCT01411579|liver|liver
1341412|NCT01411579|metastases|metastases
1341413|NCT01411579|hepatocarcinoma|hepatocarcinoma
1341414|NCT01411579|MR|mr
1341415|NCT01411579|DWI|dwi
1341416|NCT01411579|chemotherapy|chemotherapy
1341417|NCT01411566|KLIPS|klips
1341418|NCT01411553|ICU|icu
1341419|NCT01411553|Telemetry|telemetry
1341420|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
1341421|NCT01411553|Infection|infection
1341422|NCT01411553|Nuisance alarms|nuisance alarms
1341423|NCT01411540|Body composition|body composition
1341424|NCT01411540|Health markers|health markers
1341425|NCT01411540|Diet|diet
1341426|NCT01411527|Hormones|hormones
1341427|NCT01411527|Endocrine Disrupters|endocrine disrupters
1341428|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
1341429|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
1341430|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
1341431|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
1341432|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
1341433|NCT01411501|Acupuncture|acupuncture
1341434|NCT01411501|Functional constipation|functional constipation
1341435|NCT01411488|Focus: anal erosion|focus: anal erosion
1341436|NCT01411449|Primovist|primovist
1341437|NCT01411449|MRI agent|mri agent
1341438|NCT01411436|Nexavar|nexavar
1341439|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1341440|NCT01411423|Nexavar|nexavar
1341441|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
1341442|NCT01411410|phase I|phase i
1341443|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
1341444|NCT01411410|paclitaxel|paclitaxel
1341445|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
1341446|NCT01411397|Infection|infection
1341447|NCT01411397|Prosthesis|prosthesis
1341448|NCT01411397|Recurrence|recurrence
1341449|NCT01411397|Strangulation|strangulation
1341450|NCT01411384|Keratoconus (KC)|keratoconus (kc)
1567111|NCT00510016|infants|infants
1341451|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
1341452|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
1341453|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
1341454|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
1341455|NCT01411371|Atrial fibrillation|atrial fibrillation
1341456|NCT01411371|Heart failure|heart failure
1341457|NCT01411371|Catheter ablation|catheter ablation
1341458|NCT01411358|influenza|influenza
1341459|NCT01411358|vaccine|vaccine
1341460|NCT01411358|immunogenicity|immunogenicity
1341461|NCT01411345|Prostate Cancer|prostate cancer
1341462|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
1341463|NCT01411332|Prostate Cancer|prostate cancer
1341464|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
1341465|NCT01411319|Prostate Cancer|prostate cancer
1341466|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
1341467|NCT01411293|cardiovascular disease|cardiovascular disease
1341468|NCT01411293|oxidative stress|oxidative stress
1341469|NCT01411293|dairy consumption|dairy consumption
1341470|NCT01411293|metabolic syndrome|metabolic syndrome
1341471|NCT01411293|obesity|obesity
1341472|NCT01411293|endothelial function|endothelial function
1341473|NCT01411267|Relapse|relapse
1341474|NCT01411267|Lymphoblastic|lymphoblastic
1341475|NCT01411267|Leukemia|leukemia
1341476|NCT01411267|AC220|ac220
1341477|NCT01411267|Refractory|refractory
1341478|NCT01411267|Myelogenous|myelogenous
1341479|NCT01411267|Acute|acute
1341480|NCT01411267|Childhood|childhood
1341481|NCT01411267|Pediatric|pediatric
1341482|NCT01411267|ALL|all
1341483|NCT01411267|AML|aml
1341484|NCT01411254|DME|dme
1341485|NCT01411241|Dengue|dengue
1341486|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1341487|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
1341488|NCT01411241|Pentaxim™|pentaxim™
1341489|NCT01411228|Gaucher disease|gaucher disease
1341490|NCT01411228|pediatrics|pediatrics
1341491|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
1341492|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
1341493|NCT01411215|observational study|observational study
1341494|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
1341495|NCT01411202|Doxycycline|doxycycline
1341496|NCT01411202|Pleurodesis|pleurodesis
1341497|NCT01411202|Pleurx catheter|pleurx catheter
1341498|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
1341499|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1341500|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
1341501|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
1341502|NCT01411189|PEG|peg
1341503|NCT01411189|EMR|emr
1341504|NCT01411189|ESD|esd
1341505|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
1341506|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
1341507|NCT01411176|suspected gastric cancer|suspected gastric cancer
1341508|NCT01411163|Premanifest|premanifest
1341509|NCT01411163|At-Risk|at-risk
1341510|NCT01411163|Huntington's Disease|huntington's disease
1341511|NCT01411163|HD|hd
1341512|NCT01411150|Premanifest|premanifest
1341513|NCT01411150|At-Risk|at-risk
1341514|NCT01411150|Huntington's Disease|huntington's disease
1341515|NCT01411150|HD|hd
1341516|NCT01411124|gabapentin|gabapentin
1341517|NCT01411124|restless leg syndrome|restless leg syndrome
1341518|NCT01411111|Drug-drug interaction|drug-drug interaction
1341519|NCT01411111|rosuvastatin|rosuvastatin
1341520|NCT01411111|asthma|asthma
1341521|NCT01411111|FLAP inhibitor|flap inhibitor
1341522|NCT01411085|Schizophrenia|schizophrenia
1341523|NCT01411085|Alcoholism|alcoholism
1341524|NCT01411085|Dual Diagnosis|dual diagnosis
1341525|NCT01411085|Desipramine|desipramine
1341526|NCT01411085|Risperidone|risperidone
1341527|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
1341528|NCT01411072|resected pancreas cancer|resected pancreas cancer
1341529|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
1341530|NCT01411046|Glucocorticoid|glucocorticoid
1341531|NCT01411046|polymorphism|polymorphism
1341532|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
1341533|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
1341534|NCT01411046|adrenal insufficiency|adrenal insufficiency
1341535|NCT01411046|prednisolone treatment|prednisolone treatment
1341536|NCT01411007|Nicotine|nicotine
1341537|NCT01411007|Cigarettes|cigarettes
1341538|NCT01411007|Smoker|smoker
1341539|NCT01411007|realtime fMRI|realtime fmri
1341540|NCT01411007|brain imaging|brain imaging
1341541|NCT01411007|imaging|imaging
1341542|NCT01410994|glomerular filtration rate|glomerular filtration rate
1341543|NCT01410955|probiotics|probiotics
1341544|NCT01410955|diarrhoea|diarrhoea
1341545|NCT01410955|prevention|prevention
1341546|NCT01410955|colon cancer|colon cancer
1341547|NCT01410955|irinotecan|irinotecan
1341548|NCT01410942|Prostate Cancer|prostate cancer
1341549|NCT01410942|Multimodal Therapy|multimodal therapy
1341550|NCT01410942|MMT|mmt
1341551|NCT01410942|Fatigue|fatigue
1341552|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
1341553|NCT01410942|CBT|cbt
1341554|NCT01410942|Radiation therapy|radiation therapy
1341555|NCT01410942|Radiotherapy|radiotherapy
1341556|NCT01410942|RT|rt
1341557|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
1341558|NCT01410942|FACIT-F|facit-f
1341559|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
1341560|NCT01410942|Methylphenidate|methylphenidate
1341561|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
1341562|NCT01410942|Ritalin|ritalin
1341563|NCT01410942|Concerta|concerta
1341564|NCT01410942|Placebo|placebo
1341565|NCT01410942|Sugar Pill|sugar pill
1341566|NCT01410929|multiple myeloma|multiple myeloma
1341567|NCT01410929|VCF|vcf
1341568|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
1341569|NCT01410929|Spine|spine
1341570|NCT01410929|Kyphoplasty|kyphoplasty
1341571|NCT01410929|Back pain|back pain
1341572|NCT01410929|Cancer|cancer
1341573|NCT01410916|STEC-HUS|stec-hus
1341574|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
1341575|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
1341576|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
1341577|NCT01410864|dural opening|dural opening
1341578|NCT01410864|dural sealing|dural sealing
1341579|NCT01410838|Obesity|obesity
1341580|NCT01410838|Food preferences|food preferences
1341581|NCT01410838|Eating Behavior|eating behavior
1341582|NCT01410825|WAS|was
1341583|NCT01410825|Wiskott|wiskott
1341584|NCT01410825|Gene Transfer|gene transfer
1341585|NCT01410825|Gene Therapy|gene therapy
1341586|NCT01410812|Interest in exercising more|interest in exercising more
1341587|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
1341588|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
1341589|NCT01410799|Aging|aging
1341590|NCT01410799|Growth Hormone|growth hormone
1341591|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
1341592|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1341593|NCT01410799|Hormones|hormones
1341594|NCT01410760|Imaging study|imaging study
1341595|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
1341596|NCT01410747|long-term treatment|long-term treatment
1341597|NCT01410747|tacrolimus|tacrolimus
1341598|NCT01410747|renal failure|renal failure
1341599|NCT01410734|cholecystectomy|cholecystectomy
1341600|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
1341601|NCT01410721|TBI|tbi
1341602|NCT01410721|PTSD|ptsd
1341603|NCT01410721|Veterans|veterans
1341604|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
1341605|NCT01410708|Dasatinin|dasatinin
1341606|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
1341607|NCT01410695|RA|ra
1341608|NCT01410695|masitinib|masitinib
1341609|NCT01410695|DMARD|dmard
1341610|NCT01410695|methotrexate|methotrexate
1341611|NCT01410682|oral hygiene|oral hygiene
1341612|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
1341613|NCT01410682|infection control|infection control
1341614|NCT01410682|intensive care|intensive care
1341615|NCT01410682|pediatric nursing|pediatric nursing
1341616|NCT01410682|pediatrics|pediatrics
1341617|NCT01410669|Self-efficacy|self-efficacy
1341618|NCT01410669|Intimate partner violence|intimate partner violence
1341619|NCT01410669|Randomized clinical trial|randomized clinical trial
1341620|NCT01410669|Depression|depression
1341621|NCT01410656|Survivors|survivors
1341622|NCT01410643|puberty|puberty
1341623|NCT01410643|body composition|body composition
1341624|NCT01410643|metabolism|metabolism
1341625|NCT01410643|obesity|obesity
1341922|NCT01409382|pregnancy|pregnancy
1341626|NCT01410643|optimization of body composition|optimization of body composition
1341627|NCT01410643|pubertal transition|pubertal transition
1341628|NCT01410604|Metformin|metformin
1341629|NCT01410604|Obesity|obesity
1341630|NCT01410604|Insulin resistance|insulin resistance
1341631|NCT01410604|Interleukin six|interleukin six
1341632|NCT01410604|Adiponectin|adiponectin
1341633|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
1341634|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
1341635|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
1341636|NCT01410591|TIPS|tips
1341637|NCT01410591|liver cirrhosis|liver cirrhosis
1341638|NCT01410591|variceal bleeding|variceal bleeding
1341639|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
1341640|NCT01410578|sTRE-1|stre-1
1341641|NCT01410578|PCT|pct
1341642|NCT01410578|CRP|crp
1341643|NCT01410578|sepsis|sepsis
1341644|NCT01410578|bacteremia|bacteremia
1341645|NCT01410578|FUO|fuo
1341646|NCT01410578|diagnosis|diagnosis
1341647|NCT01410578|prognosis|prognosis
1341648|NCT01410565|Bladder Cancer|bladder cancer
1341649|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
1341650|NCT01410565|NMIBC|nmibc
1341651|NCT01410565|Apaziquone|apaziquone
1454229|NCT00950677|Symlin|symlin
1341652|NCT01410565|EOquin|eoquin
1341653|NCT01410565|GU Cancer|gu cancer
1341654|NCT01410565|TURBT|turbt
1341655|NCT01410552|Primary prevention|primary prevention
1341656|NCT01410552|Secondary prevention|secondary prevention
1341657|NCT01410539|Stent Thrombosis|stent thrombosis
1341658|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
1341659|NCT01410539|Bare Metal Stent|bare metal stent
1341660|NCT01410539|Drug Eluting Stent|drug eluting stent
1341661|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
1341662|NCT01410539|Optical Coherence Tomography|optical coherence tomography
1341663|NCT01410539|OCT|oct
1341664|NCT01410526|VAC|vac
1341665|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
1341666|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
1341667|NCT01410526|Peritonitis|peritonitis
1341668|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
1341669|NCT01410500|multiple myeloma|multiple myeloma
1341670|NCT01410487|pulmonary circulation|pulmonary circulation
1341671|NCT01410474|Meningococcal|meningococcal
1341672|NCT01410474|ACWY|acwy
1341673|NCT01410474|bacterial meningitis|bacterial meningitis
1341674|NCT01410474|conjugate vaccine|conjugate vaccine
1341675|NCT01410474|healthy|healthy
1341676|NCT01410474|children|children
1341677|NCT01410474|adolescents|adolescents
1341678|NCT01410474|Taiwan|taiwan
1341679|NCT01410461|painful bladder|painful bladder
1341680|NCT01410461|physical therapy|physical therapy
1341681|NCT01410461|levator ani|levator ani
1341682|NCT01410448|Immunosuppression|immunosuppression
1341683|NCT01410448|Kidney transplantation|kidney transplantation
1341684|NCT01410448|everolimus|everolimus
1341685|NCT01410448|safety|safety
1341686|NCT01410422|COPD|copd
1341687|NCT01410422|Bronchiectasis|bronchiectasis
1341688|NCT01410422|Metabolomics|metabolomics
1341689|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
1341690|NCT01410409|Treatment Outcome|treatment outcome
1341691|NCT01410409|Time Factors|time factors
1341692|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
1341693|NCT01410409|Rehabilitation|rehabilitation
1341694|NCT01410409|Combined Modality Therapy|combined modality therapy
1341695|NCT01410409|Middle Aged|middle aged
1341696|NCT01410409|Aged|aged
1341697|NCT01410409|Aged, 80 and over|aged, 80 and over
1341698|NCT01410409|Male|male
1341699|NCT01410409|Female|female
1341700|NCT01410409|Humans|humans
1341701|NCT01410409|Analysis of Variance|analysis of variance
1341702|NCT01410396|Atrial Fibrillation|atrial fibrillation
1341703|NCT01410396|Stroke|stroke
1341704|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
1341705|NCT01410383|dyslipidemia,|dyslipidemia,
1341706|NCT01410383|thyroid,|thyroid,
1341707|NCT01410383|safety,|safety,
1341708|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
1341709|NCT01410383|coronary artery disease|coronary artery disease
1341710|NCT01410370|Endostar|endostar
1341711|NCT01410370|Radiotherapy|radiotherapy
1341712|NCT01410370|Brain Metastases|brain metastases
1341713|NCT01410357|serious mental illness|serious mental illness
1341714|NCT01410357|diabetes|diabetes
1341715|NCT01410344|HIV|hiv
1341716|NCT01410344|ALL|all
1341717|NCT01410344|AML|aml
1341718|NCT01410344|MDS|mds
1341719|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1341720|NCT01410331|CLI|cli
1341721|NCT01410331|peripheral vascular disease|peripheral vascular disease
1341722|NCT01410331|PVD|pvd
1341723|NCT01410331|PAD|pad
1341724|NCT01410331|SDF-1|sdf-1
1341725|NCT01410318|Atherosclerosis|atherosclerosis
1341726|NCT01410318|PESA|pesa
1341727|NCT01410318|Subclinical|subclinical
1341728|NCT01410318|Cardiovascular diseases|cardiovascular diseases
1341729|NCT01410318|Coronary disease|coronary disease
1342026|NCT01409174|Proleukin|proleukin
1341730|NCT01410318|Heart diseases|heart diseases
1341731|NCT01410318|Heart Failure|heart failure
1341732|NCT01410318|Myocardial Infarction|myocardial infarction
1341734|NCT01410318|Arteriosclerosis|arteriosclerosis
1341735|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
1341736|NCT01410305|HIV+ Children|hiv+ children
1341737|NCT01410305|HIV+ Young Adults|hiv+ young adults
1341738|NCT01410292|fiber|fiber
1341739|NCT01410292|glycemic index|glycemic index
1341740|NCT01410292|glycemic response|glycemic response
1341741|NCT01410292|diabetes|diabetes
1341742|NCT01410292|ghrelin|ghrelin
1341743|NCT01410279|pulmonary hypertension|pulmonary hypertension
1341744|NCT01410279|inspiratory muscle training|inspiratory muscle training
1341745|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
1341746|NCT01410279|pulmonary functional|pulmonary functional
1341747|NCT01410279|functional capacity|functional capacity
1341748|NCT01410279|quality of life|quality of life
1341749|NCT01410266|medical abortion|medical abortion
1341750|NCT01410266|first trimester|first trimester
1341751|NCT01410266|follow-up|follow-up
1341752|NCT01410266|pregnancy test|pregnancy test
1341753|NCT01410214|NSCLC|nsclc
1341754|NCT01410214|EGFR Mutation Positive|egfr mutation positive
1341755|NCT01410214|complete resection|complete resection
1341756|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
1341757|NCT01410201|Epiretinal Membrane|epiretinal membrane
1341758|NCT01410201|Macular Edema|macular edema
1341759|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
1341760|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
1341761|NCT01410188|open-angle glaucoma|open-angle glaucoma
1341762|NCT01410188|glaucoma|glaucoma
1341763|NCT01410188|ocular hypertension|ocular hypertension
1341764|NCT01410188|intraocular pressure|intraocular pressure
1341765|NCT01410162|Renal|renal
1341766|NCT01410162|Kidney/Pancreas|kidney/pancreas
1341767|NCT01410162|Transplant|transplant
1341768|NCT01410162|conversion|conversion
1341769|NCT01410162|bioequivalence|bioequivalence
1341770|NCT01410162|Mycophenolate Acid|mycophenolate acid
1341771|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
1341772|NCT01410136|Knee|knee
1341773|NCT01410136|Femur|femur
1341774|NCT01410136|Articular cartilage|articular cartilage
1341775|NCT01410136|Lesions|lesions
1341776|NCT01410136|Defects|defects
1341777|NCT01410136|Osteochondral graft|osteochondral graft
1341778|NCT01410136|Cartilage treatments|cartilage treatments
1341779|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
1341780|NCT01410136|OCD|ocd
1341781|NCT01410110|Substance Abuse|substance abuse
1341782|NCT01410110|Substance Dependence|substance dependence
1341783|NCT01410110|Cognitive Impairment|cognitive impairment
1341784|NCT01410084|vitamin D|vitamin d
1341785|NCT01410084|falls|falls
1341786|NCT01410084|deficiency|deficiency
1341787|NCT01410084|insufficiency|insufficiency
1341788|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
1341789|NCT01410058|HIV|hiv
1341790|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
1341791|NCT01410058|herbal medicine|herbal medicine
1341792|NCT01410058|pharmacokinetics|pharmacokinetics
1341793|NCT01410058|herbal pharmacology|herbal pharmacology
1341794|NCT01410045|Turner syndrome|turner syndrome
1341795|NCT01410045|infertility|infertility
1341796|NCT01410045|ovarian insufficiency|ovarian insufficiency
1341797|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
1341798|NCT01410032|clavicle|clavicle
1341799|NCT01410032|clavicular|clavicular
1341800|NCT01410032|fracture|fracture
1341801|NCT01410032|midshaft|midshaft
1341802|NCT01410032|plate|plate
1341803|NCT01410032|ESIN|esin
1341804|NCT01410032|intramedullary|intramedullary
1341805|NCT01410032|flexible|flexible
1341806|NCT01410032|nailing|nailing
1341807|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
1341808|NCT01410019|severe infection|severe infection
1341809|NCT01410019|gene therapy|gene therapy
1341810|NCT01410019|HLA identical family donor|hla identical family donor
1341811|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
1341812|NCT01410006|NF1|nf1
1341813|NCT01410006|neurofibromatosis|neurofibromatosis
1341814|NCT01410006|NF|nf
1341815|NCT01409993|BMI greater than 25|bmi greater than 25
1341816|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
1341817|NCT01409980|delta phalanx|delta phalanx
1341818|NCT01409980|thumb reconstructed|thumb reconstructed
1341819|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
1341820|NCT01409967|Anemia|anemia
1341821|NCT01409967|Transfusion|transfusion
1341822|NCT01409967|Biological markers|biological markers
1341823|NCT01409954|Fusion|fusion
1341824|NCT01409954|Spine|spine
1341825|NCT01409954|Decompression|decompression
1341826|NCT01409954|Pseudarthrosis|pseudarthrosis
1341827|NCT01409954|bone harvest|bone harvest
1341828|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
1341829|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
1341830|NCT01409941|NTproBNP|ntprobnp
1341831|NCT01409941|hsTNT|hstnt
1341832|NCT01409941|GDF-15|gdf-15
1341833|NCT01409928|obesity|obesity
1341834|NCT01409928|adolescent|adolescent
1341835|NCT01409928|pediatric|pediatric
1341836|NCT01409928|weight loss|weight loss
1341837|NCT01409928|bariatric surgery|bariatric surgery
1341838|NCT01409928|gastric banding|gastric banding
1341839|NCT01409915|Alzheimer's disease|alzheimer's disease
1341840|NCT01409915|neuropsychological assessment|neuropsychological assessment
1341841|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1341842|NCT01409915|Leukine|leukine
1341843|NCT01409876|histoscanning|histoscanning
1341844|NCT01409876|brachytherapy|brachytherapy
1341845|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
1341846|NCT01409837|Oligospermia|oligospermia
1341847|NCT01409837|Male infertility|male infertility
1341848|NCT01409837|Lisinopril|lisinopril
1341849|NCT01409824|clinical decision support system|clinical decision support system
1567112|NCT00510016|opioid withdrawal|opioid withdrawal
1454472|NCT00949780|ABR|abr
1341850|NCT01409824|performance based incentives|performance based incentives
1341851|NCT01409824|quality of maternal health care services|quality of maternal health care services
1341852|NCT01409798|Hyperparathyroidism|hyperparathyroidism
1341853|NCT01409798|Hypercalcemia|hypercalcemia
1341854|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
1341855|NCT01409759|Perforators|perforators
1341856|NCT01409759|Interposition plasty|interposition plasty
1341857|NCT01409759|Contracture release|contracture release
1341858|NCT01409746|twin|twin
1341859|NCT01409746|brain development|brain development
1341860|NCT01409746|MRI|mri
1341861|NCT01409720|bony metastases|bony metastases
1341862|NCT01409720|physical exercise|physical exercise
1341863|NCT01409694|Alzheimer Disease|alzheimer disease
1341864|NCT01409694|Vitamin D|vitamin d
1341865|NCT01409694|Cholecalciferol|cholecalciferol
1341866|NCT01409694|Memantine|memantine
1341867|NCT01409694|Cognition Disorders|cognition disorders
1341868|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
1341869|NCT01409616|Pharmacodynamics|pharmacodynamics
1341870|NCT01409616|darexaban|darexaban
1341871|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
1341872|NCT01409616|clopidogrel|clopidogrel
1341873|NCT01409616|YM150|ym150
1341874|NCT01409616|Phase 1|phase 1
1341875|NCT01409603|Pharmacodynamics|pharmacodynamics
1341876|NCT01409603|darexaban|darexaban
1341877|NCT01409603|naproxen|naproxen
1341878|NCT01409603|YM150|ym150
1341879|NCT01409603|Phase 1|phase 1
1341880|NCT01409590|Schizophrenia|schizophrenia
1341881|NCT01409590|weight gain|weight gain
1341882|NCT01409590|atypical neuroleptics|atypical neuroleptics
1341883|NCT01409577|Coronary stenosis|coronary stenosis
1341884|NCT01409577|stent|stent
1341885|NCT01409577|fractional flow reserve|fractional flow reserve
1341886|NCT01409564|Alzheimer's dementia|alzheimer's dementia
1341887|NCT01409564|Cilostazol|cilostazol
1341888|NCT01409551|Pleural effusion|pleural effusion
1341889|NCT01409551|VATS|vats
1341890|NCT01409551|hyperthermia|hyperthermia
1341891|NCT01409551|thoracostomy|thoracostomy
1341892|NCT01409551|pleurodesis|pleurodesis
1341893|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
1341894|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
1341895|NCT01409486|Pompe disease|pompe disease
1341896|NCT01409486|Alpha glucosidase|alpha glucosidase
1341897|NCT01409486|Newborn screening|newborn screening
1341898|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
1341899|NCT01409486|The study aims:|the study aims:
1341900|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
1341901|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
1341902|NCT01409473|Prostate cancer|prostate cancer
1341903|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
1341904|NCT01409473|Radiosurgery|radiosurgery
1341905|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
1341906|NCT01409473|SBRT|sbrt
1341907|NCT01409473|IMRT|imrt
1341908|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
1341909|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
1341910|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
1341911|NCT01409473|Intraprostatic lesions|intraprostatic lesions
1341912|NCT01409473|IPL|ipl
1341913|NCT01409421|adherence|adherence
1341914|NCT01409421|glaucoma|glaucoma
1341915|NCT01409421|motivational interviewing|motivational interviewing
1341916|NCT01409408|Hypertension|hypertension
1341917|NCT01409408|Diabetes Mellitus|diabetes mellitus
1341918|NCT01409408|Vascular stiffness|vascular stiffness
1341919|NCT01409408|Endothelial function|endothelial function
1341920|NCT01409395|Drug drug interaction|drug drug interaction
1341921|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
1341923|NCT01409382|physical activity|physical activity
1341924|NCT01409382|sedentary lifestyle|sedentary lifestyle
1341925|NCT01409382|high-glycemic index diet|high-glycemic index diet
1341926|NCT01409382|take-home baby|take-home baby
1341927|NCT01409382|recurrent miscarriages|recurrent miscarriages
1341928|NCT01409382|preterm delivery|preterm delivery
1341929|NCT01409356|Obesity|obesity
1341930|NCT01409356|Portal hypertension|portal hypertension
1341931|NCT01409356|Cirrhosis|cirrhosis
1341932|NCT01409356|Diet|diet
1341933|NCT01409356|Exercise|exercise
1341934|NCT01409343|advanced solid cancers|advanced solid cancers
1341935|NCT01409343|metastatic solid cancers|metastatic solid cancers
1341936|NCT01409330|insulin sensitivity|insulin sensitivity
1341937|NCT01409330|type 2 diabetes|type 2 diabetes
1341938|NCT01409330|diet intervention|diet intervention
1341939|NCT01409317|Major Depression|major depression
1341940|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1341941|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
1341942|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1341943|NCT01409317|rTMS|rtms
1341944|NCT01409317|DTMS|dtms
1341945|NCT01409317|fMRI|fmri
1341946|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
1341947|NCT01409304|Major depression|major depression
1341948|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
1341949|NCT01409304|Naturalistic Trial|naturalistic trial
1341950|NCT01409304|DTMS|dtms
1341951|NCT01409291|low socioeconomic status|low socioeconomic status
1341952|NCT01409291|stress|stress
1341953|NCT01409291|women|women
1341954|NCT01409291|children|children
1341955|NCT01409291|cortisol|cortisol
1341956|NCT01409265|stroke rehabilitation|stroke rehabilitation
1341957|NCT01409265|perceptual deficits|perceptual deficits
1341958|NCT01409252|Stroke|stroke
1341959|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
1341960|NCT01409252|surgery|surgery
1341961|NCT01409239|hospital|hospital
1341962|NCT01409239|diabetes|diabetes
1341963|NCT01409239|glycemic variability|glycemic variability
1341964|NCT01409239|autonomic tone|autonomic tone
1341965|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
1341966|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
1341967|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
1341968|NCT01409226|diagnostic|diagnostic
1341970|NCT01409226|BI-RADS 4|bi-rads 4
1341971|NCT01409226|mammographically occult|mammographically occult
1341972|NCT01409200|Prostate cancer|prostate cancer
1341973|NCT01409200|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1341974|NCT01409200|Ductal adenocarcinoma|ductal adenocarcinoma
1341975|NCT01409200|Androgen deprivation therapy|androgen deprivation therapy
1341976|NCT01409200|ADT|adt
1341977|NCT01409200|Hormonal therapy|hormonal therapy
1341978|NCT01409200|Suspected lymph node metastasis|suspected lymph node metastasis
1341979|NCT01409200|TxN1M0 or TxNxM1a|txn1m0 or txnxm1a
1341980|NCT01409200|Progression-free|progression-free
1341981|NCT01409200|Pathologic complete response|pathologic complete response
1341982|NCT01409200|pCR|pcr
1341983|NCT01409200|Systemic therapy|systemic therapy
1341984|NCT01409200|Radical prostatectomy|radical prostatectomy
1341985|NCT01409200|Pelvic lymph node dissection|pelvic lymph node dissection
1341986|NCT01409200|Axitinib|axitinib
1341987|NCT01409200|AG-013736|ag-013736
1341988|NCT01409187|Melanoma|melanoma
1341989|NCT01409187|Metastatic Melanoma|metastatic melanoma
1341990|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
1341991|NCT01409187|IPI-Biotherapy|ipi-biotherapy
1341992|NCT01409187|Ipilimumab|ipilimumab
1341993|NCT01409187|Yervoy|yervoy
1341994|NCT01409187|BMS-734016|bms-734016
1341995|NCT01409187|MDX010|mdx010
1341996|NCT01409187|Interferon|interferon
1341997|NCT01409187|IFN Alpha-2b|ifn alpha-2b
1341998|NCT01409187|Intron A|intron a
1341999|NCT01409187|Interferon Apha-2b|interferon apha-2b
1342000|NCT01409187|Interleukin-2|interleukin-2
1342001|NCT01409187|IL-2|il-2
1342002|NCT01409187|Aldesleukin|aldesleukin
1342003|NCT01409187|Proleukin|proleukin
1342004|NCT01409174|Melanoma|melanoma
1342005|NCT01409174|Metastatic|metastatic
1342006|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
1342007|NCT01409174|Chemonaive|chemonaive
1342008|NCT01409174|Advanced stage IV|advanced stage iv
1342009|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
1342010|NCT01409174|1.0 cm or larger|1.0 cm or larger
1342011|NCT01409174|Ipilimumab|ipilimumab
1342012|NCT01409174|Yervoy|yervoy
1342013|NCT01409174|BMS-734016|bms-734016
1342014|NCT01409174|MDX010|mdx010
1342015|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
1342016|NCT01409174|Intron A|intron a
1342017|NCT01409174|Temozolomide|temozolomide
1342018|NCT01409174|Temodar|temodar
1342019|NCT01409174|Cisplatin|cisplatin
1342020|NCT01409174|Platinol-AQ|platinol-aq
1342021|NCT01409174|Platinol|platinol
1342022|NCT01409174|CDDP|cddp
1342023|NCT01409174|Interleukin-2|interleukin-2
1342024|NCT01409174|IL-2|il-2
1342025|NCT01409174|Aldesleukin|aldesleukin
1342059|NCT01409122|nitric oxide|nitric oxide
1342060|NCT01409122|sodium nitrite|sodium nitrite
1342061|NCT01409122|sildenafil|sildenafil
1342063|NCT01409122|pulmonary hypertension|pulmonary hypertension
1342064|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
1342065|NCT01409109|Schizophrenia|schizophrenia
1342066|NCT01409109|Schizoaffective|schizoaffective
1342067|NCT01409109|Neuroimaging|neuroimaging
1342068|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1342069|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1342070|NCT01409109|Spectroscopy|spectroscopy
1342071|NCT01409083|infiltration|infiltration
1342072|NCT01409083|extravasation|extravasation
1342073|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
1342074|NCT01409083|sodium bicarbonate|sodium bicarbonate
1342075|NCT01409070|MDS|mds
1342076|NCT01409057|Inflammation parameters|inflammation parameters
1342077|NCT01409057|Various blood values|various blood values
1342078|NCT01409057|Clinical Outcome|clinical outcome
1342079|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
1342080|NCT01409057|SAPS-Score|saps-score
1342081|NCT01409057|SOFA-Score|sofa-score
1342082|NCT01409057|Duration of artificial respiration|duration of artificial respiration
1342083|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
1342084|NCT01409044|Music Listening|music listening
1342085|NCT01409044|Opioids|opioids
1342086|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
1342087|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
1342088|NCT01409031|newborns|newborns
1342089|NCT01409031|respiratory failure|respiratory failure
1342090|NCT01409031|pulmonary hypertension|pulmonary hypertension
1342091|NCT01409031|treatment|treatment
1342092|NCT01409018|pediatric|pediatric
1342093|NCT01409018|cancer|cancer
1342094|NCT01409018|invasive fungal disease|invasive fungal disease
1342095|NCT01409018|antifungal agent|antifungal agent
1342096|NCT01408992|Hearing screening|hearing screening
1342097|NCT01408992|Questionnaire|questionnaire
1342098|NCT01408992|Hearing disability|hearing disability
1342099|NCT01408979|Severe preeclampsia|severe preeclampsia
1342100|NCT01408979|magnesium sulfate|magnesium sulfate
1342101|NCT01408979|anticonvulsivant|anticonvulsivant
1342102|NCT01408966|Dark chocolate|dark chocolate
1342103|NCT01408966|Catechins|catechins
1342104|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
1342105|NCT01408966|Cirrhosis|cirrhosis
1342106|NCT01408966|Portal Hypertension|portal hypertension
1342107|NCT01408953|Keloid|keloid
1342108|NCT01408927|Thienopyridine resistance|thienopyridine resistance
1342109|NCT01408927|Aspirin resistance|aspirin resistance
1342110|NCT01408927|Platelet reactivity|platelet reactivity
1342111|NCT01408901|peripheral arterial disease|peripheral arterial disease
1342112|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
1342113|NCT01408901|PAD|pad
1342114|NCT01408901|GM-CSF|gm-csf
1342115|NCT01408901|sargramostim|sargramostim
1342116|NCT01408901|leukine|leukine
1342117|NCT01408901|treadmill exercise|treadmill exercise
1342118|NCT01408875|Chronic Heart Failure|chronic heart failure
1342119|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
1342120|NCT01408875|Exercise training|exercise training
1342121|NCT01408875|Peak VO2|peak vo2
1342122|NCT01408875|Electrical myostimulation|electrical myostimulation
1342123|NCT01408862|GLP1|glp1
1342124|NCT01408862|GIP|gip
1342125|NCT01408862|platelets|platelets
1342126|NCT01408862|human|human
1342127|NCT01408862|aggregation|aggregation
1342128|NCT01408849|Endoscopy|endoscopy
1342129|NCT01408849|Herbal medicine|herbal medicine
1342130|NCT01408849|Phytotherapy|phytotherapy
1342131|NCT01408836|Vasculitis|vasculitis
1342132|NCT01408836|ANCA|anca
1342133|NCT01408836|Therapy|therapy
1342134|NCT01408836|Plasma exchange|plasma exchange
1342135|NCT01408836|Immunosuppression|immunosuppression
1342136|NCT01408823|Pediatrics|pediatrics
1342137|NCT01408823|Scoliosis|scoliosis
1342138|NCT01408823|Pharmacokinetics|pharmacokinetics
1342139|NCT01408823|Hemorrhage|hemorrhage
1342140|NCT01408823|Orthopedic Surgery|orthopedic surgery
1342141|NCT01408810|infliximab|infliximab
1342142|NCT01408810|ulcerative colitis|ulcerative colitis
1342143|NCT01408810|histologic remission|histologic remission
1342144|NCT01408797|clonal deletion|clonal deletion
1342145|NCT01408797|kidney transplantation|kidney transplantation
1342146|NCT01408784|calories|calories
1342147|NCT01408784|counting|counting
1342148|NCT01408784|obesity|obesity
1342149|NCT01408784|overweight|overweight
1342150|NCT01408784|categories|categories
1342151|NCT01408784|calorie|calorie
1342152|NCT01408784|method|method
1342153|NCT01408784|counting calories|counting calories
1342154|NCT01408784|lose weight|lose weight
1342155|NCT01408784|diet|diet
1342156|NCT01408784|energy balance|energy balance
1342157|NCT01408784|energy intake|energy intake
1342158|NCT01408784|24 hours recall|24 hours recall
1342159|NCT01408784|food intake|food intake
1342160|NCT01408771|Urodynamics|urodynamics
1342161|NCT01408771|Overactive Bladder|overactive bladder
1342162|NCT01408745|medical device|medical device
1342163|NCT01408745|sternal closure|sternal closure
1342164|NCT01408745|sternotomy|sternotomy
1342165|NCT01408745|dehiscence|dehiscence
1342166|NCT01408745|sternal wound healing|sternal wound healing
1342167|NCT01408745|randomized trial|randomized trial
1342168|NCT01408745|steel wire|steel wire
1342169|NCT01408732|Epistaxis|epistaxis
1342170|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1342171|NCT01408732|HHT|hht
1342172|NCT01408732|Sclerotherapy|sclerotherapy
1342173|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
1342174|NCT01408719|Beta-Glucan|beta-glucan
1342175|NCT01408719|Barley|barley
1342176|NCT01408719|Molecular Weight|molecular weight
1342177|NCT01408719|Viscosity|viscosity
1342178|NCT01408719|Cholesterol|cholesterol
1342179|NCT01408719|Stable isotope|stable isotope
1342180|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
1342181|NCT01408719|Gut microbiota|gut microbiota
1342182|NCT01408693|hip fracture|hip fracture
1342183|NCT01408693|hemiarthroplasty|hemiarthroplasty
1342184|NCT01408693|endoprosthesis|endoprosthesis
1342185|NCT01408693|elderly|elderly
1342186|NCT01408693|minimally invasive surgery|minimally invasive surgery
1342187|NCT01408693|anterior approach|anterior approach
1342188|NCT01408693|geriatric patients|geriatric patients
1342189|NCT01408680|End-stage Renal Disease|end-stage renal disease
1342190|NCT01408680|Hemodialysis|hemodialysis
1342191|NCT01408680|Cardiovascular Disease|cardiovascular disease
1342192|NCT01408680|Antioxidants|antioxidants
1342193|NCT01408680|Atherosclerosis|atherosclerosis
1342194|NCT01408680|Coenzyme Q10|coenzyme q10
1342195|NCT01408667|insulin sensitivity|insulin sensitivity
1342196|NCT01408667|cardiometabolic risk|cardiometabolic risk
1342197|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
1342198|NCT01408654|Suicidal Ideation|suicidal ideation
1342199|NCT01408654|Loneliness|loneliness
1342200|NCT01408654|Social Support|social support
1342201|NCT01408654|Voluntary Workers|voluntary workers
1342202|NCT01408654|Friends/Companions|friends/companions
1342203|NCT01408654|Prevention|prevention
1342204|NCT01408654|Aged|aged
1342205|NCT01408641|topiramate|topiramate
1342206|NCT01408641|PTSD|ptsd
1342207|NCT01408641|drinking|drinking
1342208|NCT01408641|alcohol|alcohol
1342209|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
1342210|NCT01408589|alcohol|alcohol
1342211|NCT01408589|craving|craving
1342212|NCT01408589|mood|mood
1342213|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
1342214|NCT01408576|Lupus|lupus
1342215|NCT01408576|Monoclonal antibody|monoclonal antibody
1342216|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
1342217|NCT01408576|Epratuzumab|epratuzumab
1342218|NCT01408563|NHL|nhl
1342219|NCT01408563|lymphoma|lymphoma
1342220|NCT01408563|leukemia|leukemia
1342221|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
1342222|NCT01408563|aplastic anemia|aplastic anemia
1342223|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
1342224|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
1342225|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
1342226|NCT01408537|vero cell|vero cell
1342227|NCT01408537|children|children
1342228|NCT01408537|immunogenicity|immunogenicity
1342229|NCT01408537|safety|safety
1342230|NCT01408524|Hypertension|hypertension
1342231|NCT01408524|emergence|emergence
1342232|NCT01408524|craniotomy|craniotomy
1342233|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
1342234|NCT01408498|Testosterone|testosterone
1342235|NCT01408498|Social psychology|social psychology
1342236|NCT01408498|Human behavior|human behavior
1342237|NCT01408459|Prostate cancer prevention|prostate cancer prevention
1342238|NCT01408446|Hypertension|hypertension
1342239|NCT01408446|Menthol|menthol
1342240|NCT01408446|Metabolism|metabolism
1342241|NCT01408433|embryo transfer|embryo transfer
1342242|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
1342243|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
1342244|NCT01408433|infertility|infertility
1342245|NCT01408433|single embryo transfer|single embryo transfer
1342246|NCT01408433|two embryo transfer|two embryo transfer
1342247|NCT01408433|double embryo transfer|double embryo transfer
1342248|NCT01408420|Renal insufficiency|renal insufficiency
1342249|NCT01408420|Acute Kidney Injury|acute kidney injury
1342250|NCT01408420|Postoperative|postoperative
1342251|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
1342252|NCT01408420|Heart surgery|heart surgery
1342253|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
1342254|NCT01408394|safety|safety
1342255|NCT01408394|pharmacokinetics|pharmacokinetics
1342256|NCT01408394|controlled release|controlled release
1342257|NCT01408394|formulation|formulation
1342258|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
1342259|NCT01408381|Cell Therapy|cell therapy
1342260|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
1342261|NCT01408368|Graves' disease|graves' disease
1342262|NCT01408368|total thyroidectomy|total thyroidectomy
1342263|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
1342264|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
1342265|NCT01408368|morbidity rate|morbidity rate
1342266|NCT01408342|Alemtuzumab|alemtuzumab
1342267|NCT01408342|Rituximab|rituximab
1342268|NCT01408342|Aplastic anemia|aplastic anemia
1342269|NCT01408342|cyclosporine|cyclosporine
1342270|NCT01408316|Healthy Volunteer|healthy volunteer
1342271|NCT01408316|PX-866|px-866
1342272|NCT01408316|PI3K Inhibitor|pi3k inhibitor
1342273|NCT01408303|dyslipidemia|dyslipidemia
1342274|NCT01408303|hyperlipidemia|hyperlipidemia
1342275|NCT01408303|cardiovascular risk|cardiovascular risk
1342276|NCT01408290|seasonal|seasonal
1342277|NCT01408290|prevention|prevention
1342278|NCT01408290|influenza|influenza
1342279|NCT01408290|infection|infection
1342280|NCT01408290|influenza vaccine|influenza vaccine
1342281|NCT01408290|vaccine|vaccine
1342282|NCT01408290|influenza in humans|influenza in humans
1342283|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
1342284|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
1342285|NCT01408238|Immunotherapy|immunotherapy
1342286|NCT01408238|Skin prick test|skin prick test
1342287|NCT01408238|Standardization|standardization
1342288|NCT01408238|Secale cereale|secale cereale
1342289|NCT01408225|MGUS|mgus
1342290|NCT01408225|Multiple Myeloma|multiple myeloma
1342291|NCT01408225|Tissue Bank|tissue bank
1342292|NCT01408199|Lenalidomide|lenalidomide
1342293|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
1342294|NCT01408186|aspirin|aspirin
1342296|NCT01408186|H2RA|h2ra
1342297|NCT01408173|caffeine|caffeine
1342298|NCT01408173|apnea|apnea
1342299|NCT01408173|prematurity|prematurity
1342300|NCT01408147|Postpartum weight retention|postpartum weight retention
1342301|NCT01408147|Low income women|low income women
1342302|NCT01408147|WIC|wic
1342303|NCT01408147|Online|online
1342304|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
1342305|NCT01408121|Platelet reactivity|platelet reactivity
1342306|NCT01408121|Genotyping|genotyping
1342307|NCT01408108|Hiatal hernia|hiatal hernia
1342308|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
1342309|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
1342310|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
1342311|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
1342312|NCT01408095|diabetes|diabetes
1342313|NCT01408095|glimepiride|glimepiride
1342314|NCT01408095|diabetes type II|diabetes type ii
1342315|NCT01408095|diabetes type 2|diabetes type 2
1342316|NCT01408095|Type 2 diabetes|type 2 diabetes
1342317|NCT01408095|diabetes mellitus|diabetes mellitus
1342318|NCT01408069|headache|headache
1342319|NCT01408069|migraine|migraine
1342320|NCT01408056|Hemangioma|hemangioma
1342321|NCT01408056|Infantile Hemangioma|infantile hemangioma
1342322|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
1342323|NCT01408056|Timolol|timolol
1342324|NCT01408056|Beta blocker|beta blocker
1342325|NCT01408056|Vascular anomaly|vascular anomaly
1342326|NCT01408030|epistaxis|epistaxis
1342327|NCT01408030|HHT|hht
1342328|NCT01408030|bevacizumab|bevacizumab
1342329|NCT01408030|tranexamic acid|tranexamic acid
1342330|NCT01408030|nosebleed|nosebleed
1342331|NCT01408030|estrogen|estrogen
1342332|NCT01408004|Renal carcinoma|renal carcinoma
1342333|NCT01408004|Resistance|resistance
1342334|NCT01408004|Reversible|reversible
1342335|NCT01408004|Translational|translational
1342336|NCT01407991|Enteral tube placement|enteral tube placement
1342337|NCT01407978|Influenza|influenza
1342338|NCT01407978|Pandemic vaccine|pandemic vaccine
1342339|NCT01407978|Seasonal vaccine|seasonal vaccine
1342340|NCT01407978|Prevention|prevention
1342341|NCT01407978|Influenza vaccine|influenza vaccine
1342342|NCT01407978|Influenza in humans|influenza in humans
1342343|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
1342344|NCT01407978|Influenza vaccine for children|influenza vaccine for children
1342345|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
1342346|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
1342347|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
1342348|NCT01407965|obesity|obesity
1342349|NCT01407965|pharmacokinetic|pharmacokinetic
1342350|NCT01407965|ertapenem|ertapenem
1342351|NCT01407965|meropenem|meropenem
1342352|NCT01407952|treatment trial|treatment trial
1342353|NCT01407952|cerebral aneurysm|cerebral aneurysm
1342354|NCT01407952|randomized|randomized
1342355|NCT01407952|coils|coils
1342356|NCT01407952|endovascular|endovascular
1342357|NCT01407952|HEAT|heat
1342358|NCT01407952|bare platinum|bare platinum
1342359|NCT01407952|Hydrogel|hydrogel
1342360|NCT01407952|Hydrocoil|hydrocoil
1342361|NCT01407939|Bitter Taste|bitter taste
1342362|NCT01407939|Bitter Blockers|bitter blockers
1342363|NCT01407939|Pediatric Medications|pediatric medications
1342364|NCT01407939|Sensory methodology|sensory methodology
1342365|NCT01407939|Children|children
1342366|NCT01407926|Depression|depression
1342367|NCT01407926|Aging|aging
1342368|NCT01407926|Clinical Effectiveness|clinical effectiveness
1342369|NCT01407926|Home Care|home care
1342370|NCT01407926|Nurse-Led|nurse-led
1342371|NCT01407900|CD NP|cd np
1342372|NCT01407900|dual receptor|dual receptor
1342373|NCT01407900|NPR A|npr a
1342374|NCT01407900|NPR B|npr b
1342375|NCT01407900|Adult, aged over 45|adult, aged over 45
1342376|NCT01407887|children|children
1342377|NCT01407874|Gout|gout
1342378|NCT01407874|Hyperuricemia|hyperuricemia
1342379|NCT01407874|Arthritis|arthritis
1342380|NCT01407874|Joint Disease|joint disease
1342381|NCT01407874|Allopurinol|allopurinol
1342382|NCT01407874|Renal Insufficiency|renal insufficiency
1342383|NCT01407835|Immunotherapy|immunotherapy
1342384|NCT01407835|Skin prick test|skin prick test
1342385|NCT01407835|Standardization|standardization
1342386|NCT01407835|Dactylis glomerata|dactylis glomerata
1342387|NCT01407822|Lung cancer|lung cancer
1342388|NCT01407822|IIIA-N2|iiia-n2
1342389|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
1342390|NCT01407822|EGFR mutations|egfr mutations
1342391|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1342392|NCT01407796|lung inflammation|lung inflammation
1342393|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
1342394|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
1342395|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
1342396|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
1342397|NCT01407783|Post-partum depression|post-partum depression
1342398|NCT01407783|Low-income mothers|low-income mothers
1342399|NCT01407783|home nurse visitation|home nurse visitation
1342400|NCT01407770|radiation toxicity|radiation toxicity
1342401|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
1342402|NCT01407770|pain|pain
1342403|NCT01407770|fatigue|fatigue
1342404|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1342405|NCT01407770|depression|depression
1342406|NCT01407770|cognitive/functional effects|cognitive/functional effects
1342407|NCT01407770|stage IA breast cancer|stage ia breast cancer
1342408|NCT01407770|stage IB breast cancer|stage ib breast cancer
1342409|NCT01407770|stage II breast cancer|stage ii breast cancer
1342410|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
1342411|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1342412|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1342413|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1342414|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1342415|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1342416|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1342417|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1342418|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1342419|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
1342420|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1342421|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1342422|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1342423|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1342424|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1342425|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1342426|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1342427|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1342428|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1342429|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1342430|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1342431|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1342432|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1342433|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1342434|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1342435|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1342436|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1342437|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1342438|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1342439|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1342440|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1342441|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1342442|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
1342443|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
1342444|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1342445|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
1342446|NCT01407718|Knee pain|knee pain
1342447|NCT01407718|tibial nailing|tibial nailing
1342448|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
1342449|NCT01407692|menstrual cycle|menstrual cycle
1342450|NCT01407692|estrogen|estrogen
1342451|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
1342452|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
1342453|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
1342454|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
1342455|NCT01407666|paravertebral block|paravertebral block
1342456|NCT01407666|epidural block|epidural block
1342457|NCT01407666|pain management|pain management
1342458|NCT01407666|liver resection|liver resection
1342459|NCT01407666|comparison|comparison
1342460|NCT01407653|Low back pain|low back pain
1342461|NCT01407653|virtual reality|virtual reality
1342462|NCT01407640|Insulin allergy|insulin allergy
1342463|NCT01407640|adverse drug reaction|adverse drug reaction
1342464|NCT01407640|diabetes|diabetes
1342465|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
1342466|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
1342467|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
1342468|NCT01407640|insulin analogs|insulin analogs
1342469|NCT01407640|intradermal testing|intradermal testing
1342470|NCT01407640|insulin antibody|insulin antibody
1342471|NCT01407640|mast cell|mast cell
1342472|NCT01407640|CD+ TCELL|cd+ tcell
1342474|NCT01407627|fructose|fructose
1342475|NCT01407627|dextrose|dextrose
1342476|NCT01407627|renin angiotensin system|renin angiotensin system
1342477|NCT01407627|kidney|kidney
1342478|NCT01407627|renal hemodynamics|renal hemodynamics
1342479|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
1342480|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
1342481|NCT01407614|external lumbar drainage|external lumbar drainage
1342482|NCT01407614|vasospasm|vasospasm
1342483|NCT01407601|vitamin K|vitamin k
1342484|NCT01407601|MK-7|mk-7
1342485|NCT01407601|Hemodialysis|hemodialysis
1342486|NCT01407601|vascular calcification|vascular calcification
1342487|NCT01407601|Matrix Gla protein|matrix gla protein
1342488|NCT01407601|Osteocalcin|osteocalcin
1342489|NCT01407588|Atrial fibrillation|atrial fibrillation
1342490|NCT01407588|Ablation|ablation
1342491|NCT01407575|Buprenorphine|buprenorphine
1342492|NCT01407575|Receptors, opioid|receptors, opioid
1342493|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
1342494|NCT01407536|Stroke|stroke
1342495|NCT01407536|Thermal Stimulation|thermal stimulation
1342496|NCT01407536|Upper Extremity|upper extremity
1342497|NCT01407536|Motor Recovery|motor recovery
1342498|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1342499|NCT01407523|Levetiracetam|levetiracetam
1342500|NCT01407523|Infusion|infusion
1342501|NCT01407523|Epilepsy|epilepsy
1342502|NCT01407523|Partial Onset Seizures|partial onset seizures
1342504|NCT01407497|Vaccine|vaccine
1342505|NCT01407497|DNA|dna
1342506|NCT01407497|Prevention|prevention
1342507|NCT01407484|Infertility|infertility
1342508|NCT01407484|Assisted reproductive technology|assisted reproductive technology
1342509|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
1342510|NCT01407484|Multicentric study|multicentric study
1342511|NCT01407484|Prospective randomized study|prospective randomized study
1342512|NCT01407471|aldosterone|aldosterone
1342513|NCT01407471|clobetasol|clobetasol
1342514|NCT01407471|atrophy|atrophy
1342515|NCT01407471|skin|skin
1342516|NCT01407471|epidermis|epidermis
1342517|NCT01407471|wound healing|wound healing
1342518|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
1342519|NCT01407471|spironolactone|spironolactone
1342520|NCT01407445|Menopause|menopause
1342521|NCT01407445|Sexual dysfunction|sexual dysfunction
1342522|NCT01407445|Tribulus|tribulus
1342523|NCT01407445|Sexuality|sexuality
1342524|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
1342525|NCT01407432|Male infertility|male infertility
1342526|NCT01407432|folic acid|folic acid
1342527|NCT01407432|in VITRO fertilization|in vitro fertilization
1342528|NCT01407432|sperm parameters|sperm parameters
1342529|NCT01407432|MTHFR genotype|mthfr genotype
1342530|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
1342531|NCT01407393|overweight|overweight
1342533|NCT01407393|weight loss|weight loss
1342534|NCT01407393|body fat|body fat
1342535|NCT01407393|waste cirumference|waste cirumference
1342536|NCT01407393|satiety|satiety
1342537|NCT01407393|appetite|appetite
1342538|NCT01407380|Advanced malignancies|advanced malignancies
1342539|NCT01407380|solid tumors|solid tumors
1342540|NCT01407380|cancer|cancer
1342541|NCT01407367|patient safety|patient safety
1342542|NCT01407367|chronic kidney disease|chronic kidney disease
1342543|NCT01407367|medical errors|medical errors
1342544|NCT01407354|robotic weight support|robotic weight support
1342545|NCT01407354|aquatic exercise|aquatic exercise
1342546|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
1342547|NCT01407354|ASIA C and D|asia c and d
1342548|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
1342549|NCT01407328|respiratory discomfort|respiratory discomfort
1342550|NCT01407328|airway obstruction|airway obstruction
1342551|NCT01407328|restrictive pathology|restrictive pathology
1342552|NCT01407328|diaphragm palsy|diaphragm palsy
1342553|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
1342554|NCT01407315|Type 1 Diabetes|type 1 diabetes
1342555|NCT01407302|Laryngeal mask airway|laryngeal mask airway
1342556|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
1342557|NCT01407263|radical prostatectomy|radical prostatectomy
1342558|NCT01407263|anastomotic suturing|anastomotic suturing
1342559|NCT01407263|lymph node dissection|lymph node dissection
1342561|NCT01407237|HIV-infection|hiv-infection
1342562|NCT01407237|renin|renin
1342563|NCT01407237|aldosterone|aldosterone
1342564|NCT01407237|visceral fat|visceral fat
1342565|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
1342566|NCT01407224|Skin to skin contact|skin to skin contact
1342567|NCT01407224|Cord Clumping|cord clumping
1342568|NCT01407224|Prelactial feeding|prelactial feeding
1342569|NCT01407211|multiple sclerosis|multiple sclerosis
1342570|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
1342571|NCT01407211|Vitamin A|vitamin a
1342572|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1342573|NCT01407211|gene expression|gene expression
1342574|NCT01407211|Th1 Cells|th1 cells
1342575|NCT01407211|Th2 Cells|th2 cells
1342576|NCT01407198|High Risk Chordoma|high risk chordoma
1342577|NCT01407185|heart failure|heart failure
1342578|NCT01407185|quality of life|quality of life
1342579|NCT01407185|fall prevention|fall prevention
1342580|NCT01407185|endurance|endurance
1342581|NCT01407185|resistive training|resistive training
1342583|NCT01407172|Peripheral arterial disease|peripheral arterial disease
1342584|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
1342585|NCT01407172|Gasotransmitter|gasotransmitter
1342586|NCT01407159|type b dissection|type b dissection
1342587|NCT01407159|thoracic stentgraft|thoracic stentgraft
1342588|NCT01407159|aortic stent|aortic stent
1342589|NCT01407159|clinical and technical success|clinical and technical success
1342590|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
1342591|NCT01407146|acute myocardial infarction|acute myocardial infarction
1342592|NCT01407146|care-seeking behavior|care-seeking behavior
1342593|NCT01407146|acute coronary syndrome|acute coronary syndrome
1342594|NCT01407146|care-seeking delay|care-seeking delay
1342595|NCT01407146|cardiac delay|cardiac delay
1342596|NCT01407146|prehospital delay|prehospital delay
1342597|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
1342598|NCT01407146|help seeking behaviors|help seeking behaviors
1342599|NCT01407146|seeking treatment|seeking treatment
1342600|NCT01407146|cardiac patients|cardiac patients
1342601|NCT01407146|decision time|decision time
1342602|NCT01407133|Neuro-otology|neuro-otology
1342603|NCT01407133|Chronic tinnitus|chronic tinnitus
1342604|NCT01407133|Sensory disability|sensory disability
1342605|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1342606|NCT01407133|Dose escalation|dose escalation
1342607|NCT01407120|Prevention|prevention
1342608|NCT01407120|Divorce|divorce
1342609|NCT01407107|nitroglycerin|nitroglycerin
1342610|NCT01407107|5-flourouracil|5-flourouracil
1342611|NCT01407107|radiation therapy|radiation therapy
1342612|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
1342613|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
1342614|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
1342615|NCT01407081|SMART goals|smart goals
1342616|NCT01407081|telehealth|telehealth
1342617|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
1342618|NCT01407055|Patients' Expectations|patients' expectations
1342619|NCT01407055|Coronary Heart Disease|coronary heart disease
1342620|NCT01407055|Illness Perception Intervention|illness perception intervention
1342621|NCT01407055|Randomized Controlled Trial|randomized controlled trial
1342622|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
1342623|NCT01407042|mobile-bearing|mobile-bearing
1342624|NCT01407042|patellofemoral pain|patellofemoral pain
1342625|NCT01407016|metronidazole infusion|metronidazole infusion
1342626|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
1342627|NCT01406990|aspirin resistance|aspirin resistance
1342628|NCT01406990|hyporesponsive|hyporesponsive
1342629|NCT01406990|CAD|cad
1342630|NCT01406990|women|women
1342631|NCT01406977|Hypophosphatasia|hypophosphatasia
1342632|NCT01406977|HPP|hpp
1342633|NCT01406977|Rathbun's disease|rathbun's disease
1342634|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
1342635|NCT01406951|sTREM-1|strem-1
1342636|NCT01406951|PCT|pct
1342637|NCT01406951|CPIS|cpis
1342638|NCT01406951|VAP|vap
1342639|NCT01406951|EVC|evc
1342640|NCT01406951|diagnosis|diagnosis
1342641|NCT01406951|prognosis|prognosis
1342642|NCT01406938|Psoriasis|psoriasis
1342643|NCT01406938|plaque|plaque
1342644|NCT01406938|inflammatory skin disease|inflammatory skin disease
1342645|NCT01406938|scaly patches|scaly patches
1342646|NCT01406938|AIN457|ain457
1342647|NCT01406938|secukinumab|secukinumab
1342648|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
1342649|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
1342650|NCT01406912|Ischemic Stroke|ischemic stroke
1342651|NCT01406912|Virtual Reality|virtual reality
1342652|NCT01406912|Nintendo Wii|nintendo wii
1342653|NCT01406912|Recreational Activity|recreational activity
1342654|NCT01406912|Motor Function|motor function
1342655|NCT01406886|Modifiable environmental|modifiable environmental
1342656|NCT01406886|behavioral factors|behavioral factors
1342657|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
1342658|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
1342659|NCT01406873|Muscular Dystrophy|muscular dystrophy
1342660|NCT01406873|Mexiletine|mexiletine
1342661|NCT01406860|Headaches|headaches
1342662|NCT01406860|Migraines|migraines
1342663|NCT01406860|Tension headaches|tension headaches
1342664|NCT01406860|Cluster headaches|cluster headaches
1342665|NCT01406847|Spinal Manipulation|spinal manipulation
1342666|NCT01406847|Body-based intervention|body-based intervention
1342667|NCT01406847|Experimental pain|experimental pain
1342668|NCT01406834|PTSD|ptsd
1342669|NCT01406834|Veterans|veterans
1342670|NCT01406834|Killing|killing
1342671|NCT01406834|Military|military
1342672|NCT01406821|PRP|prp
1342673|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
1342674|NCT01406821|platelet|platelet
1342675|NCT01406821|tendinosis|tendinosis
1342676|NCT01406821|tendinitis|tendinitis
1342677|NCT01406821|tendonitis|tendonitis
1342678|NCT01406821|tendinopathy|tendinopathy
1342679|NCT01406821|enthesopathy|enthesopathy
1342680|NCT01406821|muscle|muscle
1342681|NCT01406821|sport|sport
1342682|NCT01406821|tendon|tendon
1342683|NCT01406821|patella|patella
1342684|NCT01406821|patellar tendon|patellar tendon
1342685|NCT01406808|genetic|genetic
1342686|NCT01406808|atherosclerosis|atherosclerosis
1342687|NCT01406808|myocardial infarction|myocardial infarction
1342688|NCT01406808|risk|risk
1342689|NCT01406808|preventive cardiology|preventive cardiology
1342690|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
1342691|NCT01406795|Venous Stasis|venous stasis
1342692|NCT01406795|Venous Occlusions|venous occlusions
1342693|NCT01406795|Venous Stenosis|venous stenosis
1342694|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1342695|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1342696|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1342697|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1342698|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
1342699|NCT01406743|Sagittal balance|sagittal balance
1342700|NCT01406743|Database|database
1342701|NCT01406730|running exercise|running exercise
1342702|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
1342703|NCT01406730|blood|blood
1342704|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
1342705|NCT01406730|intervention|intervention
1342706|NCT01406730|untrained|untrained
1342707|NCT01406730|males|males
1342708|NCT01406717|SPIL1033|spil1033
1342709|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
1342710|NCT01406691|sleep|sleep
1342711|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
1342712|NCT01406691|circadian|circadian
1342713|NCT01406691|teen|teen
1342714|NCT01406691|adolescent|adolescent
1342715|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
1342716|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
1342717|NCT01406678|myocardial injury|myocardial injury
1342718|NCT01406665|diabetes|diabetes
1342719|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
1342720|NCT01406652|septic bursitis|septic bursitis
1342721|NCT01406652|bursectomy|bursectomy
1342722|NCT01406652|primary closure|primary closure
1342723|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
1342724|NCT01406639|Nosebleeds|nosebleeds
1342725|NCT01406639|Ranibizumab|ranibizumab
1342726|NCT01406639|Lucentis|lucentis
1342727|NCT01406626|HIV|hiv
1342728|NCT01406626|AIDS|aids
1342729|NCT01406626|Health navigation|health navigation
1342730|NCT01406626|Viral load|viral load
1342731|NCT01406626|Corrections|corrections
1342732|NCT01406613|Observational|observational
1342733|NCT01406613|Bone Density|bone density
1342734|NCT01406613|alendronate|alendronate
1342735|NCT01406613|ibandronate|ibandronate
1342736|NCT01406613|risedronate|risedronate
1342737|NCT01406613|postmenopausal|postmenopausal
1342738|NCT01406613|osteoporosis|osteoporosis
1342739|NCT01406600|recombinant hCG|recombinant hcg
1342740|NCT01406600|poor responder|poor responder
1342741|NCT01406600|oocyte maturity|oocyte maturity
1342742|NCT01406587|Burning|burning
1342743|NCT01406587|Dysuria|dysuria
1342744|NCT01406587|Frequency|frequency
1342745|NCT01406587|Pain|pain
1342746|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
1342747|NCT01406587|Uncomplicated UTI|uncomplicated uti
1342748|NCT01406587|Urinary Tract Infection|urinary tract infection
1342749|NCT01406587|UTI|uti
1567113|NCT00510016|abstinence syndrome|abstinence syndrome
1567114|NCT00510016|methadone|methadone
1342750|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
1342751|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
1342752|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
1342753|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
1342754|NCT01406561|Meniscectomy|meniscectomy
1342755|NCT01406561|Knee Pain|knee pain
1342756|NCT01406561|Postoperative Pain|postoperative pain
1342757|NCT01406548|Osteopenia|osteopenia
1342758|NCT01406548|osteoporosis|osteoporosis
1342759|NCT01406548|low bone mineral density|low bone mineral density
1342760|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
1342761|NCT01406535|myocardial perfusion|myocardial perfusion
1342762|NCT01406535|angiogenesis|angiogenesis
1342763|NCT01406535|coronary artery disease|coronary artery disease
1342764|NCT01406535|therapy refractory|therapy refractory
1342765|NCT01406522|Acetylcholine|acetylcholine
1342766|NCT01406522|Cholinesterases|cholinesterases
1342767|NCT01406522|Cocaine|cocaine
1342768|NCT01406522|Self-Administration|self-administration
1342769|NCT01406509|Safety|safety
1342770|NCT01406509|Conjugate vaccine|conjugate vaccine
1342771|NCT01406496|Insulin bolus|insulin bolus
1342772|NCT01406496|glucose excursions|glucose excursions
1342773|NCT01406496|post-prandial|post-prandial
1342774|NCT01406496|timing|timing
1342775|NCT01406496|meal content|meal content
1342776|NCT01406483|Platelet reactivity|platelet reactivity
1342777|NCT01406483|CABG|cabg
1342778|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
1342779|NCT01406470|IGIV|igiv
1342780|NCT01406470|Primary Immune Deficiency|primary immune deficiency
1342781|NCT01406470|Immunoglobulin G|immunoglobulin g
1342782|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1342783|NCT01406444|Anorexia Nervosa|anorexia nervosa
1342784|NCT01406444|Osteopenia|osteopenia
1342785|NCT01406444|Osteoporosis|osteoporosis
1342786|NCT01406444|Bone density|bone density
1342787|NCT01406431|pitavastatin|pitavastatin
1342788|NCT01406431|Livalo|livalo
1342789|NCT01406418|Influenza|influenza
1342790|NCT01406418|Virus|virus
1342791|NCT01406418|Monoclonal|monoclonal
1342792|NCT01406418|Antibody|antibody
1342793|NCT01406418|Immunization|immunization
1342794|NCT01406418|Treatment|treatment
1342795|NCT01406405|Degenerative disc disease|degenerative disc disease
1342796|NCT01406405|spinal stenosis|spinal stenosis
1342797|NCT01406405|herniated disc|herniated disc
1342798|NCT01406392|Misoprostol|misoprostol
1342799|NCT01406392|Sublingual|sublingual
1342800|NCT01406392|Induced|induced
1342801|NCT01406392|Labor|labor
1342802|NCT01406366|Pediatric oral health|pediatric oral health
1342803|NCT01406366|Bright Futures|bright futures
1342804|NCT01406366|Health promotion|health promotion
1342805|NCT01406353|Mitral Stenosis|mitral stenosis
1342806|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
1342807|NCT01406314|Phase 1|phase 1
1342808|NCT01406314|Patient|patient
1342809|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
1342810|NCT01406314|Amyloidosis|amyloidosis
1342811|NCT01406301|prescribing information|prescribing information
1342812|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
1342813|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
1342814|NCT01406262|albiglutide|albiglutide
1342815|NCT01406262|QT interval|qt interval
1342816|NCT01406262|cardiac repolarization|cardiac repolarization
1342817|NCT01406262|ECG study|ecg study
1342818|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
1342819|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
1342820|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
1342821|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1342823|NCT01406249|SP|sp
1342824|NCT01406236|Female|female
1342825|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
1342826|NCT01406236|PCI|pci
1342827|NCT01406236|diagnostic angiography|diagnostic angiography
1342828|NCT01406223|Nicotine addiction|nicotine addiction
1342829|NCT01406223|Cigarette smoking|cigarette smoking
1342830|NCT01406223|Smoking cessation|smoking cessation
1342831|NCT01406223|Zyban|zyban
1342832|NCT01406223|Chantix|chantix
1342833|NCT01406223|Nicotine patches|nicotine patches
1342834|NCT01406223|varenicline|varenicline
1342835|NCT01406223|bupropion|bupropion
1342836|NCT01406223|fMRI|fmri
1342837|NCT01406210|Lung Transplant|lung transplant
1342838|NCT01406210|REflux Surgery|reflux surgery
1342839|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1342840|NCT01406210|Fundoplication|fundoplication
1342841|NCT01406197|Progesterone|progesterone
1342842|NCT01406197|Progestins|progestins
1342843|NCT01406197|Preterm labor|preterm labor
1342844|NCT01406197|Premature birth|premature birth
1342845|NCT01406197|Uterine electromyography|uterine electromyography
1342846|NCT01406197|Uterine contractility|uterine contractility
1342847|NCT01406184|Child Abuse|child abuse
1342848|NCT01406184|Child Neglect|child neglect
1342849|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
1342850|NCT01406184|Child Well-Care Compliance|child well-care compliance
1342851|NCT01406184|Child Immunization Compliance|child immunization compliance
1342852|NCT01406171|Isavuconazole|isavuconazole
1342854|NCT01406171|BAL8557|bal8557
1342855|NCT01406171|Midazolam|midazolam
1342856|NCT01406171|Healthy volunteers|healthy volunteers
1342857|NCT01406158|Solifenacin succinate|solifenacin succinate
1342858|NCT01406158|VESIcare|vesicare
1342859|NCT01406158|Healthy Volunteers|healthy volunteers
1342860|NCT01406158|YM905|ym905
1342861|NCT01406145|Alzheimer's Disease|alzheimer's disease
1342862|NCT01406145|ASP0777|asp0777
1342863|NCT01406132|ASP015K|asp015k
1342864|NCT01406132|Healthy volunteers|healthy volunteers
1342865|NCT01406106|Hypercholesterolemia|hypercholesterolemia
1342866|NCT01406106|Lipids|lipids
1342867|NCT01406106|Cardiovascular disease|cardiovascular disease
1342868|NCT01406106|Risks factors|risks factors
1342869|NCT01406106|Primary Care|primary care
1342870|NCT01406093|Candidemia|candidemia
1342871|NCT01406093|Early-onset|early-onset
1342872|NCT01406093|Late-onset|late-onset
1342873|NCT01406093|Health-care associated|health-care associated
1342874|NCT01406093|Nosocomial|nosocomial
1342875|NCT01406080|Photoaging|photoaging
1342876|NCT01406080|Photodamage|photodamage
1342877|NCT01406080|Adapalene|adapalene
1342878|NCT01406080|Differin|differin
1342879|NCT01406067|social skills training,|social skills training,
1342880|NCT01406067|social competence training,|social competence training,
1342881|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
1342882|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
1342883|NCT01406067|randomized controlled trial|randomized controlled trial
1342884|NCT01406054|athletes|athletes
1342885|NCT01406054|injury prevention|injury prevention
1342886|NCT01406054|neuromuscular training|neuromuscular training
1342887|NCT01406054|public school|public school
1342888|NCT01406054|physical education|physical education
1342889|NCT01406054|knee|knee
1342890|NCT01406054|sports|sports
1342891|NCT01406054|ACL|acl
1342892|NCT01406054|KIPP|kipp
1342893|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
1342894|NCT01406041|Hyponatremia|hyponatremia
1342895|NCT01406041|Hypernatremia|hypernatremia
1342896|NCT01406041|Electrolytes disorder|electrolytes disorder
1342897|NCT01406028|IVF|ivf
1342898|NCT01406028|Stress|stress
1342899|NCT01406028|Infertility|infertility
1342900|NCT01406015|Obesity|obesity
1342901|NCT01406015|Insulin resistance|insulin resistance
1342902|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
1342903|NCT01406002|Pharmacokinetics|pharmacokinetics
1342904|NCT01406002|darexaban|darexaban
1342905|NCT01406002|YM150|ym150
1342906|NCT01406002|rifampicin|rifampicin
1342907|NCT01406002|Phase 1|phase 1
1342908|NCT01405989|Pharmacokinetics|pharmacokinetics
1342909|NCT01405989|darexaban|darexaban
1342910|NCT01405989|ketoconazole|ketoconazole
1342911|NCT01405989|Phase 1|phase 1
1342912|NCT01405976|sleep apneas|sleep apneas
1342913|NCT01405976|noninvasive ventilation|noninvasive ventilation
1342914|NCT01405976|CPAP|cpap
1342915|NCT01405963|Amgen|amgen
1342916|NCT01405963|AMG 157|amg 157
1342917|NCT01405963|Asthma|asthma
1342918|NCT01405898|hypertension|hypertension
1342919|NCT01405898|nitrite|nitrite
1342920|NCT01405898|blood pressure|blood pressure
1342921|NCT01405898|endothelial function|endothelial function
1342922|NCT01405885|Universal Influenza|universal influenza
1342923|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
1342924|NCT01405885|Electroporation|electroporation
1342925|NCT01405885|H1 and H5|h1 and h5
1342926|NCT01405885|DNA Vaccination|dna vaccination
1342927|NCT01405885|Influenza|influenza
1342928|NCT01405885|INO-3510|ino-3510
1342929|NCT01405859|Tourette|tourette
1342930|NCT01405859|tic|tic
1342931|NCT01405859|Tourette's|tourette's
1342932|NCT01405859|Tourette syndrome|tourette syndrome
1342933|NCT01405859|Tourette's syndrome|tourette's syndrome
1342934|NCT01405807|Vasculitis|vasculitis
1342935|NCT01405807|ANCA|anca
1342936|NCT01405807|Refractory|refractory
1342937|NCT01405742|Hemophilia|hemophilia
1342938|NCT01405742|Prophylaxis|prophylaxis
1342939|NCT01405742|Recombinant factor VIII|recombinant factor viii
1342940|NCT01405716|Mindfulness|mindfulness
1342941|NCT01405716|Back Pain|back pain
1342942|NCT01405716|Older adults|older adults
1342943|NCT01405703|Clavicle Fractures|clavicle fractures
1342944|NCT01405703|Numbness|numbness
1342945|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
1342946|NCT01405703|open plate fixation|open plate fixation
1342947|NCT01405703|incision related numbness|incision related numbness
1342948|NCT01405703|union rates|union rates
1342949|NCT01405703|subjective|subjective
1342950|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
1342951|NCT01405703|Diaphyseal|diaphyseal
1342952|NCT01405690|CAD|cad
1342953|NCT01405690|CTCA|ctca
1567115|NCT00510016|heroin|heroin
1342954|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
1342955|NCT01405677|Hepatitis A|hepatitis a
1342956|NCT01405677|Vaccination|vaccination
1342957|NCT01405677|Immunisation|immunisation
1342958|NCT01405651|ONO-6950|ono-6950
1342959|NCT01405651|Healthy adult subjects|healthy adult subjects
1342960|NCT01405625|Asthma|asthma
1342961|NCT01405625|Health literacy|health literacy
1342962|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
1342963|NCT01405599|Ulimorelin|ulimorelin
1342964|NCT01405599|Hepatic Impairment|hepatic impairment
1342965|NCT01405586|elderly|elderly
1342966|NCT01405586|chemotherapy|chemotherapy
1342967|NCT01405573|Child Pugh B|child pugh b
1342968|NCT01405573|first line|first line
1342969|NCT01405547|Gestational Diabetes|gestational diabetes
1342970|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
1342971|NCT01405547|Gestational Insulinemia|gestational insulinemia
1342972|NCT01405547|Maternal Obesity|maternal obesity
1342973|NCT01405547|Human Milk|human milk
1342974|NCT01405547|Lactogenesis|lactogenesis
1342975|NCT01405547|Obstetrics|obstetrics
1342976|NCT01405547|Nutrition|nutrition
1342977|NCT01405547|Infant Growth|infant growth
1342978|NCT01405534|Catheterization, Central Venous|catheterization, central venous
1342979|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
1342980|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
1342981|NCT01405508|N01258|n01258
1342982|NCT01405508|Brivaracetam|brivaracetam
1342983|NCT01405508|Epilepsy|epilepsy
1342984|NCT01405508|IV|iv
1342985|NCT01405508|intravenous|intravenous
1342986|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
1342987|NCT01405495|Working Memory|working memory
1342988|NCT01405495|Attentional Bias|attentional bias
1342989|NCT01405495|Connectivity|connectivity
1342990|NCT01405495|Structural Neuroimaging|structural neuroimaging
1342991|NCT01405495|Functional Neuroimaging|functional neuroimaging
1342992|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
1342993|NCT01405495|Arterial Spin Labelling|arterial spin labelling
1342994|NCT01405495|Cortisol|cortisol
1342995|NCT01405495|Psychophysiology|psychophysiology
1342996|NCT01405495|Early development of|early development of
1342997|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
1342998|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
1342999|NCT01405469|Achalasia|achalasia
1343000|NCT01405469|Heller myotomy|heller myotomy
1343001|NCT01405469|Dysphagia|dysphagia
1343002|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
1343003|NCT01405456|HIV-infection|hiv-infection
1343004|NCT01405456|eplerenone|eplerenone
1343005|NCT01405456|aldosterone|aldosterone
1343006|NCT01405456|visceral fat|visceral fat
1343326|NCT01404169|Donepezil|donepezil
1343007|NCT01405456|lipodystrophy|lipodystrophy
1343008|NCT01405443|Simulator training|simulator training
1343009|NCT01405443|Flexible endoscopy|flexible endoscopy
1343010|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
1343011|NCT01405443|Colonoscopy|colonoscopy
1343012|NCT01405443|Training|training
1343013|NCT01405443|Performance|performance
1343014|NCT01405417|Achalasia|achalasia
1343015|NCT01405417|Heller myotomy|heller myotomy
1343016|NCT01405417|Dysphagia|dysphagia
1343017|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
1343018|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
1343019|NCT01405404|No Intervention Control|no intervention control
1343020|NCT01405404|Intervention no childcare discount|intervention no childcare discount
1343021|NCT01405404|Intervention with childcare discount|intervention with childcare discount
1343022|NCT01405391|Pharma Mar|pharma mar
1343023|NCT01405391|PM01183|pm01183
1343024|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
1343025|NCT01405391|Dose finding phase I|dose finding phase i
1343026|NCT01405365|Periodontitis|periodontitis
1343027|NCT01405365|Periodontal diseases|periodontal diseases
1343028|NCT01405365|Obesity|obesity
1343029|NCT01405365|Metronidazole|metronidazole
1343030|NCT01405365|Prognosis|prognosis
1343031|NCT01405365|Probing depth|probing depth
1343032|NCT01405365|Periodontal attachment loss|periodontal attachment loss
1343033|NCT01405352|obesity|obesity
1343034|NCT01405352|vitamin A|vitamin a
1343035|NCT01405352|immune system|immune system
1343036|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
1343037|NCT01405326|biological therapy|biological therapy
1343038|NCT01405326|adalimumab|adalimumab
1343039|NCT01405326|ability to work|ability to work
1343040|NCT01405326|sick leaves|sick leaves
1343041|NCT01405287|stent|stent
1343042|NCT01405287|drug eluting stent|drug eluting stent
1343043|NCT01405287|healing|healing
1343044|NCT01405287|endothelium|endothelium
1343045|NCT01405287|DES|des
1343046|NCT01405287|OCT|oct
1343047|NCT01405287|MI|mi
1343048|NCT01405287|ACS|acs
1343049|NCT01405248|Butylphthalide|butylphthalide
1343050|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
1343051|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
1343052|NCT01405222|exacerbation|exacerbation
1343053|NCT01405222|COPD|copd
1343054|NCT01405222|Cough|cough
1343056|NCT01405209|AF|af
1343057|NCT01405209|biosignals|biosignals
1343058|NCT01405196|double-blind|double-blind
1343059|NCT01405196|placebo-controlled|placebo-controlled
1343060|NCT01405196|multicenter|multicenter
1343061|NCT01405196|dose-ranging|dose-ranging
1343062|NCT01405196|efficacy|efficacy
1343063|NCT01405196|safety|safety
1343064|NCT01405196|lupus.|lupus.
1343065|NCT01405183|Hepatitis C|hepatitis c
1343066|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
1343067|NCT01405183|Colorectal Cancer|colorectal cancer
1343068|NCT01405170|bioequivalence study|bioequivalence study
1343069|NCT01405170|methylprednisolone|methylprednisolone
1343070|NCT01405170|suspension|suspension
1343071|NCT01405170|tablets|tablets
1343072|NCT01405170|fed|fed
1343073|NCT01405157|bioequivalence study|bioequivalence study
1343074|NCT01405157|methylprednisolone|methylprednisolone
1343075|NCT01405157|suspension|suspension
1343076|NCT01405157|tablets|tablets
1343077|NCT01405157|fasting|fasting
1343078|NCT01405144|Photoaging|photoaging
1343079|NCT01405144|Actinic keratosis|actinic keratosis
1343080|NCT01405144|5-fluoruracil|5-fluoruracil
1343081|NCT01405144|Carcinogenesis|carcinogenesis
1343082|NCT01405131|bioequivalence study|bioequivalence study
1343083|NCT01405131|methylprednisolone|methylprednisolone
1343084|NCT01405131|suspension|suspension
1343085|NCT01405131|tablets|tablets
1343086|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
1343087|NCT01405118|550 Metformin|550 metformin
1343088|NCT01405092|volume|volume
1343089|NCT01405092|acute kidney injury|acute kidney injury
1343090|NCT01405092|continuous renal replacement|continuous renal replacement
1343091|NCT01405079|Lung cancer|lung cancer
1343092|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
1343093|NCT01405079|Adjuvant treatment|adjuvant treatment
1343094|NCT01405079|EGFR mutations|egfr mutations
1343095|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1343096|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
1343097|NCT01405066|Ionizing radiation|ionizing radiation
1343098|NCT01405066|Advanced medical imaging|advanced medical imaging
1343099|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
1343100|NCT01405053|Central Nervous System|central nervous system
1343101|NCT01405040|Cardiac|cardiac
1343102|NCT01405040|Output|output
1343103|NCT01405040|Preload|preload
1343104|NCT01405040|Lung|lung
1343105|NCT01405040|Water|water
1343106|NCT01405027|HCV|hcv
1343107|NCT01405027|Genotype1|genotype1
1343108|NCT01405027|Naive|naive
1343109|NCT01405027|Partial responder|partial responder
1343110|NCT01405027|Relapser|relapser
1343111|NCT01405014|Hold Me Tight|hold me tight
1343112|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
1343513|NCT01403272|wounds|wounds
1343113|NCT01405014|Relationship enhancement|relationship enhancement
1343114|NCT01405014|Couples counseling|couples counseling
1343115|NCT01405014|Marital therapy|marital therapy
1343116|NCT01405014|Acquired brain injury|acquired brain injury
1343117|NCT01405014|Traumatic brain injury|traumatic brain injury
1343118|NCT01405014|Stroke|stroke
1343119|NCT01405001|Emergencies|emergencies
1343120|NCT01405001|War|war
1343121|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
1343122|NCT01404988|Heart Failure|heart failure
1343123|NCT01404988|Telemedicine|telemedicine
1343124|NCT01404988|Medication Adherence|medication adherence
1343125|NCT01404975|Delirium|delirium
1343126|NCT01404975|PVB|pvb
1343128|NCT01404975|Opioid|opioid
1343129|NCT01404975|Aortic Valve replacement|aortic valve replacement
1343130|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
1343131|NCT01404962|children|children
1343132|NCT01404962|Korea|korea
1343133|NCT01404962|vaccine|vaccine
1343134|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
1343135|NCT01404949|Tretinoin|tretinoin
1343136|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
1343137|NCT01404949|ATRA|atra
1343138|NCT01404949|Vesanoid|vesanoid
1343139|NCT01404949|Arsenic Trioxide|arsenic trioxide
1343140|NCT01404949|ATO|ato
1343141|NCT01404949|Trisenox|trisenox
1343142|NCT01404949|11-040|11-040
1343143|NCT01404936|Lymphoma|lymphoma
1343144|NCT01404936|Hodgkin's Disease|hodgkin's disease
1343145|NCT01404936|Stage III and IV|stage iii and iv
1343146|NCT01404936|Adriamycin|adriamycin
1343147|NCT01404936|Doxorubicin|doxorubicin
1343148|NCT01404936|Rubex|rubex
1343149|NCT01404936|Bleomycin|bleomycin
1343150|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
1343151|NCT01404936|BLM|blm
1343152|NCT01404936|Dacarbazine|dacarbazine
1343153|NCT01404936|DTIC-DOME|dtic-dome
1343154|NCT01404936|Interferon-2A|interferon-2a
1343155|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
1343156|NCT01404936|Roferon-A|roferon-a
1343157|NCT01404936|Velban|velban
1343158|NCT01404936|Vinblastine|vinblastine
1343159|NCT01404910|Pregnancy|pregnancy
1343160|NCT01404910|Preeclampsia|preeclampsia
1343161|NCT01404910|Pre-term|pre-term
1343162|NCT01404910|sFlt-1|sflt-1
1455996|NCT00944658|Imaging|imaging
1343163|NCT01404910|Apheresis|apheresis
1343164|NCT01404910|Hypertension|hypertension
1343165|NCT01404910|Proteinuria|proteinuria
1343166|NCT01404910|VEGF|vegf
1343167|NCT01404897|carbohydrate|carbohydrate
1343168|NCT01404897|DASH diet|dash diet
1343169|NCT01404897|blood pressure|blood pressure
1343170|NCT01404897|cholesterol|cholesterol
1343171|NCT01404884|myopia|myopia
1343172|NCT01404884|astigmatism|astigmatism
1343173|NCT01404884|presbyopia|presbyopia
1343174|NCT01404884|SUPRACOR|supracor
1343175|NCT01404884|multifocal|multifocal
1343176|NCT01404871|OCD|ocd
1343177|NCT01404871|pharmacogenetics|pharmacogenetics
1343178|NCT01404871|cortical inhibition|cortical inhibition
1343179|NCT01404871|genetics|genetics
1343180|NCT01404858|IVF|ivf
1343181|NCT01404858|Lifestyle habits|lifestyle habits
1343182|NCT01404845|exudative AMD|exudative amd
1343183|NCT01404845|dietary supplements|dietary supplements
1343184|NCT01404845|macular pigment|macular pigment
1343185|NCT01404845|lutein|lutein
1343186|NCT01404845|zeaxanthin|zeaxanthin
1343187|NCT01404845|Nutrof total|nutrof total
1343188|NCT01404845|in one eye|in one eye
1343189|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
1343190|NCT01404832|Proton pump inhibitor|proton pump inhibitor
1343191|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
1343192|NCT01404793|Liver Transplantation|liver transplantation
1343193|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
1343194|NCT01404793|Rocuronium|rocuronium
1343195|NCT01404793|Metabolomics|metabolomics
1343196|NCT01404793|Pharmacokinetics|pharmacokinetics
1343197|NCT01404793|Clinical Marker|clinical marker
1343198|NCT01404780|Double lumen ET intubation|double lumen et intubation
1343199|NCT01404780|Laryngoscope|laryngoscope
1343200|NCT01404780|Lung Surgery|lung surgery
1343201|NCT01404767|Vascular surgery|vascular surgery
1343202|NCT01404767|esmolol|esmolol
1343203|NCT01404767|hemodynamic control|hemodynamic control
1343204|NCT01404754|MDMA|mdma
1343205|NCT01404754|mood|mood
1343206|NCT01404754|subjective effects|subjective effects
1343207|NCT01404754|interpersonal closeness|interpersonal closeness
1343208|NCT01404741|MDS|mds
1343209|NCT01404741|CMML|cmml
1343210|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1343211|NCT01404741|5-azacytidine|5-azacytidine
1343212|NCT01404728|Vaginal length|vaginal length
1343213|NCT01404728|Sexual dysfunction|sexual dysfunction
1343214|NCT01404715|Drug drug interaction|drug drug interaction
1343215|NCT01404702|Neuroblastoma|neuroblastoma
1343216|NCT01404702|Pediatrics|pediatrics
1343217|NCT01404702|Refractory|refractory
1343218|NCT01404702|Immunotherapy|immunotherapy
1343219|NCT01404702|Biological therapy|biological therapy
1343220|NCT01404702|Lymphocytes|lymphocytes
1343221|NCT01404702|Cancer|cancer
1343222|NCT01404702|Bisphosphonate|bisphosphonate
1343223|NCT01404689|dexmedetomidine|dexmedetomidine
1343224|NCT01404689|midazolam|midazolam
1343225|NCT01404689|ERCP|ercp
1343226|NCT01404689|cholangiopancreatography|cholangiopancreatography
1343227|NCT01404689|sedation|sedation
1343228|NCT01404689|propofol|propofol
1343229|NCT01404676|Glucose variability|glucose variability
1343230|NCT01404676|Oxidative stress|oxidative stress
1343231|NCT01404676|Endothelial cell function|endothelial cell function
1343232|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
1343233|NCT01404663|side effects|side effects
1343234|NCT01404650|GIST|gist
1343235|NCT01404650|Refractory|refractory
1343236|NCT01404650|Gastrointestinal|gastrointestinal
1343237|NCT01404650|Stromal|stromal
1343238|NCT01404650|Tumor|tumor
1343239|NCT01404611|with tubes|with tubes
1343240|NCT01404559|Amputee|amputee
1343241|NCT01404559|Transtibial|transtibial
1343242|NCT01404559|Military|military
1343243|NCT01404559|Gait|gait
1343244|NCT01404559|Rehabilitation|rehabilitation
1343245|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
1343246|NCT01404533|NTBI|ntbi
1343247|NCT01404533|Iron|iron
1343248|NCT01404533|Absorption|absorption
1343249|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
1343250|NCT01404520|#13 Quality of Life|#13 quality of life
1343251|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
1343252|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
1343253|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
1343254|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
1343255|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
1343256|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
1343257|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
1343258|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
1343259|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
1343260|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
1343261|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
1343262|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
1343263|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
1343264|NCT01404494|Haptic Skills|haptic skills
1343265|NCT01404494|Computer Assisted Interface|computer assisted interface
1343266|NCT01404494|TBI|tbi
1343267|NCT01404494|Traumatic Brain Injury|traumatic brain injury
1343268|NCT01404481|Urinary retention|urinary retention
1343269|NCT01404481|CISC|cisc
1343270|NCT01404481|Single use|single use
1343271|NCT01404481|Re use|re use
1343272|NCT01404442|midazolam|midazolam
1343273|NCT01404442|ketamine|ketamine
1343274|NCT01404442|intrathecal|intrathecal
1343275|NCT01404442|pain|pain
1343276|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
1343277|NCT01404429|Active|active
1343278|NCT01404390|Phase I|phase i
1343279|NCT01404390|Japanese|japanese
1343280|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
1343281|NCT01404364|Triamcinolone|triamcinolone
1343282|NCT01404364|Chlorpromazine|chlorpromazine
1343283|NCT01404364|Refractory glaucoma|refractory glaucoma
1343284|NCT01404364|Blind painful eye|blind painful eye
1343285|NCT01404351|Reduction mammaplasty|reduction mammaplasty
1343286|NCT01404351|Breast reduction|breast reduction
1343287|NCT01404351|PlasmaBlade|plasmablade
1343288|NCT01404351|PEAK|peak
1343289|NCT01404325|Lung transplantation|lung transplantation
1343290|NCT01404325|everolimus|everolimus
1343291|NCT01404325|kidney function|kidney function
1343292|NCT01404299|Frailty,|frailty,
1343293|NCT01404299|nutritional supplementation,|nutritional supplementation,
1343294|NCT01404299|functional status|functional status
1343295|NCT01404260|chemotherapy|chemotherapy
1343296|NCT01404260|maintenance therapy|maintenance therapy
1343297|NCT01404260|gefitinib|gefitinib
1343298|NCT01404247|retina|retina
1343299|NCT01404247|optic nerve|optic nerve
1343300|NCT01404247|fovea|fovea
1343301|NCT01404247|Eyes|eyes
1343302|NCT01404247|Neonates|neonates
1343303|NCT01404234|Cystic fibrosis|cystic fibrosis
1343304|NCT01404234|CF|cf
1343305|NCT01404234|PA|pa
1343306|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
1343307|NCT01404234|AZLI|azli
1343308|NCT01404234|aztreonam|aztreonam
1343309|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
1343310|NCT01404195|Nutritional supplement|nutritional supplement
1343311|NCT01404195|CaHMB|cahmb
1343312|NCT01404195|Barthel index|barthel index
1343313|NCT01404195|Frailty|frailty
1343314|NCT01404182|seasonal|seasonal
1343315|NCT01404182|prevention|prevention
1343316|NCT01404182|influenza|influenza
1343317|NCT01404182|infection|infection
1343318|NCT01404182|influenza vaccine|influenza vaccine
1343319|NCT01404182|vaccine|vaccine
1343320|NCT01404182|influenza in humans|influenza in humans
1343321|NCT01404169|Alzheimer Disease|alzheimer disease
1343322|NCT01404169|Dementia|dementia
1343323|NCT01404169|Delirium|delirium
1343324|NCT01404169|Amnestic|amnestic
1343325|NCT01404169|Cognitive Disorders|cognitive disorders
1343327|NCT01404169|Brain Diseases|brain diseases
1343328|NCT01404169|Central Nervous System Diseases|central nervous system diseases
1343329|NCT01404169|Nervous System Diseases|nervous system diseases
1343330|NCT01404169|Tauopathies|tauopathies
1343331|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
1343332|NCT01404169|Mental Disorders|mental disorders
1343333|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
1343334|NCT01404169|Enzy|enzy
1343335|NCT01404156|Esophageal cancer|esophageal cancer
1343336|NCT01404156|Neoadjuvant|neoadjuvant
1343337|NCT01404156|Chemotherapy|chemotherapy
1343338|NCT01404156|Chemoradiation|chemoradiation
1343339|NCT01404156|Surgery|surgery
1343340|NCT01404156|Esophagectomy|esophagectomy
1343341|NCT01404156|Adenocarcinoma|adenocarcinoma
1343342|NCT01404156|Gastroesophageal|gastroesophageal
1343343|NCT01404130|isotretinoin|isotretinoin
1343344|NCT01404130|hippocampus|hippocampus
1343345|NCT01404130|memory|memory
1343346|NCT01404130|learning|learning
1343347|NCT01404130|CANTAB|cantab
1343348|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
1343349|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
1343350|NCT01404052|transcranial ultrasound|transcranial ultrasound
1343351|NCT01404039|learning|learning
1343352|NCT01404039|pain perception|pain perception
1343353|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1343354|NCT01404013|Montelukast|montelukast
1343355|NCT01404013|Cough variant asthma|cough variant asthma
1343356|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
1343357|NCT01403987|Education|education
1343358|NCT01403987|Ascites|ascites
1343359|NCT01403987|Liver|liver
1343360|NCT01403987|Guidelines|guidelines
1343361|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
1567116|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
1343362|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
1343363|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
1343364|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1343365|NCT01403896|Plerixafor|plerixafor
1343366|NCT01403896|Healthy Donors|healthy donors
1343367|NCT01403896|Stem Cell Graft|stem cell graft
1343368|NCT01403883|Rectal cancer|rectal cancer
1343369|NCT01403883|Temporary stoma|temporary stoma
1343370|NCT01403883|Psychological disorders|psychological disorders
1343371|NCT01403870|Low Back Pain|low back pain
1343372|NCT01403857|Acceptability|acceptability
1343373|NCT01403857|liking|liking
1343374|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
1343375|NCT01403844|Dietary Guidelines|dietary guidelines
1343376|NCT01403844|fruits|fruits
1343377|NCT01403844|biomarkers|biomarkers
1343378|NCT01403844|carotenoids|carotenoids
1343379|NCT01403844|MyPlate|myplate
1343380|NCT01403844|vegetables|vegetables
1343381|NCT01403818|ASP1941|asp1941
1343382|NCT01403818|ipragliflozin|ipragliflozin
1343383|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
1343384|NCT01403818|Drug-Drug interaction|drug-drug interaction
1343385|NCT01403818|Pharmacokinetics|pharmacokinetics
1343386|NCT01403805|Oral care|oral care
1343387|NCT01403805|Vaccine|vaccine
1343388|NCT01403805|Pneumonia|pneumonia
1343389|NCT01403805|Elderly|elderly
1343390|NCT01403805|Prevention|prevention
1343391|NCT01403805|Primary care|primary care
1343392|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
1343393|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
1343394|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
1343395|NCT01403779|Breast cancer|breast cancer
1343396|NCT01403779|Hypofractionation|hypofractionation
1343397|NCT01403766|pediatric|pediatric
1343398|NCT01403766|kidney|kidney
1343399|NCT01403766|transplant|transplant
1343401|NCT01403766|creatinine|creatinine
1343402|NCT01403766|cystatin C|cystatin c
1343403|NCT01403766|iohexol|iohexol
1343404|NCT01403753|Obesity|obesity
1343405|NCT01403753|Child|child
1343406|NCT01403753|Dietary Habits|dietary habits
1343407|NCT01403740|acquired haemophilia|acquired haemophilia
1343408|NCT01403740|factor VIII|factor viii
1343409|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
1343410|NCT01403714|acute heart failure|acute heart failure
1343411|NCT01403701|physical therapy|physical therapy
1343412|NCT01403701|pelvic prolapse|pelvic prolapse
1343413|NCT01403701|incontinence|incontinence
1343414|NCT01403701|quality of life|quality of life
1343415|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
1343416|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
1343417|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
1343418|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
1343419|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
1343420|NCT01403662|bipolar disorder|bipolar disorder
1343421|NCT01403662|depression|depression
1343422|NCT01403662|major depression|major depression
1343423|NCT01403662|bipolar I depression|bipolar i depression
1343424|NCT01403662|bipolar II depression|bipolar ii depression
1343425|NCT01403662|bipolar I disorder|bipolar i disorder
1343426|NCT01403662|bipolar II disorder|bipolar ii disorder
1343427|NCT01403662|minocycline|minocycline
1343428|NCT01403662|minocin|minocin
1343429|NCT01403623|Hypothermia|hypothermia
1343430|NCT01403623|Newborn|newborn
1343431|NCT01403623|Resuscitation|resuscitation
1343432|NCT01403623|Plastic bag|plastic bag
1343433|NCT01403610|TH-302|th-302
1343434|NCT01403610|Bevacizumab|bevacizumab
1343435|NCT01403610|Phase 2|phase 2
1343436|NCT01403610|Glioma|glioma
1343437|NCT01403610|High Grade Glioma|high grade glioma
1343438|NCT01403610|CNS|cns
1343439|NCT01403597|Skin wrinkling|skin wrinkling
1343440|NCT01403597|Skin aging|skin aging
1343441|NCT01403597|Skin pigmentation|skin pigmentation
1343442|NCT01403545|Safety|safety
1343443|NCT01403545|Tolerability|tolerability
1343444|NCT01403545|Pharmacokinetics|pharmacokinetics
1343445|NCT01403545|Liposomal Curcumin|liposomal curcumin
1343446|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1343447|NCT01403532|Kallmann Syndrome|kallmann syndrome
1343448|NCT01403532|LH|lh
1343449|NCT01403532|FSH|fsh
1343450|NCT01403506|kidney transplantation|kidney transplantation
1343451|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
1343452|NCT01403506|living donor|living donor
1343453|NCT01403506|delayed graft function|delayed graft function
1343454|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
1343455|NCT01403493|Patient education|patient education
1343456|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
1343457|NCT01403467|Bronchial disease|bronchial disease
1343458|NCT01403467|asthma|asthma
1343459|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1343460|NCT01403467|Bronchoconstriction|bronchoconstriction
1343461|NCT01403454|chronic kidney disease|chronic kidney disease
1343462|NCT01403454|web-based application|web-based application
1343463|NCT01403454|dialysis education|dialysis education
1343464|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
1343465|NCT01403428|Asthma|asthma
1343466|NCT01403428|non invasive ventilation|non invasive ventilation
1343467|NCT01403428|pediatrics|pediatrics
1343468|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
1343469|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
1343470|NCT01403402|Congenital Myopathy|congenital myopathy
1343471|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
1343472|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
1343473|NCT01403389|Kidney Transplant|kidney transplant
1343474|NCT01403389|Delayed Graft Function|delayed graft function
1343475|NCT01403350|Malaria|malaria
1343476|NCT01403350|Fever|fever
1343477|NCT01403350|Acute febrile illness|acute febrile illness
1343478|NCT01403350|Pneumonia|pneumonia
1343479|NCT01403350|Community health worker|community health worker
1343480|NCT01403350|Rapid diagnostic test|rapid diagnostic test
1343481|NCT01403337|peripheral arterial disease|peripheral arterial disease
1343482|NCT01403337|myocardial infarction|myocardial infarction
1343483|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
1343484|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
1343485|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
1343486|NCT01403311|Astrocytoma|astrocytoma
1343487|NCT01403311|Brain stem glioma|brain stem glioma
1343488|NCT01403311|Ependymoma|ependymoma
1343489|NCT01403311|Glioblastoma|glioblastoma
1343490|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
1343491|NCT01403311|Gliosarcoma|gliosarcoma
1343492|NCT01403311|oligodendroglioma|oligodendroglioma
1343493|NCT01403311|Medulloblastoma|medulloblastoma
1343494|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
1343495|NCT01403311|ALA|ala
1343496|NCT01403298|Adolescent|adolescent
1343497|NCT01403298|HIV|hiv
1343498|NCT01403298|AIDS|aids
1343499|NCT01403298|Sexual risk|sexual risk
1343500|NCT01403298|Family|family
1343501|NCT01403298|Prevention|prevention
1343502|NCT01403298|Juvenile Drug Court|juvenile drug court
1343503|NCT01403298|Juvenile Justice|juvenile justice
1343504|NCT01403298|Drug Use|drug use
1343505|NCT01403298|Marijuana|marijuana
1343506|NCT01403285|Glioblastoma|glioblastoma
1343507|NCT01403285|stable disease|stable disease
1343508|NCT01403272|pressure ulcers|pressure ulcers
1343509|NCT01403272|stage 1|stage 1
1343510|NCT01403272|stage 2|stage 2
1343511|NCT01403272|stage 3|stage 3
1343512|NCT01403272|stage 4|stage 4
1343514|NCT01403272|sores|sores
1343515|NCT01403272|infection|infection
1343516|NCT01403272|bioburden|bioburden
1343517|NCT01403272|bacterial contamination|bacterial contamination
1343518|NCT01403272|bed linen|bed linen
1343519|NCT01403272|sheets|sheets
1343520|NCT01403272|underpad|underpad
1343521|NCT01403272|skin assessment|skin assessment
1343522|NCT01403272|microclimate|microclimate
1343523|NCT01403272|shear|shear
1343524|NCT01403272|friction|friction
1343525|NCT01403272|moisture|moisture
1343526|NCT01403272|fabrics|fabrics
1343527|NCT01403272|long term care|long term care
1343528|NCT01403272|nursing home|nursing home
1343529|NCT01403272|decubitus ulcer|decubitus ulcer
1343530|NCT01403272|bed ridden|bed ridden
1343531|NCT01403272|anti-microbial|anti-microbial
1343532|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1343534|NCT01403259|Oxaliplatin|oxaliplatin
1343535|NCT01403246|CLL|cll
1343536|NCT01403246|Lenalidomide|lenalidomide
1343537|NCT01403246|Chlorambucil|chlorambucil
1343538|NCT01403246|No previous treatment|no previous treatment
1343539|NCT01403233|Pharmacokinetics|pharmacokinetics
1343540|NCT01403233|Safety|safety
1343541|NCT01403207|Sex differences|sex differences
1343542|NCT01403207|knee joint|knee joint
1343543|NCT01403207|inflammatory mediators|inflammatory mediators
1343544|NCT01403207|Vitamin D|vitamin d
1343545|NCT01403207|osteoarthritis|osteoarthritis
1343546|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
1343547|NCT01403194|CPAP|cpap
1343548|NCT01403194|BiPAP|bipap
1343549|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
1343550|NCT01403181|HCV|hcv
1343551|NCT01403181|T cells|t cells
1343552|NCT01403181|cytokines|cytokines
1343553|NCT01403181|cytotoxicity|cytotoxicity
1343554|NCT01403181|proliferation|proliferation
1343555|NCT01403168|Osteopathy|osteopathy
1343556|NCT01403168|Breast cancer|breast cancer
1343557|NCT01403168|Pain|pain
1343558|NCT01403155|H5N1|h5n1
1343559|NCT01403155|Avian Influenza|avian influenza
1343560|NCT01403155|DNA Vaccine|dna vaccine
1343561|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
1343562|NCT01403155|Electroporation|electroporation
1343563|NCT01403155|Healthy Adults|healthy adults
1343564|NCT01403142|heart transplant|heart transplant
1343565|NCT01403142|vasculopathy|vasculopathy
1343566|NCT01403129|keratoconus|keratoconus
1343567|NCT01403129|keratoconus-suspect|keratoconus-suspect
1343568|NCT01403129|ultrasound exam|ultrasound exam
1343569|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
1343570|NCT01403116|testosterone|testosterone
1343571|NCT01403116|male hypogonadism|male hypogonadism
1343572|NCT01403116|low testosterone|low testosterone
1343573|NCT01403090|Pulmonary Embolism|pulmonary embolism
1343574|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
1343575|NCT01403090|Venous Thromboembolism|venous thromboembolism
1343576|NCT01403090|Central Line Catheter|central line catheter
1343577|NCT01403090|Vena Cava Filters|vena cava filters
1343578|NCT01403077|Superficial femoral artery|superficial femoral artery
1343579|NCT01403077|Peripheral arterial disease|peripheral arterial disease
1343580|NCT01403077|Atherosclerosis|atherosclerosis
1343581|NCT01403077|Intermittent Claudication|intermittent claudication
1343582|NCT01403077|Vascular Diseases|vascular diseases
1343583|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
1343584|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
1343585|NCT01403038|healthy volunteers|healthy volunteers
1343586|NCT01403038|elagolix|elagolix
1343587|NCT01403038|endometriosis|endometriosis
1343588|NCT01403038|ovarian reserve|ovarian reserve
1343589|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
1343590|NCT01403038|ovulation|ovulation
1343591|NCT01403038|ovarian activity|ovarian activity
1343592|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
1343593|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
1343594|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
1343595|NCT01402999|Growth disorders|growth disorders
1343596|NCT01402999|Saizen|saizen
1343597|NCT01402999|Easypod|easypod
1343598|NCT01402999|Growth hormone|growth hormone
1343599|NCT01402999|Pediatric subject|pediatric subject
1343600|NCT01402986|Asthma|asthma
1343601|NCT01402986|Tralokinumab|tralokinumab
1343602|NCT01402986|CAT-354|cat-354
1343603|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
1343604|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
1343605|NCT01402908|PI-88|pi-88
1343606|NCT01402908|Phase III|phase iii
1343607|NCT01402908|Adjuvant Therapy|adjuvant therapy
1343608|NCT01402908|Hepatoma|hepatoma
1343609|NCT01402908|Liver Cancer|liver cancer
1343610|NCT01402895|Nerve conduction|nerve conduction
1343611|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
1343612|NCT01402895|with neurodynamic component|with neurodynamic component
1343613|NCT01402882|traumatic brain injury|traumatic brain injury
1343614|NCT01402882|tranexamic acid|tranexamic acid
1343615|NCT01402882|antifibrinolytic|antifibrinolytic
1343616|NCT01402882|randomised|randomised
1343617|NCT01402882|clinical trial|clinical trial
1343618|NCT01402869|Methemoglobin|methemoglobin
1343619|NCT01402869|Methemoglobinemia|methemoglobinemia
1343620|NCT01402869|Prilocaine|prilocaine
1343621|NCT01402869|Lidocaine|lidocaine
1343622|NCT01402856|Prevention|prevention
1343623|NCT01402856|Adolescent|adolescent
1343624|NCT01402856|Trauma|trauma
1343625|NCT01402856|Driving|driving
1343626|NCT01402843|phase III combination study|phase iii combination study
1343627|NCT01402830|cancer|cancer
1343628|NCT01402830|depression|depression
1343629|NCT01402830|pain|pain
1343630|NCT01402817|NF1|nf1
1343631|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
1343632|NCT01402817|Sunitinib|sunitinib
1343633|NCT01402817|Sutent®|sutent®
1343634|NCT01402739|PoC|poc
1343635|NCT01402739|ROTEM|rotem
1343636|NCT01402739|Multiplate|multiplate
1343637|NCT01402739|transfusion|transfusion
1343638|NCT01402739|cardiac surgery|cardiac surgery
1343639|NCT01402739|drainage blood loss|drainage blood loss
1343640|NCT01402739|chest tube output|chest tube output
1343641|NCT01402726|renal artery|renal artery
1343642|NCT01402726|sympathetic nerves|sympathetic nerves
1343643|NCT01402726|modification|modification
1343644|NCT01402726|heart failure|heart failure
1343645|NCT01402700|Peripheral arterial disease|peripheral arterial disease
1343646|NCT01402700|claudication|claudication
1343647|NCT01402700|stent|stent
1343648|NCT01402700|VISI-Pro|visi-pro
1343649|NCT01402700|Iliac artery|iliac artery
1343650|NCT01402687|Stem Cell Transplant|stem cell transplant
1343651|NCT01402687|Mucositis|mucositis
1343652|NCT01402674|Obesity treatment|obesity treatment
1343653|NCT01402674|Phentermine|phentermine
1343654|NCT01402674|Withholding treatment|withholding treatment
1343655|NCT01402674|Phentermine dependence|phentermine dependence
1343656|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
1343657|NCT01402661|psoriatic arthritis|psoriatic arthritis
1343658|NCT01402661|disease registry|disease registry
1343659|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
1343660|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
1343661|NCT01402648|Adenoma recurrence|adenoma recurrence
1343662|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
1343663|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
1343664|NCT01402635|crowding|crowding
1343665|NCT01402635|Point-of-Care Systems|point-of-care systems
1343666|NCT01402635|emergency medicine|emergency medicine
1343667|NCT01402609|Continuity of care|continuity of care
1343668|NCT01402609|Patient safety|patient safety
1343669|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
1343670|NCT01402596|Deep Sedation|deep sedation
1343671|NCT01402596|Pediatrics|pediatrics
1343672|NCT01402596|Emergency Hospital Services|emergency hospital services
1343673|NCT01402596|Midazolam|midazolam
1343674|NCT01402596|Chloral hydrate|chloral hydrate
1343675|NCT01402596|Randomized controlled trial|randomized controlled trial
1343676|NCT01402583|Hepatitis C|hepatitis c
1343677|NCT01402583|Gender|gender
1343678|NCT01402583|Menopause|menopause
1343679|NCT01402583|Sustained viral response|sustained viral response
1343680|NCT01402583|Cytokines|cytokines
1343681|NCT01402570|disability|disability
1343682|NCT01402570|polio|polio
1343683|NCT01402570|rehabilitation|rehabilitation
1343684|NCT01402570|wellness|wellness
1343685|NCT01402557|Obesity|obesity
1343686|NCT01402557|Body Weight Changes|body weight changes
1343687|NCT01402557|Internet|internet
1343689|NCT01402544|Choroidal neovascularization|choroidal neovascularization
1343690|NCT01402544|Ranibizumab|ranibizumab
1343691|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
1343692|NCT01402544|Genome|genome
1343693|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
1343694|NCT01402531|nosebleed|nosebleed
1343695|NCT01402531|Bevacizumab|bevacizumab
1343696|NCT01402531|Avastin|avastin
1343697|NCT01402518|achalasia|achalasia
1343698|NCT01402518|myotomy|myotomy
1343699|NCT01402518|endoscopic myotomy|endoscopic myotomy
1343700|NCT01402518|difficulty swallowing|difficulty swallowing
1343701|NCT01402505|obesity|obesity
1343702|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
1343703|NCT01402505|transvaginal NOTES|transvaginal notes
1343704|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
1343705|NCT01402492|Cocaine|cocaine
1343706|NCT01402492|Substance-Related disorders|substance-related disorders
1343707|NCT01402492|Opioid abuse|opioid abuse
1343708|NCT01402492|Opioid dependence|opioid dependence
1343709|NCT01402492|abuse|abuse
1343710|NCT01402492|addiction|addiction
1343711|NCT01402492|treatment|treatment
1343712|NCT01402492|buprenorphine|buprenorphine
1343713|NCT01402492|naltrexone|naltrexone
1343714|NCT01402492|Suboxone|suboxone
1343715|NCT01402492|Vivitrol|vivitrol
1343716|NCT01402479|migraine,|migraine,
1343717|NCT01402479|ramipril,|ramipril,
1343718|NCT01402479|hypertension|hypertension
1343719|NCT01402466|Drug users|drug users
1343720|NCT01402466|criminal justice|criminal justice
1343721|NCT01402466|HIV care|hiv care
1343722|NCT01402466|HAART|haart
1343723|NCT01402466|incarceration|incarceration
1343724|NCT01402453|Incentives|incentives
1343725|NCT01402453|Social psychology|social psychology
1343726|NCT01402453|Randomized trial|randomized trial
1343727|NCT01402453|Hypertension|hypertension
1343728|NCT01402453|Intervention|intervention
1343729|NCT01402453|Pilot Study|pilot study
1343730|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
1343731|NCT01402440|Phase 1,|phase 1,
1343732|NCT01402440|CD79 Mutation|cd79 mutation
1343733|NCT01402427|Coronary Artery Disease|coronary artery disease
1343734|NCT01402427|Coronary Angiography|coronary angiography
1343735|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
1343736|NCT01402427|Transradial|transradial
1343737|NCT01402427|Radial Artery Spasm|radial artery spasm
1343738|NCT01402427|Verapamil|verapamil
1343739|NCT01402427|Adverse Effects|adverse effects
1343740|NCT01402414|atopic dermatitis|atopic dermatitis
1343741|NCT01402414|NB-UVB|nb-uvb
1343742|NCT01402414|phototherapy|phototherapy
1343743|NCT01402414|balneophototherapy|balneophototherapy
1343744|NCT01402414|Bath-PUVA|bath-puva
1343745|NCT01402414|SCORAD index|scorad index
1343746|NCT01402401|HER2+,|her2+,
1343747|NCT01402401|Gastric Cancer,|gastric cancer,
1343748|NCT01402401|HSP90,|hsp90,
1343749|NCT01402401|2nd-line,|2nd-line,
1343750|NCT01402401|Trastuzumab|trastuzumab
1343751|NCT01402375|Pain Management|pain management
1343752|NCT01402375|Emergency Medicine|emergency medicine
1343753|NCT01402375|Extremity Injuries|extremity injuries
1343754|NCT01402362|Ethiopians|ethiopians
1343755|NCT01402362|Diabetes Mellitus|diabetes mellitus
1343756|NCT01402362|Glucose tolerance|glucose tolerance
1343757|NCT01402362|Israel|israel
1343758|NCT01402362|Included in the year 2000 study|included in the year 2000 study
1343759|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
1343760|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
1343761|NCT01402336|ovulation induction|ovulation induction
1343762|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
1343763|NCT01402310|Onset of labor|onset of labor
1343764|NCT01402310|Bishop score|bishop score
1343765|NCT01402310|Cervical length|cervical length
1343766|NCT01402310|Multiple proteins|multiple proteins
1343767|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
1343768|NCT01402297|apocynin|apocynin
1343769|NCT01402297|COPD|copd
1343770|NCT01402284|Novel Drug Combinations|novel drug combinations
1343771|NCT01402284|Protease Inhibitors|protease inhibitors
1343772|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
1343773|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
1343774|NCT01402284|Multiple Myeloma|multiple myeloma
1343775|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1343776|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1343777|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1343778|NCT01402245|pneumonia|pneumonia
1343779|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
1343780|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1343781|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
1343782|NCT01402232|contrast medium|contrast medium
1343783|NCT01402232|creatinine clearance|creatinine clearance
1343784|NCT01402232|coronary angiography|coronary angiography
1343785|NCT01402232|diabetes|diabetes
1343786|NCT01402232|chronic kidney disease|chronic kidney disease
1343787|NCT01402232|predictive model|predictive model
1343788|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
1343789|NCT01402219|contrast medium|contrast medium
1343790|NCT01402219|creatinine clearance|creatinine clearance
1343791|NCT01402219|coronary angiography|coronary angiography
1343792|NCT01402219|chronic kidney disease|chronic kidney disease
1343793|NCT01402206|Depression|depression
1343794|NCT01402206|Intervention|intervention
1343795|NCT01402206|Primary health care|primary health care
1343796|NCT01402193|Breast Cancer|breast cancer
1343797|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
1343798|NCT01402193|TGF-beta1|tgf-beta1
1343799|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1343800|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
1343801|NCT01402180|chemoradiation|chemoradiation
1343802|NCT01402180|Nimotuzumab|nimotuzumab
1343803|NCT01402141|Chungkookjang|chungkookjang
1343804|NCT01402141|histamine|histamine
1343805|NCT01402141|skin reaction|skin reaction
1343806|NCT01402141|wheal|wheal
1343807|NCT01402128|Soluble fiber|soluble fiber
1343808|NCT01402128|Polycan|polycan
1343809|NCT01402128|Overweight|overweight
1343810|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
1343811|NCT01402115|Polycan|polycan
1343812|NCT01402115|Bone metabolism|bone metabolism
1343813|NCT01402115|Osteocalcin|osteocalcin
1343814|NCT01402115|Deoxypyridinoline|deoxypyridinoline
1343815|NCT01402102|Aged garlic|aged garlic
1343816|NCT01402102|Hyperlipidemic|hyperlipidemic
1343817|NCT01402102|LDL|ldl
1343818|NCT01402102|HDL|hdl
1343819|NCT01402102|Triglyceride|triglyceride
1343820|NCT01402089|phenotyping|phenotyping
1343821|NCT01402089|cytochrome p450|cytochrome p450
1343822|NCT01402089|erlotinib|erlotinib
1343823|NCT01402089|sunitinib|sunitinib
1343824|NCT01402089|lung cancer|lung cancer
1343825|NCT01402089|renal-cell cancer|renal-cell cancer
1343826|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1343827|NCT01402076|Pharmacokinetics|pharmacokinetics
1343832|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
1343834|NCT01402037|Prevention|prevention
1343835|NCT01402037|First degree relatives|first degree relatives
1343836|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
1343837|NCT01402011|Prolotherapy|prolotherapy
1343838|NCT01402011|regenerative injection therapy|regenerative injection therapy
1343839|NCT01402011|dextrose injections|dextrose injections
1343840|NCT01401998|cystic kidney disease|cystic kidney disease
1343841|NCT01401998|polycystic kidney disease|polycystic kidney disease
1343842|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
1343843|NCT01401998|genetic disease|genetic disease
1343844|NCT01401985|Opioid induced constipation|opioid induced constipation
1343846|NCT01401985|Constipation|constipation
1343847|NCT01401985|Opioid side effects|opioid side effects
1343848|NCT01401985|morphine induced constipation|morphine induced constipation
1343849|NCT01401972|prostate|prostate
1343850|NCT01401972|cancer|cancer
1343851|NCT01401972|ultrasound|ultrasound
1343852|NCT01401972|spectroscopy|spectroscopy
1343853|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
1343854|NCT01401959|Adjuvant|adjuvant
1343855|NCT01401959|Residual Disease|residual disease
1343856|NCT01401959|eribulin|eribulin
1343857|NCT01401959|Trastuzumab|trastuzumab
1343858|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
1343859|NCT01401920|cross-sectional area|cross-sectional area
1343860|NCT01401920|passive leg elevation|passive leg elevation
1343861|NCT01401920|trendelenburg position|trendelenburg position
1343862|NCT01401920|open heart surgery|open heart surgery
1343870|NCT01401894|advanced cancer|advanced cancer
1343871|NCT01401868|solid tumor|solid tumor
1343872|NCT01401868|recurrent|recurrent
1343873|NCT01401868|advanced|advanced
1343874|NCT01401868|metastatic|metastatic
1343875|NCT01401855|Diagnosis|diagnosis
1343876|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
1343877|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
1343878|NCT01401829|endometrial cancer|endometrial cancer
1343879|NCT01401829|aerobic walking|aerobic walking
1343880|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
1343881|NCT01401829|quality of life|quality of life
1343882|NCT01401816|Adolescents|adolescents
1343883|NCT01401816|Sexually Active|sexually active
1343884|NCT01401816|Unprotected Sex|unprotected sex
1343885|NCT01401816|Emergency Contraception|emergency contraception
1343886|NCT01401803|periorbital|periorbital
1343887|NCT01401803|glabella|glabella
1343888|NCT01401803|ptosis|ptosis
1343889|NCT01401803|eyelid|eyelid
1343890|NCT01401803|brow|brow
1343891|NCT01401790|Children|children
1343892|NCT01401790|Adolescents|adolescents
1343893|NCT01401790|Telehomecare|telehomecare
1343894|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
1343895|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1343896|NCT01401751|Artificial Pancreas|artificial pancreas
1343897|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
1343898|NCT01401725|venous thromboembolism|venous thromboembolism
1343899|NCT01401725|thromboprophylaxis|thromboprophylaxis
1343900|NCT01401725|anticoagulants|anticoagulants
1343901|NCT01401725|hospitalized medical patients|hospitalized medical patients
1343902|NCT01401725|electronic order sets|electronic order sets
1343903|NCT01401725|decision support|decision support
1343904|NCT01401725|knowledge translation|knowledge translation
1343905|NCT01401725|patient safety|patient safety
1343906|NCT01401712|ON-Q|on-q
1343907|NCT01401712|epidural|epidural
1343908|NCT01401712|analgesia|analgesia
1343909|NCT01401699|Barrett's|barrett's
1343910|NCT01401699|esophagus|esophagus
1343911|NCT01401699|OCT|oct
1343912|NCT01401699|imaging|imaging
1343913|NCT01401673|Chronic Cough|chronic cough
1343914|NCT01401673|Indantadol|indantadol
1343915|NCT01401660|low back pain|low back pain
1343916|NCT01401647|cardiac arrest|cardiac arrest
1343917|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1343918|NCT01401647|ventricular fibrillation|ventricular fibrillation
1343919|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
1343920|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
1343921|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
1343922|NCT01401621|behavioral economics|behavioral economics
1343923|NCT01401621|nudge|nudge
1343924|NCT01401621|scratch off|scratch off
1343925|NCT01401621|blood pressure check|blood pressure check
1343926|NCT01401621|cholesterol test|cholesterol test
1343927|NCT01401608|VT|vt
1343928|NCT01401608|ventricular tachycardia|ventricular tachycardia
1343929|NCT01401608|ablation|ablation
1343930|NCT01401608|magnetic navigation|magnetic navigation
1343931|NCT01401608|robotic|robotic
1343932|NCT01401582|health care|health care
1343933|NCT01401582|dementia care|dementia care
1343934|NCT01401582|caregiver support|caregiver support
1343935|NCT01401582|epidemiological study|epidemiological study
1343936|NCT01401569|Exercise,|exercise,
1343937|NCT01401569|counseling,|counseling,
1343938|NCT01401569|smoking cessation,|smoking cessation,
1343939|NCT01401569|depressive disorders|depressive disorders
1343940|NCT01401556|osteoporosis|osteoporosis
1343941|NCT01401556|fracture|fracture
1343942|NCT01401556|treatment|treatment
1343943|NCT01401556|guidelines|guidelines
1343944|NCT01401556|quality|quality
1343945|NCT01401543|testosterone|testosterone
1343946|NCT01401543|energy|energy
1343947|NCT01401543|libido|libido
1343948|NCT01401543|erectile function|erectile function
1343949|NCT01401543|weak muscles|weak muscles
1343950|NCT01401530|Neoplasms|neoplasms
1343951|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
1343952|NCT01401530|Lymphoma|lymphoma
1343953|NCT01401530|Non-Hodgkin|non-hodgkin
1343954|NCT01401530|T- Cell|t- cell
1343955|NCT01401530|Lymphatic Diseases|lymphatic diseases
1343956|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
1343957|NCT01401530|lmmune System Diseases|lmmune system diseases
1343958|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
1343959|NCT01401504|Anti-cancer|anti-cancer
1343960|NCT01401504|ASP3026|asp3026
1343961|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
1343962|NCT01401491|schizophrenia|schizophrenia
1343963|NCT01401491|clozapine|clozapine
1343964|NCT01401491|fluvoxamine|fluvoxamine
1343965|NCT01401491|metabolic syndrome|metabolic syndrome
1343966|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1343967|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
1343968|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
1343969|NCT01401465|PAR|par
1343970|NCT01401452|Monoclonals|monoclonals
1343971|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1343972|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
1343973|NCT01401452|Adalimumab|adalimumab
1343974|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
1343975|NCT01401452|Co-morbidities|co-morbidities
1343976|NCT01401452|Antibodies|antibodies
1343977|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
1343978|NCT01401439|cystic fibrosis|cystic fibrosis
1343979|NCT01401439|body mass index|body mass index
1343980|NCT01401439|fat free mass|fat free mass
1343981|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
1343982|NCT01401426|overweight|overweight
1343983|NCT01401426|Obesity, Morbid|obesity, morbid
1343984|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
1343985|NCT01401374|Autoimmunity|autoimmunity
1343986|NCT01401374|Thyroid Disease|thyroid disease
1343987|NCT01401296|Depression|depression
1343988|NCT01401296|Online-Therapy|online-therapy
1343989|NCT01401296|Deprexis|deprexis
1343990|NCT01401296|Self-help|self-help
1343991|NCT01401257|PXT3003|pxt3003
1343992|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
1343993|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
1343994|NCT01401231|depression|depression
1343995|NCT01401231|pregnancy|pregnancy
1343996|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
1343997|NCT01401218|acute kidney injury|acute kidney injury
1343998|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
1343999|NCT01401205|dyspnea|dyspnea
1344000|NCT01401205|airway diameter|airway diameter
1344001|NCT01401192|thymidylate synthase|thymidylate synthase
1344002|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
1344003|NCT01401179|antibiotic therapy|antibiotic therapy
1344004|NCT01401140|Coronary Artery Bypass|coronary artery bypass
1344005|NCT01401140|Coronary Artery Surgery|coronary artery surgery
1344006|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
1344007|NCT01401140|Coronary Revascularization|coronary revascularization
1344008|NCT01401140|Cardiac microdialysis|cardiac microdialysis
1344009|NCT01401140|Custodiol|custodiol
1344010|NCT01401140|St Thomas|st thomas
1344011|NCT01401140|Cardioplegic solutions|cardioplegic solutions
1344012|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1344013|NCT01401127|Exercise|exercise
1344014|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
1344015|NCT01401127|CSII|csii
1344016|NCT01401127|Insulin Pump Therapy|insulin pump therapy
1344017|NCT01401114|Wellnara|wellnara
1344018|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
1344019|NCT01401101|mental health|mental health
1344020|NCT01401101|PTSD|ptsd
1344021|NCT01401101|primary care|primary care
1344022|NCT01401101|quality improvement|quality improvement
1344023|NCT01401101|collaborative care|collaborative care
1344024|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
1344025|NCT01401075|Quality of Life|quality of life
1344026|NCT01401075|QoL|qol
1344027|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
1344028|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
1344029|NCT01401075|5-FU|5-fu
1344030|NCT01401075|Viscum album|viscum album
1344031|NCT01401062|metastatic breast cancer|metastatic breast cancer
1344032|NCT01401062|TGF-beta|tgf-beta
1344033|NCT01401062|fresolimumab|fresolimumab
1344034|NCT01401062|monoclonal antibody|monoclonal antibody
1344035|NCT01401062|radiation therapy|radiation therapy
1344036|NCT01401062|abscopal response|abscopal response
1344037|NCT01401049|Fospropofol|fospropofol
1344038|NCT01401049|Propofol|propofol
1344039|NCT01401049|Colonoscopy|colonoscopy
1344040|NCT01401049|Lusedra|lusedra
1344041|NCT01401036|acute myocardial infarction|acute myocardial infarction
1344042|NCT01401036|stents|stents
1344043|NCT01401036|angioplasty|angioplasty
1344044|NCT01401036|thrombosis|thrombosis
1344045|NCT01401010|neutropenia|neutropenia
1344046|NCT01401010|doripenem|doripenem
1344047|NCT01400997|Growth disorders|growth disorders
1344048|NCT01400997|Saizen|saizen
1344049|NCT01400997|Easypod|easypod
1344050|NCT01400997|Growth hormone|growth hormone
1344051|NCT01400997|Pediatric subject|pediatric subject
1344052|NCT01400984|Growth disorders|growth disorders
1344053|NCT01400984|Saizen|saizen
1344054|NCT01400984|Easypod|easypod
1344055|NCT01400984|Growth hormone|growth hormone
1344056|NCT01400984|Pediatric subject|pediatric subject
1344057|NCT01400971|Diabetes|diabetes
1344058|NCT01400971|Insulin|insulin
1344059|NCT01400971|Progression|progression
1344060|NCT01400971|Patient Reported Measures|patient reported measures
1344061|NCT01400971|Adherence|adherence
1344062|NCT01400971|Heterogeneity|heterogeneity
1344063|NCT01400971|Hypoglycemia|hypoglycemia
1344064|NCT01400958|fatigue|fatigue
1344065|NCT01400958|external beam radiation|external beam radiation
1344066|NCT01400958|EBRT|ebrt
1344067|NCT01400958|radiation therapy|radiation therapy
1344068|NCT01400958|placebo|placebo
1344069|NCT01400958|cognitive function|cognitive function
1344070|NCT01400958|TMZ|tmz
1344071|NCT01400958|Temozolomide|temozolomide
1344072|NCT01400945|GERD|gerd
1344073|NCT01400945|endoscopy|endoscopy
1344074|NCT01400945|LA grade|la grade
1344075|NCT01400945|heartburn|heartburn
1344076|NCT01400932|inflammatory lesion|inflammatory lesion
1344077|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
1344078|NCT01400932|once daily|once daily
1344079|NCT01400932|acne vulgaris|acne vulgaris
1344080|NCT01400932|vehicle gel|vehicle gel
1344081|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
1344082|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
1344083|NCT01400919|Peripheral arterial disease|peripheral arterial disease
1344084|NCT01400919|claudication|claudication
1344085|NCT01400919|stent|stent
1344086|NCT01400919|EverFlex|everflex
1344087|NCT01400919|GPS|gps
1344088|NCT01400919|Iliac Artery|iliac artery
1344089|NCT01400893|Acute Renal Failure|acute renal failure
1344090|NCT01400893|Acute kidney injury|acute kidney injury
1344091|NCT01400893|Acute tubular necrosis|acute tubular necrosis
1344092|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1344093|NCT01400893|Severe sepsis|severe sepsis
1344094|NCT01400893|Selective cytopheretic device|selective cytopheretic device
1344095|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
1344096|NCT01400867|Infections|infections
1344097|NCT01400867|Pediatrics|pediatrics
1344098|NCT01400867|Teflaro|teflaro
1344099|NCT01400867|cephalosporin|cephalosporin
1344100|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
1344101|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
1344102|NCT01400815|smoking|smoking
1344103|NCT01400815|smoking cessation|smoking cessation
1344104|NCT01400815|quitting smoking|quitting smoking
1344105|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
1344106|NCT01400763|focus of study|focus of study
1344107|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
1344108|NCT01400737|ibuprofen|ibuprofen
1344109|NCT01400737|prophylaxis|prophylaxis
1344110|NCT01400737|VELBW|velbw
1344111|NCT01400724|menopause|menopause
1344112|NCT01400724|metabolic syndrome|metabolic syndrome
1344113|NCT01400724|myo-inositol|myo-inositol
1344114|NCT01400724|insulin resistance|insulin resistance
1344115|NCT01400724|cocoa polyphenols|cocoa polyphenols
1344116|NCT01400724|isoflavones|isoflavones
1344117|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
1344118|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
1344119|NCT01400698|Saizen|saizen
1344120|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
1344121|NCT01400698|Final height|final height
1344122|NCT01400698|Bone age|bone age
1344123|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
1344124|NCT01400685|CLL|cll
1344125|NCT01400685|Leukemia|leukemia
1344126|NCT01400685|Untreated|untreated
1344127|NCT01400685|B-CLL|b-cll
1344128|NCT01400685|SLL|sll
1344134|NCT01400646|Rivaroxaban|rivaroxaban
1344135|NCT01400646|JNJ-39039039|jnj-39039039
1344136|NCT01400646|BAY59-7939|bay59-7939
1344137|NCT01400646|Warfarin|warfarin
1344138|NCT01400646|Transition|transition
1344139|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
1344140|NCT01400633|Dacogen|dacogen
1344141|NCT01400633|decitabine|decitabine
1344142|NCT01400633|epigenetic therapy|epigenetic therapy
1344143|NCT01400633|hypomethylating agent|hypomethylating agent
1344144|NCT01400620|oral mucositis|oral mucositis
1344145|NCT01400620|chemoradiation|chemoradiation
1344146|NCT01400620|head and neck cancer|head and neck cancer
1344147|NCT01400607|cartilage|cartilage
1344148|NCT01400607|knee surgery|knee surgery
1344149|NCT01400607|cartilage injury|cartilage injury
1344150|NCT01400607|knee pain|knee pain
1344151|NCT01400607|cartilage repair|cartilage repair
1344152|NCT01400607|cartilage damage|cartilage damage
1344153|NCT01400607|cartilage lesion|cartilage lesion
1344154|NCT01400607|cartilage defect|cartilage defect
1344155|NCT01400607|articular cartilage lesion|articular cartilage lesion
1344156|NCT01400607|articular cartilage defect|articular cartilage defect
1344157|NCT01400607|juvenile|juvenile
1344158|NCT01400607|cells|cells
1344159|NCT01400607|ISTO Technologies|isto technologies
1344160|NCT01400607|Neocartilage|neocartilage
1344161|NCT01400607|RevaFlex|revaflex
1457275|NCT00939757|YM178|ym178
1344162|NCT01400594|Onychomycosis|onychomycosis
1344163|NCT01400555|Prostate Cancer|prostate cancer
1344164|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1344165|NCT01400555|Abiraterone Acetate|abiraterone acetate
1344166|NCT01400555|Docetaxel|docetaxel
1344167|NCT01400555|Prednisone|prednisone
1344168|NCT01400555|Dexamethasone|dexamethasone
1344169|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
1344170|NCT01400542|Alzheimer Disease|alzheimer disease
1344171|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
1344172|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
1344173|NCT01400542|Cognitive functions|cognitive functions
1344174|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
1344175|NCT01400529|Osteoarthritis|osteoarthritis
1344176|NCT01400529|knee|knee
1344177|NCT01400529|hip|hip
1344178|NCT01400529|population based|population based
1344179|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
1344180|NCT01400516|Bone erosion|bone erosion
1344181|NCT01400516|Osteopenia|osteopenia
1344182|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
1344183|NCT01400503|Multicentric|multicentric
1344184|NCT01400503|Castleman|castleman
1344185|NCT01400503|Siltuximab|siltuximab
1344186|NCT01400503|Long term safety|long term safety
1344187|NCT01400477|Drug Trial|drug trial
1344188|NCT01400477|Smoking|smoking
1344189|NCT01400477|Smoking Cessation|smoking cessation
1344190|NCT01400477|Cognition|cognition
1344191|NCT01400477|Mental Focus|mental focus
1344192|NCT01400464|Giant Cell Arteritis|giant cell arteritis
1344193|NCT01400464|prednisone|prednisone
1344194|NCT01400464|pharmacokinetics|pharmacokinetics
1344195|NCT01400438|Herceptin|herceptin
1344196|NCT01400438|Breast cancer|breast cancer
1344197|NCT01400438|Quality of life|quality of life
1344198|NCT01400438|fatigue|fatigue
1344199|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
1344205|NCT01400360|cerebral vasospasm|cerebral vasospasm
1344206|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
1344207|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
1344208|NCT01400360|intraarterial treatment|intraarterial treatment
1344209|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
1344210|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
1344211|NCT01400334|Sudden Cardiac Death|sudden cardiac death
1344212|NCT01400334|Positron Emission Tomography|positron emission tomography
1344213|NCT01400334|Hibernating Myocardium|hibernating myocardium
1344214|NCT01400334|Denervated Myocardium|denervated myocardium
1344215|NCT01400321|dental implant|dental implant
1344216|NCT01400321|soft tissue maintenance|soft tissue maintenance
1344217|NCT01400321|bone remodelling|bone remodelling
1344218|NCT01400321|inclined atrophy|inclined atrophy
1344219|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
1344220|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
1344221|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
1344222|NCT01400295|contrast medium|contrast medium
1344223|NCT01400295|creatinine clearance|creatinine clearance
1344224|NCT01400295|coronary angiography|coronary angiography
1344225|NCT01400295|diabetes|diabetes
1344226|NCT01400295|chronic kidney disease|chronic kidney disease
1344227|NCT01400269|PACE|pace
1344228|NCT01400256|diagnostic|diagnostic
1344229|NCT01400243|Marijuana|marijuana
1344230|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
1344231|NCT01400243|Nicotine|nicotine
1344232|NCT01400230|computed tomography|computed tomography
1344233|NCT01400230|intravascular ultrasound|intravascular ultrasound
1344234|NCT01400230|coronary stenosis|coronary stenosis
1344235|NCT01400230|fractional flow reserve|fractional flow reserve
1344236|NCT01400217|Primary Care|primary care
1344237|NCT01400217|Particle size|particle size
1344238|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
1344239|NCT01400217|Asthma Management|asthma management
1344240|NCT01400217|Maintenance Therapy|maintenance therapy
1344241|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
1344242|NCT01400204|hangover|hangover
1344243|NCT01400204|next day effects|next day effects
1344244|NCT01400204|MDMA|mdma
1344245|NCT01400204|Alcohol|alcohol
1344246|NCT01400191|Metformin|metformin
1344247|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
1344248|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1344249|NCT01400191|Gluconeogenesis|gluconeogenesis
1344250|NCT01400191|Pharmacodynamics|pharmacodynamics
1344251|NCT01400191|Pharmacogenetics|pharmacogenetics
1344252|NCT01400178|cochlear implant|cochlear implant
1344253|NCT01400178|children|children
1344254|NCT01400178|follow up|follow up
1344255|NCT01400178|results|results
1344256|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
1344257|NCT01400165|Human Experimentation|human experimentation
1344258|NCT01400165|Bioequivalence|bioequivalence
1344259|NCT01400165|Brand name|brand name
1344260|NCT01400165|Generic|generic
1344261|NCT01400165|Healthy volunteers|healthy volunteers
1344262|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
1344263|NCT01400139|Pain|pain
1344264|NCT01400139|Nonmalignant pain|nonmalignant pain
1344265|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
1344266|NCT01400139|Opioid|opioid
1344267|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
1344268|NCT01400113|Acute Agitation|acute agitation
1344269|NCT01400113|schizophrenia|schizophrenia
1344270|NCT01400113|bipolar|bipolar
1344271|NCT01400113|psychosis|psychosis
1344272|NCT01400113|panss-ec|panss-ec
1344273|NCT01400100|octreotide|octreotide
1344274|NCT01400100|intraarterial|intraarterial
1344275|NCT01400100|pancreatic hardness|pancreatic hardness
1344276|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
1344277|NCT01400100|durometer|durometer
1344278|NCT01400100|dynamometer|dynamometer
1344279|NCT01400087|colonoscopy|colonoscopy
1344280|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
1344281|NCT01400087|Cecal intubation|cecal intubation
1344282|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
1344283|NCT01400087|Trainee|trainee
1344284|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
1344285|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
1344286|NCT01400022|lichen|lichen
1344287|NCT01400022|sclerosus|sclerosus
1344288|NCT01400022|genital|genital
1344289|NCT01400022|vulvar|vulvar
1344290|NCT01400022|UVA1|uva1
1344291|NCT01400009|Statin|statin
1344292|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
1344293|NCT01400009|myalgia|myalgia
1344294|NCT01400009|vitamin D|vitamin d
1344295|NCT01399996|probiotic|probiotic
1344296|NCT01399996|microbiota|microbiota
1344297|NCT01399996|transit time|transit time
1344298|NCT01399996|immunity|immunity
1344299|NCT01399996|immune function|immune function
1344300|NCT01399996|constipation|constipation
1344301|NCT01399996|bowel function|bowel function
1344302|NCT01399983|six minute walk|six minute walk
1344303|NCT01399970|Mobile Teledermatology|mobile teledermatology
1344304|NCT01399970|Telemedicine|telemedicine
1344305|NCT01399970|Acne|acne
1344306|NCT01399957|Multiple Sclerosis|multiple sclerosis
1344307|NCT01399957|Dalfampridine-ER|dalfampridine-er
1344308|NCT01399957|Walking speed|walking speed
1344309|NCT01399944|bitter taste|bitter taste
1344310|NCT01399944|psychophysics|psychophysics
1344311|NCT01399944|genetics|genetics
1344312|NCT01399944|epigenetics|epigenetics
1344313|NCT01399944|bitterness sensitivity|bitterness sensitivity
1344314|NCT01399931|Early stage|early stage
1344315|NCT01399918|Kidney|kidney
1344316|NCT01399918|Everolimus|everolimus
1344317|NCT01399918|Bevacizumab|bevacizumab
1344318|NCT01399918|10-226|10-226
1344319|NCT01399918|non-clear cell histology|non-clear cell histology
1344320|NCT01399918|Advanced|advanced
1344321|NCT01399905|Parkinson's disease|parkinson's disease
1344322|NCT01399905|Levodopa|levodopa
1344323|NCT01399905|Carbidopa|carbidopa
1344324|NCT01399905|Blood brain barrier|blood brain barrier
1344325|NCT01399879|Surface potential|surface potential
1344326|NCT01399879|Electrical|electrical
1344327|NCT01399879|Motion stabilization|motion stabilization
1344328|NCT01399866|D-cycloserine|d-cycloserine
1344329|NCT01399866|Smoking cues|smoking cues
1344330|NCT01399866|Cognitive remediation|cognitive remediation
1344331|NCT01399866|physiologic reactivity|physiologic reactivity
1344332|NCT01399866|craving|craving
1344333|NCT01399853|immunogenicity|immunogenicity
1344334|NCT01399853|safety|safety
1344335|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
1344336|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1344337|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
1344338|NCT01399788|Bioequivalence|bioequivalence
1344339|NCT01399788|Healthy Volunteers|healthy volunteers
1344340|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
1344341|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
1344342|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
1344343|NCT01399762|stroke, acute|stroke, acute
1344344|NCT01399762|mechanical recanalization|mechanical recanalization
1344345|NCT01399762|interventional neuroradiology|interventional neuroradiology
1344346|NCT01399762|clinical registry|clinical registry
1344347|NCT01399749|Cartilage|cartilage
1344348|NCT01399749|Articular|articular
1344349|NCT01399749|Femoral|femoral
1344350|NCT01399749|Knee|knee
1344351|NCT01399749|Chondrocytes|chondrocytes
1344352|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
1344353|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
1344354|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
1344355|NCT01399723|Severe pneumonia|severe pneumonia
1344356|NCT01399710|colorectal cancer|colorectal cancer
1344357|NCT01399710|CT colonography|ct colonography
1344358|NCT01399710|CAD|cad
1344359|NCT01399671|depression|depression
1344360|NCT01399671|vestibular|vestibular
1344361|NCT01399658|Brachytherapy|brachytherapy
1344362|NCT01399658|Gynecological cancer|gynecological cancer
1344363|NCT01399645|Randomized trial|randomized trial
1344364|NCT01399645|Open label|open label
1344365|NCT01399645|Pilot study|pilot study
1344366|NCT01399645|Single center|single center
1344367|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
1344368|NCT01399606|Narcolepsy|narcolepsy
1344369|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
1344370|NCT01399593|AMR|amr
1344371|NCT01399593|Acute Humoral Rejection|acute humoral rejection
1344372|NCT01399593|AHR|ahr
1344373|NCT01399593|Living Donor|living donor
1344374|NCT01399593|Kidney Transplant|kidney transplant
1344375|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
1344376|NCT01399567|pain|pain
1344377|NCT01399567|depression|depression
1344378|NCT01399567|nursing homes|nursing homes
1344379|NCT01399567|diffusion of innovations|diffusion of innovations
1344380|NCT01399567|clinical trial|clinical trial
1344381|NCT01399541|Symptoms|symptoms
1344382|NCT01399541|Symptoms cluster|symptoms cluster
1344383|NCT01399541|Fatigue|fatigue
1344384|NCT01399541|Depression|depression
1344385|NCT01399541|Sleeplessness|sleeplessness
1344386|NCT01399541|Social support|social support
1344387|NCT01399541|Stigma|stigma
1344388|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
1344389|NCT01399515|Valproic acid|valproic acid
1344390|NCT01399502|Depression|depression
1344391|NCT01399502|Self Care|self care
1344392|NCT01399489|Aerobic exercise|aerobic exercise
1344393|NCT01399489|Moderate intensity|moderate intensity
1344394|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
1344395|NCT01399489|Post exercise hypotension|post exercise hypotension
1344396|NCT01399476|Achalasia|achalasia
1344397|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
1344398|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
1344399|NCT01399437|Default Network|default network
1344400|NCT01399437|Schizophrenia|schizophrenia
1344401|NCT01399437|fMRI|fmri
1344402|NCT01399437|Spatial Attention|spatial attention
1344403|NCT01399437|Sentinel Function|sentinel function
1344404|NCT01399424|Shigellosis|shigellosis
1344405|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
1344406|NCT01399424|Conjugate Vaccine|conjugate vaccine
1344407|NCT01399424|Shigella|shigella
1344408|NCT01399424|Vaccine|vaccine
1344409|NCT01399411|Self-Reported|self-reported
1344410|NCT01399411|Farming|farming
1344411|NCT01399411|Agriculture|agriculture
1344412|NCT01399411|Disease Validation|disease validation
1344413|NCT01399411|Autoimmune Disorders|autoimmune disorders
1344414|NCT01399398|Brain Scan|brain scan
1344415|NCT01399398|Kinetic Analysis|kinetic analysis
1344416|NCT01399398|Healthy Subjects|healthy subjects
1344417|NCT01399398|Healthy Volunteer|healthy volunteer
1344418|NCT01399398|HV|hv
1344419|NCT01399385|Arteriosclerosis|arteriosclerosis
1344420|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
1344421|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
1344422|NCT01399385|Hardening of the arteries|hardening of the arteries
1344423|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
1344424|NCT01399385|Cardiovascular Disease|cardiovascular disease
1344425|NCT01399385|Heart Disease|heart disease
1344426|NCT01399385|Healthy Volunteer|healthy volunteer
1344427|NCT01399385|HV|hv
1344428|NCT01399372|neurotoxicity|neurotoxicity
1344429|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1344430|NCT01399372|radiation toxicity|radiation toxicity
1344431|NCT01399372|cognitive/functional effects|cognitive/functional effects
1344432|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1344433|NCT01399359|breast cancer|breast cancer
1344434|NCT01399346|Insulin aspart|insulin aspart
1344435|NCT01399346|Type 1 diabetes|type 1 diabetes
1344436|NCT01399346|Glucose clamp|glucose clamp
1344437|NCT01399346|Pharmacodynamics|pharmacodynamics
1344438|NCT01399346|Pharmacokinetics|pharmacokinetics
1344439|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
1344440|NCT01399333|PDCAAS|pdcaas
1344441|NCT01399333|Bariatric patient|bariatric patient
1344442|NCT01399320|Pilonidal disease|pilonidal disease
1344443|NCT01399320|Excision|excision
1344444|NCT01399320|cyanoacrylate|cyanoacrylate
1344445|NCT01399307|Stem|stem
1344446|NCT01399307|Cell|cell
1344447|NCT01399307|Antria|antria
1344448|NCT01399307|Adipose|adipose
1344449|NCT01399307|Stromal|stromal
1344450|NCT01399307|Vascular|vascular
1344451|NCT01399307|Fraction|fraction
1344452|NCT01399307|Shahram|shahram
1344453|NCT01399307|Shah|shah
1344454|NCT01399307|Rahimian|rahimian
1344455|NCT01399294|Palliative Care|palliative care
1344456|NCT01399294|Advanced Cancer|advanced cancer
1344457|NCT01399294|Constipation|constipation
1344458|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
1344459|NCT01399294|Syndrome Distribution|syndrome distribution
1344460|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
1344461|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
1344462|NCT01399268|cytokine|cytokine
1344463|NCT01399268|desmosine|desmosine
1344464|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
1344465|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
1344466|NCT01399203|contrast medium|contrast medium
1344467|NCT01399203|creatinine clearance|creatinine clearance
1344468|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
1344469|NCT01399164|Vitamin B-12|vitamin b-12
1344470|NCT01399151|Vitamin D|vitamin d
1344471|NCT01399151|Immune function|immune function
1344472|NCT01399138|Pre-diabetes|pre-diabetes
1344473|NCT01399138|Metabolic syndrome|metabolic syndrome
1344474|NCT01399138|Diabetes|diabetes
1344475|NCT01399138|Hypertension|hypertension
1344476|NCT01399138|Blueberries|blueberries
1344477|NCT01399138|Anthocyanins|anthocyanins
1344478|NCT01399138|Insulin sensitivity|insulin sensitivity
1344479|NCT01399138|Insulin resistance|insulin resistance
1344480|NCT01399125|Alzheimer's|alzheimer's
1344481|NCT01399125|Rivastigmine|rivastigmine
1344482|NCT01399125|Patch|patch
1344483|NCT01399125|Dementia|dementia
1344484|NCT01399112|Smoking Cessation|smoking cessation
1344485|NCT01399112|First episode psychosis|first episode psychosis
1344486|NCT01399112|Electronic Decision Support System|electronic decision support system
1344487|NCT01399099|scar|scar
1344488|NCT01399099|incision|incision
1344489|NCT01399099|wound healing|wound healing
1344490|NCT01399099|scarring|scarring
1344491|NCT01399099|post-surgical|post-surgical
1344492|NCT01399086|Cancer|cancer
1344493|NCT01399086|Breast|breast
1344494|NCT01399086|Metastatic|metastatic
1344495|NCT01399086|Hormonotherapy|hormonotherapy
1344496|NCT01399073|stroke|stroke
1344497|NCT01399073|neglect|neglect
1344498|NCT01399073|hemianopsia|hemianopsia
1344499|NCT01399073|virtual reality|virtual reality
1344500|NCT01399060|Cough|cough
1344501|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
1344502|NCT01399047|Batten Disease|batten disease
1344503|NCT01399034|Epigenomics|epigenomics
1344504|NCT01399034|DNA methylation|dna methylation
1344505|NCT01399034|MicroRNA|microrna
1344506|NCT01399034|Periodontitis|periodontitis
1344507|NCT01399034|Inflammation|inflammation
1344508|NCT01399034|Obesity|obesity
1344509|NCT01399021|Parotidectomy|parotidectomy
1344510|NCT01399021|Drain removal|drain removal
1344511|NCT01399021|Timing|timing
1344512|NCT01399021|Hematoma|hematoma
1344513|NCT01399021|Surgical wound infection|surgical wound infection
1344514|NCT01399008|Hyperuricemia|hyperuricemia
1344515|NCT01398995|Type 1 Diabetes|type 1 diabetes
1344516|NCT01398995|Exercise|exercise
1344517|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1344518|NCT01398969|Randomized|randomized
1344519|NCT01398969|Double Blind|double blind
1344520|NCT01398969|Fecal Transplant|fecal transplant
1344521|NCT01398969|Recurrent|recurrent
1344522|NCT01398969|Clostridium difficile infection|clostridium difficile infection
1344523|NCT01398969|CDI|cdi
1344524|NCT01398969|HBT|hbt
1344525|NCT01398969|Diarrhea|diarrhea
1344526|NCT01398969|Frozen HBT|frozen hbt
1344527|NCT01398969|Thawed HBT|thawed hbt
1344528|NCT01398969|Fecal Enema|fecal enema
1344529|NCT01398956|Levetiracetam|levetiracetam
1344530|NCT01398956|Epilepsy|epilepsy
1344531|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
1344532|NCT01398943|flow-mediated dilation|flow-mediated dilation
1344533|NCT01398943|arterial stiffness|arterial stiffness
1344534|NCT01398943|intima-media thickness|intima-media thickness
1344535|NCT01398943|pulse wave velocity|pulse wave velocity
1344536|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1344537|NCT01398943|inflammatory markers|inflammatory markers
1344538|NCT01398943|blood lipids|blood lipids
1344539|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
1344540|NCT01398943|body mass index|body mass index
1344541|NCT01398943|hemoglobin A1c|hemoglobin a1c
1344542|NCT01398943|complete blood count|complete blood count
1344543|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
1344544|NCT01398943|pulmonary function test|pulmonary function test
1344545|NCT01398943|lung|lung
1344546|NCT01398943|COPD|copd
1344547|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
1344548|NCT01398917|psc|psc
1344549|NCT01398917|dominant stricture|dominant stricture
1344550|NCT01398904|BDD|bdd
1344551|NCT01398878|Medical education, graduate|medical education, graduate
1344552|NCT01398878|Patient care|patient care
1344553|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
1344554|NCT01398878|Work schedule tolerance|work schedule tolerance
1344555|NCT01398865|BDD|bdd
1344556|NCT01398826|Type 1 Diabetes|type 1 diabetes
1344557|NCT01398826|Exercise|exercise
1344558|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
1344560|NCT01398813|XLHED|xlhed
1344561|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
1344562|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
1344563|NCT01398761|Continuity of patient care|continuity of patient care
1344564|NCT01398761|Workflow|workflow
1344565|NCT01398761|Quality of signout|quality of signout
1344566|NCT01398761|Web based|web based
1344567|NCT01398761|Handoffs|handoffs
1344568|NCT01398761|Multi disciplinary|multi disciplinary
1344569|NCT01398761|Written signout|written signout
1344570|NCT01398761|Information science|information science
1344571|NCT01398748|Parkinson's disease|parkinson's disease
1344572|NCT01398748|Neuroprotection|neuroprotection
1344573|NCT01398748|Glutathione|glutathione
1344574|NCT01398748|Intranasal|intranasal
1344575|NCT01398722|cardiac surgery|cardiac surgery
1344576|NCT01398722|prognosis|prognosis
1344577|NCT01398722|intensive insulin therapy|intensive insulin therapy
1344578|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
1344579|NCT01398709|Prognosis|prognosis
1344580|NCT01398709|Cardiac Surgery|cardiac surgery
1344581|NCT01398709|Rewarming Rate|rewarming rate
1344582|NCT01398696|Patient Information Leaflets|patient information leaflets
1344583|NCT01398696|primary care|primary care
1344584|NCT01398696|patient behaviour|patient behaviour
1344585|NCT01398696|pharyngitis|pharyngitis
1344586|NCT01398696|gastroenteritis|gastroenteritis
1344587|NCT01398670|Type I Diabetes|type i diabetes
1344588|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
1344589|NCT01398670|Humalog®|humalog®
1344590|NCT01398670|Humalog Mix|humalog mix
1344591|NCT01398670|Wockhardt|wockhardt
1344592|NCT01398670|Biosimilar|biosimilar
1344593|NCT01398670|Phase 3|phase 3
1344594|NCT01398657|localized|localized
1344595|NCT01398657|High risk|high risk
1344596|NCT01398657|Prostate Cancer|prostate cancer
1344597|NCT01398657|Randomized|randomized
1344598|NCT01398657|Cryotherapy|cryotherapy
1344599|NCT01398657|Cryoablation|cryoablation
1344600|NCT01398657|Adjuvant|adjuvant
1344601|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
1344602|NCT01398657|Hormone therapy|hormone therapy
1344603|NCT01398657|ADT|adt
1344604|NCT01398644|Phlebotomy|phlebotomy
1344605|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
1344606|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
1344607|NCT01398644|maintenance therapy|maintenance therapy
1344608|NCT01398631|Risk scores|risk scores
1344609|NCT01398631|ACS|acs
1344610|NCT01398631|HEART-score|heart-score
1344611|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
1344612|NCT01398618|tuberculosis|tuberculosis
1344613|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
1344614|NCT01398618|preventive therapy|preventive therapy
1344615|NCT01398618|9-month isoniazid|9-month isoniazid
1344616|NCT01398618|4-month rifampin|4-month rifampin
1344617|NCT01398605|Postmenopausal women|postmenopausal women
1344618|NCT01398605|Physical activity|physical activity
1344619|NCT01398605|Cardiovascular risks|cardiovascular risks
1344620|NCT01398605|Cardiac function|cardiac function
1344621|NCT01398605|Dose-response|dose-response
1344622|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
1344623|NCT01398592|T2DM|t2dm
1344624|NCT01398592|vildagliptin|vildagliptin
1344625|NCT01398592|sitagliptin|sitagliptin
1344626|NCT01398592|FPG|fpg
1344627|NCT01398592|DPP-4|dpp-4
1344628|NCT01398579|intestinal metaplasia|intestinal metaplasia
1344629|NCT01398579|dysplasia|dysplasia
1344630|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
1344631|NCT01398566|TBI|tbi
1344632|NCT01398566|concussion|concussion
1344633|NCT01398566|brain injury|brain injury
1344634|NCT01398553|stroke|stroke
1344635|NCT01398553|tbi|tbi
1344636|NCT01398553|rehabilitation|rehabilitation
1344637|NCT01398553|upper limb|upper limb
1344638|NCT01398527|Long-Term Care|long-term care
1344639|NCT01398527|Vitamin D|vitamin d
1344640|NCT01398501|AML|aml
1344641|NCT01398501|FLT3-ITD|flt3-itd
1344642|NCT01398501|Stem cell transplant|stem cell transplant
1344643|NCT01398488|Trough levels|trough levels
1344644|NCT01398488|Education|education
1344645|NCT01398488|Adherence|adherence
1344646|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
1344647|NCT01398449|esophagectomy|esophagectomy
1344648|NCT01398449|elective nodal irradiation|elective nodal irradiation
1344649|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
1344650|NCT01398436|Central venous saturation|central venous saturation
1344651|NCT01398436|Mixed venous saturation|mixed venous saturation
1344652|NCT01398436|Right atrium|right atrium
1344653|NCT01398436|Central Venous Catheter position|central venous catheter position
1344654|NCT01398423|Hypertension|hypertension
1344655|NCT01398423|Diabetes mellitis|diabetes mellitis
1344656|NCT01398423|Nephropathy|nephropathy
1344657|NCT01398423|Albuminuria|albuminuria
1344658|NCT01398410|Rabeprazole|rabeprazole
1344659|NCT01398410|proton pump inhibitor|proton pump inhibitor
1344660|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
1344661|NCT01398410|Aspirin|aspirin
1344662|NCT01398410|Gastric Ulcer|gastric ulcer
1344663|NCT01398410|Duodenal Ulcer|duodenal ulcer
1344664|NCT01398397|HED|hed
1344665|NCT01398397|XLHED|xlhed
1344666|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
1344667|NCT01398384|ST Elevation MI|st elevation mi
1344668|NCT01398384|STEMI|stemi
1344669|NCT01398371|Heart failure|heart failure
1344670|NCT01398371|Digoxin withdrawal|digoxin withdrawal
1344671|NCT01398358|obesity|obesity
1344672|NCT01398358|prevention|prevention
1344673|NCT01398358|children|children
1344674|NCT01398319|prevention|prevention
1344675|NCT01398319|alcohol abuse|alcohol abuse
1344676|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
1344677|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1344678|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
1344679|NCT01398306|Neoplasms|neoplasms
1344680|NCT01398306|Adenocarcinoma|adenocarcinoma
1344681|NCT01398306|Kidney Neoplasms|kidney neoplasms
1344682|NCT01398306|Urologic Neoplasms|urologic neoplasms
1344683|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
1344684|NCT01398306|Neoplasms by Site|neoplasms by site
1344685|NCT01398306|Kidney Diseases|kidney diseases
1344686|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
1344687|NCT01398306|Biological Markers|biological markers
1344688|NCT01398280|Rosacea|rosacea
1344689|NCT01398280|Dermatology|dermatology
1344690|NCT01398280|UCSD|ucsd
1344691|NCT01398280|Skin disease|skin disease
1344692|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1344693|NCT01398254|Mortality|mortality
1344694|NCT01398228|Quality of care|quality of care
1344695|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
1344696|NCT01398215|umbilical hernia|umbilical hernia
1344697|NCT01398215|ventral hernia|ventral hernia
1344698|NCT01398202|Vitamin D status|vitamin d status
1344699|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
1344700|NCT01398202|Vitamin D3|vitamin d3
1344701|NCT01398202|RCT|rct
1344702|NCT01398202|Bio-efficacy|bio-efficacy
1344703|NCT01398189|clozapine|clozapine
1344704|NCT01398189|PET|pet
1344705|NCT01398189|schizophrenia|schizophrenia
1344706|NCT01398189|schizoaffective disorder|schizoaffective disorder
1344707|NCT01398176|gamma delta T cell|gamma delta t cell
1344708|NCT01398176|proliferation|proliferation
1344709|NCT01398163|probiotics|probiotics
1344710|NCT01398163|digestive well-being|digestive well-being
1344711|NCT01398163|fMRI|fmri
1344712|NCT01398163|brain-gut axis|brain-gut axis
1344713|NCT01398150|gamma delta T cell|gamma delta t cell
1344714|NCT01398150|proliferation|proliferation
1344715|NCT01398150|cytokine secretion|cytokine secretion
1344716|NCT01398150|immune function|immune function
1344717|NCT01398150|antioxidant status|antioxidant status
1344718|NCT01398137|Ragweed allergy|ragweed allergy
1344719|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
1344720|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
1344721|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
1344722|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
1344723|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
1344724|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
1344725|NCT01398059|Sedentary Behavior|sedentary behavior
1344726|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
1344727|NCT01398059|Pediatrics|pediatrics
1344728|NCT01398046|dasatinib|dasatinib
1344729|NCT01398046|betaine|betaine
1344730|NCT01398046|betaine hydrochloride|betaine hydrochloride
1344731|NCT01398046|pharmacokinetics|pharmacokinetics
1344732|NCT01398046|healthy volunteer|healthy volunteer
1344733|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
1344734|NCT01398033|In-stent stenosis|in-stent stenosis
1344735|NCT01398033|long lesions|long lesions
1344736|NCT01398033|drug-coated balloon|drug-coated balloon
1344737|NCT01398020|Bowel Preparation|bowel preparation
1344738|NCT01398020|Patient comfort|patient comfort
1344739|NCT01398020|Bi-Peglyte|bi-peglyte
1344740|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
1344741|NCT01397968|partial onset seizures|partial onset seizures
1344742|NCT01397968|treatment resistant|treatment resistant
1344743|NCT01397968|partial epilepsy|partial epilepsy
1344744|NCT01397955|Julina|julina
1344745|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
1344746|NCT01397942|Diet intervention|diet intervention
1344747|NCT01397942|Type 2 diabetes|type 2 diabetes
1344748|NCT01397942|Vegetables|vegetables
1344749|NCT01397942|Phytochemicals|phytochemicals
1344750|NCT01397916|CLL|cll
1344751|NCT01397916|IDO|ido
1344752|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
1344753|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
1344754|NCT01397877|endometrial cancer|endometrial cancer
1344755|NCT01397877|BKM|bkm
1344756|NCT01397877|monotherapy|monotherapy
1344757|NCT01397877|metastatic|metastatic
1344758|NCT01397877|initial treatment|initial treatment
1344759|NCT01397864|Hereditary Angioedema|hereditary angioedema
1344760|NCT01397864|HAE|hae
1344761|NCT01397864|Angioedema|angioedema
1344762|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
1344763|NCT01397864|rhC1INH|rhc1inh
1344764|NCT01397864|registry|registry
1344765|NCT01397838|Osteopenia|osteopenia
1344766|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
1344767|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
1344768|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
1344769|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
1344770|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
1344771|NCT01397799|AML|aml
1344772|NCT01397799|Refractory|refractory
1344773|NCT01397799|Elderly|elderly
1344774|NCT01397773|Hemodialysis|hemodialysis
1344775|NCT01397773|peritoneal dialysis|peritoneal dialysis
1344776|NCT01397773|chronic kidney disease|chronic kidney disease
1344777|NCT01397773|inflammation|inflammation
1344778|NCT01397773|carotis intima media thickness|carotis intima media thickness
1344779|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
1344780|NCT01397760|OMALIZUMABE|omalizumabe
1344781|NCT01397747|Cancer|cancer
1344782|NCT01397747|Colorectal Cancer|colorectal cancer
1344783|NCT01397747|Neoplasm|neoplasm
1344784|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
1344785|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
1344786|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1344787|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
1344788|NCT01397747|Neoplasms by Site|neoplasms by site
1344789|NCT01397747|Neoplasms|neoplasms
1344790|NCT01397747|Digestive System Diseases|digestive system diseases
1344791|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
1344792|NCT01397747|Colonic Diseases|colonic diseases
1344793|NCT01397747|Intestinal Diseases|intestinal diseases
1344794|NCT01397747|Rectal Diseases|rectal diseases
1344795|NCT01397734|CML|cml
1344796|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
1344797|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
1344798|NCT01397734|Arsenic|arsenic
1344799|NCT01397734|Arsenic trioxide|arsenic trioxide
1344800|NCT01397734|Imatinib|imatinib
1344801|NCT01397734|Dasatinib|dasatinib
1344802|NCT01397734|Nilotinib|nilotinib
1344803|NCT01397734|TKI|tki
1344804|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1344805|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1344806|NCT01397721|pulmonary vasculature|pulmonary vasculature
1344807|NCT01397721|pulmonary hypertension|pulmonary hypertension
1344808|NCT01397721|atherosclerosis|atherosclerosis
1344809|NCT01397721|smokers|smokers
1344810|NCT01397721|emphysema|emphysema
1344811|NCT01397708|Melanoma|melanoma
1344812|NCT01397708|Unresectable|unresectable
1344813|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
1344814|NCT01397682|Frail elderly|frail elderly
1344815|NCT01397682|Italy/epidemiology|italy/epidemiology
1344816|NCT01397682|Geriatric Health Service|geriatric health service
1344817|NCT01397682|Polypharmacy|polypharmacy
1344818|NCT01397682|Biological Markers|biological markers
1344819|NCT01397682|Epidemiologic Research Design|epidemiologic research design
1344820|NCT01397656|cardiac arrest|cardiac arrest
1344821|NCT01397656|CPR|cpr
1344822|NCT01397656|resuscitation|resuscitation
1344824|NCT01397656|quality|quality
1344825|NCT01397565|Cholecystectomy|cholecystectomy
1344826|NCT01397565|Laparoscopy|laparoscopy
1344827|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
1344828|NCT01397565|Post-operative pain|post-operative pain
1344829|NCT01397565|Recovery time|recovery time
1344830|NCT01397526|Congenital heart disease|congenital heart disease
1344831|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
1344832|NCT01397526|Capillary leak|capillary leak
1345132|NCT01396161|Phase 1|phase 1
1344833|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
1344834|NCT01397526|Children|children
1344835|NCT01397513|Fibrin network structure|fibrin network structure
1344836|NCT01397513|Aspirin treatment|aspirin treatment
1344837|NCT01397513|Platelet microparticles|platelet microparticles
1344838|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
1344839|NCT01397474|peripheral perfusion|peripheral perfusion
1344840|NCT01397474|critically ill patients|critically ill patients
1344841|NCT01397474|fluid administration|fluid administration
1344842|NCT01397448|Rabeprazole|rabeprazole
1344843|NCT01397448|proton pump inhibitor|proton pump inhibitor
1344844|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
1344845|NCT01397448|Aspirin|aspirin
1344846|NCT01397448|Gastric Ulcer|gastric ulcer
1344847|NCT01397448|Duodenal Ulcer|duodenal ulcer
1344848|NCT01397435|Lysosomal diseases|lysosomal diseases
1344849|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
1344850|NCT01397435|MRI|mri
1344851|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
1344852|NCT01397422|Parkinsonism|parkinsonism
1344853|NCT01397370|Safety|safety
1344854|NCT01397370|Tolerability|tolerability
1344855|NCT01397370|Pharmacokinetics|pharmacokinetics
1344856|NCT01397370|Pharmacodynamics|pharmacodynamics
1344857|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
1344858|NCT01397357|Myocardial Ischemia|myocardial ischemia
1344859|NCT01397357|Coronary Artery Disease|coronary artery disease
1344860|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
1344861|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
1344862|NCT01397331|inhalational anesthesia|inhalational anesthesia
1344863|NCT01397331|intravenous anesthesia|intravenous anesthesia
1344864|NCT01397331|cardiac surgery|cardiac surgery
1344865|NCT01397318|TaiChi Exercise|taichi exercise
1344866|NCT01397318|pregnant women|pregnant women
1344867|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
1344868|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
1344869|NCT01397305|pemetrexed|pemetrexed
1344870|NCT01397305|Neoplasms|neoplasms
1344871|NCT01397305|Rectal Neoplasms|rectal neoplasms
1344872|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
1344873|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
1344874|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1344875|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
1344876|NCT01397305|Neoplasms by Site|neoplasms by site
1344877|NCT01397305|Rectal Diseases|rectal diseases
1344878|NCT01397305|Digestive System Diseases|digestive system diseases
1344879|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
1344880|NCT01397305|Intestinal Diseases|intestinal diseases
1344881|NCT01397305|Pharmacologic Actions|pharmacologic actions
1344882|NCT01397305|Therapeutic Uses|therapeutic uses
1344883|NCT01397305|Antineoplastic Agents|antineoplastic agents
1344884|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
1344885|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1344886|NCT01397305|Folic Acid Antagonists|folic acid antagonists
1344887|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
1344888|NCT01397305|Antimetabolites|antimetabolites
1344889|NCT01397292|Bronchoscopy|bronchoscopy
1344890|NCT01397292|Interventional Pulmonary|interventional pulmonary
1344891|NCT01397292|Pleuroscopy|pleuroscopy
1344892|NCT01397292|Tracheostomy|tracheostomy
1344893|NCT01397279|type 2 diabetes|type 2 diabetes
1344894|NCT01397279|insulin sensitivity|insulin sensitivity
1344895|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
1344896|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1344897|NCT01397266|Cocaine|cocaine
1344898|NCT01397266|impulsivity|impulsivity
1344899|NCT01397266|rating scale|rating scale
1344900|NCT01397253|Automated Communication Tools|automated communication tools
1344901|NCT01397253|Medication errors|medication errors
1344902|NCT01397253|PCP communication|pcp communication
1344903|NCT01397227|Malaria|malaria
1344904|NCT01397227|Plasmodium falciparum|plasmodium falciparum
1344905|NCT01397227|Vaccination|vaccination
1344906|NCT01397227|Prophylaxis|prophylaxis
1344907|NCT01397227|Adenovirus|adenovirus
1344908|NCT01397188|PiCCO|picco
1344909|NCT01397175|Coronary artery disease|coronary artery disease
1344910|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
1344911|NCT01397175|Drug-eluting stent|drug-eluting stent
1344912|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1344913|NCT01397149|Thrombocytopenia|thrombocytopenia
1344914|NCT01397149|Alkylating agents|alkylating agents
1344915|NCT01397149|Purine derivatives|purine derivatives
1344916|NCT01397149|TPO receptor agonist|tpo receptor agonist
1344917|NCT01397136|Human embryo|human embryo
1344918|NCT01397136|Culture media|culture media
1344919|NCT01397136|Cell-free DNA|cell-free dna
1344920|NCT01397136|In vitro fertilization|in vitro fertilization
1344921|NCT01397136|Infertility|infertility
1344922|NCT01397123|BMI z-score|bmi z-score
1344923|NCT01397123|children|children
1344924|NCT01397123|overweight|overweight
1345051|NCT01396551|Realtime tracking|realtime tracking
1344925|NCT01397123|school-based intervention|school-based intervention
1345935|NCT01392469|imatinib|imatinib
1344926|NCT01397123|trained teachers|trained teachers
1344927|NCT01397123|fruit|fruit
1344928|NCT01397123|vegetables|vegetables
1344929|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
1344930|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
1344931|NCT01397084|heartburn|heartburn
1344932|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
1344933|NCT01397084|reflux esophagitis|reflux esophagitis
1344934|NCT01397084|Phase IV|phase iv
1344935|NCT01397071|Avocado, antioxidant|avocado, antioxidant
1344936|NCT01397045|Lung|lung
1344937|NCT01397045|Nodule|nodule
1344938|NCT01397045|Rehabilitation|rehabilitation
1344939|NCT01397045|VATS|vats
1344940|NCT01397045|Thoracotomy|thoracotomy
1344941|NCT01397032|attention bias modification treatment|attention bias modification treatment
1344942|NCT01397032|cognitive bias modification|cognitive bias modification
1344943|NCT01397032|attention training|attention training
1344944|NCT01397032|social anxiety|social anxiety
1344945|NCT01397019|Pancreatic cancer|pancreatic cancer
1344946|NCT01397019|Chemotherapy|chemotherapy
1344947|NCT01397019|Chemoradiotherapy|chemoradiotherapy
1344948|NCT01397006|Fibromyalgia|fibromyalgia
1344949|NCT01397006|pregabalin|pregabalin
1344950|NCT01397006|Lyrica|lyrica
1344951|NCT01396980|hemodialysis|hemodialysis
1344952|NCT01396980|intensive care|intensive care
1344953|NCT01396980|microcirculation|microcirculation
1344954|NCT01396967|capsulorhexis|capsulorhexis
1344955|NCT01396954|Liver cirrhosis|liver cirrhosis
1344956|NCT01396954|Diabetes mellitus|diabetes mellitus
1344957|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
1344958|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
1344959|NCT01396954|Insulin resistance.|insulin resistance.
1344960|NCT01396941|Diabetes|diabetes
1344961|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
1344962|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
1344963|NCT01396915|whole muscle volume|whole muscle volume
1344964|NCT01396915|fasting glucose|fasting glucose
1344965|NCT01396915|insulin|insulin
1344966|NCT01396915|blood urea nitrogen|blood urea nitrogen
1344967|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
1344968|NCT01396889|Echinacea|echinacea
1344969|NCT01396889|viral infections|viral infections
1344970|NCT01396876|Medical clown|medical clown
1344971|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
1344972|NCT01396876|Emergency procedures|emergency procedures
1344973|NCT01396863|Renal dialysis|renal dialysis
1344974|NCT01396863|Hemodiafiltration|hemodiafiltration
1344975|NCT01396863|Hemodialysis|hemodialysis
1344977|NCT01396850|Psychotic Patients|psychotic patients
1344978|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
1344979|NCT01396837|Diabetic Ulcer|diabetic ulcer
1344980|NCT01396837|Diabetic Wound|diabetic wound
1344981|NCT01396837|Chronic Ulcer|chronic ulcer
1344982|NCT01396837|Chronic Wound|chronic wound
1344983|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
1344984|NCT01396837|Neuropathic DFU|neuropathic dfu
1344985|NCT01396837|DFU|dfu
1344986|NCT01396824|Malnutrition|malnutrition
1344987|NCT01396824|Undernutrition|undernutrition
1344988|NCT01396824|Nutrition Assessment|nutrition assessment
1344989|NCT01396824|Nutritional Assessment|nutritional assessment
1344990|NCT01396824|Nutritional Index|nutritional index
1344991|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
1344992|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
1344993|NCT01396824|Nutritional Status|nutritional status
1344994|NCT01396824|Prognosis|prognosis
1344995|NCT01396824|Heart Failure|heart failure
1344996|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
1344997|NCT01396824|Body Composition|body composition
1344998|NCT01396824|Body Weights and Measures|body weights and measures
1344999|NCT01396811|Tinea Pedis|tinea pedis
1345000|NCT01396811|Antifungal|antifungal
1345001|NCT01396798|serious infections|serious infections
1345002|NCT01396798|meningitis|meningitis
1345003|NCT01396785|Tinea Pedis|tinea pedis
1345004|NCT01396785|Antifungal|antifungal
1345005|NCT01396772|prediabetes|prediabetes
1345006|NCT01396772|diabetes prevention|diabetes prevention
1345007|NCT01396772|adults|adults
1345008|NCT01396772|lifestyle intervention|lifestyle intervention
1345009|NCT01396772|Social Cognitive Theory|social cognitive theory
1345010|NCT01396772|dietary intake|dietary intake
1345011|NCT01396772|physical activity|physical activity
1345012|NCT01396759|Bubble CPAP|bubble cpap
1345013|NCT01396759|Humidified high flow|humidified high flow
1345014|NCT01396759|Hypoxaemia|hypoxaemia
1345015|NCT01396759|Nasal prong|nasal prong
1345016|NCT01396759|Severe pneumonia|severe pneumonia
1345017|NCT01396733|thyroid|thyroid
1345018|NCT01396733|cancer|cancer
1345019|NCT01396733|redifferentiation|redifferentiation
1345020|NCT01396733|lipoic acid|lipoic acid
1345021|NCT01396707|HER2|her2
1345022|NCT01396707|Trastuzumab|trastuzumab
1345023|NCT01396707|XELOX|xelox
1345024|NCT01396707|PHASE 2|phase 2
1345025|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
1345026|NCT01396668|locally advanced|locally advanced
1345027|NCT01396655|breast cancer|breast cancer
1345028|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1345029|NCT01396655|molecular marker|molecular marker
1345030|NCT01396655|FDG PET|fdg pet
1345031|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
1345032|NCT01396642|Topical Emollient Therapy|topical emollient therapy
1345033|NCT01396642|Emollient|emollient
1345034|NCT01396642|Preterm|preterm
1345035|NCT01396642|Hospital Acquired Infection|hospital acquired infection
1345036|NCT01396629|cartridge IOL|cartridge iol
1345037|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
1345038|NCT01396603|Optical Coherence Tomography|optical coherence tomography
1345039|NCT01396603|Optical biopsy|optical biopsy
1345040|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
1345041|NCT01396590|Central Nervous System|central nervous system
1345042|NCT01396577|Central Nervous System|central nervous system
1345043|NCT01396564|Type 2 diabetes|type 2 diabetes
1458321|NCT00935558|Zadaxin|zadaxin
1345044|NCT01396564|Resistin|resistin
1345045|NCT01396564|Inflammation|inflammation
1345046|NCT01396564|Insulin Resistance|insulin resistance
1345047|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
1345048|NCT01396551|Anchored Transponder|anchored transponder
1345049|NCT01396551|Lung cancer|lung cancer
1345050|NCT01396551|Calypso system|calypso system
1345052|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
1345053|NCT01396525|Atherosclerosis|atherosclerosis
1345054|NCT01396525|Peripheral artery disease|peripheral artery disease
1345055|NCT01396525|Peripheral vascular disease|peripheral vascular disease
1345057|NCT01396525|Claudication|claudication
1345058|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1345059|NCT01396525|Stent|stent
1345060|NCT01396525|PAOD|paod
1345061|NCT01396525|PVD|pvd
1345062|NCT01396512|Japanese Encephalitis|japanese encephalitis
1345063|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
1345064|NCT01396512|IMOJEV™|imojev™
1345065|NCT01396512|CD.JEVAX™|cd.jevax™
1345066|NCT01396499|Leukemia|leukemia
1345067|NCT01396499|Acute leukemias|acute leukemias
1345068|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
1345069|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
1345070|NCT01396499|AML|aml
1345071|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1345072|NCT01396499|ALL|all
1345073|NCT01396499|BKM120|bkm120
1345074|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
1345075|NCT01396486|Fish Oil|fish oil
1345076|NCT01396486|Inositol|inositol
1345077|NCT01396486|Natural supplements|natural supplements
1345078|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
1345079|NCT01396486|Mania|mania
1345080|NCT01396486|Depression|depression
1345081|NCT01396486|Children|children
1345082|NCT01396473|afterschool|afterschool
1345083|NCT01396473|accelerometers|accelerometers
1345084|NCT01396473|plate waste|plate waste
1345085|NCT01396473|policy|policy
1345086|NCT01396473|environment|environment
1345087|NCT01396460|respiratory quotient|respiratory quotient
1345088|NCT01396460|fat oxidation|fat oxidation
1345089|NCT01396460|morbid obesity|morbid obesity
1345090|NCT01396460|bariatric|bariatric
1345091|NCT01396460|Bariatric Surgery|bariatric surgery
1345092|NCT01396447|Bipolar I disorder|bipolar i disorder
1345093|NCT01396447|Bipolar depression|bipolar depression
1345094|NCT01396447|Depression|depression
1345095|NCT01396447|Bipolar disorder|bipolar disorder
1345096|NCT01396395|Nicorandil|nicorandil
1345097|NCT01396395|Stable angina|stable angina
1345098|NCT01396382|neuroendocrine|neuroendocrine
1345099|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
1345100|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
1345101|NCT01396382|carcinoid|carcinoid
1345102|NCT01396382|carcinoid tumor|carcinoid tumor
1345103|NCT01396382|islet cell tumor|islet cell tumor
1345104|NCT01396382|APUDoma|apudoma
1345105|NCT01396382|Gallium|gallium
1345106|NCT01396382|PET Scan|pet scan
1345107|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
1345108|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1345109|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
1345110|NCT01396343|Demyelinating Disease|demyelinating disease
1345111|NCT01396317|PMR|pmr
1345112|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
1345113|NCT01396317|Tocilizumab|tocilizumab
1345114|NCT01396317|Hospital for Special Surgery|hospital for special surgery
1345115|NCT01396317|HSS|hss
1345116|NCT01396317|Robert Spiera|robert spiera
1345117|NCT01396304|leg ulcer|leg ulcer
1345118|NCT01396304|infection|infection
1345119|NCT01396304|closure|closure
1345120|NCT01396304|wound dressings|wound dressings
1345121|NCT01396239|DMD|dmd
1345122|NCT01396226|Atrial refractoriness|atrial refractoriness
1345123|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
1345124|NCT01396226|IKACh|ikach
1345125|NCT01396213|larazotide acetate|larazotide acetate
1345126|NCT01396187|Type 2 diabetes|type 2 diabetes
1345127|NCT01396187|safety|safety
1345128|NCT01396187|multiple dose|multiple dose
1345129|NCT01396187|intravenous|intravenous
1345130|NCT01396174|breast cancer|breast cancer
1345131|NCT01396174|breast tumor|breast tumor
1345133|NCT01396161|Multiple Doses|multiple doses
1345134|NCT01396161|Safety|safety
1345135|NCT01396161|Pharmacokinetics|pharmacokinetics
1345136|NCT01396161|Pharmacodynamics|pharmacodynamics
1345137|NCT01396161|Healthy Volunteers|healthy volunteers
1345138|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
1345139|NCT01396148|Children and young adults with GIST|children and young adults with gist
1345140|NCT01396148|sunitinib malate|sunitinib malate
1345141|NCT01396148|pharmacokinetics|pharmacokinetics
1345142|NCT01396148|tumor response|tumor response
1345143|NCT01396148|overall survival|overall survival
1345144|NCT01396148|tumor KIT mutation status|tumor kit mutation status
1345145|NCT01396135|Phase 1|phase 1
1345146|NCT01396135|Pharmacokinetics|pharmacokinetics
1345147|NCT01396135|Healthy|healthy
1345148|NCT01396135|Japanese|japanese
1345149|NCT01396135|Non-smokers|non-smokers
1345150|NCT01396135|Major Depressive Disorder|major depressive disorder
1345151|NCT01396135|CP-601|cp-601
1345153|NCT01396096|Bariatric Surgery|bariatric surgery
1345154|NCT01396083|Visual impairment|visual impairment
1345155|NCT01396083|macular edema|macular edema
1345156|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
1345157|NCT01396083|Dexamethasone implant|dexamethasone implant
1345158|NCT01396083|Ranibizumab|ranibizumab
1345159|NCT01396057|Visual impairment|visual impairment
1345160|NCT01396057|macular edema|macular edema
1345161|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
1345162|NCT01396057|Dexamethasone implant|dexamethasone implant
1345163|NCT01396057|Ranibizumab|ranibizumab
1345164|NCT01396044|Quality improvement|quality improvement
1345165|NCT01396044|Checklist|checklist
1345166|NCT01396044|Critical care|critical care
1345167|NCT01396044|Anti-bacterial agents|anti-bacterial agents
1345168|NCT01396044|Mechanical ventilation|mechanical ventilation
1345169|NCT01395966|with tubes|with tubes
1345170|NCT01395953|Buspirone|buspirone
1345171|NCT01395953|Buspar|buspar
1345172|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
1345173|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
1345174|NCT01395953|Children|children
1345175|NCT01395953|Adolescents|adolescents
1345176|NCT01395953|Anxiety|anxiety
1345177|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
1345178|NCT01395927|Canagliflozin|canagliflozin
1345179|NCT01395927|Rifampin|rifampin
1345180|NCT01395927|Pharmacokinetics|pharmacokinetics
1345181|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
1345182|NCT01395901|Palonosetron|palonosetron
1345183|NCT01395901|Ondansetron|ondansetron
1345184|NCT01395901|Pediatric|pediatric
1345185|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1345186|NCT01395836|Cardiology|cardiology
1345187|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
1345188|NCT01395836|Cardiac Surgery|cardiac surgery
1345189|NCT01395784|Oxycodone|oxycodone
1345190|NCT01395784|Opioid abuse|opioid abuse
1345191|NCT01395771|Effect|effect
1345192|NCT01395771|Phone call|phone call
1345193|NCT01395771|Intervention|intervention
1345194|NCT01395771|Promote|promote
1345195|NCT01395771|HAART adherence|haart adherence
1345196|NCT01395758|KRAS mutation|kras mutation
1345197|NCT01395758|metastatic NSCLC|metastatic nsclc
1345198|NCT01395745|SLE|sle
1345199|NCT01395745|Lupus|lupus
1345200|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1345201|NCT01395745|Autoimmune Diseases|autoimmune diseases
1345202|NCT01395745|A-623|a-623
1345203|NCT01395745|Blisibimod|blisibimod
1345204|NCT01395719|renal transplantation|renal transplantation
1345205|NCT01395719|glomerular filtration rate|glomerular filtration rate
1345206|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
1345207|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
1345208|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
1345209|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
1345210|NCT01395706|ICG fluorescence technique|icg fluorescence technique
1345211|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
1345212|NCT01395680|cancer adolescent|cancer adolescent
1345213|NCT01395680|resilience|resilience
1345214|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
1345215|NCT01395641|AADC|aadc
1345216|NCT01395641|DDC|ddc
1345217|NCT01395641|Gene Therapy|gene therapy
1345218|NCT01395641|AAV2-AADC|aav2-aadc
1345219|NCT01395641|Viral Vector|viral vector
1345220|NCT01395641|Gene Transfer|gene transfer
1345221|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
1345222|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1345223|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1345224|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1345225|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1345226|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1345427|NCT01394809|wrist fracture|wrist fracture
1345227|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1345228|NCT01395589|allergy|allergy
1345229|NCT01395589|clinical trial|clinical trial
1345230|NCT01395589|exacerbation|exacerbation
1345231|NCT01395589|pediatrics|pediatrics
1345232|NCT01395576|Genu recurvatum|genu recurvatum
1345233|NCT01395576|Knee hyper extension|knee hyper extension
1345234|NCT01395576|Orthosis|orthosis
1345235|NCT01395576|Gait analysis|gait analysis
1345236|NCT01395576|Post stroke|post stroke
1345237|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
1345238|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
1345239|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
1345240|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
1345241|NCT01395511|Acupuncture,|acupuncture,
1345242|NCT01395511|Randomized controlled trial|randomized controlled trial
1345243|NCT01395498|CMV|cmv
1345244|NCT01395498|PCP|pcp
1345245|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
1345246|NCT01395485|Amgen|amgen
1345247|NCT01395485|Adolescent|adolescent
1345248|NCT01395485|Single Dose|single dose
1345249|NCT01395485|Safety|safety
1345250|NCT01395485|Pharmacokinetics|pharmacokinetics
1345251|NCT01395472|TBI|tbi
1345252|NCT01395472|Acute physical exercise|acute physical exercise
1345253|NCT01395472|Cognitive functions|cognitive functions
1345254|NCT01395472|Mood|mood
1345255|NCT01395459|screening|screening
1345256|NCT01395459|cancer prevention|cancer prevention
1345257|NCT01395459|IVR|ivr
1345258|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
1345259|NCT01395420|Phase 1|phase 1
1345260|NCT01395420|open label|open label
1345261|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
1345262|NCT01395420|Pharmacokinetics|pharmacokinetics
1345263|NCT01395420|CAZ104|caz104
1345264|NCT01395420|Avibactam|avibactam
1345265|NCT01395420|Ceftazidime|ceftazidime
1345266|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
1345267|NCT01395407|Brain|brain
1345268|NCT01395407|Neoplasm|neoplasm
1345269|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
1345270|NCT01395407|Radiosurgery|radiosurgery
1345271|NCT01395394|Phenylketonuria|phenylketonuria
1345272|NCT01395394|PKU|pku
1345273|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
1345274|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
1345275|NCT01395394|BH4|bh4
1345276|NCT01395394|Kuvan|kuvan
1345277|NCT01395394|Oxidative stress|oxidative stress
1345278|NCT01395368|subjective|subjective
1345279|NCT01395368|unilateral|unilateral
1345280|NCT01395368|bilateral|bilateral
1345281|NCT01395368|non-pulsatile|non-pulsatile
1345282|NCT01395368|6 month's duration or longer|6 month's duration or longer
1345283|NCT01395355|binge eating|binge eating
1345284|NCT01395355|loss of control eating|loss of control eating
1345285|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
1345286|NCT01395355|emotional eating|emotional eating
1345287|NCT01395342|Pregnant women|pregnant women
1345288|NCT01395342|Pre-eclampsia|pre-eclampsia
1345289|NCT01395342|Exercise|exercise
1345290|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
1345291|NCT01395342|Parturition|parturition
1345292|NCT01395303|infarction|infarction
1345293|NCT01395303|stroke|stroke
1345294|NCT01395303|diabetes|diabetes
1345295|NCT01395303|fracture|fracture
1345296|NCT01395303|aortic stenosis|aortic stenosis
1345297|NCT01395303|cancer|cancer
1345298|NCT01395303|death|death
1345299|NCT01395303|vitamin D|vitamin d
1345300|NCT01395303|androgens|androgens
1345301|NCT01395303|thyroid hormones|thyroid hormones
1345302|NCT01395290|staphylococcus aureus|staphylococcus aureus
1345303|NCT01395290|vitamin D|vitamin d
1345304|NCT01395277|Nitric Oxide|nitric oxide
1345305|NCT01395277|Vascular Function|vascular function
1345306|NCT01395277|Aging|aging
1345307|NCT01395277|Blood Pressure|blood pressure
1345308|NCT01395277|Arterial Stiffness|arterial stiffness
1345309|NCT01395277|Cardiovascular Disease|cardiovascular disease
1345310|NCT01395277|Cerebral Blood Flow|cerebral blood flow
1345311|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
1345312|NCT01395251|diagnosis|diagnosis
1345313|NCT01395251|sensitivity|sensitivity
1345314|NCT01395251|glucocorticoids|glucocorticoids
1345315|NCT01395238|fathers|fathers
1345316|NCT01395238|parenting|parenting
1345317|NCT01395238|high-risk|high-risk
1345318|NCT01395238|child maltreatment|child maltreatment
1345319|NCT01395238|prevention|prevention
1345320|NCT01395225|Fat Emulsifying|fat emulsifying
1345321|NCT01395225|Radical Cystectomy|radical cystectomy
1345322|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
1345323|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
1345324|NCT01395225|Bladder Cancer|bladder cancer
1345325|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
1345326|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
1345327|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
1345328|NCT01395212|Intramyocardial injections|intramyocardial injections
1345329|NCT01395212|NOGA procedure|noga procedure
1345330|NCT01395212|Acute myocardial infarction|acute myocardial infarction
1345331|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
1345332|NCT01395199|Thalassemia|thalassemia
1345333|NCT01395199|Iron overload|iron overload
1345334|NCT01395186|varicocele|varicocele
1345335|NCT01395186|pain|pain
1345336|NCT01395173|detection|detection
1345337|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1345338|NCT01395160|ADHD|adhd
1345339|NCT01395160|Bipolar Disorder|bipolar disorder
1345340|NCT01395160|Electrophysiological|electrophysiological
1345341|NCT01395160|EEG|eeg
1345342|NCT01395160|ERP|erp
1345343|NCT01395160|Attention|attention
1345344|NCT01395160|Motivation|motivation
1345345|NCT01395160|Mood instability|mood instability
1345346|NCT01395147|Drug Therapy|drug therapy
1345347|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
1345348|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
1345349|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
1345350|NCT01395134|Thyroid surgery|thyroid surgery
1345351|NCT01395121|c-KIT mutation|c-kit mutation
1345352|NCT01395121|advanced disease|advanced disease
1345353|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1345354|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
1345355|NCT01395095|risk factor|risk factor
1345356|NCT01395095|lifestyle|lifestyle
1345357|NCT01395082|Myocarditis|myocarditis
1345358|NCT01395082|Pericarditis|pericarditis
1345359|NCT01395082|Vaccinia virus|vaccinia virus
1345360|NCT01395082|ACAM2000®|acam2000®
1345361|NCT01395082|Smallpox vaccine|smallpox vaccine
1345362|NCT01395069|Post-cataract surgery|post-cataract surgery
1345363|NCT01395069|macular edema|macular edema
1345364|NCT01395056|breast neoplasm|breast neoplasm
1345365|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
1345366|NCT01395056|Drug Therapy|drug therapy
1345367|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
1345368|NCT01395043|TAP catheter|tap catheter
1345369|NCT01395017|Pancreatic cancer|pancreatic cancer
1345370|NCT01395017|Dasatinib|dasatinib
1345371|NCT01395017|chemotherapy|chemotherapy
1345372|NCT01395017|Locally advanced|locally advanced
1345373|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
1345374|NCT01394978|Pleural air leak|pleural air leak
1345375|NCT01394978|Pulmonary resection|pulmonary resection
1345376|NCT01394978|Open thoracotomy|open thoracotomy
1345377|NCT01394965|ECG|ecg
1345378|NCT01394965|Mapping|mapping
1345379|NCT01394965|ecg mapping|ecg mapping
1345380|NCT01394965|arrythmias|arrythmias
1345381|NCT01394952|Cardiovascular disease|cardiovascular disease
1345382|NCT01394952|Diabetes Mellitus|diabetes mellitus
1345383|NCT01394952|Dulaglutide|dulaglutide
1345384|NCT01394939|Vaccinia|vaccinia
1345385|NCT01394939|Vaccinia Virus|vaccinia virus
1345386|NCT01394939|JX-594|jx-594
1345387|NCT01394939|Jennerex|jennerex
1345388|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
1345389|NCT01394939|Colorectal cancer|colorectal cancer
1345390|NCT01394939|Colon Cancer|colon cancer
1345391|NCT01394939|Rectal Cancer|rectal cancer
1345392|NCT01394939|oncolytic virus|oncolytic virus
1345393|NCT01394939|viral therapy|viral therapy
1345394|NCT01394939|RAS mutant|ras mutant
1345395|NCT01394939|Erbitux failure|erbitux failure
1345396|NCT01394939|Oxaliplatin failure|oxaliplatin failure
1345397|NCT01394939|FOLFOX failure|folfox failure
1345398|NCT01394939|FOLFIRI failure|folfiri failure
1345399|NCT01394939|Irinotecan failure|irinotecan failure
1345400|NCT01394939|Pexa-Vec|pexa-vec
1345401|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
1345402|NCT01394926|U/S - Ultrasound|u/s - ultrasound
1345403|NCT01394926|Assess effectiveness|assess effectiveness
1345404|NCT01394900|HIV|hiv
1345405|NCT01394900|sexually transmitted infection|sexually transmitted infection
1345406|NCT01394900|STI|sti
1345407|NCT01394900|men who have sex with men|men who have sex with men
1345408|NCT01394900|MSM|msm
1345409|NCT01394900|couples|couples
1345410|NCT01394900|African American|african american
1345411|NCT01394900|Black|black
1345412|NCT01394887|Metformin, inflammation|metformin, inflammation
1345413|NCT01394887|resistin|resistin
1345414|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
1345415|NCT01394887|children|children
1345416|NCT01394874|osteoarthritis|osteoarthritis
1345417|NCT01394874|exercise|exercise
1345418|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
1345419|NCT01394861|ESD|esd
1345420|NCT01394861|EMR|emr
1345421|NCT01394861|Early Gastric Cancer|early gastric cancer
1345422|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
1345423|NCT01394861|Master Slave Robot|master slave robot
1345424|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
1345425|NCT01394835|Patient after lung transplantation|patient after lung transplantation
1345426|NCT01394809|osteoporosis|osteoporosis
1345428|NCT01394809|mental practice|mental practice
1345429|NCT01394809|mirror therapy|mirror therapy
1345430|NCT01394809|immobilization|immobilization
1345431|NCT01394809|elderly|elderly
1345432|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
1345433|NCT01394770|hypertension|hypertension
1345434|NCT01394770|dialysis|dialysis
1345435|NCT01394770|aliskiren|aliskiren
1345436|NCT01394770|amlodipine|amlodipine
1345437|NCT01394770|outcome|outcome
1345438|NCT01394744|metal|metal
1345440|NCT01394744|cytokine|cytokine
1345441|NCT01394744|hip arthroplasty|hip arthroplasty
1345442|NCT01394744|blood|blood
1345443|NCT01394744|Assessment|assessment
1345444|NCT01394744|cytokine profile|cytokine profile
1345445|NCT01394718|analgesic adjunct|analgesic adjunct
1345446|NCT01394718|acetaminophen|acetaminophen
1345447|NCT01394718|spine fusion surgery|spine fusion surgery
1345448|NCT01394718|opiate reduction|opiate reduction
1345449|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
1345450|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
1345451|NCT01394692|intraoperative MRI|intraoperative mri
1345452|NCT01394692|glioma surgery|glioma surgery
1345453|NCT01394692|extent of resection|extent of resection
1345454|NCT01394679|Lung Cancer|lung cancer
1345455|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
1345456|NCT01394653|YM060|ym060
1345457|NCT01394653|ramosetron|ramosetron
1345458|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
1345459|NCT01394653|OD tablet|od tablet
1345460|NCT01394653|bioequivalence|bioequivalence
1345461|NCT01394614|Cataplexy|cataplexy
1345462|NCT01394614|MSLT|mslt
1345463|NCT01394614|Hypocretin|hypocretin
1345464|NCT01394614|HLA typing|hla typing
1345465|NCT01394614|Polysomnography|polysomnography
1345466|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
1345467|NCT01394601|Antipsychotics|antipsychotics
1345468|NCT01394601|schizophrenia|schizophrenia
1345469|NCT01394601|acute inpatient|acute inpatient
1345470|NCT01394588|Cardiac Surgery|cardiac surgery
1345471|NCT01394588|Perioperative Glucose Control|perioperative glucose control
1345472|NCT01394575|breast cancer|breast cancer
1345473|NCT01394575|radiotherapy|radiotherapy
1345474|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
1345475|NCT01394575|tumor bed|tumor bed
1345476|NCT01394575|IMRT|imrt
1345477|NCT01394536|Post-operative|post-operative
1345478|NCT01394536|post-op|post-op
1345479|NCT01394536|nausea|nausea
1345480|NCT01394536|vomiting|vomiting
1345481|NCT01394510|insulin secretion|insulin secretion
1345482|NCT01394510|beta-cell function|beta-cell function
1345483|NCT01394510|oxidative stress|oxidative stress
1345484|NCT01394510|type 2 diabetes|type 2 diabetes
1345485|NCT01394497|Liver Transplantation|liver transplantation
1345486|NCT01394497|Graft Survival|graft survival
1345487|NCT01394497|Graft Rejection|graft rejection
1345488|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
1345489|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
1345490|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
1345491|NCT01394497|Tissue Donors|tissue donors
1345492|NCT01394497|Cold Ischemia|cold ischemia
1345493|NCT01394471|schizophrenia|schizophrenia
1345494|NCT01394471|schizoaffective disorder|schizoaffective disorder
1345495|NCT01394471|oxytocin|oxytocin
1345496|NCT01394471|OT|ot
1345497|NCT01394471|social cognition|social cognition
1345498|NCT01394471|social functioning|social functioning
1345499|NCT01394471|paranoia|paranoia
1345500|NCT01394471|psychosis|psychosis
1345501|NCT01394471|psychotic symptoms|psychotic symptoms
1345502|NCT01394471|social deficits|social deficits
1345503|NCT01394471|intranasal administration|intranasal administration
1345504|NCT01394458|catheter related infection|catheter related infection
1345505|NCT01394458|bacteremia|bacteremia
1345506|NCT01394458|hemodialysis|hemodialysis
1345507|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
1345508|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
1345509|NCT01394393|obesity treatment|obesity treatment
1345510|NCT01394393|evidence based intervention|evidence based intervention
1345511|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
1345512|NCT01394393|virtual reality environments|virtual reality environments
1345513|NCT01394380|sugar|sugar
1345514|NCT01394380|sweetened beverages|sweetened beverages
1345515|NCT01394380|hepatic steatosis|hepatic steatosis
1345516|NCT01394380|visceral obesity|visceral obesity
1345517|NCT01394380|metabolic syndrome|metabolic syndrome
1345518|NCT01394367|respiratory therapy|respiratory therapy
1345519|NCT01394367|exercise therapy|exercise therapy
1345520|NCT01394367|oxygen uptake|oxygen uptake
1345521|NCT01394367|quality of life|quality of life
1345522|NCT01394367|right ventricular function|right ventricular function
1345523|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
1345524|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
1345525|NCT01394341|Liraglutide|liraglutide
1345527|NCT01394341|Dialysis|dialysis
1345528|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
1345529|NCT01394341|Safety|safety
1345530|NCT01394341|Efficacy|efficacy
1345531|NCT01394328|Delirium|delirium
1345532|NCT01394328|Dementia|dementia
1345533|NCT01394328|Confusion Assessment Method|confusion assessment method
1345534|NCT01394328|Elderly|elderly
1345535|NCT01394315|diffuse optical tomography|diffuse optical tomography
1345536|NCT01394315|response|response
1345537|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1345538|NCT01394315|breast cancer|breast cancer
1345539|NCT01394302|Trigger Finger|trigger finger
1345540|NCT01394289|Standardization|standardization
1345541|NCT01394289|Immunotherapy|immunotherapy
1345542|NCT01394289|Skin prick test|skin prick test
1345543|NCT01394263|prostate cancer|prostate cancer
1345544|NCT01394263|PSA|psa
1345545|NCT01394263|testosterone suppression|testosterone suppression
1345546|NCT01394250|Pain|pain
1345547|NCT01394250|Anxiety|anxiety
1345548|NCT01394250|IV Cannulation|iv cannulation
1345549|NCT01394250|Topical Lidocaine|topical lidocaine
1345550|NCT01394250|Buzzy|buzzy
1345551|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
1346192|NCT01391585|self-monitoring|self-monitoring
1345552|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
1345553|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
1345554|NCT01394224|Healthy volunteers|healthy volunteers
1345555|NCT01394224|Japanese|japanese
1345556|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
1345557|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
1345558|NCT01394198|Somatic Dysfunction|somatic dysfunction
1345559|NCT01394198|Correlational Study|correlational study
1345560|NCT01394198|Endoscopy|endoscopy
1345561|NCT01394185|marijuana|marijuana
1345562|NCT01394185|dronabinol|dronabinol
1345563|NCT01394185|pharmacotherapy|pharmacotherapy
1345564|NCT01394172|Tidal Volume|tidal volume
1345565|NCT01394172|Pediatric|pediatric
1345566|NCT01394172|Difficult airway|difficult airway
1345567|NCT01394172|Ventilation|ventilation
1345568|NCT01394172|Airway management|airway management
1345569|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
1345570|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
1345571|NCT01394146|phosphorus metabolism|phosphorus metabolism
1345572|NCT01394133|HIV Infected Women|hiv infected women
1345573|NCT01394120|Pancreas cancer|pancreas cancer
1345574|NCT01394120|Targeted Therapy|targeted therapy
1345575|NCT01394107|Thromboprophylaxis|thromboprophylaxis
1345576|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
1345577|NCT01394107|Pregnancy|pregnancy
1345578|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
1345579|NCT01394107|Spinal haematoma|spinal haematoma
1345580|NCT01394094|Gum chewing|gum chewing
1345581|NCT01394094|Bowel function|bowel function
1345582|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
1345583|NCT01394081|Veterans|veterans
1345584|NCT01394081|Health Care Utilization|health care utilization
1345585|NCT01394081|Rural Health|rural health
1345586|NCT01394081|Patient Navigation|patient navigation
1345587|NCT01394081|Motivational Interviewing|motivational interviewing
1345588|NCT01394068|Selenium level|selenium level
1345589|NCT01394068|Various blood values|various blood values
1345590|NCT01394068|Duration of artificial respiration|duration of artificial respiration
1345591|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
1345592|NCT01394068|SOFA-Score|sofa-score
1345593|NCT01394068|SAPS-Score|saps-score
1345594|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
1345595|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
1345596|NCT01394055|Gastroparesis|gastroparesis
1345597|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
1345598|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
1345599|NCT01394029|iron overload|iron overload
1345600|NCT01394029|iron chelation|iron chelation
1345601|NCT01394029|deferasirox|deferasirox
1345602|NCT01394029|observational|observational
1345603|NCT01394003|Advanced cancer|advanced cancer
1345604|NCT01393977|Spinal Cord Injuries|spinal cord injuries
1345605|NCT01393977|Stem Cell Transplantation|stem cell transplantation
1345606|NCT01393977|Rehabilitation|rehabilitation
1345607|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
1345608|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
1345609|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
1345610|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
1345611|NCT01393912|crenolanib|crenolanib
1345612|NCT01393912|radiation therapy|radiation therapy
1345613|NCT01393912|malignant brain tumors|malignant brain tumors
1345614|NCT01393912|pediatric|pediatric
1345615|NCT01393899|tofacitinib|tofacitinib
1345617|NCT01393899|CP-690,550|cp-690,550
1345618|NCT01393899|maintenance therapy|maintenance therapy
1345619|NCT01393886|Obesity Surgery|obesity surgery
1345620|NCT01393873|Obesity|obesity
1345621|NCT01393873|Type 2 DM|type 2 dm
1345622|NCT01393860|Diabetes|diabetes
1345623|NCT01393860|aliskiren|aliskiren
1345624|NCT01393860|hypertension|hypertension
1345625|NCT01393860|renal impairment|renal impairment
1345626|NCT01393847|Sickle Cell|sickle cell
1345627|NCT01393847|Pain|pain
1345628|NCT01393847|Genetics|genetics
1345629|NCT01393847|Sickle Cell Disease|sickle cell disease
1345630|NCT01393847|Healthy Volunteer|healthy volunteer
1345631|NCT01393847|HV|hv
1345632|NCT01393834|Delayed cord clamping|delayed cord clamping
1345633|NCT01393834|Umbilical cord|umbilical cord
1345635|NCT01393834|Cord milking|cord milking
1345636|NCT01393808|Type 2 diabetes|type 2 diabetes
1345637|NCT01393808|Paricalcitol|paricalcitol
1345638|NCT01393808|Proteinuria|proteinuria
1345639|NCT01393808|Sodium intake|sodium intake
1345640|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
1345641|NCT01393795|Pain|pain
1345642|NCT01393782|high output shock|high output shock
1345643|NCT01393782|distributive shock|distributive shock
1345644|NCT01393782|warm shock|warm shock
1345645|NCT01393782|septic shock|septic shock
1345646|NCT01393782|pressor|pressor
1345647|NCT01393782|angiotensin|angiotensin
1345648|NCT01393782|ATII|atii
1345649|NCT01393782|vasopressor|vasopressor
1345650|NCT01393769|Retinoblastoma|retinoblastoma
1345651|NCT01393769|RTB|rtb
1345652|NCT01393769|Ocular tumour|ocular tumour
1345653|NCT01393769|Melfalan|melfalan
1345654|NCT01393769|Enucleation|enucleation
1345655|NCT01393769|Tumor of the eye|tumor of the eye
1345656|NCT01393769|Eye|eye
1345657|NCT01393769|Ocular cancer|ocular cancer
1345658|NCT01393769|Ocular chemotherapy|ocular chemotherapy
1345659|NCT01393769|Ophthalmic artery|ophthalmic artery
1345660|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
1345661|NCT01393743|Central Nervous System|central nervous system
1345662|NCT01393730|prostate|prostate
1345663|NCT01393730|metastatic|metastatic
1345664|NCT01393730|castrate resistant|castrate resistant
1345665|NCT01393704|myomectomy|myomectomy
1345666|NCT01393704|vasopressin|vasopressin
1345667|NCT01393704|blood loss|blood loss
1345668|NCT01393691|nighttime fears|nighttime fears
1345669|NCT01393691|anxiety|anxiety
1345670|NCT01393691|sleep|sleep
1345671|NCT01393691|actigraphy|actigraphy
1345672|NCT01393691|intervention|intervention
1345673|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
1345674|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
1345675|NCT01393639|treatment of RA|treatment of ra
1345676|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
1345677|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
1345678|NCT01393587|Oxidative Stress|oxidative stress
1345679|NCT01393587|Laproscopy|laproscopy
1345680|NCT01393561|Rhinitis|rhinitis
1345681|NCT01393561|Common cold|common cold
1345682|NCT01393561|Nasal symptoms|nasal symptoms
1345683|NCT01393561|Children|children
1345684|NCT01393548|Rhinitis|rhinitis
1345685|NCT01393548|common cold|common cold
1345686|NCT01393548|nasal symptoms|nasal symptoms
1345687|NCT01393548|children|children
1345688|NCT01393535|Adiponectin|adiponectin
1345689|NCT01393535|Prognosis|prognosis
1345690|NCT01393535|Cardiac Surgery|cardiac surgery
1345691|NCT01393522|headache|headache
1345692|NCT01393522|migraine|migraine
1345693|NCT01393509|PU-H71|pu-h71
1345694|NCT01393509|Solid Tumor|solid tumor
1345695|NCT01393509|Lymphoma|lymphoma
1345696|NCT01393509|11-041|11-041
1345697|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
1345698|NCT01393496|prematurity|prematurity
1345699|NCT01393496|anemia|anemia
1345700|NCT01393496|transfusion|transfusion
1345701|NCT01393483|esophagectomy|esophagectomy
1345702|NCT01393483|endoscopy|endoscopy
1345703|NCT01393483|biopsy|biopsy
1345704|NCT01393483|Tissue mesothelin|tissue mesothelin
1345705|NCT01393483|Serum mesothelin|serum mesothelin
1345706|NCT01393483|11-037|11-037
1345707|NCT01393470|HPV|hpv
1345708|NCT01393470|Vaccine|vaccine
1345709|NCT01393470|long-term efficacy|long-term efficacy
1345710|NCT01393470|registry-based study|registry-based study
1345711|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
1345712|NCT01393457|cocaine|cocaine
1345713|NCT01393457|cognition|cognition
1345714|NCT01393457|medication|medication
1345715|NCT01393457|treatment|treatment
1345716|NCT01393444|Electrocorticography|electrocorticography
1345717|NCT01393444|Tetraplegia|tetraplegia
1345718|NCT01393444|Spinal cord injury|spinal cord injury
1345719|NCT01393444|Brainstem stroke|brainstem stroke
1345720|NCT01393444|Neuroprosthetic|neuroprosthetic
1345721|NCT01393444|Brain-computer interface|brain-computer interface
1345722|NCT01393444|Direct brain interface|direct brain interface
1345723|NCT01393444|Neural activity|neural activity
1345724|NCT01393444|Motor cortex|motor cortex
1345725|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
1345726|NCT01393431|Predictive value of pH|predictive value of ph
1345727|NCT01393418|Erythropoietin|erythropoietin
1345728|NCT01393418|Cardiac Surgery|cardiac surgery
1345729|NCT01393418|Renal Biomarker|renal biomarker
1345730|NCT01393418|Acute Kidney Injury|acute kidney injury
1345731|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
1345732|NCT01393392|smoking cessation|smoking cessation
1345733|NCT01393392|methadone treatment|methadone treatment
1345734|NCT01393392|nicotine addiction|nicotine addiction
1345735|NCT01393392|drug treatment|drug treatment
1345736|NCT01393392|drug addiction|drug addiction
1345737|NCT01393392|tobacco dependence|tobacco dependence
1345738|NCT01393327|physical training|physical training
1345739|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
1345740|NCT01393327|right ventricular pump function|right ventricular pump function
1345741|NCT01393327|PEA|pea
1345742|NCT01393301|Nicotine dependence|nicotine dependence
1345743|NCT01393301|Smoking, cessation|smoking, cessation
1345744|NCT01393301|Quitting|quitting
1345745|NCT01393301|Anxiety symptoms|anxiety symptoms
1345746|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
1345747|NCT01393275|diabetes|diabetes
1345748|NCT01393275|exercise|exercise
1345749|NCT01393275|intervention|intervention
1345750|NCT01393275|rehabilitation|rehabilitation
1345751|NCT01393275|metabolic rate|metabolic rate
1345752|NCT01393275|sport|sport
1345753|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1345754|NCT01393249|Pediatric|pediatric
1345755|NCT01393249|Asparaginase|asparaginase
1345756|NCT01393249|Pancreatitis|pancreatitis
1345757|NCT01393223|Interstitial Cystitis|interstitial cystitis
1345758|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
1345759|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
1345760|NCT01393223|Liposome|liposome
1345761|NCT01393223|LP-08|lp-08
1345762|NCT01393210|insulin sensitivity|insulin sensitivity
1345763|NCT01393210|adipose tissue|adipose tissue
1345764|NCT01393210|inflammation|inflammation
1345765|NCT01393197|HCC|hcc
1345766|NCT01393197|TACE|tace
1345767|NCT01393184|Target therapy|target therapy
1345768|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
1345769|NCT01393171|Cystocele|cystocele
1345770|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
1345771|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1345772|NCT01393145|salmeterol|salmeterol
1345773|NCT01393145|fluticasone|fluticasone
1345774|NCT01393145|formoterol|formoterol
1345775|NCT01393145|FEV1|fev1
1345776|NCT01393145|Moderate-to-severe|moderate-to-severe
1345777|NCT01393132|Dry Eye|dry eye
1345778|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
1345779|NCT01393132|Graft vs. Host Disease|graft vs. host disease
1345780|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
1345781|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
1345782|NCT01393132|Scleroderma|scleroderma
1345783|NCT01393106|HL|hl
1345784|NCT01393106|idelalisib|idelalisib
1345785|NCT01393106|CAL-101|cal-101
1345786|NCT01393106|GS-1101|gs-1101
1345787|NCT01393106|PI3K|pi3k
1345788|NCT01393093|HCC|hcc
1345789|NCT01393093|TACE|tace
1345790|NCT01393080|nimotuzumab|nimotuzumab
1345791|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
1345792|NCT01393080|chemotherapy|chemotherapy
1345793|NCT01393067|cSEMS|csems
1345794|NCT01393067|NEPS|neps
1345795|NCT01393067|ERCP|ercp
1345796|NCT01393067|biliary stricture|biliary stricture
1345797|NCT01393067|biliary stenosis|biliary stenosis
1345798|NCT01393067|liver transplantation|liver transplantation
1345799|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
1345800|NCT01393054|hypertension|hypertension
1345801|NCT01393054|elderly|elderly
1345802|NCT01393028|coronary artery disease|coronary artery disease
1345803|NCT01393028|angina pectoris|angina pectoris
1346193|NCT01391585|self-management|self-management
1345804|NCT01393028|Stable chest pain complaints|stable chest pain complaints
1345805|NCT01393015|automatic|automatic
1345806|NCT01393015|automation|automation
1345807|NCT01393015|oxygen|oxygen
1345808|NCT01393015|weaning|weaning
1345809|NCT01393015|COPD|copd
1345810|NCT01393015|exacerbation|exacerbation
1345811|NCT01393002|intensive care|intensive care
1345812|NCT01393002|candidemia|candidemia
1345813|NCT01393002|fungal infection|fungal infection
1345814|NCT01392976|cancer|cancer
1345815|NCT01392976|advanced|advanced
1345816|NCT01392976|solid|solid
1345817|NCT01392976|tumor|tumor
1345818|NCT01392976|gemcitabine|gemcitabine
1345819|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
1345820|NCT01392976|CO-1.01|co-1.01
1345821|NCT01392976|CO-101|co-101
1345822|NCT01392976|CO101|co101
1345823|NCT01392963|botox|botox
1345824|NCT01392963|depression|depression
1345825|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
1345826|NCT01392937|AIOL|aiol
1345827|NCT01392937|multipurpose solution|multipurpose solution
1345828|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
1345933|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
1345934|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
1345829|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
1345830|NCT01392911|Dose Ranging|dose ranging
1345831|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
1345832|NCT01392911|Maximum tolerable dose|maximum tolerable dose
1345833|NCT01392911|Pharmacokinetics|pharmacokinetics
1345834|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
1345835|NCT01392911|Rifampicin|rifampicin
1345836|NCT01392911|Rifafour|rifafour
1345837|NCT01392911|Safety|safety
1345838|NCT01392911|Tolerability|tolerability
1345839|NCT01392911|Max Tolerable Dose|max tolerable dose
1345840|NCT01392898|liraglutide|liraglutide
1345841|NCT01392898|insulin|insulin
1345842|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
1345843|NCT01392885|Schizophrenia|schizophrenia
1345844|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
1345845|NCT01392885|Brain Health|brain health
1345846|NCT01392885|Exercise|exercise
1345847|NCT01392885|Mental Health|mental health
1345848|NCT01392885|Poor memory|poor memory
1345849|NCT01392872|Immunosuppressant|immunosuppressant
1345850|NCT01392872|Quality of life|quality of life
1345851|NCT01392872|Cognitive function|cognitive function
1345852|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1345853|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
1345854|NCT01392833|iga nephropathy|iga nephropathy
1345855|NCT01392833|chronic kidney disease|chronic kidney disease
1345856|NCT01392833|proteinuria|proteinuria
1345857|NCT01392833|steroids|steroids
1345858|NCT01392833|azathioprine|azathioprine
1345859|NCT01392820|Phase I|phase i
1345860|NCT01392820|Japan|japan
1345861|NCT01392820|Elderly|elderly
1345863|NCT01392820|SAD|sad
1345864|NCT01392820|MAD|mad
1345865|NCT01392807|Phase 1|phase 1
1345866|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
1345867|NCT01392807|pharmacokinetics|pharmacokinetics
1345868|NCT01392807|NKTR-118|nktr-118
1345869|NCT01392807|Child-Pugh scale|child-pugh scale
1345870|NCT01392807|AUC|auc
1345871|NCT01392807|Cmax|cmax
1345872|NCT01392807|tmax|tmax
1345873|NCT01392807|t1/2|t1/2
1345874|NCT01392794|YM060|ym060
1345875|NCT01392794|ramosetron|ramosetron
1345876|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
1345877|NCT01392794|OD tablet|od tablet
1345878|NCT01392794|bioequivalence|bioequivalence
1345879|NCT01392781|PCOS|pcos
1345880|NCT01392781|hsC-RP|hsc-rp
1345881|NCT01392781|Lp-PLA2|lp-pla2
1345882|NCT01392781|cardiovascular risk|cardiovascular risk
1345883|NCT01392768|Epilepsy|epilepsy
1345884|NCT01392768|Partial|partial
1345885|NCT01392768|Seizures|seizures
1345886|NCT01392768|Adjunctive|adjunctive
1345887|NCT01392690|No condition|no condition
1345888|NCT01392690|Primary prevention|primary prevention
1345889|NCT01392690|Anxiety|anxiety
1345890|NCT01392677|dapagliflozin|dapagliflozin
1345891|NCT01392677|diabetes|diabetes
1345892|NCT01392677|hyperglycaemia|hyperglycaemia
1345893|NCT01392651|Urinary stress incontinence|urinary stress incontinence
1345894|NCT01392651|TVT|tvt
1345895|NCT01392638|Sildenafil|sildenafil
1345896|NCT01392638|Nitric oxide synthase|nitric oxide synthase
1345897|NCT01392638|Polymorphism|polymorphism
1345898|NCT01392638|Hemodynamics|hemodynamics
1345899|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
1345900|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
1345901|NCT01392625|Heart failure|heart failure
1345902|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
1345903|NCT01392625|Stem Cells|stem cells
1345904|NCT01392612|thrombosis|thrombosis
1345905|NCT01392612|hypertension|hypertension
1345906|NCT01392612|gender|gender
1345907|NCT01392612|endothelium|endothelium
1345908|NCT01392599|CRPS Type II|crps type ii
1345909|NCT01392599|Pain|pain
1345910|NCT01392599|Surgery|surgery
1345911|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
1345912|NCT01392599|Sudeck|sudeck
1345913|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
1345914|NCT01392599|Causalgia|causalgia
1345915|NCT01392599|Algodystrophy|algodystrophy
1345916|NCT01392586|survival|survival
1345917|NCT01392586|systemic therapy|systemic therapy
1345918|NCT01392586|upfront surgery|upfront surgery
1345919|NCT01392534|Hypertension|hypertension
1345920|NCT01392534|Telmisartan|telmisartan
1345921|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
1345922|NCT01392534|Potassium|potassium
1345923|NCT01392534|Glucose metabolism|glucose metabolism
1345924|NCT01392534|Lipid metabolism|lipid metabolism
1345925|NCT01392521|Safety|safety
1345926|NCT01392521|Tolerability|tolerability
1345927|NCT01392521|Pharmacokinetics|pharmacokinetics
1345928|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
1345929|NCT01392495|imatinib|imatinib
1345930|NCT01392495|6MWD|6mwd
1345931|NCT01392482|Schizophrenia|schizophrenia
1345932|NCT01392482|Bipolar Disorder|bipolar disorder
1345936|NCT01392469|bosentan|bosentan
1345937|NCT01392469|sildenafil|sildenafil
1568262|NCT00506467|Vibration Response Imaging|vibration response imaging
1345938|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
1345939|NCT01392443|INC424|inc424
1345940|NCT01392443|Ruxolitinib|ruxolitinib
1345941|NCT01392443|Myelofibrosis|myelofibrosis
1345943|NCT01392430|Primary prophylaxis|primary prophylaxis
1345944|NCT01392430|Secondary prophylaxis|secondary prophylaxis
1345945|NCT01392430|Discontinuation|discontinuation
1345946|NCT01392391|Stroke|stroke
1345947|NCT01392391|Exercise|exercise
1345948|NCT01392391|Protein synthesis|protein synthesis
1345949|NCT01392391|Protein breakdown|protein breakdown
1345950|NCT01392391|Muscle atrophy|muscle atrophy
1345951|NCT01392391|Muscle phenotype|muscle phenotype
1345952|NCT01392391|Inflammation|inflammation
1345953|NCT01392391|Insulin resistance|insulin resistance
1345954|NCT01392391|Fitness|fitness
1345955|NCT01392378|Prevenar 13|prevenar 13
1345956|NCT01392378|13vPnC|13vpnc
1345957|NCT01392378|Antipyretic medication|antipyretic medication
1345958|NCT01392378|Healthy subjects|healthy subjects
1345959|NCT01392365|Crohn's disease|crohn's disease
1345960|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
1345961|NCT01392365|Diagnosis, Differential|diagnosis, differential
1345962|NCT01392352|pazopanib|pazopanib
1345963|NCT01392352|hypertension|hypertension
1345964|NCT01392352|forearm blood flow|forearm blood flow
1345965|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
1345966|NCT01392339|CPAP|cpap
1345967|NCT01392339|hypoxia|hypoxia
1345968|NCT01392339|sleep|sleep
1345969|NCT01392339|translational science|translational science
1345970|NCT01392339|gene expression|gene expression
1345971|NCT01392326|Psoriatic arthritis|psoriatic arthritis
1345972|NCT01392326|PsA|psa
1345973|NCT01392326|ACR|acr
1345974|NCT01392326|CASPAR|caspar
1345975|NCT01392313|carnitine, kidney|carnitine, kidney
1345976|NCT01392287|Geriatric|geriatric
1345977|NCT01392287|Older adults|older adults
1345978|NCT01392287|Major Depressive Disorder|major depressive disorder
1345979|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1345980|NCT01392287|memantine hydrochloride|memantine hydrochloride
1345981|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
1345982|NCT01392287|NAAG|naag
1345983|NCT01392287|Cognitive impairment|cognitive impairment
1345984|NCT01392248|EEG|eeg
1345985|NCT01392248|breast cancer surgery|breast cancer surgery
1345986|NCT01392248|prediction|prediction
1345987|NCT01392248|acute postoperative pain|acute postoperative pain
1345988|NCT01392248|chronic pain|chronic pain
1345989|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
1345990|NCT01392222|focus group|focus group
1345991|NCT01392222|11-108|11-108
1345992|NCT01392209|BEVACIZUMAB|bevacizumab
1345993|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
1345994|NCT01392209|Brain|brain
1345995|NCT01392209|CNS|cns
1345996|NCT01392209|anti-VEGF antibody|anti-vegf antibody
1345997|NCT01392209|11-057|11-057
1345998|NCT01392196|Renal Impairment|renal impairment
1345999|NCT01392183|Kidney cancer|kidney cancer
1346000|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
1346001|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
1346002|NCT01392183|RCC|rcc
1346003|NCT01392183|Metastatic|metastatic
1346004|NCT01392183|Locally advanced|locally advanced
1346005|NCT01392183|Complete response|complete response
1346006|NCT01392183|CR|cr
1346007|NCT01392183|Partial Response|partial response
1346008|NCT01392183|PR|pr
1346009|NCT01392183|Overall survival|overall survival
1346010|NCT01392183|OS|os
1346011|NCT01392183|Time to progression|time to progression
1346012|NCT01392183|TTP|ttp
1346013|NCT01392183|Pazopanib|pazopanib
1346014|NCT01392183|GW786034|gw786034
1346015|NCT01392183|Temsirolimus|temsirolimus
1346016|NCT01392183|CCI-779|cci-779
1346017|NCT01392183|Torisel|torisel
1346018|NCT01392183|Benadryl|benadryl
1346019|NCT01392183|Diphenhydramine|diphenhydramine
1346020|NCT01392183|TemPa|tempa
1346021|NCT01392170|Leukemia|leukemia
1346022|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
1346023|NCT01392170|CML|cml
1346024|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
1346025|NCT01392170|TKI|tki
1346026|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
1346027|NCT01392170|CCyR|ccyr
1346028|NCT01392170|Minimal residual disease|minimal residual disease
1346029|NCT01392170|MRD|mrd
1346030|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
1346031|NCT01392170|Pegasys|pegasys
1346032|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
1346033|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
1346034|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
1346035|NCT01392144|Radiation pneumonitis|radiation pneumonitis
1346036|NCT01392144|RP|rp
1346037|NCT01392144|Nitric oxide|nitric oxide
1346038|NCT01392144|NO|no
1346039|NCT01392144|Thoracic|thoracic
1346040|NCT01392144|Esophagus cancer|esophagus cancer
1346041|NCT01392144|Lung cancer|lung cancer
1346042|NCT01392144|Radiation therapy|radiation therapy
1568263|NCT00506467|VRI|vri
1346043|NCT01392144|radiotherapy|radiotherapy
1346044|NCT01392144|RT|rt
1346045|NCT01392144|XRT|xrt
1346046|NCT01392144|Airway|airway
1346047|NCT01392144|Alveolar|alveolar
1346048|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
1346049|NCT01392144|Questionnaires|questionnaires
1346050|NCT01392131|Oncoxin|oncoxin
1346051|NCT01392131|Safety of Oncoxin|safety of oncoxin
1346052|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
1346053|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
1346054|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
1346055|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
1346056|NCT01392105|Myocardial infarction|myocardial infarction
1346057|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
1346058|NCT01392092|Contingency Management|contingency management
1346059|NCT01392092|Drug Self-Administration|drug self-administration
1346060|NCT01392079|CLL|cll
1346061|NCT01392079|17p deletion|17p deletion
1346062|NCT01392079|refractory to fludarabine|refractory to fludarabine
1346063|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
1346064|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
1346065|NCT01392066|breast neoplasms|breast neoplasms
1346066|NCT01392066|spouses/partners|spouses/partners
1346067|NCT01392066|couples|couples
1346068|NCT01392066|interpersonal relations|interpersonal relations
1346069|NCT01392066|psychosocial adjustment|psychosocial adjustment
1346070|NCT01392066|psychological adaptation|psychological adaptation
1346071|NCT01392066|depression|depression
1346072|NCT01392066|quality of life|quality of life
1346073|NCT01392066|dyadic coping|dyadic coping
1346074|NCT01392066|coping behavior|coping behavior
1346075|NCT01392066|cohort|cohort
1346076|NCT01392066|questionnaire|questionnaire
1346077|NCT01392053|labor|labor
1346078|NCT01392053|pain|pain
1346079|NCT01392053|massage|massage
1346080|NCT01392027|Pancreatic Cancer|pancreatic cancer
1346081|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
1346082|NCT01392027|Diseases of the pancreas|diseases of the pancreas
1346083|NCT01392014|malaria|malaria
1346084|NCT01392014|DHP|dhp
1346085|NCT01392014|PQ|pq
1346086|NCT01392014|gametocytes|gametocytes
1346087|NCT01391975|arteriovenous fistula|arteriovenous fistula
1346088|NCT01391975|surveillance|surveillance
1346089|NCT01391975|arterial stenosis|arterial stenosis
1346090|NCT01391975|venous stenosis|venous stenosis
1346091|NCT01391962|Pharmacodynamics|pharmacodynamics
1346092|NCT01391962|VEGF Inhibitor|vegf inhibitor
1346093|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
1346094|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
1346095|NCT01391962|Gene Expression Profiling|gene expression profiling
1346096|NCT01391949|disability|disability
1346097|NCT01391949|walking|walking
1346098|NCT01391949|feedback|feedback
1346099|NCT01391949|exercise|exercise
1346100|NCT01391923|Lipolysis|lipolysis
1346101|NCT01391923|Cryolipolysis|cryolipolysis
1346102|NCT01391923|Fat Reduction|fat reduction
1346103|NCT01391910|rhinosinusitis|rhinosinusitis
1346104|NCT01391897|somatoform disorders|somatoform disorders
1346105|NCT01391897|PTSD|ptsd
1346106|NCT01391897|epigenetics|epigenetics
1346107|NCT01391897|psychotherapy|psychotherapy
1346108|NCT01391897|psychosomatics|psychosomatics
1346109|NCT01391884|Incretin hormones|incretin hormones
1346110|NCT01391884|GLP-1|glp-1
1346111|NCT01391884|GIP|gip
1346112|NCT01391884|Uremia|uremia
1346113|NCT01391884|Dialysis|dialysis
1346114|NCT01391858|Pregabalin|pregabalin
1346115|NCT01391858|Postoperative pain|postoperative pain
1346116|NCT01391858|Mastectomy|mastectomy
1346117|NCT01391845|progesterone|progesterone
1346118|NCT01391845|glycodelin-A|glycodelin-a
1346119|NCT01391845|ulipristal acetate|ulipristal acetate
1346120|NCT01391832|rTMS|rtms
1346121|NCT01391832|PTSD|ptsd
1346122|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
1346123|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1346124|NCT01391832|combat related PTSD|combat related ptsd
1346125|NCT01391832|OEF|oef
1346126|NCT01391832|OIF|oif
1346127|NCT01391832|Veterans|veterans
1346128|NCT01391832|operation enduring freedom|operation enduring freedom
1346720|NCT01389141|ovary|ovary
1346129|NCT01391832|operation iraqi freedom|operation iraqi freedom
1346130|NCT01391832|CPT|cpt
1346131|NCT01391832|cognitive processing therapy|cognitive processing therapy
1346132|NCT01391819|Brazil|brazil
1346133|NCT01391819|Incidence|incidence
1346134|NCT01391819|Dengue virus|dengue virus
1346135|NCT01391819|Dengue|dengue
1346136|NCT01391819|Dengue infection|dengue infection
1346137|NCT01391806|Breast cancer|breast cancer
1346138|NCT01391806|Preoperative breast MRI|preoperative breast mri
1346139|NCT01391806|Breast-conserving surgery|breast-conserving surgery
1346140|NCT01391806|Mastectomy|mastectomy
1346141|NCT01391806|Prospective study|prospective study
1346142|NCT01391793|Renal scarring|renal scarring
1346143|NCT01391793|Dexamethasone|dexamethasone
1346144|NCT01391793|Child|child
1346145|NCT01391793|Corticosteroids|corticosteroids
1346146|NCT01391793|Pediatric|pediatric
1346147|NCT01391793|Urinary tract infection|urinary tract infection
1346148|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
1346149|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
1346150|NCT01391780|women,|women,
1346151|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
1346152|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
1346153|NCT01391767|Ridge Preservation|ridge preservation
1346154|NCT01391767|Dental Implant|dental implant
1346155|NCT01391767|Histology|histology
1346156|NCT01391754|child abuse|child abuse
1346157|NCT01391741|Parkinson´s Disease|parkinson´s disease
1346158|NCT01391741|Walking|walking
1346159|NCT01391741|Exercise|exercise
1346160|NCT01391741|Automaticity|automaticity
1346161|NCT01391741|Dual Task|dual task
1346162|NCT01391741|Visual Cues|visual cues
1346163|NCT01391741|Cueing|cueing
1346164|NCT01391741|Neuroplasticity|neuroplasticity
1346165|NCT01391741|Gait analysis|gait analysis
1346166|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
1346167|NCT01391715|Proton pump inhibitor|proton pump inhibitor
1346168|NCT01391715|standard dose|standard dose
1346169|NCT01391715|Double dose|double dose
1346170|NCT01391676|glaucoma|glaucoma
1346171|NCT01391676|trabeculectomy|trabeculectomy
1346172|NCT01391676|filtering bleb|filtering bleb
1346173|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
1346174|NCT01391663|Drug Therapy|drug therapy
1346175|NCT01391650|ACL|acl
1346176|NCT01391650|double-bundle|double-bundle
1346177|NCT01391650|navigation system|navigation system
1346178|NCT01391637|Long term follow-up|long term follow-up
1346179|NCT01391637|HuCNS-SC cells|hucns-sc cells
1346180|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
1346181|NCT01391624|chocolate|chocolate
1346182|NCT01391624|craving|craving
1346183|NCT01391624|addiction|addiction
1346184|NCT01391624|compulsion|compulsion
1346185|NCT01391598|fibromyalgia|fibromyalgia
1346186|NCT01391598|intravenous lidocaine|intravenous lidocaine
1346187|NCT01391598|substance P|substance p
1346188|NCT01391598|interleukins|interleukins
1346189|NCT01391585|Text|text
1346190|NCT01391585|SMS|sms
1346191|NCT01391585|diabetes|diabetes
1346194|NCT01391585|adherence|adherence
1346195|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
1346196|NCT01391572|esophagectomy|esophagectomy
1346197|NCT01391572|radiation|radiation
1346198|NCT01391572|tumor bed|tumor bed
1346199|NCT01391572|elective nodal irradiation|elective nodal irradiation
1346200|NCT01391559|breathing difficulty|breathing difficulty
1346201|NCT01391520|Acute Kidney Injury|acute kidney injury
1346202|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
1346203|NCT01391520|Labile Iron|labile iron
1346204|NCT01391520|Iron Chelation|iron chelation
1346205|NCT01391520|Deferiprone|deferiprone
1346206|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
1346207|NCT01391507|COR-1|cor-1
1346208|NCT01391507|Heart failure|heart failure
1346209|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
1346210|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
1346211|NCT01391494|Inactivated Vaccine|inactivated vaccine
1346212|NCT01391494|Human Diploid cell|human diploid cell
1346213|NCT01391494|Safety|safety
1346214|NCT01391494|Immunogenicity|immunogenicity
1346215|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
1346216|NCT01391481|Perfluorocarbon|perfluorocarbon
1346217|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1346218|NCT01391481|Acute lung injury|acute lung injury
1346219|NCT01391455|Inguinal hernia repair|inguinal hernia repair
1346220|NCT01391455|Mesh|mesh
1346221|NCT01391455|Groin pain|groin pain
1346222|NCT01391455|Testicular pain|testicular pain
1346223|NCT01391442|follow up of troop,|follow up of troop,
1346224|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
1346225|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
1346226|NCT01391416|Chronic kidney disease|chronic kidney disease
1346227|NCT01391403|Schizophrenia|schizophrenia
1346228|NCT01391403|Risperidone|risperidone
1346229|NCT01391403|Artemisinin|artemisinin
1346230|NCT01391403|Toxoplasma|toxoplasma
1346231|NCT01391403|Immune|immune
1346232|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
1346233|NCT01391390|Schizophrenia|schizophrenia
1346234|NCT01391390|Melatonin|melatonin
1346235|NCT01391390|Oxidative Stress|oxidative stress
1346236|NCT01391390|Antioxidant|antioxidant
1346237|NCT01391377|HDL|hdl
1346238|NCT01391377|High density Lipoprotein|high density lipoprotein
1346239|NCT01391377|Peripheral arterial disease|peripheral arterial disease
1346240|NCT01391377|Tredaptive|tredaptive
1346241|NCT01391377|Niacin|niacin
1346242|NCT01391377|Laropiprant|laropiprant
1346243|NCT01391377|Plaque|plaque
1346244|NCT01391377|Atherosclerosis|atherosclerosis
1346245|NCT01391377|Lipid content|lipid content
1568264|NCT00506454|Fatigue|fatigue
1346246|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
1346247|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
1346248|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
1346249|NCT01391351|serum miRNA|serum mirna
1346250|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
1346251|NCT01391338|Prostatitis|prostatitis
1346252|NCT01391338|Chronic|chronic
1346253|NCT01391338|Pelvic Pain|pelvic pain
1346254|NCT01391338|NIH-CPSI|nih-cpsi
1346255|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
1346256|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
1346257|NCT01391260|EGFR Mutation Positive|egfr mutation positive
1346258|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
1346259|NCT01391247|open angle glaucoma|open angle glaucoma
1346260|NCT01391247|low tension glaucoma|low tension glaucoma
1346261|NCT01391247|oximetry|oximetry
1346262|NCT01391234|Metastatic bone disease|metastatic bone disease
1346263|NCT01391234|Bone metastases|bone metastases
1346264|NCT01391234|Radiation therapy|radiation therapy
1346265|NCT01391234|TomoTherapy|tomotherapy
1346266|NCT01391221|Depression|depression
1346267|NCT01391221|Inflammation|inflammation
1346268|NCT01391221|Cognition|cognition
1346269|NCT01391221|Pain|pain
1346270|NCT01391221|Allostatic load|allostatic load
1346271|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
1346272|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
1346273|NCT01391195|low level laser therapy|low level laser therapy
1346274|NCT01391195|muscle performance|muscle performance
1346275|NCT01391195|fatigue index|fatigue index
1346276|NCT01391195|endurance training|endurance training
1346277|NCT01391195|ventilatory threshold|ventilatory threshold
1346278|NCT01391195|VO2Max|vo2max
1346279|NCT01391195|VO2Peak|vo2peak
1346280|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
1346281|NCT01391182|blood loss|blood loss
1346282|NCT01391182|total hip arthroplasty|total hip arthroplasty
1346283|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
1346284|NCT01391182|Amicar|amicar
1346285|NCT01391156|minoxidil|minoxidil
1346286|NCT01391156|finasteride|finasteride
1346287|NCT01391156|topical|topical
1346288|NCT01391156|lotion|lotion
1346289|NCT01391156|male pattern hair loss|male pattern hair loss
1346290|NCT01391156|androgenetic alopecia|androgenetic alopecia
1346291|NCT01391143|Prostate cancer|prostate cancer
1346292|NCT01391143|Melanoma|melanoma
1346293|NCT01391143|Renal cell carcinoma|renal cell carcinoma
1346294|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
1346295|NCT01391143|Head and neck cancer|head and neck cancer
1346296|NCT01391143|Bladder cancer|bladder cancer
1346297|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
1346298|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
1346299|NCT01391130|Cancer|cancer
1346300|NCT01391130|Tumor|tumor
1346301|NCT01391130|Metastasis|metastasis
1346302|NCT01391117|TMC649128|tmc649128
1346303|NCT01391117|HCV|hcv
1346304|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
1346305|NCT01391117|Hepatitis C|hepatitis c
1346306|NCT01391117|Hep C|hep c
1346307|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
1346308|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1346309|NCT01391104|Exercise|exercise
1346310|NCT01391104|Six-minute walk test|six-minute walk test
1346311|NCT01391104|sildenafil|sildenafil
1346312|NCT01391078|glaucoma|glaucoma
1346313|NCT01391078|IOP|iop
1346314|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
1346315|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
1346316|NCT01391078|fluctuation|fluctuation
1346317|NCT01391078|comparison|comparison
1346318|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
1346319|NCT01391065|FLT PET|flt pet
1346320|NCT01391065|F-Miso PET|f-miso pet
1346321|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
1346322|NCT01391065|Cervix|cervix
1346323|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
1346324|NCT01391052|Intrauterine system|intrauterine system
1346325|NCT01391052|reproductive age|reproductive age
1346326|NCT01391052|menstrual bleeding|menstrual bleeding
1346327|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
1346328|NCT01391039|Contrast Ultrasound|contrast ultrasound
1346329|NCT01391039|Microinvasion|microinvasion
1346330|NCT01391039|Elastography|elastography
1346331|NCT01391026|Medical informatics|medical informatics
1346332|NCT01391026|Health services accessibility|health services accessibility
1346333|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
1346334|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1346335|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
1346336|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
1346337|NCT01391013|Darunavir|darunavir
1346338|NCT01391013|Ritonavir|ritonavir
1568265|NCT00506454|Hemodialysis|hemodialysis
1346339|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
1346340|NCT01391013|Prezista|prezista
1346341|NCT01391000|rotator cuff surgery|rotator cuff surgery
1346342|NCT01391000|pain|pain
1346343|NCT01391000|exercise therapy|exercise therapy
1346345|NCT01390974|PCI|pci
1346346|NCT01390974|thienopyridines|thienopyridines
1346347|NCT01390974|prasugrel therapy|prasugrel therapy
1346348|NCT01390974|clopidogrel therapy|clopidogrel therapy
1346349|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
1346350|NCT01390935|guideline adherence|guideline adherence
1346351|NCT01390935|systolic heart failure|systolic heart failure
1346352|NCT01390909|epilepsy|epilepsy
1346353|NCT01390909|anti-epileptic drug|anti-epileptic drug
1346354|NCT01390909|polytherapy|polytherapy
1346355|NCT01390909|adherence|adherence
1346356|NCT01390909|Medicaid|medicaid
1346357|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
1346358|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
1346359|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
1346360|NCT01390818|Solid Tumor|solid tumor
1346361|NCT01390818|Phase I|phase i
1346362|NCT01390766|Antirejection|antirejection
1346363|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
1346364|NCT01390727|hypertension|hypertension
1346365|NCT01390727|device-guided breathing|device-guided breathing
1346366|NCT01390727|autonomic function|autonomic function
1346367|NCT01390727|Resperate|resperate
1346368|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
1346369|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1346370|NCT01390714|pharmacokinetics|pharmacokinetics
1346371|NCT01390714|pharmacodynamics|pharmacodynamics
1346372|NCT01390701|randomized|randomized
1346373|NCT01390701|cross-over|cross-over
1346374|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1346375|NCT01390701|felodipin|felodipin
1346376|NCT01390701|hypertension|hypertension
1346377|NCT01390701|blood pressure|blood pressure
1346378|NCT01390701|treatment|treatment
1346379|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
1346380|NCT01390688|Low-grade inflammation|low-grade inflammation
1346381|NCT01390688|Cognitive dysfunction|cognitive dysfunction
1346382|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
1346383|NCT01390662|parathyroid hormone|parathyroid hormone
1346384|NCT01390649|ITP|itp
1346385|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
1346386|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
1346387|NCT01390636|Eating Disorder Only|eating disorder only
1346388|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
1346389|NCT01390623|Short-term antibiotic|short-term antibiotic
1346390|NCT01390623|Ceftriaxone|ceftriaxone
1346391|NCT01390623|Cefixime|cefixime
1346392|NCT01390623|Women|women
1346393|NCT01390623|Efficacy|efficacy
1346394|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
1346395|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
1346396|NCT01390610|Type 2 Diabetes|type 2 diabetes
1346397|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1346398|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1346399|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1346400|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1346401|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1346402|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1346403|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1346404|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1346405|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
1346406|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1346407|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1346408|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1346409|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
1346410|NCT01390571|adult glioblastoma|adult glioblastoma
1346411|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
1346412|NCT01390571|adult gliosarcoma|adult gliosarcoma
1346413|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
1346414|NCT01390558|Down Syndrome|down syndrome
1346415|NCT01390558|Orthotics|orthotics
1346416|NCT01390558|Gait Analysis|gait analysis
1346417|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
1346418|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
1346419|NCT01390545|subcutaneous|subcutaneous
1346420|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
1346421|NCT01390532|Gated blood-pool|gated blood-pool
1346422|NCT01390532|D-SPECT|d-spect
1346423|NCT01390532|Pharmacological stress|pharmacological stress
1346424|NCT01390532|NYHA III/IV|nyha iii/iv
1346425|NCT01390532|LVEF < 35 %|lvef < 35 %
1346426|NCT01390532|QRS > 120 ms|qrs > 120 ms
1346427|NCT01390532|optimal medical treatment|optimal medical treatment
1346428|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
1346429|NCT01390519|mRCC,|mrcc,
1346430|NCT01390519|observational,|observational,
1346431|NCT01390519|Afinitor,|afinitor,
1346432|NCT01390519|everolimus,|everolimus,
1346433|NCT01390519|2.line|2.line
1346434|NCT01390506|cardiac arrest|cardiac arrest
1346435|NCT01390506|resuscitation|resuscitation
1346436|NCT01390506|neurological outcome|neurological outcome
1346437|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
1346438|NCT01390480|vitamin D|vitamin d
1346439|NCT01390480|Autoimmune disease|autoimmune disease
1346440|NCT01390480|diabetes|diabetes
1346441|NCT01390467|Paracetamol|paracetamol
1346442|NCT01390467|Cognitive impact|cognitive impact
1346443|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
1346444|NCT01390441|RA|ra
1346445|NCT01390441|Rituximab|rituximab
1346446|NCT01390441|Rituxan|rituxan
1346447|NCT01390441|MabThera|mabthera
1346448|NCT01390441|Methotrexate|methotrexate
1346449|NCT01390441|Rheumatrex|rheumatrex
1346450|NCT01390441|Trexall|trexall
1346451|NCT01390441|MK-8808|mk-8808
1346452|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
1346453|NCT01390402|Natural killer cells|natural killer cells
1346454|NCT01390402|Stem Cell Transplantation|stem cell transplantation
1346455|NCT01390402|Immune cells|immune cells
1346456|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
1346457|NCT01390402|CML|cml
1346458|NCT01390402|Human leukocyte antigen|human leukocyte antigen
1346459|NCT01390402|HLA|hla
1346460|NCT01390402|Graft-vs-host disease|graft-vs-host disease
1346461|NCT01390402|GVHD|gvhd
1346462|NCT01390402|Antithymocyte globulin|antithymocyte globulin
1346463|NCT01390402|ATG|atg
1346464|NCT01390402|Thymoglobulin|thymoglobulin
1346465|NCT01390402|Interleukin-2|interleukin-2
1346466|NCT01390402|IL-2|il-2
1346467|NCT01390402|Aldesleukin|aldesleukin
1346468|NCT01390402|Proleukin|proleukin
1346469|NCT01390402|Fludarabine|fludarabine
1346470|NCT01390402|Fludarabine phosphate|fludarabine phosphate
1346471|NCT01390402|Fludara|fludara
1346472|NCT01390402|Tacrolimus|tacrolimus
1346473|NCT01390402|Prograf|prograf
1346474|NCT01390402|Busulfan|busulfan
1346475|NCT01390402|Busulfex|busulfex
1346476|NCT01390402|Myleran|myleran
1346477|NCT01390402|Methotrexate|methotrexate
1346478|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
1346479|NCT01390389|MR Spectroscopy|mr spectroscopy
1346480|NCT01390389|Coenzyme Q10|coenzyme q10
1346481|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
1346482|NCT01390376|Schizophrenia|schizophrenia
1346483|NCT01390376|NMDA|nmda
1346484|NCT01390376|DAAOI|daaoi
1346485|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
1346486|NCT01390363|immunization|immunization
1346487|NCT01390363|reminder systems|reminder systems
1346488|NCT01390350|Schnitzler syndrome|schnitzler syndrome
1346489|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
1346490|NCT01390337|AC220|ac220
1346491|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1346492|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
1346493|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
1346494|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
1346495|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
1346496|NCT01390337|Kinase|kinase
1346497|NCT01390337|Kinase Inhibitor|kinase inhibitor
1346498|NCT01390337|Pharmacokinetics|pharmacokinetics
1346499|NCT01390337|ASP2689|asp2689
1346500|NCT01390337|quizartinib|quizartinib
1346501|NCT01390324|Migraine|migraine
1346502|NCT01390324|Naratriptan|naratriptan
1346503|NCT01390324|Naproxen|naproxen
1346504|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
1346505|NCT01390272|Hypertension|hypertension
1346506|NCT01390272|Telephone|telephone
1346507|NCT01390272|Disease Management|disease management
1346508|NCT01390272|Veterans|veterans
1346509|NCT01390272|Pharmacists|pharmacists
1346510|NCT01390272|Nurses|nurses
1346511|NCT01390246|Pregnancy|pregnancy
1346512|NCT01390246|Tobacco use disorder|tobacco use disorder
1346513|NCT01390246|Smoking cessation|smoking cessation
1346514|NCT01390246|Bupropion SR|bupropion sr
1346515|NCT01390246|Zyban|zyban
1346516|NCT01390233|Labor, obstetric|labor, obstetric
1346517|NCT01390233|Labor, induced|labor, induced
1346518|NCT01390220|Epilepsy|epilepsy
1346519|NCT01390220|seizure clusters|seizure clusters
1346520|NCT01390220|acute repetitive seizures|acute repetitive seizures
1346521|NCT01390220|rescue treatment|rescue treatment
1346522|NCT01390220|ARTEMIS|artemis
1346523|NCT01390207|hCG triggering|hcg triggering
1346524|NCT01390207|pregnancy|pregnancy
1346525|NCT01390207|GnRH antagonist|gnrh antagonist
1346526|NCT01390194|liver disease|liver disease
1346527|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
1346528|NCT01390155|Electrocardiography|electrocardiography
1346529|NCT01390155|Coronary Artery Disease|coronary artery disease
1346530|NCT01390155|Atrial Fibrillation|atrial fibrillation
1346531|NCT01390155|Heart Atria|heart atria
1346532|NCT01390155|Coronary Circulation|coronary circulation
1346533|NCT01390155|Ischemia|ischemia
1346534|NCT01390116|gamma delta T cell|gamma delta t cell
1346535|NCT01390116|natural killer cell|natural killer cell
1346536|NCT01390116|proliferation|proliferation
1346537|NCT01390116|cytokine secretion|cytokine secretion
1346538|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
1346539|NCT01390103|hip pain|hip pain
1346540|NCT01390090|piriformis muscle|piriformis muscle
1346541|NCT01390077|homogentisic acid|homogentisic acid
1346542|NCT01390051|birth weight|birth weight
1346543|NCT01390051|thrombosis|thrombosis
1346544|NCT01390051|anticoagulant therapy|anticoagulant therapy
1346545|NCT01390025|Influenza|influenza
1346546|NCT01390025|Monoclonal antibody|monoclonal antibody
1346547|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
1346548|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
1346549|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
1346550|NCT01389973|STELARA|stelara
1346551|NCT01389973|ustekinumab|ustekinumab
1346552|NCT01389947|mesenteric ischemia|mesenteric ischemia
1346553|NCT01389947|extracorporeal circulation|extracorporeal circulation
1346554|NCT01389947|microcirculation|microcirculation
1346555|NCT01389947|cardiac surgery|cardiac surgery
1346556|NCT01389947|IFABP|ifabp
1346557|NCT01389947|citrullinemia|citrullinemia
1346558|NCT01389947|glycocalyx|glycocalyx
1346559|NCT01389947|vascular occlusion test|vascular occlusion test
1346560|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
1346561|NCT01389934|levo-bupicaine|levo-bupicaine
1346562|NCT01389934|Radical|radical
1346563|NCT01389934|Mastectomy|mastectomy
1346564|NCT01389921|lower urinary tract|lower urinary tract
1346565|NCT01389921|sensory evoked potential|sensory evoked potential
1346566|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
1346567|NCT01389921|electroencephalogram|electroencephalogram
1346568|NCT01389921|cortical processing|cortical processing
1346569|NCT01389921|bladder sensations|bladder sensations
1346570|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
1346571|NCT01389921|overactive bladder|overactive bladder
1346572|NCT01389895|Lupus|lupus
1346573|NCT01389895|Cutaneous lupus|cutaneous lupus
1346574|NCT01389882|mechanical ventilation|mechanical ventilation
1346575|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
1346576|NCT01389882|pressure support|pressure support
1346577|NCT01389869|Emotional tears|emotional tears
1346578|NCT01389869|Postprandial plasma|postprandial plasma
1346579|NCT01389869|Chemosignal|chemosignal
1346580|NCT01389869|Obesity|obesity
1346581|NCT01389869|Appetite|appetite
1346582|NCT01389869|Food intake|food intake
1346583|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
1346584|NCT01389856|PPHN|pphn
1346585|NCT01389843|Heart failure|heart failure
1346586|NCT01389843|Registry|registry
1346587|NCT01389843|Cohort|cohort
1346588|NCT01389843|Heart Disease|heart disease
1346589|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
1346590|NCT01389830|End of Life|end of life
1346591|NCT01389830|EOL|eol
1346592|NCT01389830|Latinos|latinos
1346593|NCT01389830|Hispanic American|hispanic american
1346594|NCT01389830|Medicare beneficiaries|medicare beneficiaries
1346595|NCT01389830|stage III diagnosis|stage iii diagnosis
1346596|NCT01389830|Breast cancer|breast cancer
1346597|NCT01389830|Colorectal cancer|colorectal cancer
1346598|NCT01389830|Prostate cancer|prostate cancer
1346599|NCT01389830|Lung cancer|lung cancer
1346600|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
1346601|NCT01389830|CPTD|cptd
1346602|NCT01389804|transplant, pediatric|transplant, pediatric
1346603|NCT01389791|muscle relaxation|muscle relaxation
1346604|NCT01389791|magnesium sulfate|magnesium sulfate
1346605|NCT01389791|rocuronium|rocuronium
1346606|NCT01389739|continuity of care|continuity of care
1346607|NCT01389739|interprofessional collaboration|interprofessional collaboration
1346608|NCT01389726|custodial grandparents|custodial grandparents
1346609|NCT01389726|kinship caregivers|kinship caregivers
1346610|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
1346611|NCT01389726|grandmothers|grandmothers
1346612|NCT01389726|grandchildren|grandchildren
1346613|NCT01389726|psychological well-being|psychological well-being
1346614|NCT01389713|ovarian reserve|ovarian reserve
1346615|NCT01389713|ovarian stimulation|ovarian stimulation
1346616|NCT01389713|clomifene citrate|clomifene citrate
1346617|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
1346618|NCT01389687|Poliomyelitis|poliomyelitis
1346619|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
1346620|NCT01389687|Polio|polio
1346621|NCT01389687|Poliovirus|poliovirus
1346622|NCT01389674|coronary stenosis|coronary stenosis
1568266|NCT00506454|Endotoxemia|endotoxemia
1460331|NCT00927550|RCT|rct
1346623|NCT01389674|Angina pectoris|angina pectoris
1346624|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
1346625|NCT01389661|Maxillary bone cysts|maxillary bone cysts
1346626|NCT01389661|Cell therapy|cell therapy
1346627|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
1346628|NCT01389661|Autologous serum scaffold|autologous serum scaffold
1346629|NCT01389648|adult|adult
1346630|NCT01389635|Abdominoplasty|abdominoplasty
1346631|NCT01389635|Epidural|epidural
1346632|NCT01389622|Acupuncture|acupuncture
1346633|NCT01389622|smoking cessation|smoking cessation
1346634|NCT01389609|Bioequivalence|bioequivalence
1346635|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
1346636|NCT01389596|safety|safety
1346637|NCT01389596|efficacy|efficacy
1346638|NCT01389596|partial onset seizures|partial onset seizures
1346639|NCT01389596|pediatric|pediatric
1346640|NCT01389596|pregabalin|pregabalin
1346641|NCT01389596|placebo-controlled|placebo-controlled
1346642|NCT01389596|double-blind|double-blind
1346643|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
1346644|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
1346645|NCT01389583|Biomarker|biomarker
1346646|NCT01389557|malaria|malaria
1346647|NCT01389557|DHP|dhp
1346648|NCT01389557|PQ|pq
1346649|NCT01389557|MST|mst
1346650|NCT01389518|Symptomatic treatment|symptomatic treatment
1346651|NCT01389518|Common Cold|common cold
1346652|NCT01389518|flu syndrome|flu syndrome
1346653|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1346654|NCT01389505|Bevacizumab|bevacizumab
1346655|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
1346656|NCT01389492|meat|meat
1346657|NCT01389492|LDL|ldl
1346658|NCT01389492|MDA|mda
1346659|NCT01389466|Avian influenza|avian influenza
1346660|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
1346661|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
1346662|NCT01389440|Gemcitabine|gemcitabine
1346663|NCT01389440|Erlotinib|erlotinib
1346664|NCT01389440|Radiotherapy|radiotherapy
1346665|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
1346666|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
1346667|NCT01389414|biliary|biliary
1346668|NCT01389414|gallbladder|gallbladder
1346669|NCT01389414|intrahepatic|intrahepatic
1346670|NCT01389414|extrahepatic|extrahepatic
1346671|NCT01389401|Larynx|larynx
1346672|NCT01389401|GERD|gerd
1346673|NCT01389401|saliva|saliva
1346674|NCT01389401|epidermal growth factor|epidermal growth factor
1346675|NCT01389388|Carotid plaques|carotid plaques
1346676|NCT01389388|inflammatory joint disease|inflammatory joint disease
1346677|NCT01389388|statins|statins
1346678|NCT01389388|inflammation|inflammation
1346679|NCT01389388|lipoprotein components|lipoprotein components
1346680|NCT01389375|Closure Device|closure device
1346681|NCT01389375|Coronary Angiography|coronary angiography
1346682|NCT01389362|Diabetes|diabetes
1346683|NCT01389362|foot ulcer|foot ulcer
1346684|NCT01389362|Chinese herbal medicine|chinese herbal medicine
1346685|NCT01389349|tonsillectomy|tonsillectomy
1346686|NCT01389349|adenotonsillectomy|adenotonsillectomy
1346687|NCT01389349|acupuncture|acupuncture
1346688|NCT01389349|children|children
1346689|NCT01389349|postoperative pain|postoperative pain
1346690|NCT01389349|postoperative nausea|postoperative nausea
1346691|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
1346692|NCT01389336|Fibromyalgia|fibromyalgia
1346693|NCT01389336|Ayurveda|ayurveda
1346694|NCT01389336|Traditional Indian Medicine|traditional indian medicine
1346695|NCT01389336|CAM|cam
1346696|NCT01389336|Pain|pain
1346697|NCT01389336|Chronic Widespread Pain|chronic widespread pain
1346698|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
1346699|NCT01389297|Internet delivered intervention|internet delivered intervention
1346700|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
1346701|NCT01389297|Internet delivered treatment|internet delivered treatment
1346702|NCT01389284|Naproxen Sodium,|naproxen sodium,
1346703|NCT01389284|dental pain|dental pain
1346704|NCT01389271|Pulmonary hypertension|pulmonary hypertension
1346705|NCT01389271|Inhaled iloprost|inhaled iloprost
1346706|NCT01389271|Efficacy|efficacy
1346707|NCT01389271|Safety|safety
1346708|NCT01389271|Tolerability|tolerability
1346709|NCT01389271|Survival|survival
1346710|NCT01389271|NYHA class III and IV|nyha class iii and iv
1346711|NCT01389219|Post partum|post partum
1346712|NCT01389219|Neonate|neonate
1346713|NCT01389219|community health care workers|community health care workers
1346714|NCT01389193|ibudilast|ibudilast
1346715|NCT01389193|migraine|migraine
1346716|NCT01389193|glial cell|glial cell
1346717|NCT01389154|diagnostic yield|diagnostic yield
1346718|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
1346719|NCT01389154|peripheral lung lesion|peripheral lung lesion
1346721|NCT01389141|follicle|follicle
1346722|NCT01389141|hormones|hormones
1346723|NCT01389141|bone|bone
1460367|NCT00927368|TKA|tka
1346724|NCT01389141|muscle|muscle
1346725|NCT01389128|labor|labor
1346726|NCT01389128|pain|pain
1346727|NCT01389128|massage|massage
1346728|NCT01389128|natural birth|natural birth
1346729|NCT01389115|liver cirrhosis|liver cirrhosis
1346730|NCT01389115|oxidative stress|oxidative stress
1346731|NCT01389115|liver transplant|liver transplant
1346732|NCT01389102|Postmenopause|postmenopause
1346733|NCT01389102|Hot Flashes|hot flashes
1346734|NCT01389102|Estradiol|estradiol
1346735|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
1346736|NCT01389102|Estradiol valerate|estradiol valerate
1346737|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
1346738|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
1346739|NCT01389102|Estrogens|estrogens
1346740|NCT01389102|Hormones|hormones
1346741|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
1346742|NCT01389102|Hormone Antagonists|hormone antagonists
1346743|NCT01389089|edema reduction|edema reduction
1346744|NCT01389089|ice|ice
1346745|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
1346746|NCT01389089|A-V Impulse compression|a-v impulse compression
1346747|NCT01389089|ankle|ankle
1346748|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
1346749|NCT01389063|endothelial function|endothelial function
1346750|NCT01389063|CCR5 receptor|ccr5 receptor
1346751|NCT01389063|Maraviroc|maraviroc
1346752|NCT01389063|Abacavir|abacavir
1346753|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
1346754|NCT01389063|EndoPAT|endopat
1346755|NCT01389037|African American|african american
1346756|NCT01389037|High blood pressure|high blood pressure
1346757|NCT01389024|sickle cell disease|sickle cell disease
1346758|NCT01389024|stroke|stroke
1346759|NCT01389024|silent cerebral infarct|silent cerebral infarct
1346760|NCT01389024|children|children
1346761|NCT01389011|PI|pi
1346762|NCT01389011|PVI|pvi
1346763|NCT01389011|Interscalene block|interscalene block
1346764|NCT01388998|fluid management|fluid management
1346765|NCT01388998|fluid therapy|fluid therapy
1346766|NCT01388998|dPP|dpp
1346767|NCT01388998|difference in pulse pressure|difference in pulse pressure
1346768|NCT01388998|PVI|pvi
1346769|NCT01388998|pleth variability index|pleth variability index
1346770|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
1346771|NCT01388985|Rabies|rabies
1346772|NCT01388985|Vaccination|vaccination
1346773|NCT01388985|Boostability|boostability
1346774|NCT01388972|Community nutritional environment|community nutritional environment
1346775|NCT01388972|Physical activity|physical activity
1346776|NCT01388946|acute postoperative pain|acute postoperative pain
1346777|NCT01388946|late pain|late pain
1346778|NCT01388946|chronic pain|chronic pain
1346779|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
1346780|NCT01388933|Crohn's Disease|crohn's disease
1346781|NCT01388933|natural|natural
1346782|NCT01388933|herbal|herbal
1346783|NCT01388933|Kampo|kampo
1346784|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
1346785|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
1346786|NCT01388933|Male and female subjects|male and female subjects
1346787|NCT01388920|COPD|copd
1346788|NCT01388920|Muscle wasting|muscle wasting
1346789|NCT01388907|myomectomy|myomectomy
1346790|NCT01388907|adhesion prevention|adhesion prevention
1346791|NCT01388907|pregnancy rate|pregnancy rate
1346792|NCT01388881|reading difficulties|reading difficulties
1346793|NCT01388868|infusion dose|infusion dose
1346794|NCT01388868|vecuronium|vecuronium
1346795|NCT01388868|motor evoked potential|motor evoked potential
1346796|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
1346797|NCT01388855|Heart Failure|heart failure
1346798|NCT01388855|Vitamin D|vitamin d
1346799|NCT01388855|Pain|pain
1346800|NCT01388855|Pilot Study|pilot study
1346801|NCT01388855|RCT|rct
1346802|NCT01388842|severe malaria|severe malaria
1346803|NCT01388842|children|children
1346804|NCT01388842|adjunctive treatment|adjunctive treatment
1346805|NCT01388829|formulation comparison|formulation comparison
1346806|NCT01388816|Randomized|randomized
1346807|NCT01388816|Double-Blind|double-blind
1346808|NCT01388816|Placebo Controlled|placebo controlled
1346809|NCT01388816|Parallel Arm|parallel arm
1346810|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
1346811|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
1346812|NCT01388816|CETP Inhibitor|cetp inhibitor
1346813|NCT01388803|bronchial blocker|bronchial blocker
1346814|NCT01388803|VATS|vats
1346815|NCT01388790|Gastric Cancer|gastric cancer
1346816|NCT01388790|Cetuximab|cetuximab
1346817|NCT01388790|EMD271786|emd271786
1346818|NCT01388790|TS-1|ts-1
1346819|NCT01388790|Cisplatin|cisplatin
1346820|NCT01388777|Breast Cancer|breast cancer
1346821|NCT01388777|Breast Carcinoma|breast carcinoma
1346822|NCT01388777|Cryoablation|cryoablation
1346823|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
1346824|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
1346825|NCT01388777|Cryoprobe|cryoprobe
1346826|NCT01388764|L-arginine supplement study|l-arginine supplement study
1346827|NCT01388751|Mallet Finger splinting|mallet finger splinting
1346828|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
1346829|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
1346830|NCT01388738|acute ischemic stroke|acute ischemic stroke
1346832|NCT01388725|sCD163|scd163
1346833|NCT01388725|PCT|pct
1346834|NCT01388725|CRP|crp
1346835|NCT01388725|WBC count|wbc count
1346836|NCT01388725|SOFA score|sofa score
1346837|NCT01388725|SIRS|sirs
1346838|NCT01388725|sepsis|sepsis
1346839|NCT01388725|severity|severity
1346840|NCT01388725|prognosis|prognosis
1346841|NCT01388712|Probiotics|probiotics
1346842|NCT01388712|constipation|constipation
1346843|NCT01388712|children|children
1346844|NCT01388699|Migraine with aura|migraine with aura
1346845|NCT01388686|sepsis|sepsis
1346846|NCT01388686|catheter|catheter
1346847|NCT01388686|blood stream infection|blood stream infection
1346848|NCT01388686|blood culture|blood culture
1346849|NCT01388673|prior RYGB procedure|prior rygb procedure
1346850|NCT01388673|regained weight over time|regained weight over time
1346851|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
1346852|NCT01388660|Healthy|healthy
1346853|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1346854|NCT01388660|Pharmacokinetics|pharmacokinetics
1346855|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
1346856|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1346857|NCT01388634|Length of hospital stay|length of hospital stay
1346858|NCT01388634|readmission|readmission
1346859|NCT01388634|ventral hernia|ventral hernia
1346860|NCT01388621|ovarian cancer|ovarian cancer
1346861|NCT01388621|fallopian cancer|fallopian cancer
1346862|NCT01388621|recurrent|recurrent
1346863|NCT01388621|platinum-sensitive|platinum-sensitive
1346864|NCT01388621|KRAS-Wildtype|kras-wildtype
1346865|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
1346866|NCT01388608|etanercept|etanercept
1346867|NCT01388608|step activity measure|step activity measure
1346868|NCT01388582|contraceptives|contraceptives
1346869|NCT01388582|hormonal|hormonal
1346870|NCT01388582|breastfeeding|breastfeeding
1346871|NCT01388582|infant weight|infant weight
1346872|NCT01388569|stage IV melanoma|stage iv melanoma
1346873|NCT01388556|exercise|exercise
1346874|NCT01388556|Parkinson disease|parkinson disease
1346875|NCT01388556|motor symptoms|motor symptoms
1346876|NCT01388556|gait|gait
1346877|NCT01388556|balance|balance
1346878|NCT01388543|Pharmacokinetics|pharmacokinetics
1346879|NCT01388543|Clinical Pharmacology|clinical pharmacology
1346880|NCT01388543|Pharmacogenomics|pharmacogenomics
1346881|NCT01388543|HIV|hiv
1346882|NCT01388517|Pityriasis alba|pityriasis alba
1346883|NCT01388517|Tacrolimus|tacrolimus
1346884|NCT01388517|Calcitriol|calcitriol
1346885|NCT01388517|Petrolatum|petrolatum
1346886|NCT01388491|Contraception|contraception
1346887|NCT01388491|Hemostasis|hemostasis
1346888|NCT01388491|Blood Coagulation|blood coagulation
1346889|NCT01388478|Safety|safety
1346890|NCT01388478|Tolerability|tolerability
1346891|NCT01388478|R(+)Pramipexole|r(+)pramipexole
1346892|NCT01388478|Alzheimer's|alzheimer's
1346893|NCT01388465|Adherence|adherence
1346894|NCT01388465|Intervention|intervention
1346895|NCT01388452|HIV|hiv
1346896|NCT01388452|routine HIV testing|routine hiv testing
1346897|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
1346898|NCT01388452|early infant diagnosis|early infant diagnosis
1346899|NCT01388452|Africa South of the Sahara|africa south of the sahara
1346900|NCT01388439|oseltamivir|oseltamivir
1346901|NCT01388439|influenza|influenza
1346902|NCT01388439|neonate|neonate
1346903|NCT01388439|premature|premature
1346904|NCT01388439|pharmacokinetics|pharmacokinetics
1346905|NCT01388413|neurogenic bladder|neurogenic bladder
1346906|NCT01388413|urinary tract infection|urinary tract infection
1346907|NCT01388400|stroke|stroke
1346908|NCT01388400|rehabilitation|rehabilitation
1346909|NCT01388400|virtual reality|virtual reality
1346910|NCT01388400|upper limb|upper limb
1346911|NCT01388387|pharmacogenetics|pharmacogenetics
1346912|NCT01388387|pharmacokinetics|pharmacokinetics
1346913|NCT01388387|tacrolimus|tacrolimus
1346914|NCT01388387|genetic polymorphism|genetic polymorphism
1346915|NCT01388387|CYP3A5|cyp3a5
1346916|NCT01388387|liver transplantation|liver transplantation
1346917|NCT01388374|Delivery of Health Care|delivery of health care
1346918|NCT01388374|Nurse Practitioners|nurse practitioners
1346919|NCT01388374|Out of Hours Medical Care|out of hours medical care
1346920|NCT01388374|Primary Health Care|primary health care
1346921|NCT01388374|Emergency Medical Services|emergency medical services
1346922|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1346923|NCT01388348|acoustic vibration|acoustic vibration
1346924|NCT01388322|Pregnancy|pregnancy
1346925|NCT01388322|Preeclampsia|preeclampsia
1346926|NCT01388322|Placental insufficiency|placental insufficiency
1346927|NCT01388283|prognostic marker|prognostic marker
1346928|NCT01388270|Hemodialysis|hemodialysis
1346929|NCT01388270|Anticoagulation|anticoagulation
1346930|NCT01388270|Clotting|clotting
1346931|NCT01388270|Coagulation|coagulation
1346932|NCT01388270|dalteparin|dalteparin
1346933|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
1346934|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
1346935|NCT01388270|Anticoagulation during HD|anticoagulation during hd
1346936|NCT01388257|Crohn Disease|crohn disease
1346937|NCT01388257|Anoperineal fistula|anoperineal fistula
1346938|NCT01388257|Anal fistula|anal fistula
1346939|NCT01388257|Proctology|proctology
1346940|NCT01388257|Drainage|drainage
1346941|NCT01388257|Colorectal Surgery|colorectal surgery
1346942|NCT01388257|Fistulotomy|fistulotomy
1346944|NCT01388257|Advancement flap|advancement flap
1346945|NCT01388257|Glue|glue
1346946|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
1346947|NCT01388257|Adalimumab|adalimumab
1346948|NCT01388244|Screening|screening
1346949|NCT01388244|Risk Assessment|risk assessment
1346950|NCT01388244|Fractures|fractures
1346951|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
1346952|NCT01388244|Fracture prevention|fracture prevention
1346953|NCT01388244|Women|women
1346954|NCT01388244|Patient prespective|patient prespective
1346955|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
1346956|NCT01388218|Physical Activity|physical activity
1346957|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
1346958|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1346959|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
1346960|NCT01388205|Myopia|myopia
1346961|NCT01388205|Outdoor activity|outdoor activity
1346962|NCT01388205|Physical activity|physical activity
1346963|NCT01388205|Randomized Controlled Trial|randomized controlled trial
1346964|NCT01388205|Pedometer|pedometer
1346965|NCT01388205|Behavior modification|behavior modification
1346966|NCT01388205|Obesity|obesity
1346967|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
1346968|NCT01388192|diabetes|diabetes
1346969|NCT01388192|sugar metabolism|sugar metabolism
1346970|NCT01388179|Autism|autism
1346972|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
1346973|NCT01388140|dissociation|dissociation
1346974|NCT01388140|psychosis|psychosis
1346975|NCT01388140|trauma|trauma
1346976|NCT01388140|parenting|parenting
1346977|NCT01388140|executive functions|executive functions
1346978|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
1346979|NCT01388101|LECT2|lect2
1346980|NCT01388088|Hypertension|hypertension
1346981|NCT01388088|Potassium|potassium
1346982|NCT01388088|Blood-pressure|blood-pressure
1346983|NCT01388075|induction|induction
1346984|NCT01388075|CYP2C9|cyp2c9
1346985|NCT01388075|Genetic variability|genetic variability
1346986|NCT01388075|Expression|expression
1346987|NCT01388062|influenza virus|influenza virus
1346988|NCT01388049|EV71|ev71
1346989|NCT01388036|heart rate|heart rate
1346990|NCT01388023|SmellX|smellx
1346991|NCT01388023|malodor|malodor
1346992|NCT01388023|halitosis|halitosis
1346993|NCT01388023|herbal formulation|herbal formulation
1346994|NCT01388023|natural medicinals|natural medicinals
1346995|NCT01388023|slow release delivery system|slow release delivery system
1346996|NCT01388023|gingivitis|gingivitis
1346997|NCT01388023|Bad Breath|bad breath
1346998|NCT01388010|probiotics|probiotics
1346999|NCT01388010|gastrointestinal well being|gastrointestinal well being
1347000|NCT01388010|digestive symptoms|digestive symptoms
1347001|NCT01388010|healthy population|healthy population
1347002|NCT01387997|HPV|hpv
1347003|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
1347004|NCT01387984|Diabetic complications|diabetic complications
1347005|NCT01387984|YKL-40|ykl-40
1347006|NCT01387971|impression cytology|impression cytology
1347007|NCT01387971|ocular surface disorders|ocular surface disorders
1347008|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
1347009|NCT01387971|Limbal insufficiency|limbal insufficiency
1347010|NCT01387958|Hepatitis C virus|hepatitis c virus
1347011|NCT01387958|Chronically infected|chronically infected
1347012|NCT01387958|treatment naive|treatment naive
1347013|NCT01387958|non responders to prior therapy|non responders to prior therapy
1347014|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
1347015|NCT01387945|Patient activation|patient activation
1347016|NCT01387945|Patient-centered care|patient-centered care
1347017|NCT01387945|Community Health Aides|community health aides
1347018|NCT01387945|Primary Health Care|primary health care
1347019|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
1347020|NCT01387932|TACE|tace
1347021|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
1347022|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
1347023|NCT01387932|Doxorubicin|doxorubicin
1347024|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
1347025|NCT01387906|mild|mild
1347026|NCT01387906|moderate|moderate
1347027|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1347029|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1347030|NCT01387893|LUTS|luts
1347031|NCT01387893|Self-Administered Maneuver|self-administered maneuver
1347032|NCT01387893|Symptomatic Relief|symptomatic relief
1347033|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
1347034|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
1347035|NCT01387880|Third line therapy|third line therapy
1347036|NCT01387880|Fourth line therapy|fourth line therapy
1347037|NCT01387880|KRAS mutation status|kras mutation status
1347038|NCT01387880|Cetuximab|cetuximab
1347039|NCT01387880|Everolimus|everolimus
1347040|NCT01387880|Irinotecan|irinotecan
1347041|NCT01387867|Exercise|exercise
1347042|NCT01387867|Hip osteoarthritis|hip osteoarthritis
1347043|NCT01387867|Randomized controlled trial|randomized controlled trial
1347044|NCT01387841|yoga|yoga
1347045|NCT01387841|chemotherapy|chemotherapy
1347046|NCT01387841|nausea|nausea
1347047|NCT01387841|vomiting|vomiting
1347048|NCT01387828|Splenic artery|splenic artery
1347049|NCT01387828|Aneurysm|aneurysm
1347050|NCT01387828|laparoscopic|laparoscopic
1347051|NCT01387828|Vascular reconstruction|vascular reconstruction
1347052|NCT01387828|Splenectomy|splenectomy
1347053|NCT01387815|Effectiveness|effectiveness
1347054|NCT01387815|Psoriasis|psoriasis
1347055|NCT01387815|Observational|observational
1347056|NCT01387815|Prospective|prospective
1347057|NCT01387815|Adalimumab|adalimumab
1347058|NCT01387815|Traditional Systemic Agents|traditional systemic agents
1347059|NCT01387815|Topical Agents|topical agents
1347060|NCT01387815|Comparative|comparative
1347061|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
1347062|NCT01387789|Product Surveillance|product surveillance
1347063|NCT01387789|Postmarketing|postmarketing
1347064|NCT01387750|Acute Pain|acute pain
1347065|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
1347066|NCT01387750|Topical Analgesic|topical analgesic
1347067|NCT01387737|TA-7284|ta-7284
1347068|NCT01387737|JNJ-28431754|jnj-28431754
1347069|NCT01387737|Canagliflozin|canagliflozin
1347070|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
1347071|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
1347072|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
1347073|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1347074|NCT01387724|regional neuroblastoma|regional neuroblastoma
1347075|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
1347076|NCT01387672|postmenopausal|postmenopausal
1347077|NCT01387672|osteoporosis|osteoporosis
1347078|NCT01387672|bone turnover|bone turnover
1347079|NCT01387672|nitrate|nitrate
1347080|NCT01387672|headache|headache
1347081|NCT01387659|Myfortic|myfortic
1347082|NCT01387659|Simulect|simulect
1347083|NCT01387659|Steroids|steroids
1347084|NCT01387659|Diabetes|diabetes
1347085|NCT01387659|Transplant|transplant
1347086|NCT01387659|Gastric emptying|gastric emptying
1347087|NCT01387659|Gastric motility|gastric motility
1347088|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
1347089|NCT01387633|Nursing care|nursing care
1347090|NCT01387633|Diabetes mellitus|diabetes mellitus
1347091|NCT01387633|Health Education|health education
1347092|NCT01387633|Patient compliance|patient compliance
1347093|NCT01387633|Social support|social support
1347094|NCT01387633|Self-efficacy|self-efficacy
1347095|NCT01387633|Adaptation strategy|adaptation strategy
1347096|NCT01387620|Phacoemulsification|phacoemulsification
1347097|NCT01387620|Corneal Edema|corneal edema
1347098|NCT01387620|Corneal Endothelium|corneal endothelium
1347099|NCT01387620|Viscoelastic Substances|viscoelastic substances
1347100|NCT01387607|Pregabalin|pregabalin
1347101|NCT01387607|fibromyalgia|fibromyalgia
1347102|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
1347103|NCT01387555|liver cancer|liver cancer
1347104|NCT01387555|liver tumor|liver tumor
1347105|NCT01387555|advanced hcc|advanced hcc
1347106|NCT01387555|hepatocellular cancer|hepatocellular cancer
1347107|NCT01387555|Jennerex|jennerex
1347108|NCT01387555|HCC|hcc
1347109|NCT01387555|sorafenib|sorafenib
1347110|NCT01387555|sorafenib failure|sorafenib failure
1347111|NCT01387555|sorafenib intolerant|sorafenib intolerant
1347112|NCT01387555|Nexavar|nexavar
1347113|NCT01387555|Nexavar failure|nexavar failure
1347114|NCT01387555|JX594|jx594
1347115|NCT01387555|oncolytic virus|oncolytic virus
1347116|NCT01387555|vaccinia|vaccinia
1347117|NCT01387555|viral therapy|viral therapy
1347118|NCT01387555|JX|jx
1347119|NCT01387555|Biotherapeutics|biotherapeutics
1347120|NCT01387555|HEP018|hep018
1347121|NCT01387555|traverse|traverse
1347122|NCT01387555|biologic|biologic
1347123|NCT01387555|Pexa-Vec|pexa-vec
1347124|NCT01387542|Schizophrenia|schizophrenia
1347125|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
1347126|NCT01387542|INVEGA|invega
1347127|NCT01387529|Reference Values|reference values
1347128|NCT01387516|nicotine|nicotine
1347129|NCT01387516|juveniles|juveniles
1347130|NCT01387516|detention|detention
1347131|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
1347132|NCT01387503|Liver Transplantation|liver transplantation
1347133|NCT01387503|Downstaging|downstaging
1347134|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
1347135|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
1347136|NCT01387503|Liver resection|liver resection
1347137|NCT01387503|Sorafenib|sorafenib
1347138|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
1347139|NCT01387490|Telephone counseling|telephone counseling
1347140|NCT01387477|hypoglycemia|hypoglycemia
1347141|NCT01387477|lactate|lactate
1347142|NCT01387477|glucose|glucose
1347143|NCT01387477|ICU|icu
1347144|NCT01387464|bromfenac concentrations|bromfenac concentrations
1347145|NCT01387464|ISV-303|isv-303
1347146|NCT01387464|Bromday|bromday
1347147|NCT01387451|Brown adipose tissue|brown adipose tissue
1347148|NCT01387451|Different regions|different regions
1347149|NCT01387451|Chinese adults|chinese adults
1347150|NCT01387438|Brown Adipose Tissue|brown adipose tissue
1347151|NCT01387438|Cross sectional study|cross sectional study
1347152|NCT01387438|Chinese Adults|chinese adults
1347153|NCT01387438|Factor|factor
1347154|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
1347155|NCT01387412|genital warts|genital warts
1347156|NCT01387412|HIV|hiv
1347157|NCT01387412|MSM|msm
1347158|NCT01387412|Peru|peru
1347159|NCT01387412|HPV|hpv
1347160|NCT01387399|ovarian cancer|ovarian cancer
1347161|NCT01387399|recurrence|recurrence
1347162|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
1347163|NCT01387399|HIPEC|hipec
1347164|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1347165|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
1347166|NCT01387399|cisplatin|cisplatin
1347167|NCT01387373|breast cancer|breast cancer
1347168|NCT01387373|metastatic|metastatic
1347169|NCT01387373|liver metastases|liver metastases
1347170|NCT01387373|intrahepatic|intrahepatic
1347171|NCT01387373|chemotherapy|chemotherapy
1347172|NCT01387360|Myopia|myopia
1347173|NCT01387360|Hyperopia|hyperopia
1347174|NCT01387360|Presbyopia|presbyopia
1347175|NCT01387360|Pseudophakia|pseudophakia
1347176|NCT01387360|LASIK|lasik
1347177|NCT01387347|Thymosin beta 4|thymosin beta 4
1347178|NCT01387347|Dry eye syndrome|dry eye syndrome
1347179|NCT01387347|Dry eye|dry eye
1347180|NCT01387334|resistive exercise|resistive exercise
1347181|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
1347182|NCT01387334|Rubber Bands|rubber bands
1347183|NCT01387334|Glycemic Control|glycemic control
1347184|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1347185|NCT01387321|Pi3K|pi3k
1347186|NCT01387321|Advanced solid tumor|advanced solid tumor
1347187|NCT01387308|Phase 1|phase 1
1347188|NCT01387308|Healthy male volunteers|healthy male volunteers
1347189|NCT01387308|pharmacokinetics|pharmacokinetics
1347190|NCT01387308|fostamatinib|fostamatinib
1347191|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
1347192|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
1347193|NCT01387295|breast cancer|breast cancer
1347194|NCT01387295|liver metastases|liver metastases
1347195|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
1347196|NCT01387256|abortion|abortion
1347197|NCT01387256|mifepristone|mifepristone
1347198|NCT01387256|misoprostol|misoprostol
1347199|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
1347200|NCT01387243|behavior modification|behavior modification
1347201|NCT01387243|overweight|overweight
1347202|NCT01387243|orlistat|orlistat
1347203|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1347204|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
1347205|NCT01387217|GSK2018682|gsk2018682
1347206|NCT01387217|First Time in Human|first time in human
1347207|NCT01387217|Healthy Volunteer|healthy volunteer
1347208|NCT01387204|MEK inhibitor|mek inhibitor
1347209|NCT01387204|elimination|elimination
1347210|NCT01387204|Phase 1|phase 1
1347211|NCT01387204|GSK1120212|gsk1120212
1347212|NCT01387204|cancer|cancer
1347213|NCT01387204|Pharmacokinetics|pharmacokinetics
1347214|NCT01387204|oncology|oncology
1347215|NCT01387204|radiolabeled ADME|radiolabeled adme
1347216|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1347217|NCT01387178|cost and cost analysis|cost and cost analysis
1347218|NCT01387178|bronchodilators|bronchodilators
1347219|NCT01387178|healthcare utilization|healthcare utilization
1347220|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
1347221|NCT01387178|tiotropium|tiotropium
1347222|NCT01387165|Latin America|latin america
1347223|NCT01387165|diabetes complications|diabetes complications
1347224|NCT01387165|patient compliance|patient compliance
1347225|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
1347226|NCT01387165|health services accessibility|health services accessibility
1347227|NCT01387152|chest pain|chest pain
1347228|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
1347229|NCT01387152|nuclear stress testing|nuclear stress testing
1347230|NCT01387152|low radiation dose|low radiation dose
1347231|NCT01387139|Ketamine|ketamine
1347232|NCT01387139|Propofol|propofol
1347336|NCT01386710|Tumors|tumors
1347233|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
1347234|NCT01387113|stroke|stroke
1347235|NCT01387113|tPA|tpa
1347236|NCT01387113|Thrombolysis|thrombolysis
1347237|NCT01387113|rt-PA|rt-pa
1347238|NCT01387113|Ischemic|ischemic
1347239|NCT01387113|CTP|ctp
1347240|NCT01387113|Imaging|imaging
1347241|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
1347242|NCT01387113|Perfusion|perfusion
1347243|NCT01387113|CTA|cta
1347244|NCT01387113|CT Angiography|ct angiography
1347245|NCT01387113|Acute ischemic stroke|acute ischemic stroke
1347246|NCT01387113|Acute stroke therapy|acute stroke therapy
1347247|NCT01387113|(AIS)|(ais)
1347248|NCT01387100|supportive employment|supportive employment
1347249|NCT01387100|vocational rehabilitation|vocational rehabilitation
1347250|NCT01387087|ASP015K|asp015k
1347251|NCT01387087|Healthy subjects|healthy subjects
1347252|NCT01387087|Pharmacodynamics|pharmacodynamics
1347253|NCT01387087|Maximum tolerated dose|maximum tolerated dose
1347254|NCT01387061|liver resection|liver resection
1347255|NCT01387061|hepatic resection|hepatic resection
1347256|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
1347257|NCT01387048|acne vulgaris|acne vulgaris
1347258|NCT01387048|late-type acne|late-type acne
1347259|NCT01387048|Skinoren|skinoren
1347260|NCT01387048|maintenance|maintenance
1347261|NCT01387022|Antiretroviral treatment|antiretroviral treatment
1347262|NCT01387022|Tenofovir|tenofovir
1347263|NCT01387022|Drug resistance|drug resistance
1347264|NCT01387022|Treatment outcome|treatment outcome
1347265|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
1347266|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
1347267|NCT01386970|Pharmacokinetics|pharmacokinetics
1347268|NCT01386970|antiretroviral therapy|antiretroviral therapy
1347269|NCT01386970|nucleoside analogs|nucleoside analogs
1347270|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
1347271|NCT01386970|clinical pharmacology|clinical pharmacology
1347272|NCT01386970|cellular pharmacology|cellular pharmacology
1347273|NCT01386970|pharmacogenetics|pharmacogenetics
1347274|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
1347275|NCT01386957|Steroid treatment|steroid treatment
1347276|NCT01386957|Proteinuria|proteinuria
1347277|NCT01386957|Child|child
1347278|NCT01386944|Rotigotine|rotigotine
1347279|NCT01386944|Neupro®|neupro®
1347280|NCT01386944|Augmentation|augmentation
1347281|NCT01386944|Restless Legs Syndrome|restless legs syndrome
1347282|NCT01386944|Moderate to severe|moderate to severe
1347283|NCT01386944|idiopathic|idiopathic
1347284|NCT01386944|adults|adults
1347285|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
1347286|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
1347287|NCT01386931|cytopathology|cytopathology
1347288|NCT01386918|Hallucinations|hallucinations
1347289|NCT01386918|Schizophrenia|schizophrenia
1347290|NCT01386905|Obesity|obesity
1347291|NCT01386879|suction|suction
1347292|NCT01386879|aspiration|aspiration
1347293|NCT01386879|general anesthesia|general anesthesia
1347294|NCT01386879|intubation|intubation
1347295|NCT01386879|endotracheal tube|endotracheal tube
1347296|NCT01386879|respiratory complications|respiratory complications
1347297|NCT01386866|AMG 706|amg 706
1347298|NCT01386866|Motesanib|motesanib
1347299|NCT01386866|Amgen|amgen
1347300|NCT01386866|Phase 1|phase 1
1347301|NCT01386853|Hyperlipidemia|hyperlipidemia
1347302|NCT01386853|Pitavastatin|pitavastatin
1347303|NCT01386853|Atorvastatin|atorvastatin
1347304|NCT01386840|Efficacy of Treatment|efficacy of treatment
1347305|NCT01386840|Severe|severe
1347306|NCT01386840|home treatment|home treatment
1347307|NCT01386840|treatment at hospital|treatment at hospital
1347308|NCT01386827|Ixiaro|ixiaro
1347309|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
1347310|NCT01386827|booster|booster
1347311|NCT01386801|Diabetes|diabetes
1347312|NCT01386801|Controls|controls
1347313|NCT01386801|Biospecimen|biospecimen
1347314|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
1347315|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
1347316|NCT01386775|XLHED|xlhed
1347317|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1347318|NCT01386775|HED|hed
1347319|NCT01386762|paralysis|paralysis
1347320|NCT01386762|paraplegia|paraplegia
1347321|NCT01386762|obesity|obesity
1347322|NCT01386749|Vibration treatment|vibration treatment
1347323|NCT01386749|Fracture healing|fracture healing
1347324|NCT01386749|Muscular function|muscular function
1347325|NCT01386736|insulin resistance|insulin resistance
1347326|NCT01386736|obesity|obesity
1347327|NCT01386736|adolescence|adolescence
1347328|NCT01386736|vitamin D supplementation|vitamin d supplementation
1347329|NCT01386723|eltrombopag|eltrombopag
1347330|NCT01386723|promacta|promacta
1347331|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
1347332|NCT01386710|GBM|gbm
1347333|NCT01386710|AA|aa
1347334|NCT01386710|AO|ao
1347335|NCT01386710|Brain|brain
1347337|NCT01386710|Malignant|malignant
1347338|NCT01386710|Glioblastoma|glioblastoma
1347339|NCT01386710|Multiforme|multiforme
1347340|NCT01386710|Anaplastic|anaplastic
1347341|NCT01386710|Astrocytoma|astrocytoma
1347342|NCT01386684|Prostate Cancer|prostate cancer
1347343|NCT01386671|Type 2 Diabetes|type 2 diabetes
1347344|NCT01386671|metformin glycinate|metformin glycinate
1347345|NCT01386671|metabolic control|metabolic control
1347346|NCT01386658|Efficacy|efficacy
1347347|NCT01386658|Hereditary angioedema|hereditary angioedema
1347348|NCT01386658|HAE|hae
1347349|NCT01386658|Pediatric|pediatric
1347350|NCT01386658|Children|children
1347351|NCT01386658|Pharmacokinetics|pharmacokinetics
1347352|NCT01386658|Safety|safety
1347353|NCT01386658|Firazyr|firazyr
1347354|NCT01386658|icatibant|icatibant
1347355|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
1347356|NCT01386645|prediabetes|prediabetes
1347357|NCT01386645|dietary glycemic index|dietary glycemic index
1347358|NCT01386645|beta-cell function|beta-cell function
1347359|NCT01386645|insulin secretion|insulin secretion
1347360|NCT01386645|oxidative stress|oxidative stress
1347361|NCT01386645|glycemic variability|glycemic variability
1347362|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
1347363|NCT01386593|Cytochrome|cytochrome
1347364|NCT01386593|Phenotyping|phenotyping
1347365|NCT01386593|Pharmacokinetics|pharmacokinetics
1347366|NCT01386580|Brain Neoplasms|brain neoplasms
1347367|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
1347368|NCT01386580|Neoplasms|neoplasms
1347369|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
1347370|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
1347371|NCT01386580|Neoplasms by Site|neoplasms by site
1347372|NCT01386580|Brain Diseases|brain diseases
1347373|NCT01386580|Central Nervous System Diseases|central nervous system diseases
1347374|NCT01386580|Nervous System Diseases|nervous system diseases
1347375|NCT01386580|Neoplastic Processes|neoplastic processes
1347376|NCT01386580|Pathologic Processes|pathologic processes
1347377|NCT01386567|hypogonadism|hypogonadism
1347378|NCT01386567|low testosterone|low testosterone
1347379|NCT01386567|low T|low t
1347380|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
1347381|NCT01386554|Acthar|acthar
1347382|NCT01386554|nephrotic syndrome|nephrotic syndrome
1347383|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
1347384|NCT01386554|proteinuria|proteinuria
1347385|NCT01386515|Adaptation|adaptation
1347386|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1347387|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
1347388|NCT01386515|Sibling|sibling
1347389|NCT01386502|Solid Tumors|solid tumors
1347390|NCT01386502|Monoclonal Antibody|monoclonal antibody
1347391|NCT01386502|Peptide Vaccine|peptide vaccine
1347392|NCT01386502|Toxicity|toxicity
1347393|NCT01386502|PD-1 ligand|pd-1 ligand
1347394|NCT01386502|Solid Tumor|solid tumor
1347395|NCT01386502|Breast Cancer|breast cancer
1347396|NCT01386502|Ovarian Cancer|ovarian cancer
1347397|NCT01386502|Pancreatic Cancer|pancreatic cancer
1347398|NCT01386502|Colon Cancer|colon cancer
1347399|NCT01386502|Sarcoma|sarcoma
1347400|NCT01386489|HIV-uninfected|hiv-uninfected
1347401|NCT01386489|Mucosal Immunity|mucosal immunity
1347402|NCT01386489|Kinetics|kinetics
1347403|NCT01386489|Cytokines|cytokines
1347404|NCT01386489|Chemokines|chemokines
1347405|NCT01386489|Healthy Volunteer|healthy volunteer
1347406|NCT01386489|HV|hv
1347407|NCT01386476|5-HT1A Receptors|5-ht1a receptors
1347408|NCT01386476|Blood Brain Barrier|blood brain barrier
1347409|NCT01386476|Drug Resistance|drug resistance
1347410|NCT01386476|Healthy Volunteer|healthy volunteer
1347411|NCT01386476|HV|hv
1347412|NCT01386437|Fungal Infection|fungal infection
1347413|NCT01386437|Immunopathogenesis|immunopathogenesis
1347414|NCT01386437|Genetics|genetics
1347415|NCT01386437|Fungal Infections|fungal infections
1347416|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
1347417|NCT01386437|Invasive Fungal Infection|invasive fungal infection
1347418|NCT01386424|Influenza|influenza
1347419|NCT01386424|Human|human
1347420|NCT01386424|Challenge Study|challenge study
1347421|NCT01386424|Healthy Volunteer|healthy volunteer
1347422|NCT01386424|HV|hv
1347423|NCT01386411|Genetic testing|genetic testing
1347424|NCT01386411|BRCA testing|brca testing
1347425|NCT01386411|Ashkenazi descent|ashkenazi descent
1347426|NCT01386411|11-086|11-086
1347427|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1347428|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1347429|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1347430|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1347431|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1347432|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1347433|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1347434|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1347435|NCT01386372|Hyponatremia|hyponatremia
1347436|NCT01386372|Vasopressin|vasopressin
1347437|NCT01386372|Tolvaptan|tolvaptan
1347438|NCT01386372|SIADH|siadh
1347439|NCT01386346|gastroesophageal junction|gastroesophageal junction
1347440|NCT01386346|GEJ|gej
1347441|NCT01386346|esophageal|esophageal
1347442|NCT01386346|esophagus|esophagus
1347443|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
1347444|NCT01386333|oxytocin|oxytocin
1347445|NCT01386333|Pick's disease|pick's disease
1347446|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
1347447|NCT01386307|Pain|pain
1347448|NCT01386307|Hospitalization|hospitalization
1347449|NCT01386281|Julina|julina
1347450|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
1347451|NCT01386268|Kogenate FS|kogenate fs
1347452|NCT01386268|Hemophilia A|hemophilia a
1347453|NCT01386255|GERD|gerd
1347454|NCT01386242|Colorectal Cancer|colorectal cancer
1347455|NCT01386242|Novaferon|novaferon
1347456|NCT01386229|hemodynamic stability|hemodynamic stability
1347457|NCT01386229|etomidate|etomidate
1347458|NCT01386229|ketamine|ketamine
1347459|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
1347460|NCT01386216|Critical limb ischemia|critical limb ischemia
1347461|NCT01386216|Peripheral vascular disease|peripheral vascular disease
1347462|NCT01386216|platelet-rich plasma|platelet-rich plasma
1347463|NCT01386203|lung cancer|lung cancer
1347464|NCT01386203|biomarkers|biomarkers
1347465|NCT01386203|breath|breath
1347466|NCT01386203|early detection|early detection
1347467|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
1347468|NCT01386177|MDMA|mdma
1347469|NCT01386177|doxazosin|doxazosin
1347470|NCT01386177|norepinephrine|norepinephrine
1347471|NCT01386177|alpha1- receptor|alpha1- receptor
1347472|NCT01386177|ecstasy|ecstasy
1347473|NCT01386177|stimulants|stimulants
1347474|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
1347475|NCT01386138|HIV|hiv
1347476|NCT01386138|HIV Risk|hiv risk
1347477|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
1347478|NCT01386138|Women|women
1347479|NCT01386138|Pregnancy|pregnancy
1347480|NCT01386138|Neonatal Health|neonatal health
1347481|NCT01386138|Drug Use|drug use
1347482|NCT01386138|Drug Treatment|drug treatment
1347483|NCT01386138|Gender-specific Treatment|gender-specific treatment
1347484|NCT01386138|Methamphetamine|methamphetamine
1347485|NCT01386138|Opioids|opioids
1347486|NCT01386138|Cocaine|cocaine
1347487|NCT01386138|Injection Drugs|injection drugs
1347488|NCT01386138|Stimulants|stimulants
1347489|NCT01386138|Alcohol|alcohol
1347490|NCT01386138|Mandrax|mandrax
1347491|NCT01386138|Marijuana|marijuana
1347492|NCT01386138|Nicotine|nicotine
1347493|NCT01386086|Aripiprazole|aripiprazole
1347494|NCT01386086|adjunctive therapy|adjunctive therapy
1347495|NCT01386086|mood stabilizers|mood stabilizers
1347496|NCT01386086|major depressive disorder|major depressive disorder
1347497|NCT01386086|postpartum|postpartum
1347498|NCT01386086|Augmentation therapy|augmentation therapy
1347499|NCT01386086|resistant|resistant
1347500|NCT01386060|Stress|stress
1347501|NCT01386060|Mindfulness|mindfulness
1347502|NCT01386060|Meditation|meditation
1347503|NCT01386047|Clinical Prediction Rules|clinical prediction rules
1347504|NCT01386047|Electronic Health Records|electronic health records
1347505|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
1347506|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
1347507|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
1347508|NCT01386021|allograft|allograft
1347509|NCT01386021|coronary|coronary
1347510|NCT01386021|patency|patency
1347511|NCT01386021|morbidity|morbidity
1347512|NCT01385969|overinflation of LMAs|overinflation of lmas
1347513|NCT01385956|metastatic|metastatic
1347514|NCT01385956|locally advanced|locally advanced
1347515|NCT01385956|combination therapy|combination therapy
1347516|NCT01385956|dose escalation|dose escalation
1347517|NCT01385956|epithelial cancer|epithelial cancer
1347518|NCT01385956|adenocarcinoma|adenocarcinoma
1347519|NCT01385956|exocrine pancreas|exocrine pancreas
1347520|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
1347521|NCT01385943|Dermoscopy|dermoscopy
1347522|NCT01385943|Clinical Photos|clinical photos
1347523|NCT01385943|Telemedicine|telemedicine
1347524|NCT01385930|Overweight|overweight
1347525|NCT01385930|Obesity|obesity
1347526|NCT01385930|lifestyle counseling|lifestyle counseling
1347527|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1347528|NCT01385917|strength and function tests|strength and function tests
1347529|NCT01385917|MRI|mri
1347530|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
1347531|NCT01385852|CME|cme
1347532|NCT01385852|OCT|oct
1347533|NCT01385852|Optical coherence tomography|optical coherence tomography
1347534|NCT01385852|macular thickness|macular thickness
1347535|NCT01385839|Alopecia|alopecia
1347536|NCT01385839|Hair transplantation|hair transplantation
1347537|NCT01385839|Needle irritation|needle irritation
1347538|NCT01385839|Medical needling|medical needling
1347539|NCT01385826|Uveitis|uveitis
1347540|NCT01385826|Juvenile arthritis|juvenile arthritis
1347541|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
1347542|NCT01385826|treatment|treatment
1347543|NCT01385813|pre-eclampsia|pre-eclampsia
1347544|NCT01385813|inflammatory markers|inflammatory markers
1347545|NCT01385813|serological biobank|serological biobank
1347546|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
1347547|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
1347548|NCT01385813|develop preeclampsia|develop preeclampsia
1347549|NCT01385800|Grass allergy|grass allergy
1347550|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
1347551|NCT01385800|Environmental Exposure Unit|environmental exposure unit
1347552|NCT01385800|Immunotherapy|immunotherapy
1347553|NCT01385800|ToleroMune Grass|toleromune grass
1347554|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
1347555|NCT01385787|myeloablative HCT|myeloablative hct
1347556|NCT01385787|PBMTC sites|pbmtc sites
1347557|NCT01385774|Intermittent Claudication|intermittent claudication
1347558|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
1347559|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
1347560|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
1347561|NCT01385761|Supraglottic airway devices|supraglottic airway devices
1347562|NCT01385735|Parkinson Disease|parkinson disease
1347563|NCT01385735|Emotion|emotion
1347564|NCT01385735|mood|mood
1347565|NCT01385735|executive function|executive function
1347566|NCT01385709|Lithium|lithium
1347567|NCT01385709|Sertraline|sertraline
1347568|NCT01385683|Healthy volunteer|healthy volunteer
1347569|NCT01385683|Pharmacokinetic|pharmacokinetic
1347570|NCT01385683|pharmacodynamic|pharmacodynamic
1347571|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
1347572|NCT01385670|Patent Foramen Ovale|patent foramen ovale
1347573|NCT01385670|PFO|pfo
1347574|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
1347575|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1347576|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
1347577|NCT01385631|Intravascular ultrasound|intravascular ultrasound
1347578|NCT01385631|IVUS|ivus
1347579|NCT01385631|Optical coherence tomography|optical coherence tomography
1347580|NCT01385631|OCT|oct
1347581|NCT01385631|Ezetimibe|ezetimibe
1347582|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1347583|NCT01385631|Atorvastatin|atorvastatin
1347584|NCT01385631|Randomized trial|randomized trial
1347585|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
1347586|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1347587|NCT01385631|Pharmacologic Actions|pharmacologic actions
1347588|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
1347589|NCT01385631|Lipid Regulating Agents|lipid regulating agents
1347590|NCT01385631|Therapeutic Uses|therapeutic uses
1347591|NCT01385592|Parkinson Disease|parkinson disease
1347592|NCT01385592|L-dopa|l-dopa
1347593|NCT01385592|Levodopa|levodopa
1347594|NCT01385592|Dyskinesia|dyskinesia
1347595|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
1347596|NCT01385579|colorectal cancer screening|colorectal cancer screening
1347597|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
1347598|NCT01385579|vulnerable populations|vulnerable populations
1347599|NCT01385579|community health center|community health center
1347600|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
1347601|NCT01385488|lymphedema|lymphedema
1347602|NCT01385488|breast cancer|breast cancer
1347603|NCT01385488|self care|self care
1347604|NCT01385488|bioelectrical impedance|bioelectrical impedance
1347605|NCT01385488|monitoring|monitoring
1347606|NCT01385475|Resistance Training|resistance training
1347607|NCT01385475|Physical Function|physical function
1347608|NCT01385475|Older Adults|older adults
1347609|NCT01385449|nerve block|nerve block
1347610|NCT01385449|shoulder surgery|shoulder surgery
1347611|NCT01385449|physical therapy|physical therapy
1347612|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
1347613|NCT01385436|cervical cancer|cervical cancer
1347696|NCT01385111|EBUS-TBNA|ebus-tbna
1347697|NCT01385111|EUS-FNA|eus-fna
1347614|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
1347615|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
1347616|NCT01385423|natural killer cells|natural killer cells
1347617|NCT01385423|haploidentical donor|haploidentical donor
1347618|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
1347619|NCT01385397|Health system organization|health system organization
1347620|NCT01385345|Vitamin D deficiency|vitamin d deficiency
1347621|NCT01385345|Insulin resistance|insulin resistance
1347622|NCT01385332|Metaphase II|metaphase ii
1347623|NCT01385332|Ovarian stimulation|ovarian stimulation
1347624|NCT01385332|Egg donors|egg donors
1347909|NCT01384084|sacropexy|sacropexy
1347625|NCT01385319|Bare metal stent|bare metal stent
1347626|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
1347627|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
1347628|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
1347629|NCT01385293|BKM120|bkm120
1347630|NCT01385293|prostate cancer|prostate cancer
1347631|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
1347632|NCT01385254|very low birthweight|very low birthweight
1347633|NCT01385254|premature|premature
1347634|NCT01385254|sibling adjustment|sibling adjustment
1347635|NCT01385254|preterm|preterm
1347636|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1347637|NCT01385241|Stigma|stigma
1347638|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
1347639|NCT01385241|HIV positive women|hiv positive women
1347640|NCT01385241|Self-efficacy|self-efficacy
1347641|NCT01385228|prostate cancer|prostate cancer
1347642|NCT01385228|metastatic|metastatic
1347643|NCT01385228|pazopanib|pazopanib
1347644|NCT01385228|docetaxel|docetaxel
1347645|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
1347646|NCT01385215|Vaccination|vaccination
1347647|NCT01385215|Mucosal Immunity|mucosal immunity
1347648|NCT01385215|Nasal Immunization|nasal immunization
1347649|NCT01385202|Atrial Fibrillation|atrial fibrillation
1347650|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1347651|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
1347652|NCT01385189|HHVI|hhvi
1347653|NCT01385189|Human Hookworm|human hookworm
1347654|NCT01385189|Hookworm|hookworm
1347655|NCT01385189|Hookworm Disease|hookworm disease
1347656|NCT01385189|N. americanus|n. americanus
1347657|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
1347658|NCT01385189|Intestinal blood loss|intestinal blood loss
1347659|NCT01385189|Iron deficiency anemia|iron deficiency anemia
1347660|NCT01385176|Heart failure|heart failure
1347661|NCT01385176|Congestive heart failure|congestive heart failure
1347662|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
1347663|NCT01385176|Vagal therapy|vagal therapy
1347664|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
1347665|NCT01385163|mental health|mental health
1347666|NCT01385163|gender-based violence|gender-based violence
1347667|NCT01385163|Africa|africa
1347668|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1347669|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1347670|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1347671|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1347672|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1347673|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
1347674|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1347675|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1347676|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1347677|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1347678|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1347679|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1347680|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1347805|NCT01384604|Phenotype|phenotype
1347681|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1347682|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1347683|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1347684|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1347685|NCT01385137|stage I breast cancer|stage i breast cancer
1347686|NCT01385137|stage II breast cancer|stage ii breast cancer
1347687|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
1347688|NCT01385137|pain|pain
1347689|NCT01385137|arthralgia|arthralgia
1347690|NCT01385124|Cannabidiol|cannabidiol
1347691|NCT01385124|GVHD|gvhd
1347692|NCT01385124|Allogeneic transplantation|allogeneic transplantation
1347693|NCT01385124|Prophylaxis|prophylaxis
1347694|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
1347695|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
1347698|NCT01385111|EUS-B-FNA|eus-b-fna
1347699|NCT01385111|lung cancer|lung cancer
1347700|NCT01385111|staging|staging
1347701|NCT01385098|Vitamin D|vitamin d
1347702|NCT01385098|Bariatric surgery|bariatric surgery
1347703|NCT01385098|Roux-en Y surgery|roux-en y surgery
1347704|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
1347705|NCT01385098|Parathyroid Hormone|parathyroid hormone
1347706|NCT01385085|Vitamin D|vitamin d
1347707|NCT01385085|Sunlight|sunlight
1347708|NCT01385085|Deficiency|deficiency
1347709|NCT01385072|acute leukemia|acute leukemia
1347710|NCT01385072|relapse|relapse
1347711|NCT01385072|induction failure|induction failure
1347712|NCT01385072|allogeneic transplantation|allogeneic transplantation
1347713|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
1347714|NCT01385046|physical inactivity|physical inactivity
1347715|NCT01385046|poor diet|poor diet
1347716|NCT01385020|Red yeast rice|red yeast rice
1347717|NCT01385020|Gemfibrozil|gemfibrozil
1347718|NCT01385020|Drug-drug interaction|drug-drug interaction
1347719|NCT01385020|Pharmacokinetics|pharmacokinetics
1347720|NCT01385007|Rural|rural
1347721|NCT01385007|Veterans|veterans
1347722|NCT01385007|Dementia|dementia
1347723|NCT01385007|Pain|pain
1347724|NCT01385007|Aggression|aggression
1347725|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
1347726|NCT01385007|presence of a caregiver|presence of a caregiver
1347727|NCT01384994|Colorectal Cancer|colorectal cancer
1347728|NCT01384994|PARLIM|parlim
1347729|NCT01384994|KRAS Wildtype|kras wildtype
1347730|NCT01384994|Liver metastases|liver metastases
1347731|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
1347732|NCT01384981|COPD|copd
1347733|NCT01384981|non invasive ventilation|non invasive ventilation
1347735|NCT01384981|exercise capacity|exercise capacity
1347736|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
1347737|NCT01384968|nitrite|nitrite
1347738|NCT01384968|exercise|exercise
1347739|NCT01384968|cycling|cycling
1347740|NCT01384955|scoliosis|scoliosis
1347741|NCT01384955|physical therapy|physical therapy
1347742|NCT01384955|long term outcome|long term outcome
1347743|NCT01384955|pulmonary function|pulmonary function
1347744|NCT01384955|physical fitness|physical fitness
1347745|NCT01384955|health related quality of life|health related quality of life
1347746|NCT01384955|psychopathology|psychopathology
1347747|NCT01384942|Bereavement|bereavement
1347748|NCT01384942|Grief|grief
1347749|NCT01384942|Mourning|mourning
1347750|NCT01384942|Loss|loss
1347751|NCT01384942|Death|death
1347752|NCT01384942|Meaning|meaning
1347753|NCT01384942|Group|group
1347754|NCT01384942|Counseling|counseling
1347755|NCT01384942|Psychotherapy|psychotherapy
1347756|NCT01384942|Uncomplicated|uncomplicated
1347757|NCT01384942|Support|support
1347758|NCT01384916|depression|depression
1347759|NCT01384916|yoga|yoga
1347760|NCT01384916|health education|health education
1347761|NCT01384916|antidepressant|antidepressant
1347762|NCT01384877|Pain|pain
1347763|NCT01384877|Cancer|cancer
1347764|NCT01384877|Lidocaine|lidocaine
1347765|NCT01384877|Sodium Channel Blockers|sodium channel blockers
1347766|NCT01384864|barrett's esophagus|barrett's esophagus
1347767|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
1347768|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
1347769|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
1347770|NCT01384838|breast cancer|breast cancer
1347771|NCT01384838|physical activity|physical activity
1347772|NCT01384838|sports|sports
1347773|NCT01384838|exercise|exercise
1347774|NCT01384825|Multiple Sclerosis|multiple sclerosis
1347775|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
1347776|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
1347777|NCT01384825|Prevalence|prevalence
1347778|NCT01384825|Case-control|case-control
1347779|NCT01384773|Keratoconus|keratoconus
1347780|NCT01384773|Ectasia|ectasia
1347781|NCT01384773|UVA light|uva light
1347782|NCT01384773|riboflavin|riboflavin
1347783|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
1347784|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
1347785|NCT01384773|irregular astigmatism|irregular astigmatism
1568267|NCT00506454|Phospholipid|phospholipid
1347786|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
1347787|NCT01384721|Coronary Artery Disease|coronary artery disease
1347788|NCT01384721|Prevalence Of Disease|prevalence of disease
1347789|NCT01384721|Prognosis|prognosis
1347790|NCT01384721|Risk Stratification|risk stratification
1347791|NCT01384708|squamous cell cancer|squamous cell cancer
1347792|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
1347793|NCT01384695|Barrett's esophagus|barrett's esophagus
1347794|NCT01384695|confocal microendoscopy|confocal microendoscopy
1347795|NCT01384617|distal pancreatectomy|distal pancreatectomy
1347796|NCT01384617|pancreatic fistula|pancreatic fistula
1347797|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
1347798|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
1347993|NCT01383655|rhinovirus|rhinovirus
1347799|NCT01384617|stapling closure|stapling closure
1347800|NCT01384604|Schizophrenia|schizophrenia
1347801|NCT01384604|Schizoaffective disorder|schizoaffective disorder
1347802|NCT01384604|Bipolar disorder|bipolar disorder
1347803|NCT01384604|Psychosis|psychosis
1347804|NCT01384604|Genetics|genetics
1347806|NCT01384591|oxidative stress|oxidative stress
1347807|NCT01384591|blood flow|blood flow
1347808|NCT01384591|antioxidant|antioxidant
1347810|NCT01384591|elderly|elderly
1347811|NCT01384552|normal weight|normal weight
1347812|NCT01384552|overweight|overweight
1347813|NCT01384552|dietary restraint|dietary restraint
1347814|NCT01384552|package unit size|package unit size
1347815|NCT01384552|food intake|food intake
1347816|NCT01384539|chronic kidney disease|chronic kidney disease
1347817|NCT01384539|vitamin D deficiency|vitamin d deficiency
1347818|NCT01384526|hormone therapy|hormone therapy
1347819|NCT01384526|ovarian aging|ovarian aging
1347820|NCT01384526|ovarian reserve|ovarian reserve
1347821|NCT01384526|fertility|fertility
1347822|NCT01384526|breast cancer|breast cancer
1347823|NCT01384513|Allogeneic HSCT|allogeneic hsct
1347824|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1347825|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
1347826|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
1347827|NCT01384474|Crew Resource Management|crew resource management
1347828|NCT01384474|Surgical safety checklist|surgical safety checklist
1347829|NCT01384474|Postoperative complications|postoperative complications
1347830|NCT01384448|stress echocardiography|stress echocardiography
1347831|NCT01384448|coronary ct angiography|coronary ct angiography
1347832|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
1347833|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1347834|NCT01384422|methotrexate-refractory|methotrexate-refractory
1347835|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
1347836|NCT01384383|IL28B CC Genotype|il28b cc genotype
1347837|NCT01384383|Treatment naive|treatment naive
1347838|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
1347839|NCT01384383|Genotype 1a/b|genotype 1a/b
1347840|NCT01384383|GS 9451|gs 9451
1347841|NCT01384383|GS 5885|gs 5885
1347842|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
1347843|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
1347844|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
1347845|NCT01384357|lymphadenopathy|lymphadenopathy
1347846|NCT01384357|needle biopsy|needle biopsy
1347847|NCT01384357|sonography|sonography
1347848|NCT01384331|Implanon users|implanon users
1347849|NCT01384331|Frequent bleeding|frequent bleeding
1347850|NCT01384331|Prolonged bleeding|prolonged bleeding
1347851|NCT01384331|Comparison of treatments|comparison of treatments
1347852|NCT01384331|Placebo controlled|placebo controlled
1347853|NCT01384331|Randomly allocated tretment|randomly allocated tretment
1347854|NCT01384292|Cancer-Related Pain|cancer-related pain
1347855|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
1347856|NCT01384292|OIC|oic
1347857|NCT01384279|metformin|metformin
1347858|NCT01384279|topiramate|topiramate
1347859|NCT01384279|obesity|obesity
1347860|NCT01384279|metabolic syndrome|metabolic syndrome
1347861|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
1347862|NCT01384253|HER2+|her2+
1347863|NCT01384253|HER-2 positive|her-2 positive
1347864|NCT01384253|intraperitoneal|intraperitoneal
1347865|NCT01384253|intra-abdominal|intra-abdominal
1347866|NCT01384253|Lead 212|lead 212
1347867|NCT01384253|Radio Immunotherapy|radio immunotherapy
1347868|NCT01384253|Alpha particle|alpha particle
1347869|NCT01384253|Antibodies|antibodies
1347870|NCT01384253|Immunoglobulins|immunoglobulins
1347871|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
1347872|NCT01384253|Immunologic Factors|immunologic factors
1347873|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
1347874|NCT01384253|Pharmacologic Actions|pharmacologic actions
1347875|NCT01384253|RIT|rit
1347876|NCT01384240|colon polyps|colon polyps
1347877|NCT01384240|colonic dysplasia|colonic dysplasia
1347878|NCT01384240|anal dysplasia|anal dysplasia
1347879|NCT01384240|microendoscopy|microendoscopy
1347880|NCT01384227|Barrett's esophagus|barrett's esophagus
1347881|NCT01384227|in vivo imaging|in vivo imaging
1347882|NCT01384227|image guide microscope|image guide microscope
1347883|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
1347884|NCT01384175|Epidural Analgesia|epidural analgesia
1347885|NCT01384175|OPCAB|opcab
1347886|NCT01384175|PCEA|pcea
1347888|NCT01384162|VEGF165|vegf165
1347889|NCT01384162|Safety|safety
1347890|NCT01384162|Intracerebroventricular|intracerebroventricular
1347891|NCT01384162|Infusion|infusion
1347892|NCT01384162|Implantable|implantable
1347893|NCT01384149|intra ocular pressure|intra ocular pressure
1347894|NCT01384149|open angle glaucoma|open angle glaucoma
1347895|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
1347896|NCT01384149|external laser treatment|external laser treatment
1347994|NCT01383655|magnesium|magnesium
1347897|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
1347898|NCT01384110|Amylase|amylase
1347899|NCT01384110|Glucosidase|glucosidase
1347900|NCT01384110|Glycemic response|glycemic response
1347901|NCT01384110|Sucrose|sucrose
1347902|NCT01384110|Seaweed|seaweed
1347903|NCT01384097|haemodynamic|haemodynamic
1347904|NCT01384097|goal-directed therapy|goal-directed therapy
1347905|NCT01384097|surgery|surgery
1347906|NCT01384097|anaesthesia|anaesthesia
1347907|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
1347908|NCT01384084|urinary incontinence|urinary incontinence
1347910|NCT01384084|sling|sling
1347911|NCT01384071|Low back pain|low back pain
1347912|NCT01384071|Unstable shoes|unstable shoes
1347913|NCT01384071|Gait|gait
1347914|NCT01384071|Balance|balance
1347915|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
1347916|NCT01384058|cardiovascular disease|cardiovascular disease
1347917|NCT01384058|coronary artery disease|coronary artery disease
1347918|NCT01384058|type 2 diabetes|type 2 diabetes
1347919|NCT01384058|small, dense LDL|small, dense ldl
1347920|NCT01384045|Type II Diabetes|type ii diabetes
1347921|NCT01384045|Diabetes|diabetes
1347922|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
1347923|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
1347924|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
1347925|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1347926|NCT01384019|microvascular occlusion|microvascular occlusion
1347927|NCT01384019|myocardial salvage|myocardial salvage
1347928|NCT01384006|Pancreas transplantation|pancreas transplantation
1347929|NCT01384006|extended donor criteria|extended donor criteria
1347930|NCT01384006|organ survival|organ survival
1347931|NCT01383993|Open-Label|open-label
1347932|NCT01383993|Pharmacokinetics|pharmacokinetics
1347933|NCT01383993|Intravenous to oral switch|intravenous to oral switch
1347934|NCT01383993|Safety|safety
1347935|NCT01383993|Voriconazole|voriconazole
1347936|NCT01383993|Immunocompromise|immunocompromise
1347937|NCT01383993|Children|children
1347938|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
1347939|NCT01383980|Enteral Nutrition|enteral nutrition
1347940|NCT01383980|Enteral Feeding|enteral feeding
1347941|NCT01383980|nasogastric tubes|nasogastric tubes
1347942|NCT01383980|gastrostomy tubes|gastrostomy tubes
1347943|NCT01383980|jejunostomy tubes|jejunostomy tubes
1347944|NCT01383954|Knee osteoarthritis|knee osteoarthritis
1347945|NCT01383941|asthma|asthma
1347946|NCT01383941|rhinitis|rhinitis
1347947|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
1347948|NCT01383941|phenotypes|phenotypes
1347949|NCT01383889|Physical exercise|physical exercise
1347950|NCT01383889|Pregnancy|pregnancy
1347951|NCT01383889|Fetal well being|fetal well being
1347952|NCT01383876|cervical|cervical
1347953|NCT01383876|laminectomy|laminectomy
1347954|NCT01383876|fusion|fusion
1347955|NCT01383876|neurological compression|neurological compression
1347956|NCT01383876|spondylosis|spondylosis
1347957|NCT01383850|preterm infants|preterm infants
1347958|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
1347959|NCT01383850|heliox|heliox
1347960|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
1347961|NCT01383837|HIV/STI|hiv/sti
1347962|NCT01383837|Prevention|prevention
1347963|NCT01383837|Adolescents|adolescents
1347964|NCT01383837|Substance Use Disorders|substance use disorders
1347965|NCT01383837|Family-based intervention|family-based intervention
1347966|NCT01383824|Hip Replacement|hip replacement
1347967|NCT01383824|Femoral Component|femoral component
1347968|NCT01383811|Treatment Resistant Depression|treatment resistant depression
1347969|NCT01383811|Exercise|exercise
1347970|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
1347971|NCT01383785|Primary PTCA|primary ptca
1347972|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
1347973|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
1347974|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1347975|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
1462007|NCT00921128|PD|pd
1347976|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
1347977|NCT01383772|Visual field tests|visual field tests
1347978|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
1347979|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1347980|NCT01383759|DEXAMETHASONE|dexamethasone
1347981|NCT01383759|MELPHALAN|melphalan
1347982|NCT01383759|11-061|11-061
1347983|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
1347984|NCT01383746|RADIOEMBOLIZATION|radioembolization
1347985|NCT01383746|tumor response|tumor response
1347986|NCT01383746|progression-free survival|progression-free survival
1347987|NCT01383746|safety|safety
1347988|NCT01383746|second-line therapy|second-line therapy
1347989|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
1347990|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
1347991|NCT01383655|wheezy bronchitis|wheezy bronchitis
1347992|NCT01383655|asthma|asthma
1347995|NCT01383629|Vitrectomy|vitrectomy
1347996|NCT01383629|Local anaesthesia|local anaesthesia
1347997|NCT01383629|Counselling|counselling
1347998|NCT01383629|Fear|fear
1347999|NCT01383629|Visual perception|visual perception
1348000|NCT01383616|osteoporosis|osteoporosis
1348001|NCT01383616|vertebral compression fractures|vertebral compression fractures
1348002|NCT01383603|Cat Allergy|cat allergy
1348003|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
1348004|NCT01383603|Immunotherapy|immunotherapy
1348005|NCT01383603|Cat-PAD|cat-pad
1348006|NCT01383590|Cat allergy|cat allergy
1348007|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
1348008|NCT01383590|Immunotherapy|immunotherapy
1348009|NCT01383590|Cat-PAD|cat-pad
1348010|NCT01383577|Hemorrhoids|hemorrhoids
1348011|NCT01383577|Ligation|ligation
1348012|NCT01383577|Pain|pain
1348013|NCT01383577|Morbidity|morbidity
1348014|NCT01383577|Patient Satisfaction|patient satisfaction
1348015|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
1348016|NCT01383551|Depression|depression
1348017|NCT01383551|Marital relationship|marital relationship
1348018|NCT01383551|Parental competence|parental competence
1348019|NCT01383538|pancreas|pancreas
1348020|NCT01383538|cancer|cancer
1348021|NCT01383538|adenocarcinoma|adenocarcinoma
1348022|NCT01383538|Oxaliplatin|oxaliplatin
1348023|NCT01383538|Leucovorin|leucovorin
1348024|NCT01383538|Irinotecan|irinotecan
1348025|NCT01383538|5-FU|5-fu
1348026|NCT01383538|IPI-926|ipi-926
1348027|NCT01383525|SLT, LTP|slt, ltp
1348028|NCT01383525|non contact|non contact
1348029|NCT01383525|Trabeculoplasty|trabeculoplasty
1348030|NCT01383525|Laser|laser
1348031|NCT01383525|intraocular pressure|intraocular pressure
1348032|NCT01383512|stroke|stroke
1348033|NCT01383512|rehabilitation|rehabilitation
1348034|NCT01383512|robotics|robotics
1348035|NCT01383512|motor control|motor control
1348036|NCT01383512|upper limb|upper limb
1348037|NCT01383486|Self Selection Tria|self selection tria
1348038|NCT01383473|cancer therapy|cancer therapy
1348039|NCT01383473|school attendance|school attendance
1348040|NCT01383473|cancer diagnosis|cancer diagnosis
1348041|NCT01383473|perception|perception
1348042|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
1348043|NCT01383460|ACLF|aclf
1348044|NCT01383460|cirrhosis|cirrhosis
1348045|NCT01383460|acute hepatitis|acute hepatitis
1348046|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
1348047|NCT01383421|Patient Support Program|patient support program
1348048|NCT01383421|adalimumab|adalimumab
1348049|NCT01383408|breath sample analysis|breath sample analysis
1348050|NCT01383408|exhalation analysis|exhalation analysis
1348051|NCT01383408|volatile organic compounds|volatile organic compounds
1348052|NCT01383408|screening|screening
1348053|NCT01383408|lung cancer|lung cancer
1348054|NCT01383408|breast cancer|breast cancer
1348055|NCT01383408|ovarian cancer|ovarian cancer
1348056|NCT01383408|canine scent detection|canine scent detection
1348057|NCT01383382|Heart Diseases|heart diseases
1348058|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
1348059|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
1348060|NCT01383382|Decision Making|decision making
1348061|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
1348062|NCT01383382|Informed Consent|informed consent
1348063|NCT01383382|Quality of Care|quality of care
1348064|NCT01383330|megesterol|megesterol
1348065|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
1348066|NCT01383317|Acute Pain|acute pain
1348067|NCT01383304|Platelet aggregation|platelet aggregation
1348068|NCT01383304|Aspirin|aspirin
1348069|NCT01383304|Drug resistance|drug resistance
1348070|NCT01383304|Thromboxane B2|thromboxane b2
1348071|NCT01383304|Pharmacologic Actions|pharmacologic actions
1348072|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1348073|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
1348074|NCT01383291|prolift|prolift
1348075|NCT01383291|IVS|ivs
1348076|NCT01383291|Surgery|surgery
1348077|NCT01383278|tobacco|tobacco
1348078|NCT01383278|smoking|smoking
1348079|NCT01383278|smoking cessation|smoking cessation
1348080|NCT01383265|screening colonoscopy|screening colonoscopy
1348081|NCT01383265|adenoma|adenoma
1348082|NCT01383265|water method|water method
1348083|NCT01383252|water method|water method
1348084|NCT01383252|air method|air method
1348085|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
1348086|NCT01383252|adenoma detection|adenoma detection
1348087|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
1348088|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
1348089|NCT01383226|endosonography|endosonography
1348090|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
1348091|NCT01383226|non-cancer patient|non-cancer patient
1348092|NCT01383213|Acute Respiratory Failure|acute respiratory failure
1348093|NCT01383213|Pneumonia|pneumonia
1348094|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
1348095|NCT01383200|efficacy|efficacy
1348096|NCT01383200|comfort|comfort
1348097|NCT01383187|Deep Burn Trauma|deep burn trauma
1348289|NCT01382290|Diffusion|diffusion
1348098|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
1348099|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
1348100|NCT01383187|Vancouver Scar Score|vancouver scar score
1348101|NCT01383187|Scarring|scarring
1348102|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
1348103|NCT01383174|Breast cancer|breast cancer
1348104|NCT01383174|Latinas|latinas
1348105|NCT01383174|Peer support counselor|peer support counselor
1348106|NCT01383174|Spanish speaking|spanish speaking
1348107|NCT01383174|Community based|community based
1348108|NCT01383161|Curcumin|curcumin
1348109|NCT01383161|Turmeric|turmeric
1348110|NCT01383161|Memory|memory
1348111|NCT01383161|Cognitive Impairment|cognitive impairment
1348112|NCT01383161|Brain Imaging|brain imaging
1348113|NCT01383161|Supplement|supplement
1348114|NCT01383148|NSCLC|nsclc
1348115|NCT01383135|Healthy volunteers|healthy volunteers
1348116|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
1348117|NCT01383122|Cesarean section|cesarean section
1348118|NCT01383109|Mass Balance|mass balance
1348119|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
1348120|NCT01383109|microdose|microdose
1348121|NCT01383109|Focus of the study: ADME|focus of the study: adme
1348122|NCT01383096|OZ439|oz439
1348123|NCT01383096|Bioavailability|bioavailability
1348124|NCT01383096|Food Effect|food effect
1348125|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
1348126|NCT01383083|Congenital heart disease|congenital heart disease
1348127|NCT01383083|Eisenmenger physiology|eisenmenger physiology
1348128|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
1348129|NCT01383070|Exclusive breast feeding|exclusive breast feeding
1348130|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
1348131|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
1348132|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
1348133|NCT01383044|Carvedilol|carvedilol
1348134|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
1348135|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
1348136|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1348137|NCT01383031|single site|single site
1348138|NCT01383031|randomized controlled trail|randomized controlled trail
1348139|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
1348140|NCT01383018|Penile Implant|penile implant
1348141|NCT01383018|Impotence|impotence
1348142|NCT01383018|Penile Prosthesis|penile prosthesis
1348143|NCT01383018|Registry|registry
1348144|NCT01383005|Treatment satisfaction|treatment satisfaction
1348145|NCT01383005|Adherence to treatment|adherence to treatment
1348146|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1348147|NCT01382992|erbB-1|erbb-1
1348148|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
1348149|NCT01382979|College students|college students
1348150|NCT01382979|Intervention and control|intervention and control
1348151|NCT01382966|sclerostin|sclerostin
1348152|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
1348153|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
1348154|NCT01382966|echocardiography|echocardiography
1348155|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
1348156|NCT01382888|Haemodialysis|haemodialysis
1348157|NCT01382888|Arteriovenous fistula|arteriovenous fistula
1348158|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
1348159|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
1348160|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
1348161|NCT01382875|Conventional care program|conventional care program
1348162|NCT01382875|Balance Ability|balance ability
1348163|NCT01382875|Quality of Life|quality of life
1348164|NCT01382862|acute ischemic stroke|acute ischemic stroke
1348165|NCT01382862|thrombolysis|thrombolysis
1348166|NCT01382862|prehospital|prehospital
1348167|NCT01382862|emergency medicine|emergency medicine
1348168|NCT01382862|suspected acute stroke|suspected acute stroke
1348169|NCT01382862|telemedicine|telemedicine
1348170|NCT01382849|amyloid|amyloid
1348171|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
1348172|NCT01382849|hemorrhages|hemorrhages
1348173|NCT01382849|cerebral spot sign|cerebral spot sign
1348174|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
1348175|NCT01382771|low back pain|low back pain
1348176|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
1348177|NCT01382771|medial branch block|medial branch block
1348178|NCT01382771|> 6 months duration|> 6 months duration
1348179|NCT01382771|non-radicular|non-radicular
1348180|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
1348181|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
1348182|NCT01382732|Pre-eclampsia|pre-eclampsia
1348183|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
1348184|NCT01382732|Carbetocin|carbetocin
1348185|NCT01382732|Oxytocin|oxytocin
1348186|NCT01382719|FSAD|fsad
1348187|NCT01382719|HSDD|hsdd
1348188|NCT01382719|female sexual dysfunction|female sexual dysfunction
1348189|NCT01382719|FSD|fsd
1348190|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
1348191|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1348192|NCT01382693|Behavioral symptoms|behavioral symptoms
1348193|NCT01382693|Long-term care|long-term care
1348194|NCT01382667|mucositis|mucositis
1348195|NCT01382667|dyspepsia|dyspepsia
1348196|NCT01382667|chemotherapy|chemotherapy
1348197|NCT01382667|GLP-2|glp-2
1348198|NCT01382667|questionnaire|questionnaire
1348199|NCT01382641|Cataract surgery|cataract surgery
1348200|NCT01382628|Diabetes|diabetes
1348201|NCT01382628|Ulcers|ulcers
1348202|NCT01382628|Equinus Deformity|equinus deformity
1348203|NCT01382628|Amputation|amputation
1348204|NCT01382628|Achilles Tendon|achilles tendon
1348205|NCT01382628|Limb Loss|limb loss
1348206|NCT01382615|Multiple Myeloma|multiple myeloma
1348207|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
1348208|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
1348209|NCT01382602|Transplantation, Autologous|transplantation, autologous
1348210|NCT01382589|vitiligo|vitiligo
1348211|NCT01382589|depigmentation|depigmentation
1348212|NCT01382589|phototherapy|phototherapy
1348213|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
1348214|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
1348215|NCT01382576|chitotriosidase activity|chitotriosidase activity
1348216|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
1348217|NCT01382563|EGID|egid
1348218|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
1348219|NCT01382563|Registry|registry
1348220|NCT01382563|Eosinophils|eosinophils
1348221|NCT01382563|Eosinophilia|eosinophilia
1348222|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
1348223|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
1348224|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
1348225|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
1348226|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
1348227|NCT01382550|antithrombin|antithrombin
1348228|NCT01382550|venous thrombosis|venous thrombosis
1348229|NCT01382550|thrombosis risk factors|thrombosis risk factors
1348230|NCT01382550|thrombophilia|thrombophilia
1348231|NCT01382537|Neck|neck
1348232|NCT01382537|Chronic|chronic
1348233|NCT01382537|Musculoskeletal|musculoskeletal
1348234|NCT01382537|Shoulder|shoulder
1348235|NCT01382524|PIV therapy|piv therapy
1348236|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
1348237|NCT01382485|non union|non union
1348238|NCT01382485|bone defect|bone defect
1348239|NCT01382485|tibia non union|tibia non union
1348240|NCT01382485|femur non union|femur non union
1348241|NCT01382485|bone graft|bone graft
1348242|NCT01382472|STEMI|stemi
1348243|NCT01382472|PPCI|ppci
1348244|NCT01382472|Statins|statins
1348245|NCT01382472|Infarct size|infarct size
1348246|NCT01382459|children|children
1348247|NCT01382446|Trauma|trauma
1348248|NCT01382446|Mechanical Ventilation|mechanical ventilation
1348249|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
1348250|NCT01382446|Oral Care|oral care
1348251|NCT01382433|Chronic Cannabis Users|chronic cannabis users
1348252|NCT01382433|negative symptoms|negative symptoms
1348253|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
1348254|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
1348255|NCT01382420|hypercortisolism|hypercortisolism
1348256|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
1348257|NCT01382420|adrenalectomy|adrenalectomy
1348258|NCT01382407|skin rash reaction|skin rash reaction
1348259|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
1348260|NCT01382407|acne|acne
1348261|NCT01382394|Sepsis|sepsis
1348262|NCT01382394|heart failure|heart failure
1348263|NCT01382394|BNP|bnp
1348264|NCT01382394|IL-6|il-6
1348265|NCT01382394|Procalcitonin|procalcitonin
1348266|NCT01382394|Prognosis|prognosis
1348267|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
1348268|NCT01382368|IPF|ipf
1348269|NCT01382368|COPD|copd
1348270|NCT01382355|Kidney transplant|kidney transplant
1348271|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
1348272|NCT01382355|Antibody|antibody
1348273|NCT01382355|Monitoring|monitoring
1348274|NCT01382342|Parkinson's disease|parkinson's disease
1348275|NCT01382342|cognition|cognition
1348276|NCT01382342|executive function|executive function
1348277|NCT01382342|rasagiline|rasagiline
1348278|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
1348279|NCT01382316|12-step facilitation|12-step facilitation
1348280|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
1348281|NCT01382316|Narcotics Anonymous|narcotics anonymous
1348282|NCT01382316|AA|aa
1348283|NCT01382316|Self-help|self-help
1348284|NCT01382303|Type 2 Diabetes|type 2 diabetes
1348285|NCT01382303|pentoxifylline|pentoxifylline
1348286|NCT01382303|proteinuria|proteinuria
1348287|NCT01382290|MRI|mri
1348288|NCT01382290|Spine|spine
1348290|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
1348291|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
1348292|NCT01382264|Primary Care Providers|primary care providers
1348293|NCT01382251|Activities of Daily Living|activities of daily living
1348294|NCT01382251|Caregivers|caregivers
1348295|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
1348296|NCT01382238|dolutegravir|dolutegravir
1348297|NCT01382238|pediatric|pediatric
1348298|NCT01382238|granule formulation|granule formulation
1348299|NCT01382238|GSK1349572|gsk1349572
1348300|NCT01382238|HIV|hiv
1348301|NCT01382225|Dry eyes|dry eyes
1348302|NCT01382225|Ocular discomfort|ocular discomfort
1348303|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
1348304|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
1348305|NCT01382186|Qualitative|qualitative
1348306|NCT01382186|User, Computer Interface|user, computer interface
1348307|NCT01382186|quantitative|quantitative
1348308|NCT01382186|survey|survey
1348309|NCT01382186|telemedicine|telemedicine
1348310|NCT01382173|Knee injury|knee injury
1348311|NCT01382173|Osteoarthritis|osteoarthritis
1348312|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
1348313|NCT01382173|Patellar dislocation|patellar dislocation
1348314|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
1348315|NCT01382160|adalimumab|adalimumab
1348316|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
1348317|NCT01382160|immunogenicity|immunogenicity
1348318|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
1348319|NCT01382134|Platelet dysfunction|platelet dysfunction
1348320|NCT01382134|Hemodilution|hemodilution
1348321|NCT01382134|Mild hypothermia|mild hypothermia
1348322|NCT01382134|NSAID|nsaid
1348323|NCT01382134|Desmopressin|desmopressin
1348324|NCT01382121|Peer modeling|peer modeling
1348325|NCT01382121|Observational learning|observational learning
1348326|NCT01382121|Obesity|obesity
1348327|NCT01382121|Adolescents|adolescents
1348328|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
1348329|NCT01382121|Aerobic fitness|aerobic fitness
1348330|NCT01382121|Health behaviour|health behaviour
1348331|NCT01382095|ETEC|etec
1348332|NCT01382095|Diarrhea|diarrhea
1348333|NCT01382095|Vaccine|vaccine
1348334|NCT01382082|cognitive function|cognitive function
1348335|NCT01382082|memory|memory
1348336|NCT01382082|attention|attention
1348337|NCT01382082|breast cancer|breast cancer
1348338|NCT01382082|lymphoma|lymphoma
1348339|NCT01382069|androgen|androgen
1348340|NCT01382069|male contraception|male contraception
1348341|NCT01382069|dimethandrolone|dimethandrolone
1348342|NCT01382069|healthy men|healthy men
1348343|NCT01382056|Peripheral Artery Disease|peripheral artery disease
1348344|NCT01382056|Pulses|pulses
1348345|NCT01382056|Beans|beans
1348346|NCT01382056|PAD|pad
1348347|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
1348348|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
1348349|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
1348350|NCT01382043|biodegradable polymer|biodegradable polymer
1348351|NCT01382043|biocompatible polymer|biocompatible polymer
1348352|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
1348353|NCT01382030|High-risk|high-risk
1348354|NCT01382030|Neoadjuvant|neoadjuvant
1348355|NCT01382030|Adjuvant|adjuvant
1348356|NCT01382030|Chemotherapy|chemotherapy
1348357|NCT01382030|Radiotherapy|radiotherapy
1348358|NCT01382017|lacosamide|lacosamide
1348359|NCT01382017|carbamazepine|carbamazepine
1348360|NCT01382017|placebo|placebo
1348361|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
1348362|NCT01382017|TMS|tms
1348363|NCT01382017|motor cortex|motor cortex
1348364|NCT01382017|sodium channel|sodium channel
1348365|NCT01382017|inhibition|inhibition
1348366|NCT01382017|threshold|threshold
1348367|NCT01382004|Neglected diseases|neglected diseases
1348368|NCT01382004|Children|children
1348369|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1348370|NCT01381991|Reflux esophagitis|reflux esophagitis
1348371|NCT01381991|i-scan|i-scan
1348372|NCT01381978|Nutritional status of scholars|nutritional status of scholars
1348373|NCT01381978|Risk factors of obesity|risk factors of obesity
1348374|NCT01381978|Socioeconomical status|socioeconomical status
1348375|NCT01381978|Physical activity habits|physical activity habits
1348376|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
1348377|NCT01381965|idiopathic macular hole|idiopathic macular hole
1348378|NCT01381965|cone outer segment tips line|cone outer segment tips line
1348379|NCT01381965|vitrectomy|vitrectomy
1348380|NCT01381952|X-ray|x-ray
1348381|NCT01381952|Image processing|image processing
1348382|NCT01381952|Neuro angiography|neuro angiography
1348383|NCT01381952|Radiation exposure|radiation exposure
1348384|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
1348385|NCT01381939|Induction of labor|induction of labor
1348386|NCT01381939|Pregnancy|pregnancy
1348387|NCT01381939|Caesarian section|caesarian section
1348388|NCT01381939|Pruritus|pruritus
1348389|NCT01381939|IUFD|iufd
1348390|NCT01381926|Type 2 diabetes|type 2 diabetes
1348391|NCT01381926|exenatide|exenatide
1348392|NCT01381926|Byetta|byetta
1348393|NCT01381913|Gastric cancer|gastric cancer
1348394|NCT01381913|Chemoradiotherapy|chemoradiotherapy
1348395|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
1348396|NCT01381913|Feasibility trial|feasibility trial
1348397|NCT01381900|Canagliflozin|canagliflozin
1348398|NCT01381900|Placebo|placebo
1348399|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
1348400|NCT01381887|Canagliflozin|canagliflozin
1348401|NCT01381887|Placebo|placebo
1348402|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
1348403|NCT01381874|Breast cancer|breast cancer
1348404|NCT01381874|Abiraterone|abiraterone
1348405|NCT01381874|Postmenopausal|postmenopausal
1348406|NCT01381874|Metastatic|metastatic
1348407|NCT01381848|Doripenem|doripenem
1348408|NCT01381848|DORIPED1003|doriped1003
1348409|NCT01381848|Intravenous|intravenous
1348410|NCT01381848|Infection|infection
1348411|NCT01381848|Colonization|colonization
1348412|NCT01381848|Prophylaxis|prophylaxis
1348413|NCT01381848|Pediatric|pediatric
1348414|NCT01381848|Antibiotic|antibiotic
1348415|NCT01381848|Pharmacokinetics|pharmacokinetics
1348416|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
1348417|NCT01381835|TMC435-C126|tmc435-c126
1348418|NCT01381835|TMC435|tmc435
1348419|NCT01381835|HCV|hcv
1348420|NCT01381835|Hepatitis C|hepatitis c
1348421|NCT01381835|Hep C|hep c
1348422|NCT01381835|severe renal impairement|severe renal impairement
1348423|NCT01381822|TH-302|th-302
1348424|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1348425|NCT01381822|RCC|rcc
1348426|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1348427|NCT01381822|GIST|gist
1348428|NCT01381822|Phase 1|phase 1
1348429|NCT01381822|Sunitinib|sunitinib
1348430|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
1348431|NCT01381822|PNET|pnet
1348432|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
1348433|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
1348434|NCT01381809|Bone Marrow disease|bone marrow disease
1348435|NCT01381809|Anemia|anemia
1348436|NCT01381809|Epoetin Alfa|epoetin alfa
1348437|NCT01381809|Eprex|eprex
1348438|NCT01381809|Erypo|erypo
1348439|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
1348440|NCT01381783|topical anaesthesia|topical anaesthesia
1348441|NCT01381783|Phacoemulsification|phacoemulsification
1348442|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
1348443|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
1348444|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
1348445|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
1348446|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
1348447|NCT01381757|Middlebrook Culture|middlebrook culture
1348448|NCT01381757|Agar Proportion Method|agar proportion method
1348449|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
1348450|NCT01381731|post PRK wound healing|post prk wound healing
1348451|NCT01381718|childhood brain tumor|childhood brain tumor
1348452|NCT01381718|neurotoxicity|neurotoxicity
1348453|NCT01381718|fatigue|fatigue
1348454|NCT01381718|cognitive/functional effects|cognitive/functional effects
1348455|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1348456|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1348457|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1348458|NCT01381653|sexual risk|sexual risk
1348459|NCT01381653|substance use|substance use
1348460|NCT01381653|HIV prevention|hiv prevention
1348461|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
1348462|NCT01381653|young men who have sex with men|young men who have sex with men
1348463|NCT01381640|paracetamol|paracetamol
1348464|NCT01381640|healthy volunteer|healthy volunteer
1348465|NCT01381640|pharmacoscintography|pharmacoscintography
1348466|NCT01381627|EBUS-TBNA|ebus-tbna
1348467|NCT01381627|Dexmedetomidine|dexmedetomidine
1348468|NCT01381627|Precedex|precedex
1348469|NCT01381627|Remifentanil|remifentanil
1348470|NCT01381627|Ultiva|ultiva
1348471|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
1348472|NCT01381627|Sedation|sedation
1348473|NCT01381627|Bronchoscopy|bronchoscopy
1348474|NCT01381627|Lung cancer|lung cancer
1348475|NCT01381627|Mediastinal node|mediastinal node
1348476|NCT01381627|Cancer staging|cancer staging
1348477|NCT01381627|Anesthesia|anesthesia
1348478|NCT01381627|Remote location|remote location
1348479|NCT01381614|retrospective database analysis|retrospective database analysis
1348480|NCT01381614|economic burden|economic burden
1348481|NCT01381601|retrospective database analysis|retrospective database analysis
1348482|NCT01381601|economic burden|economic burden
1348483|NCT01381575|HPV infection|hpv infection
1348484|NCT01381575|Human Papillomavirus|human papillomavirus
1348485|NCT01381575|Cervical cancer|cervical cancer
1348486|NCT01381575|HPV-16|hpv-16
1348487|NCT01381575|HPV-18|hpv-18
1348488|NCT01381575|vaccine|vaccine
1348489|NCT01381562|intra-abdominal infection|intra-abdominal infection
1348490|NCT01381562|belly|belly
1348491|NCT01381562|Gram-negative pathogen|gram-negative pathogen
1348492|NCT01381562|abscess|abscess
1348493|NCT01381562|peritonitis|peritonitis
1348494|NCT01381549|Gram-negative|gram-negative
1348495|NCT01381549|uropathogens|uropathogens
1348496|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
1348497|NCT01381549|pyelonephritis|pyelonephritis
1348498|NCT01381536|Anti Blys Antibody|anti blys antibody
1348499|NCT01381523|resource utilization|resource utilization
1348500|NCT01381523|naproxen sodium|naproxen sodium
1348501|NCT01381523|cost and cost analysis|cost and cost analysis
1348502|NCT01381523|triptan|triptan
1348503|NCT01381523|migraine|migraine
1348504|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
1348505|NCT01381510|Adherence|adherence
1348506|NCT01381510|Acute urinary retention|acute urinary retention
1348507|NCT01381510|Enlarged prostate|enlarged prostate
1348508|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
1348509|NCT01381510|Surgery|surgery
1348510|NCT01381510|Cost and cost analysis|cost and cost analysis
1348511|NCT01381497|presenteeism|presenteeism
1348512|NCT01381497|migraine disorders|migraine disorders
1348513|NCT01381497|work productivity|work productivity
1348514|NCT01381497|triptan|triptan
1348515|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
1348516|NCT01381497|absenteeism|absenteeism
1348517|NCT01381484|Periorbital wrinkles|periorbital wrinkles
1348518|NCT01381484|Efficacy and safety|efficacy and safety
1348519|NCT01381432|Antirejection|antirejection
1348520|NCT01381419|pharmacokinetics|pharmacokinetics
1348521|NCT01381419|safety|safety
1348522|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
1348523|NCT01381419|single ascending dose|single ascending dose
1348524|NCT01381393|osteoporosis|osteoporosis
1348525|NCT01381393|ibandronate|ibandronate
1348526|NCT01381380|myofascial pain|myofascial pain
1348527|NCT01381380|trigger point injection|trigger point injection
1348528|NCT01381380|manual therapy|manual therapy
1348529|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1348530|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
1348531|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
1348532|NCT01381367|Acute exacerbation|acute exacerbation
1348533|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
1348534|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
1348535|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
1348536|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
1348537|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
1348538|NCT01381328|genotypic evaluations|genotypic evaluations
1348539|NCT01381328|phenotypic evaluations|phenotypic evaluations
1348540|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
1348541|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
1348542|NCT01381315|Prevention of lymphedema|prevention of lymphedema
1348543|NCT01381302|Severity of disease|severity of disease
1348544|NCT01381276|Vitamin A|vitamin a
1348545|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
1348546|NCT01381250|Being atleast 18 years old|being atleast 18 years old
1348547|NCT01381237|Balance|balance
1348548|NCT01381237|Postural|postural
1348549|NCT01381237|Rehabilitation|rehabilitation
1348550|NCT01381237|Therapy|therapy
1348551|NCT01381237|computer-assisted|computer-assisted
1348552|NCT01381237|Video Games|video games
1348553|NCT01381237|Center of Pressure|center of pressure
1348554|NCT01381224|low back pain|low back pain
1348555|NCT01381224|lumbar|lumbar
1348556|NCT01381224|injection|injection
1348557|NCT01381224|lumbar pain|lumbar pain
1348558|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
1348559|NCT01381198|cerebral palsy|cerebral palsy
1348560|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
1348561|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
1348562|NCT01381198|gait analysis|gait analysis
1348563|NCT01381198|single event multilevel surgery|single event multilevel surgery
1348564|NCT01381198|randomized trial|randomized trial
1348565|NCT01381198|crouch gait|crouch gait
1348566|NCT01381185|myocardial infarction|myocardial infarction
1348567|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1348568|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
1348569|NCT01381172|Heart Failure|heart failure
1348570|NCT01381172|Congestive Heart Failure|congestive heart failure
1348571|NCT01381172|Chronic heart disease|chronic heart disease
1348572|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
1348573|NCT01381172|CCM|ccm
1348574|NCT01381172|CHF|chf
1348575|NCT01381159|Adherence|adherence
1348576|NCT01381159|Asthma Control|asthma control
1348577|NCT01381159|Asthma Quality Of Life|asthma quality of life
1348578|NCT01381159|Motivational Communication|motivational communication
1348579|NCT01381159|Motivational Interviewing|motivational interviewing
1348580|NCT01381146|criminal behavior|criminal behavior
1348581|NCT01381146|substance abuse|substance abuse
1348582|NCT01381146|HIV risk behavior|hiv risk behavior
1348583|NCT01381146|criminogenic thinking|criminogenic thinking
1348584|NCT01381146|shame|shame
1348585|NCT01381146|guilt|guilt
1348586|NCT01381146|empathy|empathy
1348587|NCT01381146|jail inmates|jail inmates
1348588|NCT01381146|restorative justice|restorative justice
1348589|NCT01381146|Crime|crime
1348590|NCT01381133|Substance abuse|substance abuse
1348591|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
1348592|NCT01381133|Continuing care|continuing care
1348593|NCT01381133|Outcomes|outcomes
1348594|NCT01381120|Flank Pain|flank pain
1348595|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1348596|NCT01381120|LUTS|luts
1348597|NCT01381120|Urgency|urgency
1348598|NCT01381120|Nocturia|nocturia
1348599|NCT01381120|Frequency|frequency
1348600|NCT01381120|Ureteroscopy|ureteroscopy
1348601|NCT01381120|Kidney Stones|kidney stones
1348602|NCT01381120|Stent|stent
1348603|NCT01381120|Incontinence|incontinence
1348604|NCT01381120|VESIcare|vesicare
1348605|NCT01381120|Ureter|ureter
1348606|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
1348607|NCT01381120|OAB|oab
1348608|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
1348609|NCT01381094|anemia|anemia
1348610|NCT01381094|chronic kidney disease|chronic kidney disease
1348611|NCT01381094|CKD|ckd
1348612|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
1348613|NCT01381094|renal impairment|renal impairment
1348614|NCT01381094|erythropoietin|erythropoietin
1348615|NCT01381094|safety|safety
1348616|NCT01381094|efficacy|efficacy
1348617|NCT01381094|tolerability|tolerability
1348618|NCT01381094|pharmacokinetics|pharmacokinetics
1348619|NCT01381081|knee osteoarthritis|knee osteoarthritis
1348620|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
1348621|NCT01381081|intra-articular knee injections|intra-articular knee injections
1348622|NCT01381068|ventilation|ventilation
1348623|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
1348624|NCT01381068|hypercapnia|hypercapnia
1348625|NCT01381068|hypocapnia|hypocapnia
1348626|NCT01381068|positive pressure ventilation|positive pressure ventilation
1348627|NCT01381068|neonates|neonates
1348628|NCT01381068|delivery room resuscitation|delivery room resuscitation
1348629|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
1348630|NCT01381055|Pentoxifylline|pentoxifylline
1348631|NCT01381055|Meglumine antimoniate|meglumine antimoniate
1348632|NCT01381055|L. braziliensis|l. braziliensis
1348633|NCT01381042|Brown Adipose Tissue|brown adipose tissue
1348634|NCT01381042|Incidence|incidence
1348635|NCT01381042|Factor|factor
1348636|NCT01381042|Human|human
1348637|NCT01381016|LH pulsatility|lh pulsatility
1348638|NCT01381016|Obesity|obesity
1348639|NCT01381016|Reproduction|reproduction
1348640|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
1348641|NCT01381003|Gene therapy|gene therapy
1348642|NCT01381003|X-CGD|x-cgd
1348643|NCT01381003|NADPH-oxidase|nadph-oxidase
1348644|NCT01381003|gp91-phox|gp91-phox
1348645|NCT01380977|crime|crime
1348646|NCT01380977|substance abuse|substance abuse
1348647|NCT01380977|HIV risk|hiv risk
1348648|NCT01380977|criminogenic thinking|criminogenic thinking
1348649|NCT01380977|shame|shame
1348650|NCT01380977|guilt|guilt
1348651|NCT01380977|restorative justice|restorative justice
1348652|NCT01380977|victim impact group|victim impact group
1348653|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1348654|NCT01380964|biomarkers|biomarkers
1348655|NCT01380964|transcriptomics|transcriptomics
1348656|NCT01380964|mironics|mironics
1348657|NCT01380964|proteomics|proteomics
1348658|NCT01380951|liver cirrhosis|liver cirrhosis
1348659|NCT01380951|chronic hepatitis B|chronic hepatitis b
1348660|NCT01380951|antiviral therapy|antiviral therapy
1348661|NCT01380951|telbivudine|telbivudine
1348662|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
1348663|NCT01380938|combination treatment|combination treatment
1348664|NCT01380938|individualized treatment|individualized treatment
1348665|NCT01380912|breast cancer|breast cancer
1348666|NCT01380912|mastectomy|mastectomy
1348667|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
1348668|NCT01380912|seroma|seroma
1348669|NCT01380912|numbers of punctures|numbers of punctures
1348670|NCT01380899|Parkinson Disease|parkinson disease
1348671|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
1348672|NCT01380899|Lewy Bodies|lewy bodies
1348673|NCT01380899|alpha-Synuclein|alpha-synuclein
1348674|NCT01380860|mesh|mesh
1348675|NCT01380860|hernia|hernia
1348676|NCT01380847|Kidney Transplantation|kidney transplantation
1348677|NCT01380847|Allograft|allograft
1348678|NCT01380847|Kidney failure|kidney failure
1348679|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
1348680|NCT01380847|Monitoring|monitoring
1348681|NCT01380847|Urine|urine
1349195|NCT01378741|delirium|delirium
1348682|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
1348683|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1348684|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
1348685|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
1348686|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
1348687|NCT01380795|circulating tumor cells|circulating tumor cells
1348688|NCT01380795|EGFR|egfr
1348689|NCT01380795|K-ras|k-ras
1348690|NCT01380782|brain tumor|brain tumor
1348691|NCT01380782|recurrent disease|recurrent disease
1348692|NCT01380756|Amgen|amgen
1348693|NCT01380756|Phase 1|phase 1
1348694|NCT01380756|Clinical Trial|clinical trial
1348695|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
1348696|NCT01380756|Open label|open label
1348697|NCT01380756|Oncology|oncology
1348698|NCT01380756|Hematology|hematology
1348699|NCT01380743|Pompe disease|pompe disease
1348700|NCT01380730|Hypercholesterolemia|hypercholesterolemia
1348701|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
1348702|NCT01380704|Depression|depression
1348703|NCT01380678|bevacizumab|bevacizumab
1348704|NCT01380678|pterygium|pterygium
1348705|NCT01380678|treatment|treatment
1348706|NCT01380678|elevation|elevation
1348707|NCT01380665|Prevena|prevena
1348708|NCT01380665|Incision|incision
1348709|NCT01380665|Management|management
1348710|NCT01380665|System|system
1348711|NCT01380665|total|total
1348712|NCT01380665|knee|knee
1348713|NCT01380665|hip|hip
1348714|NCT01380665|replacement|replacement
1348715|NCT01380665|Surgery|surgery
1348716|NCT01380665|Negative|negative
1348717|NCT01380665|Pressure|pressure
1348718|NCT01380665|dressing|dressing
1348719|NCT01380665|KCI|kci
1348720|NCT01380652|COPD III/IV|copd iii/iv
1348721|NCT01380652|Activity Monitoring|activity monitoring
1348722|NCT01380652|SenseWear|sensewear
1348723|NCT01380652|Vibration training|vibration training
1348724|NCT01380652|Galileo|galileo
1348725|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
1348726|NCT01380639|COPD III/IV|copd iii/iv
1348727|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
1348728|NCT01380639|Vibration training|vibration training
1348729|NCT01380639|Galileo|galileo
1348730|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
1348731|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
1348732|NCT01380626|COPD|copd
1348733|NCT01380626|exercise training|exercise training
1348734|NCT01380626|muscle biopsy|muscle biopsy
1348735|NCT01380613|HIV|hiv
1348736|NCT01380613|depression|depression
1348737|NCT01380613|drug use,|drug use,
1348738|NCT01380613|risk reduction|risk reduction
1348739|NCT01380600|Vaccinia|vaccinia
1348740|NCT01380600|Vaccinia Virus|vaccinia virus
1348741|NCT01380600|JX-594|jx-594
1348742|NCT01380600|Jennerex|jennerex
1348743|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
1348744|NCT01380600|Colorectal cancer|colorectal cancer
1348745|NCT01380600|Colon Cancer|colon cancer
1348746|NCT01380600|Rectal Cancer|rectal cancer
1348747|NCT01380600|Pexa-Vec|pexa-vec
1348748|NCT01380587|ALL|all
1348749|NCT01380587|XCL1|xcl1
1348750|NCT01380587|Cytokines|cytokines
1348751|NCT01380587|Prognosis|prognosis
1348752|NCT01380574|atrial fibrillation|atrial fibrillation
1348753|NCT01380574|cardioversion|cardioversion
1348754|NCT01380574|stroke|stroke
1348755|NCT01380574|thromboembolism|thromboembolism
1348756|NCT01380561|asimadoline|asimadoline
1348757|NCT01380561|pharmacokinetic|pharmacokinetic
1568268|NCT00506454|Emulsion|emulsion
1348758|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
1348759|NCT01380561|metabolite profile|metabolite profile
1348760|NCT01380561|14C-asimadoline|14c-asimadoline
1348761|NCT01380561|metabolites|metabolites
1348762|NCT01380561|single and multiple oral doses|single and multiple oral doses
1348763|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
1348764|NCT01380535|Methoxsalen|methoxsalen
1348765|NCT01380535|UVADEX|uvadex
1348766|NCT01380535|Chronic graft versus host disease (cGvHD): National Institute Health Consensus Criteria|chronic graft versus host disease (cgvhd): national institute health consensus criteria
1348767|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
1348768|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
1348769|NCT01380496|bioequivalence|bioequivalence
1348770|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
1348771|NCT01380496|fed|fed
1348772|NCT01380483|bioequivalence|bioequivalence
1348773|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
1348774|NCT01380483|fasting|fasting
1348775|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1348776|NCT01380470|Diagnosis differential|diagnosis differential
1348777|NCT01380470|Dyspnea/classification|dyspnea/classification
1348778|NCT01380470|Dyspnea/etiology|dyspnea/etiology
1348779|NCT01380457|bioequivalence|bioequivalence
1348780|NCT01380457|dronabinol|dronabinol
1348781|NCT01380457|fasting|fasting
1348782|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
1348783|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
1348784|NCT01380444|Sliding hip screw|sliding hip screw
1348785|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
1348786|NCT01380418|Obesity|obesity
1348787|NCT01380405|Inhalators|inhalators
1348788|NCT01380405|Education|education
1348789|NCT01380405|Primary care|primary care
1348790|NCT01380392|Liver cancer|liver cancer
1348791|NCT01380392|Uncertainty|uncertainty
1348792|NCT01380392|Personality|personality
1348793|NCT01380392|coping strategies|coping strategies
1348794|NCT01380379|physical violence|physical violence
1348795|NCT01380379|sexual violence|sexual violence
1348796|NCT01380366|Malabsorption|malabsorption
1348797|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
1348798|NCT01380353|Breast cancer prevention|breast cancer prevention
1348799|NCT01380340|Seniors|seniors
1348800|NCT01380340|Driving|driving
1348801|NCT01380340|Group work|group work
1348802|NCT01380327|cockroach|cockroach
1348803|NCT01380327|immunotherapy|immunotherapy
1348804|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
1348805|NCT01380327|inner city asthma|inner city asthma
1348806|NCT01380314|leishmaniasis|leishmaniasis
1348807|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
1348808|NCT01380314|miltefosine|miltefosine
1348809|NCT01380314|oral therapy|oral therapy
1348810|NCT01380314|treatment|treatment
1348811|NCT01380314|imiquimod|imiquimod
1348812|NCT01380301|Leishmaniasis|leishmaniasis
1348813|NCT01380301|Miltefosine|miltefosine
1348814|NCT01380301|Antimony|antimony
1348815|NCT01380301|Therapy|therapy
1348816|NCT01380288|Alzheimer's disease|alzheimer's disease
1348817|NCT01380288|rivastigmine patch|rivastigmine patch
1348818|NCT01380288|white matter change|white matter change
1348819|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
1348820|NCT01380262|Colorectal Cancer|colorectal cancer
1348821|NCT01380262|Skin Rash|skin rash
1348822|NCT01380262|Pre-emptive treatment|pre-emptive treatment
1348823|NCT01380262|Doxycycline|doxycycline
1348824|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
1348825|NCT01380262|Cetuximab|cetuximab
1348826|NCT01380262|Panitumumab|panitumumab
1348827|NCT01380249|Phase I|phase i
1348828|NCT01380249|Phase I multiple doses|phase i multiple doses
1348829|NCT01380249|PDM08|pdm08
1348830|NCT01380249|Cancer Treatment|cancer treatment
1348831|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
1348832|NCT01380249|Advanced Solid Tumors|advanced solid tumors
1348833|NCT01380249|Prodimed|prodimed
1348834|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
1348835|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
1348836|NCT01380197|pain|pain
1348837|NCT01380197|sickle cell|sickle cell
1348838|NCT01380197|nubain|nubain
1348839|NCT01380197|morphine|morphine
1348840|NCT01380197|acute chest|acute chest
1348841|NCT01380197|side effects|side effects
1348842|NCT01380184|Relapsed cancer|relapsed cancer
1348843|NCT01380158|pessary|pessary
1348844|NCT01380158|preterm birth|preterm birth
1348845|NCT01380158|short cervix|short cervix
1348846|NCT01380158|cervical incompetence|cervical incompetence
1348847|NCT01380145|multiple myeloma|multiple myeloma
1348848|NCT01380145|MAGE-A3|mage-a3
1348849|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
1348850|NCT01380132|Fecal incontinence|fecal incontinence
1348851|NCT01380132|Treatment|treatment
1348852|NCT01380132|Surgery|surgery
1348853|NCT01380119|sputum conversion|sputum conversion
1348854|NCT01380119|liver biochemistry|liver biochemistry
1348855|NCT01380119|weight loss|weight loss
1348856|NCT01380119|quality of life|quality of life
1348857|NCT01380106|Multiple myeloma|multiple myeloma
1348858|NCT01380106|Relapsed|relapsed
1348859|NCT01380106|Revlimid|revlimid
1348860|NCT01380093|abuse potential|abuse potential
1348861|NCT01380093|abuse liability|abuse liability
1348862|NCT01380093|recreational opioid use|recreational opioid use
1348863|NCT01380093|morphine|morphine
1348864|NCT01380067|Inguinal hernia|inguinal hernia
1348865|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
1348866|NCT01380067|Recurrence|recurrence
1348867|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
1348868|NCT01380054|Quality of life|quality of life
1348869|NCT01380054|Coping|coping
1348870|NCT01380054|Depression|depression
1348871|NCT01380054|Anxiety|anxiety
1348872|NCT01380054|Social support|social support
1348873|NCT01380054|Control beliefs|control beliefs
1348874|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
1348875|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
1348876|NCT01380028|corticosteroid|corticosteroid
1348877|NCT01380028|treatment|treatment
1348878|NCT01380028|neurosurgery|neurosurgery
1348879|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
1348880|NCT01380015|osteoarthritis|osteoarthritis
1348881|NCT01380015|spearmint|spearmint
1348882|NCT01380015|rosmarinic acid|rosmarinic acid
1348883|NCT01380002|care needs|care needs
1348884|NCT01379976|lung|lung
1348885|NCT01379976|cancer|cancer
1348886|NCT01379976|non small cell lung cancer|non small cell lung cancer
1349393|NCT01378026|SNP|snp
1348887|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
1348888|NCT01379937|influenza|influenza
1348889|NCT01379937|H5N1|h5n1
1348890|NCT01379937|vaccine|vaccine
1348891|NCT01379937|children|children
1348892|NCT01379911|Satiety|satiety
1348893|NCT01379911|Food intake|food intake
1348894|NCT01379911|Yogurt|yogurt
1348895|NCT01379898|Pheochromocytoma|pheochromocytoma
1348896|NCT01379898|Doxazosin|doxazosin
1348897|NCT01379898|Phenoxybenzamine|phenoxybenzamine
1348898|NCT01379885|Pain|pain
1348899|NCT01379885|immunization|immunization
1348900|NCT01379885|distraction|distraction
1348901|NCT01379885|hypnosis|hypnosis
1348902|NCT01379885|injections|injections
1348903|NCT01379885|anxiety|anxiety
1348904|NCT01379872|Prostate|prostate
1348905|NCT01379872|Head and Neck|head and neck
1348906|NCT01379872|Anal|anal
1348907|NCT01379846|Immunostimulation|immunostimulation
1348908|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
1348909|NCT01379846|HIB|hib
1348910|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
1348911|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
1348912|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
1348913|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
1348914|NCT01379820|NASAL cpap|nasal cpap
1348915|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
1348916|NCT01379820|PNEUMOTHORAX|pneumothorax
1348917|NCT01379820|COMPENSATION BAG|compensation bag
1348918|NCT01379781|prevention|prevention
1348919|NCT01379781|postpartum depression|postpartum depression
1348920|NCT01379755|stability|stability
1348921|NCT01379755|single-radius|single-radius
1348922|NCT01379755|multi-radius|multi-radius
1348923|NCT01379755|total knee arthroplasty|total knee arthroplasty
1348924|NCT01379742|prostate cancer|prostate cancer
1348925|NCT01379742|prostate brachytherapy|prostate brachytherapy
1348926|NCT01379729|Type 1 Diabetes|type 1 diabetes
1348927|NCT01379729|Transplantation|transplantation
1348928|NCT01379729|Beta Cells|beta cells
1348929|NCT01379729|Encapsulation|encapsulation
1348930|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
1348931|NCT01379703|Protease inhibitor|protease inhibitor
1348932|NCT01379703|Kaletra®|kaletra®
1348933|NCT01379690|HbA1c|hba1c
1348934|NCT01379677|Coronary Artery Disease|coronary artery disease
1348935|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
1348936|NCT01379677|Rubidium|rubidium
1348937|NCT01379677|Technetium|technetium
1348938|NCT01379664|Sevoflurane|sevoflurane
1348939|NCT01379664|Isoflurane|isoflurane
1348940|NCT01379664|volatile anesthetic|volatile anesthetic
1348941|NCT01379664|duration of hospitalization|duration of hospitalization
1348942|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
1348943|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
1348944|NCT01379638|cardiac output|cardiac output
1348945|NCT01379638|flow rate|flow rate
1348946|NCT01379638|lactate|lactate
1348947|NCT01379625|fatty acid oxidation|fatty acid oxidation
1348948|NCT01379625|triheptanoin|triheptanoin
1348949|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
1348950|NCT01379625|LCHADD|lchadd
1348951|NCT01379625|VLCADD|vlcadd
1348952|NCT01379625|CPT2|cpt2
1348953|NCT01379625|TFP|tfp
1348954|NCT01379612|Ultrasound elastography|ultrasound elastography
1348955|NCT01379612|Rectal cancer|rectal cancer
1463205|NCT00916552|Epo|epo
1348956|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
1348957|NCT01379599|cocaine|cocaine
1348958|NCT01379599|heroin|heroin
1348959|NCT01379599|STIs|stis
1348960|NCT01379599|HIV|hiv
1348961|NCT01379599|brief motivational intervention|brief motivational intervention
1348962|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
1348963|NCT01379586|ONO-4053|ono-4053
1348964|NCT01379586|Healthy adult subjects|healthy adult subjects
1348965|NCT01379586|First time in humans|first time in humans
1348966|NCT01379573|hydroxychloroquine|hydroxychloroquine
1348967|NCT01379573|Plaquenil|plaquenil
1348968|NCT01379573|congenital heart block|congenital heart block
1348969|NCT01379573|neonatal lupus|neonatal lupus
1348970|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
1348971|NCT01379573|Sjogren's syndrome|sjogren's syndrome
1348972|NCT01379573|autoantibodies|autoantibodies
1348973|NCT01379573|SSA/Ro|ssa/ro
1348974|NCT01379573|SSB/La|ssb/la
1348975|NCT01379573|autoimmunity|autoimmunity
1348976|NCT01379573|pregnancy|pregnancy
1348977|NCT01379573|immunoglobulin|immunoglobulin
1348978|NCT01379547|Procalcitonin|procalcitonin
1348979|NCT01379547|sepsis|sepsis
1348980|NCT01379547|ICU|icu
1348981|NCT01379547|antibiotic|antibiotic
1348982|NCT01379547|antibiotic duration|antibiotic duration
1348983|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
1348984|NCT01379534|Solid tumors,|solid tumors,
1348985|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
1348986|NCT01379534|Endometrial Cancer,|endometrial cancer,
1348987|NCT01379534|Second-line treatment,|second-line treatment,
1348988|NCT01379534|VEGF,|vegf,
1348989|NCT01379534|Neoplasms,|neoplasms,
1348990|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
1348991|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
1348992|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
1348993|NCT01379534|Cancer,|cancer,
1348994|NCT01379534|Carcinoma,|carcinoma,
1348995|NCT01379534|Uterine Diseases,|uterine diseases,
1348996|NCT01379534|Female Genital Diseases,|female genital diseases,
1348997|NCT01379534|Tumors,|tumors,
1348998|NCT01379534|Oral Administration,|oral administration,
1348999|NCT01379534|Capsules,|capsules,
1349000|NCT01379534|Tablets,|tablets,
1349001|NCT01379534|CHIR258,|chir258,
1349002|NCT01379534|CHIR-258,|chir-258,
1349003|NCT01379534|CHIR 258,|chir 258,
1349004|NCT01379534|TKI258,|tki258,
1349005|NCT01379534|TKI-258,|tki-258,
1349006|NCT01379534|TKI 258|tki 258
1349007|NCT01379521|Localised|localised
1349008|NCT01379521|unresectable|unresectable
1349009|NCT01379521|chemoembolization|chemoembolization
1349010|NCT01379495|burns|burns
1349011|NCT01379495|rehabilitation|rehabilitation
1349012|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
1349013|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
1349014|NCT01379469|severe liver disease|severe liver disease
1349015|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
1349016|NCT01379443|Children|children
1349017|NCT01379443|Rehabilitation|rehabilitation
1349018|NCT01379443|Family Functioning|family functioning
1349019|NCT01379443|Mental Health|mental health
1349020|NCT01379443|Costs|costs
1349021|NCT01379443|Integration|integration
1349022|NCT01379430|Vaccine|vaccine
1349023|NCT01379430|Immune response|immune response
1349024|NCT01379417|Prematurity|prematurity
1349025|NCT01379417|Nutrition|nutrition
1349026|NCT01379417|Growth|growth
1349027|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
1349028|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1349029|NCT01379391|Platelet Engraftment|platelet engraftment
1349030|NCT01379391|TPO|tpo
1349031|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
1349032|NCT01379352|liver transplantation|liver transplantation
1349033|NCT01379352|vecuronium|vecuronium
1349034|NCT01379339|Cabazitaxel|cabazitaxel
1349035|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
1349036|NCT01379339|Phase I|phase i
1349037|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
1349038|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
1349039|NCT01379339|Head and Neck|head and neck
1349040|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
1349041|NCT01379339|Locally Advanced|locally advanced
1349042|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1349043|NCT01379313|gas exchange|gas exchange
1349044|NCT01379313|inspiratory time|inspiratory time
1349045|NCT01379313|expiratory time|expiratory time
1349046|NCT01379313|I:E ratio|i:e ratio
1349047|NCT01379300|Hemophilia B|hemophilia b
1349048|NCT01379287|Iso-Fludelone|iso-fludelone
1349049|NCT01379287|KOS-1803|kos-1803
1349050|NCT01379287|Dose-Escalation|dose-escalation
1349051|NCT01379287|10-202|10-202
1349052|NCT01379274|MDS|mds
1349053|NCT01379274|Low risk disease|low risk disease
1349054|NCT01379274|IPSS|ipss
1349055|NCT01379261|STEMI|stemi
1349056|NCT01379261|primary PCI|primary pci
1349057|NCT01379261|Hypothermia|hypothermia
1349058|NCT01379261|Endovascular cooling|endovascular cooling
1349059|NCT01379261|Cardiac MRI|cardiac mri
1349187|NCT01378780|diet|diet
1349060|NCT01379235|independent 65 years old and above|independent 65 years old and above
1349061|NCT01379222|AAA|aaa
1349062|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1349063|NCT01379222|EVAR|evar
1349064|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
1349065|NCT01379209|AHSCT|ahsct
1349066|NCT01379209|Bone Marrow Transplant|bone marrow transplant
1349067|NCT01379209|Leukemia|leukemia
1349068|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
1349069|NCT01379209|hematological malignancies|hematological malignancies
1349070|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
1349071|NCT01379209|GvHD|gvhd
1349072|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1349073|NCT01379209|Stem Cell|stem cell
1349074|NCT01379209|Transplantation|transplantation
1349075|NCT01379196|Graves Orbitopathy|graves orbitopathy
1349076|NCT01379196|Macrolide antibiotics|macrolide antibiotics
1349077|NCT01379196|Inflammation|inflammation
1349078|NCT01379196|Clinical Activity Score|clinical activity score
1349079|NCT01379183|Healthy|healthy
1349080|NCT01379183|Men|men
1349081|NCT01379183|Women|women
1349082|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
1349083|NCT01379183|Aged between 18-70 years|aged between 18-70 years
1349084|NCT01379170|brown adipose tissue|brown adipose tissue
1349085|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
1349086|NCT01379170|insulin resistance|insulin resistance
1349087|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
1349088|NCT01379131|Manifestation|manifestation
1349089|NCT01379131|Coronary Heart Disease|coronary heart disease
1349090|NCT01379131|Myocardial infarction|myocardial infarction
1349091|NCT01379131|Angina pectoris|angina pectoris
1349092|NCT01379131|Unheralded|unheralded
1349093|NCT01379131|General Practice Research Database|general practice research database
1349094|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1349095|NCT01379131|CALIBER|caliber
1349096|NCT01379118|Total knee replacement|total knee replacement
1349097|NCT01379105|Electromyography|electromyography
1349098|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
1349099|NCT01379105|Neuromuscular agents|neuromuscular agents
1349100|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
1349101|NCT01379092|Radiography|radiography
1349102|NCT01379092|Breast Specimen Imaging|breast specimen imaging
1349103|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
1349104|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
1349105|NCT01379066|Electronic nose|electronic nose
1349106|NCT01379066|Gas chromatography|gas chromatography
1349107|NCT01379053|Staphylococcus aureus|staphylococcus aureus
1349108|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
1349109|NCT01379053|Nosocomial disease|nosocomial disease
1349110|NCT01379053|Electronic nose|electronic nose
1349111|NCT01379053|Gas chromatography|gas chromatography
1349112|NCT01379040|Cystic Fibrosis|cystic fibrosis
1349113|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
1349114|NCT01379040|Volatile Organic Compounds|volatile organic compounds
1349115|NCT01379040|Electronic nose|electronic nose
1349116|NCT01379040|Gas Chromatography|gas chromatography
1349117|NCT01379027|Depression|depression
1349118|NCT01379027|Website intervention|website intervention
1349119|NCT01379027|CBT|cbt
1349120|NCT01379014|Decisional conflict|decisional conflict
1349121|NCT01379014|Disclosure|disclosure
1349122|NCT01379014|Mental Health history|mental health history
1349123|NCT01379014|Mental health service users|mental health service users
1349124|NCT01379014|Decision Aid Tool|decision aid tool
1349125|NCT01379014|Vocational Specialists|vocational specialists
1349126|NCT01379001|cholinergic function|cholinergic function
1349127|NCT01379001|aging|aging
1349128|NCT01379001|pharmacologic MRI|pharmacologic mri
1349129|NCT01378949|pain score|pain score
1349130|NCT01378936|criminal behavior|criminal behavior
1349131|NCT01378936|substance abuse|substance abuse
1349132|NCT01378936|HIV risk behavior|hiv risk behavior
1349133|NCT01378936|criminogenic thinking|criminogenic thinking
1349134|NCT01378936|shame|shame
1349135|NCT01378936|guilt|guilt
1349136|NCT01378936|empathy|empathy
1349137|NCT01378936|jail inmates|jail inmates
1349138|NCT01378936|restorative justice|restorative justice
1349139|NCT01378936|crime|crime
1349140|NCT01378923|Mindfulness|mindfulness
1349141|NCT01378923|Values|values
1349142|NCT01378923|Jail Inmates|jail inmates
1349143|NCT01378923|Impulsivity|impulsivity
1349144|NCT01378923|Substance Abuse|substance abuse
1349145|NCT01378923|HIV risk behavior|hiv risk behavior
1349146|NCT01378923|Anxiety|anxiety
1349147|NCT01378923|Depression|depression
1349148|NCT01378923|Criminogenic Thinking|criminogenic thinking
1349149|NCT01378910|HIV|hiv
1349150|NCT01378910|TROPISM|tropism
1349151|NCT01378910|PBMC|pbmc
1349152|NCT01378910|GENOTYPE|genotype
1349153|NCT01378910|454 SEQUENCING|454 sequencing
1349154|NCT01378897|bariatric surgery|bariatric surgery
1349155|NCT01378897|gastric bypass surgery|gastric bypass surgery
1349156|NCT01378884|Gastroparesis|gastroparesis
1349157|NCT01378884|Domperidone|domperidone
1349158|NCT01378884|Motilium|motilium
1349160|NCT01378871|T-Cell|t-cell
1349161|NCT01378871|Leukemia|leukemia
1349162|NCT01378871|Lymphoma|lymphoma
1349163|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
1349164|NCT01378871|ATL|atl
1349165|NCT01378858|Smoking|smoking
1349166|NCT01378858|Substance-Related Disorders|substance-related disorders
1349167|NCT01378858|medication adherence|medication adherence
1349168|NCT01378858|Methadone|methadone
1349169|NCT01378845|Morbus Raynaud|morbus raynaud
1349170|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
1349171|NCT01378845|Vasospastic disorder|vasospastic disorder
1349172|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
1349173|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
1349174|NCT01378832|wound infection|wound infection
1349175|NCT01378832|colorectal surgery|colorectal surgery
1349176|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1349177|NCT01378819|Postoperative pain|postoperative pain
1349178|NCT01378806|overweight|overweight
1349179|NCT01378806|obesity|obesity
1349180|NCT01378806|adults|adults
1349181|NCT01378806|children|children
1349182|NCT01378793|Acupressure|acupressure
1349183|NCT01378793|Insomnia|insomnia
1349184|NCT01378793|Sleep Disorders|sleep disorders
1349185|NCT01378780|Stroke|stroke
1349186|NCT01378780|hypertension|hypertension
1349188|NCT01378780|sodium|sodium
1349189|NCT01378780|physical activity|physical activity
1349190|NCT01378767|Dietary restriction|dietary restriction
1349191|NCT01378767|oxidative stress|oxidative stress
1349192|NCT01378767|fasting|fasting
1349193|NCT01378754|hydrodilation|hydrodilation
1349194|NCT01378754|general anesthetic|general anesthetic
1349196|NCT01378741|cardiac surgery|cardiac surgery
1349197|NCT01378741|postoperative sedation|postoperative sedation
1349198|NCT01378728|Optical imaging|optical imaging
1349199|NCT01378728|Fluorescence imaging|fluorescence imaging
1349200|NCT01378728|Chronic and acute wounds|chronic and acute wounds
1349201|NCT01378728|Wound bacteria|wound bacteria
1349202|NCT01378728|Bacterial biofilms|bacterial biofilms
1349203|NCT01378728|Pathogenic bacteria|pathogenic bacteria
1349204|NCT01378728|Microorganisms|microorganisms
1349205|NCT01378728|Wound infection|wound infection
1349206|NCT01378728|Wound healing|wound healing
1349207|NCT01378728|Treatment response assessment|treatment response assessment
1349208|NCT01378715|coronary artery disease|coronary artery disease
1349209|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
1349210|NCT01378715|statins|statins
1349211|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
1349212|NCT01378702|Mistletoe|mistletoe
1349213|NCT01378702|Anthroposophical medicine|anthroposophical medicine
1349214|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
1349215|NCT01378663|Postoperative pain management|postoperative pain management
1349216|NCT01378650|Tinnitus|tinnitus
1349217|NCT01378650|Medication therapy management|medication therapy management
1349218|NCT01378650|Cilostazol|cilostazol
1349219|NCT01378650|Antiplatelet agents|antiplatelet agents
1349220|NCT01378637|Leg|leg
1349221|NCT01378637|Robotic device|robotic device
1349222|NCT01378637|AMES|ames
1349223|NCT01378637|Stroke|stroke
1349224|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
1349225|NCT01378637|Rehabilitation|rehabilitation
1349226|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
1349227|NCT01378611|VNS|vns
1349228|NCT01378611|immune system|immune system
1349229|NCT01378598|erlotinib|erlotinib
1349230|NCT01378598|educational intervention|educational intervention
1349231|NCT01378598|direct care nurse|direct care nurse
1349232|NCT01378585|DLBS1033|dlbs1033
1349233|NCT01378585|safety|safety
1349234|NCT01378585|fibrinolytic|fibrinolytic
1349235|NCT01378585|fibrinogenolytic|fibrinogenolytic
1349236|NCT01378585|antiplatelet|antiplatelet
1349237|NCT01378572|ICD|icd
1349238|NCT01378572|sudden cardiac death|sudden cardiac death
1349239|NCT01378572|mapping|mapping
1349240|NCT01378559|Penis prosthesis|penis prosthesis
1349241|NCT01378559|Titan|titan
1349242|NCT01378559|Satisfaction|satisfaction
1349243|NCT01378559|Complications|complications
1349244|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
1349245|NCT01378533|dose-dense|dose-dense
1349246|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
1349247|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
1349248|NCT01378533|3 years DFS|3 years dfs
1349249|NCT01378533|the tolerance|the tolerance
1349250|NCT01378520|breathlessness|breathlessness
1349251|NCT01378520|resistive load breathing|resistive load breathing
1349252|NCT01378520|beta-endorphins|beta-endorphins
1349253|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
1349254|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
1349255|NCT01378494|osteoporosis|osteoporosis
1349256|NCT01378494|bone|bone
1349257|NCT01378494|HIV|hiv
1349258|NCT01378494|antiretrovirals|antiretrovirals
1349259|NCT01378494|inflammation|inflammation
1349260|NCT01378455|handwriting|handwriting
1349261|NCT01378455|cerebral palsy|cerebral palsy
1349262|NCT01378455|visual perception|visual perception
1349263|NCT01378455|sensory function|sensory function
1349264|NCT01378455|motor function|motor function
1349265|NCT01378455|computerized handwriting programs|computerized handwriting programs
1349266|NCT01378442|Cerebral palsy|cerebral palsy
1349267|NCT01378442|bone density|bone density
1349268|NCT01378442|bone strength|bone strength
1349269|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
1349270|NCT01378429|PAR|par
1349271|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
1349272|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
1349273|NCT01378416|cancer|cancer
1349274|NCT01378403|Schizophrenia|schizophrenia
1349275|NCT01378403|Cognitive deficites|cognitive deficites
1349276|NCT01378403|Degraded objects|degraded objects
1349277|NCT01378403|Magnocellular pathway|magnocellular pathway
1349278|NCT01378390|Complex perianal fistula|complex perianal fistula
1349279|NCT01378390|Crohn disease|crohn disease
1349280|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
1349281|NCT01378390|Liposuction|liposuction
1349282|NCT01378377|MEK inhibitor|mek inhibitor
1349283|NCT01378377|Temsirolimus|temsirolimus
1349284|NCT01378377|Solid Tumor|solid tumor
1349285|NCT01378377|Phase I|phase i
1349286|NCT01378377|Pimasertib|pimasertib
1349287|NCT01378338|GERD|gerd
1349288|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
1349289|NCT01378338|Rate of complete resolution|rate of complete resolution
1349290|NCT01378338|rate of recurrence|rate of recurrence
1349291|NCT01378338|QOL|qol
1349390|NCT01378039|Treatment response|treatment response
1349391|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1349392|NCT01378026|G72|g72
1349292|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
1349293|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
1349294|NCT01378325|spinal|spinal
1349295|NCT01378325|cesarean delivery|cesarean delivery
1349296|NCT01378325|phenylephrine|phenylephrine
1349297|NCT01378325|hypotension|hypotension
1349298|NCT01378312|vaccine|vaccine
1349299|NCT01378312|TB|tb
1349300|NCT01378312|tuberculosis|tuberculosis
1349301|NCT01378299|testosterone|testosterone
1349302|NCT01378273|neuroprotection|neuroprotection
1349303|NCT01378273|erythropoietin|erythropoietin
1349304|NCT01378273|Epo|epo
1349305|NCT01378273|ELGANs|elgans
1349306|NCT01378273|preterm|preterm
1349307|NCT01378273|neonate|neonate
1349308|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
1349309|NCT01378260|Claudication|claudication
1349310|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
1349311|NCT01378260|PAD Study|pad study
1349313|NCT01378260|atherosclerosis|atherosclerosis
1349314|NCT01378260|Intermittent claudication|intermittent claudication
1349315|NCT01378260|leg pain|leg pain
1349316|NCT01378247|Heart Failure|heart failure
1349317|NCT01378247|Family Nursing|family nursing
1349318|NCT01378247|Health-Related Quality of Life|health-related quality of life
1349319|NCT01378247|Heart Failure Clinic|heart failure clinic
1349320|NCT01378221|vitamin D|vitamin d
1349321|NCT01378221|cardiac surgery|cardiac surgery
1349322|NCT01378221|inflammation|inflammation
1349323|NCT01378221|immune system|immune system
1349324|NCT01378221|age|age
1349325|NCT01378208|Intermittent fasting|intermittent fasting
1349326|NCT01378208|Meal frequency|meal frequency
1349327|NCT01378208|body composition|body composition
1349328|NCT01378208|cognitive function|cognitive function
1349329|NCT01378208|glucose metabolism|glucose metabolism
1349330|NCT01378195|Alzheimer's Disease|alzheimer's disease
1349331|NCT01378195|Dementia|dementia
1349332|NCT01378195|caregiving|caregiving
1349333|NCT01378195|caregiver|caregiver
1349334|NCT01378195|coping|coping
1349335|NCT01378195|coping with caregiving|coping with caregiving
1349336|NCT01378195|stress|stress
1349337|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
1349338|NCT01378182|Wilson's Disease|wilson's disease
1349339|NCT01378169|SIRS|sirs
1349340|NCT01378169|Sepsis|sepsis
1349341|NCT01378169|Severe Sepsis|severe sepsis
1349342|NCT01378169|Septic Shock|septic shock
1349343|NCT01378169|Inflammatory processes|inflammatory processes
1349344|NCT01378169|Cytokines|cytokines
1349345|NCT01378169|HLA-DR|hla-dr
1349346|NCT01378169|HLA type II|hla type ii
1349347|NCT01378169|Chemokines|chemokines
1349348|NCT01378169|TLR expression|tlr expression
1349349|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
1349350|NCT01378169|Bacterial DNA detection|bacterial dna detection
1349351|NCT01378169|Prognosis factors|prognosis factors
1349352|NCT01378169|Infection|infection
1349353|NCT01378169|Diagnosis|diagnosis
1349354|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
1349355|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
1349356|NCT01378156|Treatment interruption|treatment interruption
1349357|NCT01378143|Colorectal Cancer|colorectal cancer
1349358|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
1349359|NCT01378143|OCZ103-OS|ocz103-os
1349360|NCT01378143|Standard of Care|standard of care
1349361|NCT01378130|CCS|ccs
1349362|NCT01378130|CSC|csc
1349363|NCT01378130|Subretinal Fluid|subretinal fluid
1349364|NCT01378130|multimodal imaging|multimodal imaging
1349365|NCT01378117|diabetes|diabetes
1349366|NCT01378117|non critical care setting|non critical care setting
1349367|NCT01378117|hyperglycemia|hyperglycemia
1349368|NCT01378117|treatment|treatment
1349369|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
1349370|NCT01378117|subcutaneous insulin|subcutaneous insulin
1349371|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
1349372|NCT01378104|chronic hepatitis c|chronic hepatitis c
1349373|NCT01378104|Koreans|koreans
1349374|NCT01378104|IL28B polymorphism|il28b polymorphism
1349375|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
1349376|NCT01378078|schizophrenia|schizophrenia
1349377|NCT01378078|negative syndrome|negative syndrome
1349378|NCT01378078|PANSS|panss
1349379|NCT01378065|POP|pop
1349380|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
1349381|NCT01378065|anterior prolapse|anterior prolapse
1349382|NCT01378065|posterior prolapse|posterior prolapse
1349383|NCT01378065|vaginal prolapse|vaginal prolapse
1349384|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
1349385|NCT01378039|COPD|copd
1349386|NCT01378039|Asthma|asthma
1349387|NCT01378039|Pathophysiology|pathophysiology
1349388|NCT01378039|Genetics|genetics
1349389|NCT01378039|Phenotype|phenotype
1349394|NCT01378013|Metabonomics|metabonomics
1349395|NCT01378013|Systems biology|systems biology
1349396|NCT01378013|Intelligent knife|intelligent knife
1349397|NCT01378013|Colorectal cancer|colorectal cancer
1349398|NCT01378013|NMR|nmr
1349399|NCT01378013|Mass spectrometry|mass spectrometry
1349400|NCT01377974|Leishmaniasis|leishmaniasis
1349401|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
1349402|NCT01377974|Therapeutics|therapeutics
1349403|NCT01377974|meglumine antimoniate|meglumine antimoniate
1349404|NCT01377974|miltefosine|miltefosine
1349405|NCT01377948|Anger|anger
1349406|NCT01377948|Aggression|aggression
1349407|NCT01377948|CBT|cbt
1349408|NCT01377948|Videogame|videogame
1349409|NCT01377948|biofeedback|biofeedback
1349410|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
1349411|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
1349412|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
1349413|NCT01377844|Diabetes mellitus|diabetes mellitus
1349414|NCT01377818|COPD|copd
1349415|NCT01377818|Exercise trainig|exercise trainig
1349416|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
1349417|NCT01377792|hypertonic saline|hypertonic saline
1349418|NCT01377792|cystic fibrosis|cystic fibrosis
1349419|NCT01377792|pulmonary inflammation|pulmonary inflammation
1349420|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
1349421|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
1349422|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
1349423|NCT01377779|Intra uterine adhesions|intra uterine adhesions
1349424|NCT01377766|Bell's palsy|bell's palsy
1349425|NCT01377766|psychological stress|psychological stress
1349426|NCT01377766|personality factors|personality factors
1349427|NCT01377766|psychological factors|psychological factors
1349428|NCT01377753|Toxicity|toxicity
1349429|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
1349430|NCT01377753|Localized Prostate Cancer|localized prostate cancer
1349431|NCT01377753|Laser Ablation|laser ablation
1349432|NCT01377753|PSA Levels|psa levels
1349433|NCT01377753|Prostate Cancer|prostate cancer
1349434|NCT01377740|Lipolysis|lipolysis
1349435|NCT01377740|Cryolipolysis|cryolipolysis
1349436|NCT01377740|Fat Reduction|fat reduction
1349437|NCT01377701|pituitary adenomas|pituitary adenomas
1349438|NCT01377701|recovery of vision|recovery of vision
1349439|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
1349440|NCT01377688|DKD|dkd
1349441|NCT01377636|Isoproterenol|isoproterenol
1349442|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
1349443|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
1349444|NCT01377623|Spinal fusion|spinal fusion
1349445|NCT01377623|Inflammatory response|inflammatory response
1349446|NCT01377623|Inflammatory markers|inflammatory markers
1349447|NCT01377623|Dexmedetomidine|dexmedetomidine
1349448|NCT01377610|Outpatient detoxification|outpatient detoxification
1349449|NCT01377610|Opioid dependence|opioid dependence
1349450|NCT01377610|Naltrexone|naltrexone
1463862|NCT00913835|3G3|3g3
1349451|NCT01377610|Vivitrol|vivitrol
1349452|NCT01377610|Buprenorphine|buprenorphine
1349453|NCT01377597|retinal vein occlusion|retinal vein occlusion
1349454|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
1349455|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
1349456|NCT01377597|visual impairment|visual impairment
1349457|NCT01377597|macular edema|macular edema
1349458|NCT01377597|ranibizumab|ranibizumab
1349459|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
1349460|NCT01377584|Patient Compliance|patient compliance
1349461|NCT01377584|Intervention Studies|intervention studies
1349462|NCT01377584|Spouses|spouses
1349463|NCT01377571|diarrhea|diarrhea
1349464|NCT01377571|fever|fever
1349465|NCT01377571|nausea|nausea
1349466|NCT01377571|vomit|vomit
1349467|NCT01377571|irritability|irritability
1349468|NCT01377558|aerobic training|aerobic training
1349469|NCT01377558|resistance training|resistance training
1349470|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
1349471|NCT01377558|diabetes|diabetes
1349472|NCT01377558|type 2 diabetes|type 2 diabetes
1349473|NCT01377558|HbA1c|hba1c
1349474|NCT01377558|endothelial dysfunction|endothelial dysfunction
1349475|NCT01377558|inflammation markers|inflammation markers
1349476|NCT01377558|Parodontitis|parodontitis
1349477|NCT01377558|Exercise intervention|exercise intervention
1349478|NCT01377558|training|training
1349479|NCT01377545|Infraclavicular|infraclavicular
1349480|NCT01377545|Nerve Block|nerve block
1349481|NCT01377545|Needle|needle
1349482|NCT01377545|Perineural Catheter|perineural catheter
1349483|NCT01377545|Volunteer|volunteer
1349484|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
1349485|NCT01377545|Sensation|sensation
1349486|NCT01377545|Strength|strength
1349487|NCT01377532|Pheochromocytoma|pheochromocytoma
1349488|NCT01377532|Paraganglioma|paraganglioma
1349489|NCT01377532|MIBG|mibg
1349490|NCT01377532|131I-MIBG|131i-mibg
1349491|NCT01377532|Resistant|resistant
1349492|NCT01377532|Relapsed|relapsed
1349493|NCT01377532|Treatment|treatment
1349494|NCT01377532|UCSF|ucsf
1349495|NCT01377532|Pediatric|pediatric
1349496|NCT01377532|Adult|adult
1349497|NCT01377532|Oncology|oncology
1349498|NCT01377519|Fibroids|fibroids
1349499|NCT01377519|Uterine|uterine
1349500|NCT01377519|Focused Ultrasound|focused ultrasound
1349501|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
1349502|NCT01377519|HIFU|hifu
1349503|NCT01377519|NOninvasive|noninvasive
1349504|NCT01377519|Treatment|treatment
1349505|NCT01377506|behavioral weight control|behavioral weight control
1349506|NCT01377506|lifestyle intervention|lifestyle intervention
1349507|NCT01377506|memory training|memory training
1349508|NCT01377506|cognitive training|cognitive training
1349509|NCT01377506|community-based|community-based
1349510|NCT01377493|chewing-gum|chewing-gum
1349511|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
1349512|NCT01377493|calcium additives|calcium additives
1349513|NCT01377493|fluoride|fluoride
1349514|NCT01377493|in situ|in situ
1349515|NCT01377467|Osteoporosis|osteoporosis
1349516|NCT01377467|Osteopenia|osteopenia
1349517|NCT01377467|Denosumab|denosumab
1349518|NCT01377467|Transplantation|transplantation
1349519|NCT01377467|Kidney|kidney
1349520|NCT01377454|mTBI|mtbi
1349521|NCT01377454|concussion|concussion
1349522|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
1349523|NCT01377454|balance|balance
1349524|NCT01377454|sensors|sensors
1349525|NCT01377441|Ibuprofen|ibuprofen
1349526|NCT01377441|Cytokines|cytokines
1349527|NCT01377441|Recovery|recovery
1349528|NCT01377441|IV ibuprofen|iv ibuprofen
1349529|NCT01377441|major surgery|major surgery
1349530|NCT01377428|COPD|copd
1349531|NCT01377428|Indacaterol|indacaterol
1349532|NCT01377428|Formoterol|formoterol
1349533|NCT01377415|arthroscopy|arthroscopy
1349534|NCT01377415|shoulder surgery|shoulder surgery
1349535|NCT01377415|subacromial|subacromial
1349536|NCT01377415|continuous bupivacaine|continuous bupivacaine
1349537|NCT01377389|Prostate cancer|prostate cancer
1349538|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
1349539|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
1349540|NCT01377389|Androgen deprivation therapy|androgen deprivation therapy
1349541|NCT01377389|ADT|adt
1349542|NCT01377389|Prostate-specific antigen|prostate-specific antigen
1349543|NCT01377389|PSA|psa
1349544|NCT01377389|Ipilimumab|ipilimumab
1349545|NCT01377389|Yervoy|yervoy
1349546|NCT01377389|BMS-734016|bms-734016
1349547|NCT01377389|MDX010|mdx010
1349548|NCT01377389|Leuprolide|leuprolide
1349549|NCT01377389|Lupron Depot|lupron depot
1349550|NCT01377389|Leuprolide Acetate|leuprolide acetate
1349551|NCT01377389|Goserelin|goserelin
1349552|NCT01377389|Zoladex|zoladex
1349553|NCT01377389|Degarelix|degarelix
1349554|NCT01377389|Firmagon|firmagon
1349555|NCT01377363|metastatic breast cancer|metastatic breast cancer
1349556|NCT01377363|primary breast cancer|primary breast cancer
1349557|NCT01377350|Heart failure|heart failure
1349558|NCT01377350|monitoring|monitoring
1349559|NCT01377337|cardiac arrest|cardiac arrest
1349560|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1349561|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
1349562|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
1349563|NCT01377337|outcome|outcome
1349564|NCT01377324|Breast cancer|breast cancer
1349565|NCT01377324|Fulvestrant|fulvestrant
1349566|NCT01377324|FES|fes
1349567|NCT01377324|PET|pet
1349568|NCT01377324|Positron|positron
1349569|NCT01377324|Emission|emission
1349570|NCT01377324|Tomography|tomography
1349571|NCT01377324|Fluoroestradiol|fluoroestradiol
1349572|NCT01377324|FES-PET|fes-pet
1349573|NCT01377324|Molecular Imaging|molecular imaging
1349574|NCT01377324|Estrogen Receptor|estrogen receptor
1349575|NCT01377311|limbal stem cell|limbal stem cell
1349576|NCT01377311|amniotic membrane|amniotic membrane
1349577|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
1349578|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
1349579|NCT01377285|chronic kidney disease|chronic kidney disease
1349580|NCT01377285|pentoxifylline|pentoxifylline
1349581|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
1349582|NCT01377272|HIV/AIDS|hiv/aids
1349583|NCT01377272|spatial epidemiology|spatial epidemiology
1349584|NCT01377272|geographic information system|geographic information system
1349585|NCT01377272|HIV-infection/Aids|hiv-infection/aids
1349586|NCT01377259|changes|changes
1349587|NCT01377259|tissue|tissue
1349588|NCT01377259|oxygenation|oxygenation
1349589|NCT01377259|saturation|saturation
1349590|NCT01377259|between|between
1349591|NCT01377259|upper|upper
1349592|NCT01377259|lower|lower
1349593|NCT01377259|extremities|extremities
1349594|NCT01377259|patients|patients
1349595|NCT01377259|Adverse Effect|adverse effect
1349596|NCT01377259|Spinal and Epidural|spinal and epidural
1349597|NCT01377246|Somatostatin.|somatostatin.
1349598|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
1349599|NCT01377246|Renal insufficiency.|renal insufficiency.
1349600|NCT01377233|Schizophrenia|schizophrenia
1349601|NCT01377233|Antipsychotic|antipsychotic
1349602|NCT01377233|Zicronapine|zicronapine
1349603|NCT01377233|Lu 31-310|lu 31-310
1349604|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
1349605|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
1349606|NCT01377220|11C-Choline|11c-choline
1349607|NCT01377220|alpha fetoprotein|alpha fetoprotein
1349707|NCT01376791|Native Americans|native americans
1349608|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
1349609|NCT01377220|Abdomen computed tomography|abdomen computed tomography
1349610|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
1349611|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
1349612|NCT01377207|Optical Coherence Tomography|optical coherence tomography
1349613|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
1349614|NCT01377207|Thrombus hystopathology|thrombus hystopathology
1349615|NCT01377207|Gender differences|gender differences
1349616|NCT01377194|Depression|depression
1349617|NCT01377194|Major Depressive Disorder|major depressive disorder
1349618|NCT01377181|Inguinal hernia|inguinal hernia
1349619|NCT01377181|Laparoscope|laparoscope
1349620|NCT01377181|Lateral us ligament|lateral us ligament
1349621|NCT01377181|Recurrence|recurrence
1349622|NCT01377181|Pediatric|pediatric
1349623|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
1349624|NCT01377155|basal insulin|basal insulin
1349625|NCT01377155|hypoglycemia|hypoglycemia
1349626|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
1349627|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
1349628|NCT01377142|hysteropexy|hysteropexy
1349629|NCT01377142|mesh|mesh
1349630|NCT01377129|Residual Rotational Laxity|residual rotational laxity
1349631|NCT01377103|heart failure|heart failure
1349632|NCT01377103|hypogonadism|hypogonadism
1349633|NCT01377103|testosterone|testosterone
1349634|NCT01377077|vitiligo|vitiligo
1349635|NCT01377077|piebaldism|piebaldism
1349636|NCT01377077|punchgrafting|punchgrafting
1349637|NCT01377077|minigrafting|minigrafting
1349638|NCT01377077|stable for at least 12 months|stable for at least 12 months
1349640|NCT01377064|physical activity|physical activity
1349641|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
1349642|NCT01377051|COPD|copd
1349643|NCT01377051|Inspiratory capacity|inspiratory capacity
1349644|NCT01377051|Residual volume|residual volume
1349645|NCT01377051|Total lung resistance|total lung resistance
1349646|NCT01377051|Arterial Oxygen|arterial oxygen
1349647|NCT01377038|Osteoarthritis|osteoarthritis
1349648|NCT01377038|Chronic pain|chronic pain
1349649|NCT01377038|Central pain|central pain
1349650|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
1349651|NCT01377012|RA|ra
1349652|NCT01377012|ACR|acr
1349653|NCT01377012|inflammatory joints|inflammatory joints
1349654|NCT01376999|Sterility|sterility
1349655|NCT01376999|FSH-r|fsh-r
1349656|NCT01376999|intrauterine insemination|intrauterine insemination
1349657|NCT01376999|unexplained sterility|unexplained sterility
1349658|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
1349659|NCT01376960|forefoot surgery|forefoot surgery
1349660|NCT01376960|Ankle Block|ankle block
1349661|NCT01376960|Popliteal Fossa Block|popliteal fossa block
1349662|NCT01376947|IUD device insertion|iud device insertion
1349663|NCT01376947|Nulliparous|nulliparous
1349664|NCT01376947|Multiparous|multiparous
1349665|NCT01376947|Pain|pain
1349666|NCT01376934|hysteroscopy|hysteroscopy
1349667|NCT01376934|saline solution|saline solution
1349668|NCT01376934|carbon dioxide|carbon dioxide
1349669|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
1349670|NCT01376921|Growth disorders|growth disorders
1349671|NCT01376921|Saizen|saizen
1349672|NCT01376921|Easypod|easypod
1349673|NCT01376921|Growth hormone|growth hormone
1349674|NCT01376921|Pediatric subject|pediatric subject
1349675|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
1349676|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
1349677|NCT01376908|Phe-restricted diet|phe-restricted diet
1349678|NCT01376908|Paediatric <4 years old|paediatric <4 years old
1349679|NCT01376908|responders to BH4|responders to bh4
1349680|NCT01376908|Phe tolerance|phe tolerance
1349681|NCT01376895|Black MSM/W|black msm/w
1349682|NCT01376895|HIV|hiv
1349683|NCT01376882|Caffeine|caffeine
1349684|NCT01376882|Withdrawal|withdrawal
1349685|NCT01376882|Cognitive function|cognitive function
1349686|NCT01376882|Mood|mood
1349687|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
1349688|NCT01376869|Hops|hops
1349689|NCT01376869|Mood|mood
1349690|NCT01376869|Cognitive Function|cognitive function
1349691|NCT01376869|Bioavailability|bioavailability
1349692|NCT01376869|Satiety|satiety
1349693|NCT01376869|Blood Pressure|blood pressure
1349694|NCT01376869|Heart rate|heart rate
1349695|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
1349696|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
1349697|NCT01376830|COPD|copd
1349698|NCT01376830|Exacerbations|exacerbations
1349699|NCT01376830|Viruses|viruses
1349700|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
1349701|NCT01376817|total parenteral nutrition|total parenteral nutrition
1349702|NCT01376817|fat emulsions|fat emulsions
1349703|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
1349704|NCT01376791|Periodontal disease|periodontal disease
1349705|NCT01376791|Atherosclerosis|atherosclerosis
1349706|NCT01376791|Oral Pathogens|oral pathogens
1349708|NCT01376791|Inflammatory cytokines|inflammatory cytokines
1349709|NCT01376791|Microbial metagenomics|microbial metagenomics
1349710|NCT01376778|Perinatology|perinatology
1349711|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
1349712|NCT01376778|Cytogam|cytogam
1349713|NCT01376778|CMVIG infusions|cmvig infusions
1349714|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
1349715|NCT01376739|Magnevist|magnevist
1349716|NCT01376739|MR angiography|mr angiography
1349717|NCT01376713|Melanoma|melanoma
1349718|NCT01376687|Osteopathic Medicine|osteopathic medicine
1349719|NCT01376687|Cervical Spine|cervical spine
1349720|NCT01376687|Kinetics|kinetics
1349721|NCT01376674|localised|localised
1349722|NCT01376674|prostate cancer|prostate cancer
1349723|NCT01376674|radiotherapy|radiotherapy
1349724|NCT01376674|immunology|immunology
1349725|NCT01376661|Prostate Cancer|prostate cancer
1349726|NCT01376661|Active Surveillance|active surveillance
1349727|NCT01376661|Low risk prostate cancer|low risk prostate cancer
1349728|NCT01376635|Chronic Kidney Disease|chronic kidney disease
1349729|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
1349730|NCT01376609|Stroke|stroke
1349731|NCT01376609|Ischaemic Stroke|ischaemic stroke
1349732|NCT01376609|Cerebral Infarction|cerebral infarction
1349733|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
1349734|NCT01376609|Brain Diseases|brain diseases
1349735|NCT01376609|Nervous System Diseases|nervous system diseases
1349736|NCT01376609|Vascular Diseases|vascular diseases
1349737|NCT01376609|Brain Infarction|brain infarction
1349738|NCT01376609|Brain Ischemia|brain ischemia
1349739|NCT01376609|mismatch|mismatch
1349740|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
1349741|NCT01376609|ischaemic penumbra|ischaemic penumbra
1349742|NCT01376609|image analysis|image analysis
1349743|NCT01376596|Remission|remission
1349744|NCT01376596|Psychosocial Functioning|psychosocial functioning
1349745|NCT01376596|Symptoms reduction|symptoms reduction
1349746|NCT01376583|Breast cancer|breast cancer
1349747|NCT01376583|Exercise|exercise
1349748|NCT01376583|Myokines|myokines
1349749|NCT01376583|AMPK|ampk
1349750|NCT01376570|HIV|hiv
1349751|NCT01376570|Opiate dependence|opiate dependence
1349752|NCT01376570|Opiate replacement therapy|opiate replacement therapy
1349753|NCT01376570|Cocaine-related disorders|cocaine-related disorders
1349754|NCT01376570|Risk Reduction Behavior|risk reduction behavior
1349755|NCT01376570|Medication Adherence|medication adherence
1349756|NCT01376570|Motivation|motivation
1349757|NCT01376557|diabetes mellitus|diabetes mellitus
1349758|NCT01376544|Neonate|neonate
1349759|NCT01376544|Weaning|weaning
1349760|NCT01376544|Assist control ventilation|assist control ventilation
1349761|NCT01376544|Pressure support ventilation|pressure support ventilation
1349762|NCT01376531|acute renal failure|acute renal failure
1349763|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
1349764|NCT01376531|transcranial Doppler|transcranial doppler
1349765|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
1349766|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
1349767|NCT01376518|acute lung injury|acute lung injury
1349768|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
1349769|NCT01376518|transcranial Doppler|transcranial doppler
1349770|NCT01376518|ventilation|ventilation
1349771|NCT01376505|Vaccine Therapy|vaccine therapy
1349772|NCT01376492|Schizophrenia|schizophrenia
1349773|NCT01376492|Sleep disturbances|sleep disturbances
1349774|NCT01376492|Quality of sleep|quality of sleep
1349775|NCT01376492|Functioning level|functioning level
1349776|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
1349777|NCT01376479|HFMD|hfmd
1349778|NCT01376479|EV71|ev71
1349779|NCT01376479|Enterovirus|enterovirus
1349780|NCT01376479|INV21|inv21
1349781|NCT01376479|Encephalitis|encephalitis
1349782|NCT01376466|acute appendicitis|acute appendicitis
1349783|NCT01376466|diagnosis|diagnosis
1349784|NCT01376466|computed tomography|computed tomography
1349785|NCT01376453|External Radiation Therapy|external radiation therapy
1349786|NCT01376453|Locally Advanced Rectal|locally advanced rectal
1349787|NCT01376453|Adenocarcinoma|adenocarcinoma
1349788|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
1349789|NCT01376414|dyspepsia|dyspepsia
1349790|NCT01376414|abdominal|abdominal
1349791|NCT01376414|pain|pain
1349792|NCT01376414|helicobacter|helicobacter
1349793|NCT01376414|pylori|pylori
1349794|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
1350102|NCT01375088|cancer|cancer
1349795|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
1349796|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
1349797|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
1349798|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1349799|NCT01376388|Pharmacogenetics|pharmacogenetics
1349800|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
1349801|NCT01376375|Acupuncture|acupuncture
1349802|NCT01376375|Low Back Pain|low back pain
1349803|NCT01376362|Cystoid Macular Edema|cystoid macular edema
1350013|NCT01375439|Pregnancy|pregnancy
1349804|NCT01376362|Intermediate Uveitis|intermediate uveitis
1349805|NCT01376362|Uveitis|uveitis
1349806|NCT01376362|OCT|oct
1349807|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
1349808|NCT01376349|depression|depression
1349809|NCT01376349|anxiety disorder|anxiety disorder
1349810|NCT01376349|cognitive/functional effects|cognitive/functional effects
1349811|NCT01376349|sexual dysfunction|sexual dysfunction
1349812|NCT01376349|cancer survivor|cancer survivor
1349813|NCT01376349|breast cancer|breast cancer
1349814|NCT01376349|cervical cancer|cervical cancer
1349815|NCT01376349|fallopian tube cancer|fallopian tube cancer
1349816|NCT01376349|uterine sarcoma|uterine sarcoma
1349817|NCT01376349|vaginal cancer|vaginal cancer
1349818|NCT01376349|vulvar cancer|vulvar cancer
1349819|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
1349820|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
1349821|NCT01376349|ovarian sarcoma|ovarian sarcoma
1349822|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
1349823|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1349824|NCT01376349|endometrial cancer|endometrial cancer
1349825|NCT01376336|environmental health|environmental health
1349826|NCT01376336|diarrhea|diarrhea
1349828|NCT01376336|HIV|hiv
1349829|NCT01376323|Safety|safety
1349830|NCT01376323|Dose Ranging|dose ranging
1349831|NCT01376323|Efficacy|efficacy
1349832|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
1349833|NCT01376258|acute urinary retention|acute urinary retention
1349834|NCT01376258|adherence|adherence
1349835|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
1349836|NCT01376258|enlarged prostate|enlarged prostate
1349837|NCT01376258|surgery|surgery
1349838|NCT01376232|Anaemia|anaemia
1349839|NCT01376232|Drug- Drug Interaction|drug- drug interaction
1349840|NCT01376219|GINA|gina
1349841|NCT01376219|direct / indirect costs|direct / indirect costs
1349842|NCT01376219|exacerbations|exacerbations
1349843|NCT01376219|European|european
1349844|NCT01376219|asthma control|asthma control
1349845|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
1349846|NCT01376102|osteoporosis|osteoporosis
1349847|NCT01376102|ibandronate|ibandronate
1349848|NCT01376089|Safety|safety
1349849|NCT01376076|schizophrenia|schizophrenia
1349850|NCT01376076|QTc|qtc
1349851|NCT01376076|cardiac repolarization|cardiac repolarization
1349852|NCT01376050|venous stasis ulcer|venous stasis ulcer
1349853|NCT01376050|leg ulcer|leg ulcer
1349854|NCT01376037|upper arm|upper arm
1349855|NCT01376037|body contouring|body contouring
1349856|NCT01376037|body shaping|body shaping
1349857|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
1349858|NCT01376024|Basal joint arthritis|basal joint arthritis
1349859|NCT01376024|CMC arthritis|cmc arthritis
1349860|NCT01376024|Osteoarthritis|osteoarthritis
1349861|NCT01376011|quercetin|quercetin
1349862|NCT01376011|brain blood flow|brain blood flow
1349863|NCT01376011|aging|aging
1349864|NCT01376011|memory|memory
1349865|NCT01375998|YAZ|yaz
1349866|NCT01375998|Dysmenorrhea|dysmenorrhea
1349867|NCT01375972|biliary cancer|biliary cancer
1349868|NCT01375972|systemic chemotherapy|systemic chemotherapy
1349869|NCT01375972|S-1|s-1
1349870|NCT01375972|gemcitabine|gemcitabine
1349871|NCT01375972|cisplatin|cisplatin
1349872|NCT01375959|resveratrol|resveratrol
1349873|NCT01375959|glucose intolerance|glucose intolerance
1349874|NCT01375959|insulin resistance|insulin resistance
1349875|NCT01375959|endothelial function|endothelial function
1349876|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
1349877|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
1349878|NCT01375933|Smoking|smoking
1349879|NCT01375933|NicVAX|nicvax
1349880|NCT01375933|Smoking vaccine|smoking vaccine
1349881|NCT01375920|Depression|depression
1349882|NCT01375920|Antiglucocorticoid|antiglucocorticoid
1349883|NCT01375920|Anti-depressants|anti-depressants
1349884|NCT01375907|blood cell counts|blood cell counts
1349885|NCT01375907|BUN|bun
1349886|NCT01375907|ALT|alt
1349887|NCT01375907|AST|ast
1349888|NCT01375907|diarrhea|diarrhea
1349889|NCT01375907|fever|fever
1349890|NCT01375907|vomit|vomit
1349891|NCT01375907|nausea|nausea
1349892|NCT01375907|loss of appetite|loss of appetite
1349893|NCT01375907|irritability|irritability
1349894|NCT01375881|HIV|hiv
1349895|NCT01375881|darunavir|darunavir
1349896|NCT01375881|ritonavir|ritonavir
1349897|NCT01375881|Prezista|prezista
1349898|NCT01375881|naive|naive
1349899|NCT01375881|experienced|experienced
1349900|NCT01375868|HPV|hpv
1349903|NCT01375855|Late stent malapposition|late stent malapposition
1349904|NCT01375855|stent thrombosis|stent thrombosis
1349905|NCT01375855|IVUS|ivus
1349906|NCT01375855|non-polimeric stent|non-polimeric stent
1349907|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
1349908|NCT01375816|recurrent colon cancer|recurrent colon cancer
1349909|NCT01375816|stage IV colon cancer|stage iv colon cancer
1349910|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1349911|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
1349912|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
1349913|NCT01375803|dietary fiber|dietary fiber
1349914|NCT01375803|fiber|fiber
1349915|NCT01375803|insulin sensitivity|insulin sensitivity
1349916|NCT01375803|insulin resistance|insulin resistance
1349917|NCT01375803|glucose metabolism|glucose metabolism
1349918|NCT01375790|whole-body vibration|whole-body vibration
1349919|NCT01375790|older people|older people
1349920|NCT01375790|exercise|exercise
1349921|NCT01375790|body balance|body balance
1349922|NCT01375790|muscle performance|muscle performance
1349923|NCT01375790|falls|falls
1349924|NCT01375790|physiotherapy|physiotherapy
1349925|NCT01375777|High cholesterol|high cholesterol
1349926|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
1349927|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
1349928|NCT01375777|Lowering cholesterol|lowering cholesterol
1349929|NCT01375777|Lowering high cholesterol|lowering high cholesterol
1349930|NCT01375777|Hypercholesterolemia|hypercholesterolemia
1349931|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
1349932|NCT01375764|Cholesterol|cholesterol
1349933|NCT01375764|High Cholesterol|high cholesterol
1349934|NCT01375764|Raised Cholesterol|raised cholesterol
1349935|NCT01375764|Elevated Cholesterol|elevated cholesterol
1349936|NCT01375764|Statin intolerant|statin intolerant
1349937|NCT01375764|Hypercholesterolemia|hypercholesterolemia
1349938|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1349939|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
1349940|NCT01375738|Early gastric cancer|early gastric cancer
1349941|NCT01375712|Hard or lumpy stools|hard or lumpy stools
1349942|NCT01375712|Stool consistency|stool consistency
1349943|NCT01375712|Stool frequency|stool frequency
1349944|NCT01375712|Constipation related symptoms|constipation related symptoms
1349945|NCT01375712|Constipation related quality of life|constipation related quality of life
1349946|NCT01375699|Breast cancer|breast cancer
1349947|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
1464451|NCT00911248|PTC299|ptc299
1349948|NCT01375699|Genitourinary cancer|genitourinary cancer
1349949|NCT01375699|Sarcoma|sarcoma
1349950|NCT01375699|Gynecologic cancer|gynecologic cancer
1349951|NCT01375686|Diabetes|diabetes
1349952|NCT01375673|Exercise|exercise
1349953|NCT01375673|Heart Failure|heart failure
1349954|NCT01375673|Mixed Effects Modeling|mixed effects modeling
1349955|NCT01375660|Vitamin D|vitamin d
1349956|NCT01375660|Glucose intolerance|glucose intolerance
1349957|NCT01375660|African American men|african american men
1349958|NCT01375647|Oral Vaccines|oral vaccines
1349959|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
1349960|NCT01375647|Tropical Enteropathy|tropical enteropathy
1349961|NCT01375634|Intubation|intubation
1349962|NCT01375634|Gastrointestinal|gastrointestinal
1349966|NCT01375608|Neutropenia|neutropenia
1349967|NCT01375608|Hemaglobin|hemaglobin
1349968|NCT01375608|Coagulation Disorders|coagulation disorders
1349969|NCT01375608|Thrombocytosis|thrombocytosis
1349970|NCT01375608|Red Blood Cells|red blood cells
1349971|NCT01375608|Sickle Cell Disease|sickle cell disease
1349972|NCT01375595|Working Memory|working memory
1349973|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
1349974|NCT01375595|Language|language
1349975|NCT01375595|Healthy Volunteer|healthy volunteer
1349976|NCT01375595|HV|hv
1349977|NCT01375582|Dry Eye|dry eye
1349978|NCT01375582|tear film|tear film
1349979|NCT01375582|lipid|lipid
1349980|NCT01375582|tear volume|tear volume
1349981|NCT01375582|environmental chamber|environmental chamber
1349982|NCT01375582|thermal imaging|thermal imaging
1349983|NCT01375569|CD105|cd105
1349984|NCT01375569|Monoclonal Antibody|monoclonal antibody
1349985|NCT01375569|Anti-Angiogenic|anti-angiogenic
1349986|NCT01375569|Chimeric|chimeric
1349987|NCT01375569|Apoptosis|apoptosis
1349988|NCT01375569|Liver Cancer|liver cancer
1349989|NCT01375556|Alcohol Clamp|alcohol clamp
1349990|NCT01375556|Pharmacogenetics|pharmacogenetics
1349991|NCT01375556|Family History of Alcoholism|family history of alcoholism
1349992|NCT01375556|Pharmacodynamics|pharmacodynamics
1349993|NCT01375556|Healthy Volunteer|healthy volunteer
1349994|NCT01375556|HV|hv
1349995|NCT01375543|Gene Identification|gene identification
1349996|NCT01375543|Genetics|genetics
1350203|NCT01374659|FDG-PET|fdg-pet
1349997|NCT01375543|Genetic Disorders|genetic disorders
1349998|NCT01375530|Prevention|prevention
1349999|NCT01375530|Vaccine|vaccine
1350000|NCT01375530|Immunity|immunity
1350001|NCT01375530|Evaluate|evaluate
1350002|NCT01375530|Screen|screen
1350003|NCT01375530|Healthy Volunteer|healthy volunteer
1350004|NCT01375530|HV|hv
1350005|NCT01375504|Obesity|obesity
1350006|NCT01375504|Body Mass Index|body mass index
1350007|NCT01375504|Mindfulness Training|mindfulness training
1350008|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
1350009|NCT01375491|doxycycline|doxycycline
1350010|NCT01375491|insulin resistance|insulin resistance
1350011|NCT01375491|obesity|obesity
1350012|NCT01375491|inflammation|inflammation
1350014|NCT01375439|vulvovaginitis|vulvovaginitis
1350015|NCT01375439|uterine cervicitis|uterine cervicitis
1350016|NCT01375439|pregnancy outcome|pregnancy outcome
1350017|NCT01375426|Non-severe pneumonia|non-severe pneumonia
1350018|NCT01375426|Treatment failure|treatment failure
1350019|NCT01375426|Double dose amoxicillin|double dose amoxicillin
1350020|NCT01375426|Children|children
1350021|NCT01375413|Parkinson's disease|parkinson's disease
1350022|NCT01375413|Gait|gait
1350023|NCT01375413|Rehabilitation|rehabilitation
1350024|NCT01375413|Cognition|cognition
1350025|NCT01375413|Freezing of gait|freezing of gait
1350026|NCT01375400|aspirin|aspirin
1350027|NCT01375400|platelet|platelet
1350028|NCT01375387|Vimpat|vimpat
1350029|NCT01375387|Pharmacokinetics|pharmacokinetics
1350030|NCT01375387|Healthy Japanese male|healthy japanese male
1350031|NCT01375387|Healthy Chinese male|healthy chinese male
1350032|NCT01375374|Vimpat|vimpat
1350033|NCT01375374|Partial seizures|partial seizures
1350034|NCT01375374|Carbamazepine|carbamazepine
1350035|NCT01375374|Hormone levels|hormone levels
1350036|NCT01375374|Lipid levels|lipid levels
1350037|NCT01375374|Lacosamide|lacosamide
1350038|NCT01375361|albuterol|albuterol
1350039|NCT01375348|Cognitive function|cognitive function
1350040|NCT01375348|Experimental pain|experimental pain
1350041|NCT01375335|Postoperative|postoperative
1350042|NCT01375335|Dobutamine|dobutamine
1350043|NCT01375335|Inotropes|inotropes
1350044|NCT01375335|Stunning|stunning
1350045|NCT01375335|Heart failure|heart failure
1350046|NCT01375309|probiotics|probiotics
1350047|NCT01375309|preterm infants|preterm infants
1350048|NCT01375309|enteral feeding|enteral feeding
1350049|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
1350050|NCT01375270|diabetes|diabetes
1350051|NCT01375270|incretin|incretin
1350052|NCT01375270|beta-cell function|beta-cell function
1350053|NCT01375270|glucolipotoxicity|glucolipotoxicity
1464578|NCT00910806|HIV|hiv
1350054|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
1350055|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
1350056|NCT01375244|bioequivalence|bioequivalence
1350057|NCT01375244|lisinopril|lisinopril
1350058|NCT01375244|fasting|fasting
1350059|NCT01375205|atopic dermatitis|atopic dermatitis
1350060|NCT01375205|skin care|skin care
1350061|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
1350062|NCT01375179|Ulcerative colitis|ulcerative colitis
1350063|NCT01375153|BNP administration|bnp administration
1350064|NCT01375153|appetite|appetite
1350065|NCT01375153|ghrelin|ghrelin
1350066|NCT01375153|PYY|pyy
1350067|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
1350068|NCT01375140|Myelofibrosis|myelofibrosis
1350069|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
1350070|NCT01375140|Ruxolitinib|ruxolitinib
1350071|NCT01375140|INCB018424|incb018424
1350072|NCT01375140|Lenalidomide|lenalidomide
1350073|NCT01375140|CC-5013|cc-5013
1350074|NCT01375140|Revlimid|revlimid
1350075|NCT01375140|Prednisone|prednisone
1350076|NCT01375140|Interactive Voice Response System|interactive voice response system
1350077|NCT01375140|IVR|ivr
1350078|NCT01375127|Observational|observational
1350079|NCT01375127|clinical follow-up data|clinical follow-up data
1350080|NCT01375114|Advanced Cancers|advanced cancers
1350081|NCT01375114|Solid Tumors|solid tumors
1350082|NCT01375114|Cancer related fatigue|cancer related fatigue
1350083|NCT01375114|CRF|crf
1350084|NCT01375114|Panax ginseng|panax ginseng
1350085|NCT01375114|Placebo|placebo
1350086|NCT01375114|Sugar pill|sugar pill
1350087|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
1350088|NCT01375114|FACIT-F|facit-f
1350089|NCT01375114|Quality of life|quality of life
1350090|NCT01375114|QOL|qol
1350091|NCT01375114|FACT-G|fact-g
1350092|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
1350093|NCT01375114|Neurocognitive function|neurocognitive function
1350094|NCT01375114|SDMT|sdmt
1350095|NCT01375114|Global Symptom Evaluation|global symptom evaluation
1350096|NCT01375114|GSE|gse
1350097|NCT01375101|lichen planus|lichen planus
1350098|NCT01375101|quercetin|quercetin
1350099|NCT01375088|propolis|propolis
1350100|NCT01375088|mucositis|mucositis
1350101|NCT01375088|radiotherapy|radiotherapy
1350103|NCT01375049|Cystic fibrosis|cystic fibrosis
1350104|NCT01375049|CF|cf
1350105|NCT01375049|PA|pa
1350106|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
1350107|NCT01375049|AZLI|azli
1350108|NCT01375049|aztreonam|aztreonam
1350109|NCT01375036|Cystic fibrosis|cystic fibrosis
1350110|NCT01375036|PA|pa
1350111|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
1350112|NCT01375036|CF|cf
1350113|NCT01375036|aztreonam|aztreonam
1350114|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
1350115|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
1350116|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
1350117|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
1350118|NCT01375010|HIV|hiv
1350119|NCT01375010|Postmenopausal women|postmenopausal women
1350120|NCT01375010|Vitamin D|vitamin d
1350121|NCT01374984|smallpox|smallpox
1350122|NCT01374984|vaccination|vaccination
1350123|NCT01374984|complications|complications
1350124|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
1350125|NCT01374971|Cimzia|cimzia
1350126|NCT01374971|Certolizumab Pegol|certolizumab pegol
1350127|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
1350128|NCT01374971|Office Based Procedure|office based procedure
1350129|NCT01374971|Biologic|biologic
1350130|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
1350131|NCT01374971|Anti-TNF|anti-tnf
1350132|NCT01374932|Asthma|asthma
1350133|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1350134|NCT01374919|Intravenous iron|intravenous iron
1350135|NCT01374919|ferumoxytol|ferumoxytol
1350136|NCT01374919|iron deficiency anemia|iron deficiency anemia
1350137|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
1350138|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
1350139|NCT01374906|SOM230|som230
1350140|NCT01374906|Cushing's Disease|cushing's disease
1350141|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
1350142|NCT01374906|Pasireotide|pasireotide
1350143|NCT01374906|Pasireotide LAR|pasireotide lar
1350144|NCT01374906|Pasireotide long-acting release|pasireotide long-acting release
1350145|NCT01374906|secondary hypercortisolism|secondary hypercortisolism
1350146|NCT01374906|secondary hypercorticism|secondary hypercorticism
1350147|NCT01374906|Itsenko-Cushing disease|itsenko-cushing disease
1350148|NCT01374906|increased secretion of adrenocorticotropic hormone (ACTH)|increased secretion of adrenocorticotropic hormone (acth)
1350149|NCT01374906|hyperpituitarism|hyperpituitarism
1350150|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
1350151|NCT01374880|Heart failure|heart failure
1350152|NCT01374880|Dyspnea|dyspnea
1350153|NCT01374880|Heart disease|heart disease
1350154|NCT01374880|Pulmonary disease|pulmonary disease
1350155|NCT01374880|Natriuretic peptide|natriuretic peptide
1350156|NCT01374880|Rehabilitation|rehabilitation
1350157|NCT01374867|Cardiogenic shock|cardiogenic shock
1350158|NCT01374867|Myocardial infarction|myocardial infarction
1350159|NCT01374867|Low-output syndrome|low-output syndrome
1350160|NCT01374867|Prognosis|prognosis
1350161|NCT01374867|Biomarkers|biomarkers
1350162|NCT01374867|Pathophysiology|pathophysiology
1350163|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
1350164|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
1350165|NCT01374854|mononuclear cell|mononuclear cell
1350166|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1350167|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
1350168|NCT01374841|Haploidentical Donors|haploidentical donors
1350169|NCT01374841|Cyclophosphamide|cyclophosphamide
1350170|NCT01374828|Toradol|toradol
1350171|NCT01374828|Ketorolac|ketorolac
1350172|NCT01374828|Normal saline|normal saline
1350173|NCT01374828|Laparoscopic|laparoscopic
1350174|NCT01374828|Postoperative pain control|postoperative pain control
1350175|NCT01374828|Incisional analgesia|incisional analgesia
1350176|NCT01374815|Children's diet quality|children's diet quality
1350177|NCT01374815|Health-related social problems|health-related social problems
1350178|NCT01374763|Naloxone|naloxone
1350179|NCT01374763|Oxycodone|oxycodone
1350180|NCT01374763|Constipation|constipation
1350181|NCT01374763|Pain, postoperative|pain, postoperative
1350182|NCT01374763|Physiological effects of drugs|physiological effects of drugs
1350183|NCT01374763|Analgesics, Opioid|analgesics, opioid
1350184|NCT01374724|Tobacco Use|tobacco use
1350185|NCT01374724|Relapse Prevention|relapse prevention
1350186|NCT01374724|Military|military
1350187|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
1350188|NCT01374724|Dual Use|dual use
1350189|NCT01374711|Endotoxin|endotoxin
1350190|NCT01374711|Inflammation|inflammation
1350191|NCT01374711|Sepsis|sepsis
1350192|NCT01374711|GM-CSF|gm-csf
1350193|NCT01374711|IFN-y|ifn-y
1350194|NCT01374698|PCI|pci
1350195|NCT01374698|Aspirin|aspirin
1350196|NCT01374698|Reload|reload
1350197|NCT01374685|BRCA1|brca1
1350198|NCT01374685|BRCA2|brca2
1350199|NCT01374685|Breast Cancer|breast cancer
1350200|NCT01374685|African American|african american
1350201|NCT01374685|Women|women
1350202|NCT01374659|124-I PET|124-i pet
1350204|NCT01374659|PET/CT|pet/ct
1350205|NCT01374659|recurrence|recurrence
1350206|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
1350207|NCT01374659|diagnostic value|diagnostic value
1350208|NCT01374646|Childhood Obesity|childhood obesity
1350209|NCT01374646|Group Treatment|group treatment
1350210|NCT01374646|Community-based Programs|community-based programs
1350211|NCT01374633|Sevoflurane|sevoflurane
1350212|NCT01374633|Brain injury|brain injury
1350213|NCT01374633|Intra cranial pressure|intra cranial pressure
1350214|NCT01374633|Sedation|sedation
1350215|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
1350216|NCT01374620|Cancer|cancer
1350319|NCT01374100|Exercise|exercise
1350217|NCT01374607|acute coronary syndrome|acute coronary syndrome
1350218|NCT01374607|myocardial ischemia|myocardial ischemia
1350219|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
1350220|NCT01374581|retreatment|retreatment
1350221|NCT01374581|artemisinin-based combination|artemisinin-based combination
1350222|NCT01374581|malaria|malaria
1350223|NCT01374581|resistant|resistant
1350224|NCT01374568|Type 2 diabetes|type 2 diabetes
1350225|NCT01374568|sitagliptin|sitagliptin
1350226|NCT01374568|Januvia|januvia
1350227|NCT01374555|Coronary artery disease|coronary artery disease
1350228|NCT01374542|Bronchoscopy|bronchoscopy
1350229|NCT01374542|Thoracoscopy|thoracoscopy
1350230|NCT01374516|Dengue Virus|dengue virus
1350231|NCT01374516|Dengue fever|dengue fever
1350232|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1350233|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
1350234|NCT01374516|Flavivirus|flavivirus
1350235|NCT01374516|Dengue Disease|dengue disease
1350236|NCT01374490|HIV +|hiv +
1350237|NCT01374490|HIV positive|hiv positive
1350238|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
1350239|NCT01374490|AIDS|aids
1350240|NCT01374490|Diarrhea|diarrhea
1350241|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
1350242|NCT01374477|Adolescent|adolescent
1350243|NCT01374477|Primipaternity|primipaternity
1350244|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
1350245|NCT01374464|Nerve block|nerve block
1350246|NCT01374451|Pancreatic|pancreatic
1350247|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
1350248|NCT01374451|PNET|pnet
1350249|NCT01374451|Pasireotide|pasireotide
1350250|NCT01374451|Everolimus|everolimus
1350251|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
1464899|NCT00909584|SCN|scn
1350252|NCT01374438|Alzheimer's disease|alzheimer's disease
1350253|NCT01374438|cognitive function|cognitive function
1350254|NCT01374438|brain glucose utilization|brain glucose utilization
1350255|NCT01374438|FDG-PET|fdg-pet
1350256|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1350257|NCT01374399|exercise|exercise
1350258|NCT01374399|survival|survival
1350259|NCT01374399|fatigue|fatigue
1350260|NCT01374399|quality of life|quality of life
1350261|NCT01374399|cancer|cancer
1350262|NCT01374399|physical performance|physical performance
1350263|NCT01374386|adolescent obesity|adolescent obesity
1350264|NCT01374373|Chemotherapy|chemotherapy
1350265|NCT01374373|Anemia|anemia
1350266|NCT01374373|Epoetin alfa|epoetin alfa
1350267|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
1350269|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1350270|NCT01374360|Soliris|soliris
1350271|NCT01374360|Eculizumab|eculizumab
1350272|NCT01374308|NASVAC|nasvac
1350273|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
1350274|NCT01374308|CHB|chb
1350275|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
1350276|NCT01374269|Exercise|exercise
1350277|NCT01374269|Physiotherapy|physiotherapy
1350278|NCT01374269|Subacute Low Back Pain|subacute low back pain
1350279|NCT01374269|Pain|pain
1350280|NCT01374269|Visual Analogue Scale|visual analogue scale
1350281|NCT01374269|oswesrty|oswesrty
1350282|NCT01374269|Roland Morris|roland morris
1350283|NCT01374269|SF-36|sf-36
1350284|NCT01374269|Quality of life|quality of life
1350285|NCT01374256|carbapenem|carbapenem
1350286|NCT01374256|sulbactam|sulbactam
1350287|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
1350288|NCT01374230|clinical outcomes|clinical outcomes
1350289|NCT01374230|radiographic outcomes|radiographic outcomes
1350290|NCT01374230|total knee arthroplasty|total knee arthroplasty
1350291|NCT01374230|survivorship|survivorship
1350292|NCT01374204|Epilepsy|epilepsy
1350293|NCT01374204|Stigma|stigma
1350294|NCT01374191|botox|botox
1350295|NCT01374191|neuroma pain|neuroma pain
1350296|NCT01374191|pain|pain
1350297|NCT01374191|chronic pain|chronic pain
1350298|NCT01374191|botulinum toxin|botulinum toxin
1350299|NCT01374191|botulinum toxin A|botulinum toxin a
1350300|NCT01374191|botox and pain|botox and pain
1350301|NCT01374191|botox and neuroma|botox and neuroma
1350302|NCT01374191|botox treatment|botox treatment
1350303|NCT01374191|onabotulinum|onabotulinum
1350304|NCT01374191|onabotulinum toxin|onabotulinum toxin
1350305|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
1350306|NCT01374165|SCD|scd
1350307|NCT01374152|stroke|stroke
1350308|NCT01374152|upper extremity|upper extremity
1350309|NCT01374152|rehabilitation|rehabilitation
1350310|NCT01374152|perfetti|perfetti
1350311|NCT01374139|Bosutinib|bosutinib
1350312|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
1350313|NCT01374113|safinamide|safinamide
1350314|NCT01374113|pharmacokinetics|pharmacokinetics
1350315|NCT01374113|renal impairment|renal impairment
1350316|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
1350317|NCT01374100|Qigong|qigong
1350318|NCT01374100|Complementary Medicine|complementary medicine
1350320|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
1350321|NCT01374100|Meditation|meditation
1350322|NCT01374100|Standard Exercise|standard exercise
1350323|NCT01374100|Chemotherapy|chemotherapy
1350324|NCT01374100|Advanced cancer|advanced cancer
1350325|NCT01374100|Quality of Life|quality of life
1350326|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
1350327|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
1350328|NCT01374100|Anxiety|anxiety
1350329|NCT01374100|Depression|depression
1350330|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
1350331|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
1350332|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
1350333|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
1350334|NCT01374087|Brachytherapy|brachytherapy
1350335|NCT01374087|Triptorelin|triptorelin
1350336|NCT01374087|Hormone Therapy|hormone therapy
1350337|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
1350338|NCT01374074|Intestinal metaplasia|intestinal metaplasia
1350339|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1350340|NCT01374074|Racial Disparity|racial disparity
1350341|NCT01374061|Emergency intubation|emergency intubation
1350342|NCT01374061|Glide scope Ranger|glide scope ranger
1350343|NCT01374061|Pre hospital|pre hospital
1350344|NCT01374035|Health Service|health service
1350345|NCT01374035|Coordination|coordination
1350346|NCT01374035|Referral letters|referral letters
1350347|NCT01374035|Mental Health|mental health
1350348|NCT01374035|Adults|adults
1568269|NCT00506441|Chronic Kidney Disease|chronic kidney disease
1350349|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1350350|NCT01374022|Randomized Controlled Trial|randomized controlled trial
1350351|NCT01374022|Respiration, Artificial|respiration, artificial
1350352|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
1350353|NCT01373996|Intensive care unit|intensive care unit
1350354|NCT01373996|Wireless Technology|wireless technology
1350355|NCT01373983|Neuropathic pain|neuropathic pain
1350356|NCT01373983|Intrathecal analgesia|intrathecal analgesia
1350357|NCT01373983|Ziconotide|ziconotide
1350358|NCT01373983|Bolus|bolus
1350359|NCT01373983|trauma|trauma
1350360|NCT01373983|central|central
1350361|NCT01373983|severe|severe
1350362|NCT01373983|chronic|chronic
1350363|NCT01373970|Functional Dyspepsia|functional dyspepsia
1350364|NCT01373970|Protonpump inhibitor|protonpump inhibitor
1350365|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
1350366|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
1350367|NCT01373957|antithrombotic management|antithrombotic management
1350368|NCT01373957|STEMI|stemi
1350369|NCT01373957|NSTE-ACS|nste-acs
1350371|NCT01373944|SPECT|spect
1350372|NCT01373944|Stress-Only|stress-only
1350373|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
1350374|NCT01373944|Anger|anger
1350375|NCT01373918|cholestasis|cholestasis
1350376|NCT01373918|neonates|neonates
1350377|NCT01373918|parenteral nutrition|parenteral nutrition
1350378|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
1350379|NCT01373905|ARDS|ards
1350380|NCT01373905|PEEP|peep
1350381|NCT01373905|Recruitment maneuver|recruitment maneuver
1350382|NCT01373879|Vaccine|vaccine
1350383|NCT01373879|Immune response|immune response
1350384|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1350385|NCT01373866|Neuronavigation|neuronavigation
1350386|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1350387|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
1350388|NCT01373853|Lens Fragmentation|lens fragmentation
1350389|NCT01373853|Cataract|cataract
1350390|NCT01373853|Phacoemulsification|phacoemulsification
1350391|NCT01373853|Femtosecond Laser|femtosecond laser
1350392|NCT01373840|focal|focal
1350393|NCT01373840|dystonia|dystonia
1350394|NCT01373840|dopamine|dopamine
1350395|NCT01373840|receptor|receptor
1350396|NCT01373827|VASER|vaser
1350397|NCT01373827|VASERShape|vasershape
1350398|NCT01373827|MC1|mc1
1350399|NCT01373827|ultrasound|ultrasound
1350400|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
1350401|NCT01373775|Heart failure|heart failure
1350402|NCT01373775|Revisit|revisit
1350403|NCT01373775|Emergency room|emergency room
1350404|NCT01373762|Adherence|adherence
1350405|NCT01373762|Motivation|motivation
1350406|NCT01373762|Health-related fitness|health-related fitness
1350407|NCT01373762|Exercise videogames|exercise videogames
1350408|NCT01373762|Physical Activity|physical activity
1350409|NCT01373749|PPHN|pphn
1350410|NCT01373749|NO inhalation|no inhalation
1350411|NCT01373749|Sildenafil|sildenafil
1350412|NCT01373749|Treatment|treatment
1350413|NCT01373749|Safety|safety
1350414|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
1350415|NCT01373723|cancer screening|cancer screening
1350416|NCT01373723|Costs and Cost Analysis|costs and cost analysis
1350417|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
1350418|NCT01373723|Clinical Trial|clinical trial
1350419|NCT01373723|Primary Health Care|primary health care
1350420|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
1350421|NCT01373697|Ibuprofen|ibuprofen
1350422|NCT01373697|muscle pain|muscle pain
1350423|NCT01373697|sprains|sprains
1350424|NCT01373697|contusions|contusions
1350425|NCT01373697|tendonitis|tendonitis
1350426|NCT01373684|Chronic hepatitis B|chronic hepatitis b
1350427|NCT01373684|HBeAg-negative|hbeag-negative
1350428|NCT01373671|Mammography|mammography
1350429|NCT01373671|Screening|screening
1350430|NCT01373671|Diagnostic|diagnostic
1350431|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
1350432|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
1350433|NCT01373632|clinical ischemic|clinical ischemic
1350434|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1350435|NCT01373619|hemodialysis patients|hemodialysis patients
1350436|NCT01373619|ivabradine|ivabradine
1350437|NCT01373619|Echocardiography|echocardiography
1350438|NCT01373619|NYHA class|nyha class
1350439|NCT01373619|6-minutes walking test|6-minutes walking test
1350440|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
1350441|NCT01373580|presbyopia|presbyopia
1350442|NCT01373580|LASIK|lasik
1350443|NCT01373580|loss of accommodation|loss of accommodation
1350444|NCT01373580|Emmetrope|emmetrope
1350445|NCT01373567|Plaque Psoriasis|plaque psoriasis
1350446|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
1350447|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
1350572|NCT01372943|infection|infection
1350448|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
1350449|NCT01373515|DCOne|dcone
1350450|NCT01373515|DCP-001|dcp-001
1350451|NCT01373515|Second complete remission of AML|second complete remission of aml
1350452|NCT01373515|Relapse AML|relapse aml
1350453|NCT01373489|type 2 diabetes|type 2 diabetes
1350454|NCT01373489|nurse case management|nurse case management
1350455|NCT01373489|telemedicine|telemedicine
1350456|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
1350457|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
1350458|NCT01373476|Diabetic Eye Problems|diabetic eye problems
1350459|NCT01373476|Retinal Disorders|retinal disorders
1350460|NCT01373463|resectable|resectable
1350461|NCT01373437|Ultrasonography|ultrasonography
1350462|NCT01373437|US|us
1350463|NCT01373437|Confirming|confirming
1350464|NCT01373437|Confirmation|confirmation
1350465|NCT01373437|Proper|proper
1350466|NCT01373437|Position|position
1350467|NCT01373437|Endotracheal tube|endotracheal tube
1350468|NCT01373437|ETT|ett
1350469|NCT01373437|Emergency department|emergency department
1350470|NCT01373437|ED|ed
1350471|NCT01373437|Applicability|applicability
1350472|NCT01373437|Accuracy|accuracy
1350473|NCT01373424|Observational study|observational study
1350474|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
1350475|NCT01373424|Cohort and case-control study|cohort and case-control study
1350476|NCT01373411|CABG|cabg
1350477|NCT01373411|Ticagrelor|ticagrelor
1350478|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1350479|NCT01373398|bladder cancer|bladder cancer
1350480|NCT01373398|EO9|eo9
1350481|NCT01373398|Apaziquone|apaziquone
1350482|NCT01373385|pediatric urology|pediatric urology
1350483|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
1350484|NCT01373385|ureteral reimplant|ureteral reimplant
1350485|NCT01373385|Deflux|deflux
1350486|NCT01373372|functional dyspepsia|functional dyspepsia
1350487|NCT01373372|GI|gi
1350488|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
1350489|NCT01373346|type II diabetes|type ii diabetes
1350490|NCT01373346|Gastric cancer|gastric cancer
1350491|NCT01373346|Long limb Roux-en Y|long limb roux-en y
1350492|NCT01373320|Smoking cessation|smoking cessation
1350493|NCT01373320|Cancer screening|cancer screening
1350494|NCT01373320|Appalachia|appalachia
1350495|NCT01373320|Group-randomized trial|group-randomized trial
1350496|NCT01373320|Faith-placed|faith-placed
1350497|NCT01373307|Overweight|overweight
1350498|NCT01373307|obesity|obesity
1350499|NCT01373307|Appalachian|appalachian
1350500|NCT01373307|intergenerational|intergenerational
1350501|NCT01373307|families|families
1350502|NCT01373307|energy balance|energy balance
1350503|NCT01373307|group-randomized trial|group-randomized trial
1350504|NCT01373294|non-muscle-invasive|non-muscle-invasive
1350505|NCT01373294|transitional cell|transitional cell
1350506|NCT01373294|oral lenalidomide|oral lenalidomide
1350507|NCT01373294|intravesical|intravesical
1350508|NCT01373281|Dengue|dengue
1350509|NCT01373281|Dengue fever|dengue fever
1350510|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1350511|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
1350512|NCT01373281|Flavivirus|flavivirus
1350513|NCT01373255|Placenta accreta|placenta accreta
1350514|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
1350515|NCT01373255|Post partum bleeding|post partum bleeding
1350516|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1350517|NCT01373229|CLL|cll
1350518|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
1350519|NCT01373190|epilepsy|epilepsy
1350520|NCT01373190|thermography|thermography
1350521|NCT01373164|Neoplasms|neoplasms
1350522|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
1350523|NCT01373164|Pancreatic Cancer|pancreatic cancer
1350524|NCT01373138|Bioequivalence|bioequivalence
1350525|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
1350526|NCT01373138|crossover|crossover
1350527|NCT01373125|Barrett's Esophagus|barrett's esophagus
1350528|NCT01373125|Intestinal metaplasia|intestinal metaplasia
1350529|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1350530|NCT01373125|Neosquamous epithelium|neosquamous epithelium
1350531|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
1350532|NCT01373112|arthroplasty|arthroplasty
1350533|NCT01373112|knee replacement|knee replacement
1350534|NCT01373112|Osteoarthritis|osteoarthritis
1350535|NCT01373112|knee Infection|knee infection
1350536|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
1350537|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
1350538|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
1350539|NCT01373099|arthroplasty|arthroplasty
1350540|NCT01373099|hip replacement|hip replacement
1350541|NCT01373099|Osteoarthritis|osteoarthritis
1350542|NCT01373099|knee Infection|knee infection
1350543|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
1350544|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
1350545|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
1350546|NCT01373086|Hypertension,|hypertension,
1350547|NCT01373086|mild hypertension,|mild hypertension,
1350548|NCT01373086|moderate hypertension,|moderate hypertension,
1350549|NCT01373086|high blood pressure,|high blood pressure,
1350550|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
1350551|NCT01373060|ASP1941|asp1941
1350552|NCT01373060|ipragliflozin|ipragliflozin
1350553|NCT01373060|plasma glucose|plasma glucose
1350554|NCT01373060|urine glucose|urine glucose
1350555|NCT01373047|liver metastases|liver metastases
1350556|NCT01373047|immunotherapy|immunotherapy
1350557|NCT01373047|regional therapy|regional therapy
1350558|NCT01373047|T cells|t cells
1350559|NCT01373008|Inhaled steroids|inhaled steroids
1350560|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1350561|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
1350562|NCT01372995|critical care|critical care
1350563|NCT01372995|nosocomial infection|nosocomial infection
1350564|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
1350565|NCT01372995|LL-37|ll-37
1350566|NCT01372995|hBD-2|hbd-2
1350567|NCT01372995|cathelicidin|cathelicidin
1350568|NCT01372995|microbial peptide|microbial peptide
1350569|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
1350570|NCT01372943|Clostridium difficile|clostridium difficile
1350571|NCT01372943|recurrent|recurrent
1350573|NCT01372930|Etanercept|etanercept
1350574|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
1350575|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
1350576|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
1350577|NCT01372904|Cisplatin|cisplatin
1350578|NCT01372904|Hearing loss|hearing loss
1350579|NCT01372904|Ototoxicity|ototoxicity
1350580|NCT01372904|Intratympanic injection|intratympanic injection
1350581|NCT01372904|Dexamethasone|dexamethasone
1350582|NCT01372904|Steroids|steroids
1350583|NCT01372904|Prevention|prevention
1350584|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
1350585|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
1350586|NCT01372878|Polyps|polyps
1350587|NCT01372878|Capsule endoscopy|capsule endoscopy
1350588|NCT01372878|Colonoscopy|colonoscopy
1350589|NCT01372852|Diabetes mellitus|diabetes mellitus
1350590|NCT01372839|Myocardial Infarction|myocardial infarction
1350591|NCT01372839|Unstable Angina|unstable angina
1350592|NCT01372826|Phase 1|phase 1
1350593|NCT01372826|Pharmacokinetics|pharmacokinetics
1350594|NCT01372826|NKTR-118|nktr-118
1350595|NCT01372826|renal impairment|renal impairment
1350596|NCT01372826|parallel study|parallel study
1350597|NCT01372826|QTcF Interval|qtcf interval
1350598|NCT01372826|AUC(0-t)|auc(0-t)
1350599|NCT01372826|Cmax|cmax
1350600|NCT01372826|tmax|tmax
1350601|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
1350602|NCT01372813|Cancer|cancer
1350603|NCT01372813|Renal|renal
1350604|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
1350605|NCT01372813|Kidney Cancer|kidney cancer
1350606|NCT01372800|adiponectin|adiponectin
1350607|NCT01372800|cardiovascular diseases|cardiovascular diseases
1350608|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
1350609|NCT01372774|neurotoxicity|neurotoxicity
1350610|NCT01372774|radiation toxicity|radiation toxicity
1350611|NCT01372774|cognitive/functional effects|cognitive/functional effects
1350612|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
1350613|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1350614|NCT01372761|Obese|obese
1350615|NCT01372761|Obesity|obesity
1350616|NCT01372761|Overweight|overweight
1350617|NCT01372748|cardiac arrest|cardiac arrest
1350618|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1350619|NCT01372735|pancreatic cancer|pancreatic cancer
1350620|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1350621|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
1350622|NCT01372722|treatment resistant|treatment resistant
1350623|NCT01372709|abdominal|abdominal
1350624|NCT01372709|aortic|aortic
1350625|NCT01372709|aneurysm|aneurysm
1350626|NCT01372683|Appetite|appetite
1350627|NCT01372683|Satiety|satiety
1350628|NCT01372683|Subjective energy|subjective energy
1350629|NCT01372683|Oats|oats
1350630|NCT01372670|Treating meal related anxiety|treating meal related anxiety
1350631|NCT01372657|cataract|cataract
1350632|NCT01372657|refraction|refraction
1350633|NCT01372657|iol|iol
1350634|NCT01372657|calculation|calculation
1350635|NCT01372657|formula|formula
1350636|NCT01372631|Reduction mammoplasty|reduction mammoplasty
1350637|NCT01372631|mastectomy|mastectomy
1350638|NCT01372631|partial mastectomy|partial mastectomy
1350639|NCT01372631|lumpectomy|lumpectomy
1568270|NCT00506441|Dialysis|dialysis
1350640|NCT01372631|breast conserving surgery|breast conserving surgery
1350641|NCT01372631|breast cancer|breast cancer
1350642|NCT01372605|Depression|depression
1350643|NCT01372605|HIV|hiv
1350644|NCT01372605|Adherence|adherence
1350645|NCT01372605|Collaborative care|collaborative care
1350646|NCT01372605|Measurement-Based Care|measurement-based care
1350647|NCT01372553|Primary care|primary care
1350648|NCT01372553|Family History|family history
1350649|NCT01372553|Risk Stratification|risk stratification
1350650|NCT01372553|Cancer|cancer
1350651|NCT01372553|Thrombosis|thrombosis
1350652|NCT01372540|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1350653|NCT01372540|MM|mm
1350654|NCT01372540|Plasma Cell Leukemia|plasma cell leukemia
1350655|NCT01372540|PCL|pcl
1350656|NCT01372540|Arry-520|arry-520
1350657|NCT01372540|Carfilzomib|carfilzomib
1350658|NCT01372540|Dexamethasone|dexamethasone
1350659|NCT01372540|Decadron|decadron
1350660|NCT01372540|Filgrastim|filgrastim
1350661|NCT01372540|G-CSF|g-csf
1350662|NCT01372540|Neupogen|neupogen
1350663|NCT01372527|medical informatics|medical informatics
1350664|NCT01372527|health IT|health it
1350665|NCT01372527|primary care|primary care
1350666|NCT01372527|screening|screening
1350667|NCT01372527|cervical cancer|cervical cancer
1350668|NCT01372527|colorectal cancer|colorectal cancer
1350669|NCT01372527|breast cancer|breast cancer
1350670|NCT01372527|mammography|mammography
1350671|NCT01372527|colonoscopy|colonoscopy
1350672|NCT01372527|pap smear|pap smear
1350673|NCT01372514|Thromboembolism|thromboembolism
1350674|NCT01372514|Venous Thromboembolism|venous thromboembolism
1350675|NCT01372514|Pulmonary Embolism|pulmonary embolism
1350676|NCT01372501|Obesity|obesity
1350677|NCT01372488|Suture self removal|suture self removal
1350678|NCT01372488|non-absorbable sutures|non-absorbable sutures
1350679|NCT01372475|Osteoarthritis|osteoarthritis
1350680|NCT01372475|Knee|knee
1350681|NCT01372475|Hyaluronan|hyaluronan
1350682|NCT01372475|Hyaluronic Acid|hyaluronic acid
1350683|NCT01372475|Viscoelastic|viscoelastic
1350684|NCT01372475|Hydrogel|hydrogel
1350685|NCT01372462|COPD|copd
1350686|NCT01372462|Ventilator|ventilator
1350687|NCT01372462|Constant work rate|constant work rate
1350688|NCT01372449|Autism|autism
1350689|NCT01372449|Psychopharmacology|psychopharmacology
1350690|NCT01372449|Clinical Trial|clinical trial
1350691|NCT01372449|Children|children
1350692|NCT01372436|dental decay|dental decay
1350693|NCT01372436|DMFT|dmft
1350694|NCT01372436|Individual Caries Risk|individual caries risk
1350695|NCT01372436|Risk factors|risk factors
1350696|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
1350697|NCT01372410|Tiotropium|tiotropium
1350698|NCT01372410|Chronic Bronchitis|chronic bronchitis
1350699|NCT01372410|Emphysema|emphysema
1350700|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1350701|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
1350702|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
1350703|NCT01372332|homonymous hemianopia|homonymous hemianopia
1350704|NCT01372332|quality of life (QoL)|quality of life (qol)
1350705|NCT01372332|visual exploration|visual exploration
1350706|NCT01372332|on-road car driving|on-road car driving
1350707|NCT01372332|driving simulator|driving simulator
1350708|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
1350709|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
1350710|NCT01372319|glaucoma|glaucoma
1350711|NCT01372319|binocular visual field loss|binocular visual field loss
1350712|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
1350713|NCT01372319|quality of life (QoL)|quality of life (qol)
1350714|NCT01372319|visual exploration|visual exploration
1350715|NCT01372319|on-road car driving|on-road car driving
1350716|NCT01372319|driving simulator|driving simulator
1350718|NCT01372293|oral contraceptive pill|oral contraceptive pill
1350719|NCT01372293|polymorphisms|polymorphisms
1350720|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
1350721|NCT01372267|Chronic Pain|chronic pain
1350722|NCT01372267|Substance Use Disorders|substance use disorders
1350723|NCT01372267|Psychoeducational control group|psychoeducational control group
1350724|NCT01372254|Cigarette Smoking|cigarette smoking
1350725|NCT01372254|Drug Use|drug use
1350726|NCT01372254|Depressed Mood|depressed mood
1350727|NCT01372241|Papanicolaou test|papanicolaou test
1350728|NCT01372241|Cervical cancer screening|cervical cancer screening
1350729|NCT01372241|Randomized controlled trial|randomized controlled trial
1350730|NCT01372241|Faith-placed|faith-placed
1350731|NCT01372241|Appalachia|appalachia
1350732|NCT01372228|hematopoietic stem cell Tx, chimerism, leukodystrophy|hematopoietic stem cell tx, chimerism, leukodystrophy
1350733|NCT01372215|Breast mass|breast mass
1350734|NCT01372215|Breast lesion|breast lesion
1350735|NCT01372202|Operable|operable
1350736|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
1350737|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
1350738|NCT01372189|molecular imaging|molecular imaging
1350739|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
1350740|NCT01372189|colorectal neoplasia|colorectal neoplasia
1350741|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
1350742|NCT01372176|Intensive care unit|intensive care unit
1350743|NCT01372176|Critical illness|critical illness
1350744|NCT01372176|Mortality|mortality
1350745|NCT01372176|Reduced quality of life|reduced quality of life
1350746|NCT01372176|Loss of lean body mass|loss of lean body mass
1350747|NCT01372176|Loss of physical function|loss of physical function
1350748|NCT01372176|Optimised nutritional support|optimised nutritional support
1350749|NCT01372176|Early initiation of nutrition|early initiation of nutrition
1350750|NCT01372176|Indirect calorimetry|indirect calorimetry
1350751|NCT01372163|Phase 1|phase 1
1350752|NCT01372163|Multiple Ascending Doses|multiple ascending doses
1350753|NCT01372163|Safety|safety
1350754|NCT01372163|Pharmacokinetics|pharmacokinetics
1350755|NCT01372163|Healthy Volunteers|healthy volunteers
1350756|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
1350757|NCT01372150|major depressive disorder|major depressive disorder
1350758|NCT01372150|MDD|mdd
1350759|NCT01372150|depression|depression
1350760|NCT01372137|NOX-H94|nox-h94
1350761|NCT01372137|Hepcidin|hepcidin
1350762|NCT01372137|Anemia|anemia
1350763|NCT01372137|Inflammation|inflammation
1350764|NCT01372124|Renal impairment|renal impairment
1350765|NCT01372124|NOX-E36|nox-e36
1350766|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
1350767|NCT01372111|Advanced|advanced
1350768|NCT01372098|Domestic Violence|domestic violence
1350769|NCT01372098|Spouse Abuse|spouse abuse
1350770|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
1350771|NCT01372046|technology transfer|technology transfer
1350772|NCT01372046|skill development|skill development
1350773|NCT01372046|organizational change|organizational change
1350774|NCT01372033|drug treatment|drug treatment
1350775|NCT01372033|substance abuse|substance abuse
1350776|NCT01372033|offenders|offenders
1350777|NCT01372033|high risk|high risk
1350778|NCT01372020|Varicose ulcer|varicose ulcer
1350779|NCT01372020|wound healing|wound healing
1350780|NCT01372020|electrical stimulation|electrical stimulation
1350781|NCT01372007|Rectal carcinoma|rectal carcinoma
1350782|NCT01371994|Radical Robotic Arm|radical robotic arm
1350783|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
1350784|NCT01371994|Vesicare|vesicare
1350785|NCT01371994|YM905|ym905
1350786|NCT01371968|Alfentanil|alfentanil
1350787|NCT01371968|optimal dose|optimal dose
1350788|NCT01371968|laryngeal mask airway|laryngeal mask airway
1350789|NCT01371955|diabetic nephropathy|diabetic nephropathy
1350790|NCT01371955|CYBA|cyba
1350791|NCT01371955|p22phox|p22phox
1350792|NCT01371955|RAGE|rage
1350793|NCT01371955|12LOX|12lox
1350794|NCT01371955|genetic|genetic
1350795|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
1350796|NCT01371955|caucasian|caucasian
1350797|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
1350798|NCT01371955|older than 18 years|older than 18 years
1350799|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
1350800|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
1350801|NCT01371916|tuberculous meningitis|tuberculous meningitis
1350802|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
1350803|NCT01371916|diagnosis|diagnosis
1350804|NCT01371903|morphine|morphine
1350805|NCT01371903|fentanyl|fentanyl
1350806|NCT01371903|dilaudid|dilaudid
1350807|NCT01371903|opioid|opioid
1350808|NCT01371903|capnography|capnography
1350809|NCT01371890|hemodialysis|hemodialysis
1350810|NCT01371890|end-stage renal disease|end-stage renal disease
1350811|NCT01371890|hypertension|hypertension
1350812|NCT01371877|urticaria|urticaria
1350813|NCT01371877|angioedema|angioedema
1350814|NCT01371877|hive|hive
1350815|NCT01371877|swelling|swelling
1350816|NCT01371864|Congenital cardiac disease|congenital cardiac disease
1350817|NCT01371864|Teamwork|teamwork
1350818|NCT01371864|Communication|communication
1350819|NCT01371864|Peri-operative|peri-operative
1350820|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
1350821|NCT01371825|LIPA|lipa
1350822|NCT01371825|Wolman Disease|wolman disease
1350823|NCT01371825|Wolman Phenotype|wolman phenotype
1350824|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
1350825|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
1350826|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
1350827|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
1350828|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
1350829|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
1350830|NCT01371825|LAL Deficiency|lal deficiency
1350831|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
1350832|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
1350833|NCT01371825|Related Disorders:|related disorders:
1350834|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1350835|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1350836|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
1350837|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
1350838|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
1350839|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
1350840|NCT01371799|Schizophrenia|schizophrenia
1350841|NCT01371786|Ciclesonide|ciclesonide
1350842|NCT01371786|Allergic Rhinitis|allergic rhinitis
1350843|NCT01371760|Multiple sclerosis|multiple sclerosis
1350844|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
1350845|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
1350846|NCT01371760|Internal jugular vein|internal jugular vein
1350847|NCT01371760|Azygous vein|azygous vein
1350848|NCT01371747|Hyperkalemia|hyperkalemia
1350849|NCT01371747|Chronic Kidney Disease|chronic kidney disease
1350850|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
1350851|NCT01371747|Hypertension|hypertension
1350852|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
1350853|NCT01371734|Major Depressive Disorder|major depressive disorder
1350855|NCT01371734|Depression|depression
1350856|NCT01371721|Major Depressive Disorder|major depressive disorder
1350857|NCT01371721|MDD|mdd
1350858|NCT01371721|Depression|depression
1350859|NCT01371708|Major Depressive Disorder|major depressive disorder
1350860|NCT01371708|MDD|mdd
1350861|NCT01371708|Depression|depression
1350862|NCT01371695|IGF-II levels|igf-ii levels
1350863|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
1350864|NCT01371669|Chronic post embolic disease|chronic post embolic disease
1350865|NCT01371669|Sleep hypoxemia|sleep hypoxemia
1350866|NCT01371669|polysomnography|polysomnography
1350867|NCT01371669|sleep apnea|sleep apnea
1350868|NCT01371669|periodic respiration|periodic respiration
1350869|NCT01371630|Leukemia|leukemia
1350870|NCT01371630|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1350871|NCT01371630|ALL|all
1350872|NCT01371630|pre-B, Philadelphia chromosome (Ph-) negative|pre-b, philadelphia chromosome (ph-) negative
1350873|NCT01371630|Maximum tolerated dose|maximum tolerated dose
1350874|NCT01371630|Inotuzumab Ozogamycin|inotuzumab ozogamycin
1350875|NCT01371630|CMC-544|cmc-544
1350876|NCT01371630|Vincristine|vincristine
1350877|NCT01371630|Rituximab|rituximab
1350878|NCT01371630|Rituxan|rituxan
1350879|NCT01371630|Cyclophosphamide|cyclophosphamide
1350880|NCT01371630|Cytoxan|cytoxan
1350881|NCT01371630|Neosar|neosar
1350882|NCT01371630|Dexamethasone|dexamethasone
1350883|NCT01371630|Decadron|decadron
1350884|NCT01371630|Mesna|mesna
1350885|NCT01371630|Mesnex|mesnex
1350886|NCT01371630|Pegfilgrastim|pegfilgrastim
1350887|NCT01371630|Neulasta|neulasta
1350888|NCT01371630|PEG-G-CSF|peg-g-csf
1350889|NCT01371630|Ara-C|ara-c
1350890|NCT01371630|Cytarabine|cytarabine
1350891|NCT01371630|Cytosar|cytosar
1350892|NCT01371630|DepoCyt|depocyt
1350893|NCT01371630|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1350894|NCT01371630|6-Mercaptopurine|6-mercaptopurine
1350895|NCT01371630|Mercaptopurine|mercaptopurine
1350896|NCT01371630|Purinethol|purinethol
1350897|NCT01371630|6-MP|6-mp
1350898|NCT01371630|Methotrexate|methotrexate
1350899|NCT01371630|Otrexup|otrexup
1350900|NCT01371630|Rasuvo|rasuvo
1350901|NCT01371630|Rheumatrex|rheumatrex
1350902|NCT01371630|Trexall|trexall
1350903|NCT01371630|Amethopterin|amethopterin
1350904|NCT01371630|Methotrexate Sodium|methotrexate sodium
1350905|NCT01371630|MTX|mtx
1350906|NCT01371630|Oncovin|oncovin
1350907|NCT01371630|Vincristine Sulfate|vincristine sulfate
1350908|NCT01371630|Vincasar Pfs|vincasar pfs
1350909|NCT01371630|Prednisone|prednisone
1350910|NCT01371630|Deltasone|deltasone
1350911|NCT01371630|Sterapred|sterapred
1350912|NCT01371630|Rayos|rayos
1350913|NCT01371630|Meticorten|meticorten
1350914|NCT01371630|Citrovorum|citrovorum
1350915|NCT01371630|Leucovorin|leucovorin
1350916|NCT01371630|Wellcovorin|wellcovorin
1350917|NCT01371630|Calcium Leucovorin|calcium leucovorin
1350918|NCT01371630|Folinic Acid|folinic acid
1350919|NCT01371630|Citrovorum Factor|citrovorum factor
1350920|NCT01371617|IPI-926|ipi-926
1350921|NCT01371617|926|926
1350922|NCT01371617|Myelofibrosis|myelofibrosis
1350923|NCT01371617|Hedgehog|hedgehog
1350924|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
1350925|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
1350926|NCT01371617|Post Polycythemia vera|post polycythemia vera
1350927|NCT01371604|Hepatitis C|hepatitis c
1350928|NCT01371604|HCV|hcv
1350929|NCT01371604|treatment-naive|treatment-naive
1350930|NCT01371591|Bleeding|bleeding
1350931|NCT01371591|gastrointestinal|gastrointestinal
1350932|NCT01371591|hemorrhage|hemorrhage
1350933|NCT01371591|ulcer|ulcer
1350935|NCT01371591|varices|varices
1350936|NCT01371591|ulcers|ulcers
1350937|NCT01371591|GI|gi
1350938|NCT01371591|stomach|stomach
1350939|NCT01371591|esophagus|esophagus
1350940|NCT01371591|duodenum|duodenum
1350941|NCT01371591|melena|melena
1350942|NCT01371591|hematemesis|hematemesis
1350943|NCT01371591|coffee-ground|coffee-ground
1350944|NCT01371578|Hepatitis C|hepatitis c
1350945|NCT01371578|HCV|hcv
1350946|NCT01371578|Rapid Virologic Response|rapid virologic response
1350947|NCT01371578|Sustained Virologic Response|sustained virologic response
1350948|NCT01371578|Direct Acting Antiviral|direct acting antiviral
1351076|NCT01370967|infant formula|infant formula
1350949|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
1350950|NCT01371578|Polymerase inhibitor|polymerase inhibitor
1350951|NCT01371578|Protease inhibitor|protease inhibitor
1350952|NCT01371578|Treatment naïve|treatment naïve
1350953|NCT01371578|GS-5885|gs-5885
1350954|NCT01371578|GS-9190|gs-9190
1350955|NCT01371578|Tegobuvir|tegobuvir
1350956|NCT01371578|GS-9451|gs-9451
1350957|NCT01371565|Cushing's Disease|cushing's disease
1350958|NCT01371565|Cushing's Syndrome|cushing's syndrome
1350959|NCT01371565|Cushings|cushings
1350960|NCT01371565|Pituitary|pituitary
1350961|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
1350962|NCT01371539|Myopia|myopia
1350963|NCT01371539|Presbyopia|presbyopia
1350964|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
1350965|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
1350966|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
1350967|NCT01371422|opioids|opioids
1350968|NCT01371422|pain|pain
1350969|NCT01371409|Stroke|stroke
1350970|NCT01371409|TMS|tms
1350971|NCT01371409|Paired Pulse|paired pulse
1350972|NCT01371409|EEG|eeg
1350973|NCT01371409|Motor Learning|motor learning
1350974|NCT01371396|Metabolic syndrome|metabolic syndrome
1350975|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1350976|NCT01371396|Obesity Metabolism|obesity metabolism
1350977|NCT01371396|Stable isotopes|stable isotopes
1350978|NCT01371396|Dietary weight loss|dietary weight loss
1350979|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
1350980|NCT01371370|hypocaloric diet|hypocaloric diet
1350981|NCT01371370|prehypertension|prehypertension
1350982|NCT01371370|hypertension|hypertension
1350983|NCT01371370|obesity|obesity
1350984|NCT01371370|arterial function|arterial function
1350985|NCT01371370|arterial stiffness|arterial stiffness
1350986|NCT01371370|pulse wave velocity|pulse wave velocity
1350987|NCT01371370|autonomic function|autonomic function
1350988|NCT01371370|endothelial function|endothelial function
1350989|NCT01371370|adipocytokines|adipocytokines
1350990|NCT01371357|Remethylation|remethylation
1350991|NCT01371357|Human Subjects|human subjects
1350992|NCT01371357|Clinical Trial|clinical trial
1350993|NCT01371357|B-vitamin|b-vitamin
1350994|NCT01371357|Creatine|creatine
1350995|NCT01371344|Liver Transplantation|liver transplantation
1350996|NCT01371344|Kidney Transplantation|kidney transplantation
1350997|NCT01371344|Heart Transplantation|heart transplantation
1350998|NCT01371344|Pharmacokinetics|pharmacokinetics
1350999|NCT01371331|Kidney Transplantation|kidney transplantation
1351000|NCT01371331|Pharmacokinetics|pharmacokinetics
1351001|NCT01371331|Heart Transplantation|heart transplantation
1351002|NCT01371331|Liver Transplantation|liver transplantation
1351003|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
1351004|NCT01371318|amputation|amputation
1351005|NCT01371318|wounds|wounds
1351006|NCT01371318|diabetic foot|diabetic foot
1351007|NCT01371318|diabetes complications|diabetes complications
1351008|NCT01371292|Physical activity|physical activity
1351009|NCT01371292|Transformational leadership|transformational leadership
1351010|NCT01371292|Physical education|physical education
1351011|NCT01371266|Glucose intolerance|glucose intolerance
1351012|NCT01371266|Insulin resistance|insulin resistance
1351013|NCT01371266|Insulin|insulin
1351014|NCT01371266|metabolic syndrome|metabolic syndrome
1351015|NCT01371266|honey|honey
1351016|NCT01371266|Inflammation|inflammation
1351017|NCT01371266|oxidative stress|oxidative stress
1351018|NCT01371253|Nintendo wii|nintendo wii
1351019|NCT01371253|postural balance|postural balance
1351020|NCT01371253|muscle strength|muscle strength
1351021|NCT01371253|elderly|elderly
1351022|NCT01371240|pancreas cancer|pancreas cancer
1351023|NCT01371240|MRI|mri
1351024|NCT01371240|CT scan|ct scan
1351025|NCT01371227|Multiple myeloma|multiple myeloma
1351026|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
1351027|NCT01371227|JNS002|jns002
1351028|NCT01371227|Bortezomib|bortezomib
1351029|NCT01371214|exercise|exercise
1351030|NCT01371214|exercise movement techniques|exercise movement techniques
1351031|NCT01371214|activities of daily living|activities of daily living
1351032|NCT01371175|HIV|hiv
1351033|NCT01371123|serum aluminum|serum aluminum
1351034|NCT01371123|parenteral nutrition|parenteral nutrition
1351035|NCT01371123|children|children
1351037|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1351038|NCT01371110|ketamine|ketamine
1351039|NCT01371110|treatment|treatment
1351040|NCT01371097|Barthel Index|barthel index
1351041|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
1351042|NCT01371097|progressive resistance training|progressive resistance training
1351043|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
1351044|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
1351045|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
1351046|NCT01371071|Prognostic markers|prognostic markers
1351047|NCT01371071|MRI|mri
1351048|NCT01371071|OCT|oct
1351049|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
1351050|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
1351051|NCT01371058|stent thrombosis|stent thrombosis
1351052|NCT01371045|Acromegaly|acromegaly
1351053|NCT01371045|Growth Hormone|growth hormone
1351054|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
1351055|NCT01371045|Somatostatin|somatostatin
1351056|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
1351057|NCT01370993|Hypoxemia|hypoxemia
1351058|NCT01370993|Model|model
1351059|NCT01370993|Bronchoscopes|bronchoscopes
1351060|NCT01370993|Monitored anesthesia care|monitored anesthesia care
1351061|NCT01370980|Medication Adherence|medication adherence
1351062|NCT01370980|Patient Compliance|patient compliance
1351063|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
1351064|NCT01370980|Administration, Oral|administration, oral
1351065|NCT01370980|Cancer|cancer
1351066|NCT01370980|Letrozol|letrozol
1351067|NCT01370980|Exemestan|exemestan
1351068|NCT01370980|Imatinib|imatinib
1351069|NCT01370980|Sunitinib|sunitinib
1351070|NCT01370980|Nilotinib|nilotinib
1351071|NCT01370980|Everolimus|everolimus
1351072|NCT01370980|Deferasirox|deferasirox
1351073|NCT01370967|infant|infant
1351074|NCT01370967|term birth|term birth
1351075|NCT01370967|human milk|human milk
1351077|NCT01370967|breast feeding|breast feeding
1351078|NCT01370967|bottle feeding|bottle feeding
1351079|NCT01370967|gastrointestinal tract|gastrointestinal tract
1351080|NCT01370967|quality of life|quality of life
1351081|NCT01370967|infant development|infant development
1351082|NCT01370954|CerefolinNAC|cerefolinnac
1351083|NCT01370954|early memory loss|early memory loss
1351084|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
1351085|NCT01370954|cognitive function|cognitive function
1351086|NCT01370954|folic acid|folic acid
1351087|NCT01370954|folate|folate
1351088|NCT01370954|L-methylfolate|l-methylfolate
1351089|NCT01370954|vitamin B12|vitamin b12
1351090|NCT01370954|methylcobalamin|methylcobalamin
1351091|NCT01370954|N-acetylcysteine|n-acetylcysteine
1351093|NCT01370954|oxidative stress|oxidative stress
1351094|NCT01370954|memory deficit|memory deficit
1351095|NCT01370954|antioxidant|antioxidant
1351096|NCT01370941|Chymosin|chymosin
1351097|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
1351098|NCT01370941|Calcium absorption|calcium absorption
1351099|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
1351100|NCT01370928|Colonoscopy performance|colonoscopy performance
1351101|NCT01370928|Pain|pain
1351102|NCT01370928|Discomfort|discomfort
1351103|NCT01370928|Screening|screening
1351104|NCT01370928|Colorectal cancer|colorectal cancer
1351105|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
1351106|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
1351107|NCT01370876|Oxaliplatin|oxaliplatin
1351108|NCT01370876|Head and Neck cancer|head and neck cancer
1351109|NCT01370863|GERD|gerd
1351110|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
1351111|NCT01370863|SPD557|spd557
1351112|NCT01370863|Proton pump inhibitors|proton pump inhibitors
1351113|NCT01370850|Retina pathology|retina pathology
1351114|NCT01370824|Diagnosis|diagnosis
1351115|NCT01370824|Clinical|clinical
1351116|NCT01370824|Punch biopsy|punch biopsy
1351117|NCT01370824|Surgical excision|surgical excision
1351118|NCT01370824|Histology|histology
1351119|NCT01370824|Histopathology|histopathology
1351120|NCT01370824|Observed agreement|observed agreement
1351121|NCT01370824|Diagnostic value|diagnostic value
1351122|NCT01370824|Accuracy|accuracy
1351123|NCT01370824|Interobserver variability|interobserver variability
1351124|NCT01370824|Intraobserver variability|intraobserver variability
1351125|NCT01370811|oxybutynin|oxybutynin
1351126|NCT01370811|clonidine|clonidine
1351127|NCT01370811|OC Oral Solution|oc oral solution
1351128|NCT01370811|sialorrhoea|sialorrhoea
1351129|NCT01370811|Parkinson's disease|parkinson's disease
1351130|NCT01370798|Severe hypospadias|severe hypospadias
1351131|NCT01370798|local oestrogen|local oestrogen
1351132|NCT01370798|promestriene|promestriene
1351133|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
1351134|NCT01370798|post-operative complications|post-operative complications
1351135|NCT01370798|fistula dehiscence|fistula dehiscence
1351136|NCT01370772|B CLL|b cll
1351137|NCT01370772|Fist line treatment|fist line treatment
1351138|NCT01370759|bowel prep|bowel prep
1351139|NCT01370759|PillCam|pillcam
1351140|NCT01370733|TMS,|tms,
1351141|NCT01370733|MDD,|mdd,
1351142|NCT01370733|Depression,|depression,
1351143|NCT01370733|sTMS,|stms,
1351144|NCT01370733|NEST,|nest,
1351145|NCT01370733|NeoSync,|neosync,
1351146|NCT01370733|EEG,|eeg,
1351147|NCT01370733|synchronous,|synchronous,
1351148|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
1351149|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
1351150|NCT01370733|antidepressant,|antidepressant,
1351151|NCT01370720|IBS|ibs
1351152|NCT01370720|mast cell activation|mast cell activation
1351153|NCT01370720|low grade inflammation|low grade inflammation
1351154|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
1351155|NCT01370668|functional remediation|functional remediation
1351156|NCT01370668|psychoeducation|psychoeducation
1351157|NCT01370668|neurocognition|neurocognition
1351158|NCT01370629|atrial fibrillation|atrial fibrillation
1351159|NCT01370629|cardioversion|cardioversion
1351160|NCT01370616|Infection|infection
1351161|NCT01370616|Diabetes complications|diabetes complications
1351162|NCT01370616|Diabetes wound infection|diabetes wound infection
1351163|NCT01370616|Soft tissue infection|soft tissue infection
1351164|NCT01370616|Osteomyelitis|osteomyelitis
1351165|NCT01370616|Diabetes mellitus|diabetes mellitus
1351166|NCT01370577|Predictors for asthma control|predictors for asthma control
1351167|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
1351168|NCT01370577|Mean frequency of PFT|mean frequency of pft
1351169|NCT01370577|sputum assessments|sputum assessments
1351170|NCT01370577|refill adherence(%)|refill adherence(%)
1351171|NCT01370577|prescription persistence|prescription persistence
1351172|NCT01370564|Heart failure|heart failure
1351173|NCT01370564|Cardiac filling pressure|cardiac filling pressure
1351174|NCT01370538|Heartburn|heartburn
1351175|NCT01370525|Heartburn|heartburn
1351176|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1351177|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
1351178|NCT01370486|Melatonin|melatonin
1351179|NCT01370486|Tonic seizures|tonic seizures
1351180|NCT01370486|Interictal discharges|interictal discharges
1351181|NCT01370486|Quality of sleep|quality of sleep
1351182|NCT01370473|Hyponatremia|hyponatremia
1351183|NCT01370460|Tranexamic Acid|tranexamic acid
1351184|NCT01370460|Blood transfusion|blood transfusion
1351185|NCT01370460|Total knee arthroplasty|total knee arthroplasty
1351186|NCT01370447|Leigh syndrome|leigh syndrome
1351187|NCT01370447|MELAS|melas
1351188|NCT01370447|Kearns-Sayre|kearns-sayre
1351189|NCT01370447|Alper's|alper's
1351190|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
1351191|NCT01370447|Friedreich's ataxia|friedreich's ataxia
1351192|NCT01370447|POLG1 deficiency|polg1 deficiency
1351193|NCT01370434|MM|mm
1351194|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
1351195|NCT01370408|BEAM|beam
1351196|NCT01370408|Oral busulfan|oral busulfan
1351197|NCT01370408|Cyclophosphamide|cyclophosphamide
1351198|NCT01370408|Etoposide|etoposide
1351199|NCT01370408|Carboplatin|carboplatin
1351200|NCT01370408|melphalan|melphalan
1351201|NCT01370395|geriatrics|geriatrics
1351202|NCT01370395|troponin|troponin
1351203|NCT01370395|electrocardiography|electrocardiography
1351204|NCT01370395|diagnosis|diagnosis
1351205|NCT01370395|myocardial infarction|myocardial infarction
1351206|NCT01370382|geriatrics|geriatrics
1351207|NCT01370382|troponin|troponin
1351208|NCT01370382|electrocardiography|electrocardiography
1351209|NCT01370382|diagnosis|diagnosis
1351210|NCT01370382|myocardial infarction|myocardial infarction
1351211|NCT01370356|smoking reduction|smoking reduction
1351212|NCT01370356|smoking cessation|smoking cessation
1351213|NCT01370330|Neuroblastoma|neuroblastoma
1351214|NCT01370330|MIBG|mibg
1351215|NCT01370330|131I-MIBG|131i-mibg
1351216|NCT01370330|Resistant|resistant
1351217|NCT01370330|Relapsed|relapsed
1351218|NCT01370330|Treatment|treatment
1351219|NCT01370330|UCSF|ucsf
1351220|NCT01370330|Pediatric|pediatric
1351221|NCT01370330|Oncology|oncology
1351222|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1351223|NCT01370304|Depression|depression
1351224|NCT01370304|Venlafaxine|venlafaxine
1351225|NCT01370304|fMRI|fmri
1351226|NCT01370291|rTMS|rtms
1351227|NCT01370291|Risperidone|risperidone
1351228|NCT01370278|Central airway obstruction|central airway obstruction
1351229|NCT01370278|lumen obstruction|lumen obstruction
1351230|NCT01370278|Sodium bicarbonate|sodium bicarbonate
1351231|NCT01370278|Baking soda|baking soda
1351232|NCT01370278|Normal saline|normal saline
1351233|NCT01370278|Salt water|salt water
1351234|NCT01370278|Airway stents|airway stents
1351235|NCT01370278|Bronchoscopy|bronchoscopy
1351236|NCT01370278|mucus obstruction|mucus obstruction
1351237|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
1351238|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
1351239|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
1351240|NCT01370265|Regadenoson Stress|regadenoson stress
1351241|NCT01370252|ankle arthrodesis|ankle arthrodesis
1351242|NCT01370252|pain|pain
1351243|NCT01370252|arthroscopic technique|arthroscopic technique
1351244|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
1351245|NCT01370239|monoclonal antibody|monoclonal antibody
1351246|NCT01370239|Lewis|lewis
1351247|NCT01370239|breast cancer|breast cancer
1351248|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
1351249|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
1351250|NCT01370213|natural killer cells|natural killer cells
1351251|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
1351252|NCT01370200|citrate|citrate
1351253|NCT01370200|anticoagulation|anticoagulation
1351254|NCT01370200|plasma exchange|plasma exchange
1351255|NCT01370200|efficacy|efficacy
1351256|NCT01370187|Bronchiolitis|bronchiolitis
1351257|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
1351258|NCT01370187|Montelukast|montelukast
1351259|NCT01370174|Falls|falls
1351260|NCT01370174|Balance|balance
1351261|NCT01370174|Protective Stepping|protective stepping
1351262|NCT01370174|Lateral Balance|lateral balance
1351263|NCT01370174|Elderly|elderly
1351264|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
1351265|NCT01370161|TIPS|tips
1351266|NCT01370161|variceal bleeding|variceal bleeding
1351267|NCT01370161|liver cirrhosis|liver cirrhosis
1351268|NCT01370161|hepatitis B|hepatitis b
1351269|NCT01370148|Pharmacokinetics|pharmacokinetics
1351270|NCT01370148|Protein Binding|protein binding
1351271|NCT01370148|Conivaptan|conivaptan
1351272|NCT01370148|Vaprisol|vaprisol
1351273|NCT01370148|Liver Disease|liver disease
1351274|NCT01370148|YM087|ym087
1351275|NCT01370135|neovascular glaucoma|neovascular glaucoma
1351276|NCT01370135|rubeosis|rubeosis
1351277|NCT01370135|anterior chamber|anterior chamber
1351278|NCT01370135|intraocular|intraocular
1351279|NCT01370135|intravitreal injections|intravitreal injections
1351280|NCT01370135|Lucentis|lucentis
1351281|NCT01370135|Ranibizumab|ranibizumab
1351282|NCT01370135|short ans longterm effects|short ans longterm effects
1351283|NCT01370135|best corrected visual acuity|best corrected visual acuity
1351284|NCT01370135|gonioscopy|gonioscopy
1351285|NCT01370135|BCVA|bcva
1351286|NCT01370135|quality of life|quality of life
1351287|NCT01370122|Women over the age of 20|women over the age of 20
1351288|NCT01370083|Dysphagia|dysphagia
1351289|NCT01370083|Viscosity|viscosity
1351290|NCT01370083|Tongue|tongue
1351291|NCT01370083|Pressure|pressure
1351292|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1351293|NCT01370057|Scoliosis|scoliosis
1351294|NCT01370057|AIS|ais
1351295|NCT01370057|Brace|brace
1351296|NCT01370057|TLSO|tlso
1351297|NCT01370044|Febrile Seizure|febrile seizure
1351298|NCT01370044|Carbon Dioxide|carbon dioxide
1351299|NCT01370044|Carbogen|carbogen
1351300|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
1351301|NCT01370031|Asthma|asthma
1351302|NCT01370031|PK|pk
1351303|NCT01370031|Adults|adults
1351304|NCT01370018|CD4 counts|cd4 counts
1351305|NCT01369992|Metastatic Cancer|metastatic cancer
1351306|NCT01369979|Lumped constant|lumped constant
1351307|NCT01369979|FDG|fdg
1351308|NCT01369979|PET|pet
1351314|NCT01369953|Genetic Counseling|genetic counseling
1351315|NCT01369953|Genetic Disorders|genetic disorders
1351316|NCT01369953|Genetic Testing|genetic testing
1351317|NCT01369953|Whole Genome Sequencing|whole genome sequencing
1351318|NCT01369940|Growth Discordancy|growth discordancy
1351319|NCT01369940|Fetal Growth|fetal growth
1351320|NCT01369940|Twin Growth|twin growth
1351321|NCT01369927|Shigellosis|shigellosis
1351322|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
1351323|NCT01369927|Conjugate Vaccine|conjugate vaccine
1351324|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
1351325|NCT01369914|Natural History Study|natural history study
1351326|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1351327|NCT01369914|GVHD|gvhd
1351333|NCT01369888|Immunotherapy|immunotherapy
1351334|NCT01369888|Cell Therapy|cell therapy
1351335|NCT01369888|IL-15 Cytokine|il-15 cytokine
1351336|NCT01369888|Melanoma|melanoma
1351337|NCT01369888|Metastatic Melanoma|metastatic melanoma
1351338|NCT01369888|Skin Cancer|skin cancer
1351339|NCT01369875|Immunotherapy|immunotherapy
1351340|NCT01369875|Cell Therapy|cell therapy
1351341|NCT01369875|Metastatic Cancer|metastatic cancer
1351342|NCT01369875|Melanoma|melanoma
1351343|NCT01369875|Metastatic Melanoma|metastatic melanoma
1351344|NCT01369875|Skin Cancer|skin cancer
1351345|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
1351346|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
1351347|NCT01369862|intranasal application|intranasal application
1351348|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
1351349|NCT01369836|Tafamidis|tafamidis
1351350|NCT01369836|Pharmacokinetics|pharmacokinetics
1351351|NCT01369836|TTR stabilization|ttr stabilization
1351352|NCT01369823|HbA1c|hba1c
1351353|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
1351354|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
1351355|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
1351356|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
1351357|NCT01369810|Epidemiological|epidemiological
1351358|NCT01369810|asthma|asthma
1351359|NCT01369810|COPD|copd
1351360|NCT01369810|reimbursement|reimbursement
1351361|NCT01369810|switch|switch
1351362|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
1351363|NCT01369797|UPSAV|upsav
1351364|NCT01369797|autonomy|autonomy
1351365|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
1351366|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
1351367|NCT01369784|R-IPI|r-ipi
1351368|NCT01369771|Confocal microscopic findings|confocal microscopic findings
1351369|NCT01369771|Ocular Hypertension|ocular hypertension
1351370|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
1351371|NCT01369771|Preservative-free eye drops|preservative-free eye drops
1351372|NCT01369758|morcellator|morcellator
1351373|NCT01369758|hysteroscope|hysteroscope
1351374|NCT01369758|myomectomy|myomectomy
1351375|NCT01369758|polypectomy|polypectomy
1351376|NCT01369758|uterine fibroids|uterine fibroids
1351377|NCT01369758|uterine polyps|uterine polyps
1351378|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
1351379|NCT01369745|Moderate to severe|moderate to severe
1351380|NCT01369719|Thalassemia|thalassemia
1351381|NCT01369719|Iron overload|iron overload
1351382|NCT01369719|transfusion|transfusion
1351383|NCT01369719|osveral|osveral
1351384|NCT01369719|desferal|desferal
1351385|NCT01369706|electromagnetic interference|electromagnetic interference
1351386|NCT01369706|hand-held metal detector|hand-held metal detector
1351387|NCT01369706|pacemaker|pacemaker
1351388|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
1351389|NCT01369693|smokeless tobacco|smokeless tobacco
1351390|NCT01369693|Nicotine|nicotine
1351391|NCT01369693|Cadmium|cadmium
1351392|NCT01369693|lead|lead
1351393|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
1351394|NCT01369680|Ketamine|ketamine
1351395|NCT01369680|Chronic pain|chronic pain
1351396|NCT01369680|Children|children
1351397|NCT01369680|Oral pain medication|oral pain medication
1351398|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
1351399|NCT01369654|Oophorectomy|oophorectomy
1351400|NCT01369654|Gynecologic condition|gynecologic condition
1351401|NCT01369641|cisplatin|cisplatin
1351402|NCT01369641|STS|sts
1351403|NCT01369641|sodium thiosulfate|sodium thiosulfate
1351404|NCT01369641|Adults|adults
1351405|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
1351406|NCT01369628|Open label|open label
1351407|NCT01369628|Dose Escalating|dose escalating
1351408|NCT01369628|Phase Ib|phase ib
1351409|NCT01369615|Malignant pain|malignant pain
1351410|NCT01369615|Nonmalignant pain|nonmalignant pain
1351411|NCT01369615|Pain|pain
1351412|NCT01369615|Pediatric|pediatric
1351413|NCT01369615|Opioid|opioid
1351414|NCT01369615|Moderate to severe|moderate to severe
1351415|NCT01369589|Xerostomia|xerostomia
1351416|NCT01369589|dry mouth|dry mouth
1351417|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
1351418|NCT01369563|rhinitis|rhinitis
1351419|NCT01369563|ciclesonide|ciclesonide
1351420|NCT01369563|intermittent rhinitis|intermittent rhinitis
1351421|NCT01369563|persistent rhinitis|persistent rhinitis
1351422|NCT01369524|fluid responsiveness|fluid responsiveness
1351423|NCT01369524|microcirculation|microcirculation
1351424|NCT01369524|Intensive Care|intensive care
1351425|NCT01369511|Disuse Atrophy|disuse atrophy
1351426|NCT01369511|Muscle|muscle
1351427|NCT01369511|Strength|strength
1351428|NCT01369511|Arthroplasty|arthroplasty
1351429|NCT01369511|Hip|hip
1351430|NCT01369511|Joint Replacement|joint replacement
1351431|NCT01369498|Hematology|hematology
1351432|NCT01369498|Myelofibrosis|myelofibrosis
1351433|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
1351434|NCT01369498|Bone Marrow Diseases|bone marrow diseases
1351435|NCT01369498|Hematologic Diseases|hematologic diseases
1351436|NCT01369498|Blood Diseases|blood diseases
1351437|NCT01369498|Leukemia|leukemia
1351438|NCT01369498|Blood Disorders|blood disorders
1351439|NCT01369485|Urinary Incontinence|urinary incontinence
1351440|NCT01369485|Overactive Bladder|overactive bladder
1351441|NCT01369485|Frequency|frequency
1351442|NCT01369485|Urgency|urgency
1351443|NCT01369459|Comorbid|comorbid
1351444|NCT01369459|ADHD|adhd
1351445|NCT01369459|SUD|sud
1351446|NCT01369459|ASU|asu
1351447|NCT01369446|In vitro fertilization|in vitro fertilization
1351448|NCT01369446|Assisted reproduction|assisted reproduction
1351449|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
1351450|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
1351451|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
1351452|NCT01369446|Prediction of blastocysts|prediction of blastocysts
1351453|NCT01369433|tivozanib|tivozanib
1351454|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
1351455|NCT01369420|pancreatic cancer|pancreatic cancer
1351456|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
1351457|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1351458|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
1351459|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
1351460|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
1351461|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
1351462|NCT01369420|Non thermal ablation|non thermal ablation
1351463|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
1351464|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
1351465|NCT01369407|Heart failure|heart failure
1351466|NCT01369407|HF|hf
1351467|NCT01369407|Heart Diseases|heart diseases
1351468|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
1351469|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
1351470|NCT01369407|Advanced heart failure|advanced heart failure
1351471|NCT01369407|Systolic Heart Failure|systolic heart failure
1351472|NCT01369394|Measles|measles
1351473|NCT01369394|Mumps|mumps
1351474|NCT01369394|Rubella|rubella
1351475|NCT01369394|MMR|mmr
1351476|NCT01369394|Prevention|prevention
1351477|NCT01369394|Tailoring|tailoring
1351478|NCT01369394|Persuasive communication|persuasive communication
1351479|NCT01369394|Children|children
1351480|NCT01369381|Cervical spine|cervical spine
1351481|NCT01369381|Endotracheal intubation|endotracheal intubation
1351482|NCT01369381|Laryngoscope|laryngoscope
1351483|NCT01369381|Biomechanics|biomechanics
1351484|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
1351485|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1351486|NCT01369368|Relapse|relapse
1351487|NCT01369368|Disease stabilization, survival|disease stabilization, survival
1351488|NCT01369355|Ustekinumab|ustekinumab
1351489|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
1351490|NCT01369355|IBD, Crohn's|ibd, crohn's
1351491|NCT01369355|UNITI|uniti
1351492|NCT01369355|colitis|colitis
1351493|NCT01369355|IL-12|il-12
1351494|NCT01369355|IL-23|il-23
1351495|NCT01369342|ustekinumab|ustekinumab
1351496|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
1351497|NCT01369342|Stelara|stelara
1351498|NCT01369342|IBD|ibd
1351499|NCT01369342|colitis|colitis
1351500|NCT01369342|crohn|crohn
1351501|NCT01369342|UNITI|uniti
1351502|NCT01369342|Crohn's|crohn's
1351503|NCT01369329|ustekinumab|ustekinumab
1351504|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
1351505|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
1351506|NCT01369329|Crohn|crohn
1351507|NCT01369329|Crohn's|crohn's
1351508|NCT01369329|IBD|ibd
1351509|NCT01369329|UNITI|uniti
1351510|NCT01369303|HIV|hiv
1351511|NCT01369290|Depression|depression
1351512|NCT01369290|Antidepressant Medication|antidepressant medication
1351513|NCT01369290|CBT|cbt
1351514|NCT01369277|PF-04991532|pf-04991532
1351515|NCT01369277|safety and tolerability|safety and tolerability
1351516|NCT01369277|PK|pk
1351517|NCT01369277|Japanese and Western population|japanese and western population
1351518|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1351519|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
1351520|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
1351521|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
1351522|NCT01369238|bee venom acupuncture|bee venom acupuncture
1351523|NCT01369238|east west collaborative medicine|east west collaborative medicine
1351524|NCT01369238|whiplash associated disorder|whiplash associated disorder
1351525|NCT01369225|Randomized|randomized
1351526|NCT01369225|Safety Study|safety study
1351527|NCT01369225|Open Label|open label
1351528|NCT01369199|Hepatitis B|hepatitis b
1351529|NCT01369199|immune-tolerant hepatitis b|immune-tolerant hepatitis b
1351530|NCT01369199|HBV|hbv
1351531|NCT01369173|Healthy|healthy
1351532|NCT01369147|SICU|sicu
1351533|NCT01369147|calories|calories
1351534|NCT01369147|TPN|tpn
1351535|NCT01369147|tube feeding|tube feeding
1351536|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
1351537|NCT01369134|self-etch adhesive|self-etch adhesive
1351538|NCT01369134|selective enamel etching|selective enamel etching
1351539|NCT01369134|Adper Easy Bond|adper easy bond
1351540|NCT01369134|Supreme Ultra|supreme ultra
1351541|NCT01369134|Molar and premolar teeth|molar and premolar teeth
1351542|NCT01369134|Adult|adult
1351543|NCT01369134|Class I and II cavities|class i and ii cavities
1351544|NCT01369121|peritumoral brain edema|peritumoral brain edema
1351545|NCT01369121|edema|edema
1351546|NCT01369121|malignant brain tumor|malignant brain tumor
1351547|NCT01369121|brain tumor|brain tumor
1351548|NCT01369121|dexamethasone|dexamethasone
1351549|NCT01369121|Decadron|decadron
1351550|NCT01369108|small Class I|small class i
1351551|NCT01369108|molar and premolar|molar and premolar
1351552|NCT01369108|low stress flowable composite|low stress flowable composite
1351553|NCT01369108|adult|adult
1351554|NCT01369108|Restoration|restoration
1351555|NCT01369108|small caries lesions|small caries lesions
1351556|NCT01369082|islet allograft function|islet allograft function
1351557|NCT01369082|c-peptide production|c-peptide production
1351558|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
1351559|NCT01369069|stroke|stroke
1351560|NCT01369069|diabetes|diabetes
1351561|NCT01369069|hyperglycemia|hyperglycemia
1351562|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
1351563|NCT01369056|treatment adherence|treatment adherence
1351564|NCT01369043|Vitamin E|vitamin e
1351565|NCT01369043|Vitamin C|vitamin c
1351566|NCT01369043|Exercise|exercise
1351567|NCT01369043|Antioxidant|antioxidant
1351568|NCT01369030|L-methylfolate|l-methylfolate
1351569|NCT01369030|Deplin|deplin
1351570|NCT01369030|depression|depression
1351571|NCT01369030|antidepressant|antidepressant
1351572|NCT01369030|combination therapy|combination therapy
1351573|NCT01369030|augmentation|augmentation
1351574|NCT01369030|folate|folate
1351575|NCT01369030|folic acid|folic acid
1351576|NCT01369030|homocysteine|homocysteine
1351577|NCT01369030|methionine|methionine
1351578|NCT01369030|MTHFR genotype|mthfr genotype
1351579|NCT01369030|C677T mutation|c677t mutation
1351580|NCT01369030|vitamin B6|vitamin b6
1351581|NCT01369030|vitamin B12|vitamin b12
1351582|NCT01369017|healthy volunteer|healthy volunteer
1351583|NCT01369017|endotoxin|endotoxin
1351584|NCT01369004|self-weighing|self-weighing
1351585|NCT01369004|self-monitoring|self-monitoring
1351586|NCT01369004|weight loss|weight loss
1351587|NCT01369004|obesity|obesity
1351588|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
1351589|NCT01368991|Sternal Closure|sternal closure
1351590|NCT01368991|Biologic Bone cement|biologic bone cement
1351591|NCT01368978|TIDM|tidm
1351592|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
1351593|NCT01368952|Prone positioning|prone positioning
1351594|NCT01368952|Positional Treatment|positional treatment
1351595|NCT01368952|Hypoxemia|hypoxemia
1351596|NCT01368939|breast imaging|breast imaging
1351597|NCT01368939|MBI|mbi
1351598|NCT01368939|dose reduction|dose reduction
1351599|NCT01368939|Tc-99m|tc-99m
1351600|NCT01368939|imaging|imaging
1351601|NCT01368939|cardiac|cardiac
1351602|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
1351603|NCT01368900|Ulthera, Inc.|ulthera, inc.
1351604|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
1351605|NCT01368887|psoriasis|psoriasis
1351606|NCT01368887|scalp psoriasis|scalp psoriasis
1351607|NCT01368861|infant|infant
1351608|NCT01368861|immunizations|immunizations
1351609|NCT01368861|pain|pain
1351610|NCT01368861|pain management|pain management
1351611|NCT01368861|vaccines|vaccines
1351612|NCT01368861|analgesia|analgesia
1351613|NCT01368848|AGMT|agmt
1351614|NCT01368848|NSCLC|nsclc
1351615|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
1351616|NCT01368848|bevacizumab|bevacizumab
1351617|NCT01368848|Avastin|avastin
1351618|NCT01368848|Cisplatin|cisplatin
1351619|NCT01368848|Docetaxel|docetaxel
1351620|NCT01368848|Taxotere|taxotere
1351621|NCT01368848|Inoperable|inoperable
1351622|NCT01368848|stages IIIB and IV|stages iiib and iv
1351623|NCT01368809|Ambulatory surgery|ambulatory surgery
1351624|NCT01368809|Pain management|pain management
1351625|NCT01368809|Perioperative outcomes|perioperative outcomes
1351626|NCT01368809|Fentanyl|fentanyl
1351627|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
1351628|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
1351629|NCT01368796|Vaccine|vaccine
1351630|NCT01368796|Influenza vaccine|influenza vaccine
1351631|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
1351632|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
1351633|NCT01368796|Seniors|seniors
1351634|NCT01368796|Acceptability of vaccines|acceptability of vaccines
1351635|NCT01368796|Influenza|influenza
1351636|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1351637|NCT01368757|CMML|cmml
1351638|NCT01368757|Lenalidomide|lenalidomide
1351639|NCT01368757|Revlimid|revlimid
1351640|NCT01368744|Breast Neoplasms|breast neoplasms
1351641|NCT01368744|Breast Diseases|breast diseases
1351642|NCT01368705|Infants|infants
1351643|NCT01368705|Nitrogen Balance|nitrogen balance
1351644|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
1351645|NCT01368705|Congenital heart disease|congenital heart disease
1351646|NCT01368705|Malnutrition|malnutrition
1351647|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
1351648|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
1351649|NCT01368679|Abdominal Aortic|abdominal aortic
1351650|NCT01368666|Aortic valve replacement|aortic valve replacement
1351651|NCT01368666|Aortic stenosis|aortic stenosis
1351652|NCT01368666|Biological valve|biological valve
1351653|NCT01368666|Sutureless valve|sutureless valve
1351654|NCT01368666|Stented valve|stented valve
1351655|NCT01368666|Aortic Valve Disease|aortic valve disease
1351656|NCT01368653|Tobacco|tobacco
1351657|NCT01368653|Smoking|smoking
1351658|NCT01368653|Smoking Cessation|smoking cessation
1351659|NCT01368653|Tobacco Dependence|tobacco dependence
1351660|NCT01368653|Tobacco Use|tobacco use
1351661|NCT01368653|Nicotine Dependence|nicotine dependence
1351662|NCT01368627|Coronary Artery Disease|coronary artery disease
1351663|NCT01368627|Restenosis|restenosis
1351664|NCT01368627|Stent thrombosis|stent thrombosis
1351665|NCT01368627|Coronary stents|coronary stents
1351666|NCT01368627|Angioplasty|angioplasty
1351667|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
1351669|NCT01368601|Lung Cancer|lung cancer
1351670|NCT01368601|CPAP|cpap
1351671|NCT01368601|PPC|ppc
1351672|NCT01368601|lobectomy|lobectomy
1351673|NCT01368601|One-lung ventilation|one-lung ventilation
1351674|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1351675|NCT01368588|stage I prostate cancer|stage i prostate cancer
1351676|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
1351677|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
1351678|NCT01368588|stage III prostate cancer|stage iii prostate cancer
1351679|NCT01368575|Ischemic|ischemic
1351680|NCT01368575|Mitral|mitral
1351681|NCT01368575|Valve|valve
1351682|NCT01368575|Insufficiency|insufficiency
1351683|NCT01368575|SVR|svr
1351684|NCT01368549|Metanx|metanx
1351685|NCT01368549|diabetes|diabetes
1351686|NCT01368549|neuropathy|neuropathy
1351687|NCT01368549|folic acid|folic acid
1351688|NCT01368549|folate|folate
1351689|NCT01368549|L-methylfolate|l-methylfolate
1351690|NCT01368549|vitamin B6|vitamin b6
1351691|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
1351692|NCT01368549|vitamin B12|vitamin b12
1351693|NCT01368549|methylcobalamin|methylcobalamin
1351694|NCT01368549|DPN|dpn
1351695|NCT01368536|High blood pressure|high blood pressure
1351696|NCT01368536|diabetes|diabetes
1351697|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1351698|NCT01368523|chronic phase|chronic phase
1351699|NCT01368523|accelerated phase|accelerated phase
1351700|NCT01368523|blastic phase|blastic phase
1351701|NCT01368523|nilotinib|nilotinib
1351702|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
1351703|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
1351704|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1351705|NCT01368510|glutamate|glutamate
1351706|NCT01368510|cingulate gyrus|cingulate gyrus
1351707|NCT01368471|STEMI|stemi
1351708|NCT01368471|myocardial infarction|myocardial infarction
1351709|NCT01368471|stent|stent
1351710|NCT01368432|TBI|tbi
1351711|NCT01368432|Depression|depression
1351712|NCT01368432|Mood|mood
1351713|NCT01368432|Behavior|behavior
1351714|NCT01368419|Endostar|endostar
1351715|NCT01368419|Radiotherapy|radiotherapy
1351716|NCT01368419|Esophageal Cancer|esophageal cancer
1351717|NCT01368406|schizophrenia|schizophrenia
1351718|NCT01368406|weight gain|weight gain
1351719|NCT01368406|intervention|intervention
1351720|NCT01368380|Breast cancer|breast cancer
1351721|NCT01368380|Partners|partners
1351722|NCT01368380|Couples|couples
1351723|NCT01368380|Attachment|attachment
1351724|NCT01368380|Intervention|intervention
1351725|NCT01368367|Burns|burns
1351726|NCT01368354|Community Led Total Sanitation|community led total sanitation
1351727|NCT01368354|Open Defecation|open defecation
1351728|NCT01368354|Cysticercosis|cysticercosis
1351729|NCT01368354|Soil transmitted helminths|soil transmitted helminths
1351730|NCT01368354|Zambia|zambia
1351731|NCT01368341|Antibiotics|antibiotics
1351732|NCT01368341|General Practice|general practice
1351733|NCT01368341|Erythema migrans|erythema migrans
1351734|NCT01368341|Borrelia|borrelia
1351735|NCT01368341|Ticks|ticks
1351736|NCT01368328|Type 2 Diabetes|type 2 diabetes
1351737|NCT01368328|Chromium|chromium
1351738|NCT01368328|Insulin resistance|insulin resistance
1351739|NCT01368302|attention bias modification treatment|attention bias modification treatment
1352146|NCT01366534|Phase 1/2|phase 1/2
1351740|NCT01368302|cognitive bias modification|cognitive bias modification
1351741|NCT01368302|attention training|attention training
1351742|NCT01368302|anxiety|anxiety
1351743|NCT01368276|Melanoma|melanoma
1351744|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
1351745|NCT01368276|oncolytic|oncolytic
1351746|NCT01368276|OncoVex|oncovex
1351747|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
1351748|NCT01368250|Aortic|aortic
1351749|NCT01368250|Stenosis|stenosis
1351750|NCT01368250|Valve|valve
1351751|NCT01368250|VARC|varc
1351752|NCT01368250|Transcatheter|transcatheter
1351753|NCT01368250|Minimal-invasive|minimal-invasive
1351754|NCT01368237|Computed tomography|computed tomography
1351755|NCT01368237|Myocardial perfusion|myocardial perfusion
1351756|NCT01368237|Coronary heart disease|coronary heart disease
1351757|NCT01368224|Skin sensitivity|skin sensitivity
1351758|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
1351759|NCT01368224|Clinical score|clinical score
1351760|NCT01368224|skin moisturization factors|skin moisturization factors
1351761|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
1351762|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
1351763|NCT01368211|Mirasol|mirasol
1351764|NCT01368211|Thrombocytopenic|thrombocytopenic
1351765|NCT01368211|Pathogen reduction|pathogen reduction
1351766|NCT01368211|Platelets|platelets
1351767|NCT01368211|Thromboelastography|thromboelastography
1351768|NCT01368211|CCI|cci
1351769|NCT01368211|Corrected Count Increment|corrected count increment
1351770|NCT01368198|Ocular Emulsion|ocular emulsion
1351771|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
1351772|NCT01368198|Tear Film Break Up Time|tear film break up time
1351773|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
1351774|NCT01368172|spinal cord injury|spinal cord injury
1351775|NCT01368172|physical activity|physical activity
1351776|NCT01368172|physical fitness|physical fitness
1351777|NCT01368133|acromegaly|acromegaly
1351778|NCT01368133|pituitary tumor|pituitary tumor
1351779|NCT01368107|IL-7|il-7
1351780|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
1351781|NCT01368107|lymphopenia|lymphopenia
1351782|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
1351783|NCT01368094|Drainage|drainage
1351784|NCT01368094|Surgical site infection|surgical site infection
1351785|NCT01368068|Perimenopause|perimenopause
1351786|NCT01368068|Depression|depression
1351787|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
1351788|NCT01368042|Quality of Life changes|quality of life changes
1351789|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1351790|NCT01368042|Chronic Kidney Disease|chronic kidney disease
1351791|NCT01368042|Hemodialysis|hemodialysis
1351792|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
1351793|NCT01368029|LGG|lgg
1351794|NCT01368029|Immune response|immune response
1351795|NCT01368029|Influenza vaccine|influenza vaccine
1351796|NCT01368029|Elderly|elderly
1351797|NCT01368029|Healthy|healthy
1351798|NCT01368029|Microbiome|microbiome
1351799|NCT01368016|Smoking Cessation|smoking cessation
1351800|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
1351801|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
1351802|NCT01367990|alopecia|alopecia
1351803|NCT01367990|hair loss|hair loss
1351804|NCT01367990|prevention|prevention
1351805|NCT01367990|radiotherapy|radiotherapy
1351806|NCT01367990|head & neck cancer|head & neck cancer
1351807|NCT01367990|radiodermatitis|radiodermatitis
1351808|NCT01367990|radiation dermatitis|radiation dermatitis
1351809|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
1351810|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
1351811|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
1351812|NCT01367977|Dysautonomia|dysautonomia
1351813|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
1351814|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
1351815|NCT01367964|Hypsarrhythmia|hypsarrhythmia
1351816|NCT01367964|Spasms, Infantile|spasms, infantile
1351817|NCT01367964|West Syndrome|west syndrome
1351818|NCT01367951|unstable chest injury|unstable chest injury
1351819|NCT01367951|flail chest|flail chest
1351820|NCT01367951|chest wall injury|chest wall injury
1351821|NCT01367951|rib fracture|rib fracture
1351822|NCT01367938|Osteoarthritis|osteoarthritis
1351823|NCT01367938|Total Knee Replacement|total knee replacement
1351824|NCT01367938|Total Knee Arthroplasty|total knee arthroplasty
1351826|NCT01367938|Knee|knee
1351827|NCT01367925|Osteoarthritis|osteoarthritis
1351828|NCT01367925|Total Knee Replacement|total knee replacement
1351829|NCT01367925|TKA|tka
1351830|NCT01367925|Knee|knee
1351831|NCT01367925|PS|ps
1351832|NCT01367925|CS|cs
1351833|NCT01367912|Luteal phase support|luteal phase support
1351834|NCT01367912|estradiol supplementation|estradiol supplementation
1351835|NCT01367912|IVF/ICSI|ivf/icsi
1351836|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
1351837|NCT01367899|Safety|safety
1351838|NCT01367899|Efficacy|efficacy
1351839|NCT01367886|Urine proteomics|urine proteomics
1351840|NCT01367886|overactive bladder|overactive bladder
1351841|NCT01367860|spine surgery|spine surgery
1351842|NCT01367860|low back pain|low back pain
1351843|NCT01367860|herniated disk|herniated disk
1351844|NCT01367847|Parenting|parenting
1351845|NCT01367847|Parent-Child Relations|parent-child relations
1351846|NCT01367847|Child Behavior|child behavior
1351847|NCT01367834|Turner Syndrome|turner syndrome
1351848|NCT01367834|growth hormone|growth hormone
1351849|NCT01367834|brain development|brain development
1351850|NCT01367821|Obstructive jaundice|obstructive jaundice
1351851|NCT01367821|ERCP|ercp
1351852|NCT01367821|Immune dysfunction|immune dysfunction
1351853|NCT01367821|Endotoxin tolerance|endotoxin tolerance
1351854|NCT01367821|Quorum sensing|quorum sensing
1351855|NCT01367808|Buprenorphine|buprenorphine
1351856|NCT01367808|Vorikonazole|vorikonazole
1351857|NCT01367808|Posakonazole|posakonazole
1351858|NCT01367808|Interactions|interactions
1351859|NCT01367795|palliation|palliation
1351860|NCT01367795|quality of life|quality of life
1351861|NCT01367795|surgery|surgery
1351862|NCT01367795|surgery; palliative|surgery; palliative
1351863|NCT01367795|lifestyle|lifestyle
1351864|NCT01367782|UPDRS|updrs
1351865|NCT01367769|Deep vein thrombosis|deep vein thrombosis
1351866|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
1351867|NCT01367769|contrast ultrasound|contrast ultrasound
1351868|NCT01367743|myocardial infarction|myocardial infarction
1351869|NCT01367743|epinephrine|epinephrine
1351870|NCT01367743|norepinephrine|norepinephrine
1351871|NCT01367743|cardiac output|cardiac output
1351872|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
1351873|NCT01367717|Creatine|creatine
1351874|NCT01367717|Creatinine|creatinine
1351875|NCT01367717|Serum Creatinine|serum creatinine
1351876|NCT01367717|Urine Creatinine|urine creatinine
1351877|NCT01367717|Creatine Monohydrate|creatine monohydrate
1351878|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
1351879|NCT01367717|Acute Kidney Injury|acute kidney injury
1351880|NCT01367717|Renal|renal
1351881|NCT01367717|Kidney|kidney
1351882|NCT01367704|gender-based violence|gender-based violence
1351883|NCT01367704|intimate partner violence|intimate partner violence
1351884|NCT01367704|relationship abuse|relationship abuse
1351885|NCT01367704|sexual harassment|sexual harassment
1351886|NCT01367704|sexual violence|sexual violence
1351887|NCT01367691|CRT|crt
1351888|NCT01367691|heart failure|heart failure
1351889|NCT01367691|CMR|cmr
1351890|NCT01367691|safety|safety
1351891|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
1351892|NCT01367639|IBSR|ibsr
1351893|NCT01367639|The Work|the work
1351894|NCT01367639|Randomized clinical trial|randomized clinical trial
1351895|NCT01367613|Advanced medical illness|advanced medical illness
1351896|NCT01367600|Advanced medical illness|advanced medical illness
1351897|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
1351898|NCT01367444|Stargardt's Disease|stargardt's disease
1351899|NCT01367431|Xanthohumol|xanthohumol
1351900|NCT01367431|Metabolic syndrome|metabolic syndrome
1351901|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
1351902|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
1351903|NCT01367418|Immune system|immune system
1351904|NCT01367418|Inflammation|inflammation
1351905|NCT01367405|Surgical decompression|surgical decompression
1351906|NCT01367405|conservative treatment|conservative treatment
1351907|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
1351908|NCT01367405|recovery|recovery
1351909|NCT01367379|Physician|physician
1351910|NCT01367379|duty loading|duty loading
1351911|NCT01367379|stress response|stress response
1352011|NCT01367067|anxiety|anxiety
1351912|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
1351913|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
1351914|NCT01367366|positron emission tomography|positron emission tomography
1351915|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
1351916|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
1351917|NCT01367327|Exercise|exercise
1351918|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
1351919|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1351920|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
1351921|NCT01367288|stage IIb breast cancer|stage iib breast cancer
1351922|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
1351923|NCT01367288|Zoledronic acid|zoledronic acid
1351924|NCT01367288|bisphosphonate|bisphosphonate
1351925|NCT01367288|zometa|zometa
1351926|NCT01367288|therapeutic response|therapeutic response
1351927|NCT01367288|VEGF serum|vegf serum
1351928|NCT01367288|tumors markers|tumors markers
1351929|NCT01367288|neoangiogenesis|neoangiogenesis
1351930|NCT01367288|apoptosis|apoptosis
1351931|NCT01367288|proliferation|proliferation
1351932|NCT01367288|disseminated tumors cells|disseminated tumors cells
1351933|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
1351934|NCT01367275|colon|colon
1351935|NCT01367275|Colorectum|colorectum
1351936|NCT01367275|Colorectal Cancer|colorectal cancer
1351937|NCT01367275|Plasma FGF|plasma fgf
1351938|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
1351939|NCT01367275|Bevacizumab|bevacizumab
1351940|NCT01367275|Brivanib|brivanib
1351941|NCT01367275|BMS-582664|bms-582664
1351942|NCT01367275|Irinotecan|irinotecan
1351943|NCT01367275|CPT-11|cpt-11
1351944|NCT01367275|Camptosar|camptosar
1351945|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
1351946|NCT01367275|bFGF|bfgf
1351947|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
1351948|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
1351949|NCT01367275|VEGFR|vegfr
1351950|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
1351951|NCT01367275|FGFR|fgfr
1351952|NCT01367262|Absorption|absorption
1351953|NCT01367262|Distribution|distribution
1351954|NCT01367262|Metabolism|metabolism
1351955|NCT01367262|Excretion|excretion
1351956|NCT01367249|cataract surgery|cataract surgery
1351957|NCT01367223|inflammatory response|inflammatory response
1351958|NCT01367223|parenteral nutrition|parenteral nutrition
1351959|NCT01367223|glutamine|glutamine
1351960|NCT01367223|amino acid|amino acid
1351961|NCT01367223|pediatric|pediatric
1351962|NCT01367223|intensive care|intensive care
1351963|NCT01367223|systemic infection|systemic infection
1351964|NCT01367223|abdominal surgery|abdominal surgery
1351965|NCT01367223|polytraumatised|polytraumatised
1351966|NCT01367223|mortality|mortality
1351967|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
1351968|NCT01367223|occurrence of infections|occurrence of infections
1351969|NCT01367210|HIV|hiv
1351970|NCT01367210|AIDS|aids
1351971|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
1351972|NCT01367210|Simplification|simplification
1351973|NCT01367210|Maraviroc|maraviroc
1351974|NCT01367210|Darunavir|darunavir
1351975|NCT01367210|Treatment experienced|treatment experienced
1351976|NCT01367210|Tropism|tropism
1351977|NCT01367197|exercise training|exercise training
1351978|NCT01367197|atrial fibrillation|atrial fibrillation
1351979|NCT01367184|VTE|vte
1351980|NCT01367184|Inferior vena cava|inferior vena cava
1351981|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
1351982|NCT01367184|Outcome data|outcome data
1351983|NCT01367184|IVC Filters|ivc filters
1351984|NCT01367158|Meningococcal disease|meningococcal disease
1351985|NCT01367158|vaccines|vaccines
1351986|NCT01367158|adolescents|adolescents
1351987|NCT01367158|prevention|prevention
1351988|NCT01367158|Meningitis|meningitis
1351989|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
1351990|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
1351991|NCT01367145|Endothelial Function|endothelial function
1351992|NCT01367145|Inflammation|inflammation
1351993|NCT01367145|Platelet Function|platelet function
1351994|NCT01367132|ultrasound|ultrasound
1351995|NCT01367132|first trimester|first trimester
1351996|NCT01367132|umbilical cord|umbilical cord
1351997|NCT01367119|Depression|depression
1351998|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
1351999|NCT01367119|Ketamine|ketamine
1352000|NCT01367119|Methohexital|methohexital
1352001|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
1352002|NCT01367093|BIOLOGICAL MARKERS|biological markers
1352003|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
1352004|NCT01367093|MORTALITY|mortality
1352005|NCT01367093|QUALITY OF LIFE|quality of life
1352006|NCT01367093|CARDIOVASCULAR|cardiovascular
1352007|NCT01367080|depression|depression
1352008|NCT01367067|claustrophobia|claustrophobia
1352009|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
1352010|NCT01367067|MRI|mri
1352012|NCT01367067|anxious patients|anxious patients
1352013|NCT01367067|phobic disorders|phobic disorders
1352014|NCT01367067|anxiety disorders|anxiety disorders
1352015|NCT01367067|mental disorders|mental disorders
1352016|NCT01367054|Metformine|metformine
1352017|NCT01367054|adverse events|adverse events
1352018|NCT01367054|bioequivalence|bioequivalence
1352019|NCT01367041|bone|bone
1352020|NCT01367041|muscle electrical activity|muscle electrical activity
1352021|NCT01367041|whole-body vibration|whole-body vibration
1352022|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
1352023|NCT01367015|Preterm|preterm
1352025|NCT01367015|AREDF|aredf
1352026|NCT01367015|Early feeding|early feeding
1352027|NCT01367015|Late feeding|late feeding
1352028|NCT01367015|Feed intolerance|feed intolerance
1352029|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
1352030|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
1352031|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
1352032|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
1352033|NCT01367002|HER2/neu|her2/neu
1352034|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
1352035|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
1352036|NCT01366976|oxidative stress|oxidative stress
1353254|NCT01362166|resonance|resonance
1352037|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
1352038|NCT01366976|acetaminophen|acetaminophen
1352039|NCT01366976|hemolysis|hemolysis
1352040|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
1352041|NCT01366963|brain fog|brain fog
1352042|NCT01366963|cognitive dysfunction|cognitive dysfunction
1352043|NCT01366937|vitamin B12|vitamin b12
1352044|NCT01366937|egg|egg
1352045|NCT01366937|14C|14c
1352046|NCT01366937|fecal excretion|fecal excretion
1352047|NCT01366924|protein turnover|protein turnover
1352048|NCT01366924|whole body protein turnover|whole body protein turnover
1352049|NCT01366924|essential amino acids|essential amino acids
1352050|NCT01366924|leucine|leucine
1352051|NCT01366911|stem cells|stem cells
1352052|NCT01366911|QCT testing|qct testing
1352053|NCT01366911|Bone density findings|bone density findings
1352054|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
1352055|NCT01366885|Autism|autism
1352056|NCT01366885|Pregnancy|pregnancy
1352057|NCT01366885|Newborn siblings|newborn siblings
1352058|NCT01366872|ankle|ankle
1352059|NCT01366872|arthritis|arthritis
1352060|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
1352061|NCT01366872|Agility LP,|agility lp,
1352062|NCT01366859|Autism|autism
1352063|NCT01366859|Children|children
1352064|NCT01366859|Behavior|behavior
1352065|NCT01366859|Glutathione|glutathione
1352066|NCT01366859|Whey Protein|whey protein
1352067|NCT01366859|Immunocal|immunocal
1352068|NCT01366859|Antioxidant|antioxidant
1352069|NCT01366846|Peanut|peanut
1352070|NCT01366833|Dysphagia|dysphagia
1352071|NCT01366833|Esophagus|esophagus
1352072|NCT01366833|Cancer|cancer
1352073|NCT01366833|Esophageal Cancer|esophageal cancer
1352074|NCT01366794|Gut hormones|gut hormones
1352075|NCT01366794|Insulin secretion|insulin secretion
1352076|NCT01366781|Gut hormones|gut hormones
1352077|NCT01366781|Insulin secretion|insulin secretion
1352078|NCT01366768|Gut hormones|gut hormones
1352079|NCT01366768|Insulin secretion|insulin secretion
1352080|NCT01366768|Normal physiology|normal physiology
1352081|NCT01366729|hemiplegia|hemiplegia
1352082|NCT01366729|walking|walking
1352083|NCT01366729|canes|canes
1352084|NCT01366729|TheraTogs|theratogs
1352085|NCT01366729|EMG|emg
1352086|NCT01366729|balance|balance
1352087|NCT01366729|Timed up and go|timed up and go
1352088|NCT01366716|Contingency Management|contingency management
1352089|NCT01366716|Cash|cash
1352090|NCT01366716|Substance Abuse|substance abuse
1352092|NCT01366703|heart failure|heart failure
1352093|NCT01366703|implantable loop recorder|implantable loop recorder
1352094|NCT01366690|HIV|hiv
1352095|NCT01366690|community health workers|community health workers
1352096|NCT01366690|randomized trial|randomized trial
1352097|NCT01366690|task shifting|task shifting
1352098|NCT01366690|Uganda|uganda
1352099|NCT01366690|retention|retention
1352100|NCT01366690|operations research|operations research
1352101|NCT01366690|implementation research|implementation research
1352102|NCT01366664|Premature Ejaculation|premature ejaculation
1352103|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
1352104|NCT01366664|Dapoxetine|dapoxetine
1352105|NCT01366664|PRILIGY|priligy
1352106|NCT01366664|Terazosin|terazosin
1352107|NCT01366664|Pharmacodynamic|pharmacodynamic
1352108|NCT01366664|Pharmacokinetic|pharmacokinetic
1352109|NCT01366651|Doripenem|doripenem
1352110|NCT01366651|DORIPED1002|doriped1002
1352111|NCT01366651|Intravenous|intravenous
1352112|NCT01366651|Pediatric|pediatric
1352113|NCT01366651|Antibiotic|antibiotic
1352114|NCT01366651|Meningitis|meningitis
1352115|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
1352116|NCT01366638|TMC435|tmc435
1352117|NCT01366638|Hepatitis C|hepatitis c
1352118|NCT01366638|Hepatitis C virus|hepatitis c virus
1352119|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
1352120|NCT01366638|Ribavirin|ribavirin
1352121|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
1352122|NCT01366625|hypertension, resistant|hypertension, resistant
1352123|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
1352124|NCT01366625|renal denervation|renal denervation
1352125|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
1352126|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1352127|NCT01366612|AML|aml
1352128|NCT01366612|CML|cml
1352129|NCT01366612|MDS|mds
1352130|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
1352131|NCT01366599|HEC|hec
1352132|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
1352133|NCT01366599|MEC|mec
1352134|NCT01366573|Pharmacokinetics|pharmacokinetics
1352135|NCT01366573|mu-opioid receptors|mu-opioid receptors
1352136|NCT01366573|Addiction|addiction
1352137|NCT01366573|Pharmacodynamics|pharmacodynamics
1352138|NCT01366573|Alcohol|alcohol
1352139|NCT01366547|Bioavailability|bioavailability
1352140|NCT01366547|Lamivudine|lamivudine
1352141|NCT01366547|Dolutegravir|dolutegravir
1352142|NCT01366547|integrase|integrase
1352143|NCT01366547|Abacavir|abacavir
1352144|NCT01366534|safety|safety
1352145|NCT01366534|Vaccine|vaccine
1352147|NCT01366534|immunogenicity|immunogenicity
1352148|NCT01366534|Malaria|malaria
1352149|NCT01366534|efficacy|efficacy
1352150|NCT01366534|sporozoite challenge|sporozoite challenge
1352151|NCT01366495|Seek|seek
1352152|NCT01366495|Test|test
1352153|NCT01366495|Treat|treat
1352154|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
1352155|NCT01366482|claudication,|claudication,
1352156|NCT01366482|atherectomy,|atherectomy,
1352157|NCT01366482|plaque excision,|plaque excision,
1352158|NCT01366482|drug-coated balloon|drug-coated balloon
1352159|NCT01366482|drug-eluting balloon|drug-eluting balloon
1352160|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
1352161|NCT01366469|coronary artery disease|coronary artery disease
1352162|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1352163|NCT01366456|Temperature Change|temperature change
1352164|NCT01366456|Moxibustion|moxibustion
1352165|NCT01366456|Warming effect|warming effect
1352166|NCT01366443|ROM PLUS|rom plus
1352167|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
1352168|NCT01366443|speculum exam|speculum exam
1352169|NCT01366443|visualization of leakage|visualization of leakage
1352170|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
1352171|NCT01366443|nitrazine testing|nitrazine testing
1352172|NCT01366443|ferning|ferning
1352173|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
1352174|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
1352175|NCT01366430|Nystagmus|nystagmus
1352176|NCT01366430|Treatment outcome|treatment outcome
1352177|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
1352178|NCT01366404|FFR|ffr
1352179|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
1352180|NCT01366391|metformin|metformin
1352181|NCT01366391|pharmacokinetic|pharmacokinetic
1352182|NCT01366313|paracetamol|paracetamol
1352183|NCT01366313|morphine|morphine
1352184|NCT01366313|median effective dose|median effective dose
1352185|NCT01366313|pain|pain
1352186|NCT01366287|Relative bioavailability|relative bioavailability
1352187|NCT01366287|food effect|food effect
1352188|NCT01366287|tablet|tablet
1352189|NCT01366287|suspension|suspension
1352190|NCT01366287|single dose|single dose
1352191|NCT01366287|crossover|crossover
1352192|NCT01366287|healthy subjects|healthy subjects
1352193|NCT01366274|Trauma|trauma
1352194|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
1352195|NCT01366261|pleural biopsy|pleural biopsy
1352196|NCT01366261|pleural effusion|pleural effusion
1352197|NCT01366261|safety|safety
1352198|NCT01366261|thoracoscopy|thoracoscopy
1352199|NCT01366222|asthma|asthma
1352200|NCT01366209|Pirfenidone|pirfenidone
1352201|NCT01366209|ASCEND|ascend
1352202|NCT01366209|IPF|ipf
1352203|NCT01366209|FVC|fvc
1352204|NCT01366196|Orthopedic Procedures|orthopedic procedures
1352205|NCT01366196|Spinal Fusions|spinal fusions
1352206|NCT01366196|Pregabalin|pregabalin
1352207|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
1352208|NCT01366196|Analgesics|analgesics
1352209|NCT01366196|Sensory System Agents|sensory system agents
1352210|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
1352211|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
1352212|NCT01366196|Pharmacologic Actions|pharmacologic actions
1352213|NCT01366196|Central Nervous System Agents|central nervous system agents
1352214|NCT01366196|Therapeutic Uses|therapeutic uses
1352215|NCT01366196|Anticonvulsants|anticonvulsants
1352216|NCT01366196|GABA Agents|gaba agents
1352217|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
1352219|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
1352220|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
1352221|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1352222|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1352223|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1352224|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1352225|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1352226|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
1352227|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1352228|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
1352229|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1352230|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
1352231|NCT01366105|Wound healing|wound healing
1352232|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
1352233|NCT01366105|V.A.C.|v.a.c.
1352234|NCT01366105|Incision|incision
1352235|NCT01366092|stem cell transplant|stem cell transplant
1352236|NCT01366092|GVHD|gvhd
1352237|NCT01366092|bone marrow transplant|bone marrow transplant
1352238|NCT01366092|cord blood transplant|cord blood transplant
1352239|NCT01366092|regulatory T cell|regulatory t cell
1352240|NCT01366092|interleukin|interleukin
1352241|NCT01366066|Stress incontinence|stress incontinence
1352242|NCT01366066|urge incontinence|urge incontinence
1352243|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
1352244|NCT01366066|vibration|vibration
1352245|NCT01366066|nerve stimulation|nerve stimulation
1352246|NCT01366053|Prostate Cancer|prostate cancer
1352247|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
1352248|NCT01366053|Agonist|agonist
1352249|NCT01366053|Antagonist|antagonist
1352250|NCT01366053|PSA Failure|psa failure
1352251|NCT01366053|PSA Rise|psa rise
1352252|NCT01366040|Patient Satisfaction|patient satisfaction
1352253|NCT01366040|Multiple Sclerosis|multiple sclerosis
1352254|NCT01366040|Autoinjector|autoinjector
1352255|NCT01366040|Avonex|avonex
1352256|NCT01366027|pseudobulbar affect|pseudobulbar affect
1352257|NCT01366014|osteoarthritis|osteoarthritis
1352258|NCT01366014|knee|knee
1352259|NCT01366014|pain|pain
1352260|NCT01366014|NSAID|nsaid
1352261|NCT01366001|Opioid|opioid
1352262|NCT01366001|Cocaine|cocaine
1352263|NCT01366001|Dependence|dependence
1352264|NCT01366001|Abuse|abuse
1352265|NCT01366001|Intravenous|intravenous
1352266|NCT01366001|Buprenorphine|buprenorphine
1352267|NCT01365988|fMRI|fmri
1352268|NCT01365988|Risk-Taking|risk-taking
1352269|NCT01365988|Decision-Making|decision-making
1352270|NCT01365988|Memory|memory
1352271|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
1352272|NCT01365975|Cohort Study|cohort study
1352273|NCT01365975|Folinic Acid, peri-conception|folinic acid, peri-conception
1352274|NCT01365975|Pediatric Leukemia|pediatric leukemia
1352275|NCT01365975|Pediatric Cancer|pediatric cancer
1352276|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1352277|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1352278|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1352279|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1352280|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1352281|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
1352282|NCT01365936|IVF|ivf
1352283|NCT01365936|ICSI|icsi
1352284|NCT01365936|OHSS|ohss
1352285|NCT01365936|PCOS|pcos
1352286|NCT01365936|recFSH|recfsh
1352287|NCT01365936|HMG|hmg
1352288|NCT01365897|Modafinil|modafinil
1352289|NCT01365897|Memory|memory
1352290|NCT01365897|Executive Functions|executive functions
1352291|NCT01365897|Memory, Short-Term|memory, short-term
1352292|NCT01365897|Attention|attention
1352293|NCT01365897|University Students|university students
1352294|NCT01365897|Stroop Effect|stroop effect
1352295|NCT01365897|Digit Span|digit span
1352296|NCT01365897|Backwards Digit Span|backwards digit span
1352297|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
1352298|NCT01365871|prostate biopsy|prostate biopsy
1352299|NCT01365871|pain|pain
1352302|NCT01365819|Crystal meth dependence|crystal meth dependence
1352303|NCT01365819|crystal meth|crystal meth
1352304|NCT01365819|methamphetamine dependence|methamphetamine dependence
1352305|NCT01365819|substance abuse|substance abuse
1352306|NCT01365806|heart transplantation|heart transplantation
1352307|NCT01365806|allograft rejection|allograft rejection
1352308|NCT01365806|QT interval|qt interval
1352309|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
1352310|NCT01365793|cerebral edema|cerebral edema
1352311|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
1352312|NCT01365793|pediatric diabetes|pediatric diabetes
1352313|NCT01365793|fluid therapy|fluid therapy
1352314|NCT01365780|microcirculation, O2c|microcirculation, o2c
1352315|NCT01365767|Crohn disease|crohn disease
1352316|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
1352317|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
1352318|NCT01365767|Small intestine|small intestine
1352319|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
1352320|NCT01365767|CDAI|cdai
1352321|NCT01365767|Calprotectin|calprotectin
1352322|NCT01365767|IBD|ibd
1352323|NCT01365767|Sonography|sonography
1352324|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
1352325|NCT01365741|PCI|pci
1352326|NCT01365741|STEMI|stemi
1352327|NCT01365741|Interventions|interventions
1352328|NCT01365741|Heart disease|heart disease
1352329|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
1352330|NCT01365741|Cross-over study|cross-over study
1352331|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
1352332|NCT01365728|Femtosecond Laser|femtosecond laser
1352333|NCT01365728|FS60|fs60
1352334|NCT01365728|iFS|ifs
1352335|NCT01365728|Intralase|intralase
1352336|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
1352337|NCT01365728|IntraLASIK|intralasik
1352338|NCT01365728|LASIK|lasik
1352339|NCT01365728|Myopia|myopia
1352340|NCT01365728|Nearsightedness|nearsightedness
1354039|NCT01359033|RIKS-HIA|riks-hia
1352341|NCT01365715|Preoperative embolization|preoperative embolization
1352342|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
1352343|NCT01365715|Therapeutic angiography|therapeutic angiography
1352344|NCT01365715|Embolization|embolization
1352345|NCT01365715|Surgical blood loss|surgical blood loss
1352346|NCT01365715|Spinal metastases|spinal metastases
1352347|NCT01365715|Spinal neoplasms|spinal neoplasms
1352348|NCT01365715|Vertebral metastases|vertebral metastases
1352349|NCT01365715|metastatic spine surgery|metastatic spine surgery
1352350|NCT01365715|Spinal surgery|spinal surgery
1352351|NCT01365702|COPD|copd
1352352|NCT01365702|tiotropium|tiotropium
1352353|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
1352354|NCT01365676|Edema|edema
1352355|NCT01365676|Depression|depression
1352356|NCT01365676|Hot Flashes|hot flashes
1352357|NCT01365676|Anxiety|anxiety
1352358|NCT01365676|Irritability|irritability
1352360|NCT01365663|Hypercholesterolemia|hypercholesterolemia
1352361|NCT01365663|LDL|ldl
1352362|NCT01365663|HDL|hdl
1352363|NCT01365663|apoB|apob
1352364|NCT01365663|hyperlipidemia|hyperlipidemia
1352365|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
1352366|NCT01365637|safety|safety
1352367|NCT01365637|tolerability|tolerability
1352368|NCT01365637|pharmacokinetics|pharmacokinetics
1352369|NCT01365637|PF-05089771|pf-05089771
1352370|NCT01365598|malaria|malaria
1352371|NCT01365598|uncomplicated malaria|uncomplicated malaria
1352372|NCT01365598|gametocytocidal drug|gametocytocidal drug
1352373|NCT01365598|gametocytocidal|gametocytocidal
1352374|NCT01365598|gametocyte|gametocyte
1352375|NCT01365598|primaquine|primaquine
1352376|NCT01365598|transmission blocking|transmission blocking
1352377|NCT01365598|malaria transmission|malaria transmission
1352378|NCT01365598|sexual parasite|sexual parasite
1352379|NCT01365598|sexual stage|sexual stage
1352380|NCT01365598|Uganda|uganda
1352381|NCT01365598|Africa|africa
1352382|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
1352383|NCT01365585|sildenafil citrate|sildenafil citrate
1352384|NCT01365585|Revatio|revatio
1352385|NCT01365572|Drug-eluting stent|drug-eluting stent
1352386|NCT01365559|multiple myeloma|multiple myeloma
1352387|NCT01365559|carfilzomib|carfilzomib
1352388|NCT01365559|relapsed|relapsed
1352389|NCT01365559|refractory|refractory
1352390|NCT01365559|bortezomib|bortezomib
1352391|NCT01365559|Oncotherapeutics|oncotherapeutics
1352392|NCT01365533|Airway Inflammation|airway inflammation
1352393|NCT01365533|Roflumilast|roflumilast
1352394|NCT01365494|Rabies|rabies
1352395|NCT01365494|rabies vaccines|rabies vaccines
1352396|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
1352397|NCT01365481|Hypertension, pediatric|hypertension, pediatric
1352398|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
1352399|NCT01365468|RAD001,|rad001,
1352400|NCT01365468|Everolimus,|everolimus,
1352401|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
1352402|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
1352403|NCT01365455|Psoriasis|psoriasis
1352404|NCT01365455|plaque|plaque
1352405|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
1352406|NCT01365455|IL-17 blocker|il-17 blocker
1352407|NCT01365455|subcutaneous|subcutaneous
1352408|NCT01365455|psoriatic arthritis|psoriatic arthritis
1352409|NCT01365455|injection|injection
1352410|NCT01365455|AIN457|ain457
1352411|NCT01365455|AIN457A|ain457a
1352412|NCT01365455|secukinumab|secukinumab
1352413|NCT01365442|Cholera|cholera
1352414|NCT01365442|Vaccination|vaccination
1352415|NCT01365442|Oral cholera vaccine|oral cholera vaccine
1352416|NCT01365442|Mass vaccination|mass vaccination
1352417|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
1352418|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
1352419|NCT01365416|diabetes|diabetes
1352420|NCT01365416|diabetes remission|diabetes remission
1352421|NCT01365416|obesity|obesity
1352422|NCT01365416|bariatric surgery|bariatric surgery
1352423|NCT01365416|gene expression|gene expression
1352424|NCT01365416|genetic variation|genetic variation
1352425|NCT01365416|metabolomics|metabolomics
1352426|NCT01365416|metabonomics|metabonomics
1352427|NCT01365416|epigenetic variation|epigenetic variation
1352428|NCT01365416|mutations|mutations
1352429|NCT01365390|prospective|prospective
1352430|NCT01365390|Incidence|incidence
1352431|NCT01365390|otitis|otitis
1352432|NCT01365390|observational|observational
1352433|NCT01365390|Epidemiological|epidemiological
1352434|NCT01365390|retrospective|retrospective
1352435|NCT01365377|Anxiety|anxiety
1352436|NCT01365377|Depression|depression
1352437|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
1352438|NCT01365377|Quality of life|quality of life
1352439|NCT01365377|Family|family
1352440|NCT01365377|ICU|icu
1352441|NCT01365364|PLM|plm
1352442|NCT01365364|dopamine|dopamine
1352443|NCT01365364|physical exercise|physical exercise
1352444|NCT01365338|schizophrenia fMRI cognition working memory ASL|schizophrenia fmri cognition working memory asl
1352445|NCT01365312|Central line associated infection|central line associated infection
1352446|NCT01365312|PICC associated infection|picc associated infection
1352447|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
1352448|NCT01365312|Central line colonization|central line colonization
1352449|NCT01365312|Ethanol Lock|ethanol lock
1352450|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
1352451|NCT01365273|Split thickness skin grafts|split thickness skin grafts
1352452|NCT01365273|Mepitel One|mepitel one
1352453|NCT01365273|Bridal Veil and staples|bridal veil and staples
1352454|NCT01365273|Pain|pain
1352455|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
1352456|NCT01365247|Trauma|trauma
1352457|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
1352458|NCT01365247|Treatment outcome|treatment outcome
1352459|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1352460|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
1352461|NCT01365247|Behavioral Treatment|behavioral treatment
1352462|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
1352463|NCT01365221|Clopidogrel|clopidogrel
1352464|NCT01365221|Prasugrel|prasugrel
1352465|NCT01365195|opioid|opioid
1352466|NCT01365195|Fentanyl|fentanyl
1352467|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
1352468|NCT01365195|Pain management|pain management
1352469|NCT01365195|Perioperative outcomes|perioperative outcomes
1352470|NCT01365195|Constipation|constipation
1352471|NCT01365195|Ileus|ileus
1352472|NCT01365195|Colorectal|colorectal
1352473|NCT01365182|prostate cancer|prostate cancer
1352474|NCT01365182|urinary incontinence|urinary incontinence
1352475|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
1352476|NCT01365182|self-management|self-management
1352477|NCT01365182|behavioral intervention|behavioral intervention
1352478|NCT01365182|quality of life|quality of life
1352479|NCT01365169|Cyberinfrastructure|cyberinfrastructure
1352481|NCT01365169|CYCORE|cycore
1352482|NCT01365169|Quality of Life|quality of life
1352483|NCT01365169|QOL|qol
1352484|NCT01365169|Head and Neck|head and neck
1352485|NCT01365169|H&N|h&n
1352486|NCT01365169|Carbon Monoxide|carbon monoxide
1352487|NCT01365169|CO|co
1352488|NCT01365169|Colorectal Cancer|colorectal cancer
1352489|NCT01365169|Oropharyngeal Cancer|oropharyngeal cancer
1352490|NCT01365169|Laryngeal Cancer|laryngeal cancer
1352491|NCT01365169|Hypopharyngeal Cancer|hypopharyngeal cancer
1352492|NCT01365169|Nasopharyngeal Cancer|nasopharyngeal cancer
1352493|NCT01365169|Smoker|smoker
1352494|NCT01365169|Recent Smoking Cessation|recent smoking cessation
1352495|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
1352496|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
1352497|NCT01365156|radiologic staging|radiologic staging
1352498|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
1352499|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
1352500|NCT01365130|esophageal cancer|esophageal cancer
1352501|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
1352502|NCT01365130|gastric cancer|gastric cancer
1352503|NCT01365104|brain blood flow|brain blood flow
1352504|NCT01365104|stroke|stroke
1352505|NCT01365104|cerebrovascular|cerebrovascular
1352506|NCT01365104|aging|aging
1352507|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
1352508|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1352509|NCT01365078|Stearidonic acid|stearidonic acid
1352510|NCT01365078|Lipid metabolism|lipid metabolism
1352511|NCT01365078|Serum triacylglycerol|serum triacylglycerol
1352512|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
1352513|NCT01365039|contact lens|contact lens
1352514|NCT01365026|Healthy Lifestyle|healthy lifestyle
1352515|NCT01365026|Health promotion|health promotion
1352516|NCT01365026|Counselling|counselling
1352517|NCT01365026|Action Plan|action plan
1352518|NCT01365026|Primary Health Care|primary health care
1352519|NCT01365013|Lifestyle|lifestyle
1352520|NCT01365013|Prediabetic State|prediabetic state
1352521|NCT01365013|Patient Education|patient education
1352522|NCT01365013|Primary Health Care|primary health care
1352523|NCT01365000|Phase 1|phase 1
1352524|NCT01365000|Pharmacokinetics|pharmacokinetics
1352525|NCT01365000|NKTR-118|nktr-118
1352526|NCT01365000|fasting or fed state|fasting or fed state
1352527|NCT01365000|cross-over study|cross-over study
1352528|NCT01365000|AUC(0-t)|auc(0-t)
1352529|NCT01365000|Cmax|cmax
1352530|NCT01365000|tmax|tmax
1352531|NCT01365000|QTcF Interval|qtcf interval
1352532|NCT01364987|transplant|transplant
1352533|NCT01364987|ASP015K|asp015k
1352534|NCT01364987|healthy subjects|healthy subjects
1352535|NCT01364974|ASP015K|asp015k
1352536|NCT01364974|Healthy subjects|healthy subjects
1352537|NCT01364961|Resveratrol|resveratrol
1352538|NCT01364961|FMD|fmd
1352539|NCT01364961|PWV|pwv
1352540|NCT01364961|HDL-cholesterol|hdl-cholesterol
1352541|NCT01364961|Macrovasculature|macrovasculature
1352542|NCT01364961|Microvasculature|microvasculature
1352543|NCT01364948|Preterm|preterm
1352544|NCT01364948|VLBW|vlbw
1352545|NCT01364948|Coconut Oil application|coconut oil application
1352546|NCT01364948|Trans epidermal water loss|trans epidermal water loss
1352547|NCT01364948|Weight gain|weight gain
1352548|NCT01364909|Sepsis|sepsis
1352549|NCT01364909|Severe sepsis|severe sepsis
1352550|NCT01364909|Septic shock|septic shock
1352551|NCT01364909|Septicaemia|septicaemia
1352552|NCT01364909|Bacteremia|bacteremia
1352553|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
1352554|NCT01364883|Vaccine|vaccine
1352555|NCT01364883|Immune response|immune response
1352556|NCT01364870|Knee OA|knee oa
1352557|NCT01364870|TENS|tens
1352558|NCT01364870|Total knee replacement|total knee replacement
1352559|NCT01364870|Knee arthroplasty|knee arthroplasty
1352560|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
1352561|NCT01364857|port wine stain of a limb|port wine stain of a limb
1352562|NCT01364831|sleep time|sleep time
1352563|NCT01364831|athletic performance|athletic performance
1352564|NCT01364792|schizophrenia|schizophrenia
1352565|NCT01364792|treatment|treatment
1352566|NCT01364792|inflammation|inflammation
1352567|NCT01364792|neuroinflammation|neuroinflammation
1352568|NCT01364792|hippocampal|hippocampal
1352569|NCT01364779|aspirin|aspirin
1352570|NCT01364779|Chronic kidney disease|chronic kidney disease
1352571|NCT01364753|Memory|memory
1352572|NCT01364753|Aviation|aviation
1352573|NCT01364714|ICU acquired weakness|icu acquired weakness
1352574|NCT01364701|Erectile dysfunction|erectile dysfunction
1352575|NCT01364701|combination therapy|combination therapy
1352576|NCT01364701|Sildenafil|sildenafil
1352577|NCT01364701|tadalafil|tadalafil
1352578|NCT01364701|PDE5i|pde5i
1352579|NCT01364701|No Conditions|no conditions
1352580|NCT01364688|coronary calcification|coronary calcification
1352581|NCT01364688|vascular calcification|vascular calcification
1352582|NCT01364688|active vitamin D|active vitamin d
1352583|NCT01364688|alfacalcidol|alfacalcidol
1352584|NCT01364675|Impaired fasting glucose|impaired fasting glucose
1352585|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
1352586|NCT01364675|Pre-diabetes|pre-diabetes
1352587|NCT01364675|Pre-hypertensives|pre-hypertensives
1352588|NCT01364675|Cardiovascular events|cardiovascular events
1352589|NCT01364662|Impulsive Aggression|impulsive aggression
1352590|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1352591|NCT01364662|ADHD|adhd
1352592|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
1352593|NCT01364649|Depressive Disorder, Major|depressive disorder, major
1352594|NCT01364649|Depression|depression
1352595|NCT01364649|Antidepressive Agents|antidepressive agents
1352596|NCT01364649|Drug Therapy|drug therapy
1352597|NCT01364636|1-Heart Failure|1-heart failure
1352598|NCT01364636|2-Acute Heart Failure|2-acute heart failure
1352599|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
1352600|NCT01364636|4-Worsening Renal Function|4-worsening renal function
1352601|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
1352602|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
1352603|NCT01364623|testosterone|testosterone
1352604|NCT01364623|pharmacokinetics|pharmacokinetics
1352605|NCT01364610|diagnosis|diagnosis
1352606|NCT01364610|pH measurement|ph measurement
1352607|NCT01364610|catheter|catheter
1352608|NCT01364610|wireless|wireless
1352609|NCT01364597|Brivaracetam|brivaracetam
1352610|NCT01364597|Epilepsy|epilepsy
1352611|NCT01364597|Child|child
1352612|NCT01364597|Infant|infant
1352613|NCT01364597|Adolescents|adolescents
1352614|NCT01364571|Staphylococcus aureus|staphylococcus aureus
1352615|NCT01364571|vaccine|vaccine
1352616|NCT01364571|staphylococcal infection|staphylococcal infection
1352617|NCT01364532|transulnar arterial access|transulnar arterial access
1352618|NCT01364532|transradial arterial access|transradial arterial access
1352619|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
1352620|NCT01364519|COPD|copd
1352621|NCT01364506|Cardiovascular capacity|cardiovascular capacity
1352622|NCT01364506|Water exercise|water exercise
1352623|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
1352624|NCT01364506|Pregnancy|pregnancy
1352625|NCT01364506|Perinatal outcomes|perinatal outcomes
1352626|NCT01364493|HER2-positive|her2-positive
1352627|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
1352628|NCT01364493|Inoperable|inoperable
1352629|NCT01364493|locally advanced|locally advanced
1352630|NCT01364493|recurrent|recurrent
1352631|NCT01364493|metastatic|metastatic
1352632|NCT01364480|Tetraplegia|tetraplegia
1352633|NCT01364480|Spinal cord injury|spinal cord injury
1352634|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
1352635|NCT01364480|Neuroprosthetic|neuroprosthetic
1352636|NCT01364480|Brain-machine interface|brain-machine interface
1352637|NCT01364480|Brain-computer interface|brain-computer interface
1352638|NCT01364480|Neural activity|neural activity
1352639|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
1352640|NCT01364454|Faecal Occult Blood test|faecal occult blood test
1352641|NCT01364454|General Practitioners Involvement|general practitioners involvement
1354040|NCT01359020|Fever|fever
1352642|NCT01364454|Patient's Participation|patient's participation
1352643|NCT01364454|Reminder|reminder
1352644|NCT01364441|ONO-2950|ono-2950
1352645|NCT01364441|healthy adult subjects|healthy adult subjects
1352646|NCT01364441|first in human|first in human
1352647|NCT01364441|safety|safety
1352648|NCT01364441|tolerability|tolerability
1352649|NCT01364441|pharmacokinetics|pharmacokinetics
1352651|NCT01364415|pasireotide|pasireotide
1352652|NCT01364415|LAR|lar
1352653|NCT01364415|NETs|nets
1352654|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
1352655|NCT01364402|scheduled for PCI|scheduled for pci
1352656|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
1352657|NCT01364389|Inflammatory Disease|inflammatory disease
1352658|NCT01364389|Rheumatic Disease|rheumatic disease
1352659|NCT01364376|Gastric Cancer|gastric cancer
1352660|NCT01364363|Transplant|transplant
1352661|NCT01364363|Allogeneic|allogeneic
1352662|NCT01364363|Allogeneic transplant|allogeneic transplant
1352663|NCT01364363|Unrelated donor transplant|unrelated donor transplant
1352664|NCT01364363|MUD|mud
1352665|NCT01364363|HSCT|hsct
1352666|NCT01364363|Stem cell transplant|stem cell transplant
1352667|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
1352668|NCT01364350|pediatrics|pediatrics
1352669|NCT01364350|post-intervention study|post-intervention study
1352670|NCT01364350|metformin|metformin
1352671|NCT01364350|complications|complications
1352672|NCT01364337|Hypertension|hypertension
1352673|NCT01364324|tuberculosis|tuberculosis
1352674|NCT01364324|pharmacokinetics|pharmacokinetics
1352675|NCT01364324|first-line drugs|first-line drugs
1352676|NCT01364324|gastrectomy|gastrectomy
1352677|NCT01364311|Dry Eye Syndromes|dry eye syndromes
1352678|NCT01364311|Dietary Supplements|dietary supplements
1352679|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
1352680|NCT01364311|Lutein|lutein
1352681|NCT01364311|Vitamin C|vitamin c
1352682|NCT01364311|Zinc|zinc
1352683|NCT01364311|ginkgo biloba|ginkgo biloba
1352684|NCT01364311|Flavinoids|flavinoids
1352685|NCT01364311|Fishoil|fishoil
1352686|NCT01364311|Zeaxanthin|zeaxanthin
1352687|NCT01364311|Vitamin E|vitamin e
1352688|NCT01364311|Copper|copper
1352689|NCT01364311|Selen|selen
1352690|NCT01364311|Alpha Lipon acid|alpha lipon acid
1352691|NCT01364311|Break up time (BUT)|break up time (but)
1352692|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
1352693|NCT01364311|Visual Acuity|visual acuity
1352694|NCT01364311|Tear film osmolarity|tear film osmolarity
1352695|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
1352696|NCT01364311|Schirmer I test|schirmer i test
1352697|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
1352698|NCT01364311|Impression cytology|impression cytology
1352699|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
1352700|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
1352701|NCT01364298|Gabapentin/B complex|gabapentin/b complex
1352702|NCT01364298|Pregabalin|pregabalin
1352703|NCT01364298|Pain|pain
1352704|NCT01364298|Neuropathic|neuropathic
1352705|NCT01364298|Gavindo|gavindo
1352706|NCT01364298|Lyrica|lyrica
1352707|NCT01364259|tic douloureux|tic douloureux
1352708|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
1352709|NCT01364246|neuromyelitis optica|neuromyelitis optica
1352710|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
1353523|NCT01361113|Phase II|phase ii
1352711|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
1352712|NCT01364220|Stroke|stroke
1352713|NCT01364220|Cerebral Infarction|cerebral infarction
1352714|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
1352715|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1352716|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
1352717|NCT01364220|Recurrence|recurrence
1352718|NCT01364194|Post operative pain|post operative pain
1352719|NCT01364194|Total knee replacement|total knee replacement
1352720|NCT01364194|Total knee arthroplasty|total knee arthroplasty
1352721|NCT01364194|Bupivacaine|bupivacaine
1352722|NCT01364194|Periarticular injection|periarticular injection
1352724|NCT01364194|Morphine consumption|morphine consumption
1352725|NCT01364181|Udenafil|udenafil
1352726|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1352727|NCT01364181|pulmonary hypertension|pulmonary hypertension
1352728|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
1352729|NCT01364181|Exercise|exercise
1352730|NCT01364181|Dyspnea|dyspnea
1352731|NCT01364129|Diabetes|diabetes
1352732|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
1352733|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
1352734|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
1352735|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
1352736|NCT01364116|children|children
1352737|NCT01364116|noninvasive|noninvasive
1352738|NCT01364103|pulse pressure variation|pulse pressure variation
1352739|NCT01364103|systolic pressure variation|systolic pressure variation
1352740|NCT01364103|central venous pressure|central venous pressure
1352741|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
1352742|NCT01364103|pleth variability index|pleth variability index
1352743|NCT01364090|hepatitis C|hepatitis c
1352744|NCT01364090|treatment|treatment
1352745|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
1352746|NCT01364077|Heart rate|heart rate
1352747|NCT01364077|Dialysis|dialysis
1352748|NCT01364077|ESRD|esrd
1352749|NCT01364077|ivabradine|ivabradine
1352750|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
1352751|NCT01363973|post-stroke|post-stroke
1352752|NCT01363960|Incidence|incidence
1352753|NCT01363960|neonatal care|neonatal care
1352754|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
1352755|NCT01363960|risk factors|risk factors
1352756|NCT01363934|Erythropoietin|erythropoietin
1352757|NCT01363934|EPO-hFC|epo-hfc
1352758|NCT01363921|CKD5|ckd5
1352759|NCT01363921|dialysis|dialysis
1352760|NCT01363921|high porous membranes|high porous membranes
1352761|NCT01363921|micro-inflammation|micro-inflammation
1352762|NCT01363908|Beta-Thalassemia|beta-thalassemia
1352763|NCT01363908|Sickle Cell Anemia|sickle cell anemia
1352764|NCT01363908|Transfusional iron overload|transfusional iron overload
1352765|NCT01363908|Iron Overload|iron overload
1352766|NCT01363908|Iron Chelation|iron chelation
1352767|NCT01363895|atrial fibrillation|atrial fibrillation
1352768|NCT01363895|catheter ablation|catheter ablation
1352769|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
1352770|NCT01363895|intervention|intervention
1352771|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1352772|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
1352773|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
1352774|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
1352775|NCT01363869|hyperuricemia|hyperuricemia
1352776|NCT01363869|gout|gout
1352777|NCT01363869|uric acid|uric acid
1352778|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
1352779|NCT01363869|green tea|green tea
1352780|NCT01363869|catechins|catechins
1352781|NCT01363869|antioxidant|antioxidant
1352782|NCT01363856|first ever stroke|first ever stroke
1352783|NCT01363843|neoadjuvant|neoadjuvant
1352784|NCT01363843|chemo/radiation|chemo/radiation
1352785|NCT01363843|rectal cancer|rectal cancer
1352786|NCT01363843|rectum cancer|rectum cancer
1352787|NCT01363843|colon cancer|colon cancer
1352788|NCT01363843|colorectal cancer|colorectal cancer
1352789|NCT01363830|Disc|disc
1352790|NCT01363830|lumbar|lumbar
1352791|NCT01363830|herniation|herniation
1352792|NCT01363804|AV-951|av-951
1352793|NCT01363804|Tivozanib|tivozanib
1352794|NCT01363804|Healthy Subjects|healthy subjects
1352795|NCT01363804|rifampin|rifampin
1352796|NCT01363804|Pharmacokinetics|pharmacokinetics
1352797|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
1352798|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
1352799|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
1352800|NCT01363791|Clinical practice guidelines|clinical practice guidelines
1352801|NCT01363791|Clinical trials|clinical trials
1352802|NCT01363791|Dietary sugars|dietary sugars
1352803|NCT01363791|Fructose|fructose
1352804|NCT01363791|High fructose corn syrup|high fructose corn syrup
1352805|NCT01363791|Fruit|fruit
1352806|NCT01363791|Isocaloric|isocaloric
1352807|NCT01363791|Hypercaloric|hypercaloric
1352808|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
1352809|NCT01363791|Triglycerides|triglycerides
1352810|NCT01363791|Cholesterol|cholesterol
1352811|NCT01363791|Glycemic control|glycemic control
1352812|NCT01363791|Insulin resistance|insulin resistance
1352813|NCT01363791|Body weight|body weight
1352814|NCT01363791|Uric acid|uric acid
1352815|NCT01363791|Blood pressure|blood pressure
1352816|NCT01363791|Fatty liver|fatty liver
1352817|NCT01363791|Fasting|fasting
1352818|NCT01363791|Postprandial|postprandial
1352819|NCT01363778|AV-951|av-951
1352820|NCT01363778|Tivozanib|tivozanib
1352821|NCT01363778|Healthy Subjects|healthy subjects
1352822|NCT01363778|ketoconazole|ketoconazole
1352823|NCT01363778|Pharmacokinetics|pharmacokinetics
1352824|NCT01363765|diagnosis|diagnosis
1352825|NCT01363765|polymerase chain reaction|polymerase chain reaction
1352826|NCT01363765|sputum smear|sputum smear
1352827|NCT01363765|stepped-wedge design|stepped-wedge design
1352828|NCT01363765|cost-effectiveness|cost-effectiveness
1352829|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
1352830|NCT01363752|Kidney|kidney
1352831|NCT01363752|Transplant|transplant
1352832|NCT01363752|Immunosuppression|immunosuppression
1352833|NCT01363752|Kidney Failure, Acute|kidney failure, acute
1352834|NCT01363752|Advagraf|advagraf
1352835|NCT01363752|Tacrolimus|tacrolimus
1352836|NCT01363752|Astagraf XL|astagraf xl
1352837|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
1352838|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
1352839|NCT01363726|< 5 years of age|< 5 years of age
1352840|NCT01363726|southern Israel|southern israel
1352841|NCT01363726|Signed informed concent|signed informed concent
1352842|NCT01363674|Growth disorders|growth disorders
1352843|NCT01363674|Saizen|saizen
1352844|NCT01363674|Easypod|easypod
1467897|NCT00900029|VLU|vlu
1352845|NCT01363674|Growth hormone|growth hormone
1352846|NCT01363674|Pediatric subject|pediatric subject
1352847|NCT01363661|angina pectoris|angina pectoris
1352848|NCT01363661|atherosclerosis|atherosclerosis
1352849|NCT01363661|endothelial dysfunction|endothelial dysfunction
1352850|NCT01363648|VCI-HS|vci-hs
1352851|NCT01363648|stroke|stroke
1352852|NCT01363648|choline alphoscerate|choline alphoscerate
1352853|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
1352854|NCT01363635|organ failure|organ failure
1352855|NCT01363635|AKI|aki
1352856|NCT01363635|PMI|pmi
1352857|NCT01363635|ALI|ali
1352858|NCT01363635|Stroke|stroke
1352859|NCT01363635|ICU death|icu death
1352860|NCT01363622|Vaspin|vaspin
1352861|NCT01363622|LGA|lga
1352862|NCT01363622|SGA|sga
1352863|NCT01363622|Insulin|insulin
1352864|NCT01363622|Blood glucose|blood glucose
1352865|NCT01363596|Infertility|infertility
1352866|NCT01363596|Fertility|fertility
1352867|NCT01363596|Reproductive Medicine|reproductive medicine
1352868|NCT01363596|Pregnancy|pregnancy
1352869|NCT01363596|Conception|conception
1352870|NCT01363596|Miscarriage|miscarriage
1352871|NCT01363596|Ovulation Detection|ovulation detection
1352872|NCT01363596|Cervical Mucus|cervical mucus
1352873|NCT01363596|IVF Alternative|ivf alternative
1352874|NCT01363583|traumatic brain injury|traumatic brain injury
1352875|NCT01363570|Macular Degeneration|macular degeneration
1352876|NCT01363570|Age related macular degeneration|age related macular degeneration
1352877|NCT01363570|Macula Risk|macula risk
1352878|NCT01363570|Genetic test|genetic test
1352879|NCT01363570|Anti-inflammatory|anti-inflammatory
1352880|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
1352881|NCT01363570|Lucentis|lucentis
1352882|NCT01363570|Ranibizumab|ranibizumab
1352883|NCT01363570|Vision loss|vision loss
1352884|NCT01363557|Randomized|randomized
1352885|NCT01363557|Brain Radiation Therapy|brain radiation therapy
1352886|NCT01363557|Lung Cancer|lung cancer
1352887|NCT01363557|Brain Metastasis|brain metastasis
1352888|NCT01363557|Gefitinib|gefitinib
1352889|NCT01363544|ADHD|adhd
1352890|NCT01363544|neurofeedback|neurofeedback
1352891|NCT01363544|exercise|exercise
1352892|NCT01363544|neurophysiology|neurophysiology
1352893|NCT01363531|Prescription|prescription
1352894|NCT01363531|Antibiotic|antibiotic
1352895|NCT01363531|Acute respiratory infections|acute respiratory infections
1352896|NCT01363531|Satisfaction|satisfaction
1352897|NCT01363531|Perception|perception
1352898|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
1352899|NCT01363531|Rhinosinusitis|rhinosinusitis
1352900|NCT01363531|Acute bronchitis|acute bronchitis
1352901|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
1352902|NCT01363518|humerus|humerus
1352903|NCT01363518|fracture|fracture
1352904|NCT01363518|operative treatment|operative treatment
1352905|NCT01363518|non-operative treatment|non-operative treatment
1352906|NCT01363492|agalsidase alfa|agalsidase alfa
1352907|NCT01363492|Replagal|replagal
1352908|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
1352909|NCT01363440|Diabetic Macular Edema|diabetic macular edema
1352910|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
1352911|NCT01363414|Dry eye|dry eye
1352912|NCT01363414|Ocular aberration|ocular aberration
1352913|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1352914|NCT01363401|ALS|als
1352915|NCT01363401|Motor neuron disease|motor neuron disease
1352916|NCT01363401|MND|mnd
1352917|NCT01363401|HYNR-CS inj|hynr-cs inj
1352918|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
1352919|NCT01363401|Intrathecal injection|intrathecal injection
1352920|NCT01363375|Plantar fascia|plantar fascia
1352921|NCT01363375|Plantar fasciitis|plantar fasciitis
1352922|NCT01363375|Foot orthosis|foot orthosis
1352923|NCT01363375|Finite element analysis|finite element analysis
1352924|NCT01363375|Gait analysis|gait analysis
1352925|NCT01363375|Plantar pressure measurement|plantar pressure measurement
1352926|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
1352927|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
1352928|NCT01363336|Adalat|adalat
1352929|NCT01363336|Hypertension|hypertension
1352930|NCT01363336|Diabetes|diabetes
1352931|NCT01363336|Chronic kidney disease|chronic kidney disease
1352932|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
1352933|NCT01363258|Elderly|elderly
1352934|NCT01363258|Dementia|dementia
1352935|NCT01363258|Care-resistant behavior|care-resistant behavior
1352936|NCT01363258|Oral health|oral health
1352937|NCT01363258|Long-term care|long-term care
1352938|NCT01363245|cost effectiveness|cost effectiveness
1352939|NCT01363245|behavioral health counseling|behavioral health counseling
1352940|NCT01363232|BKM120|bkm120
1352941|NCT01363232|MEK162|mek162
1352942|NCT01363232|RAS RAF mutations|ras raf mutations
1352943|NCT01363232|triple negative breast cancer|triple negative breast cancer
1352944|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
1352945|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
1352946|NCT01363232|PI3K inhibitor|pi3k inhibitor
1352947|NCT01363232|MEK inhibitor|mek inhibitor
1352948|NCT01363206|Melanoma|melanoma
1352949|NCT01363206|GM-CSF|gm-csf
1352950|NCT01363206|Ipilimumab|ipilimumab
1352951|NCT01363206|Immunologic Response|immunologic response
1352952|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
1352953|NCT01363193|Obesity|obesity
1352954|NCT01363193|Body Mass Index|body mass index
1352955|NCT01363193|Venous thromboembolism|venous thromboembolism
1352956|NCT01363193|Atrial fibrillation|atrial fibrillation
1352957|NCT01363193|Lean body weight|lean body weight
1352958|NCT01363193|Unfractionated heparin|unfractionated heparin
1352959|NCT01363193|heparin|heparin
1352960|NCT01363167|vitamin D|vitamin d
1352961|NCT01363167|preterm infants|preterm infants
1352962|NCT01363167|calcium|calcium
1352963|NCT01363167|bone|bone
1352964|NCT01363167|parathyroid hormone|parathyroid hormone
1352965|NCT01363154|Children's Health|children's health
1352966|NCT01363154|Pediatrics|pediatrics
1352967|NCT01363154|Epilepsy|epilepsy
1352968|NCT01363154|Photoparoxysmal|photoparoxysmal
1352969|NCT01363154|Photosensitive|photosensitive
1352971|NCT01363154|Mozart|mozart
1352972|NCT01363154|K-448|k-448
1352973|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
1352974|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1352975|NCT01363141|Abdominal Fat|abdominal fat
1352976|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
1352977|NCT01363141|Hypertension|hypertension
1352978|NCT01363141|Hyperglycemia|hyperglycemia
1352979|NCT01363141|Insulin Resistance|insulin resistance
1352980|NCT01363141|Thrombosis state|thrombosis state
1352981|NCT01363128|Leukemia|leukemia
1352982|NCT01363128|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1352983|NCT01363128|CD-20 Positive Acute Lymphoblastic Leukemia|cd-20 positive acute lymphoblastic leukemia
1352984|NCT01363128|Any level of CD20 expression|any level of cd20 expression
1352985|NCT01363128|Lymphoblastic lymphoma|lymphoblastic lymphoma
1352986|NCT01363128|Central Venous Catheter|central venous catheter
1352988|NCT01363128|HCVAD|hcvad
1352989|NCT01363128|Cyclophosphamide|cyclophosphamide
1352990|NCT01363128|Cytoxan|cytoxan
1352991|NCT01363128|Neosar|neosar
1352992|NCT01363128|Mesna|mesna
1352993|NCT01363128|Mesnex|mesnex
1352994|NCT01363128|Doxorubicin|doxorubicin
1352995|NCT01363128|Adriamycin|adriamycin
1352996|NCT01363128|Rubex|rubex
1352997|NCT01363128|Vincristine|vincristine
1352998|NCT01363128|Dexamethasone|dexamethasone
1352999|NCT01363128|Decadron|decadron
1353000|NCT01363128|Ofatumumab|ofatumumab
1353001|NCT01363128|Arzerra|arzerra
1353002|NCT01363128|Methotrexate|methotrexate
1353003|NCT01363128|Cytarabine|cytarabine
1353004|NCT01363128|Ara-C|ara-c
1353005|NCT01363128|Cytosar|cytosar
1353006|NCT01363128|DepoCyt|depocyt
1353007|NCT01363128|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1353008|NCT01363115|Body Weight|body weight
1353009|NCT01363115|Dietary Supplement|dietary supplement
1353010|NCT01363115|Calcium|calcium
1353011|NCT01363115|Vitamin D|vitamin d
1353012|NCT01363102|Muscle strength|muscle strength
1353013|NCT01363102|functional mobility|functional mobility
1353014|NCT01363102|outcome|outcome
1353015|NCT01363102|intensive care unit|intensive care unit
1353016|NCT01363102|quality of life|quality of life
1353017|NCT01363037|HIV infections|hiv infections
1353018|NCT01363037|Anti-HIV agents|anti-hiv agents
1353019|NCT01363037|HIV-1|hiv-1
1353020|NCT01363024|Solid Cancers|solid cancers
1353021|NCT01363011|HIV-1|hiv-1
1353022|NCT01363011|Treatment Naive|treatment naive
1353023|NCT01363011|Treatment Experienced|treatment experienced
1353024|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
1353025|NCT01362959|Delirium|delirium
1353026|NCT01362959|Psychomotor Agitation|psychomotor agitation
1353027|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
1353028|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
1353029|NCT01362946|Conduct problems|conduct problems
1353030|NCT01362946|callous-unemotional traits|callous-unemotional traits
1353031|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
1353032|NCT01362933|PE|pe
1353033|NCT01362933|DVT|dvt
1353034|NCT01362933|SVT|svt
1353035|NCT01362933|LMWH|lmwh
1353036|NCT01362933|VKA|vka
1353037|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
1353038|NCT01362920|Sepsis|sepsis
1353039|NCT01362920|Septic shock|septic shock
1353040|NCT01362920|Procalcitonin|procalcitonin
1353041|NCT01362920|PCT|pct
1353042|NCT01362881|Early|early
1353043|NCT01362881|Onset|onset
1353044|NCT01362881|Scoliosis|scoliosis
1353045|NCT01362868|Glaucoma|glaucoma
1353046|NCT01362868|Triggerfish|triggerfish
1353047|NCT01362868|Water drinking test|water drinking test
1354041|NCT01359020|Ibuprofen|ibuprofen
1353048|NCT01362855|Advance Care Planning|advance care planning
1353049|NCT01362855|End of life|end of life
1353050|NCT01362855|Knowledge translation|knowledge translation
1353051|NCT01362855|Goals of care|goals of care
1353052|NCT01362855|Advance directive|advance directive
1353053|NCT01362855|Lining will|lining will
1353054|NCT01362842|Lung Cancer|lung cancer
1353055|NCT01362842|Symptom distress|symptom distress
1353056|NCT01362842|Post-operation|post-operation
1353057|NCT01362842|Anxiety|anxiety
1353058|NCT01362842|Depression|depression
1353059|NCT01362842|Uncertainty|uncertainty
1353060|NCT01362842|Fear of recurrence|fear of recurrence
1353061|NCT01362842|Self-efficacy|self-efficacy
1353062|NCT01362842|Needs|needs
1353063|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
1353064|NCT01362803|Pharmacokinetics|pharmacokinetics
1353065|NCT01362803|Pharmacodynamics|pharmacodynamics
1353066|NCT01362803|Response Rate|response rate
1353067|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
1353068|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
1353069|NCT01362803|NF1|nf1
1353070|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
1353071|NCT01362790|Immune Therapy|immune therapy
1353072|NCT01362790|Immunotoxin|immunotoxin
1353073|NCT01362790|T-Cell Depletion|t-cell depletion
1353074|NCT01362790|Mesothelioma|mesothelioma
1353075|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
1353076|NCT01362777|Exercise training program|exercise training program
1353077|NCT01362777|Inflammation|inflammation
1353078|NCT01362777|Oxidative Stress|oxidative stress
1353079|NCT01362777|Resistance to insulin|resistance to insulin
1353080|NCT01362764|Abiraterone Acetate|abiraterone acetate
1353081|NCT01362764|ZYTIGA|zytiga
1353082|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
1353083|NCT01362725|spinal cord stimulation|spinal cord stimulation
1353084|NCT01362725|systolic heart failure|systolic heart failure
1353085|NCT01362712|breast cancer|breast cancer
1353086|NCT01362712|radiotherapy|radiotherapy
1353087|NCT01362712|chemoradiotherapy|chemoradiotherapy
1353088|NCT01362712|radiation|radiation
1353089|NCT01362712|chemoradiation|chemoradiation
1353090|NCT01362712|[F-18]|[f-18]
1353091|NCT01362699|Alcoholism|alcoholism
1353092|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
1353093|NCT01362699|Substance-Related Disorders|substance-related disorders
1353094|NCT01362699|Mental Disorders|mental disorders
1353095|NCT01362699|Alcohol Dependence|alcohol dependence
1353096|NCT01362699|JNJ-31001074|jnj-31001074
1353097|NCT01362699|Bavisant|bavisant
1353098|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
1353099|NCT01362686|medication adherence|medication adherence
1353100|NCT01362673|Phase 1|phase 1
1353101|NCT01362673|Pharmacokinetics|pharmacokinetics
1353102|NCT01362673|food effect|food effect
1353103|NCT01362673|Healthy Japanese|healthy japanese
1353104|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
1353105|NCT01362660|post-natal monitoring|post-natal monitoring
1353106|NCT01362660|exposure in utero|exposure in utero
1353107|NCT01362647|Muscle Relaxation|muscle relaxation
1353108|NCT01362634|HIV/AIDS|hiv/aids
1353109|NCT01362634|substance use|substance use
1353110|NCT01362634|club drugs|club drugs
1353111|NCT01362634|sexual risk|sexual risk
1353112|NCT01362621|Allergic asthma|allergic asthma
1353113|NCT01362621|Pediatrics|pediatrics
1353114|NCT01362621|Exacerbations|exacerbations
1353115|NCT01362621|Perennial aeroallergens|perennial aeroallergens
1353116|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
1353117|NCT01362608|Gout|gout
1353118|NCT01362608|Inflammatory gout|inflammatory gout
1353119|NCT01362608|acute gout|acute gout
1353120|NCT01362595|leucine administration|leucine administration
1353121|NCT01362595|red blood cell transfusion|red blood cell transfusion
1353122|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
1353123|NCT01362582|Pancreatic cancer|pancreatic cancer
1353124|NCT01362582|progression under chemotherapy|progression under chemotherapy
1353125|NCT01362582|parenteral nutrition|parenteral nutrition
1353126|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1353127|NCT01362582|chemotherapy|chemotherapy
1353128|NCT01362569|endotoxin|endotoxin
1353129|NCT01362569|neutrophil function|neutrophil function
1353130|NCT01362569|albumin function|albumin function
1353131|NCT01362543|PTSD|ptsd
1353132|NCT01362543|Depression|depression
1353133|NCT01362543|Refugees|refugees
1353134|NCT01362543|Trauma|trauma
1353135|NCT01362517|Vaccination|vaccination
1353136|NCT01362517|Immunisation|immunisation
1353137|NCT01362517|Virus|virus
1353138|NCT01362517|Diphtheria|diphtheria
1353139|NCT01362517|Pertussis|pertussis
1353140|NCT01362517|Tetanus|tetanus
1353141|NCT01362517|Hepatitis B|hepatitis b
1353142|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
1353143|NCT01362517|Immunity|immunity
1353144|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
1353145|NCT01362504|Neonatal sepsis|neonatal sepsis
1353146|NCT01362504|Prognosis|prognosis
1353147|NCT01362504|Sepsis marker|sepsis marker
1353148|NCT01362504|Clinical sepsis|clinical sepsis
1353149|NCT01362504|Proven sepsis|proven sepsis
1353150|NCT01362491|Headache|headache
1353151|NCT01362478|schizophrenia|schizophrenia
1353152|NCT01362478|gene promoter|gene promoter
1353153|NCT01362478|methylation|methylation
1353154|NCT01362478|endophenotype|endophenotype
1353155|NCT01362478|epigenetic|epigenetic
1353156|NCT01362452|Leukemia|leukemia
1353157|NCT01362452|Lymphoma|lymphoma
1353158|NCT01362452|CD19-specific T cells|cd19-specific t cells
1353159|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
1353160|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
1353161|NCT01362452|B-cell leukemia|b-cell leukemia
1353162|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1353163|NCT01362452|ALL|all
1353164|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
1353165|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1353166|NCT01362452|NHL|nhl
1353167|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1353168|NCT01362452|SLL|sll
1353169|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1353170|NCT01362452|CLL|cll
1353171|NCT01362452|White blood cells|white blood cells
1353172|NCT01362452|T cells|t cells
1353173|NCT01362452|Melphalan|melphalan
1353174|NCT01362452|Alkeran|alkeran
1353175|NCT01362452|Thiotepa|thiotepa
1353176|NCT01362452|Fludarabine|fludarabine
1353177|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
1353178|NCT01362452|Fludara|fludara
1353179|NCT01362452|ATG|atg
1353180|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
1353181|NCT01362452|Thymoglobulin|thymoglobulin
1353182|NCT01362452|Rituxan|rituxan
1353183|NCT01362452|Rituximab|rituximab
1353184|NCT01362452|Cyclophosphamide|cyclophosphamide
1353185|NCT01362452|Cytoxan|cytoxan
1353186|NCT01362452|Neosar|neosar
1353187|NCT01362439|Schizophrenia|schizophrenia
1353188|NCT01362439|Paliperidone|paliperidone
1353189|NCT01362426|schizophrenia|schizophrenia
1353190|NCT01362426|paliperidone palmitate|paliperidone palmitate
1353191|NCT01362426|INVEGA SUSTENNA|invega sustenna
1353192|NCT01362426|registries|registries
1353193|NCT01362426|quality of healthcare|quality of healthcare
1353194|NCT01362413|pseudarthrosis|pseudarthrosis
1353195|NCT01362413|mineralization|mineralization
1353196|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
1353197|NCT01362413|serum|serum
1353198|NCT01362400|LUNG NEOPLASMS|lung neoplasms
1353199|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
1353200|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
1353201|NCT01362387|Medical abortion|medical abortion
1353202|NCT01362387|abortion follow-up|abortion follow-up
1353203|NCT01362361|Second line colorectal cancer|second line colorectal cancer
1353204|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
1353205|NCT01362322|dTpa|dtpa
1353206|NCT01362322|Boostrix|boostrix
1353207|NCT01362309|Alcohol|alcohol
1353208|NCT01362309|Cues|cues
1353209|NCT01362309|Extinction|extinction
1353210|NCT01362309|D-Cycloserine|d-cycloserine
1353211|NCT01362296|NRAS|nras
1353212|NCT01362296|docetaxel|docetaxel
1353213|NCT01362296|NSCLC|nsclc
1353214|NCT01362296|GSK1120212|gsk1120212
1353215|NCT01362296|MEK inhibitor|mek inhibitor
1353216|NCT01362296|targeted therapy|targeted therapy
1353217|NCT01362296|KRAS|kras
1353218|NCT01362296|BRAF|braf
1353219|NCT01362270|Anxiolytics|anxiolytics
1353220|NCT01362270|Sedatives|sedatives
1353221|NCT01362270|Acupuncture Therapy|acupuncture therapy
1353222|NCT01362244|Quality of Life|quality of life
1353223|NCT01362244|Intranasal Steroids|intranasal steroids
1353524|NCT01361113|LCCC 1028|lccc 1028
1353224|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
1353225|NCT01362244|Polyp Relapse|polyp relapse
1353226|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
1353227|NCT01362244|Surgery|surgery
1353228|NCT01362231|Fibrosis|fibrosis
1353229|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
1353230|NCT01362231|Lung Diseases|lung diseases
1353231|NCT01362231|Interstitial|interstitial
1353232|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
1353233|NCT01362192|Telangiectasis|telangiectasis
1353234|NCT01362192|Spider Veins|spider veins
1353235|NCT01362192|Excel V|excel v
1353236|NCT01362192|Cutera|cutera
1353237|NCT01362192|Laser|laser
1353238|NCT01362192|Leg Veins|leg veins
1353239|NCT01362192|Venulectasia|venulectasia
1353240|NCT01362192|Lower Extremity veins|lower extremity veins
1353241|NCT01362192|Laser light|laser light
1353242|NCT01362192|KTP|ktp
1353243|NCT01362192|532nm|532nm
1353244|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
1353245|NCT01362179|filgrastim|filgrastim
1353246|NCT01362179|long term incidence|long term incidence
1353247|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
1353248|NCT01362166|Chinese medicine|chinese medicine
1353249|NCT01362166|channel|channel
1353250|NCT01362166|acupuncture|acupuncture
1353251|NCT01362166|ZuSanLi|zusanli
1353252|NCT01362166|XianGu|xiangu
1353253|NCT01362166|frequency response|frequency response
1353255|NCT01362166|male volunteer|male volunteer
1353256|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
1353257|NCT01362153|Golimumab|golimumab
1353258|NCT01362153|Simponi|simponi
1353259|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
1353260|NCT01362153|PK|pk
1353261|NCT01362153|PD|pd
1353262|NCT01362140|Randomized|randomized
1353263|NCT01362140|Darbepoetin alfa|darbepoetin alfa
1353264|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
1353265|NCT01362140|Placebo-controlled|placebo-controlled
1353266|NCT01362140|low risk MDS|low risk mds
1353267|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
1353268|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
1353269|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
1353270|NCT01362114|Hwa-byung|hwa-byung
1353271|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
1353272|NCT01362114|Anxiety|anxiety
1353273|NCT01362101|cue reactivity|cue reactivity
1353274|NCT01362101|physiologic activation|physiologic activation
1353275|NCT01362101|craving|craving
1353276|NCT01362101|smoking cues|smoking cues
1353277|NCT01362101|Behavioral therapy|behavioral therapy
1353278|NCT01362088|microcirculation|microcirculation
1353279|NCT01362088|intensive care|intensive care
1353280|NCT01362088|ultrafiltration|ultrafiltration
1353281|NCT01362088|CVVH|cvvh
1353282|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
1353283|NCT01362075|Local infiltration analgesia|local infiltration analgesia
1353284|NCT01362049|Stabilization exercise|stabilization exercise
1353285|NCT01362049|Physical therapy|physical therapy
1353286|NCT01362049|Rehabilitation|rehabilitation
1353287|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
1353288|NCT01362010|Acne|acne
1353289|NCT01362010|Acne Vulgaris|acne vulgaris
1353290|NCT01362010|Topical|topical
1353291|NCT01362010|Minocycline|minocycline
1353292|NCT01362010|Foam|foam
1353293|NCT01362010|Phase II|phase ii
1353294|NCT01361997|Antiseptics|antiseptics
1353295|NCT01361997|Hemoculture contamination|hemoculture contamination
1353296|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
1353297|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1353298|NCT01361984|COPD|copd
1353299|NCT01361984|Emphysema|emphysema
1353300|NCT01361984|Chronic Bronchitis|chronic bronchitis
1353301|NCT01361984|Brovana|brovana
1353302|NCT01361984|Serevent|serevent
1353303|NCT01361971|Insulin resistance|insulin resistance
1353304|NCT01361971|Inflammation|inflammation
1353305|NCT01361971|Hypoxia|hypoxia
1353306|NCT01361945|ER+|er+
1353307|NCT01361945|HER2+|her2+
1353308|NCT01361945|Breast|breast
1353309|NCT01361919|compressions|compressions
1353310|NCT01361919|quality|quality
1353311|NCT01361919|teaching method|teaching method
1353312|NCT01361919|feedback|feedback
1353313|NCT01361919|CPR performance - how well do students perform CPR when taught with feedback?|cpr performance - how well do students perform cpr when taught with feedback?
1353314|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
1353315|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
1353316|NCT01361906|Postural Balance|postural balance
1353317|NCT01361906|Eye/hand coordination|eye/hand coordination
1353318|NCT01361893|SIDS|sids
1353319|NCT01361893|African American|african american
1353320|NCT01361893|Infants|infants
1353321|NCT01361893|Disparity|disparity
1353322|NCT01361880|African American|african american
1353323|NCT01361880|Anticipatory Guidance|anticipatory guidance
1353324|NCT01361880|Health Promotion|health promotion
1353325|NCT01361880|Infant Mortality|infant mortality
1353326|NCT01361880|Injury Prevention|injury prevention
1353327|NCT01361880|Nurses|nurses
1353328|NCT01361880|Parent Education|parent education
1353329|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
1353330|NCT01361867|motor adaptation|motor adaptation
1353331|NCT01361867|lower extremity motor learning|lower extremity motor learning
1353332|NCT01361854|polysomnography|polysomnography
1353333|NCT01361854|portable monitoring|portable monitoring
1353334|NCT01361854|sleep|sleep
1353335|NCT01361854|sleep disordered breathing|sleep disordered breathing
1353336|NCT01361854|home based polysomnography|home based polysomnography
1353337|NCT01361841|Latanoprost|latanoprost
1353338|NCT01361841|bimatoprost|bimatoprost
1353339|NCT01361841|travoprost|travoprost
1353340|NCT01361841|non responders|non responders
1353341|NCT01361828|Bevacizumab|bevacizumab
1353342|NCT01361828|VEP|vep
1353343|NCT01361828|ERG|erg
1353344|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
1353345|NCT01361815|Depression|depression
1353346|NCT01361815|MDD|mdd
1353347|NCT01361815|SSRIs|ssris
1353348|NCT01361815|TMS|tms
1353349|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
1353350|NCT01361789|Anterior crucial ligament|anterior crucial ligament
1353351|NCT01361789|Coxib|coxib
1353352|NCT01361789|Dexamethasone|dexamethasone
1353353|NCT01361776|immune response|immune response
1468335|NCT00899431|CLL|cll
1353354|NCT01361776|TBE-vaccine|tbe-vaccine
1353355|NCT01361776|elderly|elderly
1353356|NCT01361776|additional doses|additional doses
1353357|NCT01361763|Dabigatran|dabigatran
1353358|NCT01361763|Microbleeds|microbleeds
1353359|NCT01361763|Microthrombi|microthrombi
1353360|NCT01361763|CADASIL|cadasil
1353361|NCT01361763|Small Vessel Disease|small vessel disease
1353362|NCT01361737|Preeclampsia|preeclampsia
1353363|NCT01361737|serological bio-bank|serological bio-bank
1353364|NCT01361737|adiponectin|adiponectin
1353365|NCT01361737|suPAR|supar
1353366|NCT01361724|Parkinson's disease|parkinson's disease
1353368|NCT01361724|Exercise|exercise
1353369|NCT01361724|Balance|balance
1353370|NCT01361724|Mobility|mobility
1353371|NCT01361698|recovery|recovery
1353372|NCT01361698|illness management|illness management
1353373|NCT01361698|rehabilitation|rehabilitation
1353374|NCT01361698|mental illness|mental illness
1353375|NCT01361698|psychosocial intervention|psychosocial intervention
1353376|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
1353377|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
1353378|NCT01361659|anginal complaints|anginal complaints
1353379|NCT01361659|Lithotripsy|lithotripsy
1353380|NCT01361659|no option patients|no option patients
1353381|NCT01361633|d-cycloserine|d-cycloserine
1353382|NCT01361633|geriatric|geriatric
1353383|NCT01361633|neuropsychology|neuropsychology
1353384|NCT01361633|cognition|cognition
1353385|NCT01361633|cognitive-enhancer|cognitive-enhancer
1353386|NCT01361633|aging|aging
1353387|NCT01361633|neuropsychological functioning|neuropsychological functioning
1353388|NCT01361620|genomic markers|genomic markers
1353389|NCT01361620|aspirin resistance|aspirin resistance
1353390|NCT01361607|Cancer pain|cancer pain
1353391|NCT01361607|Opioid therapy|opioid therapy
1353392|NCT01361607|Inadequate analgesia|inadequate analgesia
1353393|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
1353394|NCT01361594|Diabetes|diabetes
1353395|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1353396|NCT01361594|Glycemic control|glycemic control
1353397|NCT01361594|Insulin infusion|insulin infusion
1353398|NCT01361581|Acute renal failure|acute renal failure
1353399|NCT01361581|Anticoagulation|anticoagulation
1353400|NCT01361581|Citrate|citrate
1353401|NCT01361581|Haemodiafiltration|haemodiafiltration
1353402|NCT01361581|Haemofiltration|haemofiltration
1353403|NCT01361581|Renal replacement therapy|renal replacement therapy
1353404|NCT01361568|pain|pain
1353405|NCT01361568|acute pain|acute pain
1353406|NCT01361568|visceral pain|visceral pain
1353407|NCT01361568|kappa agonist|kappa agonist
1353408|NCT01361568|opioid analgesics|opioid analgesics
1353409|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
1353410|NCT01361568|physiological effects of drugs|physiological effects of drugs
1353411|NCT01361568|surgery|surgery
1353412|NCT01361568|hysterectomy|hysterectomy
1353413|NCT01361568|post-operative|post-operative
1353414|NCT01361568|post-operative complications|post-operative complications
1353415|NCT01361542|TNF|tnf
1353416|NCT01361542|BMD|bmd
1353417|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
1353418|NCT01361542|bone health|bone health
1353419|NCT01361542|Anti TNF therapy|anti tnf therapy
1353420|NCT01361542|Disease activity|disease activity
1353421|NCT01361529|dose escalation|dose escalation
1353422|NCT01361516|Urolithiasis|urolithiasis
1353423|NCT01361516|ESWL|eswl
1353710|NCT01360346|Intravenous Sedation|intravenous sedation
1353428|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
1353429|NCT01361503|Asperger's Syndrome|asperger's syndrome
1353431|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1353432|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
1353433|NCT01361477|General surgical ICU|general surgical icu
1353434|NCT01361477|ICU Siamitra|icu siamitra
1353435|NCT01361477|ICU Salad-Samung|icu salad-samung
1353436|NCT01361477|Data registry|data registry
1353437|NCT01361477|ICU refusal|icu refusal
1353438|NCT01361477|ICU complications|icu complications
1353439|NCT01361477|ICU resource utilization|icu resource utilization
1353440|NCT01361477|Adverse events|adverse events
1353441|NCT01361477|ICU readmission|icu readmission
1353442|NCT01361451|parasternal electromyogram|parasternal electromyogram
1353443|NCT01361451|neural respiratory drive|neural respiratory drive
1353444|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1353445|NCT01361451|respiratory physiology|respiratory physiology
1353446|NCT01361451|Acute exacerbation|acute exacerbation
1353447|NCT01361425|hypertension|hypertension
1353448|NCT01361425|ultrasonography|ultrasonography
1353449|NCT01361425|preeclampsia|preeclampsia
1353450|NCT01361425|clinical trials|clinical trials
1353451|NCT01361425|treatment|treatment
1353452|NCT01361425|methyldopa|methyldopa
1353453|NCT01361412|ragweed allergy|ragweed allergy
1353454|NCT01361412|immunotherapy|immunotherapy
1353455|NCT01361399|Sore Throat|sore throat
1354140|NCT01358487|Internet|internet
1353456|NCT01361386|Long-term follow up|long-term follow up
1353457|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
1353458|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
1353459|NCT01361386|Asia|asia
1353460|NCT01361386|quality of life|quality of life
1353461|NCT01361347|milk allergy|milk allergy
1353462|NCT01361347|desensitization|desensitization
1353463|NCT01361347|anaphylaxis|anaphylaxis
1353464|NCT01361347|school-age|school-age
1353465|NCT01361334|(other than AML M3)|(other than aml m3)
1353466|NCT01361321|follow up|follow up
1353467|NCT01361321|Guided bone regeneration|guided bone regeneration
1353468|NCT01361321|Micro computerized tomography|micro computerized tomography
1353469|NCT01361321|histological examination|histological examination
1353470|NCT01361308|Menopause|menopause
1353471|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
1353472|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
1353473|NCT01361308|Climacteric Symptoms|climacteric symptoms
1353474|NCT01361308|Mesafem|mesafem
1353475|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
1353476|NCT01361295|Atrial fibrillation|atrial fibrillation
1353477|NCT01361295|cerebral embolism|cerebral embolism
1353478|NCT01361295|catheter ablation|catheter ablation
1353479|NCT01361282|Total Corneal Power|total corneal power
1353480|NCT01361282|Optical Coherence Tomography|optical coherence tomography
1353481|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
1353482|NCT01361256|Macular Degeneration|macular degeneration
1353483|NCT01361256|Visual Impairment|visual impairment
1353484|NCT01361256|Implantable Telescope|implantable telescope
1353485|NCT01361243|Pediatric Overweight|pediatric overweight
1353486|NCT01361243|Pediatric Obesity|pediatric obesity
1353493|NCT01361204|stress|stress
1353494|NCT01361204|students|students
1353495|NCT01361204|pharmacy practice|pharmacy practice
1353496|NCT01361204|theanine|theanine
1353497|NCT01361204|pharmacy training|pharmacy training
1353498|NCT01361191|DLBCL|dlbcl
1353499|NCT01361191|PET|pet
1353500|NCT01361191|IPI|ipi
1353501|NCT01361191|R-MegaCHOP|r-megachop
1353502|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
1353503|NCT01361165|Pediatric|pediatric
1353504|NCT01361165|Data Analysis|data analysis
1353505|NCT01361152|total knee arthroplasty|total knee arthroplasty
1353506|NCT01361152|fixed-bearing|fixed-bearing
1353507|NCT01361152|mobile-bearing|mobile-bearing
1353508|NCT01361152|long-term|long-term
1353509|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
1353510|NCT01361139|Interstitial lung disease|interstitial lung disease
1353511|NCT01361139|Asthma|asthma
1353512|NCT01361139|Sarcoidosis|sarcoidosis
1353513|NCT01361139|Pulmonary hypertension|pulmonary hypertension
1353514|NCT01361139|Ultrasound|ultrasound
1353515|NCT01361139|Doppler|doppler
1353516|NCT01361139|Lung disease diagnosis|lung disease diagnosis
1353517|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
1353518|NCT01361113|RCC|rcc
1353519|NCT01361113|Votrient|votrient
1353520|NCT01361113|Pazopanib|pazopanib
1353521|NCT01361113|Nephrectomy|nephrectomy
1353522|NCT01361113|Neoadjuvant|neoadjuvant
1353525|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1353526|NCT01361100|Otolaryngology|otolaryngology
1353527|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
1353528|NCT01361074|Virtual reality|virtual reality
1353529|NCT01361074|Augmented reality|augmented reality
1353530|NCT01361074|In vivo exposure|in vivo exposure
1353531|NCT01361074|One session treatment|one session treatment
1353532|NCT01361074|ICT|ict
1353533|NCT01361074|Efficacy|efficacy
1353534|NCT01361074|Specific phobia|specific phobia
1353535|NCT01361074|Anxiety disorders|anxiety disorders
1353536|NCT01361061|liver cirrhosis|liver cirrhosis
1353537|NCT01361061|screening|screening
1353538|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
1353539|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
1353540|NCT01361048|trichomonas|trichomonas
1353541|NCT01361035|health literacy|health literacy
1353542|NCT01361035|cancer screening|cancer screening
1353543|NCT01361035|doctor-patient communication|doctor-patient communication
1353544|NCT01361035|standardized patient|standardized patient
1353545|NCT01361035|continuing medical education|continuing medical education
1353546|NCT01360996|PCOS|pcos
1353547|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
1353548|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
1353549|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
1353550|NCT01360970|methotrexate|methotrexate
1353551|NCT01360957|Obesity|obesity
1353552|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
1353553|NCT01360931|Lung cancer|lung cancer
1353554|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1353555|NCT01360905|PTL|ptl
1353556|NCT01360905|Multiples|multiples
1353557|NCT01360892|Hepatitis B virus|hepatitis b virus
1353558|NCT01360892|Hepatitis C virus|hepatitis c virus
1353559|NCT01360892|Chronic hepatitis|chronic hepatitis
1353560|NCT01360892|Liver chlorosis|liver chlorosis
1468541|NCT00898859|ADAM|adam
1353561|NCT01360892|Liver stiffness|liver stiffness
1353562|NCT01360892|Liver fibrosis|liver fibrosis
1353563|NCT01360879|Hepatitis B virus|hepatitis b virus
1353564|NCT01360879|Hepatitis C virus|hepatitis c virus
1353565|NCT01360879|Chronic hepatitis|chronic hepatitis
1353566|NCT01360879|Liver cirrhosis|liver cirrhosis
1353567|NCT01360879|Liver stiffness|liver stiffness
1353568|NCT01360879|Liver fibrosis|liver fibrosis
1353569|NCT01360866|OPC-34712|opc-34712
1353570|NCT01360866|brexpiprazole|brexpiprazole
1353571|NCT01360866|Major Depressive Disorder|major depressive disorder
1353572|NCT01360866|Adjunctive Treatment|adjunctive treatment
1353573|NCT01360853|pancreatic cancer|pancreatic cancer
1353574|NCT01360853|gemcitabine|gemcitabine
1353575|NCT01360853|ON 01910.Na|on 01910.na
1353576|NCT01360853|rigosertib sodium|rigosertib sodium
1353577|NCT01360840|Asymptomatic|asymptomatic
1353578|NCT01360840|mildly symptomatic|mildly symptomatic
1353579|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
1353580|NCT01360840|mCRPC|mcrpc
1353581|NCT01360827|Safety|safety
1353582|NCT01360827|tolerability|tolerability
1353583|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
1353584|NCT01360827|TLR9 agonists|tlr9 agonists
1353585|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1353586|NCT01360827|First line subjects|first line subjects
1353587|NCT01360827|recurrent/metastatic|recurrent/metastatic
1353588|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1353589|NCT01360788|lung function|lung function
1353590|NCT01360788|symptoms|symptoms
1353591|NCT01360788|activity-related dyspnea|activity-related dyspnea
1353592|NCT01360788|quadriceps muscle function|quadriceps muscle function
1353593|NCT01360788|exercise capacity|exercise capacity
1353594|NCT01360788|physical activity in daily life|physical activity in daily life
1353595|NCT01360788|muscle biopsy|muscle biopsy
1353596|NCT01360788|systemic inflammation|systemic inflammation
1353597|NCT01360788|GOLD stage I|gold stage i
1353598|NCT01360788|pulmonary function|pulmonary function
1353599|NCT01360775|Nutritional status|nutritional status
1353600|NCT01360775|Dependent patients|dependent patients
1353601|NCT01360775|Nutritional educational intervention|nutritional educational intervention
1353602|NCT01360775|Caregivers|caregivers
1353603|NCT01360775|Clinical assay|clinical assay
1353604|NCT01360762|Secondary prophylaxis|secondary prophylaxis
1353605|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
1353606|NCT01360762|Relapses|relapses
1353607|NCT01360762|HIV co-infection|hiv co-infection
1353608|NCT01360762|Pentamidine|pentamidine
1353609|NCT01360762|Ethiopia|ethiopia
1353610|NCT01360749|Pain management|pain management
1353611|NCT01360749|Lidocaine|lidocaine
1353612|NCT01360736|Suicide Prevention|suicide prevention
1353613|NCT01360736|Suicide Attempt|suicide attempt
1353614|NCT01360736|Suicide Ideation|suicide ideation
1353615|NCT01360736|Randomized Controlled Trial|randomized controlled trial
1353616|NCT01360736|Safety Planning|safety planning
1353617|NCT01360710|male age 18-30 years old|male age 18-30 years old
1353618|NCT01360710|presence of central obesity|presence of central obesity
1353711|NCT01360346|Critically ill ICU patient|critically ill icu patient
1353619|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
1353620|NCT01360710|not on any medication|not on any medication
1353621|NCT01360697|Diabetes|diabetes
1353622|NCT01360697|Structured care|structured care
1353623|NCT01360671|PPHN|pphn
1353624|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
1353625|NCT01360671|sildenafil|sildenafil
1353626|NCT01360671|iv|iv
1353627|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
1353628|NCT01360658|Solar urticaria|solar urticaria
1353629|NCT01360658|Minimal urticaria dose|minimal urticaria dose
1353630|NCT01360658|Quality of life|quality of life
1353631|NCT01360658|Safety|safety
1353632|NCT01360645|OPC-34712|opc-34712
1353633|NCT01360645|brexpiprazole|brexpiprazole
1353634|NCT01360645|Major Depressive Disorder|major depressive disorder
1353635|NCT01360645|Adjunctive Treatment|adjunctive treatment
1353636|NCT01360632|OPC-34712|opc-34712
1353637|NCT01360632|brexpiprazole|brexpiprazole
1353638|NCT01360632|Major Depressive Disorder|major depressive disorder
1353639|NCT01360632|Adjunctive Treatment|adjunctive treatment
1353640|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
1353641|NCT01360606|Liver|liver
1353642|NCT01360606|Mets|mets
1353643|NCT01360593|Pancreas|pancreas
1353644|NCT01360567|green tea|green tea
1353645|NCT01360567|EGCG|egcg
1353646|NCT01360567|type 2 diabetes|type 2 diabetes
1353647|NCT01360567|hyperlipidemia|hyperlipidemia
1353648|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
1353649|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
1353650|NCT01360541|Barrett oesophagus|barrett oesophagus
1353651|NCT01360541|Low grade dysplasia|low grade dysplasia
1353652|NCT01360541|Radiofrequency ablation|radiofrequency ablation
1353653|NCT01360528|Folic acid replacement|folic acid replacement
1353654|NCT01360528|Folic acid|folic acid
1353655|NCT01360528|Preterm neonate|preterm neonate
1353656|NCT01360515|esophagoscope|esophagoscope
1353657|NCT01360515|esophageal disease|esophageal disease
1353658|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
1353659|NCT01360515|esophageal varices|esophageal varices
1353660|NCT01360502|capsule endoscopy|capsule endoscopy
1353661|NCT01360502|cardiac pacemaker|cardiac pacemaker
1353662|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
1353663|NCT01360476|hypertension|hypertension
1353664|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
1353665|NCT01360476|Vitamin D|vitamin d
1353666|NCT01360476|African-Americans|african-americans
1353667|NCT01360463|drug abuse counseling|drug abuse counseling
1353668|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
1353669|NCT01360463|HIV infection|hiv infection
1353670|NCT01360463|injection drug users|injection drug users
1353671|NCT01360463|AIDS|aids
1353672|NCT01360450|opioid withdrawal|opioid withdrawal
1353673|NCT01360450|Neonatal Pain, Agitation, and Sedation Scale (NPASS)|neonatal pain, agitation, and sedation scale (npass)
1353674|NCT01360450|duraclon|duraclon
1353675|NCT01360437|coronary angioplasty|coronary angioplasty
1353676|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
1353677|NCT01360437|prasugrel|prasugrel
1353678|NCT01360437|ticagrelor|ticagrelor
1353679|NCT01360437|CAD|cad
1353680|NCT01360437|ACS|acs
1353681|NCT01360424|osteoporosis|osteoporosis
1353682|NCT01360424|teriparatide|teriparatide
1353683|NCT01360424|bone turnover|bone turnover
1353684|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
1353685|NCT01360411|elastography|elastography
1353686|NCT01360411|strain ratio|strain ratio
1353687|NCT01360411|pancreas|pancreas
1353688|NCT01360411|GI wall lesions|gi wall lesions
1353689|NCT01360411|lymph nodes|lymph nodes
1353690|NCT01360398|pathogen|pathogen
1353691|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1353692|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
1353693|NCT01360398|COPD|copd
1353694|NCT01360398|respiratory|respiratory
1353695|NCT01360398|AECOPD|aecopd
1353696|NCT01360398|exacerbation|exacerbation
1353697|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
1353698|NCT01360385|Retinal oximetry|retinal oximetry
1353699|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
1353700|NCT01360385|Visual acuity|visual acuity
1353701|NCT01360385|Central retinal thickness|central retinal thickness
1353702|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
1353703|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
1353704|NCT01360359|low back pain|low back pain
1353705|NCT01360359|core stabilization|core stabilization
1353706|NCT01360359|trunk muscle exercises|trunk muscle exercises
1353707|NCT01360359|physical therapy|physical therapy
1353708|NCT01360359|RCT|rct
1353709|NCT01360346|Enteral Sedation|enteral sedation
1353800|NCT01360073|PPI|ppi
1353717|NCT01360346|BPS|bps
1353718|NCT01360346|Propofol|propofol
1353719|NCT01360346|Midazolam|midazolam
1353720|NCT01360346|Hydroxyzine|hydroxyzine
1353721|NCT01360346|Lorazepam|lorazepam
1353722|NCT01360346|Melatonin|melatonin
1353723|NCT01360333|Dehydration|dehydration
1353724|NCT01360333|Hydration|hydration
1353725|NCT01360320|Green tea|green tea
1353726|NCT01360320|polyphenol|polyphenol
1353727|NCT01360320|catechin|catechin
1353729|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
1353730|NCT01360320|colorectal adenoma|colorectal adenoma
1353731|NCT01360320|adenoma prevention|adenoma prevention
1353732|NCT01360320|colon cancer prevention|colon cancer prevention
1353733|NCT01360307|psychometric validation|psychometric validation
1353734|NCT01360307|major depressive disorder|major depressive disorder
1353735|NCT01360307|patient-reported outcome|patient-reported outcome
1353736|NCT01360294|Asthma|asthma
1353737|NCT01360294|Small airways disease|small airways disease
1353738|NCT01360294|Questionnaire|questionnaire
1353739|NCT01360281|Quadriceps strength|quadriceps strength
1353740|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
1353741|NCT01360281|NMES|nmes
1353742|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
1353743|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
1353744|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
1353745|NCT01360242|Acute STEMI|acute stemi
1353746|NCT01360242|Thrombus aspiration|thrombus aspiration
1353747|NCT01360242|Angioplasty|angioplasty
1353748|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
1353749|NCT01360229|Parkinsons Disease|parkinsons disease
1353750|NCT01360229|Fatigue|fatigue
1353751|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
1353752|NCT01360216|Intrauterine contraception|intrauterine contraception
1353753|NCT01360216|Intrauterine devices|intrauterine devices
1353754|NCT01360216|Single-rod implant|single-rod implant
1353755|NCT01360216|Hormonal contraception|hormonal contraception
1353756|NCT01360190|MDD|mdd
1353757|NCT01360190|major depressive disorder|major depressive disorder
1353758|NCT01360190|QEEG|qeeg
1353759|NCT01360190|electroencephalograph|electroencephalograph
1353760|NCT01360190|fluoxtine|fluoxtine
1353761|NCT01360190|placebo|placebo
1353762|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
1353763|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
1353764|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
1353765|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1353766|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1353767|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1353768|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1353769|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1353770|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1353771|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1353772|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1353773|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1353774|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1353775|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1353776|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1353777|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1353778|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1353779|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1353786|NCT01360099|Atypical Hip Fracture|atypical hip fracture
1353787|NCT01360099|Biosphosphonates|biosphosphonates
1353788|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
1353789|NCT01360099|Osteoporosis|osteoporosis
1353790|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1353791|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1353792|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
1353793|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
1353794|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
1353795|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
1353796|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
1353797|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
1353798|NCT01360073|MI|mi
1353799|NCT01360073|low dose aspirin|low dose aspirin
1353801|NCT01360073|epidemiology|epidemiology
1353802|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
1353803|NCT01360047|MI|mi
1353804|NCT01360047|low dose aspirin|low dose aspirin
1353805|NCT01360047|PPI|ppi
1353806|NCT01360047|epidemiology|epidemiology
1353807|NCT01360034|Obstetric labor, premature|obstetric labor, premature
1353808|NCT01360034|Short cervix|short cervix
1353809|NCT01360034|Nifedipine|nifedipine
1353810|NCT01360034|Indomethacin|indomethacin
1353811|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
1353812|NCT01360008|Catheter ablation|catheter ablation
1353813|NCT01360008|Cohort Study|cohort study
1353814|NCT01360008|cryoballoon|cryoballoon
1353815|NCT01360008|radiofrequency|radiofrequency
1353816|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
1353817|NCT01359982|Advanced Solid Tumors|advanced solid tumors
1353818|NCT01359982|Lymphomas|lymphomas
1353819|NCT01359982|Safety|safety
1353820|NCT01359982|Blood flow|blood flow
1353821|NCT01359982|Nitric oxide|nitric oxide
1353822|NCT01359982|Cancer|cancer
1353823|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
1353824|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
1353825|NCT01359969|Hereditary Angioedema|hereditary angioedema
1353826|NCT01359969|HAE|hae
1353827|NCT01359969|Angioedema|angioedema
1353828|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
1353829|NCT01359969|rhC1INH|rhc1inh
1353830|NCT01359969|Pediatrics|pediatrics
1353831|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
1353832|NCT01359943|RA|ra
1353833|NCT01359943|secukinumab|secukinumab
1353834|NCT01359943|AIN457|ain457
1353835|NCT01359943|inflammatory joints|inflammatory joints
1353836|NCT01359943|American College of Rheumatology|american college of rheumatology
1353837|NCT01359943|ACR|acr
1353838|NCT01359904|dialysate glucose|dialysate glucose
1353839|NCT01359904|glycemic control|glycemic control
1353840|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
1353841|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
1353842|NCT01359878|Postpartum bleeding|postpartum bleeding
1353843|NCT01359878|Postnatal bleeding|postnatal bleeding
1353844|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
1353845|NCT01359878|Transfusion|transfusion
1353846|NCT01359878|Haemostatis|haemostatis
1353847|NCT01359878|Thrombelastography|thrombelastography
1353848|NCT01359865|Total hip arthroplasty|total hip arthroplasty
1353849|NCT01359865|lumbar plexus block|lumbar plexus block
1353850|NCT01359865|spinal anesthesia|spinal anesthesia
1353851|NCT01359865|range of motion|range of motion
1353852|NCT01359865|Anesthetic Technique|anesthetic technique
1353853|NCT01359865|Post-operative Pain Scores|post-operative pain scores
1353854|NCT01359852|JNJ-42491293|jnj-42491293
1353855|NCT01359852|JNJ-40411813|jnj-40411813
1353856|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
1353857|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
1353858|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
1353859|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
1353860|NCT01359826|Widespread Pain|widespread pain
1353861|NCT01359826|Fibromyalgia|fibromyalgia
1353862|NCT01359826|Fatigue|fatigue
1353863|NCT01359826|Pain|pain
1353864|NCT01359826|Quality of Life|quality of life
1353865|NCT01359800|HIV|hiv
1353866|NCT01359800|HAART|haart
1353867|NCT01359774|Energy|energy
1353868|NCT01359774|Metabolism|metabolism
1353869|NCT01359774|Spectroscopy|spectroscopy
1353870|NCT01359761|Suicide|suicide
1353871|NCT01359761|Cognitive Therapy|cognitive therapy
1353872|NCT01359761|Inpatient|inpatient
1353873|NCT01359761|Military|military
1353874|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
1353875|NCT01359735|Wound|wound
1353876|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
1353877|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
1353878|NCT01359735|Head or neck|head or neck
1353879|NCT01359722|N-acetylcysteine|n-acetylcysteine
1353880|NCT01359722|Myocardial Revascularization|myocardial revascularization
1353881|NCT01359722|Acute Renal Failure|acute renal failure
1353882|NCT01359722|Oxidative Stress|oxidative stress
1353883|NCT01359696|solid cancers|solid cancers
1353884|NCT01359670|Duchenne|duchenne
1353885|NCT01359670|muscular dystrophy|muscular dystrophy
1353886|NCT01359670|tadalafil|tadalafil
1353887|NCT01359670|sildenafil|sildenafil
1353888|NCT01359670|muscle ischemia|muscle ischemia
1353889|NCT01359670|exercise|exercise
1353890|NCT01359657|Relapsed|relapsed
1353891|NCT01359657|Refractory|refractory
1353892|NCT01359631|Chronic Cluster Headache|chronic cluster headache
1353893|NCT01359618|Phase I|phase i
1353894|NCT01359618|Safety|safety
1353895|NCT01359618|tolerability|tolerability
1353896|NCT01359618|healthy|healthy
1353897|NCT01359618|major depressive disorder|major depressive disorder
1353898|NCT01359618|thorough QT|thorough qt
1353899|NCT01359618|maximum tolerated dose|maximum tolerated dose
1353900|NCT01359618|elimination|elimination
1353901|NCT01359618|heart electrical signal|heart electrical signal
1353902|NCT01359605|ADME|adme
1353903|NCT01359605|Healthy volunteers|healthy volunteers
1353904|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1353905|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1353906|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1353907|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1353908|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1353909|NCT01359579|renal impairment|renal impairment
1353910|NCT01359579|phase 1|phase 1
1353911|NCT01359579|healthy volunteers|healthy volunteers
1353912|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
1353913|NCT01359540|Bone Loss|bone loss
1353914|NCT01359540|Femoral Remodeling|femoral remodeling
1353915|NCT01359540|Bone mineral density|bone mineral density
1353916|NCT01359540|THA|tha
1353917|NCT01359540|DXA|dxa
1353918|NCT01359540|DEXA|dexa
1353919|NCT01359540|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
1353920|NCT01359527|Total Hip Replacement|total hip replacement
1353921|NCT01359527|Hip Resurfacing|hip resurfacing
1353922|NCT01359527|Femoral Remodeling|femoral remodeling
1353923|NCT01359527|Bone Loss|bone loss
1353924|NCT01359527|Bone Mineral Density|bone mineral density
1353925|NCT01359527|BMD|bmd
1353926|NCT01359527|DXA|dxa
1353927|NCT01359527|DEXA|dexa
1353928|NCT01359527|THA|tha
1353929|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
1353930|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
1353931|NCT01359488|rhGH|rhgh
1353932|NCT01359488|hGH|hgh
1353933|NCT01359488|Versartis|versartis
1353934|NCT01359488|AGHD|aghd
1353935|NCT01359488|Hormones|hormones
1353936|NCT01359488|Hormone substitute|hormone substitute
1353937|NCT01359488|Endocrin System disease|endocrin system disease
1353938|NCT01359488|Bone disease|bone disease
1353939|NCT01359488|Bone disease, developmental|bone disease, developmental
1353940|NCT01359488|Bone diseases|bone diseases
1353941|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
1353942|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
1353943|NCT01359488|Metabolism diseases|metabolism diseases
1353944|NCT01359488|Hypopituitarism|hypopituitarism
1353945|NCT01359488|Pituitary disease|pituitary disease
1353946|NCT01359488|Hypothalmic disease|hypothalmic disease
1353947|NCT01359488|Brain disease|brain disease
1353948|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
1353949|NCT01359488|Hormone replacement therapy|hormone replacement therapy
1353951|NCT01359488|IGFBP-3|igfbp-3
1353952|NCT01359475|Acetal crowns|acetal crowns
1353953|NCT01359475|Primary molars|primary molars
1353954|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
1353955|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
1353956|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
1353957|NCT01359449|Meningitis|meningitis
1353958|NCT01359449|Meningococcal Infection|meningococcal infection
1353959|NCT01359449|Menactra®|menactra®
1353960|NCT01359449|MenC|menc
1353961|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
1353962|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
1353963|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
1353964|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
1353965|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
1353966|NCT01359371|Smoking Cessation|smoking cessation
1353967|NCT01359371|Telephone|telephone
1353968|NCT01359371|Hospital Volunteers|hospital volunteers
1353969|NCT01359358|MRSA|mrsa
1353970|NCT01359358|MLST|mlst
1353971|NCT01359358|PFGE|pfge
1353972|NCT01359358|Resistance|resistance
1353973|NCT01359358|isolated from colonization|isolated from colonization
1353974|NCT01359345|NSF|nsf
1353975|NCT01359345|ESRD|esrd
1353976|NCT01359345|MRA|mra
1353977|NCT01359345|MRI|mri
1353978|NCT01359345|occurrence of NSF|occurrence of nsf
1353979|NCT01359345|Use of Gadollinum|use of gadollinum
1353980|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
1353981|NCT01359332|hypothermia therapy|hypothermia therapy
1353982|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
1353983|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
1353984|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
1353985|NCT01359332|seizures)|seizures)
1353986|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
1353987|NCT01359306|Acute myocardial infarction|acute myocardial infarction
1353988|NCT01359306|Right ventricular infarction|right ventricular infarction
1353989|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
1353990|NCT01359306|Prognosis|prognosis
1353991|NCT01359280|HIV|hiv
1353992|NCT01359280|AIDS|aids
1353993|NCT01359280|Medication|medication
1353994|NCT01359280|Adherence|adherence
1353995|NCT01359241|dysglycemia|dysglycemia
1353996|NCT01359241|diabetes|diabetes
1353997|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
1353998|NCT01359228|Rosacea|rosacea
1353999|NCT01359202|Stroke|stroke
1354000|NCT01359202|ICH|ich
1354001|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
1354002|NCT01359202|acute stroke|acute stroke
1354003|NCT01359202|rfVIIa|rfviia
1354004|NCT01359202|Niastase|niastase
1354005|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
1354006|NCT01359163|bioequivalence study|bioequivalence study
1354007|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
1354008|NCT01359163|Femulen|femulen
1354009|NCT01359137|Behavior|behavior
1354010|NCT01359137|Drug users|drug users
1354011|NCT01359137|Criminal Justice|criminal justice
1354012|NCT01359137|Probation|probation
1354013|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
1354014|NCT01359124|Exercise Therapies|exercise therapies
1354015|NCT01359111|Intradermal injections|intradermal injections
1354016|NCT01359111|Vaccination|vaccination
1354017|NCT01359098|swimmer's ear|swimmer's ear
1354018|NCT01359098|ear drops|ear drops
1354019|NCT01359098|ear foam|ear foam
1354020|NCT01359098|otic foam|otic foam
1354021|NCT01359098|ear infection|ear infection
1354022|NCT01359098|ear pain|ear pain
1354023|NCT01359098|ear inflammation|ear inflammation
1354024|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
1354025|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
1354026|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
1354027|NCT01359072|coping|coping
1354028|NCT01359072|psychological distress|psychological distress
1354029|NCT01359072|self-administered intervention|self-administered intervention
1354030|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
1354031|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
1354032|NCT01359046|CAUTI|cauti
1354033|NCT01359046|UTI|uti
1354034|NCT01359033|Myocardial Infarction|myocardial infarction
1354035|NCT01359033|UK|uk
1354036|NCT01359033|Sweden|sweden
1354037|NCT01359033|National audit registry|national audit registry
1354038|NCT01359033|MINAP|minap
1354042|NCT01359020|Acetaminophen|acetaminophen
1354043|NCT01359020|Dipyrone|dipyrone
1354044|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
1354045|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
1354046|NCT01358994|metformin|metformin
1354047|NCT01358994|type 2 diabetes|type 2 diabetes
1354048|NCT01358994|e-GFR|e-gfr
1354049|NCT01358994|creatinine|creatinine
1354050|NCT01358994|lactic acidosis|lactic acidosis
1354051|NCT01358955|mild cognitive impairment|mild cognitive impairment
1354052|NCT01358955|cognitive therapy|cognitive therapy
1354053|NCT01358955|prevention|prevention
1354054|NCT01358916|antimicrobial resistance|antimicrobial resistance
1354055|NCT01358916|antibiotic prescription|antibiotic prescription
1354056|NCT01358916|primary health care|primary health care
1354057|NCT01358916|cluster-randomized trial|cluster-randomized trial
1354058|NCT01358890|over weight|over weight
1354059|NCT01358890|obesity|obesity
1354060|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
1354061|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
1354062|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
1354063|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
1354064|NCT01358825|Long-term follow up|long-term follow up
1354065|NCT01358825|Persistence|persistence
1354066|NCT01358825|Infanrix hexa|infanrix hexa
1354067|NCT01358812|RAS Wild-Type|ras wild-type
1354068|NCT01358812|BRAF Wild-Type|braf wild-type
1354069|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
1354070|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
1354071|NCT01358786|Quilting suture|quilting suture
1354072|NCT01358786|seroma|seroma
1354073|NCT01358786|Procedure|procedure
1354074|NCT01358786|Surgery|surgery
1354075|NCT01358773|Obesity|obesity
1354076|NCT01358773|Therapy|therapy
1354077|NCT01358773|Interdisciplinary|interdisciplinary
1354078|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
1354079|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
1354080|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
1354081|NCT01358760|DHEA|dhea
1354082|NCT01358760|Prasterone|prasterone
1354083|NCT01358760|Vaginorm|vaginorm
1354084|NCT01358760|Menopause|menopause
1354085|NCT01358760|Intrarosa|intrarosa
1354086|NCT01358734|AML|aml
1354087|NCT01358734|elderly|elderly
1354088|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
1354089|NCT01358734|vidaza|vidaza
1354090|NCT01358734|azacitidine|azacitidine
1354091|NCT01358734|elderly AML|elderly aml
1354092|NCT01358734|revlimid|revlimid
1354093|NCT01358734|lenalidomide|lenalidomide
1354094|NCT01358695|Lateral Canthal Lines|lateral canthal lines
1354095|NCT01358695|Crow's Feet|crow's feet
1354096|NCT01358669|Denosumab|denosumab
1354097|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
1354098|NCT01358643|OEF/OIF|oef/oif
1354099|NCT01358643|Physical Activity|physical activity
1354100|NCT01358643|Preferences|preferences
1354101|NCT01358630|Periodontitis|periodontitis
1354102|NCT01358630|Vascular disease|vascular disease
1354103|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
1354104|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
1354105|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
1354106|NCT01358604|regional neuroblastoma|regional neuroblastoma
1354107|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
1354108|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1354109|NCT01358578|Psoriasis,|psoriasis,
1354110|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
1354111|NCT01358578|scaly patches|scaly patches
1354112|NCT01358578|Psoriasis|psoriasis
1354113|NCT01358578|inflammatory skin disease|inflammatory skin disease
1354114|NCT01358552|Neevo|neevo
1354115|NCT01358552|Neevo DHA|neevo dha
1354116|NCT01358552|L-methylfolate|l-methylfolate
1354117|NCT01358552|anemia during pregnancy|anemia during pregnancy
1354118|NCT01358552|folic acid|folic acid
1354119|NCT01358552|vitamin B12|vitamin b12
1354120|NCT01358552|prenatal vitamins|prenatal vitamins
1354121|NCT01358552|hemoglobin|hemoglobin
1354122|NCT01358552|iron deficiency|iron deficiency
1354123|NCT01358552|Pregnancy|pregnancy
1354124|NCT01358539|palliation|palliation
1354125|NCT01358539|pain education|pain education
1354126|NCT01358526|Low back pain|low back pain
1354127|NCT01358526|Chronic pain|chronic pain
1354128|NCT01358526|Opioid|opioid
1354129|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
1354130|NCT01358513|Positron Emission Tomography|positron emission tomography
1354131|NCT01358513|Inflammation|inflammation
1354132|NCT01358513|Calcification|calcification
1354133|NCT01358500|opioid dependence|opioid dependence
1354134|NCT01358500|tolerant|tolerant
1354135|NCT01358500|dependent|dependent
1354136|NCT01358487|Major depression|major depression
1354137|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
1354138|NCT01358487|Mood Management|mood management
1354139|NCT01358487|Self-help|self-help
1354141|NCT01358474|Parkinson disease|parkinson disease
1354142|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
1354143|NCT01358474|Gaucher disease|gaucher disease
1354144|NCT01358474|healthy volunteer|healthy volunteer
1354145|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
1354146|NCT01358422|Prospective observational study|prospective observational study
1354147|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
1354148|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
1354149|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
1354150|NCT01358422|aspirin alone therapy|aspirin alone therapy
1354151|NCT01358422|non-cardiac surgery|non-cardiac surgery
1354152|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1354153|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
1354154|NCT01358422|OBTAIN|obtain
1354155|NCT01358422|Simon Howell|simon howell
1354156|NCT01358422|ESA|esa
1354157|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
1354158|NCT01358409|steatosis|steatosis
1354159|NCT01358409|MR spectroscopy|mr spectroscopy
1354160|NCT01358409|Nebivolol|nebivolol
1354161|NCT01358409|cardiac MRI|cardiac mri
1354162|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
1354163|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1354164|NCT01358383|Pharmacokinetics|pharmacokinetics
1354165|NCT01358383|VIMOVO|vimovo
1354166|NCT01358383|fasting state|fasting state
1354167|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
1354168|NCT01358383|taken on empty stomach|taken on empty stomach
1354169|NCT01358370|LAL Deficiency|lal deficiency
1354170|NCT01358370|LIPA|lipa
1354171|NCT01358370|Wolman disease|wolman disease
1354172|NCT01358370|Wolman Phenotype|wolman phenotype
1354173|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
1354174|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
1354175|NCT01358357|Lurasidone|lurasidone
1354176|NCT01358357|Latuda|latuda
1354177|NCT01358357|Bipolar I|bipolar i
1354178|NCT01358318|obesity|obesity
1354179|NCT01358318|satiety|satiety
1354180|NCT01358318|soy protein|soy protein
1354181|NCT01358318|soy fiber|soy fiber
1354182|NCT01358318|control appetite|control appetite
1354183|NCT01358318|reduce food intake|reduce food intake
1354184|NCT01358305|muscle|muscle
1354185|NCT01358305|synthesis|synthesis
1354186|NCT01358305|mTOR|mtor
1354187|NCT01358305|antioxidant|antioxidant
1354188|NCT01358305|inflammatory markers|inflammatory markers
1354189|NCT01358305|soy protein|soy protein
1354190|NCT01358305|whey|whey
1354191|NCT01358305|casein|casein
1354192|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
1354193|NCT01358292|Anterior Knee Pain|anterior knee pain
1354194|NCT01358292|Nail positioning|nail positioning
1354195|NCT01358253|Rituximab|rituximab
1354196|NCT01358253|HyperCVAD|hypercvad
1354197|NCT01358240|Econazole Nitrate|econazole nitrate
1354198|NCT01358240|Foam|foam
1354199|NCT01358240|Quinnova|quinnova
1354200|NCT01358240|Tinea Pedis|tinea pedis
1354201|NCT01358214|Sub-urethral Sling|sub-urethral sling
1354202|NCT01358214|Treatment Outcome|treatment outcome
1354203|NCT01358214|Quality of Life|quality of life
1354204|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1354205|NCT01358188|Gaucher disease|gaucher disease
1354206|NCT01358188|immunity|immunity
1354207|NCT01358188|inflammation|inflammation
1354208|NCT01358188|macrophage activation|macrophage activation
1354209|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
1354210|NCT01358175|AS|as
1354211|NCT01358175|ASAS|asas
1354212|NCT01358175|inflammatory back pain|inflammatory back pain
1354213|NCT01358162|Tuberculosis|tuberculosis
1354214|NCT01358136|Thyroidectomy|thyroidectomy
1354215|NCT01358136|Mitochondria|mitochondria
1354216|NCT01358123|liver cirrhosis|liver cirrhosis
1354217|NCT01358123|portal hypertension|portal hypertension
1354218|NCT01358123|survival|survival
1354219|NCT01358123|von willebrand factor|von willebrand factor
1354220|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
1354221|NCT01358110|palliative care|palliative care
1354222|NCT01358110|cancer|cancer
1354223|NCT01358110|emergency medicine|emergency medicine
1354224|NCT01358110|end- of- life care|end- of- life care
1354225|NCT01358097|Head and neck cancer|head and neck cancer
1354226|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
1354227|NCT01358097|Human papillomavirus|human papillomavirus
1354228|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
1354229|NCT01358097|Radiation treatment|radiation treatment
1354230|NCT01358097|Chemotherapy|chemotherapy
1354231|NCT01358097|Induction chemotherapy|induction chemotherapy
1354232|NCT01358097|Immune status|immune status
1354233|NCT01358097|Immune monitoring|immune monitoring
1354234|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
1354235|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1354236|NCT01358084|MPM|mpm
1354237|NCT01358084|Maintenance treatment|maintenance treatment
1354238|NCT01358084|NGR-hTNF|ngr-htnf
1354239|NCT01358071|NGR-hTNF|ngr-htnf
1354240|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1354241|NCT01358071|Doxorubicin|doxorubicin
1354242|NCT01358071|Platinum-resistant|platinum-resistant
1354243|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
1354244|NCT01358071|Ovarian Cancer|ovarian cancer
1354245|NCT01358071|Advanced or metastatic|advanced or metastatic
1354246|NCT01358058|Brain tumors|brain tumors
1354247|NCT01358058|Radiation|radiation
1354248|NCT01358058|Proton|proton
1354249|NCT01358058|Gliomas|gliomas
1354250|NCT01358045|Topical|topical
1354251|NCT01358045|Diclofenac|diclofenac
1354252|NCT01358045|Vitamin D3|vitamin d3
1354253|NCT01358032|Fear of falling|fear of falling
1354254|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
1354255|NCT01358032|Randomized controlled trial|randomized controlled trial
1354256|NCT01358032|Frailty|frailty
1354257|NCT01358032|Accidental Falls|accidental falls
1354258|NCT01358006|JNJ-40411813|jnj-40411813
1354259|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
1354260|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
1354261|NCT01358006|Male Volunteers|male volunteers
1354262|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
1354263|NCT01357993|Concerta|concerta
1354264|NCT01357993|Adults|adults
1354265|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
1354266|NCT01357993|ADHD|adhd
1354267|NCT01357993|Long term safety|long term safety
1354268|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
1354269|NCT01357954|Postural control|postural control
1354270|NCT01357954|Targeted Training|targeted training
1354271|NCT01357954|Gross motor function|gross motor function
1354272|NCT01357954|Cerebral palsy|cerebral palsy
1354273|NCT01357941|venous thromboembolism|venous thromboembolism
1354274|NCT01357941|thromboembolism|thromboembolism
1354275|NCT01357941|deep vein thrombosis|deep vein thrombosis
1354276|NCT01357941|pulmonary embolism|pulmonary embolism
1354277|NCT01357941|thromboprophylaxis|thromboprophylaxis
1354278|NCT01357941|thrombosis|thrombosis
1354279|NCT01357941|embolism and thrombosis|embolism and thrombosis
1354280|NCT01357941|cardiovascular diseases|cardiovascular diseases
1354281|NCT01357941|venous thrombosis|venous thrombosis
1354282|NCT01357941|vascular diseases|vascular diseases
1354283|NCT01357941|anticoagulants|anticoagulants
1354284|NCT01357941|hematologic agents|hematologic agents
1354285|NCT01357941|cardiovascular agents|cardiovascular agents
1354286|NCT01357941|enoxaparin|enoxaparin
1354287|NCT01357941|dalteparin|dalteparin
1354288|NCT01357941|tinzaparin|tinzaparin
1354289|NCT01357941|pregnancy complications|pregnancy complications
1354290|NCT01357928|TEG|teg
1354291|NCT01357928|Thromboelastography|thromboelastography
1354292|NCT01357928|Coagulation|coagulation
1354293|NCT01357915|Cytomegalovirus|cytomegalovirus
1354294|NCT01357915|Vaccine|vaccine
1354295|NCT01357889|pharmacokinetics|pharmacokinetics
1354296|NCT01357889|pharmacodynamics|pharmacodynamics
1354297|NCT01357889|GSK716155|gsk716155
1354298|NCT01357889|albiglutide|albiglutide
1354299|NCT01357863|Lapatinib|lapatinib
1354300|NCT01357863|Observational Study|observational study
1354301|NCT01357863|Trastuzumab|trastuzumab
1354302|NCT01357863|Brazil|brazil
1354303|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
1354304|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
1354305|NCT01357837|Analgesia|analgesia
1354306|NCT01357837|Pain|pain
1354307|NCT01357837|Painful|painful
1354308|NCT01357824|Intubation|intubation
1354309|NCT01357824|Sellick´s maneuver|sellick´s maneuver
1354310|NCT01357824|aspiration|aspiration
1354311|NCT01357824|[E05.497.578]|[e05.497.578]
1354312|NCT01357811|Genz-112638|genz-112638
1354313|NCT01357811|digoxin|digoxin
1354314|NCT01357798|Headache|headache
1354315|NCT01357798|Allodynia|allodynia
1354316|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
1354317|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
1354318|NCT01357785|Periodontal regeneration|periodontal regeneration
1354319|NCT01357785|Clinical trial|clinical trial
1354320|NCT01357785|Deep intraosseous defects|deep intraosseous defects
1354321|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
1354322|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
1354323|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
1354324|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
1354325|NCT01357720|Vaccination|vaccination
1354326|NCT01357720|Immunisation|immunisation
1354327|NCT01357720|Virus|virus
1354328|NCT01357720|Diphtheria|diphtheria
1354329|NCT01357720|Pertussis|pertussis
1354330|NCT01357720|Tetanus|tetanus
1354331|NCT01357720|Hepatitis B|hepatitis b
1354332|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
1354333|NCT01357720|Immunity|immunity
1354334|NCT01357694|psychotherapy|psychotherapy
1354335|NCT01357694|depression|depression
1354336|NCT01357694|anxiety|anxiety
1354337|NCT01357694|surgical patients|surgical patients
1354338|NCT01357681|Huntington Disease|huntington disease
1354339|NCT01357681|Cognition|cognition
1354340|NCT01357681|Motor|motor
1354341|NCT01357681|Behaviour|behaviour
1354342|NCT01357681|Functional Capacity|functional capacity
1354343|NCT01357681|Quality of Life|quality of life
1354344|NCT01357681|Biomarker|biomarker
1354345|NCT01357681|MRI|mri
1354346|NCT01357681|Huntingtin|huntingtin
1354347|NCT01357681|EGCG|egcg
1354348|NCT01357655|Myelogenous|myelogenous
1354349|NCT01357655|Chronic|chronic
1354350|NCT01357655|BCR-ABL Positive|bcr-abl positive
1354351|NCT01357642|asthma|asthma
1354352|NCT01357642|bronchial asthma|bronchial asthma
1354353|NCT01357642|shortness of breath|shortness of breath
1354354|NCT01357629|Vaccination follow-up|vaccination follow-up
1354355|NCT01357616|Glaucoma|glaucoma
1354356|NCT01357616|Open-angle glaucoma|open-angle glaucoma
1354357|NCT01357616|Ocular hypertension|ocular hypertension
1354358|NCT01357616|OAG|oag
1354359|NCT01357616|OH|oh
1354360|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
1354361|NCT01357577|PTSD|ptsd
1354362|NCT01357577|Substance Use Disorders|substance use disorders
1354363|NCT01357564|dementia|dementia
1354364|NCT01357564|caregivers|caregivers
1354365|NCT01357564|tailored activity|tailored activity
1354366|NCT01357551|obesity|obesity
1354367|NCT01357551|intervention studies|intervention studies
1354368|NCT01357551|patient adherence|patient adherence
1354369|NCT01357538|Bibrocathol|bibrocathol
1354370|NCT01357538|eye ointment|eye ointment
1354371|NCT01357538|blepharitis|blepharitis
1354372|NCT01357538|eye lid|eye lid
1354373|NCT01357525|Pancreas|pancreas
1354374|NCT01357525|Resected|resected
1354375|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
1354376|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
1354377|NCT01357512|prostate biopsy|prostate biopsy
1354378|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
1354379|NCT01357486|CHILD B|child b
1354380|NCT01357486|palliative management|palliative management
1354381|NCT01357486|Sorafenib|sorafenib
1354382|NCT01357486|Pravastatin|pravastatin
1354383|NCT01357473|hormonal values|hormonal values
1354384|NCT01357473|menstruations|menstruations
1354385|NCT01357473|pregnancy|pregnancy
1354386|NCT01357473|antagonist|antagonist
1354387|NCT01357460|Emphysema|emphysema
1354388|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
1354389|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
1354390|NCT01357447|Sjogren's syndrome|sjogren's syndrome
1354391|NCT01357447|Cough|cough
1354487|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
1354392|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
1354393|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
1354394|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
1354395|NCT01357382|low fat diet|low fat diet
1354396|NCT01357382|low carbohydrate diet|low carbohydrate diet
1354397|NCT01357369|bacteria infections|bacteria infections
1354398|NCT01357343|Low back pain|low back pain
1354399|NCT01357343|Chiropractic|chiropractic
1354400|NCT01357343|Acupuncture|acupuncture
1354401|NCT01357343|Integrated care|integrated care
1354402|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
1354403|NCT01357317|Kidney disease|kidney disease
1354404|NCT01357317|Hyperphosphatemia|hyperphosphatemia
1354405|NCT01357317|Parathyroid hormone|parathyroid hormone
1354406|NCT01357304|Group treatment|group treatment
1354407|NCT01357304|Physical activity referral|physical activity referral
1354408|NCT01357304|Type 2 diabetes|type 2 diabetes
1354409|NCT01357304|Hypertension|hypertension
1354410|NCT01357291|Behavior|behavior
1354411|NCT01357291|Drug users|drug users
1354412|NCT01357291|Inmates|inmates
1354413|NCT01357278|osteoporosis|osteoporosis
1354414|NCT01357278|exercise|exercise
1354415|NCT01357278|intervention|intervention
1354416|NCT01357278|rehabilitation|rehabilitation
1354417|NCT01357278|bone mineral density|bone mineral density
1354418|NCT01357278|muscle strength|muscle strength
1354419|NCT01357265|Seasonal Influenza|seasonal influenza
1354420|NCT01357265|vaccine|vaccine
1354421|NCT01357252|Diabetes mellitus|diabetes mellitus
1354422|NCT01357252|vildagliptin|vildagliptin
1354423|NCT01357239|Fragile X Syndrome|fragile x syndrome
1354424|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
1354425|NCT01357239|Genetic Diseases|genetic diseases
1354426|NCT01357239|X-Linked|x-linked
1354427|NCT01357239|Escalante's syndrome|escalante's syndrome
1354428|NCT01357226|measurement in two environments|measurement in two environments
1354429|NCT01357213|Botulism, Clostridium|botulism, clostridium
1354430|NCT01357187|Lumbar pathology|lumbar pathology
1354431|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
1354432|NCT01357096|intervention|intervention
1354433|NCT01357096|CABG or PTCA|cabg or ptca
1354434|NCT01357083|Melatonin|melatonin
1354435|NCT01357083|Periodicity|periodicity
1354436|NCT01357083|Depressive disorder, major|depressive disorder, major
1354437|NCT01357083|Serum|serum
1354438|NCT01357083|Depression|depression
1354439|NCT01357057|Medical records|medical records
1354440|NCT01357057|Outcome scale|outcome scale
1354441|NCT01357057|Biological biomarkers|biological biomarkers
1354442|NCT01357044|Semen quality|semen quality
1354443|NCT01357044|Plant extracts|plant extracts
1354444|NCT01357031|Amitriptyline|amitriptyline
1354445|NCT01357031|Placebo|placebo
1354446|NCT01357031|Melatonin|melatonin
1354447|NCT01357031|Migraine|migraine
1354448|NCT01357031|Headache|headache
1354449|NCT01357031|Drug therapy|drug therapy
1354450|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
1354451|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
1354452|NCT01357018|Disease activity|disease activity
1354453|NCT01357018|EQ-5D|eq-5d
1354454|NCT01357018|Quality of life|quality of life
1354455|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
1354456|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
1354457|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
1354458|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
1354459|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
1354587|NCT01356394|Obesity|obesity
1354460|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
1354461|NCT01356979|Medical thoracoscopy|medical thoracoscopy
1354462|NCT01356979|Pleural effusion|pleural effusion
1354463|NCT01356979|Malignant pleural diseases|malignant pleural diseases
1354464|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
1354465|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
1354466|NCT01356953|Aerobic Exercise|aerobic exercise
1354467|NCT01356953|Blood Pressure|blood pressure
1354468|NCT01356940|Ambulation|ambulation
1354469|NCT01356927|long acting reversible contraception|long acting reversible contraception
1354470|NCT01356927|medical abortion|medical abortion
1354471|NCT01356927|DMPA|dmpa
1354472|NCT01356927|etonogestrel implant|etonogestrel implant
1354473|NCT01356927|Implanon|implanon
1354474|NCT01356927|contraceptive continuation|contraceptive continuation
1354475|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
1354476|NCT01356875|Transfusion|transfusion
1354477|NCT01356875|Hydralazine|hydralazine
1354478|NCT01356875|valproic acid|valproic acid
1354479|NCT01356862|mastectomy|mastectomy
1354480|NCT01356862|axillary node dissection|axillary node dissection
1354481|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
1354482|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
1354483|NCT01356849|Proteinuria|proteinuria
1354484|NCT01356836|Coronary collateral development|coronary collateral development
1354485|NCT01356836|monocyte subsets|monocyte subsets
1354486|NCT01356836|collateralization|collateralization
1354488|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
1354490|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1354491|NCT01356823|cervical Cancer|cervical cancer
1354492|NCT01356810|Delirium|delirium
1354493|NCT01356810|Primary Prevention|primary prevention
1354494|NCT01356810|Elderly|elderly
1354495|NCT01356797|knee arthroscopy|knee arthroscopy
1354496|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
1354497|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
1354498|NCT01356784|Sick-listed|sick-listed
1354499|NCT01356784|Tailored physical activity|tailored physical activity
1354500|NCT01356784|Patient education|patient education
1354501|NCT01356784|Returning to work|returning to work
1354502|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
1354503|NCT01356784|columna|columna
1354504|NCT01356784|upper body|upper body
1354505|NCT01356771|Risk Assessment|risk assessment
1354506|NCT01356771|Intervention|intervention
1354507|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
1354508|NCT01356745|acute pain|acute pain
1354509|NCT01356745|prehospital setting|prehospital setting
1354510|NCT01356732|mechanical ventilation|mechanical ventilation
1354511|NCT01356732|Midazolam|midazolam
1354512|NCT01356732|Ramsay|ramsay
1354513|NCT01356732|Sufentanil|sufentanil
1354514|NCT01356719|Tracheostomy|tracheostomy
1354515|NCT01356719|adverse effects|adverse effects
1354516|NCT01356719|Critical Care|critical care
1354517|NCT01356719|standards|standards
1354518|NCT01356719|safety|safety
1354519|NCT01356706|liver metastases|liver metastases
1354520|NCT01356706|colorectal cancer|colorectal cancer
1354521|NCT01356706|surgery|surgery
1354522|NCT01356706|prognosis|prognosis
1354523|NCT01356693|Cough|cough
1354524|NCT01356693|Common cold|common cold
1354525|NCT01356693|Child|child
1354526|NCT01356693|Adolescent|adolescent
1354527|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
1354528|NCT01356680|intermediate stage|intermediate stage
1354529|NCT01356680|PET|pet
1354530|NCT01356667|American Indians|american indians
1354531|NCT01356667|Native Americans|native americans
1354532|NCT01356667|substance abuse|substance abuse
1354533|NCT01356667|culture|culture
1354534|NCT01356654|Stroke|stroke
1354535|NCT01356654|TDCS|tdcs
1354536|NCT01356654|Gait|gait
1354537|NCT01356654|Balance|balance
1354538|NCT01356654|loss of postural balance|loss of postural balance
1354539|NCT01356641|Antibiotic treatment|antibiotic treatment
1354540|NCT01356641|Non perforated appendicitis|non perforated appendicitis
1354541|NCT01356641|Children|children
1354542|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1354543|NCT01356628|HCC|hcc
1354544|NCT01356628|Liver Cancer|liver cancer
1354545|NCT01356628|PD-0332991|pd-0332991
1354546|NCT01356615|anticoagulation|anticoagulation
1354547|NCT01356615|hemodialysis|hemodialysis
1354548|NCT01356615|heparin|heparin
1354549|NCT01356615|lipids|lipids
1354550|NCT01356615|low molecular weight heparins|low molecular weight heparins
1354551|NCT01356602|Gout|gout
1354552|NCT01356602|arthritis|arthritis
1354553|NCT01356602|gout flare|gout flare
1354554|NCT01356602|acute gout|acute gout
1354555|NCT01356602|gouty|gouty
1354556|NCT01356602|rheumatic disease|rheumatic disease
1354557|NCT01356602|uric acid|uric acid
1354558|NCT01356563|hemodialysis|hemodialysis
1354559|NCT01356563|pharmacist|pharmacist
1354560|NCT01356563|medication-related problems|medication-related problems
1354561|NCT01356563|compliance|compliance
1354562|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
1354563|NCT01356498|gout|gout
1354564|NCT01356498|chronic gout|chronic gout
1354565|NCT01356485|Sickle cell anemia|sickle cell anemia
1354566|NCT01356485|Sickle cell disease|sickle cell disease
1354567|NCT01356485|Sickling crisis|sickling crisis
1354568|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
1354569|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
1354570|NCT01356485|Oxygen therapeutic|oxygen therapeutic
1354571|NCT01356485|Hemoglobin solutions|hemoglobin solutions
1354572|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
1354573|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1354574|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
1354575|NCT01356472|linezolid|linezolid
1354576|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
1354577|NCT01356459|Pressure ulcers|pressure ulcers
1354578|NCT01356459|ICU|icu
1354579|NCT01356459|Prevention|prevention
1354580|NCT01356446|safety|safety
1354581|NCT01356446|team|team
1354582|NCT01356446|team performance|team performance
1354583|NCT01356446|surgery|surgery
1354584|NCT01356446|outcome|outcome
1354585|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
1354586|NCT01356420|SLOS|slos
1354588|NCT01356394|Metabolic Syndrome|metabolic syndrome
1354589|NCT01356394|Microalbuminuria|microalbuminuria
1354590|NCT01356394|Chronic Kidney Disease|chronic kidney disease
1354591|NCT01356381|Diabetes mellitus|diabetes mellitus
1354592|NCT01356381|vildagliptin|vildagliptin
1354593|NCT01356368|Lung cancer|lung cancer
1354594|NCT01356355|Stent discomfort|stent discomfort
1354595|NCT01356355|Herbmed plus|herbmed plus
1354596|NCT01356355|Tolterodine|tolterodine
1354597|NCT01356342|Influenza|influenza
1354598|NCT01356342|Vaccine|vaccine
1354599|NCT01356342|Immunogenicity|immunogenicity
1354600|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
1354601|NCT01356316|Influenza|influenza
1354602|NCT01356316|Vaccine|vaccine
1354603|NCT01356316|Immunogenicity|immunogenicity
1354604|NCT01356303|Lung cancer|lung cancer
1354605|NCT01356290|Medulloblastoma|medulloblastoma
1354606|NCT01356290|Relapse|relapse
1354607|NCT01356290|Children|children
1354608|NCT01356290|antiangiogenic|antiangiogenic
1354609|NCT01356290|metronomic|metronomic
1354610|NCT01356290|intrathecal|intrathecal
1354611|NCT01356277|renal|renal
1354612|NCT01356277|allograft|allograft
1354613|NCT01356277|immunosuppressive|immunosuppressive
1354614|NCT01356277|immunosuppression|immunosuppression
1354615|NCT01356277|adherence|adherence
1354616|NCT01356277|medication|medication
1354617|NCT01356277|compliance|compliance
1354618|NCT01356264|colorectal cancer|colorectal cancer
1354619|NCT01356264|colorectal surgery|colorectal surgery
1354620|NCT01356264|prehabilitation|prehabilitation
1354621|NCT01356264|surgical recovery|surgical recovery
1354622|NCT01356264|exercise|exercise
1354623|NCT01356264|referred for scheduled resection|referred for scheduled resection
1354624|NCT01356251|Quality of life|quality of life
1354625|NCT01356251|support group|support group
1354626|NCT01356251|questionnaires|questionnaires
1354627|NCT01356251|Internet-based support group|internet-based support group
1354628|NCT01356251|11-066|11-066
1354629|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
1354630|NCT01356199|Gonalgia|gonalgia
1354631|NCT01356199|Quality of Life|quality of life
1354632|NCT01356199|Dietary supplement|dietary supplement
1354633|NCT01356199|Nutrition|nutrition
1354634|NCT01356186|Suicide|suicide
1354635|NCT01356186|Cognitive Therapy|cognitive therapy
1354636|NCT01356186|Inpatient|inpatient
1354637|NCT01356186|Military|military
1354638|NCT01356173|solid cancers|solid cancers
1354639|NCT01356160|Hepatitis C|hepatitis c
1354641|NCT01356160|Rapid Virologic Response|rapid virologic response
1354642|NCT01356160|Sustained Virologic Response|sustained virologic response
1354643|NCT01356160|Direct Acting Antiviral|direct acting antiviral
1354644|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
1354645|NCT01356160|Protease inhibitor|protease inhibitor
1354646|NCT01356160|Treatment naïve|treatment naïve
1354647|NCT01356160|GS-5885|gs-5885
1354648|NCT01356160|GS-9451|gs-9451
1354649|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
1354650|NCT01356134|multiple sclerosis|multiple sclerosis
1354651|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
1354652|NCT01356134|CCSVI|ccsvi
1354653|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
1354654|NCT01356134|fundus|fundus
1354655|NCT01356134|retina|retina
1354656|NCT01356108|Conduit|conduit
1354657|NCT01356108|Pulmonic|pulmonic
1354658|NCT01356108|Stenosis|stenosis
1354659|NCT01356108|Regurgitation|regurgitation
1354660|NCT01356108|Dysfunctional|dysfunctional
1354661|NCT01356095|Tuberculosis|tuberculosis
1354662|NCT01356095|Treatment Adherence|treatment adherence
1354663|NCT01356095|knowledge translation|knowledge translation
1354664|NCT01356095|Educational outreach|educational outreach
1354665|NCT01356069|BPD|bpd
1354666|NCT01356069|MHS|mhs
1354667|NCT01356069|heavy users|heavy users
1354668|NCT01356069|sequential psychotherapy|sequential psychotherapy
1354669|NCT01356004|severe resistant|severe resistant
1354670|NCT01355991|Spinal Cord Injury|spinal cord injury
1354671|NCT01355991|Tetraplegia|tetraplegia
1354672|NCT01355991|Pulmonary Function|pulmonary function
1354673|NCT01355991|Bronchodilator|bronchodilator
1354674|NCT01355965|completed standard first line therapy|completed standard first line therapy
1354675|NCT01355965|platinum based double regimen|platinum based double regimen
1354676|NCT01355965|Progressive Disease|progressive disease
1354677|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
1354678|NCT01355952|Obesity|obesity
1354679|NCT01355952|Weight Loss|weight loss
1354680|NCT01355952|Schizophrenia|schizophrenia
1354681|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
1354682|NCT01355939|Hernia|hernia
1354683|NCT01355939|Adhesiolysis|adhesiolysis
1354684|NCT01355939|Adhesions|adhesions
1354685|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
1354686|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
1354687|NCT01355939|Mesh|mesh
1354688|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
1354689|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
1354690|NCT01355939|Laparoscopic Approach|laparoscopic approach
1354691|NCT01355939|Open Approach|open approach
1354692|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
1354693|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
1354694|NCT01355926|Monopolar Cautery|monopolar cautery
1355109|NCT01354197|Readmission|readmission
1354695|NCT01355926|Oral Cavity Lesions|oral cavity lesions
1354696|NCT01355926|Quality of life|quality of life
1354697|NCT01355926|Assessing Pain|assessing pain
1354698|NCT01355926|11-034|11-034
1354699|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
1354700|NCT01355913|chromosmal aberrations|chromosmal aberrations
1354701|NCT01355913|cytogenetics|cytogenetics
1354702|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
1354703|NCT01355913|CD34+ cells|cd34+ cells
1354704|NCT01355913|peripheral blood|peripheral blood
1354705|NCT01355900|Total knee arthroplasty|total knee arthroplasty
1354706|NCT01355900|Tourniquet|tourniquet
1354707|NCT01355900|Blood loss|blood loss
1354708|NCT01355900|Volume loading test|volume loading test
1354709|NCT01355887|blood loss|blood loss
1354710|NCT01355887|hepatectomy|hepatectomy
1354711|NCT01355887|prospective study|prospective study
1354712|NCT01355887|PTC|ptc
1354713|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
1354714|NCT01355861|sarcopenia|sarcopenia
1354716|NCT01355861|rehabilitation|rehabilitation
1354717|NCT01355861|exercise|exercise
1354718|NCT01355848|Suicide|suicide
1354719|NCT01355848|Brief Intervention|brief intervention
1354720|NCT01355848|Youth|youth
1354721|NCT01355848|Acute Medical Setting|acute medical setting
1354722|NCT01355848|Readiness to Change|readiness to change
1354723|NCT01355848|Suicidality|suicidality
1354724|NCT01355835|Parkinson's disease|parkinson's disease
1354725|NCT01355835|gait|gait
1354726|NCT01355835|deep brain stimulation|deep brain stimulation
1354727|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
1354728|NCT01355835|subthalamic nucleus|subthalamic nucleus
1354729|NCT01355822|abortion|abortion
1354730|NCT01355822|perinatal death|perinatal death
1354731|NCT01355822|IUGR|iugr
1354732|NCT01355822|preterm birth|preterm birth
1354733|NCT01355822|placental abruption|placental abruption
1354734|NCT01355822|preeclampsia|preeclampsia
1354735|NCT01355809|Six-Minute Walk Test|six-minute walk test
1354736|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
1354737|NCT01355757|24-week follow-up|24-week follow-up
1354738|NCT01355757|quality of life|quality of life
1354739|NCT01355757|rehabilitation achievement|rehabilitation achievement
1354740|NCT01355757|rotator cuff repair|rotator cuff repair
1354741|NCT01355744|humans|humans
1354742|NCT01355744|insect bites|insect bites
1354743|NCT01355731|Registered Nurse|registered nurse
1354744|NCT01355731|Behaviors|behaviors
1354745|NCT01355731|Attitudes|attitudes
1354746|NCT01355692|DME|dme
1354747|NCT01355692|Laser|laser
1354748|NCT01355692|Selective laser therapy|selective laser therapy
1354749|NCT01355692|photocoagulation|photocoagulation
1354750|NCT01355666|pressure ulcers|pressure ulcers
1354751|NCT01355666|stage 1|stage 1
1354752|NCT01355666|stage 2|stage 2
1354753|NCT01355666|stage 3|stage 3
1354754|NCT01355666|stage 4|stage 4
1354755|NCT01355666|wounds|wounds
1354756|NCT01355666|sores|sores
1354757|NCT01355666|infection|infection
1354758|NCT01355666|bioburden|bioburden
1354759|NCT01355666|bacterial contamination|bacterial contamination
1354760|NCT01355666|bed linen|bed linen
1354761|NCT01355666|sheets|sheets
1354762|NCT01355666|underpad|underpad
1354763|NCT01355666|skin assessment|skin assessment
1354764|NCT01355666|microclimate|microclimate
1354765|NCT01355666|shear|shear
1354766|NCT01355666|friction|friction
1354767|NCT01355666|moisture|moisture
1354768|NCT01355666|fabrics|fabrics
1354769|NCT01355666|long term care|long term care
1354770|NCT01355666|nursing home|nursing home
1354771|NCT01355666|decubitus ulcer|decubitus ulcer
1354772|NCT01355666|bed ridden|bed ridden
1354773|NCT01355666|anti-microbial|anti-microbial
1354774|NCT01355653|heat|heat
1354775|NCT01355653|device|device
1354776|NCT01355653|safety|safety
1354777|NCT01355653|performance|performance
1354778|NCT01355653|heatwrap|heatwrap
1354779|NCT01355653|elderly|elderly
1354780|NCT01355653|overweight|overweight
1354781|NCT01355640|heel lance|heel lance
1354782|NCT01355640|pain|pain
1354783|NCT01355640|newborn|newborn
1354784|NCT01355627|CSF leaks|csf leaks
1354785|NCT01355627|Skull base surgery|skull base surgery
1354786|NCT01355627|pseudomeningocele|pseudomeningocele
1354787|NCT01355627|TachoSil®|tachosil®
1354788|NCT01355627|Prevention|prevention
1354789|NCT01355627|post-operative|post-operative
1354790|NCT01355614|Crohn's Disease|crohn's disease
1354791|NCT01355614|Fistula|fistula
1354792|NCT01355575|Microbiota|microbiota
1354793|NCT01355575|Insulin resistance|insulin resistance
1354794|NCT01355575|Bacterial endotoxin|bacterial endotoxin
1354795|NCT01355575|Hepatic triglyceride|hepatic triglyceride
1354796|NCT01355575|Inflammation|inflammation
1354797|NCT01355549|Shoulder pain|shoulder pain
1354798|NCT01355549|Rotator cuff disease|rotator cuff disease
1354799|NCT01355549|Spinal cord injuries|spinal cord injuries
1354800|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
1354801|NCT01355549|Rehabilitation|rehabilitation
1354802|NCT01355536|Preterm birth|preterm birth
1354803|NCT01355536|Preterm labour|preterm labour
1354809|NCT01355536|Ovarian cysts|ovarian cysts
1354810|NCT01355536|Anti Muller Hormone|anti muller hormone
1354811|NCT01355536|Hypertension|hypertension
1354812|NCT01355523|Breast cancer surgery|breast cancer surgery
1354813|NCT01355523|Melatonin|melatonin
1354814|NCT01355523|Depression|depression
1354815|NCT01355523|Anxiety|anxiety
1354816|NCT01355523|Sleep disturbances|sleep disturbances
1354817|NCT01355523|Cognitive function|cognitive function
1354818|NCT01355471|rosacea|rosacea
1354819|NCT01355458|rosacea|rosacea
1354820|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
1354821|NCT01355419|CPAP|cpap
1354822|NCT01355419|actigraphy|actigraphy
1354823|NCT01355419|sleep|sleep
1354824|NCT01355419|physical activity|physical activity
1354830|NCT01355393|Breast Cancer|breast cancer
1354831|NCT01355393|HER2+|her2+
1354832|NCT01355393|Vaccine|vaccine
1354833|NCT01355393|Stage II|stage ii
1354834|NCT01355393|Stage III|stage iii
1354835|NCT01355393|Stage IV|stage iv
1354836|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
1354837|NCT01355380|Inhaled iloprost|inhaled iloprost
1354838|NCT01355380|Quality of life|quality of life
1354839|NCT01355367|BAYA1040 CR|baya1040 cr
1354840|NCT01355367|Nifedipine|nifedipine
1354841|NCT01355367|Essential hypertension|essential hypertension
1354842|NCT01355367|Japanese Patients|japanese patients
1354843|NCT01355367|Phase III|phase iii
1354844|NCT01355367|Extension study|extension study
1354845|NCT01355354|Phase 1|phase 1
1354846|NCT01355354|healthy volunteers|healthy volunteers
1354847|NCT01355354|pharmacokinetics|pharmacokinetics
1354848|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
1354849|NCT01355354|RA, Fostamatinib|ra, fostamatinib
1354850|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
1354851|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
1354852|NCT01355354|Fostamatinib|fostamatinib
1354853|NCT01355354|Digoxin|digoxin
1354854|NCT01355354|drug-drug interaction|drug-drug interaction
1354855|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
1354856|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
1354857|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
1354858|NCT01355328|light|light
1354859|NCT01355315|EECP|eecp
1354860|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
1354861|NCT01355315|endothelin-1|endothelin-1
1354862|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
1354863|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
1354864|NCT01355302|Cancer|cancer
1354865|NCT01355302|Solid Tumors|solid tumors
1354866|NCT01355302|Gastric|gastric
1354867|NCT01355302|Phase I|phase i
1354868|NCT01355302|Phase II|phase ii
1354869|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
1354870|NCT01355276|Cinitapride|cinitapride
1354871|NCT01355276|efficacy|efficacy
1354872|NCT01355276|safety|safety
1354873|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
1354874|NCT01355263|vitamin a|vitamin a
1354875|NCT01355263|preschool children|preschool children
1354876|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
1354877|NCT01355263|supplementation effect|supplementation effect
1354878|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
1354879|NCT01355224|obesity|obesity
1354880|NCT01355224|genetics|genetics
1354881|NCT01355224|risk assessment|risk assessment
1354882|NCT01355224|health behaviors|health behaviors
1354883|NCT01355224|randomized controlled trial|randomized controlled trial
1354884|NCT01355211|Altered Mental Status|altered mental status
1354885|NCT01355211|non-convulsive seizure|non-convulsive seizure
1354886|NCT01355211|status epilepticus|status epilepticus
1354887|NCT01355211|electroencephalography|electroencephalography
1354888|NCT01355185|Seed movement|seed movement
1354889|NCT01355185|implants|implants
1354890|NCT01355185|prostate brachytherapy|prostate brachytherapy
1354891|NCT01355185|localized|localized
1354892|NCT01355172|Influenza|influenza
1354893|NCT01355172|Vaccine|vaccine
1354894|NCT01355172|Immunogenicity|immunogenicity
1354895|NCT01355159|Pregnancy|pregnancy
1354896|NCT01355159|Folic Acid supplementation|folic acid supplementation
1354897|NCT01355159|Preeclampsia|preeclampsia
1354898|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
1354899|NCT01355133|Urinary incontinence|urinary incontinence
1354900|NCT01355133|Myoblasts|myoblasts
1354901|NCT01355133|Muscle derived cells|muscle derived cells
1354902|NCT01355133|Stem cells|stem cells
1355304|NCT01353248|Hepatitis C|hepatitis c
1354903|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
1354904|NCT01355107|selenium level measurement|selenium level measurement
1354905|NCT01355094|temporary abdomen closure|temporary abdomen closure
1354906|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
1354907|NCT01355094|open abdomen|open abdomen
1354908|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
1354909|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
1354910|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
1354911|NCT01355094|critical care|critical care
1354912|NCT01355081|Drug Therapy|drug therapy
1354913|NCT01355068|phenytoin|phenytoin
1354914|NCT01355068|chewable tablets|chewable tablets
1354915|NCT01355068|dilantin|dilantin
1354916|NCT01355068|epanutin|epanutin
1354917|NCT01355068|infatabs|infatabs
1354918|NCT01355068|bioequivalence|bioequivalence
1354919|NCT01355068|Partial seizure|partial seizure
1354920|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
1354921|NCT01355029|Stroke caregivers|stroke caregivers
1354922|NCT01355029|Family Caregivers|family caregivers
1354923|NCT01355029|Stroke|stroke
1354924|NCT01355016|RSV|rsv
1354925|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1354926|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
1354927|NCT01354977|Metabolic Diseases|metabolic diseases
1354928|NCT01354977|Diabetes Mellitus|diabetes mellitus
1354929|NCT01354977|Endocrin System Diseases|endocrin system diseases
1354930|NCT01354977|Resveratrol|resveratrol
1354931|NCT01354977|Therapeutic Uses|therapeutic uses
1354932|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
1354933|NCT01354964|Insulin Resistance|insulin resistance
1354934|NCT01354964|Endocrine System|endocrine system
1354935|NCT01354964|Vitamin D|vitamin d
1354936|NCT01354951|Focal Brachytherapy|focal brachytherapy
1354937|NCT01354951|Endorectal coil MRI|endorectal coil mri
1354938|NCT01354951|Quality of Life|quality of life
1354939|NCT01354951|11-056|11-056
1354940|NCT01354938|Bronchitis|bronchitis
1354941|NCT01354925|Diabetes type 2|diabetes type 2
1354942|NCT01354925|Fasting|fasting
1354943|NCT01354925|Ramadan|ramadan
1354944|NCT01354925|Insulin analogues|insulin analogues
1354945|NCT01354912|mycobacterial infection|mycobacterial infection
1354946|NCT01354912|culture|culture
1354947|NCT01354912|ct scan|ct scan
1354948|NCT01354886|in-vitro fertilization|in-vitro fertilization
1354949|NCT01354886|reproductive disorder|reproductive disorder
1354950|NCT01354873|Colonoscopy|colonoscopy
1354951|NCT01354873|Colon Polyps|colon polyps
1354952|NCT01354860|knee osteoarthritis|knee osteoarthritis
1354953|NCT01354847|extracorporeal circulation|extracorporeal circulation
1354954|NCT01354847|platelet dysfunction|platelet dysfunction
1354955|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
1354956|NCT01354847|Multiplate|multiplate
1354957|NCT01354821|Aorta|aorta
1354958|NCT01354821|Aneurysm|aneurysm
1354959|NCT01354821|endovascular|endovascular
1354960|NCT01354821|stent-graft|stent-graft
1354961|NCT01354808|Cilostazol|cilostazol
1354962|NCT01354808|Platelet|platelet
1354963|NCT01354808|Inflammation|inflammation
1354964|NCT01354808|Myonecrosis|myonecrosis
1354965|NCT01354795|EUS FNA|eus fna
1354966|NCT01354795|stylet|stylet
1354967|NCT01354795|suction|suction
1354968|NCT01354782|Pharmacokinetic|pharmacokinetic
1354969|NCT01354782|Roflumilast|roflumilast
1354970|NCT01354756|sleep apnea|sleep apnea
1354971|NCT01354756|polysomnography|polysomnography
1354972|NCT01354756|obesity|obesity
1354973|NCT01354756|bariatric surgery|bariatric surgery
1354974|NCT01354743|atrophy|atrophy
1354975|NCT01354743|rhytids|rhytids
1354976|NCT01354743|glabellar|glabellar
1354977|NCT01354743|periorbital|periorbital
1354978|NCT01354730|incidence|incidence
1354979|NCT01354730|nature|nature
1354980|NCT01354730|seriousness|seriousness
1354981|NCT01354730|ADRs|adrs
1354982|NCT01354730|vaccination|vaccination
1354983|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
1354984|NCT01354704|enoxaparin|enoxaparin
1354985|NCT01354691|Alzheimer's Disease|alzheimer's disease
1354986|NCT01354691|Dementia|dementia
1354987|NCT01354691|Memory Loss|memory loss
1354988|NCT01354691|Cognitive Impairment|cognitive impairment
1354989|NCT01354691|Brain Diseases|brain diseases
1354990|NCT01354691|Central Nervous System Diseases|central nervous system diseases
1354991|NCT01354691|Nervous System Diseases|nervous system diseases
1354992|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
1354993|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1354994|NCT01354691|Mental Disorders|mental disorders
1354995|NCT01354691|Depression|depression
1354996|NCT01354691|Anxiety|anxiety
1354997|NCT01354678|heart failure|heart failure
1354998|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
1354999|NCT01354665|Multiple sclerosis|multiple sclerosis
1355000|NCT01354665|Interferon beta-1b|interferon beta-1b
1355001|NCT01354665|Fatigue|fatigue
1355002|NCT01354665|Depression|depression
1355003|NCT01354652|lactic acidosis|lactic acidosis
1355004|NCT01354652|entecavir|entecavir
1355005|NCT01354652|lamivudine|lamivudine
1355305|NCT01353248|HCV|hcv
1355006|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
1355007|NCT01354626|Dietary protein|dietary protein
1355008|NCT01354626|NAFLD|nafld
1355009|NCT01354600|Obesity|obesity
1355010|NCT01354600|Appetite|appetite
1355011|NCT01354600|Hormones|hormones
1355012|NCT01354600|Exercise|exercise
1355013|NCT01354600|Body Weight|body weight
1355014|NCT01354587|immunodeficiency|immunodeficiency
1355015|NCT01354574|energy metabolism|energy metabolism
1355016|NCT01354574|lipids|lipids
1355017|NCT01354574|lipoproteins|lipoproteins
1355018|NCT01354574|satiety|satiety
1355019|NCT01354574|glycemic load|glycemic load
1355020|NCT01354574|insulin|insulin
1355021|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
1355022|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
1355023|NCT01354561|paediatric patients|paediatric patients
1355024|NCT01354548|Trismus|trismus
1355025|NCT01354548|Cancer|cancer
1355026|NCT01354548|Radiotherapy|radiotherapy
1355027|NCT01354548|Quality of life|quality of life
1355028|NCT01354535|periprosthetic|periprosthetic
1355029|NCT01354535|femur fractures|femur fractures
1355030|NCT01354535|Vancouver B1|vancouver b1
1355031|NCT01354509|Normothermia|normothermia
1355032|NCT01354509|fever control|fever control
1355033|NCT01354509|Outcome study|outcome study
1355034|NCT01354496|Healthy Volunteers|healthy volunteers
1355035|NCT01354496|Bioavailability|bioavailability
1355036|NCT01354483|spinal cord injury|spinal cord injury
1355037|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
1355038|NCT01354483|lithium carbonate|lithium carbonate
1355039|NCT01354470|Meth|meth
1355040|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
1355041|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
1355042|NCT01354470|Modafinil|modafinil
1355043|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
1355044|NCT01354444|Memory problems|memory problems
1355045|NCT01354444|Alzheimer's Disease|alzheimer's disease
1355046|NCT01354431|Advanced/Metastatic|advanced/metastatic
1355047|NCT01354431|clear cell component|clear cell component
1355048|NCT01354392|Relapsed or refractory|relapsed or refractory
1355049|NCT01354392|Large B-Cell|large b-cell
1355050|NCT01354392|Diffuse|diffuse
1355051|NCT01354340|Cholesterol|cholesterol
1355052|NCT01354340|LDL-cholesterol|ldl-cholesterol
1355053|NCT01354340|Coronary artery disease|coronary artery disease
1355054|NCT01354340|Red yeast rice|red yeast rice
1355055|NCT01354340|Plants extract|plants extract
1355056|NCT01354340|Cholesterol excess|cholesterol excess
1355057|NCT01354340|Delivery of Health Care|delivery of health care
1355058|NCT01354327|Delivery of Health Care|delivery of health care
1355059|NCT01354327|Cholesterol|cholesterol
1355060|NCT01354327|LDL-cholesterol|ldl-cholesterol
1355061|NCT01354327|Coronary artery disease|coronary artery disease
1355062|NCT01354327|Red yeast rice|red yeast rice
1355063|NCT01354327|Plants extract|plants extract
1355064|NCT01354327|Cholesterol excess|cholesterol excess
1355065|NCT01354314|HIV|hiv
1355066|NCT01354314|Neurocognitive impairment|neurocognitive impairment
1355067|NCT01354314|Memory|memory
1355068|NCT01354314|Dementia|dementia
1355069|NCT01354314|CSF marker|csf marker
1355070|NCT01354314|Functional assessment|functional assessment
1355071|NCT01354314|MRS|mrs
1355072|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1355073|NCT01354314|Arterial spin labeling|arterial spin labeling
1355074|NCT01354314|SSRI|ssri
1355075|NCT01354301|kidney transplantation|kidney transplantation
1355076|NCT01354301|thymoglobulin|thymoglobulin
1355077|NCT01354301|everolimus|everolimus
1355078|NCT01354288|Diabetes|diabetes
1355079|NCT01354288|Children|children
1355080|NCT01354288|Disease management|disease management
1355081|NCT01354288|Ketosis|ketosis
1355082|NCT01354288|Hypoglycemia|hypoglycemia
1355083|NCT01354288|Parents|parents
1355084|NCT01354288|Education|education
1355085|NCT01354275|PCOS|pcos
1355086|NCT01354275|IVF/ICSI|ivf/icsi
1355087|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
1355088|NCT01354275|GnRH Antagonist|gnrh antagonist
1355089|NCT01354275|GnRH Agonist|gnrh agonist
1355090|NCT01354262|Diabetes|diabetes
1355091|NCT01354262|Vitamin D deficiency|vitamin d deficiency
1355092|NCT01354262|Hemoglobin A1c|hemoglobin a1c
1355093|NCT01354249|preoperative fasting|preoperative fasting
1355094|NCT01354249|insulin resistance|insulin resistance
1355095|NCT01354249|carbohydrates|carbohydrates
1355096|NCT01354249|whey protein|whey protein
1355097|NCT01354249|inflammatory response|inflammatory response
1355098|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
1355099|NCT01354223|SHCL|shcl
1355100|NCT01354223|stenfilcon A|stenfilcon a
1355101|NCT01354223|ocufilcon B|ocufilcon b
1355102|NCT01354223|daily disposable|daily disposable
1355103|NCT01354223|substantial equivalence|substantial equivalence
1355104|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
1355105|NCT01354210|Patient Adherence|patient adherence
1355106|NCT01354210|HIV|hiv
1355107|NCT01354197|Adverse events|adverse events
1355108|NCT01354197|Mortality|mortality
1355110|NCT01354197|Surgical intensive care unit|surgical intensive care unit
1355111|NCT01354171|active surveillance|active surveillance
1355112|NCT01354171|low risk prostate cancer|low risk prostate cancer
1355113|NCT01354132|schizophrenia|schizophrenia
1355114|NCT01354132|schizoaffective|schizoaffective
1355115|NCT01354132|schizophreniform|schizophreniform
1355116|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
1355117|NCT01354106|Skin condition after wear|skin condition after wear
1355118|NCT01354093|MacTel|mactel
1355119|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
1355120|NCT01354080|constipation|constipation
1355121|NCT01354080|massage|massage
1355122|NCT01354080|tensegrity|tensegrity
1355123|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1355124|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
1355125|NCT01354067|Single Limb|single limb
1355126|NCT01354067|Elastic Resistance|elastic resistance
1355127|NCT01354067|Resistance Training|resistance training
1355128|NCT01354067|Minor Muscle Mass|minor muscle mass
1355129|NCT01354067|Local muscle training|local muscle training
1355130|NCT01354054|Knee OA|knee oa
1355131|NCT01354054|TENS|tens
1355132|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
1355133|NCT01354028|premature infant|premature infant
1355134|NCT01354028|massage therapy|massage therapy
1355135|NCT01354028|sleep induction|sleep induction
1355136|NCT01354028|relaxation|relaxation
1355137|NCT01354015|Diabetes|diabetes
1355138|NCT01354015|Technology|technology
1355139|NCT01354002|human biological samples|human biological samples
1355140|NCT01354002|tissue banking|tissue banking
1355141|NCT01353989|hepatitis A|hepatitis a
1355142|NCT01353989|vaccination|vaccination
1355143|NCT01353989|elderly|elderly
1355144|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
1355145|NCT01353976|Econazole Nitrate|econazole nitrate
1355146|NCT01353976|Foam|foam
1355147|NCT01353976|Quinnova|quinnova
1355148|NCT01353976|Tinea Pedis|tinea pedis
1355149|NCT01353950|Costimulatory molecules|costimulatory molecules
1355150|NCT01353950|Cystic Fibrosis|cystic fibrosis
1355151|NCT01353950|Biomarkers|biomarkers
1355152|NCT01353937|wound healing|wound healing
1355153|NCT01353924|Allergy|allergy
1355154|NCT01353924|Vaccine|vaccine
1355155|NCT01353924|rBet v 1|rbet v 1
1355156|NCT01353924|Prevention|prevention
1355157|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
1355158|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
1355159|NCT01353885|Anterior Approach|anterior approach
1355160|NCT01353885|Posterior Approach|posterior approach
1355161|NCT01353885|Anterolateral Approach|anterolateral approach
1355162|NCT01353885|Cohort Study|cohort study
1355163|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
1355164|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
1355165|NCT01353872|Fatigue|fatigue
1355166|NCT01353872|Tennis|tennis
1355167|NCT01353872|Nutrition|nutrition
1355168|NCT01353872|Tournament simulation|tournament simulation
1355169|NCT01353872|Delivery of Health Care|delivery of health care
1355170|NCT01353846|oocyte donation program|oocyte donation program
1355171|NCT01353846|natural cycle|natural cycle
1355172|NCT01353846|hormone replacement therapy|hormone replacement therapy
1355173|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
1355174|NCT01353820|Probiotic|probiotic
1355175|NCT01353820|Cholesterol lowering|cholesterol lowering
1355176|NCT01353820|Dairy|dairy
1355177|NCT01353807|Fish oil|fish oil
1355178|NCT01353807|Pregnancy|pregnancy
1355179|NCT01353807|RCT|rct
1355180|NCT01353807|Birth weight|birth weight
1355181|NCT01353807|Gestational age|gestational age
1355182|NCT01353807|Asthma and allergies|asthma and allergies
1355183|NCT01353807|Metabolic syndrome|metabolic syndrome
1355184|NCT01353807|Obesity|obesity
1355185|NCT01353794|SORAFENIB|sorafenib
1355186|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
1355187|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
1355188|NCT01353794|OBSERVATIONAL STUDY|observational study
1355189|NCT01353781|Phase 1|phase 1
1355190|NCT01353781|advanced solid tumor|advanced solid tumor
1355191|NCT01353781|AKT|akt
1355192|NCT01353781|Ascending|ascending
1355193|NCT01353781|Japanese|japanese
1355194|NCT01353768|Influenza|influenza
1355195|NCT01353755|specific immunotherapy|specific immunotherapy
1355196|NCT01353755|SIT|sit
1355197|NCT01353729|12-lead ECG|12-lead ecg
1355198|NCT01353729|cardiac repolarization|cardiac repolarization
1355199|NCT01353729|QTc|qtc
1355200|NCT01353729|influenza|influenza
1355201|NCT01353729|GR121167|gr121167
1355202|NCT01353729|zanamivir|zanamivir
1355203|NCT01353703|Infanrix hexa™|infanrix hexa™
1355204|NCT01353703|Primary vaccination|primary vaccination
1355205|NCT01353703|India|india
1355206|NCT01353703|combination vaccine|combination vaccine
1355207|NCT01353703|infants|infants
1355208|NCT01353690|Cell Therapy|cell therapy
1355209|NCT01353690|Heart Failure|heart failure
1355210|NCT01353690|Heart Disease|heart disease
1355211|NCT01353690|Myocardial Infarction|myocardial infarction
1356311|NCT01349166|Cytokines|cytokines
1355212|NCT01353690|Myocardial Ischemia|myocardial ischemia
1355213|NCT01353690|Autologous|autologous
1355214|NCT01353690|Muscle-derived Cell|muscle-derived cell
1355215|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1355216|NCT01353677|QOL|qol
1355217|NCT01353664|rollover protocol|rollover protocol
1355218|NCT01353664|romidepsin|romidepsin
1355219|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
1355220|NCT01353664|Celgene Corporation|celgene corporation
1355221|NCT01353664|continuing treatment|continuing treatment
1355222|NCT01353638|Peritoneal dialysis|peritoneal dialysis
1355223|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
1355224|NCT01353638|Heat shock protein|heat shock protein
1355225|NCT01353638|Peritoneal cells|peritoneal cells
1355226|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
1355227|NCT01353625|Neoplasm|neoplasm
1355228|NCT01353625|Malignancy|malignancy
1355229|NCT01353625|Carcinoma|carcinoma
1355230|NCT01353625|Lymphoma|lymphoma
1355231|NCT01353625|Leukemia|leukemia
1355232|NCT01353625|Multiple myeloma|multiple myeloma
1355233|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
1355234|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
1355235|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
1355236|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
1355237|NCT01353599|Spinal Cord Injury|spinal cord injury
1355238|NCT01353599|Tetraplegia|tetraplegia
1355239|NCT01353599|Pulmonary Function|pulmonary function
1355240|NCT01353573|Brain Neoplasms|brain neoplasms
1355241|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
1355242|NCT01353573|Neoplasms|neoplasms
1355243|NCT01353560|integrative medicine|integrative medicine
1355244|NCT01353560|barriers to utilization|barriers to utilization
1355245|NCT01353560|communication|communication
1355246|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
1355247|NCT01353521|complex renal cysts|complex renal cysts
1355248|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
1355249|NCT01353508|Sodium excretion,|sodium excretion,
1355250|NCT01353508|LCZ696|lcz696
1355251|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
1355252|NCT01353482|mesothelioma|mesothelioma
1355253|NCT01353482|vorinostat|vorinostat
1355254|NCT01353456|Ambulation|ambulation
1355255|NCT01353456|Side effects|side effects
1355256|NCT01353456|Serum sCD40L|serum scd40l
1355257|NCT01353456|Bowel function|bowel function
1355258|NCT01353456|Postoperative pain|postoperative pain
1355259|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1355260|NCT01353443|AAA|aaa
1355261|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
1355262|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
1355263|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
1355264|NCT01353417|Grafting, kidney|grafting, kidney
1355265|NCT01353417|Transplantation, kidney|transplantation, kidney
1355266|NCT01353391|Diabetes|diabetes
1355267|NCT01353391|MiTy|mity
1355268|NCT01353391|Metformin in Women|metformin in women
1355269|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
1355270|NCT01353378|dexmedetomidine|dexmedetomidine
1355271|NCT01353378|emergence delirium|emergence delirium
1355272|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
1355273|NCT01353378|preschool children|preschool children
1355274|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
1355275|NCT01353352|Evaluation|evaluation
1355276|NCT01353352|C-Spine|c-spine
1355277|NCT01353352|Nursing|nursing
1355278|NCT01353352|Clinical Decision Rule|clinical decision rule
1355279|NCT01353339|Kidney Transplant|kidney transplant
1355280|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
1355281|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
1355282|NCT01353326|hip resurfacing|hip resurfacing
1355283|NCT01353326|bone mineral density|bone mineral density
1355284|NCT01353326|cemented|cemented
1355285|NCT01353326|cementless|cementless
1355286|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
1355287|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1355288|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1355289|NCT01353313|Prematurity|prematurity
1355290|NCT01353313|Mechanical ventilation|mechanical ventilation
1355291|NCT01353313|Intubation|intubation
1355292|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
1355293|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1355294|NCT01353300|cystic nephroma|cystic nephroma
1355295|NCT01353300|neuroblastoma|neuroblastoma
1355296|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
1355297|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
1355298|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
1355299|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
1355300|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
1355301|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
1355302|NCT01353287|Live case transmission|live case transmission
1355303|NCT01353261|Platelet reactivity|platelet reactivity
1355309|NCT01353248|Combination Therapy|combination therapy
1355310|NCT01353248|HCV RNA|hcv rna
1355311|NCT01353248|Polymerase inhibitor|polymerase inhibitor
1355312|NCT01353248|Protease inhibitor|protease inhibitor
1355313|NCT01353248|Treatment naïve|treatment naïve
1355314|NCT01353248|GS-5885|gs-5885
1355315|NCT01353248|GS-9451|gs-9451
1355316|NCT01353248|Tegobuvir|tegobuvir
1355317|NCT01353235|COPD|copd
1355318|NCT01353235|acute respiratory failure|acute respiratory failure
1355319|NCT01353235|mechanical ventilation|mechanical ventilation
1355320|NCT01353235|non invasive ventilation|non invasive ventilation
1355321|NCT01353235|steroids|steroids
1355322|NCT01353222|Bladder cancer|bladder cancer
1355323|NCT01353222|Renal pelvis cancer|renal pelvis cancer
1355324|NCT01353222|Ureteral cancer|ureteral cancer
1355325|NCT01353222|Urethral cancer|urethral cancer
1355326|NCT01353222|Bladder|bladder
1355327|NCT01353222|Renal pelvis|renal pelvis
1355328|NCT01353222|Ureter|ureter
1355329|NCT01353222|Urethra|urethra
1355330|NCT01353222|Immune therapy|immune therapy
1355331|NCT01353222|Immunotherapy|immunotherapy
1355332|NCT01353222|Vaccine|vaccine
1355333|NCT01353222|Dendritic cells|dendritic cells
1355334|NCT01353222|Antigen-presenting cells|antigen-presenting cells
1355335|NCT01353222|Antigen presenting cells|antigen presenting cells
1355336|NCT01353222|Cancer vaccine|cancer vaccine
1355337|NCT01353222|Urothelial carcinoma|urothelial carcinoma
1355338|NCT01353222|Urothelial neoplasms|urothelial neoplasms
1355339|NCT01353222|Neoplasms by site|neoplasms by site
1355340|NCT01353222|Neoplasms|neoplasms
1355341|NCT01353196|carotid|carotid
1355342|NCT01353196|atherosclerosis|atherosclerosis
1355343|NCT01353196|cognitive function|cognitive function
1355344|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
1355345|NCT01353170|Serum calcium|serum calcium
1355346|NCT01353170|Dialysate|dialysate
1355347|NCT01353170|Mass balance|mass balance
1355348|NCT01353170|Blood pressure|blood pressure
1355349|NCT01353157|cytokine|cytokine
1355350|NCT01353157|cardiac surgery|cardiac surgery
1355351|NCT01353157|clinical scoring system|clinical scoring system
1355352|NCT01353144|aspirin|aspirin
1355353|NCT01353144|peptic ulcer|peptic ulcer
1355354|NCT01353131|electrocardiogram,|electrocardiogram,
1355355|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
1355356|NCT01353131|heart failure|heart failure
1355357|NCT01353131|sudden cardiac death|sudden cardiac death
1355358|NCT01353131|ECG scoring|ecg scoring
1355359|NCT01353131|Delayed enhancement|delayed enhancement
1355360|NCT01353118|diabetes|diabetes
1355361|NCT01353118|bariatric surgery|bariatric surgery
1355362|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
1355363|NCT01353118|retinopathy|retinopathy
1355364|NCT01353118|neuropathy|neuropathy
1355365|NCT01353118|nephropathy|nephropathy
1355366|NCT01353105|cystic fibrosis|cystic fibrosis
1355367|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1355368|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
1356086|NCT01350050|articaine|articaine
1355369|NCT01353092|Randomized Controlled Trial|randomized controlled trial
1355370|NCT01353092|Major depression|major depression
1355371|NCT01353092|Hamilton|hamilton
1355372|NCT01353092|PEMF|pemf
1355373|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1355374|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
1355375|NCT01353053|Immunosuppression|immunosuppression
1355376|NCT01353053|Cytomegalovirus|cytomegalovirus
1355377|NCT01353053|Renal Transplant|renal transplant
1355378|NCT01353053|Atrophy/interstitial|atrophy/interstitial
1355379|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
1355380|NCT01353014|Nutrigenomics|nutrigenomics
1355381|NCT01353014|Diet|diet
1355382|NCT01353014|Nutrition|nutrition
1355383|NCT01353001|Intervention Studies|intervention studies
1355384|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
1355385|NCT01353001|C-Reactive Protein|c-reactive protein
1355386|NCT01352988|C17.300.475|c17.300.475
1355387|NCT01352988|C17.800.480|c17.800.480
1355388|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
1355389|NCT01352975|Dark Adaptation|dark adaptation
1355390|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
1355392|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
1355393|NCT01352962|Urethra Cancer|urethra cancer
1355394|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
1355395|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
1355396|NCT01352962|Ureter Cancer|ureter cancer
1355397|NCT01352962|Urethral Cancer|urethral cancer
1355398|NCT01352962|Solid Tumor|solid tumor
1355399|NCT01352962|Pancreatic Cancer|pancreatic cancer
1355400|NCT01352962|Ovarian Cancer|ovarian cancer
1355401|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
1355415|NCT01352936|vancomycin|vancomycin
1355416|NCT01352936|teicoplanin|teicoplanin
1355417|NCT01352923|PEAR1 gene|pear1 gene
1355418|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
1355419|NCT01352897|Cholesterol|cholesterol
1355420|NCT01352897|rosuvastatin|rosuvastatin
1355421|NCT01352897|retrospective|retrospective
1355422|NCT01352884|Cancer|cancer
1355423|NCT01352884|Carcinoma|carcinoma
1355424|NCT01352884|Tumor|tumor
1355425|NCT01352884|Solid tumor|solid tumor
1355426|NCT01352884|Metastatic|metastatic
1355427|NCT01352884|Melanoma|melanoma
1355428|NCT01352871|Immunity, Innate|immunity, innate
1355429|NCT01352871|Attention|attention
1355430|NCT01352871|Concentration|concentration
1355431|NCT01352858|Arthritis|arthritis
1355432|NCT01352858|RA|ra
1355433|NCT01352858|Auto-immune disorders|auto-immune disorders
1355434|NCT01352832|Chronic NSAID use|chronic nsaid use
1355435|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
1355436|NCT01352793|phase 3 safety study|phase 3 safety study
1355437|NCT01352793|5700 healthy subjects|5700 healthy subjects
1355438|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
1355439|NCT01352793|2|2
1355440|NCT01352793|and 6|and 6
1355441|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
1355442|NCT01352780|motivational interviewing|motivational interviewing
1355443|NCT01352780|psoriasis|psoriasis
1355444|NCT01352780|self management|self management
1355445|NCT01352767|insulin injection|insulin injection
1355446|NCT01352754|Hip fracture|hip fracture
1355447|NCT01352754|Troponin T|troponin t
1355448|NCT01352754|myocardial infarction|myocardial infarction
1355449|NCT01352741|low back pain|low back pain
1355450|NCT01352741|neuropathic|neuropathic
1355451|NCT01352741|pain assessment|pain assessment
1355452|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
1355453|NCT01352741|severe chronic|severe chronic
1355454|NCT01352728|Unresectable|unresectable
1355455|NCT01352689|CKD-828|ckd-828
1355456|NCT01352689|Hypertension|hypertension
1355457|NCT01352689|Primary Hypertension|primary hypertension
1355458|NCT01352689|Healthy Volunteer|healthy volunteer
1355459|NCT01352689|S-Amlodipine|s-amlodipine
1355460|NCT01352689|Telmisartan|telmisartan
1355461|NCT01352689|Amlodipine|amlodipine
1355462|NCT01352689|Pharmacokinetic|pharmacokinetic
1355463|NCT01352689|Phase 1|phase 1
1355464|NCT01352676|renal colic|renal colic
1355465|NCT01352676|flank pain|flank pain
1355466|NCT01352676|back pain|back pain
1355467|NCT01352663|Type I Diabetes|type i diabetes
1355468|NCT01352663|Wockhardt|wockhardt
1355469|NCT01352663|Insulin Analogue|insulin analogue
1355470|NCT01352650|leukemia|leukemia
1355471|NCT01352637|Traumatic Event|traumatic event
1355472|NCT01352637|Trauma Survivor|trauma survivor
1355473|NCT01352637|Exposure Therapy|exposure therapy
1355474|NCT01352637|PTSD DCS|ptsd dcs
1355475|NCT01352637|Virtual Reality Exposure|virtual reality exposure
1355476|NCT01352637|Veteran|veteran
1355477|NCT01352637|Combat-related PTSD|combat-related ptsd
1355478|NCT01352611|Tactile Defensiveness|tactile defensiveness
1355479|NCT01352611|Autistic Disorder|autistic disorder
1355480|NCT01352598|prostate cancer|prostate cancer
1355481|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
1355482|NCT01352572|Antidepressant Response|antidepressant response
1355483|NCT01352572|Signal Transduction|signal transduction
1355484|NCT01352572|Lymphocyte|lymphocyte
1355485|NCT01352572|Biomarkers|biomarkers
1355486|NCT01352572|Depressed Patients|depressed patients
1355487|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
1355488|NCT01352559|Pharmacogenomics|pharmacogenomics
1355489|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
1355490|NCT01352559|Depressed Patients|depressed patients
1355491|NCT01352559|biomarkers|biomarkers
1355492|NCT01352559|phenotype|phenotype
1355493|NCT01352559|Antidepressant Response|antidepressant response
1355494|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
1355495|NCT01352546|vaginismus|vaginismus
1355496|NCT01352546|painful sex|painful sex
1355497|NCT01352546|painful intercourse|painful intercourse
1355498|NCT01352546|dyspareunia|dyspareunia
1355499|NCT01352546|inability to have intercourse|inability to have intercourse
1355500|NCT01352546|inability to consummate marriage|inability to consummate marriage
1355501|NCT01352546|vaginal spasm|vaginal spasm
1355502|NCT01352546|"hitting a wall"|"hitting a wall"
1355503|NCT01352546|pain during sex|pain during sex
1355504|NCT01352546|pain during intercourse|pain during intercourse
1355505|NCT01352546|burning with intercourse|burning with intercourse
1355506|NCT01352520|systemic therapy|systemic therapy
1355507|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
1355508|NCT01352520|ALCL|alcl
1355509|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
1355510|NCT01352520|LyP|lyp
1355511|NCT01352520|mycosis fungoides|mycosis fungoides
1355512|NCT01352520|MF|mf
1355513|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
1355514|NCT01352520|skin lymphomas|skin lymphomas
1355515|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
1355516|NCT01352520|tumor lymphocytes|tumor lymphocytes
1355517|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
1355518|NCT01352520|CD30+ expression|cd30+ expression
1355519|NCT01352520|Hematologic Disorder|hematologic disorder
1355520|NCT01352520|Lymphoma|lymphoma
1355521|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
1355522|NCT01352494|docetaxel|docetaxel
1355523|NCT01352494|gemcitabine|gemcitabine
1355524|NCT01352481|Speech sound development|speech sound development
1355525|NCT01352468|ADHD|adhd
1355526|NCT01352468|cognitive training|cognitive training
1355527|NCT01352455|Hemodialysis|hemodialysis
1355528|NCT01352455|Pediatric|pediatric
1355529|NCT01352455|Outcomes|outcomes
1355530|NCT01352455|Comparative Effectiveness|comparative effectiveness
1355531|NCT01352455|End Stage Renal Disease|end stage renal disease
1355532|NCT01352442|Presbyopia|presbyopia
1355533|NCT01352442|Accommodation|accommodation
1355534|NCT01352442|Near visual acuity|near visual acuity
1355535|NCT01352442|LASIK|lasik
1355536|NCT01352429|adult|adult
1355537|NCT01352429|histologically confirmed|histologically confirmed
1355538|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
1355539|NCT01352416|heart bypass surgery|heart bypass surgery
1355540|NCT01352416|heart valve surgery|heart valve surgery
1355541|NCT01352403|obesity|obesity
1355542|NCT01352403|bariatric surgery|bariatric surgery
1355543|NCT01352403|gastric bypass|gastric bypass
1355544|NCT01352403|life style intervention|life style intervention
1355545|NCT01352403|cardiac function|cardiac function
1355546|NCT01352390|behavioral economics|behavioral economics
1355547|NCT01352390|nudge|nudge
1355548|NCT01352390|artwork|artwork
1355549|NCT01352390|Pap smear|pap smear
1355550|NCT01352390|Blood pressure check|blood pressure check
1355551|NCT01352390|Cholesterol test|cholesterol test
1355552|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
1355553|NCT01352364|Physiotherapy.|physiotherapy.
1355554|NCT01352364|Deafness.|deafness.
1355555|NCT01352364|Postural balance.|postural balance.
1355556|NCT01352364|Motor skills.|motor skills.
1355557|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
1355558|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
1355559|NCT01352338|REPEAT|repeat
1355560|NCT01352338|multiple myeloma|multiple myeloma
1355561|NCT01352338|revlimid|revlimid
1355562|NCT01352338|lenalidomide|lenalidomide
1355563|NCT01352338|cyclophosphamide|cyclophosphamide
1355564|NCT01352338|endoxan|endoxan
1355565|NCT01352338|prednisone|prednisone
1355566|NCT01352338|lenalidomide refractory|lenalidomide refractory
1355567|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1355568|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1355569|NCT01352312|B-cell|b-cell
1355570|NCT01352312|leukemia|leukemia
1355571|NCT01352312|lymphoma|lymphoma
1355572|NCT01352312|bendamustine|bendamustine
1355573|NCT01352312|pentostatin|pentostatin
1355574|NCT01352312|ofatumumab|ofatumumab
1355575|NCT01352312|NHL|nhl
1355576|NCT01352312|CLL|cll
1355577|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
1355578|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
1355579|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
1355580|NCT01352299|TrueView laryngoscope|trueview laryngoscope
1355581|NCT01352286|Multiple myeloma|multiple myeloma
1355582|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
1355583|NCT01352286|Received initial treatment previously|received initial treatment previously
1355584|NCT01352273|advanced Solid tumors|advanced solid tumors
1355585|NCT01352273|harboring RAS|harboring ras
1355586|NCT01352273|harboring BRAFV600E|harboring brafv600e
1355587|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
1355588|NCT01352260|Neuromonitoring|neuromonitoring
1355589|NCT01352260|Aortic Arch Replacement|aortic arch replacement
1355590|NCT01352221|iron deficiency|iron deficiency
1355591|NCT01352221|anaemia|anaemia
1355592|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
1355593|NCT01352221|Crohn's Disease|crohn's disease
1355594|NCT01352208|ASP9521|asp9521
1355595|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
1355596|NCT01352208|Phase 1/2|phase 1/2
1355597|NCT01352195|Forever Free|forever free
1355598|NCT01352143|Neonates|neonates
1355599|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
1355600|NCT01352130|Ondansetron|ondansetron
1355601|NCT01352130|Granisetron|granisetron
1355602|NCT01352130|QTc interval|qtc interval
1355603|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
1355604|NCT01352091|breast cancer|breast cancer
1356612|NCT01347996|Leukemia|leukemia
1355605|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
1355607|NCT01352091|Zoladex|zoladex
1355608|NCT01352078|Non healing ulcer|non healing ulcer
1355609|NCT01352078|Wound|wound
1355610|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
1355611|NCT01352078|Acne Inversa|acne inversa
1355612|NCT01352078|Hidradenitis|hidradenitis
1355613|NCT01352065|Pharmacokinetics|pharmacokinetics
1355614|NCT01352065|Exercise performance|exercise performance
1355615|NCT01352065|Athletes|athletes
1355616|NCT01352052|chronic widespread pain|chronic widespread pain
1355617|NCT01352052|fibromyalgia|fibromyalgia
1355618|NCT01352052|outcome assessment|outcome assessment
1355619|NCT01352052|functional ability|functional ability
1355620|NCT01352052|AMPS|amps
1355621|NCT01352052|rehabilitation|rehabilitation
1355622|NCT01352039|Heparin Sodium|heparin sodium
1355623|NCT01352039|Thromboprophylaxis|thromboprophylaxis
1355624|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
1355625|NCT01352013|Fibromyalgia|fibromyalgia
1355626|NCT01352013|Omega-3|omega-3
1355627|NCT01352013|Chronic Pain|chronic pain
1355628|NCT01352013|Fatigue|fatigue
1355629|NCT01352013|Mood|mood
1355630|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1355631|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
1355632|NCT01352000|self help|self help
1355633|NCT01352000|smoking cessation|smoking cessation
1355634|NCT01352000|cancer prevention|cancer prevention
1355635|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1355636|NCT01351974|breast cancer|breast cancer
1355637|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
1355638|NCT01351974|axillary recurrence|axillary recurrence
1355639|NCT01351961|Hypertension|hypertension
1355640|NCT01351961|Cognitive function|cognitive function
1355641|NCT01351948|Immune response|immune response
1355642|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
1355643|NCT01351935|lymphoma|lymphoma
1355644|NCT01351935|leukemia|leukemia
1355645|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1355646|NCT01351935|b-cell malignancies|b-cell malignancies
1355647|NCT01351935|Btk inhibitor|btk inhibitor
1355648|NCT01351935|Phase 1b|phase 1b
1355649|NCT01351935|Avila Therapeutics|avila therapeutics
1355650|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1355651|NCT01351883|immunomodulating diet|immunomodulating diet
1355652|NCT01351883|postoperative infection|postoperative infection
1355653|NCT01351857|Type 1 Diabetes|type 1 diabetes
1355654|NCT01351857|17 to 20 years of age|17 to 20 years of age
1355655|NCT01351844|Aromatase inhibitor|aromatase inhibitor
1355656|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
1355657|NCT01351844|Exercise|exercise
1355658|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1355659|NCT01351831|Resistance training|resistance training
1355660|NCT01351831|Physical Therapy Modalities|physical therapy modalities
1355661|NCT01351831|Randomized Controlled Trial|randomized controlled trial
1355662|NCT01351805|vitamin D|vitamin d
1355663|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
1355664|NCT01351805|fish oil|fish oil
1355665|NCT01351805|prevention|prevention
1355666|NCT01351805|trial|trial
1355667|NCT01351805|autoimmune disease|autoimmune disease
1355668|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
1355669|NCT01351805|psoriasis|psoriasis
1355670|NCT01351805|systemic inflammation|systemic inflammation
1355671|NCT01351805|Interleukin-6|interleukin-6
1355672|NCT01351805|C-reactive peptide|c-reactive peptide
1355673|NCT01351805|tumor necrosis factor|tumor necrosis factor
1355674|NCT01351805|osteoarthritis|osteoarthritis
1355675|NCT01351779|Intraocular pressure|intraocular pressure
1355676|NCT01351779|Contact lens sensor|contact lens sensor
1355677|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
1355678|NCT01351766|Behavioral Activation|behavioral activation
1355679|NCT01351753|Obesity|obesity
1355680|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
1355681|NCT01351753|Hypertension|hypertension
1355682|NCT01351753|Dyslipidemia|dyslipidemia
1355683|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
1355684|NCT01351740|HIV|hiv
1355685|NCT01351740|Anti-HIV Agents|anti-hiv agents
1355686|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
1355687|NCT01351727|seniors|seniors
1355688|NCT01351727|seizures|seizures
1355689|NCT01351727|epilepsy|epilepsy
1355690|NCT01351727|quality of life|quality of life
1355691|NCT01351714|D3 resection|d3 resection
1355692|NCT01351714|right colectomy|right colectomy
1355693|NCT01351714|MDCT angiography|mdct angiography
1355694|NCT01351714|lymphadenectomy|lymphadenectomy
1355695|NCT01351714|safe|safe
1355696|NCT01351714|right colon|right colon
1355697|NCT01351714|preoperative|preoperative
1355698|NCT01351701|Diabetic foot|diabetic foot
1355699|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
1355700|NCT01351701|Wagner's Grading|wagner's grading
1355701|NCT01351701|eastern India|eastern india
1355702|NCT01351688|Phase 1|phase 1
1355703|NCT01351688|Metastatic|metastatic
1355704|NCT01351688|Castration resistant|castration resistant
1355705|NCT01351688|Prostate cancer|prostate cancer
1355706|NCT01351688|Androgen receptor|androgen receptor
1355707|NCT01351688|Down regulation|down regulation
1355708|NCT01351688|Japanese|japanese
1355709|NCT01351675|Chronic kidney disease|chronic kidney disease
1355710|NCT01351675|Type 2 diabetes|type 2 diabetes
1355711|NCT01351675|Diabetic nephropathy|diabetic nephropathy
1355712|NCT01351662|Lupus|lupus
1355713|NCT01351662|stress|stress
1355714|NCT01351649|exercise|exercise
1355715|NCT01351649|adolescent|adolescent
1355716|NCT01351649|intervention|intervention
1355717|NCT01351649|female|female
1355718|NCT01351649|counseling|counseling
1355719|NCT01351636|chronic kidney disease|chronic kidney disease
1355720|NCT01351636|hypertension|hypertension
1355721|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
1355722|NCT01351623|Chemotherapy|chemotherapy
1355723|NCT01351623|10-228|10-228
1355724|NCT01351610|Critical Limb Ischemia|critical limb ischemia
1355725|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1355726|NCT01351610|Peripheral Artery Disease|peripheral artery disease
1355727|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
1355728|NCT01351610|Stem Cell Therapy|stem cell therapy
1355729|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
1355730|NCT01351597|recurrent breast cancer|recurrent breast cancer
1355731|NCT01351597|metastatic breast cancer|metastatic breast cancer
1355732|NCT01351597|docetaxel|docetaxel
1355733|NCT01351597|oxaliplatin|oxaliplatin
1355734|NCT01351584|Breast Cancer|breast cancer
1355735|NCT01351584|Advanced Breast Cancer|advanced breast cancer
1355736|NCT01351584|Epidemiology|epidemiology
1355737|NCT01351584|Registry|registry
1355738|NCT01351584|Health Services Research|health services research
1355739|NCT01351584|Germany|germany
1355740|NCT01351584|Palliative Treatment|palliative treatment
1355741|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
1355742|NCT01351584|Nutrition Assessment|nutrition assessment
1355743|NCT01351584|Physical Activity|physical activity
1355744|NCT01351519|Glioma|glioma
1355745|NCT01351519|Glioblastoma|glioblastoma
1355746|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
1355747|NCT01351519|Astrocytoma|astrocytoma
1355748|NCT01351519|Brain Tumor|brain tumor
1355749|NCT01351506|Body weight|body weight
1355750|NCT01351506|Body mass index|body mass index
1355751|NCT01351506|Weight change|weight change
1355752|NCT01351506|ICU outcomes|icu outcomes
1355753|NCT01351493|pressure sore|pressure sore
1355754|NCT01351493|nitric oxide|nitric oxide
1355755|NCT01351480|Auto-immune Disease|auto-immune disease
1355756|NCT01351480|Arthritis|arthritis
1355757|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
1355758|NCT01351467|Parkinson's|parkinson's
1355759|NCT01351467|genetic|genetic
1355760|NCT01351467|online|online
1355761|NCT01351467|GWAS|gwas
1355762|NCT01351467|genome wide association|genome wide association
1355763|NCT01351454|Depression|depression
1355764|NCT01351454|Substance Use|substance use
1355765|NCT01351454|HIV Medication Adherence|hiv medication adherence
1355766|NCT01351454|Behavioral Activation|behavioral activation
1355767|NCT01351441|Geriatric|geriatric
1355768|NCT01351441|Pharmacoeconomics|pharmacoeconomics
1355769|NCT01351441|Health Literacy|health literacy
1355770|NCT01351441|Adherence|adherence
1355771|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
1355772|NCT01351428|NICOM|nicom
1355773|NCT01351428|Hypertension|hypertension
1355774|NCT01351428|Pregnancy|pregnancy
1355775|NCT01351428|Pre-Eclampsia|pre-eclampsia
1355776|NCT01351402|Massage|massage
1355777|NCT01351402|Rest|rest
1355778|NCT01351389|Brief|brief
1355779|NCT01351389|Alcohol|alcohol
1355780|NCT01351389|Intervention|intervention
1355781|NCT01351389|Sex|sex
1355782|NCT01351389|Risk|risk
1355783|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
1356189|NCT01349634|goiter|goiter
1355784|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
1355785|NCT01351363|Pain threshold|pain threshold
1355786|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
1355787|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
1355788|NCT01351337|stimulation, Tractography|stimulation, tractography
1355789|NCT01351324|Endothelial function|endothelial function
1355790|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
1355791|NCT01351324|Insulin sensitivity|insulin sensitivity
1355792|NCT01351311|treatment|treatment
1355793|NCT01351311|exercise|exercise
1355794|NCT01351311|resistance training|resistance training
1355795|NCT01351311|swiss ball|swiss ball
1355796|NCT01351311|functional capacity|functional capacity
1355797|NCT01351259|Mechanical ventilation|mechanical ventilation
1355798|NCT01351259|Intubation|intubation
1355799|NCT01351259|Cuff pressure|cuff pressure
1355800|NCT01351259|Microaspiration|microaspiration
1355801|NCT01351246|Program Evaluation|program evaluation
1355802|NCT01351246|ADHD|adhd
1355803|NCT01351233|Cataract|cataract
1355804|NCT01351220|CRC screening|crc screening
1355805|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
1355806|NCT01351220|Filipino|filipino
1355807|NCT01351220|Dissemination|dissemination
1355808|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
1355810|NCT01351194|HR|hr
1355811|NCT01351181|Diabetes|diabetes
1355812|NCT01351168|Parkinson's disease|parkinson's disease
1355813|NCT01351168|zolpidem|zolpidem
1355814|NCT01351155|acute respiratory failure|acute respiratory failure
1355815|NCT01351155|noninvasive ventilation|noninvasive ventilation
1355816|NCT01351129|formulation comparison|formulation comparison
1355817|NCT01351116|brachytherapy|brachytherapy
1355818|NCT01351116|external beam radiation|external beam radiation
1355819|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
1355820|NCT01351116|lung cancer|lung cancer
1355821|NCT01351116|quality of life|quality of life
1355822|NCT01351116|radiation treatment|radiation treatment
1355823|NCT01351116|bronchus|bronchus
1355824|NCT01351103|LGK974|lgk974
1355825|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1355826|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
1355827|NCT01351103|RNF43 mutation|rnf43 mutation
1355828|NCT01351103|RSPO fusion|rspo fusion
1355829|NCT01351103|melanoma|melanoma
1355830|NCT01351103|triple negative breast cancer|triple negative breast cancer
1355831|NCT01351103|PDR001|pdr001
1355832|NCT01351103|immunotherapy|immunotherapy
1355833|NCT01351103|head and neck scc|head and neck scc
1355834|NCT01351103|cervical scc|cervical scc
1355835|NCT01351103|esophageal scc|esophageal scc
1355836|NCT01351103|lung scc|lung scc
1355837|NCT01351077|Developmental Delay|developmental delay
1355838|NCT01351064|ADHD|adhd
1355839|NCT01351012|Canola oil|canola oil
1355840|NCT01351012|High oleic canola oil|high oleic canola oil
1355841|NCT01351012|Flax oil|flax oil
1355842|NCT01351012|ALA|ala
1355843|NCT01351012|DHA|dha
1355844|NCT01351012|Metabolic syndrome|metabolic syndrome
1355845|NCT01351012|Cardiovascular disease|cardiovascular disease
1355846|NCT01351012|Endothelial function|endothelial function
1355847|NCT01351012|FADS1|fads1
1355848|NCT01351012|Gut microbiome|gut microbiome
1355849|NCT01351012|Body composition|body composition
1355850|NCT01351012|Psychosocial status|psychosocial status
1355851|NCT01351012|Cholesterol|cholesterol
1355852|NCT01351012|Lipids|lipids
1355853|NCT01351012|Lipoproteins|lipoproteins
1355854|NCT01351012|Inflammation|inflammation
1355855|NCT01351012|Lipid peroxidation|lipid peroxidation
1355856|NCT01350999|Drug Therapy|drug therapy
1355857|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1355858|NCT01350973|Drug Therapy|drug therapy
1355859|NCT01350960|hypercholesterolemia|hypercholesterolemia
1355860|NCT01350960|hyperlipidemia|hyperlipidemia
1355862|NCT01350960|HDL|hdl
1355863|NCT01350960|PCSK9|pcsk9
1355864|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
1355865|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1355866|NCT01350947|CMML|cmml
1355867|NCT01350921|phase 1|phase 1
1355868|NCT01350921|ticagrelor|ticagrelor
1355869|NCT01350921|venlafaxine|venlafaxine
1355870|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
1355871|NCT01350882|kidney transplantation|kidney transplantation
1355872|NCT01350882|acute humoral rejection|acute humoral rejection
1355873|NCT01350882|rituximab|rituximab
1355874|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
1355875|NCT01350843|Men|men
1355876|NCT01350843|Orange Juice|orange juice
1355877|NCT01350843|Cholesterol|cholesterol
1355878|NCT01350843|Obesity|obesity
1355879|NCT01350830|inguinal hernia|inguinal hernia
1355880|NCT01350830|groin hernia|groin hernia
1355881|NCT01350830|chronic pain|chronic pain
1355882|NCT01350830|mesh repair|mesh repair
1355883|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
1355884|NCT01350804|RA|ra
1355885|NCT01350804|ACR|acr
1355886|NCT01350804|inflammatory joints|inflammatory joints
1355887|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
1355888|NCT01350765|Birth asphyxia|birth asphyxia
1355889|NCT01350765|Low birth weight|low birth weight
1355890|NCT01350765|neonatal sepsis|neonatal sepsis
1355891|NCT01350765|mortality|mortality
1355892|NCT01350765|community based interventions|community based interventions
1355893|NCT01350752|cost effectiveness|cost effectiveness
1355894|NCT01350752|provider knowledge|provider knowledge
1355895|NCT01350752|schools|schools
1355896|NCT01350726|Cirrhosis|cirrhosis
1355897|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
1355898|NCT01350713|skin|skin
1355899|NCT01350713|burn|burn
1355900|NCT01350713|povidone iodine|povidone iodine
1355901|NCT01350713|cold water|cold water
1355902|NCT01350700|QOL|qol
1355903|NCT01350687|Calcium Phosphore|calcium phosphore
1355904|NCT01350687|Renagel|renagel
1355905|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
1355906|NCT01350674|endoscopy|endoscopy
1355907|NCT01350674|EBUS|ebus
1355908|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
1355909|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
1355910|NCT01350661|Asthma|asthma
1355911|NCT01350661|Questionnaires|questionnaires
1355912|NCT01350648|Viral Hepatitis|viral hepatitis
1355913|NCT01350648|Prospective Cohort|prospective cohort
1355914|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
1355915|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
1355916|NCT01350648|HIV-HBV Co-Infection|hiv-hbv co-infection
1355917|NCT01350648|Hepatitis B|hepatitis b
1355918|NCT01350648|Hepatitis C|hepatitis c
1355919|NCT01350648|Hepatitis|hepatitis
1355920|NCT01350635|Specific Immunotherapy|specific immunotherapy
1355921|NCT01350635|Grass pollen vaccine|grass pollen vaccine
1355922|NCT01350635|Allergy|allergy
1355923|NCT01350635|Grass Pollen Allergy|grass pollen allergy
1355924|NCT01350622|pain management|pain management
1355925|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
1355926|NCT01350596|Bioequivalence Study|bioequivalence study
1355927|NCT01350596|Ibuprofen|ibuprofen
1355928|NCT01350596|Alivium|alivium
1355929|NCT01350583|tumor related pain|tumor related pain
1355930|NCT01350570|acupuncture|acupuncture
1355931|NCT01350570|loperamide|loperamide
1355932|NCT01350570|functional diarrhea|functional diarrhea
1355933|NCT01350570|IBS|ibs
1355934|NCT01350557|Elderly|elderly
1355935|NCT01350557|Hip fracture|hip fracture
1355936|NCT01350557|Intervention program|intervention program
1355937|NCT01350544|HIV|hiv
1355938|NCT01350544|Adherence|adherence
1355939|NCT01350544|African American/Black|african american/black
1355940|NCT01350544|Disparities|disparities
1355941|NCT01350531|Obesity|obesity
1355942|NCT01350531|African American adolescents|african american adolescents
1355943|NCT01350531|Motivation|motivation
1355944|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
1355945|NCT01350518|Metabolic Syndrome|metabolic syndrome
1355946|NCT01350518|Hepatic steatosis|hepatic steatosis
1355947|NCT01350505|Postural Balance|postural balance
1355948|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1355949|NCT01350492|pain|pain
1355950|NCT01350492|brain imaging|brain imaging
1355951|NCT01350492|exercise|exercise
1355952|NCT01350479|Cross infection|cross infection
1355953|NCT01350479|Long term care|long term care
1355954|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
1355955|NCT01350453|CIT|cit
1355956|NCT01350453|Stroke|stroke
1355957|NCT01350427|leucine supplementation|leucine supplementation
1355958|NCT01350427|BCCA supplementation|bcca supplementation
1355959|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
1355960|NCT01350401|Melanoma|melanoma
1355961|NCT01350401|Cell Therapy|cell therapy
1355962|NCT01350401|T Cell Therapy|t cell therapy
1355963|NCT01350401|NY-ESO-1|ny-eso-1
1355964|NCT01350401|Immuno-oncology|immuno-oncology
1355965|NCT01350401|Metastatic|metastatic
1355966|NCT01350401|Previously treated|previously treated
1355967|NCT01350401|T Cell Receptor|t cell receptor
1355968|NCT01350388|Chronic Kidney Disease|chronic kidney disease
1355969|NCT01350388|Diabetes|diabetes
1355970|NCT01350388|Febuxostat|febuxostat
1355971|NCT01350388|Inflammation|inflammation
1355972|NCT01350388|Hyperuricemia|hyperuricemia
1355973|NCT01350362|tideglusib|tideglusib
1355974|NCT01350362|Alzheimer|alzheimer
1355975|NCT01350362|NP-12|np-12
1355976|NCT01350362|NP031112|np031112
1355977|NCT01350362|ARGO|argo
1355978|NCT01350362|Noscira|noscira
1355979|NCT01350349|Depression|depression
1355980|NCT01350349|Dementia|dementia
1355981|NCT01350349|Geriatrics|geriatrics
1355982|NCT01350310|Heart failure|heart failure
1355983|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
1355984|NCT01350310|Stem cells|stem cells
1355985|NCT01350297|tetraplegia|tetraplegia
1355986|NCT01350297|reinnervation|reinnervation
1355987|NCT01350297|phrenic nerve|phrenic nerve
1355988|NCT01350284|Antioxidants|antioxidants
1355989|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
1355990|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
1355991|NCT01350271|Hookworm|hookworm
1355992|NCT01350271|Necator americanus|necator americanus
1355993|NCT01350271|Mebendazole|mebendazole
1355994|NCT01350258|allogeneic HSCT|allogeneic hsct
1355995|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1355996|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
1355997|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
1355998|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
1355999|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1356000|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
1356001|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1356002|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
1356003|NCT01350245|Lymphoma|lymphoma
1356004|NCT01350245|Hodgkin's Disease|hodgkin's disease
1356005|NCT01350245|Aplastic Anemia|aplastic anemia
1356006|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1356007|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
1356008|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
1356009|NCT01350232|sickle cell|sickle cell
1356010|NCT01350232|SS disease|ss disease
1356011|NCT01350232|SC disease|sc disease
1356709|NCT01347606|thyroid|thyroid
1356012|NCT01350232|S-thalassemia|s-thalassemia
1356013|NCT01350232|transplant|transplant
1356014|NCT01350232|bone marrow transplant|bone marrow transplant
1356015|NCT01350232|stem cell transplant|stem cell transplant
1356016|NCT01350232|matched sibling|matched sibling
1356017|NCT01350232|haploidentical|haploidentical
1356018|NCT01350232|hemoglobinopathy|hemoglobinopathy
1356019|NCT01350232|anemia|anemia
1356020|NCT01350232|desensitization|desensitization
1356021|NCT01350219|Cord blood stem cells|cord blood stem cells
1356022|NCT01350219|Immune modulation|immune modulation
1356023|NCT01350219|Stem cell educator|stem cell educator
1356024|NCT01350219|Autoimmunity|autoimmunity
1356025|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
1356026|NCT01350219|Type 1 diabetes|type 1 diabetes
1356027|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1356028|NCT01350206|Liver Neoplasms|liver neoplasms
1356029|NCT01350206|Therapeutic|therapeutic
1356030|NCT01350206|Chemoembolization,|chemoembolization,
1356031|NCT01350206|TACE|tace
1356032|NCT01350206|hepatic resection|hepatic resection
1356033|NCT01350193|Manuka Honey|manuka honey
1356034|NCT01350193|Irrigation|irrigation
1356035|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
1356036|NCT01350180|biochemical failure|biochemical failure
1356037|NCT01350180|hormonal therapy|hormonal therapy
1356038|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
1356039|NCT01350167|Liver Cancer|liver cancer
1356040|NCT01350167|Ultrasound|ultrasound
1356041|NCT01350167|Computed Tomography|computed tomography
1356042|NCT01350167|Alpha fetoprotein|alpha fetoprotein
1356043|NCT01350167|Cirrhosis|cirrhosis
1356044|NCT01350167|Screening|screening
1356045|NCT01350167|Advanced Liver Disease|advanced liver disease
1356046|NCT01350154|clinical trial|clinical trial
1356047|NCT01350154|sildenafil|sildenafil
1356048|NCT01350154|revatio|revatio
1356049|NCT01350154|muscular dystrophy|muscular dystrophy
1356050|NCT01350154|adult|adult
1356051|NCT01350154|nNOS|nnos
1356052|NCT01350141|Hypercholesterolemia|hypercholesterolemia
1356053|NCT01350141|dyslipidemia|dyslipidemia
1356054|NCT01350141|high cholesterol|high cholesterol
1356055|NCT01350141|LDL|ldl
1356056|NCT01350141|antibody|antibody
1356057|NCT01350141|PCSK9|pcsk9
1356058|NCT01350141|PF-04950615|pf-04950615
1356059|NCT01350141|RN316|rn316
1356060|NCT01350128|COPD|copd
1356061|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
1356062|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
1356063|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
1356064|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
1356065|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
1356066|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
1356067|NCT01350115|Smo inhibitor,|smo inhibitor,
1356068|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
1356069|NCT01350115|BCCs|bccs
1356070|NCT01350102|Adult|adult
1356071|NCT01350089|energy drinks|energy drinks
1356072|NCT01350089|alcohol intoxication|alcohol intoxication
1356073|NCT01350076|intraoperative fluid|intraoperative fluid
1356074|NCT01350076|pediatric|pediatric
1356075|NCT01350076|goal directed therapy|goal directed therapy
1356076|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
1356077|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
1356078|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
1356079|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
1356080|NCT01350063|water|water
1356081|NCT01350063|tubewell|tubewell
1356082|NCT01350063|diarrhea|diarrhea
1356083|NCT01350063|chlorination|chlorination
1356084|NCT01350063|safe storage|safe storage
1356085|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
1356087|NCT01350037|patient-controlled sedation|patient-controlled sedation
1356088|NCT01350037|propofol|propofol
1356089|NCT01350037|alfentanil|alfentanil
1356090|NCT01350037|remifentanil|remifentanil
1356091|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1356092|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
1356093|NCT01350024|Blepharoptosis|blepharoptosis
1356094|NCT01350024|Ptosis surgery|ptosis surgery
1356095|NCT01350024|Pain Control|pain control
1356096|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
1356097|NCT01350011|Buprenorphine|buprenorphine
1356098|NCT01350011|Varenicline|varenicline
1356099|NCT01350011|Smoking Cessation|smoking cessation
1356100|NCT01350011|Addiction|addiction
1356101|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
1356102|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
1356103|NCT01349985|Naltrexone|naltrexone
1356104|NCT01349985|problem drinking|problem drinking
1356105|NCT01349985|medication adherence|medication adherence
1356106|NCT01349985|adherence|adherence
1356107|NCT01349985|smartphone|smartphone
1356108|NCT01349920|biological markers|biological markers
1356109|NCT01349920|endoscopy|endoscopy
1356110|NCT01349920|gastrointestinal|gastrointestinal
1356111|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
1356112|NCT01349868|COPD|copd
1356113|NCT01349829|Hepatitis A|hepatitis a
1356114|NCT01349829|Vaccination|vaccination
1356115|NCT01349829|Immunity|immunity
1356116|NCT01349816|COPD|copd
1356117|NCT01349803|COPD|copd
1356118|NCT01349790|ITP|itp
1356119|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
1356120|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
1356121|NCT01349764|vitamin D replacement|vitamin d replacement
1356122|NCT01349764|Urolithiasis|urolithiasis
1356123|NCT01349764|deficiency|deficiency
1356124|NCT01349764|insufficiency|insufficiency
1356125|NCT01349751|abdominal incision|abdominal incision
1356126|NCT01349751|hyperbaric|hyperbaric
1356127|NCT01349751|isobaric|isobaric
1356128|NCT01349751|levobupivacaine|levobupivacaine
1356129|NCT01349751|spinal anaesthesia|spinal anaesthesia
1356130|NCT01349725|Safety|safety
1356131|NCT01349699|endotoxemia|endotoxemia
1356132|NCT01349699|inflammation|inflammation
1356133|NCT01349699|iron|iron
1356134|NCT01349699|iron chelation|iron chelation
1356135|NCT01349699|cytokines|cytokines
1356136|NCT01349686|Food|food
1356137|NCT01349686|Fluids|fluids
1356138|NCT01349686|Labor|labor
1356139|NCT01349673|Open-label|open-label
1356140|NCT01349673|Proctitis|proctitis
1356141|NCT01349673|Proctosigmoiditis|proctosigmoiditis
1356142|NCT01349673|Ulcerative|ulcerative
1356143|NCT01349673|Salix|salix
1356144|NCT01349673|Budesonide foam|budesonide foam
1356145|NCT01349673|Budesonide|budesonide
1356146|NCT01349673|Rectal|rectal
1356147|NCT01349673|Gastrointestinal|gastrointestinal
1356148|NCT01349673|Colitis|colitis
1356149|NCT01349673|UC|uc
1356150|NCT01349673|UP|up
1356151|NCT01349673|UPS|ups
1356152|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
1356153|NCT01349673|Proctocolitis|proctocolitis
1356154|NCT01349673|Ulcer|ulcer
1356155|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
1356156|NCT01349673|Gastroenteritis|gastroenteritis
1356157|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
1356158|NCT01349673|Digestive System Diseases|digestive system diseases
1356159|NCT01349673|Rectal Diseases|rectal diseases
1356160|NCT01349673|Intestinal Diseases|intestinal diseases
1356161|NCT01349673|Colonic Diseases|colonic diseases
1356162|NCT01349673|Sigmoid Diseases|sigmoid diseases
1356163|NCT01349673|Pathologic Processes|pathologic processes
1356164|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
1356165|NCT01349673|Bronchodilator Agents|bronchodilator agents
1356166|NCT01349673|Autonomic Agents|autonomic agents
1356167|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
1356168|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
1356169|NCT01349673|Pharmacologic Actions|pharmacologic actions
1356170|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
1356171|NCT01349673|Respiratory System Agents|respiratory system agents
1356172|NCT01349673|Therapeutic Uses|therapeutic uses
1356173|NCT01349673|Glucocorticoids|glucocorticoids
1356174|NCT01349673|Hormones|hormones
1356175|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
1356176|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
1356177|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
1356178|NCT01349660|GBM|gbm
1356179|NCT01349660|Bevacizumab|bevacizumab
1356180|NCT01349660|PI3K Pathway|pi3k pathway
1356181|NCT01349660|BKM120|bkm120
1356182|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
1356183|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
1356184|NCT01349647|OPT-821|opt-821
1356185|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
1356186|NCT01349647|Vaccine|vaccine
1356187|NCT01349647|08-095|08-095
1356188|NCT01349634|iodine|iodine
1356190|NCT01349634|cretinism|cretinism
1356191|NCT01349634|child nutrition|child nutrition
1356192|NCT01349634|cognition|cognition
1356193|NCT01349621|Abnormal Pap results|abnormal pap results
1356194|NCT01349621|Colposcopy|colposcopy
1356195|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1356196|NCT01349608|Motivational Interviewing|motivational interviewing
1356197|NCT01349608|Health Coaching|health coaching
1356198|NCT01349608|Physical Activity|physical activity
1356199|NCT01349582|flow diversion|flow diversion
1356200|NCT01349582|endovascular treatment|endovascular treatment
1356201|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
1356202|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
1356203|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
1356204|NCT01349582|vertebral aneurysm|vertebral aneurysm
1356205|NCT01349556|cancer|cancer
1356206|NCT01349556|chemotherapy|chemotherapy
1356207|NCT01349556|EGFR inhibitors|egfr inhibitors
1356208|NCT01349556|tretinoin|tretinoin
1356209|NCT01349556|EGFRi drug rash|egfri drug rash
1356210|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
1356211|NCT01349543|RSV|rsv
1356212|NCT01349543|Immunology|immunology
1356213|NCT01349543|Viral infection|viral infection
1356214|NCT01349543|Bronchiolitis|bronchiolitis
1356215|NCT01349543|Viral challenge|viral challenge
1356216|NCT01349543|Viral lung disease|viral lung disease
1356217|NCT01349530|Usual medical care|usual medical care
1356218|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
1356219|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
1356220|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
1356221|NCT01349517|Esophageal Cancer|esophageal cancer
1356222|NCT01349491|Atrial Fibrillation|atrial fibrillation
1356223|NCT01349491|Ranolazine|ranolazine
1356224|NCT01349478|paraplegia|paraplegia
1356225|NCT01349478|tetraplegia|tetraplegia
1356226|NCT01349478|passive gait training|passive gait training
1356227|NCT01349478|O2 consumption|o2 consumption
1356228|NCT01349478|exercise capacity|exercise capacity
1356229|NCT01349478|CVD risk factors|cvd risk factors
1356230|NCT01349478|spasticity|spasticity
1356231|NCT01349478|pain|pain
1356232|NCT01349478|bladder, bowel|bladder, bowel
1356233|NCT01349478|well being|well being
1356234|NCT01349465|Hepatitis C|hepatitis c
1356235|NCT01349465|Hepatitis|hepatitis
1356237|NCT01349465|Liver disease|liver disease
1356238|NCT01349465|Virus Infection|virus infection
1356239|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
1356240|NCT01349452|Adenoviridae Infections|adenoviridae infections
1356241|NCT01349452|Ganciclovir|ganciclovir
1356242|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
1356243|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
1356244|NCT01349426|Lung resection|lung resection
1356245|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
1356246|NCT01349426|Fissure closure|fissure closure
1356247|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
1356248|NCT01349426|Bipolar fusion|bipolar fusion
1356249|NCT01349426|Procedure cost|procedure cost
1356250|NCT01349413|Functional dyspepsia|functional dyspepsia
1356251|NCT01349413|symptom response|symptom response
1356252|NCT01349413|postprandial fullness|postprandial fullness
1356253|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
1356254|NCT01349413|acid suppression|acid suppression
1356255|NCT01349400|asymptomatic|asymptomatic
1356256|NCT01349400|minimally symptomatic|minimally symptomatic
1356257|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
1356258|NCT01349322|stage IA breast cancer|stage ia breast cancer
1356259|NCT01349322|stage IB breast cancer|stage ib breast cancer
1356260|NCT01349322|stage II breast cancer|stage ii breast cancer
1356261|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1356262|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1356263|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1356264|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1356265|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1356266|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
1356267|NCT01349309|Head and Neck Cancer|head and neck cancer
1356268|NCT01349309|Dysphagia|dysphagia
1356269|NCT01349296|Solid Tumors|solid tumors
1356270|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
1356271|NCT01349283|Hepatitis B Virus|hepatitis b virus
1356272|NCT01349283|Antigen|antigen
1356273|NCT01349283|Antibody|antibody
1356274|NCT01349283|Vaccination|vaccination
1356275|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
1356276|NCT01349270|immunoglobulin|immunoglobulin
1356277|NCT01349270|prednisone|prednisone
1356278|NCT01349257|Asthmatic patients|asthmatic patients
1356279|NCT01349244|hydronephrosis|hydronephrosis
1356280|NCT01349244|CT|ct
1356281|NCT01349244|POC US|poc us
1356282|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
1356283|NCT01349231|ketamine|ketamine
1356284|NCT01349231|glutamate|glutamate
1356285|NCT01349218|Potassium|potassium
1356286|NCT01349218|Infants|infants
1356287|NCT01349218|Heel Stick|heel stick
1356288|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
1356289|NCT01349218|IV catheter blood samples|iv catheter blood samples
1356290|NCT01349218|perioperatively|perioperatively
1356291|NCT01349218|elective surgical procedures|elective surgical procedures
1356292|NCT01349205|OSA|osa
1356293|NCT01349205|Caffeine|caffeine
1356294|NCT01349205|Tonsillectomy|tonsillectomy
1356295|NCT01349205|Adenoidectomy|adenoidectomy
1356296|NCT01349205|Sleep Study|sleep study
1356297|NCT01349192|MRSA|mrsa
1356298|NCT01349192|Cystic Fibrosis|cystic fibrosis
1356299|NCT01349192|Early Infection|early infection
1356300|NCT01349192|Treatment|treatment
1356301|NCT01349179|Hip|hip
1356302|NCT01349179|Arthroplasty|arthroplasty
1356303|NCT01349179|Metal on metal|metal on metal
1356304|NCT01349179|operated on 2002|operated on 2002
1356305|NCT01349166|Obesity|obesity
1356306|NCT01349166|Type 2 diabetes|type 2 diabetes
1356307|NCT01349166|glucose intolerance|glucose intolerance
1356308|NCT01349166|Physical Activity|physical activity
1356309|NCT01349166|Inflammation|inflammation
1356310|NCT01349166|HPA axis|hpa axis
1356312|NCT01349153|Physical Activity|physical activity
1356313|NCT01349153|Young Adults|young adults
1356314|NCT01349153|Cancer Survivors|cancer survivors
1356315|NCT01349127|Vitamin D|vitamin d
1356316|NCT01349127|Cholecalciferol|cholecalciferol
1356317|NCT01349127|Nutrient requirements|nutrient requirements
1356318|NCT01349127|Randomised Controlled Trial|randomised controlled trial
1356319|NCT01349127|Lactation|lactation
1356320|NCT01349127|pregnancy|pregnancy
1356321|NCT01349127|Cord blood|cord blood
1356322|NCT01349127|Human milk|human milk
1356323|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
1356324|NCT01349127|deficiency|deficiency
1356325|NCT01349127|insufficiency|insufficiency
1356326|NCT01349127|nutrition|nutrition
1356327|NCT01349114|aliskiren|aliskiren
1356328|NCT01349114|endothelial function|endothelial function
1356329|NCT01349114|hypertension|hypertension
1356330|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1356331|NCT01349101|HSCT|hsct
1356332|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
1356333|NCT01349101|cyclophosphamide|cyclophosphamide
1356334|NCT01349101|graft-versus-host disease|graft-versus-host disease
1356335|NCT01349101|GVHD|gvhd
1356336|NCT01349088|breast cancer|breast cancer
1356337|NCT01349088|metastatic breast cancer|metastatic breast cancer
1356338|NCT01349088|stage IV breast cancer|stage iv breast cancer
1356339|NCT01349088|motesanib|motesanib
1356340|NCT01349088|ixabepilone|ixabepilone
1356341|NCT01349088|capecitabine|capecitabine
1356342|NCT01349075|Unresectable|unresectable
1356343|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
1356344|NCT01349075|TheraSphere|therasphere
1356345|NCT01349075|Yttrium-90|yttrium-90
1356346|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
1356347|NCT01349062|HIV Infections|hiv infections
1356348|NCT01349049|AML|aml
1356349|NCT01349049|relapsed|relapsed
1356350|NCT01349049|refractory|refractory
1356351|NCT01349036|GBM|gbm
1356352|NCT01349036|Glioblastoma|glioblastoma
1356353|NCT01349036|brain cancer|brain cancer
1356354|NCT01349023|energy content|energy content
1356355|NCT01349023|energy density|energy density
1356356|NCT01349023|energy intake|energy intake
1356357|NCT01349023|pre-portioned entrees|pre-portioned entrees
1356358|NCT01349010|hyperlipidemia|hyperlipidemia
1356359|NCT01348997|cancer|cancer
1356360|NCT01348997|cancer survivors|cancer survivors
1356361|NCT01348997|internet|internet
1356362|NCT01348997|depression|depression
1356363|NCT01348997|anxiety|anxiety
1356364|NCT01348984|postoperative|postoperative
1356365|NCT01348984|pain score|pain score
1356366|NCT01348984|morphine consumption|morphine consumption
1356367|NCT01348971|sodium nitrate|sodium nitrate
1356368|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
1356369|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
1356370|NCT01348971|myocardial injury|myocardial injury
1356371|NCT01348958|Patello femoral|patello femoral
1356372|NCT01348958|osteoarthritis|osteoarthritis
1356373|NCT01348958|arthroplasty|arthroplasty
1356374|NCT01348945|Partial tear ACL|partial tear acl
1356375|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
1356376|NCT01348932|asthma|asthma
1356377|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
1356378|NCT01348932|YKL-40|ykl-40
1356379|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
1356380|NCT01348932|Real time PCR|real time pcr
1356381|NCT01348932|gene|gene
1356382|NCT01348919|Cancer|cancer
1356383|NCT01348919|Multiple myeloma|multiple myeloma
1356384|NCT01348919|CEP-18770|cep-18770
1356385|NCT01348919|Lenalidomide|lenalidomide
1356386|NCT01348919|Dexamethasone|dexamethasone
1356387|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
1356388|NCT01348893|Mental health|mental health
1356389|NCT01348893|Education|education
1356390|NCT01348893|Mind Body Therapies|mind body therapies
1356391|NCT01348880|drug-drug interaction|drug-drug interaction
1356392|NCT01348867|Diabetes|diabetes
1356393|NCT01348867|Structured Care|structured care
1356394|NCT01348854|astigmatism|astigmatism
1356395|NCT01348841|community wound care|community wound care
1356396|NCT01348841|systematic wound team referral|systematic wound team referral
1356397|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
1356398|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1356399|NCT01348828|Fenestrated|fenestrated
1356400|NCT01348828|Renal Stent|renal stent
1356401|NCT01348828|Juxtarenal|juxtarenal
1356402|NCT01348828|Pararenal|pararenal
1356403|NCT01348828|Endologix|endologix
1356404|NCT01348828|Renal|renal
1356405|NCT01348802|Knowledge Translation|knowledge translation
1356406|NCT01348802|Push-out Evidence|push-out evidence
1356407|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
1356408|NCT01348802|Pain|pain
1356409|NCT01348802|Interdisciplinary|interdisciplinary
1356410|NCT01348802|Physician|physician
1356411|NCT01348802|Rehabilitation|rehabilitation
1356412|NCT01348802|Nursing|nursing
1356413|NCT01348802|Knowledge Uptake|knowledge uptake
1356414|NCT01348789|Hair removal|hair removal
1356415|NCT01348789|Hair Clearance|hair clearance
1356416|NCT01348789|Epilation|epilation
1356417|NCT01348776|hair reduction|hair reduction
1356418|NCT01348776|hair removal|hair removal
1356419|NCT01348776|hair clearance|hair clearance
1356420|NCT01348750|PTSD|ptsd
1356421|NCT01348750|Healing Touch|healing touch
1356422|NCT01348750|Guided Imagery|guided imagery
1356423|NCT01348750|Military|military
1356424|NCT01348750|Complementary Medicine|complementary medicine
1356425|NCT01348737|Phase 1|phase 1
1356426|NCT01348737|healthy volunteers|healthy volunteers
1356427|NCT01348737|double-blind|double-blind
1356428|NCT01348737|placebo-controlled|placebo-controlled
1356429|NCT01348737|AZD3839|azd3839
1356430|NCT01348737|pharmacokinetics|pharmacokinetics
1356431|NCT01348737|Alzheimer's Disease|alzheimer's disease
1356432|NCT01348724|Radioactive carbon|radioactive carbon
1356433|NCT01348724|Absorption|absorption
1356434|NCT01348724|Distribution|distribution
1356435|NCT01348724|Metabolism|metabolism
1356436|NCT01348724|Excretion|excretion
1356437|NCT01348724|Healthy Volunteers|healthy volunteers
1356438|NCT01348711|Pre-eclampsia|pre-eclampsia
1356439|NCT01348698|Adrenal Cancer|adrenal cancer
1356440|NCT01348698|Pheochromocytoma|pheochromocytoma
1356441|NCT01348698|Functioning Tumor|functioning tumor
1356442|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
1356443|NCT01348698|Gene Expression|gene expression
1356444|NCT01348698|Adrenal Tumor|adrenal tumor
1356445|NCT01348672|Age related macular degeneration|age related macular degeneration
1356446|NCT01348672|Glaucoma|glaucoma
1356447|NCT01348672|Diabetic retinopathy|diabetic retinopathy
1356448|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
1356449|NCT01348672|Blood flow|blood flow
1356450|NCT01348672|Vascular function|vascular function
1356451|NCT01348672|High resolution imaging|high resolution imaging
1356452|NCT01348659|Hypertonic saline|hypertonic saline
1356453|NCT01348659|Extracellular fluid|extracellular fluid
1356454|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
1356455|NCT01348646|Smoking|smoking
1356456|NCT01348646|Adolescence|adolescence
1356457|NCT01348646|Brief intervention|brief intervention
1356458|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
1356459|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
1356460|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
1356461|NCT01348620|single port cholecystectomy|single port cholecystectomy
1356462|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1356463|NCT01348607|sleep disorders|sleep disorders
1356464|NCT01348607|fatigue|fatigue
1356465|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
1356466|NCT01348594|Vitamin D|vitamin d
1471567|NCT00890656|ALL|all
1356467|NCT01348594|In vitro Fertilization|in vitro fertilization
1356468|NCT01348581|Adult|adult
1356469|NCT01348581|Aged|aged
1356470|NCT01348581|Aged, 80 and over|aged, 80 and over
1356471|NCT01348581|Bandages|bandages
1356472|NCT01348581|Biological Dressings|biological dressings
1356473|NCT01348581|Chronic Disease|chronic disease
1356474|NCT01348581|Collagen|collagen
1356475|NCT01348581|Epithelium|epithelium
1356476|NCT01348581|Extracellular Matrix|extracellular matrix
1356477|NCT01348581|Fibroblasts|fibroblasts
1356478|NCT01348581|Granulation Tissue|granulation tissue
1356479|NCT01348581|Humans|humans
1356480|NCT01348581|Leg Ulcer|leg ulcer
1356481|NCT01348581|Middle Aged|middle aged
1356482|NCT01348581|Prospective Studies|prospective studies
1356483|NCT01348581|Soft Tissue Injuries|soft tissue injuries
1356484|NCT01348581|Treatment Outcome|treatment outcome
1356485|NCT01348581|Varicose Ulcer|varicose ulcer
1356486|NCT01348581|Wound Healing|wound healing
1356487|NCT01348581|Wounds and Injuries|wounds and injuries
1356488|NCT01348555|COPD|copd
1356489|NCT01348542|Chronic Insomnia|chronic insomnia
1356586|NCT01348061|CSF|csf
1356490|NCT01348542|Short Sleep Duration|short sleep duration
1356491|NCT01348542|Trazodone|trazodone
1356492|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
1356493|NCT01348542|Efficacy|efficacy
1356494|NCT01348529|OCD|ocd
1356495|NCT01348529|CBT|cbt
1356496|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
1356497|NCT01348516|HIV|hiv
1356498|NCT01348490|PMF|pmf
1356499|NCT01348490|PPV-MF|ppv-mf
1356500|NCT01348490|PET-MF|pet-mf
1356501|NCT01348477|inguinal|inguinal
1356502|NCT01348477|hernia|hernia
1356503|NCT01348477|pain|pain
1356504|NCT01348477|inguinodynia|inguinodynia
1356505|NCT01348477|mesh|mesh
1356506|NCT01348464|appendectomy|appendectomy
1356507|NCT01348464|appendicitis|appendicitis
1356508|NCT01348464|laparoscopic surgery|laparoscopic surgery
1356509|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
1356510|NCT01348451|ALS|als
1356511|NCT01348438|high risk|high risk
1356512|NCT01348438|surgical valve replacement|surgical valve replacement
1356513|NCT01348425|PAD|pad
1356514|NCT01348412|non resectable metastases|non resectable metastases
1356515|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
1356516|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
1356517|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
1356518|NCT01348386|Potassium hydroxide.|potassium hydroxide.
1356519|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
1356520|NCT01348373|drug eluting stents|drug eluting stents
1356521|NCT01348334|Sling surgery|sling surgery
1356522|NCT01348334|synthetic meshes|synthetic meshes
1356523|NCT01348334|ultrapromesh®|ultrapromesh®
1356524|NCT01348334|mix mesh|mix mesh
1356525|NCT01348334|incontinence|incontinence
1356526|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
1356527|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
1356528|NCT01348308|AIDS-defining events|aids-defining events
1356529|NCT01348308|Immune restoration|immune restoration
1356530|NCT01348295|Mechanical ventilation|mechanical ventilation
1356531|NCT01348295|Children|children
1356532|NCT01348295|Neonates|neonates
1356533|NCT01348295|Pediatric intensive care|pediatric intensive care
1356534|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
1356535|NCT01348282|Controlled Randomized Trial|controlled randomized trial
1356536|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
1356537|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
1356538|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
1356539|NCT01348282|HIV Infection|hiv infection
1356540|NCT01348269|bone marrow edema|bone marrow edema
1356541|NCT01348269|Aclasta|aclasta
1356542|NCT01348256|colorectal carcinoma|colorectal carcinoma
1356543|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
1356544|NCT01348256|adjuvant treatment|adjuvant treatment
1356545|NCT01348256|dendritic cells|dendritic cells
1356546|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
1356547|NCT01348230|Premature labor|premature labor
1356548|NCT01348230|Uromodulin|uromodulin
1356549|NCT01348230|Glycosylation|glycosylation
1356550|NCT01348217|unoperated cancers|unoperated cancers
1356551|NCT01348217|oesophagus|oesophagus
1356552|NCT01348217|radiochemotherapy|radiochemotherapy
1356553|NCT01348217|with and without increased doses|with and without increased doses
1356554|NCT01348204|Cystic Fibrosis|cystic fibrosis
1356555|NCT01348191|Thyrotrophin|thyrotrophin
1356556|NCT01348191|Pregnancy|pregnancy
1356557|NCT01348191|Human myometrium|human myometrium
1356558|NCT01348191|Relaxation|relaxation
1356559|NCT01348191|Contractility|contractility
1356560|NCT01348152|Gastric Emptying|gastric emptying
1356561|NCT01348139|Asthma|asthma
1356562|NCT01348139|patients|patients
1356563|NCT01348139|lung function|lung function
1356564|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1356565|NCT01348126|NSCLC|nsclc
1356566|NCT01348126|Lung cancer|lung cancer
1356567|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
1356568|NCT01348113|alcohol dependence|alcohol dependence
1356569|NCT01348113|Alcohol problem|alcohol problem
1356570|NCT01348100|Schizophrenia|schizophrenia
1356571|NCT01348100|Iloperidone|iloperidone
1356572|NCT01348100|Depot|depot
1356573|NCT01348100|Injection|injection
1356574|NCT01348087|Fragile X Syndrome|fragile x syndrome
1356575|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
1356576|NCT01348087|Genetic Diseases|genetic diseases
1356577|NCT01348087|X-Linked|x-linked
1356578|NCT01348087|Escalante's syndrome|escalante's syndrome
1356579|NCT01348074|warfarin|warfarin
1356580|NCT01348074|surgery|surgery
1356581|NCT01348074|management|management
1356582|NCT01348074|thromboembolism|thromboembolism
1356583|NCT01348074|bleeding|bleeding
1356584|NCT01348061|Alzheimers Disease|alzheimers disease
1356585|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
1356587|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
1356588|NCT01348061|Biomarker|biomarker
1356589|NCT01348061|Heavy Water|heavy water
1356590|NCT01348061|Cargo proteins|cargo proteins
1356591|NCT01348048|palliative care|palliative care
1356592|NCT01348048|end-of-life care|end-of-life care
1356593|NCT01348048|randomized clinical trial|randomized clinical trial
1356594|NCT01348048|quality of life|quality of life
1356595|NCT01348048|needs assessment|needs assessment
1356596|NCT01348048|patient satisfaction|patient satisfaction
1356597|NCT01348048|cost-effectiveness|cost-effectiveness
1356598|NCT01348048|Screening|screening
1356599|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
1356600|NCT01348035|Arginine vasopressin|arginine vasopressin
1356601|NCT01348035|Total Kidney Volume|total kidney volume
1356602|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
1356603|NCT01348009|Gastric cancer|gastric cancer
1356604|NCT01348009|First-line therapy|first-line therapy
1356605|NCT01348009|Tesetaxel|tesetaxel
1356606|NCT01348009|Taxane|taxane
1356607|NCT01348009|Capecitabine|capecitabine
1356608|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
1356609|NCT01348009|Cisplatin|cisplatin
1356610|NCT01348009|Platinum|platinum
1356611|NCT01347996|AML|aml
1356613|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
1356614|NCT01347996|Minimal Residual Disease|minimal residual disease
1356615|NCT01347996|Ceplene|ceplene
1356616|NCT01347996|Histamine|histamine
1356617|NCT01347996|interleukin 2|interleukin 2
1356618|NCT01347983|RA|ra
1356619|NCT01347970|childhood cancer survivor|childhood cancer survivor
1356620|NCT01347970|CHF|chf
1356621|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
1356622|NCT01347944|MORE|more
1356623|NCT01347944|Monitoring Revlimid|monitoring revlimid
1356624|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
1356625|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
1356626|NCT01347944|5q deletion|5q deletion
1356627|NCT01347944|lenalidomide|lenalidomide
1356628|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
1356629|NCT01347892|Talar injury|talar injury
1356630|NCT01347892|ankle|ankle
1356631|NCT01347892|lesion|lesion
1356632|NCT01347892|defect|defect
1356633|NCT01347892|cartilage repair|cartilage repair
1356634|NCT01347879|Acne vulgaris|acne vulgaris
1356635|NCT01347879|PDT|pdt
1356636|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
1356637|NCT01347866|PI3K|pi3k
1356638|NCT01347866|mTOR|mtor
1356639|NCT01347866|MEK|mek
1356640|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
1356641|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
1356642|NCT01347827|Oximetry|oximetry
1356643|NCT01347827|Brain metabolism|brain metabolism
1356644|NCT01347814|Domperidone|domperidone
1356645|NCT01347814|gastric emptying|gastric emptying
1356646|NCT01347814|obesity|obesity
1356647|NCT01347814|diabetes mellitus|diabetes mellitus
1356648|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
1356649|NCT01347814|Pharmacologic Actions|pharmacologic actions
1356650|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
1356651|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
1356652|NCT01347814|Humans|humans
1356653|NCT01347801|GLP-1|glp-1
1356654|NCT01347801|Inflammation|inflammation
1356655|NCT01347801|Glucose|glucose
1356656|NCT01347788|Prostate cancer|prostate cancer
1356657|NCT01347788|Castration Resistant|castration resistant
1356658|NCT01347788|Bone Metastases|bone metastases
1356659|NCT01347775|Renal failure|renal failure
1356660|NCT01347775|Respiratory muscles|respiratory muscles
1356661|NCT01347775|Resistance training|resistance training
1356662|NCT01347762|cannabis dependence|cannabis dependence
1356663|NCT01347762|marijuana dependence|marijuana dependence
1356664|NCT01347762|cannabis use disorders|cannabis use disorders
1356665|NCT01347762|cannabis withdrawal|cannabis withdrawal
1356666|NCT01347762|nabilone|nabilone
1356667|NCT01347749|Meditation|meditation
1356668|NCT01347749|Mindfulness|mindfulness
1356669|NCT01347749|Compassion|compassion
1356670|NCT01347749|Group Psychotherapy|group psychotherapy
1356671|NCT01347749|Emotional Regulation|emotional regulation
1356672|NCT01347749|fMRI|fmri
1356673|NCT01347710|Coronary Artery Disease.|coronary artery disease.
1356674|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
1356675|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
1356676|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
1356677|NCT01347697|rectal neoplasms|rectal neoplasms
1356678|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
1356679|NCT01347697|bioprosthesis|bioprosthesis
1356680|NCT01347697|surgical flaps|surgical flaps
1356681|NCT01347697|locomotion|locomotion
1356682|NCT01347697|lesser pelvis|lesser pelvis
1356683|NCT01347684|headache|headache
1356684|NCT01347684|elavil|elavil
1356685|NCT01347684|splints|splints
1356686|NCT01347684|physical therapy|physical therapy
1356687|NCT01347684|behavioral therapy|behavioral therapy
1356688|NCT01347671|analgesia|analgesia
1356689|NCT01347671|analgesics|analgesics
1356690|NCT01347671|pain|pain
1356691|NCT01347671|chronic pain|chronic pain
1356692|NCT01347671|neuropathic pain|neuropathic pain
1356693|NCT01347658|etravirine|etravirine
1356694|NCT01347658|Echinacea purpurea|echinacea purpurea
1356695|NCT01347658|interaction|interaction
1356696|NCT01347645|locally advanced|locally advanced
1356697|NCT01347645|metastatic colon|metastatic colon
1356698|NCT01347645|rectal cancer|rectal cancer
1356699|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
1356700|NCT01347632|Vaginal discharge|vaginal discharge
1356701|NCT01347632|Vaginal infections|vaginal infections
1356702|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
1356703|NCT01347619|anti-psychotic use|anti-psychotic use
1356704|NCT01347619|Nursing Home|nursing home
1356705|NCT01347619|Long-term care|long-term care
1356706|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
1356707|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
1356708|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
1356710|NCT01347606|secure|secure
1356711|NCT01347606|surgery|surgery
1356712|NCT01347606|methylene|methylene
1356713|NCT01347606|blue|blue
1356714|NCT01347593|ceftizoxime|ceftizoxime
1356715|NCT01347593|Cesarean|cesarean
1356716|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
1356717|NCT01347580|Heart attack|heart attack
1356718|NCT01347580|heart disease|heart disease
1356719|NCT01347580|cardiovascular disease|cardiovascular disease
1356720|NCT01347580|stroke|stroke
1356721|NCT01347580|reperfusion|reperfusion
1356722|NCT01347580|pre hospital settings|pre hospital settings
1356723|NCT01347580|ticagrelor|ticagrelor
1356724|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
1356725|NCT01347567|Fingerstick BNP test|fingerstick bnp test
1356726|NCT01347567|Home Health Management System|home health management system
1356727|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
1356728|NCT01347567|Hospital Readmission|hospital readmission
1356729|NCT01347567|Prevention|prevention
1356730|NCT01347554|drug-eluting stent|drug-eluting stent
1356731|NCT01347554|everolimus|everolimus
1356732|NCT01347554|zotarolimus|zotarolimus
1356733|NCT01347554|myocardial ischemia|myocardial ischemia
1356734|NCT01347554|cardiovascular diseases|cardiovascular diseases
1356735|NCT01347554|MACE|mace
1356736|NCT01347554|safety|safety
1356737|NCT01347541|PTSD|ptsd
1356738|NCT01347528|Medication adherence|medication adherence
1356739|NCT01347528|Heart failure|heart failure
1356740|NCT01347528|Telemonitoring|telemonitoring
1356741|NCT01347528|Determinants of adherence|determinants of adherence
1356742|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
1356743|NCT01347515|bioavailability|bioavailability
1356744|NCT01347515|bioactivity|bioactivity
1356745|NCT01347489|gender|gender
1356746|NCT01347476|prostate-specific antigen|prostate-specific antigen
1356747|NCT01347476|radical prostatectomy|radical prostatectomy
1356748|NCT01347450|Flavonoids|flavonoids
1356749|NCT01347450|cacao|cacao
1356750|NCT01347450|lipid peroxidation|lipid peroxidation
1356751|NCT01347450|plasma|plasma
1356752|NCT01347437|HIV|hiv
1356753|NCT01347437|antiretroviral medication|antiretroviral medication
1356754|NCT01347437|adherence|adherence
1356755|NCT01347437|adolescent|adolescent
1356756|NCT01347424|NSCLC|nsclc
1356757|NCT01347424|NPC|npc
1356758|NCT01347398|Sleep apnoea|sleep apnoea
1356759|NCT01347398|Diagnosis|diagnosis
1356760|NCT01347398|Blood pressure|blood pressure
1356761|NCT01347398|Body mass index|body mass index
1356762|NCT01347398|Breath analysis|breath analysis
1356763|NCT01347385|Fibroids|fibroids
1356764|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
1356765|NCT01347385|Barbed suture|barbed suture
1356766|NCT01347372|peer support|peer support
1356767|NCT01347372|peer mentoring|peer mentoring
1356768|NCT01347372|peer counselling|peer counselling
1356769|NCT01347372|arthritis|arthritis
1356770|NCT01347372|chronic disease|chronic disease
1356771|NCT01347372|inflammatory arthritis|inflammatory arthritis
1356772|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
1356773|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
1356774|NCT01347359|Peer support|peer support
1356775|NCT01347359|Peer mentoring|peer mentoring
1356776|NCT01347359|Peer counselling|peer counselling
1356777|NCT01347359|Arthritis|arthritis
1356778|NCT01347359|Inflammatory arthritis|inflammatory arthritis
1356779|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
1356780|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
1356781|NCT01347359|Chronic disease|chronic disease
1356782|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1356783|NCT01347346|Primary immune deficiency|primary immune deficiency
1356784|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
1356785|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
1356786|NCT01347333|liver metastases|liver metastases
1356787|NCT01347333|stereotactic radiotherapy|stereotactic radiotherapy
1356788|NCT01347320|Prostate cancer|prostate cancer
1356789|NCT01347320|preoperative staging|preoperative staging
1356791|NCT01347320|Free surgical margins|free surgical margins
1356792|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
1356793|NCT01347307|spinal metastases|spinal metastases
1356794|NCT01347307|vertebral metastases|vertebral metastases
1356795|NCT01347307|benign spinal tumors|benign spinal tumors
1356796|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
1356797|NCT01347281|[18F]HX4|[18f]hx4
1356798|NCT01347281|hypoxia|hypoxia
1356799|NCT01347281|PET|pet
1356800|NCT01347281|phase II trial|phase ii trial
1356801|NCT01347268|coasting|coasting
1356802|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
1356803|NCT01347268|GnRH antagonist|gnrh antagonist
1356804|NCT01347268|IVF|ivf
1356805|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1356806|NCT01347242|Primary immune deficiency|primary immune deficiency
1356807|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
1356808|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
1356809|NCT01347229|Glaucoma|glaucoma
1356810|NCT01347229|Triggerfish|triggerfish
1357200|NCT01345721|Boost|boost
1356811|NCT01347229|body position|body position
1356812|NCT01347216|Drug treatment|drug treatment
1356813|NCT01347216|Treatment pathways|treatment pathways
1356814|NCT01347216|Clinical routine|clinical routine
1356815|NCT01347216|Registry|registry
1356816|NCT01347216|Treatment outcomes|treatment outcomes
1356817|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
1356818|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
1356819|NCT01347216|Prostanoid|prostanoid
1356820|NCT01347216|Sildenafil|sildenafil
1356821|NCT01347216|Bosentan|bosentan
1356822|NCT01347216|Macitentan|macitentan
1356823|NCT01347216|Sitaxentan|sitaxentan
1356824|NCT01347216|Ambrisentan|ambrisentan
1356825|NCT01347216|Imatinib|imatinib
1356826|NCT01347216|Epoprostenol|epoprostenol
1356827|NCT01347216|Treprostinil|treprostinil
1356828|NCT01347216|Iloprost|iloprost
1356829|NCT01347216|Infusion pump|infusion pump
1356830|NCT01347216|Riociguat|riociguat
1356831|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
1356832|NCT01347216|Quality of life|quality of life
1356833|NCT01347216|Patient-related outcomes|patient-related outcomes
1356834|NCT01347216|Economic model|economic model
1356835|NCT01347216|Adverse event|adverse event
1356836|NCT01347216|Safety|safety
1356837|NCT01347216|Combination therapy|combination therapy
1356838|NCT01347216|Internet|internet
1356839|NCT01347216|Europe|europe
1356840|NCT01347216|Australia|australia
1356841|NCT01347216|Japan|japan
1356842|NCT01347216|Eisenmenger|eisenmenger
1356843|NCT01347216|Adults|adults
1356844|NCT01347216|Children|children
1356845|NCT01347216|Selexipag|selexipag
1356846|NCT01347203|phase I|phase i
1356847|NCT01347203|healthy volunteers|healthy volunteers
1356848|NCT01347203|crossover study|crossover study
1356849|NCT01347203|pharmacokinetics|pharmacokinetics
1356850|NCT01347203|pharmacodynamics|pharmacodynamics
1356851|NCT01347190|Cystic Fibrosis|cystic fibrosis
1356852|NCT01347164|bisexual|bisexual
1356853|NCT01347164|HIV prevention|hiv prevention
1356854|NCT01347151|Glide scope|glide scope
1356855|NCT01347151|Pentax|pentax
1356856|NCT01347151|C spine movement|c spine movement
1356857|NCT01347138|Screening|screening
1356858|NCT01347138|depression|depression
1356859|NCT01347138|case management|case management
1356860|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
1356861|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
1356862|NCT01347112|smoking|smoking
1356863|NCT01347112|tobacco dependence|tobacco dependence
1356864|NCT01347112|alcohol dependence|alcohol dependence
1356866|NCT01347099|OCD|ocd
1356867|NCT01347099|Internet|internet
1356868|NCT01347099|Reduce symptom burden|reduce symptom burden
1356869|NCT01347073|Urea Cycle Disorder|urea cycle disorder
1356870|NCT01347073|UCD|ucd
1356871|NCT01347073|GT4P|gt4p
1356872|NCT01347073|Buphenyl|buphenyl
1356873|NCT01347073|hyperammonemia|hyperammonemia
1356874|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
1356875|NCT01347060|Asthma|asthma
1356876|NCT01347060|treatment|treatment
1356877|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
1356878|NCT01347060|Medicare|medicare
1356879|NCT01347060|Outcomes|outcomes
1356880|NCT01347060|costs|costs
1356881|NCT01347047|Amyloidosis|amyloidosis
1356882|NCT01347047|Known or Suspected|known or suspected
1356883|NCT01347034|radiation|radiation
1356884|NCT01347034|neoadjuvant|neoadjuvant
1356885|NCT01347034|intratumoral|intratumoral
1356886|NCT01347034|autologous|autologous
1356887|NCT01347034|dendritic cells|dendritic cells
1356888|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
1356889|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
1356890|NCT01347008|Sildenafil|sildenafil
1357170|NCT01345825|gait|gait
1356891|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
1356892|NCT01347008|Laser Doppler Imaging|laser doppler imaging
1356893|NCT01346982|Darunavir|darunavir
1356894|NCT01346982|Silimarine|silimarine
1356895|NCT01346982|interaction|interaction
1356896|NCT01346969|Skin scarring|skin scarring
1356897|NCT01346969|cicatrix|cicatrix
1356898|NCT01346969|breast scar|breast scar
1356899|NCT01346956|Cigarette|cigarette
1356900|NCT01346956|Smoking|smoking
1356901|NCT01346956|Cardiovascular Effects|cardiovascular effects
1356902|NCT01346956|2D Echocardiography|2d echocardiography
1356903|NCT01346956|Doppler|doppler
1356904|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
1356905|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1356906|NCT01346930|IPF|ipf
1356907|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
1356908|NCT01346917|Colorectal cancer|colorectal cancer
1356909|NCT01346917|Laparoscopic surgery|laparoscopic surgery
1356910|NCT01346917|Postoperative ileus|postoperative ileus
1356911|NCT01346917|Lidocaine|lidocaine
1356912|NCT01346917|Early oral feeding|early oral feeding
1356913|NCT01346878|Ultra deep sequencing|ultra deep sequencing
1356914|NCT01346878|Virological failure|virological failure
1356915|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
1356916|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
1356917|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
1356918|NCT01346865|DES|des
1356919|NCT01346865|Coronary Artery Disease|coronary artery disease
1356920|NCT01346852|pediatrics|pediatrics
1356921|NCT01346852|Medicaid|medicaid
1356922|NCT01346852|asthma|asthma
1356923|NCT01346852|outcomes|outcomes
1356924|NCT01346852|asthma medication ratio|asthma medication ratio
1356925|NCT01346839|Diagnostic delay|diagnostic delay
1356926|NCT01346839|Prevention|prevention
1356927|NCT01346839|Diagnostic errors|diagnostic errors
1356928|NCT01346826|Crohn's disease|crohn's disease
1356929|NCT01346826|Ulcerative colitis|ulcerative colitis
1356930|NCT01346826|Infliximab|infliximab
1356931|NCT01346826|Infusion reaction|infusion reaction
1356932|NCT01346813|Newborns|newborns
1356933|NCT01346813|Premature|premature
1356934|NCT01346813|Pain|pain
1356935|NCT01346813|Pain assessment|pain assessment
1356936|NCT01346813|Painful Procedures|painful procedures
1356937|NCT01346813|Stressful Procedures|stressful procedures
1356938|NCT01346813|Endotracheal Intubation|endotracheal intubation
1356939|NCT01346813|Analgesia|analgesia
1356940|NCT01346813|Sedation|sedation
1356941|NCT01346813|Longterm effects of pain|longterm effects of pain
1356942|NCT01346813|Epidemiology|epidemiology
1356943|NCT01346787|carfilzomib|carfilzomib
1356944|NCT01346787|dexamethasone|dexamethasone
1356945|NCT01346787|cyclophosphamide|cyclophosphamide
1356946|NCT01346787|multiple myeloma|multiple myeloma
1356947|NCT01346787|newly diagnosed|newly diagnosed
1356948|NCT01346774|cystitis|cystitis
1356949|NCT01346774|pyelonephritis|pyelonephritis
1356950|NCT01346774|bladder infection|bladder infection
1356951|NCT01346774|kidney infection|kidney infection
1356952|NCT01346761|Genetic Counseling|genetic counseling
1356953|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
1356954|NCT01346761|Genetic Testing|genetic testing
1356955|NCT01346761|BRCA1 gene|brca1 gene
1356956|NCT01346761|BRCA2 gene|brca2 gene
1356957|NCT01346761|Risk Communication|risk communication
1356958|NCT01346748|vasospasm prevention|vasospasm prevention
1356959|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
1356960|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
1356961|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
1356962|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
1356963|NCT01346735|India|india
1356964|NCT01346709|Operative surgical procedures|operative surgical procedures
1356965|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
1356966|NCT01346709|Epidemiological Study|epidemiological study
1356967|NCT01346709|ARISCAT score|ariscat score
1356968|NCT01346709|Risk Score|risk score
1356969|NCT01346709|Europe|europe
1356970|NCT01346709|PERISCOPE|periscope
1356971|NCT01346709|observational study|observational study
1356972|NCT01346709|Mild respiratory failure|mild respiratory failure
1356973|NCT01346709|Severe respiratory failure|severe respiratory failure
1356974|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
1356975|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1356976|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
1356977|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
1356978|NCT01346709|Pleural effusion|pleural effusion
1356979|NCT01346709|Atelectasis|atelectasis
1356980|NCT01346709|Pneumothorax|pneumothorax
1356981|NCT01346709|Bronchospasm|bronchospasm
1356982|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
1356983|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
1356984|NCT01346709|Prospective Evaluation|prospective evaluation
1356985|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
1357102|NCT01346241|Anxiety|anxiety
1357173|NCT01345812|ART|art
1356986|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
1356987|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
1356988|NCT01346670|Red yeast rice|red yeast rice
1356989|NCT01346670|Lovastatin|lovastatin
1356990|NCT01346670|Bioavailability|bioavailability
1356991|NCT01346657|Nifidipine|nifidipine
1356992|NCT01346657|red yeast rice|red yeast rice
1356993|NCT01346657|drug-drug interaction|drug-drug interaction
1356994|NCT01346644|Probiotic|probiotic
1356995|NCT01346644|infant nutrition|infant nutrition
1356996|NCT01346644|safety|safety
1356997|NCT01346644|infections|infections
1356998|NCT01346618|bone age|bone age
1356999|NCT01346618|children|children
1357000|NCT01346618|x-ray|x-ray
1357001|NCT01346618|ultrasound|ultrasound
1357002|NCT01346618|ultrasound based method|ultrasound based method
1357003|NCT01346618|safe|safe
1357004|NCT01346618|valid|valid
1357005|NCT01346618|reproducable|reproducable
1357006|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
1357007|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
1357008|NCT01346592|vaccine|vaccine
1357009|NCT01346592|influenza|influenza
1357010|NCT01346592|adjuvant|adjuvant
1357011|NCT01346592|MF-59|mf-59
1357012|NCT01346592|pediatric|pediatric
1357013|NCT01346579|stage IA breast cancer|stage ia breast cancer
1357014|NCT01346579|stage IB breast cancer|stage ib breast cancer
1357015|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1357016|NCT01346566|Cionni Ring|cionni ring
1357017|NCT01346566|In-the-bag IOL|in-the-bag iol
1357018|NCT01346566|Subluxated lenses|subluxated lenses
1357019|NCT01346566|Intraoperative Performance|intraoperative performance
1357020|NCT01346566|Postoperative Outcome|postoperative outcome
1357021|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
1357022|NCT01346527|diabetes|diabetes
1357023|NCT01346527|pregnancy|pregnancy
1357024|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
1357025|NCT01346527|neonatal|neonatal
1357026|NCT01346527|lipid|lipid
1357027|NCT01346527|lipotoxicity|lipotoxicity
1357028|NCT01346527|neurodevelopment|neurodevelopment
1357029|NCT01346514|Homeless Persons|homeless persons
1357030|NCT01346514|Housing|housing
1357031|NCT01346514|Case Management|case management
1357032|NCT01346514|Veterans|veterans
1357033|NCT01346514|Substance Related Disorders|substance related disorders
1357034|NCT01346514|Mental Disorders|mental disorders
1357035|NCT01346514|Social Adjustment|social adjustment
1357036|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
1357037|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
1357038|NCT01346449|Obesity|obesity
1357039|NCT01346423|Sick leave|sick leave
1357040|NCT01346423|musculoskeletal pain|musculoskeletal pain
1357041|NCT01346423|return to work|return to work
1357042|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
1357043|NCT01346423|randomised controlled trial|randomised controlled trial
1357044|NCT01346410|pancreatic cancer|pancreatic cancer
1357045|NCT01346397|rejection|rejection
1357046|NCT01346397|survival|survival
1357047|NCT01346397|alemtuzumab|alemtuzumab
1357048|NCT01346397|cyclosporine|cyclosporine
1357049|NCT01346397|tacrolimus|tacrolimus
1357050|NCT01346384|intracuff pressure|intracuff pressure
1357051|NCT01346384|laryngeal tube|laryngeal tube
1357052|NCT01346384|nitrous oxide|nitrous oxide
1357053|NCT01346371|Allergic|allergic
1357054|NCT01346371|conjunctivitis|conjunctivitis
1357055|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
1357056|NCT01346358|Advanced Solid Tumors|advanced solid tumors
1357057|NCT01346345|Recession|recession
1357058|NCT01346319|dose escalating|dose escalating
1357059|NCT01346293|Tetanus|tetanus
1357060|NCT01346293|Diphtheria|diphtheria
1357061|NCT01346293|Pertussis|pertussis
1357062|NCT01346293|DTap-IPV|dtap-ipv
1357063|NCT01346293|DAPTACEL®|daptacel®
1357064|NCT01346293|VARIVAX®|varivax®
1357065|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
1357066|NCT01346280|Multidisciplinary Care|multidisciplinary care
1357067|NCT01346280|Patient Experiences|patient experiences
1357068|NCT01346280|Quality of Care Outcomes|quality of care outcomes
1357069|NCT01346267|nausea and vomiting|nausea and vomiting
1357070|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
1357071|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1357072|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1357073|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
1357074|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1357075|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
1357076|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1357077|NCT01346267|childhood mixed glioma|childhood mixed glioma
1357078|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
1357079|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1357171|NCT01345825|physiotherapy|physiotherapy
1357172|NCT01345825|Gyro sensor|gyro sensor
1357080|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1357081|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1357082|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1357083|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1357084|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1357085|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1357086|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1357087|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
1357088|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
1357089|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
1357090|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1357091|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1357092|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
1357093|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
1357094|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1357095|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1357096|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
1357097|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1357098|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1357099|NCT01346267|childhood meningioma|childhood meningioma
1357100|NCT01346254|after|after
1357101|NCT01346241|Panic|panic
1357103|NCT01346228|Panic|panic
1357104|NCT01346228|Panic Disorder|panic disorder
1357105|NCT01346228|Anxiety|anxiety
1357106|NCT01346215|heparin|heparin
1357107|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
1357108|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
1357109|NCT01346215|fibrinolytic agents|fibrinolytic agents
1357110|NCT01346215|anticoagulants|anticoagulants
1357111|NCT01346215|aPTT|aptt
1357112|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
1357113|NCT01346189|Cardiovascular Disease|cardiovascular disease
1357114|NCT01346163|Schizophrenia|schizophrenia
1357115|NCT01346163|Cognitive Impairment|cognitive impairment
1357116|NCT01346163|Electrophysiology|electrophysiology
1357117|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
1357118|NCT01346137|ovulation|ovulation
1357119|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
1357120|NCT01346137|meloxicam|meloxicam
1357121|NCT01346124|radiation|radiation
1357122|NCT01346124|IMRT|imrt
1357123|NCT01346124|IMPT|impt
1357124|NCT01346098|diabetes|diabetes
1357125|NCT01346098|islet transplantation|islet transplantation
1357126|NCT01346098|pancreas|pancreas
1357127|NCT01346098|pancreatectomy|pancreatectomy
1357128|NCT01346085|islet transplantation|islet transplantation
1357129|NCT01346085|brittle diabetes|brittle diabetes
1357130|NCT01346085|type 1 diabetes|type 1 diabetes
1357131|NCT01346072|tolvaptan|tolvaptan
1357132|NCT01346072|copeptin|copeptin
1357133|NCT01346072|heart failure|heart failure
1357134|NCT01346072|vasopressin antagonist|vasopressin antagonist
1357135|NCT01346059|Clostridium|clostridium
1357136|NCT01346059|Colitis|colitis
1357137|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
1357138|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
1357139|NCT01346046|Type 2 Diabetes|type 2 diabetes
1357140|NCT01346046|Adults 18 years and older|adults 18 years and older
1357141|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
1357142|NCT01346033|Type 2 Diabetes|type 2 diabetes
1357143|NCT01346033|Adults 18 years and older|adults 18 years and older
1357144|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
1357145|NCT01345968|anemia|anemia
1357146|NCT01345968|transfusion|transfusion
1357147|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
1357148|NCT01345929|cUTI|cuti
1357149|NCT01345890|swallowing|swallowing
1357150|NCT01345890|stroke|stroke
1357151|NCT01345890|aspiration|aspiration
1357152|NCT01345890|human|human
1357153|NCT01345890|electrical stimulation|electrical stimulation
1357154|NCT01345890|post stroke dysphagia|post stroke dysphagia
1357155|NCT01345877|burn injury|burn injury
1357156|NCT01345877|cold pressor test|cold pressor test
1357157|NCT01345877|gender|gender
1357158|NCT01345877|pain|pain
1357159|NCT01345877|pain sensitivity|pain sensitivity
1357160|NCT01345877|pain prediction|pain prediction
1357161|NCT01345877|psychometrics|psychometrics
1357162|NCT01345877|quantitative sensory testing|quantitative sensory testing
1357163|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
1357164|NCT01345825|osteoarthrosis|osteoarthrosis
1357165|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
1357166|NCT01345825|knee|knee
1357167|NCT01345825|resistance training|resistance training
1357168|NCT01345825|Muscle power|muscle power
1357169|NCT01345825|gait analysis|gait analysis
1357174|NCT01345812|IVF|ivf
1357175|NCT01345812|Timelapse|timelapse
1357176|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
1357177|NCT01345799|Crohn's Disease|crohn's disease
1357178|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
1357179|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
1357180|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
1357181|NCT01345760|Actinic Keratosis|actinic keratosis
1357182|NCT01345760|microRNA|microrna
1357183|NCT01345760|Dicer|dicer
1357184|NCT01345760|Drosha|drosha
1357185|NCT01345760|RISC|risc
1357186|NCT01345760|microprocessor complex|microprocessor complex
1357187|NCT01345760|Argonaute|argonaute
1357188|NCT01345760|DGCR8|dgcr8
1357189|NCT01345760|TARBP|tarbp
1357190|NCT01345747|laryngeal tube suction|laryngeal tube suction
1357191|NCT01345747|gynecology|gynecology
1357192|NCT01345747|laparoscopic surgery|laparoscopic surgery
1357193|NCT01345721|Meningococcal|meningococcal
1357194|NCT01345721|ACWY|acwy
1357195|NCT01345721|Conjugate Vaccine|conjugate vaccine
1357196|NCT01345721|Meningitis|meningitis
1357197|NCT01345721|Toddlers|toddlers
1357198|NCT01345721|Children|children
1357199|NCT01345721|Persistence|persistence
1357201|NCT01345708|Low dose rituximab|low dose rituximab
1357202|NCT01345708|WAIHA|waiha
1357203|NCT01345708|CHD|chd
1357204|NCT01345695|Childhood diarrhea|childhood diarrhea
1357205|NCT01345695|childhood pneumonia|childhood pneumonia
1357206|NCT01345695|telemedicine|telemedicine
1357207|NCT01345695|cluster|cluster
1357208|NCT01345695|treatment-control trial|treatment-control trial
1357209|NCT01345656|Chronic Heart Failure|chronic heart failure
1357210|NCT01345643|Transfusion|transfusion
1357211|NCT01345643|Hemoglobin level|hemoglobin level
1357212|NCT01345630|Double-blind|double-blind
1357213|NCT01345630|comparative|comparative
1357214|NCT01345630|trial|trial
1357215|NCT01345630|maraviroc|maraviroc
1357216|NCT01345630|versus|versus
1357217|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
1357218|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
1357219|NCT01345630|antiretroviral-naive|antiretroviral-naive
1357220|NCT01345630|Ccr5 tropic|ccr5 tropic
1357221|NCT01345630|Hiv 1|hiv 1
1357222|NCT01345630|patients.|patients.
1357223|NCT01345591|BTI|bti
1357224|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
1357225|NCT01345591|Facial Trauma|facial trauma
1357226|NCT01345591|Fat Grafts|fat grafts
1357227|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
1357228|NCT01345591|Wounded warriors|wounded warriors
1357229|NCT01345578|Urea Cycle Disorders|urea cycle disorders
1357230|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
1357231|NCT01345578|Citrullinemia|citrullinemia
1357232|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
1357233|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
1357234|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
1357235|NCT01345552|Oligo mets|oligo mets
1357236|NCT01345552|Oligometastatic disease|oligometastatic disease
1357237|NCT01345539|Oligo mets|oligo mets
1357238|NCT01345539|Oligometastatic disease|oligometastatic disease
1357239|NCT01345513|Genomic Analysis|genomic analysis
1357240|NCT01345513|Sequencing|sequencing
1357241|NCT01345513|Genetic|genetic
1357242|NCT01345513|Biopsy|biopsy
1357243|NCT01345513|Solid tumors|solid tumors
1357244|NCT01345500|Overweight|overweight
1357245|NCT01345500|Obese|obese
1357246|NCT01345500|Type 2 Diabetic|type 2 diabetic
1357247|NCT01345500|Diabetes|diabetes
1357248|NCT01345500|Weight loss|weight loss
1357249|NCT01345500|Physical activity|physical activity
1357250|NCT01345500|Diet|diet
1357251|NCT01345500|Prepackaged meals|prepackaged meals
1357252|NCT01345487|appetite|appetite
1357253|NCT01345487|protein|protein
1357254|NCT01345487|legumes|legumes
1357255|NCT01345487|meat|meat
1357256|NCT01345448|Glaucoma|glaucoma
1357257|NCT01345448|Brimonidine|brimonidine
1357258|NCT01345448|Transdermal|transdermal
1357259|NCT01345435|telemonitoring|telemonitoring
1357260|NCT01345435|usual care|usual care
1357261|NCT01345435|telemedicine|telemedicine
1357262|NCT01345435|telehealth|telehealth
1357263|NCT01345435|home care|home care
1357264|NCT01345435|Health Care Quality|health care quality
1357265|NCT01345435|Access|access
1357266|NCT01345435|Evaluation|evaluation
1357267|NCT01345409|Musculoskeletal pain|musculoskeletal pain
1357268|NCT01345409|Chronic pain|chronic pain
1357269|NCT01345409|Acupuncture|acupuncture
1357270|NCT01345409|Chiropractic|chiropractic
1357271|NCT01345396|Asthma|asthma
1357272|NCT01345396|Health education|health education
1357273|NCT01345396|Pregnancy|pregnancy
1357274|NCT01345383|smoking|smoking
1357275|NCT01345383|bronchoscopy|bronchoscopy
1357276|NCT01345383|cough|cough
1357277|NCT01345370|Glioblastoma|glioblastoma
1357278|NCT01345357|Solid tumors|solid tumors
1357279|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
1357280|NCT01345357|Gemcitabine|gemcitabine
1357281|NCT01345357|Cisplatin|cisplatin
1357282|NCT01345357|Cancer|cancer
1357283|NCT01345357|Neoplasms|neoplasms
1357284|NCT01345357|Antineoplastic agents|antineoplastic agents
1357285|NCT01345318|Crohn's Disease|crohn's disease
1357286|NCT01345318|safety|safety
1357287|NCT01345318|efficacy|efficacy
1357288|NCT01345318|pharmacokinetics|pharmacokinetics
1357289|NCT01345318|pharmacodynamics|pharmacodynamics
1357290|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
1357291|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
1357292|NCT01345305|Biomarkers|biomarkers
1357293|NCT01345305|Quantitative EEG|quantitative eeg
1357294|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
1357295|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
1357296|NCT01345305|Optical Coherence Tomography|optical coherence tomography
1357297|NCT01345266|Pharyngometry|pharyngometry
1357298|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
1357299|NCT01345266|HRCT|hrct
1357300|NCT01345266|Inhalation Profiles|inhalation profiles
1357301|NCT01345253|SLEDAI|sledai
1357302|NCT01345253|Asia|asia
1357303|NCT01345253|placebo|placebo
1357304|NCT01345253|BLys|blys
1357305|NCT01345253|PGA|pga
1357306|NCT01345253|BILAG|bilag
1357307|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
1357308|NCT01345253|SELENA|selena
1357309|NCT01345253|Lupus|lupus
1357310|NCT01345253|SRI|sri
1357311|NCT01345253|efficacy|efficacy
1357312|NCT01345253|B cell|b cell
1357313|NCT01345253|SLE Flare Index|sle flare index
1357314|NCT01345253|belimumab|belimumab
1357315|NCT01345253|safety|safety
1357316|NCT01345253|phase III|phase iii
1357317|NCT01345253|B lymphocyte|b lymphocyte
1357318|NCT01345240|Africa|africa
1357319|NCT01345240|Plasmodium falciparum|plasmodium falciparum
1357320|NCT01345240|Malaria vaccine|malaria vaccine
1357321|NCT01345240|hepatitis B|hepatitis b
1357322|NCT01345240|EPI|epi
1357323|NCT01345227|Type 1 diabetes|type 1 diabetes
1357324|NCT01345227|islet transplantation|islet transplantation
1357325|NCT01345227|autotransplantation|autotransplantation
1357326|NCT01345214|ONO-7746|ono-7746
1357327|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
1357328|NCT01345214|Thrombocytopenia|thrombocytopenia
1357329|NCT01345201|Phase 1|phase 1
1357330|NCT01345201|dose escalation|dose escalation
1357331|NCT01345201|histologically confirmed|histologically confirmed
1357332|NCT01345201|malignancy metastatic|malignancy metastatic
1357333|NCT01345175|rectal|rectal
1357334|NCT01345175|colon|colon
1357335|NCT01345175|PLACEBO|placebo
1357336|NCT01345175|RIFAXIMIN|rifaximin
1357337|NCT01345175|metronidazole|metronidazole
1357338|NCT01345175|11-045|11-045
1357339|NCT01345162|Herniotomy|herniotomy
1357340|NCT01345149|Obesity|obesity
1357341|NCT01345149|Pregnancy|pregnancy
1357342|NCT01345149|Intervention|intervention
1357343|NCT01345149|Diet|diet
1357344|NCT01345149|Physical activity|physical activity
1357345|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
1357346|NCT01345136|Vestibular schwannoma|vestibular schwannoma
1357347|NCT01345136|Hearing|hearing
1357348|NCT01345110|dementia|dementia
1357349|NCT01345110|mild cognitive impairment|mild cognitive impairment
1357350|NCT01345110|prevalence|prevalence
1357351|NCT01345110|incidence|incidence
1357352|NCT01345110|elderly|elderly
1357353|NCT01345110|longitudinal study|longitudinal study
1357354|NCT01345110|population study|population study
1357355|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
1357356|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
1357357|NCT01345097|young patient|young patient
1357358|NCT01345097|elderly patient|elderly patient
1357359|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
1357360|NCT01345071|Pregnancy|pregnancy
1357361|NCT01345071|Anti-TNF|anti-tnf
1357362|NCT01345071|Preconceptional counselling|preconceptional counselling
1357363|NCT01345071|Disease activity|disease activity
1357364|NCT01345058|Epilepsy|epilepsy
1357365|NCT01345058|antiepileptic drug|antiepileptic drug
1357366|NCT01345058|polytherapy|polytherapy
1357367|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
1357368|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
1357369|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
1357370|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
1357371|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
1357372|NCT01345045|Mononeuropathy|mononeuropathy
1357373|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
1357374|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
1357375|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
1357376|NCT01345045|Painful|painful
1357377|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
1357378|NCT01345045|Neuralgia|neuralgia
1357379|NCT01345019|zoledronic acid|zoledronic acid
1357380|NCT01345019|hematologic malignancies|hematologic malignancies
1357382|NCT01345019|skeletal-related event|skeletal-related event
1357383|NCT01345019|blood cancer|blood cancer
1357384|NCT01345019|lytic bone lesions|lytic bone lesions
1357385|NCT01345019|bone metastases|bone metastases
1357386|NCT01345019|myeloma|myeloma
1357387|NCT01345019|fractures|fractures
1357388|NCT01345019|spinal cord compression|spinal cord compression
1357389|NCT01345019|radiation to bone|radiation to bone
1357390|NCT01345019|surgery to bone|surgery to bone
1357391|NCT01345019|bisphosphonates|bisphosphonates
1357392|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
1357393|NCT01345019|Paraproteinemias|paraproteinemias
1357394|NCT01345019|Neoplasms|neoplasms
1357395|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
1357396|NCT01345019|Bone Neoplasms|bone neoplasms
1357397|NCT01345019|Bone Marrow Diseases|bone marrow diseases
1357398|NCT01345019|Blood Protein Disorders|blood protein disorders
1357399|NCT01345019|Hematologic Diseases|hematologic diseases
1357400|NCT01345019|multiple myeloma|multiple myeloma
1357401|NCT01345019|denosumab|denosumab
1357402|NCT01345019|Neoplastic Processes|neoplastic processes
1357403|NCT01345019|Bone Diseases|bone diseases
1357404|NCT01345019|Diphosphonates|diphosphonates
1357405|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
1357406|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
1357407|NCT01345006|SMD|smd
1357505|NCT01344512|Ceftazidime|ceftazidime
1357408|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
1357409|NCT01344993|Dry AMD|dry amd
1357410|NCT01344993|Geographic atrophy|geographic atrophy
1357411|NCT01344941|Vaccine response|vaccine response
1357412|NCT01344941|Human Lymphocytes|human lymphocytes
1357413|NCT01344915|Patella|patella
1357414|NCT01344915|Knee|knee
1357415|NCT01344915|Brace|brace
1357416|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
1357417|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
1357418|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
1357419|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
1357420|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
1357421|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1357422|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1357423|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1357424|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
1357425|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1357426|NCT01344824|large cell lung cancer|large cell lung cancer
1357427|NCT01344811|telemonitoring|telemonitoring
1357428|NCT01344811|usual care|usual care
1357429|NCT01344811|telehealth|telehealth
1357430|NCT01344811|home care|home care
1357431|NCT01344811|Health Care Quality|health care quality
1357432|NCT01344811|Access|access
1357433|NCT01344811|Evaluation|evaluation
1357434|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
1357435|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
1357436|NCT01344798|gene therapy|gene therapy
1357437|NCT01344798|AAV vector|aav vector
1357438|NCT01344798|neuromuscular disease|neuromuscular disease
1357439|NCT01344798|orphan disease|orphan disease
1357440|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
1357441|NCT01344785|Intramedullary nailing|intramedullary nailing
1357442|NCT01344785|Hip function|hip function
1357443|NCT01344785|Pain|pain
1357444|NCT01344772|femoral neck fracture|femoral neck fracture
1357445|NCT01344772|total hip arthroplasty|total hip arthroplasty
1357446|NCT01344772|internal fixation|internal fixation
1357447|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
1357448|NCT01344759|MRI|mri
1357449|NCT01344759|Pediatrics|pediatrics
1357450|NCT01344759|Dexmedetomidine|dexmedetomidine
1357451|NCT01344759|Propofol|propofol
1357452|NCT01344759|Anesthesia|anesthesia
1357453|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
1357454|NCT01344733|Major Depressive Disorder|major depressive disorder
1357455|NCT01344733|MDD|mdd
1357456|NCT01344720|Low Back Pain|low back pain
1357457|NCT01344720|Etoricoxib|etoricoxib
1357458|NCT01344720|Oxycodone|oxycodone
1357459|NCT01344707|Hematologic Malignancies|hematologic malignancies
1357460|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1357461|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1357462|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1357463|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
1357464|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1357465|NCT01344707|Malignant Lymphomas|malignant lymphomas
1357466|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
1357467|NCT01344707|4SC-202|4sc-202
1357468|NCT01344707|Phase I|phase i
1357469|NCT01344694|Epicardial fat|epicardial fat
1357470|NCT01344694|Visceral fat|visceral fat
1357471|NCT01344694|atherosclerosis|atherosclerosis
1357472|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
1357473|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
1357474|NCT01344668|Diabetes|diabetes
1357475|NCT01344642|HIV|hiv
1357476|NCT01344642|RNA|rna
1357477|NCT01344616|computer-based behavioral support|computer-based behavioral support
1357478|NCT01344603|cardiac surgery|cardiac surgery
1357479|NCT01344603|cardiac anesthesia|cardiac anesthesia
1357480|NCT01344603|epidural|epidural
1357481|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
1357482|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
1357483|NCT01344577|socket preservation|socket preservation
1357484|NCT01344577|porcine biomaterial|porcine biomaterial
1357485|NCT01344564|Prostate cancer|prostate cancer
1357486|NCT01344564|Hormone therapy|hormone therapy
1357487|NCT01344564|Testosterone measures|testosterone measures
1357488|NCT01344538|ginger|ginger
1357489|NCT01344538|Zingiber officinale|zingiber officinale
1357490|NCT01344538|Cancer Risk Reductive|cancer risk reductive
1357491|NCT01344538|Eicosanoids|eicosanoids
1357492|NCT01344538|Colorectal Cancer|colorectal cancer
1357493|NCT01344538|Inflammation|inflammation
1357494|NCT01344525|obesity therapy|obesity therapy
1357495|NCT01344525|metabolic syndrome|metabolic syndrome
1357496|NCT01344525|gastrointestinal tract|gastrointestinal tract
1357497|NCT01344525|microbiota|microbiota
1357498|NCT01344525|metabolomics|metabolomics
1357499|NCT01344525|micronutrients|micronutrients
1357500|NCT01344525|outcome|outcome
1357501|NCT01344525|sustainability|sustainability
1357502|NCT01344512|Pharmacokinetic|pharmacokinetic
1357503|NCT01344512|Population|population
1357504|NCT01344512|Children|children
1357506|NCT01344512|Ciprofloxacin|ciprofloxacin
1357507|NCT01344512|Voriconazole|voriconazole
1357508|NCT01344512|Pediatric|pediatric
1357509|NCT01344499|women|women
1357510|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
1357511|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
1357512|NCT01344473|Remineralisation|remineralisation
1357513|NCT01344473|White Spot Lesions|white spot lesions
1357514|NCT01344473|Orthodontic treatment|orthodontic treatment
1357515|NCT01344473|Tooth Mousse creme|tooth mousse creme
1357516|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
1357517|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
1357518|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
1357519|NCT01344447|MRA|mra
1357520|NCT01344447|CTA|cta
1357521|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
1357522|NCT01344447|Stroke|stroke
1357523|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
1357524|NCT01344421|Movement capture system|movement capture system
1357525|NCT01344421|Movement analysis|movement analysis
1357526|NCT01344421|Hip dysplasia|hip dysplasia
1357527|NCT01344421|Hip pain|hip pain
1357528|NCT01344421|Quality of life|quality of life
1357529|NCT01344421|Physical function|physical function
1357530|NCT01344408|Dizziness|dizziness
1357531|NCT01344408|rehabilitation|rehabilitation
1357532|NCT01344408|geriatric|geriatric
1357533|NCT01344408|IT-technology|it-technology
1357534|NCT01344382|Adolescent|adolescent
1357535|NCT01344382|Parent|parent
1357536|NCT01344382|Substance Abuse|substance abuse
1357537|NCT01344382|Parent Training|parent training
1357538|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
1357539|NCT01344382|CRAFT|craft
1357540|NCT01344382|Community Reinforcement Approach|community reinforcement approach
1357541|NCT01344382|Addiction|addiction
1472876|NCT00885729|knee|knee
1357542|NCT01344382|Family Intervention|family intervention
1357543|NCT01344369|Healthy Subjects|healthy subjects
1357544|NCT01344369|Bioequivalence|bioequivalence
1357545|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
1357546|NCT01344356|head and neck tumors|head and neck tumors
1357547|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1357548|NCT01344330|Colon cancer|colon cancer
1357549|NCT01344330|Prevention|prevention
1357550|NCT01344330|Cruciferous vegetables|cruciferous vegetables
1357551|NCT01344330|Histone status|histone status
1357552|NCT01344304|aprepitant therapy|aprepitant therapy
1357553|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
1357554|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
1357555|NCT01344304|dexamethasone|dexamethasone
1357556|NCT01344304|colorectal cancer|colorectal cancer
1357557|NCT01344304|FOLFOX|folfox
1357558|NCT01344304|XELOX|xelox
1357559|NCT01344304|SOX|sox
1357560|NCT01344291|hyperprolactinoma|hyperprolactinoma
1357561|NCT01344291|turmeric|turmeric
1357562|NCT01344291|amenorrhea|amenorrhea
1357563|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
1357564|NCT01344265|global end diastolic volume|global end diastolic volume
1357565|NCT01344239|aortic aneurysm|aortic aneurysm
1357566|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
1357567|NCT01344239|preconditioning|preconditioning
1357568|NCT01344239|pulmonary injury|pulmonary injury
1357569|NCT01344239|intestinal injury|intestinal injury
1357570|NCT01344226|steroid responder|steroid responder
1357571|NCT01344213|Pregabalin|pregabalin
1357572|NCT01344213|Celecoxib|celecoxib
1357573|NCT01344213|Intrathecal morphine|intrathecal morphine
1357574|NCT01344213|Total knee arthroplasty|total knee arthroplasty
1357575|NCT01344200|Pharmacokinetics|pharmacokinetics
1357576|NCT01344200|Celecoxib|celecoxib
1357577|NCT01344200|Pediatric|pediatric
1357578|NCT01344200|Peds QL|peds ql
1357579|NCT01344200|CYP2C9|cyp2c9
1357580|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
1357581|NCT01344174|HBV|hbv
1357582|NCT01344174|Dexamethasone|dexamethasone
1357583|NCT01344174|Prognosis|prognosis
1357584|NCT01344161|Vitamin D|vitamin d
1357585|NCT01344161|Metabolic profile|metabolic profile
1357586|NCT01344161|Overweight|overweight
1357587|NCT01344161|Obesity|obesity
1357588|NCT01344148|Anti- TB|anti- tb
1357589|NCT01344148|HAART|haart
1357590|NCT01344148|choice of the right moment|choice of the right moment
1357591|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1357592|NCT01344135|Muscular Atrophy|muscular atrophy
1357593|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
1357594|NCT01344135|Counselling|counselling
1357595|NCT01344096|Gaucher disease|gaucher disease
1357596|NCT01344096|Thrombocytopathy|thrombocytopathy
1357597|NCT01344096|Imiglucerase|imiglucerase
1357598|NCT01344070|innovator formulations|innovator formulations
1357599|NCT01344070|generic formulations|generic formulations
1357600|NCT01344070|bioequivalence|bioequivalence
1357601|NCT01344070|interchangeability|interchangeability
1357602|NCT01344070|inter-patch variation|inter-patch variation
1357603|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
1357604|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
1357605|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
1357606|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
1357607|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
1357608|NCT01344044|Brain-Computer Interface|brain-computer interface
1357609|NCT01344018|adult angiosarcoma|adult angiosarcoma
1357610|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
1357611|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
1357612|NCT01344018|adult liposarcoma|adult liposarcoma
1357613|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1357614|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
1357615|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1357616|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1357617|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1357618|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
1357619|NCT01344005|small cell lung cancer|small cell lung cancer
1357620|NCT01344005|tobacco use disorder|tobacco use disorder
1357621|NCT01343992|Embryo transfer|embryo transfer
1357622|NCT01343992|Implantation rate|implantation rate
1357623|NCT01343992|Pregnancy rate|pregnancy rate
1357624|NCT01343992|bedrest|bedrest
1357625|NCT01343992|neutral|neutral
1357626|NCT01343992|benevolent|benevolent
1357627|NCT01343992|deterious|deterious
1357628|NCT01343992|implantation|implantation
1357629|NCT01343992|gestation rates|gestation rates
1357630|NCT01343953|severe aplastic anemia|severe aplastic anemia
1357631|NCT01343953|cord blood transplantation|cord blood transplantation
1357632|NCT01343940|RCT|rct
1357633|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
1357634|NCT01343940|efficacy trial|efficacy trial
1357635|NCT01343940|high risk population|high risk population
1357636|NCT01343927|Chronic low back pain|chronic low back pain
1357637|NCT01343927|Community health center|community health center
1357638|NCT01343927|Yoga|yoga
1357639|NCT01343927|Physical therapy|physical therapy
1357640|NCT01343927|Minority populations|minority populations
1357641|NCT01343927|Health education|health education
1357642|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
1357643|NCT01343862|brain contusion|brain contusion
1357644|NCT01343849|breast cancer|breast cancer
1357645|NCT01343849|auto antibodies|auto antibodies
1357646|NCT01343836|autologous tenocytes|autologous tenocytes
1357647|NCT01343836|cell therapy|cell therapy
1357648|NCT01343836|eccentric exercises|eccentric exercises
1357649|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1357650|NCT01343810|Meditation|meditation
1357651|NCT01343810|Psychological stress|psychological stress
1357652|NCT01343810|Sleep quality|sleep quality
1357653|NCT01343810|Cardiovascular disease|cardiovascular disease
1357654|NCT01343810|Inflammation|inflammation
1357655|NCT01343797|Glycemic index|glycemic index
1357656|NCT01343797|Insulinemic index|insulinemic index
1357657|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
1357658|NCT01343797|Fructose syrup|fructose syrup
1357659|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
1357660|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
1357661|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
1357662|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
1357663|NCT01343797|Non-smoker|non-smoker
1357664|NCT01343784|Voiding trial|voiding trial
1357665|NCT01343784|sling|sling
1357666|NCT01343784|post-operative assessment|post-operative assessment
1357667|NCT01343784|urinary retention|urinary retention
1357668|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
1357669|NCT01343771|bone density|bone density
1357670|NCT01343771|DHEA|dhea
1357671|NCT01343771|estrogen therapy|estrogen therapy
1357672|NCT01343771|eating disorder|eating disorder
1357673|NCT01343693|DDD|ddd
1357674|NCT01343693|Deformity|deformity
1357675|NCT01343693|Tumor|tumor
1357676|NCT01343693|Fracture|fracture
1357677|NCT01343693|Cervical|cervical
1357678|NCT01343667|GORE Neuro Protection System|gore neuro protection system
1357679|NCT01343667|GORE Flow Reversal System|gore flow reversal system
1357680|NCT01343667|carotid artery stenosis|carotid artery stenosis
1357681|NCT01343667|embolic protection device|embolic protection device
1357682|NCT01343667|reverse flow|reverse flow
1357683|NCT01343667|proximal occlusion device|proximal occlusion device
1357684|NCT01343667|GNPS|gnps
1357685|NCT01343667|Parodi|parodi
1357686|NCT01343667|EMPiRE|empire
1357687|NCT01343667|distal embolization|distal embolization
1357688|NCT01343667|minimizing risks of CAS|minimizing risks of cas
1357689|NCT01343667|PAES|paes
1357690|NCT01343667|embolic filter|embolic filter
1357691|NCT01343654|HIV medication adherence|hiv medication adherence
1357692|NCT01343654|drug use|drug use
1357693|NCT01343654|rural|rural
1357694|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
1357695|NCT01343641|Kidney Disease|kidney disease
1357696|NCT01343641|Chronic Kidney Disease|chronic kidney disease
1357697|NCT01343641|Growth Hormone|growth hormone
1357698|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
1357699|NCT01343602|stroke|stroke
1357700|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
1357701|NCT01343602|participation|participation
1357702|NCT01343602|Physical Therapy|physical therapy
1357703|NCT01343602|Occupational Therapy|occupational therapy
1357704|NCT01343563|Depression|depression
1357705|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1357706|NCT01343563|EEG|eeg
1357707|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
1357708|NCT01343550|Borderline Personality Disorder|borderline personality disorder
1357709|NCT01343550|Borderline Personality|borderline personality
1357710|NCT01343550|Borderline|borderline
1357711|NCT01343537|Brain Bleed|brain bleed
1357712|NCT01343537|SAH|sah
1357713|NCT01343537|Vasospasm|vasospasm
1357714|NCT01343524|cystic fibrosis|cystic fibrosis
1357715|NCT01343524|spirometry|spirometry
1357716|NCT01343524|PFT's|pft's
1357717|NCT01343524|pulmonary function test|pulmonary function test
1357718|NCT01343511|Autism|autism
1357719|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
1357720|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
1357721|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
1357722|NCT01343498|Advanced Solid Tumors|advanced solid tumors
1357723|NCT01343498|BEZ235|bez235
1357724|NCT01343498|mTOR Inhibitor|mtor inhibitor
1357725|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1357726|NCT01343485|Gardasil vaccine|gardasil vaccine
1357727|NCT01343472|Behavior|behavior
1357728|NCT01343472|Drug users|drug users
1357729|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
1357730|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
1357731|NCT01343459|Breast conserving therapy|breast conserving therapy
1357732|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
1357733|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
1357734|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
1357735|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
1357736|NCT01343433|Delirium|delirium
1357737|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
1357738|NCT01343433|Bright light therapy|bright light therapy
1357739|NCT01343433|Intensive Care Unit|intensive care unit
1357740|NCT01343420|Skin tests|skin tests
1357741|NCT01343420|Dog Hair|dog hair
1357742|NCT01343420|Allergy Extract|allergy extract
1357743|NCT01343394|Autologous|autologous
1357744|NCT01343394|Stem Cells|stem cells
1357745|NCT01343394|Hearing Loss|hearing loss
1357746|NCT01343394|Children|children
1357747|NCT01343381|Heparin|heparin
1357748|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1357749|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
1357750|NCT01343368|Post-menarchal|post-menarchal
1357751|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
1357752|NCT01343355|HAM|ham
1357753|NCT01343355|TSP|tsp
1357754|NCT01343342|omega-3|omega-3
1357755|NCT01343342|PUFA|pufa
1357756|NCT01343342|fatty acids|fatty acids
1357757|NCT01343342|cardiovascular disease|cardiovascular disease
1357758|NCT01343342|gene expression|gene expression
1357759|NCT01343329|Traumatic Brain Injury|traumatic brain injury
1357760|NCT01343329|Dysautonomia|dysautonomia
1357761|NCT01343329|Brain Injury|brain injury
1357762|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
1357763|NCT01343316|Enteral Feeds|enteral feeds
1357764|NCT01343316|Supplemental Feeds|supplemental feeds
1357765|NCT01343316|Transpyloric Tube|transpyloric tube
1357766|NCT01343316|Nasogastric Tube|nasogastric tube
1357767|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
1357768|NCT01343303|knee pain|knee pain
1357769|NCT01343303|pain measurement|pain measurement
1357770|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1357771|NCT01343290|Pharmacokinetic|pharmacokinetic
1357772|NCT01343290|Oral Bioavailability|oral bioavailability
1357773|NCT01343290|Food effect|food effect
1357774|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
1357775|NCT01343277|Trabectedin|trabectedin
1357776|NCT01343277|Yondelis|yondelis
1357777|NCT01343277|Dacarbazine|dacarbazine
1357778|NCT01343277|Anthracycline|anthracycline
1357779|NCT01343277|L-sarcoma|l-sarcoma
1357780|NCT01343264|Radical Pleurectomy|radical pleurectomy
1357781|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
1357782|NCT01343264|Cisplatin|cisplatin
1357783|NCT01343264|Pemetrexed|pemetrexed
1357784|NCT01343264|Radiation|radiation
1357785|NCT01343251|dialysis|dialysis
1357786|NCT01343251|HeRO graft|hero graft
1357787|NCT01343251|catheter|catheter
1357788|NCT01343251|chronic renal failure|chronic renal failure
1357789|NCT01343251|end stage renal disease|end stage renal disease
1357790|NCT01343251|renal insufficiency|renal insufficiency
1357791|NCT01343238|obesity|obesity
1357792|NCT01343238|diet|diet
1357793|NCT01343238|exercise|exercise
1357794|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
1357795|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
1357796|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
1357797|NCT01343212|stiffness|stiffness
1357798|NCT01343186|Peginterferon|peginterferon
1357799|NCT01343186|Healthy subject|healthy subject
1357800|NCT01343186|Pharmacokinetics|pharmacokinetics
1357801|NCT01343186|Pharmacodynamics|pharmacodynamics
1357802|NCT01343186|Safety|safety
1357803|NCT01343173|Leukemia|leukemia
1357804|NCT01343173|Adult Chronic|adult chronic
1357805|NCT01343173|Myeloid|myeloid
1357806|NCT01343147|Hyperthermia|hyperthermia
1357807|NCT01343147|Microwave diathermy|microwave diathermy
1357808|NCT01343147|Hot packs|hot packs
1357809|NCT01343147|Pain|pain
1357810|NCT01343147|Physical function|physical function
1357811|NCT01343134|Retina|retina
1357812|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1357813|NCT01343134|Macular detachment|macular detachment
1357814|NCT01343134|Spectral domain OCT|spectral domain oct
1357815|NCT01343134|Microperimetry|microperimetry
1357816|NCT01343121|Radiotherapy|radiotherapy
1357817|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
1357818|NCT01343121|Bladder Cancer|bladder cancer
1357819|NCT01343108|Emotional Labor|emotional labor
1357820|NCT01343108|Burnout|burnout
1357821|NCT01343108|Job Satisfaction|job satisfaction
1357822|NCT01343108|Emotional Intelligence|emotional intelligence
1357823|NCT01343108|Job stress|job stress
1357824|NCT01343108|Job involvement|job involvement
1357825|NCT01343095|ICU Delirium|icu delirium
1357826|NCT01343095|Delirium|delirium
1357827|NCT01343095|Sleep Quality|sleep quality
1357828|NCT01343095|Sleep Efficiency|sleep efficiency
1357829|NCT01343095|ICU Noise|icu noise
1357830|NCT01343095|Noise Reduction|noise reduction
1357831|NCT01343095|Earplugs|earplugs
1357832|NCT01343095|Noise Canceling Headphones|noise canceling headphones
1357833|NCT01343069|safety|safety
1357834|NCT01343069|team|team
1357835|NCT01343069|team performance|team performance
1357836|NCT01343069|surgery|surgery
1357837|NCT01343069|outcome|outcome
1357838|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
1357839|NCT01343056|Diabetes|diabetes
1357840|NCT01343056|Self Management Support (SMS)|self management support (sms)
1357841|NCT01343043|Sarcoma|sarcoma
1357842|NCT01343043|Cell Therapy|cell therapy
1357843|NCT01343043|T Cell Therapy|t cell therapy
1357844|NCT01343043|NY-ESO-1|ny-eso-1
1357845|NCT01343043|Immuno-oncology|immuno-oncology
1357846|NCT01343043|Metastatic|metastatic
1357847|NCT01343043|Previously treated|previously treated
1357848|NCT01343043|T Cell Receptor|t cell receptor
1357849|NCT01343017|Anaesthesia|anaesthesia
1357850|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
1357851|NCT01343017|Functional residual capacity|functional residual capacity
1357852|NCT01343017|Cardiac output|cardiac output
1357853|NCT01343017|Sevoflurane|sevoflurane
1357854|NCT01343004|BA058|ba058
1357855|NCT01343004|abaloparatide|abaloparatide
1357856|NCT01343004|Abaloparatide-SC|abaloparatide-sc
1357857|NCT01343004|osteoporosis|osteoporosis
1357858|NCT01343004|postmenopausal|postmenopausal
1357859|NCT01343004|bone loss|bone loss
1357860|NCT01343004|ACTIVE|active
1357861|NCT01343004|fracture|fracture
1357862|NCT01342991|Haemorrhoids|haemorrhoids
1357863|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
1357864|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
1357865|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
1357866|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
1357867|NCT01342978|HPV|hpv
1357868|NCT01342978|HNSCC|hnscc
1358172|NCT01341431|Bee venom|bee venom
1357869|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
1357870|NCT01342952|pediatrics|pediatrics
1357871|NCT01342939|Monogenetic diabetes|monogenetic diabetes
1357872|NCT01342939|Diabetes mellitus|diabetes mellitus
1357873|NCT01342926|age-related macular degeneration|age-related macular degeneration
1357874|NCT01342926|geographic atrophy|geographic atrophy
1357875|NCT01342926|dry AMD|dry amd
1357876|NCT01342900|tissue oxygenation|tissue oxygenation
1357877|NCT01342900|higk risk surgery|higk risk surgery
1357878|NCT01342900|high risk patient|high risk patient
1357879|NCT01342900|postoperative complications|postoperative complications
1357880|NCT01342874|inositol|inositol
1357881|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
1357882|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
1357883|NCT01342861|protein supplementation|protein supplementation
1357884|NCT01342861|caloric intake|caloric intake
1357885|NCT01342861|breakfast|breakfast
1357886|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
1357887|NCT01342861|albumin|albumin
1357888|NCT01342861|Length of stay|length of stay
1357889|NCT01342848|NSTE-ACS|nste-acs
1357890|NCT01342848|PCI|pci
1357891|NCT01342848|Thrombus Aspiration|thrombus aspiration
1357892|NCT01342848|IVUS|ivus
1357893|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
1357894|NCT01342835|propofol|propofol
1357895|NCT01342835|sevoflurane|sevoflurane
1357896|NCT01342835|postoperative pain|postoperative pain
1357897|NCT01342835|children|children
1357898|NCT01342822|Heart disease|heart disease
1357899|NCT01342822|Coronary Revascularization|coronary revascularization
1357900|NCT01342809|Depression|depression
1357901|NCT01342809|Hopelessness|hopelessness
1357902|NCT01342809|Suicidal ideation|suicidal ideation
1357903|NCT01342796|Cell mediated immunity|cell mediated immunity
1357904|NCT01342796|cell mediated immune response|cell mediated immune response
1357905|NCT01342796|Children|children
1357906|NCT01342796|adjuvanted|adjuvanted
1357907|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1357908|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1357909|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1357910|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1357911|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1357912|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1357913|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
1357914|NCT01342731|Tigecycline|tigecycline
1357915|NCT01342731|A.baumannii|a.baumannii
1357916|NCT01342731|Drug safety|drug safety
1357917|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
1357918|NCT01342718|Herbal medicine|herbal medicine
1357919|NCT01342718|Probiotics|probiotics
1357920|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
1357921|NCT01342679|dasatinib|dasatinib
1357922|NCT01342679|complete molecular response|complete molecular response
1357923|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
1357924|NCT01342666|Tomato|tomato
1357925|NCT01342666|Lycopene|lycopene
1357926|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
1357927|NCT01342666|Dyslipidemia|dyslipidemia
1357928|NCT01342653|Peritoneal|peritoneal
1357929|NCT01342653|Carcinomatosis|carcinomatosis
1357930|NCT01342653|Gastric|gastric
1357931|NCT01342653|Cancer|cancer
1357932|NCT01342653|NIPS|nips
1357933|NCT01342653|HIPEC|hipec
1357934|NCT01342627|Renal Carcinoma|renal carcinoma
1357935|NCT01342627|Metastatic|metastatic
1357936|NCT01342627|Sorafenib|sorafenib
1357937|NCT01342627|Elderly|elderly
1357938|NCT01342614|Hypertension|hypertension
1357939|NCT01342614|Insulin Resistance|insulin resistance
1357940|NCT01342614|Hyperinsulinemia|hyperinsulinemia
1357941|NCT01342614|Metformin|metformin
1357942|NCT01342614|Fosinopril|fosinopril
1357943|NCT01342588|Pedicle screws|pedicle screws
1357944|NCT01342588|safety|safety
1357945|NCT01342575|ACDF|acdf
1357946|NCT01342549|Alcohol Use Disorders|alcohol use disorders
1357947|NCT01342549|Traumatic Brain Injury|traumatic brain injury
1357948|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
1357949|NCT01342536|Depression|depression
1357950|NCT01342523|Smoking Cessation|smoking cessation
1357951|NCT01342523|Smoking|smoking
1357952|NCT01342523|Nicotine|nicotine
1357953|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
1357954|NCT01342510|General Anesthesia|general anesthesia
1357955|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
1357956|NCT01342471|Physical activity intervention|physical activity intervention
1357957|NCT01342471|walking|walking
1357959|NCT01342471|sedentary|sedentary
1357960|NCT01342458|Knee osteoarthritis|knee osteoarthritis
1357961|NCT01342458|Shoes|shoes
1357962|NCT01342458|Gait|gait
1357963|NCT01342458|Biomechanics|biomechanics
1357964|NCT01342432|low back pain|low back pain
1357965|NCT01342432|balance reeducation|balance reeducation
1357966|NCT01342432|pain|pain
1357967|NCT01342432|function|function
1357968|NCT01342367|Prostate cancer|prostate cancer
1358368|NCT01340547|Safety|safety
1357969|NCT01342367|Quality of Life|quality of life
1357970|NCT01342354|Pancreatic Cancer|pancreatic cancer
1357971|NCT01342354|Stereotactic Radiation|stereotactic radiation
1357972|NCT01342328|Sleep disruption|sleep disruption
1357973|NCT01342328|Sleep hygiene|sleep hygiene
1357974|NCT01342328|Sedative agents and sleep|sedative agents and sleep
1357975|NCT01342328|Electroencephalography|electroencephalography
1357976|NCT01342328|REM sleep|rem sleep
1357977|NCT01342328|Magnetoencephalography|magnetoencephalography
1357978|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
1357979|NCT01342302|Breast Cancer|breast cancer
1357980|NCT01342302|Couples|couples
1357981|NCT01342302|Distress|distress
1357982|NCT01342302|Online Support|online support
1357983|NCT01342302|e-health|e-health
1357984|NCT01342302|Intervention|intervention
1357985|NCT01342302|Relationships|relationships
1357986|NCT01342289|Nonmyeloablative|nonmyeloablative
1357987|NCT01342289|Allogeneic|allogeneic
1357988|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
1357989|NCT01342289|Tacrolimus|tacrolimus
1357990|NCT01342289|Cyclophosphamide|cyclophosphamide
1357991|NCT01342276|Heart failure|heart failure
1357992|NCT01342276|Self-management|self-management
1357993|NCT01342276|Telehealth|telehealth
1357994|NCT01342276|Internet|internet
1357995|NCT01342263|Chronic disease management|chronic disease management
1357996|NCT01342263|Ischemic heart disease|ischemic heart disease
1357997|NCT01342263|Heart failure|heart failure
1357998|NCT01342263|Chronic kidney disease|chronic kidney disease
1357999|NCT01342263|Diabetes|diabetes
1358000|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1358001|NCT01342263|Telehealth|telehealth
1358002|NCT01342263|Internet|internet
1358003|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
1358004|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
1358005|NCT01342237|Brain tumors|brain tumors
1358006|NCT01342237|Stem cell transplantation|stem cell transplantation
1358007|NCT01342237|topotecan|topotecan
1358008|NCT01342237|thiotepa|thiotepa
1358009|NCT01342237|carboplatin|carboplatin
1358010|NCT01342237|melphalan|melphalan
1358011|NCT01342237|etoposide|etoposide
1358012|NCT01342224|pancreatic|pancreatic
1358013|NCT01342224|cancer|cancer
1358014|NCT01342224|adenocarcinoma|adenocarcinoma
1358015|NCT01342224|vaccine|vaccine
1358016|NCT01342211|PF-04950615|pf-04950615
1358017|NCT01342211|RN316|rn316
1358018|NCT01342198|pregabalin|pregabalin
1358019|NCT01342198|pharmacokinetics|pharmacokinetics
1358020|NCT01342198|bioavailability|bioavailability
1358021|NCT01342198|bioequivalence|bioequivalence
1358022|NCT01342185|Medical ozone therapy|medical ozone therapy
1358023|NCT01342185|chronic hepatitis B|chronic hepatitis b
1358024|NCT01342172|Bladder Cancer|bladder cancer
1358025|NCT01342172|Urothelial Cancer|urothelial cancer
1358026|NCT01342172|Chemotherapy|chemotherapy
1358027|NCT01342172|First-line|first-line
1358028|NCT01342172|Metastatic|metastatic
1358029|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
1358030|NCT01342146|pegylated Somatropin|pegylated somatropin
1358031|NCT01342146|PEG-GH|peg-gh
1358032|NCT01342146|Growth hormone|growth hormone
1358033|NCT01342146|PEG-rhGH|peg-rhgh
1358034|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
1358035|NCT01342146|Phase 2 study|phase 2 study
1358036|NCT01342120|atypical antipsychotics|atypical antipsychotics
1358037|NCT01342120|quetiapine|quetiapine
1358038|NCT01342107|Contact Lenses|contact lenses
1358039|NCT01342107|Contact Lens Care|contact lens care
1358040|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
1358041|NCT01342107|Myopia|myopia
1358042|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
1358043|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
1358044|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
1358045|NCT01342068|Osteopathic medicine|osteopathic medicine
1358046|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
1358047|NCT01342068|OMT|omt
1358048|NCT01342068|Wright's Test|wright's test
1358049|NCT01342068|Adson's Test|adson's test
1358050|NCT01342068|Halstead's Maneuver|halstead's maneuver
1358051|NCT01342068|TOS|tos
1358052|NCT01342068|Vascular Sonography|vascular sonography
1358053|NCT01342042|diabetes|diabetes
1358054|NCT01342042|rRE-4|rre-4
1358055|NCT01342042|exenatide|exenatide
1358056|NCT01342042|metformin|metformin
1358057|NCT01342042|CSPC ZhongQi|cspc zhongqi
1358058|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
1358059|NCT01342016|prograf|prograf
1358060|NCT01342016|nephritis|nephritis
1358061|NCT01342016|leflunomide|leflunomide
1358062|NCT01342016|immunosuppressant|immunosuppressant
1358063|NCT01342003|HCV infection|hcv infection
1358064|NCT01342003|genotype 1a|genotype 1a
1358065|NCT01342003|genotype 1 b|genotype 1 b
1358066|NCT01341990|Contact Lenses|contact lenses
1358067|NCT01341990|Contact Lens Care|contact lens care
1358068|NCT01341990|Multi-Purpose Solution|multi-purpose solution
1358069|NCT01341977|Contact Lenses|contact lenses
1358070|NCT01341977|Contact Lens Care|contact lens care
1358071|NCT01341977|Multi-Purpose Solution|multi-purpose solution
1358072|NCT01341964|Clopidogrel|clopidogrel
1358073|NCT01341964|Aspirin|aspirin
1358074|NCT01341964|Interaction|interaction
1358075|NCT01341951|liver failure, Acute|liver failure, acute
1358076|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
1358077|NCT01341925|childhood depression|childhood depression
1358078|NCT01341899|Type 1 diabetes|type 1 diabetes
1358079|NCT01341899|stem cell|stem cell
1358080|NCT01341899|C-peptide|c-peptide
1358081|NCT01341899|Immune function|immune function
1358082|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
1358083|NCT01341886|THS suppression|ths suppression
1358084|NCT01341886|metformin|metformin
1358085|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
1358086|NCT01341821|Leadership Style|leadership style
1358087|NCT01341821|Team Climate|team climate
1358088|NCT01341808|Crohn's disease|crohn's disease
1358089|NCT01341808|Ulcerative colitis|ulcerative colitis
1358090|NCT01341808|Hepatitis A|hepatitis a
1358091|NCT01341808|vaccine|vaccine
1358092|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
1358976|NCT01338012|vaccine|vaccine
1358093|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
1358094|NCT01341782|Paricalcitol|paricalcitol
1358095|NCT01341782|Hemodialysis|hemodialysis
1358096|NCT01341782|Maxacalcitol|maxacalcitol
1358097|NCT01341756|Gastric Cancer|gastric cancer
1358098|NCT01341756|Radiotherapy|radiotherapy
1358099|NCT01341756|palliation|palliation
1358100|NCT01341756|bleeding|bleeding
1358101|NCT01341756|pain|pain
1358102|NCT01341756|obstruction|obstruction
1358103|NCT01341743|chronic hepatitis B|chronic hepatitis b
1358104|NCT01341743|inadequate response|inadequate response
1358105|NCT01341743|NUC therapy|nuc therapy
1358106|NCT01341730|Atherosclerosis|atherosclerosis
1358107|NCT01341730|Pioglitazone|pioglitazone
1358108|NCT01341730|Atorvastatin|atorvastatin
1358109|NCT01341730|PET CT|pet ct
1358110|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1358111|NCT01341717|Sitagliptin|sitagliptin
1358112|NCT01341717|Insulin|insulin
1358113|NCT01341704|malaria|malaria
1358114|NCT01341704|vaccine|vaccine
1358115|NCT01341704|clinical trials|clinical trials
1358116|NCT01341704|proof of concept|proof of concept
1358117|NCT01341704|efficacy|efficacy
1358118|NCT01341691|chronic kidney disease|chronic kidney disease
1358119|NCT01341691|K2CG chewing gum|k2cg chewing gum
1358120|NCT01341691|phosphorus|phosphorus
1358121|NCT01341691|saliva|saliva
1358122|NCT01341678|chronic kidney disease|chronic kidney disease
1358123|NCT01341678|phosphorus|phosphorus
1358124|NCT01341678|circadian rhythm|circadian rhythm
1358125|NCT01341678|saliva|saliva
1358126|NCT01341665|hyponatremia|hyponatremia
1358127|NCT01341665|SIADH|siadh
1358128|NCT01341665|copeptin|copeptin
1358129|NCT01341639|combination vaccine|combination vaccine
1358130|NCT01341639|diphtheria|diphtheria
1358131|NCT01341639|pertussis|pertussis
1358132|NCT01341639|tetanus|tetanus
1358133|NCT01341639|hepatitis B|hepatitis b
1358134|NCT01341639|Hep B|hep b
1358135|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
1358136|NCT01341639|Hib|hib
1358137|NCT01341639|polio|polio
1358138|NCT01341639|poliovirus|poliovirus
1358139|NCT01341626|delinquency|delinquency
1358140|NCT01341626|drug use|drug use
1358141|NCT01341626|HIV risk behavior|hiv risk behavior
1358142|NCT01341626|economic costs|economic costs
1358143|NCT01341600|Clopidogrel|clopidogrel
1358144|NCT01341600|Pharmacogenetics|pharmacogenetics
1358145|NCT01341600|Platelets|platelets
1358146|NCT01341600|Healthy Subjects|healthy subjects
1358147|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
1358148|NCT01341587|diabetes|diabetes
1358149|NCT01341587|mobile technology|mobile technology
1358150|NCT01341574|spatial neglect|spatial neglect
1358151|NCT01341574|stroke|stroke
1358152|NCT01341548|Nasal|nasal
1358153|NCT01341548|Cluster Headache|cluster headache
1358154|NCT01341548|Episodic Cluster|episodic cluster
1358155|NCT01341548|Headache|headache
1358156|NCT01341548|Phase 3|phase 3
1358157|NCT01341548|Civamide|civamide
1358158|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
1358159|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
1358160|NCT01341496|Metastatic Cancer|metastatic cancer
1358161|NCT01341496|Cancer Vaccine|cancer vaccine
1358162|NCT01341496|Immunotherapy|immunotherapy
1358163|NCT01341496|Chest Metastases|chest metastases
1358164|NCT01341496|Sarcoma|sarcoma
1358165|NCT01341496|Melanoma|melanoma
1358166|NCT01341483|erectile dysfunction|erectile dysfunction
1358167|NCT01341483|internal pudendal artery|internal pudendal artery
1358168|NCT01341483|erection|erection
1358169|NCT01341483|coronary artery disease|coronary artery disease
1358170|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
1358171|NCT01341431|Parkinson disease|parkinson disease
1358173|NCT01341431|Motor fluctuations|motor fluctuations
1358174|NCT01341431|Disease progression|disease progression
1358175|NCT01341418|tibia|tibia
1358176|NCT01341418|suprapatellar|suprapatellar
1358177|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
1358178|NCT01341379|Ureagenesis|ureagenesis
1358179|NCT01341379|Urea cycle|urea cycle
1358180|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
1358181|NCT01341366|Laparoscopic surgery|laparoscopic surgery
1358182|NCT01341340|Stent|stent
1358183|NCT01341340|Infrapopliteal|infrapopliteal
1358184|NCT01341340|Tibial|tibial
1358185|NCT01341340|Limb Salvage|limb salvage
1358186|NCT01341327|Left Main|left main
1358187|NCT01341314|joint pain|joint pain
1358188|NCT01341314|stiffness|stiffness
1358189|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
1358190|NCT01341301|TJU 2 Step|tju 2 step
1358191|NCT01341301|HSCT|hsct
1358192|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1358193|NCT01341288|prostate cancer|prostate cancer
1358194|NCT01341288|EUCLIDIAN|euclidian
1358195|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
1358196|NCT01341288|robot|robot
1358197|NCT01341288|brachytherapy|brachytherapy
1358198|NCT01341288|seed implantation|seed implantation
1358199|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
1358200|NCT01341275|duration of protection|duration of protection
1358201|NCT01341275|adolescent immunization|adolescent immunization
1358202|NCT01341275|anamnestic response|anamnestic response
1358203|NCT01341275|booster dose|booster dose
1358204|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
1358205|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
1358206|NCT01341262|thalidomide|thalidomide
1358207|NCT01341262|induction therapy|induction therapy
1358208|NCT01341236|VLBW|vlbw
1358209|NCT01341236|IUGR|iugr
1358210|NCT01341236|NIRS|nirs
1358211|NCT01341236|enteral nutrition|enteral nutrition
1358212|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
1358213|NCT01341210|Patients Satisfaction|patients satisfaction
1358214|NCT01341210|Decision Making|decision making
1358215|NCT01341210|Informed Consent|informed consent
1358216|NCT01341197|Fecal immunochemical test|fecal immunochemical test
1358217|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
1568271|NCT00506441|Hyperphosphatemia|hyperphosphatemia
1358218|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
1358219|NCT01341197|Mass screening|mass screening
1358220|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
1358221|NCT01341184|rifabutin|rifabutin
1358222|NCT01341184|rifampin|rifampin
1358223|NCT01341184|TMC207|tmc207
1358224|NCT01341184|tuberculosis|tuberculosis
1358225|NCT01341171|tamoxifen|tamoxifen
1358226|NCT01341171|aromatase inhibitors|aromatase inhibitors
1358227|NCT01341171|breast cancer|breast cancer
1358228|NCT01341171|platelets|platelets
1358229|NCT01341158|Malignatn Melanoma|malignatn melanoma
1358230|NCT01341145|hypertension|hypertension
1358231|NCT01341145|aerobic exercise|aerobic exercise
1358232|NCT01341145|relaxation|relaxation
1358233|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1358234|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1358235|NCT01341145|brain health|brain health
1358237|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
1358238|NCT01341132|MRI|mri
1358239|NCT01341132|Liver|liver
1358240|NCT01341106|chronic hepatitis B|chronic hepatitis b
1358241|NCT01341106|liver fibrosis|liver fibrosis
1358242|NCT01341106|treatment with Entecavir|treatment with entecavir
1358243|NCT01341080|Balance|balance
1358244|NCT01341080|Postural impairment|postural impairment
1358245|NCT01341080|Falls|falls
1358246|NCT01341080|Parkinson Disease|parkinson disease
1358247|NCT01341054|mucositis|mucositis
1358248|NCT01341054|chamomilla|chamomilla
1358249|NCT01341054|therapeutics|therapeutics
1358250|NCT01341028|weight loss|weight loss
1358251|NCT01341028|appetite|appetite
1358252|NCT01341028|ghrelin|ghrelin
1358253|NCT01341028|PYY|pyy
1358254|NCT01341028|GLP-1|glp-1
1358255|NCT01341028|insulin|insulin
1358256|NCT01341028|laparoscopic|laparoscopic
1358257|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1358258|NCT01341028|gastric fundus resection|gastric fundus resection
1358259|NCT01341002|Postoperative Care|postoperative care
1358260|NCT01341002|red blood cell transfusion|red blood cell transfusion
1358261|NCT01341002|venous oxygen saturation|venous oxygen saturation
1358262|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
1358263|NCT01340976|Cancer Related Anemia|cancer related anemia
1358264|NCT01340963|Chagas heart disease|chagas heart disease
1358265|NCT01340963|ventricular tachycardia|ventricular tachycardia
1358266|NCT01340963|atrial fibrillation|atrial fibrillation
1358267|NCT01340963|stroke|stroke
1358268|NCT01340963|cardiac death|cardiac death
1358269|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
1358270|NCT01340950|Prevention|prevention
1358271|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
1358272|NCT01340950|Neuropsychological Tests|neuropsychological tests
1358273|NCT01340937|Diphtheria|diphtheria
1358274|NCT01340937|Tetanus|tetanus
1358275|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
1358276|NCT01340937|Poliomyelitis|poliomyelitis
1358277|NCT01340937|Hepatitis B infection|hepatitis b infection
1358278|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
1358279|NCT01340924|Gestational diabetes|gestational diabetes
1358280|NCT01340924|Type 2 diabetes|type 2 diabetes
1358281|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
1358282|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
1358283|NCT01340898|meningococcal diseases|meningococcal diseases
1358284|NCT01340898|Immunogenicity|immunogenicity
1358285|NCT01340898|Neisseria meningitidis|neisseria meningitidis
1358286|NCT01340898|co-administration|co-administration
1358287|NCT01340898|routine vaccines|routine vaccines
1358288|NCT01340885|attention|attention
1358289|NCT01340885|mild cognitive impairment|mild cognitive impairment
1358290|NCT01340885|dementia|dementia
1358291|NCT01340872|iron deficiency|iron deficiency
1358292|NCT01340872|anaemia|anaemia
1358293|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
1358294|NCT01340872|ulcerative colitis|ulcerative colitis
1358295|NCT01340859|Suicide|suicide
1358296|NCT01340859|Cognitive Therapy|cognitive therapy
1358297|NCT01340859|Inpatient|inpatient
1358298|NCT01340859|Military|military
1358299|NCT01340846|gemfibrozil|gemfibrozil
1358300|NCT01340846|BRAF|braf
1358301|NCT01340846|Drug Interactions|drug interactions
1358302|NCT01340846|GSK2118436|gsk2118436
1358303|NCT01340846|warfarin|warfarin
1358304|NCT01340846|ketoconazole|ketoconazole
1358305|NCT01340846|BRAF inhibitor|braf inhibitor
1358306|NCT01340846|oncology|oncology
1358307|NCT01340846|BRAF positive tumor|braf positive tumor
1358308|NCT01340833|GSK2118436|gsk2118436
1358309|NCT01340833|BRAF inhibitor|braf inhibitor
1358310|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
1358311|NCT01340833|Oncology|oncology
1358312|NCT01340833|absolute bioavailability|absolute bioavailability
1358313|NCT01340833|microtracer|microtracer
1358314|NCT01340781|inpatients|inpatients
1358315|NCT01340781|medical|medical
1358316|NCT01340781|polysomnogram|polysomnogram
1358317|NCT01340781|questionnaires|questionnaires
1358318|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
1358319|NCT01340755|Rectal cancer|rectal cancer
1358320|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
1358321|NCT01340742|Abdominal surgery|abdominal surgery
1358322|NCT01340742|Perioperative complications|perioperative complications
1358323|NCT01340729|melanoma|melanoma
1358324|NCT01340729|TPI 287|tpi 287
1358325|NCT01340729|tumor recurrence|tumor recurrence
1358326|NCT01340729|tumor progression|tumor progression
1358327|NCT01340729|novel taxane analog|novel taxane analog
1358328|NCT01340703|optic disc pit|optic disc pit
1358329|NCT01340703|retinal detachment|retinal detachment
1358330|NCT01340703|retinoschisis|retinoschisis
1358331|NCT01340703|vitrectomy|vitrectomy
1358332|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
1358333|NCT01340690|ADHD|adhd
1358334|NCT01340690|children|children
1358335|NCT01340690|adolescents|adolescents
1358336|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
1358337|NCT01340690|ADHDRS - IV|adhdrs - iv
1358338|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1358339|NCT01340677|Pharmacokinetic|pharmacokinetic
1358340|NCT01340677|Dose proportionality|dose proportionality
1358341|NCT01340664|Canagliflozin|canagliflozin
1358342|NCT01340664|Placebo|placebo
1358343|NCT01340664|Metformin|metformin
1358344|NCT01340664|Hemoglobin A1c|hemoglobin a1c
1358345|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
1358346|NCT01340651|myelofibrosis|myelofibrosis
1358347|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
1358348|NCT01340651|PMF|pmf
1358349|NCT01340651|PET-MF|pet-mf
1358350|NCT01340651|PPV-MF|ppv-mf
1358351|NCT01340638|Seal pressure|seal pressure
1358352|NCT01340638|Cookgas|cookgas
1358353|NCT01340638|AirQ|airq
1358354|NCT01340638|LMA|lma
1358355|NCT01340638|supraglottic device|supraglottic device
1358356|NCT01340625|Healthy Subjects|healthy subjects
1358357|NCT01340612|large aneurysm|large aneurysm
1358358|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
1358359|NCT01340612|recurring aneurysm|recurring aneurysm
1358360|NCT01340586|PHARMACOKINETIC|pharmacokinetic
1358361|NCT01340586|NOS|nos
1358362|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
1358363|NCT01340573|pegylated interferon|pegylated interferon
1358364|NCT01340573|PegIntron Pen|pegintron pen
1358365|NCT01340573|Ribavirin|ribavirin
1358366|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
1358367|NCT01340547|Phase I|phase i
1358369|NCT01340547|PK|pk
1358370|NCT01340547|ECG QTc|ecg qtc
1358371|NCT01340547|Efficacy|efficacy
1358372|NCT01340547|Palifosfamide-tris|palifosfamide-tris
1358373|NCT01340547|non-randomized|non-randomized
1358374|NCT01340534|Surgical wound infection|surgical wound infection
1358375|NCT01340534|Oxygen|oxygen
1358376|NCT01340534|Cesarean|cesarean
1358377|NCT01340521|Pituitary Hormone Response|pituitary hormone response
1358378|NCT01340521|Clomiphene Citrate|clomiphene citrate
1358379|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
1358380|NCT01340521|Luteinizing Hormone|luteinizing hormone
1358381|NCT01340508|Pathological complete response|pathological complete response
1358382|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
1358383|NCT01340508|Rectal cancer|rectal cancer
1358384|NCT01340495|Breast Cancer|breast cancer
1358385|NCT01340495|Mastectomy|mastectomy
1358386|NCT01340482|XLH|xlh
1358387|NCT01340469|nosocomial infections|nosocomial infections
1358388|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
1358389|NCT01340469|preterm infants|preterm infants
1358390|NCT01340469|ver low birth weight|ver low birth weight
1358391|NCT01340469|probiotics|probiotics
1358392|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
1358393|NCT01340456|Midazolam|midazolam
1358394|NCT01340456|CYP3A4|cyp3a4
1358395|NCT01340456|Enzyme induction|enzyme induction
1358396|NCT01340456|Drug metabolism|drug metabolism
1358397|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
1358398|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
1358399|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
1358400|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
1358401|NCT01340430|pathologic complete response|pathologic complete response
1358402|NCT01340417|melatonin|melatonin
1358403|NCT01340417|preterm|preterm
1358404|NCT01340417|deficiency|deficiency
1358405|NCT01340417|neuroprotection|neuroprotection
1358406|NCT01340391|cast, radius fracture|cast, radius fracture
1358407|NCT01340378|neonatal surgery|neonatal surgery
1358408|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
1358409|NCT01340339|Jaundice|jaundice
1358410|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
1358411|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
1568272|NCT00506441|Phosphate binder|phosphate binder
1358412|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
1358413|NCT01340326|valsartan|valsartan
1358414|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
1358415|NCT01340300|Colorectal|colorectal
1358416|NCT01340300|Breast|breast
1358417|NCT01340300|Insulin|insulin
1358418|NCT01340300|Exercise|exercise
1358419|NCT01340287|Plant sterol|plant sterol
1358420|NCT01340287|Hypercholesterolemia|hypercholesterolemia
1358421|NCT01340287|diet|diet
1358422|NCT01340287|dairy|dairy
1358423|NCT01340287|isoprostanes|isoprostanes
1358424|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
1358425|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
1358426|NCT01340274|Concerned Significant Others|concerned significant others
1358427|NCT01340274|Identified Problem Gambler|identified problem gambler
1358428|NCT01340274|Therapeutics|therapeutics
1358429|NCT01340261|Pediatric|pediatric
1358430|NCT01340261|Chronic Pain|chronic pain
1358431|NCT01340248|food effect|food effect
1358432|NCT01340248|pharmacokinetics|pharmacokinetics
1358433|NCT01340248|healthy male volunteers|healthy male volunteers
1358434|NCT01340222|Preterm labour|preterm labour
1358435|NCT01340222|monocyte|monocyte
1358436|NCT01340222|lymphocyte|lymphocyte
1358437|NCT01340222|MCP-1|mcp-1
1358438|NCT01340222|Treg Lymphocytes|treg lymphocytes
1358439|NCT01340222|biologic markers|biologic markers
1358440|NCT01340222|immunology|immunology
1358441|NCT01340222|HLA-DR|hla-dr
1358442|NCT01340222|Th17|th17
1358443|NCT01340183|Phase I|phase i
1358444|NCT01340183|safety|safety
1358445|NCT01340183|tolerability|tolerability
1358446|NCT01340183|pharmacokinetics|pharmacokinetics
1358447|NCT01340183|AZD5099|azd5099
1358448|NCT01340183|volunteers|volunteers
1358449|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
1358450|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
1358451|NCT01340183|single intravenous doses|single intravenous doses
1358452|NCT01340183|healthy volunteers|healthy volunteers
1358453|NCT01340157|Fexinidazole|fexinidazole
1358454|NCT01340157|Phase I|phase i
1358455|NCT01340157|Bioavailability study|bioavailability study
1358456|NCT01340157|Food effect|food effect
1358457|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
1358458|NCT01340144|total knee replacement|total knee replacement
1358459|NCT01340144|patellar crepitus|patellar crepitus
1358460|NCT01340144|Replacement of knee joint|replacement of knee joint
1358461|NCT01340131|CKD-828|ckd-828
1358462|NCT01340131|Hypertension|hypertension
1358463|NCT01340131|Primary Hypertension|primary hypertension
1358464|NCT01340131|Healthy Volunteer|healthy volunteer
1358465|NCT01340131|S-Amlodipine|s-amlodipine
1358466|NCT01340131|Telmisartan|telmisartan
1358467|NCT01340131|Amlodipine|amlodipine
1358468|NCT01340131|Pharmacokinetic|pharmacokinetic
1358469|NCT01340131|Phase 1|phase 1
1358470|NCT01340118|Asthma|asthma
1358471|NCT01340118|FEF25-75|fef25-75
1358472|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
1358473|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
1358474|NCT01340118|children|children
1358475|NCT01340105|Microwave ablation|microwave ablation
1358476|NCT01340105|Radiofrequency ablation|radiofrequency ablation
1358477|NCT01340105|Randomised controlled trial|randomised controlled trial
1358478|NCT01340092|Family Navigator|family navigator
1358479|NCT01340092|Autistic Disorder|autistic disorder
1358480|NCT01340092|Early Intervention|early intervention
1358481|NCT01340092|Developmental Disabilities|developmental disabilities
1358482|NCT01340092|Child Development Disorders|child development disorders
1358483|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
1358484|NCT01340066|urinary incontinence|urinary incontinence
1358485|NCT01340066|stress incontinence|stress incontinence
1358486|NCT01340066|urge incontinence|urge incontinence
1358487|NCT01340066|mixed incontinence|mixed incontinence
1358488|NCT01340040|Phase I|phase i
1358489|NCT01340040|cancer|cancer
1358490|NCT01340040|solid tumours|solid tumours
1358491|NCT01340040|advanced solid malignancies|advanced solid malignancies
1358492|NCT01340040|dose escalation|dose escalation
1358493|NCT01340040|Insulin like growth factor|insulin like growth factor
1358494|NCT01340040|Japanese|japanese
1358495|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
1358496|NCT01340027|Frequency|frequency
1358497|NCT01340027|Micturition|micturition
1358498|NCT01340027|Urgency|urgency
1358499|NCT01340027|Urinary incontinence|urinary incontinence
1358500|NCT01340027|Urgency incontinence|urgency incontinence
1358501|NCT01340027|YM178|ym178
1358502|NCT01340014|Glaucoma|glaucoma
1358503|NCT01340014|Intraocular pressure|intraocular pressure
1358504|NCT01340014|Tonometry, ocular|tonometry, ocular
1358505|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
1358506|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
1358507|NCT01340001|Deep brain stimulation|deep brain stimulation
1358508|NCT01339988|Stem-cells|stem-cells
1358509|NCT01339988|Transplantation|transplantation
1358510|NCT01339988|Busulfex|busulfex
1358511|NCT01339988|Cyclophosphamide|cyclophosphamide
1358512|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
1358513|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
1358514|NCT01339975|Nephrectomy|nephrectomy
1358515|NCT01339975|Antiangiogenics|antiangiogenics
1358516|NCT01339975|Chemokines|chemokines
1358517|NCT01339975|Prognostic value|prognostic value
1358518|NCT01339975|Carcinoma|carcinoma
1358519|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
1358520|NCT01339975|Kidney Neoplasms|kidney neoplasms
1358521|NCT01339975|Kidney Diseases|kidney diseases
1358522|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1358523|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
1358524|NCT01339975|Neoplasms|neoplasms
1358525|NCT01339975|Adenocarcinoma|adenocarcinoma
1358526|NCT01339975|Urologic Neoplasms|urologic neoplasms
1358527|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
1358528|NCT01339975|Neoplasms by Site|neoplasms by site
1358529|NCT01339975|Urologic Diseases|urologic diseases
1358530|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
1358531|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
1358532|NCT01339975|Pharmacologic Actions|pharmacologic actions
1358533|NCT01339975|Biomarkers|biomarkers
1358534|NCT01339975|Targeted therapies|targeted therapies
1358535|NCT01339975|Surgery|surgery
1358536|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1358538|NCT01339949|wet AMD|wet amd
1358539|NCT01339949|Macular Degeneration|macular degeneration
1358540|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
1358541|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
1358542|NCT01339949|IRay|iray
1358543|NCT01339949|radiation|radiation
1358544|NCT01339949|Oraya|oraya
1358545|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
1358546|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
1358547|NCT01339949|radiosurgery|radiosurgery
1358548|NCT01339949|x-ray|x-ray
1358549|NCT01339949|Lucentis|lucentis
1358550|NCT01339949|external beam radiation|external beam radiation
1358551|NCT01339923|Meningococcal disease|meningococcal disease
1358552|NCT01339923|Vaccines|vaccines
1358553|NCT01339923|intercalated administration|intercalated administration
1358554|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
1358555|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
1358556|NCT01339897|N6022, GSNORi|n6022, gsnori
1358557|NCT01339884|Friedreich ataxia|friedreich ataxia
1358558|NCT01339884|Resveratrol|resveratrol
1358559|NCT01339884|Frataxin|frataxin
1358560|NCT01339884|Cardiomyopathy|cardiomyopathy
1358561|NCT01339884|Oxidative stress|oxidative stress
1358562|NCT01339871|Pazopanib|pazopanib
1358563|NCT01339871|Vorinostat|vorinostat
1358564|NCT01339871|Advanced Malignancies|advanced malignancies
1358565|NCT01339845|Cholera vaccine|cholera vaccine
1358566|NCT01339845|Behaviour change intervention|behaviour change intervention
1358567|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
1358568|NCT01339845|Prevention of cholera|prevention of cholera
1358569|NCT01339845|Control of Cholera|control of cholera
1358570|NCT01339845|Vaccination|vaccination
1358571|NCT01339806|mTBI|mtbi
1358572|NCT01339806|Concussion|concussion
1358573|NCT01339793|corporate social responsibility|corporate social responsibility
1358574|NCT01339793|social identity theory|social identity theory
1358575|NCT01339793|stakeholder theory|stakeholder theory
1358576|NCT01339793|organizational commitment|organizational commitment
1358577|NCT01339793|organizational performance|organizational performance
1358578|NCT01339767|Autism|autism
1358579|NCT01339767|Language Acquisition|language acquisition
1358580|NCT01339767|Language Development|language development
1358581|NCT01339767|Toddlers|toddlers
1358582|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
1358583|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
1358584|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1358585|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
1358586|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
1358587|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
1358588|NCT01339741|Vitamin D Supplement|vitamin d supplement
1358589|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
1358590|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
1358591|NCT01339715|Ryodoraku|ryodoraku
1358592|NCT01339715|Heart Rate Variability|heart rate variability
1358593|NCT01339715|Traditional medicine|traditional medicine
1358594|NCT01339715|Autonomic Nervous System|autonomic nervous system
1358595|NCT01339715|Acupuncture|acupuncture
1358596|NCT01339715|Far Infrared Ray|far infrared ray
1358597|NCT01339715|CV12 Acupoint|cv12 acupoint
1358598|NCT01339702|Traumatic Brain Injury|traumatic brain injury
1358599|NCT01339702|TBI|tbi
1358600|NCT01339702|Head Trauma|head trauma
1358601|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
1358602|NCT01339702|Trauma, Brain|trauma, brain
1358603|NCT01339689|PTSD|ptsd
1358604|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
1358605|NCT01339689|pharmacotherapy|pharmacotherapy
1358606|NCT01339689|ganaxolone|ganaxolone
1358607|NCT01339676|Vitamin D|vitamin d
1358608|NCT01339676|Multiple Sclerosis|multiple sclerosis
1358609|NCT01339676|MRI|mri
1358610|NCT01339676|Randomised Trial|randomised trial
1358611|NCT01339676|Finland|finland
1358612|NCT01339650|Solid Tumor|solid tumor
1358613|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
1358614|NCT01339650|Breast Cancer 1|breast cancer 1
1358615|NCT01339650|Breast Cancer 2|breast cancer 2
1358616|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
1358617|NCT01339650|Solid Tumors|solid tumors
1358618|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
1358619|NCT01339637|Diabetes Risk Factors|diabetes risk factors
1358620|NCT01339637|Dark Skin|dark skin
1358621|NCT01339624|analgesia|analgesia
1358622|NCT01339624|renal colic|renal colic
1358623|NCT01339624|ketorolac|ketorolac
1358624|NCT01339624|nasal fentanyl|nasal fentanyl
1358625|NCT01339624|morphine.|morphine.
1358626|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
1358627|NCT01339611|quality of life|quality of life
1358628|NCT01339611|medical adherence|medical adherence
1358629|NCT01339611|warfarin|warfarin
1358630|NCT01339611|Health education|health education
1358631|NCT01339572|autologous transplantation|autologous transplantation
1358632|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
1358633|NCT01339559|Epilepsy|epilepsy
1358634|NCT01339559|Brivaracetam|brivaracetam
1358635|NCT01339559|Partial Onset Seizures|partial onset seizures
1358636|NCT01339559|Adjunctive treatment|adjunctive treatment
1358637|NCT01339546|ecologic|ecologic
1358638|NCT01339546|cross sectional|cross sectional
1358639|NCT01339546|trend analysis|trend analysis
1358640|NCT01339533|ALI|ali
1358641|NCT01339533|ARDS|ards
1358642|NCT01339481|Orencia|orencia
1358643|NCT01339481|Abatacept|abatacept
1358644|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
1358645|NCT01339481|Infusion|infusion
1358646|NCT01339468|advagraf|advagraf
1358647|NCT01339468|prograf|prograf
1358648|NCT01339468|living donor liver transplantation|living donor liver transplantation
1358649|NCT01339468|FK506|fk506
1358650|NCT01339468|Immunosuppressant|immunosuppressant
1358651|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
1358652|NCT01339455|NMO|nmo
1358653|NCT01339455|Devic's Disease|devic's disease
1358654|NCT01339455|Stem Cell Transplant|stem cell transplant
1358655|NCT01339429|wound|wound
1358656|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
1358657|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
1358658|NCT01339390|Obesity|obesity
1358659|NCT01339390|Veteran|veteran
1358660|NCT01339390|Self Care|self care
1358661|NCT01339390|Patient Education|patient education
1358662|NCT01339390|Peer Group|peer group
1358663|NCT01339377|Ozone|ozone
1358664|NCT01339377|Oxygen|oxygen
1358665|NCT01339377|Oxygen-Ozone|oxygen-ozone
1358666|NCT01339377|AO-1000|ao-1000
1358667|NCT01339377|ActiveO|activeo
1358668|NCT01339377|Herniated Disc|herniated disc
1358669|NCT01339377|Disc|disc
1358670|NCT01339377|Lumbar|lumbar
1358671|NCT01339351|breast cancer|breast cancer
1358672|NCT01339351|social connection|social connection
1358673|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
1358674|NCT01339325|Quality of Life|quality of life
1358675|NCT01339325|Postoperative Pain|postoperative pain
1358676|NCT01339325|Cosmetics|cosmetics
1358677|NCT01339325|Complication|complication
1358678|NCT01339312|Rabies|rabies
1358679|NCT01339312|Rabies virus|rabies virus
1358680|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
1358681|NCT01339299|COS|cos
1358682|NCT01339299|ART|art
1358683|NCT01339299|Infertility|infertility
1358684|NCT01339273|TAP block|tap block
1358685|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
1358686|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
1358687|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
1358688|NCT01339247|Bioequivalence|bioequivalence
1358689|NCT01339247|Paroxetine reference/test|paroxetine reference/test
1358690|NCT01339247|healthy volunteers|healthy volunteers
1358691|NCT01339247|Fed condition|fed condition
1358692|NCT01339234|treadmill exercise|treadmill exercise
1358693|NCT01339234|rehabilitation|rehabilitation
1358694|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
1358695|NCT01339234|functional ability|functional ability
1358696|NCT01339234|quality of life|quality of life
1358698|NCT01339221|Observational|observational
1358699|NCT01339221|Rotarix™|rotarix™
1358700|NCT01339221|post-marketing|post-marketing
1358701|NCT01339208|Type 2 Diabetes|type 2 diabetes
1358702|NCT01339195|Dementia|dementia
1358703|NCT01339195|Alzheimer disease|alzheimer disease
1358704|NCT01339195|stroke|stroke
1358705|NCT01339195|cognitive impairment|cognitive impairment
1358706|NCT01339182|somatropin|somatropin
1358707|NCT01339182|PK|pk
1358708|NCT01339182|PD|pd
1358709|NCT01339182|male|male
1358710|NCT01339182|pharmacokinetics|pharmacokinetics
1358711|NCT01339182|pharmacodynamics|pharmacodynamics
1358712|NCT01339182|safety|safety
1358713|NCT01339169|YF476|yf476
1358714|NCT01339169|Hypergastrinaemia|hypergastrinaemia
1358715|NCT01339169|netazepide|netazepide
1358716|NCT01339169|gastric carcinoids|gastric carcinoids
1358717|NCT01339156|Safety|safety
1358718|NCT01339156|Tolerability|tolerability
1358719|NCT01339156|Food Effect|food effect
1358720|NCT01339156|Pharmacokinetics|pharmacokinetics
1358721|NCT01339143|Vildagliptin|vildagliptin
1358722|NCT01339130|Alzheimer disease|alzheimer disease
1358723|NCT01339130|Stroke|stroke
1358724|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
1358725|NCT01339130|Lewy Body Dementia|lewy body dementia
1358726|NCT01339130|Huntington Disease|huntington disease
1358727|NCT01339130|mild cognitive impairment|mild cognitive impairment
1358728|NCT01339130|vascular injury|vascular injury
1358729|NCT01339130|Parkinson's disease|parkinson's disease
1358730|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
1358731|NCT01339117|children|children
1358732|NCT01339117|chronic abdominal pain|chronic abdominal pain
1358733|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
1358734|NCT01339104|Cardiovascular safety|cardiovascular safety
1358735|NCT01339078|Biliary strictures|biliary strictures
1358736|NCT01339078|liver transplantation|liver transplantation
1358737|NCT01339065|ketamine|ketamine
1358738|NCT01339065|inflammatory|inflammatory
1358739|NCT01339065|pro inflammatory|pro inflammatory
1358740|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
1358741|NCT01339052|BKM120|bkm120
1358742|NCT01339052|Brain tumor|brain tumor
1358743|NCT01339039|AMD3100|amd3100
1358744|NCT01339039|plerixafor|plerixafor
1358745|NCT01339039|Mozobil|mozobil
1358746|NCT01339039|bevacizumab|bevacizumab
1358747|NCT01339026|Acute coronary syndrome|acute coronary syndrome
1358748|NCT01339026|Platelet reactivity|platelet reactivity
1358749|NCT01339026|Clopidogrel|clopidogrel
1358750|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
1358751|NCT01339013|Quantification|quantification
1358752|NCT01339013|ventilatory requirements|ventilatory requirements
1358753|NCT01339013|charcoal filter|charcoal filter
1358754|NCT01339000|Colorectal Cancer|colorectal cancer
1358755|NCT01339000|Breast Cancer|breast cancer
1358756|NCT01339000|Immunization|immunization
1358757|NCT01339000|Immunocompromised Host|immunocompromised host
1358758|NCT01339000|Bladder Cancer|bladder cancer
1358759|NCT01339000|Colon Cancer|colon cancer
1358761|NCT01338987|Lupron|lupron
1358762|NCT01338987|Thymic Renewal|thymic renewal
1358763|NCT01338987|Stem Cell Transplant|stem cell transplant
1358764|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1358765|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
1358766|NCT01338987|Myelodyplastic Syndrome|myelodyplastic syndrome
1359053|NCT01337765|BEZ235,|bez235,
1358767|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1358768|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1358769|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1358770|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1358771|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1358772|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1358773|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1358774|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1358775|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1358776|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1358777|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1358778|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1358779|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1358780|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1358781|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1358782|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1358783|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
1358784|NCT01338961|Hypothermia|hypothermia
1358785|NCT01338961|Normothermia|normothermia
1358786|NCT01338961|Troponin I|troponin i
1358787|NCT01338961|Bleeding|bleeding
1358788|NCT01338935|CW 002|cw 002
1358789|NCT01338935|Phase I trial|phase i trial
1358790|NCT01338935|safety|safety
1358791|NCT01338935|efficacy|efficacy
1358792|NCT01338935|pharmacokinetics|pharmacokinetics
1358793|NCT01338935|estimated dose|estimated dose
1358794|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
1358795|NCT01338935|Treatment Effectiveness|treatment effectiveness
1358796|NCT01338935|Drug Antagonism|drug antagonism
1358797|NCT01338909|prasugrel|prasugrel
1358798|NCT01338909|clopidogrel|clopidogrel
1358799|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1358800|NCT01338909|high platelet reactivity|high platelet reactivity
1358801|NCT01338896|Rotigotine|rotigotine
1358802|NCT01338896|Neupro|neupro
1358803|NCT01338883|HIV-1 Infection|hiv-1 infection
1358804|NCT01338883|CCR5-tropic|ccr5-tropic
1358805|NCT01338883|Anti-retroviral naive|anti-retroviral naive
1358806|NCT01338870|Phase 2|phase 2
1358807|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
1358808|NCT01338870|Type 2 diabetes|type 2 diabetes
1358809|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
1358810|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
1358811|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
1358812|NCT01338857|sorafenib|sorafenib
1358813|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
1358814|NCT01338844|Poor oocyte quality|poor oocyte quality
1358815|NCT01338844|IVF failure|ivf failure
1358816|NCT01338831|prostate cancer,|prostate cancer,
1358817|NCT01338831|breast cancer,|breast cancer,
1358818|NCT01338831|prolactin,|prolactin,
1358819|NCT01338831|prolactin receptor|prolactin receptor
1358820|NCT01338831|uterine leiomyoma|uterine leiomyoma
1358821|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
1358822|NCT01338818|hyperactivity|hyperactivity
1358823|NCT01338805|Partial onset seizure|partial onset seizure
1358824|NCT01338805|seizure frequency|seizure frequency
1358825|NCT01338805|nervous system diseases|nervous system diseases
1358826|NCT01338805|central nervous system diseases|central nervous system diseases
1358827|NCT01338805|CNS|cns
1358828|NCT01338805|brain diseases|brain diseases
1358829|NCT01338805|neurologic manifestations|neurologic manifestations
1358830|NCT01338805|adjunctive treatment|adjunctive treatment
1358831|NCT01338805|AEDs|aeds
1358832|NCT01338805|antiepileptic drug|antiepileptic drug
1358833|NCT01338779|Tolerance|tolerance
1358834|NCT01338779|Renal|renal
1358835|NCT01338779|Allograft|allograft
1358836|NCT01338779|B Cell Signature|b cell signature
1358837|NCT01338766|spondylolisthesis|spondylolisthesis
1358838|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
1358839|NCT01338753|breast|breast
1358840|NCT01338753|cancer|cancer
1358841|NCT01338753|Pharmacogenomics|pharmacogenomics
1358842|NCT01338753|bevacizumab|bevacizumab
1358843|NCT01338740|Chrohn's disease|chrohn's disease
1358844|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
1358845|NCT01338714|HBV carrier|hbv carrier
1358846|NCT01338714|HBV DNA title|hbv dna title
1358847|NCT01338714|Chinese Medicine|chinese medicine
1358848|NCT01338714|Liver function|liver function
1358849|NCT01338714|RHD-1|rhd-1
1358850|NCT01338701|TBI|tbi
1358851|NCT01338701|Headaches|headaches
1358852|NCT01338701|Military|military
1358853|NCT01338701|Acupuncture|acupuncture
1358854|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
1358855|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
1358856|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
1358857|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1358858|NCT01338662|Parkinson`s disease|parkinson`s disease
1358859|NCT01338649|Parkinson's disease|parkinson's disease
1358860|NCT01338649|Daytime somnolence|daytime somnolence
1358861|NCT01338649|Sleepiness|sleepiness
1358862|NCT01338649|Light therapy|light therapy
1358863|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
1358864|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
1358865|NCT01338636|ambrisentan|ambrisentan
1358866|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
1358867|NCT01338623|bioequivalence|bioequivalence
1358868|NCT01338623|tansulosine|tansulosine
1358869|NCT01338610|Ocular discomfort|ocular discomfort
1358870|NCT01338597|thyroidectomy|thyroidectomy
1358871|NCT01338597|invasiveness|invasiveness
1358872|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
1358873|NCT01338584|Post prostatectomy|post prostatectomy
1358874|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
1358875|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
1359587|NCT01335776|CBT-I|cbt-i
1358876|NCT01338571|stool fatty acid|stool fatty acid
1358877|NCT01338532|Hip osteoarthritis|hip osteoarthritis
1358878|NCT01338532|Exercise|exercise
1358879|NCT01338532|Patient Education|patient education
1358880|NCT01338532|Total Hip Replacement|total hip replacement
1358881|NCT01338506|Military|military
1358882|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
1358883|NCT01338506|PTSD|ptsd
1358884|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
1358885|NCT01338506|Combat|combat
1358886|NCT01338506|Psychological Treatment|psychological treatment
1358887|NCT01338506|Psychotherapy|psychotherapy
1358888|NCT01338506|Trauma|trauma
1358889|NCT01338506|Posttraumatic Stress|posttraumatic stress
1358890|NCT01338506|Prolonged Exposure|prolonged exposure
1358891|NCT01338506|Exposure therapy|exposure therapy
1358892|NCT01338506|Behavior Therapy|behavior therapy
1358893|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
1358894|NCT01338506|Stress Disorders|stress disorders
1358895|NCT01338506|Drug Abuse|drug abuse
1358896|NCT01338506|Drug Dependence|drug dependence
1358897|NCT01338506|Alcohol Abuse|alcohol abuse
1358898|NCT01338506|Alcohol Dependence|alcohol dependence
1358899|NCT01338506|Substance Use Disorders|substance use disorders
1358900|NCT01338506|Alcoholism|alcoholism
1358901|NCT01338480|trauma|trauma
1358902|NCT01338480|surgery|surgery
1358903|NCT01338480|informed consent|informed consent
1358904|NCT01338467|Glaucoma|glaucoma
1358905|NCT01338467|Refractory glaucoma|refractory glaucoma
1358906|NCT01338467|Cyclocoagulation|cyclocoagulation
1358907|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
1358908|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
1358909|NCT01338428|rape|rape
1358910|NCT01338428|sexual assault|sexual assault
1358911|NCT01338428|intervention|intervention
1358912|NCT01338428|female university students|female university students
1358913|NCT01338415|pediatric|pediatric
1358914|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
1358915|NCT01338415|bosentan|bosentan
1358916|NCT01338415|Tracleer|tracleer
1358917|NCT01338363|acid suppressing drugs|acid suppressing drugs
1358918|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
1358919|NCT01338363|children|children
1358920|NCT01338350|safety|safety
1358921|NCT01338350|tolerability|tolerability
1358922|NCT01338350|pharmacokinetics|pharmacokinetics
1358923|NCT01338350|pharmacodynamics|pharmacodynamics
1358924|NCT01338350|AZD5423|azd5423
1358925|NCT01338350|Japanese|japanese
1358926|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
1358927|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
1358928|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
1358929|NCT01338324|Biomarker|biomarker
1358930|NCT01338324|Pharmacokinetics|pharmacokinetics
1358931|NCT01338324|Villous|villous
1358932|NCT01338324|Simvastatin|simvastatin
1358933|NCT01338324|Celiac disease|celiac disease
1358934|NCT01338298|Schizophrenia|schizophrenia
1358935|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
1358936|NCT01338298|Hormone|hormone
1358937|NCT01338298|Menstrual|menstrual
1358938|NCT01338285|Industry Hygiene|industry hygiene
1358939|NCT01338285|Molecular Epidemiology|molecular epidemiology
1358940|NCT01338285|Cancer Susceptability|cancer susceptability
1358941|NCT01338285|Genotoxocity|genotoxocity
1358942|NCT01338285|FISH|fish
1358943|NCT01338142|postmenopausal|postmenopausal
1358944|NCT01338142|women|women
1358945|NCT01338142|absorption|absorption
1358946|NCT01338142|calcium|calcium
1358947|NCT01338142|amorphous calcium|amorphous calcium
1358948|NCT01338129|vitamin c|vitamin c
1358949|NCT01338129|ascorbic acid|ascorbic acid
1358950|NCT01338129|ankle fracture|ankle fracture
1358951|NCT01338129|crps|crps
1358952|NCT01338129|rds|rds
1358953|NCT01338129|crps prevention|crps prevention
1358954|NCT01338116|computerized decision support system|computerized decision support system
1358955|NCT01338116|PCR|pcr
1358956|NCT01338116|antibiotic treatment|antibiotic treatment
1358957|NCT01338103|Pemphigus|pemphigus
1358958|NCT01338103|Rituximab|rituximab
1358959|NCT01338103|Cylex|cylex
1358960|NCT01338090|VEGF imaging|vegf imaging
1358961|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
1358962|NCT01338090|biomarker|biomarker
1358963|NCT01338090|mTOR inhibition|mtor inhibition
1358964|NCT01338077|Alginate|alginate
1358965|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
1358966|NCT01338064|Silicosis|silicosis
1358967|NCT01338051|Community based participatory research|community based participatory research
1358968|NCT01338025|HIV|hiv
1358969|NCT01338025|Bridging|bridging
1358970|NCT01338025|Strategy|strategy
1358971|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
1358972|NCT01338012|prostate cancer|prostate cancer
1358973|NCT01338012|prostate|prostate
1358974|NCT01338012|immune therapy|immune therapy
1358975|NCT01338012|immunotherapy|immunotherapy
1358977|NCT01338012|dendritic cells|dendritic cells
1358978|NCT01338012|antigen-presenting cells|antigen-presenting cells
1358979|NCT01338012|antigen presenting cells|antigen presenting cells
1358980|NCT01338012|cancer vaccine|cancer vaccine
1358981|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
1358982|NCT01338012|Sipuleucel-T|sipuleucel-t
1358983|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
1358984|NCT01338012|booster|booster
1358985|NCT01338012|retreatment|retreatment
1358986|NCT01338012|immune memory|immune memory
1358987|NCT01338012|immune response|immune response
1358988|NCT01337986|Multiple Sclerosis|multiple sclerosis
1358989|NCT01337986|Optic Neuritis|optic neuritis
1358990|NCT01337986|Ampyra|ampyra
1358991|NCT01337986|Dalfampridine|dalfampridine
1358992|NCT01337986|Fampridine|fampridine
1358993|NCT01337986|Remote Optic Neuritis|remote optic neuritis
1358994|NCT01337986|Contrast Sensitivity|contrast sensitivity
1358995|NCT01337986|Treatment|treatment
1358996|NCT01337973|violence|violence
1358997|NCT01337973|aggression|aggression
1358998|NCT01337973|Substance-Related Disorders|substance-related disorders
1358999|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
1359000|NCT01337973|Drug-Related Disorders|drug-related disorders
1359001|NCT01337960|Stroke|stroke
1359002|NCT01337960|Robotics|robotics
1359003|NCT01337960|Neurorehabilitation|neurorehabilitation
1359004|NCT01337947|Type 1 diabetes|type 1 diabetes
1359005|NCT01337947|adolescents|adolescents
1359006|NCT01337947|exercise|exercise
1359007|NCT01337947|vascular function|vascular function
1359008|NCT01337934|Septic shock|septic shock
1359009|NCT01337934|Sepsis|sepsis
1359010|NCT01337934|Albumin|albumin
1359011|NCT01337934|Lactated Ringer|lactated ringer
1359012|NCT01337908|depression|depression
1359013|NCT01337908|quality of life|quality of life
1359014|NCT01337908|disability|disability
1359015|NCT01337895|Dairy|dairy
1359016|NCT01337895|obesity|obesity
1359017|NCT01337895|overweight|overweight
1359018|NCT01337895|weight loss|weight loss
1359019|NCT01337895|adults|adults
1359020|NCT01337882|Air Pollution|air pollution
1359021|NCT01337882|Diesel exhaust|diesel exhaust
1359022|NCT01337882|Biodiesel exhaust|biodiesel exhaust
1359023|NCT01337882|Vascular function|vascular function
1359024|NCT01337882|Fibrinolysis|fibrinolysis
1359025|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
1359026|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
1359027|NCT01337856|time-effectiveness|time-effectiveness
1359028|NCT01337856|hand hygiene protocols|hand hygiene protocols
1359029|NCT01337843|Chronic low back pain|chronic low back pain
1359030|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
1359031|NCT01337843|coping|coping
1359032|NCT01337843|mindfulness|mindfulness
1359033|NCT01337843|physical activity|physical activity
1359034|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
1359035|NCT01337830|smoking|smoking
1359036|NCT01337830|smokeless|smokeless
1359037|NCT01337830|aversion|aversion
1359038|NCT01337830|nicotine|nicotine
1359039|NCT01337830|nicotine replacement|nicotine replacement
1359040|NCT01337817|smoking|smoking
1359041|NCT01337817|smokeless|smokeless
1359042|NCT01337817|aversion|aversion
1359043|NCT01337817|nicotine|nicotine
1359044|NCT01337817|nicotine replacement|nicotine replacement
1359045|NCT01337791|chronic hepatitis B|chronic hepatitis b
1359046|NCT01337791|hepatitis B virus|hepatitis b virus
1359047|NCT01337791|perinatal transmission|perinatal transmission
1359048|NCT01337791|Telbivudine|telbivudine
1359049|NCT01337778|gender based violence|gender based violence
1359050|NCT01337778|maternal and child health|maternal and child health
1359051|NCT01337778|women|women
1359052|NCT01337778|India|india
1359054|NCT01337765|MEK162|mek162
1359055|NCT01337765|RAS RAF mutations,|ras raf mutations,
1359056|NCT01337765|triple negative breast cancer|triple negative breast cancer
1359057|NCT01337765|pancreatic cancer,|pancreatic cancer,
1359058|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
1359059|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
1359060|NCT01337765|MEK inhibitor|mek inhibitor
1359061|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
1359062|NCT01337752|multiple myeloma|multiple myeloma
1359063|NCT01337752|renal insufficiency|renal insufficiency
1359064|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
1359065|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
1359066|NCT01337739|Dexmedetomidine|dexmedetomidine
1359067|NCT01337739|Sedation|sedation
1359068|NCT01337739|Opioids|opioids
1359069|NCT01337726|Depression|depression
1359070|NCT01337726|Heart Failure|heart failure
1359071|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1359072|NCT01337726|Quality of Life|quality of life
1359073|NCT01337726|Functional Impairment|functional impairment
1359074|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
1359076|NCT01337700|Autism|autism
1359077|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
1359078|NCT01337700|Asperger Syndrome|asperger syndrome
1359079|NCT01337700|Asperger|asperger
1359080|NCT01337700|PDD|pdd
1359081|NCT01337700|PDD-NOS|pdd-nos
1359082|NCT01337687|Autism|autism
1359083|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
1359084|NCT01337687|Oxytocin|oxytocin
1359085|NCT01337687|Hollander|hollander
1359086|NCT01337687|ASD|asd
1359087|NCT01337687|Asperger Syndrome|asperger syndrome
1359088|NCT01337687|Asperger|asperger
1568273|NCT00506428|aging|aging
1359089|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1359090|NCT01337661|COPD|copd
1359091|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
1359092|NCT01337661|AECOPD|aecopd
1359093|NCT01337648|Fecal biomarkers|fecal biomarkers
1359094|NCT01337648|Radiation biodosimetry|radiation biodosimetry
1359095|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
1359096|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1359097|NCT01337648|Gene expression profiles|gene expression profiles
1359098|NCT01337648|Fecal metabolites|fecal metabolites
1359099|NCT01337609|Depression|depression
1359100|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
1359101|NCT01337609|Probiotic|probiotic
1359102|NCT01337609|Bacillus Coagulans|bacillus coagulans
1359103|NCT01337596|pain|pain
1359104|NCT01337596|neuropathic pain|neuropathic pain
1359105|NCT01337596|headaches|headaches
1359106|NCT01337583|HIV Infections|hiv infections
1359107|NCT01337583|Anti-HIV agents|anti-hiv agents
1359108|NCT01337583|HIV-1|hiv-1
1359109|NCT01337570|HIV Infections|hiv infections
1359110|NCT01337570|Anti-HIV agents|anti-hiv agents
1359111|NCT01337570|HIV-1|hiv-1
1359112|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
1359113|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
1359114|NCT01337544|NK CELL|nk cell
1359115|NCT01337544|IL-15|il-15
1359116|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
1359117|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
1359118|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
1359119|NCT01337518|Prostate Specific Antigen|prostate specific antigen
1359120|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1359121|NCT01337518|Adenocarcinoma|adenocarcinoma
1359122|NCT01337518|Androgen Receptor|androgen receptor
1359123|NCT01337518|Metastases|metastases
1359124|NCT01337505|INNO-206|inno-206
1359125|NCT01337505|Phase 1|phase 1
1359126|NCT01337505|DOXO-EMCH|doxo-emch
1359127|NCT01337505|Advanced solid tumors|advanced solid tumors
1359128|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
1359129|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
1359130|NCT01337466|Phase I|phase i
1359131|NCT01337466|FIAU|fiau
1359132|NCT01337466|Fialuridine|fialuridine
1359133|NCT01337466|Biodistribution|biodistribution
1359134|NCT01337466|Dosimetry|dosimetry
1359135|NCT01337466|Prosthetic|prosthetic
1359136|NCT01337466|Joint|joint
1359137|NCT01337466|Infection|infection
1359138|NCT01337466|PET-CT|pet-ct
1359139|NCT01337453|botulinum toxin|botulinum toxin
1359140|NCT01337453|flu like symptoms|flu like symptoms
1359141|NCT01337453|frequency of FLS|frequency of fls
1359142|NCT01337453|Botox|botox
1359143|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
1359144|NCT01337440|sitagliptin|sitagliptin
1359145|NCT01337440|bile acids|bile acids
1359146|NCT01337440|GLP-1|glp-1
1359147|NCT01337427|multiple sclerosis|multiple sclerosis
1359148|NCT01337427|relapsing|relapsing
1359150|NCT01337427|injectable|injectable
1359151|NCT01337427|subcutaneous|subcutaneous
1359152|NCT01337427|SC|sc
1359153|NCT01337427|PEGylated|pegylated
1359154|NCT01337427|interferon|interferon
1359155|NCT01337427|PEG|peg
1359156|NCT01337427|OCT|oct
1359157|NCT01337427|Optical Coherence Tomography|optical coherence tomography
1359158|NCT01337414|age-related macular degeneration|age-related macular degeneration
1359159|NCT01337414|screening|screening
1359160|NCT01337414|monitoring|monitoring
1359161|NCT01337414|diagnosis|diagnosis
1359162|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
1359163|NCT01337401|Cediranib|cediranib
1359164|NCT01337401|ASPS|asps
1359165|NCT01337401|Sarcoma|sarcoma
1359166|NCT01337362|Diabetes|diabetes
1359167|NCT01337362|Hypoglycaemia|hypoglycaemia
1359168|NCT01337362|EEG|eeg
1359169|NCT01337362|Thermography|thermography
1359170|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
1359171|NCT01337362|QTc interval|qtc interval
1359172|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
1359173|NCT01337362|Hormone response|hormone response
1359174|NCT01337349|Pentoxifylline|pentoxifylline
1359175|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
1359176|NCT01337349|Left Systolic Function|left systolic function
1359177|NCT01337349|Biomarkers|biomarkers
1359178|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
1359179|NCT01337310|Advanced solid tumors|advanced solid tumors
1359180|NCT01337297|crack cocaine|crack cocaine
1359181|NCT01337297|addiction|addiction
1359182|NCT01337297|tDCS|tdcs
1359183|NCT01337297|ERP|erp
1359184|NCT01337297|P300|p300
1359185|NCT01337297|attention|attention
1359186|NCT01337297|inhibitory control|inhibitory control
1359187|NCT01337297|working memory|working memory
1359188|NCT01337271|artificial, ventilation|artificial, ventilation
1359189|NCT01337271|mechanical ventilation|mechanical ventilation
1359190|NCT01337271|weaning|weaning
1359191|NCT01337258|cost effectiveness|cost effectiveness
1359192|NCT01337258|dutasteride|dutasteride
1359193|NCT01337258|elevated risk population|elevated risk population
1359194|NCT01337258|Prostate cancer|prostate cancer
1359195|NCT01337258|prevention|prevention
1359196|NCT01337245|Envenomation|envenomation
1359197|NCT01337245|Coral Snake|coral snake
1359198|NCT01337245|Antivenom|antivenom
1359199|NCT01337245|Micrurus fulvius|micrurus fulvius
1359200|NCT01337232|language development disorders|language development disorders
1359201|NCT01337232|learning disorders|learning disorders
1359202|NCT01337232|sentences|sentences
1359203|NCT01337232|syntax|syntax
1359204|NCT01337232|school-age|school-age
1359205|NCT01337232|language|language
1359206|NCT01337219|cystic fibrosis|cystic fibrosis
1359207|NCT01337219|bioequivalence|bioequivalence
1359208|NCT01337219|pharmacokinetic|pharmacokinetic
1359209|NCT01337219|sputum|sputum
1359210|NCT01337219|plasma|plasma
1359211|NCT01337206|Esophageal Stenosis|esophageal stenosis
1359212|NCT01337206|Esopageal Strictures|esopageal strictures
1359213|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
1359214|NCT01337193|stress urinary incontinence|stress urinary incontinence
1359215|NCT01337193|exercise|exercise
1359216|NCT01337193|pelvic floor muscles|pelvic floor muscles
1359217|NCT01337193|biofeedback|biofeedback
1359218|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
1359219|NCT01337180|lung function|lung function
1359220|NCT01337180|respiratory symptoms|respiratory symptoms
1359221|NCT01337180|dust|dust
1359222|NCT01337180|inflammation|inflammation
1359223|NCT01337180|prospective|prospective
1359224|NCT01337167|Diphtheria|diphtheria
1359225|NCT01337167|Tetanus|tetanus
1359226|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
1359227|NCT01337167|Poliomyelitis|poliomyelitis
1359228|NCT01337167|Hepatitis B infection|hepatitis b infection
1359229|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
1359230|NCT01337154|NSCLC|nsclc
1359231|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
1359232|NCT01337154|tamibarotene|tamibarotene
1359233|NCT01337141|Telemedicine|telemedicine
1359234|NCT01337141|Type 1 diabetes|type 1 diabetes
1359235|NCT01337141|Metabolic control optimisation|metabolic control optimisation
1359236|NCT01337141|Health care costs|health care costs
1359237|NCT01337141|Intervention study|intervention study
1359238|NCT01337141|Access to internet|access to internet
1359239|NCT01337115|Postoperative pain|postoperative pain
1359240|NCT01337115|Knee arthroplasty|knee arthroplasty
1359241|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
1359242|NCT01337115|Sciatic nerve block|sciatic nerve block
1359243|NCT01337115|Femoral nerve block|femoral nerve block
1359244|NCT01337102|Lung Cancer|lung cancer
1359245|NCT01337102|Stage 3b|stage 3b
1359246|NCT01337102|Stage 4|stage 4
1359247|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
1359248|NCT01337102|Quality Of Life|quality of life
1359249|NCT01337102|Palliative Care|palliative care
1359250|NCT01337102|Randomized|randomized
1359251|NCT01337102|Lung Cancer Scale|lung cancer scale
1359252|NCT01337089|Cancer pain|cancer pain
1359253|NCT01337089|Opioid therapy|opioid therapy
1359254|NCT01337089|Inadequate analgesia|inadequate analgesia
1359255|NCT01337089|Optimized chronic opioid therapy|optimized chronic opioid therapy
1359256|NCT01337063|Adverse drug events|adverse drug events
1359257|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
1359258|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
1359259|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
1359260|NCT01337037|Lung cancer|lung cancer
1359261|NCT01337037|lobectomy|lobectomy
1359262|NCT01337024|HRV|hrv
1359263|NCT01337024|NDO|ndo
1359264|NCT01337024|BoNT/A,|bont/a,
1359265|NCT01337024|adverse effects|adverse effects
1359266|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
1359267|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
1359268|NCT01336998|arginine supplementation|arginine supplementation
1359269|NCT01336998|calprotectin|calprotectin
1359270|NCT01336985|Chemoembolization|chemoembolization
1359271|NCT01336985|Hepatic Metastases|hepatic metastases
1359272|NCT01336985|Irinotecan|irinotecan
1359273|NCT01336985|Drug Eluding Beads|drug eluding beads
1359274|NCT01336985|Colorectal Cancer|colorectal cancer
1359275|NCT01336985|Liver Cancer|liver cancer
1359276|NCT01336985|Hepatic Cancer|hepatic cancer
1359277|NCT01336985|Melanoma|melanoma
1359278|NCT01336959|Acute Kidney Injury|acute kidney injury
1359279|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
1359280|NCT01336959|CABG|cabg
1359281|NCT01336959|Cardiac Surgery|cardiac surgery
1359282|NCT01336946|lifestyle|lifestyle
1359283|NCT01336946|mental disorder|mental disorder
1359285|NCT01336907|AMD|amd
1359286|NCT01336907|Wet-treated CNV|wet-treated cnv
1359287|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1475131|NCT00876681|UCSD|ucsd
1359288|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1359289|NCT01336855|HIV|hiv
1359290|NCT01336855|Observational|observational
1359291|NCT01336855|Pathogenesis|pathogenesis
1359292|NCT01336855|Immunology|immunology
1359293|NCT01336855|Virology|virology
1359294|NCT01336855|Control|control
1359295|NCT01336855|Healthy control|healthy control
1359296|NCT01336855|Men who have sex with men|men who have sex with men
1359297|NCT01336842|panobinostat|panobinostat
1359298|NCT01336842|cisplatin|cisplatin
1359299|NCT01336842|pemetrexed|pemetrexed
1359300|NCT01336842|dose escalation|dose escalation
1359301|NCT01336829|Hepatitis C|hepatitis c
1359302|NCT01336829|HIV|hiv
1359303|NCT01336829|TMC125IFD1001|tmc125ifd1001
1359304|NCT01336829|TMC125|tmc125
1359305|NCT01336829|Intelence|intelence
1359306|NCT01336829|etravirine|etravirine
1359307|NCT01336829|ETR|etr
1359308|NCT01336829|TMC278|tmc278
1359309|NCT01336829|telaprevir|telaprevir
1359310|NCT01336829|TVR|tvr
1359311|NCT01336829|VX-950|vx-950
1359312|NCT01336829|healthy volunteers|healthy volunteers
1359313|NCT01336829|crossover|crossover
1359314|NCT01336816|smoking|smoking
1359315|NCT01336816|smokeless|smokeless
1359316|NCT01336816|aversion|aversion
1359317|NCT01336816|nicotine|nicotine
1359318|NCT01336816|nicotine replacement|nicotine replacement
1359319|NCT01336790|Lymphatic disease|lymphatic disease
1359320|NCT01336790|Lymphedema|lymphedema
1359321|NCT01336790|Lymphangiomatosis|lymphangiomatosis
1359322|NCT01336790|Lymphangiectasia|lymphangiectasia
1359323|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
1359324|NCT01336790|Vascular Anomalies|vascular anomalies
1359325|NCT01336777|obesity|obesity
1359326|NCT01336777|adipocyte differentiation|adipocyte differentiation
1359327|NCT01336777|inflammation|inflammation
1359328|NCT01336777|insulin resistance|insulin resistance
1359329|NCT01336777|visceral fat|visceral fat
1359330|NCT01336777|regional fat depots|regional fat depots
1359331|NCT01336764|driving distress|driving distress
1359332|NCT01336764|veterans|veterans
1359333|NCT01336764|OEF/OIF|oef/oif
1359334|NCT01336738|Phase 2|phase 2
1359335|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
1359336|NCT01336738|Type 2 diabetes|type 2 diabetes
1359337|NCT01336725|Morbid obesity|morbid obesity
1359338|NCT01336725|Patient education|patient education
1359339|NCT01336712|CML|cml
1359340|NCT01336712|CLL|cll
1359341|NCT01336712|AML|aml
1359342|NCT01336712|ALL|all
1359343|NCT01336712|MDS|mds
1359344|NCT01336712|HD|hd
1359345|NCT01336712|NHL|nhl
1359346|NCT01336712|MFB|mfb
1359347|NCT01336712|P.vera|p.vera
1359348|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
1359349|NCT01336699|shigellosis, vaccine, Shigella sonnei, WRSs2, WRSs3|shigellosis, vaccine, shigella sonnei, wrss2, wrss3
1359350|NCT01336673|Glucophage XR|glucophage xr
1359351|NCT01336673|Tolerability|tolerability
1359352|NCT01336660|Effectiveness|effectiveness
1359353|NCT01336660|New Antivenom|new antivenom
1359354|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
1359355|NCT01336634|BRAF V600E|braf v600e
1359356|NCT01336634|trametinib|trametinib
1359357|NCT01336634|dabrafenib|dabrafenib
1359358|NCT01336634|GSK2118436|gsk2118436
1359359|NCT01336634|GSK1120212|gsk1120212
1359360|NCT01336634|Oncology|oncology
1359361|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
1359362|NCT01336621|Partial-onset seizures|partial-onset seizures
1359363|NCT01336621|retigabine IR|retigabine ir
1359364|NCT01336621|Open Label Extension|open label extension
1359365|NCT01336621|GW582892|gw582892
1359366|NCT01336621|Epilepsy|epilepsy
1359367|NCT01336595|total knee arthroplasty|total knee arthroplasty
1359368|NCT01336595|oxidized zirconium|oxidized zirconium
1359369|NCT01336595|genesis II|genesis ii
1359370|NCT01336595|femoral component|femoral component
1359371|NCT01336595|cobalt chrome|cobalt chrome
1359372|NCT01336582|suitable candidate|suitable candidate
1359373|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
1359374|NCT01336582|Advanced Solid Tumor|advanced solid tumor
1359375|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
1359376|NCT01336569|Ocular Hypertension|ocular hypertension
1359377|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
1359378|NCT01336569|IOP|iop
1359379|NCT01336556|Oral appliance|oral appliance
1359380|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
1359381|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1359382|NCT01336556|Snore|snore
1359383|NCT01336543|Non small cell lung cancer|non small cell lung cancer
1359384|NCT01336543|Inoperable Stage III|inoperable stage iii
1359385|NCT01336543|Inoperable|inoperable
1359386|NCT01336543|Stage III|stage iii
1359387|NCT01336530|Oesophageal pain|oesophageal pain
1359388|NCT01336530|Radiotherapy|radiotherapy
1359389|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
1359390|NCT01336530|Oesophageal symptoms|oesophageal symptoms
1359391|NCT01336517|Stroke|stroke
1359392|NCT01336517|Hemiplegia|hemiplegia
1359393|NCT01336517|AFO|afo
1359394|NCT01336517|Gait|gait
1359395|NCT01336478|NK|nk
1359396|NCT01336478|natural killer|natural killer
1359397|NCT01336478|immunotherapy|immunotherapy
1359398|NCT01336478|leukemia|leukemia
1359399|NCT01336478|hematological malignancies|hematological malignancies
1359400|NCT01336478|stem cell transplantation|stem cell transplantation
1359401|NCT01336478|adoptive therapy|adoptive therapy
1359402|NCT01336439|Bruxism|bruxism
1359403|NCT01336439|Polysomnography|polysomnography
1359404|NCT01336439|Botulinum toxin type A|botulinum toxin type a
1359405|NCT01336439|Masseter muscle|masseter muscle
1359406|NCT01336439|Temporal muscle|temporal muscle
1359407|NCT01336426|Peripheral Artery Disease|peripheral artery disease
1359408|NCT01336426|PAD|pad
1359409|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
1359410|NCT01336413|pregnenolone|pregnenolone
1359411|NCT01336413|Veteran|veteran
1359412|NCT01336413|OEF/OIF|oef/oif
1359413|NCT01336413|neurosteroid|neurosteroid
1359414|NCT01336413|allopregnanolone|allopregnanolone
1359415|NCT01336400|Single cell haplotyping|single cell haplotyping
1359416|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
1359417|NCT01336361|Palliative Care|palliative care
1359418|NCT01336361|Physical Therapy|physical therapy
1359419|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
1359420|NCT01336348|Prasugrel|prasugrel
1359421|NCT01336348|Tirofiban|tirofiban
1359422|NCT01336348|Clopidogrel|clopidogrel
1359423|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
1359424|NCT01336348|P2Y12 blockers|p2y12 blockers
1359425|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
1359426|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
1359427|NCT01336335|treatment|treatment
1359428|NCT01336322|beta-cell function|beta-cell function
1359429|NCT01336322|insulin resistance|insulin resistance
1359430|NCT01336309|Yoga|yoga
1359431|NCT01336283|COPD|copd
1359432|NCT01336283|Exercise Training|exercise training
1359433|NCT01336270|Melanoma|melanoma
1359434|NCT01336270|NK cells|nk cells
1359435|NCT01336270|T lymphocytes|t lymphocytes
1359436|NCT01336270|macrophages|macrophages
1359437|NCT01336257|Decision Support Techniques|decision support techniques
1359438|NCT01336257|Electronic Health Records|electronic health records
1359439|NCT01336257|Reminder Systems|reminder systems
1359440|NCT01336257|Early Detection of Cancer|early detection of cancer
1359441|NCT01336257|Mammography|mammography
1359442|NCT01336257|Women|women
1359443|NCT01336244|Safety|safety
1359444|NCT01336244|Tolerability|tolerability
1359445|NCT01336244|Pharmacokinetics|pharmacokinetics
1359446|NCT01336231|quality of life|quality of life
1359447|NCT01336231|cognitive functions|cognitive functions
1359448|NCT01336231|antiangiogenic agents|antiangiogenic agents
1359449|NCT01336231|kidney cancer|kidney cancer
1359450|NCT01336231|metastatic|metastatic
1359451|NCT01336218|Phase 1|phase 1
1359452|NCT01336218|healthy volunteers|healthy volunteers
1359453|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
1359454|NCT01336218|RA|ra
1359455|NCT01336218|Fostamatinib|fostamatinib
1359456|NCT01336218|Rifampicin|rifampicin
1359457|NCT01336218|drug-drug interaction|drug-drug interaction
1359458|NCT01336218|Pharmacokinetics|pharmacokinetics
1359459|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
1359460|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
1359461|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
1359462|NCT01336192|Advanced NSCLC|advanced nsclc
1359463|NCT01336192|Maintenance therapy|maintenance therapy
1359464|NCT01336192|Gemcitabine|gemcitabine
1359465|NCT01336179|gingivitis|gingivitis
1359466|NCT01336179|dental plaque|dental plaque
1359467|NCT01336179|oral hygiene|oral hygiene
1359468|NCT01336179|toothbrush|toothbrush
1359469|NCT01336179|chewing sticks|chewing sticks
1359470|NCT01336166|H1N1|h1n1
1359471|NCT01336166|Vaccine|vaccine
1359472|NCT01336166|Immunogenicity|immunogenicity
1359473|NCT01336166|Safety|safety
1359474|NCT01336153|Safety|safety
1359475|NCT01336153|Efficacy|efficacy
1359476|NCT01336153|MLC601|mlc601
1359477|NCT01336153|motor recovery|motor recovery
1359478|NCT01336140|regadenoson|regadenoson
1359479|NCT01336140|chronic kidney disease|chronic kidney disease
1359480|NCT01336140|renal failure|renal failure
1359481|NCT01336140|lexiscan|lexiscan
1359482|NCT01336140|aminophylline|aminophylline
1359483|NCT01336140|SPECT|spect
1359484|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
1359485|NCT01336140|pharmacologic stress test|pharmacologic stress test
1359610|NCT01335594|Endoscopy|endoscopy
1359611|NCT01335568|Hepatocyte|hepatocyte
1359583|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
1359584|NCT01335776|Actigraphy|actigraphy
1359585|NCT01335776|Noninferiority|noninferiority
1359586|NCT01335776|MBSR|mbsr
1567117|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
1567118|NCT00509951|Neuroses|neuroses
1568274|NCT00506428|sleep|sleep
1359486|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
1359487|NCT01336127|Occupational Therapy|occupational therapy
1359488|NCT01336127|Parkinson's Disease|parkinson's disease
1359489|NCT01336127|Effectiveness|effectiveness
1359490|NCT01336127|RCT|rct
1359491|NCT01336127|Activities of daily living|activities of daily living
1359492|NCT01336127|Participation|participation
1359493|NCT01336127|Caregiver's Burden|caregiver's burden
1359494|NCT01336127|Economic evaluation|economic evaluation
1359495|NCT01336101|PAD|pad
1359496|NCT01336101|SFA|sfa
1359497|NCT01336088|dyskinesia|dyskinesia
1359498|NCT01336088|Parkinson's disease|parkinson's disease
1359499|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
1359500|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
1359501|NCT01336062|advanced|advanced
1359502|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
1359503|NCT01336010|Hepatitis C|hepatitis c
1359504|NCT01336010|Acute Hepatitis C|acute hepatitis c
1359505|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
1359506|NCT01335997|Low-density lipoprotein|low-density lipoprotein
1359507|NCT01335997|LDL|ldl
1359508|NCT01335997|High-density lipoprotein|high-density lipoprotein
1359509|NCT01335997|HDL|hdl
1359510|NCT01335997|Niacin|niacin
1359511|NCT01335997|Lipid modifying therapy|lipid modifying therapy
1359512|NCT01335997|Cholesterol|cholesterol
1359513|NCT01335997|High cholesterol|high cholesterol
1359514|NCT01335997|Triglycerides|triglycerides
1359515|NCT01335984|telemonitoring|telemonitoring
1359516|NCT01335984|usual care|usual care
1359517|NCT01335984|telemedicine|telemedicine
1359518|NCT01335984|telehealth|telehealth
1359519|NCT01335984|home care|home care
1359520|NCT01335984|Health Care Quality|health care quality
1359521|NCT01335984|Access|access
1359522|NCT01335984|Evaluation|evaluation
1359523|NCT01335971|COPD|copd
1359524|NCT01335971|Nrf2|nrf2
1359525|NCT01335971|Sulforaphane|sulforaphane
1359526|NCT01335945|Cryoablation|cryoablation
1359527|NCT01335945|Cryotherapy|cryotherapy
1359528|NCT01335945|Cryosurgery|cryosurgery
1359529|NCT01335945|Pancreas|pancreas
1359530|NCT01335945|Pancreatic Cancer|pancreatic cancer
1359531|NCT01335945|Celiac Plexus|celiac plexus
1359532|NCT01335945|Pain|pain
1359533|NCT01335945|Abdominal pain|abdominal pain
1359534|NCT01335932|Acute Lung Injury|acute lung injury
1359535|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1359536|NCT01335932|Respiratory Failure|respiratory failure
1359537|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
1359538|NCT01335932|Infection|infection
1359539|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
1359540|NCT01335932|Non-immunocompromised|non-immunocompromised
1359541|NCT01335932|Valganciclovir|valganciclovir
1359542|NCT01335919|Hemoglobin|hemoglobin
1359543|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
1359544|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
1359545|NCT01335906|Cancer Screening Tests|cancer screening tests
1359546|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
1359547|NCT01335906|Mammography|mammography
1359548|NCT01335906|Informed Consent|informed consent
1359549|NCT01335906|Consent Forms|consent forms
1359550|NCT01335893|Imaging|imaging
1359551|NCT01335893|Indocyanine Green|indocyanine green
1359552|NCT01335893|Lung Cancer|lung cancer
1359553|NCT01335893|Lung Neoplasms|lung neoplasms
1359554|NCT01335893|Preliminary Study|preliminary study
1359555|NCT01335880|Obesity|obesity
1359556|NCT01335880|Heart Disease|heart disease
1359557|NCT01335880|Seniors|seniors
1359558|NCT01335880|Elderly|elderly
1359559|NCT01335880|Chronic Disease|chronic disease
1359560|NCT01335880|Prevention|prevention
1359561|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
1359562|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
1359563|NCT01335854|CPAP adherence|cpap adherence
1359564|NCT01335828|Echography|echography
1359565|NCT01335828|Elastography|elastography
1359566|NCT01335828|Thyroid nodules|thyroid nodules
1359567|NCT01335828|Needles punction|needles punction
1359568|NCT01335828|Thyroid surgery|thyroid surgery
1359569|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
1359570|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
1359571|NCT01335802|Pre-eclampsia|pre-eclampsia
1359572|NCT01335802|Gestational hypertension|gestational hypertension
1359573|NCT01335802|Pregnancy Complications|pregnancy complications
1359574|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
1359575|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
1359576|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
1359577|NCT01335789|marijuana|marijuana
1359578|NCT01335789|substance abuse|substance abuse
1359579|NCT01335789|drug abuse|drug abuse
1359580|NCT01335789|marijuana dependence|marijuana dependence
1359581|NCT01335789|drug addiction|drug addiction
1359582|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1359589|NCT01335763|Multicentre before-after design|multicentre before-after design
1359590|NCT01335763|Glycemic control|glycemic control
1359591|NCT01335763|Community pharmacists|community pharmacists
1359592|NCT01335750|corneal staining|corneal staining
1359593|NCT01335698|Pediatric|pediatric
1359594|NCT01335685|Drug Therapy|drug therapy
1359595|NCT01335672|Myocardial infarction|myocardial infarction
1359596|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1359597|NCT01335672|General Practice Research Database|general practice research database
1359598|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1359599|NCT01335672|CALIBER|caliber
1359600|NCT01335659|FFR|ffr
1359601|NCT01335659|IVUS|ivus
1359602|NCT01335659|QCA|qca
1359603|NCT01335633|MS|ms
1359604|NCT01335633|Neuropsychological tests|neuropsychological tests
1359605|NCT01335607|HCV|hcv
1359606|NCT01335607|Hepatitis C Virus|hepatitis c virus
1359607|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
1359608|NCT01335594|Deglutition Disorders|deglutition disorders
1359609|NCT01335594|Manometry|manometry
1359612|NCT01335568|Scaffold|scaffold
1359613|NCT01335568|Matrix|matrix
1359614|NCT01335568|Liver cirrhosis|liver cirrhosis
1359615|NCT01335568|Liver insufficiency|liver insufficiency
1359616|NCT01335529|HCV infection|hcv infection
1359617|NCT01335529|HIV-1 infection|hiv-1 infection
1359618|NCT01335503|gluten|gluten
1359619|NCT01335451|AZD5213|azd5213
1359620|NCT01335451|safety|safety
1359621|NCT01335451|pharmacokinetics|pharmacokinetics
1359622|NCT01335451|single dose|single dose
1359623|NCT01335451|repeated dose|repeated dose
1359624|NCT01335451|young|young
1359625|NCT01335451|elderly|elderly
1359626|NCT01335451|Japanese|japanese
1359627|NCT01335451|healthy subject|healthy subject
1359628|NCT01335438|total knee arthroplasty|total knee arthroplasty
1359629|NCT01335438|cemented|cemented
1359630|NCT01335438|cementless|cementless
1359631|NCT01335438|fixation|fixation
1359632|NCT01335438|posterior stabilized|posterior stabilized
1359633|NCT01335438|cruciate retaining|cruciate retaining
1359634|NCT01335425|Language problems|language problems
1359635|NCT01335425|childhood epilepsy|childhood epilepsy
1359636|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
1359637|NCT01335425|brain maturation|brain maturation
1359638|NCT01335425|structral connectivity|structral connectivity
1359639|NCT01335425|functional connectivity|functional connectivity
1359640|NCT01335399|Newly Diagnosed|newly diagnosed
1359641|NCT01335399|Previously Untreated|previously untreated
1359642|NCT01335373|Vaginal candidiasis|vaginal candidiasis
1359643|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
1359644|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
1359645|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
1359646|NCT01335360|nevirapine|nevirapine
1359647|NCT01335360|pharmacokinetics|pharmacokinetics
1359648|NCT01335347|Influenza|influenza
1359649|NCT01335347|pandemic|pandemic
1359650|NCT01335347|avian influenza|avian influenza
1359651|NCT01335347|H5N1|h5n1
1359652|NCT01335347|flu|flu
1359653|NCT01335334|Effectiveness|effectiveness
1359654|NCT01335334|eradication|eradication
1359655|NCT01335334|Asymptomatic|asymptomatic
1359656|NCT01335321|viscosupplementation|viscosupplementation
1359657|NCT01335321|intra-articular injection|intra-articular injection
1359658|NCT01335321|hyaluronic acid|hyaluronic acid
1359659|NCT01335321|osteoarthritis|osteoarthritis
1359660|NCT01335321|knee|knee
1359661|NCT01335308|Pediatric Obesity|pediatric obesity
1359662|NCT01335308|Motivational Interviewing|motivational interviewing
1359663|NCT01335308|Overweight|overweight
1359664|NCT01335308|Behavior Change|behavior change
1359665|NCT01335295|Flavocoxid|flavocoxid
1359666|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
1359667|NCT01335295|pilot study|pilot study
1359668|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
1359669|NCT01335243|Orthopedic Procedures|orthopedic procedures
1359670|NCT01335243|Spine|spine
1359671|NCT01335243|Interbody fusion|interbody fusion
1359672|NCT01335243|Arthrodesis|arthrodesis
1359673|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
1359674|NCT01335243|CT Scan|ct scan
1359675|NCT01335243|Spine balance|spine balance
1359676|NCT01335243|Instrumented fusion|instrumented fusion
1359677|NCT01335243|Posterior fusion|posterior fusion
1359678|NCT01335243|Degenerative spine|degenerative spine
1359679|NCT01335243|painful|painful
1359680|NCT01335230|HIV|hiv
1359681|NCT01335230|HCV|hcv
1359682|NCT01335230|Hepatitis C|hepatitis c
1359683|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
1359684|NCT01335230|HIV/HCV|hiv/hcv
1359685|NCT01335217|Depression|depression
1359686|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1359687|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
1359878|NCT01334359|fitness|fitness
1359688|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
1359689|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
1359690|NCT01335204|Prostate Cancer|prostate cancer
1359691|NCT01335204|JEVTANA|jevtana
1359692|NCT01335204|Cabazitaxel|cabazitaxel
1359693|NCT01335204|Bavituximab|bavituximab
1359694|NCT01335191|HIV|hiv
1359695|NCT01335191|vaccine|vaccine
1359696|NCT01335191|lipopeptide|lipopeptide
1359697|NCT01335191|Tat|tat
1359698|NCT01335191|TUTI-16|tuti-16
1359699|NCT01335191|THYMON|thymon
1359700|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
1359701|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
1359702|NCT01335178|Passive smoking|passive smoking
1359703|NCT01335178|Child health|child health
1359704|NCT01335178|Prevention|prevention
1359705|NCT01335178|Tobacco control|tobacco control
1359706|NCT01335178|Motivational Interviewing|motivational interviewing
1359707|NCT01335178|Air quality|air quality
1359708|NCT01335178|Pilot Study|pilot study
1359709|NCT01335165|PNH|pnh
1359710|NCT01335152|stress|stress
1359711|NCT01335152|depression|depression
1359712|NCT01335152|anxiety|anxiety
1359713|NCT01335152|web|web
1359714|NCT01335152|internet|internet
1359715|NCT01335152|coping|coping
1359716|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
1359717|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
1359718|NCT01335126|Artificial tears|artificial tears
1359719|NCT01335100|Functional outcome|functional outcome
1359720|NCT01335100|Quality of life|quality of life
1359721|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
1359722|NCT01335100|Advanced tracking technologies|advanced tracking technologies
1359723|NCT01335100|Time-space activity.|time-space activity.
1359724|NCT01335100|walking speed|walking speed
1359725|NCT01335100|distances|distances
1359726|NCT01335100|number of walking events and destinations|number of walking events and destinations
1359727|NCT01335087|sleep apnea|sleep apnea
1359728|NCT01335087|secondary prevention|secondary prevention
1359729|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
1359730|NCT01335061|Hemophilia B|hemophilia b
1359731|NCT01335061|on-demand|on-demand
1359732|NCT01335061|prophylaxis|prophylaxis
1359733|NCT01335061|nonacog alfa|nonacog alfa
1359734|NCT01335061|BeneFIX|benefix
1359735|NCT01335061|FIX|fix
1359736|NCT01335048|Clopidogrel|clopidogrel
1359737|NCT01335048|Statins|statins
1359738|NCT01335048|Platelet reactivity|platelet reactivity
1359739|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
1359740|NCT01335035|Iron metabolism,|iron metabolism,
1359741|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
1359742|NCT01335035|haematological diseases|haematological diseases
1359743|NCT01335009|melanoma|melanoma
1359744|NCT01335009|malignant|malignant
1359745|NCT01335009|metastatic|metastatic
1359746|NCT01334983|cancer|cancer
1359747|NCT01334983|function|function
1359748|NCT01334983|fatigue|fatigue
1359749|NCT01334983|late stage|late stage
1359750|NCT01334983|metastases|metastases
1359751|NCT01334983|quality of life|quality of life
1359752|NCT01334983|functional decline in cancer|functional decline in cancer
1359753|NCT01334944|Pain|pain
1359754|NCT01334944|Fever|fever
1359755|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
1359756|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
1359757|NCT01334918|pharmacologic stress|pharmacologic stress
1359758|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1359759|NCT01334918|regadenoson|regadenoson
1359760|NCT01334918|ischemia|ischemia
1359761|NCT01334905|Overactive Bladder|overactive bladder
1359762|NCT01334905|Urinary incontinence|urinary incontinence
1359763|NCT01334905|YM178|ym178
1359764|NCT01334905|mirabegron|mirabegron
1359765|NCT01334905|Food effect|food effect
1359766|NCT01334879|radiation|radiation
1359767|NCT01334879|retinopathy|retinopathy
1359768|NCT01334879|anti-VEGF|anti-vegf
1359770|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
1359771|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
1359772|NCT01334866|MICS CABG|mics cabg
1359773|NCT01334840|Cardiovascular risk|cardiovascular risk
1359774|NCT01334840|Cholecystokinin|cholecystokinin
1359775|NCT01334840|Gallbladder emptying|gallbladder emptying
1359776|NCT01334840|Lipid absorption|lipid absorption
1359777|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
1359778|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
1359779|NCT01334827|topical microbicide|topical microbicide
1359780|NCT01334827|primary prevention|primary prevention
1359781|NCT01334827|HIV|hiv
1359782|NCT01334827|AIDS|aids
1359783|NCT01334827|drug delivery systems|drug delivery systems
1359784|NCT01334801|aortic stenosis|aortic stenosis
1359785|NCT01334801|von Willebrand factor|von willebrand factor
1359786|NCT01334801|mitral valve replacement|mitral valve replacement
1359787|NCT01334801|aortic valve replacement|aortic valve replacement
1359788|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
1359789|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
1359790|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
1359791|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
1359792|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1359793|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
1359794|NCT01334788|sleep deprivation|sleep deprivation
1359795|NCT01334788|sleep restriction|sleep restriction
1359796|NCT01334775|Inguinal hernia|inguinal hernia
1359797|NCT01334775|Postoperative pain|postoperative pain
1359798|NCT01334775|Surgical mesh|surgical mesh
1359799|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
1359800|NCT01334762|letrozole|letrozole
1359801|NCT01334762|clomiphene citrate|clomiphene citrate
1359802|NCT01334762|IUI|iui
1359803|NCT01334749|Stroke|stroke
1359804|NCT01334749|Dementia|dementia
1359805|NCT01334749|Dementia, Vascular|dementia, vascular
1359806|NCT01334749|Alzheimer's Disease|alzheimer's disease
1359807|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
1359808|NCT01334749|Brain Ischemia|brain ischemia
1359809|NCT01334736|smoking cessation|smoking cessation
1359810|NCT01334736|contingency management|contingency management
1359811|NCT01334736|spirometry|spirometry
1359812|NCT01334736|lung age|lung age
1359813|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
1359814|NCT01334710|Liver cancer|liver cancer
1359815|NCT01334697|Cardiotrophin-1|cardiotrophin-1
1359816|NCT01334697|CT-1|ct-1
1359817|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1359818|NCT01334684|Metformin Efficacy|metformin efficacy
1359819|NCT01334684|Gene Expression Profiles|gene expression profiles
1359820|NCT01334684|Personalized Medicine|personalized medicine
1359821|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
1359822|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
1359823|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
1359824|NCT01334658|Corneal endothelium|corneal endothelium
1359825|NCT01334658|Cataract surgery|cataract surgery
1359826|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
1359827|NCT01334658|Phacoemulsification|phacoemulsification
1359828|NCT01334645|Copeptin|copeptin
1359829|NCT01334645|Troponin|troponin
1359830|NCT01334645|Diagnosis|diagnosis
1359831|NCT01334645|Chest pain|chest pain
1359832|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
1359833|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
1359834|NCT01334645|Unstable Angina|unstable angina
1359835|NCT01334632|Electrophysiological study|electrophysiological study
1359836|NCT01334632|Nerve block|nerve block
1359837|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
1359838|NCT01334632|Shoulder surgery|shoulder surgery
1359839|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
1359840|NCT01334619|Drug delivery,volume|drug delivery,volume
1359841|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
1359842|NCT01334606|diabetes|diabetes
1359843|NCT01334606|pen needle|pen needle
1359844|NCT01334606|basal insulin|basal insulin
1359845|NCT01334606|long-acting insulin|long-acting insulin
1359846|NCT01334554|African American|african american
1359847|NCT01334554|Women|women
1359848|NCT01334554|Metabolic Syndrome|metabolic syndrome
1359849|NCT01334554|Endothelial function|endothelial function
1359850|NCT01334554|Sildenafil citrate|sildenafil citrate
1359851|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
1359852|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
1359853|NCT01334528|Repeated measures|repeated measures
1359854|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1359855|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1359856|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1359857|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1359858|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
1359859|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
1359860|NCT01334489|Cervical pessary|cervical pessary
1359861|NCT01334489|Cervical lenght|cervical lenght
1359862|NCT01334476|Data Repository|data repository
1359863|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
1359864|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
1359865|NCT01334437|blood test|blood test
1359866|NCT01334437|ovarian cancer|ovarian cancer
1359867|NCT01334437|Associated Auto Antibodies|associated auto antibodies
1359868|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
1359869|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
1359870|NCT01334424|Propofol|propofol
1359871|NCT01334424|oxidative stress|oxidative stress
1359872|NCT01334398|Traumatic Brain Injury|traumatic brain injury
1359873|NCT01334372|suicide|suicide
1359874|NCT01334372|veterans|veterans
1359875|NCT01334372|assessment|assessment
1359876|NCT01334372|CAMS|cams
1359877|NCT01334359|physical activity|physical activity
1359879|NCT01334359|brain health|brain health
1359880|NCT01334359|cognition|cognition
1359881|NCT01334359|scholastic achievement|scholastic achievement
1359882|NCT01334359|preadolescent children|preadolescent children
1359883|NCT01334346|Running|running
1359884|NCT01334346|Footwear|footwear
1359885|NCT01334346|Injury incidence|injury incidence
1359886|NCT01334346|injury risk|injury risk
1359887|NCT01334346|pain|pain
1359888|NCT01334333|kidney transplant|kidney transplant
1359889|NCT01334333|tacrolimus|tacrolimus
1359890|NCT01334333|medication adherence|medication adherence
1359891|NCT01334333|depression|depression
1359892|NCT01334333|neuropsychological|neuropsychological
1359893|NCT01334333|cognition|cognition
1359894|NCT01334333|Self-efficacy|self-efficacy
1359895|NCT01334333|everyday problem solving|everyday problem solving
1359896|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
1359897|NCT01334320|elective neck dissection|elective neck dissection
1359898|NCT01334320|"watchful waiting"|"watchful waiting"
1359899|NCT01334320|survival benefit|survival benefit
1359900|NCT01334320|recurrence rate|recurrence rate
1359901|NCT01334307|Emphysema|emphysema
1359902|NCT01334307|RePneu|repneu
1359904|NCT01334294|AMD|amd
1359905|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
1359906|NCT01334281|Sensitization|sensitization
1359907|NCT01334281|Organ Transplant|organ transplant
1359908|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
1359909|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
1359910|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1359911|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1359912|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1359913|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1359914|NCT01334268|STENT THROMBOSIS|stent thrombosis
1359915|NCT01334268|RESTENOTIC LESION|restenotic lesion
1359916|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1359917|NCT01334268|REAL-WORLD|real-world
1359918|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
1359919|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
1359920|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
1359921|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1359922|NCT01334242|Pharmacodynamics|pharmacodynamics
1359923|NCT01334229|sitagliptin|sitagliptin
1359924|NCT01334229|diabetes|diabetes
1359925|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
1359926|NCT01334216|smoking|smoking
1359927|NCT01334216|quitting|quitting
1359928|NCT01334216|tobacco|tobacco
1359929|NCT01334216|Parental|parental
1359930|NCT01334203|Chronic angina|chronic angina
1359931|NCT01334203|Angina pectoris|angina pectoris
1359932|NCT01334203|Coronary artery disease|coronary artery disease
1359933|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1359934|NCT01334203|ETT|ett
1359935|NCT01334190|AE adverse event|ae adverse event
1359936|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1359937|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1359938|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
1359939|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1359940|NCT01334190|DCF data collection forms|dcf data collection forms
1359941|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
1359942|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1359943|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1359944|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1360046|NCT01333787|children|children
1360047|NCT01333774|Diabetes|diabetes
1359945|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
1359946|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
1359947|NCT01334190|IRB Institutional Review Board|irb institutional review board
1359948|NCT01334190|IU international units|iu international units
1359949|NCT01334190|mg milligram(s)|mg milligram(s)
1359950|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1359951|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
1359952|NCT01334190|SAE serious adverse event|sae serious adverse event
1359953|NCT01334190|µg microgram|µg microgram
1359954|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
1359955|NCT01334190|WB Western Blot|wb western blot
1359956|NCT01334190|post-marketing monitoring|post-marketing monitoring
1359957|NCT01334190|safety|safety
1359958|NCT01334190|efficacy|efficacy
1359959|NCT01334190|acceptability|acceptability
1359960|NCT01334164|substance use disorder|substance use disorder
1359961|NCT01334164|offenders|offenders
1359962|NCT01334164|reentry|reentry
1359963|NCT01334164|HIV risk behavior|hiv risk behavior
1359964|NCT01334164|recidivism|recidivism
1359965|NCT01334138|hypertension|hypertension
1359966|NCT01334138|sodium|sodium
1359967|NCT01334138|diet|diet
1359968|NCT01334125|Double Diabetes|double diabetes
1359969|NCT01334125|Type 1 diabetes|type 1 diabetes
1359970|NCT01334125|Type 2 diabetes|type 2 diabetes
1359971|NCT01334125|Obesity|obesity
1359972|NCT01334125|Acanthosis nigricans|acanthosis nigricans
1359973|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
1359974|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
1359975|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1359976|NCT01334112|Liver Cancer|liver cancer
1359977|NCT01334112|Axitinib|axitinib
1359978|NCT01334112|AG-013736|ag-013736
1359980|NCT01334073|Phase I|phase i
1359981|NCT01334073|Axitinib|axitinib
1359982|NCT01334073|Everolimus|everolimus
1359983|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
1359984|NCT01334073|solid tumor|solid tumor
1359985|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
1359986|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
1359987|NCT01334021|Genomic Testing|genomic testing
1359988|NCT01334021|Genetic Testing|genetic testing
1359989|NCT01334021|HER2 Negative|her2 negative
1359990|NCT01334021|Primary Invasive Breast Cancer|primary invasive breast cancer
1359991|NCT01334021|Stage I|stage i
1359992|NCT01334021|Stage II|stage ii
1359993|NCT01334021|Stage III|stage iii
1359994|NCT01334021|Registry|registry
1359995|NCT01334021|Biopsy|biopsy
1359996|NCT01334021|Tumor sampling|tumor sampling
1359997|NCT01334008|Circulating tumor DNA|circulating tumor dna
1359998|NCT01334008|Choroidal Melanoma|choroidal melanoma
1359999|NCT01333995|Peer counselling|peer counselling
1360000|NCT01333995|Infant|infant
1360001|NCT01333995|Intervention|intervention
1360002|NCT01333995|breastfeeding|breastfeeding
1360003|NCT01333995|complementary feeding|complementary feeding
1360004|NCT01333995|stunting|stunting
1360005|NCT01333982|Neonatal Sepsis|neonatal sepsis
1360006|NCT01333982|Evaluation|evaluation
1360007|NCT01333982|Bangladesh|bangladesh
1360008|NCT01333982|Drying|drying
1360009|NCT01333982|Wrapping|wrapping
1360010|NCT01333982|Bathing|bathing
1360011|NCT01333943|Total Knee Replacement|total knee replacement
1360012|NCT01333943|Regional Anesthesia|regional anesthesia
1360013|NCT01333943|Quadriceps|quadriceps
1360014|NCT01333943|Muscle Strength|muscle strength
1360015|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
1360016|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
1360017|NCT01333930|immunological effects|immunological effects
1360018|NCT01333930|Active O2|active o2
1360019|NCT01333930|strenuous exercise|strenuous exercise
1360020|NCT01333930|procedures|procedures
1360021|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
1360022|NCT01333930|blood sampling scheme|blood sampling scheme
1360023|NCT01333917|Curcumin|curcumin
1360024|NCT01333917|Colorectal Cancer|colorectal cancer
1360025|NCT01333917|GWAS|gwas
1360026|NCT01333865|Memantine|memantine
1360027|NCT01333865|Namenda|namenda
1360028|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
1360029|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
1360030|NCT01333865|Adults|adults
1360031|NCT01333852|head and neck cancer|head and neck cancer
1360032|NCT01333852|paclitaxel|paclitaxel
1360033|NCT01333852|metformin|metformin
1360034|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
1360035|NCT01333839|CABG surgery|cabg surgery
1360036|NCT01333839|exercise intervention|exercise intervention
1360037|NCT01333839|insulin sensitivity|insulin sensitivity
1360038|NCT01333839|muscle mass|muscle mass
1360039|NCT01333813|immune response|immune response
1360040|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
1360041|NCT01333813|Persistence|persistence
1360042|NCT01333813|challenge dose|challenge dose
1360043|NCT01333787|dietary fiber|dietary fiber
1360044|NCT01333787|clinical trial|clinical trial
1360045|NCT01333787|constipation|constipation
1360048|NCT01333774|Acarbose|acarbose
1360049|NCT01333774|Diet|diet
1360050|NCT01333774|Compliance|compliance
1360051|NCT01333774|Advising|advising
1360052|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
1360053|NCT01333748|breast cancer|breast cancer
1360054|NCT01333748|ovarian cancer|ovarian cancer
1360055|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
1360056|NCT01333735|cognitive functions|cognitive functions
1360057|NCT01333735|quality of life|quality of life
1360058|NCT01333735|breast cancer|breast cancer
1360059|NCT01333735|chemotherapy|chemotherapy
1360060|NCT01333735|ages patients|ages patients
1360061|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
1360062|NCT01333709|Tailored treatment strategy|tailored treatment strategy
1360063|NCT01333709|MRI volumetry|mri volumetry
1360064|NCT01333709|Early tumor response|early tumor response
1360065|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1360066|NCT01333696|Pemetrexed|pemetrexed
1360067|NCT01333683|tinnitus|tinnitus
1360068|NCT01333683|hearing loss|hearing loss
1360069|NCT01333683|arterial hypertension|arterial hypertension
1360070|NCT01333683|ototoxicity|ototoxicity
1360071|NCT01333657|sTREM-1|strem-1
1360072|NCT01333657|sepsis|sepsis
1360073|NCT01333657|SIRS|sirs
1360075|NCT01333657|urine|urine
1360076|NCT01333657|diagnosis|diagnosis
1360077|NCT01333657|prognosis|prognosis
1360078|NCT01333644|HIV Infection|hiv infection
1360079|NCT01333644|Endothelial function|endothelial function
1360080|NCT01333644|Cardiovascular Disease|cardiovascular disease
1360081|NCT01333644|Inflammation|inflammation
1360082|NCT01333644|Antiretroviral medication|antiretroviral medication
1360083|NCT01333644|Treatment naive|treatment naive
1360084|NCT01333644|Treatment experienced|treatment experienced
1360085|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
1360086|NCT01333618|Filter Tilt|filter tilt
1360087|NCT01333618|Preventional efficiency|preventional efficiency
1360088|NCT01333618|Günther Tulip filter|günther tulip filter
1360089|NCT01333618|Transfemoral Approach|transfemoral approach
1360090|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
1360091|NCT01333605|Chemotherapy|chemotherapy
1360092|NCT01333605|IGEV|igev
1360093|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
1360094|NCT01333592|Type 2 diabetes|type 2 diabetes
1360095|NCT01333592|HbA1c|hba1c
1360096|NCT01333592|Long-term study|long-term study
1360097|NCT01333553|birthmark|birthmark
1360098|NCT01333540|constipation|constipation
1360099|NCT01333540|opioid induced|opioid induced
1360100|NCT01333514|diabetes|diabetes
1360101|NCT01333514|prandial|prandial
1360102|NCT01333514|insulin|insulin
1360103|NCT01333514|aspart|aspart
1360104|NCT01333514|carbohydrate|carbohydrate
1360105|NCT01333514|inpatient|inpatient
1360106|NCT01333514|novolog|novolog
1360107|NCT01333501|Multiple sclerosis|multiple sclerosis
1360108|NCT01333501|cognitive symptoms|cognitive symptoms
1360109|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
1360110|NCT01333501|fingolimod|fingolimod
1360111|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1360112|NCT01333488|Traumatic|traumatic
1360113|NCT01333488|Brain|brain
1360114|NCT01333488|Injury|injury
1360115|NCT01333475|Targeted Therapy|targeted therapy
1360116|NCT01333475|KRAS Mutation|kras mutation
1360117|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
1360118|NCT01333475|Colorectal Cancer|colorectal cancer
1360119|NCT01333449|Decitabine|decitabine
1360120|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
1360121|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
1360122|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
1360123|NCT01333423|Breast Cancer|breast cancer
1360124|NCT01333423|Metastatic Triple Negative|metastatic triple negative
1360125|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
1360126|NCT01333423|Locally advanced|locally advanced
1360127|NCT01333423|Stage IV|stage iv
1360128|NCT01333423|Metastatic|metastatic
1360129|NCT01333423|Seliciclib|seliciclib
1360130|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
1360131|NCT01333423|Doxil|doxil
1360132|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
1360133|NCT01333410|vitiligo|vitiligo
1360134|NCT01333410|tacrolimus|tacrolimus
1360135|NCT01333410|mometasone furoate|mometasone furoate
1360136|NCT01333371|Distal Radius|distal radius
1360137|NCT01333371|Volar locked plating|volar locked plating
1360138|NCT01333371|Cost Effectiveness|cost effectiveness
1360139|NCT01333371|Randomization|randomization
1360140|NCT01333371|Outcomes|outcomes
1360141|NCT01333358|Relapsing|relapsing
1360142|NCT01333358|remitting|remitting
1360143|NCT01333345|Cataract replacement surgery|cataract replacement surgery
1360144|NCT01333345|implantation|implantation
1360145|NCT01333345|EC-3 IOL|ec-3 iol
1360146|NCT01333332|Pancreas|pancreas
1360147|NCT01333332|Radiation|radiation
1360148|NCT01333319|liver transplantation|liver transplantation
1360242|NCT01332864|cephalgia|cephalgia
1360149|NCT01333319|acute kidney injury|acute kidney injury
1360150|NCT01333306|tDCS|tdcs
1360151|NCT01333306|cognitive training|cognitive training
1360152|NCT01333293|mastocytosis|mastocytosis
1360153|NCT01333293|omalizumab|omalizumab
1360154|NCT01333267|Endocrine System Diseases|endocrine system diseases
1360155|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
1360156|NCT01333267|Hormones|hormones
1360157|NCT01333267|Postmenopausal Women|postmenopausal women
1360158|NCT01333267|Bone metabolism|bone metabolism
1360159|NCT01333267|Physiologic Properties|physiologic properties
1360160|NCT01333267|African-Americans|african-americans
1360161|NCT01333254|urinary tract infections|urinary tract infections
1360162|NCT01333254|urinary catheterisation|urinary catheterisation
1360163|NCT01333241|Hispanic Americans|hispanic americans
1360164|NCT01333241|Cardiovascular disease|cardiovascular disease
1360165|NCT01333241|Obesity|obesity
1360166|NCT01333241|Intervention|intervention
1360167|NCT01333215|Suicide, Attempted|suicide, attempted
1360168|NCT01333215|Cognitive Symptoms|cognitive symptoms
1360169|NCT01333202|Fresh lime|fresh lime
1360170|NCT01333202|nicotine gum|nicotine gum
1360171|NCT01333202|smoking cessation|smoking cessation
1360172|NCT01333202|craving|craving
1360173|NCT01333189|total knee arthroplasty|total knee arthroplasty
1360174|NCT01333189|osteoarthritis|osteoarthritis
1360175|NCT01333189|biomechanics|biomechanics
1360176|NCT01333189|gait|gait
1360177|NCT01333176|Type 2 Diabetes|type 2 diabetes
1360178|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
1360179|NCT01333150|Temporomandibular disorders|temporomandibular disorders
1360180|NCT01333150|Orofacial pain|orofacial pain
1360181|NCT01333137|Triple negative breast cancer|triple negative breast cancer
1360182|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
1360183|NCT01333098|anxiety|anxiety
1360184|NCT01333098|older adult|older adult
1360185|NCT01333098|memory|memory
1360186|NCT01333098|cognitive|cognitive
1360187|NCT01333098|Saint Louis|saint louis
1360188|NCT01333098|treatment|treatment
1360189|NCT01333098|Non-dementia cognitive impairment in older adults with anxiety disorders.|non-dementia cognitive impairment in older adults with anxiety disorders.
1360190|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1360191|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1360192|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1360193|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1360194|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1360195|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1360196|NCT01333085|tongue cancer|tongue cancer
1360197|NCT01333072|Autistic Disorder|autistic disorder
1360198|NCT01333059|Sedation|sedation
1360199|NCT01333059|Cycling|cycling
1360200|NCT01333059|Pediatric|pediatric
1360201|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
1360202|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1360203|NCT01333046|CTL|ctl
1360204|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1360205|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1360206|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
1360207|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
1360208|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
1360209|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
1360210|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
1360211|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
1360212|NCT01333020|emulsion|emulsion
1360213|NCT01333020|protein|protein
1360214|NCT01333020|cross-linking|cross-linking
1360215|NCT01333020|gastric emptying|gastric emptying
1360216|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
1360217|NCT01332955|HIV Infection|hiv infection
1360218|NCT01332955|Telaprevir|telaprevir
1360219|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
1360220|NCT01332955|Ribavirin|ribavirin
1360221|NCT01332955|Pharmacokinetic|pharmacokinetic
1360222|NCT01332955|Pharmacogenetic|pharmacogenetic
1360223|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
1360224|NCT01332942|Anemia|anemia
1360225|NCT01332929|brain radiation therapy|brain radiation therapy
1360226|NCT01332929|Bevacizumab|bevacizumab
1360227|NCT01332929|brain metastasis|brain metastasis
1360228|NCT01332929|solid tumor|solid tumor
1360229|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
1360230|NCT01332916|cognitive troubles|cognitive troubles
1360231|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
1360232|NCT01332890|Drug interaction|drug interaction
1360233|NCT01332890|revaprazan|revaprazan
1360234|NCT01332890|Itopride HCI|itopride hci
1360235|NCT01332877|Obesity|obesity
1360236|NCT01332877|Weight loss|weight loss
1360237|NCT01332877|Ghrelin|ghrelin
1360238|NCT01332877|Satiety|satiety
1360239|NCT01332877|Hunger|hunger
1360240|NCT01332864|headache|headache
1360241|NCT01332864|migraine|migraine
1360243|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
1360244|NCT01332851|child welfare|child welfare
1360245|NCT01332851|child protective services|child protective services
1360246|NCT01332851|child abuse|child abuse
1360247|NCT01332851|child neglect|child neglect
1360248|NCT01332851|infant|infant
1360249|NCT01332851|parenting|parenting
1360250|NCT01332825|olfaction|olfaction
1360251|NCT01332825|smell dysfunction|smell dysfunction
1360252|NCT01332812|Dexamethasone|dexamethasone
1360253|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1360254|NCT01332812|General Anesthesia|general anesthesia
1360255|NCT01332812|neuropsychological tests|neuropsychological tests
1360256|NCT01332799|cardiovascular disease|cardiovascular disease
1360257|NCT01332799|kidney transplantation|kidney transplantation
1360258|NCT01332786|AML|aml
1360259|NCT01332760|ergonomics|ergonomics
1360260|NCT01332760|workplace|workplace
1360261|NCT01332760|occupational|occupational
1360262|NCT01332760|tool|tool
1360263|NCT01332760|dental|dental
1360264|NCT01332760|dentist|dentist
1360265|NCT01332747|TC|tc
1360266|NCT01332747|TG|tg
1360267|NCT01332747|HDL|hdl
1360268|NCT01332747|LDL|ldl
1360269|NCT01332747|VLDL|vldl
1360270|NCT01332734|microcirculation|microcirculation
1360271|NCT01332734|SDF|sdf
1360272|NCT01332734|magnesium sulfate|magnesium sulfate
1360273|NCT01332721|TRC105|trc105
1360274|NCT01332721|CD105|cd105
1360275|NCT01332721|Endoglin|endoglin
1360276|NCT01332721|Solid Tumors|solid tumors
1360277|NCT01332721|Avastin|avastin
1360278|NCT01332721|Bevacizumab|bevacizumab
1360279|NCT01332708|high complex carbohydrates|high complex carbohydrates
1360280|NCT01332708|hypocaloric diet|hypocaloric diet
1360281|NCT01332708|cholinergic status|cholinergic status
1360282|NCT01332708|overweight|overweight
1360283|NCT01332708|obese|obese
1360284|NCT01332695|tremor|tremor
1360285|NCT01332695|WHIGET|whiget
1360286|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
1360287|NCT01332682|head and neck cancer|head and neck cancer
1360288|NCT01332682|resistance training|resistance training
1360289|NCT01332682|nutrition counseling|nutrition counseling
1360290|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
1360291|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
1360292|NCT01332669|chemoembolization|chemoembolization
1360293|NCT01332669|drug eluting beads|drug eluting beads
1360294|NCT01332669|HCC|hcc
1360295|NCT01332669|Liver cancer|liver cancer
1360296|NCT01332669|Korea|korea
1360297|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
1360298|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
1360299|NCT01332643|infertility|infertility
1360300|NCT01332643|genetic screening|genetic screening
1360301|NCT01332643|trisomy 21|trisomy 21
1360302|NCT01332643|Down syndrome|down syndrome
1360303|NCT01332630|Breast cancer|breast cancer
1360304|NCT01332630|Brain metastases|brain metastases
1360305|NCT01332630|TPI 287|tpi 287
1360306|NCT01332630|Computed Tomography|computed tomography
1360307|NCT01332630|CT|ct
1360308|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
1360309|NCT01332630|MRI|mri
1360310|NCT01332617|Multiple Myeloma|multiple myeloma
1360311|NCT01332617|Simvastatin|simvastatin
1360312|NCT01332617|Zoledronic|zoledronic
1360313|NCT01332617|Bortezomib|bortezomib
1360314|NCT01332617|Bendamustine|bendamustine
1360315|NCT01332617|Methylprednisolone|methylprednisolone
1360316|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
1360317|NCT01332565|GSK1349572|gsk1349572
1360318|NCT01332565|pharmacokinetics|pharmacokinetics
1360319|NCT01332565|Japanese|japanese
1360320|NCT01332565|HIV|hiv
1360321|NCT01332552|pharmacokinetics|pharmacokinetics
1360322|NCT01332552|First administration to human|first administration to human
1360323|NCT01332552|antiviral activity|antiviral activity
1360324|NCT01332552|safety|safety
1360325|NCT01332552|hepatitis C|hepatitis c
1360326|NCT01332526|FFT|fft
1360327|NCT01332526|inflammation|inflammation
1360328|NCT01332526|lipid metabolism|lipid metabolism
1360329|NCT01332526|hyperuricemia|hyperuricemia
1360330|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
1360331|NCT01332513|Healthy Volunteers|healthy volunteers
1360332|NCT01332500|Triptans|triptans
1360333|NCT01332500|Migraine|migraine
1360334|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
1360335|NCT01332487|prostate surgery|prostate surgery
1360336|NCT01332487|alpha-blocker|alpha-blocker
1360337|NCT01332487|enlarged prostate|enlarged prostate
1360338|NCT01332487|acute urinary retention|acute urinary retention
1360339|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
1360340|NCT01332474|Botox|botox
1360341|NCT01332474|JCP|jcp
1360342|NCT01332448|Xenical|xenical
1360343|NCT01332448|Alli|alli
1360344|NCT01332448|safety|safety
1360345|NCT01332448|meta-analysis|meta-analysis
1360346|NCT01332448|liver-function test|liver-function test
1360347|NCT01332448|Roche|roche
1360348|NCT01332448|orlistat|orlistat
1360349|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
1360350|NCT01332370|Retrospective|retrospective
1360351|NCT01332370|Type 2 Diabetes|type 2 diabetes
1360352|NCT01332370|Cost Analysis|cost analysis
1360353|NCT01332370|Rosiglitazone|rosiglitazone
1360354|NCT01332370|Sitagliptin|sitagliptin
1360355|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
1360356|NCT01332357|hospitalization|hospitalization
1360357|NCT01332357|emergency department|emergency department
1360358|NCT01332357|asthma|asthma
1360359|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
1360360|NCT01332344|Asthma|asthma
1360361|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
1360362|NCT01332344|outcomes|outcomes
1360363|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
1360364|NCT01332331|pediatric|pediatric
1360365|NCT01332292|inhalation profiles|inhalation profiles
1360366|NCT01332292|pharmacokinetics|pharmacokinetics
1360367|NCT01332292|pharyngometry|pharyngometry
1360368|NCT01332292|asthma|asthma
1360369|NCT01332292|pediatric subjects|pediatric subjects
1360370|NCT01332292|GW685698|gw685698
1360371|NCT01332292|Fluticasone furoate|fluticasone furoate
1360372|NCT01332292|safety|safety
1360373|NCT01332266|Cancer|cancer
1360374|NCT01332266|head and neck|head and neck
1360375|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1360376|NCT01332266|phase I|phase i
1360377|NCT01332266|phase II|phase ii
1360378|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
1360379|NCT01332240|staging|staging
1360380|NCT01332240|endosonography|endosonography
1360381|NCT01332240|lung cancer|lung cancer
1360382|NCT01332240|stage III|stage iii
1360383|NCT01332214|Phase 1|phase 1
1360384|NCT01332214|healthy male volunteers|healthy male volunteers
1360385|NCT01332214|dose escalation|dose escalation
1360386|NCT01332214|pharmacokinetics|pharmacokinetics
1360387|NCT01332214|Single Ascending Dose|single ascending dose
1360388|NCT01332214|AZD2820 Cmax|azd2820 cmax
1360389|NCT01332214|tmax|tmax
1360390|NCT01332214|t1/2λz|t1/2λz
1360391|NCT01332201|Advagraf|advagraf
1360392|NCT01332201|Heart|heart
1360393|NCT01332201|Lung|lung
1360394|NCT01332201|Pancreas|pancreas
1360395|NCT01332201|Transplant|transplant
1360396|NCT01332201|Immunosuppression|immunosuppression
1360397|NCT01332201|Pharmacokinetics|pharmacokinetics
1360398|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
1360399|NCT01332162|Pacing|pacing
1360400|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
1360401|NCT01332149|Pain|pain
1360402|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
1360403|NCT01332149|Placebo controlled|placebo controlled
1360404|NCT01332110|Footwear|footwear
1360405|NCT01332110|Motion Analysis|motion analysis
1360406|NCT01332110|Running Injury|running injury
1360407|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1360408|NCT01332097|Exacerbation|exacerbation
1360409|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
1360410|NCT01332084|SOTI|soti
1360411|NCT01332084|tolerance|tolerance
1360412|NCT01332084|desensitization|desensitization
1360413|NCT01332084|challenge test|challenge test
1360414|NCT01332084|HA wheat cereals|ha wheat cereals
1360415|NCT01332071|Metformin|metformin
1360416|NCT01332071|Rosiglitazone|rosiglitazone
1360417|NCT01332071|Healthy volunteers|healthy volunteers
1360418|NCT01332071|Avandamet|avandamet
1360419|NCT01332071|Fed conditions|fed conditions
1360420|NCT01332071|Bioequivalence|bioequivalence
1360421|NCT01332058|Peripheral arterial disease|peripheral arterial disease
1360422|NCT01332058|Walking|walking
1360423|NCT01332058|Motivational Interviewing|motivational interviewing
1360424|NCT01332032|cost effectiveness|cost effectiveness
1360425|NCT01332032|screening mammography|screening mammography
1360426|NCT01332032|repeat mammography|repeat mammography
1360427|NCT01332032|telephone counseling|telephone counseling
1360428|NCT01332032|computerized reminders|computerized reminders
1360429|NCT01332032|compliance|compliance
1360430|NCT01332019|Subcutaneous|subcutaneous
1360431|NCT01332019|Extension|extension
1360432|NCT01332019|Interferon|interferon
1360434|NCT01332019|PEGylated|pegylated
1360435|NCT01332019|Injectable|injectable
1360436|NCT01332019|SC|sc
1360437|NCT01332019|PEG|peg
1360438|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
1360439|NCT01332019|Relapsing|relapsing
1360440|NCT01331993|Phase 1|phase 1
1360441|NCT01331993|crossover|crossover
1360442|NCT01331993|bioequivalence|bioequivalence
1360443|NCT01331993|naproxen|naproxen
1360444|NCT01331993|esomeprazole|esomeprazole
1360445|NCT01331993|vimovo|vimovo
1360446|NCT01331993|healthy volunteers|healthy volunteers
1360447|NCT01331980|cystic fibrosis|cystic fibrosis
1360448|NCT01331980|bone|bone
1360449|NCT01331967|pioglitazone|pioglitazone
1360450|NCT01331967|optical coherence tomography|optical coherence tomography
1360451|NCT01331967|microRNA|microrna
1360452|NCT01331967|neointima|neointima
1360453|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
1360454|NCT01331941|AMG 386|amg 386
1360455|NCT01331941|Pharmacokinetic|pharmacokinetic
1360456|NCT01331941|Renal Impairment|renal impairment
1360457|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
1360458|NCT01331915|Metastatic Melanoma|metastatic melanoma
1360459|NCT01331915|Safety|safety
1360460|NCT01331915|Theravac vaccine|theravac vaccine
1360461|NCT01331915|HLA-A2 typing|hla-a2 typing
1360462|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
1360463|NCT01331902|Adenosine|adenosine
1360464|NCT01331902|Nicorandil|nicorandil
1360465|NCT01331902|Fractional Flow Reserve|fractional flow reserve
1360466|NCT01331902|Maximal Hyperemia|maximal hyperemia
1360467|NCT01331889|transfusion|transfusion
1360468|NCT01331889|liver transplantation|liver transplantation
1360469|NCT01331889|potassium|potassium
1360470|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
1360471|NCT01331863|Bronchial disease|bronchial disease
1360472|NCT01331863|Lung cancer surgery|lung cancer surgery
1360473|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
1360474|NCT01331863|homograft|homograft
1360475|NCT01331863|Tracheal disease|tracheal disease
1360476|NCT01331863|Benign|benign
1360477|NCT01331863|Malignant|malignant
1360478|NCT01331824|Bladder Cancer|bladder cancer
1360479|NCT01331824|Urothelial Cancer|urothelial cancer
1360480|NCT01331824|Chemotherapy|chemotherapy
1360481|NCT01331824|Second-line|second-line
1360482|NCT01331824|Metastatic|metastatic
1360483|NCT01331811|HIV|hiv
1360484|NCT01331811|Tuberculosis|tuberculosis
1360485|NCT01331811|Diagnosis|diagnosis
1360486|NCT01331811|Pediatrics|pediatrics
1360487|NCT01331811|Asia|asia
1360488|NCT01331811|Africa|africa
1360489|NCT01331798|Abdominoplasty|abdominoplasty
1360490|NCT01331785|paracentesis|paracentesis
1360491|NCT01331785|ascites|ascites
1360492|NCT01331785|hypotension|hypotension
1360493|NCT01331772|Breast cancer|breast cancer
1360494|NCT01331772|Adapted Physical activity|adapted physical activity
1360495|NCT01331772|Nutrition|nutrition
1360496|NCT01331772|Assessment|assessment
1360497|NCT01331772|Patient education|patient education
1360498|NCT01331759|Burnout|burnout
1360499|NCT01331759|Subthreshold Disorder|subthreshold disorder
1360500|NCT01331707|drug-eluting stent|drug-eluting stent
1360501|NCT01331707|Zotarolimus|zotarolimus
1360502|NCT01331707|Everolimus|everolimus
1360503|NCT01331707|all comers population|all comers population
1360504|NCT01331707|target vessel failure|target vessel failure
1360505|NCT01331707|coronary artery disease|coronary artery disease
1360506|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
1360507|NCT01331681|VEGF Trap-Eye|vegf trap-eye
1360508|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
1360509|NCT01331642|Lymphatic Diseases|lymphatic diseases
1360510|NCT01331642|Metabolism, Inborn Errors|metabolism, inborn errors
1360511|NCT01331642|Genetic Diseases, Inborn|genetic diseases, inborn
1360512|NCT01331642|Lipidoses|lipidoses
1360513|NCT01331642|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1360514|NCT01331642|Metabolic Diseases|metabolic diseases
1360515|NCT01331642|Lipid Metabolism Disorders|lipid metabolism disorders
1360516|NCT01331629|breast cancer|breast cancer
1360517|NCT01331629|fatigue|fatigue
1360518|NCT01331629|quality of life|quality of life
1360519|NCT01331629|art-therapie|art-therapie
1360520|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
1360521|NCT01331616|Prospective study|prospective study
1360522|NCT01331616|Glioblastoma|glioblastoma
1360523|NCT01331616|Avastin|avastin
1360524|NCT01331616|Visual Evoked Potential|visual evoked potential
1360525|NCT01331616|Optic neuropathy|optic neuropathy
1360526|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
1360527|NCT01331603|MDS|mds
1360528|NCT01331603|primary myelofibrosis|primary myelofibrosis
1360529|NCT01331603|low+high risk MDS patients|low+high risk mds patients
1360530|NCT01331603|patients|patients
1360531|NCT01331577|Healthy|healthy
1360532|NCT01331577|Primary Prevention|primary prevention
1360533|NCT01331577|Stress|stress
1360534|NCT01331577|Kinesiology|kinesiology
1360535|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
1360536|NCT01331577|Prevention|prevention
1360537|NCT01331564|Pregnancy|pregnancy
1360538|NCT01331564|Postpartum|postpartum
1360539|NCT01331564|Weight gain|weight gain
1360540|NCT01331564|Weight retention|weight retention
1360541|NCT01331564|Behavior|behavior
1360542|NCT01331564|Electronic Media|electronic media
1360543|NCT01331564|Randomized Clinical Trial|randomized clinical trial
1360544|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
1360545|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
1360546|NCT01331538|posture|posture
1360547|NCT01331525|Small cell lung cancer|small cell lung cancer
1360548|NCT01331525|Chemotherapy|chemotherapy
1360549|NCT01331525|Immunotherapy|immunotherapy
1360550|NCT01331525|CTLA-4|ctla-4
1360551|NCT01331525|Ipilimumab|ipilimumab
1360552|NCT01331512|Clinical Geriatrics|clinical geriatrics
1360553|NCT01331512|Biomechanics|biomechanics
1360554|NCT01331512|Epidemiology|epidemiology
1360555|NCT01331512|Decline in Ambulation|decline in ambulation
1360556|NCT01331499|Blood loss|blood loss
1360557|NCT01331499|transfusions|transfusions
1360558|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
1360559|NCT01331486|Prehypertension|prehypertension
1360560|NCT01331486|Mild hypertension|mild hypertension
1360561|NCT01331486|Flow mediated dilation|flow mediated dilation
1360562|NCT01331486|Hawthorn|hawthorn
1360563|NCT01331473|Carotid Artery|carotid artery
1360564|NCT01331473|Stenting|stenting
1360565|NCT01331473|CAS|cas
1360566|NCT01331473|proximal protection|proximal protection
1360567|NCT01331460|HIV|hiv
1360568|NCT01331460|HIV risk|hiv risk
1360569|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
1360570|NCT01331460|Drug Use|drug use
1360571|NCT01331460|Women|women
1360572|NCT01331460|Drug Treatment|drug treatment
1360573|NCT01331460|opioids|opioids
1360574|NCT01331460|injection drug use|injection drug use
1360575|NCT01331460|stimulants|stimulants
1360576|NCT01331460|gender-specific treatment|gender-specific treatment
1360577|NCT01331395|Infertility|infertility
1360578|NCT01331395|IVF|ivf
1360579|NCT01331395|Acupuncture|acupuncture
1360580|NCT01331382|Resveratrol|resveratrol
1360581|NCT01331382|Piperine|piperine
1360582|NCT01331382|Cerebral blood flow|cerebral blood flow
1360583|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
1360584|NCT01331382|Bioavailability|bioavailability
1360585|NCT01331369|adherence|adherence
1360586|NCT01331369|compliance|compliance
1360587|NCT01331369|persistence|persistence
1360588|NCT01331369|drop out|drop out
1360589|NCT01331369|abandon|abandon
1360590|NCT01331356|Chronic proctalgia|chronic proctalgia
1360591|NCT01331356|Botulinum toxin type A|botulinum toxin type a
1360592|NCT01331356|Ganglion Impar|ganglion impar
1360593|NCT01331356|Perineal pain|perineal pain
1360594|NCT01331356|Pudendal neuralgia|pudendal neuralgia
1360595|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
1360596|NCT01331343|Diabetes|diabetes
1360597|NCT01331343|Glycemic Control|glycemic control
1360598|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
1360599|NCT01331330|Depressive Disorder|depressive disorder
1360600|NCT01331330|Unipolar|unipolar
1360601|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
1360602|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
1360603|NCT01331317|Plasma NTproBNP|plasma ntprobnp
1360604|NCT01331317|UAER|uaer
1360605|NCT01331304|Bipolar disorder|bipolar disorder
1360606|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
1360607|NCT01331304|Lithium|lithium
1360608|NCT01331304|Quetiapine|quetiapine
1360609|NCT01331291|bosutinib|bosutinib
1360610|NCT01331291|SKI-606|ski-606
1360611|NCT01331278|total joint replacement|total joint replacement
1360612|NCT01331278|knee|knee
1360613|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
1360614|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
1360615|NCT01331265|specific health outcomes|specific health outcomes
1360616|NCT01331239|Cushing Disease|cushing disease
1360617|NCT01331239|LCI699|lci699
1360618|NCT01331239|Pituitary Gland|pituitary gland
1360619|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
1360620|NCT01331213|Pregabalin|pregabalin
1360621|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
1360622|NCT01331213|motor|motor
1360623|NCT01331213|sensation|sensation
1360624|NCT01331213|colon|colon
1360625|NCT01331213|human|human
1360626|NCT01331200|ischemic stroke|ischemic stroke
1360627|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
1360628|NCT01331200|early mobilization|early mobilization
1360629|NCT01331200|patient safety|patient safety
1360630|NCT01331200|length of stay|length of stay
1360631|NCT01331187|Echocardiography|echocardiography
1360632|NCT01331187|Heart failure|heart failure
1360633|NCT01331187|Ultrasonography|ultrasonography
1360634|NCT01331187|pocket-size device|pocket-size device
1360635|NCT01331187|Aorta|aorta
1360636|NCT01331187|Education|education
1360637|NCT01331174|knee|knee
1360638|NCT01331174|osteoarthritis|osteoarthritis
1360639|NCT01331174|physical therapy|physical therapy
1360640|NCT01331174|pulsed short wave|pulsed short wave
1360641|NCT01331161|shingles vaccine|shingles vaccine
1360642|NCT01331161|immune responses|immune responses
1360643|NCT01331148|sickle cell disease|sickle cell disease
1360644|NCT01331148|vitamin D|vitamin d
1360645|NCT01331148|pediatrics|pediatrics
1360646|NCT01331148|pain|pain
1360647|NCT01331135|pediatrics|pediatrics
1360648|NCT01331135|sirolimus|sirolimus
1360649|NCT01331135|relapse|relapse
1360650|NCT01331109|Fibromyalgia|fibromyalgia
1360651|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
1360652|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
1360653|NCT01331109|milnacipran|milnacipran
1360654|NCT01331109|Savella|savella
1360655|NCT01331109|loss of therapeutic response|loss of therapeutic response
1360656|NCT01331109|Forest Research Institute|forest research institute
1360657|NCT01331109|Pain|pain
1360658|NCT01331109|Fatigue|fatigue
1361161|NCT01328860|Stem Cells|stem cells
1360659|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
1360660|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
1360661|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
1360662|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1360663|NCT01331057|Bilingualism|bilingualism
1360664|NCT01331057|Language|language
1360665|NCT01331057|Evaluation transcultural|evaluation transcultural
1360666|NCT01331057|Intra Familial Relationship|intra familial relationship
1360667|NCT01331057|Transmissions mother|transmissions mother
1360668|NCT01331057|Tongue french|tongue french
1360669|NCT01331057|Language tamil|language tamil
1360670|NCT01331057|Language arabic|language arabic
1360671|NCT01331057|Language soninke|language soninke
1360672|NCT01331057|Language cultural|language cultural
1360673|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
1360675|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
1360676|NCT01331044|Children|children
1360677|NCT01331044|Body composition|body composition
1360678|NCT01331044|Microbiota|microbiota
1360679|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
1360680|NCT01331044|Acceptability of RUTF|acceptability of rutf
1360681|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
1360783|NCT01330576|cooling|cooling
1360682|NCT01331044|Changes in body composition|changes in body composition
1360683|NCT01331044|Gut microbiota|gut microbiota
1360684|NCT01331044|Genome wide association|genome wide association
1360685|NCT01331031|temporomandibular disorder|temporomandibular disorder
1360686|NCT01331031|adolescents|adolescents
1360687|NCT01331005|Macular Edema|macular edema
1360688|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
1360689|NCT01330992|Circadian rhythms|circadian rhythms
1360690|NCT01330992|Melatonin|melatonin
1360691|NCT01330992|Ocular light exposure|ocular light exposure
1360692|NCT01330992|Darkness Exposure|darkness exposure
1360693|NCT01330992|Performance|performance
1360694|NCT01330992|Alertness|alertness
1360695|NCT01330979|Intraocular pressure|intraocular pressure
1360696|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
1360697|NCT01330953|Anemia|anemia
1360698|NCT01330940|Kidney stones|kidney stones
1360699|NCT01330940|Calcium|calcium
1360700|NCT01330940|citrate|citrate
1360701|NCT01330927|VA106483|va106483
1360702|NCT01330927|Nocturia|nocturia
1360703|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1360704|NCT01330927|BPH|bph
1360705|NCT01330927|Elderly|elderly
1360706|NCT01330927|Males|males
1360707|NCT01330927|Nocturnal voids|nocturnal voids
1360708|NCT01330927|Anti-diuretic|anti-diuretic
1360709|NCT01330914|Obesity, Morbid|obesity, morbid
1360710|NCT01330914|Bariatric Surgery|bariatric surgery
1360711|NCT01330914|Gastric Bypass|gastric bypass
1360712|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
1360713|NCT01330914|Vitamin D|vitamin d
1360714|NCT01330914|Bone Density|bone density
1360715|NCT01330914|Body Composition|body composition
1360716|NCT01330914|Weight Loss|weight loss
1360717|NCT01330888|war|war
1360718|NCT01330888|religion|religion
1360719|NCT01330888|caregiver|caregiver
1360720|NCT01330888|combat stress disorder|combat stress disorder
1360721|NCT01330862|patient outcomes|patient outcomes
1360722|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1360723|NCT01330849|School|school
1360724|NCT01330849|Behavioral Intervention|behavioral intervention
1360725|NCT01330849|RCT|rct
1360726|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
1360727|NCT01330823|L-Carnitine|l-carnitine
1360728|NCT01330823|quality of life|quality of life
1360729|NCT01330823|survival|survival
1360730|NCT01330823|malnutrition|malnutrition
1360731|NCT01330823|cancer cachexia|cancer cachexia
1360732|NCT01330823|fatigue|fatigue
1360733|NCT01330810|Pharmacokinetics|pharmacokinetics
1360734|NCT01330810|Dietary Supplements|dietary supplements
1360735|NCT01330810|Curcumin|curcumin
1360736|NCT01330797|Cataract|cataract
1360737|NCT01330797|Intravitreal|intravitreal
1360738|NCT01330797|Ranibizumab|ranibizumab
1360739|NCT01330797|LOCS III|locs iii
1360740|NCT01330758|Phase I|phase i
1360741|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
1360742|NCT01330758|Bioavailability|bioavailability
1360743|NCT01330758|AZD8931|azd8931
1360744|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
1360745|NCT01330745|mesenteric|mesenteric
1360746|NCT01330745|microcirculatory function|microcirculatory function
1360747|NCT01330732|SPINESCAN®|spinescan®
1360748|NCT01330732|kyphosis|kyphosis
1360749|NCT01330719|Periodontitis|periodontitis
1360750|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
1360751|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
1360752|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
1360753|NCT01330693|ADHD|adhd
1360754|NCT01330693|Atomoxetine|atomoxetine
1360755|NCT01330693|Biomarker|biomarker
1360756|NCT01330680|coffee|coffee
1360757|NCT01330680|caffeine|caffeine
1360758|NCT01330680|blood pressure|blood pressure
1360759|NCT01330680|nutrigenetics|nutrigenetics
1360760|NCT01330680|gene polymorphisms|gene polymorphisms
1360761|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
1360762|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
1360763|NCT01330667|Breastfeeding|breastfeeding
1360764|NCT01330667|Limited Formula|limited formula
1360765|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
1360766|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
1360767|NCT01330654|Age forty to seventy five|age forty to seventy five
1360768|NCT01330641|Tendonitis|tendonitis
1360769|NCT01330641|Rotator Cuff|rotator cuff
1360770|NCT01330641|Shoulder|shoulder
1360771|NCT01330641|Injection|injection
1360772|NCT01330628|peripheral arterial disease|peripheral arterial disease
1360773|NCT01330628|in stent restenosis|in stent restenosis
1360774|NCT01330628|peripheral vascular disease|peripheral vascular disease
1360776|NCT01330615|plantar warts|plantar warts
1360777|NCT01330615|cryotherapy|cryotherapy
1360778|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
1360779|NCT01330589|Clopidogrel|clopidogrel
1360780|NCT01330589|St. John's Wort|st. john's wort
1360781|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
1360782|NCT01330576|Hypothermia|hypothermia
1360784|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
1360786|NCT01330576|neonates|neonates
1360787|NCT01330576|preterm|preterm
1360788|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
1360789|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
1360790|NCT01330550|pre-diabetics|pre-diabetics
1360791|NCT01330537|perceptual development|perceptual development
1360792|NCT01330537|topological perception theory|topological perception theory
1360793|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
1360794|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
1360795|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
1360796|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
1360797|NCT01330537|Detect the size of the hole|detect the size of the hole
1360798|NCT01330511|Newborn infant|newborn infant
1360799|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
1360800|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
1360801|NCT01330511|Diagnostic algorithm|diagnostic algorithm
1360802|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
1360803|NCT01330498|duration of natalizumab|duration of natalizumab
1360804|NCT01330498|stratification of risk for PML|stratification of risk for pml
1360805|NCT01330472|Alprazolam|alprazolam
1360806|NCT01330472|Xanax|xanax
1360807|NCT01330472|Bioequivalence|bioequivalence
1360808|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
1360809|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
1360810|NCT01330446|Head and Neck Cancer|head and neck cancer
1360811|NCT01330446|HNC|hnc
1360812|NCT01330446|Fatigue|fatigue
1360813|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
1360814|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
1360815|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
1360816|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
1360817|NCT01330446|Armodafinil|armodafinil
1360818|NCT01330446|Nuvigil|nuvigil
1360819|NCT01330446|Placebo|placebo
1360820|NCT01330446|Sugar Pill|sugar pill
1360821|NCT01330446|Questionnaires|questionnaires
1360822|NCT01330446|Surveys|surveys
1360823|NCT01330394|Alcoholism|alcoholism
1360824|NCT01330394|Lesch's typology|lesch's typology
1360825|NCT01330394|tDCS|tdcs
1360826|NCT01330394|ERP|erp
1360827|NCT01330394|P300|p300
1360828|NCT01330394|FAB|fab
1360829|NCT01330394|MMSE|mmse
1360830|NCT01330394|Cognitive tasks|cognitive tasks
1360831|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
1360832|NCT01330368|SLE|sle
1360833|NCT01330368|Lupus|lupus
1360834|NCT01330368|children with SLE|children with sle
1360835|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
1360836|NCT01330329|Obesity|obesity
1360837|NCT01330329|Weight loss|weight loss
1360838|NCT01330329|Exercise|exercise
1360839|NCT01330329|Intervention studies|intervention studies
1360840|NCT01330303|Bioequivalence|bioequivalence
1360841|NCT01330303|Healthy volunteers|healthy volunteers
1360842|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
1360843|NCT01330303|Fed administration|fed administration
1360844|NCT01330290|Rotigotine|rotigotine
1360845|NCT01330290|Neupro®|neupro®
1360846|NCT01330290|Parkinson|parkinson
1360847|NCT01330290|Treatment preference|treatment preference
1360848|NCT01330290|Care-giving|care-giving
1360849|NCT01330277|Metabolic Diseases|metabolic diseases
1360850|NCT01330277|Biomarker|biomarker
1360851|NCT01330277|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1360852|NCT01330277|Lysosomal Storage Diseases|lysosomal storage diseases
1360853|NCT01330277|Morbus Hunter|morbus hunter
1361375|NCT01327989|STAR|star
1360854|NCT01330277|Mucopolysaccharidoses|mucopolysaccharidoses
1360855|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
1360856|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
1360857|NCT01330238|Low back pain|low back pain
1360858|NCT01330238|Modic changes|modic changes
1360859|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
1360860|NCT01330238|Efficacy|efficacy
1360861|NCT01330238|Zoledronic acid|zoledronic acid
1360862|NCT01330238|Bisphosphonates|bisphosphonates
1360864|NCT01330199|Healthy|healthy
1360865|NCT01330199|Female|female
1360866|NCT01330199|Volunteer|volunteer
1360867|NCT01330160|stroke|stroke
1360868|NCT01330160|Brain ischemia|brain ischemia
1360869|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
1360870|NCT01330160|Dementia, Vascular|dementia, vascular
1360871|NCT01330160|Alzheimer's disease|alzheimer's disease
1360872|NCT01330147|HPV|hpv
1360873|NCT01330147|oral cancer|oral cancer
1360874|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
1360875|NCT01330147|tonsillectomy|tonsillectomy
1360876|NCT01330134|procedural|procedural
1360877|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
1360981|NCT01329666|Endocrinology|endocrinology
1360878|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
1360879|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
1360880|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1360881|NCT01330108|PAH|pah
1360882|NCT01330108|WHO Group 1|who group 1
1360883|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
1360884|NCT01330095|Very low birth weight infant|very low birth weight infant
1360885|NCT01330095|Enteral feeding|enteral feeding
1360886|NCT01330095|Growth|growth
1360887|NCT01330095|amount of enteral feeding|amount of enteral feeding
1360888|NCT01330082|Photodynamic therapy|photodynamic therapy
1360889|NCT01330082|Light-emitting diode|light-emitting diode
1360890|NCT01330082|toluidine blue|toluidine blue
1360891|NCT01330082|scaling and root planing|scaling and root planing
1360892|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
1360893|NCT01330043|smoking cessation intervention|smoking cessation intervention
1360894|NCT01330017|Seasonal allergies|seasonal allergies
1360895|NCT01329991|RA|ra
1360896|NCT01329991|Methotrexate|methotrexate
1360897|NCT01329978|Hepatitis C|hepatitis c
1360898|NCT01329978|HCV|hcv
1360899|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
1360900|NCT01329965|Cardiovascular disease|cardiovascular disease
1360901|NCT01329965|Inflammation|inflammation
1360902|NCT01329965|LPS|lps
1360903|NCT01329965|Endotoxin|endotoxin
1360904|NCT01329939|Asthma|asthma
1360905|NCT01329939|Obesity|obesity
1360906|NCT01329939|Pediatric|pediatric
1360907|NCT01329939|Inflammation|inflammation
1360908|NCT01329939|Leukotriene|leukotriene
1360909|NCT01329939|Montelukast|montelukast
1360910|NCT01329926|Parkinson's disease|parkinson's disease
1360911|NCT01329926|Neural stem cells|neural stem cells
1360912|NCT01329900|Chemotherapy|chemotherapy
1360913|NCT01329900|Stem Cell Collection|stem cell collection
1360914|NCT01329900|Ofatumumab|ofatumumab
1360915|NCT01329900|Arzerra|arzerra
1360916|NCT01329900|Ifosfamide|ifosfamide
1360917|NCT01329900|Ifex|ifex
1360918|NCT01329900|Etoposide|etoposide
1360919|NCT01329900|VePesid|vepesid
1360920|NCT01329900|Mesna|mesna
1360921|NCT01329900|Mesnex|mesnex
1360922|NCT01329900|G-CSF|g-csf
1360923|NCT01329900|Filgrastim|filgrastim
1360924|NCT01329900|Neupogen|neupogen
1360925|NCT01329900|Apheresis|apheresis
1360926|NCT01329887|microcirculation|microcirculation
1360927|NCT01329887|SDF|sdf
1360928|NCT01329887|ketanserin|ketanserin
1360929|NCT01329887|severe sepsis|severe sepsis
1360930|NCT01329861|chronic back pain|chronic back pain
1360931|NCT01329861|internet based treatment|internet based treatment
1360932|NCT01329861|pain management programme|pain management programme
1360933|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
1360934|NCT01329861|minimal therapist contact|minimal therapist contact
1360935|NCT01329848|Accommodation|accommodation
1360936|NCT01329848|Reading|reading
1360937|NCT01329848|Autorefraction|autorefraction
1360938|NCT01329822|type 2 diabetes|type 2 diabetes
1360939|NCT01329822|overweight|overweight
1360940|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
1360941|NCT01329809|colon cancer|colon cancer
1360942|NCT01329809|liver metastasis|liver metastasis
1360943|NCT01329809|Pexa-vec|pexa-vec
1360944|NCT01329809|JX-594|jx-594
1360945|NCT01329796|dysmenorrhea,|dysmenorrhea,
1360946|NCT01329796|pelvic pain|pelvic pain
1360947|NCT01329796|dyspareunia|dyspareunia
1360948|NCT01329796|endometriosis|endometriosis
1360949|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
1360950|NCT01329770|Hyperactivity|hyperactivity
1360951|NCT01329770|Anxiety|anxiety
1360952|NCT01329770|Cognitive problems|cognitive problems
1360953|NCT01329770|Behavioural symptoms|behavioural symptoms
1360954|NCT01329770|Fragile X syndrome|fragile x syndrome
1360955|NCT01329770|Autism|autism
1360956|NCT01329770|inherited Genetic condition|inherited genetic condition
1360957|NCT01329757|Spinal Cord Injury|spinal cord injury
1360958|NCT01329757|Growth Hormone|growth hormone
1360959|NCT01329757|Trauma|trauma
1360960|NCT01329757|Incomplete|incomplete
1360961|NCT01329757|ASIA|asia
1360962|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
1360963|NCT01329731|white spot lesion|white spot lesion
1360964|NCT01329731|initial caries|initial caries
1360965|NCT01329731|fluoride|fluoride
1360966|NCT01329731|amine fluoride|amine fluoride
1360967|NCT01329731|orthodontics|orthodontics
1360968|NCT01329731|remineralization|remineralization
1360969|NCT01329731|brackets|brackets
1360970|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
1360971|NCT01329718|Epi Pro Colon Test|epi pro colon test
1360972|NCT01329718|CRC|crc
1360973|NCT01329692|RYGB|rygb
1360974|NCT01329692|Intervention|intervention
1360975|NCT01329692|follow-up|follow-up
1360976|NCT01329692|standard-of-care|standard-of-care
1360977|NCT01329692|Back on Track program|back on track program
1360978|NCT01329692|poor weight loss|poor weight loss
1360979|NCT01329692|morbidly obese|morbidly obese
1360980|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
1360982|NCT01329666|Hypercalcemia|hypercalcemia
1360983|NCT01329666|Vitamin D deficiency|vitamin d deficiency
1360984|NCT01329666|Parathyroid Hormone|parathyroid hormone
1360985|NCT01329666|Osteoporosis|osteoporosis
1360986|NCT01329666|Bone Density|bone density
1360987|NCT01329666|Vitamin D repletion|vitamin d repletion
1360988|NCT01329666|Vitamin D Supplements|vitamin d supplements
1360989|NCT01329653|cerebral blood volume|cerebral blood volume
1360990|NCT01329653|aging|aging
1360991|NCT01329653|exercise|exercise
1360992|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
1360993|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
1360994|NCT01329601|cognitive training|cognitive training
1360995|NCT01329601|Alzheimer disease|alzheimer disease
1360996|NCT01329601|tertiary prevention|tertiary prevention
1360997|NCT01329588|Female sex workers|female sex workers
1360998|NCT01329588|West Africa|west africa
1360999|NCT01329588|Presumptive treatment|presumptive treatment
1361000|NCT01329588|Sexually transmitted infections|sexually transmitted infections
1361001|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
1361002|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
1361003|NCT01329562|Menstrual migraine|menstrual migraine
1361004|NCT01329562|Menstrually-related migraine|menstrually-related migraine
1361005|NCT01329562|Treximet|treximet
1361006|NCT01329562|CGRP|cgrp
1361007|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
1361008|NCT01329536|Alzheimer's Disease|alzheimer's disease
1361009|NCT01329536|Agitation|agitation
1361010|NCT01329536|Genetics|genetics
1361011|NCT01329536|Apolipoprotein|apolipoprotein
1361012|NCT01329536|ApoE4|apoe4
1361013|NCT01329523|Dementia|dementia
1361014|NCT01329523|Insulin-like growth factor|insulin-like growth factor
1361015|NCT01329523|IGF|igf
1361016|NCT01329523|APO E4|apo e4
1361017|NCT01329523|Genetics|genetics
1361018|NCT01329510|ADHD|adhd
1361019|NCT01329510|Adult|adult
1361020|NCT01329484|Alzheimer|alzheimer
1361021|NCT01329484|Dementia|dementia
1361022|NCT01329484|Computer|computer
1361023|NCT01329484|Cognitive training|cognitive training
1361024|NCT01329484|Reminiscence therapy|reminiscence therapy
1361025|NCT01329458|FLL|fll
1361026|NCT01329458|CEUS|ceus
1361027|NCT01329458|SonoVue|sonovue
1361028|NCT01329458|HCC|hcc
1361029|NCT01329458|Liver metastases|liver metastases
1361030|NCT01329458|Hemangiomas|hemangiomas
1361031|NCT01329458|FNH|fnh
1361032|NCT01329445|Cartilage repair|cartilage repair
1361033|NCT01329445|Articular cartilage defects|articular cartilage defects
1361034|NCT01329432|surfactant|surfactant
1361035|NCT01329432|intubation|intubation
1361036|NCT01329432|spontaneous breathing|spontaneous breathing
1361037|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1361038|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
1361039|NCT01329406|Milnacipran|milnacipran
1361040|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
1361041|NCT01329406|Knee pain|knee pain
1361042|NCT01329393|Disability|disability
1361043|NCT01329393|Social Security|social security
1361044|NCT01329393|Representative Payee|representative payee
1361045|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
1361046|NCT01329367|EVASYON|evasyon
1361047|NCT01329367|GENOI|genoi
1361048|NCT01329367|antioxidants|antioxidants
1361049|NCT01329367|legume|legume
1361050|NCT01329367|fish|fish
1361051|NCT01329354|Follicular lymphoma|follicular lymphoma
1361052|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
1361053|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
1361054|NCT01329354|Cell Therapy|cell therapy
1361055|NCT01329354|Maintenance therapy|maintenance therapy
1361056|NCT01329354|Rituximab|rituximab
1361057|NCT01329341|PTSD|ptsd
1361058|NCT01329341|Service Dogs|service dogs
1361059|NCT01329328|whole-body vibration|whole-body vibration
1361060|NCT01329328|radiofrequency|radiofrequency
1361061|NCT01329328|hormonal status|hormonal status
1361062|NCT01329328|muscular strength|muscular strength
1361064|NCT01329276|COPD|copd
1361065|NCT01329276|Symbicort|symbicort
1361066|NCT01329276|Turbohaler|turbohaler
1361067|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
1361068|NCT01329276|Functional Imaging|functional imaging
1361069|NCT01329276|Budesonide|budesonide
1361070|NCT01329276|Formoterol|formoterol
1361071|NCT01329263|menthol cigarettes|menthol cigarettes
1361072|NCT01329250|Tuberculosis|tuberculosis
1361073|NCT01329250|Moxifloxacin|moxifloxacin
1361074|NCT01329250|Pharmacokinetics|pharmacokinetics
1361075|NCT01329250|Safety|safety
1361076|NCT01329237|drug-eluting stent|drug-eluting stent
1361077|NCT01329237|coronary endothelial function|coronary endothelial function
1361078|NCT01329237|coronary imaging|coronary imaging
1361079|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
1361080|NCT01329211|Gastroparesis|gastroparesis
1361081|NCT01329211|Quality of Life|quality of life
1361082|NCT01329198|tourette|tourette
1361083|NCT01329198|tourette's|tourette's
1361084|NCT01329198|TS|ts
1361289|NCT01328353|telehealth|telehealth
1361085|NCT01329198|tourette syndrome|tourette syndrome
1361086|NCT01329198|tourette's syndrome|tourette's syndrome
1361087|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
1361088|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
1361089|NCT01329172|PUFA|pufa
1361090|NCT01329172|Cystic Fibrosis|cystic fibrosis
1361091|NCT01329172|Nasal brushing|nasal brushing
1361092|NCT01329172|Mucins|mucins
1361093|NCT01329172|Mucin production|mucin production
1361094|NCT01329159|High altitude|high altitude
1361095|NCT01329159|respiratory function|respiratory function
1361096|NCT01329159|cardiorespiratory health|cardiorespiratory health
1361097|NCT01329159|indoor pollution|indoor pollution
1361098|NCT01329146|pulse pressure variation|pulse pressure variation
1361099|NCT01329146|preload dependency|preload dependency
1361100|NCT01329146|one-lung ventilation|one-lung ventilation
1361101|NCT01329146|thoracic surgery|thoracic surgery
1361102|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
1361103|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
1361104|NCT01329133|ventral striatum|ventral striatum
1361105|NCT01329133|subthalamic nucleus|subthalamic nucleus
1361106|NCT01329107|Rehabilitation|rehabilitation
1361107|NCT01329107|Enhanced Recovery|enhanced recovery
1361108|NCT01329107|Health related Qouality of Life|health related qouality of life
1361109|NCT01329107|Patient outcomes|patient outcomes
1361110|NCT01329094|Severe mental illness|severe mental illness
1361111|NCT01329094|physical activity|physical activity
1361112|NCT01329094|evaluation|evaluation
1361113|NCT01329081|Rehabilitation|rehabilitation
1361114|NCT01329081|Strength training|strength training
1361115|NCT01329081|Long-term effect|long-term effect
1361116|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
1361117|NCT01329068|breast cancer|breast cancer
1361118|NCT01329042|Potassium sodium citrate|potassium sodium citrate
1361119|NCT01329042|stone recurrence|stone recurrence
1361120|NCT01329042|ESWL|eswl
1361121|NCT01329042|PCNL|pcnl
1361122|NCT01329042|Hypocitraturia|hypocitraturia
1361123|NCT01329042|intervention|intervention
1361124|NCT01329029|COPD|copd
1361125|NCT01329029|Roflumilast|roflumilast
1361126|NCT01329029|Daxas|daxas
1361127|NCT01329016|Pregnancy|pregnancy
1361128|NCT01329016|Glyburide|glyburide
1361129|NCT01329016|Metformin|metformin
1361130|NCT01329016|Pharmacokinetics|pharmacokinetics
1361131|NCT01329016|Pharmacodynamics|pharmacodynamics
1361132|NCT01329003|Silicosis|silicosis
1361133|NCT01328990|IPTc|iptc
1361134|NCT01328990|malaria|malaria
1361135|NCT01328990|children|children
1361136|NCT01328990|pharmacokinetics|pharmacokinetics
1361137|NCT01328990|amodiaquiane|amodiaquiane
1361138|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1361139|NCT01328964|pediatric|pediatric
1361140|NCT01328964|asthma|asthma
1361141|NCT01328964|outcomes|outcomes
1361142|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
1361143|NCT01328938|Pegfilgrastim|pegfilgrastim
1361144|NCT01328938|neutropenia|neutropenia
1361145|NCT01328925|Rotavirus|rotavirus
1361146|NCT01328925|Viral gastroenteritis|viral gastroenteritis
1361147|NCT01328925|Gastroenteritis|gastroenteritis
1361148|NCT01328912|ischemic preconditioning|ischemic preconditioning
1361149|NCT01328912|cardiac surgery|cardiac surgery
1361150|NCT01328912|vascular surgery|vascular surgery
1361151|NCT01328899|Emphysema|emphysema
1361152|NCT01328899|COPD|copd
1361153|NCT01328899|RePneu|repneu
1361154|NCT01328886|omalizumab|omalizumab
1361155|NCT01328886|allergic asthma|allergic asthma
1361156|NCT01328886|pediatric patients|pediatric patients
1361157|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
1361158|NCT01328873|stem cell transplant|stem cell transplant
1361159|NCT01328873|leukemia|leukemia
1361160|NCT01328860|Autologous|autologous
1361162|NCT01328860|Spinal Cord Injury|spinal cord injury
1361163|NCT01328860|Children|children
1361164|NCT01328834|Nephritis, Lupus|nephritis, lupus
1361165|NCT01328834|Tacrolimus|tacrolimus
1361166|NCT01328821|Safety|safety
1361167|NCT01328821|Tolerability|tolerability
1361168|NCT01328821|Pharmacokinetics|pharmacokinetics
1361169|NCT01328821|Healthy volunteers|healthy volunteers
1361170|NCT01328808|Acetaminophen|acetaminophen
1361171|NCT01328808|Preterm Infants|preterm infants
1361172|NCT01328795|Cardiogoniometry|cardiogoniometry
1361173|NCT01328795|Chest Pain Unit|chest pain unit
1361174|NCT01328795|ST-elevation|st-elevation
1361175|NCT01328795|Troponin|troponin
1361176|NCT01328795|Catheter intervention|catheter intervention
1361177|NCT01328795|Fast Track|fast track
1361178|NCT01328782|elbow fracture|elbow fracture
1361179|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
1361180|NCT01328782|elbow|elbow
1361181|NCT01328782|fracture|fracture
1361182|NCT01328782|pain management|pain management
1361183|NCT01328782|pediatric|pediatric
1361184|NCT01328769|uric acid|uric acid
1361185|NCT01328769|febuxostat|febuxostat
1361186|NCT01328769|hypertension|hypertension
1361191|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
1361193|NCT01328704|Iron deficiency|iron deficiency
1361194|NCT01328704|Vitamin D deficiency|vitamin d deficiency
1361195|NCT01328704|Anemia|anemia
1361196|NCT01328704|Athletes|athletes
1361197|NCT01328704|Triathletes|triathletes
1361198|NCT01328704|Triathlon|triathlon
1361199|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
1361200|NCT01328691|thrombus|thrombus
1361201|NCT01328691|body mass index|body mass index
1361202|NCT01328691|grade|grade
1361203|NCT01328678|Alopecia Areata|alopecia areata
1361204|NCT01328678|Vitamin D|vitamin d
1361205|NCT01328678|Parathyroid|parathyroid
1361206|NCT01328678|Calcium|calcium
1361208|NCT01328652|LTH|lth
1361209|NCT01328639|Collaborative care|collaborative care
1361210|NCT01328639|Diabetes management|diabetes management
1361211|NCT01328639|Depression management|depression management
1361212|NCT01328639|Primary care|primary care
1361213|NCT01328626|Safety|safety
1361214|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
1361215|NCT01328626|Pharmacokinetics|pharmacokinetics
1361216|NCT01328626|ABT-199|abt-199
1361217|NCT01328626|Preliminary Efficacy|preliminary efficacy
1361218|NCT01328626|Cancer|cancer
1361219|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1361220|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1361221|NCT01328613|BDNF|bdnf
1361222|NCT01328613|Homeosis|homeosis
1361223|NCT01328613|Women|women
1361224|NCT01328613|Childbirth|childbirth
1361225|NCT01328613|Major Depressive Disorder|major depressive disorder
1361226|NCT01328600|Placenta|placenta
1361227|NCT01328600|Pregnancy|pregnancy
1361228|NCT01328600|Hypertension|hypertension
1361229|NCT01328600|Supplementation|supplementation
1361230|NCT01328600|Antibody|antibody
1361236|NCT01328574|Progression-Free Survival|progression-free survival
1361237|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
1361238|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
1361239|NCT01328574|Ureter Cancer|ureter cancer
1361240|NCT01328574|Survival|survival
1361241|NCT01328574|Bladder Cancer|bladder cancer
1361242|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
1361243|NCT01328574|Urothelial Cancer|urothelial cancer
1361244|NCT01328561|Arginine|arginine
1361245|NCT01328561|Oxytocin|oxytocin
1361246|NCT01328561|Vasopressin|vasopressin
1361247|NCT01328561|Placebo|placebo
1361248|NCT01328561|Analgesia|analgesia
1361249|NCT01328561|Healthy Volunteer|healthy volunteer
1361250|NCT01328561|HV|hv
1361251|NCT01328548|varicella-zoster virus|varicella-zoster virus
1361252|NCT01328548|vaccine|vaccine
1361253|NCT01328548|T-cell|t-cell
1361254|NCT01328548|genes|genes
1361255|NCT01328548|frail elderly|frail elderly
1361256|NCT01328548|immunosenescence|immunosenescence
1361257|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
1361258|NCT01328509|Zinc|zinc
1361259|NCT01328496|Hematologic Malignancies|hematologic malignancies
1361260|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
1361261|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
1361262|NCT01328483|Neonates|neonates
1361263|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
1361264|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
1361265|NCT01328470|platelet|platelet
1361266|NCT01328470|cilostazol|cilostazol
1361267|NCT01328470|clopidogrel|clopidogrel
1361268|NCT01328470|chronic kidney disease|chronic kidney disease
1361269|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
1361270|NCT01328457|kala-azar|kala-azar
1361271|NCT01328457|Paromomycin|paromomycin
1361272|NCT01328457|Bangladesh|bangladesh
1361273|NCT01328457|Injections, Intramuscular|injections, intramuscular
1361274|NCT01328457|Treatment Outcome|treatment outcome
1361275|NCT01328457|Patient compliance|patient compliance
1361276|NCT01328457|Medication adherence|medication adherence
1361277|NCT01328457|Drug toxicity|drug toxicity
1361278|NCT01328431|Tobacco Use Cessation|tobacco use cessation
1361279|NCT01328431|Smoking Cessation|smoking cessation
1361280|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
1361281|NCT01328431|Brief Intervention|brief intervention
1361282|NCT01328418|Lengthening|lengthening
1361283|NCT01328392|LPR|lpr
1361284|NCT01328392|GERD|gerd
1361285|NCT01328366|Quality of Life|quality of life
1361286|NCT01328366|Psychosocial factors|psychosocial factors
1361287|NCT01328353|triage|triage
1361288|NCT01328353|aprn|aprn
1361290|NCT01328353|CCHCN|cchcn
1361291|NCT01328353|advanced practice nurse|advanced practice nurse
1361292|NCT01328353|improve family quality of life|improve family quality of life
1361293|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
1361294|NCT01328353|telehealth triage intervention|telehealth triage intervention
1361295|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
1361296|NCT01328301|gait|gait
1361297|NCT01328301|hemiplegia|hemiplegia
1361298|NCT01328301|treadmill|treadmill
1361299|NCT01328301|physiotherapy|physiotherapy
1361300|NCT01328301|rehabilitation|rehabilitation
1361301|NCT01328288|HIV related adverse events|hiv related adverse events
1361302|NCT01328288|Immunological failure|immunological failure
1361303|NCT01328288|virological failure|virological failure
1361304|NCT01328288|quality of life|quality of life
1361305|NCT01328288|depression|depression
1361306|NCT01328288|genotypic resistance|genotypic resistance
1361307|NCT01328275|HIV related adverse events|hiv related adverse events
1361308|NCT01328275|immunological failure|immunological failure
1361309|NCT01328275|virological failure|virological failure
1361310|NCT01328275|quality of life|quality of life
1361311|NCT01328275|depression|depression
1361312|NCT01328275|genotypic resistance|genotypic resistance
1361313|NCT01328262|Hemoglobins|hemoglobins
1361314|NCT01328249|Breast Cancer|breast cancer
1361315|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
1361316|NCT01328236|Bortezomib|bortezomib
1361317|NCT01328236|PCL|pcl
1361318|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
1361319|NCT01328223|radiotherapy|radiotherapy
1361320|NCT01328223|sorafenib|sorafenib
1361321|NCT01328210|metabolic syndrome|metabolic syndrome
1361322|NCT01328210|Phlebotomy|phlebotomy
1361323|NCT01328210|blood letting|blood letting
1361324|NCT01328210|hypertension|hypertension
1361325|NCT01328210|insulin sensitivity|insulin sensitivity
1361326|NCT01328197|Treovance|treovance
1361327|NCT01328197|aneurysm|aneurysm
1361328|NCT01328197|AAA|aaa
1361329|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
1361330|NCT01328132|Liver|liver
1361331|NCT01328132|transplant|transplant
1361332|NCT01328132|albumin|albumin
1361333|NCT01328067|MRgFus|mrgfus
1361334|NCT01328067|Uterine Fibroids|uterine fibroids
1361335|NCT01328067|Pelvic Pain|pelvic pain
1361336|NCT01328067|Quality of Life|quality of life
1361337|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1361338|NCT01328054|cancer|cancer
1361339|NCT01328054|cardiac repolarization|cardiac repolarization
1361340|NCT01328054|Holter monitor|holter monitor
1361341|NCT01328054|pharmacokinetics|pharmacokinetics
1361342|NCT01328054|GW572016|gw572016
1361343|NCT01328054|lapatinib|lapatinib
1361344|NCT01328054|QTc interval|qtc interval
1361345|NCT01328054|safety|safety
1361346|NCT01328054|ECG|ecg
1361347|NCT01328041|GSK1349572|gsk1349572
1361348|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
1361349|NCT01328041|Integrase inhibitor|integrase inhibitor
1361350|NCT01328041|ART-experienced|art-experienced
1361351|NCT01328041|dolutegravir|dolutegravir
1361352|NCT01328028|Invasive cervical cancer|invasive cervical cancer
1361353|NCT01328028|Human papillomavirus|human papillomavirus
1361354|NCT01328015|hyperhidrosis|hyperhidrosis
1361355|NCT01328015|oxybutynin|oxybutynin
1361356|NCT01328015|plantar sweating|plantar sweating
1361357|NCT01328015|compensatory sweating|compensatory sweating
1361358|NCT01328002|Fibromyalgia|fibromyalgia
1361359|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
1361360|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
1361361|NCT01328002|milnacipran|milnacipran
1361362|NCT01328002|Savella|savella
1361363|NCT01328002|loss of therapeutic response|loss of therapeutic response
1361364|NCT01328002|Forest Research Institute|forest research institute
1361365|NCT01328002|Pain|pain
1361366|NCT01328002|Fatigue|fatigue
1361367|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
1361368|NCT01328002|Randomized Withdrawal|randomized withdrawal
1361369|NCT01327989|Solitaire FR Device|solitaire fr device
1361370|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
1361371|NCT01327989|Recanalization|recanalization
1361372|NCT01327989|Brain artery recanalization|brain artery recanalization
1361373|NCT01327989|Neurovascular intervention|neurovascular intervention
1361374|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
1361376|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
1361377|NCT01327976|Obesity|obesity
1361378|NCT01327976|Bariatric surgery|bariatric surgery
1361379|NCT01327976|Excess weight loss|excess weight loss
1361380|NCT01327976|Vagus nerve|vagus nerve
1361381|NCT01327976|Vagal blocking|vagal blocking
1361382|NCT01327976|vBloc Therapy|vbloc therapy
1361383|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
1361384|NCT01327963|GERD|gerd
1361385|NCT01327963|Heartburn|heartburn
1361386|NCT01327963|Reflux|reflux
1361387|NCT01327963|Regurgitation|regurgitation
1361388|NCT01327963|Hoarseness|hoarseness
1361389|NCT01327963|Cough|cough
1361390|NCT01327950|Percutaneous treatment|percutaneous treatment
1361391|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
1361392|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
1361393|NCT01327911|Mactel|mactel
1361394|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
1361395|NCT01327898|MSM|msm
1361396|NCT01327898|HIV/AIDS|hiv/aids
1361397|NCT01327898|sexual risk|sexual risk
1361398|NCT01327898|substance use|substance use
1361399|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
1361400|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
1361401|NCT01327872|TLD|tld
1361402|NCT01327846|Cardiovascular Death|cardiovascular death
1361403|NCT01327846|Myocardial Infarction|myocardial infarction
1361404|NCT01327846|Stroke|stroke
1361405|NCT01327846|Canakinumab|canakinumab
1361406|NCT01327846|IL-1B|il-1b
1361407|NCT01327846|hsCRP|hscrp
1361408|NCT01327820|Oxygen consumption|oxygen consumption
1361409|NCT01327820|Aortic Aneurysm|aortic aneurysm
1361410|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
1361411|NCT01327807|Registries|registries
1361412|NCT01327807|Cystinosis|cystinosis
1361413|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
1361414|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
1361415|NCT01327807|Cystine|cystine
1361416|NCT01327807|Kidney|kidney
1361417|NCT01327807|Rare Diseases|rare diseases
1361418|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
1361419|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
1361420|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
1361421|NCT01327768|Stroke,|stroke,
1361422|NCT01327768|Stem Cell,|stem cell,
1361423|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
1361424|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
1361425|NCT01327755|Selenium|selenium
1361426|NCT01327755|HIV/ AIDS|hiv/ aids
1361427|NCT01327755|CD4 counts|cd4 counts
1361428|NCT01327755|Antiretroviral therapy|antiretroviral therapy
1361429|NCT01327742|Relay|relay
1361430|NCT01327742|Thoracic|thoracic
1361431|NCT01327742|Aneurysm|aneurysm
1361432|NCT01327729|pegylated interferon|pegylated interferon
1361433|NCT01327729|interferon|interferon
1361434|NCT01327729|HCV|hcv
1361435|NCT01327729|genotype 4|genotype 4
1361436|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1361437|NCT01327703|Cystic Fibrosis|cystic fibrosis
1361438|NCT01327703|Steatorrhea|steatorrhea
1361439|NCT01327703|Malabsorption|malabsorption
1361440|NCT01327703|Malnutrition|malnutrition
1361441|NCT01327677|pain management|pain management
1361442|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
1361443|NCT01327677|safety|safety
1361444|NCT01327677|craniotomy|craniotomy
1361445|NCT01327664|Quiescent uveitis|quiescent uveitis
1361446|NCT01327664|intermediate uveitis|intermediate uveitis
1361447|NCT01327664|panuveitis|panuveitis
1361448|NCT01327664|posterior uveitis|posterior uveitis
1361449|NCT01327664|uveitis|uveitis
1361450|NCT01327651|Drug Administration Schedule|drug administration schedule
1361451|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
1361452|NCT01327651|Pharmacokinetics|pharmacokinetics
1361453|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1361454|NCT01327625|Graft versus host disease|graft versus host disease
1361455|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
1361456|NCT01327625|Azithromycin|azithromycin
1361457|NCT01327625|N-acetylcystein|n-acetylcystein
1361458|NCT01327625|Fluticasone|fluticasone
1361459|NCT01327625|Inhaled steroid|inhaled steroid
1361460|NCT01327612|AMG 655|amg 655
1361461|NCT01327612|AMG 479|amg 479
1361462|NCT01327612|Apoptosis|apoptosis
1361463|NCT01327612|Monoclonal Antibody|monoclonal antibody
1361464|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
1361465|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
1361466|NCT01327612|Bevacizumab|bevacizumab
1361467|NCT01327612|Modified FOLFOX6|modified folfox6
1361468|NCT01327612|mFOLFOX6|mfolfox6
1361469|NCT01327612|FOLFOX|folfox
1361470|NCT01327612|Lymphoma|lymphoma
1361471|NCT01327612|Trail Receptor|trail receptor
1361472|NCT01327612|ganitumab|ganitumab
1361473|NCT01327612|conatumumab|conatumumab
1361474|NCT01327599|Open-angle glaucoma|open-angle glaucoma
1361475|NCT01327599|Ocular hypertension|ocular hypertension
1361476|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
1361477|NCT01327599|Intraocular pressure|intraocular pressure
1361478|NCT01327586|disability|disability
1361479|NCT01327586|substance abuse|substance abuse
1361480|NCT01327586|cocaine abuse|cocaine abuse
1361481|NCT01327586|dual diagnosis|dual diagnosis
1361482|NCT01327586|representative payee|representative payee
1361483|NCT01327586|HIV risk reduction|hiv risk reduction
1361484|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
1361485|NCT01327573|complement protein|complement protein
1361486|NCT01327573|eculizumab|eculizumab
1361487|NCT01327573|Kidney transplantation|kidney transplantation
1361488|NCT01327560|hemodialysis patients|hemodialysis patients
1361489|NCT01327560|sleep quality|sleep quality
1361490|NCT01327560|restless legs syndrome|restless legs syndrome
1361491|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
1361492|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
1361493|NCT01327547|HIV coinfection|hiv coinfection
1361494|NCT01327547|maraviroc|maraviroc
1361495|NCT01327547|CCR5 blocker|ccr5 blocker
1361496|NCT01327547|entry inhibitor|entry inhibitor
1361497|NCT01327547|liver disease|liver disease
1361498|NCT01327547|viral hepatitis|viral hepatitis
1361499|NCT01327534|STEMI|stemi
1361500|NCT01327534|clopidogrel|clopidogrel
1361501|NCT01327534|prasugrel|prasugrel
1361502|NCT01327534|platelet reactivity index|platelet reactivity index
1361503|NCT01327534|ST resolution|st resolution
1361504|NCT01327495|Androgen replacement in men|androgen replacement in men
1361505|NCT01327482|Raltegravir|raltegravir
1361506|NCT01327482|Pharmacokinetics|pharmacokinetics
1361507|NCT01327456|health literacy|health literacy
1361508|NCT01327456|self-management|self-management
1361509|NCT01327456|inhaler technique|inhaler technique
1361510|NCT01327443|NAFLD|nafld
1361511|NCT01327443|NASH|nash
1361512|NCT01327443|Weight loss|weight loss
1361513|NCT01327443|Exercise|exercise
1361514|NCT01327443|NAS scores|nas scores
1361515|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
1361516|NCT01327430|glycerophosphates|glycerophosphates
1361517|NCT01327430|sphingomyelins|sphingomyelins
1361518|NCT01327417|Depression|depression
1361519|NCT01327404|Depression|depression
1361520|NCT01327404|Diabetes Mellitus|diabetes mellitus
1361521|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
1361522|NCT01327391|tolerance|tolerance
1361523|NCT01327391|quality of life|quality of life
1361524|NCT01327391|cardiovascular risk|cardiovascular risk
1361525|NCT01327391|Hemodialysis patients|hemodialysis patients
1361526|NCT01327365|significant coronary artery disease|significant coronary artery disease
1361527|NCT01327365|PCI|pci
1361528|NCT01327365|radial approach|radial approach
1361529|NCT01327365|women|women
1361530|NCT01327365|bifurcation lesion|bifurcation lesion
1361531|NCT01327365|ostial lesion|ostial lesion
1361532|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
1361533|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
1361534|NCT01327352|lupus|lupus
1361535|NCT01327326|Pain modulation|pain modulation
1361536|NCT01327326|Experimental pain|experimental pain
1361537|NCT01327313|alpha v integrin|alpha v integrin
1361538|NCT01327313|antibody|antibody
1361539|NCT01327313|solid tumor|solid tumor
1361540|NCT01327313|Japanese|japanese
1361541|NCT01327313|EMD525797|emd525797
1361542|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
1361543|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
1361544|NCT01327300|Mesalamine|mesalamine
1361545|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
1361546|NCT01327300|5-ASA drugs|5-asa drugs
1361547|NCT01327300|Apriso ™|apriso ™
1361548|NCT01327287|thoracic epidural|thoracic epidural
1361549|NCT01327287|blunt|blunt
1361550|NCT01327287|blunt thoracic injury|blunt thoracic injury
1361551|NCT01327274|Pectus excavatum|pectus excavatum
1361552|NCT01327274|Chest wall deformity|chest wall deformity
1361553|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
1361554|NCT01327274|Pectus Severity Index|pectus severity index
1361555|NCT01327274|pediatric medical device|pediatric medical device
1361556|NCT01327274|magnetic alteration|magnetic alteration
1361557|NCT01327274|sunken chest|sunken chest
1361558|NCT01327261|levodopa|levodopa
1361559|NCT01327261|benserazide|benserazide
1361560|NCT01327261|bioequivalence|bioequivalence
1361561|NCT01327261|pharmacokinetics|pharmacokinetics
1361562|NCT01327261|A Single - Dose|a single - dose
1361563|NCT01327261|Randomized- Sequence|randomized- sequence
1361564|NCT01327261|Open -Label Crossover Study|open -label crossover study
1361565|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
1361566|NCT01327248|HRCT|hrct
1361567|NCT01327248|Sputum|sputum
1361568|NCT01327248|Blood|blood
1361569|NCT01327248|Inflammation|inflammation
1361570|NCT01327248|adaptive immune system|adaptive immune system
1361571|NCT01327248|innate immune system|innate immune system
1361572|NCT01327222|age-related macular degeneration|age-related macular degeneration
1361573|NCT01327222|bevacizumab|bevacizumab
1361574|NCT01327196|dementia|dementia
1361575|NCT01327196|cardiovascular risk|cardiovascular risk
1361576|NCT01327196|elderly|elderly
1361577|NCT01327196|aging|aging
1361578|NCT01327196|older 65-100 years|older 65-100 years
1361579|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
1361580|NCT01327157|Dental Occlusion.|dental occlusion.
1361581|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
1361582|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
1361583|NCT01327092|Injury|injury
1361584|NCT01327092|Injury Prevention|injury prevention
1361585|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
1361586|NCT01327092|Injury Hazards|injury hazards
1361587|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
1361588|NCT01327092|CHIP|chip
1361589|NCT01327092|Literacy Promotion|literacy promotion
1361590|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
1361591|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
1361592|NCT01327092|young children|young children
1361593|NCT01327079|NICU|nicu
1361594|NCT01327079|Methadone|methadone
1361595|NCT01327079|neonates|neonates
1361596|NCT01327066|QTc|qtc
1361597|NCT01327066|ECG Effects|ecg effects
1361598|NCT01327053|locally advanced basal cell carcinoma,|locally advanced basal cell carcinoma,
1361599|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
1361600|NCT01327040|light|light
1361601|NCT01327040|melatonin|melatonin
1361602|NCT01327040|circadian|circadian
1361603|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
1361604|NCT01327040|circadian light sensitivity|circadian light sensitivity
1361605|NCT01327040|circadian timing system|circadian timing system
1361606|NCT01327027|vasopressin|vasopressin
1361607|NCT01327027|antisocial|antisocial
1361608|NCT01327027|affiliation|affiliation
1361609|NCT01327014|Hyperlipidemia|hyperlipidemia
1361610|NCT01327014|Cholesterol|cholesterol
1361611|NCT01327014|Lipids|lipids
1361612|NCT01327014|Lipoproteins|lipoproteins
1361613|NCT01327014|XueZhiKang|xuezhikang
1361614|NCT01327014|Botanical|botanical
1361615|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
1361616|NCT01326988|Spinal anesthesia|spinal anesthesia
1361617|NCT01326988|ultrasound|ultrasound
1361618|NCT01326988|real-time|real-time
1361619|NCT01326975|infant, premature|infant, premature
1361620|NCT01326975|infant, very low birth weight|infant, very low birth weight
1361621|NCT01326975|diaphragm|diaphragm
1361622|NCT01326975|apnea|apnea
1361623|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
1361624|NCT01326936|Online education|online education
1361625|NCT01326936|Medical education|medical education
1361626|NCT01326936|Substance abuse training|substance abuse training
1361627|NCT01326936|Drug abuse training|drug abuse training
1361628|NCT01326923|Head|head
1361629|NCT01326923|Neck|neck
1361630|NCT01326923|Locally advanced|locally advanced
1361631|NCT01326923|Squamous Cell|squamous cell
1361632|NCT01326923|Hypopharynx|hypopharynx
1361633|NCT01326923|Larynx|larynx
1361634|NCT01326923|Oral Cavity|oral cavity
1361635|NCT01326923|Base of Tongue|base of tongue
1361636|NCT01326923|Tonsil|tonsil
1361637|NCT01326923|Neck lymph node|neck lymph node
1361638|NCT01326923|Resection|resection
1361639|NCT01326910|Eczema|eczema
1361640|NCT01326884|aortic aneurysm|aortic aneurysm
1361641|NCT01326884|iliac aneurysm|iliac aneurysm
1361642|NCT01326884|endovascular procedures|endovascular procedures
1361643|NCT01326871|cancer|cancer
1361644|NCT01326871|immunotherapy|immunotherapy
1361645|NCT01326871|immunochemotherapy|immunochemotherapy
1361646|NCT01326871|combinational therapy|combinational therapy
1361647|NCT01326871|targeted|targeted
1361648|NCT01326871|metastatic|metastatic
1361649|NCT01326871|muscle invasive|muscle invasive
1361650|NCT01326871|interleukin-2|interleukin-2
1361651|NCT01326871|cisplatin|cisplatin
1361652|NCT01326871|gemcitabine|gemcitabine
1361653|NCT01326871|antitumor|antitumor
1361655|NCT01326871|T-cell receptor|t-cell receptor
1361656|NCT01326871|p53|p53
1361657|NCT01326871|p53 gene|p53 gene
1361658|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
1361659|NCT01326871|urothelial cancer|urothelial cancer
1361660|NCT01326871|bladder cancer|bladder cancer
1361661|NCT01326871|renal pelvis cancer|renal pelvis cancer
1361662|NCT01326871|ureters cancer|ureters cancer
1361663|NCT01326871|urethra cancer|urethra cancer
1361664|NCT01326871|HLA-A2 positive|hla-a2 positive
1361665|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
1361666|NCT01326871|HLA complex|hla complex
1361667|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
1361668|NCT01326858|Ocular discomfort|ocular discomfort
1361669|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
1361670|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
1361671|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
1361672|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
1361673|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
1361674|NCT01326845|vomiting|vomiting
1361675|NCT01326832|THA|tha
1361676|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
1361677|NCT01326819|Skin pigmentation|skin pigmentation
1362373|NCT01323712|LV mass|lv mass
1361678|NCT01326819|Regional oxygen saturation|regional oxygen saturation
1361679|NCT01326806|Parent-based intervention|parent-based intervention
1361680|NCT01326806|Sexual risk behavior|sexual risk behavior
1361681|NCT01326806|Adolescents|adolescents
1361682|NCT01326793|telepsychiatry|telepsychiatry
1361683|NCT01326793|MDD|mdd
1361684|NCT01326793|Depression|depression
1361685|NCT01326793|Major Depressive Disorder|major depressive disorder
1361686|NCT01326793|Skype|skype
1361687|NCT01326793|college|college
1361688|NCT01326793|university|university
1361689|NCT01326780|Acne|acne
1361690|NCT01326780|Irritation|irritation
1361691|NCT01326780|Safety|safety
1361692|NCT01326780|Sebum|sebum
1361693|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
1361694|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
1361695|NCT01326741|hypotension|hypotension
1361696|NCT01326728|Relapse|relapse
1361697|NCT01326728|Hematologic Malignancy|hematologic malignancy
1361698|NCT01326728|Allogeneic|allogeneic
1361699|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1361700|NCT01326728|Leukemia|leukemia
1361701|NCT01326728|Lymphoma|lymphoma
1361702|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
1361703|NCT01326715|Multiple Sclerosis|multiple sclerosis
1361704|NCT01326715|MRI|mri
1361705|NCT01326715|Manganese Enhanced MRI|manganese enhanced mri
1361706|NCT01326715|Optic Neuritis|optic neuritis
1361707|NCT01326715|Healthy Volunteer|healthy volunteer
1361708|NCT01326676|Polypill|polypill
1361709|NCT01326676|Red Heart Pill|red heart pill
1361710|NCT01326676|Cardiovascular disease|cardiovascular disease
1361711|NCT01326676|Secondary prevention|secondary prevention
1361712|NCT01326676|carotid intima media thickness|carotid intima media thickness
1361713|NCT01326663|Veterans|veterans
1361714|NCT01326663|TBI|tbi
1361715|NCT01326663|Alcoholism|alcoholism
1361716|NCT01326663|Mood|mood
1361717|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
1361718|NCT01326637|primary health care|primary health care
1361719|NCT01326637|aged|aged
1361720|NCT01326624|heart failure|heart failure
1361721|NCT01326624|ventricular dysfunction|ventricular dysfunction
1361722|NCT01326624|sudden death|sudden death
1361723|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
1361724|NCT01326624|ventricular tachycardia|ventricular tachycardia
1361725|NCT01326624|ventricular fibrillation|ventricular fibrillation
1361726|NCT01326624|wearable defibrillator|wearable defibrillator
1361727|NCT01326611|Chronic lung disease|chronic lung disease
1361728|NCT01326611|Clarithromycin|clarithromycin
1361729|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
1361730|NCT01326598|V Go™|v go™
1361731|NCT01326598|Type 2 Diabetes|type 2 diabetes
1361732|NCT01326598|Insulin|insulin
1361733|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
1361734|NCT01326585|Scleral Buckling|scleral buckling
1361735|NCT01326585|Dexamethasone|dexamethasone
1361736|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
1361737|NCT01326572|HIV|hiv
1361738|NCT01326572|Pulmonary disease|pulmonary disease
1361739|NCT01326572|emphysema|emphysema
1361740|NCT01326572|COPD|copd
1361741|NCT01326559|induction chemotherapy|induction chemotherapy
1361742|NCT01326559|docetaxel|docetaxel
1361743|NCT01326559|cisplatin|cisplatin
1361744|NCT01326559|fluorouracil|fluorouracil
1361745|NCT01326559|cetuximab|cetuximab
1361746|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1361747|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
1361748|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
1361749|NCT01326546|HBeAg positive|hbeag positive
1361750|NCT01326533|pre-diabetes|pre-diabetes
1361751|NCT01326533|hydroxychloroquine|hydroxychloroquine
1361752|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
1361753|NCT01326533|insulin resistance|insulin resistance
1361754|NCT01326533|insulin secretion|insulin secretion
1361755|NCT01326533|glucose tolerance|glucose tolerance
1361756|NCT01326507|pulmonary embolism|pulmonary embolism
1361757|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
1361758|NCT01326507|cardiac biomarkers|cardiac biomarkers
1361759|NCT01326507|risk stratification|risk stratification
1361760|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
1361761|NCT01326494|Asthma|asthma
1361762|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
1361763|NCT01326481|TRC105|trc105
1361764|NCT01326481|Breast Cancer|breast cancer
1361765|NCT01326481|CD105|cd105
1361766|NCT01326481|Endoglin|endoglin
1361767|NCT01326481|TRACON Pharma|tracon pharma
1361768|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
1361769|NCT01326481|Department of Defense|department of defense
1361770|NCT01326468|head and neck cancer|head and neck cancer
1361771|NCT01326468|temsirolimus|temsirolimus
1361772|NCT01326468|cetuximab|cetuximab
1361773|NCT01326468|cisplatin|cisplatin
1361774|NCT01326468|radiation therapy|radiation therapy
1361775|NCT01326455|transradial|transradial
1361776|NCT01326455|angiogram|angiogram
1361777|NCT01326455|device|device
1361778|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
1361779|NCT01326442|weight loss|weight loss
1361780|NCT01326442|overweight|overweight
1361781|NCT01326442|body composition|body composition
1361782|NCT01326442|visceral obesity|visceral obesity
1361783|NCT01326442|insulin|insulin
1361784|NCT01326442|glucose tolerance|glucose tolerance
1361785|NCT01326442|cholesterol|cholesterol
1361786|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
1361787|NCT01326429|Sodium|sodium
1361788|NCT01326429|Hyponatremia|hyponatremia
1361789|NCT01326429|Hypernatremia|hypernatremia
1361790|NCT01326429|Emergency department|emergency department
1361791|NCT01326416|obesity|obesity
1361792|NCT01326416|metabolic syndrome|metabolic syndrome
1361793|NCT01326416|leucine|leucine
1361794|NCT01326416|arginine|arginine
1361795|NCT01326416|physical activity|physical activity
1361796|NCT01326403|proximal|proximal
1361797|NCT01326403|hip|hip
1361798|NCT01326403|fractures|fractures
1361799|NCT01326338|Diarrhea|diarrhea
1361800|NCT01326325|Cancer|cancer
1361801|NCT01326325|Refractory pain|refractory pain
1361802|NCT01326325|Uncontrolled pain|uncontrolled pain
1361803|NCT01326325|Ketamine|ketamine
1361804|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
1361805|NCT01326286|Prostatectomy|prostatectomy
1361806|NCT01326286|radiotherapy|radiotherapy
1361807|NCT01326286|quality of life|quality of life
1361808|NCT01326273|CMV|cmv
1361809|NCT01326273|cytomegalovirus|cytomegalovirus
1361810|NCT01326273|autologous|autologous
1361811|NCT01326273|leukemia|leukemia
1361812|NCT01326273|hematological malignancies|hematological malignancies
1361813|NCT01326273|stem cell transplantation|stem cell transplantation
1361814|NCT01326273|CMV reactivation|cmv reactivation
1361815|NCT01326273|adoptive therapy|adoptive therapy
1361816|NCT01326260|resuscitation|resuscitation
1361817|NCT01326260|trauma|trauma
1361818|NCT01326260|THAM|tham
1361819|NCT01326260|colloids|colloids
1361820|NCT01326260|crystalloids|crystalloids
1361821|NCT01326234|Smoking|smoking
1361822|NCT01326234|Motivation|motivation
1361823|NCT01326234|Cessation|cessation
1361824|NCT01326221|Truvada|truvada
1361825|NCT01326221|tenofovir|tenofovir
1361826|NCT01326221|emtricitabine|emtricitabine
1361827|NCT01326221|Pharmacokinetics|pharmacokinetics
1361828|NCT01326221|Healthy Volunteers|healthy volunteers
1361829|NCT01326208|electrical impedance tomography|electrical impedance tomography
1361830|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
1361831|NCT01326208|regional ventilation delay index|regional ventilation delay index
1361832|NCT01326195|HIV Prevention|hiv prevention
1361833|NCT01326195|Dating Violence|dating violence
1361834|NCT01326195|Females|females
1361835|NCT01326195|Romantic relationships|romantic relationships
1361836|NCT01326195|Adolescents|adolescents
1361837|NCT01326195|Sexuality|sexuality
1361838|NCT01326195|Underserved youth|underserved youth
1361839|NCT01326182|asthma|asthma
1361840|NCT01326182|depression|depression
1361841|NCT01326182|Latino|latino
1361842|NCT01326169|Alcohol|alcohol
1361843|NCT01326169|brief intervention|brief intervention
1361844|NCT01326169|injuries|injuries
1361845|NCT01326156|Osteoarthritis|osteoarthritis
1361846|NCT01326156|Knee|knee
1361847|NCT01326156|Knee cap|knee cap
1361848|NCT01326156|Patella|patella
1361849|NCT01326156|Patellofemoral|patellofemoral
1361850|NCT01326143|MRD|mrd
1361851|NCT01326143|Narval|narval
1361852|NCT01326143|Oral appliance|oral appliance
1361853|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
1361854|NCT01326143|OSAH|osah
1361855|NCT01326143|OSA treatment|osa treatment
1361856|NCT01326130|Integrated care network|integrated care network
1361857|NCT01326130|Chronic care model|chronic care model
1361858|NCT01326130|Health services research|health services research
1361859|NCT01326117|gastroparesis|gastroparesis
1361860|NCT01326117|gastric emptying|gastric emptying
1361861|NCT01326117|diabetes|diabetes
1361862|NCT01326117|Stomach Diseases|stomach diseases
1361863|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
1361864|NCT01326117|Digestive System Diseases|digestive system diseases
1361865|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1361866|NCT01326117|Neurologic Manifestations|neurologic manifestations
1361867|NCT01326117|Paralysis|paralysis
1361868|NCT01326117|Signs and Symptoms|signs and symptoms
1361869|NCT01326117|Pharmacologic Actions|pharmacologic actions
1361870|NCT01326104|Medulloblastoma|medulloblastoma
1361871|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
1361872|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
1478359|NCT00863811|IOP|iop
1361873|NCT01326078|sedation|sedation
1361874|NCT01326078|children|children
1361875|NCT01326078|leukemia|leukemia
1361876|NCT01326078|bone marrow biopsy|bone marrow biopsy
1361877|NCT01326013|Stool|stool
1361878|NCT01326013|Feces|feces
1361879|NCT01326013|Gastrointestinal|gastrointestinal
1361880|NCT01326013|Pathogen|pathogen
1361881|NCT01326013|Panel|panel
1361882|NCT01326013|xTAG GPP|xtag gpp
1361883|NCT01326013|Infectious colitis|infectious colitis
1361884|NCT01326013|Gastroenteritis|gastroenteritis
1361885|NCT01326013|Detection|detection
1361886|NCT01325987|Type 2 diabetes|type 2 diabetes
1361887|NCT01325987|Vitamin D deficiency|vitamin d deficiency
1361888|NCT01325987|Glycemic control|glycemic control
1361889|NCT01325974|Malaria|malaria
1361890|NCT01325974|Plasmodium falciparum|plasmodium falciparum
1361891|NCT01325974|Diagnosis|diagnosis
1361892|NCT01325974|Rapid diagnostic test|rapid diagnostic test
1361893|NCT01325974|malaria transmission|malaria transmission
1361894|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
1361895|NCT01325948|COPD|copd
1361896|NCT01325935|Coronary Artery Disease|coronary artery disease
1361897|NCT01325935|Coronary Disease|coronary disease
1361898|NCT01325935|Myocardial Ischemia|myocardial ischemia
1361899|NCT01325935|Heart Disease|heart disease
1361900|NCT01325935|Cardiovascular Disease|cardiovascular disease
1361901|NCT01325935|Arteriosclerosis|arteriosclerosis
1361902|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
1361903|NCT01325935|Vascular Disease|vascular disease
1361904|NCT01325935|Clopidogrel|clopidogrel
1361905|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1361906|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
1361907|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1361908|NCT01325818|Coronary Artery Disease|coronary artery disease
1361909|NCT01325818|Coronary Disease|coronary disease
1361910|NCT01325818|Dyslipidemia|dyslipidemia
1361911|NCT01325818|Stable Angina Pectoris|stable angina pectoris
1361912|NCT01325818|Heart Diseases|heart diseases
1361913|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
1361914|NCT01325818|Arteriosclerosis|arteriosclerosis
1361915|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
1361916|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
1361917|NCT01325818|Rosuvastatin|rosuvastatin
1361918|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
1361919|NCT01325818|Antilipemic Agents|antilipemic agents
1361920|NCT01325818|Antimetabolites|antimetabolites
1361921|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1361922|NCT01325818|Pharmacologic Actions|pharmacologic actions
1361923|NCT01325818|Therapeutic Uses|therapeutic uses
1361924|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1361925|NCT01325805|Miscarriage|miscarriage
1361926|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
1361928|NCT01325805|Overweight|overweight
1361929|NCT01325805|Diet|diet
1361930|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
1361931|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
1361932|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
1361933|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
1361934|NCT01325779|deep venous thrombosis|deep venous thrombosis
1361935|NCT01325779|DVT|dvt
1361936|NCT01325779|enoxaparin|enoxaparin
1361937|NCT01325779|heparin|heparin
1361938|NCT01325779|surgical intensive care|surgical intensive care
1361939|NCT01325766|Cystic Fibrosis|cystic fibrosis
1361940|NCT01325766|Yoga|yoga
1361941|NCT01325701|PCI-32765|pci-32765
1361942|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
1361943|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1361944|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1361945|NCT01325701|Germinal Center B-Cell|germinal center b-cell
1361946|NCT01325701|Activated B-Cell|activated b-cell
1361947|NCT01325688|PEP005|pep005
1361948|NCT01325688|Peplin|peplin
1361949|NCT01325688|sBCC|sbcc
1361950|NCT01325675|Atrial fibrillation|atrial fibrillation
1361951|NCT01325675|Motor activity|motor activity
1361952|NCT01325649|rectal cancer|rectal cancer
1361953|NCT01325649|MRI|mri
1361954|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
1361955|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
1361956|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
1361957|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
1361958|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
1361959|NCT01325636|Graft versus Host|graft versus host
1361960|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
1361961|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
1361962|NCT01325610|vitamin D|vitamin d
1361963|NCT01325610|kidney|kidney
1361964|NCT01325610|renal|renal
1361965|NCT01325597|Heart failure|heart failure
1361966|NCT01325597|Electric stimulation|electric stimulation
1361967|NCT01325597|Breathing exercises|breathing exercises
1361968|NCT01325571|prograf|prograf
1361969|NCT01325571|immunosuppressant|immunosuppressant
1361970|NCT01325558|cancer|cancer
1361971|NCT01325558|tissue factor|tissue factor
1361972|NCT01325558|solid tumor|solid tumor
1361973|NCT01325558|ovarian cancer|ovarian cancer
1361974|NCT01325558|breast cancer|breast cancer
1361975|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
1361976|NCT01325558|colon cancer|colon cancer
1361977|NCT01325558|pancreatic cancer|pancreatic cancer
1361978|NCT01325558|head and neck cancer|head and neck cancer
1361979|NCT01325558|prostate cancer|prostate cancer
1361980|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
1361981|NCT01325558|metastatic|metastatic
1361982|NCT01325558|gemcitabine|gemcitabine
1361983|NCT01325558|anti-tumor|anti-tumor
1361984|NCT01325558|venous thromboembolism|venous thromboembolism
1361985|NCT01325545|Stroke|stroke
1361986|NCT01325545|Atrial Fibrillation|atrial fibrillation
1361987|NCT01325532|depression|depression
1361988|NCT01325532|Major Depressive Disorder|major depressive disorder
1361989|NCT01325532|MDD|mdd
1361990|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
1361991|NCT01325532|CES|ces
1361992|NCT01325506|Prostatectomy|prostatectomy
1361993|NCT01325493|opioid tolerance|opioid tolerance
1361994|NCT01325493|hyperalgesia|hyperalgesia
1361995|NCT01325493|scoliosis|scoliosis
1361996|NCT01325493|pupillometry|pupillometry
1361997|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1361998|NCT01325480|Pacing|pacing
1361999|NCT01325480|His Bundle|his bundle
1362000|NCT01325467|coronary artery disease|coronary artery disease
1362001|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
1362002|NCT01325467|ischemia|ischemia
1362003|NCT01325467|exercise testing|exercise testing
1362004|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
1362005|NCT01325454|Pleural effusion|pleural effusion
1362006|NCT01325454|angiogenic cytokine|angiogenic cytokine
1362007|NCT01325454|fibrinolytic activity|fibrinolytic activity
1362008|NCT01325441|BBI608|bbi608
1362009|NCT01325415|Phase 1|phase 1
1362010|NCT01325415|healthy male volunteers|healthy male volunteers
1362011|NCT01325415|cross-over study|cross-over study
1362012|NCT01325415|NKTR-118|nktr-118
1362013|NCT01325402|Radioligand|radioligand
1362014|NCT01325402|Alzheimers disease|alzheimers disease
1362015|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
1362016|NCT01325402|Beta amyloid|beta amyloid
1362017|NCT01325376|overweight|overweight
1362018|NCT01325376|obesity|obesity
1362019|NCT01325363|Schizophrenia|schizophrenia
1362020|NCT01325363|Novel metaphor|novel metaphor
1362021|NCT01325298|Keratoconus|keratoconus
1362022|NCT01325298|Ectasia|ectasia
1362023|NCT01325298|cross linking|cross linking
1362024|NCT01325298|collagen cross linking|collagen cross linking
1362025|NCT01325298|corneal crosslinking|corneal crosslinking
1362026|NCT01325298|corneal diseases|corneal diseases
1362027|NCT01325298|eye diseases|eye diseases
1362028|NCT01325285|Intraocular pressure|intraocular pressure
1362029|NCT01325285|Hypercapnia|hypercapnia
1362030|NCT01325285|Hyperoxia|hyperoxia
1362031|NCT01325285|Rebreathing circuit|rebreathing circuit
1362032|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
1362033|NCT01325246|ventral hernia|ventral hernia
1362034|NCT01325246|repair|repair
1362035|NCT01325246|clinical|clinical
1362036|NCT01325246|reoperation|reoperation
1362037|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
1362038|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
1362039|NCT01325207|Breast Cancer|breast cancer
1362040|NCT01325194|DLBCL|dlbcl
1362041|NCT01325194|FL grade 3B|fl grade 3b
1362042|NCT01325194|high risk|high risk
1362043|NCT01325194|CNS prophylaxis|cns prophylaxis
1362044|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
1362045|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
1362046|NCT01325181|Ranibizumab|ranibizumab
1362047|NCT01325181|Photodynamic therapy|photodynamic therapy
1362048|NCT01325168|PTSD|ptsd
1362049|NCT01325168|empathy|empathy
1362050|NCT01325168|oxytocin|oxytocin
1362051|NCT01325155|Air Pollution|air pollution
1362052|NCT01325155|particulate matter|particulate matter
1362053|NCT01325155|cardiovascular Disease|cardiovascular disease
1362054|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
1362055|NCT01325129|ESIN|esin
1362056|NCT01325129|Clavicular Fracture|clavicular fracture
1362057|NCT01325129|Dislocation|dislocation
1362058|NCT01325129|Children|children
1362059|NCT01325129|Adolescents|adolescents
1362060|NCT01325116|STEMI|stemi
1362061|NCT01325116|Medication Adherence|medication adherence
1362062|NCT01325116|Quality Improvement|quality improvement
1362063|NCT01325103|Spinal cord injury|spinal cord injury
1362064|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
1362065|NCT01325103|Bone marrow|bone marrow
1362066|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
1362067|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
1362068|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
1362069|NCT01325077|pain|pain
1362070|NCT01325064|Carotid Artery Diseases|carotid artery diseases
1362071|NCT01325064|Blood Pressure|blood pressure
1362072|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1362073|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
1362074|NCT01325064|Retinal Vessels|retinal vessels
1362075|NCT01325051|raltegravir|raltegravir
1362374|NCT01323712|Vitamin D|vitamin d
1362076|NCT01325051|pharmacokinetics|pharmacokinetics
1362077|NCT01325051|healthy|healthy
1362078|NCT01325051|male|male
1362079|NCT01325051|volunteers|volunteers
1362080|NCT01325051|gastrointestinal|gastrointestinal
1362081|NCT01325051|tract|tract
1362082|NCT01325038|resting metabolic rate|resting metabolic rate
1362083|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1362084|NCT01325025|Demyelinating Diseases|demyelinating diseases
1362085|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
1362086|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
1362087|NCT01325025|Relaxometry|relaxometry
1362088|NCT01325025|Spectroscopy|spectroscopy
1362089|NCT01325025|Longitudinal Studies|longitudinal studies
1362091|NCT01325012|Surgery|surgery
1362092|NCT01325012|Catheter|catheter
1362093|NCT01325012|Nerve Block|nerve block
1362094|NCT01325012|Popliteal|popliteal
1362095|NCT01325012|Subgluteal|subgluteal
1362096|NCT01325012|Sciatic|sciatic
1362097|NCT01325012|UCSD|ucsd
1362098|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
1362099|NCT01325012|Perineural Catheter|perineural catheter
1362100|NCT01325012|Orthopedic Surgery|orthopedic surgery
1362101|NCT01325012|foot surgery surgery|foot surgery surgery
1362102|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
1362103|NCT01325012|age =>18|age =>18
1362104|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
1362105|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
1362106|NCT01324973|Medical Informatics|medical informatics
1362107|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
1362108|NCT01324973|Health Education|health education
1362109|NCT01324973|Diet|diet
1362110|NCT01324973|Exercise|exercise
1362111|NCT01324960|IPSS|ipss
1362112|NCT01324960|High risk|high risk
1362113|NCT01324960|Azacitidine|azacitidine
1362114|NCT01324960|Ceplene|ceplene
1362115|NCT01324947|Myeloma|myeloma
1362116|NCT01324947|Multiple Myeloma|multiple myeloma
1362117|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
1362118|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1362119|NCT01324947|Refractory Myeloma|refractory myeloma
1362120|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
1362121|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
1362122|NCT01324947|Pomalidomide|pomalidomide
1362123|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
1362124|NCT01324947|Bortezomib-resistant|bortezomib-resistant
1362125|NCT01324947|Companion|companion
1362126|NCT01324934|acute rejection|acute rejection
1362127|NCT01324934|chronic rejection|chronic rejection
1362128|NCT01324934|subclinical rejection|subclinical rejection
1362129|NCT01324934|renal transplantation|renal transplantation
1362130|NCT01324934|steroid-free|steroid-free
1362131|NCT01324934|kidney transplantation|kidney transplantation
1362132|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
1362133|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
1362134|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
1362135|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
1362136|NCT01324895|Antibiotics|antibiotics
1362137|NCT01324895|Prokinteics|prokinteics
1362138|NCT01324895|Prokinetic Agents|prokinetic agents
1362139|NCT01324882|colonoscopy|colonoscopy
1362140|NCT01324869|KH902|kh902
1362141|NCT01324869|Diabetic macular Edema|diabetic macular edema
1362142|NCT01324869|Intravitreal injection|intravitreal injection
1362143|NCT01324869|Multiple injections|multiple injections
1362144|NCT01324869|20 patients|20 patients
1362145|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
1362146|NCT01324856|pancreatic cancer|pancreatic cancer
1362147|NCT01324856|periampulary cancer|periampulary cancer
1362148|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
1362149|NCT01324843|Safety and Tolerability|safety and tolerability
1362150|NCT01324843|Intradermal Electroporation|intradermal electroporation
1362151|NCT01324817|Non-Contact|non-contact
1362152|NCT01324817|Radar|radar
1362153|NCT01324817|Doppler|doppler
1362154|NCT01324817|Respiratory|respiratory
1362155|NCT01324817|Respiration|respiration
1362156|NCT01324817|Breathing|breathing
1362157|NCT01324817|Rate|rate
1362158|NCT01324817|Frequency|frequency
1362159|NCT01324817|Respiratory Mechanics|respiratory mechanics
1362160|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
1362161|NCT01324817|Apnea|apnea
1362162|NCT01324817|Sleep Apnea|sleep apnea
1362163|NCT01324804|postoperative wound healing|postoperative wound healing
1362164|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
1362165|NCT01324765|Women|women
1362166|NCT01324765|PTSD|ptsd
1362167|NCT01324765|Group Therapy|group therapy
1362168|NCT01324765|Incarceration|incarceration
1362169|NCT01324752|Drug-drug interaction|drug-drug interaction
1362170|NCT01324752|Pharmacokinetics|pharmacokinetics
1362171|NCT01324752|PA21|pa21
1362172|NCT01324726|Bacterial colonization|bacterial colonization
1362375|NCT01323712|LV function|lv function
1362475|NCT01323400|GIST|gist
1362173|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
1362174|NCT01324687|Telemedicine|telemedicine
1362175|NCT01324687|Geriatrics|geriatrics
1362176|NCT01324674|Common Mental Disorder|common mental disorder
1362177|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
1362178|NCT01324674|Spiritual well-being|spiritual well-being
1362179|NCT01324648|Guided self-help|guided self-help
1362180|NCT01324648|Telephone delivery|telephone delivery
1362181|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
1362182|NCT01324648|Bibliotherapy|bibliotherapy
1362183|NCT01324635|glioma|glioma
1362184|NCT01324635|meningioma|meningioma
1362185|NCT01324635|brain metastasis|brain metastasis
1362186|NCT01324635|stereotactic|stereotactic
1362187|NCT01324635|radiotherapy|radiotherapy
1362188|NCT01324635|radiosurgery|radiosurgery
1362189|NCT01324622|Spinal Cord Diseases|spinal cord diseases
1362190|NCT01324622|Myelopathy|myelopathy
1362191|NCT01324622|Myeloradiculopathy|myeloradiculopathy
1362192|NCT01324622|Laminectomy|laminectomy
1362193|NCT01324622|Laminoplasty|laminoplasty
1362194|NCT01324609|choroidal nevus|choroidal nevus
1362195|NCT01324609|vitrectomy|vitrectomy
1362196|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1362197|NCT01324596|Bortezomib|bortezomib
1362198|NCT01324596|R-CHOP|r-chop
1362199|NCT01324596|Molecular profiling|molecular profiling
1362200|NCT01324596|Chemotherapy|chemotherapy
1362201|NCT01324570|Pain|pain
1362202|NCT01324570|Opioid|opioid
1362203|NCT01324570|Analgesia|analgesia
1362204|NCT01324570|Moderate to severe pain|moderate to severe pain
1362205|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
1362206|NCT01324557|CAPD patients|capd patients
1362207|NCT01324557|Insulin pump|insulin pump
1362208|NCT01324544|Acute Pain|acute pain
1362209|NCT01324544|Opioid|opioid
1362210|NCT01324544|Analgesia|analgesia
1362211|NCT01324531|Bankart repair|bankart repair
1362212|NCT01324531|remplissage|remplissage
1362213|NCT01324531|Hill-Sachs defect|hill-sachs defect
1362214|NCT01324531|shoulder instability|shoulder instability
1362215|NCT01324531|anterior shoulder instability|anterior shoulder instability
1362216|NCT01324492|phase Ib,|phase ib,
1362217|NCT01324492|RAD001,|rad001,
1362218|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
1362219|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
1362220|NCT01324479|hepatocellular,|hepatocellular,
1362221|NCT01324479|gastric,|gastric,
1362222|NCT01324479|renal cell,|renal cell,
1362223|NCT01324479|c-MET,|c-met,
1362224|NCT01324479|refractory,|refractory,
1362225|NCT01324479|glioblastoma,|glioblastoma,
1362226|NCT01324479|breast,|breast,
1362227|NCT01324479|nasopharyngeal,|nasopharyngeal,
1362228|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
1362229|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
1362230|NCT01324453|STEMI|stemi
1362231|NCT01324453|Post Conditioning|post conditioning
1362232|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
1362233|NCT01324440|Bacterial Vaccines|bacterial vaccines
1362234|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
1362235|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
1362236|NCT01324427|Telemedicine|telemedicine
1362237|NCT01324427|Virtual Medical Visit|virtual medical visit
1362238|NCT01324427|Quality of Life|quality of life
1362239|NCT01324427|11-022|11-022
1362240|NCT01324401|Peanut Allergy|peanut allergy
1362241|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
1362242|NCT01324362|FP|fp
1362243|NCT01324362|Asthma|asthma
1362244|NCT01324362|Sont|sont
1362245|NCT01324362|FSC|fsc
1362246|NCT01324362|BHR|bhr
1362247|NCT01324349|Hepatic|hepatic
1362248|NCT01324349|Topical Hemostat|topical hemostat
1362249|NCT01324336|ALL|all
1362250|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1362251|NCT01324336|6-Mercaptopurine|6-mercaptopurine
1362252|NCT01324336|Pediatric|pediatric
1362253|NCT01324323|ROMI-001|romi-001
1362254|NCT01324323|romi|romi
1362255|NCT01324323|Romidepsin|romidepsin
1362256|NCT01324323|Istodax|istodax
1362257|NCT01324323|advanced malignancy|advanced malignancy
1362258|NCT01324323|PK|pk
1362259|NCT01324323|pharmacokinetics|pharmacokinetics
1362260|NCT01324310|ROMI-001|romi-001
1362261|NCT01324310|romi|romi
1362262|NCT01324310|Romidepsin|romidepsin
1362263|NCT01324310|Istodax|istodax
1362264|NCT01324310|advanced malignancy|advanced malignancy
1362265|NCT01324310|PK|pk
1362266|NCT01324310|pharmacokinetics|pharmacokinetics
1362267|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1362268|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
1362269|NCT01324297|Skin Tests|skin tests
1362270|NCT01324297|Biological Markers|biological markers
1362271|NCT01324284|Lubiprostone|lubiprostone
1362272|NCT01324284|Bowel preparation regime|bowel preparation regime
1362273|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
1362274|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
1362275|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
1362276|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
1362277|NCT01324258|MEK inhibitor|mek inhibitor
1362278|NCT01324258|GSK1120212|gsk1120212
1362279|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
1362280|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
1362281|NCT01324245|Salt|salt
1362282|NCT01324245|Balance|balance
1362283|NCT01324245|Renin Angiotensin System|renin angiotensin system
1362284|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
1362285|NCT01324245|Sodium|sodium
1362286|NCT01324219|nursing staff|nursing staff
1362287|NCT01324219|residents|residents
1362288|NCT01324206|Whole-Body|whole-body
1362289|NCT01324206|Development|development
1362290|NCT01324206|Exposure|exposure
1362291|NCT01324206|Magnetic|magnetic
1362292|NCT01324206|Resonance|resonance
1362293|NCT01324180|ALL|all
1362294|NCT01324180|Relapsed|relapsed
1362295|NCT01324180|Refractory|refractory
1362296|NCT01324167|schizophrenia|schizophrenia
1362297|NCT01324167|schizoaffective disorder|schizoaffective disorder
1362298|NCT01324141|Anal Cancer|anal cancer
1362299|NCT01324141|Radioprotector|radioprotector
1362300|NCT01324141|Topical|topical
1362301|NCT01324141|Radiation|radiation
1362302|NCT01324141|Dermatitis|dermatitis
1362303|NCT01324128|PA21|pa21
1362304|NCT01324128|Phosphate Binder|phosphate binder
1362305|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1362306|NCT01324102|Neoplasms|neoplasms
1362307|NCT01324089|Resveratrol|resveratrol
1362308|NCT01324089|Piperine|piperine
1362309|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1362310|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1362311|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
1362312|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1362313|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
1362314|NCT01324037|diagnostic algorithm|diagnostic algorithm
1362315|NCT01324024|Menopause|menopause
1362316|NCT01324024|Aging|aging
1362317|NCT01324024|Memory|memory
1362318|NCT01324024|Women|women
1362319|NCT01323998|enlarged prostate|enlarged prostate
1362320|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
1362321|NCT01323998|alpha-blocker|alpha-blocker
1362322|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
1362323|NCT01323972|Malaria|malaria
1362324|NCT01323972|Plasmodium falciparum|plasmodium falciparum
1362325|NCT01323959|BoostrixTM Polio|boostrixtm polio
1362326|NCT01323959|dTpa-IPV|dtpa-ipv
1362327|NCT01323959|booster|booster
1362328|NCT01323946|H5N1|h5n1
1362329|NCT01323946|influenza infection|influenza infection
1362330|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
1362331|NCT01323933|Solid tumors|solid tumors
1362332|NCT01323933|Oncology|oncology
1362333|NCT01323933|Cancer|cancer
1362334|NCT01323920|Stem Cell Transplant|stem cell transplant
1362335|NCT01323920|Allogeneic Transplant|allogeneic transplant
1362336|NCT01323920|Donors|donors
1362337|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
1362338|NCT01323907|Omegaven|omegaven
1362339|NCT01323907|liver disease|liver disease
1362340|NCT01323907|Cholestasis|cholestasis
1362341|NCT01323907|Fat emulsions|fat emulsions
1362342|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
1362343|NCT01323842|renal colic|renal colic
1362344|NCT01323842|hydronephrosis|hydronephrosis
1362345|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
1362346|NCT01323842|ultrasound|ultrasound
1362347|NCT01323842|emergency medicine|emergency medicine
1362348|NCT01323842|urolithiasis|urolithiasis
1362349|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
1362350|NCT01323829|Botulinum toxin type A|botulinum toxin type a
1362351|NCT01323829|EMG|emg
1362352|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
1362353|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
1362354|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
1362355|NCT01323777|Cataracts|cataracts
1362356|NCT01323777|Intraocular lens|intraocular lens
1362357|NCT01323777|Multifocal|multifocal
1362359|NCT01323777|Astigmatism|astigmatism
1362360|NCT01323777|Presbyopia|presbyopia
1362361|NCT01323764|Hydrocephalus|hydrocephalus
1362362|NCT01323764|CSF shunts|csf shunts
1362363|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1362364|NCT01323764|NPH|nph
1362365|NCT01323764|ShuntCheck|shuntcheck
1362366|NCT01323764|Shunt Malfunction|shunt malfunction
1362367|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
1362368|NCT01323738|Psychoeducation|psychoeducation
1362369|NCT01323738|Group Control|group control
1362370|NCT01323725|Team-based financial incentives|team-based financial incentives
1362371|NCT01323725|Smoking cessation|smoking cessation
1362372|NCT01323712|CKD|ckd
1362376|NCT01323699|Parkinson Disease|parkinson disease
1362378|NCT01323699|Depression|depression
1362379|NCT01323647|IPV|ipv
1362380|NCT01323647|PoliorixTM|poliorixtm
1362381|NCT01323647|China|china
1362382|NCT01323608|Thalassemia|thalassemia
1362383|NCT01323608|hypercalciuria|hypercalciuria
1362384|NCT01323608|vitamin D|vitamin d
1362385|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
1362386|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
1362387|NCT01323595|Pain control|pain control
1362388|NCT01323595|testicular sperm extraction|testicular sperm extraction
1362389|NCT01323595|sperm|sperm
1362390|NCT01323582|Gastroparesis|gastroparesis
1362391|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
1362392|NCT01323582|Gastric Emptying|gastric emptying
1362393|NCT01323582|Prokinetic Agents|prokinetic agents
1362394|NCT01323582|Macrolides|macrolides
1362395|NCT01323582|Erythromycin|erythromycin
1362396|NCT01323582|Azithromycin|azithromycin
1362397|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
1362398|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
1362399|NCT01323582|AZI|azi
1362400|NCT01323569|Sativex|sativex
1362401|NCT01323569|Cannabinoids|cannabinoids
1362402|NCT01323569|Abuse potential|abuse potential
1362403|NCT01323569|Addiction|addiction
1362404|NCT01323556|Panic disorder|panic disorder
1362405|NCT01323556|agoraphobia|agoraphobia
1362406|NCT01323556|panic attacks|panic attacks
1362407|NCT01323556|exposure based learning|exposure based learning
1362408|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
1362409|NCT01323556|fear augmentation|fear augmentation
1362410|NCT01323556|in vivo exposure|in vivo exposure
1362411|NCT01323543|Back Pain,|back pain,
1362412|NCT01323543|Back Pains, Low|back pains, low
1362413|NCT01323543|Low Back Pains|low back pains
1362414|NCT01323543|Pain, Low Back|pain, low back
1362415|NCT01323543|Pains, Low Back|pains, low back
1362416|NCT01323543|Lumbago|lumbago
1362417|NCT01323543|Lower Back Pain|lower back pain
1362418|NCT01323543|Back Pain, Lower|back pain, lower
1362419|NCT01323543|Back Pains, Lower|back pains, lower
1362420|NCT01323543|Lower Back Pains|lower back pains
1362421|NCT01323543|Pain, Lower Back|pain, lower back
1362422|NCT01323543|Pains, Lower Back|pains, lower back
1362423|NCT01323543|Low Back Ache|low back ache
1362424|NCT01323543|Ache, Low Back|ache, low back
1362425|NCT01323543|Aches, Low Back|aches, low back
1362426|NCT01323543|Back Ache, Low|back ache, low
1362427|NCT01323543|Back Aches, Low|back aches, low
1362428|NCT01323543|Low Back Aches|low back aches
1362429|NCT01323543|Low Backache|low backache
1362430|NCT01323543|Backache, Low|backache, low
1362431|NCT01323543|Backaches, Low|backaches, low
1362432|NCT01323543|Low Backaches|low backaches
1362433|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
1362434|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
1362435|NCT01323543|Low Back Pain, Postural|low back pain, postural
1362436|NCT01323543|Postural Low Back Pain|postural low back pain
1362437|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
1362438|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
1362439|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
1362440|NCT01323530|metastatic breast cancer|metastatic breast cancer
1362441|NCT01323517|skin|skin
1362442|NCT01323517|DACTINOMYCIN|dactinomycin
1362443|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
1362444|NCT01323517|MELPHALAN|melphalan
1362445|NCT01323517|Isolated Limb Infusion|isolated limb infusion
1362446|NCT01323517|10-101|10-101
1362447|NCT01323504|Stage 5 arteritis|stage 5 arteritis
1362448|NCT01323504|Stage 6 arteritis|stage 6 arteritis
1362449|NCT01323504|rutherford classification|rutherford classification
1362450|NCT01323491|smoking cessation|smoking cessation
1362451|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
1362452|NCT01323491|routine smokers|routine smokers
1362453|NCT01323478|Depressive Disorder|depressive disorder
1362454|NCT01323478|Depression|depression
1362455|NCT01323478|Depressive Disorder, Major|depressive disorder, major
1362456|NCT01323478|Mood Disorders|mood disorders
1362457|NCT01323478|Mental Disorders|mental disorders
1362458|NCT01323478|Behavioural Symptoms|behavioural symptoms
1362459|NCT01323465|Sativex|sativex
1362460|NCT01323465|Cytochrome P450|cytochrome p450
1362461|NCT01323465|Pharmacokinetics|pharmacokinetics
1362462|NCT01323465|Cannabinoids|cannabinoids
1362463|NCT01323465|ketoconazole|ketoconazole
1362464|NCT01323465|omeprazole|omeprazole
1362465|NCT01323465|rifampicin|rifampicin
1362466|NCT01323452|entecavir|entecavir
1362467|NCT01323452|hepatitis B|hepatitis b
1362468|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
1362469|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
1362470|NCT01323426|autologous|autologous
1362471|NCT01323413|stroke|stroke
1362472|NCT01323413|penumbra|penumbra
1362473|NCT01323413|determinants|determinants
1362474|NCT01323413|CT perfusion|ct perfusion
1362476|NCT01323400|Resistant|resistant
1362477|NCT01323400|Pazopanib|pazopanib
1362478|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1362479|NCT01323400|Best supportive care|best supportive care
1362480|NCT01323400|Progression-free survival|progression-free survival
1362481|NCT01323400|Overall survival|overall survival
1362482|NCT01323400|Objective response rate|objective response rate
1362483|NCT01323400|Best response|best response
1362484|NCT01323400|Tolerance profile|tolerance profile
1362485|NCT01323374|Fibromyalgia|fibromyalgia
1362486|NCT01323374|FMS|fms
1362487|NCT01323374|droxidopa|droxidopa
1362488|NCT01323374|pain|pain
1362489|NCT01323361|inflammation|inflammation
1362490|NCT01323361|laparoscopy|laparoscopy
1362491|NCT01323361|hernia|hernia
1362492|NCT01323361|incisional|incisional
1362493|NCT01323361|trauma|trauma
1362494|NCT01323348|Diabetes|diabetes
1362495|NCT01323348|Diabetes Education|diabetes education
1362496|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
1362497|NCT01323348|HbA1c|hba1c
1362498|NCT01323335|Uric Acid|uric acid
1362499|NCT01323335|Rasburicase|rasburicase
1362500|NCT01323335|Inflammatory Markers|inflammatory markers
1362501|NCT01323322|Health Disparities|health disparities
1362502|NCT01323322|Diversity|diversity
1362503|NCT01323322|Socioeconomic Status|socioeconomic status
1362504|NCT01323322|Epidemiology|epidemiology
1362505|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
1362506|NCT01323309|Therapy|therapy
1362507|NCT01323309|11-021|11-021
1362508|NCT01323296|Myocardial infarction|myocardial infarction
1362509|NCT01323296|Magnetic resonance|magnetic resonance
1362510|NCT01323296|Nanoparticle|nanoparticle
1362511|NCT01323296|Iron|iron
1362512|NCT01323296|Inflammation|inflammation
1362513|NCT01323283|Omega-3|omega-3
1362514|NCT01323283|physical activity|physical activity
1362515|NCT01323283|children|children
1362516|NCT01323283|obesity|obesity
1362517|NCT01323283|sedentary|sedentary
1362518|NCT01323283|accelerometry|accelerometry
1362519|NCT01323283|BMI|bmi
1362520|NCT01323283|fatty acids|fatty acids
1362521|NCT01323283|inflammatory markers|inflammatory markers
1362522|NCT01323283|intervention|intervention
1362523|NCT01323283|randomized|randomized
1362524|NCT01323283|double blind|double blind
1362525|NCT01323270|Healthy adolescents|healthy adolescents
1362526|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
1362527|NCT01323257|TMC435-C115|tmc435-c115
1362528|NCT01323257|TMC435|tmc435
1362529|NCT01323257|HCV|hcv
1362530|NCT01323257|Hepatitis C|hepatitis c
1362531|NCT01323257|Hep C|hep c
1362532|NCT01323257|healthy volunteers|healthy volunteers
1362533|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
1362534|NCT01323244|TMC435-C213|tmc435-c213
1362535|NCT01323244|TMC435|tmc435
1362536|NCT01323244|HCV|hcv
1362537|NCT01323244|Hepatitis C|hepatitis c
1362538|NCT01323231|XY-Zone|xy-zone
1362539|NCT01323231|school drop-out risk|school drop-out risk
1362540|NCT01323231|protective factors|protective factors
1362541|NCT01323231|truancy|truancy
1362542|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
1362543|NCT01323218|OSAHS|osahs
1362544|NCT01323218|Vitamin D|vitamin d
1362545|NCT01323205|JNJ-40411813|jnj-40411813
1362546|NCT01323192|Concerta|concerta
1362547|NCT01323192|Adults|adults
1362548|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1362549|NCT01323192|ADHD|adhd
1362550|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
1362551|NCT01323179|Postoperative pain|postoperative pain
1362552|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
1362553|NCT01323166|rectal cancer|rectal cancer
1362554|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
1362555|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
1362556|NCT01323114|non-morbidly obese|non-morbidly obese
1362557|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
1362558|NCT01323088|Childhood obesity|childhood obesity
1362559|NCT01323088|Visceral fat|visceral fat
1362560|NCT01323088|Insulin resistance|insulin resistance
1362561|NCT01323088|Liver fat|liver fat
1362562|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
1362563|NCT01323088|Regular exercise|regular exercise
1362564|NCT01323062|chemotherapy naive|chemotherapy naive
1362565|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
1362566|NCT01323062|Phase 1b|phase 1b
1362567|NCT01323062|Bavituximab|bavituximab
1362568|NCT01323062|Chimeric 3G4|chimeric 3g4
1362569|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
1362570|NCT01323049|extubation strategy|extubation strategy
1362571|NCT01323010|asthma|asthma
1362572|NCT01323010|albuterol|albuterol
1362573|NCT01323010|metered dose inhalers|metered dose inhalers
1362574|NCT01322984|ASD|asd
1362575|NCT01322984|Startle|startle
1362576|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
1362577|NCT01322971|Infertility|infertility
1362578|NCT01322971|Miscarriage|miscarriage
1362579|NCT01322971|Metronidazole|metronidazole
1362580|NCT01322958|bedside ultrasound|bedside ultrasound
1362581|NCT01322932|Medication Adherence|medication adherence
1362582|NCT01322932|HIV Infection|hiv infection
1362583|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
1362584|NCT01322932|efavirenz|efavirenz
1362585|NCT01322932|emtricitabine|emtricitabine
1362586|NCT01322932|Patient Satisfaction|patient satisfaction
1362587|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1362588|NCT01322919|PresbyLASIK|presbylasik
1362589|NCT01322919|Presbyopia|presbyopia
1362590|NCT01322919|LASIK|lasik
1362591|NCT01322919|Supracor|supracor
1362592|NCT01322919|refractive|refractive
1362593|NCT01322919|Myopia|myopia
1362594|NCT01322919|Hyperopia|hyperopia
1362595|NCT01322906|ABMLF|abmlf
1362596|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
1362597|NCT01322906|Liver Failure|liver failure
1362598|NCT01322906|Transplantation|transplantation
1362599|NCT01322893|Metastatic breast cancer|metastatic breast cancer
1362600|NCT01322893|Circulating tumour cells|circulating tumour cells
1362601|NCT01322893|CTC|ctc
1362602|NCT01322893|Prognostic factors|prognostic factors
1362603|NCT01322893|Treatment response|treatment response
1362604|NCT01322880|domestic violence|domestic violence
1362605|NCT01322867|bioequivalence study|bioequivalence study
1362606|NCT01322867|alprazolam|alprazolam
1362607|NCT01322867|frontal|frontal
1362608|NCT01322854|IMRT|imrt
1362609|NCT01322854|Integrated boost|integrated boost
1362610|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
1362611|NCT01322854|breast cancer|breast cancer
1362612|NCT01322854|breast conserving surgery|breast conserving surgery
1362613|NCT01322841|CHICA|chica
1362614|NCT01322841|clinical decision support|clinical decision support
1362615|NCT01322828|Bicep|bicep
1362616|NCT01322828|Tendon|tendon
1362617|NCT01322828|Distal|distal
1362618|NCT01322828|Ruptures|ruptures
1362619|NCT01322828|Randomized|randomized
1362620|NCT01322828|Surgery|surgery
1362621|NCT01322815|colon cancer|colon cancer
1362622|NCT01322815|metastatic|metastatic
1362623|NCT01322815|vaccine|vaccine
1362624|NCT01322802|Ovarian Cancer|ovarian cancer
1362625|NCT01322802|Vaccine|vaccine
1362626|NCT01322802|Stage III|stage iii
1362627|NCT01322802|Stage IV|stage iv
1362628|NCT01322802|Remission|remission
1362629|NCT01322789|Diabetes mellitus|diabetes mellitus
1362630|NCT01322789|Stem cells|stem cells
1362631|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
1362632|NCT01322789|Autoimmune diseases|autoimmune diseases
1362633|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
1362634|NCT01322776|Recurrent|recurrent
1362635|NCT01322776|Bortezomib|bortezomib
1362636|NCT01322776|Combination Treatment|combination treatment
1362637|NCT01322737|resection|resection
1362638|NCT01322737|open|open
1362639|NCT01322737|laparoscopic|laparoscopic
1362640|NCT01322737|benign|benign
1362641|NCT01322737|malignant|malignant
1362642|NCT01322737|disease|disease
1362643|NCT01322737|colon|colon
1362644|NCT01322737|gastric|gastric
1362645|NCT01322724|colonoscopy|colonoscopy
1362646|NCT01322724|colon cancer screening|colon cancer screening
1362647|NCT01322724|patient discomfort scores|patient discomfort scores
1362648|NCT01322724|sedation medication requirements|sedation medication requirements
1362649|NCT01322724|water insertion method|water insertion method
1362650|NCT01322711|Thromboxane|thromboxane
1362651|NCT01322711|Aspirin|aspirin
1362652|NCT01322711|Atorvastatin|atorvastatin
1362653|NCT01322711|Platelet activation|platelet activation
1362654|NCT01322711|Thrombin Activation|thrombin activation
1362655|NCT01322711|Oxidative stress|oxidative stress
1362656|NCT01322698|ICU|icu
1362657|NCT01322685|Tuberculosis|tuberculosis
1362658|NCT01322685|Lung cancer|lung cancer
1362659|NCT01322672|Anesthetic Agents|anesthetic agents
1362660|NCT01322672|POCD|pocd
1362661|NCT01322672|Delirium|delirium
1362662|NCT01322672|Cognitive Testing|cognitive testing
1362663|NCT01322672|Aging|aging
1362664|NCT01322672|Surgery|surgery
1362665|NCT01322672|fMRI|fmri
1362666|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
1362667|NCT01322672|White Matter|white matter
1362668|NCT01322659|Mechanical ventilation|mechanical ventilation
1362669|NCT01322659|Weaning|weaning
1362670|NCT01322659|Noninvasive ventilation|noninvasive ventilation
1362671|NCT01322659|Acute respiratory failure|acute respiratory failure
1362672|NCT01322659|Helmet|helmet
1362673|NCT01322646|ADHD|adhd
1362674|NCT01322646|Driving|driving
1362675|NCT01322646|Behavior modification|behavior modification
1362676|NCT01322633|Pantoprazole|pantoprazole
1362677|NCT01322633|proton pump inhibitor|proton pump inhibitor
1362678|NCT01322633|gastric cancer|gastric cancer
1362679|NCT01322633|digestive system cancer|digestive system cancer
1362680|NCT01322633|cancer|cancer
1362681|NCT01322607|Exercise|exercise
1362682|NCT01322607|Rehabilitation|rehabilitation
1362683|NCT01322607|Stroke|stroke
1362684|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1362685|NCT01322594|COPD|copd
1362686|NCT01322581|Plasmodium Falciparum|plasmodium falciparum
1362687|NCT01322581|Genome-Wide Expression|genome-wide expression
1362688|NCT01322581|Antibody Profiling by Protein Microarray|antibody profiling by protein microarray
1362689|NCT01322581|Multiplex Cytokine Analysis|multiplex cytokine analysis
1362690|NCT01322581|Children and Adults|children and adults
1362691|NCT01322581|Malaria|malaria
1362692|NCT01322568|Aging|aging
1362693|NCT01322568|Gene|gene
1362694|NCT01322568|Environment|environment
1362695|NCT01322568|Inflammation|inflammation
1362696|NCT01322568|Iceland|iceland
1362697|NCT01322555|PBR28|pbr28
1362698|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
1362699|NCT01322555|Propofol|propofol
1362700|NCT01322555|Autism|autism
1362701|NCT01322555|Immune Response|immune response
1362702|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
1362704|NCT01322555|Healthy Volunteer|healthy volunteer
1362705|NCT01322555|HV|hv
1362706|NCT01322529|nulliparity|nulliparity
1362707|NCT01322529|pregnant women|pregnant women
1362708|NCT01322529|pregnancy outcomes|pregnancy outcomes
1362709|NCT01322529|pregnancy complications|pregnancy complications
1362710|NCT01322490|PROSTVAC|prostvac
1362711|NCT01322490|metastatic|metastatic
1362712|NCT01322490|prostate cancer|prostate cancer
1362713|NCT01322490|castrate-resistant|castrate-resistant
1362714|NCT01322490|vaccine|vaccine
1362715|NCT01322490|immunotherapy|immunotherapy
1362716|NCT01322490|Phase 3|phase 3
1362717|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
1362718|NCT01322464|Sativex|sativex
1362719|NCT01322464|bio-availability|bio-availability
1362720|NCT01322464|cannabinoid|cannabinoid
1362721|NCT01322464|pharmacokinetics|pharmacokinetics
1362722|NCT01322451|Safety|safety
1362723|NCT01322451|Tolerability|tolerability
1362724|NCT01322451|Pharmacokinetics|pharmacokinetics
1362725|NCT01322438|healthy volunteers|healthy volunteers
1362726|NCT01322438|rifampin|rifampin
1362727|NCT01322438|pharmacokinetics|pharmacokinetics
1362728|NCT01322438|single dose|single dose
1362729|NCT01322412|Adapted physical activity|adapted physical activity
1362730|NCT01322412|breast cancer|breast cancer
1362731|NCT01322399|low back pain|low back pain
1362732|NCT01322399|chronic pain|chronic pain
1362733|NCT01322399|manual therapy|manual therapy
1362734|NCT01322399|Structural Integration|structural integration
1362735|NCT01322386|PSC|psc
1362736|NCT01322386|BA|ba
1362737|NCT01322373|Alzheimer's disease|alzheimer's disease
1362738|NCT01322373|magnetoencephalography|magnetoencephalography
1362739|NCT01322373|MEG|meg
1362740|NCT01322373|SNI|sni
1362741|NCT01322347|End Stage Renal Disease|end stage renal disease
1362742|NCT01322347|Hemodialysis|hemodialysis
1362743|NCT01322347|SFP|sfp
1362744|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
1362745|NCT01322334|Snoring|snoring
1362746|NCT01322334|Sleep apnea|sleep apnea
1362747|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
1362748|NCT01322321|ACZ885|acz885
1362749|NCT01322321|diabetes|diabetes
1362750|NCT01322321|type 1|type 1
1362751|NCT01322321|C-peptide|c-peptide
1362752|NCT01322308|lupus|lupus
1362753|NCT01322308|HDL particles|hdl particles
1362754|NCT01322308|endothelial function|endothelial function
1362755|NCT01322308|pioglitazone|pioglitazone
1362756|NCT01322243|Anxiety|anxiety
1362757|NCT01322243|Metabolic state|metabolic state
1362758|NCT01322243|Stress|stress
1362759|NCT01322230|Instructional Design|instructional design
1362760|NCT01322230|Online learning module|online learning module
1362761|NCT01322230|Surgical education|surgical education
1362762|NCT01322217|Medication adherence|medication adherence
1362763|NCT01322217|Substance use|substance use
1362764|NCT01322217|Sexual risk behaviors|sexual risk behaviors
1362765|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
1362766|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
1362767|NCT01322178|cetuximab|cetuximab
1362768|NCT01322178|colorectal carcinoma|colorectal carcinoma
1362769|NCT01322165|Marfan syndrome|marfan syndrome
1362770|NCT01322165|Turner syndrome|turner syndrome
1362771|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
1362772|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1362773|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
1362774|NCT01322165|Aneurysm|aneurysm
1362775|NCT01322165|Genetic|genetic
1362776|NCT01322165|aortic|aortic
1362777|NCT01322165|thoracic|thoracic
1362778|NCT01322165|mutation|mutation
1362779|NCT01322165|dissection|dissection
1362780|NCT01322152|metastases|metastases
1362781|NCT01322152|neoplasm|neoplasm
1362782|NCT01322139|Sativex|sativex
1362783|NCT01322139|Cannabinoid|cannabinoid
1362784|NCT01322139|Electrocardiogram|electrocardiogram
1362785|NCT01322139|QT interval|qt interval
1362786|NCT01322113|BIPOLAR|bipolar
1362787|NCT01322113|MANIA|mania
1362788|NCT01322113|DEPRESSION|depression
1362789|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
1362790|NCT01322087|Nutrition|nutrition
1362791|NCT01322087|new energy dense food concept|new energy dense food concept
1362792|NCT01322074|Acute postoperative pain|acute postoperative pain
1362793|NCT01322074|systemic inflammation|systemic inflammation
1362795|NCT01322074|IL6|il6
1362796|NCT01322061|Gallbladder removal|gallbladder removal
1362797|NCT01322061|acute cholecystitis|acute cholecystitis
1362798|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
1362799|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
1362800|NCT01322048|Traumatic Brain Injury|traumatic brain injury
1362801|NCT01322048|Agitation|agitation
1362802|NCT01322048|Severe TBI|severe tbi
1362803|NCT01322048|TBI|tbi
1362804|NCT01322048|Catecholamines|catecholamines
1362805|NCT01322048|Heart rate variability|heart rate variability
1362806|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
1362807|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1362808|NCT01322048|Cognitive Impairment|cognitive impairment
1362809|NCT01322022|Autism|autism
1362810|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
1362811|NCT01322022|Sleep Problems|sleep problems
1362812|NCT01322022|Sleep Disturbances|sleep disturbances
1362813|NCT01322022|Interventions|interventions
1362814|NCT01322009|Children|children
1362815|NCT01322009|Brain injury|brain injury
1362816|NCT01322009|Trauma|trauma
1362817|NCT01321996|PET/CT|pet/ct
1362818|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
1362819|NCT01321996|IPF|ipf
1362820|NCT01321996|NSIP|nsip
1362821|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1362822|NCT01321931|Smoking Cessation|smoking cessation
1362823|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
1362824|NCT01321892|HRME|hrme
1362825|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
1362826|NCT01321892|Optical imaging technology|optical imaging technology
1362827|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
1362828|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
1362829|NCT01321892|Cancer surgery|cancer surgery
1362830|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
1362831|NCT01321892|Oral cavity|oral cavity
1362832|NCT01321892|Oropharynx|oropharynx
1362833|NCT01321892|Larynx|larynx
1362834|NCT01321892|Hypopharynx|hypopharynx
1362835|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
1362836|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
1362837|NCT01321879|Sepsis|sepsis
1362838|NCT01321879|Staphylococcus aureus|staphylococcus aureus
1362839|NCT01321879|Enterococci|enterococci
1362840|NCT01321879|Streptococci|streptococci
1362841|NCT01321879|Pneumococci|pneumococci
1362842|NCT01321879|Corynebacterium|corynebacterium
1362843|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
1362844|NCT01321879|Telavancin|telavancin
1362845|NCT01321879|Vibativ|vibativ
1362846|NCT01321866|Angioplasty|angioplasty
1362847|NCT01321866|cutting balloon|cutting balloon
1362848|NCT01321853|Home health care|home health care
1362849|NCT01321853|Medication Management|medication management
1362850|NCT01321853|Cognitive impairment|cognitive impairment
1362851|NCT01321853|Medication adherence|medication adherence
1362852|NCT01321853|Older adults|older adults
1362853|NCT01321853|Care Coordination management|care coordination management
1362854|NCT01321840|Endometriosis|endometriosis
1362855|NCT01321840|pain|pain
1362856|NCT01321840|sart|sart
1362857|NCT01321840|autonomic nervous system|autonomic nervous system
1362858|NCT01321840|fMRI|fmri
1362859|NCT01321840|perfusion|perfusion
1362860|NCT01321840|connectivity|connectivity
1362861|NCT01321840|hypnotherapy|hypnotherapy
1362862|NCT01321840|traditional Chinese medicine|traditional chinese medicine
1362863|NCT01321827|ABPA|abpa
1362864|NCT01321814|Hyperacusis|hyperacusis
1362865|NCT01321814|Personality|personality
1362866|NCT01321814|Comorbidity|comorbidity
1362867|NCT01321814|Treatment|treatment
1362868|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
1362869|NCT01321801|Pregabalin|pregabalin
1362870|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1362871|NCT01321801|Postoperative pain|postoperative pain
1362872|NCT01321801|Opioid consumption|opioid consumption
1362873|NCT01321788|thromboprophylaxis|thromboprophylaxis
1362874|NCT01321788|pregnancy|pregnancy
1362875|NCT01321788|post-cesarian section|post-cesarian section
1362876|NCT01321762|Prolapse|prolapse
1362877|NCT01321762|Childbirth|childbirth
1362878|NCT01321762|Pregnancy|pregnancy
1362879|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
1362880|NCT01321749|stroke secondary prevention|stroke secondary prevention
1362881|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
1362882|NCT01321736|dietary fiber|dietary fiber
1362883|NCT01321736|enteral nutrition|enteral nutrition
1362884|NCT01321736|laxation|laxation
1362885|NCT01321723|Osteoporosis|osteoporosis
1362886|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
1362887|NCT01321723|Bone Diseases|bone diseases
1362888|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
1362889|NCT01321710|sleep hygiene|sleep hygiene
1362890|NCT01321710|actigraphy|actigraphy
1362891|NCT01321710|maternal|maternal
1362892|NCT01321710|infant|infant
1362893|NCT01321710|postpartum period|postpartum period
1362894|NCT01321710|immunization|immunization
1362895|NCT01321710|acetaminophen|acetaminophen
1362896|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
1362989|NCT01321320|ICUAP|icuap
1362897|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
1362898|NCT01321697|groin|groin
1362899|NCT01321671|pregabalin|pregabalin
1362900|NCT01321671|pharmacokinetics|pharmacokinetics
1362901|NCT01321671|bioavailability|bioavailability
1362902|NCT01321671|bioequivalence|bioequivalence
1362903|NCT01321658|Geriatric Assessment|geriatric assessment
1362904|NCT01321658|Perioperative Care|perioperative care
1362905|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
1362906|NCT01321658|Frail Elderly|frail elderly
1362907|NCT01321645|Acne Vulgaris|acne vulgaris
1362908|NCT01321645|Homoeopathy|homoeopathy
1362909|NCT01321645|Homeopathy|homeopathy
1362910|NCT01321645|Azadirachta Indica|azadirachta indica
1362911|NCT01321632|Acne Vulgaris|acne vulgaris
1362912|NCT01321632|Homoeopathy|homoeopathy
1362913|NCT01321632|Zingiber officinalis|zingiber officinalis
1362914|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
1362915|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
1362916|NCT01321619|Varicell|varicell
1362917|NCT01321606|infection|infection
1362918|NCT01321606|probiotics|probiotics
1362919|NCT01321567|rabeprazole sodium|rabeprazole sodium
1362920|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
1362921|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
1362922|NCT01321541|DLBCL|dlbcl
1362923|NCT01321541|relapsed|relapsed
1362924|NCT01321541|aggressive NHL|aggressive nhl
1362925|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1362926|NCT01321541|Rituximab|rituximab
1362927|NCT01321541|Rituxan|rituxan
1362928|NCT01321541|Pixantrone|pixantrone
1362930|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
1362931|NCT01321541|de novo DLBCL|de novo dlbcl
1362932|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
1362933|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
1362934|NCT01321502|treatment of herpes|treatment of herpes
1362935|NCT01321489|Phase III|phase iii
1362936|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
1362937|NCT01321489|Erectile dysfunction|erectile dysfunction
1362938|NCT01321437|Melanoma|melanoma
1362939|NCT01321437|Axitinib|axitinib
1362940|NCT01321437|Anti-angiogenesis|anti-angiogenesis
1362941|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
1362942|NCT01321424|Dry Eye|dry eye
1362943|NCT01321424|Tear Osmolarity|tear osmolarity
1362944|NCT01321424|Meibomain Gland Disease|meibomain gland disease
1362945|NCT01321424|Aqueous Dificiency|aqueous dificiency
1362946|NCT01321424|Tear film abnormality|tear film abnormality
1362947|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
1362948|NCT01321411|Work of Breathing|work of breathing
1362949|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
1362950|NCT01321398|High Frequency Oscillation|high frequency oscillation
1362951|NCT01321398|Oscillation|oscillation
1362952|NCT01321398|HFO|hfo
1362953|NCT01321398|Transpulmonary pressure|transpulmonary pressure
1362954|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1362955|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1362956|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1362957|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1362958|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1362959|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1362960|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1362961|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1362962|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1362963|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1362964|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1362965|NCT01321346|Relapse|relapse
1362966|NCT01321346|Lymphoblastic|lymphoblastic
1362967|NCT01321346|Leukemia|leukemia
1362968|NCT01321346|Panobinostat|panobinostat
1362969|NCT01321346|LBH589|lbh589
1362970|NCT01321346|Refractory|refractory
1362971|NCT01321346|Hodgkin's|hodgkin's
1362972|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1362973|NCT01321346|Lymphoma|lymphoma
1362974|NCT01321346|Myelogenous|myelogenous
1362975|NCT01321346|Acute|acute
1362976|NCT01321346|Childhood|childhood
1362977|NCT01321346|Pediatric|pediatric
1362978|NCT01321346|ALL|all
1362979|NCT01321346|AML|aml
1362980|NCT01321346|NHL|nhl
1362981|NCT01321346|HD|hd
1362982|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
1362983|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
1362984|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
1362985|NCT01321333|human neural stem cells|human neural stem cells
1362986|NCT01321333|stem cells|stem cells
1362987|NCT01321333|stem cells transplant|stem cells transplant
1362988|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
1362990|NCT01321320|Critical illness|critical illness
1362991|NCT01321320|Muscle wasting|muscle wasting
1362993|NCT01321307|Aphtostomatitis|aphtostomatitis
1362994|NCT01321307|Mucositis|mucositis
1362995|NCT01321307|Mouth sores|mouth sores
1362996|NCT01321307|Natural|natural
1362997|NCT01321307|Herbal|herbal
1362998|NCT01321281|Osteoarthritis|osteoarthritis
1362999|NCT01321268|orange peel skin|orange peel skin
1363000|NCT01321268|cellulite|cellulite
1363001|NCT01321255|Myocardial Infarction|myocardial infarction
1363002|NCT01321255|Treatment Adherence|treatment adherence
1363003|NCT01321242|Resting heart rate|resting heart rate
1363004|NCT01321242|Stable Angina|stable angina
1363005|NCT01321242|Hypertension|hypertension
1363006|NCT01321242|beta-blockers|beta-blockers
1363007|NCT01321229|Sleep apnea|sleep apnea
1363008|NCT01321229|NIHSS scale|nihss scale
1363009|NCT01321229|FIM scale|fim scale
1363010|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
1363011|NCT01321216|rotavirus|rotavirus
1363012|NCT01321216|gastroenteritis|gastroenteritis
1363013|NCT01321216|children|children
1363014|NCT01321216|Pediatric|pediatric
1363015|NCT01321216|dehydration|dehydration
1363016|NCT01321216|vaccine|vaccine
1363017|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
1363018|NCT01321177|Schizophrenia|schizophrenia
1363019|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
1363020|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
1363021|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
1363022|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
1363023|NCT01321177|First Episode|first episode
1363024|NCT01321151|Mild Brain Injury|mild brain injury
1363025|NCT01321151|Concussions|concussions
1363026|NCT01321151|Resveratrol|resveratrol
1363027|NCT01321151|Boxers|boxers
1363028|NCT01321151|ImPACT|impact
1363029|NCT01321151|MRI|mri
1363030|NCT01321138|Electrophysiological study|electrophysiological study
1363031|NCT01321138|Nerve block|nerve block
1363032|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
1363033|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
1363034|NCT01321125|Antiseptics|antiseptics
1363035|NCT01321125|Administration cutaneously|administration cutaneously
1363036|NCT01321125|Chlorine compounds|chlorine compounds
1363037|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
1363038|NCT01321112|Conversion|conversion
1363039|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
1363040|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
1363041|NCT01321112|Liver transplantation|liver transplantation
1363042|NCT01321112|Gene expression|gene expression
1363043|NCT01321099|Iron absorption|iron absorption
1363044|NCT01321099|Complementary food fortificant|complementary food fortificant
1363045|NCT01321099|Young children|young children
1363046|NCT01321086|PAD|pad
1363047|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
1363048|NCT01321060|acute fluid collection|acute fluid collection
1363049|NCT01321060|catheter drainage|catheter drainage
1363050|NCT01321060|repeated aspiration|repeated aspiration
1363051|NCT01321047|sedation|sedation
1363052|NCT01321047|benzodiazepine|benzodiazepine
1363053|NCT01321047|opioid|opioid
1363054|NCT01321047|propofol|propofol
1363055|NCT01321034|Lipoprotein (a)|lipoprotein (a)
1363056|NCT01321034|LPA|lpa
1363057|NCT01321034|Niacin|niacin
1363058|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
1363059|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
1363060|NCT01321008|Stage I/II|stage i/ii
1363061|NCT01321008|Radiation therapy|radiation therapy
1363062|NCT01321008|XRT|xrt
1363063|NCT01321008|chemotherapy|chemotherapy
1363064|NCT01321008|CHOP|chop
1363065|NCT01321008|Cyclophosphamide|cyclophosphamide
1363066|NCT01321008|Cytoxan|cytoxan
1363067|NCT01321008|Neosar|neosar
1363068|NCT01321008|Adriamycin|adriamycin
1363069|NCT01321008|Doxorubicin|doxorubicin
1363070|NCT01321008|Rubex|rubex
1363071|NCT01321008|Vincristine|vincristine
1363072|NCT01321008|Oncovin|oncovin
1363073|NCT01321008|Prednisone|prednisone
1363074|NCT01320995|Second degree vaginal tear|second degree vaginal tear
1363075|NCT01320995|Perineal ultrasound|perineal ultrasound
1363076|NCT01320995|Anal incontinence|anal incontinence
1363077|NCT01320982|Schizophrenia|schizophrenia
1363078|NCT01320982|schizoaffective disorder|schizoaffective disorder
1363079|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
1363080|NCT01320956|hypnosis|hypnosis
1363081|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
1363082|NCT01320956|surgery|surgery
1363083|NCT01320956|children|children
1363084|NCT01320956|anxiety|anxiety
1363085|NCT01320956|morphine|morphine
1363086|NCT01320956|pain|pain
1363087|NCT01320956|A-VAS|a-vas
1363088|NCT01320956|orthopaedics|orthopaedics
1363089|NCT01320956|osteotomy|osteotomy
1363090|NCT01320956|tenotomy|tenotomy
1363091|NCT01320956|arthrodesis|arthrodesis
1363092|NCT01320956|spinal column surgery|spinal column surgery
1363093|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
1363094|NCT01320943|HBsAg loss|hbsag loss
1363095|NCT01320943|seroconversion|seroconversion
1363096|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
1363097|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
1363098|NCT01320930|Exercise capacity|exercise capacity
1363099|NCT01320930|Quality of life|quality of life
1363101|NCT01320917|contraceptives hormonal|contraceptives hormonal
1363102|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
1363103|NCT01320917|cardiovascular risk|cardiovascular risk
1363104|NCT01320904|Closed Kinetic Chain|closed kinetic chain
1363105|NCT01320904|NMES|nmes
1363106|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
1363107|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
1363108|NCT01320878|pulmonary hypertension|pulmonary hypertension
1363109|NCT01320852|Transplant|transplant
1363110|NCT01320826|colonoscopy|colonoscopy
1363111|NCT01320826|primary care physicians|primary care physicians
1363112|NCT01320826|quality assurance|quality assurance
1363113|NCT01320813|da vinci robot|da vinci robot
1363114|NCT01320813|Thyroidectomy|thyroidectomy
1363115|NCT01320787|Brain|brain
1363116|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1363117|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
1363118|NCT01320787|Estrogen receptor|estrogen receptor
1363119|NCT01320787|ER|er
1363120|NCT01320787|Progesterone receptor|progesterone receptor
1363121|NCT01320787|PR|pr
1363122|NCT01320787|Negative for ErbB2|negative for erbb2
1363123|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
1363124|NCT01320787|CNS|cns
1363125|NCT01320761|Formulation Comparison|formulation comparison
1363126|NCT01320748|Abstinence from alcohol|abstinence from alcohol
1363127|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
1363128|NCT01320748|Social Support|social support
1363129|NCT01320748|Psychosocial Support Systems|psychosocial support systems
1363130|NCT01320748|Psychological support|psychological support
1363131|NCT01320748|Cognitive Support|cognitive support
1363132|NCT01320748|Emotional Support|emotional support
1363133|NCT01320748|Mental Support|mental support
1363134|NCT01320748|Psychosocial Support|psychosocial support
1363135|NCT01320748|Intervention Studies|intervention studies
1363136|NCT01320748|Prevention & control|prevention & control
1363137|NCT01320748|Preventive therapy|preventive therapy
1363138|NCT01320748|Treatment|treatment
1363139|NCT01320748|Therapy|therapy
1363140|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
1363141|NCT01320748|fMRI|fmri
1363142|NCT01320748|Imaging|imaging
1363143|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1363144|NCT01320748|MRI Scans|mri scans
1363145|NCT01320748|MRI, Functional|mri, functional
1363146|NCT01320748|Clinical Protocols|clinical protocols
1363147|NCT01320748|Protocols, Treatment|protocols, treatment
1363148|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
1363149|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
1363150|NCT01320735|Lucrin Depot|lucrin depot
1363151|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
1363152|NCT01320735|advanced prostate cancer|advanced prostate cancer
1363153|NCT01320735|Leuprorelin|leuprorelin
1363154|NCT01320722|renin angiotensin system|renin angiotensin system
1363155|NCT01320722|vitamin D|vitamin d
1363156|NCT01320722|uric acid|uric acid
1363157|NCT01320722|allopurinol|allopurinol
1363158|NCT01320722|probenecid|probenecid
1363159|NCT01320722|endothelial function|endothelial function
1363160|NCT01320709|Emergency contraception|emergency contraception
1363161|NCT01320709|Contraception|contraception
1363162|NCT01320670|pharmacoresistance|pharmacoresistance
1363163|NCT01320657|Self-ligating|self-ligating
1363164|NCT01320657|orthodontic|orthodontic
1363165|NCT01320657|appliance|appliance
1363166|NCT01320657|expansion|expansion
1363167|NCT01320657|dental inclination|dental inclination
1363168|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
1363169|NCT01320644|Uterine prolapse|uterine prolapse
1363170|NCT01320644|vaginal prolapse|vaginal prolapse
1363171|NCT01320644|mesh erosion|mesh erosion
1363172|NCT01320644|urinary incontinence|urinary incontinence
1363173|NCT01320644|bowel symptoms|bowel symptoms
1363174|NCT01320631|uterine prolapse|uterine prolapse
1363175|NCT01320631|vaginal prolapse|vaginal prolapse
1363176|NCT01320618|uterine prolapse|uterine prolapse
1363177|NCT01320618|vaginal prolapse|vaginal prolapse
1363178|NCT01320618|mesh erosion|mesh erosion
1363179|NCT01320618|urinary incontinence|urinary incontinence
1363180|NCT01320618|bowel symptoms|bowel symptoms
1363181|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
1363182|NCT01320592|breast cancer|breast cancer
1363183|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
1363184|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
1363185|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
1363186|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
1363187|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
1363188|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
1363189|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
1363190|NCT01320579|atopic dermatitis|atopic dermatitis
1363191|NCT01320579|cis-urocanic acid|cis-urocanic acid
1363192|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
1363193|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
1363194|NCT01320566|AeriSeal|aeriseal
1363195|NCT01320566|treatment|treatment
1363196|NCT01320566|device|device
1363197|NCT01320566|breathing|breathing
1363198|NCT01320566|COPD|copd
1363199|NCT01320566|emphysema|emphysema
1363200|NCT01320566|heterogeneous|heterogeneous
1363201|NCT01320566|homogeneous|homogeneous
1363202|NCT01320566|Pathologic Processes|pathologic processes
1363203|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
1363204|NCT01320566|Lung Diseases|lung diseases
1363205|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1363206|NCT01320527|dietary supplement|dietary supplement
1363207|NCT01320527|cognition|cognition
1363208|NCT01320527|mood|mood
1363209|NCT01320527|Alzheimer's disease|alzheimer's disease
1363210|NCT01320527|memory loss|memory loss
1363211|NCT01320501|Lung Cancer|lung cancer
1363212|NCT01320488|Breast Cancer|breast cancer
1363213|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
1363214|NCT01320475|epidural opioid|epidural opioid
1363215|NCT01320475|ketamine|ketamine
1363216|NCT01320475|adverse effect|adverse effect
1363217|NCT01320462|Smoking|smoking
1363218|NCT01320462|quit|quit
1363219|NCT01320462|surgery|surgery
1363220|NCT01320462|anesthesia|anesthesia
1363221|NCT01320462|champix|champix
1363223|NCT01320449|Proteomics|proteomics
1363224|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
1363225|NCT01320449|Fat metabolism|fat metabolism
1363226|NCT01320449|Protein metabolism|protein metabolism
1363227|NCT01320436|Ulcerative colitis|ulcerative colitis
1363228|NCT01320436|Curcumin|curcumin
1363229|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
1363230|NCT01320384|ALI|ali
1363231|NCT01320371|barbed sutures|barbed sutures
1363232|NCT01320371|knotted sutures|knotted sutures
1363233|NCT01320371|total knee arthroplasty|total knee arthroplasty
1363234|NCT01320371|knee surgery|knee surgery
1363235|NCT01320358|Patient compliance|patient compliance
1363236|NCT01320358|ECMPS-IEM|ecmps-iem
1363237|NCT01320358|transplantation|transplantation
1363238|NCT01320358|renal maintenance|renal maintenance
1363239|NCT01320358|Proteus|proteus
1363240|NCT01320345|Diabetes Mellitus|diabetes mellitus
1363241|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1363242|NCT01320345|Retinopathy|retinopathy
1363243|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
1363244|NCT01320345|Fenofibrate|fenofibrate
1363245|NCT01320332|Ulcerative colitis|ulcerative colitis
1363246|NCT01320332|ASP3291|asp3291
1363247|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
1363248|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
1363249|NCT01320267|Resectable right colon cancer|resectable right colon cancer
1363250|NCT01320254|Palliative treatment|palliative treatment
1363251|NCT01320254|Panitumumab|panitumumab
1363252|NCT01320254|Cisplatin|cisplatin
1363253|NCT01320254|Cisplatinum|cisplatinum
1363254|NCT01320254|Gemcitabine|gemcitabine
1363255|NCT01320254|Vectibix|vectibix
1363256|NCT01320228|Obesity|obesity
1363257|NCT01320228|orlistat|orlistat
1363258|NCT01320228|fat excretion|fat excretion
1363259|NCT01320228|fiber|fiber
1363260|NCT01320228|dairy calcium|dairy calcium
1363261|NCT01320215|da Vinci Robot|da vinci robot
1363262|NCT01320215|uterine prolapse|uterine prolapse
1363263|NCT01320215|vaginal prolapse|vaginal prolapse
1363264|NCT01320215|sacrohysteropexy|sacrohysteropexy
1363265|NCT01320202|End Stage Renal Disease|end stage renal disease
1363266|NCT01320202|Hemodialysis|hemodialysis
1363267|NCT01320202|SFP|sfp
1363268|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
1363269|NCT01320189|Energy intake|energy intake
1363270|NCT01320189|Protein requirement|protein requirement
1363271|NCT01320189|Satiety|satiety
1363272|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
1363273|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
1363274|NCT01320137|Immunological assay|immunological assay
1363275|NCT01320137|Birch allergy|birch allergy
1364071|NCT01316744|pain|pain
1363276|NCT01320124|Contractures|contractures
1363277|NCT01320124|Total knee arthroplasty|total knee arthroplasty
1363278|NCT01320124|Tissue bank|tissue bank
1363279|NCT01320124|Osteoarthritis|osteoarthritis
1363280|NCT01320124|Gene expressions|gene expressions
1363281|NCT01320111|progression free survival|progression free survival
1363282|NCT01320111|paclitaxel|paclitaxel
1363283|NCT01320111|sorafenib|sorafenib
1363284|NCT01320111|metastatic breast cancer|metastatic breast cancer
1363285|NCT01320098|Attention|attention
1363286|NCT01320098|Behavior Problems|behavior problems
1363287|NCT01320098|Compliance|compliance
1363288|NCT01320098|Evaluation|evaluation
1363289|NCT01320098|Preschool|preschool
1363290|NCT01320098|ADHD|adhd
1363291|NCT01320098|Overactive|overactive
1363292|NCT01320098|Inattentive|inattentive
1363293|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
1363294|NCT01320085|Metastatic melanoma,|metastatic melanoma,
1363295|NCT01320085|BRAF-mutant,|braf-mutant,
1363296|NCT01320085|NRAS-mutant|nras-mutant
1363297|NCT01320072|aspirin|aspirin
1363298|NCT01320072|asthma|asthma
1363299|NCT01320072|diagnosis|diagnosis
1363300|NCT01320072|prostaglandins|prostaglandins
1363301|NCT01320072|leukotrienes|leukotrienes
1363302|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
1363303|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
1363304|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
1363305|NCT01320059|Positron Emission Tomography|positron emission tomography
1363306|NCT01320059|PET Scan|pet scan
1363307|NCT01320059|CT|ct
1363308|NCT01320059|Computed Tomography|computed tomography
1363309|NCT01320046|Urinary Incontinence|urinary incontinence
1363310|NCT01320046|Vulvar pruritus|vulvar pruritus
1363311|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
1363312|NCT01320033|acne vulgaris|acne vulgaris
1363313|NCT01320033|inflammatory lesions|inflammatory lesions
1363314|NCT01320020|Cancer|cancer
1363315|NCT01320020|Neoplasm|neoplasm
1363316|NCT01320020|Carcinoma|carcinoma
1363317|NCT01320020|intravenous|intravenous
1363318|NCT01320020|Monoclonal Antibody|monoclonal antibody
1363319|NCT01320020|Removab|removab
1363320|NCT01319994|glucocorticoid|glucocorticoid
1363321|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1363322|NCT01319981|ALL|all
1363323|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
1363324|NCT01319981|Cytoxan|cytoxan
1363325|NCT01319981|Neosar|neosar
1363326|NCT01319981|Mesnex|mesnex
1363327|NCT01319981|Liposomal Vincristine|liposomal vincristine
1363328|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
1363329|NCT01319981|Marqibo|marqibo
1363330|NCT01319981|Dexamethasone|dexamethasone
1363331|NCT01319981|Adriamycin|adriamycin
1363332|NCT01319981|Rubex|rubex
1363333|NCT01319981|Cytarabine|cytarabine
1363334|NCT01319981|Cytosar|cytosar
1363335|NCT01319981|DepoCyt|depocyt
1363336|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1363337|NCT01319981|Imatinib Mesylate|imatinib mesylate
1363338|NCT01319981|Gleevec|gleevec
1363339|NCT01319981|ST1571|st1571
1363340|NCT01319981|NSC-716051|nsc-716051
1363341|NCT01319981|Filgrastim|filgrastim
1363342|NCT01319981|Neupogen|neupogen
1363343|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
1363344|NCT01319968|Vaginal atrophy|vaginal atrophy
1363345|NCT01319955|Pneumonia|pneumonia
1363346|NCT01319955|Influenza|influenza
1363347|NCT01319955|Child|child
1363348|NCT01319955|Respiratory|respiratory
1363349|NCT01319955|Pathogen|pathogen
1363350|NCT01319942|Radiotherapy|radiotherapy
1363351|NCT01319942|Sorafenib|sorafenib
1363352|NCT01319942|Treatment outcome|treatment outcome
1363353|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
1363354|NCT01319903|sepsis|sepsis
1363355|NCT01319903|inflammation|inflammation
1363356|NCT01319903|complement|complement
1363357|NCT01319903|immune system|immune system
1363358|NCT01319890|all histologic subtypes|all histologic subtypes
1363359|NCT01319890|benign|benign
1363360|NCT01319890|malignant|malignant
1363361|NCT01319864|leukemia|leukemia
1363362|NCT01319851|bone marrow transplant|bone marrow transplant
1363363|NCT01319851|sickle cell disease|sickle cell disease
1363364|NCT01319851|thalassemia|thalassemia
1363365|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
1363366|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
1363367|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
1363368|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
1363369|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
1363370|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
1363371|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
1363372|NCT01319851|Fanconi anemia|fanconi anemia
1363373|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
1363374|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
1363375|NCT01319851|severe aplastic anemia|severe aplastic anemia
1363376|NCT01319838|neuroblastoma|neuroblastoma
1363377|NCT01319838|isotretinoin|isotretinoin
1364764|NCT01314521|Depression|depression
1363378|NCT01319812|Vascular intervention|vascular intervention
1363379|NCT01319812|Endovascular|endovascular
1363380|NCT01319812|Peripheral stent|peripheral stent
1363381|NCT01319799|Embolism|embolism
1363382|NCT01319799|Nervous system|nervous system
1363383|NCT01319799|Aorta|aorta
1363384|NCT01319799|Valves|valves
1363385|NCT01319799|Ultrasonics|ultrasonics
1363386|NCT01319786|Hypertension|hypertension
1363387|NCT01319786|Microvascular function|microvascular function
1363388|NCT01319760|STEMI|stemi
1363389|NCT01319747|atrial|atrial
1363390|NCT01319747|fibrillation|fibrillation
1363391|NCT01319747|pvi|pvi
1363392|NCT01319747|vats|vats
1363393|NCT01319747|ablation|ablation
1363394|NCT01319734|Vitamin C|vitamin c
1363395|NCT01319734|Oxidative stress|oxidative stress
1363396|NCT01319734|Type 2DM|type 2dm
1363397|NCT01319721|Amniotic membrane|amniotic membrane
1363398|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
1363399|NCT01319721|Limbal|limbal
1363400|NCT01319721|Conjunctival|conjunctival
1363401|NCT01319721|Mitomycin C|mitomycin c
1363402|NCT01319721|Recurrent pterygium|recurrent pterygium
1363403|NCT01319721|Pterygium|pterygium
1363404|NCT01319708|ovarian stimulation|ovarian stimulation
1363405|NCT01319708|climiphene citrate|climiphene citrate
1363406|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
1363407|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
1363408|NCT01319695|corifollitropin alfa|corifollitropin alfa
1363409|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
1363410|NCT01319695|IVF|ivf
1363411|NCT01319682|Pain|pain
1363412|NCT01319682|Preemptive|preemptive
1363413|NCT01319682|Lidocaine|lidocaine
1363414|NCT01319682|Intravenous|intravenous
1363415|NCT01319682|Lumbar fusion|lumbar fusion
1363416|NCT01319656|Chronic diseases|chronic diseases
1363417|NCT01319656|Primary care|primary care
1363418|NCT01319656|Rehabilitation|rehabilitation
1363419|NCT01319656|Chronic Care Model|chronic care model
1363420|NCT01319656|Patient centered medical home|patient centered medical home
1363421|NCT01319643|Oxygen|oxygen
1363422|NCT01319643|Hyperoxia|hyperoxia
1363423|NCT01319643|Intensive care unit|intensive care unit
1363424|NCT01319643|Mortality|mortality
1363425|NCT01319643|Organ dysfunction|organ dysfunction
1363426|NCT01319643|Postoperative care|postoperative care
1363427|NCT01319630|sepsis|sepsis
1363428|NCT01319630|microcirculation|microcirculation
1363429|NCT01319630|saline|saline
1363430|NCT01319630|crystalloid|crystalloid
1363431|NCT01319630|colloid|colloid
1363432|NCT01319630|albumin|albumin
1363433|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
1363434|NCT01319578|chronic kidney disease|chronic kidney disease
1363435|NCT01319578|phosphorus|phosphorus
1363436|NCT01319578|phosphate|phosphate
1363437|NCT01319578|saliva|saliva
1363438|NCT01319578|K2CG|k2cg
1363439|NCT01319578|medical food|medical food
1363440|NCT01319578|chitosan|chitosan
1363441|NCT01319565|Young TIL|young til
1363442|NCT01319565|Metastatic Melanoma|metastatic melanoma
1363443|NCT01319565|Immunotherapy|immunotherapy
1363444|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
1363445|NCT01319565|Skin Cancer|skin cancer
1363446|NCT01319552|red blood cells|red blood cells
1363447|NCT01319552|transfusion|transfusion
1363448|NCT01319552|storage|storage
1363449|NCT01319552|sickle cell disease|sickle cell disease
1363450|NCT01319552|β-thalassemia|β-thalassemia
1363451|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
1363452|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1363453|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1363454|NCT01319526|HIV infection|hiv infection
1363455|NCT01319500|Drug Utilization|drug utilization
1363456|NCT01319500|Oral Contraceptives|oral contraceptives
1363457|NCT01319474|Deep vein thrombosis|deep vein thrombosis
1363458|NCT01319474|Pulmonary embolism|pulmonary embolism
1363459|NCT01319474|Ultrasound|ultrasound
1363460|NCT01319474|Pregnancy|pregnancy
1363461|NCT01319461|Osteoarthritis|osteoarthritis
1363462|NCT01319461|Hyalgan|hyalgan
1363463|NCT01319448|Sickle cell disease|sickle cell disease
1363464|NCT01319448|Malaria|malaria
1363465|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
1363466|NCT01319448|prophylaxis|prophylaxis
1363467|NCT01319435|Ciprofloxacin|ciprofloxacin
1363468|NCT01319435|Neonates|neonates
1363469|NCT01319435|Gram negative infection|gram negative infection
1363470|NCT01319422|myeloma|myeloma
1363471|NCT01319422|multiple myeloma|multiple myeloma
1363472|NCT01319422|pomalidomide|pomalidomide
1363473|NCT01319422|immunomodulatory|immunomodulatory
1363474|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
1363475|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1363476|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
1363477|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
1363478|NCT01319409|Randomized clinical trial|randomized clinical trial
1363479|NCT01319396|breathing rate|breathing rate
1363480|NCT01319383|HIV-1 Infection|hiv-1 infection
1363481|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
1363482|NCT01319383|Stable ART|stable art
1363483|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
1363484|NCT01319383|Leukapheresis|leukapheresis
1363485|NCT01319383|Vorinostat|vorinostat
1363486|NCT01319383|HIV RNA expression|hiv rna expression
1363487|NCT01319383|PK visits|pk visits
1363488|NCT01319331|diabetes|diabetes
1363489|NCT01319331|type 1 diabetes|type 1 diabetes
1363490|NCT01319331|AAT|aat
1363491|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
1363492|NCT01319279|Pharmacokinetics|pharmacokinetics
1363493|NCT01319279|Hydrocodone|hydrocodone
1363494|NCT01319279|Extended Release|extended release
1363495|NCT01319279|Hepatic impairment|hepatic impairment
1363496|NCT01319266|hydrocodone|hydrocodone
1363497|NCT01319266|extended release|extended release
1363498|NCT01319266|pharmacokinetics|pharmacokinetics
1363499|NCT01319266|renal impairment|renal impairment
1363500|NCT01319253|Cystic Fibrosis|cystic fibrosis
1363501|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
1363502|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
1363503|NCT01319227|Stress shielding|stress shielding
1363504|NCT01319227|Short femoral stem|short femoral stem
1363505|NCT01319227|Porous Titanium Construct|porous titanium construct
1363506|NCT01319227|Polyethylene wear|polyethylene wear
1363507|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
1363508|NCT01319188|Age-related macular degeneration|age-related macular degeneration
1363509|NCT01319188|ranibizumab|ranibizumab
1363510|NCT01319188|acute thromboembolic events|acute thromboembolic events
1363511|NCT01319188|coronary artery disease|coronary artery disease
1363512|NCT01319188|cerebrovascular disease|cerebrovascular disease
1363513|NCT01319175|hip flexion strength training|hip flexion strength training
1363514|NCT01319175|elastic bands|elastic bands
1363515|NCT01319175|external resistance|external resistance
1363516|NCT01319162|PCOS|pcos
1363517|NCT01319149|molecular methods|molecular methods
1363518|NCT01319136|new infusion test method|new infusion test method
1363519|NCT01319136|reference method|reference method
1363520|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
1363521|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
1363522|NCT01319110|Cardiac Arrest|cardiac arrest
1363523|NCT01319110|Post Cardiac Arrest|post cardiac arrest
1363524|NCT01319110|CoQ10|coq10
1363525|NCT01319110|Ubiquinone|ubiquinone
1363526|NCT01319110|Post Arrest|post arrest
1363527|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
1363528|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
1363529|NCT01319058|Tonsillectomy|tonsillectomy
1363530|NCT01319058|Tonsillotomy|tonsillotomy
1363531|NCT01319058|Inflammation|inflammation
1363532|NCT01319058|Pain|pain
1363533|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
1363534|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1363535|NCT01319045|Congenital Heart Disease|congenital heart disease
1363536|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
1363537|NCT01319045|Prostacyclin|prostacyclin
1363538|NCT01319045|Iloprost|iloprost
1363539|NCT01319019|lung function|lung function
1363540|NCT01319019|bronchodilator|bronchodilator
1363541|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
1363542|NCT01319006|relative bioavailability|relative bioavailability
1363543|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
1363544|NCT01318980|ADME|adme
1363545|NCT01318980|IV radiolabelled|iv radiolabelled
1363546|NCT01318980|pharmacokinetics|pharmacokinetics
1363547|NCT01318967|Renal blood flow|renal blood flow
1363548|NCT01318967|Regional renal blood flow|regional renal blood flow
1363549|NCT01318967|MRI|mri
1363550|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
1363551|NCT01318941|Ophthalmology|ophthalmology
1363552|NCT01318941|Age-related macular degeneration|age-related macular degeneration
1363553|NCT01318941|Diabetic Macular Edema|diabetic macular edema
1363554|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
1363555|NCT01318941|LUMINOUS|luminous
1363556|NCT01318941|Ranibizumab|ranibizumab
1363557|NCT01318928|Periodontitis|periodontitis
1363558|NCT01318928|antibiotics|antibiotics
1363559|NCT01318928|treatment period|treatment period
1363560|NCT01318928|microbiology|microbiology
1363561|NCT01318915|Kidney transplantation|kidney transplantation
1363562|NCT01318915|Living donor transplant|living donor transplant
1363563|NCT01318915|Graft rejection|graft rejection
1363564|NCT01318915|Graft loss|graft loss
1363565|NCT01318915|Induction with rituximab and ATG|induction with rituximab and atg
1363566|NCT01318915|Immunosuppression (IS)|immunosuppression (is)
1363567|NCT01318889|Dexpanthenol|dexpanthenol
1363568|NCT01318889|Radiotherapy|radiotherapy
1363569|NCT01318889|chemotherapy|chemotherapy
1363570|NCT01318889|Mucositis|mucositis
1363571|NCT01318876|influenza|influenza
1363572|NCT01318876|vaccine safety|vaccine safety
1363573|NCT01318876|adverse events|adverse events
1363574|NCT01318876|health care workers|health care workers
1363575|NCT01318863|aged matched normal control samples|aged matched normal control samples
1363576|NCT01318850|schizophrenia|schizophrenia
1363577|NCT01318850|cognitive remediation|cognitive remediation
1363578|NCT01318850|fMRI|fmri
1363579|NCT01318837|OABSS|oabss
1363580|NCT01318837|IPSS|ipss
1363581|NCT01318837|PPBC|ppbc
1363582|NCT01318837|Solifenacin|solifenacin
1363583|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
1363584|NCT01318824|Newborn Infant|newborn infant
1363585|NCT01318824|BiPAP|bipap
1363586|NCT01318824|NIPPV|nippv
1363587|NCT01318811|Heparin|heparin
1363588|NCT01318811|CRRT|crrt
1363589|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
1363590|NCT01318811|CVVHD|cvvhd
1363591|NCT01318811|Anticoagulation|anticoagulation
1363592|NCT01318798|Development|development
1363593|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
1363594|NCT01318798|Acute renal failure|acute renal failure
1363595|NCT01318798|Liver Surgery|liver surgery
1363596|NCT01318798|Prediction score|prediction score
1363597|NCT01318798|Validation|validation
1363598|NCT01318798|Clinical consequences|clinical consequences
1363599|NCT01318798|Decision curve analysis|decision curve analysis
1363600|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
1363601|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
1363602|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
1363603|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
1363604|NCT01318733|Rosacea|rosacea
1363605|NCT01318720|Neck Pain|neck pain
1363606|NCT01318720|Thrust Manipulation|thrust manipulation
1363607|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
1363608|NCT01318707|Severe Hemophilia A|severe hemophilia a
1363609|NCT01318707|Hemophilia A Patients|hemophilia a patients
1363610|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
1363611|NCT01318694|Chronic hepatitis C|chronic hepatitis c
1363612|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
1363613|NCT01318681|driving, memory, cognition|driving, memory, cognition
1363614|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
1363615|NCT01318655|Phase I|phase i
1363616|NCT01318655|Japan|japan
1363617|NCT01318655|SAD|sad
1363618|NCT01318655|MAD|mad
1363619|NCT01318642|Adenocarcinoma|adenocarcinoma
1363620|NCT01318642|pancreas|pancreas
1363621|NCT01318642|pancreatic cancer|pancreatic cancer
1363622|NCT01318642|local|local
1363623|NCT01318642|unresectable|unresectable
1363624|NCT01318642|stage II|stage ii
1363625|NCT01318642|stage III|stage iii
1363626|NCT01318616|hip adduction strength training|hip adduction strength training
1363627|NCT01318616|Improvement in adductor strength|improvement in adductor strength
1363628|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
1363629|NCT01318590|Abdominal Pain|abdominal pain
1363630|NCT01318590|Celiac bloc|celiac bloc
1363631|NCT01318590|Endosonography|endosonography
1363632|NCT01318564|Type II Diabetes|type ii diabetes
1363633|NCT01318564|Unit dose packaging devices|unit dose packaging devices
1363634|NCT01318564|Metformin|metformin
1363635|NCT01318564|Lisinopril|lisinopril
1363636|NCT01318564|Enalapril|enalapril
1363637|NCT01318564|Atorvastatin|atorvastatin
1363638|NCT01318564|Lipitor|lipitor
1363639|NCT01318564|Simvastatin|simvastatin
1363640|NCT01318564|Aspirin|aspirin
1363641|NCT01318564|Questionnaires|questionnaires
1363642|NCT01318551|Anemia|anemia
1363643|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
1363644|NCT01318499|cataract|cataract
1363645|NCT01318499|inflammation|inflammation
1363646|NCT01318499|pain|pain
1363647|NCT01318499|inflammatory cells|inflammatory cells
1363648|NCT01318499|aqueous flare|aqueous flare
1363649|NCT01318473|cancer|cancer
1363650|NCT01318460|coronary artery disease|coronary artery disease
1363651|NCT01318460|levosimendan|levosimendan
1363652|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
1363653|NCT01318460|cardiac surgery|cardiac surgery
1363654|NCT01318447|Hepatic metastases|hepatic metastases
1363655|NCT01318447|Liver metastases|liver metastases
1363656|NCT01318447|Colorectal cancer|colorectal cancer
1363657|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
1363658|NCT01318447|Accuray|accuray
1363659|NCT01318447|CyberKnife|cyberknife
1363660|NCT01318434|Outpatient|outpatient
1363661|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
1363662|NCT01318356|Q fever|q fever
1363663|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
1363664|NCT01318356|Doxycycline|doxycycline
1363665|NCT01318356|Fatigue|fatigue
1363666|NCT01318356|Coxiella|coxiella
1363667|NCT01318343|Cryolipolysis|cryolipolysis
1364765|NCT01314521|Adolescents|adolescents
1363668|NCT01318343|Abdominal Fat|abdominal fat
1363669|NCT01318343|Adipose Tissue|adipose tissue
1363670|NCT01318343|Fat Reduction|fat reduction
1363671|NCT01318343|Non Invasive|non invasive
1363672|NCT01318304|innate immunity|innate immunity
1363673|NCT01318304|HIV|hiv
1363674|NCT01318304|pregnancy|pregnancy
1363675|NCT01318304|vaginal immunity|vaginal immunity
1363676|NCT01318291|IVF|ivf
1363677|NCT01318291|Drop out|drop out
1363678|NCT01318278|Hypotension|hypotension
1363679|NCT01318278|Low blood pressure|low blood pressure
1363680|NCT01318278|Neonate|neonate
1363681|NCT01318278|Dopamine|dopamine
1363682|NCT01318278|Vasopressin|vasopressin
1363683|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
1363684|NCT01318265|drug interactions|drug interactions
1363685|NCT01318265|ketoconazole|ketoconazole
1363686|NCT01318265|pharmacokinetics|pharmacokinetics
1363687|NCT01318265|human volunteers|human volunteers
1363688|NCT01318252|Elevated IOP|elevated iop
1363689|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
1363690|NCT01318226|shingles|shingles
1363691|NCT01318226|analgesia|analgesia
1363692|NCT01318226|neuropathic pain|neuropathic pain
1363693|NCT01318213|VRE|vre
1363694|NCT01318213|MRSA|mrsa
1363695|NCT01318200|Primary liver cancer|primary liver cancer
1363696|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
1363697|NCT01318200|CyberKnife|cyberknife
1363698|NCT01318200|Accuray|accuray
1363699|NCT01318200|TACE|tace
1363700|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
1363701|NCT01318187|renal colic|renal colic
1363702|NCT01318187|paracetamol|paracetamol
1363703|NCT01318187|morphine|morphine
1363704|NCT01318187|emergency department|emergency department
1363705|NCT01318174|Pulmonary embolism|pulmonary embolism
1363706|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1363707|NCT01318161|Epidural analgesia|epidural analgesia
1363708|NCT01318161|Patient controlled analgesia|patient controlled analgesia
1363709|NCT01318161|Colorectal cancer|colorectal cancer
1363710|NCT01318161|Morbidity|morbidity
1363711|NCT01318161|Mortality|mortality
1363712|NCT01318148|Echinocandins|echinocandins
1363713|NCT01318148|Caspofungin|caspofungin
1363714|NCT01318148|Pharmacokinetics|pharmacokinetics
1363715|NCT01318148|Prophylaxis|prophylaxis
1363716|NCT01318148|Antifungal|antifungal
1363717|NCT01318148|Aspergillosis|aspergillosis
1363718|NCT01318148|Acute Leucemia|acute leucemia
1363719|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1363720|NCT01318135|Diabetes Mellitus|diabetes mellitus
1363721|NCT01318135|Drug Therapy|drug therapy
1363722|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1363723|NCT01318122|Diabetes Mellitus|diabetes mellitus
1363724|NCT01318122|Drug Therapy|drug therapy
1363725|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1363726|NCT01318109|Diabetes Mellitus|diabetes mellitus
1363727|NCT01318109|Drug Therapy|drug therapy
1363728|NCT01318096|safety|safety
1363729|NCT01318096|efficacy|efficacy
1363730|NCT01318096|raltegravir|raltegravir
1363731|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
1363732|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1363733|NCT01318083|Diabetes Mellitus|diabetes mellitus
1363734|NCT01318083|Drug Therapy|drug therapy
1363735|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
1363736|NCT01318070|Diabetes Mellitus|diabetes mellitus
1363737|NCT01318070|Drug Therapy|drug therapy
1363738|NCT01318057|Pharmacogenetics|pharmacogenetics
1363739|NCT01318057|Warfarin|warfarin
1363740|NCT01318057|Personalized Medicine|personalized medicine
1363741|NCT01318057|Puerto Ricans|puerto ricans
1363742|NCT01318057|Physiogenomics|physiogenomics
1363743|NCT01318057|Hispanics|hispanics
1363744|NCT01318057|Anticoagulants|anticoagulants
1363745|NCT01318057|Cardiovascular|cardiovascular
1363746|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
1363747|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
1363748|NCT01318044|thiopental|thiopental
1363749|NCT01318044|propofol|propofol
1363750|NCT01318044|sedation|sedation
1363752|NCT01318031|DDI|ddi
1363753|NCT01318031|Healthy Volunteers|healthy volunteers
1363754|NCT01318018|depression|depression
1363755|NCT01318018|bispectral index|bispectral index
1363756|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
1363757|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
1363758|NCT01317992|Medication overuse headache|medication overuse headache
1363759|NCT01317992|ibudilast|ibudilast
1363760|NCT01317992|glia|glia
1363761|NCT01317940|Leukemia|leukemia
1363762|NCT01317940|ALL|all
1363763|NCT01317940|Vitamin D|vitamin d
1363764|NCT01317940|Bone Density|bone density
1363765|NCT01317940|Body Fat|body fat
1363766|NCT01317940|Obesity|obesity
1363767|NCT01317940|Adipose|adipose
1363768|NCT01317927|belionstat|belionstat
1363769|NCT01317927|warfarin|warfarin
1363770|NCT01317927|hematological malignancy|hematological malignancy
1363771|NCT01317927|solid tumors|solid tumors
1363772|NCT01317927|PK/PD study|pk/pd study
1363773|NCT01317901|follicular lymphoma|follicular lymphoma
1363774|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
1363775|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
1363776|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1363777|NCT01317901|indolent lymphoma|indolent lymphoma
1363778|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
1363779|NCT01317888|anti-body treatment|anti-body treatment
1363780|NCT01317888|survival|survival
1363781|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
1363782|NCT01317849|folic acid|folic acid
1363783|NCT01317849|B vitamins|b vitamins
1363784|NCT01317849|secondary prevention|secondary prevention
1363785|NCT01317849|stroke|stroke
1363786|NCT01317849|randomized controlled trial|randomized controlled trial
1363787|NCT01317849|homocysteine|homocysteine
1363788|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
1363789|NCT01317836|PET|pet
1363790|NCT01317836|PET-CT|pet-ct
1363791|NCT01317836|diagnosis|diagnosis
1363792|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
1363793|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
1363794|NCT01317810|Observational|observational
1363795|NCT01317810|Registry|registry
1363796|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
1363797|NCT01317797|MT203|mt203
1363798|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
1363799|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
1363800|NCT01317784|diagnosis screening|diagnosis screening
1363801|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
1363802|NCT01317784|HCV antibodies|hcv antibodies
1363803|NCT01317784|serologic tests|serologic tests
1363804|NCT01317784|Bedside testing|bedside testing
1363805|NCT01317784|diagnostic test kits|diagnostic test kits
1363806|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
1363807|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
1363808|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
1363809|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
1363810|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
1363811|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
1363812|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
1363813|NCT01317693|LI-ESWT|li-eswt
1363814|NCT01317693|Erectile Dysfunction|erectile dysfunction
1363815|NCT01317693|ED|ed
1363816|NCT01317693|Shock waves|shock waves
1363817|NCT01317693|Therapy|therapy
1363818|NCT01317680|Erectile Dysfunction|erectile dysfunction
1363819|NCT01317680|ED|ed
1363820|NCT01317680|PDE5 inhibitors|pde5 inhibitors
1363821|NCT01317680|LI-ESWT|li-eswt
1363822|NCT01317667|Ricin|ricin
1363823|NCT01317667|RVEc|rvec
1363824|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
1363825|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
1363826|NCT01317615|Large cell carcinoma,|large cell carcinoma,
1363827|NCT01317615|Lung cancer,|lung cancer,
1363828|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
1363829|NCT01317615|RAD001|rad001
1363830|NCT01317602|Atrial Fibrillation|atrial fibrillation
1363832|NCT01317589|Pain|pain
1363833|NCT01317589|Cancer of Head and Neck|cancer of head and neck
1363834|NCT01317589|methadone|methadone
1363835|NCT01317589|Fentanyl|fentanyl
1363836|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1363837|NCT01317576|Exercise|exercise
1363838|NCT01317563|asthma|asthma
1363839|NCT01317563|obesity|obesity
1363840|NCT01317563|nutrition|nutrition
1363841|NCT01317563|antioxidant|antioxidant
1363842|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
1363843|NCT01317550|NSCLC|nsclc
1363844|NCT01317550|Symptoms|symptoms
1363845|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
1363846|NCT01317550|CXRT|cxrt
1363847|NCT01317550|Fatigue|fatigue
1363848|NCT01317550|Pain|pain
1363849|NCT01317550|Disturbed Sleep|disturbed sleep
1363850|NCT01317550|Lack of Appetite|lack of appetite
1363851|NCT01317550|Drowsiness|drowsiness
1363852|NCT01317550|Armodafinil|armodafinil
1363853|NCT01317550|Nuvigil|nuvigil
1363854|NCT01317550|Minocycline|minocycline
1363855|NCT01317550|Dynacin|dynacin
1363856|NCT01317550|Minocin|minocin
1363857|NCT01317550|Minocin PAC|minocin pac
1363858|NCT01317550|Myrac|myrac
1363859|NCT01317550|Solodyn|solodyn
1363860|NCT01317550|Placebo|placebo
1363861|NCT01317537|personal health records|personal health records
1363862|NCT01317524|Milk|milk
1363863|NCT01317524|Homogenization|homogenization
1363864|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
1363865|NCT01317524|Postprandial inflammation|postprandial inflammation
1363866|NCT01317524|Overweight|overweight
1363867|NCT01317498|ART|art
1363868|NCT01317498|antiretroviral|antiretroviral
1363869|NCT01317498|treatment|treatment
1363870|NCT01317498|Vietnam|vietnam
1363871|NCT01317498|Asia|asia
1363872|NCT01317498|viral load|viral load
1363873|NCT01317485|diverticulitis|diverticulitis
1363874|NCT01317485|perforation|perforation
1363875|NCT01317485|sigmoidectomy|sigmoidectomy
1363876|NCT01317485|sigmoid resection|sigmoid resection
1363877|NCT01317485|lavage|lavage
1363878|NCT01317485|laparoscopic|laparoscopic
1363879|NCT01317485|wash-out|wash-out
1363881|NCT01317485|hartmann|hartmann
1363882|NCT01317485|end-colostomy|end-colostomy
1363883|NCT01317485|primary anastomosis|primary anastomosis
1363981|NCT01316991|chewing gum|chewing gum
1363884|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
1363885|NCT01317459|Self management|self management
1363886|NCT01317459|Diabetes type one|diabetes type one
1363887|NCT01317459|Empowerment|empowerment
1363888|NCT01317459|Intrinsic motivation|intrinsic motivation
1363889|NCT01317446|gingivitis index|gingivitis index
1363890|NCT01317446|plaque index|plaque index
1363891|NCT01317446|discoloration index|discoloration index
1363892|NCT01317446|mouth rinse|mouth rinse
1363893|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
1363894|NCT01317446|clinical trial|clinical trial
1363895|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
1363896|NCT01317433|K-RAS wild-type|k-ras wild-type
1363897|NCT01317433|FOLFIRI|folfiri
1363898|NCT01317433|Cetuximab|cetuximab
1363899|NCT01317407|postoperative delirium|postoperative delirium
1363900|NCT01317394|non-albicans candidemia|non-albicans candidemia
1363901|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
1363902|NCT01317368|TAP block|tap block
1363903|NCT01317368|Prostatectomy|prostatectomy
1363904|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
1363905|NCT01317355|Cancer|cancer
1363906|NCT01317355|Symptom burden|symptom burden
1363907|NCT01317355|Symptom cluster|symptom cluster
1363908|NCT01317355|Distress|distress
1363909|NCT01317355|Pain|pain
1363910|NCT01317355|Fatigue|fatigue
1363911|NCT01317355|Sleep disorder|sleep disorder
1363912|NCT01317355|HRQoL|hrqol
1363913|NCT01317342|liver transplantation|liver transplantation
1363914|NCT01317342|machine liver perfusion|machine liver perfusion
1363915|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
1363916|NCT01317342|donation after cardiac death|donation after cardiac death
1363917|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
1363918|NCT01317342|liver reperfusion injury|liver reperfusion injury
1363919|NCT01317303|paired associative stimulation|paired associative stimulation
1363920|NCT01317303|theta burst stimulation|theta burst stimulation
1363921|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
1363922|NCT01317303|neuroplasticity|neuroplasticity
1363923|NCT01317303|healthy controls|healthy controls
1363924|NCT01317290|Conversion of ALA|conversion of ala
1363925|NCT01317277|interventions|interventions
1363926|NCT01317277|technology|technology
1363927|NCT01317277|drug abuse|drug abuse
1363928|NCT01317277|methamphetamine|methamphetamine
1363929|NCT01317264|β-glucan|β-glucan
1363930|NCT01317264|cholesterol|cholesterol
1363931|NCT01317264|bile acids|bile acids
1363932|NCT01317264|blood glucose|blood glucose
1363933|NCT01317264|appetite|appetite
1363934|NCT01317251|Obesity prevention|obesity prevention
1363935|NCT01317251|appetite regulation|appetite regulation
1363936|NCT01317251|hyperlipidemia|hyperlipidemia
1363937|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
1363938|NCT01317225|Progesterone|progesterone
1363939|NCT01317225|Obstetric labor, premature|obstetric labor, premature
1363940|NCT01317225|Short cervix|short cervix
1363941|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
1363942|NCT01317212|Carboplatin|carboplatin
1363943|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
1363944|NCT01317199|Rising psa|rising psa
1363945|NCT01317186|FGF 23|fgf 23
1363946|NCT01317186|ADMA|adma
1363947|NCT01317186|chronic kidney disease|chronic kidney disease
1363948|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
1363949|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
1363950|NCT01317173|FGF 23|fgf 23
1363951|NCT01317173|Klotho|klotho
1363952|NCT01317160|Achilles Tendon|achilles tendon
1363953|NCT01317160|Immobilization|immobilization
1363954|NCT01317160|Wound Healing|wound healing
1363955|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
1363956|NCT01317160|Ultrasonography|ultrasonography
1363957|NCT01317160|Microdialysis|microdialysis
1363958|NCT01317147|pharmacokinetics|pharmacokinetics
1363959|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
1363960|NCT01317147|gastric bypass|gastric bypass
1363961|NCT01317147|depression|depression
1363962|NCT01317147|bioavailability|bioavailability
1363963|NCT01317147|drug absorption|drug absorption
1363964|NCT01317147|area under curve|area under curve
1363965|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1363966|NCT01317134|Prognostic factors|prognostic factors
1363967|NCT01317134|Signal transduction|signal transduction
1363968|NCT01317134|Genetics|genetics
1363969|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
1363970|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
1363971|NCT01317108|node-negative|node-negative
1363972|NCT01317095|Rigid fixation|rigid fixation
1363973|NCT01317095|Sternal closure|sternal closure
1363974|NCT01317095|Open heart surgery|open heart surgery
1363975|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
1363976|NCT01317017|Psoriasis|psoriasis
1363977|NCT01317004|Multiple sclerosis|multiple sclerosis
1363978|NCT01317004|Fingolimod|fingolimod
1363979|NCT01317004|Disease Modifying Therapy|disease modifying therapy
1363980|NCT01317004|TSQM-9|tsqm-9
1363982|NCT01316991|appetite|appetite
1363983|NCT01316991|hunger|hunger
1363984|NCT01316991|satiety|satiety
1363985|NCT01316991|metabolic|metabolic
1363986|NCT01316991|nutrition|nutrition
1363987|NCT01316991|gut peptide hormones|gut peptide hormones
1363988|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
1363989|NCT01316965|Postoperative delirium|postoperative delirium
1363990|NCT01316965|elderly|elderly
1363991|NCT01316965|prevention|prevention
1363992|NCT01316965|stepped wedge design|stepped wedge design
1363993|NCT01316965|healthcare workers|healthcare workers
1363994|NCT01316952|carvedilol|carvedilol
1363995|NCT01316952|propranolol|propranolol
1363996|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
1363997|NCT01316952|beta- blockers|beta- blockers
1363998|NCT01316952|Coreg|coreg
1363999|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
1364000|NCT01316926|fast condition|fast condition
1364001|NCT01316926|Paroxetine reference/test|paroxetine reference/test
1364002|NCT01316926|healthy volunteers|healthy volunteers
1364003|NCT01316926|Bioequivalence|bioequivalence
1364004|NCT01316913|tiotropium|tiotropium
1364005|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1364006|NCT01316913|COPD|copd
1364007|NCT01316913|long-acting beta agonist|long-acting beta agonist
1364008|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1364009|NCT01316900|tiotropium|tiotropium
1364010|NCT01316900|COPD|copd
1364011|NCT01316900|long-acting beta agonist|long-acting beta agonist
1364012|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1364013|NCT01316887|COPD|copd
1364014|NCT01316887|nDPI|ndpi
1364015|NCT01316887|long-acting beta agonist|long-acting beta agonist
1364016|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
1364017|NCT01316887|tolerability|tolerability
1364018|NCT01316887|safety|safety
1364019|NCT01316874|Valrubicin|valrubicin
1364020|NCT01316874|CIS|cis
1364021|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
1364022|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
1364023|NCT01316848|AV-951|av-951
1364024|NCT01316848|tivozanib|tivozanib
1364025|NCT01316848|healthy Subjects|healthy subjects
1364026|NCT01316848|food Effect|food effect
1364027|NCT01316848|pharmacokinetics|pharmacokinetics
1567119|NCT00509951|Evidence-Based Treatment|evidence-based treatment
1364028|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
1364029|NCT01316822|CSF1R|csf1r
1364030|NCT01316822|M-CSF|m-csf
1364031|NCT01316822|CSF-1|csf-1
1364032|NCT01316822|c-FMS|c-fms
1364033|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
1364034|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
1364035|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
1364036|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
1364037|NCT01316809|Brain|brain
1364038|NCT01316809|Tumor|tumor
1364039|NCT01316809|Recurrent|recurrent
1364040|NCT01316809|Surgery|surgery
1364041|NCT01316809|Radiation|radiation
1364042|NCT01316809|Glioma|glioma
1364043|NCT01316809|Brain Tumor|brain tumor
1364044|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
1364045|NCT01316809|Astrocytoma|astrocytoma
1364046|NCT01316809|Brainstem Glioma|brainstem glioma
1364047|NCT01316796|Sickle Cell Disease|sickle cell disease
1364048|NCT01316796|Hemolysis|hemolysis
1364049|NCT01316796|Anemia|anemia
1364050|NCT01316796|Nitric Oxide|nitric oxide
1364051|NCT01316796|Blood Flow|blood flow
1364052|NCT01316796|Leg Ulcer|leg ulcer
1364053|NCT01316796|Sickle Cell Anemia|sickle cell anemia
1364054|NCT01316796|Thalassemia|thalassemia
1364055|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
1364056|NCT01316783|Africans|africans
1364057|NCT01316783|Obesity|obesity
1364058|NCT01316783|Diabetes|diabetes
1364059|NCT01316783|Heart Disease|heart disease
1364060|NCT01316783|Genetic|genetic
1364061|NCT01316783|African Descent|african descent
1364062|NCT01316783|Cardiovascular Disease|cardiovascular disease
1364063|NCT01316770|Xerostomia|xerostomia
1364064|NCT01316770|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
1364065|NCT01316770|Interventional Study|interventional study
1364066|NCT01316770|Sjogren Syndrome|sjogren syndrome
1364067|NCT01316770|Dry Mouth|dry mouth
1364068|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1364069|NCT01316744|anxiety disorder|anxiety disorder
1364070|NCT01316744|depression|depression
1364072|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1364073|NCT01316744|neuropathy|neuropathy
1364074|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1364075|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
1364076|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1364282|NCT01316471|Internet Interventions|internet interventions
1364077|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1364078|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1364079|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1364080|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1364081|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1364082|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1364083|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1364084|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1364085|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1364086|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1364087|NCT01316744|mast cell leukemia|mast cell leukemia
1364088|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1364089|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1364090|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
1364091|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1364092|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1364093|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1364094|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1364095|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
1364096|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1364097|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1364098|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1364099|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1364100|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1364101|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1364102|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1364103|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1364104|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1364105|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1364106|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1364107|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1364108|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1364109|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1364110|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1364111|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1364112|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1364113|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1364114|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1364115|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1364116|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1364117|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1364118|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1364119|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1364120|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1364121|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1364122|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1364123|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1364124|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1364125|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1364126|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1364127|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1364128|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1364129|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1364130|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1364131|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1364132|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1364133|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1364134|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1364135|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1364136|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1364137|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1364138|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1364139|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1364387|NCT01316133|Proteinuria|proteinuria
1364140|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1364141|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1364142|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1364143|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1364144|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1364145|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1364146|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1364147|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1364148|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1364149|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1364150|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1364151|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1364152|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1364153|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1364154|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1364155|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1364156|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1364157|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1364158|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1364159|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1364160|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1364161|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1364162|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1364163|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1364164|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1567120|NCT00509951|Clinical Investigation|clinical investigation
1364165|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1364166|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1364167|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1364168|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1364169|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1364170|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1364171|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1364172|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1364173|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1364174|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1364175|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1364176|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1364177|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1364178|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1364179|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1364180|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1364181|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1364182|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1364183|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1364184|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1364185|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1364186|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1364187|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1364188|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1364189|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1364190|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1364191|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1364192|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1365137|NCT01312857|liver|liver
1364193|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1364194|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1364195|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1364196|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1364197|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1364198|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1364199|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1364283|NCT01316471|Behavioral Interventions|behavioral interventions
1364200|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1364201|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1364202|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1364203|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1364204|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1364205|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1364206|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1364207|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1364208|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1364209|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1364210|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1364211|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1364212|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1364213|NCT01316744|intraocular lymphoma|intraocular lymphoma
1364214|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1364215|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1364216|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1364217|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1364218|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1364219|NCT01316744|primary myelofibrosis|primary myelofibrosis
1364220|NCT01316744|essential thrombocythemia|essential thrombocythemia
1364221|NCT01316744|polycythemia vera|polycythemia vera
1364222|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
1364223|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1364224|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
1364225|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
1364226|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
1364227|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
1364228|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
1364229|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1364230|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1364231|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1364232|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1364234|NCT01316718|diarrhoea|diarrhoea
1364235|NCT01316679|HCC|hcc
1364236|NCT01316679|Liver Disease without HCC|liver disease without hcc
1364237|NCT01316666|orthostatic hypotension|orthostatic hypotension
1364238|NCT01316666|Multiple System Atrophy|multiple system atrophy
1364239|NCT01316666|Pure Autonomic Failure|pure autonomic failure
1364240|NCT01316666|Parkinson's Disease|parkinson's disease
1364241|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
1364242|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
1364243|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
1364244|NCT01316627|Mirror Retraining|mirror retraining
1364245|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
1364246|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
1364247|NCT01316614|Stylet|stylet
1364248|NCT01316614|Solid Mass|solid mass
1364249|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
1364250|NCT01316588|recolonization|recolonization
1364251|NCT01316588|Plastic adhesive drape|plastic adhesive drape
1364252|NCT01316588|microbial sealant|microbial sealant
1364253|NCT01316588|SSI|ssi
1364254|NCT01316588|bacterial growth|bacterial growth
1364255|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
1364256|NCT01316575|Postoperative Complications|postoperative complications
1364257|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
1364258|NCT01316575|Colorectal Surgery|colorectal surgery
1364259|NCT01316549|fludarabine|fludarabine
1364260|NCT01316549|pharmacokinetics|pharmacokinetics
1364261|NCT01316549|pediatric|pediatric
1364262|NCT01316549|allogeneic|allogeneic
1364263|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
1364264|NCT01316536|pain, agitation, music|pain, agitation, music
1364265|NCT01316523|Lenalidomide|lenalidomide
1364266|NCT01316523|Rituximab|rituximab
1364267|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
1364268|NCT01316510|Probiotic|probiotic
1364269|NCT01316510|bifidobacteria|bifidobacteria
1364270|NCT01316510|intestinal motility|intestinal motility
1364271|NCT01316497|Acute kidney injury|acute kidney injury
1364272|NCT01316497|Ischemic preconditioning|ischemic preconditioning
1364273|NCT01316497|Congenital heart defects|congenital heart defects
1364274|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
1364275|NCT01316497|Infant|infant
1364276|NCT01316497|Child|child
1364277|NCT01316484|Cognitive Debriefing|cognitive debriefing
1364278|NCT01316471|Chronic Pain|chronic pain
1364279|NCT01316471|Abdominal Pain|abdominal pain
1364280|NCT01316471|Headache|headache
1364281|NCT01316471|Adolescents|adolescents
1364284|NCT01316458|Prostate cancer,|prostate cancer,
1364285|NCT01316458|radical prostatectomy,|radical prostatectomy,
1364286|NCT01316458|PSA rise|psa rise
1364287|NCT01316445|Electroencephalography|electroencephalography
1364288|NCT01316445|Benzodiazepines|benzodiazepines
1364289|NCT01316445|Midazolam|midazolam
1364290|NCT01316432|Cenderitide|cenderitide
1364291|NCT01316432|CD-NP|cd-np
1364292|NCT01316432|Natriuretic peptide|natriuretic peptide
1364293|NCT01316432|Heart failure|heart failure
1364294|NCT01316432|Chronic heart failure|chronic heart failure
1364296|NCT01316432|CHF|chf
1364297|NCT01316406|safety|safety
1364298|NCT01316406|efficacy|efficacy
1364299|NCT01316406|treatment|treatment
1364300|NCT01316406|PPES|ppes
1364301|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
1364302|NCT01316406|Hand-foot syndrome|hand-foot syndrome
1364303|NCT01316406|capecitabine|capecitabine
1364304|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
1364305|NCT01316367|Health Promotion Education|health promotion education
1364306|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1364307|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
1364308|NCT01316367|Spain|spain
1364309|NCT01316354|Arabinoxylan|arabinoxylan
1364310|NCT01316354|Beta glucan|beta glucan
1364311|NCT01316354|Whole grain|whole grain
1364312|NCT01316354|Dietary fibre|dietary fibre
1364313|NCT01316354|Metabolic syndrome|metabolic syndrome
1364314|NCT01316354|Glycemic index|glycemic index
1364315|NCT01316354|Satiety|satiety
1364316|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
1364317|NCT01316302|Social Anxiety Disorder|social anxiety disorder
1364318|NCT01316302|Social Phobia|social phobia
1364319|NCT01316302|SAD|sad
1364320|NCT01316289|tibial fractures|tibial fractures
1364321|NCT01316289|pilon|pilon
1364322|NCT01316289|pilon fractures|pilon fractures
1364323|NCT01316289|tibial plafond|tibial plafond
1364324|NCT01316289|reduction quality|reduction quality
1364325|NCT01316289|anatomical reduction|anatomical reduction
1364326|NCT01316289|functional outcome|functional outcome
1364327|NCT01316289|ankle joint|ankle joint
1364328|NCT01316276|Cystic Fibrosis|cystic fibrosis
1364329|NCT01316276|Respiratory Infections|respiratory infections
1364330|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1364331|NCT01316276|CFTR|cftr
1364332|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
1364333|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
1364334|NCT01316250|nilotinib|nilotinib
1364335|NCT01316250|complete cytogenetic response|complete cytogenetic response
1364336|NCT01316250|imatinib mesylate|imatinib mesylate
1364337|NCT01316237|Hepatitis C|hepatitis c
1364338|NCT01316237|HCV|hcv
1364339|NCT01316237|HCV RNA|hcv rna
1364340|NCT01316237|Polymerase inhibitor|polymerase inhibitor
1364341|NCT01316237|Treatment naïve|treatment naïve
1364342|NCT01316237|GS-6620|gs-6620
1364343|NCT01316224|Psoriasis|psoriasis
1364344|NCT01316224|Incidence|incidence
1364345|NCT01316224|Quality of Life|quality of life
1364346|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
1364347|NCT01316224|Prevalence|prevalence
1364348|NCT01316211|Back Pains|back pains
1364349|NCT01316211|Pain, Back|pain, back
1364350|NCT01316211|Pains, Back|pains, back
1364351|NCT01316211|Backache|backache
1364352|NCT01316211|Backaches|backaches
1364353|NCT01316211|Back Ache|back ache
1364354|NCT01316211|Ache, Back|ache, back
1364355|NCT01316211|Aches, Back|aches, back
1364356|NCT01316211|Back Aches|back aches
1364357|NCT01316211|Back Pain without Radiation|back pain without radiation
1364358|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
1364359|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
1364360|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
1364361|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
1364362|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
1364363|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
1364364|NCT01316211|Back Pain with Radiation|back pain with radiation
1364365|NCT01316211|Stenosis, spinal|stenosis, spinal
1364366|NCT01316211|Caudal stenosis|caudal stenosis
1364367|NCT01316211|Spondylopathy|spondylopathy
1364368|NCT01316211|Spondylopathies|spondylopathies
1364369|NCT01316211|Low back pain|low back pain
1364370|NCT01316211|Lower back pain|lower back pain
1364371|NCT01316198|human study|human study
1364372|NCT01316198|AMD|amd
1364373|NCT01316198|lutein|lutein
1364374|NCT01316198|zeaxanthin|zeaxanthin
1365934|NCT01309412|siltuximab|siltuximab
1364375|NCT01316198|optical density|optical density
1364376|NCT01316185|Hepatitis D|hepatitis d
1364377|NCT01316185|HDV|hdv
1364378|NCT01316185|Hepatitis|hepatitis
1364379|NCT01316172|consultation|consultation
1364380|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
1364381|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1364382|NCT01316146|Lymphoma|lymphoma
1364383|NCT01316146|T lymphocytes|t lymphocytes
1364384|NCT01316133|Tacrolimus|tacrolimus
1364385|NCT01316133|Prograf|prograf
1364386|NCT01316133|FK506|fk506
1364388|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
1364389|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
1364390|NCT01316120|HPV|hpv
1364391|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
1364392|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
1364393|NCT01316107|ASP1941|asp1941
1364394|NCT01316107|Diabetes mellitus|diabetes mellitus
1364395|NCT01316107|nateglinide|nateglinide
1364396|NCT01316107|long-term safety|long-term safety
1364397|NCT01316094|Renal impairment|renal impairment
1364398|NCT01316094|ASP1941|asp1941
1364399|NCT01316094|Pharmacokinetics|pharmacokinetics
1364400|NCT01316081|antioxidant supplementation|antioxidant supplementation
1364401|NCT01316081|childhood obesity|childhood obesity
1364402|NCT01316081|hepcidin|hepcidin
1364403|NCT01316081|iron status|iron status
1364404|NCT01316081|oxidative stress|oxidative stress
1364405|NCT01316081|inflammation|inflammation
1364406|NCT01316068|diabetic nephropathy|diabetic nephropathy
1364407|NCT01316068|albuminuria|albuminuria
1364408|NCT01316068|type 2 diabetes|type 2 diabetes
1364409|NCT01316068|sulodexide|sulodexide
1364410|NCT01316042|Puberty|puberty
1364411|NCT01316042|Hormones|hormones
1364412|NCT01316029|Laying-on-of-hands|laying-on-of-hands
1364413|NCT01316029|Therapeutic touch|therapeutic touch
1364414|NCT01316029|cross-sectional study|cross-sectional study
1364415|NCT01316029|healing environment|healing environment
1364416|NCT01316029|safety and effectiveness|safety and effectiveness
1364417|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
1364418|NCT01316016|obesity|obesity
1364419|NCT01316016|glucose intolerance|glucose intolerance
1364420|NCT01316016|cholesterol|cholesterol
1364421|NCT01316016|blood pressure|blood pressure
1364422|NCT01316003|cone outer segment tips line|cone outer segment tips line
1364423|NCT01316003|Optical coherence tomography|optical coherence tomography
1364424|NCT01315990|Phase IV Study|phase iv study
1567426|NCT00509184|untreated|untreated
1364425|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
1364426|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
1364427|NCT01315990|first-line treatment|first-line treatment
1364428|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
1364429|NCT01315990|rash|rash
1364430|NCT01315990|vitamin K1|vitamin k1
1364431|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1364432|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
1364433|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
1364434|NCT01315964|cholesterol|cholesterol
1364435|NCT01315964|plant sterols|plant sterols
1364436|NCT01315964|atherosclerosis|atherosclerosis
1364437|NCT01315964|arterial stiffness|arterial stiffness
1364438|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
1364439|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
1364440|NCT01315925|invasive fungal infection|invasive fungal infection
1364441|NCT01315925|Aspergillosis|aspergillosis
1364442|NCT01315925|candidiasis|candidiasis
1364443|NCT01315912|clomiphene citrate|clomiphene citrate
1364444|NCT01315912|infertility|infertility
1364445|NCT01315912|letrozole|letrozole
1364446|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
1364447|NCT01315899|Systemic sclerosis|systemic sclerosis
1364448|NCT01315886|sublingual|sublingual
1364449|NCT01315886|fentanyl|fentanyl
1364450|NCT01315886|titration|titration
1364451|NCT01315886|conversion|conversion
1364452|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
1364453|NCT01315886|pain intensity difference|pain intensity difference
1364455|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
1364456|NCT01315886|ESAS|esas
1364457|NCT01315873|myeloma|myeloma
1364458|NCT01315873|multiple myeloma|multiple myeloma
1364459|NCT01315873|relapsed myeloma|relapsed myeloma
1364460|NCT01315873|refractory myeloma|refractory myeloma
1364461|NCT01315860|Low Back Pain|low back pain
1364462|NCT01315860|Pregnancy|pregnancy
1364463|NCT01315860|Biomechanics|biomechanics
1364464|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
1364465|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
1364466|NCT01315795|polycystic liver disease|polycystic liver disease
1364467|NCT01315782|Sepsis|sepsis
1364468|NCT01315782|Severe sepsis|severe sepsis
1364469|NCT01315782|Septic shock|septic shock
1364470|NCT01315782|Alveolar dead space|alveolar dead space
1364471|NCT01315782|Multi-organ failure|multi-organ failure
1364472|NCT01315730|stuttering|stuttering
1364473|NCT01315730|haptic|haptic
1364474|NCT01315730|feedback|feedback
1364475|NCT01315730|fluency|fluency
1364476|NCT01315691|Cystic Fibrosis|cystic fibrosis
1364477|NCT01315691|Respiratory Infections|respiratory infections
1364478|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1364479|NCT01315691|Amikacin|amikacin
1364480|NCT01315691|Anti-bacterial agents|anti-bacterial agents
1364481|NCT01315678|Cystic Fibrosis|cystic fibrosis
1364482|NCT01315678|Respiratory Infections|respiratory infections
1364483|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1364484|NCT01315678|CFTR|cftr
1364485|NCT01315678|Amikacin|amikacin
1364486|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
1364487|NCT01315665|broccoli sprouts|broccoli sprouts
1364488|NCT01315665|sulforaphane|sulforaphane
1364489|NCT01315665|triterpenoid|triterpenoid
1364490|NCT01315665|Nrf2 activation|nrf2 activation
1364491|NCT01315665|cystic fibrosis|cystic fibrosis
1364492|NCT01315665|healthy volunteers|healthy volunteers
1364493|NCT01315665|anti-inflammatory|anti-inflammatory
1364494|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
1364495|NCT01315652|2 Education|2 education
1364496|NCT01315652|3 Co-morbidities|3 co-morbidities
1364497|NCT01315652|4 Nurse|4 nurse
1364498|NCT01315639|Dementia|dementia
1364499|NCT01315639|Cognitive impairment|cognitive impairment
1364500|NCT01315639|Memory impairment|memory impairment
1364501|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
1364502|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
1364503|NCT01315639|Plasma|plasma
1364504|NCT01315639|Biomarker|biomarker
1364505|NCT01315639|Longitudinal|longitudinal
1364506|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
1364507|NCT01315639|Oculomotor impairment|oculomotor impairment
1364508|NCT01315626|Bronchiectasis|bronchiectasis
1364509|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
1364510|NCT01315626|pulmonary infections|pulmonary infections
1364511|NCT01315574|Glaucoma|glaucoma
1364512|NCT01315574|Xalatan|xalatan
1364513|NCT01315574|Travatan Z|travatan z
1364514|NCT01315574|Latanoprost|latanoprost
1364515|NCT01315574|Travoprost|travoprost
1364516|NCT01315574|Dry Eye|dry eye
1364517|NCT01315561|acute low back pain|acute low back pain
1364518|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
1364519|NCT01315561|disability|disability
1364520|NCT01315561|MSAT|msat
1364521|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
1364522|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1364523|NCT01315548|Chronic pancreatitis|chronic pancreatitis
1364524|NCT01315535|Mandibular Advancement|mandibular advancement
1364525|NCT01315535|Oral Appliance|oral appliance
1364526|NCT01315535|TMD|tmd
1364527|NCT01315522|Stents|stents
1364528|NCT01315522|Endoscopy|endoscopy
1364529|NCT01315522|Cholangiopancreatography|cholangiopancreatography
1364530|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
1364531|NCT01315509|Severe mental illness|severe mental illness
1364532|NCT01315509|Dental measures|dental measures
1364533|NCT01315509|Resistant depression|resistant depression
1364534|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
1364535|NCT01315496|Sepsis|sepsis
1364536|NCT01315496|Septic shock|septic shock
1364537|NCT01315483|Breast cancer|breast cancer
1364538|NCT01315483|survivors|survivors
1364539|NCT01315483|weight lose|weight lose
1364540|NCT01315483|dietary pattern|dietary pattern
1364541|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
1364542|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
1364543|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
1364544|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
1364545|NCT01315418|infections - firemen|infections - firemen
1364546|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
1364547|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
1364548|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
1364549|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
1364550|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
1364551|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
1364552|NCT01315405|Emotional facial expression|emotional facial expression
1364553|NCT01315405|Apathy|apathy
1364554|NCT01315405|Mirror neurons|mirror neurons
1364555|NCT01315379|Prolonged Exposure|prolonged exposure
1364556|NCT01315379|CBT|cbt
1364557|NCT01315379|PTSD|ptsd
1364558|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
1364559|NCT01315379|Post Concussive Syndrome|post concussive syndrome
1364560|NCT01315366|Vitamin D|vitamin d
1364561|NCT01315366|Elderly|elderly
1364562|NCT01315366|Cardiovascular profile|cardiovascular profile
1364563|NCT01315366|Insulin resistance|insulin resistance
1364564|NCT01315366|Gene polymorphisms|gene polymorphisms
1364565|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
1364566|NCT01315314|Glucose degradation products|glucose degradation products
1365935|NCT01309412|bortezomib|bortezomib
1364567|NCT01315314|Inflammation|inflammation
1364568|NCT01315314|Endothelial dysfunction|endothelial dysfunction
1364569|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
1364570|NCT01315314|Peritoneal dialysis|peritoneal dialysis
1364571|NCT01315301|Efavirenz|efavirenz
1364572|NCT01315301|Rifampicin|rifampicin
1364573|NCT01315301|HAART|haart
1364574|NCT01315301|Anti Tuberculosis|anti tuberculosis
1364575|NCT01315288|Medical decision making|medical decision making
1364576|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
1364577|NCT01315275|visual impairment|visual impairment
1364578|NCT01315275|macular edema|macular edema
1364579|NCT01315275|ranibizumab|ranibizumab
1364580|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
1364581|NCT01315262|Sildenafil 100|sildenafil 100
1364582|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
1364583|NCT01315249|QVA149|qva149
1364584|NCT01315249|indacaterol|indacaterol
1364585|NCT01315249|NVA237|nva237
1364586|NCT01315249|COPD|copd
1364587|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
1364588|NCT01315210|Fibromyalgia|fibromyalgia
1364589|NCT01315210|Fatigue|fatigue
1364590|NCT01315210|D-Ribose|d-ribose
1364591|NCT01315197|Low back Pain|low back pain
1364592|NCT01315184|Interactive Voice Response|interactive voice response
1364593|NCT01315184|Computer-based Treatment|computer-based treatment
1364594|NCT01315184|Opioid Agonist|opioid agonist
1364595|NCT01315184|Buprenorphine|buprenorphine
1364596|NCT01315184|Methadone|methadone
1364597|NCT01315171|medium chain triglycerides|medium chain triglycerides
1364598|NCT01315171|hypoglycemia|hypoglycemia
1364599|NCT01315171|cognitive function|cognitive function
1364600|NCT01315171|functional MRI|functional mri
1364601|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
1364602|NCT01315158|Body Mass Index|body mass index
1364603|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
1364604|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
1364605|NCT01315132|2 Step Approach|2 step approach
1364606|NCT01315132|Hematological malignancies|hematological malignancies
1364607|NCT01315132|leukemia|leukemia
1364608|NCT01315132|lymphoma|lymphoma
1364609|NCT01315132|multiple myeloma|multiple myeloma
1364610|NCT01315132|Hodgkin's Disease|hodgkin's disease
1364611|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
1364612|NCT01315093|poor responders|poor responders
1364613|NCT01315080|mammillary fistula|mammillary fistula
1364614|NCT01315080|triamcinolone|triamcinolone
1364615|NCT01315080|ultrasound management|ultrasound management
1364616|NCT01315080|percutaneous treatment|percutaneous treatment
1364617|NCT01315067|kidney transplantation|kidney transplantation
1364618|NCT01315067|acute rejection|acute rejection
1364619|NCT01315067|diagnosis|diagnosis
1364620|NCT01315067|urine analysis|urine analysis
1364621|NCT01315067|urinary peptides|urinary peptides
1364622|NCT01315067|mass spectrometry|mass spectrometry
1364623|NCT01315067|allograft biopsy|allograft biopsy
1364624|NCT01315067|pathology|pathology
1364625|NCT01315067|diagnostic study|diagnostic study
1364626|NCT01315054|IDUs|idus
1364627|NCT01315054|high risk behaviors|high risk behaviors
1364628|NCT01315054|HIV|hiv
1364629|NCT01315054|MMT dosage and retention|mmt dosage and retention
1364630|NCT01315054|psychosocial services|psychosocial services
1364631|NCT01315028|mania|mania
1364632|NCT01315028|hypomania|hypomania
1364633|NCT01315028|bipolar affective disorder|bipolar affective disorder
1364634|NCT01315028|psychological intervention|psychological intervention
1364635|NCT01315028|cognitive therapy|cognitive therapy
1364636|NCT01315015|Breast cancer|breast cancer
1364637|NCT01315015|Breast neoplasm|breast neoplasm
1364638|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
1364639|NCT01315015|Breast density|breast density
1364640|NCT01315015|Early detection of cancer|early detection of cancer
1364641|NCT01315015|Cancer screening test|cancer screening test
1364642|NCT01315015|Secondary prevention|secondary prevention
1364643|NCT01315002|nicotine|nicotine
1364644|NCT01315002|schizophrenia|schizophrenia
1364645|NCT01315002|endophenotype|endophenotype
1364646|NCT01314976|Children|children
1364647|NCT01314976|parasite|parasite
1364648|NCT01314976|intestinal|intestinal
1364649|NCT01314976|treatment|treatment
1364650|NCT01314976|RCT|rct
1364651|NCT01314937|preschool-age children|preschool-age children
1364652|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
1364653|NCT01314937|growth|growth
1364654|NCT01314937|development|development
1364655|NCT01314937|deworming|deworming
1364656|NCT01314924|Hypertension|hypertension
1364657|NCT01314924|Endothelial dysfunction|endothelial dysfunction
1364658|NCT01314924|Vascular stiffness|vascular stiffness
1364659|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
1364660|NCT01314911|H1N1|h1n1
1364661|NCT01314911|Complications|complications
1364662|NCT01314911|PCR|pcr
1364663|NCT01314911|Seasonal Influenza|seasonal influenza
1364664|NCT01314911|Viral Shedding|viral shedding
1364665|NCT01314898|Single dose|single dose
1364666|NCT01314898|cross-over|cross-over
1364667|NCT01314898|active-control|active-control
1364668|NCT01314898|placebo control|placebo control
1364669|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
1364670|NCT01314885|Healthy|healthy
1364671|NCT01314872|Overactive bladder|overactive bladder
1364672|NCT01314872|MK-4618|mk-4618
1364673|NCT01314872|tolterodine|tolterodine
1364674|NCT01314859|Nifedipine|nifedipine
1364675|NCT01314859|Obstetric Labor|obstetric labor
1364676|NCT01314859|Premature|premature
1364677|NCT01314859|Tocolysis|tocolysis
1364678|NCT01314833|Luminal A|luminal a
1364679|NCT01314833|Luminal B|luminal b
1365252|NCT01312441|Vitamin D|vitamin d
1364680|NCT01314833|Her-2 overexpression|her-2 overexpression
1364681|NCT01314833|DFS|dfs
1364682|NCT01314833|DDFS|ddfs
1364683|NCT01314833|OS|os
1364684|NCT01314820|Knee|knee
1364685|NCT01314820|Osteoarthritis|osteoarthritis
1364686|NCT01314820|Effusion.|effusion.
1364687|NCT01314807|COPD|copd
1364688|NCT01314781|Overactive Bladder|overactive bladder
1364689|NCT01314781|urinary frequency|urinary frequency
1364690|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
1364691|NCT01314755|Nutrition|nutrition
1364692|NCT01314755|Carcinoma|carcinoma
1364693|NCT01314755|Infection|infection
1364694|NCT01314755|Post-operative|post-operative
1364695|NCT01314755|Surgery|surgery
1364696|NCT01314755|Immune-enhancing|immune-enhancing
1364697|NCT01314742|neonates|neonates
1364698|NCT01314742|mechanical ventilation|mechanical ventilation
1364699|NCT01314742|oral care|oral care
1364700|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
1364701|NCT01314742|feasibility|feasibility
1364702|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
1364703|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
1364704|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
1364705|NCT01314729|composite-wire retainer|composite-wire retainer
1364706|NCT01314690|obesity|obesity
1364707|NCT01314690|low calorie diet|low calorie diet
1364708|NCT01314690|intestinal microbiota|intestinal microbiota
1364709|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
1364710|NCT01314690|fat mass|fat mass
1567121|NCT00509951|Young Patients|young patients
1482066|NCT00848692|CFS|cfs
1364711|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
1364712|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
1364713|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
1364714|NCT01314664|CIS|cis
1364715|NCT01314664|BCG Refractory|bcg refractory
1364716|NCT01314651|Migraine Disorders|migraine disorders
1364717|NCT01314651|Chronic migraine|chronic migraine
1364718|NCT01314651|Insomnia|insomnia
1364719|NCT01314651|Behavioral sleep management|behavioral sleep management
1364720|NCT01314612|Insomnia|insomnia
1364721|NCT01314612|group psychotherapy|group psychotherapy
1364722|NCT01314612|nightmares|nightmares
1364723|NCT01314612|PTSD|ptsd
1364724|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
1364725|NCT01314612|Veterans|veterans
1364726|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
1364727|NCT01314599|Leukemia|leukemia
1364728|NCT01314599|lurbinectedin|lurbinectedin
1364729|NCT01314599|PM01183|pm01183
1364730|NCT01314599|Pharma Mar|pharma mar
1364731|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
1364732|NCT01314586|hypercholesterolemia|hypercholesterolemia
1364733|NCT01314586|postmenopause|postmenopause
1364734|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
1364735|NCT01314586|flaxseed|flaxseed
1364736|NCT01314586|lignans|lignans
1364737|NCT01314586|enterolactone|enterolactone
1364738|NCT01314586|enterodiol|enterodiol
1364739|NCT01314586|serum cholesterol|serum cholesterol
1364740|NCT01314586|LDL cholesterol|ldl cholesterol
1364741|NCT01314573|High intensity exercise training|high intensity exercise training
1364742|NCT01314573|Vascular health|vascular health
1364743|NCT01314573|Endothelial function|endothelial function
1364744|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
1364745|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
1364746|NCT01314573|Aerobic capacity|aerobic capacity
1364747|NCT01314573|Arterial stiffness|arterial stiffness
1364748|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
1364749|NCT01314560|Lowe syndrome|lowe syndrome
1364750|NCT01314560|OCRL|ocrl
1364751|NCT01314560|Haemostasis|haemostasis
1364752|NCT01314560|Bleeding Disorders|bleeding disorders
1364753|NCT01314560|Platelet Function Tests|platelet function tests
1364754|NCT01314547|Environment|environment
1364755|NCT01314547|spondylarthritis|spondylarthritis
1364756|NCT01314547|vasculitis|vasculitis
1364757|NCT01314547|stress|stress
1364758|NCT01314547|life event|life event
1364759|NCT01314547|vaccine|vaccine
1364760|NCT01314534|Kabuki syndrome|kabuki syndrome
1364761|NCT01314534|Genetic|genetic
1364762|NCT01314534|CGH-array|cgh-array
1364763|NCT01314521|Suicide|suicide
1364766|NCT01314508|pre-pubertal children|pre-pubertal children
1364767|NCT01314508|pre-transplant|pre-transplant
1364768|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
1364769|NCT01314495|Alopecia Areata|alopecia areata
1364770|NCT01314482|Neuropathic pain|neuropathic pain
1364771|NCT01314482|Minocycline|minocycline
1364772|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
1364773|NCT01314456|Prostate biopsy|prostate biopsy
1364774|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
1365346|NCT01311960|bevacizumab|bevacizumab
1364775|NCT01314456|Prostate cancer|prostate cancer
1364776|NCT01314443|smoking cessation|smoking cessation
1364777|NCT01314443|gamma-tocopherol|gamma-tocopherol
1364778|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
1364779|NCT01314443|oxidative stress|oxidative stress
1364780|NCT01314417|Uveitis|uveitis
1364781|NCT01314417|Macular Edema|macular edema
1364782|NCT01314417|Methotrexate|methotrexate
1364783|NCT01314404|Human papillomavirus|human papillomavirus
1364784|NCT01314404|Prevalence|prevalence
1364785|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
1364786|NCT01314404|Willingness to Participate|willingness to participate
1364787|NCT01314404|Vaccine|vaccine
1364788|NCT01314404|HPV|hpv
1364789|NCT01314391|stage I Wilms tumor|stage i wilms tumor
1364790|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
1364791|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
1364792|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
1364793|NCT01314391|stage V Wilms tumor|stage v wilms tumor
1364794|NCT01314391|renal failure|renal failure
1364795|NCT01314378|Mindfulness|mindfulness
1364796|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
1364797|NCT01314378|Smoking|smoking
1364798|NCT01314378|Impulsivity|impulsivity
1364799|NCT01314378|Inhibitory Control|inhibitory control
1364800|NCT01314326|Optical Coherence Tomography|optical coherence tomography
1364801|NCT01314326|Glaucoma|glaucoma
1482201|NCT00848081|BPH|bph
1364802|NCT01314326|Advanced Imaging|advanced imaging
1364803|NCT01314313|SAPIEN XT|sapien xt
1364804|NCT01314313|SAPIEN 3|sapien 3
1364805|NCT01314313|Transfemoral|transfemoral
1364806|NCT01314313|Transapical|transapical
1364807|NCT01314313|Transaortic|transaortic
1364808|NCT01314313|NovaFlex|novaflex
1364809|NCT01314313|TAVI|tavi
1364810|NCT01314313|Aortic Stenosis|aortic stenosis
1364811|NCT01314313|THV|thv
1364812|NCT01314313|Aortic Valve|aortic valve
1364813|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
1364814|NCT01314313|tAVR|tavr
1364815|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
1364816|NCT01314300|Plaster|plaster
1364817|NCT01314300|Lidocaine|lidocaine
1364818|NCT01314287|Anaesthesia|anaesthesia
1364819|NCT01314287|pulmonary complications|pulmonary complications
1364820|NCT01314287|Atelectasis|atelectasis
1364821|NCT01314274|Epistaxis|epistaxis
1364822|NCT01314274|Osler|osler
1364823|NCT01314274|Weber|weber
1364824|NCT01314274|Rendu|rendu
1364825|NCT01314274|HHT|hht
1364826|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
1364827|NCT01314248|airway sealing pressure|airway sealing pressure
1364828|NCT01314248|fiberoptic assessment|fiberoptic assessment
1364829|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
1364830|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
1364831|NCT01314248|complications were also evaluated|complications were also evaluated
1364832|NCT01314235|anticoagulation with ASS|anticoagulation with ass
1364833|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
1364834|NCT01314209|dexmedetomidine|dexmedetomidine
1364835|NCT01314209|pharmacokinetics|pharmacokinetics
1364836|NCT01314209|critical illness|critical illness
1364837|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
1364838|NCT01314196|biceps|biceps
1364839|NCT01314196|resistance training|resistance training
1364840|NCT01314196|rehabilitation|rehabilitation
1364841|NCT01314196|impact syndrome|impact syndrome
1364842|NCT01314183|Knee|knee
1364843|NCT01314183|Physical Therapy|physical therapy
1364844|NCT01314183|Exercise|exercise
1364845|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
1364846|NCT01314157|low back pain|low back pain
1364847|NCT01314157|pain|pain
1364848|NCT01314157|incapacity|incapacity
1364849|NCT01314157|life quality|life quality
1364850|NCT01314157|rehabilitation|rehabilitation
1364851|NCT01314144|axillary clearance|axillary clearance
1364852|NCT01314144|wound infiltration|wound infiltration
1364853|NCT01314144|wound infusion|wound infusion
1364854|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
1364855|NCT01314118|abiraterone acetate|abiraterone acetate
1364856|NCT01314118|prednisone|prednisone
1364857|NCT01314118|zytiga|zytiga
1364858|NCT01314092|crohn's disease|crohn's disease
1364859|NCT01314092|fistula|fistula
1364860|NCT01314092|complex|complex
1364861|NCT01314079|Crohn's fistula|crohn's fistula
1364962|NCT01313598|Treatment-refractory|treatment-refractory
1364862|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
1364863|NCT01314053|Daptomycin|daptomycin
1364864|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
1364865|NCT01314040|Dietary protein|dietary protein
1364866|NCT01314040|Biomarkers|biomarkers
1364867|NCT01314040|filtration rate|filtration rate
1364868|NCT01314040|urinary acid excretion|urinary acid excretion
1364869|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1364870|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
1364871|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
1364872|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
1364873|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
1364976|NCT01313546|Femoral nerve block|femoral nerve block
1364874|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
1364875|NCT01313988|dose-response study|dose-response study
1364876|NCT01313988|blood lipid profile|blood lipid profile
1364877|NCT01313988|plant sterols|plant sterols
1364878|NCT01313988|fish oil|fish oil
1364879|NCT01313975|Electrolyte disturbances|electrolyte disturbances
1364880|NCT01313975|Fluid balance|fluid balance
1364881|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
1364882|NCT01313975|traumatic brain injury|traumatic brain injury
1364883|NCT01313975|Cerebral salt wasting|cerebral salt wasting
1364884|NCT01313975|SIADH|siadh
1364885|NCT01313975|Diabetes insipidus|diabetes insipidus
1364886|NCT01313962|antiviral|antiviral
1364887|NCT01313962|intranasal|intranasal
1364888|NCT01313962|influenza|influenza
1364889|NCT01313949|Diabetes|diabetes
1364890|NCT01313949|Peer Support|peer support
1364891|NCT01313949|Structured Care|structured care
1364892|NCT01313936|Neuroblastoma|neuroblastoma
1364893|NCT01313936|MIBG|mibg
1364894|NCT01313936|131I-MIBG|131i-mibg
1364895|NCT01313936|Irinotecan|irinotecan
1364896|NCT01313936|Vincristine|vincristine
1364897|NCT01313936|Resistant|resistant
1364898|NCT01313936|Relapsed|relapsed
1364899|NCT01313936|Treatment|treatment
1364900|NCT01313936|UCSF|ucsf
1364901|NCT01313936|Pediatric|pediatric
1364902|NCT01313936|Oncology|oncology
1364903|NCT01313923|Pemphigus|pemphigus
1364904|NCT01313910|HIV|hiv
1364905|NCT01313910|diarrhea|diarrhea
1364906|NCT01313897|Multiple Myeloma|multiple myeloma
1364907|NCT01313832|ventricular septal defect|ventricular septal defect
1364908|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
1364909|NCT01313832|pulmonary hypertension|pulmonary hypertension
1364910|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
1364911|NCT01313819|Freezing|freezing
1364912|NCT01313806|dementia|dementia
1364913|NCT01313806|memory loss|memory loss
1364914|NCT01313806|cognitive decline|cognitive decline
1364915|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
1364916|NCT01313793|Healthy Volunteers|healthy volunteers
1364917|NCT01313780|cancer related pain|cancer related pain
1364918|NCT01313767|spasticity|spasticity
1364919|NCT01313767|upperlimb|upperlimb
1364920|NCT01313767|Botulinum toxin|botulinum toxin
1364921|NCT01313754|Skin closure|skin closure
1364922|NCT01313754|dermabond|dermabond
1364923|NCT01313754|vicryl|vicryl
1364924|NCT01313754|monocryl|monocryl
1364925|NCT01313754|Suburethral sling|suburethral sling
1364926|NCT01313754|Transobturator Sling|transobturator sling
1364927|NCT01313754|Pain|pain
1364928|NCT01313754|Discomfort|discomfort
1364929|NCT01313754|Skin irritation|skin irritation
1364930|NCT01313728|Acne|acne
1364931|NCT01313728|Irritation|irritation
1364932|NCT01313715|Safety|safety
1364933|NCT01313715|Immunogenicity|immunogenicity
1364934|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
1364935|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
1364936|NCT01313689|OMB157|omb157
1364937|NCT01313689|Lymphocytic|lymphocytic
1364938|NCT01313689|Chronic|chronic
1364939|NCT01313689|Safety|safety
1364940|NCT01313689|Refractory|refractory
1365175|NCT01312740|effect on weight loss|effect on weight loss
1364941|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1364942|NCT01313689|Oncology|oncology
1364943|NCT01313689|Ofatumumab|ofatumumab
1364944|NCT01313689|Efficacy|efficacy
1364945|NCT01313689|Physicians' Choice|physicians' choice
1364946|NCT01313689|Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia|bulky fludarabine refractory chronic lymphocytic leukemia
1364948|NCT01313676|COPD|copd
1364949|NCT01313676|Cardiovascular disease|cardiovascular disease
1364950|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
1364951|NCT01313676|Survival|survival
1364952|NCT01313663|GW786034|gw786034
1364953|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
1364954|NCT01313663|NSCLC|nsclc
1364955|NCT01313663|pemetrexed|pemetrexed
1364956|NCT01313663|pazopanib|pazopanib
1364957|NCT01313650|long-acting beta agonist|long-acting beta agonist
1364958|NCT01313650|anticholinergic|anticholinergic
1364959|NCT01313637|anticholinergic|anticholinergic
1364960|NCT01313637|long-acting beta agonist|long-acting beta agonist
1364961|NCT01313598|Patients with solid tumors|patients with solid tumors
1364963|NCT01313585|Primary care|primary care
1364964|NCT01313585|asthma management|asthma management
1364965|NCT01313585|inhaler device|inhaler device
1364966|NCT01313585|maintenance therapy|maintenance therapy
1364967|NCT01313585|reliever therapy|reliever therapy
1364968|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
1364969|NCT01313572|Coronary Artery Disease|coronary artery disease
1364970|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
1364971|NCT01313559|Castrate Resistant|castrate resistant
1364972|NCT01313559|Chemotherapy Naive|chemotherapy naive
1364973|NCT01313559|Prostate Cancer|prostate cancer
1364974|NCT01313559|SOM230|som230
1364975|NCT01313559|Everolimus|everolimus
1364977|NCT01313546|total knee arthroplasty|total knee arthroplasty
1364978|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
1364979|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
1364980|NCT01313507|PID|pid
1364981|NCT01313494|COPD|copd
1364982|NCT01313494|Roflumilast|roflumilast
1364983|NCT01313494|FEV1|fev1
1364984|NCT01313494|China|china
1364985|NCT01313481|Older persons|older persons
1364986|NCT01313481|Exercise|exercise
1364987|NCT01313481|Balance|balance
1364988|NCT01313468|NEAT|neat
1364989|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
1364990|NCT01313468|stroke volume|stroke volume
1364991|NCT01313455|Oligomenorrhea|oligomenorrhea
1364992|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
1364993|NCT01313455|Obesity|obesity
1364994|NCT01313455|Hyperandrogenism|hyperandrogenism
1364995|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1364996|NCT01313455|PCOS|pcos
1364997|NCT01313455|Polycystic Ovary|polycystic ovary
1364998|NCT01313455|Healthy Volunteer|healthy volunteer
1364999|NCT01313455|HV|hv
1365000|NCT01313442|Gut Microbiota|gut microbiota
1365001|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
1365003|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
1365004|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
1365005|NCT01313429|Metastatic Cancer|metastatic cancer
1365006|NCT01313429|Cancer Vaccine|cancer vaccine
1365007|NCT01313429|Immunotherapy|immunotherapy
1365008|NCT01313429|Adjuvant Therapy|adjuvant therapy
1365009|NCT01313429|Chest Metastases|chest metastases
1365010|NCT01313429|Cancer|cancer
1365011|NCT01313429|Melanoma|melanoma
1365012|NCT01313429|Lung Cancer|lung cancer
1365013|NCT01313429|Sarcoma|sarcoma
1365014|NCT01313416|Adjuvant Therapy|adjuvant therapy
1365015|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
1365016|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
1365017|NCT01313416|Vaccination|vaccination
1365018|NCT01313416|PD-1 Receptor|pd-1 receptor
1365019|NCT01313416|Pancreas Cancer|pancreas cancer
1365020|NCT01313416|Pancreatic Cancer|pancreatic cancer
1365021|NCT01313403|5-HT1A Receptors|5-ht1a receptors
1365022|NCT01313403|Major Depression|major depression
1365023|NCT01313403|PET Imaging|pet imaging
1365024|NCT01313403|Depression|depression
1365025|NCT01313403|Healthy Volunteer|healthy volunteer
1365026|NCT01313403|HV|hv
1365027|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1365028|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1365029|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1365030|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1365031|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1365032|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1365033|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1365034|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1365035|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1365036|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1365037|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1365038|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1365039|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1365040|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1365041|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1365042|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1365043|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1365044|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1365045|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1365046|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1365135|NCT01312857|colon|colon
1365136|NCT01312857|rectal|rectal
1365047|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1365048|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1365049|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1365050|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1365051|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1365052|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1365053|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
1365054|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1365055|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
1365056|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
1365057|NCT01313390|tongue cancer|tongue cancer
1365058|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1365059|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1365060|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1365061|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1365062|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1365063|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1365064|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
1365065|NCT01313325|hippotherapy|hippotherapy
1365066|NCT01313325|neuromuscular disorders|neuromuscular disorders
1365067|NCT01313325|balance deficits|balance deficits
1365068|NCT01313325|participation|participation
1365069|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1365070|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
1365071|NCT01313247|Paracetamol|paracetamol
1365073|NCT01313247|cancer pain|cancer pain
1365074|NCT01313221|plaque psoriasis|plaque psoriasis
1365075|NCT01313221|moderate|moderate
1365076|NCT01313221|severe|severe
1365077|NCT01313221|etanercept|etanercept
1365078|NCT01313221|Enbrel|enbrel
1365079|NCT01313221|topical|topical
1365081|NCT01313208|Enbrel|enbrel
1365082|NCT01313208|DMARD|dmard
1365083|NCT01313208|Joint Count|joint count
1365084|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
1365085|NCT01313208|Etanercept|etanercept
1365086|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
1365087|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
1365088|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
1365089|NCT01313156|Type 2 Diabetes|type 2 diabetes
1365090|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
1365091|NCT01313130|traumatic brain injury|traumatic brain injury
1365092|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
1365093|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
1365094|NCT01313130|resting state functional connectivity|resting state functional connectivity
1365095|NCT01313130|genetic factors|genetic factors
1365096|NCT01313117|chemotherapy|chemotherapy
1365097|NCT01313117|peripheral neuropathy|peripheral neuropathy
1365098|NCT01313117|paclitaxel|paclitaxel
1365099|NCT01313117|breast cancer|breast cancer
1365100|NCT01313078|Ovarian Cancer|ovarian cancer
1365101|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
1365102|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
1365103|NCT01313078|Relapsed or Refractory|relapsed or refractory
1365104|NCT01313078|Pegaspargase|pegaspargase
1365105|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
1365106|NCT01313065|VX15/2503|vx15/2503
1365107|NCT01313065|Semaphorin 4D|semaphorin 4d
1365108|NCT01313065|SEMA4D|sema4d
1365109|NCT01313065|CD100|cd100
1365110|NCT01313065|safety|safety
1365111|NCT01313065|tolerability|tolerability
1365112|NCT01313065|pharmacokinetics|pharmacokinetics
1365113|NCT01313065|pharmacodynamics|pharmacodynamics
1365114|NCT01313065|advanced solid tumors|advanced solid tumors
1365115|NCT01313052|Psychotic|psychotic
1365116|NCT01313052|Criminal|criminal
1365117|NCT01313039|Breast Cancer|breast cancer
1365118|NCT01313039|ER-negative|er-negative
1365119|NCT01313039|Allred Score|allred score
1365120|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
1365121|NCT01313026|Transanal irrigation|transanal irrigation
1365122|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
1365123|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
1365124|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
1365125|NCT01312948|OSA|osa
1365126|NCT01312948|CPAP|cpap
1365127|NCT01312948|CPAP mask|cpap mask
1365128|NCT01312948|Non-invasive ventilation|non-invasive ventilation
1365129|NCT01312948|NIV|niv
1365130|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
1365131|NCT01312935|Heparin|heparin
1365132|NCT01312935|Angioplasty|angioplasty
1365133|NCT01312935|LMWH|lmwh
1365134|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
1365138|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
1365139|NCT01312857|DEXAMETHASONE|dexamethasone
1365140|NCT01312857|FLOXURIDINE|floxuridine
1365141|NCT01312857|FLUOROURACIL|fluorouracil
1365142|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1365143|NCT01312857|LEUCOVORIN|leucovorin
1365144|NCT01312857|10-137|10-137
1365145|NCT01312831|cobalamin|cobalamin
1365146|NCT01312831|B12|b12
1365147|NCT01312831|homocysteine|homocysteine
1365148|NCT01312831|MMA|mma
1365149|NCT01312831|holotranscobalamin|holotranscobalamin
1365150|NCT01312831|Eligen|eligen
1365151|NCT01312805|asthma|asthma
1365152|NCT01312805|clinical decision support|clinical decision support
1365153|NCT01312805|CHICA|chica
1365154|NCT01312792|Severe Pneumonia|severe pneumonia
1365155|NCT01312792|Pneumonia|pneumonia
1365156|NCT01312792|ARI|ari
1365157|NCT01312792|IMCI|imci
1365158|NCT01312792|Modified IMCI|modified imci
1365159|NCT01312792|1st level Health facilities|1st level health facilities
1365160|NCT01312792|Children|children
1365161|NCT01312792|Operational Research|operational research
1365162|NCT01312792|Bangladesh|bangladesh
1365163|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
1365164|NCT01312779|Mitral Valve Replacement|mitral valve replacement
1365165|NCT01312779|23mm CEP|23mm cep
1365166|NCT01312779|Magna|magna
1365167|NCT01312740|obesity|obesity
1365168|NCT01312740|dietary treatment|dietary treatment
1365169|NCT01312740|high protein diet|high protein diet
1365170|NCT01312740|Low glycaemic index|low glycaemic index
1365171|NCT01312740|adipocytes|adipocytes
1365172|NCT01312740|fat mass|fat mass
1365173|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
1365174|NCT01312740|improvement of complications|improvement of complications
1365176|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
1365177|NCT01312727|Hereditary renal diseases|hereditary renal diseases
1365178|NCT01312727|Uromodulin|uromodulin
1365179|NCT01312727|Renin gene|renin gene
1365180|NCT01312714|Hemodialysis|hemodialysis
1365181|NCT01312714|Peritoneal dialysis|peritoneal dialysis
1365182|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
1365183|NCT01312714|blood pressure|blood pressure
1365184|NCT01312714|arterial stiffness|arterial stiffness
1365185|NCT01312714|Heart function|heart function
1365186|NCT01312714|Renin-angiotensin system|renin-angiotensin system
1365188|NCT01312714|FGF-23|fgf-23
1365189|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
1365190|NCT01312701|cancer|cancer
1365191|NCT01312701|immunomonitoring|immunomonitoring
1365192|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
1365193|NCT01312701|chronic inflamation|chronic inflamation
1365194|NCT01312701|anticancertherapy|anticancertherapy
1365195|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
1365196|NCT01312675|severe sepsis|severe sepsis
1365197|NCT01312675|mechanical ventilation|mechanical ventilation
1365198|NCT01312610|orange juice|orange juice
1365199|NCT01312610|cognitive function|cognitive function
1365200|NCT01312610|flavonoids|flavonoids
1365201|NCT01312610|flavanones|flavanones
1365202|NCT01312597|Flavonoid|flavonoid
1365203|NCT01312597|Cognitive performance|cognitive performance
1365204|NCT01312597|Cognitive function|cognitive function
1365205|NCT01312597|Executive function|executive function
1365206|NCT01312597|fMRI|fmri
1365207|NCT01312597|Cerebral blood flow|cerebral blood flow
1365208|NCT01312597|Acute|acute
1365209|NCT01312584|Flavanol|flavanol
1365210|NCT01312584|Cocoa|cocoa
1365211|NCT01312584|Vascular function|vascular function
1365212|NCT01312584|Absorption|absorption
1365213|NCT01312584|Metabolism|metabolism
1365214|NCT01312584|Alkalisation|alkalisation
1365215|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
1365216|NCT01312558|Mediterranean diet|mediterranean diet
1365217|NCT01312558|exercise|exercise
1365218|NCT01312558|weight loss|weight loss
1365219|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
1365220|NCT01312558|lipid peroxidation|lipid peroxidation
1365221|NCT01312545|orbital implant|orbital implant
1365222|NCT01312545|evisceration|evisceration
1365223|NCT01312545|economic|economic
1365224|NCT01312545|polyethylene|polyethylene
1365225|NCT01312545|porous|porous
1365226|NCT01312532|Total knee arthroplasty|total knee arthroplasty
1365227|NCT01312532|Fixed-bearing|fixed-bearing
1365228|NCT01312532|Mobile-bearing|mobile-bearing
1365229|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
1365230|NCT01312506|metastatic|metastatic
1365231|NCT01312506|melanoma|melanoma
1365232|NCT01312506|CNS|cns
1365233|NCT01312493|Head and neck cancer|head and neck cancer
1365234|NCT01312493|Phase II|phase ii
1365235|NCT01312493|Locally advanced|locally advanced
1365236|NCT01312493|Panitumumab|panitumumab
1365237|NCT01312493|Vectibix|vectibix
1365238|NCT01312493|Lineberger|lineberger
1365239|NCT01312493|Radiation Therapy|radiation therapy
1365240|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
1365241|NCT01312493|Stage III to IVB|stage iii to ivb
1365242|NCT01312480|Tobacco|tobacco
1365243|NCT01312480|Tobacco Prevention|tobacco prevention
1365244|NCT01312480|Tobacco Cessation|tobacco cessation
1365245|NCT01312480|5A's Model|5a's model
1365246|NCT01312480|Adolescence|adolescence
1365247|NCT01312480|Media Use|media use
1365248|NCT01312454|intravitreal injection|intravitreal injection
1365249|NCT01312454|intraocular pressure|intraocular pressure
1365250|NCT01312454|open-angle glaucoma|open-angle glaucoma
1365251|NCT01312454|ocular hypertension|ocular hypertension
1365253|NCT01312441|Ergocalciferol|ergocalciferol
1365254|NCT01312415|total knee arthroplasty|total knee arthroplasty
1365255|NCT01312415|total knee replacement|total knee replacement
1365256|NCT01312415|local infiltration analgesia|local infiltration analgesia
1365257|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
1365258|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
1365259|NCT01312363|Alzheimer's disease|alzheimer's disease
1365260|NCT01312363|Rivastigmine|rivastigmine
1365261|NCT01312363|Patch|patch
1365262|NCT01312363|Tolerability|tolerability
1365263|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1365264|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
1365265|NCT01312350|head and neck cancer|head and neck cancer
1365266|NCT01312350|base of tongue|base of tongue
1365267|NCT01312350|Locally advanced|locally advanced
1365268|NCT01312337|gefitinib|gefitinib
1365269|NCT01312337|EGFR mutation negative|egfr mutation negative
1365270|NCT01312337|NSCLC|nsclc
1365271|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1365272|NCT01312324|thymic cancer|thymic cancer
1365273|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
1365274|NCT01312311|weekly docetaxel|weekly docetaxel
1365275|NCT01312311|cisplatin|cisplatin
1365276|NCT01312298|Arthritis|arthritis
1365277|NCT01312298|General anaesthesia|general anaesthesia
1365278|NCT01312298|Spinal anaesthesia|spinal anaesthesia
1365279|NCT01312285|osteoarthritis|osteoarthritis
1365280|NCT01312285|painful hips|painful hips
1365281|NCT01312272|Schizophrenia|schizophrenia
1365282|NCT01312272|Social Intelligence|social intelligence
1365283|NCT01312272|Perception, Social|perception, social
1365284|NCT01312272|Oxytocin|oxytocin
1365285|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
1365286|NCT01312259|Interstitial Cystitis|interstitial cystitis
1365287|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
1365288|NCT01312259|Fecal incontinence|fecal incontinence
1365289|NCT01312259|Constipation|constipation
1365290|NCT01312259|Sexual dysfunction|sexual dysfunction
1365291|NCT01312259|Dyspareunia|dyspareunia
1365292|NCT01312259|Vulvodynia|vulvodynia
1365293|NCT01312246|vessel ligation|vessel ligation
1365294|NCT01312246|colon resection|colon resection
1365295|NCT01312207|tractional retinoschisis|tractional retinoschisis
1365296|NCT01312207|traction retinal detachment|traction retinal detachment
1365297|NCT01312194|Periapical Periodontitis|periapical periodontitis
1365298|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
1365299|NCT01312194|Root canal Therapy|root canal therapy
1365300|NCT01312194|Adolescent|adolescent
1365301|NCT01312181|Technology based intervention|technology based intervention
1365302|NCT01312181|HIV primary care clinic|hiv primary care clinic
1365303|NCT01312181|Brief behavioral intervention|brief behavioral intervention
1365304|NCT01312181|Drug abuse|drug abuse
1365305|NCT01312168|Cardiovascular disease|cardiovascular disease
1365306|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
1365307|NCT01312168|Endothelium|endothelium
1365308|NCT01312168|Vascular function|vascular function
1365309|NCT01312168|Inflammation|inflammation
1365310|NCT01312168|Sleep Apnea|sleep apnea
1365311|NCT01312168|Obstructive|obstructive
1365312|NCT01312155|endotracheal|endotracheal
1365313|NCT01312155|intubation|intubation
1365314|NCT01312155|video|video
1365315|NCT01312155|time|time
1365316|NCT01312129|Alcohol|alcohol
1365317|NCT01312129|Sulfasalazine|sulfasalazine
1365318|NCT01312116|Internet treatment|internet treatment
1365320|NCT01312116|guided self-help|guided self-help
1365321|NCT01312103|Safety Planning|safety planning
1365322|NCT01312090|Weight loss|weight loss
1365323|NCT01312090|brown adipose tissue|brown adipose tissue
1365324|NCT01312090|white adipose tissue|white adipose tissue
1365325|NCT01312090|muscle, metabolism|muscle, metabolism
1365326|NCT01312090|cold exposure|cold exposure
1365327|NCT01312077|total hip arthroplasty|total hip arthroplasty
1365328|NCT01312077|total hip replacement|total hip replacement
1365329|NCT01312077|local infiltration analgesia|local infiltration analgesia
1365330|NCT01312077|wound infusion|wound infusion
1365331|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
1365332|NCT01312064|rituximab|rituximab
1365333|NCT01312064|everolimus|everolimus
1365334|NCT01312038|Eustachian tube|eustachian tube
1365335|NCT01312038|otitis|otitis
1365336|NCT01312038|middle-ear pressure|middle-ear pressure
1365337|NCT01312038|simethicone|simethicone
1365338|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
1365529|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
1365339|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
1365340|NCT01311986|atopic dermatitis|atopic dermatitis
1365341|NCT01311986|nummular eczema|nummular eczema
1365342|NCT01311986|chemokines|chemokines
1365343|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
1365344|NCT01311960|pterygium|pterygium
1365345|NCT01311960|recurrent pterygium|recurrent pterygium
1365347|NCT01311960|VEGF|vegf
1365348|NCT01311960|anti-VEGF|anti-vegf
1365349|NCT01311947|Chronic hepatitis B|chronic hepatitis b
1365350|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
1365351|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
1365352|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
1365353|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
1365354|NCT01311908|Reflux esophagitis|reflux esophagitis
1365355|NCT01311895|acute|acute
1365356|NCT01311895|pain|pain
1365357|NCT01311895|emergency department|emergency department
1365358|NCT01311895|hydromorphone|hydromorphone
1365359|NCT01311856|Behavioral intervention|behavioral intervention
1365360|NCT01311856|Exercise|exercise
1365361|NCT01311856|Physical Assessment|physical assessment
1482969|NCT00844987|HGF|hgf
1365362|NCT01311856|Questionnaire|questionnaire
1365363|NCT01311856|Survey|survey
1365364|NCT01311856|Telephone counseling|telephone counseling
1365365|NCT01311856|Internet interventions|internet interventions
1365366|NCT01311856|Overweight cancer survivors|overweight cancer survivors
1365367|NCT01311856|Exercise and weight management program|exercise and weight management program
1365368|NCT01311791|Left ventricular augmentation|left ventricular augmentation
1365369|NCT01311791|Left ventricular restoration|left ventricular restoration
1365370|NCT01311765|Postoperative peritonitis|postoperative peritonitis
1365371|NCT01311765|Intra-abdominal infection|intra-abdominal infection
1365372|NCT01311765|Surgery|surgery
1365373|NCT01311765|Laparotomy|laparotomy
1365374|NCT01311765|Nosocomial infection|nosocomial infection
1365375|NCT01311765|Antibiotic therapy|antibiotic therapy
1365376|NCT01311765|Duration of treatment|duration of treatment
1365377|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
1365378|NCT01311752|human papillomavirus|human papillomavirus
1365379|NCT01311752|follow up|follow up
1365380|NCT01311739|Pharmacokinetics|pharmacokinetics
1365381|NCT01311713|cancer|cancer
1365382|NCT01311713|tumors|tumors
1365383|NCT01311713|PARP|parp
1365384|NCT01311700|Ischemia|ischemia
1365385|NCT01311700|Reperfusion|reperfusion
1365386|NCT01311700|Myocardial infarction|myocardial infarction
1365387|NCT01311700|Beta blockers|beta blockers
1365388|NCT01311700|Metoprolol|metoprolol
1365389|NCT01311700|Acute myocardial infarction|acute myocardial infarction
1365390|NCT01311700|Necrosis|necrosis
1365391|NCT01311700|Salvaged Myocardium|salvaged myocardium
1365392|NCT01311687|Myeloma|myeloma
1365393|NCT01311687|Multiple Myeloma|multiple myeloma
1365394|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
1365395|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
1365396|NCT01311687|Refractory Myeloma|refractory myeloma
1365397|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
1365398|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
1365399|NCT01311687|Pomalidomide|pomalidomide
1365400|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
1365401|NCT01311687|Bortezomib-resistant|bortezomib-resistant
1365402|NCT01311648|recombinant factor VIII|recombinant factor viii
1365403|NCT01311648|pediatric use|pediatric use
1365404|NCT01311635|Phase 1|phase 1
1365405|NCT01311635|bioavailability study|bioavailability study
1365406|NCT01311635|AZD1981|azd1981
1365407|NCT01311635|tablets|tablets
1365408|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
1365409|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
1365410|NCT01311622|drug-drug interaction|drug-drug interaction
1365411|NCT01311622|Phase 1|phase 1
1365412|NCT01311622|healthy subjects|healthy subjects
1365413|NCT01311622|warfarin|warfarin
1365414|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
1365416|NCT01311622|fostamatinib open-label|fostamatinib open-label
1365417|NCT01311622|pharmacokinetics|pharmacokinetics
1365418|NCT01311622|pharmacodynamics|pharmacodynamics
1365419|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
1365420|NCT01311609|Systane, Dry Eye|systane, dry eye
1365421|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
1365422|NCT01311583|Self-care|self-care
1365423|NCT01311583|Teach Back|teach back
1365425|NCT01311557|Diphtheria|diphtheria
1365426|NCT01311557|Pertussis|pertussis
1365427|NCT01311557|Tdap vaccine|tdap vaccine
1365428|NCT01311557|Adacel®|adacel®
1365429|NCT01311531|Fracture|fracture
1365430|NCT01311531|Radius|radius
1365431|NCT01311531|Surgery|surgery
1365432|NCT01311531|Osteosynthesis|osteosynthesis
1365433|NCT01311518|Thymosin Beta 4|thymosin beta 4
1365434|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
1365435|NCT01311518|RGN-352|rgn-352
1365436|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
1365437|NCT01311492|Alzheimer's Disease|alzheimer's disease
1365438|NCT01311492|exercise|exercise
1365439|NCT01311492|physical activity|physical activity
1365440|NCT01311492|intervention|intervention
1365441|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
1365442|NCT01311479|Interstitial Cystitis|interstitial cystitis
1365443|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
1365444|NCT01311466|Liver transplantation|liver transplantation
1365445|NCT01311466|Overall survival|overall survival
1365446|NCT01311440|RCT|rct
1365447|NCT01311440|modified Atkins diet|modified atkins diet
1365448|NCT01311440|epilepsy|epilepsy
1365449|NCT01311440|adults|adults
1365450|NCT01311440|ketogenic diet|ketogenic diet
1365451|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
1365452|NCT01311388|cancer|cancer
1365453|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
1365454|NCT01311362|Steady-state|steady-state
1365455|NCT01311362|Ambrisentan|ambrisentan
1365456|NCT01311362|St. Johns Wort|st. johns wort
1365457|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
1365458|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
1365459|NCT01311336|Pegfilgrastim|pegfilgrastim
1365460|NCT01311336|Loratadine|loratadine
1365461|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
1365462|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
1365463|NCT01311323|Left Main Narrowing|left main narrowing
1365464|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
1365465|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1365466|NCT01311323|Drug-Eluting Stent|drug-eluting stent
1365467|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
1365468|NCT01311284|Nasotracheal intubation|nasotracheal intubation
1365469|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
1365470|NCT01311284|Airtraq|airtraq
1365471|NCT01311284|McGrath|mcgrath
1365472|NCT01311284|Manikin|manikin
1365473|NCT01311284|airway management|airway management
1365474|NCT01311271|Stroke|stroke
1365475|NCT01311271|Cerebrovascular disease|cerebrovascular disease
1365476|NCT01311271|hemiplegia|hemiplegia
1365477|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
1365478|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1365479|NCT01311271|rTMS|rtms
1365480|NCT01311271|rehabilitation|rehabilitation
1365481|NCT01311271|Upper Extremity|upper extremity
1365482|NCT01311258|AML|aml
1365483|NCT01311258|MDS|mds
1365484|NCT01311245|Risky drinking|risky drinking
1365485|NCT01311245|Brief intervention|brief intervention
1365486|NCT01311245|Computer-generated feedback|computer-generated feedback
1365487|NCT01311245|Stage-tailored|stage-tailored
1365488|NCT01311245|Non-stage-tailored|non-stage-tailored
1365489|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
1365490|NCT01311206|knee osteoarthritis|knee osteoarthritis
1365491|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
1365492|NCT01311206|quadriceps volume|quadriceps volume
1365493|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
1365494|NCT01311193|Circadian rhythms|circadian rhythms
1365495|NCT01311193|Sleep-wake cycles|sleep-wake cycles
1365496|NCT01311193|Melatonin|melatonin
1365497|NCT01311193|Borderline Personality Disorder|borderline personality disorder
1365498|NCT01311193|Light therapy|light therapy
1365499|NCT01311167|Dexamethasone|dexamethasone
1365500|NCT01311167|Sodium|sodium
1365501|NCT01311154|carriers|carriers
1365502|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
1365503|NCT01311154|AMR|amr
1365504|NCT01311154|antibiotic|antibiotic
1365505|NCT01311128|Blood pressure|blood pressure
1365506|NCT01311128|Heart rate|heart rate
1365507|NCT01311128|Cardiac output|cardiac output
1365508|NCT01311128|Critical care|critical care
1365509|NCT01311128|Perioperative care|perioperative care
1365510|NCT01311102|Pain score|pain score
1365511|NCT01311102|IUD placement|iud placement
1365512|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1365513|NCT01311076|Insulin|insulin
1365514|NCT01311076|Glucose|glucose
1365515|NCT01311076|Drug Therapy|drug therapy
1365516|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
1365517|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
1365518|NCT01311024|Children|children
1365519|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
1365520|NCT01311011|Critical Limb Ischemia|critical limb ischemia
1365521|NCT01310998|Schizophrenia|schizophrenia
1365522|NCT01310998|high intensity exercise|high intensity exercise
1365523|NCT01310998|interval training exercise|interval training exercise
1365524|NCT01310985|Rectal Cancer|rectal cancer
1365525|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
1365526|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
1365527|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1365528|NCT01310894|Prostatic Disease|prostatic disease
1365530|NCT01310894|Urogenital neoplasm|urogenital neoplasm
1365531|NCT01310894|Genital disease,male|genital disease,male
1365532|NCT01310894|Male urogenital disease|male urogenital disease
1365533|NCT01310894|Neoplasms|neoplasms
1365534|NCT01310894|Neoplasms by site|neoplasms by site
1365535|NCT01310894|Prostatic neoplasm|prostatic neoplasm
1365536|NCT01310894|Carcinoma|carcinoma
1365537|NCT01310881|Neurogenesis|neurogenesis
1365538|NCT01310881|hippocampal stem cells|hippocampal stem cells
1365539|NCT01310881|depression|depression
1365540|NCT01310881|stroke|stroke
1365541|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
1365542|NCT01310868|adult gliosarcoma|adult gliosarcoma
1365543|NCT01310868|adult glioblastoma|adult glioblastoma
1365544|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
1365545|NCT01310855|adult glioblastoma|adult glioblastoma
1365546|NCT01310855|adult gliosarcoma|adult gliosarcoma
1365547|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
1365548|NCT01310842|Smoker|smoker
1365549|NCT01310842|Smoking Cessation|smoking cessation
1365550|NCT01310842|Social Determinants|social determinants
1365551|NCT01310842|Environmental Effects|environmental effects
1365552|NCT01310842|Individual-level effects|individual-level effects
1365553|NCT01310842|Nicotine patch|nicotine patch
1365554|NCT01310842|Smart Phone|smart phone
1365555|NCT01310842|SP|sp
1365556|NCT01310842|Global Positioning System|global positioning system
1365557|NCT01310842|GPS|gps
1365558|NCT01310842|Questionnaires|questionnaires
1365559|NCT01310842|Saliva samples|saliva samples
1365560|NCT01310829|Genetic counselor|genetic counselor
1365561|NCT01310829|Genetic counseling degree program|genetic counseling degree program
1365562|NCT01310829|Genetic counseling students|genetic counseling students
1365563|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
1365564|NCT01310829|VR|vr
1365565|NCT01310829|Genetic counseling|genetic counseling
1365566|NCT01310829|hereditary cancers|hereditary cancers
1365567|NCT01310829|Questionnaires|questionnaires
1365568|NCT01310829|Physiological measurements|physiological measurements
1365569|NCT01310829|Skin sensors|skin sensors
1365570|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
1365571|NCT01310816|bone sarcoma|bone sarcoma
1365572|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
1365573|NCT01310803|Neoplasms|neoplasms
1365574|NCT01310803|Urologic Neoplasms|urologic neoplasms
1365575|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
1365576|NCT01310803|Neoplasms by Site|neoplasms by site
1365577|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
1365578|NCT01310803|Urologic Diseases|urologic diseases
1365579|NCT01310803|TURBT|turbt
1365580|NCT01310803|Valstar|valstar
1365581|NCT01310790|septic shock|septic shock
1365582|NCT01310790|lactic acid clearance|lactic acid clearance
1365583|NCT01310790|ScVO2|scvo2
1365584|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
1365585|NCT01310777|Ocular Hypertension|ocular hypertension
1365586|NCT01310777|OAG|oag
1365587|NCT01310777|OHT|oht
1365588|NCT01310764|Intraocular pressure|intraocular pressure
1365589|NCT01310764|Trabeculectomy|trabeculectomy
1365590|NCT01310764|Mitomycin C|mitomycin c
1365591|NCT01310764|Bevacizumab|bevacizumab
1365592|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
1365593|NCT01310738|Leishmania infantum|leishmania infantum
1365594|NCT01310738|Leishmania chagasi|leishmania chagasi
1365595|NCT01310725|CABG|cabg
1365596|NCT01310725|LIMA|lima
1365597|NCT01310725|saphenous vein|saphenous vein
1365598|NCT01310725|radial artery|radial artery
1365599|NCT01310712|hyperhidrosis|hyperhidrosis
1365600|NCT01310712|oxybutynin|oxybutynin
1365601|NCT01310699|Colonoscopy|colonoscopy
1365602|NCT01310699|Diagnostic imaging|diagnostic imaging
1365603|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
1365604|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
1365605|NCT01310699|Flat Polyp|flat polyp
1365606|NCT01310699|Nonpolypoid|nonpolypoid
1365607|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
1365608|NCT01310699|Primary Prevention|primary prevention
1365609|NCT01310699|Endoscopy|endoscopy
1365610|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
1365611|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
1365612|NCT01310673|Gout|gout
1365613|NCT01310673|Allopurinol|allopurinol
1365614|NCT01310673|Acute gout|acute gout
1365615|NCT01310647|estradiol|estradiol
1365616|NCT01310647|testosterone|testosterone
1365617|NCT01310647|combined oral contraceptive|combined oral contraceptive
1365618|NCT01310647|low responders|low responders
1365619|NCT01310647|ICSI|icsi
1365620|NCT01310634|Neonates|neonates
1365621|NCT01310634|Parenting|parenting
1365622|NCT01310634|Anxiety|anxiety
1365623|NCT01310634|Depression|depression
1365624|NCT01310621|Neonate|neonate
1365625|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
1365626|NCT01310621|surfactant lung lavage|surfactant lung lavage
1365627|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
1365628|NCT01310608|A-View|a-view
1365629|NCT01310608|Distal ascending aorta|distal ascending aorta
1365732|NCT01310166|RRMS|rrms
1365630|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
1365631|NCT01310608|CABG|cabg
1365632|NCT01310608|Cerebral embolisation|cerebral embolisation
1365633|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
1365634|NCT01310595|Proprioception|proprioception
1365635|NCT01310595|Postural balance|postural balance
1365636|NCT01310582|Sevoflurane|sevoflurane
1365637|NCT01310582|Desflurane|desflurane
1365638|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
1365639|NCT01310556|OGTT|ogtt
1365640|NCT01310556|coronary artery disease|coronary artery disease
1365641|NCT01310543|Teenage pregnancy|teenage pregnancy
1365642|NCT01310543|Adolescent|adolescent
1365643|NCT01310543|Sexual health|sexual health
1365644|NCT01310543|Youth development|youth development
1365645|NCT01310530|Breast Cancer|breast cancer
1365646|NCT01310530|Partial Breast|partial breast
1365647|NCT01310530|Proton Beam|proton beam
1365648|NCT01310517|Angiogram|angiogram
1365649|NCT01310517|Injected Contrast|injected contrast
1483304|NCT00843479|Aging|aging
1365650|NCT01310517|Heart Function|heart function
1365651|NCT01310517|contrast dye|contrast dye
1365652|NCT01310478|Recombinant human endostatin|recombinant human endostatin
1365653|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
1365654|NCT01310478|DLT|dlt
1365655|NCT01310478|MTD|mtd
1365656|NCT01310478|Pharmacokinetics|pharmacokinetics
1365657|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
1365658|NCT01310426|Anal Sphincter injury|anal sphincter injury
1365659|NCT01310426|Fecal Incontinence|fecal incontinence
1365660|NCT01310413|Influenza|influenza
1365661|NCT01310413|H5N1|h5n1
1365662|NCT01310413|Pandemic|pandemic
1365663|NCT01310400|Influenza|influenza
1365664|NCT01310400|Virus|virus
1365665|NCT01310400|Vaccination|vaccination
1365666|NCT01310400|Immunisation|immunisation
1365667|NCT01310387|Lung cancer|lung cancer
1365668|NCT01310387|Cancer pain|cancer pain
1365669|NCT01310387|Opioid|opioid
1365670|NCT01310374|influenza vaccine|influenza vaccine
1365671|NCT01310374|immune response|immune response
1365672|NCT01310374|dynamic changes|dynamic changes
1365673|NCT01310361|Pharyngitis|pharyngitis
1365674|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
1365675|NCT01310361|Exudate|exudate
1365676|NCT01310361|Erythema Penicillin|erythema penicillin
1365677|NCT01310361|Amoxicillin|amoxicillin
1365678|NCT01310348|Bone|bone
1365679|NCT01310348|Muscle strength|muscle strength
1365680|NCT01310348|whole-body vibration|whole-body vibration
1365681|NCT01310335|sclerostin|sclerostin
1365682|NCT01310335|whole-body vibration|whole-body vibration
1365683|NCT01310322|Phase I|phase i
1365684|NCT01310322|Healthy male volunteers|healthy male volunteers
1365685|NCT01310322|mild asthmatics|mild asthmatics
1365686|NCT01310322|pharmacokinetics|pharmacokinetics
1365687|NCT01310322|Bioavailability and AUC|bioavailability and auc
1365688|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
1365689|NCT01310309|Stents|stents
1365690|NCT01310309|Drug-eluting Stent|drug-eluting stent
1365691|NCT01310309|Angioplasty|angioplasty
1365692|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
1365693|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
1365694|NCT01310309|Stent Thrombosis|stent thrombosis
1365695|NCT01310296|Phase 1|phase 1
1365696|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
1365697|NCT01310296|Mass Balance|mass balance
1365698|NCT01310296|ADME|adme
1365699|NCT01310296|Absolute Bioavailability|absolute bioavailability
1365700|NCT01310283|dental caries|dental caries
1365701|NCT01310283|children|children
1365702|NCT01310283|mutans streptococci|mutans streptococci
1365703|NCT01310283|lactobacilli|lactobacilli
1365704|NCT01310283|cariogenic bacteria|cariogenic bacteria
1365705|NCT01310244|Phase 1/2|phase 1/2
1365706|NCT01310244|MTD|mtd
1365707|NCT01310244|stage IV|stage iv
1365708|NCT01310244|NSCLC|nsclc
1365709|NCT01310244|chemo-naive|chemo-naive
1365710|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
1365711|NCT01310244|lung cancer|lung cancer
1365712|NCT01310244|non-small-cell|non-small-cell
1365713|NCT01310244|phase I|phase i
1365714|NCT01310244|Belinostat|belinostat
1365715|NCT01310244|Carboplatin|carboplatin
1365716|NCT01310244|Paclitaxel|paclitaxel
1365717|NCT01310244|adenocarcinoma|adenocarcinoma
1365718|NCT01310244|PXD-101|pxd-101
1365719|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
1365720|NCT01310231|Metformin|metformin
1365721|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
1365722|NCT01310205|HCV|hcv
1365723|NCT01310205|Genotype 1|genotype 1
1365724|NCT01310205|relapsers|relapsers
1365725|NCT01310205|non cirrhotic|non cirrhotic
1365726|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
1365727|NCT01310179|gene therapy|gene therapy
1365728|NCT01310179|advanced solid tumors|advanced solid tumors
1365729|NCT01310179|Head and Neck cancer|head and neck cancer
1365730|NCT01310179|intratumoral therapy|intratumoral therapy
1365731|NCT01310166|Multiple sclerosis|multiple sclerosis
1365733|NCT01310166|relapsing-remitting|relapsing-remitting
1365734|NCT01310166|fingolimod|fingolimod
1365735|NCT01310166|biomarkers|biomarkers
1365736|NCT01310140|Metabolic Syndrome|metabolic syndrome
1365737|NCT01310140|Insulin Resistance|insulin resistance
1365738|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
1365739|NCT01310140|Major Depressive Disorder|major depressive disorder
1365740|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
1365741|NCT01310140|Cortisol|cortisol
1365742|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
1365743|NCT01310127|NSAID|nsaid
1365744|NCT01310127|Ocular Inflammation|ocular inflammation
1365745|NCT01310127|bromfenac|bromfenac
1365746|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
1365747|NCT01310114|Stem cells|stem cells
1365748|NCT01310114|Stroke|stroke
1365749|NCT01310114|PDA001|pda001
1365750|NCT01310114|Celgene|celgene
1365751|NCT01310114|cenplacel-L|cenplacel-l
1365752|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1365753|NCT01310101|Refractory|refractory
1365754|NCT01310101|Relapse|relapse
1365755|NCT01310101|Ofatumumab|ofatumumab
1365756|NCT01310101|Dexamethasone|dexamethasone
1365757|NCT01310088|Childhood|childhood
1365758|NCT01310088|Child|child
1365759|NCT01310088|adolescent|adolescent
1365760|NCT01310088|central blood pressure|central blood pressure
1365761|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1365762|NCT01310088|ABPM|abpm
1365763|NCT01310088|clinic blood pressure|clinic blood pressure
1365764|NCT01310088|pulse wave velocity|pulse wave velocity
1365765|NCT01310088|PWV|pwv
1365766|NCT01310088|Pulse cave analysis|pulse cave analysis
1365767|NCT01310088|PWA|pwa
1365768|NCT01310088|heart rate variability|heart rate variability
1365769|NCT01310088|HRV|hrv
1365770|NCT01310088|Echocardiography|echocardiography
1365771|NCT01310088|Urine microalbuminuria|urine microalbuminuria
1365772|NCT01310088|blood samples|blood samples
1365773|NCT01310075|Mastectomy|mastectomy
1365774|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
1365775|NCT01310075|Breast Reconstruction|breast reconstruction
1365776|NCT01310075|Tissue Expander|tissue expander
1365777|NCT01310075|Alloderm|alloderm
1365778|NCT01310075|Surgimend|surgimend
1365779|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
1365780|NCT01310062|microarray|microarray
1365781|NCT01310062|gene expression profiling|gene expression profiling
1365782|NCT01310062|biomarkers|biomarkers
1365783|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
1365784|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
1365785|NCT01309997|Imatinib|imatinib
1365786|NCT01309997|Rituximab|rituximab
1365787|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
1365788|NCT01309984|Monitored anesthesia care|monitored anesthesia care
1365789|NCT01309971|Assessment|assessment
1365790|NCT01309971|Questionable Caries|questionable caries
1365791|NCT01309958|Dental Caries|dental caries
1365792|NCT01309958|Intervention|intervention
1365793|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
1365794|NCT01309919|intrauterine device|intrauterine device
1365795|NCT01309919|Mirena|mirena
1365796|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
1365797|NCT01309919|postpartum contraception|postpartum contraception
1365798|NCT01309893|Contact lens|contact lens
1365799|NCT01309880|Contact lens|contact lens
1365800|NCT01309854|Phase 1|phase 1
1365801|NCT01309854|healthy volunteers|healthy volunteers
1365802|NCT01309854|pharmacokinetics|pharmacokinetics
1365803|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
1365804|NCT01309854|RA|ra
1365805|NCT01309854|fostamatinib|fostamatinib
1365806|NCT01309854|pioglitazone|pioglitazone
1365807|NCT01309854|drug-drug interaction|drug-drug interaction
1365808|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
1365809|NCT01309828|Renal Insufficiency|renal insufficiency
1365810|NCT01309828|Kidney Diseases|kidney diseases
1365811|NCT01309828|Hypertension|hypertension
1365812|NCT01309828|Drug Therapy|drug therapy
1365813|NCT01309815|neoplasms|neoplasms
1365814|NCT01309815|existentialism|existentialism
1365815|NCT01309815|existential concerns|existential concerns
1365816|NCT01309815|Meaning making|meaning making
1365817|NCT01309815|early palliative phase|early palliative phase
1365818|NCT01309815|elderly|elderly
1365819|NCT01309802|botox|botox
1365820|NCT01309802|raynaud's|raynaud's
1365821|NCT01309802|botulinum toxin|botulinum toxin
1365822|NCT01309802|botulinum toxin A|botulinum toxin a
1365823|NCT01309802|raynaud's disease|raynaud's disease
1365824|NCT01309802|raynaud's syndrome|raynaud's syndrome
1365825|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
1365826|NCT01309802|ischemic digits|ischemic digits
1365827|NCT01309802|ischemia|ischemia
1365828|NCT01309802|botox treatment|botox treatment
1365829|NCT01309802|onabotulinum|onabotulinum
1365830|NCT01309802|onabotulinum toxin|onabotulinum toxin
1365933|NCT01309412|CNTO 328|cnto 328
1365831|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
1365832|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
1365833|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
1365834|NCT01309789|Antigens, CD30|antigens, cd30
1365835|NCT01309789|Drug Therapy|drug therapy
1365836|NCT01309789|Hematologic Diseases|hematologic diseases
1365837|NCT01309789|Lymphoma|lymphoma
1366147|NCT01308411|Asthma|asthma
1365838|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
1365839|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1365840|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
1365841|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
1365842|NCT01309737|Xeljanz|xeljanz
1365843|NCT01309737|tofacitinib|tofacitinib
1365844|NCT01309737|Jak-inhibitor|jak-inhibitor
1365845|NCT01309737|oral treatment|oral treatment
1365846|NCT01309737|chronic|chronic
1365847|NCT01309737|severe|severe
1365848|NCT01309737|moderate|moderate
1365849|NCT01309737|Pruritus|pruritus
1365850|NCT01309737|Itch|itch
1365851|NCT01309737|DLQI|dlqi
1365852|NCT01309737|treatment|treatment
1365853|NCT01309737|safety|safety
1365854|NCT01309737|efficacy|efficacy
1365855|NCT01309737|CP-690,550|cp-690,550
1365856|NCT01309737|Plaque Psoriasis|plaque psoriasis
1365857|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
1365858|NCT01309724|Hypotension|hypotension
1365859|NCT01309724|Fluid|fluid
1365860|NCT01309711|MRI|mri
1365861|NCT01309711|Biomarkers|biomarkers
1365862|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
1365863|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
1365864|NCT01309698|Drug interaction|drug interaction
1365865|NCT01309685|Cognition|cognition
1365866|NCT01309685|Smoking|smoking
1365867|NCT01309685|Nicotine|nicotine
1365868|NCT01309685|Varenicline|varenicline
1365869|NCT01309685|Withdrawal|withdrawal
1365870|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1365871|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1365872|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
1365873|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
1365874|NCT01309659|Anemia|anemia
1365875|NCT01309659|Unexplained anemia|unexplained anemia
1365876|NCT01309659|elderly|elderly
1365877|NCT01309659|geriatric|geriatric
1365878|NCT01309659|older adults|older adults
1365879|NCT01309659|UAE|uae
1365880|NCT01309659|over 65|over 65
1365881|NCT01309659|iron|iron
1365882|NCT01309659|pactte|pactte
1365883|NCT01309659|pactee|pactee
1365884|NCT01309659|aging|aging
1365885|NCT01309659|aged|aged
1365886|NCT01309659|old|old
1365887|NCT01309659|older|older
1365888|NCT01309646|Primary vaccination|primary vaccination
1365889|NCT01309646|combination vaccine|combination vaccine
1365890|NCT01309646|South Korea|south korea
1365891|NCT01309633|locally advanced|locally advanced
1365892|NCT01309633|metastatic|metastatic
1365893|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
1365894|NCT01309581|depression|depression
1365895|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
1365896|NCT01309581|ketamine|ketamine
1365897|NCT01309581|antidepressant|antidepressant
1365898|NCT01309555|Growth disorders|growth disorders
1365899|NCT01309555|Saizen|saizen
1365900|NCT01309555|easypod™|easypod™
1365901|NCT01309555|Growth hormone|growth hormone
1365902|NCT01309555|Pediatric subject|pediatric subject
1365903|NCT01309542|major depressive disorder|major depressive disorder
1365904|NCT01309542|desvenlafaxine|desvenlafaxine
1365905|NCT01309542|antidepressant|antidepressant
1365906|NCT01309529|general thoracic surgery|general thoracic surgery
1365907|NCT01309529|epidural analgesia|epidural analgesia
1365908|NCT01309529|postoperative retention of urine|postoperative retention of urine
1365909|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
1365910|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
1365911|NCT01309516|Postnatal depression|postnatal depression
1365912|NCT01309516|Maternal depression|maternal depression
1365913|NCT01309516|Psychosocial intervention|psychosocial intervention
1365914|NCT01309490|high eIF4E expression|high eif4e expression
1365915|NCT01309490|solid tumor cancer|solid tumor cancer
1365916|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
1365917|NCT01309477|Tacrolimus|tacrolimus
1365918|NCT01309451|diabetic macular edema|diabetic macular edema
1365919|NCT01309451|DME|dme
1365920|NCT01309438|Healthy|healthy
1365921|NCT01309438|Renal Insufficiency|renal insufficiency
1365922|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
1365923|NCT01309438|Erythromycin|erythromycin
1365924|NCT01309438|Pharmacokinetic|pharmacokinetic
1365925|NCT01309438|Pharmacodynamic|pharmacodynamic
1365926|NCT01309425|tapentadol|tapentadol
1365927|NCT01309425|NUCYNTA|nucynta
1365928|NCT01309425|CG5503|cg5503
1365929|NCT01309425|R331333|r331333
1365930|NCT01309425|pharmacokinetics|pharmacokinetics
1365931|NCT01309425|healthy volunteer|healthy volunteer
1365932|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
1365936|NCT01309412|dexamethasone|dexamethasone
1365937|NCT01309399|bone formation rate|bone formation rate
1365938|NCT01309399|total hip arthroplasty|total hip arthroplasty
1365939|NCT01309386|Tapentadol|tapentadol
1365940|NCT01309386|Tumor related pain|tumor related pain
1365941|NCT01309386|Opioid|opioid
1365942|NCT01309386|Cancer related pain|cancer related pain
1365943|NCT01309386|Morphine|morphine
1365944|NCT01309373|Schizophrenia|schizophrenia
1365945|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
1365946|NCT01309373|Remission|remission
1365947|NCT01309373|Psychosocial|psychosocial
1365948|NCT01309373|Symtomatic|symtomatic
1365949|NCT01309373|Integration|integration
1365950|NCT01309373|Schizoaffective|schizoaffective
1365951|NCT01309373|Adherence|adherence
1365952|NCT01309360|ultrasound|ultrasound
1365953|NCT01309360|methaemoglobin|methaemoglobin
1365954|NCT01309360|prilocaine|prilocaine
1365955|NCT01309360|regional anesthesia|regional anesthesia
1365956|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
1365957|NCT01309360|adult outpatients|adult outpatients
1365958|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
1365959|NCT01309360|distal forearm|distal forearm
1365960|NCT01309360|hand|hand
1365961|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
1365963|NCT01309334|PET-scan|pet-scan
1365964|NCT01309334|multiple myeloma|multiple myeloma
1365965|NCT01309334|prognosis|prognosis
1365966|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
1365967|NCT01309321|Perinatal|perinatal
1365968|NCT01309321|Handwashing|handwashing
1365969|NCT01309321|Neonatal|neonatal
1365970|NCT01309321|Morbidity|morbidity
1365971|NCT01309321|Mortality|mortality
1365972|NCT01309321|Primiparous|primiparous
1365973|NCT01309321|Health behavior|health behavior
1365974|NCT01309321|Developing countries|developing countries
1365975|NCT01309321|Sepsis|sepsis
1365976|NCT01309321|Omphalitis|omphalitis
1365977|NCT01309321|Infectious disease|infectious disease
1365978|NCT01309321|Bangladesh|bangladesh
1365979|NCT01309308|cervical length|cervical length
1365980|NCT01309308|sweeping the membranes|sweeping the membranes
1365981|NCT01309256|distal gastrectomy|distal gastrectomy
1365982|NCT01309256|Robotic gastrectomy|robotic gastrectomy
1365983|NCT01309256|registry|registry
1365984|NCT01309256|learning curve|learning curve
1365985|NCT01309256|cost-effectiveness|cost-effectiveness
1365986|NCT01309256|quality of life|quality of life
1365987|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
1365988|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
1365989|NCT01309243|HIV|hiv
1365990|NCT01309243|HIV-1|hiv-1
1365991|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
1365992|NCT01309230|Stage III|stage iii
1365993|NCT01309230|Stage IV|stage iv
1365994|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
1365995|NCT01309230|ovarian cancer|ovarian cancer
1365996|NCT01309230|Adjuvant|adjuvant
1365997|NCT01309230|immunotherapy|immunotherapy
1365998|NCT01309204|open-angle glaucoma|open-angle glaucoma
1365999|NCT01309204|ocular hypertension|ocular hypertension
1366000|NCT01309204|OAG|oag
1366001|NCT01309204|OHT|oht
1366002|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
1366003|NCT01309191|Minoxidil|minoxidil
1366004|NCT01309191|Microarray|microarray
1366005|NCT01309165|stroke|stroke
1366006|NCT01309165|cognition|cognition
1366007|NCT01309165|cognitive strategies|cognitive strategies
1366008|NCT01309165|motor skill acquisition|motor skill acquisition
1366009|NCT01309165|participation|participation
1366010|NCT01309152|cefazolin|cefazolin
1366011|NCT01309152|microdialysis|microdialysis
1366012|NCT01309152|morbid obesity|morbid obesity
1366013|NCT01309152|pharmacokinetics|pharmacokinetics
1366014|NCT01309126|Colorectal Cancer|colorectal cancer
1366015|NCT01309126|KRAS Wild Type|kras wild type
1366016|NCT01309126|Imprime PGG|imprime pgg
1366017|NCT01309126|Cetuximab|cetuximab
1366018|NCT01309126|Phase 3|phase 3
1366019|NCT01309126|Efficacy|efficacy
1366020|NCT01309126|Safety|safety
1366021|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
1366022|NCT01309087|Gene Expression|gene expression
1366023|NCT01309087|Lung Cancer|lung cancer
1366024|NCT01309087|Smoking|smoking
1366025|NCT01309074|Anxiety|anxiety
1366026|NCT01309074|Epilepsy|epilepsy
1366027|NCT01309048|bone metastasis|bone metastasis
1366028|NCT01309048|Patients with bone metastasis|patients with bone metastasis
1366029|NCT01309035|Prothesis fixation|prothesis fixation
1366030|NCT01309035|Bloodlessness|bloodlessness
1366031|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1366032|NCT01309022|T1D|t1d
1366033|NCT01309022|T1DM|t1dm
1366034|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
1366035|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
1366036|NCT01309022|Islet Transplant|islet transplant
1366037|NCT01309022|Tacrolimus|tacrolimus
1366038|NCT01309022|Sirolimus|sirolimus
1366039|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
1366040|NCT01309022|Mycophenolic acid|mycophenolic acid
1366041|NCT01309009|Infantile Colic|infantile colic
1366042|NCT01309009|Tachykinin antagonist|tachykinin antagonist
1366043|NCT01309009|Nepadutant|nepadutant
1366044|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
1366248|NCT01307969|ropivacaine|ropivacaine
1366045|NCT01308996|edentulous ridge|edentulous ridge
1366046|NCT01308996|alveolar ridge defect|alveolar ridge defect
1366047|NCT01308996|posterior mandible defect|posterior mandible defect
1366048|NCT01308996|bone morphogenic protein|bone morphogenic protein
1366049|NCT01308996|osseointegration|osseointegration
1483794|NCT00841529|LAA|laa
1366050|NCT01308983|Prehypertension|prehypertension
1366051|NCT01308983|Flow mediated dilation|flow mediated dilation
1366052|NCT01308983|Pulse wave velocity|pulse wave velocity
1366053|NCT01308983|carotid compliance|carotid compliance
1366054|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
1366055|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
1366056|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
1366057|NCT01308944|fallopian tube cancer|fallopian tube cancer
1366058|NCT01308931|Contraception|contraception
1366060|NCT01308931|Essure|essure
1366061|NCT01308931|Tubal ligation|tubal ligation
1366062|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
1366063|NCT01308918|Thoracic surgery|thoracic surgery
1366064|NCT01308918|Double lumen tube intubation|double lumen tube intubation
1366065|NCT01308918|GlideScope|glidescope
1366066|NCT01308918|Stylet|stylet
1366067|NCT01308905|Neuroblastoma|neuroblastoma
1366068|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
1366069|NCT01308879|Mental health outcomes|mental health outcomes
1366070|NCT01308879|Quality improvement|quality improvement
1366071|NCT01308879|Feedback|feedback
1366072|NCT01308879|Clinical trial|clinical trial
1366073|NCT01308866|cardiovascular diseases|cardiovascular diseases
1366074|NCT01308866|patient education|patient education
1366075|NCT01308866|primary health care|primary health care
1366076|NCT01308866|consumer participation|consumer participation
1366077|NCT01308866|decision aids|decision aids
1366078|NCT01308840|Unresectable|unresectable
1366079|NCT01308840|metastatic|metastatic
1366080|NCT01308840|biliary tract|biliary tract
1366081|NCT01308840|gallbladder cancer|gallbladder cancer
1366082|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
1366083|NCT01308814|Perimenopause|perimenopause
1366084|NCT01308814|Menopause|menopause
1366085|NCT01308814|Depression|depression
1366086|NCT01308814|Cardiovascular health|cardiovascular health
1366087|NCT01308801|fibromyalgia|fibromyalgia
1366088|NCT01308801|pain|pain
1366089|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1366090|NCT01308801|rehabilitation exercise|rehabilitation exercise
1366091|NCT01308801|quality of life|quality of life
1366092|NCT01308788|glaucoma blood flow|glaucoma blood flow
1366093|NCT01308775|SIS.NET|sis.net
1366094|NCT01308736|tobacco|tobacco
1366095|NCT01308736|nicotine|nicotine
1366096|NCT01308736|cigarette smoking|cigarette smoking
1366097|NCT01308710|endothelial function|endothelial function
1366098|NCT01308710|lipids|lipids
1366099|NCT01308710|pediatrics|pediatrics
1366100|NCT01308697|Flail|flail
1366101|NCT01308697|Chest|chest
1366102|NCT01308671|coronary artery disease|coronary artery disease
1366103|NCT01308671|varenicline|varenicline
1366104|NCT01308671|clopidogrel|clopidogrel
1366105|NCT01308658|TMC114-C176|tmc114-c176
1366106|NCT01308658|TMC114|tmc114
1366107|NCT01308658|DRV|drv
1366108|NCT01308658|HIV|hiv
1366109|NCT01308658|Healthy volunteers|healthy volunteers
1366110|NCT01308645|SBP Injection|sbp injection
1366111|NCT01308645|HCC|hcc
1366112|NCT01308632|glioblastoma|glioblastoma
1366113|NCT01308632|temozolamide|temozolamide
1366114|NCT01308632|radiotherapy|radiotherapy
1366115|NCT01308632|TMZ|tmz
1366116|NCT01308632|irinotecan|irinotecan
1366117|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
1366118|NCT01308606|TMC435-C116|tmc435-c116
1366119|NCT01308606|TMC435|tmc435
1366120|NCT01308606|HCV|hcv
1366121|NCT01308606|Hepatitis C|hepatitis c
1366122|NCT01308606|Hep C|hep c
1366123|NCT01308606|healthy volunteers|healthy volunteers
1366124|NCT01308554|TAP block|tap block
1366125|NCT01308554|Pain|pain
1366126|NCT01308554|Obesity|obesity
1366127|NCT01308554|Surgery|surgery
1366128|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
1366129|NCT01308528|Venous Thromboembolism|venous thromboembolism
1366130|NCT01308515|knee|knee
1366131|NCT01308515|osteoarthritis|osteoarthritis
1366132|NCT01308515|joint|joint
1366133|NCT01308515|replacement|replacement
1366134|NCT01308515|knee surgery|knee surgery
1366135|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
1366136|NCT01308502|LPR|lpr
1366137|NCT01308502|GERD|gerd
1366138|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
1366139|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
1366140|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
1366141|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
1366142|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
1366143|NCT01308450|ADHD Normative Control Group|adhd normative control group
1366144|NCT01308424|Herpes Labialis|herpes labialis
1366145|NCT01308424|Herpes Simplex|herpes simplex
1366146|NCT01308424|Herpes|herpes
1366148|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
1366149|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
1366150|NCT01308411|Airways inflammation|airways inflammation
1366151|NCT01308411|Step down|step down
1366152|NCT01308411|Predicting response|predicting response
1366153|NCT01308372|cardiovascular risk|cardiovascular risk
1366154|NCT01308372|France|france
1366155|NCT01308372|General practice|general practice
1366156|NCT01308372|Primary prevention|primary prevention
1366157|NCT01308372|Non treated patients|non treated patients
1366158|NCT01308359|fetal movement|fetal movement
1366159|NCT01308346|Bioabsorbable|bioabsorbable
1366160|NCT01308346|Coronary Stent|coronary stent
1366161|NCT01308346|Everolimus|everolimus
1366162|NCT01308346|drug eluting stents|drug eluting stents
1366163|NCT01308346|stents|stents
1366164|NCT01308346|angioplasty|angioplasty
1366165|NCT01308346|coronary artery disease|coronary artery disease
1366166|NCT01308346|total coronary occlusion|total coronary occlusion
1366167|NCT01308346|coronary artery restenosis|coronary artery restenosis
1366168|NCT01308346|stent thrombosis|stent thrombosis
1366169|NCT01308346|myocardial ischemia|myocardial ischemia
1366170|NCT01308346|coronary artery stenosis|coronary artery stenosis
1366171|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
1366172|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
1366173|NCT01308307|Amblyopia|amblyopia
1366174|NCT01308294|Melanoma|melanoma
1366175|NCT01308294|Stage II-IV|stage ii-iv
1366176|NCT01308294|Immunotherapy|immunotherapy
1366177|NCT01308294|Vaccination|vaccination
1366178|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
1366179|NCT01308294|IMP321|imp321
1366180|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
1366181|NCT01308268|STH|sth
1366182|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
1366183|NCT01308268|mass drug administration|mass drug administration
1366184|NCT01308229|Bifurcation|bifurcation
1366185|NCT01308229|Dedicated|dedicated
1366186|NCT01308229|Drug-eluting stent|drug-eluting stent
1366187|NCT01308229|Angioplasty|angioplasty
1366188|NCT01308229|Coronary artery disease|coronary artery disease
1366189|NCT01308229|Coronary artery stenosis|coronary artery stenosis
1366190|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
1366191|NCT01308216|Hemiplegia|hemiplegia
1366192|NCT01308216|Rehabilitation|rehabilitation
1366193|NCT01308216|Physiotherapy|physiotherapy
1366194|NCT01308216|Ischemic stroke|ischemic stroke
1366195|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
1366196|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
1366197|NCT01308190|Rectal Cancer|rectal cancer
1366198|NCT01308190|T2-T3s-N0|t2-t3s-n0
1366199|NCT01308164|Type 1 diabetes|type 1 diabetes
1366200|NCT01308164|Insulin Pump Therapy|insulin pump therapy
1366201|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
1366202|NCT01308138|Physical Activity|physical activity
1366203|NCT01308138|pathology|pathology
1366204|NCT01308138|Physical Deconditioning|physical deconditioning
1366205|NCT01308125|Stable Angina|stable angina
1366206|NCT01308125|Coronary artery disease|coronary artery disease
1366207|NCT01308125|PCI|pci
1366208|NCT01308125|Reperfusion|reperfusion
1366209|NCT01308125|Myocardial Infarction|myocardial infarction
1366210|NCT01308125|collateral flow pressure index|collateral flow pressure index
1366211|NCT01308125|CFpI|cfpi
1366212|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
1366213|NCT01308125|PICSO|picso
1366214|NCT01308112|Iron|iron
1366215|NCT01308112|Plasmodium|plasmodium
1366216|NCT01308112|Malaria|malaria
1366217|NCT01308112|Pregnancy|pregnancy
1366218|NCT01308112|Kenya|kenya
1366219|NCT01308099|POTS|pots
1366220|NCT01308099|Vascular Endothelial Function|vascular endothelial function
1366221|NCT01308086|Cancer|cancer
1366222|NCT01308086|colorectal cancer|colorectal cancer
1366223|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
1366224|NCT01308086|capecitabine|capecitabine
1366225|NCT01308086|oxaliplatin|oxaliplatin
1366226|NCT01308086|5 fluorouracil|5 fluorouracil
1366227|NCT01308060|Canthal lines|canthal lines
1366228|NCT01308034|non GIST sarcomas|non gist sarcomas
1366229|NCT01308034|sunitinib|sunitinib
1366230|NCT01308034|radiotherapy|radiotherapy
1366231|NCT01308034|dose escalation|dose escalation
1366232|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
1366233|NCT01308021|Allergy|allergy
1366234|NCT01308021|Grass pollen|grass pollen
1366235|NCT01308021|Hypersensitivity|hypersensitivity
1366236|NCT01308021|Immune system disorder|immune system disorder
1366237|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1366238|NCT01308008|Mobility Limitation|mobility limitation
1366239|NCT01307995|GDM|gdm
1366240|NCT01307995|incretin effect|incretin effect
1366241|NCT01307995|gestation|gestation
1366242|NCT01307995|reversibility|reversibility
1366243|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
1366244|NCT01307982|Nervous System Diseases|nervous system diseases
1366245|NCT01307982|Fundoplication|fundoplication
1366246|NCT01307982|Enteral Nutrition|enteral nutrition
1366247|NCT01307969|liposomes|liposomes
1366249|NCT01307969|dental anesthesia|dental anesthesia
1366250|NCT01307969|dentistry|dentistry
1366251|NCT01307943|MBSR|mbsr
1366252|NCT01307943|adolescent|adolescent
1366253|NCT01307943|mental health|mental health
1366254|NCT01307930|Echinocandin|echinocandin
1366255|NCT01307930|Obesity|obesity
1366256|NCT01307930|Pharmacokinetics|pharmacokinetics
1366257|NCT01307930|Pharmacodynamics|pharmacodynamics
1366258|NCT01307930|Fungal infection|fungal infection
1366259|NCT01307917|diabetes mellitus|diabetes mellitus
1366260|NCT01307917|diabetic nephropathy|diabetic nephropathy
1366261|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
1366262|NCT01307917|flavonoids|flavonoids
1366263|NCT01307917|flow-mediated dilation|flow-mediated dilation
1366264|NCT01307904|Glycemic index|glycemic index
1366265|NCT01307904|Dates|dates
1366266|NCT01307904|Blood glucose|blood glucose
1366267|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
1366268|NCT01307891|Metastatic breast cancer|metastatic breast cancer
1366269|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
1366270|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
1366271|NCT01307891|HER-2-neu negative|her-2-neu negative
1366272|NCT01307891|ER negative, PR negative|er negative, pr negative
1366273|NCT01307865|midface volume loss|midface volume loss
1366274|NCT01307865|aging of midface|aging of midface
1366275|NCT01307865|sculptra|sculptra
1366276|NCT01307865|sculptra aesthetic|sculptra aesthetic
1366277|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
1366278|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
1366279|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
1366280|NCT01307852|Radiation treatment|radiation treatment
1366281|NCT01307852|Radiotherapy|radiotherapy
1366282|NCT01307852|External beam radiation|external beam radiation
1366283|NCT01307852|Dosimetry|dosimetry
1366284|NCT01307839|labor|labor
1366285|NCT01307839|epidural|epidural
1366286|NCT01307826|massage|massage
1366287|NCT01307826|shoulder|shoulder
1366288|NCT01307826|pain|pain
1366289|NCT01307826|range of motion|range of motion
1366290|NCT01307826|restricted range of motion|restricted range of motion
1366291|NCT01307813|colon distal|colon distal
1366292|NCT01307813|surgical resection|surgical resection
1366293|NCT01307787|exercise|exercise
1366294|NCT01307787|education|education
1366295|NCT01307787|self-management|self-management
1366296|NCT01307787|rehabilitation|rehabilitation
1366297|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
1366298|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
1366299|NCT01307748|aromatherapy|aromatherapy
1366300|NCT01307748|stress|stress
1366301|NCT01307748|older adults|older adults
1366302|NCT01307748|stress-related change|stress-related change
1366303|NCT01307735|myocarditis|myocarditis
1366305|NCT01307735|hyperemia|hyperemia
1366306|NCT01307735|fibrosis|fibrosis
1366307|NCT01307735|necrosis|necrosis
1366308|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
1366309|NCT01307722|left atrial distensibility|left atrial distensibility
1366310|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
1366311|NCT01307722|decompensation|decompensation
1366312|NCT01307722|rehospitalization|rehospitalization
1366313|NCT01307722|prognosis|prognosis
1366314|NCT01307722|all-cause mortality|all-cause mortality
1366315|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
1366316|NCT01307722|the duration of hospitalization|the duration of hospitalization
1366317|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
1366318|NCT01307696|PVP Mesh|pvp mesh
1366319|NCT01307683|Pregnancy|pregnancy
1366320|NCT01307683|Overweight|overweight
1366321|NCT01307683|Obese|obese
1366322|NCT01307683|Stress|stress
1366323|NCT01307683|Mindfulness|mindfulness
1366324|NCT01307657|clopidogrel|clopidogrel
1366325|NCT01307657|platelet|platelet
1366326|NCT01307657|platelet function test|platelet function test
1366327|NCT01307657|healthy|healthy
1366328|NCT01307657|Platelet function tests|platelet function tests
1366329|NCT01307644|Overweight|overweight
1366330|NCT01307644|Obesity|obesity
1366331|NCT01307644|Rural Health|rural health
1366332|NCT01307644|Weight Loss|weight loss
1366333|NCT01307644|Weight Maintenance|weight maintenance
1366334|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
1366335|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
1366336|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
1366337|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1366338|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1366339|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1366926|NCT01305512|Taxane|taxane
1366340|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1366341|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1366342|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1366435|NCT01307280|high blood pressure|high blood pressure
1366343|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1366344|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1366345|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1366346|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1366347|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1366348|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1366349|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1366350|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1366351|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1366352|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1366353|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1366354|NCT01307514|DIABETES|diabetes
1366355|NCT01307514|PHARMACOKINETICS|pharmacokinetics
1366356|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
1366357|NCT01307514|INSULIN|insulin
1366358|NCT01307501|Cryoablation|cryoablation
1366359|NCT01307501|Cryotherapy|cryotherapy
1366360|NCT01307501|Cryosurgery|cryosurgery
1366361|NCT01307501|Metastatic|metastatic
1366362|NCT01307501|Lung|lung
1366363|NCT01307501|Pleura|pleura
1366364|NCT01307501|Tumors|tumors
1366365|NCT01307488|HIV|hiv
1366366|NCT01307488|AIDS|aids
1366367|NCT01307488|Atazanavir|atazanavir
1366368|NCT01307488|Simplification|simplification
1366369|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
1366370|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
1366371|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
1366372|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
1366373|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
1366374|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
1366375|NCT01307475|PTSD|ptsd
1366376|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
1366377|NCT01307475|Endogenous Depression|endogenous depression
1366378|NCT01307475|Neurotic Depression|neurotic depression
1366379|NCT01307475|Depressive Syndrome|depressive syndrome
1366380|NCT01307475|Melancholia|melancholia
1366381|NCT01307475|Depressive Neurosis|depressive neurosis
1366382|NCT01307475|Unipolar Depression|unipolar depression
1366383|NCT01307475|Depressive Symptoms|depressive symptoms
1366384|NCT01307475|Emotional Depression|emotional depression
1366385|NCT01307475|Quality of Life|quality of life
1366386|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
1366387|NCT01307449|immune responses|immune responses
1366388|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
1366389|NCT01307436|Combined Vaccines|combined vaccines
1366390|NCT01307436|DTP Vaccine|dtp vaccine
1366391|NCT01307436|MMR Vaccine|mmr vaccine
1366392|NCT01307423|psoriasis|psoriasis
1366393|NCT01307423|Arthritis|arthritis
1366394|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
1366395|NCT01307423|inflammation|inflammation
1366396|NCT01307423|skin condition|skin condition
1366397|NCT01307423|inflammatory cells|inflammatory cells
1366398|NCT01307423|apremilast|apremilast
1366399|NCT01307423|CC-10004|cc-10004
1366400|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
1366401|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
1366402|NCT01307384|Total Hip Arthroplasty|total hip arthroplasty
1366403|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
1366404|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
1366405|NCT01307384|THA|tha
1366406|NCT01307384|THR|thr
1366407|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
1366408|NCT01307371|Diabetes;|diabetes;
1366409|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
1366410|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
1366411|NCT01307371|Left Ventricular Function|left ventricular function
1366412|NCT01307332|Multiple Sclerosis|multiple sclerosis
1366413|NCT01307332|MS|ms
1366414|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1366415|NCT01307332|RRMS|rrms
1366416|NCT01307332|Alemtuzumab|alemtuzumab
1366417|NCT01307332|Demyelination|demyelination
1366418|NCT01307332|Remyelination|remyelination
1366419|NCT01307332|Tolerogenic|tolerogenic
1366420|NCT01307332|T cells|t cells
1366421|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
1366422|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
1366423|NCT01307332|Nervous System Diseases|nervous system diseases
1366424|NCT01307332|Demyelinating Diseases|demyelinating diseases
1366425|NCT01307332|Autoimmune Diseases|autoimmune diseases
1366426|NCT01307332|Immune System Diseases|immune system diseases
1366427|NCT01307319|Allergies|allergies
1366428|NCT01307319|Hayfever|hayfever
1366429|NCT01307306|Thermal injury|thermal injury
1366430|NCT01307306|Chemical Burn|chemical burn
1366431|NCT01307306|Flame Burn|flame burn
1366432|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
1366433|NCT01307280|weight loss|weight loss
1366434|NCT01307280|cost-effective analysis|cost-effective analysis
1366436|NCT01307280|randomized clinical trial|randomized clinical trial
1366437|NCT01307280|behavioral interventions|behavioral interventions
1366438|NCT01307280|physical activity|physical activity
1366439|NCT01307280|dietary change|dietary change
1366440|NCT01307280|obesity|obesity
1366441|NCT01307267|Phase 1|phase 1
1366442|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1366443|NCT01307267|Advanced malignancies|advanced malignancies
1366444|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1366445|NCT01307241|prognostic factor|prognostic factor
1366446|NCT01307241|pharmacogenetics.|pharmacogenetics.
1366447|NCT01307228|Knowledge translation|knowledge translation
1366448|NCT01307228|Policymakers|policymakers
1366449|NCT01307228|Health systems|health systems
1366450|NCT01307215|TAP block|tap block
1366451|NCT01307215|incision pain|incision pain
1366452|NCT01307215|total hysterectomy|total hysterectomy
1366453|NCT01307202|knee|knee
1366454|NCT01307202|arthroplasty|arthroplasty
1366455|NCT01307202|postoperative pain|postoperative pain
1366456|NCT01307202|gabapentin|gabapentin
1366457|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1366458|NCT01307189|Exercise|exercise
1366459|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
1366460|NCT01307189|Bronchodilation|bronchodilation
1366461|NCT01307189|Tiotropium|tiotropium
1366462|NCT01307176|ataxia|ataxia
1366463|NCT01307176|exercise|exercise
1366464|NCT01307176|training|training
1366465|NCT01307176|cerebellar|cerebellar
1366466|NCT01307176|rehabilitation|rehabilitation
1366467|NCT01307163|saliva|saliva
1366468|NCT01307163|liver transplantation|liver transplantation
1366469|NCT01307163|children|children
1366470|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
1366471|NCT01307163|children and adolescents|children and adolescents
1366472|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
1366473|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
1366474|NCT01307150|Atopic Dermatitis|atopic dermatitis
1366475|NCT01307150|Dead Sea|dead sea
1366476|NCT01307150|Climatotherapy|climatotherapy
1366477|NCT01307150|SCORAD|scorad
1366478|NCT01307124|safety and efficacy|safety and efficacy
1366479|NCT01307124|low dose LPV/r|low dose lpv/r
1366480|NCT01307124|standard dose LPV/r|standard dose lpv/r
1366481|NCT01307124|HIV infected children|hiv infected children
1366482|NCT01307111|Misoprostol|misoprostol
1366483|NCT01307111|IUD insertion|iud insertion
1366484|NCT01307111|Nulliparous Women|nulliparous women
1366485|NCT01307111|Contraception|contraception
1366486|NCT01307111|Family Planning|family planning
1366487|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
1366488|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
1366489|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
1366490|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
1366491|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
1366492|NCT01307098|Acid lipase disease|acid lipase disease
1366493|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
1366494|NCT01307098|LAL Deficiency|lal deficiency
1366495|NCT01307098|LIPA Deficiency|lipa deficiency
1366496|NCT01307098|Wolman disease|wolman disease
1366497|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
1366498|NCT01307085|lung injury|lung injury
1366499|NCT01307085|pulmonary resection|pulmonary resection
1366500|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
1366501|NCT01307059|Growth disorders|growth disorders
1366502|NCT01307059|Saizen|saizen
1366503|NCT01307059|Easypod|easypod
1366504|NCT01307059|Growth hormone|growth hormone
1366505|NCT01307059|Pediatric subject|pediatric subject
1366506|NCT01307046|Essential hypertension|essential hypertension
1366507|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
1366508|NCT01307046|Antihypertensive agents|antihypertensive agents
1366509|NCT01307046|Blood pressure|blood pressure
1366510|NCT01307033|Essential hypertension|essential hypertension
1366511|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
1366512|NCT01307033|Antihypertensive agents|antihypertensive agents
1366513|NCT01307033|Blood pressure|blood pressure
1366514|NCT01307020|Moderate to severe pain|moderate to severe pain
1366515|NCT01307020|Postoperative pain|postoperative pain
1366516|NCT01307020|Analgesics|analgesics
1366517|NCT01307020|Dexketoprofen|dexketoprofen
1366518|NCT01307020|Tramadol|tramadol
1366519|NCT01306994|Exercise Test|exercise test
1366520|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
1366521|NCT01306994|Stress Test|stress test
1366522|NCT01306981|Diabetes Mellitus|diabetes mellitus
1366523|NCT01306981|Diabetes Complications|diabetes complications
1366524|NCT01306981|Retinal Diseases|retinal diseases
1366525|NCT01306981|Endothelial Growth Factors|endothelial growth factors
1366526|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
1366527|NCT01306981|Ranibizumab|ranibizumab
1366528|NCT01306981|Vitrectomy|vitrectomy
1366529|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
1367636|NCT01302626|SCLC|sclc
1366530|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
1366531|NCT01306968|mTBI|mtbi
1366532|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
1366533|NCT01306968|post concussive symptoms|post concussive symptoms
1366534|NCT01306968|active duty military|active duty military
1366535|NCT01306968|veterans|veterans
1366536|NCT01306955|retinal vasculitis|retinal vasculitis
1366537|NCT01306955|posterior uveitis|posterior uveitis
1366538|NCT01306955|methylprednisolone|methylprednisolone
1366539|NCT01306942|HER2 positive breast cancer|her2 positive breast cancer
1366540|NCT01306942|first line treatment|first line treatment
1366541|NCT01306942|Dasatinib|dasatinib
1366542|NCT01306942|SRC kinase|src kinase
1366543|NCT01306942|Trastuzumab resistance|trastuzumab resistance
1366544|NCT01306929|Huntington Disease.|huntington disease.
1366545|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
1366546|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
1366547|NCT01306877|hemorrhoid|hemorrhoid
1366548|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
1366549|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
1366550|NCT01306864|Peptic Ulcer|peptic ulcer
1366551|NCT01306864|Recurrent Bleeding|recurrent bleeding
1366552|NCT01306864|Injection Therapy|injection therapy
1366553|NCT01306864|Thermal Probe|thermal probe
1366554|NCT01306851|fibrin glue|fibrin glue
1366555|NCT01306851|anastomotic leak|anastomotic leak
1366556|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
1366557|NCT01306838|Short bowel syndrome|short bowel syndrome
1366558|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
1366559|NCT01306838|Small intestine perforation|small intestine perforation
1366560|NCT01306838|Enterostomy|enterostomy
1366561|NCT01306838|Intralipid|intralipid
1366562|NCT01306838|Microlipid|microlipid
1366563|NCT01306838|Fish oil|fish oil
1366564|NCT01306825|Daptomycin|daptomycin
1366565|NCT01306825|Bone disease,infectious|bone disease,infectious
1366566|NCT01306825|Osteomyelitis|osteomyelitis
1366567|NCT01306825|Diabetic foot|diabetic foot
1366568|NCT01306825|Staphylococcus aureus|staphylococcus aureus
1366569|NCT01306812|Adolescent|adolescent
1366570|NCT01306812|Alcohol|alcohol
1366571|NCT01306812|Criminology|criminology
1366572|NCT01306812|Genes|genes
1366573|NCT01306812|Environment|environment
1366574|NCT01306812|Mono amine Oxidase|mono amine oxidase
1366575|NCT01306812|Serotonin|serotonin
1366576|NCT01306812|Social Support|social support
1366577|NCT01306799|Barrett's Esophagus|barrett's esophagus
1366578|NCT01306799|Erosive Esophagitis|erosive esophagitis
1366579|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
1366580|NCT01306799|Bone|bone
1366581|NCT01306799|Bone Density|bone density
1366582|NCT01306799|GERD|gerd
1366583|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
1366584|NCT01306773|Influenza A|influenza a
1366585|NCT01306773|convalescent plasma|convalescent plasma
1366586|NCT01306773|death|death
1366587|NCT01306760|depression|depression
1366588|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
1366589|NCT01306760|ketamine|ketamine
1366590|NCT01306747|Chronic pain|chronic pain
1366591|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
1366592|NCT01306747|Patient education|patient education
1366593|NCT01306734|Extracorporeal circulation|extracorporeal circulation
1366594|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
1366595|NCT01306734|aortic aneurism|aortic aneurism
1366596|NCT01306734|neurological injury|neurological injury
1366597|NCT01306734|inflammation|inflammation
1366598|NCT01306734|coagulation|coagulation
1366599|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
1366600|NCT01306708|Shoulder|shoulder
1366601|NCT01306708|SPADI|spadi
1366602|NCT01306695|Dementia|dementia
1366603|NCT01306695|Depressive symptoms|depressive symptoms
1366604|NCT01306695|Caregiver Burden|caregiver burden
1366605|NCT01306695|Hispanic|hispanic
1366606|NCT01306695|Latino|latino
1366607|NCT01306695|Intervention|intervention
1366608|NCT01306695|Geriatric Depression Scale|geriatric depression scale
1366609|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
1366610|NCT01306656|Endocrinology|endocrinology
1366611|NCT01306656|Metabolic Bone Disease|metabolic bone disease
1366612|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
1366613|NCT01306656|PHPT|phpt
1366614|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
1366615|NCT01306656|Bone Mineral Density|bone mineral density
1366616|NCT01306656|Hyper-calcemia|hyper-calcemia
1366617|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
1366618|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1366619|NCT01306643|iNHL|inhl
1366620|NCT01306643|NHL|nhl
1366621|NCT01306643|CAL-101|cal-101
1366622|NCT01306643|PI3K|pi3k
1366623|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1366624|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
1366625|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1366626|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
1366627|NCT01306630|AV-951|av-951
1366628|NCT01306630|tivozanib|tivozanib
1366629|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
1366630|NCT01306604|Genetic Diseases|genetic diseases
1366631|NCT01306604|Lipidoses|lipidoses
1366632|NCT01306604|Lipid Metabolism|lipid metabolism
1366633|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
1366634|NCT01306604|Metabolic Diseases|metabolic diseases
1366635|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
1366636|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
1366637|NCT01306591|Bevacizumab|bevacizumab
1366638|NCT01306591|Multicenter Randomized Study|multicenter randomized study
1366639|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
1366641|NCT01306578|Plasma exchange|plasma exchange
1366642|NCT01306565|Unstable angina|unstable angina
1366643|NCT01306565|NSTMI|nstmi
1366644|NCT01306565|Statin|statin
1366645|NCT01306565|Atorvastatin|atorvastatin
1366646|NCT01306552|Tobacco use|tobacco use
1366647|NCT01306552|Adolescents|adolescents
1366648|NCT01306552|Primary prevention|primary prevention
1366649|NCT01306552|Program effectiveness|program effectiveness
1366650|NCT01306552|Parental component|parental component
1366651|NCT01306539|deep brain stimulation|deep brain stimulation
1366652|NCT01306539|subthalamic nucleus|subthalamic nucleus
1366653|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
1366654|NCT01306526|Vulnerable plaque|vulnerable plaque
1366655|NCT01306526|Coronary artery disease|coronary artery disease
1366656|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
1366657|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
1366658|NCT01306513|emphysema|emphysema
1366659|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
1366660|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
1366661|NCT01306500|Gastric lavage|gastric lavage
1366662|NCT01306500|Neonate|neonate
1366663|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
1366664|NCT01306500|Feeding problems|feeding problems
1366665|NCT01306487|macular hole|macular hole
1366666|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
1366667|NCT01306448|constipation|constipation
1366668|NCT01306448|gastro|gastro
1366669|NCT01306448|vibrating capsule|vibrating capsule
1366670|NCT01306448|safety|safety
1366671|NCT01306435|Osteoarthritis|osteoarthritis
1366672|NCT01306435|Low Power Laser Therapy|low power laser therapy
1366673|NCT01306435|Exercise|exercise
1366674|NCT01306435|Knee|knee
1366675|NCT01306422|hoodia gordonii|hoodia gordonii
1366676|NCT01306422|energy intake|energy intake
1366677|NCT01306422|food intake|food intake
1366678|NCT01306422|efficacy|efficacy
1366679|NCT01306422|body weight|body weight
1366680|NCT01306422|functional food|functional food
1366681|NCT01306422|plant extract|plant extract
1366682|NCT01306422|safety|safety
1366683|NCT01306422|steroid glycosides|steroid glycosides
1366684|NCT01306422|tolerability|tolerability
1366685|NCT01306409|anemia|anemia
1366686|NCT01306409|kidney disease|kidney disease
1366687|NCT01306396|NAFLD|nafld
1366688|NCT01306396|metabolic syndrome|metabolic syndrome
1366689|NCT01306396|children|children
1366690|NCT01306396|fructose|fructose
1366691|NCT01306383|SODIS|sodis
1366692|NCT01306383|waterborne|waterborne
1366693|NCT01306383|Disease|disease
1366694|NCT01306383|Diarrhoea|diarrhoea
1366695|NCT01306383|dysentery|dysentery
1366696|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
1366697|NCT01306370|fibrin glue|fibrin glue
1366698|NCT01306370|tranexamic acid|tranexamic acid
1366699|NCT01306370|topic|topic
1366700|NCT01306357|Turner's syndrome|turner's syndrome
1366701|NCT01306357|somatropin|somatropin
1366702|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
1366703|NCT01306344|Qualitative Research|qualitative research
1366704|NCT01306344|Interview, Psychological|interview, psychological
1366705|NCT01306344|Patients|patients
1366706|NCT01306344|Nurses|nurses
1366707|NCT01306344|Physicians|physicians
1366708|NCT01306305|Influenza|influenza
1366709|NCT01306305|Virus|virus
1366710|NCT01306305|Vaccination|vaccination
1366711|NCT01306305|Immunisation|immunisation
1366712|NCT01306292|Pulmonary hypertension|pulmonary hypertension
1366713|NCT01306292|Right heart Catheterization|right heart catheterization
1366714|NCT01306279|Cystic Fibrosis|cystic fibrosis
1366715|NCT01306279|Infection|infection
1366716|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
1366717|NCT01306279|Hypermutators|hypermutators
1366718|NCT01306279|Bacterial diversity|bacterial diversity
1366719|NCT01306279|Quorum sensing|quorum sensing
1366720|NCT01306266|active duty|active duty
1366721|NCT01306266|blast induced|blast induced
1366722|NCT01306266|headache|headache
1366723|NCT01306253|Influenza|influenza
1366724|NCT01306253|Virus|virus
1366725|NCT01306253|Vaccination|vaccination
1366927|NCT01305499|AML|aml
1366726|NCT01306253|Immunisation|immunisation
1366727|NCT01306240|Infant newborn|infant newborn
1366728|NCT01306240|Infant preterm|infant preterm
1366729|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
1366730|NCT01306240|surfactant|surfactant
1366731|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
1366732|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
1366733|NCT01306227|Infant, newborn|infant, newborn
1366734|NCT01306227|Infant, preterm|infant, preterm
1366735|NCT01306227|Thyroid|thyroid
1366736|NCT01306227|Outcome|outcome
1366737|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
1366738|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
1366739|NCT01306201|Hospital Setting|hospital setting
1366740|NCT01306188|metastatic cancer|metastatic cancer
1366741|NCT01306188|lymphopenia|lymphopenia
1366742|NCT01306188|T cell receptor diversity|t cell receptor diversity
1366743|NCT01306149|biochemical parameters|biochemical parameters
1366744|NCT01306149|mineral metabolism|mineral metabolism
1366745|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
1366746|NCT01306149|incident PD patients|incident pd patients
1366747|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
1366748|NCT01306136|Prolonged exposure|prolonged exposure
1366749|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
1366750|NCT01306123|bioavailability|bioavailability
1366751|NCT01306123|pharmacokinetics|pharmacokinetics
1366752|NCT01306123|cyanocobalamin|cyanocobalamin
1366753|NCT01306123|intranasal|intranasal
1366754|NCT01306123|intramuscular|intramuscular
1366755|NCT01306110|Liver fibrosis|liver fibrosis
1366756|NCT01306110|diabetes|diabetes
1366757|NCT01306110|Fibroscan|fibroscan
1366758|NCT01306110|Fibrotest|fibrotest
1366759|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
1366760|NCT01306097|Zinc Supplement|zinc supplement
1366761|NCT01306097|Diarrhea|diarrhea
1366762|NCT01306097|Sever Diarrhea|sever diarrhea
1366763|NCT01306084|Respiratory Infections|respiratory infections
1366764|NCT01306084|Norovirus|norovirus
1366765|NCT01306084|Adenovirus|adenovirus
1366766|NCT01306084|Viral Infection|viral infection
1366767|NCT01306084|Respiratory Viruses|respiratory viruses
1366768|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
1366769|NCT01306058|TRC105|trc105
1366770|NCT01306058|Sorafenib|sorafenib
1366771|NCT01306058|Liver Cancer|liver cancer
1366772|NCT01306058|Monoclonal Antibody|monoclonal antibody
1366773|NCT01306045|AZD6244|azd6244
1366774|NCT01306045|MK-2206|mk-2206
1366775|NCT01306045|Lapatinib|lapatinib
1366776|NCT01306045|Erlotinib|erlotinib
1366777|NCT01306045|Sunitinib|sunitinib
1366778|NCT01306045|Lung Cancer|lung cancer
1366779|NCT01306045|Thymic Cancer|thymic cancer
1366780|NCT01306045|Small Cell Lung Cancer|small cell lung cancer
1366781|NCT01306045|Non-Small Cell Lung Cancer|non-small cell lung cancer
1366782|NCT01306032|PARP Inhibitor|parp inhibitor
1366783|NCT01306032|BRCA Mutations|brca mutations
1366784|NCT01306032|DNA Damage Repair|dna damage repair
1366785|NCT01306032|Pharmacodynamics|pharmacodynamics
1366786|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
1366787|NCT01306032|Ovarian Cancer|ovarian cancer
1366788|NCT01306032|Breast Cancer|breast cancer
1366789|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
1366790|NCT01306032|Peritoneal Cancer|peritoneal cancer
1366791|NCT01306019|X-Linked Severe Combined Immunodeficiency (XSCID)|x-linked severe combined immunodeficiency (xscid)
1366792|NCT01306019|Gene Transfer|gene transfer
1366793|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
1366794|NCT01306019|Common Gamma Chain (GC), Immune Reconstitution|common gamma chain (gc), immune reconstitution
1366795|NCT01306019|Immune Reconstitution|immune reconstitution
1366796|NCT01306019|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
1366797|NCT01306019|SCID|scid
1366798|NCT01306006|Mortality|mortality
1366799|NCT01306006|Vaccines|vaccines
1366800|NCT01305954|Breast|breast
1366801|NCT01305954|Cancer|cancer
1366802|NCT01305954|Breast Cancer|breast cancer
1366803|NCT01305954|New Diagnosis|new diagnosis
1366804|NCT01305954|Treatment|treatment
1366805|NCT01305954|Chemotherapy|chemotherapy
1366806|NCT01305954|Blood|blood
1366807|NCT01305954|Blood Draw|blood draw
1366808|NCT01305954|Lab Draw|lab draw
1366809|NCT01305954|Gene|gene
1366810|NCT01305954|Gene Therapy|gene therapy
1366811|NCT01305954|Geriatric|geriatric
1366812|NCT01305954|Oncology|oncology
1366813|NCT01305954|Muss|muss
1366814|NCT01305954|UNC|unc
1366815|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
1366816|NCT01305954|Initial Treatment|initial treatment
1366817|NCT01305954|CBC|cbc
1366818|NCT01305941|everolimus|everolimus
1366819|NCT01305941|trastuzumab|trastuzumab
1366820|NCT01305941|vinorelbine|vinorelbine
1366821|NCT01305941|RAD001|rad001
1366822|NCT01305941|Breast Cancer|breast cancer
1366823|NCT01305941|Herceptin|herceptin
1366824|NCT01305941|Navelbine|navelbine
1366825|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1366826|NCT01305941|Brain Metastases|brain metastases
1366827|NCT01305915|single-session group|single-session group
1366828|NCT01305915|psychoeducational intervention|psychoeducational intervention
1366829|NCT01305889|Depression|depression
1366830|NCT01305889|Cerebral perfusion|cerebral perfusion
1366831|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
1366832|NCT01305889|Problem Solving Therapy|problem solving therapy
1366833|NCT01305889|Sertraline|sertraline
1366834|NCT01305876|yoga|yoga
1366835|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
1366836|NCT01305876|intervention|intervention
1366837|NCT01305876|school|school
1366838|NCT01305876|meditation|meditation
1366839|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
1366840|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
1366841|NCT01305850|Aliskiren|aliskiren
1366842|NCT01305850|Losartan|losartan
1366843|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
1366844|NCT01305837|multiple sclerosis|multiple sclerosis
1366845|NCT01305837|methylprednisolone|methylprednisolone
1366846|NCT01305837|osteopontin|osteopontin
1366847|NCT01305837|inflammation|inflammation
1366848|NCT01305837|demyelinating|demyelinating
1366849|NCT01305824|arteriovenous fistula|arteriovenous fistula
1366850|NCT01305824|AVF|avf
1366851|NCT01305824|hemodialysis|hemodialysis
1366852|NCT01305824|vascular access|vascular access
1366853|NCT01305824|dialysis|dialysis
1366854|NCT01305824|fistula|fistula
1366855|NCT01305824|PRT-201|prt-201
1366856|NCT01305824|vonapanitase|vonapanitase
1366857|NCT01305824|kidney|kidney
1366858|NCT01305824|renal|renal
1366859|NCT01305811|Complex Medical Illness|complex medical illness
1366860|NCT01305811|Gulf War Illness|gulf war illness
1366861|NCT01305811|Veteran|veteran
1366862|NCT01305798|Biometric Screenings|biometric screenings
1366863|NCT01305798|Active Choice|active choice
1366864|NCT01305798|Behavioral Economics|behavioral economics
1366865|NCT01305798|Default|default
1366866|NCT01305772|SCCHN|scchn
1366867|NCT01305772|untreated|untreated
1366868|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
1366869|NCT01305759|Total knee arthroplasty|total knee arthroplasty
1366870|NCT01305759|Total hip arthroplasty|total hip arthroplasty
1366871|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
1366872|NCT01305759|Social class|social class
1366873|NCT01305759|Health related quality of life|health related quality of life
1366874|NCT01305746|SLE|sle
1366875|NCT01305746|Lupus|lupus
1366876|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1366877|NCT01305746|A-623|a-623
1366878|NCT01305746|Autoimmune Diseases|autoimmune diseases
1366879|NCT01305746|Blisibimod|blisibimod
1366880|NCT01305733|Pain relief|pain relief
1366881|NCT01305720|mydriatic|mydriatic
1366882|NCT01305720|NIRS|nirs
1366883|NCT01305720|preterm|preterm
1366884|NCT01305720|eye drops|eye drops
1366885|NCT01305720|cerebral|cerebral
1366886|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
1366887|NCT01305707|Consolidation ECT|consolidation ect
1366888|NCT01305707|Pharmacotherapy|pharmacotherapy
1366889|NCT01305707|Efficacy|efficacy
1366890|NCT01305707|Depression|depression
1366891|NCT01305707|Prevention|prevention
1366892|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
1366893|NCT01305707|Drug therapy|drug therapy
1366894|NCT01305668|COPD|copd
1366895|NCT01305668|Emphysema phenotype|emphysema phenotype
1366896|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
1366897|NCT01305642|Postnatal development|postnatal development
1366898|NCT01305642|Breast milk fortification|breast milk fortification
1366899|NCT01305642|Composition of breast milk|composition of breast milk
1366900|NCT01305629|HIV|hiv
1366901|NCT01305629|Medication Adherence|medication adherence
1366902|NCT01305629|Substance Use|substance use
1366903|NCT01305629|Older adults|older adults
1366904|NCT01305629|Treatment|treatment
1366905|NCT01305616|Open angle Glaucoma|open angle glaucoma
1366906|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
1366907|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
1366908|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
1366909|NCT01305616|cataract|cataract
1366910|NCT01305590|HIV|hiv
1366911|NCT01305590|AIDS|aids
1366912|NCT01305590|Medication Adherence|medication adherence
1366913|NCT01305590|Commitment Devices|commitment devices
1366914|NCT01305590|Behavioral Economics|behavioral economics
1366915|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
1366916|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
1366917|NCT01305564|Vena cava|vena cava
1366918|NCT01305564|Vena cava filter|vena cava filter
1366919|NCT01305564|Inferior vena cava|inferior vena cava
1366920|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
1366921|NCT01305525|SCS|scs
1484942|NCT00837005|CAD|cad
1366922|NCT01305525|St. Jude Medical|st. jude medical
1366923|NCT01305525|Neuromodulation|neuromodulation
1366924|NCT01305512|Solid|solid
1366925|NCT01305512|Tumor|tumor
1366928|NCT01305447|smoking cessation|smoking cessation
1366929|NCT01305447|exercise maintenance|exercise maintenance
1366930|NCT01305447|preventing relapse|preventing relapse
1366931|NCT01305447|weight gain|weight gain
1366932|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
1366933|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
1366934|NCT01305434|mulberry leaf extract|mulberry leaf extract
1366935|NCT01305434|post prandial blood glucose|post prandial blood glucose
1366936|NCT01305421|ICU|icu
1366937|NCT01305421|muscle strength|muscle strength
1366938|NCT01305421|mechanical ventilation|mechanical ventilation
1366939|NCT01305421|weaning|weaning
1366940|NCT01305408|Bipolar I Disorder|bipolar i disorder
1366941|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
1366942|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
1366943|NCT01305369|ASTHMA|asthma
1366944|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
1366945|NCT01305369|PRASUGREL|prasugrel
1366946|NCT01305369|INFLAMMATION|inflammation
1366947|NCT01305356|degenerative joint disease|degenerative joint disease
1366948|NCT01305356|DJD|djd
1366949|NCT01305356|joint fusion|joint fusion
1366950|NCT01305356|hindfoot|hindfoot
1366951|NCT01305356|congenital deformity|congenital deformity
1366952|NCT01305356|osteoarthritis|osteoarthritis
1366953|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
1366954|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
1366955|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
1366956|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
1366957|NCT01305356|autologous bone graft|autologous bone graft
1366958|NCT01305356|autogenous bone graft|autogenous bone graft
1366959|NCT01305356|beta-TCP|beta-tcp
1366960|NCT01305356|bovine collagen|bovine collagen
1366961|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
1366962|NCT01305343|Spinal Deformity|spinal deformity
1366963|NCT01305343|Scoliosis|scoliosis
1366964|NCT01305343|Neurologic complications|neurologic complications
1366965|NCT01305330|small renal mass|small renal mass
1366966|NCT01305330|active surveillance|active surveillance
1366967|NCT01305330|kidney mass|kidney mass
1366968|NCT01305330|kidney tumour|kidney tumour
1366969|NCT01305317|Statin|statin
1366970|NCT01305291|dietary fiber|dietary fiber
1366971|NCT01305291|satiety response|satiety response
1366972|NCT01305291|hunger|hunger
1366973|NCT01305291|CCK|cck
1366974|NCT01305291|PYY|pyy
1366975|NCT01305291|ghrelin|ghrelin
1366976|NCT01305291|GIP|gip
1366977|NCT01305291|GLP-1|glp-1
1366978|NCT01305278|Balance|balance
1366979|NCT01305278|Rehabilitation|rehabilitation
1366980|NCT01305278|Vestibular|vestibular
1366981|NCT01305265|sore throat|sore throat
1366982|NCT01305265|dysphagia|dysphagia
1366983|NCT01305265|hoarseness|hoarseness
1366984|NCT01305265|post operative|post operative
1366985|NCT01305265|endotracheal intubation|endotracheal intubation
1366986|NCT01305239|Observational|observational
1366987|NCT01305239|epidemiological|epidemiological
1366988|NCT01305239|cohort|cohort
1366989|NCT01305239|cross-sectional|cross-sectional
1366990|NCT01305239|prospective|prospective
1366991|NCT01305239|multicenter|multicenter
1366992|NCT01305239|survey|survey
1366993|NCT01305239|France.|france.
1366994|NCT01305226|THR 100|thr 100
1366995|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
1366996|NCT01305161|1Allergy|1allergy
1366997|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
1366998|NCT01305148|warfarin|warfarin
1366999|NCT01305148|genetic testing|genetic testing
1367000|NCT01305148|personalized medicine|personalized medicine
1367001|NCT01305148|anti-coagulants|anti-coagulants
1367002|NCT01305148|coumadin|coumadin
1367003|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
1367004|NCT01305122|Glioma|glioma
1367005|NCT01305122|Neurocognitive functions|neurocognitive functions
1367006|NCT01305096|heart rate variability|heart rate variability
1367007|NCT01305096|oxygen uptake|oxygen uptake
1367008|NCT01305096|heart rate recovery|heart rate recovery
1367009|NCT01305096|perceived stress|perceived stress
1367010|NCT01305096|sleep|sleep
1367011|NCT01305096|blood pressure|blood pressure
1367012|NCT01305096|body mass index|body mass index
1367013|NCT01305096|body weight|body weight
1367014|NCT01305096|hand grip strength|hand grip strength
1367015|NCT01305096|sleep quality|sleep quality
1367016|NCT01305096|subjective health complaints|subjective health complaints
1367017|NCT01305096|blood lipids|blood lipids
1367018|NCT01305096|salivary cortisol|salivary cortisol
1367019|NCT01305096|blood sugar|blood sugar
1367020|NCT01305096|HbA1C|hba1c
1367021|NCT01305096|Adiponectin|adiponectin
1367022|NCT01305096|Leptin|leptin
1367023|NCT01305096|Adipolipoproteins|adipolipoproteins
1367024|NCT01305096|blood proteins|blood proteins
1367025|NCT01305096|cytokines|cytokines
1367026|NCT01305096|insomnia|insomnia
1367027|NCT01305096|sleeplessness|sleeplessness
1367028|NCT01305096|yoga|yoga
1367029|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
1367030|NCT01305070|POBA|poba
1367031|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
1367032|NCT01305070|Superficial femoral artery|superficial femoral artery
1367033|NCT01305057|dry skin condition|dry skin condition
1367034|NCT01305044|tai chi|tai chi
1367035|NCT01305044|elderly cancer survivor|elderly cancer survivor
1367036|NCT01305044|mind body intervention|mind body intervention
1367037|NCT01305031|Asphyxia|asphyxia
1367038|NCT01305031|Resuscitation|resuscitation
1367039|NCT01305031|Room Air|room air
1367040|NCT01305018|Branched-chain amino acids|branched-chain amino acids
1367041|NCT01305018|Leucine|leucine
1367042|NCT01305018|Muscle damage|muscle damage
1367043|NCT01305018|Inflammation|inflammation
1367044|NCT01305018|supplementation|supplementation
1367045|NCT01305018|resistance exercise-induced|resistance exercise-induced
1367046|NCT01305005|blood flow|blood flow
1367047|NCT01304992|Dietary protein|dietary protein
1367048|NCT01304992|Lupin protein|lupin protein
1367049|NCT01304992|Cholesterol metabolism|cholesterol metabolism
1367050|NCT01304992|Protein metabolism|protein metabolism
1367051|NCT01304992|Hypercholesterolemia|hypercholesterolemia
1367052|NCT01304992|Protein-enriched drinks|protein-enriched drinks
1367053|NCT01304979|acupuncture|acupuncture
1367054|NCT01304979|auricular acu-therapy|auricular acu-therapy
1367055|NCT01304979|gua sha therapy|gua sha therapy
1367056|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
1367057|NCT01304979|post surgical pain|post surgical pain
1367058|NCT01304979|post surgical recovery|post surgical recovery
1367059|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
1367061|NCT01304966|HPV|hpv
1367062|NCT01304953|General anaesthetics|general anaesthetics
1367063|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
1367064|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
1367065|NCT01304953|propofol|propofol
1367066|NCT01304953|anaesthetic volatile|anaesthetic volatile
1367067|NCT01304953|evoflurane|evoflurane
1367068|NCT01304953|antiemetics|antiemetics
1367069|NCT01304953|reopisetron|reopisetron
1367070|NCT01304953|postoperative pain|postoperative pain
1367071|NCT01304940|Stress|stress
1367072|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1367073|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
1367074|NCT01304927|Reproduction|reproduction
1367075|NCT01304927|Sex hormones|sex hormones
1367076|NCT01304927|Glucose metabolism|glucose metabolism
1367077|NCT01304927|Bone metabolism|bone metabolism
1367078|NCT01304927|Calcium|calcium
1367079|NCT01304927|Sperm|sperm
1367080|NCT01304927|testis|testis
1367081|NCT01304927|bone|bone
1367082|NCT01304927|endocrinology|endocrinology
1367083|NCT01304914|Respiratory tract infections|respiratory tract infections
1367084|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
1367085|NCT01304914|Pediatrics|pediatrics
1367086|NCT01304914|Specimen collection|specimen collection
1367087|NCT01304901|Acute asthma|acute asthma
1367088|NCT01304901|Children|children
1367089|NCT01304901|Montelukast|montelukast
1367090|NCT01304901|Emergency room|emergency room
1367091|NCT01304888|Food consumption|food consumption
1367092|NCT01304875|Fabry disease|fabry disease
1367093|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
1367094|NCT01304875|exercise|exercise
1367095|NCT01304875|pulmonary|pulmonary
1367096|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
1367097|NCT01304849|PET CT scan|pet ct scan
1367098|NCT01304849|Escalated BEACOPP|escalated beacopp
1367099|NCT01304849|ABVD|abvd
1367100|NCT01304849|Response adapted therapy|response adapted therapy
1367101|NCT01304836|Kidney|kidney
1367102|NCT01304836|Diabetes Mellitus|diabetes mellitus
1367103|NCT01304836|Transplant|transplant
1367104|NCT01304836|Immunosuppression|immunosuppression
1367105|NCT01304823|T1R2/T1R3|t1r2/t1r3
1367106|NCT01304823|gastric emptying|gastric emptying
1367107|NCT01304823|gut|gut
1367108|NCT01304823|lactisole|lactisole
1367109|NCT01304823|nutrient sensing|nutrient sensing
1367110|NCT01304810|NicVAX|nicvax
1367111|NCT01304810|Smoking cessation|smoking cessation
1367112|NCT01304797|MM302|mm302
1367113|NCT01304797|Breast Cancer|breast cancer
1367114|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
1367115|NCT01304797|metastatic|metastatic
1367116|NCT01304784|Solid tumors|solid tumors
1367117|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
1367118|NCT01304771|Safety|safety
1367119|NCT01304771|AKSB|aksb
1367120|NCT01304771|probiotic|probiotic
1367121|NCT01304771|synbiotic|synbiotic
1367122|NCT01304771|enterococcus|enterococcus
1367123|NCT01304771|Saccharomyces|saccharomyces
1367124|NCT01304771|elderly|elderly
1367125|NCT01304771|influenza|influenza
1367126|NCT01304771|vaccine|vaccine
1367127|NCT01304771|immune|immune
1367128|NCT01304771|response|response
1367129|NCT01304693|AMD|amd
1367130|NCT01304693|Wet AMD|wet amd
1367131|NCT01304693|Exudative|exudative
1367132|NCT01304693|CNV|cnv
1367133|NCT01304667|Vulvar cancer|vulvar cancer
1367134|NCT01304667|Radiotherapy|radiotherapy
1367135|NCT01304667|Chemotherapy|chemotherapy
1367136|NCT01304654|acute lung injury|acute lung injury
1367137|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
1367138|NCT01304654|neoplasms|neoplasms
1367139|NCT01304654|child|child
1367140|NCT01304641|Dyslipidemia|dyslipidemia
1367141|NCT01304641|Cardiovascular|cardiovascular
1367142|NCT01304641|Statin|statin
1367143|NCT01304628|asthma|asthma
1367144|NCT01304615|Overweight|overweight
1367145|NCT01304615|Obesity|obesity
1367146|NCT01304615|Young Adults|young adults
1367147|NCT01304615|Energy Density|energy density
1367148|NCT01304615|Culinary Skills|culinary skills
1367149|NCT01304615|Physical Activity|physical activity
1367150|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
1367151|NCT01304615|Family History of diabetes|family history of diabetes
1367152|NCT01304602|colorectal cancer|colorectal cancer
1367153|NCT01304602|BKM120|bkm120
1367154|NCT01304602|irinotecan|irinotecan
1367155|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
1367156|NCT01304589|vulvodynia|vulvodynia
1367157|NCT01304589|PVD|pvd
1367158|NCT01304576|stroke|stroke
1367159|NCT01304576|parietal lesions|parietal lesions
1367160|NCT01304550|non-invasive|non-invasive
1367161|NCT01304550|hemoglobin|hemoglobin
1367162|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
1367163|NCT01304524|Cervical cancer|cervical cancer
1367164|NCT01304524|Papillomavirus|papillomavirus
1367165|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
1367166|NCT01304485|sodium acetate c11|sodium acetate c11
1367167|NCT01304485|PET|pet
1367168|NCT01304485|prostate cancer|prostate cancer
1367169|NCT01304485|rising PSA|rising psa
1367170|NCT01304485|PSA recurrence|psa recurrence
1367171|NCT01304485|biochemical recurrence|biochemical recurrence
1367172|NCT01304472|coronary angioplasty|coronary angioplasty
1367173|NCT01304472|clopidogrel resistance|clopidogrel resistance
1367174|NCT01304472|prasugrel|prasugrel
1367175|NCT01304446|Nutritional support|nutritional support
1367176|NCT01304446|Cancer|cancer
1367177|NCT01304446|Malnutrition|malnutrition
1367178|NCT01304446|Child|child
1367179|NCT01304446|Adolescent|adolescent
1367180|NCT01304446|pediatric|pediatric
1367181|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
1367182|NCT01304420|Ultrasonography|ultrasonography
1367183|NCT01304420|Cartilage|cartilage
1367184|NCT01304420|Cartilage biomarkers|cartilage biomarkers
1367185|NCT01304420|Bone biomarkers|bone biomarkers
1367186|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
1367187|NCT01304407|Calcium absorption|calcium absorption
1367188|NCT01304407|Bone density|bone density
1367189|NCT01304394|Parenteral Nutrition|parenteral nutrition
1367190|NCT01304394|Multi Chamber Bag|multi chamber bag
1367191|NCT01304381|Heart failure|heart failure
1367192|NCT01304381|Palliative care|palliative care
1367193|NCT01304381|Integrated care|integrated care
1367194|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
1367195|NCT01304368|Randomized Controlled Trial|randomized controlled trial
1367196|NCT01304368|Neck Pain|neck pain
1367197|NCT01304368|Sensory Thresholds|sensory thresholds
1367198|NCT01304368|Pain Measurements|pain measurements
1367199|NCT01304355|IBS|ibs
1367200|NCT01304355|Cognition|cognition
1367201|NCT01304355|Kynurenine Pathway|kynurenine pathway
1367202|NCT01304355|Gastrointestinal|gastrointestinal
1367203|NCT01304342|Propofol|propofol
1367204|NCT01304342|remifentanil|remifentanil
1367205|NCT01304342|fentanyl|fentanyl
1367206|NCT01304342|ERCP|ercp
1367207|NCT01304342|Quality of sedation|quality of sedation
1367208|NCT01304342|recovery|recovery
1367209|NCT01304342|satisfaction|satisfaction
1367210|NCT01304342|respiratory depression|respiratory depression
1367211|NCT01304303|solid|solid
1367212|NCT01304303|tumor|tumor
1367213|NCT01304303|taxane|taxane
1367214|NCT01304303|platinum|platinum
1367215|NCT01304290|inflammatory process|inflammatory process
1367216|NCT01304290|hyperglycaemia|hyperglycaemia
1367217|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
1367218|NCT01304290|organ survival|organ survival
1367219|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
1367220|NCT01304277|Replagal|replagal
1367221|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
1367222|NCT01304251|short-term fasting|short-term fasting
1367223|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
1367224|NCT01304251|toxicity|toxicity
1367225|NCT01304251|side-effects|side-effects
1367226|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
1485300|NCT00835432|GBR|gbr
1367227|NCT01304225|diabetic retinopathy|diabetic retinopathy
1367228|NCT01304225|photocoagulation|photocoagulation
1367229|NCT01304225|PASCAL laser|pascal laser
1367230|NCT01304212|total knee arthroplasty|total knee arthroplasty
1367231|NCT01304212|intraarticular infiltration|intraarticular infiltration
1367232|NCT01304212|femoral block|femoral block
1367233|NCT01304199|Cancer survivor|cancer survivor
1367234|NCT01304199|Neoplasms|neoplasms
1367235|NCT01304199|Treatments|treatments
1367236|NCT01304199|Physical status|physical status
1367237|NCT01304199|Psychosocial status|psychosocial status
1367238|NCT01304199|Survivorship survey|survivorship survey
1367239|NCT01304199|Survivorship care|survivorship care
1367240|NCT01304199|Research|research
1367241|NCT01304199|Cancer patient|cancer patient
1367637|NCT01302626|lung cancer|lung cancer
1367242|NCT01304186|Health literacy|health literacy
1367243|NCT01304186|HIV|hiv
1367244|NCT01304186|Medication Adherence|medication adherence
1367245|NCT01304186|IMB Model|imb model
1367246|NCT01304173|BCG|bcg
1367247|NCT01304173|refractory|refractory
1367248|NCT01304173|NMIBC|nmibc
1367249|NCT01304173|CIS|cis
1367250|NCT01304173|non-muscle invasive|non-muscle invasive
1367251|NCT01304160|pancreatic cancer|pancreatic cancer
1367252|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
1367253|NCT01304160|radiation|radiation
1367254|NCT01304160|gemcitabine|gemcitabine
1367255|NCT01304160|locally advanced|locally advanced
1367256|NCT01304147|ketamine|ketamine
1367257|NCT01304147|depression|depression
1367258|NCT01304147|treatment resistance|treatment resistance
1367259|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
1367260|NCT01304147|glutamate|glutamate
1367261|NCT01304147|NMDA receptor|nmda receptor
1367262|NCT01304121|Bone tumors|bone tumors
1367263|NCT01304121|Bioactive glass|bioactive glass
1367264|NCT01304121|Autogenous bone grafting|autogenous bone grafting
1367265|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
1367266|NCT01304121|PET imaging|pet imaging
1367267|NCT01304108|Venous Thromboembolism|venous thromboembolism
1367268|NCT01304108|Delivery of Health Care|delivery of health care
1367269|NCT01304108|Quality Improvement|quality improvement
1367270|NCT01304108|Evidence-Based Practice|evidence-based practice
1367271|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
1367272|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
1367273|NCT01304069|Pharmacokinetics|pharmacokinetics
1367274|NCT01304069|Pharmacodynamics|pharmacodynamics
1367275|NCT01304056|Ventilatory physiology|ventilatory physiology
1367276|NCT01304043|ovarian tumors|ovarian tumors
1367277|NCT01304043|rare ovarian tumors|rare ovarian tumors
1367278|NCT01304043|germinal tumors|germinal tumors
1367279|NCT01304043|sexual cords tumors|sexual cords tumors
1367280|NCT01304043|observatory|observatory
1367281|NCT01304043|forum|forum
1367282|NCT01304030|Empathy|empathy
1367283|NCT01304017|rehabilitation|rehabilitation
1367284|NCT01304017|stroke|stroke
1367285|NCT01304017|intervention|intervention
1367286|NCT01304017|physical activity|physical activity
1367287|NCT01304017|participation|participation
1367288|NCT01304004|Obesity|obesity
1367289|NCT01304004|Yogurt|yogurt
1367290|NCT01304004|Proteins|proteins
1367291|NCT01304004|Fibres|fibres
1367292|NCT01304004|Women|women
1367293|NCT01304004|Satiety|satiety
1367294|NCT01303952|cold agglutinin disease|cold agglutinin disease
1367295|NCT01303952|hemolysis|hemolysis
1367296|NCT01303952|eculizumab|eculizumab
1367297|NCT01303952|terminal complement inhibition|terminal complement inhibition
1367298|NCT01303939|Glaucoma|glaucoma
1367299|NCT01303939|MRI Brain Scan|mri brain scan
1367300|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
1367301|NCT01303926|QoL|qol
1367302|NCT01303926|EQ5D score|eq5d score
1367303|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
1367304|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
1367305|NCT01303926|maintenance|maintenance
1367306|NCT01303913|COPD|copd
1367307|NCT01303913|Oxygen desaturation|oxygen desaturation
1367308|NCT01303913|Walking test|walking test
1367309|NCT01303900|Haemophilia|haemophilia
1367310|NCT01303900|Cardiovascular disease|cardiovascular disease
1367311|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
1367312|NCT01303900|Prospective|prospective
1367313|NCT01303900|QRISK2|qrisk2
1367314|NCT01303900|Hypertension|hypertension
1367315|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
1367316|NCT01303900|Diabetes|diabetes
1367317|NCT01303900|Obesity|obesity
1367318|NCT01303887|PACIFICO|pacifico
1367319|NCT01303887|Follicular Lymphoma|follicular lymphoma
1367320|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1367321|NCT01303887|Rituximab|rituximab
1367322|NCT01303887|R-CVP|r-cvp
1367323|NCT01303887|R-FC|r-fc
1367324|NCT01303887|Older|older
1367325|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
1367326|NCT01303874|Inflammatory arthritis|inflammatory arthritis
1367327|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
1367328|NCT01303874|Etanercept|etanercept
1367329|NCT01303874|Combination Therapy|combination therapy
1367330|NCT01303861|Nicotine addiction|nicotine addiction
1367331|NCT01303861|Cigarette smoking|cigarette smoking
1367332|NCT01303861|Smoking cessation|smoking cessation
1367333|NCT01303861|Zyban|zyban
1367334|NCT01303861|Chantix|chantix
1367335|NCT01303861|Nicotine patches|nicotine patches
1367336|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
1367337|NCT01303861|varenicline|varenicline
1367338|NCT01303861|bupropion|bupropion
1367339|NCT01303848|Blood lactate|blood lactate
1367340|NCT01303848|Lipid transfer proteins|lipid transfer proteins
1367341|NCT01303848|Lactate|lactate
1367342|NCT01303848|PLTP|pltp
1367343|NCT01303848|CETP|cetp
1367344|NCT01303848|PPARs|ppars
1367345|NCT01303848|CLOCk|clock
1367346|NCT01303848|Bal1|bal1
1367347|NCT01303835|malignant glioma|malignant glioma
1367348|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
1367349|NCT01303835|quality of life|quality of life
1367350|NCT01303835|naltrexone|naltrexone
1367351|NCT01303809|Perioperative care|perioperative care
1367352|NCT01303809|Fast-track|fast-track
1367353|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
1367354|NCT01303809|ERAS|eras
1367355|NCT01303809|Obesity|obesity
1367356|NCT01303809|Bariatric surgery|bariatric surgery
1367357|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1367359|NCT01303783|Nifedipine GITS|nifedipine gits
1367360|NCT01303783|Candesartan|candesartan
1367361|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
1367362|NCT01303783|Combination therapy|combination therapy
1367363|NCT01303770|Multiple Sclerosis|multiple sclerosis
1367364|NCT01303770|Cognitive impairment|cognitive impairment
1367365|NCT01303770|Self-management programs|self-management programs
1367366|NCT01303770|Occupational Therapy|occupational therapy
1367367|NCT01303770|Rehabilitation|rehabilitation
1367368|NCT01303757|obesity|obesity
1367369|NCT01303731|Spinal anesthesia|spinal anesthesia
1367370|NCT01303731|Cesarean section|cesarean section
1367371|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
1367372|NCT01303731|Fentanyl|fentanyl
1367373|NCT01303731|Local Anesthetics|local anesthetics
1367374|NCT01303718|LV Dysfunction|lv dysfunction
1367375|NCT01303718|Heart Failure|heart failure
1367376|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
1367377|NCT01303705|cancer of the prostate|cancer of the prostate
1367378|NCT01303705|prostate cancer|prostate cancer
1367379|NCT01303692|bone mineral loss|bone mineral loss
1367380|NCT01303692|prostate cancer|prostate cancer
1367381|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
1367382|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
1367383|NCT01303679|Positive estrogen receptors|positive estrogen receptors
1367384|NCT01303679|Negative HER2 receptors|negative her2 receptors
1367385|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
1367386|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
1367387|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
1367388|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
1367389|NCT01303640|Coronary stent|coronary stent
1367390|NCT01303627|Remifentanil|remifentanil
1367391|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
1367392|NCT01303627|Hemodynamic changing|hemodynamic changing
1367393|NCT01303627|Infusion|infusion
1367394|NCT01303627|Ureterorenoscopy|ureterorenoscopy
1367395|NCT01303614|hysterosalpingography|hysterosalpingography
1367396|NCT01303614|prilocaine|prilocaine
1367397|NCT01303614|local anaesthetic|local anaesthetic
1367398|NCT01303614|pain relief|pain relief
1367399|NCT01303614|gynecological pathology|gynecological pathology
1367400|NCT01303601|Olanzapine|olanzapine
1367401|NCT01303601|Monotherapy|monotherapy
1367402|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
1367403|NCT01303588|elderly patients|elderly patients
1367404|NCT01303575|Adolescents|adolescents
1367405|NCT01303575|Youth|youth
1367406|NCT01303575|Sexual Health|sexual health
1367407|NCT01303575|Sex Education|sex education
1367408|NCT01303575|Pregnancy Prevention|pregnancy prevention
1367409|NCT01303575|Abstinence Education|abstinence education
1367410|NCT01303575|HIV|hiv
1367411|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
1367412|NCT01303575|STI|sti
1367413|NCT01303575|Chlamydia|chlamydia
1367414|NCT01303575|Gonorrhea|gonorrhea
1367415|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
1367416|NCT01303575|American Indian|american indian
1367417|NCT01303575|Alaska Native|alaska native
1367418|NCT01303575|Native American|native american
1367419|NCT01303575|Internet-Based|internet-based
1367420|NCT01303575|Computer-based Education|computer-based education
1367421|NCT01303575|Computer-based learning|computer-based learning
1367422|NCT01303562|oat|oat
1367423|NCT01303562|barley|barley
1367424|NCT01303562|whole grain|whole grain
1485499|NCT00834483|Safety|safety
1367425|NCT01303562|bioavailability|bioavailability
1367426|NCT01303562|phytochemical|phytochemical
1367427|NCT01303549|Liver transplantation|liver transplantation
1367428|NCT01303549|Hepatic transplant|hepatic transplant
1367429|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
1367430|NCT01303549|Anidulafungin|anidulafungin
1367431|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
1367432|NCT01303523|LMWH|lmwh
1367433|NCT01303523|heparin|heparin
1367434|NCT01303523|immobilization|immobilization
1367435|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
1367436|NCT01303523|leg injuries|leg injuries
1367437|NCT01303523|thromboembolism|thromboembolism
1367438|NCT01303510|Influenza|influenza
1367439|NCT01303510|Virus|virus
1367440|NCT01303510|Vaccination|vaccination
1367441|NCT01303510|Immunisation|immunisation
1367442|NCT01303497|Angiosarcoma|angiosarcoma
1367443|NCT01303497|Paclitaxel|paclitaxel
1367444|NCT01303497|bevacizumab|bevacizumab
1367638|NCT01302626|RNA|rna
1367445|NCT01303471|pain assessment|pain assessment
1367446|NCT01303471|anesthesia|anesthesia
1367447|NCT01303471|analgesia|analgesia
1367448|NCT01303471|opioid|opioid
1367449|NCT01303471|HRV|hrv
1367450|NCT01303471|APV|apv
1367451|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
1367452|NCT01303471|pupil size|pupil size
1367453|NCT01303458|community resource|community resource
1367454|NCT01303458|well-child care visit|well-child care visit
1367455|NCT01303458|low-income|low-income
1367456|NCT01303432|Joint discomfort|joint discomfort
1367457|NCT01303432|Functional Food|functional food
1367458|NCT01303432|Joint function|joint function
1367459|NCT01303432|Mobilee|mobilee
1367460|NCT01303419|mammography|mammography
1367461|NCT01303406|randomized withdrawal|randomized withdrawal
1367462|NCT01303406|idebenone|idebenone
1367463|NCT01303406|friedreich's ataxia|friedreich's ataxia
1367464|NCT01303406|Miconos|miconos
1367465|NCT01303406|Patient reported outcome|patient reported outcome
1367466|NCT01303406|ICARS|icars
1367467|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
1367468|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
1367469|NCT01303380|canakinumab|canakinumab
1367470|NCT01303380|HIDS|hids
1367471|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
1367472|NCT01303380|MKD|mkd
1367473|NCT01303367|Dementia|dementia
1367474|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
1367475|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
1367476|NCT01303315|C19 246 300|c19 246 300
1367477|NCT01303302|C19 246 300|c19 246 300
1367478|NCT01303289|Total Enteral Nutrition|total enteral nutrition
1367479|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
1367480|NCT01303289|T-Diet plus Standard|t-diet plus standard
1367481|NCT01303289|Lipidic profile|lipidic profile
1367482|NCT01303289|Quality of life|quality of life
1367483|NCT01303276|retinal vein occlusion|retinal vein occlusion
1367484|NCT01303276|anti-VEGF|anti-vegf
1367485|NCT01303276|blood flow|blood flow
1367486|NCT01303263|efficiency|efficiency
1367487|NCT01303263|cost-awareness|cost-awareness
1367488|NCT01303263|hospitals|hospitals
1367489|NCT01303263|graduate medical education|graduate medical education
1367490|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
1367491|NCT01303250|hemodynamic optimization|hemodynamic optimization
1367492|NCT01303250|crystalloid|crystalloid
1367493|NCT01303250|colloid|colloid
1367494|NCT01303237|LA SCCHN|la scchn
1367495|NCT01303237|Cetuximab|cetuximab
1367496|NCT01303237|RT|rt
1367497|NCT01303237|PMS|pms
1367498|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
1367499|NCT01303224|Colon, irritable|colon, irritable
1367500|NCT01303224|Bowel disease|bowel disease
1367501|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
1367502|NCT01303211|Vaccine efficacy|vaccine efficacy
1367503|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
1367504|NCT01303198|CPAP|cpap
1367505|NCT01303198|APAP|apap
1367506|NCT01303198|sleep apnea|sleep apnea
1367507|NCT01303185|Psoriatic Nail|psoriatic nail
1367508|NCT01303185|Pulsed dye laser|pulsed dye laser
1367509|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
1367510|NCT01303159|Pancreatic Cancer|pancreatic cancer
1367511|NCT01303159|Radiofrequency|radiofrequency
1367512|NCT01303159|Ablation|ablation
1367513|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1367514|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
1367515|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1367516|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
1367517|NCT01303081|Smoking Cessation|smoking cessation
1367518|NCT01303081|Work-site|work-site
1367519|NCT01303081|Incentives|incentives
1367520|NCT01303081|Health Behavior|health behavior
1367521|NCT01303081|Smoking|smoking
1367522|NCT01303068|CF|cf
1367523|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
1367524|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1367525|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
1367526|NCT01303055|Metabolic Diseases|metabolic diseases
1367527|NCT01303055|Endocrine System Diseases|endocrine system diseases
1367528|NCT01303055|Metformin|metformin
1367529|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
1367530|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
1367531|NCT01303055|Pharmacologic Actions|pharmacologic actions
1367532|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
1367533|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
1367534|NCT01303042|insulin LISPRO|insulin lispro
1367535|NCT01303042|Insulin therapy|insulin therapy
1367629|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
1367536|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
1367537|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1367538|NCT01303042|Quality of Life|quality of life
1367539|NCT01303042|Hypoglycemia|hypoglycemia
1367540|NCT01303042|Diabetes Mellitus|diabetes mellitus
1367541|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
1367542|NCT01303029|Pancreatic cancer|pancreatic cancer
1367543|NCT01303029|gemcitabine|gemcitabine
1367544|NCT01303029|erlotinib|erlotinib
1367545|NCT01303029|capecitabine|capecitabine
1367546|NCT01302990|Influenza|influenza
1367547|NCT01302990|Respiratory disease|respiratory disease
1367548|NCT01302990|Prevention|prevention
1367549|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
1367550|NCT01302977|Fetal anomalies|fetal anomalies
1367551|NCT01302964|Autistic Disorder|autistic disorder
1367552|NCT01302964|Asperger's Disorder|asperger's disorder
1367553|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
1367554|NCT01302951|pharmacokinetics|pharmacokinetics
1367555|NCT01302951|liver resection|liver resection
1367556|NCT01302938|Double-blind|double-blind
1367557|NCT01302938|Placebo-controlled|placebo-controlled
1367558|NCT01302938|frequency|frequency
1367559|NCT01302938|urgency|urgency
1367560|NCT01302938|web-based|web-based
1367561|NCT01302938|incontinence|incontinence
1367562|NCT01302938|methodology|methodology
1367563|NCT01302938|ediary|ediary
1367564|NCT01302938|safety|safety
1367565|NCT01302938|efficacy|efficacy
1367566|NCT01302938|tolerability ER|tolerability er
1367567|NCT01302938|overactive bladder|overactive bladder
1367568|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
1367569|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
1367570|NCT01302886|BHQ880,|bhq880,
1367571|NCT01302886|MM|mm
1367572|NCT01302873|Tinnitus|tinnitus
1367573|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
1367574|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
1367575|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
1367576|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
1367577|NCT01302860|children|children
1367578|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
1367579|NCT01302860|CIAS-1 gene|cias-1 gene
1367580|NCT01302860|NALP-3|nalp-3
1367581|NCT01302860|NLRP3|nlrp3
1367582|NCT01302860|ACZ885|acz885
1367583|NCT01302860|Ilaris|ilaris
1367584|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
1367585|NCT01302860|antibody|antibody
1367586|NCT01302860|autosomal dominant|autosomal dominant
1367587|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
1367588|NCT01302847|Integrase Inhibitors|integrase inhibitors
1367589|NCT01302847|Infant|infant
1367590|NCT01302847|Child|child
1367591|NCT01302847|Adolescent|adolescent
1367592|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1367593|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1367594|NCT01302834|human papilloma virus infection|human papilloma virus infection
1367595|NCT01302821|breast - male|breast - male
1367596|NCT01302821|breast - female|breast - female
1367597|NCT01302821|metastatic|metastatic
1367598|NCT01302821|invasive|invasive
1367599|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1367600|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1367601|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1367602|NCT01302808|malignant pleural effusion|malignant pleural effusion
1367603|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
1367604|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1367605|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1367606|NCT01302808|large cell lung cancer|large cell lung cancer
1367607|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
1367608|NCT01302795|Interleukin 1 beta|interleukin 1 beta
1367609|NCT01302795|Canakinumab|canakinumab
1367610|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
1367611|NCT01302782|Altitude|altitude
1367612|NCT01302782|Glucose|glucose
1367613|NCT01302769|Acute Sore Throat|acute sore throat
1367614|NCT01302769|Ear Acupuncture|ear acupuncture
1367615|NCT01302756|gestational diabetes|gestational diabetes
1367616|NCT01302756|gestational hypertension|gestational hypertension
1367617|NCT01302756|folic acid|folic acid
1367618|NCT01302743|Diabetes|diabetes
1367619|NCT01302743|Metformin|metformin
1367620|NCT01302743|Cinnamon|cinnamon
1367621|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
1367622|NCT01302730|spondylarthritis|spondylarthritis
1367623|NCT01302730|inflammatory back pain|inflammatory back pain
1367624|NCT01302730|seronegative|seronegative
1367625|NCT01302717|Left ventricular pacing|left ventricular pacing
1367626|NCT01302704|Vitamin D|vitamin d
1367627|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
1367628|NCT01302691|Essential hypertension|essential hypertension
1368124|NCT01300533|Melanoma|melanoma
1367630|NCT01302691|Antihypertensive agents|antihypertensive agents
1367631|NCT01302691|Blood pressure|blood pressure
1367632|NCT01302652|acromegaly|acromegaly
1367633|NCT01302652|growth hormone|growth hormone
1367634|NCT01302652|growth hormone deficiency|growth hormone deficiency
1367635|NCT01302626|NSCLC|nsclc
1367639|NCT01302626|DNA|dna
1367640|NCT01302626|imaging|imaging
1367641|NCT01302626|genomics|genomics
1367642|NCT01302626|proteomics|proteomics
1367643|NCT01302626|predictive model|predictive model
1367644|NCT01302626|prospective study|prospective study
1367645|NCT01302613|rectal cancer|rectal cancer
1367646|NCT01302574|T1R2/T1R3|t1r2/t1r3
1367647|NCT01302574|gastric emptying|gastric emptying
1367648|NCT01302574|gut|gut
1367649|NCT01302574|lactisole|lactisole
1367650|NCT01302574|nutrient sensing|nutrient sensing
1367651|NCT01302561|adults|adults
1367652|NCT01302561|fiber|fiber
1367653|NCT01302561|cold|cold
1367654|NCT01302561|flu|flu
1367655|NCT01302561|immune function|immune function
1367656|NCT01302561|microbiota|microbiota
1367657|NCT01302548|Abscess|abscess
1367658|NCT01302548|Wound Irrigation|wound irrigation
1367659|NCT01302548|Wound Debridement|wound debridement
1367660|NCT01302548|Wound Healing|wound healing
1367661|NCT01302548|Incision and drainage|incision and drainage
1367662|NCT01302548|Chlorhexidine|chlorhexidine
1367663|NCT01302535|Yoga|yoga
1367664|NCT01302535|Hypertension|hypertension
1367665|NCT01302535|Quality of Life|quality of life
1367666|NCT01302535|Primary Health Care|primary health care
1367667|NCT01302509|Nutritional support.|nutritional support.
1367668|NCT01302509|Cancer.|cancer.
1367669|NCT01302509|Malnutrition.|malnutrition.
1367670|NCT01302509|Child.|child.
1367671|NCT01302509|Adolescent|adolescent
1367672|NCT01302496|Previously Treated|previously treated
1367673|NCT01302496|Unresectable|unresectable
1367674|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
1367675|NCT01302470|biventricular pacing|biventricular pacing
1367676|NCT01302457|Thermal Burn Trauma|thermal burn trauma
1367677|NCT01302444|treprostinil|treprostinil
1367678|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
1367679|NCT01302431|experimental|experimental
1367680|NCT01302431|intervention|intervention
1367681|NCT01302431|nurse-led|nurse-led
1367682|NCT01302431|nurse specialist|nurse specialist
1367683|NCT01302431|multiple sclerosis|multiple sclerosis
1367684|NCT01302431|support of caregivers|support of caregivers
1367685|NCT01302418|Respiratory Virus|respiratory virus
1367686|NCT01302418|Influenza|influenza
1367687|NCT01302418|RSV|rsv
1367688|NCT01302418|Parainfluenza|parainfluenza
1367689|NCT01302418|Metapneumovirus|metapneumovirus
1367690|NCT01302418|Rhinovirus|rhinovirus
1367691|NCT01302418|Coxsackie virus|coxsackie virus
1367692|NCT01302418|Echo virus|echo virus
1367693|NCT01302418|Adenovirus|adenovirus
1367694|NCT01302418|Coronavirus|coronavirus
1367695|NCT01302418|Bocavirus|bocavirus
1367696|NCT01302405|Advanced solid tumor|advanced solid tumor
1367697|NCT01302405|cancer|cancer
1367698|NCT01302405|phase 1|phase 1
1367699|NCT01302405|pancreatic cancer|pancreatic cancer
1367700|NCT01302405|colon cancer|colon cancer
1367701|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
1367702|NCT01302405|Progressive cancer|progressive cancer
1367703|NCT01302405|metastatic solid tumor|metastatic solid tumor
1367704|NCT01302379|Obesity|obesity
1367705|NCT01302379|Survival|survival
1367706|NCT01302379|Weight loss|weight loss
1367707|NCT01302379|Metformin|metformin
1367708|NCT01302379|Biological markers|biological markers
1367709|NCT01302366|multiple myeloma|multiple myeloma
1367710|NCT01302366|myeloma|myeloma
1367711|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
1367712|NCT01302366|smoldering myeloma|smoldering myeloma
1367713|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
1367714|NCT01302353|Phase I trial|phase i trial
1367715|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
1367716|NCT01302353|Health volunteer|health volunteer
1367717|NCT01302340|Dementia|dementia
1367718|NCT01302340|Alzheimer|alzheimer
1367719|NCT01302340|Cannabis|cannabis
1485899|NCT00832702|MRI|mri
1367720|NCT01302340|THC|thc
1367721|NCT01302340|Behavioral Disturbances|behavioral disturbances
1367722|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
1367723|NCT01302327|Wolfram syndrome|wolfram syndrome
1367724|NCT01302327|Diabetes mellitus|diabetes mellitus
1367725|NCT01302327|Exenatide|exenatide
1367726|NCT01302327|GLP-1 analog|glp-1 analog
1367727|NCT01302327|beta cell function|beta cell function
1367728|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
1367729|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
1367730|NCT01302275|neuropathic pain|neuropathic pain
1367731|NCT01302275|oxcarbazepine|oxcarbazepine
1367732|NCT01302275|pain mechanism|pain mechanism
1367733|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
1367734|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
1367735|NCT01302249|Glaucoma|glaucoma
1367736|NCT01302249|Intraocular pressure|intraocular pressure
1367737|NCT01302249|Ocular hypertension|ocular hypertension
1367738|NCT01302236|Elderly|elderly
1367739|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
1367740|NCT01302236|Hypertension|hypertension
1367741|NCT01302236|Eplerenone|eplerenone
1367742|NCT01302223|burns|burns
1367743|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
1367744|NCT01302223|inflammation|inflammation
1367745|NCT01302223|Cytokine Storm|cytokine storm
1367746|NCT01302210|MRSA|mrsa
1367747|NCT01302210|Cluster Randomized Trial|cluster randomized trial
1367748|NCT01302210|Infection Control Intervention|infection control intervention
1367749|NCT01302197|Stroke|stroke
1367750|NCT01302197|Body Composition|body composition
1367751|NCT01302197|Glucose Tolerance|glucose tolerance
1367752|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
1367753|NCT01302171|adult stem cells|adult stem cells
1367754|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
1367755|NCT01302171|bone marrow stem cells|bone marrow stem cells
1367756|NCT01302171|autologous|autologous
1367757|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
1367758|NCT01302171|intracoronary injection|intracoronary injection
1367759|NCT01302171|left ventricular function|left ventricular function
1367760|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
1367761|NCT01302158|Drug-Drug interaction|drug-drug interaction
1367762|NCT01302158|ASP1941|asp1941
1367763|NCT01302158|Glimepiride|glimepiride
1367764|NCT01302158|Healthy subjects|healthy subjects
1367765|NCT01302145|pharmacokinetics|pharmacokinetics
1367766|NCT01302145|metformin|metformin
1367767|NCT01302145|Drug to drug interaction|drug to drug interaction
1367768|NCT01302145|ASP1941|asp1941
1367769|NCT01302132|Mass Balance|mass balance
1367770|NCT01302132|ASP1941|asp1941
1367771|NCT01302132|Pharmacokinetics|pharmacokinetics
1367772|NCT01302119|Onychomycosis|onychomycosis
1367773|NCT01302119|nail fungus|nail fungus
1367774|NCT01302119|toenail fungus|toenail fungus
1367775|NCT01302119|fungal nail|fungal nail
1367776|NCT01302119|hyperkeratosis|hyperkeratosis
1367777|NCT01302119|nail infection|nail infection
1367778|NCT01302119|nail treatment|nail treatment
1367779|NCT01302119|toenail infection|toenail infection
1367780|NCT01302119|toenail treatment|toenail treatment
1367781|NCT01302119|foot dermatoses|foot dermatoses
1367782|NCT01302119|fungal culture|fungal culture
1367783|NCT01302119|onycholysis|onycholysis
1367784|NCT01302119|podiatrist|podiatrist
1367785|NCT01302119|podiatry|podiatry
1367786|NCT01302119|subungual|subungual
1367787|NCT01302119|tinea unguium|tinea unguium
1367788|NCT01302119|antifungal|antifungal
1367789|NCT01302119|anti-fungal|anti-fungal
1367790|NCT01302119|dermatologist|dermatologist
1367791|NCT01302119|dermatology|dermatology
1367792|NCT01302119|dermatophyte|dermatophyte
1367793|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
1367794|NCT01302119|yellow nail|yellow nail
1367795|NCT01302119|thick nail|thick nail
1367796|NCT01302119|brittle nail|brittle nail
1367797|NCT01302119|crumbling nail|crumbling nail
1367798|NCT01302119|discolored nail|discolored nail
1367799|NCT01302119|weak nail|weak nail
1367800|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
1367801|NCT01302106|Clofarabine|clofarabine
1367802|NCT01302106|Low Dose Cytarabine|low dose cytarabine
1367803|NCT01302106|Poor risk MDS|poor risk mds
1367804|NCT01302080|prospective|prospective
1367805|NCT01302080|cohort|cohort
1367806|NCT01302080|sertraline|sertraline
1367807|NCT01302080|long-term impact|long-term impact
1367808|NCT01302080|cognition|cognition
1367809|NCT01302080|emotional and physical development|emotional and physical development
1367810|NCT01302080|pubertal maturation|pubertal maturation
1367811|NCT01302054|Bladder Overactive|bladder overactive
1367812|NCT01302054|Overactive urinary bladder|overactive urinary bladder
1367813|NCT01302054|Overactive Bladder|overactive bladder
1367814|NCT01302041|bone turnover|bone turnover
1367815|NCT01302041|hormone-naïve|hormone-naïve
1367816|NCT01302041|prostate specific antigen|prostate specific antigen
1367817|NCT01302041|Prostate Cancer|prostate cancer
1367818|NCT01302028|Renal Impairment|renal impairment
1367819|NCT01302028|ASP1941|asp1941
1367820|NCT01302028|Pharmacokinetics|pharmacokinetics
1367821|NCT01302002|Breast Cancer|breast cancer
1367822|NCT01302002|Metformin|metformin
1367823|NCT01302002|Pre-Surgery|pre-surgery
1367824|NCT01301989|Sleep|sleep
1367825|NCT01301989|Children|children
1367826|NCT01301989|Disparities|disparities
1367827|NCT01301989|Minority|minority
1367828|NCT01301989|Urban|urban
1367829|NCT01301976|nutritional state|nutritional state
1367830|NCT01301976|nutrients intake|nutrients intake
1367831|NCT01301976|ulcerative colitis|ulcerative colitis
1367832|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
1367833|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
1367834|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
1368430|NCT01299285|Absorption|absorption
1367835|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
1367836|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
1367837|NCT01301950|Knee Replacement, Total|knee replacement, total
1367838|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
1367839|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
1367840|NCT01301950|Replacement, Total Knee|replacement, total knee
1367841|NCT01301950|Total Knee Replacement|total knee replacement
1367842|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
1367843|NCT01301937|Leishmania braziliensis|leishmania braziliensis
1367844|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
1367845|NCT01301937|Treatment Effectiveness|treatment effectiveness
1367846|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1367847|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
1367848|NCT01301924|Leishmania braziliensis|leishmania braziliensis
1367849|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
1367850|NCT01301924|Treatment Effectiveness|treatment effectiveness
1367851|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1367852|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
1367853|NCT01301911|Cipatinib|cipatinib
1367854|NCT01301911|phase I|phase i
1367855|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
1367856|NCT01301898|Hunter syndrome|hunter syndrome
1367857|NCT01301898|MPS II|mps ii
1367858|NCT01301898|Idursulfase|idursulfase
1367859|NCT01301885|endometriosis|endometriosis
1367860|NCT01301885|dysmenorrhea|dysmenorrhea
1367861|NCT01301885|infertility|infertility
1367862|NCT01301885|biomarker|biomarker
1367863|NCT01301885|drug target|drug target
1367864|NCT01301859|older adults|older adults
1367865|NCT01301859|adherence|adherence
1367866|NCT01301859|antidepressant|antidepressant
1367867|NCT01301859|depression|depression
1367868|NCT01301833|insulin resistance|insulin resistance
1367869|NCT01301820|maintenance treatment|maintenance treatment
1367870|NCT01301820|Disease free survival|disease free survival
1367871|NCT01301807|Relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
1367872|NCT01301807|RRMM|rrmm
1367873|NCT01301807|Carfilzomib|carfilzomib
1367874|NCT01301807|Panobinostat|panobinostat
1367875|NCT01301807|LBH589B|lbh589b
1367876|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
1367877|NCT01301794|Fish oil|fish oil
1367878|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
1367879|NCT01301768|Dietary Intervention|dietary intervention
1367880|NCT01301768|Pregnancy Jail|pregnancy jail
1367881|NCT01301768|Iodine Deficiency|iodine deficiency
1367882|NCT01301768|Iodine Nutrition|iodine nutrition
1367883|NCT01301768|Dietary Habits|dietary habits
1367884|NCT01301768|Urinary Iodine|urinary iodine
1367885|NCT01301768|Pregnancy|pregnancy
1367886|NCT01301768|Group Education|group education
1367887|NCT01301768|Cluster Randomized Trial|cluster randomized trial
1367888|NCT01301768|Primary Health Care|primary health care
1367889|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
1367890|NCT01301690|neck mass|neck mass
1367891|NCT01301690|ultrasound|ultrasound
1367893|NCT01301690|BMVC|bmvc
1367894|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
1367895|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
1367896|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
1367897|NCT01301651|Virtual Reality|virtual reality
1367898|NCT01301651|Balance|balance
1367899|NCT01301651|Parkinson's disease|parkinson's disease
1367900|NCT01301651|Dual Task|dual task
1367901|NCT01301625|MitraClip|mitraclip
1367902|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
1367903|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
1367904|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
1367905|NCT01301625|congestive heart failure|congestive heart failure
1367906|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
1367907|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1367908|NCT01301599|alpha blocker|alpha blocker
1367909|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
1367910|NCT01301599|combination therapy|combination therapy
1367911|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
1367912|NCT01301560|NSCLC|nsclc
1367914|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
1367915|NCT01301521|Pre-Diabetes|pre-diabetes
1367916|NCT01301521|cinnamon|cinnamon
1367917|NCT01301508|atopic dermatitis|atopic dermatitis
1367918|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
1367919|NCT01301482|Acute Sore Throat|acute sore throat
1367920|NCT01301482|Ear Acupuncture|ear acupuncture
1367921|NCT01301456|Phase 1|phase 1
1367922|NCT01301456|Type 2 Diabetes|type 2 diabetes
1367923|NCT01301456|CVX-096|cvx-096
1367924|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
1367925|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
1367926|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1367927|NCT01301430|Oncolytic virus|oncolytic virus
1367928|NCT01301417|Compression Anastomosis|compression anastomosis
1368229|NCT01300078|Hot Flashes|hot flashes
1367929|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
1367930|NCT01301404|Spinal morphine|spinal morphine
1367931|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
1367932|NCT01301404|blood sugar|blood sugar
1367933|NCT01301404|carbohydrate drink|carbohydrate drink
1367934|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
1367935|NCT01301365|autonomic response|autonomic response
1367936|NCT01301352|Critical Care|critical care
1367937|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
1367938|NCT01301352|Child|child
1367939|NCT01301352|Infant|infant
1367940|NCT01301352|Adolescent|adolescent
1367941|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
1367942|NCT01301352|Enteral Nutrition|enteral nutrition
1367943|NCT01301339|Pre-Diabetes|pre-diabetes
1367944|NCT01301339|Diabetes|diabetes
1367945|NCT01301339|cardiovascular risks|cardiovascular risks
1367946|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
1367947|NCT01301326|laser treatment|laser treatment
1367948|NCT01301313|Acute heart failure|acute heart failure
1367949|NCT01301313|Children|children
1367950|NCT01301313|Levosimendan|levosimendan
1367951|NCT01301313|Inotropic treatment|inotropic treatment
1367952|NCT01301274|hyponatremia|hyponatremia
1367953|NCT01301274|maintenance solutions|maintenance solutions
1367954|NCT01301274|pediatrics|pediatrics
1367955|NCT01301261|Sugammadex|sugammadex
1367956|NCT01301261|entropy|entropy
1367957|NCT01301261|bispectral index|bispectral index
1367958|NCT01301261|blood pressure|blood pressure
1367959|NCT01301261|heart rate|heart rate
1367960|NCT01301261|oxygenation|oxygenation
1367961|NCT01301261|end-tidal CO2|end-tidal co2
1367962|NCT01301261|hemodynamics|hemodynamics
1367963|NCT01301261|general anesthesia|general anesthesia
1367964|NCT01301248|locally advanced,|locally advanced,
1367965|NCT01301248|unresectable,|unresectable,
1367966|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
1367967|NCT01301248|stage III/IV|stage iii/iv
1367968|NCT01301235|Mitochondria|mitochondria
1367969|NCT01301222|octreotide|octreotide
1367970|NCT01301222|pancreatic fistula|pancreatic fistula
1367971|NCT01301222|soft pancreas|soft pancreas
1367972|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
1367973|NCT01301196|sedentary behaviour|sedentary behaviour
1367974|NCT01301196|diabetes|diabetes
1367975|NCT01301196|structured education|structured education
1367976|NCT01301196|18-30 years olds|18-30 years olds
1367977|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
1367978|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
1367979|NCT01301183|Anorexia Nervosa|anorexia nervosa
1367980|NCT01301183|Estrogen|estrogen
1367981|NCT01301183|Teenagers|teenagers
1367982|NCT01301183|IGF-1|igf-1
1367983|NCT01301170|Neck pain|neck pain
1367984|NCT01301170|Dry Needling|dry needling
1367985|NCT01301170|Manual Therapy|manual therapy
1367986|NCT01301170|Manipulation|manipulation
1367987|NCT01301144|Tuberculosis|tuberculosis
1367988|NCT01301144|Urea Breath Test|urea breath test
1367989|NCT01301118|Transplantation Infection|transplantation infection
1367990|NCT01301118|Wound of skin|wound of skin
1367991|NCT01301118|Burns|burns
1367992|NCT01301118|Graft Loss|graft loss
1367993|NCT01301118|Infection|infection
1367994|NCT01301105|pain regulation|pain regulation
1367995|NCT01301105|social stress|social stress
1367996|NCT01301105|affect|affect
1367997|NCT01301105|attention|attention
1367998|NCT01301105|brain|brain
1367999|NCT01301105|immune|immune
1368000|NCT01301105|endocrine|endocrine
1368001|NCT01301079|Remifentanil|remifentanil
1368002|NCT01301079|Hyperalgesia|hyperalgesia
1368003|NCT01301079|Ketamine|ketamine
1368004|NCT01301079|Von Frey's filament|von frey's filament
1368005|NCT01301079|Algometer|algometer
1368006|NCT01301079|Interleukines|interleukines
1368007|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
1368008|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
1368009|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
1368010|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
1368011|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
1368012|NCT01301053|hypoglycemia|hypoglycemia
1368013|NCT01301053|reducing ICU mortality|reducing icu mortality
1368014|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
1368015|NCT01301027|End stage renal disease|end stage renal disease
1368016|NCT01301027|Hemodialysis|hemodialysis
1368017|NCT01301027|Pioglitazone|pioglitazone
1368018|NCT01301027|Adipokines|adipokines
1368907|NCT01297192|YM178|ym178
1368019|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
1368020|NCT01301001|Vulvodynia|vulvodynia
1368021|NCT01300988|HIV infection|hiv infection
1368022|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
1368023|NCT01300988|CCR5 expression|ccr5 expression
1368024|NCT01300988|Treatment Naive|treatment naive
1368025|NCT01300975|Leishmaniasis|leishmaniasis
1368026|NCT01300975|intralesional antimony|intralesional antimony
1368027|NCT01300975|cryotherapy|cryotherapy
1368028|NCT01300962|Xeloda|xeloda
1368029|NCT01300962|Capecitabine|capecitabine
1368030|NCT01300962|BKM120|bkm120
1368031|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1368032|NCT01300962|Metastatic|metastatic
1368033|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
1368034|NCT01300949|Contrast Sensitivity|contrast sensitivity
1368035|NCT01300949|Pelli-Robson Test|pelli-robson test
1368036|NCT01300923|Fragile X Syndrome|fragile x syndrome
1368037|NCT01300923|Acamprosate|acamprosate
1368038|NCT01300910|Adult Males|adult males
1368039|NCT01300910|Circumcision|circumcision
1368040|NCT01300910|HIV prevention|hiv prevention
1368041|NCT01300910|Device|device
1368042|NCT01300910|Shang Ring|shang ring
1368043|NCT01300897|cortical function, motor evoked potential responses|cortical function, motor evoked potential responses
1368044|NCT01300845|Oxygen mask|oxygen mask
1368045|NCT01300845|Oxygen cannula|oxygen cannula
1368046|NCT01300845|Humidification|humidification
1368047|NCT01300845|Oxygen therapy|oxygen therapy
1368048|NCT01300845|Intensive Care Unit|intensive care unit
1368049|NCT01300832|Surgery|surgery
1368050|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
1368051|NCT01300832|Preoperative|preoperative
1368052|NCT01300819|Rotigotine|rotigotine
1368053|NCT01300819|Neupro®|neupro®
1368054|NCT01300819|Non-motor symptoms|non-motor symptoms
1368055|NCT01300806|HIV|hiv
1368056|NCT01300806|harmful substance use|harmful substance use
1368057|NCT01300793|V-RICE|v-rice
1368058|NCT01300793|Relapsed NHL|relapsed nhl
1368059|NCT01300793|Primary Refractory NHL|primary refractory nhl
1368060|NCT01300780|bleaching agent|bleaching agent
1368061|NCT01300780|tooth bleaching|tooth bleaching
1368062|NCT01300780|sensibility|sensibility
1368063|NCT01300754|Osgood-Schlatter|osgood-schlatter
1368064|NCT01300754|Tendinosis|tendinosis
1368065|NCT01300754|Apophysitis|apophysitis
1368066|NCT01300754|Enthesopathy|enthesopathy
1368067|NCT01300754|Dextrose.|dextrose.
1368068|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
1368069|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
1368070|NCT01300715|zygapophysial joint|zygapophysial joint
1368071|NCT01300715|facet joint|facet joint
1368072|NCT01300715|low back pain|low back pain
1368073|NCT01300715|radiofrequency|radiofrequency
1368074|NCT01300715|neurotomy|neurotomy
1368075|NCT01300689|HPV|hpv
1368076|NCT01300689|MSM|msm
1368077|NCT01300689|Vaccine|vaccine
1368078|NCT01300689|China|china
1368079|NCT01300676|Tualang honey|tualang honey
1368080|NCT01300676|HRT|hrt
1368081|NCT01300676|safety profiles|safety profiles
1368082|NCT01300676|cardiovascular parameters|cardiovascular parameters
1368083|NCT01300676|hormonal levels|hormonal levels
1368084|NCT01300676|bone changes|bone changes
1368085|NCT01300676|postmenopausal women|postmenopausal women
1368086|NCT01300650|Heart failure|heart failure
1368087|NCT01300650|Inflammation|inflammation
1368088|NCT01300650|Interleukin-1|interleukin-1
1368089|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
1368090|NCT01300637|schizophrenia|schizophrenia
1368091|NCT01300637|clozapine|clozapine
1368092|NCT01300637|metabolic dysregulation|metabolic dysregulation
1368093|NCT01300637|metformin|metformin
1368094|NCT01300624|Aphasia|aphasia
1368096|NCT01300624|treatment|treatment
1368097|NCT01300624|verbs|verbs
1368098|NCT01300624|sentences|sentences
1368099|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
1368100|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
1368101|NCT01300611|Platelet Engraftment|platelet engraftment
1368102|NCT01300611|Immune Reconstitution|immune reconstitution
1368103|NCT01300611|Mucositis|mucositis
1368104|NCT01300585|Breast|breast
1368105|NCT01300585|Cancer|cancer
1368106|NCT01300559|efficacy|efficacy
1368107|NCT01300559|hemoglobin|hemoglobin
1368108|NCT01300559|spine|spine
1368109|NCT01300546|Frequent migraine|frequent migraine
1368110|NCT01300546|Migraine transformation|migraine transformation
1368111|NCT01300546|Migraine|migraine
1368112|NCT01300546|Treximet|treximet
1368113|NCT01300546|Naproxen|naproxen
1368114|NCT01300546|Sumatriptan|sumatriptan
1368115|NCT01300533|Cancer|cancer
1368116|NCT01300533|Neoplasms|neoplasms
1368117|NCT01300533|Solid Tumor|solid tumor
1368118|NCT01300533|Ovarian Cancer|ovarian cancer
1368119|NCT01300533|Lung Cancer|lung cancer
1368120|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
1368121|NCT01300533|Pancreatic Cancer|pancreatic cancer
1368122|NCT01300533|Breast Cancer|breast cancer
1368123|NCT01300533|Endometrial Cancer|endometrial cancer
1368125|NCT01300533|Prostate Cancer|prostate cancer
1368126|NCT01300533|Skin Cancer|skin cancer
1368127|NCT01300533|Head and Neck Cancer|head and neck cancer
1368128|NCT01300533|Solid Malignancies|solid malignancies
1368129|NCT01300520|Fluoroscopy|fluoroscopy
1368130|NCT01300520|Femoral fracture|femoral fracture
1368131|NCT01300520|Tibial fracture|tibial fracture
1368132|NCT01300520|Spinal Fusion|spinal fusion
1368133|NCT01300507|stent thrombosis|stent thrombosis
1368134|NCT01300507|intra coronary imaging|intra coronary imaging
1368135|NCT01300507|blood platelet function testing|blood platelet function testing
1368136|NCT01300494|bifurcation lesion|bifurcation lesion
1368137|NCT01300494|optimal viewing angle|optimal viewing angle
1368138|NCT01300494|automated software|automated software
1368139|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
1368140|NCT01300455|Insomnia|insomnia
1368141|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
1368142|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
1368143|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1368144|NCT01300442|diaphragm|diaphragm
1368145|NCT01300442|electrical stimulation|electrical stimulation
1368146|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
1368147|NCT01300429|core biopsy|core biopsy
1368148|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
1368149|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
1368150|NCT01300429|11-014|11-014
1368151|NCT01300416|Kidney transplantation|kidney transplantation
1368152|NCT01300416|mycophenolate sodium|mycophenolate sodium
1368153|NCT01300416|EC-MPS|ec-mps
1368154|NCT01300416|Health Related Quality of Life|health related quality of life
1368155|NCT01300416|GI symptoms|gi symptoms
1368156|NCT01300416|Immunosuppressants|immunosuppressants
1368157|NCT01300416|HRQL|hrql
1368158|NCT01300416|PGWB|pgwb
1368159|NCT01300416|GIQLI|giqli
1368160|NCT01300390|liver transplant|liver transplant
1368161|NCT01300390|end-stage liver disease|end-stage liver disease
1368162|NCT01300390|cirrhosis|cirrhosis
1368163|NCT01300377|Post-operative pain|post-operative pain
1368164|NCT01300377|pain|pain
1368165|NCT01300377|pacemaker|pacemaker
1368166|NCT01300377|defibrillator|defibrillator
1368167|NCT01300377|post-operative narcotic use|post-operative narcotic use
1368168|NCT01300377|local anesthesia|local anesthesia
1368169|NCT01300351|Advanced breast cancer|advanced breast cancer
1368170|NCT01300351|metastatic breast cancer|metastatic breast cancer
1368171|NCT01300338|Diabetes|diabetes
1368172|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
1368173|NCT01300312|eperisone|eperisone
1368174|NCT01300312|diclofenac|diclofenac
1368175|NCT01300312|low back pain|low back pain
1368176|NCT01300299|lung cancer|lung cancer
1368177|NCT01300299|radiation|radiation
1368178|NCT01300299|stereotactic|stereotactic
1368179|NCT01300273|Diabetic nephropathy|diabetic nephropathy
1368180|NCT01300273|Podocyte|podocyte
1368181|NCT01300273|Low Protein Diet|low protein diet
1368182|NCT01300273|Ketoanalogs|ketoanalogs
1368183|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1368184|NCT01300234|chronic hepatitis B|chronic hepatitis b
1368185|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
1368186|NCT01300221|Three dimension echocardiography|three dimension echocardiography
1368187|NCT01300221|Congenital heart disease|congenital heart disease
1368188|NCT01300221|Z-score|z-score
1368189|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
1368190|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
1368191|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
1368192|NCT01300208|lupus|lupus
1368193|NCT01300195|VATS|vats
1368194|NCT01300195|standardized surgery|standardized surgery
1368195|NCT01300195|persistent pain|persistent pain
1368197|NCT01300169|Suicide|suicide
1368198|NCT01300169|Assessment|assessment
1368199|NCT01300169|Intervention|intervention
1368200|NCT01300169|CAMS|cams
1368201|NCT01300156|Hodgkin's disease|hodgkin's disease
1368202|NCT01300156|lymphoma|lymphoma
1368203|NCT01300156|Relapsed|relapsed
1368204|NCT01300156|refractory|refractory
1368205|NCT01300130|neurological development|neurological development
1368206|NCT01300130|preterm infants|preterm infants
1368207|NCT01300130|fatty acid status|fatty acid status
1368208|NCT01300117|cardiac surgery|cardiac surgery
1368209|NCT01300117|adamts13|adamts13
1368210|NCT01300117|TTP|ttp
1368211|NCT01300117|extracorporeal circulation|extracorporeal circulation
1368212|NCT01300117|Heart-Lung Machine|heart-lung machine
1368213|NCT01300104|prostate cancer progression|prostate cancer progression
1368214|NCT01300104|active surveillance|active surveillance
1368215|NCT01300104|whole grain rye|whole grain rye
1368216|NCT01300104|exercise|exercise
1368217|NCT01300104|insulin sensitivity|insulin sensitivity
1368218|NCT01300104|quality of life|quality of life
1368219|NCT01300091|Shoulder|shoulder
1368220|NCT01300091|Pain|pain
1368221|NCT01300091|Range of Motion|range of motion
1368222|NCT01300091|Disability Evaluation|disability evaluation
1368223|NCT01300091|Function|function
1368224|NCT01300091|Sick Leave|sick leave
1368225|NCT01300091|Primary Health Care|primary health care
1368226|NCT01300091|Visual Analog Scale|visual analog scale
1368227|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
1368228|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
1368230|NCT01300078|Hot Flushes|hot flushes
1368231|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
1368232|NCT01300078|Menopausal Symptoms|menopausal symptoms
1368233|NCT01300052|psoriasis|psoriasis
1368234|NCT01300039|nephrolithiasis|nephrolithiasis
1368235|NCT01300039|urolithiasis|urolithiasis
1368236|NCT01300039|hyperoxaluria|hyperoxaluria
1368237|NCT01300039|Helicobacter pylori|helicobacter pylori
1368238|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
1368239|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
1368240|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
1368241|NCT01300026|PI3K delta|pi3k delta
1368242|NCT01300026|Lymphoid|lymphoid
1368243|NCT01300026|NHL|nhl
1368244|NCT01300026|MCL|mcl
1368245|NCT01300026|Hematologic|hematologic
1368246|NCT01300026|CLL|cll
1368247|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1368248|NCT01300013|Intravenous|intravenous
1368249|NCT01300013|IV|iv
1368250|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
1368251|NCT01300013|Hospitalized|hospitalized
1368252|NCT01300013|Acute heart failure|acute heart failure
1368253|NCT01300013|Heart failure|heart failure
1368254|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
1368255|NCT01300013|pharmacokinetics|pharmacokinetics
1368256|NCT01300013|Pharmacodynamics|pharmacodynamics
1368257|NCT01300013|Dyspnea|dyspnea
1368258|NCT01300013|hospitalization|hospitalization
1368259|NCT01300013|In-patient|in-patient
1368260|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
1368261|NCT01300013|Double-blind|double-blind
1368262|NCT01300013|Randomized|randomized
1368263|NCT01300013|Placebo-controlled|placebo-controlled
1368264|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
1368265|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
1368266|NCT01299987|Early Breast Cancer|early breast cancer
1368267|NCT01299987|Elderly Patients|elderly patients
1368268|NCT01299974|Family-centered|family-centered
1368269|NCT01299974|teaching|teaching
1368270|NCT01299974|residents|residents
1368271|NCT01299974|family faculty|family faculty
1368272|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
1368273|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
1368274|NCT01299961|Ultrasound|ultrasound
1368275|NCT01299948|HIV|hiv
1368276|NCT01299948|AIDS|aids
1368277|NCT01299948|CD4|cd4
1368278|NCT01299948|progression|progression
1368279|NCT01299948|immune activation|immune activation
1368280|NCT01299935|stress reduction|stress reduction
1368281|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
1368282|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
1368283|NCT01299922|Lupus nephritis|lupus nephritis
1368284|NCT01299922|Therapy|therapy
1368285|NCT01299922|Cyclosporin|cyclosporin
1368286|NCT01299922|Mycophenolic acid|mycophenolic acid
1368287|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
1368288|NCT01299909|Smoking|smoking
1368289|NCT01299909|Smoking cessation|smoking cessation
1368290|NCT01299909|Addiction|addiction
1368291|NCT01299909|behavioral intervention|behavioral intervention
1368292|NCT01299909|Nicotine|nicotine
1368293|NCT01299909|Tobacco|tobacco
1368294|NCT01299909|Mindfulness|mindfulness
1368295|NCT01299909|Meditation|meditation
1368296|NCT01299909|MBSR|mbsr
1368297|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1368298|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1368299|NCT01299909|MBCT|mbct
1368300|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
1368301|NCT01299909|MBRP|mbrp
1368302|NCT01299909|Mindfulness Training|mindfulness training
1368303|NCT01299909|Nicotine Patch|nicotine patch
1368304|NCT01299909|Quit Line|quit line
1368305|NCT01299909|Phone counseling|phone counseling
1368306|NCT01299909|Freedom from Smoking|freedom from smoking
1368307|NCT01299896|Cigarette Smoking|cigarette smoking
1368308|NCT01299896|Smoking, Tobacco|smoking, tobacco
1368309|NCT01299896|Tobacco Smoking|tobacco smoking
1368310|NCT01299896|Smoking Cessation|smoking cessation
1368311|NCT01299896|Tobacco Dependence|tobacco dependence
1368312|NCT01299883|Cancer|cancer
1368313|NCT01299883|CVD|cvd
1368314|NCT01299883|African American|african american
1368315|NCT01299883|Health Education Intervention|health education intervention
1368316|NCT01299883|Intervention RCT|intervention rct
1368317|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
1368318|NCT01299857|pemphigus|pemphigus
1368319|NCT01299857|Mabthéra (R)|mabthéra (r)
1368320|NCT01299857|B lymphocytes|b lymphocytes
1368321|NCT01299857|desmogleines|desmogleines
1368322|NCT01299844|Type 2 Diabetes|type 2 diabetes
1368323|NCT01299818|central pain|central pain
1368324|NCT01299818|spine surgey|spine surgey
1368325|NCT01299818|outcome|outcome
1368326|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
1368327|NCT01299805|Drug Therapy|drug therapy
1368328|NCT01299805|pharmacodynamic|pharmacodynamic
1368329|NCT01299792|spinal cord injury|spinal cord injury
1368330|NCT01299792|urodynamics|urodynamics
1368331|NCT01299792|ultrasound|ultrasound
1368332|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
1368333|NCT01299779|hyponatremia|hyponatremia
1368335|NCT01299779|PEG-ELS|peg-els
1368336|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
1368337|NCT01299766|Memory|memory
1368338|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
1368339|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
1368340|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
1368341|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
1368342|NCT01299714|Human Papilloma Virus|human papilloma virus
1368343|NCT01299714|vaccine|vaccine
1368344|NCT01299714|stress|stress
1368345|NCT01299714|cervical cancer|cervical cancer
1368346|NCT01299714|GARDASIL|gardasil
1368347|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
1368348|NCT01299701|refractory|refractory
1368349|NCT01299701|core phase|core phase
1368350|NCT01299701|extension phase|extension phase
1368351|NCT01299701|dose escalation|dose escalation
1368352|NCT01299701|standard chemotherapy|standard chemotherapy
1368353|NCT01299701|docetaxel|docetaxel
1368354|NCT01299701|paclitaxel|paclitaxel
1368355|NCT01299701|carboplatin|carboplatin
1368356|NCT01299701|safety|safety
1368357|NCT01299701|tolerability|tolerability
1368358|NCT01299675|MR conditional|mr conditional
1368359|NCT01299649|CAD|cad
1368360|NCT01299636|PM060184|pm060184
1368361|NCT01299636|Phase I|phase i
1368362|NCT01299636|Pharma Mar|pharma mar
1368363|NCT01299623|breast cancer|breast cancer
1368364|NCT01299623|breast cancer prevention|breast cancer prevention
1368365|NCT01299623|African American women|african american women
1368366|NCT01299610|Atopic Dermatitis|atopic dermatitis
1368367|NCT01299610|GW870086X|gw870086x
1368368|NCT01299610|TIS|tis
1368369|NCT01299610|IGA|iga
1368370|NCT01299597|repeat dose|repeat dose
1368371|NCT01299597|statins|statins
1368372|NCT01299597|safety and tolerability|safety and tolerability
1368373|NCT01299597|drug interaction|drug interaction
1368374|NCT01299597|sb649868|sb649868
1368375|NCT01299597|healthy male subjects|healthy male subjects
1368376|NCT01299597|pharmacokinetics|pharmacokinetics
1368377|NCT01299558|pharmacokinetics|pharmacokinetics
1368378|NCT01299558|GW642444|gw642444
1368379|NCT01299558|absolute bioavailability|absolute bioavailability
1368380|NCT01299558|healthy subjects|healthy subjects
1368381|NCT01299558|fluticasone furoate|fluticasone furoate
1368382|NCT01299558|GW685698|gw685698
1368383|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
1368384|NCT01299545|Anti TNF|anti tnf
1368385|NCT01299545|Infliximab|infliximab
1368386|NCT01299545|Methotrexate|methotrexate
1368387|NCT01299545|DMARDs|dmards
1368388|NCT01299545|Gene expression biomarkers|gene expression biomarkers
1368389|NCT01299519|obesity|obesity
1368390|NCT01299519|weight loss|weight loss
1368391|NCT01299519|insulin resistance|insulin resistance
1368392|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
1368393|NCT01299506|trabectedin|trabectedin
1368394|NCT01299506|Netherlands|netherlands
1368395|NCT01299493|carcinoma|carcinoma
1368396|NCT01299493|colorectal cancer|colorectal cancer
1368397|NCT01299493|community health centers|community health centers
1368398|NCT01299493|cluster-randomized|cluster-randomized
1368399|NCT01299493|health behavior|health behavior
1368400|NCT01299480|Healthy adolescents|healthy adolescents
1368401|NCT01299467|Asthma|asthma
1368402|NCT01299467|duration of action|duration of action
1368403|NCT01299467|allergen challenge|allergen challenge
1368404|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
1368405|NCT01299428|HYPERNATREMİA|hypernatremia
1368406|NCT01299428|NEWBORN|newborn
1368407|NCT01299428|NA VALUES|na values
1368408|NCT01299415|ASA404,|asa404,
1368409|NCT01299415|Phase I,|phase i,
1368410|NCT01299415|Oncology,|oncology,
1368411|NCT01299415|CYP1A2,|cyp1a2,
1368412|NCT01299415|fluvoxamine,|fluvoxamine,
1368413|NCT01299415|drug drug interaction,|drug drug interaction,
1368414|NCT01299415|Novartis,|novartis,
1368415|NCT01299415|Antisoma|antisoma
1368416|NCT01299389|Paliperidone palmitate|paliperidone palmitate
1368417|NCT01299389|Schizophrenia|schizophrenia
1368418|NCT01299376|Essential hypertension|essential hypertension
1368419|NCT01299376|Antihypertensive agents|antihypertensive agents
1368420|NCT01299376|Blood pressure|blood pressure
1368421|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
1368422|NCT01299363|Prolapse|prolapse
1368423|NCT01299363|Pain with intercourse|pain with intercourse
1368424|NCT01299363|Dyspareunia|dyspareunia
1368425|NCT01299363|Post operative pain|post operative pain
1368426|NCT01299350|Heart failure|heart failure
1368427|NCT01299350|Nt-proBNP|nt-probnp
1368428|NCT01299324|CHF|chf
1368429|NCT01299311|insulin sensitivity|insulin sensitivity
1368431|NCT01299285|Distribution|distribution
1368432|NCT01299285|Metabolism|metabolism
1368433|NCT01299285|Excretion|excretion
1368434|NCT01299285|Mass balance|mass balance
1368435|NCT01299285|Metabolic profile|metabolic profile
1368436|NCT01299285|Radiolabeled study|radiolabeled study
1368437|NCT01299285|14C|14c
1368438|NCT01299259|Text message reminders|text message reminders
1368439|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
1368440|NCT01299259|PID|pid
1368441|NCT01299259|Primary care follow-up|primary care follow-up
1368442|NCT01299259|Emergency department care|emergency department care
1368443|NCT01299259|Discharge instructions|discharge instructions
1368444|NCT01299246|Diabetic Foot|diabetic foot
1368445|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
1368446|NCT01299246|early detection of DFP|early detection of dfp
1368447|NCT01299220|Erlotinib|erlotinib
1368448|NCT01299220|Acitretin|acitretin
1368449|NCT01299220|Rash|rash
1368450|NCT01299220|Dermatology|dermatology
1368451|NCT01299220|Oncology|oncology
1368452|NCT01299207|Stents|stents
1368453|NCT01299207|Drug-Eluting Stents|drug-eluting stents
1368454|NCT01299207|Stent Thrombosis|stent thrombosis
1368455|NCT01299207|Bleeding|bleeding
1368456|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
1368457|NCT01299194|BRONCHIECTASIS|bronchiectasis
1368458|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
1368459|NCT01299194|STATIN|statin
1368460|NCT01299194|OUTCOME|outcome
1368461|NCT01299181|Bronchiectasis|bronchiectasis
1368462|NCT01299181|Outcome|outcome
1368463|NCT01299181|Statin therapy|statin therapy
1368464|NCT01299168|global gene expression|global gene expression
1368465|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
1368466|NCT01299155|Intraocular Lens|intraocular lens
1368467|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
1368468|NCT01299142|Influenza|influenza
1368469|NCT01299142|antibodies|antibodies
1368470|NCT01299142|monoclonal|monoclonal
1368471|NCT01299142|virus|virus
1368472|NCT01299129|Uveitis|uveitis
1368473|NCT01299129|Cystoid macular edema|cystoid macular edema
1368474|NCT01299129|microperimetry|microperimetry
1368475|NCT01299129|functional visual acuity|functional visual acuity
1368476|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
1368477|NCT01299116|AE-adverse event|ae-adverse event
1368478|NCT01299116|FDA-(U.S.) Food and Drug Administration|fda-(u.s.) food and drug administration
1368479|NCT01299116|GCP-Good Clinical Practice guidelines|gcp-good clinical practice guidelines
1368480|NCT01299116|ICH-International Committee on Harmonisation|ich-international committee on harmonisation
1368481|NCT01299116|IRB-Institutional Review Board|irb-institutional review board
1368482|NCT01299116|IU-International units|iu-international units
1368483|NCT01299116|mg-milligram(s)|mg-milligram(s)
1368484|NCT01299116|mm3-cubic millimeter(s)|mm3-cubic millimeter(s)
1368485|NCT01299116|LARC-Long-Acting reversible contraception|larc-long-acting reversible contraception
1368486|NCT01299116|PPCNC-Planned Parenthood of North Carolina|ppcnc-planned parenthood of north carolina
1368487|NCT01299116|SAE-serious adverse event|sae-serious adverse event
1368488|NCT01299116|SARC-Short-Acting reversible contraception|sarc-short-acting reversible contraception
1368489|NCT01299116|µg-microgram|µg-microgram
1368490|NCT01299116|ULN-upper limit of the normal range|uln-upper limit of the normal range
1368491|NCT01299116|SubQ-subcutaneous|subq-subcutaneous
1368493|NCT01299103|rhytide|rhytide
1368494|NCT01299090|wrinkles|wrinkles
1368495|NCT01299090|rhytides|rhytides
1368496|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
1368497|NCT01299077|Methycobal|methycobal
1368498|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
1368499|NCT01299064|symptoms reduction|symptoms reduction
1368500|NCT01299064|mental health|mental health
1368501|NCT01299051|Weight Management|weight management
1368502|NCT01299051|Employee Health|employee health
1368503|NCT01299038|Crestor|crestor
1368504|NCT01299038|TFBP|tfbp
1368505|NCT01299038|rosuvastatin|rosuvastatin
1368506|NCT01299025|balance|balance
1368507|NCT01299025|walking|walking
1368508|NCT01298999|Barrett's Esophagus|barrett's esophagus
1368509|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
1368510|NCT01298999|GERD|gerd
1368511|NCT01298999|Acid Reflux|acid reflux
1368512|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
1368513|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
1368514|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
1368515|NCT01298960|Pregnancy Rate|pregnancy rate
1368516|NCT01298960|Growth Hormone|growth hormone
1368517|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
1368518|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
1368519|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
1368520|NCT01298921|Headache|headache
1368521|NCT01298921|Cluster Headache|cluster headache
1368522|NCT01298921|Oxygen Therapy|oxygen therapy
1368523|NCT01298908|varicose veins, oedema|varicose veins, oedema
1368524|NCT01298895|optical components|optical components
1368525|NCT01298895|pseudoexfoliation|pseudoexfoliation
1368526|NCT01298895|cataract|cataract
1368527|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
1368528|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
1368529|NCT01298882|Overweight|overweight
1368530|NCT01298882|Obesity|obesity
1368531|NCT01298869|CKD|ckd
1368532|NCT01298869|HPV infection|hpv infection
1368533|NCT01298869|HPV vaccine|hpv vaccine
1368534|NCT01298869|antibodies titer|antibodies titer
1368535|NCT01298856|hydrotherapy|hydrotherapy
1368536|NCT01298856|chronic ankle instability|chronic ankle instability
1368537|NCT01298856|ankle taping|ankle taping
1368538|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
1368539|NCT01298817|Obesity|obesity
1368540|NCT01298817|Aging|aging
1368541|NCT01298817|Soy|soy
1368542|NCT01298817|Weight Loss|weight loss
1368543|NCT01298817|Ectopic Fat|ectopic fat
1368544|NCT01298778|chronic pain post delivery|chronic pain post delivery
1368545|NCT01298778|postpartum depression|postpartum depression
1368546|NCT01298778|tailored pain management|tailored pain management
1368547|NCT01298765|buccal soluble film|buccal soluble film
1368548|NCT01298739|asthma control level , ACQ|asthma control level , acq
1368549|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
1368550|NCT01298726|DIABETES MELLITUS|diabetes mellitus
1368551|NCT01298713|Hormonoresistance|hormonoresistance
1368552|NCT01298713|tamoxifen|tamoxifen
1368553|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
1368554|NCT01298713|mTor inhibitor|mtor inhibitor
1368555|NCT01298687|open-angle glaucoma|open-angle glaucoma
1368556|NCT01298687|ocular hypertension|ocular hypertension
1368557|NCT01298687|divided dose|divided dose
1368558|NCT01298661|Exercise Test|exercise test
1368559|NCT01298661|Reproducibility of Results|reproducibility of results
1368560|NCT01298661|Mortality|mortality
1368561|NCT01298648|Crohn's Disease|crohn's disease
1368562|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
1368563|NCT01298635|cataract|cataract
1368564|NCT01298635|trabeculectomy|trabeculectomy
1368565|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
1368566|NCT01298609|Fibromyalgia|fibromyalgia
1368567|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
1368568|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
1368569|NCT01298570|K-RAS mutation|k-ras mutation
1368570|NCT01298570|BRAF mutation|braf mutation
1368571|NCT01298570|Regorafenib|regorafenib
1368572|NCT01298570|BAY 73-4506|bay 73-4506
1368573|NCT01298570|FOLFIRI|folfiri
1368574|NCT01298570|Irinotecan|irinotecan
1368575|NCT01298570|5-FU|5-fu
1368576|NCT01298570|Leucovorin|leucovorin
1368577|NCT01298570|Placebo|placebo
1368578|NCT01298570|Phase II|phase ii
1368579|NCT01298570|Multi-Center|multi-center
1368580|NCT01298570|Randomized|randomized
1368581|NCT01298570|Lineberger|lineberger
1368582|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
1368583|NCT01298570|UNC|unc
1368584|NCT01298557|Traumatic brain injury|traumatic brain injury
1368585|NCT01298557|Post-concussive symptoms|post-concussive symptoms
1368586|NCT01298557|Brain imaging|brain imaging
1368587|NCT01298557|Neurocognitive testing|neurocognitive testing
1368588|NCT01298544|Vaccine|vaccine
1368589|NCT01298544|Prevenar|prevenar
1368590|NCT01298544|Pneumococcal disease|pneumococcal disease
1368591|NCT01298531|Etanercept|etanercept
1368592|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
1368593|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
1368594|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
1368595|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
1368596|NCT01298492|Active Crohn's disease|active crohn's disease
1368597|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
1368598|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
1368599|NCT01298479|volume delivery|volume delivery
1368600|NCT01298466|identification|identification
1368601|NCT01298466|chronic|chronic
1368602|NCT01298466|neuropathic|neuropathic
1368603|NCT01298466|low back pain|low back pain
1368604|NCT01298466|primary care|primary care
1368605|NCT01298466|pregabalin|pregabalin
1368606|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1368607|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1368608|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
1368609|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
1368610|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1368611|NCT01298388|cancer survivor|cancer survivor
1368612|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1368613|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1368614|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1368615|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
1368616|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
1368617|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
1368714|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
1368618|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
1368810|NCT01297569|Diabetic retinopathy|diabetic retinopathy
1368619|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1368620|NCT01298375|Metabolic flexibility|metabolic flexibility
1368621|NCT01298375|Mitochondrial function|mitochondrial function
1368622|NCT01298375|Human primary myoblasts|human primary myoblasts
1368623|NCT01298375|Lipid metabolism|lipid metabolism
1368624|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
1368625|NCT01298336|Clarithromycin|clarithromycin
1368626|NCT01298336|Moxifloxacin|moxifloxacin
1368627|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
1368628|NCT01298323|Locally advanced|locally advanced
1368629|NCT01298323|Metastatic|metastatic
1368630|NCT01298323|Vandetanib|vandetanib
1368631|NCT01298323|Patient Outreach|patient outreach
1368632|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
1368633|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
1368634|NCT01298284|Variceal bleeding|variceal bleeding
1368635|NCT01298284|portal hypertension|portal hypertension
1368636|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
1368637|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
1368638|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
1368639|NCT01298284|rebleeding|rebleeding
1368640|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
1368641|NCT01298271|primaryprevention|primaryprevention
1368642|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
1368643|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
1368644|NCT01298245|diabetes|diabetes
1368645|NCT01298245|diabetic retinopathy|diabetic retinopathy
1368646|NCT01298245|Chinese|chinese
1368647|NCT01298245|gene|gene
1368648|NCT01298245|associations|associations
1368649|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
1368650|NCT01298206|swine flu|swine flu
1368651|NCT01298206|virus disease|virus disease
1368652|NCT01298206|Avian flu|avian flu
1368653|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
1368654|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
1368655|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
1368656|NCT01298167|Cyanoacrylate|cyanoacrylate
1368657|NCT01298167|Fast Absorbing Gut|fast absorbing gut
1368658|NCT01298167|Mohs Surgery|mohs surgery
1368659|NCT01298167|Epidermal closure method|epidermal closure method
1368660|NCT01298154|Food intake|food intake
1368661|NCT01298154|Blood glucose|blood glucose
1368662|NCT01298154|Pulses|pulses
1368663|NCT01298154|Protein|protein
1368664|NCT01298141|Replagal|replagal
1368665|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
1368666|NCT01298141|agalsidase alfa|agalsidase alfa
1368667|NCT01298115|chronic kidney disease|chronic kidney disease
1368668|NCT01298115|dialysis|dialysis
1368669|NCT01298115|pre dialysis education|pre dialysis education
1368670|NCT01298115|transplantation|transplantation
1368671|NCT01298115|conservative care|conservative care
1368672|NCT01298102|kidney|kidney
1368673|NCT01298102|transplantation|transplantation
1368674|NCT01298102|haemodialysis|haemodialysis
1368675|NCT01298102|vaccination|vaccination
1368676|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
1368677|NCT01298089|Flap|flap
1368678|NCT01298089|LASIK|lasik
1368679|NCT01298089|Corneal|corneal
1368680|NCT01298076|Diabetes|diabetes
1368681|NCT01298076|Retinopathy|retinopathy
1368682|NCT01298076|Macular oedema|macular oedema
1368683|NCT01298076|Laser|laser
1368684|NCT01298076|Photocoagulation|photocoagulation
1368685|NCT01298076|Fovea|fovea
1368686|NCT01298076|Steroid|steroid
1368687|NCT01298076|Bevacizumab|bevacizumab
1368688|NCT01298076|Intravitreal|intravitreal
1368689|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
1368690|NCT01298024|Achilles tendon rupture|achilles tendon rupture
1368691|NCT01298024|Non-surgical treatment|non-surgical treatment
1368692|NCT01298024|Exercise|exercise
1368693|NCT01298024|Neuromuscular training|neuromuscular training
1368694|NCT01298011|operable|operable
1368695|NCT01298011|pancreas|pancreas
1368696|NCT01298011|Abraxane|abraxane
1368697|NCT01298011|Gemcitabine|gemcitabine
1368698|NCT01298011|Preoperative|preoperative
1368699|NCT01298011|potentially|potentially
1368700|NCT01298011|Pancreatic Cancer|pancreatic cancer
1368701|NCT01297985|Serious mental illness|serious mental illness
1368702|NCT01297985|Psychiatric disability|psychiatric disability
1368703|NCT01297985|Mental health peer-led|mental health peer-led
1368704|NCT01297985|Mental illness education|mental illness education
1368705|NCT01297985|Illness self-management|illness self-management
1368706|NCT01297972|Aplastic Anemia|aplastic anemia
1368707|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
1368708|NCT01297959|Surgical Wound Infection|surgical wound infection
1368709|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
1368710|NCT01297959|Singlet Oxygen|singlet oxygen
1368711|NCT01297959|Peroxidase|peroxidase
1368712|NCT01297959|Glucose Oxidase|glucose oxidase
1368713|NCT01297959|Colorectal surgery|colorectal surgery
1368715|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
1368716|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
1368717|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1368718|NCT01297933|cholestasis|cholestasis
1368719|NCT01297933|short bowel syndrome|short bowel syndrome
1368720|NCT01297933|Omegaven|omegaven
1368721|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
1368722|NCT01297920|Ocular Hypertension|ocular hypertension
1368723|NCT01297920|Brinzolamide|brinzolamide
1368724|NCT01297920|Brimonidine|brimonidine
1368725|NCT01297920|Intraocular pressure|intraocular pressure
1368726|NCT01297907|Crohn's Disease|crohn's disease
1368727|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
1368728|NCT01297907|Fractional exhaled NO|fractional exhaled no
1368729|NCT01297907|Methacholine Challenge Test|methacholine challenge test
1368730|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
1368731|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
1368732|NCT01297894|A. baumannii|a. baumannii
1368733|NCT01297894|colistin|colistin
1368734|NCT01297894|fosfomycin|fosfomycin
1368735|NCT01297881|Caucasian outpatients|caucasian outpatients
1368736|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
1368737|NCT01297881|dyspnea|dyspnea
1368738|NCT01297881|cough|cough
1368739|NCT01297881|sputum|sputum
1368740|NCT01297829|ibuprofen|ibuprofen
1368741|NCT01297829|postoperative narcotics|postoperative narcotics
1368742|NCT01297829|visual analog pain scale|visual analog pain scale
1368743|NCT01297829|inguinal hernia repair|inguinal hernia repair
1368744|NCT01297829|umbilical hernia repair|umbilical hernia repair
1368745|NCT01297790|Cough|cough
1368746|NCT01297790|Inhalational cough challenges|inhalational cough challenges
1368747|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
1368748|NCT01297790|Chronic cough.|chronic cough.
1368749|NCT01297777|Mast cell|mast cell
1368750|NCT01297777|Mastocytosis|mastocytosis
1368751|NCT01297777|Mast cell disease|mast cell disease
1368752|NCT01297738|diet manipulation|diet manipulation
1368753|NCT01297738|serotonin|serotonin
1368754|NCT01297738|dopamine|dopamine
1368755|NCT01297738|insulin sensitivity|insulin sensitivity
1368756|NCT01297725|Cesarean section|cesarean section
1368757|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
1368758|NCT01297725|Fascia [*surgery]|fascia [*surgery]
1368759|NCT01297725|Randomized Controlled Trial|randomized controlled trial
1368760|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
1368761|NCT01297725|Pain, postoperative|pain, postoperative
1368762|NCT01297725|Surgical wound infection|surgical wound infection
1368763|NCT01297712|screening colonoscopy|screening colonoscopy
1368764|NCT01297712|adenoma|adenoma
1368765|NCT01297712|hyperplastic polyp|hyperplastic polyp
1368766|NCT01297712|differential diagnosis|differential diagnosis
1368767|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
1368768|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
1368769|NCT01297699|Thyroid eye disease|thyroid eye disease
1487212|NCT00827476|ovary|ovary
1368770|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1368771|NCT01297699|Tocilizumab|tocilizumab
1368772|NCT01297699|EUGOGO|eugogo
1368774|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
1368775|NCT01297686|Workplace injury|workplace injury
1368776|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
1368777|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
1368778|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
1368779|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
1368780|NCT01297673|spinal cord injury|spinal cord injury
1368781|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1368782|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
1368783|NCT01297660|compliance|compliance
1368784|NCT01297660|video urodynamic|video urodynamic
1368785|NCT01297660|spinal cord injury|spinal cord injury
1368786|NCT01297647|urinary tract infection|urinary tract infection
1368787|NCT01297647|urodynamics|urodynamics
1368788|NCT01297647|spinal cord injury|spinal cord injury
1368789|NCT01297634|Botulinum toxin type A|botulinum toxin type a
1368790|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
1368791|NCT01297634|Randomized controlled trial|randomized controlled trial
1368792|NCT01297634|Double-blinded trial|double-blinded trial
1368793|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
1368794|NCT01297634|Electromyographic activity|electromyographic activity
1368795|NCT01297634|Frontal Area|frontal area
1368796|NCT01297621|breast hypertrophy|breast hypertrophy
1368797|NCT01297621|physical activity|physical activity
1368798|NCT01297621|sexuality|sexuality
1368799|NCT01297621|patient satisfaction|patient satisfaction
1368800|NCT01297595|relative bioavailability|relative bioavailability
1368801|NCT01297595|pharmacokinetics|pharmacokinetics
1368802|NCT01297595|crizotinib|crizotinib
1368803|NCT01297595|oral liquid formulation|oral liquid formulation
1368804|NCT01297595|formulated capsule|formulated capsule
1368805|NCT01297582|ONO-6950|ono-6950
1368806|NCT01297582|Healthy Adult Subjects|healthy adult subjects
1368807|NCT01297569|Diabetic macular edema|diabetic macular edema
1368808|NCT01297569|Macular edema|macular edema
1368809|NCT01297569|DME|dme
1368811|NCT01297569|Diabetic eye disease|diabetic eye disease
1368812|NCT01297569|anti-VEGF|anti-vegf
1368813|NCT01297569|ranibizumab|ranibizumab
1368814|NCT01297569|Lucentis|lucentis
1368815|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
1368816|NCT01297543|Induction chemotherapy|induction chemotherapy
1368817|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
1368818|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
1368819|NCT01297543|Leukemia|leukemia
1368820|NCT01297543|Myelodysplasia|myelodysplasia
1368821|NCT01297530|Phase I|phase i
1368822|NCT01297530|Dose Escalation|dose escalation
1368823|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
1368824|NCT01297530|Neoplasms|neoplasms
1368825|NCT01297517|AOG|aog
1368826|NCT01297517|OHT|oht
1368827|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
1368828|NCT01297517|Ocular Hypertension|ocular hypertension
1368829|NCT01297504|palivizumab|palivizumab
1368830|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
1368831|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
1368832|NCT01297504|usage patterns|usage patterns
1368833|NCT01297491|NSCLC|nsclc
1368834|NCT01297491|PI3K|pi3k
1368835|NCT01297465|Ovulation Induction|ovulation induction
1368836|NCT01297465|Ovarian Stimulation|ovarian stimulation
1368837|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
1368838|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
1368839|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
1368840|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
1368841|NCT01297452|BKM120|bkm120
1368842|NCT01297452|CARBOPLATIN|carboplatin
1368843|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1368844|NCT01297452|Chemotherapy|chemotherapy
1368845|NCT01297452|10-192|10-192
1368846|NCT01297439|shoulder dystocia,|shoulder dystocia,
1368847|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
1368848|NCT01297439|pushing maneuver|pushing maneuver
1368849|NCT01297413|allogeneic|allogeneic
1368850|NCT01297413|adult|adult
1368851|NCT01297413|stem|stem
1368852|NCT01297413|cells|cells
1368853|NCT01297413|stroke|stroke
1368854|NCT01297413|ischemic|ischemic
1368855|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
1368856|NCT01297387|Diabetic Patients|diabetic patients
1368857|NCT01297387|Critical Limb Ischemia|critical limb ischemia
1368858|NCT01297387|Revascularization|revascularization
1368859|NCT01297374|Obesity|obesity
1368860|NCT01297348|Lybrel|lybrel
1368861|NCT01297348|levonorgestrel|levonorgestrel
1368862|NCT01297348|ethinyl estradiol|ethinyl estradiol
1368863|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
1368864|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
1368865|NCT01297348|safety|safety
1368866|NCT01297348|database study|database study
1368867|NCT01297348|case-control study|case-control study
1368868|NCT01297335|intrathecal|intrathecal
1368869|NCT01297335|clonidine|clonidine
1368870|NCT01297335|poorly|poorly
1368871|NCT01297335|controlled|controlled
1368872|NCT01297335|hypertension|hypertension
1368873|NCT01297322|vascular closure system|vascular closure system
1368874|NCT01297322|manual compression|manual compression
1368875|NCT01297322|femoral arteriotomy|femoral arteriotomy
1368876|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
1368877|NCT01297309|PTH 1-84|pth 1-84
1368878|NCT01297309|Hypoparathyroidism|hypoparathyroidism
1368879|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
1368880|NCT01297309|NPSP558|npsp558
1368881|NCT01297296|heart failure|heart failure
1368882|NCT01297296|percutaneous|percutaneous
1368883|NCT01297296|interventional cardiology|interventional cardiology
1368884|NCT01297296|apical remodeling|apical remodeling
1368885|NCT01297296|LV dilatation|lv dilatation
1368886|NCT01297296|akinesis|akinesis
1368887|NCT01297296|dyskinesis|dyskinesis
1368888|NCT01297296|myocardial infarction|myocardial infarction
1368889|NCT01297283|Heart failure|heart failure
1368890|NCT01297283|Cardiac resynchronization|cardiac resynchronization
1368891|NCT01297283|Leadless ECG|leadless ecg
1368892|NCT01297283|Follow-up|follow-up
1368893|NCT01297244|AV-951|av-951
1368894|NCT01297244|Tivozanib|tivozanib
1368895|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1368896|NCT01297244|RCC|rcc
1368897|NCT01297244|Biomarkers|biomarkers
1368898|NCT01297231|fibroglandular tissue|fibroglandular tissue
1368899|NCT01297231|tamoxifen|tamoxifen
1368900|NCT01297231|MRI|mri
1368901|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
1368902|NCT01297231|10-217|10-217
1368903|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
1368904|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
1368905|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1368906|NCT01297205|Premature infants|premature infants
1368908|NCT01297192|Mirabegron|mirabegron
1368909|NCT01297192|DDI|ddi
1368910|NCT01297192|Phase I|phase i
1368911|NCT01297192|Solifenacin|solifenacin
1368912|NCT01297192|Pharmacokinetics|pharmacokinetics
1368913|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
1368914|NCT01297179|Pharmacokinetics|pharmacokinetics
1368915|NCT01297179|Oral contraceptives|oral contraceptives
1368916|NCT01297179|Drug interactions|drug interactions
1368917|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
1368918|NCT01297153|Congenital Cataract|congenital cataract
1368919|NCT01297153|Children younger than 2 years|children younger than 2 years
1368920|NCT01297153|Aphakia|aphakia
1368921|NCT01297153|Primary IOL Implantation|primary iol implantation
1368922|NCT01297140|Psychiatry|psychiatry
1368923|NCT01297140|Behaviour|behaviour
1368924|NCT01297140|Alzheimer's|alzheimer's
1368925|NCT01297140|Personality|personality
1368926|NCT01297088|Proof of Mechanism|proof of mechanism
1368927|NCT01297088|Phase I|phase i
1368928|NCT01297088|Neoplasm|neoplasm
1368929|NCT01297088|Inflammation|inflammation
1368930|NCT01297075|Health Services Research|health services research
1368931|NCT01297075|Chronic Care|chronic care
1368932|NCT01297075|Outreach Visits|outreach visits
1368933|NCT01297075|Primary care|primary care
1368934|NCT01297075|chronic disease management|chronic disease management
1368935|NCT01297062|Diabetes|diabetes
1368936|NCT01297062|exenatide|exenatide
1368937|NCT01297062|Amylin|amylin
1368938|NCT01297062|Lilly|lilly
1368939|NCT01297062|QT interval|qt interval
1368940|NCT01297049|Diabetes|diabetes
1368941|NCT01297049|obesity|obesity
1368942|NCT01297049|behavior therapy|behavior therapy
1368943|NCT01297049|self management|self management
1368944|NCT01297036|Pharmacokinetics|pharmacokinetics
1368945|NCT01297036|Bioequivalence|bioequivalence
1368946|NCT01297036|Donepezil|donepezil
1368947|NCT01297023|calcium phosphate|calcium phosphate
1368948|NCT01297023|vitamin d3|vitamin d3
1368949|NCT01297023|bone metabolism|bone metabolism
1368950|NCT01297023|human study|human study
1368951|NCT01297010|Nausea and Vomiting|nausea and vomiting
1368952|NCT01297010|Vomiting|vomiting
1368953|NCT01297010|Postoperative|postoperative
1368954|NCT01297010|Anesthesia|anesthesia
1368955|NCT01296997|calcium phosphate|calcium phosphate
1368956|NCT01296997|incretins|incretins
1368957|NCT01296997|human study|human study
1368958|NCT01296984|Rectal cancer|rectal cancer
1368959|NCT01296984|APR|apr
1368960|NCT01296958|Taenia solium|taenia solium
1368961|NCT01296958|cysticercosis|cysticercosis
1368962|NCT01296958|neurocysticercosis|neurocysticercosis
1368963|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
1368964|NCT01296919|Histopathology|histopathology
1368965|NCT01296919|Infundibulum|infundibulum
1368966|NCT01296919|Lamina propria|lamina propria
1368967|NCT01296919|Uncinate process|uncinate process
1368968|NCT01296906|Reminder/recall messages|reminder/recall messages
1368969|NCT01296906|reminders|reminders
1368970|NCT01296906|recall|recall
1368971|NCT01296906|immunizations|immunizations
1368972|NCT01296906|immunization information systems|immunization information systems
1368973|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
1368974|NCT01296906|population-based reminder/recall|population-based reminder/recall
1368975|NCT01296867|Laser ablation algorithms|laser ablation algorithms
1368976|NCT01296867|Excimer laser|excimer laser
1368977|NCT01296867|Refractive correction|refractive correction
1368978|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
1368979|NCT01296854|spa therapy|spa therapy
1368980|NCT01296841|telemedicine|telemedicine
1368981|NCT01296841|remote consultation|remote consultation
1368982|NCT01296841|telehealth|telehealth
1368983|NCT01296841|ehealth|ehealth
1368984|NCT01296841|image archiving|image archiving
1368985|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
1368986|NCT01296815|Kaposi sarcoma|kaposi sarcoma
1368987|NCT01296815|HIV|hiv
1368988|NCT01296815|Bevacizumab|bevacizumab
1368989|NCT01296802|Ecstasy|ecstasy
1368990|NCT01296802|MDMA|mdma
1368991|NCT01296802|Serotonin|serotonin
1368992|NCT01296802|Neurotoxicity|neurotoxicity
1368993|NCT01296802|dexfenfluramine|dexfenfluramine
1368994|NCT01296802|Positron emission tomography|positron emission tomography
1368995|NCT01296802|altanserin|altanserin
1368996|NCT01296802|5-HT2A receptor|5-ht2a receptor
1368997|NCT01296776|exercise|exercise
1368998|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
1368999|NCT01296776|bone mineral density|bone mineral density
1369000|NCT01296776|falls|falls
1369001|NCT01296776|physical fitness|physical fitness
1369002|NCT01296776|pain|pain
1369003|NCT01296763|Irinotecan|irinotecan
1369004|NCT01296763|Cisplatin|cisplatin
1369005|NCT01296763|Carboplatin|carboplatin
1369006|NCT01296763|Mitomycin-C|mitomycin-c
1369007|NCT01296763|Olaparib|olaparib
1369008|NCT01296763|AZD2281|azd2281
1369009|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
1369010|NCT01296711|CDP6038|cdp6038
1369011|NCT01296711|Interleukin-6|interleukin-6
1369012|NCT01296698|Smoking Cessation|smoking cessation
1369117|NCT01296269|oxytocin|oxytocin
1369013|NCT01296698|Tobacco Use Disorder|tobacco use disorder
1369014|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
1369015|NCT01296672|Finasteride|finasteride
1369016|NCT01296672|Placebo|placebo
1369017|NCT01296672|Prostate cancer|prostate cancer
1369018|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
1369019|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
1369020|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
1369021|NCT01296659|sarcoma|sarcoma
1369022|NCT01296659|Ridaforolimus|ridaforolimus
1369023|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
1369024|NCT01296659|unresectable sarcoma|unresectable sarcoma
1369025|NCT01296646|Alcohol|alcohol
1369026|NCT01296646|Alcoholics|alcoholics
1369027|NCT01296646|Substance Abuse|substance abuse
1369028|NCT01296646|Alcohol Abuse|alcohol abuse
1369029|NCT01296646|Alcohol Addiction|alcohol addiction
1369030|NCT01296633|health literacy|health literacy
1369031|NCT01296633|patient education|patient education
1369032|NCT01296633|medication adherence|medication adherence
1369033|NCT01296633|patient/provider communication|patient/provider communication
1369034|NCT01296633|Diabetes Mellitus|diabetes mellitus
1369035|NCT01296607|Pharmacodynamics|pharmacodynamics
1369036|NCT01296607|Pharmacokinetics|pharmacokinetics
1369037|NCT01296607|Urocortin 2|urocortin 2
1369038|NCT01296607|Urocortin 3|urocortin 3
1369039|NCT01296607|Reproducibility|reproducibility
1369040|NCT01296607|Onset/ Offset|onset/ offset
1369041|NCT01296607|Forearm blood flow|forearm blood flow
1369042|NCT01296607|Plethysmography|plethysmography
1369043|NCT01296607|Heart Failure|heart failure
1369044|NCT01296581|Cancer|cancer
1369045|NCT01296581|Tumors|tumors
1369046|NCT01296581|VEGFR|vegfr
1369047|NCT01296581|PDGFR|pdgfr
1369048|NCT01296568|metastatic solid tumors|metastatic solid tumors
1369049|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
1369050|NCT01296568|Pancreas NOS|pancreas nos
1369051|NCT01296568|Absorption|absorption
1369052|NCT01296568|Distribution|distribution
1369053|NCT01296568|Metabolism|metabolism
1369054|NCT01296568|Excretion|excretion
1369055|NCT01296568|Mass balance|mass balance
1369056|NCT01296568|Metabolic profile|metabolic profile
1369057|NCT01296568|Radiolabeled study|radiolabeled study
1369058|NCT01296516|Women|women
1369059|NCT01296516|Postpartum|postpartum
1369061|NCT01296503|Multiple Myeloma|multiple myeloma
1369062|NCT01296503|Treatment|treatment
1369063|NCT01296503|Maintenance|maintenance
1369064|NCT01296503|Thalidomide|thalidomide
1369065|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
1369066|NCT01296477|Asthma|asthma
1369067|NCT01296477|ASTHMA IQ tool|asthma iq tool
1369068|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
1369069|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
1369070|NCT01296464|Parkinson's Disease|parkinson's disease
1369071|NCT01296464|Motor response|motor response
1369072|NCT01296464|Wearing-off|wearing-off
1369073|NCT01296451|Hepatitis C|hepatitis c
1369074|NCT01296451|vaccine|vaccine
1369075|NCT01296451|Adenovirus|adenovirus
1369076|NCT01296451|MVA|mva
1369077|NCT01296451|chronic infection|chronic infection
1369078|NCT01296451|interferon|interferon
1369079|NCT01296451|ribavirin|ribavirin
1369080|NCT01296425|Growth disorders|growth disorders
1369081|NCT01296425|Saizen|saizen
1369082|NCT01296425|Easypod|easypod
1369083|NCT01296425|Growth hormone|growth hormone
1369084|NCT01296425|Pediatric subject|pediatric subject
1369085|NCT01296399|in stent restenosis|in stent restenosis
1369086|NCT01296399|bare metal stent|bare metal stent
1369087|NCT01296399|drug eluting stent|drug eluting stent
1369088|NCT01296399|de novo lesion|de novo lesion
1369089|NCT01296373|HIV-1|hiv-1
1369090|NCT01296373|immune|immune
1369091|NCT01296373|restoration|restoration
1369092|NCT01296373|observational|observational
1369093|NCT01296360|immune response|immune response
1369094|NCT01296360|IC51-325|ic51-325
1369095|NCT01296360|Japanese Encephalitis|japanese encephalitis
1369096|NCT01296360|Intercell AG|intercell ag
1369097|NCT01296347|Ketamine|ketamine
1369098|NCT01296347|Thoracotomy|thoracotomy
1369099|NCT01296347|VATS|vats
1369100|NCT01296347|Pain|pain
1369101|NCT01296334|opioids|opioids
1369102|NCT01296334|analgesia|analgesia
1369103|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
1369104|NCT01296334|quantitative sensory testing|quantitative sensory testing
1369105|NCT01296334|inflammatory injury|inflammatory injury
1369106|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1369107|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
1369108|NCT01296308|Complementary Medicine|complementary medicine
1369109|NCT01296308|Alternative Medicine|alternative medicine
1369110|NCT01296308|Integrative Medicine|integrative medicine
1369111|NCT01296308|Quality of Life|quality of life
1369112|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
1369113|NCT01296295|smoking cessation advice|smoking cessation advice
1369114|NCT01296295|spirometry|spirometry
1369115|NCT01296295|primary health care|primary health care
1369116|NCT01296269|social cognition|social cognition
1369118|NCT01296269|vasopressin|vasopressin
1369119|NCT01296269|decision making|decision making
1369120|NCT01296269|social decision making|social decision making
1369121|NCT01296256|Bendamustine|bendamustine
1369122|NCT01296256|Conditioning Therapy|conditioning therapy
1369123|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
1369124|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
1369125|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
1369126|NCT01296243|Tesetaxel|tesetaxel
1369127|NCT01296243|Taxanes|taxanes
1369128|NCT01296243|Chemotherapy-naive|chemotherapy-naive
1369129|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
1369130|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
1369131|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
1369132|NCT01296165|Travel|travel
1369133|NCT01296165|Spread|spread
1369134|NCT01296165|Antibiotic resistance|antibiotic resistance
1369135|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
1369136|NCT01296139|Prostatectomy|prostatectomy
1369137|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
1369138|NCT01296139|Imaging Study|imaging study
1369139|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
1369140|NCT01296139|Prostate Cancer|prostate cancer
1369141|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
1369142|NCT01296126|MRI|mri
1369143|NCT01296126|TBI|tbi
1369144|NCT01296126|Traumatic Brain Injury|traumatic brain injury
1369145|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
1369146|NCT01296126|PTSD|ptsd
1369147|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
1369148|NCT01296100|nutrition|nutrition
1369149|NCT01296100|physical activity|physical activity
1369150|NCT01296087|Asthma|asthma
1369151|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
1369152|NCT01296074|monocyte|monocyte
1369153|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
1369154|NCT01296074|cardiac surgery|cardiac surgery
1369155|NCT01296061|Dialysis|dialysis
1369156|NCT01296061|Renal Transplantation|renal transplantation
1369157|NCT01296061|Failure of allograft|failure of allograft
1369158|NCT01296048|weight|weight
1369159|NCT01296048|body fat|body fat
1369160|NCT01296048|total body water|total body water
1369161|NCT01296048|bone mass|bone mass
1369162|NCT01296048|muscle mass|muscle mass
1369163|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
1369164|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
1369165|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
1369166|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
1369167|NCT01296009|embryonic implantation|embryonic implantation
1369168|NCT01296009|endometrial receptivity|endometrial receptivity
1369169|NCT01296009|traditional Chinese medicines|traditional chinese medicines
1369170|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
1369171|NCT01296009|pregnant rate|pregnant rate
1369172|NCT01295970|Surgery of the brain|surgery of the brain
1369173|NCT01295970|Radiosurgery|radiosurgery
1369174|NCT01295970|Brain Metastasis|brain metastasis
1369175|NCT01295944|Chemotherapy|chemotherapy
1369176|NCT01295944|Brain Tumor|brain tumor
1369177|NCT01295944|Spinal Cord Tumor|spinal cord tumor
1369178|NCT01295944|Malignancy|malignancy
1369179|NCT01295944|Neurologic|neurologic
1369180|NCT01295931|Near-infrared|near-infrared
1369181|NCT01295931|NIR|nir
1369182|NCT01295931|Indocyanine green|indocyanine green
1369183|NCT01295931|ICG|icg
1369184|NCT01295931|Melanoma|melanoma
1369185|NCT01295931|Fluorescent dyes|fluorescent dyes
1369186|NCT01295931|Lymph nodes|lymph nodes
1369187|NCT01295931|Experimental camera|experimental camera
1369188|NCT01295918|probiotic|probiotic
1369189|NCT01295918|AAD|aad
1369190|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
1369191|NCT01295918|diarrhea|diarrhea
1369192|NCT01295892|menopause|menopause
1369193|NCT01295892|obesity|obesity
1369194|NCT01295892|capillary|capillary
1369195|NCT01295892|microcirculation|microcirculation
1369196|NCT01295892|estrogen|estrogen
1369197|NCT01295892|Microvascular Function|microvascular function
1369198|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
1369199|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
1369200|NCT01295866|nasal nitric oxide|nasal nitric oxide
1369201|NCT01295866|atopy|atopy
1369202|NCT01295827|Melanoma|melanoma
1369203|NCT01295827|Carcinoma|carcinoma
1369204|NCT01295827|Cancer|cancer
1369205|NCT01295827|Advanced cancer|advanced cancer
1369206|NCT01295827|Metastatic cancer|metastatic cancer
1369207|NCT01295827|Metastatic melanoma|metastatic melanoma
1369208|NCT01295827|PD-1|pd-1
1369209|NCT01295827|PD1|pd1
1369210|NCT01295814|Interstitial cystitis|interstitial cystitis
1369211|NCT01295814|Humira|humira
1369212|NCT01295814|Adalimumab|adalimumab
1369213|NCT01295801|Linezolid|linezolid
1369214|NCT01295801|Vitamin B6|vitamin b6
1369215|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
1369216|NCT01295775|diabetic retinopathy|diabetic retinopathy
1369217|NCT01295775|sulodexide|sulodexide
1369218|NCT01295775|hard exudates|hard exudates
1369219|NCT01295775|microaneurysms|microaneurysms
1369220|NCT01295775|hemorrhages|hemorrhages
1369221|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
1369222|NCT01295762|Children|children
1369223|NCT01295762|Cancer|cancer
1369224|NCT01295762|Immunomonitoring|immunomonitoring
1369225|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
1369226|NCT01295762|Immunotherapy|immunotherapy
1369227|NCT01295749|cardiac arrest|cardiac arrest
1369228|NCT01295749|No Flow|no flow
1369229|NCT01295749|Emergency|emergency
1369230|NCT01295749|Nurse|nurse
1369231|NCT01295749|laryngeal Tube|laryngeal tube
1369232|NCT01295736|scleroderma|scleroderma
1369233|NCT01295736|digital|digital
1369234|NCT01295736|ulcer|ulcer
1369235|NCT01295723|Breast cancer|breast cancer
1369236|NCT01295723|Radiation therapy|radiation therapy
1369237|NCT01295723|Mobetron|mobetron
1369238|NCT01295723|IOERT|ioert
1369239|NCT01295723|IORT|iort
1369240|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
1369241|NCT01295723|Partial breast radiation|partial breast radiation
1369242|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
1369243|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
1369244|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
1369245|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
1369246|NCT01295710|unrelated donor|unrelated donor
1369247|NCT01295710|GVHD|gvhd
1369248|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
1369249|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
1369250|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
1369251|NCT01295684|cranberry|cranberry
1369252|NCT01295684|cardiovascular|cardiovascular
1369253|NCT01295684|adhesion|adhesion
1369254|NCT01295684|polyphenol|polyphenol
1369255|NCT01295658|cancer|cancer
1369256|NCT01295658|cancer survivorship|cancer survivorship
1369257|NCT01295658|psychosocial needs|psychosocial needs
1369258|NCT01295658|cancer experience|cancer experience
1369259|NCT01295658|metastatic breast cancer|metastatic breast cancer
1369260|NCT01295658|breast cancer|breast cancer
1369261|NCT01295658|caregiver|caregiver
1369262|NCT01295645|Stem Cell Transplant|stem cell transplant
1369263|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
1369264|NCT01295645|Bladder inflammation|bladder inflammation
1369265|NCT01295645|Frequent urination|frequent urination
1369266|NCT01295645|Pain|pain
1369267|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
1369268|NCT01295645|BK virus|bk virus
1369269|NCT01295645|BKV|bkv
1369270|NCT01295645|Cidofovir|cidofovir
1369271|NCT01295645|Vistide|vistide
1369272|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1369273|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
1369274|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
1369275|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
1369276|NCT01295632|Refractory breast cancer|refractory breast cancer
1369277|NCT01295632|Relapsed breast cancer|relapsed breast cancer
1369278|NCT01295619|Dura|dura
1369279|NCT01295619|Sealant|sealant
1369280|NCT01295619|Cranial|cranial
1369281|NCT01295619|Craniotomy|craniotomy
1369282|NCT01295619|CSF leakage|csf leakage
1369283|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
1369284|NCT01295606|cefazolin|cefazolin
1369285|NCT01295606|prophylaxis|prophylaxis
1369286|NCT01295606|pharmacokinetics|pharmacokinetics
1369287|NCT01295606|newborn|newborn
1369288|NCT01295593|CLL previously treated|cll previously treated
1369289|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
1369290|NCT01295567|CABG|cabg
1369291|NCT01295567|dipyridamole|dipyridamole
1369292|NCT01295567|HS-troponin-I|hs-troponin-i
1369293|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
1369294|NCT01295541|ICU LOS|icu los
1369295|NCT01295541|Progressive Mobility|progressive mobility
1369296|NCT01295541|Deconditioning|deconditioning
1369297|NCT01295528|blood pressure|blood pressure
1369298|NCT01295528|heart rate|heart rate
1369299|NCT01295515|HIV|hiv
1369300|NCT01295515|Replication|replication
1369301|NCT01295515|Antiretroviral|antiretroviral
1369302|NCT01295515|Interferon|interferon
1369303|NCT01295515|Reservoirs|reservoirs
1369304|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1369305|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1369306|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1369307|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1369308|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1369309|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1369310|NCT01295463|sexual dysfunction|sexual dysfunction
1369395|NCT01295242|HPV|hpv
1369396|NCT01295242|Cervical Cancer|cervical cancer
1369311|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1369312|NCT01295463|infertility|infertility
1369313|NCT01295463|colon cancer|colon cancer
1369314|NCT01295463|male breast cancer|male breast cancer
1369315|NCT01295463|breast cancer|breast cancer
1369316|NCT01295463|germ cell tumor|germ cell tumor
1369317|NCT01295463|ovarian sarcoma|ovarian sarcoma
1369318|NCT01295463|uterine sarcoma|uterine sarcoma
1369319|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1369320|NCT01295463|osteosarcoma|osteosarcoma
1369321|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
1369322|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
1369323|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1369324|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1369325|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1369326|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1369327|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1369328|NCT01295463|mast cell leukemia|mast cell leukemia
1369329|NCT01295463|hairy cell leukemia|hairy cell leukemia
1369330|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
1369331|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1369332|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
1369333|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
1369334|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1369335|NCT01295463|small intestine lymphoma|small intestine lymphoma
1369336|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1369337|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1369338|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
1369339|NCT01295463|intraocular lymphoma|intraocular lymphoma
1369340|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1369341|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1369342|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1369343|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1369344|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
1369345|NCT01295463|central nervous system leukemia|central nervous system leukemia
1369346|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1369347|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1369348|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1369349|NCT01295463|Kaposi sarcoma|kaposi sarcoma
1369350|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
1487947|NCT00824811|HNC|hnc
1369351|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1369352|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
1369353|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
1369354|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
1369355|NCT01295450|Phase III|phase iii
1369356|NCT01295450|Apevinat BC|apevinat bc
1369357|NCT01295450|Lack of appetite|lack of appetite
1369358|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
1369359|NCT01295424|Cardiac Arrest|cardiac arrest
1369360|NCT01295424|Intensive Care Unit|intensive care unit
1369361|NCT01295424|Emergency Medical Service|emergency medical service
1369362|NCT01295385|type 2 diabetes|type 2 diabetes
1369363|NCT01295385|Cardiovascular diseases|cardiovascular diseases
1369364|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
1369365|NCT01295372|Schizophrenia|schizophrenia
1369366|NCT01295372|Antipsychotic|antipsychotic
1369367|NCT01295372|Risperidone|risperidone
1369368|NCT01295372|Lu 31-130|lu 31-130
1369369|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1369370|NCT01295359|Walking|walking
1369371|NCT01295359|Hospital|hospital
1369372|NCT01295359|Exercise Tolerance|exercise tolerance
1369373|NCT01295359|Physical Therapy|physical therapy
1369374|NCT01295320|Herpes Zoster|herpes zoster
1369375|NCT01295320|vaccine|vaccine
1369376|NCT01295320|safety|safety
1369377|NCT01295320|immunogenicity|immunogenicity
1369378|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
1369379|NCT01295307|relapsed|relapsed
1369380|NCT01295307|refractory|refractory
1369381|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
1369382|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
1369383|NCT01295294|Contraception|contraception
1369384|NCT01295294|Contraceptive Methods|contraceptive methods
1369385|NCT01295294|Intrauterine devices|intrauterine devices
1369386|NCT01295294|Mirena|mirena
1369387|NCT01295268|Vulvar pain|vulvar pain
1369388|NCT01295268|Vulvodynia|vulvodynia
1369389|NCT01295268|Vestibulodynia|vestibulodynia
1369390|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
1369391|NCT01295255|Allergic rhinitis|allergic rhinitis
1369392|NCT01295255|Psychological status|psychological status
1369393|NCT01295255|Asthma|asthma
1369394|NCT01295255|Aeroallergen|aeroallergen
1369397|NCT01295216|prehypertension|prehypertension
1369398|NCT01295216|blood pressure|blood pressure
1369399|NCT01295216|mobile technology|mobile technology
1369400|NCT01295216|Latin America|latin america
1369401|NCT01295216|behavioral change|behavioral change
1369402|NCT01295216|healthy lifestyles|healthy lifestyles
1369403|NCT01295216|mHealth|mhealth
1369404|NCT01295177|wound healing|wound healing
1369405|NCT01295177|diabetes mellitus|diabetes mellitus
1369406|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
1369407|NCT01295138|Constipation|constipation
1369408|NCT01295138|Caesarean section|caesarean section
1369409|NCT01295138|Abdominal Pain|abdominal pain
1369410|NCT01295138|Nausea|nausea
1369411|NCT01295138|Vomiting|vomiting
1369412|NCT01295125|Infected ventral hernia|infected ventral hernia
1369413|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
1369414|NCT01295099|scar formation|scar formation
1369415|NCT01295099|5-FU|5-fu
1369416|NCT01295099|genetic link|genetic link
1369417|NCT01295099|psychological impact|psychological impact
1369418|NCT01295099|social impact|social impact
1369419|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
1369420|NCT01295086|Her2|her2
1369421|NCT01295086|Dose finding|dose finding
1369422|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
1369423|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
1369424|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
1369425|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
1369426|NCT01295073|Trientine|trientine
1369427|NCT01295073|Cataract surgery|cataract surgery
1369428|NCT01295073|Macular Edema|macular edema
1369429|NCT01295060|Acromegaly|acromegaly
1369430|NCT01295060|Octreotide|octreotide
1369431|NCT01295060|IGF-1|igf-1
1369432|NCT01295060|Growth Hormone|growth hormone
1369433|NCT01295060|Implant|implant
1369434|NCT01295060|Hydrogel|hydrogel
1369435|NCT01295047|Marfan Syndrome|marfan syndrome
1369436|NCT01295047|Large arterial function|large arterial function
1369437|NCT01295047|LV function|lv function
1369438|NCT01295047|atenolol|atenolol
1369439|NCT01295047|perindopril|perindopril
1369440|NCT01295047|verapamil|verapamil
1369441|NCT01295047|central arterial pressure|central arterial pressure
1369443|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
1369444|NCT01295034|vitamin D|vitamin d
1369445|NCT01295034|low bone density|low bone density
1369446|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
1369447|NCT01295008|Fabry disease|fabry disease
1369448|NCT01295008|Male pattern baldness|male pattern baldness
1369449|NCT01295008|Alopecia|alopecia
1369450|NCT01295008|GLA gene mutation|gla gene mutation
1369451|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
1369452|NCT01294995|short term consumption|short term consumption
1369453|NCT01294995|Chinese liquor|chinese liquor
1369454|NCT01294995|serum lipids|serum lipids
1369455|NCT01294995|uric acid|uric acid
1369456|NCT01294995|inflammation biomarkers|inflammation biomarkers
1369457|NCT01294982|OAB|oab
1369458|NCT01294982|Over Active Bladder|over active bladder
1369459|NCT01294982|overactive bladder|overactive bladder
1369460|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
1369461|NCT01294982|Urinary Incontinence|urinary incontinence
1369462|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
1369463|NCT01294956|Dry eye|dry eye
1369464|NCT01294956|artificial tears|artificial tears
1369465|NCT01294956|corneal staining|corneal staining
1369466|NCT01294943|Intensive Care Units|intensive care units
1369467|NCT01294943|Biofilms|biofilms
1369468|NCT01294943|Tongue|tongue
1369469|NCT01294943|Infection|infection
1369470|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
1369471|NCT01294930|hip fracture|hip fracture
1369472|NCT01294930|mortality|mortality
1369473|NCT01294930|complications|complications
1369474|NCT01294904|Hormone|hormone
1369475|NCT01294904|Sperm|sperm
1369476|NCT01294904|Chronic kidney disease|chronic kidney disease
1369477|NCT01294891|Rheology|rheology
1369478|NCT01294891|Sickle cell|sickle cell
1369479|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1369480|NCT01294891|contrast ultrasound|contrast ultrasound
1369481|NCT01294878|anti-IgE treatment|anti-ige treatment
1369482|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
1369483|NCT01294878|omalizumab|omalizumab
1369484|NCT01294865|Sepsis|sepsis
1369485|NCT01294865|late-onset|late-onset
1369486|NCT01294865|suPAR|supar
1369487|NCT01294852|prophylactic|prophylactic
1369488|NCT01294852|surfactant|surfactant
1369489|NCT01294852|premature|premature
1369490|NCT01294852|mechanical ventilation|mechanical ventilation
1369491|NCT01294852|mortality|mortality
1369492|NCT01294852|morbidities|morbidities
1369493|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
1369494|NCT01294839|RVOTs pacing|rvots pacing
1369495|NCT01294839|RVA pacing|rva pacing
1369496|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
1369497|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
1369695|NCT01294137|sleep apnea|sleep apnea
1369498|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1369499|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
1369500|NCT01294826|Neoplasms by Site|neoplasms by site
1369501|NCT01294826|Neoplasms|neoplasms
1369502|NCT01294826|Digestive System Diseases|digestive system diseases
1369503|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
1369504|NCT01294826|Colonic Diseases|colonic diseases
1369505|NCT01294826|Intestinal Diseases|intestinal diseases
1369506|NCT01294826|Rectal Diseases|rectal diseases
1369507|NCT01294826|Cetuximab|cetuximab
1369508|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
1369509|NCT01294826|EGFR protein, human|egfr protein, human
1369510|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
1369511|NCT01294813|Ventilation|ventilation
1369512|NCT01294813|Bronchoscopy|bronchoscopy
1369513|NCT01294813|Lung Impedance|lung impedance
1369514|NCT01294813|Recruitment|recruitment
1369515|NCT01294800|Parkinson's disease|parkinson's disease
1369516|NCT01294787|COPD|copd
1369517|NCT01294787|QVA149|qva149
1369518|NCT01294787|tiotropium|tiotropium
1369519|NCT01294787|exercise|exercise
1369520|NCT01294787|exercise tolerance|exercise tolerance
1369521|NCT01294787|combination bronchodilator|combination bronchodilator
1369522|NCT01294787|moderate to severe COPD|moderate to severe copd
1369523|NCT01294774|Lupus erythematosus|lupus erythematosus
1369524|NCT01294774|skin lupus|skin lupus
1369525|NCT01294761|HIV-1|hiv-1
1369526|NCT01294761|AIDS|aids
1369527|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
1369528|NCT01294748|Coronary Artery Disease|coronary artery disease
1369529|NCT01294748|Drug-eluting Stent|drug-eluting stent
1369530|NCT01294748|Sirolimus|sirolimus
1369531|NCT01294735|Temozolomide|temozolomide
1369532|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
1369533|NCT01294735|melanoma|melanoma
1369534|NCT01294735|advanced neoplasm|advanced neoplasm
1369535|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
1369536|NCT01294722|anti-TNF α|anti-tnf α
1369537|NCT01294709|angina pectoris|angina pectoris
1369538|NCT01294709|coronary artery disease|coronary artery disease
1369539|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
1369540|NCT01294709|exercise tolerance,|exercise tolerance,
1369541|NCT01294696|Osteoarthritis|osteoarthritis
1369542|NCT01294696|Standard of care|standard of care
1369543|NCT01294683|Low-density lipoprotein|low-density lipoprotein
1369544|NCT01294683|LDL|ldl
1369545|NCT01294683|High-density lipoprotein|high-density lipoprotein
1369546|NCT01294683|HDL|hdl
1369547|NCT01294683|Niacin|niacin
1369548|NCT01294683|Lipid modifying therapy|lipid modifying therapy
1369549|NCT01294683|Cholesterol|cholesterol
1369550|NCT01294683|High cholesterol|high cholesterol
1369551|NCT01294683|Triglycerides|triglycerides
1369552|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
1369553|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
1369554|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
1369555|NCT01294670|Pediatric|pediatric
1369556|NCT01294670|10-096|10-096
1369557|NCT01294670|POETIC|poetic
1369558|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
1369559|NCT01294657|Obesity|obesity
1369560|NCT01294657|Cancer Risk|cancer risk
1369561|NCT01294657|African Americans|african americans
1369562|NCT01294657|Diet|diet
1369563|NCT01294657|Physical Activity|physical activity
1369564|NCT01294631|Canagliflozin|canagliflozin
1369565|NCT01294631|JNJ-28431754|jnj-28431754
1369566|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
1369567|NCT01294631|Pharmacokinetic|pharmacokinetic
1369568|NCT01294631|Pharmacodynamic|pharmacodynamic
1369569|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1369570|NCT01294618|nilotinib|nilotinib
1369571|NCT01294618|pegylated interferon|pegylated interferon
1369572|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
1369573|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
1369574|NCT01294605|DTPa|dtpa
1369576|NCT01294605|IPV|ipv
1369577|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1369578|NCT01294579|Ofatumumab|ofatumumab
1369579|NCT01294579|Relapsed|relapsed
1369580|NCT01294579|Rituximab|rituximab
1369581|NCT01294579|Bendamustine|bendamustine
1369582|NCT01294566|safety|safety
1369583|NCT01294566|motilin agonist|motilin agonist
1369584|NCT01294566|single dose|single dose
1369585|NCT01294566|ascending dose|ascending dose
1369586|NCT01294566|GSK1322888|gsk1322888
1369587|NCT01294566|migrating motor complex|migrating motor complex
1369588|NCT01294566|tolerability|tolerability
1369589|NCT01294566|FTIH|ftih
1369590|NCT01294566|gastric emptying|gastric emptying
1369591|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1369592|NCT01294527|cardiac pacing|cardiac pacing
1369593|NCT01294527|electrical stimulation|electrical stimulation
1369594|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
1369595|NCT01294514|Respiratory Rate|respiratory rate
1369596|NCT01294501|Medication administration|medication administration
1369597|NCT01294501|Medication errors|medication errors
1369598|NCT01294501|Health Literacy|health literacy
1370098|NCT01292382|Memory|memory
1369599|NCT01294501|Pediatric Emergency Department|pediatric emergency department
1369600|NCT01294501|Web-based education|web-based education
1369601|NCT01294488|PCIT|pcit
1369602|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
1369603|NCT01294488|Practitioner Fidelity|practitioner fidelity
1369604|NCT01294462|acute coronary syndrome|acute coronary syndrome
1369605|NCT01294462|coronary disease|coronary disease
1369606|NCT01294462|coronary artery disease|coronary artery disease
1369607|NCT01294436|Phase3|phase3
1369608|NCT01294436|Clinical trial|clinical trial
1369609|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1369610|NCT01294423|Phase3|phase3
1369611|NCT01294423|Clinical trial|clinical trial
1369612|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
1369613|NCT01294397|Amgen|amgen
1369614|NCT01294397|Phase 1|phase 1
1369615|NCT01294397|Postmenopausal|postmenopausal
1369616|NCT01294397|Osteopenia|osteopenia
1369617|NCT01294397|Rheumatoid|rheumatoid
1369618|NCT01294397|Bone Mineral Density|bone mineral density
1369619|NCT01294397|Arthritis|arthritis
1369620|NCT01294397|Pharmacokinetics|pharmacokinetics
1369621|NCT01294397|Osteoporosis|osteoporosis
1369622|NCT01294371|Lucrin Depot|lucrin depot
1369623|NCT01294371|genital endometriosis|genital endometriosis
1369624|NCT01294371|6 months therapy|6 months therapy
1369625|NCT01294358|Pancreatic Cancer|pancreatic cancer
1369626|NCT01294358|Regional Therapy|regional therapy
1369627|NCT01294358|Selective Arterial Infusion|selective arterial infusion
1369628|NCT01294358|Locally Advanced Disease|locally advanced disease
1369629|NCT01294345|Birth Defects|birth defects
1369630|NCT01294345|Genomics|genomics
1369631|NCT01294345|Congenital Malformations|congenital malformations
1369632|NCT01294332|Cognition|cognition
1369633|NCT01294332|TBI|tbi
1369634|NCT01294332|Mood|mood
1369635|NCT01294332|Aerobic Exercise Training|aerobic exercise training
1369636|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
1369637|NCT01294332|Traumatic Brain Injury|traumatic brain injury
1369638|NCT01294319|Cortical Resistance|cortical resistance
1369639|NCT01294319|ACTH|acth
1369640|NCT01294319|Glucocorticoid|glucocorticoid
1369641|NCT01294319|Mifepristone|mifepristone
1369642|NCT01294319|SPIRONOLACTONE|spironolactone
1369643|NCT01294319|Exercise|exercise
1369644|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
1369645|NCT01294319|Healthy Volunteer|healthy volunteer
1369646|NCT01294319|HV|hv
1369647|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
1369648|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
1369649|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
1369650|NCT01294267|Radio Frequency Ablation|radio frequency ablation
1369651|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
1369652|NCT01294267|Hemodynamic Management|hemodynamic management
1369653|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
1369654|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
1369655|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
1369656|NCT01294267|Coronary Intervention|coronary intervention
1369657|NCT01294267|Impella 2.5|impella 2.5
1369658|NCT01294267|Circulation Support system|circulation support system
1369659|NCT01294254|wound reepithelialization|wound reepithelialization
1369660|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
1369661|NCT01294241|Wound healing|wound healing
1369662|NCT01294241|Epithelialization|epithelialization
1369663|NCT01294215|BAYA1040|baya1040
1369664|NCT01294215|Nifedipine|nifedipine
1369665|NCT01294215|Essential hypertension|essential hypertension
1369666|NCT01294215|Japanese Patients|japanese patients
1369667|NCT01294215|Phase III|phase iii
1369668|NCT01294215|combination study|combination study
1369669|NCT01294215|14024|14024
1369670|NCT01294202|GIST|gist
1369671|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1369672|NCT01294202|unresectable|unresectable
1369673|NCT01294202|metastatic|metastatic
1369674|NCT01294202|AT13387|at13387
1369675|NCT01294202|Astex|astex
1369676|NCT01294202|Gleevec|gleevec
1369677|NCT01294202|Imatinib|imatinib
1369678|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
1369679|NCT01294176|Optic Neuritis|optic neuritis
1369680|NCT01294176|Lipoic Acid|lipoic acid
1369681|NCT01294176|Multiple Sclerosis|multiple sclerosis
1369682|NCT01294176|Antioxidant|antioxidant
1369684|NCT01294176|Acute|acute
1369685|NCT01294163|Xenon|xenon
1369686|NCT01294163|Sevoflurane|sevoflurane
1369687|NCT01294163|Propofol|propofol
1369688|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
1369689|NCT01294163|Anaesthesia|anaesthesia
1369690|NCT01294163|Coronary artery disease|coronary artery disease
1369691|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
1369692|NCT01294137|frail|frail
1369693|NCT01294137|elderly|elderly
1369694|NCT01294137|hospitalized|hospitalized
1369696|NCT01294137|oximetry|oximetry
1369697|NCT01294111|Fatigue|fatigue
1369698|NCT01294111|Quality of life|quality of life
1369699|NCT01294111|Elderly|elderly
1369700|NCT01294098|Femoral Fractures|femoral fractures
1369701|NCT01294098|Pediatrics|pediatrics
1369702|NCT01294098|Pain, Postoperative|pain, postoperative
1369703|NCT01294072|curcumin|curcumin
1369704|NCT01294072|plant exosomes|plant exosomes
1369705|NCT01294072|malignant colon tissue|malignant colon tissue
1369706|NCT01294059|Fibromyalgia|fibromyalgia
1369707|NCT01294059|Hyperalgesia|hyperalgesia
1369709|NCT01294059|Central Sensitization|central sensitization
1369710|NCT01294046|Episodic migraine headache|episodic migraine headache
1369711|NCT01294020|Transplant|transplant
1369712|NCT01294020|Liver|liver
1369713|NCT01294020|Tacrolimus|tacrolimus
1369714|NCT01294020|Kidney|kidney
1369715|NCT01294020|Heart|heart
1369716|NCT01294020|Lung|lung
1369717|NCT01294020|Immunosuppression|immunosuppression
1369718|NCT01294020|Advagraf|advagraf
1369719|NCT01294020|Pharmacokinetics|pharmacokinetics
1369720|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
1369721|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
1369722|NCT01293968|Ibuprofen|ibuprofen
1369723|NCT01293968|treatment efficacy|treatment efficacy
1369724|NCT01293955|cartilage|cartilage
1369725|NCT01293955|knee osteoarthritis|knee osteoarthritis
1369726|NCT01293955|protective effect|protective effect
1369727|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
1369728|NCT01293916|pediatric|pediatric
1369729|NCT01293916|femur|femur
1369730|NCT01293916|femoral|femoral
1369731|NCT01293916|fracture|fracture
1369732|NCT01293916|spica|spica
1369733|NCT01293916|cast|cast
1369734|NCT01293916|diaphyseal|diaphyseal
1369735|NCT01293916|single|single
1369736|NCT01293916|double|double
1369737|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
1369738|NCT01293903|Immunomodulation|immunomodulation
1369739|NCT01293890|adherence|adherence
1369740|NCT01293890|medication|medication
1369741|NCT01293890|exacerbations|exacerbations
1369742|NCT01293890|hospital admission|hospital admission
1369743|NCT01293877|Laparoscopy|laparoscopy
1369744|NCT01293877|obesity|obesity
1369745|NCT01293877|gastric|gastric
1369746|NCT01293877|restrictive|restrictive
1369747|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
1369748|NCT01293851|Biomarkers|biomarkers
1369749|NCT01293851|Gene Expression|gene expression
1369750|NCT01293851|Neuropathic Pain|neuropathic pain
1369751|NCT01293851|Neurotoxicity|neurotoxicity
1369752|NCT01293851|Chemotherapy|chemotherapy
1369753|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
1369754|NCT01293851|Cancer|cancer
1369755|NCT01293838|Adolescents|adolescents
1369756|NCT01293838|Anxiety Disorder|anxiety disorder
1369757|NCT01293838|Cipralex|cipralex
1369758|NCT01293838|Social Phobia|social phobia
1369759|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
1369760|NCT01293838|Panic Disorder|panic disorder
1369761|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
1369762|NCT01293838|physiological arousal|physiological arousal
1369763|NCT01293838|stress response|stress response
1369764|NCT01293838|salivary cortisol|salivary cortisol
1369765|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
1369766|NCT01293838|heart rate variability|heart rate variability
1369767|NCT01293799|Randomized|randomized
1369768|NCT01293799|Peritoneal dialysis|peritoneal dialysis
1369769|NCT01293799|Peritonitis|peritonitis
1369770|NCT01293799|Primary prevention|primary prevention
1369771|NCT01293799|Quality control|quality control
1369772|NCT01293799|Self care|self care
1369773|NCT01293799|Kidney failure, chronic|kidney failure, chronic
1369774|NCT01293786|magnesium|magnesium
1369775|NCT01293786|kidney transplantation|kidney transplantation
1369776|NCT01293786|hypomagnesemia|hypomagnesemia
1369777|NCT01293773|Randomized controlled trial|randomized controlled trial
1369778|NCT01293773|Drug-eluting Stent|drug-eluting stent
1369779|NCT01293773|Multicenter study|multicenter study
1369780|NCT01293760|intrauterine device|intrauterine device
1369781|NCT01293760|contraception|contraception
1369782|NCT01293747|Estrogen|estrogen
1369783|NCT01293747|Progesterone|progesterone
1369784|NCT01293747|Microspheres|microspheres
1369785|NCT01293747|Menopause|menopause
1369786|NCT01293747|Pharmacokinetics|pharmacokinetics
1369787|NCT01293734|bronchial asthma|bronchial asthma
1369788|NCT01293734|cold type|cold type
1369789|NCT01293734|heat type|heat type
1369790|NCT01293734|Asthenia type|asthenia type
1369791|NCT01293734|TCM syndrome|tcm syndrome
1369792|NCT01293734|symptoms|symptoms
1369793|NCT01293734|physical signs|physical signs
1369794|NCT01293721|Bone Mineral Density|bone mineral density
1369795|NCT01293721|Vibration|vibration
1369796|NCT01293721|Rehabilitation|rehabilitation
1369797|NCT01293721|Fracture healing rate|fracture healing rate
1369798|NCT01293708|Octogenarians|octogenarians
1369800|NCT01293708|mortality|mortality
1369999|NCT01292850|chloride|chloride
1369801|NCT01293708|prospective observational|prospective observational
1369802|NCT01293708|Elderly|elderly
1369803|NCT01293695|hot flashes|hot flashes
1369804|NCT01293695|post menopausal women|post menopausal women
1369805|NCT01293695|skin conductance monitors|skin conductance monitors
1369806|NCT01293695|hypnosis|hypnosis
1369807|NCT01293695|hypnotizability|hypnotizability
1369808|NCT01293669|Type 2 Diabetes|type 2 diabetes
1369809|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1369810|NCT01293604|Barley|barley
1369811|NCT01293604|Oats|oats
1369812|NCT01293604|Whole grains|whole grains
1369813|NCT01293604|Cardiovascular disease|cardiovascular disease
1369814|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
1369815|NCT01293591|Garlic|garlic
1369816|NCT01293591|Cancer biomarkers|cancer biomarkers
1369817|NCT01293591|Gene expression|gene expression
1369818|NCT01293591|Oxidative stress|oxidative stress
1369819|NCT01293591|DNA damage|dna damage
1369820|NCT01293578|Decision Aids|decision aids
1369821|NCT01293578|Shared Medical Decision Making|shared medical decision making
1369822|NCT01293578|Patient Education|patient education
1369823|NCT01293578|Endocrine System Diseases|endocrine system diseases
1369824|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
1369825|NCT01293578|Metabolic Diseases|metabolic diseases
1369826|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
1369827|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1369828|NCT01293565|XLHED|xlhed
1369829|NCT01293565|HED|hed
1369830|NCT01293539|Retinoblastoma|retinoblastoma
1369831|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
1369832|NCT01293539|angiography|angiography
1369833|NCT01293526|Heart failure|heart failure
1369834|NCT01293526|echocardiography|echocardiography
1369835|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
1369836|NCT01293500|SIRS|sirs
1369837|NCT01293500|shock|shock
1369838|NCT01293500|sepsis|sepsis
1369839|NCT01293500|pediatric|pediatric
1369840|NCT01293500|inter-facility transport|inter-facility transport
1369841|NCT01293500|specialized transport|specialized transport
1369842|NCT01293500|NIRS monitoring|nirs monitoring
1369843|NCT01293487|Phase 1|phase 1
1369844|NCT01293487|Osteopenia|osteopenia
1369845|NCT01293487|RN564|rn564
1369846|NCT01293448|Esophagectomy|esophagectomy
1369847|NCT01293448|Barrett's Esophagus|barrett's esophagus
1369848|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
1369849|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
1369850|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
1369851|NCT01293435|Antibiotics|antibiotics
1369852|NCT01293435|Infection management|infection management
1369853|NCT01293435|Use of Resources|use of resources
1369854|NCT01293435|MRSA|mrsa
1369855|NCT01293435|PRSP|prsp
1369856|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
1369857|NCT01293396|insulin aspart 30|insulin aspart 30
1369858|NCT01293396|insulin aspart 70|insulin aspart 70
1369859|NCT01293396|insulin aspart|insulin aspart
1369860|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
1369861|NCT01293396|consecutive mixed meals|consecutive mixed meals
1369862|NCT01293344|Cardiovascular diseases|cardiovascular diseases
1369863|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
1369864|NCT01293344|Sex differences|sex differences
1369865|NCT01293344|Women|women
1369866|NCT01293344|Men|men
1369867|NCT01293344|Cardiovascular risk|cardiovascular risk
1369868|NCT01293344|Lipid profile|lipid profile
1369869|NCT01293344|Blood pressure|blood pressure
1369870|NCT01293344|Insulin sensitivity|insulin sensitivity
1369871|NCT01293344|Inflammatory markers|inflammatory markers
1369872|NCT01293344|Endothelial function|endothelial function
1369873|NCT01293344|Oxidative stress|oxidative stress
1369874|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
1369875|NCT01293318|Copeptin|copeptin
1369876|NCT01293318|Vasopressin|vasopressin
1369877|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
1369878|NCT01293305|osteoarthritis|osteoarthritis
1369879|NCT01293292|Osteoporosis|osteoporosis
1369880|NCT01293292|Forsteo|forsteo
1369881|NCT01293292|Teriparatide|teriparatide
1369882|NCT01293279|HCV viral genotypes|hcv viral genotypes
1369883|NCT01293279|host genotypes|host genotypes
1369884|NCT01293279|IL28B|il28b
1369885|NCT01293279|ITPA|itpa
1369886|NCT01293279|RNA|rna
1369887|NCT01293279|China|china
1369888|NCT01293266|Propofol|propofol
1369889|NCT01293266|Metabolic Acidosis|metabolic acidosis
1369890|NCT01293266|Pediatric Cardiology|pediatric cardiology
1369891|NCT01293266|Anesthesia|anesthesia
1369892|NCT01293227|Wrist Fracture|wrist fracture
1369893|NCT01293214|limb transplantation|limb transplantation
1369894|NCT01293214|limb allotransplantation|limb allotransplantation
1369895|NCT01293214|hand transplantation|hand transplantation
1369896|NCT01293214|hand allotransplantation|hand allotransplantation
1370000|NCT01292850|spray|spray
1369897|NCT01293214|hand amputation|hand amputation
1369898|NCT01293214|leg transplantation|leg transplantation
1369899|NCT01293201|SAR|sar
1370099|NCT01292382|Cognition|cognition
1369900|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1369901|NCT01293188|Aortic Valve Replacement|aortic valve replacement
1369902|NCT01293188|Bioprosthetic|bioprosthetic
1369903|NCT01293175|whole grains|whole grains
1369904|NCT01293175|polyphenols|polyphenols
1369905|NCT01293175|overweight|overweight
1369906|NCT01293175|bioavailability|bioavailability
1369907|NCT01293175|antioxidant status|antioxidant status
1369908|NCT01293175|inflammation|inflammation
1369909|NCT01293162|Metabolic syndrome|metabolic syndrome
1369910|NCT01293162|Cardiovascular risk|cardiovascular risk
1369911|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
1369912|NCT01293149|femoral nerve block|femoral nerve block
1369913|NCT01293136|knee|knee
1369914|NCT01293136|reconstructive surgery|reconstructive surgery
1369915|NCT01293136|femoral nerve block|femoral nerve block
1369917|NCT01293123|raltegravir|raltegravir
1369918|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
1369919|NCT01293110|urodynamics|urodynamics
1369920|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
1369921|NCT01293110|neurological disease/injury|neurological disease/injury
1369922|NCT01293084|mucociliary clearance|mucociliary clearance
1369923|NCT01293084|children|children
1369924|NCT01293084|cystic fibrosis|cystic fibrosis
1369925|NCT01293084|hypertonic saline|hypertonic saline
1369926|NCT01293071|Antibiotic rotation|antibiotic rotation
1369927|NCT01293071|Cycling|cycling
1369928|NCT01293071|Mixing|mixing
1369929|NCT01293071|Gram-negative|gram-negative
1369930|NCT01293071|EU|eu
1369931|NCT01293071|Multi center|multi center
1369932|NCT01293071|Multi Centre|multi centre
1369933|NCT01293071|Cluster randomized trial|cluster randomized trial
1369934|NCT01293071|Cross over|cross over
1369935|NCT01293058|opioid|opioid
1369936|NCT01293058|overdose|overdose
1369937|NCT01293058|naloxone|naloxone
1369938|NCT01293058|intranasal|intranasal
1369939|NCT01293045|Osteoporosis|osteoporosis
1369940|NCT01293045|Postmenopausal women|postmenopausal women
1369941|NCT01293045|Functional food|functional food
1369942|NCT01293045|Hydrolysed collagen|hydrolysed collagen
1369943|NCT01293045|Bone metabolism|bone metabolism
1369944|NCT01293045|Bone marker of resorption|bone marker of resorption
1369945|NCT01293045|Bone marker of formation|bone marker of formation
1369946|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
1369947|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
1369948|NCT01293032|HER2/Neu Negative|her2/neu negative
1369949|NCT01293032|Breast Cancer|breast cancer
1369950|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
1369951|NCT01293019|Osteopathic treatment|osteopathic treatment
1369952|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1369953|NCT01292980|sDTI|sdti
1369954|NCT01292980|Pressure ulcers|pressure ulcers
1369955|NCT01292980|Therapy surfaces|therapy surfaces
1369956|NCT01292980|Mattresses|mattresses
1369957|NCT01292980|Deep Tissue Injury|deep tissue injury
1369958|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
1369959|NCT01292967|Flavanol|flavanol
1369960|NCT01292967|cocoa|cocoa
1369961|NCT01292967|maltitol|maltitol
1369962|NCT01292967|absorption|absorption
1369963|NCT01292967|metabolism|metabolism
1369964|NCT01292967|chocolate|chocolate
1369965|NCT01292967|food matrix|food matrix
1369966|NCT01292967|bioavailability|bioavailability
1369967|NCT01292954|blueberries|blueberries
1369968|NCT01292954|vascular function|vascular function
1369970|NCT01292954|Blood pressure|blood pressure
1369971|NCT01292954|Laser Doppler|laser doppler
1369972|NCT01292954|pharmacokinetics|pharmacokinetics
1369973|NCT01292954|absorption|absorption
1369974|NCT01292954|metabolism|metabolism
1369975|NCT01292954|polyphenols|polyphenols
1369976|NCT01292954|flavonoids|flavonoids
1369977|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
1369978|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
1369979|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
1369980|NCT01292889|Major Depressive Disorder|major depressive disorder
1369981|NCT01292889|Depression|depression
1369982|NCT01292889|Winter Blues|winter blues
1369983|NCT01292876|MTURR|mturr
1369984|NCT01292876|ECM|ecm
1369985|NCT01292876|Muscle Loss|muscle loss
1369986|NCT01292876|Tendon|tendon
1369987|NCT01292876|Tendon Repair|tendon repair
1369988|NCT01292876|Muscle Repair|muscle repair
1369989|NCT01292876|Soft Tissue Repair|soft tissue repair
1369990|NCT01292876|Scaffold|scaffold
1369991|NCT01292876|Extracellular Matrix|extracellular matrix
1369992|NCT01292863|Peritoneal dialysis|peritoneal dialysis
1369993|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
1369994|NCT01292850|Topical|topical
1369995|NCT01292850|Skin|skin
1369996|NCT01292850|sterility|sterility
1369997|NCT01292850|ethylchloride|ethylchloride
1369998|NCT01292850|ethyl|ethyl
1370001|NCT01292837|Levetiracetam|levetiracetam
1370002|NCT01292837|Epilepsy|epilepsy
1370003|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
1370004|NCT01292824|Hepatitis C virus|hepatitis c virus
1370005|NCT01292824|Entry|entry
1370006|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
1370007|NCT01292824|High density lipoprotein|high density lipoprotein
1370008|NCT01292824|Liver transplantation|liver transplantation
1370009|NCT01292811|Spinal Cord Injury|spinal cord injury
1370010|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
1370011|NCT01292811|Hand function|hand function
1370012|NCT01292811|Tetraplegia|tetraplegia
1370013|NCT01292798|Diabetes|diabetes
1370014|NCT01292798|Macula|macula
1370015|NCT01292798|Edema|edema
1370016|NCT01292798|Retina|retina
1370017|NCT01292772|breast cancer|breast cancer
1370018|NCT01292772|bilateral mastectomy|bilateral mastectomy
1370019|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
1370020|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
1370021|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
1370022|NCT01292759|stroke volume|stroke volume
1370023|NCT01292759|cardiac output|cardiac output
1370024|NCT01292759|validation|validation
1370025|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
1370026|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
1370027|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
1370028|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
1370029|NCT01292707|malaria|malaria
1370031|NCT01292707|fever|fever
1370032|NCT01292707|treatment|treatment
1370033|NCT01292694|supine hypertension|supine hypertension
1370034|NCT01292694|autonomic failure|autonomic failure
1370035|NCT01292694|angiotensin|angiotensin
1370036|NCT01292694|losartan|losartan
1370037|NCT01292694|captopril|captopril
1370038|NCT01292681|colorectal cancer|colorectal cancer
1370039|NCT01292681|FDG-PET-CT|fdg-pet-ct
1370040|NCT01292681|MRS,|mrs,
1370041|NCT01292681|DCE-MRI|dce-mri
1370042|NCT01292681|DWI|dwi
1370043|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
1370044|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
1370045|NCT01292642|nicotine dependence|nicotine dependence
1370046|NCT01292642|cannabis dependence|cannabis dependence
1370047|NCT01292642|smoking cessation|smoking cessation
1370048|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
1370049|NCT01292629|intraocular lens|intraocular lens
1370050|NCT01292629|IOL|iol
1370051|NCT01292629|cataract|cataract
1370052|NCT01292629|Hoya|hoya
1370053|NCT01292629|surgical|surgical
1370054|NCT01292629|optics|optics
1370055|NCT01292629|ocular|ocular
1370056|NCT01292629|visual acuity|visual acuity
1370057|NCT01292577|Schizophrenia|schizophrenia
1370058|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
1370059|NCT01292577|Cannabis|cannabis
1370060|NCT01292577|Alcohol|alcohol
1370061|NCT01292577|Substance Misuse|substance misuse
1370062|NCT01292577|Cognition|cognition
1370063|NCT01292577|Psychosocial Treatment|psychosocial treatment
1370064|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
1370065|NCT01292577|Personal Therapy|personal therapy
1370066|NCT01292577|Treatment as Usual|treatment as usual
1370067|NCT01292551|single ventricle physiology|single ventricle physiology
1370068|NCT01292551|Fontan procedure|fontan procedure
1370069|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
1370070|NCT01292525|renal allograft|renal allograft
1370071|NCT01292525|stable renal function|stable renal function
1370072|NCT01292512|Bereavement management|bereavement management
1370073|NCT01292512|Complicated grief|complicated grief
1370074|NCT01292499|psychotherapy|psychotherapy
1370075|NCT01292499|psychoeducation|psychoeducation
1370076|NCT01292499|depression|depression
1370077|NCT01292447|Pain measurement|pain measurement
1370078|NCT01292447|Intrauterine devices|intrauterine devices
1370079|NCT01292447|Lidocaine|lidocaine
1370080|NCT01292434|Diet|diet
1370081|NCT01292434|Obesity|obesity
1370082|NCT01292434|Child Preschool|child preschool
1370083|NCT01292434|Treatment Outcome|treatment outcome
1370084|NCT01292434|Body Mass Index|body mass index
1370085|NCT01292434|Intervention Studies|intervention studies
1370086|NCT01292434|Randomized Controlled Trial|randomized controlled trial
1370087|NCT01292434|Child Day Care Centers|child day care centers
1370088|NCT01292434|Schools Nursery|schools nursery
1370089|NCT01292434|Child Care|child care
1370090|NCT01292408|autophagy|autophagy
1370091|NCT01292408|hydroxychloroquine|hydroxychloroquine
1370092|NCT01292408|hypoxia|hypoxia
1370093|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
1370094|NCT01292395|dietary supplement|dietary supplement
1370095|NCT01292395|protein metabolism|protein metabolism
1370096|NCT01292395|bone turnover|bone turnover
1370097|NCT01292382|Elderly|elderly
1370100|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1370101|NCT01292369|breath test|breath test
1370102|NCT01292369|colon cancer|colon cancer
1370103|NCT01292369|breast cancer|breast cancer
1370104|NCT01292343|third molars|third molars
1370105|NCT01292343|triclosan|triclosan
1370106|NCT01292343|toothpaste|toothpaste
1370107|NCT01292343|dry socket|dry socket
1370108|NCT01292343|wound infection|wound infection
1370109|NCT01292330|liver Tumor|liver tumor
1370110|NCT01292317|NGAL|ngal
1370111|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
1370112|NCT01292317|contrast media nephropathy|contrast media nephropathy
1370113|NCT01292317|CIN|cin
1370114|NCT01292317|volume expansion|volume expansion
1370115|NCT01292317|acute kidney injury|acute kidney injury
1370116|NCT01292317|contrast media|contrast media
1370117|NCT01292304|Cirrhotic|cirrhotic
1370118|NCT01292304|Tolvaptan|tolvaptan
1370119|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
1370120|NCT01292291|stage I prostate cancer|stage i prostate cancer
1370121|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
1370122|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
1370123|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
1370124|NCT01292278|cerebral vasospasm|cerebral vasospasm
1370125|NCT01292278|neuropeptide Y|neuropeptide y
1370126|NCT01292278|spontaneous|spontaneous
1370127|NCT01292278|aneurysmal|aneurysmal
1370128|NCT01292265|Arthritis|arthritis
1370129|NCT01292265|Joint pain|joint pain
1370130|NCT01292265|Inflammation|inflammation
1370131|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
1370132|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
1370133|NCT01292239|Hepatitis C|hepatitis c
1370134|NCT01292239|Hepatitis C virus|hepatitis c virus
1370135|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
1370136|NCT01292239|Ribavirin|ribavirin
1370137|NCT01292239|Viral RNA|viral rna
1370138|NCT01292213|Chronic cough|chronic cough
1370139|NCT01292213|Haemophilus influenzae|haemophilus influenzae
1370140|NCT01292200|Chinese women|chinese women
1370141|NCT01292200|Mammography|mammography
1370142|NCT01292200|Breast Cancer|breast cancer
1370143|NCT01292187|Osteoporosis|osteoporosis
1370144|NCT01292187|Osteopenia|osteopenia
1370145|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
1370146|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
1370147|NCT01292187|Bone Diseases|bone diseases
1370148|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
1370149|NCT01292187|Salmon calcitonin|salmon calcitonin
1370150|NCT01292187|Calcitonin|calcitonin
1370151|NCT01292174|HIV prevention|hiv prevention
1370152|NCT01292161|Hepatitis C|hepatitis c
1370153|NCT01292161|Silymarin|silymarin
1370154|NCT01292161|Quality of life|quality of life
1370155|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
1370156|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
1370157|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
1370158|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
1370159|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1370160|NCT01292122|Wounds|wounds
1370161|NCT01292122|Grafts|grafts
1370162|NCT01292122|Wound Healing|wound healing
1370163|NCT01292122|Cell Therapy|cell therapy
1370164|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
1370165|NCT01292109|endoscopy|endoscopy
1370166|NCT01292109|colonoscopy|colonoscopy
1370167|NCT01292109|preparation for surgery|preparation for surgery
1370168|NCT01292096|homelessness|homelessness
1370169|NCT01292096|substance use|substance use
1370170|NCT01292096|frequent hospitalization|frequent hospitalization
1370171|NCT01292096|frequent users of health services|frequent users of health services
1370172|NCT01292096|enhanced care management|enhanced care management
1370173|NCT01292096|coordination services p|coordination services p
1370174|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
1370175|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
1370176|NCT01292070|Injections, Intradermal|injections, intradermal
1370177|NCT01292057|Alcohol|alcohol
1370178|NCT01292057|Aripiprazole|aripiprazole
1370179|NCT01292057|Impulsivity|impulsivity
1370180|NCT01292057|Alcoholism|alcoholism
1370181|NCT01292057|drinking|drinking
1370182|NCT01292057|treatment|treatment
1370183|NCT01292057|craving|craving
1370184|NCT01292057|brain imaging|brain imaging
1370185|NCT01292057|genetics|genetics
1370186|NCT01292044|elastography|elastography
1370187|NCT01292044|cytology|cytology
1370188|NCT01292031|VAP|vap
1370189|NCT01292031|MDR-GNB|mdr-gnb
1370190|NCT01292031|colistin|colistin
1370191|NCT01292031|meropenem|meropenem
1370192|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
1370193|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
1370194|NCT01292005|pancreatitis|pancreatitis
1370195|NCT01292005|pancreatic necrosis|pancreatic necrosis
1370196|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
1370400|NCT01291290|rAAA|raaa
1370197|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
1370198|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
1370199|NCT01291992|Non-convulsive seizures|non-convulsive seizures
1370200|NCT01291992|Cardiac Surgery|cardiac surgery
1370201|NCT01291992|Postop|postop
1370202|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
1370203|NCT01291979|Pain|pain
1370204|NCT01291979|Preemptive|preemptive
1370205|NCT01291979|Lidocaine|lidocaine
1370206|NCT01291979|Intravenous|intravenous
1370207|NCT01291979|Tonsillectomy|tonsillectomy
1370208|NCT01291966|medication errors|medication errors
1370209|NCT01291966|Patient Compliance|patient compliance
1370210|NCT01291966|patient safety|patient safety
1370211|NCT01291966|polypharmacy|polypharmacy
1370212|NCT01291953|atrial fibrillation|atrial fibrillation
1370213|NCT01291953|screening|screening
1370214|NCT01291953|prevention|prevention
1370215|NCT01291953|case finding|case finding
1370216|NCT01291953|primary care|primary care
1370217|NCT01291927|Periampullary carcinoma|periampullary carcinoma
1370218|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
1370219|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
1370220|NCT01291927|lymphadenectomy|lymphadenectomy
1370221|NCT01291914|Osteoarthritis|osteoarthritis
1370222|NCT01291914|knee|knee
1370223|NCT01291914|intra-articular|intra-articular
1370224|NCT01291914|safety|safety
1370225|NCT01291914|efficacy|efficacy
1370226|NCT01291914|pharmacokinetics|pharmacokinetics
1370227|NCT01291914|pain|pain
1370228|NCT01291901|pain|pain
1370229|NCT01291901|cancer|cancer
1370230|NCT01291901|malignancy|malignancy
1370231|NCT01291901|intractable|intractable
1370232|NCT01291901|gene therapy|gene therapy
1370233|NCT01291901|enkephalin|enkephalin
1370234|NCT01291901|opioid|opioid
1370235|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1370236|NCT01291875|Periodontal Disease|periodontal disease
1370237|NCT01291875|metabolic control|metabolic control
1370238|NCT01291875|periodontal treatment|periodontal treatment
1370239|NCT01291875|inflammatory markers|inflammatory markers
1370240|NCT01291849|nasal surgery|nasal surgery
1370241|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
1370242|NCT01291849|septoplasty|septoplasty
1370244|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
1370245|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
1370246|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
1370247|NCT01291836|biomarker|biomarker
1370248|NCT01291823|gefitinib|gefitinib
1370249|NCT01291823|radiation|radiation
1370250|NCT01291823|esophageal cancer|esophageal cancer
1370251|NCT01291797|congenital heart disease|congenital heart disease
1370252|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
1370253|NCT01291797|AEEG|aeeg
1370254|NCT01291797|sleep wake cycles|sleep wake cycles
1370255|NCT01291784|monoclonal antibody|monoclonal antibody
1370256|NCT01291771|End stage renal disease|end stage renal disease
1370257|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
1370258|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
1370259|NCT01291771|coronary flow reserve|coronary flow reserve
1370260|NCT01291771|index of microvascular resistance|index of microvascular resistance
1370261|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
1370262|NCT01291758|Persian Gulf War|persian gulf war
1370263|NCT01291758|Gulf War Syndrome|gulf war syndrome
1370264|NCT01291758|GWI|gwi
1370265|NCT01291758|Gulf War Illness|gulf war illness
1370266|NCT01291758|Exercise|exercise
1370267|NCT01291758|Chronic Fatigue|chronic fatigue
1370268|NCT01291758|Fibromyalgia|fibromyalgia
1370269|NCT01291758|Veterans|veterans
1370270|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
1370271|NCT01291758|Migraine headaches|migraine headaches
1370272|NCT01291758|Neuropathy|neuropathy
1370273|NCT01291719|closed loop glucose control|closed loop glucose control
1370274|NCT01291719|intensive care glucose control|intensive care glucose control
1370275|NCT01291706|Transcranial Doppler|transcranial doppler
1370276|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
1370277|NCT01291706|Neurological deterioration|neurological deterioration
1370278|NCT01291706|Brain CT scan|brain ct scan
1370279|NCT01291693|Hazardous drinking|hazardous drinking
1370280|NCT01291693|general hospital|general hospital
1370281|NCT01291693|brief intervention|brief intervention
1370282|NCT01291693|Motivational Interviewing|motivational interviewing
1370283|NCT01291693|computer-generated feedback|computer-generated feedback
1370284|NCT01291693|stage-tailored|stage-tailored
1370285|NCT01291693|delivery channel|delivery channel
1370286|NCT01291680|Pregnancy|pregnancy
1370287|NCT01291680|Chronic pain|chronic pain
1370288|NCT01291680|Fibromyalgia|fibromyalgia
1370289|NCT01291654|PDA|pda
1370290|NCT01291654|Paracetamol|paracetamol
1370291|NCT01291654|Indomethacin|indomethacin
1370292|NCT01291654|Ibuprofen|ibuprofen
1370293|NCT01291641|Hyperlipidemias|hyperlipidemias
1370399|NCT01291303|optimized ventilation|optimized ventilation
1370294|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1370295|NCT01291641|Probucol|probucol
1370296|NCT01291641|Cilostazol|cilostazol
1370297|NCT01291628|Capecitabine|capecitabine
1370298|NCT01291628|Hand and foot syndrome|hand and foot syndrome
1370299|NCT01291628|Socks|socks
1370300|NCT01291628|Copper|copper
1370301|NCT01291628|Toxicity|toxicity
1370302|NCT01291602|NXL104|nxl104
1370303|NCT01291602|ceftazidime|ceftazidime
1370304|NCT01291602|CAZ104|caz104
1370305|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
1370306|NCT01291602|Phase 1|phase 1
1370307|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
1370308|NCT01291589|HIV-infected|hiv-infected
1370309|NCT01291589|MSM|msm
1370310|NCT01291589|HIV prevention|hiv prevention
1370311|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
1370312|NCT01291576|Rectal endometriosis|rectal endometriosis
1370313|NCT01291576|Colorectal resection|colorectal resection
1370314|NCT01291576|Nodule excision|nodule excision
1370315|NCT01291576|Rectal shaving|rectal shaving
1370316|NCT01291576|Functional outcomes|functional outcomes
1370317|NCT01291576|Constipation|constipation
1370318|NCT01291563|TMC207TBC1003|tmc207tbc1003
1370319|NCT01291563|TMC207|tmc207
1370320|NCT01291563|M.Tuberculosis|m.tuberculosis
1370321|NCT01291563|TBC|tbc
1370322|NCT01291563|Moxifloxacin|moxifloxacin
1370323|NCT01291563|ECG|ecg
1370324|NCT01291563|QT/QTc|qt/qtc
1370325|NCT01291563|Healthy volunteers|healthy volunteers
1370326|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
1370327|NCT01291537|Advanced|advanced
1370328|NCT01291537|Severe form|severe form
1370329|NCT01291524|pregabalin|pregabalin
1370330|NCT01291524|pharmacokinetics|pharmacokinetics
1370331|NCT01291524|bioavailability|bioavailability
1370332|NCT01291524|bioequivalence|bioequivalence
1370333|NCT01291511|Schizophrenia|schizophrenia
1370334|NCT01291511|Mental Disorders|mental disorders
1370335|NCT01291511|Antipsychotic Agents|antipsychotic agents
1370336|NCT01291511|Iloperdione|iloperdione
1370337|NCT01291511|Relapse Prevention|relapse prevention
1370338|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
1370339|NCT01291485|HIV|hiv
1370340|NCT01291485|Medication adherence|medication adherence
1370341|NCT01291485|computer-based intervention|computer-based intervention
1370342|NCT01291472|ketorolac|ketorolac
1370343|NCT01291472|pain|pain
1370344|NCT01291472|pregnancy|pregnancy
1370345|NCT01291472|non-pregnant state|non-pregnant state
1370346|NCT01291459|HIV|hiv
1370347|NCT01291459|naive patients|naive patients
1370348|NCT01291459|maraviroc|maraviroc
1370349|NCT01291459|raltegravir|raltegravir
1370350|NCT01291446|Intestinal gas production|intestinal gas production
1370351|NCT01291446|Intestinal microbiota|intestinal microbiota
1370352|NCT01291407|Combined Modality|combined modality
1370353|NCT01291407|Gastric Cancer|gastric cancer
1370354|NCT01291407|Radiation Therapy|radiation therapy
1370355|NCT01291407|S-1|s-1
1370356|NCT01291394|Growth disorders|growth disorders
1370357|NCT01291394|Saizen|saizen
1370358|NCT01291394|Easypod|easypod
1370359|NCT01291394|Growth hormone|growth hormone
1370360|NCT01291394|Pediatric subject|pediatric subject
1370361|NCT01291381|allergic rhinitis|allergic rhinitis
1370362|NCT01291381|peripheral tolerance|peripheral tolerance
1370363|NCT01291381|regulatory T cells|regulatory t cells
1370364|NCT01291381|specific immunotherapy|specific immunotherapy
1370365|NCT01291381|Tr1 cells|tr1 cells
1370366|NCT01291368|Sedation|sedation
1370367|NCT01291368|Delirium|delirium
1370368|NCT01291368|PTSD|ptsd
1370369|NCT01291368|Depression|depression
1370370|NCT01291368|Anxiety|anxiety
1370371|NCT01291368|HRQoL|hrqol
1370372|NCT01291368|CAM-ICU|cam-icu
1370373|NCT01291368|RASS|rass
1370374|NCT01291368|SF-36|sf-36
1370375|NCT01291368|ICU-memory tool|icu-memory tool
1370376|NCT01291368|Antipsychotic Agents|antipsychotic agents
1370377|NCT01291368|Mobilization|mobilization
1370378|NCT01291368|ICU-nursing|icu-nursing
1370379|NCT01291368|ICU|icu
1370380|NCT01291368|intensive care|intensive care
1370381|NCT01291368|critical care|critical care
1370382|NCT01291368|critical care nursing|critical care nursing
1370383|NCT01291355|Maternal position|maternal position
1370384|NCT01291355|Occipitoposterior position|occipitoposterior position
1370385|NCT01291355|Labor|labor
1370386|NCT01291355|Dystocia|dystocia
1370387|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
1370388|NCT01291342|Pregnancy|pregnancy
1370389|NCT01291342|Preeclampsia|preeclampsia
1370390|NCT01291342|Volatile biomarkers|volatile biomarkers
1370391|NCT01291342|Chemical sensors|chemical sensors
1370392|NCT01291342|Nanomaterials|nanomaterials
1370393|NCT01291342|Nanosensors|nanosensors
1370394|NCT01291342|NA-NOSE|na-nose
1370395|NCT01291329|stem cell|stem cell
1370396|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
1370397|NCT01291303|Non invasive ventilation|non invasive ventilation
1370398|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
1370401|NCT01291290|Platelets|platelets
1370402|NCT01291290|TEG|teg
1370403|NCT01291290|Massive bleeding|massive bleeding
1370404|NCT01291290|Coagulopathy|coagulopathy
1370405|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1370406|NCT01291277|esophageal varices|esophageal varices
1370407|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
1370408|NCT01291277|ligation|ligation
1370409|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
1370410|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
1370411|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
1370412|NCT01291238|learning disability|learning disability
1370413|NCT01291238|blood lipids|blood lipids
1370414|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
1370672|NCT01290172|Liver transplant|liver transplant
1370415|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
1370416|NCT01291238|adolescents|adolescents
1370417|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
1370418|NCT01291238|absorptiometry photos|absorptiometry photos
1370419|NCT01291225|playgrounds|playgrounds
1370420|NCT01291225|farms|farms
1370421|NCT01291225|injury prevention|injury prevention
1370422|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
1370423|NCT01291225|safe play|safe play
1370424|NCT01291225|rural|rural
1370425|NCT01291212|In Vitro Fertilization|in vitro fertilization
1370426|NCT01291212|Testosterone|testosterone
1370427|NCT01291212|Ovarian Stimulation|ovarian stimulation
1370428|NCT01291212|Luteinizing Hormone|luteinizing hormone
1370429|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
1370430|NCT01291186|spinal anesthesia|spinal anesthesia
1370431|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
1370432|NCT01291186|median effective dose|median effective dose
1370433|NCT01291186|height|height
1370434|NCT01291147|pain|pain
1370435|NCT01291147|anaesthetic|anaesthetic
1370436|NCT01291121|Age related macular degeneration|age related macular degeneration
1370437|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
1370438|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
1370439|NCT01291082|Breast cancer|breast cancer
1370440|NCT01291082|metastasis|metastasis
1370441|NCT01291082|bone|bone
1370442|NCT01291082|diffusion MRI|diffusion mri
1370443|NCT01291069|Fontan|fontan
1370444|NCT01291069|Tadalafil|tadalafil
1370445|NCT01291069|Exercise performance|exercise performance
1370446|NCT01291056|Clomiphene citrate|clomiphene citrate
1370447|NCT01291056|Mood symptoms|mood symptoms
1370448|NCT01291056|Infertility|infertility
1370449|NCT01291056|Superovulation|superovulation
1370450|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
1370451|NCT01291043|Shiatsu|shiatsu
1370452|NCT01291043|Fibromyalgia|fibromyalgia
1370453|NCT01291043|Pain|pain
1370454|NCT01291043|Quality of sleep|quality of sleep
1370455|NCT01291043|Balance|balance
1370456|NCT01291043|Quality of life|quality of life
1370457|NCT01291017|Advanced stage|advanced stage
1370458|NCT01290952|off-pump|off-pump
1370459|NCT01290952|bypass|bypass
1370460|NCT01290952|coronary artery surgery|coronary artery surgery
1370461|NCT01290939|adult glioblastoma|adult glioblastoma
1370462|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
1370463|NCT01290939|Cognition Disorders|cognition disorders
1370464|NCT01290939|functional defects|functional defects
1370465|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
1370466|NCT01290926|sorafenib|sorafenib
1370467|NCT01290926|capecitabine|capecitabine
1370468|NCT01290926|FDG-PET|fdg-pet
1370469|NCT01290926|early metabolic response|early metabolic response
1370470|NCT01290913|peanut allergy|peanut allergy
1370471|NCT01290913|Xolair|xolair
1370472|NCT01290900|NXL104|nxl104
1370473|NCT01290900|CAZ104|caz104
1370474|NCT01290900|Ceftazidime|ceftazidime
1370475|NCT01290900|CXL104|cxl104
1370476|NCT01290900|Ceftaroline|ceftaroline
1370477|NCT01290900|Healthy Male Volunteers|healthy male volunteers
1370478|NCT01290900|Phase 1|phase 1
1370479|NCT01290900|OT|ot
1370480|NCT01290900|Single Dose Study|single dose study
1370481|NCT01290874|Asthma|asthma
1370482|NCT01290874|Blacks|blacks
1370483|NCT01290874|LABA|laba
1370484|NCT01290874|Tiotropium|tiotropium
1370485|NCT01290874|Spiriva|spiriva
1370486|NCT01290874|African American|african american
1370487|NCT01290874|Serevent|serevent
1370488|NCT01290874|salmeterol|salmeterol
1370489|NCT01290874|Foradil|foradil
1370490|NCT01290874|formoterol|formoterol
1370491|NCT01290874|Advair|advair
1370492|NCT01290874|Symbicort|symbicort
1370493|NCT01290874|Dulera|dulera
1370494|NCT01290861|Huntington's Disease|huntington's disease
1370495|NCT01290861|Cognitive Battery|cognitive battery
1370496|NCT01290861|Cognitive Testing|cognitive testing
1370497|NCT01290861|Cognition|cognition
1370498|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
1370499|NCT01290848|pediatrics|pediatrics
1370500|NCT01290848|Health Promotion Campaign|health promotion campaign
1370501|NCT01290848|Community events|community events
1370502|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
1370503|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
1370504|NCT01290835|Breast cancer|breast cancer
1370505|NCT01290822|Biventricular pacing|biventricular pacing
1370506|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
1370507|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
1370508|NCT01290822|Congestive heart failure|congestive heart failure
1370509|NCT01290822|Cardiac allograft|cardiac allograft
1370510|NCT01290822|Cardiac surgery|cardiac surgery
1370511|NCT01290822|AVD|avd
1370512|NCT01290822|VVD|vvd
1370513|NCT01290822|LV pacing site|lv pacing site
1370514|NCT01290822|pacing optimization|pacing optimization
1370515|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1370516|NCT01290809|lung cancer|lung cancer
1370517|NCT01290783|mCRC|mcrc
1370518|NCT01290783|CRC|crc
1370519|NCT01290783|colorectal|colorectal
1370520|NCT01290783|irinotecan|irinotecan
1370521|NCT01290783|Hyaluronic acid|hyaluronic acid
1370522|NCT01290783|Hyaluronan|hyaluronan
1370523|NCT01290770|obesity|obesity
1370524|NCT01290770|men|men
1370525|NCT01290770|TFPI|tfpi
1370526|NCT01290770|Lipoprotein(a)|lipoprotein(a)
1370527|NCT01290770|Lp(a)|lp(a)
1370528|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
1370529|NCT01290770|aspirin|aspirin
1370530|NCT01290744|leprosy|leprosy
1370531|NCT01290744|ENL|enl
1370532|NCT01290744|clofazimine|clofazimine
1370533|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
1370534|NCT01290731|Hepatitis C virus|hepatitis c virus
1370535|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
1370536|NCT01290731|Ribavirin|ribavirin
1370537|NCT01290731|Viral RNA|viral rna
1370538|NCT01290705|Knee|knee
1489421|NCT00819403|low hdl|low hdl
1370539|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
1370540|NCT01290705|Pain|pain
1370541|NCT01290705|Patella|patella
1370542|NCT01290705|Exercise Therapy|exercise therapy
1370543|NCT01290692|Brain Neoplasms|brain neoplasms
1370673|NCT01290172|portal hypertension|portal hypertension
1370544|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
1370545|NCT01290692|Brain Diseases|brain diseases
1370546|NCT01290692|Neoplasms|neoplasms
1370547|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
1370548|NCT01290692|Glioblastoma|glioblastoma
1370549|NCT01290692|Astrocytoma|astrocytoma
1370550|NCT01290692|Nervous System Diseases|nervous system diseases
1370551|NCT01290692|Central Nervous System Diseases|central nervous system diseases
1370552|NCT01290692|Glioma|glioma
1370553|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
1370554|NCT01290692|Recurrent glioma|recurrent glioma
1370555|NCT01290692|Cancer vaccine|cancer vaccine
1370556|NCT01290692|Immunotherapy|immunotherapy
1370557|NCT01290692|Killer T cells|killer t cells
1370558|NCT01290692|Activated T cells|activated t cells
1370559|NCT01290692|GM-CSF|gm-csf
1370560|NCT01290692|Activated lymphocytes|activated lymphocytes
1370561|NCT01290679|Hepatitis C|hepatitis c
1370562|NCT01290679|TMC435|tmc435
1370563|NCT01290679|HCV|hcv
1370564|NCT01290679|Hep C|hep c
1370565|NCT01290679|genotype 1|genotype 1
1370566|NCT01290601|malaria|malaria
1370567|NCT01290601|Plasmodium vivax|plasmodium vivax
1370568|NCT01290601|adults|adults
1370569|NCT01290601|treatment|treatment
1370570|NCT01290601|tafenoquine|tafenoquine
1370571|NCT01290562|SBRT|sbrt
1370572|NCT01290562|spinal Metastases|spinal metastases
1370573|NCT01290562|Paraspinal Metastases|paraspinal metastases
1370574|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
1370575|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
1370576|NCT01290536|Liver metastases|liver metastases
1370577|NCT01290510|tendinopathy|tendinopathy
1370578|NCT01290510|hyaluronan|hyaluronan
1370579|NCT01290510|tendon|tendon
1370580|NCT01290510|hyaluronic acid|hyaluronic acid
1370581|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
1370582|NCT01290458|Eccentric training|eccentric training
1370583|NCT01290458|Free radicals|free radicals
1370584|NCT01290458|Antioxidant supplements|antioxidant supplements
1370585|NCT01290458|Training adaptations|training adaptations
1370586|NCT01290458|Lipid profile|lipid profile
1370587|NCT01290445|varenicline|varenicline
1370588|NCT01290445|smoking|smoking
1370589|NCT01290445|smoking cessation|smoking cessation
1370590|NCT01290445|cohort study|cohort study
1370591|NCT01290445|drug safety|drug safety
1370592|NCT01290445|prospective study|prospective study
1370593|NCT01290432|female fertility|female fertility
1370594|NCT01290432|ovarian reserve|ovarian reserve
1370595|NCT01290432|oocyte quality|oocyte quality
1370596|NCT01290432|oocyte quantity|oocyte quantity
1370597|NCT01290432|antimullerian hormone|antimullerian hormone
1370598|NCT01290432|AMH|amh
1370599|NCT01290432|dietary supplements|dietary supplements
1370600|NCT01290432|inofolic plus|inofolic plus
1370601|NCT01290432|myoinositol|myoinositol
1370602|NCT01290432|folic acid|folic acid
1370603|NCT01290419|RSV|rsv
1370604|NCT01290406|Endometrial cancer,|endometrial cancer,
1370605|NCT01290406|uterine cancer,|uterine cancer,
1370606|NCT01290406|PI3K,|pi3k,
1370608|NCT01290406|targeted therapy|targeted therapy
1370609|NCT01290393|vaccine|vaccine
1370610|NCT01290393|Spontaneous abortions|spontaneous abortions
1370611|NCT01290393|Human papillomavirus|human papillomavirus
1370612|NCT01290393|HPV|hpv
1370613|NCT01290393|Cervarix|cervarix
1370614|NCT01290393|pregnancy|pregnancy
1370615|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
1370616|NCT01290380|simvastatin,|simvastatin,
1370617|NCT01290380|caffeine,|caffeine,
1370618|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
1370619|NCT01290380|ASA404,|asa404,
1370620|NCT01290380|PK data|pk data
1370621|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
1370622|NCT01290367|Low back pain|low back pain
1370623|NCT01290367|Back pain|back pain
1370624|NCT01290367|Degenerative Disc Disease|degenerative disc disease
1370625|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
1370626|NCT01290367|Stem Cells|stem cells
1370627|NCT01290367|Adult Stem Cells|adult stem cells
1370628|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
1370629|NCT01290367|Mesoblast|mesoblast
1370630|NCT01290354|Brain penetration|brain penetration
1370631|NCT01290354|positron emission tomography|positron emission tomography
1370632|NCT01290354|Lapatinib|lapatinib
1370633|NCT01290341|fungal infection|fungal infection
1370634|NCT01290341|athlete foot|athlete foot
1370635|NCT01290328|anemia|anemia
1370636|NCT01290328|kidney transplant|kidney transplant
1370637|NCT01290328|alloimmunity|alloimmunity
1370638|NCT01290289|Labor|labor
1370639|NCT01290289|Epidural|epidural
1370640|NCT01290289|Combined spinal epidural|combined spinal epidural
1370641|NCT01290289|pethidine|pethidine
1370642|NCT01290276|Ondansetron|ondansetron
1370643|NCT01290276|Methylphenidate|methylphenidate
1370644|NCT01290263|Glioblastoma|glioblastoma
1370645|NCT01290263|GBM|gbm
1370646|NCT01290263|Brain Tumor|brain tumor
1370647|NCT01290263|Glioma|glioma
1370648|NCT01290237|vancomycin|vancomycin
1370649|NCT01290237|loading dose|loading dose
1370650|NCT01290237|pharmacokinetic|pharmacokinetic
1370651|NCT01290237|pediatric|pediatric
1370652|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1370653|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
1370654|NCT01290211|maraviroc|maraviroc
1370655|NCT01290211|fosamprenavir|fosamprenavir
1370656|NCT01290211|drug interaction|drug interaction
1370657|NCT01290211|pharmacokinetics|pharmacokinetics
1370658|NCT01290211|HIV|hiv
1370659|NCT01290211|AIDS|aids
1370660|NCT01290211|CCR5|ccr5
1370661|NCT01290211|protease inhibitor|protease inhibitor
1370662|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
1370663|NCT01290198|Laser Doppler|laser doppler
1370664|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
1370665|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
1370666|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
1370667|NCT01290198|thermal hyperemia|thermal hyperemia
1370668|NCT01290198|intradermal microdialysis|intradermal microdialysis
1370669|NCT01290198|fluconazole|fluconazole
1370670|NCT01290185|Arthroplasty|arthroplasty
1370671|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
1370674|NCT01290159|tolerance to heat|tolerance to heat
1370675|NCT01290146|Heart Failure|heart failure
1370676|NCT01290146|Levosimendan|levosimendan
1370677|NCT01290146|Inotropic agents|inotropic agents
1370678|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1370679|NCT01290146|Vasodilators|vasodilators
1370680|NCT01290146|Diuretics|diuretics
1370681|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
1370682|NCT01290120|B-ALL|b-all
1370683|NCT01290120|Adult patients|adult patients
1370684|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1370685|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1370686|NCT01290081|Tuberculosis|tuberculosis
1370687|NCT01290081|Injecting drug users|injecting drug users
1370688|NCT01290081|Case management|case management
1370689|NCT01290068|Intraocular Lens|intraocular lens
1370690|NCT01290055|yellow fever|yellow fever
1370691|NCT01290055|vaccine|vaccine
1370692|NCT01290055|memory T cells|memory t cells
1370693|NCT01290029|pediatric|pediatric
1370694|NCT01290029|CKD|ckd
1370695|NCT01290029|dialysis|dialysis
1370696|NCT01290029|paediatric|paediatric
1370697|NCT01290016|randomized controlled trial|randomized controlled trial
1370698|NCT01290016|children|children
1370699|NCT01290016|obesity|obesity
1370700|NCT01290016|nutrition|nutrition
1370701|NCT01290016|exercise|exercise
1370702|NCT01290003|Antibacterial agents|antibacterial agents
1370703|NCT01290003|Neonate|neonate
1370704|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
1370705|NCT01290003|Neonatal sepsis|neonatal sepsis
1370706|NCT01289977|Sandfly|sandfly
1370707|NCT01289977|leishmaniasis|leishmaniasis
1370708|NCT01289977|immune response|immune response
1370709|NCT01289977|individuals age 18-50|individuals age 18-50
1370710|NCT01289951|HIV|hiv
1370711|NCT01289951|VHC|vhc
1370712|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
1370713|NCT01289951|Pharmacokinetic|pharmacokinetic
1370714|NCT01289951|Raltegravir|raltegravir
1370715|NCT01289938|pharmacokinetic|pharmacokinetic
1370716|NCT01289938|pharmacogenetic|pharmacogenetic
1370717|NCT01289938|Metoclopramide|metoclopramide
1370718|NCT01289938|Diphenhydramine|diphenhydramine
1370719|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
1370720|NCT01289925|dietary supplement|dietary supplement
1370721|NCT01289925|selenium|selenium
1370722|NCT01289925|healthy volunteer|healthy volunteer
1370723|NCT01289925|Johns Hopkins|johns hopkins
1370724|NCT01289925|older|older
1370725|NCT01289925|aging|aging
1370726|NCT01289925|geriatrics|geriatrics
1370727|NCT01289925|baltimore|baltimore
1370728|NCT01289925|mineral|mineral
1370729|NCT01289925|over 70|over 70
1370730|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
1370731|NCT01289912|Autism|autism
1370732|NCT01289912|Neurocognition|neurocognition
1370733|NCT01289912|RAD001|rad001
1370734|NCT01289912|Everolimus|everolimus
1370735|NCT01289912|Afinitor|afinitor
1370736|NCT01289912|TSC|tsc
1370737|NCT01289899|BR-A-657|br-a-657
1370738|NCT01289899|Fimasartan|fimasartan
1370739|NCT01289899|multiple-dose|multiple-dose
1370740|NCT01289899|pharmacokinetic|pharmacokinetic
1370741|NCT01289899|pharmacodynamic|pharmacodynamic
1370742|NCT01289899|safety|safety
1370743|NCT01289886|single-dose|single-dose
1370744|NCT01289886|pharmacokinetic|pharmacokinetic
1370745|NCT01289886|pharmacodynamic|pharmacodynamic
1370746|NCT01289886|safety|safety
1370747|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
1370748|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
1370749|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
1370750|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
1370751|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1370752|NCT01289847|Immunoglobulins|immunoglobulins
1370753|NCT01289847|Bacterial Infections|bacterial infections
1370754|NCT01289834|RSA|rsa
1370755|NCT01289834|Bone Cement|bone cement
1370756|NCT01289808|Glucose|glucose
1370757|NCT01289808|analgesic|analgesic
1370758|NCT01289808|newborns|newborns
1370759|NCT01289795|Stroke|stroke
1370760|NCT01289795|Cerebral Infarction|cerebral infarction
1370761|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
1370762|NCT01289795|Brain Diseases|brain diseases
1370763|NCT01289795|Central Nervous System Diseases|central nervous system diseases
1370764|NCT01289782|Hepatitis C|hepatitis c
1370765|NCT01289782|TMC435|tmc435
1370766|NCT01289782|HCV|hcv
1370767|NCT01289782|Hep C|hep c
1370768|NCT01289782|Genotype 1|genotype 1
1370769|NCT01289756|pharmacokinetic|pharmacokinetic
1370770|NCT01289756|clomiphene|clomiphene
1370771|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
1370772|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
1370773|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
1370774|NCT01289743|atanercept|atanercept
1370775|NCT01289743|therapy|therapy
1370776|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
1370777|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
1370778|NCT01289730|etanercept|etanercept
1370779|NCT01289730|therapy|therapy
1370780|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
1370781|NCT01289717|biomarkers|biomarkers
1370782|NCT01289717|proteogenomic profiling|proteogenomic profiling
1370783|NCT01289717|acute rejection|acute rejection
1370784|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
1370785|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
1370786|NCT01289704|CMT1A,|cmt1a,
1370787|NCT01289704|rehabilitation,|rehabilitation,
1370788|NCT01289704|treadmill,|treadmill,
1370789|NCT01289704|stretching,|stretching,
1370790|NCT01289704|proprioception,|proprioception,
1370791|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
1370792|NCT01289691|One Lung Ventilation|one lung ventilation
1370793|NCT01289691|Atelectasis|atelectasis
1370794|NCT01289691|Oxygenation|oxygenation
1370795|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
1370796|NCT01289678|interleukin-2|interleukin-2
1370797|NCT01289665|lubricating|lubricating
1370798|NCT01289665|gel|gel
1370799|NCT01289665|speculum|speculum
1370800|NCT01289665|Pain, Pelvic|pain, pelvic
1370801|NCT01289665|Examination, Gynecological|examination, gynecological
1370802|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
1370803|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1370804|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1370805|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1370806|NCT01289639|insulin resistance|insulin resistance
1370807|NCT01289639|pioglitazone|pioglitazone
1370808|NCT01289639|fenofibrate|fenofibrate
1370809|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
1370810|NCT01289613|Bispectral Index|bispectral index
1370811|NCT01289613|Anesthesia|anesthesia
1370812|NCT01289613|Asymmetry|asymmetry
1370813|NCT01289587|Diabetes|diabetes
1370814|NCT01289587|Physical activity|physical activity
1370815|NCT01289587|Body composition|body composition
1370816|NCT01289587|Aerobic fitness|aerobic fitness
1370817|NCT01289587|Metabolic control|metabolic control
1370818|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
1370819|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
1370820|NCT01289548|kidney transplantation|kidney transplantation
1370821|NCT01289535|Influenza vaccine|influenza vaccine
1370822|NCT01289535|immune response|immune response
1370823|NCT01289535|elderly|elderly
1370824|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1370825|NCT01289522|recurrent or metastatic|recurrent or metastatic
1370826|NCT01289522|first line chemotherapy|first line chemotherapy
1370827|NCT01289522|cetuximab|cetuximab
1370828|NCT01289522|docetaxel|docetaxel
1370829|NCT01289522|cisplatin|cisplatin
1370830|NCT01289522|antineoplastic agents|antineoplastic agents
1370831|NCT01289522|First Line Palliative Treatment|first line palliative treatment
1370832|NCT01289496|Ribavirin|ribavirin
1370833|NCT01289496|Pegasys|pegasys
1370834|NCT01289496|Hepatitis|hepatitis
1370835|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
1370836|NCT01289483|difficult airway|difficult airway
1370837|NCT01289483|fospropofol|fospropofol
1370838|NCT01289470|NIRS Technology|nirs technology
1370839|NCT01289470|Cardiovascular surgery|cardiovascular surgery
1370840|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
1370841|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
1370842|NCT01289457|AML|aml
1370843|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1370844|NCT01289457|MDS|mds
1370845|NCT01289457|Relapsed|relapsed
1370846|NCT01289457|Refractory|refractory
1370847|NCT01289457|Clofarabine|clofarabine
1370848|NCT01289457|Clofarex|clofarex
1370849|NCT01289457|Clolar|clolar
1370850|NCT01289457|Idarubicin|idarubicin
1370851|NCT01289457|Idamycin|idamycin
1370852|NCT01289457|Cytarabine|cytarabine
1370853|NCT01289457|Ara-C|ara-c
1370854|NCT01289457|Cytosar|cytosar
1370855|NCT01289457|DepoCyt|depocyt
1370856|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1370857|NCT01289444|palliative care|palliative care
1370858|NCT01289444|AIDS|aids
1370859|NCT01289444|adolescents|adolescents
1370860|NCT01289444|quality of life|quality of life
1370861|NCT01289444|adherence|adherence
1370862|NCT01289444|spiritual|spiritual
1370863|NCT01289444|threat appraisal|threat appraisal
1370864|NCT01289444|treatment congruence|treatment congruence
1370865|NCT01289444|treatment preferences|treatment preferences
1370866|NCT01289444|dialysis|dialysis
1370867|NCT01289444|hospitalization|hospitalization
1370868|NCT01289444|communication|communication
1370869|NCT01289444|family intervention|family intervention
1370870|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
1370871|NCT01289444|decision making|decision making
1370872|NCT01289444|advance care planning|advance care planning
1370873|NCT01289444|end of life|end of life
1370874|NCT01289418|H1N1|h1n1
1370875|NCT01289418|vaccine safety|vaccine safety
1370876|NCT01289418|adverse events|adverse events
1370877|NCT01289418|health care workers|health care workers
1370878|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
1370879|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
1370880|NCT01289405|speech therapy|speech therapy
1370881|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
1370882|NCT01289392|CPAP|cpap
1370883|NCT01289392|Oral appliance|oral appliance
1370884|NCT01289392|Aerobic exercise|aerobic exercise
1370885|NCT01289392|Resistance training|resistance training
1370886|NCT01289379|pneumoperitoneum|pneumoperitoneum
1370887|NCT01289379|laparoscopy|laparoscopy
1370888|NCT01289379|HFJV|hfjv
1370889|NCT01289379|cardiovascular|cardiovascular
1370890|NCT01289379|Symptomatic|symptomatic
1370891|NCT01289353|triple negative|triple negative
1370892|NCT01289353|breast cancer|breast cancer
1370893|NCT01289353|adjuvant therapy|adjuvant therapy
1370894|NCT01289353|Carboplatin|carboplatin
1370895|NCT01289353|chemotherapy|chemotherapy
1370896|NCT01289353|radiation therapy|radiation therapy
1370897|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
1370898|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
1370899|NCT01289340|wound healing|wound healing
1370900|NCT01289340|pain|pain
1370901|NCT01289340|burn|burn
1370902|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
1370903|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
1370904|NCT01289301|renal transplantation|renal transplantation
1370905|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
1370906|NCT01289301|everolimus|everolimus
1370907|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
1370908|NCT01289301|mTOR inhibitor|mtor inhibitor
1370909|NCT01289288|colorectal cancer screening|colorectal cancer screening
1370910|NCT01289288|Chinese Americans|chinese americans
1370911|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
1370912|NCT01289275|tobacco cessation|tobacco cessation
1370913|NCT01289275|smoking cessation|smoking cessation
1370914|NCT01289275|telephone|telephone
1370915|NCT01289275|self-help|self-help
1370916|NCT01289275|smoking abstinence|smoking abstinence
1370917|NCT01289275|tobacco use disorder|tobacco use disorder
1370918|NCT01289275|hospital|hospital
1370919|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
1370920|NCT01289275|disparity|disparity
1370921|NCT01289262|Cesarean section|cesarean section
1370922|NCT01289262|Kerr incision|kerr incision
1370923|NCT01289262|Purse string suturing in CS|purse string suturing in cs
1370924|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
1370925|NCT01289249|meropenem|meropenem
1370926|NCT01289249|child|child
1370927|NCT01289249|bacterial infection|bacterial infection
1370928|NCT01289249|treatment evaluation|treatment evaluation
1370929|NCT01289236|Shoulder Pain|shoulder pain
1370930|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
1370931|NCT01289210|B cell|b cell
1370932|NCT01289210|lymphoma|lymphoma
1370933|NCT01289184|Occupational Health Hazards|occupational health hazards
1370934|NCT01289184|Air Pollution|air pollution
1370935|NCT01289184|Photocopiers|photocopiers
1370936|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
1370937|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
1567122|NCT00509951|Phobic Disorders|phobic disorders
1567123|NCT00509951|Fear|fear
1370938|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
1370939|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
1370940|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
1370941|NCT01289158|MLYCD|mlycd
1370942|NCT01289145|Action Planning|action planning
1370943|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
1370944|NCT01289145|Randomized Controlled Trial|randomized controlled trial
1370945|NCT01289145|Stages of change|stages of change
1370946|NCT01289145|Health behavior|health behavior
1370947|NCT01289145|Motivation|motivation
1370948|NCT01289132|Drug Therapy|drug therapy
1370949|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1370950|NCT01289119|Drug Therapy|drug therapy
1370951|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
1370952|NCT01289106|HIV infection|hiv infection
1370953|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
1370954|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
1370955|NCT01289093|inguinal hernia|inguinal hernia
1370956|NCT01289093|incisional hernia|incisional hernia
1370957|NCT01289093|quality of life|quality of life
1370958|NCT01289093|disease-specific|disease-specific
1370959|NCT01289080|Schizophrenia|schizophrenia
1370960|NCT01289080|psychiatric disorders|psychiatric disorders
1370961|NCT01289080|renal failure|renal failure
1370962|NCT01289067|Metastatic|metastatic
1370963|NCT01289067|Castration Resistant|castration resistant
1370964|NCT01289067|Prostate Cancer|prostate cancer
1370965|NCT01289054|Female|female
1370966|NCT01289054|Pregnancy|pregnancy
1370967|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
1370968|NCT01289054|Complications|complications
1370969|NCT01289054|Registry|registry
1370970|NCT01289054|Pregnant Registry|pregnant registry
1370971|NCT01289054|CML|cml
1370972|NCT01289054|GIST|gist
1370973|NCT01289054|Gleevec|gleevec
1370974|NCT01289054|Tasigna|tasigna
1370975|NCT01289054|Glivec|glivec
1370976|NCT01289054|Pregnancy Exposure|pregnancy exposure
1370977|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
1370978|NCT01289041|PI3K pathway|pi3k pathway
1370979|NCT01289041|second-line treatment|second-line treatment
1370980|NCT01289028|GIST|gist
1370981|NCT01289028|Imatinib|imatinib
1370982|NCT01289028|Sunitinib|sunitinib
1370983|NCT01289028|Gastrointestinal|gastrointestinal
1370984|NCT01289028|Stromal|stromal
1370985|NCT01289028|Tumors|tumors
1370986|NCT01289015|fungal infection|fungal infection
1370987|NCT01289015|athlete foot|athlete foot
1370988|NCT01288989|Advanced Solid Tumors|advanced solid tumors
1370989|NCT01288976|Mitral Valve|mitral valve
1370990|NCT01288976|Mitral Regurgitation|mitral regurgitation
1370991|NCT01288976|MitraClip|mitraclip
1370992|NCT01288976|Mitral Valve Surgery|mitral valve surgery
1370993|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
1370994|NCT01288963|melanoma|melanoma
1370995|NCT01288963|IL-2|il-2
1370996|NCT01288963|Aldesleukin|aldesleukin
1370997|NCT01288950|BCG vaccine|bcg vaccine
1370998|NCT01288950|Vitamin D|vitamin d
1370999|NCT01288950|Cholecalciferol|cholecalciferol
1371000|NCT01288950|Tuberculosis|tuberculosis
1371001|NCT01288937|Milnacipran|milnacipran
1371002|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
1371003|NCT01288937|Diabetic neuropathy|diabetic neuropathy
1371004|NCT01288937|Neuropathic pain|neuropathic pain
1371005|NCT01288911|Metastatic|metastatic
1371006|NCT01288911|MDV3100|mdv3100
1371007|NCT01288911|Prostate|prostate
1371008|NCT01288911|progressive|progressive
1371009|NCT01288911|Cancer|cancer
1371010|NCT01288911|enzalutamide|enzalutamide
1371011|NCT01288898|ASP1941|asp1941
1371012|NCT01288898|Diabetes Mellitus|diabetes mellitus
1371013|NCT01288898|Multiple ascending doses|multiple ascending doses
1371014|NCT01288898|Healthy subjects|healthy subjects
1371015|NCT01288885|ASP1941|asp1941
1371016|NCT01288885|Diabetes Mellitus|diabetes mellitus
1371017|NCT01288885|First in Men|first in men
1371018|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
1371019|NCT01288859|polyphenols|polyphenols
1371020|NCT01288859|curcumin|curcumin
1371021|NCT01288859|bioavailability|bioavailability
1371022|NCT01288859|cocoa|cocoa
1371023|NCT01288846|medication list|medication list
1371024|NCT01288846|changes in medication|changes in medication
1371025|NCT01288846|prescription medication|prescription medication
1371026|NCT01288833|Colonoscopy|colonoscopy
1371027|NCT01288833|Diagnostic Imaging|diagnostic imaging
1371028|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
1371029|NCT01288833|Primary Prevention|primary prevention
1371030|NCT01288833|Cost and Cost Analysis|cost and cost analysis
1371031|NCT01288833|Endoscopy|endoscopy
1371032|NCT01288807|Fibromyalgia|fibromyalgia
1371033|NCT01288807|pain|pain
1371034|NCT01288794|Cirrhosis|cirrhosis
1371035|NCT01288794|Uncomplicated ascites|uncomplicated ascites
1371036|NCT01288794|Refractory ascites|refractory ascites
1371037|NCT01288794|Chronic albumin treatment|chronic albumin treatment
1371038|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
1371039|NCT01288768|Meniscal injury|meniscal injury
1371040|NCT01288768|Knee arthroscopy|knee arthroscopy
1371041|NCT01288768|Middleaged|middleaged
1371042|NCT01288768|Functional outcome|functional outcome
1371043|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
1371044|NCT01288755|TMC278-C153|tmc278-c153
1371045|NCT01288755|TMC278|tmc278
1371046|NCT01288755|HIV|hiv
1371047|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
1371048|NCT01288742|TMC435-C108|tmc435-c108
1371049|NCT01288742|TMC435|tmc435
1371050|NCT01288742|HPC|hpc
1371051|NCT01288742|HCV|hcv
1371052|NCT01288742|Hepatitis C|hepatitis c
1371054|NCT01288716|Autism|autism
1371055|NCT01288716|Asperger Syndrome|asperger syndrome
1371056|NCT01288703|urinary incontinence|urinary incontinence
1371057|NCT01288690|Refugees|refugees
1371058|NCT01288690|Trauma|trauma
1371059|NCT01288690|Narrative|narrative
1371060|NCT01288690|Exposure|exposure
1371061|NCT01288690|Middle East|middle east
1371062|NCT01288690|Therapy|therapy
1371063|NCT01288677|Healthy volunteer|healthy volunteer
1371064|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
1371065|NCT01288677|TMC649128|tmc649128
1371066|NCT01288677|HCV|hcv
1371067|NCT01288677|Hepatitis C|hepatitis c
1371068|NCT01288677|healthy volunteers|healthy volunteers
1371069|NCT01288677|Phase I trial|phase i trial
1371070|NCT01288664|Lupus Nephritis|lupus nephritis
1371071|NCT01288664|Tacrolimus|tacrolimus
1371072|NCT01288664|Induction Phase|induction phase
1371073|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
1371074|NCT01288651|Iron deficiency|iron deficiency
1371075|NCT01288651|Exercise|exercise
1371076|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
1371077|NCT01288638|Metabolic Syndrome|metabolic syndrome
1371078|NCT01288638|Pulse|pulse
1371079|NCT01288638|Lifestyle Intervention|lifestyle intervention
1371080|NCT01288638|Aerobic Exercise|aerobic exercise
1371081|NCT01288638|Diet|diet
1371082|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
1371083|NCT01288612|Barrett's Esophagus|barrett's esophagus
1371084|NCT01288599|Laparoscopy|laparoscopy
1371085|NCT01288599|Randomized|randomized
1371086|NCT01288599|Single port access|single port access
1371087|NCT01288599|Adnexal disease|adnexal disease
1371088|NCT01288599|LESS|less
1371089|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
1371090|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
1371091|NCT01288586|Osteoarthritis|osteoarthritis
1371092|NCT01288560|medical imaging|medical imaging
1371093|NCT01288560|heart failure|heart failure
1371094|NCT01288560|morbidity and mortality|morbidity and mortality
1371095|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
1371096|NCT01288560|knowledge translation|knowledge translation
1371097|NCT01288560|cost effectiveness|cost effectiveness
1371098|NCT01288560|quality of life|quality of life
1371099|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
1371100|NCT01288547|cognition|cognition
1371101|NCT01288547|attention|attention
1371102|NCT01288547|methylxanthine|methylxanthine
1371103|NCT01288521|kidney transplantation|kidney transplantation
1371104|NCT01288521|tacrolimus|tacrolimus
1371105|NCT01288521|P-glycoprotein|p-glycoprotein
1371106|NCT01288521|ABCB1|abcb1
1371107|NCT01288521|genotyping|genotyping
1371108|NCT01288482|Methacholine challenge|methacholine challenge
1371109|NCT01288482|nebulizer|nebulizer
1371110|NCT01288482|English-Wright|english-wright
1371111|NCT01288482|AeroEclipse II|aeroeclipse ii
1371112|NCT01288469|10020603|10020603
1371113|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
1371114|NCT01288430|Heat shock protein 90|heat shock protein 90
1371115|NCT01288430|Advanced solid tumors|advanced solid tumors
1371116|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
1371117|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
1371118|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
1371119|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
1371120|NCT01288417|HIV infections|hiv infections
1371121|NCT01288417|HCV infections|hcv infections
1371122|NCT01288417|interaction|interaction
1371123|NCT01288417|pharmacokinetics|pharmacokinetics
1371124|NCT01288417|raltegravir|raltegravir
1371125|NCT01288417|boceprevir|boceprevir
1371126|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
1371127|NCT01288378|fungal infection|fungal infection
1371128|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1371129|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1567124|NCT00509951|Phobias|phobias
1371130|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1371131|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1371132|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1371133|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1371134|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1371135|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1371136|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1371137|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1371138|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1371139|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1371140|NCT01288365|heart failure|heart failure
1371141|NCT01288365|preserved ejection fraction|preserved ejection fraction
1371142|NCT01288352|early treatment|early treatment
1371143|NCT01288352|rhythm control|rhythm control
1371144|NCT01288352|atrial fibrillation|atrial fibrillation
1371145|NCT01288352|cardiovascular complications|cardiovascular complications
1371146|NCT01288313|human milk|human milk
1371147|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
1371148|NCT01288313|linolenic acid|linolenic acid
1371149|NCT01288313|rapeseed oil|rapeseed oil
1371150|NCT01288287|Certolizumab pegol|certolizumab pegol
1371151|NCT01288287|Cimzia®|cimzia®
1371152|NCT01288274|Contraception|contraception
1371153|NCT01288274|Family planning|family planning
1371154|NCT01288274|Task Shifting|task shifting
1371155|NCT01288274|Community based distribution|community based distribution
1371156|NCT01288274|Ethiopia|ethiopia
1371157|NCT01288274|DMPA|dmpa
1371158|NCT01288248|Airway|airway
1371159|NCT01288248|Airway laryngeal mask|airway laryngeal mask
1371160|NCT01288248|Endotracheal tube|endotracheal tube
1371161|NCT01288248|Respiration artificial|respiration artificial
1371162|NCT01288248|Laryngospasm|laryngospasm
1371163|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
1371164|NCT01288235|proton radiotherapy|proton radiotherapy
1371165|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
1371166|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
1371167|NCT01288222|unrelated donor|unrelated donor
1371168|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
1371169|NCT01288209|Hepatitis C|hepatitis c
1371170|NCT01288209|Hepatitis C virus|hepatitis c virus
1371171|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
1371172|NCT01288209|Ribavirin|ribavirin
1371173|NCT01288209|Viral RNA|viral rna
1371174|NCT01288196|CNTO 6785|cnto 6785
1371175|NCT01288196|Intravenous|intravenous
1371176|NCT01288196|Subcutaneous|subcutaneous
1371177|NCT01288196|Pharmacokinetics|pharmacokinetics
1371178|NCT01288196|Immunogenicity|immunogenicity
1371179|NCT01288196|Safety|safety
1371180|NCT01288196|Tolerability|tolerability
1371181|NCT01288183|tobacco|tobacco
1371182|NCT01288183|smoking|smoking
1371183|NCT01288183|tDCS|tdcs
1371184|NCT01288183|DLPFC|dlpfc
1371185|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
1371186|NCT01288157|healthy|healthy
1371187|NCT01288157|adult|adult
1371188|NCT01288157|Chinese|chinese
1371189|NCT01288157|male|male
1371190|NCT01288157|Simponi|simponi
1371191|NCT01288157|CNTO 148|cnto 148
1371192|NCT01288144|Screening|screening
1371193|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
1371194|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
1371195|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
1371196|NCT01288131|Treatment|treatment
1371392|NCT01287260|Nifedipine|nifedipine
1371197|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
1371198|NCT01288105|drug-eluting stents|drug-eluting stents
1371199|NCT01288105|noncardiac surgery|noncardiac surgery
1371200|NCT01288092|Metastatic breast cancer|metastatic breast cancer
1371201|NCT01288092|HER2 negative|her2 negative
1371202|NCT01288092|HR positive|hr positive
1371203|NCT01288092|PI3K pathway|pi3k pathway
1371204|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
1371205|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
1371206|NCT01288079|Major Depressive Disorder|major depressive disorder
1371207|NCT01288079|MDD|mdd
1371208|NCT01288079|Monotherapy|monotherapy
1371209|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
1371210|NCT01288066|Shoulder|shoulder
1371211|NCT01288066|Total arthroplasty|total arthroplasty
1371212|NCT01288066|Hemiarthroplasty|hemiarthroplasty
1371213|NCT01288066|Resurfacing|resurfacing
1371214|NCT01288066|Glenoid|glenoid
1371215|NCT01288066|Constant score|constant score
1371216|NCT01288040|stroke|stroke
1371217|NCT01288040|treadmill|treadmill
1371218|NCT01288040|walking|walking
1371219|NCT01288040|hemiparesis|hemiparesis
1371220|NCT01288040|training|training
1371221|NCT01288014|immune response|immune response
1371222|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
1371223|NCT01288014|cytokine levels|cytokine levels
1371224|NCT01288014|immunization|immunization
1371225|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
1371226|NCT01287975|Brain Computer Interface|brain computer interface
1371227|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
1371228|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
1371229|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
1371230|NCT01287975|Haptic Knob|haptic knob
1371231|NCT01287962|Apatinib|apatinib
1371232|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
1371233|NCT01287962|VEGFR TKIs|vegfr tkis
1371234|NCT01287949|Diphtheria|diphtheria
1371235|NCT01287949|Tetanus|tetanus
1371236|NCT01287949|Poliomyelitis|poliomyelitis
1371237|NCT01287949|Pertussis (acellular)|pertussis (acellular)
1371238|NCT01287949|Biological/vaccine|biological/vaccine
1371239|NCT01287936|Chronic Stroke|chronic stroke
1371240|NCT01287936|Stable Stroke|stable stroke
1371241|NCT01287923|Hematology|hematology
1371242|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
1371243|NCT01287910|Cardiac|cardiac
1371244|NCT01287910|Angina|angina
1371245|NCT01287910|Chest pain|chest pain
1371246|NCT01287897|Crohn's Disease|crohn's disease
1371247|NCT01287897|safety|safety
1371248|NCT01287897|efficacy|efficacy
1371249|NCT01287897|pharmacokinetics|pharmacokinetics
1371250|NCT01287897|pharmacodynamics|pharmacodynamics
1371251|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
1371253|NCT01287884|VBG|vbg
1371254|NCT01287884|pH|ph
1371255|NCT01287884|pCO2|pco2
1371256|NCT01287871|Cervical Cancer Screening|cervical cancer screening
1371257|NCT01287845|Prostate cancer|prostate cancer
1371258|NCT01287845|Neoplasm|neoplasm
1371259|NCT01287845|Diagnostic Imaging|diagnostic imaging
1371260|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
1371261|NCT01287845|PET-diagnosis|pet-diagnosis
1371262|NCT01287832|Methicillin-resistant|methicillin-resistant
1371263|NCT01287832|Staphylococcus aureus|staphylococcus aureus
1371264|NCT01287806|ulinastatin|ulinastatin
1371265|NCT01287806|inhalation injury|inhalation injury
1371266|NCT01287780|Humans|humans
1371267|NCT01287780|Prostheses and Implants|prostheses and implants
1371268|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
1371269|NCT01287780|Surgical sponges|surgical sponges
1371270|NCT01287780|Treatment outcomes|treatment outcomes
1371271|NCT01287767|Dementia|dementia
1371272|NCT01287767|Depression|depression
1371273|NCT01287767|Burden of care|burden of care
1371274|NCT01287767|Psychosocial intervention|psychosocial intervention
1371275|NCT01287767|Family home care|family home care
1371276|NCT01287702|early feeding|early feeding
1371277|NCT01287702|varices bleeding|varices bleeding
1371278|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
1371279|NCT01287689|Non-interventional trial|non-interventional trial
1371280|NCT01287689|immunodeficiency|immunodeficiency
1371281|NCT01287689|outcome study, registry|outcome study, registry
1371282|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
1371283|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
1371284|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
1371285|NCT01287689|factors for treatment success|factors for treatment success
1371286|NCT01287689|long-term tolerability|long-term tolerability
1371287|NCT01287689|quality of life|quality of life
1371288|NCT01287637|Rectal cancer|rectal cancer
1371289|NCT01287637|Temporary ileostomy|temporary ileostomy
1371290|NCT01287637|Ealy reversal|ealy reversal
1371291|NCT01287637|Morbidity|morbidity
1371292|NCT01287637|Mortality|mortality
1371293|NCT01287637|Quality of life|quality of life
1371294|NCT01287637|Economic effect|economic effect
1371295|NCT01287624|triple negative breast cancer|triple negative breast cancer
1371296|NCT01287624|fine line chemotherapy|fine line chemotherapy
1371297|NCT01287611|Cesarean section|cesarean section
1371298|NCT01287611|Kerr incision|kerr incision
1371299|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
1371300|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
1371301|NCT01287598|Phase I|phase i
1371302|NCT01287598|Probe substrate|probe substrate
1371303|NCT01287598|target therapy|target therapy
1371304|NCT01287598|small molecule|small molecule
1371305|NCT01287598|pharmacokinetics|pharmacokinetics
1371306|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
1371307|NCT01287585|Arginine|arginine
1371308|NCT01287585|Arginine deiminase|arginine deiminase
1371309|NCT01287585|ADI-PEG 20|adi-peg 20
1371310|NCT01287572|TcCO2|tcco2
1371311|NCT01287572|sedation|sedation
1371312|NCT01287572|procedure|procedure
1371313|NCT01287572|PICU|picu
1371314|NCT01287559|NEC|nec
1371315|NCT01287559|Premature Infant|premature infant
1371316|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
1371317|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
1371318|NCT01287533|Vertebral fracture|vertebral fracture
1371319|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
1371320|NCT01287494|elderly|elderly
1371321|NCT01287494|care management|care management
1371322|NCT01287494|primary care|primary care
1371323|NCT01287481|Fibromyalgia|fibromyalgia
1371324|NCT01287481|Behavioral interventions|behavioral interventions
1371325|NCT01287481|Psychological interventions|psychological interventions
1371326|NCT01287468|phytomedicines|phytomedicines
1371327|NCT01287468|breast cancer|breast cancer
1371328|NCT01287468|stromal fibroblasts|stromal fibroblasts
1371329|NCT01287468|MDSCs|mdscs
1371330|NCT01287468|functional mechanism|functional mechanism
1371331|NCT01287455|Asthma|asthma
1371332|NCT01287455|Vitamin D|vitamin d
1371333|NCT01287455|airway reactivity|airway reactivity
1371334|NCT01287455|metacholine challenge test|metacholine challenge test
1371335|NCT01287429|Ultrasonography|ultrasonography
1371336|NCT01287416|Suicide Intervention|suicide intervention
1371337|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
1371338|NCT01287416|Resilience Retreat|resilience retreat
1371339|NCT01287416|First Nations|first nations
1371340|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
1371341|NCT01287403|Cereals|cereals
1371342|NCT01287403|Alkylresorcinols|alkylresorcinols
1371343|NCT01287403|Betaine|betaine
1371344|NCT01287403|Phenolics|phenolics
1371345|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
1371346|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
1371347|NCT01287390|oral cavity|oral cavity
1371348|NCT01287390|oropharynx|oropharynx
1371349|NCT01287390|hypopharynx|hypopharynx
1371350|NCT01287390|larynx|larynx
1371351|NCT01287377|tobacco cessation|tobacco cessation
1371352|NCT01287377|smoking cessation|smoking cessation
1371353|NCT01287377|nicotine|nicotine
1371354|NCT01287377|counseling|counseling
1371355|NCT01287377|telephone|telephone
1371356|NCT01287377|self-help|self-help
1371357|NCT01287377|smoking abstinence|smoking abstinence
1371358|NCT01287377|tobacco use disorder|tobacco use disorder
1371359|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
1371360|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
1371361|NCT01287364|PAR|par
1371362|NCT01287351|Real-world|real-world
1371363|NCT01287351|observational|observational
1371364|NCT01287351|Fluticasone propionate|fluticasone propionate
1371365|NCT01287351|Metred dose inhaler|metred dose inhaler
1371366|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
1371367|NCT01287351|Asthma management|asthma management
1371368|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
1371369|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
1371370|NCT01287351|USA|usa
1371371|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1371372|NCT01287325|Cough|cough
1371373|NCT01287325|DNK333|dnk333
1371374|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
1371375|NCT01287299|pregnancy|pregnancy
1371376|NCT01287299|obesity|obesity
1371377|NCT01287299|diet glycemic load|diet glycemic load
1371378|NCT01287299|body composition|body composition
1371379|NCT01287299|body fat|body fat
1371380|NCT01287299|gestational weight gain|gestational weight gain
1371381|NCT01287299|insulin resistance|insulin resistance
1371382|NCT01287286|Cancers|cancers
1371383|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
1371384|NCT01287286|Chemotherapy|chemotherapy
1371385|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
1371386|NCT01287273|frozen-thawed|frozen-thawed
1371387|NCT01287273|IVF|ivf
1371388|NCT01287273|incubation|incubation
1371389|NCT01287273|pregnancy rate|pregnancy rate
1371390|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
1371391|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
1371393|NCT01287260|Essential hypertension|essential hypertension
1371394|NCT01287260|Japanese Patients|japanese patients
1371395|NCT01287260|Phase III|phase iii
1371396|NCT01287260|13176|13176
1371397|NCT01287247|Cervical dystonia|cervical dystonia
1371398|NCT01287247|Blepharospasm|blepharospasm
1371399|NCT01287208|Physical activity|physical activity
1371400|NCT01287208|Accelerometer|accelerometer
1371401|NCT01287208|Steps|steps
1371402|NCT01287208|Medical residents|medical residents
1371403|NCT01287195|Ulcerative Colitis|ulcerative colitis
1371404|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
1371405|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
1371406|NCT01287169|Bisphenol A|bisphenol a
1371407|NCT01287156|Recruitment|recruitment
1371408|NCT01287156|TBI|tbi
1371409|NCT01287156|Screening|screening
1371410|NCT01287156|Traumatic Brain Injury|traumatic brain injury
1371411|NCT01287143|Fever|fever
1371412|NCT01287143|Signs and Symptoms|signs and symptoms
1371413|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
1371414|NCT01287130|Antibodies|antibodies
1371415|NCT01287130|Pharmacokinetics|pharmacokinetics
1371416|NCT01287130|Kinase Inhibitors|kinase inhibitors
1371417|NCT01287130|Colon Cancer|colon cancer
1371419|NCT01287130|Colorectal Cancer|colorectal cancer
1371420|NCT01287130|Solid Tumor|solid tumor
1371421|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
1371422|NCT01287104|Hematologic Malignacies|hematologic malignacies
1371423|NCT01287104|Leukemia|leukemia
1371424|NCT01287104|Lymphoma|lymphoma
1371425|NCT01287104|Ewing Sarcoma|ewing sarcoma
1371426|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
1371427|NCT01287104|Neuroblastoma|neuroblastoma
1371428|NCT01287104|Healthy Donor|healthy donor
1371429|NCT01287078|Chronic GVHD of the Lung|chronic gvhd of the lung
1371430|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1371431|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
1371432|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
1371433|NCT01287078|GVHD|gvhd
1371434|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
1371435|NCT01287078|Lung|lung
1371436|NCT01287065|Fluticasone furoate|fluticasone furoate
1371437|NCT01287065|Vilanterol|vilanterol
1371438|NCT01287065|Efficacy|efficacy
1371439|NCT01287065|FEV1|fev1
1371440|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
1371441|NCT01287052|Migraine|migraine
1371442|NCT01287052|Pediatric|pediatric
1371443|NCT01287052|Adolescent|adolescent
1371444|NCT01287052|Nitrous Oxide|nitrous oxide
1371445|NCT01287026|MRI Catheterization|mri catheterization
1371446|NCT01287026|Right Heart Catheterization|right heart catheterization
1371447|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
1371448|NCT01287026|MRI Safety|mri safety
1371449|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
1371450|NCT01287026|Heart Catheterization|heart catheterization
1371451|NCT01287026|Heart Disease|heart disease
1371452|NCT01287026|Cardiovascular Disease|cardiovascular disease
1371453|NCT01287013|Image Guided Procedures|image guided procedures
1371454|NCT01287013|Xperguide CT|xperguide ct
1371455|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
1371456|NCT01287013|Navigation|navigation
1371457|NCT01287013|Image Guided Procedure|image guided procedure
1371458|NCT01287013|Cancer|cancer
1371459|NCT01287013|Granuloma|granuloma
1371460|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
1371461|NCT01287000|Petroleum|petroleum
1371462|NCT01287000|Dispersant(s)|dispersant(s)
1371463|NCT01287000|Oil Spill|oil spill
1371464|NCT01287000|Longitudinal Study|longitudinal study
1371465|NCT01286987|BRCA1 Protein|brca1 protein
1371466|NCT01286987|BRCA2 Protein|brca2 protein
1371467|NCT01286961|Bowel preparation|bowel preparation
1371468|NCT01286961|Polyethylene glycols|polyethylene glycols
1371469|NCT01286961|Colonoscopy|colonoscopy
1371470|NCT01286961|Outpatient|outpatient
1371471|NCT01286948|LNG gel|lng gel
1371472|NCT01286948|oral LNG|oral lng
1371473|NCT01286948|follicle rupture|follicle rupture
1371474|NCT01286948|intra-vaginal administration|intra-vaginal administration
1371475|NCT01286948|growth of the leading follicle|growth of the leading follicle
1371476|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
1371477|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
1371478|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
1371479|NCT01286935|Parkinson's Disease|parkinson's disease
1371480|NCT01286935|PD|pd
1371481|NCT01286935|Levodopa|levodopa
1371482|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
1371483|NCT01286922|diabetes|diabetes
1371484|NCT01286922|exercise|exercise
1371485|NCT01286922|insulin resistance|insulin resistance
1371486|NCT01286922|interval training|interval training
1371487|NCT01286922|physical activity|physical activity
1371488|NCT01286909|Metabolic|metabolic
1371489|NCT01286896|advanced solid tumors|advanced solid tumors
1371490|NCT01286883|stem cell markers|stem cell markers
1371491|NCT01286883|prognostic markers|prognostic markers
1371492|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
1371493|NCT01286883|circulating tumor cells|circulating tumor cells
1371494|NCT01286883|tumor microenvironment|tumor microenvironment
1371495|NCT01286883|colorectal cancer|colorectal cancer
1371496|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
1371497|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
1371498|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
1371499|NCT01286831|Beta-2 agonist|beta-2 agonist
1371500|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
1371501|NCT01286831|Radiolabel|radiolabel
1371502|NCT01286818|Colon Cancer|colon cancer
1371503|NCT01286818|Rectal Cancer|rectal cancer
1371504|NCT01286766|unresectable|unresectable
1371505|NCT01286766|locally advanced|locally advanced
1371506|NCT01286740|HIV-1|hiv-1
1371507|NCT01286740|HIV|hiv
1371508|NCT01286740|Treatment Experienced|treatment experienced
1371509|NCT01286701|Bioequivalence|bioequivalence
1371510|NCT01286701|crossover|crossover
1371511|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
1371512|NCT01286701|fed|fed
1371513|NCT01286688|Bioequivalence|bioequivalence
1371514|NCT01286688|crossover|crossover
1371515|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
1371516|NCT01286688|Fasting|fasting
1371517|NCT01286675|ASCT|asct
1371518|NCT01286675|G-CSF|g-csf
1371519|NCT01286662|gardner syndrome|gardner syndrome
1371520|NCT01286662|colorectal carcinoma|colorectal carcinoma
1371521|NCT01286662|desmoid tumor|desmoid tumor
1371522|NCT01286662|resection|resection
1371523|NCT01286662|colon|colon
1371524|NCT01286649|Alopecia|alopecia
1371525|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
1371526|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
1371527|NCT01286636|artificial neural network|artificial neural network
1371528|NCT01286610|vibration|vibration
1371529|NCT01286610|ICU|icu
1371530|NCT01286610|blood pressure|blood pressure
1371531|NCT01286610|intracranial pressure|intracranial pressure
1371532|NCT01286610|infection|infection
1371533|NCT01286610|indirect calorimetry|indirect calorimetry
1371534|NCT01286597|lactose intolerance|lactose intolerance
1371535|NCT01286597|DNA sequencing|dna sequencing
1371536|NCT01286597|psychosocial factors|psychosocial factors
1371537|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
1371538|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
1371539|NCT01286584|varenicline|varenicline
1371540|NCT01286584|alcohol|alcohol
1371541|NCT01286584|placebo|placebo
1371542|NCT01286584|smoking cessation|smoking cessation
1371543|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
1371544|NCT01286545|Infliximab|infliximab
1371545|NCT01286545|Radiographic progression|radiographic progression
1371546|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
1371547|NCT01286519|pharmacokinetics|pharmacokinetics
1371548|NCT01286506|Pulse pressure variation|pulse pressure variation
1371549|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
1371550|NCT01286506|Volume status|volume status
1371551|NCT01286506|Critical care|critical care
1371552|NCT01286493|HIV|hiv
1371553|NCT01286493|booster|booster
1371554|NCT01286493|rabies|rabies
1371555|NCT01286493|immune response|immune response
1371556|NCT01286480|Health Care Transition|health care transition
1371557|NCT01286480|Adolescent|adolescent
1371558|NCT01286467|PF-04449913|pf-04449913
1371559|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
1371560|NCT01286467|Solid tumor|solid tumor
1371561|NCT01286467|Pharmacokinetics|pharmacokinetics
1371562|NCT01286467|Safety|safety
1371563|NCT01286467|Pharmacodynamics|pharmacodynamics
1371564|NCT01286454|BIOAVAILABILITY|bioavailability
1371565|NCT01286454|FOOD EFFECT|food effect
1371566|NCT01286441|Verruca vulgaris|verruca vulgaris
1371567|NCT01286428|liver|liver
1371568|NCT01286428|cancer|cancer
1371569|NCT01286428|tumor|tumor
1371570|NCT01286428|ablation|ablation
1371571|NCT01286428|Pathfinder|pathfinder
1371572|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
1371573|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
1371574|NCT01286415|combat|combat
1371575|NCT01286415|military|military
1371576|NCT01286415|CPT|cpt
1371577|NCT01286415|group therapy|group therapy
1371578|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
1371579|NCT01286402|bupropion|bupropion
1371580|NCT01286389|Mild cognitive impairment|mild cognitive impairment
1371581|NCT01286389|Dementia|dementia
1371582|NCT01286389|Obesity|obesity
1371583|NCT01286389|Overweight|overweight
1371584|NCT01286389|diet|diet
1371585|NCT01286389|caloric restriction|caloric restriction
1371586|NCT01286389|body composition|body composition
1371587|NCT01286389|weight loss|weight loss
1371588|NCT01286376|Symbiotics|symbiotics
1371589|NCT01286376|Fiber|fiber
1371590|NCT01286376|Constipation|constipation
1371591|NCT01286363|Bite force|bite force
1371592|NCT01286363|Dental occlusion|dental occlusion
1371593|NCT01286363|Face|face
1371594|NCT01286363|Mastication|mastication
1371595|NCT01286363|Morphology|morphology
1371596|NCT01286350|motivational interviewing|motivational interviewing
1371597|NCT01286350|problem solving skills training|problem solving skills training
1371598|NCT01286350|family communication|family communication
1371599|NCT01286350|social support|social support
1371600|NCT01286350|adolescents|adolescents
1371601|NCT01286337|axilla|axilla
1371602|NCT01286337|surgery|surgery
1371603|NCT01286337|technique|technique
1371604|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
1371605|NCT01286324|Matricaria|matricaria
1371606|NCT01286324|Chamomile|chamomile
1371607|NCT01286324|Herb|herb
1371608|NCT01286324|Insomnia|insomnia
1371609|NCT01286311|Health Education|health education
1371610|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1371611|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
1371612|NCT01286311|Patient Education as Topic|patient education as topic
1371613|NCT01286298|diode laser|diode laser
1371614|NCT01286298|gingival enlargement|gingival enlargement
1371615|NCT01286298|gingival overgrowth|gingival overgrowth
1371616|NCT01286298|gingival hyperplasia|gingival hyperplasia
1371617|NCT01286298|orthodontics|orthodontics
1371618|NCT01286285|influenza|influenza
1371619|NCT01286285|acute respiratory infections|acute respiratory infections
1371620|NCT01286285|paediatric|paediatric
1371621|NCT01286285|intensive care units|intensive care units
1371622|NCT01286285|epidemiology|epidemiology
1371623|NCT01286259|HIV|hiv
1371624|NCT01286259|HAART suppressed|haart suppressed
1371625|NCT01286259|Disulfiram|disulfiram
1371626|NCT01286259|Antabuse|antabuse
1371627|NCT01286259|Latent reservoir|latent reservoir
1371628|NCT01286259|Eradication|eradication
1371629|NCT01286259|Cure|cure
1371630|NCT01286246|Progesterone|progesterone
1371631|NCT01286246|Randomized controlled trial|randomized controlled trial
1371632|NCT01286233|fatigue|fatigue
1371633|NCT01286233|sleep disorders|sleep disorders
1371634|NCT01286233|depression|depression
1371635|NCT01286233|stage IA breast cancer|stage ia breast cancer
1371636|NCT01286233|stage IB breast cancer|stage ib breast cancer
1371637|NCT01286233|stage II breast cancer|stage ii breast cancer
1371638|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
1371639|NCT01286207|Migraine headache|migraine headache
1371640|NCT01286181|COPD|copd
1371641|NCT01286181|Biofeedback|biofeedback
1371642|NCT01286181|Dyspnea|dyspnea
1371643|NCT01286181|Quality of life|quality of life
1371644|NCT01286181|Stress|stress
1371645|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
1371646|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
1371647|NCT01286155|Barrett's esophagus|barrett's esophagus
1371648|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
1371649|NCT01286155|GERD|gerd
1371650|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
1371651|NCT01286116|heart failure|heart failure
1371652|NCT01286116|percutaneous|percutaneous
1371653|NCT01286116|interventional cardiology|interventional cardiology
1371654|NCT01286116|apical remodeling|apical remodeling
1371655|NCT01286116|LV dilatation|lv dilatation
1371656|NCT01286116|akinesis|akinesis
1371657|NCT01286116|dyskinesis|dyskinesis
1371658|NCT01286116|myocardial infarction|myocardial infarction
1371659|NCT01286103|Canagliflozin|canagliflozin
1371660|NCT01286103|Pharmacokinetics|pharmacokinetics
1371661|NCT01286103|Pharmacodynamics|pharmacodynamics
1371662|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
1371663|NCT01286090|Placebo|placebo
1371664|NCT01286090|Diabetes mellitus|diabetes mellitus
1371665|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
1371666|NCT01286077|Multiple Myeloma|multiple myeloma
1371667|NCT01286077|bortezomib|bortezomib
1371668|NCT01286077|hematology|hematology
1371669|NCT01286077|bone marrow cancer|bone marrow cancer
1371670|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
1371671|NCT01286077|bone mineral density|bone mineral density
1371672|NCT01286077|bone markers|bone markers
1371673|NCT01286064|adenocarcinoma,|adenocarcinoma,
1371674|NCT01286064|colorectal tumors,|colorectal tumors,
1371675|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
1371676|NCT01286064|fluorescence,|fluorescence,
1371677|NCT01286064|tumor markers.|tumor markers.
1371678|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
1371679|NCT01286038|platelets|platelets
1371680|NCT01286025|medical education|medical education
1371681|NCT01286025|problem-based learning|problem-based learning
1371682|NCT01286025|interactive tutorial|interactive tutorial
1371683|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
1371684|NCT01285986|Graft patency|graft patency
1371685|NCT01285986|Limb salvage|limb salvage
1371686|NCT01285960|Uterine fibroids|uterine fibroids
1371687|NCT01285960|MRgFUS|mrgfus
1371688|NCT01285960|ExAblate|exablate
1371689|NCT01285960|Focused Ultrasound|focused ultrasound
1371690|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
1371691|NCT01285947|pain experience|pain experience
1371692|NCT01285947|energy devices|energy devices
1371693|NCT01285947|Ulthera|ulthera
1371694|NCT01285947|Thermage|thermage
1371695|NCT01285947|VBeam|vbeam
1371696|NCT01285921|hippocampal|hippocampal
1371697|NCT01285921|vestibular test|vestibular test
1371698|NCT01285908|Baroreceptor|baroreceptor
1371699|NCT01285908|Norepinephrine|norepinephrine
1371700|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
1371701|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
1371702|NCT01285908|Blood Pressure|blood pressure
1371703|NCT01285895|Lung and heart transplantations|lung and heart transplantations
1371704|NCT01285895|Mucoviscidosis|mucoviscidosis
1371705|NCT01285895|Educational needs|educational needs
1371706|NCT01285882|Lung transplantations|lung transplantations
1371707|NCT01285882|Representations|representations
1371708|NCT01285882|Mucoviscidosis|mucoviscidosis
1371709|NCT01285869|Pneumonia|pneumonia
1371710|NCT01285869|Intervention Studies|intervention studies
1371711|NCT01285869|Aged|aged
1371712|NCT01285869|Aged, 80 and over|aged, 80 and over
1371713|NCT01285869|Geriatric Assessment|geriatric assessment
1371714|NCT01285856|patients|patients
1371715|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
1371716|NCT01285856|buprenorphine|buprenorphine
1371717|NCT01285856|methadone|methadone
1371718|NCT01285830|Infants|infants
1371719|NCT01285830|Probiotics|probiotics
1371720|NCT01285830|Prevention|prevention
1371721|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
1371722|NCT01285830|Eczema|eczema
1371724|NCT01285830|Sensitization|sensitization
1371725|NCT01285830|Microbiota|microbiota
1371726|NCT01285830|Chemokines|chemokines
1371727|NCT01285791|morbid obesity|morbid obesity
1371728|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
1371729|NCT01285791|gastric bypass|gastric bypass
1371730|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
1371731|NCT01285791|gastric banding|gastric banding
1371732|NCT01285791|visceral fat|visceral fat
1371733|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
1371734|NCT01285778|panitumumab|panitumumab
1371735|NCT01285778|chemoradiation|chemoradiation
1371736|NCT01285778|anal cancer|anal cancer
1371737|NCT01285778|GEMCAD-09-02|gemcad-09-02
1371738|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
1371739|NCT01285739|Tracheostomy.|tracheostomy.
1371740|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
1371741|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
1371742|NCT01285726|Peritoneal dialysis|peritoneal dialysis
1371743|NCT01285726|Hydration status|hydration status
1371744|NCT01285726|Residual renal function|residual renal function
1371745|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
1371746|NCT01285726|Body composition monitor|body composition monitor
1371747|NCT01285713|Dehydration|dehydration
1371748|NCT01285713|Gastroenteritis|gastroenteritis
1371749|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
1371750|NCT01285687|Tonsillectomy|tonsillectomy
1371751|NCT01285687|Post-Operative Pain|post-operative pain
1371752|NCT01285687|Acupuncture|acupuncture
1371753|NCT01285674|cisplatin|cisplatin
1371754|NCT01285674|ototoxicity|ototoxicity
1371755|NCT01285674|intratympanic steroids|intratympanic steroids
1371756|NCT01285661|Deep venous thrombosis|deep venous thrombosis
1371757|NCT01285661|Pulmonary embolism|pulmonary embolism
1371758|NCT01285661|Ultrasonography|ultrasonography
1371759|NCT01285661|D-dimer|d-dimer
1371760|NCT01285661|Venous thromboembolism|venous thromboembolism
1371761|NCT01285661|Bleeding|bleeding
1371762|NCT01285648|chest tubes,|chest tubes,
1371763|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
1371764|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
1371765|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
1371766|NCT01285648|postoperative|postoperative
1371767|NCT01285622|Surgery; gynecological|surgery; gynecological
1371768|NCT01285622|Stroke volume|stroke volume
1371769|NCT01285596|Pharmacokinetics|pharmacokinetics
1371770|NCT01285596|Cardiography|cardiography
1371771|NCT01285596|Impedance|impedance
1371772|NCT01285596|Age groups|age groups
1371773|NCT01285596|Gender Identity|gender identity
1371774|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
1371775|NCT01285583|TRO19622|tro19622
1371776|NCT01285583|Olesoxime|olesoxime
1371777|NCT01285583|Trophos|trophos
1371778|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
1371779|NCT01285544|statins|statins
1371780|NCT01285544|cholesterol|cholesterol
1371781|NCT01285544|hypercholesterolemia|hypercholesterolemia
1371782|NCT01285544|atorvastatin|atorvastatin
1371783|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
1371784|NCT01285531|lumbar puncture|lumbar puncture
1371785|NCT01285531|Compass|compass
1371786|NCT01285531|pressure transducer|pressure transducer
1371787|NCT01285531|manometry|manometry
1371788|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
1371789|NCT01285518|Type 2 diabetes|type 2 diabetes
1371790|NCT01285518|intravenous|intravenous
1371791|NCT01285518|single dose|single dose
1371792|NCT01285505|alprazolam|alprazolam
1371793|NCT01285505|sublingual|sublingual
1371794|NCT01285505|bioequivalence|bioequivalence
1371795|NCT01285492|COPD|copd
1371796|NCT01285492|QVA149|qva149
1371797|NCT01285492|NVA237|nva237
1371798|NCT01285492|indacaterol|indacaterol
1371799|NCT01285492|combination bronchodilator|combination bronchodilator
1371800|NCT01285479|Fingolimod|fingolimod
1371801|NCT01285479|FTY720|fty720
1371802|NCT01285479|Gilenya|gilenya
1371803|NCT01285479|Multiple sclerosis|multiple sclerosis
1371804|NCT01285479|MS|ms
1371805|NCT01285479|Safety|safety
1371806|NCT01285479|Pregnancy|pregnancy
1371807|NCT01285479|Pregnancy outcomes|pregnancy outcomes
1371808|NCT01285466|Cancer|cancer
1371809|NCT01285466|BEZ235|bez235
1371810|NCT01285466|BKM120|bkm120
1371811|NCT01285466|paclitaxel|paclitaxel
1371812|NCT01285466|trastuzumab|trastuzumab
1371813|NCT01285453|ASA404,|asa404,
1371814|NCT01285453|vadimezan,|vadimezan,
1371815|NCT01285453|docetaxel|docetaxel
1371816|NCT01285440|breast|breast
1371817|NCT01285440|biopsy|biopsy
1371818|NCT01285440|suspicious lesion|suspicious lesion
1371819|NCT01285440|molecular breast imaging|molecular breast imaging
1371820|NCT01285427|DNA, sequencing|dna, sequencing
1371821|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
1371822|NCT01285414|Glioblastoma|glioblastoma
1371823|NCT01285414|Brain Neoplasms|brain neoplasms
1371824|NCT01285414|Brain Cancer|brain cancer
1371825|NCT01285414|Verubulin|verubulin
1371826|NCT01285401|Multiple Sclerosis|multiple sclerosis
1371827|NCT01285401|Rebif|rebif
1371828|NCT01285401|VigantOL® oil|vigantol® oil
1371829|NCT01285401|Vitamin D|vitamin d
1371830|NCT01285401|Add-on treatment|add-on treatment
1371831|NCT01285388|Safety|safety
1371832|NCT01285388|Tolerability|tolerability
1371833|NCT01285388|Pharmacokinetic|pharmacokinetic
1371834|NCT01285362|Fatty Liver Disease|fatty liver disease
1371835|NCT01285362|Hepatic Steatosis|hepatic steatosis
1371836|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
1371837|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
1371838|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
1371839|NCT01285362|Elevated Transaminases|elevated transaminases
1371840|NCT01285362|Fish oil supplements|fish oil supplements
1371841|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
1371842|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1371843|NCT01285336|DNA repair system|dna repair system
1371844|NCT01285336|polymorphism|polymorphism
1371845|NCT01285336|susceptibility|susceptibility
1371846|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
1371847|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
1371848|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
1371849|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
1371850|NCT01285297|Angina|angina
1371851|NCT01285284|Colonoscopy|colonoscopy
1371852|NCT01285284|Music|music
1371853|NCT01285284|Tolerance|tolerance
1371854|NCT01285284|Pain|pain
1371855|NCT01285284|Anxiety|anxiety
1371856|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
1371857|NCT01285271|xenon|xenon
1371858|NCT01285271|sevoflurane|sevoflurane
1371859|NCT01285271|cardiac anesthesia|cardiac anesthesia
1371860|NCT01285271|CABG|cabg
1371861|NCT01285271|Bypass surgery|bypass surgery
1371862|NCT01285258|Peripartum|peripartum
1371863|NCT01285258|hysterectomy|hysterectomy
1371864|NCT01285258|placenta accreta|placenta accreta
1371865|NCT01285258|mortality|mortality
1371866|NCT01285245|insulin sensitivity|insulin sensitivity
1371867|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
1371868|NCT01285245|inflammation|inflammation
1371869|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
1371870|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
1371871|NCT01285219|Polyethylene glycols|polyethylene glycols
1371872|NCT01285219|Neutropenia|neutropenia
1371873|NCT01285219|Drug therapy, combination|drug therapy, combination
1371874|NCT01285193|hypertension|hypertension
1371875|NCT01285193|high blood pressure|high blood pressure
1371876|NCT01285193|treatment|treatment
1371877|NCT01285193|breath control|breath control
1371878|NCT01285193|breathing exercise|breathing exercise
1371879|NCT01285193|audio CD|audio cd
1371880|NCT01285180|COPD|copd
1371881|NCT01285180|Quality of life|quality of life
1371882|NCT01285180|sociodemographic data|sociodemographic data
1371883|NCT01285180|cost-of-illness data|cost-of-illness data
1371884|NCT01285180|roflumilast|roflumilast
1371885|NCT01285180|Daxas|daxas
1371886|NCT01285167|COPD|copd
1371887|NCT01285167|Quality of life|quality of life
1371888|NCT01285167|lung function|lung function
1371889|NCT01285167|spirometry|spirometry
1371890|NCT01285167|roflumilast|roflumilast
1371891|NCT01285167|Daxas|daxas
1371892|NCT01285167|severe COPD|severe copd
1371893|NCT01285154|Hip dysplasia|hip dysplasia
1371894|NCT01285154|Triple Osteotomy|triple osteotomy
1371895|NCT01285154|Femoral Head Coverage|femoral head coverage
1371896|NCT01285154|Femoral Head Medialization|femoral head medialization
1371897|NCT01285141|HIV Infections|hiv infections
1371898|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1371899|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
1371900|NCT01285115|Jingji-zhengchong|jingji-zhengchong
1371901|NCT01285115|Gamisoyosan|gamisoyosan
1371902|NCT01285115|anxiety|anxiety
1371903|NCT01285063|overweight|overweight
1371904|NCT01285063|obesity|obesity
1371905|NCT01285063|physical fitness|physical fitness
1371906|NCT01285063|kinder garden|kinder garden
1371907|NCT01285063|preschool|preschool
1371908|NCT01285050|HIV|hiv
1371909|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
1371910|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1371911|NCT01285050|AIDS Virus|aids virus
1371912|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
1371913|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
1371914|NCT01285050|Hepatitis C|hepatitis c
1371915|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
1371916|NCT01285050|Hepatitis C virus|hepatitis c virus
1371917|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
1371918|NCT01285050|Hepatitis C antigens|hepatitis c antigens
1371919|NCT01285024|total hip arthroplasty|total hip arthroplasty
1371920|NCT01285024|transfusion|transfusion
1371921|NCT01285024|hemostat|hemostat
1371922|NCT01285011|arthrodesis|arthrodesis
1371923|NCT01285011|PIP joint|pip joint
1371924|NCT01284998|forefoot deformities|forefoot deformities
1371925|NCT01284998|basal osteotomy|basal osteotomy
1371926|NCT01284959|cognitive function|cognitive function
1371927|NCT01284959|subjective experiences|subjective experiences
1371928|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
1371929|NCT01284959|paliperidone extended-release|paliperidone extended-release
1371930|NCT01284959|risperidone|risperidone
1371931|NCT01284946|PCT sporadic or familial|pct sporadic or familial
1371932|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
1371933|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
1371934|NCT01284933|Stroke|stroke
1371935|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
1371936|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
1371937|NCT01284933|Carotid Arteries|carotid arteries
1371938|NCT01284933|Carotid Artery Plaque|carotid artery plaque
1371939|NCT01284933|Atherosclerosis|atherosclerosis
1371940|NCT01284920|MDV3100|mdv3100
1371941|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
1371942|NCT01284920|docetaxel|docetaxel
1371943|NCT01284920|PSA level|psa level
1371944|NCT01284907|Asthma|asthma
1371945|NCT01284907|Asthma therapy|asthma therapy
1371946|NCT01284907|Randomized controlled trial|randomized controlled trial
1371947|NCT01284907|children|children
1371948|NCT01284894|Dysphagia|dysphagia
1371949|NCT01284894|Conventional manometry|conventional manometry
1371950|NCT01284894|High resolution manometry|high resolution manometry
1371951|NCT01284881|MRA|mra
1371952|NCT01284881|compliance|compliance
1371953|NCT01284881|OSAHS|osahs
1371954|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
1371955|NCT01284868|Pharmacodynamics|pharmacodynamics
1371956|NCT01284868|Pharmacokinetics|pharmacokinetics
1371957|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
1371958|NCT01284842|sleep-deprivation|sleep-deprivation
1371959|NCT01284842|virtual reality|virtual reality
1371960|NCT01284842|residency|residency
1371961|NCT01284842|performance|performance
1371962|NCT01284816|severely obese patients|severely obese patients
1371963|NCT01284803|patients|patients
1371964|NCT01284803|moderate depression|moderate depression
1371965|NCT01284777|cancerology|cancerology
1371966|NCT01284777|genetic|genetic
1371967|NCT01284764|Endoscopy|endoscopy
1371968|NCT01284764|Gastrectomy|gastrectomy
1371969|NCT01284764|Stomach neoplasms|stomach neoplasms
1371970|NCT01284738|TM|tm
1371971|NCT01284738|TI|ti
1371972|NCT01284738|MP|mp
1371973|NCT01284712|treatment by bleedings|treatment by bleedings
1371974|NCT01284699|Parkinson|parkinson
1371975|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
1371976|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
1371977|NCT01284686|Pathophysiology|pathophysiology
1371978|NCT01284686|Parkinson|parkinson
1371979|NCT01284686|neuronal oscillations|neuronal oscillations
1371980|NCT01284673|Cord blood stem|cord blood stem
1371981|NCT01284673|neonatal asphyxia|neonatal asphyxia
1371982|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
1371983|NCT01284647|Teprenone|teprenone
1371984|NCT01284647|Sucralfate|sucralfate
1371985|NCT01284634|Cannabidiol|cannabidiol
1371986|NCT01284634|Fatty liver|fatty liver
1371987|NCT01284634|Diabetes|diabetes
1371988|NCT01284634|Body fat|body fat
1371989|NCT01284608|Observational|observational
1371990|NCT01284608|prospective|prospective
1371991|NCT01284608|metabolic changes|metabolic changes
1371992|NCT01284608|metabolic syndrome|metabolic syndrome
1371993|NCT01284608|diabetes|diabetes
1372676|NCT01281241|MTWA|mtwa
1371994|NCT01284608|prostatic cancer|prostatic cancer
1371995|NCT01284608|risk fracture|risk fracture
1371996|NCT01284595|Radioactive carbon|radioactive carbon
1371997|NCT01284595|Absorption|absorption
1371998|NCT01284595|Distribution|distribution
1371999|NCT01284595|Metabolism|metabolism
1372000|NCT01284595|Excretion|excretion
1372001|NCT01284595|Healthy Volunteers|healthy volunteers
1372002|NCT01284582|CETP|cetp
1372003|NCT01284582|Vaccine|vaccine
1372004|NCT01284582|Cholesterol|cholesterol
1372005|NCT01284582|Inhibition|inhibition
1372006|NCT01284556|partial onset seizures|partial onset seizures
1372007|NCT01284530|Epilepsy|epilepsy
1372008|NCT01284530|Pediatrics|pediatrics
1372009|NCT01284530|Young Adults|young adults
1372010|NCT01284517|Bipolar I Depression|bipolar i depression
1372011|NCT01284517|Lurasidone|lurasidone
1372012|NCT01284517|Latuda|latuda
1372013|NCT01284491|Breast reduction|breast reduction
1372014|NCT01284491|PlasmaBlade|plasmablade
1372015|NCT01284491|Electrosurgery|electrosurgery
1372016|NCT01284491|PEAK Surgical|peak surgical
1372017|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
1372018|NCT01284491|Medtronic|medtronic
1372019|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
1372020|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
1372021|NCT01284465|Minority women|minority women
1372022|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
1372023|NCT01284452|Septic shock|septic shock
1372024|NCT01284452|Severe sepsis|severe sepsis
1372025|NCT01284452|Acute lung injury|acute lung injury
1372026|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
1372027|NCT01284452|ARDS|ards
1372028|NCT01284426|Chronic urticaria|chronic urticaria
1372029|NCT01284426|Natural course|natural course
1372030|NCT01284426|Remission|remission
1372031|NCT01284400|heart failure|heart failure
1372032|NCT01284400|disease management|disease management
1372033|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
1372034|NCT01284387|immunization|immunization
1372035|NCT01284387|amyloid imaging|amyloid imaging
1372036|NCT01284387|injection|injection
1372037|NCT01284387|vaccine|vaccine
1372038|NCT01284374|HPV Vaccines|hpv vaccines
1372039|NCT01284374|Attitude to Health|attitude to health
1372040|NCT01284374|Decision Making|decision making
1372041|NCT01284374|Qualitative Research|qualitative research
1372042|NCT01284361|intermittent catheter|intermittent catheter
1372043|NCT01284361|preference|preference
1372044|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
1372045|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
1372046|NCT01284335|Advanced solid tumors|advanced solid tumors
1372047|NCT01284335|Unresectable|unresectable
1372048|NCT01284335|Metastatic|metastatic
1372049|NCT01284335|Limited treatment options|limited treatment options
1372050|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
1372051|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
1372052|NCT01284309|YM178|ym178
1372053|NCT01284283|Arthrosis|arthrosis
1372054|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
1372055|NCT01284283|Arthritic Joint|arthritic joint
1372056|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
1372057|NCT01284283|Osteoarthritis|osteoarthritis
1372058|NCT01284283|Total Ankle Replacement|total ankle replacement
1372059|NCT01284270|Cardiac MRI|cardiac mri
1372060|NCT01284270|Plaque|plaque
1372061|NCT01284257|EC-MPS|ec-mps
1372062|NCT01284257|MMF|mmf
1372063|NCT01284257|kidney transplant|kidney transplant
1372064|NCT01284257|outcomes|outcomes
1372065|NCT01284257|mycophenolate sodium|mycophenolate sodium
1372066|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
1372067|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
1372068|NCT01284244|pessary|pessary
1372069|NCT01284244|conservative management|conservative management
1372070|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
1372071|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
1372072|NCT01284205|superficial bladder cancer|superficial bladder cancer
1372073|NCT01284192|B-cell Lymphoma|b-cell lymphoma
1372074|NCT01284192|Advanced Malignancies|advanced malignancies
1372075|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
1372076|NCT01284192|ASP3026|asp3026
1372077|NCT01284192|Solid Tumor|solid tumor
1372078|NCT01284179|Functional Chest Pain|functional chest pain
1372079|NCT01284179|Functional GI Disorders|functional gi disorders
1372080|NCT01284179|Home Hypnotherapy|home hypnotherapy
1372081|NCT01284153|respiratory gating|respiratory gating
1372082|NCT01284153|prone radiotherapy|prone radiotherapy
1372083|NCT01284153|breast cancer|breast cancer
1372084|NCT01284140|Critical illness|critical illness
1372085|NCT01284140|Sleep|sleep
1372086|NCT01284140|Polysomnography|polysomnography
1372087|NCT01284140|Respiratory failure|respiratory failure
1372088|NCT01284140|Circadian rhythm|circadian rhythm
1372089|NCT01284140|Sedation|sedation
1372090|NCT01284127|superficial siderosis|superficial siderosis
1372091|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
1372092|NCT01284114|Hypertension|hypertension
1372093|NCT01284114|Aliskiren|aliskiren
1372094|NCT01284088|Male Circumcision|male circumcision
1372095|NCT01284088|HIV Prevention|hiv prevention
1372096|NCT01284088|Medical Device|medical device
1372097|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
1372098|NCT01284062|Phase 2A|phase 2a
1372099|NCT01284062|Double-blind|double-blind
1372100|NCT01284062|Randomized|randomized
1372101|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
1372102|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
1372103|NCT01284049|Intralipid 20%®|intralipid 20%®
1372104|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
1372105|NCT01284049|Liver diseases|liver diseases
1372106|NCT01284036|Healthy subject|healthy subject
1372108|NCT01284036|PK study|pk study
1372109|NCT01284036|healthy volunteers|healthy volunteers
1372110|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
1372111|NCT01284023|acute compartment syndrome|acute compartment syndrome
1372112|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1372113|NCT01283997|Multiple Myeloma|multiple myeloma
1372114|NCT01283997|Neuropathy|neuropathy
1372115|NCT01283997|Peripheral Nerve Function|peripheral nerve function
1372116|NCT01283997|Touch Detection Threshold|touch detection threshold
1372117|NCT01283997|Nerve Damage|nerve damage
1372118|NCT01283997|Thalidomide|thalidomide
1372119|NCT01283997|Bortezomib|bortezomib
1372121|NCT01283997|Minocycline|minocycline
1372122|NCT01283997|Dynacin|dynacin
1372123|NCT01283997|Minocin|minocin
1372124|NCT01283997|Minocin PAC|minocin pac
1372125|NCT01283997|Myrac|myrac
1372126|NCT01283997|Solodyn|solodyn
1372127|NCT01283984|Safety|safety
1372128|NCT01283984|tolerability|tolerability
1372129|NCT01283984|healthy|healthy
1372130|NCT01283984|inhaled|inhaled
1372131|NCT01283984|respiratory disease|respiratory disease
1372132|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
1372133|NCT01283945|VEGFRs|vegfrs
1372134|NCT01283945|FGFR1|fgfr1
1372135|NCT01283945|angiogenesis|angiogenesis
1372136|NCT01283906|Mucositis|mucositis
1372137|NCT01283906|Head and Neck Cancer|head and neck cancer
1372138|NCT01283906|Squamous Cell Cancer|squamous cell cancer
1372139|NCT01283906|Chemotherapy|chemotherapy
1372140|NCT01283906|Radiation Therapy|radiation therapy
1372141|NCT01283906|Oral Rinse|oral rinse
1372142|NCT01283880|kidney|kidney
1372143|NCT01283880|transplantation|transplantation
1372144|NCT01283880|metabolic acidosis|metabolic acidosis
1372145|NCT01283880|renal tubular acidosis|renal tubular acidosis
1372146|NCT01283880|nephrocalcinosis|nephrocalcinosis
1372147|NCT01283815|Laparoscopy|laparoscopy
1372148|NCT01283815|Drainage|drainage
1372149|NCT01283815|Appendectomy|appendectomy
1372150|NCT01283789|breast|breast
1372151|NCT01283789|cancer|cancer
1372152|NCT01283789|metastatic|metastatic
1372153|NCT01283789|metastasis|metastasis
1372154|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
1372155|NCT01283750|care coordination|care coordination
1372156|NCT01283750|dementia care|dementia care
1372157|NCT01283750|intervention|intervention
1372158|NCT01283750|unmet needs|unmet needs
1372159|NCT01283750|community|community
1372160|NCT01283750|older adults|older adults
1372161|NCT01283750|caregiver|caregiver
1372162|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
1372163|NCT01283737|OCD|ocd
1372164|NCT01283737|Mosaicplasty|mosaicplasty
1372165|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
1372166|NCT01283737|DBX|dbx
1372167|NCT01283737|DBX Putty|dbx putty
1372168|NCT01283724|Endometriosis|endometriosis
1372169|NCT01283724|DEXA|dexa
1372170|NCT01283724|Adolescent|adolescent
1372171|NCT01283724|Safety|safety
1372172|NCT01283724|Efficacy|efficacy
1372173|NCT01283724|Post-menarche|post-menarche
1372174|NCT01283711|wrinkles reduction|wrinkles reduction
1372175|NCT01283711|rhytides reduction|rhytides reduction
1372176|NCT01283711|RF treatment|rf treatment
1372177|NCT01283698|psoriasis|psoriasis
1372178|NCT01283698|topical|topical
1372179|NCT01283698|PPT|ppt
1372180|NCT01283685|Exercise, Physical|exercise, physical
1372181|NCT01283672|Whole grains|whole grains
1372182|NCT01283672|Barley|barley
1372183|NCT01283672|Oats|oats
1372184|NCT01283672|Cardiovascular disease|cardiovascular disease
1372185|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
1372186|NCT01283672|Endothelial function|endothelial function
1372187|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
1372188|NCT01283659|computed tomographic angiography|computed tomographic angiography
1372189|NCT01283659|coronary angiogram|coronary angiogram
1372190|NCT01283659|cost effectiveness|cost effectiveness
1372191|NCT01283659|QoL|qol
1372192|NCT01283659|Heart failure|heart failure
1372193|NCT01283659|diagnostic accuracy|diagnostic accuracy
1372194|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
1372195|NCT01283633|neuromodulation|neuromodulation
1372196|NCT01283633|remote presence robotics|remote presence robotics
1372197|NCT01283620|stroke|stroke
1372198|NCT01283620|extremity, upper|extremity, upper
1372199|NCT01283607|in vitro fertilization|in vitro fertilization
1372200|NCT01283607|e-health|e-health
1372201|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
1372202|NCT01283607|psychosocial risk profile|psychosocial risk profile
1372203|NCT01283607|emotional maladjustment|emotional maladjustment
1372204|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
1372205|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
1372206|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
1372207|NCT01283542|pasireotide LAR,|pasireotide lar,
1372208|NCT01283542|tumor volume|tumor volume
1372209|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
1372210|NCT01283529|Cardiac output|cardiac output
1372211|NCT01283529|Children|children
1372212|NCT01283516|ALK inhibitor,|alk inhibitor,
1372213|NCT01283516|NSCLC,|nsclc,
1372214|NCT01283516|LDK378,|ldk378,
1372215|NCT01283516|ceritinib,|ceritinib,
1372216|NCT01283516|genetic abnormalities|genetic abnormalities
1372217|NCT01283503|PI3K,|pi3k,
1372218|NCT01283503|Advanced solid tumor|advanced solid tumor
1372219|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
1372220|NCT01283477|Caesarean Delivery|caesarean delivery
1372221|NCT01283477|Pruritis|pruritis
1372222|NCT01283477|Intrathecal Morphine|intrathecal morphine
1372223|NCT01283477|Acupuncture At LI11|acupuncture at li11
1372224|NCT01283464|Retinol|retinol
1372225|NCT01283464|Tretinoin|tretinoin
1372226|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
1372227|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
1372228|NCT01283425|insulin Lispro|insulin lispro
1372229|NCT01283425|Insulin Aspart|insulin aspart
1372230|NCT01283425|Quick-set infusion set|quick-set infusion set
1372231|NCT01283412|Delirium|delirium
1372232|NCT01283412|Dexmedetomidine|dexmedetomidine
1372233|NCT01283412|Adult Patients|adult patients
1372234|NCT01283412|Elective Major Surgery|elective major surgery
1372235|NCT01283412|General Anesthesia|general anesthesia
1372236|NCT01283360|MSM|msm
1372237|NCT01283360|HIV negative|hiv negative
1372238|NCT01283360|microbicide|microbicide
1372239|NCT01283360|prevention|prevention
1372240|NCT01283347|Parkinson's disease|parkinson's disease
1372241|NCT01283334|Head and Neck Cancer|head and neck cancer
1372242|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
1372243|NCT01283321|Hemostasis|hemostasis
1372244|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
1372245|NCT01283321|Fibrinogen|fibrinogen
1372246|NCT01283321|platelet|platelet
1372247|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1372248|NCT01283308|India|india
1372249|NCT01283308|Prevention & Control|prevention & control
1372250|NCT01283308|Lifestyle Intervention|lifestyle intervention
1372251|NCT01283308|Translational Research|translational research
1372252|NCT01283269|Rehabilitation|rehabilitation
1372253|NCT01283269|Cognitive Intervention|cognitive intervention
1372254|NCT01283269|Prevention|prevention
1372255|NCT01283243|ARFI Imaging|arfi imaging
1372256|NCT01283243|Normal values|normal values
1372257|NCT01283243|HIV infection|hiv infection
1372258|NCT01283230|ARFI imaging|arfi imaging
1372259|NCT01283230|normal values|normal values
1372260|NCT01283230|chronic liver disease|chronic liver disease
1372261|NCT01283230|liver donors|liver donors
1372262|NCT01283230|kidney donors|kidney donors
1372263|NCT01283191|substance use|substance use
1372264|NCT01283191|drug use|drug use
1372265|NCT01283191|drug abuse|drug abuse
1372266|NCT01283191|exercise|exercise
1372267|NCT01283191|physical activity|physical activity
1372268|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
1372269|NCT01283165|health education|health education
1372270|NCT01283165|Polyparasitism|polyparasitism
1372271|NCT01283165|school based deworming program|school based deworming program
1372272|NCT01283165|integrated control of parasites|integrated control of parasites
1372273|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
1372274|NCT01283152|HE|he
1372275|NCT01283152|Cirrhosis|cirrhosis
1372276|NCT01283152|PSE|pse
1372277|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
1372278|NCT01283152|Hepatic coma|hepatic coma
1372279|NCT01283152|AMS|ams
1372280|NCT01283152|Altered mental status|altered mental status
1372281|NCT01283152|Complications of cirrhosis|complications of cirrhosis
1372282|NCT01283152|Chronic liver disease|chronic liver disease
1372283|NCT01283139|SLE|sle
1372284|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
1372285|NCT01283139|Sifalimumab|sifalimumab
1372286|NCT01283139|MEDI-545|medi-545
1372287|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
1372288|NCT01283113|Visceral Fat|visceral fat
1372289|NCT01283113|Waist Circumference|waist circumference
1372290|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
1372291|NCT01283113|Metabolic Syndrome|metabolic syndrome
1372292|NCT01283113|Obesity|obesity
1372293|NCT01283113|Type 2 Diabetes|type 2 diabetes
1372294|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
1372295|NCT01283087|TNS|tns
1372296|NCT01283087|Spinal anesthesia|spinal anesthesia
1372297|NCT01283087|Lidocaine|lidocaine
1372298|NCT01283048|Kidney Cancer|kidney cancer
1372299|NCT01283048|Avastin|avastin
1372300|NCT01283022|Pharmacokinetics|pharmacokinetics
1372301|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
1372302|NCT01283022|Induction of labor|induction of labor
1372303|NCT01283022|Cervical Ripening|cervical ripening
1372304|NCT01283022|Rate of Cesarean section|rate of cesarean section
1372305|NCT01283009|pneumoniae|pneumoniae
1372306|NCT01282996|Mechanical ventilation|mechanical ventilation
1372307|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
1372308|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
1372309|NCT01282996|Protective lung ventilation|protective lung ventilation
1372310|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
1372311|NCT01282996|General anesthesia|general anesthesia
1372312|NCT01282996|Abdominal surgery|abdominal surgery
1372313|NCT01282983|fiber|fiber
1372314|NCT01282983|orange juice|orange juice
1372315|NCT01282983|digestive symptom|digestive symptom
1372316|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
1372317|NCT01282931|Women|women
1372318|NCT01282931|Stage IV|stage iv
1372319|NCT01282931|Metastatic|metastatic
1372320|NCT01282931|Breast Cancer|breast cancer
1372321|NCT01282931|Progressed|progressed
1372322|NCT01282931|Progression|progression
1372323|NCT01282918|ICD|icd
1372324|NCT01282918|DF Test|df test
1372325|NCT01282918|intra-operative DF testing|intra-operative df testing
1372326|NCT01282918|VT|vt
1372327|NCT01282892|Visceral fat|visceral fat
1372328|NCT01282892|fatty liver|fatty liver
1372329|NCT01282892|atherosclerosis|atherosclerosis
1372330|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
1372331|NCT01282879|Itraconazole oral solution|itraconazole oral solution
1372332|NCT01282879|invasive fungal infections|invasive fungal infections
1372333|NCT01282879|prophylaxis|prophylaxis
1372334|NCT01282879|Graft vs Host Disease|graft vs host disease
1372335|NCT01282879|transplantation|transplantation
1372336|NCT01282853|peptic ulcer|peptic ulcer
1372337|NCT01282853|hemorrhage|hemorrhage
1372338|NCT01282853|rapid urease test|rapid urease test
1372339|NCT01282853|urea breath test|urea breath test
1372340|NCT01282840|LUTS|luts
1372341|NCT01282814|Bioequivalence|bioequivalence
1372342|NCT01282814|Healthy Subjects|healthy subjects
1372343|NCT01282801|Bioequivalence|bioequivalence
1372344|NCT01282801|Healthy Subjects|healthy subjects
1372345|NCT01282788|infant nutrition|infant nutrition
1372346|NCT01282788|complementary feeding|complementary feeding
1372347|NCT01282788|malnutrition|malnutrition
1372348|NCT01282788|stunting of growth|stunting of growth
1372349|NCT01282775|overweight|overweight
1372350|NCT01282775|obesity|obesity
1372351|NCT01282775|worksite|worksite
1372352|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
1372353|NCT01282762|End Stage Renal Disease|end stage renal disease
1372354|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
1372355|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
1372356|NCT01282749|Overweight|overweight
1372357|NCT01282749|Obesity|obesity
1372358|NCT01282749|African American|african american
1372359|NCT01282749|Women|women
1372360|NCT01282749|Translational|translational
1372361|NCT01282749|Faith based|faith based
1372362|NCT01282749|Community based participatory research|community based participatory research
1372363|NCT01282736|eating disorder|eating disorder
1372364|NCT01282736|binge eating|binge eating
1372365|NCT01282684|Safety|safety
1372366|NCT01282684|Tolerability|tolerability
1372367|NCT01282684|Pharmacokinetics|pharmacokinetics
1372368|NCT01282684|PLX5622|plx5622
1372369|NCT01282671|breathing exercises|breathing exercises
1372370|NCT01282671|cardiac surgery|cardiac surgery
1372371|NCT01282671|lung function|lung function
1372372|NCT01282671|postoperative complication|postoperative complication
1372373|NCT01282671|positive expiratory pressure|positive expiratory pressure
1372374|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
1372375|NCT01282645|Cranial defect|cranial defect
1372376|NCT01282645|PSI|psi
1372377|NCT01282645|patient specific implant|patient specific implant
1372378|NCT01282645|PEEK|peek
1372379|NCT01282645|polyether ether ketone|polyether ether ketone
1372380|NCT01282645|craniectomy|craniectomy
1372381|NCT01282645|craniotomy|craniotomy
1372382|NCT01282632|depression|depression
1372383|NCT01282632|treatment resistant depression|treatment resistant depression
1372384|NCT01282632|unipolar|unipolar
1372385|NCT01282632|non- psychotic major depression|non- psychotic major depression
1372386|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
1372387|NCT01282632|risperidone|risperidone
1372388|NCT01282632|olanzapine|olanzapine
1372389|NCT01282632|double blind comparison|double blind comparison
1372390|NCT01282632|randomized|randomized
1372391|NCT01282606|Chemonucleolysis|chemonucleolysis
1372392|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
1372393|NCT01282606|Hernia|hernia
1372394|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
1372395|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
1372396|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
1372397|NCT01282502|rectal cancer|rectal cancer
1372398|NCT01282502|chemotherapy|chemotherapy
1372399|NCT01282502|chemoradiation|chemoradiation
1372400|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
1372401|NCT01282476|Panobinostat|panobinostat
1372402|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
1372403|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
1372404|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
1372405|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
1372406|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
1372407|NCT01282476|lymphoma|lymphoma
1372408|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
1372409|NCT01282450|Radiotherapy|radiotherapy
1372410|NCT01282450|NSCLC|nsclc
1372411|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
1372412|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1372413|NCT01282424|iNHL|inhl
1372414|NCT01282424|NHL|nhl
1372415|NCT01282424|GS-1101|gs-1101
1372416|NCT01282424|CAL-101|cal-101
1372417|NCT01282424|PI3K|pi3k
1372418|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1372419|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
1372420|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
1372421|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
1372422|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
1372423|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
1372424|NCT01282372|Sleep|sleep
1372425|NCT01282372|Psoriatic arthritis|psoriatic arthritis
1372426|NCT01282372|Work Productivity|work productivity
1372427|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
1372428|NCT01282359|Educational asthma program|educational asthma program
1372429|NCT01282359|Clusters analysis study|clusters analysis study
1372430|NCT01282359|Asthma Control Test|asthma control test
1372431|NCT01282346|Glaucoma shunt|glaucoma shunt
1372432|NCT01282346|Ocular implant|ocular implant
1372433|NCT01282346|Gold|gold
1372434|NCT01282346|Trabeculectomy|trabeculectomy
1372435|NCT01282320|Randomized Controlled Trial|randomized controlled trial
1372436|NCT01282320|Clinical Tria|clinical tria
1372437|NCT01282320|Postmenopause|postmenopause
1372438|NCT01282320|Hot-flashes|hot-flashes
1372439|NCT01282320|Quality of life|quality of life
1372440|NCT01282320|Physical Fitness|physical fitness
1372441|NCT01282307|Guided Self-Determination|guided self-determination
1372442|NCT01282307|Improving insight|improving insight
1372443|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
1372444|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
1372445|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
1372446|NCT01282281|Bipolar Disorder|bipolar disorder
1372447|NCT01282281|Youth|youth
1372448|NCT01282281|Adults|adults
1372449|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
1372450|NCT01282268|fragile X syndrome|fragile x syndrome
1372451|NCT01282268|autism spectrum disorder|autism spectrum disorder
1372452|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
1372453|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
1372454|NCT01282203|General surgery|general surgery
1372455|NCT01282203|General anesthesia|general anesthesia
1372456|NCT01282203|Inhalation anesthesia|inhalation anesthesia
1372457|NCT01282203|Sevorane|sevorane
1372458|NCT01282203|Sevoflurane|sevoflurane
1372459|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
1372460|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
1372461|NCT01282164|glucagon stimulation test|glucagon stimulation test
1372462|NCT01282164|insulin tolerance test|insulin tolerance test
1372463|NCT01282164|growth hormone deficiency|growth hormone deficiency
1372464|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
1372465|NCT01282151|NSCLC|nsclc
1372466|NCT01282151|Non Squamous cell|non squamous cell
1372467|NCT01282151|Docetaxel|docetaxel
1372468|NCT01282151|Pemetrexed|pemetrexed
1372469|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
1372470|NCT01282125|general population|general population
1372471|NCT01282125|prevalence|prevalence
1372472|NCT01282125|Norway|norway
1372473|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
1372474|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
1372475|NCT01282086|Sevorane|sevorane
1372476|NCT01282086|Sevoflurane|sevoflurane
1372477|NCT01282086|General anesthesia|general anesthesia
1372478|NCT01282086|Inhalation anesthesia|inhalation anesthesia
1372479|NCT01282086|General surgery|general surgery
1372581|NCT01281605|Type 2 diabetes|type 2 diabetes
1372480|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
1372481|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
1372482|NCT01282073|Proteinuria|proteinuria
1372483|NCT01282073|Renal function|renal function
1372484|NCT01282060|HBA1C|hba1c
1372485|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
1372486|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
1372487|NCT01282047|Lenalidomide|lenalidomide
1372488|NCT01282047|Kaposi|kaposi
1372489|NCT01282047|HIV|hiv
1372490|NCT01282047|efficacy|efficacy
1372491|NCT01282047|safety|safety
1372492|NCT01282034|CHONDRAL|chondral
1372493|NCT01282034|OSTEOCHONDRAL|osteochondral
1372494|NCT01282021|RBC Antigens|rbc antigens
1372495|NCT01282021|Molecular Typing|molecular typing
1372496|NCT01282021|Ethiopian Sub-Populations|ethiopian sub-populations
1372497|NCT01282021|Immunohematology|immunohematology
1372498|NCT01282021|Immune Response|immune response
1372499|NCT01282008|Online Surveys|online surveys
1372500|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
1372501|NCT01282008|Message Testing|message testing
1372502|NCT01282008|Focus Groups|focus groups
1372503|NCT01281995|Biologic Samples|biologic samples
1372504|NCT01281995|Hydrocortisone|hydrocortisone
1372505|NCT01281995|Laboratory Research Specimens|laboratory research specimens
1372506|NCT01281995|Glucocorticoids|glucocorticoids
1372507|NCT01281995|Immune Modulation|immune modulation
1372508|NCT01281995|Healthy Volunteer|healthy volunteer
1372509|NCT01281995|HV|hv
1372510|NCT01281982|Imaging|imaging
1372511|NCT01281982|Gliomas|gliomas
1372512|NCT01281982|Pet Scan|pet scan
1372513|NCT01281982|Blood Brain Barrier|blood brain barrier
1372514|NCT01281982|P-Glycoprotein|p-glycoprotein
1372515|NCT01281982|Brain Tumor|brain tumor
1372516|NCT01281982|Glioma|glioma
1372517|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
1372518|NCT01281982|Astrocytoma|astrocytoma
1372519|NCT01281969|Placebo Controlled|placebo controlled
1372520|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1372521|NCT01281969|Children and Adolescents|children and adolescents
1372522|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
1372523|NCT01281969|PANDAS|pandas
1372524|NCT01281956|Epilepsy|epilepsy
1372525|NCT01281956|Drug Trial|drug trial
1372526|NCT01281956|Serotonin|serotonin
1372527|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
1372528|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
1372529|NCT01281956|Partial Epilepsy|partial epilepsy
1372530|NCT01281930|Superficial abscess|superficial abscess
1372531|NCT01281930|packing material|packing material
1372532|NCT01281930|wick|wick
1372533|NCT01281930|incision and drainage|incision and drainage
1372534|NCT01281917|velcade|velcade
1372535|NCT01281917|temsirolimus|temsirolimus
1372536|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
1372537|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
1372538|NCT01281891|Pain: Postoperative|pain: postoperative
1372539|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
1372540|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
1372541|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
1372542|NCT01281839|Hepatitis C|hepatitis c
1372543|NCT01281839|TMC435|tmc435
1372544|NCT01281839|HCV|hcv
1372545|NCT01281839|Hep C|hep c
1372546|NCT01281839|Genotype 1|genotype 1
1372547|NCT01281813|TMC114IFD3001|tmc114ifd3001
1372548|NCT01281813|TMC114|tmc114
1372549|NCT01281813|HIV|hiv
1372550|NCT01281813|Darunavir|darunavir
1372551|NCT01281813|PREZISTA|prezista
1372552|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
1372553|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
1372554|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
1372555|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
1372556|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
1372557|NCT01281735|treatment outcome|treatment outcome
1372558|NCT01281735|side effects|side effects
1372559|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
1372560|NCT01281735|pediatrics|pediatrics
1372561|NCT01281722|healthy adults|healthy adults
1372562|NCT01281722|melanoma|melanoma
1372563|NCT01281696|Breast cancer|breast cancer
1372564|NCT01281696|CNS metastasis|cns metastasis
1372565|NCT01281696|Brain metastasis|brain metastasis
1372566|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
1372567|NCT01281696|Bevacizumab|bevacizumab
1372568|NCT01281696|Etoposide|etoposide
1372569|NCT01281696|Cisplatin|cisplatin
1372570|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
1372571|NCT01281657|Fingolimod|fingolimod
1372572|NCT01281657|FTY720|fty720
1372573|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
1372574|NCT01281657|Multiple sclerosis|multiple sclerosis
1372575|NCT01281657|MS|ms
1372576|NCT01281657|Safety|safety
1372577|NCT01281657|Efficacy|efficacy
1372578|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
1372579|NCT01281631|ALS|als
1372580|NCT01281618|Barrett's esophagus|barrett's esophagus
1372582|NCT01281605|Basal insulin|basal insulin
1372583|NCT01281605|Insulin detemir|insulin detemir
1372584|NCT01281605|Insulin titration algorithm|insulin titration algorithm
1372585|NCT01281579|Pharmacokinetics|pharmacokinetics
1372586|NCT01281579|Pharmacodynamics|pharmacodynamics
1372587|NCT01281579|Canagliflozin|canagliflozin
1372588|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
1372589|NCT01281566|Feeding intolerance|feeding intolerance
1372590|NCT01281566|Enteral feeding|enteral feeding
1372591|NCT01281566|Nasogastric tube|nasogastric tube
1372592|NCT01281566|Neonate|neonate
1372593|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
1372594|NCT01281553|Placebo|placebo
1372595|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1372596|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
1372597|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
1372598|NCT01281540|Placebo|placebo
1372599|NCT01281540|Idiopathic|idiopathic
1372600|NCT01281540|Stomach Diseases|stomach diseases
1372601|NCT01281540|Stomach|stomach
1372602|NCT01281527|Paliperidone palmitate|paliperidone palmitate
1372603|NCT01281527|Schizophrenia|schizophrenia
1372604|NCT01281527|Intramuscular injection|intramuscular injection
1372605|NCT01281501|Dyspepsia|dyspepsia
1372606|NCT01281501|Emergency treatment|emergency treatment
1372607|NCT01281501|Pantoprazole|pantoprazole
1372608|NCT01281501|Antacid|antacid
1372609|NCT01281501|Pain measurement|pain measurement
1372610|NCT01281475|Angelman syndrome|angelman syndrome
1372611|NCT01281475|Levodopa|levodopa
1372612|NCT01281475|Carbidopa|carbidopa
1372613|NCT01281475|L-dopa|l-dopa
1372614|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
1372615|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
1372616|NCT01281436|childhood|childhood
1372617|NCT01281436|overweight|overweight
1372618|NCT01281436|obesity|obesity
1372619|NCT01281436|Health information technology|health information technology
1372620|NCT01281436|HeartSmartKids|heartsmartkids
1372621|NCT01281436|Motivational Interviewing|motivational interviewing
1372622|NCT01281410|respiratory muscles|respiratory muscles
1372623|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
1372624|NCT01281410|inspiratory muscle training|inspiratory muscle training
1372625|NCT01281397|cardiac surgery|cardiac surgery
1372626|NCT01281397|aggregometry|aggregometry
1372627|NCT01281397|thromboelastometry|thromboelastometry
1372628|NCT01281397|platelet function|platelet function
1372629|NCT01281397|bleeding|bleeding
1372630|NCT01281397|antiplatelet therapy|antiplatelet therapy
1372631|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1372632|NCT01281384|echocardiography|echocardiography
1372633|NCT01281384|heart failure|heart failure
1372634|NCT01281384|imaging|imaging
1372635|NCT01281384|cost effectiveness|cost effectiveness
1372636|NCT01281384|quality of life|quality of life
1372637|NCT01281384|definitive diagnosis|definitive diagnosis
1372638|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
1372639|NCT01281358|Premature infants|premature infants
1372640|NCT01281358|Motor Development|motor development
1372641|NCT01281345|icu|icu
1372642|NCT01281345|candida|candida
1372643|NCT01281345|epidemiology|epidemiology
1372644|NCT01281345|blood stream infection|blood stream infection
1372645|NCT01281345|candidemia|candidemia
1372646|NCT01281332|menopause|menopause
1372647|NCT01281332|hot flash|hot flash
1372648|NCT01281332|quality of life|quality of life
1372649|NCT01281319|preterm labor|preterm labor
1372650|NCT01281319|PROM|prom
1372651|NCT01281319|mycoplasma|mycoplasma
1372652|NCT01281319|ureaplasma|ureaplasma
1372653|NCT01281319|high risk pregnancy|high risk pregnancy
1372654|NCT01281306|hypertension|hypertension
1372655|NCT01281306|blood pressure|blood pressure
1372656|NCT01281306|LCZ696|lcz696
1372657|NCT01281306|dual-acting|dual-acting
1372658|NCT01281306|neprilysin|neprilysin
1372659|NCT01281306|nep inhibitor|nep inhibitor
1372660|NCT01281306|vasopeptidase|vasopeptidase
1372661|NCT01281306|angiotensin receptor|angiotensin receptor
1372662|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
1372663|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
1372664|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
1372665|NCT01281267|facial transplantation|facial transplantation
1372666|NCT01281267|face transplantation|face transplantation
1372667|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
1372668|NCT01281267|VCA|vca
1372669|NCT01281267|composite tissue allograft|composite tissue allograft
1372670|NCT01281267|facial allograft|facial allograft
1372671|NCT01281254|Fallopian tube cancer|fallopian tube cancer
1372672|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
1372673|NCT01281254|AMG386|amg386
1372674|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1372675|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
1372677|NCT01281241|mechanical alternans|mechanical alternans
1372678|NCT01281228|Exenatide|exenatide
1372679|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
1372680|NCT01281228|Incretin hormones|incretin hormones
1372681|NCT01281228|GLP-1 agonist|glp-1 agonist
1372683|NCT01281228|Reward|reward
1372684|NCT01281215|Pharmaceutical Education|pharmaceutical education
1372685|NCT01281215|Rational Drug Use|rational drug use
1372686|NCT01281215|Asthma|asthma
1372687|NCT01281202|Cocaine|cocaine
1372688|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
1372689|NCT01281202|Cocaine Treatment|cocaine treatment
1372690|NCT01281202|Vigabatrin|vigabatrin
1372691|NCT01281202|CPP-109|cpp-109
1372692|NCT01281202|Catalyst|catalyst
1372693|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
1372694|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1372695|NCT01281189|ALS|als
1372696|NCT01281189|Motor Neurone Disease|motor neurone disease
1372697|NCT01281137|stage IA breast cancer|stage ia breast cancer
1372698|NCT01281137|stage IB breast cancer|stage ib breast cancer
1372699|NCT01281137|stage II breast cancer|stage ii breast cancer
1372700|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
1372701|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
1372702|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
1372703|NCT01281098|Pegaptanib|pegaptanib
1372704|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
1372705|NCT01281085|Shoulder|shoulder
1372706|NCT01281085|Outcome treatment|outcome treatment
1372707|NCT01281085|Validation Studies|validation studies
1372708|NCT01281085|Biomechanics|biomechanics
1372709|NCT01281033|primary PCI|primary pci
1372710|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1372711|NCT01281033|thrombus aspiration|thrombus aspiration
1372712|NCT01281020|Glaucoma|glaucoma
1372713|NCT01281020|Adherence|adherence
1372714|NCT01281020|Fixed combination therapy|fixed combination therapy
1372715|NCT01281007|Herpes Simplex Virus|herpes simplex virus
1372716|NCT01280994|Lung Disease|lung disease
1372717|NCT01280994|Pulmonary Disease|pulmonary disease
1372718|NCT01280994|Diagnostic Imaging|diagnostic imaging
1372719|NCT01280994|MRI|mri
1372720|NCT01280981|Menorrhagia|menorrhagia
1372721|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
1372722|NCT01280981|Lysteda|lysteda
1372723|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
1372724|NCT01280942|clinical deterioration|clinical deterioration
1372725|NCT01280942|detection algorithms|detection algorithms
1372726|NCT01280942|automated warning systems|automated warning systems
1372727|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
1372728|NCT01280929|Ranibizumab|ranibizumab
1372729|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
1372730|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
1372731|NCT01280903|Hypertension|hypertension
1372732|NCT01280903|Exercise|exercise
1372733|NCT01280903|Physical activity|physical activity
1372734|NCT01280903|Self Efficacy|self efficacy
1372735|NCT01280903|Patient Compliance|patient compliance
1372736|NCT01280903|Aged|aged
1372737|NCT01280890|Dementia|dementia
1372738|NCT01280890|Nursing home|nursing home
1372739|NCT01280890|Person-centred Care|person-centred care
1372740|NCT01280890|Staff training|staff training
1372741|NCT01280877|optic neuropathy|optic neuropathy
1372742|NCT01280877|visual field|visual field
1372743|NCT01280877|electric stimulation|electric stimulation
1372744|NCT01280877|alternating current|alternating current
1372745|NCT01280877|perimetry|perimetry
1372746|NCT01280851|Living renal donor|living renal donor
1372747|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
1372748|NCT01280851|Renal vascular anatomy|renal vascular anatomy
1372749|NCT01280851|Renal function|renal function
1372750|NCT01280812|mobile phone|mobile phone
1372751|NCT01280812|physical activity|physical activity
1372752|NCT01280812|women|women
1372753|NCT01280812|maintenance|maintenance
1372754|NCT01280812|health promotion|health promotion
1372755|NCT01280812|prevention|prevention
1372756|NCT01280799|Anorexia Nervosa|anorexia nervosa
1372757|NCT01280799|Adolescents|adolescents
1372758|NCT01280799|Family Treatment|family treatment
1372759|NCT01280799|Eating Disorder|eating disorder
1372760|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
1372761|NCT01280786|AML|aml
1372762|NCT01280786|leukemia|leukemia
1372763|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
1372764|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
1372765|NCT01280747|Prior authorization|prior authorization
1372766|NCT01280747|Fibromyalgia|fibromyalgia
1372767|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
1372768|NCT01280747|Policy|policy
1372769|NCT01280747|Real World Data|real world data
1372770|NCT01280734|melatonin|melatonin
1372771|NCT01280734|circadin|circadin
1372772|NCT01280734|zolpidem|zolpidem
1372773|NCT01280734|body sway|body sway
1373053|NCT01279369|Trauma|trauma
1372774|NCT01280734|postural instability|postural instability
1372776|NCT01280708|Nephrology|nephrology
1373158|NCT01278901|13C-UBT|13c-ubt
1372777|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
1372778|NCT01280708|Data base|data base
1372779|NCT01280708|Epidemiology|epidemiology
1372780|NCT01280695|Type 2|type 2
1372781|NCT01280695|Diabetes Mellitus|diabetes mellitus
1372782|NCT01280695|Diabetes|diabetes
1372783|NCT01280695|High blood sugar|high blood sugar
1372784|NCT01280695|Blood sugar|blood sugar
1372785|NCT01280695|Blood glucose|blood glucose
1372786|NCT01280695|Glucose|glucose
1372787|NCT01280682|type 1 diabetes|type 1 diabetes
1372788|NCT01280682|age|age
1372789|NCT01280682|course of disease|course of disease
1372790|NCT01280682|autoantibodies|autoantibodies
1372791|NCT01280682|C-peptide levels|c-peptide levels
1372792|NCT01280669|Non-infectious|non-infectious
1372793|NCT01280669|Uveitis|uveitis
1372794|NCT01280669|Panuveitis|panuveitis
1372795|NCT01280643|stage IVA colon cancer|stage iva colon cancer
1372796|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
1372797|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
1372798|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
1372799|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
1372800|NCT01280617|Renal Transplant|renal transplant
1372801|NCT01280617|Thymoglubulin|thymoglubulin
1372802|NCT01280591|Naproxen sodium|naproxen sodium
1372803|NCT01280591|Diphenhydramine|diphenhydramine
1372804|NCT01280578|Migraine|migraine
1372805|NCT01280565|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit
1372806|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
1372807|NCT01280539|Multiple Sclerosis|multiple sclerosis
1372808|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1372809|NCT01280539|Cortical Excitability|cortical excitability
1372810|NCT01280487|ZSTK474|zstk474
1372811|NCT01280487|PI3K inhibitor|pi3k inhibitor
1372812|NCT01280474|depression during pregnancy|depression during pregnancy
1372813|NCT01280474|postpartum depression|postpartum depression
1372814|NCT01280474|pregnancy outcomes|pregnancy outcomes
1372815|NCT01280474|newborn development|newborn development
1372816|NCT01280474|paternal psychopathology|paternal psychopathology
1372817|NCT01280461|Pneumonia|pneumonia
1372818|NCT01280448|Lung Cancer|lung cancer
1372819|NCT01280448|Tobacco Smoking|tobacco smoking
1372820|NCT01280448|gene polymorphism|gene polymorphism
1372821|NCT01280435|Online Discourse|online discourse
1372822|NCT01280435|e-Learning|e-learning
1372823|NCT01280435|Biopsy|biopsy
1372824|NCT01280435|Virtual Pathologic Section|virtual pathologic section
1372825|NCT01280422|ROCDR|rocdr
1372826|NCT01280396|metabolic|metabolic
1372827|NCT01280396|SGAs|sgas
1372828|NCT01280396|clozapine|clozapine
1372829|NCT01280383|non-invasive ventilation|non-invasive ventilation
1372830|NCT01280383|diaphragm|diaphragm
1372831|NCT01280383|electrical activity|electrical activity
1372832|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1372833|NCT01280383|critically ill patients|critically ill patients
1372834|NCT01280370|Incisional hernia repair|incisional hernia repair
1372835|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
1372836|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
1372837|NCT01280357|Labor & Delivery|labor & delivery
1372838|NCT01280331|Bunionectomy|bunionectomy
1372839|NCT01280305|schizophrenia|schizophrenia
1372840|NCT01280305|schizoaffective disorder|schizoaffective disorder
1372841|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
1372842|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
1372843|NCT01280266|Pathological Conditions|pathological conditions
1372844|NCT01280266|Signs and Symptoms|signs and symptoms
1372845|NCT01280266|Blood circulation|blood circulation
1372846|NCT01280253|Predictor|predictor
1372847|NCT01280253|outcome|outcome
1372848|NCT01280253|biochemical|biochemical
1372849|NCT01280240|anemia|anemia
1372850|NCT01280240|cancer|cancer
1372851|NCT01280240|CIA|cia
1372852|NCT01280227|Symptom management|symptom management
1372853|NCT01280227|Symptom assessment|symptom assessment
1372854|NCT01280227|Patient satisfaction|patient satisfaction
1372855|NCT01280227|Patient-provider communication|patient-provider communication
1372856|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
1372857|NCT01280201|Pazopanib|pazopanib
1372858|NCT01280201|GETNE|getne
1372859|NCT01280201|Biomarkers|biomarkers
1372860|NCT01280188|Diabetes|diabetes
1372861|NCT01280175|BDP|bdp
1372862|NCT01280175|Formoterol|formoterol
1372863|NCT01280175|pMDI|pmdi
1372864|NCT01280175|Aerochamber Plus|aerochamber plus
1372865|NCT01280175|Charcoal|charcoal
1372866|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
1372867|NCT01280149|substance P|substance p
1372868|NCT01280149|allergic rhinitis|allergic rhinitis
1372869|NCT01280149|allergen immunotherapy|allergen immunotherapy
1372870|NCT01280136|HIV|hiv
1372871|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
1372872|NCT01280136|Pregnancy Prevention|pregnancy prevention
1372873|NCT01280136|Abstinence Education|abstinence education
1372874|NCT01280136|Adolescents|adolescents
1372875|NCT01280136|Sexual Health|sexual health
1372876|NCT01280123|Parkinson's Disease|parkinson's disease
1372877|NCT01280123|Biomarkers|biomarkers
1372878|NCT01280110|dry eye|dry eye
1372879|NCT01280110|pseudophakia|pseudophakia
1372880|NCT01280110|cornea|cornea
1372881|NCT01280110|lubricating drop|lubricating drop
1372883|NCT01280110|blood aqueous barrier|blood aqueous barrier
1372884|NCT01280110|blood-retina barrier|blood-retina barrier
1372885|NCT01280097|Intensive care unit delirium|intensive care unit delirium
1372886|NCT01280097|Sleep disruption|sleep disruption
1372887|NCT01280097|Sleep hygiene|sleep hygiene
1372888|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
1372889|NCT01280097|Sedative agents and sleep|sedative agents and sleep
1372890|NCT01280097|Circadian rhythm|circadian rhythm
1372891|NCT01280097|Cognitive disorder|cognitive disorder
1372892|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
1372893|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
1372894|NCT01280097|Immune function|immune function
1372895|NCT01280097|REM sleep|rem sleep
1372896|NCT01280084|neonate activity|neonate activity
1372897|NCT01280084|labour analgesia|labour analgesia
1372898|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
1372899|NCT01280032|kyphoplasty|kyphoplasty
1372900|NCT01280032|spinal metastases|spinal metastases
1372901|NCT01280019|functional residual capacity|functional residual capacity
1372902|NCT01280019|electrical impedance tomography|electrical impedance tomography
1372903|NCT01280019|inflammatory parameters|inflammatory parameters
1372904|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
1372905|NCT01280006|Hypoxia|hypoxia
1372906|NCT01280006|Sleep|sleep
1372907|NCT01280006|Blood Pressure|blood pressure
1372908|NCT01280006|Hypertension|hypertension
1372909|NCT01280006|Myocardial Infarction|myocardial infarction
1372910|NCT01280006|Stroke|stroke
1372911|NCT01280006|Ventilation|ventilation
1372912|NCT01280006|Brain|brain
1372913|NCT01280006|Cerebral Blood Flow|cerebral blood flow
1372914|NCT01280006|Renal Blood Flow|renal blood flow
1372915|NCT01279980|ERAS|eras
1372916|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
1372917|NCT01279980|Painbuster|painbuster
1372918|NCT01279980|Epidural|epidural
1372919|NCT01279980|colorectal surgery|colorectal surgery
1372920|NCT01279980|enhanced recovery program|enhanced recovery program
1372921|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
1372922|NCT01279967|ADI-PEG 20|adi-peg 20
1372923|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
1372924|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
1372925|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
1372926|NCT01279928|retinal vessel calibre|retinal vessel calibre
1372927|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
1372928|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
1372929|NCT01279915|ASP0456|asp0456
1372930|NCT01279915|Pharmacokinetics|pharmacokinetics
1372931|NCT01279915|safety|safety
1372932|NCT01279915|tolerability|tolerability
1372933|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1372934|NCT01279902|rituximab|rituximab
1372935|NCT01279902|CHOP|chop
1372936|NCT01279902|abbreviated therapy|abbreviated therapy
1372937|NCT01279889|hypotension|hypotension
1372938|NCT01279889|cesarean delivery|cesarean delivery
1372939|NCT01279889|cardiac output|cardiac output
1372940|NCT01279889|blood pressure|blood pressure
1372941|NCT01279889|plethysmography variability index|plethysmography variability index
1372942|NCT01279863|Pneumonia|pneumonia
1372943|NCT01279863|Cough|cough
1372944|NCT01279863|Shortness of breath|shortness of breath
1372945|NCT01279863|VRI|vri
1372946|NCT01279850|Lyrica|lyrica
1372947|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1372948|NCT01279850|Safety|safety
1372949|NCT01279850|Neuropathic Pain|neuropathic pain
1372950|NCT01279850|Post Marketing Surveillance|post marketing surveillance
1372951|NCT01279837|swallowing disorders|swallowing disorders
1372952|NCT01279837|swallowing therapy|swallowing therapy
1372953|NCT01279837|head neck cancer|head neck cancer
1372954|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
1372955|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
1372956|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
1372957|NCT01279798|Lung Cancer|lung cancer
1372958|NCT01279798|NSCLC|nsclc
1372959|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
1372960|NCT01279785|Molecular Imaging|molecular imaging
1372961|NCT01279785|PSMA|psma
1372962|NCT01279785|adenocarcinoma|adenocarcinoma
1372963|NCT01279785|prostatectomy|prostatectomy
1372964|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
1372965|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
1372966|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
1372967|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
1372968|NCT01279733|microarray|microarray
1372969|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
1372970|NCT01279720|Gene therapy|gene therapy
1372971|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
1372972|NCT01279681|neurotoxicity|neurotoxicity
1372973|NCT01279681|cognitive/functional effects|cognitive/functional effects
1372974|NCT01279681|stage IVA colon cancer|stage iva colon cancer
1372975|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
1372976|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
1372977|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
1372978|NCT01279681|recurrent colon cancer|recurrent colon cancer
1372979|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
1372980|NCT01279668|Montelukast|montelukast
1372981|NCT01279668|Persistent cough|persistent cough
1372982|NCT01279668|Adults|adults
1372983|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
1372984|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
1372985|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
1372986|NCT01279642|Nursing|nursing
1372987|NCT01279642|Pediatric|pediatric
1372988|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
1372989|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
1372990|NCT01279616|sickle cell|sickle cell
1372991|NCT01279616|stem cell transplant|stem cell transplant
1372992|NCT01279603|Cancer|cancer
1372993|NCT01279590|Hyperlipidemia|hyperlipidemia
1372994|NCT01279590|Dyslipidemia|dyslipidemia
1372995|NCT01279590|Metabolic diseases|metabolic diseases
1372996|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
1372997|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
1372998|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
1372999|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
1373000|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
1373001|NCT01279590|Frederickson Type IIa|frederickson type iia
1373002|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
1373003|NCT01279577|Crohn´s disease|crohn´s disease
1373004|NCT01279577|Trichuris suis|trichuris suis
1373005|NCT01279577|randomized|randomized
1373006|NCT01279577|placebo|placebo
1373007|NCT01279577|induction of remission|induction of remission
1373008|NCT01279577|porcine whipworm|porcine whipworm
1373009|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
1373010|NCT01279538|Kidney Transplantation|kidney transplantation
1373011|NCT01279538|Pharmacokinetics|pharmacokinetics
1373012|NCT01279538|Pharmacology|pharmacology
1373013|NCT01279538|ASKP1240|askp1240
1373014|NCT01279525|Falls|falls
1373015|NCT01279525|Prevention|prevention
1373016|NCT01279525|Elderly|elderly
1373017|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
1373018|NCT01279499|Morbid obesity|morbid obesity
1373019|NCT01279499|Sevoflurane|sevoflurane
1373020|NCT01279499|Propofol|propofol
1373021|NCT01279499|Remifentanyl|remifentanyl
1373023|NCT01279499|Cardiovascular stability|cardiovascular stability
1373024|NCT01279499|Recovery scores|recovery scores
1373025|NCT01279499|Drug consumption|drug consumption
1373026|NCT01279486|Pregnancy,|pregnancy,
1373027|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1373028|NCT01279473|CML|cml
1373029|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1373153|NCT01278927|stress management|stress management
1373030|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
1373031|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
1373032|NCT01279460|chronic kidney disease|chronic kidney disease
1373033|NCT01279460|CKD|ckd
1373034|NCT01279460|pulse wave velocity|pulse wave velocity
1373035|NCT01279460|PWV|pwv
1373036|NCT01279447|infrapatellar nerve|infrapatellar nerve
1373037|NCT01279447|saphenous nerve|saphenous nerve
1373038|NCT01279447|knee arthroscopy|knee arthroscopy
1373039|NCT01279447|nerve block|nerve block
1373040|NCT01279408|Palliative treatment|palliative treatment
1373041|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1373042|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
1373043|NCT01279395|atherosclerosis|atherosclerosis
1373044|NCT01279395|cholesterol|cholesterol
1373045|NCT01279395|cyclooxygenase|cyclooxygenase
1373046|NCT01279395|gene expression|gene expression
1373047|NCT01279395|lipid metabolism|lipid metabolism
1373048|NCT01279382|Symptoms|symptoms
1373049|NCT01279382|Psychological status|psychological status
1373050|NCT01279382|Hypnotherapy|hypnotherapy
1373051|NCT01279382|Relaxation training|relaxation training
1373052|NCT01279369|Pregnancy|pregnancy
1373054|NCT01279369|Placental Abruption|placental abruption
1373055|NCT01279369|Fetal fibronectin|fetal fibronectin
1373056|NCT01279356|Liver diseases|liver diseases
1373057|NCT01279356|Volatile organic compounds|volatile organic compounds
1373058|NCT01279356|Inflammation|inflammation
1373059|NCT01279356|Oxidative stress|oxidative stress
1373060|NCT01279356|non-invasive tests|non-invasive tests
1373061|NCT01279343|labor induction|labor induction
1373062|NCT01279343|foley bulb|foley bulb
1373063|NCT01279343|misoprostol|misoprostol
1373064|NCT01279330|Colorectal Cancer|colorectal cancer
1373065|NCT01279330|Screening|screening
1373066|NCT01279330|General Practitioner|general practitioner
1373067|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
1373068|NCT01279304|breast cancer|breast cancer
1373069|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
1373070|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
1373071|NCT01279304|radiotherapy|radiotherapy
1373072|NCT01279304|risk model|risk model
1373073|NCT01279304|overall survival|overall survival
1373074|NCT01279304|relapse free survival|relapse free survival
1373075|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
1373076|NCT01279291|advanced solid tumor|advanced solid tumor
1373077|NCT01279291|Ovarian cancer|ovarian cancer
1373078|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
1373079|NCT01279291|Fallopian tube cancer|fallopian tube cancer
1373080|NCT01279278|Colorectal Cancer|colorectal cancer
1373081|NCT01279278|Screening|screening
1373082|NCT01279278|General Practitioner|general practitioner
1373083|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
1373084|NCT01279265|Lactobacillus|lactobacillus
1373085|NCT01279265|Probiotic|probiotic
1373086|NCT01279265|Crying time|crying time
1373087|NCT01279265|Fecal microbiota|fecal microbiota
1373088|NCT01279265|Calprotectin|calprotectin
1373089|NCT01279265|Colic|colic
1373090|NCT01279265|Infant Crying|infant crying
1373091|NCT01279265|Barr Diary|barr diary
1373092|NCT01279265|Breath Hydrogen|breath hydrogen
1373093|NCT01279265|Clinical Design|clinical design
1373094|NCT01279239|Poly Trauma|poly trauma
1373095|NCT01279239|Metabonomics|metabonomics
1373096|NCT01279239|NMR|nmr
1373097|NCT01279239|MOF|mof
1373098|NCT01279200|letrozole|letrozole
1373099|NCT01279200|ovulation monitoring|ovulation monitoring
1373100|NCT01279200|pregnancy rate|pregnancy rate
1373101|NCT01279187|dental|dental
1373102|NCT01279187|implant|implant
1373103|NCT01279174|Hip, arthrosis|hip, arthrosis
1373104|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
1373105|NCT01279148|biopsy guidance|biopsy guidance
1373106|NCT01279148|tracking device|tracking device
1373107|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
1373108|NCT01279109|gestational weight gain|gestational weight gain
1373109|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1373110|NCT01279096|relapse|relapse
1373111|NCT01279096|childhood|childhood
1373112|NCT01279096|clofarabine|clofarabine
1373113|NCT01279070|Schizophrenia|schizophrenia
1373114|NCT01279070|Cognitive remediation|cognitive remediation
1373115|NCT01279070|Group training|group training
1373116|NCT01279070|Executive function|executive function
1373117|NCT01279070|Social functioning|social functioning
1373118|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
1373119|NCT01279044|HIV|hiv
1373120|NCT01279044|MSM|msm
1373121|NCT01279044|SUMSM|sumsm
1373122|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
1373123|NCT01279018|breast cancer|breast cancer
1373124|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
1373125|NCT01279018|neuropathic pain|neuropathic pain
1373126|NCT01279005|MSM|msm
1373127|NCT01279005|focus group|focus group
1373128|NCT01279005|HIV|hiv
1373129|NCT01279005|risk-taking|risk-taking
1373130|NCT01279005|risk-denial|risk-denial
1373131|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
1373132|NCT01278992|fatigue|fatigue
1373133|NCT01278992|adaptogen|adaptogen
1373134|NCT01278992|Rhodiola rosea|rhodiola rosea
1373135|NCT01278979|obstetric|obstetric
1373136|NCT01278979|perineal tear|perineal tear
1373137|NCT01278979|perineal injury|perineal injury
1373138|NCT01278979|diagnosis|diagnosis
1373139|NCT01278966|Epilepsy|epilepsy
1373140|NCT01278966|Diet|diet
1373141|NCT01278966|the Modified Atkins Diet|the modified atkins diet
1373142|NCT01278966|Ketogenic diet|ketogenic diet
1373143|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1373144|NCT01278953|atrial fibrillation|atrial fibrillation
1373145|NCT01278953|radiofrequency ablation|radiofrequency ablation
1373146|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
1373147|NCT01278953|ablation catheter|ablation catheter
1373149|NCT01278953|contact force sensing|contact force sensing
1373150|NCT01278953|contact force|contact force
1373151|NCT01278953|contact force assisted ablation|contact force assisted ablation
1373152|NCT01278927|exercise|exercise
1373154|NCT01278927|post transplant|post transplant
1373155|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
1373156|NCT01278901|helicobacter pylori|helicobacter pylori
1373157|NCT01278901|urease test|urease test
1373159|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
1373160|NCT01278888|Lung cancer|lung cancer
1373161|NCT01278888|Pain|pain
1373162|NCT01278888|Quality of life|quality of life
1373163|NCT01278888|Economy|economy
1373164|NCT01278875|High density lipoproteins|high density lipoproteins
1373165|NCT01278875|Acute coronary syndromes|acute coronary syndromes
1373166|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
1373167|NCT01278875|HDL: proteomics|hdl: proteomics
1373168|NCT01278875|Nitric Acid production|nitric acid production
1373169|NCT01278862|Crowns|crowns
1373170|NCT01278862|posterior teeth|posterior teeth
1373171|NCT01278862|CAD CAM crowns|cad cam crowns
1373172|NCT01278862|digital veneer system|digital veneer system
1373173|NCT01278862|Lava|lava
1373174|NCT01278862|clinical|clinical
1373175|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
1373176|NCT01278849|refractory,|refractory,
1373177|NCT01278849|core phase,|core phase,
1373178|NCT01278849|extension phase,|extension phase,
1373179|NCT01278849|dose escalation,|dose escalation,
1373180|NCT01278849|standard chemotherapy,|standard chemotherapy,
1373181|NCT01278849|pharmacokinetics,|pharmacokinetics,
1373182|NCT01278849|doctaxel,|doctaxel,
1373183|NCT01278849|paclitaxel,|paclitaxel,
1373184|NCT01278849|carboplatin,|carboplatin,
1373185|NCT01278849|safety,|safety,
1373186|NCT01278849|tolerability,|tolerability,
1373187|NCT01278849|hepatic impairment|hepatic impairment
1373188|NCT01278836|Flap|flap
1373189|NCT01278836|leg defect|leg defect
1373190|NCT01278836|reconstruction|reconstruction
1373191|NCT01278836|tissue|tissue
1373192|NCT01278823|obesity|obesity
1373193|NCT01278823|type 2 diabetes|type 2 diabetes
1373194|NCT01278810|Icaritin,|icaritin,
1373195|NCT01278810|ERa36|era36
1373196|NCT01278784|Dry eye syndromes|dry eye syndromes
1373197|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
1373198|NCT01278771|CHD|chd
1373199|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
1373200|NCT01278758|refractory,|refractory,
1373201|NCT01278758|core phase,|core phase,
1373202|NCT01278758|extension phase,|extension phase,
1373203|NCT01278758|dose escalation,|dose escalation,
1373204|NCT01278758|standard chemotherapy,|standard chemotherapy,
1373205|NCT01278758|doctaxel,|doctaxel,
1373206|NCT01278758|paclitaxel,|paclitaxel,
1373207|NCT01278758|carboplatin,|carboplatin,
1373208|NCT01278758|safety,|safety,
1373209|NCT01278758|tolerability|tolerability
1373210|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
1373211|NCT01278745|prevention|prevention
1373212|NCT01278745|cardiac transplantation|cardiac transplantation
1373213|NCT01278745|rituximab|rituximab
1373214|NCT01278732|arterial hypertension|arterial hypertension
1373215|NCT01278719|Antrochoanal polyp|antrochoanal polyp
1373216|NCT01278719|Ethmoidal polyp|ethmoidal polyp
1373217|NCT01278719|Recurrence|recurrence
1373218|NCT01278719|Risk factors|risk factors
1373219|NCT01278719|Environmental factors|environmental factors
1373220|NCT01278719|Gene expression|gene expression
1373221|NCT01278719|Micro array|micro array
1373222|NCT01278719|Mutation|mutation
1373223|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
1373224|NCT01278680|Behavioral economics|behavioral economics
1373225|NCT01278680|Incentives|incentives
1373226|NCT01278680|Health|health
1373227|NCT01278667|ADHD|adhd
1373228|NCT01278667|Memory|memory
1373229|NCT01278667|Social|social
1373230|NCT01278667|Emotion|emotion
1373231|NCT01278667|Methylphenidate|methylphenidate
1373232|NCT01278641|Fibromyalgia|fibromyalgia
1373233|NCT01278641|Widespread pain|widespread pain
1373234|NCT01278641|Fatigue|fatigue
1373235|NCT01278641|Physical exercise|physical exercise
1373236|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1373237|NCT01278602|Chemotherapy|chemotherapy
1373238|NCT01278602|R-ESHAP|r-eshap
1373239|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
1373240|NCT01278576|Muscle spasticity|muscle spasticity
1373241|NCT01278576|Stroke|stroke
1373242|NCT01278576|Botulinum Toxins|botulinum toxins
1373243|NCT01278576|Lower extremity|lower extremity
1373244|NCT01278576|Ankle|ankle
1373245|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
1373246|NCT01278537|elderly|elderly
1373247|NCT01278537|cancer surgery|cancer surgery
1373248|NCT01278537|quality of life|quality of life
1373249|NCT01278537|empowerment|empowerment
1373250|NCT01278537|shared-decision|shared-decision
1373251|NCT01278524|Delirium|delirium
1373252|NCT01278524|Analgosedation|analgosedation
1373254|NCT01278524|Pain|pain
1373255|NCT01278524|Implementation|implementation
1373447|NCT01277809|Aging|aging
1373256|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
1373257|NCT01278511|Prehospital Emergency Care|prehospital emergency care
1373258|NCT01278511|Cervical Spine Injuries|cervical spine injuries
1373259|NCT01278511|Cervical Spine Fractures|cervical spine fractures
1373260|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
1373261|NCT01278498|Escitalopram|escitalopram
1373262|NCT01278498|Depression|depression
1373263|NCT01278498|Stroke|stroke
1373264|NCT01278485|Diabetes complications|diabetes complications
1373265|NCT01278472|cholecystectomy|cholecystectomy
1373266|NCT01278472|laparoscopic|laparoscopic
1373267|NCT01278472|single-port|single-port
1373268|NCT01278472|gallstones|gallstones
1373269|NCT01278459|endothelial function|endothelial function
1373270|NCT01278459|cardiovascular|cardiovascular
1373271|NCT01278446|Cow's Milk Allergy|cow's milk allergy
1373272|NCT01278446|CMA|cma
1373273|NCT01278433|Polio|polio
1373274|NCT01278433|Poliovirus|poliovirus
1373275|NCT01278433|IMOVAX Polio™|imovax polio™
1373276|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
1373277|NCT01278407|DLB|dlb
1373278|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
1373279|NCT01278407|Lewy Body Disease|lewy body disease
1373280|NCT01278407|Dementia|dementia
1373281|NCT01278407|E2020|e2020
1373282|NCT01278407|Donepezil|donepezil
1373283|NCT01278407|Aricept|aricept
1373284|NCT01278394|Onychomycosis|onychomycosis
1373285|NCT01278394|Fungal Nail|fungal nail
1373286|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
1373287|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
1373288|NCT01278355|pain|pain
1373289|NCT01278355|acupuncture|acupuncture
1373290|NCT01278342|Sandostatin LAR|sandostatin lar
1373291|NCT01278342|High Dose|high dose
1373292|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
1373293|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
1373294|NCT01278342|acromegalic patients|acromegalic patients
1373295|NCT01278342|octreotide acetate|octreotide acetate
1373296|NCT01278342|Somavert|somavert
1373297|NCT01278342|Dostinex|dostinex
1373298|NCT01278342|pegvisomant|pegvisomant
1373299|NCT01278342|cabergoline|cabergoline
1373300|NCT01278342|not adequately controlled|not adequately controlled
1373301|NCT01278342|active acromegaly|active acromegaly
1373302|NCT01278329|Music|music
1373303|NCT01278329|Foetal learning|foetal learning
1373304|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
1373305|NCT01278316|PTSD|ptsd
1373306|NCT01278316|TBI|tbi
1373307|NCT01278316|Cognition|cognition
1373308|NCT01278316|Cognitive Training|cognitive training
1373309|NCT01278303|Coarctation|coarctation
1373310|NCT01278303|Aorta|aorta
1373311|NCT01278290|Triptorelin acetate|triptorelin acetate
1373312|NCT01278290|precocious puberty|precocious puberty
1373313|NCT01278290|premature thelarche|premature thelarche
1373314|NCT01278290|GnRH analog|gnrh analog
1373315|NCT01278290|Diagnostic validation study|diagnostic validation study
1373316|NCT01278277|Stargardt disease|stargardt disease
1373317|NCT01278277|macula|macula
1373318|NCT01278277|electroretinogram|electroretinogram
1373319|NCT01278277|saffron|saffron
1373320|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
1373321|NCT01278264|Ultrasound guided|ultrasound guided
1373322|NCT01278264|Abdominoplasty|abdominoplasty
1373323|NCT01278238|Hypotension|hypotension
1373324|NCT01278238|Caesarean section|caesarean section
1373325|NCT01278238|Spinal anaesthesia|spinal anaesthesia
1373326|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
1373327|NCT01278238|Phenylephrine|phenylephrine
1373328|NCT01278225|Neurofeedback|neurofeedback
1373329|NCT01278225|Neural Function|neural function
1373330|NCT01278225|Neuromodulation|neuromodulation
1373331|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
1373332|NCT01278225|Electroencephalogram|electroencephalogram
1373333|NCT01278225|EEG|eeg
1373334|NCT01278225|Biofeedback|biofeedback
1373335|NCT01278225|BF|bf
1373336|NCT01278225|Quality of Life|quality of life
1373337|NCT01278225|QOL|qol
1373338|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
1373339|NCT01278225|PQAS|pqas
1373340|NCT01278225|Brief Symptom Inventory|brief symptom inventory
1373341|NCT01278225|BSI|bsi
1373342|NCT01278225|Sleep Disturbances|sleep disturbances
1373343|NCT01278225|Fatigue|fatigue
1373344|NCT01278225|Questionnaires|questionnaires
1373345|NCT01278212|breast cancer|breast cancer
1373346|NCT01278212|breast neoplasm|breast neoplasm
1373347|NCT01278212|breast tumor|breast tumor
1373348|NCT01278212|radiotherapy|radiotherapy
1373349|NCT01278212|radiation|radiation
1373350|NCT01278212|accelerated|accelerated
1373351|NCT01278212|lumpectomy|lumpectomy
1373352|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
1373353|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
1373354|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
1373446|NCT01277809|Long term care|long term care
1373355|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
1373356|NCT01278186|Coronary stenosis|coronary stenosis
1373357|NCT01278186|Bifurcation|bifurcation
1373358|NCT01278186|Drug-eluting balloon|drug-eluting balloon
1373359|NCT01278186|Drug-eluting stent|drug-eluting stent
1374266|NCT01274533|ATLL|atll
1373360|NCT01278186|Angiographic follow-up|angiographic follow-up
1373361|NCT01278186|Late Lumen Loss|late lumen loss
1373362|NCT01278186|Restenosis|restenosis
1373363|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
1373364|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
1373365|NCT01278173|CPS|cps
1373366|NCT01278173|Epilepsy|epilepsy
1373367|NCT01278173|Seizures|seizures
1373368|NCT01278173|Brain diseases|brain diseases
1373369|NCT01278173|Central Nervous System Diseases|central nervous system diseases
1373370|NCT01278173|Nervous System Diseases|nervous system diseases
1373371|NCT01278173|Neurologic Manifestations|neurologic manifestations
1373372|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
1373373|NCT01278173|GABA Agents|gaba agents
1373374|NCT01278147|cancer|cancer
1373375|NCT01278147|fatigue program education|fatigue program education
1373376|NCT01278121|Obesity|obesity
1373377|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1373378|NCT01278121|Cardiovascular diseases|cardiovascular diseases
1373379|NCT01278108|Safety|safety
1373380|NCT01278108|Tolerability|tolerability
1373381|NCT01278108|Pharmacokinetics|pharmacokinetics
1373382|NCT01278095|Safety|safety
1373383|NCT01278095|Tolerability|tolerability
1373384|NCT01278095|Pharmacokinetics|pharmacokinetics
1373385|NCT01278082|Randomized|randomized
1373386|NCT01278082|double-blind|double-blind
1373387|NCT01278082|Placebo-controlled|placebo-controlled
1373388|NCT01278082|budesonide|budesonide
1373389|NCT01278082|collagenous colitis|collagenous colitis
1373390|NCT01278082|acute treatment|acute treatment
1373391|NCT01278082|maintaining remission|maintaining remission
1373392|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
1373393|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
1373394|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
1373395|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
1373396|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
1373397|NCT01278043|Antiplatelet|antiplatelet
1373398|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
1373399|NCT01278043|Coronary artery disease|coronary artery disease
1373400|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
1373401|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
1373402|NCT01278017|enterocolitis|enterocolitis
1373403|NCT01278017|ceftriaxone|ceftriaxone
1373529|NCT01277510|parathyroid hormone|parathyroid hormone
1373404|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
1373405|NCT01277991|Bioequivalence|bioequivalence
1373406|NCT01277991|healthy volunteer study|healthy volunteer study
1373407|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
1373408|NCT01277978|Caesarean section|caesarean section
1373409|NCT01277978|Cardiovascular effects|cardiovascular effects
1373410|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
1373411|NCT01277978|Carbetocin|carbetocin
1373412|NCT01277978|Oxytocin|oxytocin
1373413|NCT01277965|Algorithm basal insulin|algorithm basal insulin
1373414|NCT01277965|physical activity|physical activity
1373415|NCT01277965|Type 1 diabetes|type 1 diabetes
1373416|NCT01277965|Insulin pump treatment|insulin pump treatment
1373417|NCT01277952|Traumatic Brain Injury|traumatic brain injury
1373418|NCT01277952|DBS|dbs
1373419|NCT01277926|Breast Cancer|breast cancer
1373420|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
1373421|NCT01277913|diabetes|diabetes
1373422|NCT01277913|vitamin D|vitamin d
1373423|NCT01277913|bone density|bone density
1373424|NCT01277913|children|children
1373425|NCT01277887|Smoking|smoking
1373426|NCT01277887|Nicotine|nicotine
1373427|NCT01277887|Nicotine polacrilex|nicotine polacrilex
1373428|NCT01277887|Nicotine replacement|nicotine replacement
1373429|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
1373430|NCT01277848|PLAC1|plac1
1373431|NCT01277848|pregnant|pregnant
1373432|NCT01277848|first prenatal visit|first prenatal visit
1373433|NCT01277848|pre-eclampsia|pre-eclampsia
1373434|NCT01277835|video-assisted|video-assisted
1373435|NCT01277835|thoracic surgery|thoracic surgery
1373436|NCT01277835|VATS|vats
1373437|NCT01277835|lidocaine infusion|lidocaine infusion
1373438|NCT01277835|VATS procedures|vats procedures
1373439|NCT01277822|Hypertension|hypertension
1373440|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
1373441|NCT01277822|High blood pressure|high blood pressure
1373442|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
1373443|NCT01277822|Untreated high blood pressure|untreated high blood pressure
1373444|NCT01277822|Untreated hypertension|untreated hypertension
1373445|NCT01277822|Essential hypertension|essential hypertension
1373448|NCT01277809|Accidental Falls|accidental falls
1373449|NCT01277809|Muscle Weakness|muscle weakness
1373450|NCT01277809|Gait|gait
1373451|NCT01277809|Physical Fitness|physical fitness
1373452|NCT01277809|Muscle Strength|muscle strength
1373453|NCT01277809|Postural Balance|postural balance
1373454|NCT01277809|Activities of Daily Living|activities of daily living
1373455|NCT01277809|Body Weight|body weight
1373456|NCT01277809|Blood Pressure|blood pressure
1373457|NCT01277809|Depression|depression
1373458|NCT01277809|Behavior|behavior
1373459|NCT01277809|Dementia|dementia
1373460|NCT01277770|Thymoglobulin|thymoglobulin
1373461|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
1373462|NCT01277770|Steroid-Free|steroid-free
1373463|NCT01277770|Immunosuppression|immunosuppression
1373464|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
1373465|NCT01277744|DSRCT|dsrct
1373466|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
1373467|NCT01277744|HIPEC|hipec
1373468|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
1373469|NCT01277744|Extensive abdominal disease|extensive abdominal disease
1373470|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
1373471|NCT01277744|Abdominal cavity|abdominal cavity
1373472|NCT01277744|Cisplatin|cisplatin
1373473|NCT01277744|Platinol-AQ|platinol-aq
1373474|NCT01277744|Platinol|platinol
1373475|NCT01277744|CDDP|cddp
1373476|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
1373477|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
1373478|NCT01277744|Ovarian germ cell|ovarian germ cell
1373479|NCT01277744|Wilms' tumor|wilms' tumor
1373480|NCT01277705|Booster vaccination|booster vaccination
1373481|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
1373482|NCT01277679|lung water measures|lung water measures
1373483|NCT01277679|pulmonary edema|pulmonary edema
1373485|NCT01277679|heart failure|heart failure
1373486|NCT01277666|Crohn's disease|crohn's disease
1373487|NCT01277666|capsule|capsule
1373488|NCT01277666|GSK1605786A|gsk1605786a
1373489|NCT01277666|quality of life|quality of life
1373490|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
1373491|NCT01277666|oral therapy|oral therapy
1373492|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
1373493|NCT01277640|male tolerance|male tolerance
1373494|NCT01277640|HIV-1|hiv-1
1373495|NCT01277640|microbicide|microbicide
1373496|NCT01277640|dapivirine|dapivirine
1373497|NCT01277627|HCV|hcv
1373498|NCT01277627|HIV|hiv
1373499|NCT01277627|Nevirapine|nevirapine
1373500|NCT01277627|HCV viral load|hcv viral load
1373501|NCT01277627|Efavirenz|efavirenz
1373502|NCT01277627|Protease inhibitors|protease inhibitors
1373503|NCT01277614|lifestyle|lifestyle
1373504|NCT01277614|diet|diet
1373505|NCT01277614|exercise|exercise
1373506|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
1373507|NCT01277601|Hep B|hep b
1373508|NCT01277601|Non cirrhotic|non cirrhotic
1373509|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
1373510|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
1373511|NCT01277588|fetal scalp sampling|fetal scalp sampling
1373512|NCT01277588|experience questionnaire|experience questionnaire
1373513|NCT01277575|stroke|stroke
1373514|NCT01277575|aphasia|aphasia
1373515|NCT01277575|language|language
1373516|NCT01277562|Breast Cancer|breast cancer
1373517|NCT01277562|Prostate Cancer|prostate cancer
1373518|NCT01277562|Osteopenia|osteopenia
1373519|NCT01277562|Osteoporosis|osteoporosis
1373520|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
1373521|NCT01277549|Leukapheresis|leukapheresis
1373522|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
1373523|NCT01277510|dialysis|dialysis
1373524|NCT01277510|sensipar|sensipar
1373525|NCT01277510|mimpara|mimpara
1373526|NCT01277510|hemodialysis|hemodialysis
1373527|NCT01277510|peritoneal dialysis|peritoneal dialysis
1373528|NCT01277510|renal|renal
1373530|NCT01277510|pediatric|pediatric
1373531|NCT01277497|Chronic kidney disease|chronic kidney disease
1373532|NCT01277497|Phosphate binder|phosphate binder
1373533|NCT01277497|Sevelamer carbonate|sevelamer carbonate
1373534|NCT01277497|Calcium acetate|calcium acetate
1373535|NCT01277497|Vascular calcification|vascular calcification
1373536|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
1373537|NCT01277484|decitabine|decitabine
1373538|NCT01277484|dose|dose
1373539|NCT01277484|schedule|schedule
1373540|NCT01277484|safety|safety
1373541|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1373542|NCT01277471|meal frequency|meal frequency
1373543|NCT01277471|type two diabetes|type two diabetes
1373544|NCT01277458|HIV|hiv
1373545|NCT01277458|MSM|msm
1373546|NCT01277458|Ethnicity|ethnicity
1373547|NCT01277445|gut microbiome|gut microbiome
1373548|NCT01277445|prebiotics|prebiotics
1373549|NCT01277445|immunological status|immunological status
1373550|NCT01277445|fructans|fructans
1373551|NCT01277432|Diabetes|diabetes
1373552|NCT01277432|Depression|depression
1373553|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
1373554|NCT01277406|Resminostat|resminostat
1373556|NCT01277406|4SC-201|4sc-201
1373557|NCT01277406|Phase I|phase i
1373558|NCT01277406|Phase II|phase ii
1374723|NCT01272999|Prevnar 13|prevnar 13
1373559|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
1373560|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
1373561|NCT01277380|swine flu|swine flu
1373562|NCT01277380|Real Time RT-PCR|real time rt-pcr
1373563|NCT01277367|Obesity|obesity
1373564|NCT01277367|Sedentary|sedentary
1373565|NCT01277367|Physical activity|physical activity
1373566|NCT01277367|exercise|exercise
1373567|NCT01277367|incentives|incentives
1373568|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
1373569|NCT01277315|ALS|als
1373570|NCT01277315|Anakinra|anakinra
1373571|NCT01277315|Kineret|kineret
1373572|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
1373573|NCT01277315|PMA|pma
1373574|NCT01277315|Safety Trial|safety trial
1373575|NCT01277315|Tolerability Trial|tolerability trial
1373576|NCT01277289|dexamethasone|dexamethasone
1373577|NCT01277289|ery-dex|ery-dex
1373578|NCT01277289|Chron's disease|chron's disease
1373579|NCT01277289|CD|cd
1373580|NCT01277276|Medical tool|medical tool
1373581|NCT01277263|Breast Cancer|breast cancer
1373582|NCT01277250|Hospitalized adults|hospitalized adults
1373583|NCT01277250|Tobacco users|tobacco users
1373584|NCT01277250|Smokers|smokers
1373585|NCT01277250|Smoking cessation|smoking cessation
1373586|NCT01277250|Web-based|web-based
1373587|NCT01277250|Transition coach|transition coach
1373588|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
1373589|NCT01277224|physical activity|physical activity
1373590|NCT01277224|obesity|obesity
1373591|NCT01277224|adiposity|adiposity
1373592|NCT01277224|children|children
1373593|NCT01277224|blood lipids|blood lipids
1373594|NCT01277224|blood pressure|blood pressure
1373595|NCT01277224|randomized controlled trials|randomized controlled trials
1373596|NCT01277211|Contraception|contraception
1373597|NCT01277211|NuvaRing|nuvaring
1373598|NCT01277198|kidney calculi|kidney calculi
1373599|NCT01277198|ureteral calculi|ureteral calculi
1373600|NCT01277198|cystoscopes|cystoscopes
1373601|NCT01277198|laparoscopes|laparoscopes
1373602|NCT01277185|calcium|calcium
1373603|NCT01277185|healthy|healthy
1373604|NCT01277185|Mexican-American adolescents|mexican-american adolescents
1373605|NCT01277185|camp|camp
1373606|NCT01277185|girls|girls
1373607|NCT01277185|boys|boys
1373608|NCT01277185|bone|bone
1373609|NCT01277172|DLBCL|dlbcl
1373610|NCT01277172|pharmacokinetics|pharmacokinetics
1373611|NCT01277172|pharmacodynamics|pharmacodynamics
1373612|NCT01277172|Rituximab|rituximab
1373613|NCT01277172|LymphomaLymphoma|lymphomalymphoma
1373614|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
1373615|NCT01277172|B-CellLymphoma|b-celllymphoma
1373616|NCT01277172|Large B-Cell|large b-cell
1373617|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
1373618|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
1373619|NCT01277172|Antineoplastic Agents|antineoplastic agents
1373620|NCT01277172|Adverse Effects|adverse effects
1373621|NCT01277159|Analgesia|analgesia
1373622|NCT01277159|Duration|duration
1373623|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
1373624|NCT01277159|Dexamethasone|dexamethasone
1373625|NCT01277159|Buprenorphine|buprenorphine
1373626|NCT01277159|Additives|additives
1373627|NCT01277159|Ankle surgery|ankle surgery
1373628|NCT01277146|Phase 1|phase 1
1373629|NCT01277146|dose escalation|dose escalation
1373630|NCT01277146|histologically confirmed|histologically confirmed
1373631|NCT01277146|malignancy metastatic|malignancy metastatic
1373632|NCT01277107|PSG|psg
1373633|NCT01277107|LPS|lps
1373634|NCT01277107|TST|tst
1373635|NCT01277107|WASO|waso
1373636|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
1373637|NCT01277081|Paracetamol|paracetamol
1373638|NCT01277081|Common cold|common cold
1373639|NCT01277068|obese patients|obese patients
1373640|NCT01277068|TRL|trl
1373641|NCT01277068|the bariatric surgery|the bariatric surgery
1373642|NCT01277042|Safety|safety
1373643|NCT01277042|HPV vaccine|hpv vaccine
1373644|NCT01277042|Immune response|immune response
1373645|NCT01277042|Human papillomavirus|human papillomavirus
1373646|NCT01277042|China|china
1373647|NCT01277016|Amyloidosis|amyloidosis
1373648|NCT01277016|Bortezomib|bortezomib
1373649|NCT01276977|Migraine|migraine
1373650|NCT01276977|Acute Migraine|acute migraine
1373651|NCT01276977|Headache|headache
1373652|NCT01276964|menses|menses
1373653|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
1373654|NCT01276964|kinetic definition of menses|kinetic definition of menses
1373655|NCT01276951|Cocoa|cocoa
1373656|NCT01276951|Chocolate|chocolate
1373657|NCT01276951|Endothelial disfunction|endothelial disfunction
1373658|NCT01276951|Cardiovascular disease|cardiovascular disease
1373659|NCT01276951|Blood Pressure|blood pressure
1373660|NCT01276951|Hypertension|hypertension
1373661|NCT01276938|Breast cancer|breast cancer
1373662|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
1373663|NCT01276938|Toxicity|toxicity
1373664|NCT01276925|Hip arthroplasty|hip arthroplasty
1373665|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
1373666|NCT01276925|Postoperative|postoperative
1373667|NCT01276925|Pain|pain
1373668|NCT01276925|Ropivacaine|ropivacaine
1373669|NCT01276899|Breast Cancer|breast cancer
1373670|NCT01276899|Triple negative breast cancer|triple negative breast cancer
1373671|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
1373672|NCT01276899|Taxanes|taxanes
1373673|NCT01276899|Metastases|metastases
1373674|NCT01276899|Biomarkers|biomarkers
1373675|NCT01276899|Resistance|resistance
1373676|NCT01276899|Biobanking|biobanking
1373677|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
1373678|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
1373679|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
1373680|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1373681|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
1373682|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
1373683|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
1373684|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
1373685|NCT01276873|Artificial Respiration|artificial respiration
1373686|NCT01276873|Suction|suction
1373687|NCT01276873|Pain|pain
1373688|NCT01276873|Nursing|nursing
1373689|NCT01276873|Neonatology|neonatology
1373690|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
1373691|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
1373692|NCT01276860|OSA|osa
1373693|NCT01276860|PVT|pvt
1373694|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
1373695|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
1373696|NCT01276847|psoriasis|psoriasis
1373697|NCT01276847|Ustekinumab|ustekinumab
1373698|NCT01276847|Stelara|stelara
1373699|NCT01276847|Etanercept|etanercept
1373700|NCT01276847|Enbrel|enbrel
1373701|NCT01276821|Bronchiolitis|bronchiolitis
1373702|NCT01276821|L-Epinephrine|l-epinephrine
1373703|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
1373704|NCT01276821|Clinical Severity Score|clinical severity score
1373705|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
1373706|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
1373707|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1373708|NCT01276769|Platinum|platinum
1373709|NCT01276730|Advanced cervical cancer|advanced cervical cancer
1373710|NCT01276730|India|india
1373711|NCT01276691|Vascular function|vascular function
1373712|NCT01276691|Inflammation|inflammation
1373713|NCT01276691|Oxidative stress|oxidative stress
1373714|NCT01276691|Hemostatic balance|hemostatic balance
1373715|NCT01276691|Aspirin|aspirin
1373716|NCT01276691|Firefighting|firefighting
1373717|NCT01276678|CAD|cad
1373718|NCT01276665|Bladder cancer|bladder cancer
1373719|NCT01276665|urinary diversion|urinary diversion
1373720|NCT01276665|Postoperative Complications|postoperative complications
1373721|NCT01276665|Fluid Therapy|fluid therapy
1373722|NCT01276665|Norepinephrine|norepinephrine
1373723|NCT01276652|Polysomnography|polysomnography
1373724|NCT01276652|Circadian rhythmicity|circadian rhythmicity
1373725|NCT01276639|Xeljanz|xeljanz
1373726|NCT01276639|tofacitinib|tofacitinib
1373727|NCT01276639|chronic|chronic
1373728|NCT01276639|Pruritus|pruritus
1373729|NCT01276639|Itch|itch
1373730|NCT01276639|DLQI|dlqi
1373731|NCT01276639|severe|severe
1373732|NCT01276639|moderate|moderate
1373733|NCT01276639|treatment|treatment
1373734|NCT01276639|safety|safety
1373735|NCT01276639|efficacy|efficacy
1373736|NCT01276639|CP-690,550|cp-690,550
1373737|NCT01276639|Plaque Psoriasis|plaque psoriasis
1373738|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
1373739|NCT01276639|Jax-inhibitor|jax-inhibitor
1373740|NCT01276639|Oral Treatment|oral treatment
1373741|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
1373742|NCT01276613|Gemcitabine|gemcitabine
1373755|NCT01276561|trial|trial
1373756|NCT01276522|Schnitzler syndrome|schnitzler syndrome
1373757|NCT01276522|IL-1 beta|il-1 beta
1373758|NCT01276522|Canakinumab|canakinumab
1373759|NCT01276522|Ilaris|ilaris
1373760|NCT01276522|Treatment|treatment
1373761|NCT01276522|Efficacy|efficacy
1373762|NCT01276522|Safety|safety
1375518|NCT01269619|posture|posture
1373763|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
1373764|NCT01276483|GIST|gist
1373765|NCT01276483|Response Monitoring|response monitoring
1373766|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
1373767|NCT01276483|Positron Emission Tomography|positron emission tomography
1373768|NCT01276483|Computer Tomography|computer tomography
1373779|NCT01276457|immunosuppression|immunosuppression
1373780|NCT01276457|kidney transplantation|kidney transplantation
1373781|NCT01276457|everolimus|everolimus
1373782|NCT01276457|safety|safety
1373783|NCT01276444|valve repair|valve repair
1373784|NCT01276444|postoperative period|postoperative period
1373785|NCT01276444|goal-directed therapy|goal-directed therapy
1373786|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
1373787|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
1373788|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
1373789|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
1373790|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
1373791|NCT01276392|multiplate|multiplate
1373792|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
1373793|NCT01276379|colorectal cancer|colorectal cancer
1373794|NCT01276379|advanced|advanced
1373795|NCT01276379|metastatic|metastatic
1373796|NCT01276379|KRAS|kras
1373797|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
1373798|NCT01276379|cetuximab|cetuximab
1373799|NCT01276366|Heel lance|heel lance
1373800|NCT01276366|Premature|premature
1373801|NCT01276366|Breast milk|breast milk
1373802|NCT01276353|Alzheimer Disease|alzheimer disease
1373803|NCT01276353|Dementia|dementia
1373804|NCT01276353|Delirium|delirium
1373805|NCT01276353|Amnestic|amnestic
1373806|NCT01276353|Cognitive Disorders|cognitive disorders
1373807|NCT01276353|Donepezil|donepezil
1373808|NCT01276353|Brain Diseases|brain diseases
1373809|NCT01276353|Central Nervous System Diseases|central nervous system diseases
1373810|NCT01276353|Nervous System Diseases|nervous system diseases
1373811|NCT01276353|Tauopathies|tauopathies
1373812|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
1373813|NCT01276353|Mental Disorders|mental disorders
1373814|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
1373815|NCT01276353|Enzy|enzy
1373816|NCT01276340|Urinary Incontinence|urinary incontinence
1373817|NCT01276340|Urinary stress incontinence|urinary stress incontinence
1373818|NCT01276340|Urinary urge incontinence|urinary urge incontinence
1373819|NCT01276340|Women|women
1373820|NCT01276340|electrical stimulation|electrical stimulation
1373821|NCT01276340|KEAT stimulator|keat stimulator
1373822|NCT01276340|quality of life|quality of life
1373823|NCT01276314|SCAR|scar
1373824|NCT01276314|anti-TNF-a|anti-tnf-a
1373825|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
1373826|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
1373827|NCT01276249|Aptus Endosystem|aptus endosystem
1373828|NCT01276249|EndoStaple|endostaple
1373829|NCT01276249|Endograft|endograft
1373830|NCT01276249|Stent Graft|stent graft
1373831|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1373832|NCT01276249|Heli-FX|heli-fx
1373833|NCT01276249|EndoAnchor|endoanchor
1373834|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
1373835|NCT01276236|Maraviroc|maraviroc
1373836|NCT01276236|CCR5|ccr5
1373838|NCT01276223|Dry eye|dry eye
1373839|NCT01276223|ocular discomfort|ocular discomfort
1373840|NCT01276197|hypertension|hypertension
1373841|NCT01276197|healthcare disparities|healthcare disparities
1373842|NCT01276197|minority health|minority health
1373843|NCT01276197|health behavior|health behavior
1373844|NCT01276184|HPV Vaccine|hpv vaccine
1373845|NCT01276184|HPV vaccination|hpv vaccination
1373846|NCT01276184|SMS|sms
1373847|NCT01276184|Text Message|text message
1373848|NCT01276184|Gardasil|gardasil
1373849|NCT01276145|pudendal artery disease|pudendal artery disease
1373850|NCT01276145|erectile dysfunction|erectile dysfunction
1373851|NCT01276145|coronary angiography|coronary angiography
1373852|NCT01276145|coronary disease|coronary disease
1373853|NCT01276145|cardiac|cardiac
1373854|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
1373855|NCT01276132|coronary disease|coronary disease
1373856|NCT01276119|CDP6038|cdp6038
1373857|NCT01276119|single-dose|single-dose
1373858|NCT01276119|pharmacokinetics|pharmacokinetics
1373859|NCT01276119|healthy subjects|healthy subjects
1373860|NCT01276106|AC-201|ac-201
1373861|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
1373862|NCT01276093|Atrial fibrillation|atrial fibrillation
1373863|NCT01276093|PVI ablation|pvi ablation
1373864|NCT01276093|Elderly patients|elderly patients
1373865|NCT01276093|Efficacy|efficacy
1373866|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
1373867|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
1375623|NCT01269190|HRME|hrme
1373868|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1373869|NCT01276041|10-142|10-142
1373870|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
1373871|NCT01276028|Acupuncture|acupuncture
1373872|NCT01276028|Hot Flashes|hot flashes
1373873|NCT01276028|Menopause|menopause
1373874|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
1373875|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
1373876|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
1373877|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
1373878|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
1373879|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
1373880|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
1373881|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
1373882|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
1373883|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
1373884|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
1373885|NCT01276002|disrupted duct|disrupted duct
1373886|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
1373887|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
1373888|NCT01275976|Systemic inflammation|systemic inflammation
1373889|NCT01275976|Sepsis|sepsis
1373890|NCT01275976|Trauma|trauma
1373891|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
1373892|NCT01275976|Cytokines|cytokines
1373893|NCT01275963|Echocardiography|echocardiography
1373894|NCT01275963|Strain imaging|strain imaging
1373895|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
1373896|NCT01275963|Cardiomyopathy|cardiomyopathy
1373897|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
1373898|NCT01275950|Tobacco vendor|tobacco vendor
1373899|NCT01275950|students|students
1373900|NCT01275950|knowledge|knowledge
1373901|NCT01275950|attitude|attitude
1373902|NCT01275950|practice|practice
1373903|NCT01275950|direct advertisements|direct advertisements
1373904|NCT01275950|surrogate advertisements|surrogate advertisements
1373905|NCT01275924|Syndesmosis|syndesmosis
1373906|NCT01275924|Injury|injury
1373907|NCT01275924|Ankle|ankle
1373908|NCT01275924|Fracture|fracture
1373909|NCT01275898|NIRS|nirs
1373910|NCT01275898|cerebral oxygenation|cerebral oxygenation
1373911|NCT01275885|cholecalciferol|cholecalciferol
1373912|NCT01275885|infant|infant
1373913|NCT01275885|bone mineral density|bone mineral density
1373914|NCT01275872|guided imagery|guided imagery
1373915|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
1373916|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
1373917|NCT01275872|quality of life|quality of life
1373918|NCT01275872|stress|stress
1373919|NCT01275872|pain|pain
1373920|NCT01275872|anxiety|anxiety
1373921|NCT01275859|Neoadjuvant|neoadjuvant
1373922|NCT01275859|Letrozole|letrozole
1373923|NCT01275859|Lapatinib|lapatinib
1373924|NCT01275859|Postmenopausal|postmenopausal
1373925|NCT01275846|heart failure|heart failure
1373926|NCT01275846|congestive heart failure|congestive heart failure
1373927|NCT01275846|telemedicine|telemedicine
1373928|NCT01275833|Implantable ICD|implantable icd
1373929|NCT01275833|First Degree AV block|first degree av block
1373930|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
1373931|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
1373932|NCT01275794|Type 2 Diabetes|type 2 diabetes
1373933|NCT01275781|Phase 1|phase 1
1373934|NCT01275781|healthy male volunteers|healthy male volunteers
1373935|NCT01275781|radioactivity|radioactivity
1373936|NCT01275781|excretion|excretion
1373937|NCT01275781|metabolism|metabolism
1373938|NCT01275781|AZD9742|azd9742
1373939|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
1373940|NCT01275768|radio-frequency ablation|radio-frequency ablation
1373941|NCT01275768|Malignant jaundice|malignant jaundice
1373942|NCT01275755|opioid therapy|opioid therapy
1373943|NCT01275755|constipation|constipation
1373944|NCT01275755|chronic noncancer pain|chronic noncancer pain
1373945|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
1373946|NCT01275755|ADL5945|adl5945
1373947|NCT01275755|Opioid Induced Constipation|opioid induced constipation
1373948|NCT01275742|Heart failure|heart failure
1373949|NCT01275742|Depression|depression
1373950|NCT01275742|Depressive symptoms|depressive symptoms
1373951|NCT01275742|Cognitive therapy|cognitive therapy
1373952|NCT01275742|Hospitalization|hospitalization
1373953|NCT01275742|Quality of life|quality of life
1373954|NCT01275729|Renal Replacement Therapy|renal replacement therapy
1373955|NCT01275729|Diuretics|diuretics
1373956|NCT01275729|Biomarkers|biomarkers
1373957|NCT01275729|Renal Insufficiency|renal insufficiency
1373958|NCT01275729|Furosemide|furosemide
1373959|NCT01275729|Therapeutic Uses|therapeutic uses
1373960|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
1373961|NCT01275729|Biological Markers|biological markers
1373962|NCT01275716|Patient Education|patient education
1373963|NCT01275716|coronary artery disease|coronary artery disease
1375720|NCT01268800|Induction|induction
1373964|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
1373965|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
1373966|NCT01275690|cardiac|cardiac
1373967|NCT01275690|pulmonary hypertension|pulmonary hypertension
1373968|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
1373969|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1373970|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
1373971|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
1373972|NCT01275625|maraviroc|maraviroc
1373973|NCT01275625|naive|naive
1373975|NCT01275625|zidovudine|zidovudine
1373976|NCT01275625|lamivudine|lamivudine
1373977|NCT01275625|combivir|combivir
1373978|NCT01275625|Clade A|clade a
1373979|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
1373980|NCT01275612|Solid tumors|solid tumors
1373981|NCT01275612|Cisplatin therapy|cisplatin therapy
1373982|NCT01275612|Acute kidney injury|acute kidney injury
1373983|NCT01275586|NF1|nf1
1373984|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
1373985|NCT01275586|nilotinib|nilotinib
1373986|NCT01275586|Tasigna|tasigna
1373987|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1373988|NCT01275573|pain threshold|pain threshold
1373989|NCT01275573|Parkinson's disease|parkinson's disease
1373990|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
1373991|NCT01275547|Patient controlled analgesia|patient controlled analgesia
1373992|NCT01275547|Morphine|morphine
1373993|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
1373994|NCT01275547|Midazolam intranasal|midazolam intranasal
1373995|NCT01275534|Stem cell transplantation|stem cell transplantation
1373996|NCT01275534|Symptom experience|symptom experience
1373997|NCT01275534|Late effects|late effects
1373998|NCT01275534|Self-management|self-management
1373999|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
1374000|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
1374001|NCT01275508|Intestinal topical application|intestinal topical application
1374002|NCT01275495|Stroke|stroke
1374003|NCT01275495|Family Caregivers|family caregivers
1374004|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
1374005|NCT01275495|Carers|carers
1374006|NCT01275495|Care Givers|care givers
1374007|NCT01275495|Depression|depression
1374008|NCT01275495|Life change events|life change events
1374009|NCT01275495|Family health|family health
1374010|NCT01275495|Quality of life|quality of life
1374011|NCT01275495|Cost|cost
1374012|NCT01275495|Intervention studies|intervention studies
1374013|NCT01275495|Clinical trial|clinical trial
1374014|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
1374015|NCT01275482|Transverse friction massage|transverse friction massage
1374016|NCT01275482|Local twitch response|local twitch response
1374017|NCT01275482|Effectiveness|effectiveness
1374018|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
1374019|NCT01275469|OGTT|ogtt
1374020|NCT01275469|PPARs|ppars
1374021|NCT01275456|allergen provocation|allergen provocation
1374022|NCT01275456|environmental challenge|environmental challenge
1374023|NCT01275456|allergen chamber|allergen chamber
1374024|NCT01275456|house dust mite|house dust mite
1374025|NCT01275456|immunotherapy|immunotherapy
1374026|NCT01275443|HIV|hiv
1374027|NCT01275430|central venous catheters|central venous catheters
1374028|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
1374029|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
1374030|NCT01275430|intravascular ECG|intravascular ecg
1374031|NCT01275430|Tip Positioning System|tip positioning system
1374032|NCT01275417|Acupuncture|acupuncture
1374033|NCT01275404|Erectile Dysfunction|erectile dysfunction
1374034|NCT01275404|focus group|focus group
1374035|NCT01275404|Quality of Life|quality of life
1374036|NCT01275404|10-204|10-204
1374037|NCT01275391|Tobacco use|tobacco use
1374038|NCT01275391|Alcohol abuse|alcohol abuse
1374039|NCT01275391|Drug abuse|drug abuse
1374040|NCT01275391|Substance use|substance use
1374041|NCT01275391|Prevention|prevention
1374042|NCT01275391|Brief intervention|brief intervention
1374043|NCT01275391|Screening|screening
1374044|NCT01275391|Adolescents|adolescents
1374045|NCT01275365|Mobility Limitation|mobility limitation
1374046|NCT01275365|Low Protein Intake|low protein intake
1374047|NCT01275365|Older Men|older men
1374048|NCT01275365|Testosterone|testosterone
1374049|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
1374050|NCT01275352|heart failure|heart failure
1374051|NCT01275339|Aortic valve stenosis|aortic valve stenosis
1374052|NCT01275339|Tadalafil|tadalafil
1374053|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1374054|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
1374055|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
1374056|NCT01275326|Indoor Air Quality|indoor air quality
1374057|NCT01275326|Infectious Aerosols|infectious aerosols
1374058|NCT01275313|Pressure ulcers|pressure ulcers
1374059|NCT01275313|wheelchairs|wheelchairs
1374060|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
1374061|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
1374062|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
1374063|NCT01275287|Complement Activation|complement activation
1374064|NCT01275274|ANCA|anca
1374065|NCT01275274|Vasculitis|vasculitis
1374066|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
1374067|NCT01275261|Stroke|stroke
1374068|NCT01275261|Urinary Tract Infection|urinary tract infection
1374069|NCT01275248|OCD|ocd
1374070|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
1374071|NCT01275222|GIST|gist
1374072|NCT01275222|everolimus|everolimus
1374073|NCT01275222|mTOR|mtor
1374074|NCT01275222|Imatinib resistant|imatinib resistant
1374075|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
1374076|NCT01275209|HCD122|hcd122
1374077|NCT01275209|Lucatumumab|lucatumumab
1374078|NCT01275209|CD40|cd40
1374079|NCT01275209|Follicular Lymphoma|follicular lymphoma
1374080|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1374081|NCT01275209|Antibody|antibody
1374082|NCT01275196|Newly diagnosed,|newly diagnosed,
1374083|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
1374084|NCT01275196|CML-CP|cml-cp
1374085|NCT01275183|HNSCC|hnscc
1374086|NCT01275183|SCC|scc
1374087|NCT01275183|head and neck|head and neck
1374088|NCT01275183|squamous cell|squamous cell
1374089|NCT01275183|nasopharyngeal|nasopharyngeal
1374090|NCT01275157|Absorption|absorption
1374091|NCT01275157|Distribution|distribution
1374092|NCT01275157|Metabolism|metabolism
1374093|NCT01275157|Excretion|excretion
1374094|NCT01275157|Mass balance|mass balance
1374095|NCT01275157|Metabolic profile|metabolic profile
1374096|NCT01275157|Radiolabeled study|radiolabeled study
1374097|NCT01275157|14C|14c
1374098|NCT01275131|Insulin analog|insulin analog
1374099|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
1374100|NCT01275131|Pharmacokinetic|pharmacokinetic
1374101|NCT01275131|Glucodynamic|glucodynamic
1374102|NCT01275131|Phase 1|phase 1
1374103|NCT01275092|robotic-assisted PCI|robotic-assisted pci
1374104|NCT01275092|coronary intervention|coronary intervention
1374105|NCT01275092|CorPath PRECISE|corpath precise
1374106|NCT01275092|PCI|pci
1374107|NCT01275079|tonsillectomy|tonsillectomy
1374108|NCT01275079|nasalance|nasalance
1374109|NCT01275079|tonsil volume|tonsil volume
1374110|NCT01275079|Thai|thai
1374111|NCT01275079|adult|adult
1374112|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
1374113|NCT01275066|MPS IV Type A|mps iv type a
1374114|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1374115|NCT01275066|MPS IVA|mps iva
1374116|NCT01275066|Morquio A Syndrome|morquio a syndrome
1374117|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
1374118|NCT01275066|LSD|lsd
1374119|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1374120|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
1374121|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
1374122|NCT01275066|GALNS|galns
1374123|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
1374124|NCT01275066|ERT|ert
1374125|NCT01275053|Leptin|leptin
1374126|NCT01275053|In Vivo|in vivo
1374127|NCT01275053|Diabetic|diabetic
1374128|NCT01275053|Obese|obese
1374129|NCT01275053|Lean|lean
1374130|NCT01275040|diabetes|diabetes
1374131|NCT01275040|mobile screening|mobile screening
1374132|NCT01275040|complications|complications
1374133|NCT01275040|primary care|primary care
1374134|NCT01275040|specialised care|specialised care
1374135|NCT01275040|quality of care|quality of care
1374136|NCT01275027|diabetes|diabetes
1374137|NCT01275027|blood sugar|blood sugar
1374139|NCT01275027|nutritional supplement|nutritional supplement
1374140|NCT01275027|nutraceutical|nutraceutical
1374141|NCT01275014|TMJ|tmj
1374142|NCT01275014|corticosteroids|corticosteroids
1374143|NCT01275014|osteoarthritis|osteoarthritis
1374144|NCT01275014|arthrocentesis|arthrocentesis
1374145|NCT01275014|pain|pain
1374146|NCT01275001|brain|brain
1374147|NCT01275001|brain development|brain development
1374148|NCT01275001|MRI|mri
1374149|NCT01275001|preschool children|preschool children
1374150|NCT01275001|cortical mantle thickness|cortical mantle thickness
1374151|NCT01275001|hippocampal volume|hippocampal volume
1374152|NCT01274988|Opiate dependence|opiate dependence
1374153|NCT01274988|Deep brain stimulation|deep brain stimulation
1374154|NCT01274988|Nucleus accumbens|nucleus accumbens
1374155|NCT01274949|LI-ESWT|li-eswt
1374156|NCT01274949|Erectile Dysfunction|erectile dysfunction
1374157|NCT01274949|Radical Prostatectomy|radical prostatectomy
1374158|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
1374159|NCT01274949|Shock wave|shock wave
1374160|NCT01274923|Erectile dysfunction|erectile dysfunction
1374161|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
1374162|NCT01274910|Fish Oil|fish oil
1374163|NCT01274910|Knee|knee
1374164|NCT01274910|Analgetics|analgetics
1374165|NCT01274897|Meningococcal|meningococcal
1374166|NCT01274897|ACWY-CRM|acwy-crm
1374167|NCT01274897|Conjugate Vaccine|conjugate vaccine
1374168|NCT01274897|Meningitis|meningitis
1374169|NCT01274897|Adolescents|adolescents
1374170|NCT01274897|Persistence|persistence
1374171|NCT01274897|Adults|adults
1374172|NCT01274884|Acromioclavicular|acromioclavicular
1374173|NCT01274884|Injury|injury
1374174|NCT01274884|Dislocation|dislocation
1374175|NCT01274884|Surgery|surgery
1374176|NCT01274871|Thoracotomy|thoracotomy
1374177|NCT01274871|Chronic Pain|chronic pain
1374178|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
1374179|NCT01274858|persistent pain|persistent pain
1374180|NCT01274858|neuropathic pain|neuropathic pain
1374181|NCT01274858|Thoracotomy|thoracotomy
1374182|NCT01274858|Chronic Pain|chronic pain
1374183|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
1374184|NCT01274845|Heliox|heliox
1374185|NCT01274845|Mechanical ventilation|mechanical ventilation
1374186|NCT01274845|Newborn|newborn
1374187|NCT01274832|Parkinson|parkinson
1374188|NCT01274832|DBS of STN|dbs of stn
1374189|NCT01274832|PD|pd
1374190|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
1374191|NCT01274832|Early treatment|early treatment
1374192|NCT01274819|delirium|delirium
1374193|NCT01274819|confusion|confusion
1374194|NCT01274806|breast cancer|breast cancer
1374195|NCT01274806|physical therapy|physical therapy
1374196|NCT01274806|massage|massage
1374197|NCT01274806|core stability|core stability
1374198|NCT01274793|functional constipation|functional constipation
1374199|NCT01274793|functional diarrhea|functional diarrhea
1374200|NCT01274793|acupuncture|acupuncture
1374201|NCT01274754|neuroprotection|neuroprotection
1374202|NCT01274754|erythromycin|erythromycin
1374203|NCT01274754|neurocognitive assessment|neurocognitive assessment
1374204|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
1374205|NCT01274741|Substance use disorder|substance use disorder
1374206|NCT01274741|Treatment efficacy|treatment efficacy
1374207|NCT01274741|Randomized trial|randomized trial
1374208|NCT01274728|Acute myocardial infarction|acute myocardial infarction
1374209|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1374210|NCT01274728|Drug-eluting balloon|drug-eluting balloon
1374211|NCT01274728|Bivalirudin|bivalirudin
1374212|NCT01274715|Behavioral health coaching|behavioral health coaching
1374213|NCT01274715|Diabetes|diabetes
1374214|NCT01274715|Emotional health|emotional health
1374215|NCT01274702|History of|history of
1374216|NCT01274702|Patients|patients
1374217|NCT01274702|acute|acute
1374218|NCT01274689|lagophthalmos|lagophthalmos
1374219|NCT01274689|parotis tumor|parotis tumor
1374220|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
1374221|NCT01274676|stenting|stenting
1374222|NCT01274676|carotid plaque|carotid plaque
1374223|NCT01274676|stenosis|stenosis
1374224|NCT01274676|angioplasty|angioplasty
1374225|NCT01274663|Single Ascending Dose|single ascending dose
1374226|NCT01274663|Phase 1|phase 1
1374227|NCT01274663|Safety and Tolerability|safety and tolerability
1374228|NCT01274663|PK|pk
1374229|NCT01274663|Healthy Subjects|healthy subjects
1374230|NCT01274637|postpartum|postpartum
1374231|NCT01274637|low molecular weight heparin|low molecular weight heparin
1374232|NCT01274637|venous thromboembolism|venous thromboembolism
1374233|NCT01274637|prophylaxis|prophylaxis
1374234|NCT01274637|Dalteparin Sodium|dalteparin sodium
1374235|NCT01274624|Colorectal|colorectal
1374236|NCT01274624|Cancer|cancer
1374237|NCT01274624|REOLYSIN®|reolysin®
1374238|NCT01274624|Chemotherapy|chemotherapy
1374239|NCT01274624|FOLFIRI|folfiri
1374240|NCT01274624|Reovirus|reovirus
1374241|NCT01274624|Oncolytic virus|oncolytic virus
1374242|NCT01274624|Fluorouracil|fluorouracil
1374243|NCT01274624|Irinotecan|irinotecan
1374244|NCT01274624|Leucovorin|leucovorin
1374245|NCT01274624|Bevacizumab|bevacizumab
1374246|NCT01274611|sweating|sweating
1374247|NCT01274611|sweat|sweat
1374248|NCT01274611|underarm|underarm
1374249|NCT01274611|axillary|axillary
1374250|NCT01274611|hyperhidrosis|hyperhidrosis
1374251|NCT01274611|botox|botox
1374252|NCT01274611|liposuction|liposuction
1374253|NCT01274611|suction-curettage|suction-curettage
1374254|NCT01274611|suction|suction
1374255|NCT01274611|curettage|curettage
1374256|NCT01274598|Probiotics|probiotics
1374257|NCT01274598|Safety|safety
1374258|NCT01274598|Elderly|elderly
1374259|NCT01274598|Lactobacillus|lactobacillus
1374261|NCT01274559|MK-0524A/ER|mk-0524a/er
1374262|NCT01274559|Hypercholesterolemia|hypercholesterolemia
1374263|NCT01274559|Dyslipidemia|dyslipidemia
1374264|NCT01274559|Niacin|niacin
1374265|NCT01274559|Laropiprant|laropiprant
1374267|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
1374268|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
1374269|NCT01274520|Cold storage preservation|cold storage preservation
1374270|NCT01274520|liver transplant|liver transplant
1374271|NCT01274520|portable bypass system|portable bypass system
1374272|NCT01274520|machine perfusion preservation|machine perfusion preservation
1374273|NCT01274520|extended criteria liver|extended criteria liver
1374274|NCT01274507|Asthma|asthma
1374275|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1374276|NCT01274507|Healthy|healthy
1374277|NCT01274507|Longitudinal Study|longitudinal study
1374278|NCT01274507|Bronchoscopy|bronchoscopy
1374279|NCT01274494|Hypertension|hypertension
1374280|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1374281|NCT01274481|Acute Lung Injury|acute lung injury
1374282|NCT01274481|pulmonary hypertension|pulmonary hypertension
1374283|NCT01274481|oxygenation|oxygenation
1374284|NCT01274481|lung mechanics|lung mechanics
1374285|NCT01274481|gas exchange|gas exchange
1374286|NCT01274455|Gene therapy|gene therapy
1374287|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
1374288|NCT01274455|gemcitabine|gemcitabine
1374289|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
1374290|NCT01274442|dental implant|dental implant
1374291|NCT01274429|Peanut allergy|peanut allergy
1374292|NCT01274429|Immunotherapy|immunotherapy
1374293|NCT01274429|OIT|oit
1374294|NCT01274416|Anorexia Nervosa|anorexia nervosa
1374295|NCT01274416|Eating Disorder|eating disorder
1374296|NCT01274416|Treatment|treatment
1374297|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
1374298|NCT01274416|Separated Family Treatment|separated family treatment
1374299|NCT01274403|Multiple Myeloma|multiple myeloma
1374300|NCT01274403|Elderly patients|elderly patients
1374301|NCT01274390|Cardiac Surgery|cardiac surgery
1374302|NCT01274390|Red Blood Cell|red blood cell
1374303|NCT01274390|Transfusion|transfusion
1374304|NCT01274390|Oxygen Saturation|oxygen saturation
1374305|NCT01274390|Microvascular Flow|microvascular flow
1374306|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
1374307|NCT01274377|cytomegalovirus|cytomegalovirus
1374308|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
1374309|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
1374310|NCT01274364|Diabetes|diabetes
1374311|NCT01274364|Structured Care|structured care
1374312|NCT01274351|First line treatment|first line treatment
1374313|NCT01274351|newly diagnosed|newly diagnosed
1374314|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
1374315|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1374316|NCT01274351|Ph+|ph+
1374317|NCT01274351|CML-CP|cml-cp
1374318|NCT01274351|major molecular response|major molecular response
1374319|NCT01274351|Social risk|social risk
1374320|NCT01274325|asthma|asthma
1374321|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
1374322|NCT01274312|Spinal cord injury|spinal cord injury
1374323|NCT01274312|Xiao Procedure|xiao procedure
1374324|NCT01274299|Infants|infants
1374325|NCT01274299|morphometry|morphometry
1374326|NCT01274299|face|face
1374327|NCT01274299|3D|3d
1374328|NCT01274286|hospital accreditation|hospital accreditation
1374329|NCT01274286|patient-centered|patient-centered
1374330|NCT01274286|healthcare quality index|healthcare quality index
1374331|NCT01274286|documentary analysis|documentary analysis
1374332|NCT01274286|meta analysis|meta analysis
1374333|NCT01274273|Bevacizumab|bevacizumab
1374334|NCT01274273|interleukin-2|interleukin-2
1374335|NCT01274273|interferon-alpha|interferon-alpha
1374336|NCT01274260|child|child
1374338|NCT01274260|lung injury|lung injury
1374339|NCT01274260|inflammation|inflammation
1374340|NCT01274260|pneumonia|pneumonia
1374341|NCT01274260|ventilator|ventilator
1374342|NCT01274247|Tongue-tie|tongue-tie
1374343|NCT01274247|Ankyloglossia|ankyloglossia
1374344|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
1374345|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1374346|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
1374347|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
1374348|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
1374349|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1374350|NCT01274156|Erectile dysfunction|erectile dysfunction
1374351|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
1374352|NCT01274143|Colorectal|colorectal
1374353|NCT01274143|Cancer|cancer
1374354|NCT01274143|Colon|colon
1374355|NCT01274143|Rectal|rectal
1374356|NCT01274143|Behavioral Intervention|behavioral intervention
1374357|NCT01274143|Screening|screening
1374358|NCT01274143|Motivational Interviewing|motivational interviewing
1374359|NCT01274143|Extended Parallel Process Model|extended parallel process model
1374360|NCT01274143|Implementation Intentions|implementation intentions
1374361|NCT01274143|Family CARE|family care
1374362|NCT01274117|Chronic renal failure|chronic renal failure
1374363|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
1374364|NCT01274104|statin-related myalgia|statin-related myalgia
1374365|NCT01274104|high cholesterol|high cholesterol
1374366|NCT01274091|Gene-diet interaction|gene-diet interaction
1374367|NCT01274091|PPARgamma gene|ppargamma gene
1374368|NCT01274091|Pro12Ala|pro12ala
1374369|NCT01274091|Fatty acids|fatty acids
1374370|NCT01274091|Dietary modification|dietary modification
1374371|NCT01274091|Insulin sensitivity|insulin sensitivity
1374372|NCT01274091|Glucose metabolism|glucose metabolism
1374373|NCT01274078|inflammation|inflammation
1374374|NCT01274078|lipids|lipids
1374375|NCT01274078|CRP|crp
1374376|NCT01274065|psychiatry|psychiatry
1374377|NCT01274065|psychiatric illness|psychiatric illness
1374378|NCT01274065|developmental disability|developmental disability
1374379|NCT01274065|mental health|mental health
1374380|NCT01274065|medication burden|medication burden
1374381|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
1374382|NCT01274052|Meal test|meal test
1374383|NCT01274052|Incretin hormones|incretin hormones
1374384|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
1374385|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
1374386|NCT01274052|Insulin|insulin
1374387|NCT01274052|C-peptide|c-peptide
1374388|NCT01274052|Glucagon|glucagon
1374389|NCT01274026|phenylketonuria|phenylketonuria
1374390|NCT01274026|PKU|pku
1374391|NCT01274026|phenylalanine|phenylalanine
1374392|NCT01274026|neurotransmitters|neurotransmitters
1374393|NCT01274026|gene|gene
1374394|NCT01274026|Kuvan|kuvan
1374395|NCT01274026|sapropterin|sapropterin
1374396|NCT01274013|Hepatitis C|hepatitis c
1374397|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
1374398|NCT01274013|Vitamin D|vitamin d
1374399|NCT01274013|Vitamin D deficiency|vitamin d deficiency
1374400|NCT01274000|diarrhea|diarrhea
1374401|NCT01274000|IBS|ibs
1374402|NCT01274000|Colonic disease|colonic disease
1374403|NCT01274000|YM060|ym060
1374404|NCT01274000|Ramosetron|ramosetron
1374405|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
1374406|NCT01273974|hemodialysis patients|hemodialysis patients
1374407|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
1374408|NCT01273922|NDV-3|ndv-3
1374409|NCT01273922|vaccine|vaccine
1374410|NCT01273922|Staphylococcus aureus|staphylococcus aureus
1374411|NCT01273922|MRSA|mrsa
1374412|NCT01273922|Candida|candida
1374413|NCT01273909|Breast Cancer|breast cancer
1374414|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
1374415|NCT01273909|Acquired Lymphedema|acquired lymphedema
1374416|NCT01273909|Congenital Lymphedema|congenital lymphedema
1374417|NCT01273896|STA-9090|sta-9090
1374418|NCT01273896|advanced breast cancer|advanced breast cancer
1374419|NCT01273896|10-145|10-145
1374420|NCT01273883|hearing|hearing
1374421|NCT01273883|magnesium|magnesium
1374422|NCT01273870|hemodialysis|hemodialysis
1374423|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
1374424|NCT01273870|performance|performance
1374425|NCT01273870|blood compatibility|blood compatibility
1374426|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
1374427|NCT01273857|Cell therapy|cell therapy
1374428|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1374429|NCT01273857|Single Ventricle|single ventricle
1374430|NCT01273857|Norwood|norwood
1374431|NCT01273857|Sano modification|sano modification
1374432|NCT01273857|Glenn|glenn
1374433|NCT01273857|Fontan|fontan
1374434|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1374435|NCT01273844|amyloidosis|amyloidosis
1374436|NCT01273844|Bortezomib|bortezomib
1374437|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
1374438|NCT01273818|inguinal hernia|inguinal hernia
1374439|NCT01273818|infection prophylaxis|infection prophylaxis
1374440|NCT01273818|topical gentamicin|topical gentamicin
1374441|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
1374442|NCT01273805|hydroxychloroquine|hydroxychloroquine
1374443|NCT01273779|sepsis|sepsis
1374444|NCT01273779|talactoferrin|talactoferrin
1374445|NCT01273779|lactoferrin|lactoferrin
1374446|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
1374447|NCT01273753|End-stage renal disease|end-stage renal disease
1374448|NCT01273753|Hemodialysis|hemodialysis
1374449|NCT01273753|Bioimpedance analysis|bioimpedance analysis
1374450|NCT01273753|Blood volume monitoring|blood volume monitoring
1374451|NCT01273740|PTFE bypass|ptfe bypass
1374452|NCT01273740|femoro-popliteal|femoro-popliteal
1374453|NCT01273740|femoro-crural|femoro-crural
1374454|NCT01273740|popliteal arteries|popliteal arteries
1374455|NCT01273740|crural arteries|crural arteries
1374456|NCT01273740|external support|external support
1374457|NCT01273740|crtical limb ischemia|crtical limb ischemia
1374458|NCT01273727|epiretinal membrane|epiretinal membrane
1374459|NCT01273727|macular pucker|macular pucker
1374460|NCT01273727|cellophane maculopathy|cellophane maculopathy
1374461|NCT01273727|macular edema|macular edema
1374462|NCT01273727|retinal edema|retinal edema
1374463|NCT01273727|ozurdex|ozurdex
1374464|NCT01273727|dexamethasone|dexamethasone
1374465|NCT01273727|intravitreal implant|intravitreal implant
1374466|NCT01273714|benign thyroid disease|benign thyroid disease
1374467|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
1374468|NCT01273714|recurrent goiter|recurrent goiter
1374469|NCT01273714|revision thyroid surgery|revision thyroid surgery
1374470|NCT01273701|amphetamine|amphetamine
1374471|NCT01273701|methamphetamine|methamphetamine
1374472|NCT01273701|psychosocial intervention|psychosocial intervention
1374473|NCT01273701|contingency management|contingency management
1374474|NCT01273701|slow prosecution|slow prosecution
1374475|NCT01273701|substance use disorder|substance use disorder
1374476|NCT01273688|pain|pain
1374477|NCT01273688|elbow|elbow
1374478|NCT01273688|tendinopathy|tendinopathy
1374479|NCT01273675|Hypertension|hypertension
1374480|NCT01273675|Primary disease|primary disease
1374481|NCT01273662|HCC|hcc
1374482|NCT01273649|muscle activation|muscle activation
1374483|NCT01273649|ACL reconstruction|acl reconstruction
1374484|NCT01273649|cryotherapy|cryotherapy
1374485|NCT01273649|TENS|tens
1374486|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
1374487|NCT01273636|Hysterectomy|hysterectomy
1374488|NCT01273636|Endometrial carcinoma|endometrial carcinoma
1374489|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
1374490|NCT01273610|Breast Neoplasms|breast neoplasms
1374491|NCT01273610|HER2 protein, human|her2 protein, human
1374492|NCT01273610|Geriatric Health Services|geriatric health services
1374493|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
1374494|NCT01273610|Geriatric Assessment|geriatric assessment
1374495|NCT01273610|Pharmacokinetics|pharmacokinetics
1374496|NCT01273610|Toxicity|toxicity
1374497|NCT01273610|Patient Adherence|patient adherence
1374498|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
1374499|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
1374500|NCT01273571|Canagliflozin|canagliflozin
1374501|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
1374502|NCT01273571|Pharmacokinetics|pharmacokinetics
1374503|NCT01273571|Pharmacodynamics|pharmacodynamics
1374504|NCT01273558|Canagliflozin|canagliflozin
1374505|NCT01273558|Renal threshold for glucose|renal threshold for glucose
1374506|NCT01273558|Pharmacodynamics|pharmacodynamics
1374507|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
1374508|NCT01273545|Premature ejaculation|premature ejaculation
1374509|NCT01273532|tapentadol|tapentadol
1374510|NCT01273532|NUCYNTA|nucynta
1374511|NCT01273532|CG5503|cg5503
1374512|NCT01273532|R331333|r331333
1374513|NCT01273532|pharmacokinetics|pharmacokinetics
1374514|NCT01273532|healthy volunteer|healthy volunteer
1374515|NCT01273519|Ankylosing|ankylosing
1374516|NCT01273519|Rheumatoid|rheumatoid
1374517|NCT01273519|Antibodies|antibodies
1374518|NCT01273519|Arthritis|arthritis
1374519|NCT01273519|Pain|pain
1374520|NCT01273519|Antirheumatic Agents|antirheumatic agents
1374521|NCT01273519|Psoriatic|psoriatic
1374522|NCT01273519|Spondylitis|spondylitis
1374523|NCT01273519|Monoclonals|monoclonals
1374524|NCT01273506|tapentadol|tapentadol
1374525|NCT01273506|NUCYNTA|nucynta
1374526|NCT01273506|CG5503|cg5503
1374527|NCT01273506|R331333|r331333
1374528|NCT01273506|pharmacokinetics|pharmacokinetics
1374529|NCT01273506|healthy volunteer|healthy volunteer
1374530|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
1374531|NCT01273493|Antineoplastic Agents|antineoplastic agents
1374532|NCT01273493|Solid tumors|solid tumors
1374533|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
1374534|NCT01273493|Chemotherapy|chemotherapy
1374535|NCT01273493|Pharmacokinetics|pharmacokinetics
1374536|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
1374537|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
1374538|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
1374539|NCT01273480|Antineoplastic Agents|antineoplastic agents
1374540|NCT01273480|Solid tumors|solid tumors
1374541|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
1374542|NCT01273480|Chemotherapy|chemotherapy
1374543|NCT01273480|Pharmacokinetics|pharmacokinetics
1374544|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
1374545|NCT01273467|Stroke|stroke
1374546|NCT01273467|CNTO0007|cnto0007
1374547|NCT01273467|42037788|42037788
1374548|NCT01273454|Open-label|open-label
1374549|NCT01273454|Non-interventional|non-interventional
1374550|NCT01273454|OROS hydromorphone|oros hydromorphone
1374551|NCT01273454|Korean cancer patients|korean cancer patients
1374552|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
1374553|NCT01273415|nomogram|nomogram
1374554|NCT01273415|Ki67|ki67
1374555|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
1374556|NCT01273402|colorectal cancer|colorectal cancer
1374557|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
1374558|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
1374559|NCT01273389|Lupus nephritis|lupus nephritis
1374560|NCT01273389|CNTO 136|cnto 136
1374561|NCT01273389|Sirukumab|sirukumab
1374562|NCT01273389|Kidney diseases|kidney diseases
1374563|NCT01273389|Proteinuria|proteinuria
1374564|NCT01273389|Glomerulonephritis|glomerulonephritis
1374566|NCT01273376|Depression|depression
1374567|NCT01273376|Major Depression|major depression
1374568|NCT01273363|Asthma|asthma
1374569|NCT01273363|Asthma in Children|asthma in children
1374570|NCT01273350|internal carotid artery|internal carotid artery
1374571|NCT01273350|common carotid artery|common carotid artery
1374572|NCT01273350|bruit|bruit
1374573|NCT01273350|tia|tia
1374574|NCT01273337|Stroke|stroke
1374575|NCT01273337|Ischemia|ischemia
1374576|NCT01273337|Ischemic Stroke|ischemic stroke
1374577|NCT01273337|Middle Cerebral Artery|middle cerebral artery
1374578|NCT01273337|MCA|mca
1374579|NCT01273337|Stem Cells|stem cells
1374580|NCT01273337|Stem Cell|stem cell
1374581|NCT01273337|Autologous Bone Marrow|autologous bone marrow
1374582|NCT01273337|Ipsilateral MCA|ipsilateral mca
1374583|NCT01273324|Osteoarthritis|osteoarthritis
1374584|NCT01273311|Brain Aging|brain aging
1374585|NCT01273311|Diabetes|diabetes
1374586|NCT01273311|Aging|aging
1374587|NCT01273311|Obesity|obesity
1374588|NCT01273311|CARDIA|cardia
1374589|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1374590|NCT01273298|exercise|exercise
1374591|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
1374592|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
1374593|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
1374594|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
1374595|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
1374596|NCT01273259|DHEA|dhea
1374597|NCT01273259|six-minute walk test|six-minute walk test
1374598|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
1374599|NCT01273220|Epidemiology|epidemiology
1374600|NCT01273220|Epidemiologic Survey|epidemiologic survey
1374601|NCT01273220|Alcohol|alcohol
1374602|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1374603|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
1374604|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
1374605|NCT01273207|Bone Marrow Transplant|bone marrow transplant
1374606|NCT01273207|Lung Transplantation|lung transplantation
1374607|NCT01273207|Bronchiolitis Obliterans|bronchiolitis obliterans
1374608|NCT01273207|Graft Versus Host Disease|graft versus host disease
1374609|NCT01273194|Palliative Care|palliative care
1374610|NCT01273194|Survey|survey
1374611|NCT01273194|Quality of Life|quality of life
1374612|NCT01273194|Attitudes|attitudes
1374613|NCT01273194|Pediatric Cancer|pediatric cancer
1374614|NCT01273181|Immunotherapy|immunotherapy
1374615|NCT01273181|Gene Therapy|gene therapy
1374616|NCT01273181|Metastatic Cancer|metastatic cancer
1374617|NCT01273181|Clinical Response|clinical response
1374618|NCT01273181|Metastatic Melanoma|metastatic melanoma
1374619|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1374620|NCT01273168|Pharmacokinetics|pharmacokinetics
1374621|NCT01273168|Advanced Cancer|advanced cancer
1374622|NCT01273168|Cytochrome P 450|cytochrome p 450
1374623|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
1374624|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
1374625|NCT01273168|Gynecologic Cancer|gynecologic cancer
1374626|NCT01273168|Breast Cancer|breast cancer
1374627|NCT01273168|Desmoid Tumor|desmoid tumor
1374788|NCT01272622|Oncology|oncology
1374628|NCT01273168|Endometrial Cancer|endometrial cancer
1374629|NCT01273168|Ovarian Cancer|ovarian cancer
1374630|NCT01273168|Uterine Cancer|uterine cancer
1374631|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
1374632|NCT01273168|Peritoneal Cancer|peritoneal cancer
1374633|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1374634|NCT01273155|Liver Dysfunction|liver dysfunction
1374635|NCT01273155|Pharmacokinetics|pharmacokinetics
1374636|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
1374637|NCT01273155|Solid Tumor|solid tumor
1374638|NCT01273155|Cancer|cancer
1374639|NCT01273155|Lymphoma|lymphoma
1374640|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
1374641|NCT01273129|Neurosurgery|neurosurgery
1374642|NCT01273129|Childhood Epilepsy|childhood epilepsy
1374643|NCT01273129|Epilepsy|epilepsy
1374644|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
1374645|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
1374646|NCT01273116|frailty|frailty
1374647|NCT01273116|integrated care|integrated care
1374648|NCT01273116|hospital|hospital
1374649|NCT01273116|geriatrics|geriatrics
1374650|NCT01273116|hospital-wide intervention|hospital-wide intervention
1374651|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1374652|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1374653|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1374654|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1374655|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1374656|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1374657|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1374658|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1374659|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1374660|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
1374661|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
1374662|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1374663|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1374664|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
1374665|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
1374666|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
1374667|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
1374668|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
1374669|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
1374670|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
1374671|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
1374672|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
1374673|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
1374674|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
1374675|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
1374676|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
1374677|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1374678|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1374679|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1374680|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
1374681|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1374682|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1374683|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1374684|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
1374685|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1374686|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
1374687|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1374688|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1374689|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1374690|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1374691|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
1374692|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1374693|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
1374694|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1374695|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1375289|NCT01270529|CKD|ckd
1374696|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1374697|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1374698|NCT01273090|intraocular lymphoma|intraocular lymphoma
1374699|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1374700|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1374701|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1374702|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1374703|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1374704|NCT01273090|small intestine lymphoma|small intestine lymphoma
1374705|NCT01273077|Rotavirus|rotavirus
1374706|NCT01273077|Rotarix|rotarix
1374707|NCT01273064|HCV|hcv
1374708|NCT01273064|Null Responders|null responders
1374709|NCT01273051|Rectal Cancer|rectal cancer
1374710|NCT01273051|Radiochemotherapy|radiochemotherapy
1374711|NCT01273051|TEM|tem
1374712|NCT01273051|Organ preservation|organ preservation
1374713|NCT01273025|pharmacokinetic|pharmacokinetic
1374714|NCT01273025|lime powder regimen|lime powder regimen
1374715|NCT01273025|kidney stone|kidney stone
1374716|NCT01273025|Oxidative stress|oxidative stress
1374717|NCT01273012|probiotic|probiotic
1374718|NCT01273012|cost-effectiveness|cost-effectiveness
1374719|NCT01273012|diarrhea|diarrhea
1374720|NCT01273012|children|children
1374721|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
1374722|NCT01272999|Acute otitis media|acute otitis media
1374724|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
1374725|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
1374726|NCT01272960|Contraception|contraception
1374727|NCT01272960|Postnatal care|postnatal care
1374728|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
1374729|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
1374730|NCT01272895|OCT images|oct images
1374731|NCT01272895|Stent strut coverage|stent strut coverage
1374732|NCT01272895|Endothelialization|endothelialization
1374733|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
1374734|NCT01272895|Stent malapposition|stent malapposition
1374735|NCT01272830|total joint arthroplasty|total joint arthroplasty
1374736|NCT01272830|synovitis|synovitis
1374737|NCT01272830|ALVAL (Aseptic Lymphocyte-Dominant Vasculitis-Associated Lesion)|alval (aseptic lymphocyte-dominant vasculitis-associated lesion)
1374738|NCT01272830|osteolysis|osteolysis
1374739|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
1374740|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
1374741|NCT01272817|Allogeneic transplant|allogeneic transplant
1374742|NCT01272817|Transplant|transplant
1374743|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
1374744|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
1374745|NCT01272765|obesity|obesity
1374746|NCT01272765|weight loss|weight loss
1374747|NCT01272765|weight management|weight management
1374748|NCT01272765|anti-psychotic medication|anti-psychotic medication
1374749|NCT01272765|Zyprexa|zyprexa
1374750|NCT01272765|Seroquel|seroquel
1374751|NCT01272765|Risperdal|risperdal
1374752|NCT01272752|obesity|obesity
1374753|NCT01272752|weight loss|weight loss
1374754|NCT01272752|weight management|weight management
1374755|NCT01272752|anti-psychotic medication|anti-psychotic medication
1374756|NCT01272752|nutriceutical|nutriceutical
1374757|NCT01272739|obesity|obesity
1374758|NCT01272739|weight loss|weight loss
1374759|NCT01272739|weight management|weight management
1374760|NCT01272739|overweight|overweight
1374761|NCT01272739|nutriceutical|nutriceutical
1374762|NCT01272687|Parkinson Disease|parkinson disease
1374763|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
1374764|NCT01272687|Brain Diseases|brain diseases
1374765|NCT01272687|Central Nervous System Diseases|central nervous system diseases
1374766|NCT01272687|Nervous System Diseases|nervous system diseases
1374767|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
1374768|NCT01272661|breastfeeding|breastfeeding
1374769|NCT01272661|low-income|low-income
1374770|NCT01272661|high-risk|high-risk
1374771|NCT01272661|African-American|african-american
1374772|NCT01272661|health disparity|health disparity
1374773|NCT01272648|Rehabilitation|rehabilitation
1374774|NCT01272648|Coping|coping
1374775|NCT01272648|Prostate cancer|prostate cancer
1374776|NCT01272648|Nursing|nursing
1374777|NCT01272648|Physiotherapy|physiotherapy
1374778|NCT01272648|Pelvic floor exercises|pelvic floor exercises
1374779|NCT01272648|Motivational Interviewing|motivational interviewing
1374780|NCT01272635|Asthma|asthma
1374781|NCT01272635|Wheezing|wheezing
1374782|NCT01272635|Respiratory Tract Illness|respiratory tract illness
1374783|NCT01272635|Azythromycin|azythromycin
1374784|NCT01272635|Prednisolone|prednisolone
1374785|NCT01272635|Preschool-age|preschool-age
1374786|NCT01272622|Quality of life|quality of life
1374787|NCT01272622|Endocrinology|endocrinology
1374789|NCT01272622|Hypothalamus|hypothalamus
1374790|NCT01272622|Irradiation|irradiation
1374791|NCT01272622|Neurosurgery|neurosurgery
1374792|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
1374793|NCT01272622|Randomized trial|randomized trial
1374794|NCT01272596|Multiple Sclerosis|multiple sclerosis
1374795|NCT01272596|Visual Contrast Acuity|visual contrast acuity
1374796|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
1374797|NCT01272596|Sloan Charts|sloan charts
1374798|NCT01272583|Type 1 diabetes|type 1 diabetes
1374799|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
1374800|NCT01272583|Glucagon|glucagon
1374801|NCT01272570|breast|breast
1374802|NCT01272570|oral|oral
1374803|NCT01272570|cancer|cancer
1374804|NCT01272557|HCC|hcc
1374805|NCT01272544|Dental caries|dental caries
1374806|NCT01272544|Epidemiology|epidemiology
1374807|NCT01272544|Gingivitis|gingivitis
1374808|NCT01272544|Oral health|oral health
1374809|NCT01272531|pharmacogenetics|pharmacogenetics
1374810|NCT01272531|bipolar disorders|bipolar disorders
1374811|NCT01272531|affective disorders|affective disorders
1374812|NCT01272531|mood disorders|mood disorders
1374813|NCT01272531|pharmacologic actions|pharmacologic actions
1374814|NCT01272531|psychotropic drugs|psychotropic drugs
1374815|NCT01272531|antimanic agents|antimanic agents
1374816|NCT01272531|antidepressant agents|antidepressant agents
1374817|NCT01272531|lithium|lithium
1374818|NCT01272531|lithium carbonate|lithium carbonate
1374819|NCT01272531|Lithobid|lithobid
1374820|NCT01272531|Eskalith|eskalith
1374821|NCT01272531|divalproex|divalproex
1374822|NCT01272531|divalproex sodium|divalproex sodium
1374823|NCT01272531|Depakote|depakote
1374824|NCT01272531|valproate|valproate
1374825|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
1374826|NCT01272479|hemodialysis|hemodialysis
1374827|NCT01272479|hepatitis C|hepatitis c
1374828|NCT01272479|inflammation|inflammation
1374829|NCT01272479|iron stores|iron stores
1374830|NCT01272479|prohepcidin|prohepcidin
1374831|NCT01272466|multiple myeloma|multiple myeloma
1374832|NCT01272466|vaccination|vaccination
1374833|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
1374834|NCT01272466|proteasome inhibition|proteasome inhibition
1374835|NCT01272453|coronary artery disease|coronary artery disease
1374836|NCT01272453|CT scan|ct scan
1374837|NCT01272453|coronary angiography|coronary angiography
1374838|NCT01272453|chest pain|chest pain
1374839|NCT01272453|aortic aneurysm|aortic aneurysm
1374840|NCT01272453|pulmonary embolism|pulmonary embolism
1374841|NCT01272440|PEG-asparaginase|peg-asparaginase
1374842|NCT01272440|children|children
1374843|NCT01272440|pharmacokinetics|pharmacokinetics
1374844|NCT01272440|antibodies|antibodies
1374845|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
1374846|NCT01272440|adverse effects|adverse effects
1374847|NCT01272414|Eyelid retraction|eyelid retraction
1374848|NCT01272414|Botulinum Toxins|botulinum toxins
1374849|NCT01272388|Aortic valve stenosis|aortic valve stenosis
1374850|NCT01272388|Tadalafil|tadalafil
1374851|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1374852|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
1374853|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
1374854|NCT01272362|Indacaterol|indacaterol
1374855|NCT01272362|COPD|copd
1374856|NCT01272362|LABA|laba
1374857|NCT01272362|Reversibility|reversibility
1374858|NCT01272349|spinal cord injury|spinal cord injury
1374859|NCT01272349|walking|walking
1374860|NCT01272349|low oxygen|low oxygen
1374861|NCT01272349|air|air
1374862|NCT01272349|strength|strength
1374863|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
1374864|NCT01272323|Cat allergy|cat allergy
1374865|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
1374866|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
1374867|NCT01272310|Combination Therapy|combination therapy
1374868|NCT01272310|Hydroxychloroquine|hydroxychloroquine
1374869|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
1374870|NCT01272310|Ribavirin|ribavirin
1374871|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
1374872|NCT01272297|LI-ESWT|li-eswt
1374873|NCT01272297|Erectile Dysfunction|erectile dysfunction
1374874|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
1374875|NCT01272297|Shock wave|shock wave
1374876|NCT01272284|Female|female
1374877|NCT01272284|Stress urinary incontinence|stress urinary incontinence
1374878|NCT01272284|Mini sling|mini sling
1374879|NCT01272284|Single incision sling|single incision sling
1374880|NCT01272284|Urinary incontinence|urinary incontinence
1374881|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
1374882|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
1374883|NCT01272284|Stress|stress
1374884|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
1374885|NCT01272284|Pathological Processes|pathological processes
1374886|NCT01272284|Urination Disorders|urination disorders
1374887|NCT01272284|Urological Disorders|urological disorders
1374888|NCT01272284|Urological Manifestations|urological manifestations
1374889|NCT01272284|Signs and Symptoms|signs and symptoms
1374890|NCT01272271|Contact lens|contact lens
1374891|NCT01272271|Infection|infection
1374892|NCT01272271|Cornea|cornea
1374893|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
1374894|NCT01272245|AML|aml
1374895|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1374896|NCT01272245|MDS|mds
1374897|NCT01272245|Omacetaxine|omacetaxine
1374898|NCT01272245|Cytarabine|cytarabine
1374899|NCT01272245|ARA-C|ara-c
1374900|NCT01272245|Cytosar|cytosar
1374901|NCT01272245|DepoCyt|depocyt
1374902|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1374903|NCT01272180|Safety|safety
1374904|NCT01272180|Immunogenicity|immunogenicity
1374905|NCT01272180|Vaccine|vaccine
1374906|NCT01272180|Meningococcal|meningococcal
1374907|NCT01272180|Seroresponse|seroresponse
1374908|NCT01272167|Post-menopausal women|post-menopausal women
1374909|NCT01272167|Grapefruit juice|grapefruit juice
1374910|NCT01272167|Naringin|naringin
1374911|NCT01272167|Vascular protection|vascular protection
1374912|NCT01272167|Bone metabolism|bone metabolism
1374913|NCT01272154|Cerebellum|cerebellum
1374914|NCT01272154|Cortical plasticity|cortical plasticity
1374915|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
1374916|NCT01272154|Dystonia|dystonia
1374917|NCT01272154|Cerebral Palsy|cerebral palsy
1374918|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1374919|NCT01272154|and|and
1374920|NCT01272141|Metastatic breast cancer|metastatic breast cancer
1376616|NCT01264757|pedometer|pedometer
1374921|NCT01272141|Triple negative breast cancer|triple negative breast cancer
1374922|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
1374923|NCT01272115|Climacteric stage|climacteric stage
1374924|NCT01272115|Integrative health care model|integrative health care model
1374925|NCT01272115|Empowerment approach|empowerment approach
1374926|NCT01272115|Primary care services|primary care services
1374927|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
1374928|NCT01272076|Geographic Atrophy|geographic atrophy
1374929|NCT01272076|Imaging|imaging
1374930|NCT01272076|OCT|oct
1374931|NCT01272063|Drusen|drusen
1374932|NCT01272063|Dry AMD|dry amd
1374933|NCT01272063|OCT|oct
1374934|NCT01272063|Imaging|imaging
1374935|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1374936|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
1374937|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
1374938|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
1374939|NCT01272050|stage III prostate cancer|stage iii prostate cancer
1374940|NCT01272024|clinical trial|clinical trial
1374941|NCT01272024|symptom education|symptom education
1374942|NCT01272024|advanced cancer|advanced cancer
1374943|NCT01272011|Respiration|respiration
1374944|NCT01272011|Spinal cord injuries|spinal cord injuries
1374945|NCT01272011|Walking recovery|walking recovery
1374946|NCT01271998|antibiotic|antibiotic
1374947|NCT01271998|healthy subjects|healthy subjects
1374948|NCT01271998|pharmacokinetics|pharmacokinetics
1374949|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
1374950|NCT01271985|Drug Combinations|drug combinations
1374951|NCT01271985|prevention and control|prevention and control
1374952|NCT01271985|Aspirin|aspirin
1374953|NCT01271985|Antihypertensive Agents|antihypertensive agents
1374954|NCT01271985|Antilipemic Agents|antilipemic agents
1374955|NCT01271959|Ovarian|ovarian
1374956|NCT01271959|Fallopian Tube|fallopian tube
1374957|NCT01271959|Peritoneal|peritoneal
1374958|NCT01271959|Uterine Neoplasms|uterine neoplasms
1374959|NCT01271959|Vulva|vulva
1374960|NCT01271959|Endometrial|endometrial
1374961|NCT01271959|Cervical|cervical
1374962|NCT01271959|Lung|lung
1374963|NCT01271959|Carcinoid|carcinoid
1374964|NCT01271959|Sarcoma|sarcoma
1374965|NCT01271959|Mesothelioma|mesothelioma
1374966|NCT01271959|Adenocarcinoma|adenocarcinoma
1374967|NCT01271959|Colorectal|colorectal
1374968|NCT01271959|Breast|breast
1374969|NCT01271959|Assay|assay
1374970|NCT01271959|Chemotherapy|chemotherapy
1374971|NCT01271959|Recurrent|recurrent
1374972|NCT01271959|Refractory|refractory
1374973|NCT01271959|Persistent|persistent
1374974|NCT01271959|Chemoresponse|chemoresponse
1374975|NCT01271933|fibromyalgia|fibromyalgia
1374976|NCT01271933|pain|pain
1374977|NCT01271933|pregabalin|pregabalin
1374978|NCT01271933|Lyrica|lyrica
1374979|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
1374980|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
1374981|NCT01271920|Hsp90,|hsp90,
1374982|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
1374983|NCT01271907|Skin Cancer|skin cancer
1494940|NCT00798850|SF36|sf36
1374984|NCT01271907|Malignancy|malignancy
1374985|NCT01271907|Immunotherapy|immunotherapy
1374986|NCT01271907|Melanoma Peptides|melanoma peptides
1374987|NCT01271907|Melanoma|melanoma
1374988|NCT01271907|Metastatic Melanoma|metastatic melanoma
1374989|NCT01271894|HIV|hiv
1374990|NCT01271894|efavirenz|efavirenz
1374991|NCT01271894|pharmacokinetic|pharmacokinetic
1374992|NCT01271881|Hemodialysis|hemodialysis
1374993|NCT01271881|Fistula|fistula
1374994|NCT01271881|Angiograph|angiograph
1374995|NCT01271881|Angiogram|angiogram
1374996|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
1374997|NCT01271868|Recombinant Factor IX|recombinant factor ix
1374998|NCT01271855|Belladonna|belladonna
1374999|NCT01271855|Opium|opium
1375000|NCT01271855|Suppository|suppository
1375001|NCT01271829|Avocados|avocados
1375002|NCT01271829|Satiety|satiety
1375003|NCT01271829|Feeding study|feeding study
1375004|NCT01271816|genetics|genetics
1375005|NCT01271816|sudden death|sudden death
1375006|NCT01271816|monitoring|monitoring
1375007|NCT01271816|loop recorder|loop recorder
1375008|NCT01271816|cardiomyopathy|cardiomyopathy
1375009|NCT01271790|Hepatitis C|hepatitis c
1375011|NCT01271790|Rapid Virologic Response|rapid virologic response
1375012|NCT01271790|Sustained Virologic Response|sustained virologic response
1375013|NCT01271790|Direct Acting Antiviral|direct acting antiviral
1375014|NCT01271790|Combination Therapy|combination therapy
1375015|NCT01271790|HCV RNA|hcv rna
1375016|NCT01271790|Polymerase inhibitor|polymerase inhibitor
1375017|NCT01271790|Protease inhibitor|protease inhibitor
1375018|NCT01271790|Treatment naïve|treatment naïve
1375019|NCT01271790|GS-9190|gs-9190
1375020|NCT01271790|GS-9451|gs-9451
1376919|NCT01263444|AZARGA®|azarga®
1375021|NCT01271777|Pre-diabetes|pre-diabetes
1375022|NCT01271777|Clamp technique|clamp technique
1375023|NCT01271777|PPARs|ppars
1375024|NCT01271777|Insulin resistance|insulin resistance
1375025|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
1375026|NCT01271751|PPARs|ppars
1375027|NCT01271738|Breast Cancer|breast cancer
1375028|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
1375029|NCT01271738|Breast Tumors|breast tumors
1375030|NCT01271738|Cancer of Breast|cancer of breast
1375031|NCT01271738|Cancer of the Breast|cancer of the breast
1375032|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
1375033|NCT01271738|Neoplasms, Breast|neoplasms, breast
1375034|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
1375035|NCT01271712|GIST|gist
1375036|NCT01271712|multikinase inhibitor|multikinase inhibitor
1375037|NCT01271699|Fabry Disease|fabry disease
1375038|NCT01271699|Fabry´s Disease|fabry´s disease
1375039|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
1375040|NCT01271699|Multiple Sclerosis|multiple sclerosis
1375041|NCT01271660|muscle cramp|muscle cramp
1375042|NCT01271660|liver cirrhosis|liver cirrhosis
1375043|NCT01271660|pregabalin|pregabalin
1375044|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
1375045|NCT01271634|cross-transmission|cross-transmission
1375046|NCT01271634|offending vessel|offending vessel
1375047|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
1375048|NCT01271608|Accident prevention|accident prevention
1375049|NCT01271608|Blood-borne pathogens|blood-borne pathogens
1375050|NCT01271608|Protective devices.|protective devices.
1375051|NCT01271608|Needlestick injuries|needlestick injuries
1375052|NCT01271608|Injections subcutaneous|injections subcutaneous
1375053|NCT01271608|Injections intradermal|injections intradermal
1375054|NCT01271595|acupuncture|acupuncture
1375055|NCT01271595|autonomic nervous system|autonomic nervous system
1375056|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
1375057|NCT01271582|Colorecatal cancer|colorecatal cancer
1375058|NCT01271582|Gastric cancer|gastric cancer
1375059|NCT01271582|Irinotecan|irinotecan
1375060|NCT01271582|UGT1A1|ugt1a1
1375061|NCT01271582|Neutropenia|neutropenia
1375062|NCT01271556|COPD|copd
1375063|NCT01271556|LABA|laba
1375064|NCT01271556|salmeterol|salmeterol
1375065|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
1375066|NCT01271543|endotracheal intubation|endotracheal intubation
1375067|NCT01271543|changes induced by|changes induced by
1375068|NCT01271543|performed|performed
1375069|NCT01271543|the aid of the SOS|the aid of the sos
1375070|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
1375071|NCT01271530|Late Effects of Polio|late effects of polio
1375072|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
1375073|NCT01271530|Fatigue|fatigue
1375074|NCT01271530|Energy cost of Walking|energy cost of walking
1375075|NCT01271530|Pain|pain
1375076|NCT01271517|Basal insulin|basal insulin
1375077|NCT01271517|long acting insulin analogs|long acting insulin analogs
1375078|NCT01271517|metabolic control|metabolic control
1375079|NCT01271517|HbA1c|hba1c
1375080|NCT01271517|C-peptide|c-peptide
1375081|NCT01271517|IGF-I|igf-i
1375082|NCT01271517|GH|gh
1375083|NCT01271517|IGFBP|igfbp
1375084|NCT01271504|Cancer|cancer
1375085|NCT01271504|liver|liver
1375086|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
1375087|NCT01271504|phase I|phase i
1375088|NCT01271504|phase II|phase ii
1375089|NCT01271491|Pediatric|pediatric
1375090|NCT01271478|inflammation|inflammation
1375091|NCT01271478|telmisartan|telmisartan
1375092|NCT01271478|captopril|captopril
1375290|NCT01270529|ESRD|esrd
1375093|NCT01271478|hemodialysis|hemodialysis
1375094|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1375095|NCT01271426|Ranibizumab|ranibizumab
1375096|NCT01271400|Infertility treatments|infertility treatments
1375097|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
1375098|NCT01271400|IVF.|ivf.
1375099|NCT01271400|ART.|art.
1375100|NCT01271400|Cryopreservation|cryopreservation
1375101|NCT01271400|Slow-Freeze|slow-freeze
1375102|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
1375103|NCT01271400|Blastocyst formation|blastocyst formation
1375104|NCT01271400|Pregnancy|pregnancy
1375105|NCT01271387|Liver disease|liver disease
1375106|NCT01271387|pharmacokinetics|pharmacokinetics
1375107|NCT01271374|African American|african american
1375108|NCT01271374|Hypertension|hypertension
1375109|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
1375110|NCT01271361|thrombus aspiration|thrombus aspiration
1375111|NCT01271361|Drug-Eluting Stent|drug-eluting stent
1375112|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
1375113|NCT01271335|CTO|cto
1375114|NCT01271335|Angioplasty|angioplasty
1375115|NCT01271335|PCI|pci
1375116|NCT01271322|PET|pet
1375117|NCT01271322|response evaluation|response evaluation
1375118|NCT01271322|neoadjuvant|neoadjuvant
1375119|NCT01271322|radiochemotherapy|radiochemotherapy
1375120|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
1375121|NCT01271322|esophageal carcinoma|esophageal carcinoma
1375122|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
1375123|NCT01271296|Addison Disease|addison disease
1375124|NCT01271296|Pharmacokinetics|pharmacokinetics
1375125|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
1375126|NCT01271296|cortisone acetate|cortisone acetate
1375127|NCT01271296|Quality of Life|quality of life
1375128|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1375129|NCT01271270|Palomid 529|palomid 529
1375130|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
1375131|NCT01271270|AMD|amd
1375132|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
1375133|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
1375134|NCT01271205|pneumonia|pneumonia
1375135|NCT01271205|RDW|rdw
1375136|NCT01271205|mortality|mortality
1375137|NCT01271205|prognostic factor|prognostic factor
1375138|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
1375139|NCT01271192|surgical resection|surgical resection
1375140|NCT01271192|adjuvant therapy|adjuvant therapy
1375141|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
1375142|NCT01271179|preservation solution|preservation solution
1375143|NCT01271179|peribiliary plexus|peribiliary plexus
1375144|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
1375145|NCT01271179|primary non-function|primary non-function
1375146|NCT01271166|Colorectal,|colorectal,
1375147|NCT01271166|Cancer|cancer
1375148|NCT01271153|Septic shock|septic shock
1375149|NCT01271127|radiation therapy|radiation therapy
1375150|NCT01271127|coronary artery disease|coronary artery disease
1375151|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
1375152|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
1375153|NCT01271101|anticoagulation|anticoagulation
1375154|NCT01271088|ototoxicity|ototoxicity
1375155|NCT01271088|aminoglycoside|aminoglycoside
1375156|NCT01271088|vancomycine|vancomycine
1375157|NCT01271088|peritoneal dialysis|peritoneal dialysis
1375158|NCT01271088|peritonitis|peritonitis
1375159|NCT01271075|urticaria|urticaria
1375160|NCT01271075|bilastine|bilastine
1375161|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
1375162|NCT01271062|gastric bypass|gastric bypass
1375163|NCT01271036|Lubricating Agents|lubricating agents
1375164|NCT01271036|Personal Lubricant|personal lubricant
1375165|NCT01270984|Imatinib mesylate|imatinib mesylate
1375166|NCT01270984|Pharmacokinetics|pharmacokinetics
1375167|NCT01270984|Healthy volunteers|healthy volunteers
1375168|NCT01270971|Onychomycosis|onychomycosis
1375169|NCT01270971|nail fungus|nail fungus
1375170|NCT01270971|toenail fungus|toenail fungus
1375171|NCT01270971|fungal nail|fungal nail
1375172|NCT01270971|hyperkeratosis|hyperkeratosis
1375173|NCT01270971|nail infection|nail infection
1375174|NCT01270971|nail treatment|nail treatment
1375175|NCT01270971|toenail infection|toenail infection
1375176|NCT01270971|toenail treatment|toenail treatment
1375177|NCT01270971|foot dermatoses|foot dermatoses
1375178|NCT01270971|fungal culture|fungal culture
1375179|NCT01270971|onycholysis|onycholysis
1375180|NCT01270971|podiatrist|podiatrist
1375181|NCT01270971|podiatry|podiatry
1375182|NCT01270971|subungual|subungual
1375183|NCT01270971|tinea unguium|tinea unguium
1375184|NCT01270971|antifungal|antifungal
1375185|NCT01270971|anti-fungal|anti-fungal
1375186|NCT01270971|dermatologist|dermatologist
1375187|NCT01270971|dermatology|dermatology
1375188|NCT01270971|dermatophyte|dermatophyte
1375189|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
1375190|NCT01270971|yellow nail|yellow nail
1375191|NCT01270971|thick nail|thick nail
1375192|NCT01270971|brittle nail|brittle nail
1375193|NCT01270971|crumbling nail|crumbling nail
1375194|NCT01270971|discolored nail|discolored nail
1375195|NCT01270971|weak nail|weak nail
1375196|NCT01270958|AVY-REG00108VN|avy-reg00108vn
1375197|NCT01270906|Neoplasms|neoplasms
1375198|NCT01270906|Cancer|cancer
1375199|NCT01270906|Tumors|tumors
1375200|NCT01270906|Administration|administration
1375201|NCT01270906|oral|oral
1375202|NCT01270906|CHIR258|chir258
1375203|NCT01270906|CHIR-258|chir-258
1375204|NCT01270906|CHIR 258|chir 258
1375205|NCT01270906|TKI258|tki258
1375206|NCT01270906|TKI-258|tki-258
1375207|NCT01270906|TKI 258|tki 258
1375208|NCT01270906|dose finding|dose finding
1375209|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1375210|NCT01270893|GIST|gist
1375211|NCT01270893|Nilotinib|nilotinib
1375212|NCT01270893|AMN107|amn107
1375213|NCT01270893|Tasigna|tasigna
1375214|NCT01270867|Ischemia|ischemia
1375215|NCT01270867|Stroke|stroke
1375216|NCT01270867|Ischemic Stroke|ischemic stroke
1375217|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
1375218|NCT01270867|Brain|brain
1375219|NCT01270867|Brain clot|brain clot
1375220|NCT01270867|Cerebrovascular disease|cerebrovascular disease
1375221|NCT01270867|Recanalization|recanalization
1375222|NCT01270867|Revascularization|revascularization
1375223|NCT01270854|Normal saline|normal saline
1375224|NCT01270854|Plasmalyte|plasmalyte
1375225|NCT01270854|Intravenous fluid|intravenous fluid
1375226|NCT01270854|Traumatic injury|traumatic injury
1375227|NCT01270854|Fluid resuscitation|fluid resuscitation
1375228|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
1375229|NCT01270815|pregabalin|pregabalin
1375230|NCT01270815|pharmacokinetics|pharmacokinetics
1375231|NCT01270815|bioavailability|bioavailability
1375232|NCT01270815|bioequivalence|bioequivalence
1375233|NCT01270802|Endothelial function|endothelial function
1375234|NCT01270802|Vitamin D|vitamin d
1375235|NCT01270802|Efavirenz|efavirenz
1375236|NCT01270802|Raltegravir|raltegravir
1375237|NCT01270789|beta-cell function|beta-cell function
1375238|NCT01270789|GLP-1 analogue|glp-1 analogue
1375239|NCT01270789|diabetes|diabetes
1375240|NCT01270776|Randomized Controlled Trial|randomized controlled trial
1375241|NCT01270776|Chlorhexidine|chlorhexidine
1375242|NCT01270776|Infant, Premature|infant, premature
1375243|NCT01270763|Obesity|obesity
1375244|NCT01270763|physical fitness|physical fitness
1375245|NCT01270763|cholesterol levels|cholesterol levels
1375246|NCT01270763|genetics|genetics
1375247|NCT01270763|weight loss|weight loss
1375248|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
1375249|NCT01270750|BOSENTAN|bosentan
1375250|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
1375251|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
1375252|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
1375253|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
1375254|NCT01270711|compliance study|compliance study
1375255|NCT01270711|effectiveness study|effectiveness study
1375256|NCT01270711|hyperprolactinemia|hyperprolactinemia
1375257|NCT01270711|Parkinson's disease|parkinson's disease
1375258|NCT01270711|retrospective cohort study|retrospective cohort study
1375259|NCT01270698|colorectal cancer|colorectal cancer
1375260|NCT01270672|MDMA|mdma
1375261|NCT01270672|carvedilol|carvedilol
1375262|NCT01270672|norepinephrine|norepinephrine
1375263|NCT01270672|alpha - beta receptor|alpha - beta receptor
1375264|NCT01270672|Ecstasy|ecstasy
1375265|NCT01270672|stimulant|stimulant
1375266|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
1375267|NCT01270646|Cardiac insufficiency|cardiac insufficiency
1375268|NCT01270646|Invasive procedure|invasive procedure
1375269|NCT01270646|Heart Failure|heart failure
1375270|NCT01270646|Noninvasive procedure|noninvasive procedure
1375271|NCT01270646|Congestive Heart Failure|congestive heart failure
1375272|NCT01270646|Mapping|mapping
1375273|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1375274|NCT01270646|Open study|open study
1375275|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
1375276|NCT01270646|Hemodynamics|hemodynamics
1375277|NCT01270620|elderly obese|elderly obese
1567125|NCT00509938|immunocompromized|immunocompromized
1375278|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
1375279|NCT01270581|high flow nasal cannula|high flow nasal cannula
1375280|NCT01270581|bubble nasal|bubble nasal
1375281|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
1375282|NCT01270568|positive psychology|positive psychology
1375283|NCT01270568|cardiovascular disease|cardiovascular disease
1375284|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
1375285|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
1375286|NCT01270529|Physical Activity|physical activity
1375287|NCT01270529|Physical Performance|physical performance
1375288|NCT01270529|Physical Functioning|physical functioning
1375291|NCT01270529|Transplant Recipients|transplant recipients
1375292|NCT01270516|diaphragm|diaphragm
1375293|NCT01270516|limb muscle|limb muscle
1375294|NCT01270516|EPA|epa
1375295|NCT01270516|HMB|hmb
1375296|NCT01270516|ICU patients|icu patients
1375297|NCT01270503|Meningitis|meningitis
1375298|NCT01270503|Meningococcal disease|meningococcal disease
1375299|NCT01270503|Menactra®|menactra®
1375300|NCT01270490|candidemia|candidemia
1375301|NCT01270490|candida sepsis|candida sepsis
1375302|NCT01270490|invasive fungal disease|invasive fungal disease
1375303|NCT01270477|Frost injury|frost injury
1375304|NCT01270451|Weight maintenance|weight maintenance
1375305|NCT01270451|Group counseling|group counseling
1375306|NCT01270451|Prevention of diseases|prevention of diseases
1375307|NCT01270425|systemic sclerosis|systemic sclerosis
1375308|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
1375309|NCT01270425|thyroid nodules|thyroid nodules
1375310|NCT01270412|Osteoarthritis|osteoarthritis
1375311|NCT01270412|PRP|prp
1375312|NCT01270412|PRGF|prgf
1375313|NCT01270412|Hyaluronic acid|hyaluronic acid
1375314|NCT01270386|NSCLC|nsclc
1375315|NCT01270386|apatinib|apatinib
1375316|NCT01270386|phase II|phase ii
1375317|NCT01270386|lung|lung
1375318|NCT01270386|cancer|cancer
1375319|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
1375320|NCT01270373|drug therapy|drug therapy
1375321|NCT01270321|Thyroid Cancer|thyroid cancer
1375322|NCT01270308|Bioequivalence|bioequivalence
1375323|NCT01270308|two way crossover|two way crossover
1375324|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
1375325|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
1375326|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
1375327|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
1375328|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
1375329|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
1375330|NCT01270295|Pentosidine|pentosidine
1375331|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
1375332|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
1375333|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1375334|NCT01270295|Alveolar epithelium|alveolar epithelium
1375335|NCT01270295|Mechanical ventilation|mechanical ventilation
1375336|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
1375337|NCT01270269|Asthenia|asthenia
1375338|NCT01270269|Muscle Weakness|muscle weakness
1375339|NCT01270269|Brain Injuries|brain injuries
1375340|NCT01270269|Critical Illness|critical illness
1375341|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
1375342|NCT01270269|Rehabilitation|rehabilitation
1375343|NCT01270269|Sepsis|sepsis
1375344|NCT01270269|Respiratory Failure|respiratory failure
1375345|NCT01270269|Delirium|delirium
1375346|NCT01270269|Over-sedation|over-sedation
1375347|NCT01270269|Immobility|immobility
1375348|NCT01270269|Aging|aging
1375349|NCT01270269|Signs and Symptoms|signs and symptoms
1375350|NCT01270269|Muscular Diseases|muscular diseases
1375351|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
1375352|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
1375353|NCT01270269|Neurologic Manifestations|neurologic manifestations
1375354|NCT01270269|Pathologic Processes|pathologic processes
1375355|NCT01270269|Brain Diseases|brain diseases
1375356|NCT01270269|Central Nervous System Diseases|central nervous system diseases
1375357|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
1375358|NCT01270269|Trauma, Nervous System|trauma, nervous system
1375359|NCT01270269|Wounds and Injuries|wounds and injuries
1375360|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
1375361|NCT01270256|allergy|allergy
1375362|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
1375363|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
1375364|NCT01270217|Automobile driving|automobile driving
1375365|NCT01270217|Driving under the influence|driving under the influence
1375366|NCT01270217|Interview, psychological|interview, psychological
1375367|NCT01270217|Brief intervention|brief intervention
1375368|NCT01270217|Brief motivational interview|brief motivational interview
1375369|NCT01270204|Dysphagia|dysphagia
1375370|NCT01270204|Swallowing Problems|swallowing problems
1567126|NCT00509938|hLF1-11|hlf1-11
1375371|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
1375372|NCT01270204|Aspiration|aspiration
1375373|NCT01270204|Regurgitation|regurgitation
1375374|NCT01270204|Acid Reflux|acid reflux
1375375|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
1375376|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
1375377|NCT01270165|lamivudine|lamivudine
1375378|NCT01270165|telbivudine|telbivudine
1375379|NCT01270165|adefovir|adefovir
1375380|NCT01270165|lamivudine resistance|lamivudine resistance
1375381|NCT01270152|ascorbic acid|ascorbic acid
1375382|NCT01270152|catheterization central venous|catheterization central venous
1375383|NCT01270152|nursing care|nursing care
1375384|NCT01270139|nanoparticles|nanoparticles
1375489|NCT01269697|AMD|amd
1375385|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
1375386|NCT01270139|plasmonics|plasmonics
1375387|NCT01270139|atherosclerosis|atherosclerosis
1375388|NCT01270139|IVUS|ivus
1375389|NCT01270139|stenting|stenting
1375390|NCT01270126|optic neuropathy|optic neuropathy
1375391|NCT01270126|alternating current stimulation|alternating current stimulation
1375392|NCT01270126|vision recovery|vision recovery
1375393|NCT01270126|restoration|restoration
1375394|NCT01270126|plasticity|plasticity
1375395|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
1375396|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
1375397|NCT01270074|azithromycin|azithromycin
1375398|NCT01270074|infant|infant
1375399|NCT01270074|pediatric|pediatric
1375400|NCT01270074|cystic fibrosis|cystic fibrosis
1375401|NCT01270074|bronchiectasis|bronchiectasis
1375402|NCT01270061|HIV testing|hiv testing
1375403|NCT01270061|black Africans|black africans
1375404|NCT01270061|immigrants|immigrants
1375405|NCT01270061|health screening|health screening
1375406|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
1375407|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
1375408|NCT01269996|JUBILEE Study|jubilee study
1375409|NCT01269996|Janumet|janumet
1375410|NCT01269996|Lantus|lantus
1377416|NCT01261325|Epilepsy|epilepsy
1375411|NCT01269983|low back pain|low back pain
1375412|NCT01269983|fascial manipulation|fascial manipulation
1375413|NCT01269983|physioterapy|physioterapy
1375414|NCT01269983|physical activity|physical activity
1375415|NCT01269957|halitosis|halitosis
1375416|NCT01269957|pediatric dentistry|pediatric dentistry
1375417|NCT01269957|mouth breathing|mouth breathing
1375418|NCT01269944|osteoarthritis|osteoarthritis
1375419|NCT01269944|knee|knee
1375420|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
1375421|NCT01269944|dGEMRIC|dgemric
1375422|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
1375423|NCT01269931|bronchoscopy|bronchoscopy
1375424|NCT01269931|education|education
1375425|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
1375426|NCT01269931|simulation|simulation
1375427|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
1375428|NCT01269918|Adult solid neoplasm|adult solid neoplasm
1375429|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
1375430|NCT01269879|epicondylitis|epicondylitis
1375431|NCT01269879|pain|pain
1375432|NCT01269879|tendon|tendon
1375433|NCT01269866|Lupus Pain|lupus pain
1375434|NCT01269866|Lupus|lupus
1375435|NCT01269866|Pain|pain
1375436|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
1375437|NCT01269866|Duloxetine|duloxetine
1375438|NCT01269866|Cymbalta|cymbalta
1375439|NCT01269853|GBM|gbm
1375440|NCT01269853|AA|aa
1375441|NCT01269853|AO|ao
1375442|NCT01269853|Brain|brain
1375443|NCT01269853|Tumors|tumors
1375444|NCT01269853|Malignant|malignant
1375445|NCT01269853|Glioblastoma|glioblastoma
1375446|NCT01269853|Multiforme|multiforme
1375447|NCT01269853|Anaplastic|anaplastic
1375448|NCT01269853|Astrocytoma|astrocytoma
1375449|NCT01269827|inflammation|inflammation
1375450|NCT01269827|pentoxifylline|pentoxifylline
1375451|NCT01269827|hemodialysis|hemodialysis
1375452|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
1375453|NCT01269814|Emergency endoscopy|emergency endoscopy
1375454|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
1375455|NCT01269801|BOTOX|botox
1375456|NCT01269801|JUVEDERM|juvederm
1375457|NCT01269801|Prospective|prospective
1375458|NCT01269801|Open Label|open label
1375459|NCT01269801|Randomized|randomized
1375460|NCT01269801|Crossover Study|crossover study
1375461|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
1375462|NCT01269788|heartburn|heartburn
1375463|NCT01269788|functional|functional
1375464|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
1375465|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
1375466|NCT01269762|Red yeast rice|red yeast rice
1375467|NCT01269762|Lovastatin|lovastatin
1375468|NCT01269762|Drug-drug interaction|drug-drug interaction
1375469|NCT01269762|Pharmacokinetics|pharmacokinetics
1375470|NCT01269749|Hyperthyroidism|hyperthyroidism
1375471|NCT01269749|Antithyroid drugs|antithyroid drugs
1375472|NCT01269749|Cancer|cancer
1375473|NCT01269749|Dosimetry|dosimetry
1375474|NCT01269749|Children|children
1375475|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
1375476|NCT01269736|arrhythmia|arrhythmia
1375477|NCT01269736|myocardial ischemia|myocardial ischemia
1375478|NCT01269723|Smoking|smoking
1375479|NCT01269723|influenza|influenza
1375480|NCT01269723|influenza vaccine|influenza vaccine
1375481|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
1375482|NCT01269710|Schizophrenia|schizophrenia
1375483|NCT01269710|Schizoaffective|schizoaffective
1375484|NCT01269710|Schizophreniform|schizophreniform
1375485|NCT01269710|Psychosis NOS|psychosis nos
1375486|NCT01269710|Mood Disorders|mood disorders
1375487|NCT01269710|Weight|weight
1375488|NCT01269710|Autism|autism
1375490|NCT01269697|food supplementation|food supplementation
1375491|NCT01269697|macular pigments|macular pigments
1375492|NCT01269697|luthéine|luthéine
1375493|NCT01269697|zéaxanthine|zéaxanthine
1375494|NCT01269697|visual acuity|visual acuity
1375495|NCT01269697|prevention|prevention
1375496|NCT01269697|genetique risk|genetique risk
1375497|NCT01269684|Kidney|kidney
1375498|NCT01269684|renal|renal
1375499|NCT01269684|transplantation|transplantation
1375500|NCT01269684|tacrolimus|tacrolimus
1375501|NCT01269684|everolimus|everolimus
1375502|NCT01269684|stable allograft recipients|stable allograft recipients
1375503|NCT01269671|Functional Abdominal Pain|functional abdominal pain
1375504|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
1375505|NCT01269671|IBS|ibs
1375506|NCT01269671|Functional Dyspepsia|functional dyspepsia
1375507|NCT01269671|Melatonin|melatonin
1375508|NCT01269671|Simethicone|simethicone
1375509|NCT01269671|Peppermint Oil|peppermint oil
1375510|NCT01269671|mentharil|mentharil
1375511|NCT01269671|functional bowel disorders|functional bowel disorders
1375512|NCT01269671|quality of life|quality of life
1375513|NCT01269645|Cancer|cancer
1375514|NCT01269645|Clinical trials|clinical trials
1375515|NCT01269632|teenagers to adult transition|teenagers to adult transition
1375516|NCT01269632|comparison|comparison
1375517|NCT01269619|back pain|back pain
1375519|NCT01269619|lumbar support|lumbar support
1375520|NCT01269619|dynamic support|dynamic support
1375521|NCT01269593|PET Scan|pet scan
1375522|NCT01269593|124I-PUH71|124i-puh71
1375523|NCT01269593|10-139|10-139
1375524|NCT01269567|RectalNeoplasms|rectalneoplasms
1375525|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
1375526|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
1375527|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1375528|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
1375529|NCT01269567|Neoplasms by Site|neoplasms by site
1375530|NCT01269567|Digestive System Diseases|digestive system diseases
1375531|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
1375532|NCT01269567|Intestinal Diseases|intestinal diseases
1375533|NCT01269567|Rectal Diseases|rectal diseases
1375534|NCT01269554|diarrhea|diarrhea
1375535|NCT01269554|Guinea-Bissau|guinea-bissau
1375536|NCT01269554|Finland|finland
1375537|NCT01269554|Children|children
1375538|NCT01269554|Adults|adults
1375539|NCT01269554|Intestinal pathogens|intestinal pathogens
1375540|NCT01269554|Bacteria|bacteria
1375541|NCT01269554|Virus|virus
1375542|NCT01269554|Parasites|parasites
1375543|NCT01269528|Palivizumab|palivizumab
1375544|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
1375545|NCT01269528|EBC|ebc
1375546|NCT01269528|MCT|mct
1375547|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
1375548|NCT01269515|HIV|hiv
1375549|NCT01269515|immune activation|immune activation
1375550|NCT01269515|immune modulating|immune modulating
1375551|NCT01269515|progression markers|progression markers
1375552|NCT01269515|vaccine|vaccine
1375553|NCT01269489|quality of life|quality of life
1375554|NCT01269489|general Slovenian population|general slovenian population
1375555|NCT01269489|EORTC QLQ C30|eortc qlq c30
1375556|NCT01269463|Attention deficit|attention deficit
1375557|NCT01269463|Hyperactivity|hyperactivity
1375558|NCT01269463|Impulsivity|impulsivity
1375559|NCT01269463|Inattention|inattention
1375560|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
1375561|NCT01269450|late abortion|late abortion
1375562|NCT01269450|preterm birth|preterm birth
1375563|NCT01269450|progesterone|progesterone
1375564|NCT01269437|mild to moderate asthma|mild to moderate asthma
1375565|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
1375566|NCT01269424|adult glioblastoma|adult glioblastoma
1375567|NCT01269424|adult gliosarcoma|adult gliosarcoma
1375568|NCT01269385|Imprime PGG|imprime pgg
1375569|NCT01269372|polyps|polyps
1375570|NCT01269372|capsule endoscopy|capsule endoscopy
1375571|NCT01269372|colonoscopy|colonoscopy
1375572|NCT01269346|Locally recurrent|locally recurrent
1375573|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
1375574|NCT01269307|Anesthesia|anesthesia
1375575|NCT01269307|Pain|pain
1375576|NCT01269307|Procedural sedation|procedural sedation
1375577|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
1375578|NCT01269294|Hepatitis C|hepatitis c
1375579|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
1375580|NCT01269294|TMC435-C117|tmc435-c117
1375581|NCT01269294|TMC435|tmc435
1375582|NCT01269294|HCV|hcv
1375583|NCT01269294|Moxifloxacin|moxifloxacin
1375584|NCT01269294|ECG|ecg
1375585|NCT01269294|QT|qt
1375586|NCT01269294|QTc|qtc
1375587|NCT01269281|Bioequivalence|bioequivalence
1375588|NCT01269281|two way crossover|two way crossover
1375589|NCT01269242|coronary restenosis|coronary restenosis
1375590|NCT01269242|angioplasty|angioplasty
1375591|NCT01269242|stent|stent
1375592|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
1375593|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
1375594|NCT01269203|multiple myeloma|multiple myeloma
1375595|NCT01269203|MM|mm
1375596|NCT01269203|maintenance therapy|maintenance therapy
1375597|NCT01269203|lenalidomide|lenalidomide
1375598|NCT01269203|bone marrow transplantation|bone marrow transplantation
1375599|NCT01269203|auto-HSCT|auto-hsct
1375600|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
1375601|NCT01269203|NF-kB inhibition|nf-kb inhibition
1375602|NCT01269203|reducing symptoms|reducing symptoms
1375603|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
1375604|NCT01269203|inflammatory cytokines|inflammatory cytokines
1375605|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
1375606|NCT01269203|NF-kB|nf-kb
1375607|NCT01269203|interleukin|interleukin
1375608|NCT01269203|IL-6|il-6
1375609|NCT01269203|tumor necrosis factor|tumor necrosis factor
1375610|NCT01269203|TNF-a|tnf-a
1375611|NCT01269203|NF-kB activation levels|nf-kb activation levels
1375612|NCT01269190|oral mucosa in vivo|oral mucosa in vivo
1375613|NCT01269190|Wide-Field In Vivo Imaging|wide-field in vivo imaging
1375614|NCT01269190|High Resolution In Vivo Imaging|high resolution in vivo imaging
1375615|NCT01269190|Oral Neoplasia|oral neoplasia
1375616|NCT01269190|Topical Fluorescent Dyes|topical fluorescent dyes
1375617|NCT01269190|contrast dye|contrast dye
1375618|NCT01269190|oral dysplasia|oral dysplasia
1375619|NCT01269190|Proflavine|proflavine
1375620|NCT01269190|oral lesions|oral lesions
1375621|NCT01269190|surgical resection|surgical resection
1375622|NCT01269190|High Resolution Microendoscope|high resolution microendoscope
1375624|NCT01269190|Identafi 3000|identafi 3000
1375625|NCT01269190|Multispectral Digital Microscope|multispectral digital microscope
1375626|NCT01269190|MDM|mdm
1375627|NCT01269190|Portable Screening System|portable screening system
1375628|NCT01269190|PS2|ps2
1375629|NCT01269177|ACPE|acpe
1375630|NCT01269177|Acute respiratory failure|acute respiratory failure
1375631|NCT01269177|Non invasive ventilation|non invasive ventilation
1375632|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
1375633|NCT01269164|Face Transplant|face transplant
1375634|NCT01269164|Facial Transplantation|facial transplantation
1375635|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
1375636|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
1375637|NCT01269151|Retinal Function|retinal function
1375638|NCT01269151|multifocal-ERG|multifocal-erg
1375639|NCT01269151|Electroretinography|electroretinography
1375640|NCT01269151|microperimetry|microperimetry
1375641|NCT01269151|Lucentis|lucentis
1375642|NCT01269151|Ranibizumab|ranibizumab
1375643|NCT01269151|longterm effects|longterm effects
1375644|NCT01269151|best corrected visual acuity|best corrected visual acuity
1375645|NCT01269151|BCVA|bcva
1375646|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
1375647|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
1375648|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
1375649|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
1375650|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
1375651|NCT01269125|cytokines|cytokines
1375652|NCT01269125|endometriosis|endometriosis
1375653|NCT01269125|fertilization rate|fertilization rate
1375654|NCT01269125|follicular fluid|follicular fluid
1375655|NCT01269125|pregnancy rate|pregnancy rate
1375656|NCT01269099|hypokalemia|hypokalemia
1375657|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
1375658|NCT01269086|Primary Heath Care|primary heath care
1375659|NCT01269086|Preventive Medicine|preventive medicine
1375660|NCT01269086|Adolescent Health Services|adolescent health services
1375661|NCT01269086|Spouses|spouses
1375662|NCT01269086|Family|family
1375663|NCT01269086|Family Practice|family practice
1375664|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
1375665|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
1375666|NCT01269047|type 1 diabetes|type 1 diabetes
1375667|NCT01269047|Symlin|symlin
1375668|NCT01269047|Byetta|byetta
1375669|NCT01269047|CGMS iPro|cgms ipro
1375670|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
1375671|NCT01269034|diabetes|diabetes
1375672|NCT01269034|healthy controls|healthy controls
1375673|NCT01269034|exenatide|exenatide
1375674|NCT01269034|byetta|byetta
1375675|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
1375676|NCT01269008|Closed loop|closed loop
1375677|NCT01269008|type 1 diabetes|type 1 diabetes
1375678|NCT01269008|Symlin|symlin
1375679|NCT01269008|Byetta|byetta
1375680|NCT01269008|diabetes|diabetes
1375681|NCT01269008|insulin|insulin
1375682|NCT01269008|insulin pump|insulin pump
1375683|NCT01268995|NODAT|nodat
1375684|NCT01268995|kidney transplantation|kidney transplantation
1375685|NCT01268995|beta cell function|beta cell function
1375686|NCT01268995|insulin|insulin
1375687|NCT01268995|Tacrolimus|tacrolimus
1375688|NCT01268995|Cyclosporine A|cyclosporine a
1375689|NCT01268982|socket preservation|socket preservation
1375690|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
1375691|NCT01268969|pilonidal disease PND|pilonidal disease pnd
1375692|NCT01268943|rectal neoplasms|rectal neoplasms
1375693|NCT01268943|aged|aged
1375694|NCT01268943|radiotherapy|radiotherapy
1375695|NCT01268943|drug therapy|drug therapy
1375696|NCT01268943|dose-escalation|dose-escalation
1375697|NCT01268943|capecitabine|capecitabine
1375698|NCT01268930|ovarian reserve|ovarian reserve
1375699|NCT01268930|endometrioma excision|endometrioma excision
1375700|NCT01268930|hemostatic matrix|hemostatic matrix
1375701|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
1375702|NCT01268930|thermal injury|thermal injury
1375703|NCT01268917|coronary artery disease|coronary artery disease
1375704|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
1375705|NCT01268917|aspirin|aspirin
1375706|NCT01268891|Azilect|azilect
1375707|NCT01268891|Motor fluctuations|motor fluctuations
1375708|NCT01268891|Parkinson´s Disease|parkinson´s disease
1375709|NCT01268891|Rasagiline|rasagiline
1375710|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
1375711|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
1375712|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
1375713|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
1375714|NCT01268865|liver fibrosis|liver fibrosis
1375715|NCT01268865|cirrhosis|cirrhosis
1375716|NCT01268865|hepatitis B|hepatitis b
1375717|NCT01268865|hepatitis C|hepatitis c
1375718|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
1375719|NCT01268800|AML|aml
1375721|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
1375722|NCT01268761|GnRH antagonist|gnrh antagonist
1375723|NCT01268761|Ascitis.|ascitis.
1375724|NCT01268748|single site surgery|single site surgery
1375725|NCT01268748|laparoscopic surgery|laparoscopic surgery
1375726|NCT01268748|pain|pain
1375727|NCT01268748|nausea|nausea
1375728|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
1375729|NCT01268735|Dry Eye|dry eye
1375730|NCT01268735|LIPCOF|lipcof
1375731|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
1375732|NCT01268722|Nitinol Stent|nitinol stent
1375733|NCT01268722|Balloon angioplasty|balloon angioplasty
1375734|NCT01268722|Chronic total occlusions|chronic total occlusions
1375735|NCT01268722|Femoropopliteal|femoropopliteal
1375736|NCT01268696|diabetes|diabetes
1375737|NCT01268696|obesity|obesity
1375738|NCT01268696|hypertension|hypertension
1375739|NCT01268696|dyslipidemia|dyslipidemia
1375740|NCT01268683|Ischemic stroke|ischemic stroke
1375741|NCT01268657|PTSD|ptsd
1375742|NCT01268657|Fear of Falling|fear of falling
1375743|NCT01268657|Older Adults|older adults
1375744|NCT01268657|Injurious Falls|injurious falls
1375745|NCT01268657|Exposure Therapy|exposure therapy
1375746|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1375747|NCT01268631|Fibromyalgia|fibromyalgia
1375748|NCT01268631|Pain modulation|pain modulation
1375749|NCT01268618|IBS|ibs
1375750|NCT01268618|Diarrhea|diarrhea
1375751|NCT01268618|Dyspepsia|dyspepsia
1375752|NCT01268605|Dental caries|dental caries
1375753|NCT01268605|Resin based composite|resin based composite
1375754|NCT01268605|Hypersensitivity|hypersensitivity
1375755|NCT01268605|Teeth|teeth
1375756|NCT01268605|Dentistry|dentistry
1375757|NCT01268605|Practice-based research network|practice-based research network
1375758|NCT01268592|fertility preservation|fertility preservation
1375759|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
1375760|NCT01268592|vitrification|vitrification
1375761|NCT01268592|egg freezing|egg freezing
1375762|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
1375763|NCT01268579|ribavirin|ribavirin
1375764|NCT01268579|VIRAZOLE|virazole
1375765|NCT01268579|tonsil|tonsil
1375766|NCT01268579|base of tongue|base of tongue
1375767|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
1375768|NCT01268579|10-218|10-218
1375769|NCT01268566|Glioblastoma|glioblastoma
1375770|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
1375771|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
1375772|NCT01268540|intraocular lens|intraocular lens
1375774|NCT01268540|cataract|cataract
1375775|NCT01268540|refractive astigmatism|refractive astigmatism
1375776|NCT01268540|Aspheric|aspheric
1375777|NCT01268540|Toric|toric
1375778|NCT01268540|Hoya|hoya
1375779|NCT01268540|Surgical|surgical
1375780|NCT01268540|Optics|optics
1375781|NCT01268540|visual acuity|visual acuity
1375782|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
1375783|NCT01268514|Complex|complex
1375784|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
1375785|NCT01268514|AWR|awr
1375786|NCT01268514|Hernia|hernia
1375787|NCT01268475|Bronchiectasis|bronchiectasis
1375788|NCT01268475|Quality of Life|quality of life
1375789|NCT01268475|Respiratory Function Tests|respiratory function tests
1375790|NCT01268475|Exercise Test|exercise test
1375791|NCT01268449|Tinnitus|tinnitus
1375792|NCT01268449|Low power laser|low power laser
1375793|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
1375794|NCT01268423|Swallowing dysfunction|swallowing dysfunction
1375795|NCT01268423|Mechanical ventilation|mechanical ventilation
1375796|NCT01268423|Intensive Care|intensive care
1375797|NCT01268410|Acute respiratory failure|acute respiratory failure
1375798|NCT01268410|Acute lung injury|acute lung injury
1375799|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
1375800|NCT01268410|Mechanical Ventilation|mechanical ventilation
1375801|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
1375803|NCT01268397|wrist fracture|wrist fracture
1375804|NCT01268397|fracture of the distal radius|fracture of the distal radius
1375805|NCT01268397|volar plate|volar plate
1375806|NCT01268397|plaster cast|plaster cast
1375807|NCT01268384|pancreatic cancer|pancreatic cancer
1375808|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1375809|NCT01268384|gemcitabine|gemcitabine
1375810|NCT01268384|capecitabine|capecitabine
1375811|NCT01268371|Coronary artery disease|coronary artery disease
1375812|NCT01268371|Stent|stent
1375813|NCT01268345|blood glucose|blood glucose
1375814|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
1375815|NCT01268319|Myocardial Infarction|myocardial infarction
1375816|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
1375817|NCT01268319|embolization|embolization
1375818|NCT01268319|necrotic core|necrotic core
1375819|NCT01268319|vulnerable plaque|vulnerable plaque
1375820|NCT01268319|coronary plaque rupture|coronary plaque rupture
1375821|NCT01268306|contact lens|contact lens
1375822|NCT01268306|corneal staining|corneal staining
1375823|NCT01268306|fluorescein staining|fluorescein staining
1375824|NCT01268306|preservatives|preservatives
1375825|NCT01268306|keratitis|keratitis
1375826|NCT01268306|punctate keratopathy|punctate keratopathy
1375827|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
1375828|NCT01268306|SPK|spk
1375829|NCT01268293|Cancer|cancer
1375830|NCT01268254|wine|wine
1375831|NCT01268254|aging|aging
1375832|NCT01268254|atherosclerosis|atherosclerosis
1375833|NCT01268254|telomere|telomere
1375834|NCT01268254|tomography|tomography
1375835|NCT01268254|coronary vessels|coronary vessels
1375836|NCT01268241|Fabry Disease|fabry disease
1375837|NCT01268241|Fabry´s Disease|fabry´s disease
1375838|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
1375839|NCT01268228|intracoronary ECG|intracoronary ecg
1375840|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
1375841|NCT01268228|side branch compromise|side branch compromise
1375842|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
1375843|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1375844|NCT01268215|Budesonide|budesonide
1375845|NCT01268215|Infasurf|infasurf
1375846|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
1375847|NCT01268189|burn wound|burn wound
1375848|NCT01268189|management with oxygen|management with oxygen
1375849|NCT01268176|Vitamin D|vitamin d
1375850|NCT01268176|vitamin D deficiency|vitamin d deficiency
1375851|NCT01268176|vitamin D absorption|vitamin d absorption
1375852|NCT01268163|Docetaxel|docetaxel
1375853|NCT01268163|Phase I|phase i
1375854|NCT01268163|Pharmacokinetic|pharmacokinetic
1375855|NCT01268163|Bioequivalence|bioequivalence
1375856|NCT01268137|MDD|mdd
1375857|NCT01268137|DBS|dbs
1375858|NCT01268124|Japanese|japanese
1375859|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
1375860|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
1375861|NCT01268085|Radiation Safety|radiation safety
1375862|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
1375863|NCT01268085|Decision Support|decision support
1375864|NCT01268085|Cat Scans|cat scans
1375865|NCT01268072|COPD|copd
1375866|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
1375867|NCT01268059|NSCLC|nsclc
1375868|NCT01268046|aging|aging
1375869|NCT01268046|postmenopausal women|postmenopausal women
1375870|NCT01268046|estrogen|estrogen
1375871|NCT01268046|memory|memory
1375872|NCT01268033|rituximab|rituximab
1375873|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
1375874|NCT01268033|minimal change disease|minimal change disease
1375875|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
1375876|NCT01268020|Alzheimer|alzheimer
1375877|NCT01268020|AD|ad
1375878|NCT01267994|Steroid|steroid
1375879|NCT01267994|Steroid-Resistant|steroid-resistant
1375880|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
1375881|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
1375882|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
1375883|NCT01267994|Meniere's Disease|meniere's disease
1375884|NCT01267994|Autoimmune|autoimmune
1375885|NCT01267994|Hearing|hearing
1375886|NCT01267981|Small bowel|small bowel
1375887|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
1375888|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
1375889|NCT01267981|polyethylene glycol|polyethylene glycol
1375890|NCT01267968|pharmacokinetics|pharmacokinetics
1375891|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
1375892|NCT01267968|GSK2251052|gsk2251052
1375893|NCT01267968|pulmonary|pulmonary
1375894|NCT01267968|healthy volunteer|healthy volunteer
1375895|NCT01267968|antimicrobial|antimicrobial
1375896|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
1375897|NCT01267929|Children with cerebral palsy|children with cerebral palsy
1375898|NCT01267929|Gross Motor Function Measure|gross motor function measure
1375899|NCT01267929|Imitative learning|imitative learning
1375900|NCT01267929|Mirror neuron|mirror neuron
1375901|NCT01267929|Action observation|action observation
1375902|NCT01267929|Conventional physical therapy|conventional physical therapy
1375903|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
1375904|NCT01267916|obesity|obesity
1375905|NCT01267916|ventilator setting|ventilator setting
1375906|NCT01267916|respiratory rate|respiratory rate
1375907|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
1375908|NCT01267890|ethics|ethics
1375909|NCT01267890|law|law
1375910|NCT01267890|surrogate|surrogate
1375911|NCT01267890|conflict|conflict
1375912|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
1375913|NCT01267877|Patient attitude|patient attitude
1375914|NCT01267877|Mammogram|mammogram
1375915|NCT01267877|Guideline|guideline
1375916|NCT01267864|migraine|migraine
1375917|NCT01267864|emergency|emergency
1375918|NCT01267864|metoclopramide|metoclopramide
1375919|NCT01267864|ketorolac|ketorolac
1375920|NCT01267864|valproate|valproate
1375921|NCT01267851|gynecologic disease|gynecologic disease
1375922|NCT01267838|Coronary artery disease|coronary artery disease
1375923|NCT01267838|Restenosis|restenosis
1375924|NCT01267838|Stent thrombosis|stent thrombosis
1375925|NCT01267825|Disc herniation|disc herniation
1375926|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
1375927|NCT01267825|Corticosteroids|corticosteroids
1375928|NCT01267786|Oxidotic stress|oxidotic stress
1375929|NCT01267773|depression|depression
1375930|NCT01267773|conduct problems|conduct problems
1375931|NCT01267760|dialysis|dialysis
1375932|NCT01267760|hemodialysis|hemodialysis
1375933|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
1375934|NCT01267747|Atrial fibrillation|atrial fibrillation
1375935|NCT01267747|Atrial Flutter|atrial flutter
1375936|NCT01267747|Primary Aldosteronism|primary aldosteronism
1375937|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
1375938|NCT01267734|Everolimus|everolimus
1375939|NCT01267734|Zotarolimus|zotarolimus
1375940|NCT01267734|Cilostazol|cilostazol
1375941|NCT01267734|Clopidogrel|clopidogrel
1375942|NCT01267721|heart surgery|heart surgery
1375943|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1375944|NCT01267695|Imatinib mesylate|imatinib mesylate
1375945|NCT01267695|Perioperative therapy|perioperative therapy
1375946|NCT01267682|Delirium|delirium
1375947|NCT01267682|Dementia|dementia
1375948|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
1375949|NCT01267682|Post-acute care|post-acute care
1375950|NCT01267669|Variceal bleeding|variceal bleeding
1375951|NCT01267669|Endoscopic therapy|endoscopic therapy
1375952|NCT01267669|Band ligation|band ligation
1375953|NCT01267669|Somatostatin|somatostatin
1375954|NCT01267669|Vasoactive drugs|vasoactive drugs
1375955|NCT01267669|Octreotide|octreotide
1375956|NCT01267643|Alefacept|alefacept
1375957|NCT01267643|Amevive|amevive
1375958|NCT01267643|Aplastic Anemia|aplastic anemia
1375959|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
1375960|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
1375961|NCT01267630|Subacute Delirium|subacute delirium
1375962|NCT01267630|Mental Disorders, Organic|mental disorders, organic
1375963|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
1375964|NCT01267630|Organic Mental Disorders|organic mental disorders
1375965|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
1375966|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
1375967|NCT01267630|Cognition Disorder|cognition disorder
1375968|NCT01267630|Confusion state|confusion state
1375969|NCT01267630|Disorientation|disorientation
1375970|NCT01267617|hemodialysis|hemodialysis
1375971|NCT01267617|hypotension|hypotension
1375972|NCT01267617|circulatory stress|circulatory stress
1375973|NCT01267617|photo-plethysmography|photo-plethysmography
1375974|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
1375975|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
1375976|NCT01267565|prevention|prevention
1375978|NCT01267565|tracheal aspiration|tracheal aspiration
1375979|NCT01267565|microaspiration|microaspiration
1375980|NCT01267552|Breast cancer|breast cancer
1375981|NCT01267552|Surgery|surgery
1375982|NCT01267552|Complications|complications
1375983|NCT01267552|Drainage|drainage
1375984|NCT01267552|Seroma|seroma
1375985|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
1375986|NCT01267526|Growth disorders|growth disorders
1375987|NCT01267526|Saizen|saizen
1375988|NCT01267526|Easypod|easypod
1375989|NCT01267526|Growth hormone|growth hormone
1375990|NCT01267526|Pediatric subject|pediatric subject
1375991|NCT01267513|oxygen saturation|oxygen saturation
1375992|NCT01267513|pulse rate|pulse rate
1375993|NCT01267513|tachycardia|tachycardia
1375994|NCT01267513|bradycardia|bradycardia
1375995|NCT01267513|hypoxia|hypoxia
1375996|NCT01267487|Heparin|heparin
1375997|NCT01267487|Protamine|protamine
1375998|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
1375999|NCT01267487|Titration|titration
1376000|NCT01267474|School children|school children
1376001|NCT01267474|Sugar intake|sugar intake
1376002|NCT01267474|Nutritional education program|nutritional education program
1376003|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
1376004|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
1376005|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
1376006|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
1376007|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
1376008|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
1376009|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
1376010|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
1376011|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
1376012|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
1376013|NCT01267396|Bioequivalence|bioequivalence
1376014|NCT01267396|Sertraline|sertraline
1376015|NCT01267396|crossover|crossover
1376016|NCT01267383|Bioequivalence|bioequivalence
1376017|NCT01267383|Sertraline|sertraline
1376018|NCT01267383|crossover|crossover
1376019|NCT01267370|clinical trial|clinical trial
1376020|NCT01267370|dietary fiber|dietary fiber
1376021|NCT01267370|constipation|constipation
1376022|NCT01267370|children|children
1376023|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
1376024|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
1376025|NCT01267357|biomarkers|biomarkers
1376026|NCT01267357|P16|p16
1376027|NCT01267357|P53|p53
1376028|NCT01267357|Prognosis|prognosis
1376029|NCT01267344|biliary tract cancer|biliary tract cancer
1376030|NCT01267344|BTC|btc
1376031|NCT01267344|cetuximaba|cetuximaba
1376032|NCT01267331|Old Myocardial Infarction|old myocardial infarction
1376033|NCT01267331|Stem Cell Therapy|stem cell therapy
1376034|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1376035|NCT01267331|Coronary Artery Disease|coronary artery disease
1376036|NCT01267318|Gastric juice|gastric juice
1376037|NCT01267318|Stomach|stomach
1376038|NCT01267318|GI|gi
1376039|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
1376040|NCT01267305|esophagectomy|esophagectomy
1376041|NCT01267305|lung resection|lung resection
1376042|NCT01267305|venous thromboembolism|venous thromboembolism
1376043|NCT01267305|low molecular weight heparin|low molecular weight heparin
1376044|NCT01267305|chest drainage|chest drainage
1376045|NCT01267305|TEG|teg
1376046|NCT01267292|cocaine dependence|cocaine dependence
1376047|NCT01267292|psychopharmacology|psychopharmacology
1376048|NCT01267292|attentional bias|attentional bias
1376049|NCT01267292|risky decision making|risky decision making
1376050|NCT01267292|buspirone|buspirone
1376051|NCT01267292|methylphenidate|methylphenidate
1376052|NCT01267227|Hyperlipidemia|hyperlipidemia
1376053|NCT01267227|Cholesterol|cholesterol
1376054|NCT01267227|Blood Pressure|blood pressure
1376055|NCT01267227|Oxidative Stress|oxidative stress
1376056|NCT01267227|Pterostilbene|pterostilbene
1376057|NCT01267227|Blueberry|blueberry
1376058|NCT01267227|Grape Extract|grape extract
1376059|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
1376060|NCT01267162|CHB|chb
1376061|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
1376062|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
1376063|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
1376064|NCT01267136|Tonsillectomy|tonsillectomy
1376065|NCT01267136|Pain|pain
1376066|NCT01267136|Pediatric|pediatric
1376067|NCT01267136|Opioids|opioids
1376068|NCT01267136|Tramadol|tramadol
1376069|NCT01267136|Codeine|codeine
1376070|NCT01267097|Pediatric Obesity|pediatric obesity
1376071|NCT01267097|Treatment|treatment
1376072|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
1376073|NCT01267097|Psychoeducation|psychoeducation
1376074|NCT01267097|Canada|canada
1376075|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
1376076|NCT01267084|Ketoconazole|ketoconazole
1376077|NCT01267084|Antineoplastic Agents|antineoplastic agents
1376078|NCT01267084|Solid tumors|solid tumors
1376079|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
1376080|NCT01267084|Chemotherapy|chemotherapy
1376081|NCT01267084|Pharmacokinetics|pharmacokinetics
1376082|NCT01267071|Entero-test|entero-test
1376083|NCT01267071|Phase I|phase i
1376084|NCT01267071|GSK962040|gsk962040
1376085|NCT01267071|i.v. microtracer|i.v. microtracer
1376086|NCT01267071|radioactivity|radioactivity
1376087|NCT01267071|pharmacokinetics|pharmacokinetics
1376088|NCT01267071|healthy volunteer|healthy volunteer
1376089|NCT01267058|Booster vaccination|booster vaccination
1376090|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
1376091|NCT01267045|Pain|pain
1376092|NCT01267045|Fatigue|fatigue
1376093|NCT01267045|Attention|attention
1376094|NCT01267045|Meditation|meditation
1376095|NCT01267019|social cognition|social cognition
1376096|NCT01267019|training intervention|training intervention
1376097|NCT01266993|Immunogenicity|immunogenicity
1376098|NCT01266993|Persistence|persistence
1376099|NCT01266993|Safety|safety
1376100|NCT01266993|Conjugate vaccine|conjugate vaccine
1376101|NCT01266993|Meningococcal vaccine|meningococcal vaccine
1376102|NCT01266980|cortisol|cortisol
1376103|NCT01266980|renal impairment|renal impairment
1376104|NCT01266980|serum potassium|serum potassium
1376105|NCT01266980|pharmacokinetics|pharmacokinetics
1376106|NCT01266980|Fluticasone furoate|fluticasone furoate
1376107|NCT01266980|heart rate|heart rate
1376108|NCT01266967|GSK2118436|gsk2118436
1376109|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
1376110|NCT01266967|Brain metastases|brain metastases
1376111|NCT01266967|Braf mutation|braf mutation
1376112|NCT01266967|Brain neoplasm|brain neoplasm
1376113|NCT01266967|BRAF inhibitor|braf inhibitor
1376114|NCT01266954|Cancer|cancer
1376115|NCT01266954|18F FDG|18f fdg
1376116|NCT01266954|PK|pk
1376117|NCT01266954|PET|pet
1376118|NCT01266954|Positron Emission Tomography|positron emission tomography
1376119|NCT01266954|PD|pd
1376120|NCT01266954|AKT Inhibitor|akt inhibitor
1376121|NCT01266954|GSK2141795|gsk2141795
1376122|NCT01266941|pharmacokinetics|pharmacokinetics
1376123|NCT01266941|hepatic impairment|hepatic impairment
1376124|NCT01266941|heart rate|heart rate
1376125|NCT01266941|serum potassium|serum potassium
1376126|NCT01266941|serum cortisol|serum cortisol
1376127|NCT01266941|GW642444M|gw642444m
1376128|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
1376129|NCT01266915|SCLE|scle
1376130|NCT01266915|CLE|cle
1376131|NCT01266915|DLE|dle
1376132|NCT01266902|HIV-1 Infection|hiv-1 infection
1376133|NCT01266902|HIV-1|hiv-1
1376134|NCT01266902|HIV|hiv
1376135|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
1376136|NCT01266902|TMC278-C222|tmc278-c222
1376137|NCT01266902|TMC278|tmc278
1376138|NCT01266902|Rilpivirine|rilpivirine
1376139|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
1376140|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
1376141|NCT01266863|E test|e test
1376142|NCT01266863|Antibiogram|antibiogram
1376143|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
1376144|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
1376145|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1376146|NCT01266837|biomarker|biomarker
1376147|NCT01266837|Everolimus|everolimus
1376148|NCT01266824|Pain|pain
1376149|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
1376150|NCT01266824|Neonates|neonates
1376151|NCT01266811|dexamethasone|dexamethasone
1376152|NCT01266811|Siltuximab|siltuximab
1376153|NCT01266811|CNTO 328|cnto 328
1376154|NCT01266811|IL-6|il-6
1376155|NCT01266811|Monoclonal Antibody|monoclonal antibody
1376156|NCT01266811|Multiple Myeloma|multiple myeloma
1376157|NCT01266811|Relapsed or Refractory|relapsed or refractory
1376158|NCT01266811|Velcade|velcade
1376159|NCT01266811|bortezomib|bortezomib
1376160|NCT01266798|Health literacy, participation|health literacy, participation
1376161|NCT01266785|crohn's|crohn's
1376162|NCT01266785|Infliximab|infliximab
1376163|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
1376164|NCT01266785|digestive tract|digestive tract
1376165|NCT01266785|Interleukin|interleukin
1376166|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
1376167|NCT01266759|Menorrhagia|menorrhagia
1376168|NCT01266759|Vaginal ring|vaginal ring
1376169|NCT01266759|Norethisterone Acetate|norethisterone acetate
1376170|NCT01266746|gas tamponade,|gas tamponade,
1376171|NCT01266746|macular hole,|macular hole,
1376172|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
1376173|NCT01266746|optical coherence tomography|optical coherence tomography
1376174|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
1376175|NCT01266720|pancreatic cancer|pancreatic cancer
1376176|NCT01266720|peptide vaccine|peptide vaccine
1376177|NCT01266720|VEGFR|vegfr
1376178|NCT01266720|gemcitabine|gemcitabine
1376179|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
1376283|NCT01266265|Tracleer|tracleer
1376180|NCT01266707|peptide vaccine|peptide vaccine
1376181|NCT01266707|VEGFR|vegfr
1376182|NCT01266694|Pericardial effusion|pericardial effusion
1376183|NCT01266694|Cardiac surgery|cardiac surgery
1376184|NCT01266694|Tamponade|tamponade
1376185|NCT01266694|colchicine|colchicine
1376186|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1376187|NCT01266668|Breast|breast
1376188|NCT01266668|Rituximab|rituximab
1376189|NCT01266642|Breast cancer|breast cancer
1376190|NCT01266642|Early invasive breast cancer|early invasive breast cancer
1376191|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
1376192|NCT01266642|Tis|tis
1376193|NCT01266642|T1|t1
1376194|NCT01266642|T2|t2
1376195|NCT01266642|N0|n0
1376196|NCT01266642|N1mic|n1mic
1376197|NCT01266642|N1a|n1a
1376198|NCT01266642|Lumpectomy|lumpectomy
1376199|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
1376200|NCT01266642|HF-WBI|hf-wbi
1376201|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
1376202|NCT01266642|CF-WBI|cf-wbi
1376203|NCT01266642|Radiation therapy|radiation therapy
1376204|NCT01266642|Radiotherapy|radiotherapy
1376205|NCT01266629|small bowel|small bowel
1376206|NCT01266616|Interleukin-12|interleukin-12
1376207|NCT01266616|Electroporation|electroporation
1376208|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1376209|NCT01266603|Metastatic Melanoma|metastatic melanoma
1376210|NCT01266603|Unresectable Melanoma|unresectable melanoma
1376211|NCT01266603|HDIL-2|hdil-2
1376212|NCT01266603|Interleukin-2|interleukin-2
1376213|NCT01266603|IL-2|il-2
1376214|NCT01266603|Aldesleukin|aldesleukin
1376215|NCT01266603|Proleukin|proleukin
1376216|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
1376217|NCT01266603|ASCI|asci
1376218|NCT01266603|recMAGE-A3|recmage-a3
1376219|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
1376220|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
1376221|NCT01266603|MAGE-A3|mage-a3
1376222|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
1376223|NCT01266577|Brain Metabolism|brain metabolism
1376224|NCT01266577|Neurochemistry|neurochemistry
1376225|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
1376226|NCT01266577|Mental Illness|mental illness
1376227|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1376228|NCT01266577|Healthy Volunteer|healthy volunteer
1376229|NCT01266577|HV|hv
1376230|NCT01266551|Antireflux procedure|antireflux procedure
1376231|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
1376232|NCT01266551|Infant sleep position|infant sleep position
1376233|NCT01266551|pH monitoring|ph monitoring
1376234|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
1376235|NCT01266486|Breast cancer|breast cancer
1376236|NCT01266486|Pharmacodynamics|pharmacodynamics
1376237|NCT01266486|AMPK|ampk
1376238|NCT01266486|PET Scan|pet scan
1376239|NCT01266473|Adults|adults
1376240|NCT01266434|moderate persistent asthma|moderate persistent asthma
1376241|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
1376242|NCT01266421|DNG|dng
1376243|NCT01266421|Anemia|anemia
1376244|NCT01266421|Depression|depression
1376245|NCT01266408|Drospirenone|drospirenone
1376246|NCT01266408|Dienogest|dienogest
1376247|NCT01266408|Metafolin|metafolin
1376248|NCT01266408|Folic acid|folic acid
1376249|NCT01266408|Safety|safety
1376250|NCT01266395|morning symptoms COPD|morning symptoms copd
1376251|NCT01266369|mastocytosis|mastocytosis
1376252|NCT01266369|D816V|d816v
1376253|NCT01266369|handicaps|handicaps
1376254|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
1376255|NCT01266356|Translation|translation
1376256|NCT01266343|Glaucoma|glaucoma
1376257|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
1376258|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
1376259|NCT01266330|dairy|dairy
1376260|NCT01266330|inflammation|inflammation
1376261|NCT01266330|reactive oxygen species|reactive oxygen species
1376262|NCT01266330|oxidative stress|oxidative stress
1376263|NCT01266330|body composition|body composition
1376264|NCT01266291|Tuberous sclerosis|tuberous sclerosis
1376265|NCT01266291|TS|ts
1376266|NCT01266291|Seizures|seizures
1376267|NCT01266278|shoulder injuries|shoulder injuries
1376268|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
1376269|NCT01266265|PAH|pah
1376270|NCT01266265|treprostinil sodium|treprostinil sodium
1376271|NCT01266265|Tyvaso|tyvaso
1376272|NCT01266265|inhalation|inhalation
1376273|NCT01266265|Ventavis|ventavis
1376274|NCT01266265|iloprost|iloprost
1376275|NCT01266265|prostacyclin|prostacyclin
1376276|NCT01266265|epoprostenol sodium|epoprostenol sodium
1376277|NCT01266265|Flolan|flolan
1376278|NCT01266265|Veletri|veletri
1376279|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
1376280|NCT01266265|Remodulin|remodulin
1376281|NCT01266265|oral ERA|oral era
1376282|NCT01266265|bosentan|bosentan
1376284|NCT01266265|ambrisentan|ambrisentan
1376285|NCT01266265|Letairis|letairis
1376286|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
1376287|NCT01266265|sildenafil|sildenafil
1376288|NCT01266265|Revatio|revatio
1376289|NCT01266265|tadalafil|tadalafil
1376290|NCT01266265|Adcirca|adcirca
1376291|NCT01266265|Opsumit|opsumit
1376292|NCT01266265|macitentan|macitentan
1376293|NCT01266265|Adempas|adempas
1376294|NCT01266265|riociguat|riociguat
1376295|NCT01266265|Orenitram|orenitram
1376296|NCT01266265|oral treprostinil|oral treprostinil
1376297|NCT01266252|neonates|neonates
1376298|NCT01266252|single organ respiratory failure|single organ respiratory failure
1376299|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
1376300|NCT01266226|Rotator cuff tears|rotator cuff tears
1376301|NCT01266226|ACP|acp
1376302|NCT01266213|fulvestrant|fulvestrant
1376303|NCT01266213|anastrozole|anastrozole
1376304|NCT01266213|goserelin|goserelin
1376305|NCT01266213|tamoxifen|tamoxifen
1376306|NCT01266213|premenopausal|premenopausal
1376307|NCT01266213|hormone receptor positive|hormone receptor positive
1376308|NCT01266200|microcirculation|microcirculation
1376309|NCT01266200|vertebral fracture|vertebral fracture
1376310|NCT01266200|inflammation|inflammation
1376311|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
1376312|NCT01266187|FOLFOX|folfox
1376313|NCT01266187|liver metastasis|liver metastasis
1376314|NCT01266187|cetuximab|cetuximab
1376315|NCT01266174|CIAS|cias
1376316|NCT01266174|Cognition|cognition
1376317|NCT01266174|Schizophrenia|schizophrenia
1376318|NCT01266174|Eltoprazine|eltoprazine
1376319|NCT01266161|dental pain|dental pain
1376320|NCT01266161|multiple dose|multiple dose
1376321|NCT01266161|ibuprofen|ibuprofen
1376322|NCT01266161|third molar extraction|third molar extraction
1376323|NCT01266135|Interstitial Lung Disease|interstitial lung disease
1376324|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
1376325|NCT01266135|Fibrosis,|fibrosis,
1376326|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
1376327|NCT01266135|Respiratory Disease,|respiratory disease,
1376328|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
1376329|NCT01266135|Biological Therapy,|biological therapy,
1376330|NCT01266135|Therapeutic Uses,|therapeutic uses,
1376331|NCT01266122|HIV|hiv
1376332|NCT01266122|Psychosocial problems|psychosocial problems
1376333|NCT01266122|MSM|msm
1376334|NCT01266122|India|india
1376335|NCT01266109|Substance Use|substance use
1376336|NCT01266109|Delinquency|delinquency
1376337|NCT01266109|Juvenile Drug Court|juvenile drug court
1376338|NCT01266109|Contingency Management|contingency management
1376339|NCT01266109|Family Engagement|family engagement
1376340|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
1376341|NCT01266096|Pet scan|pet scan
1376342|NCT01266096|10-155|10-155
1376343|NCT01266096|melanoma|melanoma
1376344|NCT01266096|brain|brain
1376345|NCT01266083|MONTANIDE ISA 51|montanide isa 51
1376346|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
1376347|NCT01266083|vaccine|vaccine
1376348|NCT01266083|10-143|10-143
1376349|NCT01266070|VHL|vhl
1376350|NCT01266070|Hemangioblastoma|hemangioblastoma
1376351|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
1376352|NCT01266070|TKI258|tki258
1376353|NCT01266057|Advanced Malignancies|advanced malignancies
1376354|NCT01266057|Metastatic cancers|metastatic cancers
1376355|NCT01266057|Sirolimus|sirolimus
1376356|NCT01266057|Hydroxychloroquine|hydroxychloroquine
1376357|NCT01266057|Vorinostat|vorinostat
1376358|NCT01266057|Plaquenil|plaquenil
1376359|NCT01266057|Rapamune|rapamune
1376360|NCT01266057|Saha|saha
1376361|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1376362|NCT01266057|MSK-390|msk-390
1376363|NCT01266057|Zolinza|zolinza
1376364|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
1376365|NCT01266044|Acupuncture|acupuncture
1376366|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
1376367|NCT01266044|Radiation Therapy|radiation therapy
1376368|NCT01266044|IMRT|imrt
1376369|NCT01266044|Dry mouth|dry mouth
1376370|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
1376371|NCT01266018|small cell lung cancer|small cell lung cancer
1376372|NCT01266018|SCLC|sclc
1376373|NCT01266018|ADI-PEG 20|adi-peg 20
1376374|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
1376375|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
1376376|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
1376377|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
1376378|NCT01265992|Chronic Kidney Disease|chronic kidney disease
1376379|NCT01265979|advanced|advanced
1376380|NCT01265979|metastatic|metastatic
1376381|NCT01265979|gastro-intestinal|gastro-intestinal
1376382|NCT01265979|stromal|stromal
1376383|NCT01265979|GIST|gist
1376384|NCT01265979|regorafenib|regorafenib
1376385|NCT01265966|Moderate Sedation|moderate sedation
1376386|NCT01265966|Sedation, Deep|sedation, deep
1376387|NCT01265953|cancer prevention|cancer prevention
1376688|NCT01264549|PCT|pct
1376388|NCT01265953|isothiocyanate|isothiocyanate
1376389|NCT01265953|sulforaphane|sulforaphane
1376390|NCT01265940|bladder cancer|bladder cancer
1376391|NCT01265940|urothelial cancer|urothelial cancer
1376392|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
1376393|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
1376394|NCT01265927|Breast Cancer|breast cancer
1376395|NCT01265927|Breast Tumors|breast tumors
1376396|NCT01265927|Cancer of Breast|cancer of breast
1376397|NCT01265927|Cancer of the Breast|cancer of the breast
1376398|NCT01265927|Genes, HER-2|genes, her-2
1376399|NCT01265927|Genes, HER2|genes, her2
1376400|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1376401|NCT01265901|First line|first line
1376402|NCT01265901|Eligible for sunitinib|eligible for sunitinib
1376404|NCT01265888|PH IPF|ph ipf
1376405|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
1376406|NCT01265862|Tracheal intubation|tracheal intubation
1376407|NCT01265862|Supraglottic airway devices|supraglottic airway devices
1376408|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
1376409|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
1376410|NCT01265823|Humira|humira
1376411|NCT01265823|Adalimumab|adalimumab
1376412|NCT01265823|Plaque Psoriasis|plaque psoriasis
1376413|NCT01265810|stomatitis|stomatitis
1376414|NCT01265810|targeted therapy|targeted therapy
1376415|NCT01265810|Caphosol|caphosol
1376416|NCT01265810|mouthrinses|mouthrinses
1376417|NCT01265771|Arrhythmia|arrhythmia
1376418|NCT01265771|Children|children
1376419|NCT01265758|Atrial fibrillation|atrial fibrillation
1376420|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
1376421|NCT01265758|ECG|ecg
1376422|NCT01265758|Telemonitoring|telemonitoring
1376423|NCT01265758|Telemetry|telemetry
1376424|NCT01265758|Holter|holter
1376425|NCT01265745|Phase I|phase i
1376426|NCT01265732|Phase 1|phase 1
1376427|NCT01265732|relative bioavailability|relative bioavailability
1376428|NCT01265732|healthy volunteers|healthy volunteers
1376429|NCT01265732|pharmacokinetics|pharmacokinetics
1376430|NCT01265732|suspension|suspension
1376431|NCT01265732|dispersion|dispersion
1376432|NCT01265719|Prospective|prospective
1376433|NCT01265719|non-interventional|non-interventional
1376434|NCT01265719|longitudinal|longitudinal
1376435|NCT01265719|cohort study|cohort study
1376436|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1376437|NCT01265680|Blood Transfusion|blood transfusion
1376438|NCT01265680|Heart surgery|heart surgery
1376439|NCT01265680|Erythropoietin|erythropoietin
1376440|NCT01265680|HRE|hre
1376441|NCT01265667|Psoriasis|psoriasis
1376442|NCT01265667|Plaque psoriasis|plaque psoriasis
1376443|NCT01265654|Advanced Breast Cancer|advanced breast cancer
1376444|NCT01265654|Hormonal Treatment|hormonal treatment
1376445|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
1376446|NCT01265615|stem-progenitor cells|stem-progenitor cells
1376447|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
1376448|NCT01265615|calcitriol|calcitriol
1376449|NCT01265615|paricalcitol|paricalcitol
1376450|NCT01265615|cholecalciferol|cholecalciferol
1376451|NCT01265615|cardiac repair|cardiac repair
1376452|NCT01265615|renal repair|renal repair
1376453|NCT01265602|Actinic Keratosis|actinic keratosis
1376454|NCT01265602|AK|ak
1376455|NCT01265602|NMSC|nmsc
1376456|NCT01265589|RDS|rds
1376457|NCT01265589|Infant, newborn|infant, newborn
1376458|NCT01265589|Vitamin A|vitamin a
1376459|NCT01265589|Surfactant|surfactant
1376460|NCT01265563|silymarin|silymarin
1376461|NCT01265563|glutathione|glutathione
1376462|NCT01265563|diabetic nephropathies|diabetic nephropathies
1376463|NCT01265563|oxidative stress|oxidative stress
1376464|NCT01265563|N-acetylcysteine|n-acetylcysteine
1376465|NCT01265563|protein tholation|protein tholation
1376466|NCT01265537|Transplant|transplant
1376467|NCT01265537|Tacrolimus|tacrolimus
1376468|NCT01265537|Diabetes after transplant|diabetes after transplant
1376469|NCT01265537|Acute rejection prevention|acute rejection prevention
1376470|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
1376471|NCT01265511|Hepatitis C|hepatitis c
1376472|NCT01265511|SCY-635|scy-635
1376473|NCT01265511|Ribavirin|ribavirin
1376474|NCT01265511|Interferon|interferon
1376475|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
1376477|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1376478|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1376479|NCT01265498|NAFLD|nafld
1376480|NCT01265498|NASH|nash
1376481|NCT01265498|obeticholic acid|obeticholic acid
1376482|NCT01265472|Translocator Protein|translocator protein
1376483|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
1376484|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
1376485|NCT01265472|Malignancy|malignancy
1376486|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
1376487|NCT01265433|GM-CSF|gm-csf
1376488|NCT01265433|MONTANIDE ISA 51|montanide isa 51
1376489|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
1376490|NCT01265433|Vaccine|vaccine
1376491|NCT01265433|10-134|10-134
1376492|NCT01265420|Dupuytren|dupuytren
1376493|NCT01265420|Dupuytren's Disease|dupuytren's disease
1376494|NCT01265407|Children|children
1376495|NCT01265407|Hemoglobinopathies|hemoglobinopathies
1376496|NCT01265407|Epidemiology|epidemiology
1376497|NCT01265407|Malaria|malaria
1376498|NCT01265394|Amyloid|amyloid
1376499|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
1376500|NCT01265394|Positron Emission Tomography|positron emission tomography
1376501|NCT01265394|Standard uptake value ratios|standard uptake value ratios
1376502|NCT01265394|Healthy Subjects|healthy subjects
1376503|NCT01265381|Cohort|cohort
1376504|NCT01265381|Radiation|radiation
1376505|NCT01265381|Thyroid Cancer|thyroid cancer
1376506|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1376507|NCT01265368|Tumor Vaccine|tumor vaccine
1376508|NCT01265368|Cell-based Therapy|cell-based therapy
1376509|NCT01265342|Bronchial Spasm|bronchial spasm
1376510|NCT01265342|Respiratory Tract Infections|respiratory tract infections
1376511|NCT01265342|Viral wheezing|viral wheezing
1376512|NCT01265342|Child, Preschool|child, preschool
1376513|NCT01265342|Beclomethasone|beclomethasone
1376514|NCT01265342|Italy|italy
1376515|NCT01265342|Physicians, Primary Care|physicians, primary care
1376516|NCT01265342|Pediatrics|pediatrics
1376517|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
1376518|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
1376519|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
1376520|NCT01265290|Cardiogenic syncope|cardiogenic syncope
1376521|NCT01265290|Pediatrics|pediatrics
1376522|NCT01265290|Children|children
1376523|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
1376524|NCT01265277|SIDS|sids
1376525|NCT01265277|infant|infant
1376526|NCT01265277|licensed day care|licensed day care
1376527|NCT01265277|sleep patterns|sleep patterns
1376528|NCT01265277|stress levels|stress levels
1376529|NCT01265264|Gout|gout
1376530|NCT01265264|hyperuricemia|hyperuricemia
1376531|NCT01265264|arthritis|arthritis
1376532|NCT01265264|joint diseases|joint diseases
1376533|NCT01265264|allopurinol|allopurinol
1376534|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1376535|NCT01265251|Neuropsychological Test|neuropsychological test
1376536|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
1376537|NCT01265251|Neuropsychological assessment|neuropsychological assessment
1376538|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
1376539|NCT01265238|Stroke|stroke
1376540|NCT01265238|Neurotomy|neurotomy
1376541|NCT01265238|Tendon surgery|tendon surgery
1376542|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
1376544|NCT01265186|Sedation|sedation
1376545|NCT01265186|BIS|bis
1376546|NCT01265186|aEEG|aeeg
1376547|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
1376548|NCT01265186|neonate|neonate
1376549|NCT01265186|newborn|newborn
1376550|NCT01265173|SBP|sbp
1376551|NCT01265173|liver cirrhosis|liver cirrhosis
1376552|NCT01265173|antibiotics|antibiotics
1376553|NCT01265134|the elders|the elders
1376554|NCT01265134|falling|falling
1376555|NCT01265134|loss balance|loss balance
1376556|NCT01265121|Acromegaly|acromegaly
1376557|NCT01265121|Insulin resistance|insulin resistance
1496917|NCT00790452|VTE|vte
1376558|NCT01265121|Euglycemic Clamp|euglycemic clamp
1376559|NCT01265121|Somatostatin analogues|somatostatin analogues
1376560|NCT01265095|VRE|vre
1376561|NCT01265069|Helicobacter pylori|helicobacter pylori
1376562|NCT01265069|concomitant therapy|concomitant therapy
1376563|NCT01265069|high dose dual therapy|high dose dual therapy
1376564|NCT01265069|antibiotic resistance|antibiotic resistance
1376565|NCT01265043|oral health|oral health
1376566|NCT01265043|oral hygiene|oral hygiene
1376567|NCT01265043|bacteria|bacteria
1376568|NCT01265043|quality of life|quality of life
1376569|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
1376570|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
1376571|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
1376572|NCT01265030|Desmoid Tumor|desmoid tumor
1376573|NCT01265030|Sirolimus|sirolimus
1376574|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
1376575|NCT01265017|type 1 diabetes|type 1 diabetes
1376576|NCT01265017|pregnancy|pregnancy
1376577|NCT01265017|insulin requirement|insulin requirement
1376578|NCT01265004|Functional outcome|functional outcome
1376579|NCT01264991|Sham|sham
1376580|NCT01264991|Meniscus tear|meniscus tear
1376581|NCT01264991|Meniscectomy|meniscectomy
1376582|NCT01264978|COPD|copd
1376583|NCT01264978|Rehabilitation|rehabilitation
1376584|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
1376585|NCT01264978|Quadriceps muscle|quadriceps muscle
1376586|NCT01264978|Magnetic stimulation|magnetic stimulation
1376587|NCT01264965|Pain|pain
1376588|NCT01264965|Analgesia|analgesia
1376589|NCT01264965|Cognitive impairment|cognitive impairment
1376590|NCT01264965|Randomized controlled trial|randomized controlled trial
1376591|NCT01264965|Physical function|physical function
1376592|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
1376593|NCT01264952|Bleomycin|bleomycin
1376594|NCT01264952|Electrochemotherapy|electrochemotherapy
1376595|NCT01264900|Psychotherapy|psychotherapy
1376596|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
1376597|NCT01264900|Aggression|aggression
1376598|NCT01264900|fMRI|fmri
1376599|NCT01264900|Behavioral Intervention|behavioral intervention
1376600|NCT01264887|analgesia|analgesia
1376601|NCT01264887|analgesics|analgesics
1376602|NCT01264887|chronic pain|chronic pain
1376603|NCT01264887|tumour related pain|tumour related pain
1376604|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
1376605|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
1376606|NCT01264848|multiple sclerosis|multiple sclerosis
1376607|NCT01264848|venous insufficiency|venous insufficiency
1376608|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
1376609|NCT01264822|Helicobacter pylori|helicobacter pylori
1376610|NCT01264822|stomach neoplasms|stomach neoplasms
1376611|NCT01264809|diabetes|diabetes
1376612|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
1376613|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
1376614|NCT01264770|OSKIRA|oskira
1376615|NCT01264770|fostamatinib|fostamatinib
1376617|NCT01264757|accelerometer|accelerometer
1376618|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
1376619|NCT01264757|adult|adult
1376620|NCT01264757|randomized trial|randomized trial
1376621|NCT01264744|Bladder cancer|bladder cancer
1376622|NCT01264744|Chromosomal aberrations|chromosomal aberrations
1376623|NCT01264744|FISH|fish
1376624|NCT01264744|Urine sample|urine sample
1376625|NCT01264731|melanoma|melanoma
1376626|NCT01264731|peptide vaccine|peptide vaccine
1376627|NCT01264731|aldara|aldara
1376628|NCT01264731|imiquimod|imiquimod
1376629|NCT01264731|immunotherapy|immunotherapy
1376630|NCT01264718|minority health|minority health
1376631|NCT01264718|child|child
1376632|NCT01264718|Medicaid|medicaid
1376633|NCT01264705|Cirrhosis|cirrhosis
1376634|NCT01264705|GI Cancer|gi cancer
1376635|NCT01264705|Hepatitis|hepatitis
1376636|NCT01264705|Oncology|oncology
1376637|NCT01264679|Iron deficiency anemia|iron deficiency anemia
1376638|NCT01264679|Feraheme|feraheme
1376639|NCT01264679|ferumoxytol|ferumoxytol
1376640|NCT01264679|chronic kidney disease|chronic kidney disease
1376642|NCT01264679|pediatric|pediatric
1376643|NCT01264679|dialysis-dependent|dialysis-dependent
1376644|NCT01264679|nondialysis-dependent|nondialysis-dependent
1376645|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
1376646|NCT01264666|postprandial|postprandial
1376647|NCT01264666|uric acid|uric acid
1376648|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
1376649|NCT01264653|cataract|cataract
1376650|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
1376651|NCT01264640|Platelets|platelets
1376652|NCT01264640|Aspirin|aspirin
1376653|NCT01264640|Clopidogrel|clopidogrel
1376654|NCT01264627|Hypertension|hypertension
1376655|NCT01264627|Blood pressure|blood pressure
1376656|NCT01264627|Breathing|breathing
1376657|NCT01264627|PetCO2|petco2
1376658|NCT01264627|Stress|stress
1376659|NCT01264614|exercise|exercise
1376660|NCT01264614|neuropsychological|neuropsychological
1376661|NCT01264614|dementia|dementia
1376662|NCT01264614|Alzheimer's Disease|alzheimer's disease
1376663|NCT01264614|mild cognitive impairment|mild cognitive impairment
1376664|NCT01264614|strength|strength
1376665|NCT01264614|MCI|mci
1376666|NCT01264614|AD|ad
1376667|NCT01264614|EEG|eeg
1376668|NCT01264614|neurophysiological|neurophysiological
1376669|NCT01264614|growth factor|growth factor
1376670|NCT01264614|cognitive decline|cognitive decline
1376671|NCT01264614|executive function|executive function
1376672|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
1376673|NCT01264601|Severe Egg Allergy|severe egg allergy
1376674|NCT01264575|spinal anesthesia|spinal anesthesia
1376675|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
1376676|NCT01264575|epinephrine|epinephrine
1376677|NCT01264575|ED50|ed50
1376678|NCT01264575|ED95|ed95
1376679|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
1376680|NCT01264562|adverse effects|adverse effects
1376681|NCT01264562|breast neoplasms|breast neoplasms
1376682|NCT01264562|cognition disorders|cognition disorders
1376683|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
1376684|NCT01264562|cortisol|cortisol
1376685|NCT01264549|ischemic stroke|ischemic stroke
1376686|NCT01264549|stroke-associated infections|stroke-associated infections
1376687|NCT01264549|biomarkers|biomarkers
1376689|NCT01264549|immune and infection parameters|immune and infection parameters
1376690|NCT01264536|lactoferrin|lactoferrin
1376691|NCT01264536|sepsis|sepsis
1376692|NCT01264536|neonates|neonates
1376693|NCT01264536|prevention|prevention
1376694|NCT01264536|infections|infections
1376695|NCT01264523|chrononutrition|chrononutrition
1376696|NCT01264523|moderately high protein|moderately high protein
1376697|NCT01264523|glycemic index|glycemic index
1376698|NCT01264523|type-2 diabetes|type-2 diabetes
1376699|NCT01264523|overweight|overweight
1376700|NCT01264523|obesity|obesity
1376701|NCT01264523|weight management|weight management
1376702|NCT01264510|conductive hearing loss|conductive hearing loss
1376703|NCT01264510|mixed hearing loss|mixed hearing loss
1376704|NCT01264510|unilateral deafness|unilateral deafness
1376705|NCT01264510|implanted with Baha|implanted with baha
1376706|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
1376707|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
1376708|NCT01264484|Advantage|advantage
1376709|NCT01264484|Non-interventional|non-interventional
1376710|NCT01264484|Post market release study|post market release study
1376711|NCT01264484|Germany|germany
1376712|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
1376713|NCT01264471|Gulf War Syndrome|gulf war syndrome
1376714|NCT01264471|Gulf War Illness|gulf war illness
1376715|NCT01264471|Mitochondrial defects|mitochondrial defects
1376716|NCT01264471|Mitochondrial disorders|mitochondrial disorders
1376717|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
1376719|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
1376720|NCT01264315|Lenalidomide|lenalidomide
1376721|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
1376722|NCT01264302|Bioequivalence|bioequivalence
1376723|NCT01264302|Finasteride|finasteride
1376724|NCT01264302|crossover|crossover
1376725|NCT01264289|Bioequivalence|bioequivalence
1376726|NCT01264289|Finasteride|finasteride
1376727|NCT01264289|crossover|crossover
1376728|NCT01264276|ROP|rop
1376729|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
1376730|NCT01264276|Telemedicine|telemedicine
1376731|NCT01264263|cIMT|cimt
1376732|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
1376733|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
1376734|NCT01264263|Korea|korea
1376735|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
1376736|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
1376737|NCT01264250|Safety|safety
1376738|NCT01264250|Tolerability|tolerability
1376739|NCT01264250|pharmacokinetics|pharmacokinetics
1376740|NCT01264250|drug metabolism|drug metabolism
1376741|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
1376742|NCT01264237|Neuropathic pain|neuropathic pain
1376743|NCT01264237|Etoricoxib|etoricoxib
1376744|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
1376745|NCT01264211|Safety of Diacerein|safety of diacerein
1376746|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
1376747|NCT01264172|Functional outcome|functional outcome
1376748|NCT01264172|Microcirculation|microcirculation
1376749|NCT01264172|Inflammatory response|inflammatory response
1376750|NCT01264159|Developing acute heart failure|developing acute heart failure
1497150|NCT00789607|MRI|mri
1376751|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1376752|NCT01264146|calcaneal fracture|calcaneal fracture
1376753|NCT01264146|calcaneal plating|calcaneal plating
1376754|NCT01264146|wound infection|wound infection
1376755|NCT01264146|microcirculation|microcirculation
1376756|NCT01264120|Obesity|obesity
1376757|NCT01264120|Bariatric surgery|bariatric surgery
1376758|NCT01264120|Health Psychology|health psychology
1376759|NCT01264081|Lapatinib|lapatinib
1376760|NCT01264081|Melanoma|melanoma
1376761|NCT01264081|ERBB4 Mutation|erbb4 mutation
1376762|NCT01264081|Malignant Melanoma|malignant melanoma
1376763|NCT01264081|Skin Cancer|skin cancer
1376764|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
1376765|NCT01264055|Rare Diseases of Airways|rare diseases of airways
1376766|NCT01264055|Bronchiectasis|bronchiectasis
1376767|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
1376768|NCT01264055|Chronic Cough|chronic cough
1376769|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
1376770|NCT01264042|Iron Supplementation,|iron supplementation,
1376771|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
1376772|NCT01264029|Well-Being|well-being
1376773|NCT01264029|Tai Chi|tai chi
1376774|NCT01264029|Obesity|obesity
1376775|NCT01264029|Mindfulness|mindfulness
1376776|NCT01264029|Meditation|meditation
1376777|NCT01264029|Overweight|overweight
1376778|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
1376779|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
1376780|NCT01263990|stroke volume|stroke volume
1376781|NCT01263977|septic shock|septic shock
1376782|NCT01263977|goal directed volume therapy|goal directed volume therapy
1376783|NCT01263977|outcome|outcome
1376784|NCT01263964|ischemic stroke|ischemic stroke
1376785|NCT01263964|troponin elevation|troponin elevation
1376786|NCT01263964|transient apical ballooning|transient apical ballooning
1376787|NCT01263964|acute coronary syndrome|acute coronary syndrome
1376788|NCT01263964|troponin elevation,|troponin elevation,
1376789|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
1376790|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
1376791|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
1376792|NCT01263938|HIV|hiv
1376793|NCT01263938|monocytes|monocytes
1376794|NCT01263938|CD16+|cd16+
1376795|NCT01263938|statins|statins
1376796|NCT01263938|mcp1|mcp1
1376797|NCT01263938|inflammation|inflammation
1376798|NCT01263925|Alprostadil|alprostadil
1376799|NCT01263925|Prostaglandin E1|prostaglandin e1
1376800|NCT01263925|Prostavasin®|prostavasin®
1376801|NCT01263925|PAOD|paod
1376802|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
1376803|NCT01263912|Cognitive development|cognitive development
1376804|NCT01263912|Growth|growth
1376805|NCT01263912|Infection|infection
1376806|NCT01263899|Lymphoid malignancies|lymphoid malignancies
1376807|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
1376808|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
1376809|NCT01263899|Indolent Lymphoma|indolent lymphoma
1376810|NCT01263899|SB1518|sb1518
1376811|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
1376812|NCT01263834|Trabeculectomy|trabeculectomy
1376813|NCT01263834|bevacizumab|bevacizumab
1376814|NCT01263834|intraocular pressure|intraocular pressure
1376815|NCT01263821|glioma|glioma
1376816|NCT01263821|biologic imaging|biologic imaging
1376817|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1376818|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
1376819|NCT01263821|perfusion imaging|perfusion imaging
1376820|NCT01263821|diffusion imaging|diffusion imaging
1376821|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
1376822|NCT01263821|radiation therapy|radiation therapy
1376823|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
1376824|NCT01263808|Indacaterol|indacaterol
1376825|NCT01263808|Moxifloxacin|moxifloxacin
1376826|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
1376827|NCT01263782|NSCLL|nscll
1376828|NCT01263782|Nonsquamous cell|nonsquamous cell
1376829|NCT01263782|Metastatic disease|metastatic disease
1376830|NCT01263782|Cixutumumab|cixutumumab
1376831|NCT01263782|IMC-A12|imc-a12
1376832|NCT01263782|Carboplatin|carboplatin
1376833|NCT01263782|Paraplatin|paraplatin
1376834|NCT01263782|Pemetrexed|pemetrexed
1376835|NCT01263782|LY231514|ly231514
1376836|NCT01263782|Alimta|alimta
1376837|NCT01263782|MTA|mta
1376838|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
1376839|NCT01263782|NSC-698037|nsc-698037
1376840|NCT01263782|Bevacizumab|bevacizumab
1376841|NCT01263782|Avastin|avastin
1376842|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1376843|NCT01263782|rhuMAb-VEGF|rhumab-vegf
1376844|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
1376845|NCT01263769|AG-013736|ag-013736
1376846|NCT01263769|Axitinib|axitinib
1376847|NCT01263769|Radical nephrectomy|radical nephrectomy
1376848|NCT01263756|Driving|driving
1376849|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
1376850|NCT01263756|ASD|asd
1376851|NCT01263756|Attention Deficits|attention deficits
1376852|NCT01263756|Adults|adults
1376853|NCT01263756|Adolescents|adolescents
1376854|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
1376855|NCT01263743|Stage 1 hypertension|stage 1 hypertension
1376856|NCT01263717|HIV|hiv
1376857|NCT01263717|lipodystrophy|lipodystrophy
1376858|NCT01263717|tesamorelin|tesamorelin
1376859|NCT01263717|Egrifta|egrifta
1376860|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
1376861|NCT01263691|AVA|ava
1376862|NCT01263691|AV7909|av7909
1376863|NCT01263691|Anthrax vaccine|anthrax vaccine
1376864|NCT01263678|Decisional Conflict|decisional conflict
1376865|NCT01263678|Coaching|coaching
1376866|NCT01263678|Decisional Regret|decisional regret
1376867|NCT01263665|stent-graft|stent-graft
1376868|NCT01263665|superficial femoral artery|superficial femoral artery
1376869|NCT01263665|SFA|sfa
1376870|NCT01263665|peripheral artery disease|peripheral artery disease
1376871|NCT01263665|PAD|pad
1376872|NCT01263652|Pain|pain
1376873|NCT01263652|intramuscular|intramuscular
1376874|NCT01263652|oral|oral
1376875|NCT01263652|spine|spine
1376876|NCT01263652|preference|preference
1376877|NCT01263639|patient satisfaction|patient satisfaction
1376878|NCT01263639|patient-physician relationship|patient-physician relationship
1376879|NCT01263639|orthopaedic trauma|orthopaedic trauma
1376880|NCT01263626|Cough|cough
1376881|NCT01263626|Chronic Cough|chronic cough
1376882|NCT01263626|Reflux|reflux
1376883|NCT01263600|Hepatitis B|hepatitis b
1376884|NCT01263600|HBV|hbv
1376885|NCT01263600|Pediatric|pediatric
1376886|NCT01263587|Hepatitis B|hepatitis b
1376887|NCT01263587|HBV|hbv
1376888|NCT01263587|Cohort Study|cohort study
1376889|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
1376890|NCT01263574|Anti infective agents|anti infective agents
1376891|NCT01263574|Catheter related infections prevention|catheter related infections prevention
1376892|NCT01263561|glaucoma|glaucoma
1376893|NCT01263561|filtration surgery|filtration surgery
1376894|NCT01263561|trabeculectomy|trabeculectomy
1376895|NCT01263561|ExPRESS shunt|express shunt
1376896|NCT01263522|primary prevention|primary prevention
1376897|NCT01263522|endurance|endurance
1376898|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
1376899|NCT01263522|training|training
1376900|NCT01263522|exercise|exercise
1376901|NCT01263522|non-responder|non-responder
1376902|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1376903|NCT01263509|Diabetes Mellitus|diabetes mellitus
1376904|NCT01263509|Drug Therapy|drug therapy
1376905|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1376906|NCT01263496|Diabetes Mellitus|diabetes mellitus
1376907|NCT01263496|Drug Therapy|drug therapy
1376908|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1376909|NCT01263483|Diabetes Mellitus|diabetes mellitus
1376910|NCT01263483|Drug Therapy|drug therapy
1376911|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1376912|NCT01263470|Diabetes Mellitus|diabetes mellitus
1376913|NCT01263470|Drug Therapy|drug therapy
1376914|NCT01263457|Growth disorders|growth disorders
1376915|NCT01263457|Saizen|saizen
1376916|NCT01263457|EasypodTM|easypodtm
1376917|NCT01263457|Growth hormone|growth hormone
1376918|NCT01263457|Pediatric subject|pediatric subject
1376920|NCT01263444|Open angle glaucoma|open angle glaucoma
1376921|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
1376922|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
1376923|NCT01263418|Follicular Lymphoma|follicular lymphoma
1376924|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
1376925|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1376926|NCT01263418|Elderly|elderly
1376927|NCT01263418|Newly Diagnosed|newly diagnosed
1376928|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1376929|NCT01263418|University of North Carolina|university of north carolina
1376930|NCT01263418|Ofatumumab|ofatumumab
1376931|NCT01263418|Arzerra|arzerra
1376932|NCT01263418|Phase 2|phase 2
1376933|NCT01263418|Geriatric|geriatric
1376934|NCT01263418|Lymphoma|lymphoma
1376935|NCT01263405|Sarcoma|sarcoma
1376936|NCT01263392|Neurogenic bladder|neurogenic bladder
1376937|NCT01263392|Spina bifida|spina bifida
1376938|NCT01263392|Intermittent catheterization|intermittent catheterization
1376939|NCT01263392|Urinary tract infections|urinary tract infections
1376940|NCT01263379|gene transfer|gene transfer
1376941|NCT01263366|Radiodermatitis|radiodermatitis
1376942|NCT01263366|Prevention|prevention
1376943|NCT01263366|Radiotherapy|radiotherapy
1376944|NCT01263366|Breast|breast
1376945|NCT01263366|Radiation Dermatitis|radiation dermatitis
1376946|NCT01263353|Carcinoid tumor,|carcinoid tumor,
1376947|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
1376948|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
1376949|NCT01263353|pasireotide LAR,|pasireotide lar,
1376950|NCT01263353|SOM230 LAR,|som230 lar,
1376951|NCT01263353|everolimus,|everolimus,
1376952|NCT01263353|RAD001,|rad001,
1376953|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
1376954|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
1376955|NCT01263340|COPD|copd
1376956|NCT01263340|observational study|observational study
1376957|NCT01263340|prevalence|prevalence
1376958|NCT01263340|characterisation|characterisation
1376959|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
1376960|NCT01263314|Hypertension|hypertension
1376961|NCT01263301|subclavian steal|subclavian steal
1376962|NCT01263301|carotid duplex|carotid duplex
1376963|NCT01263301|subclavian stenosis|subclavian stenosis
1376964|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
1376965|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
1376966|NCT01263275|depression|depression
1376967|NCT01263275|direct current stimulation|direct current stimulation
1376968|NCT01263275|alternative electrode montage|alternative electrode montage
1376969|NCT01263262|Surgical site infection|surgical site infection
1376970|NCT01263262|Corneal toxicity|corneal toxicity
1376971|NCT01263262|Ototoxicity|ototoxicity
1376972|NCT01263262|Povidone-iodine|povidone-iodine
1376973|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
1376974|NCT01263249|Femoral|femoral
1376975|NCT01263249|Nerve Block|nerve block
1376976|NCT01263249|Anterior|anterior
1376977|NCT01263249|Posterior|posterior
1376978|NCT01263249|Continuous Infusion|continuous infusion
1376979|NCT01263249|Perineural Catheter|perineural catheter
1376980|NCT01263249|Volunteer|volunteer
1376981|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
1376982|NCT01263236|Depression|depression
1376983|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
1376984|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
1376985|NCT01263210|Ventilation tube treatment|ventilation tube treatment
1376986|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
1376987|NCT01263184|shoulder|shoulder
1376988|NCT01263184|strength|strength
1376989|NCT01263184|quality of life|quality of life
1376990|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1376991|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
1376992|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
1376993|NCT01263158|randomised controlled trial|randomised controlled trial
1376994|NCT01263158|nulliparous women|nulliparous women
1376995|NCT01263158|slow labour progress|slow labour progress
1376996|NCT01263158|prolonged labour|prolonged labour
1376997|NCT01263158|oxytocin augmentation|oxytocin augmentation
1376998|NCT01263158|operative delivery|operative delivery
1376999|NCT01263158|childbirth experience|childbirth experience
1377000|NCT01263132|Polyneuropathy|polyneuropathy
1377001|NCT01263132|Diabetes Mellitus|diabetes mellitus
1377002|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
1377003|NCT01263080|mirtazapine|mirtazapine
1377004|NCT01263080|folic acid|folic acid
1377005|NCT01263080|schizophrenia|schizophrenia
1377006|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
1377007|NCT01263067|PTSD|ptsd
1377008|NCT01263067|Car Accident|car accident
1377009|NCT01263067|Auto Accident|auto accident
1377010|NCT01263067|Lifespan Integration|lifespan integration
1377011|NCT01263054|Back Pain|back pain
1377806|NCT01259674|treatment|treatment
1377012|NCT01263054|Low Back Pain|low back pain
1377013|NCT01263054|Discogenic Back Pain|discogenic back pain
1377014|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
1377015|NCT01263015|GSK1349572|gsk1349572
1377016|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
1377017|NCT01263015|Treatment-naive|treatment-naive
1377018|NCT01263015|HIV Infection|hiv infection
1377019|NCT01263015|Dolutegravir|dolutegravir
1377020|NCT01263015|integrase inhibitor|integrase inhibitor
1377021|NCT01263015|Atripla|atripla
1377022|NCT01262989|Bioequivalence|bioequivalence
1377023|NCT01262989|Tamsulosin|tamsulosin
1377024|NCT01262989|Healthy volunteers|healthy volunteers
1377025|NCT01262989|Fast conditions|fast conditions
1377026|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
1377027|NCT01262963|GSK2118436|gsk2118436
1377028|NCT01262963|BRAF inhibitor|braf inhibitor
1377029|NCT01262963|BRAF positive tumor|braf positive tumor
1377030|NCT01262963|ADME|adme
1377031|NCT01262963|Oncology|oncology
1377032|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
1377033|NCT01262924|Booster vaccination|booster vaccination
1377034|NCT01262898|tolerability|tolerability
1377035|NCT01262898|pharmacokinetics|pharmacokinetics
1377036|NCT01262898|13 C oral breath test|13 c oral breath test
1567127|NCT00509938|antimicrobial|antimicrobial
1377037|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
1377038|NCT01262898|gastroparesis|gastroparesis
1377039|NCT01262898|gut motility|gut motility
1377040|NCT01262898|phase II|phase ii
1377041|NCT01262898|pharmacodynamics|pharmacodynamics
1377042|NCT01262898|repeat dose|repeat dose
1377043|NCT01262898|gastric emptying|gastric emptying
1377044|NCT01262898|symptoms|symptoms
1377045|NCT01262898|GSK962040|gsk962040
1377046|NCT01262885|pharmacokinetics|pharmacokinetics
1377047|NCT01262885|tolerability|tolerability
1377048|NCT01262885|single dose|single dose
1377049|NCT01262885|antibiotics|antibiotics
1377050|NCT01262885|repeat dose|repeat dose
1377051|NCT01262885|GSK2251052|gsk2251052
1377052|NCT01262885|safety|safety
1377053|NCT01262872|Haemophilus influenzae|haemophilus influenzae
1377054|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
1377055|NCT01262872|The Gambia|the gambia
1377056|NCT01262872|immunogenicity|immunogenicity
1377057|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
1377058|NCT01262872|infants|infants
1377059|NCT01262872|safety|safety
1377060|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
1377061|NCT01262872|children|children
1377062|NCT01262846|HIV|hiv
1377063|NCT01262846|Flu vaccination|flu vaccination
1377064|NCT01262846|HIV infected individuals|hiv infected individuals
1377065|NCT01262846|Fluzone SD|fluzone sd
1377066|NCT01262846|Fluzone HD|fluzone hd
1377067|NCT01262820|Pazopanib|pazopanib
1377068|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
1377069|NCT01262820|After Progress on first line therapy|after progress on first line therapy
1377070|NCT01262820|Using Bevacizumab|using bevacizumab
1377071|NCT01262807|fracture|fracture
1377072|NCT01262807|radius|radius
1377073|NCT01262807|adult|adult
1377074|NCT01262807|range of motion|range of motion
1377075|NCT01262794|Healthy volunteers|healthy volunteers
1377076|NCT01262794|Japanese|japanese
1377077|NCT01262781|neonatal adiposity|neonatal adiposity
1377078|NCT01262781|metabolic syndrome|metabolic syndrome
1377079|NCT01262781|fructose|fructose
1377277|NCT01262040|10-180|10-180
1377080|NCT01262781|maternal diet|maternal diet
1377081|NCT01262768|Nutrition|nutrition
1377082|NCT01262768|Obesity|obesity
1377083|NCT01262768|Parent|parent
1377084|NCT01262768|Portion Size Estimation|portion size estimation
1377085|NCT01262768|Accuracy|accuracy
1377086|NCT01262755|GERD|gerd
1377087|NCT01262755|IBS|ibs
1377088|NCT01262755|Minority|minority
1377089|NCT01262742|pregnancy|pregnancy
1377090|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
1377091|NCT01262742|Cesarean delivery|cesarean delivery
1377092|NCT01262742|carbetocin|carbetocin
1377093|NCT01262729|xenon inhalation|xenon inhalation
1377094|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
1377095|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
1377096|NCT01262729|efficacy|efficacy
1377097|NCT01262729|safety|safety
1377098|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
1377099|NCT01262716|PDT|pdt
1377100|NCT01262716|Photofrin|photofrin
1377101|NCT01262716|Photosensitizer|photosensitizer
1377102|NCT01262690|First-in-human (FIH)|first-in-human (fih)
1377103|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
1377104|NCT01262690|TAM-163|tam-163
1377105|NCT01262690|PF-05230901|pf-05230901
1377106|NCT01262690|Cachexia|cachexia
1377107|NCT01262677|Partial epilepsy|partial epilepsy
1377108|NCT01262677|partial seizures|partial seizures
1377109|NCT01262677|epilepsy|epilepsy
1377110|NCT01262677|seizures|seizures
1377111|NCT01262677|adjunctive therapy|adjunctive therapy
1377112|NCT01262677|intervention|intervention
1377113|NCT01262677|controlled-release|controlled-release
1377114|NCT01262677|placebo-controlled|placebo-controlled
1377115|NCT01262677|seizure|seizure
1377116|NCT01262664|Advanced prostate cancer|advanced prostate cancer
1377117|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
1377118|NCT01262664|Prohibitin-TP01|prohibitin-tp01
1377119|NCT01262651|Cancer pain|cancer pain
1377120|NCT01262651|Opioid therapy|opioid therapy
1377121|NCT01262651|Inadequate analgesia|inadequate analgesia
1377122|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
1377123|NCT01262625|stable angina|stable angina
1377124|NCT01262625|recurrent chest pain|recurrent chest pain
1377125|NCT01262625|chest pain|chest pain
1377126|NCT01262625|angina equivalent|angina equivalent
1377127|NCT01262625|diagnosis|diagnosis
1377128|NCT01262625|coronary artery disease|coronary artery disease
1377129|NCT01262612|cediranib|cediranib
1377130|NCT01262612|malignant ascites|malignant ascites
1377131|NCT01262612|malignant pleural effusion|malignant pleural effusion
1377254|NCT01262079|immunity|immunity
1377132|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
1377133|NCT01262599|TRAM flap surgery|tram flap surgery
1377134|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
1377135|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
1377136|NCT01262586|Vildagliptin|vildagliptin
1377137|NCT01262586|Glimepiride|glimepiride
1377138|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
1377139|NCT01262560|pain|pain
1377140|NCT01262560|dysphagia|dysphagia
1377141|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1377142|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1377143|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1377144|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1377145|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1377146|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1377147|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1377148|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1377149|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
1377150|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
1377151|NCT01262560|esophagitis|esophagitis
1377152|NCT01262534|Psoriasis|psoriasis
1377153|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
1377154|NCT01262521|Dietary nitrate|dietary nitrate
1377155|NCT01262508|autonomic nervous system|autonomic nervous system
1377156|NCT01262482|adenocarcinoma|adenocarcinoma
1377157|NCT01262482|gastric|gastric
1377158|NCT01262482|gastroesophageal junction|gastroesophageal junction
1377159|NCT01262482|Relapsed|relapsed
1377160|NCT01262482|sorafenib|sorafenib
1377161|NCT01262482|oxaliplatin|oxaliplatin
1377162|NCT01262443|Atrial flutter|atrial flutter
1377163|NCT01262430|Osteoarthritis|osteoarthritis
1377164|NCT01262417|colorectal cancer|colorectal cancer
1377165|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
1377166|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
1377167|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
1377168|NCT01262391|Overactive bladder|overactive bladder
1377169|NCT01262391|Pediatric|pediatric
1377170|NCT01262391|Pharmacokinetics|pharmacokinetics
1377171|NCT01262391|Single-dose|single-dose
1377179|NCT01262339|iontophoresis|iontophoresis
1377180|NCT01262339|BTX-A|btx-a
1377181|NCT01262300|Immunosenescence|immunosenescence
1377182|NCT01262300|Shingles|shingles
1377183|NCT01262300|Vitamin D|vitamin d
1377184|NCT01262300|Varicella Zoster Virus|varicella zoster virus
1377185|NCT01262300|Vaccine|vaccine
1377186|NCT01262300|Immune Response|immune response
1377187|NCT01262300|Geriatrics|geriatrics
1377188|NCT01262287|Randomized Trial|randomized trial
1377189|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
1377190|NCT01262287|Dutasteride Treatment|dutasteride treatment
1377191|NCT01262261|opioid dependence|opioid dependence
1377192|NCT01262261|opioid addiction|opioid addiction
1377193|NCT01262261|buprenorphine|buprenorphine
1377194|NCT01262261|implant|implant
1377195|NCT01262261|methadone|methadone
1377196|NCT01262261|heroin|heroin
1377197|NCT01262261|suboxone|suboxone
1377198|NCT01262261|opioid pain medication|opioid pain medication
1377199|NCT01262261|opioid withdrawal|opioid withdrawal
1377200|NCT01262248|small colorectal polyps|small colorectal polyps
1377201|NCT01262248|narrow band imaging|narrow band imaging
1377202|NCT01262248|vascularization|vascularization
1377203|NCT01262248|computer-based classification|computer-based classification
1377204|NCT01262235|Solid tumor|solid tumor
1377205|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1377206|NCT01262235|Hodgkin's Disease|hodgkin's disease
1377207|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
1377208|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
1377209|NCT01262235|Carcinoid|carcinoid
1377210|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
1377211|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
1377212|NCT01262222|10-206|10-206
1377213|NCT01262209|Vision loss|vision loss
1377214|NCT01262209|Chronic glaucoma|chronic glaucoma
1377215|NCT01262209|Low vision rehabilitation|low vision rehabilitation
1377216|NCT01262196|Trauma|trauma
1377217|NCT01262196|Hemorrhage|hemorrhage
1377218|NCT01262196|Hemorrhagic shock|hemorrhagic shock
1377219|NCT01262196|Lactic acidosis|lactic acidosis
1377220|NCT01262196|Oxygen carriers|oxygen carriers
1377221|NCT01262196|Oxygen therapeutics|oxygen therapeutics
1377222|NCT01262196|Hemoglobin solutions|hemoglobin solutions
1377223|NCT01262196|Red cell substitutes|red cell substitutes
1377224|NCT01262196|PEG-hemoglobin|peg-hemoglobin
1377225|NCT01262183|oesophagus cancer|oesophagus cancer
1377226|NCT01262183|chemoradiotherapy|chemoradiotherapy
1377227|NCT01262183|panitumumab|panitumumab
1377228|NCT01262183|irresectable|irresectable
1377229|NCT01262170|dietary supplement|dietary supplement
1377230|NCT01262170|nutraceutical|nutraceutical
1377231|NCT01262157|Erectile dysfunction|erectile dysfunction
1377232|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
1377233|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
1377234|NCT01262144|Cervical Cancer|cervical cancer
1377235|NCT01262144|PET CT|pet ct
1377236|NCT01262144|SUV Max|suv max
1377237|NCT01262131|Fibromyalgia|fibromyalgia
1377238|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
1377239|NCT01262118|Cholesterol metabolism|cholesterol metabolism
1377240|NCT01262118|Cholesterol flux|cholesterol flux
1377241|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
1377242|NCT01262118|Tasocitinib|tasocitinib
1377243|NCT01262118|CP-690|cp-690
1377244|NCT01262118|550|550
1377245|NCT01262105|CFU|cfu
1377246|NCT01262105|surgery site|surgery site
1377247|NCT01262092|opioid dependent|opioid dependent
1377248|NCT01262092|detoxification|detoxification
1377249|NCT01262092|buprenorphine|buprenorphine
1377250|NCT01262092|suboxone|suboxone
1377251|NCT01262092|opiate|opiate
1377252|NCT01262079|influenza|influenza
1377253|NCT01262079|healthy volunteer|healthy volunteer
1377255|NCT01262079|antibody|antibody
1377256|NCT01262079|blood sample|blood sample
1377257|NCT01262066|hypertension|hypertension
1377258|NCT01262066|stress reduction|stress reduction
1377259|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
1377260|NCT01262053|CPOE|cpoe
1377261|NCT01262053|Wrong Patient|wrong patient
1377262|NCT01262053|Juxtaposition|juxtaposition
1377263|NCT01262053|Patient Safety|patient safety
1377264|NCT01262053|Medical Errors|medical errors
1377265|NCT01262040|NBI|nbi
1377266|NCT01262040|ENDOMETRIUM|endometrium
1377267|NCT01262040|FALLOPIAN TUBE|fallopian tube
1377268|NCT01262040|OVARY|ovary
1377269|NCT01262040|PERITONEUM|peritoneum
1377270|NCT01262040|Surgery|surgery
1377271|NCT01262040|Lung|lung
1377272|NCT01262040|Pancreatic|pancreatic
1377273|NCT01262040|Esophageal|esophageal
1377274|NCT01262040|thorascopic|thorascopic
1377275|NCT01262040|laparoscopic|laparoscopic
1377276|NCT01262040|robotic|robotic
1377281|NCT01262027|Dovitinib|dovitinib
1377282|NCT01262027|TKI258|tki258
1377283|NCT01262014|platinum|platinum
1377284|NCT01262014|resistant|resistant
1377285|NCT01262014|advanced|advanced
1377286|NCT01262014|ovarian|ovarian
1377287|NCT01262014|cancer|cancer
1377288|NCT01261975|Ocular Surgery|ocular surgery
1377289|NCT01261975|Intraocular Lens|intraocular lens
1377290|NCT01261962|Humoral immunity|humoral immunity
1377291|NCT01261962|Neutrophil function|neutrophil function
1377292|NCT01261962|Gene expression|gene expression
1377293|NCT01261949|Tinnitus|tinnitus
1377294|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
1377295|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
1377296|NCT01261949|sensation disorders|sensation disorders
1377297|NCT01261949|hearing disorders|hearing disorders
1377298|NCT01261936|Menorrhagia|menorrhagia
1377299|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
1377300|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
1377301|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
1377302|NCT01261897|postoperative pain|postoperative pain
1377303|NCT01261897|US-guided nerve block|us-guided nerve block
1377304|NCT01261897|total knee arthroplasty|total knee arthroplasty
1377305|NCT01261884|Pregnancy|pregnancy
1377306|NCT01261884|Exercise|exercise
1377307|NCT01261884|Hypertension|hypertension
1377308|NCT01261884|Preeclampsia|preeclampsia
1377309|NCT01261884|Resistance exercise|resistance exercise
1377310|NCT01261858|Sternal closure|sternal closure
1377311|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
1377312|NCT01261858|Biologic bone cement|biologic bone cement
1377313|NCT01261845|Delivery of Health Care|delivery of health care
1377314|NCT01261845|Equity in Health Services|equity in health services
1377315|NCT01261845|Ethnic Groups|ethnic groups
1377316|NCT01261845|Health Services Research|health services research
1377317|NCT01261845|Health Surveys|health surveys
1377318|NCT01261845|Immigration|immigration
1377319|NCT01261845|Referral and Consultation|referral and consultation
1377320|NCT01261845|Resource Allocation|resource allocation
1377321|NCT01261845|Social Justice|social justice
1377322|NCT01261845|Vulnerable Populations|vulnerable populations
1377323|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
1377324|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
1377325|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
1377330|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
1377331|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
1377332|NCT01261780|pain|pain
1377333|NCT01261780|hyperalgesia|hyperalgesia
1377334|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
1377335|NCT01261728|Gemcitabine|gemcitabine
1377336|NCT01261728|Cisplatin|cisplatin
1377337|NCT01261728|Bladder|bladder
1377338|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
1377339|NCT01261728|ureterectomy|ureterectomy
1377340|NCT01261728|10-208|10-208
1377341|NCT01261702|Magnesium sulphate|magnesium sulphate
1377342|NCT01261702|Post Pulmonary Resection|post pulmonary resection
1377343|NCT01261702|Pain|pain
1377344|NCT01261689|Epidural analgesia|epidural analgesia
1377345|NCT01261689|Instrumental delivery|instrumental delivery
1377346|NCT01261689|Maternal outcome|maternal outcome
1377347|NCT01261689|Neonatal outcome|neonatal outcome
1377348|NCT01261676|caesarean section|caesarean section
1377349|NCT01261676|labour, obstetric|labour, obstetric
1377350|NCT01261676|implementation guidelines|implementation guidelines
1377351|NCT01261676|quality indicators|quality indicators
1377352|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
1377353|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
1377354|NCT01261624|poly JIA|poly jia
1377355|NCT01261598|Positron-Emission Tomography|positron-emission tomography
1377356|NCT01261598|PET Scan|pet scan
1377357|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1377358|NCT01261598|Radiation Oncology|radiation oncology
1377359|NCT01261598|SUV|suv
1377360|NCT01261585|Positron-Emission Tomography|positron-emission tomography
1377361|NCT01261585|PET Scan|pet scan
1377362|NCT01261585|FDG|fdg
1377363|NCT01261585|FLT|flt
1377364|NCT01261585|FMISO|fmiso
1377365|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1377366|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
1377367|NCT01261585|SUV|suv
1377368|NCT01261572|ASP3550|asp3550
1377369|NCT01261572|Degarelix|degarelix
1377370|NCT01261572|Prostate cancer|prostate cancer
1377371|NCT01261572|Prostatic neoplasms|prostatic neoplasms
1377372|NCT01261559|Computed tomography|computed tomography
1377758|NCT01259830|pain relief|pain relief
1377373|NCT01261559|Radiation dose|radiation dose
1377374|NCT01261559|Dose reduction|dose reduction
1377375|NCT01261559|Breast displacement|breast displacement
1377376|NCT01261559|Chrysalis device|chrysalis device
1377377|NCT01261559|Image quality|image quality
1377378|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
1377379|NCT01261533|vitreous body substitute|vitreous body substitute
1377380|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
1377381|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
1377382|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1377383|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
1377384|NCT01261494|Metabolic Diseases|metabolic diseases
1377385|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
1377386|NCT01261494|PPARs|ppars
1377387|NCT01261494|OGTT|ogtt
1377388|NCT01261481|Bioavailability|bioavailability
1377389|NCT01261468|Chronic pain|chronic pain
1377390|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
1377391|NCT01261468|Neurologic Examination|neurologic examination
1377392|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
1377393|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1377394|NCT01261442|posterior tibial nerve|posterior tibial nerve
1377395|NCT01261442|regional anesthesia|regional anesthesia
1377396|NCT01261442|nerve conduction study|nerve conduction study
1377397|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
1377398|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
1377399|NCT01261429|nilotinib|nilotinib
1377400|NCT01261416|seizures|seizures
1377401|NCT01261416|epilepsy|epilepsy
1377402|NCT01261416|neonatal|neonatal
1377403|NCT01261416|levetiracetam|levetiracetam
1377404|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
1377405|NCT01261390|Sleep Apnea|sleep apnea
1377406|NCT01261390|Heart Disease|heart disease
1377407|NCT01261390|Risk factors for heart disease|risk factors for heart disease
1377408|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
1377409|NCT01261364|GeneSight|genesight
1377410|NCT01261364|Assurex|assurex
1377411|NCT01261364|AssureRx|assurerx
1377412|NCT01261351|Pre eclampsia|pre eclampsia
1377413|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
1377414|NCT01261338|PCBs|pcbs
1377415|NCT01261338|Olestra|olestra
1377417|NCT01261325|Brivaracetam|brivaracetam
1377418|NCT01261325|Partial Onset Seizures|partial onset seizures
1377419|NCT01261325|Adjunctive treatment|adjunctive treatment
1377420|NCT01261312|SGI-110|sgi-110
1377421|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
1377422|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
1377423|NCT01261312|AML|aml
1377424|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
1377425|NCT01261299|Human microdosing trial|human microdosing trial
1377426|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
1377427|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
1377428|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
1377429|NCT01261299|Individualized Medicine|individualized medicine
1377430|NCT01261299|Carboplatin|carboplatin
1377431|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
1377432|NCT01261286|inflammation|inflammation
1377433|NCT01261286|receptor downregulation|receptor downregulation
1377434|NCT01261286|reduced response|reduced response
1377435|NCT01261286|calcium channels|calcium channels
1377436|NCT01261286|PK-PD relationship|pk-pd relationship
1377437|NCT01261273|PCI|pci
1377438|NCT01261273|observational registry|observational registry
1377439|NCT01261260|uridine|uridine
1377440|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
1377441|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
1377442|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1377443|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
1377444|NCT01261234|Carotid Artery Disease|carotid artery disease
1377445|NCT01261234|Carotid Artery Stenting|carotid artery stenting
1377446|NCT01261234|In stent restenosis|in stent restenosis
1377447|NCT01261234|Cardiovascular event|cardiovascular event
1377448|NCT01261234|Intima Media Thickness|intima media thickness
1377449|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
1377450|NCT01261182|Malnutrition|malnutrition
1377451|NCT01261182|School feeding|school feeding
1377452|NCT01261182|Infant nutrition|infant nutrition
1377453|NCT01261182|Mother's nutrition|mother's nutrition
1377454|NCT01261182|Fortified food|fortified food
1377455|NCT01261182|Anemia|anemia
1377456|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
1377457|NCT01261182|Effectiveness|effectiveness
1377458|NCT01261182|Impact evaluation studies|impact evaluation studies
1377459|NCT01261182|Uganda|uganda
1377460|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
1377461|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
1377462|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
1377463|NCT01261130|HHVI|hhvi
1377464|NCT01261130|Human Hookworm|human hookworm
1377465|NCT01261130|Hookworm|hookworm
1377466|NCT01261130|Hookworm Disease|hookworm disease
1377467|NCT01261130|N. americanus|n. americanus
1377468|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
1377469|NCT01261130|Intestinal blood loss|intestinal blood loss
1377470|NCT01261130|Iron deficiency anemia|iron deficiency anemia
1377471|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
1377472|NCT01261117|İbuprofen|ibuprofen
1377473|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
1377474|NCT01261104|hearing loss|hearing loss
1377475|NCT01261104|handicap|handicap
1377476|NCT01261104|counseling|counseling
1377477|NCT01261091|Neurocritical Care|neurocritical care
1377478|NCT01261091|Ischemic Stroke|ischemic stroke
1377479|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
1377480|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1377481|NCT01261091|Tracheostomy|tracheostomy
1377482|NCT01261091|Tracheotomy|tracheotomy
1377483|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
1377484|NCT01261091|Weaning|weaning
1377485|NCT01261091|Ventilation|ventilation
1377486|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
1377487|NCT01261078|duration of anesthesia|duration of anesthesia
1377488|NCT01261078|quality of anesthesia|quality of anesthesia
1377489|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
1377490|NCT01261065|beta blockers|beta blockers
1377491|NCT01261065|heart failure|heart failure
1377492|NCT01261065|contractility|contractility
1377493|NCT01261065|remodeling|remodeling
1377494|NCT01261052|glucose sensors|glucose sensors
1377495|NCT01261052|artificial pancreas|artificial pancreas
1377496|NCT01261052|Diabetes Mellitus|diabetes mellitus
1377497|NCT01261013|Keratoconus|keratoconus
1377498|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
1377873|NCT01259401|Rehabilitation|rehabilitation
1377499|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
1377500|NCT01261000|Acromegaly|acromegaly
1377501|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
1377502|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
1377503|NCT01260974|Invasive fungal infections|invasive fungal infections
1377504|NCT01260974|Liver Transplantation|liver transplantation
1377807|NCT01259674|syrup|syrup
1377505|NCT01260974|Organ Transplantation|organ transplantation
1377506|NCT01260974|Mycoses|mycoses
1377507|NCT01260974|Fungus Diseases|fungus diseases
1377508|NCT01260974|Antifungal Agents|antifungal agents
1377509|NCT01260974|Invasive Mycosis|invasive mycosis
1377510|NCT01260948|Bioequivalence|bioequivalence
1377511|NCT01260948|Healthy Subjects|healthy subjects
1377512|NCT01260935|GERD|gerd
1377513|NCT01260935|laparoscopic surgery|laparoscopic surgery
1377514|NCT01260935|gastroesophageal|gastroesophageal
1377515|NCT01260935|reflux|reflux
1377516|NCT01260922|Bioequivalence|bioequivalence
1377517|NCT01260922|Healthy Subjects|healthy subjects
1377518|NCT01260896|Bioequivalence|bioequivalence
1377519|NCT01260896|Healthy Subjects|healthy subjects
1377520|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
1377521|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
1377522|NCT01260883|infants|infants
1377523|NCT01260883|postoperative analgesia|postoperative analgesia
1377524|NCT01260883|safety|safety
1377525|NCT01260857|Spirinolactone|spirinolactone
1567128|NCT00509938|peptide|peptide
1377526|NCT01260857|Hydroflumethiazide|hydroflumethiazide
1377527|NCT01260857|Hypertension|hypertension
1377528|NCT01260857|Filipinos|filipinos
1377529|NCT01260857|Diabetes mellitus|diabetes mellitus
1377530|NCT01260857|Proteinuria|proteinuria
1377531|NCT01260831|BedsidePEWS|bedsidepews
1377532|NCT01260831|Intensive Care|intensive care
1377533|NCT01260818|Tranexamic Acid|tranexamic acid
1377534|NCT01260805|bioequivalence|bioequivalence
1377535|NCT01260805|study|study
1377536|NCT01260805|ethinylestradiol|ethinylestradiol
1377537|NCT01260805|gestodene|gestodene
1377538|NCT01260740|Traumatic Brain Injury|traumatic brain injury
1377539|NCT01260740|Explicit Learning|explicit learning
1377540|NCT01260740|Primary Motor Cortex|primary motor cortex
1377541|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1377542|NCT01260740|Implicit Learning|implicit learning
1377543|NCT01260740|Healthy Volunteer|healthy volunteer
1377544|NCT01260740|HV|hv
1377545|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
1377546|NCT01260675|phase 1 study|phase 1 study
1377547|NCT01260675|volunteers|volunteers
1377548|NCT01260662|Deep Procedural Sedation|deep procedural sedation
1377549|NCT01260662|Propofol|propofol
1377550|NCT01260662|Ketamine|ketamine
1377551|NCT01260662|Emergency Department|emergency department
1377552|NCT01260662|Monitoring|monitoring
1377553|NCT01260662|Capnography|capnography
1377554|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
1377555|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
1377556|NCT01260649|ketamine|ketamine
1377557|NCT01260649|Major Depression|major depression
1377957|NCT01259024|LC Bead|lc bead
1377558|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
1377559|NCT01260623|asthma|asthma
1377560|NCT01260623|pharmacokinetics|pharmacokinetics
1377561|NCT01260623|prednisone|prednisone
1377562|NCT01260623|prednisolone|prednisolone
1377563|NCT01260623|asthma exacerbation|asthma exacerbation
1377564|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
1377565|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
1377566|NCT01260597|smoking|smoking
1377567|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
1377568|NCT01260584|thienopyridine|thienopyridine
1377569|NCT01260584|antiplatelet|antiplatelet
1377570|NCT01260584|prasugrel|prasugrel
1377571|NCT01260584|clopidogrel|clopidogrel
1377572|NCT01260571|blackheads and pimples|blackheads and pimples
1377573|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
1377574|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
1377575|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
1377576|NCT01260493|very frail|very frail
1377577|NCT01260493|case manager|case manager
1377578|NCT01260493|integrated care|integrated care
1377579|NCT01260493|multiprofessional|multiprofessional
1377580|NCT01260493|intervention|intervention
1377581|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
1377582|NCT01260480|Head and neck neoplasms|head and neck neoplasms
1377583|NCT01260480|Diagnostic imaging|diagnostic imaging
1377584|NCT01260467|recurrent|recurrent
1377585|NCT01260454|Qutenza|qutenza
1377586|NCT01260454|Capsaicin|capsaicin
1377587|NCT01260454|Remodulin|remodulin
1377588|NCT01260454|Treprostinil|treprostinil
1377589|NCT01260428|hypoxia|hypoxia
1377590|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
1377591|NCT01260428|cardiac output|cardiac output
1377592|NCT01260428|PEEP|peep
1377593|NCT01260428|Effects of hypoxia|effects of hypoxia
1377594|NCT01260415|colorectal cancer|colorectal cancer
1377595|NCT01260415|liver metastases|liver metastases
1377596|NCT01260415|panitumumab|panitumumab
1377597|NCT01260415|FOLFOX|folfox
1377598|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
1377599|NCT01260402|heart failure|heart failure
1377600|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
1377601|NCT01260402|Coronary disease|coronary disease
1377602|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
1377603|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
1377604|NCT01260402|Hemodynamics|hemodynamics
1377605|NCT01260402|Randomized Controlled Trials|randomized controlled trials
1377606|NCT01260402|Open Study|open study
1377607|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1377608|NCT01260389|COPD|copd
1377609|NCT01260376|VLDL-TG|vldl-tg
1377610|NCT01260376|Metabolism|metabolism
1377611|NCT01260376|Exercise|exercise
1377612|NCT01260376|Free Fatty Acids|free fatty acids
1377613|NCT01260350|PSI-7977|psi-7977
1377614|NCT01260350|Sofosbuvir|sofosbuvir
1377615|NCT01260350|GS-7977|gs-7977
1377616|NCT01260350|GS-5885|gs-5885
1377617|NCT01260350|GS-9669|gs-9669
1377618|NCT01260350|FDC|fdc
1377619|NCT01260350|ribavirin|ribavirin
1377620|NCT01260350|RBV|rbv
1377621|NCT01260350|Pegylated Interferon|pegylated interferon
1377622|NCT01260350|PEG-IFN|peg-ifn
1377623|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
1377624|NCT01260350|HCV|hcv
1377625|NCT01260350|Hepatitis|hepatitis
1377626|NCT01260350|Genotype 1|genotype 1
1377627|NCT01260350|Genotype 2|genotype 2
1377628|NCT01260350|Genotype 3|genotype 3
1377629|NCT01260350|GT 1|gt 1
1377630|NCT01260350|GT 2|gt 2
1377631|NCT01260350|GT 3|gt 3
1377632|NCT01260350|Hemophilia|hemophilia
1377633|NCT01260337|Weight loss|weight loss
1377634|NCT01260337|Type 2 Diabetes|type 2 diabetes
1377635|NCT01260337|Behavior Modification|behavior modification
1377636|NCT01260337|portion control|portion control
1377637|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
1377638|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
1377639|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
1377640|NCT01260311|Observational|observational
1377641|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
1377642|NCT01260272|Cardiovascular|cardiovascular
1377643|NCT01260272|Risk Factors|risk factors
1377644|NCT01260272|Cardiovascular Disease|cardiovascular disease
1377645|NCT01260272|Glucose|glucose
1377646|NCT01260272|Blood Pressure|blood pressure
1377647|NCT01260272|BMI|bmi
1377648|NCT01260272|Weight|weight
1377649|NCT01260272|Waist Circumference|waist circumference
1377650|NCT01260259|Pediatric|pediatric
1377651|NCT01260259|Cardiac|cardiac
1377652|NCT01260259|Surgery|surgery
1377653|NCT01260259|Cardiopulmonary|cardiopulmonary
1377654|NCT01260259|Bypass|bypass
1377655|NCT01260259|Myocardial|myocardial
1377656|NCT01260259|Kidney|kidney
1377657|NCT01260259|Lung|lung
1377658|NCT01260259|Injury|injury
1377659|NCT01260233|smoking cessation|smoking cessation
1377660|NCT01260233|complications|complications
1377661|NCT01260233|cigarettes|cigarettes
1377662|NCT01260233|preoperative|preoperative
1377663|NCT01260233|perioperative|perioperative
1377664|NCT01260233|surgery|surgery
1377665|NCT01260233|education|education
1377666|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
1377667|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
1377668|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
1377669|NCT01260207|Best Practice Guidelines|best practice guidelines
1377670|NCT01260207|Compliance|compliance
1377671|NCT01260207|Health Care Utilization|health care utilization
1377672|NCT01260168|Cancer|cancer
1377673|NCT01260168|Colorectal Cancer|colorectal cancer
1377674|NCT01260168|Neoplasm|neoplasm
1377675|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
1377676|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
1377677|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1377678|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
1377679|NCT01260168|Neoplasms by Site|neoplasms by site
1377680|NCT01260168|Neoplasms|neoplasms
1377681|NCT01260168|Digestive System Diseases|digestive system diseases
1377682|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
1377683|NCT01260168|Colonic Diseases|colonic diseases
1377684|NCT01260168|Intestinal Diseases|intestinal diseases
1377685|NCT01260168|Rectal Diseases|rectal diseases
1377686|NCT01260129|BPH|bph
1377687|NCT01260129|silodosin|silodosin
1377688|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
1377689|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
1377690|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
1377691|NCT01260103|Temozolomide|temozolomide
1377692|NCT01260103|Temodar|temodar
1377693|NCT01260103|TMZ|tmz
1377694|NCT01260103|Antineoplastons|antineoplastons
1377695|NCT01260103|ANP therapy|anp therapy
1377696|NCT01260103|Atengenal (A10)|atengenal (a10)
1377697|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
1377698|NCT01260090|Minimally conscious states|minimally conscious states
1377699|NCT01260090|Persistently vegetative states|persistently vegetative states
1377700|NCT01260090|Traumatic brain injury|traumatic brain injury
1377701|NCT01260064|Appendicitis|appendicitis
1377702|NCT01260064|Open appendectomy|open appendectomy
1377703|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
1377704|NCT01260064|Endoclip|endoclip
1377705|NCT01260064|Intracorporeal suture|intracorporeal suture
1377706|NCT01260064|Quality-of-life|quality-of-life
1377707|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
1377708|NCT01260038|observational study|observational study
1377709|NCT01260038|EGFR mutation analysis|egfr mutation analysis
1377710|NCT01260038|EGFR mutation status|egfr mutation status
1377711|NCT01260038|testing turn around time|testing turn around time
1377712|NCT01260025|Tolerability|tolerability
1377713|NCT01260025|Pharmacokinetics|pharmacokinetics
1377714|NCT01260025|Endostatin|endostatin
1377715|NCT01260025|antiangiogenesis|antiangiogenesis
1377716|NCT01260025|cancer|cancer
1377717|NCT01260012|Schistosoma mansoni|schistosoma mansoni
1377718|NCT01260012|Schistosomiasis|schistosomiasis
1377719|NCT01260012|periportal fibrosis|periportal fibrosis
1377720|NCT01260012|antioxidant|antioxidant
1377721|NCT01260012|fibrosis reversal|fibrosis reversal
1377722|NCT01259999|malnutrition|malnutrition
1377723|NCT01259999|oleic-acid|oleic-acid
1567129|NCT00509938|lactoferrin|lactoferrin
1377724|NCT01259999|micronutrient supplement|micronutrient supplement
1377725|NCT01259999|old peoples home|old peoples home
1377726|NCT01259986|Vitiligo|vitiligo
1377727|NCT01259986|Laser|laser
1377728|NCT01259986|Segmental vitiligo|segmental vitiligo
1377729|NCT01259986|Acral vitiligo|acral vitiligo
1377730|NCT01259973|Pharmacogenetics|pharmacogenetics
1377731|NCT01259973|Antipsychotics|antipsychotics
1377732|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
1377733|NCT01259947|headache|headache
1377734|NCT01259947|migraine|migraine
1377735|NCT01259947|medicinal plant|medicinal plant
1377736|NCT01259947|essential oil|essential oil
1377737|NCT01259947|phytotherapy|phytotherapy
1377738|NCT01259934|Randomized Phase III trial|randomized phase iii trial
1377739|NCT01259934|Adjuvant therapy|adjuvant therapy
1377740|NCT01259934|Interferon|interferon
1377741|NCT01259934|Melanoma|melanoma
1377742|NCT01259921|EEG biofeedback|eeg biofeedback
1377743|NCT01259921|neurofeedback|neurofeedback
1377744|NCT01259921|PTSD|ptsd
1377745|NCT01259921|Affect Regulation|affect regulation
1377746|NCT01259921|Chronic Trauma|chronic trauma
1377747|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
1377748|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
1377874|NCT01259401|Behavior therapy|behavior therapy
1377749|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
1377750|NCT01259856|Polycythemia vera|polycythemia vera
1377751|NCT01259856|Essential thrombocythemia|essential thrombocythemia
1377752|NCT01259856|Hydroxyurea|hydroxyurea
1377753|NCT01259856|PEGASYS|pegasys
1377754|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
1377755|NCT01259843|Acute aortic syndrome|acute aortic syndrome
1377756|NCT01259830|fast-track|fast-track
1377757|NCT01259830|colon or rectal surgery|colon or rectal surgery
1377759|NCT01259817|Polycythemia Vera|polycythemia vera
1377760|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
1377761|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
1377762|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
1377763|NCT01259817|PEGASYS|pegasys
1377764|NCT01259804|peanut|peanut
1377765|NCT01259804|food allergy|food allergy
1377766|NCT01259804|anaphylaxis|anaphylaxis
1377767|NCT01259804|immunotherapy|immunotherapy
1377768|NCT01259778|Growth disorders|growth disorders
1377769|NCT01259778|Saizen|saizen
1377770|NCT01259778|easypod™|easypod™
1377771|NCT01259778|Growth hormone|growth hormone
1377772|NCT01259778|Pediatric subject|pediatric subject
1377773|NCT01259765|llama antibody|llama antibody
1377774|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
1377775|NCT01259765|children|children
1377776|NCT01259752|Trauma|trauma
1377777|NCT01259752|ankle sprain|ankle sprain
1377778|NCT01259752|emergency|emergency
1377779|NCT01259752|compression stocking|compression stocking
1377780|NCT01259739|trained cyclists|trained cyclists
1377781|NCT01259739|no medications|no medications
1377782|NCT01259739|no diseases|no diseases
1377783|NCT01259739|non-smokers|non-smokers
1377784|NCT01259726|Diarrhea|diarrhea
1377785|NCT01259726|Clostridium difficile|clostridium difficile
1377786|NCT01259726|Clostridium infections|clostridium infections
1377787|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
1377788|NCT01259726|Bacterial Infections|bacterial infections
1377789|NCT01259726|Pharmacologic Actions|pharmacologic actions
1377790|NCT01259713|Ambisome|ambisome
1377792|NCT01259713|invasive fungal infection|invasive fungal infection
1377793|NCT01259713|prophylaxis|prophylaxis
1377794|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
1377795|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
1377796|NCT01259700|High blood pressure|high blood pressure
1377797|NCT01259700|Primary care|primary care
1377798|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
1377799|NCT01259700|Salt reduction|salt reduction
1377800|NCT01259687|Electrocardiogram|electrocardiogram
1377801|NCT01259687|Arterial line waveform|arterial line waveform
1377802|NCT01259687|Cardiac output|cardiac output
1377803|NCT01259674|Pediatric|pediatric
1377804|NCT01259674|children|children
1377805|NCT01259674|acute cough|acute cough
1377808|NCT01259674|protective natural extracts|protective natural extracts
1377809|NCT01259661|physical activity|physical activity
1377810|NCT01259661|metabolic syndrome|metabolic syndrome
1377811|NCT01259661|postmenopausal women|postmenopausal women
1377812|NCT01259661|exercise training|exercise training
1377813|NCT01259648|remifentanil|remifentanil
1377814|NCT01259648|anesthesia induction|anesthesia induction
1377815|NCT01259648|reactional tachycardia|reactional tachycardia
1377816|NCT01259635|Parkinson's disease|parkinson's disease
1377817|NCT01259635|freezing of gait|freezing of gait
1377818|NCT01259609|Diabetic Macular Edema|diabetic macular edema
1377819|NCT01259609|Ciliary Body|ciliary body
1377820|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
1377821|NCT01259609|Vitrectomy|vitrectomy
1377822|NCT01259596|anxiety|anxiety
1377823|NCT01259596|rural|rural
1377824|NCT01259596|elderly|elderly
1377825|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
1377826|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
1377827|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
1377828|NCT01259531|strong|strong
1377829|NCT01259531|silodosin|silodosin
1377830|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
1377831|NCT01259531|BPH|bph
1377832|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
1377833|NCT01259505|no number|no number
1377834|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
1377835|NCT01259479|Solid Tumors|solid tumors
1377836|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
1377837|NCT01259479|Parmacokinetics|parmacokinetics
1377838|NCT01259479|Pharmacogenomics|pharmacogenomics
1377839|NCT01259479|Satraplatin|satraplatin
1377840|NCT01259479|Cancer|cancer
1377841|NCT01259479|Solid Tumor|solid tumor
1377842|NCT01259479|Brain Tumor|brain tumor
1377843|NCT01259466|Smoking cessation|smoking cessation
1377844|NCT01259466|Overweight|overweight
1377845|NCT01259466|Obesity|obesity
1377846|NCT01259466|Internet treatment|internet treatment
1377847|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
1377848|NCT01259453|Syringe exchange programs|syringe exchange programs
1377849|NCT01259453|Injection drug users|injection drug users
1377850|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
1377851|NCT01259440|Telemedicine|telemedicine
1377852|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
1377853|NCT01259440|treatment adherence|treatment adherence
1377854|NCT01259427|Mental Disorders|mental disorders
1377855|NCT01259427|Psychotic Disorders|psychotic disorders
1377856|NCT01259427|Schizophrenia|schizophrenia
1377857|NCT01259427|Stigmatization|stigmatization
1377858|NCT01259427|Mood Disorders|mood disorders
1377859|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
1377860|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1377861|NCT01259414|Liver Neoplasms|liver neoplasms
1377862|NCT01259414|Survival analysis|survival analysis
1377863|NCT01259414|treatment outcome|treatment outcome
1377864|NCT01259414|administration drugs|administration drugs
1377865|NCT01259414|Chemoembolization,|chemoembolization,
1377866|NCT01259414|TACE|tace
1377867|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
1377868|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
1377869|NCT01259414|iopamidol|iopamidol
1377870|NCT01259414|lipiodol|lipiodol
1377871|NCT01259414|distilled water|distilled water
1377872|NCT01259401|Sleep|sleep
1377875|NCT01259401|Insomnia|insomnia
1377876|NCT01259388|Multiple sclerosis|multiple sclerosis
1377877|NCT01259388|Lithium|lithium
1377878|NCT01259349|cataract,|cataract,
1377879|NCT01259349|phacoemulsification,|phacoemulsification,
1377880|NCT01259349|one percent ultrasound|one percent ultrasound
1377881|NCT01259349|endothelial cell density|endothelial cell density
1377882|NCT01259336|Itraconazole|itraconazole
1377883|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
1377884|NCT01259336|Aspergillosis|aspergillosis
1377885|NCT01259336|fungal ball|fungal ball
1377886|NCT01259336|mycetoma|mycetoma
1377887|NCT01259336|efficacy|efficacy
1377888|NCT01259336|safety|safety
1377889|NCT01259310|fertility|fertility
1377890|NCT01259310|women|women
1377891|NCT01259310|epilepsy|epilepsy
1377892|NCT01259310|pregnancy|pregnancy
1377893|NCT01259310|seizures|seizures
1377894|NCT01259310|seizure frequency|seizure frequency
1377895|NCT01259310|ovulation|ovulation
1377896|NCT01259310|menstruation|menstruation
1377897|NCT01259310|hormones|hormones
1377898|NCT01259310|progesterone|progesterone
1377899|NCT01259297|Aliskiren|aliskiren
1377900|NCT01259297|Elderly|elderly
1377901|NCT01259297|Major Cardiovascular Events|major cardiovascular events
1377902|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
1377903|NCT01259284|Breast cancer|breast cancer
1377904|NCT01259284|Colorectal cancer|colorectal cancer
1377905|NCT01259284|Genitourinary cancer|genitourinary cancer
1377906|NCT01259284|Head and neck cancers|head and neck cancers
1377907|NCT01259284|Lung cancer|lung cancer
1377908|NCT01259284|Melanoma|melanoma
1377909|NCT01259284|Sarcoma|sarcoma
1377910|NCT01259284|Atorvastatin|atorvastatin
1377911|NCT01259284|Lipitor|lipitor
1377912|NCT01259284|Fish Oil supplement|fish oil supplement
1377913|NCT01259284|Placebo|placebo
1377914|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
1377915|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
1377916|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
1377917|NCT01259245|Tai chi|tai chi
1377918|NCT01259219|HIV|hiv
1377919|NCT01259219|Completion of TB treamtment|completion of tb treamtment
1377920|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
1377921|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
1377922|NCT01259193|Sorafenib|sorafenib
1377923|NCT01259193|Zoledronic Acid|zoledronic acid
1377924|NCT01259193|toxic reaction|toxic reaction
1377925|NCT01259180|acupuncture|acupuncture
1377926|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
1377927|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
1377928|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
1377929|NCT01259115|Healthy subjects|healthy subjects
1377930|NCT01259115|Opioid|opioid
1377931|NCT01259115|Transdermal|transdermal
1377932|NCT01259102|Healthy subjects|healthy subjects
1377933|NCT01259102|Opioid|opioid
1377934|NCT01259102|Transdermal|transdermal
1377935|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
1377936|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
1377937|NCT01259063|GEMCITABINE|gemcitabine
1377938|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
1377939|NCT01259063|urinary|urinary
1377940|NCT01259063|BCG-Refractory|bcg-refractory
1377941|NCT01259063|Intravesical|intravesical
1377942|NCT01259063|10-165|10-165
1377943|NCT01259050|ALS treatment|als treatment
1377944|NCT01259050|Zinc|zinc
1377945|NCT01259050|Copper|copper
1377946|NCT01259050|BMAA|bmaa
1377947|NCT01259050|ALS|als
1377948|NCT01259037|Elastography|elastography
1377949|NCT01259037|Cutaneous|cutaneous
1377950|NCT01259037|Imaging|imaging
1377951|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
1377952|NCT01259024|chemoembolization|chemoembolization
1377953|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
1377954|NCT01259024|liver cancer|liver cancer
1377955|NCT01259024|doxorubicin|doxorubicin
1377956|NCT01259024|drug-eluting beads|drug-eluting beads
1377958|NCT01259011|end stage renal disease|end stage renal disease
1377959|NCT01259011|dialysis|dialysis
1377960|NCT01259011|end of life decision making|end of life decision making
1377961|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
1377962|NCT01258985|Knee|knee
1377963|NCT01258985|Knee osteoarthritis|knee osteoarthritis
1377964|NCT01258985|osteoarthritis|osteoarthritis
1377965|NCT01258985|Knee pain|knee pain
1377966|NCT01258985|Tai Chi|tai chi
1377967|NCT01258985|Physical Therapy|physical therapy
1377968|NCT01258985|mind-body exercise|mind-body exercise
1377969|NCT01258972|Bifurcation lesions|bifurcation lesions
1377970|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
1377971|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
1377972|NCT01258933|Leukemia|leukemia
1377973|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1377974|NCT01258933|CLL|cll
1377975|NCT01258933|Lymphoma|lymphoma
1377976|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1377977|NCT01258933|SLL|sll
1377978|NCT01258933|Ofatumumab|ofatumumab
1377979|NCT01258920|Schizophrenia|schizophrenia
1377980|NCT01258920|Paliperidone palmitate|paliperidone palmitate
1377981|NCT01258920|Intramascular Injection|intramascular injection
1377982|NCT01258907|BI-204|bi-204
1377983|NCT01258868|Mesothelioma|mesothelioma
1377984|NCT01258868|Esophageal Cancer|esophageal cancer
1377985|NCT01258868|Lung Cancer|lung cancer
1377986|NCT01258868|Thoracic Malignancies|thoracic malignancies
1377987|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
1377988|NCT01258842|Influenza|influenza
1377989|NCT01258842|Prevention|prevention
1377990|NCT01258842|Probiotic|probiotic
1377991|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
1377992|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
1377993|NCT01258816|Pharmacokinetics|pharmacokinetics
1377994|NCT01258816|Elacytarabine|elacytarabine
1377995|NCT01258816|CP-4055|cp-4055
1377996|NCT01258803|asthma|asthma
1377997|NCT01258803|children|children
1377998|NCT01258803|persistent|persistent
1377999|NCT01258790|TS|ts
1378000|NCT01258790|tics|tics
1378001|NCT01258790|tourette|tourette
1378002|NCT01258777|Healthy volunteers|healthy volunteers
1378003|NCT01258777|Japanese male|japanese male
1378004|NCT01258777|Caucasian male|caucasian male
1378005|NCT01258777|Simponi|simponi
1378006|NCT01258764|hypertension|hypertension
1378007|NCT01258764|Blood Pressure control|blood pressure control
1378008|NCT01258764|hypertension treatment|hypertension treatment
1378009|NCT01258764|antihypertensive|antihypertensive
1378010|NCT01258764|N of 1 study|n of 1 study
1378011|NCT01258751|Healthy Volunteers|healthy volunteers
1378012|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
1378013|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
1378014|NCT01258673|Fimasartan|fimasartan
1378015|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
1378016|NCT01258647|infant nutrition|infant nutrition
1378017|NCT01258647|complementary feeding|complementary feeding
1378018|NCT01258647|malnutrition|malnutrition
1378019|NCT01258647|stunting of growth|stunting of growth
1378020|NCT01258634|Osteosarcoma|osteosarcoma
1378021|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
1378022|NCT01258634|Lung Metastases Only|lung metastases only
1378023|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
1378024|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1378025|NCT01258608|Mapatumumab|mapatumumab
1378026|NCT01258608|HGS1012|hgs1012
1378027|NCT01258608|sorafenib|sorafenib
1378028|NCT01258595|Influenza|influenza
1378029|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1378030|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
1378031|NCT01258595|Influenza vaccines|influenza vaccines
1378032|NCT01258582|HIV|hiv
1378033|NCT01258582|Testing|testing
1378034|NCT01258582|HIV Seronegativity|hiv seronegativity
1378035|NCT01258569|laparoscopic|laparoscopic
1378036|NCT01258569|colon|colon
1378037|NCT01258569|resection|resection
1378038|NCT01258569|Entereg|entereg
1378039|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
1378040|NCT01258543|Non-specific back pain|non-specific back pain
1378041|NCT01258543|Inter-examiner reliability|inter-examiner reliability
1378042|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
1378043|NCT01258517|RDS|rds
1378044|NCT01258517|surfactant|surfactant
1378045|NCT01258517|cerebral oxygenation|cerebral oxygenation
1378046|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
1378047|NCT01258504|Steady-state|steady-state
1378048|NCT01258504|Bosentan|bosentan
1378049|NCT01258504|St. Johns Wort|st. johns wort
1378050|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
1378051|NCT01258465|Communication|communication
1378450|NCT01256593|Lyrica|lyrica
1378052|NCT01258465|Pivotal Response Training|pivotal response training
1378053|NCT01258465|Picture Exchange Communication System|picture exchange communication system
1378054|NCT01258439|HIV|hiv
1378055|NCT01258439|cardiovascular disease|cardiovascular disease
1378056|NCT01258439|post prandial lipids|post prandial lipids
1378057|NCT01258439|ritonavir|ritonavir
1378058|NCT01258439|darunavir|darunavir
1378059|NCT01258439|raltegravir|raltegravir
1378060|NCT01258439|arterial stiffness|arterial stiffness
1378061|NCT01258439|tonometry|tonometry
1378062|NCT01258413|Cervical Cancer|cervical cancer
1378063|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
1378064|NCT01258413|Overall survival|overall survival
1378065|NCT01258413|Disease-free five-years survival|disease-free five-years survival
1378066|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
1378067|NCT01258361|preoperative fasting|preoperative fasting
1378068|NCT01258296|Postoperative pain|postoperative pain
1378069|NCT01258296|Breast reconstruction|breast reconstruction
1378070|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
1378071|NCT01258257|Aneurysm|aneurysm
1378072|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
1378073|NCT01258257|Lumbar drain|lumbar drain
1378074|NCT01258257|Cerebral vasospasm|cerebral vasospasm
1378075|NCT01258257|Cerebral Ventricles|cerebral ventricles
1378076|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
1378077|NCT01258257|Prospective Studies|prospective studies
1378078|NCT01258257|Drainage/methods*|drainage/methods*
1378079|NCT01258257|Humans|humans
1378080|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
1378081|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
1378082|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
1378083|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
1378084|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
1378085|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
1378086|NCT01258205|Amgen|amgen
1378087|NCT01258205|AMG 139|amg 139
1378088|NCT01258205|Crohn's Disease|crohn's disease
1378089|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1378090|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1378091|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
1378092|NCT01258192|cisplatin|cisplatin
1378093|NCT01258153|Infantile Colic|infantile colic
1378094|NCT01258153|tachykinin antagonist|tachykinin antagonist
1378095|NCT01258153|Nepadutant|nepadutant
1378096|NCT01258140|CT angiography|ct angiography
1378097|NCT01258140|radiation dose|radiation dose
1378098|NCT01258140|contrast medium|contrast medium
1378099|NCT01258127|Pemetrexed|pemetrexed
1378100|NCT01258127|Vinorelbine|vinorelbine
1378101|NCT01258127|Carboplatin|carboplatin
1378102|NCT01258114|Overweight|overweight
1378103|NCT01258114|Obesity|obesity
1378104|NCT01258114|Balneotherapy|balneotherapy
1378105|NCT01258114|Spa Therapy|spa therapy
1378106|NCT01258114|balneology|balneology
1498833|NCT00783757|TOBI|tobi
1378107|NCT01258114|hydrotherapy|hydrotherapy
1378108|NCT01258114|SF 12|sf 12
1378109|NCT01258114|Nutritional counselling|nutritional counselling
1378110|NCT01258114|Zelen double consent|zelen double consent
1378111|NCT01258114|Lifestyle modification program|lifestyle modification program
1378112|NCT01258114|IMC|imc
1378113|NCT01258088|psoriasis|psoriasis
1378114|NCT01258075|type 2 diabetes mellitus|type 2 diabetes mellitus
1378115|NCT01258075|blood glucose|blood glucose
1378116|NCT01258075|anti-diabetic|anti-diabetic
1378117|NCT01258075|bile acid sequestrant|bile acid sequestrant
1378118|NCT01258075|colesevelam HCl|colesevelam hcl
1378119|NCT01258075|oral suspension|oral suspension
1378120|NCT01258075|pediatric|pediatric
1378121|NCT01258075|add-on therapy|add-on therapy
1378122|NCT01258075|add-on to metformin|add-on to metformin
1378123|NCT01258075|metformin|metformin
1378124|NCT01258075|adolescent|adolescent
1378125|NCT01258075|lipid|lipid
1378126|NCT01258049|Plasmodium infections|plasmodium infections
1378127|NCT01258049|Remittent fever|remittent fever
1378128|NCT01258049|Artemether|artemether
1378129|NCT01258049|Artemesinins|artemesinins
1378130|NCT01258049|Quinine|quinine
1378131|NCT01258049|Malaria|malaria
1378132|NCT01258049|Protozoan infections|protozoan infections
1378133|NCT01258049|sublingual drug delivery|sublingual drug delivery
1378134|NCT01258049|Parasitic disease|parasitic disease
1378135|NCT01258049|Antiprotozoan agents|antiprotozoan agents
1378136|NCT01258036|Bone microarchitecture|bone microarchitecture
1378137|NCT01258036|Bone mineral density|bone mineral density
1378138|NCT01258036|Bone markers|bone markers
1378139|NCT01258036|hereditary determinism|hereditary determinism
1378140|NCT01258010|Red blood cell transfusion|red blood cell transfusion
1378141|NCT01258010|Neurosurgery|neurosurgery
1378142|NCT01258010|Orthopedic surgery|orthopedic surgery
1378143|NCT01258010|Tranexamic acid|tranexamic acid
1378144|NCT01258010|Surgical blood loss|surgical blood loss
1378145|NCT01257997|No specific experimental conditions|no specific experimental conditions
1378146|NCT01257971|Cholesterol|cholesterol
1378147|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
1378148|NCT01257971|cardiovascular risk|cardiovascular risk
1378149|NCT01257971|LDLl|ldll
1378150|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
1378151|NCT01257932|Breast Cancer|breast cancer
1378152|NCT01257906|acne|acne
1378153|NCT01257906|Ziana|ziana
1378154|NCT01257906|clindamycin|clindamycin
1378155|NCT01257906|tretinoin|tretinoin
1378156|NCT01257893|migraine|migraine
1378157|NCT01257893|chronic migraine|chronic migraine
1378158|NCT01257893|migraine with aura|migraine with aura
1378159|NCT01257893|migraine without aura|migraine without aura
1378160|NCT01257893|aspirin|aspirin
1378161|NCT01257893|platelets|platelets
1378162|NCT01257880|Migraine|migraine
1378163|NCT01257880|Migraine with Aura|migraine with aura
1378164|NCT01257880|Aura|aura
1378165|NCT01257880|Patent Foramen Ovale|patent foramen ovale
1378166|NCT01257880|Platelets|platelets
1378167|NCT01257880|Sleep Apnea|sleep apnea
1378168|NCT01257880|Cognitive Function|cognitive function
1378169|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
1378170|NCT01257867|Oxidative stress|oxidative stress
1378171|NCT01257867|Neurogenesis|neurogenesis
1378172|NCT01257867|Lithium|lithium
1378173|NCT01257867|Lithia water|lithia water
1378174|NCT01257854|busulfan|busulfan
1378175|NCT01257854|pharmacogenetic|pharmacogenetic
1378176|NCT01257854|pharmacokinetic|pharmacokinetic
1378177|NCT01257854|toxicity|toxicity
1378178|NCT01257854|survival|survival
1378179|NCT01257841|Fasting|fasting
1378180|NCT01257841|Gut hormones|gut hormones
1378181|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
1378182|NCT01257815|Diabetes mellitus|diabetes mellitus
1378183|NCT01257815|Diabetic retinopathy|diabetic retinopathy
1378184|NCT01257815|Macular oedema|macular oedema
1378185|NCT01257815|Visual acuity|visual acuity
1378186|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
1378187|NCT01257789|learning curve|learning curve
1378188|NCT01257789|complications|complications
1378189|NCT01257789|operative time|operative time
1378190|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
1378191|NCT01257776|Diabetes|diabetes
1378192|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
1378193|NCT01257776|Regenerative Therapy|regenerative therapy
1378194|NCT01257763|needles/adverse effects|needles/adverse effects
1378195|NCT01257763|administration, cutaneous|administration, cutaneous
1378196|NCT01257763|erythema|erythema
1378197|NCT01257763|pain measurement|pain measurement
1378198|NCT01257763|Safety|safety
1378199|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
1378200|NCT01257750|corneal neovascularization|corneal neovascularization
1378201|NCT01257750|pazopanib|pazopanib
1378202|NCT01257750|votrient|votrient
1378203|NCT01257750|rosacea|rosacea
1378204|NCT01257737|Urea Cycle Disorders|urea cycle disorders
1378205|NCT01257737|GT4P|gt4p
1378206|NCT01257737|HPN-100|hpn-100
1378207|NCT01257737|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
1378208|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
1378209|NCT01257737|Phenylbutyrate|phenylbutyrate
1378210|NCT01257737|Hyperion|hyperion
1378211|NCT01257737|BUPHENYL|buphenyl
1378212|NCT01257737|hyperammonemia|hyperammonemia
1378213|NCT01257724|Knowledge translation|knowledge translation
1378214|NCT01257724|Community based organizations|community based organizations
1378215|NCT01257724|HIV/AIDS|hiv/aids
1378216|NCT01257711|Gastric Cancer|gastric cancer
1378217|NCT01257711|Gastrectomy|gastrectomy
1378218|NCT01257711|Billroth 2|billroth 2
1378219|NCT01257711|Roux-en-Y|roux-en-y
1378220|NCT01257698|Vitrectomy|vitrectomy
1378221|NCT01257698|Gas bubble|gas bubble
1378222|NCT01257698|Retinal detachment|retinal detachment
1378223|NCT01257698|Macular hole|macular hole
1378224|NCT01257698|Aqueous suppressant|aqueous suppressant
1378225|NCT01257672|acute gastroenteritis|acute gastroenteritis
1378226|NCT01257672|vomiting|vomiting
1378227|NCT01257672|ondansetron|ondansetron
1378228|NCT01257672|domperidon|domperidon
1378229|NCT01257672|symptomatic treatment|symptomatic treatment
1378230|NCT01257659|Rectocele|rectocele
1378231|NCT01257659|Trans anal STARR resection|trans anal starr resection
1378232|NCT01257659|Transvaginal repair|transvaginal repair
1378233|NCT01257633|da Vinci surgical robot|da vinci surgical robot
1378234|NCT01257633|laryngeal cancer|laryngeal cancer
1378235|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
1378236|NCT01257620|Coeliac Disease|coeliac disease
1378237|NCT01257594|Gliomas|gliomas
1378238|NCT01257594|Erlotinib|erlotinib
1378239|NCT01257594|Glioblastoma|glioblastoma
1378240|NCT01257594|GBM|gbm
1378241|NCT01257594|Gliosarcoma|gliosarcoma
1378242|NCT01257594|Glioma|glioma
1378243|NCT01257581|ALS|als
1378244|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
1378245|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1378246|NCT01257581|Creatine|creatine
1378247|NCT01257581|Tamoxifen|tamoxifen
1378248|NCT01257581|Selection Design|selection design
1378249|NCT01257542|randomized|randomized
1378250|NCT01257542|parallel|parallel
1378251|NCT01257542|double-blind|double-blind
1378255|NCT01257542|safety|safety
1378256|NCT01257542|dextromethorphan|dextromethorphan
1378257|NCT01257529|pregabalin|pregabalin
1378258|NCT01257529|pharmacokinetics|pharmacokinetics
1378259|NCT01257529|bioavailability|bioavailability
1378260|NCT01257529|bioequivalence|bioequivalence
1378261|NCT01257516|pregabalin|pregabalin
1378262|NCT01257516|pharmacokinetics|pharmacokinetics
1378263|NCT01257516|bioavailability|bioavailability
1378264|NCT01257516|bioequivalence|bioequivalence
1378265|NCT01257503|children|children
1378266|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
1378267|NCT01257503|homeopathy|homeopathy
1378268|NCT01257477|Diarrhea|diarrhea
1378269|NCT01257477|IBS|ibs
1378270|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
1378271|NCT01257464|CFRD|cfrd
1378272|NCT01257464|sitagliptin|sitagliptin
1378273|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
1378274|NCT01257464|incretins|incretins
1378275|NCT01257464|hyperglycemia|hyperglycemia
1378276|NCT01257464|GIP|gip
1378277|NCT01257464|GLP-1|glp-1
1378278|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
1378279|NCT01257412|Phase III|phase iii
1378280|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1378281|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
1378282|NCT01257360|RAS-Wildtype|ras-wildtype
1378283|NCT01257360|Radiotherapy|radiotherapy
1378284|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
1378285|NCT01257347|Medication adherence|medication adherence
1378286|NCT01257347|clinical inertia|clinical inertia
1378287|NCT01257347|treatment intensification|treatment intensification
1378288|NCT01257347|quality of care|quality of care
1378289|NCT01257334|type 2 diabetes|type 2 diabetes
1378290|NCT01257308|lung cancer|lung cancer
1378291|NCT01257295|dietary fiber|dietary fiber
1378292|NCT01257295|energy intake|energy intake
1378293|NCT01257295|appetite|appetite
1378294|NCT01257295|satiety hormones|satiety hormones
1378295|NCT01257295|glucose|glucose
1378296|NCT01257295|gastric emptying|gastric emptying
1378297|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
1378298|NCT01257269|ADAMTS13|adamts13
1378299|NCT01257269|Von Willebrand factor|von willebrand factor
1378300|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
1378301|NCT01257269|Thrombocytopenia|thrombocytopenia
1378302|NCT01257269|Hemolytic anemia|hemolytic anemia
1378303|NCT01257256|infertile patients|infertile patients
1378304|NCT01257243|cough|cough
1378305|NCT01257243|symptoms|symptoms
1378306|NCT01257243|cold|cold
1378307|NCT01257243|flu|flu
1378308|NCT01257217|Intraocular Lens|intraocular lens
1378309|NCT01257217|Presbyopia|presbyopia
1378310|NCT01257217|multifocal|multifocal
1378311|NCT01257191|Vehicle Emissions|vehicle emissions
1378312|NCT01257191|Diesel Exhaust|diesel exhaust
1378313|NCT01257165|Automobile driving|automobile driving
1378314|NCT01257165|Zopiclone|zopiclone
1378315|NCT01257165|Drug safety|drug safety
1378316|NCT01257165|Traffic accidents|traffic accidents
1378317|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
1378318|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
1378319|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
1378320|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
1378321|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
1378322|NCT01257126|diclofenac potassium|diclofenac potassium
1378323|NCT01257126|nimesulide|nimesulide
1378324|NCT01257126|fever|fever
1378325|NCT01257126|pain|pain
1378326|NCT01257113|shoulder pain|shoulder pain
1378327|NCT01257113|shoulder impingement|shoulder impingement
1378328|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
1378329|NCT01257113|supervised exercise|supervised exercise
1378330|NCT01257113|homebased exercise|homebased exercise
1378334|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1378335|NCT01257087|Obesity|obesity
1378336|NCT01257087|Bariatric Surgery|bariatric surgery
1378337|NCT01257087|Glycaemic control|glycaemic control
1378338|NCT01257087|Microvascular complications|microvascular complications
1378339|NCT01257087|Intensive|intensive
1378340|NCT01257087|Conservative|conservative
1378341|NCT01257074|Herpes Simplex|herpes simplex
1378342|NCT01257061|Dermatitis|dermatitis
1378343|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
1378344|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
1378345|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1378346|NCT01257048|method evaluation|method evaluation
1378347|NCT01257035|Rectum cancer|rectum cancer
1378348|NCT01257035|FAZA|faza
1378349|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
1378350|NCT01257035|Radiotherapy|radiotherapy
1378351|NCT01257035|Chemoradiotherapy|chemoradiotherapy
1378352|NCT01257022|Prevention|prevention
1378354|NCT01257022|Substance use|substance use
1378355|NCT01257022|Hispanic|hispanic
1378356|NCT01257022|Adolescents|adolescents
1378357|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
1378358|NCT01257022|Behavioral intervention|behavioral intervention
1378359|NCT01257009|sympathetic activity|sympathetic activity
1378360|NCT01257009|chronic kidney disease|chronic kidney disease
1378361|NCT01257009|atorvastatin|atorvastatin
1378362|NCT01257009|lipitor|lipitor
1378363|NCT01256983|Sleep quality|sleep quality
1378364|NCT01256983|Daytime Sleepiness|daytime sleepiness
1378365|NCT01256944|PCOS|pcos
1378366|NCT01256944|DM|dm
1378367|NCT01256944|Hypertension|hypertension
1378368|NCT01256944|CVD|cvd
1378369|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
1378370|NCT01256931|booster with Fluarix|booster with fluarix
1378371|NCT01256918|cataract|cataract
1378372|NCT01256918|phacoemulsification|phacoemulsification
1378373|NCT01256918|phacochop|phacochop
1378374|NCT01256918|phacotip|phacotip
1378375|NCT01256879|cimetidine|cimetidine
1378376|NCT01256879|pharmacokinetics|pharmacokinetics
1378377|NCT01256879|formulation|formulation
1378378|NCT01256866|Dexmedetomidine|dexmedetomidine
1378379|NCT01256866|Midazolam|midazolam
1378380|NCT01256866|Sedation|sedation
1378381|NCT01256866|Mechanical ventilation|mechanical ventilation
1378382|NCT01256866|Critically ill patients|critically ill patients
1378383|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
1378384|NCT01256827|age-related macular degeneration|age-related macular degeneration
1378385|NCT01256827|ranibizumab|ranibizumab
1378386|NCT01256827|geographic atrophy|geographic atrophy
1378387|NCT01256827|ANCHOR Study|anchor study
1378388|NCT01256827|MARINA Study|marina study
1378389|NCT01256814|HIV/AIDS|hiv/aids
1378390|NCT01256814|Adult|adult
1378391|NCT01256814|Behavioral Intervention|behavioral intervention
1378392|NCT01256814|Sleep|sleep
1378393|NCT01256814|Physical Activity|physical activity
1378394|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
1378395|NCT01256801|Gene Expression Profiling|gene expression profiling
1378396|NCT01256801|immunotherapy|immunotherapy
1378397|NCT01256788|viscosupplementation|viscosupplementation
1378398|NCT01256788|meniscus tear|meniscus tear
1378399|NCT01256788|degenerative joint disease|degenerative joint disease
1378400|NCT01256775|atherosclerosis|atherosclerosis
1378401|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
1378805|NCT01255007|metastases|metastases
1378402|NCT01256775|intermittent claudication|intermittent claudication
1378403|NCT01256775|Nitric Oxide / NO|nitric oxide / no
1378404|NCT01256762|imetelstat|imetelstat
1378405|NCT01256762|imetelstat sodium|imetelstat sodium
1378406|NCT01256762|GRN163L|grn163l
1378407|NCT01256762|telomerase inhibitor|telomerase inhibitor
1378408|NCT01256762|telomerase inhibition|telomerase inhibition
1378409|NCT01256762|metastatic breast cancer|metastatic breast cancer
1378410|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
1378411|NCT01256762|Bevacizumab|bevacizumab
1378412|NCT01256762|Paclitaxel|paclitaxel
1378413|NCT01256762|Avastin|avastin
1378414|NCT01256762|Taxol|taxol
1378415|NCT01256762|HER-2-negative|her-2-negative
1378416|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
1378417|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
1378418|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
1378419|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
1378420|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
1378421|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
1378422|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
1378423|NCT01256684|DHEA|dhea
1378424|NCT01256684|Prasterone|prasterone
1378425|NCT01256684|Vaginorm|vaginorm
1378426|NCT01256684|Menopause|menopause
1378427|NCT01256684|Intrarosa|intrarosa
1378428|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
1378429|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
1378430|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
1378431|NCT01256671|DHEA|dhea
1378432|NCT01256671|Prasterone|prasterone
1378433|NCT01256671|Vaginorm|vaginorm
1378434|NCT01256671|Menopause|menopause
1378435|NCT01256671|Intrarosa|intrarosa
1378436|NCT01256658|P. falciparum|p. falciparum
1378437|NCT01256658|malaria|malaria
1378438|NCT01256658|asymptomatic carriers|asymptomatic carriers
1378439|NCT01256658|bed-nets|bed-nets
1378440|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
1378441|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
1378442|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
1378443|NCT01256645|weaning|weaning
1378444|NCT01256645|mechanical ventilation|mechanical ventilation
1378445|NCT01256645|blood transfusion|blood transfusion
1378446|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
1378447|NCT01256619|Marvelon|marvelon
1378448|NCT01256619|PMS|pms
1378449|NCT01256619|serum Lipids|serum lipids
1378451|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1378452|NCT01256593|Safety|safety
1378453|NCT01256593|Neuropathic Pain|neuropathic pain
1378454|NCT01256593|Post Marketing Surveillance|post marketing surveillance
1378455|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
1378456|NCT01256554|SSRS|ssrs
1378457|NCT01256554|Radiation|radiation
1378458|NCT01256554|Radiotherapy|radiotherapy
1378459|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
1378460|NCT01256554|MESCC|mescc
1378461|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
1378462|NCT01256528|Breast reconstruction|breast reconstruction
1378463|NCT01256528|Mastectomy|mastectomy
1378464|NCT01256528|Breast cancer|breast cancer
1378465|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
1378466|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
1378467|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
1378468|NCT01256489|KPro|kpro
1378469|NCT01256489|Keratoprosthesis|keratoprosthesis
1378470|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
1378471|NCT01256489|Infliximab|infliximab
1378472|NCT01256489|Corneal Blindness|corneal blindness
1378473|NCT01256450|buccal soluble film|buccal soluble film
1378474|NCT01256450|enriched enrollment|enriched enrollment
1378475|NCT01256450|randomized withdrawal|randomized withdrawal
1378476|NCT01256437|Acneiform eruption|acneiform eruption
1378477|NCT01256437|papulopustular|papulopustular
1378478|NCT01256437|EGFR|egfr
1378479|NCT01256437|cetuximab|cetuximab
1378480|NCT01256437|erlotinib|erlotinib
1378481|NCT01256437|gefitinib|gefitinib
1378482|NCT01256437|panitumumab|panitumumab
1378483|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
1378484|NCT01256424|CIN|cin
1378485|NCT01256411|hypertension|hypertension
1378486|NCT01256411|blood pressure|blood pressure
1378487|NCT01256411|LCZ696|lcz696
1378488|NCT01256411|dual-acting|dual-acting
1378489|NCT01256411|neprilysin|neprilysin
1378490|NCT01256411|nep inhibitor|nep inhibitor
1378491|NCT01256411|vasopeptidase|vasopeptidase
1378492|NCT01256411|angiotensin receptor|angiotensin receptor
1378493|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
1378494|NCT01256372|Cardiac surgery|cardiac surgery
1378495|NCT01256372|Acute kidney injury|acute kidney injury
1378496|NCT01256346|Premature|premature
1378497|NCT01256346|baby|baby
1378498|NCT01256346|heart rate|heart rate
1378499|NCT01256346|resuscitation|resuscitation
1378500|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
1378501|NCT01256307|Exercise training program|exercise training program
1378502|NCT01256307|Inflammation|inflammation
1378503|NCT01256307|Oxidative Stress|oxidative stress
1378504|NCT01256307|Insulin resistance|insulin resistance
1378505|NCT01256294|Renal transplant|renal transplant
1378506|NCT01256294|kidney transplant|kidney transplant
1378507|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
1499333|NCT00781742|MDD|mdd
1378508|NCT01256294|anti-rejection medication|anti-rejection medication
1378509|NCT01256294|pharmacokinetics|pharmacokinetics
1378510|NCT01256294|tacrolimus|tacrolimus
1378511|NCT01256281|Sickle Cell Disease|sickle cell disease
1378512|NCT01256281|Pain|pain
1378513|NCT01256281|Vasoocclusion|vasoocclusion
1378514|NCT01256281|Nerve Block|nerve block
1378515|NCT01256281|Regional Anesthesia|regional anesthesia
1378516|NCT01256268|metastatic|metastatic
1378517|NCT01256268|recurrent|recurrent
1378518|NCT01256268|Solid Cancer|solid cancer
1378519|NCT01256255|transplant|transplant
1378520|NCT01256255|influenza infection|influenza infection
1378521|NCT01256242|tendon|tendon
1378522|NCT01256242|shoulder|shoulder
1378523|NCT01256242|rotator cuff|rotator cuff
1378524|NCT01256242|Glenohumeral|glenohumeral
1378525|NCT01256229|deafness|deafness
1378526|NCT01256229|hearing loss|hearing loss
1378527|NCT01256229|developmental delay|developmental delay
1378528|NCT01256229|mental retardation|mental retardation
1378529|NCT01256216|Arthritis|arthritis
1378530|NCT01256216|Osteoarthritis|osteoarthritis
1378531|NCT01256216|Arthroplasty|arthroplasty
1378533|NCT01256203|Porfimer sodium|porfimer sodium
1378534|NCT01256203|Phototoxicity|phototoxicity
1378535|NCT01256203|Sunscreen|sunscreen
1378536|NCT01256177|Bipolar Depression|bipolar depression
1378537|NCT01256177|Mental disease,|mental disease,
1378538|NCT01256164|fibrin sealants|fibrin sealants
1378539|NCT01256164|hemostatics|hemostatics
1378540|NCT01256164|time to hemostasis|time to hemostasis
1378541|NCT01256151|Bioequivalence|bioequivalence
1378542|NCT01256151|sublingual|sublingual
1378543|NCT01256151|alprazolam|alprazolam
1378544|NCT01256151|pharmacokinetics|pharmacokinetics
1378545|NCT01256138|Allogene MSCs|allogene mscs
1378546|NCT01256138|transplantation|transplantation
1378547|NCT01256138|chronic liver diseases|chronic liver diseases
1378548|NCT01256138|portal vein|portal vein
1378549|NCT01256125|allogene MSCs|allogene mscs
1378550|NCT01256125|transplantation|transplantation
1378551|NCT01256125|chronic liver diseases|chronic liver diseases
1378552|NCT01256125|peripheral vein|peripheral vein
1378553|NCT01256112|obesity|obesity
1378554|NCT01256112|behavioral intervention|behavioral intervention
1378555|NCT01256112|family based|family based
1378556|NCT01256112|weight loss|weight loss
1378557|NCT01256099|Self-help treatment|self-help treatment
1378558|NCT01256099|Internet treatment|internet treatment
1378559|NCT01256099|CBT|cbt
1378560|NCT01256099|Prevention|prevention
1378561|NCT01256099|Comorbidity|comorbidity
1378562|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
1378563|NCT01256060|Oxytocin|oxytocin
1378564|NCT01256060|Clinical Trial|clinical trial
1378565|NCT01256060|Children|children
1378566|NCT01256060|Pharmacology|pharmacology
1378567|NCT01256047|immunonutrition|immunonutrition
1378568|NCT01256047|hepatectomy|hepatectomy
1378569|NCT01256047|Th1|th1
1378570|NCT01256047|Th2|th2
1378571|NCT01256034|immunonutrition|immunonutrition
1378572|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
1378573|NCT01256034|Th1|th1
1378574|NCT01256034|Th2|th2
1378575|NCT01256008|Breast Cancer|breast cancer
1378576|NCT01256008|Depression|depression
1378577|NCT01256008|Anxiety|anxiety
1378578|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1378579|NCT01255995|PXF|pxf
1378580|NCT01255982|Bipolar depression|bipolar depression
1378581|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
1378582|NCT01255982|functioning|functioning
1378583|NCT01255982|cognitive function|cognitive function
1378584|NCT01255969|Dialysis|dialysis
1378585|NCT01255969|Physical exercise|physical exercise
1378586|NCT01255969|Clinical Trial|clinical trial
1378587|NCT01255969|Quality of Life|quality of life
1378588|NCT01255969|Performance|performance
1378589|NCT01255969|Fitness|fitness
1378590|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
1378591|NCT01255969|Vascular access|vascular access
1378592|NCT01255956|restenosis|restenosis
1378593|NCT01255956|ISR|isr
1378594|NCT01255956|in-stent restenosis|in-stent restenosis
1378595|NCT01255956|drug eluting stent|drug eluting stent
1378596|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
1378597|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
1378598|NCT01255943|MRSA|mrsa
1378599|NCT01255943|bloodstream infections|bloodstream infections
1378600|NCT01255943|hemodialysis|hemodialysis
1378601|NCT01255930|Pregnant Women|pregnant women
1378602|NCT01255930|Sonographic Textures|sonographic textures
1378603|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
1378604|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
1378704|NCT01255397|natural cycle IVF|natural cycle ivf
1378605|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
1378606|NCT01255878|Sleep bruxism|sleep bruxism
1378607|NCT01255878|Gabapentine|gabapentine
1378608|NCT01255878|Occlusal splint|occlusal splint
1378609|NCT01255878|Polysomnography|polysomnography
1378610|NCT01255865|Thermometry|thermometry
1378611|NCT01255865|Deep Tissue Temperature|deep tissue temperature
1378612|NCT01255865|Core Temperature|core temperature
1378613|NCT01255865|Body Temperature|body temperature
1378614|NCT01255865|Rectal Temperature|rectal temperature
1378615|NCT01255865|Oral Temperature|oral temperature
1378616|NCT01255852|atorvastatin|atorvastatin
1378617|NCT01255852|intracranial artery stenting|intracranial artery stenting
1378618|NCT01255852|restenosis|restenosis
1378619|NCT01255839|double-balloon|double-balloon
1378620|NCT01255839|balloon catheter|balloon catheter
1378621|NCT01255839|prostaglandin|prostaglandin
1378622|NCT01255839|minprostin|minprostin
1378623|NCT01255839|induction of labour|induction of labour
1378624|NCT01255839|fetal outcome|fetal outcome
1378625|NCT01255826|Preterm|preterm
1378626|NCT01255826|Neonates|neonates
1378627|NCT01255826|Delivery room|delivery room
1378628|NCT01255826|Resuscitation|resuscitation
1378629|NCT01255826|Ventilation|ventilation
1378630|NCT01255826|Neopuff|neopuff
1378631|NCT01255826|CPAP|cpap
1378632|NCT01255813|Chronic Cluster Headache|chronic cluster headache
1378633|NCT01255787|Major Depressive Disorder|major depressive disorder
1378634|NCT01255787|Depression|depression
1378635|NCT01255787|Melancholia|melancholia
1378636|NCT01255787|Drug Therapy|drug therapy
1378637|NCT01255774|subfoveal CNV|subfoveal cnv
1378638|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
1378639|NCT01255774|macular degeneration|macular degeneration
1378640|NCT01255761|Certolizumab Pegol|certolizumab pegol
1378641|NCT01255761|Cimzia|cimzia
1378642|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
1378643|NCT01255761|CDAI|cdai
1378644|NCT01255761|RAPID3|rapid3
1378645|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
1378646|NCT01255735|pediatrics|pediatrics
1378647|NCT01255735|voice|voice
1378648|NCT01255735|voice therapy|voice therapy
1378649|NCT01255735|vocal therapy|vocal therapy
1378650|NCT01255735|hoarseness|hoarseness
1378651|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
1378652|NCT01255709|Asthma|asthma
1378653|NCT01255709|shortness of breath|shortness of breath
1378654|NCT01255709|wheezing|wheezing
1378655|NCT01255696|Celiac Disease|celiac disease
1378656|NCT01255696|Coeliac Disease|coeliac disease
1378657|NCT01255696|Celiac Sprue|celiac sprue
1378658|NCT01255696|Keliakia Disease|keliakia disease
1378659|NCT01255683|Chronic|chronic
1378660|NCT01255683|Sinusitis|sinusitis
1378661|NCT01255683|Steroid|steroid
1378662|NCT01255683|treatment|treatment
1378663|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
1378664|NCT01255670|Quinsy|quinsy
1378665|NCT01255670|Penicillin|penicillin
1378666|NCT01255670|Metronidazole|metronidazole
1378667|NCT01255670|Recurrence|recurrence
1378668|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
1378669|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
1378670|NCT01255605|Burkina Faso.|burkina faso.
1378671|NCT01255592|Bronchiectasis|bronchiectasis
1378672|NCT01255592|Neutrophil|neutrophil
1378673|NCT01255592|Respiratory disease|respiratory disease
1378674|NCT01255592|Sputum|sputum
1378675|NCT01255579|asthma|asthma
1378676|NCT01255579|small airways|small airways
1378677|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
1378678|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
1378679|NCT01255540|80 years of age.|80 years of age.
1378680|NCT01255488|Search engine|search engine
1378681|NCT01255488|Clinical decision-making|clinical decision-making
1378682|NCT01255488|Research abstracts|research abstracts
1378683|NCT01255488|Full-text manuscripts|full-text manuscripts
1378684|NCT01255488|Family Nurse Practitioners|family nurse practitioners
1378685|NCT01255462|AMD,|amd,
1378686|NCT01255462|ARMD,|armd,
1378687|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
1378688|NCT01255462|Eye Disease,|eye disease,
1378689|NCT01255462|Wet AMD,|wet amd,
1378690|NCT01255462|Neovascular AMD,|neovascular amd,
1378691|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
1378692|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
1378693|NCT01255462|Drusen,|drusen,
1378694|NCT01255462|Geographic Atrophy,|geographic atrophy,
1378695|NCT01255462|Complement,|complement,
1378696|NCT01255462|C5,|c5,
1378697|NCT01255462|Antibody|antibody
1378698|NCT01255449|Forced oscillation technique|forced oscillation technique
1378699|NCT01255449|Respiratory input impedance|respiratory input impedance
1378700|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1378701|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
1378702|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
1378703|NCT01255397|male infertility|male infertility
1378705|NCT01255397|in-vitro fertilization|in-vitro fertilization
1378706|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
1378707|NCT01255371|HIV|hiv
1378708|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
1378709|NCT01255371|Sub saharian Africa|sub saharian africa
1378711|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
1378712|NCT01255358|AT|at
1378713|NCT01255358|Ery-Dex|ery-dex
1378714|NCT01255358|Dexamethasone|dexamethasone
1378715|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
1378716|NCT01255345|Physiotherapy|physiotherapy
1378717|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
1378718|NCT01255345|Pain measurements|pain measurements
1378719|NCT01255345|Physical activity|physical activity
1378720|NCT01255345|Quality of life|quality of life
1378721|NCT01255332|ITP|itp
1378722|NCT01255319|MDS|mds
1378723|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1378724|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
1378725|NCT01255306|Silicone oil|silicone oil
1378726|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
1378727|NCT01255293|Retinal detachment|retinal detachment
1378728|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
1378729|NCT01255293|Diabetic retinopathy|diabetic retinopathy
1378730|NCT01255293|Vitrectomy|vitrectomy
1378731|NCT01255293|Silicone oil|silicone oil
1378732|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
1378733|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
1378734|NCT01255280|Sexual risk behavior|sexual risk behavior
1378735|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
1378736|NCT01255280|Behavioral activation|behavioral activation
1378737|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
1378738|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
1378739|NCT01255241|Lower Limbs Deformities|lower limbs deformities
1378740|NCT01255241|kinetics|kinetics
1378741|NCT01255241|kinematics|kinematics
1378742|NCT01255241|gait|gait
1378743|NCT01255241|energy expenditure|energy expenditure
1378744|NCT01255228|obesity|obesity
1378745|NCT01255228|body composition|body composition
1378746|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
1378747|NCT01255228|low glycemic index|low glycemic index
1378748|NCT01255215|malaria|malaria
1378749|NCT01255215|children|children
1378750|NCT01255202|preeclampsia|preeclampsia
1378752|NCT01255202|twin|twin
1378753|NCT01255202|pregnancy|pregnancy
1378754|NCT01255202|pp13|pp13
1378755|NCT01255202|prediction|prediction
1378756|NCT01255202|kongo red|kongo red
1378757|NCT01255189|NIRS|nirs
1378758|NCT01255176|Infant|infant
1378759|NCT01255176|Physical Therapy|physical therapy
1378760|NCT01255163|Alzheimer's|alzheimer's
1378761|NCT01255163|Brain insulin resistance|brain insulin resistance
1378762|NCT01255163|Diabetes|diabetes
1378763|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
1378764|NCT01255150|Molecular Profiling|molecular profiling
1378765|NCT01255150|Smoking Status|smoking status
1378766|NCT01255150|Wood Smoke Exposure|wood smoke exposure
1378767|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
1378768|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
1378769|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
1378770|NCT01255137|Clinical Activity|clinical activity
1378771|NCT01255137|Response Rate|response rate
1378772|NCT01255137|Measurable Disease|measurable disease
1378773|NCT01255137|Biological Markers|biological markers
1378774|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
1378775|NCT01255111|Chronic respiratory failure|chronic respiratory failure
1378776|NCT01255111|Noninvasive ventilation|noninvasive ventilation
1378777|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
1378778|NCT01255111|Sleep|sleep
1378779|NCT01255111|Sleep fragmentation|sleep fragmentation
1378780|NCT01255085|Obesity|obesity
1378781|NCT01255085|Food intake regulation|food intake regulation
1378782|NCT01255085|blood glucose regulation|blood glucose regulation
1378783|NCT01255085|protein|protein
1378784|NCT01255085|fiber|fiber
1378785|NCT01255085|pulses|pulses
1378786|NCT01255085|yellow peas|yellow peas
1378787|NCT01255072|TMS|tms
1378788|NCT01255072|elderly|elderly
1378789|NCT01255072|depression|depression
1378790|NCT01255072|neuronavegation|neuronavegation
1378791|NCT01255072|neurocognition|neurocognition
1378792|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
1378793|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
1378794|NCT01255059|Lung cancer|lung cancer
1378795|NCT01255033|perioperative surgery|perioperative surgery
1378796|NCT01255033|regional oxygenation|regional oxygenation
1378797|NCT01255033|hypoxemia|hypoxemia
1378798|NCT01255033|brain hypoxemia|brain hypoxemia
1378799|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
1378800|NCT01255020|α-Keto Acid|α-keto acid
1378801|NCT01255020|Restricted Protein Diet|restricted protein diet
1378802|NCT01255020|Residual Renal Function|residual renal function
1378803|NCT01255007|Colorectal|colorectal
1378804|NCT01255007|liver|liver
1378806|NCT01255007|Primovist|primovist
1378807|NCT01255007|MRI|mri
1378808|NCT01255007|CT|ct
1378809|NCT01255007|cancer|cancer
1378810|NCT01255007|resection|resection
1378811|NCT01255007|MDCT|mdct
1378812|NCT01255007|Diffusion|diffusion
1378813|NCT01255007|Weighted|weighted
1378814|NCT01255007|3T|3t
1378815|NCT01254994|hepatitis B|hepatitis b
1378816|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
1378817|NCT01254994|entecavir|entecavir
1378818|NCT01254994|treatment|treatment
1378819|NCT01254994|predicting|predicting
1378820|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
1378821|NCT01254981|DES|des
1378822|NCT01254981|Angina pectoris|angina pectoris
1378823|NCT01254981|Stent|stent
1378824|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
1378825|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
1378826|NCT01254942|exercise|exercise
1378827|NCT01254942|hip fractures|hip fractures
1378828|NCT01254942|rehabilitation|rehabilitation
1378829|NCT01254942|aged|aged
1378830|NCT01254942|aged 80 and over|aged 80 and over
1378831|NCT01254929|Cancer|cancer
1378832|NCT01254929|Bone metastases|bone metastases
1378833|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
1378834|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
1378835|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
1378836|NCT01254903|Radiation|radiation
1378837|NCT01254903|Radiotherapy|radiotherapy
1378838|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
1378839|NCT01254903|MESCC|mescc
1378840|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
1378841|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1378842|NCT01254890|CMML|cmml
1378843|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
1378844|NCT01254890|MDS|mds
1378845|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
1378846|NCT01254890|AML|aml
1378847|NCT01254890|5-azacitidine|5-azacitidine
1378848|NCT01254890|Azacitidine|azacitidine
1378849|NCT01254890|5-aza|5-aza
1378850|NCT01254890|Vidaza|vidaza
1378851|NCT01254890|5-AZC|5-azc
1378852|NCT01254890|AZA-CR|aza-cr
1378853|NCT01254890|Ladakamycin|ladakamycin
1378854|NCT01254890|NSC-102816|nsc-102816
1378855|NCT01254890|Sorafenib|sorafenib
1378856|NCT01254890|Nexavar|nexavar
1378857|NCT01254890|BAY43-9006|bay43-9006
1378858|NCT01254877|HIV|hiv
1378859|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
1378860|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1378861|NCT01254864|Sunitinib Malate|sunitinib malate
1378862|NCT01254864|SUO11248|suo11248
1378863|NCT01254864|Sutent|sutent
1378864|NCT01254864|BMS-354825|bms-354825
1378865|NCT01254864|Sprycel|sprycel
1378866|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
1378867|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
1378868|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
1378869|NCT01254825|Saphenous nerve|saphenous nerve
1378870|NCT01254825|Pain|pain
1378871|NCT01254825|Ultrasound block|ultrasound block
1378872|NCT01254812|pulmonary function|pulmonary function
1378873|NCT01254812|BD-TAP-block|bd-tap-block
1378874|NCT01254786|VATS|vats
1378875|NCT01254786|one lung ventilation|one lung ventilation
1378876|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
1378877|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
1378878|NCT01254721|Acute bipolar mania|acute bipolar mania
1378879|NCT01254721|Seroquel XR|seroquel xr
1378880|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
1378881|NCT01254721|Quetiapine fumarate|quetiapine fumarate
1378882|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
1378883|NCT01254695|Fecal Incontinence|fecal incontinence
1378884|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
1378885|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
1378886|NCT01254682|wrist|wrist
1378887|NCT01254682|joint|joint
1378888|NCT01254682|arthroscopy|arthroscopy
1378889|NCT01254682|hyaluronan|hyaluronan
1378890|NCT01254682|hyaluronic acid|hyaluronic acid
1378891|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
1378892|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
1378893|NCT01254669|Brief Negotiated Interview|brief negotiated interview
1378894|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
1378895|NCT01254669|HPV vaccine|hpv vaccine
1378896|NCT01254669|cervical cancer|cervical cancer
1378897|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
1378898|NCT01254643|Uterine cervical cancer|uterine cervical cancer
1378899|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
1378900|NCT01254630|Herpes zoster|herpes zoster
1378901|NCT01254630|vaccine|vaccine
1378902|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
1378903|NCT01254630|immunocompromised|immunocompromised
1378904|NCT01254630|herpes zoster-associated pain|herpes zoster-associated pain
1378905|NCT01254630|solid tumor malignancy|solid tumor malignancy
1378906|NCT01254630|hematologic malignancy|hematologic malignancy
1378907|NCT01254604|Tafluprost|tafluprost
1378908|NCT01254604|Glaucoma|glaucoma
1378909|NCT01254604|Ocular Hypertension|ocular hypertension
1378910|NCT01254604|Timolol|timolol
1378911|NCT01254604|Eye Disorder|eye disorder
1378912|NCT01254604|Preservative-Free|preservative-free
1378913|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
1378914|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1378915|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1378916|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1378917|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1378918|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1378919|NCT01254591|stage I colon cancer|stage i colon cancer
1378920|NCT01254591|stage IIA colon cancer|stage iia colon cancer
1378921|NCT01254591|stage IIB colon cancer|stage iib colon cancer
1378922|NCT01254591|stage IIC colon cancer|stage iic colon cancer
1378923|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
1378924|NCT01254591|stage I rectal cancer|stage i rectal cancer
1378925|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
1378926|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
1378927|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
1378928|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
1378929|NCT01254591|stage IA breast cancer|stage ia breast cancer
1378930|NCT01254591|stage IB breast cancer|stage ib breast cancer
1378931|NCT01254591|stage II breast cancer|stage ii breast cancer
1378932|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
1378933|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
1378934|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
1378935|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
1378936|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
1378937|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1378938|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1378939|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1378940|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
1378941|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
1378942|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
1378943|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1378944|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1378945|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1378946|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1378947|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1378948|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1378949|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1378950|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1378951|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1378952|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
1378953|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
1378954|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1378955|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
1378956|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
1378957|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
1378958|NCT01254591|tongue cancer|tongue cancer
1378959|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
1378960|NCT01254565|Renal Dialysis|renal dialysis
1378961|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1378962|NCT01254565|Parathyroid hormone|parathyroid hormone
1378963|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1378964|NCT01254539|Bone marrow|bone marrow
1378965|NCT01254539|Stem cells|stem cells
1378966|NCT01254539|Autologous|autologous
1378967|NCT01254539|Safety|safety
1378968|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
1378969|NCT01254513|Elderly patients|elderly patients
1378970|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
1378971|NCT01254513|castration-resistant|castration-resistant
1378972|NCT01254500|patients with brain lesions|patients with brain lesions
1378973|NCT01254474|Depolarization, tissue|depolarization, tissue
1378974|NCT01254474|Repolarization, tissue|repolarization, tissue
1378975|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
1378976|NCT01254474|Action potentials, monophasic|action potentials, monophasic
1378977|NCT01254474|Mapping, Catheter|mapping, catheter
1378978|NCT01254474|Cardiac activation|cardiac activation
1378979|NCT01254461|Phase 1|phase 1
1378980|NCT01254461|Drug-Drug interaction|drug-drug interaction
1378981|NCT01254461|pravastatin|pravastatin
1378982|NCT01254461|AZD1981|azd1981
1378983|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
1378984|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
1378985|NCT01254448|Alzheimer's Disease|alzheimer's disease
1378986|NCT01254435|Colonoscopy|colonoscopy
1378987|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
1378988|NCT01254435|Quality control|quality control
1378989|NCT01254422|Dengue fever|dengue fever
1378990|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
1378991|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
1378992|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
1378993|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
1378994|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
1378995|NCT01254357|Burns|burns
1378996|NCT01254357|Trauma|trauma
1378997|NCT01254357|Outcomes|outcomes
1378998|NCT01254357|Quality of Life|quality of life
1378999|NCT01254344|Colorectal surgery|colorectal surgery
1379000|NCT01254318|hematological malignancy|hematological malignancy
1379001|NCT01254318|fungal infection|fungal infection
1379002|NCT01254318|leukemia|leukemia
1379003|NCT01254305|Depression|depression
1379004|NCT01254305|Fatigue|fatigue
1379005|NCT01254305|Major Depressive Disorder|major depressive disorder
1379006|NCT01254266|morbid obesity|morbid obesity
1379007|NCT01254266|adolescents|adolescents
1379008|NCT01254266|inpatient treatment|inpatient treatment
1379009|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
1379010|NCT01254253|chronic total occlusion|chronic total occlusion
1379011|NCT01254253|coronary angiography|coronary angiography
1379012|NCT01254253|single photon emission CT|single photon emission ct
1379013|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
1379014|NCT01254227|Cardiac iron overload,|cardiac iron overload,
1379015|NCT01254227|deferasirox,|deferasirox,
1379016|NCT01254227|deferoxamine|deferoxamine
1379017|NCT01254214|Mindfulness|mindfulness
1379018|NCT01254214|Quality of life|quality of life
1379019|NCT01254214|Transplantation|transplantation
1379020|NCT01254214|Renal disease|renal disease
1379021|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
1379022|NCT01254188|CML,|cml,
1379023|NCT01254188|nilotinib,|nilotinib,
1379024|NCT01254188|myelogenous,|myelogenous,
1379025|NCT01254188|Philadelphia chromosome|philadelphia chromosome
1379026|NCT01254162|Oily Skin|oily skin
1379027|NCT01254162|Sebum|sebum
1379028|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
1379029|NCT01254123|Exenatide|exenatide
1379030|NCT01254123|myocardial infarction|myocardial infarction
1379031|NCT01254123|MRI|mri
1379032|NCT01254123|PCI|pci
1379130|NCT01253590|ECG monitor|ecg monitor
1379033|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
1379034|NCT01254071|GI198745|gi198745
1379035|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
1379036|NCT01254071|Dutasteride|dutasteride
1379037|NCT01254071|food effect|food effect
1379038|NCT01254071|healthy male subjects|healthy male subjects
1379039|NCT01254071|north-east Asian ancestry|north-east asian ancestry
1379040|NCT01254071|Bioequivalence|bioequivalence
1379041|NCT01254071|cross-over design|cross-over design
1379042|NCT01254071|Pilot bioequivalence|pilot bioequivalence
1379044|NCT01254032|COPD|copd
1379045|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1379046|NCT01254019|DMD|dmd
1379047|NCT01254019|968|968
1379048|NCT01254019|GSK|gsk
1379049|NCT01254019|Duchenne|duchenne
1379050|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
1379051|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
1379052|NCT01253980|pneumonitis|pneumonitis
1379053|NCT01253980|paraffin|paraffin
1379054|NCT01253980|kerosene|kerosene
1379055|NCT01253967|Gastroenteritis|gastroenteritis
1379056|NCT01253967|Hospital surveillance|hospital surveillance
1379057|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
1379058|NCT01253954|invasive candida infection|invasive candida infection
1379059|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
1379060|NCT01253928|body composition|body composition
1379061|NCT01253928|insulin sensitivity|insulin sensitivity
1379062|NCT01253928|protein metabolism|protein metabolism
1379063|NCT01253928|pioglitazone|pioglitazone
1379064|NCT01253889|Functional echocardiography|functional echocardiography
1379065|NCT01253889|oral glucose|oral glucose
1379066|NCT01253889|neonatal stress|neonatal stress
1379067|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
1379068|NCT01253850|hiv|hiv
1379069|NCT01253850|antiretroviral|antiretroviral
1379070|NCT01253850|adherence|adherence
1379071|NCT01253850|adolescent|adolescent
1379072|NCT01253837|L19|l19
1379073|NCT01253837|antibody|antibody
1379074|NCT01253837|monoclonal|monoclonal
1379075|NCT01253837|tumor targeting|tumor targeting
1379076|NCT01253837|TNFa|tnfa
1379077|NCT01253837|colorectal cancer|colorectal cancer
1567130|NCT00509860|Advanced Sarcomas|advanced sarcomas
1567131|NCT00509860|Irinotecan|irinotecan
1379078|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
1379186|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
1379187|NCT01253213|Contrast agent|contrast agent
1379079|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
1379080|NCT01253824|NPC-01|npc-01
1379081|NCT01253824|IKH-01|ikh-01
1379082|NCT01253824|Pharmacodynamics|pharmacodynamics
1379083|NCT01253824|Norethisterone|norethisterone
1379084|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
1379085|NCT01253824|Estradiol|estradiol
1379086|NCT01253824|Progesterone|progesterone
1379087|NCT01253824|FSH|fsh
1379088|NCT01253824|LH|lh
1379089|NCT01253798|exercise|exercise
1379090|NCT01253798|hydrotherapy|hydrotherapy
1379091|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
1379092|NCT01253759|Choroidal melanoma|choroidal melanoma
1379093|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
1379094|NCT01253746|NTD|ntd
1379095|NCT01253746|open NTD|open ntd
1379096|NCT01253746|spina bifida|spina bifida
1379097|NCT01253746|anencephaly|anencephaly
1379098|NCT01253746|closed NTD|closed ntd
1379099|NCT01253746|lipomeningocele|lipomeningocele
1379100|NCT01253746|tethered cord.|tethered cord.
1379101|NCT01253733|Cystic Fibrosis|cystic fibrosis
1379102|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
1379103|NCT01253733|Type 1 Diabetes|type 1 diabetes
1379104|NCT01253733|Chronic Disease Management|chronic disease management
1379105|NCT01253733|SMS|sms
1379106|NCT01253733|Text messages|text messages
1379107|NCT01253733|Internet|internet
1379108|NCT01253733|Healthcare Interactions|healthcare interactions
1379109|NCT01253720|obesity|obesity
1379110|NCT01253720|text messages|text messages
1379111|NCT01253720|internet|internet
1379112|NCT01253720|cancer|cancer
1379113|NCT01253720|overweight|overweight
1379114|NCT01253707|Solid Tumors|solid tumors
1379115|NCT01253707|C-met inhibitor|c-met inhibitor
1379116|NCT01253694|Diabetes|diabetes
1379117|NCT01253694|edema|edema
1379118|NCT01253694|ranibizumab|ranibizumab
1379119|NCT01253694|bevacizumab|bevacizumab
1379120|NCT01253694|refractory|refractory
1379121|NCT01253681|AMG 386|amg 386
1379122|NCT01253681|Ovarian Cancer|ovarian cancer
1379123|NCT01253655|Healthy Volunteers|healthy volunteers
1379124|NCT01253629|Fragile X Syndrome|fragile x syndrome
1379125|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
1379126|NCT01253629|Genetic Diseases|genetic diseases
1379127|NCT01253629|X-Linked|x-linked
1379128|NCT01253603|Asthma|asthma
1379129|NCT01253590|atrial fibrillation|atrial fibrillation
1379131|NCT01253590|Blood pressure device|blood pressure device
1379132|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
1379133|NCT01253551|VX-950HEP1001|vx-950hep1001
1379134|NCT01253551|hepatitis|hepatitis
1379135|NCT01253551|telaprevir|telaprevir
1379136|NCT01253551|raltegravir|raltegravir
1379137|NCT01253551|crossover|crossover
1379138|NCT01253551|healthy volunteers|healthy volunteers
1379140|NCT01253525|Adenocarcinoma|adenocarcinoma
1379141|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
1379142|NCT01253512|Ischemic Stroke|ischemic stroke
1379143|NCT01253512|Thrombolysis|thrombolysis
1379144|NCT01253486|expressive writing|expressive writing
1379145|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
1379146|NCT01253473|COPD|copd
1379147|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1379148|NCT01253460|CLL|cll
1379149|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1379150|NCT01253460|SLL|sll
1379151|NCT01253460|Cyclophosphamide|cyclophosphamide
1379152|NCT01253460|Rituximab|rituximab
1379153|NCT01253460|Sapacitabine|sapacitabine
1379154|NCT01253460|Cytoxan|cytoxan
1379155|NCT01253460|Neosar|neosar
1379156|NCT01253460|Rituxan|rituxan
1379157|NCT01253434|Transdermal Administration|transdermal administration
1379158|NCT01253421|MDD|mdd
1379159|NCT01253421|Major Depressive Disorder|major depressive disorder
1379160|NCT01253421|Amisulpride|amisulpride
1379161|NCT01253408|anandamide|anandamide
1379162|NCT01253408|cannabinoid|cannabinoid
1379163|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
1379164|NCT01253408|gastric|gastric
1379165|NCT01253408|motility|motility
1379166|NCT01253408|small bowel|small bowel
1379167|NCT01253395|Exercise|exercise
1379168|NCT01253395|Pain|pain
1379169|NCT01253369|pazopanib|pazopanib
1379170|NCT01253317|Rett Syndrome|rett syndrome
1379171|NCT01253317|IGF-1|igf-1
1379172|NCT01253317|Increlex|increlex
1379173|NCT01253317|Mecasermin|mecasermin
1379174|NCT01253317|IGF1|igf1
1379175|NCT01253317|MECP2|mecp2
1379176|NCT01253317|RTT|rtt
1379177|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1379178|NCT01253252|Prosthesis|prosthesis
1379179|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1379180|NCT01253252|Positron-emission Tomography|positron-emission tomography
1379181|NCT01253252|Spiral computed tomography|spiral computed tomography
1379182|NCT01253252|Biological markers|biological markers
1379183|NCT01253239|Visual outcomes|visual outcomes
1379184|NCT01253239|Patient satisfaction|patient satisfaction
1379185|NCT01253213|Prostate cancer|prostate cancer
1379188|NCT01253213|BR55|br55
1379189|NCT01253213|VEGFR2|vegfr2
1379190|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
1379191|NCT01253200|Typical Atrial Flutter|typical atrial flutter
1379192|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
1379193|NCT01253200|Heart Diseases|heart diseases
1379194|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
1379195|NCT01253161|advanced|advanced
1379196|NCT01253161|metastatic|metastatic
1379197|NCT01253161|unresectable|unresectable
1379198|NCT01253161|carcinoma|carcinoma
1379199|NCT01253161|gastrointestinal tract|gastrointestinal tract
1379200|NCT01253161|lungs|lungs
1379201|NCT01253161|colon|colon
1379202|NCT01253161|liver|liver
1379203|NCT01253161|rectum|rectum
1379204|NCT01253161|small intestine|small intestine
1379205|NCT01253161|stomach|stomach
1379206|NCT01253161|pancreatic|pancreatic
1379207|NCT01253148|Liver|liver
1379208|NCT01253148|Bile Duct|bile duct
1379209|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
1379210|NCT01253096|Interleukin|interleukin
1379211|NCT01253096|IL2|il2
1379212|NCT01253096|monoclonal|monoclonal
1379213|NCT01253096|antibody|antibody
1379214|NCT01253096|cytokine|cytokine
1379215|NCT01253096|metastatic|metastatic
1379216|NCT01253096|melanoma|melanoma
1379217|NCT01253096|tumor targeting|tumor targeting
1379218|NCT01253096|intratumoral|intratumoral
1379219|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
1379220|NCT01253083|Mobility|mobility
1379221|NCT01253083|Developmental Delay|developmental delay
1379222|NCT01253083|Cerebral Palsy|cerebral palsy
1379223|NCT01253083|Early Walking|early walking
1379224|NCT01253083|Postural Control|postural control
1379225|NCT01253057|cleaning staff|cleaning staff
1379226|NCT01253057|antineoplastic agents|antineoplastic agents
1379227|NCT01253044|OEF/OIF|oef/oif
1379228|NCT01253044|Veterans|veterans
1379229|NCT01253044|Psychotherapy|psychotherapy
1379230|NCT01253031|hearing loss|hearing loss
1379231|NCT01253031|aging|aging
1379232|NCT01253031|short term memory|short term memory
1379233|NCT01253031|attentional blink|attentional blink
1379234|NCT01253018|stroke|stroke
1379235|NCT01253018|robotics|robotics
1379236|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
1379237|NCT01252992|Extrapulmonary|extrapulmonary
1379238|NCT01252992|Tuberculosis|tuberculosis
1379239|NCT01252992|Paradoxical reaction|paradoxical reaction
1379240|NCT01252992|Risk factors|risk factors
1379241|NCT01252992|Incidence|incidence
1379242|NCT01252992|CT scan|ct scan
1379243|NCT01252992|Natural history|natural history
1379244|NCT01252992|Immune system phenomena|immune system phenomena
1379245|NCT01252992|Immune markers|immune markers
1379246|NCT01252992|Gene Expression Profiling|gene expression profiling
1379247|NCT01252979|MELAS|melas
1379248|NCT01252979|Ketones|ketones
1379249|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
1379250|NCT01252979|MCT oil|mct oil
1379251|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
1379252|NCT01252979|Heteroplasmy|heteroplasmy
1379253|NCT01252979|3243AG|3243ag
1379254|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
1379255|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
1379256|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
1379257|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
1379258|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
1379259|NCT01252966|Tobacco|tobacco
1379260|NCT01252966|Smoking|smoking
1379261|NCT01252966|Cognition|cognition
1379262|NCT01252966|Behavioral Training|behavioral training
1379263|NCT01252966|Relapse|relapse
1379264|NCT01252953|vascular disease|vascular disease
1379265|NCT01252953|lipids|lipids
1379266|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
1379267|NCT01252953|anacetrapib|anacetrapib
1379268|NCT01252940|HIV-1|hiv-1
1379269|NCT01252940|HIV|hiv
1379270|NCT01252940|Treatment Experienced|treatment experienced
1379271|NCT01252914|Open angle|open angle
1379272|NCT01252914|Glaucoma|glaucoma
1379273|NCT01252914|Surgery|surgery
1379274|NCT01252914|Ocular Hypertension|ocular hypertension
1379275|NCT01252914|Eye Diseases|eye diseases
1379276|NCT01252901|WT1|wt1
1379277|NCT01252901|Wilms Tumor|wilms tumor
1379278|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
1379279|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
1379280|NCT01252901|Proteinuria|proteinuria
1379281|NCT01252888|Open angle|open angle
1379282|NCT01252888|Glaucoma|glaucoma
1379283|NCT01252888|Surgery|surgery
1379284|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
1379285|NCT01252888|Ocular Hypertension|ocular hypertension
1379286|NCT01252888|Eye Diseases|eye diseases
1379287|NCT01252875|LDL-C|ldl-c
1379288|NCT01252875|Cholesterol|cholesterol
1379289|NCT01252875|Stroke|stroke
1379290|NCT01252875|Transient ischemic attack|transient ischemic attack
1379291|NCT01252875|Statin|statin
1379292|NCT01252875|Lipid lowering therapy|lipid lowering therapy
1379293|NCT01252862|Open angle|open angle
1379294|NCT01252862|Glaucoma|glaucoma
1379295|NCT01252862|Surgery|surgery
1379296|NCT01252862|Ocular Hypertension|ocular hypertension
1379297|NCT01252862|eye diseases|eye diseases
1379298|NCT01252849|Open angle|open angle
1379299|NCT01252849|Glaucoma|glaucoma
1379300|NCT01252849|surgery|surgery
1379301|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
1379302|NCT01252849|Ocular Hypertension|ocular hypertension
1379303|NCT01252849|Eye Diseases|eye diseases
1379304|NCT01252823|Hemodialysis|hemodialysis
1379305|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
1379306|NCT01252823|Cardiac Death|cardiac death
1379307|NCT01252823|Implantable Loop Recorder|implantable loop recorder
1379308|NCT01252810|CATH Catheterization|cath catheterization
1379309|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
1379310|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
1379311|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
1379312|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
1379313|NCT01252810|NYHA New York Heart Association|nyha new york heart association
1379314|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
1379315|NCT01252810|SCr Serum creatinine|scr serum creatinine
1379316|NCT01252797|brain metastases|brain metastases
1379317|NCT01252784|higher risk MDS|higher risk mds
1379318|NCT01252771|phosphorus|phosphorus
1379319|NCT01252771|dialysis|dialysis
1379320|NCT01252771|PhosLo|phoslo
1379321|NCT01252732|ABSSSI|absssi
1379322|NCT01252732|Skin Infection|skin infection
1379323|NCT01252732|Abscess|abscess
1379324|NCT01252719|ABSSSI|absssi
1379325|NCT01252719|Skin Infection|skin infection
1379326|NCT01252719|Abscess|abscess
1379327|NCT01252706|brief intervention|brief intervention
1379328|NCT01252706|alcohol|alcohol
1379329|NCT01252706|nicotine|nicotine
1379330|NCT01252706|drug abuse|drug abuse
1379331|NCT01252654|Lasik|lasik
1379332|NCT01252654|Femtosecond Laser|femtosecond laser
1379333|NCT01252654|Visumax|visumax
1379334|NCT01252654|IntraLase|intralase
1379335|NCT01252654|Myopia|myopia
1379336|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
1379338|NCT01252628|CRC|crc
1379339|NCT01252628|SCCHN|scchn
1379340|NCT01252628|PX-866|px-866
1379341|NCT01252628|Cetuximab|cetuximab
1379342|NCT01252628|ERBITUX|erbitux
1379343|NCT01252628|Colon|colon
1379344|NCT01252628|Head and Neck|head and neck
1379345|NCT01252628|Colorectal cancer|colorectal cancer
1379346|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
1379347|NCT01252628|PI-3K|pi-3k
1379348|NCT01252628|PI3 kinase|pi3 kinase
1379349|NCT01252628|PI3K|pi3k
1379350|NCT01252615|ICD|icd
1379351|NCT01252615|HF|hf
1379352|NCT01252615|cardiac arrest|cardiac arrest
1379353|NCT01252615|VF|vf
1379354|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
1379355|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
1379356|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
1379357|NCT01252589|Quality of Life|quality of life
1379358|NCT01252589|Symptoms|symptoms
1379359|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
1379360|NCT01252589|Questionnaire|questionnaire
1379361|NCT01252576|FSFI|fsfi
1379362|NCT01252576|female sexual function|female sexual function
1379363|NCT01252576|italian validation|italian validation
1379364|NCT01252563|ENTER10|enter10
1379365|NCT01252563|Hypertension|hypertension
1379366|NCT01252563|Japanese|japanese
1379367|NCT01252563|Norvasc 10mg|norvasc 10mg
1379368|NCT01252563|Post Marketing surveillance|post marketing surveillance
1379369|NCT01252550|IBS|ibs
1379370|NCT01252550|GI|gi
1379371|NCT01252550|QOL|qol
1379372|NCT01252550|Pathophysiology|pathophysiology
1379373|NCT01252550|Gut microbiota|gut microbiota
1379374|NCT01252550|Danone|danone
1379375|NCT01252550|Activia|activia
1379376|NCT01252550|Probiotics|probiotics
1379377|NCT01252537|HIV|hiv
1379378|NCT01252537|Tuberculosis|tuberculosis
1379379|NCT01252537|Immunosuppression|immunosuppression
1379380|NCT01252537|ART|art
1379381|NCT01252537|Ethiopia|ethiopia
1379382|NCT01252537|Primary health care|primary health care
1379383|NCT01252524|diabetes mellitus|diabetes mellitus
1379384|NCT01252524|fiber|fiber
1379385|NCT01252524|glycemic control|glycemic control
1379386|NCT01252524|calcium polycarbophil|calcium polycarbophil
1379387|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
1379388|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
1379389|NCT01252511|Obesity surgery|obesity surgery
1379390|NCT01252511|Bariatric surgery|bariatric surgery
1379391|NCT01252498|Cancer of the head and neck|cancer of the head and neck
1379392|NCT01252498|Radiotherapy|radiotherapy
1379393|NCT01252498|Prostaglandins|prostaglandins
1379394|NCT01252485|AML|aml
1379395|NCT01252485|Registry study|registry study
1379396|NCT01252485|Biology and Outcome|biology and outcome
1379397|NCT01252485|Higher Risk MDS|higher risk mds
1379398|NCT01252472|Flomax|flomax
1379399|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
1379400|NCT01252472|Tamsulosin|tamsulosin
1379401|NCT01252459|AA-PET|aa-pet
1379402|NCT01252459|T1-Gd-MRI|t1-gd-mri
1379403|NCT01252459|re-irradiation|re-irradiation
1379404|NCT01252459|recurrent glioma|recurrent glioma
1379405|NCT01252446|ICD 10|icd 10
1379406|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
1379407|NCT01252446|Comorbidity|comorbidity
1379408|NCT01252446|Social-demographic profile|social-demographic profile
1379409|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
1379410|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
1379411|NCT01252420|Pulmonary Embolism|pulmonary embolism
1379412|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
1379413|NCT01252420|Limited duration treatment|limited duration treatment
1379414|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1379415|NCT01252407|Sympathetic nervous system|sympathetic nervous system
1379416|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
1379417|NCT01252407|heart rate|heart rate
1379418|NCT01252342|Oxytocin|oxytocin
1379419|NCT01252342|Intramyometrial|intramyometrial
1379420|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
1379421|NCT01252329|selective neck dissection|selective neck dissection
1379422|NCT01252329|elective lymph node management|elective lymph node management
1379423|NCT01252329|clinical nodal observation|clinical nodal observation
1379424|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
1379425|NCT01252264|biorepository|biorepository
1379426|NCT01252264|genetics|genetics
1379427|NCT01252264|craniofacial|craniofacial
1379428|NCT01252264|cleft lip|cleft lip
1379429|NCT01252264|cleft palate|cleft palate
1379430|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
1379431|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
1379432|NCT01252251|eye|eye
1379433|NCT01252251|10-123|10-123
1379434|NCT01252225|Chronic Cough|chronic cough
1379435|NCT01252225|Lidocaine|lidocaine
1379436|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
1379437|NCT01252199|Shigamabs|shigamabs
1379438|NCT01252199|Monoclonal|monoclonal
1379439|NCT01252199|Antibodies|antibodies
1379440|NCT01252199|Shiga|shiga
1379441|NCT01252199|Toxin|toxin
1379442|NCT01252199|E.coli|e.coli
1379443|NCT01252199|HUS|hus
1379444|NCT01252199|Bloody|bloody
1379445|NCT01252199|Diarrhea|diarrhea
1379446|NCT01252186|Contraception|contraception
1379447|NCT01252186|Hemostasis|hemostasis
1379448|NCT01252186|Blood Coagulation|blood coagulation
1379449|NCT01252173|endotracheal|endotracheal
1379450|NCT01252173|intubation|intubation
1379451|NCT01252173|tracheal|tracheal
1379452|NCT01252173|pressure|pressure
1379453|NCT01252173|cufflator|cufflator
1379454|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
1379455|NCT01252160|QUTENZA|qutenza
1379456|NCT01252134|Soft Contact lens|soft contact lens
1379457|NCT01252134|Multi-purpose solution|multi-purpose solution
1379458|NCT01252134|Wettability|wettability
1379459|NCT01252121|Dry Eye|dry eye
1379460|NCT01252121|Ocular Retention Time|ocular retention time
1379461|NCT01252108|Helicobacter pylori|helicobacter pylori
1379462|NCT01252108|peptic ulcer disease|peptic ulcer disease
1379463|NCT01252108|stomach ulcers|stomach ulcers
1379464|NCT01252108|gastric cancer|gastric cancer
1379465|NCT01252095|PG545|pg545
1379466|NCT01252095|Phase I|phase i
1379467|NCT01252095|Progen|progen
1379468|NCT01252095|antimetastatic|antimetastatic
1379469|NCT01252095|antiangiogenic|antiangiogenic
1379470|NCT01252095|advanced cancer patients|advanced cancer patients
1379471|NCT01252095|solid tumors|solid tumors
1379472|NCT01252095|solid tumours|solid tumours
1379473|NCT01252082|metabolic control|metabolic control
1379474|NCT01252082|fasting plasma glucose|fasting plasma glucose
1379475|NCT01252082|glycated hemoglobin|glycated hemoglobin
1379476|NCT01252043|cholestasis|cholestasis
1379477|NCT01252043|children|children
1379478|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
1379479|NCT01252004|Left ventricular ballooning|left ventricular ballooning
1379480|NCT01251978|Choroidal melanoma|choroidal melanoma
1379481|NCT01251978|Ranibizumab|ranibizumab
1379482|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
1379483|NCT01251978|CSTIP|cstip
1379484|NCT01251978|Indocyanine Green|indocyanine green
1379485|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
1379486|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
1379487|NCT01251965|AML|aml
1379488|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
1379489|NCT01251965|ALL|all
1379490|NCT01251965|Ruxolitinib|ruxolitinib
1379491|NCT01251965|Jakafi|jakafi
1379492|NCT01251965|INC424|inc424
1379493|NCT01251965|INCB018424|incb018424
1379494|NCT01251926|Bevacizumab|bevacizumab
1379495|NCT01251926|Camptothecin|camptothecin
1379496|NCT01251926|EZN-2208|ezn-2208
1379497|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
1379498|NCT01251926|Advanced Cancer|advanced cancer
1379499|NCT01251926|Cancer|cancer
1379500|NCT01251926|Solid Tumor|solid tumor
1379501|NCT01251913|Tissue Harvest|tissue harvest
1379502|NCT01251913|Hospice|hospice
1379503|NCT01251913|Autopsy|autopsy
1379504|NCT01251913|Crainiotomy|crainiotomy
1379505|NCT01251913|Brain Tumor|brain tumor
1379506|NCT01251913|Glioma|glioma
1379507|NCT01251913|Astrocytoma|astrocytoma
1379508|NCT01251900|Triple Negative Disease|triple negative disease
1379509|NCT01251900|BRCA1|brca1
1379510|NCT01251900|BRCA2|brca2
1379511|NCT01251900|Hispanic/Latino|hispanic/latino
1379512|NCT01251900|Breast Cancer|breast cancer
1379513|NCT01251887|Lipids|lipids
1379514|NCT01251887|Obesity|obesity
1379515|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
1379516|NCT01251887|Overweight|overweight
1379517|NCT01251848|Sitaxentan|sitaxentan
1379518|NCT01251848|ritonavir|ritonavir
1379519|NCT01251848|drug interaction|drug interaction
1379520|NCT01251848|pharmacokinetics|pharmacokinetics
1379521|NCT01251835|Sitaxsentan|sitaxsentan
1379522|NCT01251835|Rifampin|rifampin
1379523|NCT01251835|Drug Interaction|drug interaction
1379524|NCT01251835|Pharmacokinetics|pharmacokinetics
1379525|NCT01251809|Asparaginase|asparaginase
1379526|NCT01251809|ALL|all
1379527|NCT01251783|term babies|term babies
1379528|NCT01251770|Hyponatremia|hyponatremia
1379529|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
1379530|NCT01251757|diabetes|diabetes
1379531|NCT01251757|cardiovascular disease|cardiovascular disease
1379532|NCT01251757|randomized clinical trial|randomized clinical trial
1379533|NCT01251757|medication adherence|medication adherence
1379534|NCT01251757|health information technology|health information technology
1379535|NCT01251757|adult|adult
1379536|NCT01251757|telephone calls|telephone calls
1379537|NCT01251757|IVR|ivr
1379538|NCT01251744|Pregnancy|pregnancy
1379539|NCT01251744|Congenital|congenital
1379540|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
1379541|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
1379542|NCT01251718|Alzheimer's Disease|alzheimer's disease
1379543|NCT01251705|Cornea|cornea
1379544|NCT01251705|SL OCT|sl oct
1379545|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
1379546|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
1379547|NCT01251705|Pentacam|pentacam
1379548|NCT01251692|Corneal erosions|corneal erosions
1379550|NCT01251679|handwashing|handwashing
1379551|NCT01251679|masks|masks
1379552|NCT01251679|infectious disease transmission|infectious disease transmission
1379553|NCT01251666|Colorectal cancer|colorectal cancer
1379554|NCT01251666|Screening|screening
1379555|NCT01251666|Average-risk population|average-risk population
1379556|NCT01251666|faecal occult blood tests|faecal occult blood tests
1379557|NCT01251640|pancreatic cancer,|pancreatic cancer,
1379558|NCT01251640|MEK-inhibitor|mek-inhibitor
1379559|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
1379560|NCT01251614|Randomized|randomized
1379561|NCT01251614|Double-blind|double-blind
1379562|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
1379563|NCT01251614|Pediatric|pediatric
1379564|NCT01251588|Cartilage legions|cartilage legions
1379565|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
1379566|NCT01251588|Microfracture|microfracture
1379567|NCT01251588|MACI|maci
1379568|NCT01251588|Autologous chondrocyte|autologous chondrocyte
1379569|NCT01251549|ReWalk|rewalk
1379570|NCT01251549|Paraplegia|paraplegia
1379571|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
1379572|NCT01251536|colorectal cancer|colorectal cancer
1379573|NCT01251536|K-Ras wildtype|k-ras wildtype
1379574|NCT01251536|first line metastatic|first line metastatic
1379575|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
1379576|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
1379577|NCT01251523|Asthma|asthma
1379578|NCT01251471|major depressive disorder|major depressive disorder
1379579|NCT01251471|MDD|mdd
1379580|NCT01251471|imaging genetics|imaging genetics
1379581|NCT01251471|pharmacoMRI|pharmacomri
1379582|NCT01251432|otitis media|otitis media
1379583|NCT01251432|Eustachian tube|eustachian tube
1379584|NCT01251432|allergy|allergy
1379585|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
1379586|NCT01251432|tympanostomy tube|tympanostomy tube
1379587|NCT01251419|Generic Medication|generic medication
1379588|NCT01251419|Brand Name Medication|brand name medication
1379589|NCT01251419|Conversion Rates|conversion rates
1379590|NCT01251419|Social Proximity|social proximity
1379591|NCT01251419|Behavioral Economics|behavioral economics
1379593|NCT01251406|Chronic Heart Failure|chronic heart failure
1379594|NCT01251406|Systolic|systolic
1379595|NCT01251393|Cocaine|cocaine
1379596|NCT01251393|crack|crack
1379597|NCT01251393|treatment|treatment
1379598|NCT01251393|dependence|dependence
1379599|NCT01251393|biperiden|biperiden
1379600|NCT01251341|inflammation|inflammation
1379601|NCT01251341|immune system|immune system
1379602|NCT01251341|cytokines|cytokines
1379603|NCT01251341|meditation|meditation
1379604|NCT01251341|compassion|compassion
1379605|NCT01251341|attention|attention
1379606|NCT01251315|Glutathione|glutathione
1379607|NCT01251315|Antioxidant|antioxidant
1379608|NCT01251315|Free radical|free radical
1379609|NCT01251315|Oxidative stress|oxidative stress
1379610|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
1379611|NCT01251315|Glutathione precursor|glutathione precursor
1379612|NCT01251302|Corus CAD|corus cad
1379613|NCT01251302|Age/Sex/Gene Expression Score|age/sex/gene expression score
1379614|NCT01251302|Molecular Genetics|molecular genetics
1379615|NCT01251302|Atherosclerosis|atherosclerosis
1379616|NCT01251302|ASGES|asges
1379617|NCT01251302|Gene Expression|gene expression
1379618|NCT01251302|GES|ges
1379619|NCT01251302|CAD|cad
1379620|NCT01251302|CVD|cvd
1379621|NCT01251302|CHD|chd
1379622|NCT01251302|Clinical Utility|clinical utility
1379623|NCT01251302|Precision Medicine|precision medicine
1379624|NCT01251302|Coronary Artery Disease|coronary artery disease
1379625|NCT01251302|Angina Pectoris|angina pectoris
1379626|NCT01251302|Chest Pain|chest pain
1379627|NCT01251302|Cardiovascular Disease|cardiovascular disease
1379628|NCT01251302|Coronary Heart Disease|coronary heart disease
1379629|NCT01251302|IMPACT|impact
1379630|NCT01251302|IMPACT-CARD|impact-card
1379631|NCT01251263|headaches|headaches
1379632|NCT01251263|migraines|migraines
1379633|NCT01251263|breakthrough bleeding|breakthrough bleeding
1379634|NCT01251263|breakthrough spotting|breakthrough spotting
1379635|NCT01251263|menstrually associated migraines|menstrually associated migraines
1379636|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
1379637|NCT01251224|asthma|asthma
1379638|NCT01251224|mouse allergen|mouse allergen
1379639|NCT01251224|environmental intervention|environmental intervention
1379640|NCT01251211|BOTULINUM TOXIN|botulinum toxin
1379641|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
1379642|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
1379643|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1379644|NCT01251185|Heart Failure|heart failure
1379645|NCT01251185|Congestive Heart Failure|congestive heart failure
1379646|NCT01251185|Non-invasive|non-invasive
1379647|NCT01251185|Device Trial|device trial
1379648|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
1379649|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
1379650|NCT01251185|Ischemia|ischemia
1379651|NCT01251185|Myocardial contractility|myocardial contractility
1379652|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1379653|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1379654|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1379655|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1379656|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1379657|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1379658|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1379659|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1379660|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1379661|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1379662|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1379663|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1379664|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1379665|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1379666|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1379667|NCT01251146|Hypertension|hypertension
1379668|NCT01251146|Bisoprolol|bisoprolol
1379669|NCT01251146|Atenolol|atenolol
1379670|NCT01251133|Communicable Diseases|communicable diseases
1379671|NCT01251133|Infection|infection
1379672|NCT01251133|Influenza|influenza
1379673|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
1379674|NCT01251133|RNA Virus Infections|rna virus infections
1379675|NCT01251133|Virus Diseases|virus diseases
1379676|NCT01251133|Respiratory Tract Infections|respiratory tract infections
1379677|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
1379678|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
1379679|NCT01251107|ABVD|abvd
1379680|NCT01251107|BEACOPP|beacopp
1379681|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
1379682|NCT01251094|Dementia|dementia
1379683|NCT01251094|Parkinson's|parkinson's
1379684|NCT01251094|impairment|impairment
1379685|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
1379686|NCT01251081|high volume hemofiltration|high volume hemofiltration
1379687|NCT01251081|sepsis|sepsis
1379688|NCT01251081|acute kidney injury|acute kidney injury
1379689|NCT01251081|survival|survival
1379789|NCT01250535|CYP4F2|cyp4f2
1379690|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
1379691|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
1379692|NCT01251055|glycine transporter|glycine transporter
1379693|NCT01251055|schizophrenia|schizophrenia
1379694|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
1379695|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
1379696|NCT01251016|Gut hormones|gut hormones
1379697|NCT01251016|Gene expression|gene expression
1379698|NCT01251016|Surgery|surgery
1379699|NCT01251003|Traumatic Brain Injury|traumatic brain injury
1379700|NCT01251003|TBI|tbi
1379701|NCT01251003|Pediatric|pediatric
1379702|NCT01251003|Chronic|chronic
1379703|NCT01250990|Niacin|niacin
1379704|NCT01250990|HDL|hdl
1379705|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
1379706|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
1379707|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
1379708|NCT01250951|Iron Overload|iron overload
1379709|NCT01250951|hemotranfusion|hemotranfusion
1379710|NCT01250951|deferasirox|deferasirox
1379711|NCT01250951|ferritin|ferritin
1379712|NCT01250951|Rare anemia|rare anemia
1379713|NCT01250951|Transfusional Iron Overload|transfusional iron overload
1379714|NCT01250938|autism|autism
1379715|NCT01250938|autism spectrum disorders|autism spectrum disorders
1379716|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
1379717|NCT01250938|intervention|intervention
1379718|NCT01250938|low-income|low-income
1379719|NCT01250938|underserved populations|underserved populations
1379720|NCT01250938|underrepresented populations|underrepresented populations
1379721|NCT01250925|Contact lens|contact lens
1379722|NCT01250925|Lens care|lens care
1379723|NCT01250912|Ablation|ablation
1379724|NCT01250912|Arrythmia|arrythmia
1379725|NCT01250912|Imaging|imaging
1379726|NCT01250899|HIV|hiv
1379727|NCT01250899|Vitamin D|vitamin d
1379728|NCT01250899|HAART|haart
1379729|NCT01250860|Manual therapy|manual therapy
1379730|NCT01250860|DoboMed exercise|dobomed exercise
1379731|NCT01250860|Spirometric test|spirometric test
1379732|NCT01250847|ARMS|arms
1379733|NCT01250847|Ultra High Risk|ultra high risk
1379734|NCT01250847|Quetiapine|quetiapine
1379735|NCT01250847|Verbal memory|verbal memory
1379736|NCT01250821|Infertility|infertility
1379737|NCT01250821|Anovulation|anovulation
1379738|NCT01250821|Ovulation induction|ovulation induction
1379739|NCT01250795|Prevention|prevention
1379740|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
1379741|NCT01250769|dental|dental
1379742|NCT01250769|dentist|dentist
1379743|NCT01250769|plaque|plaque
1379744|NCT01250769|IP Cleaning|ip cleaning
1379745|NCT01250756|vaccine|vaccine
1379746|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
1379747|NCT01250743|genotype 1|genotype 1
1379748|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
1379749|NCT01250717|prostatectomy|prostatectomy
1379750|NCT01250717|docetaxel|docetaxel
1379751|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
1379752|NCT01250691|pneumonia|pneumonia
1379753|NCT01250691|ICU|icu
1379754|NCT01250691|isolation room|isolation room
1379755|NCT01250691|clinical epidemiology|clinical epidemiology
1379756|NCT01250691|infection control|infection control
1379757|NCT01250678|multiple sclerosis|multiple sclerosis
1379758|NCT01250678|cognitive impairment|cognitive impairment
1379759|NCT01250678|natalizumab|natalizumab
1379760|NCT01250678|SDMT|sdmt
1379761|NCT01250665|multiple sclerosis|multiple sclerosis
1379762|NCT01250665|cognitive impairment|cognitive impairment
1379763|NCT01250665|interferon-beta 1b|interferon-beta 1b
1379764|NCT01250665|corpus callosum index|corpus callosum index
1379765|NCT01250652|Chronic urticaria|chronic urticaria
1379766|NCT01250652|Urticaria|urticaria
1379767|NCT01250652|Antihistamine|antihistamine
1379768|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1379769|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
1379770|NCT01250639|Genome-wide association study|genome-wide association study
1379771|NCT01250626|Inulin|inulin
1379772|NCT01250626|childhood GFR formula|childhood gfr formula
1379773|NCT01250587|Open label|open label
1379774|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
1379775|NCT01250574|CD64|cd64
1379776|NCT01250574|Procalcitonin|procalcitonin
1379777|NCT01250561|gabapentin|gabapentin
1379778|NCT01250561|valacyclovir|valacyclovir
1379779|NCT01250561|phn|phn
1379780|NCT01250561|shingles|shingles
1379781|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
1379782|NCT01250548|RA|ra
1379783|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
1379784|NCT01250535|Drug drug interactions|drug drug interactions
1379785|NCT01250535|Warfarin|warfarin
1379786|NCT01250535|Anticoagulants|anticoagulants
1379787|NCT01250535|Lovastatin|lovastatin
1379788|NCT01250535|Statins|statins
1379790|NCT01250535|Vitamin K|vitamin k
1379791|NCT01250509|Obesity|obesity
1379792|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
1379793|NCT01250509|Mindful eating|mindful eating
1379794|NCT01250509|Stress|stress
1379795|NCT01250509|Overnutrition|overnutrition
1379796|NCT01250509|Nutrition Disorders|nutrition disorders
1379797|NCT01250509|Overweight|overweight
1379798|NCT01250509|Body Weight|body weight
1379799|NCT01250509|Signs and Symptoms|signs and symptoms
1379800|NCT01250496|regadenoson|regadenoson
1379801|NCT01250496|lexiscan|lexiscan
1379802|NCT01250496|aminophylline|aminophylline
1379803|NCT01250496|SPECT|spect
1379804|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
1379805|NCT01250496|pharmacologic stress test|pharmacologic stress test
1379806|NCT01250483|prostate|prostate
1379807|NCT01250483|prostate-specific antigen|prostate-specific antigen
1379808|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
1379809|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
1379810|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
1379811|NCT01250444|Hypertension|hypertension
1379812|NCT01250444|Breathing Exercises|breathing exercises
1379813|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
1379814|NCT01250418|Bispectral Index|bispectral index
1379815|NCT01250418|Ketamine|ketamine
1379816|NCT01250392|Active choice|active choice
1379817|NCT01250392|Nurse visits|nurse visits
1379818|NCT01250392|Behavioral economics|behavioral economics
1379819|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
1379820|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
1379821|NCT01250353|conjunctival healing|conjunctival healing
1379822|NCT01250353|pterygium|pterygium
1379823|NCT01250353|latex biomembrane|latex biomembrane
1379824|NCT01250353|pterygium surgery|pterygium surgery
1379825|NCT01250340|Diabetes|diabetes
1379826|NCT01250340|Isoprostanes|isoprostanes
1379827|NCT01250340|Thromboxane|thromboxane
1379828|NCT01250340|Aspirin|aspirin
1379829|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
1379830|NCT01250327|endovascular valve insertion|endovascular valve insertion
1379831|NCT01250327|economic evaluation|economic evaluation
1379832|NCT01250327|valved stent|valved stent
1379833|NCT01250314|osteoporosis|osteoporosis
1379834|NCT01250314|men|men
1379835|NCT01250314|bone micro-architecture|bone micro-architecture
1379836|NCT01250314|bone markers|bone markers
1379837|NCT01250301|Smoking Cessation|smoking cessation
1379838|NCT01250301|Tobacco Dependence|tobacco dependence
1379839|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
1379840|NCT01250288|Health Information Technology|health information technology
1379841|NCT01250288|Health Records, Personal|health records, personal
1379842|NCT01250288|Hospital Information Systems|hospital information systems
1379843|NCT01250288|Patient Access to Records|patient access to records
1379844|NCT01250288|Medical Records|medical records
1379845|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
1379846|NCT01250275|Canola Oil|canola oil
1379847|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
1379848|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
1379849|NCT01250275|PAD|pad
1379850|NCT01250262|low back pain|low back pain
1379851|NCT01250262|obese|obese
1379852|NCT01250262|fear avoidance|fear avoidance
1379853|NCT01250262|disability and low back pain|disability and low back pain
1379854|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
1379855|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
1379856|NCT01250236|brimonidine|brimonidine
1379857|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
1379858|NCT01250236|cornea|cornea
1379859|NCT01250236|corneal thickness|corneal thickness
1379860|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
1379861|NCT01250223|Prognosis|prognosis
1379862|NCT01250223|Progression-Free Survival|progression-free survival
1379863|NCT01250223|Outcome|outcome
1379864|NCT01250223|International Cooperation|international cooperation
1379865|NCT01250223|Data Collection|data collection
1379866|NCT01250223|Prospective studies|prospective studies
1379867|NCT01250223|Rare Diseases|rare diseases
1567132|NCT00509860|Camptosar|camptosar
1379868|NCT01250210|contraception|contraception
1379869|NCT01250210|pregnancy prevention|pregnancy prevention
1379870|NCT01250197|Normal Volunteers|normal volunteers
1379871|NCT01250184|Myofascial pain|myofascial pain
1379872|NCT01250184|Trigger points.|trigger points.
1379873|NCT01250184|Lidocaine injection.|lidocaine injection.
1379874|NCT01250184|Physical therapy|physical therapy
1379875|NCT01250171|Dry eye|dry eye
1379876|NCT01250171|IL17/ IL-1β|il17/ il-1β
1379877|NCT01250171|Biologic|biologic
1379878|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
1379879|NCT01250158|PILP|pilp
1379880|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
1379881|NCT01250158|IHP|ihp
1379882|NCT01250158|Liver metastases|liver metastases
1379883|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
1379884|NCT01250132|Traumatic brain injury|traumatic brain injury
1379885|NCT01250132|Paediatrics|paediatrics
1379886|NCT01250132|Hypopituitarism|hypopituitarism
1379887|NCT01250106|probiotics|probiotics
1379888|NCT01250106|prevention|prevention
1379889|NCT01250106|dietary intervention|dietary intervention
1379890|NCT01250106|insulin resistance|insulin resistance
1379891|NCT01250106|obesity|obesity
1379892|NCT01250106|type 2 diabetes|type 2 diabetes
1379893|NCT01250015|colorectal cancer|colorectal cancer
1379894|NCT01250015|consent|consent
1379895|NCT01250015|screening|screening
1379896|NCT01250002|Pain|pain
1379897|NCT01250002|MQOR 40|mqor 40
1379898|NCT01250002|Lidocaine|lidocaine
1379899|NCT01250002|Gynecologic|gynecologic
1379900|NCT01250002|Surgery|surgery
1379901|NCT01250002|Laparoscopic|laparoscopic
1379902|NCT01249989|Physical Activity|physical activity
1379903|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
1379904|NCT01249989|Diet|diet
1379905|NCT01249989|Health Behavior|health behavior
1379906|NCT01249976|blood culture|blood culture
1379907|NCT01249976|central venous catheter|central venous catheter
1379908|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
1379909|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
1379910|NCT01249963|acute pancreatitis|acute pancreatitis
1379911|NCT01249963|enteral nutrition|enteral nutrition
1379912|NCT01249963|nutritional status|nutritional status
1379913|NCT01249963|pancreas|pancreas
1379914|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
1379915|NCT01249950|Morbid obesity|morbid obesity
1379916|NCT01249950|teenagers|teenagers
1379917|NCT01249950|co-morbidities|co-morbidities
1379918|NCT01249950|bariatric surgery|bariatric surgery
1379919|NCT01249950|epidemiology|epidemiology
1379920|NCT01249937|Macular Degeneration|macular degeneration
1379921|NCT01249937|Age-related macular degeneration|age-related macular degeneration
1379922|NCT01249937|Anti-inflammatory|anti-inflammatory
1379923|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
1379924|NCT01249937|Lucentis|lucentis
1379925|NCT01249937|Ranibizumab|ranibizumab
1379926|NCT01249937|Kenalog|kenalog
1379927|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
1379928|NCT01249937|Vision loss|vision loss
1380894|NCT01245413|peel-value|peel-value
1379929|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
1379930|NCT01249911|Infants|infants
1379931|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
1379932|NCT01249885|pacifier sucking|pacifier sucking
1379933|NCT01249885|children|children
1379934|NCT01249885|occlusion|occlusion
1379935|NCT01249885|drooling|drooling
1379936|NCT01249872|open gastric by-pass|open gastric by-pass
1379937|NCT01249872|super morbidly obese patients|super morbidly obese patients
1379938|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
1379939|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
1379940|NCT01249872|Lung function tests|lung function tests
1379941|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
1379942|NCT01249872|Postoperative Ambulation|postoperative ambulation
1379943|NCT01249859|stomach disease|stomach disease
1379944|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
1379945|NCT01249859|chemotherapy|chemotherapy
1379946|NCT01249859|Prognostic|prognostic
1379947|NCT01249833|Influenza|influenza
1379948|NCT01249833|Cognition|cognition
1379949|NCT01249833|Attention|attention
1379950|NCT01249833|Simple Reaction Time|simple reaction time
1379951|NCT01249833|Alertness|alertness
1379952|NCT01249833|Calmness|calmness
1379953|NCT01249833|Contentment|contentment
1379954|NCT01249833|Mood|mood
1379955|NCT01249820|anidulafungin|anidulafungin
1379956|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
1379957|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
1379958|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
1379959|NCT01249820|AML-MDS|aml-mds
1379960|NCT01249820|pharmacokinetics|pharmacokinetics
1379961|NCT01249807|Cancer Screening|cancer screening
1567133|NCT00509860|CPT-11|cpt-11
1501147|NCT00773682|hands|hands
1379962|NCT01249807|health service utilization model|health service utilization model
1379963|NCT01249807|quality of health life|quality of health life
1379964|NCT01249794|NIV|niv
1379965|NCT01249794|non invasive ventilation|non invasive ventilation
1379966|NCT01249794|cardiac surgery|cardiac surgery
1379967|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
1379968|NCT01249768|Prospective study|prospective study
1379969|NCT01249768|diagnostic accuracy|diagnostic accuracy
1379970|NCT01249768|CSF|csf
1379971|NCT01249768|MRI|mri
1379972|NCT01249742|diabetes mellitus|diabetes mellitus
1379973|NCT01249742|adolescent|adolescent
1379974|NCT01249742|online intervention|online intervention
1379975|NCT01249742|psychosocial|psychosocial
1379976|NCT01249742|quality of life|quality of life
1379977|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
1379978|NCT01249716|follow-up home visit|follow-up home visit
1379979|NCT01249716|Geriatric Disorder|geriatric disorder
1379980|NCT01249716|rehabilitation|rehabilitation
1379981|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
1379982|NCT01249677|type 2 diabetes|type 2 diabetes
1379983|NCT01249677|first phase insulin secretion|first phase insulin secretion
1379984|NCT01249677|beta-cell rest|beta-cell rest
1379985|NCT01249677|basal insulin|basal insulin
1379986|NCT01249664|sham-controlled|sham-controlled
1379987|NCT01249664|pathologic myopia|pathologic myopia
1379988|NCT01249664|mCNV|mcnv
1379989|NCT01249664|choroidal neovascularization|choroidal neovascularization
1379990|NCT01249664|intravitreal injection|intravitreal injection
1379991|NCT01249664|vision loss|vision loss
1379992|NCT01249664|macular damage|macular damage
1379993|NCT01249651|Patients, Single|patients, single
1379994|NCT01249638|Bevacizumab|bevacizumab
1379995|NCT01249638|Capecitabine|capecitabine
1379996|NCT01249638|Irinotecan|irinotecan
1379997|NCT01249638|mCRC|mcrc
1379998|NCT01249625|Influenza|influenza
1379999|NCT01249625|H1N1|h1n1
1380000|NCT01249625|Respiratory protection|respiratory protection
1380001|NCT01249625|N95 respirator|n95 respirator
1380002|NCT01249625|Medical mask|medical mask
1380003|NCT01249625|Personal protective equipment|personal protective equipment
1380004|NCT01249625|Facial protective equipment|facial protective equipment
1380005|NCT01249625|Pandemic planning|pandemic planning
1380006|NCT01249612|Knee joint icing|knee joint icing
1380007|NCT01249612|knee-extension strength|knee-extension strength
1380008|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
1380009|NCT01249599|apical balooning syndrome|apical balooning syndrome
1380010|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
1380011|NCT01249599|endothelial function|endothelial function
1380012|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
1380013|NCT01249599|platelet adhesion|platelet adhesion
1380014|NCT01249599|arterial compliance|arterial compliance
1380015|NCT01249573|fascia therapy|fascia therapy
1380016|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
1380017|NCT01249573|acute ankle distortion|acute ankle distortion
1380018|NCT01249495|leg ulcer|leg ulcer
1380019|NCT01249495|wound therapy|wound therapy
1380020|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
1380021|NCT01249482|Helicobacter pylori|helicobacter pylori
1380022|NCT01249482|reflux|reflux
1380023|NCT01249482|acid rebound|acid rebound
1380024|NCT01249391|Hand|hand
1380025|NCT01249391|osteoarthritis|osteoarthritis
1380026|NCT01249391|splint|splint
1380027|NCT01249391|pain|pain
1380028|NCT01249391|deformity|deformity
1380029|NCT01249391|function|function
1380030|NCT01249378|Nutrition|nutrition
1380031|NCT01249378|Lipid|lipid
1380032|NCT01249378|Digestion|digestion
1380033|NCT01249378|Endotoxemia|endotoxemia
1380034|NCT01249378|Inflammation|inflammation
1380035|NCT01249378|Metabolism|metabolism
1380036|NCT01249378|Stable Isotope|stable isotope
1380037|NCT01249378|Obesity|obesity
1380038|NCT01249365|medically significant conditions|medically significant conditions
1380039|NCT01249365|cervical neoplasia|cervical neoplasia
1380040|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
1380041|NCT01249365|HPV vaccine|hpv vaccine
1380042|NCT01249352|Esophageal Cancer|esophageal cancer
1380043|NCT01249352|Nimotuzumab|nimotuzumab
1380044|NCT01249352|EF024|ef024
1380045|NCT01249352|EF024-201|ef024-201
1380046|NCT01249339|smokeless tobacco|smokeless tobacco
1380047|NCT01249339|Nicotine|nicotine
1380048|NCT01249339|Cadmium|cadmium
1380049|NCT01249339|lead|lead
1380050|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
1380051|NCT01249326|Morbid obesity,|morbid obesity,
1380052|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
1380053|NCT01249326|Nitrogen balance,|nitrogen balance,
1380054|NCT01249326|Protein requirement,|protein requirement,
1380055|NCT01249326|Weight loss|weight loss
1380056|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
1380057|NCT01249313|Risk|risk
1380058|NCT01249313|outcome|outcome
1567134|NCT00509847|S. epidermidis|s. epidermidis
1380059|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
1380060|NCT01249287|stroke|stroke
1380061|NCT01249287|stem cell|stem cell
1380062|NCT01249274|cocaine abuse|cocaine abuse
1380063|NCT01249274|cocaine dependence|cocaine dependence
1380064|NCT01249274|postpartum period|postpartum period
1380065|NCT01249261|Postmenopausal Women|postmenopausal women
1380066|NCT01249261|Osteoporosis|osteoporosis
1380067|NCT01249248|Heart rate variability|heart rate variability
1380068|NCT01249248|Autonomic dysfunction|autonomic dysfunction
1380069|NCT01249248|Exercise|exercise
1380070|NCT01249248|Sports|sports
1380071|NCT01249248|Competition|competition
1380072|NCT01249248|Athletes|athletes
1380073|NCT01249209|obesity|obesity
1380074|NCT01249209|adults|adults
1380075|NCT01249209|lifestyle intervention|lifestyle intervention
1380176|NCT01248767|addiction|addiction
1380076|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
1380077|NCT01249183|Diphtheria|diphtheria
1380078|NCT01249183|Tetanus|tetanus
1380079|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
1380080|NCT01249183|Diphteria|diphteria
1380081|NCT01249183|Biological / vaccine|biological / vaccine
1380082|NCT01249170|Communication skills|communication skills
1380083|NCT01249157|MRI|mri
1380084|NCT01249157|PEM|pem
1380085|NCT01249157|10-189|10-189
1380086|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
1380087|NCT01249144|Quarter Diopter|quarter diopter
1380088|NCT01249144|Biaspheric|biaspheric
1380089|NCT01249105|MK-2206|mk-2206
1380090|NCT01249105|GBM|gbm
1380091|NCT01249092|biliary cirrhosis|biliary cirrhosis
1380092|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
1380093|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
1380094|NCT01249066|Prognosis|prognosis
1380095|NCT01249066|Observation study|observation study
1380096|NCT01249053|OPA1|opa1
1380097|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
1380098|NCT01249053|Prognosis|prognosis
1380099|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
1380100|NCT01249040|Frozen shoulder|frozen shoulder
1380101|NCT01249040|pain scale|pain scale
1380102|NCT01249040|range of motion(ROM)|range of motion(rom)
1380103|NCT01249040|muscle strength|muscle strength
1380104|NCT01249040|shoulder arthrography|shoulder arthrography
1380105|NCT01249027|Drug eluting stents|drug eluting stents
1380106|NCT01249027|Stents|stents
1380107|NCT01249027|China|china
1380108|NCT01249027|DES|des
1380109|NCT01249027|XIENCE V EECSS|xience v eecss
1380110|NCT01249001|pediatrics|pediatrics
1380111|NCT01249001|nausea|nausea
1380112|NCT01249001|vomiting|vomiting
1380113|NCT01249001|chemotherapy|chemotherapy
1380114|NCT01249001|antiemetic|antiemetic
1380115|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
1380116|NCT01248988|Safety|safety
1380117|NCT01248988|Synflorix|synflorix
1380118|NCT01248988|Pneumococcal diseases|pneumococcal diseases
1380119|NCT01248975|asthma|asthma
1380120|NCT01248975|GSK2190915|gsk2190915
1380121|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1380122|NCT01248962|CARBOPLATIN|carboplatin
1380123|NCT01248962|DEXAMETHASONE|dexamethasone
1380124|NCT01248962|GEMCITABINE|gemcitabine
1380125|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
1380126|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
1380127|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
1380128|NCT01248962|Fallopian Tubes|fallopian tubes
1380130|NCT01248949|Advanced solid tumors|advanced solid tumors
1380131|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
1380132|NCT01248949|MEDI3617|medi3617
1380133|NCT01248949|Ang2|ang2
1380134|NCT01248949|Ovarian cancer|ovarian cancer
1380135|NCT01248949|Malignant glioma|malignant glioma
1380136|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
1380137|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
1380138|NCT01248923|plasmacytoma|plasmacytoma
1380139|NCT01248923|kinesin spindle protein|kinesin spindle protein
1380140|NCT01248923|anti-mitotic|anti-mitotic
1380141|NCT01248884|combination vaccine|combination vaccine
1380142|NCT01248884|Primary vaccination|primary vaccination
1380143|NCT01248871|renal|renal
1380144|NCT01248871|transplantation|transplantation
1380145|NCT01248871|Volatile|volatile
1380146|NCT01248871|anesthetic|anesthetic
1380147|NCT01248845|Mechanical ventilation|mechanical ventilation
1380148|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
1380149|NCT01248832|tobacco cessation|tobacco cessation
1380150|NCT01248832|smoking cessation|smoking cessation
1380151|NCT01248832|telephone|telephone
1380152|NCT01248832|self-help|self-help
1380153|NCT01248832|smoking abstinence|smoking abstinence
1380154|NCT01248832|tobacco use disorder|tobacco use disorder
1380155|NCT01248832|disparity|disparity
1380156|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1380157|NCT01248819|Nebulization|nebulization
1380158|NCT01248819|Ropivacaine|ropivacaine
1380159|NCT01248806|Lung nodule|lung nodule
1501396|NCT00772590|HIV|hiv
1380160|NCT01248806|Screening|screening
1380161|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
1380162|NCT01248806|Lung cancer|lung cancer
1380163|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
1380164|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
1380165|NCT01248780|injection|injection
1380166|NCT01248780|golimumab|golimumab
1380167|NCT01248780|simponi|simponi
1380168|NCT01248767|Pathological gambling|pathological gambling
1380169|NCT01248767|"at risk gambling"|"at risk gambling"
1380170|NCT01248767|cohort|cohort
1380171|NCT01248767|cognitive distortions|cognitive distortions
1380172|NCT01248767|impulsivity|impulsivity
1380173|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
1380174|NCT01248767|gambling trajectory|gambling trajectory
1380175|NCT01248767|gambling practice evolution|gambling practice evolution
1380177|NCT01248754|Neurosurgery|neurosurgery
1380178|NCT01248754|Neuronavigation|neuronavigation
1380179|NCT01248754|Positron emission tomography|positron emission tomography
1380180|NCT01248754|FDOPA|fdopa
1380181|NCT01248741|prostate cancer|prostate cancer
1380182|NCT01248741|interstitial radiation,|interstitial radiation,
1380183|NCT01248741|brachytherapy|brachytherapy
1380184|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
1380185|NCT01248728|Clinical Trial|clinical trial
1380186|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
1380187|NCT01248728|Toddlers|toddlers
1380188|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
1380189|NCT01248715|pneumonia, viral|pneumonia, viral
1380190|NCT01248715|respiratory tract infections|respiratory tract infections
1380191|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
1380192|NCT01248702|Myocardial Infarction|myocardial infarction
1380193|NCT01248702|Heart Failure|heart failure
1380194|NCT01248702|Sudden Cardiac Death|sudden cardiac death
1380195|NCT01248702|Critical Pathways|critical pathways
1380196|NCT01248676|cancer radiation patient education|cancer radiation patient education
1380197|NCT01248663|pancreatic cancer|pancreatic cancer
1380198|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
1380199|NCT01248663|delayed gastric emptying|delayed gastric emptying
1380200|NCT01248663|reconstruction|reconstruction
1380201|NCT01248650|Safety evaluation|safety evaluation
1380202|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
1380203|NCT01248637|pancreas|pancreas
1380204|NCT01248637|pancreatic cancer|pancreatic cancer
1380205|NCT01248637|pancreatic tumor|pancreatic tumor
1380206|NCT01248637|pimonidazole|pimonidazole
1380207|NCT01248637|hypoxia|hypoxia
1380208|NCT01248637|whipple's resection|whipple's resection
1380209|NCT01248624|Palliative Care|palliative care
1380210|NCT01248624|Quality of Life|quality of life
1380211|NCT01248624|Satisfaction with Care|satisfaction with care
1380212|NCT01248611|pain|pain
1380213|NCT01248611|adverse effects|adverse effects
1380214|NCT01248611|safety|safety
1380215|NCT01248611|feasibility|feasibility
1380216|NCT01248585|Symptom Control|symptom control
1380217|NCT01248572|Cataract|cataract
1380218|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
1380219|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
1380220|NCT01248572|Effective lens position|effective lens position
1380221|NCT01248546|Breast cancer|breast cancer
1380222|NCT01248546|Computer-aided detection|computer-aided detection
1380223|NCT01248546|Mammography screening|mammography screening
1380224|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
1380225|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
1380226|NCT01248520|Pregnancy|pregnancy
1380227|NCT01248520|Influenza Vaccination|influenza vaccination
1380228|NCT01248507|COPD|copd
1380229|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
1380230|NCT01248481|Basal insulin|basal insulin
1380231|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
1380232|NCT01248468|Pain, Migraine|pain, migraine
1380233|NCT01248455|Monoclonal Antibody|monoclonal antibody
1380234|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
1380235|NCT01248455|Response Rate|response rate
1380236|NCT01248455|Pharmacokinetics|pharmacokinetics
1380237|NCT01248455|Biological Activity|biological activity
1380238|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
1380239|NCT01248455|SMM|smm
1380240|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
1380241|NCT01248442|Autoimmune disease|autoimmune disease
1380242|NCT01248442|Diabetes|diabetes
1380243|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
1380244|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
1380245|NCT01248429|myalgia|myalgia
1380246|NCT01248416|Aromatase|aromatase
1380247|NCT01248416|Growth|growth
1380248|NCT01248416|Letrozole|letrozole
1380249|NCT01248416|Anastrozole|anastrozole
1380250|NCT01248416|GH|gh
1380251|NCT01248416|Children|children
1380252|NCT01248416|Puberty|puberty
1380253|NCT01248403|RAD001|rad001
1380254|NCT01248403|Paclitaxel|paclitaxel
1380255|NCT01248403|gastric cancer|gastric cancer
1380256|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
1380257|NCT01248390|traumatic brain injury|traumatic brain injury
1380258|NCT01248390|post-concussion|post-concussion
1380259|NCT01248377|Cephalosporins|cephalosporins
1380260|NCT01248377|Drug hypersensitivity|drug hypersensitivity
1380261|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
1380262|NCT01248299|Chemotherapy|chemotherapy
1380263|NCT01248299|Best Supportive Care|best supportive care
1380264|NCT01248286|Diabetes|diabetes
1380265|NCT01248286|Prediabetes|prediabetes
1380266|NCT01248286|Prevention|prevention
1380267|NCT01248286|Whole grain|whole grain
1380268|NCT01248286|Advanced glycation end products|advanced glycation end products
1380269|NCT01248286|Insulin sensitivity|insulin sensitivity
1380270|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
1380271|NCT01248273|MUC-1 KLH|muc-1 klh
1380272|NCT01248273|QS-21|qs-21
1380273|NCT01248273|TF(C)-KLH|tf(c)-klh
1380274|NCT01248273|TN(C)-KLH|tn(c)-klh
1380275|NCT01248273|Immunization|immunization
1380276|NCT01248273|Vaccine|vaccine
1380277|NCT01248273|09-184|09-184
1380278|NCT01248260|Fetal body size|fetal body size
1380279|NCT01248260|Fetal brain size|fetal brain size
1380280|NCT01248260|Folic acid|folic acid
1380281|NCT01248247|Non small cell lung cancer|non small cell lung cancer
1380282|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
1380283|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
1380284|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
1380285|NCT01248234|elderly|elderly
1380286|NCT01248234|hypertensive|hypertensive
1380287|NCT01248234|anesthesia|anesthesia
1380288|NCT01248221|Breath test|breath test
1380289|NCT01248221|Dyspepsia|dyspepsia
1380290|NCT01248221|Gastric Emptying|gastric emptying
1380291|NCT01248221|Gastroparesis|gastroparesis
1380292|NCT01248208|egg allergy|egg allergy
1380293|NCT01248208|influenza vaccine|influenza vaccine
1380294|NCT01248195|Schizophrenia|schizophrenia
1380295|NCT01248195|Schizophreniform disorder|schizophreniform disorder
1380296|NCT01248195|Schizoaffective disorder|schizoaffective disorder
1380297|NCT01248195|Imaging|imaging
1380298|NCT01248195|Prognosis|prognosis
1380299|NCT01248195|Treatment guidelines|treatment guidelines
1380300|NCT01248195|Pharmacogenetics|pharmacogenetics
1380301|NCT01248182|acetabular fracture|acetabular fracture
1380302|NCT01248182|pelvic ring injury|pelvic ring injury
1380303|NCT01248143|Green Tea|green tea
1380304|NCT01248143|Fermented papaya preparation|fermented papaya preparation
1380305|NCT01248143|Diabetes|diabetes
1380306|NCT01248143|Cardiovascular diseases|cardiovascular diseases
1380307|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
1380308|NCT01248143|Glucose|glucose
1380309|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
1380310|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
1380311|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
1380312|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
1380313|NCT01248130|Children|children
1380314|NCT01248130|Cognitive Functioning|cognitive functioning
1380315|NCT01248117|PCV|pcv
1380316|NCT01248117|polypoidal|polypoidal
1380317|NCT01248117|choroidal|choroidal
1380318|NCT01248117|vasculopathy|vasculopathy
1380319|NCT01248104|Cardiac Surgery|cardiac surgery
1380320|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
1380321|NCT01248104|Blood transfusion|blood transfusion
1380322|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
1380323|NCT01248104|tranexamic acid|tranexamic acid
1380324|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
1380325|NCT01248078|elective cesarean section|elective cesarean section
1380326|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
1380327|NCT01248078|cefazoline|cefazoline
1380328|NCT01248078|wound infection|wound infection
1380329|NCT01248065|Asthma|asthma
1380330|NCT01248065|Vitamin D|vitamin d
1380331|NCT01248065|Corticosteroids|corticosteroids
1380332|NCT01248065|Treatment failure|treatment failure
1380333|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
1380334|NCT01248026|Cardiovascular disease|cardiovascular disease
1380335|NCT01248026|Buttermilk|buttermilk
1380336|NCT01248026|Blood lipids|blood lipids
1380337|NCT01248026|Cholesterol absorption|cholesterol absorption
1380338|NCT01248026|Cholesterol synthesis|cholesterol synthesis
1380339|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
1380340|NCT01248000|FDG-PET|fdg-pet
1380341|NCT01248000|prognostic factor|prognostic factor
1380342|NCT01248000|clinical trial|clinical trial
1380343|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
1380344|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1380345|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
1380346|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
1380347|NCT01247948|spine surgery|spine surgery
1380348|NCT01247948|navigation assisted|navigation assisted
1380349|NCT01247935|Pain|pain
1380350|NCT01247935|Acupuncture|acupuncture
1380351|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1380352|NCT01247935|Colonoscopy|colonoscopy
1380353|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
1380354|NCT01247922|Ependymoma|ependymoma
1380355|NCT01247922|Erlotinib|erlotinib
1380356|NCT01247922|Tarceva|tarceva
1380357|NCT01247883|Phase 1|phase 1
1380358|NCT01247883|relative bioavailability|relative bioavailability
1380359|NCT01247883|healthy volunteers|healthy volunteers
1380360|NCT01247883|pharmacokinetics|pharmacokinetics
1380361|NCT01247883|solution|solution
1380362|NCT01247883|tablet|tablet
1380363|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
1380364|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1380365|NCT01247857|Nebulization|nebulization
1380366|NCT01247857|Ropivacaine|ropivacaine
1380367|NCT01247844|adult Males|adult males
1380368|NCT01247844|circumcision|circumcision
1380369|NCT01247844|HIV prevention|hiv prevention
1380370|NCT01247844|device|device
1380464|NCT01247493|tolerability|tolerability
1380371|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
1380372|NCT01247805|Bioequivalence|bioequivalence
1380373|NCT01247805|Powder for oral suspention|powder for oral suspention
1380374|NCT01247792|sepsis|sepsis
1380375|NCT01247792|organ failure|organ failure
1380376|NCT01247792|end-of-life decisions|end-of-life decisions
1380377|NCT01247792|patient-centered communication|patient-centered communication
1380378|NCT01247779|gynecology|gynecology
1380379|NCT01247779|oncology|oncology
1380380|NCT01247779|coelioscopy|coelioscopy
1380381|NCT01247779|robot|robot
1380382|NCT01247779|morbidity|morbidity
1380383|NCT01247727|Heart rate variability|heart rate variability
1380384|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1380385|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
1380386|NCT01247714|Diabetic|diabetic
1380387|NCT01247714|Enteral Nutrition|enteral nutrition
1380388|NCT01247714|Glycaemic response|glycaemic response
1380389|NCT01247714|Metabolic Syndrome|metabolic syndrome
1380390|NCT01247714|Insulin resistance|insulin resistance
1380391|NCT01247714|Lipidic profile|lipidic profile
1380392|NCT01247701|UCB|ucb
1380393|NCT01247701|Umbilical Cord Blood|umbilical cord blood
1380394|NCT01247701|Transplant|transplant
1380395|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
1380396|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
1380397|NCT01247701|Pediatric|pediatric
1380398|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
1380399|NCT01247701|Busulfan|busulfan
1380400|NCT01247701|Cytoxan|cytoxan
1380401|NCT01247701|Cyclophosphamide|cyclophosphamide
1380402|NCT01247701|Fludarabine|fludarabine
1380403|NCT01247688|Lymphoid|lymphoid
1380404|NCT01247688|hematologic malignancy|hematologic malignancy
1380405|NCT01247688|UCB|ucb
1380406|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
1380407|NCT01247688|Total Body Irradiation|total body irradiation
1380408|NCT01247688|Cytoxan|cytoxan
1380409|NCT01247688|Cyclophosphamide|cyclophosphamide
1380410|NCT01247688|Fludarabine|fludarabine
1380411|NCT01247662|Autism spectrum disorder|autism spectrum disorder
1380412|NCT01247662|Social Responsiveness Scale|social responsiveness scale
1380413|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
1380414|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
1380415|NCT01247662|psychometric|psychometric
1380416|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
1380417|NCT01247649|Non invasive|non invasive
1380418|NCT01247649|Type 1 diabetes|type 1 diabetes
1380419|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
1380421|NCT01247636|Elderly|elderly
1380422|NCT01247636|Balance|balance
1380423|NCT01247636|Mobility|mobility
1380424|NCT01247636|Fear of falling|fear of falling
1380425|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
1380426|NCT01247597|Thyroid Cancer|thyroid cancer
1380427|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
1380428|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
1380429|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
1380430|NCT01247597|PPB|ppb
1380431|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1380432|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1380433|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1380434|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1380435|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1380436|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1380437|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1380438|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1501771|NCT00771082|OA|oa
1380439|NCT01247558|Metanx®|metanx®
1380440|NCT01247558|diabetes|diabetes
1380441|NCT01247558|neuropathy|neuropathy
1380442|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
1380443|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
1380444|NCT01247558|folic acid|folic acid
1380445|NCT01247558|folate|folate
1380446|NCT01247558|L-methylfolate|l-methylfolate
1380447|NCT01247558|vitamin B6|vitamin b6
1380448|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
1380449|NCT01247558|vitamin B12|vitamin b12
1380450|NCT01247558|methylcobalamin|methylcobalamin
1380451|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
1380452|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1380453|NCT01247545|Cardioprotection|cardioprotection
1380454|NCT01247545|Clinical Outcomes|clinical outcomes
1380455|NCT01247532|Cancer|cancer
1380456|NCT01247532|Fatigue|fatigue
1380457|NCT01247532|Mindfulness|mindfulness
1380458|NCT01247532|Meditation|meditation
1380459|NCT01247532|Neoplasms|neoplasms
1380460|NCT01247506|microRNA|microrna
1380461|NCT01247493|fludarabine|fludarabine
1380462|NCT01247493|AML|aml
1380463|NCT01247493|Efficacy|efficacy
1380465|NCT01247454|CVD|cvd
1380466|NCT01247454|primary prevention|primary prevention
1380467|NCT01247454|ASA|asa
1380468|NCT01247454|physician behavioral change|physician behavioral change
1380469|NCT01247454|Patient behavioral change|patient behavioral change
1380470|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
1380471|NCT01247428|Coronary Artery Disease|coronary artery disease
1380472|NCT01247428|Drug-eluting Stent|drug-eluting stent
1380473|NCT01247428|Sirolimus|sirolimus
1380474|NCT01247415|anaphylaxis|anaphylaxis
1380475|NCT01247415|allergy|allergy
1380476|NCT01247415|IgE mediated|ige mediated
1380477|NCT01247415|ORS|ors
1380478|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
1380479|NCT01247415|Allergic-like reactions|allergic-like reactions
1380480|NCT01247415|H1N1|h1n1
1380481|NCT01247415|Arepanrix|arepanrix
1380482|NCT01247402|peripheral arterial disease|peripheral arterial disease
1380483|NCT01247402|in-stent restenosis|in-stent restenosis
1380484|NCT01247402|drug eluting balloon|drug eluting balloon
1380485|NCT01247389|laparoscopy|laparoscopy
1380486|NCT01247389|colon resection|colon resection
1380487|NCT01247389|incisional hernia|incisional hernia
1380488|NCT01247376|inflammation|inflammation
1380489|NCT01247376|arthroscopy|arthroscopy
1380490|NCT01247376|knee|knee
1380491|NCT01247376|microdialysis|microdialysis
1380492|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
1380493|NCT01247311|Vitamin D|vitamin d
1380494|NCT01247311|pulse wave velocity|pulse wave velocity
1380495|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1380496|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
1380497|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
1380498|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
1380499|NCT01247285|Bioequivalence|bioequivalence
1380500|NCT01247285|Healthy Subjects|healthy subjects
1380501|NCT01247272|Bioequivalence|bioequivalence
1380502|NCT01247272|Healthy Subjects|healthy subjects
1380503|NCT01247259|allergic rhinitis|allergic rhinitis
1380504|NCT01247259|immunotherapy|immunotherapy
1380505|NCT01247259|sublingual|sublingual
1380506|NCT01247246|Oral Mucositis|oral mucositis
1380507|NCT01247246|Head and Neck|head and neck
1380508|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
1380509|NCT01247246|Mucositis|mucositis
1380510|NCT01247246|Stomatitis|stomatitis
1380511|NCT01247246|Neoplasms by Site|neoplasms by site
1380512|NCT01247246|Neoplasms|neoplasms
1380513|NCT01247246|Gastroenteritis|gastroenteritis
1380514|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
1380515|NCT01247246|Digestive System Diseases|digestive system diseases
1380516|NCT01247246|Mouth Diseases|mouth diseases
1380517|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
1380518|NCT01247246|SCV-07|scv-07
1380519|NCT01247233|breast cancer|breast cancer
1380520|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
1380521|NCT01247233|invasive cancer|invasive cancer
1380522|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
1380523|NCT01247233|Lumpectomy|lumpectomy
1380524|NCT01247220|Macular Edema|macular edema
1380525|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
1380526|NCT01247220|Ranibizumab|ranibizumab
1380527|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
1380528|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
1380529|NCT01247207|Nonsense mutation|nonsense mutation
1380530|NCT01247207|Premature stop codon|premature stop codon
1380531|NCT01247207|DMD|dmd
1380532|NCT01247207|BMD|bmd
1380533|NCT01247207|nmDBMD|nmdbmd
1380534|NCT01247207|DBMD|dbmd
1380535|NCT01247207|Ataluren|ataluren
1380536|NCT01247207|PTC124|ptc124
1380537|NCT01247194|hepatitis C|hepatitis c
1380538|NCT01247194|NS5A|ns5a
1380539|NCT01247194|HCV RNA|hcv rna
1380540|NCT01247181|compliance|compliance
1380541|NCT01247181|observance|observance
1380542|NCT01247181|mobile phone|mobile phone
1380543|NCT01247181|SMS|sms
1380544|NCT01247181|text message|text message
1380545|NCT01247181|ARV|arv
1380546|NCT01247181|HAART|haart
1380547|NCT01247181|AIDS|aids
1380548|NCT01247168|Refractory|refractory
1380549|NCT01247168|Solid tumors|solid tumors
1380550|NCT01247168|Cancer|cancer
1380551|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1380552|NCT01247142|exhaled breath condensate|exhaled breath condensate
1380553|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
1380554|NCT01247103|healthy volunteers|healthy volunteers
1380555|NCT01247103|safety|safety
1380556|NCT01247103|tolerability|tolerability
1380557|NCT01247090|hypertension|hypertension
1380558|NCT01247090|end stage renal disease|end stage renal disease
1380559|NCT01247090|vasopressin|vasopressin
1380560|NCT01247090|Arginine Vasopressin|arginine vasopressin
1380561|NCT01247090|AVP|avp
1380562|NCT01247090|Pitressin®|pitressin®
1380563|NCT01247077|selenium|selenium
1380564|NCT01247077|neuropsychological testing|neuropsychological testing
1380565|NCT01247077|autoantibodies|autoantibodies
1380566|NCT01247064|Bronchiolitis|bronchiolitis
1380567|NCT01247064|Hypertonic Saline|hypertonic saline
1380568|NCT01247051|priming|priming
1380569|NCT01247051|cardiac surgery|cardiac surgery
1380570|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
1380571|NCT01247051|precoating|precoating
1380572|NCT01246999|Influenza|influenza
1380573|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
1380574|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
1380575|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
1380576|NCT01246973|Oral Curcumin|oral curcumin
1380577|NCT01246973|Radiation Dermatitis|radiation dermatitis
1380578|NCT01246973|Breast Cancer Patients|breast cancer patients
1380579|NCT01246960|cancer|cancer
1380580|NCT01246960|stomach|stomach
1380581|NCT01246960|esophagus|esophagus
1380582|NCT01246960|gastroesophageal|gastroesophageal
1380583|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
1380584|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
1380585|NCT01246947|Mitral Value Surgery|mitral value surgery
1380586|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
1380587|NCT01246908|TRD|trd
1380588|NCT01246895|Cartilage repair|cartilage repair
1380589|NCT01246895|Cartilage|cartilage
1380590|NCT01246895|Knee|knee
1380591|NCT01246895|Knee Pain|knee pain
1380592|NCT01246895|Microfracture|microfracture
1380593|NCT01246895|Arthroscopy|arthroscopy
1380594|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
1380595|NCT01246895|Chondrogenesis|chondrogenesis
1380596|NCT01246895|Scaffold|scaffold
1380597|NCT01246895|Chitosan|chitosan
1380598|NCT01246895|Articular Cartilage Repair|articular cartilage repair
1380599|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
1380600|NCT01246882|wireless inertial sensing|wireless inertial sensing
1380601|NCT01246882|mobile health|mobile health
1380602|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
1380603|NCT01246856|Cardiotoxicity|cardiotoxicity
1380604|NCT01246856|Breast cancer treatment|breast cancer treatment
1380605|NCT01246856|MIBG scintigraphy|mibg scintigraphy
1380606|NCT01246856|Strain Echocardiography|strain echocardiography
1380607|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
1380608|NCT01246843|sunitinib|sunitinib
1380609|NCT01246843|sorafenib|sorafenib
1380610|NCT01246843|cognitive functioning|cognitive functioning
1380611|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
1380612|NCT01246817|temsirolimus|temsirolimus
1380613|NCT01246817|FLT-PET|flt-pet
1380614|NCT01246817|FDG-PET|fdg-pet
1380615|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
1380616|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
1380617|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
1380618|NCT01246804|HIV infections|hiv infections
1380619|NCT01246804|interaction|interaction
1380620|NCT01246804|pharmacokinetics|pharmacokinetics
1380621|NCT01246791|NPC-01|npc-01
1380622|NCT01246791|Pharmacokinetics|pharmacokinetics
1380623|NCT01246791|Healthy female volunteer|healthy female volunteer
1380624|NCT01246791|Norethisterone|norethisterone
1380625|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
1380626|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
1380627|NCT01246765|Pregnancy|pregnancy
1380628|NCT01246765|Medication use during pregnancy|medication use during pregnancy
1380629|NCT01246752|AML, Leukemia|aml, leukemia
1380630|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
1380631|NCT01246752|HSCT|hsct
1380632|NCT01246752|Stem Cell Transplantation|stem cell transplantation
1380633|NCT01246752|Tx|tx
1380634|NCT01246752|Chemotherapy|chemotherapy
1380635|NCT01246739|mild hypercortisolism|mild hypercortisolism
1380636|NCT01246739|adrenal tumour|adrenal tumour
1380637|NCT01246739|surgical procedures, elective|surgical procedures, elective
1380638|NCT01246739|indication|indication
1380639|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
1380640|NCT01246713|acetaminophen|acetaminophen
1380641|NCT01246713|excipients|excipients
1380642|NCT01246700|Parkinson's disease|parkinson's disease
1380643|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
1380644|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
1380645|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
1380646|NCT01246609|acid base balance|acid base balance
1380647|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
1380648|NCT01246583|Multi Site|multi site
1380649|NCT01246583|Randomized|randomized
1380650|NCT01246583|Placebo Controlled|placebo controlled
1380651|NCT01246583|Double Blind|double blind
1380652|NCT01246583|Parallel Group|parallel group
1380653|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
1380742|NCT01246102|Cancer|cancer
1380654|NCT01246583|topical treatment|topical treatment
1380655|NCT01246583|skin diseases|skin diseases
1380656|NCT01246583|papulosquamous|papulosquamous
1380657|NCT01246570|exercise|exercise
1380658|NCT01246570|heart|heart
1380659|NCT01246570|coronary disease|coronary disease
1380660|NCT01246570|rehabilitation|rehabilitation
1380661|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
1380662|NCT01246544|Patient Safety|patient safety
1380663|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
1380664|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
1380665|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
1380666|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
1380667|NCT01246531|Urolithiasis|urolithiasis
1380668|NCT01246531|Renal calculi|renal calculi
1380669|NCT01246531|Aging|aging
1380670|NCT01246531|Osteoporosis|osteoporosis
1380671|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
1380672|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
1380673|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
1380674|NCT01246427|Homeopathic treatment|homeopathic treatment
1380675|NCT01246427|Hot flashes|hot flashes
1380676|NCT01246427|Quality of life|quality of life
1380677|NCT01246427|Hot flash score|hot flash score
1380678|NCT01246414|Asthma|asthma
1380679|NCT01246414|Exhaled breath condensates|exhaled breath condensates
1380680|NCT01246414|Cytokines|cytokines
1380681|NCT01246388|Fibrosis|fibrosis
1380682|NCT01246388|Steatosis|steatosis
1380683|NCT01246388|Liver biopsy|liver biopsy
1380684|NCT01246388|Elastography|elastography
1380685|NCT01246388|MRI|mri
1380686|NCT01246349|Motivational Interviewing|motivational interviewing
1380687|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
1380688|NCT01246349|Health Behaviours|health behaviours
1380689|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
1380690|NCT01246336|Biomarkers|biomarkers
1380691|NCT01246336|Exhaled breath|exhaled breath
1380692|NCT01246336|Nanothechnology|nanothechnology
1380693|NCT01246323|Visual analogue scale|visual analogue scale
1380694|NCT01246323|pain level|pain level
1380695|NCT01246323|analgesia|analgesia
1380696|NCT01246323|combined anesthesia|combined anesthesia
1380697|NCT01246284|Alopecia areata|alopecia areata
1380698|NCT01246284|Intralesional|intralesional
1380699|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
1380700|NCT01246284|Concentration|concentration
1380701|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
1380702|NCT01246258|otolith|otolith
1380703|NCT01246258|vestibular tests|vestibular tests
1380704|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
1380705|NCT01246219|Idiopathic Short stature|idiopathic short stature
1380706|NCT01246219|Self Image|self image
1380707|NCT01246219|GH therapy|gh therapy
1380708|NCT01246219|Psychological distress|psychological distress
1380709|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
1380710|NCT01246206|● Hodgkin disease,|● hodgkin disease,
1380711|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
1380712|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
1380713|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
1380714|NCT01246206|● Multiple Myeloma|● multiple myeloma
1380715|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
1567135|NCT00509847|Staphylococcus|staphylococcus
1567136|NCT00509847|Lactoferrin|lactoferrin
1380716|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
1380717|NCT01246193|CKD-828|ckd-828
1380718|NCT01246193|Hypertension|hypertension
1380719|NCT01246193|Primary Hypertension|primary hypertension
1380720|NCT01246193|Healthy Volunteer|healthy volunteer
1380721|NCT01246193|S-Amlodipine|s-amlodipine
1380722|NCT01246193|Telmisartan|telmisartan
1380723|NCT01246193|Amlodipine|amlodipine
1380724|NCT01246193|Pharmacokinetic|pharmacokinetic
1380725|NCT01246193|Phase 1|phase 1
1380851|NCT01245673|Advanced Disease|advanced disease
1380726|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
1380727|NCT01246167|Proximal humerus fracture|proximal humerus fracture
1380728|NCT01246167|conservative|conservative
1380729|NCT01246167|locking plate|locking plate
1380730|NCT01246167|Philos|philos
1380731|NCT01246167|Hemiprosthesis|hemiprosthesis
1380732|NCT01246154|ASTHMA|asthma
1380733|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
1380734|NCT01246141|replacement|replacement
1380735|NCT01246141|repair|repair
1380736|NCT01246141|outcomes|outcomes
1380737|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
1380738|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
1380739|NCT01246128|PET Imaging|pet imaging
1380740|NCT01246102|Targeted Therapy|targeted therapy
1380741|NCT01246102|HER2 Positive Cancer|her2 positive cancer
1380743|NCT01246102|Solid Tumor|solid tumor
1380744|NCT01246102|Breast Cancer|breast cancer
1380745|NCT01246089|Ranibizumab|ranibizumab
1380746|NCT01246089|Myopia|myopia
1380747|NCT01246089|Complications|complications
1380748|NCT01246089|Neovascularization|neovascularization
1380749|NCT01246089|OCT|oct
1380750|NCT01246050|Heart Failure|heart failure
1380751|NCT01246050|Outcome Assessment|outcome assessment
1380752|NCT01246050|Congestive Heart Failure|congestive heart failure
1380753|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1380754|NCT01246037|Beta-blocker|beta-blocker
1380755|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
1380756|NCT01245998|Thrombophlebitis|thrombophlebitis
1380757|NCT01245998|Venous thrombosis|venous thrombosis
1380758|NCT01245998|Pulmonary embolism|pulmonary embolism
1380759|NCT01245998|Anticoagulants|anticoagulants
1380760|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
1380761|NCT01245985|SCCHN|scchn
1380762|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1380763|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
1380764|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
1380765|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
1380766|NCT01245972|pulsed dye laser|pulsed dye laser
1380767|NCT01245972|PDL|pdl
1380768|NCT01245972|basal cell carcinoma|basal cell carcinoma
1380769|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
1380770|NCT01245972|BCC|bcc
1380771|NCT01245972|SCC|scc
1380772|NCT01245972|594nM laser|594nm laser
1380773|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1380774|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1380775|NCT01245959|Induction chemotherapy|induction chemotherapy
1380776|NCT01245959|Clinical trial|clinical trial
1380777|NCT01245946|Acne moderate|acne moderate
1380778|NCT01245946|Photodynamic Therapy|photodynamic therapy
1380779|NCT01245946|Topical retinoids|topical retinoids
1380780|NCT01245946|Antimicrobial agents|antimicrobial agents
1380781|NCT01245933|COPD|copd
1380782|NCT01245933|register|register
1380783|NCT01245933|comorbidities|comorbidities
1380784|NCT01245933|systemic inflammation|systemic inflammation
1380785|NCT01245920|Dental implant|dental implant
1380786|NCT01245920|Alveolar bone|alveolar bone
1380787|NCT01245920|Clinical attachment Level|clinical attachment level
1380788|NCT01245907|Hot flashes|hot flashes
1380789|NCT01245907|Menopause|menopause
1380790|NCT01245907|HRQoL|hrqol
1380791|NCT01245907|Applied relaxation|applied relaxation
1380792|NCT01245907|Insomnia|insomnia
1380793|NCT01245907|Women's knowledge|women's knowledge
1380794|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
1380795|NCT01245894|Fractional Flow Reserve|fractional flow reserve
1380796|NCT01245881|controlled trial|controlled trial
1380797|NCT01245881|fractional photothermolysis|fractional photothermolysis
1380798|NCT01245881|laser surgery|laser surgery
1380799|NCT01245881|melasma|melasma
1380800|NCT01245881|pigment disorder|pigment disorder
1380801|NCT01245868|Spinal anaesthesia|spinal anaesthesia
1380802|NCT01245868|Bupivacaine|bupivacaine
1380803|NCT01245868|Lidocaine|lidocaine
1380804|NCT01245868|Duration of blockade|duration of blockade
1380805|NCT01245855|Prostaglandin E1|prostaglandin e1
1380806|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
1380807|NCT01245855|Cardiac troponin T|cardiac troponin t
1380808|NCT01245855|Creatine kinase-MB|creatine kinase-mb
1380809|NCT01245829|Cross Infection|cross infection
1380810|NCT01245829|Nosocomial Infection|nosocomial infection
1380811|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
1567137|NCT00509847|hLF1-11|hlf1-11
1380812|NCT01245829|Hospital Paperwork|hospital paperwork
1380813|NCT01245829|Observation Charts|observation charts
1380814|NCT01245829|Critical Care|critical care
1380815|NCT01245829|Contamination|contamination
1380816|NCT01245816|colon polyps|colon polyps
1380817|NCT01245803|rosuvastatin|rosuvastatin
1380818|NCT01245803|angioplasty|angioplasty
1380819|NCT01245803|acute coronary syndrome|acute coronary syndrome
1380820|NCT01245790|Phase 1|phase 1
1380821|NCT01245790|healthy volunteers|healthy volunteers
1380822|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
1380823|NCT01245790|pharmacokinetics|pharmacokinetics
1380824|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
1380826|NCT01245790|fostamatinib|fostamatinib
1380827|NCT01245790|Patients|patients
1380828|NCT01245777|RLS|rls
1380829|NCT01245777|Pregnancy|pregnancy
1380830|NCT01245777|Iron Deficiency|iron deficiency
1380831|NCT01245777|Anaemia|anaemia
1380832|NCT01245764|Cervical cancer|cervical cancer
1380833|NCT01245764|vulvar cancer|vulvar cancer
1380834|NCT01245764|vaginal cancer|vaginal cancer
1380835|NCT01245764|genital warts|genital warts
1380836|NCT01245764|human papillomavirus|human papillomavirus
1380837|NCT01245751|Shingles|shingles
1380838|NCT01245751|Vaccine|vaccine
1380839|NCT01245712|Adenocarcinoma of the breast|adenocarcinoma of the breast
1380840|NCT01245712|Lumpectomy|lumpectomy
1380841|NCT01245712|Stage 0 breast cancer|stage 0 breast cancer
1380842|NCT01245712|Stage I breast cancer|stage i breast cancer
1380843|NCT01245712|Stage II breast cancer|stage ii breast cancer
1380844|NCT01245712|Accelerated partial breast irradiation|accelerated partial breast irradiation
1380845|NCT01245712|APBI|apbi
1380846|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
1380847|NCT01245686|Diet interventions|diet interventions
1380848|NCT01245686|Physical activity interventions|physical activity interventions
1380849|NCT01245686|Medication adherence|medication adherence
1380850|NCT01245686|Tailored interventions|tailored interventions
1380852|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
1380853|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
1380854|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
1380855|NCT01245660|Phase 0|phase 0
1380856|NCT01245660|Bladder carcinoma|bladder carcinoma
1380857|NCT01245660|egf pathway|egf pathway
1380858|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
1380859|NCT01245660|cystectomy|cystectomy
1380860|NCT01245660|LAPATINIB|lapatinib
1380861|NCT01245647|women|women
1380862|NCT01245647|HIV|hiv
1380863|NCT01245647|alcohol|alcohol
1380864|NCT01245647|medication|medication
1380865|NCT01245647|adherence|adherence
1380866|NCT01245647|acceptability|acceptability
1380867|NCT01245621|palliative care|palliative care
1380868|NCT01245621|end of life care|end of life care
1380869|NCT01245621|quality of life|quality of life
1380870|NCT01245621|caregivers|caregivers
1380871|NCT01245608|Atorvastatin|atorvastatin
1380872|NCT01245608|Aspirin|aspirin
1380873|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1380874|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1380875|NCT01245608|antihypertensive agents|antihypertensive agents
1380876|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
1380877|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
1380878|NCT01245530|Alzheimer disease|alzheimer disease
1380879|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
1380880|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
1380881|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
1380882|NCT01245452|Tocilizumab|tocilizumab
1380883|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
1380884|NCT01245426|Asthma|asthma
1380885|NCT01245426|GW870086|gw870086
1380886|NCT01245426|Efficacy|efficacy
1380887|NCT01245426|FEV1|fev1
1380888|NCT01245413|Stoma|stoma
1380889|NCT01245413|adhesive|adhesive
1380890|NCT01245413|warm|warm
1380891|NCT01245413|moist|moist
1380892|NCT01245413|cycling|cycling
1380893|NCT01245413|men|men
1380895|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
1380896|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
1380897|NCT01245400|Z-Lig|z-lig
1380898|NCT01245400|allograft|allograft
1380900|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
1380901|NCT01245400|ACLR|aclr
1380902|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1380903|NCT01245400|EU|eu
1380904|NCT01245400|European Union|european union
1380905|NCT01245400|S. Africa|s. africa
1380906|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
1380907|NCT01245387|prospective|prospective
1380908|NCT01245387|observational|observational
1380909|NCT01245387|Phase 4|phase 4
1380910|NCT01245387|non-interventional|non-interventional
1380911|NCT01245387|open-label|open-label
1380912|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
1380913|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
1380914|NCT01245361|Infliximab|infliximab
1380915|NCT01245348|Schizophrenia|schizophrenia
1380916|NCT01245348|Bipolar Disorder|bipolar disorder
1380917|NCT01245348|atypical antipsychotic|atypical antipsychotic
1380918|NCT01245348|adherence|adherence
1380919|NCT01245348|cost effectiveness|cost effectiveness
1380920|NCT01245348|pharmacogenetics|pharmacogenetics
1380921|NCT01245348|mental illness|mental illness
1380922|NCT01245348|SULT4A1|sult4a1
1380923|NCT01245335|CLI|cli
1380924|NCT01245335|Critical Limb Ischemia|critical limb ischemia
1380925|NCT01245335|PAOD|paod
1380926|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
1380927|NCT01245335|Stem Cells|stem cells
1380928|NCT01245335|Limb amputation|limb amputation
1380929|NCT01245335|Leg ulcers|leg ulcers
1380930|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
1380931|NCT01245296|Umbilical cord|umbilical cord
1380932|NCT01245296|cord clamping|cord clamping
1380933|NCT01245296|iron|iron
1380934|NCT01245296|Ferritin|ferritin
1380935|NCT01245296|newborn|newborn
1380936|NCT01245296|jaundice|jaundice
1380937|NCT01245296|infant|infant
1380938|NCT01245296|development|development
1380939|NCT01245296|infections|infections
1380940|NCT01245283|knee|knee
1380941|NCT01245283|osteoarthritis|osteoarthritis
1380942|NCT01245283|pain|pain
1380943|NCT01245283|function|function
1380944|NCT01245283|impairment|impairment
1380945|NCT01245270|anthocyanin|anthocyanin
1380946|NCT01245270|blaeberries|blaeberries
1380947|NCT01245270|bilberries|bilberries
1380948|NCT01245270|blueberries|blueberries
1380949|NCT01245270|mirtoselect|mirtoselect
1380950|NCT01245270|glucose AUC|glucose auc
1380951|NCT01245257|Inflammation|inflammation
1380952|NCT01245257|Urea Synthesis|urea synthesis
1380953|NCT01245257|Catabolism|catabolism
1380954|NCT01245257|Nitrogen balance|nitrogen balance
1380955|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1380956|NCT01245179|sickle cell anemia|sickle cell anemia
1380957|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
1380958|NCT01245179|HDAC inhibitor|hdac inhibitor
1380959|NCT01245179|hemoglobin F|hemoglobin f
1380960|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
1380961|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
1380962|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
1380963|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
1380964|NCT01245127|Schnitzler syndrome|schnitzler syndrome
1380965|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
1380966|NCT01245088|Crohn's disease|crohn's disease
1380967|NCT01245088|chondroitin sulfate|chondroitin sulfate
1380968|NCT01245062|MEK inhibitor|mek inhibitor
1380969|NCT01245062|Cancer|cancer
1380970|NCT01245062|Metastatic Melanoma|metastatic melanoma
1380971|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
1380972|NCT01245062|GSK1120212|gsk1120212
1380973|NCT01245049|MMR|mmr
1380974|NCT01245049|dTpa-IPV|dtpa-ipv
1380975|NCT01245049|Boostrix Polio|boostrix polio
1380976|NCT01245049|Repevax|repevax
1380977|NCT01245049|Priorix|priorix
1380978|NCT01245036|Sarcoidosis|sarcoidosis
1380979|NCT01245036|Tuberculosis|tuberculosis
1380980|NCT01245010|Metabolic Syndrome|metabolic syndrome
1380981|NCT01245010|Water|water
1380982|NCT01245010|Obesity|obesity
1380983|NCT01245010|Clinical trial|clinical trial
1380984|NCT01245010|Prevention|prevention
1380985|NCT01244997|Partial edentulism|partial edentulism
1380986|NCT01244997|Bone atrophy|bone atrophy
1380987|NCT01244997|Bone healing|bone healing
1380988|NCT01244984|asthma|asthma
1380989|NCT01244984|Fluticasone furoate|fluticasone furoate
1380990|NCT01244984|GW642444|gw642444
1380991|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
1380992|NCT01244958|leflunomide|leflunomide
1380993|NCT01244958|rituximab|rituximab
1380994|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
1380995|NCT01244945|Functional Constipation|functional constipation
1380996|NCT01244945|Functional Foods|functional foods
1380997|NCT01244945|Probiotics|probiotics
1380998|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
1380999|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1381000|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
1381001|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
1381002|NCT01244906|Myelofibrosis|myelofibrosis
1381003|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1381004|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
1381005|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1381006|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
1381007|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
1381008|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
1381009|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
1381010|NCT01244906|Myeloma|myeloma
1381011|NCT01244880|PF-02545920|pf-02545920
1381012|NCT01244880|ketamine|ketamine
1381013|NCT01244880|fMRI|fmri
1381014|NCT01244880|associative Learning|associative learning
1381015|NCT01244854|chronic mental disorders|chronic mental disorders
1381016|NCT01244854|cardiovascular disease|cardiovascular disease
1381017|NCT01244854|behavior change|behavior change
1381018|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
1381019|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1381020|NCT01244841|Discharge|discharge
1381021|NCT01244841|Health status|health status
1381022|NCT01244841|Quality of care|quality of care
1381023|NCT01244815|Bi-polar I disorder|bi-polar i disorder
1381024|NCT01244815|antipsychotic|antipsychotic
1381025|NCT01244815|serotonin|serotonin
1381026|NCT01244815|dopamine|dopamine
1381027|NCT01244815|noradrenalin|noradrenalin
1381028|NCT01244815|histamine|histamine
1381029|NCT01244815|pediatric|pediatric
1381030|NCT01244802|yellow fever vaccine|yellow fever vaccine
1381031|NCT01244789|endometrial cancer|endometrial cancer
1381032|NCT01244789|chemotherapy|chemotherapy
1381033|NCT01244789|carboplatin|carboplatin
1381034|NCT01244789|paclitaxel|paclitaxel
1381035|NCT01244789|Stage 1 & 2|stage 1 & 2
1381036|NCT01244789|node-negative|node-negative
1381037|NCT01244789|intermediate risk|intermediate risk
1381038|NCT01244789|high risk|high risk
1381039|NCT01244763|Kidney|kidney
1381040|NCT01244763|Chronic Kidney Disease|chronic kidney disease
1381041|NCT01244763|CKD|ckd
1381042|NCT01244763|Renal|renal
1381043|NCT01244763|Anemia|anemia
1381044|NCT01244763|Oral anemia treatment|oral anemia treatment
1381045|NCT01244763|Hemoglobin levels|hemoglobin levels
1381046|NCT01244763|Erythropoietin|erythropoietin
1381047|NCT01244763|Blood count|blood count
1381048|NCT01244763|Predialysis|predialysis
1381049|NCT01244763|Pre-dialysis|pre-dialysis
1381050|NCT01244763|Hb|hb
1381051|NCT01244763|Non-dialysis|non-dialysis
1381052|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
1381053|NCT01244737|Brain neoplasms|brain neoplasms
1381054|NCT01244737|Children|children
1381055|NCT01244737|Positron-Emission Tomography|positron-emission tomography
1381056|NCT01244737|18F-FLT|18f-flt
1381057|NCT01244711|Major Depression|major depression
1381058|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
1381059|NCT01244711|Benzodiazepine|benzodiazepine
1381060|NCT01244711|Quetiapine|quetiapine
1381061|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
1381062|NCT01244685|bowel resection|bowel resection
1381063|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
1381064|NCT01244685|fluid management|fluid management
1381065|NCT01244672|Hemorrhoids|hemorrhoids
1381066|NCT01244672|THD|thd
1381067|NCT01244672|Ferguson|ferguson
1381068|NCT01244659|Tacrolimus|tacrolimus
1381069|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
1381070|NCT01244659|Kidney transplantation|kidney transplantation
1381071|NCT01244646|Diabetes Mellitus|diabetes mellitus
1381072|NCT01244646|Type 2|type 2
1381073|NCT01244646|DMT2|dmt2
1381074|NCT01244646|T2DM|t2dm
1381075|NCT01244646|metformin|metformin
1381076|NCT01244646|sulfonylurea|sulfonylurea
1381077|NCT01244646|hypoglycemia|hypoglycemia
1381078|NCT01244646|weight|weight
1381079|NCT01244646|quality of life|quality of life
1381080|NCT01244646|compliance|compliance
1381081|NCT01244633|Tourette's|tourette's
1381082|NCT01244633|Ecopipam|ecopipam
1381083|NCT01244633|Dopamine receptors|dopamine receptors
1381084|NCT01244633|Efficacy|efficacy
1381085|NCT01244633|Safety|safety
1381086|NCT01244633|Adults|adults
1381087|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
1381088|NCT01244594|Spinal Cord Injury|spinal cord injury
1381089|NCT01244594|Cycling|cycling
1381090|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
1381091|NCT01244581|middle ear effusion|middle ear effusion
1381092|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
1381093|NCT01244581|tympanometry|tympanometry
1381094|NCT01244568|Prostate Cancer|prostate cancer
1381095|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
1381096|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
1381097|NCT01244542|Schizophrenia|schizophrenia
1381098|NCT01244542|DSM IV criteria|dsm iv criteria
1381099|NCT01244542|Pain insensitivity|pain insensitivity
1381100|NCT01244542|Painful perception|painful perception
1381101|NCT01244542|Opioid receptors|opioid receptors
1381102|NCT01244490|ADHD|adhd
1381103|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
1381104|NCT01244477|Trust|trust
1381105|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1381106|NCT01244464|Poliomyelitis|poliomyelitis
1381107|NCT01244464|IMOVAX POLIO™|imovax polio™
1381108|NCT01244464|Polio|polio
1381109|NCT01244451|CLL|cll
1381110|NCT01244451|relapsed|relapsed
1381111|NCT01244451|refractory|refractory
1381112|NCT01244451|Bendamustine|bendamustine
1381113|NCT01244451|Ofatumumab|ofatumumab
1381114|NCT01244438|endometrial cancer|endometrial cancer
1381115|NCT01244438|FGFR2 mutations|fgfr2 mutations
1381116|NCT01244412|Fundus photography|fundus photography
1381117|NCT01244399|inositol|inositol
1381118|NCT01244399|caffeine|caffeine
1381119|NCT01244399|NTDs|ntds
1381120|NCT01244386|Computed tomography|computed tomography
1381121|NCT01244386|Iterative reconstruction|iterative reconstruction
1381122|NCT01244386|Automatic tube current modulation|automatic tube current modulation
1381123|NCT01244386|Crohn's disease|crohn's disease
1381124|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
1381125|NCT01244386|Radiation dose optimization|radiation dose optimization
1381126|NCT01244386|C reactive protein|c reactive protein
1381127|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
1381128|NCT01244373|posterior capsule opacification|posterior capsule opacification
1381129|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
1381130|NCT01244360|resveratrol|resveratrol
1381131|NCT01244360|insulin|insulin
1381132|NCT01244360|inflammation|inflammation
1381133|NCT01244360|cognition|cognition
1381134|NCT01244360|metabolism|metabolism
1381135|NCT01244347|folic acid|folic acid
1381136|NCT01244347|malformations|malformations
1381137|NCT01244347|prevention|prevention
1381138|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
1381139|NCT01244321|End stage heart failure|end stage heart failure
1381140|NCT01244321|heart transplantation|heart transplantation
1381141|NCT01244321|Ventricular assist device|ventricular assist device
1381142|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
1381422|NCT01242982|closed|closed
1381143|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
1381144|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
1381145|NCT01244308|LV pacing configuration|lv pacing configuration
1381146|NCT01244308|CRT|crt
1381147|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1381148|NCT01244308|Heart failure|heart failure
1381149|NCT01244295|Grief|grief
1381150|NCT01244295|Bereavement|bereavement
1381151|NCT01244295|Psychotherapy|psychotherapy
1381152|NCT01244295|Randomized controlled trial|randomized controlled trial
1381153|NCT01244295|Treatment study|treatment study
1381154|NCT01244282|brain imaging|brain imaging
1381155|NCT01244269|Parkinson's disease|parkinson's disease
1381156|NCT01244269|Methylphenidate|methylphenidate
1381157|NCT01244269|Non motor symptoms|non motor symptoms
1381158|NCT01244269|Postural control|postural control
1381159|NCT01244243|stroke|stroke
1381160|NCT01244243|rehabilitation|rehabilitation
1381161|NCT01244204|vitamin D deficiency|vitamin d deficiency
1381162|NCT01244204|tuberculin sin test|tuberculin sin test
1381163|NCT01244204|immunity|immunity
1381164|NCT01244204|tuberculosis|tuberculosis
1381165|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
1381166|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
1381167|NCT01244191|c-Met inhibitor|c-met inhibitor
1381168|NCT01244178|Sepsis|sepsis
1381169|NCT01244178|Insulin|insulin
1381170|NCT01244139|BIIB033|biib033
1381171|NCT01244139|Multiple Sclerosis|multiple sclerosis
1381172|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
1381173|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
1381174|NCT01244139|remyelination|remyelination
1381175|NCT01244139|myelin repair|myelin repair
1381176|NCT01244139|Multiple ascending dose|multiple ascending dose
1381177|NCT01244139|Secondary progessive MS|secondary progessive ms
1381178|NCT01244126|otitis media|otitis media
1381179|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
1381180|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
1381181|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
1381182|NCT01244087|Quality of life|quality of life
1381183|NCT01244087|breast cancer|breast cancer
1381184|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
1381185|NCT01244035|High blood pressure|high blood pressure
1381186|NCT01244022|Colorectal cancer|colorectal cancer
1381187|NCT01244022|Surgical stress response|surgical stress response
1381188|NCT01244022|interleukins|interleukins
1381189|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
1381190|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
1381191|NCT01243970|Spinal anaesthesia|spinal anaesthesia
1381192|NCT01243970|phenylephrine|phenylephrine
1381193|NCT01243970|ephedrine|ephedrine
1381194|NCT01243970|ECG changes|ecg changes
1381195|NCT01243970|Caesarean delivery|caesarean delivery
1381196|NCT01243970|Myocardial ischaemia|myocardial ischaemia
1381197|NCT01243970|Cardiac output|cardiac output
1381198|NCT01243970|hypotension|hypotension
1381199|NCT01243944|INCB018424|incb018424
1381200|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
1381201|NCT01243931|Optical coherence tomography|optical coherence tomography
1381202|NCT01243931|Corneal opacity|corneal opacity
1381203|NCT01243931|Corneal dystrophy|corneal dystrophy
1381204|NCT01243918|Acute respiratory failure|acute respiratory failure
1567138|NCT00509847|Bacteraemia|bacteraemia
1381205|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
1381206|NCT01243918|Non invasive ventilation|non invasive ventilation
1381207|NCT01243918|High concentration mask|high concentration mask
1381208|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
1381209|NCT01243879|fasting|fasting
1381210|NCT01243879|starvation|starvation
1381211|NCT01243879|calorie restriction|calorie restriction
1381212|NCT01243879|fMRI|fmri
1381213|NCT01243840|Central aortic pressure|central aortic pressure
1381214|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
1381215|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
1381216|NCT01243840|Vascular aging|vascular aging
1381217|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
1381218|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
1381219|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
1381220|NCT01243814|hyaluronate|hyaluronate
1381221|NCT01243814|hyaluronic acid|hyaluronic acid
1381222|NCT01243814|viscosupplementation|viscosupplementation
1381223|NCT01243801|chronic pain|chronic pain
1381224|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
1381225|NCT01243801|hyperalgesia|hyperalgesia
1381226|NCT01243801|ketamine|ketamine
1381227|NCT01243801|quantitative sensory testing|quantitative sensory testing
1381228|NCT01243788|COPD|copd
1381229|NCT01243788|Seretide|seretide
1381230|NCT01243788|Combivent|combivent
1381231|NCT01243788|effect and safety|effect and safety
1381423|NCT01242956|stroke|stroke
1381232|NCT01243788|Twelve weeks|twelve weeks
1381233|NCT01243775|NSCLC|nsclc
1381234|NCT01243762|Colorectal cancer|colorectal cancer
1381235|NCT01243762|Solid tumors|solid tumors
1381236|NCT01243762|Ovarian cancer|ovarian cancer
1381237|NCT01243762|Fallopian tube cancer|fallopian tube cancer
1381238|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
1381239|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
1381240|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
1381241|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
1381242|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
1381243|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
1381244|NCT01243749|Stent Thrombosis|stent thrombosis
1381245|NCT01243749|Restenotic Lesion|restenotic lesion
1381246|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1381247|NCT01243749|Real-world|real-world
1381248|NCT01243736|anemic|anemic
1381249|NCT01243736|bleeding|bleeding
1381250|NCT01243736|blood in stool|blood in stool
1381251|NCT01243736|abdomen pain|abdomen pain
1381252|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
1381253|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
1381254|NCT01243723|Dyschesia treatment|dyschesia treatment
1381255|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
1381256|NCT01243723|Quality of life|quality of life
1381257|NCT01243723|Bowel function index|bowel function index
1381258|NCT01243697|Desogestrel|desogestrel
1381259|NCT01243697|Chemosensitivity|chemosensitivity
1381260|NCT01243684|Spinal cord|spinal cord
1381261|NCT01243684|cervical spondylosis|cervical spondylosis
1381262|NCT01243684|myelopathy|myelopathy
1381263|NCT01243671|Behçet's, intestinal|behçet's, intestinal
1381264|NCT01243658|Oxytocin|oxytocin
1381265|NCT01243658|BPD|bpd
1381266|NCT01243658|Borderline|borderline
1381267|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
1381268|NCT01243632|chemotherapy|chemotherapy
1381269|NCT01243632|gemcitabine|gemcitabine
1381270|NCT01243632|cisplatin|cisplatin
1381271|NCT01243632|long infusion|long infusion
1381272|NCT01243619|PET|pet
1381273|NCT01243619|CT|ct
1381274|NCT01243619|radiotherapy|radiotherapy
1381275|NCT01243606|Anxiety|anxiety
1381276|NCT01243606|Depression|depression
1381277|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
1381278|NCT01243606|Panic Disorder|panic disorder
1381279|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
1381280|NCT01243606|Social Anxiety Disorder|social anxiety disorder
1381281|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
1381282|NCT01243606|CBT|cbt
1381283|NCT01243593|pediatrics|pediatrics
1381284|NCT01243593|anesthesia|anesthesia
1381285|NCT01243593|pyeloplasty|pyeloplasty
1381286|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
1381287|NCT01243593|Regional Anesthesia|regional anesthesia
1381288|NCT01243580|PK and safety|pk and safety
1381289|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
1381290|NCT01243554|Exercise training|exercise training
1381291|NCT01243554|Pregnancy|pregnancy
1381292|NCT01243554|Obesity|obesity
1381293|NCT01243528|Malnutrition|malnutrition
1381294|NCT01243528|Infection|infection
1381295|NCT01243528|Neurological|neurological
1381296|NCT01243515|Central Venous Pressure|central venous pressure
1381297|NCT01243515|Kidney Diseases|kidney diseases
1381298|NCT01243515|Chronic Kidney Disease|chronic kidney disease
1381299|NCT01243515|Healthy Subjects|healthy subjects
1381300|NCT01243515|Non-Invasive Monitor|non-invasive monitor
1381302|NCT01243489|compliance|compliance
1381303|NCT01243489|compliance supporting measures|compliance supporting measures
1381304|NCT01243489|complete cytogenetic response|complete cytogenetic response
1381305|NCT01243489|mayor molecular remission|mayor molecular remission
1381306|NCT01243489|Philadelphia chromosome|philadelphia chromosome
1381307|NCT01243489|BCR-ABL|bcr-abl
1381308|NCT01243489|Imatinib|imatinib
1381309|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1381310|NCT01243489|smart blister|smart blister
1381311|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
1381312|NCT01243476|5q deletion|5q deletion
1381313|NCT01243476|anemia|anemia
1381314|NCT01243476|lenalidomide|lenalidomide
1381315|NCT01243476|red blood cells transfusion|red blood cells transfusion
1381316|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
1381317|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
1381318|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1381319|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1381320|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1381321|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
1381322|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
1381323|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
1381324|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
1381325|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
1381326|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
1381620|NCT01242098|Asthma|asthma
1381327|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
1381328|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
1381329|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
1381330|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1381331|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1381332|NCT01243385|stage III prostate cancer|stage iii prostate cancer
1381333|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
1381334|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
1381335|NCT01243372|recurrent colon cancer|recurrent colon cancer
1381336|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
1381337|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
1381338|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
1381339|NCT01243372|stage IVA colon cancer|stage iva colon cancer
1381340|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
1381341|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
1381342|NCT01243372|stage III rectal cancer|stage iii rectal cancer
1381343|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
1381344|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
1381345|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
1381346|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
1381347|NCT01243281|hepatitis B|hepatitis b
1381348|NCT01243281|HBeAg|hbeag
1381349|NCT01243281|pegylated interferon|pegylated interferon
1381350|NCT01243281|entecavir|entecavir
1381351|NCT01243255|hypercholesterolemia|hypercholesterolemia
1381352|NCT01243255|low density lipoprotein|low density lipoprotein
1381353|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
1381354|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
1381355|NCT01243216|Pregnancy|pregnancy
1381356|NCT01243216|Labor|labor
1381357|NCT01243216|Epidural Analgesia|epidural analgesia
1381358|NCT01243216|Epidural Anesthesia|epidural anesthesia
1381359|NCT01243216|Spinal Anesthesia|spinal anesthesia
1381360|NCT01243216|Ultrasound|ultrasound
1381361|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
1381362|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
1381363|NCT01243216|Cesarean delivery|cesarean delivery
1381364|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
1381365|NCT01243190|leukemia|leukemia
1381366|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
1381367|NCT01243190|SLL|sll
1381368|NCT01243190|CLL|cll
1381369|NCT01243190|ofatumumab|ofatumumab
1381370|NCT01243190|untreated|untreated
1381371|NCT01243190|early stage|early stage
1381372|NCT01243190|high-risk|high-risk
1381373|NCT01243177|Lacosamide|lacosamide
1381374|NCT01243177|Vimpat®|vimpat®
1381375|NCT01243177|Epilepsy|epilepsy
1381376|NCT01243177|Monotherapy|monotherapy
1381377|NCT01243177|Velocity|velocity
1381378|NCT01243164|confidence|confidence
1381379|NCT01243164|wheelchair performance|wheelchair performance
1381380|NCT01243151|Hypercholesterolemia|hypercholesterolemia
1381381|NCT01243151|Dyslipidemia|dyslipidemia
1381382|NCT01243151|LDL|ldl
1381383|NCT01243151|High Cholesterol|high cholesterol
1381384|NCT01243151|Japanese Volunteers|japanese volunteers
1381385|NCT01243151|PF-04950615|pf-04950615
1381386|NCT01243151|RN316|rn316
1381387|NCT01243138|Cross-sectional|cross-sectional
1381388|NCT01243138|epidemiological study|epidemiological study
1567139|NCT00509834|hLF1-11|hlf1-11
1502908|NCT00766506|PCA|pca
1381389|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
1381390|NCT01243125|Blockage|blockage
1381391|NCT01243125|Encrustation|encrustation
1381392|NCT01243125|Catheter|catheter
1381393|NCT01243125|Spinal Cord Injury|spinal cord injury
1381394|NCT01243125|SCI|sci
1381395|NCT01243086|Macular Degeneration|macular degeneration
1381396|NCT01243086|Age-related macular degeneration|age-related macular degeneration
1381397|NCT01243086|Anti-inflammatory|anti-inflammatory
1381398|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
1381399|NCT01243086|Lucentis|lucentis
1381400|NCT01243086|Ranibizumab|ranibizumab
1381401|NCT01243086|OZURDEX|ozurdex
1381402|NCT01243086|Dexamethasone|dexamethasone
1381403|NCT01243086|Vision loss|vision loss
1381404|NCT01243073|imetelstat|imetelstat
1381405|NCT01243073|imetelstat sodium|imetelstat sodium
1381406|NCT01243073|GRN163L|grn163l
1381407|NCT01243073|telomerase inhibitor|telomerase inhibitor
1381408|NCT01243073|telomerase|telomerase
1381409|NCT01243073|essential thrombocytosis|essential thrombocytosis
1381410|NCT01243073|essential thrombocythemia|essential thrombocythemia
1381411|NCT01243073|ET|et
1381412|NCT01243073|polycythemia vera|polycythemia vera
1381413|NCT01243073|PV|pv
1381414|NCT01243060|Sleep Aid|sleep aid
1381415|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
1381416|NCT01243008|Lyme disease|lyme disease
1381417|NCT01243008|Borreliosis|borreliosis
1381418|NCT01243008|Azithromycin|azithromycin
1381419|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
1381420|NCT01242982|subcapital|subcapital
1381421|NCT01242982|shaft|shaft
1381424|NCT01242956|video-based training|video-based training
1381425|NCT01242956|rehabilitation|rehabilitation
1381426|NCT01242943|I131|i131
1381427|NCT01242943|L19|l19
1381428|NCT01242943|antibody|antibody
1381429|NCT01242943|monoclonal|monoclonal
1381430|NCT01242943|tumour targeting|tumour targeting
1381431|NCT01242943|radioimmunotherapy|radioimmunotherapy
1381432|NCT01242943|cancer|cancer
1381433|NCT01242930|imetelstat|imetelstat
1381434|NCT01242930|imetelstat sodium|imetelstat sodium
1381435|NCT01242930|GRN163L|grn163l
1381436|NCT01242930|telomerase inhibitor|telomerase inhibitor
1381437|NCT01242930|telomerase inhibition|telomerase inhibition
1381438|NCT01242930|multiple myeloma|multiple myeloma
1381439|NCT01242930|myeloma|myeloma
1381440|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
1381441|NCT01242904|dialysis solutions|dialysis solutions
1381442|NCT01242904|renal replacement therapy|renal replacement therapy
1381443|NCT01242904|peritoneal dialysis|peritoneal dialysis
1381444|NCT01242904|bimodal solution|bimodal solution
1381445|NCT01242904|glucose sparing therapy|glucose sparing therapy
1381446|NCT01242891|Ventricular Assist Device|ventricular assist device
1381447|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
1381448|NCT01242878|HbSS|hbss
1381449|NCT01242878|Sickle cell anemia|sickle cell anemia
1381450|NCT01242878|HbSC|hbsc
1381451|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
1381452|NCT01242878|Hemoglobinopathy|hemoglobinopathy
1381453|NCT01242878|Hemoglobinopathies|hemoglobinopathies
1381454|NCT01242865|Stress|stress
1381455|NCT01242865|Anxiety|anxiety
1381456|NCT01242865|Resilience|resilience
1381457|NCT01242865|Mindfulness|mindfulness
1381458|NCT01242865|Quality of Life|quality of life
1381459|NCT01242865|Stress Management|stress management
1381460|NCT01242852|Hysteroscopy|hysteroscopy
1381461|NCT01242852|infertility|infertility
1381462|NCT01242852|subfertility|subfertility
1381463|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
1381464|NCT01242852|intracavitary pathology|intracavitary pathology
1381465|NCT01242852|IVF|ivf
1381466|NCT01242852|ICSI|icsi
1381467|NCT01242852|in vitro fertilization|in vitro fertilization
1381468|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
1381469|NCT01242839|CACICOL20|cacicol20
1381470|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
1381471|NCT01242813|fevers|fevers
1381472|NCT01242813|rashes|rashes
1381473|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
1381474|NCT01242813|periorbital edema|periorbital edema
1381475|NCT01242813|TNFR1|tnfr1
1381476|NCT01242800|male breast cancer|male breast cancer
1381477|NCT01242800|stage IV breast cancer|stage iv breast cancer
1381478|NCT01242787|Chronic hepatitis B|chronic hepatitis b
1381479|NCT01242787|LB80380|lb80380
1381480|NCT01242787|treatment-naive|treatment-naive
1381481|NCT01242787|entecavir|entecavir
1381482|NCT01242787|Extension|extension
1381483|NCT01242774|AML|aml
1381484|NCT01242774|bone marrow|bone marrow
1381485|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
1381486|NCT01242774|acute leukemia|acute leukemia
1381487|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
1381489|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
1381490|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
1381491|NCT01242735|OCD|ocd
1381492|NCT01242735|Exercise|exercise
1381493|NCT01242735|Aerobic Exercise|aerobic exercise
1381494|NCT01242722|Heart failure|heart failure
1381495|NCT01242722|auto threshold|auto threshold
1381496|NCT01242722|pacing|pacing
1381497|NCT01242722|CRT-D recipients|crt-d recipients
1381498|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
1381499|NCT01242696|Drug Eluting Stents|drug eluting stents
1381500|NCT01242696|Observational|observational
1381501|NCT01242696|All-Comers|all-comers
1381502|NCT01242657|Tobacco Use Cessation|tobacco use cessation
1381503|NCT01242657|Youth Tobacco Use|youth tobacco use
1381504|NCT01242657|Physical Activity|physical activity
1381505|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
1381506|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
1381507|NCT01242605|unresectable|unresectable
1381508|NCT01242605|advanced|advanced
1381509|NCT01242566|Temozolomide|temozolomide
1381510|NCT01242566|Elderly|elderly
1381511|NCT01242566|Glioblastoma|glioblastoma
1381512|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
1381513|NCT01242540|Pain|pain
1381514|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1381515|NCT01242527|dyslipidemia|dyslipidemia
1381516|NCT01242527|hyperlipidemia|hyperlipidemia
1381517|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
1381518|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
1381519|NCT01242514|OSKIRA|oskira
1381520|NCT01242514|Fostamatinib|fostamatinib
1381521|NCT01242501|Prevention|prevention
1381522|NCT01242501|Counseling|counseling
1381523|NCT01242501|Behavioral interventions|behavioral interventions
1381524|NCT01242501|HIV risk reduction|hiv risk reduction
1381525|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
1381526|NCT01242488|CDP6038|cdp6038
1381527|NCT01242488|Interleukin-6|interleukin-6
1381528|NCT01242488|Tocilizumab|tocilizumab
1381529|NCT01242475|tuberculosis|tuberculosis
1381530|NCT01242475|rdESAT-6|rdesat-6
1381531|NCT01242475|CFP-10|cfp-10
1381532|NCT01242475|skin test|skin test
1381533|NCT01242475|diagnostic test|diagnostic test
1381534|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
1381535|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
1381536|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
1381537|NCT01242462|Preterm Newborn Infant|preterm newborn infant
1381538|NCT01242462|Mean Airway Pressure|mean airway pressure
1381539|NCT01242462|Mean Arterial Pressure|mean arterial pressure
1381540|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
1381541|NCT01242449|Breast cancer|breast cancer
1381542|NCT01242449|Metastatic|metastatic
1381543|NCT01242449|HER2 positive|her2 positive
1381544|NCT01242449|vinorelbine|vinorelbine
1381545|NCT01242436|Ovarian Cancer|ovarian cancer
1381546|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
1381547|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
1381548|NCT01242436|therapy|therapy
1381549|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
1381550|NCT01242410|Short cervix|short cervix
1381551|NCT01242410|Preterm birth|preterm birth
1381552|NCT01242410|Cervical pessary|cervical pessary
1381553|NCT01242410|Twins|twins
1381554|NCT01242371|Schizophrenia|schizophrenia
1381555|NCT01242371|Schizoaffective|schizoaffective
1381556|NCT01242371|Probiotic supplements|probiotic supplements
1381557|NCT01242371|Gliadin|gliadin
1381558|NCT01242371|Casein|casein
1381559|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
1381560|NCT01242345|Hypoxemia|hypoxemia
1381561|NCT01242345|Capnography|capnography
1381562|NCT01242345|Integrated pulmonary index|integrated pulmonary index
1381563|NCT01242345|Sedation|sedation
1381564|NCT01242345|Propofol|propofol
1381565|NCT01242345|Safety|safety
1381566|NCT01242332|perioperative|perioperative
1381567|NCT01242332|pregabalin|pregabalin
1381568|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
1381569|NCT01242332|postoperative pain management|postoperative pain management
1381570|NCT01242319|quality improvement|quality improvement
1381571|NCT01242319|implementation trials|implementation trials
1381572|NCT01242319|cholesterol guidelines|cholesterol guidelines
1381573|NCT01242319|patient activation|patient activation
1381574|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
1381575|NCT01242280|Acute variceal bleeding|acute variceal bleeding
1381576|NCT01242280|Massive bleeding|massive bleeding
1381577|NCT01242280|Liver Cirrhosis|liver cirrhosis
1381578|NCT01242280|Esophageal tamponade|esophageal tamponade
1381579|NCT01242280|Esophageal stent|esophageal stent
1381580|NCT01242267|multiple myeloma|multiple myeloma
1381581|NCT01242267|transplant|transplant
1381582|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
1381583|NCT01242254|KH902|kh902
1381584|NCT01242254|age-related macular degeneration|age-related macular degeneration
1381585|NCT01242254|choroidal neovascularization|choroidal neovascularization
1381586|NCT01242254|intravitreal injection|intravitreal injection
1381587|NCT01242254|multiple injections|multiple injections
1381588|NCT01242241|Propofol|propofol
1381589|NCT01242241|Childhood obesity|childhood obesity
1381590|NCT01242241|Pharmacodynamics|pharmacodynamics
1381591|NCT01242228|ASP1941|asp1941
1381592|NCT01242228|Diabetes mellitus|diabetes mellitus
1381593|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
1381594|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
1381595|NCT01242228|long-term safety|long-term safety
1381596|NCT01242215|ASP1941|asp1941
1381597|NCT01242215|Diabetes mellitus|diabetes mellitus
1381598|NCT01242215|sulfonylurea|sulfonylurea
1381599|NCT01242202|ASP1941|asp1941
1381600|NCT01242202|Diabetes mellitus|diabetes mellitus
1381601|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
1381602|NCT01242202|long-term safety|long-term safety
1381603|NCT01242150|Acute Respiratory Failure|acute respiratory failure
1381604|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
1381605|NCT01242150|Infants|infants
1381606|NCT01242150|Helmet|helmet
1381607|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
1381608|NCT01242111|MPS IV Type A|mps iv type a
1381609|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1381610|NCT01242111|MPS IVA|mps iva
1381611|NCT01242111|Morquio A Syndrome|morquio a syndrome
1381612|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
1381614|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1381615|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
1381616|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
1381617|NCT01242111|GALNS|galns
1381618|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
1381619|NCT01242111|ERT|ert
1381621|NCT01242098|Combination therapy|combination therapy
1381622|NCT01242098|Primary care management|primary care management
1381623|NCT01242098|Switch|switch
1381624|NCT01242098|ICS/LABA|ics/laba
1381625|NCT01242098|Fostair|fostair
1381626|NCT01242098|Seretide|seretide
1381627|NCT01242085|alignment|alignment
1381628|NCT01242072|malignancy|malignancy
1381629|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
1381630|NCT01242072|non small cell lung cancer|non small cell lung cancer
1381631|NCT01242072|small cell lung cancer|small cell lung cancer
1381632|NCT01242072|testicular cancer|testicular cancer
1381633|NCT01242072|thymoma|thymoma
1381634|NCT01242072|ovarian cancer|ovarian cancer
1381635|NCT01242072|osteosarcoma|osteosarcoma
1381636|NCT01242059|Obesity|obesity
1381637|NCT01242059|Food intake regulation|food intake regulation
1381638|NCT01242059|blood glucose regulation|blood glucose regulation
1381639|NCT01242059|protein|protein
1381640|NCT01242059|fiber|fiber
1381641|NCT01242059|pulses|pulses
1381642|NCT01242059|yellow peas|yellow peas
1381643|NCT01242046|female sexual arousal|female sexual arousal
1381644|NCT01242033|red raspberries|red raspberries
1381645|NCT01242033|post-prandial|post-prandial
1381646|NCT01242033|oxidative stress|oxidative stress
1381647|NCT01242033|antioxidants|antioxidants
1381648|NCT01242033|polyphenols|polyphenols
1381649|NCT01242033|vitamin C|vitamin c
1381650|NCT01242033|acute dietary intervention|acute dietary intervention
1381651|NCT01242007|Myotonic dystrophy|myotonic dystrophy
1381652|NCT01242007|Steinert's disease|steinert's disease
1381653|NCT01241981|Breast|breast
1381654|NCT01241981|Cancer|cancer
1381655|NCT01241981|Digital|digital
1381656|NCT01241981|Mammography|mammography
1381657|NCT01241981|Tomosynthesis|tomosynthesis
1381658|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1381659|NCT01241968|Myocardial Ischemia|myocardial ischemia
1381660|NCT01241968|Refractory Angina|refractory angina
1381661|NCT01241955|CPR|cpr
1381662|NCT01241942|Lung Transplant|lung transplant
1381663|NCT01241942|Emphysema|emphysema
1381664|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1381665|NCT01241942|Cystic Fibrosis|cystic fibrosis
1381666|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
1381667|NCT01241942|Bronchiectasis|bronchiectasis
1381668|NCT01241942|Sarcoidosis|sarcoidosis
1381669|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
1381670|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1381671|NCT01241929|advanced cancer|advanced cancer
1381672|NCT01241916|elbow, splint|elbow, splint
1381673|NCT01241903|Platelet activation|platelet activation
1381674|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
1381675|NCT01241890|Cystic Fibrosis|cystic fibrosis
1381676|NCT01241890|Children|children
1381677|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
1381678|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
1381679|NCT01241890|Volatile Organic Compounds|volatile organic compounds
1503230|NCT00765284|HDL|hdl
1381680|NCT01241890|Home monitoring|home monitoring
1381681|NCT01241890|Quality of life|quality of life
1381682|NCT01241838|Heart failure|heart failure
1381683|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
1381684|NCT01241838|Diastolic dysfunction|diastolic dysfunction
1381685|NCT01241825|capsule endoscopy|capsule endoscopy
1381686|NCT01241825|chewing gum|chewing gum
1381687|NCT01241825|small bowel transit time|small bowel transit time
1381688|NCT01241812|knee|knee
1381689|NCT01241812|osteoarthritis|osteoarthritis
1381690|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
1381691|NCT01241799|pancreatic biopsy|pancreatic biopsy
1381692|NCT01241799|randomized|randomized
1381693|NCT01241799|single blind|single blind
1381694|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
1381695|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
1381696|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1381697|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
1381698|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
1381699|NCT01241773|TMC435-C123|tmc435-c123
1381700|NCT01241773|TMC435|tmc435
1381701|NCT01241773|HCV|hcv
1381702|NCT01241773|Hepatitis C|hepatitis c
1381703|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
1381704|NCT01241760|VX-950-C211|vx-950-c211
1381705|NCT01241760|VX-950|vx-950
1381706|NCT01241760|IL28B|il28b
1381707|NCT01241760|Telaprevir|telaprevir
1381708|NCT01241760|Hepatitis C|hepatitis c
1381709|NCT01241760|BID|bid
1381710|NCT01241760|Q8h|q8h
1381711|NCT01241760|SOC|soc
1381712|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
1381713|NCT01241721|Breast Diseases|breast diseases
1381714|NCT01241721|Breast Neoplasms|breast neoplasms
1381715|NCT01241721|Neoplasms|neoplasms
1381716|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
1382091|NCT01240291|glutamine|glutamine
1381717|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
1381718|NCT01241682|Mesothelioma|mesothelioma
1381719|NCT01241682|Dendritic cells|dendritic cells
1381720|NCT01241682|Cyclophosphamide|cyclophosphamide
1381721|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
1381722|NCT01241682|Immunotherapy|immunotherapy
1381723|NCT01241656|Prostate cancer|prostate cancer
1381724|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
1381725|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
1381726|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
1381727|NCT01241643|interleukin-7|interleukin-7
1381728|NCT01241643|immune-based therapies|immune-based therapies
1381729|NCT01241643|HIV|hiv
1381730|NCT01241643|infectious disease|infectious disease
1381731|NCT01241643|immune non-responders|immune non-responders
1381732|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
1381733|NCT01241630|Spinal cord injury|spinal cord injury
1381734|NCT01241630|Xiao Procedure|xiao procedure
1381735|NCT01241617|Lung disease|lung disease
1381736|NCT01241617|Lobectomy|lobectomy
1381737|NCT01241617|Pulmonary resection|pulmonary resection
1381738|NCT01241591|CP-690,550|cp-690,550
1381739|NCT01241591|Etanercept|etanercept
1381740|NCT01241591|Moderate|moderate
1381741|NCT01241591|Severe|severe
1381742|NCT01241591|Chronic|chronic
1381743|NCT01241591|Plaque|plaque
1381744|NCT01241591|Psoriasis|psoriasis
1381745|NCT01241591|Efficacy|efficacy
1381746|NCT01241591|Safety|safety
1381747|NCT01241591|Tofacitinib|tofacitinib
1381748|NCT01241591|Xeljanz|xeljanz
1381749|NCT01241591|OPT Compare|opt compare
1381750|NCT01241591|OPT|opt
1381751|NCT01241591|head-to-head|head-to-head
1381752|NCT01241591|non-inferiority|non-inferiority
1381753|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
1381754|NCT01241591|short-term|short-term
1381755|NCT01241591|Itch|itch
1381756|NCT01241591|Pruritus|pruritus
1381757|NCT01241591|Plaque psoriasis|plaque psoriasis
1381758|NCT01241591|DLQI|dlqi
1381759|NCT01241578|Obesity|obesity
1381760|NCT01241578|Behavior Therapy|behavior therapy
1381761|NCT01241578|Lifestyle|lifestyle
1381762|NCT01241578|Technology|technology
1381763|NCT01241578|Cellular Phone|cellular phone
1381764|NCT01241565|lung cancer|lung cancer
1381765|NCT01241565|lobectomy|lobectomy
1381766|NCT01241565|wedge resection|wedge resection
1381767|NCT01241552|Clostridium difficile|clostridium difficile
1381768|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
1381769|NCT01241552|vancomycin|vancomycin
1381770|NCT01241552|metronidazole|metronidazole
1381771|NCT01241552|monoclonal antibody|monoclonal antibody
1381772|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
1381773|NCT01241526|COPD|copd
1381774|NCT01241526|COMET|comet
1381775|NCT01241526|Disease management|disease management
1381776|NCT01241513|glutathione|glutathione
1381777|NCT01241513|redox status|redox status
1381778|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
1381779|NCT01241513|ventilation|ventilation
1381780|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
1381781|NCT01241500|MDS|mds
1381782|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
1381783|NCT01241461|Advanced Cancer|advanced cancer
1381784|NCT01241461|Metastatic Cancer|metastatic cancer
1381785|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
1381786|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1381787|NCT01241422|Asthma|asthma
1381788|NCT01241422|Mild asthma|mild asthma
1381789|NCT01241422|Singulair|singulair
1381790|NCT01241422|JNJ 40929837|jnj 40929837
1381791|NCT01241422|Montelukast|montelukast
1381792|NCT01241409|Healthy|healthy
1381793|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
1381794|NCT01241409|Rabeprazole sodium|rabeprazole sodium
1381795|NCT01241409|Pharmacokinetics|pharmacokinetics
1381796|NCT01241409|Bioequivalence|bioequivalence
1381797|NCT01241409|Safety|safety
1381798|NCT01241396|Multiple Myeloma|multiple myeloma
1381799|NCT01241396|observational|observational
1381800|NCT01241396|survey|survey
1381801|NCT01241396|non-interventional|non-interventional
1381802|NCT01241396|international|international
1381803|NCT01241396|epidemiology|epidemiology
1381804|NCT01241396|treatment|treatment
1381805|NCT01241396|routine clinical practice|routine clinical practice
1381806|NCT01241396|retrospective|retrospective
1381807|NCT01241396|prospective|prospective
1381808|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
1381809|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1381810|NCT01241383|bosentan|bosentan
1381811|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
1381812|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
1381813|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
1381814|NCT01241370|Insulin-resistance|insulin-resistance
1381815|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
1381816|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
1381817|NCT01241357|Iron|iron
1381818|NCT01241357|Iron overload|iron overload
1381819|NCT01241357|Hepatic iron concentration|hepatic iron concentration
1381820|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
1381821|NCT01241357|Magnetic susceptibility|magnetic susceptibility
1381822|NCT01241357|Susceptometer|susceptometer
1381823|NCT01241344|Adv|adv
1381824|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
1381825|NCT01241344|HSCT|hsct
1381826|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
1381827|NCT01241318|neonate|neonate
1381828|NCT01241318|omphalitis|omphalitis
1381829|NCT01241318|neonatal mortality|neonatal mortality
1381830|NCT01241318|maternal health|maternal health
1381831|NCT01241318|umbilical cord infection|umbilical cord infection
1381832|NCT01241305|Vasculitis|vasculitis
1381833|NCT01241305|CSS|css
1381834|NCT01241305|EGPA|egpa
1381835|NCT01241305|GCA|gca
1381836|NCT01241305|GPA|gpa
1381837|NCT01241305|WG|wg
1381838|NCT01241305|MPA|mpa
1381839|NCT01241305|PAN|pan
1381840|NCT01241305|TAK|tak
1381841|NCT01241279|cataract surgery|cataract surgery
1381842|NCT01241279|intraocular lens|intraocular lens
1381843|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
1381844|NCT01241266|high risk|high risk
1381845|NCT01241266|None-Interventional Study|none-interventional study
1381846|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
1381847|NCT01241253|legumes|legumes
1381848|NCT01241253|glycemic response|glycemic response
1381849|NCT01241253|glucose|glucose
1381850|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
1381851|NCT01241227|liver fibrosis|liver fibrosis
1381852|NCT01241227|survival|survival
1381853|NCT01241227|transient elastography|transient elastography
1381854|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
1381856|NCT01241214|Allergic rhinitis|allergic rhinitis
1381857|NCT01241214|Allergies|allergies
1381858|NCT01241201|intestinal health|intestinal health
1381859|NCT01241201|probiotics|probiotics
1381860|NCT01241201|inflammation|inflammation
1381861|NCT01241201|biomarkers|biomarkers
1381862|NCT01241188|tuberculosis|tuberculosis
1381863|NCT01241188|rdESAT-6|rdesat-6
1381864|NCT01241188|CFP-10|cfp-10
1381865|NCT01241188|skin test|skin test
1381866|NCT01241188|diagnostic test|diagnostic test
1381867|NCT01241175|IOP|iop
1381868|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
1381869|NCT01241175|magnesium sulfate|magnesium sulfate
1381870|NCT01241162|Neuroblastoma|neuroblastoma
1381871|NCT01241162|Ewings sarcoma|ewings sarcoma
1381872|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
1381873|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
1381874|NCT01241162|synovial sarcoma|synovial sarcoma
1381875|NCT01241162|high-risk|high-risk
1381876|NCT01241162|relapsed|relapsed
1381877|NCT01241162|children|children
1567140|NCT00509834|Candida|candida
1503482|NCT00763958|HIV|hiv
1381878|NCT01241149|Nissen fundoplication|nissen fundoplication
1381879|NCT01241149|non-acid reflux disease|non-acid reflux disease
1381880|NCT01241149|anti-reflux surgery|anti-reflux surgery
1381881|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
1381882|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
1381883|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
1381884|NCT01241097|endothelial function|endothelial function
1381885|NCT01241097|statins|statins
1381886|NCT01241097|ezetimibe|ezetimibe
1381887|NCT01241097|pleiotropism|pleiotropism
1381888|NCT01241084|asthmatic children|asthmatic children
1381889|NCT01241071|Lumbar region|lumbar region
1381890|NCT01241071|Pain|pain
1381891|NCT01241071|Fascia|fascia
1381892|NCT01241071|Electromyography|electromyography
1381893|NCT01241071|Goniometry|goniometry
1381894|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
1381895|NCT01241032|DA-8159|da-8159
1381896|NCT01241032|Udenafil|udenafil
1381897|NCT01241032|Alcohol|alcohol
1381898|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
1381899|NCT01241006|Relapse|relapse
1381900|NCT01241006|Corticosteroids|corticosteroids
1381901|NCT01240993|parenting intervention|parenting intervention
1381902|NCT01240993|mother-child relations|mother-child relations
1381903|NCT01240993|substance abuse|substance abuse
1381904|NCT01240993|attachment|attachment
1381905|NCT01240993|child development|child development
1381906|NCT01240967|Phase 1|phase 1
1381907|NCT01240967|healthy volunteers|healthy volunteers
1381908|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
1381909|NCT01240967|pharmacokinetics|pharmacokinetics
1381910|NCT01240967|TC-5214|tc-5214
1381911|NCT01240954|Rhinitis|rhinitis
1381912|NCT01240954|Allergic|allergic
1381913|NCT01240954|Immunotherapy|immunotherapy
1381914|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
1381915|NCT01240902|Valvular Heart Disease|valvular heart disease
1381916|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
1381917|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
1381918|NCT01240902|High Risk|high risk
1381919|NCT01240902|Aortic Valve Replacement|aortic valve replacement
1381920|NCT01240889|Ragweed allergies|ragweed allergies
1381921|NCT01240889|acoustic rhinometry|acoustic rhinometry
1381922|NCT01240889|nasal allergen challenge|nasal allergen challenge
1381923|NCT01240876|Sciatica|sciatica
1381924|NCT01240876|Pain|pain
1381925|NCT01240863|osteoarthritis|osteoarthritis
1381926|NCT01240863|low back pain|low back pain
1381927|NCT01240863|Moderate to Severe Pain|moderate to severe pain
1381928|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
1381929|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
1381930|NCT01240850|Methotrexate|methotrexate
1381931|NCT01240850|Prednisone|prednisone
1381932|NCT01240850|Aorta|aorta
1381933|NCT01240837|glycaemic index|glycaemic index
1381934|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
1381935|NCT01240837|palm sugar|palm sugar
1381936|NCT01240837|diabetes|diabetes
1381937|NCT01240824|bladder cancer|bladder cancer
1381938|NCT01240824|urothelial carcinoma|urothelial carcinoma
1381939|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
1381940|NCT01240824|ureter|ureter
1381941|NCT01240811|intrauterine device|intrauterine device
1381942|NCT01240811|IUD|iud
1381943|NCT01240811|levonorgestrel|levonorgestrel
1381944|NCT01240811|copper|copper
1381945|NCT01240811|CD4|cd4
1381946|NCT01240811|CCR5|ccr5
1381947|NCT01240811|microflora|microflora
1381948|NCT01240798|Depression|depression
1381949|NCT01240798|Anxiety|anxiety
1381950|NCT01240798|Coronary disease|coronary disease
1381951|NCT01240785|gestational diabetes|gestational diabetes
1381952|NCT01240785|metformin|metformin
1381953|NCT01240785|insulin|insulin
1381954|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
1381955|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1381956|NCT01240759|Metformin|metformin
1381957|NCT01240746|Influenza|influenza
1381958|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
1381959|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
1381960|NCT01240746|Influenza viruses|influenza viruses
1381961|NCT01240746|Fluzone®|fluzone®
1381962|NCT01240720|I131|i131
1381963|NCT01240720|F16|f16
1381964|NCT01240720|antibody|antibody
1381965|NCT01240720|monoclonal|monoclonal
1381966|NCT01240720|tumor targeting|tumor targeting
1381967|NCT01240720|radioimmunotherapy|radioimmunotherapy
1381968|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
1381969|NCT01240720|Patients with different cancer types|patients with different cancer types
1381970|NCT01240694|Lupus|lupus
1381972|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
1381973|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1381974|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
1381975|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
1381976|NCT01240681|tumor response|tumor response
1381977|NCT01240681|mastectomy|mastectomy
1381978|NCT01240668|Hyponatremia|hyponatremia
1381979|NCT01240668|Euvolemia|euvolemia
1381980|NCT01240668|Hypervolemia|hypervolemia
1381981|NCT01240668|Euvolemic|euvolemic
1381982|NCT01240668|Hypervolemic|hypervolemic
1381983|NCT01240655|LCL161|lcl161
1381984|NCT01240655|solid tumors|solid tumors
1381985|NCT01240655|paclitaxel|paclitaxel
1381986|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
1381987|NCT01240642|refractory|refractory
1381988|NCT01240642|core phase|core phase
1381989|NCT01240642|extension phase|extension phase
1381990|NCT01240642|dose escalation|dose escalation
1381991|NCT01240642|standard chemotherapy|standard chemotherapy
1381992|NCT01240642|doctaxel|doctaxel
1381993|NCT01240642|paclitaxel|paclitaxel
1381994|NCT01240642|carboplatin|carboplatin
1381995|NCT01240642|safety|safety
1381996|NCT01240642|tolerability|tolerability
1381997|NCT01240616|Nicotine|nicotine
1381998|NCT01240616|Mecamylamine|mecamylamine
1381999|NCT01240616|Attention|attention
1382000|NCT01240616|fMRI|fmri
1382001|NCT01240616|Default Network|default network
1382002|NCT01240616|Healthy Volunteer|healthy volunteer
1382003|NCT01240616|HV|hv
1382004|NCT01240603|Artemisinin|artemisinin
1382005|NCT01240603|Malaria|malaria
1382006|NCT01240603|Drug Resistance|drug resistance
1382007|NCT01240603|Hemoglobin E|hemoglobin e
1382008|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
1382009|NCT01240590|Crolibulin|crolibulin
1382010|NCT01240590|Solid Tumors|solid tumors
1382011|NCT01240590|ATC|atc
1382012|NCT01240577|IPdR|ipdr
1382013|NCT01240577|Pharmacokinetics|pharmacokinetics
1382014|NCT01240577|Early Phase I|early phase i
1382015|NCT01240577|Cancer|cancer
1382016|NCT01240577|Solid Tumor|solid tumor
1382017|NCT01240577|Lymphoma|lymphoma
1382018|NCT01240551|Imaging|imaging
1382019|NCT01240551|Bone Metastasis|bone metastasis
1382020|NCT01240551|Bone Scan|bone scan
1382021|NCT01240551|Radiopharmaceutical|radiopharmaceutical
1382022|NCT01240551|Pet Scan|pet scan
1382023|NCT01240551|Prostate Cancer|prostate cancer
1382024|NCT01240525|graft versus host disease|graft versus host disease
1382025|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1382026|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1382027|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1382028|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1382029|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1382030|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1382031|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1382032|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1382033|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1382034|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1382035|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1382036|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1382037|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1382038|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1382039|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
1382040|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
1382041|NCT01240525|Plasma cell myeloma|plasma cell myeloma
1382042|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
1382043|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
1382044|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
1382045|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
1382046|NCT01240499|Weight management|weight management
1382047|NCT01240499|New weight paradigm|new weight paradigm
1382048|NCT01240499|Overweight women|overweight women
1382049|NCT01240499|Eating behaviors|eating behaviors
1382050|NCT01240499|Appetite ratings|appetite ratings
1382051|NCT01240499|Blood lipids|blood lipids
1382052|NCT01240486|IRIS|iris
1382053|NCT01240486|HIV|hiv
1382054|NCT01240486|Immune|immune
1382055|NCT01240486|Reconstitution|reconstitution
1382056|NCT01240486|Inflammatory|inflammatory
1382057|NCT01240486|Syndrome|syndrome
1382058|NCT01240473|kala azar|kala azar
1382059|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
1382060|NCT01240473|diagnosis|diagnosis
1382061|NCT01240473|drug resistance|drug resistance
1382062|NCT01240473|Therapeutics|therapeutics
1382063|NCT01240473|Capacity Building|capacity building
1382064|NCT01240447|NSCLC|nsclc
1382065|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
1382066|NCT01240447|advanced lung cancer|advanced lung cancer
1382067|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
1382068|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
1382069|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
1382071|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1382072|NCT01240395|MBCT|mbct
1382073|NCT01240369|VEGFC|vegfc
1382074|NCT01240369|CTTN|cttn
1382075|NCT01240369|miR326|mir326
1382076|NCT01240369|ESCC|escc
1382077|NCT01240369|NSCLC|nsclc
1382078|NCT01240356|transcranial doppler|transcranial doppler
1382079|NCT01240356|sonothrombolysis|sonothrombolysis
1382080|NCT01240356|ultrasound|ultrasound
1382081|NCT01240356|stroke|stroke
1382082|NCT01240343|Biobank|biobank
1382083|NCT01240343|Genetics|genetics
1382084|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
1382085|NCT01240330|Effects of compression therapy|effects of compression therapy
1382086|NCT01240330|Peak Flow Velocity|peak flow velocity
1382087|NCT01240317|expert system|expert system
1382088|NCT01240317|decision support system|decision support system
1382089|NCT01240317|human patient simulator|human patient simulator
1382090|NCT01240317|anesthesia|anesthesia
1382092|NCT01240291|trauma|trauma
1382093|NCT01240291|alanyl-glutamine|alanyl-glutamine
1382094|NCT01240265|Vitamin D deficiency|vitamin d deficiency
1382095|NCT01240265|Rickets|rickets
1382096|NCT01240265|Infant|infant
1382097|NCT01240265|Nutrition|nutrition
1382098|NCT01240252|diabetes|diabetes
1382099|NCT01240252|insulin resistance|insulin resistance
1382100|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
1382101|NCT01240239|telemedicine|telemedicine
1382102|NCT01240213|Vitamin D|vitamin d
1382103|NCT01240213|lifestyle intervention|lifestyle intervention
1382104|NCT01240213|postmenopausal women|postmenopausal women
1382105|NCT01240200|diabetes|diabetes
1382106|NCT01240200|elderly|elderly
1382107|NCT01240200|insulin injections|insulin injections
1382108|NCT01240187|epilepsy|epilepsy
1382109|NCT01240174|Antibiotic|antibiotic
1382110|NCT01240174|Antimicrobial|antimicrobial
1382111|NCT01240174|Prescribing|prescribing
1382112|NCT01240174|Cough|cough
1382113|NCT01240174|Acute Bronchitis|acute bronchitis
1382114|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
1382117|NCT01240148|Allodynia|allodynia
1382118|NCT01240148|hyperalgesia|hyperalgesia
1382119|NCT01240148|paresthesia|paresthesia
1382120|NCT01240135|Contact Lens Wear|contact lens wear
1382121|NCT01240135|Contact Lens Solution|contact lens solution
1382122|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
1382123|NCT01240135|Myopia|myopia
1382124|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
1382125|NCT01240096|Functional dyspepsia|functional dyspepsia
1382126|NCT01240096|Weight loss|weight loss
1382127|NCT01240096|Mirtazapine|mirtazapine
1382128|NCT01240083|Depression|depression
1382129|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
1382130|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
1382131|NCT01240083|Alternative treatment methods|alternative treatment methods
1382132|NCT01240070|diabetes,|diabetes,
1382133|NCT01240070|cardiovascular|cardiovascular
1382134|NCT01240070|risk factor|risk factor
1382135|NCT01240070|cardiovascular event|cardiovascular event
1382136|NCT01240070|intervention|intervention
1382137|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
1382138|NCT01240057|Fetal Surgery|fetal surgery
1382139|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
1382140|NCT01240044|Newborn Pain|newborn pain
1382141|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
1382142|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
1382143|NCT01240031|Malnutrition|malnutrition
1382144|NCT01240031|Nutritional Risk|nutritional risk
1382145|NCT01240031|Intake|intake
1382146|NCT01240031|Food sensory|food sensory
1382147|NCT01240031|Nutritional therapy|nutritional therapy
1382148|NCT01240031|Energy|energy
1382149|NCT01240031|Protein|protein
1382150|NCT01240031|Handgrip strength|handgrip strength
1382151|NCT01240031|Reaction time|reaction time
1382152|NCT01240031|Quality of Life|quality of life
1382153|NCT01239979|coronary artery disease|coronary artery disease
1382154|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
1382155|NCT01239966|Acute renal Failure|acute renal failure
1382156|NCT01239953|In-stent restenosis|in-stent restenosis
1382157|NCT01239953|Drug-eluting balloon|drug-eluting balloon
1382158|NCT01239953|Drug-eluting stent|drug-eluting stent
1382159|NCT01239953|Angiography|angiography
1382160|NCT01239953|Minimal lumen diameter|minimal lumen diameter
1382161|NCT01239940|In-stent restenosis|in-stent restenosis
1382162|NCT01239940|Drug-eluting balloon|drug-eluting balloon
1382163|NCT01239940|Drug-eluting stent|drug-eluting stent
1382164|NCT01239940|Angiography|angiography
1382165|NCT01239940|Minimal lumen diameter|minimal lumen diameter
1503861|NCT00762346|NTX|ntx
1382166|NCT01239927|diverticulitis|diverticulitis
1382167|NCT01239927|hartmann|hartmann
1382168|NCT01239927|anastomosis|anastomosis
1382169|NCT01239914|drug eluting stent|drug eluting stent
1382170|NCT01239914|coronary artery disease|coronary artery disease
1382171|NCT01239914|Korean registry|korean registry
1382172|NCT01239901|sickle cell disease|sickle cell disease
1382173|NCT01239901|sickle cell anemia|sickle cell anemia
1382174|NCT01239901|sickled cells|sickled cells
1382175|NCT01239901|blood vessel|blood vessel
1382176|NCT01239901|iron overload|iron overload
1382177|NCT01239888|Depression|depression
1382178|NCT01239888|Treatment resistant depression|treatment resistant depression
1382179|NCT01239888|Oxytocin|oxytocin
1382180|NCT01239888|Estrogen Modulators|estrogen modulators
1382181|NCT01239888|HPA axis|hpa axis
1382182|NCT01239888|Mental Disorders|mental disorders
1382183|NCT01239888|Estrogens|estrogens
1382184|NCT01239888|Tibolone|tibolone
1382185|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
1382186|NCT01239888|Androgens|androgens
1382187|NCT01239888|Hormones|hormones
1382188|NCT01239888|Hormone Substitutes|hormone substitutes
1382189|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
1382190|NCT01239888|Pharmacologic Actions|pharmacologic actions
1382191|NCT01239888|Hormone Antagonists|hormone antagonists
1382192|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
1382193|NCT01239888|Estrogen Antagonists|estrogen antagonists
1382194|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
1382195|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
1382196|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
1382197|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
1382198|NCT01239823|osteoarthritis|osteoarthritis
1382199|NCT01239823|whole body vibration|whole body vibration
1382200|NCT01239823|mobility|mobility
1382201|NCT01239823|rehabilitation|rehabilitation
1382202|NCT01239810|hyaluronic acid|hyaluronic acid
1382203|NCT01239810|cartilage|cartilage
1382204|NCT01239810|T2 mapping|t2 mapping
1382205|NCT01239810|quantitative|quantitative
1382207|NCT01239810|volume|volume
1382208|NCT01239784|pediatrics|pediatrics
1382209|NCT01239784|Heart Defects|heart defects
1382210|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
1382211|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
1382212|NCT01239771|Safety|safety
1382213|NCT01239771|tolerability|tolerability
1382214|NCT01239771|healthy|healthy
1382215|NCT01239771|stable disease|stable disease
1382216|NCT01239771|oral|oral
1382217|NCT01239771|tablet|tablet
1382218|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
1382219|NCT01239719|Allergic dermatitis|allergic dermatitis
1382220|NCT01239693|Stunting|stunting
1382221|NCT01239693|Growth failure|growth failure
1382222|NCT01239693|Malnutrition|malnutrition
1382223|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
1382224|NCT01239693|LNS|lns
1382225|NCT01239693|Prevention|prevention
1382226|NCT01239693|Malawi|malawi
1382227|NCT01239693|Sub-Saharan Africa|sub-saharan africa
1382228|NCT01239693|Dietary supplementation|dietary supplementation
1382229|NCT01239693|Efficacy|efficacy
1382230|NCT01239693|Pregnancy|pregnancy
1382231|NCT01239693|Infancy|infancy
1382232|NCT01239693|Newborn|newborn
1382233|NCT01239680|hemorrhagic shock|hemorrhagic shock
1382234|NCT01239680|glutamine|glutamine
1382235|NCT01239680|trauma resuscitation|trauma resuscitation
1382236|NCT01239680|department of defense|department of defense
1382237|NCT01239680|trauma|trauma
1382238|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
1382239|NCT01239654|acute|acute
1382240|NCT01239654|coronary|coronary
1382241|NCT01239654|syndrome|syndrome
1382242|NCT01239654|everolimus|everolimus
1382243|NCT01239654|zotarolimus|zotarolimus
1382244|NCT01239654|optical|optical
1382245|NCT01239654|coherence|coherence
1382246|NCT01239654|tomography|tomography
1382247|NCT01239641|Uterine Fibroids|uterine fibroids
1382248|NCT01239641|Myoectomy|myoectomy
1382249|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
1382250|NCT01239641|ablation|ablation
1382251|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
1382252|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
1382253|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
1382254|NCT01239563|kidney transplantation|kidney transplantation
1382255|NCT01239563|donation after cardiac death|donation after cardiac death
1382256|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
1382257|NCT01239563|thymoglobulin|thymoglobulin
1382258|NCT01239563|steroid avoidance|steroid avoidance
1382259|NCT01239563|lymphocyte|lymphocyte
1382260|NCT01239550|Insulin|insulin
1382261|NCT01239550|Detemir|detemir
1382262|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
1382263|NCT01239550|Diabetes|diabetes
1382264|NCT01239550|Obesity|obesity
1382265|NCT01239550|Neurotransmitters|neurotransmitters
1382266|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
1382267|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
1382268|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
1382269|NCT01239472|cytokines|cytokines
1382270|NCT01239472|kidney transplant|kidney transplant
1382271|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
1382272|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
1382273|NCT01239446|mediastinal irradiation|mediastinal irradiation
1382274|NCT01239446|Coronary Artery Disease|coronary artery disease
1382275|NCT01239394|NHL|nhl
1382276|NCT01239394|ofatumumab|ofatumumab
1382277|NCT01239381|proton radiation|proton radiation
1382278|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
1382279|NCT01239381|SBRT|sbrt
1382280|NCT01239368|Multiple Myeloma|multiple myeloma
1382281|NCT01239368|High Risk|high risk
1382282|NCT01239368|Newly Diagnosed|newly diagnosed
1382283|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
1382284|NCT01239368|Autologous|autologous
1382285|NCT01239329|Complex multiple disabilities|complex multiple disabilities
1382286|NCT01239329|Malnutrition|malnutrition
1382287|NCT01239277|muscle|muscle
1382288|NCT01239277|FSR|fsr
1382289|NCT01239277|protein|protein
1382290|NCT01239277|carbohydrate|carbohydrate
1382291|NCT01239277|leucine|leucine
1382292|NCT01239251|GlowCap|glowcap
1382293|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
1382294|NCT01239238|asthma|asthma
1382295|NCT01239238|children|children
1382296|NCT01239238|home monitoring|home monitoring
1382297|NCT01239238|exhaled breath condensate|exhaled breath condensate
1382298|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
1382299|NCT01239238|volatile organic compounds|volatile organic compounds
1382300|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
1382301|NCT01239212|seizures|seizures
1382302|NCT01239212|neonate|neonate
1382303|NCT01239212|levetiracetam|levetiracetam
1382304|NCT01239212|Epilepsy|epilepsy
1382305|NCT01239212|central nervous system diseases|central nervous system diseases
1382306|NCT01239212|anticonvulsants|anticonvulsants
1382307|NCT01239199|Infants|infants
1382308|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
1382309|NCT01239199|Asthma|asthma
1382310|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
1382311|NCT01239199|environment|environment
1382312|NCT01239186|methylation|methylation
1382313|NCT01239186|micro array|micro array
1382314|NCT01239186|locus H19|locus h19
1382315|NCT01239186|male infertility|male infertility
1382316|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
1382317|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1382318|NCT01239173|Amygdala|amygdala
1382319|NCT01239173|emotion regulation|emotion regulation
1382320|NCT01239173|memory|memory
1382321|NCT01239160|lymphedema|lymphedema
1382322|NCT01239160|pneumatic compression device|pneumatic compression device
1382323|NCT01239160|randomised clinical trial|randomised clinical trial
1382324|NCT01239160|volume reduction|volume reduction
1382325|NCT01239147|weight maintenance|weight maintenance
1382326|NCT01239134|Malignant melanoma|malignant melanoma
1382327|NCT01239134|Metastatic|metastatic
1382328|NCT01239134|Unresectable|unresectable
1382329|NCT01239134|Stage III or Stage IV|stage iii or stage iv
1382330|NCT01239134|Solid tumor|solid tumor
1382331|NCT01239121|drug toxicity|drug toxicity
1382332|NCT01239121|drug interactions|drug interactions
1382333|NCT01239121|electronic health records|electronic health records
1382334|NCT01239121|medical errors|medical errors
1382335|NCT01239043|Meningitis|meningitis
1382336|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
1382337|NCT01239043|Meningococcal Infections|meningococcal infections
1382338|NCT01239043|Menactra®|menactra®
1382339|NCT01239043|Menomune®|menomune®
1382340|NCT01239043|Meningococcal vaccine|meningococcal vaccine
1382341|NCT01239030|inattention|inattention
1382342|NCT01239030|impulsivity|impulsivity
1382343|NCT01239030|hyperactivity|hyperactivity
1382344|NCT01239030|ADHD|adhd
1382345|NCT01239004|dyslipidemia|dyslipidemia
1382346|NCT01239004|hyperlipidemia|hyperlipidemia
1382347|NCT01239004|hyperglycemia|hyperglycemia
1382348|NCT01239004|impaired fasting glucose|impaired fasting glucose
1567141|NCT00509834|candidaemia|candidaemia
1567142|NCT00509834|lactoferrin|lactoferrin
1382349|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
1382350|NCT01238952|solid tumors|solid tumors
1382351|NCT01238952|breast cancer|breast cancer
1382352|NCT01238952|triple negative breast cancer|triple negative breast cancer
1382353|NCT01238952|HER2 negative|her2 negative
1382354|NCT01238952|ER negative|er negative
1382355|NCT01238952|PR negative|pr negative
1382356|NCT01238939|solid tumors|solid tumors
1382357|NCT01238939|colorectal cancer|colorectal cancer
1382358|NCT01238926|Oxidative stress|oxidative stress
1382359|NCT01238926|Parkinson's disease|parkinson's disease
1382360|NCT01238926|Homocysteine|homocysteine
1382361|NCT01238926|Glutathione|glutathione
1382362|NCT01238926|B vitamins|b vitamins
1382363|NCT01238887|Satiety|satiety
1382364|NCT01238887|Food Intake|food intake
1382365|NCT01238887|Weight Loss|weight loss
1382366|NCT01238887|Oxidative Stress|oxidative stress
1382367|NCT01238887|botanicals|botanicals
1382368|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
1382369|NCT01238861|Asthma|asthma
1382370|NCT01238861|Benralizumab|benralizumab
1382371|NCT01238861|MEDI-563|medi-563
1382372|NCT01238848|Hypertonic|hypertonic
1382373|NCT01238848|Saline|saline
1382374|NCT01238848|Bronchiolitis|bronchiolitis
1382375|NCT01238848|Efficacy|efficacy
1382376|NCT01238835|Sapien XT Valve|sapien xt valve
1382377|NCT01238835|Valvular Heart Disease|valvular heart disease
1382378|NCT01238835|Aortic Stenosis|aortic stenosis
1382379|NCT01238835|Heart Valve Therapy|heart valve therapy
1382380|NCT01238835|Transapical|transapical
1382381|NCT01238835|Transcatheter|transcatheter
1382382|NCT01238809|Compliance|compliance
1382383|NCT01238809|France|france
1382384|NCT01238796|telavancin|telavancin
1382385|NCT01238796|Pharmacokinetics|pharmacokinetics
1382386|NCT01238796|Severe renal disease|severe renal disease
1382387|NCT01238796|VIBATIV®|vibativ®
1382388|NCT01238796|ASP9809|asp9809
1382389|NCT01238770|Ovarian cancer|ovarian cancer
1382390|NCT01238757|Prospective Studies|prospective studies
1382391|NCT01238757|Humans, pediatric|humans, pediatric
1382392|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
1382393|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
1382394|NCT01238757|Intensive Care|intensive care
1382395|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
1382396|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
1382397|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
1382398|NCT01238757|Prevalence|prevalence
1382399|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
1382400|NCT01238757|Child|child
1382401|NCT01238757|Child, Preschool|child, preschool
1382402|NCT01238757|Infant|infant
1382403|NCT01238757|Infant, Newborn|infant, newborn
1382404|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
1382405|NCT01238757|Respiratory Rate*|respiratory rate*
1382406|NCT01238731|Valve replacement|valve replacement
1382407|NCT01238731|pulmonary hypertension|pulmonary hypertension
1382408|NCT01238731|long term follow up|long term follow up
1382409|NCT01238718|lidocaine|lidocaine
1382410|NCT01238718|anesthetic depth|anesthetic depth
1382411|NCT01238718|hemodynamics|hemodynamics
1382412|NCT01238718|rapid sequence induction|rapid sequence induction
1382414|NCT01238705|Hypertension|hypertension
1382415|NCT01238705|Antihypertensive Agents|antihypertensive agents
1382416|NCT01238705|Combination|combination
1382417|NCT01238705|Sexual Dysfunction|sexual dysfunction
1382418|NCT01238705|Oxidative Stress|oxidative stress
1382419|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1382420|NCT01238692|DLBCL|dlbcl
1382421|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
1382422|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
1382423|NCT01238692|B-cell Lymphoma|b-cell lymphoma
1382424|NCT01238692|Panobinostat|panobinostat
1382425|NCT01238692|LBH589|lbh589
1382426|NCT01238692|Rituximab|rituximab
1382427|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1382428|NCT01238679|safety|safety
1382429|NCT01238679|tolerability|tolerability
1382430|NCT01238679|pharmacokinetics|pharmacokinetics
1382431|NCT01238679|healthy volunteers|healthy volunteers
1382432|NCT01238666|liver|liver
1382433|NCT01238666|cancer|cancer
1382434|NCT01238666|tumor|tumor
1382435|NCT01238666|ablation|ablation
1382436|NCT01238666|Pathfinder|pathfinder
1382437|NCT01238653|liver|liver
1382438|NCT01238653|cancer|cancer
1382439|NCT01238653|tumor|tumor
1382440|NCT01238653|Pathfinder|pathfinder
1382441|NCT01238640|Smoking Cessation|smoking cessation
1382442|NCT01238640|Nicotine|nicotine
1382443|NCT01238627|Smoking Cessation|smoking cessation
1382444|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
1382445|NCT01238614|maternal depression|maternal depression
1382446|NCT01238614|clinical decision support|clinical decision support
1382447|NCT01238601|Breast augmentation|breast augmentation
1567143|NCT00509782|Solid Tumors|solid tumors
1504207|NCT00760877|CML|cml
1382448|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
1382449|NCT01238575|PDD|pdd
1382450|NCT01238575|PDD-NOS|pdd-nos
1382451|NCT01238575|Autistic Disorder|autistic disorder
1382452|NCT01238575|Autism|autism
1382453|NCT01238575|Asperger's Disorder|asperger's disorder
1382454|NCT01238575|Hyperactivity|hyperactivity
1382455|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1382456|NCT01238575|ADHD|adhd
1382457|NCT01238575|Medication|medication
1382458|NCT01238575|Drug|drug
1382459|NCT01238575|Guanfacine|guanfacine
1382460|NCT01238575|Intuniv|intuniv
1382461|NCT01238575|Placebo|placebo
1382462|NCT01238575|Methylphenidate|methylphenidate
1382463|NCT01238562|cancer patient|cancer patient
1382464|NCT01238562|chemotherapy|chemotherapy
1382465|NCT01238562|carboplatin|carboplatin
1382466|NCT01238562|taxol|taxol
1382467|NCT01238562|cyclophosphamide|cyclophosphamide
1382468|NCT01238562|pharmorubicin|pharmorubicin
1382469|NCT01238549|Spinal Cord Injuries|spinal cord injuries
1382470|NCT01238549|Quality of Life|quality of life
1382471|NCT01238536|Epidural Steroid Injection|epidural steroid injection
1382472|NCT01238536|Low Back Pain|low back pain
1382473|NCT01238536|Spinal Stenosis|spinal stenosis
1382474|NCT01238536|Elderly|elderly
1382475|NCT01238523|tibia|tibia
1382476|NCT01238523|shaft|shaft
1382477|NCT01238523|fracture|fracture
1382478|NCT01238523|children|children
1382479|NCT01238497|SAPIEN XT™|sapien xt™
1382480|NCT01238497|Transfemoral|transfemoral
1382481|NCT01238497|NovaFlex|novaflex
1382482|NCT01238497|NovaFlex+|novaflex+
1382483|NCT01238497|NF|nf
1382484|NCT01238497|NF+|nf+
1382485|NCT01238497|Transapical|transapical
1382486|NCT01238497|Transaortic|transaortic
1382487|NCT01238497|Ascendra2|ascendra2
1382488|NCT01238497|Ascendra+|ascendra+
1382489|NCT01238497|Asc+|asc+
1382490|NCT01238497|aortic stenosis|aortic stenosis
1382491|NCT01238497|aortic valve|aortic valve
1382492|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
1382493|NCT01238497|THV|thv
1382494|NCT01238484|Ankle Equinus|ankle equinus
1382495|NCT01238484|Ankle contracture|ankle contracture
1382496|NCT01238484|Diabetes Mellitus|diabetes mellitus
1382497|NCT01238484|Dynasplint|dynasplint
1382498|NCT01238484|AFD|afd
1382499|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
1382500|NCT01238471|Propranolol|propranolol
1382501|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
1382502|NCT01238471|premature infant|premature infant
1382503|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
1382504|NCT01238458|Alzheimer's disease|alzheimer's disease
1382505|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
1382506|NCT01238445|Pediatric|pediatric
1382507|NCT01238432|Pediatric|pediatric
1382508|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
1382509|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
1382510|NCT01238406|Type 1 diabetes|type 1 diabetes
1382511|NCT01238406|Closed loop|closed loop
1382512|NCT01238406|Artificial Pancreas|artificial pancreas
1382513|NCT01238380|Monogenic diabetes|monogenic diabetes
1382514|NCT01238380|HNF1A|hnf1a
1382515|NCT01238380|HNF4A|hnf4a
1382516|NCT01238380|GCK|gck
1382517|NCT01238380|genetic testing|genetic testing
1382518|NCT01238380|health economic model|health economic model
1382519|NCT01238354|Weight Loss|weight loss
1382520|NCT01238354|Social support|social support
1382521|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
1382522|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
1382523|NCT01238328|HSCT|hsct
1382524|NCT01238315|Batten's disease|batten's disease
1382525|NCT01238315|INCL|incl
1382526|NCT01238315|LINCL|lincl
1382527|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
1382528|NCT01238315|NCL|ncl
1382529|NCT01238289|peer education|peer education
1382530|NCT01238289|diabetes|diabetes
1382531|NCT01238289|randomized|randomized
1382532|NCT01238289|trial|trial
1382533|NCT01238276|soft tissue infection|soft tissue infection
1382534|NCT01238276|wound infection|wound infection
1382535|NCT01238276|cellulitis|cellulitis
1382536|NCT01238276|foot ulcer|foot ulcer
1382537|NCT01238276|Diabetes|diabetes
1382538|NCT01238276|antibiotics|antibiotics
1382539|NCT01238276|cefazolin|cefazolin
1382540|NCT01238276|cephazolin|cephazolin
1382541|NCT01238276|Ancef|ancef
1382542|NCT01238276|Kefzol|kefzol
1382543|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
1382544|NCT01238276|ultrasound|ultrasound
1382545|NCT01238276|MRSA|mrsa
1382546|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1382547|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
1382548|NCT01238250|16p11.2|16p11.2
1382549|NCT01238250|16p11.2 del|16p11.2 del
1382550|NCT01238250|16p11.2 deletion|16p11.2 deletion
1382551|NCT01238250|16p11.2 dup|16p11.2 dup
1382552|NCT01238250|16p11.2 duplication|16p11.2 duplication
1382553|NCT01238250|chromosome 16|chromosome 16
1382554|NCT01238250|chromosome 16p|chromosome 16p
1382555|NCT01238250|chromosome 16p11|chromosome 16p11
1382556|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
1382557|NCT01238250|1q21.1|1q21.1
1382558|NCT01238250|1q21.1 del|1q21.1 del
1382559|NCT01238250|1q21.1 deletion|1q21.1 deletion
1382560|NCT01238250|1q21.1 dup|1q21.1 dup
1382561|NCT01238250|1q21.1 duplication|1q21.1 duplication
1382562|NCT01238250|chromosome 1|chromosome 1
1382563|NCT01238250|chromosome 1q|chromosome 1q
1382564|NCT01238250|chromosome 1q21|chromosome 1q21
1382565|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
1382566|NCT01238250|genetic mutation|genetic mutation
1382567|NCT01238250|genetic variant|genetic variant
1382568|NCT01238250|gene variant|gene variant
1382569|NCT01238250|autism|autism
1382570|NCT01238250|ADNP|adnp
1382571|NCT01238250|ANKRD11|ankrd11
1382572|NCT01238250|ARID1B|arid1b
1382573|NCT01238250|ASXL3|asxl3
1382574|NCT01238250|ACTL6B|actl6b
1382575|NCT01238250|AHDC1|ahdc1
1382576|NCT01238250|BAF190|baf190
1382577|NCT01238250|ANK2|ank2
1382578|NCT01238250|ASH1L|ash1l
1382579|NCT01238250|BCL11A|bcl11a
1382580|NCT01238250|CHD2|chd2
1382581|NCT01238250|CHD8|chd8
1382582|NCT01238250|CTNNB1|ctnnb1
1382583|NCT01238250|CUL3|cul3
1382584|NCT01238250|DST|dst
1382585|NCT01238250|DYRK1A|dyrk1a
1382586|NCT01238250|FOXP1|foxp1
1382587|NCT01238250|GRIN2B|grin2b
1382588|NCT01238250|KDM6B|kdm6b
1382589|NCT01238250|KMT2E|kmt2e
1382590|NCT01238250|MBD5|mbd5
1382591|NCT01238250|MED13L|med13l
1382592|NCT01238250|PTEN|pten
1382593|NCT01238250|REST|rest
1382594|NCT01238250|SCN2A|scn2a
1382595|NCT01238250|SMARCC1|smarcc1
1382596|NCT01238250|SMARCC2|smarcc2
1382597|NCT01238250|SYNGAP1|syngap1
1382598|NCT01238250|HIVEP2|hivep2
1382599|NCT01238250|HNRNPH2|hnrnph2
1382600|NCT01238250|PPP2R5D|ppp2r5d
1382601|NCT01238250|CHAMP1|champ1
1382602|NCT01238250|CSNK2A1|csnk2a1
1382603|NCT01238250|CTBP1|ctbp1
1382604|NCT01238250|DDX3X|ddx3x
1382605|NCT01238250|DNMT3A|dnmt3a
1382606|NCT01238250|DSCAM|dscam
1382607|NCT01238250|GRIN2A|grin2a
1382608|NCT01238250|KAT6A|kat6a
1382609|NCT01238250|KATNAL2|katnal2
1382610|NCT01238250|KDM5B|kdm5b
1382611|NCT01238250|KMT2C|kmt2c
1382612|NCT01238250|KMT5B|kmt5b
1382613|NCT01238250|SUV420H1|suv420h1
1382614|NCT01238250|PACS1|pacs1
1382615|NCT01238250|PBRM1|pbrm1
1382616|NCT01238250|PTCHD1|ptchd1
1382617|NCT01238250|PURA|pura
1382618|NCT01238250|SETBP1|setbp1
1382619|NCT01238250|SETD5|setd5
1382620|NCT01238250|SMARCA4|smarca4
1382621|NCT01238250|STXBP1|stxbp1
1382622|NCT01238250|TBR1|tbr1
1382623|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
1382624|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
1382625|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
1382626|NCT01238237|Brain Tumor|brain tumor
1382627|NCT01238237|EGFR|egfr
1382628|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1382629|NCT01238237|EGFRvIII|egfrviii
1382630|NCT01238224|Insulin resistance|insulin resistance
1382631|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
1382632|NCT01238224|Microdialysis|microdialysis
1382633|NCT01238224|Type 2 diabetes|type 2 diabetes
1382634|NCT01238224|Endothelial dysfunction|endothelial dysfunction
1382635|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
1382636|NCT01238185|oral leukoplakia|oral leukoplakia
1382637|NCT01238172|stage I prostate cancer|stage i prostate cancer
1382638|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
1382639|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
1382640|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1382641|NCT01238159|Natural killer cell|natural killer cell
1382642|NCT01238159|T cell|t cell
1382643|NCT01238159|Lymphoma|lymphoma
1382644|NCT01238159|Radiation|radiation
1382645|NCT01238159|Chemotherapy|chemotherapy
1382646|NCT01238120|Cancer|cancer
1382647|NCT01238120|Cognitive difficulties|cognitive difficulties
1382648|NCT01238107|Cachexia|cachexia
1382649|NCT01238107|Cancer|cancer
1382650|NCT01238094|colorectal cancer|colorectal cancer
1382651|NCT01238094|simvastatin|simvastatin
1382652|NCT01238094|second-line chemotherapy|second-line chemotherapy
1382653|NCT01238081|Cystic fibrosis|cystic fibrosis
1382654|NCT01238055|advanced gastric cancer|advanced gastric cancer
1382655|NCT01238055|sunitinib|sunitinib
1382656|NCT01238055|docetaxel|docetaxel
1382657|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
1382658|NCT01238029|Dose finding study|dose finding study
1382659|NCT01238029|Combination|combination
1382660|NCT01237990|liver|liver
1382661|NCT01237990|cancer|cancer
1382662|NCT01237990|tumor|tumor
1382663|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
1382664|NCT01237951|Stem Cell Transplant|stem cell transplant
1382665|NCT01237951|Busulfan|busulfan
1382666|NCT01237951|Myleran|myleran
1382667|NCT01237951|Busulfex|busulfex
1382668|NCT01237951|Gemcitabine|gemcitabine
1382669|NCT01237951|Gemzar|gemzar
1382670|NCT01237951|Melphalan|melphalan
1382671|NCT01237951|Alkeran|alkeran
1382672|NCT01237951|Decadron|decadron
1382673|NCT01237951|Dexamethasone|dexamethasone
1382674|NCT01237951|G-CSF|g-csf
1382675|NCT01237951|Filgrastim|filgrastim
1382676|NCT01237951|Neupogen|neupogen
1382677|NCT01237925|Sunburn|sunburn
1382678|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
1382679|NCT01237925|Gel|gel
1382680|NCT01237925|Cream|cream
1382681|NCT01237899|Kidney|kidney
1382682|NCT01237899|Renal|renal
1382683|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
1382684|NCT01237886|heart rate variability|heart rate variability
1382685|NCT01237886|respiratory rate variability|respiratory rate variability
1382686|NCT01237873|Aliskiren|aliskiren
1382687|NCT01237873|Amlodipine|amlodipine
1382688|NCT01237873|Essential hypertension|essential hypertension
1382689|NCT01237873|Long term|long term
1382690|NCT01237860|Foot drop|foot drop
1382691|NCT01237860|Thigh muscle weakness|thigh muscle weakness
1382692|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
1382693|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
1382694|NCT01237847|IBD|ibd
1382695|NCT01237847|Crohn's disease|crohn's disease
1382696|NCT01237847|ulcerative colitis|ulcerative colitis
1382697|NCT01237847|adolescent|adolescent
1382698|NCT01237808|AML|aml
1382699|NCT01237808|NPM1 Mutation|npm1 mutation
1382700|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
1382701|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
1382702|NCT01237795|Chloramine T|chloramine t
1382703|NCT01237795|Complete Denture|complete denture
1382704|NCT01237795|Dental Plaque Index|dental plaque index
1382705|NCT01237795|Dentifrice|dentifrice
1382706|NCT01237795|Denture Bases|denture bases
1382707|NCT01237795|Denture Cleansers|denture cleansers
1382708|NCT01237795|Edentulous Mouth|edentulous mouth
1382709|NCT01237795|Fluorosurfactant|fluorosurfactant
1382710|NCT01237795|Oral Health|oral health
1382711|NCT01237795|Toothpaste|toothpaste
1382712|NCT01237782|Candida|candida
1382713|NCT01237782|Complete Denture|complete denture
1382714|NCT01237782|Dental Plaque Index|dental plaque index
1382715|NCT01237782|Denture Bases|denture bases
1382716|NCT01237782|Denture Cleansers|denture cleansers
1382717|NCT01237782|Edentulous Mouth|edentulous mouth
1382718|NCT01237782|Mutans Streptococci|mutans streptococci
1382719|NCT01237782|Oral Health|oral health
1382720|NCT01237782|Propolis|propolis
1382721|NCT01237782|Streptococcus mutans|streptococcus mutans
1382722|NCT01237769|vitamin D|vitamin d
1382723|NCT01237769|Metabolic syndrome|metabolic syndrome
1382724|NCT01237769|Hypertension|hypertension
1382725|NCT01237769|Dyslipidemia|dyslipidemia
1382726|NCT01237769|Dysglycemia|dysglycemia
1382727|NCT01237769|Inflammation|inflammation
1382728|NCT01237756|pediatric anesthesia|pediatric anesthesia
1382729|NCT01237756|endotracheal tube|endotracheal tube
1382730|NCT01237756|electrical impedance tomography|electrical impedance tomography
1382731|NCT01237756|misplacement|misplacement
1382732|NCT01237756|endobronchial|endobronchial
1382733|NCT01237743|Embolism|embolism
1382734|NCT01237743|Nervous system|nervous system
1382735|NCT01237743|Aorta|aorta
1382736|NCT01237743|Valves|valves
1382737|NCT01237743|Ultrasonics|ultrasonics
1382738|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1382739|NCT01237730|peristomal wound infection|peristomal wound infection
1382740|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
1382741|NCT01237717|hypertension|hypertension
1382742|NCT01237691|drug use|drug use
1382743|NCT01237691|drug arrests|drug arrests
1382744|NCT01237691|incarceration|incarceration
1382745|NCT01237678|Immunogen|immunogen
1382746|NCT01237678|Lung|lung
1382747|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
1382748|NCT01237678|Carboplatin|carboplatin
1382749|NCT01237678|ADC|adc
1382750|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
1382751|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
1382752|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
1382753|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
1382754|NCT01237639|Red Cells|red cells
1382755|NCT01237639|Transfusion|transfusion
1382756|NCT01237639|Trigger|trigger
1382757|NCT01237639|Threshold|threshold
1382758|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
1382759|NCT01237626|Driving|driving
1382760|NCT01237626|Aging|aging
1382761|NCT01237626|Older drivers|older drivers
1382762|NCT01237626|Medical Fitness to drive|medical fitness to drive
1382763|NCT01237626|Health Status|health status
1382764|NCT01237626|At-fault collisions|at-fault collisions
1382765|NCT01237613|Achilles|achilles
1382766|NCT01237613|Rupture|rupture
1382767|NCT01237613|Tendon|tendon
1382768|NCT01237613|Artelon|artelon
1382769|NCT01237600|Ocular surface damage|ocular surface damage
1382770|NCT01237600|Limbal deficiency|limbal deficiency
1382771|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
1382772|NCT01237587|Adolescents|adolescents
1382773|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
1382774|NCT01237574|Liver Diseases|liver diseases
1382775|NCT01237574|Alcoholic|alcoholic
1382776|NCT01237574|Metabolic Diseases|metabolic diseases
1382777|NCT01237574|cohort|cohort
1382778|NCT01237574|liver disease|liver disease
1382879|NCT01237145|elispot|elispot
1382779|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1382780|NCT01237561|COPD Guidelines|copd guidelines
1382781|NCT01237561|Patient Activation|patient activation
1382782|NCT01237561|Lung Age|lung age
1382783|NCT01237548|water pipe smoking|water pipe smoking
1382784|NCT01237548|acute effect|acute effect
1382785|NCT01237548|Endothelial|endothelial
1382786|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
1382787|NCT01237535|Unexplained infertility|unexplained infertility
1382788|NCT01237535|Insemination|insemination
1382789|NCT01237535|Luteal phase support|luteal phase support
1382790|NCT01237535|Ovarian stimulation|ovarian stimulation
1382791|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1382792|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
1382793|NCT01237522|Pharmacokinetics|pharmacokinetics
1382794|NCT01237522|Pharmacogenetics|pharmacogenetics
1382795|NCT01237509|EEG|eeg
1382796|NCT01237509|Sleep|sleep
1382797|NCT01237509|device|device
1382798|NCT01237509|diabetes|diabetes
1382799|NCT01237509|hypoglycemia|hypoglycemia
1382800|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
1382801|NCT01237483|HNSCC|hnscc
1382802|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
1382803|NCT01237470|inguinal hernia|inguinal hernia
1382804|NCT01237470|hernia recurrence|hernia recurrence
1382805|NCT01237470|no mesh techniques|no mesh techniques
1382806|NCT01237470|Desarda technique|desarda technique
1382807|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
1382808|NCT01237431|Water drinking|water drinking
1382809|NCT01237431|osmoreceptors|osmoreceptors
1382810|NCT01237431|autonomic failure|autonomic failure
1382811|NCT01237431|syncope|syncope
1382812|NCT01237431|blood pressure|blood pressure
1382813|NCT01237431|liver transplant|liver transplant
1382814|NCT01237405|osteoarthritis|osteoarthritis
1382815|NCT01237405|nuclear medicine|nuclear medicine
1382816|NCT01237405|macrophages|macrophages
1382817|NCT01237392|wound debridement|wound debridement
1382818|NCT01237392|requiring debridement|requiring debridement
1382819|NCT01237366|HIV/AIDS|hiv/aids
1382820|NCT01237366|Methamphetamine|methamphetamine
1382821|NCT01237366|Trauma|trauma
1382822|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
1382823|NCT01237340|immunogenicity|immunogenicity
1382824|NCT01237340|growth hormone|growth hormone
1382825|NCT01237340|antibodies|antibodies
1382826|NCT01237340|GH biomarkers|gh biomarkers
1382827|NCT01237340|IGF-I|igf-i
1382828|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
1382829|NCT01237327|Advanced|advanced
1382830|NCT01237327|Postmenopausal|postmenopausal
1382831|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
1382832|NCT01237314|type 2 diabetes|type 2 diabetes
1382833|NCT01237314|metformin|metformin
1382834|NCT01237314|glargine|glargine
1382835|NCT01237314|exenatide|exenatide
1382836|NCT01237314|glycemic impact of food|glycemic impact of food
1382837|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
1382838|NCT01237301|Type 2 Diabetes|type 2 diabetes
1382839|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
1382840|NCT01237275|Pharmacogenomics|pharmacogenomics
1382841|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
1382842|NCT01237275|Depressed Patients|depressed patients
1382843|NCT01237262|psoriasis|psoriasis
1382844|NCT01237262|immune infiltrate|immune infiltrate
1382845|NCT01237262|dendritic cells|dendritic cells
1382846|NCT01237262|cytokine expression|cytokine expression
1382847|NCT01237249|Multiple Myeloma|multiple myeloma
1382848|NCT01237249|Velcade|velcade
1382849|NCT01237249|Revlimid|revlimid
1382850|NCT01237236|Advanced solid tumor|advanced solid tumor
1382851|NCT01237236|lymphoma|lymphoma
1382852|NCT01237223|Aliskiren|aliskiren
1382853|NCT01237223|Amlodipine|amlodipine
1382854|NCT01237223|Essential hypertension|essential hypertension
1382855|NCT01237210|Parkinson's Disease|parkinson's disease
1382856|NCT01237210|PD|pd
1382857|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1382858|NCT01237184|initial dental implant stability|initial dental implant stability
1382859|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
1382860|NCT01237184|bicortical fixation|bicortical fixation
1382861|NCT01237171|Brachytherapy|brachytherapy
1382862|NCT01237171|Lung Brachytherapy|lung brachytherapy
1382863|NCT01237171|NSCLC|nsclc
1382864|NCT01237171|Sub-lobar resection|sub-lobar resection
1382865|NCT01237158|GAD1,|gad1,
1382866|NCT01237158|GAD67,|gad67,
1382867|NCT01237158|bipolar,|bipolar,
1382868|NCT01237158|GABA,|gaba,
1382869|NCT01237158|Glutamate,|glutamate,
1382870|NCT01237158|Reelin,|reelin,
1382871|NCT01237158|Rln,|rln,
1382872|NCT01237158|Spectroscopy|spectroscopy
1382873|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
1382874|NCT01237145|pigeon|pigeon
1382875|NCT01237145|bird fancier|bird fancier
1382876|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
1382877|NCT01237145|BAL|bal
1382878|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
1382880|NCT01237145|antigen|antigen
1382881|NCT01237106|PCOS|pcos
1382882|NCT01237106|IVM|ivm
1382883|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
1382884|NCT01237106|In Vitro Maturation|in vitro maturation
1382885|NCT01237106|IVF|ivf
1382886|NCT01237093|Fish Diet|fish diet
1382887|NCT01237093|Meat Diet|meat diet
1382888|NCT01237093|Biomarkers|biomarkers
1382889|NCT01237093|Stable Isotopes|stable isotopes
1382890|NCT01237093|Dietary Intake|dietary intake
1382891|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
1382892|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
1382893|NCT01237067|Carboplatin|carboplatin
1382894|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
1382895|NCT01237067|Breast Cancer|breast cancer
1382896|NCT01237067|Ovarian Cancer|ovarian cancer
1382897|NCT01237067|Uterine Cancer|uterine cancer
1382898|NCT01237067|Cervical Cancer|cervical cancer
1382899|NCT01237067|Peritoneal Cancer|peritoneal cancer
1382900|NCT01237067|Endometrial Cancer|endometrial cancer
1382901|NCT01237067|Fallopian Tube Cancer|fallopian tube cancer
1382902|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
1382903|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
1382904|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
1382905|NCT01237054|Serum M-Protein|serum m-protein
1382906|NCT01237054|DCE-MRI|dce-mri
1382907|NCT01237054|Multiple Myeloma|multiple myeloma
1382908|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
1382909|NCT01237054|SMM|smm
1382910|NCT01237054|MM|mm
1382911|NCT01237041|Child|child
1382912|NCT01237041|Body Fat|body fat
1382913|NCT01237041|Niacin|niacin
1382914|NCT01237041|Growth Hormone|growth hormone
1382915|NCT01237041|Obesity|obesity
1382916|NCT01237041|Growth Hormones|growth hormones
1382917|NCT01237041|Short Stature|short stature
1382918|NCT01237041|Children|children
1382919|NCT01237015|Neonate|neonate
1382920|NCT01237015|Oral feeding|oral feeding
1382921|NCT01237015|Nasal CPAP|nasal cpap
1382922|NCT01237015|Sucking|sucking
1382923|NCT01237015|Swallowing|swallowing
1382924|NCT01237015|Breathing|breathing
1382925|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
1382926|NCT01236989|anatomical resection|anatomical resection
1382927|NCT01236989|non-anatomical resection|non-anatomical resection
1382928|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
1382929|NCT01236963|Clinical trial|clinical trial
1382930|NCT01236963|Prevention mouthrinse|prevention mouthrinse
1382931|NCT01236963|Dental Floss|dental floss
1382932|NCT01236950|Clinical Trial|clinical trial
1382933|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
1382934|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
1382935|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
1382936|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
1382937|NCT01236898|pharmacokinetics|pharmacokinetics
1382938|NCT01236898|hIBM|hibm
1382939|NCT01236872|Nitrate|nitrate
1382940|NCT01236872|Nitrite|nitrite
1382941|NCT01236872|Vegetable|vegetable
1382942|NCT01236872|Aortic stiffness|aortic stiffness
1382943|NCT01236859|Gabapentin|gabapentin
1382944|NCT01236859|prophylaxis|prophylaxis
1382945|NCT01236859|incidence of pruritus|incidence of pruritus
1382946|NCT01236859|intrathecal morphine|intrathecal morphine
1382947|NCT01236846|Vitamin D fortification|vitamin d fortification
1382948|NCT01236846|Yogurt Drink|yogurt drink
1382949|NCT01236846|Efficacy|efficacy
1382950|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
1382951|NCT01236833|Isotonic Solution|isotonic solution
1382952|NCT01236833|Intestinal Disease|intestinal disease
1382953|NCT01236833|Feeding Intolerance|feeding intolerance
1382954|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
1382955|NCT01236833|Newborn|newborn
1382956|NCT01236833|Premature Infant|premature infant
1382957|NCT01236820|L5|l5
1382958|NCT01236820|LDL|ldl
1382959|NCT01236820|Cardiovascular disease|cardiovascular disease
1382960|NCT01236820|Chronic kidney disease|chronic kidney disease
1382961|NCT01236820|Hemodialysis|hemodialysis
1382962|NCT01236807|Adenosine|adenosine
1382963|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
1382964|NCT01236807|MR perfusion|mr perfusion
1382965|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1382966|NCT01236807|FFR|ffr
1382967|NCT01236807|Pressure wire|pressure wire
1382968|NCT01236807|Coronary Disease|coronary disease
1382969|NCT01236807|Heart Diseases|heart diseases
1382970|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
1382971|NCT01236807|Arteriosclerosis|arteriosclerosis
1382972|NCT01236781|breast cancer|breast cancer
1382973|NCT01236781|screening|screening
1382974|NCT01236781|diagnostics|diagnostics
1382975|NCT01236781|diagnosis|diagnosis
1382976|NCT01236781|high-risk|high-risk
1382977|NCT01236781|breast neoplasms|breast neoplasms
1382978|NCT01236781|digital mammography|digital mammography
1382979|NCT01236781|mammography|mammography
1382980|NCT01236781|tomosynthesis|tomosynthesis
1382981|NCT01236781|dense breasts|dense breasts
1382982|NCT01236781|radiation dose|radiation dose
1382983|NCT01236781|comparison|comparison
1382984|NCT01236781|Hologic|hologic
1382985|NCT01236781|Pennsylvania|pennsylvania
1382986|NCT01236781|Philadelphia|philadelphia
1382987|NCT01236781|breast study|breast study
1382988|NCT01236781|mammo|mammo
1382989|NCT01236781|tomo|tomo
1382990|NCT01236781|mammary|mammary
1382991|NCT01236768|Contraceptive|contraceptive
1382992|NCT01236755|children|children
1382993|NCT01236755|corneal reshaping|corneal reshaping
1382994|NCT01236755|myopia|myopia
1382995|NCT01236755|myopia progression|myopia progression
1382996|NCT01236755|orthokeratology|orthokeratology
1382997|NCT01236742|children|children
1382998|NCT01236742|corneal reshaping|corneal reshaping
1382999|NCT01236742|myopia|myopia
1383000|NCT01236742|myopia progression|myopia progression
1383001|NCT01236742|orthokeratology|orthokeratology
1383002|NCT01236729|knee replacement|knee replacement
1383003|NCT01236729|disability|disability
1383004|NCT01236729|older people|older people
1383005|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
1383006|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
1383007|NCT01236716|chemotherapy|chemotherapy
1383008|NCT01236703|SIRS|sirs
1383009|NCT01236703|Sepsis|sepsis
1383010|NCT01236703|hematological infection score|hematological infection score
1383011|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
1383012|NCT01236690|Cinobufacin injection|cinobufacin injection
1383013|NCT01236690|hepatoma|hepatoma
1383014|NCT01236677|Pathogen|pathogen
1383015|NCT01236664|memory training|memory training
1383016|NCT01236664|mnemonics|mnemonics
1383017|NCT01236664|cognition|cognition
1383018|NCT01236664|work|work
1383019|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
1383020|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
1383021|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
1383022|NCT01236638|CYT387|cyt387
1383023|NCT01236625|Tissue Adhesions|tissue adhesions
1383024|NCT01236625|Adhesiolysis|adhesiolysis
1383025|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
1383026|NCT01236625|Prospective cohort study|prospective cohort study
1383027|NCT01236625|Quality of life|quality of life
1383028|NCT01236612|Plasmodium|plasmodium
1383029|NCT01236612|falciparum|falciparum
1383030|NCT01236612|malaria|malaria
1383031|NCT01236612|chloroquine|chloroquine
1383032|NCT01236612|immunity|immunity
1383033|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
1383034|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
1383035|NCT01236586|Toxicity|toxicity
1383036|NCT01236586|Pharmacokinetics|pharmacokinetics
1383037|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
1383038|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
1383039|NCT01236586|Cancer|cancer
1383040|NCT01236586|Solid Tumor|solid tumor
1383041|NCT01236586|Brain Tumor|brain tumor
1383042|NCT01236586|Wilms Tumor|wilms tumor
1383043|NCT01236586|Osteosarcoma|osteosarcoma
1383044|NCT01236586|Lymphoma|lymphoma
1383045|NCT01236573|Gene Therapy|gene therapy
1383046|NCT01236573|Immunotherapy|immunotherapy
1383047|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
1383048|NCT01236573|Metastatic Melanoma|metastatic melanoma
1383049|NCT01236534|Multiple Sclerosis|multiple sclerosis
1383050|NCT01236534|Constipation|constipation
1383051|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
1383052|NCT01236521|Back pain|back pain
1383053|NCT01236521|Care Management|care management
1383054|NCT01236521|Pain|pain
1383055|NCT01236521|Patient outcomes|patient outcomes
1383056|NCT01236521|Patient-center Care|patient-center care
1383057|NCT01236521|Primary care|primary care
1383058|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
1383059|NCT01236508|Stroke|stroke
1383060|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
1383061|NCT01236508|FDG PET|fdg pet
1383062|NCT01236508|MRI|mri
1383063|NCT01236508|TIA|tia
1383064|NCT01236495|thoracotomy|thoracotomy
1383065|NCT01236495|postoperative pain|postoperative pain
1383066|NCT01236495|spinal morphine|spinal morphine
1383067|NCT01236482|Pregnancy|pregnancy
1383068|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
1383069|NCT01236482|Uterine tone|uterine tone
1504950|NCT00757367|FDKP|fdkp
1383070|NCT01236482|Oxytocin|oxytocin
1383071|NCT01236482|Ergometrine|ergometrine
1383072|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
1383073|NCT01236469|Aortic Valve|aortic valve
1383074|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
1383075|NCT01236456|cyclophosphamide|cyclophosphamide
1383076|NCT01236456|autoimmune|autoimmune
1383077|NCT01236430|Hyperlipidemia|hyperlipidemia
1383078|NCT01236430|statin|statin
1383079|NCT01236430|Ezetimibe|ezetimibe
1383080|NCT01236430|Zetia|zetia
1383081|NCT01236430|Atorvastatin|atorvastatin
1383082|NCT01236430|Lipitor|lipitor
1383083|NCT01236391|Pharmacyclics|pharmacyclics
1383084|NCT01236391|Mantle|mantle
1383085|NCT01236391|Mantle Cell|mantle cell
1383086|NCT01236391|Lymphoma|lymphoma
1383087|NCT01236391|Non-Hodgkins|non-hodgkins
1383088|NCT01236391|Bortezomib|bortezomib
1383089|NCT01236391|Velcade|velcade
1383090|NCT01236391|Naive|naive
1383091|NCT01236391|PCYC|pcyc
1383092|NCT01236378|Organ Transplants|organ transplants
1383093|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
1383094|NCT01236378|Pharmacokinetics|pharmacokinetics
1383095|NCT01236365|Type 1 diabetes|type 1 diabetes
1383096|NCT01236365|Children|children
1383097|NCT01236365|Statins|statins
1383098|NCT01236365|Hypercholesterolemia|hypercholesterolemia
1383099|NCT01236365|Lipoproteins|lipoproteins
1383100|NCT01236365|C reactive protein|c reactive protein
1383101|NCT01236365|Continuous glucose monitors|continuous glucose monitors
1383102|NCT01236365|Adolescence|adolescence
1383103|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
1383104|NCT01236365|Toll like receptors|toll like receptors
1383105|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
1383106|NCT01236365|Nutrition|nutrition
1383107|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
1383108|NCT01236313|TEE|tee
1383109|NCT01236313|Cardiac Surgery|cardiac surgery
1383110|NCT01236313|Pulse Pressure|pulse pressure
1383111|NCT01236300|Pancreatic cysts|pancreatic cysts
1383112|NCT01236274|Myocardial Infarction|myocardial infarction
1383113|NCT01236274|Antipsychotic agents|antipsychotic agents
1383114|NCT01236274|Self-controlled case series method|self-controlled case series method
1383115|NCT01236274|General Practice Research Database|general practice research database
1383116|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1383117|NCT01236274|CALIBER|caliber
1383118|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
1383119|NCT01236248|drugs|drugs
1383120|NCT01236248|youth|youth
1383121|NCT01236248|parent|parent
1383122|NCT01236248|computer|computer
1383123|NCT01236248|prevention|prevention
1383124|NCT01236222|commuter cycling|commuter cycling
1383125|NCT01236222|fitness|fitness
1383126|NCT01236222|metabolic syndrome|metabolic syndrome
1383127|NCT01236222|children|children
1383128|NCT01236196|pain|pain
1383129|NCT01236196|chronic pain|chronic pain
1383130|NCT01236196|cognitive therapy|cognitive therapy
1383131|NCT01236196|telehealth|telehealth
1383132|NCT01236183|manual skill|manual skill
1383133|NCT01236183|anesthesia residents|anesthesia residents
1383134|NCT01236170|Amputees|amputees
1383135|NCT01236170|spinal cord injuries|spinal cord injuries
1383136|NCT01236170|quality of life|quality of life
1383137|NCT01236170|satisfaction|satisfaction
1383138|NCT01236170|healthcare disparities|healthcare disparities
1383139|NCT01236170|wheelchairs|wheelchairs
1383140|NCT01236157|Cardiology|cardiology
1383141|NCT01236144|Myeloid|myeloid
1383142|NCT01236144|Leukaemia|leukaemia
1383143|NCT01236144|Acute|acute
1383144|NCT01236144|Myelodysplastic|myelodysplastic
1383145|NCT01236144|Pilot|pilot
1383146|NCT01236144|Cardiff|cardiff
1383147|NCT01236144|Haematology|haematology
1383148|NCT01236144|Burnett|burnett
1383149|NCT01236144|AC220|ac220
1383150|NCT01236144|Plerixafor|plerixafor
1383151|NCT01236144|Ganetespib|ganetespib
1383152|NCT01236092|resolution of low back pain|resolution of low back pain
1383153|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
1383154|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
1383155|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
1383156|NCT01236066|Rotarix|rotarix
1383157|NCT01236066|RotaTeq|rotateq
1383158|NCT01236066|Gastroenteritis|gastroenteritis
1383159|NCT01236053|renal cancer|renal cancer
1383160|NCT01236053|pancreatic cancer|pancreatic cancer
1383161|NCT01236053|epidemiology|epidemiology
1383162|NCT01236053|renal cell carcinoma|renal cell carcinoma
1383163|NCT01236053|nervous system cancer|nervous system cancer
1383164|NCT01236053|lung cancer|lung cancer
1383165|NCT01236053|breast cancer|breast cancer
1383166|NCT01236053|case-control|case-control
1383167|NCT01236053|GPRD|gprd
1383168|NCT01236053|Gapabentin|gapabentin
1383169|NCT01236053|cancer|cancer
1383170|NCT01236053|anal cancer|anal cancer
1383171|NCT01236053|bone and joint cancer|bone and joint cancer
1383172|NCT01236053|renal pelvis cancer|renal pelvis cancer
1383173|NCT01236053|penis cancer|penis cancer
1383174|NCT01236053|stomach cancer|stomach cancer
1383175|NCT01236053|bladder cancer|bladder cancer
1383176|NCT01236040|H5N1|h5n1
1383177|NCT01236040|Influenza|influenza
1383178|NCT01236040|Pandemic|pandemic
1383179|NCT01236001|Lacosamide|lacosamide
1383180|NCT01236001|Vimpat®|vimpat®
1383181|NCT01235975|Neisseria meningitidis|neisseria meningitidis
1383182|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
1383183|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
1383184|NCT01235975|meningococcal diseases|meningococcal diseases
1383185|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
1383186|NCT01235975|Immunogenicity|immunogenicity
1383187|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
1383191|NCT01235962|VEGFR inhibitor|vegfr inhibitor
1383192|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
1383193|NCT01235949|Immunogenicity|immunogenicity
1383195|NCT01235949|Fever|fever
1383196|NCT01235949|Primary vaccination|primary vaccination
1383197|NCT01235949|Booster vaccination|booster vaccination
1383198|NCT01235949|Pneumococcal disease|pneumococcal disease
1383199|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
1383200|NCT01235936|anemia|anemia
1383201|NCT01235936|chronic kidney disease|chronic kidney disease
1383202|NCT01235936|CKD|ckd
1383203|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
1383204|NCT01235936|renal impairment|renal impairment
1383205|NCT01235936|erythropoietin|erythropoietin
1383206|NCT01235936|safety|safety
1383207|NCT01235936|efficacy|efficacy
1383208|NCT01235936|tolerability|tolerability
1383209|NCT01235936|pharmacokinetics|pharmacokinetics
1383210|NCT01235923|anemia|anemia
1383211|NCT01235923|transfusions|transfusions
1383212|NCT01235923|erythropoiesis|erythropoiesis
1383213|NCT01235923|neonate|neonate
1383214|NCT01235923|preterm|preterm
1383219|NCT01235897|Neoplasms|neoplasms
1383220|NCT01235897|Paclitaxel|paclitaxel
1383221|NCT01235897|Trastuzumab|trastuzumab
1383222|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
1383223|NCT01235871|Safety|safety
1383224|NCT01235871|Tolerability|tolerability
1383225|NCT01235871|SB1578|sb1578
1383226|NCT01235858|Epidural analgesia|epidural analgesia
1383227|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
1383228|NCT01235858|Aseptic technique|aseptic technique
1383229|NCT01235858|gown|gown
1383230|NCT01235858|no gown|no gown
1383231|NCT01235832|cholesterol|cholesterol
1383232|NCT01235832|triglycerides|triglycerides
1383233|NCT01235832|low-density lipoprotein|low-density lipoprotein
1383234|NCT01235832|high-density lipoprotein|high-density lipoprotein
1383235|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
1383236|NCT01235819|type 1 diabetes|type 1 diabetes
1383237|NCT01235819|exenatide|exenatide
1383238|NCT01235819|sitagliptin|sitagliptin
1383239|NCT01235806|scaphoid|scaphoid
1383240|NCT01235806|MRI|mri
1383241|NCT01235806|ESAOTE|esaote
1383242|NCT01235793|Relapsed|relapsed
1383243|NCT01235793|Refractory|refractory
1383244|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
1383245|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
1383246|NCT01235793|Temozolomide|temozolomide
1383247|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
1383248|NCT01235793|RBEAM|rbeam
1383249|NCT01235793|Conditioning Regimen|conditioning regimen
1383250|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
1383251|NCT01235767|birth weight|birth weight
1383252|NCT01235767|prematurity|prematurity
1383253|NCT01235767|gestational age|gestational age
1383254|NCT01235767|low birth weight|low birth weight
1383255|NCT01235767|pregnancy|pregnancy
1383256|NCT01235767|nutrition|nutrition
1383257|NCT01235767|Vietnam|vietnam
1383258|NCT01235754|testosterone|testosterone
1383259|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
1383260|NCT01235754|menopause|menopause
1383261|NCT01235741|Pramlintide|pramlintide
1383262|NCT01235741|Metreleptin|metreleptin
1383263|NCT01235741|Obesity|obesity
1383264|NCT01235741|Amylin|amylin
1383265|NCT01235741|Takeda|takeda
1383266|NCT01235715|osteoarthritis|osteoarthritis
1383267|NCT01235715|total knee replacement|total knee replacement
1383268|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
1383269|NCT01235676|obesity|obesity
1383270|NCT01235676|lifestyle|lifestyle
1383271|NCT01235676|pregnancy|pregnancy
1383272|NCT01235676|newborn infant|newborn infant
1383273|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
1383274|NCT01235637|COMFORT B score|comfort b score
1383275|NCT01235637|Bis score|bis score
1383276|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
1383277|NCT01235624|Rare disease|rare disease
1383278|NCT01235624|Genetics|genetics
1383279|NCT01235598|Cimzia®|cimzia®
1383280|NCT01235598|CDP870|cdp870
1383282|NCT01235598|Certolizumab Pegol|certolizumab pegol
1383283|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
1383284|NCT01235598|MRI|mri
1383285|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
1383286|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1383287|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
1383288|NCT01235572|De|de
1383581|NCT01234207|Bifocals|bifocals
1383289|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
1383290|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1383291|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1383292|NCT01235546|Pregnancy|pregnancy
1383293|NCT01235546|Cesarean section|cesarean section
1383294|NCT01235546|Antibiotic|antibiotic
1383295|NCT01235546|Infections|infections
1383296|NCT01235533|late-life depression|late-life depression
1383297|NCT01235533|recurrence of depression|recurrence of depression
1383298|NCT01235533|cognition|cognition
1383299|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1383300|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
1383301|NCT01235481|exercise therapy|exercise therapy
1383302|NCT01235481|chronic lung disease|chronic lung disease
1383303|NCT01235481|self-efficacy|self-efficacy
1383304|NCT01235468|umbilical cord blood|umbilical cord blood
1383305|NCT01235468|ex vivo expansion|ex vivo expansion
1383306|NCT01235468|engraftment|engraftment
1383307|NCT01235468|GVHD|gvhd
1383308|NCT01235455|Multiple Sclerosis|multiple sclerosis
1383309|NCT01235455|Adherence|adherence
1383310|NCT01235455|Interferon beta-1b|interferon beta-1b
1383311|NCT01235455|Coping styles|coping styles
1383312|NCT01235442|Psoriasis|psoriasis
1383313|NCT01235442|Topical|topical
1383314|NCT01235442|etanercept|etanercept
1383315|NCT01235442|clobetasol propionate|clobetasol propionate
1383316|NCT01235429|Diabetes|diabetes
1383317|NCT01235429|Behavioral intervention|behavioral intervention
1383318|NCT01235429|diabetes self-management|diabetes self-management
1383319|NCT01235429|Native Hawaiians|native hawaiians
1383320|NCT01235429|health disparities|health disparities
1383321|NCT01235403|Epilepsy treatment.|epilepsy treatment.
1383322|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
1383323|NCT01235403|Seizures|seizures
1383324|NCT01235390|Postmenopausal women|postmenopausal women
1383325|NCT01235390|walnuts|walnuts
1383326|NCT01235377|prescribing patterns|prescribing patterns
1383327|NCT01235377|thiazide|thiazide
1383328|NCT01235377|chlorthalidone|chlorthalidone
1383329|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
1383330|NCT01235377|target dose|target dose
1383331|NCT01235377|cluster randomized trial|cluster randomized trial
1383332|NCT01235364|Foley catheter|foley catheter
1383333|NCT01235364|induction|induction
1383334|NCT01235364|labour|labour
1383335|NCT01235364|skin conductance|skin conductance
1383336|NCT01235364|visual analogue scale|visual analogue scale
1383337|NCT01235364|mechanical method|mechanical method
1383338|NCT01235351|Myocardial infarction|myocardial infarction
1383339|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
1383340|NCT01235351|Clopidogrel|clopidogrel
1383341|NCT01235351|Genetics|genetics
1383342|NCT01235351|Platelet Function|platelet function
1383343|NCT01235325|vitamin K|vitamin k
1383344|NCT01235325|supplementation|supplementation
1383345|NCT01235325|bone health indices|bone health indices
1383346|NCT01235325|adult|adult
1383347|NCT01235325|Crohn's disease|crohn's disease
1383348|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
1383349|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
1383350|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
1383351|NCT01235260|Cancer|cancer
1383352|NCT01235260|Cancer incidence|cancer incidence
1383353|NCT01235260|Cancer mortality|cancer mortality
1383354|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
1383355|NCT01235234|Dry eye disease|dry eye disease
1383356|NCT01235234|KCS|kcs
1383357|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
1383358|NCT01235208|Overweight|overweight
1383359|NCT01235208|Obesity|obesity
1383360|NCT01235208|Metabolic syndrome|metabolic syndrome
1383361|NCT01235208|Diet|diet
1383362|NCT01235208|Carbohydrate|carbohydrate
1383363|NCT01235208|Low glycemic index|low glycemic index
1383364|NCT01235208|Eurodiet|eurodiet
1383365|NCT01235195|bioequivalence study|bioequivalence study
1383366|NCT01235195|sertraline 50 mg|sertraline 50 mg
1383367|NCT01235195|capsules vs tablets|capsules vs tablets
1383368|NCT01235182|acute dyspnea|acute dyspnea
1383369|NCT01235182|prehospital emergency setting|prehospital emergency setting
1383370|NCT01235182|differential diagnosis|differential diagnosis
1383371|NCT01235182|ultrasound|ultrasound
1383372|NCT01235182|NT-proBNP|nt-probnp
1383373|NCT01235156|Premature ventricular contraction|premature ventricular contraction
1383374|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
1383375|NCT01235143|incidence|incidence
1383376|NCT01235143|emergence agitation|emergence agitation
1383377|NCT01235143|sevoflurane|sevoflurane
1383378|NCT01235143|desflurane|desflurane
1383379|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
1383380|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1383381|NCT01235091|HIV prevention|hiv prevention
1383382|NCT01235091|substance abuse|substance abuse
1383383|NCT01235091|high risk behaviors|high risk behaviors
1383960|NCT01232400|esmolol|esmolol
1383384|NCT01235091|peer intervention|peer intervention
1383385|NCT01235065|airway management|airway management
1383386|NCT01235065|trauma|trauma
1383387|NCT01235065|intubation|intubation
1383388|NCT01235052|Head and neck neoplasms|head and neck neoplasms
1383389|NCT01235052|Positron Emission Tomography|positron emission tomography
1383390|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
1383391|NCT01235026|Obesity|obesity
1383392|NCT01235026|Type-2 Diabetes|type-2 diabetes
1383393|NCT01235026|Metabolic syndrome|metabolic syndrome
1383394|NCT01235026|Low grade inflammation|low grade inflammation
1383395|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
1383396|NCT01235026|Insulin resistance|insulin resistance
1383397|NCT01235026|Lipopolysaccharide|lipopolysaccharide
1383398|NCT01235026|LPS-binding protein|lps-binding protein
1383399|NCT01235026|sCD14|scd14
1383400|NCT01235026|Synbiotic|synbiotic
1383401|NCT01235026|Oligofructose|oligofructose
1383402|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
1383403|NCT01235026|probiotic|probiotic
1383404|NCT01235026|Prebiotic|prebiotic
1383405|NCT01235013|HIV-1 infection|hiv-1 infection
1383406|NCT01235013|Maraviroc|maraviroc
1383407|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
1383408|NCT01235000|Influenza vaccines|influenza vaccines
1383409|NCT01235000|Infant|infant
1383410|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
1383411|NCT01235000|Prime-boost response|prime-boost response
1383412|NCT01234987|Cancer|cancer
1383413|NCT01234987|Breast Cancer|breast cancer
1383414|NCT01234987|Colon cancer|colon cancer
1383415|NCT01234987|Lung Cancer|lung cancer
1383416|NCT01234974|multiple myeloma|multiple myeloma
1383417|NCT01234948|Halitosis|halitosis
1383418|NCT01234948|VSC|vsc
1383419|NCT01234948|Periodontitis|periodontitis
1383420|NCT01234948|Gingivitis|gingivitis
1383421|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
1383422|NCT01234948|Real-time PCR|real-time pcr
1383423|NCT01234909|Missed immunizations|missed immunizations
1383424|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1383425|NCT01234883|dehydration|dehydration
1383426|NCT01234883|gastroenteritis|gastroenteritis
1383427|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
1383428|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
1383429|NCT01234857|mTOR|mtor
1383430|NCT01234857|breast cancer|breast cancer
1383431|NCT01234857|estrogen receptor positive|estrogen receptor positive
1383432|NCT01234844|pet-therapy|pet-therapy
1383433|NCT01234844|guinea-pigs|guinea-pigs
1383434|NCT01234844|rehabilitation|rehabilitation
1383435|NCT01234844|elderly|elderly
1383436|NCT01234831|MRSA|mrsa
1383437|NCT01234831|colonization|colonization
1383438|NCT01234831|nucleic acid amplification|nucleic acid amplification
1383439|NCT01234831|chromogenic agar|chromogenic agar
1383440|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
1383441|NCT01234818|LNG-IUS|lng-ius
1383442|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1383443|NCT01234753|Adults with CHD|adults with chd
1383444|NCT01234753|GUCH|guch
1383445|NCT01234753|Congenital heart disease|congenital heart disease
1383446|NCT01234753|Computer-based education|computer-based education
1383447|NCT01234753|Nursing|nursing
1383448|NCT01234740|Los Angeles|los angeles
1383449|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
1383450|NCT01234714|Fatty Liver|fatty liver
1383451|NCT01234714|Liver|liver
1383452|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
1383453|NCT01234714|Surgery|surgery
1383454|NCT01234701|Liver|liver
1383455|NCT01234701|Neoplasms|neoplasms
1383456|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
1383457|NCT01234701|Surgery|surgery
1383458|NCT01234701|Pathology|pathology
1383459|NCT01234688|Exercise Tolerance|exercise tolerance
1383460|NCT01234688|Physical Endurance|physical endurance
1383461|NCT01234675|Fibromyalgia|fibromyalgia
1383462|NCT01234675|Sleep disorders|sleep disorders
1383463|NCT01234675|Forest Laboratories|forest laboratories
1383464|NCT01234675|Milnacipran|milnacipran
1383465|NCT01234662|Elective cesarean sections|elective cesarean sections
1383466|NCT01234662|Postoperative pain level|postoperative pain level
1383467|NCT01234662|Spinal anesthesia|spinal anesthesia
1383468|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
1383469|NCT01234662|Epidural catheter|epidural catheter
1383470|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
1383471|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
1383472|NCT01234649|metabolic dysfunction|metabolic dysfunction
1383473|NCT01234649|impaired fasting glucose|impaired fasting glucose
1383474|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
1383475|NCT01234649|incretin mimetic|incretin mimetic
1383476|NCT01234636|Platelets|platelets
1383477|NCT01234636|Platelet aggregation|platelet aggregation
1383478|NCT01234636|Platelet activation|platelet activation
1383479|NCT01234636|Platelet function|platelet function
1383480|NCT01234636|Light transmission aggregometry|light transmission aggregometry
1383481|NCT01234636|Flow cytometry|flow cytometry
1383482|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
1383483|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
1383484|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
1383485|NCT01234636|dietary supplement|dietary supplement
1383486|NCT01234636|short-term intervention|short-term intervention
1383487|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
1383488|NCT01234610|Exercise|exercise
1383489|NCT01234610|Aortic aneurysm|aortic aneurysm
1383490|NCT01234610|Feasibility|feasibility
1383491|NCT01234610|Vascular disease|vascular disease
1383492|NCT01234571|Pulmonary hypertension|pulmonary hypertension
1383493|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
1383494|NCT01234571|End-stage renal disease|end-stage renal disease
1383495|NCT01234571|Hemo-dialysis|hemo-dialysis
1383496|NCT01234558|depression|depression
1383497|NCT01234558|NMDA antagonist|nmda antagonist
1383498|NCT01234558|treatment resistant|treatment resistant
1383499|NCT01234519|ureter cancer|ureter cancer
1383500|NCT01234519|renal pelvis cancer|renal pelvis cancer
1383501|NCT01234519|bladder cancer|bladder cancer
1383502|NCT01234519|urethra|urethra
1383503|NCT01234506|long term care|long term care
1383504|NCT01234506|lignans|lignans
1383505|NCT01234506|oxidative stress|oxidative stress
1383506|NCT01234506|inflammation|inflammation
1383507|NCT01234506|aging|aging
1383508|NCT01234506|dementia|dementia
1383509|NCT01234506|postural balance|postural balance
1383510|NCT01234506|depression|depression
1383511|NCT01234506|muscle weakness|muscle weakness
1383512|NCT01234506|quality of life|quality of life
1383513|NCT01234506|pain|pain
1383514|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
1383515|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1383516|NCT01234467|Elderly|elderly
1383517|NCT01234467|Newly Diagnosed|newly diagnosed
1383518|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1383519|NCT01234467|University of North Carolina|university of north carolina
1383520|NCT01234467|Bendamustine|bendamustine
1383521|NCT01234467|Rituximab|rituximab
1383522|NCT01234467|Rituxan|rituxan
1383523|NCT01234467|Treanda|treanda
1383524|NCT01234467|Phase 2|phase 2
1383525|NCT01234467|Geriatric|geriatric
1383526|NCT01234467|Lymphoma|lymphoma
1383527|NCT01234428|laparoscopy|laparoscopy
1383528|NCT01234428|adjustable gastric banding|adjustable gastric banding
1383529|NCT01234428|morbid obesity|morbid obesity
1383530|NCT01234428|esophageal motility|esophageal motility
1383531|NCT01234428|esophageal dilatation|esophageal dilatation
1383532|NCT01234415|nasal|nasal
1383533|NCT01234415|septum|septum
1383534|NCT01234415|reconstruction|reconstruction
1383535|NCT01234402|Breast Cancer|breast cancer
1383536|NCT01234363|Renal allograft|renal allograft
1383537|NCT01234363|kidney|kidney
1383538|NCT01234363|fibrosis|fibrosis
1383539|NCT01234363|elastography|elastography
1383540|NCT01234363|elasticity|elasticity
1383541|NCT01234337|Breast Cancer|breast cancer
1383542|NCT01234337|HER2-neu|her2-neu
1383543|NCT01234324|Stomach Neoplasms|stomach neoplasms
1383544|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
1383545|NCT01234324|gastric cancer|gastric cancer
1383546|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
1383547|NCT01234285|sepsis|sepsis
1383548|NCT01234285|septic shock|septic shock
1383549|NCT01234285|anticoagulation|anticoagulation
1383550|NCT01234285|intensive care unit|intensive care unit
1383551|NCT01234272|patients with|patients with
1383552|NCT01234272|undergoing|undergoing
1383553|NCT01234272|gastrectomy|gastrectomy
1383554|NCT01234259|Wrinkles|wrinkles
1383555|NCT01234259|rhytides|rhytides
1383556|NCT01234259|Cellulite|cellulite
1383557|NCT01234259|circumference reduction|circumference reduction
1383558|NCT01234246|Colorectal cancer|colorectal cancer
1383559|NCT01234246|Sexual function|sexual function
1383560|NCT01234246|Sexual dysfunction|sexual dysfunction
1383561|NCT01234246|Quality of (sexual) life|quality of (sexual) life
1383562|NCT01234246|Partners|partners
1383563|NCT01234246|Body image|body image
1383564|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
1383565|NCT01234246|Depressive symptoms|depressive symptoms
1383566|NCT01234246|Personality|personality
1383567|NCT01234233|hypothermia, accidental|hypothermia, accidental
1383568|NCT01234233|prewarming|prewarming
1383569|NCT01234233|body temperature monitoring|body temperature monitoring
1383570|NCT01234233|preoperative warming|preoperative warming
1383571|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
1383572|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
1383573|NCT01234220|Aldosterone|aldosterone
1383574|NCT01234220|Primary Aldosteronism|primary aldosteronism
1383575|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
1383576|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
1383577|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
1383578|NCT01234207|Progressive addition lenses|progressive addition lenses
1383579|NCT01234207|Customized free-form|customized free-form
1383580|NCT01234207|Presbyopia|presbyopia
1383582|NCT01234207|Subjective assessment|subjective assessment
1383583|NCT01234207|Visual performance|visual performance
1383584|NCT01234207|Visual acuity|visual acuity
1383585|NCT01234207|Amsler grid|amsler grid
1383586|NCT01234194|Composite Variability Index|composite variability index
1383587|NCT01234194|Bispectral Index|bispectral index
1383588|NCT01234194|Electromyography|electromyography
1383589|NCT01234194|Nociception|nociception
1383591|NCT01234155|Exercise|exercise
1383592|NCT01234155|Diabetes|diabetes
1383593|NCT01234155|Obesity|obesity
1383594|NCT01234155|Insulin Sensitivity|insulin sensitivity
1383595|NCT01234155|Insulin Secretion|insulin secretion
1383596|NCT01234155|Beta-cell Function|beta-cell function
1383597|NCT01234155|Glycemic Control|glycemic control
1383598|NCT01234155|GIP|gip
1383599|NCT01234155|GLP-1|glp-1
1383600|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
1383601|NCT01234129|multiple myeloma|multiple myeloma
1383602|NCT01234129|stem cell transplant|stem cell transplant
1383603|NCT01234129|zoledronic acid|zoledronic acid
1383604|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
1383605|NCT01234116|Health Care Workers|health care workers
1383606|NCT01234103|sexually transmitted infection|sexually transmitted infection
1383607|NCT01234103|sexual risk|sexual risk
1383608|NCT01234103|HIV|hiv
1383609|NCT01234103|young adults|young adults
1383610|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
1383611|NCT01234090|Aphasia|aphasia
1383612|NCT01234090|Quality of Life|quality of life
1383613|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
1383614|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
1383615|NCT01234064|Graduated Compression Stockings|graduated compression stockings
1383616|NCT01234064|Randomized Controlled Trial|randomized controlled trial
1383617|NCT01234064|Noncardiac Surgery|noncardiac surgery
1383618|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
1383619|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
1383620|NCT01234012|melanoma|melanoma
1383621|NCT01234012|breast cancer|breast cancer
1383622|NCT01234012|ovarian cancer|ovarian cancer
1383623|NCT01234012|prostate cancer|prostate cancer
1383624|NCT01234012|esophageal cancer|esophageal cancer
1383625|NCT01234012|uterine cancer|uterine cancer
1383626|NCT01234012|sarcoma|sarcoma
1383627|NCT01234012|NY-ESO-1|ny-eso-1
1383628|NCT01233999|Scleroderma|scleroderma
1383629|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
1383630|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
1383631|NCT01233986|Atherosclerosis|atherosclerosis
1383632|NCT01233986|Apolipoprotein B48|apolipoprotein b48
1383633|NCT01233973|nursing home|nursing home
1383634|NCT01233973|advance care planning|advance care planning
1383635|NCT01233960|Crohn's Disease|crohn's disease
1383636|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
1383637|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
1383638|NCT01233934|Insect bites|insect bites
1383639|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
1383640|NCT01233934|Gel|gel
1383641|NCT01233934|Cream|cream
1383642|NCT01233882|Renal impairment|renal impairment
1383643|NCT01233882|healthy volunteers|healthy volunteers
1383644|NCT01233869|Bosutinib|bosutinib
1383645|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1383646|NCT01233856|ADHD|adhd
1383647|NCT01233843|induction chemotherapy|induction chemotherapy
1383648|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
1383649|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
1383650|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
1383651|NCT01233817|Neuromuscular disorder|neuromuscular disorder
1383652|NCT01233817|Progressive strength training|progressive strength training
1383653|NCT01233817|Children|children
1383654|NCT01233804|influenza vaccination rates|influenza vaccination rates
1383655|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
1383656|NCT01233791|levator pain|levator pain
1383657|NCT01233791|dyspareunia|dyspareunia
1383658|NCT01233778|Cardiovascular disease|cardiovascular disease
1383659|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
1383660|NCT01233778|Inflammation|inflammation
1383661|NCT01233778|Endothelial function|endothelial function
1383662|NCT01233778|Canola oil|canola oil
1383663|NCT01233765|Periodontitis|periodontitis
1383664|NCT01233765|Neutrophil|neutrophil
1383665|NCT01233765|Inflammation|inflammation
1383666|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
1383667|NCT01233752|pharmacogenetics|pharmacogenetics
1383668|NCT01233752|pharmacokinetics|pharmacokinetics
1383669|NCT01233739|rhizarthrosis|rhizarthrosis
1383670|NCT01233739|Chondroitin sulfate|chondroitin sulfate
1383671|NCT01233739|Placebo|placebo
1383672|NCT01233726|Critical illness|critical illness
1383673|NCT01233726|Hyperglycemia|hyperglycemia
1383674|NCT01233726|Mechanical Ventilation|mechanical ventilation
1383675|NCT01233726|Enteral nutrition|enteral nutrition
1383676|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
1383677|NCT01233726|Malnutrition|malnutrition
1383678|NCT01233726|Insulin resistance|insulin resistance
1383679|NCT01233726|Metabolic stress|metabolic stress
1383680|NCT01233713|Emergency Surgery|emergency surgery
1383681|NCT01233713|Bowel perforation|bowel perforation
1383682|NCT01233713|Diverticulitis|diverticulitis
1383683|NCT01233713|Neoplasms|neoplasms
1383684|NCT01233713|Postoperative Complications|postoperative complications
1383685|NCT01233713|Randomized Controlled Trial|randomized controlled trial
1383686|NCT01233700|living donation|living donation
1383687|NCT01233700|organ donation|organ donation
1383688|NCT01233700|psychological adaptation|psychological adaptation
1383689|NCT01233700|mental health|mental health
1383690|NCT01233700|physical well-being|physical well-being
1383691|NCT01233700|interpersonal relations|interpersonal relations
1383692|NCT01233700|quality of life|quality of life
1383693|NCT01233700|psychosocial factors|psychosocial factors
1383694|NCT01233687|Recurrent|recurrent
1383695|NCT01233687|progressive|progressive
1383696|NCT01233687|advanced|advanced
1383697|NCT01233648|heart failure|heart failure
1383698|NCT01233648|CRT-D|crt-d
1383699|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
1383700|NCT01233609|valproic acid|valproic acid
1383701|NCT01233609|visual field|visual field
1383702|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
1383703|NCT01233596|monocanalicular intubation|monocanalicular intubation
1383704|NCT01233596|bicanalicular intubation|bicanalicular intubation
1383705|NCT01233596|complications|complications
1383706|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
1383707|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
1383708|NCT01233570|Topical Tacrolimus|topical tacrolimus
1383709|NCT01233570|Protopic|protopic
1383710|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
1383711|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
1383712|NCT01233570|Granulomatous chelitis|granulomatous chelitis
1383713|NCT01233570|Oral crohns disease|oral crohns disease
1383714|NCT01233570|Perianal crohns disease|perianal crohns disease
1383715|NCT01233544|Colorectal carcinoma|colorectal carcinoma
1383716|NCT01233544|Liver metastases|liver metastases
1383717|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
1383718|NCT01233544|Radiofrequency ablation|radiofrequency ablation
1383719|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
1383720|NCT01233492|adult glioblastoma|adult glioblastoma
1383721|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
1383722|NCT01233492|adult gliosarcoma|adult gliosarcoma
1383723|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1383724|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1383725|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
1383726|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1383727|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
1383728|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1383729|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1383730|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1383731|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
1383732|NCT01233414|Autism|autism
1383733|NCT01233414|Children|children
1383734|NCT01233414|Behavior Therapy|behavior therapy
1383735|NCT01233414|Aggression|aggression
1383736|NCT01233414|Tantrums|tantrums
1383737|NCT01233414|Noncompliance|noncompliance
1383738|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
1383739|NCT01233375|cancer|cancer
1383740|NCT01233375|metastatic|metastatic
1383741|NCT01233375|pancreatic|pancreatic
1383742|NCT01233375|pancreas|pancreas
1383743|NCT01233375|adenocarcinoma|adenocarcinoma
1383744|NCT01233375|gemcitabine|gemcitabine
1383745|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
1383746|NCT01233375|CO-1.01|co-1.01
1383747|NCT01233375|CO-101|co-101
1383748|NCT01233375|CO101|co101
1383749|NCT01233375|Stage 4|stage 4
1383750|NCT01233375|Stage IV|stage iv
1383751|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
1383752|NCT01233375|Second-Line Therapy|second-line therapy
1383753|NCT01233362|Cholera|cholera
1383754|NCT01233362|Vaccine|vaccine
1383755|NCT01233362|Kolkata|kolkata
1383756|NCT01233362|West Bengal|west bengal
1383757|NCT01233362|India|india
1383758|NCT01233362|Immunogenicity|immunogenicity
1383759|NCT01233362|Vaccination Schedules|vaccination schedules
1383760|NCT01233349|overweight|overweight
1383761|NCT01233349|obesity|obesity
1383762|NCT01233349|weight loss|weight loss
1383763|NCT01233349|body fat|body fat
1383764|NCT01233349|waist circumference|waist circumference
1383765|NCT01233349|satiety|satiety
1383766|NCT01233336|ACS,|acs,
1383767|NCT01233336|HGF,|hgf,
1383768|NCT01233336|myocardial infarction|myocardial infarction
1383769|NCT01233336|markers of myocardial injury|markers of myocardial injury
1383770|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
1383771|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
1383772|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
1383773|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1383774|NCT01233323|Heart Failure|heart failure
1383775|NCT01233323|Heart Diseases|heart diseases
1383776|NCT01233310|Crohn's Disease|crohn's disease
1383777|NCT01233297|wheeze|wheeze
1383778|NCT01233297|infections|infections
1383779|NCT01233271|algorithm|algorithm
1383780|NCT01233271|tight glycemic control|tight glycemic control
1383781|NCT01233271|glucose control|glucose control
1383782|NCT01233271|intensive care|intensive care
1383783|NCT01233271|insulin|insulin
1383785|NCT01233258|Haemophilia treatment|haemophilia treatment
1383786|NCT01233258|rFVIII|rfviii
1383787|NCT01233245|Multiple Sclerosis|multiple sclerosis
1383788|NCT01233245|Adherence|adherence
1383789|NCT01233245|Interferon beta-1b|interferon beta-1b
1383790|NCT01233245|Coping Styles|coping styles
1383791|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
1383792|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
1383793|NCT01233219|pharmacogenetics|pharmacogenetics
1383794|NCT01233219|pharmacokinetics|pharmacokinetics
1383795|NCT01233206|PCOS|pcos
1383796|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
1383797|NCT01233206|Cancelled cycles|cancelled cycles
1383798|NCT01233206|OHSS|ohss
1383799|NCT01233206|Infertility|infertility
1383800|NCT01233193|Home blood pressure measurement|home blood pressure measurement
1383801|NCT01233193|Pharmaceutical Services|pharmaceutical services
1383802|NCT01233193|Medication adherence|medication adherence
1383803|NCT01233193|hypertension management|hypertension management
1383804|NCT01233193|Blood Pressure|blood pressure
1383805|NCT01233180|neck pain|neck pain
1383806|NCT01233180|massage|massage
1383807|NCT01233180|hyperthermia, induced|hyperthermia, induced
1383808|NCT01233180|touch perception|touch perception
1383809|NCT01233180|randomized controlled trial|randomized controlled trial
1383810|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
1383811|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
1383812|NCT01233167|major adverse cardiac events|major adverse cardiac events
1383813|NCT01233167|bleeding|bleeding
1383814|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
1383815|NCT01233102|liver Cirrhosis|liver cirrhosis
1383816|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
1383817|NCT01233102|Hepatic artery infusion|hepatic artery infusion
1383818|NCT01233102|Intravenous infusion|intravenous infusion
1383819|NCT01233089|Myopia|myopia
1383820|NCT01233089|contact lenses|contact lenses
1383821|NCT01233089|children|children
1383822|NCT01233063|behavior change|behavior change
1383823|NCT01233063|physical activity|physical activity
1383824|NCT01233063|nutrition|nutrition
1383825|NCT01233063|fruits and vegetables|fruits and vegetables
1383826|NCT01233063|saturated fat|saturated fat
1383827|NCT01233063|trans fat|trans fat
1383828|NCT01233063|added sugars|added sugars
1383829|NCT01233063|email|email
1383830|NCT01233063|web|web
1383831|NCT01233063|obesity|obesity
1383832|NCT01233063|aging|aging
1383833|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
1383834|NCT01233024|Adult|adult
1383835|NCT01233024|Women|women
1383836|NCT01233024|Dietary Fiber|dietary fiber
1383837|NCT01233024|Satiety Response|satiety response
1383838|NCT01233024|Food Intake|food intake
1383839|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
1383840|NCT01233011|Pediatric|pediatric
1383841|NCT01233011|Observational study|observational study
1383842|NCT01232998|Patient Satisfaction|patient satisfaction
1383843|NCT01232985|Atopic Dermatitis|atopic dermatitis
1383844|NCT01232985|Pruritus|pruritus
1383845|NCT01232972|vitrification|vitrification
1383846|NCT01232972|egg freezing|egg freezing
1383847|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
1383848|NCT01232972|female fertility potential|female fertility potential
1383849|NCT01232972|fertility preservation|fertility preservation
1383850|NCT01232972|Fertility preservation, female|fertility preservation, female
1383851|NCT01232959|Gallbladder removal|gallbladder removal
1383852|NCT01232946|Diabetes|diabetes
1383853|NCT01232946|Myocardial metabolism|myocardial metabolism
1383855|NCT01232920|uveitis|uveitis
1383856|NCT01232920|antimetabolite|antimetabolite
1383857|NCT01232920|immunosuppressive|immunosuppressive
1383858|NCT01232920|clinical trial|clinical trial
1383859|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
1383860|NCT01232894|indacaterol|indacaterol
1383861|NCT01232894|COPD|copd
1383862|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
1383863|NCT01232868|Innate immunity|innate immunity
1383864|NCT01232868|Adaptive immunity|adaptive immunity
1383865|NCT01232868|Slu shot|slu shot
1383866|NCT01232868|Elderly|elderly
1383867|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1383868|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1383869|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1383870|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1383871|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1383872|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1383873|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1383874|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
1383875|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1383876|NCT01232803|Rectal Microbicides|rectal microbicides
1383877|NCT01232803|Tenofovir|tenofovir
1383878|NCT01232803|Rectal use|rectal use
1383879|NCT01232803|Rectal mucosal damage|rectal mucosal damage
1383880|NCT01232790|Schizophrenia|schizophrenia
1383881|NCT01232790|working memory|working memory
1383882|NCT01232790|N-Acetylcysteine|n-acetylcysteine
1383883|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
1383884|NCT01232777|Bevacizumab|bevacizumab
1383885|NCT01232777|Avastin|avastin
1383886|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1383887|NCT01232751|health|health
1383888|NCT01232751|women|women
1383889|NCT01232725|BSID III|bsid iii
1383890|NCT01232725|Human Milk|human milk
1383891|NCT01232725|Donor Human Milk|donor human milk
1383892|NCT01232725|Preterm infant|preterm infant
1383893|NCT01232725|Breastfeeding|breastfeeding
1383894|NCT01232712|MUC1|muc1
1383895|NCT01232712|ImMucin|immucin
1383896|NCT01232712|Vaccine|vaccine
1383897|NCT01232712|Multiple Myeloma|multiple myeloma
1383898|NCT01232699|obesity|obesity
1383899|NCT01232699|weight loss|weight loss
1383900|NCT01232699|internet treatment|internet treatment
1383901|NCT01232699|motivational interviewing|motivational interviewing
1383902|NCT01232686|Communicable Diseases|communicable diseases
1383903|NCT01232686|Epidemiology|epidemiology
1383904|NCT01232686|Population surveillance|population surveillance
1383905|NCT01232686|Computerized Medical Record|computerized medical record
1383906|NCT01232686|Data collection|data collection
1383907|NCT01232673|Critical Limb Ischemia|critical limb ischemia
1383908|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
1383909|NCT01232673|Diabetes Mellitus|diabetes mellitus
1383910|NCT01232673|Major Amputation|major amputation
1383911|NCT01232647|osteoporosis|osteoporosis
1383912|NCT01232647|vitamin K|vitamin k
1383913|NCT01232647|BONE MINERAL DENSITY|bone mineral density
1383914|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
1383915|NCT01232634|pediatrics|pediatrics
1383916|NCT01232634|haemophilia|haemophilia
1383917|NCT01232634|ultrasound|ultrasound
1383918|NCT01232634|MRI|mri
1383919|NCT01232634|arthropathy|arthropathy
1383920|NCT01232608|Coronary Artery Disease|coronary artery disease
1383921|NCT01232608|Atherosclerosis.|atherosclerosis.
1383922|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
1383923|NCT01232608|Exercise|exercise
1383924|NCT01232608|HbA1c|hba1c
1383925|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
1383926|NCT01232608|Inflammation|inflammation
1383927|NCT01232595|Clostridium difficile,|clostridium difficile,
1383928|NCT01232595|C. difficile,|c. difficile,
1383929|NCT01232595|CDI,|cdi,
1383930|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
1383931|NCT01232595|CDAD,|cdad,
1383932|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
1383933|NCT01232595|PMC,|pmc,
1383934|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
1383935|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
1383936|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
1383937|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
1383938|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1383939|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
1383940|NCT01232543|Atopic Dermatitis|atopic dermatitis
1383941|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
1383942|NCT01232504|Allo-HSCT|allo-hsct
1383943|NCT01232504|rhGM-CSF|rhgm-csf
1383944|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
1383945|NCT01232478|Cystic Fibrosis|cystic fibrosis
1383946|NCT01232478|Adherence|adherence
1383947|NCT01232478|Problem-Solving|problem-solving
1383948|NCT01232478|Adolescents|adolescents
1383949|NCT01232478|Education|education
1383950|NCT01232478|Skills Remediation|skills remediation
1383951|NCT01232465|sperm DNA integrity|sperm dna integrity
1383952|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
1383953|NCT01232465|IVF outcome|ivf outcome
1383954|NCT01232452|lung cancer|lung cancer
1383955|NCT01232452|advanced|advanced
1383956|NCT01232452|non-small cell|non-small cell
1383957|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
1383958|NCT01232413|ASP1941|asp1941
1383959|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
1383961|NCT01232400|cardiac function|cardiac function
1383962|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
1383963|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
1383964|NCT01232387|neonatal anemia|neonatal anemia
1383965|NCT01232387|perinatal epidemiology|perinatal epidemiology
1383966|NCT01232387|Kleihauer-Betke|kleihauer-betke
1383967|NCT01232387|flow cytometry|flow cytometry
1383968|NCT01232374|Nimotuzumab|nimotuzumab
1383969|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
1383970|NCT01232374|chemo-irradiation|chemo-irradiation
1383971|NCT01232361|ADHD|adhd
1383973|NCT01232361|Pharmacokinetics|pharmacokinetics
1383974|NCT01232348|bronchial asthma|bronchial asthma
1383975|NCT01232348|Symbicort|symbicort
1383976|NCT01232335|bronchial asthma|bronchial asthma
1383977|NCT01232335|Symbicort|symbicort
1383978|NCT01232335|long term use,|long term use,
1383979|NCT01232322|bronchial asthma|bronchial asthma
1383980|NCT01232322|Pulmicort Respules|pulmicort respules
1383981|NCT01232322|long term use|long term use
1383982|NCT01232322|pediatrics|pediatrics
1383983|NCT01232309|Arterial Health|arterial health
1383984|NCT01232309|Fiber|fiber
1383985|NCT01232309|Chitin-glucan|chitin-glucan
1383986|NCT01232309|oxidized LDL|oxidized ldl
1383987|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
1383988|NCT01232296|HCC|hcc
1383989|NCT01232296|Liver cancer|liver cancer
1383990|NCT01232296|Child Pugh A|child pugh a
1383991|NCT01232296|HCC Stage C|hcc stage c
1383992|NCT01232257|Chronic kidney disease|chronic kidney disease
1383993|NCT01232257|Chronic kidney failure|chronic kidney failure
1383994|NCT01232257|End stage kidney disease|end stage kidney disease
1383995|NCT01232257|End stage renal disease|end stage renal disease
1383996|NCT01232257|Hydrogen sulfide|hydrogen sulfide
1383997|NCT01232257|N-acetylcysteine|n-acetylcysteine
1383998|NCT01232257|Acetylcysteine|acetylcysteine
1383999|NCT01232244|Incretin hormones|incretin hormones
1384000|NCT01232244|Glucagon|glucagon
1384001|NCT01232244|Satiety|satiety
1384002|NCT01232244|Hunger|hunger
1384003|NCT01232244|Energy expenditure|energy expenditure
1384004|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1384005|NCT01232231|decolonization|decolonization
1384006|NCT01232231|random allocation|random allocation
1384007|NCT01232231|outpatient|outpatient
1384008|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
1384009|NCT01232218|Stroke|stroke
1384010|NCT01232218|Hemiplegic|hemiplegic
1384011|NCT01232218|Shoulder pain|shoulder pain
1384012|NCT01232218|range of motion|range of motion
1384013|NCT01232218|scapula|scapula
1384014|NCT01232218|mobilization|mobilization
1384015|NCT01232205|antioxidant supplementation|antioxidant supplementation
1385285|NCT01226147|SLE|sle
1384016|NCT01232205|preeclampsia|preeclampsia
1384017|NCT01232153|chest tube|chest tube
1384018|NCT01232153|preoxygenation|preoxygenation
1384019|NCT01232153|NIV|niv
1384020|NCT01232153|out-of-hospital|out-of-hospital
1384021|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
1384022|NCT01232140|COPD|copd
1384023|NCT01232140|exacerbation|exacerbation
1384024|NCT01232140|antibiotic treatment|antibiotic treatment
1384025|NCT01232140|CRP|crp
1384026|NCT01232140|sputum|sputum
1384027|NCT01232140|inflammation|inflammation
1384028|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
1384029|NCT01232088|drug labelling|drug labelling
1384030|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
1384031|NCT01232088|European ICU|european icu
1384032|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
1384033|NCT01232062|breast neoplasm|breast neoplasm
1384034|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
1384035|NCT01232062|Drug Therapy|drug therapy
1384036|NCT01232049|healthy volunteers|healthy volunteers
1384037|NCT01232036|healthy volunteers|healthy volunteers
1384038|NCT01232023|Indobufen|indobufen
1384039|NCT01232023|healthy volunteers|healthy volunteers
1384040|NCT01232010|SK-3530|sk-3530
1384041|NCT01232010|renal impairment|renal impairment
1384042|NCT01232010|healthy volunteers|healthy volunteers
1384043|NCT01231997|Udenafil|udenafil
1384044|NCT01231997|DA-8159|da-8159
1384045|NCT01231997|renal impairment|renal impairment
1384046|NCT01231997|healthy volunteers|healthy volunteers
1384047|NCT01231984|diabetes|diabetes
1384048|NCT01231984|obesity|obesity
1384049|NCT01231984|hypoglycemia|hypoglycemia
1384050|NCT01231984|hyperglycemia|hyperglycemia
1384051|NCT01231984|pen needle|pen needle
1384052|NCT01231971|amyloid|amyloid
1384053|NCT01231971|plaques|plaques
1384054|NCT01231971|neuroimaging|neuroimaging
1384055|NCT01231971|biomarkers|biomarkers
1384056|NCT01231971|cognition disorder|cognition disorder
1384057|NCT01231971|early detection|early detection
1384058|NCT01231971|Amnestic MCI|amnestic mci
1384059|NCT01231971|pre-dementia|pre-dementia
1384060|NCT01231971|dementia|dementia
1384061|NCT01231971|Alzheimer's disease|alzheimer's disease
1384062|NCT01231971|tau|tau
1384063|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
1384064|NCT01231945|Cervical Cancer|cervical cancer
1384065|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1384066|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1384067|NCT01231932|Fatigue|fatigue
1384068|NCT01231932|Cancer|cancer
1384069|NCT01231932|Cancer Therapy|cancer therapy
1384070|NCT01231932|Cancer Treatment|cancer treatment
1384071|NCT01231932|Gene Expression Patterns|gene expression patterns
1384072|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
1384073|NCT01231880|Malaria|malaria
1384074|NCT01231867|Coronary Heart Disease|coronary heart disease
1384075|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
1384076|NCT01231867|Drug interactions|drug interactions
1384077|NCT01231867|Clopidogrel|clopidogrel
1384078|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
1384079|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1384080|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
1384081|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
1384082|NCT01231828|sleep|sleep
1384083|NCT01231828|cirrhosis|cirrhosis
1384084|NCT01231828|encephalopathy|encephalopathy
1384085|NCT01231828|simulated driving|simulated driving
1384086|NCT01231828|sleep disorders|sleep disorders
1384087|NCT01231815|Heart transplantation|heart transplantation
1384088|NCT01231789|cardiac surgery|cardiac surgery
1384089|NCT01231789|RIPC|ripc
1384090|NCT01231789|brain injury|brain injury
1384091|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
1384092|NCT01231776|sleep|sleep
1384093|NCT01231776|acupuncture|acupuncture
1384094|NCT01231763|HIV prevention|hiv prevention
1384095|NCT01231763|Vaginal film|vaginal film
1384096|NCT01231763|Microbicide|microbicide
1384097|NCT01231763|Administration, intravaginal|administration, intravaginal
1384098|NCT01231737|Prophylasy|prophylasy
1384099|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
1384100|NCT01231737|prulifloxacin|prulifloxacin
1384101|NCT01231737|phosphomycin|phosphomycin
1384102|NCT01231711|depression|depression
1384103|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
1384104|NCT01231711|functional status|functional status
1384105|NCT01231711|veteran|veteran
1384106|NCT01231711|military|military
1384107|NCT01231711|stigma|stigma
1384108|NCT01231711|mental health self-efficacy|mental health self-efficacy
1384109|NCT01231698|septic shock|septic shock
1384110|NCT01231698|esmolol|esmolol
1384111|NCT01231698|tachycardia|tachycardia
1384112|NCT01231698|betablockers|betablockers
1384113|NCT01231685|Liver fibrosis|liver fibrosis
1384114|NCT01231685|HIV|hiv
1384115|NCT01231685|Hepatitis C Virus|hepatitis c virus
1384116|NCT01231685|Coinfection|coinfection
1384117|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
1384118|NCT01231659|Letrozole|letrozole
1384119|NCT01231659|Breast cancer|breast cancer
1384120|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
1384121|NCT01231659|Estrogen receptor positive|estrogen receptor positive
1384122|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
1384123|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
1384124|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
1384125|NCT01231646|Epilepsy|epilepsy
1384126|NCT01231646|Psychiatric conditions|psychiatric conditions
1384127|NCT01231633|Macular Edema|macular edema
1384128|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
1384129|NCT01231620|Seasonal Influenza|seasonal influenza
1384130|NCT01231620|Pandemic|pandemic
1384131|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
1384132|NCT01231620|Influenza|influenza
1384133|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
1384134|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
1384135|NCT01231620|Influenza, seasonal|influenza, seasonal
1384136|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
1384137|NCT01231620|Zanamivir|zanamivir
1384138|NCT01231620|Pharmacologic Actions|pharmacologic actions
1384139|NCT01231620|Antiviral Agents|antiviral agents
1384140|NCT01231620|Anti-Infective Agents|anti-infective agents
1384141|NCT01231620|H1N1|h1n1
1384142|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
1384143|NCT01231620|Influenza B virus|influenza b virus
1384144|NCT01231594|BRAF Inhibitor|braf inhibitor
1384145|NCT01231594|Cancer|cancer
1384146|NCT01231594|Safety|safety
1384147|NCT01231594|GSK2118436|gsk2118436
1384148|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
1384149|NCT01231568|food effect; high fat meal|food effect; high fat meal
1384150|NCT01231568|GSK2118436|gsk2118436
1384151|NCT01231568|pharmacokinetic|pharmacokinetic
1384152|NCT01231568|particle size|particle size
1384153|NCT01231568|BRAF inhibitor|braf inhibitor
1384154|NCT01231568|BRAF positive tumor|braf positive tumor
1384155|NCT01231555|antiretroviral|antiretroviral
1384156|NCT01231555|HAART|haart
1384157|NCT01231555|NNRTI|nnrti
1384158|NCT01231555|emtricitabine|emtricitabine
1384159|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
1384261|NCT01231035|antiplatelet therapy|antiplatelet therapy
1384160|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
1384161|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
1384162|NCT01231555|tenofovir|tenofovir
1384163|NCT01231555|abacavir|abacavir
1384164|NCT01231555|Retroviridae Infections|retroviridae infections
1384165|NCT01231555|GSK2248761|gsk2248761
1384166|NCT01231555|lamivudine|lamivudine
1384167|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
1384168|NCT01231555|HIV infection|hiv infection
1384169|NCT01231555|efavirenz|efavirenz
1384170|NCT01231542|GSK1349572|gsk1349572
1384171|NCT01231542|pharmacokinetics|pharmacokinetics
1384172|NCT01231542|dolutegravir|dolutegravir
1384173|NCT01231542|integrase|integrase
1384174|NCT01231542|rifabutin|rifabutin
1384175|NCT01231542|rifampin|rifampin
1384176|NCT01231516|ART-experienced|art-experienced
1384177|NCT01231516|Integrase inhibitor|integrase inhibitor
1384178|NCT01231516|Raltegravir|raltegravir
1384179|NCT01231516|GSK1349572|gsk1349572
1384180|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
1384181|NCT01231503|Africa|africa
1384182|NCT01231503|malaria vaccine|malaria vaccine
1384183|NCT01231503|schedule|schedule
1384185|NCT01231503|Plasmodium falciparum|plasmodium falciparum
1384186|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
1384187|NCT01231477|sevoflurane|sevoflurane
1384188|NCT01231477|Cytokines|cytokines
1384189|NCT01231477|Immune response|immune response
1384190|NCT01231464|safety|safety
1384191|NCT01231464|efficacy|efficacy
1384192|NCT01231464|placebo|placebo
1384193|NCT01231464|allergic rhinitis|allergic rhinitis
1384194|NCT01231464|fluticasone furoate|fluticasone furoate
1384195|NCT01231451|HIV Infection|hiv infection
1384196|NCT01231438|Renal failure stage 3B|renal failure stage 3b
1384197|NCT01231425|Back pain|back pain
1384198|NCT01231425|cervicalgia|cervicalgia
1384199|NCT01231425|dorsalgia|dorsalgia
1384200|NCT01231425|lumbalgia|lumbalgia
1384201|NCT01231425|acupuncture|acupuncture
1384202|NCT01231386|Female Breast Cancer|female breast cancer
1384203|NCT01231386|miRNA expression|mirna expression
1384204|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
1384205|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
1384206|NCT01231373|varicose veins|varicose veins
1384207|NCT01231360|claudication|claudication
1384208|NCT01231360|peripheral artery disease|peripheral artery disease
1384209|NCT01231360|PAD|pad
1384210|NCT01231347|pancreas|pancreas
1384211|NCT01231347|gemcitabine|gemcitabine
1384212|NCT01231347|metastatic|metastatic
1384213|NCT01231347|jaundice|jaundice
1384308|NCT01230905|Coronary Artery Disease|coronary artery disease
1384309|NCT01230879|Aging lung|aging lung
1384214|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
1384215|NCT01231256|Quality of life|quality of life
1384216|NCT01231256|preventive health consultation|preventive health consultation
1384217|NCT01231256|General practice|general practice
1384218|NCT01231256|resources|resources
1384219|NCT01231256|life style|life style
1384220|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
1384221|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
1384222|NCT01231204|Breast Cancer|breast cancer
1384223|NCT01231204|Mastectomy|mastectomy
1384224|NCT01231204|UCSD|ucsd
1384225|NCT01231204|Surgery|surgery
1384226|NCT01231204|PVB Catheter|pvb catheter
1384227|NCT01231204|Paravertebral Catheter|paravertebral catheter
1384228|NCT01231204|Breast Pain|breast pain
1384229|NCT01231204|Mastectomy Pain|mastectomy pain
1384230|NCT01231204|Postoperative Pain|postoperative pain
1384231|NCT01231139|Brain Injury|brain injury
1384232|NCT01231139|Temperature|temperature
1384233|NCT01231139|Paracetamol|paracetamol
1384234|NCT01231139|Phase 2|phase 2
1384235|NCT01231139|TBI|tbi
1384236|NCT01231126|Induced labor|induced labor
1384237|NCT01231126|Misoprostol|misoprostol
1384238|NCT01231126|Postpartum blood|postpartum blood
1384239|NCT01231126|Erythrocyte indices|erythrocyte indices
1384240|NCT01231126|Vaginal delivery|vaginal delivery
1384241|NCT01231113|malaria,|malaria,
1384242|NCT01231113|pregnancy,|pregnancy,
1384243|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
1384244|NCT01231113|efficacy,|efficacy,
1384245|NCT01231113|safety,|safety,
1384246|NCT01231113|Ghana|ghana
1384247|NCT01231087|energy expenditure|energy expenditure
1384248|NCT01231087|morbid obesity|morbid obesity
1384249|NCT01231087|bariatric surgery|bariatric surgery
1384250|NCT01231087|nutritional follow-up|nutritional follow-up
1384251|NCT01231074|obesity|obesity
1384252|NCT01231074|weight gain|weight gain
1384253|NCT01231074|metformin|metformin
1384254|NCT01231074|psychotropic drugs|psychotropic drugs
1384255|NCT01231061|spine metastasis|spine metastasis
1384256|NCT01231061|SBRT|sbrt
1384257|NCT01231061|Radiosurgery|radiosurgery
1384258|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
1384259|NCT01231035|stent thrombosis|stent thrombosis
1384260|NCT01231035|platelet function|platelet function
1384262|NCT01231022|breast neoplasm|breast neoplasm
1384263|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
1384264|NCT01231022|Stem Cells|stem cells
1384265|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
1384266|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
1384267|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1384268|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1384269|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
1384270|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
1384271|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
1384272|NCT01230996|stage III cervical cancer|stage iii cervical cancer
1384273|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
1384274|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1384275|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1384276|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1384277|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1384278|NCT01230983|cardiac toxicity|cardiac toxicity
1384279|NCT01230957|Clostridium difficile infection|clostridium difficile infection
1384280|NCT01230957|Diarrhea|diarrhea
1384281|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
1384282|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
1384283|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
1384284|NCT01230944|GERD|gerd
1384286|NCT01230944|CNF|cnf
1384287|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
1384288|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
1384289|NCT01230944|Antireflux surgery|antireflux surgery
1384290|NCT01230931|Acetabulum|acetabulum
1384291|NCT01230931|Fracture|fracture
1384292|NCT01230931|Hemostatis|hemostatis
1384293|NCT01230931|Vitagel|vitagel
1384294|NCT01230931|Fibrin sealant|fibrin sealant
1384295|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1384296|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
1384297|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
1384298|NCT01230918|Fibrogenesis|fibrogenesis
1384299|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
1384300|NCT01230918|Sudden Death|sudden death
1384301|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
1384302|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
1384303|NCT01230905|Hormonal Toxicity|hormonal toxicity
1384304|NCT01230905|Quantitative PET|quantitative pet
1384305|NCT01230905|Myocardial blood flow|myocardial blood flow
1384306|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
1384307|NCT01230905|Endothelial dysfunction|endothelial dysfunction
1384717|NCT01228916|smoking|smoking
1384310|NCT01230879|Airway remodeling|airway remodeling
1384311|NCT01230879|Airway segmentation|airway segmentation
1384312|NCT01230879|Chest CT|chest ct
1384313|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
1384314|NCT01230840|fiber|fiber
1384315|NCT01230840|calcium|calcium
1384316|NCT01230840|magnesium|magnesium
1384317|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1384318|NCT01230827|golimumab|golimumab
1384319|NCT01230827|juvenile arthritis|juvenile arthritis
1384320|NCT01230827|GO KIDS|go kids
1384321|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
1384322|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
1384323|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
1384324|NCT01230788|ALL|all
1384325|NCT01230788|Leukemia|leukemia
1384326|NCT01230788|Rituximab|rituximab
1384327|NCT01230788|Pediatrics|pediatrics
1384328|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
1384329|NCT01230762|Premature ejaculation|premature ejaculation
1384330|NCT01230762|Sexual dysfunction|sexual dysfunction
1384331|NCT01230762|Sexual intercourse|sexual intercourse
1384332|NCT01230762|Ejaculation|ejaculation
1384333|NCT01230762|Erectile Dysfunction|erectile dysfunction
1384334|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1384335|NCT01230749|Diabetes Mellitus|diabetes mellitus
1384336|NCT01230749|Hyperglycemia|hyperglycemia
1384337|NCT01230749|JNJ-41443532|jnj-41443532
1384338|NCT01230749|Pioglitazone|pioglitazone
1384339|NCT01230749|Placebo|placebo
1384340|NCT01230697|Advanced|advanced
1384341|NCT01230697|hepatocarcinoma|hepatocarcinoma
1384342|NCT01230684|CEUS|ceus
1384343|NCT01230684|Endoleaks|endoleaks
1384344|NCT01230684|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1384345|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
1384346|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
1384347|NCT01230632|assisted reproduction technology|assisted reproduction technology
1384348|NCT01230632|Metabolic risk factors|metabolic risk factors
1384349|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
1384350|NCT01230606|Percutaneous Intervention|percutaneous intervention
1384351|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
1384352|NCT01230606|Catheterization|catheterization
1384353|NCT01230606|Coronary Catheterization|coronary catheterization
1384354|NCT01230606|Same day Discharge|same day discharge
1384355|NCT01230606|Next Day Discharge|next day discharge
1384356|NCT01230606|Patient Satisfaction|patient satisfaction
1384357|NCT01230606|Multi-Center|multi-center
1384358|NCT01230606|Randomized|randomized
1384359|NCT01230606|Low-risk PCI|low-risk pci
1384360|NCT01230606|BlindedClosure device|blindedclosure device
1384361|NCT01230606|Vascular closure device|vascular closure device
1384362|NCT01230580|Protease Inhibitors|protease inhibitors
1384363|NCT01230580|RNA virus infections|rna virus infections
1384364|NCT01230580|Virus diseases|virus diseases
1384365|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
1384366|NCT01230580|Immune system diseases|immune system diseases
1384367|NCT01230580|Anti-infective Agents|anti-infective agents
1384368|NCT01230580|Drug resistance|drug resistance
1384369|NCT01230567|Problem wounds|problem wounds
1384370|NCT01230567|Non healing wounds|non healing wounds
1384372|NCT01230567|SCC|scc
1384373|NCT01230567|Vasculitis|vasculitis
1384374|NCT01230554|contact lens|contact lens
1384375|NCT01230541|Semen characteristics|semen characteristics
1384376|NCT01230541|Erectile Dysfunction|erectile dysfunction
1384377|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
1384378|NCT01230502|immunosuppression|immunosuppression
1384379|NCT01230502|anti-rejection|anti-rejection
1384380|NCT01230502|immune tolerance|immune tolerance
1384381|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
1384382|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1384383|NCT01230476|Chemoradiation|chemoradiation
1384384|NCT01230476|Cetuximab|cetuximab
1384385|NCT01230463|Pain, Postoperative|pain, postoperative
1384386|NCT01230463|Ketorolac|ketorolac
1384387|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1384388|NCT01230463|Intraoperative Care|intraoperative care
1384389|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
1384390|NCT01230437|montelukast|montelukast
1384391|NCT01230437|asthma|asthma
1384392|NCT01230437|allergic rhinitis|allergic rhinitis
1384393|NCT01230437|nasal epithelial cells|nasal epithelial cells
1384394|NCT01230437|inflammatory mediators|inflammatory mediators
1384395|NCT01230424|OA|oa
1384396|NCT01230424|Knee arthritis|knee arthritis
1384397|NCT01230424|MRI|mri
1384398|NCT01230424|Steroid|steroid
1384399|NCT01230411|Episodic migraine|episodic migraine
1384400|NCT01230385|lersivirine|lersivirine
1384401|NCT01230385|UK-453|uk-453
1384402|NCT01230385|061|061
1384403|NCT01230385|safety|safety
1384404|NCT01230385|tolerability|tolerability
1384405|NCT01230385|pharmacokinetics|pharmacokinetics
1384406|NCT01230385|HIV|hiv
1384407|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1384408|NCT01230385|NNRTI|nnrti
1384409|NCT01230359|Autism|autism
1384410|NCT01230359|Children|children
1384411|NCT01230359|ASD|asd
1384412|NCT01230359|Vitamin B6|vitamin b6
1384413|NCT01230359|Magnesium|magnesium
1384414|NCT01230320|Cost estimates|cost estimates
1384415|NCT01230320|Complete Denture|complete denture
1384416|NCT01230320|Dental Economics|dental economics
1384417|NCT01230320|Dental Impression Technique|dental impression technique
1384418|NCT01230320|Denture Retention|denture retention
1384419|NCT01230320|Edentulous|edentulous
1384420|NCT01230320|Edentulism|edentulism
1384421|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
1384422|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
1384423|NCT01230320|Patient Satisfaction|patient satisfaction
1384424|NCT01230320|Quality of Health Care|quality of health care
1384425|NCT01230320|Quality of Life|quality of life
1384426|NCT01230307|Vitamin D|vitamin d
1384427|NCT01230307|Systolic failure|systolic failure
1384428|NCT01230307|Genomics|genomics
1384429|NCT01230307|Biomarkers|biomarkers
1384430|NCT01230307|Exercise|exercise
1384431|NCT01230307|Quality of Life|quality of life
1384432|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
1384433|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
1384434|NCT01230294|strain measurement|strain measurement
1384435|NCT01230294|chronic heart failure|chronic heart failure
1384436|NCT01230294|pulmonary hypertension|pulmonary hypertension
1384438|NCT01230281|Oxidative stress|oxidative stress
1384439|NCT01230281|Antioxidant|antioxidant
1384440|NCT01230281|Black bean|black bean
1384441|NCT01230268|C3G|c3g
1384442|NCT01230268|Oxidative stress|oxidative stress
1384443|NCT01230268|Antioxidant|antioxidant
1384444|NCT01230268|Mulberry|mulberry
1384445|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
1384446|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
1384447|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
1384448|NCT01230255|open abdomen|open abdomen
1384449|NCT01230255|percutaneous|percutaneous
1384450|NCT01230242|Mirena|mirena
1384451|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
1384452|NCT01230242|postpartum insertion|postpartum insertion
1384453|NCT01230229|Intermittent claudication|intermittent claudication
1384454|NCT01230229|Superficial femoral artery|superficial femoral artery
1384455|NCT01230229|Stenting|stenting
1384456|NCT01230229|Medical treatment|medical treatment
1384457|NCT01230229|Quality of life|quality of life
1384458|NCT01230216|coronary artery disease|coronary artery disease
1384459|NCT01230216|hypertension|hypertension
1384460|NCT01230190|infants|infants
1384461|NCT01230190|adaptive immunology|adaptive immunology
1384462|NCT01230190|atopic dermatitis|atopic dermatitis
1384463|NCT01230190|probiotics|probiotics
1384464|NCT01230151|Deep Brain Stimulation|deep brain stimulation
1384466|NCT01230151|Parkinson's disease|parkinson's disease
1384467|NCT01230151|PD|pd
1384468|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
1384469|NCT01230125|Inflammation|inflammation
1384470|NCT01230125|Pain|pain
1384471|NCT01230125|Ocular surgery|ocular surgery
1384472|NCT01230099|Critical Illness|critical illness
1384473|NCT01230099|Mechanical Ventilation|mechanical ventilation
1384474|NCT01230099|Palliative Care|palliative care
1384475|NCT01230099|Caregivers|caregivers
1384476|NCT01230086|ICD|icd
1384477|NCT01230086|DFT-testing|dft-testing
1384478|NCT01230073|ICD|icd
1384479|NCT01230073|Home-Monitoring|home-monitoring
1384480|NCT01230073|Quality of life|quality of life
1384481|NCT01230060|ocular surgery|ocular surgery
1384482|NCT01230060|phacoemulsification|phacoemulsification
1384483|NCT01230047|depression|depression
1384484|NCT01230047|anxiety|anxiety
1384485|NCT01230047|psychoeducation|psychoeducation
1384486|NCT01230047|self-help|self-help
1384487|NCT01230047|psychosocial|psychosocial
1384488|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
1384489|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
1384490|NCT01230008|radiotherapy|radiotherapy
1384491|NCT01230008|chemotherapy|chemotherapy
1384492|NCT01230008|rituximab|rituximab
1384493|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
1384494|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1384495|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1384496|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1384497|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
1384498|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1384499|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1384500|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
1385010|NCT01227473|diabetes|diabetes
1384501|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
1384502|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
1384503|NCT01229891|vitamin D fortification|vitamin d fortification
1384504|NCT01229891|yogurt drink|yogurt drink
1384505|NCT01229891|type 2 diabetes|type 2 diabetes
1384506|NCT01229891|efficacy|efficacy
1384507|NCT01229852|Fibromyalgia|fibromyalgia
1384508|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1384509|NCT01229852|Pain|pain
1384510|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
1384511|NCT01229839|Liver Neoplasms|liver neoplasms
1384512|NCT01229839|Therapeutic|therapeutic
1384513|NCT01229839|Chemoembolization,|chemoembolization,
1384514|NCT01229839|TACE|tace
1384515|NCT01229839|pharmacokinetics|pharmacokinetics
1384516|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
1384517|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
1384518|NCT01229839|Humans|humans
1384519|NCT01229826|Uterine fibroids|uterine fibroids
1384520|NCT01229826|Uterine leiomyomas|uterine leiomyomas
1384521|NCT01229826|MR Elastography|mr elastography
1384522|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1384523|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1384524|NCT01229813|Untreated|untreated
1384525|NCT01229813|First line|first line
1384526|NCT01229813|Chemotherapy|chemotherapy
1384527|NCT01229813|Maintenance treatment|maintenance treatment
1384528|NCT01229813|KRAS wt|kras wt
1384529|NCT01229813|KRAS mutated|kras mutated
1384530|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
1384531|NCT01229813|Metronomic capecitabine|metronomic capecitabine
1384532|NCT01229813|bevacizumab|bevacizumab
1384533|NCT01229813|erlotinib|erlotinib
1384534|NCT01229813|Translational research|translational research
1384535|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
1384536|NCT01229787|asthma|asthma
1384537|NCT01229787|allergies|allergies
1384538|NCT01229787|obesity|obesity
1384539|NCT01229761|HIV|hiv
1384540|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1384541|NCT01229761|Breast Feeding|breast feeding
1384542|NCT01229761|Infant Mortality|infant mortality
1384543|NCT01229761|Morbidity|morbidity
1384550|NCT01229735|epilepsy|epilepsy
1384551|NCT01229735|partial seizures|partial seizures
1384552|NCT01229722|adherence|adherence
1384553|NCT01229722|reminders|reminders
1384554|NCT01229722|text messages|text messages
1384556|NCT01229722|mHealth|mhealth
1384557|NCT01229709|Tinnitus|tinnitus
1384558|NCT01229709|Mindfulness|mindfulness
1384559|NCT01229709|MBSR|mbsr
1384560|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1384561|NCT01229709|MBTR|mbtr
1384562|NCT01229696|Popliteal|popliteal
1384563|NCT01229696|UCSD|ucsd
1384564|NCT01229696|Postoperative pain|postoperative pain
1384565|NCT01229696|Foot surgery|foot surgery
1384566|NCT01229696|Ankle surgery|ankle surgery
1384567|NCT01229696|Popliteal Catheter|popliteal catheter
1384568|NCT01229696|Popliteal Nerve Block|popliteal nerve block
1384569|NCT01229696|Lower extremity surgery|lower extremity surgery
1384570|NCT01229696|Bifurcation|bifurcation
1384571|NCT01229696|Catheter Insertion Site|catheter insertion site
1384572|NCT01229683|UCSD|ucsd
1384573|NCT01229683|Perineural Nerve Block|perineural nerve block
1384574|NCT01229683|Shoulder Surgery|shoulder surgery
1384575|NCT01229683|Pain|pain
1384576|NCT01229683|Grip Strength|grip strength
1384577|NCT01229683|Sensation|sensation
1384578|NCT01229683|Interscalene Nerve Block|interscalene nerve block
1384579|NCT01229670|Heart failure|heart failure
1384580|NCT01229670|Hemorheology|hemorheology
1384581|NCT01229670|Atherothrombosis|atherothrombosis
1384582|NCT01229670|Angiogenesis|angiogenesis
1384583|NCT01229657|Reopening of macular hole;|reopening of macular hole;
1384584|NCT01229657|Visual acuity;|visual acuity;
1384585|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
1384586|NCT01229657|Vitrectomy|vitrectomy
1384594|NCT01229631|Periodontitis|periodontitis
1384595|NCT01229631|Dietary supplementation|dietary supplementation
1384596|NCT01229618|Prostate Cancer|prostate cancer
1384597|NCT01229592|infection|infection
1384598|NCT01229592|catheter|catheter
1384599|NCT01229592|bacteriaemia|bacteriaemia
1384600|NCT01229592|ethanol|ethanol
1384601|NCT01229579|poliomyelitis|poliomyelitis
1384603|NCT01229579|zinc supplement|zinc supplement
1384604|NCT01229579|diarrhea|diarrhea
1384605|NCT01229579|placebo|placebo
1384606|NCT01229579|double blind randomized control trial|double blind randomized control trial
1384607|NCT01229579|elemental zinc|elemental zinc
1384608|NCT01229579|seroconversion|seroconversion
1384609|NCT01229579|bOPV|bopv
1384610|NCT01229579|infants|infants
1384611|NCT01229579|immunity|immunity
1384612|NCT01229527|Colonoscopy|colonoscopy
1384613|NCT01229527|Remifentanil|remifentanil
1384614|NCT01229527|Sedation|sedation
1384615|NCT01229514|Children|children
1384616|NCT01229514|before|before
1384617|NCT01229514|the age of 2 years|the age of 2 years
1385101|NCT01226862|Stroke|stroke
1384618|NCT01229475|Atrial fibrillation|atrial fibrillation
1384619|NCT01229475|recurrence|recurrence
1384620|NCT01229475|repeat procedure|repeat procedure
1384621|NCT01229475|linear ablation|linear ablation
1384622|NCT01229475|stepwise approach|stepwise approach
1384623|NCT01229449|Dental pain|dental pain
1384624|NCT01229449|Ibuprofen|ibuprofen
1384625|NCT01229449|Acetaminophen|acetaminophen
1384626|NCT01229449|Nurofen Plus®|nurofen plus®
1384627|NCT01229449|Panadeine® Extra|panadeine® extra
1384628|NCT01229436|Dupuytren's|dupuytren's
1384629|NCT01229436|treatment|treatment
1384630|NCT01229436|injection|injection
1384631|NCT01229436|recovery|recovery
1384632|NCT01229436|health care resources|health care resources
1384633|NCT01229397|Influenza|influenza
1384634|NCT01229397|Virus|virus
1384635|NCT01229397|Vaccination|vaccination
1384636|NCT01229397|Immunisation|immunisation
1384637|NCT01229371|Influenza|influenza
1384639|NCT01229371|Vaccination|vaccination
1384640|NCT01229371|Immunisation|immunisation
1384641|NCT01229358|vascular surgery|vascular surgery
1384642|NCT01229358|wound infection|wound infection
1384643|NCT01229358|wound complication|wound complication
1384644|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
1384645|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
1384646|NCT01229293|Mechanical muscle function|mechanical muscle function
1384647|NCT01229293|Muscle strength|muscle strength
1384648|NCT01229293|Hip replacement|hip replacement
1384649|NCT01229293|Osteoarthritis|osteoarthritis
1384650|NCT01229293|Hip arthroplasty|hip arthroplasty
1384651|NCT01229280|Bioequivalence|bioequivalence
1384652|NCT01229280|Darifenacin|darifenacin
1384653|NCT01229280|Healthy volunteers|healthy volunteers
1384654|NCT01229280|Postprandial|postprandial
1384655|NCT01229267|Herpes zoster|herpes zoster
1384656|NCT01229267|vaccine|vaccine
1384657|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
1384658|NCT01229267|immunocompromised|immunocompromised
1384659|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
1384660|NCT01229254|Betrixaban|betrixaban
1384661|NCT01229254|MK-4448|mk-4448
1384662|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
1384663|NCT01229241|local anesthetic|local anesthetic
1384664|NCT01229241|epidural|epidural
1384665|NCT01229241|pharmacokinetics|pharmacokinetics
1384666|NCT01229241|plasmatic concentration|plasmatic concentration
1384667|NCT01229241|epidural continuous infusion|epidural continuous infusion
1384668|NCT01229202|trabeculectomy|trabeculectomy
1384669|NCT01229202|glaucoma surgery|glaucoma surgery
1384670|NCT01229202|bevacizumab|bevacizumab
1384671|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
1384672|NCT01229202|glaucoma|glaucoma
1384673|NCT01229189|Vitamin D|vitamin d
1384674|NCT01229189|Effectiveness|effectiveness
1384675|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
1384676|NCT01229163|Motivational Incentive|motivational incentive
1384677|NCT01229163|Automation|automation
1384678|NCT01229163|Contingency Management|contingency management
1384679|NCT01229163|Counseling Adherance|counseling adherance
1384680|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
1384681|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
1384682|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
1384683|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
1384684|NCT01229150|PERK Level|perk level
1384685|NCT01229150|Lung Cancer|lung cancer
1384686|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
1384687|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1384688|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
1384689|NCT01229072|Safety|safety
1384690|NCT01229072|Non-inferiority|non-inferiority
1384691|NCT01229059|FFA|ffa
1384692|NCT01229059|insulin resistance|insulin resistance
1384693|NCT01229059|mitochondria|mitochondria
1384694|NCT01229046|presumed sepsis|presumed sepsis
1384695|NCT01229033|Atrial fibrillation|atrial fibrillation
1384696|NCT01229033|ablation|ablation
1384697|NCT01229033|atrial flutter|atrial flutter
1384698|NCT01229020|Emphysema|emphysema
1384699|NCT01229020|COPD|copd
1384700|NCT01229020|lung sounds|lung sounds
1384701|NCT01229020|vibration response imaging|vibration response imaging
1384702|NCT01229007|Hemophilia A|hemophilia a
1384703|NCT01229007|Children|children
1384704|NCT01228994|smoking cessation treatment|smoking cessation treatment
1384705|NCT01228994|baclofen|baclofen
1384706|NCT01228994|Smoking cessation counselling|smoking cessation counselling
1384707|NCT01228968|obesity|obesity
1384708|NCT01228942|ovarian cancer|ovarian cancer
1384709|NCT01228942|fallopian tube cancer|fallopian tube cancer
1384710|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
1384711|NCT01228929|Dry Eye|dry eye
1384712|NCT01228929|Non-invasive instruments|non-invasive instruments
1384713|NCT01228929|MGD|mgd
1384714|NCT01228929|Environment|environment
1384715|NCT01228929|Thermal Imaging|thermal imaging
1384716|NCT01228916|tobacco|tobacco
1384718|NCT01228916|secondhand smoke|secondhand smoke
1384719|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
1384720|NCT01228851|Parkinson's Disease|parkinson's disease
1384721|NCT01228851|Rehabilitation|rehabilitation
1384722|NCT01228851|Balance|balance
1384723|NCT01228851|Exercise|exercise
1384724|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
1384725|NCT01228851|H&Y 2.5-3|h&y 2.5-3
1384726|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
1384727|NCT01228838|PHN|phn
1384728|NCT01228838|capsaicin|capsaicin
1384729|NCT01228838|herpes zoster|herpes zoster
1384730|NCT01228838|shingles|shingles
1384731|NCT01228838|analgesics|analgesics
1384732|NCT01228838|neuropathy|neuropathy
1384733|NCT01228825|Cardiac surgery|cardiac surgery
1384734|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
1384735|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
1384736|NCT01228825|Cefuroxime|cefuroxime
1384737|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
1384738|NCT01228799|trabeculectomy,|trabeculectomy,
1384739|NCT01228799|canaloplasty,|canaloplasty,
1384740|NCT01228799|glaucoma surgery|glaucoma surgery
1384741|NCT01228799|non-penetrating surgery|non-penetrating surgery
1384742|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
1384743|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
1384744|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1384758|NCT01228708|COPD|copd
1384759|NCT01228695|steroids|steroids
1384760|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
1384761|NCT01228682|Sodium|sodium
1384762|NCT01228682|SIADH|siadh
1384763|NCT01228682|Hyponatremia|hyponatremia
1384764|NCT01228682|Vasopressin|vasopressin
1384765|NCT01228682|Salt|salt
1384766|NCT01228682|Water|water
1384767|NCT01228656|Psoriasis|psoriasis
1384768|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
1384769|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
1384770|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
1384771|NCT01228617|Smoking Cessation|smoking cessation
1384772|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
1384773|NCT01228604|open label|open label
1384774|NCT01228604|Ritalin®|ritalin®
1384775|NCT01228604|ADHD|adhd
1384776|NCT01228578|Multivitamins|multivitamins
1384777|NCT01228578|HIV/AIDS|hiv/aids
1384778|NCT01228578|Immune reconstitution|immune reconstitution
1384779|NCT01228578|Weight Gain|weight gain
1384780|NCT01228578|Quality of Life|quality of life
1384781|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
1384782|NCT01228552|Acute Migraine Treatment|acute migraine treatment
1384783|NCT01228552|Migraine Treatment|migraine treatment
1384784|NCT01228552|Migraine|migraine
1384785|NCT01228552|Headache|headache
1384786|NCT01228552|Treatment|treatment
1384787|NCT01228539|PTSD|ptsd
1384788|NCT01228539|Anger|anger
1384789|NCT01228539|Aggression|aggression
1384790|NCT01228539|Military|military
1384791|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
1384792|NCT01228487|Oxidative Stress|oxidative stress
1384793|NCT01228487|Biomarker|biomarker
1384794|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
1384795|NCT01228461|Adolescent and Young Adults|adolescent and young adults
1384796|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
1384797|NCT01228448|PET|pet
1384798|NCT01228435|NSCLC|nsclc
1384799|NCT01228435|IPI-504|ipi-504
1384800|NCT01228435|ALK translocation|alk translocation
1384801|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
1384802|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
1384803|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
1384804|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
1384805|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
1384806|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
1384807|NCT01228409|Psoriasis|psoriasis
1384808|NCT01228409|phototherapy|phototherapy
1384809|NCT01228409|soriatane|soriatane
1384810|NCT01228409|acitretin|acitretin
1384811|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
1384812|NCT01228396|bladder|bladder
1384813|NCT01228396|optic neuritis|optic neuritis
1384814|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
1384815|NCT01228396|AIMSPRO|aimspro
1384816|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
1384817|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
1384818|NCT01228383|Monoclonal antibody|monoclonal antibody
1384819|NCT01228383|Rabies|rabies
1384820|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
1384821|NCT01228370|sildosin|sildosin
1384822|NCT01228370|neurogenic bladder|neurogenic bladder
1384823|NCT01228370|voiding dysfunction|voiding dysfunction
1384824|NCT01228357|Pharmacogenomics|pharmacogenomics
1384825|NCT01228357|Depressed Patients|depressed patients
1384826|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
1384827|NCT01228344|demographics|demographics
1384828|NCT01228344|malaria|malaria
1384829|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1384830|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1384831|NCT01228318|HAART|haart
1384832|NCT01228318|Antiresorptive drugs|antiresorptive drugs
1384833|NCT01228318|HIV/AIDS|hiv/aids
1384834|NCT01228318|Bone loss|bone loss
1384835|NCT01228305|ventricular septal defect|ventricular septal defect
1384836|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
1384837|NCT01228305|oxidative stress|oxidative stress
1384838|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
1384839|NCT01228305|acetaminophen|acetaminophen
1384840|NCT01228305|hemolysis|hemolysis
1384841|NCT01228305|acute kidney injury|acute kidney injury
1384842|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
1384843|NCT01228292|Anticoagulation|anticoagulation
1384844|NCT01228292|Intensive Care Medicine|intensive care medicine
1384845|NCT01228292|Hemodialysis|hemodialysis
1384846|NCT01228292|Critical Ill Patients|critical ill patients
1384847|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
1384848|NCT01228279|Dialysis Solutions|dialysis solutions
1384849|NCT01228279|Artificial Kidney|artificial kidney
1384850|NCT01228279|Renal Replacement Therapy|renal replacement therapy
1384851|NCT01228279|Renal Dialysis|renal dialysis
1384852|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
1384853|NCT01228279|Leptin|leptin
1384854|NCT01228279|Icodextrin|icodextrin
1384855|NCT01228266|Multiple Sclerosis|multiple sclerosis
1384856|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
1384857|NCT01228227|Myonecrosis|myonecrosis
1384858|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
1384859|NCT01228227|Myocardial Infarction|myocardial infarction
1384860|NCT01228188|FTMH|ftmh
1384862|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
1384863|NCT01228149|glaucoma|glaucoma
1384864|NCT01228149|trabeculectomy|trabeculectomy
1384865|NCT01228149|intraocular pressure|intraocular pressure
1384866|NCT01228136|Adenotonsillectomy|adenotonsillectomy
1384867|NCT01228136|Tranexamic acid|tranexamic acid
1384868|NCT01228136|Blood loss|blood loss
1384869|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
1384870|NCT01228084|sulforaphane|sulforaphane
1384871|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
1384872|NCT01228084|prostate cancer|prostate cancer
1384873|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
1384874|NCT01228084|phase II|phase ii
1384875|NCT01228071|testosterone deficiency|testosterone deficiency
1384876|NCT01228071|hypogonadism|hypogonadism
1384877|NCT01228058|Trauma|trauma
1384878|NCT01228058|Coagulopathy|coagulopathy
1384879|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
1384880|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
1384881|NCT01228019|Usual practice re-examination|usual practice re-examination
1384882|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
1384883|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
1384884|NCT01227993|Finasteride|finasteride
1384885|NCT01227993|Proscar|proscar
1384886|NCT01227993|Retinal Eye Disease|retinal eye disease
1384887|NCT01227980|Addiction|addiction
1384888|NCT01227980|Alcohol|alcohol
1384889|NCT01227980|Alcohol Treatment|alcohol treatment
1384890|NCT01227980|Alcoholics|alcoholics
1384891|NCT01227980|Alcohol Dependence|alcohol dependence
1384892|NCT01227980|Anxiety Disorder|anxiety disorder
1384893|NCT01227980|Alcoholism|alcoholism
1384894|NCT01227967|Adaptive Design|adaptive design
1384895|NCT01227967|At Risk|at risk
1384896|NCT01227967|H1N1|h1n1
1384897|NCT01227967|Synergy|synergy
1384898|NCT01227967|TCAD|tcad
1384899|NCT01227954|cognitive/functional effects|cognitive/functional effects
1384900|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
1384901|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1384902|NCT01227941|advanced solid tumors|advanced solid tumors
1384903|NCT01227941|ovarian cancer|ovarian cancer
1384904|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1384905|NCT01227941|Doxil|doxil
1384906|NCT01227941|Caelyx|caelyx
1384907|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1384908|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
1384909|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
1384910|NCT01227928|ovarian cancer|ovarian cancer
1384911|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
1384912|NCT01227928|gynecologic cancer|gynecologic cancer
1384913|NCT01227928|anti-angiogenesis|anti-angiogenesis
1384914|NCT01227928|pazopanib|pazopanib
1384915|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
1384916|NCT01227902|Seizures|seizures
1384917|NCT01227902|retigabine IR|retigabine ir
1384918|NCT01227902|GW582892|gw582892
1384919|NCT01227902|Epilepsy|epilepsy
1384920|NCT01227902|Open label, flexible dose|open label, flexible dose
1384921|NCT01227902|Partial-onset seizures|partial-onset seizures
1384922|NCT01227889|Metastatic melanoma|metastatic melanoma
1384923|NCT01227889|melanoma|melanoma
1384924|NCT01227889|BRAF mutant|braf mutant
1384925|NCT01227889|Advanced melanoma|advanced melanoma
1384926|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
1567144|NCT00509782|Anti-Tumor Effects|anti-tumor effects
1507175|NCT00749606|Obesity|obesity
1384927|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
1384928|NCT01227850|Leptin|leptin
1384929|NCT01227850|IGF1|igf1
1384930|NCT01227850|Refeeding Index|refeeding index
1384931|NCT01227850|Hypophosphataemia|hypophosphataemia
1384932|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
1384933|NCT01227837|omega 3|omega 3
1384934|NCT01227837|CRT_AICD|crt_aicd
1384935|NCT01227837|congestive heart failure|congestive heart failure
1384936|NCT01227837|CHF|chf
1384937|NCT01227824|integrase inhibitor|integrase inhibitor
1384938|NCT01227824|HIV Infection|hiv infection
1384939|NCT01227824|raltegravir|raltegravir
1384940|NCT01227824|GSK1349572|gsk1349572
1384941|NCT01227811|Darifenacin|darifenacin
1384942|NCT01227811|Bioequivalence|bioequivalence
1384943|NCT01227811|Healthy volunteers|healthy volunteers
1384944|NCT01227811|Postprandial|postprandial
1384945|NCT01227798|influenza A, H1N1|influenza a, h1n1
1384946|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
1384947|NCT01227772|OTSGC-A24|otsgc-a24
1384948|NCT01227772|A Phase I/IIa study|a phase i/iia study
1384949|NCT01227772|HLA-A24-positive|hla-a24-positive
1384950|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
1384951|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1384952|NCT01227694|Cell therapy|cell therapy
1384953|NCT01227694|Regenerative therapy|regenerative therapy
1384954|NCT01227694|Advance therapy|advance therapy
1384955|NCT01227694|Bone marrow|bone marrow
1384956|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
1384957|NCT01227694|Autologous|autologous
1384958|NCT01227694|Interventional clinical trial|interventional clinical trial
1384959|NCT01227694|Osteoarthrosis|osteoarthrosis
1384960|NCT01227694|Osteoarthritis|osteoarthritis
1384961|NCT01227694|Knee|knee
1384962|NCT01227655|Parkinson|parkinson
1384963|NCT01227655|PD|pd
1384964|NCT01227655|Wearing-off|wearing-off
1384965|NCT01227655|Levodopa/DDCI|levodopa/ddci
1384966|NCT01227642|Prostate Cancer|prostate cancer
1384967|NCT01227642|Prostate brachytherapy|prostate brachytherapy
1384968|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
1384969|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
1384970|NCT01227603|Bioequivalence|bioequivalence
1384971|NCT01227603|Nifedipine|nifedipine
1384972|NCT01227603|Candesartan|candesartan
1384973|NCT01227603|FDC|fdc
1384974|NCT01227590|Herbal medicine|herbal medicine
1384975|NCT01227590|African Potato|african potato
1384976|NCT01227590|Hypoxis obtusa|hypoxis obtusa
1384977|NCT01227590|Drug interaction|drug interaction
1384978|NCT01227590|HIV Infections|hiv infections
1384979|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1384980|NCT01227590|Healthy Subjects|healthy subjects
1384981|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
1384982|NCT01227590|Lopinavir|lopinavir
1384983|NCT01227590|Ritonavir|ritonavir
1384984|NCT01227577|CML|cml
1384985|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1384986|NCT01227577|Leukemia|leukemia
1384987|NCT01227577|CML-CP|cml-cp
1384988|NCT01227577|Nilotinib|nilotinib
1384989|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
1384990|NCT01227564|active immunization|active immunization
1384991|NCT01227564|amyloid imaging|amyloid imaging
1384992|NCT01227551|Melanoma|melanoma
1384993|NCT01227551|CALM|calm
1384994|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
1384995|NCT01227512|Hyponatremia|hyponatremia
1384996|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
1384997|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
1384998|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
1384999|NCT01227512|Fluid Restriction|fluid restriction
1385000|NCT01227512|Tolvaptan|tolvaptan
1385001|NCT01227486|Intubation, intratracheal|intubation, intratracheal
1385002|NCT01227486|Ultrasonography|ultrasonography
1385003|NCT01227486|Auscultation|auscultation
1385004|NCT01227486|Capnography|capnography
1385005|NCT01227486|Obesity|obesity
1385006|NCT01227473|prediabetes|prediabetes
1385007|NCT01227473|African Americans|african americans
1385008|NCT01227473|mindfulness|mindfulness
1385009|NCT01227473|behavioral|behavioral
1385011|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
1385012|NCT01227434|Glioblastoma|glioblastoma
1385013|NCT01227434|Gliosarcoma|gliosarcoma
1385014|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
1385015|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
1385016|NCT01227434|Malignant glioma|malignant glioma
1385017|NCT01227434|GBM|gbm
1385018|NCT01227421|influenza|influenza
1567145|NCT00509782|ZIO-101|zio-101
1385019|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
1385020|NCT01227395|HIV|hiv
1385021|NCT01227395|Post Marketing Surveillance|post marketing surveillance
1385022|NCT01227369|Bisphosphonates|bisphosphonates
1385023|NCT01227369|OPSAT-Q|opsat-q
1385117|NCT01226771|interferon|interferon
1385024|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
1385025|NCT01227343|Gender differences|gender differences
1385026|NCT01227343|nicotine|nicotine
1385027|NCT01227343|cigarette smoking habits|cigarette smoking habits
1385028|NCT01227343|behavior changes|behavior changes
1385029|NCT01227317|Dyspnea|dyspnea
1385030|NCT01227317|Mortality|mortality
1385031|NCT01227291|Glaucoma|glaucoma
1385032|NCT01227291|IOP|iop
1385033|NCT01227291|siRNAs|sirnas
1385034|NCT01227291|RNAi|rnai
1385035|NCT01227291|beta inhibitor|beta inhibitor
1385036|NCT01227278|Benralizumab|benralizumab
1385037|NCT01227278|MEDI-563|medi-563
1385038|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1385039|NCT01227226|Dry eye|dry eye
1385040|NCT01227187|Hemodialysis|hemodialysis
1385041|NCT01227187|Anticoagulation|anticoagulation
1385042|NCT01227187|Xigris|xigris
1385043|NCT01227187|PTT|ptt
1385044|NCT01227174|propofol only|propofol only
1385045|NCT01227174|safety and efficacy|safety and efficacy
1385046|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
1385047|NCT01227161|general anesthesia|general anesthesia
1385048|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
1385049|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1385050|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1385051|NCT01227122|NGAL plasmatic level|ngal plasmatic level
1385052|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
1385053|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
1385054|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
1385055|NCT01227109|Infections|infections
1385056|NCT01227109|Cancer|cancer
1385057|NCT01227109|Procalcitonin|procalcitonin
1385058|NCT01227109|C reactive protein|c reactive protein
1385059|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
1385060|NCT01227083|AQLQ and cAQOL|aqlq and caqol
1385061|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
1385062|NCT01227057|exposure therapy|exposure therapy
1385063|NCT01227057|case management|case management
1385064|NCT01227057|older adults|older adults
1385065|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
1385066|NCT01227044|Substance Abuse Counseling|substance abuse counseling
1385067|NCT01227044|Adherence (medication)|adherence (medication)
1385068|NCT01227044|Alcohol Abuse|alcohol abuse
1385069|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
1385070|NCT01227044|Naltrexone|naltrexone
1385071|NCT01227044|Vivitrol|vivitrol
1385072|NCT01227044|HIV|hiv
1385073|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
1385074|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
1385075|NCT01227005|Transfusion|transfusion
1385076|NCT01227005|Whole Blood|whole blood
1385077|NCT01227005|Trauma|trauma
1385078|NCT01227005|Coagulopathy|coagulopathy
1385079|NCT01227005|Component Therapy|component therapy
1385080|NCT01227005|Civilian|civilian
1385081|NCT01227005|Military|military
1385082|NCT01226992|Clostridium difficile|clostridium difficile
1385083|NCT01226992|Fecal Transplant|fecal transplant
1385084|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
1385085|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
1385086|NCT01226992|Fever|fever
1385087|NCT01226979|rectal cancer|rectal cancer
1385088|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
1385089|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
1385090|NCT01226953|Vaccine|vaccine
1385091|NCT01226953|Anti-PRP antibody|anti-prp antibody
1385092|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
1385093|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
1385094|NCT01226901|tumor|tumor
1385095|NCT01226901|cancer|cancer
1385096|NCT01226888|brown adipose tissue|brown adipose tissue
1385097|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
1385098|NCT01226875|SWL|swl
1385099|NCT01226875|kidney stones|kidney stones
1385100|NCT01226875|renal calculi|renal calculi
1385102|NCT01226862|Telemedicine|telemedicine
1385103|NCT01226862|Telestroke|telestroke
1385104|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
1385105|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
1385106|NCT01226823|cholestasis|cholestasis
1385107|NCT01226823|pregnancy|pregnancy
1385108|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
1385109|NCT01226823|ICP|icp
1385110|NCT01226797|Chronic HCV infection|chronic hcv infection
1385111|NCT01226797|raised ALT|raised alt
1385112|NCT01226797|transaminitis|transaminitis
1385113|NCT01226797|HCV infection|hcv infection
1385114|NCT01226771|hepatitis V virus|hepatitis v virus
1385115|NCT01226771|genotype 1|genotype 1
1385116|NCT01226771|ribavirin|ribavirin
1385118|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
1385119|NCT01226758|Safety|safety
1385120|NCT01226758|Tolerability|tolerability
1385121|NCT01226758|Efficacy|efficacy
1385122|NCT01226758|Influenza|influenza
1385123|NCT01226758|Flu|flu
1385124|NCT01226758|Virus|virus
1385125|NCT01226758|Vaccine|vaccine
1385126|NCT01226745|Multiple sclerosis|multiple sclerosis
1385127|NCT01226745|ONO-4641|ono-4641
1385128|NCT01226745|MSC2430913A|msc2430913a
1385129|NCT01226745|Efficacy|efficacy
1385130|NCT01226732|Solid tumor|solid tumor
1385131|NCT01226732|Capecitabine|capecitabine
1385132|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
1385133|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
1385134|NCT01226719|Panitumumab|panitumumab
1385135|NCT01226719|Oxaliplatin|oxaliplatin
1385136|NCT01226719|Irinotecan|irinotecan
1385137|NCT01226719|Leucovorin|leucovorin
1385138|NCT01226719|5-Fluorouracil|5-fluorouracil
1385139|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
1385140|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
1385141|NCT01226706|detrusor instability|detrusor instability
1385142|NCT01226706|non-neurogenic|non-neurogenic
1385143|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
1385144|NCT01226706|Female Urogenital Diseases|female urogenital diseases
1385145|NCT01226706|Urologic Diseases|urologic diseases
1385146|NCT01226706|Urination Disorders|urination disorders
1385147|NCT01226706|Urinary Incontinence|urinary incontinence
1385148|NCT01226693|pharmacokinetic|pharmacokinetic
1385149|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
1385150|NCT01226693|balanced incomplete block design|balanced incomplete block design
1385151|NCT01226693|PH-797804|ph-797804
1385152|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
1385153|NCT01226680|Dry Eye|dry eye
1385154|NCT01226680|Schirmer test|schirmer test
1385155|NCT01226680|corneal staining|corneal staining
1385156|NCT01226680|OSDI|osdi
1385157|NCT01226680|OCI|oci
1385158|NCT01226667|fibromyalgia|fibromyalgia
1385159|NCT01226667|lyrica|lyrica
1385160|NCT01226667|pregabalin|pregabalin
1385161|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
1385162|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1385163|NCT01226641|SCORE|score
1385164|NCT01226641|Telemedicine|telemedicine
1385165|NCT01226641|Arterial blood pressure|arterial blood pressure
1385166|NCT01226641|Daily physical activity|daily physical activity
1385167|NCT01226628|Macular degeneration|macular degeneration
1385168|NCT01226628|Age-related macular degeneration|age-related macular degeneration
1385169|NCT01226628|Cell therapy|cell therapy
1385170|NCT01226628|CNTO 2476|cnto 2476
1385171|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
1385172|NCT01226628|hUTC|hutc
1385173|NCT01226628|Geographic Atrophy|geographic atrophy
1385174|NCT01226628|Subretinal|subretinal
1385175|NCT01226628|Visual Acuity|visual acuity
1385176|NCT01226615|Chondroitin sulphate|chondroitin sulphate
1385177|NCT01226615|Knee osteoarthritis|knee osteoarthritis
1385178|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1385179|NCT01226602|Ticagrelor|ticagrelor
1385180|NCT01226602|Healthy|healthy
1385181|NCT01226602|Coronary flow velocity|coronary flow velocity
1385182|NCT01226602|Adenosine|adenosine
1385183|NCT01226589|Cancer cancer|cancer cancer
1385184|NCT01226589|MRS|mrs
1385185|NCT01226589|Treatment response|treatment response
1385186|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
1385187|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
1385188|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
1385189|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
1385190|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
1385191|NCT01226576|MRgFUS|mrgfus
1385192|NCT01226576|Prostate Cancer|prostate cancer
1385193|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
1385194|NCT01226576|Localized Prostate Cancer|localized prostate cancer
1385195|NCT01226576|InSightec|insightec
1385196|NCT01226576|ExAblate|exablate
1385197|NCT01226563|STEMI|stemi
1385198|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
1385199|NCT01226563|Congestive Heart Failure|congestive heart failure
1385200|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
1385201|NCT01226563|Devices, Medical|devices, medical
1385202|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
1385203|NCT01226550|Irinotecan|irinotecan
1385204|NCT01226550|Pharmacokinetics|pharmacokinetics
1385205|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
1385206|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
1385207|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
1385208|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
1385209|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
1385210|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
1385211|NCT01226498|Inflammation Mediators|inflammation mediators
1385212|NCT01226485|Cancer|cancer
1385213|NCT01226485|Terminal|terminal
1385214|NCT01226485|Solid Tumor|solid tumor
1385215|NCT01226485|End Stage|end stage
1385216|NCT01226485|Metastatic|metastatic
1385217|NCT01226472|PTCL|ptcl
1385218|NCT01226472|CTCL|ctcl
1385219|NCT01226472|MF|mf
1385220|NCT01226472|SS|ss
1385221|NCT01226459|Female Pattern Baldness|female pattern baldness
1385222|NCT01226433|AE adverse event|ae adverse event
1385223|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1385224|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1385225|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
1385226|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1385227|NCT01226433|DCF data collection forms|dcf data collection forms
1385228|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
1385229|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1385230|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1385231|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1385232|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
1385233|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
1385234|NCT01226433|IRB Institutional Review Board|irb institutional review board
1385235|NCT01226433|IU International units|iu international units
1385236|NCT01226433|mg milligram(s)|mg milligram(s)
1385237|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1385238|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
1385239|NCT01226433|SAE serious adverse event|sae serious adverse event
1385240|NCT01226433|µg microgram|µg microgram
1385241|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
1385242|NCT01226433|WB Western Blot|wb western blot
1385243|NCT01226420|GVHD|gvhd
1385244|NCT01226420|Alefacept|alefacept
1385245|NCT01226420|Amevive|amevive
1385246|NCT01226407|Solid Tumour|solid tumour
1385247|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
1385248|NCT01226394|HIPEC|hipec
1385249|NCT01226394|controlled clinical trial|controlled clinical trial
1385250|NCT01226381|Paracetamol and setrons|paracetamol and setrons
1385251|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
1385252|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
1385253|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1385254|NCT01226329|Minority Groups|minority groups
1385255|NCT01226329|Decision Making|decision making
1385256|NCT01226329|Patient Participation|patient participation
1385257|NCT01226329|Mental Health Services|mental health services
1385258|NCT01226329|retention|retention
1385259|NCT01226329|attendance|attendance
1385260|NCT01226329|patient activation|patient activation
1385261|NCT01226329|Hispanic Americans|hispanic americans
1385262|NCT01226329|patient-provider communication|patient-provider communication
1385263|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
1385264|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
1385265|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
1385266|NCT01226290|VizAblate|vizablate
1385267|NCT01226264|Uterine cervical cancer|uterine cervical cancer
1385268|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
1385269|NCT01226264|recurrence|recurrence
1385270|NCT01226251|oral malodour|oral malodour
1385271|NCT01226251|halitosis|halitosis
1385272|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
1385273|NCT01226225|Patients with recent coronary event|patients with recent coronary event
1385274|NCT01226212|Older people|older people
1385275|NCT01226212|Synbiotic|synbiotic
1385276|NCT01226212|Prebiotic|prebiotic
1385277|NCT01226212|Probiotic|probiotic
1385278|NCT01226212|Bacteria|bacteria
1385279|NCT01226212|Immune|immune
1385280|NCT01226186|Knee replacement|knee replacement
1385281|NCT01226186|Pain control|pain control
1385282|NCT01226186|Self medication|self medication
1385283|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
1385284|NCT01226147|Lupus Nephritis|lupus nephritis
1385286|NCT01226147|retinoid|retinoid
1385287|NCT01226147|tamibarotene|tamibarotene
1385288|NCT01226134|Functional Dyspepsia|functional dyspepsia
1385289|NCT01226134|Itopride|itopride
1385290|NCT01226134|Gastric Emptying|gastric emptying
1385291|NCT01226134|Gastric Accommodation|gastric accommodation
1385292|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
1385293|NCT01226121|dupuytren|dupuytren
1385294|NCT01226121|dupuytren's|dupuytren's
1385295|NCT01226095|Osteoarthritis|osteoarthritis
1385296|NCT01226095|Pain|pain
1385297|NCT01226095|Morning stiffness|morning stiffness
1385298|NCT01226069|superficial phlebitis|superficial phlebitis
1385299|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
1385394|NCT01225510|open-label|open-label
1385300|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
1385301|NCT01226069|Hirudoid cream|hirudoid cream
1385303|NCT01226056|advanced solid tumors|advanced solid tumors
1385304|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
1385305|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
1385306|NCT01226056|tumor molecular targets|tumor molecular targets
1385307|NCT01226030|Advanced Solid Tumors|advanced solid tumors
1385308|NCT01226017|Oxytocin|oxytocin
1385309|NCT01226017|Animal Assisted therapy|animal assisted therapy
1385310|NCT01226017|Farm animals|farm animals
1385311|NCT01226017|Healthy nursing students|healthy nursing students
1385312|NCT01226004|radiosurgery|radiosurgery
1385313|NCT01226004|prostate|prostate
1385314|NCT01226004|cancer|cancer
1385315|NCT01226004|early|early
1385316|NCT01226004|intermediate|intermediate
1385317|NCT01226004|CyberKnife|cyberknife
1385318|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
1385319|NCT01225978|Genetic Information|genetic information
1385320|NCT01225978|Variant Updates|variant updates
1385321|NCT01225978|Information Technology|information technology
1385322|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1385323|NCT01225978|Hearing Loss|hearing loss
1385324|NCT01225978|Oncology|oncology
1385325|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
1385326|NCT01225952|phacoemulsification|phacoemulsification
1385327|NCT01225952|intraocular lens|intraocular lens
1385328|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
1385329|NCT01225939|Healthy|healthy
1385330|NCT01225926|Intraocular Lens|intraocular lens
1385331|NCT01225926|Toric|toric
1385332|NCT01225913|asthma|asthma
1385333|NCT01225913|lung function|lung function
1385334|NCT01225913|inflammation|inflammation
1385335|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1385336|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1385337|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
1385338|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
1385339|NCT01225796|Bicarbonate|bicarbonate
1385340|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
1385341|NCT01225796|Urinary TGF-beta|urinary tgf-beta
1385342|NCT01225796|Urinary acid excretion|urinary acid excretion
1385343|NCT01225770|green tea|green tea
1385344|NCT01225770|gargling|gargling
1385345|NCT01225770|prophylaxis|prophylaxis
1385346|NCT01225770|influenza|influenza
1385347|NCT01225770|Respiratory Tract Infections|respiratory tract infections
1385348|NCT01225770|high school students|high school students
1385349|NCT01225757|Echocardiography|echocardiography
1385350|NCT01225757|HIPEC|hipec
1385351|NCT01225692|Brain Injury|brain injury
1385352|NCT01225692|Head Trauma|head trauma
1385353|NCT01225692|Trauma Systems|trauma systems
1385354|NCT01225692|Head Injury Guideline|head injury guideline
1385355|NCT01225692|Time to Tertiary Care|time to tertiary care
1385356|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
1385357|NCT01225679|Phox2B gene|phox2b gene
1385358|NCT01225679|invasive ventilation|invasive ventilation
1385359|NCT01225679|genetics|genetics
1385360|NCT01225679|late-onset|late-onset
1385361|NCT01225679|sleep|sleep
1385362|NCT01225679|central sleep apnea|central sleep apnea
1385363|NCT01225666|MOD-4023|mod-4023
1385364|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
1385365|NCT01225666|Phase II|phase ii
1385366|NCT01225653|Latanoprost|latanoprost
1385367|NCT01225653|vasodilation|vasodilation
1385368|NCT01225653|diabetic retinopathy|diabetic retinopathy
1385369|NCT01225640|Tuberculosis|tuberculosis
1385370|NCT01225640|EBA|eba
1385371|NCT01225640|WBA|wba
1385372|NCT01225627|Chronic disease management|chronic disease management
1385373|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1385374|NCT01225627|Discharge planning|discharge planning
1385375|NCT01225627|Discharge coordinator|discharge coordinator
1385376|NCT01225614|Home ventilation|home ventilation
1385377|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
1385378|NCT01225575|large cartilage defects|large cartilage defects
1385379|NCT01225575|knee joint|knee joint
1385380|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
1385381|NCT01225562|Heart attack|heart attack
1507792|NCT00747214|CRP|crp
1385382|NCT01225562|Heart Disease|heart disease
1385383|NCT01225562|Acute coronary syndrome|acute coronary syndrome
1385384|NCT01225562|ACS|acs
1385385|NCT01225562|Cardiovascular Disease|cardiovascular disease
1385386|NCT01225549|Allergen Challenge|allergen challenge
1385387|NCT01225549|Asthma|asthma
1385388|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
1385389|NCT01225536|BRAF mutations|braf mutations
1385390|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
1385391|NCT01225510|CVX-060|cvx-060
1385392|NCT01225510|PF-04856884|pf-04856884
1385393|NCT01225510|phase 2|phase 2
1385395|NCT01225510|bevacizumab|bevacizumab
1385396|NCT01225510|anti-angiogenic|anti-angiogenic
1385397|NCT01225497|Randomized|randomized
1385398|NCT01225497|Pilot study|pilot study
1385399|NCT01225497|VISA-A|visa-a
1385400|NCT01225497|VAS|vas
1385401|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
1385402|NCT01225471|novel epitope peptide|novel epitope peptide
1385403|NCT01225471|CTL|ctl
1385404|NCT01225471|advanced prostate cancer|advanced prostate cancer
1385405|NCT01225458|Elderly patients|elderly patients
1385406|NCT01225458|renal insufficiency|renal insufficiency
1385407|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
1385408|NCT01225419|Plerixafor|plerixafor
1385409|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
1385410|NCT01225419|children|children
1385411|NCT01225406|Third line ARV therapy|third line arv therapy
1385412|NCT01225406|HIV RNA|hiv rna
1385413|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
1385414|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
1385415|NCT01225406|Drug resistance|drug resistance
1385416|NCT01225380|Hepatitis C|hepatitis c
1385417|NCT01225380|HCV|hcv
1385418|NCT01225380|Rapid Virologic Response|rapid virologic response
1385419|NCT01225380|Sustained Virologic Response|sustained virologic response
1385420|NCT01225380|Direct Acting Antiviral|direct acting antiviral
1385421|NCT01225380|Combination Therapy|combination therapy
1385422|NCT01225380|HCV RNA|hcv rna
1385423|NCT01225380|Polymerase inhibitor|polymerase inhibitor
1385424|NCT01225380|Protease inhibitor|protease inhibitor
1385425|NCT01225380|Treatment naïve|treatment naïve
1385426|NCT01225380|GS-9190|gs-9190
1385427|NCT01225380|GS-9256|gs-9256
1385428|NCT01225354|Cheek|cheek
1385429|NCT01225354|Cheek flattening|cheek flattening
1385430|NCT01225354|Malar deficiency|malar deficiency
1385431|NCT01225354|Filler|filler
1385432|NCT01225341|HSV-1|hsv-1
1385433|NCT01225341|Herpes labialis|herpes labialis
1385434|NCT01225341|Cold sores|cold sores
1385435|NCT01225341|Fever blisters|fever blisters
1385436|NCT01225289|Multiple Sclerosis|multiple sclerosis
1385437|NCT01225289|Vitamin A|vitamin a
1385438|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1385439|NCT01225289|Th1 Cells|th1 cells
1385440|NCT01225289|Th2 Cells|th2 cells
1385441|NCT01225276|CIDP|cidp
1385442|NCT01225276|IVIG|ivig
1385443|NCT01225263|Migraine disorders|migraine disorders
1385444|NCT01225263|Headache|headache
1385445|NCT01225263|Simvastatin|simvastatin
1385446|NCT01225263|Vitamin D|vitamin d
1385447|NCT01225250|Caudal septal extension graft|caudal septal extension graft
1385448|NCT01225250|Primary rhinoplasty|primary rhinoplasty
1385449|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
1385450|NCT01225237|diarrhea|diarrhea
1385451|NCT01225237|IBS|ibs
1385452|NCT01225237|Colonic disease|colonic disease
1385453|NCT01225237|YM060|ym060
1385454|NCT01225224|ASP015K|asp015k
1385455|NCT01225224|Ethnic difference|ethnic difference
1385456|NCT01225198|Vitamins|vitamins
1385457|NCT01225198|Minerals|minerals
1385458|NCT01225185|neurological complications|neurological complications
1385459|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
1385460|NCT01225159|tight glycemic control|tight glycemic control
1385461|NCT01225159|cardiac surgery|cardiac surgery
1385462|NCT01225146|Ischemic|ischemic
1385463|NCT01225146|Central|central
1385464|NCT01225146|Retinal|retinal
1385465|NCT01225146|Vein|vein
1385466|NCT01225146|Occlusion|occlusion
1385467|NCT01225146|Ranibizumab|ranibizumab
1385468|NCT01225146|Lucentis|lucentis
1385469|NCT01225146|CRVO|crvo
1385470|NCT01225146|ISCRVO|iscrvo
1385471|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
1385472|NCT01225107|Burns|burns
1385473|NCT01225107|Infections|infections
1385474|NCT01225107|Cranberry|cranberry
1385475|NCT01225094|AAA|aaa
1385476|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
1385477|NCT01225094|acute kidney injury|acute kidney injury
1385478|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
1385479|NCT01225081|ASP1941|asp1941
1385480|NCT01225081|Diabetes mellitus|diabetes mellitus
1385481|NCT01225081|pioglitazone|pioglitazone
1385482|NCT01225042|infectious diarrhea|infectious diarrhea
1385483|NCT01225042|probiotics|probiotics
1385484|NCT01225042|prevention|prevention
1385485|NCT01225042|dietary intervention|dietary intervention
1385486|NCT01225042|E. coli infection|e. coli infection
1385487|NCT01225042|intestinal infection|intestinal infection
1385488|NCT01225042|intestinal resistance|intestinal resistance
1385489|NCT01225029|premature birth|premature birth
1385490|NCT01225029|late preterm birth|late preterm birth
1385491|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
1385492|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
1385493|NCT01225003|gliomas|gliomas
1385494|NCT01225003|magnetic resonance|magnetic resonance
1385495|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
1385496|NCT01225003|MR spectroscopy|mr spectroscopy
1385497|NCT01225003|grading|grading
1385597|NCT01224535|Arid Areas|arid areas
1385498|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
1385499|NCT01224990|accurate staging|accurate staging
1385500|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
1385501|NCT01224990|non-invasive|non-invasive
1385502|NCT01224925|carious exposure|carious exposure
1385503|NCT01224925|pulp capping|pulp capping
1385504|NCT01224925|MTA|mta
1385505|NCT01224925|Dycal|dycal
1385506|NCT01224912|Insomnia|insomnia
1385507|NCT01224912|Intervention|intervention
1385508|NCT01224912|Self-help|self-help
1385509|NCT01224912|Internet|internet
1385510|NCT01224899|Heart Failure|heart failure
1385511|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
1385512|NCT01224899|Sympathectomy|sympathectomy
1385513|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1385514|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
1385515|NCT01224886|Aging|aging
1385516|NCT01224886|Insulin resistance|insulin resistance
1385517|NCT01224886|Ectopic lipids|ectopic lipids
1385518|NCT01224886|Obesity|obesity
1385519|NCT01224886|Exercise|exercise
1385520|NCT01224886|Physical activity|physical activity
1385521|NCT01224886|Oxidative capacity|oxidative capacity
1385522|NCT01224886|Diabetes|diabetes
1385523|NCT01224886|Metabolic syndrome|metabolic syndrome
1385524|NCT01224873|breast cancer|breast cancer
1385525|NCT01224873|bone metastasis|bone metastasis
1385526|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
1385527|NCT01224873|bone scintigraphy|bone scintigraphy
1385528|NCT01224873|fluoride PET/CT|fluoride pet/ct
1385529|NCT01224873|FDG-PET/CT|fdg-pet/ct
1385530|NCT01224860|Telmisartan|telmisartan
1385531|NCT01224860|Losartan|losartan
1385532|NCT01224860|Renal transplant|renal transplant
1385533|NCT01224847|AMD|amd
1385534|NCT01224847|Intravitreal Injection|intravitreal injection
1385535|NCT01224847|Anesthesia|anesthesia
1385536|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
1385537|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
1385538|NCT01224821|anti-B1 Antibody|anti-b1 antibody
1385539|NCT01224821|Bexxar|bexxar
1385540|NCT01224821|radioimmunotherapy|radioimmunotherapy
1385541|NCT01224821|tositumomab|tositumomab
1385542|NCT01224808|von Willebrand Disease|von willebrand disease
1385543|NCT01224795|uncomplicated influenza|uncomplicated influenza
1385544|NCT01224782|Zemplar capsules|zemplar capsules
1385545|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
1385546|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1385547|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
1385548|NCT01224756|Tonsillitis|tonsillitis
1385549|NCT01224756|Pharyngitis|pharyngitis
1385550|NCT01224756|Sore Throat|sore throat
1385551|NCT01224756|Drug Therapy|drug therapy
1385552|NCT01224717|Osteoporosis|osteoporosis
1385553|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
1385554|NCT01224704|Water Deprivation|water deprivation
1385555|NCT01224704|Thirst|thirst
1385556|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
1385557|NCT01224704|Obesity|obesity
1385558|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
1385559|NCT01224691|TGF Beta|tgf beta
1385560|NCT01224691|RSV|rsv
1385561|NCT01224691|Asthma|asthma
1385562|NCT01224691|Healthy Volunteer|healthy volunteer
1385563|NCT01224678|breast cancer|breast cancer
1385564|NCT01224665|stage II bladder cancer|stage ii bladder cancer
1385565|NCT01224665|stage III bladder cancer|stage iii bladder cancer
1385566|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1385567|NCT01224652|gastric cancer|gastric cancer
1385568|NCT01224652|paclitaxel|paclitaxel
1385569|NCT01224652|irinotecan|irinotecan
1385570|NCT01224639|dengue fever|dengue fever
1385571|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
1385572|NCT01224639|TDV|tdv
1385573|NCT01224639|Drug therapy|drug therapy
1385574|NCT01224626|VRE|vre
1385575|NCT01224626|Japanese|japanese
1385576|NCT01224626|Post Marketing Surveillance|post marketing surveillance
1385577|NCT01224600|lower limbs|lower limbs
1385578|NCT01224600|Arterial Diseases|arterial diseases
1385579|NCT01224587|Imaging technique|imaging technique
1385580|NCT01224587|gastric transport through the gut|gastric transport through the gut
1385681|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
1385682|NCT01224184|HIV|hiv
1385581|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
1385582|NCT01224561|Thinness|thinness
1385583|NCT01224561|Leanness|leanness
1385584|NCT01224561|healthy volunteers|healthy volunteers
1385585|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
1385586|NCT01224548|vegan|vegan
1385587|NCT01224548|diet|diet
1385588|NCT01224548|diabetes|diabetes
1385589|NCT01224548|overweight|overweight
1385590|NCT01224548|workplace|workplace
1385591|NCT01224548|nutrition|nutrition
1385592|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
1385593|NCT01224535|Complementary foods|complementary foods
1385594|NCT01224535|Amaranth|amaranth
1385595|NCT01224535|Food Based approaches|food based approaches
1385596|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
1385598|NCT01224535|Africa|africa
1385599|NCT01224522|Randomized Controlled Trial|randomized controlled trial
1385600|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
1385601|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
1385602|NCT01224509|Cervix|cervix
1385603|NCT01224509|EP3 receptors|ep3 receptors
1385604|NCT01224509|Mifepristone|mifepristone
1385605|NCT01224509|Prostaglandin|prostaglandin
1385606|NCT01224509|Receptors|receptors
1385607|NCT01224509|Steroids|steroids
1385608|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
1385609|NCT01224496|Chinese herbal concoction|chinese herbal concoction
1385610|NCT01224496|Supportive management|supportive management
1385611|NCT01224444|colon polyps|colon polyps
1385612|NCT01224444|adenoma resection|adenoma resection
1385613|NCT01224444|colon cancer screening|colon cancer screening
1385614|NCT01224444|colonoscopy|colonoscopy
1385615|NCT01224431|pain|pain
1385616|NCT01224431|lidocaine|lidocaine
1385617|NCT01224431|lumbar puncture|lumbar puncture
1385618|NCT01224431|j-tip|j-tip
1385619|NCT01224418|Tacrolimus|tacrolimus
1385620|NCT01224418|Prograf|prograf
1385621|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
1385622|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
1385623|NCT01224392|colorectal cancer|colorectal cancer
1385624|NCT01224392|colorectal neoplasms|colorectal neoplasms
1385625|NCT01224392|radiotherapy|radiotherapy
1385626|NCT01224392|chemoradiotherapy|chemoradiotherapy
1385627|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
1385628|NCT01224379|Lumbar spine|lumbar spine
1385629|NCT01224379|fusion|fusion
1385630|NCT01224379|adjacent instability|adjacent instability
1385631|NCT01224379|topping-off.|topping-off.
1385632|NCT01224366|Add-on to insulin|add-on to insulin
1385633|NCT01224327|Liver cirrhosis|liver cirrhosis
1385634|NCT01224327|Radiology|radiology
1385635|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
1385636|NCT01224327|Umbilical Cord|umbilical cord
1385637|NCT01224314|Haemodynamics|haemodynamics
1385638|NCT01224314|Hypotension|hypotension
1385639|NCT01224314|Potassium|potassium
1385640|NCT01224314|Haemodialysis|haemodialysis
1385641|NCT01224314|Dialysis fluids|dialysis fluids
1385642|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
1385643|NCT01224301|school-based clinics|school-based clinics
1385644|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
1385645|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
1385646|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
1385647|NCT01224288|RCC|rcc
1385648|NCT01224288|Kidney cancer|kidney cancer
1385649|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1385650|NCT01224288|mRCC|mrcc
1385651|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
1385652|NCT01224288|DCE-CT|dce-ct
1385653|NCT01224288|Tumor perfusion|tumor perfusion
1385654|NCT01224275|group based care|group based care
1385655|NCT01224275|antenatal care|antenatal care
1385656|NCT01224275|parents satisfaction|parents satisfaction
1385657|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
1385658|NCT01224262|influenza vaccine|influenza vaccine
1385659|NCT01224262|seasonal influenza|seasonal influenza
1385660|NCT01224262|novel vaccine|novel vaccine
1385661|NCT01224262|flu|flu
1385662|NCT01224249|Selenium|selenium
1385663|NCT01224249|Selenoprotein P|selenoprotein p
1385664|NCT01224249|Fish|fish
1385665|NCT01224249|Shellfish|shellfish
1385666|NCT01224249|Bioavailability|bioavailability
1385667|NCT01224223|asthma|asthma
1385668|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
1385669|NCT01224210|portal hypertension|portal hypertension
1385670|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
1385671|NCT01224210|right heart catheterization|right heart catheterization
1385672|NCT01224210|transpulmonary gradient|transpulmonary gradient
1385673|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
1385674|NCT01224210|Ambrisentan|ambrisentan
1385675|NCT01224210|Letairis|letairis
1385676|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
1385677|NCT01224197|TMC435HPC1004|tmc435hpc1004
1385678|NCT01224197|TMC435|tmc435
1385679|NCT01224197|HCV|hcv
1385680|NCT01224197|Hepatitis C|hepatitis c
1385683|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
1385684|NCT01224184|Substance Abuse Detection|substance abuse detection
1385685|NCT01224184|Randomized Controlled Trial|randomized controlled trial
1385686|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
1385687|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
1385688|NCT01224054|Tolerance alimentary|tolerance alimentary
1385689|NCT01224054|Morbid obesity|morbid obesity
1385690|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1385691|NCT01224041|Tacrolimus|tacrolimus
1385692|NCT01224041|Prograf|prograf
1385693|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
1386088|NCT01222338|XDR-TB|xdr-tb
1385694|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1385695|NCT01224028|Tacrolimus|tacrolimus
1385696|NCT01224028|Prograf|prograf
1385697|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
1385698|NCT01224028|Albuminurea|albuminurea
1385699|NCT01224028|Proteinurea|proteinurea
1385700|NCT01224028|FK506|fk506
1385701|NCT01224002|Cross-Sectional|cross-sectional
1385702|NCT01224002|Observational|observational
1385703|NCT01224002|Comparative|comparative
1385704|NCT01224002|Retrospective|retrospective
1385705|NCT01224002|Feasibility|feasibility
1385706|NCT01224002|Dental Decay|dental decay
1385707|NCT01224002|Drug Abuse|drug abuse
1385708|NCT01224002|Survey|survey
1385709|NCT01223989|overweight|overweight
1385710|NCT01223989|obesity|obesity
1385711|NCT01223989|bread|bread
1385712|NCT01223989|hypocaloric diet|hypocaloric diet
1385713|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
1385714|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
1385715|NCT01223963|Macrolane|macrolane
1385716|NCT01223963|Retrospective|retrospective
1385717|NCT01223924|cancer|cancer
1385718|NCT01223898|CML,|cml,
1385719|NCT01223898|nilotinib,|nilotinib,
1385720|NCT01223898|midazolam|midazolam
1385721|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
1385722|NCT01223833|breast cancer|breast cancer
1385723|NCT01223833|postmenopausal|postmenopausal
1385724|NCT01223833|aromatase inhibitors|aromatase inhibitors
1385725|NCT01223833|tamoxifen|tamoxifen
1385726|NCT01223833|arthralgia|arthralgia
1385727|NCT01223833|IGF-I|igf-i
1385728|NCT01223833|BMI|bmi
1385729|NCT01223833|grip strength|grip strength
1385730|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
1385731|NCT01223794|Fall|fall
1385732|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
1385733|NCT01223781|Freezing|freezing
1385734|NCT01223781|biofeedback|biofeedback
1385735|NCT01223781|motor learning|motor learning
1385736|NCT01223781|freezing of gait in PD|freezing of gait in pd
1385737|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1385738|NCT01223755|Sirolimus|sirolimus
1385739|NCT01223755|Renal insufficiency|renal insufficiency
1385740|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
1385741|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
1385742|NCT01223729|Quality of life;|quality of life;
1385743|NCT01223729|Depression.|depression.
1385744|NCT01223716|amblyopia treatment|amblyopia treatment
1385745|NCT01223716|neural plasticity|neural plasticity
1385746|NCT01223716|perceptual learning|perceptual learning
1385747|NCT01223716|vision therapy|vision therapy
1385748|NCT01223716|spatial vision|spatial vision
1385749|NCT01223716|video games|video games
1385750|NCT01223716|occlusion therapy|occlusion therapy
1385751|NCT01223703|n-3 PUFAs|n-3 pufas
1385752|NCT01223703|Heart Failure|heart failure
1385753|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
1385754|NCT01223703|Ejection Fraction|ejection fraction
1385755|NCT01223703|Exercise Capacity|exercise capacity
1385756|NCT01223690|sepsis|sepsis
1385757|NCT01223690|infection|infection
1385758|NCT01223690|bacteremia|bacteremia
1385759|NCT01223690|clarithromycin|clarithromycin
1385760|NCT01223664|ABMSC|abmsc
1385761|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
1385762|NCT01223664|Liver cirrhosis|liver cirrhosis
1385763|NCT01223664|Transplantation|transplantation
1385764|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1385765|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
1385766|NCT01223651|Accuracy|accuracy
1385767|NCT01223651|Altitude|altitude
1385768|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
1385769|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
1385770|NCT01223612|Diabetes Mellitus|diabetes mellitus
1385771|NCT01223612|Diabetes Complications|diabetes complications
1385772|NCT01223612|Retinal Diseases|retinal diseases
1385773|NCT01223612|Edema|edema
1385774|NCT01223612|Endothelial Growth Factors|endothelial growth factors
1385775|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
1385776|NCT01223612|Ranibizumab|ranibizumab
1385777|NCT01223612|Laser therapy|laser therapy
1385778|NCT01223599|pilonidal disease|pilonidal disease
1385779|NCT01223599|natal cleft|natal cleft
1385780|NCT01223599|limberg flap|limberg flap
1385781|NCT01223560|Artificial pancreas|artificial pancreas
1385782|NCT01223560|Model predictive control|model predictive control
1385783|NCT01223560|Virtual patient|virtual patient
1385784|NCT01223547|Carbohydrate counting|carbohydrate counting
1385785|NCT01223547|Insulin bolus calculation|insulin bolus calculation
1385786|NCT01223534|Tuberculosis|tuberculosis
1385787|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
1385788|NCT01223534|Tuberculin skin test|tuberculin skin test
1385789|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
1385790|NCT01223534|Contact-tracing study|contact-tracing study
1385791|NCT01223521|Contraception|contraception
1385792|NCT01223521|Abortion|abortion
1385793|NCT01223521|First trimester|first trimester
1385794|NCT01223521|Intrauterine device|intrauterine device
1385795|NCT01223482|Miscarriage|miscarriage
1385796|NCT01223482|Karyotyping|karyotyping
1385797|NCT01223482|Genetic testing|genetic testing
1385798|NCT01223469|Atrial Fibrillation|atrial fibrillation
1385799|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
1385800|NCT01223469|Contact Force|contact force
1385801|NCT01223469|RF Ablation|rf ablation
1385802|NCT01223469|Radiofrequency|radiofrequency
1385803|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
1385804|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1385805|NCT01223456|Saxagliptin|saxagliptin
1385806|NCT01223456|type 2 diabetes|type 2 diabetes
1385807|NCT01223456|clinical practice|clinical practice
1385808|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1385809|NCT01223443|Drug Eluting Stent|drug eluting stent
1385810|NCT01223443|Saphenous Vein Graft|saphenous vein graft
1385811|NCT01223430|septic shock|septic shock
1385812|NCT01223430|shock reversal|shock reversal
1385814|NCT01223430|traditional Chinese medicine|traditional chinese medicine
1385815|NCT01223404|nicotine|nicotine
1385816|NCT01223404|mecamylamine|mecamylamine
1385817|NCT01223404|attention|attention
1385818|NCT01223404|default network|default network
1385819|NCT01223404|fMRI|fmri
1385820|NCT01223391|orthostatic|orthostatic
1385821|NCT01223391|abdominal compression|abdominal compression
1385822|NCT01223365|moderate to severe pain|moderate to severe pain
1385823|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1385824|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
1385825|NCT01223365|traumatic injury|traumatic injury
1385826|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
1385827|NCT01223365|back pain|back pain
1385828|NCT01223365|neck pain|neck pain
1385829|NCT01223365|osteoarthritis|osteoarthritis
1385830|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
1385831|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
1385832|NCT01223352|children|children
1385833|NCT01223352|pediatric|pediatric
1385834|NCT01223352|bosentan|bosentan
1385835|NCT01223339|Ertugliflozin|ertugliflozin
1385836|NCT01223339|Japanese and Western population|japanese and western population
1385837|NCT01223339|pharmacokinetics|pharmacokinetics
1385838|NCT01223339|pharmacodynamics|pharmacodynamics
1385839|NCT01223326|Acetylcysteine|acetylcysteine
1385840|NCT01223313|Contraception|contraception
1385841|NCT01223313|Woman's Condom|woman's condom
1385842|NCT01223313|Female Condom|female condom
1385843|NCT01223313|Condom|condom
1385844|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
1385845|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1385846|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1385847|NCT01223287|Prematurity|prematurity
1385848|NCT01223287|Mechanical ventilation|mechanical ventilation
1385849|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
1385850|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
1385851|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1385852|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1385853|NCT01223274|Prematurity|prematurity
1385854|NCT01223274|Mechanical ventilation|mechanical ventilation
1385855|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
1385856|NCT01223274|Surfactant|surfactant
1385857|NCT01223274|Intubation|intubation
1385858|NCT01223274|Pulse oximetry|pulse oximetry
1385859|NCT01223274|Oxygen saturation|oxygen saturation
1385860|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
1385861|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1385862|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1385863|NCT01223261|Prematurity|prematurity
1385864|NCT01223261|Laparotomy|laparotomy
1385865|NCT01223261|Drainage|drainage
1385866|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
1385867|NCT01223261|Focal intestinal performation|focal intestinal performation
1385868|NCT01223248|radiation|radiation
1508447|NCT00744575|eeg|eeg
1385869|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
1385870|NCT01223248|IGIMRT|igimrt
1385871|NCT01223248|RT|rt
1385872|NCT01223248|10-154|10-154
1385873|NCT01223235|FALLOPIAN TUBE|fallopian tube
1385874|NCT01223235|OVARY|ovary
1385875|NCT01223235|PERITONEUM|peritoneum
1386174|NCT01222039|Expanded|expanded
1385876|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1385877|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
1385878|NCT01223235|MUC-1 KLH|muc-1 klh
1385879|NCT01223235|OPT-821|opt-821
1385880|NCT01223235|TF (C) - KLH|tf (c) - klh
1385881|NCT01223235|TN(C)-KLH|tn(c)-klh
1385882|NCT01223235|10-099|10-099
1385883|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
1385884|NCT01223222|Impetigo|impetigo
1385885|NCT01223222|Gram-negative|gram-negative
1385886|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
1385989|NCT01222754|Radiation Therapy|radiation therapy
1385887|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
1385889|NCT01223209|Carcinoma|carcinoma
1385890|NCT01223209|Curative surgery|curative surgery
1385891|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
1385892|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
1385893|NCT01223196|insulin resistance|insulin resistance
1385894|NCT01223183|cystic fibrosis|cystic fibrosis
1385895|NCT01223183|nuclear medicine|nuclear medicine
1385896|NCT01223183|aerosol|aerosol
1385897|NCT01223183|nebulizer|nebulizer
1385898|NCT01223170|Tailoring|tailoring
1385899|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
1385900|NCT01223170|Internet based intervention|internet based intervention
1385901|NCT01223170|Exercise|exercise
1385902|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
1385903|NCT01223157|obesity|obesity
1385904|NCT01223157|endocannabinoids|endocannabinoids
1385905|NCT01223144|Cognition|cognition
1385906|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
1385907|NCT01223144|Iowa Gambling Task|iowa gambling task
1385908|NCT01223144|facial emotion recognition|facial emotion recognition
1385909|NCT01223118|Oocyte|oocyte
1385910|NCT01223118|vitrification|vitrification
1385911|NCT01223118|IVF|ivf
1385912|NCT01223118|PGD|pgd
1385913|NCT01223118|embryo biopsy|embryo biopsy
1385914|NCT01223105|slow freeze|slow freeze
1385915|NCT01223105|cryopreservation|cryopreservation
1385916|NCT01223105|vitrification|vitrification
1385917|NCT01223105|oocyte preservation|oocyte preservation
1385918|NCT01223092|IVF|ivf
1385919|NCT01223092|infertility|infertility
1385920|NCT01223092|DNA|dna
1385921|NCT01223079|r-hFSH|r-hfsh
1385922|NCT01223079|r-hLH|r-hlh
1385923|NCT01223066|Macrolane|macrolane
1385924|NCT01223053|Sprain|sprain
1385925|NCT01223053|Strain|strain
1385926|NCT01223053|Pain|pain
1385927|NCT01223053|Ankle Pain|ankle pain
1385928|NCT01223053|Knee Pain|knee pain
1385929|NCT01223053|Wrist Pain|wrist pain
1385930|NCT01223053|Hand Pain|hand pain
1385931|NCT01223027|Dovitinib|dovitinib
1385932|NCT01223027|TKI|tki
1385933|NCT01223027|Renal cell cancer|renal cell cancer
1385934|NCT01223027|RCC|rcc
1385935|NCT01223027|mRCC|mrcc
1385936|NCT01223014|Radioactive|radioactive
1385937|NCT01223014|ADME|adme
1385938|NCT01223014|Neuropathic pain|neuropathic pain
1385939|NCT01223001|Depression|depression
1385940|NCT01223001|Traumatic brain injury|traumatic brain injury
1385941|NCT01223001|Duloxetine|duloxetine
1385942|NCT01223001|Cymbalta|cymbalta
1385943|NCT01223001|impaired cognitive function|impaired cognitive function
1385944|NCT01222975|risperidone fasting study|risperidone fasting study
1385945|NCT01222936|LBH581|lbh581
1385946|NCT01222936|Panobinostat|panobinostat
1385947|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
1385948|NCT01222923|Risperidone fed study|risperidone fed study
1385949|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
1385950|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
1385951|NCT01222871|Treatment|treatment
1385952|NCT01222858|Obesity|obesity
1385953|NCT01222858|Primary Care|primary care
1385954|NCT01222858|Internet|internet
1385955|NCT01222858|Technology|technology
1385956|NCT01222858|Behavior Modification|behavior modification
1385957|NCT01222819|Febrile neutropenia|febrile neutropenia
1385958|NCT01222819|growth factors|growth factors
1385959|NCT01222819|leukemia|leukemia
1385960|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1385961|NCT01222806|Cocaine|cocaine
1385962|NCT01222806|Cue-Induced Craving|cue-induced craving
1385963|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
1385964|NCT01222806|Cocaine Craving|cocaine craving
1385965|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
1385966|NCT01222793|Antipsychotic|antipsychotic
1385967|NCT01222793|Obesity|obesity
1385968|NCT01222793|Low Weight Gain|low weight gain
1385969|NCT01222793|Schizophrenia|schizophrenia
1385970|NCT01222793|Food Craving|food craving
1385971|NCT01222780|Hematologic Malignancies|hematologic malignancies
1385972|NCT01222780|Vincristine Sulfate|vincristine sulfate
1385973|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
1385974|NCT01222780|Pharmacokinetics|pharmacokinetics
1385975|NCT01222780|Solid Tumors|solid tumors
1385976|NCT01222780|Cancer|cancer
1385977|NCT01222780|Pediatrics|pediatrics
1385978|NCT01222780|Sarcoma|sarcoma
1385979|NCT01222780|Wilms Tumor|wilms tumor
1385980|NCT01222780|Leukemia|leukemia
1385981|NCT01222780|Lymphoma|lymphoma
1385982|NCT01222780|Brain Tumor|brain tumor
1385983|NCT01222767|EFT|eft
1385984|NCT01222767|PNET|pnet
1385985|NCT01222767|EOE|eoe
1385986|NCT01222754|Newly Diagnosed|newly diagnosed
1385987|NCT01222754|DIPG|dipg
1385988|NCT01222754|CC 5013|cc 5013
1385990|NCT01222754|Lenalidomide|lenalidomide
1385992|NCT01222754|Brain Tumor|brain tumor
1385993|NCT01222754|Glioma|glioma
1385994|NCT01222754|Pediatrics|pediatrics
1385995|NCT01222741|AIRE- Autoimmune Regulator Gene|aire- autoimmune regulator gene
1385996|NCT01222741|APECED- Autoimmune Polyendocrinopathy-Candidiasis Ectodermal Dystrophy|apeced- autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
1385997|NCT01222741|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
1385998|NCT01222741|CMC- Chronic Mucocutaneous Candidiasis|cmc- chronic mucocutaneous candidiasis
1385999|NCT01222728|PET Imaging|pet imaging
1386000|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
1386001|NCT01222728|Neurofibromatosis|neurofibromatosis
1386002|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
1386003|NCT01222728|NF2|nf2
1386004|NCT01222702|CDIFF|cdiff
1386005|NCT01222702|CDAD|cdad
1386006|NCT01222702|CDI|cdi
1386007|NCT01222702|Clostridium difficile infection|clostridium difficile infection
1386008|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1386009|NCT01222676|stage II bladder cancer|stage ii bladder cancer
1386010|NCT01222676|stage III bladder cancer|stage iii bladder cancer
1386011|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
1386012|NCT01222663|peritonitis|peritonitis
1386013|NCT01222663|septic shock|septic shock
1386014|NCT01222663|hemoperfusion|hemoperfusion
1386015|NCT01222663|Polymyxin B|polymyxin b
1386016|NCT01222663|endotoxin|endotoxin
1386017|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1386018|NCT01222650|I-PSS|i-pss
1386019|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
1386020|NCT01222637|advanced solid cancers|advanced solid cancers
1386021|NCT01222637|metastatic solid cancers|metastatic solid cancers
1386022|NCT01222624|advanced solid malignancies|advanced solid malignancies
1386023|NCT01222611|HIV|hiv
1386024|NCT01222611|HCV|hcv
1386025|NCT01222611|HIV/HCV|hiv/hcv
1386026|NCT01222611|Coinfection|coinfection
1386027|NCT01222611|Fosamprenavir|fosamprenavir
1386028|NCT01222585|Metronidazole|metronidazole
1386029|NCT01222585|Neonate|neonate
1386030|NCT01222585|Premature|premature
1386031|NCT01222585|Sepsis|sepsis
1386032|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
1386033|NCT01222572|radiation therapy|radiation therapy
1386034|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
1386035|NCT01222572|stereotactic boost|stereotactic boost
1386036|NCT01222559|Cartilage defects|cartilage defects
1386037|NCT01222559|Knee joint|knee joint
1386038|NCT01222559|Femoral Condyle|femoral condyle
1386039|NCT01222507|tinnitus|tinnitus
1386040|NCT01222507|cognition|cognition
1386041|NCT01222507|brain processing speed|brain processing speed
1386042|NCT01222507|Brain Fitness Program|brain fitness program
1386043|NCT01222507|Posit Science|posit science
1386044|NCT01222494|Child Psychiatry|child psychiatry
1386045|NCT01222494|Obesity|obesity
1386046|NCT01222494|Antipsychotic|antipsychotic
1386047|NCT01222481|Head and Neck Cancer|head and neck cancer
1386048|NCT01222481|Functional Status|functional status
1386049|NCT01222481|Cognitive Status|cognitive status
1386050|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
1386051|NCT01222481|Performance-based Assessments|performance-based assessments
1386052|NCT01222481|Cancer|cancer
1386053|NCT01222481|Function|function
1386054|NCT01222481|Cognition|cognition
1386055|NCT01222481|Quality of Life|quality of life
1386056|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
1386057|NCT01222455|Phase 1|phase 1
1386058|NCT01222455|Healthy volunteers|healthy volunteers
1386059|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
1386060|NCT01222455|Pharmacokinetics|pharmacokinetics
1386061|NCT01222455|Fostamatinib|fostamatinib
1386062|NCT01222442|Respiratory disease|respiratory disease
1386063|NCT01222442|Bronchiolitis|bronchiolitis
1386064|NCT01222442|Emphysema|emphysema
1386065|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
1386066|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
1386067|NCT01222390|Tissue Expander|tissue expander
1386068|NCT01222390|3-D Camera|3-d camera
1386069|NCT01222390|Breast Reconstruction|breast reconstruction
1386070|NCT01222390|Crescentric|crescentric
1386071|NCT01222390|Expander Profile|expander profile
1386072|NCT01222390|Fill-Volume|fill-volume
1386073|NCT01222390|Lower Pole|lower pole
1386074|NCT01222390|Upper Pole|upper pole
1386075|NCT01222390|Acellular Dermis|acellular dermis
1386076|NCT01222390|3-D Imaging|3-d imaging
1386077|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
1386078|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1386079|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1386080|NCT01222364|Prematurity|prematurity
1386081|NCT01222351|Alzheimer's disease|alzheimer's disease
1386082|NCT01222351|Positron emission tomography|positron emission tomography
1386083|NCT01222351|Biomarker|biomarker
1386084|NCT01222351|Plasma Aβ|plasma aβ
1386085|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
1386086|NCT01222338|Mycobacterium|mycobacterium
1386087|NCT01222338|MDR-TB|mdr-tb
1386089|NCT01222338|HIV|hiv
1386090|NCT01222338|HCV|hcv
1386091|NCT01222325|kidney calculi|kidney calculi
1386092|NCT01222325|urolithiasis|urolithiasis
1386093|NCT01222325|urologic surgical procedures|urologic surgical procedures
1386094|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
1386095|NCT01222312|advanced NSCLC|advanced nsclc
1386096|NCT01222312|oxaliplatin|oxaliplatin
1386097|NCT01222312|cisplatin|cisplatin
1386098|NCT01222312|docetaxel|docetaxel
1386099|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
1386100|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
1386101|NCT01222273|cystic fibrosis|cystic fibrosis
1386102|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
1386103|NCT01222273|A. fumigatus|a. fumigatus
1386104|NCT01222273|Immune response|immune response
1386105|NCT01222260|Amyloidosis|amyloidosis
1386106|NCT01222260|Dexamethasone|dexamethasone
1386107|NCT01222260|Bendamustine|bendamustine
1386108|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
1386109|NCT01222247|Betamethasone|betamethasone
1386110|NCT01222247|Celestone|celestone
1386111|NCT01222247|Steroids|steroids
1386112|NCT01222247|Perinatology|perinatology
1386113|NCT01222221|adult gliosarcoma|adult gliosarcoma
1386114|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
1386115|NCT01222221|adult glioblastoma|adult glioblastoma
1386116|NCT01222208|Bowel resection|bowel resection
1386117|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
1386118|NCT01222195|Red cell transfusion independence|red cell transfusion independence
1386119|NCT01222195|Darbepoetin alfa|darbepoetin alfa
1386120|NCT01222195|Lenalidomide|lenalidomide
1386121|NCT01222195|CC-5013|cc-5013
1386122|NCT01222195|Revlimid|revlimid
1386123|NCT01222195|Aranesp|aranesp
1386124|NCT01222195|Erythropoietin|erythropoietin
1386125|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
1386126|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
1386127|NCT01222182|statin|statin
1386128|NCT01222182|dose equivalent|dose equivalent
1386129|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
1386130|NCT01222169|Anesthesia|anesthesia
1386131|NCT01222169|Children|children
1386132|NCT01222169|Larynx|larynx
1386133|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
1386134|NCT01222156|Catheter ablation|catheter ablation
1386135|NCT01222156|Electrophysiology|electrophysiology
1386136|NCT01222156|Magnetic|magnetic
1386137|NCT01222156|Mapping|mapping
1386138|NCT01222156|Remote navigation|remote navigation
1386139|NCT01222143|AML|aml
1386140|NCT01222143|NOVE-HiDAC|nove-hidac
1386141|NCT01222143|Nilotinib|nilotinib
1386142|NCT01222130|HIV|hiv
1386143|NCT01222130|Infant infection|infant infection
1386144|NCT01222130|Diagnosis|diagnosis
1386145|NCT01222130|Non-virological algorithm|non-virological algorithm
1386146|NCT01222117|Acute Limb Ischemia|acute limb ischemia
1386147|NCT01222104|vascular closure|vascular closure
1386148|NCT01222104|Angio-Seal|angio-seal
1386149|NCT01222104|Interventional radiology|interventional radiology
1386150|NCT01222104|femoral artery|femoral artery
1386151|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
1386152|NCT01222078|re-treatment|re-treatment
1386153|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
1386154|NCT01222078|beta-cell preservation|beta-cell preservation
1386155|NCT01222065|Glaucoma|glaucoma
1386156|NCT01222065|Neurotubules|neurotubules
1386157|NCT01222065|Birefringence|birefringence
1386158|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
1386159|NCT01222052|high risk breast cancer|high risk breast cancer
1386160|NCT01222052|low risk breast cancer|low risk breast cancer
1386161|NCT01222052|uPA|upa
1386162|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
1386163|NCT01222052|PAI|pai
1386164|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
1386165|NCT01222039|Graft versus host disease|graft versus host disease
1386166|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
1386167|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
1386168|NCT01222039|Adipose tissue|adipose tissue
1386169|NCT01222039|Allotransplant|allotransplant
1386170|NCT01222039|Allogenic|allogenic
1386171|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
1386172|NCT01222039|Immune System Diseases|immune system diseases
1386173|NCT01222039|Chronic|chronic
1386175|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
1386176|NCT01222026|Osteopenia|osteopenia
1386177|NCT01222026|Osteoporosis|osteoporosis
1386178|NCT01221987|Human papillomavirus|human papillomavirus
1386179|NCT01221987|neoplasia|neoplasia
1386180|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
1386181|NCT01221961|Major spine surgery|major spine surgery
1386182|NCT01221961|Hemoglobin|hemoglobin
1386183|NCT01221961|Blood transfusion|blood transfusion
1386184|NCT01221948|Deep Brain Stimulation|deep brain stimulation
1386185|NCT01221948|Parkinson's Disease|parkinson's disease
1386186|NCT01221935|retrospective chart review study|retrospective chart review study
1386187|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
1386188|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
1386189|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
1386190|NCT01221909|bleeding|bleeding
1386191|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
1386192|NCT01221909|operative duration|operative duration
1386193|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
1386194|NCT01221883|Posttraumatic Stress|posttraumatic stress
1386195|NCT01221883|Prevention|prevention
1386196|NCT01221883|Diazepam|diazepam
1386197|NCT01221870|Metastatic breast cancer|metastatic breast cancer
1386198|NCT01221870|First-line therapy|first-line therapy
1386199|NCT01221870|Tesetaxel|tesetaxel
1386200|NCT01221870|Oral taxane|oral taxane
1386201|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
1386202|NCT01221857|Hematological Malignancies|hematological malignancies
1386203|NCT01221857|HLA Mismatched Donors|hla mismatched donors
1386204|NCT01221857|Cord Blood Transplantation|cord blood transplantation
1386205|NCT01221844|Lactoferrin|lactoferrin
1386206|NCT01221844|Pregnancy|pregnancy
1386207|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
1386208|NCT01221844|Iron deficiency|iron deficiency
1386209|NCT01221844|Iron deficiency anemia|iron deficiency anemia
1386210|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
1386211|NCT01221805|deep venous thrombosis|deep venous thrombosis
1386212|NCT01221805|pulmonary embolism|pulmonary embolism
1386213|NCT01221805|venous thromboembolism|venous thromboembolism
1386215|NCT01221805|Wells score|wells score
1386216|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
1386217|NCT01221792|PTSD|ptsd
1386218|NCT01221792|Anxiety|anxiety
1386219|NCT01221792|Trauma|trauma
1386220|NCT01221792|Assault|assault
1386221|NCT01221792|Victim|victim
1386222|NCT01221792|Witness|witness
1386223|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
1386224|NCT01221792|Combat veteran|combat veteran
1386225|NCT01221792|Flashbacks|flashbacks
1386226|NCT01221792|Nightmares|nightmares
1386227|NCT01221792|Sleep Disturbance|sleep disturbance
1386228|NCT01221792|Hyperarousal|hyperarousal
1386229|NCT01221792|Numbness|numbness
1386230|NCT01221792|Avoidance|avoidance
1386231|NCT01221779|Intensive language therapy|intensive language therapy
1386232|NCT01221779|Anomia|anomia
1386233|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
1386234|NCT01221766|adnexal|adnexal
1386235|NCT01221766|hair and nail|hair and nail
1386236|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
1386237|NCT01221766|children|children
1386238|NCT01221753|SSCHN|sschn
1386239|NCT01221753|HPV|hpv
1386240|NCT01221753|IMRT|imrt
1386241|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
1386242|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
1386243|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
1386244|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
1386245|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
1386246|NCT01221740|To compare outcome differences|to compare outcome differences
1386247|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
1386248|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
1386249|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
1567146|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
1386250|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
1386251|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
1386252|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
1386253|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
1386254|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
1386255|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
1386256|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
1386257|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
1386258|NCT01221740|greater 6 months|greater 6 months
1386259|NCT01221740|QST|qst
1386260|NCT01221740|10 weeks|10 weeks
1386261|NCT01221740|milnacipran|milnacipran
1386262|NCT01221740|pain intensity|pain intensity
1386263|NCT01221740|mood|mood
1386264|NCT01221740|activity|activity
1386265|NCT01221740|interference|interference
1386266|NCT01221740|sleep|sleep
1386267|NCT01221740|side effects|side effects
1386268|NCT01221740|age|age
1386269|NCT01221740|gender|gender
1386270|NCT01221740|medical comorbidities|medical comorbidities
1386271|NCT01221740|pain diagnosis|pain diagnosis
1386272|NCT01221740|pain duration|pain duration
1386273|NCT01221740|disability status|disability status
1386274|NCT01221727|Amgen|amgen
1386275|NCT01221727|Phase 1|phase 1
1386276|NCT01221727|Postmenopausal|postmenopausal
1386277|NCT01221727|Osteoporosis|osteoporosis
1386278|NCT01221714|nutritional supplements|nutritional supplements
1386279|NCT01221714|supplements|supplements
1386280|NCT01221714|vitamins|vitamins
1386281|NCT01221714|omega-3|omega-3
1386282|NCT01221714|Amerisciences|amerisciences
1386283|NCT01221714|Carlos Montesinos|carlos montesinos
1386284|NCT01221701|depression|depression
1386285|NCT01221701|psychological treatments|psychological treatments
1386286|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
1386287|NCT01221701|child social/emotional functioning|child social/emotional functioning
1386288|NCT01221701|parenting|parenting
1386289|NCT01221701|home visitation|home visitation
1386290|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
1386291|NCT01221688|large operable breast cancer|large operable breast cancer
1386292|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1386293|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
1386294|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
1386295|NCT01221675|Radio Immunotherapy|radio immunotherapy
1386296|NCT01221675|Lutetium|lutetium
1386297|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
1386298|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
1386299|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
1386300|NCT01221662|Siwu tang|siwu tang
1386301|NCT01221662|brain hypoperfusion|brain hypoperfusion
1386302|NCT01221662|cognition function|cognition function
1386303|NCT01221623|Peyronie's Disease|peyronie's disease
1386304|NCT01221623|penile plaque|penile plaque
1386305|NCT01221623|penile curvature|penile curvature
1386306|NCT01221610|Stenosis|stenosis
1386307|NCT01221610|Occlusions|occlusions
1386308|NCT01221610|SFA|sfa
1386309|NCT01221610|PTA|pta
1386310|NCT01221610|POBA|poba
1386311|NCT01221610|DRB|drb
1386312|NCT01221597|Peyronie's Disease|peyronie's disease
1386313|NCT01221597|penile plaque|penile plaque
1386314|NCT01221597|penile curvature|penile curvature
1386315|NCT01221584|Dyslipidaemia|dyslipidaemia
1386316|NCT01221584|LDL-C goals|ldl-c goals
1386317|NCT01221584|guidelines|guidelines
1386318|NCT01221571|Phase I|phase i
1386319|NCT01221571|Dose escalation|dose escalation
1386320|NCT01221571|AFM 13|afm 13
1386321|NCT01221571|Natural killer cell|natural killer cell
1386322|NCT01221545|Diabetes Mellitus|diabetes mellitus
1386323|NCT01221519|Phase I|phase i
1386324|NCT01221519|Bioavailability|bioavailability
1386325|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1386326|NCT01221519|Diabetic treatment|diabetic treatment
1386327|NCT01221519|Metformin|metformin
1386328|NCT01221519|High blood sugar|high blood sugar
1386329|NCT01221506|unresectable|unresectable
1386330|NCT01221506|metastatic|metastatic
1386331|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
1386332|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
1386333|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
1386334|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
1386335|NCT01221454|ABMSC|abmsc
1386336|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
1386337|NCT01221454|Liver Failure|liver failure
1386338|NCT01221454|Transplantation|transplantation
1509061|NCT00742326|HIV|hiv
1386339|NCT01221441|Cartilage|cartilage
1386340|NCT01221441|Knee|knee
1386341|NCT01221441|Osteoarthritis|osteoarthritis
1386342|NCT01221428|Ulcerative colitis|ulcerative colitis
1386343|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
1386344|NCT01221428|Umbilical Cord|umbilical cord
1386345|NCT01221389|hemorrhage|hemorrhage
1386346|NCT01221389|plasma|plasma
1386347|NCT01221389|coagulopathy|coagulopathy
1386348|NCT01221389|trauma|trauma
1386349|NCT01221363|Life style disease|life style disease
1386350|NCT01221363|Obesity|obesity
1386351|NCT01221363|Sedentary behaviour|sedentary behaviour
1386352|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
1386353|NCT01221350|Asthma|asthma
1386354|NCT01221350|Allergic rhinitis|allergic rhinitis
1386355|NCT01221350|Respiratory disease|respiratory disease
1386356|NCT01221350|Allergy|allergy
1386357|NCT01221350|Lipoic acid|lipoic acid
1386358|NCT01221350|Thioctic acid|thioctic acid
1386359|NCT01221350|Antioxidant|antioxidant
1386360|NCT01221350|Oxidative stress|oxidative stress
1386361|NCT01221311|stenosis|stenosis
1386362|NCT01221311|bile duct|bile duct
1386363|NCT01221311|chronic pancreatitis|chronic pancreatitis
1386364|NCT01221311|postoperative|postoperative
1386365|NCT01221311|post-liver transplant|post-liver transplant
1386366|NCT01221285|Cockroach|cockroach
1386367|NCT01221285|Immunotherapy|immunotherapy
1386368|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
1386369|NCT01221285|Inner city asthma|inner city asthma
1386370|NCT01221272|SPECT MPI|spect mpi
1386371|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
1386372|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
1386373|NCT01221207|casting|casting
1386374|NCT01221207|wound care|wound care
1386375|NCT01221194|diabetes|diabetes
1386376|NCT01221194|foot ulcer prevention|foot ulcer prevention
1386377|NCT01221194|therapeutic stockings|therapeutic stockings
1386378|NCT01221181|Dense deposit disease|dense deposit disease
1386379|NCT01221181|C3 nephropathy|c3 nephropathy
1386380|NCT01221181|Eculizumab|eculizumab
1386381|NCT01221168|prostate|prostate
1386382|NCT01221168|cancer|cancer
1386383|NCT01221168|genetic|genetic
1386384|NCT01221168|epidemiology|epidemiology
1386385|NCT01221168|susceptibility|susceptibility
1386386|NCT01221155|Musculoskeletal|musculoskeletal
1386387|NCT01221142|Hypothermia, ICH|hypothermia, ich
1386388|NCT01221129|zinc|zinc
1386389|NCT01221129|reticulocyte|reticulocyte
1386390|NCT01221129|PBMC|pbmc
1386391|NCT01221129|whole blood|whole blood
1386392|NCT01221129|transcriptome|transcriptome
1386393|NCT01221129|microarray|microarray
1386394|NCT01221116|coronary artery disease,|coronary artery disease,
1386395|NCT01221116|aortic stenosis,|aortic stenosis,
1386396|NCT01221116|heart failure|heart failure
1386397|NCT01221103|Dexamethasone|dexamethasone
1386398|NCT01221103|Ofatumumab|ofatumumab
1386399|NCT01221103|Bendamustine|bendamustine
1386400|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1386401|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1386402|NCT01221090|Type 2 diabetes|type 2 diabetes
1386403|NCT01221090|Health disparities|health disparities
1386404|NCT01221090|Central Texas|central texas
1386405|NCT01221090|PDA|pda
1386406|NCT01221090|CDSMP|cdsmp
1386407|NCT01221077|NSCLC|nsclc
1386408|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
1386409|NCT01221077|OSI-906|osi-906
1386410|NCT01221077|IGF-IR|igf-ir
1386411|NCT01221077|Tarceva|tarceva
1386412|NCT01221077|Erlotinib|erlotinib
1386413|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1386414|NCT01221077|EGFR|egfr
1386415|NCT01221077|Chemonaive|chemonaive
1386416|NCT01221077|Activating mutations|activating mutations
1386417|NCT01221064|Breast cancer|breast cancer
1386418|NCT01221064|Axillary clearance|axillary clearance
1386419|NCT01221064|lymphorrhoea|lymphorrhoea
1386420|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
1386421|NCT01221025|Parecoxib;|parecoxib;
1386422|NCT01221025|emergence delirium;|emergence delirium;
1386423|NCT01221025|postoperative pain;|postoperative pain;
1386424|NCT01221025|elderly patients;|elderly patients;
1386425|NCT01221025|abdominal surgery|abdominal surgery
1386426|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
1386427|NCT01220999|Clinical trial|clinical trial
1386428|NCT01220999|CS-1008 mAb|cs-1008 mab
1386429|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
1386430|NCT01220999|Positron-Emission Tomography|positron-emission tomography
1386431|NCT01220999|Pharmacokinetics|pharmacokinetics
1386432|NCT01220999|Pharmacodynamics|pharmacodynamics
1386433|NCT01220999|apoptosis|apoptosis
1386434|NCT01220999|caspases|caspases
1386435|NCT01220986|Liver regeneration|liver regeneration
1386436|NCT01220986|Innate immune response|innate immune response
1386437|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
1386438|NCT01220973|stage III prostate cancer|stage iii prostate cancer
1386439|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
1386440|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
1386441|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
1386442|NCT01220960|art therapy|art therapy
1386443|NCT01220960|breast cancer|breast cancer
1386444|NCT01220960|women|women
1386445|NCT01220960|young women|young women
1386446|NCT01220960|older women|older women
1386447|NCT01220960|quality of life|quality of life
1386448|NCT01220960|meaning making|meaning making
1386449|NCT01220960|support group|support group
1386450|NCT01220960|art making|art making
1386451|NCT01220960|art symbols|art symbols
1386452|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
1386453|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
1386454|NCT01220908|Emphysema|emphysema
1386455|NCT01220908|coil|coil
1386456|NCT01220908|RePneu|repneu
1386457|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
1386553|NCT01220505|lordosis|lordosis
1386458|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1386459|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
1386460|NCT01220856|Islet transplantation|islet transplantation
1386461|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
1386462|NCT01220843|chronic renal failure|chronic renal failure
1386463|NCT01220843|FGF23|fgf23
1386464|NCT01220843|Sevelamer carbonate|sevelamer carbonate
1386465|NCT01220830|Multiple sclerosis|multiple sclerosis
1386466|NCT01220830|RFQMR|rfqmr
1386467|NCT01220830|Cytotron|cytotron
1386468|NCT01220830|EDSS|edss
1386469|NCT01220830|QOL assessment with FAMS|qol assessment with fams
1386470|NCT01220817|prostate|prostate
1386471|NCT01220817|cancer|cancer
1386473|NCT01220817|psadt|psadt
1386474|NCT01220817|pomegranate|pomegranate
1386475|NCT01220817|POMx|pomx
1386476|NCT01220791|methylprednisolone|methylprednisolone
1386477|NCT01220791|IVF|ivf
1386478|NCT01220791|progesterone|progesterone
1386479|NCT01220791|corticosteroid|corticosteroid
1386480|NCT01220791|late follicular phase|late follicular phase
1386481|NCT01220791|pregnancy rates|pregnancy rates
1386482|NCT01220765|hypoxemia|hypoxemia
1386483|NCT01220765|capnography|capnography
1386484|NCT01220765|sedation|sedation
1386485|NCT01220752|IMRT|imrt
1386486|NCT01220752|carbon ion therapy|carbon ion therapy
1386487|NCT01220752|paranasal sinus|paranasal sinus
1386488|NCT01220752|nasal cavity|nasal cavity
1386489|NCT01220752|adenocarcinoma|adenocarcinoma
1386490|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
1386491|NCT01220739|ischemic stroke|ischemic stroke
1386492|NCT01220739|transcranial laser|transcranial laser
1386493|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
1386494|NCT01220739|therapy|therapy
1386495|NCT01220726|OAB|oab
1386496|NCT01220713|Traumatic Brain Injury|traumatic brain injury
1386497|NCT01220713|Veterans|veterans
1386498|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
1386499|NCT01220713|OEF/OIF|oef/oif
1386500|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
1386501|NCT01220713|Blast Exposure|blast exposure
1386502|NCT01220687|Prematurity|prematurity
1386503|NCT01220687|Oxygen exposure|oxygen exposure
1386504|NCT01220687|Nitric Oxide|nitric oxide
1386505|NCT01220674|neuropsychological assessment|neuropsychological assessment
1386506|NCT01220674|cognitive impairment|cognitive impairment
1386507|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
1386508|NCT01220661|Colorectal Surgery|colorectal surgery
1386509|NCT01220661|Surgical Wound Infection|surgical wound infection
1386510|NCT01220661|Laparoscopy|laparoscopy
1386511|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
1386512|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
1386513|NCT01220648|interferon alfa|interferon alfa
1386514|NCT01220648|nilotinib|nilotinib
1386515|NCT01220648|combination|combination
1386516|NCT01220648|CML|cml
1386517|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
1386518|NCT01220635|Depressive Symptoms|depressive symptoms
1386519|NCT01220635|Depression prevention|depression prevention
1386520|NCT01220635|Adolescents|adolescents
1386521|NCT01220635|School-Based Services|school-based services
1386522|NCT01220635|Health Behavior|health behavior
1386523|NCT01220622|Stroke|stroke
1386524|NCT01220622|Mild cognitive impairment|mild cognitive impairment
1386525|NCT01220622|Nimodipine|nimodipine
1386526|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
1386527|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
1386528|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
1386529|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1386530|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1386531|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
1386532|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
1386533|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
1386534|NCT01220570|breast cancer|breast cancer
1386535|NCT01220570|ridaforolimus|ridaforolimus
1386536|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
1386537|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
1386538|NCT01220531|DiGeorge Anomaly|digeorge anomaly
1386539|NCT01220531|Thymus Transplantation|thymus transplantation
1386540|NCT01220531|DiGeorge Syndrome|digeorge syndrome
1386541|NCT01220531|Athymia|athymia
1386542|NCT01220531|Low T cell numbers|low t cell numbers
1386543|NCT01220531|Immunoreconstitution|immunoreconstitution
1386544|NCT01220531|Immunodeficiency|immunodeficiency
1386545|NCT01220531|Complete DiGeorge|complete digeorge
1386546|NCT01220531|Typical DiGeorge|typical digeorge
1386547|NCT01220531|Atypical DiGeorge|atypical digeorge
1386548|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
1386549|NCT01220505|scoliosis|scoliosis
1386550|NCT01220505|kyphosis|kyphosis
1386551|NCT01220505|spinal deformity|spinal deformity
1386552|NCT01220505|curvature|curvature
1386554|NCT01220492|liver cirrhosis|liver cirrhosis
1386555|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
1386556|NCT01220492|ascites|ascites
1386557|NCT01220492|serum albumin|serum albumin
1386558|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
1386559|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
1386560|NCT01220479|Child, Adolescent|child, adolescent
1386561|NCT01220440|ADHD|adhd
1386562|NCT01220440|Children|children
1386563|NCT01220440|Methylphenidate|methylphenidate
1386564|NCT01220440|Dextroamphetamine|dextroamphetamine
1386565|NCT01220440|Placebo|placebo
1386566|NCT01220440|Crossover|crossover
1386567|NCT01220440|Double Blind|double blind
1386568|NCT01220440|Neuropsychological tests|neuropsychological tests
1386569|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
1386570|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
1386571|NCT01220427|radical prostatectomy|radical prostatectomy
1386572|NCT01220427|micro-RNA|micro-rna
1386573|NCT01220401|Nightmare|nightmare
1386574|NCT01220401|PTSD|ptsd
1386575|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
1386576|NCT01220401|Suicide|suicide
1386577|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
1386578|NCT01220401|Sleep|sleep
1386579|NCT01220388|Aldosterone|aldosterone
1386580|NCT01220388|L-lysine|l-lysine
1386581|NCT01220388|Cortisol|cortisol
1386582|NCT01220388|Adrenal glands|adrenal glands
1386583|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
1386584|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
1386585|NCT01220375|Multiple Myeloma|multiple myeloma
1386586|NCT01220375|Plerixafor|plerixafor
1386587|NCT01220362|Analgesia, Epidural|analgesia, epidural
1386588|NCT01220362|Urodynamics|urodynamics
1386589|NCT01220362|Urinary Retention|urinary retention
1386590|NCT01220284|solid tumors|solid tumors
1386591|NCT01220284|oral treatment|oral treatment
1386592|NCT01220284|platinum compound|platinum compound
1386593|NCT01220284|vinca alkaloid|vinca alkaloid
1386594|NCT01220284|drug combination|drug combination
1386595|NCT01220271|Glioma|glioma
1386596|NCT01220271|Glioblastoma|glioblastoma
1386597|NCT01220245|endoluminal|endoluminal
1386598|NCT01220245|surgical|surgical
1386599|NCT01220245|bypass|bypass
1386600|NCT01220245|patency|patency
1386601|NCT01220245|quality of life|quality of life
1386602|NCT01220245|multicentre|multicentre
1386603|NCT01220245|RCT|rct
1386604|NCT01220245|superficial femoral artery|superficial femoral artery
1386605|NCT01220245|vascular patency|vascular patency
1386606|NCT01220232|Lersivirine|lersivirine
1386607|NCT01220232|UK-453|uk-453
1386608|NCT01220232|061|061
1386609|NCT01220232|NNRTI|nnrti
1386610|NCT01220232|Abacavir|abacavir
1386611|NCT01220232|Lamivudine|lamivudine
1386612|NCT01220232|Combivir|combivir
1386613|NCT01220232|Pharmacokinetics|pharmacokinetics
1386614|NCT01220232|Drug Interaction|drug interaction
1386615|NCT01220232|HIV|hiv
1386616|NCT01220232|AIDS|aids
1386617|NCT01220219|pregabalin|pregabalin
1386618|NCT01220219|pharmacokinetics|pharmacokinetics
1386619|NCT01220219|bioavailability|bioavailability
1386620|NCT01220219|bioequivalence|bioequivalence
1386621|NCT01220206|ED|ed
1386622|NCT01220206|POMx|pomx
1386623|NCT01220206|Pomegranate|pomegranate
1386624|NCT01220206|Erectile dysfunction|erectile dysfunction
1386625|NCT01220180|epilepsy|epilepsy
1386626|NCT01220180|neuropathic pain|neuropathic pain
1386627|NCT01220180|fibromyalgia|fibromyalgia
1386628|NCT01220180|post-market surveillance|post-market surveillance
1386629|NCT01220180|prospective observational|prospective observational
1386630|NCT01220154|ovarian|ovarian
1386631|NCT01220154|cancer|cancer
1386632|NCT01220154|fallopian tube|fallopian tube
1386633|NCT01220154|peritoneal|peritoneal
1386634|NCT01220154|intraperitoneal|intraperitoneal
1386635|NCT01220154|bevacizumab|bevacizumab
1386636|NCT01220154|carboplatin|carboplatin
1386637|NCT01220154|paclitaxel|paclitaxel
1386638|NCT01220154|chemo-naive|chemo-naive
1386639|NCT01220128|WT1|wt1
1386640|NCT01220128|neoadjuvant|neoadjuvant
1386641|NCT01220128|tumor antigen|tumor antigen
1386642|NCT01220128|immunotherapy|immunotherapy
1386643|NCT01220128|breast cancer|breast cancer
1386644|NCT01220128|adult|adult
1386645|NCT01220115|sickle cell disease|sickle cell disease
1386646|NCT01220115|iron over load|iron over load
1386647|NCT01220102|acne|acne
1386648|NCT01220102|Epiduo|epiduo
1386649|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
1386650|NCT01220089|obesity|obesity
1386651|NCT01220089|weight loss|weight loss
1386652|NCT01220076|Tamoxifen,|tamoxifen,
1386653|NCT01220076|Breat Cancer|breat cancer
1386654|NCT01220076|Pharmacogenetic|pharmacogenetic
1386655|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
1386656|NCT01220063|RSHF|rshf
1386657|NCT01220063|Irinotecan|irinotecan
1386658|NCT01220063|Colorectal Cancer|colorectal cancer
1386659|NCT01220063|metastases|metastases
1386660|NCT01220050|Paricalcitol|paricalcitol
1386661|NCT01220050|Renal transplant|renal transplant
1386662|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1386663|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
1386664|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
1386665|NCT01219998|Postoperative Complications|postoperative complications
1386666|NCT01219998|Acute Kidney Failure|acute kidney failure
1386667|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
1386668|NCT01219998|NGAL|ngal
1386669|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
1386863|NCT01219296|IVF|ivf
1386670|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
1386671|NCT01219985|liver neoplasm|liver neoplasm
1386672|NCT01219985|respiratory motion|respiratory motion
1386673|NCT01219972|Bone marrow transplant|bone marrow transplant
1386674|NCT01219972|Pulmonary complications|pulmonary complications
1386675|NCT01219959|ESRD|esrd
1386676|NCT01219959|Diabetes|diabetes
1386677|NCT01219959|CAPD|capd
1386678|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
1386679|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
1386680|NCT01219920|Phase III|phase iii
1386681|NCT01219920|FOLFOXIRI|folfoxiri
1386682|NCT01219920|FOLFIRI|folfiri
1386683|NCT01219894|Coronary Disease|coronary disease
1386684|NCT01219894|Stent|stent
1386685|NCT01219894|Healing|healing
1386686|NCT01219894|Anti-platelet therapy|anti-platelet therapy
1386687|NCT01219881|desflurane|desflurane
1386688|NCT01219881|sevoflurane|sevoflurane
1386689|NCT01219855|Parathyroid Diseases|parathyroid diseases
1386690|NCT01219855|Renal Insufficiency|renal insufficiency
1386691|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
1386692|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1386693|NCT01219855|Vitamin D|vitamin d
1386694|NCT01219855|Hyperparathyroidism|hyperparathyroidism
1386695|NCT01219855|Kidney Diseases|kidney diseases
1386696|NCT01219855|Kidney Failure|kidney failure
1386697|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
1386698|NCT01219842|Intermittent claudication|intermittent claudication
1386699|NCT01219842|Health Related Quality of Life|health related quality of life
1386700|NCT01219842|Walking performance|walking performance
1386701|NCT01219842|Daily walking capacity|daily walking capacity
1386702|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
1386703|NCT01219829|Pancreatic Cancer|pancreatic cancer
1386704|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
1386705|NCT01219829|Field Effect|field effect
1386706|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
1386707|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
1386708|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
1386709|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
1386710|NCT01219777|bevacizumab|bevacizumab
1386711|NCT01219777|paclitaxel|paclitaxel
1386712|NCT01219777|carboplatin|carboplatin
1386713|NCT01219777|ovarian|ovarian
1386714|NCT01219777|cancer|cancer
1386715|NCT01219777|fallopian tube|fallopian tube
1386716|NCT01219777|primary peritoneal|primary peritoneal
1386717|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
1386718|NCT01219764|quadruple therapy|quadruple therapy
1386719|NCT01219764|Amoxicillin|amoxicillin
1386720|NCT01219764|Metronidazole|metronidazole
1386721|NCT01219764|Clarithromycin|clarithromycin
1386722|NCT01219764|Rabeprazole|rabeprazole
1386723|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
1386724|NCT01219725|Body composition|body composition
1386725|NCT01219725|Endothelial function|endothelial function
1386726|NCT01219725|Lipoprotein profile|lipoprotein profile
1567147|NCT00509769|MBC|mbc
1386727|NCT01219725|Inflammatory markers|inflammatory markers
1386728|NCT01219725|Aerobic capacity|aerobic capacity
1386729|NCT01219725|Thrombotic markers|thrombotic markers
1386730|NCT01219725|Arterial stiffness|arterial stiffness
1386731|NCT01219725|Cardiac function|cardiac function
1386732|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
1386733|NCT01219712|NT-proBNP|nt-probnp
1386734|NCT01219712|non-cardiac surgery|non-cardiac surgery
1386735|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
1386736|NCT01219712|cardiac complications|cardiac complications
1386737|NCT01219699|advanced solid tumors|advanced solid tumors
1386738|NCT01219699|mutation|mutation
1386739|NCT01219699|amplification|amplification
1386740|NCT01219699|wild type|wild type
1386741|NCT01219699|PIK3CA gene|pik3ca gene
1386742|NCT01219699|dose-escalation|dose-escalation
1386743|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
1386744|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
1386745|NCT01219673|Epithelial carcinoma|epithelial carcinoma
1386746|NCT01219673|Oropharynx|oropharynx
1386747|NCT01219673|Larynx|larynx
1386951|NCT01218841|Surgery|surgery
1386748|NCT01219673|Symptom-management|symptom-management
1386749|NCT01219673|Chemoradiation|chemoradiation
1386750|NCT01219673|Placebo|placebo
1386751|NCT01219673|Armodafinil|armodafinil
1386752|NCT01219673|Nuvigil|nuvigil
1386753|NCT01219673|Bupropion|bupropion
1386754|NCT01219673|Wellbutrin|wellbutrin
1386755|NCT01219673|Wellbutrin SR|wellbutrin sr
1386756|NCT01219673|Zyban|zyban
1386757|NCT01219673|Minocycline|minocycline
1386758|NCT01219673|Dynacin|dynacin
1386759|NCT01219673|Minocin|minocin
1386760|NCT01219673|Minocin PAC|minocin pac
1386761|NCT01219673|Myrac|myrac
1386762|NCT01219673|Solodyn|solodyn
1386763|NCT01219660|sleep|sleep
1386764|NCT01219660|apnea|apnea
1386765|NCT01219647|Multiple Sclerosis|multiple sclerosis
1386766|NCT01219647|Exercise|exercise
1386767|NCT01219647|Cognition|cognition
1386768|NCT01219621|Symphony DR 2550,|symphony dr 2550,
1386769|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
1386770|NCT01219621|Sorin,|sorin,
1386771|NCT01219621|Ela Medical,|ela medical,
1386772|NCT01219621|DDD Mode,|ddd mode,
1386773|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
1386774|NCT01219621|AV-Conduction,|av-conduction,
1386775|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
1386776|NCT01219621|Congestive Heart Failure,|congestive heart failure,
1386777|NCT01219621|Cardiac Function,|cardiac function,
1386778|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
1386779|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
1386780|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
1386781|NCT01219621|Long AV-delays.|long av-delays.
1386782|NCT01219621|Ventricular Function,|ventricular function,
1386783|NCT01219621|Implantation,|implantation,
1386784|NCT01219595|Urinary Tract Infection|urinary tract infection
1386786|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
1386787|NCT01219582|Acarbose|acarbose
1386788|NCT01219582|Metformin|metformin
1386789|NCT01219582|Drug Therapy, Combination|drug therapy, combination
1386790|NCT01219569|blindness|blindness
1386791|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
1386792|NCT01219556|Hypertension|hypertension
1386793|NCT01219556|Antihypertensive Agents|antihypertensive agents
1386794|NCT01219556|Drug Therapy, Combination|drug therapy, combination
1386795|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
1386796|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
1386797|NCT01219543|Advanced solid malignancies|advanced solid malignancies
1386798|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
1386799|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
1386800|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
1386801|NCT01219543|Gastric cancer|gastric cancer
1386802|NCT01219543|Solid tumour|solid tumour
1386803|NCT01219543|AZD1480|azd1480
1386804|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
1386805|NCT01219530|gestational carrier|gestational carrier
1386806|NCT01219530|intended parent|intended parent
1386807|NCT01219517|IVF|ivf
1386808|NCT01219517|embryo biopsy|embryo biopsy
1386809|NCT01219517|DNA fingerprinting|dna fingerprinting
1386810|NCT01219517|SNP|snp
1386811|NCT01219504|PGD|pgd
1386812|NCT01219504|IVF|ivf
1386813|NCT01219491|egg donor|egg donor
1386814|NCT01219491|recipients|recipients
1386815|NCT01219491|donor characteristics|donor characteristics
1386816|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
1386817|NCT01219465|Diabetes Mellitus|diabetes mellitus
1386818|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1386819|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
1386820|NCT01219465|Umbilical cord|umbilical cord
1386821|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
1386822|NCT01219452|Umbilical cord|umbilical cord
1386823|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
1386824|NCT01219452|Children|children
1386825|NCT01219439|discarded pathological specimens|discarded pathological specimens
1386826|NCT01219439|discarded media|discarded media
1386827|NCT01219439|IVF|ivf
1386828|NCT01219426|Gambling|gambling
1386829|NCT01219426|cognitive distortions|cognitive distortions
1386830|NCT01219426|assessment tool|assessment tool
1386831|NCT01219426|validation|validation
1386832|NCT01219426|French|french
1386833|NCT01219413|aliskiren|aliskiren
1386834|NCT01219413|renin inhibitor|renin inhibitor
1386835|NCT01219413|proteinuria|proteinuria
1386836|NCT01219413|chronic kidney diseases|chronic kidney diseases
1386837|NCT01219413|ACE inhibitor|ace inhibitor
1386838|NCT01219400|DPP-4|dpp-4
1386839|NCT01219400|GLP-1|glp-1
1386840|NCT01219400|Glucagon|glucagon
1386841|NCT01219400|Catecholamines|catecholamines
1386842|NCT01219400|Counterregulation|counterregulation
1386843|NCT01219400|Insulin-treatment|insulin-treatment
1386844|NCT01219400|Type 2 diabetes|type 2 diabetes
1386845|NCT01219387|AMH|amh
1386846|NCT01219387|inhibin B|inhibin b
1386847|NCT01219387|infertility|infertility
1386848|NCT01219374|egg donor|egg donor
1386849|NCT01219361|Donated embryos|donated embryos
1386850|NCT01219348|IDO enzyme|ido enzyme
1386851|NCT01219348|Vaccination trial|vaccination trial
1386852|NCT01219348|Immunotherapy|immunotherapy
1386853|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
1386854|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
1386855|NCT01219335|IVF|ivf
1386856|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
1386857|NCT01219322|ASA I or II|asa i or ii
1386858|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1386859|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
1386860|NCT01219309|Developmental coordination disorder|developmental coordination disorder
1386861|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
1386862|NCT01219296|infertility|infertility
1386864|NCT01219283|PGD|pgd
1386865|NCT01219283|IVF|ivf
1386866|NCT01219270|Radiocontrast media,|radiocontrast media,
1386867|NCT01219270|hyponatremia|hyponatremia
1386868|NCT01219257|SpA|spa
1386869|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
1386870|NCT01219257|Ultrasonography|ultrasonography
1386871|NCT01219257|Synovitis|synovitis
1386872|NCT01219257|Enthesitis|enthesitis
1386873|NCT01219244|memory|memory
1386874|NCT01219244|diet|diet
1386875|NCT01219244|elderly|elderly
1386876|NCT01219244|cognition|cognition
1386877|NCT01219244|prevention|prevention
1386878|NCT01219244|lifestyle|lifestyle
1386879|NCT01219231|Exercise|exercise
1386880|NCT01219231|elderly|elderly
1386881|NCT01219231|cognition|cognition
1386882|NCT01219231|prevention|prevention
1386883|NCT01219231|cognitive decline|cognitive decline
1386884|NCT01219231|Lifestyle|lifestyle
1386885|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1386886|NCT01219218|Myocardial Ischemia|myocardial ischemia
1386887|NCT01219218|Refractory Angina|refractory angina
1386888|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
1386889|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
1386890|NCT01219179|Hypernatremia|hypernatremia
1386891|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
1386892|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
1386893|NCT01219140|POMx|pomx
1386894|NCT01219140|Osteopenia|osteopenia
1386895|NCT01219140|postmenopausal women|postmenopausal women
1386896|NCT01219140|Pomegranate|pomegranate
1386897|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1386898|NCT01219114|Daptomycin|daptomycin
1386899|NCT01219114|endocarditis|endocarditis
1386900|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
1386901|NCT01219101|Ethinyl estradiol|ethinyl estradiol
1386902|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
1386903|NCT01219101|Intrauterine insemination|intrauterine insemination
1386904|NCT01219049|Diet|diet
1386905|NCT01219049|Fibromyalgia|fibromyalgia
1386906|NCT01219049|Pain|pain
1386907|NCT01219049|Drug|drug
1386908|NCT01219049|Amino-acid|amino-acid
1386909|NCT01219049|Fatigue|fatigue
1386910|NCT01219036|Asthma|asthma
1386911|NCT01219036|Non-adherence|non-adherence
1386912|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
1386913|NCT01219023|Hand foot syndrome|hand foot syndrome
1386914|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
1386915|NCT01219023|chemotherapy|chemotherapy
1386916|NCT01219023|Sunitinib|sunitinib
1386917|NCT01219023|Capecitebine|capecitebine
1386918|NCT01219023|Sildenafil|sildenafil
1386919|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
1386920|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
1386921|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
1386922|NCT01219010|QT|qt
1386923|NCT01219010|Siltuximab|siltuximab
1386924|NCT01219010|CNTO 328|cnto 328
1386925|NCT01219010|IL-6|il-6
1509845|NCT00739570|EMG|emg
1386926|NCT01219010|Monoclonal Antibody|monoclonal antibody
1386927|NCT01218997|Alcoholism|alcoholism
1386928|NCT01218997|Alcohol dependence|alcohol dependence
1386929|NCT01218984|Opiate Dependence|opiate dependence
1386930|NCT01218971|Alcohol Dependence|alcohol dependence
1386931|NCT01218958|Alcoholism|alcoholism
1386932|NCT01218932|primaquine|primaquine
1386933|NCT01218932|chloroquine|chloroquine
1386934|NCT01218932|pharmacokinetic|pharmacokinetic
1386935|NCT01218932|interactions|interactions
1386936|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
1386937|NCT01218867|Clinical Response|clinical response
1386938|NCT01218867|Metastatic Cancer|metastatic cancer
1386939|NCT01218867|Immunotherapy|immunotherapy
1386940|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
1386941|NCT01218867|Metastatic Melanoma|metastatic melanoma
1386942|NCT01218854|Biopsy|biopsy
1386943|NCT01218854|Surgical Navigation|surgical navigation
1386944|NCT01218854|Image-guided Therapy|image-guided therapy
1386945|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
1386946|NCT01218854|Cancer|cancer
1386947|NCT01218841|Fish oil|fish oil
1386948|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
1386949|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
1386950|NCT01218841|Immune response|immune response
1386952|NCT01218828|Contrast|contrast
1386953|NCT01218828|nephropathy|nephropathy
1386954|NCT01218828|cardiac catheterization|cardiac catheterization
1386955|NCT01218828|angiography|angiography
1386956|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
1386957|NCT01218802|HIV|hiv
1386958|NCT01218802|Heart Disease|heart disease
1386959|NCT01218802|Bone Density|bone density
1386960|NCT01218789|Blindness|blindness
1386961|NCT01218789|Eye Diseases|eye diseases
1386962|NCT01218789|Nap Disorders|nap disorders
1386963|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
1386964|NCT01218789|Sleep disorders|sleep disorders
1387060|NCT01218204|Statin|statin
1386965|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
1386966|NCT01218789|Dyssomnias|dyssomnias
1386967|NCT01218789|Nervous System Diseases|nervous system diseases
1386968|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
1386969|NCT01218763|Cardiac Event recorder|cardiac event recorder
1386970|NCT01218763|Sensitivity|sensitivity
1386971|NCT01218763|Efficacy|efficacy
1386972|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
1386973|NCT01218685|Immunocompromised patients|immunocompromised patients
1386974|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
1386975|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
1386976|NCT01218672|BPH|bph
1386977|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1386978|NCT01218659|Fabry Disease|fabry disease
1386979|NCT01218646|Influenza|influenza
1386980|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
1386981|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
1386982|NCT01218646|Influenza viruses|influenza viruses
1386983|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
1386984|NCT01218607|Pulmonary Circulation|pulmonary circulation
1386985|NCT01218607|Ventricular Function, Right|ventricular function, right
1386986|NCT01218607|Echocardiography, Stress|echocardiography, stress
1386987|NCT01218607|Ergometry|ergometry
1386988|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
1386989|NCT01218594|Stage III|stage iii
1386990|NCT01218594|Unresectable|unresectable
1386991|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
1386992|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
1386993|NCT01218555|kidney cancer|kidney cancer
1386994|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
1386995|NCT01218542|Secondary brain malignancies|secondary brain malignancies
1386996|NCT01218542|RapidArc|rapidarc
1386997|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
1386998|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
1386999|NCT01218490|surgery|surgery
1387000|NCT01218490|ovarian cancer|ovarian cancer
1387001|NCT01218490|lymphadectomy|lymphadectomy
1387002|NCT01218477|Leukemia|leukemia
1387003|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
1387004|NCT01218464|Liver Failure|liver failure
1387005|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
1387006|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
1387007|NCT01218464|Ascite|ascite
1387008|NCT01218464|Serum Albumin|serum albumin
1387009|NCT01218425|dopamine|dopamine
1387010|NCT01218425|EEG|eeg
1387011|NCT01218425|episodic memory|episodic memory
1387012|NCT01218425|contingent negative variation|contingent negative variation
1387013|NCT01218425|response preparation|response preparation
1387014|NCT01218425|levodopa|levodopa
1387015|NCT01218425|methylphenidate|methylphenidate
1387016|NCT01218412|Physical Activity|physical activity
1387017|NCT01218412|Motivational Interviewing|motivational interviewing
1387018|NCT01218412|Web-based|web-based
1387019|NCT01218412|Physician Referral|physician referral
1387020|NCT01218399|Asthma|asthma
1387021|NCT01218386|ICSI|icsi
1387022|NCT01218386|GnRH antagonists|gnrh antagonists
1387023|NCT01218386|planning|planning
1387024|NCT01218373|older people|older people
1387025|NCT01218373|living independently at home|living independently at home
1387026|NCT01218360|Crohn's disease|crohn's disease
1387027|NCT01218360|standard-of-care|standard-of-care
1387028|NCT01218360|Crohn Disease|crohn disease
1387029|NCT01218360|Active Crohn's Disease|active crohn's disease
1387030|NCT01218347|OATP1B1|oatp1b1
1387031|NCT01218347|rosuvastatin|rosuvastatin
1387032|NCT01218321|antiepileptic drugs|antiepileptic drugs
1387033|NCT01218321|mitochondria|mitochondria
1387034|NCT01218308|Influenza|influenza
1387035|NCT01218295|COPD|copd
1387036|NCT01218295|inspiratory muscles training|inspiratory muscles training
1387037|NCT01218282|COPD|copd
1387038|NCT01218282|home exercise training|home exercise training
1387039|NCT01218269|anastomoses|anastomoses
1387040|NCT01218256|diabetes mellitus|diabetes mellitus
1387041|NCT01218256|type 2 diabetes|type 2 diabetes
1387042|NCT01218256|T2DM|t2dm
1387043|NCT01218256|resistance training|resistance training
1387044|NCT01218256|hypertrophy training|hypertrophy training
1388229|NCT01213173|chest pain|chest pain
1387045|NCT01218256|endurance training|endurance training
1387046|NCT01218243|Acupuncture|acupuncture
1387047|NCT01218243|Mild and moderate BPH|mild and moderate bph
1387048|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
1387049|NCT01218217|TB|tb
1387050|NCT01218217|Tuberculosis|tuberculosis
1387051|NCT01218217|EBA|eba
1387052|NCT01218217|Pulmonary|pulmonary
1387053|NCT01218217|Early Bactericidal Activity|early bactericidal activity
1387054|NCT01218204|Pharmacodynamics|pharmacodynamics
1387055|NCT01218204|Lipids|lipids
1387056|NCT01218204|Dyslipidemia|dyslipidemia
1387057|NCT01218204|Safety|safety
1387058|NCT01218204|GSK1292263|gsk1292263
1387059|NCT01218204|Ezetimibe|ezetimibe
1387061|NCT01218204|Pharmacokinetics|pharmacokinetics
1387062|NCT01218204|Tolerability|tolerability
1387063|NCT01218204|Atorvastatin|atorvastatin
1387064|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
1387065|NCT01218191|scintigraphy|scintigraphy
1387066|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
1387067|NCT01218178|acute myocardial infarction|acute myocardial infarction
1387068|NCT01218178|acute kidney injury|acute kidney injury
1387069|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
1387070|NCT01218178|primary PCI|primary pci
1387071|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
1387072|NCT01218178|N-acetylcysteine|n-acetylcysteine
1387073|NCT01218165|Healthy Eldery People|healthy eldery people
1387075|NCT01218152|MPNST|mpnst
1387076|NCT01218152|plasma|plasma
1387077|NCT01218152|microarray CGH|microarray cgh
1387078|NCT01218139|neurofibroma|neurofibroma
1387079|NCT01218139|MPNST|mpnst
1387080|NCT01218139|array CGH|array cgh
1387081|NCT01218139|sequencing|sequencing
1387082|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
1387083|NCT01218113|safety|safety
1387084|NCT01218113|vaccine|vaccine
1387085|NCT01218113|immunogenicity|immunogenicity
1387086|NCT01218113|reactogenicity|reactogenicity
1387087|NCT01218113|HIV infection|hiv infection
1387088|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
1387089|NCT01218074|bleeding|bleeding
1387090|NCT01218074|blood sparing procedure|blood sparing procedure
1387091|NCT01218074|desmopressin|desmopressin
1387092|NCT01218074|aggregometry|aggregometry
1387093|NCT01218074|thromboelastography|thromboelastography
1387094|NCT01218061|Pre-diabetes|pre-diabetes
1387095|NCT01218061|Type 2 diabetes|type 2 diabetes
1387096|NCT01218061|Biomarkers|biomarkers
1387097|NCT01218061|Cohort|cohort
1387098|NCT01218061|Diabetes Risk Score|diabetes risk score
1387099|NCT01218048|Carcinoma|carcinoma
1387100|NCT01218048|Head and Neck|head and neck
1387101|NCT01218048|Cetuximab|cetuximab
1387102|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
1387103|NCT01218035|Hip osteoarthritis|hip osteoarthritis
1387104|NCT01218035|Bisphophonate therapy|bisphophonate therapy
1387105|NCT01218035|Zoledronic acid|zoledronic acid
1387106|NCT01218035|Radiostereometric analysis|radiostereometric analysis
1387107|NCT01218035|Osteoporosis|osteoporosis
1387108|NCT01218009|asthma|asthma
1387109|NCT01218009|dry powder inhaler|dry powder inhaler
1387110|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
1387111|NCT01218009|SABA|saba
1387112|NCT01218009|bronchoconstriction|bronchoconstriction
1387113|NCT01218009|bronchodilation|bronchodilation
1387114|NCT01218009|bronchodilator|bronchodilator
1387115|NCT01218009|metered dose inhaler|metered dose inhaler
1387116|NCT01217996|working memory intervention|working memory intervention
1387117|NCT01217996|memory impairment|memory impairment
1387118|NCT01217996|cognitive late effects|cognitive late effects
1387119|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
1387120|NCT01217970|methamphetamine|methamphetamine
1387121|NCT01217970|dependence|dependence
1387122|NCT01217970|stimulant|stimulant
1387123|NCT01217970|amphetamine|amphetamine
1387124|NCT01217970|los angeles|los angeles
1387125|NCT01217970|meth|meth
1387126|NCT01217970|speed|speed
1387127|NCT01217970|crank|crank
1387128|NCT01217970|abuse|abuse
1387129|NCT01217957|Drug therapy|drug therapy
1387130|NCT01217944|Pathologic myopia|pathologic myopia
1387131|NCT01217944|PM|pm
1387132|NCT01217944|choroidal neovascularization|choroidal neovascularization
1387133|NCT01217944|CNV|cnv
1387134|NCT01217944|ranibizumab|ranibizumab
1387135|NCT01217944|verteporfin PDT|verteporfin pdt
1387136|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
1387137|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1387138|NCT01217931|Clear cell component|clear cell component
1387139|NCT01217931|RCC|rcc
1387140|NCT01217931|Bevacizumab|bevacizumab
1387141|NCT01217931|Everolimus|everolimus
1387142|NCT01217931|Pazopanib|pazopanib
1387143|NCT01217931|GW786034|gw786034
1387144|NCT01217931|Avastin|avastin
1387145|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1387146|NCT01217931|rhuMAb-VEGF|rhumab-vegf
1387147|NCT01217931|Afinitor|afinitor
1387148|NCT01217931|RAD001|rad001
1387149|NCT01217918|PH-797804|ph-797804
1387150|NCT01217918|Japanese|japanese
1387151|NCT01217918|Phase 1|phase 1
1387152|NCT01217918|multiple dose study|multiple dose study
1387153|NCT01217905|Phase 1|phase 1
1387154|NCT01217905|Type 2 diabetes|type 2 diabetes
1387155|NCT01217905|obesity|obesity
1387156|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
1387157|NCT01217905|AZD7687|azd7687
1387158|NCT01217892|Type 2 diabetes|type 2 diabetes
1387159|NCT01217892|metformin treated|metformin treated
1387160|NCT01217892|inadequate control|inadequate control
1387161|NCT01217892|metformin treatment alone|metformin treatment alone
1387162|NCT01217879|Cough|cough
1387163|NCT01217879|Telmisartan|telmisartan
1387164|NCT01217879|Bradykinin|bradykinin
1387165|NCT01217879|Tolerability|tolerability
1387166|NCT01217866|laparoscopic|laparoscopic
1387167|NCT01217866|vaginal|vaginal
1387168|NCT01217866|hysterectomy|hysterectomy
1387169|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
1387170|NCT01217788|Generalized Social Phobia|generalized social phobia
1387171|NCT01217788|Social Anxiety Disorder|social anxiety disorder
1387172|NCT01217788|Social Phobia|social phobia
1387173|NCT01217788|Phobic Disorders|phobic disorders
1387174|NCT01217788|Phobias|phobias
1387175|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
1387176|NCT01217762|Oraya|oraya
1387177|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
1387178|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
1387179|NCT01217762|radiosurgery|radiosurgery
1387180|NCT01217762|radiotherapy|radiotherapy
1387181|NCT01217762|IRay|iray
1387182|NCT01217762|AMD|amd
1387183|NCT01217762|Macular Degeneration|macular degeneration
1387184|NCT01217762|Wet AMD|wet amd
1387185|NCT01217762|xray|xray
1387186|NCT01217762|radiation|radiation
1387187|NCT01217762|x ray|x ray
1387188|NCT01217762|external beam radiation|external beam radiation
1387189|NCT01217762|Ranibizumab|ranibizumab
1387190|NCT01217762|Lucentis|lucentis
1387191|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
1387192|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
1387193|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1387194|NCT01217723|Lymphoma|lymphoma
1387195|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
1387196|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
1387197|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1387198|NCT01217710|Physical Activity|physical activity
1387199|NCT01217710|Self Management|self management
1387200|NCT01217710|Exercise|exercise
1387201|NCT01217710|Technology|technology
1387202|NCT01217710|Motivational Interviewing|motivational interviewing
1387203|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
1387204|NCT01217697|Abiraterone Acetate|abiraterone acetate
1387205|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
1387206|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
1387207|NCT01217658|Randomized Trial|randomized trial
1387208|NCT01217658|Infant Colic|infant colic
1387209|NCT01217658|Abusive Head Trauma|abusive head trauma
1387210|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
1387211|NCT01217645|Major depression disorder|major depression disorder
1387212|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
1387213|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
1387214|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
1387215|NCT01217593|mastectomy|mastectomy
1387216|NCT01217593|breast cancer|breast cancer
1387217|NCT01217593|breast surgery|breast surgery
1387218|NCT01217580|c-section|c-section
1387219|NCT01217580|cesarean section|cesarean section
1387220|NCT01217580|TAP block|tap block
1387221|NCT01217580|pain|pain
1387222|NCT01217580|pain after delivery|pain after delivery
1387223|NCT01217580|pain after C-section|pain after c-section
1387224|NCT01217580|pain after C-section delivery|pain after c-section delivery
1387225|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
1387226|NCT01217580|pain after cesarean|pain after cesarean
1387227|NCT01217567|cicatrix|cicatrix
1387228|NCT01217567|cesarean section|cesarean section
1387229|NCT01217567|sutures|sutures
1387230|NCT01217567|surgical staples|surgical staples
1387231|NCT01217567|postoperative pain|postoperative pain
1387232|NCT01217567|Infection|infection
1387233|NCT01217554|Low Back Pain|low back pain
1387234|NCT01217554|Disability|disability
1387235|NCT01217554|Kinematic measures|kinematic measures
1387236|NCT01217541|Dementia|dementia
1387237|NCT01217541|BPSD|bpsd
1387238|NCT01217541|Quality of Life|quality of life
1387239|NCT01217541|Person-centred care|person-centred care
1387240|NCT01217541|Job satisfaction|job satisfaction
1387241|NCT01217541|Nursing home|nursing home
1387242|NCT01217541|Primary care|primary care
1387243|NCT01217528|ICD|icd
1387244|NCT01217528|CRTD|crtd
1387245|NCT01217528|Sudden cardiac death|sudden cardiac death
1387246|NCT01217528|Device settings|device settings
1387247|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
1387248|NCT01217502|Aged|aged
1387249|NCT01217502|Homes for the aged|homes for the aged
1387250|NCT01217502|Self management|self management
1387251|NCT01217502|Personal autonomy|personal autonomy
1387252|NCT01217502|Disease management|disease management
1387253|NCT01217502|Self efficacy|self efficacy
1387254|NCT01217502|Participation|participation
1387255|NCT01217489|breast|breast
1387256|NCT01217489|cancer|cancer
1387257|NCT01217489|diagnosis|diagnosis
1387258|NCT01217489|electrical|electrical
1387259|NCT01217489|non-invasive|non-invasive
1387260|NCT01217489|mammography|mammography
1387261|NCT01217476|Diabetic foot|diabetic foot
1387262|NCT01217476|Neuropathic|neuropathic
1387263|NCT01217476|Wound|wound
1387264|NCT01217476|Growth factor|growth factor
1387265|NCT01217463|Diabetic foot|diabetic foot
1387266|NCT01217463|Neuropathic|neuropathic
1387267|NCT01217463|Wound|wound
1387268|NCT01217463|Growth factor|growth factor
1387269|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1387270|NCT01217424|pain|pain
1387271|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1387272|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1387273|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1387274|NCT01217398|iris melanoma|iris melanoma
1387275|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
1387276|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
1387277|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
1387278|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
1387279|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
1387280|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
1387281|NCT01217333|Telephones|telephones
1387282|NCT01217333|Community-Based Participatory Research|community-based participatory research
1387283|NCT01217333|Participation, Patient|participation, patient
1387284|NCT01217333|Rural health services|rural health services
1387285|NCT01217320|rheumatology|rheumatology
1387286|NCT01217320|creatine supplementation|creatine supplementation
1387287|NCT01217320|quality of life|quality of life
1387288|NCT01217320|strength|strength
1387289|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
1387290|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
1387291|NCT01217307|Metformin|metformin
1387292|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
1387293|NCT01217307|Coronary artery disease|coronary artery disease
1387294|NCT01217307|Heart failure|heart failure
1387295|NCT01217307|Diabetes|diabetes
1387296|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
1387297|NCT01217294|analgesia, post-operative|analgesia, post-operative
1387298|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
1387299|NCT01217294|ultrasound guided|ultrasound guided
1387300|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
1387301|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
1387302|NCT01217255|Hemophilia|hemophilia
1387303|NCT01217255|Burden of Illness|burden of illness
1387304|NCT01217255|Pediatric|pediatric
1387305|NCT01217255|Quality of Life|quality of life
1387306|NCT01217255|Disability|disability
1387307|NCT01217255|Participation|participation
1387308|NCT01217242|cerebral palsy|cerebral palsy
1387309|NCT01217242|walking activity|walking activity
1387310|NCT01217242|physical activity|physical activity
1510297|NCT00738036|Opioid|opioid
1387311|NCT01217242|participation|participation
1387312|NCT01217242|activity performance|activity performance
1387313|NCT01217242|activity capacity|activity capacity
1387314|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
1387315|NCT01217216|Breast Cancer|breast cancer
1387316|NCT01217216|Weight loss|weight loss
1387317|NCT01217216|Group Intervention|group intervention
1387318|NCT01217216|Telephone Intervention|telephone intervention
1387319|NCT01217177|Cervical cancer,|cervical cancer,
1387320|NCT01217177|radiotherapy,|radiotherapy,
1387321|NCT01217177|chemotherapy,|chemotherapy,
1387322|NCT01217177|rad001,|rad001,
1387323|NCT01217177|everolimus|everolimus
1387324|NCT01217164|nutrition|nutrition
1387325|NCT01217164|very low birth weight|very low birth weight
1387326|NCT01217164|premature|premature
1387327|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
1387328|NCT01217151|Goal-Directed Therapy|goal-directed therapy
1387329|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
1387330|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
1387331|NCT01217112|Dyslipidemias|dyslipidemias
1387332|NCT01217112|Diabetes|diabetes
1387333|NCT01217112|Liver Fat|liver fat
1387334|NCT01217112|Body Fat|body fat
1387335|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
1387336|NCT01217060|Adenocarcinoma|adenocarcinoma
1387337|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
1387338|NCT01217060|Thoracic esophagus|thoracic esophagus
1387339|NCT01217060|Gastroesophageal junction|gastroesophageal junction
1387340|NCT01217060|Chemoradiotherapy|chemoradiotherapy
1387341|NCT01217060|Esophagectomy|esophagectomy
1387342|NCT01217060|5-Fluorouracil|5-fluorouracil
1387343|NCT01217060|Docetaxel|docetaxel
1387344|NCT01217060|Radiation|radiation
1387345|NCT01217060|Radiotherapy|radiotherapy
1387347|NCT01217060|IMRT|imrt
1387348|NCT01217060|Taxotere|taxotere
1387349|NCT01217060|Adrucil|adrucil
1387350|NCT01217060|Efudex|efudex
1387351|NCT01217060|Dexamethasone|dexamethasone
1387352|NCT01217060|Decadron|decadron
1387353|NCT01217047|Spinal cord injury|spinal cord injury
1387354|NCT01217047|Functional electrical stimulation|functional electrical stimulation
1387355|NCT01217047|Rehabilitation|rehabilitation
1387356|NCT01217047|Growth factors|growth factors
1387357|NCT01217047|Cytokines|cytokines
1387358|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1387359|NCT01217034|TACE|tace
1387360|NCT01217034|sorafenib|sorafenib
1387361|NCT01217034|Time to untreatable progression|time to untreatable progression
1387362|NCT01217034|TTUP|ttup
1387363|NCT01217008|Spinal Cord Injury|spinal cord injury
1387364|NCT01217008|GRNOPC1|grnopc1
1387365|NCT01216995|Heart Attack|heart attack
1387366|NCT01216995|Regenerative Cells|regenerative cells
1387367|NCT01216995|Stem Cells|stem cells
1387368|NCT01216982|Mood Disorders|mood disorders
1387369|NCT01216982|Depression|depression
1387370|NCT01216982|Combat Disorders|combat disorders
1387371|NCT01216982|Stress Disorders|stress disorders
1387372|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
1387373|NCT01216982|Military Personnel|military personnel
1387374|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
1387375|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
1387376|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
1387377|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
1387378|NCT01216956|insulin resistance|insulin resistance
1387379|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
1387380|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
1387381|NCT01216891|Schizophrenia|schizophrenia
1387382|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
1387383|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
1387384|NCT01216891|Delusional Disorder|delusional disorder
1387385|NCT01216891|Psychosis|psychosis
1387386|NCT01216891|First episode|first episode
1387387|NCT01216865|Diabetic foot|diabetic foot
1387388|NCT01216865|critical limb ischemia|critical limb ischemia
1387389|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
1387390|NCT01216865|umbilical cord|umbilical cord
1387391|NCT01216813|esophageal cancer|esophageal cancer
1387392|NCT01216813|gastric cancer|gastric cancer
1387393|NCT01216813|cervical cancer|cervical cancer
1387394|NCT01216813|fallopian tube cancer|fallopian tube cancer
1387395|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
1387396|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
1387397|NCT01216813|ovarian sarcoma|ovarian sarcoma
1387398|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
1387399|NCT01216813|endometrial cancer|endometrial cancer
1387400|NCT01216813|uterine sarcoma|uterine sarcoma
1387401|NCT01216813|vaginal cancer|vaginal cancer
1387402|NCT01216813|vulvar cancer|vulvar cancer
1387403|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1387404|NCT01216800|ototoxicity|ototoxicity
1387405|NCT01216800|radiation toxicity|radiation toxicity
1387406|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
1387407|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
1387408|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
1387409|NCT01216761|Bacteremia|bacteremia
1387410|NCT01216761|Blood culture|blood culture
1387411|NCT01216761|Contamination|contamination
1387412|NCT01216761|Antiseptic agents|antiseptic agents
1387413|NCT01216748|airway blood flow|airway blood flow
1387414|NCT01216748|albuterol|albuterol
1387415|NCT01216748|acidosis|acidosis
1387416|NCT01216748|alkalosis|alkalosis
1387417|NCT01216735|smokers|smokers
1387418|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
1387419|NCT01216735|brachial flow|brachial flow
1387420|NCT01216735|airway blood flow|airway blood flow
1387421|NCT01216735|albuterol|albuterol
1387422|NCT01216735|spirometry|spirometry
1387423|NCT01216735|endothelial dysfunction|endothelial dysfunction
1387424|NCT01216722|Muscle Wasting|muscle wasting
1387425|NCT01216722|Strengthening|strengthening
1387426|NCT01216722|Liver Disease|liver disease
1387427|NCT01216722|Transplant|transplant
1387428|NCT01216709|Infant|infant
1387429|NCT01216709|Dietary Supplements|dietary supplements
1387430|NCT01216709|Food, Fortified|food, fortified
1387431|NCT01216709|Iron Absorption|iron absorption
1387432|NCT01216696|ipilimumab|ipilimumab
1387433|NCT01216696|melanoma|melanoma
1387434|NCT01216696|NY-ESO-1|ny-eso-1
1387435|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1387436|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1387437|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1388230|NCT01213173|heart rate|heart rate
1387438|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1387439|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1387440|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1387441|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1387442|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1387443|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1387444|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1387445|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1387446|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1387447|NCT01216670|Reveal® XT|reveal® xt
1387448|NCT01216670|Acute Heart Failure|acute heart failure
1387449|NCT01216670|Low Ejection Fraction|low ejection fraction
1387450|NCT01216670|Reveal® XT implanted|reveal® xt implanted
1387451|NCT01216657|melanoma|melanoma
1387452|NCT01216657|sunitinib|sunitinib
1387453|NCT01216644|gastric cancer|gastric cancer
1387454|NCT01216644|perioperative|perioperative
1387455|NCT01216644|FLOT|flot
1387456|NCT01216644|ECF|ecf
1387457|NCT01216644|pathological complete remission|pathological complete remission
1387458|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
1387459|NCT01216631|seronegative|seronegative
1387460|NCT01216631|oligoarthritis|oligoarthritis
1387461|NCT01216631|infliximab|infliximab
1387462|NCT01216631|intraarticular|intraarticular
1387463|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
1387464|NCT01216618|insulin Lispro|insulin lispro
1387465|NCT01216618|Insulin Asprt.|insulin asprt.
1387466|NCT01216592|COPD|copd
1387467|NCT01216592|Airway inflammation|airway inflammation
1387468|NCT01216592|Symptoms|symptoms
1387469|NCT01216592|Lung function|lung function
1387470|NCT01216592|Correlation|correlation
1387471|NCT01216553|Bronchiolitis|bronchiolitis
1387472|NCT01216553|Infants|infants
1387473|NCT01216553|Nebulized Inhalation|nebulized inhalation
1387474|NCT01216553|RSV|rsv
1387475|NCT01216553|Oxygen|oxygen
1387476|NCT01216540|vancomycin|vancomycin
1387477|NCT01216540|nephrotoxicity|nephrotoxicity
1387478|NCT01216540|length of stay|length of stay
1387479|NCT01216540|costs|costs
1387480|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
1387481|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
1387482|NCT01216514|crohn disease|crohn disease
1387483|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
1387484|NCT01216514|immunological markers|immunological markers
1387485|NCT01216514|serological markers|serological markers
1387486|NCT01216514|ANCA|anca
1387487|NCT01216514|ASCA|asca
1387488|NCT01216488|Forearm surgery|forearm surgery
1387489|NCT01216488|Hand surgery|hand surgery
1387490|NCT01216488|Anesthesia|anesthesia
1387491|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
1387492|NCT01216449|Citalopram|citalopram
1387493|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1387494|NCT01216449|fMRI|fmri
1387495|NCT01216449|Pharmacokinetics|pharmacokinetics
1387496|NCT01216449|Pharmacodynamics|pharmacodynamics
1387497|NCT01216449|Amygdala|amygdala
1387498|NCT01216449|Elderly|elderly
1387499|NCT01216436|melanoma|melanoma
1387500|NCT01216436|immunotherapy|immunotherapy
1387501|NCT01216436|dendritic cell|dendritic cell
1387502|NCT01216436|GITR-ligand|gitr-ligand
1387503|NCT01216436|CTLA-4|ctla-4
1387504|NCT01216423|Patent Foramen Ovale|patent foramen ovale
1387505|NCT01216423|Pulmonary embolism|pulmonary embolism
1387506|NCT01216423|Stroke|stroke
1387507|NCT01216410|Nausea|nausea
1387508|NCT01216410|Vomiting|vomiting
1387509|NCT01216371|carcinoma|carcinoma
1387510|NCT01216371|metastases|metastases
1387511|NCT01216371|renal|renal
1387512|NCT01216371|lung|lung
1387513|NCT01216358|Headache|headache
1387514|NCT01216358|Contraception|contraception
1387515|NCT01216319|Biodesign|biodesign
1387516|NCT01216319|Nipple Reconstruction|nipple reconstruction
1387517|NCT01216319|Breast Cancer|breast cancer
1387518|NCT01216319|Mastectomy|mastectomy
1387519|NCT01216306|Obesity|obesity
1387520|NCT01216306|Physical Activity|physical activity
1387521|NCT01216306|Sedentary Activity|sedentary activity
1387522|NCT01216306|Television viewing|television viewing
1387523|NCT01216306|Latino|latino
1387524|NCT01216306|Hispanic|hispanic
1387525|NCT01216306|Preschool|preschool
1387526|NCT01216306|School|school
1387527|NCT01216306|Head Start|head start
1387528|NCT01216293|Drug Therapy|drug therapy
1387529|NCT01216280|Natura-alpha|natura-alpha
1387530|NCT01216280|ulcerative colitis|ulcerative colitis
1387531|NCT01216280|cytokines|cytokines
1387532|NCT01216280|Th1|th1
1387533|NCT01216280|Th17|th17
1387534|NCT01216267|chromogranin A|chromogranin a
1387535|NCT01216267|neuroendocrine|neuroendocrine
1387536|NCT01216267|carcinoid|carcinoid
1388231|NCT01213160|Phase I|phase i
1387537|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
1387538|NCT01216254|breast cancer|breast cancer
1387539|NCT01216254|stage 2|stage 2
1387540|NCT01216254|breast conserving therapy|breast conserving therapy
1387541|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
1387542|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
1387543|NCT01216202|Rectal cancer|rectal cancer
1387544|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
1387545|NCT01216202|Pelvic surgery|pelvic surgery
1387546|NCT01216202|Sexual function|sexual function
1387547|NCT01216202|Wellbeing|wellbeing
1387548|NCT01216202|Hormone levels|hormone levels
1387549|NCT01216202|Spermatogenesis|spermatogenesis
1387550|NCT01216189|Rectal cancer|rectal cancer
1387655|NCT01215838|Eovist|eovist
1387551|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
1387552|NCT01216189|Pelvic surgery|pelvic surgery
1387553|NCT01216189|Sexual function|sexual function
1387554|NCT01216189|Wellbeing|wellbeing
1387555|NCT01216189|Hormone levels|hormone levels
1387556|NCT01216176|Breast Cancer|breast cancer
1387557|NCT01216176|Postmenopausal|postmenopausal
1387558|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
1387559|NCT01216176|AZD0530|azd0530
1387560|NCT01216176|Anastrozole|anastrozole
1387561|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
1387562|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
1387563|NCT01216176|Pharmacokinetic|pharmacokinetic
1387565|NCT01216176|Hormone Receptor|hormone receptor
1387566|NCT01216176|Estrogen Receptor|estrogen receptor
1387567|NCT01216176|Progesterone Receptor|progesterone receptor
1387568|NCT01216176|ER+|er+
1387569|NCT01216176|PR+|pr+
1387570|NCT01216176|HER negative|her negative
1387571|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
1387572|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
1387573|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
1387574|NCT01216150|coronary surgery|coronary surgery
1387575|NCT01216150|hemorrhage|hemorrhage
1387576|NCT01216150|aspirin|aspirin
1387577|NCT01216150|clopidogrel|clopidogrel
1387578|NCT01216137|Multiple Sclerosis|multiple sclerosis
1387579|NCT01216137|Fatigue|fatigue
1387580|NCT01216137|Balance|balance
1387581|NCT01216137|Upright Postural Control|upright postural control
1387582|NCT01216137|Dizziness|dizziness
1387583|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
1387584|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
1387585|NCT01216098|Intrapartum|intrapartum
1387586|NCT01216098|Clinical trial|clinical trial
1387587|NCT01216098|Perinatal|perinatal
1387588|NCT01216098|Doula|doula
1387589|NCT01216098|VBAC|vbac
1387590|NCT01216098|Perinatal Outcomes|perinatal outcomes
1387591|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1387592|NCT01216072|Disease Modifying Therapy|disease modifying therapy
1387593|NCT01216072|fingolimod|fingolimod
1387594|NCT01216072|Patient Reported Outcomes|patient reported outcomes
1387595|NCT01216059|adherence|adherence
1387596|NCT01216059|text message|text message
1387597|NCT01216059|reminder|reminder
1387598|NCT01216059|adolescents|adolescents
1387599|NCT01216033|Breast cancer|breast cancer
1387600|NCT01216033|Diagnostics|diagnostics
1387601|NCT01216033|HER2|her2
1387602|NCT01216033|Imaging|imaging
1387603|NCT01216033|Metastases|metastases
1387604|NCT01216033|SPECT|spect
1387605|NCT01216033|Imaging of metastases|imaging of metastases
1387606|NCT01216020|Head and Neck Cancer|head and neck cancer
1387607|NCT01216020|Radiotherapy|radiotherapy
1387608|NCT01216020|Cetuximab|cetuximab
1387609|NCT01216020|Cisplatin|cisplatin
1387610|NCT01216007|Plasma|plasma
1387611|NCT01216007|bupivacaine|bupivacaine
1387612|NCT01216007|concentration|concentration
1387613|NCT01216007|caudal|caudal
1387614|NCT01216007|epidural|epidural
1387615|NCT01216007|TIVA|tiva
1387616|NCT01216007|Inhalational|inhalational
1387617|NCT01216007|anesthesia|anesthesia
1387618|NCT01216007|Caudal epidural|caudal epidural
1387619|NCT01215981|influenza vaccine|influenza vaccine
1387620|NCT01215955|Type 2 Diabetes|type 2 diabetes
1387621|NCT01215955|Insulin|insulin
1387622|NCT01215955|Algorithms|algorithms
1387623|NCT01215955|Blood glucose levels|blood glucose levels
1387624|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
1387625|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
1387626|NCT01215929|mood|mood
1387627|NCT01215929|retention|retention
1387628|NCT01215929|sleep|sleep
1387629|NCT01215916|Solid tumors|solid tumors
1387630|NCT01215890|Crohn's disease|crohn's disease
1387631|NCT01215890|Low bone mineral density|low bone mineral density
1387632|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
1387633|NCT01215890|bisphosphonate|bisphosphonate
1387634|NCT01215877|Bladder cancer|bladder cancer
1387635|NCT01215877|Previously treated patients|previously treated patients
1387636|NCT01215877|Tesetaxel|tesetaxel
1387637|NCT01215877|Oral taxane|oral taxane
1387638|NCT01215864|metastatic tumors|metastatic tumors
1387639|NCT01215864|refractory tumors|refractory tumors
1387640|NCT01215864|recurrent tumors|recurrent tumors
1387641|NCT01215851|Tuberculosis|tuberculosis
1387643|NCT01215851|TMC207|tmc207
1387644|NCT01215851|pretomanid|pretomanid
1387645|NCT01215851|Early Bactericidal Activity|early bactericidal activity
1387646|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
1387647|NCT01215851|PA-824|pa-824
1387648|NCT01215851|bedaquiline|bedaquiline
1387649|NCT01215851|pyrazinamide|pyrazinamide
1387650|NCT01215851|moxifloxacin|moxifloxacin
1387651|NCT01215851|ethambutol|ethambutol
1387652|NCT01215851|rifafour|rifafour
1387653|NCT01215838|HCC|hcc
1387654|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
1387656|NCT01215838|MR|mr
1387657|NCT01215838|MRI|mri
1387658|NCT01215838|magnetic resonance|magnetic resonance
1387659|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1387660|NCT01215825|systemic steroid|systemic steroid
1387661|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1387662|NCT01215799|HRPC|hrpc
1387663|NCT01215760|peripheral nerve injury|peripheral nerve injury
1387664|NCT01215760|sensory reeducation|sensory reeducation
1387665|NCT01215760|brain plasticity|brain plasticity
1387666|NCT01215760|training with a mirror|training with a mirror
1387667|NCT01215760|rehabilitation|rehabilitation
1387668|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
1387669|NCT01215721|Incontinence|incontinence
1387670|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
1387671|NCT01215721|Prostate Cancer|prostate cancer
1387672|NCT01215708|Kidney calculi|kidney calculi
1387673|NCT01215708|Lithotripsy|lithotripsy
1387674|NCT01215708|Calcium channel blockers|calcium channel blockers
1387675|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
1387676|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
1387677|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
1387678|NCT01215682|infections|infections
1387679|NCT01215682|immune system|immune system
1387680|NCT01215682|vitamin D|vitamin d
1387681|NCT01215682|sport|sport
1387682|NCT01215682|children|children
1387683|NCT01215669|Influenza|influenza
1387684|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
1387685|NCT01215669|Intradermal Injections|intradermal injections
1387686|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
1387687|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
1387688|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
1387690|NCT01215630|Exercise tests|exercise tests
1387691|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
1387692|NCT01215630|VO2max|vo2max
1387693|NCT01215617|Randomized controlled study|randomized controlled study
1387694|NCT01215617|Exercise training|exercise training
1387695|NCT01215617|Lung function|lung function
1387696|NCT01215617|Heart function|heart function
1387697|NCT01215604|elderly patients|elderly patients
1387698|NCT01215604|acute infection|acute infection
1387699|NCT01215604|translation initiation factors|translation initiation factors
1387700|NCT01215604|eIF4E|eif4e
1387701|NCT01215604|eIF4G|eif4g
1387702|NCT01215591|Neonatal|neonatal
1510803|NCT00736424|DBS|dbs
1387703|NCT01215591|Nasal CPAP|nasal cpap
1387704|NCT01215591|Randomized controlled trial|randomized controlled trial
1387705|NCT01215591|Weaning|weaning
1387706|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
1387707|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
1387708|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
1387709|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
1387710|NCT01215578|Neoplasms|neoplasms
1387711|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1387712|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
1387713|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
1387714|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
1387715|NCT01215578|Neoplasms by Site|neoplasms by site
1387716|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
1387717|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
1387718|NCT01215578|Adenocarcinoma|adenocarcinoma
1387719|NCT01215578|Carcinoma|carcinoma
1387720|NCT01215578|Adenoma|adenoma
1387721|NCT01215578|Digestive System Diseases|digestive system diseases
1387722|NCT01215578|Pancreatic Diseases|pancreatic diseases
1387723|NCT01215578|Endocrine System Diseases|endocrine system diseases
1387724|NCT01215578|Sunitinib|sunitinib
1387725|NCT01215578|Antineoplastic Agents|antineoplastic agents
1387726|NCT01215578|Therapeutic Uses|therapeutic uses
1387727|NCT01215578|Pharmacologic Actions|pharmacologic actions
1387728|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
1387729|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
1387730|NCT01215578|Growth Substances|growth substances
1387731|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
1387732|NCT01215578|Growth Inhibitors|growth inhibitors
1387733|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1387734|NCT01215565|Carcinoma|carcinoma
1387735|NCT01215565|Fibrosis|fibrosis
1387736|NCT01215565|Liver Neoplasms|liver neoplasms
1388232|NCT01213160|cancer|cancer
1387737|NCT01215565|Pathologic Processes|pathologic processes
1387738|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
1387739|NCT01215565|Neoplasms by Site|neoplasms by site
1387740|NCT01215565|Neoplasms|neoplasms
1387741|NCT01215565|Liver Diseases|liver diseases
1387742|NCT01215565|Adenocarcinoma|adenocarcinoma
1387743|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1387744|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
1387745|NCT01215565|Sunitinib|sunitinib
1387746|NCT01215565|Antineoplastic Agents|antineoplastic agents
1387747|NCT01215565|Therapeutic Uses|therapeutic uses
1387748|NCT01215565|Pharmacologic Actions|pharmacologic actions
1387749|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
1387750|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
1387846|NCT01214928|vitamin D|vitamin d
1387751|NCT01215565|Growth Substances|growth substances
1387752|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
1387753|NCT01215565|Growth Inhibitors|growth inhibitors
1387754|NCT01215500|solid tumor cancer|solid tumor cancer
1387755|NCT01215500|epithelial carcinoma|epithelial carcinoma
1387756|NCT01215487|CML Predictive Study|cml predictive study
1387757|NCT01215461|Neonatal mortality|neonatal mortality
1387758|NCT01215461|Preterm birth|preterm birth
1387759|NCT01215461|Low gestational age|low gestational age
1387760|NCT01215461|VLBW|vlbw
1387761|NCT01215448|Fatigue|fatigue
1387762|NCT01215448|Quality of life|quality of life
1387763|NCT01215448|Lifestyle|lifestyle
1387764|NCT01215448|Complementary medicine|complementary medicine
1387765|NCT01215422|Surgical procedures|surgical procedures
1387766|NCT01215422|Intubation|intubation
1387767|NCT01215422|Anesthesiologist|anesthesiologist
1387768|NCT01215422|Laryngoscope|laryngoscope
1387769|NCT01215422|Videolaryngoscope|videolaryngoscope
1387770|NCT01215409|Levitra|levitra
1387771|NCT01215409|Erectile dysfunction|erectile dysfunction
1387772|NCT01215409|Taiwan|taiwan
1387773|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
1387774|NCT01215396|Mental Performance|mental performance
1387775|NCT01215396|Muscular Performance|muscular performance
1387776|NCT01215396|Central Fatigue Theory|central fatigue theory
1387777|NCT01215383|HDL|hdl
1387778|NCT01215383|psychiatric patients|psychiatric patients
1387779|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
1387780|NCT01215357|Pathological Gambling|pathological gambling
1387781|NCT01215357|ecopipam|ecopipam
1387782|NCT01215357|Dopamine|dopamine
1387783|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
1387784|NCT01215331|Treatment|treatment
1387785|NCT01215331|Insulin|insulin
1387786|NCT01215331|Metformin|metformin
1387787|NCT01215331|Glyburide|glyburide
1387788|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
1387789|NCT01215292|testosterone|testosterone
1387790|NCT01215292|acyline|acyline
1387791|NCT01215292|ketoconazole|ketoconazole
1387792|NCT01215292|dutasteride|dutasteride
1387793|NCT01215292|anastrazole|anastrazole
1387794|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
1387795|NCT01215279|Respiratory disease|respiratory disease
1387796|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1387797|NCT01215266|Bladder cancer|bladder cancer
1387798|NCT01215266|Chemotherapy|chemotherapy
1387799|NCT01215266|Urothelium cancer|urothelium cancer
1387800|NCT01215253|Sudden Death|sudden death
1387801|NCT01215253|Ranolazine|ranolazine
1387802|NCT01215253|Heart failure|heart failure
1387803|NCT01215253|Ventricular tachycardia|ventricular tachycardia
1387804|NCT01215253|Ventricular fibrillation|ventricular fibrillation
1387805|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1387806|NCT01215214|metabolite profiles|metabolite profiles
1387807|NCT01215214|pharmacokinetics|pharmacokinetics
1387808|NCT01215214|CYP3A|cyp3a
1387809|NCT01215214|metabolomics|metabolomics
1387810|NCT01215201|Periodontal maintenance|periodontal maintenance
1387811|NCT01215201|≥5mm probing depth|≥5mm probing depth
1387812|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
1387813|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
1387814|NCT01215188|Pneumonia|pneumonia
1387815|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1387816|NCT01215175|Pneumococcal disease|pneumococcal disease
1387817|NCT01215149|HIV|hiv
1387818|NCT01215110|Bedaquiline|bedaquiline
1387819|NCT01215110|Sirturo|sirturo
1387820|NCT01215110|Early Bactericidal Activity|early bactericidal activity
1387821|NCT01215110|EBA|eba
1387822|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
1387823|NCT01215110|TMC207|tmc207
1387824|NCT01215084|Human Volunteers|human volunteers
1387825|NCT01215071|Lymphadenectomy|lymphadenectomy
1387826|NCT01215071|Extension|extension
1387827|NCT01215071|Bladder cancer|bladder cancer
1387828|NCT01215058|Compliance, France|compliance, france
1387829|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
1387830|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
1387831|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
1387832|NCT01215032|insulin levels|insulin levels
1387833|NCT01215032|metformin|metformin
1387834|NCT01215019|traumatic brain injury|traumatic brain injury
1387835|NCT01214993|GSK1349572|gsk1349572
1387836|NCT01214993|para-aminohippurate|para-aminohippurate
1387837|NCT01214993|iohexol|iohexol
1387838|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
1387839|NCT01214980|Wound healing|wound healing
1387840|NCT01214980|Split thickness wound healing|split thickness wound healing
1387841|NCT01214980|Skin graft donor site healing|skin graft donor site healing
1387842|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
1387843|NCT01214954|Total Hip Replacement|total hip replacement
1387844|NCT01214954|Rehabilitation|rehabilitation
1387845|NCT01214954|Resistance training|resistance training
1387847|NCT01214928|cholecalciferol|cholecalciferol
1387848|NCT01214928|hemodialysis|hemodialysis
1387849|NCT01214928|randomized controlled trial|randomized controlled trial
1387850|NCT01214928|pilot|pilot
1387851|NCT01214889|Diphtheria|diphtheria
1387852|NCT01214889|Tetanus|tetanus
1387853|NCT01214889|Pertussis|pertussis
1387854|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
1387855|NCT01214889|Poliomyelitis|poliomyelitis
1387856|NCT01214889|PENTAXIM™|pentaxim™
1387857|NCT01214889|TETRAXIM™|tetraxim™
1387858|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
1387859|NCT01214850|Meningococcal vaccines|meningococcal vaccines
1387860|NCT01214850|Meningococcal B|meningococcal b
1387861|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
1387862|NCT01214837|Meningococcal|meningococcal
1387863|NCT01214837|ACWY|acwy
1387864|NCT01214837|Conjugate Vaccine|conjugate vaccine
1387865|NCT01214837|Meningitis|meningitis
1387866|NCT01214837|Infants|infants
1387867|NCT01214837|Persistence|persistence
1387868|NCT01214824|Diabetes|diabetes
1387869|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
1387870|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
1387871|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
1387872|NCT01214811|Pain during wear|pain during wear
1387873|NCT01214798|sesamoid displacement,|sesamoid displacement,
1387874|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
1387875|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
1387876|NCT01214772|pregnancy|pregnancy
1387877|NCT01214772|heparin|heparin
1387878|NCT01214772|fertilization|fertilization
1387879|NCT01214759|HIV|hiv
1387880|NCT01214759|prevention|prevention
1387881|NCT01214759|prophylaxis|prophylaxis
1387882|NCT01214759|Raltegravir|raltegravir
1387883|NCT01214759|Truvada|truvada
1387884|NCT01214746|Statin|statin
1387885|NCT01214746|L-NMMA|l-nmma
1387886|NCT01214746|Healthy subjects|healthy subjects
1387887|NCT01214746|Nephrology|nephrology
1387888|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
1387889|NCT01214694|TBI|tbi
1387890|NCT01214694|intracranial edema|intracranial edema
1387891|NCT01214694|brain edema|brain edema
1387892|NCT01214694|craniocerebral trauma|craniocerebral trauma
1387893|NCT01214694|head injury|head injury
1387894|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
1387895|NCT01214694|subdural hematoma|subdural hematoma
1387896|NCT01214694|brain concussion|brain concussion
1387897|NCT01214694|head injuries, closed|head injuries, closed
1387898|NCT01214694|epidural hematoma|epidural hematoma
1387899|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
1387900|NCT01214694|cortical contusion|cortical contusion
1387901|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
1387902|NCT01214694|Nervous System Diseases|nervous system diseases
1387903|NCT01214694|Wounds and Injuries|wounds and injuries
1387904|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
1387905|NCT01214694|Central Nervous System Diseases|central nervous system diseases
1387906|NCT01214694|Trauma, Nervous System|trauma, nervous system
1387907|NCT01214694|Brain Diseases|brain diseases
1387908|NCT01214694|Brain Injuries|brain injuries
1387909|NCT01214681|Biomarkers|biomarkers
1387910|NCT01214681|Colorectal cancer|colorectal cancer
1387911|NCT01214681|Resistant starch|resistant starch
1387912|NCT01214681|Polydextrose|polydextrose
1387913|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
1387914|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
1387915|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1387916|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
1387917|NCT01214642|Advanced Cancer|advanced cancer
1387918|NCT01214642|Cancer|cancer
1387919|NCT01214629|Advanced Cancer|advanced cancer
1387920|NCT01214629|Metastatic Cancer|metastatic cancer
1387921|NCT01214629|Cancer|cancer
1387922|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
1387923|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
1387924|NCT01214577|PEP005|pep005
1387925|NCT01214577|Peplin|peplin
1387926|NCT01214577|Photo-damage|photo-damage
1387927|NCT01214564|PEP005|pep005
1387928|NCT01214564|Peplin|peplin
1387929|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
1387930|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
1387931|NCT01214525|Meatal stenosis|meatal stenosis
1387932|NCT01214525|Meatotomy|meatotomy
1387933|NCT01214525|Uroflow|uroflow
1387934|NCT01214525|Postvoid residual|postvoid residual
1387935|NCT01214499|Refractory angina|refractory angina
1387936|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
1387937|NCT01214499|Stem cells|stem cells
1387938|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
1387939|NCT01214486|HIV|hiv
1387940|NCT01214486|RAL|ral
1387941|NCT01214486|Raltegravir|raltegravir
1387942|NCT01214486|Isentress|isentress
1387943|NCT01214486|Pharmacokinetics|pharmacokinetics
1387944|NCT01214473|Clinical sepsis|clinical sepsis
1387945|NCT01214473|Pneumonia|pneumonia
1387946|NCT01214473|Diarrhea|diarrhea
1387947|NCT01214473|Probiotics|probiotics
1387948|NCT01214473|Synbiotics|synbiotics
1387949|NCT01214460|MET|met
1387950|NCT01214447|Hemodialysis|hemodialysis
1387951|NCT01214447|Inflammation|inflammation
1387952|NCT01214447|Malnutrition|malnutrition
1387953|NCT01214447|Phase Angle|phase angle
1387954|NCT01214434|Cradle Cap|cradle cap
1387955|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
1387956|NCT01214421|Kidney Disease|kidney disease
1387957|NCT01214421|ADPKD|adpkd
1387958|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1387959|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
1387960|NCT01214395|haemodialysis|haemodialysis
1387961|NCT01214395|peritoneal dialysis|peritoneal dialysis
1387962|NCT01214382|Gastric Bypass|gastric bypass
1387963|NCT01214382|Bariatric Surgery|bariatric surgery
1387964|NCT01214382|Sertraline|sertraline
1387965|NCT01214382|Zoloft|zoloft
1387966|NCT01214382|Pharmacokinetic|pharmacokinetic
1387967|NCT01214369|intraosseous injection|intraosseous injection
1387968|NCT01214369|X-tip|x-tip
1387969|NCT01214369|PDL injection|pdl injection
1387970|NCT01214369|Supplementary Injection|supplementary injection
1387971|NCT01214356|diabetes|diabetes
1387972|NCT01214356|kidney disease|kidney disease
1387973|NCT01214356|vitamin D|vitamin d
1387974|NCT01214343|sorafenib|sorafenib
1387975|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
1387976|NCT01214343|HAIC|haic
1387977|NCT01214343|Low dose FP|low dose fp
1387978|NCT01214343|cisplatin|cisplatin
1387979|NCT01214343|fluorouracil|fluorouracil
1387980|NCT01214330|cervical cancer|cervical cancer
1387981|NCT01214317|multiple sclerosis|multiple sclerosis
1387982|NCT01214317|mitoxantrone|mitoxantrone
1387983|NCT01214317|plasmapheresis|plasmapheresis
1387984|NCT01214317|induction therapy|induction therapy
1387985|NCT01214304|Colposcopy|colposcopy
1387986|NCT01214291|fractures|fractures
1387987|NCT01214291|prostate cancer|prostate cancer
1387988|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
1387989|NCT01214278|bioavailability|bioavailability
1387990|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
1387991|NCT01214278|EPA|epa
1387992|NCT01214278|DHA|dha
1387993|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
1387994|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1387995|NCT01214187|IPF|ipf
1387996|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
1387997|NCT01214187|carbon monoxide|carbon monoxide
1387998|NCT01214174|cataract|cataract
1387999|NCT01214174|inflammation|inflammation
1388000|NCT01214161|IUD|iud
1388001|NCT01214161|Lidocaine gel|lidocaine gel
1388002|NCT01214135|Mental disorder|mental disorder
1388003|NCT01214135|antipsychotic treatment|antipsychotic treatment
1388004|NCT01214122|Phase 1|phase 1
1388005|NCT01214122|Drug-Drug interaction|drug-drug interaction
1388006|NCT01214122|warfarin|warfarin
1388007|NCT01214122|AZD9668|azd9668
1388008|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
1388009|NCT01214122|pharmacokinetics|pharmacokinetics
1388010|NCT01214122|pharmacodynamics|pharmacodynamics
1388011|NCT01214096|Chronic Heart failure|chronic heart failure
1388012|NCT01214096|rhNRG-1|rhnrg-1
1388013|NCT01214096|MRI|mri
1388014|NCT01214083|N-acetylcysteine|n-acetylcysteine
1388015|NCT01214083|naltrexone|naltrexone
1388016|NCT01214070|Visual Perception|visual perception
1388017|NCT01214070|Vision, Ocular|vision, ocular
1388018|NCT01214070|Neuronal Plasticity|neuronal plasticity
1388019|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
1388020|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
1388021|NCT01214057|TIVA|tiva
1388022|NCT01214057|surgical field visualization|surgical field visualization
1388023|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
1388024|NCT01214031|Adenomatous polyps|adenomatous polyps
1388025|NCT01214031|Colonoscopy|colonoscopy
1388026|NCT01214005|nicotine|nicotine
1388027|NCT01214005|reinforcement|reinforcement
1388028|NCT01214005|craving|craving
1388029|NCT01214005|relapse|relapse
1388030|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
1388031|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
1388032|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
1388033|NCT01213914|Burns|burns
1388034|NCT01213914|Hemofiltration|hemofiltration
1388035|NCT01213914|Vasopressins|vasopressins
1388036|NCT01213914|Kidney Failure Acute|kidney failure acute
1388037|NCT01213914|Shock, Septic|shock, septic
1388038|NCT01213901|Insulin absorption|insulin absorption
1388039|NCT01213901|Insulin injection technique|insulin injection technique
1388040|NCT01213888|Diabetic retinopathy|diabetic retinopathy
1388041|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
1388042|NCT01213888|macular edema|macular edema
1388043|NCT01213875|heart failure|heart failure
1388044|NCT01213875|nursing|nursing
1388045|NCT01213875|home based intervention|home based intervention
1388046|NCT01213875|cost|cost
1388047|NCT01213875|efficacy|efficacy
1388048|NCT01213862|Home Based education|home based education
1388049|NCT01213862|Knowledge of Disease|knowledge of disease
1388050|NCT01213862|Self-Care Skills|self-care skills
1388051|NCT01213862|Quality of Life|quality of life
1388052|NCT01213862|Heart Failure|heart failure
1388053|NCT01213862|Randomized Clinical Trial|randomized clinical trial
1388054|NCT01213836|Stable schizophrenia|stable schizophrenia
1388055|NCT01213836|cognitive functioning|cognitive functioning
1388056|NCT01213823|invasive candidiasis|invasive candidiasis
1388057|NCT01213823|candidemia|candidemia
1388058|NCT01213823|severe hepatic injury|severe hepatic injury
1388059|NCT01213823|echinocandins|echinocandins
1388060|NCT01213823|anidulafungin|anidulafungin
1388061|NCT01213823|caspofungin|caspofungin
1388062|NCT01213823|micafungin|micafungin
1388063|NCT01213810|HIV|hiv
1388064|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
1388065|NCT01213810|vaccine|vaccine
1388066|NCT01213810|T cell|t cell
1388067|NCT01213810|immunogenicity|immunogenicity
1388068|NCT01213810|safety|safety
1388069|NCT01213797|Suicide|suicide
1388070|NCT01213771|Preoperative|preoperative
1388071|NCT01213771|Intervention|intervention
1388072|NCT01213771|Support|support
1388073|NCT01213771|Care|care
1388074|NCT01213758|liver function|liver function
1388075|NCT01213758|galactose|galactose
1388076|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
1388077|NCT01213758|PET/CT|pet/ct
1388078|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
1388079|NCT01213758|SBRT|sbrt
1388080|NCT01213745|lung|lung
1388081|NCT01213745|cancer|cancer
1388082|NCT01213745|quality of life|quality of life
1388083|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
1388084|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
1388085|NCT01213706|airway blood flow|airway blood flow
1388086|NCT01213706|albuterol|albuterol
1388087|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
1388088|NCT01213706|Nitric Oxide|nitric oxide
1388089|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
1388090|NCT01213693|COPD|copd
1388091|NCT01213693|Bacteria|bacteria
1388092|NCT01213693|Virus|virus
1388093|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
1388094|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
1388095|NCT01213654|Lung cancer|lung cancer
1388096|NCT01213654|VATS Lobectomy|vats lobectomy
1388097|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
1388098|NCT01213641|CIAS1 protein|cias1 protein
1388099|NCT01213641|NLRP3 protein|nlrp3 protein
1388100|NCT01213641|human cryopyrin protein|human cryopyrin protein
1388101|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
1388102|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
1388103|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
1388104|NCT01213641|NALP3|nalp3
1388105|NCT01213641|canakinumab|canakinumab
1388106|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
1388107|NCT01213628|abdominal surgery|abdominal surgery
1388108|NCT01213628|hypothermia|hypothermia
1388109|NCT01213628|wound desiccation|wound desiccation
1388110|NCT01213628|warming|warming
1388111|NCT01213602|Trauma patients|trauma patients
1388112|NCT01213589|descending|descending
1388113|NCT01213589|thoracic|thoracic
1388114|NCT01213589|aortic|aortic
1388115|NCT01213589|dissection|dissection
1388116|NCT01213589|Valiant|valiant
1388117|NCT01213589|Medtronic|medtronic
1388118|NCT01213589|Type B|type b
1388119|NCT01213589|VIRTUE|virtue
1388120|NCT01213589|stent|stent
1388121|NCT01213576|Lymphatic filariasis|lymphatic filariasis
1388122|NCT01213576|microfilaria|microfilaria
1388123|NCT01213576|Albendazole|albendazole
1388124|NCT01213576|ivermectin|ivermectin
1388125|NCT01213576|human immunodeficiency|human immunodeficiency
1388126|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1388127|NCT01213537|Heart failure|heart failure
1388128|NCT01213524|nicotine|nicotine
1388129|NCT01213524|craving|craving
1388130|NCT01213524|dual-diagnosis|dual-diagnosis
1388131|NCT01213524|comorbidity|comorbidity
1388132|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
1388133|NCT01213498|Nephrology|nephrology
1388134|NCT01213498|Atorvastatin|atorvastatin
1388135|NCT01213498|L-NMMA|l-nmma
1388137|NCT01213472|ASCI|asci
1388138|NCT01213472|melanoma|melanoma
1388139|NCT01213472|tumor antigen|tumor antigen
1388140|NCT01213472|unresectable|unresectable
1388141|NCT01213472|progressive|progressive
1388142|NCT01213472|NY-ESO-1|ny-eso-1
1388143|NCT01213472|adult|adult
1388144|NCT01213472|cancer-testis antigen|cancer-testis antigen
1388145|NCT01213472|Immunotherapy|immunotherapy
1388146|NCT01213459|Human papillomavirus|human papillomavirus
1388147|NCT01213446|Von Willebrand Disease|von willebrand disease
1388148|NCT01213420|Donor sites after wound closure|donor sites after wound closure
1388149|NCT01213407|Dendritic cell|dendritic cell
1388150|NCT01213407|Cancer vaccine|cancer vaccine
1388151|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
1388152|NCT01213407|Interleukine-12|interleukine-12
1388153|NCT01213407|Individualised autologous therapy|individualised autologous therapy
1388154|NCT01213407|Brain cancer|brain cancer
1388155|NCT01213407|Temozolomide|temozolomide
1388156|NCT01213407|Radiotherapy|radiotherapy
1388157|NCT01213407|Irradiation|irradiation
1388158|NCT01213407|High-grade glioma|high-grade glioma
1388159|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
1388160|NCT01213407|Somatic cell therapy|somatic cell therapy
1388161|NCT01213407|Leukocyte apheresis|leukocyte apheresis
1388162|NCT01213407|Neurosurgery|neurosurgery
1388163|NCT01213407|Neurooncology|neurooncology
1388164|NCT01213407|Neurology|neurology
1388165|NCT01213407|Immunology|immunology
1388166|NCT01213407|Tumor immunology|tumor immunology
1388167|NCT01213407|Transfusion medicine|transfusion medicine
1388168|NCT01213407|Monocyte|monocyte
1388169|NCT01213407|Killer cell|killer cell
1388170|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
1388171|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
1388172|NCT01213394|Framingham score|framingham score
1388173|NCT01213394|kidney transplant|kidney transplant
1388174|NCT01213394|immunosuppression|immunosuppression
1388175|NCT01213394|cardiovascular disease|cardiovascular disease
1388176|NCT01213394|CellCept|cellcept
1388177|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
1388178|NCT01213355|Randomized|randomized
1388179|NCT01213355|double-blind|double-blind
1388180|NCT01213355|placebo-controlled|placebo-controlled
1388181|NCT01213355|5-way crossover|5-way crossover
1388182|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
1567148|NCT00509769|Breast cancer|breast cancer
1388183|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
1388184|NCT01213342|dry eye disease|dry eye disease
1388185|NCT01213316|HIV|hiv
1388186|NCT01213316|antiretroviral|antiretroviral
1388187|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
1388188|NCT01213316|Raltegravir|raltegravir
1388189|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
1388190|NCT01213303|cardiovascular risk|cardiovascular risk
1388191|NCT01213303|metabolic syndrome|metabolic syndrome
1388192|NCT01213303|fatty acids|fatty acids
1388193|NCT01213303|oxysterols|oxysterols
1388194|NCT01213303|antioxidants|antioxidants
1388195|NCT01213303|oxidative stress|oxidative stress
1388196|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
1388197|NCT01213290|Stylet|stylet
1388198|NCT01213277|Diabetes Mellitus|diabetes mellitus
1388199|NCT01213277|HbA1c|hba1c
1388200|NCT01213277|Glycation Rate|glycation rate
1388201|NCT01213277|Fructosamine|fructosamine
1388202|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
1388203|NCT01213238|Liver metastasis|liver metastasis
1388204|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
1388205|NCT01213238|HAI|hai
1388206|NCT01213238|Eloxatin|eloxatin
1388207|NCT01213238|Xeloda|xeloda
1388208|NCT01213238|Avastin|avastin
1388209|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1388210|NCT01213238|rhuMAb-VEGF|rhumab-vegf
1388211|NCT01213238|Oxaliplatin|oxaliplatin
1388212|NCT01213238|Capecitabine|capecitabine
1388213|NCT01213238|Bevacizumab|bevacizumab
1388214|NCT01213225|Elderly|elderly
1388215|NCT01213225|Hospitalization|hospitalization
1388216|NCT01213225|Geriatrics|geriatrics
1388217|NCT01213225|Mortality|mortality
1388218|NCT01213225|Readmission|readmission
1388219|NCT01213225|Length of Stay|length of stay
1388220|NCT01213212|Caloric restriction|caloric restriction
1388221|NCT01213212|type 2 diabetes|type 2 diabetes
1388222|NCT01213212|abdominal obesity|abdominal obesity
1388223|NCT01213212|renal disease|renal disease
1388224|NCT01213186|stem cell|stem cell
1388225|NCT01213186|hiv|hiv
1388226|NCT01213186|CD4|cd4
1388227|NCT01213186|immune activation|immune activation
1388228|NCT01213173|angina pectoris|angina pectoris
1388233|NCT01213160|solid tumours|solid tumours
1388234|NCT01213160|advanced solid malignancies|advanced solid malignancies
1388235|NCT01213160|dose escalation|dose escalation
1388236|NCT01213160|FGFR TKI|fgfr tki
1388237|NCT01213160|Japanese|japanese
1388238|NCT01213147|Pregnancy|pregnancy
1388239|NCT01213147|Clomiphene Citrate|clomiphene citrate
1388240|NCT01213147|Fertilization|fertilization
1388241|NCT01213147|Buserelin|buserelin
1388242|NCT01213134|Medical Education|medical education
1388243|NCT01213134|Resident Training|resident training
1388244|NCT01213134|Portfolio|portfolio
1388245|NCT01213121|bipolar depression|bipolar depression
1388246|NCT01213121|heart rate variability|heart rate variability
1388247|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
1388248|NCT01213121|electroencephalography|electroencephalography
1388249|NCT01213108|Örebro prevention program|örebro prevention program
1388250|NCT01213108|Youth drinking|youth drinking
1388251|NCT01213095|Lymphoma|lymphoma
1388252|NCT01213095|B-Cell|b-cell
1388253|NCT01213095|Marginal Zone|marginal zone
1388254|NCT01213095|Rituximab|rituximab
1388255|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
1388256|NCT01213082|Proton beam irradiation|proton beam irradiation
1388257|NCT01213082|ranibizumab|ranibizumab
1388258|NCT01213082|bevacizumab|bevacizumab
1388259|NCT01213082|anti-VEGF therapy|anti-vegf therapy
1388260|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1388261|NCT01213056|Chronic Headache Pain|chronic headache pain
1388262|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
1388263|NCT01213043|emphysema|emphysema
1388264|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
1388265|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
1388266|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
1388267|NCT01213030|HX4|hx4
1388268|NCT01213030|[F-18]HX4|[f-18]hx4
1388269|NCT01213030|FMISO|fmiso
1388270|NCT01213030|[F-18]FMISO|[f-18]fmiso
1388271|NCT01213030|Solitary Tumor|solitary tumor
1388272|NCT01213030|Hypoxia|hypoxia
1388273|NCT01213017|Certolizumab pegol|certolizumab pegol
1388274|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
1388275|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
1388276|NCT01213017|RAPID 3|rapid 3
1388277|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
1388278|NCT01213004|lung|lung
1388279|NCT01213004|abdominal|abdominal
1388280|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
1388281|NCT01213004|10-146|10-146
1388282|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
1388284|NCT01212978|Endothelium,Vascular|endothelium,vascular
1388285|NCT01212978|Arterial Remodeling|arterial remodeling
1388286|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
1388287|NCT01212978|Nitric Oxide|nitric oxide
1388288|NCT01212978|Walking|walking
1388289|NCT01212978|Software|software
1388290|NCT01212965|Selenium|selenium
1388291|NCT01212965|Lymphatic Malformations|lymphatic malformations
1388292|NCT01212965|Adolescents|adolescents
1388293|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
1388294|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
1388295|NCT01212900|Atherosclerosis|atherosclerosis
1388296|NCT01212900|Cardiovascular Disease|cardiovascular disease
1388297|NCT01212900|Cardiac MRI|cardiac mri
1388298|NCT01212900|Cardiac CT|cardiac ct
1388299|NCT01212900|Cholesterol|cholesterol
1388300|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1388301|NCT01212887|recurrent colon cancer|recurrent colon cancer
1388302|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
1388303|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
1388304|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
1388305|NCT01212887|stage IV colon cancer|stage iv colon cancer
1388306|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
1388307|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
1388308|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
1388309|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
1388310|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
1388311|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
1388312|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
1388313|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
1388314|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
1388315|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
1388316|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
1388317|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
1388318|NCT01212887|recurrent breast cancer|recurrent breast cancer
1388319|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
1388320|NCT01212887|stage IV breast cancer|stage iv breast cancer
1388321|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1388322|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1388323|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
1388324|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1388325|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1388326|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1388327|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1388328|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1388329|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1388330|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1388331|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1388332|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1388333|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1388637|NCT01211587|Phase 2|phase 2
1388334|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1388335|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1388336|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1388337|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1388338|NCT01212848|Suicidal ideation|suicidal ideation
1388340|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
1388341|NCT01212835|Morbid obesity|morbid obesity
1388342|NCT01212835|esophagitis|esophagitis
1388343|NCT01212835|GERD|gerd
1388344|NCT01212835|silastic ring|silastic ring
1388345|NCT01212835|Gastric bypass|gastric bypass
1388346|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1388347|NCT01212783|depression|depression
1388348|NCT01212783|psychological treatments|psychological treatments
1388349|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
1388350|NCT01212783|child development|child development
1388351|NCT01212783|parenting|parenting
1388352|NCT01212783|home visitation|home visitation
1388353|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
1388354|NCT01212770|Psoriasis|psoriasis
1388355|NCT01212770|Arthritis|arthritis
1388356|NCT01212770|inflammation|inflammation
1388357|NCT01212770|skin condition|skin condition
1388358|NCT01212770|inflammatory cells|inflammatory cells
1388359|NCT01212770|apremilast|apremilast
1388360|NCT01212770|CC-10004|cc-10004
1388361|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
1388362|NCT01212757|Psoriasis|psoriasis
1388363|NCT01212757|Arthritis|arthritis
1388364|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
1388365|NCT01212757|inflammation|inflammation
1388366|NCT01212757|skin condition|skin condition
1388367|NCT01212757|inflammatory cells|inflammatory cells
1388368|NCT01212757|apremilast|apremilast
1388369|NCT01212757|CC-10004|cc-10004
1388370|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
1388371|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
1388372|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
1388373|NCT01212718|Colorectal Cancer|colorectal cancer
1388374|NCT01212718|non resectable metastasis|non resectable metastasis
1388375|NCT01212718|reference lesion|reference lesion
1388376|NCT01212718|biopsy|biopsy
1388377|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
1388378|NCT01212679|nerve growth factor|nerve growth factor
1388379|NCT01212679|traumatic brain injury|traumatic brain injury
1388380|NCT01212679|intranasal|intranasal
1388381|NCT01212679|prognosis|prognosis
1388382|NCT01212679|neurological function|neurological function
1388383|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
1388384|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
1388385|NCT01212666|Saphenous nerve|saphenous nerve
1388386|NCT01212666|Pain|pain
1388387|NCT01212666|Ultrasound block|ultrasound block
1388388|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
1388389|NCT01212653|Golimumab|golimumab
1388390|NCT01212653|Simponi|simponi
1388391|NCT01212653|Anti-TNF alpha|anti-tnf alpha
1388392|NCT01212653|EPCs|epcs
1388393|NCT01212653|Vascular stiffness|vascular stiffness
1388394|NCT01212640|Transfusion, distress|transfusion, distress
1388395|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
1388396|NCT01212601|safety|safety
1388397|NCT01212601|efficacy|efficacy
1388398|NCT01212601|Chinese patients|chinese patients
1388399|NCT01212601|practice|practice
1388400|NCT01212588|BPD|bpd
1388401|NCT01212588|Borderline|borderline
1388402|NCT01212588|personality disorder|personality disorder
1388403|NCT01212588|mifepristone|mifepristone
1388404|NCT01212575|Mental disorder|mental disorder
1388405|NCT01212575|Antipsychotic treatment|antipsychotic treatment
1388406|NCT01212562|basal cell carcinoma|basal cell carcinoma
1388407|NCT01212562|cryosurgery|cryosurgery
1388408|NCT01212562|imiquimod|imiquimod
1388409|NCT01212562|immunocryosurgery|immunocryosurgery
1388410|NCT01212549|basal cell carcinoma|basal cell carcinoma
1388411|NCT01212549|cryosurgery|cryosurgery
1388412|NCT01212549|imiquimod|imiquimod
1388413|NCT01212549|immunocryosurgery|immunocryosurgery
1388414|NCT01212536|children|children
1388415|NCT01212536|intubation|intubation
1388416|NCT01212536|laryngoscope|laryngoscope
1388417|NCT01212523|propofol|propofol
1388418|NCT01212523|isoflurane|isoflurane
1388419|NCT01212523|pulmonary hypertension|pulmonary hypertension
1388420|NCT01212523|congenital heart disease|congenital heart disease
1388421|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
1388422|NCT01212510|circulating tumor markers|circulating tumor markers
1388423|NCT01212510|circulating tumor cell|circulating tumor cell
1388424|NCT01212510|circulating tumor DNA|circulating tumor dna
1388425|NCT01212510|marker's kinetic|marker's kinetic
1388426|NCT01212497|mindfulness|mindfulness
1388427|NCT01212497|meditation|meditation
1388428|NCT01212497|training|training
1388429|NCT01212497|coaching|coaching
1388430|NCT01212497|virtual coach|virtual coach
1388431|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
1388432|NCT01212458|gesunde Probanden|gesunde probanden
1388433|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
1388434|NCT01212406|Organ rejection|organ rejection
1388435|NCT01212406|Lung transplantation|lung transplantation
1388436|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
1388437|NCT01212406|Vitamin D|vitamin d
1388438|NCT01212406|Prevention|prevention
1388439|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
1388440|NCT01212393|emergency|emergency
1388441|NCT01212393|prevention|prevention
1388442|NCT01212393|thromboprophylaxis|thromboprophylaxis
1388443|NCT01212393|medical|medical
1388444|NCT01212393|hosptitalization|hosptitalization
1388445|NCT01212393|health care risks|health care risks
1388446|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1388447|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1388448|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
1388449|NCT01212367|Gene transfer|gene transfer
1388450|NCT01212367|Immunology|immunology
1388451|NCT01212367|Cancer|cancer
1388452|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
1388453|NCT01212354|selective dose escalation|selective dose escalation
1388454|NCT01212354|hypoxia|hypoxia
1388455|NCT01212354|head cancer|head cancer
1388456|NCT01212354|neck cancer|neck cancer
1388457|NCT01212341|Allogenetic NK cells|allogenetic nk cells
1388458|NCT01212341|Lymphomas|lymphomas
1388459|NCT01212341|Solid tumors|solid tumors
1388460|NCT01212328|T2DM|t2dm
1388461|NCT01212328|Decision support software|decision support software
1388462|NCT01212328|care coordinator|care coordinator
1388463|NCT01212315|Wound infection|wound infection
1388464|NCT01212315|SSI|ssi
1388466|NCT01212302|Clopidogrel|clopidogrel
1388467|NCT01212302|ASA|asa
1388468|NCT01212302|Low Response|low response
1388469|NCT01212302|Resistance|resistance
1388470|NCT01212263|PCOS|pcos
1388471|NCT01212263|Clomiphene resistance|clomiphene resistance
1388472|NCT01212263|ovulation induction|ovulation induction
1388473|NCT01212263|low dose uFSH|low dose ufsh
1388474|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
1388475|NCT01212237|glioma|glioma
1388476|NCT01212237|meningioma|meningioma
1388477|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
1388478|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
1388479|NCT01212211|Falls|falls
1388480|NCT01212211|Gait|gait
1388481|NCT01212211|elderly|elderly
1388482|NCT01212185|oxytocin|oxytocin
1388483|NCT01212185|alcohol withdrawal|alcohol withdrawal
1388484|NCT01212185|lorazepam|lorazepam
1388485|NCT01212185|alcoholism|alcoholism
1388486|NCT01212185|intranasal administration|intranasal administration
1388487|NCT01212185|CIWA-Ar|ciwa-ar
1388488|NCT01212172|Hair removal|hair removal
1388489|NCT01212172|Laser|laser
1388490|NCT01212172|Diode laser|diode laser
1388491|NCT01212159|Internet based monitoring system|internet based monitoring system
1388492|NCT01212146|Artichokes|artichokes
1388493|NCT01212146|Constipation|constipation
1388494|NCT01212146|Functional Foods|functional foods
1388495|NCT01212146|Prebiotics|prebiotics
1388496|NCT01212146|Probiotics|probiotics
1388497|NCT01212120|Diabetic foot|diabetic foot
1388498|NCT01212107|Advanced cancer|advanced cancer
1388499|NCT01212107|Metastatic cancer|metastatic cancer
1388500|NCT01212107|Oncology|oncology
1388501|NCT01212094|Rituximab|rituximab
1388502|NCT01212094|Multiple Sclerosis|multiple sclerosis
1388503|NCT01212094|Intrathecal|intrathecal
1388504|NCT01212094|MS|ms
1388505|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
1388506|NCT01212094|SP-MS|sp-ms
1388507|NCT01212081|Virtual Reality|virtual reality
1388508|NCT01212081|Schizophrenia|schizophrenia
1388509|NCT01212081|Cannabis|cannabis
1388510|NCT01212081|Assessment|assessment
1388511|NCT01212081|Craving|craving
1388512|NCT01212068|MEG|meg
1388513|NCT01212068|Epilepsy|epilepsy
1388514|NCT01212068|Brain Imaging|brain imaging
1388515|NCT01212068|Brain Scan|brain scan
1388516|NCT01212068|Auditory Processing|auditory processing
1388517|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
1388518|NCT01212055|PBSC Collection|pbsc collection
1388519|NCT01212055|Immunodeficiency|immunodeficiency
1388520|NCT01212055|Spectra Apheresis System|spectra apheresis system
1388521|NCT01212055|Stem Cell Mobilization|stem cell mobilization
1388522|NCT01212055|Leukapheresis|leukapheresis
1388523|NCT01212042|Pneumonia|pneumonia
1388731|NCT01211184|Body fluids|body fluids
1388524|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
1388525|NCT01212042|HIV|hiv
1388526|NCT01212042|Immunocompromised Host|immunocompromised host
1388527|NCT01212042|Respiratory Infection|respiratory infection
1388528|NCT01212042|Mycobacteria|mycobacteria
1388529|NCT01212029|Near Infrared|near infrared
1388530|NCT01212029|Optical Imaging|optical imaging
1388531|NCT01212029|Brain Imaging|brain imaging
1388532|NCT01212029|Healthy Volunteer|healthy volunteer
1388533|NCT01212029|HV|hv
1388534|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
1388745|NCT01211145|Pain|pain
1388535|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
1388536|NCT01212016|Peanut Allergy|peanut allergy
1388537|NCT01212016|T Cell|t cell
1388538|NCT01212016|IgE|ige
1388539|NCT01212016|Food Allergy|food allergy
1388540|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
1388541|NCT01212003|Active Tuberculosis|active tuberculosis
1388542|NCT01212003|Latent Tuberculosis|latent tuberculosis
1388543|NCT01212003|Tuberculosis|tuberculosis
1388544|NCT01212003|TB|tb
1388545|NCT01211990|Pediatric|pediatric
1388546|NCT01211990|Children|children
1388547|NCT01211990|Cancer|cancer
1388548|NCT01211990|Bone Marrow Transplant|bone marrow transplant
1388549|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
1388550|NCT01211977|Autoinflammatory|autoinflammatory
1388551|NCT01211977|Interleukin-1|interleukin-1
1388552|NCT01211951|Dry eye syndromes|dry eye syndromes
1388553|NCT01211951|Corneal diseases|corneal diseases
1388554|NCT01211951|Conjunctival diseases|conjunctival diseases
1388555|NCT01211938|phase II/III|phase ii/iii
1388556|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
1388557|NCT01211938|re irradiation|re irradiation
1388558|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
1388559|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
1388560|NCT01211912|Fetal movement|fetal movement
1388561|NCT01211912|Fetal breathing|fetal breathing
1388562|NCT01211912|Acetaminophen|acetaminophen
1388563|NCT01211899|polymorphism,|polymorphism,
1388564|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
1388565|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
1388566|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
1388567|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
1388568|NCT01211873|CNS|cns
1388569|NCT01211873|Contrast Agent|contrast agent
1388570|NCT01211873|MRI|mri
1388571|NCT01211873|Dotarem|dotarem
1388572|NCT01211873|Magnevist|magnevist
1388573|NCT01211860|DCCR|dccr
1388574|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
1388575|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
1388576|NCT01211860|Triglycerides|triglycerides
1388577|NCT01211860|Pharmacokinetics|pharmacokinetics
1388578|NCT01211847|triglycerides|triglycerides
1388579|NCT01211847|Apo B|apo b
1388580|NCT01211847|non-HDL|non-hdl
1388581|NCT01211847|statin|statin
1388582|NCT01211847|fenofibrate|fenofibrate
1388583|NCT01211795|Migraine|migraine
1388584|NCT01211795|Prevention|prevention
1388585|NCT01211795|Treatment|treatment
1388586|NCT01211795|Ketoprofen|ketoprofen
1388587|NCT01211795|Trigeminal nerve|trigeminal nerve
1388588|NCT01211782|Alzheimer's disease|alzheimer's disease
1388589|NCT01211782|AD|ad
1388590|NCT01211782|AC-1204|ac-1204
1388591|NCT01211782|ketogenic|ketogenic
1388592|NCT01211782|ketosis|ketosis
1388593|NCT01211769|PUFAs|pufas
1388594|NCT01211769|Alcoholism|alcoholism
1388595|NCT01211769|Treatment|treatment
1388596|NCT01211769|Effectiveness|effectiveness
1388597|NCT01211743|SILS|sils
1388598|NCT01211743|Oxidative Stress|oxidative stress
1388599|NCT01211743|8-epiPGF2a|8-epipgf2a
1388600|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
1388601|NCT01211730|Liver|liver
1388602|NCT01211730|transplantation|transplantation
1388603|NCT01211730|Glucose|glucose
1388604|NCT01211730|Hyperglycemia|hyperglycemia
1388605|NCT01211730|Insulin|insulin
1388606|NCT01211730|Rejection|rejection
1388607|NCT01211730|Hypoglycemia|hypoglycemia
1388608|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
1388609|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
1388610|NCT01211717|Diabetes|diabetes
1388611|NCT01211717|Muscle Damage|muscle damage
1388612|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
1388613|NCT01211691|Hematologic|hematologic
1388614|NCT01211691|Leukemia|leukemia
1388615|NCT01211691|Malignancies|malignancies
1388616|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1388617|NCT01211665|IVMP|ivmp
1388618|NCT01211665|corticosteroids|corticosteroids
1388619|NCT01211665|IRIS|iris
1388620|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
1388621|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
1388622|NCT01211665|PML|pml
1388623|NCT01211652|Compliance|compliance
1388624|NCT01211652|France|france
1388732|NCT01211184|Complications|complications
1388625|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
1388626|NCT01211613|Manipulation|manipulation
1388627|NCT01211613|Chiropractic|chiropractic
1388628|NCT01211613|Low Back Pain|low back pain
1388629|NCT01211600|Staples|staples
1388630|NCT01211600|Sutures|sutures
1388631|NCT01211600|Wound infections|wound infections
1388632|NCT01211600|Cosmesis|cosmesis
1388633|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
1388634|NCT01211587|Parkinson's Disease|parkinson's disease
1388635|NCT01211587|Cognition|cognition
1388636|NCT01211587|Safinamide|safinamide
1388638|NCT01211587|Non-demented patients|non-demented patients
1388639|NCT01211587|Levodopa|levodopa
1388640|NCT01211587|Dopamine agonist|dopamine agonist
1388641|NCT01211535|Soft contact lenses|soft contact lenses
1388642|NCT01211535|Multi-purpose Solution|multi-purpose solution
1388643|NCT01211522|Delirium|delirium
1388644|NCT01211522|Intensive care|intensive care
1388645|NCT01211522|Mechanical ventilation|mechanical ventilation
1388646|NCT01211522|Antipsychotic|antipsychotic
1388647|NCT01211522|Haloperidol|haloperidol
1388648|NCT01211522|Ziprasidone|ziprasidone
1388649|NCT01211522|Randomized|randomized
1388650|NCT01211522|Placebo|placebo
1388651|NCT01211522|Sepsis|sepsis
1388652|NCT01211522|Sedation|sedation
1388653|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
1388654|NCT01211509|montelukast|montelukast
1388655|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
1388656|NCT01211509|lung transplantation|lung transplantation
1388657|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1388658|NCT01211496|functional testing|functional testing
1388659|NCT01211496|resistance training|resistance training
1388660|NCT01211496|velocity training|velocity training
1388661|NCT01211496|elderly|elderly
1388662|NCT01211496|geriatric|geriatric
1388663|NCT01211496|knee|knee
1388664|NCT01211496|leg|leg
1388665|NCT01211496|leg strength|leg strength
1388666|NCT01211483|Lung cancer|lung cancer
1388667|NCT01211470|MRSA|mrsa
1388668|NCT01211470|ABSSSI|absssi
1388669|NCT01211470|Staphylococcus aureus|staphylococcus aureus
1388670|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
1388671|NCT01211444|OSA|osa
1388672|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
1388673|NCT01211444|Sleep apnea|sleep apnea
1388674|NCT01211431|cesarean section|cesarean section
1388675|NCT01211431|pain|pain
1388676|NCT01211431|ropivacain|ropivacain
1388677|NCT01211431|diclofena|diclofena
1388678|NCT01211431|morphine|morphine
1388679|NCT01211405|MDMA|mdma
1388680|NCT01211405|Psychotherapy|psychotherapy
1388681|NCT01211405|Veterans|veterans
1388682|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
1388683|NCT01211379|colorectal cancer screening|colorectal cancer screening
1388684|NCT01211379|primary care|primary care
1388685|NCT01211379|health disparities|health disparities
1388686|NCT01211366|cell saver|cell saver
1388687|NCT01211366|allogeneic RBCs|allogeneic rbcs
1388688|NCT01211366|washed cells|washed cells
1388689|NCT01211366|PRBC transfusion|prbc transfusion
1388690|NCT01211353|Alcohol|alcohol
1388691|NCT01211353|Brief Intervention|brief intervention
1388692|NCT01211353|Personalized Feedback|personalized feedback
1388693|NCT01211353|Veterans|veterans
1388694|NCT01211340|Hospice|hospice
1388695|NCT01211340|Caregivers|caregivers
1388696|NCT01211340|Interdisciplinary Team|interdisciplinary team
1388697|NCT01211340|Pain management|pain management
1388698|NCT01211314|hypertension|hypertension
1388699|NCT01211314|Fixed combination|fixed combination
1388700|NCT01211314|lercanidipine|lercanidipine
1388701|NCT01211314|enalapril|enalapril
1388702|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1388703|NCT01211301|obesity|obesity
1388704|NCT01211301|overweight|overweight
1388705|NCT01211301|weight loss|weight loss
1388706|NCT01211301|randomized controlled trial|randomized controlled trial
1388707|NCT01211301|Medifast|medifast
1388708|NCT01211288|HIV|hiv
1388709|NCT01211288|Implant|implant
1388710|NCT01211288|Crown|crown
1388711|NCT01211275|mesothelioma|mesothelioma
1388712|NCT01211275|chemotherapy|chemotherapy
1388713|NCT01211275|translational research|translational research
1388714|NCT01211275|axitinib|axitinib
1388715|NCT01211262|Melanoma|melanoma
1388716|NCT01211262|Phase I|phase i
1388717|NCT01211262|Biologic|biologic
1388718|NCT01211249|Methotrexate-refractory|methotrexate-refractory
1388719|NCT01211223|Chronic periodontitis|chronic periodontitis
1388720|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
1388721|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
1388722|NCT01211223|Scaling and Root Planning|scaling and root planning
1388723|NCT01211223|Periodontal treatment|periodontal treatment
1388724|NCT01211210|rectal cancer|rectal cancer
1388725|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
1388726|NCT01211210|oxaliplatin|oxaliplatin
1388727|NCT01211210|radiation|radiation
1388728|NCT01211184|Hip surgery|hip surgery
1388729|NCT01211184|Metabolism|metabolism
1388730|NCT01211184|Glucose|glucose
1388733|NCT01211171|Cough|cough
1388734|NCT01211171|Telmisartan|telmisartan
1388735|NCT01211171|Bradykinin|bradykinin
1388736|NCT01211171|Tolerability|tolerability
1388737|NCT01211158|emergency department|emergency department
1388738|NCT01211158|procedural sedation|procedural sedation
1388739|NCT01211158|ketofol|ketofol
1388740|NCT01211158|ketamine|ketamine
1388741|NCT01211158|propofol|propofol
1388742|NCT01211158|conscious sedation|conscious sedation
1388743|NCT01211145|Migraine|migraine
1388744|NCT01211145|Headache|headache
1388746|NCT01211145|Efficacy|efficacy
1388747|NCT01211145|Adolescents|adolescents
1388748|NCT01211132|Colon polyps|colon polyps
1388749|NCT01211132|Adenoma detection|adenoma detection
1388750|NCT01211132|Cap|cap
1388751|NCT01211132|Standard|standard
1388752|NCT01211132|Colon Cancer|colon cancer
1388753|NCT01211106|Treatment|treatment
1388754|NCT01211106|PTSD|ptsd
1388755|NCT01211106|Addiction|addiction
1388756|NCT01211093|vibration|vibration
1388757|NCT01211093|muscle|muscle
1388758|NCT01211093|cerebrovascular accident|cerebrovascular accident
1388759|NCT01211093|exercise|exercise
1388760|NCT01211093|rehabilitation|rehabilitation
1388761|NCT01211080|infancy hemangioma|infancy hemangioma
1388762|NCT01211080|propranolol|propranolol
1388763|NCT01211080|study design|study design
1388764|NCT01211080|side effects|side effects
1388765|NCT01211080|safety|safety
1388766|NCT01211067|Inguinal hernia|inguinal hernia
1388767|NCT01211067|Inguinal ring|inguinal ring
1388768|NCT01211067|Histology|histology
1388769|NCT01211067|Hernioplasty|hernioplasty
1388770|NCT01211067|Lichtenstein|lichtenstein
1388771|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
1388772|NCT01211028|Critical leg ischemia|critical leg ischemia
1388773|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
1388774|NCT01211028|Autologous|autologous
1388775|NCT01211028|Angiogenesis|angiogenesis
1388776|NCT01211002|Radiotherapy|radiotherapy
1388777|NCT01211002|rh-endostatin|rh-endostatin
1388778|NCT01211002|chemotherapy|chemotherapy
1388779|NCT01211002|NSCLC|nsclc
1388780|NCT01210976|levosimendan|levosimendan
1388781|NCT01210976|CABG|cabg
1388782|NCT01210976|AVR|avr
1388783|NCT01210950|distraction|distraction
1388784|NCT01210950|osteogenesis|osteogenesis
1388785|NCT01210950|limb length discrepancy|limb length discrepancy
1388786|NCT01210950|callus|callus
1388787|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
1388788|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
1388789|NCT01210937|Stroke|stroke
1388790|NCT01210937|Cerebrovascular|cerebrovascular
1388791|NCT01210937|Atherosclerosis|atherosclerosis
1388792|NCT01210924|children|children
1388793|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1388794|NCT01210924|antiretroviral therapy|antiretroviral therapy
1388795|NCT01210924|China|china
1388796|NCT01210924|Mortality|mortality
1388797|NCT01210911|pancreatic cancer|pancreatic cancer
1388798|NCT01210911|metformin|metformin
1388799|NCT01210911|MAPK pathway|mapk pathway
1388800|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
1388801|NCT01210911|gemcitabine|gemcitabine
1388802|NCT01210898|Influenza|influenza
1388803|NCT01210898|Trivalent|trivalent
1388804|NCT01210898|Adjuvanted|adjuvanted
1388805|NCT01210898|Vaccine|vaccine
1388806|NCT01210898|Children|children
1388807|NCT01210885|Meningococcal Disease|meningococcal disease
1388808|NCT01210885|Vaccines|vaccines
1388809|NCT01210885|Adolescents|adolescents
1388810|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1388925|NCT01210417|Hypovolemia|hypovolemia
1388811|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1388812|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1388813|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1388814|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1388815|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1388816|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1388817|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1388818|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1388819|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1388820|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1388821|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1388822|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1388823|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1388824|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1388825|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1388826|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1388827|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1388828|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1388829|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1388830|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1388831|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1388832|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1388833|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1388834|NCT01210872|tongue cancer|tongue cancer
1388835|NCT01210859|detrusitol|detrusitol
1388836|NCT01210859|overactive|overactive
1388837|NCT01210859|bladder|bladder
1388838|NCT01210859|ureteral|ureteral
1388839|NCT01210859|stents|stents
1388840|NCT01210846|AV-951|av-951
1388841|NCT01210846|tivozanib|tivozanib
1388843|NCT01210846|advanced solid tumors|advanced solid tumors
1388844|NCT01210846|pharmacokinetics|pharmacokinetics
1388845|NCT01210833|Finger Fractures|finger fractures
1388846|NCT01210833|Tendon Injuries|tendon injuries
1388847|NCT01210833|Soft Tissue Injuries|soft tissue injuries
1388848|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
1388849|NCT01210768|Phase II|phase ii
1388850|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1388851|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
1388852|NCT01210768|Breast Cancer|breast cancer
1388853|NCT01210755|Antithrombotics|antithrombotics
1388854|NCT01210755|Haemostatics|haemostatics
1388855|NCT01210755|Antidote|antidote
1388856|NCT01210729|stroke|stroke
1388857|NCT01210729|mechanical recanalization|mechanical recanalization
1388858|NCT01210729|self-expanding stent|self-expanding stent
1388859|NCT01210729|Solitaire|solitaire
1512298|NCT00730704|HPV|hpv
1388860|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
1388861|NCT01210716|Autoimmune diseases|autoimmune diseases
1388862|NCT01210716|Kidney transplant|kidney transplant
1388863|NCT01210716|Hematologic disorders|hematologic disorders
1388864|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
1388865|NCT01210716|Neurologic disorders|neurologic disorders
1388866|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
1388867|NCT01210703|CPAP|cpap
1388868|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1388869|NCT01210690|Levetiracetam|levetiracetam
1388870|NCT01210690|Keppra® Oral Solution|keppra® oral solution
1388871|NCT01210690|Keppra® in Children|keppra® in children
1388872|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
1388873|NCT01210677|Sarcoidosis|sarcoidosis
1388874|NCT01210664|Diabetes|diabetes
1388875|NCT01210664|Treg|treg
1388876|NCT01210651|Yoga|yoga
1388877|NCT01210651|Major Depression|major depression
1388878|NCT01210651|Self-Efficacy|self-efficacy
1388879|NCT01210651|Self-Esteem|self-esteem
1388880|NCT01210651|Hatha yoga|hatha yoga
1388881|NCT01210651|mind-body therapies|mind-body therapies
1388882|NCT01210651|depression|depression
1388883|NCT01210625|Constipation|constipation
1388884|NCT01210599|Back Pain|back pain
1388885|NCT01210599|Bisphosphonate|bisphosphonate
1388886|NCT01210599|Pamidronate|pamidronate
1388887|NCT01210599|Bone Pain|bone pain
1388888|NCT01210573|Heart Failure|heart failure
1388889|NCT01210573|Heart-Assist Devices|heart-assist devices
1388890|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
1388891|NCT01210560|Kidney Disease|kidney disease
1388892|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
1388893|NCT01210521|Asthmatic Patients|asthmatic patients
1388894|NCT01210521|Vitamin D|vitamin d
1388895|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
1388896|NCT01210521|cholecalciferol|cholecalciferol
1388897|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
1388898|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
1388899|NCT01210482|Torisel|torisel
1388900|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1388901|NCT01210469|elderly|elderly
1388902|NCT01210469|postural balance|postural balance
1388903|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
1388904|NCT01210469|posture|posture
1388905|NCT01210469|muscle strength|muscle strength
1388906|NCT01210469|muscle stretching exercises|muscle stretching exercises
1388907|NCT01210456|Chronic Kidney Disease|chronic kidney disease
1388908|NCT01210456|Contrast Media|contrast media
1388909|NCT01210456|Acute Kidney Injury|acute kidney injury
1388910|NCT01210456|N-Acetylcysteine|n-acetylcysteine
1388911|NCT01210456|Bicarbonate|bicarbonate
1388912|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
1388913|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
1388914|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
1388915|NCT01210430|Reactive Oxygen Species|reactive oxygen species
1388916|NCT01210430|Oxidative Stress|oxidative stress
1388917|NCT01210430|Angiotensin II|angiotensin ii
1388918|NCT01210430|Nitric Oxide|nitric oxide
1388919|NCT01210430|Blood Flow|blood flow
1388920|NCT01210430|POTS|pots
1388921|NCT01210430|Ascorbic Acid|ascorbic acid
1388922|NCT01210430|Vitamin C|vitamin c
1388923|NCT01210430|Losartan|losartan
1388924|NCT01210417|Trauma|trauma
1388926|NCT01210417|Hemorrhage|hemorrhage
1388927|NCT01210417|Out of hospital trauma|out of hospital trauma
1388928|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
1388929|NCT01210378|NSCLC|nsclc
1388930|NCT01210378|Nitroglycerin|nitroglycerin
1388931|NCT01210378|Tumour perfusion|tumour perfusion
1388932|NCT01210378|Hypoxia|hypoxia
1388933|NCT01210378|Toxicity|toxicity
1388934|NCT01210378|Phase II|phase ii
1388936|NCT01210365|CHF functional class II|chf functional class ii
1388937|NCT01210365|Patients with CHF|patients with chf
1388938|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
1388939|NCT01210352|surgical pain|surgical pain
1388940|NCT01210352|acute pain|acute pain
1388941|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
1388942|NCT01210339|phase 1|phase 1
1388943|NCT01210339|cross-over|cross-over
1388944|NCT01210339|drug-drug Interaction|drug-drug interaction
1388945|NCT01210339|esomeprazole|esomeprazole
1388946|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
1388947|NCT01210339|clopidogrel|clopidogrel
1388948|NCT01210339|healthy volunteers|healthy volunteers
1388949|NCT01210339|cardiovascular disease|cardiovascular disease
1388950|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
1388951|NCT01210326|TESE|tese
1388952|NCT01210326|TESA|tesa
1388953|NCT01210326|non obstructive|non obstructive
1388954|NCT01210326|azoospermi|azoospermi
1388955|NCT01210313|physical activity|physical activity
1388956|NCT01210300|caesarean section|caesarean section
1388957|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
1388958|NCT01210300|repeat caesarean section|repeat caesarean section
1388959|NCT01210300|childbirth expectation|childbirth expectation
1388960|NCT01210300|childbirth experience|childbirth experience
1388961|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
1388962|NCT01210287|HBsAg negative|hbsag negative
1388963|NCT01210287|HBcAb positive|hbcab positive
1388964|NCT01210287|lymphoma|lymphoma
1388965|NCT01210287|rituximab|rituximab
1388966|NCT01210261|OSA|osa
1388967|NCT01210261|CPAP|cpap
1388968|NCT01210261|APAP|apap
1388969|NCT01210261|SPAP|spap
1388970|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
1388971|NCT01210261|Sleep Apnea|sleep apnea
1388972|NCT01210235|colorectal cancer screening|colorectal cancer screening
1388973|NCT01210235|preventive health|preventive health
1388974|NCT01210235|primary care|primary care
1388975|NCT01210209|Ewing sarcoma|ewing sarcoma
1388976|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
1388977|NCT01210196|Fabry|fabry
1388978|NCT01210183|Dextrose|dextrose
1388979|NCT01210183|Cartilage|cartilage
1388980|NCT01210183|Regeneration|regeneration
1388981|NCT01210170|asthma,|asthma,
1388982|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
1388983|NCT01210170|airway blood flow,|airway blood flow,
1388984|NCT01210170|mometasone,|mometasone,
1388985|NCT01210170|albuterol|albuterol
1388986|NCT01210170|spirometry|spirometry
1388987|NCT01210144|Infertility|infertility
1388988|NCT01210144|Gonal-f|gonal-f
1388989|NCT01210144|gene expression|gene expression
1388990|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
1388991|NCT01210144|Follitropin alfa|follitropin alfa
1388992|NCT01210144|endometrium|endometrium
1388993|NCT01210131|Toxicity|toxicity
1388994|NCT01210131|Progression|progression
1388995|NCT01210131|Survival|survival
1388996|NCT01210131|SCLC|sclc
1388997|NCT01210118|Pregnancy|pregnancy
1388998|NCT01210118|Smoking cessation|smoking cessation
1388999|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
1389000|NCT01210105|intubation|intubation
1389001|NCT01210105|video laryngoscopes|video laryngoscopes
1389002|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
1389003|NCT01210079|methadone|methadone
1389004|NCT01210079|gabapentin|gabapentin
1389005|NCT01210079|opioid addiction|opioid addiction
1389006|NCT01210066|inflammation|inflammation
1389007|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
1389008|NCT01210066|bupenorphine|bupenorphine
1389009|NCT01210066|prescription opioid abuse|prescription opioid abuse
1389010|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
1389011|NCT01210040|Pregnancy|pregnancy
1389012|NCT01210040|Iron deficiency|iron deficiency
1389013|NCT01210040|Iron supplementation|iron supplementation
1389014|NCT01210040|Burkina Faso|burkina faso
1389015|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
1389016|NCT01210014|treatment|treatment
1389017|NCT01210014|zinc sulphate|zinc sulphate
1389018|NCT01209975|blood flow|blood flow
1389019|NCT01209975|glaucoma|glaucoma
1389020|NCT01209975|SLT|slt
1389021|NCT01209936|Body Fat|body fat
1389022|NCT01209936|Total body water|total body water
1389023|NCT01209923|Percent body fat|percent body fat
1389024|NCT01209923|Body Composition|body composition
1389025|NCT01209923|Stayhealthy|stayhealthy
1389026|NCT01209897|Smoking|smoking
1389027|NCT01209871|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1389028|NCT01209871|Recombinant DNA|recombinant dna
1389029|NCT01209871|Fusion DNA Vaccine|fusion dna vaccine
1389030|NCT01209871|Waldenström macroglobulinemia|waldenström macroglobulinemia
1389031|NCT01209858|epilepsy|epilepsy
1389032|NCT01209845|depression|depression
1389033|NCT01209845|suicide ideation|suicide ideation
1389034|NCT01209845|emergency department|emergency department
1389035|NCT01209845|ketamine|ketamine
1389036|NCT01209832|Metastatic Tumors|metastatic tumors
1389037|NCT01209832|Lymphoma|lymphoma
1389038|NCT01209819|Bone Mineral Density|bone mineral density
1389039|NCT01209819|Adults|adults
1389040|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
1389041|NCT01209767|Cellulite|cellulite
1389042|NCT01209767|Cryolipolysis|cryolipolysis
1389043|NCT01209767|Zeltiq|zeltiq
1389044|NCT01209767|Subcision|subcision
1389045|NCT01209754|Pregnancy|pregnancy
1389046|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
1389047|NCT01209754|Mother|mother
1389048|NCT01209754|Infant|infant
1389049|NCT01209754|malformations|malformations
1389050|NCT01209754|HIV|hiv
1389051|NCT01209728|insomnia|insomnia
1389052|NCT01209728|insomniacs|insomniacs
1389053|NCT01209728|simulated driving|simulated driving
1389054|NCT01209728|alcohol|alcohol
1389055|NCT01209728|ethanol|ethanol
1389056|NCT01209715|airway blood flow,|airway blood flow,
1389057|NCT01209715|COPD,|copd,
1389058|NCT01209715|endothelial dysfunction|endothelial dysfunction
1389059|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
1389060|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
1389061|NCT01209663|General Surgery|general surgery
1389062|NCT01209663|Emergency treatment|emergency treatment
1389063|NCT01209663|Postoperative care|postoperative care
1389064|NCT01209663|Intermediate care unit|intermediate care unit
1389065|NCT01209663|High dependency unit|high dependency unit
1389066|NCT01209663|Mortality|mortality
1389067|NCT01209637|stable coronary artery disease|stable coronary artery disease
1389068|NCT01209637|significant coronary stenosis|significant coronary stenosis
1389069|NCT01209624|prospective|prospective
1389070|NCT01209624|non-interventional|non-interventional
1389071|NCT01209624|observational|observational
1389072|NCT01209624|multi-center|multi-center
1389073|NCT01209624|long-term|long-term
1389074|NCT01209598|soft tissue|soft tissue
1389075|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
1389076|NCT01209598|10-094|10-094
1389077|NCT01209572|energy expenditure|energy expenditure
1389078|NCT01209572|heart rate|heart rate
1389079|NCT01209572|accelerometry|accelerometry
1389080|NCT01209572|body temperature|body temperature
1389081|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
1389082|NCT01209546|Bronchiectasis|bronchiectasis
1389083|NCT01209546|Pulmonary function|pulmonary function
1389084|NCT01209546|Respiratory muscle strength|respiratory muscle strength
1389085|NCT01209546|Respiratory secretions|respiratory secretions
1389086|NCT01209533|Asthma|asthma
1389087|NCT01209520|Lung Cancer|lung cancer
1389088|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
1389089|NCT01209520|NSCLC|nsclc
1389090|NCT01209520|Methylation Analysis|methylation analysis
1389091|NCT01209520|Hypermethylation|hypermethylation
1389092|NCT01209520|Targeted Genes|targeted genes
1389093|NCT01209520|Tumorigenesis|tumorigenesis
1389094|NCT01209520|Tumor Supressor Genes|tumor supressor genes
1389095|NCT01209507|Adrenal suppression|adrenal suppression
1389096|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
1389097|NCT01209507|Quality of life|quality of life
1389098|NCT01209494|sudden cardiac death|sudden cardiac death
1389099|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1389100|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
1389101|NCT01209494|genetic syndromes|genetic syndromes
1389102|NCT01209494|calcium metabolism|calcium metabolism
1389103|NCT01209494|ventricular repolarization|ventricular repolarization
1389105|NCT01209494|T wave|t wave
1389106|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
1389107|NCT01209494|alternans|alternans
1389108|NCT01209494|late potentials|late potentials
1389109|NCT01209494|risk stratification|risk stratification
1389110|NCT01209481|fruits|fruits
1389111|NCT01209481|vegetables|vegetables
1389112|NCT01209481|primary health care|primary health care
1389113|NCT01209481|nutritional education|nutritional education
1389114|NCT01209455|Acetylcysteine|acetylcysteine
1389115|NCT01209455|Adverse effects|adverse effects
1389116|NCT01209455|Acetaminophen|acetaminophen
1389117|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
1389118|NCT01209442|Glioblastoma|glioblastoma
1389119|NCT01209442|Multiforme|multiforme
1389120|NCT01209429|Calorie restriction|calorie restriction
1389121|NCT01209429|GH/IGF-I axis|gh/igf-i axis
1389122|NCT01209429|STATb5|statb5
1389123|NCT01209429|SIRT1|sirt1
1389124|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
1389125|NCT01209429|Fasting|fasting
1389126|NCT01209429|Growth hormone|growth hormone
1389127|NCT01209429|IGF-1|igf-1
1389128|NCT01209416|ghrelin|ghrelin
1389129|NCT01209416|metabolism|metabolism
1389130|NCT01209416|type 2 diabetes|type 2 diabetes
1389131|NCT01209416|insulin resistance|insulin resistance
1389132|NCT01209403|Dialysis|dialysis
1389133|NCT01209403|Malnutrition|malnutrition
1389134|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
1389135|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
1389136|NCT01209403|Inflammation|inflammation
1389137|NCT01209390|osteochondral|osteochondral
1389138|NCT01209390|regenerative|regenerative
1389139|NCT01209390|repair|repair
1389140|NCT01209390|cartilage lesion|cartilage lesion
1389141|NCT01209377|standard|standard
1389142|NCT01209377|fixed|fixed
1389143|NCT01209377|no focus|no focus
1389144|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
1389145|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
1389146|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
1389147|NCT01209364|comparative|comparative
1389148|NCT01209364|randomized|randomized
1389149|NCT01209364|double-blind|double-blind
1389150|NCT01209364|non-inferior|non-inferior
1389151|NCT01209364|knee OA|knee oa
1389152|NCT01209351|Pharmacokinetics|pharmacokinetics
1389153|NCT01209351|Pharmacodynamics|pharmacodynamics
1389154|NCT01209351|teduglutide|teduglutide
1389155|NCT01209325|human papilloma virus infection|human papilloma virus infection
1389156|NCT01209325|anal cancer|anal cancer
1389157|NCT01209325|penile cancer|penile cancer
1389158|NCT01209325|HIV infection|hiv infection
1389159|NCT01209299|recurrent melanoma|recurrent melanoma
1389160|NCT01209299|stage IIIC melanoma|stage iiic melanoma
1389161|NCT01209299|stage IV melanoma|stage iv melanoma
1389162|NCT01209286|Blinatumomab|blinatumomab
1389163|NCT01209286|B-ALL|b-all
1389164|NCT01209286|adult ALL|adult all
1389165|NCT01209286|relapsed ALL|relapsed all
1389166|NCT01209286|refractory ALL|refractory all
1389167|NCT01209286|Leukemia|leukemia
1389169|NCT01209286|Lymphatic diseases|lymphatic diseases
1389170|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
1389171|NCT01209286|bispecific antibody|bispecific antibody
1389172|NCT01209286|anti-CD19|anti-cd19
1389173|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
1389174|NCT01209273|Quality of Life|quality of life
1389175|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
1389176|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
1389177|NCT01209273|End Stage Renal Disease|end stage renal disease
1389178|NCT01209260|Transseptal Puncture|transseptal puncture
1389179|NCT01209260|Radiofrequency Energy|radiofrequency energy
1389180|NCT01209260|Left Atrium Access|left atrium access
1389181|NCT01209260|Left Atrial Catheterization|left atrial catheterization
1389182|NCT01209260|Ablation|ablation
1389183|NCT01209260|Transseptal Catheterization|transseptal catheterization
1389184|NCT01209260|Electrocautery|electrocautery
1389185|NCT01209260|Catheter Ablation|catheter ablation
1389186|NCT01209260|Atrial Fibrillation|atrial fibrillation
1389187|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
1389188|NCT01209247|Commensal flora|commensal flora
1389189|NCT01209247|Emergence of resistance|emergence of resistance
1389190|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1389191|NCT01209234|MRSA|mrsa
1389192|NCT01209195|Ovarian cancer|ovarian cancer
1389193|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
1389194|NCT01209195|Breast cancer|breast cancer
1389195|NCT01209195|Fallopian tube cancer|fallopian tube cancer
1389196|NCT01209169|Kidney Renal|kidney renal
1389197|NCT01209117|formulation|formulation
1389198|NCT01209117|bioavailability|bioavailability
1389199|NCT01209117|pharmacokinetics|pharmacokinetics
1389200|NCT01209117|GSK2248761|gsk2248761
1389201|NCT01209104|omeprazole|omeprazole
1389202|NCT01209104|proton pump inhibitor|proton pump inhibitor
1389203|NCT01209104|COPD|copd
1389204|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
1389205|NCT01209104|bioavailability|bioavailability
1389206|NCT01209104|food-effect|food-effect
1389207|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1389208|NCT01209078|linezolid|linezolid
1389209|NCT01209078|repeat dose|repeat dose
1389210|NCT01209078|GSK1322322|gsk1322322
1389211|NCT01209065|integrase|integrase
1389212|NCT01209065|fosamprenavir|fosamprenavir
1389213|NCT01209065|ritonavir|ritonavir
1389214|NCT01209065|GSK1349572|gsk1349572
1389215|NCT01209052|COPD|copd
1389216|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
1389217|NCT01209039|Schizophrenia|schizophrenia
1389219|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
1389220|NCT01209026|moxifloxacin|moxifloxacin
1389221|NCT01209026|QTc|qtc
1389222|NCT01209026|GW642444|gw642444
1389223|NCT01209026|pharmacokinetics|pharmacokinetics
1389224|NCT01209013|PDT|pdt
1389225|NCT01209013|porfimer sodium|porfimer sodium
1389226|NCT01209013|BE|be
1390017|NCT01205451|upper limb|upper limb
1389227|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
1389228|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
1389229|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1389230|NCT01209000|FSGS|fsgs
1389231|NCT01209000|Minimal change disease|minimal change disease
1389232|NCT01209000|MCD|mcd
1389233|NCT01209000|Membranous Nephropathy|membranous nephropathy
1389234|NCT01209000|MN|mn
1389235|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
1389236|NCT01209000|Neph Syndrome|neph syndrome
1389237|NCT01209000|NEPTUNE|neptune
1389238|NCT01209000|NephCure|nephcure
1389239|NCT01209000|Halpin|halpin
1389240|NCT01208974|Breast Cancer|breast cancer
1389241|NCT01208974|Nipple Area Complex|nipple area complex
1389242|NCT01208974|Mastectomy|mastectomy
1389243|NCT01208974|Radiation Therapy|radiation therapy
1389244|NCT01208974|Nipple-Sparing|nipple-sparing
1389245|NCT01208974|Breast Reconstruction|breast reconstruction
1389246|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
1389247|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
1389248|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
1389249|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
1389250|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
1389251|NCT01208961|Epanova|epanova
1389252|NCT01208961|Lovaza|lovaza
1389253|NCT01208961|bioavailability|bioavailability
1389254|NCT01208961|pharmacokinetics|pharmacokinetics
1389255|NCT01208961|low-fat meal|low-fat meal
1389256|NCT01208961|high-fat meal|high-fat meal
1389257|NCT01208948|macular edema|macular edema
1389258|NCT01208948|diabetes mellitus|diabetes mellitus
1389259|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
1389260|NCT01208935|Randomized|randomized
1389261|NCT01208935|Double blind|double blind
1389262|NCT01208935|double-dummy|double-dummy
1389263|NCT01208935|placebo-controlled|placebo-controlled
1389264|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1389265|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
1389266|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
1389267|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
1389268|NCT01208831|Advanced tumors|advanced tumors
1389269|NCT01208831|hedgehog|hedgehog
1389270|NCT01208831|smoothened inhibitor|smoothened inhibitor
1389271|NCT01208792|Auto antibodies|auto antibodies
1389272|NCT01208792|Target antigens|target antigens
1389273|NCT01208792|2D-immunoblot|2d-immunoblot
1389274|NCT01208792|Reactive oxygen species|reactive oxygen species
1389275|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
1389276|NCT01208792|Systemic sclerosis|systemic sclerosis
1389277|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
1389278|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
1389279|NCT01208792|Congenital heart defect|congenital heart defect
1389280|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
1389281|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
1389282|NCT01208792|Sjögren's syndrome|sjögren's syndrome
1389283|NCT01208779|Compliance|compliance
1389284|NCT01208779|HR+ breast cancer|hr+ breast cancer
1389285|NCT01208779|epidemiology|epidemiology
1389286|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
1389287|NCT01208753|Safety|safety
1389288|NCT01208753|Tolerability|tolerability
1389289|NCT01208753|Pharmacokinetics|pharmacokinetics
1389290|NCT01208740|Gonadotropins|gonadotropins
1389291|NCT01208740|infertility|infertility
1389293|NCT01208740|metformin|metformin
1389294|NCT01208740|PCOS|pcos
1389295|NCT01208740|poor prognosis|poor prognosis
1389296|NCT01208740|poor responder|poor responder
1389297|NCT01208727|Myocardial infarction|myocardial infarction
1389298|NCT01208727|Postconditioning|postconditioning
1389299|NCT01208727|Microvascular obstruction|microvascular obstruction
1389300|NCT01208727|No reflow|no reflow
1389301|NCT01208727|MRI|mri
1389302|NCT01208714|Renal artery stenosis|renal artery stenosis
1389303|NCT01208714|Atherosclerosis|atherosclerosis
1389304|NCT01208714|Arterial hypertension|arterial hypertension
1389305|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
1389306|NCT01208714|Stenting|stenting
1389307|NCT01208701|Atorvastatin|atorvastatin
1389309|NCT01208701|NO|no
1389310|NCT01208701|Nephrology|nephrology
1389311|NCT01208701|Diabetes Mellitus|diabetes mellitus
1389312|NCT01208688|Spinal Cord Injuries|spinal cord injuries
1389313|NCT01208662|Lenalidomide|lenalidomide
1389314|NCT01208662|Bortezomib|bortezomib
1389315|NCT01208662|Dexamethasone|dexamethasone
1389316|NCT01208662|Stem Cell Transplant|stem cell transplant
1389317|NCT01208662|Myeloma|myeloma
1389318|NCT01208662|Multiple Myeloma|multiple myeloma
1389319|NCT01208649|exenatide|exenatide
1389320|NCT01208649|hepatic steatosis|hepatic steatosis
1389321|NCT01208649|insulin resistance|insulin resistance
1389322|NCT01208649|insulin sensitizers|insulin sensitizers
1389323|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1389324|NCT01208649|- GLP1-Analog|- glp1-analog
1389325|NCT01208636|Vitamin D deficiency|vitamin d deficiency
1389326|NCT01208636|Sun|sun
1389327|NCT01208636|Genetics|genetics
1389328|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
1389329|NCT01208571|Harmful use|harmful use
1389330|NCT01208571|Hazardous use|hazardous use
1389331|NCT01208571|Dependence|dependence
1389332|NCT01208558|Blood pressure|blood pressure
1389334|NCT01208558|Diet Therapy|diet therapy
1389335|NCT01208558|Dietary carbohydrates|dietary carbohydrates
1389336|NCT01208558|Dietary fiber|dietary fiber
1389337|NCT01208558|Exercise Therapy|exercise therapy
1389338|NCT01208558|Food|food
1389339|NCT01208558|Glucose intolerance|glucose intolerance
1389340|NCT01208558|Lifestyle|lifestyle
1389341|NCT01208558|Physiotherapy|physiotherapy
1389342|NCT01208558|Stroke|stroke
1389343|NCT01208558|TIA|tia
1389344|NCT01208558|Waist circumference|waist circumference
1389345|NCT01208558|Weight loss|weight loss
1389346|NCT01208545|taxol|taxol
1389347|NCT01208545|vincristine|vincristine
1389348|NCT01208545|oxaliplatin|oxaliplatin
1389349|NCT01208545|chemotherapy|chemotherapy
1389350|NCT01208545|nerve degeneration|nerve degeneration
1389351|NCT01208545|nerve conduction|nerve conduction
1389352|NCT01208545|cancer|cancer
1389353|NCT01208545|nerve conduction studies|nerve conduction studies
1389354|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
1389355|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1389357|NCT01208519|Colonisation|colonisation
1389358|NCT01208519|Screening|screening
1389359|NCT01208519|Gram-negative|gram-negative
1389360|NCT01208493|prematurity|prematurity
1389361|NCT01208493|enteral feeding|enteral feeding
1389362|NCT01208493|proteins|proteins
1389363|NCT01208493|formula|formula
1389364|NCT01208480|stage II breast cancer|stage ii breast cancer
1389365|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
1389366|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
1389367|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
1389368|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
1389369|NCT01208428|Depression|depression
1389370|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
1389371|NCT01208415|iliac aneurysm|iliac aneurysm
1389372|NCT01208415|branch|branch
1389373|NCT01208415|connections|connections
1389374|NCT01208415|endovascular graft|endovascular graft
1389375|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
1389376|NCT01208415|Aneurysm|aneurysm
1389377|NCT01208415|Vascular Diseases|vascular diseases
1389378|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
1389379|NCT01208363|Iron fortification|iron fortification
1389380|NCT01208363|polyphenols|polyphenols
1389381|NCT01208363|NaFeEDTA|nafeedta
1389382|NCT01208363|cowpea|cowpea
1389383|NCT01208363|school feeding program|school feeding program
1389384|NCT01208350|Weight Loss|weight loss
1389385|NCT01208350|Motivation|motivation
1389386|NCT01208350|Workplace|workplace
1389387|NCT01208350|Web platform|web platform
1389388|NCT01208337|Rejection|rejection
1389389|NCT01208324|Cognitive difficulties|cognitive difficulties
1389390|NCT01208324|memory impairment|memory impairment
1389391|NCT01208324|mood changes|mood changes
1389392|NCT01208324|brain activation|brain activation
1389393|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
1389394|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
1389395|NCT01208311|cirrhosis|cirrhosis
1389396|NCT01208298|Cold Sore Patch|cold sore patch
1389397|NCT01208272|Body Mass Index|body mass index
1389398|NCT01208272|Bulimia/therapy|bulimia/therapy
1389399|NCT01208272|Comorbidity|comorbidity
1389400|NCT01208272|Interpersonal Relations|interpersonal relations
1389401|NCT01208272|Psychotherapy/methods|psychotherapy/methods
1389402|NCT01208259|Body Mass Index|body mass index
1389403|NCT01208259|Bulimia/therapy|bulimia/therapy
1389404|NCT01208259|Comorbidity|comorbidity
1389405|NCT01208259|Interpersonal Relations|interpersonal relations
1389406|NCT01208259|Psychotherapy/methods|psychotherapy/methods
1389407|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
1389408|NCT01208220|Collagenase Santyl|collagenase santyl
1389409|NCT01208220|Enzymatic debridement|enzymatic debridement
1389410|NCT01208220|maintenance debridement|maintenance debridement
1389411|NCT01208220|VAC|vac
1389412|NCT01208220|NPWT|npwt
1389413|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
1389414|NCT01208194|Maintenance therapy|maintenance therapy
1389415|NCT01208194|Immunomodulator|immunomodulator
1389416|NCT01208168|toenail fungus|toenail fungus
1389417|NCT01208168|onychomycosis|onychomycosis
1389418|NCT01208168|nail infection|nail infection
1389419|NCT01208155|Phase 1|phase 1
1389420|NCT01208155|Healthy|healthy
1389421|NCT01208155|pharmacokinetics|pharmacokinetics
1389422|NCT01208155|Fostamatinib|fostamatinib
1389423|NCT01208142|toe walker|toe walker
1389424|NCT01208142|Pediatric toe walking|pediatric toe walking
1389425|NCT01208142|ankle flexion|ankle flexion
1389426|NCT01208129|toenail fungus|toenail fungus
1389427|NCT01208129|onychomycosis|onychomycosis
1389428|NCT01208129|nail infection|nail infection
1389429|NCT01208116|Atherosclerosis|atherosclerosis
1389430|NCT01208116|Prognosis|prognosis
1389431|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
1389432|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
1389433|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
1389434|NCT01208116|coronary artery calcification score|coronary artery calcification score
1389435|NCT01208116|Ankle-brachial index|ankle-brachial index
1389436|NCT01208103|Cancer|cancer
1389437|NCT01208103|Small bowel|small bowel
1389438|NCT01208103|Ampulla of Vater|ampulla of vater
1389439|NCT01208103|CAPOX Chemotherapy|capox chemotherapy
1389440|NCT01208103|Bevacizumab|bevacizumab
1389441|NCT01208103|Capecitabine|capecitabine
1389442|NCT01208103|Oxaliplatin|oxaliplatin
1389443|NCT01208103|Xeloda|xeloda
1389444|NCT01208103|Eloxatin|eloxatin
1389445|NCT01208103|Avastin|avastin
1389446|NCT01208103|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1389447|NCT01208103|rhuMab-VEGF|rhumab-vegf
1389448|NCT01208090|psoriasis|psoriasis
1389449|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
1389450|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
1389451|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
1389452|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
1389453|NCT01208077|Acute CHF|acute chf
1389454|NCT01208077|Stroke syndromes|stroke syndromes
1389455|NCT01208077|Systemic infection|systemic infection
1389456|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
1389457|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1389458|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1389459|NCT01208064|large cell lung cancer|large cell lung cancer
1389460|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1389461|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1389462|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1389463|NCT01208025|Plaque|plaque
1389464|NCT01208025|Imaging|imaging
1389465|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
1389466|NCT01207999|Human papillomavirus|human papillomavirus
1389467|NCT01207960|dental phobia|dental phobia
1389468|NCT01207960|psychotherapy|psychotherapy
1389469|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
1389470|NCT01207960|efficacy|efficacy
1389471|NCT01207960|wait-list control|wait-list control
1389472|NCT01207947|Vardenafil|vardenafil
1389473|NCT01207947|Erectile dysfunction|erectile dysfunction
1389474|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1389475|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
1389476|NCT01207934|diabetes|diabetes
1389477|NCT01207934|obesity|obesity
1389478|NCT01207908|DMD|dmd
1389479|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1389480|NCT01207908|Insulin like growth factor|insulin like growth factor
1389481|NCT01207908|6 minute walk test|6 minute walk test
1389482|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
1389483|NCT01207869|Extremely premature infant|extremely premature infant
1389484|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
1389485|NCT01207869|umbilical cord|umbilical cord
1389486|NCT01207856|Multiple sclerosis|multiple sclerosis
1389487|NCT01207856|functional MRI|functional mri
1389488|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
1389489|NCT01207856|ecological evaluation|ecological evaluation
1389490|NCT01207856|neuroplasticity|neuroplasticity
1389491|NCT01207843|Computed tomography|computed tomography
1389492|NCT01207830|Obesity|obesity
1389493|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
1389494|NCT01207804|Obesity|obesity
1389495|NCT01207791|drug abuse|drug abuse
1389496|NCT01207791|emergency department|emergency department
1389497|NCT01207791|brief intervention|brief intervention
1389498|NCT01207791|motivational interviewing|motivational interviewing
1389499|NCT01207791|SBIRT|sbirt
1389500|NCT01207778|brain|brain
1389501|NCT01207778|development|development
1389502|NCT01207778|erythropoietin|erythropoietin
1389503|NCT01207778|neuroprotection|neuroprotection
1389504|NCT01207778|MRI|mri
1389505|NCT01207765|Multiple Myeloma|multiple myeloma
1389506|NCT01207765|Zevalin|zevalin
1389507|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
1389508|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
1389509|NCT01207739|Doxycycline|doxycycline
1389510|NCT01207739|Clarithromycin|clarithromycin
1389511|NCT01207739|Hydroxychloroquine|hydroxychloroquine
1389512|NCT01207700|post discharge intervention|post discharge intervention
1389513|NCT01207700|adherence|adherence
1389514|NCT01207700|compliance|compliance
1389515|NCT01207700|community health worker|community health worker
1389516|NCT01207674|Pathological gambling|pathological gambling
1389517|NCT01207674|"at risk gambling"|"at risk gambling"
1389518|NCT01207674|gambling practice evolution|gambling practice evolution
1389519|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
1389520|NCT01207674|gambling trajectory|gambling trajectory
1389521|NCT01207674|cognitive distortions|cognitive distortions
1389522|NCT01207674|ADHD|adhd
1389523|NCT01207674|addiction|addiction
1389524|NCT01207674|recourse to care|recourse to care
1389525|NCT01207661|Mesenchymal cells|mesenchymal cells
1389526|NCT01207661|osteoarthritis|osteoarthritis
1389527|NCT01207661|intra articular injection|intra articular injection
1389528|NCT01207648|Interferon beta 1a|interferon beta 1a
1389529|NCT01207648|Autoimmune Diseases|autoimmune diseases
1389530|NCT01207648|Demyelinating Diseases|demyelinating diseases
1389531|NCT01207648|Immune System Diseases|immune system diseases
1389532|NCT01207648|Immunologic Factors|immunologic factors
1389533|NCT01207648|Nervous System Diseases|nervous system diseases
1389534|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
1389535|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
1389536|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
1389537|NCT01207648|Retrospective Cohort Study|retrospective cohort study
1389538|NCT01207635|Cancer|cancer
1389539|NCT01207635|Arimidex|arimidex
1389540|NCT01207609|Obesity|obesity
1389541|NCT01207609|Morbid Obesity|morbid obesity
1389542|NCT01207609|Bariatric Surgery|bariatric surgery
1389543|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
1389544|NCT01207596|Pain|pain
1389545|NCT01207596|Neuropathy|neuropathy
1389546|NCT01207596|Neuropathic Pain|neuropathic pain
1389547|NCT01207596|Hydromorphone|hydromorphone
1389549|NCT01207583|infant|infant
1389550|NCT01207583|healthy subjects|healthy subjects
1389551|NCT01207570|flexibility|flexibility
1389552|NCT01207570|muscle|muscle
1389553|NCT01207570|stretching|stretching
1389554|NCT01207570|cerebral palsy|cerebral palsy
1389555|NCT01207570|developmental|developmental
1389556|NCT01207557|Healthcare personnel|healthcare personnel
1389557|NCT01207557|influenza|influenza
1389558|NCT01207557|immunization|immunization
1389559|NCT01207557|flu|flu
1389560|NCT01207557|vaccine|vaccine
1389561|NCT01207544|motor|motor
1389562|NCT01207544|balance|balance
1389563|NCT01207544|developmental|developmental
1389564|NCT01207544|physiotherapy|physiotherapy
1389565|NCT01207531|sepsis|sepsis
1389566|NCT01207531|miRNA|mirna
1389567|NCT01207518|influenza|influenza
1389568|NCT01207518|immunization|immunization
1389569|NCT01207518|healthcare personnel|healthcare personnel
1389570|NCT01207505|bipolar disorder|bipolar disorder
1389571|NCT01207505|depression|depression
1389572|NCT01207505|mania|mania
1389573|NCT01207505|emotion regulation|emotion regulation
1389574|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
1389575|NCT01207505|group therapy|group therapy
1389576|NCT01207505|mindfulness|mindfulness
1389577|NCT01207492|nilotinib|nilotinib
1389578|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
1389579|NCT01207453|Milnacipran|milnacipran
1389580|NCT01207453|Pain|pain
1389581|NCT01207440|CML|cml
1389582|NCT01207440|ALL|all
1389583|NCT01207440|PH|ph
1389584|NCT01207440|ponatinib|ponatinib
1389585|NCT01207440|Ph+ALL|ph+all
1389586|NCT01207440|T315I mutation|t315i mutation
1389587|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
1389588|NCT01207427|opioid therapy|opioid therapy
1389589|NCT01207427|constipation|constipation
1389590|NCT01207427|chronic noncancer pain|chronic noncancer pain
1389591|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
1389592|NCT01207427|ADL5945|adl5945
1389593|NCT01207414|Schizophrenia|schizophrenia
1389594|NCT01207414|iloperidone|iloperidone
1389595|NCT01207414|switch|switch
1389596|NCT01207414|gradual switch|gradual switch
1389597|NCT01207414|immediate switch|immediate switch
1389598|NCT01207401|intrauterine device|intrauterine device
1389599|NCT01207401|local anesthetic|local anesthetic
1389600|NCT01207388|Blinatumomab|blinatumomab
1389601|NCT01207388|MRD|mrd
1389602|NCT01207388|B-ALL|b-all
1389603|NCT01207388|Minimal residual disease|minimal residual disease
1389604|NCT01207388|adult ALL|adult all
1389605|NCT01207388|Leukemia|leukemia
1389606|NCT01207388|ALL|all
1389607|NCT01207388|Lymphatic diseases|lymphatic diseases
1389608|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
1389609|NCT01207388|bispecific antibody|bispecific antibody
1389610|NCT01207388|anti-CD19|anti-cd19
1389611|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
1389612|NCT01207375|memory|memory
1389613|NCT01207375|learning|learning
1389614|NCT01207375|Traumatic Brain Injury|traumatic brain injury
1389615|NCT01207375|cognition|cognition
1389616|NCT01207375|treatment|treatment
1389617|NCT01207375|therapy|therapy
1389618|NCT01207349|Type 2 diabetes|type 2 diabetes
1389619|NCT01207349|Secondary prevention|secondary prevention
1389620|NCT01207349|Physical activity|physical activity
1389621|NCT01207349|Nutritional education|nutritional education
1389622|NCT01207349|HbA1c|hba1c
1389623|NCT01207349|Reunion island|reunion island
1389720|NCT01206842|functional capacity|functional capacity
1389721|NCT01206842|training|training
1389722|NCT01206842|neurocognition|neurocognition
1389624|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
1389625|NCT01207336|stroke|stroke
1389626|NCT01207336|rehabilitation|rehabilitation
1389627|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
1389628|NCT01207336|nerve stimulation|nerve stimulation
1389629|NCT01207310|smoking|smoking
1389630|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
1389631|NCT01207297|Lupus nephritis|lupus nephritis
1389632|NCT01207297|tacrolimus|tacrolimus
1389633|NCT01207297|cyclophosphamide|cyclophosphamide
1389634|NCT01207271|depression|depression
1389635|NCT01207271|community mental health|community mental health
1389636|NCT01207271|treatment|treatment
1389637|NCT01207271|psychotherapy|psychotherapy
1389638|NCT01207271|mediators|mediators
1389639|NCT01207258|Motivational Interviewing|motivational interviewing
1389640|NCT01207258|Brief Intervention|brief intervention
1389641|NCT01207258|Intimate Partner Violence|intimate partner violence
1389642|NCT01207258|Domestic Violence|domestic violence
1389643|NCT01207258|Alcohol Abuse|alcohol abuse
1389644|NCT01207245|Cystic fibrosis|cystic fibrosis
1389645|NCT01207245|Tobramycin|tobramycin
1389646|NCT01207245|Pharmacokinetics|pharmacokinetics
1389647|NCT01207245|Toxicity|toxicity
1389648|NCT01207232|seasonal influenza|seasonal influenza
1389649|NCT01207232|behavioral economics|behavioral economics
1389650|NCT01207232|implementation intentions|implementation intentions
1389651|NCT01207232|planning prompt|planning prompt
1389652|NCT01207232|nudge|nudge
1389653|NCT01207219|psychosis|psychosis
1389654|NCT01207219|yoga|yoga
1389655|NCT01207219|aerobic exercise|aerobic exercise
1389656|NCT01207219|memory|memory
1389657|NCT01207219|attention|attention
1389658|NCT01207219|neuro cognition|neuro cognition
1389659|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
1389660|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
1389661|NCT01207206|Severe opiate side effects|severe opiate side effects
1389662|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
1389663|NCT01207180|emergency medicine|emergency medicine
1389664|NCT01207180|primary care physicians|primary care physicians
1389665|NCT01207141|Liver Transplantation|liver transplantation
1389666|NCT01207141|Thymoglobulin|thymoglobulin
1389667|NCT01207141|Rejection|rejection
1389668|NCT01207102|Breast cancer|breast cancer
1389669|NCT01207102|Triple negative|triple negative
1389670|NCT01207089|Safety|safety
1389671|NCT01207089|tolerability|tolerability
1389673|NCT01207089|healthy|healthy
1389674|NCT01207089|overweight|overweight
1389675|NCT01207089|obese|obese
1389676|NCT01207076|CD45+ disease|cd45+ disease
1389677|NCT01207063|Radiotherapy|radiotherapy
1389678|NCT01207063|NSCLC|nsclc
1389679|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
1389680|NCT01207050|sleep disorders|sleep disorders
1389681|NCT01207050|traumatic brain injury|traumatic brain injury
1389682|NCT01207024|knee arthrosis|knee arthrosis
1389683|NCT01207024|obesity|obesity
1389684|NCT01207024|MRI|mri
1389685|NCT01207024|bariatric surgery|bariatric surgery
1389686|NCT01206998|preterm labor|preterm labor
1389687|NCT01206998|progesterone|progesterone
1389688|NCT01206998|tocolysis|tocolysis
1389689|NCT01206998|cervical length|cervical length
1389690|NCT01206985|Paracetamol|paracetamol
1389691|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
1389692|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
1389693|NCT01206972|venous thromboembolism|venous thromboembolism
1389694|NCT01206972|prevention|prevention
1389695|NCT01206972|orthopaedic surgery|orthopaedic surgery
1389696|NCT01206959|BP|bp
1389697|NCT01206946|Respiratory distress|respiratory distress
1389698|NCT01206946|Antenatal steroids|antenatal steroids
1389699|NCT01206946|late preterm|late preterm
1389700|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
1389701|NCT01206933|Tat Protein|tat protein
1389702|NCT01206933|HCV|hcv
1389703|NCT01206920|HIV|hiv
1389704|NCT01206920|AIDS|aids
1389705|NCT01206920|Co-morbidities|co-morbidities
1389706|NCT01206907|sickle cell anemia|sickle cell anemia
1389707|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1389708|NCT01206907|burn victim|burn victim
1389709|NCT01206907|cancer|cancer
1389710|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
1389711|NCT01206894|lung cancer|lung cancer
1389712|NCT01206894|chest wall invasion|chest wall invasion
1389713|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
1389714|NCT01206881|breast cancer|breast cancer
1389715|NCT01206881|neoadjuvant|neoadjuvant
1389716|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
1389717|NCT01206881|PET scan|pet scan
1389718|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
1389719|NCT01206855|MIST Therapy|mist therapy
1390018|NCT01205451|spasticity|spasticity
1389723|NCT01206829|Hearing Impaired Persons|hearing impaired persons
1389724|NCT01206829|Tinnitus|tinnitus
1389725|NCT01206829|Life Change Events|life change events
1389726|NCT01206829|Adaptation, Psychological|adaptation, psychological
1389727|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
1389728|NCT01206829|Cognitive Therapy|cognitive therapy
1389729|NCT01206829|Avoidance Learning|avoidance learning
1389730|NCT01206829|Escape Reaction|escape reaction
1389731|NCT01206803|ovarian stimulation|ovarian stimulation
1389732|NCT01206803|recombinant FSH|recombinant fsh
1389733|NCT01206803|GnRH-antagonist|gnrh-antagonist
1389734|NCT01206803|corifollitropin alfa|corifollitropin alfa
1389735|NCT01206790|PTSD|ptsd
1389736|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
1389737|NCT01206790|torture victims|torture victims
1389738|NCT01206790|immune system|immune system
1389739|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
1389740|NCT01206777|B-cell malignancies|b-cell malignancies
1389741|NCT01206764|RCC,|rcc,
1389742|NCT01206764|mTOR pathway,|mtor pathway,
1389743|NCT01206764|angiogenesis,|angiogenesis,
1389744|NCT01206764|PFS,|pfs,
1389745|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
1389746|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
1389747|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
1389748|NCT01206725|Diabetes type 2|diabetes type 2
1389749|NCT01206725|exercise|exercise
1389750|NCT01206725|tissue Doppler velocity|tissue doppler velocity
1389751|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
1389752|NCT01206712|insulin glargine|insulin glargine
1389753|NCT01206712|Metformin|metformin
1389754|NCT01206686|seasonal influenza|seasonal influenza
1389755|NCT01206686|behavioral economics|behavioral economics
1389756|NCT01206686|nudge|nudge
1389757|NCT01206686|implementations intentions|implementations intentions
1389758|NCT01206686|vaccination|vaccination
1389759|NCT01206621|dyspnea|dyspnea
1389760|NCT01206621|COPD|copd
1389761|NCT01206621|CHF|chf
1389762|NCT01206621|asthma|asthma
1389763|NCT01206608|Breast augmentation|breast augmentation
1389764|NCT01206608|Pain|pain
1389765|NCT01206608|Analgesia|analgesia
1389766|NCT01206595|Postoperative Pain|postoperative pain
1389767|NCT01206595|Bunionectomy|bunionectomy
1389768|NCT01206595|Analgesia|analgesia
1389769|NCT01206569|glomerulonephritis|glomerulonephritis
1389770|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
1389771|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
1389772|NCT01206556|HPV|hpv
1389773|NCT01206543|Craniopharyngioma|craniopharyngioma
1389774|NCT01206543|Surgery|surgery
1389775|NCT01206543|Intraoperative imaging|intraoperative imaging
1389776|NCT01206543|Rate of total removal|rate of total removal
1389777|NCT01206530|histologically documented|histologically documented
1389778|NCT01206530|advanced|advanced
1389779|NCT01206530|metastatic|metastatic
1389780|NCT01206530|adenocarcinoma|adenocarcinoma
1389781|NCT01206530|colon|colon
1389782|NCT01206530|rectum|rectum
1389783|NCT01206517|asenapine|asenapine
1389784|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
1389785|NCT01206517|bipolar I disorder|bipolar i disorder
1389786|NCT01206504|West Nile virus|west nile virus
1389787|NCT01206504|WNV|wnv
1389788|NCT01206504|Encephalitis|encephalitis
1389789|NCT01206504|Meningitis|meningitis
1389790|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
1389791|NCT01206504|Monoclonal Antibody|monoclonal antibody
1389792|NCT01206504|WNND|wnnd
1389793|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
1389794|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
1389795|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
1389796|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
1389797|NCT01206413|overweight; treatment; women|overweight; treatment; women
1389798|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
1389799|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
1389800|NCT01206361|Real world|real world
1389801|NCT01206361|observational|observational
1389802|NCT01206361|retrospective|retrospective
1389803|NCT01206361|database analysis|database analysis
1389804|NCT01206348|Acne|acne
1389805|NCT01206335|Cancer Cachexia|cancer cachexia
1389806|NCT01206335|Anorexia|anorexia
1389807|NCT01206335|Advanced Malignancies|advanced malignancies
1389808|NCT01206335|Weight Loss|weight loss
1389809|NCT01206335|Fatigue|fatigue
1389810|NCT01206335|Karnofsky|karnofsky
1389811|NCT01206335|C-Reactive Protein|c-reactive protein
1389812|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
1389813|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
1389814|NCT01206309|Graft vs Host Disease|graft vs host disease
1389815|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1389816|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
1389817|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1389915|NCT01205971|Randomized clinical trial|randomized clinical trial
1389818|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
1389819|NCT01206296|Adjuvant|adjuvant
1389820|NCT01206296|Intraperitoneal|intraperitoneal
1389821|NCT01206296|Gemcitabine|gemcitabine
1389822|NCT01206296|Pancreas|pancreas
1389823|NCT01206296|Adenocarcinoma|adenocarcinoma
1389921|NCT01205958|needle|needle
1389824|NCT01206283|traumatic brain injury|traumatic brain injury
1389825|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
1389826|NCT01206283|secondary brain ischemia|secondary brain ischemia
1389827|NCT01206283|microdialysis|microdialysis
1389828|NCT01206283|modified Lund concept|modified lund concept
1389829|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
1389830|NCT01206283|intracranial pressure|intracranial pressure
1389831|NCT01206270|Klinefelter|klinefelter
1389832|NCT01206270|Leydig|leydig
1389833|NCT01206270|Testicular Tumor|testicular tumor
1389834|NCT01206270|LH|lh
1389835|NCT01206270|Infertility|infertility
1389836|NCT01206257|Survey|survey
1389837|NCT01206257|Angiography|angiography
1389838|NCT01206257|ADR|adr
1389839|NCT01206257|Image quality|image quality
1389840|NCT01206244|dry eye|dry eye
1389841|NCT01206244|tear meniscus|tear meniscus
1389842|NCT01206244|tear osmolarity|tear osmolarity
1389843|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
1389844|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
1389845|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
1389846|NCT01206205|Bortezomib|bortezomib
1389847|NCT01206205|Lenalidomide|lenalidomide
1389848|NCT01206205|induction therapy|induction therapy
1389849|NCT01206205|consolidation therapy|consolidation therapy
1389850|NCT01206205|maintenance therapy|maintenance therapy
1389851|NCT01206205|High dose therapy|high dose therapy
1389852|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
1389853|NCT01206192|Intimate Terrorism|intimate terrorism
1389854|NCT01206192|Situational couple violence|situational couple violence
1389855|NCT01206192|Mental health|mental health
1389857|NCT01206192|Women|women
1389858|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
1389859|NCT01206166|Randomized trial|randomized trial
1389860|NCT01206166|Parental nutrition|parental nutrition
1389861|NCT01206166|Enteral nutrition|enteral nutrition
1389862|NCT01206166|Intensive care unit|intensive care unit
1389863|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
1389864|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
1389865|NCT01206114|vaccination|vaccination
1389866|NCT01206114|pandemic|pandemic
1389867|NCT01206114|effectiveness|effectiveness
1389868|NCT01206075|Beta Thalassemia Major|beta thalassemia major
1389869|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
1389870|NCT01206075|Gene Transfer Techniques|gene transfer techniques
1389871|NCT01206062|blood pressure|blood pressure
1389872|NCT01206062|antihypertensive|antihypertensive
1389873|NCT01206062|systolic|systolic
1389874|NCT01206062|diastolic|diastolic
1389875|NCT01206062|heart failure|heart failure
1389876|NCT01206062|myocardial infarction|myocardial infarction
1389877|NCT01206062|stroke|stroke
1389878|NCT01206062|chronic kidney disease|chronic kidney disease
1389879|NCT01206062|dementia|dementia
1389880|NCT01206062|cognitive decline|cognitive decline
1389881|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
1389882|NCT01206049|Inoperable|inoperable
1389883|NCT01206049|KRAS mutation|kras mutation
1389884|NCT01206049|Biological treatment|biological treatment
1389885|NCT01206049|Combination chemotherapy|combination chemotherapy
1389886|NCT01206049|Monoclonal antibody|monoclonal antibody
1389887|NCT01206036|castration|castration
1389888|NCT01206036|prostate cancer|prostate cancer
1389889|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
1389890|NCT01206036|PSA|psa
1389891|NCT01206036|Docetaxel|docetaxel
1389892|NCT01206036|Temsirolimus|temsirolimus
1389893|NCT01206036|disease progression free survival|disease progression free survival
1389894|NCT01206036|DPFS|dpfs
1389895|NCT01206036|dose escalation|dose escalation
1389896|NCT01206023|Multiple Sclerosis|multiple sclerosis
1389897|NCT01206023|Breath|breath
1389898|NCT01206023|Diagnosis|diagnosis
1389899|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
1389900|NCT01206010|Tobacco Dependence|tobacco dependence
1389901|NCT01206010|Smoking cessation|smoking cessation
1389902|NCT01206010|Varenicline|varenicline
1389903|NCT01206010|Tailored dosing|tailored dosing
1389904|NCT01205997|magnesium|magnesium
1389905|NCT01205997|fentanyl|fentanyl
1389906|NCT01205997|intrathecal|intrathecal
1389907|NCT01205997|pain|pain
1389908|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
1389909|NCT01205984|Computed tomography scan|computed tomography scan
1389910|NCT01205984|Methylprednisolone|methylprednisolone
1389911|NCT01205971|Motivational interviewing|motivational interviewing
1389912|NCT01205971|Community-based multimodal intervention|community-based multimodal intervention
1389913|NCT01205971|Dental Health Advocates|dental health advocates
1389914|NCT01205971|Prevention of ECC|prevention of ecc
1389916|NCT01205958|Cervical pain|cervical pain
1389917|NCT01205958|Neck pain|neck pain
1389918|NCT01205958|western medicine|western medicine
1389919|NCT01205958|oriental medicine|oriental medicine
1389920|NCT01205958|acupuncture|acupuncture
1389922|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
1389923|NCT01205945|Screening|screening
1389924|NCT01205945|Mortality|mortality
1389925|NCT01205932|venous thromboembolism|venous thromboembolism
1389926|NCT01205932|prevention|prevention
1389927|NCT01205932|othopaedic surgery|othopaedic surgery
1389928|NCT01205919|Tinnitus|tinnitus
1389929|NCT01205919|Internet Training|internet training
1389930|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
1389931|NCT01205919|CBT|cbt
1389932|NCT01205906|Tinnitus|tinnitus
1389933|NCT01205906|Internet Training|internet training
1389934|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
1389935|NCT01205906|CBT|cbt
1389936|NCT01205880|combination treatment|combination treatment
1389937|NCT01205880|topical corticosteroid|topical corticosteroid
1389938|NCT01205880|vitamin D analogue|vitamin d analogue
1389939|NCT01205880|clobex|clobex
1389940|NCT01205880|vectical|vectical
1389941|NCT01205880|clobetasol|clobetasol
1389942|NCT01205880|calcitriol|calcitriol
1389943|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
1389944|NCT01205867|tolerability|tolerability
1389945|NCT01205867|safety|safety
1389946|NCT01205867|AZD8848|azd8848
1389947|NCT01205867|pharmacokinetics|pharmacokinetics
1389948|NCT01205867|pharmacodynamics|pharmacodynamics
1389949|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
1389950|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
1389951|NCT01205854|ultrasonography|ultrasonography
1389952|NCT01205854|remission|remission
1389953|NCT01205854|imaging remission|imaging remission
1389954|NCT01205854|tight control|tight control
1389955|NCT01205854|treat to target|treat to target
1389956|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
1389957|NCT01205841|Buffalo Rule|buffalo rule
1389958|NCT01205841|Bernese Ankle Rules|bernese ankle rules
1389959|NCT01205841|Low Risk Exam|low risk exam
1389960|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
1389961|NCT01205841|Clinical decision rule|clinical decision rule
1389962|NCT01205841|Ankle injury|ankle injury
1389963|NCT01205841|Ankle sprain|ankle sprain
1389964|NCT01205841|Inversion trauma|inversion trauma
1389965|NCT01205828|liver cancer|liver cancer
1389966|NCT01205828|hepatocellular|hepatocellular
1389967|NCT01205828|temozolomide|temozolomide
1389968|NCT01205828|veliparib|veliparib
1389969|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
1389970|NCT01205789|Drug eluting stents|drug eluting stents
1389971|NCT01205789|Stents|stents
1389972|NCT01205789|Angioplasty|angioplasty
1389973|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
1389974|NCT01205776|Drug eluting stents|drug eluting stents
1389975|NCT01205776|Stents|stents
1389976|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
1389977|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1389978|NCT01205737|DLBCL|dlbcl
1389979|NCT01205737|pharmacokinetics|pharmacokinetics
1389980|NCT01205737|pharmacodynamics|pharmacodynamics
1389981|NCT01205711|recurrent colon cancer|recurrent colon cancer
1389982|NCT01205711|stage IV colon cancer|stage iv colon cancer
1389983|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
1389984|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
1389985|NCT01205672|Endometrium|endometrium
1389986|NCT01205672|Gynecologic malignancy|gynecologic malignancy
1389987|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
1389988|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
1389989|NCT01205672|Metformin|metformin
1389990|NCT01205646|prostate cancer|prostate cancer
1389991|NCT01205646|metastatic|metastatic
1389992|NCT01205646|zoledronate|zoledronate
1389993|NCT01205646|zometa|zometa
1389994|NCT01205633|neurodegenerative disease|neurodegenerative disease
1389995|NCT01205633|neurovascular disease|neurovascular disease
1389996|NCT01205633|fatigue|fatigue
1389997|NCT01205633|Hubbard Foundation|hubbard foundation
1389998|NCT01205633|angioplasty|angioplasty
1389999|NCT01205620|CABG|cabg
1390000|NCT01205607|traumatic brain injury|traumatic brain injury
1390001|NCT01205594|CABG surgery|cabg surgery
1390002|NCT01205581|Fluzone|fluzone
1390003|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
1390004|NCT01205555|intra uterine insemination|intra uterine insemination
1390005|NCT01205529|Atrial Fibrillation|atrial fibrillation
1390006|NCT01205529|ST elevation|st elevation
1390007|NCT01205529|Genotype|genotype
1390008|NCT01205503|chemobrain|chemobrain
1390009|NCT01205503|Oxidative Stress|oxidative stress
1390010|NCT01205503|Mesna|mesna
1390011|NCT01205477|Anserine bursitis|anserine bursitis
1390012|NCT01205464|Persistent symptoms|persistent symptoms
1390013|NCT01205464|Doxycycline|doxycycline
1390014|NCT01205464|Placebo|placebo
1390015|NCT01205464|Neuroborreliosis|neuroborreliosis
1390016|NCT01205451|GSK1358820|gsk1358820
1390019|NCT01205451|post-stroke|post-stroke
1390021|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
1390022|NCT01205438|Lupus|lupus
1390023|NCT01205438|autoimmune disease|autoimmune disease
1390024|NCT01205438|LY2127399|ly2127399
1390025|NCT01205438|Immune System Disease|immune system disease
1390026|NCT01205425|Computed coronary angiography|computed coronary angiography
1390027|NCT01205425|Stent implantation|stent implantation
1390028|NCT01205425|IVUS|ivus
1390029|NCT01205386|CTO|cto
1390030|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
1390031|NCT01205386|PAOD|paod
1390032|NCT01205386|SFA|sfa
1390033|NCT01205386|superficial femoral artery|superficial femoral artery
1390034|NCT01205360|Analgesia, labour;|analgesia, labour;
1390035|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
1390036|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
1390037|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
1390038|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
1390039|NCT01205347|Statin|statin
1390040|NCT01205347|Myocardial infarction|myocardial infarction
1390041|NCT01205347|Insulin sensitivity|insulin sensitivity
1390042|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
1390043|NCT01205334|GBM|gbm
1390044|NCT01205334|Brain Cancer|brain cancer
1390045|NCT01205334|CTL|ctl
1390046|NCT01205321|Neoplasm|neoplasm
1390047|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
1390048|NCT01205321|PET tracer|pet tracer
1390049|NCT01205308|Plant stanols|plant stanols
1390050|NCT01205308|type 1 diabetes|type 1 diabetes
1390051|NCT01205308|sterol metabolism|sterol metabolism
1390052|NCT01205308|cholesterol|cholesterol
1390053|NCT01205295|hip|hip
1390054|NCT01205295|shoulder|shoulder
1390055|NCT01205295|mental disorders|mental disorders
1390056|NCT01205295|anxiety|anxiety
1390057|NCT01205295|concern|concern
1390058|NCT01205295|efficacy of treatment|efficacy of treatment
1390059|NCT01205282|ASD|asd
1390060|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1390061|NCT01205269|safety|safety
1390062|NCT01205269|inhalation|inhalation
1390063|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
1390064|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
1390065|NCT01205243|Abacavir|abacavir
1390066|NCT01205243|post-marketing surveillance|post-marketing surveillance
1390067|NCT01205230|Esomeprazole|esomeprazole
1390068|NCT01205230|Pharmacogenetics|pharmacogenetics
1390069|NCT01205230|Pharmacokinetics|pharmacokinetics
1390070|NCT01205230|Ketoconazole|ketoconazole
1390071|NCT01205230|Pazopanib|pazopanib
1390072|NCT01205230|Drug Interaction|drug interaction
1390073|NCT01205230|Safety|safety
1390074|NCT01205230|Solid Tumors|solid tumors
1390075|NCT01205217|lapatinib|lapatinib
1390076|NCT01205217|epirubicin|epirubicin
1390077|NCT01205217|cyclophosphamide|cyclophosphamide
1390078|NCT01205217|trastuzumab|trastuzumab
1390079|NCT01205217|paclitaxel|paclitaxel
1390080|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
1390081|NCT01205217|Breast Cancer|breast cancer
1390082|NCT01205204|Clonidine|clonidine
1390083|NCT01205204|Fentanyl|fentanyl
1390084|NCT01205204|Bupivacaine|bupivacaine
1390085|NCT01205204|Spinal Anesthesia|spinal anesthesia
1390086|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
1390087|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
1390088|NCT01205191|Anxiety|anxiety
1390089|NCT01205191|Primary care|primary care
1390090|NCT01205191|Effectiveness trial|effectiveness trial
1390091|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
1390092|NCT01205152|Hypophosphatasia|hypophosphatasia
1390093|NCT01205152|HPP|hpp
1390094|NCT01205152|Bone disease|bone disease
1390095|NCT01205152|Soft bones|soft bones
1390096|NCT01205152|Low alkaline phosphatase|low alkaline phosphatase
1390097|NCT01205152|Genetic metabolic disorder|genetic metabolic disorder
1390098|NCT01205152|Alkaline phosphatase|alkaline phosphatase
1390099|NCT01205152|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1390100|NCT01205152|Rickets|rickets
1390101|NCT01205152|Osteomalacia|osteomalacia
1390102|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
1390103|NCT01205139|TMC435-C114|tmc435-c114
1390104|NCT01205139|TMC435|tmc435
1390105|NCT01205139|HCV|hcv
1390106|NCT01205139|Hepatitis C|hepatitis c
1390107|NCT01205126|Pain|pain
1390108|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
1390109|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
1390110|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
1390111|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
1390112|NCT01205100|Behavioral Research|behavioral research
1390113|NCT01205100|Biofeedback|biofeedback
1390114|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
1390115|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
1390116|NCT01205035|Macular Telangiectasia|macular telangiectasia
1390117|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
1390118|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
1390119|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
1390120|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
1390121|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
1390122|NCT01205009|in-vitro fertilization|in-vitro fertilization
1390123|NCT01205009|poor responders|poor responders
1390124|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
1390125|NCT01205009|Fertility Agents, Female|fertility agents, female
1390126|NCT01204996|monoclonal antibody|monoclonal antibody
1390127|NCT01204996|solid tumor|solid tumor
1390128|NCT01204996|chemotherapy|chemotherapy
1390129|NCT01204996|standard of care|standard of care
1390130|NCT01204983|very low birth weight infant|very low birth weight infant
1390131|NCT01204983|donor human milk|donor human milk
1390132|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
1390133|NCT01204970|Small airways|small airways
1390135|NCT01204970|Lung transplantation|lung transplantation
1390136|NCT01204957|Homocysteine|homocysteine
1390137|NCT01204957|Insulin-like growth factor|insulin-like growth factor
1390138|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
1390139|NCT01204957|Serum estrogen|serum estrogen
1390140|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
1390141|NCT01204957|Thyroid hormones|thyroid hormones
1390142|NCT01204931|reflux|reflux
1390143|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
1390144|NCT01204931|GERD|gerd
1390145|NCT01204918|MDD|mdd
1390146|NCT01204918|Depression|depression
1390147|NCT01204918|Treatment refractory|treatment refractory
1390148|NCT01204918|Glutamate|glutamate
1390149|NCT01204918|Riluzole|riluzole
1390150|NCT01204918|Major depressive disorder|major depressive disorder
1390151|NCT01204918|psychopharmacology|psychopharmacology
1390152|NCT01204918|rilutek|rilutek
1390153|NCT01204905|HIV-1|hiv-1
1390154|NCT01204905|CD4|cd4
1390155|NCT01204905|Viral Load|viral load
1390156|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1390157|NCT01204866|Allergic-Like Reaction|allergic-like reaction
1390158|NCT01204866|Selected Formulation Components|selected formulation components
1390159|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
1390160|NCT01204840|in vitro fertilization|in vitro fertilization
1390161|NCT01204840|IVF|ivf
1390162|NCT01204840|poor responder|poor responder
1390163|NCT01204840|growth hormone|growth hormone
1390164|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
1390165|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
1390166|NCT01204814|HIV|hiv
1390167|NCT01204814|Drug resistance|drug resistance
1390168|NCT01204814|mutations|mutations
1390169|NCT01204814|ARV's|arv's
1390170|NCT01204801|Cancer|cancer
1390171|NCT01204801|Breast Cancer|breast cancer
1390172|NCT01204801|Breast Tumor|breast tumor
1390173|NCT01204801|Breast Neoplasm|breast neoplasm
1390174|NCT01204801|Neoplasms by Site|neoplasms by site
1390175|NCT01204801|Neoplasms|neoplasms
1390176|NCT01204801|Breast Diseases|breast diseases
1390177|NCT01204801|Breast Conserving Surgery|breast conserving surgery
1390178|NCT01204801|Breast Conservation|breast conservation
1390179|NCT01204801|Partial Mastectomy|partial mastectomy
1390180|NCT01204801|Lumpectomy|lumpectomy
1390181|NCT01204801|Mastectomy|mastectomy
1390183|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
1390184|NCT01204801|Primary Therapy|primary therapy
1390185|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
1390186|NCT01204801|Thermotherapy|thermotherapy
1390187|NCT01204801|Fever Therapy|fever therapy
1390188|NCT01204801|Hot Temperature|hot temperature
1390189|NCT01204801|Hyperthermia|hyperthermia
1390190|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
1390191|NCT01204801|Hyperthermia, Local|hyperthermia, local
1390192|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
1390193|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
1390194|NCT01204801|Microwave|microwave
1390195|NCT01204801|Focused Microwave|focused microwave
1390196|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
1390197|NCT01204801|Minimally Invasive|minimally invasive
1390198|NCT01204801|Doxorubicin|doxorubicin
1390199|NCT01204801|Epirubicin|epirubicin
1390200|NCT01204801|Epidoxirubicin|epidoxirubicin
1390201|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
1390202|NCT01204801|Immunologic Factors|immunologic factors
1390203|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
1390204|NCT01204801|Chemotherapy|chemotherapy
1390205|NCT01204801|Drug Therapy|drug therapy
1390206|NCT01204801|Pharmalogic Actions|pharmalogic actions
1390207|NCT01204801|Antirheumatic Agents|antirheumatic agents
1390208|NCT01204801|Therapeutic Uses|therapeutic uses
1390209|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1390210|NCT01204801|Alkylating Agents|alkylating agents
1390211|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1390212|NCT01204801|Antineoplastic Agents|antineoplastic agents
1390213|NCT01204801|Myeloblative Agonists|myeloblative agonists
1390214|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
1390215|NCT01204801|Anthracycline Agents|anthracycline agents
1390216|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
1390217|NCT01204788|AML|aml
1390218|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
1390219|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
1390220|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
1390221|NCT01204788|Infection|infection
1390222|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
1390223|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
1390224|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
1390225|NCT01204749|AMGEN|amgen
1390226|NCT01204749|AMG 386|amg 386
1390227|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
1390228|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
1390229|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
1390230|NCT01204749|Paclitaxel|paclitaxel
1390231|NCT01204749|Ovarian Cancer|ovarian cancer
1390232|NCT01204749|TRINOVA-1|trinova-1
1390233|NCT01204736|tendon transfer|tendon transfer
1390234|NCT01204736|elbow|elbow
1390235|NCT01204723|Marijuana Abuse|marijuana abuse
1390236|NCT01204723|Nicotine Dependence|nicotine dependence
1390237|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
1390238|NCT01204723|neurokinin Receptor|neurokinin receptor
1390239|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
1390240|NCT01204723|Substance P|substance p
1390241|NCT01204723|Recurrence|recurrence
1390242|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
1390243|NCT01204723|Substance-Related Disorders|substance-related disorders
1390244|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
1390245|NCT01204723|Mental Disorders|mental disorders
1390246|NCT01204723|Disease Attributes|disease attributes
1390247|NCT01204723|Pathologic Processes|pathologic processes
1390248|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
1390249|NCT01204723|Therapeutic Uses|therapeutic uses
1390250|NCT01204723|Psychotropic Drugs|psychotropic drugs
1390251|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
1390252|NCT01204723|Analgesics|analgesics
1390253|NCT01204723|Sensory System Agents|sensory system agents
1390254|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
1390255|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
1390256|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1390257|NCT01204723|Narcotic Antagonists|narcotic antagonists
1390258|NCT01204723|cannabis|cannabis
1390259|NCT01204710|Prostate Cancer|prostate cancer
1390260|NCT01204684|dendritic cells|dendritic cells
1390261|NCT01204684|glioma|glioma
1390262|NCT01204684|vaccine|vaccine
1390263|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
1390264|NCT01204671|influenza infection|influenza infection
1390265|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
1390266|NCT01204658|Haemophilus influenzae|haemophilus influenzae
1390267|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
1390268|NCT01204658|immunogenicity|immunogenicity
1390269|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
1390270|NCT01204658|infants|infants
1390271|NCT01204658|safety|safety
1390272|NCT01204619|peritoneal dialysis|peritoneal dialysis
1390273|NCT01204567|HLRQ|hlrq
1390274|NCT01204567|elderly|elderly
1390275|NCT01204567|aerobic fitness|aerobic fitness
1390276|NCT01204567|cognitive capacity|cognitive capacity
1390277|NCT01204554|perforator flaps|perforator flaps
1390278|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
1390279|NCT01204528|Dysfunction in CKD|dysfunction in ckd
1390281|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
1390282|NCT01204515|abdominal pain|abdominal pain
1390283|NCT01204515|urgency|urgency
1390284|NCT01204515|bloating|bloating
1390285|NCT01204515|diarrhea|diarrhea
1390286|NCT01204515|constipation|constipation
1390287|NCT01204502|Gene therapy|gene therapy
1390288|NCT01204502|Haploidentical|haploidentical
1390289|NCT01204502|Bone marrow transplant|bone marrow transplant
1390290|NCT01204502|Graft versus host disease|graft versus host disease
1390291|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
1390292|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
1390293|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
1390294|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1390295|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1390296|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1390297|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1390298|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
1390299|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
1390300|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1390301|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
1390302|NCT01204437|primary carcinoma|primary carcinoma
1390303|NCT01204437|elderly non frail patients|elderly non frail patients
1390304|NCT01204437|EC|ec
1390305|NCT01204437|CMF|cmf
1390306|NCT01204437|Capecitabine|capecitabine
1390307|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
1390308|NCT01204424|minimal invasive|minimal invasive
1390309|NCT01204424|sinus floor augmentation|sinus floor augmentation
1390310|NCT01204424|sinuslift|sinuslift
1390311|NCT01204424|dental implants|dental implants
1390312|NCT01204411|Efficacy|efficacy
1390313|NCT01204411|Safety|safety
1390314|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
1390315|NCT01204411|Malaria|malaria
1390316|NCT01204411|Plasmodium falciparum|plasmodium falciparum
1390317|NCT01204411|Malnutrition|malnutrition
1390318|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
1390319|NCT01204385|Acute Otitis Media|acute otitis media
1390320|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
1390321|NCT01204385|etiology|etiology
1390322|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
1390323|NCT01204372|First-line chemotherapy|first-line chemotherapy
1390324|NCT01204372|Combination chemotherapy|combination chemotherapy
1390325|NCT01204372|Targeted agents|targeted agents
1390326|NCT01204346|adolescents|adolescents
1390327|NCT01204346|MBT|mbt
1390328|NCT01204346|depression|depression
1390329|NCT01204346|emerging personality disorder|emerging personality disorder
1390330|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
1390331|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
1390332|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
1390333|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
1390334|NCT01204333|Thrombolysis|thrombolysis
1390335|NCT01204333|Thrombectomy|thrombectomy
1390336|NCT01204320|Restenosis|restenosis
1390337|NCT01204320|POBA|poba
1390338|NCT01204320|Stenting|stenting
1390339|NCT01204320|Paclitaxel|paclitaxel
1390340|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
1390341|NCT01204281|Acute respiratory failure|acute respiratory failure
1390342|NCT01204281|Mechanical ventilation|mechanical ventilation
1390343|NCT01204268|cerebral ischemia|cerebral ischemia
1390344|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
1390345|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
1390346|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
1390347|NCT01204242|Breast Cancer|breast cancer
1390348|NCT01204229|Alcohol Consumption|alcohol consumption
1390349|NCT01204229|Social Anxiety|social anxiety
1390350|NCT01204229|Depression|depression
1390351|NCT01204229|Brief Intervention|brief intervention
1390352|NCT01204229|Motivational Interviewing|motivational interviewing
1390353|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
1390354|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
1390355|NCT01204229|Sub-Clinical Depression|sub-clinical depression
1390356|NCT01204216|Hemoglobin A1c|hemoglobin a1c
1390357|NCT01204216|HbA1c|hba1c
1390358|NCT01204216|glycated serum proteins|glycated serum proteins
1390359|NCT01204216|fructosamine|fructosamine
1390360|NCT01204216|glycated albumin|glycated albumin
1390361|NCT01204216|glycation gap|glycation gap
1390362|NCT01204203|mesothelioma|mesothelioma
1390363|NCT01204203|zoledronic acid|zoledronic acid
1390364|NCT01204203|zometa|zometa
1390365|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
1390366|NCT01204203|CT scan|ct scan
1390367|NCT01204203|PET scan|pet scan
1390368|NCT01204190|Administration|administration
1390369|NCT01204190|Cutaneous|cutaneous
1390370|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1390371|NCT01204177|MEK inhibitor|mek inhibitor
1390372|NCT01204177|Sorafenib|sorafenib
1390373|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
1390374|NCT01204177|Safety|safety
1390375|NCT01204164|AML|aml
1390376|NCT01204164|ALL|all
1390377|NCT01204164|MDS|mds
1390378|NCT01204164|CML in blast crisis|cml in blast crisis
1390379|NCT01204164|Multiple Myeloma|multiple myeloma
1390380|NCT01204164|Carfilzomib refractory|carfilzomib refractory
1390381|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
1390382|NCT01204112|Drug-Drug Interaction|drug-drug interaction
1390383|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
1390384|NCT01204112|550)|550)
1390385|NCT01204112|Rifampin|rifampin
1390386|NCT01204112|Healthy Volunteers|healthy volunteers
1390387|NCT01204099|PX-866|px-866
1390388|NCT01204099|Non small cell lung cancer|non small cell lung cancer
1390389|NCT01204099|solid tumors|solid tumors
1390390|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
1390391|NCT01204099|docetaxel|docetaxel
1390392|NCT01204099|NSCLC|nsclc
1390393|NCT01204099|taxotere|taxotere
1390394|NCT01204099|SCCHN|scchn
1390395|NCT01204099|PI-3K|pi-3k
1390396|NCT01204099|PI3 kinase|pi3 kinase
1390397|NCT01204099|PI3K|pi3k
1390398|NCT01204086|Major Depressive Disorder|major depressive disorder
1390399|NCT01204086|Antidepressants|antidepressants
1390400|NCT01204086|Pharmacogenetics|pharmacogenetics
1390401|NCT01204086|venlafaxine|venlafaxine
1390402|NCT01204086|fluoxetine|fluoxetine
1390403|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
1390404|NCT01204034|COPD|copd
1390405|NCT01204034|Formoterol|formoterol
1390406|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
1390407|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
1390408|NCT01204034|Functional Imaging|functional imaging
1390409|NCT01204034|Central and Peripheral Airways|central and peripheral airways
1390410|NCT01204034|BODE index|bode index
1390411|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
1390412|NCT01204034|Borg CR10 scale|borg cr10 scale
1390413|NCT01204021|Stress|stress
1390414|NCT01204021|loneliness|loneliness
1390415|NCT01204021|social isolation|social isolation
1390416|NCT01204021|autonomic activity|autonomic activity
1390417|NCT01204021|inflammation|inflammation
1390418|NCT01204021|Perceived social isolation|perceived social isolation
1390419|NCT01204021|Chronic stress|chronic stress
1390420|NCT01203982|CIMT|cimt
1390421|NCT01203982|IVUS-VH|ivus-vh
1390422|NCT01203982|Coronary artery disease|coronary artery disease
1390423|NCT01203956|AutoAdjust|autoadjust
1390424|NCT01203956|SmartFlex|smartflex
1390425|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
1390426|NCT01203956|Patient reported outcomes|patient reported outcomes
1390427|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1390428|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
1390429|NCT01203943|Fibrosis|fibrosis
1390430|NCT01203943|Interstitial Lung Disease|interstitial lung disease
1390431|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
1390432|NCT01203943|CC-930|cc-930
1390434|NCT01203930|SLL|sll
1390435|NCT01203930|GS-1101|gs-1101
1390436|NCT01203930|CAL-101|cal-101
1390437|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
1390438|NCT01203930|Rituximab|rituximab
1390439|NCT01203930|Rituxan|rituxan
1390440|NCT01203917|Gefitinib|gefitinib
1390441|NCT01203917|EGFR TKI|egfr tki
1390442|NCT01203917|efficacy|efficacy
1390443|NCT01203917|Caucasian patients|caucasian patients
1390444|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
1390445|NCT01203917|safety|safety
1390446|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
1390447|NCT01203891|SPECT|spect
1390448|NCT01203891|Imaging|imaging
1390449|NCT01203891|Healthy brain|healthy brain
1390450|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
1390451|NCT01203878|Imiquimod|imiquimod
1390452|NCT01203878|Photodynamic therapy|photodynamic therapy
1390453|NCT01203878|Actinic keratoses|actinic keratoses
1390454|NCT01203878|Sequential therapy|sequential therapy
1390455|NCT01203878|Therapeutic uses|therapeutic uses
1390456|NCT01203865|Fibromyalgia|fibromyalgia
1390457|NCT01203865|Fatigue|fatigue
1390458|NCT01203852|hypertension|hypertension
1390459|NCT01203852|antihypertensive drug|antihypertensive drug
1390460|NCT01203852|pharmacogenetics|pharmacogenetics
1390461|NCT01203852|genetics|genetics
1390462|NCT01203852|blood pressure|blood pressure
1390463|NCT01203852|glucose|glucose
1390464|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
1390465|NCT01203839|invasive ductal breast|invasive ductal breast
1390466|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
1390467|NCT01203839|radiation|radiation
1390468|NCT01203839|10-114|10-114
1390469|NCT01203826|Hypophosphatasia|hypophosphatasia
1390470|NCT01203826|HPP|hpp
1390471|NCT01203826|Bone Disease|bone disease
1390472|NCT01203826|Soft Bones|soft bones
1390473|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
1390474|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
1390475|NCT01203826|alkaline phosphatase|alkaline phosphatase
1390476|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1390477|NCT01203826|rickets|rickets
1390478|NCT01203826|osteomalacia|osteomalacia
1390479|NCT01203813|Chronic kidney disease|chronic kidney disease
1390480|NCT01203813|Quality improvement|quality improvement
1390481|NCT01203813|Self management support|self management support
1390482|NCT01203813|Electronic health records|electronic health records
1390483|NCT01203813|Clinical decision support|clinical decision support
1390484|NCT01203813|Electronic reminders|electronic reminders
1390485|NCT01203813|Patient outreach|patient outreach
1390486|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
1390487|NCT01203787|HCC|hcc
1390488|NCT01203787|Liver Cancer|liver cancer
1390489|NCT01203774|Diabetes|diabetes
1390490|NCT01203761|loneliness|loneliness
1390491|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
1390492|NCT01203735|Valproic acid|valproic acid
1390493|NCT01203735|Chemotherapy|chemotherapy
1390494|NCT01203735|Radiotherapy|radiotherapy
1390495|NCT01203722|Reduced intensity|reduced intensity
1390496|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
1390497|NCT01203722|Acute leukemias|acute leukemias
1390498|NCT01203722|Chronic leukemias|chronic leukemias
1390499|NCT01203722|Myelodysplasia|myelodysplasia
1390500|NCT01203722|Lymphomas|lymphomas
1390501|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
1390502|NCT01203709|lupus|lupus
1390503|NCT01203709|nephritis|nephritis
1390504|NCT01203709|glomerulonephritis|glomerulonephritis
1390505|NCT01203709|nephropathy|nephropathy
1390506|NCT01203709|refractory|refractory
1390507|NCT01203696|Clopidogrel|clopidogrel
1390508|NCT01203696|Platelet reactivity|platelet reactivity
1390509|NCT01203696|Amlodipine|amlodipine
1390510|NCT01203683|depression|depression
1390511|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
1390512|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
1390513|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
1390514|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
1390515|NCT01203670|Lipase|lipase
1390516|NCT01203670|Amylase|amylase
1390517|NCT01203657|exercise|exercise
1390518|NCT01203657|physical activity|physical activity
1390519|NCT01203657|tai chi|tai chi
1390520|NCT01203644|Postoperative pain|postoperative pain
1390521|NCT01203644|Analgesia|analgesia
1390522|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
1390523|NCT01203618|Pituitary tumor|pituitary tumor
1390524|NCT01203618|Pituitary adenoma|pituitary adenoma
1390525|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
1390526|NCT01203605|Operative surgical procedures|operative surgical procedures
1390527|NCT01203605|mortality|mortality
1390528|NCT01203605|adverse effects|adverse effects
1390529|NCT01203605|Postoperative complications|postoperative complications
1390530|NCT01203605|Epidemiological Study|epidemiological study
1390531|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
1390532|NCT01203592|Albuterol|albuterol
1390533|NCT01203592|Neuromuscular transmission|neuromuscular transmission
1390534|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
1390535|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
1390536|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
1390537|NCT01203566|SILS|sils
1390538|NCT01203566|Single-port access|single-port access
1390539|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
1390540|NCT01203566|Appendectomy|appendectomy
1390541|NCT01203553|Incisional hernias|incisional hernias
1390542|NCT01203553|Prophylaxis|prophylaxis
1390543|NCT01203553|Preperitoneal mesh|preperitoneal mesh
1390544|NCT01203527|H1N1 influenza|h1n1 influenza
1390545|NCT01203527|Swine flu|swine flu
1390546|NCT01203527|Oseltamivir|oseltamivir
1390547|NCT01203527|Tamiflu|tamiflu
1390548|NCT01203527|Pregnancy|pregnancy
1390549|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
1390550|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390551|NCT01203514|Prematurity|prematurity
1390552|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
1390553|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
1390554|NCT01203514|Blood loss|blood loss
1390555|NCT01203514|Phlebotomy|phlebotomy
1390556|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
1390557|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390558|NCT01203501|Prematurity|prematurity
1390559|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
1390560|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
1390561|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390562|NCT01203488|Prematurity|prematurity
1390563|NCT01203488|Vitamin A|vitamin a
1390564|NCT01203488|Chronic Lung Disease|chronic lung disease
1390565|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
1390566|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390567|NCT01203475|Prematurity|prematurity
1390568|NCT01203475|Growth Curve|growth curve
1390569|NCT01203475|Head Circumference|head circumference
1390570|NCT01203475|Length|length
1390571|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
1390572|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390573|NCT01203449|Prematurity|prematurity
1390574|NCT01203449|Gestational Age|gestational age
1390575|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
1390576|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1390577|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390578|NCT01203436|Prematurity|prematurity
1390579|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
1390580|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390581|NCT01203423|Prematurity|prematurity
1390582|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
1390583|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
1390584|NCT01203410|Term infant|term infant
1390585|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
1390586|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
1390587|NCT01203371|naftopidil|naftopidil
1390588|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
1390589|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
1390590|NCT01203371|LUTS|luts
1390591|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
1390592|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390593|NCT01203358|Prematurity|prematurity
1390594|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
1390595|NCT01203358|Surfactant|surfactant
1390596|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
1390597|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1390598|NCT01203345|Prematurity|prematurity
1390599|NCT01203345|Septicemia|septicemia
1390600|NCT01203345|Meningitis|meningitis
1390601|NCT01203345|Urinary tract infection|urinary tract infection
1390602|NCT01203345|Immune globulin|immune globulin
1390603|NCT01203332|HIV testing|hiv testing
1390604|NCT01203332|Latino|latino
1390605|NCT01203332|Latina|latina
1390606|NCT01203332|Men who have sex with men|men who have sex with men
1390607|NCT01203319|immunogenicity|immunogenicity
1390608|NCT01203319|safety|safety
1390609|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1390610|NCT01203319|nonresponders|nonresponders
1390611|NCT01203306|bevacizumab|bevacizumab
1390612|NCT01203306|somatostatin analogue|somatostatin analogue
1390613|NCT01203306|metronomic capecitabine|metronomic capecitabine
1390614|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
1390615|NCT01203280|icing|icing
1390616|NCT01203280|boxer|boxer
1390617|NCT01203280|balance|balance
1390618|NCT01203280|neck range of motion|neck range of motion
1390619|NCT01203280|neck isometric strength|neck isometric strength
1390620|NCT01203280|balance performance|balance performance
1390621|NCT01203267|Breast Neoplasms|breast neoplasms
1390622|NCT01203267|Neoadjuvant|neoadjuvant
1390623|NCT01203267|Chemotherapy|chemotherapy
1390624|NCT01203267|Paclitaxel|paclitaxel
1390625|NCT01203267|Carboplatin|carboplatin
1390626|NCT01203267|Pathological Complete Remission|pathological complete remission
1390627|NCT01203254|Colesevelam|colesevelam
1390628|NCT01203254|IBD|ibd
1390629|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
1390630|NCT01203254|Crohns disease|crohns disease
1390631|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
1390632|NCT01203228|Myeloablative conditionig|myeloablative conditionig
1390633|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1390634|NCT01203228|MUD|mud
1390635|NCT01203215|exercise|exercise
1390636|NCT01203215|physical activity|physical activity
1390637|NCT01203215|women|women
1390638|NCT01203215|community|community
1390639|NCT01203202|PE|pe
1390640|NCT01203202|IELT|ielt
1390641|NCT01203202|DCIT|dcit
1390642|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
1390643|NCT01203176|Endometrial polyp|endometrial polyp
1390644|NCT01203176|Endometrial carcinoma|endometrial carcinoma
1390645|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
1390646|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
1390647|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
1390648|NCT01203163|PDT|pdt
1390649|NCT01203163|porfimer sodium|porfimer sodium
1390650|NCT01203163|esophageal cancer|esophageal cancer
1390651|NCT01203163|NSCLC|nsclc
1390652|NCT01203163|HGD in BE|hgd in be
1390653|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
1390654|NCT01203124|Intranasal|intranasal
1390655|NCT01203124|Biomarker|biomarker
1390656|NCT01203124|Healthy|healthy
1390657|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
1390658|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
1390659|NCT01203098|prevention|prevention
1390660|NCT01203098|venous thromboembolism|venous thromboembolism
1390661|NCT01203098|edoxaban|edoxaban
1390662|NCT01203098|anticoagulants|anticoagulants
1390663|NCT01203072|prevention|prevention
1390664|NCT01203072|venous thromboembolism|venous thromboembolism
1390665|NCT01203072|edoxaban|edoxaban
1390666|NCT01203072|factor Xa|factor xa
1390667|NCT01203046|DURATION OF THERAPY|duration of therapy
1390668|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
1390669|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
1390670|NCT01203033|single cell network profiling|single cell network profiling
1390671|NCT01203033|AML|aml
1390672|NCT01203033|SCNP|scnp
1390673|NCT01203020|Hodgkin's|hodgkin's
1390674|NCT01203020|non-Hodgkin's|non-hodgkin's
1390675|NCT01203020|lymphomas|lymphomas
1390676|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
1390677|NCT01203020|HPCT|hpct
1390678|NCT01203020|busulfex|busulfex
1390679|NCT01203020|fludarabine|fludarabine
1390680|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
1390681|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
1390682|NCT01202994|Alzheimer's disease|alzheimer's disease
1390683|NCT01202994|Mild cognitive impairment|mild cognitive impairment
1390684|NCT01202994|PET|pet
1390685|NCT01202994|Practice effects|practice effects
1390686|NCT01202981|glistenings|glistenings
1390687|NCT01202981|contrast sensitivity|contrast sensitivity
1390688|NCT01202981|visual quality|visual quality
1390689|NCT01202981|straylight|straylight
1390690|NCT01202981|AcrySof IOL|acrysof iol
1390691|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
1390692|NCT01202955|Smoking, Abstinence|smoking, abstinence
1391095|NCT01201382|Prevention|prevention
1390693|NCT01202929|High Resolution Manometry|high resolution manometry
1390694|NCT01202929|achalasia|achalasia
1390695|NCT01202929|dysphagia|dysphagia
1390696|NCT01202929|GERD|gerd
1390697|NCT01202929|chest pain|chest pain
1390698|NCT01202929|Post fundoplication|post fundoplication
1390699|NCT01202916|children with congenital heart disease|children with congenital heart disease
1390700|NCT01202903|omalizumab|omalizumab
1390701|NCT01202903|asthma|asthma
1390702|NCT01202903|immunoglobulin E|immunoglobulin e
1390703|NCT01202903|IgE|ige
1390704|NCT01202890|lenalidomide|lenalidomide
1390705|NCT01202890|revlimid|revlimid
1390706|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
1390707|NCT01202890|doxil|doxil
1390708|NCT01202890|bevacizumab|bevacizumab
1390709|NCT01202890|avastin|avastin
1390710|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1390711|NCT01202890|ovarian cancer|ovarian cancer
1390712|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
1390713|NCT01202877|MDS|mds
1390714|NCT01202877|Refractory acute leukemias|refractory acute leukemias
1390715|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
1390716|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
1390717|NCT01202877|AML|aml
1390718|NCT01202877|5-Azacytidine|5-azacytidine
1390719|NCT01202877|Azacitidine|azacitidine
1390720|NCT01202877|5-aza|5-aza
1390721|NCT01202877|Vidaza|vidaza
1390722|NCT01202877|5-AZC|5-azc
1390723|NCT01202877|AZA-CR|aza-cr
1390724|NCT01202877|Ladakamycin|ladakamycin
1390725|NCT01202877|NSC-102816|nsc-102816
1390726|NCT01202877|PKC412|pkc412
1390727|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
1390728|NCT01202864|ICH|ich
1390729|NCT01202864|Stroke|stroke
1390730|NCT01202864|Cerebrovascular accident|cerebrovascular accident
1390731|NCT01202851|radiotherapy|radiotherapy
1390732|NCT01202851|radiation therapy|radiation therapy
1390733|NCT01202851|stretching|stretching
1390734|NCT01202851|relaxation|relaxation
1390735|NCT01202851|quality of life|quality of life
1390736|NCT01202851|QOL|qol
1390737|NCT01202851|fatigue|fatigue
1390738|NCT01202851|sleep disturbances|sleep disturbances
1390739|NCT01202851|mental health|mental health
1390740|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
1390741|NCT01202851|work productivity|work productivity
1390742|NCT01202851|home productivity|home productivity
1390743|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
1390744|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
1390745|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
1390746|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
1390747|NCT01202825|TMC647055|tmc647055
1390748|NCT01202825|HPC|hpc
1390749|NCT01202825|Hepatitis C|hepatitis c
1390750|NCT01202825|Healthy volunteers|healthy volunteers
1390751|NCT01202825|TMC435|tmc435
1390752|NCT01202812|Sickle Cell Anemia|sickle cell anemia
1390753|NCT01202812|Sickle Cell Disease|sickle cell disease
1390754|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
1390755|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
1390756|NCT01202812|Inflammation|inflammation
1390757|NCT01202812|Quality of Life|quality of life
1390758|NCT01202812|Sickle Thalassemia|sickle thalassemia
1390759|NCT01202812|C-Reative Protein|c-reative protein
1390760|NCT01202812|Hemolytic Anemia|hemolytic anemia
1390761|NCT01202812|Hemostasis|hemostasis
1390762|NCT01202812|Biomarkers|biomarkers
1390763|NCT01202812|Coagulation|coagulation
1390764|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
1390765|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
1390766|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
1390767|NCT01202812|Fish Oils|fish oils
1390768|NCT01202812|Drug: Placebo|drug: placebo
1390769|NCT01202812|Drug: LOVAZA|drug: lovaza
1390770|NCT01202799|Pharmacokinetics|pharmacokinetics
1390771|NCT01202799|Healthy volunteers|healthy volunteers
1390772|NCT01202799|PENNSAID|pennsaid
1390773|NCT01202799|Topical NSAID|topical nsaid
1390774|NCT01202799|Diclofenac|diclofenac
1390775|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
1390776|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
1390777|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
1390778|NCT01202734|CONCERTA|concerta
1390779|NCT01202734|Methylphenidate HCl|methylphenidate hcl
1390780|NCT01202734|Pharmacokinetic|pharmacokinetic
1390781|NCT01202734|Safety|safety
1390782|NCT01202734|Adult|adult
1390783|NCT01202734|Men|men
1390784|NCT01202734|Male|male
1390785|NCT01202721|Congenital|congenital
1390786|NCT01202721|Aortic Valve|aortic valve
1390787|NCT01202721|Bicuspid|bicuspid
1390788|NCT01202721|Aortopathy|aortopathy
1390789|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
1390790|NCT01202708|chronic renal failure|chronic renal failure
1390791|NCT01202708|hemodiafiltration|hemodiafiltration
1390792|NCT01202682|Healthy subject exercise study|healthy subject exercise study
1390793|NCT01202656|Fertility Agents, Female|fertility agents, female
1390794|NCT01202656|In vitro fertilization|in vitro fertilization
1390795|NCT01202643|Thin Endometrium|thin endometrium
1390796|NCT01202643|Asherman's Syndrome|asherman's syndrome
1390797|NCT01202643|Endometrial Scarring|endometrial scarring
1390798|NCT01202630|Clostridium difficile|clostridium difficile
1390799|NCT01202630|diarrhea|diarrhea
1390800|NCT01202617|Seroquel XR|seroquel xr
1390801|NCT01202617|schizophrenia|schizophrenia
1390802|NCT01202617|relapse prevention|relapse prevention
1390803|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
1390804|NCT01202604|mood event|mood event
1390805|NCT01202604|manic or depressive|manic or depressive
1390806|NCT01202604|Greece|greece
1390807|NCT01202591|Breast Cancer|breast cancer
1390808|NCT01202591|ER+|er+
1390809|NCT01202591|FGFR1|fgfr1
1390810|NCT01202591|Exemestane|exemestane
1390811|NCT01202591|AZD4547|azd4547
1390812|NCT01202591|Fulvestrant|fulvestrant
1390813|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
1390814|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
1390815|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
1390816|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
1390817|NCT01202552|influenza|influenza
1390818|NCT01202552|aged|aged
1390819|NCT01202552|intradermal injection|intradermal injection
1390820|NCT01202526|Insulin resistance|insulin resistance
1390821|NCT01202526|Gastric bypass|gastric bypass
1390822|NCT01202513|Vitiligo|vitiligo
1390823|NCT01202513|Repigmentation|repigmentation
1390824|NCT01202487|Laceration|laceration
1390825|NCT01202487|Lacerations|lacerations
1390826|NCT01202487|LET|let
1390827|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
1390828|NCT01202487|LAT|lat
1390829|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
1390830|NCT01202487|Tissue Adhesive|tissue adhesive
1390831|NCT01202487|Skin Glue|skin glue
1390832|NCT01202487|Pre-Treatment with LET|pre-treatment with let
1390833|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
1390834|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
1390835|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
1390836|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
1390837|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
1390838|NCT01202487|Histoacryl|histoacryl
1390839|NCT01202461|Diabetic macular edema|diabetic macular edema
1390840|NCT01202461|Combination therapy for DME|combination therapy for dme
1390841|NCT01202461|DME|dme
1390842|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1390843|NCT01202448|central nervous system|central nervous system
1390844|NCT01202448|prognosis|prognosis
1390845|NCT01202435|pregabalin|pregabalin
1390846|NCT01202435|pharmacokinetics|pharmacokinetics
1390847|NCT01202435|bioavailability|bioavailability
1390848|NCT01202435|bioequivalence|bioequivalence
1390849|NCT01202422|pregabalin|pregabalin
1390850|NCT01202422|pharmacokinetics|pharmacokinetics
1390851|NCT01202422|bioavailability|bioavailability
1390852|NCT01202422|bioequivalence|bioequivalence
1390853|NCT01202409|Ampulla of Vater|ampulla of vater
1390854|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
1390855|NCT01202409|Metastatic|metastatic
1390856|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
1390857|NCT01202409|KRAS|kras
1390858|NCT01202409|Capecitabine|capecitabine
1390859|NCT01202409|Xeloda|xeloda
1390860|NCT01202409|Oxaliplatin|oxaliplatin
1390861|NCT01202409|Eloxatin|eloxatin
1390862|NCT01202409|CAPOX|capox
1390863|NCT01202409|Panitumumab|panitumumab
1390864|NCT01202409|Vectibix|vectibix
1390865|NCT01202396|pouch|pouch
1390866|NCT01202396|pouchitis|pouchitis
1390867|NCT01202396|ulcerative colitis|ulcerative colitis
1390868|NCT01202396|microbiota|microbiota
1390869|NCT01202396|defensins|defensins
1390870|NCT01202396|epithelial integrity|epithelial integrity
1390871|NCT01202370|Cancer|cancer
1390872|NCT01202370|Tumors|tumors
1390873|NCT01202357|Psychotic Disorders|psychotic disorders
1390874|NCT01202357|Psychosis|psychosis
1390875|NCT01202344|Angioplasty|angioplasty
1390876|NCT01202344|Stenosis|stenosis
1390877|NCT01202344|Restenosis|restenosis
1390878|NCT01202344|Elastic Recoil|elastic recoil
1390879|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
1390880|NCT01202344|Target lesion in native artery|target lesion in native artery
1390881|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
1390882|NCT01202331|Bacterial Infections|bacterial infections
1390883|NCT01202331|Chlamydia Infections|chlamydia infections
1390884|NCT01202331|Eye Diseases|eye diseases
1390885|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
1390886|NCT01202318|Stroke,Acute|stroke,acute
1390887|NCT01202305|HIV|hiv
1390888|NCT01202305|HIV persistence|hiv persistence
1390889|NCT01202305|Lymph node fibrosis|lymph node fibrosis
1390890|NCT01202292|overweight|overweight
1390891|NCT01202292|obesity|obesity
1390892|NCT01202292|motivational intervention|motivational intervention
1390893|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
1390894|NCT01202266|Multiple Ascending Dose|multiple ascending dose
1390895|NCT01202266|Phase 1|phase 1
1390896|NCT01202266|Safety and Tolerability|safety and tolerability
1390897|NCT01202266|PK|pk
1390898|NCT01202266|Healthy Subjects|healthy subjects
1390899|NCT01202253|Ecalta|ecalta
1390900|NCT01202253|Eraxis|eraxis
1390901|NCT01202253|Candida|candida
1390902|NCT01202253|Candidemia|candidemia
1390903|NCT01202253|Systemic Candidiasis|systemic candidiasis
1390904|NCT01202253|ICU|icu
1390905|NCT01202253|Intensive Care Unit|intensive care unit
1390906|NCT01202253|Critical Care Unit|critical care unit
1390907|NCT01202240|Drug-Drug Interaction|drug-drug interaction
1390908|NCT01202240|Healthy Volunteers|healthy volunteers
1390909|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
1390910|NCT01202240|550)|550)
1390911|NCT01202240|Ketoconazole|ketoconazole
1390912|NCT01202227|Central Nervous System Diseases|central nervous system diseases
1390913|NCT01202227|Therapeutic Uses|therapeutic uses
1390914|NCT01202227|Wounds and Injuries|wounds and injuries
1390915|NCT01202227|Trauma|trauma
1390916|NCT01202227|Nervous System|nervous system
1390917|NCT01202227|pregabalin|pregabalin
1390918|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
1390919|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
1390920|NCT01202162|Induction|induction
1390921|NCT01202162|Coughing|coughing
1390922|NCT01202162|Anesthesia|anesthesia
1390923|NCT01202149|eczema|eczema
1390924|NCT01202149|elidel|elidel
1390925|NCT01202149|non-medicated device|non-medicated device
1390926|NCT01202149|hylatopic plus|hylatopic plus
1390927|NCT01202149|pimecrolimus|pimecrolimus
1390928|NCT01202149|bilateral comparison study|bilateral comparison study
1390929|NCT01202149|topical therapy|topical therapy
1390930|NCT01202136|pancreatic cyst|pancreatic cyst
1390931|NCT01202136|IPMN|ipmn
1390932|NCT01202136|PAN INs|pan ins
1390933|NCT01202136|Pancreatic cancer|pancreatic cancer
1390934|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
1390935|NCT01202071|Rabeprazole|rabeprazole
1390936|NCT01202071|proton pump inhibitor|proton pump inhibitor
1390937|NCT01202071|pharmacokinetics|pharmacokinetics
1390938|NCT01202071|pharmacodynamics|pharmacodynamics
1390939|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
1390940|NCT01202058|Coronary artery disease|coronary artery disease
1390941|NCT01202058|Drug-eluting stents|drug-eluting stents
1390942|NCT01202058|Reservoir technology|reservoir technology
1390943|NCT01202045|Echocardiography, Stress|echocardiography, stress
1390944|NCT01202045|right heart catheterization|right heart catheterization
1390945|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1390946|NCT01202032|Advanced solid tumors|advanced solid tumors
1390947|NCT01202032|Dose escalation|dose escalation
1390948|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
1390949|NCT01202019|cardiovascular risk|cardiovascular risk
1390950|NCT01202019|exercise|exercise
1390951|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
1390952|NCT01202006|Heart failure|heart failure
1390953|NCT01202006|Diagnosis|diagnosis
1390954|NCT01202006|Treatment|treatment
1390955|NCT01202006|Primary care|primary care
1390956|NCT01201993|syncope|syncope
1390957|NCT01201993|evaluation|evaluation
1390958|NCT01201993|recurrence|recurrence
1390959|NCT01201993|morbidity|morbidity
1390960|NCT01201980|essential arterial hypertension|essential arterial hypertension
1390961|NCT01201980|calcium antagonist|calcium antagonist
1390962|NCT01201967|Collaborative care|collaborative care
1390963|NCT01201967|Cardiovascular disease|cardiovascular disease
1390964|NCT01201967|Depression|depression
1390965|NCT01201967|Anxiety|anxiety
1390966|NCT01201954|pain|pain
1390967|NCT01201954|sucrose|sucrose
1390968|NCT01201954|newborn|newborn
1390969|NCT01201954|mechanical ventilation|mechanical ventilation
1390970|NCT01201876|Dental Caries|dental caries
1390971|NCT01201876|Assessments|assessments
1390972|NCT01201876|dental materials|dental materials
1390973|NCT01201863|Testosterone|testosterone
1390974|NCT01201863|Traumatic Brain Injury|traumatic brain injury
1390975|NCT01201863|Hypogonadism|hypogonadism
1390976|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
1390977|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
1390978|NCT01201850|radiation necrosis|radiation necrosis
1390979|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
1390980|NCT01201850|Central Nervous System Tumors|central nervous system tumors
1390981|NCT01201837|Acute coronary syndrome|acute coronary syndrome
1390982|NCT01201837|HDL mimetic|hdl mimetic
1390983|NCT01201837|ApoA-I|apoa-i
1390984|NCT01201824|lung cancer|lung cancer
1390985|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
1390986|NCT01201824|pulmonary nodules|pulmonary nodules
1390987|NCT01201824|VATS procedures|vats procedures
1390988|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
1390989|NCT01201811|Taiwan|taiwan
1390990|NCT01201811|Azacitidine|azacitidine
1390991|NCT01201811|Vidaza|vidaza
1390992|NCT01201811|Celgene|celgene
1390993|NCT01201811|Pathologic Processes|pathologic processes
1390994|NCT01201811|Neoplasms|neoplasms
1390995|NCT01201811|Bone Marrow Diseases|bone marrow diseases
1390996|NCT01201811|Hematologic Diseases|hematologic diseases
1390997|NCT01201811|Antineoplastic Agents|antineoplastic agents
1514962|NCT00720785|CML|cml
1390998|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
1390999|NCT01201811|Antimetabolites|antimetabolites
1391000|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1391001|NCT01201811|Pharmacologic Actions|pharmacologic actions
1391002|NCT01201811|Therapeutic Uses|therapeutic uses
1391003|NCT01201811|Enzyme inhibitors|enzyme inhibitors
1391004|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
1391005|NCT01201772|coronary artery disease|coronary artery disease
1391006|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
1391007|NCT01201772|prasugrel therapy|prasugrel therapy
1391008|NCT01201759|cardiovascular risk|cardiovascular risk
1391009|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
1391010|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
1391011|NCT01201746|periodontal Disease|periodontal disease
1391012|NCT01201746|hsCRP|hscrp
1391013|NCT01201746|Fibrinogen|fibrinogen
1391014|NCT01201746|WBCs|wbcs
1391015|NCT01201720|cirrhosis|cirrhosis
1391016|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
1391017|NCT01201707|Multiple Sclerosis|multiple sclerosis
1391018|NCT01201707|Angioplasty|angioplasty
1391019|NCT01201707|Vein|vein
1391020|NCT01201694|Advanced malignancies|advanced malignancies
1391021|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
1391022|NCT01201694|Turmeric|turmeric
1391023|NCT01201694|Dietary supplements|dietary supplements
1391024|NCT01201681|Post-operative pain|post-operative pain
1391025|NCT01201681|intra-operative pain|intra-operative pain
1391026|NCT01201681|root canal therapy|root canal therapy
1391027|NCT01201681|feasibility|feasibility
1391028|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
1391029|NCT01201668|post-operative pain|post-operative pain
1391030|NCT01201668|root canal therapy|root canal therapy
1391031|NCT01201668|feasibility|feasibility
1391032|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
1391033|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
1391034|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
1391035|NCT01201655|Splenectomy;|splenectomy;
1391036|NCT01201642|Bell's palsy|bell's palsy
1391037|NCT01201642|Prednisolone|prednisolone
1391038|NCT01201642|acupuncture|acupuncture
1391039|NCT01201629|Ischemic Strokes|ischemic strokes
1391040|NCT01201629|t DC stimulation|t dc stimulation
1391041|NCT01201629|Functional recovery|functional recovery
1391042|NCT01201616|Cognitive function|cognitive function
1391043|NCT01201616|mood|mood
1391044|NCT01201616|women|women
1391045|NCT01201616|high fat diet|high fat diet
1391046|NCT01201616|high carbohydrate diet|high carbohydrate diet
1391047|NCT01201603|Women|women
1391048|NCT01201603|Orange Juice|orange juice
1391049|NCT01201603|Insulin Resistance|insulin resistance
1391050|NCT01201603|Obesity|obesity
1391051|NCT01201590|Insulin resistance|insulin resistance
1391052|NCT01201590|obesity|obesity
1391053|NCT01201590|cocoa|cocoa
1391054|NCT01201590|women|women
1391055|NCT01201577|Quorum sensing|quorum sensing
1391056|NCT01201577|Prebiotics|prebiotics
1391057|NCT01201577|Probiotics|probiotics
1391058|NCT01201577|Sepsis|sepsis
1391059|NCT01201564|umbilical hernia,|umbilical hernia,
1391060|NCT01201564|wound complications,|wound complications,
1391061|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
1391062|NCT01201564|quality of life,|quality of life,
1391063|NCT01201564|sublay mesh repair,|sublay mesh repair,
1391064|NCT01201564|recurrence rate|recurrence rate
1391065|NCT01201551|Alphagan|alphagan
1391066|NCT01201551|Xalatan|xalatan
1391067|NCT01201551|corneal temperature|corneal temperature
1391068|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
1391069|NCT01201512|TMJD pain|tmjd pain
1391070|NCT01201512|feasibility|feasibility
1391071|NCT01201486|Ultrasound|ultrasound
1391072|NCT01201486|Pregnancy|pregnancy
1391073|NCT01201486|Fetal heart defects|fetal heart defects
1391074|NCT01201486|Color doppler|color doppler
1391075|NCT01201473|effect of participation|effect of participation
1391076|NCT01201473|effect of association|effect of association
1391077|NCT01201460|glucose testing|glucose testing
1391078|NCT01201447|Assessment|assessment
1391079|NCT01201447|Questionable Caries|questionable caries
1391080|NCT01201434|cystic fibrosis|cystic fibrosis
1391081|NCT01201434|probiotics|probiotics
1391082|NCT01201434|pulmonary|pulmonary
1391083|NCT01201434|infections|infections
1391084|NCT01201421|patient satisfaction|patient satisfaction
1391085|NCT01201421|assessments|assessments
1391086|NCT01201421|dental caries|dental caries
1391087|NCT01201421|dental materials|dental materials
1391088|NCT01201408|Dental Caries|dental caries
1391089|NCT01201408|Assessments|assessments
1391090|NCT01201408|dental materials|dental materials
1391091|NCT01201395|Dental Caries|dental caries
1391092|NCT01201395|Assessment|assessment
1391093|NCT01201395|dental materials|dental materials
1391094|NCT01201382|Depression|depression
1391097|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
1391098|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
1391099|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
1391100|NCT01201369|Coronary Artery Stent|coronary artery stent
1391101|NCT01201369|Optical Coherence Tomography|optical coherence tomography
1391102|NCT01201356|Fingolimod|fingolimod
1391103|NCT01201356|FTY720|fty720
1391104|NCT01201356|Relapsing forms of MS|relapsing forms of ms
1391105|NCT01201356|Multiple Sclerosis|multiple sclerosis
1391106|NCT01201356|Efficacy|efficacy
1391107|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
1391108|NCT01201343|Interferon-beta|interferon-beta
1391109|NCT01201330|ONJ|onj
1391110|NCT01201317|Analgesic effect|analgesic effect
1391111|NCT01201304|Anxiety sensitivity|anxiety sensitivity
1391112|NCT01201304|Panic|panic
1391113|NCT01201291|TBI|tbi
1391114|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
1391115|NCT01201291|Outcome|outcome
1391116|NCT01201291|GOS|gos
1391117|NCT01201291|GOSE|gose
1391118|NCT01201278|intranasal insulin|intranasal insulin
1391119|NCT01201252|children|children
1391120|NCT01201252|gastroenteritis|gastroenteritis
1391121|NCT01201252|Rotavirus|rotavirus
1391122|NCT01201239|raltegravir|raltegravir
1391123|NCT01201239|HIV-1|hiv-1
1391124|NCT01201239|drug resistance|drug resistance
1391125|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
1391126|NCT01201226|PTEN|pten
1391127|NCT01201226|PI3K activating peptide|pi3k activating peptide
1391128|NCT01201226|Low ovarian reserve|low ovarian reserve
1391129|NCT01201226|Gonadotrophins|gonadotrophins
1391130|NCT01201213|Bupivacaine|bupivacaine
1391131|NCT01201213|levobupivacaine|levobupivacaine
1391132|NCT01201213|ropivacaine|ropivacaine
1391133|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
1391134|NCT01201200|Right Ventricular Function|right ventricular function
1391135|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
1391136|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
1391137|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
1391138|NCT01201174|with documented family history of HS.|with documented family history of hs.
1391139|NCT01201174|spherocyte morphology,|spherocyte morphology,
1391140|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
1391141|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
1391142|NCT01201161|Retinal detachment|retinal detachment
1391143|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
1391144|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
1391145|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
1391146|NCT01201148|depression|depression
1391147|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1391148|NCT01201148|random noise stimulation|random noise stimulation
1391149|NCT01201148|oscillatory tDCS|oscillatory tdcs
1391150|NCT01201148|intermittent tDCS|intermittent tdcs
1391151|NCT01201122|Pediatric|pediatric
1391152|NCT01201122|Ulcerative colitis|ulcerative colitis
1391153|NCT01201122|5-ASA|5-asa
1391154|NCT01201122|Mesalamine|mesalamine
1391155|NCT01201122|Dosing|dosing
1391156|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
1391157|NCT01201109|Entrapment neuropathies|entrapment neuropathies
1391158|NCT01201109|Diabetes|diabetes
1391159|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
1391160|NCT01201096|liver metastasis|liver metastasis
1391161|NCT01201096|peptide receptor therapy|peptide receptor therapy
1391162|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
1391163|NCT01201057|SPL7013|spl7013
1391164|NCT01201057|VivaGel|vivagel
1391165|NCT01201057|bacterial vaginosis|bacterial vaginosis
1391166|NCT01201057|BV|bv
1391167|NCT01201044|BAI|bai
1391168|NCT01201044|3DCRT|3dcrt
1391169|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
1391170|NCT01201018|Tumor|tumor
1391171|NCT01201018|cancer|cancer
1391172|NCT01201018|metastasis|metastasis
1391173|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
1391174|NCT01200992|Neoplasms|neoplasms
1391175|NCT01200992|Urologic Neoplasms|urologic neoplasms
1391176|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
1391177|NCT01200992|Neoplasms by Site|neoplasms by site
1391178|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
1391179|NCT01200992|Urologic Diseases|urologic diseases
1391180|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
1391181|NCT01200992|Intravesical drug administration|intravesical drug administration
1391182|NCT01200979|Cytokine|cytokine
1391183|NCT01200979|Lymphocyte|lymphocyte
1391184|NCT01200979|Toll-Like Receptor|toll-like receptor
1391185|NCT01200979|NK Cell|nk cell
1391186|NCT01200979|Innate Immunity|innate immunity
1391187|NCT01200979|Pregnancy|pregnancy
1391188|NCT01200979|Immune Function|immune function
1391189|NCT01200966|Essential Tremor|essential tremor
1391190|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1391191|NCT01200966|Ethanol|ethanol
1391192|NCT01200966|Alcohol|alcohol
1391193|NCT01200966|Alcohol Clamp|alcohol clamp
1391195|NCT01200953|Select Agents|select agents
1391196|NCT01200953|Biosafety|biosafety
1391197|NCT01200953|Bioterrorism|bioterrorism
1391198|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
1391199|NCT01200953|Infectious Disease|infectious disease
1391200|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
1391201|NCT01200940|GLP-1|glp-1
1391202|NCT01200940|Glucose Tolerance|glucose tolerance
1391203|NCT01200940|Gut Hormones|gut hormones
1391204|NCT01200940|Gastric Bypass|gastric bypass
1391205|NCT01200940|Roux-en-Y|roux-en-y
1391206|NCT01200940|Bariatric Surgery|bariatric surgery
1391207|NCT01200927|infant|infant
1391208|NCT01200927|sitting|sitting
1391209|NCT01200927|postural control|postural control
1391210|NCT01200914|Hemodialysis|hemodialysis
1391211|NCT01200914|Fistula|fistula
1391212|NCT01200914|Angiograph|angiograph
1391213|NCT01200914|Angiogram|angiogram
1391214|NCT01200901|depression|depression
1391215|NCT01200901|healthy|healthy
1391216|NCT01200875|PRP|prp
1391217|NCT01200875|platelet rich plasma|platelet rich plasma
1391218|NCT01200875|platelet|platelet
1391219|NCT01200875|growth hormone|growth hormone
1391220|NCT01200875|tendonitis|tendonitis
1391221|NCT01200875|tendinosis|tendinosis
1391222|NCT01200875|tendinopathy|tendinopathy
1391223|NCT01200875|enthesopathy|enthesopathy
1391224|NCT01200875|muscle|muscle
1391225|NCT01200875|sport|sport
1391226|NCT01200875|tendon|tendon
1391227|NCT01200862|Obese|obese
1391228|NCT01200862|obesity|obesity
1391229|NCT01200862|hypogonadism|hypogonadism
1391230|NCT01200862|hypogonadotropic|hypogonadotropic
1391231|NCT01200862|hyperestrogenemic|hyperestrogenemic
1391232|NCT01200862|testosterone|testosterone
1391233|NCT01200862|hypogonadal|hypogonadal
1391234|NCT01200836|Statins|statins
1391235|NCT01200836|Immune Modulation|immune modulation
1391236|NCT01200836|Healthy Volunteer|healthy volunteer
1391237|NCT01200823|Laboratory Research|laboratory research
1391238|NCT01200823|Biologic Samples|biologic samples
1391239|NCT01200823|Tissue Collection|tissue collection
1391240|NCT01200823|Tissue Procurement|tissue procurement
1391241|NCT01200771|FDG-PET/CT|fdg-pet/ct
1391242|NCT01200771|FUO|fuo
1391243|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
1391244|NCT01200771|Fever of unknown origin|fever of unknown origin
1391245|NCT01200745|neck pain|neck pain
1391246|NCT01200745|capsaicin|capsaicin
1391247|NCT01200745|dermal patch|dermal patch
1391248|NCT01200732|Tadalafil|tadalafil
1391249|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
1391250|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
1391251|NCT01200719|brain electrical stimulation|brain electrical stimulation
1391252|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
1391253|NCT01200719|rehabilitation|rehabilitation
1391254|NCT01200706|children aged under 5 years|children aged under 5 years
1391255|NCT01200706|Non-severe|non-severe
1391256|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1391257|NCT01200693|Drug-Eluting Stents|drug-eluting stents
1391258|NCT01200680|Pediatric and Adult|pediatric and adult
1391259|NCT01200680|Gene Identification|gene identification
1391260|NCT01200680|Rare Bone Cancer|rare bone cancer
1391261|NCT01200680|All Chordoma Sites|all chordoma sites
1391262|NCT01200680|Sporadic Chordoma|sporadic chordoma
1391263|NCT01200680|Bone Cancer|bone cancer
1391264|NCT01200654|Population pharmacokinetics|population pharmacokinetics
1391265|NCT01200654|Linezolid|linezolid
1391266|NCT01200654|Monolix|monolix
1391267|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
1391268|NCT01200641|melatonin|melatonin
1391269|NCT01200641|gabapentin|gabapentin
1391270|NCT01200641|anxiety|anxiety
1391271|NCT01200641|pain|pain
1391272|NCT01200641|retrobulbar block|retrobulbar block
1391273|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
1391274|NCT01200628|acute PTSD|acute ptsd
1391275|NCT01200628|PTSD|ptsd
1391276|NCT01200628|motor vehicle accident|motor vehicle accident
1391277|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
1391278|NCT01200589|Randomized trial|randomized trial
1391279|NCT01200589|Ofatumumab|ofatumumab
1391280|NCT01200589|Rituximab|rituximab
1391281|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
1391282|NCT01200576|CRF: Case Report Form|crf: case report form
1391283|NCT01200576|DM: Data Management|dm: data management
1391284|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
1391285|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
1391286|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
1391287|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
1391288|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
1391289|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
1391290|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
1391291|NCT01200576|PI: Principal Investigator|pi: principal investigator
1391587|NCT01199614|PTH|pth
1391292|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
1391293|NCT01200576|Sino-Implant (II)|sino-implant (ii)
1391294|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
1391295|NCT01200576|Zarin|zarin
1391296|NCT01200563|MIST Therapy|mist therapy
1391297|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
1391298|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
1391299|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
1391300|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
1391301|NCT01200550|GERD Impact Scale|gerd impact scale
1391303|NCT01200537|poor responders|poor responders
1391304|NCT01200537|follicle synchrony|follicle synchrony
1391305|NCT01200537|IVF response|ivf response
1391306|NCT01200537|estrogen|estrogen
1391307|NCT01200537|estradiol (E2)|estradiol (e2)
1391308|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
1391309|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
1391310|NCT01200524|Analgesic effect|analgesic effect
1391311|NCT01200511|intraocular lens|intraocular lens
1391312|NCT01200511|multifocal|multifocal
1391313|NCT01200511|toric|toric
1391314|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
1391315|NCT01200498|Post Polycythemia Vera|post polycythemia vera
1391316|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
1391317|NCT01200498|SB939|sb939
1391318|NCT01200498|PMF|pmf
1391319|NCT01200498|post-PV MF|post-pv mf
1391320|NCT01200498|post-ET MF|post-et mf
1391321|NCT01200485|Supportive Care|supportive care
1391322|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
1391323|NCT01200485|Chemotherapy|chemotherapy
1391324|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
1391325|NCT01200485|Hematologic malignancies|hematologic malignancies
1391326|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
1391327|NCT01200472|EHOA|ehoa
1391328|NCT01200459|Obesity|obesity
1391329|NCT01200459|Weight Loss|weight loss
1391330|NCT01200459|Healthy Lifestyle|healthy lifestyle
1391331|NCT01200459|Social|social
1391332|NCT01200459|Mobile|mobile
1391333|NCT01200459|Facebook|facebook
1391334|NCT01200459|Text Messages|text messages
1391335|NCT01200446|Asthma|asthma
1391336|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
1391337|NCT01200446|Inflammation|inflammation
1391338|NCT01200446|Airway|airway
1391339|NCT01200446|Fish Oil|fish oil
1391340|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
1391341|NCT01200446|DHA|dha
1391342|NCT01200433|dexmedetomidine|dexmedetomidine
1391343|NCT01200433|propofol|propofol
1391344|NCT01200433|cerebral blood flow|cerebral blood flow
1391345|NCT01200433|brain oxygenation|brain oxygenation
1391346|NCT01200420|Antisense|antisense
1391347|NCT01200420|miR-122 antagonist|mir-122 antagonist
1391348|NCT01200420|host factor|host factor
1391349|NCT01200420|CHC|chc
1391350|NCT01200407|Hypertension|hypertension
1391351|NCT01200407|fixed drug combination|fixed drug combination
1391352|NCT01200407|Filipinos|filipinos
1391353|NCT01200407|Amlodipine|amlodipine
1391354|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
1391355|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
1391356|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
1391357|NCT01200394|Diabetic nephropathy|diabetic nephropathy
1391358|NCT01200394|chronic kidney disease|chronic kidney disease
1391359|NCT01200394|PF-00489791|pf-00489791
1391360|NCT01200394|phosphodiesterase|phosphodiesterase
1391361|NCT01200394|PDE5|pde5
1391362|NCT01200381|ICD|icd
1391363|NCT01200381|CRTD|crtd
1391364|NCT01200381|Remote care|remote care
1391365|NCT01200381|Remote monitoring|remote monitoring
1391366|NCT01200381|Heart failure|heart failure
1391367|NCT01200368|vaccine|vaccine
1391368|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
1391369|NCT01200355|MICAFUNGIN|micafungin
1391370|NCT01200355|POSACONAZOLE|posaconazole
1391371|NCT01200355|antifungal|antifungal
1391372|NCT01200355|prolonged neutropenia|prolonged neutropenia
1391373|NCT01200355|10-038|10-038
1391374|NCT01200342|Uveal melanoma|uveal melanoma
1391375|NCT01200342|Carboplatin|carboplatin
1391376|NCT01200342|Genasense|genasense
1391377|NCT01200342|Paclitaxel|paclitaxel
1391378|NCT01200342|oblimersen|oblimersen
1391379|NCT01200342|GCP|gcp
1391380|NCT01200329|Hodgkin's disease|hodgkin's disease
1391381|NCT01200329|Relapsed|relapsed
1391382|NCT01200329|Refractory|refractory
1391383|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
1391384|NCT01200329|Busulfan|busulfan
1391385|NCT01200329|Gemcitabine|gemcitabine
1391386|NCT01200329|Melphalan|melphalan
1391387|NCT01200316|Colon Cancer|colon cancer
1391388|NCT01200316|Abdominal Surgery|abdominal surgery
1391389|NCT01200316|Stress|stress
1391390|NCT01200316|Rocking Motion|rocking motion
1391391|NCT01200316|Salivary Cortisol|salivary cortisol
1391392|NCT01200316|Postoperative Ileus|postoperative ileus
1391393|NCT01200303|colon cancer|colon cancer
1391394|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
1391395|NCT01200303|colon screening|colon screening
1391396|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
1391397|NCT01200303|Computer Aided Detection|computer aided detection
1391398|NCT01200303|Electronic Cleansing|electronic cleansing
1391399|NCT01200290|end stage renal disease|end stage renal disease
1391400|NCT01200290|end stage kidney disease|end stage kidney disease
1391401|NCT01200290|ESRD|esrd
1391402|NCT01200290|Uremia|uremia
1391403|NCT01200290|Renal Dialysis|renal dialysis
1391404|NCT01200277|osteoporosis|osteoporosis
1391405|NCT01200277|vertebral fracture|vertebral fracture
1391406|NCT01200277|vertebroplasty|vertebroplasty
1391407|NCT01200277|percutaneous|percutaneous
1391408|NCT01200238|STA9090|sta9090
1391409|NCT01200238|STA-9090|sta-9090
1391410|NCT01200238|HSP90|hsp90
1391411|NCT01200212|Palliative Therapy|palliative therapy
1391412|NCT01200212|bevacizimab|bevacizimab
1391413|NCT01200212|Avastin|avastin
1391414|NCT01200212|Xeloda|xeloda
1391415|NCT01200212|metastatic breast cancer|metastatic breast cancer
1391416|NCT01200212|Progression Free Survival|progression free survival
1391417|NCT01200212|Time to Progression|time to progression
1391418|NCT01200212|Overall survival|overall survival
1391419|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
1391420|NCT01200173|product - infections - children|product - infections - children
1391421|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
1391422|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
1391423|NCT01200160|Latin America|latin america
1391424|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
1391425|NCT01200160|Cholesterol|cholesterol
1391426|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
1391427|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
1391428|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
1391429|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
1391430|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
1391431|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
1391432|NCT01200082|alcoholic liver disease|alcoholic liver disease
1391433|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
1391434|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
1391435|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
1391436|NCT01200069|depression,myalgia|depression,myalgia
1391437|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
1391438|NCT01200056|Statin-naive patient.|statin-naive patient.
1391439|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
1391440|NCT01200056|Clinical outcomes.|clinical outcomes.
1391441|NCT01200043|Childhood obesity|childhood obesity
1391442|NCT01200043|metabolic syndrome|metabolic syndrome
1391443|NCT01200043|insulin resistance|insulin resistance
1391444|NCT01200043|intrahepatic fat|intrahepatic fat
1391445|NCT01200043|hypertension|hypertension
1391446|NCT01200030|Sitting balance|sitting balance
1391447|NCT01200030|Stroke|stroke
1391448|NCT01200017|T cell depleted|t cell depleted
1391449|NCT01200017|Matched unrelated donors|matched unrelated donors
1391450|NCT01200017|Haplocompatible donors|haplocompatible donors
1391451|NCT01200017|Graft vs Host Disease|graft vs host disease
1391452|NCT01200017|Hemoglobinopathies|hemoglobinopathies
1391453|NCT01200017|Leukemia|leukemia
1391454|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
1391455|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
1391456|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1391457|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
1391458|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1391459|NCT01200017|Lymphoma|lymphoma
1391460|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
1391461|NCT01200017|Preleukemia|preleukemia
1391462|NCT01200017|Osteopetrosis|osteopetrosis
1391463|NCT01200017|Pancytopenia|pancytopenia
1391464|NCT01200017|Immune System Diseases|immune system diseases
1391465|NCT01200017|Hematologic Diseases|hematologic diseases
1391466|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
1391467|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
1391468|NCT01200017|Neoplasms|neoplasms
1391469|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
1391470|NCT01200017|Lymphatic Diseases|lymphatic diseases
1391471|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
1391472|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
1391473|NCT01200017|Bone Marrow Diseases|bone marrow diseases
1391474|NCT01200017|Precancerous Conditions|precancerous conditions
1391475|NCT01200017|Osteosclerosis|osteosclerosis
1391476|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
1391477|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
1391478|NCT01200017|Bone Diseases|bone diseases
1391479|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
1391480|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
1391481|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
1392379|NCT01196169|prosthesis|prosthesis
1391482|NCT01200004|Advanced solid tumor|advanced solid tumor
1391483|NCT01200004|Azacitidine|azacitidine
1391484|NCT01200004|Grifola frondosa|grifola frondosa
1391485|NCT01200004|Basidiomycete fungus|basidiomycete fungus
1391486|NCT01200004|Lenalidomide|lenalidomide
1391487|NCT01199978|radiation|radiation
1391488|NCT01199978|fractionated proton radiation|fractionated proton radiation
1391489|NCT01199952|contraception|contraception
1391490|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
1391492|NCT01199939|Etravirine|etravirine
1391493|NCT01199939|Darunavir|darunavir
1391494|NCT01199939|Prezista|prezista
1391495|NCT01199939|Intelence|intelence
1391496|NCT01199939|Ritonavir|ritonavir
1391497|NCT01199939|INROADS|inroads
1391498|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
1391499|NCT01199926|Parathyroid hormone|parathyroid hormone
1391500|NCT01199926|Lean mass|lean mass
1391501|NCT01199926|Muscular strength|muscular strength
1391502|NCT01199926|Glucose tolerance|glucose tolerance
1391503|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
1391504|NCT01199900|Healthy People|healthy people
1391505|NCT01199900|Glucocorticoids|glucocorticoids
1391506|NCT01199900|Prednisone|prednisone
1391507|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
1391508|NCT01199874|Rotavirus|rotavirus
1391509|NCT01199874|Rotavirus vaccine|rotavirus vaccine
1391510|NCT01199874|Dosing schedule|dosing schedule
1391511|NCT01199874|Immunogenicity|immunogenicity
1391512|NCT01199874|Breast feeding|breast feeding
1391513|NCT01199874|Pakistan|pakistan
1391514|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
1391516|NCT01199861|Immune response|immune response
1391517|NCT01199848|nutrition|nutrition
1391518|NCT01199848|polyphenolic|polyphenolic
1391519|NCT01199848|strawberry|strawberry
1391520|NCT01199848|insulin resistance|insulin resistance
1391521|NCT01199848|metabolic syndrome|metabolic syndrome
1391522|NCT01199835|obesity|obesity
1391523|NCT01199835|metabolic syndrome|metabolic syndrome
1391524|NCT01199835|fecal fat excretion|fecal fat excretion
1391525|NCT01199835|fecal calcium|fecal calcium
1391526|NCT01199835|weight loss|weight loss
1391527|NCT01199835|appetite regulation|appetite regulation
1391528|NCT01199835|intestinal micro flora|intestinal micro flora
1391529|NCT01199835|lipid profile|lipid profile
1391530|NCT01199835|energy balance|energy balance
1391531|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
1391532|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
1391533|NCT01199783|Antimicrobial therapy|antimicrobial therapy
1391534|NCT01199783|Daptomycin|daptomycin
1391535|NCT01199770|pasta|pasta
1391536|NCT01199770|appetite|appetite
1391537|NCT01199770|hunger|hunger
1391538|NCT01199770|satiety|satiety
1391539|NCT01199770|nutrition|nutrition
1391540|NCT01199770|metabolic|metabolic
1391541|NCT01199770|gut peptide hormones|gut peptide hormones
1391542|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
1391543|NCT01199757|ocular symptoms|ocular symptoms
1391544|NCT01199757|nasal symptoms|nasal symptoms
1391545|NCT01199757|Allergic Rhinitis|allergic rhinitis
1391546|NCT01199757|Symptom Free Days|symptom free days
1391547|NCT01199757|Quality of Life|quality of life
1391548|NCT01199744|Influenza|influenza
1391549|NCT01199744|Relenza®|relenza®
1391550|NCT01199744|SSMP|ssmp
1391551|NCT01199731|raltegravir|raltegravir
1391552|NCT01199731|NNRTI|nnrti
1391553|NCT01199731|ritonavir|ritonavir
1391554|NCT01199731|darunavir|darunavir
1391555|NCT01199731|HIV|hiv
1391556|NCT01199731|GSK2248761|gsk2248761
1391557|NCT01199731|antiretroviral|antiretroviral
1391558|NCT01199731|HIV Infection|hiv infection
1391559|NCT01199731|HAART|haart
1391560|NCT01199718|Multiple myeloma|multiple myeloma
1391561|NCT01199718|Plasmacytoma|plasmacytoma
1391562|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
1391563|NCT01199705|SCIG|scig
1391564|NCT01199705|Primary immunodeficiency|primary immunodeficiency
1391565|NCT01199705|PID|pid
1391566|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1391567|NCT01199679|Heartburn|heartburn
1391568|NCT01199679|Regurgitation|regurgitation
1391569|NCT01199679|Dyspepsia|dyspepsia
1391570|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
1391571|NCT01199666|Underimmunization|underimmunization
1391572|NCT01199653|clavicle fractures|clavicle fractures
1391573|NCT01199653|midshaft|midshaft
1391574|NCT01199653|dislocated|dislocated
1391575|NCT01199653|operative treatment|operative treatment
1391576|NCT01199653|conservative treatment|conservative treatment
1391577|NCT01199653|non-operative treatment|non-operative treatment
1391578|NCT01199653|randomized controlled trial|randomized controlled trial
1391579|NCT01199653|bone plates|bone plates
1391580|NCT01199627|total hip replacement|total hip replacement
1391581|NCT01199627|tranexamic acid|tranexamic acid
1391582|NCT01199614|Hypoparathyroidism|hypoparathyroidism
1391583|NCT01199614|Hypopara|hypopara
1391584|NCT01199614|HPTH|hpth
1391585|NCT01199614|Hypocalcemia|hypocalcemia
1391586|NCT01199614|Hypercalciuria|hypercalciuria
1391588|NCT01199614|PTH(1-84)|pth(1-84)
1391589|NCT01199588|VLU|vlu
1391590|NCT01199588|Venous Leg Ulcers|venous leg ulcers
1391591|NCT01199588|Ulcers|ulcers
1391592|NCT01199588|chronic wounds|chronic wounds
1391593|NCT01199588|wounds|wounds
1391594|NCT01199588|Nexagon|nexagon
1391595|NCT01199588|CoDa|coda
1391596|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1391597|NCT01199575|CLL|cll
1391598|NCT01199575|Relapsed or Refractory|relapsed or refractory
1391599|NCT01199575|previously treated|previously treated
1391600|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
1391601|NCT01199523|YM178|ym178
1391602|NCT01199523|Mirabegron|mirabegron
1391603|NCT01199523|QT|qt
1391604|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
1391605|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
1391606|NCT01199484|Cow's milk allergy|cow's milk allergy
1391607|NCT01199484|food allergy|food allergy
1391608|NCT01199484|oral desensitization|oral desensitization
1391609|NCT01199484|randomized trial|randomized trial
1391610|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
1391611|NCT01199471|Sevoflurane|sevoflurane
1391612|NCT01199471|Physician's Practice Patterns|physician's practice patterns
1391613|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
1391614|NCT01199471|Chinese|chinese
1391615|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
1391616|NCT01199458|Barrier pressure|barrier pressure
1391617|NCT01199445|vitamin A deficiency|vitamin a deficiency
1391618|NCT01199432|Primary Breast Cancer|primary breast cancer
1391619|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
1391620|NCT01199419|drug-eluting stent|drug-eluting stent
1391621|NCT01199419|CABG|cabg
1391622|NCT01199419|cost-effectiveness|cost-effectiveness
1391623|NCT01199406|gallstone|gallstone
1391624|NCT01199406|gallbladder|gallbladder
1391625|NCT01199406|cholecystectomy|cholecystectomy
1391626|NCT01199406|laparoscopic|laparoscopic
1391627|NCT01199406|pain|pain
1391628|NCT01199393|breast neoplasm|breast neoplasm
1391629|NCT01199393|drug therapy|drug therapy
1391630|NCT01199393|polymorphism|polymorphism
1391631|NCT01199393|gene|gene
1391632|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
1391633|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
1391634|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
1391635|NCT01199341|Phase 1|phase 1
1391636|NCT01199341|Drug-Drug interaction|drug-drug interaction
1391637|NCT01199341|warfarin|warfarin
1391638|NCT01199341|AZD1981|azd1981
1391639|NCT01199328|Nexium|nexium
1391640|NCT01199328|aspirin|aspirin
1391641|NCT01199328|peptic ulcers|peptic ulcers
1391642|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
1391643|NCT01199328|Esomoeprazole|esomoeprazole
1391644|NCT01199315|safety|safety
1391645|NCT01199315|tolerability|tolerability
1391646|NCT01199315|AZD1446|azd1446
1391647|NCT01199315|AD|ad
1391648|NCT01199315|ADHD|adhd
1391649|NCT01199315|Japanese|japanese
1391650|NCT01199302|Amgen|amgen
1391651|NCT01199302|Crohn's|crohn's
1391652|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
1391653|NCT01199302|IBD|ibd
1391654|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
1391655|NCT01199302|IBS|ibs
1391656|NCT01199302|Inflammation|inflammation
1391657|NCT01199302|bowel|bowel
1391658|NCT01199302|colon|colon
1391659|NCT01199302|gastrointestinal|gastrointestinal
1391660|NCT01199289|Amgen|amgen
1391661|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
1391662|NCT01199289|wheezing|wheezing
1391663|NCT01199276|Delirium|delirium
1391664|NCT01199276|Hip Fracture|hip fracture
1391665|NCT01199276|Elderly|elderly
1391666|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
1391667|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
1391668|NCT01199224|Solid Tumors|solid tumors
1391669|NCT01199224|veliparib|veliparib
1391670|NCT01199224|refractory|refractory
1391671|NCT01199224|relapsed|relapsed
1391672|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
1391673|NCT01199198|Hyponatremia|hyponatremia
1391674|NCT01199198|Serum sodium|serum sodium
1391675|NCT01199198|Tolvaptan|tolvaptan
1391676|NCT01199198|Placebo|placebo
1391677|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
1391678|NCT01199159|misoprostol|misoprostol
1391679|NCT01199159|hysterectomy|hysterectomy
1391680|NCT01199159|operative blood loss|operative blood loss
1391681|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
1391682|NCT01199146|Abiraterone acetate|abiraterone acetate
1391683|NCT01199120|Omega-3|omega-3
1391684|NCT01199120|Cognition|cognition
1391685|NCT01199120|Malnourishment|malnourishment
1391686|NCT01199107|PTSD|ptsd
1391687|NCT01199107|Anxiety|anxiety
1391688|NCT01199107|Behavior Therapy|behavior therapy
1391689|NCT01199107|Prolonged Exposure|prolonged exposure
1391690|NCT01199107|Exercise|exercise
1391691|NCT01199107|Wellness|wellness
1391692|NCT01199107|Posttraumatic|posttraumatic
1391693|NCT01199107|Stress|stress
1391694|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
1391695|NCT01199094|high bone mass|high bone mass
1391696|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
1391697|NCT01199094|bone turnover markers|bone turnover markers
1391698|NCT01199068|PPAR gamma agonist|ppar gamma agonist
1391699|NCT01199068|Tumor|tumor
1391700|NCT01199068|Cancer|cancer
1391701|NCT01199068|Antineoplastic Agent|antineoplastic agent
1391702|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
1391703|NCT01199068|Erlotinib|erlotinib
1391704|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
1391705|NCT01199068|Neoplasms|neoplasms
1391706|NCT01199055|PPAR gamma agonist|ppar gamma agonist
1391707|NCT01199055|Tumor|tumor
1391708|NCT01199055|Cancer|cancer
1391709|NCT01199055|Antineoplastic Agent|antineoplastic agent
1391710|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
1391711|NCT01199055|Carboplatin|carboplatin
1391712|NCT01199055|Paclitaxel|paclitaxel
1391713|NCT01199055|Neoplasms|neoplasms
1391714|NCT01199029|Healthy People|healthy people
1391715|NCT01199029|Glucocorticoids|glucocorticoids
1391716|NCT01199029|Prednisone|prednisone
1391717|NCT01199016|Acute otitis media|acute otitis media
1391718|NCT01199016|Prevnar 13|prevnar 13
1391719|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
1391720|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
1391721|NCT01198977|multiple sclerosis|multiple sclerosis
1391722|NCT01198977|Fatigue|fatigue
1391723|NCT01198977|exercise|exercise
1391724|NCT01198977|telemedicine|telemedicine
1391725|NCT01198977|motivational interviewing|motivational interviewing
1391726|NCT01198977|counseling|counseling
1391727|NCT01198977|depression|depression
1391728|NCT01198977|physical activity|physical activity
1391729|NCT01198964|ECoG|ecog
1391730|NCT01198964|Epilepsy|epilepsy
1391731|NCT01198964|cortical|cortical
1391732|NCT01198964|stimulation|stimulation
1391733|NCT01198964|Electrocorticography|electrocorticography
1391734|NCT01198964|electrodes|electrodes
1391735|NCT01198964|mapping|mapping
1391736|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
1391737|NCT01198925|Infectious disease|infectious disease
1391738|NCT01198925|piperacillin|piperacillin
1391739|NCT01198925|continuous infusion|continuous infusion
1391740|NCT01198925|extended infusion|extended infusion
1391741|NCT01198912|rhinosinusitis|rhinosinusitis
1391742|NCT01198912|doxycycline|doxycycline
1391743|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
1391744|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
1391745|NCT01198899|gen mutation|gen mutation
1391746|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
1391747|NCT01198886|Mobility disability|mobility disability
1391748|NCT01198886|Older adults|older adults
1391749|NCT01198886|Physical activity|physical activity
1391750|NCT01198886|Nutritional status|nutritional status
1391751|NCT01198860|HBsAg|hbsag
1391752|NCT01198847|child overweight|child overweight
1391753|NCT01198847|child obesity|child obesity
1391754|NCT01198847|prevention|prevention
1391755|NCT01198847|targeted intervention|targeted intervention
1391756|NCT01198847|development of overweight|development of overweight
1391757|NCT01198834|ankle sprains|ankle sprains
1391758|NCT01198821|pancreas|pancreas
1391759|NCT01198821|adenocarcinoma|adenocarcinoma
1391760|NCT01198821|metastatic|metastatic
1391761|NCT01198821|unresectable|unresectable
1391762|NCT01198808|Bladder cancer|bladder cancer
1391763|NCT01198808|chemotherapy|chemotherapy
1391764|NCT01198808|T cells|t cells
1391765|NCT01198808|Immunotherapy|immunotherapy
1391766|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
1391767|NCT01198795|depression|depression
1391768|NCT01198795|major depressive disorder|major depressive disorder
1391769|NCT01198795|escitalopram|escitalopram
1391770|NCT01198795|Lexapro|lexapro
1391771|NCT01198795|pediatric|pediatric
1391772|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
1391773|NCT01198756|Influenza|influenza
1391774|NCT01198743|Genetics modifications|genetics modifications
1391775|NCT01198743|colorectal cancer|colorectal cancer
1391776|NCT01198743|prognosis aim|prognosis aim
1391777|NCT01198743|DNA|dna
1391778|NCT01198743|Plasma|plasma
1391779|NCT01198730|DM|dm
1391780|NCT01198730|CAD|cad
1391781|NCT01198730|Meal tolerance test|meal tolerance test
1391782|NCT01198730|Acarbose|acarbose
1391783|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
1515842|NCT00718094|IBD|ibd
1391784|NCT01198704|Cirrhosis|cirrhosis
1391785|NCT01198704|Transplantation|transplantation
1391786|NCT01198691|metallic staples|metallic staples
1391787|NCT01198691|absorbable staples|absorbable staples
1391788|NCT01198691|Cesarean Delivery|cesarean delivery
1391789|NCT01198665|RAD001|rad001
1391790|NCT01198665|chemotherpy|chemotherpy
1391791|NCT01198665|T cell lymphoma|t cell lymphoma
1391792|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
1391794|NCT01198626|CAP|cap
1391795|NCT01198626|pneumonia|pneumonia
1391796|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
1391797|NCT01198626|bacterial infections|bacterial infections
1391798|NCT01198626|anti-bacterial agents|anti-bacterial agents
1391799|NCT01198626|anti-infective agents|anti-infective agents
1391800|NCT01198626|lung disease, interstitial|lung disease, interstitial
1391801|NCT01198626|respiratory tract diseases|respiratory tract diseases
1391802|NCT01198626|respiratory tract infections|respiratory tract infections
1391803|NCT01198626|community-acquired infections|community-acquired infections
1391804|NCT01198613|Ragweed allergy|ragweed allergy
1391805|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
1391806|NCT01198613|Exposure chamber|exposure chamber
1391807|NCT01198613|Immunotherapy|immunotherapy
1391808|NCT01198613|ToleroMune Ragweed|toleromune ragweed
1391809|NCT01198587|Diarrhea|diarrhea
1391810|NCT01198587|Gastroenteritis|gastroenteritis
1391811|NCT01198587|Zinc Supplementation|zinc supplementation
1391812|NCT01198574|anemia|anemia
1391813|NCT01198574|iron supplementation|iron supplementation
1391814|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
1391815|NCT01198574|adolescents|adolescents
1391816|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1391817|NCT01198561|Major Depressive Disorder|major depressive disorder
1391818|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
1391819|NCT01198522|L19|l19
1391820|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
1391821|NCT01198509|psoriatic arthritis|psoriatic arthritis
1391822|NCT01198509|periodontitis|periodontitis
1391823|NCT01198509|microbiota|microbiota
1391824|NCT01198509|microbiome|microbiome
1391825|NCT01198509|vancomycin|vancomycin
1391826|NCT01198509|doxycycline|doxycycline
1391827|NCT01198509|T cell|t cell
1391828|NCT01198509|Th17|th17
1391829|NCT01198496|hypertension|hypertension
1391830|NCT01198496|stroke|stroke
1391831|NCT01198496|blood pressure|blood pressure
1391832|NCT01198483|refraction|refraction
1391833|NCT01198483|refractive error|refractive error
1391834|NCT01198483|combined surgery|combined surgery
1391835|NCT01198483|microincision|microincision
1391836|NCT01198483|smallincision|smallincision
1391837|NCT01198483|cataract surgery|cataract surgery
1391838|NCT01198483|vitrectomy|vitrectomy
1391839|NCT01198470|Low back pain|low back pain
1391840|NCT01198470|Leg pain|leg pain
1391841|NCT01198470|Discogenic pain|discogenic pain
1391842|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
1391843|NCT01198470|Herniated disc|herniated disc
1391844|NCT01198470|Radiculopathy|radiculopathy
1391845|NCT01198457|Clodronate|clodronate
1391846|NCT01198457|Compliance|compliance
1391847|NCT01198444|Contraception|contraception
1391848|NCT01198444|Compliance|compliance
1391849|NCT01198431|Appetite regulation|appetite regulation
1391850|NCT01198431|Physical activity|physical activity
1391851|NCT01198431|Energy balance|energy balance
1391852|NCT01198418|STI|sti
1391853|NCT01198418|MSM|msm
1391854|NCT01198418|HIV|hiv
1391855|NCT01198418|Prevention|prevention
1391856|NCT01198418|Men having sex with men|men having sex with men
1391857|NCT01198405|coronary artery disease|coronary artery disease
1391858|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
1391859|NCT01198392|gastric cancer|gastric cancer
1391860|NCT01198379|aspirin|aspirin
1391861|NCT01198379|aspirin resistance|aspirin resistance
1391862|NCT01198379|hemodialysis|hemodialysis
1391863|NCT01198379|cardiovascular|cardiovascular
1391864|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
1391865|NCT01198366|Tuberculosis|tuberculosis
1391866|NCT01198366|Vaccine|vaccine
1391867|NCT01198366|Immunogenicity|immunogenicity
1391868|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
1391869|NCT01198353|Schizophrenia|schizophrenia
1391870|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
1391871|NCT01198353|Ziprasidone|ziprasidone
1391872|NCT01198353|Switch|switch
1391873|NCT01198353|Metabolic syndrome|metabolic syndrome
1391874|NCT01198327|RVO|rvo
1391875|NCT01198327|CRVO|crvo
1391876|NCT01198327|BRVO|brvo
1391877|NCT01198327|Horizon|horizon
1391878|NCT01198327|Bravo|bravo
1391879|NCT01198327|Cruise|cruise
1391880|NCT01198314|long term|long term
1391881|NCT01198314|stable|stable
1391882|NCT01198314|recipients|recipients
1391883|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
1391884|NCT01198301|Gene Expression Profiling|gene expression profiling
1391885|NCT01198301|Drug Therapy|drug therapy
1391886|NCT01198288|COPD|copd
1391887|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
1391888|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
1391889|NCT01198262|polymerase chain reaction|polymerase chain reaction
1391890|NCT01198236|hematological malignancy|hematological malignancy
1391891|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
1391892|NCT01198223|denture stomatitis|denture stomatitis
1391893|NCT01198223|nystatin|nystatin
1391894|NCT01198223|garlic|garlic
1391895|NCT01198210|pain|pain
1391896|NCT01198210|tonsillectomy|tonsillectomy
1391897|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
1391898|NCT01198210|postoperative pain|postoperative pain
1391899|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
1391900|NCT01198197|PET Imaging|pet imaging
1391901|NCT01198197|Brain Imaging|brain imaging
1391902|NCT01198197|Healthy Volunteer|healthy volunteer
1391903|NCT01198197|HV|hv
1391904|NCT01198145|diarrhea|diarrhea
1391905|NCT01198145|gastrointestinal complications|gastrointestinal complications
1391906|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1391907|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
1391908|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
1391909|NCT01198132|Rebif|rebif
1391910|NCT01198132|Vitamin D3|vitamin d3
1391911|NCT01198132|Cholecalciferol|cholecalciferol
1391912|NCT01198119|oral cavity tumor|oral cavity tumor
1391913|NCT01198119|narrow band imaging|narrow band imaging
1391914|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
1391915|NCT01198106|simulator sickness|simulator sickness
1391916|NCT01198106|scopolamine|scopolamine
1391917|NCT01198106|cinnarizine|cinnarizine
1391918|NCT01198093|Alzheimer's disease|alzheimer's disease
1391919|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
1391920|NCT01198093|cohort study|cohort study
1391921|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
1391922|NCT01198067|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1391923|NCT01198067|B-cell lymphoproliferative disorder|b-cell lymphoproliferative disorder
1391924|NCT01198067|Bone marrow|bone marrow
1391925|NCT01198067|Lymphoplasmacytic cells|lymphoplasmacytic cells
1391926|NCT01198067|Monoclonal gammopathy|monoclonal gammopathy
1391927|NCT01198067|Pomalidomide|pomalidomide
1391928|NCT01198067|Actimid|actimid
1391929|NCT01198067|CC-4047|cc-4047
1391930|NCT01198054|AML|aml
1391931|NCT01198054|Lenalidomide|lenalidomide
1391932|NCT01198028|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1391933|NCT01198028|Cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
1391934|NCT01198028|CSCC|cscc
1391935|NCT01198028|epidermal growth factor receptor|epidermal growth factor receptor
1391936|NCT01198028|EGFR|egfr
1391937|NCT01198028|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1391938|NCT01198028|recurrent|recurrent
1391939|NCT01198028|Erlotinib|erlotinib
1391940|NCT01198028|Erlotinib hydrochloride|erlotinib hydrochloride
1391941|NCT01198028|OSI-774|osi-774
1391942|NCT01198028|Tarceva|tarceva
1391943|NCT01198015|Rett syndrome|rett syndrome
1391944|NCT01198015|Nutritional status|nutritional status
1391945|NCT01198015|Creatine metabolism|creatine metabolism
1391946|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
1391947|NCT01197989|pustulosis|pustulosis
1391948|NCT01197989|soles|soles
1391949|NCT01197989|teflon|teflon
1391950|NCT01197976|psoriasis|psoriasis
1391951|NCT01197976|soles|soles
1391952|NCT01197976|teflon|teflon
1391953|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
1391954|NCT01197950|acupuncture|acupuncture
1391955|NCT01197950|labour|labour
1391956|NCT01197950|pain|pain
1391957|NCT01197950|pain relief|pain relief
1391958|NCT01197950|complementary|complementary
1391959|NCT01197924|child cancer brain|child cancer brain
1391960|NCT01197898|Diabetic|diabetic
1391961|NCT01197898|Foot|foot
1391962|NCT01197898|Ulcers|ulcers
1391963|NCT01197898|Wounds|wounds
1391964|NCT01197833|varicose veins|varicose veins
1391965|NCT01197833|Great saphenous vein|great saphenous vein
1391966|NCT01197833|varicosities|varicosities
1391967|NCT01197820|HIFU|hifu
1391968|NCT01197820|mobile organs|mobile organs
1391969|NCT01197820|thermometry|thermometry
1391970|NCT01197820|MR|mr
1391971|NCT01197820|liver|liver
1391972|NCT01197820|kidney|kidney
1391973|NCT01197820|cancer|cancer
1391974|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
1391975|NCT01197807|Suctioning|suctioning
1391976|NCT01197807|Wiping|wiping
1391977|NCT01197807|Neonate|neonate
1391978|NCT01197807|Resuscitation|resuscitation
1391979|NCT01197794|Efficacy|efficacy
1391980|NCT01197794|safety|safety
1391981|NCT01197794|tolerability|tolerability
1391982|NCT01197794|dose finding|dose finding
1391983|NCT01197794|asthma patients|asthma patients
1391984|NCT01197781|Phase I|phase i
1391985|NCT01197781|FosD|fosd
1391986|NCT01197781|fostamatinib disodium|fostamatinib disodium
1391987|NCT01197781|verapamil|verapamil
1391988|NCT01197781|healthy volunteers|healthy volunteers
1391989|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
1391990|NCT01197742|Diabetes|diabetes
1391991|NCT01197742|STEMI|stemi
1391992|NCT01197742|NSTEMI|nstemi
1392575|NCT01195220|teenagers|teenagers
1391993|NCT01197742|Myocardial infarction|myocardial infarction
1391994|NCT01197729|Myocardial infarction|myocardial infarction
1391995|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
1391996|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
1391997|NCT01197729|Register|register
1391998|NCT01197729|CARDS|cards
1391999|NCT01197716|Chest Pain Unit|chest pain unit
1392000|NCT01197716|Myocardial infarction|myocardial infarction
1392001|NCT01197716|Register|register
1392002|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
1392003|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
1392004|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
1392005|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
1392006|NCT01197703|Registry|registry
1392007|NCT01197690|Bronchial asthma|bronchial asthma
1392008|NCT01197690|level of control of asthma|level of control of asthma
1392009|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
1392010|NCT01197690|asthma control test (ACT)|asthma control test (act)
1392011|NCT01197677|CMR|cmr
1392012|NCT01197677|Register|register
1392013|NCT01197677|CAD|cad
1392014|NCT01197677|myocard scarring|myocard scarring
1392015|NCT01197651|Aorta|aorta
1392016|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
1392017|NCT01197651|Surgical operation|surgical operation
1392018|NCT01197651|Aortic dissection|aortic dissection
1392019|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
1392020|NCT01197638|Catheter ablation|catheter ablation
1392021|NCT01197638|Register|register
1392022|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
1392023|NCT01197599|Healthy Control|healthy control
1392024|NCT01197586|surfactant protein B|surfactant protein b
1392025|NCT01197586|differential diagnostics|differential diagnostics
1392026|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1392027|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1392028|NCT01197560|relapsed|relapsed
1392029|NCT01197560|refractory|refractory
1392030|NCT01197560|relapsed/refractory|relapsed/refractory
1392031|NCT01197560|DLBCL|dlbcl
1392032|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1392033|NCT01197547|Menorrhagia|menorrhagia
1392034|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
1392035|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
1392036|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
1392037|NCT01197482|asthma|asthma
1392038|NCT01197482|inhalation|inhalation
1392039|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
1392040|NCT01197456|Breast cancer|breast cancer
1392041|NCT01197456|Ovarian insufficiency|ovarian insufficiency
1392042|NCT01197456|Ovarian failure|ovarian failure
1392043|NCT01197456|Reproduction|reproduction
1392044|NCT01197443|obesity|obesity
1392045|NCT01197443|overweight|overweight
1392046|NCT01197443|overweight children|overweight children
1392047|NCT01197443|overweight parents|overweight parents
1392048|NCT01197443|families with overweight child|families with overweight child
1392049|NCT01197443|body mass index|body mass index
1392050|NCT01197443|BMI|bmi
1392051|NCT01197443|weight|weight
1392052|NCT01197443|childhood obesity|childhood obesity
1392053|NCT01197443|diet|diet
1392054|NCT01197443|treatment|treatment
1392055|NCT01197443|parent modeling|parent modeling
1392056|NCT01197443|traffic light diet|traffic light diet
1392057|NCT01197443|stop light diet|stop light diet
1392058|NCT01197430|volleyball|volleyball
1392059|NCT01197430|neck vertical stability training|neck vertical stability training
1392060|NCT01197430|eye-hand coordination|eye-hand coordination
1392061|NCT01197417|Sickle Cell Disease|sickle cell disease
1392062|NCT01197417|Magnesium Sulfate|magnesium sulfate
1392063|NCT01197417|Pediatric|pediatric
1392064|NCT01197404|HIV Prevention|hiv prevention
1392065|NCT01197378|cystinosis|cystinosis
1392066|NCT01197378|cysteamine|cysteamine
1392067|NCT01197378|inheritable disease|inheritable disease
1392068|NCT01197378|orphan disease|orphan disease
1392069|NCT01197378|CTNS protein, human|ctns protein, human
1392070|NCT01197378|metabolic disease|metabolic disease
1392071|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
1392072|NCT01197365|Acidified milk|acidified milk
1392073|NCT01197365|Beta-palmitate|beta-palmitate
1392074|NCT01197365|Bifidobacteria|bifidobacteria
1392075|NCT01197365|Infant formula|infant formula
1392076|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
1392077|NCT01197365|Growth|growth
1392078|NCT01197365|Infants|infants
1392079|NCT01197365|Prebiotics|prebiotics
1392080|NCT01197352|Alcohol|alcohol
1392081|NCT01197352|Abuse|abuse
1392082|NCT01197352|Drinking|drinking
1392083|NCT01197352|Behavior|behavior
1392084|NCT01197352|Text|text
1392085|NCT01197352|Computer|computer
1392086|NCT01197339|acute phonotrauma|acute phonotrauma
1392087|NCT01197339|computer modeling|computer modeling
1392088|NCT01197339|resonant voice|resonant voice
1392089|NCT01197339|breathy voice|breathy voice
1392090|NCT01197339|voice rest|voice rest
1392091|NCT01197339|relaxation|relaxation
1392092|NCT01197326|patient deterioration|patient deterioration
1392093|NCT01197326|unplanned ICU admissions|unplanned icu admissions
1392094|NCT01197326|rapid response teams|rapid response teams
1392095|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
1392096|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
1392097|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1392099|NCT01197274|skin prick test|skin prick test
1392100|NCT01197274|mite sensitivity|mite sensitivity
1392101|NCT01197261|Severe pain|severe pain
1392102|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
1392103|NCT01197261|Interstitial Cystitis|interstitial cystitis
1392104|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
1392105|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
1392106|NCT01197248|cystocele|cystocele
1392107|NCT01197248|voiding|voiding
1392108|NCT01197248|dysfunction|dysfunction
1392109|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
1392110|NCT01197222|Laparoscopic|laparoscopic
1392111|NCT01197222|EndoClear|endoclear
1392112|NCT01197222|Lens Cleaning Device|lens cleaning device
1392113|NCT01197209|Prostate Cancer|prostate cancer
1392114|NCT01197209|Prostatectomy|prostatectomy
1392115|NCT01197209|Postectomy|postectomy
1392116|NCT01197209|Oncology|oncology
1392117|NCT01197209|REIC|reic
1392118|NCT01197209|Dikkoff|dikkoff
1392119|NCT01197209|Apoptosis|apoptosis
1392120|NCT01197196|Migraine|migraine
1392121|NCT01197196|Obesity|obesity
1392122|NCT01197196|Weight loss|weight loss
1392123|NCT01197196|Lifestyle|lifestyle
1392124|NCT01197196|Behavior|behavior
1392125|NCT01197183|Hypothyroidism|hypothyroidism
1392126|NCT01197183|Thyroid hormones|thyroid hormones
1392127|NCT01197170|Hormonal therapies|hormonal therapies
1392128|NCT01197170|Estrogen receptor|estrogen receptor
1392129|NCT01197170|Progesterone receptor|progesterone receptor
1392130|NCT01197170|Hormone blockade|hormone blockade
1392131|NCT01197170|Hormone-positive tumors|hormone-positive tumors
1392132|NCT01197170|Advanced cancer|advanced cancer
1392133|NCT01197170|Metastatic cancer|metastatic cancer
1392134|NCT01197170|Avastin|avastin
1392135|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1392136|NCT01197170|rhuMAB-VEGF|rhumab-vegf
1392137|NCT01197170|Afinitor|afinitor
1392138|NCT01197170|RAD001|rad001
1392139|NCT01197170|Nexavar|nexavar
1392140|NCT01197170|BAY43-9006|bay43-9006
1392141|NCT01197170|OSI-774|osi-774
1392142|NCT01197170|Tarceva|tarceva
1392143|NCT01197157|chronic hepatitis C|chronic hepatitis c
1392144|NCT01197157|genotype 4|genotype 4
1392145|NCT01197157|treatment naive patients|treatment naive patients
1392146|NCT01197157|Egypt|egypt
1392147|NCT01197144|TNF|tnf
1392148|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1392149|NCT01197144|Autonomic|autonomic
1392150|NCT01197144|Vagus|vagus
1392151|NCT01197144|adalimumab|adalimumab
1392152|NCT01197131|autism|autism
1392153|NCT01197131|autism spectrum disorder|autism spectrum disorder
1392154|NCT01197131|steroids|steroids
1392155|NCT01197131|steroid metabolites|steroid metabolites
1392156|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
1392157|NCT01197131|hormone formation|hormone formation
1392158|NCT01197131|androgen precursor|androgen precursor
1392159|NCT01197118|gastric cancer|gastric cancer
1392160|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
1392161|NCT01197118|OLF regimen|olf regimen
1392162|NCT01197118|survival rate|survival rate
1392163|NCT01197105|gingivitis|gingivitis
1392164|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
1392165|NCT01197105|natural products|natural products
1392166|NCT01197092|Diabetes|diabetes
1392167|NCT01197079|HPV|hpv
1392168|NCT01197079|Vaccine|vaccine
1392169|NCT01197079|Vaccine utilization|vaccine utilization
1392170|NCT01197079|Disease awareness|disease awareness
1392171|NCT01197053|Peanut Allergy|peanut allergy
1392172|NCT01197053|Food Allergy|food allergy
1392173|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
1392174|NCT01197053|Food Challenge|food challenge
1392175|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
1392176|NCT01197040|Complete remission|complete remission
1392177|NCT01197040|Myfortic|myfortic
1516324|NCT00716300|obesity|obesity
1392178|NCT01197040|Minimal Change Disease|minimal change disease
1392179|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
1392180|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
1392181|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
1392182|NCT01196988|influenza infection|influenza infection
1392183|NCT01196975|Influenza|influenza
1392184|NCT01196962|central venous catheter|central venous catheter
1392185|NCT01196962|complications|complications
1392186|NCT01196962|internal jugular vein|internal jugular vein
1392187|NCT01196962|randomized trial|randomized trial
1392577|NCT01195207|CNTO 3157|cnto 3157
1392188|NCT01196962|subclavian vein|subclavian vein
1392189|NCT01196949|Ankle|ankle
1392190|NCT01196949|Chronic|chronic
1392191|NCT01196949|Instability|instability
1392192|NCT01196949|Manipulative|manipulative
1392193|NCT01196949|Rehabilitative|rehabilitative
1392194|NCT01196949|Manipulation|manipulation
1392195|NCT01196949|Rehabilitation|rehabilitation
1392196|NCT01196936|Cancer survivors|cancer survivors
1392197|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
1392198|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
1392199|NCT01196897|Atrial fibrillation|atrial fibrillation
1392200|NCT01196897|Stroke|stroke
1392201|NCT01196897|Warfarin|warfarin
1392202|NCT01196897|Coumadin|coumadin
1392203|NCT01196897|TIA|tia
1392204|NCT01196897|Trans Ischemic Attack|trans ischemic attack
1392205|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
1392206|NCT01196871|Fabry disease|fabry disease
1392207|NCT01196871|drug drug interaction|drug drug interaction
1392208|NCT01196845|adipose tissue|adipose tissue
1392209|NCT01196845|obese patients|obese patients
1392210|NCT01196845|inflammation|inflammation
1392211|NCT01196845|oxidative stress|oxidative stress
1392212|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
1392213|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
1392214|NCT01196793|Feverish illness in children|feverish illness in children
1392215|NCT01196767|Sternotomy|sternotomy
1392216|NCT01196767|Pain|pain
1392217|NCT01196767|Respiratory function|respiratory function
1392218|NCT01196767|Opiates|opiates
1392219|NCT01196767|Patient-controlled|patient-controlled
1392220|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
1392221|NCT01196754|Pharmacokinetics|pharmacokinetics
1392222|NCT01196754|Sevoflurane|sevoflurane
1392223|NCT01196754|Fluorides|fluorides
1392224|NCT01196754|Sedation|sedation
1392225|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
1392226|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
1392227|NCT01196754|Consent of patients|consent of patients
1392228|NCT01196754|Arterial line|arterial line
1392229|NCT01196715|Quality of Life|quality of life
1392230|NCT01196715|Erythroid response|erythroid response
1392231|NCT01196715|disease progression|disease progression
1392232|NCT01196715|survival|survival
1392233|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
1392234|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
1392235|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
1392236|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
1392237|NCT01196715|Incidence of disease progression|incidence of disease progression
1392238|NCT01196715|Overall Survival|overall survival
1392239|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
1392240|NCT01196702|granulomatous disease|granulomatous disease
1392241|NCT01196702|crohns disease|crohns disease
1392242|NCT01196702|bronchiectasis|bronchiectasis
1392243|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
1392244|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
1392245|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
1392246|NCT01196689|Asthma|asthma
1392247|NCT01196676|AZD4451|azd4451
1392248|NCT01196676|Bipolar|bipolar
1392249|NCT01196676|depression|depression
1392250|NCT01196663|TMS|tms
1392251|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
1392252|NCT01196637|brachial plexopathy|brachial plexopathy
1392253|NCT01196637|ultrasonography|ultrasonography
1392254|NCT01196624|PTSD|ptsd
1392255|NCT01196624|FLASHBACKS|flashbacks
1392256|NCT01196624|TMS|tms
1392257|NCT01196624|EXPOSURE|exposure
1392258|NCT01196611|Voice disorders|voice disorders
1392259|NCT01196611|Voice|voice
1392260|NCT01196598|pelvic floor|pelvic floor
1392261|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
1392262|NCT01196585|Pleura|pleura
1392263|NCT01196585|biopsy|biopsy
1392264|NCT01196585|diagnosis|diagnosis
1392265|NCT01196585|CT|ct
1392266|NCT01196585|ultrasonography|ultrasonography
1392267|NCT01196572|stricture|stricture
1392268|NCT01196572|urethra|urethra
1392269|NCT01196572|laser|laser
1392270|NCT01196572|urethrotomy|urethrotomy
1392271|NCT01196572|holmium|holmium
1392272|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
1392273|NCT01196559|ovarian cancer|ovarian cancer
1392274|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1392275|NCT01196546|vildagliptin|vildagliptin
1392276|NCT01196546|metformin|metformin
1392277|NCT01196533|Non Invasive, Invasive, optical, light source, color image sensor,|non invasive, invasive, optical, light source, color image sensor,
1392278|NCT01196533|, Hemodynamic, Arterial Systolic, Arterial Diastolic, MAP, PA Systolic,|, hemodynamic, arterial systolic, arterial diastolic, map, pa systolic,
1392279|NCT01196533|PA Diastolic, Heart rate, Stroke volume, CBC, WBC, RBC, Hgb, HCT ,Iron.|pa diastolic, heart rate, stroke volume, cbc, wbc, rbc, hgb, hct ,iron.
1392476|NCT01195662|Cardiovascular Agents|cardiovascular agents
1392280|NCT01196533|PLT, PH, PCO2, PO2, HCO3, SaO2 , Na, K, Cl, CO2, Bun, Cr, Gluc, HGB (A1C),|plt, ph, pco2, po2, hco3, sao2 , na, k, cl, co2, bun, cr, gluc, hgb (a1c),
1392281|NCT01196533|TBiLi, LDL, HDL.|tbili, ldl, hdl.
1392282|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
1392283|NCT01196520|Epstein-Barr Virus|epstein-barr virus
1392284|NCT01196520|Malaria|malaria
1392285|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
1392286|NCT01196494|Colorectal stent|colorectal stent
1392413|NCT01195987|Arthritis|arthritis
1392287|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
1392288|NCT01196494|Lavage|lavage
1392289|NCT01196494|Stent|stent
1392291|NCT01196468|Testing|testing
1392292|NCT01196468|Targeted|targeted
1392293|NCT01196468|Indicator|indicator
1392294|NCT01196468|Diseases|diseases
1392295|NCT01196468|Anal dysplasia|anal dysplasia
1392296|NCT01196468|Cervical dysplasia|cervical dysplasia
1392297|NCT01196468|STI|sti
1392298|NCT01196468|Lymphoma|lymphoma
1392299|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
1392300|NCT01196468|Exanthema|exanthema
1392301|NCT01196468|Thrombocytpaenia|thrombocytpaenia
1392302|NCT01196468|Lymphopaenia|lymphopaenia
1392303|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
1392304|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
1392305|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1392306|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1392307|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1392308|NCT01196403|stage I bladder cancer|stage i bladder cancer
1392309|NCT01196403|stage II bladder cancer|stage ii bladder cancer
1392310|NCT01196403|stage III bladder cancer|stage iii bladder cancer
1392311|NCT01196377|Asthma|asthma
1392312|NCT01196377|Acute asthma|acute asthma
1392313|NCT01196377|Pediatrics|pediatrics
1392314|NCT01196364|Girls|girls
1392315|NCT01196351|boys|boys
1392316|NCT01196351|obesity|obesity
1392317|NCT01196351|physical activity|physical activity
1392318|NCT01196351|exercise|exercise
1392319|NCT01196338|Ankle fracture|ankle fracture
1392320|NCT01196338|Return to work|return to work
1392321|NCT01196338|Return to function|return to function
1392322|NCT01196338|Rehabilitation|rehabilitation
1392323|NCT01196338|Weight-bearing|weight-bearing
1392324|NCT01196325|Diabetes|diabetes
1392325|NCT01196325|Diabetic Macular Edema|diabetic macular edema
1392326|NCT01196325|Laser|laser
1392327|NCT01196325|Anti-VEGF|anti-vegf
1392328|NCT01196325|Morphology|morphology
1392329|NCT01196325|Blood Flow|blood flow
1392330|NCT01196325|Vision|vision
1392331|NCT01196312|anxiety sensitivity|anxiety sensitivity
1392332|NCT01196312|heroin|heroin
1392333|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
1392334|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1392335|NCT01196299|traumatic brain injury|traumatic brain injury
1392336|NCT01196299|Metabolite changes|metabolite changes
1392337|NCT01196299|Cerebral perfusion|cerebral perfusion
1392338|NCT01196299|Hemorrhagic burden|hemorrhagic burden
1392339|NCT01196286|First-episode psychosis|first-episode psychosis
1392340|NCT01196286|cognitive remediation|cognitive remediation
1392341|NCT01196286|family psychoeducation|family psychoeducation
1392342|NCT01196273|Cardiac Diseases,|cardiac diseases,
1392343|NCT01196273|HIV-Infection,|hiv-infection,
1392344|NCT01196273|AIDS,|aids,
1392345|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
1392346|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
1392347|NCT01196273|Risk Factors,|risk factors,
1392348|NCT01196273|coronary heart disease,|coronary heart disease,
1392349|NCT01196273|heart failure,|heart failure,
1392350|NCT01196273|metabolic syndrome|metabolic syndrome
1392351|NCT01196260|efficiency|efficiency
1392352|NCT01196260|capecitabine|capecitabine
1392353|NCT01196260|oxaliplatin|oxaliplatin
1392354|NCT01196260|colorectal cancer|colorectal cancer
1392355|NCT01196247|pancreatic cancer|pancreatic cancer
1392356|NCT01196247|molecular profiling|molecular profiling
1392357|NCT01196247|SU2C|su2c
1392358|NCT01196247|Second line therapy|second line therapy
1392359|NCT01196247|Stage 4|stage 4
1392360|NCT01196208|Disease, Hodgkin|disease, hodgkin
1392361|NCT01196208|Lymphoma|lymphoma
1392362|NCT01196208|Monomethylauristatin E|monomethylauristatin e
1392363|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1392364|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
1392365|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1392366|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
1392367|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
1392368|NCT01196208|Antigens, CD30|antigens, cd30
1392369|NCT01196208|Hematologic Diseases|hematologic diseases
1392370|NCT01196208|Immunotherapy|immunotherapy
1392371|NCT01196195|antiretroviral therapy|antiretroviral therapy
1392372|NCT01196195|child|child
1392373|NCT01196195|HIV-1|hiv-1
1392374|NCT01196169|daptomycin|daptomycin
1392375|NCT01196169|vancomycin|vancomycin
1392376|NCT01196169|perioperative|perioperative
1392377|NCT01196169|prophylaxis|prophylaxis
1392378|NCT01196169|arthroplasty|arthroplasty
1392380|NCT01196169|preoperative|preoperative
1392381|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
1392382|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
1392383|NCT01196156|Saizen|saizen
1392384|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
1392385|NCT01196156|Insulin resistance|insulin resistance
1392386|NCT01196143|Ovulation induction|ovulation induction
1392387|NCT01196143|Intrauterine insemination|intrauterine insemination
1392388|NCT01196143|Gonal-f|gonal-f
1392389|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
1392390|NCT01196143|Female infertility|female infertility
1392391|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
1392392|NCT01196130|CRC|crc
1392393|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
1392394|NCT01196130|Biomarker determination|biomarker determination
1392395|NCT01196130|Tumor tissue|tumor tissue
1392396|NCT01196130|Treatment protocols|treatment protocols
1392397|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
1392398|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1392399|NCT01196117|Salivary Cortisol|salivary cortisol
1392400|NCT01196117|Apnea|apnea
1392401|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
1392402|NCT01196091|Lupus|lupus
1392403|NCT01196091|SLE|sle
1392404|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
1392405|NCT01196091|autoimmune disease|autoimmune disease
1392406|NCT01196091|LY2127399|ly2127399
1392407|NCT01196091|Immune system disease|immune system disease
1392408|NCT01196026|Influenza|influenza
1392409|NCT01196026|H1N1|h1n1
1392410|NCT01196026|Fluarix|fluarix
1392411|NCT01196026|Pandemrix|pandemrix
1392412|NCT01195987|Hepatitis C|hepatitis c
1392414|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
1392415|NCT01195961|Direct Current Stimulation|direct current stimulation
1392416|NCT01195961|Learning|learning
1392417|NCT01195961|Cognitive Enhancement|cognitive enhancement
1392418|NCT01195961|Cognitive Tasks|cognitive tasks
1392419|NCT01195961|Cognitive Training|cognitive training
1392420|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
1392421|NCT01195961|Learning Disability|learning disability
1392422|NCT01195961|Cognition Disorder|cognition disorder
1392423|NCT01195948|Uveitis|uveitis
1392424|NCT01195948|Oral Tolerance|oral tolerance
1392425|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1392426|NCT01195922|Oral Cancer|oral cancer
1392427|NCT01195922|mTOR Inhibitors|mtor inhibitors
1392428|NCT01195922|Targeted Therapies|targeted therapies
1392429|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
1392430|NCT01195922|Head and Neck Cancer|head and neck cancer
1392431|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
1392432|NCT01195922|Tongue Cancer|tongue cancer
1392433|NCT01195883|IV fluid|iv fluid
1392434|NCT01195883|recovery|recovery
1392435|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
1392436|NCT01195883|improved patient recovery|improved patient recovery
1392437|NCT01195870|Multiple sclerosis|multiple sclerosis
1392438|NCT01195870|Rebif|rebif
1392439|NCT01195870|Interferon beta-1a|interferon beta-1a
1392440|NCT01195857|Multiple sclerosis|multiple sclerosis
1392441|NCT01195857|Rebif|rebif
1392442|NCT01195857|Interferon beta-1a|interferon beta-1a
1392443|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
1392444|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
1392445|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
1392446|NCT01195792|Opioid receptors|opioid receptors
1392447|NCT01195792|Body weight|body weight
1392448|NCT01195792|Over-eating behaviour|over-eating behaviour
1392449|NCT01195792|Obesity|obesity
1392450|NCT01195792|Fat mass|fat mass
1392451|NCT01195779|immunogenicity|immunogenicity
1392452|NCT01195779|safety|safety
1392453|NCT01195779|Influenza|influenza
1392454|NCT01195779|children|children
1392455|NCT01195779|vaccine|vaccine
1392456|NCT01195766|Hodgkin|hodgkin
1392457|NCT01195766|Ofatumumab|ofatumumab
1392458|NCT01195766|Lymphoma|lymphoma
1392459|NCT01195753|Urea cycle Disorders|urea cycle disorders
1516715|NCT00714870|BMI|bmi
1392460|NCT01195740|Suicide Ideation|suicide ideation
1392461|NCT01195740|Depression|depression
1392462|NCT01195740|Family Conflict|family conflict
1392463|NCT01195701|female sexual dysfunction|female sexual dysfunction
1392464|NCT01195701|anorgasmia|anorgasmia
1392465|NCT01195701|clitoral complex|clitoral complex
1392466|NCT01195701|pelvic MRI|pelvic mri
1392467|NCT01195701|testosterone|testosterone
1392468|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1392469|NCT01195662|Diabetes Mellitus|diabetes mellitus
1392470|NCT01195662|Endocrine System Diseases|endocrine system diseases
1392471|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
1392472|NCT01195662|Metabolic Diseases|metabolic diseases
1392473|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
1392474|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1392475|NCT01195662|Antihypertensive Agents|antihypertensive agents
1392477|NCT01195662|Pharmacological Actions|pharmacological actions
1392478|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
1392479|NCT01195623|varicose veins|varicose veins
1392480|NCT01195623|venous insufficiency|venous insufficiency
1392481|NCT01195623|surgery|surgery
1392482|NCT01195623|duplex|duplex
1392483|NCT01195623|recurrence|recurrence
1392484|NCT01195597|electronic cigarette|electronic cigarette
1392485|NCT01195597|ENDD|endd
1392486|NCT01195597|nicotine|nicotine
1392487|NCT01195597|smoking cessation|smoking cessation
1392488|NCT01195597|smoking reduction|smoking reduction
1392489|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
1392490|NCT01195558|Non-24|non-24
1392491|NCT01195558|N24HSWD|n24hswd
1392492|NCT01195558|Blindness|blindness
1392493|NCT01195558|Sleep|sleep
1392494|NCT01195558|Wake|wake
1392495|NCT01195558|Circadian Rhythm|circadian rhythm
1392496|NCT01195558|Nap|nap
1392497|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
1392498|NCT01195532|hypoglycemic drug|hypoglycemic drug
1392499|NCT01195519|peritoneal dialysis|peritoneal dialysis
1392500|NCT01195519|hemodialysis patients|hemodialysis patients
1392501|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
1392502|NCT01195493|Chronic periodontitis|chronic periodontitis
1392503|NCT01195480|Immunotherapy|immunotherapy
1392504|NCT01195480|Gene Therapy|gene therapy
1392505|NCT01195480|Paediatric|paediatric
1392506|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
1392507|NCT01195441|Preeclampsia|preeclampsia
1392508|NCT01195441|Doppler ultrasound|doppler ultrasound
1392509|NCT01195441|First trimester|first trimester
1392510|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
1392511|NCT01195402|COPD|copd
1392512|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
1392513|NCT01195389|dementia|dementia
1392514|NCT01195389|memory loss|memory loss
1392515|NCT01195389|cognitive decline|cognitive decline
1392516|NCT01195376|PI3K|pi3k
1392517|NCT01195376|mTOR|mtor
1392518|NCT01195376|Advanced solid tumor|advanced solid tumor
1392519|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
1392520|NCT01195350|Ischemic Stroke|ischemic stroke
1392521|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
1392522|NCT01195350|Blood pressure|blood pressure
1392523|NCT01195350|Intensive care|intensive care
1392524|NCT01195337|Sedentary minority adult|sedentary minority adult
1392525|NCT01195337|Psychosocial factors|psychosocial factors
1392526|NCT01195337|Environmental factors|environmental factors
1392527|NCT01195337|Obesity|obesity
1392528|NCT01195337|Physical Activity|physical activity
1392529|NCT01195337|PA|pa
1392530|NCT01195337|Cancer Risk|cancer risk
1392531|NCT01195337|African Americans|african americans
1392532|NCT01195337|Latino|latino
1392533|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1392534|NCT01195324|Warfarin|warfarin
1392535|NCT01195324|Pharmacokinetic|pharmacokinetic
1392536|NCT01195324|Pharmacodynamic|pharmacodynamic
1392537|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
1392538|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
1392539|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
1392540|NCT01195298|metastatic breast cancer|metastatic breast cancer
1392541|NCT01195298|elderly patients|elderly patients
1392542|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
1392543|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
1392544|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1392545|NCT01195285|Quality of life|quality of life
1392546|NCT01195285|Biliary Cholic|biliary cholic
1392547|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
1392548|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
1392549|NCT01195259|rosiglitazone|rosiglitazone
1392550|NCT01195259|ADOPT|adopt
1392551|NCT01195259|metformin|metformin
1392552|NCT01195259|malignancy|malignancy
1392553|NCT01195259|RECORD|record
1392554|NCT01195246|end stage renal failure|end stage renal failure
1392555|NCT01195246|renal failure|renal failure
1392556|NCT01195246|kidney failure|kidney failure
1392557|NCT01195246|kidney failure, chronic|kidney failure, chronic
1392558|NCT01195246|chronic kidney failure|chronic kidney failure
1392559|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
1392560|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
1392561|NCT01195246|hepatitis B|hepatitis b
1392562|NCT01195246|hepatitis|hepatitis
1392564|NCT01195246|prevention and control|prevention and control
1392565|NCT01195246|dialysis|dialysis
1392566|NCT01195233|Xerostomia|xerostomia
1392567|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
1392568|NCT01195233|BioXtra|bioxtra
1392569|NCT01195220|STI screening|sti screening
1392570|NCT01195220|Emergency Department|emergency department
1392571|NCT01195220|Chlamydia|chlamydia
1392572|NCT01195220|Gonorrhea|gonorrhea
1392573|NCT01195220|HIV|hiv
1392574|NCT01195220|behavior|behavior
1392576|NCT01195220|intervention|intervention
1392578|NCT01195207|healthy volunteers|healthy volunteers
1392579|NCT01195207|asthma|asthma
1392580|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
1392581|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
1392582|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
1392583|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
1392584|NCT01195181|ribavirin|ribavirin
1392585|NCT01195181|chronic hepatitis C|chronic hepatitis c
1392586|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
1392587|NCT01195181|viral kinetics|viral kinetics
1392588|NCT01195168|PCOS|pcos
1392589|NCT01195155|PCOS|pcos
1392590|NCT01195142|PCOS|pcos
1392591|NCT01195129|Stent|stent
1392592|NCT01195129|cerebral aneursym|cerebral aneursym
1392593|NCT01195129|neurology|neurology
1392594|NCT01195129|radiology|radiology
1392595|NCT01195116|Post-operative pain management|post-operative pain management
1392596|NCT01195116|Pain Management|pain management
1392597|NCT01195116|Painful bladder syndrome|painful bladder syndrome
1392598|NCT01195116|frequency and urgency|frequency and urgency
1392599|NCT01195116|Dexmedetomidine|dexmedetomidine
1392600|NCT01195116|hydrodistension|hydrodistension
1392601|NCT01195103|Procedural sedation|procedural sedation
1392602|NCT01195103|Regional Anesthesia block|regional anesthesia block
1392603|NCT01195103|Orthopedic surgery|orthopedic surgery
1392604|NCT01195103|Lusedra|lusedra
1392605|NCT01195103|Fospropofol disodium|fospropofol disodium
1392606|NCT01195103|Midazolam|midazolam
1392607|NCT01195090|sitagliptin|sitagliptin
1392608|NCT01195090|pioglitazone|pioglitazone
1392609|NCT01195090|type 2 diabetes|type 2 diabetes
1392610|NCT01195077|HIV|hiv
1392611|NCT01195077|Dietary intervention|dietary intervention
1392612|NCT01195077|Algae|algae
1392613|NCT01195077|HIV progression|hiv progression
1392614|NCT01195077|Algae specific kind|algae specific kind
1392615|NCT01195064|COPD patients|copd patients
1392616|NCT01195064|OSAS patients|osas patients
1392617|NCT01195064|cardiovascular surgery|cardiovascular surgery
1392618|NCT01195064|Endothelial function|endothelial function
1392619|NCT01195051|Medication Reconciliation|medication reconciliation
1392620|NCT01195051|Inpatient|inpatient
1392621|NCT01195051|Electronic Medical Records|electronic medical records
1392622|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
1392623|NCT01195025|Blood volume|blood volume
1392624|NCT01195025|blood coagulation|blood coagulation
1392625|NCT01195025|volume kinetics|volume kinetics
1392626|NCT01195012|child|child
1392627|NCT01195012|primary care|primary care
1392628|NCT01195012|treatment|treatment
1392629|NCT01195012|parenting|parenting
1392630|NCT01195012|lifestyle behaviors|lifestyle behaviors
1392631|NCT01194999|OAB|oab
1392632|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
1392633|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
1392634|NCT01194999|VESIcare|vesicare
1392635|NCT01194999|Urgency|urgency
1392636|NCT01194999|Nocturia|nocturia
1392637|NCT01194999|Frequency|frequency
1392638|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
1392639|NCT01194999|UUI|uui
1392640|NCT01194999|Pubovaginal Sling|pubovaginal sling
1392641|NCT01194999|PVS|pvs
1392642|NCT01194999|Incontinence|incontinence
1392643|NCT01194986|Receptor binding|receptor binding
1392644|NCT01194986|Histamine H3 receptor|histamine h3 receptor
1392645|NCT01194986|binding|binding
1392646|NCT01194986|radioligand|radioligand
1392647|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
1392648|NCT01194960|cancer of prostate|cancer of prostate
1392649|NCT01194960|cancer of the prostate|cancer of the prostate
1392650|NCT01194960|neoplasms prostate|neoplasms prostate
1392651|NCT01194960|neoplasms prostatic|neoplasms prostatic
1392652|NCT01194960|prostate cancer|prostate cancer
1392653|NCT01194960|prostate neoplasms|prostate neoplasms
1392654|NCT01194960|prostatic cancer|prostatic cancer
1392655|NCT01194960|prostate specific antigen|prostate specific antigen
1392656|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
1392657|NCT01194947|banal-appearing nevi|banal-appearing nevi
1392659|NCT01194934|Stem Cell Transplantation|stem cell transplantation
1392660|NCT01194934|SDF-1|sdf-1
1392661|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
1392662|NCT01194934|Spiegelmer|spiegelmer
1392663|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
1392664|NCT01194908|Breast Cancer|breast cancer
1392665|NCT01194908|Breast Tumors|breast tumors
1392666|NCT01194908|Breast Neoplasms|breast neoplasms
1392667|NCT01194895|esophagectomy|esophagectomy
1392668|NCT01194895|acute lung injury|acute lung injury
1392669|NCT01194895|protective ventilation|protective ventilation
1392670|NCT01194869|Breast Cancer|breast cancer
1392671|NCT01194856|HIV|hiv
1392672|NCT01194856|Lipoatrophy|lipoatrophy
1392673|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
1392674|NCT01194817|total knee arthroplasty|total knee arthroplasty
1392675|NCT01194817|total knee replacement|total knee replacement
1392676|NCT01194817|cementless TKA|cementless tka
1392677|NCT01194817|high flexion|high flexion
1392678|NCT01194817|trabecular metal|trabecular metal
1392679|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
1392680|NCT01194804|Eculizumab|eculizumab
1392681|NCT01194804|PNH|pnh
1392682|NCT01194791|Amyloidosis|amyloidosis
1392683|NCT01194791|Lenalidomide|lenalidomide
1392684|NCT01194713|Alzheimer Disease|alzheimer disease
1392685|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
1392686|NCT01194713|Sleep|sleep
1392687|NCT01194713|Abeta|abeta
1392688|NCT01194700|lung bioavailability|lung bioavailability
1392689|NCT01194700|asthma|asthma
1392690|NCT01194700|seretide|seretide
1392691|NCT01194700|Spacer|spacer
1392692|NCT01194687|Estrogens|estrogens
1392693|NCT01194687|Fecal Microbiome|fecal microbiome
1392694|NCT01194687|Fecal Occult Blood|fecal occult blood
1392695|NCT01194674|Microplasmin|microplasmin
1392696|NCT01194674|Macular Edema|macular edema
1392697|NCT01194674|Uveitis|uveitis
1392698|NCT01194661|Inhibitory Control|inhibitory control
1392699|NCT01194661|Executive Function|executive function
1392700|NCT01194661|fMRI|fmri
1392701|NCT01194661|TMS|tms
1392702|NCT01194661|TBI|tbi
1392703|NCT01194661|Traumatic Brain Injury|traumatic brain injury
1392704|NCT01194661|Healthy Volunteer|healthy volunteer
1392705|NCT01194661|HV|hv
1392706|NCT01194648|urinary incontinence|urinary incontinence
1392707|NCT01194648|male erectile disorder|male erectile disorder
1392708|NCT01194648|therapy-related toxicity|therapy-related toxicity
1392709|NCT01194648|stage I prostate cancer|stage i prostate cancer
1392710|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
1392711|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
1392712|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1392713|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1392714|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1392715|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1392716|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1392717|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1392718|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1392719|NCT01194609|Low dose radiation|low dose radiation
1392720|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
1392721|NCT01194609|Cervical cancer|cervical cancer
1392722|NCT01194609|Pilot study|pilot study
1392723|NCT01194596|smoking cessation advice|smoking cessation advice
1392724|NCT01194596|spirometry|spirometry
1392725|NCT01194596|primary health care|primary health care
1392726|NCT01194583|electronic cigarette|electronic cigarette
1392727|NCT01194583|nicotine|nicotine
1392728|NCT01194583|smoking cessation|smoking cessation
1392729|NCT01194583|smoking reduction|smoking reduction
1392730|NCT01194557|history of fever|history of fever
1392731|NCT01194557|measured fever|measured fever
1392732|NCT01194557|appropriate treatment|appropriate treatment
1392733|NCT01194557|appropriate referral|appropriate referral
1392734|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
1392735|NCT01194531|PGS|pgs
1392736|NCT01194531|In Vitro Fertilization|in vitro fertilization
1392737|NCT01194531|IVF|ivf
1392738|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
1392739|NCT01194531|PGD|pgd
1392740|NCT01194518|Life experience|life experience
1392741|NCT01194518|Life style|life style
1392742|NCT01194518|Health behavior|health behavior
1392743|NCT01194518|Mixed method|mixed method
1392744|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1392745|NCT01194505|obturator nerve block|obturator nerve block
1392746|NCT01194505|sciatic nerve block|sciatic nerve block
1392747|NCT01194505|femoral nerve block|femoral nerve block
1392748|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
1392749|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
1392750|NCT01194492|plasma albumin|plasma albumin
1392751|NCT01194492|inflammatory reaction|inflammatory reaction
1392752|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1392753|NCT01194479|type 1 diabetes|type 1 diabetes
1392754|NCT01194479|hypoglycemia|hypoglycemia
1392755|NCT01194479|formoterol|formoterol
1392756|NCT01194466|Head and Neck Cancer|head and neck cancer
1392757|NCT01194466|Oral Cancer|oral cancer
1392758|NCT01194466|Laryngeal Cancer|laryngeal cancer
1392759|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
1392760|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
1392761|NCT01194466|Oral Mucositis|oral mucositis
1392763|NCT01194466|Function|function
1392764|NCT01194466|TENS|tens
1392765|NCT01194466|Functional Pain|functional pain
1392766|NCT01194466|Non-pharamcologic|non-pharamcologic
1392767|NCT01194466|Quality of Life|quality of life
1392768|NCT01194427|Preoperative|preoperative
1392769|NCT01194427|Neoadjuvant|neoadjuvant
1392971|NCT01193478|NS5A|ns5a
1392770|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
1392771|NCT01194362|aortic valve disease|aortic valve disease
1392871|NCT01193920|GBS|gbs
1392772|NCT01194362|gene expression|gene expression
1392773|NCT01194349|S. pneumoniae|s. pneumoniae
1392774|NCT01194349|thrombocytosis|thrombocytosis
1392775|NCT01194349|pediatric patients|pediatric patients
1392776|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
1392777|NCT01194336|Central nervous system|central nervous system
1392778|NCT01194336|Cholinesterase|cholinesterase
1392779|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
1392780|NCT01194323|esophageal erosion|esophageal erosion
1392781|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
1392782|NCT01194310|glaucoma|glaucoma
1392783|NCT01194310|cataract|cataract
1392784|NCT01194297|influenza|influenza
1392785|NCT01194297|premature infant|premature infant
1392786|NCT01194297|very low birth weight infant|very low birth weight infant
1392787|NCT01194297|immunization|immunization
1392788|NCT01194297|vaccine|vaccine
1392789|NCT01194271|Hormone Ablation|hormone ablation
1392790|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
1392791|NCT01194271|Radical prostatectomy|radical prostatectomy
1392792|NCT01194271|Leuprolide Acetate|leuprolide acetate
1392793|NCT01194271|Lupron Depot|lupron depot
1392794|NCT01194271|Ipilimumab|ipilimumab
1392795|NCT01194271|BMS-734016|bms-734016
1392796|NCT01194271|MDX010|mdx010
1392797|NCT01194258|Type 2 diabetes|type 2 diabetes
1392798|NCT01194245|Type 1 diabetes|type 1 diabetes
1392799|NCT01194232|Cystic Fibrosis|cystic fibrosis
1392800|NCT01194232|CF|cf
1392801|NCT01194232|CMRI|cmri
1392802|NCT01194232|vascularization|vascularization
1392803|NCT01194232|perfusion|perfusion
1392804|NCT01194219|Plaque Psoriasis|plaque psoriasis
1392805|NCT01194193|Cancer|cancer
1392806|NCT01194193|Advanced solid tumours|advanced solid tumours
1392807|NCT01194193|lymphomas|lymphomas
1392808|NCT01194193|dose escalation|dose escalation
1392809|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
1392810|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
1392811|NCT01194193|oral administration|oral administration
1392812|NCT01194193|intermittent dosing|intermittent dosing
1392813|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
1392814|NCT01194180|BCG|bcg
1392815|NCT01194180|MVA85A|mva85a
1392816|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
1392817|NCT01194141|Barth syndrome|barth syndrome
1392818|NCT01194141|cardiomyopathy|cardiomyopathy
1392819|NCT01194141|mitochondria|mitochondria
1392820|NCT01194141|cardiolipin|cardiolipin
1392821|NCT01194128|caregivers,|caregivers,
1392822|NCT01194128|institutionalization,|institutionalization,
1392823|NCT01194128|dementia patients,|dementia patients,
1392824|NCT01194128|bereavement,|bereavement,
1392825|NCT01194128|grief|grief
1392826|NCT01194128|complicated grief|complicated grief
1392827|NCT01194115|surgical site infection|surgical site infection
1392828|NCT01194115|obesity|obesity
1392829|NCT01194115|pregnancy|pregnancy
1392830|NCT01194115|cesarean section|cesarean section
1392831|NCT01194115|cesarean delivery|cesarean delivery
1392832|NCT01194102|Stroke|stroke
1392833|NCT01194102|Exercise|exercise
1392834|NCT01194102|Physical function|physical function
1392835|NCT01194102|Community program|community program
1392836|NCT01194102|Patient education|patient education
1392837|NCT01194102|Self-management|self-management
1392838|NCT01194089|Nicotine|nicotine
1392839|NCT01194089|Postoperative pain|postoperative pain
1392840|NCT01194089|Bariatric surgery|bariatric surgery
1392841|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
1392842|NCT01194076|exposure and response prevention|exposure and response prevention
1392843|NCT01194076|pediatric|pediatric
1392844|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
1392845|NCT01194076|child|child
1392846|NCT01194076|anxiety|anxiety
1392847|NCT01194076|intensive|intensive
1392848|NCT01194076|OCD|ocd
1392849|NCT01194076|CBT|cbt
1392850|NCT01194063|short bowel syndrome|short bowel syndrome
1392851|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1392852|NCT01194063|pediatric|pediatric
1392853|NCT01194037|Hepatitis C|hepatitis c
1392854|NCT01194037|HCV|hcv
1392855|NCT01194037|Interferon|interferon
1392856|NCT01194037|Hanferon|hanferon
1392857|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
1392858|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
1392859|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
1392860|NCT01193972|Smoking cessation|smoking cessation
1392861|NCT01193972|Smoking|smoking
1392862|NCT01193972|Tobacco|tobacco
1392863|NCT01193946|Protein requirement|protein requirement
1392864|NCT01193946|Elderly women|elderly women
1392865|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
1392866|NCT01193933|adult ALL|adult all
1392867|NCT01193933|Ph-negative|ph-negative
1392972|NCT01193478|GS-5885|gs-5885
1392868|NCT01193933|dexamethasone|dexamethasone
1392869|NCT01193933|L-asparaginase|l-asparaginase
1392870|NCT01193920|Group B streptococcus|group b streptococcus
1392872|NCT01193920|Vaccine|vaccine
1392873|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
1392874|NCT01193907|Typhoid fever|typhoid fever
1392875|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
1392876|NCT01193907|Vi polysaccharide|vi polysaccharide
1392877|NCT01193907|Immunogenicity|immunogenicity
1392878|NCT01193894|IBD|ibd
1392879|NCT01193894|UC|uc
1392880|NCT01193894|Profermin|profermin
1392881|NCT01193894|Fresubin|fresubin
1392882|NCT01193894|Probiotics|probiotics
1392883|NCT01193894|Dietetic|dietetic
1392884|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
1392885|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
1392886|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
1392887|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
1392888|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
1392889|NCT01193803|Septic arthritis|septic arthritis
1392890|NCT01193803|Molecular methods|molecular methods
1392891|NCT01193790|chronic tonsillitis|chronic tonsillitis
1392892|NCT01193790|radio-frequency coblation|radio-frequency coblation
1392893|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
1392894|NCT01193777|Carnitine|carnitine
1392895|NCT01193777|Shock|shock
1392896|NCT01193777|Sepsis|sepsis
1392897|NCT01193764|acne|acne
1392898|NCT01193764|cocoa|cocoa
1392899|NCT01193764|chocolate|chocolate
1392900|NCT01193764|gelatin|gelatin
1392901|NCT01193764|pustule|pustule
1392902|NCT01193764|comedones|comedones
1392903|NCT01193764|papules|papules
1392904|NCT01193764|pustules|pustules
1392905|NCT01193751|Birth Asphyxia|birth asphyxia
1392906|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
1392907|NCT01193751|Death|death
1392908|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
1392909|NCT01193738|osteopathy|osteopathy
1392910|NCT01193725|Combat Disorders|combat disorders
1392911|NCT01193725|Exposure Therapy|exposure therapy
1392912|NCT01193725|Army Personnel|army personnel
1392913|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
1392914|NCT01193660|umbilical cord blood|umbilical cord blood
1392915|NCT01193660|stem cell|stem cell
1392916|NCT01193660|cerebral palsy|cerebral palsy
1392917|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
1392918|NCT01193621|early evaluation|early evaluation
1392919|NCT01193621|pharmacokinetics|pharmacokinetics
1392920|NCT01193621|pharmacodynamics|pharmacodynamics
1392921|NCT01193621|Biodistribution|biodistribution
1392922|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
1392923|NCT01193608|Randomized|randomized
1392924|NCT01193608|Safety Study|safety study
1392925|NCT01193608|Adaptive|adaptive
1392926|NCT01193608|Double Blind|double blind
1392927|NCT01193582|Prevenar|prevenar
1392928|NCT01193582|catch-up|catch-up
1392929|NCT01193582|pneumococcal|pneumococcal
1392930|NCT01193582|pneumonia|pneumonia
1392931|NCT01193556|Tonsillectomy|tonsillectomy
1392932|NCT01193556|PlasmaBlade|plasmablade
1392933|NCT01193556|Electrosurgery|electrosurgery
1392934|NCT01193556|PEAK Surgical|peak surgical
1392935|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
1392936|NCT01193556|Medtronic|medtronic
1392937|NCT01193530|Sleep Disturbances|sleep disturbances
1392938|NCT01193530|Depression|depression
1392939|NCT01193530|Anxiety|anxiety
1392940|NCT01193530|Fatigue|fatigue
1392941|NCT01193530|Quality of life|quality of life
1567149|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
1392942|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
1392944|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
1392945|NCT01193517|Azacitidine|azacitidine
1392946|NCT01193517|5-Azacytidine|5-azacytidine
1392947|NCT01193517|5-aza|5-aza
1392948|NCT01193517|Vidaza|vidaza
1392949|NCT01193517|5-AZC|5-azc
1392950|NCT01193517|AZA-CR|aza-cr
1392951|NCT01193517|Ladakamycin|ladakamycin
1392952|NCT01193517|NSC-102816|nsc-102816
1392953|NCT01193517|Capecitabine|capecitabine
1392954|NCT01193517|Oxaliplatin|oxaliplatin
1392955|NCT01193517|CAPOX|capox
1392956|NCT01193517|Xeloda|xeloda
1392957|NCT01193517|Eloxatin|eloxatin
1392958|NCT01193517|Hypermethylation|hypermethylation
1392959|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
1392960|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
1392961|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
1392962|NCT01193491|Phase 1|phase 1
1392963|NCT01193491|AML|aml
1392964|NCT01193491|CML|cml
1392965|NCT01193491|MPD|mpd
1392966|NCT01193491|Client Proteins|client proteins
1392967|NCT01193491|Hsp90|hsp90
1392968|NCT01193478|Hepatitis C|hepatitis c
1392969|NCT01193478|HCV RNA|hcv rna
1392970|NCT01193478|multiple ascending dose|multiple ascending dose
1392973|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
1392974|NCT01193465|Humidity|humidity
1392975|NCT01193465|Temperature|temperature
1392976|NCT01193465|Low Flow Anesthesia|low flow anesthesia
1392977|NCT01193452|elderly patients|elderly patients
1392978|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
1392979|NCT01193452|chemotherapy|chemotherapy
1392980|NCT01193452|S-1|s-1
1392981|NCT01193452|5-fluorouracil|5-fluorouracil
1392982|NCT01193452|leucovorin|leucovorin
1392983|NCT01193439|thoracoscopy|thoracoscopy
1392984|NCT01193439|pleural diseases|pleural diseases
1392985|NCT01193439|complications|complications
1392986|NCT01193439|safety|safety
1392987|NCT01193426|Hepatic|hepatic
1392988|NCT01193426|cirrhosis|cirrhosis
1392989|NCT01193426|IL-6|il-6
1392990|NCT01193426|IL-8|il-8
1392991|NCT01193426|Leptine|leptine
1392992|NCT01193413|acute pancreatitis|acute pancreatitis
1392993|NCT01193413|Drainage|drainage
1392994|NCT01193413|Pancreatic surgery|pancreatic surgery
1392995|NCT01193413|Biological Markers/analysis|biological markers/analysis
1392996|NCT01193413|Infection diagnosis|infection diagnosis
1392997|NCT01193413|ROC Curve|roc curve
1392998|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
1392999|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
1393000|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
1393001|NCT01193400|Clofarabine|clofarabine
1393002|NCT01193400|Cytarabine|cytarabine
1393003|NCT01193374|Childhood Obesity|childhood obesity
1393004|NCT01193374|Primary Care|primary care
1393005|NCT01193374|Counseling|counseling
1393006|NCT01193374|Screening|screening
1393007|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
1393008|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
1393009|NCT01193335|premature|premature
1393010|NCT01193335|immunization|immunization
1393011|NCT01193335|safety.|safety.
1393012|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
1393013|NCT01193283|Aplastic Anemia|aplastic anemia
1393014|NCT01193283|Immunosuppression|immunosuppression
1393015|NCT01193283|T-Cells|t-cells
1393016|NCT01193283|Hematopoiesis|hematopoiesis
1393017|NCT01193283|Autoimmunity|autoimmunity
1393018|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
1393019|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
1393020|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
1393021|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1393022|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1393023|NCT01193270|Prematurity|prematurity
1393024|NCT01193231|Laser Vision Correction|laser vision correction
1393025|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
1393026|NCT01193231|PRK|prk
1393027|NCT01193231|Nearsighted|nearsighted
1393028|NCT01193231|Myopia|myopia
1393029|NCT01193205|Borderline Personality Disorder|borderline personality disorder
1393030|NCT01193205|Skills Training|skills training
1393031|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
1393032|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
1393033|NCT01193192|Neevo|neevo
1393034|NCT01193192|Neevo DHA|neevo dha
1393035|NCT01193192|L-methylfolate|l-methylfolate
1393036|NCT01193192|anemia during pregnancy|anemia during pregnancy
1393037|NCT01193192|folic acid|folic acid
1393038|NCT01193192|vitamin B12|vitamin b12
1393039|NCT01193192|prenatal vitamins|prenatal vitamins
1393040|NCT01193192|hemoglobin|hemoglobin
1393041|NCT01193192|iron deficiency|iron deficiency
1393042|NCT01193192|Pregnancy|pregnancy
1393043|NCT01193166|Schizophrenia|schizophrenia
1393044|NCT01193166|Risperidone|risperidone
1393045|NCT01193166|Risperdal|risperdal
1393046|NCT01193166|Paliperidone palmitate|paliperidone palmitate
1393047|NCT01193166|Aripiprazole|aripiprazole
1393048|NCT01193166|Haloperidol|haloperidol
1393049|NCT01193166|Olanzapine|olanzapine
1393050|NCT01193166|Paliperidone|paliperidone
1393051|NCT01193166|Perphenazine|perphenazine
1393052|NCT01193166|Quetiapine|quetiapine
1393053|NCT01193153|schizoaffective disorder|schizoaffective disorder
1393054|NCT01193153|paliperidone palmitate|paliperidone palmitate
1393055|NCT01193153|INVEGA SUSTENNA|invega sustenna
1393056|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
1393057|NCT01193140|veliparib|veliparib
1393058|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
1393059|NCT01193140|Temodar|temodar
1393060|NCT01193140|temozolomide|temozolomide
1393061|NCT01193140|ABT-888|abt-888
1393062|NCT01193140|Solid Tumors|solid tumors
1393063|NCT01193114|substance abuse|substance abuse
1393064|NCT01193114|homeless mothers|homeless mothers
1393065|NCT01193101|hypertension|hypertension
1393066|NCT01193101|blood pressure|blood pressure
1393067|NCT01193101|LCZ696|lcz696
1393068|NCT01193101|dual-acting|dual-acting
1393069|NCT01193101|neprilysin|neprilysin
1393070|NCT01193101|nep inhibitor|nep inhibitor
1393071|NCT01193101|vasopeptidase|vasopeptidase
1393072|NCT01193101|angiotensin receptor|angiotensin receptor
1393073|NCT01193101|ARNi|arni
1393074|NCT01193101|Essential hypertension|essential hypertension
1393075|NCT01193088|CMT|cmt
1393076|NCT01193088|CMT1A|cmt1a
1393363|NCT01192087|Cetuximab|cetuximab
1393077|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
1393078|NCT01193075|CMT|cmt
1393079|NCT01193075|HMSN|hmsn
1393080|NCT01193075|HMN|hmn
1393081|NCT01193075|HSN|hsn
1393082|NCT01193075|CMT1|cmt1
1393083|NCT01193075|CMT2|cmt2
1393084|NCT01193062|healthy volunteers|healthy volunteers
1393085|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
1393086|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
1393087|NCT01193062|serial sampling|serial sampling
1393088|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
1393089|NCT01193036|Psychosocial|psychosocial
1393090|NCT01193036|Skin Problems|skin problems
1393091|NCT01193036|Supportive Care|supportive care
1393092|NCT01193036|Melanoma|melanoma
1393093|NCT01193036|Questionnaire|questionnaire
1393094|NCT01193023|Prospective Studies|prospective studies
1393095|NCT01193023|Humans, pediatric|humans, pediatric
1393096|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
1393097|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
1393098|NCT01193023|Intensive Care|intensive care
1393099|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
1393100|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
1393101|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
1393102|NCT01193023|Prevalence|prevalence
1393103|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
1393104|NCT01192997|Meningitis|meningitis
1393105|NCT01192997|Meningococci|meningococci
1393106|NCT01192997|Meningitis C|meningitis c
1393107|NCT01192997|Meningitis A|meningitis a
1393108|NCT01192997|Meningitis W135|meningitis w135
1393109|NCT01192997|Meningitis Y|meningitis y
1393110|NCT01192997|Antibody|antibody
1393111|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
1393112|NCT01192958|swine flu|swine flu
1393113|NCT01192958|novel h1n1v|novel h1n1v
1393114|NCT01192958|novel h1n1|novel h1n1
1393115|NCT01192958|h1n1|h1n1
1393116|NCT01192945|Azacitidin|azacitidin
1393117|NCT01192945|Vidaza|vidaza
1393118|NCT01192945|Piaza|piaza
1393119|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
1393120|NCT01192945|MDS|mds
1393121|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1393122|NCT01192945|CMML|cmml
1393123|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
1393124|NCT01192945|AML|aml
1393125|NCT01192945|daily routine|daily routine
1393126|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
1393127|NCT01192945|germany|germany
1393128|NCT01192945|non-interventional study|non-interventional study
1393129|NCT01192919|bronchial carcinoma|bronchial carcinoma
1393130|NCT01192919|registry|registry
1393131|NCT01192919|real life treatment|real life treatment
1393132|NCT01192919|cohort study|cohort study
1393133|NCT01192919|NSCLC|nsclc
1393134|NCT01192919|SCLC|sclc
1393135|NCT01192919|Germany|germany
1393136|NCT01192854|Clevudine|clevudine
1393137|NCT01192854|efficacy|efficacy
1393138|NCT01192854|safety|safety
1393139|NCT01192854|chronic hepatitis B|chronic hepatitis b
1393140|NCT01192841|physician uniform|physician uniform
1393141|NCT01192841|MRSA|mrsa
1393142|NCT01192841|bacterial contamination|bacterial contamination
1393143|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
1393144|NCT01192802|albendazole|albendazole
1393145|NCT01192802|ascaris|ascaris
1393146|NCT01192802|trichiurus|trichiurus
1393147|NCT01192802|hookworms|hookworms
1393148|NCT01192789|Severe pneumonia|severe pneumonia
1393149|NCT01192789|Pneumonia|pneumonia
1393150|NCT01192789|Lady health workers|lady health workers
1393151|NCT01192789|Amoxicillin|amoxicillin
1393152|NCT01192789|Treatment failure|treatment failure
1393153|NCT01192789|Injectable Antibiotics|injectable antibiotics
1393154|NCT01192789|Referral treatment|referral treatment
1393155|NCT01192789|Health Facility|health facility
1393156|NCT01192789|Under five children|under five children
1393157|NCT01192789|home based management|home based management
1393158|NCT01192789|community case management|community case management
1393159|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
1393160|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
1393161|NCT01192776|Hypothermia|hypothermia
1393162|NCT01192776|Neonatal depression|neonatal depression
1393163|NCT01192776|Perinatal asphyxia|perinatal asphyxia
1393164|NCT01192776|Fetal acidosis|fetal acidosis
1393165|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1393166|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1393167|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1393168|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1393169|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1393170|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1393171|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1393172|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1393173|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1393174|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1393175|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1393176|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1393177|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1393178|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1393179|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1393180|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1393181|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1393182|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
1393183|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1393184|NCT01192737|pandemic|pandemic
1393185|NCT01192737|A/H1N1|a/h1n1
1393186|NCT01192737|pregnancy|pregnancy
1393187|NCT01192737|cohort|cohort
1393188|NCT01192737|vaccine|vaccine
1393189|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
1393190|NCT01192724|Antiplatelet|antiplatelet
1393191|NCT01192724|Coronary artery diseae|coronary artery diseae
1393192|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
1393193|NCT01192711|diabetes|diabetes
1393194|NCT01192711|telemedicine|telemedicine
1393195|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
1393196|NCT01192698|cirrhosis|cirrhosis
1393197|NCT01192698|hepatitis C|hepatitis c
1393198|NCT01192685|Depression|depression
1393199|NCT01192685|Depressed|depressed
1393201|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1393202|NCT01192646|maternal health|maternal health
1393203|NCT01192646|birth preparedness|birth preparedness
1393204|NCT01192646|cost effectiveness|cost effectiveness
1393205|NCT01192646|male involvement|male involvement
1393206|NCT01192646|delivery at hospital|delivery at hospital
1393207|NCT01192646|complication readiness|complication readiness
1393208|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
1393209|NCT01192633|Sarcoma|sarcoma
1393210|NCT01192633|gemcitabine|gemcitabine
1393211|NCT01192633|vincristine|vincristine
1393212|NCT01192633|cisplatin|cisplatin
1393213|NCT01192633|chemotherapy|chemotherapy
1393214|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
1393215|NCT01192620|Pathway|pathway
1393216|NCT01192594|symptom management|symptom management
1393217|NCT01192594|empowerment|empowerment
1393218|NCT01192594|medication adherence|medication adherence
1393219|NCT01192594|recovery|recovery
1393220|NCT01192594|schizophrenia|schizophrenia
1393221|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
1393222|NCT01192594|psychological adjustment|psychological adjustment
1393223|NCT01192594|psychiatric case managers|psychiatric case managers
1393224|NCT01192594|psychosis|psychosis
1393225|NCT01192594|insight|insight
1393226|NCT01192594|cognitive function|cognitive function
1393227|NCT01192581|brain hypoperfusion|brain hypoperfusion
1393228|NCT01192581|Vuloven|vuloven
1393229|NCT01192581|computed tomography perfusion|computed tomography perfusion
1393230|NCT01192555|Neuroblastoma|neuroblastoma
1393231|NCT01192555|Chemotherapy|chemotherapy
1393232|NCT01192555|Pediatrics|pediatrics
1393233|NCT01192555|Cytoxan|cytoxan
1393234|NCT01192555|immunotherapy|immunotherapy
1393235|NCT01192555|vaccine|vaccine
1393236|NCT01192529|Senile|senile
1393237|NCT01192529|Dementia|dementia
1393238|NCT01192529|Neurodegenerative|neurodegenerative
1393239|NCT01192529|Supressi|supressi
1393240|NCT01192529|Specific diet|specific diet
1393241|NCT01192529|Cognitive Status|cognitive status
1393242|NCT01192529|Memory|memory
1393243|NCT01192529|Malnutrition|malnutrition
1393244|NCT01192529|Parkinson|parkinson
1393245|NCT01192529|Alzheimer|alzheimer
1393246|NCT01192516|Osteoarthritis|osteoarthritis
1393247|NCT01192516|Activity Pacing|activity pacing
1393248|NCT01192503|Restless Legs Syndrome|restless legs syndrome
1393249|NCT01192503|rasagiline|rasagiline
1393250|NCT01192503|futility|futility
1393251|NCT01192477|Air pollution|air pollution
1393252|NCT01192477|Ozone|ozone
1393253|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
1393254|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
1393255|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1393256|NCT01192438|prostate|prostate
1393257|NCT01192438|cancer|cancer
1393258|NCT01192438|ablation|ablation
1393259|NCT01192438|laser-induced|laser-induced
1393260|NCT01192438|focal therapy|focal therapy
1393455|NCT01191801|Cancer|cancer
1393261|NCT01192425|PNH clone cells|pnh clone cells
1393262|NCT01192425|Aplastic Anemia|aplastic anemia
1393263|NCT01192425|AA|aa
1393264|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
1393265|NCT01192425|MDS|mds
1393266|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
1393267|NCT01192425|FLAER|flaer
1393268|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1393269|NCT01192412|hypertension|hypertension
1393270|NCT01192412|pregnancy|pregnancy
1393271|NCT01192412|antihypertensive therapy|antihypertensive therapy
1393272|NCT01192412|perinatal outcome|perinatal outcome
1393273|NCT01192412|maternal outcome|maternal outcome
1393274|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
1393275|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
1393276|NCT01192399|Eculizumab|eculizumab
1393277|NCT01192399|PNH|pnh
1393278|NCT01192399|Japan|japan
1393279|NCT01192360|pediatrics|pediatrics
1393280|NCT01192360|Heart Disease|heart disease
1393281|NCT01192360|Cystic Fibrosis|cystic fibrosis
1393282|NCT01192360|Severe Asthma|severe asthma
1393283|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
1393284|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
1393285|NCT01192321|intraocular lens|intraocular lens
1393286|NCT01192321|Toric|toric
1393287|NCT01192308|Breast cancer|breast cancer
1393288|NCT01192308|Tamoxifen|tamoxifen
1393289|NCT01192308|Pharmacokinetics|pharmacokinetics
1393290|NCT01192308|Pharmacogenetics|pharmacogenetics
1393291|NCT01192308|CYP2D6|cyp2d6
1393292|NCT01192295|Malignant pain|malignant pain
1393293|NCT01192295|Nonmalignant pain|nonmalignant pain
1393294|NCT01192295|Pediatric|pediatric
1393295|NCT01192295|Opioid|opioid
1393296|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
1393297|NCT01192282|Female Genital Warts|female genital warts
1393298|NCT01192282|HPV Typing|hpv typing
1393299|NCT01192282|HIV Status|hiv status
1393300|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
1393301|NCT01192282|Socio-economic Burdens|socio-economic burdens
1393302|NCT01192269|cheek cells|cheek cells
1393303|NCT01192269|phospholipids|phospholipids
1393304|NCT01192269|fatty acids|fatty acids
1393305|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
1393306|NCT01192269|Buccal Cheek cells|buccal cheek cells
1393307|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
1393308|NCT01192256|smoking|smoking
1393309|NCT01192256|cessation|cessation
1393310|NCT01192256|mortality|mortality
1393311|NCT01192256|quality of life|quality of life
1393312|NCT01192243|Objective response rate|objective response rate
1393313|NCT01192243|Time to Progression|time to progression
1393314|NCT01192243|Quality of Live|quality of live
1393315|NCT01192230|Objective response rate|objective response rate
1393316|NCT01192230|Disease control rate|disease control rate
1393317|NCT01192230|Disease free survival|disease free survival
1393318|NCT01192230|Overall survival|overall survival
1393319|NCT01192230|Quality of Live|quality of live
1393320|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
1393321|NCT01192230|toxicity|toxicity
1393322|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
1393323|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
1393324|NCT01192217|bullectomy|bullectomy
1393325|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
1393326|NCT01192191|GW642444|gw642444
1393327|NCT01192191|COPD|copd
1393328|NCT01192191|Fluticasone Furoate|fluticasone furoate
1393329|NCT01192178|pediatric|pediatric
1393330|NCT01192178|exacerbation|exacerbation
1393331|NCT01192178|viral induced exacerbation|viral induced exacerbation
1393332|NCT01192178|asthma|asthma
1393333|NCT01192165|Taxotere|taxotere
1393334|NCT01192165|Cisplatin|cisplatin
1393335|NCT01192165|Carboplatin|carboplatin
1393336|NCT01192165|Trametinib|trametinib
1393337|NCT01192165|GSK1120212|gsk1120212
1393338|NCT01192165|Tarceva|tarceva
1393339|NCT01192165|KRAS|kras
1393340|NCT01192165|Pemetrexed|pemetrexed
1393341|NCT01192165|MEK inhibitor|mek inhibitor
1393342|NCT01192165|nab-Paclitaxel|nab-paclitaxel
1393343|NCT01192165|Docetaxel|docetaxel
1393344|NCT01192165|Alimta|alimta
1393345|NCT01192165|Abraxane|abraxane
1393346|NCT01192165|Erlotinib|erlotinib
1393347|NCT01192113|Mecobalamin|mecobalamin
1393348|NCT01192113|peripheral neuropathy|peripheral neuropathy
1393349|NCT01192113|diabetic neuropathy|diabetic neuropathy
1393350|NCT01192100|Protein-rich breakfast|protein-rich breakfast
1393351|NCT01192100|Breakfast Skipping|breakfast skipping
1393352|NCT01192100|Adolescents|adolescents
1393353|NCT01192100|Obesity|obesity
1393354|NCT01192100|Increased dietary protein|increased dietary protein
1393355|NCT01192100|Breakfast|breakfast
1393356|NCT01192100|fMRI|fmri
1393357|NCT01192100|Ghrelin|ghrelin
1393358|NCT01192100|PYY|pyy
1393359|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
1393360|NCT01192087|carbon ion therapy|carbon ion therapy
1393456|NCT01191801|Malignancy|malignancy
1393361|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
1393362|NCT01192087|radioimmunotherapy|radioimmunotherapy
1393364|NCT01192074|Obstetric|obstetric
1393365|NCT01192074|Analgesia|analgesia
1393366|NCT01192074|Anesthesia|anesthesia
1393367|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
1393368|NCT01192074|Obstetric Analgesia|obstetric analgesia
1393369|NCT01192074|ultrasound|ultrasound
1393370|NCT01192074|ultrasonography|ultrasonography
1393371|NCT01192074|epidural analgesia|epidural analgesia
1393372|NCT01192074|epidural anesthesia|epidural anesthesia
1393373|NCT01192074|spinal anesthesia|spinal anesthesia
1393374|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
1393375|NCT01192074|neuraxial analgesia|neuraxial analgesia
1393376|NCT01192074|pregnancy|pregnancy
1393377|NCT01192074|labor|labor
1393378|NCT01192074|cesarean delivery|cesarean delivery
1393379|NCT01192074|cesarean section|cesarean section
1393380|NCT01192061|autonomic nervous system|autonomic nervous system
1393381|NCT01192061|heart rate variability|heart rate variability
1393382|NCT01192061|blood pressure variability|blood pressure variability
1393383|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
1393384|NCT01192061|vascular dysregulation|vascular dysregulation
1393385|NCT01192048|Congenital Heart Disease|congenital heart disease
1393386|NCT01192048|birth defect|birth defect
1393387|NCT01192048|genetics|genetics
1393388|NCT01192048|gene|gene
1393389|NCT01192048|DNA|dna
1393390|NCT01192048|direct sequencing|direct sequencing
1393391|NCT01192048|microarray|microarray
1393392|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
1393393|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
1393394|NCT01192048|chromosomal copy number change|chromosomal copy number change
1393395|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
1393396|NCT01192048|exome sequencing|exome sequencing
1393397|NCT01192048|whole exome sequencing|whole exome sequencing
1393398|NCT01192035|Africa, Western|africa, western
1393399|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1393400|NCT01192022|Liver resection|liver resection
1393401|NCT01192022|Liver transplantation|liver transplantation
1393402|NCT01192022|Liver surgery|liver surgery
1393403|NCT01192022|Secondary hemostasis|secondary hemostasis
1393404|NCT01192009|Leucine|leucine
1393405|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
1393406|NCT01192009|Atrophy|atrophy
1393407|NCT01192009|Proteolysis|proteolysis
1393408|NCT01191996|SPMS|spms
1393409|NCT01191996|PPMS|ppms
1393410|NCT01191996|MS|ms
1393411|NCT01191996|Multiple Sclerosis|multiple sclerosis
1393412|NCT01191970|epidural|epidural
1393413|NCT01191970|beta-endorphins|beta-endorphins
1393414|NCT01191970|breast-feeding|breast-feeding
1393415|NCT01191970|colostrum|colostrum
1393416|NCT01191970|feeding|feeding
1393417|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
1393418|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1393419|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1393420|NCT01191918|donepezil|donepezil
1393421|NCT01191918|bipolar disorder|bipolar disorder
1393422|NCT01191918|mania|mania
1393423|NCT01191918|lithium|lithium
1567150|NCT00509769|HER2|her2
1393424|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1393425|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1393426|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1393427|NCT01191892|stage III bladder cancer|stage iii bladder cancer
1393428|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
1393429|NCT01191892|anterior urethral cancer|anterior urethral cancer
1393430|NCT01191892|posterior urethral cancer|posterior urethral cancer
1393431|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1393432|NCT01191892|ureter cancer|ureter cancer
1393433|NCT01191866|diabetes mellitus|diabetes mellitus
1393434|NCT01191866|psychosocial|psychosocial
1393435|NCT01191866|metabolic control|metabolic control
1393436|NCT01191866|quality of life questionnaires|quality of life questionnaires
1393437|NCT01191866|children|children
1393438|NCT01191866|adolescents|adolescents
1393439|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
1393440|NCT01191853|Biologic Samples|biologic samples
1393441|NCT01191853|Laboratory Research Samples|laboratory research samples
1393442|NCT01191853|Swine Flu|swine flu
1393443|NCT01191853|Immunization|immunization
1393444|NCT01191853|Healthy Volunteer|healthy volunteer
1393445|NCT01191853|HV|hv
1393446|NCT01191840|staphylococci|staphylococci
1393447|NCT01191814|pancreatic cancer|pancreatic cancer
1393448|NCT01191814|obstructive jaundice|obstructive jaundice
1393449|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
1393450|NCT01191801|Leukemia|leukemia
1393451|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
1393452|NCT01191801|Hematologic|hematologic
1393453|NCT01191801|Hematologic diseases|hematologic diseases
1393454|NCT01191801|Blood|blood
1393457|NCT01191801|Vosaroxin|vosaroxin
1393458|NCT01191801|Cytarabine|cytarabine
1393755|NCT01190592|Dairy|dairy
1393459|NCT01191801|First Relapsed AML|first relapsed aml
1393460|NCT01191801|Refractory AML|refractory aml
1393461|NCT01191801|VALOR|valor
1393462|NCT01191801|Sunesis|sunesis
1393463|NCT01191801|Voreloxin|voreloxin
1393464|NCT01191801|SNS-595|sns-595
1393465|NCT01191788|Depression|depression
1393466|NCT01191788|Substance Use|substance use
1393467|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
1393468|NCT01191775|Oligonucleotide|oligonucleotide
1393469|NCT01191775|DNAi|dnai
1393470|NCT01191775|Oncology|oncology
1393471|NCT01191775|Antineoplastic agent|antineoplastic agent
1393472|NCT01191775|Lymphoma|lymphoma
1393473|NCT01191775|PNT2258|pnt2258
1393474|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
1393475|NCT01191762|phosphate|phosphate
1393476|NCT01191762|calcium|calcium
1393477|NCT01191762|chronic kidney disease|chronic kidney disease
1393478|NCT01191749|Hematologic Disorder|hematologic disorder
1393479|NCT01191749|Aplastic Anemia|aplastic anemia
1393480|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
1393481|NCT01191749|T-LGL|t-lgl
1393482|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
1393483|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1393484|NCT01191749|CLL|cll
1393485|NCT01191749|Chemotherapy|chemotherapy
1393486|NCT01191749|Alemtuzumab|alemtuzumab
1393487|NCT01191736|hands only|hands only
1393488|NCT01191736|CPR|cpr
1393489|NCT01191736|resuscitation|resuscitation
1393490|NCT01191736|cardiac arrest|cardiac arrest
1393491|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
1393492|NCT01191723|Healthy Volunteers|healthy volunteers
1393493|NCT01191710|progesterone|progesterone
1393494|NCT01191697|HER2 positive|her2 positive
1393495|NCT01191671|Child Development|child development
1393496|NCT01191671|Child|child
1393497|NCT01191671|Daycare centers|daycare centers
1393498|NCT01191671|Language|language
1393499|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
1393500|NCT01191645|Esophageal motility|esophageal motility
1393501|NCT01191645|Remifentanil|remifentanil
1393502|NCT01191645|Metoclopramide|metoclopramide
1393503|NCT01191645|Naloxone|naloxone
1393504|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
1393505|NCT01191632|T cell|t cell
1393506|NCT01191632|surgery|surgery
1393507|NCT01191632|radiation|radiation
1393508|NCT01191619|McIvor retractor|mcivor retractor
1393509|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
1393510|NCT01191606|pressure controlled|pressure controlled
1393511|NCT01191606|volume controlled|volume controlled
1393512|NCT01191606|arterial oxygenation|arterial oxygenation
1393513|NCT01191606|one lung ventilation|one lung ventilation
1393514|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
1393515|NCT01191593|postoperative pain|postoperative pain
1393516|NCT01191593|US-guided nerve block|us-guided nerve block
1393517|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
1393518|NCT01191567|acute wounds|acute wounds
1393519|NCT01191567|postoperative wounds|postoperative wounds
1393520|NCT01191541|ara-c|ara-c
1393521|NCT01191541|As2O3|as2o3
1393522|NCT01191541|pediatric|pediatric
1393523|NCT01191541|acute|acute
1393524|NCT01191528|Adult|adult
1393525|NCT01191528|Post|post
1393526|NCT01191528|operative|operative
1393527|NCT01191528|oximetry|oximetry
1393528|NCT01191528|capnometry|capnometry
1393529|NCT01191528|Integrated|integrated
1393530|NCT01191528|Pulmonary|pulmonary
1393531|NCT01191528|Index|index
1393532|NCT01191528|End-tidal|end-tidal
1393533|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
1393534|NCT01191528|post-operative|post-operative
1393535|NCT01191515|Previous Cataract patients|previous cataract patients
1393536|NCT01191515|Monofocal IOL implant|monofocal iol implant
1393537|NCT01191515|Evaluation|evaluation
1393538|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
1393539|NCT01191476|Sevoflurane|sevoflurane
1393540|NCT01191476|Propofol|propofol
1393541|NCT01191476|Economics|economics
1393542|NCT01191476|Pharmaceutical|pharmaceutical
1393543|NCT01191476|Chinese|chinese
1393544|NCT01191450|chlortalidone|chlortalidone
1393545|NCT01191450|amiloride|amiloride
1393546|NCT01191450|arterial hypertension|arterial hypertension
1393547|NCT01191424|Asthma|asthma
1393548|NCT01191424|PK|pk
1393549|NCT01191424|Adolescents|adolescents
1393550|NCT01191424|Adults|adults
1393551|NCT01191411|colorectal neoplasms|colorectal neoplasms
1393552|NCT01191411|screening|screening
1393553|NCT01191398|Hypersalivation|hypersalivation
1393554|NCT01191398|Conscious Sedation|conscious sedation
1393555|NCT01191398|Procedural Sedation|procedural sedation
1393556|NCT01191398|Ketamine|ketamine
1393557|NCT01191398|Atropine|atropine
1393558|NCT01191398|Glycopyrrolate|glycopyrrolate
1393559|NCT01191385|HCC|hcc
1393560|NCT01191385|Liver cancer|liver cancer
1393561|NCT01191385|Cancer of liver|cancer of liver
1393562|NCT01191385|Cancer, liver|cancer, liver
1393563|NCT01191385|Hepatic cancer|hepatic cancer
1393564|NCT01191385|Cancer, hepatic|cancer, hepatic
1393565|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
1393566|NCT01191372|Hemophilia A|hemophilia a
1393567|NCT01191372|Hemophilia B|hemophilia b
1393568|NCT01191372|pharmacokinetics|pharmacokinetics
1393569|NCT01191372|pharmacodynamics|pharmacodynamics
1393570|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
1393571|NCT01191333|Mood Disorder|mood disorder
1393572|NCT01191333|Depression|depression
1393573|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
1393574|NCT01191333|Depressive Disorder|depressive disorder
1393575|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
1393576|NCT01191333|substance related disorders|substance related disorders
1393577|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
1393578|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
1393579|NCT01191333|Veterans|veterans
1393580|NCT01191333|mental health|mental health
1393581|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
1393582|NCT01191307|Primary dystonia|primary dystonia
1393583|NCT01191307|Epilepsy|epilepsy
1393584|NCT01191307|Hydrocephalus|hydrocephalus
1393585|NCT01191307|Bladder Control|bladder control
1393586|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
1393587|NCT01191294|Melanoma|melanoma
1393588|NCT01191294|Simulation Training|simulation training
1393589|NCT01191294|Medical Students|medical students
1393590|NCT01191281|food habits|food habits
1393591|NCT01191281|nutrition requirements|nutrition requirements
1393592|NCT01191281|antiretroviral therapy|antiretroviral therapy
1393593|NCT01191255|ESRD|esrd
1393594|NCT01191255|end-stage renal disease|end-stage renal disease
1393595|NCT01191255|dialysis|dialysis
1393596|NCT01191255|hemodialysis|hemodialysis
1393597|NCT01191255|peritoneal dialysis|peritoneal dialysis
1393598|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
1393599|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
1393600|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
1393601|NCT01191255|phosphate binder|phosphate binder
1393602|NCT01191255|kidney failure|kidney failure
1393603|NCT01191255|renal failure|renal failure
1393604|NCT01191242|methadone|methadone
1393605|NCT01191242|genetic|genetic
1393606|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
1393607|NCT01191190|Leukemia|leukemia
1393608|NCT01191190|Chronic leukemia|chronic leukemia
1393609|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1393610|NCT01191190|Relapsed|relapsed
1393611|NCT01191190|Refractory|refractory
1393612|NCT01191177|oral fish oil|oral fish oil
1393613|NCT01191177|Lovaza|lovaza
1393614|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
1393615|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
1393616|NCT01191151|Orthopedic surgery|orthopedic surgery
1393617|NCT01191151|sports medicine|sports medicine
1393618|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
1393619|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
1393620|NCT01191138|Pancreatic fistula|pancreatic fistula
1393621|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
1393622|NCT01191138|Whipple Operation|whipple operation
1393623|NCT01191086|Epilepsy|epilepsy
1393624|NCT01191086|partial onset seizure|partial onset seizure
1393625|NCT01191086|adjunctive therapy|adjunctive therapy
1393626|NCT01191073|edentulous|edentulous
1393627|NCT01191060|Progression free survival prolongation|progression free survival prolongation
1393628|NCT01191060|Disease Progression|disease progression
1393629|NCT01191060|Overall survival|overall survival
1393631|NCT01191021|propofol|propofol
1393632|NCT01191021|general anesthesia|general anesthesia
1393633|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
1393634|NCT01190995|Pain|pain
1393635|NCT01190995|Neonate|neonate
1393636|NCT01190995|Procedure|procedure
1393637|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
1393638|NCT01190969|Elderly|elderly
1393639|NCT01190969|malnutrition|malnutrition
1393640|NCT01190969|nutritional supplement|nutritional supplement
1393641|NCT01190943|localized osteosarcoma|localized osteosarcoma
1393642|NCT01190943|metastatic osteosarcoma|metastatic osteosarcoma
1393643|NCT01190943|recurrent osteosarcoma|recurrent osteosarcoma
1393644|NCT01190917|Autism|autism
1393645|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
1393646|NCT01190917|Disorder|disorder
1393647|NCT01190917|Autistic|autistic
1393648|NCT01190917|Asperger Syndrome|asperger syndrome
1393649|NCT01190917|social skills group|social skills group
1393650|NCT01190917|behavioral intervention|behavioral intervention
1393651|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
1393652|NCT01190917|fMRI|fmri
1393653|NCT01190917|Functional MRI|functional mri
1393654|NCT01190917|MRI, Functional|mri, functional
1393655|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
1393656|NCT01190917|Functional|functional
1394436|NCT01187485|Androderm®|androderm®
1393657|NCT01190904|Androgen deficiency|androgen deficiency
1393658|NCT01190904|Erectile dysfunction|erectile dysfunction
1393659|NCT01190904|Coronary Artery Disease|coronary artery disease
1393660|NCT01190904|Coronary Revascularization|coronary revascularization
1393661|NCT01190904|Diabetes mellitus|diabetes mellitus
1393662|NCT01190904|MI|mi
1393663|NCT01190904|Stroke|stroke
1393664|NCT01190904|MACCE|macce
1393665|NCT01190904|DM|dm
1393666|NCT01190904|ED|ed
1393667|NCT01190904|CAD|cad
1393668|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
1393669|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
1393670|NCT01190891|Shoulder pain|shoulder pain
1393671|NCT01190891|Shoulder impingement|shoulder impingement
1393672|NCT01190839|Crohn's Disease|crohn's disease
1393673|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
1393674|NCT01190839|infliximab|infliximab
1393675|NCT01190839|TNF-alpha|tnf-alpha
1393676|NCT01190826|Stable moderate asthma|stable moderate asthma
1393677|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
1393678|NCT01190800|Alzheimer's Disease|alzheimer's disease
1393679|NCT01190800|Capacity assessment|capacity assessment
1393680|NCT01190800|Decision-making assessment|decision-making assessment
1393681|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
1393682|NCT01190800|Capacity to vote|capacity to vote
1393683|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
1393684|NCT01190787|Multiple Myeloma|multiple myeloma
1393685|NCT01190787|Elderly Patients|elderly patients
1393686|NCT01190787|Diagnosis|diagnosis
1393687|NCT01190787|Velcade subcutaneous|velcade subcutaneous
1393688|NCT01190787|Prednisone|prednisone
1393689|NCT01190787|Melphalan|melphalan
1393690|NCT01190787|Cyclophosphamide|cyclophosphamide
1393691|NCT01190774|dental anxiety|dental anxiety
1393692|NCT01190774|state anxiety|state anxiety
1393693|NCT01190774|randomised control trial|randomised control trial
1393694|NCT01190774|psychological intervention|psychological intervention
1393695|NCT01190761|Bioequivalence|bioequivalence
1393696|NCT01190761|Galantamine|galantamine
1393697|NCT01190761|Reminyl|reminyl
1393698|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
1393699|NCT01190761|Healthy subjects|healthy subjects
1393700|NCT01190748|Bioequivalence|bioequivalence
1393701|NCT01190748|Galantamine|galantamine
1393702|NCT01190748|Reminyl|reminyl
1393703|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
1393704|NCT01190748|Healthy subjects|healthy subjects
1393705|NCT01190735|Caffeine|caffeine
1393706|NCT01190735|Parkinson's Disease|parkinson's disease
1393707|NCT01190735|Parkinson Disease|parkinson disease
1393708|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
1393709|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
1393710|NCT01190735|Brain Diseases|brain diseases
1393711|NCT01190735|Central Nervous System Diseases|central nervous system diseases
1393712|NCT01190735|Nervous System Diseases|nervous system diseases
1393713|NCT01190735|Movement Disorders|movement disorders
1393714|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
1393715|NCT01190735|Caffeine citrate|caffeine citrate
1393716|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1393717|NCT01190735|Pharmacologic Actions|pharmacologic actions
1393718|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
1393719|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
1393720|NCT01190735|Central Nervous System Agents|central nervous system agents
1393721|NCT01190735|Therapeutic Uses|therapeutic uses
1393722|NCT01190722|Day case surgery|day case surgery
1393723|NCT01190722|postoperative pain|postoperative pain
1393724|NCT01190722|NSAIDs|nsaids
1393725|NCT01190722|Coxibs|coxibs
1393726|NCT01190709|Close Fracture|close fracture
1393727|NCT01190709|Tibia|tibia
1393728|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
1393729|NCT01190709|Dynamic Compression Plate|dynamic compression plate
1393730|NCT01190696|Spica Cast|spica cast
1393731|NCT01190696|TEN|ten
1393732|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
1393733|NCT01190696|Children|children
1393734|NCT01190670|ASP015K|asp015k
1393735|NCT01190670|tacrolimus|tacrolimus
1393736|NCT01190670|healthy volunteers|healthy volunteers
1393737|NCT01190657|Teprenone|teprenone
1393738|NCT01190657|safety|safety
1393739|NCT01190657|efficacy|efficacy
1393740|NCT01190657|acute gastric lesion|acute gastric lesion
1393741|NCT01190657|chronic gastritis|chronic gastritis
1393742|NCT01190644|Red Blood Cell Mass|red blood cell mass
1393743|NCT01190644|Plasma Volume|plasma volume
1393744|NCT01190644|Solid Tumors|solid tumors
1393745|NCT01190631|intraocular lens|intraocular lens
1393746|NCT01190631|cataracts|cataracts
1393747|NCT01190631|total residual spherical aberration|total residual spherical aberration
1393748|NCT01190631|high order aberrations|high order aberrations
1393749|NCT01190605|HIV|hiv
1393750|NCT01190605|postpartum|postpartum
1393751|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
1393752|NCT01190592|Resistance training|resistance training
1393753|NCT01190592|Body Composition|body composition
1393754|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
1393756|NCT01190579|Coronary Artery Disease|coronary artery disease
1393757|NCT01190579|Chest Pain|chest pain
1393758|NCT01190579|Computed Tomography|computed tomography
1393759|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1393760|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
1393761|NCT01190566|chemotherapy|chemotherapy
1393762|NCT01190553|amantadine|amantadine
1393763|NCT01190553|parkinson disease|parkinson disease
1393764|NCT01190553|dyskinesia|dyskinesia
1393765|NCT01190540|On site support services.|on site support services.
1393766|NCT01190540|mid level health professionals.|mid level health professionals.
1393767|NCT01190540|cost effectiveness.|cost effectiveness.
1393768|NCT01190540|infectious disease.|infectious disease.
1393769|NCT01190540|capacity building.|capacity building.
1393770|NCT01190514|DVS SR|dvs sr
1393771|NCT01190514|healthy|healthy
1393772|NCT01190514|Bioequivalence study|bioequivalence study
1393773|NCT01190501|blood pressure|blood pressure
1393774|NCT01190501|antihypertensive treatments|antihypertensive treatments
1393775|NCT01190488|End of life decision making|end of life decision making
1393776|NCT01190488|End of life decision aid|end of life decision aid
1393777|NCT01190488|Palliative care decision making|palliative care decision making
1393778|NCT01190488|Palliative care decision aid|palliative care decision aid
1393779|NCT01190488|Advanced care planning|advanced care planning
1393780|NCT01190488|Decision Aid|decision aid
1393781|NCT01190475|Endometriosis|endometriosis
1393782|NCT01190475|Infertility|infertility
1393783|NCT01190475|Pain|pain
1393784|NCT01190475|Vaginal Diseases|vaginal diseases
1393785|NCT01190475|Uterine Diseases|uterine diseases
1393786|NCT01190462|recurrent colon cancer|recurrent colon cancer
1393787|NCT01190462|stage III colon cancer|stage iii colon cancer
1393788|NCT01190462|stage IV colon cancer|stage iv colon cancer
1393789|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
1393790|NCT01190462|stage III rectal cancer|stage iii rectal cancer
1393791|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
1393792|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1393793|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1393794|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1393795|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1393796|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1393797|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1393798|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1393799|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1393800|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1393801|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1393802|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1393803|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1393804|NCT01190436|Hypertension|hypertension
1393805|NCT01190436|Diabetes Mellitus|diabetes mellitus
1393806|NCT01190436|Bisoprolol|bisoprolol
1393808|NCT01190410|Certolizumab Pegol|certolizumab pegol
1393809|NCT01190410|Cimzia®|cimzia®
1393810|NCT01190410|Crohn's Disease|crohn's disease
1393811|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
1393812|NCT01190397|Warming goggles|warming goggles
1393813|NCT01190384|Metabolic Syndrome|metabolic syndrome
1393814|NCT01190384|Inflammation|inflammation
1393815|NCT01190384|Antioxidants|antioxidants
1393816|NCT01190384|Satiety|satiety
1393817|NCT01190384|Fiber|fiber
1393818|NCT01190371|Artemisinin tolerance|artemisinin tolerance
1393819|NCT01190345|breast cancer|breast cancer
1393820|NCT01190332|common bile duct stones|common bile duct stones
1393821|NCT01190319|blood pressure|blood pressure
1393822|NCT01190319|strawberry|strawberry
1393823|NCT01190319|fruit phenolics|fruit phenolics
1393824|NCT01190319|LDL oxidation|ldl oxidation
1393825|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
1393826|NCT01190254|Asenapine|asenapine
1393827|NCT01190254|adolescents|adolescents
1393828|NCT01190254|schizophrenia|schizophrenia
1393829|NCT01190254|phase IIIb|phase iiib
1393830|NCT01190254|placebo-controlled|placebo-controlled
1393831|NCT01190241|targeted therapy|targeted therapy
1393832|NCT01190241|individualized medicine|individualized medicine
1393833|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1393834|NCT01190241|kinome profiling|kinome profiling
1393835|NCT01190241|Metastasized|metastasized
1393836|NCT01190228|Japanese Encephalitis|japanese encephalitis
1393837|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1393838|NCT01190228|Varicella|varicella
1393839|NCT01190228|Varicella vaccine|varicella vaccine
1393840|NCT01190215|Influenza|influenza
1393841|NCT01190215|Pandemrix|pandemrix
1393842|NCT01190215|H1N1|h1n1
1393843|NCT01190215|Fluarix|fluarix
1393845|NCT01190202|Plasmodium falciparum|plasmodium falciparum
1393846|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
1393847|NCT01190189|HPV vaccine|hpv vaccine
1393848|NCT01190189|Medically significant conditions|medically significant conditions
1393849|NCT01190189|Cervical neoplasia|cervical neoplasia
1393850|NCT01190176|HPV|hpv
1393851|NCT01190176|HPV vaccine|hpv vaccine
1393852|NCT01190176|Cervical neoplasia|cervical neoplasia
1393853|NCT01190176|Human papillomavirus|human papillomavirus
1393854|NCT01190176|Papillomavirus|papillomavirus
1393855|NCT01190176|Cervical cancer|cervical cancer
1393856|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
1393857|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
1393858|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
1393859|NCT01190150|Menorraghia|menorraghia
1393860|NCT01190137|Optimal vitamin D status|optimal vitamin d status
1393861|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
1393862|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
1393863|NCT01190137|Breast fed infants|breast fed infants
1393864|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
1393865|NCT01190124|HIV infections|hiv infections
1393866|NCT01190124|HIV-1|hiv-1
1393867|NCT01190124|HIV-2|hiv-2
1393868|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1393869|NCT01190124|AIDS|aids
1393870|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
1393871|NCT01190124|Raltegravir|raltegravir
1393872|NCT01190124|Integrase Inhibitors|integrase inhibitors
1393873|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
1393874|NCT01190111|interleukin-7|interleukin-7
1393875|NCT01190111|immune-based therapy|immune-based therapy
1393876|NCT01190111|HIV|hiv
1393877|NCT01190111|viral disease|viral disease
1393878|NCT01190098|Partial epilepsy|partial epilepsy
1393879|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
1393880|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
1393881|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
1393882|NCT01190085|alcoholism|alcoholism
1393883|NCT01190085|ghrelin|ghrelin
1393884|NCT01190085|craving|craving
1393885|NCT01190072|Blood lipids|blood lipids
1393886|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
1393887|NCT01190072|lipid lowering treatment|lipid lowering treatment
1393888|NCT01190059|Lung|lung
1393889|NCT01190059|Transplantation|transplantation
1393890|NCT01190059|Lung Transplantation|lung transplantation
1393891|NCT01190059|Transplantation Lung|transplantation lung
1393892|NCT01190046|elderly|elderly
1393893|NCT01190046|muscle|muscle
1393894|NCT01190046|disuse|disuse
1393895|NCT01190046|osteoarthritis|osteoarthritis
1393896|NCT01190046|exercise|exercise
1393897|NCT01189994|Fibromyalgia|fibromyalgia
1393898|NCT01189994|Acupuncture|acupuncture
1393899|NCT01189994|Randomized Controlled Trial|randomized controlled trial
1393900|NCT01189994|Pain|pain
1393901|NCT01189994|Quality of Life|quality of life
1393902|NCT01189968|Phase 1,|phase 1,
1393903|NCT01189968|dose escalation,|dose escalation,
1393904|NCT01189968|histologically|histologically
1393905|NCT01189968|confirmed|confirmed
1393906|NCT01189968|malignancy|malignancy
1393907|NCT01189968|metastatic|metastatic
1393908|NCT01189955|thyroidectomy|thyroidectomy
1393909|NCT01189955|harmonic|harmonic
1393911|NCT01189942|Phase 1|phase 1
1393912|NCT01189942|dose escalation|dose escalation
1393913|NCT01189942|histologically|histologically
1393914|NCT01189942|confirmed|confirmed
1393915|NCT01189942|malignancy|malignancy
1393916|NCT01189942|metastatic|metastatic
1393917|NCT01189929|Phase 1,|phase 1,
1393918|NCT01189929|dose escalation,|dose escalation,
1393919|NCT01189929|histologically|histologically
1393920|NCT01189929|cytologically|cytologically
1393921|NCT01189929|confirmed|confirmed
1393922|NCT01189929|malignancy|malignancy
1393923|NCT01189929|metastatic|metastatic
1393924|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
1393925|NCT01189877|Direct pO2 Measurements|direct po2 measurements
1393926|NCT01189877|10-121|10-121
1393927|NCT01189851|breast|breast
1393928|NCT01189851|IORT|iort
1393929|NCT01189851|electronic brachytherapy|electronic brachytherapy
1393930|NCT01189838|Cancer|cancer
1393931|NCT01189838|cysteine-rich 61|cysteine-rich 61
1393932|NCT01189838|prognosis|prognosis
1393933|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
1393934|NCT01189825|Physiological|physiological
1393935|NCT01189825|Antidepressive Agents|antidepressive agents
1393936|NCT01189812|hopelessness|hopelessness
1393937|NCT01189812|alone|alone
1393938|NCT01189812|sad|sad
1393939|NCT01189812|troubled|troubled
1393940|NCT01189812|depression|depression
1393941|NCT01189799|Co-occurring Disorders|co-occurring disorders
1393942|NCT01189799|Depression|depression
1393943|NCT01189799|Substance Dependence|substance dependence
1393944|NCT01189799|Motivational Therapy|motivational therapy
1393945|NCT01189799|Aftercare|aftercare
1393946|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
1393947|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
1393948|NCT01189786|CD34+ Selection|cd34+ selection
1393949|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
1393950|NCT01189773|pain control|pain control
1393951|NCT01189773|limb trauma|limb trauma
1393952|NCT01189734|common bile duct stones|common bile duct stones
1393953|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
1393954|NCT01189734|intraoperative ercp|intraoperative ercp
1393955|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
1393956|NCT01189721|remifentanil|remifentanil
1393957|NCT01189721|hyperalgesia|hyperalgesia
1393958|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
1393959|NCT01189708|Abdominal hernia|abdominal hernia
1393960|NCT01189695|HIV or AIDS|hiv or aids
1393961|NCT01189695|Lopinavir|lopinavir
1393962|NCT01189695|Ritonavir|ritonavir
1393963|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
1393964|NCT01189695|treatment failure|treatment failure
1393965|NCT01189695|treatment experienced|treatment experienced
1393966|NCT01189695|NNRTI failure|nnrti failure
1393967|NCT01189695|monotherapy|monotherapy
1393968|NCT01189682|catheter|catheter
1393969|NCT01189682|dressing|dressing
1393970|NCT01189682|chlorhexidine|chlorhexidine
1393971|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
1393972|NCT01189669|PCOS|pcos
1393973|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
1393974|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1393975|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1393976|NCT01189643|TEMOZOLOMIDE|temozolomide
1393977|NCT01189643|DSRCT|dsrct
1393978|NCT01189643|10-091|10-091
1393979|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
1393980|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
1393981|NCT01189617|Personal Lubricant|personal lubricant
1393982|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
1393983|NCT01189578|Recreational|recreational
1393984|NCT01189578|cocaine|cocaine
1393985|NCT01189578|fMRI|fmri
1393986|NCT01189578|neuroimaging|neuroimaging
1393987|NCT01189578|craving|craving
1393988|NCT01189578|impulsivity|impulsivity
1393989|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
1393990|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
1393991|NCT01189526|macular edema|macular edema
1393992|NCT01189526|intravitreal injection|intravitreal injection
1393993|NCT01189526|ranibizumab|ranibizumab
1393994|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
1393995|NCT01189513|Gliosarcoma|gliosarcoma
1393996|NCT01189513|SCH 900105|sch 900105
1393997|NCT01189500|Pharmacokinetic|pharmacokinetic
1393998|NCT01189500|safety and tolerability|safety and tolerability
1393999|NCT01189500|genetic testing|genetic testing
1394000|NCT01189500|CYP 2D6|cyp 2d6
1394001|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
1394002|NCT01189487|Unasyn-S|unasyn-s
1394003|NCT01189487|community acquired pneumonia|community acquired pneumonia
1394004|NCT01189487|bacterial pneumonia|bacterial pneumonia
1394005|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
1394006|NCT01189461|pegaptanib sodium|pegaptanib sodium
1394007|NCT01189461|diabetic macular edema|diabetic macular edema
1394008|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
1394009|NCT01189448|Pregnancy,|pregnancy,
1394010|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
1394011|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
1394012|NCT01189448|prevention,|prevention,
1394013|NCT01189448|spiramycine,|spiramycine,
1394014|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
1394015|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
1394016|NCT01189435|Lung|lung
1394017|NCT01189435|recurrent|recurrent
1394018|NCT01189435|10-097|10-097
1394019|NCT01189435|Gefitinib|gefitinib
1394020|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1394021|NCT01189422|T1DM|t1dm
1394022|NCT01189409|Constipation|constipation
1394023|NCT01189409|Opioids|opioids
1394024|NCT01189409|Cancer|cancer
1394025|NCT01189409|Polyethylene glycol|polyethylene glycol
1394026|NCT01189409|Sennosides|sennosides
1394027|NCT01189409|Opioid Therapy|opioid therapy
1394028|NCT01189396|asthma|asthma
1394029|NCT01189396|bronchospasm|bronchospasm
1394030|NCT01189396|COPD|copd
1394031|NCT01189396|reversibility|reversibility
1394032|NCT01189396|efficacy|efficacy
1394033|NCT01189383|Melanoma|melanoma
1394034|NCT01189383|Vaccine|vaccine
1394035|NCT01189383|Dendritic Cell|dendritic cell
1394036|NCT01189383|Immune response|immune response
1394037|NCT01189383|Safety|safety
1394038|NCT01189383|Efficacy|efficacy
1394039|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
1394040|NCT01189370|kidney|kidney
1394041|NCT01189370|cancer|cancer
1394042|NCT01189357|meniscal transplant|meniscal transplant
1394043|NCT01189344|Obesity|obesity
1394044|NCT01189344|LT4|lt4
1394045|NCT01189344|Absorption|absorption
1394046|NCT01189344|Thyroid function|thyroid function
1394047|NCT01189331|Coronary artery disease|coronary artery disease
1394048|NCT01189331|CT|ct
1394049|NCT01189331|Computational flow dynamics|computational flow dynamics
1394050|NCT01189305|Drug Abuse|drug abuse
1394051|NCT01189305|Female Patients|female patients
1394052|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
1394053|NCT01189292|PONV|ponv
1394054|NCT01189292|thyroid surgery|thyroid surgery
1394055|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1394056|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1394057|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1394058|NCT01189253|adult angiosarcoma|adult angiosarcoma
1394059|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1394060|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
1394061|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1394062|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
1394063|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
1394064|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
1394065|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1394066|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1394067|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
1394068|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
1394069|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
1394070|NCT01189227|stage IV colon cancer|stage iv colon cancer
1394071|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
1394072|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
1394073|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1394074|NCT01189227|liver metastases|liver metastases
1394075|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
1394076|NCT01189136|Voiding dysfunction|voiding dysfunction
1394077|NCT01189123|influenza|influenza
1394078|NCT01189123|vaccine|vaccine
1394079|NCT01189123|cell mediated immunity|cell mediated immunity
1394080|NCT01189123|elderly|elderly
1394081|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
1394082|NCT01189110|smoking cessation|smoking cessation
1394083|NCT01189110|veterans|veterans
1394084|NCT01189110|auriculotherapy|auriculotherapy
1394085|NCT01189084|Alzheimer's disease|alzheimer's disease
1394086|NCT01189084|amyloid beta|amyloid beta
1394087|NCT01189084|vaccine|vaccine
1394088|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
1394089|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
1394090|NCT01189071|Kidney calculi|kidney calculi
1394091|NCT01189058|Perinatal stroke|perinatal stroke
1394092|NCT01189058|Periventricular venous infarction|periventricular venous infarction
1394093|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
1394094|NCT01189058|Neonatal stroke|neonatal stroke
1394095|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
1394096|NCT01189058|Fetal stroke|fetal stroke
1394097|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
1394098|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
1394099|NCT01189058|CIMT|cimt
1394100|NCT01189058|Cerebral palsy|cerebral palsy
1394101|NCT01189058|Congenital hemiplegia|congenital hemiplegia
1394102|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
1394103|NCT01189058|Neuroplasticity|neuroplasticity
1394104|NCT01189058|Developmental plasticity|developmental plasticity
1394105|NCT01189045|Stroke|stroke
1394106|NCT01189045|Exercise|exercise
1394107|NCT01189045|Rehabilitation|rehabilitation
1394108|NCT01189045|Risk factors|risk factors
1394109|NCT01189019|ranibizumab|ranibizumab
1394110|NCT01189019|Wet macular degeneration|wet macular degeneration
1394111|NCT01189019|macular degeneration|macular degeneration
1394112|NCT01189019|PED|ped
1394113|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
1394114|NCT01188967|Drugs, Investigational|drugs, investigational
1394115|NCT01188967|Nicotine Dependence|nicotine dependence
1394116|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
1394117|NCT01188967|Relapse Prevention|relapse prevention
1394118|NCT01188967|Smoking Cessation|smoking cessation
1394119|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
1394120|NCT01188954|Seroma|seroma
1394121|NCT01188954|Doxycycline|doxycycline
1394122|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
1394123|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
1394124|NCT01188954|Prevent Seroma Formation|prevent seroma formation
1394125|NCT01188915|Hodgkin disease|hodgkin disease
1394126|NCT01188915|Breast cancer|breast cancer
1394127|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
1394128|NCT01188876|carboplatin|carboplatin
1394129|NCT01188876|recurrent|recurrent
1394130|NCT01188876|platinum sensitive|platinum sensitive
1394131|NCT01188876|pralatrexate|pralatrexate
1394132|NCT01188850|CIN 2 or 3|cin 2 or 3
1394133|NCT01188850|cervical cancer|cervical cancer
1394134|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1394135|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
1394136|NCT01188837|Manipulation Therapy|manipulation therapy
1394137|NCT01188811|Multiple Sclerosis|multiple sclerosis
1394138|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
1394139|NCT01188811|Neuroprotective agents|neuroprotective agents
1394140|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
1394141|NCT01188811|Optical coherence tomography|optical coherence tomography
1394142|NCT01188811|Gait|gait
1394143|NCT01188811|Thioctic acid|thioctic acid
1394144|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
1394145|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
1394146|NCT01188798|Graft versus host disease|graft versus host disease
1394147|NCT01188798|Tacrolimus|tacrolimus
1394148|NCT01188798|Sirolimus|sirolimus
1394149|NCT01188798|Methotrexate|methotrexate
1394150|NCT01188798|Pentostatin|pentostatin
1394151|NCT01188785|siRNA|sirna
1394152|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
1394153|NCT01188785|Cancer|cancer
1394154|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1394155|NCT01188785|Pancreatic cancer|pancreatic cancer
1394156|NCT01188785|Solid tumor|solid tumor
1394157|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
1394158|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
1394159|NCT01188772|Hepatitis C Virus|hepatitis c virus
1394160|NCT01188772|HCV|hcv
1394161|NCT01188772|hepatitis|hepatitis
1394162|NCT01188772|Genotype 1|genotype 1
1394163|NCT01188772|Genotype 2|genotype 2
1394164|NCT01188772|Genotype 3|genotype 3
1394165|NCT01188759|Aspergillosis|aspergillosis
1394166|NCT01188759|Combination Therapy|combination therapy
1394167|NCT01188759|Voriconazole|voriconazole
1394168|NCT01188759|Anidulafungin|anidulafungin
1394169|NCT01188746|catheter|catheter
1394170|NCT01188746|palliative|palliative
1394171|NCT01188746|quality of life|quality of life
1394172|NCT01188746|10-059|10-059
1394173|NCT01188733|portal hypertension|portal hypertension
1394174|NCT01188733|varices|varices
1394175|NCT01188733|cirrhosis|cirrhosis
1394176|NCT01188733|octreotide|octreotide
1394177|NCT01188733|somatostatin analog|somatostatin analog
1394178|NCT01188733|Child Pugh Class A,B|child pugh class a,b
1394179|NCT01188707|Non small cell lung cancer|non small cell lung cancer
1394180|NCT01188707|Belinostat|belinostat
1394181|NCT01188707|Erlotinib|erlotinib
1394182|NCT01188707|HDAC inhibitor|hdac inhibitor
1394183|NCT01188707|Phase I/II|phase i/ii
1394184|NCT01188681|CLL|cll
1394185|NCT01188681|TRU-016|tru-016
1394186|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1394187|NCT01188681|relapsed CLL|relapsed cll
1394188|NCT01188681|bendamustine|bendamustine
1394189|NCT01188668|Pharmacokinetic|pharmacokinetic
1394190|NCT01188668|safety and tolerability|safety and tolerability
1394191|NCT01188668|genetic testing|genetic testing
1394192|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
1394193|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
1394194|NCT01188642|childhood obesity|childhood obesity
1394195|NCT01188642|adipocytokines|adipocytokines
1394196|NCT01188642|physical exercise|physical exercise
1394197|NCT01188642|nutrition education|nutrition education
1394198|NCT01188629|Preventive Care|preventive care
1394199|NCT01188629|Medication Management|medication management
1394200|NCT01188629|Electronic Medical Records|electronic medical records
1394201|NCT01188629|Automated Telephone System|automated telephone system
1394202|NCT01188616|Childhood Obesity|childhood obesity
1394203|NCT01188616|Obesity Intervention|obesity intervention
1394204|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
1394205|NCT01188577|asthma|asthma
1394206|NCT01188577|bronchospasm|bronchospasm
1394207|NCT01188577|wheezing|wheezing
1394208|NCT01188577|shortness of breath|shortness of breath
1394209|NCT01188564|Hereditary Angioedema|hereditary angioedema
1394210|NCT01188564|HAE|hae
1394211|NCT01188564|Angioedema|angioedema
1394212|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
1394213|NCT01188564|rhC1INH|rhc1inh
1394214|NCT01188551|myringotomy|myringotomy
1394215|NCT01188551|pressure equalization tubes|pressure equalization tubes
1394216|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
1394217|NCT01188525|pharmacokinetics|pharmacokinetics
1394218|NCT01188525|enzymes|enzymes
1394219|NCT01188525|metabolism prediction|metabolism prediction
1394220|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
1394221|NCT01188473|Status Asthmaticus|status asthmaticus
1394222|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
1394223|NCT01188473|Asthma in Children|asthma in children
1394224|NCT01188460|Insomnia|insomnia
1394225|NCT01188460|Chronic pain|chronic pain
1394226|NCT01188447|cervical-spine injuries|cervical-spine injuries
1394227|NCT01188447|cervical-spine fractures|cervical-spine fractures
1394228|NCT01188447|spinal cord injury|spinal cord injury
1394229|NCT01188447|neck injury|neck injury
1394230|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
1394231|NCT01188447|paramedics|paramedics
1394232|NCT01188447|emergency medical services|emergency medical services
1394233|NCT01188434|Methamphetamine|methamphetamine
1394234|NCT01188434|Substance Abuse|substance abuse
1394235|NCT01188434|Child Neglect|child neglect
1394632|NCT01186705|colon|colon
1394236|NCT01188434|Child Welfare|child welfare
1394237|NCT01188434|Evidence Based Practice|evidence based practice
1394238|NCT01188382|Intracranial pressure|intracranial pressure
1394239|NCT01188382|resistance|resistance
1394240|NCT01188382|CSF outflow|csf outflow
1394241|NCT01188382|elderly|elderly
1394242|NCT01188382|reference value|reference value
1394243|NCT01188369|levosimendan|levosimendan
1394244|NCT01188369|heart failure|heart failure
1394245|NCT01188369|inotropics|inotropics
1394246|NCT01188369|diastolic dysfunction|diastolic dysfunction
1394247|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
1394248|NCT01188369|aortic valve stenosis|aortic valve stenosis
1394249|NCT01188356|Reply|reply
1394250|NCT01188356|Symphony|symphony
1394251|NCT01188356|Atrial arrhythmias|atrial arrhythmias
1394252|NCT01188356|V pacing|v pacing
1394253|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
1394254|NCT01188343|Japanese Encephalitis|japanese encephalitis
1394255|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
1394256|NCT01188343|Measles|measles
1394257|NCT01188343|Mumps|mumps
1394258|NCT01188343|Rubella|rubella
1394259|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
1394260|NCT01188291|Optical Coherence Tomography|optical coherence tomography
1394261|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
1394262|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
1394263|NCT01188291|Hypopnea syndrome|hypopnea syndrome
1394264|NCT01188291|Glaucoma|glaucoma
1394265|NCT01188252|Phase I|phase i
1394266|NCT01188252|Dose escalation|dose escalation
1394267|NCT01188252|Kinase inhibitor|kinase inhibitor
1394395|NCT01187667|critical care|critical care
1394268|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
1394269|NCT01188239|electronic cigarette|electronic cigarette
1394270|NCT01188239|nicotine|nicotine
1394271|NCT01188239|smoking cessation|smoking cessation
1394272|NCT01188239|smoking reduction|smoking reduction
1394273|NCT01188187|custirsen sodium|custirsen sodium
1394274|NCT01188187|prostate cancer|prostate cancer
1394275|NCT01188187|overall survival|overall survival
1394276|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
1394278|NCT01188174|primary induction failure|primary induction failure
1394279|NCT01188161|Posturography|posturography
1394280|NCT01188161|Balance|balance
1394281|NCT01188161|Falls|falls
1394282|NCT01188161|Gyroscope|gyroscope
1394283|NCT01188161|Rotational Chair|rotational chair
1394284|NCT01188161|Vestibular|vestibular
1394285|NCT01188161|Movement Disorders|movement disorders
1394286|NCT01188135|depression|depression
1394287|NCT01188135|interactive voice messaging|interactive voice messaging
1394288|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
1394290|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
1394291|NCT01188109|Pancreatic cancer|pancreatic cancer
1394292|NCT01188096|glioma|glioma
1394293|NCT01188096|pediatrics|pediatrics
1394294|NCT01188096|cancer|cancer
1394295|NCT01188096|brain tumor|brain tumor
1394296|NCT01188096|low grade glioma|low grade glioma
1394297|NCT01188083|NASH|nash
1394298|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
1394299|NCT01188083|Hispanic|hispanic
1394300|NCT01188083|overweight|overweight
1394301|NCT01188070|Behavioral/Social|behavioral/social
1394302|NCT01188070|Cardiology|cardiology
1394303|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
1394304|NCT01188070|Congestive Heart Failure|congestive heart failure
1394305|NCT01188070|Heart Disease|heart disease
1394306|NCT01188070|Knowledge Dissemination|knowledge dissemination
1394307|NCT01188070|Lipids|lipids
1394308|NCT01188070|Nursing|nursing
1394309|NCT01188070|Health Promotion|health promotion
1394310|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
1394311|NCT01188057|Bioequivalence|bioequivalence
1394312|NCT01188057|ALPRAZOLAM|alprazolam
1394313|NCT01188057|Healthy subjects|healthy subjects
1394314|NCT01188044|Motor activity|motor activity
1394315|NCT01188044|Infant|infant
1394316|NCT01188044|Validation studies|validation studies
1394317|NCT01188044|Malawi|malawi
1394318|NCT01188044|Sub-Saharan Africa|sub-saharan africa
1394319|NCT01188031|Bioequivalence|bioequivalence
1394320|NCT01188031|ALPRAZOLAM|alprazolam
1394321|NCT01188031|Healthy subjects|healthy subjects
1394322|NCT01188018|Smoking|smoking
1394323|NCT01188018|Smoking Cessation|smoking cessation
1394324|NCT01188018|Nicotine Dependence|nicotine dependence
1394325|NCT01188018|Tobacco Use Cessation|tobacco use cessation
1394326|NCT01188018|Health Education|health education
1394327|NCT01188018|Patient Education|patient education
1394328|NCT01188005|OSAS|osas
1394329|NCT01188005|Sleep Apnoea|sleep apnoea
1394330|NCT01188005|IL6|il6
1394331|NCT01188005|TNFα|tnfα
1394332|NCT01188005|Oxidative Stress|oxidative stress
1394333|NCT01188005|Antioxidants|antioxidants
1394334|NCT01187992|Atorvastatin|atorvastatin
1394335|NCT01187992|Acute coronary syndrome|acute coronary syndrome
1394435|NCT01187498|Clinical trial|clinical trial
1394336|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
1394337|NCT01187979|Cash incentive|cash incentive
1394338|NCT01187979|HIV prevention|hiv prevention
1394339|NCT01187979|Adolescents|adolescents
1394340|NCT01187979|South Africa|south africa
1394341|NCT01187979|HIV|hiv
1394342|NCT01187966|Parkinson's Disease|parkinson's disease
1394343|NCT01187966|PD|pd
1394344|NCT01187966|Levodopa|levodopa
1394345|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
1394346|NCT01187953|Tacrolimus|tacrolimus
1394347|NCT01187953|Acute Rejection|acute rejection
1394348|NCT01187953|Kidney|kidney
1394349|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
1394350|NCT01187940|Psychoeducation|psychoeducation
1394351|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1394352|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
1394353|NCT01187914|Ablation|ablation
1394354|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
1394355|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
1394356|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
1394357|NCT01187888|PSP|psp
1394358|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
1394359|NCT01187888|Rasagiline|rasagiline
1394360|NCT01187888|Azilect|azilect
1394361|NCT01187888|PROSPERA|prospera
1394362|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
1394363|NCT01187823|Chronic heart failure|chronic heart failure
1394364|NCT01187823|Central sleep apnea|central sleep apnea
1394365|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
1394366|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
1394367|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
1394368|NCT01187758|antibiotic use|antibiotic use
1394369|NCT01187758|antibiotic prescription|antibiotic prescription
1394370|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
1394371|NCT01187758|MRSA|mrsa
1394372|NCT01187745|renal calculi|renal calculi
1394373|NCT01187732|skin damage|skin damage
1394374|NCT01187732|intertrigo|intertrigo
1394375|NCT01187732|dermatitis|dermatitis
1394376|NCT01187732|erythema|erythema
1394377|NCT01187732|aggression|aggression
1519210|NCT00704743|RCT|rct
1394378|NCT01187732|body Wipes|body wipes
1394379|NCT01187732|soaps|soaps
1394380|NCT01187732|no rinse|no rinse
1394381|NCT01187732|cost effectiveness|cost effectiveness
1394382|NCT01187732|nursing home residents|nursing home residents
1394383|NCT01187732|nurse|nurse
1394384|NCT01187719|HIV|hiv
1394385|NCT01187719|pregnancy|pregnancy
1394386|NCT01187719|phenytoin|phenytoin
1394387|NCT01187719|ARV prophylaxis|arv prophylaxis
1394388|NCT01187719|nevirapine|nevirapine
1394389|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
1394390|NCT01187706|quality of life|quality of life
1394391|NCT01187680|Tissue adhesions|tissue adhesions
1394392|NCT01187680|Laparoscopy|laparoscopy
1394393|NCT01187667|delirium|delirium
1394394|NCT01187667|prevention|prevention
1394396|NCT01187667|haloperidol|haloperidol
1394397|NCT01187654|myocardial infarction|myocardial infarction
1394398|NCT01187654|bone marrow stem cell|bone marrow stem cell
1394399|NCT01187654|AC133|ac133
1394400|NCT01187654|mono nuclear cell|mono nuclear cell
1394401|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
1394402|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
1394403|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
1394404|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
1394405|NCT01187615|Phase I|phase i
1394406|NCT01187576|Physical activity|physical activity
1394407|NCT01187576|Hypertension|hypertension
1394408|NCT01187576|Diabetes mellitus|diabetes mellitus
1394409|NCT01187576|Motivational interviewing|motivational interviewing
1394410|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
1394411|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
1394412|NCT01187550|Growth hormone|growth hormone
1394413|NCT01187537|Knee Replacement|knee replacement
1394414|NCT01187537|Analgesia|analgesia
1394415|NCT01187537|Analgesics|analgesics
1394416|NCT01187537|Nerve blocks|nerve blocks
1394417|NCT01187537|Recovery of functions|recovery of functions
1394418|NCT01187537|Post operative analgesia|post operative analgesia
1394419|NCT01187524|Patient Registry|patient registry
1394420|NCT01187524|FMR1 Gene|fmr1 gene
1394421|NCT01187524|Fragile X Syndrome|fragile x syndrome
1394422|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
1394423|NCT01187524|Premature Ovarian Failure|premature ovarian failure
1394424|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
1394425|NCT01187511|Addiction|addiction
1394426|NCT01187511|Alcohol Dependence|alcohol dependence
1394427|NCT01187511|Anxiety|anxiety
1394428|NCT01187511|CRH Antagonist|crh antagonist
1394429|NCT01187511|Stress Induced Craving|stress induced craving
1394430|NCT01187498|Overactive bladder|overactive bladder
1394431|NCT01187498|Behavioral treatment|behavioral treatment
1394432|NCT01187498|Drug therapy|drug therapy
1394433|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
1394434|NCT01187498|Urinary incontinence|urinary incontinence
1394437|NCT01187485|Testosterone|testosterone
1394438|NCT01187485|refractory|refractory
1394439|NCT01187485|prostate|prostate
1394440|NCT01187485|cancer|cancer
1394441|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
1394442|NCT01187472|Head|head
1394443|NCT01187472|neck|neck
1394444|NCT01187472|cancer|cancer
1394445|NCT01187472|advanced|advanced
1394446|NCT01187472|oral cavity|oral cavity
1394447|NCT01187472|lip|lip
1394448|NCT01187472|larynx|larynx
1394449|NCT01187459|Vitamin D|vitamin d
1394450|NCT01187459|Crohn's Disease|crohn's disease
1394451|NCT01187459|Dose Response|dose response
1394452|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1394453|NCT01187433|Dengue|dengue
1394454|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
1394455|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
1394456|NCT01187420|Cerebral vasospasm|cerebral vasospasm
1394457|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
1394458|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
1394459|NCT01187394|Frozen Plasma|frozen plasma
1394460|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
1394461|NCT01187394|Cardiac Surgery|cardiac surgery
1394462|NCT01187394|Bleeding|bleeding
1394463|NCT01187394|Knowledge Translation|knowledge translation
1394464|NCT01187368|heart failure|heart failure
1394465|NCT01187368|LVAS|lvas
1394466|NCT01187368|LVAD|lvad
1394467|NCT01187368|bridge-to-transplant|bridge-to-transplant
1394468|NCT01187368|rotary pump|rotary pump
1394469|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
1394470|NCT01187355|Multi-purpose solution|multi-purpose solution
1394471|NCT01187342|Stroke|stroke
1394472|NCT01187329|Hyperglycemia|hyperglycemia
1394473|NCT01187329|open heart surgery|open heart surgery
1394474|NCT01187329|bypass|bypass
1394475|NCT01187316|Facial Pain|facial pain
1394476|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
1394477|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1394478|NCT01187316|Adolescent|adolescent
1394479|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
1394480|NCT01187290|stage IIIA, N2|stage iiia, n2
1394481|NCT01187277|stroke|stroke
1394482|NCT01187277|rehabilitation|rehabilitation
1394483|NCT01187277|gait training|gait training
1394484|NCT01187277|robot-assisted therapy|robot-assisted therapy
1394485|NCT01187251|tinnitus|tinnitus
1394486|NCT01187251|mp3 players|mp3 players
1394487|NCT01187251|noise induced hearing loss|noise induced hearing loss
1394488|NCT01187251|high frequencies audiometry|high frequencies audiometry
1394489|NCT01187251|acoustic otoemissions|acoustic otoemissions
1394490|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1394491|NCT01187238|Stage II|stage ii
1394492|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
1394493|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1394494|NCT01187238|Cisplatin|cisplatin
1394495|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
1394496|NCT01187225|Fibrinogen|fibrinogen
1394497|NCT01187225|Bleeding|bleeding
1394498|NCT01187225|Cryoprecipitate|cryoprecipitate
1394499|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
1394500|NCT01187199|Metastatic cancer|metastatic cancer
1394501|NCT01187199|Chemotherapy|chemotherapy
1394502|NCT01187199|Avastin|avastin
1394503|NCT01187199|Carboplatin|carboplatin
1394504|NCT01187199|Paclitaxel|paclitaxel
1394505|NCT01187199|Sorafenib|sorafenib
1394506|NCT01187199|Temsirolimus|temsirolimus
1394507|NCT01187186|Liver disease|liver disease
1394508|NCT01187186|ASP1941|asp1941
1394509|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
1394510|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
1394511|NCT01187134|sepsis|sepsis
1394512|NCT01187134|shock, septic|shock, septic
1394513|NCT01187134|quality assurance, health care|quality assurance, health care
1394514|NCT01187134|quality control|quality control
1394515|NCT01187134|Survival Rate|survival rate
1394516|NCT01187134|Follow-Up Studies|follow-up studies
1394517|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
1394518|NCT01187121|Graduated Sanctions|graduated sanctions
1394519|NCT01187121|Probationary failure|probationary failure
1394520|NCT01187121|recidivism|recidivism
1394521|NCT01187121|drug relapse|drug relapse
1394522|NCT01187121|criminal justice|criminal justice
1394523|NCT01187108|Cobalt|cobalt
1394524|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
1394525|NCT01187108|Monge's Disease|monge's disease
1394526|NCT01187108|Acetazolamide|acetazolamide
1394527|NCT01187108|N-acetylcysteine|n-acetylcysteine
1394528|NCT01187108|Altitude Sickness|altitude sickness
1394529|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
1394530|NCT01187095|Involuntary childlessness|involuntary childlessness
1394531|NCT01187095|Infertility|infertility
1394532|NCT01187095|IVF|ivf
1394533|NCT01187095|EWI|ewi
1394633|NCT01186705|rectal|rectal
1394534|NCT01187095|Couples in IVF treatment|couples in ivf treatment
1394535|NCT01187095|Psychosocial intervention|psychosocial intervention
1394536|NCT01187082|overactive bladder|overactive bladder
1394537|NCT01187082|women|women
1394538|NCT01187082|bladder training|bladder training
1394539|NCT01187082|groups|groups
1394540|NCT01187069|Motivation|motivation
1394541|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
1394542|NCT01187069|practice nurses|practice nurses
1394543|NCT01187069|general practice|general practice
1394544|NCT01187069|Self-determination Theory|self-determination theory
1394545|NCT01187056|Shared decision-making|shared decision-making
1394546|NCT01187056|Risk information|risk information
1394547|NCT01187056|Decision aids|decision aids
1394548|NCT01187043|Liver Function|liver function
1394549|NCT01187043|Steady State Exposure|steady state exposure
1394550|NCT01187030|Frozen Plasma|frozen plasma
1394551|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
1394552|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
1394553|NCT01187030|RAND UCLA|rand ucla
1394554|NCT01187030|Modified Delphi Methodology|modified delphi methodology
1394555|NCT01187030|Expert Panel|expert panel
1394556|NCT01187030|Appropriateness Rating|appropriateness rating
1394557|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
1394558|NCT01187017|Aplastic Anemia|aplastic anemia
1394559|NCT01187017|Immunosuppression|immunosuppression
1394560|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
1394561|NCT01187017|T-Cells|t-cells
1394562|NCT01186965|Diabetes|diabetes
1394563|NCT01186965|Second Life|second life
1394564|NCT01186965|virtual community|virtual community
1394565|NCT01186965|diabetes education|diabetes education
1394566|NCT01186965|diabetes support group|diabetes support group
1394567|NCT01186952|overweight|overweight
1394568|NCT01186952|obesity|obesity
1394569|NCT01186952|type 2 diabetes|type 2 diabetes
1394570|NCT01186952|caloric restriction|caloric restriction
1394571|NCT01186952|exercise program|exercise program
1394572|NCT01186952|epicardial fat|epicardial fat
1394573|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
1394574|NCT01186939|MDS|mds
1394575|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
1394576|NCT01186926|OSA|osa
1394577|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
1394578|NCT01186926|sleep apnea|sleep apnea
1394579|NCT01186913|SCID disorders|scid disorders
1394580|NCT01186913|natural history study|natural history study
1394581|NCT01186900|skin abscess|skin abscess
1394582|NCT01186900|needle aspiration|needle aspiration
1394583|NCT01186900|incision and drainage|incision and drainage
1394584|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
1394585|NCT01186861|NSCLC|nsclc
1394586|NCT01186861|Erlotinib|erlotinib
1394587|NCT01186861|OSI-906|osi-906
1394588|NCT01186861|Placebo|placebo
1394589|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
1394590|NCT01186848|Stretch marks|stretch marks
1394591|NCT01186848|Striae distensae|striae distensae
1394592|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
1394593|NCT01186796|Women|women
1394594|NCT01186796|Fulvestrant Study|fulvestrant study
1394595|NCT01186796|Post Menopausal Women|post menopausal women
1394596|NCT01186796|Hormones|hormones
1394597|NCT01186796|Healthy Adult Women|healthy adult women
1394598|NCT01186783|heart rate|heart rate
1394599|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1394600|NCT01186783|ivabradine|ivabradine
1394601|NCT01186783|sepsis|sepsis
1394602|NCT01186783|cardiogenic shock|cardiogenic shock
1394603|NCT01186770|Treatment of Opioid-Induced Constipation in Subjects with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in subjects with chronic, non-malignant pain
1394604|NCT01186744|OPT Retreatment|opt retreatment
1394605|NCT01186744|OPT|opt
1394606|NCT01186744|chronic|chronic
1394607|NCT01186744|moderate|moderate
1394608|NCT01186744|severe|severe
1394609|NCT01186744|treatment|treatment
1394610|NCT01186744|safety|safety
1394611|NCT01186744|treatment withdrawal|treatment withdrawal
1394612|NCT01186744|retreatment|retreatment
1394613|NCT01186744|retreatment withdrawal|retreatment withdrawal
1394614|NCT01186744|CP-690,550|cp-690,550
1394615|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
1394616|NCT01186744|Plaque Psoriasis|plaque psoriasis
1394617|NCT01186744|tofacitinib|tofacitinib
1394618|NCT01186744|Xeljanz|xeljanz
1394619|NCT01186744|nail psoriasis|nail psoriasis
1394620|NCT01186744|Jak-inhibitor|jak-inhibitor
1394621|NCT01186744|oral treatment|oral treatment
1394622|NCT01186744|Pruritus|pruritus
1394623|NCT01186744|Itch|itch
1394624|NCT01186744|DLQI|dlqi
1394625|NCT01186744|rebound|rebound
1394626|NCT01186744|intermittent|intermittent
1394627|NCT01186744|retreat|retreat
1394728|NCT01186393|Dietary Meetings|dietary meetings
1394628|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
1394629|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
1394630|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
1394631|NCT01186705|MK-2206|mk-2206
1394634|NCT01186705|10-068|10-068
1394635|NCT01186666|Atherosclerosis|atherosclerosis
1394636|NCT01186666|Vulnerable plaque|vulnerable plaque
1394637|NCT01186666|Intravascular ultrasound|intravascular ultrasound
1394638|NCT01186666|Virtual histology|virtual histology
1394639|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
1394640|NCT01186666|Positron emission tomography|positron emission tomography
1394641|NCT01186666|Multidetector computed tomography|multidetector computed tomography
1394642|NCT01186640|T-PLL|t-pll
1394643|NCT01186640|Polychemotherapy|polychemotherapy
1394644|NCT01186640|Alemtuzumab|alemtuzumab
1394645|NCT01186640|Efficacy|efficacy
1394646|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
1394647|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
1394648|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
1394649|NCT01186627|Mortality|mortality
1394650|NCT01186627|Apgar Score|apgar score
1394651|NCT01186614|cardiac arrest|cardiac arrest
1394652|NCT01186614|ECMO|ecmo
1394653|NCT01186614|hypothermia|hypothermia
1394654|NCT01186614|automated CPR|automated cpr
1394655|NCT01186614|coronary intervention|coronary intervention
1394656|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
1394657|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
1394658|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
1394659|NCT01186601|Melanoma|melanoma
1394660|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
1394661|NCT01186588|Canagliflozin|canagliflozin
1394662|NCT01186588|JNJ-28431754|jnj-28431754
1394663|NCT01186588|Liver diseases|liver diseases
1394664|NCT01186588|Hepatic impairment|hepatic impairment
1394665|NCT01186588|Pharmacokinetic|pharmacokinetic
1394666|NCT01186588|Normal hepatic function|normal hepatic function
1394667|NCT01186575|HIV Infections|hiv infections
1394668|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1394669|NCT01186575|Circumcision, Male|circumcision, male
1394670|NCT01186575|Coitus|coitus
1394671|NCT01186575|Patient Compliance|patient compliance
1394672|NCT01186575|Cellular Phone|cellular phone
1394673|NCT01186562|Pancreatitis|pancreatitis
1394674|NCT01186562|Pancreatectomy|pancreatectomy
1394675|NCT01186562|Islet autotransplant|islet autotransplant
1394676|NCT01186562|Sitagliptin|sitagliptin
1394677|NCT01186562|Diabetes|diabetes
1394678|NCT01186549|propofol|propofol
1394679|NCT01186549|ephedrine|ephedrine
1394680|NCT01186549|pain|pain
1394681|NCT01186536|Whey Protein|whey protein
1394682|NCT01186536|Soy Protein|soy protein
1394683|NCT01186536|Resistance training|resistance training
1394684|NCT01186536|Weight Management|weight management
1394685|NCT01186523|Obesity|obesity
1394686|NCT01186523|Weight Management|weight management
1394687|NCT01186523|Physical Activity|physical activity
1394688|NCT01186497|Healthy|healthy
1394689|NCT01186497|Rabeprazole sodium|rabeprazole sodium
1394690|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
1394691|NCT01186497|Pharmacokinetics|pharmacokinetics
1394692|NCT01186497|Bioavailability|bioavailability
1394693|NCT01186497|Safety|safety
1394694|NCT01186497|Adult|adult
1394695|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
1394696|NCT01186484|Abiraterone acetate|abiraterone acetate
1394697|NCT01186484|JNJ-212082|jnj-212082
1394698|NCT01186471|Symptomatic treatment|symptomatic treatment
1394699|NCT01186471|Cognition|cognition
1394700|NCT01186471|Cognitive deficits|cognitive deficits
1394701|NCT01186471|Schizophrenia|schizophrenia
1394702|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
1394703|NCT01186445|Cardioprotective effect|cardioprotective effect
1394704|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
1394705|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
1394706|NCT01186445|Cardiac MRI|cardiac mri
1394707|NCT01186419|Beta-thalassemia|beta-thalassemia
1394708|NCT01186419|Sickle cell anemia|sickle cell anemia
1394709|NCT01186419|Transfusional iron overload|transfusional iron overload
1394710|NCT01186419|Iron overload|iron overload
1394711|NCT01186419|Iron chelation|iron chelation
1394712|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
1394713|NCT01186406|gliosarcoma|gliosarcoma
1394714|NCT01186406|malignant glioma|malignant glioma
1394715|NCT01186406|glioma|glioma
1394716|NCT01186406|Gliadel|gliadel
1394717|NCT01186406|carmustine wafers|carmustine wafers
1394718|NCT01186406|Avastin|avastin
1394719|NCT01186406|bevacizumab|bevacizumab
1394720|NCT01186406|Temodar|temodar
1394721|NCT01186406|temozolomide|temozolomide
1394722|NCT01186406|Pro00025180|pro00025180
1394723|NCT01186406|Desjardins|desjardins
1394724|NCT01186406|Duke|duke
1394725|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
1394726|NCT01186393|Weight Loss|weight loss
1394727|NCT01186393|Potatoes|potatoes
1394922|NCT01185639|adrenal|adrenal
1394729|NCT01186393|Glycemic Control|glycemic control
1394730|NCT01186380|TEE|tee
1394731|NCT01186380|Transesophageal|transesophageal
1394732|NCT01186380|Transducer|transducer
1394733|NCT01186380|Esophagus|esophagus
1394835|NCT01185977|Major Depressive Disorder|major depressive disorder
1394836|NCT01185977|Fluoxetine|fluoxetine
1394734|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
1394735|NCT01186367|breast cancer|breast cancer
1394736|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
1394737|NCT01186367|15-147|15-147
1394738|NCT01186354|Type 2 diabetes|type 2 diabetes
1394739|NCT01186354|health literacy|health literacy
1394740|NCT01186354|genetic literacy|genetic literacy
1394741|NCT01186354|genetic risk|genetic risk
1394742|NCT01186341|Chronic Pain|chronic pain
1394743|NCT01186328|Relapse|relapse
1394744|NCT01186328|T cell|t cell
1394745|NCT01186328|Lymphoblastic|lymphoblastic
1394746|NCT01186328|Leukemia|leukemia
1394747|NCT01186328|EZN3042|ezn3042
1394748|NCT01186328|Refractory|refractory
1394749|NCT01186328|Precursor B|precursor b
1394750|NCT01186328|Pre B cell|pre b cell
1394751|NCT01186328|Survivan|survivan
1394752|NCT01186328|Acute|acute
1394753|NCT01186328|Childhood|childhood
1394754|NCT01186328|Pediatric|pediatric
1394755|NCT01186315|Addiction|addiction
1394756|NCT01186315|Posttraumatic Stress|posttraumatic stress
1394757|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
1394758|NCT01186302|medical abortion|medical abortion
1394759|NCT01186302|Nepal|nepal
1394760|NCT01186302|midlevel providers|midlevel providers
1394761|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
1394762|NCT01186263|liver metastases|liver metastases
1394763|NCT01186263|MAA|maa
1394764|NCT01186263|B20|b20
1394765|NCT01186263|SIR spheres|sir spheres
1394766|NCT01186263|SPECT|spect
1394767|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
1394768|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
1394769|NCT01186250|pioglitazone|pioglitazone
1394770|NCT01186250|insulin resistance|insulin resistance
1394771|NCT01186250|heart transplant|heart transplant
1519681|NCT00702598|RCT|rct
1394772|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
1394773|NCT01186237|Quality of Life|quality of life
1394774|NCT01186211|knee, joint|knee, joint
1394775|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
1394776|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
1394777|NCT01186198|Predilatation Balloon|predilatation balloon
1394778|NCT01186198|Angioplasty|angioplasty
1394779|NCT01186198|Myocardial Ischemia|myocardial ischemia
1394780|NCT01186198|Coronary Stenosis|coronary stenosis
1394781|NCT01186198|PCI|pci
1394782|NCT01186198|PTCA|ptca
1394783|NCT01186198|CTO|cto
1394784|NCT01186185|sudden|sudden
1394785|NCT01186185|sensorineural|sensorineural
1394786|NCT01186185|hearing loss|hearing loss
1394787|NCT01186185|fludrocortisone|fludrocortisone
1394788|NCT01186185|mineralocorticoid|mineralocorticoid
1394789|NCT01186185|steroid|steroid
1394790|NCT01186172|ethanol|ethanol
1394791|NCT01186172|lock therapy|lock therapy
1394792|NCT01186172|vascular access|vascular access
1394793|NCT01186172|central venous catheter|central venous catheter
1394794|NCT01186172|sepsis|sepsis
1394795|NCT01186159|COX-2|cox-2
1394796|NCT01186159|PMNL|pmnl
1394797|NCT01186159|pain|pain
1394798|NCT01186159|macrophages|macrophages
1394799|NCT01186159|NSAIDs|nsaids
1394800|NCT01186146|coronary disease|coronary disease
1394801|NCT01186146|stents|stents
1394802|NCT01186146|antiplatelet drugs|antiplatelet drugs
1394803|NCT01186146|drug-eluting stents|drug-eluting stents
1394804|NCT01186133|coronary disease|coronary disease
1394805|NCT01186133|drug eluting stent|drug eluting stent
1394806|NCT01186120|coronary disease|coronary disease
1394807|NCT01186120|stent|stent
1394808|NCT01186107|coronary disease|coronary disease
1394809|NCT01186107|stent|stent
1394810|NCT01186094|Coronary Artery Disease|coronary artery disease
1394811|NCT01186094|Stent|stent
1394812|NCT01186081|Rectal cancer|rectal cancer
1394813|NCT01186081|Preoperative CCRT|preoperative ccrt
1394814|NCT01186081|Postoperative CCRT|postoperative ccrt
1394815|NCT01186081|Capecitabine|capecitabine
1394816|NCT01186068|Rosacea, erythema|rosacea, erythema
1394817|NCT01186055|Smoking Relapse|smoking relapse
1394818|NCT01186055|Nicotine Abstinence|nicotine abstinence
1394819|NCT01186042|HIV|hiv
1394820|NCT01186042|Aging|aging
1394821|NCT01186042|Neuropsychological function|neuropsychological function
1394822|NCT01186042|Activity|activity
1394823|NCT01186042|Sleep patterns|sleep patterns
1394824|NCT01186042|Frailty|frailty
1394825|NCT01186042|Emotional well-being|emotional well-being
1394826|NCT01186042|Sexual health|sexual health
1394827|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
1394828|NCT01186029|Nausea and Vomiting|nausea and vomiting
1394829|NCT01186016|Genetic Education|genetic education
1394830|NCT01186016|Smoking Cessation|smoking cessation
1394831|NCT01186016|Quitting Smoking|quitting smoking
1394923|NCT01185639|bone cancer|bone cancer
1394832|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
1394833|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
1394834|NCT01186003|Diabetes|diabetes
1394837|NCT01185977|QEEG|qeeg
1394838|NCT01185977|cordance|cordance
1394839|NCT01185977|ATR|atr
1394840|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
1394841|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
1394842|NCT01185951|Achilles Tendon|achilles tendon
1394843|NCT01185951|Patella|patella
1394844|NCT01185951|Allergy|allergy
1394845|NCT01185951|Necrosis|necrosis
1394846|NCT01185951|Infection|infection
1394847|NCT01185938|statin|statin
1394848|NCT01185938|CIN|cin
1394849|NCT01185938|periprocedural damage|periprocedural damage
1394850|NCT01185925|PDE5-inhibition|pde5-inhibition
1394851|NCT01185925|exercise ventilation|exercise ventilation
1394852|NCT01185925|heart failure|heart failure
1394853|NCT01185925|sildenafil|sildenafil
1394854|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
1394855|NCT01185912|Cardiac MRI|cardiac mri
1394856|NCT01185912|Cardiac ultrasound|cardiac ultrasound
1394857|NCT01185912|Cardiac surgery|cardiac surgery
1394858|NCT01185899|heart attack|heart attack
1394859|NCT01185899|acute myocardial infarction|acute myocardial infarction
1394860|NCT01185899|STEMI|stemi
1394861|NCT01185899|NSTEMI|nstemi
1394862|NCT01185899|Unstable Angina|unstable angina
1394863|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
1394864|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
1394865|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1394866|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1394867|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1394868|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1567151|NCT00509756|healthy subjects|healthy subjects
1394869|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1394870|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1394871|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1394872|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1394873|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1394874|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
1394875|NCT01185821|BAF312|baf312
1394876|NCT01185821|siponimod|siponimod
1394877|NCT01185821|Multiple Sclerosis|multiple sclerosis
1394878|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1394879|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
1394880|NCT01185821|MS|ms
1394881|NCT01185821|RRMS|rrms
1394882|NCT01185821|inflammatory disease|inflammatory disease
1394883|NCT01185808|sinusitis|sinusitis
1394884|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
1394885|NCT01185795|yogurt|yogurt
1394886|NCT01185795|probiotic|probiotic
1394887|NCT01185795|cholesterol|cholesterol
1394888|NCT01185782|Infertility|infertility
1394889|NCT01185782|Ovulation induction|ovulation induction
1394890|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
1394891|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
1394892|NCT01185782|gonadotropin|gonadotropin
1394893|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
1394894|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
1394895|NCT01185769|Vitamin E|vitamin e
1394896|NCT01185769|Absorption|absorption
1394897|NCT01185756|Heart failure|heart failure
1394898|NCT01185756|Sudden death|sudden death
1394899|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1394900|NCT01185756|MIBG scintigraphy|mibg scintigraphy
1394901|NCT01185743|healthy volunteers|healthy volunteers
1394902|NCT01185743|antipsychotics|antipsychotics
1394903|NCT01185743|gene expression|gene expression
1394904|NCT01185730|Pulmonary hypertension|pulmonary hypertension
1394905|NCT01185730|Prognostic factors|prognostic factors
1394906|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
1394907|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
1394908|NCT01185730|use anorectics|use anorectics
1394909|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
1394910|NCT01185678|Contraception|contraception
1394911|NCT01185678|Compliance|compliance
1394912|NCT01185665|FBSS|fbss
1394913|NCT01185652|Smoking|smoking
1394914|NCT01185652|airflow obstruction|airflow obstruction
1394915|NCT01185652|pulmonary function tests|pulmonary function tests
1394916|NCT01185639|lung cancer|lung cancer
1394917|NCT01185639|metastatic|metastatic
1394918|NCT01185639|SBRT|sbrt
1394919|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
1394920|NCT01185639|liver|liver
1394921|NCT01185639|spine|spine
1394924|NCT01185639|Spinal Column|spinal column
1394925|NCT01185626|patients|patients
1394926|NCT01185600|transfusion complications|transfusion complications
1394927|NCT01185600|washed RBC|washed rbc
1394928|NCT01185600|microparticles|microparticles
1394929|NCT01185600|storage lesion|storage lesion
1394930|NCT01185587|SCN5A protein|scn5a protein
1394931|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
1394932|NCT01185561|Diabetes|diabetes
1394933|NCT01185561|SWEEP|sweep
1394934|NCT01185561|Dysphoria|dysphoria
1394935|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
1394936|NCT01185535|topical anesthesia|topical anesthesia
1394937|NCT01185535|tracheal intubation|tracheal intubation
1394938|NCT01185535|difficult airway|difficult airway
1394939|NCT01185509|HER2 negative|her2 negative
1394940|NCT01185509|HER2 positive|her2 positive
1394941|NCT01185496|diabetes mellitus|diabetes mellitus
1394942|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
1394943|NCT01185483|Submucosal tumor|submucosal tumor
1394944|NCT01185483|Minimal invasive|minimal invasive
1394945|NCT01185483|Gastroscopy|gastroscopy
1394946|NCT01185470|Chronic pain|chronic pain
1394947|NCT01185470|Morphine Sufate|morphine sufate
1394948|NCT01185470|Intrathecal|intrathecal
1394949|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
1394950|NCT01185457|Shoulder surgery|shoulder surgery
1394951|NCT01185457|Beach chair position|beach chair position
1394952|NCT01185457|Interscalene block|interscalene block
1394953|NCT01185457|HRV|hrv
1394954|NCT01185457|Autonomic nervous system|autonomic nervous system
1394955|NCT01185444|Knee Balance|knee balance
1394956|NCT01185444|Hyaluronate|hyaluronate
1394957|NCT01185444|Osteoarthritis|osteoarthritis
1394958|NCT01185444|Viscosupplementation|viscosupplementation
1394959|NCT01185431|Ficus Carica|ficus carica
1394960|NCT01185431|Functional Constipation|functional constipation
1394961|NCT01185431|Dietary Supplement|dietary supplement
1394962|NCT01185431|Fig Paste|fig paste
1394963|NCT01185405|Voriconazole|voriconazole
1394964|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
1394965|NCT01185405|Intensive care unit|intensive care unit
1394966|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
1394967|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
1394969|NCT01185379|cerebral blood flow|cerebral blood flow
1394970|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
1394971|NCT01185379|cognitive function|cognitive function
1394972|NCT01185379|mood|mood
1394973|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
1394974|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
1394975|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
1394976|NCT01185366|Translocation carcinoma|translocation carcinoma
1394977|NCT01185366|Chromophobe|chromophobe
1394978|NCT01185366|Everolimus|everolimus
1394979|NCT01185366|Sunitinib|sunitinib
1394980|NCT01185366|Afinitor|afinitor
1394981|NCT01185366|RAD001|rad001
1394982|NCT01185366|Sunitinib Malate|sunitinib malate
1394983|NCT01185366|SUO11248|suo11248
1394984|NCT01185366|Sutent|sutent
1394985|NCT01185366|ESPN|espn
1394986|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
1394987|NCT01185353|RA|ra
1394988|NCT01185340|Depression|depression
1394989|NCT01185340|MDD|mdd
1394990|NCT01185327|Regurgitation|regurgitation
1394991|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
1394992|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
1394993|NCT01185301|Arthritis|arthritis
1394994|NCT01185301|Erosion|erosion
1394995|NCT01185301|Humira|humira
1394996|NCT01185301|Adalimumab|adalimumab
1394997|NCT01185301|Injection|injection
1394998|NCT01185301|Rheumatoid|rheumatoid
1394999|NCT01185301|Methotrexate|methotrexate
1395000|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
1395001|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
1395002|NCT01185249|CHF|chf
1395003|NCT01185249|congestive heart failure|congestive heart failure
1395004|NCT01185236|Diabetes mellitus|diabetes mellitus
1395005|NCT01185223|Valganciclovir|valganciclovir
1395006|NCT01185223|Ganciclovir|ganciclovir
1395007|NCT01185223|Antiviral Drug|antiviral drug
1395008|NCT01185223|CMV disease|cmv disease
1395009|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
1395010|NCT01185197|Corticosteroid|corticosteroid
1395011|NCT01185197|Mycophenolate|mycophenolate
1395012|NCT01185197|Remission|remission
1395013|NCT01185197|Safety|safety
1395014|NCT01185184|Relative bioavailability|relative bioavailability
1395015|NCT01185184|controlled release|controlled release
1395016|NCT01185184|Phase 1|phase 1
1395017|NCT01185184|CP-690|cp-690
1395018|NCT01185184|550|550
1395019|NCT01185171|Larynx|larynx
1395020|NCT01185171|Lip|lip
1395021|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
1395022|NCT01185158|Larynx|larynx
1395023|NCT01185158|Lip|lip
1395024|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
1395025|NCT01185145|breast-conservation|breast-conservation
1395026|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
1395028|NCT01185145|IMRT|imrt
1395029|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
1395030|NCT01185145|breast brachytherapy|breast brachytherapy
1395031|NCT01185145|lumpectomy|lumpectomy
1395032|NCT01185145|early stage breast cancer|early stage breast cancer
1395033|NCT01185145|DCIS|dcis
1395034|NCT01185145|Mammosite|mammosite
1395035|NCT01185132|breast-conservation|breast-conservation
1395036|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
1395037|NCT01185132|breast cancer|breast cancer
1395038|NCT01185132|early-stage breast cancer|early-stage breast cancer
1395039|NCT01185132|DCIS|dcis
1395040|NCT01185132|lumpectomy|lumpectomy
1395041|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
1395042|NCT01185132|APBI|apbi
1395043|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
1395044|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
1395045|NCT01185132|3D CRT|3d crt
1395046|NCT01185132|IMRT|imrt
1395047|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
1395048|NCT01185093|Cells|cells
1395049|NCT01185093|Prevention|prevention
1395050|NCT01185093|Cancer education|cancer education
1395051|NCT01185093|Nutrition|nutrition
1395052|NCT01185093|Healthy living|healthy living
1395053|NCT01185093|Physical activity|physical activity
1395054|NCT01185093|Dangers of tobacco|dangers of tobacco
1395055|NCT01185093|Sun protection|sun protection
1395056|NCT01185080|AZD8848|azd8848
1395057|NCT01185080|allergic rhinitis|allergic rhinitis
1395058|NCT01185080|efficacy|efficacy
1395059|NCT01185080|tolerability|tolerability
1395060|NCT01185080|safety|safety
1395061|NCT01185080|nasal symptoms|nasal symptoms
1395062|NCT01185067|Hypertension|hypertension
1395063|NCT01185067|Endothelial function|endothelial function
1395064|NCT01185067|Antioxidants|antioxidants
1395065|NCT01185067|Oxidative stress|oxidative stress
1395066|NCT01185067|Grapes|grapes
1395067|NCT01185067|Polyphenols|polyphenols
1395068|NCT01185067|Resveratrol|resveratrol
1395069|NCT01185067|Quercetin|quercetin
1395070|NCT01185067|Anthocyanins|anthocyanins
1395071|NCT01185067|Flavanols|flavanols
1395072|NCT01185067|Flavonols|flavonols
1395073|NCT01185067|Congestive heart failure|congestive heart failure
1395074|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1395075|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
1395076|NCT01185067|HFNEF|hfnef
1395077|NCT01185067|HFPSF|hfpsf
1395078|NCT01185067|HFPEF|hfpef
1395079|NCT01185067|DHF|dhf
1395080|NCT01185054|Pediatrics|pediatrics
1395081|NCT01185054|Gastroenteritis|gastroenteritis
1395082|NCT01185054|Oral Rehydration|oral rehydration
1395083|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
1395084|NCT01185041|Arterial Stiffness|arterial stiffness
1395085|NCT01185041|Wave Reflection|wave reflection
1395086|NCT01185041|Watermelon Supplementation|watermelon supplementation
1395087|NCT01185041|Aortic Blood Pressure|aortic blood pressure
1395088|NCT01185041|Obesity|obesity
1395089|NCT01185028|Chronic HCV|chronic hcv
1395090|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
1395091|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
1395092|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
1395093|NCT01185028|Nitazoxanide|nitazoxanide
1395094|NCT01185028|Hepatitis C|hepatitis c
1395095|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
1395096|NCT01185002|CE|ce
1395097|NCT01185002|colonoscopy|colonoscopy
1395098|NCT01185002|colon|colon
1395099|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
1395100|NCT01184976|H5N1|h5n1
1395101|NCT01184976|Avian Influenza|avian influenza
1395102|NCT01184976|DNA Vaccine|dna vaccine
1395103|NCT01184976|Electroporation|electroporation
1395104|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
1395105|NCT01184963|PCOS|pcos
1395106|NCT01184963|High protein diet|high protein diet
1395107|NCT01184924|Arthritis|arthritis
1395108|NCT01184924|Tai Chi|tai chi
1395109|NCT01184911|Malaria|malaria
1395110|NCT01184911|Pregnancy|pregnancy
1395111|NCT01184898|AML|aml
1395112|NCT01184898|mTOR|mtor
1395113|NCT01184898|rapamycin|rapamycin
1395114|NCT01184885|hyperCVAD|hypercvad
1395115|NCT01184885|rapamycin|rapamycin
1395116|NCT01184885|lymphoid malignancies|lymphoid malignancies
1395117|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
1395118|NCT01184885|B and T cell|b and t cell
1395119|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
1395120|NCT01184885|burkitt lymphoma|burkitt lymphoma
1395121|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
1395122|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
1395123|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
1395124|NCT01184885|adult t cell leukemia|adult t cell leukemia
1395125|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
1395126|NCT01184872|Skin infection|skin infection
1395127|NCT01184872|Daptomycin|daptomycin
1395128|NCT01184872|Elderly|elderly
1395129|NCT01184872|Gram positive|gram positive
1395130|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
1395131|NCT01184859|nocturia|nocturia
1395132|NCT01184859|bladder function|bladder function
1395133|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
1395134|NCT01184846|CIDP|cidp
1395135|NCT01184833|Multiple sclerosis|multiple sclerosis
1395136|NCT01184833|Interferon beta-1b|interferon beta-1b
1395137|NCT01184833|Compliance to treatment|compliance to treatment
1395138|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
1395139|NCT01184820|Pharmacokinetics|pharmacokinetics
1395140|NCT01184820|Safety|safety
1395141|NCT01184807|Advanced solid tumor|advanced solid tumor
1395142|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
1395143|NCT01184768|type 2 diabetes|type 2 diabetes
1395144|NCT01184768|HbA1c|hba1c
1395145|NCT01184768|vitamin D|vitamin d
1395146|NCT01184768|diagnosis|diagnosis
1395147|NCT01184755|Device-guided breathing|device-guided breathing
1395148|NCT01184755|hypertension|hypertension
1395149|NCT01184755|behavioral intervention|behavioral intervention
1395150|NCT01184755|stress reduction|stress reduction
1395151|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
1395152|NCT01184729|aerobic capacity|aerobic capacity
1395153|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
1395154|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1395155|NCT01184703|Glycemic Index Diet|glycemic index diet
1395156|NCT01184703|HbA1c|hba1c
1395157|NCT01184703|Lipids|lipids
1395158|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
1395159|NCT01184690|diagnostic yield|diagnostic yield
1395160|NCT01184664|Smoking cessation|smoking cessation
1395161|NCT01184664|Tobacco dependence|tobacco dependence
1395162|NCT01184664|Varenicline|varenicline
1395163|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
1395164|NCT01184664|Combination therapy|combination therapy
1395165|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1395166|NCT01184651|CAH|cah
1395167|NCT01184651|sex differences|sex differences
1395168|NCT01184651|adolescence|adolescence
1395169|NCT01184651|androgen|androgen
1395170|NCT01184651|behavior|behavior
1395171|NCT01184651|gender development|gender development
1395172|NCT01184638|Cognitive Disorders|cognitive disorders
1395173|NCT01184638|General anesthesia|general anesthesia
1395174|NCT01184638|Sevoflurane|sevoflurane
1395175|NCT01184638|Propofol|propofol
1395176|NCT01184638|Memory|memory
1395177|NCT01184625|Myositis|myositis
1395178|NCT01184625|Physical exercise|physical exercise
1395179|NCT01184625|Disability|disability
1395180|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
1395181|NCT01184599|Aliskiren|aliskiren
1395182|NCT01184599|Albuminuria|albuminuria
1395183|NCT01184599|Angiotensinogen|angiotensinogen
1395184|NCT01184599|collagen type IV|collagen type iv
1395185|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
1395186|NCT01184599|aldosterone|aldosterone
1395187|NCT01184599|renin|renin
1395188|NCT01184599|prorenin receptor|prorenin receptor
1395189|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
1395190|NCT01184599|oxidative stress|oxidative stress
1395191|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
1395192|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
1395193|NCT01184586|function|function
1395194|NCT01184586|DASH|dash
1395195|NCT01184586|MHQ|mhq
1395196|NCT01184586|pain|pain
1395197|NCT01184586|strength|strength
1395198|NCT01184573|chronic pancreatitis|chronic pancreatitis
1395199|NCT01184573|breath test|breath test
1395200|NCT01184573|bicarbonate|bicarbonate
1395201|NCT01184560|obesity|obesity
1395202|NCT01184534|Lung Biopsy|lung biopsy
1395203|NCT01184534|Multimedia patient education tool|multimedia patient education tool
1395204|NCT01184534|Multimedia Education Tool|multimedia education tool
1395205|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
1395206|NCT01184534|Computerized Tomography|computerized tomography
1395207|NCT01184534|CT|ct
1395208|NCT01184534|Questionnaire|questionnaire
1395209|NCT01184534|Lung nodules|lung nodules
1395210|NCT01184508|classic with aura|classic with aura
1395211|NCT01184508|common without aura|common without aura
1395212|NCT01184508|migraine|migraine
1395213|NCT01184508|headache|headache
1395214|NCT01184495|Erythropoietin|erythropoietin
1395215|NCT01184495|Chronic renal failure|chronic renal failure
1395216|NCT01184495|Hemodialysis|hemodialysis
1395217|NCT01184495|Anemia|anemia
1395218|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
1395219|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
1395220|NCT01184482|recurrent lung cancer|recurrent lung cancer
1395221|NCT01184482|cetuximab|cetuximab
1395222|NCT01184482|lapatinib|lapatinib
1395223|NCT01184456|AIDS|aids
1395224|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1395225|NCT01184456|HIV|hiv
1395226|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
1395227|NCT01184443|Anorexia Nervosa|anorexia nervosa
1395228|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
1395229|NCT01184443|Olanzapine|olanzapine
1395230|NCT01184443|Pediatric|pediatric
1395231|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
1395232|NCT01184430|goal-directed therapy|goal-directed therapy
1395233|NCT01184430|cardiac surgery|cardiac surgery
1395234|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
1395235|NCT01184404|Congenital heart disease|congenital heart disease
1395236|NCT01184404|Cardiac surgery|cardiac surgery
1395237|NCT01184404|Bosentan|bosentan
1395238|NCT01184378|infant formula|infant formula
1395239|NCT01184378|dairy fat|dairy fat
1395240|NCT01184378|soluble milk protein|soluble milk protein
1395241|NCT01184365|fatigue|fatigue
1395242|NCT01184365|energy management|energy management
1395243|NCT01184365|spinal cord injury|spinal cord injury
1395244|NCT01184365|self-efficacy|self-efficacy
1395245|NCT01184365|environment|environment
1395246|NCT01184339|Staphylococcus|staphylococcus
1395247|NCT01184339|aureus|aureus
1395248|NCT01184339|methicillin|methicillin
1395249|NCT01184339|resistant|resistant
1395250|NCT01184339|MRSA|mrsa
1395251|NCT01184339|MSSA|mssa
1395252|NCT01184339|Blood Culture|blood culture
1395253|NCT01184339|diagnostic|diagnostic
1395254|NCT01184326|RAD001|rad001
1395255|NCT01184326|pazopanib|pazopanib
1395256|NCT01184326|everolimus|everolimus
1395257|NCT01184326|advanced cancer|advanced cancer
1395258|NCT01184313|aortic valve surgery|aortic valve surgery
1395259|NCT01184313|CPB|cpb
1395260|NCT01184313|lung injury|lung injury
1395261|NCT01184300|CYP2C19*2|cyp2c19*2
1395262|NCT01184300|Pharmacogenomics|pharmacogenomics
1395263|NCT01184300|Clopidogrel|clopidogrel
1395264|NCT01184300|Prasugrel|prasugrel
1395265|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
1395266|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
1395267|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
1395268|NCT01184235|Circadian Disorders|circadian disorders
1395269|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
1395270|NCT01184235|Mood Disorders|mood disorders
1395271|NCT01184235|Executive Functioning|executive functioning
1395272|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
1395273|NCT01184196|knee replacement|knee replacement
1395274|NCT01184196|knee arthroplasty|knee arthroplasty
1395275|NCT01184196|total knee replacement|total knee replacement
1395276|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
1395277|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
1395279|NCT01184170|metabolism|metabolism
1395280|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
1395281|NCT01184144|Endometriosis|endometriosis
1395282|NCT01184144|Peritoneal fluid|peritoneal fluid
1395283|NCT01184144|Cytokines|cytokines
1395284|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
1395285|NCT01184131|Mentor Training|mentor training
1395286|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
1395287|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
1395288|NCT01184118|asthma|asthma
1395289|NCT01184118|sleep apnea|sleep apnea
1395290|NCT01184092|Bioequivalence|bioequivalence
1395291|NCT01184092|healthy volunteer study|healthy volunteer study
1395292|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
1395293|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
1395294|NCT01184079|HPV Vaccines|hpv vaccines
1395295|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
1395296|NCT01184066|Chemotherapy|chemotherapy
1395297|NCT01184066|Patient Adherence|patient adherence
1395298|NCT01184066|African Americans|african americans
1395299|NCT01184066|Cancer Survivor|cancer survivor
1395300|NCT01184066|Decision Making|decision making
1395301|NCT01184066|Communication|communication
1395302|NCT01184066|Quality of Life|quality of life
1395303|NCT01184066|Social Support|social support
1395304|NCT01184066|Patient Education|patient education
1395305|NCT01184053|endometrial|endometrial
1395306|NCT01184053|carcinoma|carcinoma
1395307|NCT01184053|recurrent|recurrent
1395308|NCT01184053|metastatic|metastatic
1395309|NCT01184053|Trisenox|trisenox
1395310|NCT01184053|arsenic trioxide|arsenic trioxide
1395311|NCT01184053|Phase II|phase ii
1395312|NCT01184053|VEGF|vegf
1395313|NCT01184053|gynecology|gynecology
1395314|NCT01184053|Lineberger|lineberger
1395315|NCT01184053|UNC|unc
1395316|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
1395317|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
1395318|NCT01184027|head and neck cancer|head and neck cancer
1395319|NCT01184027|surgery|surgery
1395320|NCT01184027|nutrition|nutrition
1395321|NCT01184014|corticosteroid|corticosteroid
1395322|NCT01184014|hyperglycemia|hyperglycemia
1395323|NCT01184014|hospital|hospital
1395324|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
1395325|NCT01184001|Healthy subjects|healthy subjects
1395326|NCT01184001|Food Effect Study|food effect study
1395328|NCT01183962|Vitamin D|vitamin d
1395329|NCT01183962|CVD|cvd
1395330|NCT01183949|Neoplasms|neoplasms
1395331|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
1395332|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
1395333|NCT01183949|Hemostatic Disorders|hemostatic disorders
1395334|NCT01183949|Paraproteinemias|paraproteinemias
1395335|NCT01183949|Blood Protein Disorders|blood protein disorders
1395336|NCT01183949|Hematologic Diseases|hematologic diseases
1395337|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
1395338|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
1395339|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
1395340|NCT01183949|Immune System Diseases|immune system diseases
1395341|NCT01183949|Bortezomib|bortezomib
1395342|NCT01183949|Antineoplastic Agents|antineoplastic agents
1395343|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
1395344|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
1395345|NCT01183936|Survival|survival
1395346|NCT01183936|Disease-Free Survival|disease-free survival
1395347|NCT01183923|asthma|asthma
1395348|NCT01183923|dietary interventions|dietary interventions
1395349|NCT01183923|mouse allergy|mouse allergy
1395350|NCT01183910|PURPURA|purpura
1395351|NCT01183910|SENILE PURPURA|senile purpura
1395352|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
1395353|NCT01183897|GM-CSF|gm-csf
1395354|NCT01183897|MAB 3F8|mab 3f8
1395355|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
1395356|NCT01183897|09-161|09-161
1395357|NCT01183884|GM-CSF|gm-csf
1395358|NCT01183884|MAB 3F8|mab 3f8
1395359|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
1395360|NCT01183884|09-160|09-160
1395361|NCT01183871|Cerebral oxygenation|cerebral oxygenation
1395362|NCT01183871|thoracotomy|thoracotomy
1395363|NCT01183871|lung resection|lung resection
1395364|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
1395365|NCT01183845|Crohn Disease|crohn disease
1395366|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
1395367|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
1395368|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
1395369|NCT01183832|Breast cancer|breast cancer
1395370|NCT01183832|radiotherapy|radiotherapy
1395371|NCT01183832|hormonotherapy|hormonotherapy
1395372|NCT01183819|cognitive function|cognitive function
1395373|NCT01183819|fMRI|fmri
1395374|NCT01183819|apoE|apoe
1395375|NCT01183819|inflammatory markers|inflammatory markers
1395376|NCT01183819|exercise|exercise
1395377|NCT01183819|cognitive intervention|cognitive intervention
1395378|NCT01183819|Space Fortress|space fortress
1395379|NCT01183806|Alzheimer's disease|alzheimer's disease
1395380|NCT01183806|Exercise|exercise
1395381|NCT01183806|Rivastigmine|rivastigmine
1395382|NCT01183806|Quality of life|quality of life
1395383|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
1395384|NCT01183780|second line|second line
1395385|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
1395386|NCT01183780|FOLFIRI|folfiri
1395387|NCT01183780|ramucirumab|ramucirumab
1395388|NCT01183780|CRC|crc
1395389|NCT01183780|mCRC|mcrc
1395390|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1395391|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
1395392|NCT01183767|Green tea extract|green tea extract
1395393|NCT01183754|coronary disease|coronary disease
1395394|NCT01183754|platelet reactivity|platelet reactivity
1395395|NCT01183754|drug-eluting stent|drug-eluting stent
1395396|NCT01183741|Hypertension|hypertension
1395397|NCT01183741|Hypotension|hypotension
1395398|NCT01183741|Blood pressure|blood pressure
1395399|NCT01183728|Knee degenerative disease|knee degenerative disease
1395400|NCT01183728|osteoarthritis|osteoarthritis
1395401|NCT01183728|gonarthrosis|gonarthrosis
1395402|NCT01183728|stem cell|stem cell
1395403|NCT01183728|cellular therapy|cellular therapy
1395404|NCT01183728|regenerative therapy|regenerative therapy
1395405|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
1395406|NCT01183728|Bone marrow|bone marrow
1395407|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
1395408|NCT01183715|Single Ascending Dose|single ascending dose
1395409|NCT01183715|Phase 1|phase 1
1395410|NCT01183715|Safety and Tolerability|safety and tolerability
1395411|NCT01183715|PK|pk
1395412|NCT01183715|Healthy Subjects|healthy subjects
1395413|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
1395414|NCT01183663|Lenalidomide|lenalidomide
1395415|NCT01183663|Bevacizumab|bevacizumab
1395416|NCT01183663|Sorafenib|sorafenib
1395417|NCT01183663|Temsirolimus|temsirolimus
1395418|NCT01183663|5-Fluorouracil|5-fluorouracil
1395419|NCT01183663|Leucovorin|leucovorin
1395420|NCT01183663|Oxaliplatin|oxaliplatin
1395421|NCT01183663|Avastin|avastin
1395422|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1395423|NCT01183663|rhuMAB-VEGF|rhumab-vegf
1395424|NCT01183663|CC-5013|cc-5013
1395425|NCT01183663|Revlimid|revlimid
1395426|NCT01183663|Nexavar|nexavar
1395427|NCT01183663|BAY 43-90006|bay 43-90006
1395428|NCT01183663|Metastatic cancer|metastatic cancer
1395429|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
1395430|NCT01183663|Advanced solid tumors|advanced solid tumors
1395431|NCT01183663|Hematologic malignancies|hematologic malignancies
1395432|NCT01183663|Colon cancer|colon cancer
1395433|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
1395434|NCT01183663|Breast cancer|breast cancer
1395435|NCT01183663|Pancreatic cancer|pancreatic cancer
1395436|NCT01183663|Gastric cancer|gastric cancer
1395437|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
1395438|NCT01183663|Prostate cancer|prostate cancer
1395439|NCT01183663|Melanoma|melanoma
1395440|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1395441|NCT01183663|Renal cell carcinoma|renal cell carcinoma
1395442|NCT01183663|Metastatic breast cancer|metastatic breast cancer
1395443|NCT01183663|Glioblastoma|glioblastoma
1395444|NCT01183663|Multiple myeloma|multiple myeloma
1395445|NCT01183637|Cartilage|cartilage
1395446|NCT01183637|Knee|knee
1395447|NCT01183637|Osteochondral|osteochondral
1395448|NCT01183624|Osteoarthritis|osteoarthritis
1395449|NCT01183624|Pain|pain
1395450|NCT01183624|Herbal medicine|herbal medicine
1395451|NCT01183624|Topical administration|topical administration
1395452|NCT01183611|safety|safety
1395453|NCT01183611|immunogenicity|immunogenicity
1395454|NCT01183611|HBV vaccine|hbv vaccine
1395455|NCT01183611|perinatal transmission|perinatal transmission
1395456|NCT01183572|multivitamins|multivitamins
1395457|NCT01183572|folate|folate
1395458|NCT01183572|iron|iron
1395459|NCT01183572|periconception|periconception
1395460|NCT01183546|rehabilitation|rehabilitation
1395461|NCT01183546|spinal cord injury|spinal cord injury
1395462|NCT01183546|wheelchairs|wheelchairs
1395463|NCT01183533|Wake-Up Stroke|wake-up stroke
1395464|NCT01183533|Ischemic stroke|ischemic stroke
1395465|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
1395466|NCT01183481|nausea|nausea
1395467|NCT01183481|vomiting|vomiting
1395468|NCT01183481|antiemetics|antiemetics
1395469|NCT01183481|radiotherapy|radiotherapy
1395470|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
1395471|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
1395472|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
1395473|NCT01183468|new-onset T1DM|new-onset t1dm
1395474|NCT01183468|new-onset T1D|new-onset t1d
1395475|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
1395476|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
1395477|NCT01183468|Aralast NP|aralast np
1395478|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
1395479|NCT01183468|AAT|aat
1395480|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
1395481|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
1395482|NCT01183455|T1D (new-onset)|t1d (new-onset)
1395483|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
1395484|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
1395485|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
1395486|NCT01183455|AAT|aat
1395487|NCT01183442|endothelial function|endothelial function
1395488|NCT01183442|insulin sensitivity|insulin sensitivity
1395489|NCT01183429|MAB 3F8|mab 3f8
1395490|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
1395491|NCT01183429|Bone Marrow|bone marrow
1395492|NCT01183429|09-159|09-159
1395493|NCT01183416|GM-CSF|gm-csf
1395494|NCT01183416|MAB 3F8|mab 3f8
1395495|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
1395496|NCT01183416|09-158|09-158
1395497|NCT01183403|stricture|stricture
1395498|NCT01183403|anti-TNF|anti-tnf
1395499|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
1395500|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
1395501|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
1395502|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
1395503|NCT01183390|Bioequivalence|bioequivalence
1395504|NCT01183390|Healthy Subjects|healthy subjects
1395505|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
1395506|NCT01183377|Eating disorder|eating disorder
1395507|NCT01183377|osteoprosis|osteoprosis
1395508|NCT01183364|solid tumor malignancies|solid tumor malignancies
1395509|NCT01183364|tumor|tumor
1395510|NCT01183364|cancer|cancer
1395511|NCT01183364|STA-9090|sta-9090
1395512|NCT01183364|ganetespib|ganetespib
1395513|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
1395514|NCT01183351|Dementia|dementia
1395515|NCT01183351|Agitation|agitation
1395516|NCT01183351|Challenging behaviour|challenging behaviour
1395517|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
1395518|NCT01183338|SpO2|spo2
1395519|NCT01183338|Oxygen saturation|oxygen saturation
1395620|NCT01182831|carcinoma pancreas|carcinoma pancreas
1395520|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
1395521|NCT01183312|Hypersomnia|hypersomnia
1395522|NCT01183312|Primary Hypersomnia|primary hypersomnia
1395523|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
1395524|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
1395525|NCT01183312|Flumazenil|flumazenil
1395526|NCT01183299|bone metabolism|bone metabolism
1395527|NCT01183299|salt intake|salt intake
1395528|NCT01183299|acid base balance|acid base balance
1395529|NCT01183299|bed rest|bed rest
1395530|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
1395531|NCT01183260|bone mineral density|bone mineral density
1395532|NCT01183260|trabecular metal|trabecular metal
1395533|NCT01183260|DEXA|dexa
1395534|NCT01183247|Everolimus,|everolimus,
1395535|NCT01183247|rapamycin,|rapamycin,
1395536|NCT01183247|prednisone,|prednisone,
1395537|NCT01183247|tacrolimus,|tacrolimus,
1395538|NCT01183247|MMF,|mmf,
1395539|NCT01183247|steroid-free,|steroid-free,
1395540|NCT01183247|protocol biopsy|protocol biopsy
1395541|NCT01183182|Lung nodule|lung nodule
1395542|NCT01183182|Lung lesion|lung lesion
1395543|NCT01183169|Chronic hepatitis C|chronic hepatitis c
1395544|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
1395545|NCT01183156|Colorectal Cancer|colorectal cancer
1395546|NCT01183156|Screening|screening
1395547|NCT01183156|Colonoscopy|colonoscopy
1395548|NCT01183156|Attendance|attendance
1395549|NCT01183156|Participation|participation
1395550|NCT01183143|Infertility|infertility
1395551|NCT01183143|Ovulation induction|ovulation induction
1395552|NCT01183143|Gonal-F|gonal-f
1395553|NCT01183143|Follitropin alpha|follitropin alpha
1395554|NCT01183143|Controlled ovarian stimulation|controlled ovarian stimulation
1395555|NCT01183130|opiate dependence|opiate dependence
1395556|NCT01183130|compliance monitoring|compliance monitoring
1395557|NCT01183130|substitution treatment|substitution treatment
1395558|NCT01183104|Type 2 Diabetes|type 2 diabetes
1395559|NCT01183104|Sitagliptin|sitagliptin
1395560|NCT01183104|Glimepiride|glimepiride
1395561|NCT01183104|Elderly patients|elderly patients
1395562|NCT01183104|Japanese|japanese
1395563|NCT01183091|Atrial fibrillation|atrial fibrillation
1395564|NCT01183091|Ablation|ablation
1395565|NCT01183078|efficacy|efficacy
1395566|NCT01183078|drill placement|drill placement
1395567|NCT01183078|nail placement|nail placement
1395568|NCT01183078|radiation|radiation
1395569|NCT01183078|Operative time|operative time
1395570|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
1395571|NCT01183078|Accuracy for nail placement|accuracy for nail placement
1395572|NCT01183065|Pralatrexate|pralatrexate
1395573|NCT01183065|Vitamin B12|vitamin b12
1395574|NCT01183065|Folic Acid|folic acid
1395575|NCT01183065|10-112|10-112
1395576|NCT01183052|COPD|copd
1395577|NCT01183052|exercise tolerance|exercise tolerance
1395578|NCT01183052|oxidative stress|oxidative stress
1395579|NCT01183039|Sedentary|sedentary
1395580|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
1395581|NCT01182987|Quality improvement|quality improvement
1395582|NCT01182987|Quality of care|quality of care
1395583|NCT01182987|Health care utilization|health care utilization
1395584|NCT01182987|Behavioral change|behavioral change
1395585|NCT01182974|fever in severe sepsis|fever in severe sepsis
1395586|NCT01182961|Gait|gait
1395587|NCT01182961|Falls|falls
1395588|NCT01182961|Virtual reality|virtual reality
1395589|NCT01182948|aerobic training|aerobic training
1395590|NCT01182948|resistance training|resistance training
1395591|NCT01182948|type 2 diabetes|type 2 diabetes
1395592|NCT01182948|therapy|therapy
1395593|NCT01182935|vitamin D|vitamin d
1395594|NCT01182935|triglycerides|triglycerides
1395595|NCT01182935|type 2 diabetes|type 2 diabetes
1395596|NCT01182922|Attendance|attendance
1395597|NCT01182922|Colorectal cancer|colorectal cancer
1395598|NCT01182922|Screening|screening
1395599|NCT01182922|Invitation letter|invitation letter
1395600|NCT01182909|NPC|npc
1395601|NCT01182909|Environmental and Genetic|environmental and genetic
1395602|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
1395603|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
1395604|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
1395605|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
1395606|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
1395607|NCT01182883|Dose Escalation|dose escalation
1395608|NCT01182883|Pharmacokinetics|pharmacokinetics
1395609|NCT01182883|Antitumor Activity|antitumor activity
1395610|NCT01182883|Biologic Activity|biologic activity
1395611|NCT01182870|vitamin D|vitamin d
1395612|NCT01182870|influenza|influenza
1395613|NCT01182870|prevention|prevention
1395614|NCT01182857|Quality of Life|quality of life
1395615|NCT01182857|Gene Therapy|gene therapy
1395616|NCT01182857|ADA-SCID|ada-scid
1395617|NCT01182857|SCID-ADA|scid-ada
1395618|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
1395619|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
1395621|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
1395622|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
1395623|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
1395624|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1395625|NCT01182818|Fabry Disease|fabry disease
1395626|NCT01182818|Fabry´s Disease|fabry´s disease
1395627|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
1395628|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1395629|NCT01182818|Stroke, Acute|stroke, acute
1395630|NCT01182818|Cerebral Stroke|cerebral stroke
1395631|NCT01182792|Endothelial Function|endothelial function
1395632|NCT01182792|Chronic Hypoxia|chronic hypoxia
1395633|NCT01182792|Oxidative Stress|oxidative stress
1395634|NCT01182779|base of skull chordoma|base of skull chordoma
1395635|NCT01182779|radiation|radiation
1395636|NCT01182779|carbon ions|carbon ions
1395637|NCT01182779|protons|protons
1395638|NCT01182766|alcohol|alcohol
1395639|NCT01182766|alcoholism|alcoholism
1395640|NCT01182766|nicotine|nicotine
1395641|NCT01182766|cigarette|cigarette
1395642|NCT01182753|Chondrosarcoma|chondrosarcoma
1395643|NCT01182753|Radiation|radiation
1395644|NCT01182753|carbon ion|carbon ion
1395645|NCT01182727|schizophrenia|schizophrenia
1395646|NCT01182727|salsalate|salsalate
1395647|NCT01182727|obesity|obesity
1395648|NCT01182714|Hysterectomy|hysterectomy
1395649|NCT01182714|Catheterisation|catheterisation
1395650|NCT01182701|Type 2 Diabetes|type 2 diabetes
1395651|NCT01182701|Asian Pacific Islanders|asian pacific islanders
1395652|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
1395653|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
1395654|NCT01182675|SCID|scid
1395655|NCT01182675|Transplant|transplant
1395656|NCT01182675|Alemtuzumab|alemtuzumab
1395657|NCT01182675|Plerixafor|plerixafor
1395658|NCT01182662|Bone Marrow Disease|bone marrow disease
1395659|NCT01182662|Aplastic Anemia|aplastic anemia
1395660|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
1395661|NCT01182662|Transplantation|transplantation
1395662|NCT01182649|Drug Eluting Stents|drug eluting stents
1395663|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
1395664|NCT01182649|Coronary Angioplasty|coronary angioplasty
1395665|NCT01182636|Bioequivalence|bioequivalence
1395666|NCT01182636|Acne Vulgaris|acne vulgaris
1395667|NCT01182623|FICE|fice
1395668|NCT01182623|Chromoendoscopy|chromoendoscopy
1395669|NCT01182623|Colonic polyps|colonic polyps
1395670|NCT01182623|Adenomas|adenomas
1395671|NCT01182623|Hyperplastic polyps|hyperplastic polyps
1395672|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
1395673|NCT01182571|Heart Transplantation|heart transplantation
1395674|NCT01182571|Symptom Distress|symptom distress
1395675|NCT01182571|Fatigue|fatigue
1395676|NCT01182571|Depression|depression
1395677|NCT01182571|Quality Of Life.|quality of life.
1395678|NCT01182558|Muscle|muscle
1395679|NCT01182558|Activation|activation
1395680|NCT01182558|Effect|effect
1395681|NCT01182558|Compound muscle action potential|compound muscle action potential
1395682|NCT01182545|Anaesthesia|anaesthesia
1395683|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1395684|NCT01182545|CO2 insufflation|co2 insufflation
1395685|NCT01182545|hemodynamic|hemodynamic
1395686|NCT01182545|hyperventilation|hyperventilation
1395687|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
1395688|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
1395689|NCT01182532|Effectiveness|effectiveness
1395690|NCT01182532|Safety|safety
1395691|NCT01182519|lung inflammation|lung inflammation
1395692|NCT01182519|lung metastases|lung metastases
1395693|NCT01182519|10-115|10-115
1395694|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
1395695|NCT01182506|cognitive|cognitive
1395696|NCT01182506|10-105|10-105
1395697|NCT01182506|Breast cancer survivor|breast cancer survivor
1395698|NCT01182493|Diabetes Mellitus|diabetes mellitus
1395699|NCT01182493|MDI|mdi
1395700|NCT01182493|pump therapy|pump therapy
1395701|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
1395702|NCT01182454|blood pressure|blood pressure
1395703|NCT01182441|atrial fibrillation|atrial fibrillation
1395704|NCT01182441|stroke|stroke
1395705|NCT01182441|TIA|tia
1395706|NCT01182441|trans ischemic attack|trans ischemic attack
1395707|NCT01182441|warfarin|warfarin
1395708|NCT01182441|Coumadin|coumadin
1395709|NCT01182428|Stents|stents
1395710|NCT01182428|Angioplasty|angioplasty
1395711|NCT01182428|Total coronary occlusions|total coronary occlusions
1395712|NCT01182428|Coronary restenosis|coronary restenosis
1395713|NCT01182428|Stent thrombosis|stent thrombosis
1395714|NCT01182428|Everolimus|everolimus
1395715|NCT01182415|CNS involvement|cns involvement
1395716|NCT01182402|opiate dependence|opiate dependence
1395717|NCT01182402|substitution treatment|substitution treatment
1395718|NCT01182402|unsupervised dosing|unsupervised dosing
1395719|NCT01182402|monitoring|monitoring
1395720|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
1395721|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1395722|NCT01182389|Catheter Ablation|catheter ablation
1395723|NCT01182389|Robotic|robotic
1395724|NCT01182376|Multaq|multaq
1395725|NCT01182376|dronedarone|dronedarone
1395726|NCT01182376|Atrial Fibrillation|atrial fibrillation
1395727|NCT01182363|maternal depression|maternal depression
1395728|NCT01182363|prematurity|prematurity
1395729|NCT01182363|early intervention|early intervention
1395730|NCT01182363|developmental delay|developmental delay
1395731|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
1395732|NCT01182324|Expectations|expectations
1395733|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1395734|NCT01182324|Clinical Trial|clinical trial
1395735|NCT01182324|Motivations|motivations
1395736|NCT01182311|Hepatitis B Virus|hepatitis b virus
1395737|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
1395738|NCT01182311|Immunity|immunity
1395739|NCT01182311|B-Cell Response|b-cell response
1395740|NCT01182311|T-Cell Response|t-cell response
1395741|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
1395742|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
1395743|NCT01182298|Latino|latino
1395745|NCT01182298|pegIFN|pegifn
1395746|NCT01182298|Viral Kinetics|viral kinetics
1395747|NCT01182298|IL-28 Haplotype|il-28 haplotype
1395748|NCT01182285|Depakote|depakote
1395749|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
1395750|NCT01182285|RAI Uptake|rai uptake
1395751|NCT01182285|Thyrogen|thyrogen
1395752|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1395753|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1395754|NCT01182246|adenocarcinoma|adenocarcinoma
1395755|NCT01182246|Pancreatic cancer|pancreatic cancer
1395756|NCT01182233|Multiple Myeloma|multiple myeloma
1395757|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
1395758|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
1395759|NCT01182233|High dose chemotherapy|high dose chemotherapy
1395760|NCT01182220|epidural|epidural
1395761|NCT01182220|labor pain|labor pain
1395762|NCT01182220|ultrasound|ultrasound
1395763|NCT01182207|Bioequivalence|bioequivalence
1395764|NCT01182207|Healthy Subjects|healthy subjects
1395765|NCT01182194|Bioequivalence|bioequivalence
1395766|NCT01182194|Healthy Subjects|healthy subjects
1395767|NCT01182181|Healthy Subjects|healthy subjects
1395768|NCT01182181|Bioequivalence|bioequivalence
1395769|NCT01182168|CISPLATIN|cisplatin
1395770|NCT01182168|GEMCITABINE|gemcitabine
1395771|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
1395772|NCT01182168|10-106|10-106
1395773|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
1395774|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
1395775|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
1395776|NCT01182116|J pouch|j pouch
1395777|NCT01182116|colorectal|colorectal
1395778|NCT01182116|rectal cancer|rectal cancer
1395779|NCT01182116|coloplasty|coloplasty
1395780|NCT01182103|Major depression|major depression
1395781|NCT01182103|BDNF|bdnf
1395782|NCT01182103|DNA methylation|dna methylation
1395783|NCT01182103|Histone modification|histone modification
1395784|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
1395785|NCT01182090|colposacropexy|colposacropexy
1395786|NCT01182090|surgery|surgery
1395787|NCT01182077|ASP015K|asp015k
1395788|NCT01182077|midazolam|midazolam
1395789|NCT01182077|healthy volunteers|healthy volunteers
1395790|NCT01182064|Heart injuries|heart injuries
1395791|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
1395792|NCT01182064|Echocardiography|echocardiography
1395793|NCT01182064|Coronary angiography|coronary angiography
1395794|NCT01182051|headache|headache
1395795|NCT01182051|anxiety|anxiety
1395796|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
1395797|NCT01182038|birth seat|birth seat
1395798|NCT01182038|childbirth|childbirth
1395799|NCT01182038|instrumental delivery|instrumental delivery
1395800|NCT01182038|upright position|upright position
1395801|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
1395802|NCT01182025|Xiyanping Injection|xiyanping injection
1395803|NCT01182025|Effectiveness|effectiveness
1395804|NCT01182025|Safety|safety
1395805|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
1395806|NCT01182012|Severe mental illness|severe mental illness
1395807|NCT01182012|Drug appropriateness|drug appropriateness
1395808|NCT01182012|Drug compliance|drug compliance
1395809|NCT01182012|Lifestyle counseling|lifestyle counseling
1395810|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1395811|NCT01181999|elderly patients|elderly patients
1395812|NCT01181999|rituximab augmentation|rituximab augmentation
1395813|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
1395814|NCT01181973|Relative bioavailability|relative bioavailability
1395815|NCT01181973|pegvisomant|pegvisomant
1395816|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
1395817|NCT01181960|Risperdal Consta|risperdal consta
1395818|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
1395819|NCT01181960|Invega Sustenna|invega sustenna
1395820|NCT01181947|Stent graft|stent graft
1395821|NCT01181947|thoracic aorta|thoracic aorta
1395822|NCT01181947|dissection|dissection
1395823|NCT01181947|aneurysm|aneurysm
1395824|NCT01181947|TEVAR|tevar
1395825|NCT01181947|VALIANT|valiant
1395826|NCT01181947|CAPTIVIA|captivia
1395827|NCT01181947|endovascular|endovascular
1395828|NCT01181934|symptomatic treatment|symptomatic treatment
1395829|NCT01181934|cognition|cognition
1395830|NCT01181934|cognitive deficits|cognitive deficits
1395831|NCT01181934|Schizophrenia|schizophrenia
1395832|NCT01181921|Alzheimer Disease|alzheimer disease
1395833|NCT01181921|Dementia|dementia
1395834|NCT01181921|Sleep Disorders|sleep disorders
1395835|NCT01181921|Galantamine|galantamine
1395836|NCT01181921|Reminyl|reminyl
1395837|NCT01181908|alcohol|alcohol
1395838|NCT01181908|drug interaction|drug interaction
1521033|NCT00696865|Safety|safety
1395839|NCT01181908|pharmacodynamic|pharmacodynamic
1395840|NCT01181895|asthma|asthma
1395841|NCT01181882|Cardiovascular Disease|cardiovascular disease
1395842|NCT01181882|Aspirin Resistance|aspirin resistance
1395843|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1395844|NCT01181882|Platelet Function|platelet function
1395845|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
1395846|NCT01181882|Aspirin|aspirin
1395847|NCT01181882|Lysophospholipids|lysophospholipids
1395848|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
1395849|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
1395850|NCT01181869|respiratory failure|respiratory failure
1395851|NCT01181869|oxygen|oxygen
1395852|NCT01181869|sleep apnoea|sleep apnoea
1395853|NCT01181869|ventilation|ventilation
1395854|NCT01181856|Vaccine|vaccine
1395855|NCT01181856|MVA 85A|mva 85a
1395856|NCT01181843|postoperative pain management|postoperative pain management
1395857|NCT01181843|respiratory depression|respiratory depression
1395858|NCT01181843|capnography|capnography
1395859|NCT01181843|duramorph|duramorph
1395860|NCT01181830|magnesium|magnesium
1395861|NCT01181830|metabolic syndrome|metabolic syndrome
1395862|NCT01181830|diabetes|diabetes
1395863|NCT01181830|family history|family history
1395864|NCT01181817|FBSS|fbss
1395865|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
1395866|NCT01181804|boceprevir|boceprevir
1395867|NCT01181804|hepatitis C|hepatitis c
1395868|NCT01181804|bioequivalence|bioequivalence
1395869|NCT01181804|SCH 503034|sch 503034
1395870|NCT01181791|probiotics|probiotics
1395871|NCT01181791|premature infants|premature infants
1395872|NCT01181791|feeding tolerance|feeding tolerance
1395873|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
1395874|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
1395875|NCT01181778|physician counseling|physician counseling
1395876|NCT01181765|Crohn's Disease|crohn's disease
1395877|NCT01181765|infliximab|infliximab
1395878|NCT01181765|capsule endoscopy|capsule endoscopy
1395879|NCT01181752|proficiency|proficiency
1395880|NCT01181752|eye drop instillation|eye drop instillation
1395881|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
1395882|NCT01181752|Ghana|ghana
1395883|NCT01181739|Colonoscopy|colonoscopy
1395884|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
1395885|NCT01181739|Colonography|colonography
1395886|NCT01181739|Colorectal Cancer|colorectal cancer
1395887|NCT01181739|Colonic Polyps|colonic polyps
1395888|NCT01181739|Screening|screening
1395889|NCT01181726|Bioequivalence|bioequivalence
1395890|NCT01181726|Healthy Subjects|healthy subjects
1395891|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
1395892|NCT01181687|pain assessment scale|pain assessment scale
1395893|NCT01181687|child|child
1395894|NCT01181687|validity|validity
1395895|NCT01181687|reliability|reliability
1395896|NCT01181674|Diabetes|diabetes
1395897|NCT01181674|Insulin|insulin
1395898|NCT01181674|Glargine|glargine
1395899|NCT01181674|Metformin|metformin
1395900|NCT01181674|Acarbose|acarbose
1395901|NCT01181674|Diet|diet
1395902|NCT01181674|Exercise|exercise
1395903|NCT01181674|Lifestyle|lifestyle
1395904|NCT01181661|Cigarette|cigarette
1395905|NCT01181661|Smoking|smoking
1395906|NCT01181661|Nicotine|nicotine
1395907|NCT01181661|Contingency Management|contingency management
1395908|NCT01181661|Voucher Reinforcement|voucher reinforcement
1395909|NCT01181661|Smoking Abstinence|smoking abstinence
1395910|NCT01181661|Internet|internet
1395911|NCT01181661|Internet-based Treatment|internet-based treatment
1395912|NCT01181661|Group Contingencies|group contingencies
1395913|NCT01181648|Survivor|survivor
1395914|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1395915|NCT01181648|Quality of Life|quality of life
1395916|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
1395917|NCT01181648|10-111|10-111
1396605|NCT01178632|Valeriana|valeriana
1395918|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
1395919|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
1395920|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
1395921|NCT01181596|indicated.|indicated.
1395922|NCT01181570|psoriasis|psoriasis
1395923|NCT01181570|adalimumab|adalimumab
1395924|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
1395925|NCT01181570|obesity|obesity
1395926|NCT01181557|quality of life|quality of life
1395927|NCT01181544|Anticoagulation|anticoagulation
1395928|NCT01181544|Heparin|heparin
1395929|NCT01181544|Hemodialysis|hemodialysis
1395930|NCT01181544|Dialysis|dialysis
1395931|NCT01181544|Renal Dialysis|renal dialysis
1395932|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
1395933|NCT01181531|Hemodialysis|hemodialysis
1395934|NCT01181531|Parathyroid|parathyroid
1395935|NCT01181531|PARADIGM|paradigm
1395936|NCT01181518|Tamoxifen|tamoxifen
1395937|NCT01181518|Pharmacogenomics|pharmacogenomics
1395938|NCT01181518|Breast cancer|breast cancer
1395939|NCT01181505|HNF4a|hnf4a
1395940|NCT01181505|CYP2D6|cyp2d6
1395941|NCT01181505|Toterodine|toterodine
1395942|NCT01181505|Genetic polymorphism|genetic polymorphism
1395943|NCT01181492|gene polymorphism|gene polymorphism
1395944|NCT01181492|CYP3A4|cyp3a4
1395945|NCT01181492|fentanyl|fentanyl
1395946|NCT01181492|HPLC|hplc
1395947|NCT01181492|Analgesics|analgesics
1395948|NCT01181479|Contraceptive|contraceptive
1395949|NCT01181466|PLVR|plvr
1395950|NCT01181466|BLVR|blvr
1395951|NCT01181466|AeriSeal|aeriseal
1395952|NCT01181466|treatment|treatment
1395953|NCT01181466|device|device
1395954|NCT01181466|breathing|breathing
1395955|NCT01181466|COPD|copd
1395956|NCT01181466|emphysema|emphysema
1395957|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
1395958|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
1395959|NCT01181466|heterogeneous|heterogeneous
1395960|NCT01181466|homogeneous|homogeneous
1395961|NCT01181466|Pathologic Processes|pathologic processes
1395962|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
1395963|NCT01181466|Lung Diseases|lung diseases
1395964|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1395965|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
1395966|NCT01181453|Randomized trial|randomized trial
1395967|NCT01181453|Clinical trial|clinical trial
1395968|NCT01181453|Dermagraft|dermagraft
1395969|NCT01181453|Standard care|standard care
1395970|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
1395971|NCT01181440|Randomized trial|randomized trial
1395972|NCT01181440|Clinical trial|clinical trial
1395973|NCT01181440|Dermagraft|dermagraft
1395974|NCT01181440|Conventional care|conventional care
1395975|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
1395976|NCT01181414|Resynchronization therapy|resynchronization therapy
1395977|NCT01181414|Ablation|ablation
1395978|NCT01181401|induction chemotherapy|induction chemotherapy
1395979|NCT01181401|radiotherapy|radiotherapy
1395980|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
1395981|NCT01181401|toxicity|toxicity
1395982|NCT01181401|LA SCCHN|la scchn
1395983|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
1395984|NCT01181401|Stage IV (UICC)|stage iv (uicc)
1395985|NCT01181375|cervical cancer|cervical cancer
1395986|NCT01181375|assay|assay
1395987|NCT01181375|hypoxia|hypoxia
1395988|NCT01181362|Endoscopy|endoscopy
1395989|NCT01181362|Head and Neck region|head and neck region
1395990|NCT01181362|Scope|scope
1395991|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
1395992|NCT01181336|Safety|safety
1395993|NCT01181336|Tolerability|tolerability
1395994|NCT01181336|Immunogenicity|immunogenicity
1395995|NCT01181336|Influenza|influenza
1395996|NCT01181336|Virus|virus
1395997|NCT01181336|Vaccine|vaccine
1395998|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
1395999|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
1396000|NCT01181297|Confirmed milk allergy|confirmed milk allergy
1396001|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1396002|NCT01181271|Lymphoma|lymphoma
1396003|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
1396004|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
1396005|NCT01181271|Hodgkin's disease|hodgkin's disease
1396006|NCT01181271|stem cell transplant|stem cell transplant
1396007|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
1396008|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
1396009|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
1396010|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
1396011|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
1396117|NCT01180894|Erythropoeisis|erythropoeisis
1396012|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
1396013|NCT01181245|Pancreatic Cancer|pancreatic cancer
1396014|NCT01181232|insomnia|insomnia
1396015|NCT01181232|zolpidem|zolpidem
1396016|NCT01181206|Surgical site infections|surgical site infections
1396017|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
1396018|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
1396019|NCT01181193|chemoradiotherapy|chemoradiotherapy
1396020|NCT01181193|vitamin D|vitamin d
1396021|NCT01181180|Ageing|ageing
1396022|NCT01181180|Balance control|balance control
1396023|NCT01181180|Falls|falls
1396024|NCT01181180|dehydration|dehydration
1396025|NCT01181167|Anticoagulants|anticoagulants
1396026|NCT01181167|Venous thromboembolism|venous thromboembolism
1396027|NCT01181167|Thromboembolism|thromboembolism
1396028|NCT01181167|Thrombosis|thrombosis
1396029|NCT01181167|enoxaparin sodium|enoxaparin sodium
1396030|NCT01181167|Embolism|embolism
1396031|NCT01181167|Deep vein thrombosis|deep vein thrombosis
1396032|NCT01181167|DU-176b|du-176b
1396033|NCT01181167|edoxaban|edoxaban
1396034|NCT01181167|factor Xa|factor xa
1396035|NCT01181167|total hip arthroplasty|total hip arthroplasty
1396036|NCT01181154|Auto-Immune|auto-immune
1396037|NCT01181154|Hemolytic|hemolytic
1396038|NCT01181154|Anemia|anemia
1396040|NCT01181154|AIHA|aiha
1396041|NCT01181154|Rituximab|rituximab
1396042|NCT01181141|Anticoagulants|anticoagulants
1396043|NCT01181141|Enoxaparin sodium|enoxaparin sodium
1396044|NCT01181141|venous thromboembolism.|venous thromboembolism.
1396045|NCT01181141|thromboembolism|thromboembolism
1396046|NCT01181141|Thrombosis|thrombosis
1396047|NCT01181141|deep vein thrombosis|deep vein thrombosis
1396048|NCT01181141|DU-176b|du-176b
1396049|NCT01181141|Edoxaban|edoxaban
1396050|NCT01181141|factor Xa|factor xa
1396051|NCT01181141|hip fracture surgery|hip fracture surgery
1396052|NCT01181141|embolism|embolism
1396053|NCT01181115|Chinese Patients|chinese patients
1396054|NCT01181115|Relapsing MS|relapsing ms
1396055|NCT01181115|Safety|safety
1396056|NCT01181115|Avonex|avonex
1396057|NCT01181115|Tolerability|tolerability
1396058|NCT01181115|Gadolinium|gadolinium
1396059|NCT01181115|Interferon Beta 1a|interferon beta 1a
1396060|NCT01181102|anticoagulant|anticoagulant
1396061|NCT01181102|venus thromboembolism|venus thromboembolism
1396062|NCT01181102|thrombosis|thrombosis
1396063|NCT01181102|thromboembolism|thromboembolism
1396064|NCT01181102|embolism and thrombosis|embolism and thrombosis
1396065|NCT01181102|deep vein thrombosis|deep vein thrombosis
1396066|NCT01181102|DU-176b|du-176b
1396067|NCT01181102|Edoxaban|edoxaban
1396068|NCT01181102|factor Xa|factor xa
1396069|NCT01181102|total knee arthroplasty|total knee arthroplasty
1396070|NCT01181102|Enoxaparin sodium|enoxaparin sodium
1396071|NCT01181076|Stem cell transplantation|stem cell transplantation
1396072|NCT01181076|Individualized Nutrition|individualized nutrition
1396073|NCT01181076|Quality of life|quality of life
1396074|NCT01181076|Oral Mucositis|oral mucositis
1396075|NCT01181076|Adult|adult
1396076|NCT01181063|Asthma|asthma
1396077|NCT01181063|Easyhaler|easyhaler
1396078|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
1396079|NCT01181037|Bbipolar H.A.|bbipolar h.a.
1396080|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
1396081|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
1396082|NCT01180959|Advanced Liver Cancer|advanced liver cancer
1396083|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
1396084|NCT01180959|Erlotinib|erlotinib
1396085|NCT01180959|Bevacizumab|bevacizumab
1396086|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
1396087|NCT01180959|HCC|hcc
1396088|NCT01180959|Avastin|avastin
1396089|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1396090|NCT01180959|rhuMAb-VEGF|rhumab-vegf
1396091|NCT01180959|OSI-774|osi-774
1396092|NCT01180959|Tarceva|tarceva
1396093|NCT01180946|FGF23|fgf23
1396094|NCT01180946|FGF-23|fgf-23
1396095|NCT01180946|vitamin D|vitamin d
1396096|NCT01180946|vitamin D deficiency|vitamin d deficiency
1396097|NCT01180946|insulin resistance|insulin resistance
1396098|NCT01180946|Healthy volunteers|healthy volunteers
1396099|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
1396100|NCT01180933|folate|folate
1396101|NCT01180933|neurological development|neurological development
1396102|NCT01180933|allergies|allergies
1396103|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
1396104|NCT01180933|allergy risk|allergy risk
1396105|NCT01180920|Dental|dental
1396106|NCT01180920|Periodontal|periodontal
1396107|NCT01180920|Surgery|surgery
1396108|NCT01180920|Gums|gums
1396109|NCT01180907|18F-FAC|18f-fac
1396110|NCT01180907|imaging|imaging
1396111|NCT01180907|cancer|cancer
1396112|NCT01180907|inflammation|inflammation
1396113|NCT01180907|PET|pet
1396114|NCT01180894|Trauma|trauma
1396115|NCT01180894|Anemia|anemia
1396116|NCT01180894|Iron|iron
1396118|NCT01180881|Proton Radiation|proton radiation
1396119|NCT01180881|CNS tumors|cns tumors
1396120|NCT01180881|Brain Tumors|brain tumors
1396121|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
1396122|NCT01180868|imaging probe|imaging probe
1396123|NCT01180868|cancer|cancer
1396124|NCT01180868|inflammatory tissue|inflammatory tissue
1396125|NCT01180868|inflammatory diseases|inflammatory diseases
1396126|NCT01180855|Melatonin|melatonin
1396127|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
1396129|NCT01180816|GBM|gbm
1396130|NCT01180816|AA|aa
1396131|NCT01180816|AO|ao
1396132|NCT01180816|Brain|brain
1396133|NCT01180816|Tumors|tumors
1396134|NCT01180816|Malignant|malignant
1396135|NCT01180816|Glioblastoma|glioblastoma
1396136|NCT01180816|Multiforme|multiforme
1396137|NCT01180816|Anaplastic|anaplastic
1396138|NCT01180816|Astrocytoma|astrocytoma
1396139|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
1396140|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
1396141|NCT01180790|HCV|hcv
1396142|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
1396143|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
1396144|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
1396145|NCT01180764|high-density lipoproteins|high-density lipoproteins
1396146|NCT01180764|fish oil|fish oil
1396147|NCT01180751|Positron Emission Tomography|positron emission tomography
1396148|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
1396149|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
1396150|NCT01180751|Oncology|oncology
1396151|NCT01180751|Neurology|neurology
1396152|NCT01180738|chronic stroke|chronic stroke
1396153|NCT01180738|walking training|walking training
1396154|NCT01180738|rehabilitation|rehabilitation
1396155|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
1396156|NCT01180738|physical therapy|physical therapy
1396158|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
1396159|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
1396160|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
1396161|NCT01180712|anthocyanin|anthocyanin
1396162|NCT01180712|blaeberries|blaeberries
1396163|NCT01180712|bilberries|bilberries
1396164|NCT01180712|blueberries|blueberries
1396165|NCT01180712|mirtoselect|mirtoselect
1396166|NCT01180712|type 2 diabetes|type 2 diabetes
1396167|NCT01180712|insulin resistance|insulin resistance
1396168|NCT01180712|Adipose tissue|adipose tissue
1396169|NCT01180712|inflammation|inflammation
1396170|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
1396171|NCT01180686|low back pain|low back pain
1396172|NCT01180686|chiropractic|chiropractic
1396173|NCT01180686|manipulation|manipulation
1396174|NCT01180673|Hypertension|hypertension
1396175|NCT01180673|Older Adults|older adults
1396176|NCT01180673|Motivational Interviewing|motivational interviewing
1396177|NCT01180673|Lifestyle Counseling|lifestyle counseling
1396178|NCT01180673|Senior Centers|senior centers
1396179|NCT01180660|Gastric Surgery|gastric surgery
1396180|NCT01180660|Pain|pain
1396181|NCT01180660|Recovery|recovery
1396182|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
1396183|NCT01180647|Extended-release naltrexone|extended-release naltrexone
1396184|NCT01180647|Prisoners|prisoners
1396185|NCT01180647|Opioid addiction prevention|opioid addiction prevention
1396186|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
1396187|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
1396188|NCT01180621|vaccine|vaccine
1396189|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
1396190|NCT01180621|Influenza Vaccine|influenza vaccine
1396191|NCT01180621|Vaccine Safety|vaccine safety
1396192|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
1396193|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
1396194|NCT01180608|neuropathic pain|neuropathic pain
1396195|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
1396196|NCT01180595|osteoarthritis|osteoarthritis
1396197|NCT01180595|arthroplasty|arthroplasty
1396198|NCT01180595|knee joint|knee joint
1396199|NCT01180595|radiography|radiography
1396200|NCT01180595|surgery|surgery
1396201|NCT01180595|Bone Density|bone density
1396202|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
1396203|NCT01180582|knee|knee
1396204|NCT01180582|arthroplasty|arthroplasty
1396205|NCT01180582|RSA|rsa
1396206|NCT01180582|migration|migration
1396207|NCT01180582|micromotion|micromotion
1396208|NCT01180582|osteoarthritis|osteoarthritis
1396209|NCT01180569|Lenalidomide|lenalidomide
1396210|NCT01180569|10-022|10-022
1396211|NCT01180556|childhood|childhood
1396212|NCT01180556|abdominal pain|abdominal pain
1396213|NCT01180556|probiotics|probiotics
1396214|NCT01180517|Angioplasty Balloon|angioplasty balloon
1396215|NCT01180504|ovarian cancer|ovarian cancer
1396216|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
1396217|NCT01180504|consolidation treatment|consolidation treatment
1396218|NCT01180504|helical tomotherapy|helical tomotherapy
1396219|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
1396220|NCT01180478|Bladder Cancer|bladder cancer
1396221|NCT01180478|Urothelial carcinoma|urothelial carcinoma
1396222|NCT01180478|Stage pTa or pT1|stage pta or pt1
1396223|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
1396224|NCT01180478|Narrow Band Imaging|narrow band imaging
1396225|NCT01180478|White Light Cystoscopy|white light cystoscopy
1396226|NCT01180478|Transurethral resection|transurethral resection
1396227|NCT01180478|Superficial bladder tumor|superficial bladder tumor
1396228|NCT01180478|Positive urine cytology|positive urine cytology
1396229|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
1396230|NCT01180452|Crohn disease|crohn disease
1396231|NCT01180452|dysplasia|dysplasia
1396232|NCT01180452|adenocarcinoma|adenocarcinoma
1396233|NCT01180452|endoscopy|endoscopy
1396234|NCT01180452|jejunum|jejunum
1396235|NCT01180452|ileum|ileum
1396236|NCT01180439|Non-invasive ventilation|non-invasive ventilation
1396237|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1396238|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
1396239|NCT01180439|Sleep study|sleep study
1396240|NCT01180439|Polysomnography|polysomnography
1396241|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
1396242|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
1396243|NCT01180400|Major Depressive Disorder|major depressive disorder
1396244|NCT01180400|MDD|mdd
1396245|NCT01180400|Depression|depression
1396246|NCT01180400|Safety|safety
1396247|NCT01180400|add-on therapy|add-on therapy
1396248|NCT01180374|Cannabis|cannabis
1396249|NCT01180374|Marijuana|marijuana
1396250|NCT01180374|Cannabidiol|cannabidiol
1396251|NCT01180374|CBD|cbd
1396252|NCT01180374|THC|thc
1396253|NCT01180374|Psychotic Disorders|psychotic disorders
1396254|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
1396255|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
1396256|NCT01180361|atherosclerosis|atherosclerosis
1396257|NCT01180361|adenosine|adenosine
1396258|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
1396259|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
1396260|NCT01180322|azacitidine|azacitidine
1396261|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1396262|NCT01180309|Tongue frenum|tongue frenum
1396263|NCT01180309|Lingual frenum|lingual frenum
1396264|NCT01180309|Audio Phonology|audio phonology
1396265|NCT01180309|Speech disorders|speech disorders
1396266|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
1396267|NCT01180283|Erectile dysfunction|erectile dysfunction
1396268|NCT01180283|Lodenafil carbonate|lodenafil carbonate
1396269|NCT01180283|Diabetes|diabetes
1396270|NCT01180270|Cervical dystonia|cervical dystonia
1396271|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
1396272|NCT01180270|botulinum toxin|botulinum toxin
1396273|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
1396274|NCT01180270|SVV|svv
1396275|NCT01180270|static graviceptive function|static graviceptive function
1396276|NCT01180244|fibromyalgia|fibromyalgia
1396277|NCT01180244|noninvasive|noninvasive
1396278|NCT01180244|electrical|electrical
1396279|NCT01180244|cortical|cortical
1396280|NCT01180244|stimulation|stimulation
1396281|NCT01180244|pain|pain
1396282|NCT01180244|brain|brain
1396283|NCT01180244|tender point|tender point
1396284|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
1396285|NCT01180218|myocardial revascularization|myocardial revascularization
1396286|NCT01180218|myocardial infarction|myocardial infarction
1396287|NCT01180205|FMD|fmd
1396288|NCT01180205|hypertension|hypertension
1396289|NCT01180205|Telmisartan|telmisartan
1396290|NCT01180205|Amlodipine|amlodipine
1396291|NCT01180192|blood loss|blood loss
1396292|NCT01180192|oxygen inhalation|oxygen inhalation
1396293|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
1396294|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
1396295|NCT01180166|Gastric cancer|gastric cancer
1396296|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1396297|NCT01180166|target therapy|target therapy
1396298|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
1396299|NCT01180153|biliary tract|biliary tract
1396300|NCT01180153|ampullary carcinoma|ampullary carcinoma
1396301|NCT01180140|Seamguard|seamguard
1396302|NCT01180140|staple-line reinforcement|staple-line reinforcement
1396303|NCT01180140|leak|leak
1396304|NCT01180140|bleeding|bleeding
1396305|NCT01180127|flavonol|flavonol
1396306|NCT01180127|exercise|exercise
1396307|NCT01180127|dentate gyrus|dentate gyrus
1396308|NCT01180127|cerebral blood volume|cerebral blood volume
1396309|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
1396407|NCT01179568|Bereavement|bereavement
1396314|NCT01180101|Obesity|obesity
1396315|NCT01180101|Chronic Kidney Disease|chronic kidney disease
1396316|NCT01180088|LIVER TUMOURS|liver tumours
1396317|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
1396318|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
1396319|NCT01180049|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1396320|NCT01180049|temsirolimus|temsirolimus
1396321|NCT01180036|Membranous Nephropathy|membranous nephropathy
1396322|NCT01180023|GBS|gbs
1396323|NCT01180023|Membrane sweeping|membrane sweeping
1396324|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
1396325|NCT01180010|Lung Cancer|lung cancer
1396326|NCT01180010|Lung Nodule|lung nodule
1396327|NCT01180010|CT scan|ct scan
1396328|NCT01179971|n-3 fatty acids|n-3 fatty acids
1396329|NCT01179971|n-6 fatty acids|n-6 fatty acids
1396330|NCT01179971|anti-inflammatory action|anti-inflammatory action
1396331|NCT01179971|clinical trial|clinical trial
1396332|NCT01179971|randomized double-blinded|randomized double-blinded
1396333|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
1396334|NCT01179958|cognitive function|cognitive function
1396335|NCT01179958|fMRI|fmri
1396336|NCT01179958|apoE|apoe
1396337|NCT01179958|inflammatory markers|inflammatory markers
1396338|NCT01179958|exercise|exercise
1396339|NCT01179945|diabetes|diabetes
1396340|NCT01179945|benzoic acid|benzoic acid
1396341|NCT01179945|benzoate|benzoate
1396342|NCT01179945|soda|soda
1396343|NCT01179945|soft drink|soft drink
1396344|NCT01179945|preservative|preservative
1396345|NCT01179945|blood sugar|blood sugar
1396346|NCT01179932|Pilot|pilot
1396347|NCT01179932|Charting|charting
1396348|NCT01179932|Anesthesia Record|anesthesia record
1396349|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
1396350|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
1396351|NCT01179932|Electrophysiology lab|electrophysiology lab
1396352|NCT01179919|Oseltamivir|oseltamivir
1396353|NCT01179919|Obesity|obesity
1396354|NCT01179919|Influenza|influenza
1396355|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
1396356|NCT01179906|CKD|ckd
1396357|NCT01179893|Myasthenia Gravis|myasthenia gravis
1396358|NCT01179893|IVIG|ivig
1396359|NCT01179893|PLEX|plex
1396360|NCT01179880|Dermatitis|dermatitis
1396361|NCT01179880|Atopic|atopic
1396366|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
1396367|NCT01179841|language|language
1396368|NCT01179841|social|social
1396369|NCT01179841|toddlers|toddlers
1396370|NCT01179828|Quantitative sensory testing|quantitative sensory testing
1396371|NCT01179828|Drug efficacy|drug efficacy
1396372|NCT01179828|Low back pain syndrome|low back pain syndrome
1396373|NCT01179828|Imipramine|imipramine
1396374|NCT01179828|Oxycodone|oxycodone
1396375|NCT01179828|Clobazam|clobazam
1396376|NCT01179828|Tolterodine|tolterodine
1396377|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
1396378|NCT01179815|Monogenetic diabetes|monogenetic diabetes
1396379|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
1396380|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
1396381|NCT01179815|Cohort Studies|cohort studies
1396382|NCT01179789|Healthy Elderly People|healthy elderly people
1396383|NCT01179776|ST-eleveation|st-eleveation
1396384|NCT01179776|Myocardial infarct|myocardial infarct
1396385|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
1396386|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
1396387|NCT01179763|Amblyopia|amblyopia
1396388|NCT01179763|Retinal layer thickness|retinal layer thickness
1396389|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
1396390|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1396391|NCT01179737|Nilotinib|nilotinib
1396392|NCT01179737|6MWD|6mwd
1396393|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
1396394|NCT01179711|accommodative esotropia|accommodative esotropia
1396395|NCT01179698|computer-assisted surgery|computer-assisted surgery
1396396|NCT01179698|bone tumor|bone tumor
1396397|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
1396398|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
1396399|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
1396400|NCT01179659|Single dose crossover BE study|single dose crossover be study
1396401|NCT01179646|Bioequivalency|bioequivalency
1396402|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
1396403|NCT01179581|Safety|safety
1396404|NCT01179581|Tolerability|tolerability
1396405|NCT01179581|Pharmacokinetics|pharmacokinetics
1396406|NCT01179568|Grief|grief
1396408|NCT01179568|Psychotherapy|psychotherapy
1396409|NCT01179568|Medication|medication
1396410|NCT01179568|Treatment study|treatment study
1396411|NCT01179555|Diabetic Complications|diabetic complications
1396412|NCT01179555|Intervention Studies|intervention studies
1396413|NCT01179555|African Americans|african americans
1396414|NCT01179555|Vision Screening|vision screening
1396415|NCT01179555|Vision, Low|vision, low
1396416|NCT01179555|Geriatric Assessment|geriatric assessment
1396417|NCT01179555|Outcomes Assessment|outcomes assessment
1396418|NCT01179555|Cultural Characteristics|cultural characteristics
1396419|NCT01179555|Cultural Competency|cultural competency
1396420|NCT01179555|Appointment Adherence|appointment adherence
1396421|NCT01179555|Cost-effectiveness|cost-effectiveness
1396422|NCT01179555|Personalization of care|personalization of care
1396423|NCT01179555|Follow-up Care|follow-up care
1396520|NCT01179009|depression|depression
1396424|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
1396425|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
1396426|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
1396427|NCT01179516|Major Depressive Disorder|major depressive disorder
1396428|NCT01179516|Depression|depression
1396429|NCT01179516|Drug Therapy|drug therapy
1396430|NCT01179503|vitamin D|vitamin d
1396431|NCT01179503|physical performance|physical performance
1396432|NCT01179490|Multiple Myeloma|multiple myeloma
1396433|NCT01179477|Left heart pacing lead|left heart pacing lead
1396434|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1396435|NCT01179477|Heart failure|heart failure
1396436|NCT01179425|marijuana|marijuana
1396437|NCT01179425|dependence|dependence
1396438|NCT01179425|cognition|cognition
1396439|NCT01179425|stress|stress
1396440|NCT01179386|methylphenidate|methylphenidate
1396441|NCT01179386|ADHD|adhd
1396442|NCT01179386|driving|driving
1396443|NCT01179386|simulator|simulator
1396444|NCT01179386|pressure|pressure
1396445|NCT01179386|adolescent|adolescent
1396446|NCT01179360|Locally advanced|locally advanced
1396447|NCT01179360|HNSCC|hnscc
1396448|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
1396449|NCT01179334|Riociguat|riociguat
1396450|NCT01179334|Blood Pressure|blood pressure
1396451|NCT01179308|regional analgesia|regional analgesia
1396452|NCT01179308|routine general anesthesia|routine general anesthesia
1396453|NCT01179308|immune system response|immune system response
1396454|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
1396455|NCT01179295|MEK inhibitor|mek inhibitor
1396456|NCT01179295|BAY86-9766|bay86-9766
1396457|NCT01179295|RDEA 119|rdea 119
1396458|NCT01179295|Solid tumor|solid tumor
1396459|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
1396460|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
1396461|NCT01179269|Pazopanib|pazopanib
1396462|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
1396463|NCT01179256|ASTHMA|asthma
1396464|NCT01179243|microcirculatory alterations|microcirculatory alterations
1396465|NCT01179243|SDF imaging|sdf imaging
1396466|NCT01179230|CAD|cad
1396467|NCT01179230|chest pain|chest pain
1396468|NCT01179230|acute coronary syndrome|acute coronary syndrome
1396469|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
1396470|NCT01179217|Sickle Cell Anemia|sickle cell anemia
1396471|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
1396472|NCT01179217|Painful Crises|painful crises
1396473|NCT01179217|Sickle Cell Pain|sickle cell pain
1396474|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
1396475|NCT01179191|chronic pain|chronic pain
1396476|NCT01179191|Embeda|embeda
1396477|NCT01179191|opioid|opioid
1396478|NCT01179191|moderate pain|moderate pain
1396479|NCT01179191|severe pain|severe pain
1396480|NCT01179191|conversion|conversion
1396481|NCT01179191|converting|converting
1396482|NCT01179191|switching|switching
1396483|NCT01179191|morphine|morphine
1396484|NCT01179191|aberrant behavior|aberrant behavior
1396485|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
1396486|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
1396487|NCT01179139|CRS|crs
1396488|NCT01179126|myocardial infarction|myocardial infarction
1396489|NCT01179126|primary angioplasty|primary angioplasty
1396490|NCT01179126|multivessel disease|multivessel disease
1396491|NCT01179126|stress echocardiography|stress echocardiography
1396492|NCT01179113|Laminectomy|laminectomy
1396493|NCT01179113|Esmolol Infusion|esmolol infusion
1396494|NCT01179113|Quality of recovery|quality of recovery
1396495|NCT01179113|beta-blockers|beta-blockers
1396496|NCT01179113|Pain management|pain management
1396497|NCT01179113|Postoperative pain|postoperative pain
1396498|NCT01179113|Opioid requirements|opioid requirements
1396499|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
1396500|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
1396501|NCT01179100|elderly|elderly
1396502|NCT01179100|general anesthesia|general anesthesia
1396503|NCT01179100|lidocaine infusion|lidocaine infusion
1396504|NCT01179100|lidocaine|lidocaine
1396505|NCT01179100|local anesthetic|local anesthetic
1396506|NCT01179100|pain management|pain management
1396507|NCT01179100|cognitive function|cognitive function
1396508|NCT01179087|sleep disordered breathing|sleep disordered breathing
1396509|NCT01179087|lung transplantation|lung transplantation
1396510|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
1396511|NCT01179061|Apelin|apelin
1396512|NCT01179061|Heart failure|heart failure
1396513|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
1396514|NCT01179061|Inotropic|inotropic
1396515|NCT01179061|Diuretic|diuretic
1396516|NCT01179035|Post-release, community health|post-release, community health
1396517|NCT01179022|Bacteremia|bacteremia
1396518|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
1396519|NCT01179022|Endobronchial Lesions|endobronchial lesions
1396521|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
1396522|NCT01178957|Type 1 diabetes|type 1 diabetes
1396523|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
1396524|NCT01178957|Hyperglycemia|hyperglycemia
1396525|NCT01178931|IVF|ivf
1396526|NCT01178931|luteal phase support|luteal phase support
1396527|NCT01178931|oral progesterone|oral progesterone
1396528|NCT01178931|vaginal progesterone|vaginal progesterone
1396529|NCT01178931|pregnancy rate|pregnancy rate
1396530|NCT01178931|safety|safety
1396531|NCT01178931|tolerability|tolerability
1396532|NCT01178918|Influenza H1N1|influenza h1n1
1396533|NCT01178918|Vaccine|vaccine
1396534|NCT01178918|Adjuvant|adjuvant
1396535|NCT01178918|T Lymphocytes|t lymphocytes
1396536|NCT01178918|Non-specific response|non-specific response
1396537|NCT01178918|Interleukin-2|interleukin-2
1396538|NCT01178918|Non-specific T cell responce|non-specific t cell responce
1396539|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
1396540|NCT01178905|breast milk|breast milk
1396541|NCT01178892|Hot Flashes|hot flashes
1396542|NCT01178892|Menopause|menopause
1396543|NCT01178892|Vasomotor symptoms|vasomotor symptoms
1396544|NCT01178892|Yoga|yoga
1396545|NCT01178892|Exercise|exercise
1396546|NCT01178892|Omega-3|omega-3
1396547|NCT01178892|Fish oil|fish oil
1396548|NCT01178879|Telehealth|telehealth
1396549|NCT01178879|nurse consultation|nurse consultation
1396550|NCT01178879|outpatient clinic|outpatient clinic
1396551|NCT01178866|thoracic surgery|thoracic surgery
1396552|NCT01178866|myocardial revascularization|myocardial revascularization
1396553|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
1396554|NCT01178866|tissue perfusion|tissue perfusion
1396555|NCT01178866|prognosis|prognosis
1396556|NCT01178853|Healthy Volunteers|healthy volunteers
1396557|NCT01178840|female condom|female condom
1396558|NCT01178840|condom|condom
1396559|NCT01178840|clinical failure|clinical failure
1396560|NCT01178840|prostate-specific antigen|prostate-specific antigen
1396561|NCT01178840|semen exposure|semen exposure
1396562|NCT01178840|acceptability|acceptability
1396563|NCT01178840|Prevention of semen exposure|prevention of semen exposure
1396564|NCT01178801|liver cancer|liver cancer
1396565|NCT01178801|data mining|data mining
1396566|NCT01178801|knowledge discovering|knowledge discovering
1396567|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
1396568|NCT01178788|Progestagens|progestagens
1396569|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
1396570|NCT01178788|Micronized Progesterone|micronized progesterone
1396571|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
1396572|NCT01178788|Preterm Delivery|preterm delivery
1396573|NCT01178788|Cervical shortening|cervical shortening
1396574|NCT01178775|fatigue|fatigue
1396575|NCT01178775|meaning|meaning
1396576|NCT01178775|education|education
1396577|NCT01178775|walking program|walking program
1396578|NCT01178762|Oral Azithromycin|oral azithromycin
1396579|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
1396580|NCT01178749|Hepatitis C|hepatitis c
1396581|NCT01178749|Interferon|interferon
1396582|NCT01178749|Symptom Distress|symptom distress
1396583|NCT01178749|Quality of Life|quality of life
1396584|NCT01178736|neoplasms|neoplasms
1396585|NCT01178723|breakfast size|breakfast size
1396586|NCT01178723|blood glucose balance|blood glucose balance
1396587|NCT01178723|hormonal profile|hormonal profile
1396588|NCT01178723|appetite hormones|appetite hormones
1396589|NCT01178723|adipokines|adipokines
1396590|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
1396591|NCT01178684|ENFD|enfd
1396592|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
1396593|NCT01178684|HIV|hiv
1396594|NCT01178684|HIV-infection|hiv-infection
1396595|NCT01178671|PTSD|ptsd
1396596|NCT01178671|trauma|trauma
1396597|NCT01178671|anxiety disorder|anxiety disorder
1396598|NCT01178671|medication|medication
1396599|NCT01178671|sertraline|sertraline
1396600|NCT01178671|mirtazapine|mirtazapine
1396601|NCT01178671|pharmacotherapy|pharmacotherapy
1396602|NCT01178632|Herbal|herbal
1396603|NCT01178632|Phytotherapy|phytotherapy
1396604|NCT01178632|Passiflora|passiflora
1396606|NCT01178632|Anxiety|anxiety
1396607|NCT01178619|IUGR fetuses|iugr fetuses
1396608|NCT01178619|symmetrical IUGR|symmetrical iugr
1396609|NCT01178619|asymmetrical IUGR|asymmetrical iugr
1396610|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
1396611|NCT01178593|IBS|ibs
1396612|NCT01178593|RCT|rct
1396613|NCT01178593|psychology|psychology
1396614|NCT01178593|hypnosis|hypnosis
1396615|NCT01178593|psychotherapy|psychotherapy
1396616|NCT01178593|group therapy|group therapy
1396617|NCT01178580|fibrinolytic activity|fibrinolytic activity
1396618|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
1396619|NCT01178580|Pleural effusion|pleural effusion
1396620|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
1396621|NCT01178567|Gastrectomy|gastrectomy
1396817|NCT01177800|Infliximab|infliximab
1396622|NCT01178567|Pulmonary Complications|pulmonary complications
1396623|NCT01178554|anxiety disorders|anxiety disorders
1396624|NCT01178554|depression|depression
1396625|NCT01178554|depressive disorders|depressive disorders
1396626|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
1522012|NCT00692861|HV|hv
1396627|NCT01178554|conduct problems|conduct problems
1396628|NCT01178541|ventricles|ventricles
1396629|NCT01178541|fetal|fetal
1396630|NCT01178541|brain|brain
1396631|NCT01178541|asymmetry|asymmetry
1396632|NCT01178528|heart failure|heart failure
1396633|NCT01178528|heart rate|heart rate
1396634|NCT01178528|ivabradine|ivabradine
1396635|NCT01178528|carvedilol|carvedilol
1396636|NCT01178515|epidemiological risk|epidemiological risk
1396637|NCT01178515|diet|diet
1396638|NCT01178515|fat intake|fat intake
1396639|NCT01178450|Renal transplant|renal transplant
1396640|NCT01178450|Hypercalcemia|hypercalcemia
1396641|NCT01178437|seizure disorder,|seizure disorder,
1396642|NCT01178437|seizures,|seizures,
1396643|NCT01178437|convulsions,|convulsions,
1396644|NCT01178437|grand mal,|grand mal,
1396645|NCT01178437|petit mal,|petit mal,
1396646|NCT01178437|absence seizures,|absence seizures,
1396647|NCT01178437|repeated seizures,|repeated seizures,
1396648|NCT01178437|children's seizures,|children's seizures,
1396649|NCT01178437|secondary epilepsy,|secondary epilepsy,
1396650|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
1396651|NCT01178437|generalized seizures,|generalized seizures,
1396652|NCT01178437|partial seizure,|partial seizure,
1396653|NCT01178437|focal seizure,|focal seizure,
1396654|NCT01178437|partial complex seizure,|partial complex seizure,
1396655|NCT01178437|anticonvulsant medication|anticonvulsant medication
1396656|NCT01178424|Unipolar depression|unipolar depression
1396657|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
1396658|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
1396659|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
1396660|NCT01178424|Relapse|relapse
1396661|NCT01178424|Depressive relapse|depressive relapse
1396662|NCT01178424|Dysphoric|dysphoric
1396663|NCT01178424|Cognitive reactivity|cognitive reactivity
1396664|NCT01178424|Serotonin transporter gene|serotonin transporter gene
1396665|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
1396666|NCT01178411|renal cell carcinoma|renal cell carcinoma
1396667|NCT01178411|melanoma|melanoma
1396668|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
1396669|NCT01178411|breast cancer|breast cancer
1396670|NCT01178411|ovarian cancer|ovarian cancer
1396671|NCT01178411|MiT tumors|mit tumors
1396672|NCT01178398|fish|fish
1396673|NCT01178398|pregnancy|pregnancy
1396674|NCT01178398|nutrition|nutrition
1396675|NCT01178398|mercury|mercury
1396676|NCT01178398|focus group|focus group
1396677|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
1396678|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1396679|NCT01178385|Autism|autism
1396680|NCT01178385|Asperger's Syndrome|asperger's syndrome
1396681|NCT01178385|Treatment|treatment
1396682|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
1396683|NCT01178385|Anxiety|anxiety
1396684|NCT01178385|Children|children
1396685|NCT01178385|Therapy|therapy
1396686|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
1396687|NCT01178372|lactulose|lactulose
1396688|NCT01178372|probiotics|probiotics
1396689|NCT01178359|cardiac arrest|cardiac arrest
1396690|NCT01178359|ventricular fibrillation|ventricular fibrillation
1396691|NCT01178359|nitrite|nitrite
1396692|NCT01178346|Pharmacoeconomic|pharmacoeconomic
1396693|NCT01178346|Quality of Life|quality of life
1396694|NCT01178346|Health Outcomes|health outcomes
1396695|NCT01178346|Smoking|smoking
1396696|NCT01178346|NicVAX|nicvax
1396697|NCT01178346|Smoking vaccine|smoking vaccine
1396698|NCT01178346|Smoking cessation|smoking cessation
1396699|NCT01178333|Thrombocytopenia|thrombocytopenia
1396700|NCT01178333|Heparin|heparin
1396701|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
1396702|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
1396703|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
1396704|NCT01178307|GI cancers|gi cancers
1396705|NCT01178307|GIST|gist
1396706|NCT01178307|Symptom Severity|symptom severity
1396707|NCT01178307|Quality of Life|quality of life
1396708|NCT01178307|Questionnaire|questionnaire
1396709|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
1396710|NCT01178307|MDASI-GIST|mdasi-gist
1396711|NCT01178307|patient-reported outcomes|patient-reported outcomes
1396712|NCT01178294|hemophilia A|hemophilia a
1396713|NCT01178294|haemophilia A|haemophilia a
1396714|NCT01178294|blood coagulation disorders|blood coagulation disorders
1396715|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
1396716|NCT01178294|coagulation protein disorder|coagulation protein disorder
1396717|NCT01178294|hematologic diseases|hematologic diseases
1396718|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
1396719|NCT01178281|Myelofibrosis|myelofibrosis
1396720|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
1396818|NCT01177800|Remicade|remicade
1396721|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1396722|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
1396723|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
1396724|NCT01178268|Drug eluting stents|drug eluting stents
1396725|NCT01178268|Stents|stents
1396726|NCT01178268|Angioplasty|angioplasty
1396727|NCT01178255|depression|depression
1396728|NCT01178255|homoeopathy|homoeopathy
1396729|NCT01178242|Labial mucous membrane|labial mucous membrane
1396730|NCT01178242|symblepharon|symblepharon
1396731|NCT01178242|dry eye|dry eye
1396732|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
1396733|NCT01178242|salivary gland|salivary gland
1396734|NCT01178242|ocular surface disease|ocular surface disease
1396735|NCT01178242|transplantation|transplantation
1396736|NCT01178229|Sleep bruxism|sleep bruxism
1396737|NCT01178229|Airway remodeling|airway remodeling
1396738|NCT01178229|Physical therapy modalities|physical therapy modalities
1396739|NCT01178229|Child preschool.|child preschool.
1396740|NCT01178216|Kidney transplant|kidney transplant
1396741|NCT01178216|highly sensitized|highly sensitized
1396742|NCT01178203|Endodontics|endodontics
1396743|NCT01178203|pain|pain
1396744|NCT01178203|visual analogue scale|visual analogue scale
1396745|NCT01178203|NSAIDs|nsaids
1396746|NCT01178190|narrow band imaging|narrow band imaging
1396747|NCT01178190|malignant lesion|malignant lesion
1396748|NCT01178190|lung cancer|lung cancer
1396749|NCT01178190|NBI|nbi
1396750|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1396751|NCT01178177|Solid organ transplantation|solid organ transplantation
1396752|NCT01178177|Hematologic disease|hematologic disease
1396753|NCT01178164|chronic pains|chronic pains
1396754|NCT01178164|unknown aetiology|unknown aetiology
1396755|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
1396756|NCT01178151|mTOR inhibition|mtor inhibition
1396757|NCT01178151|cancer|cancer
1396758|NCT01178138|substance abuse|substance abuse
1396759|NCT01178125|Pregnancy Prevention|pregnancy prevention
1396760|NCT01178125|Oral Contraceptives|oral contraceptives
1396761|NCT01178112|Metastasis|metastasis
1396762|NCT01178112|Carboplatin|carboplatin
1396763|NCT01178112|Trientine|trientine
1396764|NCT01178112|Chemotherapy|chemotherapy
1396765|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1396766|NCT01178073|Ambrisentan|ambrisentan
1396767|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
1396768|NCT01178073|Tadalafil|tadalafil
1396769|NCT01178073|PAH|pah
1396770|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
1396771|NCT01178060|Stroke|stroke
1396772|NCT01178060|Risk|risk
1396773|NCT01178060|Communication|communication
1396774|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
1396775|NCT01178060|Improve Risk Communication|improve risk communication
1396776|NCT01178034|Warfarin|warfarin
1396777|NCT01178034|Dose|dose
1396778|NCT01178034|Pharmacogenetic|pharmacogenetic
1396779|NCT01178034|INR|inr
1396780|NCT01178021|malaria|malaria
1396781|NCT01178021|vivax|vivax
1396782|NCT01178021|relapse|relapse
1396783|NCT01178008|Insomnia|insomnia
1396784|NCT01178008|Post-partum Depression|post-partum depression
1396785|NCT01178008|Electroacupuncture|electroacupuncture
1396786|NCT01178008|Acupuncture|acupuncture
1396787|NCT01178008|Randomized Clinical Trial|randomized clinical trial
1396788|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
1396789|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
1396790|NCT01177969|Autism|autism
1396791|NCT01177969|Anxiety|anxiety
1396792|NCT01177969|Asperger's Syndrome|asperger's syndrome
1396793|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
1396794|NCT01177969|Treatment|treatment
1396795|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
1396796|NCT01177969|Fears|fears
1396797|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
1396798|NCT01177956|1st-line|1st-line
1396799|NCT01177956|Cetuximab|cetuximab
1396800|NCT01177956|Chemotherapy|chemotherapy
1396801|NCT01177956|EMR 62241 -055|emr 62241 -055
1396802|NCT01177956|Merck KGaA|merck kgaa
1396803|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
1398087|NCT01172704|HIV/AIDS|hiv/aids
1396804|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1396805|NCT01177865|stage I prostate cancer|stage i prostate cancer
1396806|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
1396807|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
1396808|NCT01177865|stage III prostate cancer|stage iii prostate cancer
1396809|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
1396810|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
1396811|NCT01177826|Hospitalized|hospitalized
1396812|NCT01177826|Rotavirus|rotavirus
1396813|NCT01177826|Children|children
1396814|NCT01177826|effectiveness|effectiveness
1396815|NCT01177826|Gastroenteritis|gastroenteritis
1396816|NCT01177800|Psoriasis|psoriasis
1522272|NCT00691743|GERD|gerd
1396819|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
1396820|NCT01177774|functional connectivity MRI|functional connectivity mri
1396821|NCT01177774|brain volumetry|brain volumetry
1396822|NCT01177774|negative reinforcement|negative reinforcement
1396824|NCT01177774|ADHD|adhd
1396825|NCT01177761|Osteoporosis|osteoporosis
1396826|NCT01177761|exercise|exercise
1396827|NCT01177761|fractures|fractures
1396828|NCT01177761|Bone Mineral Density|bone mineral density
1396829|NCT01177761|CHD-risk|chd-risk
1396830|NCT01177748|Stroke|stroke
1396831|NCT01177748|Cardiac Monitoring|cardiac monitoring
1396832|NCT01177735|Pomalidomide|pomalidomide
1396833|NCT01177735|multiple myeloma|multiple myeloma
1396834|NCT01177735|relapsed|relapsed
1396835|NCT01177722|Diphtheria|diphtheria
1396836|NCT01177722|Tetanus|tetanus
1396837|NCT01177722|Whooping cough|whooping cough
1396838|NCT01177722|Hepatitis B|hepatitis b
1396839|NCT01177722|Poliomyelitis|poliomyelitis
1396840|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
1396841|NCT01177709|schizophrenia|schizophrenia
1396842|NCT01177709|antipsychotics|antipsychotics
1396843|NCT01177709|obesity|obesity
1396844|NCT01177709|diabetes|diabetes
1396845|NCT01177696|caregivers|caregivers
1396846|NCT01177696|Family Health|family health
1396847|NCT01177696|Psychotherapeutic|psychotherapeutic
1396848|NCT01177696|Primary Health Care|primary health care
1396849|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
1396850|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
1396851|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
1396852|NCT01177631|Portal vein|portal vein
1396853|NCT01177631|Proteomics|proteomics
1396854|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1396855|NCT01177618|COPD|copd
1396856|NCT01177618|Emphysema|emphysema
1396857|NCT01177618|Chronic Bronchitis|chronic bronchitis
1396858|NCT01177618|Genetics|genetics
1396859|NCT01177618|Association Studies|association studies
1396860|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
1396861|NCT01177566|Atopic dermatitis|atopic dermatitis
1396862|NCT01177566|Elidel|elidel
1396863|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
1396864|NCT01177566|Eletone|eletone
1396865|NCT01177566|medical device cream|medical device cream
1396866|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
1396867|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
1396868|NCT01177527|Waldenstrom|waldenstrom
1396869|NCT01177527|myeloma|myeloma
1396870|NCT01177527|smoldering|smoldering
1396871|NCT01177527|lymphoma|lymphoma
1396872|NCT01177527|MGUS|mgus
1396873|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
1396874|NCT01177514|Refractive surgery|refractive surgery
1396875|NCT01177514|PRK|prk
1396876|NCT01177514|PAIN|pain
1396877|NCT01177514|Gabapentin|gabapentin
1396878|NCT01177501|Ovarian cancer|ovarian cancer
1396879|NCT01177501|Topotecan|topotecan
1396880|NCT01177501|Carboplatine|carboplatine
1396881|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
1396882|NCT01177488|Military|military
1396883|NCT01177488|Health Service Delivery|health service delivery
1396884|NCT01177488|Behavioral Symptoms|behavioral symptoms
1396885|NCT01177488|Telepsychology|telepsychology
1396886|NCT01177488|Behavioral Activation|behavioral activation
1396887|NCT01177488|Exposure Therapy|exposure therapy
1396888|NCT01177488|Veterans|veterans
1396889|NCT01177488|Telemedicine|telemedicine
1396890|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
1396891|NCT01177462|coordinate system|coordinate system
1396892|NCT01177462|normal|normal
1396893|NCT01177449|prolotherapy|prolotherapy
1396894|NCT01177436|prostate cancer|prostate cancer
1396895|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
1396896|NCT01177423|restorative odontology|restorative odontology
1396897|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
1396899|NCT01177410|Diarrhea|diarrhea
1396900|NCT01177410|IBS-D|ibs-d
1396901|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
1396902|NCT01177410|Abdominal pain|abdominal pain
1396903|NCT01177410|Bloating|bloating
1396904|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
1396905|NCT01177397|Multiple Myeloma|multiple myeloma
1396906|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
1396907|NCT01177384|T2DM|t2dm
1396908|NCT01177358|Scar|scar
1396909|NCT01177358|Botox|botox
1396910|NCT01177332|FFA|ffa
1396911|NCT01177332|Liver|liver
1396912|NCT01177332|steatosis|steatosis
1396913|NCT01177332|exercise|exercise
1396914|NCT01177319|Parkinson's Disease|parkinson's disease
1396915|NCT01177319|Glutathione|glutathione
1396916|NCT01177306|ADHD, working memory|adhd, working memory
1396917|NCT01177293|biological availability|biological availability
1396918|NCT01177293|bioavailability|bioavailability
1396919|NCT01177293|amlodipine|amlodipine
1396920|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
1396921|NCT01177293|ODT|odt
1396922|NCT01177293|tablets|tablets
1396923|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
1396924|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
1396925|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
1396926|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
1396927|NCT01177215|Algorithm|algorithm
1396928|NCT01177215|Treatment Protocol|treatment protocol
1396929|NCT01177215|Thoracic Drainage Device|thoracic drainage device
1396930|NCT01177202|HAC1, H1N1|hac1, h1n1
1396931|NCT01177189|Oxidative Stress|oxidative stress
1396932|NCT01177189|Free radicals|free radicals
1396933|NCT01177189|Aging|aging
1396934|NCT01177176|Cigarette smoking|cigarette smoking
1396935|NCT01177176|Tobacco smoking|tobacco smoking
1396936|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
1396937|NCT01177163|Canagliflozin|canagliflozin
1396938|NCT01177163|JNJ-28431754|jnj-28431754
1396939|NCT01177163|Insulin|insulin
1396940|NCT01177163|Pharmacokinetic|pharmacokinetic
1396941|NCT01177163|Pharmacodynamic|pharmacodynamic
1396942|NCT01177163|SGLT-1|sglt-1
1396943|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
1396944|NCT01177150|Canagliflozin|canagliflozin
1396945|NCT01177150|Pharmacodynamic|pharmacodynamic
1396946|NCT01177150|Pharmacokinetic|pharmacokinetic
1396947|NCT01177150|Safety|safety
1396948|NCT01177150|Tolerability|tolerability
1396949|NCT01177137|tinnitus|tinnitus
1396950|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
1396951|NCT01177137|standard of care|standard of care
1396952|NCT01177137|directive counseling|directive counseling
1396953|NCT01177137|sound therapy|sound therapy
1396954|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
1396955|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
1396956|NCT01177124|Breast cancer|breast cancer
1396957|NCT01177124|Survivors|survivors
1396958|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
1396959|NCT01177124|Symptoms|symptoms
1396960|NCT01177124|Immune markers|immune markers
1396961|NCT01177085|obesity|obesity
1396962|NCT01177085|weight|weight
1396963|NCT01177085|weight-loss|weight-loss
1396964|NCT01177085|mushroom|mushroom
1396965|NCT01177085|oxidative|oxidative
1396966|NCT01177085|stress|stress
1396967|NCT01177085|immune|immune
1396968|NCT01177085|function|function
1396969|NCT01177085|inflammation|inflammation
1396970|NCT01177072|PTSD|ptsd
1396971|NCT01177059|Gene Therapy|gene therapy
1396972|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
1396973|NCT01177059|OZ1|oz1
1396974|NCT01177059|HIV-1 Infections|hiv-1 infections
1396975|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
1396976|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
1396977|NCT01177007|Colonic Diseases|colonic diseases
1396978|NCT01177007|Intestinal Diseases|intestinal diseases
1396979|NCT01177007|Rectal Diseases|rectal diseases
1396980|NCT01177007|Neoplastic Processes|neoplastic processes
1396981|NCT01177007|Pathologic Processes|pathologic processes
1396982|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
1396983|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
1396984|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
1396985|NCT01177007|Adenocarcinoma|adenocarcinoma
1396986|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
1396987|NCT01177007|Liver Diseases|liver diseases
1396988|NCT01177007|Neoplasms|neoplasms
1396989|NCT01177007|Carcinoma|carcinoma
1396990|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
1396991|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
1396992|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
1396993|NCT01177007|Liver Neoplasms|liver neoplasms
1396994|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1396995|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
1396996|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
1396997|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1396998|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
1396999|NCT01177007|Neoplasms by Site|neoplasms by site
1397000|NCT01177007|Digestive System Diseases|digestive system diseases
1397001|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
1397002|NCT01176981|pediatrics|pediatrics
1397003|NCT01176981|Osteosarcoma|osteosarcoma
1397004|NCT01176981|Methotrexate|methotrexate
1397005|NCT01176981|Outpatient|outpatient
1397006|NCT01176968|Eplerenone|eplerenone
1397007|NCT01176968|myocardial infarction|myocardial infarction
1397008|NCT01176968|mortality|mortality
1397009|NCT01176968|morbidity|morbidity
1397010|NCT01176955|Acne|acne
1397011|NCT01176955|Acne vulgaris|acne vulgaris
1397012|NCT01176955|Adherence|adherence
1522556|NCT00690976|gay|gay
1397013|NCT01176955|Compliance|compliance
1397014|NCT01176955|MEMS|mems
1397015|NCT01176955|Benzoyl peroxide|benzoyl peroxide
1397016|NCT01176929|Suicide, Attempted|suicide, attempted
1397017|NCT01176929|prevention suicidal act|prevention suicidal act
1397018|NCT01176929|telephone contact|telephone contact
1397019|NCT01176929|professional coordination|professional coordination
1397020|NCT01176916|breast cancer|breast cancer
1397021|NCT01176916|Aromasin|aromasin
1397022|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
1397023|NCT01176916|endocrine therapy|endocrine therapy
1397024|NCT01176890|truncal vagotomy|truncal vagotomy
1397025|NCT01176890|GLP-1|glp-1
1397026|NCT01176890|gastric emptying|gastric emptying
1397027|NCT01176890|appetite|appetite
1397028|NCT01176890|food intake|food intake
1397029|NCT01176864|Small-Bowel Disorders|small-bowel disorders
1397030|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
1397031|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
1397032|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
1397033|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
1397034|NCT01176825|bipolar disorder|bipolar disorder
1397035|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
1397036|NCT01176825|alcohol abuse|alcohol abuse
1397037|NCT01176825|drug abuse|drug abuse
1397038|NCT01176825|high risk behaviors|high risk behaviors
1397039|NCT01176825|medication adherence|medication adherence
1397040|NCT01176825|psychosocial functioning|psychosocial functioning
1397041|NCT01176812|Facialwasting|facialwasting
1397042|NCT01176812|Juvederm|juvederm
1397043|NCT01176812|Restylane|restylane
1397044|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
1397045|NCT01176786|infection|infection
1397046|NCT01176786|tissue expander|tissue expander
1397047|NCT01176786|breast implant|breast implant
1397048|NCT01176786|breast reconstruction|breast reconstruction
1397049|NCT01176786|Infections rates|infections rates
1397050|NCT01176760|vagotomy|vagotomy
1397051|NCT01176760|vagus|vagus
1397052|NCT01176760|GLP-1|glp-1
1397053|NCT01176760|Insulin secretion|insulin secretion
1397054|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
1397055|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
1397056|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
1397057|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
1397058|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
1397059|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
1397060|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
1397061|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
1397062|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
1397063|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
1397064|NCT01176734|Tinnitus, Objective|tinnitus, objective
1397065|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
1397066|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
1397067|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
1397068|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
1397069|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
1397070|NCT01176721|schizophrenic disorders|schizophrenic disorders
1397071|NCT01176721|psychosis|psychosis
1397072|NCT01176721|psychotic|psychotic
1397073|NCT01176721|dementia|dementia
1397074|NCT01176721|delusional|delusional
1397075|NCT01176721|delusions|delusions
1397076|NCT01176721|hallucinations|hallucinations
1397077|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
1397078|NCT01176721|illusions|illusions
1397079|NCT01176721|split mind|split mind
1397080|NCT01176721|mental health disorder|mental health disorder
1397081|NCT01176721|schizoid|schizoid
1397082|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
1397083|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
1397084|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
1397085|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
1397086|NCT01176721|mental illness|mental illness
1397087|NCT01176721|tardive dyskinesia|tardive dyskinesia
1397088|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
1397089|NCT01176721|NMS|nms
1397090|NCT01176721|antipsychotics|antipsychotics
1397091|NCT01176721|atypical antipsychotics|atypical antipsychotics
1398088|NCT01172704|HIV Testing|hiv testing
1397092|NCT01176721|psychosocial treatments|psychosocial treatments
1397093|NCT01176721|rehabilitation|rehabilitation
1397094|NCT01176708|liver transplantation|liver transplantation
1397095|NCT01176708|kidney transplanted|kidney transplanted
1397096|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
1397097|NCT01176708|insulin secretion|insulin secretion
1397098|NCT01176708|vagotomy|vagotomy
1397099|NCT01176682|NSAID-treated patients|nsaid-treated patients
1397100|NCT01176682|gastrointestinal events|gastrointestinal events
1397101|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
1397102|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
1397103|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
1397104|NCT01176669|Apatinib|apatinib
1397105|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
1397106|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
1397107|NCT01176669|ER/PR Negative|er/pr negative
1397108|NCT01176669|Her2/Neu Negative|her2/neu negative
1397109|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1397110|NCT01176656|Hypoglycemia|hypoglycemia
1397111|NCT01176643|SLE|sle
1397112|NCT01176643|Yoga|yoga
1397113|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
1397114|NCT01176617|Atrial Fibrillation|atrial fibrillation
1397115|NCT01176617|A-Fib|a-fib
1397116|NCT01176617|AF|af
1397117|NCT01176617|Persistent|persistent
1397118|NCT01176617|Permanent|permanent
1397119|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
1397120|NCT01176617|Ablation|ablation
1397121|NCT01176604|Hepatocellular carcinoma (HCC) of the liver|hepatocellular carcinoma (hcc) of the liver
1397122|NCT01176604|Hepatocellular cancer|hepatocellular cancer
1397123|NCT01176604|Hepatocellular carcinoma|hepatocellular carcinoma
1397124|NCT01176604|Liver cancer|liver cancer
1397125|NCT01176604|HCC|hcc
1397126|NCT01176604|Humanitarian Device Exemption|humanitarian device exemption
1397127|NCT01176604|Liver Diseases|liver diseases
1397128|NCT01176604|(HDE)|(hde)
1397129|NCT01176604|Radioactive|radioactive
1397130|NCT01176604|TheraSphere|therasphere
1397131|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
1397132|NCT01176565|Acute hypertensive response|acute hypertensive response
1397133|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
1397134|NCT01176565|blood pressure|blood pressure
1397135|NCT01176565|outcome|outcome
1397136|NCT01176565|nicardipine|nicardipine
1397137|NCT01176552|Kidney Cancer|kidney cancer
1397138|NCT01176552|Renal cell carcinoma|renal cell carcinoma
1397139|NCT01176552|High risk|high risk
1397140|NCT01176552|Adjuvant therapy|adjuvant therapy
1397141|NCT01176526|Coping|coping
1397142|NCT01176526|Quality of Life|quality of life
1397143|NCT01176526|Prostate Cancer|prostate cancer
1397144|NCT01176513|Prostate Cancer|prostate cancer
1397145|NCT01176513|MRI|mri
1397146|NCT01176513|PET|pet
1397147|NCT01176513|GE-148 (18F)|ge-148 (18f)
1397148|NCT01176500|PET Imaging|pet imaging
1397149|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
1397150|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
1397151|NCT01176500|Solid Tumors|solid tumors
1397152|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1397153|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
1397154|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1397155|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1397156|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1397157|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1397158|NCT01176474|stage IV melanoma|stage iv melanoma
1397159|NCT01176474|stage IIIC melanoma|stage iiic melanoma
1397160|NCT01176461|recurrent melanoma|recurrent melanoma
1397161|NCT01176461|stage IIIA melanoma|stage iiia melanoma
1397162|NCT01176461|stage IIIB melanoma|stage iiib melanoma
1397163|NCT01176461|stage IIIC melanoma|stage iiic melanoma
1397164|NCT01176461|stage IV melanoma|stage iv melanoma
1397165|NCT01176448|Cicatrix|cicatrix
1397166|NCT01176448|Dermabrasion|dermabrasion
1397167|NCT01176448|Coagulation, Laser|coagulation, laser
1397168|NCT01176435|Levodopa|levodopa
1397169|NCT01176435|Albinism|albinism
1397170|NCT01176435|Vision|vision
1397171|NCT01176422|AML|aml
1397172|NCT01176422|MDS|mds
1397173|NCT01176396|Dental Caries|dental caries
1397174|NCT01176396|Preventive Dentistry|preventive dentistry
1397175|NCT01176396|Dental Prophylaxis|dental prophylaxis
1397176|NCT01176396|Dental Care|dental care
1397177|NCT01176383|Nicotine addiction|nicotine addiction
1397178|NCT01176383|Behaviour|behaviour
1397179|NCT01176383|Gene test|gene test
1397180|NCT01176383|Lung cancer|lung cancer
1397181|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
1397182|NCT01176370|Heart Failure|heart failure
1397183|NCT01176370|Device|device
1397184|NCT01176370|Implantable|implantable
1397185|NCT01176370|Active|active
1397186|NCT01176370|Class III and Class IV|class iii and class iv
1397187|NCT01176370|Counterpulsation|counterpulsation
1397188|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
1397189|NCT01176357|atherosclerosis|atherosclerosis
1397190|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
1397191|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
1397192|NCT01176344|Vitamin D supplementation|vitamin d supplementation
1397193|NCT01176344|Osteoarthritis|osteoarthritis
1397194|NCT01176344|Knee|knee
1397195|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
1397196|NCT01176344|Cartilage|cartilage
1397197|NCT01176344|MRI|mri
1397198|NCT01176318|cough|cough
1397199|NCT01176318|exacerbation|exacerbation
1397200|NCT01176318|quality of life|quality of life
1397201|NCT01176305|Thromboembolic event|thromboembolic event
1397202|NCT01176292|total knee replacement|total knee replacement
1397203|NCT01176292|high flexion|high flexion
1397204|NCT01176292|range of motion|range of motion
1397205|NCT01176292|rotating platform|rotating platform
1397206|NCT01176292|TKA|tka
1397207|NCT01176279|Critical illness|critical illness
1397208|NCT01176279|Hyperglycemia|hyperglycemia
1397209|NCT01176279|Catheters, Indwelling|catheters, indwelling
1397210|NCT01176279|Intensive care unit|intensive care unit
1397211|NCT01176266|Hypophosphatasia|hypophosphatasia
1397212|NCT01176266|HPP|hpp
1397213|NCT01176266|Bone Disease|bone disease
1397214|NCT01176266|Soft Bones|soft bones
1397215|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
1397216|NCT01176266|Genetic metabolic disorder|genetic metabolic disorder
1397217|NCT01176266|Alkaline phosphatase|alkaline phosphatase
1397218|NCT01176266|Tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
1397219|NCT01176266|Rickets|rickets
1397220|NCT01176266|Osteomalacia|osteomalacia
1397221|NCT01176253|Type I DM|type i dm
1397222|NCT01176240|lightheadedness|lightheadedness
1397223|NCT01176240|unsteadiness|unsteadiness
1397224|NCT01176240|dizziness|dizziness
1397225|NCT01176240|weak|weak
1397226|NCT01176240|fatigue|fatigue
1397227|NCT01176240|concentration|concentration
1397228|NCT01176240|head & neck pain|head & neck pain
1397229|NCT01176240|standing/walking for a short time|standing/walking for a short time
1397230|NCT01176240|standing/walking for a long time|standing/walking for a long time
1397231|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
1397232|NCT01176240|falls|falls
1397233|NCT01176240|NOH|noh
1397234|NCT01176240|Parkinson's disease|parkinson's disease
1397235|NCT01176240|weakness|weakness
1397236|NCT01176227|bloating|bloating
1397237|NCT01176227|constipation|constipation
1397238|NCT01176227|diarrhea|diarrhea
1397239|NCT01176227|gas|gas
1397240|NCT01176227|mucous|mucous
1397241|NCT01176227|cramping|cramping
1397242|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
1397243|NCT01176214|tracheostomy|tracheostomy
1397244|NCT01176214|sedation|sedation
1397245|NCT01176214|weaning|weaning
1397246|NCT01176201|SLV337|slv337
1397247|NCT01176201|Diabetes|diabetes
1397248|NCT01176201|Relative bioavailability|relative bioavailability
1397249|NCT01176201|ADME|adme
1397250|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
1397251|NCT01176188|Environmental Stressors|environmental stressors
1397252|NCT01176188|Sleep|sleep
1397253|NCT01176188|Psychological Outcomes|psychological outcomes
1397254|NCT01176188|Pediatrics|pediatrics
1397255|NCT01176175|Progesterone|progesterone
1397256|NCT01176175|Microspheres|microspheres
1397257|NCT01176175|postmenopausal|postmenopausal
1397258|NCT01176175|Luteal phase support|luteal phase support
1397259|NCT01176162|Non Invasive measurement|non invasive measurement
1397260|NCT01176162|Preterm infants|preterm infants
1397261|NCT01176162|Aldosterone resistance|aldosterone resistance
1397262|NCT01176149|Diabetes|diabetes
1397263|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
1397264|NCT01176136|ADHD|adhd
1397265|NCT01176136|School-Based|school-based
1397266|NCT01176136|Organizational Skills|organizational skills
1397267|NCT01176136|Homework|homework
1397268|NCT01176136|Time Management|time management
1397269|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
1397270|NCT01176123|Insomnia|insomnia
1397271|NCT01176123|Traumatic Stress|traumatic stress
1397272|NCT01176110|hypothermia|hypothermia
1397273|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
1397274|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
1397275|NCT01176097|Effect of fasting|effect of fasting
1397276|NCT01176097|Safety|safety
1397277|NCT01176097|Tolerability|tolerability
1397278|NCT01176084|low carbohydrate diet|low carbohydrate diet
1397279|NCT01176084|obesity|obesity
1397280|NCT01176084|moderate exercise|moderate exercise
1397281|NCT01176084|men|men
1397282|NCT01176071|galactomannan|galactomannan
1397283|NCT01176071|beta-D-glucan|beta-d-glucan
1397284|NCT01176071|aspergillosis|aspergillosis
1397285|NCT01176071|outcome|outcome
1397286|NCT01176058|Phase 3b|phase 3b
1397287|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
1397288|NCT01176058|ICC|icc
1397289|NCT01176045|Dry Eye Disease|dry eye disease
1397290|NCT01176045|Osmolarity|osmolarity
1398457|NCT01171456|Pregnancy|pregnancy
1397291|NCT01176045|Refractive Surgery|refractive surgery
1397292|NCT01176045|Lasik|lasik
1397293|NCT01176045|TearLab|tearlab
1397294|NCT01176032|Aliskiren|aliskiren
1397295|NCT01176032|hypertension|hypertension
1397296|NCT01176032|concentric LVH|concentric lvh
1397297|NCT01176032|LV remodeling|lv remodeling
1397298|NCT01176032|LVMI|lvmi
1397299|NCT01176032|biomarkers|biomarkers
1397300|NCT01176032|PICP|picp
1397301|NCT01176032|CT-1|ct-1
1397302|NCT01176032|MMP-1|mmp-1
1397303|NCT01176032|TIMP-1|timp-1
1397304|NCT01176032|AnxA5|anxa5
1397305|NCT01176032|Aldosterone|aldosterone
1397306|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
1397307|NCT01176019|Amniocentesis|amniocentesis
1397308|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
1397309|NCT01176019|First trimester screening|first trimester screening
1397310|NCT01176019|Down syndrome|down syndrome
1397311|NCT01176006|DOCK8|dock8
1397312|NCT01176006|Molluscum|molluscum
1397313|NCT01176006|Transplant|transplant
1397314|NCT01176006|Immunodeficiency|immunodeficiency
1397315|NCT01175993|Motor Training|motor training
1397316|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1397317|NCT01175993|Balance|balance
1397318|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1397319|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
1397320|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1397321|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1397322|NCT01175954|Partial Epilepsy|partial epilepsy
1397323|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
1397324|NCT01175928|Pneumatic Compression Device|pneumatic compression device
1397325|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
1397326|NCT01175915|Reduning Injection|reduning injection
1397327|NCT01175915|Effectiveness|effectiveness
1397328|NCT01175915|Safety|safety
1397329|NCT01175902|Normal tension glaucoma|normal tension glaucoma
1397330|NCT01175876|MMSE|mmse
1397331|NCT01175876|NSE|nse
1397332|NCT01175876|S100B|s100b
1397333|NCT01175876|hsCRP|hscrp
1397334|NCT01175876|DWI-MRI|dwi-mri
1397335|NCT01175863|intravascular ultrasound|intravascular ultrasound
1397336|NCT01175863|fractional flow reserve|fractional flow reserve
1397337|NCT01175824|Metabolic Diseases|metabolic diseases
1397338|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1397339|NCT01175824|Glargine|glargine
1397340|NCT01175824|Diabetes Mellitus|diabetes mellitus
1397341|NCT01175824|Insulin LISPRO|insulin lispro
1397342|NCT01175824|Insulin|insulin
1397343|NCT01175811|Metabolic Diseases|metabolic diseases
1397344|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1397345|NCT01175811|Glargine|glargine
1397346|NCT01175811|Diabetes Mellitus|diabetes mellitus
1397347|NCT01175811|Insulin LISPRO|insulin lispro
1397348|NCT01175811|Insulin|insulin
1397349|NCT01175798|Vitamin D deficiency|vitamin d deficiency
1397350|NCT01175798|End-stage renal disease|end-stage renal disease
1397351|NCT01175798|Immunity|immunity
1397352|NCT01175772|Ovary|ovary
1397353|NCT01175772|Carcinoma|carcinoma
1397354|NCT01175772|Maintenance|maintenance
1397355|NCT01175772|Metronomic|metronomic
1397356|NCT01175772|Chemotherapy|chemotherapy
1397357|NCT01175772|Time to Progression|time to progression
1397358|NCT01175772|overall survival|overall survival
1397359|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
1397360|NCT01175759|Recurrent Abortions|recurrent abortions
1397361|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
1397362|NCT01175759|Hormones|hormones
1397363|NCT01175759|Skin tests|skin tests
1397364|NCT01175759|Allergen|allergen
1397365|NCT01175759|Immunotherapy|immunotherapy
1397366|NCT01175759|Hypersensitivity|hypersensitivity
1397367|NCT01175759|Skin reaction|skin reaction
1397368|NCT01175746|healthy adult patients|healthy adult patients
1397369|NCT01175746|ASA class I|asa class i
1397370|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
1397371|NCT01175733|Panitumumab|panitumumab
1397372|NCT01175733|Chemoradiation|chemoradiation
1397373|NCT01175733|Pancreatic cancer|pancreatic cancer
1397374|NCT01175733|Locally advanced|locally advanced
1397375|NCT01175733|Inoperable|inoperable
1397376|NCT01175720|gingival recession|gingival recession
1397377|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
1397378|NCT01175720|root coverage|root coverage
1397379|NCT01175694|Brachytherapy|brachytherapy
1397380|NCT01175694|APBI|apbi
1397381|NCT01175694|dose modification|dose modification
1397382|NCT01175694|local recurrences|local recurrences
1397383|NCT01175694|side effects|side effects
1397384|NCT01175694|cosmetic result|cosmetic result
1397385|NCT01175681|rheumatic heart disease|rheumatic heart disease
1397386|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
1397387|NCT01175681|heart valve prolapse|heart valve prolapse
1397388|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
1397389|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
1397390|NCT01175655|Lung transplant|lung transplant
1397391|NCT01175642|Schizophrenia|schizophrenia
1397392|NCT01175642|Psychosis|psychosis
1397393|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
1397394|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1397395|NCT01175629|Depression|depression
1397396|NCT01175629|Diabetes|diabetes
1397397|NCT01175629|Cardiovascular Disease|cardiovascular disease
1397398|NCT01175629|Depressive Disorder|depressive disorder
1397399|NCT01175629|Behavioral Symptoms|behavioral symptoms
1397400|NCT01175629|Metabolic Diseases|metabolic diseases
1397401|NCT01175629|Mental Disorders|mental disorders
1397402|NCT01175629|Anxiety Disorders|anxiety disorders
1397403|NCT01175616|Depression|depression
1397404|NCT01175616|Adults|adults
1397504|NCT01175161|Postpartum Contraception|postpartum contraception
1397405|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
1397406|NCT01175577|mixed carotenes|mixed carotenes
1397407|NCT01175564|TC-5214|tc-5214
1397408|NCT01175564|safety|safety
1397409|NCT01175564|pharmacokinetics|pharmacokinetics
1397410|NCT01175564|single dose|single dose
1397411|NCT01175564|repeated dose|repeated dose
1397412|NCT01175564|Japanese|japanese
1397413|NCT01175564|healthy subjects|healthy subjects
1397414|NCT01175551|Preterm Birth|preterm birth
1397415|NCT01175551|Cervix|cervix
1397416|NCT01175551|Cervical Shortening|cervical shortening
1397417|NCT01175551|Cervical remodeling|cervical remodeling
1397419|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
1397420|NCT01175538|Lactulose|lactulose
1397421|NCT01175499|laryngoscopy|laryngoscopy
1397422|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
1397423|NCT01175499|laryngoscopes|laryngoscopes
1397424|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
1397425|NCT01175499|endoscopy|endoscopy
1397426|NCT01175499|biopsy|biopsy
1397427|NCT01175486|thiazolidinediones|thiazolidinediones
1397428|NCT01175486|diabetes|diabetes
1397429|NCT01175486|retinopathy|retinopathy
1397430|NCT01175486|nephropathy|nephropathy
1397431|NCT01175460|esophageal Cancer|esophageal cancer
1397432|NCT01175460|radiation|radiation
1397433|NCT01175460|s-1|s-1
1397434|NCT01175460|nedaplatin|nedaplatin
1397435|NCT01175447|S-1|s-1
1397436|NCT01175447|radiation|radiation
1397437|NCT01175447|esophageal Cancer|esophageal cancer
1397438|NCT01175434|Asthma|asthma
1397439|NCT01175421|snoring|snoring
1397440|NCT01175421|sleep apnea|sleep apnea
1397441|NCT01175421|sleep study|sleep study
1397442|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
1397443|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
1397444|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
1397445|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
1397446|NCT01175408|Strip Counting,|strip counting,
1397447|NCT01175408|Type 2 Diabetes|type 2 diabetes
1397448|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
1397449|NCT01175395|CNV|cnv
1397450|NCT01175395|AMD|amd
1397451|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
1397452|NCT01175395|CNVM|cnvm
1397453|NCT01175395|subfoveal|subfoveal
1397454|NCT01175382|Male Urogenital Diseases|male urogenital diseases
1397455|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
1397456|NCT01175382|Behavioral Medicine|behavioral medicine
1397457|NCT01175382|Drug Therapy|drug therapy
1397458|NCT01175369|Asthma|asthma
1397459|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
1397460|NCT01175330|Ischemic Heart Disease|ischemic heart disease
1397461|NCT01175330|Atrial Fibrillation|atrial fibrillation
1397462|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
1397463|NCT01175317|Hemodynamic optimization|hemodynamic optimization
1397464|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
1397465|NCT01175317|Goal-directed fluid|goal-directed fluid
1397466|NCT01175304|sleep|sleep
1397467|NCT01175304|sleep apnea|sleep apnea
1397468|NCT01175304|work|work
1397469|NCT01175304|sleep habits|sleep habits
1397470|NCT01175304|sleepiness|sleepiness
1397471|NCT01175291|colon|colon
1397472|NCT01175291|rectum|rectum
1397473|NCT01175291|colorectal|colorectal
1397474|NCT01175291|metastatic|metastatic
1397475|NCT01175291|adenocarcinoma|adenocarcinoma
1397476|NCT01175278|vertebral|vertebral
1397477|NCT01175278|compression|compression
1397478|NCT01175278|fracture|fracture
1397479|NCT01175278|VCF|vcf
1397480|NCT01175278|kyphoplasty|kyphoplasty
1397481|NCT01175278|spine|spine
1397482|NCT01175265|clinically stable|clinically stable
1397483|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
1397484|NCT01175265|COPD|copd
1397485|NCT01175265|breathing retraining|breathing retraining
1397486|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
1397487|NCT01175265|cardiac autonomic function|cardiac autonomic function
1397488|NCT01175265|quality of life|quality of life
1397489|NCT01175265|exercise capacity|exercise capacity
1397490|NCT01175265|pulmonary function|pulmonary function
1397491|NCT01175252|Gastroenteritis|gastroenteritis
1397492|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
1398558|NCT01171157|Influenza|influenza
1397493|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
1397494|NCT01175226|Human rhinovirus|human rhinovirus
1397495|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
1523110|NCT00689026|PEG|peg
1397496|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
1397497|NCT01175226|Aviragen|aviragen
1397498|NCT01175187|evron|evron
1397499|NCT01175174|asthma|asthma
1397500|NCT01175174|preschool children|preschool children
1397501|NCT01175174|adenosine provocation test|adenosine provocation test
1397502|NCT01175174|metacholine provocation test|metacholine provocation test
1397503|NCT01175174|pediatric emergency department|pediatric emergency department
1397505|NCT01175161|Intrauterine device|intrauterine device
1397506|NCT01175161|feasibility|feasibility
1397507|NCT01175161|IUD|iud
1397508|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
1397509|NCT01175148|HSCT|hsct
1397510|NCT01175148|HPC|hpc
1397511|NCT01175148|HCT|hct
1397512|NCT01175148|BMT|bmt
1397513|NCT01175148|lipitor|lipitor
1397514|NCT01175148|atorvastatin|atorvastatin
1397515|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
1397516|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1397517|NCT01175148|allogeneic transplant|allogeneic transplant
1397518|NCT01175148|GVHD|gvhd
1397519|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
1397520|NCT01175148|Graft vs Host Disease|graft vs host disease
1397521|NCT01175135|schizophrenia|schizophrenia
1397522|NCT01175135|acute exacerbation|acute exacerbation
1397523|NCT01175135|inpatient|inpatient
1397524|NCT01175109|Chordoma|chordoma
1397525|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
1397526|NCT01175096|carcinoid tumor|carcinoid tumor
1397527|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
1397528|NCT01175083|Catch-up vaccination|catch-up vaccination
1397529|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
1397530|NCT01175083|Sickle cell disease|sickle cell disease
1397531|NCT01175083|Booster vaccination|booster vaccination
1397532|NCT01175083|Safety|safety
1397533|NCT01175083|Immunogenicity|immunogenicity
1397534|NCT01175083|Pneumococcal disease|pneumococcal disease
1397535|NCT01175070|diabetic macular oedema|diabetic macular oedema
1397536|NCT01175070|ischaemia|ischaemia
1397537|NCT01175070|anti VEGF|anti vegf
1397538|NCT01175070|pegaptanib|pegaptanib
1397539|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
1397540|NCT01175057|feasibility|feasibility
1397541|NCT01175057|compliance|compliance
1397542|NCT01175057|telemedical home monitoring|telemedical home monitoring
1397543|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
1397544|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
1397545|NCT01175044|Revision|revision
1397546|NCT01175044|Knee|knee
1397547|NCT01175044|Arthroplasty|arthroplasty
1397548|NCT01175044|Betadine|betadine
1397549|NCT01175044|Lavage|lavage
1397550|NCT01175044|Infection|infection
1397551|NCT01175018|Acute myocardial infarction|acute myocardial infarction
1397552|NCT01175018|Heart Failure|heart failure
1397553|NCT01175018|Cardiac Remodeling|cardiac remodeling
1397554|NCT01175005|Fever|fever
1397555|NCT01175005|Central venous catheter|central venous catheter
1397556|NCT01175005|Procalcitonin|procalcitonin
1397557|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
1397558|NCT01174992|Fibrin sealant|fibrin sealant
1397559|NCT01174992|CSF leak|csf leak
1397560|NCT01174979|Morbus Meniere|morbus meniere
1397561|NCT01174979|Sudden hearing loss|sudden hearing loss
1397562|NCT01174979|Blast injury|blast injury
1397563|NCT01174979|Presbyacusis|presbyacusis
1397564|NCT01174979|Chron. Otitis Media|chron. otitis media
1397565|NCT01174966|oxygen challenge test|oxygen challenge test
1397566|NCT01174966|shock|shock
1397567|NCT01174966|mortality|mortality
1397568|NCT01174966|Oxygen Delivery Index|oxygen delivery index
1397569|NCT01174966|cardiac output index|cardiac output index
1397570|NCT01174953|prostate cancer|prostate cancer
1397571|NCT01174940|myelogenous leukemia|myelogenous leukemia
1397572|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
1397573|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
1397574|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
1397575|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1397576|NCT01174940|Hodgkin's disease|hodgkin's disease
1397577|NCT01174927|Substance use disorder|substance use disorder
1397578|NCT01174927|Stress|stress
1397579|NCT01174901|cephalalgia|cephalalgia
1397580|NCT01174901|copeptins|copeptins
1397581|NCT01174901|biomarkers|biomarkers
1397582|NCT01174901|headache|headache
1397583|NCT01174901|C-terminal provasopression|c-terminal provasopression
1397584|NCT01174901|physiological stress response|physiological stress response
1397585|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
1397586|NCT01174888|AML|aml
1397587|NCT01174875|Epigenetics|epigenetics
1397588|NCT01174875|Development|development
1397589|NCT01174875|Metabolic|metabolic
1397590|NCT01174875|Neurodevelopment|neurodevelopment
1397591|NCT01174862|aspirin|aspirin
1397592|NCT01174862|aspirin responsiveness|aspirin responsiveness
1397593|NCT01174862|long-term outcome|long-term outcome
1397594|NCT01174862|CABG|cabg
1397595|NCT01174849|otitis media|otitis media
1397596|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
1397597|NCT01174849|randomised controlled trial|randomised controlled trial
1397598|NCT01174849|high-risk children|high-risk children
1397599|NCT01174849|indigenous|indigenous
1397600|NCT01174849|Australia|australia
1397601|NCT01174836|CT utilization|ct utilization
1397602|NCT01174836|physician attitudes|physician attitudes
1397603|NCT01174810|Parkinson's Disease|parkinson's disease
1397605|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
1397606|NCT01174784|Chronic Total Occlusions|chronic total occlusions
1397607|NCT01174784|Superficial Femoral Artery|superficial femoral artery
1397608|NCT01174784|Popliteal Artery|popliteal artery
1397609|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
1397610|NCT01174771|Cortical excitability|cortical excitability
1397611|NCT01174771|parkinsonism|parkinsonism
1397612|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
1397613|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
1397614|NCT01174771|PSP|psp
1397615|NCT01174771|CBD|cbd
1397616|NCT01174771|CBGD|cbgd
1397617|NCT01174758|balance|balance
1397618|NCT01174758|mobility|mobility
1397619|NCT01174758|ON/OFF Levodopa|on/off levodopa
1397620|NCT01174732|asthma|asthma
1397621|NCT01174732|bronchospasm|bronchospasm
1397622|NCT01174732|COPD|copd
1397623|NCT01174732|chronic respiratory disease|chronic respiratory disease
1397624|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
1397625|NCT01174719|Humanalbumin|humanalbumin
1397626|NCT01174719|Ringer Lactate|ringer lactate
1397627|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
1397628|NCT01174706|infections|infections
1397629|NCT01174706|flu|flu
1397630|NCT01174706|abdominal pain|abdominal pain
1397631|NCT01174706|chest pain|chest pain
1397632|NCT01174706|cold|cold
1397633|NCT01174706|fever|fever
1397634|NCT01174706|different acute care conditions|different acute care conditions
1397635|NCT01174693|prospective|prospective
1397636|NCT01174693|randomized|randomized
1397637|NCT01174693|open label|open label
1397638|NCT01174693|multi-center|multi-center
1397639|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
1397640|NCT01174680|cardiogoniometry|cardiogoniometry
1397641|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
1397642|NCT01174667|Myofascial pain|myofascial pain
1397643|NCT01174667|Trigger points|trigger points
1397644|NCT01174641|unilateral neglect|unilateral neglect
1397645|NCT01174641|TMS intervention|tms intervention
1397646|NCT01174628|Exercise Tolerance|exercise tolerance
1397647|NCT01174628|Venous Thrombosis|venous thrombosis
1397648|NCT01174628|Pulmonary Embolism|pulmonary embolism
1397649|NCT01174628|Quality of Life (QOL)|quality of life (qol)
1397650|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
1397651|NCT01174589|Lower limb strength training|lower limb strength training
1397652|NCT01174589|Randomized clinical trial|randomized clinical trial
1397653|NCT01174589|Patients with Hip fracture|patients with hip fracture
1397654|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
1397655|NCT01174576|coffee|coffee
1397656|NCT01174576|appetite|appetite
1397657|NCT01174576|energy intake|energy intake
1397658|NCT01174576|inflammation|inflammation
1397659|NCT01174576|cortisol|cortisol
1397660|NCT01174576|glucose|glucose
1397661|NCT01174576|randomized controlled trial|randomized controlled trial
1397662|NCT01174550|chest pain|chest pain
1397663|NCT01174550|coronary artery disease|coronary artery disease
1397664|NCT01174550|CAD|cad
1397665|NCT01174537|NDV|ndv
1397666|NCT01174537|Metastatic|metastatic
1397667|NCT01174537|Refractory|refractory
1397668|NCT01174537|Cancer|cancer
1397669|NCT01174537|Progression-free|progression-free
1397670|NCT01174537|survival|survival
1397671|NCT01174537|recurrent|recurrent
1397672|NCT01174524|Quality of life|quality of life
1397673|NCT01174524|Menopause|menopause
1397674|NCT01174524|Contraception|contraception
1397675|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
1397676|NCT01174511|A-1 COOL CREAM|a-1 cool cream
1397677|NCT01174498|discomfort|discomfort
1397678|NCT01174498|distress|distress
1397679|NCT01174498|hurt|hurt
1397680|NCT01174498|sting|sting
1397681|NCT01174485|Liposuction|liposuction
1397682|NCT01174485|exercise|exercise
1397683|NCT01174485|metabolism|metabolism
1397684|NCT01174485|adiposity|adiposity
1397685|NCT01174472|Dialysis access|dialysis access
1397686|NCT01174472|angioplasty|angioplasty
1397687|NCT01174472|drug eluting balloon|drug eluting balloon
1397688|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
1397689|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
1397690|NCT01174433|Tryton Stent|tryton stent
1397691|NCT01174420|ologen|ologen
1397692|NCT01174420|Mitomycin-C|mitomycin-c
1397693|NCT01174420|Collagen Matrix|collagen matrix
1397694|NCT01174420|trabeculectomy|trabeculectomy
1397695|NCT01174420|glaucoma|glaucoma
1397696|NCT01174420|filtering surgery|filtering surgery
1397697|NCT01174394|Acupuncture|acupuncture
1397698|NCT01174394|Post Stroke Depression|post stroke depression
1397699|NCT01174394|Depressive Disorder|depressive disorder
1397700|NCT01174394|Cardiovascular Accident|cardiovascular accident
1397701|NCT01174394|Stroke|stroke
1397702|NCT01174394|Apoplexy|apoplexy
1397703|NCT01174394|CVA|cva
1397704|NCT01174381|Non communicable disease|non communicable disease
1397705|NCT01174381|Lifestyle Modification|lifestyle modification
1397706|NCT01174381|Community Based organization|community based organization
1397707|NCT01174381|community based study|community based study
1397708|NCT01174342|Intraocular pressure|intraocular pressure
1397709|NCT01174342|Ocular tonometry|ocular tonometry
1397710|NCT01174342|Obstetric delivery|obstetric delivery
1397711|NCT01174316|Acute exacerbation|acute exacerbation
1397712|NCT01174316|Respiratory insufficiency|respiratory insufficiency
1397713|NCT01174316|Respiratory failure|respiratory failure
1397714|NCT01174316|Hypercapnia|hypercapnia
1397715|NCT01174316|Hypoventilation|hypoventilation
1397716|NCT01174316|Sleep|sleep
1397717|NCT01174316|Hypoxia|hypoxia
1397718|NCT01174316|Titration|titration
1397719|NCT01174316|Non Invasive Ventilation|non invasive ventilation
1397720|NCT01174290|subsyndromal delirium|subsyndromal delirium
1397721|NCT01174290|delirium|delirium
1397722|NCT01174290|haloperidol|haloperidol
1397723|NCT01174290|antipsychotic|antipsychotic
1397724|NCT01174290|randomized controlled trial|randomized controlled trial
1397725|NCT01174290|placebo-controlled|placebo-controlled
1397726|NCT01174290|intensive care unit|intensive care unit
1397727|NCT01174290|critical care|critical care
1397728|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
1397729|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
1397730|NCT01174277|transplant|transplant
1397731|NCT01174277|stem cell|stem cell
1397732|NCT01174251|general anesthesia|general anesthesia
1397733|NCT01174251|electrocardiography|electrocardiography
1397734|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
1397735|NCT01174238|Melanoma|melanoma
1397736|NCT01174238|Axitinib|axitinib
1397737|NCT01174238|Carboplatin|carboplatin
1397738|NCT01174238|Paclitaxel|paclitaxel
1397739|NCT01174225|Copper IUD|copper iud
1397740|NCT01174225|Nova T 200|nova t 200
1397741|NCT01174225|Flexi T 380|flexi t 380
1397742|NCT01174225|expulsion|expulsion
1397743|NCT01174225|contraception satisfaction|contraception satisfaction
1397744|NCT01174225|post-abortion contraception|post-abortion contraception
1397745|NCT01174212|revision|revision
1397746|NCT01174212|infection|infection
1397747|NCT01174212|knee|knee
1397748|NCT01174212|hip|hip
1397749|NCT01174212|replacement|replacement
1397750|NCT01174212|antibiotics|antibiotics
1397751|NCT01174173|Angina|angina
1397752|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
1397753|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1397754|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
1397755|NCT01174160|Atrial Fibrillation|atrial fibrillation
1397756|NCT01174121|Digestive Tract Cancers|digestive tract cancers
1397757|NCT01174121|Breast Cancer|breast cancer
1397758|NCT01174121|Glioblastoma|glioblastoma
1397759|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
1397760|NCT01174121|Urothelial Cancers|urothelial cancers
1397761|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1397762|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
1397763|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
1397764|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
1397765|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
1397766|NCT01174108|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1397767|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
1397768|NCT01174095|Ischemic Myocardium|ischemic myocardium
1397769|NCT01174095|Ischemia|ischemia
1397770|NCT01174082|Multiple Myeloma|multiple myeloma
1397771|NCT01174082|Vaccine|vaccine
1397772|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
1397773|NCT01174069|NOTES|notes
1397774|NCT01174069|cholecystectomy|cholecystectomy
1397775|NCT01174069|endoscopic|endoscopic
1397776|NCT01174056|Lung inflammation|lung inflammation
1397777|NCT01174056|positron emission tomography|positron emission tomography
1397778|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
1397779|NCT01174056|rosiglitazone|rosiglitazone
1397780|NCT01174056|zileuton|zileuton
1397781|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
1397782|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
1397783|NCT01174043|Erlotinib|erlotinib
1397784|NCT01174017|prostate cancer|prostate cancer
1397785|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
1397786|NCT01174017|seed migration|seed migration
1397787|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
1397788|NCT01173991|carbohydrate counting|carbohydrate counting
1397789|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1398559|NCT01171131|TBI|tbi
1397790|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
1397791|NCT01173978|Incretin hormones|incretin hormones
1397792|NCT01173978|Glucagon|glucagon
1397793|NCT01173978|Insulin/c-peptide|insulin/c-peptide
1397794|NCT01173978|Plasma glucose|plasma glucose
1397795|NCT01173978|Insulin resistance|insulin resistance
1397796|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
1397797|NCT01173978|Inactivity|inactivity
1397798|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
1397799|NCT01173913|oral docetaxel|oral docetaxel
1397800|NCT01173913|ModraDoc|modradoc
1397801|NCT01173913|pharmacokinetics|pharmacokinetics
1397802|NCT01173913|safety|safety
1397803|NCT01173913|MTD|mtd
1397804|NCT01173913|DLT|dlt
1397805|NCT01173900|human papillomavirus|human papillomavirus
1397806|NCT01173900|vaccine|vaccine
1397807|NCT01173900|school girls|school girls
1397808|NCT01173900|Tanzania|tanzania
1397809|NCT01173900|acceptability|acceptability
1397810|NCT01173900|vaccine coverage|vaccine coverage
1397811|NCT01173900|Cervical cancer prevention|cervical cancer prevention
1397812|NCT01173874|Cognition|cognition
1397813|NCT01173874|Function|function
1397814|NCT01173874|Attention|attention
1397815|NCT01173874|Vigilance|vigilance
1397816|NCT01173874|Verbal Memory|verbal memory
1397817|NCT01173874|Visual Memory|visual memory
1397818|NCT01173874|Processing Speed|processing speed
1397819|NCT01173874|Problem Solving|problem solving
1397820|NCT01173874|Social Cognition|social cognition
1397821|NCT01173848|CKD|ckd
1397822|NCT01173848|Vitamin D|vitamin d
1397823|NCT01173835|Adolescent tobacco use|adolescent tobacco use
1397824|NCT01173835|Tobacco Free and Win|tobacco free and win
1397825|NCT01173835|Incentive-based intervention|incentive-based intervention
1397826|NCT01173835|Contingency Management|contingency management
1397827|NCT01173835|Smoking Prevention|smoking prevention
1397828|NCT01173835|Smoking cessation|smoking cessation
1397829|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
1397830|NCT01173822|hemorrhage|hemorrhage
1397831|NCT01173822|trials|trials
1397832|NCT01173822|surgery|surgery
1397833|NCT01173809|AF|af
1397834|NCT01173809|Catheter Ablation|catheter ablation
1397835|NCT01173809|Recurrence of AF|recurrence of af
1397836|NCT01173809|Amiodarone|amiodarone
1397837|NCT01173783|Heart failure|heart failure
1397838|NCT01173783|Cardiac insufficiency|cardiac insufficiency
1397839|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
1397840|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
1397841|NCT01173783|ICD|icd
1397842|NCT01173783|CRT|crt
1397843|NCT01173783|Register|register
1397844|NCT01173757|Healthy Volunteers|healthy volunteers
1397845|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
1397846|NCT01173731|Parkinson Disease|parkinson disease
1397847|NCT01173731|L-dopa|l-dopa
1397848|NCT01173731|Levodopa|levodopa
1397849|NCT01173731|Dyskinesia|dyskinesia
1397850|NCT01173731|involuntary movement|involuntary movement
1397851|NCT01173731|motor complication|motor complication
1397852|NCT01173718|Hemodialysis|hemodialysis
1397853|NCT01173718|Vascular Graft|vascular graft
1397854|NCT01173705|Obesity|obesity
1397855|NCT01173705|Insulin Resistance|insulin resistance
1397856|NCT01173705|Inflammation|inflammation
1397857|NCT01173692|Oropharynx Cancer|oropharynx cancer
1397858|NCT01173692|Radiation Therapy|radiation therapy
1397859|NCT01173692|XRT|xrt
1397860|NCT01173692|Radiotherapy|radiotherapy
1397861|NCT01173692|Minocycline|minocycline
1397862|NCT01173692|Symptoms|symptoms
1397863|NCT01173692|Head and Neck|head and neck
1397864|NCT01173679|CLL|cll
1397865|NCT01173679|fludarabine|fludarabine
1397866|NCT01173679|rituximab|rituximab
1397867|NCT01173679|dasatinib|dasatinib
1397868|NCT01173679|refractory|refractory
1397869|NCT01173679|relapsed|relapsed
1397870|NCT01173666|RAS|ras
1397871|NCT01173666|LVMI|lvmi
1397872|NCT01173666|Renal revascularization|renal revascularization
1397873|NCT01173653|smoking|smoking
1397874|NCT01173653|smoking cessation|smoking cessation
1397875|NCT01173653|health behavior|health behavior
1397876|NCT01173640|drug interactions|drug interactions
1397877|NCT01173640|midazolam|midazolam
1397878|NCT01173640|cytochrome P450|cytochrome p450
1397879|NCT01173640|resveratrol|resveratrol
1397880|NCT01173640|pharmacokinetics|pharmacokinetics
1397881|NCT01173627|Bioequivalence|bioequivalence
1397882|NCT01173627|Fentanyl|fentanyl
1397883|NCT01173588|bowel function|bowel function
1397884|NCT01173588|functional foods|functional foods
1397885|NCT01173562|Healthy volunteers|healthy volunteers
1397886|NCT01173562|Parasitic Diseases|parasitic diseases
1397887|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
1397888|NCT01173562|Anthelmintics|anthelmintics
1397889|NCT01173562|Antiparasitic Agents|antiparasitic agents
1397890|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
1397891|NCT01173562|Pediatric|pediatric
1397892|NCT01173549|Canagliflozin|canagliflozin
1397893|NCT01173549|Pharmacodynamic|pharmacodynamic
1397894|NCT01173549|Glucose absorption|glucose absorption
1397895|NCT01173549|Glucose metabolism|glucose metabolism
1397896|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
1397897|NCT01173523|relapsed|relapsed
1397898|NCT01173523|refractory|refractory
1397900|NCT01173510|AIDS|aids
1397901|NCT01173510|Atripla|atripla
1397902|NCT01173510|Truvada|truvada
1397903|NCT01173510|Raltegravir|raltegravir
1397904|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
1397905|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1397906|NCT01173497|Triple negative breast cancer|triple negative breast cancer
1397907|NCT01173497|Brain metastasis|brain metastasis
1397908|NCT01173497|BSI-201|bsi-201
1397909|NCT01173497|iniparib|iniparib
1398202|NCT01172184|Prognosis|prognosis
1397910|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
1397911|NCT01173484|Vomiting|vomiting
1397912|NCT01173484|Dyspepsia|dyspepsia
1397913|NCT01173484|GERD|gerd
1397914|NCT01173471|Raised intraocular pressure|raised intraocular pressure
1397915|NCT01173458|cancer|cancer
1397916|NCT01173458|lung|lung
1397917|NCT01173458|small cell|small cell
1397918|NCT01173445|cancer|cancer
1397919|NCT01173445|kidney|kidney
1397920|NCT01173445|renal cell|renal cell
1397921|NCT01173445|tumor cells|tumor cells
1397922|NCT01173445|circulating tumor cells|circulating tumor cells
1397923|NCT01173445|circulating endothelial cells|circulating endothelial cells
1397924|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
1397925|NCT01173432|metabolic dysfunction|metabolic dysfunction
1397926|NCT01173432|metabolic syndrome|metabolic syndrome
1397927|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
1397928|NCT01173419|Great Saphenous Vein|great saphenous vein
1397929|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
1397930|NCT01173406|Adherence|adherence
1397931|NCT01173406|Education|education
1397932|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
1397933|NCT01173393|OHCA|ohca
1397934|NCT01173393|EMS|ems
1397935|NCT01173393|Emergency medical System|emergency medical system
1397936|NCT01173393|non-VF|non-vf
1397937|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
1397938|NCT01173380|Soy|soy
1397939|NCT01173380|Equol|equol
1397940|NCT01173380|Metabolic syndrome|metabolic syndrome
1397941|NCT01173380|Endothelial function|endothelial function
1397942|NCT01173367|Fever|fever
1397943|NCT01173367|ICU|icu
1397944|NCT01173367|Acetaminophen|acetaminophen
1397945|NCT01173367|Inflammatory mediators|inflammatory mediators
1397946|NCT01173367|Safety|safety
1397947|NCT01173354|COPD|copd
1397948|NCT01173354|Protein metabolism|protein metabolism
1397949|NCT01173354|Essential amino acid intake|essential amino acid intake
1397950|NCT01173328|exercise tolerance|exercise tolerance
1397951|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
1397952|NCT01173328|respiratory mechanics|respiratory mechanics
1397953|NCT01173315|Type 2 diabetes|type 2 diabetes
1397954|NCT01173315|micronutrients|micronutrients
1397955|NCT01173315|nephropathy|nephropathy
1397956|NCT01173315|neuropathy|neuropathy
1397957|NCT01173302|Rabies|rabies
1397958|NCT01173302|Anti-rabies antibody|anti-rabies antibody
1397959|NCT01173302|Persistence|persistence
1397960|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
1397961|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
1397962|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1397963|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
1397964|NCT01173276|Fertility|fertility
1397965|NCT01173276|HIV|hiv
1397966|NCT01173276|HIV Discordant|hiv discordant
1397967|NCT01173276|Infertility|infertility
1397968|NCT01173276|Intrauterine Insemination|intrauterine insemination
1397969|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
1397970|NCT01173276|Sperm Washing|sperm washing
1397971|NCT01173263|breathing machine|breathing machine
1397972|NCT01173263|mechanical ventilator|mechanical ventilator
1397973|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
1397974|NCT01173237|tracheal intubation|tracheal intubation
1397975|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
1397976|NCT01173237|neonate|neonate
1397977|NCT01173237|surfactant|surfactant
1397978|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
1397979|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
1397980|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
1397981|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
1397982|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
1397983|NCT01173172|Head and neck cancer|head and neck cancer
1397984|NCT01173172|toxicities|toxicities
1397985|NCT01173172|response rate|response rate
1397986|NCT01173159|Parenteral Nutrition|parenteral nutrition
1397987|NCT01173159|Cholestasis|cholestasis
1397988|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
1397989|NCT01173133|Free Flap|free flap
1397990|NCT01173133|Surgery|surgery
1397991|NCT01173133|Ischemia|ischemia
1397992|NCT01173133|Outcome|outcome
1397993|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
1397994|NCT01173133|Monitoring|monitoring
1397995|NCT01173094|Critical limb ischemia|critical limb ischemia
1397996|NCT01173094|Diabetes Mellitus|diabetes mellitus
1397997|NCT01173094|Diabetes foot|diabetes foot
1397998|NCT01173081|Jones fracture|jones fracture
1397999|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
1398000|NCT01173081|teriparatide|teriparatide
1398001|NCT01173081|fracture healing|fracture healing
1398002|NCT01173068|Ertapenem|ertapenem
1398003|NCT01173068|Clinical outcome|clinical outcome
1398004|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
1398005|NCT01173042|Overweight|overweight
1398006|NCT01173042|Obese|obese
1398007|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
1398008|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
1398009|NCT01173029|Genetic polymorphisms|genetic polymorphisms
1398010|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
1398011|NCT01173029|Risk markers|risk markers
1398012|NCT01173029|Adverse events|adverse events
1398013|NCT01173029|Acute myocardial infarction|acute myocardial infarction
1398014|NCT01173029|Stroke|stroke
1398015|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
1398016|NCT01173003|Medical abortion|medical abortion
1398017|NCT01173003|mifepristone|mifepristone
1398018|NCT01173003|misoprostol|misoprostol
1398019|NCT01173003|Tunisia|tunisia
1398020|NCT01172990|ST Depression|st depression
1398021|NCT01172977|Diabetes mellitus|diabetes mellitus
1398022|NCT01172977|Stroke|stroke
1398023|NCT01172964|Los Angeles|los angeles
1398024|NCT01172951|Post-prandial|post-prandial
1398025|NCT01172951|Nutrigenomic|nutrigenomic
1398026|NCT01172951|Test meal|test meal
1398027|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
1398028|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
1398029|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
1398030|NCT01172938|Psoriasis|psoriasis
1398031|NCT01172938|Arthritis|arthritis
1398032|NCT01172938|inflammation|inflammation
1398033|NCT01172938|skin condition|skin condition
1398034|NCT01172938|inflammatory cells|inflammatory cells
1398035|NCT01172938|apremilast|apremilast
1398036|NCT01172938|CC-10004|cc-10004
1398037|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
1398038|NCT01172925|NSCLC|nsclc
1398039|NCT01172925|dyspnea|dyspnea
1398040|NCT01172925|phase II|phase ii
1398041|NCT01172925|crossover|crossover
1398042|NCT01172925|tiotropium|tiotropium
1398043|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1398044|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1398045|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1398046|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1398047|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1398048|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1398049|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1398050|NCT01172912|testicular mature teratoma|testicular mature teratoma
1398051|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1398052|NCT01172912|testicular immature teratoma|testicular immature teratoma
1398053|NCT01172899|Bariatric Surgery|bariatric surgery
1398054|NCT01172899|Adolescent|adolescent
1398055|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
1398056|NCT01172873|OCD|ocd
1398057|NCT01172873|DCS|dcs
1398058|NCT01172873|D-cycloserine|d-cycloserine
1398059|NCT01172873|CBT|cbt
1398060|NCT01172873|E/RP|e/rp
1398061|NCT01172873|exposure response prevention|exposure response prevention
1398062|NCT01172860|Inoperable|inoperable
1398063|NCT01172860|Colorectal|colorectal
1398064|NCT01172860|Endoscopic|endoscopic
1398065|NCT01172860|Electroporation|electroporation
1398066|NCT01172860|Outpatient|outpatient
1398067|NCT01172834|Nurses|nurses
1398068|NCT01172795|Whiplash associated disorder|whiplash associated disorder
1398069|NCT01172795|chronic pain|chronic pain
1398070|NCT01172795|neural inhibition|neural inhibition
1398071|NCT01172795|neuropsychological tests|neuropsychological tests
1398072|NCT01172769|HNSCC|hnscc
1398073|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
1398074|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
1398075|NCT01172743|Diabetes Mellitus|diabetes mellitus
1398076|NCT01172743|Diabetes|diabetes
1398077|NCT01172743|Type-2|type-2
1398078|NCT01172743|Adult Onset|adult onset
1398079|NCT01172730|Post operative pain|post operative pain
1398080|NCT01172730|thoracic epidural|thoracic epidural
1398081|NCT01172730|acute pain|acute pain
1567152|NCT00509743|Adult volunteers|adult volunteers
1398082|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
1398083|NCT01172717|Carcinoid|carcinoid
1398084|NCT01172717|Carcinoid syndrome|carcinoid syndrome
1398085|NCT01172704|Motivational Interviewing|motivational interviewing
1398086|NCT01172704|Serious Mental Illness|serious mental illness
1398089|NCT01172691|Liver transplant|liver transplant
1398090|NCT01172665|Celiac Disease|celiac disease
1398091|NCT01172652|Bipolar disorder|bipolar disorder
1398093|NCT01172652|Panic|panic
1398094|NCT01172652|GAD|gad
1398095|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
1398096|NCT01172639|CoBRA|cobra
1398097|NCT01172626|epilepsy|epilepsy
1398098|NCT01172626|valproate sodium|valproate sodium
1398099|NCT01172626|metabolic enzymes|metabolic enzymes
1398100|NCT01172626|adverse effects|adverse effects
1398101|NCT01172626|systemic adverse effects|systemic adverse effects
1398102|NCT01172613|allergic rhinitis|allergic rhinitis
1398365|NCT01171807|Steroid adverse events|steroid adverse events
1398103|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
1398104|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
1398105|NCT01172613|skin prick test|skin prick test
1398106|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
1398107|NCT01172600|radiating back pain|radiating back pain
1398108|NCT01172600|epidural block|epidural block
1398109|NCT01172600|steroid|steroid
1398110|NCT01172600|recurrent low back pain|recurrent low back pain
1398111|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
1398112|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
1398113|NCT01172587|Couples Treatment|couples treatment
1398114|NCT01172587|Alcohol Use|alcohol use
1398115|NCT01172587|Effects on Youth|effects on youth
1398116|NCT01172574|Osteoporosis|osteoporosis
1398117|NCT01172574|Pain|pain
1398118|NCT01172574|Kyphosis|kyphosis
1398119|NCT01172574|Posture|posture
1398120|NCT01172574|Exercise therapy|exercise therapy
1398121|NCT01172548|Resected GIST|resected gist
1398122|NCT01172548|primary GIST|primary gist
1398123|NCT01172548|tumor recurrence|tumor recurrence
1398124|NCT01172548|KIT receptor|kit receptor
1398125|NCT01172548|KIT positive|kit positive
1398126|NCT01172548|advanced GIST|advanced gist
1398127|NCT01172548|minimal toxicity|minimal toxicity
1398128|NCT01172548|GIST|gist
1398129|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
1398130|NCT01172535|Pediatric dosing|pediatric dosing
1398131|NCT01172535|World Health Organization|world health organization
1398132|NCT01172522|Under eye dark circles|under eye dark circles
1398133|NCT01172522|Under eye puffiness|under eye puffiness
1398134|NCT01172509|plasticity|plasticity
1398135|NCT01172509|excitatory|excitatory
1398136|NCT01172509|inhibitory|inhibitory
1398137|NCT01172509|synaptic plasticity|synaptic plasticity
1398138|NCT01172509|R-Baclofen|r-baclofen
1398140|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
1398141|NCT01172509|biomarker|biomarker
1398142|NCT01172509|autism|autism
1398143|NCT01172483|primary care|primary care
1398144|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
1398145|NCT01172483|promotion physical activity|promotion physical activity
1398146|NCT01172483|chronic disorders|chronic disorders
1398147|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
1398148|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
1398149|NCT01172457|low back pain|low back pain
1398150|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
1398151|NCT01172457|epidural fibrosis|epidural fibrosis
1398152|NCT01172457|ozone therapy|ozone therapy
1398153|NCT01172457|oxygen therapy|oxygen therapy
1398154|NCT01172457|epiduroscopy|epiduroscopy
1398155|NCT01172457|spinal endoscopy|spinal endoscopy
1398156|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
1398157|NCT01172431|hypertension|hypertension
1398158|NCT01172431|renal insufficiency|renal insufficiency
1398159|NCT01172431|indapamide|indapamide
1398160|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
1398161|NCT01172418|adult|adult
1398162|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
1398163|NCT01172405|Headache|headache
1398164|NCT01172405|Migraine|migraine
1398165|NCT01172405|Ibuprofen|ibuprofen
1398166|NCT01172405|Caffeine|caffeine
1398167|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
1398168|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
1398169|NCT01172340|behavioral|behavioral
1398170|NCT01172340|diet|diet
1398171|NCT01172340|exercise|exercise
1398172|NCT01172314|NSCLC|nsclc
1398173|NCT01172314|Weight loss|weight loss
1398174|NCT01172314|protein metabolism|protein metabolism
1398175|NCT01172314|essential amino acid intake|essential amino acid intake
1398176|NCT01172301|CF|cf
1398177|NCT01172301|protein metabolism|protein metabolism
1398178|NCT01172301|essential amino acid intake|essential amino acid intake
1398179|NCT01172288|Tic disorders,|tic disorders,
1398180|NCT01172288|Tourette syndrome|tourette syndrome
1398181|NCT01172288|Chronic Tic Disorders|chronic tic disorders
1398182|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1398183|NCT01172275|OCD|ocd
1398184|NCT01172262|Tinnitus|tinnitus
1398185|NCT01172262|MRI|mri
1398186|NCT01172262|fMRI|fmri
1398187|NCT01172262|task based MRI|task based mri
1398188|NCT01172262|Otolaryngology|otolaryngology
1399043|NCT01169142|Vitamin D|vitamin d
1398189|NCT01172249|Osteoarthritis|osteoarthritis
1398190|NCT01172249|Knee|knee
1398191|NCT01172249|Glucosamine|glucosamine
1398192|NCT01172249|Chondroitin|chondroitin
1398193|NCT01172223|HER2-positive|her2-positive
1398194|NCT01172223|early breast cancer|early breast cancer
1398195|NCT01172197|local anesthetic|local anesthetic
1398196|NCT01172197|levobupivacaine|levobupivacaine
1398197|NCT01172197|ropivacaine|ropivacaine
1398198|NCT01172197|femoral perineural block|femoral perineural block
1398199|NCT01172184|Left atrial distensibility|left atrial distensibility
1398200|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
1398201|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
1398203|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
1398204|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
1398205|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
1398206|NCT01172171|Intracoronary melatonin|intracoronary melatonin
1398207|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
1398208|NCT01172145|apathy|apathy
1398209|NCT01172145|Alzheimer's disease|alzheimer's disease
1398210|NCT01172145|activities of daily living performance|activities of daily living performance
1398211|NCT01172145|caregiver burden|caregiver burden
1398212|NCT01172132|Leukemia|leukemia
1398213|NCT01172132|Lymphoma|lymphoma
1398214|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
1398215|NCT01172132|Neutropenia|neutropenia
1398216|NCT01172132|Acute respiratory failure|acute respiratory failure
1398217|NCT01172132|Mechanical ventilation|mechanical ventilation
1398218|NCT01172132|Post ICU burden|post icu burden
1398219|NCT01172132|ICU triage|icu triage
1398220|NCT01172132|Dialysis|dialysis
1398221|NCT01172132|Septic shock|septic shock
1398222|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
1398223|NCT01172106|Postpartum psychosis|postpartum psychosis
1398224|NCT01172106|Perceived social support|perceived social support
1398225|NCT01172106|Family psychoeducation|family psychoeducation
1398226|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
1398227|NCT01172093|prevalence|prevalence
1398228|NCT01172093|diabetes mellitus|diabetes mellitus
1398229|NCT01172093|Chinese|chinese
1398230|NCT01172080|colonoscopy|colonoscopy
1398231|NCT01172080|adherence|adherence
1398232|NCT01172080|reminders|reminders
1398233|NCT01172080|quality|quality
1398234|NCT01172067|CRT|crt
1398235|NCT01172067|heart failure|heart failure
1398236|NCT01172067|optimization|optimization
1398237|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
1398238|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
1398239|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1398240|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1398241|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1398242|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1398243|NCT01172028|male breast cancer|male breast cancer
1398244|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
1398245|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
1398246|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
1398247|NCT01172028|stage IV breast cancer|stage iv breast cancer
1398248|NCT01172028|recurrent breast cancer|recurrent breast cancer
1398249|NCT01172028|stage III prostate cancer|stage iii prostate cancer
1398250|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
1398251|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
1398252|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
1398253|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
1398254|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
1398255|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1398256|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1398257|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1398258|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1398259|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1398260|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1398261|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1398262|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1398263|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1398264|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1398265|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1398266|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1398267|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1398268|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1399332|NCT01167959|Diabetes|diabetes
1398269|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1398270|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1398271|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1398272|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1398273|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1398274|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1398774|NCT01170130|Lidocaine|lidocaine
1398275|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1398276|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1398277|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1398278|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1398279|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
1398280|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
1398281|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
1398282|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1398283|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1398284|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1398285|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1398286|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1398287|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1398288|NCT01172028|stage III gastric cancer|stage iii gastric cancer
1398289|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
1398290|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
1398291|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1398292|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1398293|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1398294|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
1398295|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
1398296|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
1398297|NCT01172002|Lupus Nephritis|lupus nephritis
1398298|NCT01172002|Leflunomide|leflunomide
1398299|NCT01172002|Azathioprine|azathioprine
1398300|NCT01171989|booster vaccination|booster vaccination
1398301|NCT01171989|combined vaccine|combined vaccine
1398302|NCT01171976|DME|dme
1398303|NCT01171976|Diabetic macula edema|diabetic macula edema
1398304|NCT01171976|RETAIN|retain
1398305|NCT01171976|ranibizumab|ranibizumab
1398306|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
1398307|NCT01171950|Thoratec Corporation|thoratec corporation
1398308|NCT01171937|ages 8-16|ages 8-16
1398309|NCT01171937|Repetitive Behaviors|repetitive behaviors
1398310|NCT01171924|Head and Neck Cancer|head and neck cancer
1398311|NCT01171924|Liver Cancer|liver cancer
1398312|NCT01171924|Breast Cancer|breast cancer
1398313|NCT01171924|Gastric Cancer|gastric cancer
1398314|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
1398315|NCT01171924|EGFR|egfr
1398316|NCT01171924|HDAC|hdac
1398317|NCT01171924|Her2|her2
1398318|NCT01171924|CUDC-101|cudc-101
1398319|NCT01171911|Endothelial shear stress|endothelial shear stress
1398320|NCT01171911|Calcium channel blocker|calcium channel blocker
1398321|NCT01171898|Non-Metastatic|non-metastatic
1398322|NCT01171898|Rising PSA|rising psa
1398323|NCT01171898|Castration-Resistant|castration-resistant
1398324|NCT01171898|Treatment-Naive|treatment-naive
1398325|NCT01171898|Post-abiraterone|post-abiraterone
1398326|NCT01171885|Superficial cervical block|superficial cervical block
1398327|NCT01171885|Thyroidectomy|thyroidectomy
1398328|NCT01171885|Pain|pain
1398329|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
1398330|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1398331|NCT01171872|Crohn's Disease|crohn's disease
1398332|NCT01171872|Ulcerative Colitis|ulcerative colitis
1398333|NCT01171872|Indeterminate Colitis|indeterminate colitis
1398334|NCT01171872|IBD|ibd
1398335|NCT01171872|CD|cd
1398336|NCT01171872|UC|uc
1398337|NCT01171872|IC|ic
1398338|NCT01171859|amyloidosis|amyloidosis
1398339|NCT01171859|transthyretin|transthyretin
1398340|NCT01171859|doxycycline|doxycycline
1398341|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
1398342|NCT01171846|prevention|prevention
1398343|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
1398344|NCT01171846|prolapse symptoms|prolapse symptoms
1398345|NCT01171846|urinary symptoms|urinary symptoms
1398346|NCT01171846|sexual function|sexual function
1398347|NCT01171846|randomised controlled trial|randomised controlled trial
1398348|NCT01171833|Anesthetic induction|anesthetic induction
1398349|NCT01171833|Desflurane|desflurane
1398350|NCT01171833|Isoflurane|isoflurane
1398351|NCT01171833|Sevoflurane|sevoflurane
1398352|NCT01171833|Ventilation|ventilation
1398353|NCT01171820|drug eluting stents|drug eluting stents
1398354|NCT01171820|stents|stents
1398355|NCT01171820|Angioplasty|angioplasty
1398356|NCT01171820|coronary artery disease|coronary artery disease
1398357|NCT01171820|total coronary occlusion|total coronary occlusion
1398358|NCT01171820|coronary artery restenosis|coronary artery restenosis
1398359|NCT01171820|stent thrombosis|stent thrombosis
1398360|NCT01171820|vascular disease|vascular disease
1398361|NCT01171820|myocardial ischemia|myocardial ischemia
1398362|NCT01171820|coronary artery stenosis|coronary artery stenosis
1398363|NCT01171807|Ulcerative colitis|ulcerative colitis
1398364|NCT01171807|Steroid-dependency|steroid-dependency
1398366|NCT01171807|Erythrocytes|erythrocytes
1398367|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
1398368|NCT01171768|angiopoietin-2|angiopoietin-2
1398369|NCT01171729|Prostate cancer|prostate cancer
1398370|NCT01171729|PSA|psa
1398371|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
1398372|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
1398373|NCT01171703|Critical limb ischemia|critical limb ischemia
1398374|NCT01171703|Diabetes|diabetes
1398375|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
1398376|NCT01171703|Stent|stent
1398377|NCT01171690|Hypoparathyroidism|hypoparathyroidism
1398378|NCT01171677|addiction|addiction
1398379|NCT01171677|exercise|exercise
1398380|NCT01171677|cognitive function|cognitive function
1398381|NCT01171677|mood|mood
1398382|NCT01171677|self efficacy|self efficacy
1398383|NCT01171664|Phase 2|phase 2
1398384|NCT01171664|SAR|sar
1398385|NCT01171664|STAHIST|stahist
1398386|NCT01171651|Vaccinia|vaccinia
1398387|NCT01171651|Vaccinia Virus|vaccinia virus
1398388|NCT01171651|JX-594|jx-594
1398389|NCT01171651|Jennerex|jennerex
1398390|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
1398391|NCT01171651|Primary Liver Cancer|primary liver cancer
1398392|NCT01171651|Liver Cancer|liver cancer
1398393|NCT01171651|Sorafenib|sorafenib
1398394|NCT01171651|Nexavar|nexavar
1398395|NCT01171651|Pexa-Vec|pexa-vec
1398396|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
1398397|NCT01171638|compartment syndrome|compartment syndrome
1398398|NCT01171638|fasciotomy|fasciotomy
1398399|NCT01171638|INVOS|invos
1398400|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
1398401|NCT01171612|Coronary Stent|coronary stent
1398402|NCT01171612|BMS stent|bms stent
1398403|NCT01171612|DES stent|des stent
1398404|NCT01171612|Date of stent implantation|date of stent implantation
1398405|NCT01171612|cardiac event|cardiac event
1398406|NCT01171612|neurovascular event|neurovascular event
1398407|NCT01171612|Bleeding|bleeding
1398408|NCT01171612|transfusion|transfusion
1398409|NCT01171599|Weight Loss|weight loss
1398410|NCT01171599|Obesity|obesity
1398411|NCT01171599|Overweight|overweight
1398412|NCT01171599|Physical Activity|physical activity
1398413|NCT01171599|Nutrition|nutrition
1398414|NCT01171599|Youth|youth
1398415|NCT01171599|Adolescent|adolescent
1398416|NCT01171599|Technology|technology
1398417|NCT01171586|Obesity|obesity
1398418|NCT01171586|overweight|overweight
1398419|NCT01171586|weight loss|weight loss
1398420|NCT01171586|weight maintenance|weight maintenance
1398421|NCT01171586|SMS|sms
1398422|NCT01171586|technology|technology
1398423|NCT01171586|cell phone|cell phone
1398424|NCT01171586|physical activity|physical activity
1398425|NCT01171586|nutrition|nutrition
1398426|NCT01171573|Polymyositis|polymyositis
1398427|NCT01171573|Dermatomyositis|dermatomyositis
1398428|NCT01171573|Inclusion Body Myositis|inclusion body myositis
1398429|NCT01171560|EZ Blocker|ez blocker
1398430|NCT01171560|Double-lumen Tube|double-lumen tube
1398431|NCT01171560|Airway|airway
1398432|NCT01171560|thoracic surgery|thoracic surgery
1398433|NCT01171560|time for intubation|time for intubation
1398434|NCT01171560|blind insertion|blind insertion
1398435|NCT01171560|conditions of surgery|conditions of surgery
1398436|NCT01171560|postoperative sore throat|postoperative sore throat
1398437|NCT01171560|postoperative hoarseness|postoperative hoarseness
1398438|NCT01171547|pharmacokinetics|pharmacokinetics
1398439|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
1524388|NCT00683839|NRT|nrt
1398440|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
1398441|NCT01171508|Sleep|sleep
1398442|NCT01171508|Heart Rate|heart rate
1398443|NCT01171495|HIV/AIDS|hiv/aids
1398444|NCT01171495|Nutrition Therapy|nutrition therapy
1398445|NCT01171495|Dietary Supplement|dietary supplement
1398446|NCT01171495|Antioxidant|antioxidant
1398447|NCT01171495|Immunity|immunity
1398448|NCT01171495|CD4 count|cd4 count
1398449|NCT01171495|Anthropometry|anthropometry
1398450|NCT01171495|Body Mass Index|body mass index
1398451|NCT01171469|Brain tumor|brain tumor
1398452|NCT01171469|Immunotherapy|immunotherapy
1398453|NCT01171469|Glioma|glioma
1398454|NCT01171456|GDM|gdm
1398455|NCT01171456|Gestational Diabetes|gestational diabetes
1398456|NCT01171456|Diabetes|diabetes
1398458|NCT01171430|multiple myeloma|multiple myeloma
1398459|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1398460|NCT01171417|Fulvestrant|fulvestrant
1398461|NCT01171417|Exemestane|exemestane
1398462|NCT01171417|postmenopausal patients|postmenopausal patients
1398463|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
1398464|NCT01171417|Hormone Receptor positive|hormone receptor positive
1398465|NCT01171417|advanced breast cancer|advanced breast cancer
1398466|NCT01171404|Acute coronary syndrome|acute coronary syndrome
1398467|NCT01171404|heart attack|heart attack
1398468|NCT01171404|myocardial infarction|myocardial infarction
1398469|NCT01171404|ACS long-tem follow up|acs long-tem follow up
1398470|NCT01171404|antithrombotic management|antithrombotic management
1398471|NCT01171404|quality of life|quality of life
1398472|NCT01171404|Antithrombotic|antithrombotic
1398473|NCT01171391|Nocturia|nocturia
1398474|NCT01171391|Pharmacokinetics|pharmacokinetics
1398475|NCT01171391|Pharmacodynamics|pharmacodynamics
1398476|NCT01171391|Water-loading|water-loading
1398477|NCT01171391|Females|females
1398478|NCT01171378|Richter's Syndrome|richter's syndrome
1398479|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
1398480|NCT01171378|Feasibility|feasibility
1398481|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
1398482|NCT01171378|CHOP|chop
1398483|NCT01171378|CHOP-0|chop-0
1398484|NCT01171378|CHOP-OR|chop-or
1398485|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
1398486|NCT01171365|Ciclesonide|ciclesonide
1398487|NCT01171365|Asthma|asthma
1398488|NCT01171365|Therapeutic Uses|therapeutic uses
1398489|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
1398490|NCT01171365|Nitric Oxide|nitric oxide
1398491|NCT01171365|Lung Diseases|lung diseases
1398492|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
1398493|NCT01171352|hemodialysis|hemodialysis
1398494|NCT01171352|dialysis|dialysis
1398495|NCT01171352|hypotension|hypotension
1398496|NCT01171352|CritLine|critline
1398497|NCT01171352|PiCCO|picco
1398498|NCT01171352|Thermodilution|thermodilution
1398499|NCT01171352|CVVHDF|cvvhdf
1398500|NCT01171352|IHD|ihd
1398501|NCT01171339|elderly|elderly
1398502|NCT01171339|multimorbidity|multimorbidity
1398503|NCT01171339|polypharmacy|polypharmacy
1398504|NCT01171339|multimedication|multimedication
1398505|NCT01171339|medication appropriateness|medication appropriateness
1398506|NCT01171339|medication appropriateness index|medication appropriateness index
1398507|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
1398508|NCT01171339|pragmatic trial|pragmatic trial
1398509|NCT01171326|topical|topical
1398510|NCT01171326|minocycline|minocycline
1398511|NCT01171326|foam|foam
1398512|NCT01171326|phase II|phase ii
1398513|NCT01171326|impetigo|impetigo
1398514|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
1398515|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1398516|NCT01171300|rectum|rectum
1398517|NCT01171287|Automobile Driving|automobile driving
1398518|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
1398519|NCT01171287|Lower Extremity|lower extremity
1398520|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
1398521|NCT01171287|Orthopedic Procedures|orthopedic procedures
1398522|NCT01171287|Reaction Time|reaction time
1398523|NCT01171287|Task Performance and Analysis|task performance and analysis
1398524|NCT01171287|Time Factors|time factors
1398525|NCT01171274|neck pain|neck pain
1398526|NCT01171274|yoga|yoga
1398527|NCT01171274|proprioception|proprioception
1398528|NCT01171274|sensory thresholds|sensory thresholds
1398529|NCT01171274|randomized controlled trial|randomized controlled trial
1398530|NCT01171261|Physical Activity|physical activity
1398531|NCT01171261|Sedentary Behavior|sedentary behavior
1398532|NCT01171261|Video Games|video games
1398533|NCT01171261|Exergames|exergames
1398534|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
1398535|NCT01171248|complications|complications
1398536|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
1398537|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
1398538|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
1398539|NCT01171222|soccer|soccer
1398540|NCT01171222|prevention|prevention
1398541|NCT01171222|veteran athletes|veteran athletes
1398542|NCT01171222|exercise|exercise
1398543|NCT01171222|Cardiovascular|cardiovascular
1398544|NCT01171209|MS|ms
1398545|NCT01171196|Sleep Apnea|sleep apnea
1398546|NCT01171196|Questionnaire|questionnaire
1398547|NCT01171183|cocaine dependence|cocaine dependence
1398548|NCT01171183|cocaine withdrawal|cocaine withdrawal
1398549|NCT01171170|non small cell lung cancer|non small cell lung cancer
1398550|NCT01171170|stage IV|stage iv
1398551|NCT01171170|nitroglycerin|nitroglycerin
1398552|NCT01171170|carboplatin|carboplatin
1398553|NCT01171170|paclitaxel|paclitaxel
1398554|NCT01171170|bevacizumab|bevacizumab
1398555|NCT01171157|Influenza-like illness|influenza-like illness
1398556|NCT01171157|vaccine effectiveness|vaccine effectiveness
1398557|NCT01171157|elderly|elderly
1398560|NCT01171131|Brain Injury|brain injury
1398561|NCT01171118|Breathing|breathing
1398562|NCT01171118|Sedation|sedation
1398563|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
1398565|NCT01171105|tolerability|tolerability
1398566|NCT01171092|stem cell|stem cell
1398567|NCT01171092|transplant|transplant
1398568|NCT01171092|myeloma|myeloma
1398569|NCT01171092|lymphoma|lymphoma
1398570|NCT01171092|BMT|bmt
1398571|NCT01171092|autologous|autologous
1398572|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
1398573|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
1398574|NCT01171053|Internet|internet
1399450|NCT01167478|Reserve|reserve
1398575|NCT01171053|Cost-effectiveness|cost-effectiveness
1398576|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
1398577|NCT01171040|left atrial distensibility|left atrial distensibility
1398578|NCT01171040|mortality|mortality
1398579|NCT01171040|heart failure|heart failure
1398580|NCT01171040|atrial fibrillation|atrial fibrillation
1398581|NCT01171040|stroke|stroke
1398582|NCT01171040|prognosis|prognosis
1398583|NCT01171027|Cholecystectomy|cholecystectomy
1398584|NCT01171027|NOTES|notes
1398585|NCT01171027|Transvaginal|transvaginal
1398586|NCT01171027|Transgastric|transgastric
1398587|NCT01171027|Natural orifice|natural orifice
1398588|NCT01171027|Gallbladder removal|gallbladder removal
1398589|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
1398590|NCT01170975|Advanced solid tumors|advanced solid tumors
1398591|NCT01170949|urticaria|urticaria
1398592|NCT01170936|Urticarial vasculitis|urticarial vasculitis
1398593|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
1398594|NCT01170923|non small cell lung cancer|non small cell lung cancer
1398595|NCT01170923|FDG PET|fdg pet
1398596|NCT01170910|Chronic renal failure|chronic renal failure
1398597|NCT01170910|Transplantation|transplantation
1398598|NCT01170910|Marginal kidney graft|marginal kidney graft
1398599|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
1398600|NCT01170897|PEGPH20|pegph20
1398601|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
1398602|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
1398603|NCT01170845|Esophagectomy|esophagectomy
1398604|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
1398605|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
1398606|NCT01170819|Cervical ripening|cervical ripening
1398607|NCT01170819|Induction of labor|induction of labor
1398608|NCT01170819|Prostaglandins|prostaglandins
1398609|NCT01170819|Mechanical methods|mechanical methods
1398610|NCT01170819|Balloon catheter|balloon catheter
1398611|NCT01170806|Intestinal lipase|intestinal lipase
1398612|NCT01170806|Orlistat|orlistat
1398613|NCT01170806|fecal fat|fecal fat
1398614|NCT01170806|obesity|obesity
1398615|NCT01170793|education, quality of life|education, quality of life
1398616|NCT01170780|Inguinal hernia|inguinal hernia
1398617|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
1398618|NCT01170780|TAPP|tapp
1398619|NCT01170780|Dexamethasone|dexamethasone
1398620|NCT01170780|Pain|pain
1398621|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
1398622|NCT01170767|Bevacizumab|bevacizumab
1398623|NCT01170767|Ranibizumab|ranibizumab
1398624|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
1398625|NCT01170728|Male Sling|male sling
1398626|NCT01170728|Fixation|fixation
1398627|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
1398628|NCT01170728|Urinary incontinence|urinary incontinence
1398629|NCT01170715|Psoriasis|psoriasis
1398630|NCT01170715|Co morbidities|co morbidities
1398631|NCT01170715|Inflammation|inflammation
1398632|NCT01170702|Cesarean Delivery|cesarean delivery
1398633|NCT01170702|Ropivicaine|ropivicaine
1398634|NCT01170702|TAP block|tap block
1398635|NCT01170689|Schizophrenia|schizophrenia
1398636|NCT01170689|inpatient|inpatient
1398637|NCT01170689|obesity|obesity
1398638|NCT01170689|prevalence|prevalence
1398639|NCT01170676|asthma|asthma
1398640|NCT01170676|smoking|smoking
1398641|NCT01170676|teens|teens
1398642|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
1398643|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
1398644|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1398645|NCT01170650|cancer|cancer
1398646|NCT01170650|ovarian|ovarian
1398647|NCT01170650|platinum-resistant|platinum-resistant
1398648|NCT01170650|Phase III|phase iii
1398649|NCT01170650|EC145|ec145
1398650|NCT01170650|EC20|ec20
1398651|NCT01170624|PhD|phd
1398652|NCT01170624|EGM|egm
1398653|NCT01170624|CRT-D|crt-d
1398654|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
1398655|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
1398656|NCT01170598|AML|aml
1398657|NCT01170598|chemotherapy|chemotherapy
1398658|NCT01170598|exercise|exercise
1398659|NCT01170598|quality of life|quality of life
1398660|NCT01170598|cancer-related fatigue|cancer-related fatigue
1398661|NCT01170598|elderly|elderly
1398662|NCT01170598|physical fitness|physical fitness
1398663|NCT01170598|muscular strength|muscular strength
1398664|NCT01170598|Feasibility|feasibility
1398665|NCT01170598|Efficacy|efficacy
1398666|NCT01170598|Safety|safety
1398667|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
1398668|NCT01170546|agility|agility
1398669|NCT01170546|knee stability|knee stability
1398670|NCT01170546|hamstring|hamstring
1398671|NCT01170546|knee internal rotator|knee internal rotator
1398672|NCT01170533|proton pump inhibitor|proton pump inhibitor
1398673|NCT01170533|clopidogrel|clopidogrel
1398674|NCT01170533|platelet function|platelet function
1398675|NCT01170520|adolescent resistant depression|adolescent resistant depression
1398676|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1398677|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
1398678|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
1398679|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
1398680|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
1398681|NCT01170481|papilloedema|papilloedema
1398682|NCT01170468|Prediabetics|prediabetics
1398683|NCT01170468|DM|dm
1398684|NCT01170468|vitamin D|vitamin d
1398685|NCT01170455|nasal|nasal
1398686|NCT01170455|intubation|intubation
1398687|NCT01170455|direct laryngoscope|direct laryngoscope
1398688|NCT01170455|blind|blind
1398689|NCT01170455|normal airway|normal airway
1398690|NCT01170429|Cough Variant Asthma|cough variant asthma
1398691|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
1398692|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
1398693|NCT01170416|Body Surface Mapping|body surface mapping
1398694|NCT01170403|coronary heart disease|coronary heart disease
1398695|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
1398696|NCT01170403|type 2 diabetes|type 2 diabetes
1398697|NCT01170403|metabolic syndrome|metabolic syndrome
1398698|NCT01170390|Obesity|obesity
1398699|NCT01170390|Body weight|body weight
1398700|NCT01170390|Oral contraception|oral contraception
1398701|NCT01170390|Efficacy|efficacy
1398702|NCT01170377|Intravenous sedation|intravenous sedation
1398703|NCT01170377|Dental treatment|dental treatment
1398704|NCT01170377|Mental retardation|mental retardation
1398705|NCT01170377|Antiepileptic drug|antiepileptic drug
1398706|NCT01170377|Valproate|valproate
1398707|NCT01170377|Propofol|propofol
1398708|NCT01170364|Obesity|obesity
1398709|NCT01170364|sibutramine|sibutramine
1398710|NCT01170364|eating behavior|eating behavior
1398711|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
1398712|NCT01170351|corticosteroids|corticosteroids
1398713|NCT01170351|cysclosporine-A|cysclosporine-a
1398714|NCT01170351|treatment|treatment
1398715|NCT01170351|treatment-naive|treatment-naive
1398716|NCT01170351|induction of remossion|induction of remossion
1398717|NCT01170351|efficacy|efficacy
1398718|NCT01170351|tolerability|tolerability
1398719|NCT01170338|smoking|smoking
1398720|NCT01170338|tobacco abuse|tobacco abuse
1398721|NCT01170325|Valproic Acid|valproic acid
1398722|NCT01170325|Divalproex|divalproex
1398723|NCT01170325|Autism|autism
1398724|NCT01170325|EEG|eeg
1398725|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
1398726|NCT01170325|Depakote|depakote
1398727|NCT01170312|Arthroscopic repair|arthroscopic repair
1398728|NCT01170312|Rotator cuff|rotator cuff
1398729|NCT01170312|Platelet rich plasma|platelet rich plasma
1398730|NCT01170312|Randomized|randomized
1398731|NCT01170312|Pilot|pilot
1398732|NCT01170299|radiation toxicity|radiation toxicity
1398733|NCT01170299|gastrointestinal complications|gastrointestinal complications
1398734|NCT01170299|cervical cancer|cervical cancer
1398735|NCT01170299|fallopian tube cancer|fallopian tube cancer
1398736|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
1398737|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
1398738|NCT01170299|ovarian sarcoma|ovarian sarcoma
1398739|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
1398740|NCT01170299|uterine sarcoma|uterine sarcoma
1398741|NCT01170299|bladder cancer|bladder cancer
1398742|NCT01170299|colon cancer|colon cancer
1398743|NCT01170299|rectal cancer|rectal cancer
1398744|NCT01170299|anal cancer|anal cancer
1398745|NCT01170286|Food allergy|food allergy
1398985|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
1398746|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
1398747|NCT01170286|Whole peanut extract|whole peanut extract
1398748|NCT01170286|Allergenic product|allergenic product
1398749|NCT01170286|Specific Immunotherapy|specific immunotherapy
1398750|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
1398751|NCT01170286|Safety|safety
1398752|NCT01170273|aged|aged
1398753|NCT01170273|vitamin d deficiency|vitamin d deficiency
1398754|NCT01170247|Procedural Sedation|procedural sedation
1398755|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
1398756|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
1398757|NCT01170221|ABSSSI|absssi
1398760|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
1398761|NCT01170208|insulin|insulin
1398762|NCT01170208|dosage software|dosage software
1398763|NCT01170195|Postmenopausal|postmenopausal
1398764|NCT01170195|licorice|licorice
1398765|NCT01170195|vaginal complaints|vaginal complaints
1398766|NCT01170156|deep sedation|deep sedation
1398767|NCT01170156|respiratory resuscitation|respiratory resuscitation
1398768|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
1398769|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
1398770|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
1398771|NCT01170143|Her2 positive|her2 positive
1398772|NCT01170130|Cataract|cataract
1398773|NCT01170130|Mydriasis|mydriasis
1398777|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
1398778|NCT01170104|Sorafenib|sorafenib
1398779|NCT01170104|TACE|tace
1398780|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
1398781|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
1398782|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
1398783|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
1398784|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1398785|NCT01170052|Temsirolimus|temsirolimus
1398786|NCT01170052|Bendamustine|bendamustine
1398787|NCT01170052|Phase 1/2|phase 1/2
1398788|NCT01170039|Constipation|constipation
1398789|NCT01170039|Diabetes|diabetes
1398790|NCT01170039|Lubiprostone|lubiprostone
1398791|NCT01170039|Amitiza|amitiza
1398792|NCT01170039|African Americans|african americans
1398793|NCT01170026|substance use|substance use
1398794|NCT01170026|adolescents|adolescents
1398795|NCT01170026|intervention|intervention
1398796|NCT01170026|truancy|truancy
1398797|NCT01170026|sexual risk behavior|sexual risk behavior
1398798|NCT01170013|substance use|substance use
1398799|NCT01170013|adolescents|adolescents
1398800|NCT01170013|initiation|initiation
1398801|NCT01169987|Multicenter study|multicenter study
1398802|NCT01169974|Microcirculation|microcirculation
1398803|NCT01169974|laser flowmetry|laser flowmetry
1398804|NCT01169974|Skin|skin
1398805|NCT01169974|Physiology|physiology
1398806|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
1398807|NCT01169948|Coronary disease|coronary disease
1398808|NCT01169948|Coronary artery bypass|coronary artery bypass
1398809|NCT01169948|Cardiac surgery|cardiac surgery
1398810|NCT01169948|Computed tomography|computed tomography
1398811|NCT01169948|Coronary angiography|coronary angiography
1398812|NCT01169935|MRI|mri
1398813|NCT01169935|SPIO|spio
1398814|NCT01169935|Healthy Volunteer|healthy volunteer
1398815|NCT01169909|Pterygium|pterygium
1398816|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
1398817|NCT01169883|adherence|adherence
1398818|NCT01169883|asthma|asthma
1398819|NCT01169883|pediatrics|pediatrics
1398820|NCT01169883|behavioral intervention|behavioral intervention
1398821|NCT01169883|inner city|inner city
1398822|NCT01169870|metastatic|metastatic
1398823|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
1398824|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
1398825|NCT01169857|Proteinuria|proteinuria
1398826|NCT01169857|Hematuria|hematuria
1398827|NCT01169857|Velcade|velcade
1398828|NCT01169857|SLE|sle
1398829|NCT01169857|Bortezomib|bortezomib
1398830|NCT01169857|Proteasome inhibitor|proteasome inhibitor
1398831|NCT01169844|Psoriatic arthritis|psoriatic arthritis
1398832|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
1398833|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
1398834|NCT01169792|Tamoxifen|tamoxifen
1398835|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
1398836|NCT01169792|Polymorphism|polymorphism
1398837|NCT01169792|Single nucleotide|single nucleotide
1398838|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
1398839|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
1398840|NCT01169753|CML|cml
1398841|NCT01169753|Nuvigil|nuvigil
1398842|NCT01169753|Armodafinil|armodafinil
1398843|NCT01169753|Fatigue|fatigue
1398844|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
1398845|NCT01169740|Neonatal|neonatal
1398846|NCT01169740|Serum bilirubin|serum bilirubin
1398847|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
1398848|NCT01169740|Skin color|skin color
1398849|NCT01169727|COPD and CCQ score|copd and ccq score
1398850|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
1398851|NCT01169714|multiple dose|multiple dose
1398852|NCT01169714|healthy volunteer|healthy volunteer
1398853|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
1398854|NCT01169714|safety|safety
1398855|NCT01169714|pharmacokinetic|pharmacokinetic
1398949|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1398856|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
1398857|NCT01169688|Cataract Surgery|cataract surgery
1398858|NCT01169688|Pupillary Dilation|pupillary dilation
1398859|NCT01169649|MK-2206|mk-2206
1398860|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
1398861|NCT01169649|10-067|10-067
1398862|NCT01169636|Chemotherapy|chemotherapy
1398863|NCT01169636|Panobinostat|panobinostat
1398864|NCT01169636|Ifosfamide|ifosfamide
1398865|NCT01169636|Mesna|mesna
1398866|NCT01169636|Etoposide|etoposide
1398867|NCT01169636|Carboplatin|carboplatin
1398868|NCT01169636|Pegfilgrastim|pegfilgrastim
1398869|NCT01169636|ICE|ice
1398870|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
1398871|NCT01169623|Nurse Performance|nurse performance
1399640|NCT01166698|Safety|safety
1398872|NCT01169623|Educational Intervention|educational intervention
1398873|NCT01169610|Alcohol|alcohol
1398874|NCT01169610|Smoking|smoking
1398875|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
1398876|NCT01169597|prednisone|prednisone
1398877|NCT01169597|clinical examination|clinical examination
1398878|NCT01169597|remission|remission
1398879|NCT01169597|ultrasonography|ultrasonography
1398880|NCT01169584|Phase I|phase i
1398881|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
1398882|NCT01169584|pediatric|pediatric
1398883|NCT01169584|vaccinia virus|vaccinia virus
1398884|NCT01169584|oncolytic virus|oncolytic virus
1398885|NCT01169584|neuroblastoma|neuroblastoma
1398886|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
1398887|NCT01169584|lymphoma|lymphoma
1398888|NCT01169584|Wilm's tumor|wilm's tumor
1398889|NCT01169584|Ewing's sarcoma|ewing's sarcoma
1398890|NCT01169584|osteosarcoma|osteosarcoma
1398891|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
1398892|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
1398893|NCT01169584|Pexa-Vec|pexa-vec
1398894|NCT01169571|Initially intubated|initially intubated
1398895|NCT01169571|Mechanically ventilated|mechanically ventilated
1398896|NCT01169571|Post-surgical|post-surgical
1398897|NCT01169545|any type of cancer|any type of cancer
1398898|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
1398899|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
1398900|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
1398901|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
1398902|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
1398903|NCT01169506|blood gas analysis|blood gas analysis
1398904|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
1398905|NCT01169493|Heart Failure|heart failure
1398906|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
1398907|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1398908|NCT01169480|Massage|massage
1398909|NCT01169480|Therapist, Massage|therapist, massage
1398910|NCT01169480|DASS|dass
1398911|NCT01169480|Depression|depression
1398912|NCT01169480|Anxiety, State|anxiety, state
1398913|NCT01169480|Anxiety, Trait|anxiety, trait
1398914|NCT01169480|Stress|stress
1398915|NCT01169480|Touch|touch
1398916|NCT01169480|Therapeutic Relationship|therapeutic relationship
1398917|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
1398918|NCT01169454|Ventriculostomy|ventriculostomy
1398919|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
1398920|NCT01169454|Vasospasm|vasospasm
1398921|NCT01169454|Human Subjects|human subjects
1398922|NCT01169441|ICD leads|icd leads
1398923|NCT01169441|Removal|removal
1398924|NCT01169441|Extraction|extraction
1398925|NCT01169441|Ventricular leads|ventricular leads
1398926|NCT01169441|Extract|extract
1398927|NCT01169441|laser|laser
1398928|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
1398929|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
1398930|NCT01169428|prevention of weight regain|prevention of weight regain
1398931|NCT01169428|Obesity|obesity
1398932|NCT01169415|Randomized|randomized
1398933|NCT01169415|Dexamethasone|dexamethasone
1398934|NCT01169415|Abbreviated|abbreviated
1398935|NCT01169415|Protracted|protracted
1398936|NCT01169415|Post-operatively|post-operatively
1398937|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1398938|NCT01169402|ECMO|ecmo
1398939|NCT01169402|extracorporeal life support|extracorporeal life support
1398940|NCT01169402|fluconazole|fluconazole
1398941|NCT01169402|diflucan|diflucan
1398942|NCT01169402|pharmacokinetics|pharmacokinetics
1398943|NCT01169402|pharmacodynamics|pharmacodynamics
1398944|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
1398945|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
1398946|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1398947|NCT01169376|regional neuroblastoma|regional neuroblastoma
1398948|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
1398950|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1398951|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1398952|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1398953|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1398954|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1398955|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1398956|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1398957|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1398958|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1398959|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1399062|NCT01169103|Insulin resistance|insulin resistance
1399643|NCT01166698|inhalation|inhalation
1398960|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1398961|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1398962|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1398963|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1398964|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1398965|NCT01169324|Parkinson's disease|parkinson's disease
1398967|NCT01169324|Dystonia|dystonia
1398969|NCT01169324|Sleep|sleep
1398970|NCT01169311|Hemorrhoids|hemorrhoids
1398971|NCT01169311|Hemorrhoid|hemorrhoid
1398972|NCT01169311|grade II, III, IV|grade ii, iii, iv
1398973|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
1398974|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1398975|NCT01169298|PTCL|ptcl
1398976|NCT01169298|HTLV-1|htlv-1
1398977|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
1398978|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
1398979|NCT01169259|vitamin D3|vitamin d3
1398980|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
1398981|NCT01169259|fish oil|fish oil
1398982|NCT01169259|cardiovascular disease|cardiovascular disease
1398983|NCT01169259|cancer|cancer
1398984|NCT01169259|primary prevention|primary prevention
1398986|NCT01169233|Sleep|sleep
1398987|NCT01169233|Alertness|alertness
1398988|NCT01169233|fatigue|fatigue
1398989|NCT01169233|performance|performance
1398990|NCT01169233|spaceflight|spaceflight
1398991|NCT01169233|isolation|isolation
1398992|NCT01169233|light|light
1398993|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
1398994|NCT01169220|Colonoscopy|colonoscopy
1398995|NCT01169220|Bowel preparation|bowel preparation
1398996|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
1398997|NCT01169207|Crohn's Disease|crohn's disease
1398998|NCT01169207|Ulcerative Colitis|ulcerative colitis
1398999|NCT01169207|Indeterminate Colitis|indeterminate colitis
1399000|NCT01169207|IBD|ibd
1399001|NCT01169207|CD|cd
1399002|NCT01169207|UC|uc
1399003|NCT01169207|IC|ic
1399004|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
1399005|NCT01169194|Crohn's Disease|crohn's disease
1399006|NCT01169194|Ulcerative Colitis|ulcerative colitis
1399007|NCT01169194|Indeterminate Colitis|indeterminate colitis
1399008|NCT01169194|IBD|ibd
1399009|NCT01169194|CD|cd
1399010|NCT01169194|UC|uc
1399011|NCT01169194|IC|ic
1399012|NCT01169194|African American IBD|african american ibd
1399013|NCT01169194|African American CD|african american cd
1399014|NCT01169194|African American UC|african american uc
1399015|NCT01169194|African American IC|african american ic
1399016|NCT01169194|Black IBD|black ibd
1399017|NCT01169194|Black CD|black cd
1399018|NCT01169194|Black UC|black uc
1399019|NCT01169194|Black IC|black ic
1399020|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
1399021|NCT01169194|African American Crohn's Disease|african american crohn's disease
1399022|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
1399023|NCT01169194|African American Indeterminate Colitis|african american indeterminate colitis
1399024|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
1399025|NCT01169194|Black Crohn's Disease|black crohn's disease
1399026|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
1399027|NCT01169194|Black Indeterminate Colitis|black indeterminate colitis
1399028|NCT01169181|Stroke|stroke
1399029|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
1399030|NCT01169181|Plegia|plegia
1399031|NCT01169181|Upper Extremity|upper extremity
1399032|NCT01169181|rTMS|rtms
1399033|NCT01169181|tDCS|tdcs
1399034|NCT01169168|fibrinogen|fibrinogen
1399035|NCT01169168|SIRS|sirs
1399036|NCT01169168|sepsis|sepsis
1399037|NCT01169168|liver disease|liver disease
1399038|NCT01169168|chronic liver disease|chronic liver disease
1399039|NCT01169168|septic shock|septic shock
1399040|NCT01169155|Smoke inhalation injury|smoke inhalation injury
1399041|NCT01169155|Burns|burns
1399042|NCT01169155|Injuries|injuries
1399044|NCT01169142|Schizophrenia|schizophrenia
1399045|NCT01169142|Severely Mentally Ill|severely mentally ill
1399046|NCT01169129|brain metastases|brain metastases
1399047|NCT01169129|radiosurgery|radiosurgery
1399048|NCT01169129|neurosurgery|neurosurgery
1399049|NCT01169129|surgery|surgery
1399050|NCT01169129|radiotherapy|radiotherapy
1399051|NCT01169129|resectable brain metastases|resectable brain metastases
1399052|NCT01169116|radiotherapy|radiotherapy
1399053|NCT01169116|radiation oncology|radiation oncology
1399054|NCT01169116|brain metastasis|brain metastasis
1399055|NCT01169116|metastases|metastases
1399056|NCT01169116|radiosurgery|radiosurgery
1399057|NCT01169116|neurosurgery|neurosurgery
1399058|NCT01169116|hypofractionation|hypofractionation
1399059|NCT01169116|stereotaxy|stereotaxy
1399060|NCT01169103|Obesity|obesity
1399061|NCT01169103|Adolescent|adolescent
1399348|NCT01167907|ankle|ankle
1399063|NCT01169103|Growth hormone|growth hormone
1399064|NCT01169103|Visceral fat|visceral fat
1399065|NCT01169103|Adolescent obesity|adolescent obesity
1399066|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
1399067|NCT01169064|Wound infection prevention|wound infection prevention
1399068|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
1399069|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
1399070|NCT01169051|Esophagectomy|esophagectomy
1399071|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
1399072|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
1399073|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
1399074|NCT01169051|Thoracic Surgery|thoracic surgery
1399075|NCT01169051|Lung Cancer|lung cancer
1399076|NCT01169051|Esophageal Cancer|esophageal cancer
1399077|NCT01169038|sarcoidosis|sarcoidosis
1399078|NCT01169038|mycobacteria|mycobacteria
1399079|NCT01169038|lung|lung
1399080|NCT01169038|pulmonary|pulmonary
1399081|NCT01169038|radiographic improvement|radiographic improvement
1399082|NCT01169025|Analgesia|analgesia
1399083|NCT01169025|Pain|pain
1399084|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
1399085|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
1399086|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1399087|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1399088|NCT01169012|Clofarabine|clofarabine
1399089|NCT01169012|Clolar|clolar
1399090|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
1399091|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
1399092|NCT01168999|low back pain|low back pain
1399093|NCT01168999|spinal manipulation|spinal manipulation
1399094|NCT01168999|manual therapy|manual therapy
1399095|NCT01168999|placebo|placebo
1399096|NCT01168986|neck pain|neck pain
1399097|NCT01168986|manual therapy|manual therapy
1399098|NCT01168986|exercise|exercise
1399099|NCT01168973|second line|second line
1399100|NCT01168973|non small cell lung cancer|non small cell lung cancer
1399101|NCT01168973|NSCLC|nsclc
1399102|NCT01168973|phase 3|phase 3
1399103|NCT01168973|ramucirumab|ramucirumab
1399104|NCT01168973|lung cancer|lung cancer
1399105|NCT01168973|docetaxel|docetaxel
1399106|NCT01168973|taxotere|taxotere
1399107|NCT01168947|sodium|sodium
1399108|NCT01168947|hypertension|hypertension
1399109|NCT01168947|fluid overload|fluid overload
1399110|NCT01168947|hemodialysis|hemodialysis
1399111|NCT01168947|dialysate|dialysate
1399112|NCT01168947|interdialytic weight gain|interdialytic weight gain
1399113|NCT01168947|intradialytic hypotension|intradialytic hypotension
1399114|NCT01168934|healthy volunteers|healthy volunteers
1399115|NCT01168934|crizotinib|crizotinib
1399116|NCT01168934|absolute bioavailability|absolute bioavailability
1399117|NCT01168934|pharmacokinetics|pharmacokinetics
1399118|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1399120|NCT01168921|Thrombocytopenia|thrombocytopenia
1399121|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
1399122|NCT01168921|SLL|sll
1399123|NCT01168921|Eltrombopag|eltrombopag
1399124|NCT01168921|Promacta|promacta
1525288|NCT00680316|CF|cf
1399125|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
1399126|NCT01168921|platelets|platelets
1399127|NCT01168908|Clinical trial|clinical trial
1399128|NCT01168908|Revatio|revatio
1399129|NCT01168908|Sildenafil|sildenafil
1399130|NCT01168908|Muscular Dystrophy|muscular dystrophy
1399131|NCT01168908|Duchenne|duchenne
1399132|NCT01168908|Becker|becker
1399133|NCT01168908|Adult|adult
1399134|NCT01168908|Adolescent|adolescent
1399135|NCT01168895|75 mg dose strength|75 mg dose strength
1399136|NCT01168895|Safety|safety
1399137|NCT01168895|Pharmacokinetics|pharmacokinetics
1399138|NCT01168882|RGB-286638|rgb-286638
1399139|NCT01168882|Hematological Malignancies|hematological malignancies
1399140|NCT01168869|Manifestation|manifestation
1399141|NCT01168869|Coronary Heart Disease|coronary heart disease
1399142|NCT01168869|Myocardial infarction|myocardial infarction
1399143|NCT01168869|Angina pectoris|angina pectoris
1399144|NCT01168869|Unheralded|unheralded
1399145|NCT01168869|General Practice Research Database|general practice research database
1399146|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
1399147|NCT01168869|CALIBER|caliber
1399148|NCT01168817|Combination Drug Therapy|combination drug therapy
1399149|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1399150|NCT01168804|multiple myeloma|multiple myeloma
1399151|NCT01168804|bendamustine|bendamustine
1399152|NCT01168804|bortezomib|bortezomib
1399153|NCT01168804|dexamethasone|dexamethasone
1399154|NCT01168791|Metastatic|metastatic
1399155|NCT01168791|Front line|front line
1399156|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
1399157|NCT01168752|Cancer|cancer
1399158|NCT01168752|solid tumour|solid tumour
1399159|NCT01168752|lymphoma|lymphoma
1399160|NCT01168752|dose-escalation|dose-escalation
1399161|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
1399162|NCT01168739|thermotolerance|thermotolerance
1399163|NCT01168739|heat acclimation|heat acclimation
1399164|NCT01168739|quercetin|quercetin
1399165|NCT01168739|exertional heat illness|exertional heat illness
1399166|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
1399167|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
1399168|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
1399169|NCT01168687|keppra|keppra
1399170|NCT01168687|levetiracetam|levetiracetam
1399171|NCT01168687|alcoholism|alcoholism
1399172|NCT01168687|genetics|genetics
1399173|NCT01168687|subjective report|subjective report
1399174|NCT01168674|Major Depressive Disorder|major depressive disorder
1399175|NCT01168674|MDD|mdd
1399176|NCT01168674|Bipolar Disorder|bipolar disorder
1399177|NCT01168674|BD|bd
1399178|NCT01168674|Depression|depression
1399179|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
1399180|NCT01168661|Stress|stress
1399181|NCT01168661|Burnout|burnout
1399182|NCT01168661|Anxiety|anxiety
1399183|NCT01168661|Depression|depression
1399184|NCT01168648|Yoga|yoga
1399185|NCT01168648|Stress|stress
1399186|NCT01168648|Stress management|stress management
1399187|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
1399188|NCT01168635|Asthma|asthma
1399189|NCT01168635|Spirometry|spirometry
1399190|NCT01168635|Pediatric|pediatric
1399191|NCT01168635|Primary Health Care|primary health care
1399192|NCT01168635|Education, Distance|education, distance
1399193|NCT01168609|Left atrial distensibility|left atrial distensibility
1399194|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
1399195|NCT01168609|tissue Doppler|tissue doppler
1399196|NCT01168609|prognosis|prognosis
1399197|NCT01168609|acute myocardial infarction|acute myocardial infarction
1399198|NCT01168596|Parkinson's Disease|parkinson's disease
1399199|NCT01168596|Fatigue|fatigue
1399200|NCT01168570|familial Mediterranean fever|familial mediterranean fever
1399201|NCT01168570|amyloidosis AA|amyloidosis aa
1399202|NCT01168570|serum amyloid A|serum amyloid a
1399203|NCT01168570|renal failure|renal failure
1399204|NCT01168570|nephrotic syndrome|nephrotic syndrome
1399205|NCT01168557|electric impedance tomography|electric impedance tomography
1399206|NCT01168557|stress-echocardiography|stress-echocardiography
1399207|NCT01168557|ventilation|ventilation
1399208|NCT01168557|perfusion|perfusion
1399209|NCT01168544|Vitamin D|vitamin d
1399210|NCT01168544|Colecalciferol|colecalciferol
1399211|NCT01168544|Nursing home|nursing home
1399212|NCT01168544|Loading dose|loading dose
1399213|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
1399214|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
1399215|NCT01168492|pediatric|pediatric
1399216|NCT01168492|gastroscopy|gastroscopy
1399217|NCT01168492|colonoscopy|colonoscopy
1399218|NCT01168492|sedation|sedation
1399219|NCT01168492|ketamine|ketamine
1399220|NCT01168479|prostate cancer|prostate cancer
1399221|NCT01168479|external beam radiotherapy|external beam radiotherapy
1399222|NCT01168479|dose escalation|dose escalation
1399223|NCT01168479|dose painting|dose painting
1399224|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
1399225|NCT01168479|MRI|mri
1399226|NCT01168479|FLAME|flame
1399227|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
1399228|NCT01168466|EEG Biofeedback|eeg biofeedback
1399229|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
1399230|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
1399231|NCT01168466|Peak Alpha Amplitude|peak alpha amplitude
1399232|NCT01168466|Quantitative EEG Assessment|quantitative eeg assessment
1399233|NCT01168453|jugular vein|jugular vein
1399234|NCT01168453|anatomy|anatomy
1399235|NCT01168453|ultrasonography|ultrasonography
1399236|NCT01168440|von Hippel-Lindau|von hippel-lindau
1399237|NCT01168440|VHL|vhl
1399238|NCT01168440|sunitinib|sunitinib
1399239|NCT01168401|Prevention of acute gastroenteritis due to infection with noroviruses|prevention of acute gastroenteritis due to infection with noroviruses
1399240|NCT01168388|Dystonia|dystonia
1400471|NCT01163019|Chest pain|chest pain
1399241|NCT01168388|Hemifacial spasm|hemifacial spasm
1399242|NCT01168388|Cervical dystonia|cervical dystonia
1399243|NCT01168388|Blepharospasm|blepharospasm
1399244|NCT01168362|coronary artery disease|coronary artery disease
1399245|NCT01168362|cardiovascular risk|cardiovascular risk
1399246|NCT01168362|pericardial fat|pericardial fat
1399247|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
1399248|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
1399249|NCT01168323|Medical Education|medical education
1399250|NCT01168323|Educational Technology|educational technology
1399251|NCT01168323|Clinical Practice Guideline|clinical practice guideline
1399252|NCT01168323|Prostate specific antigen|prostate specific antigen
1399253|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
1399254|NCT01168297|Obesity|obesity
1399349|NCT01167907|arthrodesis|arthrodesis
1399255|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1399256|NCT01168297|Genetics|genetics
1399257|NCT01168297|Energy Expenditure|energy expenditure
1399258|NCT01168297|Physical Activity|physical activity
1399259|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
1399260|NCT01168271|Observational|observational
1399261|NCT01168271|Newborns|newborns
1399262|NCT01168271|Hospitalized|hospitalized
1399263|NCT01168271|Febrile|febrile
1399264|NCT01168271|Resistance|resistance
1399265|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
1399266|NCT01168258|Diabetes|diabetes
1399267|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
1399268|NCT01168258|Diabetic Macular Edema|diabetic macular edema
1399269|NCT01168245|Alzheimer Disease|alzheimer disease
1399270|NCT01168245|Dementia|dementia
1399271|NCT01168245|Brain Diseases|brain diseases
1399272|NCT01168245|Central Nervous System Diseases|central nervous system diseases
1399273|NCT01168245|Nervous System Disease|nervous system disease
1399274|NCT01168245|Cognitive Training|cognitive training
1399275|NCT01168245|Cortical Reorganization|cortical reorganization
1399276|NCT01168245|Brain Plasticity|brain plasticity
1399277|NCT01168193|surgery|surgery
1399278|NCT01168193|post operative|post operative
1399279|NCT01168193|complications|complications
1399280|NCT01168193|length of stay|length of stay
1399281|NCT01168180|Traditional Thai Massage|traditional thai massage
1399282|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
1399283|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1399284|NCT01168167|MK 0518|mk 0518
1399285|NCT01168167|HIV-1 DNA species|hiv-1 dna species
1399286|NCT01168167|viral slope|viral slope
1399287|NCT01168167|Ribonucleic Acid|ribonucleic acid
1399288|NCT01168167|DNA, Complementary|dna, complementary
1399289|NCT01168154|Diverticula|diverticula
1399290|NCT01168154|Diverticular disease|diverticular disease
1399291|NCT01168154|Diverticulitis|diverticulitis
1399292|NCT01168154|Probiotics|probiotics
1399293|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
1399294|NCT01168128|Enteral Nutrition|enteral nutrition
1399295|NCT01168128|Parenteral Nutrition|parenteral nutrition
1399296|NCT01168128|Critically ill|critically ill
1399297|NCT01168128|Nutrition Therapy|nutrition therapy
1399298|NCT01168128|Nutrition Support|nutrition support
1399299|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
1399300|NCT01168128|Guideline Adherence|guideline adherence
1399301|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
1399302|NCT01168128|Nutrition Surveys|nutrition surveys
1399303|NCT01168128|Questionnaires|questionnaires
1399304|NCT01168063|Helicobacter pylori|helicobacter pylori
1399305|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
1399306|NCT01168063|Antibiotic resistance|antibiotic resistance
1399307|NCT01168063|Treatment protocols|treatment protocols
1399308|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
1399309|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
1399310|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
1399311|NCT01168050|or amplification.|or amplification.
1399312|NCT01168037|Aorta|aorta
1399313|NCT01168037|Aneurysm|aneurysm
1399314|NCT01168037|endovascular|endovascular
1399315|NCT01168037|stent-graft|stent-graft
1399316|NCT01168024|Acute Kidney Injury|acute kidney injury
1399317|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
1399318|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
1399319|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
1399320|NCT01167985|quaternary ammonium|quaternary ammonium
1399321|NCT01167985|dental|dental
1399322|NCT01167985|Endodotnic|endodotnic
1399323|NCT01167985|pulp|pulp
1399324|NCT01167985|bacteria|bacteria
1399325|NCT01167985|Root canal sealer|root canal sealer
1399326|NCT01167985|temporary filling|temporary filling
1399327|NCT01167985|provisional restoration|provisional restoration
1399328|NCT01167972|M + mutation|m + mutation
1399329|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
1399330|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
1399331|NCT01167959|Obesity|obesity
1399333|NCT01167959|Bariatric surgery|bariatric surgery
1399334|NCT01167946|Alopecia Areata|alopecia areata
1399335|NCT01167946|Alopecia totalis|alopecia totalis
1399336|NCT01167946|Alopecia Universalis|alopecia universalis
1399337|NCT01167946|Ophiasic alopecia|ophiasic alopecia
1399338|NCT01167946|Oral Pulse steroid|oral pulse steroid
1399339|NCT01167946|Methylprednisolone|methylprednisolone
1399340|NCT01167933|Bioequivalence|bioequivalence
1399341|NCT01167933|Crossover|crossover
1399342|NCT01167933|Simvastatin|simvastatin
1399343|NCT01167920|High Blood Pressure|high blood pressure
1399344|NCT01167920|Hypertension|hypertension
1399345|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
1399346|NCT01167920|Wireless communication of measurements|wireless communication of measurements
1399347|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
1399350|NCT01167907|internal fixation|internal fixation
1399351|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
1399352|NCT01167894|Bioequivalence|bioequivalence
1399353|NCT01167894|Crossover|crossover
1399354|NCT01167894|Simvastatin|simvastatin
1399355|NCT01167868|fostamatinib disodium|fostamatinib disodium
1399356|NCT01167868|FosD|fosd
1399357|NCT01167868|Japanese|japanese
1399358|NCT01167868|Healthy volunteers|healthy volunteers
1399359|NCT01167868|Phase 1|phase 1
1399360|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
1399361|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
1399362|NCT01167868|Healthy White volunteers|healthy white volunteers
1399363|NCT01167855|Pediatric Asthma|pediatric asthma
1399364|NCT01167855|Low-income|low-income
1399365|NCT01167855|Arkansas Delta Region|arkansas delta region
1399366|NCT01167829|Experimental|experimental
1399367|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
1399368|NCT01167829|taken 3x/day|taken 3x/day
1399369|NCT01167803|Bariatric surgery|bariatric surgery
1399370|NCT01167803|Anesthesia|anesthesia
1399371|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
1399372|NCT01167790|Fluorescence visualization|fluorescence visualization
1399373|NCT01167777|CT|ct
1399374|NCT01167777|GC|gc
1399375|NCT01167777|NG|ng
1399376|NCT01167777|chlamydia|chlamydia
1399377|NCT01167777|gonorrhoeae|gonorrhoeae
1399378|NCT01167764|hemoptysis|hemoptysis
1399379|NCT01167764|recurrence|recurrence
1399380|NCT01167751|Myocardial infarction|myocardial infarction
1399381|NCT01167751|Bone marrow stem cells|bone marrow stem cells
1399382|NCT01167751|AC133|ac133
1399383|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1399384|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
1399385|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
1399386|NCT01167725|stage III colon cancer|stage iii colon cancer
1399387|NCT01167725|stage IV colon cancer|stage iv colon cancer
1399388|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
1399389|NCT01167699|patient preference|patient preference
1399390|NCT01167699|WHO step I/II|who step i/ii
1399391|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
1399392|NCT01167686|Respiratory infection|respiratory infection
1399393|NCT01167686|Viral infection|viral infection
1399394|NCT01167686|Food supplement|food supplement
1399395|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
1399396|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
1399397|NCT01167673|selenium|selenium
1399398|NCT01167673|curcumin|curcumin
1399399|NCT01167673|green tea|green tea
1399400|NCT01167660|Coagulation tests|coagulation tests
1399401|NCT01167660|Neonates|neonates
1399402|NCT01167660|Non invasive|non invasive
1399403|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
1399404|NCT01167634|Weight Loss|weight loss
1399405|NCT01167634|Motivation|motivation
1399406|NCT01167634|Contracts|contracts
1399407|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
1399408|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
1399409|NCT01167621|HFO-ventilation|hfo-ventilation
1399410|NCT01167608|Parkinson's disease|parkinson's disease
1399411|NCT01167608|Depression|depression
1399412|NCT01167608|Anxiety|anxiety
1399413|NCT01167608|Treatment|treatment
1399414|NCT01167595|Critically ill|critically ill
1399415|NCT01167595|Nutrition therapy|nutrition therapy
1399416|NCT01167595|Enteral nutrition|enteral nutrition
1399417|NCT01167582|blood transfusion|blood transfusion
1399418|NCT01167582|red blood cell transfusion|red blood cell transfusion
1399419|NCT01167582|myocardial infarction|myocardial infarction
1399420|NCT01167582|acute coronary syndrome|acute coronary syndrome
1399421|NCT01167582|anemia|anemia
1399422|NCT01167569|Free Radicals|free radicals
1399423|NCT01167569|Ascorbic Acid|ascorbic acid
1399424|NCT01167569|Cardiac Surgery|cardiac surgery
1399425|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
1399426|NCT01167556|Family intervention|family intervention
1399427|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
1399428|NCT01167556|Motivational Interviewing|motivational interviewing
1399429|NCT01167556|Cannabis use|cannabis use
1399430|NCT01167530|Everolimus|everolimus
1399431|NCT01167530|Radiotherapy|radiotherapy
1399432|NCT01167530|Chemotherapy|chemotherapy
1399433|NCT01167517|Breast milk|breast milk
1399434|NCT01167517|Feeding|feeding
1399435|NCT01167517|Prematurity|prematurity
1399436|NCT01167517|Low birth weight infant|low birth weight infant
1399437|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
1399438|NCT01167504|saliva|saliva
1399439|NCT01167504|food|food
1399440|NCT01167504|sensory|sensory
1399441|NCT01167504|oral health|oral health
1399442|NCT01167504|film|film
1399443|NCT01167504|pellicle|pellicle
1399444|NCT01167491|Wegener|wegener
1399445|NCT01167491|CD4+ T cells|cd4+ t cells
1399446|NCT01167491|DAP12|dap12
1399447|NCT01167491|NKG2D|nkg2d
1399448|NCT01167478|Exercise|exercise
1399449|NCT01167478|Caffeine|caffeine
1399451|NCT01167465|Diaper Dermatitis|diaper dermatitis
1399452|NCT01167465|Diaper Rash|diaper rash
1399453|NCT01167465|Erythema|erythema
1399454|NCT01167452|Obesity|obesity
1399455|NCT01167452|Pharmacokinetics|pharmacokinetics
1399456|NCT01167452|MRSA|mrsa
1399457|NCT01167452|Tuberculosis|tuberculosis
1399458|NCT01167452|PCP|pcp
1399459|NCT01167439|OPMD, dysphagia|opmd, dysphagia
1399460|NCT01167439|Dysphagia severity|dysphagia severity
1399461|NCT01167439|Nutritional state|nutritional state
1399462|NCT01167439|Speech quality|speech quality
1399463|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
1399464|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1399465|NCT01167426|RRMS|rrms
1399466|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
1399467|NCT01167426|CIS|cis
1399468|NCT01167426|Copaxone|copaxone
1399469|NCT01167426|glatiramer acetate|glatiramer acetate
1399470|NCT01167426|Autoject 2|autoject 2
1399471|NCT01167400|exercise|exercise
1399472|NCT01167400|executive function|executive function
1399473|NCT01167400|older adults|older adults
1399474|NCT01167387|carbohydrate|carbohydrate
1399475|NCT01167387|glucose metabolism|glucose metabolism
1399476|NCT01167387|surgery, outcome|surgery, outcome
1399477|NCT01167387|major elective surgery|major elective surgery
1399478|NCT01167387|urology|urology
1399479|NCT01167387|hyperglicemia|hyperglicemia
1399480|NCT01167374|HCC|hcc
1399481|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
1399482|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
1399483|NCT01167348|auricular acupressure|auricular acupressure
1399484|NCT01167348|obesity|obesity
1399485|NCT01167348|schizophrenia|schizophrenia
1399486|NCT01167348|body weight|body weight
1399487|NCT01167335|partial onset seizure|partial onset seizure
1399488|NCT01167335|seizure frequency|seizure frequency
1399489|NCT01167335|nervous system diseases|nervous system diseases
1399490|NCT01167335|central nervous system diseases|central nervous system diseases
1399492|NCT01167335|brain diseases|brain diseases
1399493|NCT01167335|neurologic manifestations|neurologic manifestations
1399494|NCT01167335|adjunctive treatment|adjunctive treatment
1399495|NCT01167335|AEDs|aeds
1399496|NCT01167335|antiepileptic drug|antiepileptic drug
1399497|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
1399498|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
1399499|NCT01167296|Intrauterine adhesion|intrauterine adhesion
1399500|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
1399501|NCT01167283|COPD|copd
1399502|NCT01167270|Infant Diet|infant diet
1399503|NCT01167270|Toddler Diet|toddler diet
1399504|NCT01167270|Responsive Feeding|responsive feeding
1399505|NCT01167270|Infant Temperament|infant temperament
1399506|NCT01167270|Parent competency|parent competency
1399507|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
1399508|NCT01167270|Rapid infant weight gain|rapid infant weight gain
1399509|NCT01167257|Overactive bladder|overactive bladder
1399510|NCT01167257|Detrusor overactivity|detrusor overactivity
1399511|NCT01167257|Liposome|liposome
1399512|NCT01167257|Botulinum toxin A|botulinum toxin a
1399513|NCT01167231|Diabetes|diabetes
1399514|NCT01167231|Acarbose|acarbose
1399515|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
1399516|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
1399517|NCT01167179|head and neck cancer|head and neck cancer
1399518|NCT01167179|nurse-led care|nurse-led care
1399519|NCT01167179|follow-up care|follow-up care
1399520|NCT01167179|professional-patient relations|professional-patient relations
1399521|NCT01167179|psychosocial adjustment|psychosocial adjustment
1399522|NCT01167179|quasi-experimental|quasi-experimental
1399523|NCT01167179|prospective|prospective
1399524|NCT01167179|quality of life|quality of life
1399525|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
1399526|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1399527|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
1399528|NCT01167166|Myelofibrosis|myelofibrosis
1399529|NCT01167166|Essential thrombocythemia|essential thrombocythemia
1399530|NCT01167166|Polycythemia vera|polycythemia vera
1399531|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
1399532|NCT01167153|Hypertension|hypertension
1399533|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
1399534|NCT01167153|BP control|bp control
1399535|NCT01167153|ABPM|abpm
1399536|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
1399537|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
1399538|NCT01167127|pain relief|pain relief
1399539|NCT01167127|bowel function|bowel function
1399540|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
1399541|NCT01167114|STA-9090|sta-9090
1399542|NCT01167101|Rebamipide|rebamipide
1399543|NCT01167101|gastric ulcer|gastric ulcer
1399544|NCT01167101|healing rate|healing rate
1399641|NCT01166698|tolerability|tolerability
1399642|NCT01166698|healthy|healthy
1399545|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
1399546|NCT01167088|Double-blind|double-blind
1399547|NCT01167088|Placebo-controlled|placebo-controlled
1399548|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1399549|NCT01167088|NAFLD|nafld
1399550|NCT01167075|critically ill|critically ill
1399551|NCT01167075|sepsis|sepsis
1399552|NCT01167075|antioxidants|antioxidants
1399553|NCT01167075|enteral nutrition|enteral nutrition
1399554|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
1399555|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
1399556|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
1399557|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
1399558|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
1399559|NCT01167036|Chiropractic|chiropractic
1399560|NCT01167036|Massage|massage
1399561|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
1399562|NCT01167023|Sickle Cell Disease|sickle cell disease
1399563|NCT01167023|Sickle Cell Anemia|sickle cell anemia
1399564|NCT01167023|Adult|adult
1399565|NCT01166997|Pulmonary embolism|pulmonary embolism
1399566|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
1399567|NCT01166997|anticoagulation|anticoagulation
1399568|NCT01166997|thrombolysis|thrombolysis
1399569|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
1399570|NCT01166984|sepsis|sepsis
1399571|NCT01166984|septic shock|septic shock
1399572|NCT01166971|presbyopia|presbyopia
1399573|NCT01166971|intraocular lens|intraocular lens
1399574|NCT01166945|Child|child
1399575|NCT01166945|Child, preschool|child, preschool
1399576|NCT01166945|Sinusitis|sinusitis
1399577|NCT01166945|Antimicrobial agents|antimicrobial agents
1399578|NCT01166932|pneumonia|pneumonia
1399579|NCT01166932|children|children
1399580|NCT01166932|antibiotics|antibiotics
1399581|NCT01166906|pain blocking|pain blocking
1399582|NCT01166893|burn wound|burn wound
1399583|NCT01166880|assessment|assessment
1399584|NCT01166867|assessment|assessment
1399585|NCT01166854|muscle and bone disease|muscle and bone disease
1399586|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
1399587|NCT01166841|cardiac surgery|cardiac surgery
1399588|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
1399589|NCT01166841|mitral valve repair|mitral valve repair
1399590|NCT01166841|mitral valve replacement|mitral valve replacement
1399591|NCT01166828|Spinal cord injury|spinal cord injury
1399592|NCT01166828|telehealth|telehealth
1399593|NCT01166828|pressure ulcers|pressure ulcers
1399594|NCT01166828|quality of life|quality of life
1399595|NCT01166815|diarrhea morbidity|diarrhea morbidity
1399596|NCT01166815|malaria incidence|malaria incidence
1399597|NCT01166815|zinc supplementation|zinc supplementation
1399598|NCT01166802|questionnaire development|questionnaire development
1399599|NCT01166802|hypervigilance|hypervigilance
1399600|NCT01166802|pain sensitivity|pain sensitivity
1399601|NCT01166789|IBS|ibs
1399602|NCT01166789|pain threshold|pain threshold
1399603|NCT01166789|constipation|constipation
1399604|NCT01166776|Wharton's jelly|wharton's jelly
1399605|NCT01166776|umbilical cord|umbilical cord
1399606|NCT01166776|decellularization|decellularization
1399607|NCT01166763|breast atypia|breast atypia
1399608|NCT01166763|high risk for breast cancer|high risk for breast cancer
1399609|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
1399610|NCT01166763|RPFNA|rpfna
1399611|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
1399612|NCT01166763|ki-67|ki-67
1399613|NCT01166763|chemoprevention|chemoprevention
1399614|NCT01166763|vitamin D3|vitamin d3
1399615|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
1399616|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1399617|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
1399618|NCT01166763|Breast Neoplasms|breast neoplasms
1399619|NCT01166763|Pharmacologic Actions|pharmacologic actions
1399620|NCT01166763|Hyperplasia|hyperplasia
1399621|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
1399622|NCT01166763|Neoplasms|neoplasms
1399623|NCT01166763|Neoplasms by Site|neoplasms by site
1399624|NCT01166763|Pathologic Processes|pathologic processes
1399625|NCT01166763|Antirheumatic Agents|antirheumatic agents
1399626|NCT01166763|Breast Diseases|breast diseases
1399627|NCT01166737|Ovarian Cancer|ovarian cancer
1399628|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
1399629|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
1399630|NCT01166737|Recurrent disease|recurrent disease
1399631|NCT01166737|Platinum-sensitive|platinum-sensitive
1399632|NCT01166737|Surgery|surgery
1399633|NCT01166737|Chemotherapy|chemotherapy
1399634|NCT01166737|Quality of Life|quality of life
1399635|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
1399636|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
1399637|NCT01166737|or Ovarian Cancer|or ovarian cancer
1399638|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
1399639|NCT01166724|Kidney transplant|kidney transplant
1399644|NCT01166685|coronary artery disease|coronary artery disease
1399645|NCT01166685|drug-eluting stent|drug-eluting stent
1399646|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
1399647|NCT01166685|bare-metal stent|bare-metal stent
1399648|NCT01166685|long-term outcome|long-term outcome
1399649|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
1399650|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
1399651|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
1399652|NCT01166659|Glaucoma|glaucoma
1399653|NCT01166659|Glaucoma device|glaucoma device
1399654|NCT01166659|Glaucoma surgery|glaucoma surgery
1399655|NCT01166659|Intraocular pressure|intraocular pressure
1399656|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1399657|NCT01166633|hyperlipidemia|hyperlipidemia
1399658|NCT01166594|Glaucoma|glaucoma
1399659|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
1399660|NCT01166594|Optic Neuropathy|optic neuropathy
1399661|NCT01166594|Bleb Failure|bleb failure
1399662|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
1399663|NCT01166581|early stage breast cancer|early stage breast cancer
1399664|NCT01166581|preoperative breast MRI|preoperative breast mri
1399665|NCT01166581|mastectomy|mastectomy
1399666|NCT01166568|Presbyopia|presbyopia
1399667|NCT01166568|Reading Vision|reading vision
1399668|NCT01166568|Near Vision|near vision
1399669|NCT01166555|Safety and tolerability|safety and tolerability
1399670|NCT01166555|Pharmacokinetics|pharmacokinetics
1399671|NCT01166555|PF-04236921|pf-04236921
1399672|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
1399673|NCT01166542|carcinoma|carcinoma
1399674|NCT01166542|squamous cell|squamous cell
1399675|NCT01166542|head|head
1399676|NCT01166542|neck|neck
1399677|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
1399678|NCT01166542|chemotherapy|chemotherapy
1399679|NCT01166542|Carboplatin|carboplatin
1399680|NCT01166542|Paclitaxel|paclitaxel
1399681|NCT01166542|metastatic|metastatic
1399682|NCT01166542|recurrent|recurrent
1399683|NCT01166516|Prolonged air leak|prolonged air leak
1399684|NCT01166516|lobectomy|lobectomy
1399685|NCT01166516|segmentectomy|segmentectomy
1399686|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
1399687|NCT01166503|pediatrics|pediatrics
1399688|NCT01166503|Esotropia|esotropia
1399689|NCT01166503|Surgery|surgery
1399690|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
1399691|NCT01166490|Immunotherapy|immunotherapy
1399692|NCT01166490|AGS-5 Antigen|ags-5 antigen
1399693|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
1399694|NCT01166490|Gastric Neoplasms|gastric neoplasms
1399695|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
1399696|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
1399697|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
1399698|NCT01166490|Drug Therapy|drug therapy
1399699|NCT01166464|tobacco|tobacco
1399700|NCT01166464|smoking|smoking
1399701|NCT01166464|text message|text message
1399702|NCT01166464|therapy|therapy
1399703|NCT01166451|iron deficiency anemia|iron deficiency anemia
1399704|NCT01166451|cognitive development|cognitive development
1399705|NCT01166451|motor development|motor development
1399706|NCT01166438|incontinence|incontinence
1399707|NCT01166438|overactive bladder|overactive bladder
1399708|NCT01166438|botox|botox
1399709|NCT01166438|anticholinergic|anticholinergic
1399710|NCT01166399|Fecal Incontinence,|fecal incontinence,
1399711|NCT01166399|bowel incontinence,|bowel incontinence,
1399712|NCT01166399|pelvic floor disorder|pelvic floor disorder
1399713|NCT01166386|rehabilitation|rehabilitation
1399714|NCT01166386|brain injury|brain injury
1399715|NCT01166373|prolapse|prolapse
1399716|NCT01166373|urinary incontinence|urinary incontinence
1399717|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
1399718|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
1399719|NCT01166373|behavioral therapy|behavioral therapy
1399720|NCT01166373|pelvic muscle training|pelvic muscle training
1399721|NCT01166360|Risk prediction|risk prediction
1399722|NCT01166360|Euroscore|euroscore
1399723|NCT01166360|GDF-15|gdf-15
1399724|NCT01166360|hsTnT|hstnt
1399725|NCT01166360|cardiac surgery|cardiac surgery
1399726|NCT01166334|Smoking|smoking
1399727|NCT01166334|Smoke|smoke
1399728|NCT01166334|Cigarette|cigarette
1399729|NCT01166334|Cessation|cessation
1399730|NCT01166334|Quit|quit
1399731|NCT01166334|Online|online
1399733|NCT01166334|Stop|stop
1399734|NCT01166321|Atypical Meningioma|atypical meningioma
1399735|NCT01166308|Recurrent Glioma|recurrent glioma
1399736|NCT01166282|inflammatory back pain|inflammatory back pain
1399737|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
1399738|NCT01166282|sacroiliitis|sacroiliitis
1399739|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1399740|NCT01166282|enthesitis|enthesitis
1399741|NCT01166282|arthritis|arthritis
1399742|NCT01166269|grass-pollen allergy|grass-pollen allergy
1399743|NCT01166256|respiratory failure|respiratory failure
1399744|NCT01166243|Hemostasis|hemostasis
1399745|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
1399746|NCT01166204|Radiotherapy|radiotherapy
1399747|NCT01166204|NSCLC|nsclc
1399748|NCT01166191|Radiotherapy|radiotherapy
1399749|NCT01166191|SCLC|sclc
1399750|NCT01166178|Multiple Sclerosis|multiple sclerosis
1399751|NCT01166178|Osteoporosis|osteoporosis
1399752|NCT01166178|Zoledronic Acid|zoledronic acid
1399753|NCT01166165|Hypertension|hypertension
1399754|NCT01166165|blood pressure|blood pressure
1399755|NCT01166165|vitamin d|vitamin d
1399756|NCT01166165|winter|winter
1399757|NCT01166165|cholecalciferol|cholecalciferol
1399758|NCT01166165|arterial stiffness|arterial stiffness
1399759|NCT01166165|renin|renin
1399760|NCT01166165|angiotensin|angiotensin
1399761|NCT01166165|aldosterone|aldosterone
1399762|NCT01166165|calcium|calcium
1399763|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
1399764|NCT01166152|developmental disorders|developmental disorders
1399765|NCT01166139|Systemic Sclerosis|systemic sclerosis
1399766|NCT01166113|Pomalidomide|pomalidomide
1399767|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
1399768|NCT01166100|Bioequivalence|bioequivalence
1399769|NCT01166100|Crossover|crossover
1399770|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
1399771|NCT01166087|Bioequivalence|bioequivalence
1399772|NCT01166087|Crossover|crossover
1399773|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
1399774|NCT01166061|Grass Allergy|grass allergy
1399775|NCT01166061|Immunotherapy|immunotherapy
1399776|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
1399777|NCT01166061|ToleroMune Grass|toleromune grass
1399778|NCT01166048|Chronic Low Back Pain|chronic low back pain
1399779|NCT01166048|Radicular component|radicular component
1399780|NCT01166048|neuropathic pain|neuropathic pain
1399781|NCT01166048|duloxetine|duloxetine
1399782|NCT01166048|CLBP|clbp
1399783|NCT01166035|Solid tumors|solid tumors
1399784|NCT01166035|Lenalidomide|lenalidomide
1399785|NCT01166035|Cetuximab|cetuximab
1399786|NCT01166035|Colorectal Cancer|colorectal cancer
1399787|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
1399788|NCT01166035|Head and Neck Cancer|head and neck cancer
1399789|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
1399790|NCT01166022|Exercise|exercise
1399791|NCT01166022|Conditioning|conditioning
1399792|NCT01166022|Strengthening|strengthening
1399793|NCT01166009|Data Collection|data collection
1399794|NCT01166009|CIBMTR|cibmtr
1399795|NCT01166009|NMDP|nmdp
1399796|NCT01166009|Stem Cell Transplantation|stem cell transplantation
1399797|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1399798|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1399799|NCT01165970|enamel|enamel
1399800|NCT01165970|dentin|dentin
1399801|NCT01165970|saliva substitute|saliva substitute
1399802|NCT01165970|demineralization|demineralization
1399803|NCT01165970|remineralization|remineralization
1399804|NCT01165957|Knee replacement|knee replacement
1399805|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
1399806|NCT01165957|Volumetric wear|volumetric wear
1399807|NCT01165957|Micro-CT analysis|micro-ct analysis
1399808|NCT01165957|Articular and backside wear|articular and backside wear
1399809|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
1399810|NCT01165931|Coronary artery disease|coronary artery disease
1399811|NCT01165905|cancer|cancer
1399812|NCT01165905|solid malignancy|solid malignancy
1399813|NCT01165905|tumor|tumor
1399814|NCT01165905|malignant neoplasm|malignant neoplasm
1399815|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
1399816|NCT01165892|Pulmonary embolism|pulmonary embolism
1399817|NCT01165892|contrast agent|contrast agent
1399818|NCT01165879|Pregnancy|pregnancy
1399819|NCT01165879|Term|term
1399820|NCT01165879|Preterm|preterm
1399821|NCT01165879|Uterine Contractions|uterine contractions
1399822|NCT01165866|Ondansetron|ondansetron
1399823|NCT01165866|Metoclopramide|metoclopramide
1399824|NCT01165866|Gastroenteritis|gastroenteritis
1399825|NCT01165840|Obesity|obesity
1399826|NCT01165840|Pharmacokinetics|pharmacokinetics
1399827|NCT01165840|Dapsone|dapsone
1399828|NCT01165840|Leprosy|leprosy
1399829|NCT01165840|Tuberculosis|tuberculosis
1399830|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
1399831|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
1399832|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
1399833|NCT01165827|Aortic valve Replacement|aortic valve replacement
1399834|NCT01165827|Aortic valve Intervention|aortic valve intervention
1399835|NCT01165814|Pain control after cesarean section|pain control after cesarean section
1399836|NCT01165801|AMD|amd
1399837|NCT01165801|Cataract surgery|cataract surgery
1399838|NCT01165801|Size of AMD|size of amd
1399839|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
1399840|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
1399841|NCT01165736|pharmacokinetics|pharmacokinetics
1399842|NCT01165736|safety|safety
1399843|NCT01165736|tolerability|tolerability
1399844|NCT01165736|Chronic Pain|chronic pain
1399845|NCT01165723|safety|safety
1399846|NCT01165723|tolerability|tolerability
1399847|NCT01165723|pharmacokinetics|pharmacokinetics
1399848|NCT01165723|pharmacodynamics|pharmacodynamics
1399849|NCT01165723|chronic pain|chronic pain
1399850|NCT01165710|Irregular heart beat|irregular heart beat
1399851|NCT01165697|Fabry Disease|fabry disease
1399852|NCT01165697|vascular disease|vascular disease
1399853|NCT01165697|storage endotheliopathy|storage endotheliopathy
1399854|NCT01165671|Primary Glioblastoma|primary glioblastoma
1399855|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
1399856|NCT01165658|NSCLC|nsclc
1399857|NCT01165658|small cell lung cancer|small cell lung cancer
1399858|NCT01165658|SCLC|sclc
1399859|NCT01165658|carcinoid|carcinoid
1399860|NCT01165658|thymic cancer|thymic cancer
1399861|NCT01165658|lung cancer|lung cancer
1399862|NCT01165658|radiation therapy|radiation therapy
1399863|NCT01165658|radiotherapy|radiotherapy
1399864|NCT01165658|proton therapy|proton therapy
1399865|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1399866|NCT01165554|Amyloid|amyloid
1399867|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
1399868|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
1399869|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
1399870|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
1399871|NCT01165489|Laryngomalacia|laryngomalacia
1399872|NCT01165489|Congenital Anomalies|congenital anomalies
1399873|NCT01165489|Associated Health Problems|associated health problems
1399874|NCT01165476|treprostinil|treprostinil
1399875|NCT01165476|bioavailability|bioavailability
1399876|NCT01165476|bioequivalence|bioequivalence
1399877|NCT01165463|Aging|aging
1399878|NCT01165463|Healthy|healthy
1399879|NCT01165450|persistent epithelial defect|persistent epithelial defect
1399880|NCT01165450|cornea|cornea
1399881|NCT01165437|Peripheral|peripheral
1399882|NCT01165437|Arterial|arterial
1399883|NCT01165437|Vascular|vascular
1399884|NCT01165411|Central Catheterization|central catheterization
1399885|NCT01165411|Central Line|central line
1399886|NCT01165411|Database|database
1399887|NCT01165411|Registry|registry
1399888|NCT01165411|Registries|registries
1399889|NCT01165398|Education|education
1399890|NCT01165398|central lines|central lines
1399891|NCT01165398|infections|infections
1399892|NCT01165398|complications|complications
1399893|NCT01165398|Bundles|bundles
1399894|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
1399895|NCT01165385|Pazopanib|pazopanib
1399896|NCT01165385|Cisplatin|cisplatin
1399897|NCT01165372|Malaria|malaria
1399898|NCT01165372|Drug resistance|drug resistance
1399899|NCT01165346|liver cancer|liver cancer
1399900|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
1399901|NCT01165333|Paediatric oncology|paediatric oncology
1399902|NCT01165333|Cilengitide|cilengitide
1399903|NCT01165333|Glioma|glioma
1399904|NCT01165307|Menorrhagia|menorrhagia
1399905|NCT01165307|Endometrial ablation|endometrial ablation
1399906|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
1399907|NCT01165294|Ketamine|ketamine
1399908|NCT01165281|Pain|pain
1399909|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
1399910|NCT01165281|Opioid analgesic|opioid analgesic
1399911|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
1399912|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
1399913|NCT01165255|congenital malformation|congenital malformation
1399914|NCT01165255|cardiovascular malformation|cardiovascular malformation
1399915|NCT01165255|cardiovascular defect|cardiovascular defect
1399916|NCT01165255|antidepressants|antidepressants
1399917|NCT01165255|pregnancy|pregnancy
1399918|NCT01165255|first trimester|first trimester
1399919|NCT01165255|Bupropion|bupropion
1399920|NCT01165255|prevalence|prevalence
1399921|NCT01165242|Neisseria meningitidis|neisseria meningitidis
1399922|NCT01165242|Adult|adult
1399923|NCT01165242|Adolescent|adolescent
1399924|NCT01165242|Safety|safety
1399925|NCT01165242|Vaccines, conjugate|vaccines, conjugate
1399926|NCT01165242|Meningococcal vaccines|meningococcal vaccines
1399927|NCT01165242|Immunogenicity|immunogenicity
1399928|NCT01165229|Immunogenicity|immunogenicity
1399929|NCT01165229|Subjects 70 years and older|subjects 70 years and older
1399930|NCT01165229|Efficacy|efficacy
1399931|NCT01165229|Herpes Zoster|herpes zoster
1399932|NCT01165229|Safety|safety
1399933|NCT01165229|Adults|adults
1399934|NCT01165229|Vaccine|vaccine
1399935|NCT01165203|immunogenicity|immunogenicity
1399936|NCT01165203|vaccine|vaccine
1399937|NCT01165203|safety|safety
1399938|NCT01165203|HIV|hiv
1399939|NCT01165203|Herpes Zoster|herpes zoster
1399940|NCT01165177|subjects 50 years and older|subjects 50 years and older
1399941|NCT01165177|vaccine|vaccine
1399942|NCT01165177|immunogenicity|immunogenicity
1399943|NCT01165177|efficacy|efficacy
1399944|NCT01165177|Herpes Zoster|herpes zoster
1399945|NCT01165177|safety|safety
1399946|NCT01165164|Dry eye|dry eye
1399947|NCT01165164|artificial tears|artificial tears
1399948|NCT01165151|obesity|obesity
1399949|NCT01165151|weight loss|weight loss
1399950|NCT01165151|group size|group size
1399951|NCT01165138|GW642444|gw642444
1399952|NCT01165138|Vilanterol|vilanterol
1399953|NCT01165138|Asthma|asthma
1399954|NCT01165138|Fluticasone Furoate|fluticasone furoate
1399955|NCT01165125|pharmacodynamics|pharmacodynamics
1399956|NCT01165125|drug interaction|drug interaction
1399957|NCT01165125|ketoconazole|ketoconazole
1399958|NCT01165125|pharmacokinetics|pharmacokinetics
1399959|NCT01165125|Fluticasone furoate|fluticasone furoate
1399960|NCT01165125|GW642444|gw642444
1399961|NCT01165099|acupuncture|acupuncture
1399962|NCT01165099|induced labour|induced labour
1399963|NCT01165099|labour outcome|labour outcome
1399964|NCT01165099|nulliparae|nulliparae
1399965|NCT01165099|pain-relief|pain-relief
1399966|NCT01165099|epidural during labour|epidural during labour
1399967|NCT01165073|Cirrhosis|cirrhosis
1399968|NCT01165073|Malnutrition|malnutrition
1399969|NCT01165073|Enteral nutrition|enteral nutrition
1399970|NCT01165060|X-ALD|x-ald
1399971|NCT01165060|AMN|amn
1399972|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
1399973|NCT01164995|MK-1775|mk-1775
1399974|NCT01164995|Carboplatin|carboplatin
1399975|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
1399976|NCT01164995|p53|p53
1399977|NCT01164956|methylphenidate|methylphenidate
1399978|NCT01164956|fatigue|fatigue
1399979|NCT01164917|Lupus|lupus
1399980|NCT01164917|Discoid Lupus|discoid lupus
1399981|NCT01164917|Cutaneous Lupus|cutaneous lupus
1399982|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
1399983|NCT01164904|Amgen|amgen
1399984|NCT01164878|Cholestasis|cholestasis
1399985|NCT01164878|Liver damage|liver damage
1399986|NCT01164878|Parenteral Nutrition|parenteral nutrition
1399987|NCT01164878|Aggressive Nutrition|aggressive nutrition
1399988|NCT01164878|Preterm|preterm
1399989|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
1567153|NCT00509730|stress urinary incontinence|stress urinary incontinence
1399990|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
1399991|NCT01164865|Soft Contact lens|soft contact lens
1399992|NCT01164865|Multi-Purpose Solution|multi-purpose solution
1399993|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
1399994|NCT01164839|coronary artery|coronary artery
1399995|NCT01164839|CT angiography|ct angiography
1399996|NCT01164839|image quality|image quality
1399997|NCT01164839|multicenter trial|multicenter trial
1399998|NCT01164826|Bioequivalence|bioequivalence
1399999|NCT01164826|Crossover|crossover
1400000|NCT01164826|Nabumetone|nabumetone
1400001|NCT01164813|Bioequivalence|bioequivalence
1400002|NCT01164813|Crossover|crossover
1400003|NCT01164813|Nabumetone|nabumetone
1400004|NCT01164800|Bioequivalence|bioequivalence
1400005|NCT01164800|Crossover|crossover
1400006|NCT01164800|Trandolapril|trandolapril
1400007|NCT01164787|Bioequivalence|bioequivalence
1400008|NCT01164787|Crossover|crossover
1400009|NCT01164787|Trandolapril|trandolapril
1400010|NCT01164774|Bioavailability|bioavailability
1400011|NCT01164774|Crossover|crossover
1400012|NCT01164774|Ramipril|ramipril
1400013|NCT01164761|Bioavailability|bioavailability
1400014|NCT01164761|Crossover|crossover
1400015|NCT01164761|Ramipril|ramipril
1400016|NCT01164722|anal cancer|anal cancer
1400017|NCT01164722|HIV infection|hiv infection
1400018|NCT01164722|human papilloma virus infection|human papilloma virus infection
1400019|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
1400020|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1400021|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
1400022|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1400023|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1400024|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1401176|NCT01160094|Lapatinib|lapatinib
1400025|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1400026|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1400027|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1400028|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1400029|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1400030|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1400031|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1400032|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1400033|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1400034|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1400035|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1400036|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
1400123|NCT01164371|unheralded coronary death|unheralded coronary death
1400037|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1400038|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1400039|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1400040|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1400041|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1400042|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1400043|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1400044|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1400045|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1400046|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1400047|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1400048|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1400049|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1400050|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1400051|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1400052|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1400053|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1400054|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1400055|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1400056|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1400057|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
1400058|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
1400059|NCT01164683|sleep apnea|sleep apnea
1400060|NCT01164683|adherence|adherence
1400061|NCT01164657|upright position|upright position
1400062|NCT01164657|birth position|birth position
1400063|NCT01164657|childbirth|childbirth
1400064|NCT01164657|instrumental deliveries|instrumental deliveries
1400065|NCT01164657|primiparous|primiparous
1400066|NCT01164644|ecchymosis|ecchymosis
1526492|NCT00675675|Tics|tics
1400067|NCT01164644|bruising|bruising
1400068|NCT01164644|rhinoplasty|rhinoplasty
1400069|NCT01164644|nose job|nose job
1400070|NCT01164644|arnica|arnica
1400071|NCT01164644|arnica montana|arnica montana
1400072|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
1400073|NCT01164631|Orthodontics|orthodontics
1400074|NCT01164631|Tonsillectomy|tonsillectomy
1400075|NCT01164631|Child|child
1400076|NCT01164618|pediatrics|pediatrics
1400077|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
1400078|NCT01164605|NRTI-regimen|nrti-regimen
1400079|NCT01164605|Raltegravir|raltegravir
1400080|NCT01164605|Elvitegravir|elvitegravir
1400081|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
1400082|NCT01164605|Fat Waste|fat waste
1400083|NCT01164592|Heart failure (HF)|heart failure (hf)
1400084|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
1400085|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
1400086|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
1400087|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
1400088|NCT01164579|Joint Structure|joint structure
1400089|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
1400090|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
1400091|NCT01164579|Tasocitinib|tasocitinib
1400092|NCT01164579|Tofacitinib|tofacitinib
1400093|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
1400094|NCT01164540|Deep venous thrombosis|deep venous thrombosis
1400095|NCT01164540|Pulmonary embolism|pulmonary embolism
1400096|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
1400097|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
1400098|NCT01164449|algorithm|algorithm
1400099|NCT01164449|tight glycemic control|tight glycemic control
1400100|NCT01164449|glucose control|glucose control
1400101|NCT01164449|intensive care|intensive care
1400102|NCT01164449|insulin|insulin
1400103|NCT01164449|ICU|icu
1400104|NCT01164423|algorithm|algorithm
1400105|NCT01164423|tight glycemic control|tight glycemic control
1401630|NCT01157819|ear drops|ear drops
1400106|NCT01164423|glucose control|glucose control
1400107|NCT01164423|intensive care|intensive care
1400109|NCT01164423|ICU|icu
1400110|NCT01164397|Hypercholesterolemia|hypercholesterolemia
1400111|NCT01164397|Statins|statins
1400112|NCT01164371|coronary disease|coronary disease
1400113|NCT01164371|cardiovascular disease|cardiovascular disease
1400114|NCT01164371|cardiovascular risk|cardiovascular risk
1400115|NCT01164371|cardiovascular risk management|cardiovascular risk management
1400116|NCT01164371|primary care|primary care
1400117|NCT01164371|angina|angina
1400118|NCT01164371|stable angina|stable angina
1400119|NCT01164371|angina pectoris|angina pectoris
1400120|NCT01164371|acute coronary syndrome|acute coronary syndrome
1400121|NCT01164371|coronary death|coronary death
1400122|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
1400892|NCT01161186|gemcitabine|gemcitabine
1400124|NCT01164371|gender differences|gender differences
1400125|NCT01164371|sex differences|sex differences
1400126|NCT01164371|myocardial infarction|myocardial infarction
1400127|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
1400128|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
1400129|NCT01164371|STEMI|stemi
1400130|NCT01164371|nSTEMI|nstemi
1400131|NCT01164371|unstable angina|unstable angina
1400132|NCT01164358|Presbyopia|presbyopia
1400133|NCT01164358|INTRACOR|intracor
1400134|NCT01164358|patient satisfaction|patient satisfaction
1400135|NCT01164358|long term|long term
1400136|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1400137|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
1400138|NCT01164345|stem cell mobilization|stem cell mobilization
1400139|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
1400140|NCT01164319|Atrial fibrillation|atrial fibrillation
1400141|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
1400142|NCT01164319|ablation|ablation
1400143|NCT01164306|LifeSkills Training|lifeskills training
1400144|NCT01164306|Tobacco prevention|tobacco prevention
1400145|NCT01164306|Tobacco cessation|tobacco cessation
1400146|NCT01164306|Healthy lifestyles|healthy lifestyles
1400147|NCT01164306|Tobacco control|tobacco control
1400148|NCT01164293|Atopy patch test|atopy patch test
1400149|NCT01164254|Exposure Assessment|exposure assessment
1400150|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
1400151|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
1400152|NCT01164241|Eczema|eczema
1400153|NCT01164241|Allergy|allergy
1400154|NCT01164241|Immunodeficiency|immunodeficiency
1400155|NCT01164241|Netherton's Syndrome|netherton's syndrome
1400156|NCT01164241|Piebaldism|piebaldism
1400157|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
1400158|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
1400159|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1400160|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
1400161|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1400162|NCT01164215|neutropenia|neutropenia
1400163|NCT01164215|diarrhea|diarrhea
1400164|NCT01164215|stage I colon cancer|stage i colon cancer
1400165|NCT01164215|stage II colon cancer|stage ii colon cancer
1400166|NCT01164215|stage III colon cancer|stage iii colon cancer
1400167|NCT01164215|stage IV colon cancer|stage iv colon cancer
1400168|NCT01164215|recurrent colon cancer|recurrent colon cancer
1400169|NCT01164215|stage I rectal cancer|stage i rectal cancer
1400170|NCT01164215|stage II rectal cancer|stage ii rectal cancer
1400171|NCT01164215|stage III rectal cancer|stage iii rectal cancer
1400172|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
1400173|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
1400174|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1400175|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1400176|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
1400177|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1400178|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
1400179|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1400180|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1400181|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1400182|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
1400183|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1400184|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
1400185|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
1400186|NCT01164189|adult glioblastoma|adult glioblastoma
1400187|NCT01164189|adult gliosarcoma|adult gliosarcoma
1400188|NCT01164189|adult mixed glioma|adult mixed glioma
1400189|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
1400190|NCT01164176|insular thyroid cancer|insular thyroid cancer
1400191|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
1400192|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1400193|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1400194|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1400195|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1400196|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1400197|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1400198|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1400199|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1400200|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1400201|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1400202|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1400203|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1400204|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1400205|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1402097|NCT01155986|pain|pain
1400206|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1400207|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1400208|NCT01164163|polycythemia vera|polycythemia vera
1400209|NCT01164163|essential thrombocythemia|essential thrombocythemia
1400210|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1400211|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
1400212|NCT01164163|primary myelofibrosis|primary myelofibrosis
1400213|NCT01164150|gastrointestinal complications|gastrointestinal complications
1400214|NCT01164150|urinary complications|urinary complications
1400215|NCT01164150|radiation toxicity|radiation toxicity
1400216|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1400217|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
1400218|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
1400219|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
1400220|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
1400221|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
1400222|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
1400223|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
1400224|NCT01164137|Adverse Drug Events|adverse drug events
1400225|NCT01164137|Medication Reconciliation|medication reconciliation
1400226|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
1400227|NCT01164124|extremely low birth weight|extremely low birth weight
1400228|NCT01164124|probiotics|probiotics
1400229|NCT01164124|growth|growth
1400230|NCT01164124|nutrition|nutrition
1400231|NCT01164124|premature infants|premature infants
1400232|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
1400233|NCT01164111|osteoarthritis|osteoarthritis
1400234|NCT01164111|hip arthroplasty|hip arthroplasty
1400235|NCT01164111|resistance training|resistance training
1567154|NCT00509730|urodynamics|urodynamics
1400236|NCT01164111|preoperative training|preoperative training
1400237|NCT01164085|Inflammation|inflammation
1400238|NCT01164085|Macular Edema|macular edema
1400239|NCT01164072|electronic cigarette|electronic cigarette
1400240|NCT01164072|nicotine|nicotine
1400241|NCT01164072|smoking cessation|smoking cessation
1400242|NCT01164072|smoking reduction|smoking reduction
1400243|NCT01164059|Schizophrenia|schizophrenia
1400244|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
1400245|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
1400246|NCT01164059|olanzapine|olanzapine
1400247|NCT01164059|quetiapine|quetiapine
1400248|NCT01164059|aripiprazole|aripiprazole
1400249|NCT01164059|haloperidol|haloperidol
1400250|NCT01164059|flupentixol|flupentixol
1400251|NCT01164046|anticoagulants|anticoagulants
1400252|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
1400253|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
1400254|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
1400255|NCT01164020|cognition|cognition
1400256|NCT01164020|supplementation creatine|supplementation creatine
1400257|NCT01164020|resistance training|resistance training
1400258|NCT01164020|aging|aging
1400259|NCT01163994|erythema migrans|erythema migrans
1400260|NCT01163994|Lyme borreliosis|lyme borreliosis
1400261|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
1400262|NCT01163994|doxycycline treatment|doxycycline treatment
1400263|NCT01163994|outcome|outcome
1400264|NCT01163994|subjective symptoms|subjective symptoms
1400265|NCT01163981|duplex Ultrasound|duplex ultrasound
1400266|NCT01163981|Haemodialysis|haemodialysis
1400267|NCT01163981|Vascular Access|vascular access
1400268|NCT01163968|Weight reduction|weight reduction
1400269|NCT01163968|Cardiac revascularization|cardiac revascularization
1400270|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
1400271|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
1400272|NCT01163968|Rural|rural
1400273|NCT01163955|Posture analysis|posture analysis
1400274|NCT01163955|Video gaming|video gaming
1400275|NCT01163955|Forward Head Position|forward head position
1400276|NCT01163955|Rounded Shoulder Position|rounded shoulder position
1400277|NCT01163955|Spine Posture|spine posture
1400278|NCT01163929|breast cancer|breast cancer
1401631|NCT01157819|ear foam|ear foam
1400279|NCT01163929|HER2 positive|her2 positive
1400280|NCT01163929|Phase II|phase ii
1400281|NCT01163929|RAD001|rad001
1400282|NCT01163929|paclitaxel|paclitaxel
1400283|NCT01163929|trastuzumab|trastuzumab
1400284|NCT01163929|everolimus|everolimus
1400285|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
1400286|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
1400287|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
1400288|NCT01163903|Advanced solid tumours|advanced solid tumours
1400289|NCT01163903|Pantoprazole|pantoprazole
1400290|NCT01163903|Doxorubicin|doxorubicin
1400291|NCT01163903|PANTO IV|panto iv
1400292|NCT01163903|Adriamycin|adriamycin
1400293|NCT01163903|no standard treatment options|no standard treatment options
1400294|NCT01163903|dose-escalation schedule|dose-escalation schedule
1400295|NCT01163903|Phase I|phase i
1400296|NCT01163903|single-centre|single-centre
1400297|NCT01163903|open label|open label
1400298|NCT01163903|dose finding|dose finding
1400299|NCT01163903|recommended phase II dose|recommended phase ii dose
1400300|NCT01163903|proton pump inhibitor|proton pump inhibitor
1400301|NCT01163903|advanced cancer|advanced cancer
1400302|NCT01163903|anthracycline|anthracycline
1400303|NCT01163903|gastric acid secretion|gastric acid secretion
1400304|NCT01163890|Depression|depression
1400305|NCT01163890|Work Performance and Productivity|work performance and productivity
1400306|NCT01163890|Worksite Intervention|worksite intervention
1400307|NCT01163877|iron absorption|iron absorption
1400308|NCT01163877|iron utilization|iron utilization
1400309|NCT01163877|malaria|malaria
1400310|NCT01163877|helminth|helminth
1400311|NCT01163877|Ivory Coast|ivory coast
1400312|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
1400313|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
1400314|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
1400315|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
1400316|NCT01163864|smoking|smoking
1400317|NCT01163864|smoking relapse|smoking relapse
1400318|NCT01163864|smoking cessation|smoking cessation
1400319|NCT01163864|pregnancy|pregnancy
1400320|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
1400321|NCT01163851|Hypercholesterolemia|hypercholesterolemia
1400322|NCT01163851|Dyslipidemia|dyslipidemia
1400323|NCT01163851|LDL|ldl
1400324|NCT01163851|Cholesterol|cholesterol
1400325|NCT01163851|High Cholesterol|high cholesterol
1400326|NCT01163851|PF-04950615|pf-04950615
1400327|NCT01163851|RN316|rn316
1400328|NCT01163838|Hypercholesterolemia|hypercholesterolemia
1400329|NCT01163838|Dyslipidemia|dyslipidemia
1400330|NCT01163838|LDL|ldl
1400331|NCT01163838|Cholesterol|cholesterol
1400332|NCT01163838|High Cholesterol|high cholesterol
1526853|NCT00674479|AML|aml
1400333|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
1400334|NCT01163799|Kidney|kidney
1400335|NCT01163799|Transplant|transplant
1400336|NCT01163799|Northwestern|northwestern
1400337|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
1400338|NCT01163799|Corticosteroids|corticosteroids
1400339|NCT01163799|Steroid avoidance|steroid avoidance
1400340|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
1400341|NCT01163773|Cardiovascular disease|cardiovascular disease
1400342|NCT01163773|Milk|milk
1400343|NCT01163773|Metabolic syndrome|metabolic syndrome
1400344|NCT01163773|Blood lipids|blood lipids
1400345|NCT01163773|Menopausal women|menopausal women
1400346|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
1400347|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1400348|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
1400349|NCT01163721|T2DM|t2dm
1400350|NCT01163721|Ranolazine|ranolazine
1400351|NCT01163721|Ranexa|ranexa
1400352|NCT01163721|HbA1c|hba1c
1400353|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
1400354|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
1400355|NCT01163669|hyperparathyroidism|hyperparathyroidism
1400356|NCT01163656|Neonate|neonate
1400357|NCT01163656|Laryngoscopes|laryngoscopes
1400358|NCT01163630|open label, randomized|open label, randomized
1400359|NCT01163630|single-center|single-center
1400360|NCT01163630|2-way crossover|2-way crossover
1400361|NCT01163630|food interaction study|food interaction study
1400362|NCT01163617|Rheumatoid|rheumatoid
1400363|NCT01163617|Arthritis|arthritis
1400364|NCT01163604|Argatroban|argatroban
1400365|NCT01163604|intracranial artery stenting|intracranial artery stenting
1400366|NCT01163604|extracranial artery stenting|extracranial artery stenting
1400367|NCT01163604|occlusion|occlusion
1400368|NCT01163604|restenosis|restenosis
1400369|NCT01163591|Diabetes|diabetes
1400370|NCT01163591|Nephropathy|nephropathy
1400371|NCT01163591|Screening|screening
1400372|NCT01163578|Transplantation|transplantation
1400373|NCT01163578|Rejection|rejection
1400374|NCT01163565|Thyroidectomy|thyroidectomy
1400375|NCT01163552|pleural metastases|pleural metastases
1400376|NCT01163513|ethnicity|ethnicity
1400377|NCT01163513|prognosis|prognosis
1400378|NCT01163474|Telemedicine|telemedicine
1400379|NCT01163474|Surgery, Cardiac|surgery, cardiac
1400380|NCT01163448|Prostate|prostate
1400381|NCT01163448|Radiation|radiation
1400382|NCT01163448|Radical prostatectomy|radical prostatectomy
1400383|NCT01163448|09-013|09-013
1400384|NCT01163435|Helicobacter pylori|helicobacter pylori
1400385|NCT01163435|antibiotic resistance|antibiotic resistance
1400386|NCT01163435|high dose dual therapy|high dose dual therapy
1400387|NCT01163435|sequential therapy|sequential therapy
1400388|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
1400389|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
1400390|NCT01163422|Right ventricular failure|right ventricular failure
1400391|NCT01163422|Pacemaker|pacemaker
1400392|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
1400393|NCT01163422|Pulmonary hypertension|pulmonary hypertension
1400394|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
1400395|NCT01163409|acupuncture|acupuncture
1400396|NCT01163409|exercise training|exercise training
1400397|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
1400398|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
1400399|NCT01163383|Neuroblastoma|neuroblastoma
1400400|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
1400401|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
1400402|NCT01163383|paraganglioma|paraganglioma
1400403|NCT01163370|creatine supplementation|creatine supplementation
1400404|NCT01163370|resistance training|resistance training
1400405|NCT01163370|osteopenia|osteopenia
1400406|NCT01163370|osteoporosis|osteoporosis
1400407|NCT01163370|bone mineral density|bone mineral density
1400408|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
1400409|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
1400410|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
1400411|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
1400412|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
1400413|NCT01163279|Age-related changes|age-related changes
1400414|NCT01163266|Major Depressive Disorder|major depressive disorder
1400415|NCT01163266|Depression|depression
1400416|NCT01163266|Melancholia|melancholia
1400417|NCT01163266|Drug Therapy|drug therapy
1400418|NCT01163253|chronic|chronic
1400419|NCT01163253|severe|severe
1400420|NCT01163253|treatment|treatment
1400421|NCT01163253|safety|safety
1400422|NCT01163253|CP-690,55|cp-690,55
1400423|NCT01163253|Plaque Psoriasis|plaque psoriasis
1400424|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
1400425|NCT01163253|Xeljanz|xeljanz
1400426|NCT01163253|Tofacitinib|tofacitinib
1400427|NCT01163240|hepatitis B|hepatitis b
1400428|NCT01163240|HBV|hbv
1400429|NCT01163240|chronic hepatitis B|chronic hepatitis b
1400430|NCT01163240|pediatric|pediatric
1400431|NCT01163227|Hallucinations,|hallucinations,
1400432|NCT01163227|psychotic,|psychotic,
1400433|NCT01163227|delusions,|delusions,
1400434|NCT01163227|cognitive deficits|cognitive deficits
1400435|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
1400436|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
1400437|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
1400438|NCT01163175|Cardiovascular disease|cardiovascular disease
1400439|NCT01163175|Trans fatty acids|trans fatty acids
1400440|NCT01163175|Ruminant|ruminant
1400441|NCT01163175|Blood lipids|blood lipids
1400442|NCT01163162|Chronic Kidney Disease|chronic kidney disease
1400443|NCT01163162|Vitamin D|vitamin d
1400444|NCT01163149|Hypophosphatasia|hypophosphatasia
1400445|NCT01163149|HPP|hpp
1400446|NCT01163149|Bone Disease|bone disease
1400447|NCT01163149|Soft Bones|soft bones
1400448|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
1400449|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
1400450|NCT01163149|alkaline phosphatase|alkaline phosphatase
1400573|NCT01162499|Dumping|dumping
1400451|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
1400452|NCT01163149|rickets|rickets
1400453|NCT01163149|osteomalacia|osteomalacia
1400454|NCT01163136|Parental decision making|parental decision making
1400455|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
1400456|NCT01163136|palliative care decision making|palliative care decision making
1400457|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
1400458|NCT01163045|neurostimulation|neurostimulation
1400459|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
1400460|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
1400461|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
1400462|NCT01163045|RCT|rct
1400463|NCT01163032|Blindness|blindness
1400464|NCT01163032|Eye Diseases|eye diseases
1400465|NCT01163032|Nap Disorders|nap disorders
1400466|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
1400467|NCT01163032|Sleep disorders|sleep disorders
1400468|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
1400469|NCT01163032|Dyssomnias|dyssomnias
1400470|NCT01163032|Nervous System Diseases|nervous system diseases
1400472|NCT01163019|acute coronary syndrome|acute coronary syndrome
1400473|NCT01163019|Emergency department|emergency department
1400474|NCT01163019|speckle tracking imaging|speckle tracking imaging
1400475|NCT01163019|2D strain|2d strain
1400476|NCT01163019|Echocardiography|echocardiography
1400477|NCT01162993|Electric stimulation therapy|electric stimulation therapy
1400478|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
1400479|NCT01162980|ACE inhibitors|ace inhibitors
1400480|NCT01162980|ARBs|arbs
1400481|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
1400482|NCT01162941|ITP|itp
1400483|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
1400484|NCT01162915|Spinal Cord Injury|spinal cord injury
1400485|NCT01162889|pharmacokinetics|pharmacokinetics
1400486|NCT01162889|Crohn's disease|crohn's disease
1400487|NCT01162876|Diabetes, Type 2|diabetes, type 2
1400488|NCT01162863|IBSC|ibsc
1400489|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
1400490|NCT01162863|constipation|constipation
1400491|NCT01162850|Melasma|melasma
1400492|NCT01162837|Acne|acne
1400493|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
1400494|NCT01162824|Microvascular dysfunction|microvascular dysfunction
1400495|NCT01162824|Coronary artery spasm|coronary artery spasm
1400496|NCT01162824|Inflammation|inflammation
1400497|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
1400498|NCT01162824|Myocardial ischemia|myocardial ischemia
1400499|NCT01162824|Early atherosclerosis|early atherosclerosis
1400500|NCT01162811|Visualization|visualization
1400501|NCT01162811|relaxation|relaxation
1400502|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
1400503|NCT01162811|hypnosis|hypnosis
1400504|NCT01162811|invasive medical procedures|invasive medical procedures
1400505|NCT01162811|atrial fibrillation|atrial fibrillation
1400506|NCT01162811|ablation|ablation
1400507|NCT01162811|catheter ablation|catheter ablation
1400508|NCT01162811|pain|pain
1400509|NCT01162811|anxiety|anxiety
1400510|NCT01162798|infant formula|infant formula
1400511|NCT01162798|premature infants|premature infants
1400512|NCT01162798|Growth and Development|growth and development
1400513|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
1400514|NCT01162785|SCH 721015|sch 721015
1400515|NCT01162785|Syn3|syn3
1400516|NCT01162785|novel excipient|novel excipient
1400517|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
1400518|NCT01162785|Intravesical|intravesical
1400519|NCT01162785|urine IFNa|urine ifna
1400520|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1400521|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
1400522|NCT01162759|hypertension, intervention|hypertension, intervention
1400523|NCT01162733|Vancomycin|vancomycin
1400524|NCT01162733|Therapeutic Levels|therapeutic levels
1400525|NCT01162733|Infectious Disease|infectious disease
1400526|NCT01162733|Recommendations|recommendations
1400527|NCT01162720|Primary knee replacement|primary knee replacement
1400528|NCT01162720|Unilateral knee replacement|unilateral knee replacement
1400529|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
1400530|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
1400531|NCT01162694|Type 2 Diabetes|type 2 diabetes
1400532|NCT01162681|SLE|sle
1400533|NCT01162681|Lupus|lupus
1400534|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1400535|NCT01162681|Autoimmune Diseases|autoimmune diseases
1400536|NCT01162681|A-623|a-623
1400537|NCT01162681|Blisibimod|blisibimod
1400538|NCT01162668|bariatric surgery|bariatric surgery
1400539|NCT01162668|obesity|obesity
1400540|NCT01162668|outcomes|outcomes
1400541|NCT01162655|Insomnia|insomnia
1400542|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1400543|NCT01162655|Internet|internet
1400544|NCT01162655|Telehealth|telehealth
1400545|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
1400546|NCT01162629|bounded saddles|bounded saddles
1400547|NCT01162629|missing teeth|missing teeth
1400548|NCT01162629|dental implants|dental implants
1400549|NCT01162629|Tooth, Nonvital|tooth, nonvital
1400550|NCT01162616|iron absorption|iron absorption
1400551|NCT01162616|polyphenols|polyphenols
1400552|NCT01162616|sodium iron EDTA|sodium iron edta
1400553|NCT01162616|sorghum|sorghum
1400554|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
1400555|NCT01162577|Weight|weight
1400556|NCT01162577|Smoking|smoking
1400557|NCT01162577|Quitline|quitline
1400558|NCT01162551|Leukemia|leukemia
1400559|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1400560|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
1400561|NCT01162525|Fecal Incontinence|fecal incontinence
1400562|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
1400563|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
1400564|NCT01162512|physical activity|physical activity
1400565|NCT01162512|obesity|obesity
1400566|NCT01162512|adolescents|adolescents
1400567|NCT01162512|telephone|telephone
1400568|NCT01162512|BMI|bmi
1400569|NCT01162512|body mass index|body mass index
1400570|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
1400571|NCT01162499|hypoglycemia|hypoglycemia
1400572|NCT01162499|Nissen fundoplication|nissen fundoplication
1400574|NCT01162486|Anti-infective agents|anti-infective agents
1400575|NCT01162486|Anti-bacterial agents|anti-bacterial agents
1400576|NCT01162486|Rifampin|rifampin
1400577|NCT01162486|Rifapentine|rifapentine
1400578|NCT01162486|Midazolam|midazolam
1400579|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
1400580|NCT01162486|Antitubercular agents|antitubercular agents
1400581|NCT01162486|Pharmacologic actions|pharmacologic actions
1400582|NCT01162473|Food hypersensitivity|food hypersensitivity
1400583|NCT01162473|Milk hypersensitivity|milk hypersensitivity
1400584|NCT01162473|Milk allergy|milk allergy
1400585|NCT01162473|Food allergy|food allergy
1400586|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
1400587|NCT01162434|Treatment resistant depression|treatment resistant depression
1400588|NCT01162434|Deep brain stimulation|deep brain stimulation
1400589|NCT01162434|Brain volumetric analysis|brain volumetric analysis
1400590|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
1400591|NCT01162421|Anti-Inflammatory|anti-inflammatory
1400592|NCT01162421|Biological Therapy|biological therapy
1400593|NCT01162421|adalimumab|adalimumab
1400594|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
1400595|NCT01162421|Antirheumatic Agents|antirheumatic agents
1400596|NCT01162421|Agents|agents
1400597|NCT01162408|ICU|icu
1400598|NCT01162395|Prostate Cancer|prostate cancer
1400599|NCT01162395|Tumour|tumour
1400600|NCT01162395|Castration Resistant|castration resistant
1400601|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
1400602|NCT01162395|Metastatic|metastatic
1400603|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
1400604|NCT01162382|TMS|tms
1400605|NCT01162382|rTMS|rtms
1400606|NCT01162382|depression|depression
1400607|NCT01162382|fcMRI|fcmri
1400608|NCT01162382|EEG|eeg
1400609|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
1400610|NCT01162356|Vitrectomy|vitrectomy
1400611|NCT01162356|Glaucoma|glaucoma
1400612|NCT01162356|Macula|macula
1400613|NCT01162356|Optic nerve|optic nerve
1400614|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
1400615|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
1400616|NCT01162330|Screening|screening
1400617|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
1400619|NCT01162330|Hearing loss|hearing loss
1400620|NCT01162317|Acupuncture|acupuncture
1400621|NCT01162317|Sleep|sleep
1400622|NCT01162317|Traumatic brain injury|traumatic brain injury
1400623|NCT01162304|Chronic Pain|chronic pain
1400624|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
1400625|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
1400626|NCT01162304|management of chronic pain|management of chronic pain
1400627|NCT01162291|intramuscular|intramuscular
1400628|NCT01162291|distribution|distribution
1400629|NCT01162291|NaCl|nacl
1400630|NCT01162291|botulinum toxin|botulinum toxin
1400631|NCT01162291|muscle|muscle
1400632|NCT01162291|volume|volume
1400633|NCT01162291|movement|movement
1400634|NCT01162291|biceps brachii|biceps brachii
1400635|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
1400636|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
1400637|NCT01162291|effect of volume|effect of volume
1400638|NCT01162291|effect of muscle movement|effect of muscle movement
1400639|NCT01162278|liver metastases|liver metastases
1400640|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1400641|NCT01162265|Tuberculosis|tuberculosis
1400642|NCT01162265|IGRA|igra
1400643|NCT01162265|latent|latent
1400644|NCT01162252|psoriasis|psoriasis
1400645|NCT01162252|mindfulness|mindfulness
1400646|NCT01162252|MBSR|mbsr
1400647|NCT01162252|stress|stress
1400648|NCT01162252|living well|living well
1400649|NCT01162239|smoking|smoking
1400650|NCT01162239|tobacco|tobacco
1400651|NCT01162239|nicotine|nicotine
1400652|NCT01162239|smoking cessation|smoking cessation
1400653|NCT01162226|gait|gait
1400654|NCT01162226|movement disorders|movement disorders
1400655|NCT01162226|balance|balance
1400656|NCT01162226|function|function
1400657|NCT01162213|Postmenopausal Women|postmenopausal women
1400658|NCT01162213|Healthy Males|healthy males
1400659|NCT01162213|Cardiovascular|cardiovascular
1400660|NCT01162213|Flavanols|flavanols
1400661|NCT01162187|secondary prevention|secondary prevention
1400662|NCT01162187|aspirin|aspirin
1400663|NCT01162187|beta blocker|beta blocker
1400664|NCT01162187|ACE inhibitor|ace inhibitor
1400665|NCT01162187|statin|statin
1401632|NCT01157819|otic foam|otic foam
1400666|NCT01162187|acute coronary syndrome|acute coronary syndrome
1400667|NCT01162187|myocardial infarction|myocardial infarction
1400668|NCT01162187|unstable angina|unstable angina
1400669|NCT01162187|trends|trends
1400670|NCT01162174|Flavanols|flavanols
1400671|NCT01162174|cardiovascular|cardiovascular
1400672|NCT01162161|sphingolipid|sphingolipid
1400673|NCT01162161|ceramide|ceramide
1400674|NCT01162161|sphingomyelinase|sphingomyelinase
1400675|NCT01162148|inspiratory muscle training|inspiratory muscle training
1400676|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
1400677|NCT01162135|Digoxin|digoxin
1400678|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
1400679|NCT01162135|Prostate Specific Antigen|prostate specific antigen
1400680|NCT01162122|Elderly|elderly
1400681|NCT01162122|Influenza|influenza
1400682|NCT01162122|Immunogenicity|immunogenicity
1400683|NCT01162122|Safety|safety
1400684|NCT01162122|Adjuvant|adjuvant
1400685|NCT01162122|Adjuvanted|adjuvanted
1400686|NCT01162122|Adjuvants|adjuvants
1400687|NCT01162122|Vaccines|vaccines
1400688|NCT01162109|Zinc|zinc
1400689|NCT01162109|sepsis|sepsis
1400690|NCT01162109|critical illness|critical illness
1400691|NCT01162109|mechanical ventilation|mechanical ventilation
1400693|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
1400694|NCT01162083|Exercise Physiology|exercise physiology
1400695|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
1400696|NCT01162083|Heart Failure|heart failure
1400697|NCT01162070|Uveitis|uveitis
1400698|NCT01162070|etiological diagnosis|etiological diagnosis
1400699|NCT01162070|standardized strategy|standardized strategy
1400700|NCT01162057|Hemodialysis|hemodialysis
1400701|NCT01162057|Hearing|hearing
1400702|NCT01162057|Hemodialysis patients|hemodialysis patients
1400703|NCT01162044|PTSD|ptsd
1400704|NCT01162044|prevention|prevention
1400705|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
1400706|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1400707|NCT01161992|PSC|psc
1400708|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
1400709|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
1400710|NCT01161953|PBC|pbc
1400711|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
1400712|NCT01161940|Bioavailability|bioavailability
1400713|NCT01161940|Nizatidine|nizatidine
1400714|NCT01161940|Crossover|crossover
1400715|NCT01161927|Bioavailability|bioavailability
1400716|NCT01161927|Nizatidine|nizatidine
1400717|NCT01161927|Crossover|crossover
1400718|NCT01161914|Type I Gaucher|type i gaucher
1400719|NCT01161901|ARDS|ards
1400720|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
1400721|NCT01161901|Lung Morphology|lung morphology
1400722|NCT01161901|Mechanical ventilation|mechanical ventilation
1400723|NCT01161901|CT scan|ct scan
1400724|NCT01161862|Closed-loop|closed-loop
1400725|NCT01161862|Artificial pancreas|artificial pancreas
1400726|NCT01161862|Bi-hormonal|bi-hormonal
1400727|NCT01161862|Insulin|insulin
1400728|NCT01161862|Glucagon|glucagon
1400729|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
1400730|NCT01161849|lactate|lactate
1400731|NCT01161849|urgent surgery|urgent surgery
1400732|NCT01161849|major surgery|major surgery
1400733|NCT01161849|surgical complications|surgical complications
1400734|NCT01161849|possum|possum
1400735|NCT01161849|sapsII|sapsii
1400736|NCT01161849|relaparotomy|relaparotomy
1400737|NCT01161810|Burn|burn
1400738|NCT01161810|Rehabilitation|rehabilitation
1400739|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
1400740|NCT01161784|Functional constipation|functional constipation
1400741|NCT01161784|Probiotic|probiotic
1400742|NCT01161784|Probiotic microorganism|probiotic microorganism
1400743|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
1400744|NCT01161758|physical therapy|physical therapy
1400745|NCT01161758|pain threshold|pain threshold
1400746|NCT01161758|electromyography|electromyography
1400747|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
1400748|NCT01161758|neck muscles|neck muscles
1400749|NCT01161745|sepsis|sepsis
1400750|NCT01161732|aortic stenosis|aortic stenosis
1400751|NCT01161732|surgery, survival|surgery, survival
1400752|NCT01161719|ADHD|adhd
1400753|NCT01161719|Parent training|parent training
1400754|NCT01161719|Videoconference|videoconference
1400755|NCT01161706|vegetable juice|vegetable juice
1400756|NCT01161706|cardiovascular|cardiovascular
1400757|NCT01161706|blood pressure|blood pressure
1400758|NCT01161693|Cesarean section|cesarean section
1400759|NCT01161693|spinal anesthesia|spinal anesthesia
1400760|NCT01161693|CSE|cse
1400761|NCT01161693|ramped up position|ramped up position
1400762|NCT01161693|TROOP pillow|troop pillow
1400763|NCT01161693|elevation pillow|elevation pillow
1400764|NCT01161693|maternal comfort|maternal comfort
1400765|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
1400766|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
1400767|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
1400768|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
1400769|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
1400770|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
1400771|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
1400772|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
1400773|NCT01161589|sensing|sensing
1400774|NCT01161589|S-ICD|s-icd
1400775|NCT01161589|ICD|icd
1400776|NCT01161589|CRT D|crt d
1400777|NCT01161576|Batten Disease|batten disease
1400778|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
1400779|NCT01161576|gene transfer|gene transfer
1400780|NCT01161563|palliative treatment|palliative treatment
1400781|NCT01161563|prostate cancer|prostate cancer
1400782|NCT01161511|CLL|cll
1400783|NCT01161511|SLL|sll
1400784|NCT01161511|CD19|cd19
1400785|NCT01161498|squamous cell|squamous cell
1400786|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
1400787|NCT01161498|Oncovex|oncovex
1400788|NCT01161498|chemoradiation|chemoradiation
1400789|NCT01161498|Cisplatin|cisplatin
1400790|NCT01161485|HIV Infections|hiv infections
1400791|NCT01161485|Treatment|treatment
1400792|NCT01161485|Methamphetamine|methamphetamine
1400793|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
1400794|NCT01161459|Treatment|treatment
1400795|NCT01161459|FK506|fk506
1400796|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
1400797|NCT01161446|HIV|hiv
1400798|NCT01161446|Home testing|home testing
1400799|NCT01161446|Self-testing|self-testing
1400800|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
1400801|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
1400802|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
1400803|NCT01161446|Oral fluids|oral fluids
1400804|NCT01161446|Homosexuality, Male|homosexuality, male
1400805|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
1400806|NCT01161446|Sexual behavior|sexual behavior
1400807|NCT01161433|Asthma|asthma
1400808|NCT01161433|Spirometry|spirometry
1400809|NCT01161433|Pediatric|pediatric
1400810|NCT01161433|Primary Health Care|primary health care
1400811|NCT01161433|Education, Distance|education, distance
1400812|NCT01161420|tongue|tongue
1400813|NCT01161420|surgery|surgery
1400814|NCT01161420|neurostimulation|neurostimulation
1400815|NCT01161420|hypoglossal nerve|hypoglossal nerve
1400816|NCT01161420|upper airway stimulation|upper airway stimulation
1400817|NCT01161381|OSAHS|osahs
1400818|NCT01161381|nonlinear analysis|nonlinear analysis
1400819|NCT01161381|polysomnography|polysomnography
1400820|NCT01161381|biosignal analysis|biosignal analysis
1400821|NCT01161381|DFA|dfa
1400822|NCT01161381|APEN|apen
1400823|NCT01161381|LLE|lle
1400824|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
1400825|NCT01161355|Safety|safety
1400826|NCT01161355|tolerability|tolerability
1400827|NCT01161355|healthy|healthy
1400828|NCT01161355|microdose|microdose
1400829|NCT01161342|Malnutrition|malnutrition
1400830|NCT01161342|Aged|aged
1400831|NCT01161342|Aged 80 and over|aged 80 and over
1400832|NCT01161342|Prevalence|prevalence
1400833|NCT01161342|Mortality|mortality
1400834|NCT01161329|stroke|stroke
1400835|NCT01161329|physical activity|physical activity
1400836|NCT01161329|balance|balance
1400837|NCT01161329|muscle-strength|muscle-strength
1400838|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
1400839|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
1400840|NCT01161316|cetuximab|cetuximab
1400841|NCT01161316|mFOLFOX-6|mfolfox-6
1400842|NCT01161303|Asthma|asthma
1400843|NCT01161303|TNF alpha|tnf alpha
1400844|NCT01161303|epithelial cell culture|epithelial cell culture
1400845|NCT01161290|Telemedicine|telemedicine
1400846|NCT01161290|Internet|internet
1400847|NCT01161290|Dyspnea|dyspnea
1400848|NCT01161290|Self care|self care
1400849|NCT01161290|Breathing Exercises|breathing exercises
1400850|NCT01161290|Real-Time Systems|real-time systems
1400851|NCT01161277|Aripiprazole|aripiprazole
1400852|NCT01161277|Haloperidol|haloperidol
1400853|NCT01161277|Ventral striatum|ventral striatum
1400854|NCT01161277|Reward|reward
1400855|NCT01161277|fMRI|fmri
1400856|NCT01161264|Elderly|elderly
1400857|NCT01161264|Influenza|influenza
1400858|NCT01161264|Immunogenicity|immunogenicity
1400859|NCT01161264|Safety|safety
1400860|NCT01161264|Influenza vaccine|influenza vaccine
1400861|NCT01161251|Atrial Fibrillation|atrial fibrillation
1400862|NCT01161251|ABI|abi
1400863|NCT01161251|PAD|pad
1400864|NCT01161251|Registry|registry
1400865|NCT01161251|Italian|italian
1400866|NCT01161225|Adolescents|adolescents
1400867|NCT01161225|Peer leader program|peer leader program
1400868|NCT01161225|asthma camp|asthma camp
1400869|NCT01161225|asthma control|asthma control
1400870|NCT01161225|quality of life|quality of life
1400871|NCT01161225|self-efficacy|self-efficacy
1400872|NCT01161225|knowledge|knowledge
1400873|NCT01161225|attitudes|attitudes
1400874|NCT01161225|barrier perceptions|barrier perceptions
1400875|NCT01161212|body mass index|body mass index
1400876|NCT01161212|health-related quality of life|health-related quality of life
1400877|NCT01161212|physical education|physical education
1400878|NCT01161212|children|children
1400879|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
1400880|NCT01161212|prevention|prevention
1400881|NCT01161212|Child|child
1400882|NCT01161212|French|french
1400883|NCT01161212|Schoolchildren|schoolchildren
1400884|NCT01161199|HIV|hiv
1400885|NCT01161199|latent reservoir|latent reservoir
1400886|NCT01161199|functional cure|functional cure
1400887|NCT01161199|leukapheresis|leukapheresis
1400888|NCT01161186|pancreas|pancreas
1400889|NCT01161186|cancer|cancer
1400890|NCT01161186|abraxane|abraxane
1400891|NCT01161186|metastatic|metastatic
1400893|NCT01161186|capecitabine|capecitabine
1400894|NCT01161186|adenocarcinoma|adenocarcinoma
1400895|NCT01161160|H1N1|h1n1
1400896|NCT01161160|Influenza|influenza
1400897|NCT01161160|Pandemic|pandemic
1400898|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
1400899|NCT01161121|Fractional flow reserve|fractional flow reserve
1400900|NCT01161121|adenosine|adenosine
1400901|NCT01161121|regadenoson|regadenoson
1400902|NCT01161108|Pediatrics|pediatrics
1400903|NCT01161108|Epilepsy|epilepsy
1400904|NCT01161108|Insomnia|insomnia
1400905|NCT01161108|Melatonin|melatonin
1400906|NCT01161095|Intrauterine Device|intrauterine device
1400907|NCT01161095|Postpartum contraception|postpartum contraception
1400908|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
1400909|NCT01161069|phase 1|phase 1
1400910|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
1400911|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
1400912|NCT01161043|diabetes|diabetes
1400913|NCT01161043|glucose|glucose
1400914|NCT01161043|sensor|sensor
1400915|NCT01161017|migraine patients|migraine patients
1400916|NCT01160991|schizophrenia|schizophrenia
1400917|NCT01160991|olanzapine|olanzapine
1400918|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
1400919|NCT01160991|amisulpride|amisulpride
1400920|NCT01160991|diabetes|diabetes
1400921|NCT01160991|insulin resistance|insulin resistance
1400922|NCT01160991|insulin secretion|insulin secretion
1400923|NCT01160991|glucose|glucose
1400924|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
1400925|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
1400926|NCT01160978|Transplantation|transplantation
1400927|NCT01160978|Simvastatin treatment|simvastatin treatment
1400928|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
1400929|NCT01160978|Rejection|rejection
1400930|NCT01160965|epidural top-up|epidural top-up
1400931|NCT01160965|emergency Caesarean section|emergency caesarean section
1400932|NCT01160952|primary prophylaxis|primary prophylaxis
1400933|NCT01160952|itraconazole|itraconazole
1400934|NCT01160952|stem cell transplantation|stem cell transplantation
1400935|NCT01160939|Exercise|exercise
1400936|NCT01160939|heart failure|heart failure
1400937|NCT01160939|rehabilitation|rehabilitation
1400938|NCT01160926|rectal cancer|rectal cancer
1400939|NCT01160926|capecitabine|capecitabine
1400940|NCT01160926|radiotherapy|radiotherapy
1400941|NCT01160926|AZD6244|azd6244
1400942|NCT01160926|MEK inhibitor|mek inhibitor
1400943|NCT01160926|AZD2171|azd2171
1400944|NCT01160926|Cediranib|cediranib
1400945|NCT01160926|VEGFR inhibitor|vegfr inhibitor
1400946|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
1400947|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
1400948|NCT01160900|cardiovascular diseases|cardiovascular diseases
1400949|NCT01160900|heart disease|heart disease
1400950|NCT01160900|hemorrhage|hemorrhage
1400951|NCT01160900|coronary angioplasty|coronary angioplasty
1400952|NCT01160900|drug eluting stents|drug eluting stents
1400953|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
1400954|NCT01160874|Cognition|cognition
1400955|NCT01160874|Sleepiness|sleepiness
1400956|NCT01160874|Driving|driving
1400957|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
1400958|NCT01160835|total knee arthroplasty|total knee arthroplasty
1400959|NCT01160835|minimally invasive|minimally invasive
1400960|NCT01160835|quadriceps-sparing|quadriceps-sparing
1400961|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
1400962|NCT01160822|Osteo arthritis|osteo arthritis
1400963|NCT01160822|pain control|pain control
1400964|NCT01160822|intra- articular injections|intra- articular injections
1400965|NCT01160822|Knee OA|knee oa
1400966|NCT01160809|Malaria|malaria
1400967|NCT01160809|Mosquito repellent|mosquito repellent
1400968|NCT01160809|LLINs|llins
1400969|NCT01160783|Autism|autism
1400970|NCT01160783|Asperger's Syndrome|asperger's syndrome
1400971|NCT01160783|Asperger Syndrome|asperger syndrome
1400972|NCT01160783|Autistic Disorder|autistic disorder
1401833|NCT01156922|Rituximab|rituximab
1400973|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
1400974|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
1400975|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
1400976|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
1400977|NCT01160783|PDD-NOS|pdd-nos
1400978|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
1400979|NCT01160770|Epilepsy|epilepsy
1400980|NCT01160770|Drop Seizures|drop seizures
1400981|NCT01160770|Clobazam|clobazam
1400982|NCT01160744|Lung neoplasms|lung neoplasms
1400983|NCT01160744|Lung cancer|lung cancer
1400984|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
1400985|NCT01160744|pemetrexed|pemetrexed
1400986|NCT01160744|ALIMTA®|alimta®
1400987|NCT01160744|squamous|squamous
1400988|NCT01160744|nonsquamous|nonsquamous
1400989|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1400990|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1400991|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
1400992|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
1400993|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1400994|NCT01160718|recurrent breast cancer|recurrent breast cancer
1400995|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
1400996|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
1400997|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
1400998|NCT01160718|stage IV breast cancer|stage iv breast cancer
1400999|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1401000|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
1401001|NCT01160705|stage III prostate cancer|stage iii prostate cancer
1401002|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
1401003|NCT01160705|bone metastases|bone metastases
1401004|NCT01160705|liver metastases|liver metastases
1401005|NCT01160705|lung metastases|lung metastases
1401006|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1401007|NCT01160692|Memory|memory
1401008|NCT01160692|Cognitive Function|cognitive function
1401009|NCT01160692|Elderly|elderly
1401010|NCT01160692|Gingko|gingko
1401011|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
1401012|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
1401013|NCT01160666|Belimumab|belimumab
1401014|NCT01160666|Sjögren's syndrome|sjögren's syndrome
1401015|NCT01160666|Sjögren disease|sjögren disease
1401016|NCT01160653|stroke|stroke
1401017|NCT01160653|Gait training|gait training
1401018|NCT01160653|Cognitive Training|cognitive training
1401020|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
1401021|NCT01160627|CIN STEMI|cin stemi
1401022|NCT01160614|Pediatric|pediatric
1401023|NCT01160614|Post-operative|post-operative
1401024|NCT01160614|Nonsurgical|nonsurgical
1401025|NCT01160614|patients|patients
1401026|NCT01160614|Opioid|opioid
1401027|NCT01160601|NSCLC|nsclc
1401028|NCT01160601|lung cancer|lung cancer
1401029|NCT01160601|non small cell lung cancer|non small cell lung cancer
1401030|NCT01160601|bavituximab|bavituximab
1401031|NCT01160601|monoclonal antibody|monoclonal antibody
1401032|NCT01160588|Anxiety|anxiety
1401033|NCT01160588|Social Phobia|social phobia
1401034|NCT01160588|Social Anxiety|social anxiety
1401035|NCT01160588|Generalized Anxiety|generalized anxiety
1401036|NCT01160588|Separation Anxiety|separation anxiety
1401037|NCT01160575|Counseling|counseling
1401038|NCT01160575|Epidemiology|epidemiology
1401039|NCT01160575|HIV|hiv
1401040|NCT01160575|AIDS|aids
1401041|NCT01160575|Prevention|prevention
1401042|NCT01160562|Prevalence|prevalence
1401043|NCT01160562|Incidence|incidence
1401044|NCT01160562|Children|children
1401045|NCT01160562|Adults|adults
1401046|NCT01160562|Global Positioning system|global positioning system
1401047|NCT01160549|Pregnancy|pregnancy
1401048|NCT01160549|Hormones|hormones
1401049|NCT01160549|Mongolia|mongolia
1401050|NCT01160549|Asian|asian
1401051|NCT01160549|Breast Cancer|breast cancer
1401052|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
1401053|NCT01160536|Genetic Testing|genetic testing
1401054|NCT01160523|Podoconiosis|podoconiosis
1401055|NCT01160523|Genetic Education|genetic education
1401056|NCT01160523|Primary Prevention|primary prevention
1401057|NCT01160523|Ethiopa|ethiopa
1401058|NCT01160523|Youth|youth
1401059|NCT01160510|Breast|breast
1401060|NCT01160510|Mammographic Density|mammographic density
1401061|NCT01160484|multiple myeloma|multiple myeloma
1401062|NCT01160484|refractory|refractory
1401063|NCT01160484|relapsed|relapsed
1401064|NCT01160484|bortezomib|bortezomib
1401065|NCT01160484|doxil|doxil
1401066|NCT01160471|Heart Failure|heart failure
1401067|NCT01160471|Computed Tomography|computed tomography
1401068|NCT01160471|Ultrasound|ultrasound
1401069|NCT01160471|Fibrosis|fibrosis
1401070|NCT01160471|Biomarker|biomarker
1401071|NCT01160458|Monoclonal Antibody|monoclonal antibody
1401072|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
1401073|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
1401074|NCT01160445|Metastatic Melanoma|metastatic melanoma
1401075|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
1401076|NCT01160445|Clinical Performance|clinical performance
1401077|NCT01160445|Tumor Regression|tumor regression
1401078|NCT01160445|Toxicity|toxicity
1401079|NCT01160432|opiate dependence|opiate dependence
1401080|NCT01160432|methadone|methadone
1401081|NCT01160432|naloxone|naloxone
1401082|NCT01160432|withdrawal symptom|withdrawal symptom
1401083|NCT01160432|substitution treatment|substitution treatment
1401084|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
1401085|NCT01160406|stroke|stroke
1401086|NCT01160406|tele ECG|tele ecg
1401087|NCT01160393|Atrial fibrillation|atrial fibrillation
1401088|NCT01160393|Cardiac surgery|cardiac surgery
1401089|NCT01160393|Prevention|prevention
1401090|NCT01160393|Conventional bypass system|conventional bypass system
1401091|NCT01160393|Miniaturized bypass system|miniaturized bypass system
1401092|NCT01160393|Arrhythmia|arrhythmia
1401093|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
1401094|NCT01160380|cancer related fatigue|cancer related fatigue
1401095|NCT01160380|fatigue|fatigue
1401096|NCT01160380|multiple myeloma|multiple myeloma
1401097|NCT01160380|cancer|cancer
1401098|NCT01160380|quality of life|quality of life
1401099|NCT01160354|Leukemia|leukemia
1401100|NCT01160354|AML|aml
1401101|NCT01160354|Clofarabine|clofarabine
1401102|NCT01160354|Plerixafor|plerixafor
1401103|NCT01160354|elderly patients|elderly patients
1401104|NCT01160354|previously untreated|previously untreated
1401105|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
1401106|NCT01160341|Metabolic syndrome|metabolic syndrome
1401107|NCT01160341|Hypogonadism|hypogonadism
1401108|NCT01160341|Testosterone|testosterone
1401109|NCT01160328|Regional Fat Storage|regional fat storage
1401110|NCT01160328|Fat Oxidation|fat oxidation
1401111|NCT01160328|Testosterone|testosterone
1401112|NCT01160328|Male|male
1567155|NCT00509730|randomized clinical trial|randomized clinical trial
1401113|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
1401114|NCT01160302|cancer|cancer
1401115|NCT01160276|renal graft|renal graft
1401116|NCT01160276|colchicine|colchicine
1401117|NCT01160276|drug interaction|drug interaction
1401118|NCT01160276|cyclosporine|cyclosporine
1401119|NCT01160276|tacrolimus|tacrolimus
1401120|NCT01160276|renal transplantation|renal transplantation
1401121|NCT01160276|renal transplant|renal transplant
1401122|NCT01160276|ABCB1|abcb1
1401123|NCT01160276|CYP3A5|cyp3a5
1401124|NCT01160276|SLCO1B1|slco1b1
1401125|NCT01160263|ALS|als
1401126|NCT01160263|serotonin|serotonin
1401127|NCT01160263|dopamine|dopamine
1401128|NCT01160237|H1N1|h1n1
1401129|NCT01160237|Pandemrix|pandemrix
1401130|NCT01160237|Fluarix|fluarix
1401131|NCT01160237|Influenza|influenza
1401132|NCT01160224|Asthma|asthma
1401133|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
1401134|NCT01160224|GW766944|gw766944
1401135|NCT01160211|1st line MBC|1st line mbc
1401136|NCT01160211|MBC|mbc
1401137|NCT01160211|hormone receptor positive|hormone receptor positive
1401138|NCT01160211|lapatinib|lapatinib
1401139|NCT01160211|trastuzumab|trastuzumab
1401140|NCT01160211|HER2 positive|her2 positive
1401141|NCT01160211|aromatase inhibitor|aromatase inhibitor
1401142|NCT01160172|vaccine|vaccine
1401143|NCT01160172|young adults|young adults
1401144|NCT01160172|Staphylococcus aureus|staphylococcus aureus
1401145|NCT01160159|Venous thrombosis|venous thrombosis
1401146|NCT01160159|Women|women
1401147|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
1401148|NCT01160159|IMT|imt
1401149|NCT01160159|Arterial stiffness|arterial stiffness
1401150|NCT01160159|Arterial compliance|arterial compliance
1401151|NCT01160159|Capillary density|capillary density
1401152|NCT01160146|Obestiy|obestiy
1401153|NCT01160146|Over weight|over weight
1401154|NCT01160146|referral patterns|referral patterns
1401155|NCT01160146|Continuing Medical Education|continuing medical education
1401156|NCT01160133|Systane|systane
1401157|NCT01160133|Refresh Tears|refresh tears
1401158|NCT01160133|Dry Eye|dry eye
1401159|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
1401160|NCT01160120|fixed dose combinations|fixed dose combinations
1401161|NCT01160120|tenofovir|tenofovir
1401162|NCT01160120|lamivudine|lamivudine
1401163|NCT01160120|efavirenz|efavirenz
1401164|NCT01160120|therapeutic drug levels|therapeutic drug levels
1401165|NCT01160120|safety and efficacy|safety and efficacy
1401166|NCT01160120|HIV|hiv
1401167|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
1401168|NCT01160107|Diagnosis|diagnosis
1401169|NCT01160107|Elderly Patients|elderly patients
1401170|NCT01160107|Imids|imids
1401171|NCT01160107|Chemotherapy|chemotherapy
1401172|NCT01160094|Trastuzumab|trastuzumab
1401173|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
1401174|NCT01160094|Breast Cancer|breast cancer
1401175|NCT01160094|Observational Study|observational study
1401177|NCT01160003|ACTH stimulation test|acth stimulation test
1401178|NCT01160003|Pharmacokinetics|pharmacokinetics
1401179|NCT01160003|Nebules|nebules
1401180|NCT01160003|Cortisol|cortisol
1401181|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
1401182|NCT01159990|HIV Seronegativity|hiv seronegativity
1401183|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
1401184|NCT01159964|PRAME|prame
1401185|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
1401186|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
1401187|NCT01159912|fluticasone propionate|fluticasone propionate
1401188|NCT01159912|Fluticasone furoate|fluticasone furoate
1401189|NCT01159899|Osteoarthritis|osteoarthritis
1401190|NCT01159899|knee arthritis|knee arthritis
1401191|NCT01159899|Knee arthrosis|knee arthrosis
1401192|NCT01159899|articular cartilage defects|articular cartilage defects
1401193|NCT01159899|osteochondral defects|osteochondral defects
1401194|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
1401195|NCT01159899|stem cells|stem cells
1401196|NCT01159899|cellules souches,|cellules souches,
1401197|NCT01159899|genou|genou
1401198|NCT01159899|arthrose genou|arthrose genou
1401199|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
1401200|NCT01159899|thérapie cellulaire|thérapie cellulaire
1401201|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
1401202|NCT01159899|régénération cartilage|régénération cartilage
1401203|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
1401204|NCT01159899|ligament|ligament
1401205|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
1401206|NCT01159899|platelet rich plasma|platelet rich plasma
1401207|NCT01159899|stem cell|stem cell
1401208|NCT01159899|regrowt cartilage|regrowt cartilage
1401209|NCT01159899|cellules souches|cellules souches
1401210|NCT01159899|PRP|prp
1401211|NCT01159886|Tuberculosis|tuberculosis
1401212|NCT01159886|IBD|ibd
1401213|NCT01159886|endoscopy|endoscopy
1401214|NCT01159860|seborrheic keratoses|seborrheic keratoses
1401215|NCT01159860|cryosurgery|cryosurgery
1401216|NCT01159860|curettage|curettage
1401217|NCT01159847|sitagliptin|sitagliptin
1401218|NCT01159847|LADA|lada
1401219|NCT01159847|C-Peptide|c-peptide
1401220|NCT01159847|Flow Cytometry|flow cytometry
1401221|NCT01159847|ELISPOT|elispot
1401222|NCT01159834|HPV infection|hpv infection
1401223|NCT01159834|Cervical cancer|cervical cancer
1401224|NCT01159834|HPV vaccine|hpv vaccine
1401225|NCT01159821|31001074|31001074
1401226|NCT01159821|Paroxetine|paroxetine
1401227|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
1401228|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
1401229|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
1401230|NCT01159795|Infant|infant
1401231|NCT01159795|Interferon|interferon
1401232|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
1401233|NCT01159756|Travacom|travacom
1401234|NCT01159756|Glaucoma|glaucoma
1401235|NCT01159756|Travoprost|travoprost
1401236|NCT01159756|Timolol|timolol
1401237|NCT01159743|lipodystrophy|lipodystrophy
1401238|NCT01159743|Lipoatrophy|lipoatrophy
1401239|NCT01159743|antiretroviral treatment|antiretroviral treatment
1401240|NCT01159704|HIV infection|hiv infection
1401241|NCT01159704|Intervention|intervention
1401242|NCT01159704|Risk-reduction|risk-reduction
1401243|NCT01159704|Injection drug users|injection drug users
1401244|NCT01159691|Rotigotine|rotigotine
1401245|NCT01159691|Neupro®|neupro®
1401246|NCT01159691|Parkinson's disease|parkinson's disease
1401247|NCT01159691|Gastrointestinal|gastrointestinal
1401248|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
1401249|NCT01159652|sleep|sleep
1401250|NCT01159652|memory|memory
1401251|NCT01159652|hypnotics|hypnotics
1401252|NCT01159652|zaleplon|zaleplon
1401253|NCT01159652|zolpidem|zolpidem
1401254|NCT01159652|Sonata|sonata
1401255|NCT01159652|Ambien|ambien
1401256|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
1401257|NCT01159652|Polysomnography|polysomnography
1401258|NCT01159652|Monitoring, sleep|monitoring, sleep
1401259|NCT01159639|aspirin resistance|aspirin resistance
1401260|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
1401261|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
1401262|NCT01159639|multiplate|multiplate
1401263|NCT01159626|Phase1|phase1
1401264|NCT01159626|Pharmacokinetics|pharmacokinetics
1401265|NCT01159626|Healthy Male|healthy male
1401266|NCT01159626|Japanese|japanese
1401267|NCT01159626|Schizophrenia|schizophrenia
1401268|NCT01159613|SVR|svr
1401269|NCT01159613|Cholesterol level|cholesterol level
1401270|NCT01159613|fibrosis score|fibrosis score
1401271|NCT01159613|HDL|hdl
1401272|NCT01159535|substance use|substance use
1401273|NCT01159535|addiction|addiction
1401274|NCT01159535|meditation|meditation
1401275|NCT01159535|mindfulness|mindfulness
1401276|NCT01159535|relapse prevention|relapse prevention
1401366|NCT01159184|social support|social support
1402083|NCT01156090|vectibix|vectibix
1401277|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
1401278|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
1401279|NCT01159509|sodium intake|sodium intake
1401280|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
1401281|NCT01159509|Status post HPS|status post hps
1401282|NCT01159483|safety|safety
1401283|NCT01159483|tolerability|tolerability
1401284|NCT01159483|pharmacokinetics|pharmacokinetics
1401285|NCT01159470|CRP velocity|crp velocity
1401286|NCT01159457|Celiac Disease|celiac disease
1401287|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
1401288|NCT01159444|noninvasive ventilation|noninvasive ventilation
1401289|NCT01159444|ventilator software|ventilator software
1401290|NCT01159444|ventilator settings|ventilator settings
1401291|NCT01159444|domiciliary ventilation|domiciliary ventilation
1401292|NCT01159431|partial seizures|partial seizures
1401293|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
1401294|NCT01159431|intractable epilepsy|intractable epilepsy
1401295|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
1401296|NCT01159431|Trigeminal Nerve|trigeminal nerve
1401297|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
1401298|NCT01159418|solid tumors|solid tumors
1401299|NCT01159418|Panobinostat|panobinostat
1401300|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
1401301|NCT01159392|brain injury|brain injury
1401302|NCT01159392|mechanical ventilation|mechanical ventilation
1401303|NCT01159392|acute lung injury|acute lung injury
1401304|NCT01159392|lung recruitment|lung recruitment
1401305|NCT01159379|IgE-mediated allergy|ige-mediated allergy
1401306|NCT01159379|Beta-lactams|beta-lactams
1401307|NCT01159379|Ertapenem|ertapenem
1401308|NCT01159379|Cross-reactivity|cross-reactivity
1401309|NCT01159379|Immediate-type skin tests|immediate-type skin tests
1401310|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
1401311|NCT01159366|myocardial infarction|myocardial infarction
1401312|NCT01159366|coronary occlusion|coronary occlusion
1401313|NCT01159366|myocardial revascularization|myocardial revascularization
1401314|NCT01159366|collaterals|collaterals
1401315|NCT01159366|prognosis|prognosis
1401316|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
1401317|NCT01159327|ED-SCLC|ed-sclc
1401318|NCT01159327|Maintenance|maintenance
1401319|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
1401320|NCT01159314|glaucoma|glaucoma
1401321|NCT01159314|Baerveldt Implants|baerveldt implants
1401322|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
1401323|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
1401324|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
1401325|NCT01159275|pharmacokinetics|pharmacokinetics
1401326|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
1401327|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
1401328|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
1401329|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
1401330|NCT01159236|Gene signatures|gene signatures
1401331|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
1401332|NCT01159236|Estrogen Receptor|estrogen receptor
1401333|NCT01159236|ER-positive|er-positive
1401334|NCT01159236|ER-negative|er-negative
1401335|NCT01159236|RCB categories II-III|rcb categories ii-iii
1401336|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1401337|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
1401338|NCT01159236|molecular testing|molecular testing
1401339|NCT01159236|Fluorouracil|fluorouracil
1401340|NCT01159236|5-fluorouracil|5-fluorouracil
1401341|NCT01159236|5-FU|5-fu
1401342|NCT01159236|Doxorubicin|doxorubicin
1401343|NCT01159236|Adriamycin|adriamycin
1401344|NCT01159236|Rubex|rubex
1401345|NCT01159236|Epirubicin|epirubicin
1401346|NCT01159236|Ellence|ellence
1401347|NCT01159236|Cyclophosphamide|cyclophosphamide
1401348|NCT01159236|Cytoxan|cytoxan
1401349|NCT01159236|Neosar|neosar
1401350|NCT01159236|Bevacizumab|bevacizumab
1401351|NCT01159236|Avastin|avastin
1401352|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
1401353|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
1401354|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
1401355|NCT01159223|low dose|low dose
1401356|NCT01159223|noninferiority|noninferiority
1401357|NCT01159223|safety and efficacy|safety and efficacy
1401358|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
1401359|NCT01159197|sleep disturbance|sleep disturbance
1401360|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
1401361|NCT01159197|inflammation|inflammation
1401362|NCT01159197|oxidative stress|oxidative stress
1401363|NCT01159197|hemodialysis|hemodialysis
1401364|NCT01159184|stress|stress
1401365|NCT01159184|coping methods|coping methods
1401367|NCT01159184|diabetes mellitus|diabetes mellitus
1401368|NCT01159145|Healthy volunteer|healthy volunteer
1401369|NCT01159145|Japanese males|japanese males
1401370|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
1401371|NCT01159132|pharmacokinetics|pharmacokinetics
1401372|NCT01159132|low dose raltegravir|low dose raltegravir
1401373|NCT01159132|HIV|hiv
1401374|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
1401375|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
1401376|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1401377|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
1401378|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1401379|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
1401380|NCT01159106|Pediatric patient|pediatric patient
1401381|NCT01159106|Infant|infant
1401382|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
1401383|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
1401384|NCT01159067|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron
1401385|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
1401386|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
1401387|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
1401388|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
1401389|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
1401390|NCT01158989|Critical care|critical care
1401391|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
1401392|NCT01158989|Nutrition, Enteral|nutrition, enteral
1528210|NCT00669110|MDD|mdd
1401393|NCT01158937|meropenem|meropenem
1401394|NCT01158937|cystic fibrosis|cystic fibrosis
1401395|NCT01158937|extended infusion|extended infusion
1401396|NCT01158937|pharmacokinetic|pharmacokinetic
1401397|NCT01158911|kidney disease|kidney disease
1401398|NCT01158911|uric acid|uric acid
1401399|NCT01158911|outcomes|outcomes
1401400|NCT01158911|cardiovascular|cardiovascular
1401401|NCT01158911|mortality|mortality
1401402|NCT01158911|kidney failure|kidney failure
1401403|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
1401404|NCT01158898|Mild to moderate asthma|mild to moderate asthma
1401405|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
1401406|NCT01158885|relapsed|relapsed
1401407|NCT01158885|relapse|relapse
1401408|NCT01158885|refractory|refractory
1401409|NCT01158885|Minimal Residual disease|minimal residual disease
1401410|NCT01158885|MRD|mrd
1401411|NCT01158885|MRD positive|mrd positive
1401412|NCT01158885|MRD+|mrd+
1401413|NCT01158885|ALL|all
1401414|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1401415|NCT01158885|AML|aml
1401416|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
1401417|NCT01158885|Relapsed AML|relapsed aml
1401418|NCT01158859|Anesthesia, General|anesthesia, general
1401419|NCT01158859|Propofol|propofol
1401420|NCT01158859|Pregabalin|pregabalin
1401421|NCT01158859|Preoperative care|preoperative care
1401422|NCT01158859|Laparoscopic surgery|laparoscopic surgery
1401423|NCT01158846|STEMI|stemi
1401424|NCT01158846|Primary PCI|primary pci
1401425|NCT01158846|anticoagulants|anticoagulants
1401426|NCT01158846|antiplatelets|antiplatelets
1401427|NCT01158833|Cerebral palsy|cerebral palsy
1401428|NCT01158833|diplegia|diplegia
1401429|NCT01158833|gait|gait
1401430|NCT01158833|classification|classification
1401431|NCT01158820|bronchoscopy|bronchoscopy
1401432|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1401433|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
1401434|NCT01158794|Iron overload|iron overload
1401435|NCT01158794|Blood Transfusion|blood transfusion
1401436|NCT01158781|TBI|tbi
1401437|NCT01158781|motor learning|motor learning
1401438|NCT01158781|robotics|robotics
1401439|NCT01158781|Functional electrical stimulation|functional electrical stimulation
1401440|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
1401441|NCT01158768|comorbidities|comorbidities
1401442|NCT01158768|climactery|climactery
1401443|NCT01158768|domestic violence against women|domestic violence against women
1401444|NCT01158768|trauma questionnaire|trauma questionnaire
1401445|NCT01158768|Violence|violence
1401446|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
1401447|NCT01158755|Intensified Regimen|intensified regimen
1401448|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
1401449|NCT01158755|Outcome|outcome
1401450|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
1401451|NCT01158729|Antithrombin III|antithrombin iii
1401452|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
1401453|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
1401454|NCT01158729|Pediatrics|pediatrics
1401455|NCT01158729|Blood Transfusion|blood transfusion
1401629|NCT01157819|swimmer's ear|swimmer's ear
1401456|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
1401457|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
1401458|NCT01158703|aspirin|aspirin
1401459|NCT01158703|clopidogrel|clopidogrel
1401460|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
1401461|NCT01158703|Plavix|plavix
1401462|NCT01158690|Intimate partner violence|intimate partner violence
1401463|NCT01158677|meniscectomy|meniscectomy
1401464|NCT01158664|dental implants|dental implants
1401465|NCT01158664|different tread pitch design|different tread pitch design
1401466|NCT01158651|NF1|nf1
1401467|NCT01158651|low-grade glioma|low-grade glioma
1401468|NCT01158651|progressive|progressive
1401469|NCT01158651|children|children
1401470|NCT01158651|Participants studied have NF Type 1 and a low grade glioma that has either not responded to one or more standard treatments.|participants studied have nf type 1 and a low grade glioma that has either not responded to one or more standard treatments.
1401471|NCT01158638|Physical Activity Enhancement|physical activity enhancement
1401472|NCT01158599|Japanese Encephalitis|japanese encephalitis
1401473|NCT01158599|Vaccination|vaccination
1401474|NCT01158599|Ixiaro|ixiaro
1401475|NCT01158599|elderly population|elderly population
1401476|NCT01158586|post total knee replacement|post total knee replacement
1401477|NCT01158586|patient control|patient control
1401478|NCT01158586|epidural analgesia|epidural analgesia
1401479|NCT01158573|Asthma|asthma
1401480|NCT01158573|Obesity|obesity
1401481|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
1401482|NCT01158560|rhinovirus infections|rhinovirus infections
1401483|NCT01158560|vitamin D|vitamin d
1401484|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
1401485|NCT01158508|cerebral aneurysm|cerebral aneurysm
1401486|NCT01158508|cerebral vasospasm|cerebral vasospasm
1401487|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
1401488|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
1401489|NCT01158456|smoking|smoking
1401490|NCT01158456|lung cancer|lung cancer
1401491|NCT01158456|ethnic racial differences|ethnic racial differences
1401492|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
1401493|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
1401494|NCT01158443|HIV+|hiv+
1401495|NCT01158443|fatigue|fatigue
1401496|NCT01158443|return to work|return to work
1401497|NCT01158430|Hypochondriasis|hypochondriasis
1401498|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
1401499|NCT01158430|ACT|act
1401500|NCT01158417|Type 2 Diabetes|type 2 diabetes
1401501|NCT01158417|Obesity|obesity
1401502|NCT01158417|Insulin Resistance|insulin resistance
1401503|NCT01158417|Resveratrol|resveratrol
1401504|NCT01158417|Inflammation|inflammation
1401505|NCT01158404|Metastatic Cancer|metastatic cancer
1401506|NCT01158404|Solid Tumors|solid tumors
1401507|NCT01158391|Premature Birth|premature birth
1401508|NCT01158378|Adherus Dural Sealant|adherus dural sealant
1401509|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
1401510|NCT01158352|Growth|growth
1401511|NCT01158352|Low weight|low weight
1401512|NCT01158352|Low height|low height
1401513|NCT01158352|Nutritional Formula|nutritional formula
1401514|NCT01158339|Low back pain|low back pain
1401515|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
1401516|NCT01158339|Group therapy|group therapy
1401517|NCT01158339|Exposure in session|exposure in session
1401518|NCT01158326|reducing symptoms|reducing symptoms
1401519|NCT01158326|events|events
1401520|NCT01158326|Common Cold|common cold
1401521|NCT01158326|flu syndrome|flu syndrome
1401522|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
1401523|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1401524|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1401525|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
1401526|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1401527|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1401528|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1401529|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
1401530|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1401531|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1401532|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1401533|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
1401534|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1401535|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1401536|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1401537|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1401538|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1401539|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
1401628|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
1401540|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1401541|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
1401542|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1401543|NCT01158300|childhood astrocytoma|childhood astrocytoma
1401544|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
1401545|NCT01158300|childhood meningioma|childhood meningioma
1401546|NCT01158300|childhood mixed glioma|childhood mixed glioma
1401547|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
1401548|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
1401549|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1401550|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
1401551|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
1401552|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1401553|NCT01158261|hemostasis|hemostasis
1401554|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
1401555|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1401556|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
1401557|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
1401558|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
1401559|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
1401560|NCT01158248|stage III cervical cancer|stage iii cervical cancer
1401561|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1401562|NCT01158235|MRSA|mrsa
1401563|NCT01158235|nose|nose
1401564|NCT01158196|laser|laser
1401565|NCT01158196|keloid|keloid
1401566|NCT01158196|scar|scar
1401567|NCT01158183|Outcomes|outcomes
1401568|NCT01158183|real world and web tool|real world and web tool
1401569|NCT01158183|electronic data capture|electronic data capture
1401570|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
1401571|NCT01158170|brain metastasis|brain metastasis
1401572|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
1401573|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
1401574|NCT01158144|Locally advanced|locally advanced
1401575|NCT01158144|Radiotherapy|radiotherapy
1401576|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
1401577|NCT01158144|Endostar|endostar
1401578|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
1401579|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
1401580|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
1401581|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
1401582|NCT01158105|Bortezomib|bortezomib
1401583|NCT01158105|Velcade|velcade
1401584|NCT01158079|Liver|liver
1401585|NCT01158079|Solid Tumors|solid tumors
1401586|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
1401587|NCT01158066|NAFLD|nafld
1401588|NCT01158066|Calcium score|calcium score
1401589|NCT01158066|Liver Fat|liver fat
1401590|NCT01158066|Visceral fat|visceral fat
1401591|NCT01158066|excessive visceral fat|excessive visceral fat
1401592|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
1401593|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
1401594|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
1401595|NCT01158040|Pregestational diabetes|pregestational diabetes
1401596|NCT01158014|pterygium|pterygium
1401597|NCT01158014|conjunctival graft|conjunctival graft
1401598|NCT01158014|recurrence|recurrence
1401599|NCT01158014|primary pterygium|primary pterygium
1401600|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
1401601|NCT01158001|Telemedicine|telemedicine
1401602|NCT01158001|Psychotherapy|psychotherapy
1401603|NCT01158001|Neuropsychological test|neuropsychological test
1401604|NCT01158001|Depression|depression
1401605|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
1401606|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
1401607|NCT01157988|clinical response|clinical response
1401608|NCT01157988|Safety and toxicity|safety and toxicity
1401609|NCT01157962|Sentinel Concept|sentinel concept
1401610|NCT01157962|Lymphadenectomy|lymphadenectomy
1401611|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
1401612|NCT01157962|Overall Survive|overall survive
1401613|NCT01157962|Improvement Therapy|improvement therapy
1401614|NCT01157936|hypertension|hypertension
1401615|NCT01157936|hyperuricemia|hyperuricemia
1401616|NCT01157936|metabolic syndrome|metabolic syndrome
1401617|NCT01157923|Type 1 diabetes|type 1 diabetes
1401618|NCT01157923|Insulin Pump Therapy|insulin pump therapy
1401619|NCT01157910|Ear infection|ear infection
1401620|NCT01157910|Chronic|chronic
1401621|NCT01157897|Malaria|malaria
1401622|NCT01157897|Plasmodium Vivax|plasmodium vivax
1401623|NCT01157897|Vaccine|vaccine
1401624|NCT01157884|body composition|body composition
1401625|NCT01157884|obesity|obesity
1401626|NCT01157884|kidney transplantation|kidney transplantation
1401627|NCT01157858|liver cyst|liver cyst
1401633|NCT01157819|ear infection|ear infection
1401634|NCT01157819|ear pain|ear pain
1401635|NCT01157819|ear inflammation|ear inflammation
1401636|NCT01157806|rectal cancer|rectal cancer
1401637|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
1401638|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
1401639|NCT01157793|Dwarfism|dwarfism
1401640|NCT01157793|Growth hormone deficiency|growth hormone deficiency
1401641|NCT01157793|Growth hormone|growth hormone
1401642|NCT01157780|Fish oil|fish oil
1401643|NCT01157767|exercise|exercise
1401644|NCT01157767|lymphedema|lymphedema
1401645|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
1402195|NCT01155544|Craving|craving
1401646|NCT01157767|post-operative radiation|post-operative radiation
1401647|NCT01157767|10-062|10-062
1401648|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
1401649|NCT01157754|good prognosis|good prognosis
1401650|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
1401651|NCT01157728|Multiple sclerosis|multiple sclerosis
1401652|NCT01157728|Cognitive impairment|cognitive impairment
1401653|NCT01157715|KH902|kh902
1401654|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1401655|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1401656|NCT01157715|intravitreal injection|intravitreal injection
1401657|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
1401658|NCT01157715|central retinal thickness|central retinal thickness
1401659|NCT01157689|malaria|malaria
1401660|NCT01157689|children|children
1401661|NCT01157689|Guinea-Bissau|guinea-bissau
1401662|NCT01157689|artemether|artemether
1401663|NCT01157689|lumefantrine|lumefantrine
1401664|NCT01157689|effectiveness|effectiveness
1401665|NCT01157676|open cystectomy|open cystectomy
1401666|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
1401667|NCT01157676|bladder cancer|bladder cancer
1401668|NCT01157663|Functional ankle instability|functional ankle instability
1401669|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
1401670|NCT01157650|stem cells implant|stem cells implant
1401671|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
1401672|NCT01157611|online based mentoring program,|online based mentoring program,
1401673|NCT01157611|type 1 diabetes,|type 1 diabetes,
1401674|NCT01157611|blood glucose,|blood glucose,
1401675|NCT01157611|satisfaction score|satisfaction score
1401676|NCT01157598|gastric adenoma|gastric adenoma
1401677|NCT01157598|early gastric cancer|early gastric cancer
1401678|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
1401679|NCT01157572|Beta-blocker|beta-blocker
1401680|NCT01157533|Vancomycin|vancomycin
1401681|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
1401683|NCT01157507|Botulinum A toxin|botulinum a toxin
1401684|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
1401685|NCT01157507|Bladder overdistention|bladder overdistention
1401686|NCT01157494|cerebral palsy|cerebral palsy
1401687|NCT01157494|hemiplegia|hemiplegia
1401688|NCT01157494|upper limb|upper limb
1401689|NCT01157494|assessment|assessment
1401690|NCT01157494|classification system|classification system
1401691|NCT01157481|Diastolic Heart Failure|diastolic heart failure
1401692|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
1401693|NCT01157481|nifedipine|nifedipine
1401694|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
1401695|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
1401696|NCT01157455|Stent|stent
1401697|NCT01157455|Coronary artery diseases|coronary artery diseases
1401698|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
1401699|NCT01157442|mhealth|mhealth
1401700|NCT01157442|access to antenatal care|access to antenatal care
1401701|NCT01157442|pregnancy|pregnancy
1401702|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
1401703|NCT01157429|Children|children
1401704|NCT01157429|Adolescents|adolescents
1401705|NCT01157429|Pharmacotherapy|pharmacotherapy
1401706|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
1401707|NCT01157416|Children|children
1401708|NCT01157416|Pharmacotherapy|pharmacotherapy
1401709|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
1401710|NCT01157390|Term-infant|term-infant
1401711|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
1401712|NCT01157390|infant formula|infant formula
1401713|NCT01157351|Schizophrenia|schizophrenia
1401714|NCT01157351|Risperidone|risperidone
1401715|NCT01157351|Risperdal|risperdal
1401716|NCT01157351|Paliperidone palmitate|paliperidone palmitate
1401717|NCT01157351|Aripiprazole|aripiprazole
1401718|NCT01157351|Haloperidol|haloperidol
1401719|NCT01157351|Olanzapine|olanzapine
1401720|NCT01157351|Paliperidone|paliperidone
1401721|NCT01157351|Perphenazine|perphenazine
1401722|NCT01157351|Quetiapine|quetiapine
1401723|NCT01157338|Catheter|catheter
1401724|NCT01157338|coronary artery disease|coronary artery disease
1401725|NCT01157338|embolus|embolus
1401726|NCT01157338|stroke|stroke
1401727|NCT01157338|retinal emboli|retinal emboli
1401728|NCT01157325|Epidural analgesia|epidural analgesia
1401729|NCT01157325|Latent analgesia|latent analgesia
1401730|NCT01157325|Active analgesia|active analgesia
1401731|NCT01157325|Cesarean section|cesarean section
1401732|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
1401733|NCT01157312|clomiphene citrate|clomiphene citrate
1401734|NCT01157312|minimal stimulation|minimal stimulation
1401735|NCT01157312|infertility treatment|infertility treatment
1401736|NCT01157299|Hemodynamics|hemodynamics
1401737|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
1401738|NCT01157299|Low cardiac output|low cardiac output
1401739|NCT01157299|Thermodilution|thermodilution
1401740|NCT01157299|Stroke volume|stroke volume
1401741|NCT01157299|Global end-diastolic volume|global end-diastolic volume
1401742|NCT01157299|Fluid responsiveness|fluid responsiveness
1401743|NCT01157299|Passive leg raising|passive leg raising
1401744|NCT01157299|Infant|infant
1401745|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
1401746|NCT01157273|Behavior|behavior
1401747|NCT01157273|Anxiety|anxiety
1401748|NCT01157273|Communication|communication
1401749|NCT01157273|Voice|voice
1401750|NCT01157260|Indoxyl sulfate|indoxyl sulfate
1401751|NCT01157260|AST-120|ast-120
1401752|NCT01157247|Anesthetic techniques|anesthetic techniques
1401753|NCT01157247|regional, spinal|regional, spinal
1401754|NCT01157247|Pain|pain
1401755|NCT01157247|lumbar puncture|lumbar puncture
1401756|NCT01157247|Analgesia, local|analgesia, local
1401757|NCT01157247|Analgesia, intravenous|analgesia, intravenous
1401758|NCT01157234|Hypertension|hypertension
1401759|NCT01157234|Kidney transplantation|kidney transplantation
1401760|NCT01157234|Renal function|renal function
1401761|NCT01157234|Nitric Oxide|nitric oxide
1401762|NCT01157234|Nebivolol|nebivolol
1401763|NCT01157208|chronic pain|chronic pain
1401764|NCT01157208|headache|headache
1401765|NCT01157208|nutrition|nutrition
1401766|NCT01157208|inflammation|inflammation
1401767|NCT01157208|complementary medicine|complementary medicine
1401768|NCT01157195|stroke|stroke
1401769|NCT01157195|chronic|chronic
1401770|NCT01157195|arm|arm
1401771|NCT01157195|rehabilitation|rehabilitation
1401772|NCT01157195|tele-health|tele-health
1401773|NCT01157182|Healthy|healthy
1401774|NCT01157182|Bioequivalence|bioequivalence
1401775|NCT01157182|Post-Menopausal|post-menopausal
1401776|NCT01157169|Bioequivalence|bioequivalence
1401777|NCT01157169|Healthy|healthy
1401778|NCT01157130|Breast Cancer|breast cancer
1401779|NCT01157130|Exercise|exercise
1401780|NCT01157130|CRP|crp
1401781|NCT01157130|C-reactive protein|c-reactive protein
1401782|NCT01157130|BMI|bmi
1401783|NCT01157130|Nevada Cancer Institute|nevada cancer institute
1401784|NCT01157130|Rehabilitation|rehabilitation
1401785|NCT01157130|Prescriptive exercise|prescriptive exercise
1401786|NCT01157130|Physical Activity|physical activity
1401787|NCT01157130|DEXA|dexa
1401788|NCT01157130|Obesity|obesity
1401789|NCT01157130|lifestyle intervention|lifestyle intervention
1401790|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
1401791|NCT01157117|food allergy|food allergy
1401792|NCT01157104|HCV|hcv
1401793|NCT01157104|Hepatitis C|hepatitis c
1401794|NCT01157078|Major Depressive Disorder|major depressive disorder
1401795|NCT01157078|MDD|mdd
1401796|NCT01157078|Depression|depression
1401797|NCT01157078|Safety|safety
1401798|NCT01157078|add-on therapy|add-on therapy
1401799|NCT01157065|Wet AMD|wet amd
1401800|NCT01157065|Intravitreal Injection|intravitreal injection
1401801|NCT01157065|Macular Degeneration|macular degeneration
1401802|NCT01157065|VEGF treatment|vegf treatment
1401803|NCT01157052|magnesium|magnesium
1401804|NCT01157052|calcium|calcium
1401805|NCT01157052|adverse effects|adverse effects
1401806|NCT01157052|kinetics, drug|kinetics, drug
1401807|NCT01157039|glutamine|glutamine
1401808|NCT01157039|oxaliplatin|oxaliplatin
1401809|NCT01157039|adverse effects|adverse effects
1401810|NCT01157026|Breast cancer|breast cancer
1401811|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
1401812|NCT01157013|Positron Emission Tomography|positron emission tomography
1401813|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
1401814|NCT01157013|Liver Cancer|liver cancer
1401815|NCT01157013|Sorafenib|sorafenib
1401816|NCT01157013|Response Evaluation|response evaluation
1401817|NCT01157000|Canagliflozin|canagliflozin
1401818|NCT01157000|Pharmacokinetic|pharmacokinetic
1401819|NCT01157000|Bioavailability|bioavailability
1401820|NCT01156974|care management|care management
1401821|NCT01156974|chronic disease|chronic disease
1401822|NCT01156974|outpatient|outpatient
1401823|NCT01156948|misoprostol|misoprostol
1401824|NCT01156948|nulliparous|nulliparous
1401825|NCT01156948|hysteroscopy|hysteroscopy
1401826|NCT01156935|Neoplasm|neoplasm
1401827|NCT01156935|Laugh-Yoga|laugh-yoga
1401828|NCT01156935|Mood|mood
1401829|NCT01156935|Quality of life|quality of life
1401830|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
1401831|NCT01156922|CFS|cfs
1401832|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
1401834|NCT01156922|B-cell depletion|b-cell depletion
1401835|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
1401836|NCT01156909|CFS|cfs
1401837|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
1401838|NCT01156909|Rituximab|rituximab
1401839|NCT01156909|B-cell depletion|b-cell depletion
1401840|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
1401841|NCT01156896|Iron stable isotopes|iron stable isotopes
1401842|NCT01156896|Iron deficiency|iron deficiency
1401843|NCT01156896|Malaria|malaria
1401844|NCT01156896|Iron supplementation|iron supplementation
1401845|NCT01156896|Iron fortification|iron fortification
1401846|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1401847|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1401848|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1401849|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1401850|NCT01156844|Indacaterol|indacaterol
1401851|NCT01156844|Asthma|asthma
1401852|NCT01156844|Bronchodilation|bronchodilation
1401853|NCT01156844|Beta-agonist|beta-agonist
1401854|NCT01156831|Esophageal cancer|esophageal cancer
1401855|NCT01156831|PET-CT planning|pet-ct planning
1401856|NCT01156818|Wheeze measurements|wheeze measurements
1401857|NCT01156805|Children|children
1401858|NCT01156805|School-based program|school-based program
1401859|NCT01156805|Obesity|obesity
1401860|NCT01156792|asthma|asthma
1401861|NCT01156792|GSK2190915|gsk2190915
1401862|NCT01156779|SR-Exenatide|sr-exenatide
1401863|NCT01156766|Fracture|fracture
1401864|NCT01156766|Radius|radius
1401865|NCT01156766|Osteosynthesis|osteosynthesis
1401866|NCT01156766|Metaphyseal|metaphyseal
1401867|NCT01156766|Pinning|pinning
1401868|NCT01156766|Locking anterior plate|locking anterior plate
1401869|NCT01156753|CR011-vcMMAE|cr011-vcmmae
1401870|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
1401871|NCT01156753|metastatic breast cancer|metastatic breast cancer
1401872|NCT01156753|breast cancer|breast cancer
1401873|NCT01156753|CDX-011|cdx-011
1401874|NCT01156753|GPNMB|gpnmb
1401875|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
1401876|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
1401877|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
1401878|NCT01156740|randomized clinical trial|randomized clinical trial
1401879|NCT01156740|amoxicillin|amoxicillin
1401880|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
1401881|NCT01156727|OEF/OIF|oef/oif
1401882|NCT01156727|Mental Health|mental health
1401883|NCT01156727|Veterans|veterans
1401884|NCT01156714|Parkinson's Disease|parkinson's disease
1401885|NCT01156714|Treadmill Training|treadmill training
1401886|NCT01156714|Exercise|exercise
1401887|NCT01156714|Cognitive Training|cognitive training
1401888|NCT01156714|Executive Function|executive function
1401889|NCT01156714|Dual Task|dual task
1401890|NCT01156701|Influenza|influenza
1401891|NCT01156701|Zanamivir|zanamivir
1401892|NCT01156701|Influenza prophylaxis|influenza prophylaxis
1401893|NCT01156701|Relenza|relenza
1401894|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
1401895|NCT01156675|Back pain|back pain
1401896|NCT01156675|Pain|pain
1401897|NCT01156675|Spinal Diseases|spinal diseases
1401898|NCT01156675|Spinal Stenosis|spinal stenosis
1401899|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
1401900|NCT01156675|Spinal Canal|spinal canal
1401901|NCT01156662|Thrombus aspiration|thrombus aspiration
1401902|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
1401903|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
1401904|NCT01156649|neurocognitive function|neurocognitive function
1401905|NCT01156649|cognition|cognition
1401906|NCT01156649|pediatrics|pediatrics
1401907|NCT01156649|children|children
1401908|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
1401909|NCT01156649|sham treatment|sham treatment
1401910|NCT01156649|randomized clinical trial|randomized clinical trial
1401911|NCT01156649|behavior|behavior
1401912|NCT01156649|treatment|treatment
1401913|NCT01156636|Diastolic Heart Failure|diastolic heart failure
1401914|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
1401915|NCT01156623|EBUS-TBNA|ebus-tbna
1401916|NCT01156623|NSCLC|nsclc
1401917|NCT01156623|Mediastinal lymph node|mediastinal lymph node
1401918|NCT01156623|tuberculosis|tuberculosis
1401919|NCT01156610|Smoking|smoking
1401920|NCT01156610|Smoking Cessation|smoking cessation
1401921|NCT01156610|Electronic Health Record|electronic health record
1401922|NCT01156610|Telephone|telephone
1401923|NCT01156597|diabetes|diabetes
1401924|NCT01156597|dyslipidemia|dyslipidemia
1401925|NCT01156597|pioglitazone|pioglitazone
1401926|NCT01156597|HDL-Cholesterol|hdl-cholesterol
1401927|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
1401928|NCT01156584|glioma|glioma
1401929|NCT01156584|glioblastoma|glioblastoma
1401930|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
1401931|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
1401932|NCT01156584|brain cancer|brain cancer
1401933|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
1401934|NCT01156584|GBM|gbm
1401935|NCT01156584|AA|aa
1401936|NCT01156584|AOD|aod
1401937|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
1401938|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1401939|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1401940|NCT01156584|malignant glioma|malignant glioma
1401941|NCT01156584|high grade glioma|high grade glioma
1401942|NCT01156545|BIBW 2992|bibw 2992
1401943|NCT01156545|Simvastatin|simvastatin
1401944|NCT01156545|NSCLC|nsclc
1401945|NCT01156545|advanced stage|advanced stage
1401946|NCT01156545|previously treated patients|previously treated patients
1401947|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
1401948|NCT01156532|adalimumab therapy|adalimumab therapy
1401949|NCT01156532|Psoriasis|psoriasis
1401950|NCT01156532|observational study|observational study
1401951|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
1401952|NCT01156519|Salivary cortisol|salivary cortisol
1401953|NCT01156519|Obesity|obesity
1401954|NCT01156506|quality of life|quality of life
1401955|NCT01156506|patient education|patient education
1401956|NCT01156506|rehabilitation|rehabilitation
1401957|NCT01156506|focus group interview|focus group interview
1567156|NCT00509730|surgery|surgery
1401958|NCT01156493|feeding intolerance|feeding intolerance
1401959|NCT01156493|prematurity|prematurity
1401960|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
1401961|NCT01156480|NEC|nec
1401962|NCT01156480|premature|premature
1401963|NCT01156480|hydrocortisone|hydrocortisone
1401964|NCT01156480|steroids|steroids
1401965|NCT01156480|anti-inflammatory|anti-inflammatory
1401966|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
1401967|NCT01156467|Premature infant|premature infant
1401968|NCT01156467|Edi-signal|edi-signal
1401969|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
1401970|NCT01156454|radiology|radiology
1401971|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
1401972|NCT01156441|Myocardial Infarction|myocardial infarction
1401973|NCT01156441|Mitral Regurgitation|mitral regurgitation
1401974|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
1401975|NCT01156428|Nephritic syndrome|nephritic syndrome
1401976|NCT01156428|Nephrotic syndrome|nephrotic syndrome
1401977|NCT01156428|Proteinuria|proteinuria
1401978|NCT01156428|Acute kidney injury|acute kidney injury
1401979|NCT01156428|Chronic kidney disease|chronic kidney disease
1401980|NCT01156428|Lupus nephritis|lupus nephritis
1401981|NCT01156415|agomelatine|agomelatine
1401982|NCT01156415|Major Depressive Disorder|major depressive disorder
1401983|NCT01156415|MDD|mdd
1401984|NCT01156415|depression|depression
1401985|NCT01156402|Obesity|obesity
1401986|NCT01156402|Pediatric Obesity|pediatric obesity
1401987|NCT01156389|malaria|malaria
1401988|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
1401989|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
1401990|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
1401991|NCT01156337|Furosemide|furosemide
1401992|NCT01156337|Sodium|sodium
1401993|NCT01156337|water restriction|water restriction
1401994|NCT01156337|decompensated heart failure|decompensated heart failure
1401995|NCT01156337|Hypertonic saline solution|hypertonic saline solution
1401996|NCT01156337|Moderate sodium restriction|moderate sodium restriction
1401997|NCT01156324|IVF|ivf
1401998|NCT01156324|Stress management|stress management
1401999|NCT01156311|BG00012|bg00012
1402000|NCT01156311|MS|ms
1402001|NCT01156311|RRMS|rrms
1402002|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
1402003|NCT01156272|heart valve|heart valve
1402004|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
1402005|NCT01156246|Healthy volunteers|healthy volunteers
1402006|NCT01156246|Dapagliflozin|dapagliflozin
1402007|NCT01156246|Diabetes Type 2|diabetes type 2
1402008|NCT01156246|Food interaction|food interaction
1402009|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
1402010|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
1402011|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
1402012|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
1402013|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
1402014|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
1402015|NCT01156168|male breast cancer|male breast cancer
1402016|NCT01156168|stage IV breast cancer|stage iv breast cancer
1402017|NCT01156168|recurrent breast cancer|recurrent breast cancer
1402018|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
1402019|NCT01156155|osteoarthritis|osteoarthritis
1402020|NCT01156155|periodontal disease|periodontal disease
1402021|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
1402022|NCT01156142|mucositis|mucositis
1402024|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1402025|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1402026|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
1402027|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1402028|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1402029|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
1402030|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
1402031|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1402032|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1402033|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1402034|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
1567157|NCT00509717|quality of health care|quality of health care
1402035|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
1402036|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
1402037|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
1402038|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1402039|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1402040|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
1402041|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1402042|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1402043|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1402044|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1402045|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1402046|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
1402047|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
1402048|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1402049|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1402050|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
1402051|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
1402052|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1402053|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1402054|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1402055|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1402056|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
1402057|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
1402058|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
1402059|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
1402060|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1402061|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1402062|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
1402063|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1402064|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1402065|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1402066|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1402067|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1402068|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1402069|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1402070|NCT01156142|salivary gland cancer|salivary gland cancer
1402071|NCT01156142|tongue cancer|tongue cancer
1402072|NCT01156129|liver transplant|liver transplant
1402073|NCT01156129|liver resection|liver resection
1402074|NCT01156116|CPAP|cpap
1402075|NCT01156116|diabetes|diabetes
1402076|NCT01156116|sleep apnea|sleep apnea
1402077|NCT01156103|obesity|obesity
1402078|NCT01156103|minority|minority
1402079|NCT01156103|child|child
1402080|NCT01156103|physical fitness|physical fitness
1402081|NCT01156103|school|school
1402082|NCT01156103|physical activity|physical activity
1402084|NCT01156077|antibiotic|antibiotic
1402085|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
1402086|NCT01156064|Endoscopy|endoscopy
1402087|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
1402088|NCT01156064|Digestive Diseases|digestive diseases
1402089|NCT01156051|ADHD|adhd
1402091|NCT01156051|sleep disturbance|sleep disturbance
1402092|NCT01156038|Atopy patch test|atopy patch test
1402093|NCT01156025|GV550|gv550
1402094|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
1402095|NCT01155986|analgesic|analgesic
1402096|NCT01155986|analgesics|analgesics
1402098|NCT01155986|chronic pain|chronic pain
1402099|NCT01155986|localized pain|localized pain
1402100|NCT01155986|focal pain|focal pain
1402101|NCT01155986|neuropathic pain|neuropathic pain
1402102|NCT01155986|postoperative pain|postoperative pain
1402103|NCT01155986|topical analgesia|topical analgesia
1402104|NCT01155973|Hypertension.|hypertension.
1402105|NCT01155973|Cardiovascular risk.|cardiovascular risk.
1402106|NCT01155973|Monitoring.|monitoring.
1402107|NCT01155973|Primary health care.|primary health care.
1402108|NCT01155973|Randomised controlled trial.|randomised controlled trial.
1402109|NCT01155973|Cluster analysis|cluster analysis
1402110|NCT01155960|Bioavailability|bioavailability
1402111|NCT01155960|Anastrozole|anastrozole
1402112|NCT01155960|Crossover|crossover
1402113|NCT01155947|Bioavailability|bioavailability
1402114|NCT01155947|Anastrozole|anastrozole
1402115|NCT01155947|Crossover|crossover
1402116|NCT01155934|Bioavailability|bioavailability
1402117|NCT01155934|Crossover|crossover
1402118|NCT01155934|Risperidone|risperidone
1402119|NCT01155921|Bioavailability|bioavailability
1402120|NCT01155921|Crossover|crossover
1402121|NCT01155921|Risperidone|risperidone
1402122|NCT01155908|Bioavailability|bioavailability
1402123|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
1402124|NCT01155908|Crossover|crossover
1402125|NCT01155895|Bioavailability|bioavailability
1402126|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
1402127|NCT01155895|Crossover|crossover
1402128|NCT01155869|alcohol dependence|alcohol dependence
1402129|NCT01155869|homelessness|homelessness
1402130|NCT01155869|naltrexone|naltrexone
1402131|NCT01155856|telemedicine|telemedicine
1402132|NCT01155856|COPD|copd
1402133|NCT01155830|inflammatory cytokines|inflammatory cytokines
1402134|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1402135|NCT01155830|ECMO|ecmo
1402136|NCT01155804|preparation of the delivery|preparation of the delivery
1402137|NCT01155804|lumbago|lumbago
1402138|NCT01155804|anxiety|anxiety
1402139|NCT01155804|urinary incontinence|urinary incontinence
1402140|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
1402141|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
1402142|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
1402143|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
1402144|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
1402145|NCT01155765|prasugrel|prasugrel
1402146|NCT01155765|Hemodialysis|hemodialysis
1402147|NCT01155752|sinusitis|sinusitis
1402148|NCT01155752|cystic fibrosis|cystic fibrosis
1402149|NCT01155752|therapy|therapy
1402150|NCT01155713|Neoplasms|neoplasms
1402151|NCT01155713|Cancer|cancer
1402152|NCT01155713|Tumors|tumors
1402153|NCT01155713|Administration, oral|administration, oral
1402154|NCT01155713|Capsules|capsules
1402155|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
1402156|NCT01155713|Bioavailability,|bioavailability,
1402157|NCT01155713|Food|food
1402158|NCT01155700|omalizumab|omalizumab
1402159|NCT01155700|allergic asthma|allergic asthma
1402160|NCT01155700|pediatric patients|pediatric patients
1402161|NCT01155687|afghanistan|afghanistan
1402162|NCT01155687|depression|depression
1402163|NCT01155687|anxiety|anxiety
1402164|NCT01155687|social stress|social stress
1402165|NCT01155687|counseling|counseling
1402166|NCT01155687|medication|medication
1402167|NCT01155687|psychotherapy|psychotherapy
1402168|NCT01155687|mental health|mental health
1402169|NCT01155674|Innate immunity|innate immunity
1402170|NCT01155674|Neutrophils|neutrophils
1402171|NCT01155674|Band forms|band forms
1402172|NCT01155648|Mechanical ventilation|mechanical ventilation
1402173|NCT01155648|Chest physiotherapy|chest physiotherapy
1402174|NCT01155648|Chest wall compression|chest wall compression
1402175|NCT01155635|Myocardial infarction|myocardial infarction
1402176|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1402177|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
1402178|NCT01155622|Hypothermia, induced|hypothermia, induced
1402179|NCT01155622|Cardiac arrest|cardiac arrest
1402180|NCT01155622|Disability evaluation|disability evaluation
1402181|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
1402182|NCT01155622|Ventricular function|ventricular function
1402183|NCT01155622|Internal cooling|internal cooling
1402184|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1402185|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
1402186|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
1402187|NCT01155570|Psoriasis|psoriasis
1402188|NCT01155557|Tension-Type Headache|tension-type headache
1402189|NCT01155557|Strength Capacity|strength capacity
1402190|NCT01155557|Neck and Shoulder|neck and shoulder
1402191|NCT01155544|Aripiprazole|aripiprazole
1402192|NCT01155544|Psychotic experiences|psychotic experiences
1402193|NCT01155544|Substance abuse|substance abuse
1402194|NCT01155544|Substance dependence|substance dependence
1402196|NCT01155544|Mood|mood
1402197|NCT01155544|Substance use|substance use
1402198|NCT01155531|Obesity|obesity
1402199|NCT01155531|Overweight|overweight
1402200|NCT01155531|Sertraline|sertraline
1402201|NCT01155531|Telenzepine|telenzepine
1402202|NCT01155531|Decrease appetite|decrease appetite
1402203|NCT01155531|Reduce appetite|reduce appetite
1402204|NCT01155531|Lose weight|lose weight
1402205|NCT01155518|hypogonadism|hypogonadism
1402206|NCT01155518|diabetes|diabetes
1402207|NCT01155518|spermatogenesis|spermatogenesis
1402208|NCT01155518|insulin resistance|insulin resistance
1402209|NCT01155492|lipopolysaccharides|lipopolysaccharides
1402210|NCT01155492|etiology|etiology
1402211|NCT01155492|inflammation|inflammation
1402212|NCT01155492|colonic bacteria|colonic bacteria
1402213|NCT01155492|intestinal permeability|intestinal permeability
1402214|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
1402215|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
1402216|NCT01155453|BKM120|bkm120
1402217|NCT01155453|RAS RAF mutations,|ras raf mutations,
1402218|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
1402219|NCT01155453|pancreatic cancer,|pancreatic cancer,
1402220|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
1402221|NCT01155453|MEK inhibitor|mek inhibitor
1402222|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
1402223|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
1402224|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
1402225|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
1402226|NCT01155401|routine management|routine management
1402227|NCT01155388|Iron deficiency anemia|iron deficiency anemia
1402228|NCT01155388|Feraheme|feraheme
1402229|NCT01155388|ferumoxytol|ferumoxytol
1402230|NCT01155388|CKD|ckd
1402231|NCT01155388|pediatric|pediatric
1402232|NCT01155388|nondialysis-dependent|nondialysis-dependent
1402233|NCT01155375|Iron deficiency anemia|iron deficiency anemia
1402234|NCT01155375|Feraheme|feraheme
1402235|NCT01155375|ferumoxytol|ferumoxytol
1402236|NCT01155375|CKD|ckd
1402237|NCT01155375|pediatric|pediatric
1402238|NCT01155375|dialysis-dependent|dialysis-dependent
1402239|NCT01155375|nondialysis-dependent|nondialysis-dependent
1402240|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
1402241|NCT01155349|brain fitness|brain fitness
1402242|NCT01155349|cognitive training|cognitive training
1402243|NCT01155349|cognitive intervention|cognitive intervention
1402244|NCT01155349|speed of processing training|speed of processing training
1402245|NCT01155349|Parkinson's disease|parkinson's disease
1402246|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
1402247|NCT01155336|Fish Oils|fish oils
1402248|NCT01155336|Platelet Function Tests|platelet function tests
1402249|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
1402250|NCT01155310|Exacerbation of COPD|exacerbation of copd
1402251|NCT01155310|Helium/Oxygen|helium/oxygen
1402252|NCT01155310|ICU|icu
1402253|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
1402254|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
1402255|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
1402256|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
1402257|NCT01155297|Quality of Life|quality of life
1402258|NCT01155297|Biological Markers|biological markers
1402259|NCT01155297|Renal Insufficiency|renal insufficiency
1402260|NCT01155297|Resistance Training|resistance training
1402261|NCT01155297|Exercise|exercise
1402262|NCT01155297|Chronic Kidney Failure|chronic kidney failure
1402263|NCT01155284|diabetes|diabetes
1402264|NCT01155284|HGB A1C|hgb a1c
1402265|NCT01155284|Beta Cell Regeneration|beta cell regeneration
1402266|NCT01155245|osteoporosis|osteoporosis
1402267|NCT01155245|HR-pQCT|hr-pqct
1402268|NCT01155245|PTH|pth
1402269|NCT01155232|osteoporosis|osteoporosis
1402270|NCT01155232|Forteo|forteo
1402271|NCT01155232|Parathyroid hormone|parathyroid hormone
1402272|NCT01155232|HR-pQCT|hr-pqct
1402273|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
1402274|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
1402275|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
1402371|NCT01154920|5-FU|5-fu
1402372|NCT01154920|Adrucil|adrucil
1402276|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
1402277|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
1402278|NCT01155206|glucagon,|glucagon,
1402279|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
1402280|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
1402281|NCT01155206|free fatty acid|free fatty acid
1402282|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
1402283|NCT01155206|particle|particle
1402284|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
1402285|NCT01155193|Children|children
1402286|NCT01155193|Pre-term infants|pre-term infants
1402287|NCT01155193|Congenital heart disease|congenital heart disease
1402288|NCT01155193|Infection|infection
1402289|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
1402290|NCT01155167|radial artery spasm|radial artery spasm
1402291|NCT01155154|wounds and lacerations|wounds and lacerations
1402292|NCT01155154|hand|hand
1402293|NCT01155154|infection|infection
1402294|NCT01155154|Antibiotics|antibiotics
1402295|NCT01155154|antibacterial agents|antibacterial agents
1402296|NCT01155128|physical activity|physical activity
1402297|NCT01155128|exercise|exercise
1402298|NCT01155128|sedentarism|sedentarism
1402299|NCT01155128|chronic renal disease|chronic renal disease
1402300|NCT01155128|failure renal chronic|failure renal chronic
1402301|NCT01155128|proteinuria|proteinuria
1402302|NCT01155128|progression|progression
1402303|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
1402304|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
1402305|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
1402306|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
1402307|NCT01155115|pediatrics|pediatrics
1402308|NCT01155115|CF|cf
1402309|NCT01155115|PCD|pcd
1402310|NCT01155115|exacerbation|exacerbation
1402311|NCT01155115|inflammatory markers|inflammatory markers
1402312|NCT01155115|induced sputum|induced sputum
1402313|NCT01155063|Exemestane|exemestane
1402314|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
1402315|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
1402316|NCT01155063|Tamoxifen|tamoxifen
1402317|NCT01155050|overweight|overweight
1402318|NCT01155050|obese|obese
1402319|NCT01155050|type II diabetes|type ii diabetes
1402320|NCT01155050|hypertension|hypertension
1402321|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
1402322|NCT01155024|Lower extremity amputation|lower extremity amputation
1402323|NCT01155024|Prosthetic Sockets|prosthetic sockets
1402324|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
1402325|NCT01155011|Older adults|older adults
1402326|NCT01155011|physical activity|physical activity
1402327|NCT01155011|sedentary|sedentary
1402328|NCT01155011|retirement communities|retirement communities
1402329|NCT01155011|advocacy|advocacy
1402330|NCT01155011|built environment|built environment
1402331|NCT01155011|peer mentoring|peer mentoring
1402332|NCT01155011|walkability|walkability
1402333|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
1402334|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
1402335|NCT01154985|alanine transaminase|alanine transaminase
1402336|NCT01154985|triglycerides|triglycerides
1402337|NCT01154985|lipids|lipids
1402338|NCT01154985|EPA|epa
1402339|NCT01154985|ethyl-EPA|ethyl-epa
1402340|NCT01154985|ethyl icosapentate|ethyl icosapentate
1402341|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
1402342|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
1402343|NCT01154985|fatty acids|fatty acids
1402344|NCT01154972|breast|breast
1402345|NCT01154972|cancer|cancer
1402346|NCT01154972|sentinel lymph node|sentinel lymph node
1402347|NCT01154959|Pulmonary TB|pulmonary tb
1402348|NCT01154959|Immune response|immune response
1402349|NCT01154959|ATT|att
1402350|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
1402351|NCT01154959|Predictors for relapse|predictors for relapse
1402352|NCT01154946|detrusor after-contraction|detrusor after-contraction
1402353|NCT01154946|urodynamic|urodynamic
1402354|NCT01154946|LUTS|luts
1402355|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
1402356|NCT01154946|bladder dysfunction|bladder dysfunction
1402357|NCT01154933|type 2 diabetes|type 2 diabetes
1402358|NCT01154933|obesity|obesity
1402359|NCT01154920|Head and Neck Cancer|head and neck cancer
1402360|NCT01154920|HNSCC|hnscc
1402361|NCT01154920|Paclitaxel|paclitaxel
1402362|NCT01154920|Carboplatin|carboplatin
1402363|NCT01154920|Cetuximab|cetuximab
1402364|NCT01154920|Docetaxel|docetaxel
1402365|NCT01154920|Taxotere|taxotere
1402366|NCT01154920|Cisplatin|cisplatin
1402367|NCT01154920|Platinol-AQ|platinol-aq
1402368|NCT01154920|Platinol|platinol
1402369|NCT01154920|CDDP|cddp
1402370|NCT01154920|Fluorouracil|fluorouracil
1402373|NCT01154920|Efudex|efudex
1402374|NCT01154920|chemotherapy|chemotherapy
1402375|NCT01154920|radiation|radiation
1402376|NCT01154920|Chemoradiotherapy|chemoradiotherapy
1402377|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
1402378|NCT01154907|Female|female
1402379|NCT01154907|South Africa|south africa
1402380|NCT01154907|Rural|rural
1402381|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
1402382|NCT01154894|arachidonic acid|arachidonic acid
1402383|NCT01154894|autism spectrum disorders|autism spectrum disorders
1402384|NCT01154894|social interaction|social interaction
1402385|NCT01154894|randomized controlled trial|randomized controlled trial
1402386|NCT01154894|DHA|dha
1402387|NCT01154855|Periodontal disease|periodontal disease
1402388|NCT01154855|Gum disease|gum disease
1402389|NCT01154855|Dental|dental
1402390|NCT01154855|Inflammation|inflammation
1402391|NCT01154855|Microorganisms|microorganisms
1402392|NCT01154855|Bacteria|bacteria
1402393|NCT01154842|FGF-23|fgf-23
1402394|NCT01154842|Dialysis|dialysis
1402395|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
1402396|NCT01154842|echocardiography|echocardiography
1402397|NCT01154829|dopamine|dopamine
1402398|NCT01154829|first episode|first episode
1402399|NCT01154829|reward|reward
1402400|NCT01154829|cognition|cognition
1402401|NCT01154829|MRI|mri
1402402|NCT01154829|fMRI|fmri
1402403|NCT01154829|PPI|ppi
1402404|NCT01154829|P300|p300
1402405|NCT01154829|P50 gating|p50 gating
1402406|NCT01154829|endophenotypes|endophenotypes
1402407|NCT01154803|Supplementation|supplementation
1402408|NCT01154803|RUTF|rutf
1402409|NCT01154803|Micronutrients|micronutrients
1402410|NCT01154803|Plumpynut|plumpynut
1402411|NCT01154803|Mixme|mixme
1402412|NCT01154803|sprinkles|sprinkles
1402413|NCT01154803|convalescence|convalescence
1402414|NCT01154803|weight|weight
1402415|NCT01154803|morbidity|morbidity
1402416|NCT01154790|healthy volunteers|healthy volunteers
1402417|NCT01154777|Neurofeedback|neurofeedback
1402418|NCT01154777|Braintraining|braintraining
1402419|NCT01154777|Autism|autism
1402420|NCT01154777|Mild|mild
1402421|NCT01154777|Moderate|moderate
1402422|NCT01154777|Mild to Moderate Autism|mild to moderate autism
1402423|NCT01154764|healthy male volunteers|healthy male volunteers
1402424|NCT01154751|Femoral artery stenosis|femoral artery stenosis
1402425|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
1402426|NCT01154725|Patient education|patient education
1402427|NCT01154725|Health-Related Quality of Life|health-related quality of life
1402428|NCT01154725|patients with stomas|patients with stomas
1402429|NCT01154725|stomatherapy|stomatherapy
1402430|NCT01154725|health economics|health economics
1402431|NCT01154712|Gambling|gambling
1402432|NCT01154712|Deep TMS|deep tms
1402433|NCT01154712|addiction|addiction
1402434|NCT01154712|Brain stimulation|brain stimulation
1402435|NCT01154699|Asthma|asthma
1402436|NCT01154699|Nocturnal Asthma|nocturnal asthma
1402437|NCT01154699|Lung volumes|lung volumes
1402438|NCT01154699|Deep inspiration|deep inspiration
1402439|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
1402440|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
1402441|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
1402442|NCT01154634|Reflux inhibition|reflux inhibition
1402443|NCT01154621|Phase I|phase i
1402444|NCT01154621|Double-blind|double-blind
1402445|NCT01154621|Randomized|randomized
1402446|NCT01154621|Placebo-controlled study|placebo-controlled study
1402447|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
1402448|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
1402449|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
1402450|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
1402451|NCT01154582|ingestive behavior|ingestive behavior
1402452|NCT01154569|drug absorption|drug absorption
1402453|NCT01154569|azithromycin|azithromycin
1402454|NCT01154569|obesity|obesity
1402455|NCT01154569|bariatric surgery|bariatric surgery
1402456|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
1402457|NCT01154556|failed NNRTI regime|failed nnrti regime
1402458|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
1402459|NCT01154530|Gastroscopy|gastroscopy
1402460|NCT01154530|Bacteria|bacteria
1402461|NCT01154530|Chlorhexidine|chlorhexidine
1402462|NCT01154530|General surgery|general surgery
1402463|NCT01154504|adrenomedullin|adrenomedullin
1402464|NCT01154504|heart failure|heart failure
1402465|NCT01154504|ultrafiltration|ultrafiltration
1402466|NCT01154504|hemofiltration|hemofiltration
1402467|NCT01154491|hip fractures|hip fractures
1402468|NCT01154491|blood substitutes|blood substitutes
1402469|NCT01154491|blood transfusion|blood transfusion
1402470|NCT01154491|intravenous infusion|intravenous infusion
1402471|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
1402472|NCT01154491|frail elderly|frail elderly
1403043|NCT01152034|Recurrence|recurrence
1402473|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
1402474|NCT01154465|Central venous catheterization|central venous catheterization
1402475|NCT01154465|Obese|obese
1402476|NCT01154465|Ultrasound guidance|ultrasound guidance
1402477|NCT01154465|Jugular|jugular
1402478|NCT01154465|Randomized|randomized
1402479|NCT01154465|Intensive Care Unit|intensive care unit
1402480|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1402481|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1402482|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
1402483|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1402484|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1402485|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1567158|NCT00509717|prescriptions, drug|prescriptions, drug
1402486|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1402487|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1402488|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1402489|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1402490|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1402491|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1402492|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1402493|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1402494|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1402495|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1402496|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1402497|NCT01154400|casein protein|casein protein
1402498|NCT01154400|whey protein|whey protein
1402499|NCT01154400|hydrolysates|hydrolysates
1402500|NCT01154400|leucine|leucine
1402501|NCT01154400|protein metabolism|protein metabolism
1402502|NCT01154400|COPD|copd
1402503|NCT01154387|Kidney|kidney
1402504|NCT01154387|Renal|renal
1402505|NCT01154387|Transplant|transplant
1402506|NCT01154387|Kidney Transplant|kidney transplant
1402507|NCT01154387|Kidney Failure|kidney failure
1402508|NCT01154387|Induction|induction
1402509|NCT01154387|Monoclonal|monoclonal
1402510|NCT01154387|Antibody|antibody
1402511|NCT01154387|T cell|t cell
1402512|NCT01154387|Anti-rejection|anti-rejection
1402513|NCT01154387|Immunosuppression|immunosuppression
1402514|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
1402515|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
1402516|NCT01154361|Bradykinin|bradykinin
1402517|NCT01154361|Non-itching edema|non-itching edema
1402518|NCT01154361|Non-allergic angioedema|non-allergic angioedema
1402519|NCT01154361|Quincke edema|quincke edema
1402520|NCT01154361|Drug induced angioedema|drug induced angioedema
1402521|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
1402522|NCT01154361|Icatibant|icatibant
1402523|NCT01154361|HOE 140|hoe 140
1402524|NCT01154348|Metformin|metformin
1402525|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
1402526|NCT01154309|Depression|depression
1402527|NCT01154309|Substance Use|substance use
1402528|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
1402529|NCT01154296|HIV|hiv
1402530|NCT01154296|Rapid Testing|rapid testing
1402531|NCT01154296|Counseling|counseling
1402532|NCT01154296|STD|std
1402533|NCT01154296|U.S.|u.s.
1402534|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
1402535|NCT01154270|radiation|radiation
1402536|NCT01154270|carbon ion therapy|carbon ion therapy
1402537|NCT01154257|Dental plaque|dental plaque
1402538|NCT01154257|Gingivitis|gingivitis
1402539|NCT01154244|Insulin resistance|insulin resistance
1402540|NCT01154244|Insulin deficiency|insulin deficiency
1402541|NCT01154244|HOMA-IR|homa-ir
1402542|NCT01154244|Drug naive|drug naive
1402543|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
1402544|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
1402545|NCT01154218|bioequivalence|bioequivalence
1402546|NCT01154218|food effect|food effect
1402547|NCT01154218|pharmacokinetics|pharmacokinetics
1402548|NCT01154218|crizotinib|crizotinib
1402549|NCT01154192|PCOS|pcos
1402550|NCT01154192|oligomenorrhea|oligomenorrhea
1402551|NCT01154192|irregular menses|irregular menses
1402552|NCT01154192|hyperandrogenemia|hyperandrogenemia
1402553|NCT01154192|elevated testosterone|elevated testosterone
1402554|NCT01154192|adolescents|adolescents
1402555|NCT01154192|androgens|androgens
1402556|NCT01154192|ovary|ovary
1402557|NCT01154192|LH|lh
1402558|NCT01154179|permissive underfeeding|permissive underfeeding
1402559|NCT01154179|hypocaloric feeding|hypocaloric feeding
1402560|NCT01154179|artificial nutrition|artificial nutrition
1402561|NCT01154140|open label|open label
1402562|NCT01154140|randomized Phase 3|randomized phase 3
1402563|NCT01154140|first line treatment|first line treatment
1402564|NCT01154140|non squamous lung cancer|non squamous lung cancer
1402565|NCT01154140|ALK translocation event positive|alk translocation event positive
1402566|NCT01154127|NVA237|nva237
1402567|NCT01154127|COPD|copd
1402568|NCT01154127|bronchodilator|bronchodilator
1402569|NCT01154127|exercise endurance|exercise endurance
1402570|NCT01154114|healthy volunteer|healthy volunteer
1402571|NCT01154114|hepatic impairment|hepatic impairment
1402572|NCT01154114|darapladib|darapladib
1402573|NCT01154114|atherosclerosis|atherosclerosis
1402574|NCT01154088|Adolescent|adolescent
1402575|NCT01154088|Vaccine, conjugate|vaccine, conjugate
1402576|NCT01154088|Adult|adult
1402577|NCT01154088|Neisseria meningitidis|neisseria meningitidis
1402578|NCT01154088|Immunogenicity|immunogenicity
1402579|NCT01154088|Meningococcal vaccine|meningococcal vaccine
1402580|NCT01154088|Safety|safety
1402581|NCT01154075|Liver transplant|liver transplant
1402582|NCT01154075|Adherence|adherence
1402583|NCT01154075|Compliance|compliance
1402584|NCT01154075|Tacrolimus|tacrolimus
1402585|NCT01154062|age-related macular degeneration|age-related macular degeneration
1402586|NCT01154062|pazopanib|pazopanib
1402587|NCT01154062|choroidal neovascularization|choroidal neovascularization
1402588|NCT01154062|GW786034|gw786034
1402589|NCT01154049|Schistosomiasis|schistosomiasis
1402590|NCT01154049|Vaccine|vaccine
1402591|NCT01154049|sm14|sm14
1402592|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1402593|NCT01154023|Behavior Therapy|behavior therapy
1402594|NCT01154010|PEMF|pemf
1402595|NCT01154010|iritis|iritis
1402596|NCT01154010|anterior uveitis|anterior uveitis
1402597|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
1402598|NCT01153958|Colposeptine|colposeptine
1402599|NCT01153958|Metronidazole|metronidazole
1402600|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
1402601|NCT01153932|968|968
1402602|NCT01153932|muscular dystrophy|muscular dystrophy
1402603|NCT01153932|duchenne|duchenne
1402604|NCT01153932|DMD|dmd
1402605|NCT01153906|autoimmune diseases|autoimmune diseases
1402606|NCT01153906|HPV vaccine|hpv vaccine
1402607|NCT01153906|papillomavirus|papillomavirus
1402608|NCT01153906|human papillomavirus|human papillomavirus
1402609|NCT01153906|HPV|hpv
1402610|NCT01153893|Pneumococcal disease|pneumococcal disease
1402611|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
1402612|NCT01153893|Catch-up vaccination|catch-up vaccination
1402613|NCT01153893|Immunogenicity|immunogenicity
1402614|NCT01153893|Booster vaccination|booster vaccination
1402615|NCT01153893|Safety|safety
1402616|NCT01153880|Altabax|altabax
1402617|NCT01153880|United States|united states
1402618|NCT01153880|topical|topical
1402619|NCT01153880|Mupirocin|mupirocin
1402620|NCT01153880|Retapamulin|retapamulin
1402621|NCT01153880|Bactroban|bactroban
1402622|NCT01153867|Schema Focused Therapy|schema focused therapy
1402623|NCT01153867|Chronic Depression|chronic depression
1402624|NCT01153867|Mechanisms of Change|mechanisms of change
1402625|NCT01153854|acute diarrhea|acute diarrhea
1402626|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
1402627|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
1402628|NCT01153828|Altargo|altargo
1402629|NCT01153828|Bactroban|bactroban
1402630|NCT01153828|Fucidin|fucidin
1402631|NCT01153828|Fusidic acid|fusidic acid
1402632|NCT01153828|Mupirocin|mupirocin
1402633|NCT01153828|topical|topical
1402634|NCT01153828|Retapamulin|retapamulin
1402635|NCT01153828|United Kingdom|united kingdom
1402636|NCT01153815|efficacy|efficacy
1402637|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
1402638|NCT01153815|safety|safety
1402639|NCT01153815|Botulinum toxin type A|botulinum toxin type a
1402640|NCT01153815|placebo|placebo
1402641|NCT01153815|spasticity|spasticity
1402642|NCT01153802|Positron Emission Tomography|positron emission tomography
1402643|NCT01153802|serotonin|serotonin
1402644|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
1402645|NCT01153802|safety of single oral doses|safety of single oral doses
1402646|NCT01153802|norepinephrine|norepinephrine
1402647|NCT01153802|dopamine|dopamine
1402648|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
1402649|NCT01153789|Vergence and postural control|vergence and postural control
1402650|NCT01153789|Dynamic visual acuity|dynamic visual acuity
1402651|NCT01153776|Arterial switch operation|arterial switch operation
1402652|NCT01153776|Transposition of the great arteries|transposition of the great arteries
1402653|NCT01153776|Congenital heart diseases|congenital heart diseases
1402654|NCT01153776|CT coronary angiography|ct coronary angiography
1402655|NCT01153763|Metastatic melanoma|metastatic melanoma
1402656|NCT01153763|BRAF mutant|braf mutant
1402657|NCT01153763|Melanoma|melanoma
1402658|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
1402659|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
1402660|NCT01153750|bile duct cancer|bile duct cancer
1402661|NCT01153737|Neck pain|neck pain
1402662|NCT01153737|Primary Health Care|primary health care
1402663|NCT01153737|Manual Therapy|manual therapy
1402664|NCT01153737|TENS|tens
1402665|NCT01153685|Fluviral®Influenza|fluviral®influenza
1402666|NCT01153659|rabeprazole|rabeprazole
1402667|NCT01153659|esomeprazole|esomeprazole
1402668|NCT01153659|h. pylori-negative|h. pylori-negative
1402669|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
1402670|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
1402671|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
1402673|NCT01153646|Gene Transfer|gene transfer
1402674|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
1402675|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
1402676|NCT01153620|Acute traumatic wounds|acute traumatic wounds
1402677|NCT01153607|Alzheimer's disease|alzheimer's disease
1402678|NCT01153607|Diagnostic imaging|diagnostic imaging
1402679|NCT01153607|PET diagnosis|pet diagnosis
1402680|NCT01153607|PET tracer|pet tracer
1402681|NCT01153594|Substance Use Disorders|substance use disorders
1402682|NCT01153594|Relapse|relapse
1402683|NCT01153594|Recovery|recovery
1402684|NCT01153594|Disease Management|disease management
1402685|NCT01153594|Long term outcomes|long term outcomes
1402686|NCT01153594|Addiction Treatment|addiction treatment
1402687|NCT01153568|Vitamin D|vitamin d
1402688|NCT01153568|osteoporosis|osteoporosis
1402689|NCT01153568|african american women|african american women
1402690|NCT01153529|PTSD|ptsd
1402691|NCT01153516|Type 2 diabetes|type 2 diabetes
1402692|NCT01153516|Bariatric surgery|bariatric surgery
1402693|NCT01153516|Obesity|obesity
1402694|NCT01153516|Weight loss|weight loss
1402695|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
1402696|NCT01153490|Quetiapine|quetiapine
1402697|NCT01153490|Psychotic experiences|psychotic experiences
1402698|NCT01153490|Cannabis dependence|cannabis dependence
1402699|NCT01153490|Craving|craving
1402700|NCT01153490|Mood|mood
1402701|NCT01153490|Substance use|substance use
1402702|NCT01153451|Pending tests|pending tests
1402703|NCT01153451|Discharge|discharge
1402704|NCT01153451|Awareness|awareness
1402705|NCT01153451|Care transitions|care transitions
1402706|NCT01153438|Diabetes|diabetes
1402707|NCT01153438|Obesity|obesity
1402708|NCT01153438|Bariatric surgery|bariatric surgery
1402709|NCT01153438|Gut hormones|gut hormones
1402710|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
1402711|NCT01153438|Insulin|insulin
1402712|NCT01153425|Osteoporosis|osteoporosis
1402713|NCT01153425|Osteopenia|osteopenia
1402714|NCT01153425|Fracture Risk|fracture risk
1402715|NCT01153425|teriparatide or Forteo|teriparatide or forteo
1402716|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
1402717|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
1402718|NCT01153399|EGFR mutations|egfr mutations
1402719|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
1402720|NCT01153386|Treprostinil|treprostinil
1402721|NCT01153386|Pharmacokinetics|pharmacokinetics
1402722|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
1402723|NCT01153347|Major Depressive Disorder|major depressive disorder
1402724|NCT01153347|MDD|mdd
1402725|NCT01153347|Depression|depression
1402726|NCT01153347|Safety|safety
1402727|NCT01153347|add-on therapy|add-on therapy
1402728|NCT01153321|Respiratory disease|respiratory disease
1402729|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1402730|NCT01153308|Morbid Obesity|morbid obesity
1402731|NCT01153308|Obesity|obesity
1402732|NCT01153308|Weight Loss|weight loss
1402733|NCT01153308|Bariatric Surgery|bariatric surgery
1402734|NCT01153295|IBS|ibs
1402735|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
1402736|NCT01153295|diagnosis|diagnosis
1402737|NCT01153295|safety|safety
1402738|NCT01153295|Health related quality of life|health related quality of life
1402739|NCT01153282|Breast Cancer patients|breast cancer patients
1402740|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
1402741|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
1402742|NCT01153269|Tolerability|tolerability
1402743|NCT01153269|Effectiveness|effectiveness
1402744|NCT01153243|inflammatory markers|inflammatory markers
1402745|NCT01153230|PQ|pq
1402746|NCT01153217|Tenofovir|tenofovir
1402747|NCT01153217|HIV-infection|hiv-infection
1402748|NCT01153217|BMD|bmd
1402749|NCT01153217|Osteoporosis|osteoporosis
1402750|NCT01153217|Osteopenia|osteopenia
1402751|NCT01153204|Erectile Dysfunction|erectile dysfunction
1402752|NCT01153204|Group Psychotherapy|group psychotherapy
1402753|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
1402754|NCT01153204|Patient Satisfaction|patient satisfaction
1402755|NCT01153204|Efficacy|efficacy
1402756|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
1402757|NCT01153191|colorectal surgery|colorectal surgery
1402758|NCT01153165|Refractory|refractory
1402759|NCT01153165|Asthma|asthma
1402760|NCT01153165|Depression|depression
1402761|NCT01153152|wisdom teeth|wisdom teeth
1402765|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
1402767|NCT01153139|Depression|depression
1402768|NCT01153139|Theta Burst Stimulation|theta burst stimulation
1402769|NCT01153126|Diagnostic Imaging|diagnostic imaging
1402770|NCT01153126|Breast Screening|breast screening
1402771|NCT01153126|Breast Cancer|breast cancer
1402772|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
1402773|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
1567159|NCT00509717|anticholesteremic agents|anticholesteremic agents
1402864|NCT01152775|understanding and retention by patients|understanding and retention by patients
1402774|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
1402775|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
1402776|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
1402777|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1402778|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
1402779|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
1402780|NCT01153100|Diabetes|diabetes
1402781|NCT01153074|Bronchopleural fistula|bronchopleural fistula
1402782|NCT01153074|Bronchoscopy|bronchoscopy
1402783|NCT01153048|Intensification of Education|intensification of education
1402784|NCT01153048|learning nest methodology|learning nest methodology
1402785|NCT01153048|peer educators|peer educators
1402786|NCT01153048|type 2 diabetes|type 2 diabetes
1402787|NCT01153048|Mali|mali
1402788|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
1402793|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
1402794|NCT01153022|Muscle spasticity|muscle spasticity
1402795|NCT01153009|Major Depressive Disorder|major depressive disorder
1402796|NCT01153009|Depression|depression
1402797|NCT01153009|Melancholia|melancholia
1402798|NCT01153009|Drug Therapy|drug therapy
1402799|NCT01152996|Depression|depression
1402800|NCT01152996|Melancholia|melancholia
1402801|NCT01152996|Paraphrenia|paraphrenia
1402802|NCT01152996|Drug Therapy|drug therapy
1402803|NCT01152983|Finger sticks|finger sticks
1402804|NCT01152983|Rapid Ring|rapid ring
1402805|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
1402806|NCT01152957|diabetes|diabetes
1402807|NCT01152957|cardiovascular|cardiovascular
1402808|NCT01152957|chronic|chronic
1402809|NCT01152957|Community Health Workers|community health workers
1402810|NCT01152957|behavioral|behavioral
1402811|NCT01152957|social|social
1402812|NCT01152957|diet|diet
1402813|NCT01152957|exercise|exercise
1402814|NCT01152957|patient|patient
1402815|NCT01152957|cholesterol|cholesterol
1402816|NCT01152957|A1C|a1c
1402817|NCT01152957|glucose|glucose
1402818|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
1402819|NCT01152931|Antioxidants|antioxidants
1402820|NCT01152931|Micronutrients|micronutrients
1402821|NCT01152931|Malaria|malaria
1402822|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
1402823|NCT01152918|HIV Prevention|hiv prevention
1402824|NCT01152918|HIV Treatment|hiv treatment
1402825|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
1402826|NCT01152918|ART for Prevention|art for prevention
1402827|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
1402828|NCT01152918|Financial Incentives|financial incentives
1402829|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
1402830|NCT01152905|Neuromuscular blockade|neuromuscular blockade
1402831|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
1402832|NCT01152905|Atracurium|atracurium
1402833|NCT01152905|Nitrous oxide|nitrous oxide
1402834|NCT01152892|end stage renal disease|end stage renal disease
1402835|NCT01152892|chronic kidney disease|chronic kidney disease
1402836|NCT01152892|cardiovascular event|cardiovascular event
1402837|NCT01152892|sudden cardiac death|sudden cardiac death
1402838|NCT01152892|autonomic function|autonomic function
1402839|NCT01152879|Parenteral Nutrition|parenteral nutrition
1402840|NCT01152879|Quality of Life|quality of life
1402841|NCT01152866|Multifollicular stimulation|multifollicular stimulation
1402842|NCT01152866|Pregnancy|pregnancy
1402843|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
1402844|NCT01152866|Fertilization in Vitro|fertilization in vitro
1402845|NCT01152866|Infertility|infertility
1402846|NCT01152853|advanced gastric cancer|advanced gastric cancer
1402847|NCT01152853|HER2|her2
1402848|NCT01152853|PF00299804|pf00299804
1402849|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
1402850|NCT01152840|RAD001|rad001
1402851|NCT01152827|Pheochromocytoma|pheochromocytoma
1402852|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
1402853|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
1402854|NCT01152827|RAD001|rad001
1402855|NCT01152814|Seasonal influenza|seasonal influenza
1402856|NCT01152814|Vaccine|vaccine
1402857|NCT01152801|mRCC,|mrcc,
1402858|NCT01152801|everolimus,|everolimus,
1402859|NCT01152801|mTOR,|mtor,
1402860|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
1402861|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
1402862|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
1402863|NCT01152775|patient education|patient education
1402865|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
1402866|NCT01152749|Smoking Cessation|smoking cessation
1402867|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
1402868|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1402869|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1402870|NCT01152710|capecitabine|capecitabine
1402871|NCT01152710|chemoradiation|chemoradiation
1402872|NCT01152710|rectal cancer|rectal cancer
1402873|NCT01152710|phase II study|phase ii study
1402874|NCT01152697|nonadherence|nonadherence
1402875|NCT01152697|noncompliance|noncompliance
1402876|NCT01152697|homeless|homeless
1402877|NCT01152697|schizophrenia|schizophrenia
1402878|NCT01152697|schizoaffective|schizoaffective
1402879|NCT01152684|CAM|cam
1402880|NCT01152684|HIV-Positive|hiv-positive
1402881|NCT01152684|Latinos|latinos
1402882|NCT01152684|US-Mexico Border region|us-mexico border region
1402883|NCT01152684|San Diego-Tijuana|san diego-tijuana
1402884|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
1402885|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
1402886|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
1402887|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
1402888|NCT01152632|acupuncture|acupuncture
1402889|NCT01152632|migraine|migraine
1402890|NCT01152632|specific acupoints|specific acupoints
1402891|NCT01152632|brain network|brain network
1402892|NCT01152580|melatonin|melatonin
1402893|NCT01152580|menopause|menopause
1402894|NCT01152580|perimenopause|perimenopause
1402895|NCT01152580|sleep|sleep
1402896|NCT01152580|osteoporosis|osteoporosis
1402897|NCT01152580|osteopenia|osteopenia
1402898|NCT01152580|anxiety|anxiety
1402899|NCT01152580|depression|depression
1402900|NCT01152580|hypertension|hypertension
1402901|NCT01152567|Hypertension|hypertension
1402902|NCT01152567|ACE|ace
1402903|NCT01152567|ARB|arb
1402904|NCT01152567|real life data|real life data
1402905|NCT01152567|CVD|cvd
1402906|NCT01152567|cost effectiveness|cost effectiveness
1402907|NCT01152554|Major Depressive Disorder|major depressive disorder
1402908|NCT01152554|MDD|mdd
1402909|NCT01152554|Depression|depression
1402910|NCT01152554|Safety|safety
1402911|NCT01152554|add-on therapy|add-on therapy
1402912|NCT01152541|Keratoconus|keratoconus
1402913|NCT01152541|Corneal Ectasia|corneal ectasia
1402914|NCT01152541|Collagen Crosslinking|collagen crosslinking
1402915|NCT01152541|Riboflavin|riboflavin
1402916|NCT01152528|bacterial vaginosis|bacterial vaginosis
1402917|NCT01152528|screening|screening
1402918|NCT01152528|abortion|abortion
1402919|NCT01152528|preterm delivery|preterm delivery
1402920|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
1402921|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
1402922|NCT01152489|Pain|pain
1402923|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
1402924|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
1402925|NCT01152463|post-op care|post-op care
1402926|NCT01152463|pneumothorax|pneumothorax
1402927|NCT01152463|pleural effusion|pleural effusion
1402928|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
1402929|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
1402930|NCT01152411|Renal Failure|renal failure
1402931|NCT01152411|Chronic Kidney Disease|chronic kidney disease
1402932|NCT01152411|Chronic Renal Failure|chronic renal failure
1402933|NCT01152398|Breast cancer|breast cancer
1402934|NCT01152398|Vaccine|vaccine
1402935|NCT01152398|Metastatic|metastatic
1402936|NCT01152398|HER-2-positive|her-2-positive
1402937|NCT01152398|Phase I|phase i
1402938|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1402939|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
1402940|NCT01152385|Japanese|japanese
1402941|NCT01152385|phase 2|phase 2
1402942|NCT01152385|AZD1656|azd1656
1402943|NCT01152385|efficacy|efficacy
1402944|NCT01152385|dose regimen|dose regimen
1402945|NCT01152385|pharmacokinetics|pharmacokinetics
1402946|NCT01152359|obesity|obesity
1402947|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
1402948|NCT01152359|diet, fat-restricted|diet, fat-restricted
1402949|NCT01152359|food preferences|food preferences
1402950|NCT01152359|quality of life|quality of life
1402951|NCT01152359|patient compliance|patient compliance
1402952|NCT01152346|Bioequivalence|bioequivalence
1402953|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
1402954|NCT01152346|MDS|mds
1402955|NCT01152346|Azacitidine|azacitidine
1402956|NCT01152320|Asthma|asthma
1402957|NCT01152320|Spirometry|spirometry
1402958|NCT01152320|Pediatric|pediatric
1402959|NCT01152320|Primary Health Care|primary health care
1403442|NCT01150344|Efficacy|efficacy
1402960|NCT01152320|Education, Distance|education, distance
1402961|NCT01152307|Depression|depression
1402962|NCT01152307|Depressive disorder|depressive disorder
1402963|NCT01152307|Decision Making|decision making
1402964|NCT01152307|Decision Aids|decision aids
1402965|NCT01152307|Decision Quality Instrument|decision quality instrument
1402966|NCT01152294|Menopause|menopause
1402967|NCT01152294|Decision making|decision making
1402968|NCT01152294|Decision aids|decision aids
1402969|NCT01152294|Decision quality instrument|decision quality instrument
1402970|NCT01152281|retention|retention
1402971|NCT01152281|attrition|attrition
1402972|NCT01152281|empowering|empowering
1402973|NCT01152281|reactance|reactance
1402974|NCT01152281|motivational|motivational
1402975|NCT01152281|goals|goals
1402976|NCT01152281|Basic control|basic control
1402977|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
1402978|NCT01152281|Instrumental|instrumental
1402979|NCT01152281|Instrumental and Empowering|instrumental and empowering
1402980|NCT01152268|sperm banking|sperm banking
1402981|NCT01152268|Adolescent males|adolescent males
1402982|NCT01152268|Infertility|infertility
1402983|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
1402984|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
1402985|NCT01152242|Insulin|insulin
1402986|NCT01152203|Bendamustine|bendamustine
1402987|NCT01152203|Bevacizumab|bevacizumab
1402988|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
1402989|NCT01152177|General Practice|general practice
1402990|NCT01152177|Point of care testing|point of care testing
1402991|NCT01152177|education|education
1402992|NCT01152164|quality of life|quality of life
1402993|NCT01152164|rectal cancer|rectal cancer
1402994|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
1402995|NCT01152151|General Practice|general practice
1402996|NCT01152151|Point of care testing|point of care testing
1402997|NCT01152151|education|education
1402998|NCT01152138|Acute myocardial infarction|acute myocardial infarction
1402999|NCT01152138|Closed cell stent|closed cell stent
1403000|NCT01152138|Open cell stent|open cell stent
1403001|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1403002|NCT01152125|Osteoarthritis|osteoarthritis
1403003|NCT01152125|stem cell implantation|stem cell implantation
1403004|NCT01152125|bone marrow|bone marrow
1403005|NCT01152125|autologous|autologous
1403006|NCT01152112|morcellator|morcellator
1403007|NCT01152112|hysteroscope|hysteroscope
1403008|NCT01152112|myomectomy|myomectomy
1403009|NCT01152112|polypectomy|polypectomy
1403010|NCT01152112|uterine fibroids|uterine fibroids
1403011|NCT01152112|uterine polyps|uterine polyps
1403012|NCT01152112|office|office
1403013|NCT01152112|cost|cost
1403014|NCT01152112|local anesthetic|local anesthetic
1403015|NCT01152112|cervical block|cervical block
1403016|NCT01152112|pain management|pain management
1403017|NCT01152099|Postmastectomy|postmastectomy
1403018|NCT01152086|Physical activity|physical activity
1403019|NCT01152086|mountain hiking|mountain hiking
1403020|NCT01152086|exercise|exercise
1403021|NCT01152086|training program|training program
1403022|NCT01152086|hopelessness|hopelessness
1403023|NCT01152086|chronic suicidality|chronic suicidality
1403024|NCT01152086|depression|depression
1403025|NCT01152086|suicide attempt|suicide attempt
1403026|NCT01152086|suicide|suicide
1403027|NCT01152073|Cholesterol|cholesterol
1403028|NCT01152073|Statin|statin
1403029|NCT01152073|Nutraceuticals|nutraceuticals
1403030|NCT01152073|Niacin|niacin
1403031|NCT01152073|Hyperlipidemia|hyperlipidemia
1403032|NCT01152073|Liquid|liquid
1403033|NCT01152060|remission of proteinuria|remission of proteinuria
1403034|NCT01152060|HBVe-antigen|hbve-antigen
1403035|NCT01152047|oxytocin|oxytocin
1403036|NCT01152047|satiety|satiety
1403037|NCT01152047|dyspepsia|dyspepsia
1403038|NCT01152034|Bipolar disorder|bipolar disorder
1403039|NCT01152034|psychosocial intervention|psychosocial intervention
1403040|NCT01152034|group therapy|group therapy
1403041|NCT01152034|relapse prevention|relapse prevention
1403042|NCT01152034|parasuicide|parasuicide
1403044|NCT01152034|hospitalization|hospitalization
1403045|NCT01152034|Medication adherence|medication adherence
1403046|NCT01152034|Self-Injurious Behavior|self-injurious behavior
1403047|NCT01152034|Quality of Life|quality of life
1403048|NCT01152021|dexmedetomidine|dexmedetomidine
1403049|NCT01152021|propofol|propofol
1403050|NCT01152021|sedation|sedation
1403051|NCT01152021|MRI|mri
1403052|NCT01152021|scanning|scanning
1403053|NCT01152021|pediatric|pediatric
1403054|NCT01152021|children|children
1403055|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
1403056|NCT01152008|Microcirculation|microcirculation
1403057|NCT01152008|laser flowmetry|laser flowmetry
1403058|NCT01152008|Skin|skin
1403059|NCT01152008|Physiology|physiology
1403060|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
1403061|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
1403062|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
1403443|NCT01150344|Failures|failures
1403063|NCT01151995|Costs of remote monitoring|costs of remote monitoring
1403064|NCT01151982|Depression|depression
1403065|NCT01151982|Primary prevention.|primary prevention.
1403066|NCT01151982|Primary health care.|primary health care.
1403067|NCT01151982|Randomised controlled trial.|randomised controlled trial.
1403068|NCT01151969|Health Service Misuse|health service misuse
1403069|NCT01151969|Overutilization of Health Services|overutilization of health services
1403070|NCT01151969|Primary Health Care|primary health care
1403071|NCT01151969|Cost Effectiveness|cost effectiveness
1403072|NCT01151969|Quality of life|quality of life
1403073|NCT01151969|Randomised Controlled Trial|randomised controlled trial
1403074|NCT01151969|Multilevel analysis|multilevel analysis
1403075|NCT01151956|observational study|observational study
1403076|NCT01151956|actinic keratosis|actinic keratosis
1403077|NCT01151956|imiquimod|imiquimod
1403078|NCT01151943|cesarean section|cesarean section
1403079|NCT01151943|continuous wound infiltration|continuous wound infiltration
1403080|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
1403081|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
1403082|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
1403083|NCT01151917|morbid obesity|morbid obesity
1403084|NCT01151917|insulin resistance|insulin resistance
1403085|NCT01151917|proteomics|proteomics
1403086|NCT01151891|Pedal puncture wounds|pedal puncture wounds
1403087|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
1403088|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
1403089|NCT01151878|constipation|constipation
1403090|NCT01151878|children|children
1403091|NCT01151865|Delirium|delirium
1403092|NCT01151865|Intensive Care Unit|intensive care unit
1403093|NCT01151865|Dexmedetomidine|dexmedetomidine
1403094|NCT01151852|Imatinib|imatinib
1403095|NCT01151852|Re-challenge|re-challenge
1403096|NCT01151839|Esophagus|esophagus
1403097|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
1403098|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
1403099|NCT01151826|Lung transplantation|lung transplantation
1403100|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
1403101|NCT01151826|Extravascular Lung Water|extravascular lung water
1403102|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
1403103|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
1403104|NCT01151800|ACS|acs
1403105|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
1403106|NCT01151800|Best Practice Guidelines|best practice guidelines
1403107|NCT01151800|Health Care Utilization|health care utilization
1403108|NCT01151800|Outcome Assessment|outcome assessment
1403109|NCT01151787|migraine|migraine
1403110|NCT01151735|Angioedema|angioedema
1403111|NCT01151735|Hereditary Diseases|hereditary diseases
1403112|NCT01151735|Orphan Disease|orphan disease
1403113|NCT01151735|HAE|hae
1403114|NCT01151709|Gout|gout
1403115|NCT01151709|Chronic condition management|chronic condition management
1403116|NCT01151709|Gout management|gout management
1403117|NCT01151696|Pain|pain
1403118|NCT01151696|morphine|morphine
1403119|NCT01151696|hydroxyzine|hydroxyzine
1403120|NCT01151696|acute pain|acute pain
1403121|NCT01151696|traumatic pain|traumatic pain
1403122|NCT01151696|anxiety|anxiety
1403123|NCT01151696|post trauma stress|post trauma stress
1403124|NCT01151696|post trauma anxiety|post trauma anxiety
1403125|NCT01151696|post trauma disorders|post trauma disorders
1403126|NCT01151683|hypertension|hypertension
1403127|NCT01151683|endothelial dysfunction|endothelial dysfunction
1403128|NCT01151670|radiation therapy|radiation therapy
1403129|NCT01151670|cognitive dysfunction|cognitive dysfunction
1403130|NCT01151670|brain tumor|brain tumor
1403131|NCT01151670|memory problems|memory problems
1403132|NCT01151670|short term memory loss|short term memory loss
1403134|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
1403135|NCT01151657|Probiotics|probiotics
1403136|NCT01151657|Treatment|treatment
1403137|NCT01151657|Adequate relief|adequate relief
1403138|NCT01151644|H1N1 VACCINE|h1n1 vaccine
1403139|NCT01151644|INFLUENZA|influenza
1403140|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
1403141|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
1403142|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
1403143|NCT01151579|Tachycardia|tachycardia
1403144|NCT01151579|tachyarrhythmias|tachyarrhythmias
1403145|NCT01151579|bronchodilator therapy|bronchodilator therapy
1403146|NCT01151579|Critically ill patients|critically ill patients
1403147|NCT01151566|Ultrasound|ultrasound
1403148|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
1403149|NCT01151566|Nephrotoxicity|nephrotoxicity
1403150|NCT01151566|CT contrast agents|ct contrast agents
1403151|NCT01151553|Cardiology|cardiology
1403152|NCT01151553|Cardiomyopathy|cardiomyopathy
1403153|NCT01151553|Cardiovascular Disease|cardiovascular disease
1403154|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
1403155|NCT01151540|Epilepsy|epilepsy
1403156|NCT01151540|Seizures|seizures
1403157|NCT01151514|No referral|no referral
1403158|NCT01151514|Late referral|late referral
1403159|NCT01151514|Acute kidney injury|acute kidney injury
1403160|NCT01151514|Intensive care unit|intensive care unit
1403161|NCT01151514|In-hospital mortality|in-hospital mortality
1403162|NCT01151514|Renal outcome|renal outcome
1403163|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
1403164|NCT01151514|Length of hospital stay|length of hospital stay
1403165|NCT01151514|Impact|impact
1403166|NCT01151514|Incidence|incidence
1403167|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
1403168|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
1403169|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
1403170|NCT01151501|ventilator weaning|ventilator weaning
1403171|NCT01151475|liver cirrhosis|liver cirrhosis
1403172|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
1403173|NCT01151475|ammonia|ammonia
1403174|NCT01151475|cerebral blood flow|cerebral blood flow
1403175|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
1403176|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
1403177|NCT01151462|Hearing loss|hearing loss
1403178|NCT01151462|Mental retardation|mental retardation
1403179|NCT01151462|Microcephaly|microcephaly
1403180|NCT01151462|Chorioretinitis|chorioretinitis
1403181|NCT01151462|Growth|growth
1403182|NCT01151436|Facial wrinkle correction|facial wrinkle correction
1403183|NCT01151410|Pediatric hypertension|pediatric hypertension
1403184|NCT01151410|primary hypertension|primary hypertension
1403185|NCT01151410|secondary|secondary
1403186|NCT01151410|hypertension|hypertension
1403187|NCT01151397|SVR|svr
1403188|NCT01151397|VITAMIN D|vitamin d
1403189|NCT01151397|Hepatitis C|hepatitis c
1403190|NCT01151397|Genotype 2,3|genotype 2,3
1403191|NCT01151397|Naive|naive
1403192|NCT01151397|RVR|rvr
1403193|NCT01151384|Cancer Patients|cancer patients
1403194|NCT01151358|radioimmunotherapy|radioimmunotherapy
1403195|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
1403196|NCT01151358|FDG-PET|fdg-pet
1403197|NCT01151358|prognostic factors|prognostic factors
1403198|NCT01151358|multicenter study|multicenter study
1403199|NCT01151345|diltiazem|diltiazem
1403200|NCT01151345|angiotrofin|angiotrofin
1403201|NCT01151345|bioequivalence|bioequivalence
1403202|NCT01151293|Type D personality|type d personality
1403203|NCT01151293|diabetes|diabetes
1403204|NCT01151293|medical compliance|medical compliance
1403205|NCT01151293|HbA1c|hba1c
1403206|NCT01151293|complication|complication
1403207|NCT01151293|mortality|mortality
1403208|NCT01151293|T2DM|t2dm
1403209|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
1403210|NCT01151267|Anesthesia|anesthesia
1403211|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
1403212|NCT01151267|Recovery from anesthesia|recovery from anesthesia
1403213|NCT01151254|Cardiac Surgery|cardiac surgery
1403214|NCT01151254|Sedation|sedation
1403215|NCT01151254|Intensive care|intensive care
1403216|NCT01151254|Volatile anesthesia|volatile anesthesia
1403217|NCT01151254|Intravenous anesthesia|intravenous anesthesia
1403218|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
1403219|NCT01151241|elbow surgery|elbow surgery
1403220|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
1403221|NCT01151241|continuous passive motion|continuous passive motion
1403222|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
1403223|NCT01151241|early discharge|early discharge
1403224|NCT01151228|gastroscopy|gastroscopy
1403225|NCT01151228|ultrasound|ultrasound
1403226|NCT01151228|stomach volume|stomach volume
1403227|NCT01151228|patients having gastroscopy|patients having gastroscopy
1403228|NCT01151215|Cancer|cancer
1403229|NCT01151215|tumour|tumour
1403230|NCT01151215|breast cancer|breast cancer
1403231|NCT01151215|metastatic|metastatic
1403232|NCT01151215|secondary|secondary
1403233|NCT01151215|locally advanced|locally advanced
1403234|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
1403235|NCT01151189|HIV|hiv
1403236|NCT01151189|Tuberculosis|tuberculosis
1403237|NCT01151189|Vaccine|vaccine
1403238|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
1403239|NCT01151176|Glucose control|glucose control
1403240|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
1403241|NCT01151176|Intensive Care|intensive care
1403242|NCT01150916|natriuretic peptide|natriuretic peptide
1403243|NCT01150916|heart failure|heart failure
1403244|NCT01150916|ascites|ascites
1403245|NCT01150916|liver cirrhosis|liver cirrhosis
1403246|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
1403247|NCT01149226|pediatric patients|pediatric patients
1403248|NCT01149226|ASA physical status I or II|asa physical status i or ii
1530593|NCT00660205|DVT|dvt
1403249|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
1403250|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
1403251|NCT01151111|Parkinson's disease|parkinson's disease
1403252|NCT01151111|Relaxation|relaxation
1403253|NCT01151111|Visual imagery|visual imagery
1403254|NCT01151111|Motor fluctuations|motor fluctuations
1403255|NCT01151111|Treatment|treatment
1403256|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
1403257|NCT01151098|Opioid|opioid
1403258|NCT01151098|Transdermal|transdermal
1403259|NCT01151098|Butrans (BTDS)|butrans (btds)
1403260|NCT01151085|Systemic Mycosis|systemic mycosis
1403261|NCT01151085|Aspergillus infection|aspergillus infection
1403262|NCT01151085|Candidiasis|candidiasis
1403263|NCT01151085|Cryptococcal infections|cryptococcal infections
1403264|NCT01151085|Japanese|japanese
1403265|NCT01151085|voriconazole|voriconazole
1403266|NCT01151085|VFEND|vfend
1403267|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
1403268|NCT01151059|seasonal influenza|seasonal influenza
1403269|NCT01151059|vaccine|vaccine
1403270|NCT01151046|Breast Cancer|breast cancer
1403271|NCT01151046|Her2 negative|her2 negative
1403272|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
1403273|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
1403274|NCT01151046|MM-121|mm-121
1403275|NCT01151046|Exemestane|exemestane
1403276|NCT01151046|Postmenopausal Women|postmenopausal women
1403277|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
1403279|NCT01151033|stent|stent
1403280|NCT01151033|coronary artery lesions|coronary artery lesions
1403281|NCT01151033|ProNOVA|pronova
1403282|NCT01151033|stent implantation|stent implantation
1403283|NCT01151020|Aortic Aneurysm|aortic aneurysm
1403284|NCT01151020|Aneurysm|aneurysm
1403285|NCT01151020|Vascular Prosthesis|vascular prosthesis
1403286|NCT01151020|Vascular Disease|vascular disease
1403287|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
1403288|NCT01151007|Kras mutation|kras mutation
1403289|NCT01151007|colorectal carcinoma|colorectal carcinoma
1403290|NCT01151007|Martinique|martinique
1403291|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
1403292|NCT01150955|Resveratrol|resveratrol
1403293|NCT01150955|Diabetes|diabetes
1403294|NCT01150955|SIRT1|sirt1
1403295|NCT01150955|STAT5|stat5
1403296|NCT01150955|IGF-I|igf-i
1403297|NCT01150955|Growth hormone|growth hormone
1403298|NCT01150955|NAFLD|nafld
1403299|NCT01150955|Longevity|longevity
1403300|NCT01150955|Substrate metabolism|substrate metabolism
1403301|NCT01150955|Calorie restriction|calorie restriction
1403302|NCT01150942|JEV|jev
1403303|NCT01150942|vero cell|vero cell
1403304|NCT01150929|Knee arthroplasty|knee arthroplasty
1403305|NCT01150929|RSA|rsa
1403306|NCT01150929|DXA|dxa
1403307|NCT01150929|Gait analysis|gait analysis
1403308|NCT01150929|Motion analysis|motion analysis
1403309|NCT01150903|erectile dysfunction|erectile dysfunction
1403310|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
1403311|NCT01150903|cardiovascular diseases|cardiovascular diseases
1403312|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
1403313|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
1403314|NCT01150890|Colonic Chron's Disease|colonic chron's disease
1403315|NCT01150877|Vitamin D|vitamin d
1403316|NCT01150877|Vitamin D3|vitamin d3
1403317|NCT01150877|colon cancer|colon cancer
1403318|NCT01150877|rectal cancer|rectal cancer
1403319|NCT01150877|Cholecalciferol|cholecalciferol
1403320|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
1403321|NCT01150825|STEMI|stemi
1403322|NCT01150825|NSTEMI|nstemi
1403323|NCT01150825|acute ischemia|acute ischemia
1403324|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
1403325|NCT01150825|elevated troponin|elevated troponin
1403326|NCT01150812|First time in man|first time in man
1403327|NCT01150812|healthy|healthy
1403328|NCT01150812|thrombin inhibitor|thrombin inhibitor
1403329|NCT01150786|inflammation|inflammation
1403330|NCT01150786|oxidative stress|oxidative stress
1403331|NCT01150786|selenium|selenium
1403332|NCT01150786|hemodialysis|hemodialysis
1403333|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
1403334|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
1403335|NCT01150760|mortality|mortality
1403336|NCT01150760|readmission|readmission
1403337|NCT01150760|length of stay|length of stay
1403338|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
1403339|NCT01150734|differences in neuromodulation|differences in neuromodulation
1403340|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
1403341|NCT01150721|Atypical Mycobacterium Infection|atypical mycobacterium infection
1403342|NCT01150721|Microbial Tests|microbial tests
1403343|NCT01150721|Molecular Tests|molecular tests
1403344|NCT01150721|Inflammation|inflammation
1403345|NCT01150721|Respiratory Secretions|respiratory secretions
1403346|NCT01150708|Syringomyelia|syringomyelia
1403347|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
1403348|NCT01150708|Natural History Study|natural history study
1403349|NCT01150708|Neurological Examination|neurological examination
1403441|NCT01150344|P. falciparum|p. falciparum
1403350|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
1403351|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
1403352|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
1403353|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
1403354|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1403355|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1403356|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1403357|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1403358|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1403359|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1403360|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1403361|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1403362|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1403363|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1403364|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
1403365|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
1403366|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
1403367|NCT01150617|Normoglycemia|normoglycemia
1403368|NCT01150617|Peripheral angioplasty|peripheral angioplasty
1403369|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
1403370|NCT01150604|Mood Management|mood management
1403371|NCT01150604|Self-help|self-help
1403372|NCT01150604|Internet|internet
1403373|NCT01150578|Echocardiography, 2D|echocardiography, 2d
1403374|NCT01150578|speckle tracking|speckle tracking
1403375|NCT01150578|Lexiscan|lexiscan
1403376|NCT01150578|regadenoson|regadenoson
1403377|NCT01150578|Myocardial ischemia|myocardial ischemia
1403378|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
1403379|NCT01150578|cost and cost analysis|cost and cost analysis
1403380|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
1403381|NCT01150578|Echocardiography|echocardiography
1403382|NCT01150552|Serology|serology
1403383|NCT01150552|Poultry|poultry
1403384|NCT01150552|H5N1 virus|h5n1 virus
1403385|NCT01150552|HPAI virus|hpai virus
1403386|NCT01150526|Acute Exercise|acute exercise
1403387|NCT01150526|Muscle Inflammation|muscle inflammation
1403388|NCT01150526|CaHMB|cahmb
1403389|NCT01150526|HMB Free Acid Gel|hmb free acid gel
1403390|NCT01150526|Healthy Subjects|healthy subjects
1403391|NCT01150513|TRIPLE-NEGATIVE|triple-negative
1403392|NCT01150513|BREAST CANCER|breast cancer
1403393|NCT01150500|Medtronic|medtronic
1403394|NCT01150500|Japan|japan
1403395|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
1403396|NCT01150500|Myocardial Ischemia|myocardial ischemia
1403397|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
1403398|NCT01150500|Coronary Artery Disease|coronary artery disease
1403399|NCT01150500|Small Vessel Stent|small vessel stent
1403400|NCT01150487|kidney transplant|kidney transplant
1403401|NCT01150474|Belladonna|belladonna
1403402|NCT01150474|Morphine|morphine
1403403|NCT01150474|Suppositories|suppositories
1403404|NCT01150474|Vaginal|vaginal
1403405|NCT01150474|Surgery|surgery
1403406|NCT01150474|Postoperative|postoperative
1403407|NCT01150474|Pain|pain
1403408|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
1403409|NCT01150448|Paliperidone palmitate|paliperidone palmitate
1403410|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
1403411|NCT01150448|R092670PSY1008|r092670psy1008
1403412|NCT01150448|Risperidone|risperidone
1403413|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
1403414|NCT01150448|Pharmacokinetics|pharmacokinetics
1403415|NCT01150422|medical abortion|medical abortion
1403416|NCT01150409|Sepsis|sepsis
1403417|NCT01150409|hydrocortisone|hydrocortisone
1403418|NCT01150396|extremely premature infant|extremely premature infant
1403419|NCT01150396|outcome|outcome
1403420|NCT01150396|follow-up|follow-up
1403421|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
1403422|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
1403423|NCT01150383|Lung Diseases|lung diseases
1403424|NCT01150383|Respiration Disorders|respiration disorders
1403425|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1403426|NCT01150383|COPD|copd
1403427|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1403428|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1403429|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
1403430|NCT01150383|oxygen|oxygen
1403431|NCT01150383|oxygen supplementation|oxygen supplementation
1403432|NCT01150370|male circumcision|male circumcision
1403433|NCT01150370|HIV|hiv
1403434|NCT01150370|Rwanda|rwanda
1403435|NCT01150370|HIV Seronegativity|hiv seronegativity
1403436|NCT01150357|Pediatric hypertension|pediatric hypertension
1403437|NCT01150357|primary hypertension|primary hypertension
1403438|NCT01150357|secondary hypertension|secondary hypertension
1403439|NCT01150344|Multicentric study|multicentric study
1403440|NCT01150344|Antimalarial|antimalarial
1403444|NCT01150344|Malarone|malarone
1403445|NCT01150344|RIAMET|riamet
1403446|NCT01150331|status epilepticus|status epilepticus
1403447|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
1403448|NCT01150331|first line treatments|first line treatments
1403449|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
1403450|NCT01150331|prehospital treatment|prehospital treatment
1403451|NCT01150318|Male|male
1403452|NCT01150318|Infertility|infertility
1403453|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
1403454|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
1403455|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
1403456|NCT01150305|Mutation|mutation
1403457|NCT01150305|Prevalence|prevalence
1403458|NCT01150292|DHA supplementation|dha supplementation
1403459|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
1403460|NCT01150292|Platelet function|platelet function
1403461|NCT01150279|medical abortion|medical abortion
1403462|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
1403463|NCT01150266|stroke|stroke
1403464|NCT01150266|ischemia|ischemia
1403465|NCT01150266|thrombolysis|thrombolysis
1403466|NCT01150266|thrombolytics|thrombolytics
1403467|NCT01150266|tPA|tpa
1403468|NCT01150266|rt-PA|rt-pa
1403469|NCT01150266|t-PA|t-pa
1403470|NCT01150266|Activase®|activase®
1403471|NCT01150266|Alteplase|alteplase
1403472|NCT01150266|wake-up stroke|wake-up stroke
1403473|NCT01150266|waking onset stroke|waking onset stroke
1403474|NCT01150266|sleep|sleep
1403475|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
1403476|NCT01150214|atrial fibrillation|atrial fibrillation
1403477|NCT01150214|af|af
1403478|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
1403479|NCT01150214|mri|mri
1403480|NCT01150214|left atrium|left atrium
1403481|NCT01150214|fibrosis|fibrosis
1403482|NCT01150214|structural remodeling|structural remodeling
1403483|NCT01150201|CKD|ckd
1403484|NCT01150201|proteinuria|proteinuria
1403485|NCT01150201|eGFR|egfr
1403486|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
1403487|NCT01150188|aging|aging
1403488|NCT01150188|lipid metabolism|lipid metabolism
1403489|NCT01150188|very low density lipoproteins|very low density lipoproteins
1403490|NCT01150188|amino acids|amino acids
1403491|NCT01150188|dietary supplements|dietary supplements
1403492|NCT01150175|END-HF|end-hf
1403493|NCT01150149|Influenza|influenza
1403494|NCT01150149|Humans|humans
1403495|NCT01150149|Experimental|experimental
1403496|NCT01150149|Challenge|challenge
1403497|NCT01150136|choline|choline
1403498|NCT01150136|cystic fibrosis|cystic fibrosis
1403499|NCT01150136|methyl metabolism|methyl metabolism
1403500|NCT01150136|oxidative stress|oxidative stress
1403501|NCT01150123|Group B streptococcus|group b streptococcus
1403502|NCT01150123|GBS|gbs
1403503|NCT01150123|Vaccine|vaccine
1403504|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
1403505|NCT01150110|Temporomandibular disorders|temporomandibular disorders
1403506|NCT01150110|occlusal splints|occlusal splints
1403507|NCT01150110|electromyography|electromyography
1403508|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
1403509|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
1403510|NCT01150097|Liver transplantation|liver transplantation
1403511|NCT01150097|Everolimus|everolimus
1403512|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
1403513|NCT01150097|Tacrolimus|tacrolimus
1403514|NCT01150097|Renal function|renal function
1403515|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
1403516|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
1403517|NCT01150071|extremely premature infant|extremely premature infant
1403518|NCT01150071|follow-up|follow-up
1403519|NCT01150071|behavior|behavior
1403520|NCT01150071|growth|growth
1403521|NCT01150071|mental health|mental health
1403522|NCT01150071|lung function|lung function
1403523|NCT01150071|spirometry|spirometry
1403524|NCT01150071|muscle mass|muscle mass
1403525|NCT01150071|bone density|bone density
1403526|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
1403527|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1403528|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1403529|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1403530|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1403531|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1403532|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1403533|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1403534|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
1403535|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
1403536|NCT01150045|stage III colon cancer|stage iii colon cancer
1403537|NCT01150032|Osteoporosis|osteoporosis
1403538|NCT01150032|Fracture|fracture
1403539|NCT01150032|Bone microarchitecture|bone microarchitecture
1403540|NCT01150019|atherosclerosis|atherosclerosis
1403541|NCT01150019|vascular inflammation|vascular inflammation
1403542|NCT01150019|resistin|resistin
1403543|NCT01150019|adiponectin|adiponectin
1403544|NCT01150019|18FDG-PET|18fdg-pet
1403545|NCT01150006|atherosclerosis|atherosclerosis
1403546|NCT01150006|vascular inflammation|vascular inflammation
1403547|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
1403548|NCT01150006|adiponectin|adiponectin
1403549|NCT01150006|leptin|leptin
1403550|NCT01150006|18FDG-PET|18fdg-pet
1403551|NCT01149993|living donation|living donation
1403552|NCT01149993|kidney transplantation|kidney transplantation
1403553|NCT01149993|delayed graft function|delayed graft function
1403554|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
1403555|NCT01149980|Bioequivalence|bioequivalence
1403556|NCT01149980|Crossover|crossover
1403557|NCT01149980|Citalopram|citalopram
1403558|NCT01149967|Bioequivalence|bioequivalence
1403559|NCT01149967|Citalopram|citalopram
1403560|NCT01149967|Crossover|crossover
1403561|NCT01149954|Bioequivalence|bioequivalence
1403562|NCT01149954|Crossover|crossover
1403563|NCT01149954|Ibuprofen|ibuprofen
1403564|NCT01149941|Bioequivalence|bioequivalence
1403565|NCT01149941|Crossover|crossover
1403566|NCT01149941|Ibuprofen|ibuprofen
1403567|NCT01149928|Fetal lung fluid|fetal lung fluid
1403568|NCT01149928|Pulmonary adaptation|pulmonary adaptation
1403569|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
1403570|NCT01149928|Epinephrine|epinephrine
1403571|NCT01149928|Stress hormones|stress hormones
1403572|NCT01149915|Advanced Leukemias|advanced leukemias
1403573|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
1403575|NCT01149915|ALL|all
1403576|NCT01149915|CML|cml
1403577|NCT01149915|MDS|mds
1403578|NCT01149915|CLL|cll
1403579|NCT01149915|MF|mf
1403580|NCT01149915|Evofosfamide|evofosfamide
1403581|NCT01149863|Autologous Transplantation|autologous transplantation
1403582|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
1403583|NCT01149850|adult glioblastoma|adult glioblastoma
1403584|NCT01149850|adult gliosarcoma|adult gliosarcoma
1403585|NCT01149837|HTLV|htlv
1403586|NCT01149837|HTLV I|htlv i
1403587|NCT01149837|HTLV II|htlv ii
1403588|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
1403589|NCT01149824|Salvia divinorum|salvia divinorum
1403590|NCT01149824|Salvinorin A|salvinorin a
1403591|NCT01149811|Dyskinesia|dyskinesia
1403592|NCT01149798|metastatic breast cancer|metastatic breast cancer
1403593|NCT01149798|combined chemotherapy|combined chemotherapy
1403594|NCT01149785|crizotinib|crizotinib
1403595|NCT01149785|healthy volunteers|healthy volunteers
1403596|NCT01149785|ketoconazole|ketoconazole
1403597|NCT01149785|pharmacokinetics|pharmacokinetics
1403598|NCT01149785|single dose|single dose
1403599|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1403600|NCT01149772|Heart Failure|heart failure
1403601|NCT01149772|Anxiety|anxiety
1403602|NCT01149772|Depression|depression
1403603|NCT01149759|Atopic Dermatitis|atopic dermatitis
1403604|NCT01149759|Eczema|eczema
1403605|NCT01149720|Relative bioavailability|relative bioavailability
1403606|NCT01149720|ARQ 197|arq 197
1403607|NCT01149707|PUR 0110|pur 0110
1403608|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
1403609|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
1403610|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
1403611|NCT01149707|Mild|mild
1403612|NCT01149707|Moderate|moderate
1403613|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
1403614|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
1403615|NCT01149694|Ulcerative colitis|ulcerative colitis
1403616|NCT01149694|Distal|distal
1403617|NCT01149694|Normal healthy volunteers|normal healthy volunteers
1403618|NCT01149681|Aplidin|aplidin
1403619|NCT01149681|Plitidepsin|plitidepsin
1403620|NCT01149681|Myelofibrosis|myelofibrosis
1403621|NCT01149681|Pharma Mar|pharma mar
1403622|NCT01149668|PCI-24781|pci-24781
1403623|NCT01149668|Lymphoma|lymphoma
1403624|NCT01149668|Non-Hodgkin's|non-hodgkin's
1403625|NCT01149668|Hodgkin Disease|hodgkin disease
1403626|NCT01149668|Multiple Myeloma|multiple myeloma
1403627|NCT01149668|Leukemia|leukemia
1403628|NCT01149668|Lymphocytic|lymphocytic
1403629|NCT01149668|Chronic|chronic
1403630|NCT01149655|Adolescent|adolescent
1403631|NCT01149655|Schizophrenia|schizophrenia
1403632|NCT01149629|Droxidopa|droxidopa
1403633|NCT01149629|Randomized|randomized
1403634|NCT01149629|Crossover|crossover
1403635|NCT01149629|Open Label|open label
1403636|NCT01149629|Bioequivalence|bioequivalence
1403637|NCT01149629|Fed Fast|fed fast
1403638|NCT01149629|TID|tid
1403639|NCT01149603|failing Fontan|failing fontan
1403640|NCT01149603|single-ventricle|single-ventricle
1403641|NCT01149603|destination therapy|destination therapy
1403642|NCT01149603|HeartMate II|heartmate ii
1403643|NCT01149603|HMII|hmii
1404429|NCT01146509|headache|headache
1403644|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
1403645|NCT01149603|ventricular assist device|ventricular assist device
1403646|NCT01149603|VAD|vad
1403647|NCT01149590|Angina|angina
1403648|NCT01149590|Coronary Heart Disease|coronary heart disease
1403649|NCT01149590|Computed Tomography|computed tomography
1403650|NCT01149590|Angiogram|angiogram
1403651|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
1403652|NCT01149590|Chest Pain|chest pain
1403653|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
1403654|NCT01149577|Olanzapine|olanzapine
1403655|NCT01149577|Schizophrenia|schizophrenia
1403656|NCT01149577|Polysomnography|polysomnography
1403657|NCT01149577|Slow wave sleep|slow wave sleep
1403658|NCT01149551|Schizophrenia|schizophrenia
1403659|NCT01149551|Bipolar disorder|bipolar disorder
1403660|NCT01149551|Genetic research|genetic research
1403661|NCT01149538|FASD|fasd
1403662|NCT01149538|FAS|fas
1403663|NCT01149538|Alcohol|alcohol
1403664|NCT01149538|Prenatal Alcohol|prenatal alcohol
1403665|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
1403666|NCT01149525|Fatigue Syndrome|fatigue syndrome
1403667|NCT01149525|Chronic/drug therapy|chronic/drug therapy
1403668|NCT01149486|Bioequivalence|bioequivalence
1403669|NCT01149486|Healthy Subjects|healthy subjects
1403670|NCT01149473|Bioequivalence|bioequivalence
1403671|NCT01149473|Healthy Subjects|healthy subjects
1403672|NCT01149447|cryptogenic stroke|cryptogenic stroke
1403673|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
1403674|NCT01149447|follow-up exams|follow-up exams
1403675|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
1403676|NCT01149434|ovarian cancers|ovarian cancers
1403677|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
1403678|NCT01149421|Type 2 Diabetes|type 2 diabetes
1403679|NCT01149421|Diabetes|diabetes
1403680|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1403681|NCT01149421|ABPM|abpm
1403682|NCT01149421|Blood Pressure|blood pressure
1403683|NCT01149421|Heart Rate|heart rate
1403684|NCT01149408|AML|aml
1403685|NCT01149408|Decitabine|decitabine
1403686|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
1403687|NCT01149408|Elderly Patients|elderly patients
1403688|NCT01149408|Cancer|cancer
1403689|NCT01149395|Heartburn|heartburn
1403690|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1403691|NCT01149382|flu shot|flu shot
1403692|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
1403693|NCT01149369|gastroparesis|gastroparesis
1403694|NCT01149369|nausea|nausea
1403695|NCT01149369|vomiting|vomiting
1403696|NCT01149343|PRAME|prame
1403697|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
1403698|NCT01149343|Malignant melanoma|malignant melanoma
1403699|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
1403700|NCT01149330|Adapalene|adapalene
1403701|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
1403702|NCT01149330|Acne Vulgaris|acne vulgaris
1403703|NCT01149317|acupuncture|acupuncture
1403704|NCT01149317|health services research|health services research
1403705|NCT01149317|chronic pain|chronic pain
1403706|NCT01149317|health disparities|health disparities
1403707|NCT01149304|brachytherapy|brachytherapy
1403708|NCT01149304|liver metastases|liver metastases
1403709|NCT01149304|irradiation|irradiation
1403710|NCT01149304|radiation induced liver disease|radiation induced liver disease
1403711|NCT01149304|dosimetry|dosimetry
1403712|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
1403713|NCT01149291|cardiorenal|cardiorenal
1403714|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
1403715|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1403716|NCT01149291|dialysis|dialysis
1403717|NCT01149291|paricalcitol|paricalcitol
1403718|NCT01149291|osteodystrophy|osteodystrophy
1403719|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
1403720|NCT01149291|chronic kidney disease|chronic kidney disease
1403721|NCT01149252|Psoriasis|psoriasis
1403722|NCT01149213|Major depressive disorder|major depressive disorder
1403723|NCT01149213|follow-up|follow-up
1403724|NCT01149213|relapse|relapse
1403725|NCT01149213|remission|remission
1403726|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
1403727|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
1403728|NCT01149200|IBS-C|ibs-c
1403729|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
1403730|NCT01149174|early single instillation|early single instillation
1403731|NCT01149174|mitomycin-C|mitomycin-c
1403732|NCT01149174|electromotive drug administration|electromotive drug administration
1403733|NCT01149161|neck dissection|neck dissection
1403734|NCT01149161|sentinel lymph node|sentinel lymph node
1403735|NCT01149161|Carcinoma|carcinoma
1403736|NCT01149161|Papillary|papillary
1403737|NCT01149161|thyroid|thyroid
1403738|NCT01149161|dissection|dissection
1403739|NCT01149148|Aortic Surgeries|aortic surgeries
1403740|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
1404905|NCT01144299|Influenza|influenza
1403741|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
1403742|NCT01149135|phototherapy|phototherapy
1403743|NCT01149135|circadian rhythms|circadian rhythms
1403744|NCT01149135|blue enriched light|blue enriched light
1403745|NCT01149135|melanopsin|melanopsin
1403746|NCT01149135|low intensity|low intensity
1403747|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
1403748|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
1403749|NCT01149122|Erlotinib|erlotinib
1403750|NCT01149109|MGMT promotor status|mgmt promotor status
1403751|NCT01149109|overall survival|overall survival
1403752|NCT01149070|Infertility|infertility
1403753|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
1403754|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
1403755|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
1403756|NCT01149070|Gonal-f|gonal-f
1403757|NCT01149070|Ovitrelle|ovitrelle
1403758|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
1403760|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
1403761|NCT01149044|STEMI|stemi
1403762|NCT01149044|Thrombectomy|thrombectomy
1403763|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
1403764|NCT01149031|Low Level Laser Therapy|low level laser therapy
1403765|NCT01149018|Fibromyalgia|fibromyalgia
1403766|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
1403767|NCT01149018|Chronic Widespread Pain|chronic widespread pain
1403768|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
1403769|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
1403770|NCT01149005|Cystic Fibrosis|cystic fibrosis
1403771|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
1403772|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
1403773|NCT01149005|Insulin Therapy|insulin therapy
1403774|NCT01148979|Major Depressive Disorder|major depressive disorder
1403775|NCT01148979|Cognitive Impairment|cognitive impairment
1403776|NCT01148979|Partial Response|partial response
1403777|NCT01148979|Residual Symptoms|residual symptoms
1403778|NCT01148940|sickle cell trait|sickle cell trait
1403779|NCT01148940|thrombosis|thrombosis
1403780|NCT01148940|D-Dimer|d-dimer
1403781|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
1403782|NCT01148914|Atrial fibrillation|atrial fibrillation
1403783|NCT01148914|Catheter ablation|catheter ablation
1403784|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
1403785|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
1403786|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
1403787|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
1403788|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
1403789|NCT01148901|Hip arthritis|hip arthritis
1403790|NCT01148901|Infliximab|infliximab
1403791|NCT01148888|pediatrics|pediatrics
1403792|NCT01148888|Anaesthesia|anaesthesia
1403793|NCT01148888|Scoliosis|scoliosis
1403794|NCT01148888|Magnesium|magnesium
1403795|NCT01148875|breast cancer screening|breast cancer screening
1403796|NCT01148875|mammography adherence|mammography adherence
1403797|NCT01148875|non-adherent|non-adherent
1403798|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
1403799|NCT01148862|X54|x54
1403800|NCT01148862|Medtronic Diabetes|medtronic diabetes
1403801|NCT01148862|Diabetes Mellitus|diabetes mellitus
1403802|NCT01148862|Type 1|type 1
1403803|NCT01148849|HER2 positive|her2 positive
1403804|NCT01148849|breast cancer|breast cancer
1403805|NCT01148849|gastric cancer|gastric cancer
1403806|NCT01148836|Coenzyme Q-10|coenzyme q-10
1403807|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1403808|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
1403809|NCT01148823|breast|breast
1403810|NCT01148823|plastic surgery|plastic surgery
1403811|NCT01148823|bandages|bandages
1403812|NCT01148823|surgical site infection|surgical site infection
1403813|NCT01148823|skin colonization|skin colonization
1403814|NCT01148810|Inflammatory muscle disease|inflammatory muscle disease
1403815|NCT01148810|Muscle weakness|muscle weakness
1403816|NCT01148810|Myositis|myositis
1403817|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
1403818|NCT01148797|Colchicine intolerant|colchicine intolerant
1403819|NCT01148797|Flare rate|flare rate
1403820|NCT01148797|Canakinumab|canakinumab
1403821|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
1403822|NCT01148784|ACL|acl
1403823|NCT01148784|ligament|ligament
1403824|NCT01148784|knee|knee
1403825|NCT01148784|allograft|allograft
1403826|NCT01148771|Pharmacokinetics|pharmacokinetics
1403827|NCT01148771|Safety|safety
1403828|NCT01148732|Endotracheal tube|endotracheal tube
1403829|NCT01148732|ultrasonography|ultrasonography
1403830|NCT01148719|Heart Failure|heart failure
1403831|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1403832|NCT01148719|Dyspnea|dyspnea
1403833|NCT01148719|Elderly|elderly
1403834|NCT01148719|Diagnosis|diagnosis
1403835|NCT01148719|Primary health care|primary health care
1403836|NCT01148706|thorax|thorax
1403837|NCT01148706|abdomen|abdomen
1403838|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
1403839|NCT01148680|Islet Cell Transplantation|islet cell transplantation
1403840|NCT01148680|Metabolic Diseases|metabolic diseases
1403841|NCT01148680|Endocrine System Diseases|endocrine system diseases
1403842|NCT01148667|atopic dermatitis|atopic dermatitis
1403843|NCT01148667|barrier function|barrier function
1403844|NCT01148667|gut|gut
1403845|NCT01148667|probiotics|probiotics
1403846|NCT01148667|skin|skin
1403847|NCT01148654|preterm birth|preterm birth
1403848|NCT01148654|preterm labor|preterm labor
1403849|NCT01148654|PTB|ptb
1403850|NCT01148654|PTL|ptl
1403851|NCT01148641|Lipid-based supplements|lipid-based supplements
1403852|NCT01148641|LNS|lns
1403853|NCT01148641|Acceptability|acceptability
1403854|NCT01148641|Infant nutrition|infant nutrition
1403855|NCT01148641|Guatemala|guatemala
1403856|NCT01148641|Malnutrition|malnutrition
1403857|NCT01148602|Acute stroke|acute stroke
1403858|NCT01148602|Emergency departments|emergency departments
1403859|NCT01148602|Quality Improvement|quality improvement
1403860|NCT01148602|Improved Processes|improved processes
1403861|NCT01148602|tPA|tpa
1403862|NCT01148602|door-to-needle|door-to-needle
1403863|NCT01148602|door-to-treatment|door-to-treatment
1403864|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
1403865|NCT01148563|congestive heart failure|congestive heart failure
1403866|NCT01148563|systolic|systolic
1403867|NCT01148563|chronic disease|chronic disease
1403868|NCT01148563|heart failure|heart failure
1403869|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
1403870|NCT01148550|late-onset liver failure|late-onset liver failure
1403871|NCT01148550|cholestasis,|cholestasis,
1403872|NCT01148550|fatty liver,|fatty liver,
1403873|NCT01148550|liver dysfunction,|liver dysfunction,
1403874|NCT01148550|cirrhosis|cirrhosis
1403875|NCT01148537|Healthy subjects|healthy subjects
1403876|NCT01148537|Opioid|opioid
1403877|NCT01148537|Transdermal|transdermal
1403878|NCT01148524|Meningococcal disease|meningococcal disease
1403879|NCT01148524|Vaccines|vaccines
1403880|NCT01148524|Adolescents|adolescents
1403881|NCT01148511|Macula degeneration|macula degeneration
1403882|NCT01148511|Ranibizumab|ranibizumab
1403883|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
1403884|NCT01148511|Treat and extend|treat and extend
1403885|NCT01148511|Treat and observe|treat and observe
1403886|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
1403887|NCT01148472|Depressive disorder, major|depressive disorder, major
1403888|NCT01148472|Randomized controlled trials|randomized controlled trials
1403889|NCT01148472|Antidepressive agents|antidepressive agents
1403890|NCT01148459|Plasmodium falciparum|plasmodium falciparum
1403891|NCT01148459|schedule|schedule
1403892|NCT01148459|HIV|hiv
1403893|NCT01148459|malaria vaccine|malaria vaccine
1403894|NCT01148459|EPI|epi
1403895|NCT01148459|Africa|africa
1403896|NCT01148446|DLBCL|dlbcl
1403897|NCT01148446|R-CHOP|r-chop
1403898|NCT01148446|R-CEOP|r-ceop
1403899|NCT01148446|Elderly patients|elderly patients
1403900|NCT01148407|breast cancer|breast cancer
1403901|NCT01148407|platelets|platelets
1403902|NCT01148407|metastatic cancer|metastatic cancer
1403903|NCT01148407|malignancy|malignancy
1403904|NCT01148394|Colorectal surgery|colorectal surgery
1403905|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
1403906|NCT01148394|fast track|fast track
1403907|NCT01148394|early feeding|early feeding
1403908|NCT01148381|Genotype|genotype
1403909|NCT01148381|Phenotype|phenotype
1403910|NCT01148381|Characterization|characterization
1403911|NCT01148368|fimasartan|fimasartan
1403912|NCT01148368|renal impairment|renal impairment
1403913|NCT01148368|hypertension|hypertension
1403914|NCT01148355|Craving|craving
1403915|NCT01148355|Moods|moods
1403916|NCT01148355|Adolescents|adolescents
1403917|NCT01148355|Nicotine|nicotine
1403918|NCT01148355|Reinforcement|reinforcement
1403919|NCT01148342|Ecstacy|ecstacy
1403920|NCT01148342|fMRI|fmri
1403921|NCT01148342|Alternative Matrices|alternative matrices
1403922|NCT01148342|Cognitive Training|cognitive training
1403923|NCT01148342|Brain Imaging|brain imaging
1403924|NCT01148329|Coronary stenting|coronary stenting
1403925|NCT01148329|Drug-eluting stent|drug-eluting stent
1403926|NCT01148329|Post-market surveillance study|post-market surveillance study
1403927|NCT01148329|Promus Element stent|promus element stent
1403928|NCT01148316|Developmental Psychiatry|developmental psychiatry
1403929|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
1403930|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
1403931|NCT01148303|Headache|headache
1403932|NCT01148303|Fasting|fasting
1403933|NCT01148303|Fasting Headache|fasting headache
1403934|NCT01148303|Ramadan|ramadan
1403935|NCT01148303|Ramadan Headache|ramadan headache
1403936|NCT01148303|Yom Kippur|yom kippur
1403937|NCT01148303|Yom Kippur Headache|yom kippur headache
1403938|NCT01148290|bulking agent|bulking agent
1403939|NCT01148290|emivulvectomy|emivulvectomy
1403940|NCT01148290|radical vulvectomy|radical vulvectomy
1403941|NCT01148290|TVT|tvt
1403942|NCT01148290|urinary incontinence|urinary incontinence
1403943|NCT01148290|vulvar cancer|vulvar cancer
1403944|NCT01148277|Endoscopies|endoscopies
1403945|NCT01148277|Liver diseases|liver diseases
1403946|NCT01148277|Propofol|propofol
1403947|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
1403948|NCT01148264|break-through|break-through
1403949|NCT01148264|emesis|emesis
1403950|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
1403951|NCT01148238|Autoimmune diabetes|autoimmune diabetes
1403952|NCT01148238|LADA|lada
1403953|NCT01148238|T-reg|t-reg
1403954|NCT01148238|cytokine|cytokine
1403955|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
1403956|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
1403957|NCT01148225|Posterior-Uveitis|posterior-uveitis
1403958|NCT01148225|Active Uveitis|active uveitis
1403959|NCT01148225|Pan-uveitis|pan-uveitis
1403960|NCT01148225|Uveitis|uveitis
1403961|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
1403962|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
1403963|NCT01148199|ERCP|ercp
1403964|NCT01148186|Polypharmacy|polypharmacy
1403965|NCT01148186|Benzodiazepine use|benzodiazepine use
1403966|NCT01148186|Oxybutynin use|oxybutynin use
1403967|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
1403968|NCT01148186|incontinence|incontinence
1403969|NCT01148173|CNS relapse|cns relapse
1403970|NCT01148173|aggressive lymphoma|aggressive lymphoma
1403971|NCT01148173|HD-ASCT|hd-asct
1403972|NCT01148160|voriconazole|voriconazole
1403973|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
1403974|NCT01148160|hematologic malignancy|hematologic malignancy
1403975|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
1403976|NCT01148160|genetic polymorphism|genetic polymorphism
1403977|NCT01148160|efficacy|efficacy
1403978|NCT01148160|safety|safety
1403979|NCT01148147|Adenosine|adenosine
1403980|NCT01148147|randomized trial|randomized trial
1403981|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
1403982|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
1403983|NCT01148108|NHL|nhl
1403984|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1403985|NCT01148108|Lymphoma|lymphoma
1403986|NCT01148108|Mantle Cell|mantle cell
1403987|NCT01148108|Diffuse Large B Cell|diffuse large b cell
1403988|NCT01148108|Multiple Myeloma|multiple myeloma
1403989|NCT01148108|Telcyta|telcyta
1403990|NCT01148108|canfosfamide|canfosfamide
1403991|NCT01148108|TLK286|tlk286
1403992|NCT01148108|Prodrug|prodrug
1403993|NCT01148108|Enzyme activated drug|enzyme activated drug
1403994|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
1403995|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
1403996|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
1403997|NCT01148108|Glutathione|glutathione
1403998|NCT01148108|Glutathione analong|glutathione analong
1403999|NCT01148095|AZD2516|azd2516
1404000|NCT01148095|Phase 1|phase 1
1404001|NCT01148095|Healthy volunteer|healthy volunteer
1404002|NCT01148095|pharmacokinetics|pharmacokinetics
1404003|NCT01148095|safety|safety
1404004|NCT01148095|tolerability|tolerability
1404005|NCT01148095|Multiple ascending doses|multiple ascending doses
1404006|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
1404007|NCT01148069|IMRT-IGRT|imrt-igrt
1404008|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
1531562|NCT00656201|Crinone|crinone
1404009|NCT01148069|seminal vesicles|seminal vesicles
1404010|NCT01148056|IMRT|imrt
1404011|NCT01148056|radiation therapy|radiation therapy
1404012|NCT01148017|Meningococcal|meningococcal
1404013|NCT01148017|ACWY|acwy
1404014|NCT01148017|Conjugate Vaccine|conjugate vaccine
1404015|NCT01148017|Meningitis|meningitis
1404016|NCT01148017|Children|children
1404017|NCT01148017|Persistence|persistence
1404018|NCT01148017|Booster dose|booster dose
1404019|NCT01148004|HIV|hiv
1404020|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
1404021|NCT01148004|Protease Inhibitors|protease inhibitors
1404022|NCT01148004|Healthy Volunteer|healthy volunteer
1404023|NCT01148004|HV|hv
1404024|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
1404025|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1404026|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1404027|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1404028|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1404029|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1404030|NCT01147991|stage I gastric cancer|stage i gastric cancer
1404031|NCT01147991|stage II gastric cancer|stage ii gastric cancer
1404032|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1404033|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1404034|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1404035|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1404036|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1404037|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1404038|NCT01147978|ICU|icu
1404039|NCT01147978|Anxiety|anxiety
1404040|NCT01147978|Depression|depression
1404041|NCT01147978|PTSD|ptsd
1404042|NCT01147965|Colon Cancer|colon cancer
1404043|NCT01147965|Lung Cancer|lung cancer
1404044|NCT01147965|Breast Cancer|breast cancer
1404045|NCT01147965|CEA|cea
1404046|NCT01147952|angina|angina
1404047|NCT01147952|gene expression|gene expression
1404048|NCT01147952|depression|depression
1404049|NCT01147952|anxiety|anxiety
1404050|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
1404051|NCT01147939|AML|aml
1404052|NCT01147939|Haematology|haematology
1404053|NCT01147939|Investigator's Choice|investigator's choice
1404054|NCT01147939|Elacytarabine|elacytarabine
1404055|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
1404056|NCT01147939|Phase III|phase iii
1404057|NCT01147939|Randomized|randomized
1404058|NCT01147939|CLAVELA|clavela
1404059|NCT01147939|CP4055-306|cp4055-306
1404060|NCT01147939|Elacyt|elacyt
1404061|NCT01147926|Constipation|constipation
1404062|NCT01147926|Male|male
1404063|NCT01147913|Major Depression|major depression
1404064|NCT01147913|Depression|depression
1404065|NCT01147913|Anxiety|anxiety
1404066|NCT01147913|Dysthymia|dysthymia
1404067|NCT01147900|Immune persistence|immune persistence
1404068|NCT01147900|Boostrix|boostrix
1404069|NCT01147900|dTpa booster study|dtpa booster study
1404070|NCT01147887|26489112|26489112
1404071|NCT01147887|Omeprazole|omeprazole
1404072|NCT01147887|Tolbutamide|tolbutamide
1404073|NCT01147874|non-therapeutic|non-therapeutic
1404074|NCT01147874|interventional|interventional
1404075|NCT01147861|T2DM|t2dm
1404076|NCT01147861|Pharmacodynamics|pharmacodynamics
1404077|NCT01147861|GSK256073|gsk256073
1404078|NCT01147848|Salmeterol|salmeterol
1404079|NCT01147848|fluticasone furoate|fluticasone furoate
1404080|NCT01147848|Vilanterol|vilanterol
1404081|NCT01147848|fluticasone propionate|fluticasone propionate
1404082|NCT01147848|GW642444|gw642444
1404083|NCT01147835|Herbal lollipops|herbal lollipops
1404084|NCT01147835|Asthma|asthma
1404085|NCT01147835|Dental Caries|dental caries
1404086|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
1404087|NCT01147835|DMFT/dmft scores|dmft/dmft scores
1404088|NCT01147822|SUTENT|sutent
1404089|NCT01147822|GW76034|gw76034
1404090|NCT01147822|Sunitinib|sunitinib
1404091|NCT01147822|Renal cell carcinoma|renal cell carcinoma
1404092|NCT01147822|Pazopanib|pazopanib
1404093|NCT01147809|Solid Tumor|solid tumor
1404094|NCT01147809|Eltrombopag|eltrombopag
1404095|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
1404096|NCT01147809|Thrombocytopenia|thrombocytopenia
1404097|NCT01147796|Thrombus|thrombus
1404098|NCT01147796|computed tomography|computed tomography
1404099|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
1404100|NCT01147770|progesterone|progesterone
1404101|NCT01147770|antagonist|antagonist
1404102|NCT01147770|rec FSH|rec fsh
1404103|NCT01147770|IVF|ivf
1404104|NCT01147770|pregnancy|pregnancy
1404105|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
1404106|NCT01147744|Efficacy|efficacy
1404107|NCT01147744|Asthma|asthma
1404108|NCT01147744|Safety|safety
1404109|NCT01147744|Fluticasone Propionate|fluticasone propionate
1404110|NCT01147744|FLAP|flap
1404111|NCT01147744|Beta-agonists|beta-agonists
1404112|NCT01147744|GSK2190915|gsk2190915
1404113|NCT01147744|Montelukast|montelukast
1404114|NCT01147744|Placebo|placebo
1404115|NCT01147744|FLAIR|flair
1404116|NCT01147731|pharmacokinetics|pharmacokinetics
1404117|NCT01147731|albiglutide|albiglutide
1404118|NCT01147731|warfarin|warfarin
1404119|NCT01147731|Healthy volunteers|healthy volunteers
1404120|NCT01147718|pharmacokinetics|pharmacokinetics
1404121|NCT01147718|albiglutide|albiglutide
1404122|NCT01147718|Healthy volunteer|healthy volunteer
1404123|NCT01147718|digoxin|digoxin
1404124|NCT01147705|Peripheral arterial disease|peripheral arterial disease
1404125|NCT01147705|Allopurinol|allopurinol
1404126|NCT01147692|albiglutide|albiglutide
1404127|NCT01147692|simvastatin|simvastatin
1404128|NCT01147692|healthy volunteers|healthy volunteers
1404129|NCT01147692|pharmacokinetics|pharmacokinetics
1404130|NCT01147679|Frontotemporal dementia|frontotemporal dementia
1404131|NCT01147679|Alzheimer's disease|alzheimer's disease
1404132|NCT01147679|Young-Onset|young-onset
1404133|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
1404134|NCT01147679|control|control
1404135|NCT01147679|social|social
1404136|NCT01147679|behavior|behavior
1404137|NCT01147679|observation|observation
1404138|NCT01147679|emotion|emotion
1404139|NCT01147679|morality|morality
1404140|NCT01147679|dementia|dementia
1404141|NCT01147679|brain|brain
1404142|NCT01147679|relationships|relationships
1404143|NCT01147679|caregiver|caregiver
1404144|NCT01147679|MRI|mri
1404145|NCT01147679|neurology|neurology
1404146|NCT01147666|Kidney|kidney
1404147|NCT01147666|End Stage Renal Disease|end stage renal disease
1404148|NCT01147666|ESRD|esrd
1404149|NCT01147666|Chronic Kidney Disease|chronic kidney disease
1404150|NCT01147666|CKD|ckd
1404151|NCT01147666|Renal|renal
1404152|NCT01147666|Anemia|anemia
1404153|NCT01147666|Oral anemia treatment|oral anemia treatment
1404154|NCT01147666|Hemoglobin levels|hemoglobin levels
1404155|NCT01147666|Blood count|blood count
1404156|NCT01147666|Erythropoietin|erythropoietin
1404157|NCT01147666|Hemodialysis|hemodialysis
1404158|NCT01147666|Normoresponder|normoresponder
1404159|NCT01147666|Hyporesponder|hyporesponder
1404160|NCT01147653|Cerebral Palsy|cerebral palsy
1404161|NCT01147653|CP|cp
1404162|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
1404163|NCT01147653|Cord Blood|cord blood
1404164|NCT01147653|Umbilical Cord Blood|umbilical cord blood
1404165|NCT01147653|Autologous Cord Blood|autologous cord blood
1404166|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
1404167|NCT01147627|newly diagnosed|newly diagnosed
1404168|NCT01147627|exenatide|exenatide
1404169|NCT01147627|premixed insulin analog|premixed insulin analog
1404170|NCT01147627|thiazolidinedione|thiazolidinedione
1404171|NCT01147627|β-cell function|β-cell function
1404172|NCT01147627|glycemic control|glycemic control
1404173|NCT01147614|Child|child
1404174|NCT01147614|adolescent|adolescent
1404175|NCT01147614|anxiety|anxiety
1404176|NCT01147614|depression|depression
1404177|NCT01147614|internalizing|internalizing
1404178|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
1404179|NCT01147614|pediatric primary care|pediatric primary care
1404180|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
1404181|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
1404182|NCT01147588|open label|open label
1404183|NCT01147588|randomized|randomized
1404184|NCT01147588|4-treatment|4-treatment
1404185|NCT01147588|3-period|3-period
1404186|NCT01147588|crossover|crossover
1404187|NCT01147588|interaction study|interaction study
1404188|NCT01147588|Safety|safety
1404189|NCT01147588|tolerability|tolerability
1404190|NCT01147588|pharmacokinetics|pharmacokinetics
1404191|NCT01147588|pharmacodynamics|pharmacodynamics
1404192|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
1404193|NCT01147562|Lung cancer|lung cancer
1404194|NCT01147562|Biopsy|biopsy
1404195|NCT01147562|Biomarker|biomarker
1404196|NCT01147562|Tissue Collection|tissue collection
1404197|NCT01147549|ADME|adme
1404198|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1404199|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1404200|NCT01147523|adipokines|adipokines
1404201|NCT01147523|spironolactone|spironolactone
1404202|NCT01147523|vitamin E|vitamin e
1404203|NCT01147523|adiponectin|adiponectin
1404204|NCT01147523|visfatin|visfatin
1404205|NCT01147523|leptin|leptin
1404206|NCT01147523|resistin|resistin
1404207|NCT01147523|TNF-alpha|tnf-alpha
1404208|NCT01147523|IL-6|il-6
1404209|NCT01147523|IL-1|il-1
1404210|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
1404211|NCT01147510|age 60-75|age 60-75
1404212|NCT01147497|IUD insertion|iud insertion
1404213|NCT01147497|nulliparous women|nulliparous women
1404214|NCT01147497|contraception|contraception
1404215|NCT01147497|family planning|family planning
1404216|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
1404217|NCT01147484|Breast Cancer|breast cancer
1404218|NCT01147471|flail chest|flail chest
1404219|NCT01147471|rib fixation|rib fixation
1404220|NCT01147458|Cross-over|cross-over
1404221|NCT01147458|safety|safety
1404222|NCT01147458|efficacy|efficacy
1404223|NCT01147458|tolerability|tolerability
1404224|NCT01147458|osteoarthritis|osteoarthritis
1404225|NCT01147458|knee|knee
1404226|NCT01147458|pain|pain
1404227|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
1404228|NCT01147432|Healthy male volunteers|healthy male volunteers
1404229|NCT01147432|capsaicin challenge|capsaicin challenge
1404230|NCT01147432|safety|safety
1404231|NCT01147432|toleration|toleration
1404232|NCT01147419|critical limb ischemia|critical limb ischemia
1404233|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
1404234|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
1404235|NCT01147419|Stent|stent
1404236|NCT01147367|exercise|exercise
1404906|NCT01144286|VVC|vvc
1404237|NCT01147367|breast cancer|breast cancer
1404238|NCT01147367|physical activity|physical activity
1404239|NCT01147367|fatigue|fatigue
1404240|NCT01147367|sleep dysfunction|sleep dysfunction
1404241|NCT01147367|cytokines|cytokines
1404242|NCT01147367|muscle strength|muscle strength
1404243|NCT01147367|inflammation|inflammation
1404244|NCT01147354|Hemodialysis|hemodialysis
1404245|NCT01147354|oxidative stress|oxidative stress
1404246|NCT01147354|selenium|selenium
1404247|NCT01147354|inflammation|inflammation
1404248|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
1404249|NCT01147341|anti-TNF therapy|anti-tnf therapy
1404250|NCT01147328|Health information technology|health information technology
1404251|NCT01147328|Health information exchange|health information exchange
1404252|NCT01147328|Virtual health record|virtual health record
1404253|NCT01147328|Health care utilization|health care utilization
1404254|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
1404255|NCT01147315|hybrid bone substitution|hybrid bone substitution
1404256|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
1404257|NCT01147315|autologous bone marrow|autologous bone marrow
1404258|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
1404259|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
1404260|NCT01147276|DPP-4|dpp-4
1404261|NCT01147276|GLP-1|glp-1
1404262|NCT01147276|Glucagon|glucagon
1404263|NCT01147276|Catecholamines|catecholamines
1404264|NCT01147276|Counterregulation|counterregulation
1404265|NCT01147276|Type 1 diabetes|type 1 diabetes
1404266|NCT01147263|Fibromyalgia|fibromyalgia
1404267|NCT01147263|Autonomic dysfunction|autonomic dysfunction
1404268|NCT01147263|Tachycardia|tachycardia
1404269|NCT01147263|Palpitations|palpitations
1404270|NCT01147224|Asthma|asthma
1404271|NCT01147224|Allergy|allergy
1404272|NCT01147224|Ciclesonide|ciclesonide
1404273|NCT01147224|Alvesco|alvesco
1404274|NCT01147224|Inhaled steroids|inhaled steroids
1404275|NCT01147211|dose defining|dose defining
1404276|NCT01147211|MK-2206|mk-2206
1404277|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
1404278|NCT01147211|NSCLC|nsclc
1404279|NCT01147198|Moderate|moderate
1404280|NCT01147198|Wasting|wasting
1404281|NCT01147198|Malnutrition|malnutrition
1404282|NCT01147198|Ready to Use Food|ready to use food
1404283|NCT01147198|Fortified Blended Flour|fortified blended flour
1404284|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
1404285|NCT01147172|Nasolabial Folds|nasolabial folds
1404286|NCT01147172|Cosmetic|cosmetic
1404287|NCT01147172|Injectable Dermal Filler|injectable dermal filler
1404288|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
1404289|NCT01147146|transurethral surgery|transurethral surgery
1404290|NCT01147133|Platelet aggregation|platelet aggregation
1404291|NCT01147133|Generic|generic
1404292|NCT01147133|Clopidogrel|clopidogrel
1404293|NCT01147133|Comparison|comparison
1404294|NCT01147133|VASP-PRI|vasp-pri
1404295|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
1404296|NCT01147107|Antiretroviral therapy|antiretroviral therapy
1404297|NCT01147081|Influenza vaccine|influenza vaccine
1404298|NCT01147081|Vaccine|vaccine
1404299|NCT01147068|Influenza|influenza
1404300|NCT01147055|crizotinib|crizotinib
1404301|NCT01147055|healthy volunteers|healthy volunteers
1404302|NCT01147055|rifampin|rifampin
1404303|NCT01147055|pharmacokinetics|pharmacokinetics
1404304|NCT01147055|single dose|single dose
1404305|NCT01147042|NADPH Oxidase-Nicotinamide Adenine Dinucleotide Phosphate|nadph oxidase-nicotinamide adenine dinucleotide phosphate
1404306|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
1404307|NCT01147042|Gene Mutation|gene mutation
1404308|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
1404309|NCT01147042|Interferon-Gamma|interferon-gamma
1404310|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1531937|NCT00654693|NTX|ntx
1404311|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1404312|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
1404313|NCT01147016|male breast cancer|male breast cancer
1404314|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1404315|NCT01147016|recurrent breast cancer|recurrent breast cancer
1404316|NCT01147016|stage IIA breast cancer|stage iia breast cancer
1404317|NCT01147016|stage IIB breast cancer|stage iib breast cancer
1404318|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
1404319|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
1404320|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
1404321|NCT01147003|Seizure frequency|seizure frequency
1404322|NCT01147003|nervous system diseases|nervous system diseases
1404323|NCT01147003|brain diseases|brain diseases
1404324|NCT01147003|neurologic manifestations|neurologic manifestations
1404325|NCT01147003|adjunctive treatment|adjunctive treatment
1404326|NCT01147003|AEDs|aeds
1404327|NCT01147003|antiepileptic drug|antiepileptic drug
1404328|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
1404329|NCT01146977|CBF(+)|cbf(+)
1404907|NCT01144286|candidiasis|candidiasis
1404330|NCT01146964|Age related cataract|age related cataract
1404331|NCT01146964|Phacoemulsification|phacoemulsification
1404332|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
1404333|NCT01146951|Epilepsy|epilepsy
1404334|NCT01146951|Seizures|seizures
1404335|NCT01146938|fimasartan|fimasartan
1404336|NCT01146938|hepatic impairment|hepatic impairment
1404337|NCT01146925|Acute Kidney Injury|acute kidney injury
1404338|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
1404339|NCT01146925|Labile Iron|labile iron
1404340|NCT01146925|Iron Chelation|iron chelation
1404341|NCT01146925|Deferiprone|deferiprone
1404342|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
1404343|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
1404344|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
1404345|NCT01146847|algorithm|algorithm
1404346|NCT01146847|tight glycemic control|tight glycemic control
1404347|NCT01146847|glucose control|glucose control
1404348|NCT01146847|intensive care|intensive care
1404349|NCT01146847|insulin|insulin
1404350|NCT01146847|ICU|icu
1404351|NCT01146808|Vaccination|vaccination
1404352|NCT01146808|Immunocompromised Host|immunocompromised host
1404353|NCT01146808|Antiviral Agents|antiviral agents
1404354|NCT01146808|Drug Resistance, Viral|drug resistance, viral
1404355|NCT01146808|Resource Allocation|resource allocation
1404356|NCT01146769|Cancer of rectum|cancer of rectum
1404357|NCT01146769|Physiotherapy|physiotherapy
1404358|NCT01146756|MEK inhibitor|mek inhibitor
1404359|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
1404360|NCT01146756|lung cancer|lung cancer
1404361|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
1404362|NCT01146730|Anxiety|anxiety
1404363|NCT01146730|Depression|depression
1404364|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
1404365|NCT01146730|Common Mental Disorders|common mental disorders
1404366|NCT01146730|Mental Health Problems|mental health problems
1404367|NCT01146730|Work Related Therapy|work related therapy
1404368|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
1404369|NCT01146717|Exercise|exercise
1404370|NCT01146704|Obesity|obesity
1404371|NCT01146691|Organizational models|organizational models
1404372|NCT01146691|Intensive care units|intensive care units
1404373|NCT01146691|Physicians|physicians
1404374|NCT01146691|Staffing and scheduling|staffing and scheduling
1404375|NCT01146691|Burnout, professional|burnout, professional
1404376|NCT01146691|Job satisfaction|job satisfaction
1404377|NCT01146691|Education, medical|education, medical
1404378|NCT01146691|Patient satisfaction|patient satisfaction
1404379|NCT01146665|alcohol consumption|alcohol consumption
1404380|NCT01146665|personalized assessment feedback|personalized assessment feedback
1404381|NCT01146665|youth|youth
1404382|NCT01146665|emergency department|emergency department
1404383|NCT01146639|EVAR DynaCT|evar dynact
1404384|NCT01146626|Vitamin D|vitamin d
1404385|NCT01146626|Hepatitis C|hepatitis c
1404386|NCT01146626|Genotype2,3|genotype2,3
1404387|NCT01146626|SVR|svr
1404388|NCT01146626|Naive|naive
1404389|NCT01146626|RVR rate|rvr rate
1404390|NCT01146626|EVR rate|evr rate
1404391|NCT01146626|SVR rate|svr rate
1404392|NCT01146613|Alcohol|alcohol
1404393|NCT01146613|Alcohol abuse|alcohol abuse
1404394|NCT01146613|Alcoholism|alcoholism
1404395|NCT01146613|Alcohol Dependence|alcohol dependence
1404396|NCT01146613|Varenicline|varenicline
1404397|NCT01146613|Drinking|drinking
1404398|NCT01146600|Primary hypersomnia|primary hypersomnia
1404399|NCT01146600|CNS hypersomnia|cns hypersomnia
1404400|NCT01146600|hypersomnia|hypersomnia
1404401|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
1404402|NCT01146600|clarithromycin|clarithromycin
1404403|NCT01146600|Narcolepsy without Cataplexy|narcolepsy without cataplexy
1404404|NCT01146587|Stroke|stroke
1404405|NCT01146587|Robotics|robotics
1404406|NCT01146587|Gait|gait
1404407|NCT01146587|Rehabilitation|rehabilitation
1404408|NCT01146574|End-Stage Renal Disease|end-stage renal disease
1404409|NCT01146574|Anemia|anemia
1404410|NCT01146574|Hemodialysis|hemodialysis
1404411|NCT01146574|Renal Anemia|renal anemia
1404412|NCT01146574|ESRD|esrd
1404413|NCT01146548|Fluoxetine effect|fluoxetine effect
1404607|NCT01145638|cancer|cancer
1404414|NCT01146548|Multiple System Atrophy|multiple system atrophy
1404415|NCT01146548|MSA|msa
1404416|NCT01146535|interferon-alpha|interferon-alpha
1404417|NCT01146535|oseltamivir|oseltamivir
1404418|NCT01146535|drug therapy, combination|drug therapy, combination
1404419|NCT01146535|influenza|influenza
1404420|NCT01146535|therapies, investigational|therapies, investigational
1404421|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
1404422|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
1404423|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
1404424|NCT01146522|Triglycerides|triglycerides
1404425|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
1404426|NCT01146522|LCQ908|lcq908
1404427|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
1404428|NCT01146509|migraine|migraine
1404430|NCT01146496|Pesticide poisoning|pesticide poisoning
1404431|NCT01146496|Suicide|suicide
1404432|NCT01146496|Unintentional poisoning|unintentional poisoning
1404433|NCT01146496|Prevention|prevention
1404434|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
1404435|NCT01146457|Obstetric anesthesia|obstetric anesthesia
1404436|NCT01146457|labor analgesia|labor analgesia
1404437|NCT01146457|morphine|morphine
1404438|NCT01146457|epidural analgesia|epidural analgesia
1404439|NCT01146444|Sunscreening Agents|sunscreening agents
1404440|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
1404441|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
1404442|NCT01146418|Fertilization In Vitro|fertilization in vitro
1404443|NCT01146405|Laparoscopic|laparoscopic
1404444|NCT01146392|Epidemiological|epidemiological
1404445|NCT01146392|COPD health care|copd health care
1404446|NCT01146392|treatment in primary care|treatment in primary care
1404447|NCT01146379|stroke|stroke
1404448|NCT01146379|upper extremity|upper extremity
1404449|NCT01146379|paresis|paresis
1404450|NCT01146379|function|function
1404451|NCT01146379|translational research|translational research
1404452|NCT01146366|Early stage lung cancer|early stage lung cancer
1404453|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
1404454|NCT01146366|Observational study|observational study
1404455|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
1404456|NCT01146353|peramivir|peramivir
1404457|NCT01146353|CVVH|cvvh
1404458|NCT01146353|CRRT|crrt
1404459|NCT01146353|CVVHD|cvvhd
1404460|NCT01146353|influenza|influenza
1404461|NCT01146353|sieving coefficient|sieving coefficient
1404462|NCT01146353|clearance|clearance
1404463|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
1404464|NCT01146340|Radiotherapy|radiotherapy
1404465|NCT01146340|Hypofractionation|hypofractionation
1404466|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
1404467|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
1404468|NCT01146327|body weight|body weight
1404469|NCT01146314|family-focused intervention|family-focused intervention
1404470|NCT01146314|pediatric obesity|pediatric obesity
1404471|NCT01146314|diabetes prevention|diabetes prevention
1404472|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1404473|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1404474|NCT01146288|obesity|obesity
1404475|NCT01146288|acetazolamide|acetazolamide
1404476|NCT01146288|furosemide|furosemide
1404477|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
1404478|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
1404479|NCT01146249|Multisensorial integration|multisensorial integration
1404480|NCT01146249|Postural control|postural control
1404481|NCT01146249|Visual reliance|visual reliance
1404482|NCT01146236|Surgical|surgical
1404483|NCT01146236|Infection|infection
1404484|NCT01146236|Post-operative|post-operative
1404485|NCT01146236|Sutures|sutures
1404486|NCT01146236|Staples|staples
1404487|NCT01146197|Hypokalemia|hypokalemia
1404488|NCT01146197|Hypomagnesemia|hypomagnesemia
1404489|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
1404490|NCT01146184|Cholelithiasis|cholelithiasis
1404491|NCT01146184|Single Incision|single incision
1404492|NCT01146184|Flexible Endoscope|flexible endoscope
1404493|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
1404494|NCT01146184|Pain|pain
1404495|NCT01146158|Axillary dissection|axillary dissection
1404496|NCT01146145|postoperative|postoperative
1404497|NCT01146145|pain|pain
1404498|NCT01146145|analgesia|analgesia
1404499|NCT01146145|morphine|morphine
1404500|NCT01146145|titration|titration
1404501|NCT01146145|ketamine|ketamine
1404502|NCT01146132|Nutrition|nutrition
1404503|NCT01146132|Physical activity|physical activity
1404504|NCT01146132|Cerebrovascular disease|cerebrovascular disease
1404505|NCT01146132|wine consumption|wine consumption
1404506|NCT01146132|BMI|bmi
1404707|NCT01145131|meat|meat
1404507|NCT01146132|Pulse transit time|pulse transit time
1404508|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
1404509|NCT01146119|HAI|hai
1404510|NCT01146119|Influenza|influenza
1404511|NCT01146119|prime|prime
1404512|NCT01146119|boost|boost
1404513|NCT01146119|immune response|immune response
1404514|NCT01146119|seroconversion|seroconversion
1404515|NCT01146119|universal|universal
1404516|NCT01146119|vaccine|vaccine
1404517|NCT01146080|drug eluting stent|drug eluting stent
1404518|NCT01146080|everolimus eluting stent|everolimus eluting stent
1404519|NCT01146080|optical coherence tomography|optical coherence tomography
1404520|NCT01146080|intravascular ultrasound|intravascular ultrasound
1404521|NCT01146067|Bioequivalence|bioequivalence
1404522|NCT01146041|Bioequivalence|bioequivalence
1404523|NCT01146015|Influenza|influenza
1404524|NCT01146015|Vaccine|vaccine
1404525|NCT01146015|CHMP criteria|chmp criteria
1404526|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
1404527|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1404528|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
1404529|NCT01145963|pasta|pasta
1404530|NCT01145963|appetite|appetite
1404531|NCT01145963|hunger|hunger
1404532|NCT01145963|satiation|satiation
1404533|NCT01145963|nutrition|nutrition
1404534|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
1404535|NCT01145950|Etanercept|etanercept
1404536|NCT01145950|Enbrel|enbrel
1404537|NCT01145950|healthy volunteers|healthy volunteers
1404538|NCT01145937|Keratoconus|keratoconus
1404539|NCT01145937|Corneal grafting|corneal grafting
1404540|NCT01145937|Corneal transplantation|corneal transplantation
1404541|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
1404542|NCT01145924|bronchoscopy|bronchoscopy
1404543|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
1404544|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
1404545|NCT01145924|lung cancer|lung cancer
1404546|NCT01145924|staging|staging
1404547|NCT01145911|Glaucoma|glaucoma
1404548|NCT01145911|Blood Flow|blood flow
1404549|NCT01145911|Progression|progression
1404550|NCT01145898|Glaucoma|glaucoma
1404551|NCT01145898|Cosopt|cosopt
1404552|NCT01145898|blood flow|blood flow
1404553|NCT01145898|progression|progression
1404554|NCT01145872|Mindfulness|mindfulness
1404555|NCT01145872|clinical trial|clinical trial
1404556|NCT01145872|intervention|intervention
1404557|NCT01145872|prevention|prevention
1404558|NCT01145859|Venous Thrombosis|venous thrombosis
1404559|NCT01145859|Pediatrics|pediatrics
1404560|NCT01145833|obesity|obesity
1404561|NCT01145833|guided self help treatment|guided self help treatment
1404562|NCT01145833|treatment method|treatment method
1404563|NCT01145833|overweight|overweight
1404564|NCT01145833|overweight children and parents|overweight children and parents
1404565|NCT01145833|families with overweight child|families with overweight child
1404566|NCT01145833|efficacy|efficacy
1404567|NCT01145833|body mass index|body mass index
1404568|NCT01145833|weight|weight
1404569|NCT01145820|third molar|third molar
1404570|NCT01145820|trauma|trauma
1404571|NCT01145820|pain|pain
1404572|NCT01145820|wound healing|wound healing
1404573|NCT01145820|post operative morbidity|post operative morbidity
1404574|NCT01145820|acute trauma|acute trauma
1404575|NCT01145820|short-term wound healing|short-term wound healing
1404576|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
1404577|NCT01145794|SHS|shs
1404578|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
1404579|NCT01145768|Double-blind|double-blind
1404580|NCT01145768|randomized|randomized
1404581|NCT01145768|placebo-controlled|placebo-controlled
1404582|NCT01145768|parallel-group study|parallel-group study
1404583|NCT01145768|Safety|safety
1404584|NCT01145768|pharmacokinetics|pharmacokinetics
1404585|NCT01145755|Depression|depression
1404586|NCT01145742|Type 2 diabetes|type 2 diabetes
1404587|NCT01145742|Hypertension|hypertension
1404588|NCT01145742|Health services research|health services research
1404589|NCT01145742|Health disparities|health disparities
1404590|NCT01145742|Behavior change|behavior change
1404591|NCT01145729|Biomarker feedback|biomarker feedback
1404592|NCT01145729|Smoking cessation|smoking cessation
1404593|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
1404594|NCT01145716|TFCC injuries|tfcc injuries
1404595|NCT01145716|Distal radius fractures|distal radius fractures
1404596|NCT01145703|Body Composition|body composition
1404597|NCT01145703|Cardiovascular Risk|cardiovascular risk
1404598|NCT01145703|Cognitive Function|cognitive function
1404599|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
1404600|NCT01145677|Alcohol dependence|alcohol dependence
1404601|NCT01145677|Alcoholism|alcoholism
1404602|NCT01145677|Topiramate|topiramate
1404603|NCT01145664|Chinese medicines|chinese medicines
1404604|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
1404605|NCT01145664|effectiveness|effectiveness
1404606|NCT01145664|safety|safety
1404608|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
1404609|NCT01145638|iron|iron
1404610|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
1404611|NCT01145638|CIA|cia
1404612|NCT01145625|Female Pattern Baldness|female pattern baldness
1404613|NCT01145612|Aortic dilation|aortic dilation
1404614|NCT01145612|Marfan syndrome|marfan syndrome
1404615|NCT01145612|Losartan|losartan
1404616|NCT01145612|Atenolol|atenolol
1404617|NCT01145573|calcium|calcium
1404618|NCT01145573|vitamin D|vitamin d
1404620|NCT01145573|pregnancy|pregnancy
1404621|NCT01145560|severe sepsis|severe sepsis
1404622|NCT01145560|TNF neutralisation|tnf neutralisation
1404623|NCT01145560|septic shock patients|septic shock patients
1404624|NCT01145547|glycemic index|glycemic index
1407159|NCT01136343|women|women
1404625|NCT01145547|Diabetes Mellitus|diabetes mellitus
1404626|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
1404627|NCT01145534|diabetes,|diabetes,
1404628|NCT01145534|medicinal plants,|medicinal plants,
1404629|NCT01145534|glucose|glucose
1404630|NCT01145482|Memory Disorders|memory disorders
1404631|NCT01145482|Alzheimer's Disease|alzheimer's disease
1404632|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1404633|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1404634|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1404635|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1404636|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1404637|NCT01145443|Organizational models|organizational models
1404638|NCT01145443|Intensive care units|intensive care units
1404639|NCT01145443|Physicians|physicians
1404640|NCT01145443|Staffing and scheduling|staffing and scheduling
1404641|NCT01145443|Burnout, professional|burnout, professional
1404642|NCT01145443|Job satisfaction|job satisfaction
1404643|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
1404644|NCT01145417|pregabalin|pregabalin
1404645|NCT01145417|safety|safety
1404646|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
1404647|NCT01145391|hypertension|hypertension
1404648|NCT01145391|blood pressure|blood pressure
1404649|NCT01145391|primary care|primary care
1404650|NCT01145391|patient centered medical home|patient centered medical home
1404651|NCT01145391|health information technology|health information technology
1404652|NCT01145391|clinical inertia|clinical inertia
1404653|NCT01145365|Crohns|crohns
1404654|NCT01145365|Fistula|fistula
1404655|NCT01145365|Perianal Abscess|perianal abscess
1404656|NCT01145365|Perianal|perianal
1404657|NCT01145352|Enbrel-JIA|enbrel-jia
1404658|NCT01145326|venipuncture|venipuncture
1404659|NCT01145326|phlebotomy|phlebotomy
1404660|NCT01145326|pain perception|pain perception
1404661|NCT01145300|COPD|copd
1404662|NCT01145300|Inflammation|inflammation
1404663|NCT01145300|Small airways|small airways
1404664|NCT01145287|Celiac disease|celiac disease
1404665|NCT01145287|Gluten-free diet|gluten-free diet
1404666|NCT01145287|Screen-detected|screen-detected
1404667|NCT01145287|Asymptomatic|asymptomatic
1404668|NCT01145287|Quality of life|quality of life
1404669|NCT01145287|Self-perceived health|self-perceived health
1404670|NCT01145287|Healthcare resource utilization|healthcare resource utilization
1404671|NCT01145274|allopurinol|allopurinol
1404672|NCT01145274|chronic kidney diseae|chronic kidney diseae
1404673|NCT01145261|Anxiety,|anxiety,
1404674|NCT01145261|Emotional Regulation|emotional regulation
1404675|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
1404676|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
1404677|NCT01145222|CNS 7056|cns 7056
1404678|NCT01145222|Procedural Sedation|procedural sedation
1404679|NCT01145222|Colonoscopy|colonoscopy
1404680|NCT01145209|Arzerra|arzerra
1404681|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
1404682|NCT01145209|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
1404683|NCT01145209|SLL|sll
1404684|NCT01145209|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1404685|NCT01145196|Retinal Disease|retinal disease
1404686|NCT01145196|Plaquenil-Induced|plaquenil-induced
1404687|NCT01145183|Cocaine Dependence|cocaine dependence
1404688|NCT01145183|Substance Related Disorders|substance related disorders
1404689|NCT01145183|genotype|genotype
1404690|NCT01145170|brainstem gliomas|brainstem gliomas
1404691|NCT01145170|pediatric patients|pediatric patients
1404692|NCT01145157|knee|knee
1404693|NCT01145157|arthroplasty|arthroplasty
1404694|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
1404695|NCT01145144|DHEA|dhea
1404696|NCT01145144|IVF outcome|ivf outcome
1404697|NCT01145144|long protocol IVF|long protocol ivf
1404698|NCT01145144|poor-responder|poor-responder
1404699|NCT01145144|recombinant LH|recombinant lh
1404700|NCT01145144|embryo quality|embryo quality
1404701|NCT01145144|pregnancy rate|pregnancy rate
1404702|NCT01145144|live birth rate|live birth rate
1404703|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
1404704|NCT01145131|muscle|muscle
1404706|NCT01145131|protein|protein
1404708|NCT01145118|Plantar Fasciitis|plantar fasciitis
1404709|NCT01145118|Physiotherapy|physiotherapy
1404710|NCT01145105|Low back pain|low back pain
1404711|NCT01145105|Sciatica|sciatica
1404712|NCT01145105|Pain|pain
1404713|NCT01145105|Physiotherapy|physiotherapy
1404714|NCT01145092|type 2 diabetes|type 2 diabetes
1404715|NCT01145092|exercise training|exercise training
1404716|NCT01145092|ATP-synthesis|atp-synthesis
1404717|NCT01145092|intramyocellular lipids|intramyocellular lipids
1404718|NCT01145092|hepatocellular lipids|hepatocellular lipids
1404719|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
1404720|NCT01145066|diabetes|diabetes
1404721|NCT01145066|metabolic syndrome|metabolic syndrome
1404722|NCT01145066|inflammation|inflammation
1404723|NCT01145066|botanical oils|botanical oils
1404724|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
1404725|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
1404726|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
1404727|NCT01145040|Mathematical modelling|mathematical modelling
1404728|NCT01145040|Nonlinear modelling|nonlinear modelling
1404729|NCT01145040|Thyroid|thyroid
1404730|NCT01145040|Pituitary|pituitary
1404731|NCT01145040|Physiological cybernetics|physiological cybernetics
1404732|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
1404733|NCT01145040|Syndrome T|syndrome t
1404734|NCT01145027|Capillary recruitment|capillary recruitment
1404735|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
1404736|NCT01145027|Dietary Intake|dietary intake
1404737|NCT01145001|smoking|smoking
1404738|NCT01145001|adolescents|adolescents
1404739|NCT01145001|contingency management|contingency management
1404740|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
1404741|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
1404742|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
1404743|NCT01144988|Functional MR Imaging|functional mr imaging
1404744|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
1404745|NCT01144975|Diabetes|diabetes
1404746|NCT01144975|Type 2|type 2
1404747|NCT01144975|Mellitus|mellitus
1404748|NCT01144962|Crohn's Disease|crohn's disease
1404749|NCT01144962|Fistula|fistula
1404750|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
1404751|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
1404752|NCT01144962|MSC|msc
1404753|NCT01144962|IBD|ibd
1404754|NCT01144949|ureteral calculi|ureteral calculi
1404755|NCT01144949|renal colic|renal colic
1404756|NCT01144949|ureteral stones|ureteral stones
1404757|NCT01144949|kidney stones|kidney stones
1404758|NCT01144949|medical expulsive therapy|medical expulsive therapy
1404759|NCT01144923|epidural steroid injection|epidural steroid injection
1404760|NCT01144923|neck pain|neck pain
1404761|NCT01144923|pharmacotherapy|pharmacotherapy
1404762|NCT01144923|radiculopathy|radiculopathy
1404763|NCT01144910|asthma|asthma
1404764|NCT01144910|preschool child|preschool child
1404765|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1404766|NCT01144910|methacholine challenge test|methacholine challenge test
1404767|NCT01144910|atopy|atopy
1404768|NCT01144897|Castrate resistant|castrate resistant
1404769|NCT01144897|Prostate cancer|prostate cancer
1404770|NCT01144897|Docetaxel|docetaxel
1404771|NCT01144897|Taxotere|taxotere
1404772|NCT01144897|PET Acetate|pet acetate
1404773|NCT01144884|Neck pain|neck pain
1404774|NCT01144884|education|education
1404775|NCT01144884|exercise|exercise
1404776|NCT01144884|clinical prediction rule|clinical prediction rule
1404777|NCT01144871|adolescent|adolescent
1404778|NCT01144871|reproductive health|reproductive health
1404779|NCT01144871|parents|parents
1404780|NCT01144871|STIs|stis
1404781|NCT01144871|confidentiality|confidentiality
1404782|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
1404783|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
1404784|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
1404785|NCT01144858|atrial fibrillation|atrial fibrillation
1404786|NCT01144858|ablation catheter|ablation catheter
1404787|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
1404788|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
1404789|NCT01144845|Thoracotomy|thoracotomy
1404790|NCT01144845|Thoracic Surgery|thoracic surgery
1404791|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
1404792|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1404793|NCT01144845|Lung Neoplasms|lung neoplasms
1404794|NCT01144845|Thoracic Nerves|thoracic nerves
1404795|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
1404796|NCT01144832|mast cells|mast cells
1404797|NCT01144819|STEMI|stemi
1405480|NCT01141946|lung cancer|lung cancer
1404798|NCT01144819|Acute myocardial infarction|acute myocardial infarction
1404799|NCT01144819|Antiplatelet therapy|antiplatelet therapy
1404800|NCT01144819|aspirin|aspirin
1404801|NCT01144819|clopidogrel|clopidogrel
1404802|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
1404803|NCT01144819|Multiplate aggregometry|multiplate aggregometry
1404804|NCT01144806|SAM|sam
1404805|NCT01144806|RUTF|rutf
1404806|NCT01144806|BIA|bia
1404807|NCT01144806|D2O|d2o
1404808|NCT01144806|Children with severe malnutrition|children with severe malnutrition
1404809|NCT01144741|rehabilitation|rehabilitation
1404810|NCT01144741|surgery|surgery
1404811|NCT01144741|therapy|therapy
1404812|NCT01144741|Quality Of Life|quality of life
1404813|NCT01144741|Health-Related Quality Of Life|health-related quality of life
1404814|NCT01144741|Health Status|health status
1404815|NCT01144741|Depressive Symptoms|depressive symptoms
1404816|NCT01144741|Situational Depression|situational depression
1404817|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
1404818|NCT01144715|Home rehabilitation|home rehabilitation
1404819|NCT01144715|robotic therapy|robotic therapy
1404820|NCT01144702|malaria|malaria
1404821|NCT01144702|Plasmodium falciparum|plasmodium falciparum
1404822|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
1404823|NCT01144702|treatment|treatment
1404824|NCT01144702|Juruá Valley|juruá valley
1404825|NCT01144702|Brazil|brazil
1404826|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
1404827|NCT01144689|mindfulness|mindfulness
1404828|NCT01144689|smoking|smoking
1404829|NCT01144689|stress|stress
1404830|NCT01144663|Infants|infants
1404831|NCT01144663|conjugate vaccine|conjugate vaccine
1404832|NCT01144663|immunogenicity|immunogenicity
1404833|NCT01144663|meningococcal vaccine|meningococcal vaccine
1404834|NCT01144663|non-inferiority|non-inferiority
1404835|NCT01144663|co-administration|co-administration
1404836|NCT01144650|Dapsone|dapsone
1404837|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1404838|NCT01144650|Neuroprotection|neuroprotection
1404839|NCT01144624|TNF neutralisation|tnf neutralisation
1404840|NCT01144611|valve replacement|valve replacement
1404841|NCT01144611|CABG|cabg
1404842|NCT01144611|SIRTS|sirts
1404843|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
1404844|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
1404845|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
1404846|NCT01144598|Work Limitation|work limitation
1404847|NCT01144585|RIPC|ripc
1404848|NCT01144585|lung protection|lung protection
1404849|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
1404850|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
1404851|NCT01144572|Quality of Life|quality of life
1404852|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
1404853|NCT01144572|Early Breast Cancer|early breast cancer
1404854|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
1404855|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
1404856|NCT01144559|Femoral|femoral
1404857|NCT01144559|Nerve Block|nerve block
1404858|NCT01144559|Bolus|bolus
1404859|NCT01144559|Continuous Infusion|continuous infusion
1404860|NCT01144559|UCSD|ucsd
1404861|NCT01144559|Perineural Catheter|perineural catheter
1404862|NCT01144559|Volunteer|volunteer
1404863|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
1404864|NCT01144546|Passive leg raising|passive leg raising
1404865|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
1404866|NCT01144546|Anesthesia hypotension|anesthesia hypotension
1404867|NCT01144507|Cystic Fibrosis|cystic fibrosis
1404868|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
1404869|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
1404870|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
1404871|NCT01144481|bone metastasis|bone metastasis
1404872|NCT01144481|breast cancer|breast cancer
1404873|NCT01144481|skeletal related event|skeletal related event
1404874|NCT01144481|HR-pQCT|hr-pqct
1404875|NCT01144481|VFA|vfa
1404876|NCT01144468|breast cancer prevention|breast cancer prevention
1404877|NCT01144468|osteoporosis|osteoporosis
1404878|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
1404879|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
1404880|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
1404881|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
1404882|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1404883|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
1404884|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
1404885|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
1404886|NCT01144429|Specific Immunotherapy|specific immunotherapy
1404887|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
1404888|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
1404889|NCT01144416|Fertilization In Vitro|fertilization in vitro
1404890|NCT01144390|heroin dependence|heroin dependence
1404891|NCT01144390|community-based|community-based
1404892|NCT01144390|MMT|mmt
1404893|NCT01144377|osteoporosis|osteoporosis
1404894|NCT01144351|MS|ms
1404895|NCT01144351|SPMS|spms
1404896|NCT01144351|RRMS|rrms
1404897|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
1404898|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
1404899|NCT01144338|exenatide once weekly|exenatide once weekly
1404900|NCT01144338|cardiovascular|cardiovascular
1404901|NCT01144338|Bydureon|bydureon
1404902|NCT01144338|Amylin|amylin
1404903|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
1404904|NCT01144312|LDLT|ldlt
1404908|NCT01144286|vaginal candidiasis|vaginal candidiasis
1404909|NCT01144260|CLL|cll
1404910|NCT01144260|leukemia|leukemia
1404911|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1404912|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
1404913|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
1404914|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1404915|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
1404916|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
1404917|NCT01144247|biotherapy|biotherapy
1404918|NCT01144247|malignant meningioma|malignant meningioma
1404919|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
1404920|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
1404921|NCT01144208|Radius fracture|radius fracture
1404922|NCT01144208|Adverse effects|adverse effects
1404923|NCT01144208|Wrist|wrist
1404924|NCT01144208|Postoperative complications|postoperative complications
1404925|NCT01144208|Colles' fracture|colles' fracture
1404926|NCT01144208|Intraoperative complications|intraoperative complications
1404927|NCT01144208|Osteoporosis|osteoporosis
1404928|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
1404929|NCT01144208|Bone Density|bone density
1404930|NCT01144182|heart failure|heart failure
1404931|NCT01144182|quality of life|quality of life
1404932|NCT01144182|readmissions|readmissions
1404933|NCT01144169|Renal cell carcinoma|renal cell carcinoma
1404934|NCT01144169|Hydroxychloroquine|hydroxychloroquine
1404935|NCT01144169|Nephrectomy|nephrectomy
1404936|NCT01144169|Autophagy|autophagy
1404937|NCT01144156|Crohn's disease|crohn's disease
1404938|NCT01144156|Small bowel|small bowel
1404939|NCT01144156|Mucosal healing|mucosal healing
1404940|NCT01144156|Capsule endoscopy|capsule endoscopy
1404941|NCT01144156|Adalimumab|adalimumab
1404942|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
1404943|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
1404944|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
1404945|NCT01144091|diabetes mellitus|diabetes mellitus
1404946|NCT01144091|creatinin level|creatinin level
1404947|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
1404948|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
1404949|NCT01144078|Adiposity|adiposity
1404950|NCT01144078|Exercise training|exercise training
1404951|NCT01144078|Older adults|older adults
1404952|NCT01144065|Myocardial infarction|myocardial infarction
1404953|NCT01144065|Cortisol|cortisol
1404954|NCT01144065|Testosterone|testosterone
1404955|NCT01144052|Natalizumab|natalizumab
1404956|NCT01144052|Interferon-beta 1b|interferon-beta 1b
1404957|NCT01144052|De-escalation|de-escalation
1404958|NCT01144052|Ticino|ticino
1404959|NCT01144026|HIV|hiv
1404960|NCT01144026|vaccine|vaccine
1404961|NCT01144026|lipopeptide|lipopeptide
1404962|NCT01144026|Tat|tat
1404963|NCT01144026|TUTI-16|tuti-16
1404964|NCT01144026|THYMON|thymon
1404965|NCT01144000|Prosthetic joint infection|prosthetic joint infection
1404966|NCT01144000|daptomycin|daptomycin
1404967|NCT01144000|staphylococcus|staphylococcus
1404968|NCT01143987|hyperparathyroidism|hyperparathyroidism
1404969|NCT01143987|pulse wave velocity|pulse wave velocity
1404970|NCT01143987|end-stage renal disease|end-stage renal disease
1404971|NCT01143987|arterial stiffness|arterial stiffness
1404972|NCT01143974|progress free survival|progress free survival
1404973|NCT01143974|response rate|response rate
1404974|NCT01143974|safety|safety
1404975|NCT01143961|Positive pressure ventilation|positive pressure ventilation
1404976|NCT01143961|Electrical impedance tomography|electrical impedance tomography
1404977|NCT01143948|Diabetes|diabetes
1404978|NCT01143948|Cirrhosis|cirrhosis
1404979|NCT01143948|Insulin|insulin
1404980|NCT01143948|Inpatient|inpatient
1404981|NCT01143935|Liver volume estimation|liver volume estimation
1404982|NCT01143935|Indian population|indian population
1404983|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
1404984|NCT01143922|GI tract malignancies|gi tract malignancies
1404985|NCT01143922|modality|modality
1404986|NCT01143922|ultrasound|ultrasound
1404987|NCT01143922|staging modality|staging modality
1404988|NCT01143909|Fresh frozen plasma|fresh frozen plasma
1404989|NCT01143909|Coagulopathy|coagulopathy
1404990|NCT01143909|Intensive care|intensive care
1404991|NCT01143909|Adverse effects|adverse effects
1404992|NCT01143909|Lung injury|lung injury
1404993|NCT01143896|Hepatitis C|hepatitis c
1404994|NCT01143896|Depression|depression
1404995|NCT01143896|Collaborative care|collaborative care
1404996|NCT01143896|Antiviral treatment|antiviral treatment
1404997|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
1404998|NCT01143883|surgical site infections|surgical site infections
1404999|NCT01143844|Oncofertility|oncofertility
1405000|NCT01143844|Fertility|fertility
1405001|NCT01143844|Late effects|late effects
1405002|NCT01143844|cancer|cancer
1405003|NCT01143844|chemotherapy|chemotherapy
1405004|NCT01143844|radiation therapy|radiation therapy
1405005|NCT01143844|survivor|survivor
1405006|NCT01143844|ovarian reserve|ovarian reserve
1405007|NCT01143844|premature ovarian failure|premature ovarian failure
1405008|NCT01143844|early menopause|early menopause
1405009|NCT01143844|healthy volunteers|healthy volunteers
1405010|NCT01143844|perimenopause|perimenopause
1405011|NCT01143844|middle age|middle age
1405012|NCT01143844|pediatric survivors|pediatric survivors
1405013|NCT01143844|healthy women|healthy women
1405014|NCT01143831|Vitamin K|vitamin k
1405015|NCT01143831|Thrombosis|thrombosis
1405016|NCT01143818|Male hypogonadism|male hypogonadism
1405017|NCT01143805|Absolute Bioavailability|absolute bioavailability
1405018|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
1405019|NCT01143792|Substance abuse|substance abuse
1405020|NCT01143792|Homelessness|homelessness
1405021|NCT01143792|HIV risk behavior|hiv risk behavior
1405022|NCT01143779|Advanced Malignancy|advanced malignancy
1405023|NCT01143779|FLT-PET Scan|flt-pet scan
1405024|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
1405025|NCT01143779|FLT|flt
1405026|NCT01143779|Positron emission tomography|positron emission tomography
1405027|NCT01143779|PET|pet
1405028|NCT01143779|Imaging Biomarker|imaging biomarker
1405029|NCT01143779|Temsirolimus|temsirolimus
1405030|NCT01143779|Topotecan|topotecan
1405031|NCT01143779|Bortezomib|bortezomib
1405032|NCT01143766|Sedation|sedation
1405033|NCT01143766|Gabapentin|gabapentin
1405034|NCT01143766|ERCP|ercp
1405035|NCT01143766|Endoscopy|endoscopy
1405036|NCT01143675|Humerus fractures|humerus fractures
1405037|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
1405038|NCT01143675|Bone and bones|bone and bones
1405039|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
1405040|NCT01143675|Surgery|surgery
1405041|NCT01143675|Postoperative complications|postoperative complications
1405042|NCT01143675|Osteoporosis|osteoporosis
1405043|NCT01143675|Intraoperative complications|intraoperative complications
1405044|NCT01143675|Bone density|bone density
1405045|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
1405046|NCT01143662|peginterferon|peginterferon
1405047|NCT01143662|interferon|interferon
1405048|NCT01143662|Pegasys|pegasys
1405049|NCT01143662|HBV|hbv
1405050|NCT01143662|Hepatitis B|hepatitis b
1405051|NCT01143662|HBeAg positive|hbeag positive
1405052|NCT01143649|Stroke|stroke
1405053|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
1405054|NCT01143649|Motor function|motor function
1405055|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
1405056|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
1405057|NCT01143623|antibiotic|antibiotic
1405058|NCT01143623|diarrhea|diarrhea
1405059|NCT01143623|probiotic|probiotic
1405060|NCT01143610|Root coverage|root coverage
1405061|NCT01143610|Graft|graft
1405062|NCT01143610|Soft tissue|soft tissue
1405063|NCT01143610|Periodontal regeneration|periodontal regeneration
1405064|NCT01143597|task-specific training|task-specific training
1405065|NCT01143597|arm and hand function|arm and hand function
1405066|NCT01143597|corticomotor plasticity|corticomotor plasticity
1405067|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
1405068|NCT01143584|Prolactin|prolactin
1405069|NCT01143584|Cabergoline|cabergoline
1405070|NCT01143584|Macroadenomas|macroadenomas
1405071|NCT01143584|escalation|escalation
1405072|NCT01143571|Microbiome|microbiome
1405073|NCT01143571|Samples|samples
1405074|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
1405075|NCT01143558|Xenodiagnosis|xenodiagnosis
1405076|NCT01143558|Ticks|ticks
1405077|NCT01143558|Skin Biopsy|skin biopsy
1405078|NCT01143558|Lyme Disease|lyme disease
1405079|NCT01143545|Cancer Vaccine|cancer vaccine
1405080|NCT01143545|Immunotherapy|immunotherapy
1405081|NCT01143545|Adjuvant Therapy|adjuvant therapy
1405082|NCT01143545|Surgical Intervention|surgical intervention
1405083|NCT01143545|Lung Cancer|lung cancer
1405084|NCT01143545|Esophageal Cancer|esophageal cancer
1405085|NCT01143545|Thymic Carcinoma|thymic carcinoma
1405086|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1405087|NCT01143532|African-Americans|african-americans
1405088|NCT01143532|MYH9|myh9
1405089|NCT01143532|Chronic Kidney Disease|chronic kidney disease
1405090|NCT01143532|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1405091|NCT01143532|Proteinuria|proteinuria
1405092|NCT01143532|Kidney Disease|kidney disease
1405093|NCT01143532|Kidney Transplant|kidney transplant
1405094|NCT01143532|African-American|african-american
1405095|NCT01143519|p53|p53
1405096|NCT01143519|Inflammatory Response|inflammatory response
1405097|NCT01143519|Gene Association|gene association
1405098|NCT01143519|Nutlin|nutlin
1405099|NCT01143519|Doxorubicin|doxorubicin
1405100|NCT01143519|Healthy Volunteer|healthy volunteer
1405101|NCT01143519|HV|hv
1405102|NCT01143506|Sense of Agency|sense of agency
1405103|NCT01143506|Ulnar Nerve Block|ulnar nerve block
1405104|NCT01143506|Healthy Volunteer|healthy volunteer
1405105|NCT01143506|fMRI|fmri
1405106|NCT01143506|EEG|eeg
1405107|NCT01143493|Genetic Polymorphism|genetic polymorphism
1407160|NCT01136343|middle age|middle age
1405108|NCT01143493|Glucocorticoid|glucocorticoid
1405109|NCT01143493|Health Volunteer|health volunteer
1405111|NCT01143480|Endotoxin|endotoxin
1405112|NCT01143480|Cytokines|cytokines
1405113|NCT01143480|Gene Association|gene association
1405114|NCT01143480|Inflammatory Response|inflammatory response
1405115|NCT01143480|Healthy Volunteer|healthy volunteer
1405116|NCT01143480|HV|hv
1405117|NCT01143467|Fatigue|fatigue
1405118|NCT01143467|Mitochondria|mitochondria
1405119|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
1405120|NCT01143467|Oxidative Stress|oxidative stress
1405121|NCT01143467|Gene Expression|gene expression
1405122|NCT01143467|Prostate Cancer|prostate cancer
1405123|NCT01143454|Cardiac Disease|cardiac disease
1405124|NCT01143454|iPS Cells|ips cells
1405125|NCT01143454|Cardiac Risk Factors|cardiac risk factors
1405126|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
1405127|NCT01143454|Heart Disease|heart disease
1405128|NCT01143454|Heart Disease Risk|heart disease risk
1405129|NCT01143441|Multiple Sclerosis|multiple sclerosis
1405130|NCT01143441|Daclizumab|daclizumab
1405131|NCT01143428|Motor Neuron Disease|motor neuron disease
1405132|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
1405133|NCT01143428|Oxidative Stress|oxidative stress
1405134|NCT01143428|Physiology|physiology
1405135|NCT01143428|PLS|pls
1405136|NCT01143389|Keratoconus|keratoconus
1405137|NCT01143389|Ectasia|ectasia
1405138|NCT01143389|cross linking|cross linking
1405139|NCT01143389|collagen cross linking|collagen cross linking
1405140|NCT01143376|Obesity|obesity
1405141|NCT01143376|exercise|exercise
1405142|NCT01143376|body composition|body composition
1405143|NCT01143376|insulin sensitivity|insulin sensitivity
1405144|NCT01143376|appetite|appetite
1405145|NCT01143376|food intake|food intake
1405146|NCT01143363|Obesity|obesity
1405147|NCT01143363|exercise|exercise
1405148|NCT01143363|appetite|appetite
1405149|NCT01143363|hunger|hunger
1405150|NCT01143363|satiety|satiety
1405151|NCT01143363|food intake|food intake
1405152|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
1405153|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
1405154|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
1405155|NCT01143324|PLIF|plif
1405156|NCT01143324|TLIF|tlif
1405157|NCT01143324|MAST procedure|mast procedure
1405158|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
1405159|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
1405160|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
1405161|NCT01143272|antibiotic|antibiotic
1405162|NCT01143272|associated|associated
1405163|NCT01143272|diarrhoea|diarrhoea
1405164|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
1405165|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
1405166|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
1405167|NCT01143259|Ileus|ileus
1405168|NCT01143259|Post operative ileus|post operative ileus
1405169|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
1405170|NCT01143246|Renal failure|renal failure
1405171|NCT01143246|Cirrhosis|cirrhosis
1405172|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
1405173|NCT01143246|Ascites|ascites
1405174|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1405175|NCT01143220|Heart Failure|heart failure
1405176|NCT01143220|Pathologic Processes|pathologic processes
1405177|NCT01143220|Heart Diseases|heart diseases
1405178|NCT01143220|Tachycardia|tachycardia
1405179|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
1405180|NCT01143220|Ventricular Flutter|ventricular flutter
1405181|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
1405182|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
1405183|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
1405184|NCT01143220|Ease of Use|ease of use
1405185|NCT01143207|AE adverse event|ae adverse event
1405186|NCT01143207|DCF data collection forms|dcf data collection forms
1405187|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
1405188|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
1405288|NCT01142804|Physical Activity|physical activity
1405189|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1405190|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
1405191|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
1405192|NCT01143207|IRB Institutional Review Board|irb institutional review board
1405193|NCT01143207|IU International units|iu international units
1405194|NCT01143207|mg milligram(s)|mg milligram(s)
1405195|NCT01143207|SAE serious adverse event|sae serious adverse event
1405196|NCT01143207|µg microgram|µg microgram
1405197|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
1405198|NCT01143194|Attention|attention
1405199|NCT01143194|Vigilance|vigilance
1405200|NCT01143194|Concentration|concentration
1405201|NCT01143194|Memory|memory
1405202|NCT01143194|Healthy Volunteer|healthy volunteer
1405203|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
1405204|NCT01143181|life threatening|life threatening
1405205|NCT01143168|stem cells;|stem cells;
1405206|NCT01143168|diabetes mellitus;|diabetes mellitus;
1405207|NCT01143168|treatment.|treatment.
1405208|NCT01143155|Pneumonia|pneumonia
1405209|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
1405210|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
1405211|NCT01143155|Failure|failure
1405212|NCT01143155|Cardiovascular events|cardiovascular events
1405213|NCT01143155|Outcome|outcome
1405214|NCT01143142|Human papillomavirus|human papillomavirus
1405215|NCT01143142|HPV|hpv
1405216|NCT01143142|Prevention|prevention
1405217|NCT01143142|Tailoring|tailoring
1405218|NCT01143142|Persuasive communication|persuasive communication
1405219|NCT01143142|Adolescent|adolescent
1405220|NCT01143129|Atrial fibrillation|atrial fibrillation
1405221|NCT01143129|Cardiac surgery|cardiac surgery
1405222|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
1405223|NCT01143129|New-onset|new-onset
1405224|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
1405225|NCT01143090|Schizophrenia|schizophrenia
1405226|NCT01143090|Lurasidone|lurasidone
1405227|NCT01143090|Latuda|latuda
1405228|NCT01143077|Lurasidone|lurasidone
1405229|NCT01143077|Schizophrenia|schizophrenia
1405230|NCT01143077|Latuda|latuda
1405231|NCT01143064|Brain Injury|brain injury
1405232|NCT01143064|Trauma|trauma
1405233|NCT01143051|Asthma|asthma
1405234|NCT01143051|Pharmacokinetics|pharmacokinetics
1405235|NCT01143051|Epinephrine|epinephrine
1405236|NCT01143051|Bronchodilator|bronchodilator
1405237|NCT01143051|metered dose inhaler|metered dose inhaler
1405238|NCT01143038|ITP|itp
1405239|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1405240|NCT01143025|Nebulization|nebulization
1405241|NCT01143025|Ropivacaine|ropivacaine
1405242|NCT01143012|Group eczema education|group eczema education
1405243|NCT01142986|Methadone|methadone
1405244|NCT01142986|Syringe exchange|syringe exchange
1405245|NCT01142986|Treatment retention|treatment retention
1405246|NCT01142986|Voucher incentives|voucher incentives
1405247|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
1405248|NCT01142947|Asthma|asthma
1405249|NCT01142947|Pharmacogenomics|pharmacogenomics
1405250|NCT01142947|Genome wide association study|genome wide association study
1405251|NCT01142947|Admixture mapping|admixture mapping
1405252|NCT01142947|Continental population groups|continental population groups
1405253|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
1405254|NCT01142934|Chlorhexidine|chlorhexidine
1405255|NCT01142934|Transparent dressings|transparent dressings
1405256|NCT01142921|Stent Occlusion|stent occlusion
1405257|NCT01142921|Biliary Bleeding|biliary bleeding
1405258|NCT01142921|Biliary Perforation|biliary perforation
1405259|NCT01142908|Cardiovascular Disease|cardiovascular disease
1405260|NCT01142908|Hypertension|hypertension
1405261|NCT01142908|Diabetes|diabetes
1405262|NCT01142908|Hyperlipidemia|hyperlipidemia
1405263|NCT01142908|Adherence|adherence
1405264|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
1405265|NCT01142882|web-based interventions|web-based interventions
1533136|NCT00649701|HIV|hiv
1405266|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
1405267|NCT01142882|comparative effectiveness research|comparative effectiveness research
1405268|NCT01142882|HIV prevention|hiv prevention
1405269|NCT01142882|hepatitis prevention|hepatitis prevention
1405270|NCT01142882|STI prevention|sti prevention
1405271|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
1405272|NCT01142869|Erbitux|erbitux
1405273|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
1405274|NCT01142843|clinical trial|clinical trial
1405275|NCT01142843|mouthwash|mouthwash
1405276|NCT01142843|green propolis|green propolis
1405277|NCT01142843|dental plaque|dental plaque
1405278|NCT01142843|gingivitis|gingivitis
1405279|NCT01142830|Craniotomy|craniotomy
1405280|NCT01142830|Pain|pain
1405281|NCT01142830|Children|children
1405282|NCT01142817|HIV|hiv
1405283|NCT01142817|Women|women
1405284|NCT01142817|Menopause|menopause
1405285|NCT01142817|Dyslipidemia|dyslipidemia
1405286|NCT01142817|Bone Mineral Density|bone mineral density
1405287|NCT01142804|Walking programs|walking programs
1405289|NCT01142804|Behavior Modification|behavior modification
1405290|NCT01142804|Social Support|social support
1405291|NCT01142791|Uterine fibroids|uterine fibroids
1405292|NCT01142791|MRgFUS|mrgfus
1405293|NCT01142791|ExAblate|exablate
1405294|NCT01142791|Focused Ultrasound|focused ultrasound
1405295|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
1405296|NCT01142765|Vaccine|vaccine
1405297|NCT01142765|Safety|safety
1405298|NCT01142765|Immunogenicity|immunogenicity
1405299|NCT01142765|Protection|protection
1405300|NCT01142765|Sporozoite challenge|sporozoite challenge
1405301|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
1405302|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
1405303|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
1405304|NCT01142687|metabolic rate|metabolic rate
1405305|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
1405306|NCT01142674|Prognosis|prognosis
1405307|NCT01142674|Outcome|outcome
1405308|NCT01142674|International Cooperation|international cooperation
1405309|NCT01142674|Biological Characteristics|biological characteristics
1405310|NCT01142674|Heterogeneity|heterogeneity
1405311|NCT01142674|Rare Diseases|rare diseases
1405312|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
1405313|NCT01142648|Electroencephalogram|electroencephalogram
1405314|NCT01142648|Electromyogram|electromyogram
1405315|NCT01142648|Entropy Index|entropy index
1405316|NCT01142648|Bispectral Index|bispectral index
1405317|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
1405318|NCT01142635|Electroencephalogram|electroencephalogram
1405319|NCT01142635|Electromyogram|electromyogram
1405320|NCT01142635|Entropy Index|entropy index
1405321|NCT01142635|Bispectral Index|bispectral index
1405322|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
1405323|NCT01142635|Propofol|propofol
1405324|NCT01142635|Intubation|intubation
1405325|NCT01142622|Ovarian Cysts|ovarian cysts
1405326|NCT01142622|Nebulization|nebulization
1405327|NCT01142622|Ropivacaine|ropivacaine
1405328|NCT01142609|Web based videoconferencing|web based videoconferencing
1405329|NCT01142609|methadone|methadone
1405330|NCT01142609|substance abuse counseling|substance abuse counseling
1405331|NCT01142583|Multiple sclerosis|multiple sclerosis
1405332|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
1405333|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1405334|NCT01142570|Mechanical Ventilation|mechanical ventilation
1405335|NCT01142557|Multiple sclerosis|multiple sclerosis
1405336|NCT01142557|Rebif|rebif
1405337|NCT01142557|Interferon-beta|interferon-beta
1405338|NCT01142544|acute lung injury|acute lung injury
1405339|NCT01142544|incidence|incidence
1405340|NCT01142544|lung damage|lung damage
1405341|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
1405342|NCT01142518|Interferon beta-1a|interferon beta-1a
1405343|NCT01142518|Multiple Sclerosis|multiple sclerosis
1405344|NCT01142505|wheeze|wheeze
1405345|NCT01142505|preschool|preschool
1405346|NCT01142505|leukotriene|leukotriene
1405347|NCT01142505|montelukast|montelukast
1405348|NCT01142505|5-lipoxygenase|5-lipoxygenase
1405349|NCT01142492|Interferon beta|interferon beta
1405350|NCT01142492|Multiple Sclerosis|multiple sclerosis
1405351|NCT01142479|Breast Cancer|breast cancer
1405352|NCT01142479|Radiotherapy|radiotherapy
1405353|NCT01142479|Chinese herbal medicine|chinese herbal medicine
1405354|NCT01142479|TPE-1|tpe-1
1405355|NCT01142479|Leukopenia|leukopenia
1405356|NCT01142466|Multiple sclerosis|multiple sclerosis
1405357|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
1405358|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1405359|NCT01142466|Rebif|rebif
1405360|NCT01142466|Beta-1, interferon|beta-1, interferon
1405361|NCT01142453|Multiple sclerosis|multiple sclerosis
1405362|NCT01142453|Rebif|rebif
1405363|NCT01142453|Interferon|interferon
1405364|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1405365|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1405366|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1405367|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1405368|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1405369|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1405370|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1405371|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1405372|NCT01142414|tongue cancer|tongue cancer
1405373|NCT01142375|AML|aml
1405374|NCT01142362|H5N1|h5n1
1405375|NCT01142362|Avian Influenza|avian influenza
1405376|NCT01142362|DNA Vaccine|dna vaccine
1405479|NCT01141959|biomarkers|biomarkers
1405377|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
1405378|NCT01142362|Electroporation|electroporation
1405379|NCT01142362|Healthy Adults|healthy adults
1405380|NCT01142349|Arthritis|arthritis
1405381|NCT01142349|Group Program|group program
1405382|NCT01142349|Pain|pain
1405383|NCT01142349|Insomnia|insomnia
1405384|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
1405385|NCT01142336|Alzheimer's Disease|alzheimer's disease
1405386|NCT01142336|Prevention|prevention
1405387|NCT01142336|Spinal Fluid|spinal fluid
1405388|NCT01142336|Biomarkers|biomarkers
1405389|NCT01142336|Simvastatin|simvastatin
1405390|NCT01142297|dental implant|dental implant
1405391|NCT01142297|implant stabilization|implant stabilization
1405392|NCT01142297|type 2 diabetes|type 2 diabetes
1407161|NCT01136343|risk factor|risk factor
1405393|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
1405394|NCT01142284|Biomarker|biomarker
1405395|NCT01142284|Endothelial Function|endothelial function
1405396|NCT01142284|Peripheral Artery Disease|peripheral artery disease
1405397|NCT01142284|Coronary Artery Disease|coronary artery disease
1405398|NCT01142284|Flow Mediated Dilation|flow mediated dilation
1405399|NCT01142284|Cilostazol|cilostazol
1405400|NCT01142284|Probucol|probucol
1405401|NCT01142271|Distal gastrectomy|distal gastrectomy
1405402|NCT01142271|Reconstruction|reconstruction
1405403|NCT01142271|Reflux|reflux
1405404|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
1405405|NCT01142258|Sleep Disturbances|sleep disturbances
1405406|NCT01142258|Alzheimer disease|alzheimer disease
1405407|NCT01142258|Insomnia|insomnia
1405408|NCT01142258|Trazodone|trazodone
1405409|NCT01142258|Treatment|treatment
1405410|NCT01142245|ulcer bleeding|ulcer bleeding
1405411|NCT01142245|endoscopic therapy|endoscopic therapy
1405412|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
1405413|NCT01142219|sickle cell disease|sickle cell disease
1405414|NCT01142219|L-arginine|l-arginine
1405415|NCT01142219|hemolysis|hemolysis
1405416|NCT01142219|nitric oxide|nitric oxide
1405417|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
1405418|NCT01142206|Obesity|obesity
1405419|NCT01142206|Weight Loss|weight loss
1405420|NCT01142206|Leisure-time activities|leisure-time activities
1405421|NCT01142206|Physical Activity|physical activity
1405422|NCT01142206|Television watching|television watching
1405423|NCT01142206|Dietary Intake|dietary intake
1405424|NCT01142206|Energy|energy
1405425|NCT01142206|Behavioral|behavioral
1405426|NCT01142206|Healthy Eating|healthy eating
1405427|NCT01142193|Epilepsy|epilepsy
1405428|NCT01142193|partial onset seizure|partial onset seizure
1405429|NCT01142193|adjunctive therapy|adjunctive therapy
1405430|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
1405431|NCT01142180|Active bleeding|active bleeding
1405432|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
1405433|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
1405434|NCT01142154|Cockayne Syndrome|cockayne syndrome
1405435|NCT01142154|Ageing|ageing
1405436|NCT01142154|pediatrics|pediatrics
1405437|NCT01142154|Pharmacokinetics|pharmacokinetics
1405438|NCT01142154|Prodarsan|prodarsan
1405439|NCT01142154|Dwarfism|dwarfism
1405440|NCT01142154|Genetic disease, inborn|genetic disease, inborn
1405441|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
1405442|NCT01142154|Tolerability|tolerability
1405443|NCT01142154|Safety|safety
1405444|NCT01142102|Bladder|bladder
1405445|NCT01142102|Radiotherapy|radiotherapy
1405446|NCT01142102|Online|online
1405447|NCT01142102|Adaptive|adaptive
1405448|NCT01142089|traveler's|traveler's
1405449|NCT01142089|diarrhea|diarrhea
1405450|NCT01142089|Rifamycin SV MMX|rifamycin sv mmx
1405451|NCT01142089|Rifamycin|rifamycin
1405452|NCT01142089|MMX|mmx
1405453|NCT01142089|Traveler's Diarrhea|traveler's diarrhea
1405454|NCT01142076|adiposity|adiposity
1405455|NCT01142063|Neratinib|neratinib
1405456|NCT01142050|stem cells;|stem cells;
1405457|NCT01142050|diabetes mellitus;|diabetes mellitus;
1405458|NCT01142050|treatment.|treatment.
1405459|NCT01142037|Healthy volunteer|healthy volunteer
1405460|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
1405461|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
1405462|NCT01142024|antioxidant prevention|antioxidant prevention
1405463|NCT01142011|Waldenstroms|waldenstroms
1405464|NCT01142011|Belimumab|belimumab
1405465|NCT01142011|anti Blys|anti blys
1405466|NCT01142011|monoclonal antibody|monoclonal antibody
1405467|NCT01141985|cataract|cataract
1405468|NCT01141985|cornea|cornea
1405469|NCT01141985|keratoplasty|keratoplasty
1405470|NCT01141972|Vitamin D|vitamin d
1405471|NCT01141972|Obesity|obesity
1405472|NCT01141972|Menopause|menopause
1405473|NCT01141972|Hot Flashes|hot flashes
1405474|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1405475|NCT01141959|cyclophosphamide|cyclophosphamide
1405476|NCT01141959|fludarabine|fludarabine
1405477|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
1405478|NCT01141959|mycophenolic acid|mycophenolic acid
1405481|NCT01141946|pleural effusion|pleural effusion
1405482|NCT01141946|post-op care|post-op care
1405483|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
1405484|NCT01141933|Creating meaning|creating meaning
1405485|NCT01141933|Therapy|therapy
1405486|NCT01141933|Cancer|cancer
1405487|NCT01141933|Oncology|oncology
1405488|NCT01141933|Existential|existential
1405489|NCT01141933|Spirituality|spirituality
1405490|NCT01141933|Quality of life|quality of life
1405492|NCT01141933|Psycho-oncology|psycho-oncology
1405493|NCT01141933|French-canadian|french-canadian
1405494|NCT01141933|Cognitive therapy|cognitive therapy
1405495|NCT01141933|Existentialism|existentialism
1405496|NCT01141920|treatment retention|treatment retention
1405497|NCT01141920|methadone maintenance|methadone maintenance
1405498|NCT01141920|treatment induction|treatment induction
1405499|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
1405500|NCT01141907|heart failure|heart failure
1405501|NCT01141907|self care|self care
1405502|NCT01141907|decision support|decision support
1405503|NCT01141907|telemonitoring|telemonitoring
1405504|NCT01141907|navigator|navigator
1405505|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
1405506|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
1405507|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
1405508|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
1405509|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
1405510|NCT01141868|insomnia|insomnia
1405511|NCT01141868|breast cancer survivor|breast cancer survivor
1405512|NCT01141868|Internet intervention|internet intervention
1405513|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
1405514|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
1405515|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
1405516|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
1405517|NCT01141855|Asthma|asthma
1405518|NCT01141855|Tobacco Use Disorder|tobacco use disorder
1405519|NCT01141855|Smoking|smoking
1405520|NCT01141855|Smoking Cessation|smoking cessation
1405521|NCT01141842|lung cancer|lung cancer
1405522|NCT01141842|exhalation analysis|exhalation analysis
1405523|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1405524|NCT01141842|cancer screening test|cancer screening test
1405525|NCT01141829|NADPH oxidase|nadph oxidase
1405526|NCT01141816|renal cell carcinoma|renal cell carcinoma
1405527|NCT01141816|radiofrequency ablation|radiofrequency ablation
1405528|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
1405529|NCT01141816|monitoring|monitoring
1405530|NCT01141816|follow up|follow up
1405531|NCT01141803|Apple|apple
1405532|NCT01141803|Apple pomace|apple pomace
1405533|NCT01141803|Metabolomics|metabolomics
1405534|NCT01141803|Gene expression|gene expression
1405535|NCT01141803|Lipid metabolism|lipid metabolism
1405536|NCT01141803|Prevention|prevention
1405537|NCT01141803|Antiinflammatory effect|antiinflammatory effect
1405538|NCT01141790|Glasgow Coma Scale|glasgow coma scale
1405539|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
1405540|NCT01141790|Ethics|ethics
1405541|NCT01141777|Spirulina platensis|spirulina platensis
1405542|NCT01141777|Insulin resistance|insulin resistance
1405543|NCT01141777|HIV/AIDS|hiv/aids
1405544|NCT01141777|HAART|haart
1405545|NCT01141777|Soya beans|soya beans
1405546|NCT01141764|pediatrics|pediatrics
1405547|NCT01141764|Epilepsy|epilepsy
1405548|NCT01141764|Deep Brain Stimulation|deep brain stimulation
1405549|NCT01141764|Positron Emission Tomography|positron emission tomography
1405550|NCT01141751|Multiple sclerosis|multiple sclerosis
1405551|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
1405552|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
1405553|NCT01141751|Beta-1, interferon|beta-1, interferon
1405554|NCT01141738|stroke|stroke
1405555|NCT01141738|caregiver|caregiver
1405556|NCT01141738|depression|depression
1405557|NCT01141738|mediators|mediators
1405558|NCT01141738|problem-solving|problem-solving
1405559|NCT01141712|HIV|hiv
1405560|NCT01141712|B-cell Lymphoma|b-cell lymphoma
1405561|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
1405562|NCT01141712|Follicular Lymphoma|follicular lymphoma
1405563|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
1405564|NCT01141699|women health behaviors|women health behaviors
1405565|NCT01141686|lung cancer|lung cancer
1405566|NCT01141673|FLT3-ITD|flt3-itd
1405567|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
1405568|NCT01141673|FLT3|flt3
1405569|NCT01141673|D835|d835
1405570|NCT01141647|Adult|adult
1405571|NCT01141647|Depression|depression
1405572|NCT01141647|Supported Employment|supported employment
1405573|NCT01141647|Health Service|health service
1405574|NCT01141647|Humans|humans
1405575|NCT01141647|Outcomes|outcomes
1405576|NCT01141647|Quality of Life|quality of life
1405577|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
1405578|NCT01141647|Workplace|workplace
1405579|NCT01141647|Spinal Cord Injuries|spinal cord injuries
1405580|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1405581|NCT01141634|Attention Deficit Disorder|attention deficit disorder
1405582|NCT01141634|ADHD|adhd
1405583|NCT01141634|ADD|add
1405584|NCT01141634|Homeopathy|homeopathy
1405585|NCT01141621|HS|hs
1405586|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
1405587|NCT01141621|splenectomy|splenectomy
1405588|NCT01141621|quality of life|quality of life
1405589|NCT01141556|selenium|selenium
1405590|NCT01141556|clinical outcome|clinical outcome
1405591|NCT01141556|heart surgery|heart surgery
1405592|NCT01141543|Plerixafor injection|plerixafor injection
1405593|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
1405594|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
1405595|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
1405596|NCT01141504|Supplemental ATP|supplemental atp
1405597|NCT01141504|Muscle Work Performed|muscle work performed
1405598|NCT01141504|Muscle Fatigue|muscle fatigue
1405599|NCT01141491|Sarcoma|sarcoma
1405600|NCT01141491|Metastatic|metastatic
1405601|NCT01141491|Vaccine|vaccine
1405602|NCT01141491|Adjuvant|adjuvant
1405603|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1405604|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
1405605|NCT01141478|Sorafenib|sorafenib
1405606|NCT01141465|Primary care|primary care
1405607|NCT01141465|Asthma management|asthma management
1405608|NCT01141465|Combined therapy|combined therapy
1405609|NCT01141465|Real-world|real-world
1405610|NCT01141465|Effectiveness|effectiveness
1405611|NCT01141465|Control|control
1405612|NCT01141465|Exacerbations|exacerbations
1405613|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1405614|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
1405615|NCT01141452|increase|increase
1405616|NCT01141452|initiate|initiate
1405617|NCT01141452|exacerbations|exacerbations
1405618|NCT01141452|treatment success|treatment success
1405619|NCT01141439|Primary care|primary care
1405620|NCT01141439|Asthma management|asthma management
1405621|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
1405622|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
1405623|NCT01141439|Fluticasone propionate|fluticasone propionate
1405624|NCT01141439|Metred dose inhaler|metred dose inhaler
1405625|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
1405626|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
1405627|NCT01141426|depression|depression
1405628|NCT01141426|treatment-resistance|treatment-resistance
1405629|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
1405630|NCT01141426|Treatment refractory depression|treatment refractory depression
1405631|NCT01141374|Stress|stress
1405632|NCT01141361|Claudication|claudication
1405633|NCT01141361|Artery|artery
1405634|NCT01141361|Ambulatory technique|ambulatory technique
1405635|NCT01141361|GPS|gps
1405636|NCT01141335|shrinkage|shrinkage
1405637|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
1405638|NCT01141322|drug-induced liver injury|drug-induced liver injury
1405639|NCT01141322|hepatitis, toxic|hepatitis, toxic
1405640|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
1405641|NCT01141309|Everolimus|everolimus
1405642|NCT01141309|Sorafenib|sorafenib
1405643|NCT01141309|Thyroid|thyroid
1405644|NCT01141309|10-060|10-060
1405645|NCT01141283|Osteoarthritis|osteoarthritis
1405646|NCT01141283|Opioid|opioid
1405647|NCT01141283|Transdermal|transdermal
1405648|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
1405649|NCT01141270|pharmacokinetics|pharmacokinetics
1405650|NCT01141270|bioequivalence|bioequivalence
1405651|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
1405652|NCT01141231|hypopharyngeal cancer|hypopharyngeal cancer
1405653|NCT01141231|laryngeal cancer|laryngeal cancer
1405654|NCT01141231|lip and oral cavity cancer|lip and oral cavity cancer
1405655|NCT01141231|nasopharyngeal cancer|nasopharyngeal cancer
1405656|NCT01141231|oropharyngeal cancer|oropharyngeal cancer
1405657|NCT01141231|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1405658|NCT01141231|salivary gland cancer|salivary gland cancer
1405659|NCT01141231|radiation toxicity|radiation toxicity
1405660|NCT01141231|xerostomia|xerostomia
1405661|NCT01141231|long-term effects of cancer treatment|long-term effects of cancer treatment
1405662|NCT01141231|oral complications of radiation therapy|oral complications of radiation therapy
1405663|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
1405664|NCT01141205|AIDS vaccines|aids vaccines
1405665|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
1405666|NCT01141205|Therapeutic vaccine|therapeutic vaccine
1405667|NCT01141205|Cellular immunity|cellular immunity
1405668|NCT01141192|vitamin D status|vitamin d status
1405669|NCT01141192|25-OH D|25-oh d
1405670|NCT01141192|ionized calcium|ionized calcium
1405671|NCT01141192|fasting glucose|fasting glucose
1405672|NCT01141192|hemoglobin A1c|hemoglobin a1c
1405673|NCT01141192|fasting insulin|fasting insulin
1405674|NCT01141192|glucose metabolism|glucose metabolism
1405675|NCT01141192|HOMA index|homa index
1405770|NCT01140880|Amphetamine|amphetamine
1405676|NCT01141192|blood lipids|blood lipids
1405677|NCT01141192|type 2 diabetes|type 2 diabetes
1405679|NCT01141192|adiposity|adiposity
1405680|NCT01141192|body fat percentage|body fat percentage
1405681|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1405682|NCT01141192|pulse wave velocity|pulse wave velocity
1405683|NCT01141192|arterial stiffness|arterial stiffness
1405684|NCT01141192|flow-mediated dilation|flow-mediated dilation
1405685|NCT01141192|African American|african american
1405686|NCT01141192|inflammatory markers|inflammatory markers
1405687|NCT01141166|ELDERLY|elderly
1405688|NCT01141166|NUTRITION|nutrition
1405689|NCT01141153|atrial fibrillation|atrial fibrillation
1405690|NCT01141153|Coronary Stent implantation|coronary stent implantation
1405691|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
1405692|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
1405693|NCT01141153|anticoagulation|anticoagulation
1405694|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
1405695|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
1405696|NCT01141114|community health centers|community health centers
1405697|NCT01141114|colorectal cancer screening|colorectal cancer screening
1405698|NCT01141114|urban health|urban health
1405699|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1405700|NCT01141101|Neonatal|neonatal
1405701|NCT01141101|Vertical transmission|vertical transmission
1405702|NCT01141101|Horizontal transmission|horizontal transmission
1405703|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
1405704|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
1405705|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
1405706|NCT01141062|Uterine Fibroids|uterine fibroids
1405707|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
1405708|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
1405709|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
1405710|NCT01141049|Gabapentin|gabapentin
1405711|NCT01141036|Propofol|propofol
1405712|NCT01141036|Midazolam|midazolam
1405713|NCT01141036|sedation|sedation
1405714|NCT01141036|cirrhosis|cirrhosis
1405715|NCT01141036|endoscopy|endoscopy
1405716|NCT01141036|recovery time|recovery time
1405717|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
1405718|NCT01141036|patient satisfaction|patient satisfaction
1405719|NCT01141036|return to baseline function|return to baseline function
1405720|NCT01141036|saturation of oxygen|saturation of oxygen
1405721|NCT01141023|Parkinson|parkinson
1405722|NCT01141023|Bio-markers|bio-markers
1405723|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
1405724|NCT01141023|Imaging|imaging
1405725|NCT01141023|Prodromal|prodromal
1405726|NCT01141010|Linguistic|linguistic
1405727|NCT01141010|Stress response|stress response
1405728|NCT01141010|Corticosteroid|corticosteroid
1405729|NCT01141010|Cesarean section|cesarean section
1405730|NCT01141010|Anxiety|anxiety
1405731|NCT01141010|Depression|depression
1405732|NCT01141010|Maternal psychosis|maternal psychosis
1405733|NCT01140997|HCV|hcv
1405734|NCT01140997|CHC|chc
1405735|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
1405736|NCT01140997|Liver Diseases|liver diseases
1405737|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
1405738|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
1405739|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
1405740|NCT01140997|Antiviral Agents|antiviral agents
1405741|NCT01140997|Virus Diseases|virus diseases
1405742|NCT01140997|Peginterferon alfa|peginterferon alfa
1405743|NCT01140984|acute graft versus host disease|acute graft versus host disease
1405744|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
1405745|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
1405746|NCT01140971|Balloon dilatation,|balloon dilatation,
1405747|NCT01140971|misoprostol,|misoprostol,
1405748|NCT01140971|cervical ripening,|cervical ripening,
1405749|NCT01140971|obstetric labor,|obstetric labor,
1405750|NCT01140971|labor induced.|labor induced.
1405751|NCT01140958|lung cancer|lung cancer
1405752|NCT01140958|pharmacoeconomics|pharmacoeconomics
1405753|NCT01140958|new agents|new agents
1405754|NCT01140932|Retina|retina
1405755|NCT01140932|Electroretinography|electroretinography
1405756|NCT01140932|Diabetes Mellitus|diabetes mellitus
1405757|NCT01140932|Glucose Intolerance|glucose intolerance
1405758|NCT01140932|Physiology|physiology
1405759|NCT01140906|Major depressive disorder|major depressive disorder
1405760|NCT01140906|Placebo-controlled|placebo-controlled
1405761|NCT01140906|Active reference|active reference
1405762|NCT01140906|Multicenter study|multicenter study
1405763|NCT01140906|Randomised study|randomised study
1405764|NCT01140906|Acute treatment|acute treatment
1405765|NCT01140893|Type 2 diabetes|type 2 diabetes
1405766|NCT01140893|CSII|csii
1405767|NCT01140893|Exenatide|exenatide
1405768|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
1405769|NCT01140880|Methamphetamine|methamphetamine
1405771|NCT01140880|Cocaine|cocaine
1405772|NCT01140880|HIV|hiv
1405773|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
1405774|NCT01140880|HIV seronegativity|hiv seronegativity
1405775|NCT01140854|hypertension|hypertension
1405776|NCT01140854|hypotension|hypotension
1405777|NCT01140854|cognitive|cognitive
1405778|NCT01140854|neurocognitive|neurocognitive
1405779|NCT01140854|cognitive dysfunction|cognitive dysfunction
1405780|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
1405781|NCT01140854|neuropsychometric|neuropsychometric
1405782|NCT01140841|Dyskinesia|dyskinesia
1405783|NCT01140828|Arthritis|arthritis
1405784|NCT01140828|Bone pain|bone pain
1405785|NCT01140828|dyspepsia|dyspepsia
1405786|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
1405787|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
1405788|NCT01140802|First degree relatives|first degree relatives
1405789|NCT01140802|Crohn's disease|crohn's disease
1405790|NCT01140802|Ulcerative colitis|ulcerative colitis
1405791|NCT01140802|Healthy control|healthy control
1405792|NCT01140776|metastasis|metastasis
1405793|NCT01140776|molecular pathology|molecular pathology
1405794|NCT01140763|metastasis|metastasis
1405795|NCT01140750|Heart Rate Variability|heart rate variability
1405796|NCT01140750|Temperature Curve Complexity|temperature curve complexity
1405797|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
1405798|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
1405799|NCT01140750|Failure to Wean|failure to wean
1405800|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
1405801|NCT01140724|pain|pain
1405802|NCT01140724|genes|genes
1405803|NCT01140724|morphine|morphine
1405804|NCT01140724|respiratory depression|respiratory depression
1405805|NCT01140724|tonsillectomy|tonsillectomy
1405806|NCT01140724|children|children
1405807|NCT01140724|Opioid adverse effects|opioid adverse effects
1405808|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
1405809|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
1405810|NCT01140724|Personalizing analgesia|personalizing analgesia
1405811|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
1405812|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
1405813|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
1405814|NCT01140685|oxidative stress|oxidative stress
1405815|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
1405816|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
1405817|NCT01140672|Healthy volunteers|healthy volunteers
1405818|NCT01140672|pharmacokinetics|pharmacokinetics
1405819|NCT01140672|safety|safety
1405820|NCT01140672|tolerability|tolerability
1405821|NCT01140672|multiple dosing|multiple dosing
1405822|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
1405823|NCT01140659|Hyperhidrosis|hyperhidrosis
1405824|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
1405825|NCT01140659|Objective measurement of sweat|objective measurement of sweat
1405826|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
1405827|NCT01140633|HIV/AIDS|hiv/aids
1405828|NCT01140633|pediatric|pediatric
1405829|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
1405830|NCT01140633|HIV Infections|hiv infections
1405831|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
1405832|NCT01140620|cognitive processes|cognitive processes
1405833|NCT01140620|healthy volunteers|healthy volunteers
1405834|NCT01140620|dopamine antagonist|dopamine antagonist
1405835|NCT01140620|schizophrenia|schizophrenia
1405836|NCT01140568|glioma|glioma
1405837|NCT01140568|PDGFR|pdgfr
1405838|NCT01140568|kinase|kinase
1405839|NCT01140568|inhibitor|inhibitor
1405840|NCT01140568|malignant|malignant
1405841|NCT01140568|nilotinib|nilotinib
1405842|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
1405843|NCT01140542|Roflumilast|roflumilast
1405844|NCT01140529|Dexmedetomidine|dexmedetomidine
1405845|NCT01140516|Antenatal|antenatal
1405846|NCT01140490|Hemodialysis|hemodialysis
1405847|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
1405848|NCT01140464|Adolescents|adolescents
1405849|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
1405850|NCT01140438|adults|adults
1405851|NCT01140438|Beta cell rest|beta cell rest
1405852|NCT01140438|Insulin secretion|insulin secretion
1405853|NCT01140425|PF-00232798|pf-00232798
1405854|NCT01140425|CCR5|ccr5
1405855|NCT01140425|QT|qt
1405856|NCT01140425|QTc|qtc
1405857|NCT01140425|pharmacokinetics|pharmacokinetics
1405858|NCT01140412|maraviroc|maraviroc
1405859|NCT01140412|fosamprenavir|fosamprenavir
1405860|NCT01140412|drug interaction|drug interaction
1405861|NCT01140412|pharmacokinetics|pharmacokinetics
1405862|NCT01140412|HIV|hiv
1405863|NCT01140412|AIDS|aids
1405864|NCT01140412|CCR5|ccr5
1405865|NCT01140412|protease inhibitor|protease inhibitor
1405866|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
1405867|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
1405868|NCT01140399|3 Ultrafiltration|3 ultrafiltration
1405869|NCT01140399|4 Dopamine|4 dopamine
1405870|NCT01140386|venous thromboembolism|venous thromboembolism
1405871|NCT01140386|duplex ultrasound|duplex ultrasound
1405872|NCT01140386|pediatric population|pediatric population
1405873|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
1405874|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
1405875|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
1405876|NCT01140373|Prostate|prostate
1405877|NCT01140373|Autologous T Cells|autologous t cells
1405878|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
1405879|NCT01140373|cyclophosphamide|cyclophosphamide
1405880|NCT01140373|09-036|09-036
1405881|NCT01140360|Neurofibromas|neurofibromas
1405882|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1405883|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
1405884|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
1405885|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
1405886|NCT01140334|Psychiatric adherence|psychiatric adherence
1405887|NCT01140334|Voucher incentives|voucher incentives
1405888|NCT01140334|Methadone treatment|methadone treatment
1405889|NCT01140321|Thalassemia|thalassemia
1405890|NCT01140321|Neridronate|neridronate
1405891|NCT01140321|Osteopenia|osteopenia
1405892|NCT01140321|Osteoporosis|osteoporosis
1405893|NCT01140308|Statin Myopathy|statin myopathy
1405894|NCT01140308|CoEnzyme Q10|coenzyme q10
1405895|NCT01140308|CoQ10|coq10
1405896|NCT01140308|Statin Myalgia|statin myalgia
1405897|NCT01140295|Preparation|preparation
1405898|NCT01140295|Pediatric|pediatric
1405899|NCT01140295|Colonoscopy|colonoscopy
1405900|NCT01140282|cancer survivor|cancer survivor
1405901|NCT01140269|Burn|burn
1405902|NCT01140269|Sepsis|sepsis
1405903|NCT01140269|Infection|infection
1405904|NCT01140256|Zinc|zinc
1405905|NCT01140256|SGA|sga
1405906|NCT01140256|AGA|aga
1405907|NCT01140256|stable isotope|stable isotope
1405908|NCT01140243|fat formulation|fat formulation
1405909|NCT01140230|rotator cuff tear|rotator cuff tear
1405910|NCT01140230|rotator cuff repair|rotator cuff repair
1405911|NCT01140230|age|age
1405912|NCT01140230|timing to surgery|timing to surgery
1405913|NCT01140217|contraception|contraception
1405914|NCT01140217|pregnancy|pregnancy
1405915|NCT01140204|stent|stent
1405916|NCT01140204|contrast media|contrast media
1405917|NCT01140204|paclitaxel|paclitaxel
1405918|NCT01140204|stent implantation|stent implantation
1405919|NCT01140191|leishmaniasis|leishmaniasis
1405920|NCT01140191|cutaneous|cutaneous
1405921|NCT01140191|WR 279,396|wr 279,396
1405922|NCT01140191|paromomycin|paromomycin
1405923|NCT01140191|gentamicin|gentamicin
1405924|NCT01140191|pharmacokinetics|pharmacokinetics
1405925|NCT01140191|safety|safety
1405926|NCT01140191|efficacy|efficacy
1405927|NCT01140191|military|military
1405928|NCT01140178|Photodynamic Therapy|photodynamic therapy
1405929|NCT01140178|Oral dysplasia|oral dysplasia
1405930|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
1405931|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
1405932|NCT01140152|intestinal transplantation|intestinal transplantation
1405933|NCT01140152|rejection|rejection
1405934|NCT01140152|proteomics|proteomics
1405935|NCT01140152|innate immunity|innate immunity
1567160|NCT00509717|community pharmacy services|community pharmacy services
1405936|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
1405937|NCT01140113|hemoconcentration|hemoconcentration
1405938|NCT01140113|ultrafiltration|ultrafiltration
1405939|NCT01140113|coronary artery disease|coronary artery disease
1405940|NCT01140087|Face Transplant|face transplant
1405941|NCT01140087|Composite Tissue Allograft|composite tissue allograft
1405942|NCT01140087|Facial Allotransplantation|facial allotransplantation
1405943|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
1405944|NCT01140048|Asthma|asthma
1405945|NCT01140035|Insulin|insulin
1405946|NCT01140035|Deceased donors|deceased donors
1405947|NCT01140035|Renal Allograft Function|renal allograft function
1405948|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
1405949|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
1405950|NCT01140009|Vaccine|vaccine
1405951|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
1405952|NCT01140009|Influenza vaccine|influenza vaccine
1405953|NCT01140009|Vaccine safety|vaccine safety
1405954|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
1405955|NCT01140009|Fluviral 2010/11|fluviral 2010/11
1405956|NCT01139983|osteosarcoma|osteosarcoma
1405957|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1405958|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1405959|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1405960|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
1405961|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1405962|NCT01139918|psoriatic arthritis|psoriatic arthritis
1405963|NCT01139918|psoriasis|psoriasis
1405964|NCT01139918|Quality of life|quality of life
1405965|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
1405966|NCT01139905|pharmacokinetic|pharmacokinetic
1405967|NCT01139905|low dose|low dose
1405968|NCT01139905|HIV-infected children|hiv-infected children
1405969|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
1405970|NCT01139892|Unruptured aneurysm|unruptured aneurysm
1405971|NCT01139892|endovascular treatment|endovascular treatment
1405972|NCT01139892|surgical treatment|surgical treatment
1405973|NCT01139892|randomized|randomized
1405974|NCT01139892|intracranial aneurysm|intracranial aneurysm
1405975|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
1405976|NCT01139879|Home Care|home care
1405977|NCT01139879|Extended Care|extended care
1405978|NCT01139879|Wound measurements|wound measurements
1407933|NCT01132612|dermatology|dermatology
1405979|NCT01139866|Long-term Safety|long-term safety
1405980|NCT01139866|Shoulder Surgery|shoulder surgery
1405981|NCT01139866|bupivacaine|bupivacaine
1405982|NCT01139853|pyloric stenosis|pyloric stenosis
1405983|NCT01139853|nasogastric tube|nasogastric tube
1405984|NCT01139853|pyloromyotomy|pyloromyotomy
1405985|NCT01139840|vitamin D2|vitamin d2
1405986|NCT01139840|vitamin D3|vitamin d3
1405987|NCT01139840|ergocalciferol|ergocalciferol
1405988|NCT01139840|cholecalciferol|cholecalciferol
1405989|NCT01139840|vitamin D status|vitamin d status
1405990|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
1405991|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
1405992|NCT01139827|atherosclerosis|atherosclerosis
1405993|NCT01139827|inflammation|inflammation
1405995|NCT01139827|Framingham risk score|framingham risk score
1405996|NCT01139827|positron emission tomography|positron emission tomography
1405997|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
1405998|NCT01139814|atrial flutter|atrial flutter
1405999|NCT01139814|AVNRT|avnrt
1406000|NCT01139814|right sided accessory pathway|right sided accessory pathway
1406001|NCT01139814|ventricular tachycardia|ventricular tachycardia
1406002|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
1406003|NCT01139801|Cervical Ripening|cervical ripening
1406004|NCT01139801|Rate of Cesearean Section|rate of cesearean section
1406005|NCT01139788|Cancer|cancer
1406006|NCT01139775|solid tumors|solid tumors
1406007|NCT01139775|Mesothelioma|mesothelioma
1406008|NCT01139775|Carcinoma|carcinoma
1406009|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1406010|NCT01139762|Enlarged Prostate|enlarged prostate
1406011|NCT01139749|oral isotretinoin|oral isotretinoin
1406012|NCT01139749|sebaceous secretion|sebaceous secretion
1406013|NCT01139749|seborrhea|seborrhea
1406014|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
1406015|NCT01139749|quality of life|quality of life
1406016|NCT01139749|Malassezia|malassezia
1406017|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
1406018|NCT01139736|IBS|ibs
1406019|NCT01139736|probiotics|probiotics
1406020|NCT01139736|rectal sensitivity|rectal sensitivity
1406021|NCT01139736|gut flora|gut flora
1406022|NCT01139736|gut bacteria|gut bacteria
1406023|NCT01139710|SARCOIDOSIS|sarcoidosis
1406024|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
1406025|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
1406026|NCT01139697|Heart failure|heart failure
1406027|NCT01139697|Cortisol|cortisol
1406028|NCT01139697|Testosterone|testosterone
1406029|NCT01139684|Exercise test|exercise test
1406030|NCT01139671|Remifentanil|remifentanil
1406031|NCT01139671|Sufentanil|sufentanil
1406032|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
1406033|NCT01139671|General anaesthesia|general anaesthesia
1406034|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
1406035|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
1406036|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
1406037|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
1406038|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
1406039|NCT01139671|Under General anaesthesia|under general anaesthesia
1406040|NCT01139671|In Ambulatory surgery|in ambulatory surgery
1406042|NCT01139645|bone|bone
1406043|NCT01139645|metabolism|metabolism
1406044|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
1406045|NCT01139645|Rabeprazole|rabeprazole
1406046|NCT01139645|Esomeprazole|esomeprazole
1406047|NCT01139645|Lanzoprazole|lanzoprazole
1406048|NCT01139645|Vitamin D|vitamin d
1406049|NCT01139645|bone and bones|bone and bones
1406050|NCT01139632|NAFLD|nafld
1406051|NCT01139632|lP-pla2|lp-pla2
1406052|NCT01139632|Coronary Arthery Disease|coronary arthery disease
1406053|NCT01139619|Biopsy Mapping|biopsy mapping
1406054|NCT01139619|Non small cell lung cancer|non small cell lung cancer
1406055|NCT01139619|NSCLC|nsclc
1406056|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
1406057|NCT01139619|Retrospective|retrospective
1406058|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
1406059|NCT01139593|IVF|ivf
1406060|NCT01139593|ICSI|icsi
1406061|NCT01139593|gonadotropin|gonadotropin
1406062|NCT01139593|am dose|am dose
1406063|NCT01139593|pm dose|pm dose
1406064|NCT01139593|pregnancy|pregnancy
1406065|NCT01139593|implantation|implantation
1406066|NCT01139593|live birth|live birth
1406067|NCT01139580|Plaque Psoriasis|plaque psoriasis
1406068|NCT01139580|Psoriasis|psoriasis
1406069|NCT01139567|Diabetic Wounds|diabetic wounds
1406070|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
1406071|NCT01139567|Laser Speckle Imaging|laser speckle imaging
1406072|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
1406073|NCT01139528|Fracture|fracture
1406074|NCT01139528|5th metacarpal bone|5th metacarpal bone
1406075|NCT01139528|Bouquet pinning|bouquet pinning
1406076|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
1406077|NCT01139515|pharmacokinetic|pharmacokinetic
1406078|NCT01139515|eletriptan|eletriptan
1406079|NCT01139515|Korean|korean
1406080|NCT01139515|crossover|crossover
1406081|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
1406082|NCT01139502|work rehabilitation|work rehabilitation
1406083|NCT01139502|cognitive therapy|cognitive therapy
1406084|NCT01139502|cognitive training|cognitive training
1406085|NCT01139502|Adaptation to work|adaptation to work
1406086|NCT01139502|Work as a treatment factor|work as a treatment factor
1406087|NCT01139489|Procalcitonin|procalcitonin
1406088|NCT01139489|antibiotic therapy|antibiotic therapy
1406089|NCT01139489|antibiotics|antibiotics
1406090|NCT01139489|sepsis|sepsis
1406091|NCT01139489|infections|infections
1406092|NCT01139489|biomarker|biomarker
1406093|NCT01139476|Multiple Myeloma|multiple myeloma
1406094|NCT01139476|MGUS|mgus
1406095|NCT01139476|Leukemia|leukemia
1406096|NCT01139476|Biorepository|biorepository
1406097|NCT01139463|antipsychotics|antipsychotics
1406098|NCT01139463|lactates|lactates
1406099|NCT01139463|side effects|side effects
1406100|NCT01139450|Atopic Dermatitis|atopic dermatitis
1406101|NCT01139437|Vaccine|vaccine
1406102|NCT01139437|HPIV2|hpiv2
1406103|NCT01139437|Infants|infants
1406104|NCT01139424|surgical leak|surgical leak
1406105|NCT01139424|endoscopic suturing|endoscopic suturing
1406106|NCT01139424|Anastomotic leakage|anastomotic leakage
1406107|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
1406108|NCT01139398|Cholesterol|cholesterol
1406109|NCT01139398|LDL-cholesterol|ldl-cholesterol
1406110|NCT01139398|Coronary artery disease|coronary artery disease
1406111|NCT01139398|Red yeast rice|red yeast rice
1406112|NCT01139398|Plants extract|plants extract
1406113|NCT01139398|Cholesterol excess.|cholesterol excess.
1406114|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
1406115|NCT01139359|Lymphoma|lymphoma
1406116|NCT01139359|Darinaparsin|darinaparsin
1406117|NCT01139359|CHOP|chop
1406118|NCT01139359|Frontline|frontline
1406119|NCT01139359|PTCL|ptcl
1406120|NCT01139359|B-cell|b-cell
1406121|NCT01139346|carcinoma|carcinoma
1406122|NCT01139346|sarcoma|sarcoma
1406123|NCT01139346|metastatic|metastatic
1406124|NCT01139346|solid tumor|solid tumor
1406125|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1406126|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1406127|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1406128|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1406129|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1406130|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1406131|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1406132|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1406133|NCT01139294|cardiac output|cardiac output
1406134|NCT01139294|dehydration|dehydration
1406135|NCT01139294|pediatrics|pediatrics
1406136|NCT01139281|Ear protection|ear protection
1406137|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
1406138|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
1406139|NCT01139281|Ototoxicity|ototoxicity
1406140|NCT01139281|Cisplatin|cisplatin
1406141|NCT01139268|embryo viability|embryo viability
1406142|NCT01139242|CRC screening status|crc screening status
1406143|NCT01139242|physical activity level|physical activity level
1406144|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
1406145|NCT01139242|Early Detection of Cancer|early detection of cancer
1406146|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
1406147|NCT01139229|Esophagogastrostomy|esophagogastrostomy
1406148|NCT01139229|Circular everted anastomosis|circular everted anastomosis
1406149|NCT01139229|Side-side anastomosis|side-side anastomosis
1406150|NCT01139229|Randomized clinical trial|randomized clinical trial
1406151|NCT01139216|Digestive system diseases|digestive system diseases
1406152|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
1406153|NCT01139216|Intestinal diseases|intestinal diseases
1406154|NCT01139216|Colonic inertia|colonic inertia
1406155|NCT01139203|HBV recurrence|hbv recurrence
1406156|NCT01139203|entecavir|entecavir
1406157|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
1406158|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
1406159|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
1406160|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
1406161|NCT01139151|4'-Thio-araC|4'-thio-arac
1406162|NCT01139151|Thiarabine|thiarabine
1406163|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
1406164|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
1408151|NCT01132222|Crossover|crossover
1406165|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
1406166|NCT01139151|MDS|mds
1406167|NCT01139151|refractory anemia|refractory anemia
1406168|NCT01139151|Excess blasts|excess blasts
1406169|NCT01139151|RAEB-1|raeb-1
1406170|NCT01139151|RAEB-2|raeb-2
1406171|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1406172|NCT01139151|CMML|cmml
1406173|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
1406174|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
1406175|NCT01139151|AML|aml
1406176|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
1406177|NCT01139151|ALL|all
1406178|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1406179|NCT01139151|CLL|cll
1406180|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
1406181|NCT01139151|CML|cml
1406182|NCT01139151|blast crisis|blast crisis
1406183|NCT01139138|Colorectal Cancer|colorectal cancer
1406184|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
1406185|NCT01139138|Colorectal Tumors|colorectal tumors
1406186|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
1406187|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
1406188|NCT01139086|chronic heart failure|chronic heart failure
1406189|NCT01139086|isokinetic test|isokinetic test
1406190|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
1406191|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
1406192|NCT01139086|endothelial function|endothelial function
1406193|NCT01139073|Halitosis|halitosis
1406194|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
1406195|NCT01139021|Children|children
1406196|NCT01139021|Meningococcal disease|meningococcal disease
1406197|NCT01139021|Prevention|prevention
1406198|NCT01139021|Vaccination|vaccination
1406199|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
1406200|NCT01138995|Drop Foot|drop foot
1406201|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
1406202|NCT01138995|Gait, Drop foot|gait, drop foot
1406203|NCT01138982|Youth mentoring|youth mentoring
1406204|NCT01138982|Effectiveness|effectiveness
1406205|NCT01138982|Sweden|sweden
1406206|NCT01138982|low-risk youth|low-risk youth
1406207|NCT01138969|proton pump inhibitor|proton pump inhibitor
1406208|NCT01138969|peptic ulcer|peptic ulcer
1406209|NCT01138969|clopidogrel|clopidogrel
1406210|NCT01138969|prevention|prevention
1406211|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
1406212|NCT01138956|N-acetylcysteine|n-acetylcysteine
1406213|NCT01138956|Antimony|antimony
1406214|NCT01138956|Immune response|immune response
1406215|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
1406216|NCT01138943|Plaque control|plaque control
1406217|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
1406218|NCT01138930|Obesity|obesity
1406219|NCT01138904|gastric cancer|gastric cancer
1406220|NCT01138904|oxaliplatin|oxaliplatin
1406221|NCT01138904|irinotecan|irinotecan
1406222|NCT01138904|sequential treatment|sequential treatment
1406223|NCT01138891|Breast implants|breast implants
1406224|NCT01138891|capsular contraction|capsular contraction
1406225|NCT01138891|sonication|sonication
1406226|NCT01138891|biofilm|biofilm
1406227|NCT01138891|Complications|complications
1406228|NCT01138891|surgery|surgery
1406229|NCT01138878|HIV|hiv
1406230|NCT01138878|testing|testing
1406231|NCT01138878|non traditional settings|non traditional settings
1406232|NCT01138878|acceptability|acceptability
1406233|NCT01138878|feasibility|feasibility
1406234|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
1406235|NCT01138865|Cytokine levels|cytokine levels
1406236|NCT01138865|Insulin resistance|insulin resistance
1406237|NCT01138865|Hypertension|hypertension
1406238|NCT01138865|Dyslipidemia|dyslipidemia
1406239|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
1406240|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1406241|NCT01138852|post-cesarean infections|post-cesarean infections
1406242|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
1406243|NCT01138852|cefuroxime|cefuroxime
1406244|NCT01138852|cesarean|cesarean
1406245|NCT01138839|HELLP 1|hellp 1
1406246|NCT01138839|Dexamethasone|dexamethasone
1406247|NCT01138839|Clinical trial|clinical trial
1406248|NCT01138826|biological availability|biological availability
1406249|NCT01138826|bioavailability|bioavailability
1406250|NCT01138826|amlodipine|amlodipine
1406251|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
1406252|NCT01138826|ODT|odt
1406253|NCT01138826|tablets|tablets
1406254|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1406255|NCT01138813|lactate editing|lactate editing
1406256|NCT01138813|metabolite content|metabolite content
1406257|NCT01138813|glioma|glioma
1406258|NCT01138774|Obesity|obesity
1406259|NCT01138774|Calorie restriction|calorie restriction
1406260|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
1406261|NCT01138774|Lipoic acid|lipoic acid
1406262|NCT01138774|Weight loss|weight loss
1406263|NCT01138774|Insulin sensitivity|insulin sensitivity
1406264|NCT01138774|Lipid metabolism|lipid metabolism
1406265|NCT01138774|Adipokines|adipokines
1406266|NCT01138774|Inflammation|inflammation
1406267|NCT01138774|Oxidative stress|oxidative stress
1406268|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
1406269|NCT01138774|Metabolomic profile|metabolomic profile
1406270|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
1406271|NCT01138761|EASI|easi
1406272|NCT01138761|REALM-SF|realm-sf
1406273|NCT01138761|nurse instruction|nurse instruction
1406274|NCT01138761|health literacy|health literacy
1406275|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
1406276|NCT01138748|radiation therapy|radiation therapy
1406277|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
1406278|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
1406279|NCT01138696|ACL|acl
1406280|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
1406281|NCT01138683|ultrafiltration|ultrafiltration
1406282|NCT01138683|diuretics|diuretics
1406283|NCT01138683|AKI|aki
1406284|NCT01138657|inflammation of uvea|inflammation of uvea
1406285|NCT01138644|Atrial Fibrillation|atrial fibrillation
1406286|NCT01138644|Atrial Flutter|atrial flutter
1406287|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
1406288|NCT01138618|Clozapine|clozapine
1406289|NCT01138618|hematological monitoring|hematological monitoring
1406290|NCT01138618|CHEMPAQ|chempaq
1406291|NCT01138618|Granulocytes|granulocytes
1406292|NCT01138618|WBC|wbc
1406293|NCT01138605|TMC114|tmc114
1406294|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
1406295|NCT01138605|TMC114-C232|tmc114-c232
1406296|NCT01138605|Darunavir|darunavir
1406297|NCT01138605|PREZISTA|prezista
1406298|NCT01138579|FBTA05|fbta05
1406299|NCT01138579|CD20|cd20
1406300|NCT01138579|CLL|cll
1406301|NCT01138579|NHL|nhl
1406302|NCT01138579|DLI|dli
1406303|NCT01138579|allogeneic transplantation|allogeneic transplantation
1406304|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
1406305|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
1406306|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
1406307|NCT01138553|biomarker|biomarker
1406308|NCT01138553|breast cancer|breast cancer
1406309|NCT01138553|antiprogesterone|antiprogesterone
1406310|NCT01138540|VAP|vap
1406311|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
1406312|NCT01138475|PTH|pth
1406313|NCT01138475|Gastric bypass surgery|gastric bypass surgery
1406314|NCT01138475|vitamin D|vitamin d
1406315|NCT01138475|paricalcitol|paricalcitol
1406316|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1406317|NCT01138462|Decolonisation|decolonisation
1406318|NCT01138462|Nursing homes|nursing homes
1406319|NCT01138462|Infection Control|infection control
1406320|NCT01138449|Vitamin A|vitamin a
1406321|NCT01138449|Neonatal mortality|neonatal mortality
1406322|NCT01138449|Infant mortality|infant mortality
1406323|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
1406324|NCT01138423|Hypertension|hypertension
1406325|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
1406326|NCT01138423|Obesity|obesity
1406327|NCT01138423|Adiposity|adiposity
1406328|NCT01138423|Clinical trial|clinical trial
1406329|NCT01138410|Immunotherapy|immunotherapy
1406330|NCT01138410|Melanoma|melanoma
1406331|NCT01138410|Gene therapy|gene therapy
1406332|NCT01138410|DNA plasmid|dna plasmid
1406333|NCT01138410|Cancer vaccine|cancer vaccine
1406334|NCT01138410|Electroporation|electroporation
1406335|NCT01138410|CTL response|ctl response
1406336|NCT01138397|Influenza|influenza
1406337|NCT01138397|Influenza vaccine|influenza vaccine
1406338|NCT01138397|Influenza virus|influenza virus
1406339|NCT01138397|Intradermal|intradermal
1406340|NCT01138384|Breast Cancer|breast cancer
1406341|NCT01138371|LDL apheresis|ldl apheresis
1406342|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
1406343|NCT01138371|Inflammatory markers|inflammatory markers
1406344|NCT01138371|Hyperlipidemia|hyperlipidemia
1406345|NCT01138371|Cardiovascular disease|cardiovascular disease
1406347|NCT01138358|lung metastases|lung metastases
1406348|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1406349|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
1406350|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1406351|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1406352|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1406353|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1406354|NCT01138345|cancer survivor|cancer survivor
1406355|NCT01138345|stage I breast cancer|stage i breast cancer
1406356|NCT01138345|stage II breast cancer|stage ii breast cancer
1406357|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
1406358|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
1406359|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
1406360|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1406361|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
1406362|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1406363|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1406364|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
1406365|NCT01138280|biofilm formation|biofilm formation
1406366|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
1406367|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
1406368|NCT01138280|cardiovascular events|cardiovascular events
1406369|NCT01138280|overall mortality|overall mortality
1406370|NCT01138280|hemodialysis|hemodialysis
1406371|NCT01138267|pharmacogenomics|pharmacogenomics
1406372|NCT01138267|ATV|atv
1406373|NCT01138267|EFV|efv
1406374|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
1406375|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
1406376|NCT01138241|HIV|hiv
1406377|NCT01138241|Chronic kidney disease|chronic kidney disease
1406378|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
1406379|NCT01138241|Tenofovir|tenofovir
1406380|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
1406381|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
1406382|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
1406383|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
1406384|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
1406385|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
1406386|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
1567161|NCT00509704|Sutent|sutent
1567162|NCT00509704|tumor necrosis|tumor necrosis
1567285|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1406387|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
1406388|NCT01138228|intravenous cannulation|intravenous cannulation
1406389|NCT01138228|vein identification|vein identification
1406390|NCT01138228|vascular identification|vascular identification
1406391|NCT01138228|vein cannulation|vein cannulation
1406392|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
1406393|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
1406394|NCT01138215|immunogenicity|immunogenicity
1406395|NCT01138215|safety and efficacy|safety and efficacy
1406396|NCT01138215|HIV-infected children|hiv-infected children
1406397|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
1406398|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
1406399|NCT01138202|pharmacokinetics|pharmacokinetics
1406400|NCT01138202|safety|safety
1406401|NCT01138202|efficacy|efficacy
1406402|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
1406403|NCT01138202|HIV/TB|hiv/tb
1406404|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
1406405|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
1406406|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
1406407|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
1406408|NCT01138189|Custom LASIK|custom lasik
1406409|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
1406410|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
1406411|NCT01138176|Phase changing material|phase changing material
1406412|NCT01138176|MR imaging|mr imaging
1406413|NCT01138163|NSCLC|nsclc
1406414|NCT01138163|second-line|second-line
1406415|NCT01138163|lung cancer|lung cancer
1406416|NCT01138163|non small cell lung cancer|non small cell lung cancer
1406417|NCT01138163|bavituximab|bavituximab
1406418|NCT01138163|monoclonal antibody|monoclonal antibody
1406419|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
1406420|NCT01138137|ovarian cancer|ovarian cancer
1406421|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
1406422|NCT01138137|peritoneal cancer|peritoneal cancer
1406423|NCT01138124|renal cell carcinoma|renal cell carcinoma
1406424|NCT01138124|epidemiology|epidemiology
1406425|NCT01138124|pancreatic cancer|pancreatic cancer
1406426|NCT01138124|renal cancer|renal cancer
1406427|NCT01138124|renal pelvis cancer|renal pelvis cancer
1406428|NCT01138124|GPRD|gprd
1406429|NCT01138124|case-control|case-control
1406430|NCT01138124|Gapabentin|gapabentin
1406431|NCT01138111|Florbetaben|florbetaben
1406432|NCT01138111|Amyloid beta-protein|amyloid beta-protein
1406434|NCT01138111|Alzheimer's disease|alzheimer's disease
1406435|NCT01138098|Persistence|persistence
1406436|NCT01138098|challenge dose|challenge dose
1406437|NCT01138098|Engerix-B|engerix-b
1406438|NCT01138098|immune response|immune response
1406439|NCT01138085|Triple negative breast cancer|triple negative breast cancer
1406440|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
1406441|NCT01138085|Solid tumors|solid tumors
1406442|NCT01138085|Endometrial Cancer|endometrial cancer
1406443|NCT01138085|Oncology|oncology
1406444|NCT01138085|GSK2141795|gsk2141795
1406445|NCT01138085|AKT Inhibitor|akt inhibitor
1406446|NCT01138085|GSK1120212|gsk1120212
1406447|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
1406448|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
1406449|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
1406450|NCT01138046|lapatinib|lapatinib
1406452|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
1406453|NCT01138046|pharmacokinetics|pharmacokinetics
1406454|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
1406455|NCT01138046|HER-2/neu|her-2/neu
1406456|NCT01138046|EGFR|egfr
1406457|NCT01138046|ErbB1|erbb1
1406458|NCT01138033|pharmacodynamics|pharmacodynamics
1406459|NCT01138033|cancer|cancer
1406460|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
1406461|NCT01138033|pharmacokinetics|pharmacokinetics
1406462|NCT01138033|solid tumors|solid tumors
1406463|NCT01138033|Phase 1|phase 1
1406464|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
1406465|NCT01138020|Cognitive treatment|cognitive treatment
1406466|NCT01138020|TBI|tbi
1406467|NCT01138007|Bupropion|bupropion
1406468|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
1406469|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
1406470|NCT01138007|IVRS HAM-D|ivrs ham-d
1406471|NCT01138007|IDS-SR|ids-sr
1406472|NCT01138007|MADRS|madrs
1406473|NCT01137994|ErbB2|erbb2
1406474|NCT01137994|Trastuzumab|trastuzumab
1406475|NCT01137994|p95HER2|p95her2
1406476|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
1406477|NCT01137994|HER2|her2
1406478|NCT01137994|Lapatinib|lapatinib
1406479|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
1406480|NCT01137981|Antiretrovirals|antiretrovirals
1406481|NCT01137981|ARV|arv
1406482|NCT01137981|HAART|haart
1406483|NCT01137981|Maraviroc|maraviroc
1406484|NCT01137981|Delavirdine|delavirdine
1406485|NCT01137981|Lamivudine|lamivudine
1406486|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
1406487|NCT01137981|Fosamprenavir|fosamprenavir
1406488|NCT01137981|APR|apr
1406489|NCT01137981|Zidovudine|zidovudine
1406490|NCT01137981|pregnancy registry|pregnancy registry
1406491|NCT01137981|Amprenavir|amprenavir
1406492|NCT01137981|HIV|hiv
1406493|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
1406494|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
1406495|NCT01137968|imetelstat|imetelstat
1406496|NCT01137968|imetelstat sodium|imetelstat sodium
1406497|NCT01137968|GRN163L|grn163l
1406498|NCT01137968|telomerase inhibitor|telomerase inhibitor
1406499|NCT01137968|telomerase inhibition|telomerase inhibition
1406500|NCT01137968|maintenance therapy|maintenance therapy
1406501|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
1406502|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
1406503|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1406504|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
1406505|NCT01137968|Bevacizumab|bevacizumab
1406506|NCT01137968|post induction chemotherapy|post induction chemotherapy
1406507|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
1406508|NCT01137955|Poorly responsive|poorly responsive
1406509|NCT01137955|Refractory|refractory
1406510|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
1406511|NCT01137955|Breath test|breath test
1406512|NCT01137942|helicobacter pylori|helicobacter pylori
1406513|NCT01137942|eradication failure|eradication failure
1406514|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
1406515|NCT01137929|Kidney|kidney
1406516|NCT01137929|Renal Scar|renal scar
1406517|NCT01137929|Urinary tract infection|urinary tract infection
1406518|NCT01137903|Diabetic foot|diabetic foot
1406519|NCT01137903|Osteomyelitis|osteomyelitis
1406520|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
1406521|NCT01137903|Foot infections|foot infections
1406522|NCT01137890|cocaine|cocaine
1406523|NCT01137890|addiction|addiction
1406524|NCT01137890|drug dependence|drug dependence
1406525|NCT01137890|anticonvulsant|anticonvulsant
1406526|NCT01137890|zonisamide|zonisamide
1406527|NCT01137890|drug self-administration|drug self-administration
1406528|NCT01137890|nicotine withdrawal|nicotine withdrawal
1406529|NCT01137890|neurocognition|neurocognition
1406530|NCT01137864|Emergency wards|emergency wards
1406531|NCT01137864|Hospitalization|hospitalization
1406532|NCT01137864|Adults|adults
1406533|NCT01137864|Antimicrobial therapy|antimicrobial therapy
1406534|NCT01137825|cognitive/functional effects|cognitive/functional effects
1406535|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1406536|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1406537|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
1406538|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1406539|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1406540|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1406541|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1406542|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1406543|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1406544|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1406545|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1406546|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1406547|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1406548|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1406549|NCT01137825|mast cell leukemia|mast cell leukemia
1406550|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1406551|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1406552|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
1406553|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1406554|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1406555|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1406556|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1406557|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
1406558|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1406559|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1568275|NCT00506428|sleep deprivation|sleep deprivation
1406560|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1406561|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1406562|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1406563|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1406564|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1406565|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1406566|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1406567|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1406568|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1406569|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1406570|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1406571|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1406572|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
1406573|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1406574|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1406575|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1406576|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1406577|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1406578|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1406579|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1406580|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1406581|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1406582|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1406583|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1406584|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1406585|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1406586|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1406587|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1406588|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1406589|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1406590|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1406591|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1406592|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1406738|NCT01137656|Aged blood|aged blood
1406593|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1406594|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1406595|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1406596|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1406597|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1406598|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1406599|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1406600|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1406601|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1406602|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1406603|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1406604|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1406605|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1406606|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1406607|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1406608|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1406609|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1406610|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1406611|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1406612|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1406613|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1406614|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1406615|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1406616|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1406617|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1406618|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1406619|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1406620|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1406621|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1406622|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1406623|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1406624|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1406625|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1406626|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1406627|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1406628|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1406629|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1406630|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1406631|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1406632|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1406633|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1406634|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1406635|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1406636|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1406637|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1406638|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1406639|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1406640|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1406641|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1406642|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1406643|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1406644|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1406645|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1406646|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1406647|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1406648|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1406649|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1406650|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1406651|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1406652|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1406653|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1406654|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1406655|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1406656|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1406657|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1406658|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1406659|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1406660|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1406661|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1406662|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1406663|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1406664|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1406665|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1406666|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1406667|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1406668|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1406669|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1406670|NCT01137825|intraocular lymphoma|intraocular lymphoma
1406671|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1406672|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1406673|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1406674|NCT01137825|primary myelofibrosis|primary myelofibrosis
1406675|NCT01137825|essential thrombocythemia|essential thrombocythemia
1406676|NCT01137825|polycythemia vera|polycythemia vera
1406677|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
1406678|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1406679|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
1406680|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
1406681|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
1535095|NCT00639847|nursing|nursing
1406682|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
1406683|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
1406684|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1406685|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1406686|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1406687|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1406688|NCT01137812|Canagliflozin|canagliflozin
1406689|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
1406690|NCT01137812|Metformin|metformin
1406691|NCT01137812|Sulphonylurea|sulphonylurea
1406692|NCT01137812|Hemoglobin A1c|hemoglobin a1c
1406693|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
1406694|NCT01137799|symptomatic treatment|symptomatic treatment
1406695|NCT01137799|cognition|cognition
1406696|NCT01137799|cognitive deficits|cognitive deficits
1406697|NCT01137799|schizophrenia|schizophrenia
1406698|NCT01137799|Alzheimer's Disease|alzheimer's disease
1406699|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
1406700|NCT01137773|Brain Hemorrhage|brain hemorrhage
1406701|NCT01137773|Traumatic Brain Injury|traumatic brain injury
1406703|NCT01137773|ICH|ich
1406704|NCT01137760|adults|adults
1406705|NCT01137760|fiber|fiber
1406706|NCT01137760|cold|cold
1406707|NCT01137760|flu|flu
1406708|NCT01137760|stress|stress
1406709|NCT01137760|microbiota|microbiota
1406710|NCT01137747|carfilzomib|carfilzomib
1406711|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
1406712|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1406713|NCT01137747|phase I|phase i
1406714|NCT01137734|Heart Diseases|heart diseases
1406715|NCT01137734|Heart Valve Diseases|heart valve diseases
1406716|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
1406717|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
1406718|NCT01137721|sickle cell disease|sickle cell disease
1406719|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
1406720|NCT01137708|drug interactions|drug interactions
1406721|NCT01137708|CYP3A|cyp3a
1406722|NCT01137708|oral contraceptive|oral contraceptive
1406723|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
1406724|NCT01137695|pramlintide|pramlintide
1406725|NCT01137695|glucose|glucose
1406726|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
1406727|NCT01137695|amylin|amylin
1406728|NCT01137682|Acromegaly|acromegaly
1406729|NCT01137682|hormone disorder|hormone disorder
1406730|NCT01137682|growth hormone|growth hormone
1406731|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
1406732|NCT01137682|pituitary tumor|pituitary tumor
1406733|NCT01137682|pasireotide|pasireotide
1406734|NCT01137682|SOM230|som230
1406735|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
1406736|NCT01137656|Blood storage|blood storage
1406737|NCT01137656|Blood transfusion|blood transfusion
1406739|NCT01137656|Blood Forearm|blood forearm
1406740|NCT01137656|Storage lesion in blood|storage lesion in blood
1406741|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1406742|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
1406743|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1406744|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1406745|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1406746|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1406747|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1406748|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1406749|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1406750|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1406751|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1406752|NCT01137643|mast cell leukemia|mast cell leukemia
1406753|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1406754|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1406755|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
1406756|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1406757|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1406758|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1406759|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1406760|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
1406761|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1406762|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1406763|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1406764|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1406765|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1406766|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1406767|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1406768|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1406769|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1406770|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1406771|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1406772|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1406773|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1406774|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1406775|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
1406776|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1406777|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1406778|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1406779|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1406780|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1406781|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1406782|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1406783|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1406784|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1406785|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1406786|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1406787|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1406788|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1406789|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1406790|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1406791|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1406792|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1406793|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1406794|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1406795|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1406796|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1406797|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1406798|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1406799|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1406800|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1406801|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1406950|NCT01137435|Pertussis|pertussis
1406951|NCT01137383|Hepatitis C|hepatitis c
1406802|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1406803|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1406804|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1406805|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1406806|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1406807|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1408439|NCT01130948|sleep apnea|sleep apnea
1406808|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1406809|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1406810|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1406811|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1406812|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1406813|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1406814|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1406815|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1406816|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1406817|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1406818|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1406819|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1406820|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1406821|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1406822|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1568276|NCT00506428|performance|performance
1535336|NCT00638859|CAP|cap
1406823|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1406824|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1406825|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1406826|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1406827|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1406828|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1406829|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1406830|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1406831|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1406832|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1406833|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1406834|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1406835|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1406836|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1406837|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1406838|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1406839|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1406840|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1406841|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1406842|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1406843|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1406844|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1406845|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1406846|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1406847|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1406848|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1406849|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1406850|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1406851|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1406852|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1406853|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1406854|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1406855|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1406856|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1406857|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1406858|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1406859|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1406860|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1406861|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1406862|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1406863|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1406864|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1406865|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1406866|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1406867|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1406962|NCT01137305|Virtual reality|virtual reality
1406868|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1406869|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1406870|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1406871|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1406872|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1406873|NCT01137643|intraocular lymphoma|intraocular lymphoma
1406874|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1406875|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1406876|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1406877|NCT01137643|primary myelofibrosis|primary myelofibrosis
1406878|NCT01137643|essential thrombocythemia|essential thrombocythemia
1406879|NCT01137643|polycythemia vera|polycythemia vera
1406880|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
1406881|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1406882|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
1406883|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
1406884|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
1406885|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
1406886|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
1406887|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1406888|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1406889|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1406890|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1406891|NCT01137643|aplastic anemia|aplastic anemia
1406892|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
1406893|NCT01137630|scalp|scalp
1406894|NCT01137630|K40a|k40a
1406895|NCT01137630|K40b|k40b
1406896|NCT01137617|spinal cord stimualtor|spinal cord stimualtor
1406897|NCT01137591|Acetaminophen|acetaminophen
1406898|NCT01137591|Acetylcysteine|acetylcysteine
1406899|NCT01137591|Antidotes|antidotes
1406900|NCT01137565|Amgen|amgen
1406901|NCT01137565|Adolescent|adolescent
1406902|NCT01137565|Safety|safety
1406903|NCT01137552|First-In-Human|first-in-human
1406904|NCT01137552|Dose Escalation|dose escalation
1406905|NCT01137552|Dose Expansion|dose expansion
1406906|NCT01137552|Advance Solid Tumors|advance solid tumors
1406907|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
1406908|NCT01137552|Advance Malignancy|advance malignancy
1406909|NCT01137552|Cancer|cancer
1406910|NCT01137552|Oncology|oncology
1406911|NCT01137552|Oncology Patients|oncology patients
1406912|NCT01137552|Phase 1|phase 1
1406913|NCT01137552|Clinical Trial|clinical trial
1406914|NCT01137552|Tumors|tumors
1406915|NCT01137552|Solid Tumors|solid tumors
1406916|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
1406917|NCT01137539|urinary incontinence|urinary incontinence
1406918|NCT01137539|stress urinary incontinence|stress urinary incontinence
1406919|NCT01137539|mid-urethral slings|mid-urethral slings
1406920|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
1406921|NCT01137539|TVT|tvt
1406922|NCT01137513|Chest Pain|chest pain
1406923|NCT01137513|Acute coronary syndrome|acute coronary syndrome
1406924|NCT01137513|AMI|ami
1406925|NCT01137487|mechanical ventilation|mechanical ventilation
1406926|NCT01137487|enteral nutrition|enteral nutrition
1406927|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
1406928|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
1406929|NCT01137487|vomiting|vomiting
1406930|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
1406931|NCT01137487|early enteral nutrition|early enteral nutrition
1406932|NCT01137487|Intensive care unit|intensive care unit
1406933|NCT01137487|Enteral Feeding|enteral feeding
1406934|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1406935|NCT01137474|Diabetes Mellitus|diabetes mellitus
1406936|NCT01137474|Endocrine System Diseases|endocrine system diseases
1406937|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
1406938|NCT01137474|Metabolic Diseases|metabolic diseases
1406939|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
1406940|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1406941|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
1406942|NCT01137474|Pharmacologic Actions|pharmacologic actions
1406943|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
1406944|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
1406945|NCT01137448|Psoriasis|psoriasis
1406946|NCT01137448|Obesity|obesity
1406947|NCT01137435|Adacel|adacel
1406948|NCT01137435|Diphtheria|diphtheria
1406949|NCT01137435|Tetanus|tetanus
1406952|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
1406953|NCT01137331|scalp|scalp
1406954|NCT01137331|dandruff|dandruff
1406955|NCT01137331|K301|k301
1406956|NCT01137331|K40|k40
1406957|NCT01137318|ADHD|adhd
1406958|NCT01137318|Impairment|impairment
1406959|NCT01137318|Treatment|treatment
1406960|NCT01137318|Cognitive Remediation|cognitive remediation
1406961|NCT01137318|Behavioral Parent Training|behavioral parent training
1406963|NCT01137305|surgical training|surgical training
1406964|NCT01137305|Health Care [N]|health care [n]
1406965|NCT01137292|observational study|observational study
1406966|NCT01137292|voriconazole|voriconazole
1406967|NCT01137292|high-risk patients|high-risk patients
1407091|NCT01136603|Adhesion formation|adhesion formation
1406968|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
1406969|NCT01137253|Nitric Oxide|nitric oxide
1406970|NCT01137253|Autonomic Nervous System|autonomic nervous system
1406971|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
1406972|NCT01137227|Physical activity|physical activity
1406973|NCT01137227|Epidemiology|epidemiology
1406974|NCT01137227|Questionnaire|questionnaire
1406975|NCT01137227|Cross-sectional study|cross-sectional study
1406976|NCT01137214|complex sleep apnea|complex sleep apnea
1406977|NCT01137201|Small bowel obstruction|small bowel obstruction
1406978|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
1406979|NCT01137201|Internal Hernia|internal hernia
1406980|NCT01137201|Mesenteric defect|mesenteric defect
1406981|NCT01137201|Morbid obesity|morbid obesity
1406982|NCT01137175|Rickettsioses|rickettsioses
1406983|NCT01137175|Scrub Typhus|scrub typhus
1406984|NCT01137175|Q fever|q fever
1406985|NCT01137175|Typhus fever|typhus fever
1406986|NCT01137175|Spotted fever|spotted fever
1406987|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
1406988|NCT01137149|Adolescent Depression|adolescent depression
1406989|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
1406990|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
1406991|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1406992|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1406993|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
1406994|NCT01137110|Levetiracetam|levetiracetam
1406995|NCT01137045|rabies vaccine|rabies vaccine
1406996|NCT01137045|vero cells|vero cells
1406997|NCT01137045|serology|serology
1406998|NCT01137045|safety|safety
1406999|NCT01137032|Psoriasis|psoriasis
1407000|NCT01137032|Atopic Dermatitis|atopic dermatitis
1407001|NCT01137019|Drug-eluting stents|drug-eluting stents
1407002|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
1407003|NCT01137006|Melanoma|melanoma
1407004|NCT01137006|Phase I|phase i
1407005|NCT01137006|antibody|antibody
1407006|NCT01137006|melanin|melanin
1407007|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
1407008|NCT01137006|glycoprotein|glycoprotein
1407009|NCT01137006|20D7S|20d7s
1407010|NCT01136993|Stroke|stroke
1407011|NCT01136993|Thrombolysis|thrombolysis
1407012|NCT01136993|Telestroke|telestroke
1407013|NCT01136980|GERD|gerd
1407014|NCT01136980|Esophagitis|esophagitis
1407015|NCT01136980|Fundoplication|fundoplication
1407016|NCT01136980|Anti-reflux surgery|anti-reflux surgery
1407017|NCT01136980|PPI dependent|ppi dependent
1407018|NCT01136928|Antiretroviral therapy|antiretroviral therapy
1407019|NCT01136928|American ginseng|american ginseng
1407020|NCT01136928|Efavirenz|efavirenz
1407021|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
1407022|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
1407023|NCT01136928|Herbal|herbal
1407024|NCT01136928|Pharmacikinetics|pharmacikinetics
1407025|NCT01136928|Healthy volunteers|healthy volunteers
1407026|NCT01136902|Diabetes Mellitus|diabetes mellitus
1407027|NCT01136902|Retinal Vessels|retinal vessels
1407028|NCT01136902|Physiology|physiology
1407029|NCT01136889|PFMT|pfmt
1407030|NCT01136889|Vaginal pessary|vaginal pessary
1407031|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
1407032|NCT01136863|hypertension|hypertension
1407033|NCT01136863|felodipine|felodipine
1407034|NCT01136863|moderate to high risk patients|moderate to high risk patients
1407035|NCT01136850|Plasmodium falciparum|plasmodium falciparum
1407036|NCT01136850|Plasmodium vivax|plasmodium vivax
1407037|NCT01136850|azithromycin|azithromycin
1407038|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
1407039|NCT01136850|low birth weight|low birth weight
1407040|NCT01136850|haemoglobin|haemoglobin
1407041|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
1407042|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
1407043|NCT01136850|Treponema pallidum|treponema pallidum
1407044|NCT01136824|Sarcoma|sarcoma
1407045|NCT01136824|questionnaire|questionnaire
1407046|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
1407047|NCT01136798|slow wave sleep|slow wave sleep
1407048|NCT01136798|exenatide and sleep|exenatide and sleep
1407049|NCT01136759|Prevention|prevention
1407050|NCT01136759|Microbicide|microbicide
1407051|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
1407052|NCT01136759|Pregnancy|pregnancy
1407053|NCT01136746|Hyperglycemia|hyperglycemia
1407054|NCT01136746|Diabetes|diabetes
1407055|NCT01136746|Hospital|hospital
1407056|NCT01136746|Diabetic|diabetic
1407158|NCT01136356|human research|human research
1407057|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
1407058|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
1407059|NCT01136681|Record Linkage|record linkage
1407060|NCT01136681|Routine Data|routine data
1407061|NCT01136681|Environment|environment
1407062|NCT01136681|Childhood Obesity|childhood obesity
1407063|NCT01136681|Low birth weight|low birth weight
1407064|NCT01136681|Premature birth|premature birth
1407065|NCT01136668|pediatrics|pediatrics
1407066|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
1407067|NCT01136668|Ostomy Surgery|ostomy surgery
1407068|NCT01136668|Anesthesia|anesthesia
1407069|NCT01136668|Regional Anesthetic|regional anesthetic
1407070|NCT01136655|asthmatic children|asthmatic children
1407071|NCT01136655|Symbicort|symbicort
1407073|NCT01136642|Nicotine|nicotine
1407074|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
1407075|NCT01136642|Attention|attention
1407076|NCT01136642|Smoking|smoking
1407077|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
1407078|NCT01136629|Lentigines|lentigines
1407080|NCT01136629|RNA extraction|rna extraction
1407081|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
1407082|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
1407083|NCT01136616|Nasal fracture|nasal fracture
1407084|NCT01136616|Nasal buttresses|nasal buttresses
1407085|NCT01136616|Septal deviation|septal deviation
1407086|NCT01136616|Nasal morphology|nasal morphology
1407087|NCT01136616|CT Scan|ct scan
1407088|NCT01136603|Abdominal wall defects|abdominal wall defects
1407089|NCT01136603|Inflammation reactions|inflammation reactions
1407090|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
1407092|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
1407093|NCT01136590|Spinal deformity correction|spinal deformity correction
1407094|NCT01136590|Surgical bleeding|surgical bleeding
1407095|NCT01136590|Transfusion practice|transfusion practice
1407096|NCT01136590|Spinal Fusion|spinal fusion
1407097|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
1407098|NCT01136590|Hemorrhage|hemorrhage
1407099|NCT01136590|Blood Transfusion|blood transfusion
1407100|NCT01136577|Jaundice|jaundice
1407101|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
1407102|NCT01136577|Phototherapy|phototherapy
1407103|NCT01136577|term newborn|term newborn
1407104|NCT01136577|LED|led
1407105|NCT01136577|Fluorescent lamps|fluorescent lamps
1407106|NCT01136564|paricalcitol|paricalcitol
1407107|NCT01136564|vitamin d|vitamin d
1407108|NCT01136564|kidney disease|kidney disease
1407109|NCT01136564|renin|renin
1407110|NCT01136564|proteinuria|proteinuria
1407111|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
1407112|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
1407113|NCT01136538|Bioequivalence|bioequivalence
1407114|NCT01136538|Crossover|crossover
1407115|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
1407116|NCT01136525|Bioequivalence|bioequivalence
1407117|NCT01136525|Crossover|crossover
1407118|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
1407119|NCT01136512|metformin|metformin
1407120|NCT01136512|vitamin B12|vitamin b12
1407121|NCT01136512|type 2 diabetes|type 2 diabetes
1407122|NCT01136512|methylmalonic acid|methylmalonic acid
1407123|NCT01136512|deficiency|deficiency
1407124|NCT01136499|Sarcoma|sarcoma
1407125|NCT01136499|Safety|safety
1407126|NCT01136499|Efficacy|efficacy
1407127|NCT01136499|PANOBINOSTAT|panobinostat
1407128|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
1407129|NCT01136473|congenital cataract|congenital cataract
1407130|NCT01136473|aphakic|aphakic
1407131|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
1407132|NCT01136473|pediatric patients|pediatric patients
1407133|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
1407134|NCT01136460|neonatal|neonatal
1407135|NCT01136460|Genotype correlation|genotype correlation
1407136|NCT01136460|Phenotype correlation|phenotype correlation
1407137|NCT01136447|Brachial plexus|brachial plexus
1407138|NCT01136447|Ultrasound|ultrasound
1407139|NCT01136421|COPD exacerbation|copd exacerbation
1407140|NCT01136421|Magnesium sulfate|magnesium sulfate
1407141|NCT01136421|Ipratropium bromide|ipratropium bromide
1407142|NCT01136421|Emergency departement|emergency departement
1407143|NCT01136395|Kidney Transplantation|kidney transplantation
1407144|NCT01136395|Rituximab|rituximab
1407145|NCT01136395|Living Donor|living donor
1407146|NCT01136395|ABO Incompatible Transplantation|abo incompatible transplantation
1407147|NCT01136395|Immunology|immunology
1407148|NCT01136395|CMV|cmv
1407149|NCT01136395|EBV|ebv
1407150|NCT01136395|Polyomavirus|polyomavirus
1407151|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
1407152|NCT01136369|metastasis|metastasis
1407153|NCT01136369|molecular pathology|molecular pathology
1407154|NCT01136356|opioid pharmacology|opioid pharmacology
1407155|NCT01136356|buprenorphine|buprenorphine
1407156|NCT01136356|morphine|morphine
1407157|NCT01136356|withdrawal|withdrawal
1407162|NCT01136330|Myotonic dystrophy|myotonic dystrophy
1407163|NCT01136330|Prognosis|prognosis
1407164|NCT01136330|Sudden death|sudden death
1407165|NCT01136330|Respiratory failure|respiratory failure
1407166|NCT01136304|Gaucher disease|gaucher disease
1407167|NCT01136304|Imiglucerase|imiglucerase
1407168|NCT01136304|Cerezyme|cerezyme
1407169|NCT01136304|Severity score|severity score
1407170|NCT01136291|pregnancy|pregnancy
1407171|NCT01136291|obesity|obesity
1407172|NCT01136291|physical exercise|physical exercise
1407173|NCT01136291|quality of life|quality of life
1407174|NCT01136278|MDMA|mdma
1407175|NCT01136278|norepinephrine|norepinephrine
1407176|NCT01136278|alpha2 receptor|alpha2 receptor
1407177|NCT01136278|Ecstasy|ecstasy
1407178|NCT01136278|stimulant|stimulant
1407179|NCT01136265|dual-time PET/CT|dual-time pet/ct
1407180|NCT01136265|sentinel node|sentinel node
1407181|NCT01136239|COPD|copd
1407182|NCT01136239|N-acetylcysteine|n-acetylcysteine
1407183|NCT01136239|airtrapping|airtrapping
1407184|NCT01136239|airway resistance|airway resistance
1407185|NCT01136239|antioxidant|antioxidant
1407186|NCT01136226|Prostate Cancer|prostate cancer
1407187|NCT01136200|Surgical and medical wards|surgical and medical wards
1407188|NCT01136200|Adults|adults
1407189|NCT01136200|Antimicrobial therapy|antimicrobial therapy
1407190|NCT01136187|Myocardial infarction|myocardial infarction
1407191|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1407192|NCT01136187|Radial|radial
1407193|NCT01136187|Bleeding|bleeding
1407194|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
1407195|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
1407196|NCT01136161|Vaccine|vaccine
1407197|NCT01136148|Mental Health|mental health
1407198|NCT01136148|Aged|aged
1407199|NCT01136148|Hospitals, general|hospitals, general
1407200|NCT01136148|Dementia|dementia
1407201|NCT01136148|Delirium|delirium
1407202|NCT01136148|Dementia and confusion|dementia and confusion
1407203|NCT01136135|Heart transplant rejection|heart transplant rejection
1407204|NCT01136135|cardiac MRI|cardiac mri
1407205|NCT01136135|diagnosis|diagnosis
1407206|NCT01136096|diabetes|diabetes
1407207|NCT01136096|physical activity|physical activity
1407208|NCT01136096|adiponectin|adiponectin
1407209|NCT01136096|metabolic risks|metabolic risks
1407210|NCT01136096|exercise|exercise
1407211|NCT01136096|primary prevention|primary prevention
1407212|NCT01136083|Tumor|tumor
1407213|NCT01136083|Angiogenesis|angiogenesis
1407214|NCT01136083|Exercise training|exercise training
1407215|NCT01136083|VEGF|vegf
1407216|NCT01136083|Myostatin|myostatin
1407217|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
1407218|NCT01136044|tensor fasciae latae|tensor fasciae latae
1407219|NCT01136044|septocutaneous perforators|septocutaneous perforators
1407220|NCT01136031|advanced gastric cancer|advanced gastric cancer
1407221|NCT01136031|1st-line failure|1st-line failure
1407222|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
1407223|NCT01136005|skin reactions|skin reactions
1407224|NCT01136005|quality of life|quality of life
1407225|NCT01136005|adherence|adherence
1407226|NCT01135966|COPD|copd
1407227|NCT01135966|Whole Body Vibration training|whole body vibration training
1407228|NCT01135966|Conventional resistance training|conventional resistance training
1407229|NCT01135953|Brain excitation|brain excitation
1407230|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
1407231|NCT01135953|administration pattern|administration pattern
1407232|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
1407233|NCT01135940|dermabond|dermabond
1407234|NCT01135940|infection|infection
1407235|NCT01135940|wound closure|wound closure
1407237|NCT01135914|visual impairment|visual impairment
1407238|NCT01135914|diabetes|diabetes
1407239|NCT01135914|macular edema|macular edema
1407240|NCT01135914|diabetic macular edema|diabetic macular edema
1407241|NCT01135914|ranibizumab|ranibizumab
1407242|NCT01135914|laser|laser
1407243|NCT01135914|photocoagulation|photocoagulation
1407244|NCT01135914|retinopathy|retinopathy
1407245|NCT01135914|retina|retina
1407246|NCT01135901|prevention|prevention
1407247|NCT01135901|public health|public health
1407248|NCT01135901|community health services|community health services
1407249|NCT01135901|Norway|norway
1407250|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
1407251|NCT01135888|exertional hyperthermia|exertional hyperthermia
1407252|NCT01135888|cooling device|cooling device
1407254|NCT01135875|Brain Tumor|brain tumor
1407255|NCT01135875|Brain Neoplasm|brain neoplasm
1407256|NCT01135875|Control|control
1407257|NCT01135875|Normal Control|normal control
1407258|NCT01135875|Volunteer|volunteer
1407259|NCT01135836|Shoulder pain|shoulder pain
1407260|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
1407261|NCT01135836|Nausea|nausea
1407262|NCT01135836|Vomiting|vomiting
1407263|NCT01135836|Abdominal fullness|abdominal fullness
1407264|NCT01135810|healthy subjects|healthy subjects
1407265|NCT01135771|glucose monitoring|glucose monitoring
1407266|NCT01135771|diabetes|diabetes
1407267|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
1407268|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
1407269|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
1407270|NCT01135719|Myopia|myopia
1407271|NCT01135719|Hyperopia|hyperopia
1407272|NCT01135719|Astigmatism|astigmatism
1407273|NCT01135719|PRK|prk
1407274|NCT01135719|LASIK|lasik
1407275|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
1407276|NCT01135706|Fractal dimension|fractal dimension
1407277|NCT01135693|Section 136|section 136
1407278|NCT01135693|Mental Health Act 1983|mental health act 1983
1407279|NCT01135693|Police|police
1407280|NCT01135693|Detention|detention
1407281|NCT01135693|Failure of community care|failure of community care
1407282|NCT01135667|clopidogrel|clopidogrel
1407283|NCT01135667|prasugrel|prasugrel
1407284|NCT01135667|low responder|low responder
1407285|NCT01135667|multiplate|multiplate
1407286|NCT01135667|verify now|verify now
1407287|NCT01135654|alcohol dependence|alcohol dependence
1407288|NCT01135654|unhealthy drinking|unhealthy drinking
1407289|NCT01135654|SBIRT|sbirt
1407290|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
1407291|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
1407292|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
1407293|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
1407294|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1407295|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
1407296|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
1407297|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
1407298|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
1407299|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
1407300|NCT01135602|Alcohol dependence|alcohol dependence
1407301|NCT01135602|Alcoholism|alcoholism
1407302|NCT01135602|Topiramate|topiramate
1407303|NCT01135589|pediatric|pediatric
1407304|NCT01135589|adolescent|adolescent
1407305|NCT01135589|micafungin|micafungin
1407306|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
1407307|NCT01135576|Fortification|fortification
1407308|NCT01135576|Fruit juice|fruit juice
1407309|NCT01135576|Functional food|functional food
1407310|NCT01135576|Bioavailability|bioavailability
1407311|NCT01135576|iron status|iron status
1407312|NCT01135576|Women|women
1407313|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
1407314|NCT01135563|pediatrics|pediatrics
1407315|NCT01135563|Solid Tumors|solid tumors
1407316|NCT01135563|CNS Tumors|cns tumors
1407317|NCT01135563|Vinblastine|vinblastine
1407318|NCT01135563|Sirolimus|sirolimus
1407319|NCT01135563|Recurrent|recurrent
1407320|NCT01135563|Refractory|refractory
1407321|NCT01135550|Pediatrics|pediatrics
1407322|NCT01135550|Vomiting|vomiting
1407323|NCT01135550|Headache|headache
1407324|NCT01135550|Radiation Therapy|radiation therapy
1407325|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1407326|NCT01135537|pharmacokinetics|pharmacokinetics
1407327|NCT01135537|pediatrics|pediatrics
1407328|NCT01135524|Osteoarthritis|osteoarthritis
1407329|NCT01135524|Opioid|opioid
1407330|NCT01135524|Transdermal|transdermal
1407331|NCT01135511|Dry eye|dry eye
1407332|NCT01135472|NEXIUM|nexium
1407333|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
1407334|NCT01135472|BLOOD DRAW|blood draw
1407335|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
1407336|NCT01135459|Lupus|lupus
1407337|NCT01135433|ASP1941|asp1941
1407338|NCT01135433|Diabetes mellitus|diabetes mellitus
1407339|NCT01135433|Metformin|metformin
1407340|NCT01135407|Parkinson's disease|parkinson's disease
1407341|NCT01135407|Deep brain stimulation|deep brain stimulation
1407342|NCT01135407|Subthalamic nucleus|subthalamic nucleus
1407343|NCT01135407|Levodopa|levodopa
1407344|NCT01135407|Selective visual attention|selective visual attention
1407345|NCT01135407|Basal ganglia diseases|basal ganglia diseases
1407346|NCT01135394|Pioglitazone|pioglitazone
1407347|NCT01135394|Type 2 diabetes|type 2 diabetes
1407348|NCT01135394|Insulin sensitivity|insulin sensitivity
1407349|NCT01135394|Healthy adults|healthy adults
1407350|NCT01135394|Thiazolidinediones|thiazolidinediones
1407441|NCT01134991|topical|topical
1407351|NCT01135394|Pharmacogenetics|pharmacogenetics
1407352|NCT01135381|care transitions|care transitions
1407353|NCT01135381|information technology|information technology
1407355|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1407356|NCT01135368|Drug Therapy|drug therapy
1407357|NCT01135342|Insomnia|insomnia
1407358|NCT01135342|Weight loss|weight loss
1407359|NCT01135342|Adults|adults
1407360|NCT01135329|Lymphoma|lymphoma
1407361|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
1407362|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
1407363|NCT01135329|Leukemia|leukemia
1407364|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1407365|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
1407366|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
1407367|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
1407368|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1407369|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
1407370|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
1407371|NCT01135329|Cyclophosphamide|cyclophosphamide
1407372|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
1407373|NCT01135329|Fludarabine|fludarabine
1407374|NCT01135329|Busulfan|busulfan
1407375|NCT01135329|Allogeneic|allogeneic
1407376|NCT01135329|Nonmyeloablative|nonmyeloablative
1407377|NCT01135329|Reduced intensity|reduced intensity
1407378|NCT01135329|Haploidentical|haploidentical
1407379|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
1407380|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
1407381|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
1407382|NCT01135303|Polysomnography|polysomnography
1407383|NCT01135303|Holter ECG|holter ecg
1407384|NCT01135303|Thoracic impedance|thoracic impedance
1407385|NCT01135303|Heart rate variability|heart rate variability
1407386|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
1407387|NCT01135251|Neuropathic pain|neuropathic pain
1407388|NCT01135251|AIDS|aids
1407389|NCT01135251|Dimiracetam|dimiracetam
1407390|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
1407391|NCT01135238|adrenalectomy|adrenalectomy
1407392|NCT01135238|metastasis|metastasis
1407393|NCT01135238|morbidity|morbidity
1407394|NCT01135238|mortality|mortality
1407395|NCT01135238|survival|survival
1407396|NCT01135225|Drug-eluting stent|drug-eluting stent
1407397|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
1407398|NCT01135225|Stent implantation|stent implantation
1407399|NCT01135225|Evolution Stent System|evolution stent system
1407400|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
1407401|NCT01135225|Feasibility study|feasibility study
1407402|NCT01135212|Hypertension|hypertension
1407403|NCT01135212|ARB|arb
1407404|NCT01135212|Fimasartan|fimasartan
1407405|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
1407406|NCT01135160|weight bearing|weight bearing
1407407|NCT01135160|pain|pain
1407408|NCT01135160|total hip arthroplasty|total hip arthroplasty
1407409|NCT01135160|total knee arthroplasty|total knee arthroplasty
1407410|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
1407411|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
1407412|NCT01135108|Spinal Cord Injuries|spinal cord injuries
1407413|NCT01135108|Pain|pain
1407414|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
1407415|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
1407416|NCT01135095|Myocardial perfusion|myocardial perfusion
1407417|NCT01135095|Low radiation dose|low radiation dose
1407418|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
1407419|NCT01135082|immunogenicity|immunogenicity
1407420|NCT01135082|safety|safety
1407421|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1407422|NCT01135082|HIV infected children|hiv infected children
1407423|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
1407424|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
1407425|NCT01135056|Randomized|randomized
1407426|NCT01135056|Open-label|open-label
1407427|NCT01135056|Multi-Centre|multi-centre
1407428|NCT01135056|Phase III|phase iii
1407429|NCT01135056|Sorafenib|sorafenib
1407430|NCT01135056|SIR-Spheres|sir-spheres
1407431|NCT01135043|acceptable sputum|acceptable sputum
1407432|NCT01135043|AFB culture|afb culture
1407433|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
1407434|NCT01135030|total knee arthroplasty|total knee arthroplasty
1407435|NCT01135004|pneumothorax|pneumothorax
1407436|NCT01135004|thoracoscopy|thoracoscopy
1407437|NCT01135004|pathogenesis|pathogenesis
1407438|NCT01135004|blebs|blebs
1407439|NCT01135004|surgery|surgery
1407440|NCT01134991|rosacea|rosacea
1407442|NCT01134991|minocycline|minocycline
1407443|NCT01134991|foam|foam
1407444|NCT01134991|phase II|phase ii
1407445|NCT01134978|repeated measures design|repeated measures design
1407446|NCT01134978|random assignment to groups|random assignment to groups
1407447|NCT01134952|sirolimus|sirolimus
1407448|NCT01134952|everolimus|everolimus
1407449|NCT01134952|mycophenolic acid|mycophenolic acid
1407450|NCT01134952|hepatitis C virus|hepatitis c virus
1407451|NCT01134952|tacrolimus|tacrolimus
1407452|NCT01134952|viral load|viral load
1407453|NCT01134926|Retained products of conception|retained products of conception
1407454|NCT01134926|residua|residua
1407455|NCT01134926|misoprostol|misoprostol
1407456|NCT01134926|expectant management|expectant management
1407457|NCT01134913|ACS|acs
1407458|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
1407459|NCT01134913|Emergency Department|emergency department
1407460|NCT01134900|Medication Errors|medication errors
1407461|NCT01134900|Adverse Drug Events|adverse drug events
1407462|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
1407463|NCT01134887|hypertension|hypertension
1407464|NCT01134887|physician-patient relations|physician-patient relations
1407465|NCT01134887|communication|communication
1407466|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1407467|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1407468|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1407469|NCT01134848|Bile ducts|bile ducts
1407470|NCT01134848|Sphincter of Oddi|sphincter of oddi
1407471|NCT01134848|Pancreatic ducts|pancreatic ducts
1407472|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1407474|NCT01134822|Lung Fibrosis|lung fibrosis
1407475|NCT01134822|Biomarkers|biomarkers
1407476|NCT01134809|Major abdominal surgery|major abdominal surgery
1407477|NCT01134770|Prenatal Substance Use|prenatal substance use
1407478|NCT01134770|Cocaine|cocaine
1407479|NCT01134770|Cigarette Smoking|cigarette smoking
1407480|NCT01134770|Mothers|mothers
1407481|NCT01134770|Pregnant women|pregnant women
1407482|NCT01134770|Smoking Mothers|smoking mothers
1407483|NCT01134757|EAR|ear
1407484|NCT01134757|LAR|lar
1407485|NCT01134757|BHR|bhr
1407486|NCT01134757|house dust mite|house dust mite
1407487|NCT01134757|alternaria|alternaria
1407488|NCT01134744|CXray|cxray
1407489|NCT01134731|depression|depression
1407490|NCT01134731|suicidality|suicidality
1407491|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
1407492|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
1407493|NCT01134718|TMC435-C119|tmc435-c119
1407494|NCT01134718|TMC435|tmc435
1407495|NCT01134718|Protease inhibitor|protease inhibitor
1407496|NCT01134718|HCV|hcv
1407497|NCT01134718|Hepatitis C|hepatitis c
1407498|NCT01134718|Bioavailability|bioavailability
1407499|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
1407500|NCT01134679|Drug Eluting Stent|drug eluting stent
1407501|NCT01134679|Clopidogrel|clopidogrel
1407502|NCT01134679|Aspirin|aspirin
1407503|NCT01134666|Colorectal neoplasms|colorectal neoplasms
1407504|NCT01134666|Intestinal neoplasms|intestinal neoplasms
1407505|NCT01134666|Neoplasms|neoplasms
1407506|NCT01134666|cetuximab|cetuximab
1407507|NCT01134666|Erbitux|erbitux
1407508|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
1407509|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
1407510|NCT01134640|mCRC|mcrc
1407511|NCT01134640|post marketing surveillance|post marketing surveillance
1407512|NCT01134640|Erbitux|erbitux
1407513|NCT01134640|Cetuximab|cetuximab
1407514|NCT01134640|KRAS|kras
1407515|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1407516|NCT01134627|Interferon-β|interferon-β
1407517|NCT01134627|Rebif®|rebif®
1407518|NCT01134627|Minocycline|minocycline
1407519|NCT01134601|Rectal Cancer|rectal cancer
1407520|NCT01134601|Radiation Therapy|radiation therapy
1407521|NCT01134601|Capecitabine|capecitabine
1407522|NCT01134601|AZD6244|azd6244
1407523|NCT01134575|Relapsed|relapsed
1407524|NCT01134575|Refractory|refractory
1407525|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1407526|NCT01134575|ALL|all
1407527|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
1407528|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
1407529|NCT01134575|CMC-544|cmc-544
1407530|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
1407531|NCT01134575|Rituxan|rituxan
1407532|NCT01134575|Rituximab|rituximab
1407533|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
1407534|NCT01134562|Renal Dialysis|renal dialysis
1407535|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1407536|NCT01134562|Parathyroid hormone|parathyroid hormone
1407537|NCT01134536|Pain, Postoperative|pain, postoperative
1407538|NCT01134536|Postoperative Pain|postoperative pain
1407539|NCT01134536|Tapentadol|tapentadol
1407540|NCT01134536|NUCYNTA|nucynta
1407541|NCT01134536|CG5503|cg5503
1407542|NCT01134536|R331333|r331333
1407543|NCT01134536|Pharmacokinetics|pharmacokinetics
1407544|NCT01134536|Postsurgical pain|postsurgical pain
1407545|NCT01134536|Children|children
1407546|NCT01134536|Adolescents|adolescents
1407547|NCT01134523|positive lymph node|positive lymph node
1407548|NCT01134510|Kidney transplantation|kidney transplantation
1407549|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
1407550|NCT01134484|complete remission|complete remission
1407551|NCT01134484|bortezomib|bortezomib
1407552|NCT01134484|thalidomide|thalidomide
1407553|NCT01134484|progression free survival|progression free survival
1407554|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
1407555|NCT01134458|cardiovascular disease|cardiovascular disease
1407556|NCT01134445|Arthroplasty|arthroplasty
1407557|NCT01134445|Replacement|replacement
1407558|NCT01134445|Hip|hip
1407559|NCT01134445|Conservative|conservative
1407560|NCT01134445|Anatomic|anatomic
1407561|NCT01134445|Cementless|cementless
1407562|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
1407563|NCT01134432|hemolytic anemia|hemolytic anemia
1407564|NCT01134432|Rituximab|rituximab
1407565|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
1407566|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
1407567|NCT01134419|Patient Safety|patient safety
1407568|NCT01134419|Medical Errors|medical errors
1407569|NCT01134419|Handoff|handoff
1407570|NCT01134419|Sign-out|sign-out
1407571|NCT01134419|Resident|resident
1407572|NCT01134419|Intern|intern
1407573|NCT01134419|Graduate Medical Education|graduate medical education
1407574|NCT01134406|Osteoarthritis|osteoarthritis
1407575|NCT01134406|knee|knee
1407576|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
1407577|NCT01134380|Acute coronary syndrome|acute coronary syndrome
1407578|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
1407579|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
1407580|NCT01134380|genotyping|genotyping
1407581|NCT01134380|stent|stent
1407582|NCT01134380|compliance|compliance
1407583|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1407584|NCT01134354|Validation study|validation study
1407585|NCT01134354|Outcome Measures|outcome measures
1407586|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
1407587|NCT01134354|Patient expectations|patient expectations
1407588|NCT01134354|Physician patient relationship|physician patient relationship
1407589|NCT01134341|Relapsed|relapsed
1407590|NCT01134341|Refractory|refractory
1407591|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
1407592|NCT01134302|Hybrid|hybrid
1407593|NCT01134302|Norwood|norwood
1407594|NCT01134302|congenital heart disease|congenital heart disease
1407595|NCT01134302|single ventricle|single ventricle
1407596|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
1407597|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
1407598|NCT01134289|photoplethysmography|photoplethysmography
1407599|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
1407600|NCT01134263|Dengue Fever|dengue fever
1407601|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1407602|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
1407603|NCT01134263|Lot Consistency|lot consistency
1407604|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
1407605|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
1407606|NCT01134237|non-surgical rate|non-surgical rate
1407607|NCT01134198|Cocaine Dependence|cocaine dependence
1407608|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
1407609|NCT01134172|Sociodemographic|sociodemographic
1407610|NCT01134172|Ethnicity|ethnicity
1407611|NCT01134172|Work-related|work-related
1407612|NCT01134172|Health system|health system
1407613|NCT01134172|QOL|qol
1407614|NCT01134172|Questionnaires|questionnaires
1407615|NCT01134172|10-071|10-071
1407616|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1407617|NCT01134146|IMRT|imrt
1407618|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1407619|NCT01134146|Radical Pleurectomy|radical pleurectomy
1407620|NCT01134146|Decortication|decortication
1407621|NCT01134146|PD|pd
1407622|NCT01134146|pleurectomy|pleurectomy
1407623|NCT01134146|lung surgery|lung surgery
1407624|NCT01134146|pleura|pleura
1407625|NCT01134094|Undisplaced|undisplaced
1407626|NCT01134094|Ankle Fracture|ankle fracture
1407627|NCT01134094|Weber B|weber b
1407628|NCT01134081|gum|gum
1407629|NCT01134081|recession|recession
1407630|NCT01134068|D-dimer|d-dimer
1407631|NCT01134068|Pulmonary embolism|pulmonary embolism
1407632|NCT01134068|Diagnostic strategy|diagnostic strategy
1407633|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
1407634|NCT01134055|ranibizumab|ranibizumab
1407635|NCT01134055|wet AMD|wet amd
1407636|NCT01134055|MD7110852|md7110852
1407637|NCT01134055|age related macular degeneration|age related macular degeneration
1407638|NCT01134055|age-related macular degeneration|age-related macular degeneration
1407639|NCT01134055|macular degeneration|macular degeneration
1407640|NCT01134055|pazopanib|pazopanib
1407641|NCT01134042|Fluticasone propionate|fluticasone propionate
1407642|NCT01134042|asthma|asthma
1407643|NCT01134042|vilanterol|vilanterol
1407644|NCT01134042|GW642444|gw642444
1407645|NCT01134042|Fluticasone furoate|fluticasone furoate
1407646|NCT01134029|obesity|obesity
1407647|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
1407648|NCT01134016|Lung cancer|lung cancer
1407649|NCT01134016|NSCLC|nsclc
1407650|NCT01134003|Gynecare Prolift|gynecare prolift
1407651|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
1407652|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
1407653|NCT01133964|Dairy proteins|dairy proteins
1568277|NCT00506428|memory|memory
1407654|NCT01133964|Appetite regulation|appetite regulation
1407655|NCT01133964|Energy expenditure|energy expenditure
1407656|NCT01133951|Helicobacter Infections|helicobacter infections
1407657|NCT01133951|Helicobacter pylori|helicobacter pylori
1407658|NCT01133951|Drug Therapy|drug therapy
1407659|NCT01133951|Precancerous Conditions|precancerous conditions
1407660|NCT01133951|Stomach Neoplasms|stomach neoplasms
1407661|NCT01133951|Incidence|incidence
1407662|NCT01133925|Coronary Artery Disease|coronary artery disease
1407663|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
1407664|NCT01133925|Drug Eluting Stent|drug eluting stent
1407665|NCT01133925|Optical Coherence Tomography|optical coherence tomography
1407666|NCT01133925|Thrombosi|thrombosi
1407667|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
1407668|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
1407669|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
1407670|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
1407671|NCT01133860|MYH9 mutations|myh9 mutations
1407672|NCT01133860|eltrombopag|eltrombopag
1407673|NCT01133834|meningococcal disease|meningococcal disease
1407674|NCT01133834|cytokines|cytokines
1407675|NCT01133821|Bipolar II Disorder|bipolar ii disorder
1407676|NCT01133821|Bipolar II Depression|bipolar ii depression
1407677|NCT01133821|Psychotherapy|psychotherapy
1407678|NCT01133821|IPSRT|ipsrt
1407679|NCT01133821|Seroquel|seroquel
1407680|NCT01133821|Quetiapine|quetiapine
1407681|NCT01133821|Placebo|placebo
1407682|NCT01133821|Sugar Pill|sugar pill
1407683|NCT01133808|diarrhea|diarrhea
1407684|NCT01133808|childhood|childhood
1407685|NCT01133808|rotavirus|rotavirus
1407686|NCT01133808|vaccine|vaccine
1407687|NCT01133808|Nicaragua|nicaragua
1407688|NCT01133795|cirrhosis|cirrhosis
1407689|NCT01133795|renal failure|renal failure
1407690|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
1407691|NCT01133795|albumine|albumine
1407692|NCT01133795|midodrine|midodrine
1407693|NCT01133769|Clavicle fracture|clavicle fracture
1407694|NCT01133769|fixation|fixation
1407695|NCT01133769|polytrauma|polytrauma
1407696|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
1407697|NCT01133743|Lenalidomide|lenalidomide
1407698|NCT01133743|Dexamethasone|dexamethasone
1407699|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
1407700|NCT01133743|Thalidomide analogues|thalidomide analogues
1407701|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
1407702|NCT01133730|regional anesthesia|regional anesthesia
1407703|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
1407704|NCT01133730|ultrasound guided|ultrasound guided
1407705|NCT01133730|opioid consumption|opioid consumption
1407823|NCT01133015|MLA|mla
1407706|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
1407707|NCT01133730|hand surgery|hand surgery
1407708|NCT01133730|wrist surgery|wrist surgery
1407709|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
1407710|NCT01133717|Sleep Apnea|sleep apnea
1407711|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
1407712|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
1407713|NCT01133691|gastric emptying|gastric emptying
1407714|NCT01133691|children|children
1407715|NCT01133691|gastric fluid volume|gastric fluid volume
1407716|NCT01133691|preoperative fasting|preoperative fasting
1407717|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
1407718|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
1407719|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
1407720|NCT01133652|Venipuncture|venipuncture
1407721|NCT01133652|Randomized Controlled Trial|randomized controlled trial
1407722|NCT01133652|Intravenous access|intravenous access
1407723|NCT01133652|Children|children
1407724|NCT01133652|Pediatric Emergency Department|pediatric emergency department
1407919|NCT01132651|itch|itch
1407725|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
1407726|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
1407727|NCT01133587|Schizophrenia|schizophrenia
1407728|NCT01133587|bipolar disorder|bipolar disorder
1407729|NCT01133587|Long term care|long term care
1407730|NCT01133587|patient admission|patient admission
1407731|NCT01133574|Healthy volunteers|healthy volunteers
1407732|NCT01133574|SLV354|slv354
1407733|NCT01133574|Phase I|phase i
1407734|NCT01133574|SRDT|srdt
1407735|NCT01133561|psoriasis|psoriasis
1407736|NCT01133561|insulin resistance|insulin resistance
1408722|NCT01129544|SCID|scid
1407737|NCT01133561|metabolic syndrome|metabolic syndrome
1407738|NCT01133561|pioglitazone|pioglitazone
1407739|NCT01133561|randomized control trial|randomized control trial
1407740|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
1407741|NCT01133522|AMG145|amg145
1407742|NCT01133522|Multiple Dose|multiple dose
1407743|NCT01133522|Statin|statin
1407744|NCT01133522|Ascending|ascending
1407745|NCT01133496|Bioequivalence|bioequivalence
1407746|NCT01133496|Alendronate Sodium|alendronate sodium
1407747|NCT01133496|crossover|crossover
1407748|NCT01133483|Bioequivalence|bioequivalence
1407749|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
1407750|NCT01133470|Bioequivalence|bioequivalence
1407751|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
1407752|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
1407753|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
1407754|NCT01133431|CKD-501|ckd-501
1407755|NCT01133431|Glimepiride|glimepiride
1407756|NCT01133431|Placebo|placebo
1407757|NCT01133431|Healthy male volunteer|healthy male volunteer
1407758|NCT01133431|Pharmacokinetic|pharmacokinetic
1407759|NCT01133431|Metabolite|metabolite
1407760|NCT01133392|insulin|insulin
1407761|NCT01133392|lispro|lispro
1407762|NCT01133366|ISIS301012|isis301012
1407763|NCT01133366|antisense|antisense
1407764|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
1407765|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
1407766|NCT01133366|mipomersen|mipomersen
1407767|NCT01133340|RADIOTHERAPY|radiotherapy
1407768|NCT01133340|CT simulation|ct simulation
1407769|NCT01133340|MRI simulation|mri simulation
1407770|NCT01133340|Endoscopic clip placement|endoscopic clip placement
1407771|NCT01133340|Rectal cancer|rectal cancer
1407772|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
1407773|NCT01133327|Carotid Artery Stenting|carotid artery stenting
1407774|NCT01133327|High Risk patient|high risk patient
1407775|NCT01133327|Carotid artery stenosis|carotid artery stenosis
1407776|NCT01133327|stroke|stroke
1407777|NCT01133327|Carotid artery disease|carotid artery disease
1407778|NCT01133327|ASTI study|asti study
1407779|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
1407780|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
1407781|NCT01133301|Borderline Personality Disorder|borderline personality disorder
1407782|NCT01133301|Dissociation|dissociation
1407783|NCT01133301|Naltrexone|naltrexone
1407784|NCT01133249|total hip|total hip
1407785|NCT01133236|Salt restriction|salt restriction
1407786|NCT01133236|Fluid restriction|fluid restriction
1407787|NCT01133236|Congestion|congestion
1407788|NCT01133236|Heart Failure|heart failure
1407789|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
1407790|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
1407791|NCT01133210|triglyceride|triglyceride
1407792|NCT01133210|cholesterol|cholesterol
1407793|NCT01133210|Maraviroc|maraviroc
1407794|NCT01133197|thumb|thumb
1407795|NCT01133197|arthritis|arthritis
1407796|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
1407797|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
1407798|NCT01133171|Cardiovascular Disease|cardiovascular disease
1407799|NCT01133171|Stroke|stroke
1407800|NCT01133158|Follicular non-Hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy|follicular non-hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy
1407801|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
1407802|NCT01133145|hand transplantation|hand transplantation
1407803|NCT01133145|knee transplantation|knee transplantation
1407804|NCT01133145|face transplantation|face transplantation
1407805|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
1407806|NCT01133119|cardiac catheterization|cardiac catheterization
1407807|NCT01133119|local anesthetic|local anesthetic
1407808|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
1407809|NCT01133119|pediatric patients|pediatric patients
1407810|NCT01133106|stroke recovery|stroke recovery
1407811|NCT01133106|quality of life|quality of life
1407812|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
1407813|NCT01133093|Nutritional assessment|nutritional assessment
1407814|NCT01133093|Epidemiology|epidemiology
1407815|NCT01133067|lung cancer|lung cancer
1407816|NCT01133067|followup|followup
1407817|NCT01133067|physical follow up|physical follow up
1407818|NCT01133067|telephonic followup|telephonic followup
1407819|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
1407820|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1407821|NCT01133015|FFR|ffr
1407822|NCT01133015|IVUS|ivus
1407824|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
1407825|NCT01132976|Personality disorders|personality disorders
1407826|NCT01132976|Personal Concerns Inventory|personal concerns inventory
1407827|NCT01132976|Non completion|non completion
1407828|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
1407829|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1407830|NCT01132937|Traumatic Brain Injury|traumatic brain injury
1407831|NCT01132937|Brain Imaging|brain imaging
1407832|NCT01132937|Brain Injuries|brain injuries
1407833|NCT01132937|TBI|tbi
1407834|NCT01132924|Early Pregnancy|early pregnancy
1407835|NCT01132924|Gestational Age|gestational age
1407836|NCT01132924|Fecundability|fecundability
1407837|NCT01132924|Ovulation|ovulation
1407838|NCT01132924|Recall|recall
1407839|NCT01132911|Solid Tumors|solid tumors
1407840|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
1407841|NCT01132911|Lymphoma|lymphoma
1407842|NCT01132911|Dose Escalation|dose escalation
1407843|NCT01132911|Pharmacokinetics|pharmacokinetics
1407844|NCT01132911|Pediatric Cancer|pediatric cancer
1407845|NCT01132911|Solid Tumor|solid tumor
1407846|NCT01132911|Sarcoma|sarcoma
1407847|NCT01132911|Wilms Tumor|wilms tumor
1407848|NCT01132911|Neuroblastoma|neuroblastoma
1407849|NCT01132898|Traumatic Brain Injury|traumatic brain injury
1407850|NCT01132898|Biomarkers|biomarkers
1407851|NCT01132898|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1407852|NCT01132898|DTI|dti
1407853|NCT01132898|Functional Capacity|functional capacity
1407854|NCT01132898|TBI|tbi
1407855|NCT01132885|MRI|mri
1407856|NCT01132885|Children|children
1407857|NCT01132885|Williams Syndrome|williams syndrome
1407858|NCT01132885|Phenotype|phenotype
1407859|NCT01132885|Brain|brain
1407860|NCT01132885|Healthy Volunteer|healthy volunteer
1407861|NCT01132885|HV|hv
1407862|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
1407863|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
1407864|NCT01132872|Dosimetry|dosimetry
1407865|NCT01132872|Healthy Volunteer|healthy volunteer
1407866|NCT01132872|HV|hv
1407867|NCT01132859|Specimen Collection|specimen collection
1407868|NCT01132859|Mucosal Immunity|mucosal immunity
1407869|NCT01132859|Immune Responses|immune responses
1407870|NCT01132859|Immunity|immunity
1407871|NCT01132859|Vaccines|vaccines
1407872|NCT01132859|Healthy Volunteer|healthy volunteer
1407873|NCT01132859|HV|hv
1407874|NCT01132833|thromboembolism|thromboembolism
1407875|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
1407876|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
1407877|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
1407878|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1407879|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1407880|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
1407881|NCT01132781|rhinosinusitis|rhinosinusitis
1407882|NCT01132781|asthma|asthma
1407883|NCT01132781|allergic rhinitis|allergic rhinitis
1407884|NCT01132781|theophylline|theophylline
1407885|NCT01132755|gastric|gastric
1407886|NCT01132755|pancreas|pancreas
1407887|NCT01132755|laparoscopy|laparoscopy
1407888|NCT01132755|peritoneal lavage|peritoneal lavage
1407889|NCT01132755|10-011|10-011
1407890|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
1407891|NCT01132742|Malnutrition|malnutrition
1407892|NCT01132742|children|children
1407893|NCT01132742|Hospital Stay|hospital stay
1407894|NCT01132742|Screening Tools|screening tools
1407895|NCT01132742|Anthropometry|anthropometry
1407896|NCT01132690|gaucher disease|gaucher disease
1407897|NCT01132690|pediatric|pediatric
1407898|NCT01132677|OA of Knee|oa of knee
1407899|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
1407900|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
1407901|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
1407902|NCT01132677|Hyaluronic Acid|hyaluronic acid
1407903|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
1407904|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
1407905|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
1407906|NCT01132677|knee Pain from OA|knee pain from oa
1407907|NCT01132664|HER2|her2
1407908|NCT01132664|BKM120|bkm120
1407909|NCT01132664|PIK3|pik3
1407910|NCT01132664|metastatic breast cancer|metastatic breast cancer
1407911|NCT01132664|brain metastases|brain metastases
1407912|NCT01132664|Herceptin|herceptin
1407913|NCT01132664|trastuzumab|trastuzumab
1407914|NCT01132664|capecitabine|capecitabine
1407915|NCT01132664|open-label|open-label
1407916|NCT01132664|maximum tolerated dose|maximum tolerated dose
1407917|NCT01132664|Phase I/Phase ll|phase i/phase ll
1407918|NCT01132651|eczema|eczema
1407920|NCT01132651|pruritus|pruritus
1407921|NCT01132651|head|head
1407922|NCT01132651|neck|neck
1407923|NCT01132638|Gastroesophageal|gastroesophageal
1407924|NCT01132638|Pantoprazole|pantoprazole
1407925|NCT01132638|erosive|erosive
1407926|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
1407927|NCT01132625|HSP90|hsp90
1407928|NCT01132625|molecular chaperone|molecular chaperone
1407929|NCT01132625|advanced solid tumors|advanced solid tumors
1407930|NCT01132625|Japan|japan
1407931|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
1407932|NCT01132612|AIN457|ain457
1567286|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1407934|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
1407935|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
1407936|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1407937|NCT01132547|cachexia|cachexia
1407938|NCT01132547|weight changes|weight changes
1407939|NCT01132547|nausea and vomiting|nausea and vomiting
1407940|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1407941|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
1407942|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1407943|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
1407944|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
1407945|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
1407946|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
1407947|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
1407948|NCT01132547|childhood liposarcoma|childhood liposarcoma
1407949|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1407950|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
1407951|NCT01132547|chondrosarcoma|chondrosarcoma
1407952|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
1407953|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1407954|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1407955|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1407956|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
1407957|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
1407958|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
1407959|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
1407960|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
1407961|NCT01132547|localized osteosarcoma|localized osteosarcoma
1407962|NCT01132547|mast cell sarcoma|mast cell sarcoma
1407963|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1407964|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
1407965|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
1407966|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
1407967|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
1407968|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1407969|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
1407970|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
1407971|NCT01132547|ovarian sarcoma|ovarian sarcoma
1407972|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
1407973|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1407974|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1407975|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1407976|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
1407977|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1407978|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1407979|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
1407980|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
1407981|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
1407982|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1407983|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
1407984|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
1407985|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
1407986|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
1407987|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
1407988|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
1407989|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
1407990|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
1407991|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
1407992|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1407993|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
1407994|NCT01132547|regional neuroblastoma|regional neuroblastoma
1407995|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
1407996|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
1407997|NCT01132547|childhood kidney tumors|childhood kidney tumors
1407998|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
1407999|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
1408000|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
1408001|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1408002|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1408003|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
1408004|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1408005|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1408006|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1408007|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1567287|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1408241|NCT01131715|Patient experience|patient experience
1408008|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1408009|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1408010|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1408011|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1408012|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1408013|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1408014|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1408015|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1408016|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1408017|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1408018|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1408019|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1408020|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
1408021|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1408022|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1408023|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
1408024|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1408025|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
1408026|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
1408027|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1408028|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1408029|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
1408030|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1408031|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1408032|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
1408033|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
1408034|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1408035|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1408036|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1408037|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1408038|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
1408039|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
1408040|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
1408041|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1408042|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1408043|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
1408044|NCT01132547|other tumor of glial origin|other tumor of glial origin
1408045|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1408046|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1408153|NCT01132209|surgery|surgery
1408047|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
1408048|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
1408049|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
1408050|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
1408051|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
1408052|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
1408053|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
1408054|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
1408055|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1408056|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
1408057|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
1408058|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
1408059|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
1408060|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
1408061|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
1408062|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
1408063|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
1408064|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
1408065|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
1408066|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
1408067|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
1408068|NCT01132547|hypothalamic glioma|hypothalamic glioma
1408438|NCT01130948|sleep|sleep
1408069|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1408070|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
1408071|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
1408072|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
1408073|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1408074|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
1408075|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
1408076|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
1408077|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
1408078|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
1408079|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
1408080|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
1408081|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
1408082|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
1408083|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
1408084|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
1408085|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1408086|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1408087|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1408088|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
1408089|NCT01132547|other myeloid malignancies|other myeloid malignancies
1408090|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1408091|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1408092|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1408093|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1408094|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
1408096|NCT01132534|NBI|nbi
1408097|NCT01132534|AFI|afi
1408098|NCT01132534|Videoendoscopy|videoendoscopy
1408099|NCT01132534|Narrow Band Imaging|narrow band imaging
1408100|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
1408101|NCT01132521|ulinastatin|ulinastatin
1408102|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
1408103|NCT01132508|Tibial plateau fracture|tibial plateau fracture
1408104|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
1408105|NCT01132508|Bone Void|bone void
1408106|NCT01132495|Stable angina|stable angina
1408107|NCT01132495|angina pectoris|angina pectoris
1408108|NCT01132495|PCI|pci
1408109|NCT01132495|FAME|fame
1408110|NCT01132495|FAME II|fame ii
1408111|NCT01132495|FFR|ffr
1408112|NCT01132495|Fractional Flow Reserve|fractional flow reserve
1408113|NCT01132495|Pressure wire|pressure wire
1408114|NCT01132482|Cystic fibrosis|cystic fibrosis
1408115|NCT01132482|CFTR|cftr
1408116|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
1408117|NCT01132482|Nasal potential difference|nasal potential difference
1408118|NCT01132482|Sweat test|sweat test
1408119|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1408120|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1408121|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
1408122|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1408123|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1408124|NCT01132456|STENT THROMBOSIS|stent thrombosis
1408125|NCT01132456|RESTENOTIC LESION|restenotic lesion
1408126|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1408127|NCT01132456|LONG LESION|long lesion
1408128|NCT01132456|DUAL VESSEL|dual vessel
1408129|NCT01132430|ADHERENCE|adherence
1408130|NCT01132430|ASTHMA CONTROL|asthma control
1408131|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
1408132|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
1408133|NCT01132417|Tigecycline, MDR|tigecycline, mdr
1408134|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
1408135|NCT01132391|anal fissure|anal fissure
1408136|NCT01132391|nitroglycerin|nitroglycerin
1408137|NCT01132391|medical treatment|medical treatment
1408138|NCT01132378|Total knee arthroplasty|total knee arthroplasty
1408139|NCT01132365|knee arthroplasty|knee arthroplasty
1408140|NCT01132352|Bioavailability|bioavailability
1408141|NCT01132352|Crossover|crossover
1408142|NCT01132352|Levetiracetam|levetiracetam
1408143|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
1408144|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
1408145|NCT01132326|Symptomatic NOH|symptomatic noh
1408146|NCT01132287|Contact lens wear|contact lens wear
1408147|NCT01132287|lubricant eye drops|lubricant eye drops
1408148|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
1408149|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
1408150|NCT01132222|Bioequivalence|bioequivalence
1408152|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
1408154|NCT01132209|incisional hernia|incisional hernia
1408155|NCT01132209|woundinfection|woundinfection
1408156|NCT01132209|burst abdomen|burst abdomen
1408157|NCT01132209|pain|pain
1408158|NCT01132196|Bioequivalence|bioequivalence
1408159|NCT01132196|Crossover|crossover
1408160|NCT01132196|Divalproex Sodium|divalproex sodium
1408161|NCT01132170|Bioequivalence|bioequivalence
1408162|NCT01132170|Crossover|crossover
1408163|NCT01132170|Divalproex Sodium|divalproex sodium
1408164|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
1408165|NCT01132144|Reproductive Techniques|reproductive techniques
1408166|NCT01132144|Embryo Implantation|embryo implantation
1408167|NCT01132144|Endometrium|endometrium
1408168|NCT01132144|Ultrasonography|ultrasonography
1408169|NCT01132131|Urinary tract infection|urinary tract infection
1408170|NCT01132131|Cystitis|cystitis
1408171|NCT01132131|Bacteruria|bacteruria
1408172|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
1408173|NCT01132118|insulin resistance|insulin resistance
1408174|NCT01132118|hydroxychloroquine|hydroxychloroquine
1408175|NCT01132118|cholesterol|cholesterol
1408176|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
1408177|NCT01132079|atopic dermatitis|atopic dermatitis
1408178|NCT01132079|barrier function|barrier function
1408179|NCT01132079|pimecrolimus|pimecrolimus
1408180|NCT01132066|swallowing|swallowing
1408181|NCT01132066|stroke|stroke
1408182|NCT01132053|JC Virus|jc virus
1408183|NCT01132040|Bioequivalence|bioequivalence
1408184|NCT01132040|Crossover|crossover
1408185|NCT01132040|Primidone|primidone
1408186|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
1408187|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
1408188|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
1408189|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
1408190|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
1408191|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
1408192|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
1408193|NCT01131975|Bioequivalence|bioequivalence
1408194|NCT01131975|Crossover|crossover
1408195|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
1408196|NCT01131962|esophageal varices|esophageal varices
1408197|NCT01131962|hematemesis|hematemesis
1408198|NCT01131962|endoscopy|endoscopy
1408199|NCT01131949|Bioequivalence|bioequivalence
1408200|NCT01131949|Crossover|crossover
1408201|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
1408202|NCT01131936|Bioequivalence|bioequivalence
1408203|NCT01131936|Amlodipine Besylate|amlodipine besylate
1408204|NCT01131923|Bioequivalence|bioequivalence
1408205|NCT01131923|Amlodipine Besylate|amlodipine besylate
1408206|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
1408207|NCT01131910|TBE-vaccine|tbe-vaccine
1408208|NCT01131910|Immunosuppression|immunosuppression
1408209|NCT01131897|Bioavailability|bioavailability
1408210|NCT01131897|Crossover|crossover
1408211|NCT01131897|Levetiracetam|levetiracetam
1408212|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
1408213|NCT01131871|obesity|obesity
1408214|NCT01131871|overweight|overweight
1408215|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
1408216|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
1408217|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1408218|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
1408219|NCT01131806|acute exacerbation|acute exacerbation
1408220|NCT01131806|life quality questionnaire|life quality questionnaire
1408221|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
1408222|NCT01131780|Bioequivalence|bioequivalence
1408223|NCT01131780|Crossover|crossover
1408224|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
1408225|NCT01131767|Bioequivalence|bioequivalence
1408226|NCT01131767|Crossover|crossover
1408227|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
1408228|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
1408229|NCT01131754|PVC occlusion|pvc occlusion
1408230|NCT01131754|PVC phlebitis|pvc phlebitis
1408231|NCT01131741|anesthesia, general|anesthesia, general
1408232|NCT01131741|blood pressure|blood pressure
1408233|NCT01131741|epinephrine|epinephrine
1408234|NCT01131741|heart rate|heart rate
1408235|NCT01131741|injections, intravenous|injections, intravenous
1408236|NCT01131728|Bioequivalence|bioequivalence
1408237|NCT01131728|Crossover|crossover
1408238|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
1408239|NCT01131715|Qualitetive interview|qualitetive interview
1408240|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
1408242|NCT01131715|Patient perception|patient perception
1408243|NCT01131702|Bioequivalence|bioequivalence
1408244|NCT01131702|Crossover|crossover
1408245|NCT01131702|Ranitidine|ranitidine
1408246|NCT01131689|metastatic HCC|metastatic hcc
1408247|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
1408248|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
1408249|NCT01131650|Diabetes|diabetes
1408250|NCT01131650|Retinopathy|retinopathy
1408251|NCT01131650|Prevalence|prevalence
1408252|NCT01131650|Population|population
1408253|NCT01131637|chronic heart failure|chronic heart failure
1408254|NCT01131637|rhNRG-1|rhnrg-1
1408255|NCT01131637|mortality|mortality
1408256|NCT01131624|Iron deficiency|iron deficiency
1408257|NCT01131611|Spinal Stenosis|spinal stenosis
1408258|NCT01131611|Rehabilitation|rehabilitation
1408259|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
1408260|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
1408261|NCT01131611|Behavioral Research|behavioral research
1408262|NCT01131598|ALI|ali
1408263|NCT01131598|SDRA|sdra
1408264|NCT01131585|Diabetic macular edema|diabetic macular edema
1408265|NCT01131585|DME|dme
1408266|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1408267|NCT01131585|PDR|pdr
1408268|NCT01131585|ranibizumab|ranibizumab
1408269|NCT01131585|laser|laser
1408270|NCT01131559|bipolar disorder|bipolar disorder
1408271|NCT01131559|manic depression|manic depression
1408272|NCT01131559|depression|depression
1408273|NCT01131559|Bipolar I or II|bipolar i or ii
1408274|NCT01131546|Essential Hypertension|essential hypertension
1408275|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
1408276|NCT01131546|Amlodipine Maleate|amlodipine maleate
1408277|NCT01131520|SBIRT|sbirt
1408278|NCT01131520|Drug abuse|drug abuse
1408279|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1408280|NCT01131507|Infants with CF|infants with cf
1408281|NCT01131494|Parkinson's disease|parkinson's disease
1408282|NCT01131494|Dysphagia|dysphagia
1408283|NCT01131494|Treatment|treatment
1408284|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
1408285|NCT01131468|ototoxicity|ototoxicity
1408286|NCT01131468|aminoglycoside|aminoglycoside
1408287|NCT01131468|vancomycine|vancomycine
1408288|NCT01131468|peritoneal dialysis|peritoneal dialysis
1408289|NCT01131468|peritonitis|peritonitis
1408290|NCT01131442|immune|immune
1408291|NCT01131429|mutation analysis|mutation analysis
1408292|NCT01131429|first-line|first-line
1408293|NCT01131429|second-line|second-line
1408294|NCT01131429|targeted therapy|targeted therapy
1408295|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
1408296|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
1408297|NCT01131364|Interleukin|interleukin
1408298|NCT01131364|IL2|il2
1408299|NCT01131364|F16|f16
1408300|NCT01131364|monoclonal|monoclonal
1408301|NCT01131364|antibody|antibody
1408302|NCT01131364|cytokine|cytokine
1408303|NCT01131364|doxorubicin|doxorubicin
1408304|NCT01131364|breast cancer|breast cancer
1408305|NCT01131364|solid tumour|solid tumour
1408306|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
1408307|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
1408308|NCT01131351|MDR-TB|mdr-tb
1408309|NCT01131351|Dose Escalation|dose escalation
1408310|NCT01131351|Phase II|phase ii
1408311|NCT01131351|Open Label|open label
1408312|NCT01131351|Non Controlled|non controlled
1408313|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
1408314|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
1408315|NCT01131325|Ph+|ph+
1408316|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
1408317|NCT01131325|CML-CP|cml-cp
1408318|NCT01131325|low imatinib trough levels|low imatinib trough levels
1408319|NCT01131312|Cervix|cervix
1408320|NCT01131312|CIN|cin
1408321|NCT01131312|HPV|hpv
1408322|NCT01131312|Triage|triage
1408323|NCT01131312|ASCUS/LSIL|ascus/lsil
1408324|NCT01131312|Pap Smear|pap smear
1408325|NCT01131312|HPV Test|hpv test
1408326|NCT01131299|HDL|hdl
1408327|NCT01131299|Cholesterol|cholesterol
1408328|NCT01131299|Lipoproteins|lipoproteins
1408329|NCT01131299|Serum Lipids|serum lipids
1408330|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
1408331|NCT01131299|Atherosclerosis|atherosclerosis
1408332|NCT01131299|Heart Disease|heart disease
1408333|NCT01131273|buprenorphine injecting|buprenorphine injecting
1408334|NCT01131273|opiate dependence|opiate dependence
1408335|NCT01131273|HIV risk|hiv risk
1408336|NCT01131273|treatment outcome|treatment outcome
1408337|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
1408339|NCT01131260|Fetal monitoring|fetal monitoring
1408340|NCT01131260|Fetal acidosis|fetal acidosis
1408341|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
1408342|NCT01131260|Perinatology|perinatology
1408344|NCT01131247|bendamustine|bendamustine
1408345|NCT01131247|ofatumumab|ofatumumab
1408346|NCT01131247|blood cancer|blood cancer
1408347|NCT01131247|leukemia|leukemia
1408348|NCT01131247|lymphoma|lymphoma
1408349|NCT01131247|lymphocyte|lymphocyte
1408350|NCT01131247|refractory|refractory
1408351|NCT01131247|Advanced|advanced
1408352|NCT01131247|relapsed|relapsed
1408353|NCT01131247|hematologic|hematologic
1408354|NCT01131247|hematology|hematology
1408355|NCT01131247|antibody|antibody
1408356|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
1408357|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
1408358|NCT01131247|nevada cancer institute|nevada cancer institute
1408359|NCT01131247|cephalon|cephalon
1408360|NCT01131247|Glaxosmithkline|glaxosmithkline
1408361|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1408362|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1408363|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1408364|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1408365|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1408366|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1408367|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1408368|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1408369|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1408370|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1408371|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1408372|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1408373|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1408374|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1408375|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1408376|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1408377|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1408378|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1408379|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
1408380|NCT01131195|recurrent breast cancer|recurrent breast cancer
1408381|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
1408382|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
1408383|NCT01131195|stage IV breast cancer|stage iv breast cancer
1408384|NCT01131169|Myeloma|myeloma
1408385|NCT01131169|Busulfan|busulfan
1408386|NCT01131169|Melphalan|melphalan
1408387|NCT01131169|Fludarabine|fludarabine
1408388|NCT01131169|T-Cell|t-cell
1408389|NCT01131169|Stem Cell Transplantation|stem cell transplantation
1408390|NCT01131169|10-051|10-051
1408391|NCT01131156|postpartum|postpartum
1408392|NCT01131156|smoking|smoking
1408393|NCT01131156|relapse|relapse
1408394|NCT01131156|breastfeeding|breastfeeding
1408395|NCT01131143|Urban community centers|urban community centers
1408396|NCT01131143|Obesity|obesity
1408397|NCT01131143|Obesity counseling|obesity counseling
1408398|NCT01131143|Low-cost intervention|low-cost intervention
1408399|NCT01131130|Contact lens|contact lens
1408400|NCT01131117|healthy|healthy
1408401|NCT01131117|women|women
1408402|NCT01131117|pregnancy|pregnancy
1408403|NCT01131104|NAION|naion
1408404|NCT01131065|Hepatitis B|hepatitis b
1408405|NCT01131065|HBV|hbv
1408406|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
1408407|NCT01131065|Liver transplantation|liver transplantation
1408408|NCT01131065|Recurrence|recurrence
1408409|NCT01131065|Reinfection|reinfection
1408410|NCT01131065|Protective titers|protective titers
1408411|NCT01131065|HBsAb|hbsab
1408412|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
1408413|NCT01131065|Niuliva|niuliva
1408414|NCT01131052|elderly populations|elderly populations
1408415|NCT01131052|diabetes|diabetes
1408416|NCT01131039|Ovarian Cancer|ovarian cancer
1408417|NCT01131026|Helicobacter pylori|helicobacter pylori
1408418|NCT01131026|levofloxacin|levofloxacin
1408419|NCT01131026|amoxicillin|amoxicillin
1408420|NCT01131026|lansoprazole|lansoprazole
1408421|NCT01131026|efficacy|efficacy
1408422|NCT01131026|safety|safety
1408423|NCT01131026|triple therapy|triple therapy
1408424|NCT01130987|resident|resident
1408425|NCT01130987|intern|intern
1408426|NCT01130987|patient safety|patient safety
1408427|NCT01130987|medical error|medical error
1408428|NCT01130987|time motion|time motion
1408429|NCT01130987|handoff|handoff
1408430|NCT01130987|sign-out|sign-out
1408431|NCT01130987|Resident Workflow|resident workflow
1408432|NCT01130987|Resident Communications|resident communications
1408433|NCT01130961|Advanced NSCLC|advanced nsclc
1408434|NCT01130961|Gefitinib|gefitinib
1408435|NCT01130961|Thai patient|thai patient
1408436|NCT01130948|hypoxia|hypoxia
1408437|NCT01130948|altitude|altitude
1408440|NCT01130948|periodic breathing|periodic breathing
1408441|NCT01130948|vigilance|vigilance
1408442|NCT01130948|psychomotor|psychomotor
1408443|NCT01130948|endothelial function|endothelial function
1408444|NCT01130935|GERD|gerd
1408445|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
1408446|NCT01130935|NSAID therapy|nsaid therapy
1408447|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
1408448|NCT01130922|stable body weight|stable body weight
1408449|NCT01130909|Healthy|healthy
1408450|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
1408451|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
1408452|NCT01130883|acute tracheitis|acute tracheitis
1408453|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
1408454|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
1408455|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
1408456|NCT01130870|Fecal incontinence|fecal incontinence
1408457|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
1408458|NCT01130870|Quality of life|quality of life
1408459|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
1408460|NCT01130818|Safety|safety
1408461|NCT01130818|Tolerability|tolerability
1408462|NCT01130818|Pharmacokinetics|pharmacokinetics
1408463|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
1408464|NCT01130818|Young healthy subjects|young healthy subjects
1408465|NCT01130818|Elderly healthy subjects|elderly healthy subjects
1408466|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
1408467|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
1408468|NCT01130792|rotavirus|rotavirus
1408469|NCT01130792|cryptosporidium|cryptosporidium
1408470|NCT01130792|probiotics|probiotics
1408471|NCT01130792|intestinal function|intestinal function
1408472|NCT01130792|immune response|immune response
1408473|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
1408474|NCT01130779|Erlotinib|erlotinib
1408475|NCT01130779|brain metastasis|brain metastasis
1408476|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
1408477|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
1408478|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
1408479|NCT01130740|Osteoarthritis|osteoarthritis
1408480|NCT01130740|Exercise|exercise
1408481|NCT01130740|Diet|diet
1408482|NCT01130740|Coping Skills|coping skills
1408483|NCT01130740|Education, Medical|education, medical
1408484|NCT01130727|diabetes mellitus|diabetes mellitus
1408485|NCT01130727|diabetic nephropathy|diabetic nephropathy
1408486|NCT01130727|hypertension|hypertension
1408487|NCT01130727|green tea|green tea
1408488|NCT01130727|cocoa|cocoa
1408489|NCT01130727|polyphenol|polyphenol
1408490|NCT01130727|nitric oxide|nitric oxide
1408491|NCT01130714|inflammation|inflammation
1408492|NCT01130714|chemotherapy|chemotherapy
1408493|NCT01130714|lung cancer|lung cancer
1408494|NCT01130701|Pancreatic Cancer|pancreatic cancer
1408495|NCT01130701|Neoadjuvant|neoadjuvant
1408496|NCT01130701|Panitumumab|panitumumab
1408497|NCT01130701|Capecitabine|capecitabine
1408498|NCT01130688|Leukemia|leukemia
1408499|NCT01130688|Zileuton|zileuton
1408500|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
1408501|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
1408502|NCT01130662|AML|aml
1408503|NCT01130662|Relapsed AML|relapsed aml
1408504|NCT01130662|Refractory AML|refractory aml
1408505|NCT01130649|Epilepsy|epilepsy
1408506|NCT01130649|Tracking|tracking
1408507|NCT01130649|Electronic diary|electronic diary
1408508|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
1408509|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
1408510|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
1408511|NCT01130623|VEGF Inhibitor|vegf inhibitor
1408512|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
1408513|NCT01130623|Dose Escalation|dose escalation
1408514|NCT01130623|Pharmacokinetics|pharmacokinetics
1408515|NCT01130623|Antitumor Activity|antitumor activity
1408516|NCT01130623|Pediatric Cancer|pediatric cancer
1408517|NCT01130623|Solid Tumor|solid tumor
1408518|NCT01130623|Sarcoma|sarcoma
1408519|NCT01130623|Neuroblastoma|neuroblastoma
1408520|NCT01130623|Wilms Tumor|wilms tumor
1408521|NCT01130623|Osteosarcoma|osteosarcoma
1408522|NCT01130623|Brain Tumor|brain tumor
1408523|NCT01130610|preoperative period|preoperative period
1408524|NCT01130610|preoperative care|preoperative care
1408525|NCT01130610|anesthesia|anesthesia
1408526|NCT01130610|program evaluation|program evaluation
1408527|NCT01130597|HF|hf
1408528|NCT01130597|Heart failure|heart failure
1408529|NCT01130597|hyperkalemia|hyperkalemia
1408530|NCT01130597|chronic kidney disease|chronic kidney disease
1408531|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
1408532|NCT01130584|Cancer Patients|cancer patients
1408533|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
1408534|NCT01130558|basal-bolus insulin|basal-bolus insulin
1408723|NCT01129544|XSCID|xscid
1408535|NCT01130558|insulin ordering|insulin ordering
1408536|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
1408537|NCT01130545|Gadolinium|gadolinium
1408538|NCT01130545|Healthy Volunteer|healthy volunteer
1408539|NCT01130545|HV|hv
1408540|NCT01130532|Erectile Dysfunction|erectile dysfunction
1408541|NCT01130532|ED|ed
1408542|NCT01130532|Impotence|impotence
1408543|NCT01130519|Advanced HLRCC|advanced hlrcc
1408544|NCT01130519|Sporadic Papillary Renal Cell Cancer|sporadic papillary renal cell cancer
1408545|NCT01130519|Papillary Kidney Cancer|papillary kidney cancer
1408546|NCT01130519|Bevacizumab|bevacizumab
1408547|NCT01130519|Erlotinib|erlotinib
1408548|NCT01130519|Kidney Cancer|kidney cancer
1408549|NCT01130519|Renal Cell Cancer|renal cell cancer
1408550|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
1408551|NCT01130519|HLRCC|hlrcc
1408552|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1408553|NCT01130467|Attention Deficit Disorder|attention deficit disorder
1408554|NCT01130467|Event related potential|event related potential
1408555|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
1408556|NCT01130441|adolescent behavior|adolescent behavior
1408557|NCT01130441|harm reduction|harm reduction
1408558|NCT01130428|Mechanical stimulation|mechanical stimulation
1408559|NCT01130428|Vibration platform|vibration platform
1408560|NCT01130428|Bone metabolism|bone metabolism
1408561|NCT01130428|ATP release|atp release
1408562|NCT01130415|Sacral neuromodulation|sacral neuromodulation
1408563|NCT01130415|Screening|screening
1408564|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
1408565|NCT01130415|Tined lead|tined lead
1408566|NCT01130402|age|age
1408567|NCT01130402|lymphadenopathy|lymphadenopathy
1408568|NCT01130402|fine needle aspiration|fine needle aspiration
1408569|NCT01130402|sonography|sonography
1408570|NCT01130389|ONJ|onj
1408571|NCT01130376|Immune based therapy|immune based therapy
1408572|NCT01130376|Therapeutic vaccination|therapeutic vaccination
1408573|NCT01130376|cytokine therapy|cytokine therapy
1408574|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
1408575|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
1408576|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
1408577|NCT01130363|Gastric cancer|gastric cancer
1408578|NCT01130363|Fundic Gland Polyps|fundic gland polyps
1408579|NCT01130324|VIBATIV|vibativ
1408580|NCT01130324|telavancin|telavancin
1408581|NCT01130324|Pregnancy|pregnancy
1408582|NCT01130324|Registry|registry
1408583|NCT01130298|testosterone,|testosterone,
1408584|NCT01130298|Pharmacokinetics|pharmacokinetics
1408585|NCT01130298|replacement,|replacement,
1408586|NCT01130298|therapy|therapy
1408587|NCT01130285|Lung Cancer|lung cancer
1408588|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
1408589|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
1408590|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
1408591|NCT01130272|Colonic diseases|colonic diseases
1408592|NCT01130272|Colonic diseases, functional|colonic diseases, functional
1408593|NCT01130272|Digestive system disease|digestive system disease
1408594|NCT01130272|Gastrointestinal disease|gastrointestinal disease
1408595|NCT01130272|Intestinal disease|intestinal disease
1408596|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
1408597|NCT01130272|Diarrhea|diarrhea
1408598|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
1408599|NCT01130259|mTNBC|mtnbc
1408600|NCT01130259|triple negative breast cancer|triple negative breast cancer
1408601|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
1408602|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
1408603|NCT01130233|rectal cancer|rectal cancer
1408604|NCT01130220|Brain Tumor|brain tumor
1408605|NCT01130220|Brain Neoplasm|brain neoplasm
1408606|NCT01130207|Obesity|obesity
1408607|NCT01130207|Diabetes|diabetes
1408608|NCT01130207|Periodontal disease|periodontal disease
1408609|NCT01130194|follicular lymphoma|follicular lymphoma
1408610|NCT01130194|radioimmunotherapy|radioimmunotherapy
1408611|NCT01130194|rituximab|rituximab
1408612|NCT01130194|C-MOPP-R|c-mopp-r
1408613|NCT01130194|autologous transplant|autologous transplant
1537790|NCT00629200|SSG|ssg
1408614|NCT01130155|Antimalarials|antimalarials
1408615|NCT01130155|Diagnosis|diagnosis
1408616|NCT01130155|Access to treatment|access to treatment
1408617|NCT01130155|Quality of care|quality of care
1408618|NCT01130129|Flavonoids|flavonoids
1408619|NCT01130129|Platelets|platelets
1408620|NCT01130103|PTSD|ptsd
1408621|NCT01130103|anxiety disorders|anxiety disorders
1408622|NCT01130103|trauma|trauma
1408623|NCT01130077|Pediatric glioma|pediatric glioma
1408624|NCT01130077|Vaccine therapy|vaccine therapy
1408625|NCT01130064|Asthma|asthma
1408626|NCT01130064|QAX576|qax576
1408627|NCT01130051|bioavailability|bioavailability
1408628|NCT01130038|Characteristic of play|characteristic of play
1408629|NCT01130038|DCD|dcd
1408630|NCT01130038|children|children
1408631|NCT01130038|Typical Development|typical development
1408632|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
1408633|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
1408634|NCT01130012|Lifestyle intervention|lifestyle intervention
1408635|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
1408636|NCT01130012|Insulin treatment|insulin treatment
1408637|NCT01130012|Pregnancy outcomes|pregnancy outcomes
1408762|NCT01129336|CTCs|ctcs
1408638|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
1408639|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
1408640|NCT01129973|speech and language|speech and language
1408641|NCT01129973|phonoaudiology|phonoaudiology
1408642|NCT01129973|marketing|marketing
1408643|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
1408644|NCT01129934|Low Back Pain,|low back pain,
1408645|NCT01129934|Emergency medicine,|emergency medicine,
1408646|NCT01129934|Promethazine,|promethazine,
1408647|NCT01129934|Morphine,|morphine,
1408648|NCT01129934|Pain relief|pain relief
1408649|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
1408650|NCT01129921|Decompression|decompression
1408651|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
1408652|NCT01129882|Schizophrenia|schizophrenia
1408653|NCT01129869|Survey|survey
1408654|NCT01129869|Perception|perception
1408655|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
1408656|NCT01129869|Research Participant Perception|research participant perception
1408657|NCT01129856|Dry eye|dry eye
1408658|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
1408659|NCT01129856|Iontophoresis|iontophoresis
1408660|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
1408661|NCT01129856|EGP-437|egp-437
1408662|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
1408663|NCT01129843|anemia|anemia
1408664|NCT01129843|iron deficiency|iron deficiency
1408665|NCT01129843|nutritional|nutritional
1408666|NCT01129843|iron supplementation|iron supplementation
1408667|NCT01129843|cluster randomized control trial|cluster randomized control trial
1408668|NCT01129830|ovarian reserve|ovarian reserve
1408669|NCT01129830|FSH|fsh
1408670|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
1408671|NCT01129830|estradiol|estradiol
1408672|NCT01129830|oocyte|oocyte
1408673|NCT01129830|IVF|ivf
1408674|NCT01129830|embryo transfer|embryo transfer
1408675|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
1408676|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
1408677|NCT01129817|Chronic Low Back Pain|chronic low back pain
1408678|NCT01129817|Randomized Controlled Trial|randomized controlled trial
1408679|NCT01129817|Subclassification|subclassification
1408680|NCT01129804|Alcohol dependence|alcohol dependence
1408681|NCT01129804|Network Support|network support
1408682|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
1408683|NCT01129804|Relapse prevention|relapse prevention
1408684|NCT01129804|Consequences of drinking|consequences of drinking
1408685|NCT01129804|Social network development|social network development
1408686|NCT01129791|Lactose intolerance|lactose intolerance
1408687|NCT01129791|Dairy products|dairy products
1408688|NCT01129791|Raw milk|raw milk
1408689|NCT01129791|Adults|adults
1408690|NCT01129765|Nasal suction|nasal suction
1408691|NCT01129765|Nasal aspiration|nasal aspiration
1408692|NCT01129765|Nasal saline irrigation|nasal saline irrigation
1408693|NCT01129765|Nasal lavage|nasal lavage
1408694|NCT01129739|Bone Marrow Disease|bone marrow disease
1408695|NCT01129739|MDS-RA|mds-ra
1408696|NCT01129739|MDS-RARS|mds-rars
1408697|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
1408698|NCT01129739|Transplant|transplant
1408699|NCT01129726|Transillumination-guided|transillumination-guided
1408700|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
1408701|NCT01129726|time|time
1408702|NCT01129726|success rate|success rate
1408703|NCT01129726|intubation|intubation
1408704|NCT01129713|GERD|gerd
1408705|NCT01129713|Acid Reflux|acid reflux
1408706|NCT01129713|Heartburn|heartburn
1408707|NCT01129713|Regurgitation|regurgitation
1408708|NCT01129713|Indigestion|indigestion
1408709|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
1408710|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
1408711|NCT01129635|Heart failure|heart failure
1408909|NCT01128790|heart failure|heart failure
1408712|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
1408713|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
1408714|NCT01129635|CRT|crt
1408715|NCT01129622|Letrozole|letrozole
1408716|NCT01129622|Breast MRI|breast mri
1408717|NCT01129622|Postmenopausal women|postmenopausal women
1408718|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
1408719|NCT01129583|Botulinum Toxin|botulinum toxin
1408720|NCT01129583|Elbow Stiffness|elbow stiffness
1408721|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
1408724|NCT01129544|SCID-X1|scid-x1
1408725|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
1408726|NCT01129518|vaccine|vaccine
1408727|NCT01129518|conjugate|conjugate
1408728|NCT01129505|pregnancy|pregnancy
1408729|NCT01129505|intervention|intervention
1408730|NCT01129505|exercise|exercise
1408731|NCT01129505|nutrition|nutrition
1408732|NCT01129505|infants|infants
1408733|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
1408734|NCT01129479|Aphasia|aphasia
1408735|NCT01129479|treatment|treatment
1408736|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
1408737|NCT01129479|stroke|stroke
1408738|NCT01129453|Salmonella|salmonella
1408739|NCT01129453|Vaccine|vaccine
1408740|NCT01129440|Children|children
1408741|NCT01129440|Fluoride varnish|fluoride varnish
1408742|NCT01129440|Glass ionomer sealant|glass ionomer sealant
1408743|NCT01129440|Prevention|prevention
1408744|NCT01129401|methamphetamine|methamphetamine
1408745|NCT01129401|men who have sex with men|men who have sex with men
1408746|NCT01129401|HIV/AIDS|hiv/aids
1408747|NCT01129362|Pertussis|pertussis
1408748|NCT01129362|Whooping Cough|whooping cough
1408749|NCT01129362|Pertussis Vaccine|pertussis vaccine
1408750|NCT01129349|Solid Tumors|solid tumors
1408751|NCT01129336|HER2-negative|her2-negative
1408752|NCT01129336|HER2|her2
1408753|NCT01129336|Metastatic breast cancer|metastatic breast cancer
1408754|NCT01129336|First Line breast cancer|first line breast cancer
1408755|NCT01129336|Second Line breast cancer|second line breast cancer
1408756|NCT01129336|Breast cancer|breast cancer
1408757|NCT01129336|Metastatic|metastatic
1408758|NCT01129336|Stage IV breast cancer|stage iv breast cancer
1408759|NCT01129336|Progression free survival|progression free survival
1408760|NCT01129336|PFS|pfs
1408761|NCT01129336|Circulating Tumor Cells|circulating tumor cells
1408763|NCT01129336|Zoledronic acid|zoledronic acid
1408764|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
1408765|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
1408766|NCT01129310|irinotecan|irinotecan
1408767|NCT01129310|capecitabine|capecitabine
1408768|NCT01129310|oxaliplatin|oxaliplatin
1408769|NCT01129310|health-related quality of life|health-related quality of life
1408770|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
1408771|NCT01129297|Obesity|obesity
1408772|NCT01129297|surgery|surgery
1408773|NCT01129297|genetic expression|genetic expression
1408774|NCT01129297|collection of samples|collection of samples
1408775|NCT01129284|Treatment Resistance|treatment resistance
1408776|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
1408777|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1408778|NCT01129284|lipoid nephrosis|lipoid nephrosis
1408779|NCT01129284|Membranous nephropathy|membranous nephropathy
1408780|NCT01129284|IgA nephropathy|iga nephropathy
1408781|NCT01129284|proteinuria|proteinuria
1408782|NCT01129258|phase 1|phase 1
1408783|NCT01129258|safety and tolerability|safety and tolerability
1408784|NCT01129258|pharmacokinetics|pharmacokinetics
1408785|NCT01129258|PK|pk
1408786|NCT01129258|pharmacodynamics|pharmacodynamics
1408787|NCT01129258|PD|pd
1408788|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
1408789|NCT01129245|Celebrex|celebrex
1408790|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
1408791|NCT01129245|ovulation|ovulation
1408792|NCT01129245|emergency contraception|emergency contraception
1408793|NCT01129232|insulin|insulin
1408794|NCT01129219|Strength|strength
1408795|NCT01129219|Function|function
1408796|NCT01129219|Mobility|mobility
1408797|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
1408798|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
1408799|NCT01129206|Adenocarcinoma|adenocarcinoma
1568278|NCT00506428|metabolism|metabolism
1408800|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
1408801|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1408802|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
1408803|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
1408804|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
1408805|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
1408806|NCT01129141|Tinnitus|tinnitus
1408807|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
1408808|NCT01129141|Counseling|counseling
1408809|NCT01129141|Education|education
1408810|NCT01129141|Evaluation studies|evaluation studies
1408811|NCT01129141|Quality of health care|quality of health care
1408812|NCT01129128|Echinacea|echinacea
1408813|NCT01129128|immune modulation|immune modulation
1408814|NCT01129128|prevention|prevention
1408815|NCT01129089|Acceptability|acceptability
1408816|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
1408817|NCT01129089|Micronutrient powder|micronutrient powder
1408818|NCT01129089|Malnutrition|malnutrition
1408819|NCT01129076|Thalassemia Major|thalassemia major
1408820|NCT01129076|Stigma|stigma
1408821|NCT01129076|Singapore|singapore
1408822|NCT01129076|Qualitative|qualitative
1408823|NCT01129050|Fish oil|fish oil
1408824|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
1408825|NCT01129050|Metabolic syndrome|metabolic syndrome
1408826|NCT01129050|Adults|adults
1408827|NCT01129037|Oncology|oncology
1408828|NCT01129024|Splenectomy|splenectomy
1408829|NCT01129024|Low Platelet Count|low platelet count
1408830|NCT01129024|Thrombopoiesis|thrombopoiesis
1408831|NCT01129024|Thrombocytopaenia|thrombocytopaenia
1408832|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1408833|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
1408834|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
1408835|NCT01129024|Hematologic Disease|hematologic disease
1408836|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
1408837|NCT01129024|S-888711|s-888711
1408838|NCT01129024|Blood Platelet Disorders|blood platelet disorders
1408839|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
1408840|NCT01129024|ITP|itp
1408841|NCT01129011|NSAID|nsaid
1408842|NCT01129011|gastric ulcers|gastric ulcers
1408843|NCT01129011|Vimovo|vimovo
1408844|NCT01129011|Esomeprazole|esomeprazole
1408845|NCT01129011|Naproxen|naproxen
1408846|NCT01128998|Sorafenib|sorafenib
1408847|NCT01128998|S1|s1
1408848|NCT01128998|Advanced Solid Tumors|advanced solid tumors
1408849|NCT01128998|RD|rd
1408850|NCT01128998|MTD|mtd
1408851|NCT01128998|DLT|dlt
1408852|NCT01128998|PK|pk
1408853|NCT01128998|PG|pg
1408854|NCT01128998|Biomarker|biomarker
1408855|NCT01128985|Canagliflozin|canagliflozin
1408856|NCT01128985|Placebo|placebo
1408857|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
1408858|NCT01128985|Pharmacokinetic|pharmacokinetic
1408859|NCT01128985|Pharmacodynamic|pharmacodynamic
1408860|NCT01128972|enamel erosion|enamel erosion
1408861|NCT01128972|tooth remineralization|tooth remineralization
1408862|NCT01128972|tooth erosion|tooth erosion
1408863|NCT01128959|Epilepsy|epilepsy
1408864|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
1408865|NCT01128959|Oral Carbamazepine|oral carbamazepine
1408866|NCT01128946|Enamel remineralization|enamel remineralization
1408867|NCT01128946|Fluoride|fluoride
1408868|NCT01128946|caries|caries
1408869|NCT01128933|Fractional flow reserve|fractional flow reserve
1408870|NCT01128933|Revascularization|revascularization
1408871|NCT01128933|Prognosis|prognosis
1408872|NCT01128933|Hemodynamics|hemodynamics
1408873|NCT01128933|Hypertension|hypertension
1408874|NCT01128920|bacterial infections|bacterial infections
1408875|NCT01128920|skin infections|skin infections
1408876|NCT01128920|HIV|hiv
1408877|NCT01128920|Hepatitis C|hepatitis c
1408878|NCT01128920|risk reduction intervention|risk reduction intervention
1408879|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
1408880|NCT01128894|GSK716155|gsk716155
1408881|NCT01128894|liraglutide|liraglutide
1408882|NCT01128894|albiglutide|albiglutide
1408883|NCT01128894|open-label|open-label
1408884|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
1408885|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
1408886|NCT01128855|Duchenne|duchenne
1408887|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1408888|NCT01128855|DMD|dmd
1408889|NCT01128855|968|968
1408890|NCT01128842|Neratinib|neratinib
1408891|NCT01128842|Capecitabine|capecitabine
1408892|NCT01128842|Combination|combination
1408893|NCT01128842|Solid Tumor|solid tumor
1408894|NCT01128829|obesity|obesity
1408895|NCT01128829|diabetes|diabetes
1408896|NCT01128829|artificial sweeteners|artificial sweeteners
1408897|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
1408898|NCT01128816|central sleep apnea|central sleep apnea
1408899|NCT01128816|heart failure|heart failure
1408900|NCT01128816|congestive heart failure|congestive heart failure
1408901|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
1408902|NCT01128816|ASV|asv
1408903|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
1408904|NCT01128803|immunotherapy|immunotherapy
1408905|NCT01128803|alpha foetoprotein|alpha foetoprotein
1408906|NCT01128803|dendritic cells|dendritic cells
1408907|NCT01128790|exercise|exercise
1408908|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
1409107|NCT01127971|patients|patients
1408910|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
1408911|NCT01128777|depression|depression
1408912|NCT01128777|anxiety|anxiety
1408913|NCT01128777|family conflict|family conflict
1408914|NCT01128777|behavior problems|behavior problems
1408915|NCT01128751|Cognition|cognition
1408916|NCT01128751|Neuroprotection|neuroprotection
1408917|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
1408918|NCT01128751|Aortic valve replacement|aortic valve replacement
1408919|NCT01128751|Micro-emboli|micro-emboli
1408920|NCT01128738|Neuromuscular Agents|neuromuscular agents
1408921|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
1408922|NCT01128738|Sweating|sweating
1408923|NCT01128738|Sweat Gland Disease|sweat gland disease
1408924|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
1408925|NCT01128738|Skin Disease|skin disease
1408926|NCT01128699|Ahmed valve|ahmed valve
1408927|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
1408928|NCT01128699|Uveitic glaucoma|uveitic glaucoma
1408929|NCT01128699|Failed glaucoma|failed glaucoma
1408930|NCT01128699|VEGF-A|vegf-a
1408931|NCT01128699|Intraocular pressure|intraocular pressure
1408932|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
1408933|NCT01128686|retrospective|retrospective
1408934|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
1408935|NCT01128686|cohort study|cohort study
1408936|NCT01128686|lamivudine|lamivudine
1408937|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
1408938|NCT01128673|Magnet resonance imaging|magnet resonance imaging
1408939|NCT01128673|Selective Head cooling|selective head cooling
1408940|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
1408941|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
1408942|NCT01128634|Verapamil|verapamil
1408943|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
1408944|NCT01128634|P-GP|p-gp
1408945|NCT01128634|LABA|laba
1408946|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
1408947|NCT01128634|LAMA|lama
1408948|NCT01128621|Pharmacokinetics|pharmacokinetics
1408949|NCT01128621|Glucose|glucose
1408950|NCT01128621|Safety|safety
1408951|NCT01128621|Male|male
1408952|NCT01128621|Female|female
1408953|NCT01128621|Metformin|metformin
1408954|NCT01128621|Pharmacodynamics|pharmacodynamics
1408955|NCT01128621|Tolerability|tolerability
1408956|NCT01128621|Type II Diabetes|type ii diabetes
1408957|NCT01128608|GERD|gerd
1408958|NCT01128608|Heartburn|heartburn
1408959|NCT01128608|Acid Reflux|acid reflux
1408960|NCT01128595|allergen challenge|allergen challenge
1408961|NCT01128595|early asthmatic response|early asthmatic response
1408962|NCT01128595|mild asthma|mild asthma
1408963|NCT01128595|late asthmatic response|late asthmatic response
1408964|NCT01128582|GERD|gerd
1408965|NCT01128582|Insomnia|insomnia
1408966|NCT01128582|Acid Reflux|acid reflux
1408967|NCT01128582|Heartburn|heartburn
1408968|NCT01128569|mild asthma|mild asthma
1408969|NCT01128569|allergen challenge|allergen challenge
1408970|NCT01128569|early asthmatic response|early asthmatic response
1408971|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
1408972|NCT01128556|histamine skin testing|histamine skin testing
1408973|NCT01128543|lapatinib|lapatinib
1408974|NCT01128543|breast cancer|breast cancer
1408975|NCT01128530|cSSSI|csssi
1408976|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
1408977|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
1408978|NCT01128530|abscess|abscess
1408979|NCT01128530|cellulitis|cellulitis
1408980|NCT01128530|bacterial infections|bacterial infections
1408981|NCT01128530|anti-bacterial agents|anti-bacterial agents
1408982|NCT01128530|anti-infective agents|anti-infective agents
1408983|NCT01128530|skin diseases, infectious|skin diseases, infectious
1408984|NCT01128530|skin diseases|skin diseases
1408985|NCT01128530|wound infection|wound infection
1408986|NCT01128517|Maternal education|maternal education
1408987|NCT01128517|Complementary food|complementary food
1408988|NCT01128517|Infant growth|infant growth
1408989|NCT01128478|Acute pancreatitis|acute pancreatitis
1408990|NCT01128478|Enteral nutrition|enteral nutrition
1408991|NCT01128478|Pancreas rest|pancreas rest
1408992|NCT01128465|propofol|propofol
1408993|NCT01128465|awake craniotomy|awake craniotomy
1408994|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
1408995|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
1568279|NCT00506415|Alzheimer's|alzheimer's
1408996|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1408997|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1408998|NCT01128413|Shock|shock
1408999|NCT01128413|Resuscitation|resuscitation
1409000|NCT01128413|Hemodynamics|hemodynamics
1409001|NCT01128413|Emergencies|emergencies
1409002|NCT01128413|Critical Care|critical care
1409003|NCT01128413|Lactic Acid|lactic acid
1409004|NCT01128413|Plasma volume|plasma volume
1409005|NCT01128400|obesity|obesity
1409006|NCT01128400|orlistat|orlistat
1409007|NCT01128400|taste perception|taste perception
1409008|NCT01128387|esophageal cancer|esophageal cancer
1409009|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
1409010|NCT01128374|Periodontal disease|periodontal disease
1409011|NCT01128374|Nonsurgical therapy|nonsurgical therapy
1409012|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1409013|NCT01128374|Bacterial burden|bacterial burden
1409014|NCT01128374|Gene polymorphisms|gene polymorphisms
1409015|NCT01128348|asthma|asthma
1409016|NCT01128348|adherence|adherence
1409017|NCT01128348|quality of life|quality of life
1409018|NCT01128348|health literacy|health literacy
1409019|NCT01128348|health disparities|health disparities
1409020|NCT01128335|Liver transplantation|liver transplantation
1409021|NCT01128335|HCV-negative recipient|hcv-negative recipient
1409022|NCT01128335|deceased donor|deceased donor
1409023|NCT01128335|sotrastaurin|sotrastaurin
1409024|NCT01128335|oran transplantation|oran transplantation
1409025|NCT01128335|tacrolimus|tacrolimus
1409026|NCT01128322|CKD-828|ckd-828
1409027|NCT01128322|Hypertension|hypertension
1409028|NCT01128322|Primary Hypertension|primary hypertension
1409029|NCT01128322|S-Amlodipine|s-amlodipine
1409030|NCT01128322|Telmisartan|telmisartan
1409031|NCT01128322|Amlodipine|amlodipine
1409032|NCT01128322|Factorial|factorial
1409033|NCT01128322|Phase 2|phase 2
1409034|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
1409035|NCT01128283|Sepsis|sepsis
1409036|NCT01128283|organ failure|organ failure
1409037|NCT01128283|cytokines|cytokines
1409038|NCT01128283|clotting factors|clotting factors
1409039|NCT01128270|Dichloroacetate|dichloroacetate
1409040|NCT01128270|Chloral Hydrate|chloral hydrate
1409041|NCT01128270|Metabolism|metabolism
1409042|NCT01128244|oral contraceptives|oral contraceptives
1409043|NCT01128244|Vitamin B6|vitamin b6
1409044|NCT01128244|birth control pills|birth control pills
1409045|NCT01128244|amino acids|amino acids
1409046|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
1409047|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
1409048|NCT01128218|Brain Neoplasms|brain neoplasms
1409049|NCT01128218|5-ALA|5-ala
1409050|NCT01128218|Aminolevulinic acid|aminolevulinic acid
1409051|NCT01128218|Fluorescence|fluorescence
1409052|NCT01128218|Gliomas|gliomas
1409053|NCT01128218|Glioblastoma|glioblastoma
1409054|NCT01128218|Surgery|surgery
1409055|NCT01128205|diabetes|diabetes
1409056|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
1409057|NCT01128205|blood pressure|blood pressure
1409058|NCT01128205|blood lipid|blood lipid
1409059|NCT01128205|blood glucose|blood glucose
1409060|NCT01128166|Heart Failure|heart failure
1409061|NCT01128166|Decompensation|decompensation
1409062|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1409063|NCT01128153|Type 2 Diabetes|type 2 diabetes
1409064|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
1409065|NCT01128153|Saxagliptin|saxagliptin
1409066|NCT01128153|Metformin|metformin
1409067|NCT01128153|Sulfonylurea|sulfonylurea
1409068|NCT01128153|Triple Oral Therapy|triple oral therapy
1409069|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
1409070|NCT01128127|knowledge translation|knowledge translation
1409071|NCT01128127|prescription|prescription
1409072|NCT01128127|primary care|primary care
1409073|NCT01128127|NSAID|nsaid
1409074|NCT01128127|PPI|ppi
1409075|NCT01128127|Gastrointestinal damage|gastrointestinal damage
1409076|NCT01128127|Inappropriate prescription|inappropriate prescription
1409077|NCT01128114|Acute bipolar mania|acute bipolar mania
1409078|NCT01128114|Seroquel XR|seroquel xr
1409079|NCT01128114|Quetiapine fumarate|quetiapine fumarate
1409080|NCT01128114|Add-on therapy|add-on therapy
1409081|NCT01128101|spironolactone|spironolactone
1409082|NCT01128101|chronic kidney disease|chronic kidney disease
1409083|NCT01128101|dialysis|dialysis
1409084|NCT01128101|LHV|lhv
1409085|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
1409086|NCT01128075|RebiSmart|rebismart
1409087|NCT01128075|Rebif|rebif
1409088|NCT01128075|Adherence|adherence
1409089|NCT01128075|Multidose|multidose
1409090|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1409091|NCT01128075|RMS|rms
1409092|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
1409093|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
1409094|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
1568280|NCT00506415|Patch|patch
1409095|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
1409096|NCT01128036|Congestive Heart failure|congestive heart failure
1409097|NCT01128036|Cardiomyopathy|cardiomyopathy
1409098|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
1409099|NCT01128023|rubidium-82|rubidium-82
1409100|NCT01128023|medical isotope production|medical isotope production
1409101|NCT01128023|Positron emission tomography|positron emission tomography
1409102|NCT01128023|clinically useful|clinically useful
1409103|NCT01127984|pacemaker|pacemaker
1409104|NCT01127984|pocket haematoma|pocket haematoma
1409105|NCT01127984|antiplatelet therapy|antiplatelet therapy
1409106|NCT01127984|fibrin glue|fibrin glue
1409108|NCT01127971|receiving|receiving
1409109|NCT01127971|irradiation|irradiation
1409110|NCT01127971|device|device
1409111|NCT01127971|External Beam|external beam
1409112|NCT01127958|In-stent restenosis|in-stent restenosis
1409113|NCT01127958|Minimal lumen diameter|minimal lumen diameter
1409114|NCT01127958|Drug eluting balloon|drug eluting balloon
1409115|NCT01127958|Drug eluting stent|drug eluting stent
1409116|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
1409117|NCT01127919|Exercise|exercise
1409118|NCT01127919|Activity|activity
1409119|NCT01127919|Adherence|adherence
1409120|NCT01127919|Genetics|genetics
1409121|NCT01127906|Healthy Volunteers|healthy volunteers
1409122|NCT01127906|cross-over|cross-over
1409123|NCT01127906|randomized|randomized
1409124|NCT01127906|placebo and active controlled|placebo and active controlled
1409125|NCT01127906|heat pain|heat pain
1409126|NCT01127906|UVB-Induced pain model|uvb-induced pain model
1409127|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
1409128|NCT01127893|Joint Diseases|joint diseases
1409129|NCT01127893|Arthritis|arthritis
1409130|NCT01127893|Rheumatic Diseases|rheumatic diseases
1409131|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
1409132|NCT01127880|Thoracotomy|thoracotomy
1409133|NCT01127880|Antibiotics|antibiotics
1409134|NCT01127854|kidney stone|kidney stone
1409135|NCT01127854|urolithiasis|urolithiasis
1409136|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
1409137|NCT01127854|calcium oxalate stone|calcium oxalate stone
1409138|NCT01127854|calcium oxalate|calcium oxalate
1409139|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
1409140|NCT01127828|Probiotic yoghurt|probiotic yoghurt
1409141|NCT01127828|Symptom severity|symptom severity
1409142|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
1409143|NCT01127815|pancreatic cancer|pancreatic cancer
1409144|NCT01127815|peritoneal metastasis|peritoneal metastasis
1409145|NCT01127815|anoikis|anoikis
1409146|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
1409147|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
1409148|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
1409149|NCT01127802|CABG|cabg
1409150|NCT01127802|functional status|functional status
1409151|NCT01127802|symptoms distress|symptoms distress
1409152|NCT01127802|quality of life|quality of life
1409153|NCT01127802|the trajectory of functional status|the trajectory of functional status
1409154|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
1409155|NCT01127802|the changes of quality of life|the changes of quality of life
1409156|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
1409157|NCT01127763|metastatic|metastatic
1409158|NCT01127763|breast|breast
1409159|NCT01127763|cancer|cancer
1409160|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
1409161|NCT01127750|MS|ms
1409162|NCT01127750|safety|safety
1409163|NCT01127750|tolerability|tolerability
1409164|NCT01127750|health outcomes|health outcomes
1409165|NCT01127737|SCCs|sccs
1409166|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
1409167|NCT01127737|Skin Self Exam|skin self exam
1409168|NCT01127737|SSE|sse
1409169|NCT01127737|Organ Transplant|organ transplant
1409170|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
1409171|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
1409172|NCT01127737|Evaluate internation information|evaluate internation information
1409173|NCT01127724|Vitamin B12|vitamin b12
1409174|NCT01127724|Aphthous stomatitis|aphthous stomatitis
1409175|NCT01127724|Cobalamin|cobalamin
1409176|NCT01127724|Doses|doses
1409177|NCT01127685|weight bearing|weight bearing
1409178|NCT01127685|acl|acl
1409179|NCT01127672|plantar fasciitis|plantar fasciitis
1409180|NCT01127672|PRP|prp
1409181|NCT01127672|platelet rich plasma|platelet rich plasma
1409182|NCT01127659|diabetes|diabetes
1409183|NCT01127659|hypogonadism|hypogonadism
1409184|NCT01127659|obesity|obesity
1409185|NCT01127659|testosterone|testosterone
1409186|NCT01127659|insulin sensitivity|insulin sensitivity
1409187|NCT01127659|inflammation|inflammation
1409188|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
1409189|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
1409190|NCT01127620|Hay fever|hay fever
1409191|NCT01127620|Allergic Rhinitis|allergic rhinitis
1409192|NCT01127620|Sneezing|sneezing
1409193|NCT01127620|Nasal congestion|nasal congestion
1409194|NCT01127620|Rhinorrhea|rhinorrhea
1409195|NCT01127620|Nasal itching|nasal itching
1409196|NCT01127620|Ocular itching|ocular itching
1409197|NCT01127620|Ocular tearing|ocular tearing
1409198|NCT01127620|Antihistamine|antihistamine
1409199|NCT01127607|parenting|parenting
1409200|NCT01127594|Melanoma|melanoma
1409201|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
1409202|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
1409203|NCT01127581|Cervidil|cervidil
1409204|NCT01127581|Cervical ripening|cervical ripening
1409205|NCT01127581|Induction of labor|induction of labor
1409206|NCT01127581|Rate of cesarean section|rate of cesarean section
1409207|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
1409208|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
1409209|NCT01127568|PTSD|ptsd
1409210|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
1409211|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
1409212|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
1409213|NCT01127555|Biliary Tract Cancer|biliary tract cancer
1409214|NCT01127555|Salvage therapy|salvage therapy
1409215|NCT01127555|FOLFOX|folfox
1409216|NCT01127516|Susceptibility testing|susceptibility testing
1409217|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
1409218|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
1409219|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
1409220|NCT01127464|HIV-1|hiv-1
1409221|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
1409222|NCT01127464|Healthy Volunteers|healthy volunteers
1409223|NCT01127451|Neoplasms|neoplasms
1409224|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
1409225|NCT01127425|nursing hours|nursing hours
1409226|NCT01127425|length of hospital stay|length of hospital stay
1409227|NCT01127425|reconvalescence|reconvalescence
1409228|NCT01127425|colorectal surgery|colorectal surgery
1409229|NCT01127425|laparoscopic|laparoscopic
1409230|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
1409231|NCT01127412|overweight|overweight
1409232|NCT01127412|physical activity|physical activity
1409233|NCT01127412|infancy|infancy
1409234|NCT01127412|body composition|body composition
1409235|NCT01127412|motor development|motor development
1409236|NCT01127412|motor activity|motor activity
1409237|NCT01127373|Breast|breast
1409238|NCT01127373|Radiation|radiation
1409239|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
1409240|NCT01127373|post mastectomy|post mastectomy
1409241|NCT01127373|post partial mastectomy|post partial mastectomy
1409242|NCT01127373|node-positive breast cancer|node-positive breast cancer
1409243|NCT01127373|10-025|10-025
1409244|NCT01127360|Anti-VEGF|anti-vegf
1409245|NCT01127360|Ranibizumab|ranibizumab
1409246|NCT01127360|Bevacizumab|bevacizumab
1409247|NCT01127360|exudative|exudative
1409248|NCT01127360|macular degeneration|macular degeneration
1409249|NCT01127334|Dyssynchrony|dyssynchrony
1409250|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
1409251|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
1409253|NCT01127321|MEDI-570|medi-570
1409254|NCT01127308|Absorption|absorption
1409255|NCT01127308|Distribution|distribution
1409256|NCT01127308|Metabolism|metabolism
1409257|NCT01127308|and Excretion|and excretion
1409258|NCT01127308|Mass Balance|mass balance
1409259|NCT01127308|Metabolic Profile|metabolic profile
1409260|NCT01127308|Radiolabel Study|radiolabel study
1409261|NCT01127295|Pharmacokinetics|pharmacokinetics
1409262|NCT01127295|Pharmacogenetic|pharmacogenetic
1409263|NCT01127295|tamoxifen|tamoxifen
1409264|NCT01127295|anti-aromatases|anti-aromatases
1409265|NCT01127295|breast cancer|breast cancer
1409266|NCT01127295|pharmacodynamy|pharmacodynamy
1409267|NCT01127295|Observance|observance
1409268|NCT01127282|influenza|influenza
1409269|NCT01127282|vitamin|vitamin
1409270|NCT01127282|improvement of symptom|improvement of symptom
1409271|NCT01127243|Hysterectomy|hysterectomy
1409272|NCT01127243|laparoscopy|laparoscopy
1409273|NCT01127243|day-case surgery|day-case surgery
1409274|NCT01127243|quality of life|quality of life
1409275|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
1409276|NCT01127230|ADRC|adrc
1409277|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
1409278|NCT01127230|stem cells|stem cells
1409279|NCT01127230|liposuction|liposuction
1409280|NCT01127230|Cytori|cytori
1409281|NCT01127230|Celution|celution
1409282|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
1409283|NCT01127217|amlodipine|amlodipine
1409284|NCT01127217|losartan|losartan
1409285|NCT01127217|hypertension|hypertension
1409287|NCT01127204|HIV|hiv
1409288|NCT01127204|Antiretroviral therapy|antiretroviral therapy
1409289|NCT01127204|Infant|infant
1409290|NCT01127204|Sub Saharian Africa|sub saharian africa
1409291|NCT01127191|military exercises|military exercises
1409292|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
1409293|NCT01127191|physiological responses|physiological responses
1409294|NCT01127191|biomechanical responses|biomechanical responses
1409483|NCT01126242|Ankle|ankle
1409295|NCT01127191|simulated military effort|simulated military effort
1409296|NCT01127191|high load carriage|high load carriage
1409297|NCT01127191|Healthy voluntary|healthy voluntary
1409298|NCT01127152|Noradrenalin relays|noradrenalin relays
1409299|NCT01127152|Automatic relays|automatic relays
1409300|NCT01127152|Manual relays|manual relays
1409301|NCT01127152|Hypotension|hypotension
1409302|NCT01127152|Intensive care unit|intensive care unit
1409303|NCT01127139|Essential hypertension|essential hypertension
1409304|NCT01127113|Myocardial infarction|myocardial infarction
1409305|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
1409306|NCT01127113|Nanoparticles|nanoparticles
1409307|NCT01127113|Mononuclear cells|mononuclear cells
1409308|NCT01127113|Cell tracking|cell tracking
1409309|NCT01127100|neuropathic pain|neuropathic pain
1409310|NCT01127100|gabapentin|gabapentin
1409311|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
1409312|NCT01127100|multicenter|multicenter
1409313|NCT01127100|non-inferiority trial|non-inferiority trial
1409314|NCT01127087|Hyperoxaluria|hyperoxaluria
1409315|NCT01127087|Oxazyme|oxazyme
1409316|NCT01127087|oxalate|oxalate
1409317|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
1409318|NCT01127074|metastatic breast cancer|metastatic breast cancer
1409319|NCT01127074|breast cancer stage IV|breast cancer stage iv
1409320|NCT01127074|vaccination|vaccination
1409321|NCT01127074|CD80|cd80
1409322|NCT01127074|immunotherapy|immunotherapy
1409323|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1409324|NCT01127061|Exercise|exercise
1409325|NCT01127061|Oxygen consumption|oxygen consumption
1409326|NCT01127048|bronchitis|bronchitis
1409327|NCT01127048|coughing|coughing
1409328|NCT01127048|children|children
1409329|NCT01127048|Ivy|ivy
1409330|NCT01127048|Hedera helix L.|hedera helix l.
1409331|NCT01127035|allergic rhinitis|allergic rhinitis
1409332|NCT01127035|alternaria alternata|alternaria alternata
1409333|NCT01127035|symptom score|symptom score
1409334|NCT01127022|Pregnancy|pregnancy
1409335|NCT01127022|Lactation|lactation
1409336|NCT01127022|Choline|choline
1409337|NCT01127022|Cognition|cognition
1409338|NCT01127022|Biomarkers|biomarkers
1409339|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
1409340|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
1409341|NCT01126970|reduced calorie diet|reduced calorie diet
1409342|NCT01126970|orlistat|orlistat
1409343|NCT01126970|velneperit|velneperit
1409344|NCT01126944|heart failure|heart failure
1409345|NCT01126944|resynchronization|resynchronization
1409346|NCT01126944|left ventricular assist device|left ventricular assist device
1409347|NCT01126931|Crohn disease|crohn disease
1409348|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
1409349|NCT01126931|IgA nephropathy|iga nephropathy
1409350|NCT01126931|Depression with reduced appetite|depression with reduced appetite
1409351|NCT01126918|Eating Disorders|eating disorders
1409352|NCT01126918|Obesity|obesity
1409353|NCT01126918|Body Dissatisfaction|body dissatisfaction
1409354|NCT01126918|Female|female
1409355|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
1409356|NCT01126905|Functional Iron Deficiency|functional iron deficiency
1409357|NCT01126905|Response to therapy|response to therapy
1409358|NCT01126905|Iron deficiency|iron deficiency
1409359|NCT01126892|Advanced Disease,|advanced disease,
1409360|NCT01126892|Resistance,|resistance,
1409361|NCT01126892|Intolerance|intolerance
1409362|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
1409363|NCT01126866|CRC|crc
1409364|NCT01126866|UICC Stages IV|uicc stages iv
1409365|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
1409366|NCT01126853|Immunization|immunization
1409367|NCT01126853|Immunity|immunity
1409368|NCT01126853|Prevention|prevention
1409369|NCT01126840|Lynch Syndrome|lynch syndrome
1409370|NCT01126840|Families|families
1409371|NCT01126840|Quality of life|quality of life
1409372|NCT01126840|QOL|qol
1409373|NCT01126840|First-degree relatives|first-degree relatives
1409374|NCT01126840|Questionnaire|questionnaire
1409375|NCT01126840|Interview|interview
1409376|NCT01126827|Bipolar Disorder|bipolar disorder
1409377|NCT01126827|Mood Disorders|mood disorders
1409378|NCT01126827|Residual Symptoms|residual symptoms
1409379|NCT01126827|Depression|depression
1409380|NCT01126827|Mania|mania
1409381|NCT01126827|Hypomania|hypomania
1409382|NCT01126827|Bipolar|bipolar
1409383|NCT01126827|Bipolar I|bipolar i
1409384|NCT01126827|Bipolar II|bipolar ii
1409385|NCT01126814|Gleevec|gleevec
1409386|NCT01126814|c-kit|c-kit
1409388|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
1409389|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
1409390|NCT01126762|fish|fish
1409391|NCT01126762|pregnancy|pregnancy
1409392|NCT01126762|methylmercury|methylmercury
1409393|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
1409484|NCT01126242|ligament injuries|ligament injuries
1409485|NCT01126242|non-surgical treatment|non-surgical treatment
1409486|NCT01126242|tape|tape
1409394|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
1409395|NCT01126736|neoplams|neoplams
1409396|NCT01126736|lung neoplasms|lung neoplasms
1409397|NCT01126736|Stage IIIB|stage iiib
1409398|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
1409399|NCT01126710|infiltration|infiltration
1409400|NCT01126710|extravasation|extravasation
1409401|NCT01126710|optical monitoring|optical monitoring
1409402|NCT01126697|Cardiac|cardiac
1409403|NCT01126697|Muscular Dystrophy|muscular dystrophy
1409404|NCT01126697|Randomized|randomized
1409405|NCT01126684|essential hypertension|essential hypertension
1409406|NCT01126671|vitamin D|vitamin d
1409407|NCT01126658|pressure-volume curve|pressure-volume curve
1409408|NCT01126658|intracranial pressure|intracranial pressure
1409409|NCT01126658|volume pressure response|volume pressure response
1409410|NCT01126658|pressure-volume relationship|pressure-volume relationship
1409411|NCT01126658|mathematical model|mathematical model
1409412|NCT01126645|Liver|liver
1409414|NCT01126632|Colonoscopy|colonoscopy
1409415|NCT01126619|Psoriasis|psoriasis
1409416|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
1409417|NCT01126554|Prognostic value|prognostic value
1409418|NCT01126528|Vitamin D|vitamin d
1409419|NCT01126528|cholecalciferol|cholecalciferol
1409420|NCT01126528|Micronutrients|micronutrients
1409421|NCT01126528|Developing countries|developing countries
1409422|NCT01126528|Bangladesh|bangladesh
1409423|NCT01126528|Infant, Newborn|infant, newborn
1409424|NCT01126528|Reproductive Health|reproductive health
1409425|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
1409426|NCT01126528|Perinatology|perinatology
1409427|NCT01126528|Immunology|immunology
1409428|NCT01126528|cathelicidin|cathelicidin
1409429|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
1409430|NCT01126515|brain injury|brain injury
1409431|NCT01126515|sequelae|sequelae
1409432|NCT01126515|stroke|stroke
1409433|NCT01126515|anoxia|anoxia
1409434|NCT01126515|trauma|trauma
1409435|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
1409436|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
1409437|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
1409438|NCT01126463|lipiodol|lipiodol
1409439|NCT01126463|rhenium|rhenium
1409440|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
1409441|NCT01126450|recurrent colon cancer|recurrent colon cancer
1409442|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
1409443|NCT01126424|Anti-muscarinics|anti-muscarinics
1409444|NCT01126424|Anti-cholinergics|anti-cholinergics
1409445|NCT01126424|Cognition|cognition
1409446|NCT01126424|Solifenacin|solifenacin
1409447|NCT01126411|pulmonary hypertension|pulmonary hypertension
1409448|NCT01126411|autoantibodies|autoantibodies
1409449|NCT01126411|immunoadsorption|immunoadsorption
1409450|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
1409451|NCT01126411|right ventricular function|right ventricular function
1409452|NCT01126385|Spinal Diseases|spinal diseases
1409453|NCT01126385|Bone strength|bone strength
1409454|NCT01126385|Transpedicular fixation|transpedicular fixation
1409455|NCT01126385|Dorsal instrumentation|dorsal instrumentation
1409456|NCT01126385|DensiProbe|densiprobe
1409457|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
1409458|NCT01126372|Prematurity|prematurity
1409459|NCT01126372|Feeding intolerances|feeding intolerances
1409460|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
1409461|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
1409462|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
1409463|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
1409464|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
1409465|NCT01126359|Lidocaine|lidocaine
1409466|NCT01126359|Dressing change|dressing change
1409467|NCT01126359|Pain management|pain management
1409468|NCT01126359|palliative care|palliative care
1409469|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
1409470|NCT01126333|Kidney transplant survival.|kidney transplant survival.
1409472|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
1409473|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
1409474|NCT01126268|Eczema|eczema
1409475|NCT01126268|Atopic dermatitis|atopic dermatitis
1409476|NCT01126268|Infection|infection
1409477|NCT01126268|Impetigo|impetigo
1409478|NCT01126268|Folliculitis|folliculitis
1409479|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
1409480|NCT01126255|progesterone|progesterone
1409481|NCT01126255|clobetasol|clobetasol
1409482|NCT01126255|randomized controlled trial|randomized controlled trial
1409487|NCT01126242|brace|brace
1409488|NCT01126242|orthotic device|orthotic device
1409489|NCT01126242|bandage|bandage
1409490|NCT01126242|cost-effectiveness|cost-effectiveness
1409491|NCT01126242|randomized trial|randomized trial
1409492|NCT01126229|Resveratrol|resveratrol
1409493|NCT01126229|Grape|grape
1409494|NCT01126229|Aging|aging
1409495|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
1409496|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
1409497|NCT01126229|Oxidative Stress|oxidative stress
1409498|NCT01126229|Functional Performance|functional performance
1409499|NCT01126216|Radiochemotherapy|radiochemotherapy
1409500|NCT01126216|head and neck cancer|head and neck cancer
1409501|NCT01126216|Paclitaxel|paclitaxel
1409502|NCT01126216|Cisplatin|cisplatin
1409503|NCT01126216|5-FU|5-fu
1409504|NCT01126203|Pseudoexfoliation|pseudoexfoliation
1409505|NCT01126203|Glaucoma|glaucoma
1409506|NCT01126203|Ocular Hypertension|ocular hypertension
1409508|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
1409509|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
1409510|NCT01126177|asthma|asthma
1409511|NCT01126164|parents|parents
1409512|NCT01126164|peer|peer
1409513|NCT01126164|basics|basics
1409514|NCT01126164|college student drinking|college student drinking
1409515|NCT01126151|drinking|drinking
1409516|NCT01126151|alcohol consequences|alcohol consequences
1409517|NCT01126138|unresectable|unresectable
1409518|NCT01126138|locally advanced|locally advanced
1409519|NCT01126138|metastatic|metastatic
1409520|NCT01126138|breast cancer|breast cancer
1409521|NCT01126125|iodine|iodine
1409522|NCT01126125|infant|infant
1409523|NCT01126125|breastfeeding|breastfeeding
1409524|NCT01126125|deficiency|deficiency
1409525|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
1409526|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
1409527|NCT01126099|double-blind|double-blind
1409528|NCT01126099|treatment|treatment
1409529|NCT01126099|prazosin|prazosin
1409530|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
1409531|NCT01126073|niacin/laropiprant|niacin/laropiprant
1409532|NCT01126073|endothelial function|endothelial function
1409533|NCT01126060|Neck dissection|neck dissection
1409534|NCT01126047|Lung Diseases|lung diseases
1409535|NCT01126034|Metoclopramide|metoclopramide
1409536|NCT01126034|Randomized Controlled Trial|randomized controlled trial
1409537|NCT01126021|Senior citizens|senior citizens
1409538|NCT01126021|mental acuity|mental acuity
1409539|NCT01126021|memory|memory
1409540|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
1409541|NCT01125995|limited disease|limited disease
1409542|NCT01125969|diabetes|diabetes
1409543|NCT01125969|glucose|glucose
1409544|NCT01125969|peer mentor|peer mentor
1409545|NCT01125969|incentives|incentives
1409546|NCT01125969|behavioral economics|behavioral economics
1409547|NCT01125969|cost-effectiveness|cost-effectiveness
1409548|NCT01125956|Diabetes|diabetes
1409549|NCT01125956|Diabetes mellitus|diabetes mellitus
1409550|NCT01125956|HbA1c|hba1c
1409551|NCT01125930|rosacea|rosacea
1409552|NCT01125930|tretinoin|tretinoin
1409553|NCT01125930|atralin|atralin
1409554|NCT01125917|Low back pain|low back pain
1409555|NCT01125917|Opioid|opioid
1409556|NCT01125917|Transdermal|transdermal
1409557|NCT01125904|Crizotinib|crizotinib
1409558|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
1409559|NCT01125891|Gemzar|gemzar
1409560|NCT01125891|ON 01910.Na|on 01910.na
1409561|NCT01125878|satiety|satiety
1409562|NCT01125878|appetite|appetite
1409563|NCT01125878|fiber|fiber
1409564|NCT01125878|starch|starch
1409565|NCT01125878|nutrition|nutrition
1409566|NCT01125865|Malignant hilar stricture|malignant hilar stricture
1409567|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
1409568|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
1409569|NCT01125852|Angiographic embolization|angiographic embolization
1409570|NCT01125852|Arterial embolization|arterial embolization
1409571|NCT01125852|Angiography|angiography
1409572|NCT01125839|osteomyelitis|osteomyelitis
1409573|NCT01125839|16S rRNA|16s rrna
1409574|NCT01125839|spine|spine
1409575|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
1409576|NCT01125800|Recurrent,|recurrent,
1409577|NCT01125800|refractory,|refractory,
1409578|NCT01125800|medulloblastoma,|medulloblastoma,
1409579|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
1409580|NCT01125800|neuroblastoma,|neuroblastoma,
1409581|NCT01125800|hepatoblastoma,|hepatoblastoma,
1409582|NCT01125800|astrocytoma,|astrocytoma,
1409583|NCT01125800|children,|children,
1409584|NCT01125800|pediatric,|pediatric,
1409585|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
1409586|NCT01125787|CLL|cll
1409587|NCT01125787|bendamustine|bendamustine
1409588|NCT01125787|ofatumumab|ofatumumab
1409589|NCT01125787|blood cancer|blood cancer
1409590|NCT01125787|leukemia|leukemia
1409591|NCT01125787|lymphocyte|lymphocyte
1409592|NCT01125787|hematology|hematology
1409593|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
1409594|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
1409595|NCT01125787|nevada cancer institute|nevada cancer institute
1409596|NCT01125787|cephalon|cephalon
1409597|NCT01125787|Glaxosmithkline|glaxosmithkline
1409598|NCT01125774|Menstrually related migraine|menstrually related migraine
1409599|NCT01125774|migraine|migraine
1409600|NCT01125774|Premenstrual migraine|premenstrual migraine
1409601|NCT01125761|Allergic dermatitis|allergic dermatitis
1409602|NCT01125722|Urinary Incontinence|urinary incontinence
1409603|NCT01125722|Overactive Bladder|overactive bladder
1409604|NCT01125722|Frequency|frequency
1409605|NCT01125722|Urgency|urgency
1409606|NCT01125709|Neuromuscular disease|neuromuscular disease
1409607|NCT01125709|Duchenne|duchenne
1409608|NCT01125709|Muscular Dystrophy|muscular dystrophy
1409609|NCT01125709|DMD|dmd
1409610|NCT01125709|Strength assessment|strength assessment
1409611|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
1409612|NCT01125709|CQMS|cqms
1409613|NCT01125709|Hand Held Myometry|hand held myometry
1409614|NCT01125709|HHM|hhm
1409615|NCT01125696|mother-to-child transmission|mother-to-child transmission
1409616|NCT01125696|HIV|hiv
1409617|NCT01125696|Hepatitis B|hepatitis b
1409618|NCT01125696|Pregnant women|pregnant women
1409619|NCT01125696|Tenofovir|tenofovir
1409620|NCT01125696|Infants|infants
1409621|NCT01125683|Phase II|phase ii
1409622|NCT01125683|Alzheimer's disease|alzheimer's disease
1409623|NCT01125683|EEG|eeg
1409624|NCT01125683|cognition|cognition
1409625|NCT01125683|pharmacodynamic|pharmacodynamic
1409626|NCT01125670|YM150|ym150
1409627|NCT01125670|Food effect|food effect
1409628|NCT01125657|YM150|ym150
1409629|NCT01125657|bioequivalence study|bioequivalence study
1409630|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
1409631|NCT01125631|Alzheimer's disease|alzheimer's disease
1409632|NCT01125631|amyloid|amyloid
1409633|NCT01125631|antibody|antibody
1409634|NCT01125631|Japanese|japanese
1409635|NCT01125618|child mortality|child mortality
1409636|NCT01125618|intervention|intervention
1409637|NCT01125618|Poverty|poverty
1409638|NCT01125618|Africa|africa
1409639|NCT01125618|Millennium Development Goal|millennium development goal
1409640|NCT01125618|Millennium Development Goals|millennium development goals
1409641|NCT01125605|PASCONAL|pasconal
1409642|NCT01125605|nervousness|nervousness
1409643|NCT01125605|nervosity|nervosity
1409644|NCT01125605|sleep disorder|sleep disorder
1409645|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
1409646|NCT01125579|nervousness|nervousness
1409647|NCT01125579|restlessness|restlessness
1409648|NCT01125579|depression|depression
1409649|NCT01125579|affective disorder|affective disorder
1409650|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
1409651|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
1409652|NCT01125527|Vaccine|vaccine
1409653|NCT01125527|Anti PRP antibody|anti prp antibody
1409654|NCT01125514|Heart failure,|heart failure,
1409655|NCT01125514|aliskiren,|aliskiren,
1409656|NCT01125514|furosemide,|furosemide,
1409657|NCT01125514|diuretic efficacy,|diuretic efficacy,
1409658|NCT01125514|interaction|interaction
1409659|NCT01125488|Maintenance therapy|maintenance therapy
1409660|NCT01125488|LNG-IUS|lng-ius
1409661|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
1409662|NCT01125488|Recurrence|recurrence
1409663|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1409664|NCT01125475|RebiSmart|rebismart
1409665|NCT01125475|Rebif|rebif
1409666|NCT01125475|Adherence|adherence
1409667|NCT01125462|Ovulation Induction|ovulation induction
1409668|NCT01125462|Infertility|infertility
1409669|NCT01125462|Gonal-f|gonal-f
1409670|NCT01125462|FertiQoL|fertiqol
1409671|NCT01125462|Quality of Life|quality of life
1409672|NCT01125449|ascorbic acid|ascorbic acid
1409673|NCT01125449|vitamin C|vitamin c
1409674|NCT01125449|antioxidants|antioxidants
1409675|NCT01125449|vitamins|vitamins
1409676|NCT01125423|Female|female
1409677|NCT01125423|age 18 to 70|age 18 to 70
1409678|NCT01125410|Fluomizin|fluomizin
1409679|NCT01125410|Dequalinium chloride|dequalinium chloride
1409680|NCT01125410|Bacterial vaginosis|bacterial vaginosis
1409681|NCT01125410|vaginal therapy|vaginal therapy
1409682|NCT01125397|bariatric surgery|bariatric surgery
1409683|NCT01125397|behavioral weight management|behavioral weight management
1409684|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
1409685|NCT01125371|Hazardous alcohol use|hazardous alcohol use
1409686|NCT01125371|Binge drinking|binge drinking
1409687|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
1409688|NCT01125371|HIV risk reduction|hiv risk reduction
1409689|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
1409690|NCT01125345|PCO|pco
1409691|NCT01125345|posterior capsule opacification|posterior capsule opacification
1409692|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
1409693|NCT01125306|Drug consumption|drug consumption
1409694|NCT01125306|The Xal-Ease device|the xal-ease device
1409695|NCT01125306|Patient's compliance|patient's compliance
1409696|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
1409697|NCT01125293|everolimus|everolimus
1409698|NCT01125293|rituximab|rituximab
1409699|NCT01125293|bortezomib|bortezomib
1409700|NCT01125293|RAD001|rad001
1409701|NCT01125293|Rituxan|rituxan
1409702|NCT01125293|Velcade|velcade
1409703|NCT01125280|Small bowel occlusion|small bowel occlusion
1409704|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
1409705|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
1409706|NCT01125280|Small bowel resection|small bowel resection
1409707|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
1409708|NCT01125267|medication adherence|medication adherence
1409709|NCT01125267|schizophrenia|schizophrenia
1409710|NCT01125267|Mexican American|mexican american
1409711|NCT01125267|multifamily groups|multifamily groups
1409712|NCT01125254|thalassemia major|thalassemia major
1409713|NCT01125254|calcium channel blockade|calcium channel blockade
1409714|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
1409715|NCT01125241|wuling capsule|wuling capsule
1409716|NCT01125241|epilepsy|epilepsy
1409717|NCT01125241|depression|depression
1409718|NCT01125241|superiority clinical research|superiority clinical research
1409719|NCT01125228|AIDS|aids
1409720|NCT01125228|Antiretroviral|antiretroviral
1409721|NCT01125228|Kaposi's Sarcoma|kaposi's sarcoma
1409722|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
1409723|NCT01125215|Capsaicin|capsaicin
1409724|NCT01125215|Nanoparticle|nanoparticle
1409725|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
1409726|NCT01125202|Intervention studies|intervention studies
1409727|NCT01125202|Computers, handheld|computers, handheld
1409728|NCT01125202|Randomized controlled trial|randomized controlled trial
1409729|NCT01125202|Sodium, dietary|sodium, dietary
1409730|NCT01125176|CLL|cll
1409731|NCT01125163|very low birth weight infants|very low birth weight infants
1409732|NCT01125163|anemia|anemia
1409733|NCT01125163|iron supplementation|iron supplementation
1409734|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
1409735|NCT01125137|Keloid|keloid
1409736|NCT01125137|MMP|mmp
1409737|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
1409738|NCT01125137|dermatology|dermatology
1409739|NCT01125124|Pleurodesis|pleurodesis
1409740|NCT01125124|Malignant pleural effusion|malignant pleural effusion
1409741|NCT01125124|Silver Nitrate|silver nitrate
1409742|NCT01125124|Pain|pain
1409743|NCT01125098|COPD|copd
1409744|NCT01125098|PRO-CT|pro-ct
1409745|NCT01125098|antibiotics|antibiotics
1409746|NCT01125085|I131|i131
1409747|NCT01125085|L19|l19
1409748|NCT01125085|antibody|antibody
1409749|NCT01125085|monoclonal|monoclonal
1409750|NCT01125085|multiple brain metastasis|multiple brain metastasis
1409751|NCT01125085|tumor targeting|tumor targeting
1409752|NCT01125085|radioimmunotherapy|radioimmunotherapy
1409753|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
1409754|NCT01125072|chest pain|chest pain
1409755|NCT01125072|echocardiography|echocardiography
1409756|NCT01125072|strain imaging|strain imaging
1409757|NCT01125059|hydromorphone|hydromorphone
1409758|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
1409759|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
1409760|NCT01125059|Spinal Fusion|spinal fusion
1409761|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
1409762|NCT01125007|Dental plaque|dental plaque
1409763|NCT01125007|Gingival abrasion|gingival abrasion
1409764|NCT01125007|toothbrushing|toothbrushing
1409765|NCT01124994|Barrett's oesophagus|barrett's oesophagus
1409766|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
1409767|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
1409768|NCT01124981|Coagulopathy|coagulopathy
1409769|NCT01124968|User-Computer Interface|user-computer interface
1409770|NCT01124968|Office Visits|office visits
1409771|NCT01124968|Primary Health Care|primary health care
1409772|NCT01124968|Patient Satisfaction|patient satisfaction
1409773|NCT01124968|Job Satisfaction|job satisfaction
1409774|NCT01124968|Health Services Research|health services research
1409775|NCT01124955|treatment|treatment
1409776|NCT01124955|acupuncture|acupuncture
1409777|NCT01124955|spine|spine
1409778|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
1409779|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
1409780|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
1409781|NCT01124916|incontinence|incontinence
1409782|NCT01124916|prolapse|prolapse
1409783|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
1409784|NCT01124903|dehydration|dehydration
1409785|NCT01124903|hypohydration|hypohydration
1409786|NCT01124903|diagnostic accuracy|diagnostic accuracy
1409787|NCT01124903|biological variation|biological variation
1409788|NCT01124903|hydration assessment|hydration assessment
1409789|NCT01124903|body mass|body mass
1409790|NCT01124903|osmolality|osmolality
1409791|NCT01124903|plasma|plasma
1409792|NCT01124903|saliva|saliva
1409793|NCT01124903|urine|urine
1409794|NCT01124890|acute myocardial infarction|acute myocardial infarction
1409795|NCT01124890|thrombolysis|thrombolysis
1409796|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
1409797|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
1409798|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
1409799|NCT01124864|HSP90|hsp90
1410186|NCT01123421|aging|aging
1409800|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
1409801|NCT01124851|Sleep disorder|sleep disorder
1409802|NCT01124838|Uveitis|uveitis
1409803|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
1409804|NCT01124825|Surgery|surgery
1409805|NCT01124812|I131|i131
1409806|NCT01124812|L19|l19
1409807|NCT01124812|antibody|antibody
1409808|NCT01124812|monoclonal|monoclonal
1409809|NCT01124812|NSCLC|nsclc
1409810|NCT01124812|lung|lung
1409811|NCT01124812|tumor targeting|tumor targeting
1409812|NCT01124812|radioimmunotherapy|radioimmunotherapy
1409813|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
1409814|NCT01124799|Hepatitis C virus|hepatitis c virus
1409815|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
1409816|NCT01124799|TMC435-C125|tmc435-c125
1409817|NCT01124799|TMC435|tmc435
1409818|NCT01124799|TMC435350|tmc435350
1409819|NCT01124799|protease inhibitor|protease inhibitor
1409820|NCT01124799|HCV|hcv
1409821|NCT01124799|Hepatitis C|hepatitis c
1409822|NCT01124799|photosensitivity|photosensitivity
1409823|NCT01124799|phototoxicity|phototoxicity
1409824|NCT01124786|cancer|cancer
1409825|NCT01124786|metastatic|metastatic
1409826|NCT01124786|pancreatic|pancreatic
1409827|NCT01124786|pancreas|pancreas
1409828|NCT01124786|adenocarcinoma|adenocarcinoma
1409829|NCT01124786|gemcitabine|gemcitabine
1409830|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
1409831|NCT01124786|CO-1.01|co-1.01
1409832|NCT01124786|CO-101|co-101
1409833|NCT01124786|CO101|co101
1409834|NCT01124786|Stage 4|stage 4
1409835|NCT01124786|Stage IV|stage iv
1409836|NCT01124773|cognition|cognition
1409837|NCT01124773|memory|memory
1409838|NCT01124773|hormone therapy|hormone therapy
1409839|NCT01124760|open label|open label
1409840|NCT01124760|2-consecutive-group|2-consecutive-group
1409841|NCT01124760|2-period|2-period
1409842|NCT01124760|1-sequence crossover study|1-sequence crossover study
1409843|NCT01124747|ASP1585|asp1585
1409844|NCT01124747|Healthy Volunteers|healthy volunteers
1409845|NCT01124734|metastatic melanoma|metastatic melanoma
1409846|NCT01124721|Cognitive training|cognitive training
1409847|NCT01124708|ADHD|adhd
1409848|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
1409849|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1409850|NCT01124695|male breast cancer|male breast cancer
1409851|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1409852|NCT01124695|recurrent breast cancer|recurrent breast cancer
1409853|NCT01124695|stage IV breast cancer|stage iv breast cancer
1409854|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1409855|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1409856|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1409857|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
1409858|NCT01124682|stage II bladder cancer|stage ii bladder cancer
1409859|NCT01124682|stage III bladder cancer|stage iii bladder cancer
1568281|NCT00506415|Cognitive|cognitive
1409860|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
1409861|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1409862|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1409863|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1409864|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
1409865|NCT01124656|thiazolidinediones|thiazolidinediones
1409866|NCT01124656|combination|combination
1409867|NCT01124656|Actos|actos
1409868|NCT01124656|HbA1c|hba1c
1409869|NCT01124656|Type 2 diabetes|type 2 diabetes
1409870|NCT01124656|Drug Therapy|drug therapy
1409871|NCT01124656|Hypertension|hypertension
1409872|NCT01124643|Replagal|replagal
1409873|NCT01124643|Agalsidase alfa|agalsidase alfa
1409874|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
1409875|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
1409876|NCT01124617|Chronic pain|chronic pain
1409877|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
1409878|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
1409879|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
1409880|NCT01124617|JNS024ER|jns024er
1409881|NCT01124617|Placebo|placebo
1409882|NCT01124604|Pain|pain
1409883|NCT01124604|Low Back Pain|low back pain
1409884|NCT01124604|Back Pain|back pain
1409885|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
1409886|NCT01124604|Tapentadol|tapentadol
1409887|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
1409888|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
1409889|NCT01124565|Lateral Canthal Lines|lateral canthal lines
1409890|NCT01124565|Crow's Feet|crow's feet
1409891|NCT01124565|Facial Wrinkles|facial wrinkles
1409892|NCT01124552|Lateral Canthal Lines|lateral canthal lines
1409893|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
1409894|NCT01124552|Facial Wrinkles|facial wrinkles
1409895|NCT01124539|Adult Patients|adult patients
1409896|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
1409897|NCT01124539|Recurrence of GBM|recurrence of gbm
1409898|NCT01124539|Gliosarcoma|gliosarcoma
1409899|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
1409900|NCT01124513|Melanin Index|melanin index
1409901|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
1409902|NCT01124513|Videodermoscopy|videodermoscopy
1409903|NCT01124513|Spectrophotometry|spectrophotometry
1409904|NCT01124500|methylphenidate|methylphenidate
1409905|NCT01124500|transdermal patch|transdermal patch
1409906|NCT01124500|placebo|placebo
1409907|NCT01124500|fatigue|fatigue
1409908|NCT01124500|10-020|10-020
1409909|NCT01124487|fat|fat
1409910|NCT01124487|inflammation|inflammation
1409911|NCT01124487|lipids|lipids
1409912|NCT01124487|total cholesterol|total cholesterol
1409913|NCT01124487|Triglycerides|triglycerides
1409914|NCT01124487|insulin sensitivity|insulin sensitivity
1409915|NCT01124461|Malignant Brain Tumors|malignant brain tumors
1409916|NCT01124461|Cancer of the Brain|cancer of the brain
1409917|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
1409918|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
1409919|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
1409920|NCT01124435|tumor response rate|tumor response rate
1409921|NCT01124435|toxicity|toxicity
1409922|NCT01124435|progression free survival|progression free survival
1409923|NCT01124435|duration of response|duration of response
1409924|NCT01124435|quality of life|quality of life
1409925|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
1409926|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1409927|NCT01124422|fluticasone propionate|fluticasone propionate
1409928|NCT01124422|dyspnea|dyspnea
1409929|NCT01124422|exercise endurance time|exercise endurance time
1409930|NCT01124422|tiotropium|tiotropium
1409931|NCT01124422|salmeterol|salmeterol
1409932|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
1409933|NCT01124422|quality of life|quality of life
1409934|NCT01124409|IGRT|igrt
1409935|NCT01124409|3DCRT|3dcrt
1409936|NCT01124409|EPID|epid
1409937|NCT01124409|CBCT|cbct
1409938|NCT01124409|HNSCC|hnscc
1409939|NCT01124383|Glycine absorption|glycine absorption
1409940|NCT01124383|Operative hysteroscopy|operative hysteroscopy
1409941|NCT01124383|Endometrial resection|endometrial resection
1409942|NCT01124383|General anesthesia|general anesthesia
1409943|NCT01124383|Local anesthesia|local anesthesia
1409944|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
1409945|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
1409946|NCT01124370|Periodic Breathing|periodic breathing
1409947|NCT01124370|Sleep Apnea|sleep apnea
1409948|NCT01124370|Central Sleep Apnea|central sleep apnea
1409949|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
1409950|NCT01124357|menorrhagia|menorrhagia
1409951|NCT01124357|ThermachoiceTM|thermachoicetm
1409952|NCT01124357|NovaSureTM|novasuretm
1409953|NCT01124357|Endometrail Ablation|endometrail ablation
1409954|NCT01124331|prospective meta-analysis|prospective meta-analysis
1409955|NCT01124331|preterm infant|preterm infant
1409956|NCT01124331|pulse oximetry|pulse oximetry
1409957|NCT01124331|oxygen saturation|oxygen saturation
1409958|NCT01124318|Lactofiltrum|lactofiltrum
1409959|NCT01124318|atopic dermatitis|atopic dermatitis
1409961|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
1409962|NCT01124318|SCORAD|scorad
1409963|NCT01124318|Behavioral Rating Scores|behavioral rating scores
1409964|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
1409965|NCT01124305|Instrumentation|instrumentation
1409966|NCT01124292|Disability|disability
1409967|NCT01124292|Quadriplegia|quadriplegia
1409968|NCT01124292|Paralysis|paralysis
1409969|NCT01124292|Assistive technology|assistive technology
1409970|NCT01124292|Quality of life|quality of life
1409971|NCT01124292|Computer access|computer access
1409972|NCT01124292|Wheeled mobility|wheeled mobility
1409973|NCT01124279|Amgen|amgen
1409974|NCT01124279|Healthy|healthy
1409975|NCT01124279|Adult|adult
1409976|NCT01124266|polyp|polyp
1409977|NCT01124266|adenoma|adenoma
1409978|NCT01124266|screening|screening
1409979|NCT01124266|colonoscopy|colonoscopy
1409980|NCT01124266|diagnosis|diagnosis
1409981|NCT01124253|adjuvant therapy|adjuvant therapy
1409982|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
1409983|NCT01124253|vinorelbine|vinorelbine
1409984|NCT01124253|cisplatin|cisplatin
1409985|NCT01124253|recombinant human endostatin|recombinant human endostatin
1409986|NCT01124253|endostar|endostar
1409987|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
1409988|NCT01124227|Congestive Heart Failure|congestive heart failure
1409989|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
1409990|NCT01124227|Symptomatic improvement|symptomatic improvement
1409991|NCT01124227|Renal function|renal function
1409992|NCT01124214|Barrett's|barrett's
1409993|NCT01124214|BE|be
1409994|NCT01124214|esophageal cancer|esophageal cancer
1409995|NCT01124214|esophageal dysplasia|esophageal dysplasia
1409996|NCT01124201|low back pain|low back pain
1409997|NCT01124201|clinical trial|clinical trial
1409998|NCT01124201|stabilization|stabilization
1409999|NCT01124201|muscle stretching exercises|muscle stretching exercises
1410000|NCT01124201|exercise therapy|exercise therapy
1410001|NCT01124188|Geriatric psychiatry|geriatric psychiatry
1410002|NCT01124188|Aged|aged
1410003|NCT01124188|Elderly|elderly
1410004|NCT01124188|Venlafaxine|venlafaxine
1410005|NCT01124188|Self efficacy|self efficacy
1410006|NCT01124188|Pain|pain
1410007|NCT01124188|Psychotherapy|psychotherapy
1410008|NCT01124188|Effexor|effexor
1410009|NCT01124175|Bioequivalence|bioequivalence
1410010|NCT01124175|Healthy Subjects|healthy subjects
1410011|NCT01124162|Bioequivalence|bioequivalence
1410012|NCT01124162|Healthy Subjects|healthy subjects
1410013|NCT01124136|Chronic Heart Failure|chronic heart failure
1410014|NCT01124136|Neurostimulation|neurostimulation
1410015|NCT01124123|Pharmacokinetics|pharmacokinetics
1410016|NCT01124123|Oral bioavailability|oral bioavailability
1410017|NCT01124123|absorption|absorption
1410018|NCT01124123|AUC|auc
1410019|NCT01124123|Bioequivalence|bioequivalence
1410020|NCT01124123|Bioavailability study|bioavailability study
1410021|NCT01124110|Operating Engineers|operating engineers
1410022|NCT01124110|Smoking Cessation|smoking cessation
1410023|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
1410024|NCT01124071|Korean Diet|korean diet
1410025|NCT01124058|restarting warfarin|restarting warfarin
1410026|NCT01124058|time to therapeutic INR|time to therapeutic inr
1410027|NCT01124045|Pediatric|pediatric
1410028|NCT01124045|Cataracts|cataracts
1410029|NCT01124045|Inflammation|inflammation
1410030|NCT01124045|Durezol|durezol
1410031|NCT01124045|Pred Forte|pred forte
1410032|NCT01124045|Difluprednate|difluprednate
1410033|NCT01124045|Prednisolone|prednisolone
1410034|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
1410035|NCT01123993|Thai traditional music|thai traditional music
1410036|NCT01123993|dementia|dementia
1410037|NCT01123993|Cognitive function|cognitive function
1410038|NCT01123993|behavioural problem|behavioural problem
1410039|NCT01123993|sleep quality|sleep quality
1410040|NCT01123993|psychological health|psychological health
1410041|NCT01123993|quality of sleep|quality of sleep
1410042|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
1410043|NCT01123967|smoking cessation|smoking cessation
1410044|NCT01123967|tobacco dependent|tobacco dependent
1410045|NCT01123954|Seasonal influenza|seasonal influenza
1410046|NCT01123954|Vaccine|vaccine
1410047|NCT01123941|Typhoid fever|typhoid fever
1410048|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
1410049|NCT01123941|Carrier protein|carrier protein
1410050|NCT01123941|Immunogenicity|immunogenicity
1410051|NCT01123928|cataract|cataract
1410052|NCT01123928|counseling|counseling
1410053|NCT01123928|surgical uptake|surgical uptake
1410054|NCT01123928|follow-up|follow-up
1410055|NCT01123915|HIV|hiv
1410056|NCT01123915|Therapeutic|therapeutic
1410057|NCT01123915|Immunotherapy|immunotherapy
1410058|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1410059|NCT01123915|Virus Diseases|virus diseases
1410060|NCT01123915|Lentivirus Infections|lentivirus infections
1410061|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
1410062|NCT01123902|Breathlessness|breathlessness
1410063|NCT01123902|Dyspnea|dyspnea
1410064|NCT01123902|Hand-held fan|hand-held fan
1410065|NCT01123902|Palliative Care|palliative care
1410066|NCT01123889|subacromial impingement|subacromial impingement
1410067|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
1410068|NCT01123889|PRP|prp
1410069|NCT01123889|platelet rich plasma|platelet rich plasma
1410070|NCT01123876|Gastric Cancer|gastric cancer
1410071|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
1410072|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
1410073|NCT01123850|CopiOs|copios
1410074|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
1410075|NCT01123850|stenosis with instability, or|stenosis with instability, or
1410076|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
1410077|NCT01123824|healthy subjects|healthy subjects
1410078|NCT01123811|adenocarcinoma|adenocarcinoma
1410079|NCT01123811|gastric cancer|gastric cancer
1410080|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
1410081|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
1410082|NCT01123798|lower extremity injury|lower extremity injury
1410083|NCT01123785|glaucoma|glaucoma
1410084|NCT01123785|ocular hypertension|ocular hypertension
1410085|NCT01123785|adenosine agonist|adenosine agonist
1410086|NCT01123785|eye drop|eye drop
1410087|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
1410088|NCT01123772|adenosine agonist|adenosine agonist
1410089|NCT01123772|eye drop|eye drop
1410090|NCT01123772|elderly volunteer|elderly volunteer
1410091|NCT01123772|older healthy volunteer|older healthy volunteer
1410092|NCT01123759|Fish|fish
1410093|NCT01123759|mercury|mercury
1410094|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
1410095|NCT01123759|infant|infant
1410096|NCT01123759|brain development|brain development
1410097|NCT01123759|pregnancy|pregnancy
1410098|NCT01123759|nursing mother|nursing mother
1410099|NCT01123759|dietary recommendations|dietary recommendations
1410100|NCT01123759|Hair mercury|hair mercury
1410101|NCT01123759|Blood mercury|blood mercury
1410102|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
1410103|NCT01123759|Infant brain health|infant brain health
1410104|NCT01123746|Seizure|seizure
1410105|NCT01123746|electrolyte|electrolyte
1410106|NCT01123746|risk factor|risk factor
1410107|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
1410108|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
1410109|NCT01123733|Breastfeeding|breastfeeding
1410110|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
1410111|NCT01123707|Major Depressive Disorder|major depressive disorder
1410112|NCT01123707|MDD|mdd
1410113|NCT01123707|Depression|depression
1410114|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
1410115|NCT01123694|quality of life|quality of life
1410116|NCT01123694|DLQI|dlqi
1410117|NCT01123694|CDLQI|cdlqi
1410118|NCT01123681|Respiration, Artificial|respiration, artificial
1410119|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
1410120|NCT01123681|Critical Illness|critical illness
1410121|NCT01123668|Smoking|smoking
1410122|NCT01123668|ADHD|adhd
1410123|NCT01123668|Nicotine|nicotine
1410124|NCT01123668|Methylphenidate|methylphenidate
1410125|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
1410251|NCT01123161|Vascular Diseases|vascular diseases
1410126|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
1410127|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
1410128|NCT01123642|depressive disorder|depressive disorder
1410129|NCT01123642|alcoholism|alcoholism
1410130|NCT01123642|Longitudinal studies|longitudinal studies
1410131|NCT01123642|readjustment|readjustment
1410132|NCT01123616|surgical site infection|surgical site infection
1410133|NCT01123616|elective colorectal surgery|elective colorectal surgery
1410134|NCT01123616|level of surgical site infection|level of surgical site infection
1410135|NCT01123616|complication of surgical site infection|complication of surgical site infection
1410136|NCT01123616|type of changed bandage|type of changed bandage
1410137|NCT01123616|frequency of bandage changing|frequency of bandage changing
1410138|NCT01123603|frequency|frequency
1410139|NCT01123603|women|women
1410140|NCT01123603|fibroids|fibroids
1410141|NCT01123603|uterine artery embolization|uterine artery embolization
1410142|NCT01123603|myomectomy|myomectomy
1410143|NCT01123603|hysterectomy|hysterectomy
1410144|NCT01123590|Thymoma|thymoma
1410145|NCT01123590|Autoimmune diseases|autoimmune diseases
1410146|NCT01123590|Immunodeficiency|immunodeficiency
1568282|NCT00506415|Decline|decline
1410147|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
1410148|NCT01123577|SBPM|sbpm
1410149|NCT01123577|Randomized Control Trial|randomized control trial
1410150|NCT01123577|Hypertension (HTN)|hypertension (htn)
1410151|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1410152|NCT01123577|HTN|htn
1410153|NCT01123577|CVD|cvd
1410154|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
1410155|NCT01123551|Nebulized morphine|nebulized morphine
1410156|NCT01123551|Intravenous morphine|intravenous morphine
1410157|NCT01123551|Post traumatic|post traumatic
1410158|NCT01123551|Pain|pain
1410159|NCT01123551|Emergency department|emergency department
1410160|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
1410161|NCT01123512|Kyphoplasty|kyphoplasty
1410162|NCT01123512|Spine|spine
1410163|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
1410164|NCT01123512|Back Pain|back pain
1410165|NCT01123499|G-CSF|g-csf
1410166|NCT01123499|Plerixafor|plerixafor
1410167|NCT01123499|Normal Volunteer|normal volunteer
1410168|NCT01123499|Apheresis|apheresis
1410169|NCT01123499|Healthy Volunteer|healthy volunteer
1410170|NCT01123499|HV|hv
1410171|NCT01123486|Intravenous opioids|intravenous opioids
1410172|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
1410173|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
1410174|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1410278|NCT01123083|T1DM|t1dm
1410175|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1410176|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
1410177|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
1410178|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
1410179|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
1410180|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
1410181|NCT01123434|prostate cancer|prostate cancer
1410182|NCT01123434|adjuvant|adjuvant
1410183|NCT01123434|hormonal|hormonal
1410184|NCT01123421|osteoporosis|osteoporosis
1410185|NCT01123421|fracture risk|fracture risk
1410187|NCT01123421|tibia|tibia
1410188|NCT01123421|sonometer|sonometer
1410189|NCT01123421|ultrasound|ultrasound
1410190|NCT01123421|BMD|bmd
1410191|NCT01123421|bone mineral density|bone mineral density
1410192|NCT01123421|DXA|dxa
1410193|NCT01123421|3D-HRpQT|3d-hrpqt
1410194|NCT01123421|waveform profiles|waveform profiles
1410195|NCT01123408|schizophrenia|schizophrenia
1410196|NCT01123408|aggression|aggression
1410197|NCT01123408|clozapine|clozapine
1410198|NCT01123408|olanzapine|olanzapine
1410199|NCT01123395|bioavailability|bioavailability
1410200|NCT01123382|Stroke|stroke
1410201|NCT01123382|Shoulder pain|shoulder pain
1410202|NCT01123382|Electrical stimulation|electrical stimulation
1410203|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
1410204|NCT01123382|Intramuscular stimulation|intramuscular stimulation
1410205|NCT01123369|Sickle Cell Disease|sickle cell disease
1410206|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
1410207|NCT01123343|limbal relaxing incision|limbal relaxing incision
1410208|NCT01123343|LRI|lri
1410209|NCT01123343|capsulorhexis|capsulorhexis
1410210|NCT01123343|surgical guidance|surgical guidance
1410211|NCT01123343|3d visualization|3d visualization
1410212|NCT01123317|Schizophrenia|schizophrenia
1410213|NCT01123317|PET|pet
1410214|NCT01123317|Oxytocin|oxytocin
1410215|NCT01123304|melanoma|melanoma
1410216|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
1410217|NCT01123278|Adiponectin|adiponectin
1410218|NCT01123278|Resistin|resistin
1410219|NCT01123278|Adipocytes|adipocytes
1410220|NCT01123278|Testosterone|testosterone
1410221|NCT01123278|Aging|aging
1410222|NCT01123278|HOMA-IR|homa-ir
1410223|NCT01123278|Insulin|insulin
1410224|NCT01123278|Hypogonadism|hypogonadism
1410225|NCT01123278|Metabolic Syndrome|metabolic syndrome
1410226|NCT01123278|Obesity|obesity
1410227|NCT01123278|Erectile Dysfunction|erectile dysfunction
1410228|NCT01123265|PsA|psa
1410229|NCT01123265|methotrexate|methotrexate
1410230|NCT01123265|Anti-TNF|anti-tnf
1410231|NCT01123265|TNF|tnf
1410232|NCT01123265|DC-Stamp|dc-stamp
1410233|NCT01123252|Lactobacillus casei|lactobacillus casei
1410234|NCT01123239|Healthcare Disparities|healthcare disparities
1410235|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
1410236|NCT01123213|pessary fitting|pessary fitting
1410237|NCT01123187|diabetes type 1|diabetes type 1
1410238|NCT01123187|kidney transplantation|kidney transplantation
1410239|NCT01123187|islet|islet
1410240|NCT01123187|hypoglycemia|hypoglycemia
1410241|NCT01123174|Suicide|suicide
1410242|NCT01123174|case management algorithm|case management algorithm
1410243|NCT01123174|suicidal behaviors|suicidal behaviors
1410244|NCT01123174|prevention of suicide|prevention of suicide
1410245|NCT01123161|Hypothermia|hypothermia
1568384|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
1410246|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1410247|NCT01123161|Cerebral Infarction|cerebral infarction
1410248|NCT01123161|Hematologic Agents|hematologic agents
1410249|NCT01123161|Stroke|stroke
1410250|NCT01123161|Nervous System Diseases|nervous system diseases
1410252|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
1410253|NCT01123161|Central Nervous System Diseases|central nervous system diseases
1410254|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
1410255|NCT01123161|Cardiovascular Agents|cardiovascular agents
1410256|NCT01123161|Body Temperature Changes|body temperature changes
1410257|NCT01123161|Brain Diseases|brain diseases
1410258|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
1410259|NCT01123161|Pharmacologic Actions|pharmacologic actions
1410260|NCT01123161|Signs and Symptoms|signs and symptoms
1410261|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
1410262|NCT01123161|Therapeutic Uses|therapeutic uses
1410263|NCT01123161|Brain Ischemia|brain ischemia
1410264|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
1410265|NCT01123161|Brain Infarction|brain infarction
1410266|NCT01123161|Plasminogen|plasminogen
1410267|NCT01123161|cooling|cooling
1410269|NCT01123161|thrombolysis|thrombolysis
1410270|NCT01123148|Brain computer interface|brain computer interface
1410271|NCT01123148|wheelchair control|wheelchair control
1410272|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
1410273|NCT01123135|postmenopausal women|postmenopausal women
1410274|NCT01123109|nulliparous women|nulliparous women
1410275|NCT01123096|Stress urinary incontinence|stress urinary incontinence
1410276|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
1410277|NCT01123083|juvenile diabetes|juvenile diabetes
1410279|NCT01123083|Type 1 diabetes|type 1 diabetes
1410280|NCT01123057|keratoconus|keratoconus
1410281|NCT01123057|collagen cross-linking|collagen cross-linking
1410282|NCT01123057|LASIK ectasia|lasik ectasia
1410283|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
1410284|NCT01123018|Memory Loss|memory loss
1410285|NCT01122992|Limbal relaxing incision|limbal relaxing incision
1410286|NCT01122992|Astigmatic correction|astigmatic correction
1410287|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
1410288|NCT01122992|Chinese eyes|chinese eyes
1410289|NCT01122966|trabeculectomy|trabeculectomy
1410290|NCT01122953|Bioequivalence|bioequivalence
1410291|NCT01122953|EPAMIN|epamin
1410292|NCT01122953|PHENYTOIN|phenytoin
1410293|NCT01122940|Bioequivalence|bioequivalence
1410294|NCT01122940|Phenytoin|phenytoin
1410295|NCT01122940|Epamin|epamin
1410296|NCT01122927|schizophrenia|schizophrenia
1410297|NCT01122927|adolescent|adolescent
1410298|NCT01122927|bipolar|bipolar
1410299|NCT01122914|Kineret|kineret
1410300|NCT01122914|Anakinra|anakinra
1410301|NCT01122914|Atopic Dermatitis|atopic dermatitis
1410302|NCT01122914|Eczema|eczema
1410303|NCT01122914|Allergic Disease|allergic disease
1410304|NCT01122862|tooth plaque|tooth plaque
1410305|NCT01122849|trouble with sleep|trouble with sleep
1410306|NCT01122849|night time nasal congestion|night time nasal congestion
1410307|NCT01122836|Massage|massage
1410308|NCT01122836|Chronic Neck Pain|chronic neck pain
1410309|NCT01122836|Dosing Study|dosing study
1410310|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
1410311|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
1410312|NCT01122810|Transplant heart patients|transplant heart patients
1410313|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
1410314|NCT01122810|Coronary stenosis|coronary stenosis
1410315|NCT01122797|PNPLA3|pnpla3
1410316|NCT01122797|fibrosis|fibrosis
1410317|NCT01122797|cirrhosis|cirrhosis
1410318|NCT01122797|alcoholic liver disease|alcoholic liver disease
1410319|NCT01122784|Plague|plague
1410320|NCT01122784|Vaccine|vaccine
1410321|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
1410322|NCT01122771|phase III|phase iii
1410323|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
1410324|NCT01122771|Bangladesh|bangladesh
1410325|NCT01122771|Combination treatment|combination treatment
1410326|NCT01122771|Ambisome|ambisome
1410327|NCT01122771|miltefosine|miltefosine
1410328|NCT01122771|paromomycin|paromomycin
1410329|NCT01122758|Cohort|cohort
1410330|NCT01122758|COPD|copd
1410331|NCT01122758|Natural history|natural history
1410332|NCT01122758|Phenotyping|phenotyping
1410333|NCT01122758|Smoking|smoking
1410334|NCT01122745|continuous block|continuous block
1410335|NCT01122745|single shot|single shot
1410336|NCT01122745|interscalene|interscalene
1410337|NCT01122745|rotator cuff surgery|rotator cuff surgery
1410338|NCT01122732|nerve block|nerve block
1410339|NCT01122732|continuous catheter|continuous catheter
1410340|NCT01122732|shoulder surgery|shoulder surgery
1410341|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
1410342|NCT01122719|Optima|optima
1410343|NCT01122719|Tacrolimus|tacrolimus
1410344|NCT01122719|Drug eluting stent|drug eluting stent
1410345|NCT01122706|tai ji|tai ji
1410346|NCT01122706|psychosocial stress|psychosocial stress
1410347|NCT01122706|primary prevention|primary prevention
1410348|NCT01122706|Trier Social Stress Test|trier social stress test
1410349|NCT01122706|salivary cortisol|salivary cortisol
1410350|NCT01122706|salivary alpha amylase|salivary alpha amylase
1410351|NCT01122706|heart rate variability|heart rate variability
1410352|NCT01122706|stress management|stress management
1410353|NCT01122693|Regional Anesthesia|regional anesthesia
1410354|NCT01122693|Pain Medicine|pain medicine
1410355|NCT01122693|Ultrasound|ultrasound
1410356|NCT01122693|Nerve Blocks|nerve blocks
1410357|NCT01122667|Renal Insufficiency|renal insufficiency
1410358|NCT01122641|Insulin resistance|insulin resistance
1410359|NCT01122641|incretins|incretins
1410360|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
1410361|NCT01122641|vildagliptin|vildagliptin
1410362|NCT01122641|microcirculation|microcirculation
1410363|NCT01122628|Distal Radial Fracture|distal radial fracture
1410364|NCT01122628|Volar Locking Plate|volar locking plate
1410365|NCT01122615|Kidney|kidney
1410366|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1410367|NCT01122615|RCC|rcc
1410368|NCT01122615|Sunitinib|sunitinib
1410369|NCT01122615|Sunitinib Malate|sunitinib malate
1410370|NCT01122615|Sutent|sutent
1410371|NCT01122615|Temsirolimus|temsirolimus
1410372|NCT01122615|Torisel|torisel
1410373|NCT01122602|Aspirin|aspirin
1410374|NCT01122589|Smoking Abstinence|smoking abstinence
1410375|NCT01122589|Smoking Cessation|smoking cessation
1410376|NCT01122576|Intra Ocular Lens|intra ocular lens
1410377|NCT01122576|Ocular surgery|ocular surgery
1410378|NCT01122576|Phacoemulsification|phacoemulsification
1410379|NCT01122563|OABSS|oabss
1410380|NCT01122563|IPSS|ipss
1410381|NCT01122563|PPBC|ppbc
1410382|NCT01122563|3-day micturition diary|3-day micturition diary
1410383|NCT01122563|Solifenacin|solifenacin
1410384|NCT01122550|OABSS|oabss
1410385|NCT01122550|IPSS|ipss
1410386|NCT01122550|PPBC|ppbc
1410387|NCT01122550|3-day micturition diary|3-day micturition diary
1410388|NCT01122537|Meningitis|meningitis
1410389|NCT01122537|infection|infection
1410390|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
1410391|NCT01122537|procalcitonin|procalcitonin
1410392|NCT01122537|adenosine deaminase|adenosine deaminase
1410393|NCT01122524|Trisomy 21|trisomy 21
1410394|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
1410395|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1410396|NCT01122472|phase III study|phase iii study
1410397|NCT01122472|after R-CHOP|after r-chop
1410398|NCT01122472|Maintenance treatment|maintenance treatment
1410399|NCT01122472|Maintenance|maintenance
1410400|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
1410401|NCT01122446|Alum-GAD|alum-gad
1410402|NCT01122446|Type 1 diabetes|type 1 diabetes
1410403|NCT01122446|prevention|prevention
1410404|NCT01122446|immune tolerance|immune tolerance
1410405|NCT01122446|glucose tolerance|glucose tolerance
1410406|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
1410407|NCT01122433|difficult airway|difficult airway
1410408|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
1410409|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
1410410|NCT01122420|Obesity|obesity
1410411|NCT01122394|stroke|stroke
1410412|NCT01122394|recurrence|recurrence
1410413|NCT01122394|blood pressure|blood pressure
1410414|NCT01122394|prevention|prevention
1410415|NCT01122381|headache, migraine|headache, migraine
1410416|NCT01122381|depression|depression
1410417|NCT01122381|disability evaluation|disability evaluation
1410418|NCT01122381|weight gain|weight gain
1410419|NCT01122368|mycoses|mycoses
1410420|NCT01122368|Micafungin|micafungin
1410421|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
1410422|NCT01122368|invasive fungal infection|invasive fungal infection
1410423|NCT01122368|intra-abdominal infection|intra-abdominal infection
1410424|NCT01122342|Testosterone|testosterone
1410425|NCT01122342|Vaginal administration|vaginal administration
1410426|NCT01122342|Aromatase inhibitors|aromatase inhibitors
1410427|NCT01122329|dementia|dementia
1410428|NCT01122316|Heart Failure|heart failure
1410429|NCT01122316|Diabetes|diabetes
1410430|NCT01122316|Metformin|metformin
1410431|NCT01122303|Autologous serum eye drops|autologous serum eye drops
1410432|NCT01122303|EGF|egf
1410433|NCT01122303|TGF-β1|tgf-β1
1410434|NCT01122303|TGF-β2|tgf-β2
1410435|NCT01122303|Fibronectin|fibronectin
1410436|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
1410437|NCT01122303|Dry eye|dry eye
1410438|NCT01122290|Emotional eating|emotional eating
1410439|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
1410440|NCT01122290|emotion induction|emotion induction
1410441|NCT01122277|Volume therapy|volume therapy
1410442|NCT01122277|Fluid therapy|fluid therapy
1410443|NCT01122277|Patients in ICU|patients in icu
1410444|NCT01122264|Erectile Dysfunction|erectile dysfunction
1410445|NCT01122251|hypertension|hypertension
1410446|NCT01122251|lercanidipine|lercanidipine
1410447|NCT01122251|valsartan|valsartan
1410448|NCT01122238|Smoking|smoking
1410449|NCT01122238|Smoking Cessation|smoking cessation
1410450|NCT01122238|Motivation|motivation
1410451|NCT01122238|Nicotine Dependence|nicotine dependence
1410452|NCT01122225|septic shock|septic shock
1410453|NCT01122225|medical intensive care|medical intensive care
1410454|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
1410455|NCT01122212|ct scans|ct scans
1410456|NCT01122212|protein s100|protein s100
1410457|NCT01122212|inpatient treatment|inpatient treatment
1410458|NCT01122186|Medication Adherence|medication adherence
1410459|NCT01122186|Methamphetamine Use|methamphetamine use
1410460|NCT01122186|Sexual Risk|sexual risk
1410461|NCT01122186|Poly-substance Use|poly-substance use
1410462|NCT01122186|HIV|hiv
1410463|NCT01122186|Treatment|treatment
1410464|NCT01122186|Motivational Interviewing|motivational interviewing
1410465|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
1410466|NCT01122186|Men Who Have Sex With Men|men who have sex with men
1410467|NCT01122173|Atrial Fibrillation|atrial fibrillation
1410468|NCT01122173|Robotic Control|robotic control
1410469|NCT01122173|Remote Control|remote control
1410470|NCT01122160|anthocyanin|anthocyanin
1410471|NCT01122160|omeprazole|omeprazole
1410472|NCT01122160|Prilosec|prilosec
1410473|NCT01122160|gastric pH|gastric ph
1410474|NCT01122160|proton pump inhibitor|proton pump inhibitor
1410475|NCT01122160|PPI|ppi
1410476|NCT01122160|nutrition|nutrition
1410477|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
1410478|NCT01122134|severe|severe
1410479|NCT01122134|malaria|malaria
1410480|NCT01122134|artesunate|artesunate
1410481|NCT01122134|intravenous|intravenous
1410482|NCT01122121|Drug Therapy|drug therapy
1410483|NCT01122121|Radiotherapy|radiotherapy
1410484|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
1410485|NCT01122108|Resin|resin
1410486|NCT01122108|Lipids|lipids
1410487|NCT01122108|Glucose|glucose
1410488|NCT01122108|Cholesterol|cholesterol
1410489|NCT01122108|Diabetes Mellitus|diabetes mellitus
1410490|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
1410491|NCT01122095|Psoriasis|psoriasis
1410492|NCT01122095|Cardiovascular risk|cardiovascular risk
1410493|NCT01122082|energy intake|energy intake
1410494|NCT01122082|energy expenditure|energy expenditure
1410495|NCT01122082|macronutrient selection|macronutrient selection
1410496|NCT01122056|Multiple Sclerosis|multiple sclerosis
1410497|NCT01122056|b1b-interferon|b1b-interferon
1410498|NCT01122056|Fatigue|fatigue
1410499|NCT01122056|Exercise|exercise
1410500|NCT01122043|Endoglide|endoglide
1410501|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
1410502|NCT01122043|Donor Insertion|donor insertion
1410503|NCT01122043|DSAEK|dsaek
1410504|NCT01122043|Corneal Transplant|corneal transplant
1410505|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
1410506|NCT01122030|Chronic pain|chronic pain
1410507|NCT01122030|Opioid physical dependence|opioid physical dependence
1410508|NCT01121991|Infertility|infertility
1410509|NCT01121991|Ovarian Stimulation|ovarian stimulation
1410510|NCT01121991|Luveris|luveris
1410511|NCT01121991|Lutropin alpha|lutropin alpha
1410512|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
1410513|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
1410514|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
1410515|NCT01121978|pathologic myopia|pathologic myopia
1410516|NCT01121965|macular hole|macular hole
1410517|NCT01121965|impending macular hole|impending macular hole
1410518|NCT01121965|stage 1 macular hole|stage 1 macular hole
1410519|NCT01121952|Ankle joint|ankle joint
1410520|NCT01121952|Talo-crural joint|talo-crural joint
1410521|NCT01121952|Vertical jump|vertical jump
1410522|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
1410524|NCT01121952|Proprioception|proprioception
1410525|NCT01121952|Pain|pain
1410526|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
1410527|NCT01121939|Gastrointestinal|gastrointestinal
1410528|NCT01121939|Bevacizumab|bevacizumab
1410529|NCT01121939|Avastin|avastin
1410530|NCT01121939|Pertuzumab|pertuzumab
1410531|NCT01121939|Omnitarg|omnitarg
1410532|NCT01121939|2C4|2c4
1410533|NCT01121939|Sandostatin|sandostatin
1410534|NCT01121939|Octreotide|octreotide
1410535|NCT01121926|Healthy subjects|healthy subjects
1410536|NCT01121926|Bioavailability|bioavailability
1410537|NCT01121926|Pharmacokinetics|pharmacokinetics
1410538|NCT01121926|Trazodone|trazodone
1410539|NCT01121926|Steady-state|steady-state
1410540|NCT01121913|Healthy subjects|healthy subjects
1410541|NCT01121900|Healthy subjects|healthy subjects
1410542|NCT01121887|smoking cessation|smoking cessation
1410543|NCT01121887|telephone counselling|telephone counselling
1410544|NCT01121887|motivational interviewing|motivational interviewing
1410545|NCT01121887|treatment integrity|treatment integrity
1410546|NCT01121887|Tobacco Smoking|tobacco smoking
1410547|NCT01121874|CMC arthritis|cmc arthritis
1410548|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
1410549|NCT01121874|basal joint arthritis|basal joint arthritis
1568385|NCT00506051|lung cancer|lung cancer
1410550|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
1410551|NCT01121861|efficacy|efficacy
1410552|NCT01121861|safety|safety
1410553|NCT01121861|predictability|predictability
1410554|NCT01121861|stability|stability
1410555|NCT01121861|toric IOL|toric iol
1410556|NCT01121861|refractive astigmatism|refractive astigmatism
1410557|NCT01121861|phacoemulsification|phacoemulsification
1410558|NCT01121822|Influenza|influenza
1410559|NCT01121822|Influenza vaccine|influenza vaccine
1410560|NCT01121822|Influenza virus|influenza virus
1410561|NCT01121822|Intramuscular|intramuscular
1410562|NCT01121809|Raltegravir|raltegravir
1410563|NCT01121809|etravirine|etravirine
1410564|NCT01121809|pharmacokinetics|pharmacokinetics
1410565|NCT01121809|intracellular|intracellular
1410566|NCT01121757|relapsed|relapsed
1410567|NCT01121757|refractory|refractory
1410568|NCT01121757|lymphoma|lymphoma
1410569|NCT01121757|follicular|follicular
1410570|NCT01121757|marginal zone|marginal zone
1410571|NCT01121744|Coronary Artery Disease|coronary artery disease
1410572|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
1410573|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
1410574|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
1410575|NCT01121731|Interferon alfa-5|interferon alfa-5
1410576|NCT01121731|Interferon|interferon
1410577|NCT01121718|lymph node|lymph node
1410578|NCT01121705|genotype 3|genotype 3
1410579|NCT01121705|Combination treatment|combination treatment
1410580|NCT01121705|Short treatment|short treatment
1410581|NCT01121692|Couples|couples
1410582|NCT01121692|Alcohol use|alcohol use
1410583|NCT01121692|HIV risk|hiv risk
1410584|NCT01121692|Outreach|outreach
1410585|NCT01121679|Older patients|older patients
1410586|NCT01121679|Aged, 80 and Over|aged, 80 and over
1410587|NCT01121679|Cardiology|cardiology
1410588|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
1410589|NCT01121666|Superovulation|superovulation
1410590|NCT01121666|Follitropin alfa|follitropin alfa
1410591|NCT01121666|r-hFSH|r-hfsh
1410592|NCT01121666|AFOLIA|afolia
1410593|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
1410594|NCT01121640|Ovarian Cancer|ovarian cancer
1410595|NCT01121640|Screening|screening
1410596|NCT01121640|Biomarkers|biomarkers
1410597|NCT01121627|Computerized Cognitive training|computerized cognitive training
1410598|NCT01121627|Quality of life|quality of life
1410599|NCT01121627|Gait Function|gait function
1410600|NCT01121627|Executive Function|executive function
1410601|NCT01121614|Harmonic scalpel|harmonic scalpel
1410602|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
1410603|NCT01121614|LOTUS|lotus
1410604|NCT01121614|LigaSure|ligasure
1410605|NCT01121614|vessel sealing|vessel sealing
1410606|NCT01121614|burst pressure|burst pressure
1410607|NCT01121614|collateral damage|collateral damage
1410608|NCT01121588|neoplasm malignant|neoplasm malignant
1410609|NCT01121588|lymphoma|lymphoma
1410610|NCT01121588|neuroblastoma|neuroblastoma
1410611|NCT01121588|Crizotinib|crizotinib
1410612|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
1410613|NCT01121588|ALK|alk
1410614|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
1410615|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
1410616|NCT01121549|Prospective|prospective
1410617|NCT01121549|non-comparative|non-comparative
1410618|NCT01121549|NIS|nis
1410619|NCT01121549|600|600
1410620|NCT01121549|postmenopausal|postmenopausal
1410621|NCT01121549|hormone-receptor|hormone-receptor
1410622|NCT01121549|positive|positive
1410623|NCT01121549|EBC|ebc
1410624|NCT01121549|tamoxifen|tamoxifen
1410625|NCT01121549|current medical practice.|current medical practice.
1410626|NCT01121536|Bipolar I Disorder|bipolar i disorder
1410627|NCT01121523|Prematurity|prematurity
1410628|NCT01121523|massage|massage
1410629|NCT01121523|stress|stress
1410630|NCT01121523|parenting|parenting
1410631|NCT01121523|infancy|infancy
1410632|NCT01121523|sleep|sleep
1410633|NCT01121523|intervention|intervention
1410634|NCT01121510|vascular closure device|vascular closure device
1410635|NCT01121497|Sedation|sedation
1410636|NCT01121497|Cognitive decline|cognitive decline
1410637|NCT01121497|Physostigmine|physostigmine
1410638|NCT01121497|Colonoscopy|colonoscopy
1410639|NCT01121471|diabetes|diabetes
1410640|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
1410641|NCT01121458|pulmonary artery|pulmonary artery
1410642|NCT01121458|vascular resistance|vascular resistance
1410643|NCT01121445|Sleep apnea|sleep apnea
1410644|NCT01121445|CPAP|cpap
1410645|NCT01121445|Saline irrigation|saline irrigation
1410646|NCT01121419|Neuroblastoma|neuroblastoma
1410647|NCT01121419|IMP3|imp3
1410648|NCT01121419|Prognosis|prognosis
1410649|NCT01121380|Healthy|healthy
1410650|NCT01121380|Volunteers|volunteers
1410651|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
1410652|NCT01121354|Cefazolin|cefazolin
1540327|NCT00619619|MDD|mdd
1410653|NCT01121354|Caphalosporin|caphalosporin
1410654|NCT01121354|antibiotic|antibiotic
1410655|NCT01121354|gram positive|gram positive
1410656|NCT01121354|Infection control|infection control
1410657|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
1410658|NCT01121341|Saphenous vein|saphenous vein
1410659|NCT01121341|Conventional vein harvesting|conventional vein harvesting
1410660|NCT01121328|Preterm neonates.|preterm neonates.
1410661|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
1410662|NCT01121315|Epidemiological|epidemiological
1410663|NCT01121315|Diabetes|diabetes
1410664|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
1410665|NCT01121315|CVD|cvd
1410666|NCT01121302|AZD5213|azd5213
1410667|NCT01121302|Phase 1|phase 1
1410668|NCT01121302|Safety|safety
1410669|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
1410670|NCT01121263|coronary heart disease|coronary heart disease
1410671|NCT01121263|coronary artery bypass|coronary artery bypass
1410672|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
1410673|NCT01121263|coronary angiography|coronary angiography
1410674|NCT01121263|drug-eluting stents|drug-eluting stents
1410675|NCT01121250|Combat disorders|combat disorders
1410676|NCT01121250|Spouses|spouses
1410677|NCT01121250|Support|support
1410678|NCT01121250|Military personnel|military personnel
1410679|NCT01121237|chronic kidney disease|chronic kidney disease
1410680|NCT01121237|end-stage renal disease|end-stage renal disease
1410681|NCT01121237|renal anaemia|renal anaemia
1410682|NCT01121237|epoetin alfa|epoetin alfa
1410683|NCT01121224|Saphenous vein graft|saphenous vein graft
1410684|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
1410685|NCT01121224|Stents|stents
1410686|NCT01121211|Testosterone|testosterone
1410687|NCT01121211|Hormones|hormones
1410688|NCT01121211|Mental Health|mental health
1410689|NCT01121198|Food effect|food effect
1410885|NCT01120171|Elderly|elderly
1410690|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
1410691|NCT01121185|Liver transplantation|liver transplantation
1410692|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
1410693|NCT01121146|Osteolysis|osteolysis
1410694|NCT01121146|Polyethylene|polyethylene
1410695|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
1410696|NCT01121146|Total Hip Replacement|total hip replacement
1410697|NCT01121146|CT|ct
1410698|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1410699|NCT01121120|Hodgkin Disease|hodgkin disease
1410700|NCT01121120|Multiple myeloma|multiple myeloma
1410701|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1410702|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
1410703|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
1410704|NCT01121107|Heart Failure|heart failure
1410705|NCT01121107|Decompensated Heart Failure|decompensated heart failure
1410706|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
1410707|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
1410708|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
1410709|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
1410710|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
1410711|NCT01121081|Male or female subjects|male or female subjects
1410712|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
1410713|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
1410714|NCT01121068|IGRA|igra
1410715|NCT01121068|variability|variability
1410716|NCT01121068|Long-term variability of IGRA|long-term variability of igra
1410717|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
1410718|NCT01121055|Patient|patient
1410719|NCT01121055|Satisfaction|satisfaction
1410720|NCT01121055|Lorazepam|lorazepam
1410721|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
1410722|NCT01121003|Fructose|fructose
1410723|NCT01121003|VLDL-triglycerides|vldl-triglycerides
1410724|NCT01121003|de novo lipogenesis|de novo lipogenesis
1410725|NCT01121003|Human metabolism|human metabolism
1410726|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
1410727|NCT01120990|Essential Hypertension|essential hypertension
1410728|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
1410729|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
1410730|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
1410731|NCT01120925|Cirrhotic|cirrhotic
1410732|NCT01120925|Stem Cells|stem cells
1410733|NCT01120925|Bone marrow stem cells|bone marrow stem cells
1410734|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
1410735|NCT01120912|oral insulin|oral insulin
1410736|NCT01120899|Diabetic Macular Edema|diabetic macular edema
1410737|NCT01120899|Microglia|microglia
1410738|NCT01120899|Minocycline|minocycline
1410739|NCT01120899|Diabetes|diabetes
1410740|NCT01120886|Ion channelopathy,|ion channelopathy,
1410741|NCT01120886|Still birth|still birth
1410742|NCT01120886|Sudden death|sudden death
1410743|NCT01120873|Hyperglycemia|hyperglycemia
1410744|NCT01120873|dyslipidemia|dyslipidemia
1410745|NCT01120873|Hypertension|hypertension
1410746|NCT01120873|Obesity|obesity
1410747|NCT01120860|Cognitive Aging|cognitive aging
1410748|NCT01120860|Apolipoproteins E|apolipoproteins e
1410749|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
1410750|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
1410751|NCT01120821|PV|pv
1410752|NCT01120769|Myocardial Infarction|myocardial infarction
1410753|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
1410754|NCT01120769|Acetaminophen|acetaminophen
1410755|NCT01120769|Lipid Peroxidation|lipid peroxidation
1410756|NCT01120756|executive dysfunction|executive dysfunction
1410757|NCT01120756|brain injury|brain injury
1410758|NCT01120756|attention|attention
1410759|NCT01120756|rehabilitation|rehabilitation
1410760|NCT01120756|fMRI|fmri
1410761|NCT01120743|liver failure|liver failure
1410762|NCT01120743|cytokines|cytokines
1410763|NCT01120743|hemodynamic instability|hemodynamic instability
1410764|NCT01120717|QVA149|qva149
1410765|NCT01120717|COPD|copd
1410766|NCT01120717|combination bronchodilator|combination bronchodilator
1410767|NCT01120704|Smoking|smoking
1410768|NCT01120704|Smoking Cessation|smoking cessation
1410769|NCT01120704|Adherence|adherence
1410770|NCT01120704|Nicotine|nicotine
1410771|NCT01120704|Motivation|motivation
1410772|NCT01120691|QVA149|qva149
1410773|NCT01120691|NVA237|nva237
1410774|NCT01120691|COPD|copd
1410775|NCT01120691|exacerbation|exacerbation
1410776|NCT01120691|combination bronchodilator|combination bronchodilator
1410777|NCT01120678|cytokines|cytokines
1410778|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
1410779|NCT01120678|neonatal sepsis|neonatal sepsis
1410780|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
1410781|NCT01120678|bacteremia|bacteremia
1410782|NCT01120678|blood culture|blood culture
1410783|NCT01120678|clinical sepsis|clinical sepsis
1410784|NCT01120665|women's health|women's health
1411388|NCT01118247|HHS|hhs
1410785|NCT01120665|hormone replacement therapy|hormone replacement therapy
1410786|NCT01120665|exercise|exercise
1410787|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
1410788|NCT01120613|Nondipping|nondipping
1410789|NCT01120613|Renal Transplant|renal transplant
1410790|NCT01120613|Chronotherapy|chronotherapy
1410791|NCT01120587|Deglutition|deglutition
1410792|NCT01120587|Fluoroscopy|fluoroscopy
1410793|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
1410794|NCT01120574|Home mechanical ventilation|home mechanical ventilation
1410795|NCT01120574|COPD|copd
1410796|NCT01120561|TDM-1 EAP|tdm-1 eap
1410797|NCT01120561|T-DM1 EAP|t-dm1 eap
1410798|NCT01120561|TDM1 EAP|tdm1 eap
1410799|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
1410800|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
1410801|NCT01120561|EAP|eap
1410802|NCT01120561|T-PAS|t-pas
1410803|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
1410804|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
1410805|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
1410806|NCT01120535|Vena Cava|vena cava
1410807|NCT01120535|Vena Cava Filter|vena cava filter
1410808|NCT01120535|Pulmonary Embolism|pulmonary embolism
1410809|NCT01120535|Venous Thromboembolism|venous thromboembolism
1410810|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
1410811|NCT01120522|Vena Cava|vena cava
1410812|NCT01120522|Vena Cava Filter|vena cava filter
1410813|NCT01120522|Pulmonary Embolism|pulmonary embolism
1410814|NCT01120522|Venous Thromboembolism|venous thromboembolism
1410815|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
1410816|NCT01120509|Vena Cava|vena cava
1410817|NCT01120509|Vena Cava Filter|vena cava filter
1410818|NCT01120509|Pulmonary Embolism|pulmonary embolism
1410819|NCT01120509|Venous Thromboembolism|venous thromboembolism
1410820|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
1410821|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
1410822|NCT01120483|mortality|mortality
1410823|NCT01120483|functional status|functional status
1410824|NCT01120470|Castration Resistant|castration resistant
1410825|NCT01120470|Prostate Cancer|prostate cancer
1410826|NCT01120470|OGX-427|ogx-427
1410827|NCT01120444|Diabetes|diabetes
1410828|NCT01120444|Insulin|insulin
1410829|NCT01120444|Blood Glucose|blood glucose
1410830|NCT01120431|dehydration|dehydration
1410831|NCT01120431|fluid therapy|fluid therapy
1410832|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1410833|NCT01120431|hyaluronidase|hyaluronidase
1410834|NCT01120431|hypodermoclysis|hypodermoclysis
1410835|NCT01120431|clysis|clysis
1410836|NCT01120431|subcutaneous hydration|subcutaneous hydration
1410837|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
1410838|NCT01120431|hyaluronan|hyaluronan
1410839|NCT01120431|rHuPH20|rhuph20
1410840|NCT01120431|pediatric|pediatric
1410841|NCT01120431|ORT|ort
1410842|NCT01120418|Endothelial cell density|endothelial cell density
1410843|NCT01120418|screening|screening
1410844|NCT01120405|Xenon|xenon
1410845|NCT01120405|Cardiac safety|cardiac safety
1410846|NCT01120405|Cardiovascular risk|cardiovascular risk
1410847|NCT01120405|Non cardiac surgery|non cardiac surgery
1410848|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
1410849|NCT01120392|Parkinson's disease|parkinson's disease
1410850|NCT01120392|Physical therapy|physical therapy
1410851|NCT01120392|Virtual Reality|virtual reality
1410852|NCT01120392|Quality of life|quality of life
1410853|NCT01120392|Motor performance|motor performance
1410854|NCT01120379|drug eluting stents|drug eluting stents
1410855|NCT01120379|Stents|stents
1410856|NCT01120379|Angioplasty|angioplasty
1410857|NCT01120379|Stent thrombosis|stent thrombosis
1410858|NCT01120353|Childhood cancer|childhood cancer
1410859|NCT01120353|Young Children|young children
1410860|NCT01120353|Adults|adults
1410861|NCT01120301|stroke|stroke
1410862|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
1410863|NCT01120288|Targeted Therapy|targeted therapy
1410864|NCT01120288|HIF|hif
1410865|NCT01120288|Antisense|antisense
1410866|NCT01120288|VEGF|vegf
1410867|NCT01120288|Cancer|cancer
1410868|NCT01120288|Solid Tumor|solid tumor
1410869|NCT01120288|Liver Metastasis|liver metastasis
1410870|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
1410871|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
1410872|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
1410873|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
1410874|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
1410875|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1410876|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
1410877|NCT01120210|Heart Failure|heart failure
1410878|NCT01120210|Cardiac Failure|cardiac failure
1410879|NCT01120197|randomized controlled trial|randomized controlled trial
1410880|NCT01120197|osteoporosis|osteoporosis
1410881|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
1410882|NCT01120197|balance|balance
1410883|NCT01120197|health-related quality of life|health-related quality of life
1410884|NCT01120171|Breast cancer|breast cancer
1410886|NCT01120171|Chemotherapy|chemotherapy
1410887|NCT01120171|Cardiotoxicity|cardiotoxicity
1410888|NCT01120158|Breast cancer|breast cancer
1410889|NCT01120158|Elderly|elderly
1410890|NCT01120158|Chemotherapy|chemotherapy
1410891|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
1410892|NCT01120145|Malaria|malaria
1410893|NCT01120145|Pregnancy|pregnancy
1410894|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1410895|NCT01120106|levosimendan|levosimendan
1410896|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
1410897|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
1410898|NCT01120106|transposition of the great arteries|transposition of the great arteries
1410899|NCT01120093|COPD|copd
1410900|NCT01120080|Smoking|smoking
1410901|NCT01120080|Tobacco|tobacco
1410902|NCT01120080|Drinking|drinking
1410903|NCT01120067|Psychology|psychology
1410904|NCT01120067|Pain|pain
1410905|NCT01120067|Veterans|veterans
1410906|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1410907|NCT01120054|Traumatic Brain Injury|traumatic brain injury
1410908|NCT01120054|Homelessness|homelessness
1410909|NCT01120015|OA|oa
1410910|NCT01120015|knee|knee
1410911|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
1410912|NCT01119989|hepatic fat content|hepatic fat content
1410913|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
1410914|NCT01119963|Preterm delivery|preterm delivery
1410915|NCT01119950|COPD|copd
1410916|NCT01119937|COPD|copd
1410917|NCT01119937|NVA237|nva237
1410918|NCT01119924|Mirtazapine|mirtazapine
1410919|NCT01119924|Smilon|smilon
1410920|NCT01119924|Depression|depression
1410921|NCT01119924|Pain|pain
1410922|NCT01119911|Blood sampling|blood sampling
1410923|NCT01119911|Venipuncture|venipuncture
1410924|NCT01119911|Peripheral venous catheter|peripheral venous catheter
1410925|NCT01119911|Complete blood count|complete blood count
1410926|NCT01119911|Basic chemistry|basic chemistry
1410927|NCT01119911|Hemolysis|hemolysis
1410928|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
1410929|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
1410930|NCT01119898|Osteoarthritis|osteoarthritis
1410931|NCT01119898|Arthritis|arthritis
1410932|NCT01119898|NSAIDs|nsaids
1410933|NCT01119898|Topical NSAID|topical nsaid
1410934|NCT01119898|Diclofenac|diclofenac
1410935|NCT01119898|PENNSAID|pennsaid
1410936|NCT01119885|chronic pain|chronic pain
1410937|NCT01119885|fentanyl matrix|fentanyl matrix
1410938|NCT01119885|arthritis|arthritis
1410939|NCT01119885|osteoarthritis|osteoarthritis
1410940|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
1410941|NCT01119872|Respiration, Artificial|respiration, artificial
1410942|NCT01119846|Tolerability|tolerability
1410943|NCT01119846|Pharmacokinetics|pharmacokinetics
1410944|NCT01119846|Safety|safety
1410945|NCT01119846|Pharmacodynamics|pharmacodynamics
1410946|NCT01119846|Glucose|glucose
1410947|NCT01119833|Sickle Cell Disease|sickle cell disease
1410948|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
1410949|NCT01119807|Intraosseous infusion|intraosseous infusion
1410950|NCT01119807|Emergency Medical Services|emergency medical services
1410951|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
1410952|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
1410953|NCT01119794|follicular lymphoma|follicular lymphoma
1410954|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
1410955|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
1410956|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
1410957|NCT01119768|GI|gi
1410958|NCT01119768|Nexium|nexium
1410959|NCT01119768|Phase IV|phase iv
1410960|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
1410961|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
1410962|NCT01119742|Tinea Pedis|tinea pedis
1410963|NCT01119742|Interdigital|interdigital
1410964|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
1410965|NCT01119716|Atrial Fibrillation|atrial fibrillation
1410966|NCT01119716|Afib|afib
1410967|NCT01119716|cardioversion|cardioversion
1410968|NCT01119716|normal sinus rhythm|normal sinus rhythm
1410969|NCT01119716|arrhythmia|arrhythmia
1410970|NCT01119716|AF|af
1410971|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
1410972|NCT01119690|Dietary|dietary
1410973|NCT01119690|Cross-Over Study|cross-over study
1410974|NCT01119690|Lipids|lipids
1410975|NCT01119690|Rapeseed oil|rapeseed oil
1410976|NCT01119690|Butter|butter
1410977|NCT01119690|Milk Fat|milk fat
1410978|NCT01119690|Unsaturated Fat|unsaturated fat
1410979|NCT01119690|Saturated Fat|saturated fat
1410980|NCT01119690|Oxidized LDL|oxidized ldl
1410981|NCT01119690|Platelet Function|platelet function
1410982|NCT01119690|Arterial Elasticity|arterial elasticity
1410983|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
1410984|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
1410985|NCT01119638|Alzheimer's disease|alzheimer's disease
1410986|NCT01119638|BPSD|bpsd
1410987|NCT01119638|escitalopram|escitalopram
1410988|NCT01119638|Risperidone|risperidone
1410989|NCT01119638|Agitation|agitation
1410990|NCT01119638|Psychosis|psychosis
1410991|NCT01119638|Dementia|dementia
1410992|NCT01119638|Elderly|elderly
1410993|NCT01119625|safety|safety
1411194|NCT01118858|pediatrics|pediatrics
1410994|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
1410995|NCT01119625|immunogenicity|immunogenicity
1410996|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1410997|NCT01119625|Haemophilus influenzae|haemophilus influenzae
1410998|NCT01119612|Malaria|malaria
1410999|NCT01119612|Iron|iron
1411000|NCT01119612|Pregnancy|pregnancy
1411001|NCT01119612|Anemia|anemia
1411002|NCT01119612|Birth Weight|birth weight
1411003|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1411004|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1411005|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1411132|NCT01119066|fludarabine|fludarabine
1411006|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1411007|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
1411008|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
1411009|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
1411010|NCT01119547|Osteoarthritis|osteoarthritis
1411011|NCT01119547|Joint Diseases|joint diseases
1411012|NCT01119547|Arthritis|arthritis
1411013|NCT01119547|Rheumatic Diseases|rheumatic diseases
1411014|NCT01119534|Cough treatment|cough treatment
1411015|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
1411016|NCT01119508|Advanced|advanced
1411017|NCT01119508|Inoperable|inoperable
1411018|NCT01119508|Melanoma|melanoma
1411019|NCT01119508|Ipilimumab|ipilimumab
1411020|NCT01119508|MDX010|mdx010
1411021|NCT01119508|BMS-734016|bms-734016
1411022|NCT01119508|Temozolomide|temozolomide
1411023|NCT01119508|Temodar|temodar
1411024|NCT01119508|TMZ|tmz
1411025|NCT01119508|skin|skin
1411026|NCT01119508|mucosal|mucosal
1411027|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
1411028|NCT01119482|meningococcal carriage|meningococcal carriage
1411029|NCT01119482|incidence|incidence
1411030|NCT01119482|prevalence|prevalence
1411031|NCT01119469|Hypochondriasis|hypochondriasis
1411032|NCT01119469|Health Anxiety|health anxiety
1411033|NCT01119469|randomized controlled trial|randomized controlled trial
1411034|NCT01119469|Cognitive Therapy|cognitive therapy
1411035|NCT01119469|Exposure Therapy|exposure therapy
1411036|NCT01119456|Tumors|tumors
1411037|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
1411038|NCT01119456|RON protein|ron protein
1411039|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
1411040|NCT01119430|major depression|major depression
1411041|NCT01119430|DU 125530|du 125530
1411042|NCT01119430|Treatment depression|treatment depression
1411043|NCT01119430|Latency antidepressant|latency antidepressant
1411044|NCT01119417|supine Hypertension|supine hypertension
1411045|NCT01119417|autonomic failure|autonomic failure
1411046|NCT01119417|BQ123|bq123
1411047|NCT01119417|BQ-123|bq-123
1411048|NCT01119417|endothelin|endothelin
1411049|NCT01119404|Metabolic Syndrome|metabolic syndrome
1411050|NCT01119404|Coronary Heart Disease|coronary heart disease
1411051|NCT01119404|Erectile Dysfunction|erectile dysfunction
1411052|NCT01119404|Arterial Elasticity|arterial elasticity
1411053|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
1411054|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
1411055|NCT01119404|Risk Assessment|risk assessment
1411056|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
1411057|NCT01119404|Diabetes Mellitus|diabetes mellitus
1411058|NCT01119404|Surrogate Markers|surrogate markers
1411059|NCT01119404|Risk Factors|risk factors
1411060|NCT01119391|IVF|ivf
1411061|NCT01119391|Lifestyle habits|lifestyle habits
1411062|NCT01119378|Post menopausal|post menopausal
1411063|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
1411064|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
1411065|NCT01119378|Dual isotope technique|dual isotope technique
1411066|NCT01119365|Healthy controls|healthy controls
1411067|NCT01119352|Safety|safety
1411068|NCT01119352|tolerability|tolerability
1411069|NCT01119352|PK|pk
1411070|NCT01119352|healthy|healthy
1411071|NCT01119352|overweight|overweight
1411072|NCT01119352|obese|obese
1411073|NCT01119339|psoriasis|psoriasis
1411074|NCT01119339|topical|topical
1411075|NCT01119339|psoriasis plaques test|psoriasis plaques test
1411076|NCT01119326|scar prevention|scar prevention
1411077|NCT01119326|healing|healing
1411078|NCT01119326|tissue|tissue
1411079|NCT01119326|AFT|aft
1411080|NCT01119326|scar analysis|scar analysis
1411081|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
1411082|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
1411083|NCT01119287|Conjunctivitis|conjunctivitis
1411084|NCT01119287|ocular allergy|ocular allergy
1411085|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
1411086|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
1411087|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
1411088|NCT01119235|Pharmacokinetics|pharmacokinetics
1411089|NCT01119235|tablet performance|tablet performance
1411090|NCT01119235|healthy volunteers|healthy volunteers
1411091|NCT01119235|open label|open label
1411092|NCT01119222|Cold pain methodology|cold pain methodology
1411093|NCT01119222|Healthy male volunteers|healthy male volunteers
1411094|NCT01119222|gabapentin|gabapentin
1411095|NCT01119222|Diphenhydramine|diphenhydramine
1411096|NCT01119222|morphine|morphine
1411097|NCT01119209|Hip fracture|hip fracture
1411098|NCT01119209|intertrochanteric|intertrochanteric
1411099|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
1411100|NCT01119196|Insulin resistance|insulin resistance
1411101|NCT01119183|Patient understanding and counseling|patient understanding and counseling
1411102|NCT01119170|nutrition|nutrition
1411103|NCT01119170|infant formula|infant formula
1411104|NCT01119170|probiotics|probiotics
1411105|NCT01119157|influenza vaccine|influenza vaccine
1411106|NCT01119157|cellular immune response|cellular immune response
1411107|NCT01119157|humoral immune response|humoral immune response
1411108|NCT01119144|Orbital|orbital
1411109|NCT01119144|fractures|fractures
1411110|NCT01119144|enophthalmos|enophthalmos
1411111|NCT01119144|diplopia|diplopia
1411112|NCT01119144|eye|eye
1411113|NCT01119131|Vitamin D|vitamin d
1411114|NCT01119131|Parkinson disease|parkinson disease
1411115|NCT01119131|accidental falls|accidental falls
1411116|NCT01119118|Metastatic|metastatic
1411117|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1411118|NCT01119118|bone metastasis|bone metastasis
1411119|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
1411120|NCT01119105|bacteria|bacteria
1411121|NCT01119092|Ankle Sprain|ankle sprain
1411122|NCT01119092|Joint Mobilization|joint mobilization
1411123|NCT01119092|Manual Therapy|manual therapy
1411124|NCT01119092|Range of Motion|range of motion
1411125|NCT01119079|labor pain|labor pain
1411126|NCT01119079|epidural|epidural
1411127|NCT01119066|Leukemia|leukemia
1411128|NCT01119066|Multiple Myeloma|multiple myeloma
1411129|NCT01119066|radiation|radiation
1411130|NCT01119066|Thiotepa|thiotepa
1411131|NCT01119066|cyclophosphamide|cyclophosphamide
1411133|NCT01119066|Clofarabine|clofarabine
1411134|NCT01119066|CliniMACS device|clinimacs device
1411135|NCT01119066|GCSF|gcsf
1411136|NCT01119066|10-050|10-050
1411137|NCT01119053|VNS|vns
1411138|NCT01119053|Depression|depression
1411139|NCT01119053|Personality-Disorder|personality-disorder
1411140|NCT01119053|Stimulation|stimulation
1411141|NCT01119040|Dislodged PEG tube|dislodged peg tube
1411142|NCT01119040|NOTES|notes
1411143|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
1411144|NCT01119027|Colorectal Skills Training|colorectal skills training
1411145|NCT01119014|Aripiprazole|aripiprazole
1411146|NCT01119014|Quetiapine|quetiapine
1411147|NCT01119014|Psychosis|psychosis
1411148|NCT01119014|Child|child
1411149|NCT01119014|Adolescent|adolescent
1411150|NCT01118988|Peer Support|peer support
1411151|NCT01118988|Social Support|social support
1411152|NCT01118988|Chronic Pain|chronic pain
1411153|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
1411154|NCT01118988|Adolescents|adolescents
1411155|NCT01118988|Children|children
1411156|NCT01118988|Pediatric|pediatric
1411157|NCT01118988|Mentorship|mentorship
1411158|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
1411159|NCT01118988|CAM|cam
1411160|NCT01118988|Pain|pain
1411161|NCT01118988|Pain Management|pain management
1411162|NCT01118988|Behavioral|behavioral
1411163|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
1411164|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
1411165|NCT01118975|Cancer Stem Cells|cancer stem cells
1411166|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
1411167|NCT01118962|Absence Seizures|absence seizures
1411168|NCT01118962|Myoclonic Seizures|myoclonic seizures
1411169|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
1411170|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
1411171|NCT01118949|Absence Seizures|absence seizures
1411172|NCT01118949|Myoclonic Seizures|myoclonic seizures
1411173|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
1411174|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1411175|NCT01118936|Daily magnesium supplement|daily magnesium supplement
1411176|NCT01118936|EQ-5D|eq-5d
1411177|NCT01118923|Bronchial challenge test|bronchial challenge test
1411178|NCT01118923|Hyperreactivity|hyperreactivity
1411179|NCT01118923|PD20 for metacholine|pd20 for metacholine
1411180|NCT01118923|Daily magnesium supplement|daily magnesium supplement
1411181|NCT01118910|Intertrigo|intertrigo
1411182|NCT01118910|Vusion|vusion
1411183|NCT01118897|Gall bladder|gall bladder
1411184|NCT01118897|Pancreatic cancers|pancreatic cancers
1411185|NCT01118897|Tomotherapy|tomotherapy
1411186|NCT01118884|Midazolam|midazolam
1411187|NCT01118884|Nitrous oxide|nitrous oxide
1411188|NCT01118884|Behaviour management|behaviour management
1411189|NCT01118871|Treatment experienced|treatment experienced
1411190|NCT01118858|CYP2D6|cyp2d6
1411191|NCT01118858|CYP3A4|cyp3a4
1411192|NCT01118858|cytochrome P450|cytochrome p450
1411193|NCT01118858|children|children
1411195|NCT01118858|dextromethorphan|dextromethorphan
1411196|NCT01118858|phenotype|phenotype
1411197|NCT01118858|genotype|genotype
1411198|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1411199|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
1411200|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
1411201|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
1411202|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
1411203|NCT01118832|Thermography|thermography
1411204|NCT01118819|Phase I|phase i
1411205|NCT01118819|Metastatic Disease|metastatic disease
1411206|NCT01118819|Solid Tumor|solid tumor
1411207|NCT01118819|Malignancy|malignancy
1411208|NCT01118819|Metastases|metastases
1411209|NCT01118819|Clinical trial|clinical trial
1411210|NCT01118819|Hypoxia|hypoxia
1411211|NCT01118819|Necrosis|necrosis
1411212|NCT01118780|GAD|gad
1411213|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
1411214|NCT01118780|Anxiety|anxiety
1411215|NCT01118767|Adherence|adherence
1411216|NCT01118767|Appointment|appointment
1411217|NCT01118767|Cell Phone|cell phone
1411218|NCT01118767|Cellular Phone|cellular phone
1411219|NCT01118767|Clinic|clinic
1411220|NCT01118767|Computers|computers
1411221|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1411222|NCT01118767|HIV/AIDS|hiv/aids
1411223|NCT01118767|Health Informatics|health informatics
1411224|NCT01118767|Health behavior|health behavior
1411225|NCT01118767|Information Technology|information technology
1411226|NCT01118767|Internet|internet
1411227|NCT01118767|Intervention|intervention
1411228|NCT01118767|Medication|medication
1411229|NCT01118767|Patient Satisfaction|patient satisfaction
1411230|NCT01118767|Patient Self-Report|patient self-report
1411231|NCT01118767|Patients|patients
1411232|NCT01118767|Peru|peru
1411233|NCT01118767|Phone|phone
1411234|NCT01118767|Public Health|public health
1411235|NCT01118767|Public Health Informatics|public health informatics
1411236|NCT01118767|Randomized|randomized
1411237|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
1411238|NCT01118767|Randomized Controlled Trials|randomized controlled trials
1411239|NCT01118767|Research|research
1411240|NCT01118767|Secondary Prevention|secondary prevention
1411241|NCT01118767|Self-Report|self-report
1411242|NCT01118767|Sex Behavior|sex behavior
1411243|NCT01118767|Sexual Behavior|sexual behavior
1411244|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
1411245|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
1411246|NCT01118767|Survey Instrument|survey instrument
1411247|NCT01118767|Surveys|surveys
1411248|NCT01118767|Telephone|telephone
1411249|NCT01118767|Telephone, Cellular|telephone, cellular
1411250|NCT01118767|Text|text
1411251|NCT01118767|Unprotected Sex|unprotected sex
1411252|NCT01118767|Viral Load result|viral load result
1411253|NCT01118767|Vulnerable Populations|vulnerable populations
1411254|NCT01118767|WWW|www
1411255|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
1411256|NCT01118767|consumer informatics|consumer informatics
1411257|NCT01118767|evidence base|evidence base
1411258|NCT01118767|follow-up|follow-up
1411259|NCT01118767|medication adherence|medication adherence
1411260|NCT01118767|medication compliance|medication compliance
1411261|NCT01118767|randomization|randomization
1411262|NCT01118767|randomized controlled study|randomized controlled study
1411263|NCT01118767|randomized trial|randomized trial
1411264|NCT01118767|randomly assigned|randomly assigned
1411265|NCT01118767|safer sex|safer sex
1411266|NCT01118767|treatment adherence|treatment adherence
1411267|NCT01118767|user centered design|user centered design
1411269|NCT01118767|world wide web|world wide web
1411270|NCT01118754|Santen|santen
1411271|NCT01118754|Dry|dry
1411272|NCT01118754|Eye|eye
1411273|NCT01118741|Rising PSA|rising psa
1411274|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
1411275|NCT01118715|distal radius fracture|distal radius fracture
1411276|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
1411277|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
1411278|NCT01118715|compression glove|compression glove
1411279|NCT01118715|edema glove|edema glove
1411280|NCT01118702|Pharmacokinetic|pharmacokinetic
1411281|NCT01118702|Methylphenidate|methylphenidate
1411282|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
1411283|NCT01118702|Ritalin-SR|ritalin-sr
1411284|NCT01118702|CONCERTA|concerta
1411285|NCT01118702|Plasma profile|plasma profile
1411389|NCT01118247|Patient satisfaction|patient satisfaction
1411390|NCT01118234|CLL|cll
1411286|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
1411287|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
1411288|NCT01118650|Inattention|inattention
1411289|NCT01118650|Hyperactivity|hyperactivity
1411290|NCT01118650|Impulsivity|impulsivity
1411291|NCT01118637|trichotillomania|trichotillomania
1411292|NCT01118637|self-help|self-help
1411293|NCT01118637|web-based|web-based
1411294|NCT01118637|habit reversal|habit reversal
1411295|NCT01118637|behavior therapy|behavior therapy
1411296|NCT01118624|Female|female
1411297|NCT01118624|Advanced|advanced
1411298|NCT01118624|Metastatic|metastatic
1411299|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1411300|NCT01118598|PCOS|pcos
1411301|NCT01118585|GERD|gerd
1411302|NCT01118585|Esophagitis|esophagitis
1411303|NCT01118585|Fundoplication|fundoplication
1411304|NCT01118585|Anti-reflux surgery|anti-reflux surgery
1411305|NCT01118585|PPI dependent|ppi dependent
1411306|NCT01118572|Celecoxib|celecoxib
1411307|NCT01118572|Celecox|celecox
1411308|NCT01118572|Pain|pain
1411309|NCT01118572|Surgery|surgery
1411310|NCT01118572|NSAIDs|nsaids
1411311|NCT01118559|YM150|ym150
1411312|NCT01118559|Food effect|food effect
1411313|NCT01118559|Healthy volunteer|healthy volunteer
1411314|NCT01118546|aspirin|aspirin
1411315|NCT01118546|coronary artery disease|coronary artery disease
1411316|NCT01118546|hypersensitivity|hypersensitivity
1411317|NCT01118546|Platelet aggregation|platelet aggregation
1411318|NCT01118533|Intubation|intubation
1411319|NCT01118533|Sore throat|sore throat
1411320|NCT01118533|Blades|blades
1411321|NCT01118533|Laryngoscopy|laryngoscopy
1411322|NCT01118533|Morbidity|morbidity
1411323|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
1411324|NCT01118520|ACE Inhibition|ace inhibition
1411325|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
1411326|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
1411327|NCT01118507|maternal blood|maternal blood
1411328|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
1411329|NCT01118494|CKD|ckd
1411330|NCT01118494|RAS|ras
1411331|NCT01118494|AGT|agt
1411332|NCT01118481|Coronary stenosis|coronary stenosis
1411333|NCT01118481|Wave intensity analysis|wave intensity analysis
1411334|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
1411335|NCT01118481|iFR|ifr
1411336|NCT01118481|Fractional Flow Reserve|fractional flow reserve
1411337|NCT01118468|Competitive Flow|competitive flow
1411338|NCT01118468|Coronary artery bypass|coronary artery bypass
1411339|NCT01118468|Wave Intensity Analysis|wave intensity analysis
1411340|NCT01118442|Aortic Stenosis|aortic stenosis
1411341|NCT01118442|Coronary Flow|coronary flow
1411342|NCT01118442|Wave Intensity Analysis|wave intensity analysis
1411343|NCT01118429|hyperhidrosis|hyperhidrosis
1411344|NCT01118429|axillary|axillary
1411345|NCT01118429|osmidrosis|osmidrosis
1411346|NCT01118429|oxybutynin|oxybutynin
1411347|NCT01118416|sexual risk|sexual risk
1411348|NCT01118416|substance use|substance use
1411349|NCT01118416|HIV|hiv
1411350|NCT01118416|prevention|prevention
1411351|NCT01118416|intervention|intervention
1411352|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
1411353|NCT01118416|young men who have sex with men|young men who have sex with men
1411354|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
1411355|NCT01118403|Coma|coma
1411356|NCT01118403|Brain Injuries|brain injuries
1411357|NCT01118403|Intensive care units|intensive care units
1411358|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
1411359|NCT01118390|telangiectasias|telangiectasias
1411360|NCT01118390|leg|leg
1411361|NCT01118390|sclerotherapy|sclerotherapy
1411362|NCT01118390|laser|laser
1411363|NCT01118390|glycose|glycose
1411364|NCT01118364|Social circumstances|social circumstances
1411365|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
1411366|NCT01118325|Platelet Aggregation|platelet aggregation
1411367|NCT01118312|Asthma|asthma
1411368|NCT01118312|Rhinitis|rhinitis
1411369|NCT01118312|Sinusitis|sinusitis
1411370|NCT01118312|Chronic|chronic
1411371|NCT01118312|ACRC|acrc
1411372|NCT01118312|STAN|stan
1411373|NCT01118312|Nasal steroid|nasal steroid
1411374|NCT01118312|Mometasone|mometasone
1411375|NCT01118312|Nasal spray|nasal spray
1411376|NCT01118286|Hypertension|hypertension
1411377|NCT01118286|Drug therapy, combination|drug therapy, combination
1411378|NCT01118273|Naproxen sodium|naproxen sodium
1411379|NCT01118273|Diphenhydramine|diphenhydramine
1411380|NCT01118273|Drugs, Investigational|drugs, investigational
1411381|NCT01118260|prostata hyperplasia|prostata hyperplasia
1411382|NCT01118260|transurethral resection|transurethral resection
1411383|NCT01118260|TIVA|tiva
1411384|NCT01118260|spinal anaesthesia|spinal anaesthesia
1411385|NCT01118247|Uncemented THA|uncemented tha
1411386|NCT01118247|alumina-on-alumina|alumina-on-alumina
1411387|NCT01118247|survival|survival
1411391|NCT01118234|Rituximab|rituximab
1411392|NCT01118234|Maintenance|maintenance
1411393|NCT01118221|oxidant stress|oxidant stress
1411394|NCT01118221|exercise|exercise
1411395|NCT01118208|Medication adherence|medication adherence
1411396|NCT01118208|Accidental overdose|accidental overdose
1411397|NCT01118208|Deliberate overdose|deliberate overdose
1411398|NCT01118208|Suicide, attempted|suicide, attempted
1411399|NCT01118182|Traumatic Brain Injury|traumatic brain injury
1411400|NCT01118182|Veterans|veterans
1411401|NCT01118182|Psychiatric Disorders|psychiatric disorders
1411402|NCT01118182|Suicide|suicide
1411403|NCT01118169|Personal values|personal values
1411404|NCT01118169|Suicidal thoughts|suicidal thoughts
1411405|NCT01118156|Suicide Nomenclature|suicide nomenclature
1411406|NCT01118130|Genetics|genetics
1411407|NCT01118130|genomics|genomics
1411408|NCT01118130|Multiple Sclerosis|multiple sclerosis
1411409|NCT01118130|beta-interferons|beta-interferons
1411410|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
1411411|NCT01118117|occlusions|occlusions
1411412|NCT01118117|Superficial Femoral Artery|superficial femoral artery
1411413|NCT01118117|SFA|sfa
1411414|NCT01118091|Immunotherapy|immunotherapy
1411415|NCT01118091|Metastatic Melanoma|metastatic melanoma
1411416|NCT01118091|Randomized|randomized
1411417|NCT01118091|Cell Therapy|cell therapy
1411418|NCT01118091|Skin Cancer|skin cancer
1411419|NCT01118091|Melanoma|melanoma
1411420|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
1411421|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
1411422|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1411423|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1411424|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1411425|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1411426|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1411427|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1411428|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1411429|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1411430|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1411431|NCT01118039|distal urethral cancer|distal urethral cancer
1411432|NCT01118039|proximal urethral cancer|proximal urethral cancer
1411433|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
1411434|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
1411435|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
1411436|NCT01118039|stage III bladder cancer|stage iii bladder cancer
1411437|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1411438|NCT01118039|stage III urethral cancer|stage iii urethral cancer
1411439|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
1411440|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1411441|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1411442|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
1411443|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1411444|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1411445|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1411446|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1411447|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
1411448|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1411449|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1411450|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1411451|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1411452|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1411453|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1411454|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
1411455|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1411456|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1411457|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1411458|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1411459|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1411460|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1411461|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1411462|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1411463|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1411464|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1411465|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1411736|NCT01117155|Astrocytoma|astrocytoma
1411466|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1411467|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1411468|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1411469|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1411470|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1411539|NCT01117883|central venous pressure|central venous pressure
1411471|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1411472|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1411473|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1411474|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1411475|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1411476|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1411477|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1411478|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1411479|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1411480|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1411481|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1411482|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1411483|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1411484|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1411485|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
1411486|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
1411487|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
1411488|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
1411489|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1411490|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1411491|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1411492|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1411493|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1411494|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1411495|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1411496|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1411497|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1411498|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1411499|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1411500|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1411501|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1411502|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1411503|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1411504|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1411505|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1411506|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1411507|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1411508|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1411509|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1411510|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1411511|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1411512|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1411513|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
1411514|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1411515|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1411516|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1411517|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1411518|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1411519|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1411520|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1411521|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
1411522|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
1411523|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
1411525|NCT01117935|prostate cancer|prostate cancer
1411526|NCT01117935|radiation therapy|radiation therapy
1411527|NCT01117935|external beam|external beam
1411528|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
1411529|NCT01117922|preterm birth|preterm birth
1411530|NCT01117922|interconceptional intervention|interconceptional intervention
1411531|NCT01117922|pregnancy outcomes|pregnancy outcomes
1411532|NCT01117909|ankle sprain|ankle sprain
1411533|NCT01117909|athletic injury|athletic injury
1411534|NCT01117909|arthritis|arthritis
1411536|NCT01117896|Rescuer fatigue|rescuer fatigue
1411537|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
1411538|NCT01117883|Perfusion pressures|perfusion pressures
1411540|NCT01117883|cardiac output|cardiac output
1411541|NCT01117883|CPR|cpr
1411542|NCT01117883|cardiac arrest|cardiac arrest
1411543|NCT01117883|Leaning|leaning
1411544|NCT01117883|incomplete release|incomplete release
1411545|NCT01117870|chronic|chronic
1411546|NCT01117870|pain|pain
1411547|NCT01117870|lumbar|lumbar
1411548|NCT01117870|Radicular|radicular
1411549|NCT01117831|Diabetes mellitus|diabetes mellitus
1411550|NCT01117805|Asthma|asthma
1411551|NCT01117779|kidney tumors|kidney tumors
1411552|NCT01117779|renal tumors|renal tumors
1411553|NCT01117779|renal cell carcinoma|renal cell carcinoma
1411554|NCT01117779|kidney lesions|kidney lesions
1411555|NCT01117779|renal lesions|renal lesions
1411556|NCT01117779|cryoablation|cryoablation
1411557|NCT01117779|cryotherapy|cryotherapy
1411558|NCT01117779|cryosurgery|cryosurgery
1411559|NCT01117766|Methodology|methodology
1411560|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
1411561|NCT01117766|Neuropathies Pain|neuropathies pain
1411562|NCT01117766|Pregabalin|pregabalin
1411563|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
1411564|NCT01117740|MPE|mpe
1411565|NCT01117740|Lungs|lungs
1411566|NCT01117740|Quality of Life|quality of life
1411567|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
1411568|NCT01117740|MDASI|mdasi
1411569|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
1411570|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
1411571|NCT01117740|Symptom burden|symptom burden
1411572|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
1411573|NCT01117740|Complications|complications
1411574|NCT01117740|Health care resource utilization|health care resource utilization
1411575|NCT01117714|Lung cancer|lung cancer
1411576|NCT01117714|Lung neoplasm|lung neoplasm
1568387|NCT00506051|vandetanib|vandetanib
1411577|NCT01117714|Pulmonary cancer|pulmonary cancer
1411578|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
1411579|NCT01117714|Lung cancer staging|lung cancer staging
1411580|NCT01117688|Ureteroscopy|ureteroscopy
1411581|NCT01117675|Telemedicine|telemedicine
1411582|NCT01117675|Home care|home care
1411583|NCT01117675|Chronic HIV infection|chronic hiv infection
1411584|NCT01117675|HIV-infected patients|hiv-infected patients
1411585|NCT01117662|transplantation|transplantation
1411586|NCT01117662|acute rejection|acute rejection
1411588|NCT01117649|PVR|pvr
1411589|NCT01117649|HES 130|hes 130
1411590|NCT01117649|pancreatic head|pancreatic head
1411591|NCT01117649|goal-directed|goal-directed
1411592|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
1411593|NCT01117636|Aspirin|aspirin
1411594|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
1411595|NCT01117623|BAY73-4506|bay73-4506
1411596|NCT01117610|pain|pain
1411597|NCT01117610|preemptive|preemptive
1411598|NCT01117610|postoperative|postoperative
1411599|NCT01117610|epidural injection|epidural injection
1411600|NCT01117610|laminectomy|laminectomy
1411601|NCT01117597|Healthy subjects|healthy subjects
1411602|NCT01117584|Type 2 diabetes|type 2 diabetes
1411603|NCT01117584|ASP1941|asp1941
1411604|NCT01117584|diabetes|diabetes
1411605|NCT01117584|metformin|metformin
1411606|NCT01117571|knee|knee
1411607|NCT01117571|osteoarthritis|osteoarthritis
1411608|NCT01117571|unicompartmental|unicompartmental
1411609|NCT01117571|arthroplasty|arthroplasty
1411610|NCT01117571|knee resurfacing|knee resurfacing
1411611|NCT01117571|Conformis|conformis
1411612|NCT01117571|patient specific|patient specific
1411613|NCT01117558|PCOS,|pcos,
1411614|NCT01117558|DM,|dm,
1411615|NCT01117558|Hypertension,|hypertension,
1411616|NCT01117558|CVD|cvd
1411617|NCT01117545|veterans,|veterans,
1411618|NCT01117545|PTSD,|ptsd,
1411619|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
1411620|NCT01117545|depression,|depression,
1411621|NCT01117545|anxiety|anxiety
1411622|NCT01117532|students,|students,
1411623|NCT01117532|depression,|depression,
1411624|NCT01117532|group therapy,|group therapy,
1411625|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
1411626|NCT01117532|energy psychology|energy psychology
1411627|NCT01117519|fluid and volume management|fluid and volume management
1411628|NCT01117519|acid-base balance|acid-base balance
1411629|NCT01117519|goal-directed therapy|goal-directed therapy
1411630|NCT01117519|transoesophageal doppler|transoesophageal doppler
1411631|NCT01117506|Angina Pectoris|angina pectoris
1411632|NCT01117506|Myocardial Ischemia|myocardial ischemia
1411633|NCT01117506|Molecular Genetics|molecular genetics
1411634|NCT01117506|Atherosclerosis|atherosclerosis
1411635|NCT01117506|Corus CAD|corus cad
1411636|NCT01117506|ASGES|asges
1411637|NCT01117506|Age/Sex/Gene Expression Score|age/sex/gene expression score
1411638|NCT01117506|Gene Expression|gene expression
1411639|NCT01117506|GES|ges
1411640|NCT01117506|CAD|cad
1411641|NCT01117506|CVD|cvd
1411642|NCT01117506|CHD|chd
1411643|NCT01117506|Precision Medicine|precision medicine
1411644|NCT01117506|Clinical Validity|clinical validity
1411750|NCT01117103|Type 2 diabetes|type 2 diabetes
1411645|NCT01117506|Myocardial Perfusion Imaging|myocardial perfusion imaging
1411646|NCT01117506|Coronary Artery Disease|coronary artery disease
1411647|NCT01117506|Chest Pain|chest pain
1411648|NCT01117506|Cardiovascular Disease|cardiovascular disease
1411649|NCT01117506|Coronary Heart Disease|coronary heart disease
1411650|NCT01117506|MPI|mpi
1411651|NCT01117506|COMPASS|compass
1411652|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1411653|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
1411654|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
1411655|NCT01117480|Adalimumab|adalimumab
1411656|NCT01117480|Clinical Effectiveness|clinical effectiveness
1411657|NCT01117467|Simulation|simulation
1411658|NCT01117467|Learning|learning
1411659|NCT01117467|Medical Students|medical students
1411660|NCT01117467|Empathy|empathy
1411661|NCT01117467|Anxiety|anxiety
1411662|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
1411663|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1411664|NCT01117454|flecainide|flecainide
1411665|NCT01117428|Advanced solid tumors|advanced solid tumors
1411666|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
1411667|NCT01117415|Gall Bladder|gall bladder
1411668|NCT01117415|Cholecystectomy|cholecystectomy
1411669|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
1411670|NCT01117402|Vault carcinoma|vault carcinoma
1411671|NCT01117402|Tomotherapy|tomotherapy
1411672|NCT01117402|Brachytherapy|brachytherapy
1411673|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
1411674|NCT01117389|Childhood cancer survivors|childhood cancer survivors
1411675|NCT01117389|cervical cancer|cervical cancer
1411676|NCT01117389|sexually transmitted infection|sexually transmitted infection
1411677|NCT01117376|Gastroparesis|gastroparesis
1411678|NCT01117376|Erythromycin|erythromycin
1411679|NCT01117376|Methylnaltrexone|methylnaltrexone
1411680|NCT01117376|ICU|icu
1411681|NCT01117363|Appetite whole grain|appetite whole grain
1411682|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
1411683|NCT01117324|Bone density|bone density
1411684|NCT01117324|infant of diabetic mother|infant of diabetic mother
1411685|NCT01117324|large birth weight|large birth weight
1411686|NCT01117311|Vagus|vagus
1411687|NCT01117311|Diabetes|diabetes
1411688|NCT01117311|Obesity|obesity
1411689|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
1411690|NCT01117298|ischemic ulcers|ischemic ulcers
1411691|NCT01117298|digital ulcers|digital ulcers
1411692|NCT01117298|digital infarcts|digital infarcts
1411693|NCT01117298|gangrene|gangrene
1411694|NCT01117298|vasodilators|vasodilators
1411695|NCT01117298|endothelial dysfunction|endothelial dysfunction
1411696|NCT01117298|scleroderma|scleroderma
1411697|NCT01117285|Occupational Therapy|occupational therapy
1411698|NCT01117285|Evidence-Based Practice|evidence-based practice
1411699|NCT01117285|Continuing Education|continuing education
1411700|NCT01117285|utilization|utilization
1411701|NCT01117285|Guideline|guideline
1411702|NCT01117285|Dementia|dementia
1411703|NCT01117285|Guideline implementation|guideline implementation
1411704|NCT01117272|PCOS|pcos
1411705|NCT01117272|hyperprolactinemia|hyperprolactinemia
1411706|NCT01117272|obesity|obesity
1411707|NCT01117272|hyperandrogenic|hyperandrogenic
1411708|NCT01117246|bone metastasis|bone metastasis
1411709|NCT01117246|pain palliation|pain palliation
1411710|NCT01117233|Healthy volunteers|healthy volunteers
1411711|NCT01117233|PK|pk
1411712|NCT01117233|PD|pd
1411713|NCT01117233|safety and toleration|safety and toleration
1411714|NCT01117220|pediatric|pediatric
1411715|NCT01117220|bipolar|bipolar
1411716|NCT01117181|Alzheimer's disease|alzheimer's disease
1411717|NCT01117181|Apathy|apathy
1411718|NCT01117181|Methylphenidate|methylphenidate
1411719|NCT01117181|Dopaminergic agents|dopaminergic agents
1411720|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
1411721|NCT01117181|Dementia|dementia
1411722|NCT01117168|Children's Oncology Group|children's oncology group
1411723|NCT01117168|Pediatric Oncology|pediatric oncology
1411724|NCT01117168|Pediatric Cancer|pediatric cancer
1411725|NCT01117168|Registration|registration
1411726|NCT01117168|Leukemia|leukemia
1411727|NCT01117168|Brain Tumor|brain tumor
1411728|NCT01117168|Sarcoma|sarcoma
1411729|NCT01117155|Brain Tumor|brain tumor
1411730|NCT01117155|Imaging|imaging
1411731|NCT01117155|FLT|flt
1411732|NCT01117155|FDG|fdg
1411733|NCT01117155|Spectroscopy|spectroscopy
1411734|NCT01117155|Glioma|glioma
1411735|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
1411738|NCT01117142|MBL|mbl
1411739|NCT01117142|SLL|sll
1411740|NCT01117142|MCL|mcl
1411741|NCT01117142|Growth|growth
1411742|NCT01117142|Development|development
1411743|NCT01117142|Aging|aging
1411744|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1411745|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
1411746|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1411747|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
1411748|NCT01117142|Healthy Volunteer|healthy volunteer
1411749|NCT01117142|HV|hv
1411751|NCT01117103|Diabetes Mellitus|diabetes mellitus
1411752|NCT01117103|Glucophage|glucophage
1411753|NCT01117103|Metformin|metformin
1411754|NCT01117090|Feasibility|feasibility
1411755|NCT01117090|SynchroMed II|synchromed ii
1411756|NCT01117090|Intrathecal catheter|intrathecal catheter
1411757|NCT01117090|Baclofen|baclofen
1411758|NCT01117077|liver transplantation|liver transplantation
1411759|NCT01117077|aspergillus infection|aspergillus infection
1411760|NCT01117077|interleukin-17|interleukin-17
1411761|NCT01117077|Treg cell|treg cell
1411762|NCT01117077|immune tolerance|immune tolerance
1411763|NCT01117064|Sleep Apnea|sleep apnea
1411764|NCT01117064|OSA|osa
1411765|NCT01117064|CPAP|cpap
1411766|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
1411767|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
1411768|NCT01117038|ED|ed
1411769|NCT01117038|Erectile Dysfunction|erectile dysfunction
1411770|NCT01117025|Resistant hypertension|resistant hypertension
1411771|NCT01117025|Atrial Fibrillation|atrial fibrillation
1411772|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
1411773|NCT01116986|Smoking|smoking
1411774|NCT01116986|Smoking Cessation|smoking cessation
1411775|NCT01116986|Nicotine|nicotine
1411776|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
1411777|NCT01116960|P4P|p4p
1411778|NCT01116947|Hypoalbuminemia|hypoalbuminemia
1411779|NCT01116947|Hyperphosphatemia|hyperphosphatemia
1411780|NCT01116947|Phosphorus|phosphorus
1411781|NCT01116947|Protein|protein
1411782|NCT01116947|CKD|ckd
1411783|NCT01116947|Dialysis|dialysis
1411784|NCT01116947|Meals|meals
1411785|NCT01116947|Lanthanum|lanthanum
1411786|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
1411787|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
1411788|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
1411789|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
1411790|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
1411791|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
1411792|NCT01116921|laryngeal mask airway|laryngeal mask airway
1411793|NCT01116921|surfactant|surfactant
1411794|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
1411795|NCT01116921|neonate|neonate
1411796|NCT01116908|Diarrhea|diarrhea
1411797|NCT01116908|Water|water
1411798|NCT01116908|Household Water Treatment|household water treatment
1411799|NCT01116908|HIV|hiv
1411800|NCT01116908|Infant Health|infant health
1411801|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
1411802|NCT01116895|Systemic|systemic
1411803|NCT01116895|Anti-psoriatic|anti-psoriatic
1411804|NCT01116882|PCI|pci
1411805|NCT01116882|heart disease|heart disease
1411806|NCT01116882|ischemic heart disease|ischemic heart disease
1411807|NCT01116869|MBC|mbc
1411808|NCT01116869|Healthy|healthy
1411809|NCT01116869|Benign disease|benign disease
1411810|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
1411811|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
1411812|NCT01116869|Benign Breast Disease|benign breast disease
1411813|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
1411814|NCT01116856|Exercise|exercise
1411815|NCT01116856|Training|training
1411816|NCT01116856|Obesity|obesity
1411817|NCT01116856|Overweight|overweight
1411818|NCT01116856|Body composition|body composition
1411819|NCT01116856|Lipidic profile|lipidic profile
1411820|NCT01116856|Nutrition|nutrition
1411821|NCT01116856|Polymorphisms|polymorphisms
1411822|NCT01116843|Oral cavity cancer|oral cavity cancer
1411823|NCT01116843|No prior treatment|no prior treatment
1411824|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
1411825|NCT01116817|neurocognitive performance|neurocognitive performance
1411826|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
1411827|NCT01116804|Primary liver cancer|primary liver cancer
1411828|NCT01116791|cytoreductive surgery|cytoreductive surgery
1411829|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
1411830|NCT01116791|cisplatin|cisplatin
1411831|NCT01116791|cancer|cancer
1411832|NCT01116791|gastric|gastric
1411833|NCT01116791|biliary|biliary
1411834|NCT01116791|pancreas|pancreas
1411835|NCT01116791|peritoneal metastases|peritoneal metastases
1411836|NCT01116791|liver metastases|liver metastases
1411837|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
1411838|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
1411839|NCT01116778|probiotics|probiotics
1411840|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
1411841|NCT01116778|efficacy and safety|efficacy and safety
1411842|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
1411843|NCT01116752|Intensive Care|intensive care
1411844|NCT01116752|Critical care|critical care
1411845|NCT01116752|Glycemic Control|glycemic control
1411846|NCT01116752|Hypoglycemia|hypoglycemia
1411847|NCT01116752|Hyperglycemia|hyperglycemia
1411848|NCT01116752|Insulin treatment|insulin treatment
1411849|NCT01116752|Organ Function|organ function
1411850|NCT01116752|PELOD|pelod
1411851|NCT01116752|Outcomes|outcomes
1411852|NCT01116752|Pediatrics|pediatrics
1411853|NCT01116713|Mastectomy|mastectomy
1411854|NCT01116713|Breast cancer|breast cancer
1411855|NCT01116713|Postoperative pain|postoperative pain
1411856|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
1411857|NCT01116700|Epilepsy|epilepsy
1411858|NCT01116700|Dexmedetomidine|dexmedetomidine
1411859|NCT01116700|Seizure|seizure
1411860|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
1411861|NCT01116661|glioma|glioma
1411862|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
1411863|NCT01116635|chemoembolization|chemoembolization
1411864|NCT01116635|drug eluting microsphere|drug eluting microsphere
1411865|NCT01116635|hepato|hepato
1411866|NCT01116635|embolotherapy|embolotherapy
1411867|NCT01116635|downstage|downstage
1411868|NCT01116622|Aerodigestive|aerodigestive
1411869|NCT01116622|Targretin|targretin
1411870|NCT01116622|Tarceva|tarceva
1411871|NCT01116609|Phenylalanine|phenylalanine
1411872|NCT01116609|Palmitate|palmitate
1411873|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
1411874|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
1411875|NCT01116596|Glutathione|glutathione
1411876|NCT01116596|Paracetamol|paracetamol
1411877|NCT01116596|elderly people|elderly people
1411878|NCT01116583|Gabapentin|gabapentin
1411879|NCT01116583|Thoracotomy|thoracotomy
1411880|NCT01116583|Pain, Postoperative|pain, postoperative
1411881|NCT01116583|Analgesia|analgesia
1411882|NCT01116583|Recovery of Function|recovery of function
1411883|NCT01116583|Quality of Life|quality of life
1411884|NCT01116570|Muscular Dystrophy|muscular dystrophy
1411885|NCT01116570|Facioscapulohumeral|facioscapulohumeral
1411886|NCT01116570|Physical training|physical training
1411887|NCT01116570|Exercise|exercise
1411888|NCT01116557|radiofrequency|radiofrequency
1411889|NCT01116557|ablation|ablation
1411890|NCT01116557|atrial fibrillation|atrial fibrillation
1411892|NCT01116557|THERMOCOOL|thermocool
1411893|NCT01116557|LASSO|lasso
1411894|NCT01116557|PVAC|pvac
1411895|NCT01116544|AMES device|ames device
1411896|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
1411897|NCT01116544|Chronic Stroke|chronic stroke
1411898|NCT01116544|Rehabilitation|rehabilitation
1411899|NCT01116544|Upper Extremity|upper extremity
1411900|NCT01116544|Biofeedback|biofeedback
1411901|NCT01116531|Pharmacokinetics|pharmacokinetics
1411902|NCT01116531|Pharmacodynamics|pharmacodynamics
1411903|NCT01116531|Interaction|interaction
1411904|NCT01116531|tramadol|tramadol
1411905|NCT01116531|duloxetine|duloxetine
1411906|NCT01116531|pregabalin|pregabalin
1411907|NCT01116505|Celiac disease|celiac disease
1411908|NCT01116505|Endomysial antibodies|endomysial antibodies
1411909|NCT01116505|Gluten-free diet|gluten-free diet
1411910|NCT01116505|Screen-detected|screen-detected
1411911|NCT01116505|Asymptomatic|asymptomatic
1411912|NCT01116505|Bone mineral density|bone mineral density
1411913|NCT01116492|SILS|sils
1411914|NCT01116492|Inflammatory reaction|inflammatory reaction
1411915|NCT01116492|a-defensins|a-defensins
1411916|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
1411917|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
1411918|NCT01116453|dysmenorrhea|dysmenorrhea
1411919|NCT01116453|acupuncture|acupuncture
1411920|NCT01116453|randomized controlled trial|randomized controlled trial
1411921|NCT01116440|Menstrual pain|menstrual pain
1411922|NCT01116440|Refractory endometriosis|refractory endometriosis
1411923|NCT01116440|Pelvic pain|pelvic pain
1411924|NCT01116427|MS|ms
1411925|NCT01116427|multiple sclerosis|multiple sclerosis
1411926|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1411927|NCT01116427|RRMS|rrms
1411928|NCT01116401|Hot Flashes|hot flashes
1411929|NCT01116401|Sleep disturbance|sleep disturbance
1411930|NCT01116401|Lupron|lupron
1411931|NCT01116401|Menopause|menopause
1411932|NCT01116388|Autism|autism
1411933|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
1411934|NCT01116388|Food Allergy|food allergy
1411935|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
1411936|NCT01116388|Diarrhea|diarrhea
1411937|NCT01116388|Constipation|constipation
1411938|NCT01116388|Reflux|reflux
1411939|NCT01116388|Abdominal pain|abdominal pain
1411940|NCT01116388|Pain after eating|pain after eating
1411941|NCT01116388|Self injurious behavior|self injurious behavior
1411942|NCT01116375|Obesity|obesity
1411944|NCT01116375|PAP therapy|pap therapy
1411945|NCT01116362|ulna|ulna
1411946|NCT01116362|median|median
1411947|NCT01116362|repair|repair
1411948|NCT01116362|primary|primary
1411949|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
1411950|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
1411951|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
1411952|NCT01116349|Hanging Support System|hanging support system
1411953|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
1411954|NCT01116336|Head and neck tumors|head and neck tumors
1411955|NCT01116336|Cancer of head and neck|cancer of head and neck
1411956|NCT01116323|Adverse events|adverse events
1411957|NCT01116323|Adverse effects|adverse effects
1411958|NCT01116323|Emergency Service, Hospital|emergency service, hospital
1411959|NCT01116323|Emergency department|emergency department
1411960|NCT01116323|Crowding|crowding
1411961|NCT01116310|Hot flushes|hot flushes
1411962|NCT01116310|Hot flashes|hot flashes
1411963|NCT01116310|menopause|menopause
1411964|NCT01116310|postmenopause|postmenopause
1411965|NCT01116310|Soy isoflavones|soy isoflavones
1411966|NCT01116310|Red clover|red clover
1411967|NCT01116310|Equol|equol
1411968|NCT01116297|breast reconstruction|breast reconstruction
1411969|NCT01116297|breast cancer|breast cancer
1411970|NCT01116297|near infrared imaging|near infrared imaging
1411971|NCT01116284|Weight Loss|weight loss
1411972|NCT01116284|Obesity|obesity
1411973|NCT01116284|Gastric Bypass|gastric bypass
1411974|NCT01116271|colorectal|colorectal
1411975|NCT01116271|second line therapy|second line therapy
1411976|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
1411977|NCT01116271|response rate|response rate
1411978|NCT01116271|Progression Free Survival|progression free survival
1411979|NCT01116258|Safety|safety
1411980|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
1411981|NCT01116232|graft versus host disease|graft versus host disease
1411982|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1411983|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1411984|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1411985|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1411986|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1411987|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1411988|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1411989|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1411990|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1411991|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1411992|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1411993|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1411994|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1411995|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1411996|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
1411997|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1411998|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1411999|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1412000|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1412001|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
1412002|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1412003|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1412004|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1412005|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1412006|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1412007|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1412008|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1412009|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1412010|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1412011|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1412012|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1412013|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1412014|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
1412015|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1412016|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1412017|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1412018|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1412019|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1412020|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1412021|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1412022|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1412023|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1412024|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1412025|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1412026|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1412027|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1412028|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1412029|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1412030|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1412031|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1412032|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1412033|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1412034|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1412035|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1412036|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1412037|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1412038|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1412039|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1412040|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1412041|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1412042|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1412043|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1412044|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1412045|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1412046|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1412047|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1412048|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1412049|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1412050|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1412051|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1412052|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1412053|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1412054|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1412055|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1412056|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1412057|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1412058|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1412059|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1412060|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1412061|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1412062|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1412063|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1412064|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1412065|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1412066|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1412067|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1412068|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1412174|NCT01115985|Healthy volunteer|healthy volunteer
1412069|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1412070|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1412071|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1412072|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1412073|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1412074|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1412075|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1412076|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1412077|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1412078|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1412079|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1412954|NCT01112865|Convenience|convenience
1412080|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1412081|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1412082|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1412083|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1412084|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1412085|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1412086|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1412087|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1412088|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1412089|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1412090|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1412091|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1412092|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1412093|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1568388|NCT00506051|phase 1|phase 1
1412094|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1412095|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1412096|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1412097|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1412098|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1412099|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1412100|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1412101|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1412102|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1412103|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1412104|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1412105|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1412106|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1412107|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1412108|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1412109|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1412110|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1412111|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1412112|NCT01116232|intraocular lymphoma|intraocular lymphoma
1412113|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1412114|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1412115|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1412116|NCT01116232|primary myelofibrosis|primary myelofibrosis
1412117|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
1412118|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
1412119|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
1412120|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
1412121|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1412122|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1412123|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1412124|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
1412125|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1412126|NCT01116219|large cell lung cancer|large cell lung cancer
1412127|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1412128|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1412129|NCT01116206|Constipation|constipation
1412130|NCT01116206|Prucalopride|prucalopride
1412131|NCT01116206|Resolor|resolor
1412132|NCT01116193|antileukemic therapy|antileukemic therapy
1412133|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
1412134|NCT01116193|lenalidomide|lenalidomide
1412135|NCT01116193|dexamethasone|dexamethasone
1412136|NCT01116180|Type 1 diabetes|type 1 diabetes
1412137|NCT01116180|Hypoglycaemia|hypoglycaemia
1412138|NCT01116180|genetic susceptibility|genetic susceptibility
1412139|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
1412140|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
1412141|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
1412142|NCT01116141|MTX|mtx
1412143|NCT01116141|CH-405|ch-405
1412144|NCT01116141|antifolates|antifolates
1412145|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
1412146|NCT01116128|Progression free survival|progression free survival
1412147|NCT01116128|Overall survival|overall survival
1412148|NCT01116128|dasatinib|dasatinib
1412149|NCT01116115|Term Infants|term infants
1412150|NCT01116115|Intestine flora|intestine flora
1412151|NCT01116115|Stool characteristics|stool characteristics
1412152|NCT01116102|dehydration|dehydration
1412153|NCT01116102|fluid therapy|fluid therapy
1412154|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1412155|NCT01116102|hyaluronidase|hyaluronidase
1412156|NCT01116102|hypodermoclysis|hypodermoclysis
1412157|NCT01116102|clysis|clysis
1412158|NCT01116102|subcutaneous hydration|subcutaneous hydration
1412159|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
1412160|NCT01116102|hyaluronan|hyaluronan
1412161|NCT01116102|rHuPH20|rhuph20
1412162|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
1412163|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
1412164|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
1412165|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
1412166|NCT01116011|Phase I|phase i
1412167|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
1412168|NCT01115998|cerebral palsy|cerebral palsy
1412169|NCT01115998|wheelchair|wheelchair
1412170|NCT01115998|disabled children|disabled children
1412171|NCT01115985|ASP1585|asp1585
1412172|NCT01115985|Drug-drug interaction|drug-drug interaction
1412173|NCT01115985|Atorvastatin|atorvastatin
1412175|NCT01115972|ASP1585|asp1585
1412176|NCT01115972|Drug-drug interaction|drug-drug interaction
1412177|NCT01115972|valsartan|valsartan
1412178|NCT01115972|Healthy volunteer|healthy volunteer
1412179|NCT01115946|ASP1585|asp1585
1412180|NCT01115946|Drug-drug interaction|drug-drug interaction
1412181|NCT01115946|enalapril|enalapril
1412182|NCT01115946|Healthy volunteer|healthy volunteer
1412183|NCT01115933|drug eluting stents|drug eluting stents
1412184|NCT01115933|small vessel|small vessel
1412185|NCT01115933|Stents|stents
1412186|NCT01115933|Everolimus|everolimus
1412187|NCT01115933|Angioplasty|angioplasty
1412188|NCT01115920|Drug Safety|drug safety
1412189|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
1412190|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
1412191|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
1412192|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
1412193|NCT01115907|Aortic|aortic
1412194|NCT01115907|Valve replacement|valve replacement
1412195|NCT01115894|problem drinking|problem drinking
1412196|NCT01115894|alcohol|alcohol
1412197|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
1412198|NCT01115855|Double-blind|double-blind
1412199|NCT01115855|eplerenone|eplerenone
1412200|NCT01115855|Japanese|japanese
1412201|NCT01115842|Vitamin D|vitamin d
1412202|NCT01115842|Acute coronary syndrome|acute coronary syndrome
1412203|NCT01115842|inflammatory cytokines|inflammatory cytokines
1412204|NCT01115803|Advanced Cancer|advanced cancer
1412205|NCT01115803|Metastatic Cancer|metastatic cancer
1412206|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
1412207|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
1412208|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
1412209|NCT01115777|Pediatric patients|pediatric patients
1412210|NCT01115777|treated with|treated with
1412211|NCT01115777|radiation therapy|radiation therapy
1412212|NCT01115777|for brain tumors|for brain tumors
1412213|NCT01115777|and non-CNS malignancies|and non-cns malignancies
1412214|NCT01115764|diastolic dysfunction|diastolic dysfunction
1412215|NCT01115751|Advanced Cancer|advanced cancer
1412216|NCT01115751|Metastatic Cancer|metastatic cancer
1412217|NCT01115751|Solid Tumors|solid tumors
1412218|NCT01115738|Plavix, Effient|plavix, effient
1412219|NCT01115725|Follitropin alfa|follitropin alfa
1412220|NCT01115725|Fertilization in vitro|fertilization in vitro
1412221|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1412222|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
1412223|NCT01115712|Healthy Volunteers|healthy volunteers
1412224|NCT01115699|Depression|depression
1412225|NCT01115699|rTMS|rtms
1412226|NCT01115660|stroke|stroke
1412227|NCT01115660|patient education|patient education
1412228|NCT01115660|medication adherence|medication adherence
1412229|NCT01115647|Malnutrition|malnutrition
1412230|NCT01115647|Nutritional intervention|nutritional intervention
1412231|NCT01115647|Behavioural intervention|behavioural intervention
1412232|NCT01115647|Burkina Faso|burkina faso
1412233|NCT01115647|Cluster randomize trial|cluster randomize trial
1412234|NCT01115634|Fibroblast|fibroblast
1412235|NCT01115634|Cell transplantation|cell transplantation
1412236|NCT01115634|Facial deformities|facial deformities
1412237|NCT01115608|Preventive Health Services|preventive health services
1412438|NCT01114789|obesity|obesity
1412238|NCT01115595|Allergic rhinitis|allergic rhinitis
1412239|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
1412240|NCT01115595|Efficacy|efficacy
1412241|NCT01115582|Inborn Errors|inborn errors
1412242|NCT01115582|Bile Acid|bile acid
1412243|NCT01115582|Pediatrics|pediatrics
1412244|NCT01115582|Liver Disease|liver disease
1412245|NCT01115569|chronic pain|chronic pain
1412246|NCT01115504|Thiamine|thiamine
1412247|NCT01115504|heart failure|heart failure
1412248|NCT01115478|Malaria|malaria
1412249|NCT01115478|Low birth weight|low birth weight
1412250|NCT01115478|Anemia|anemia
1412955|NCT01112865|Children|children
1412251|NCT01115478|Perinatal mortality|perinatal mortality
1412252|NCT01115478|Vitamin A|vitamin a
1412253|NCT01115478|Zinc|zinc
1412254|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
1412255|NCT01115465|silicone elastomer|silicone elastomer
1412256|NCT01115452|potassium nitrate|potassium nitrate
1412257|NCT01115452|tooth sensitivity|tooth sensitivity
1412258|NCT01115452|dentin sensitivity|dentin sensitivity
1412259|NCT01115439|falciparum malaria|falciparum malaria
1412260|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
1412261|NCT01115413|teenage|teenage
1412262|NCT01115413|pregnancy|pregnancy
1412263|NCT01115413|obstetrical risk|obstetrical risk
1412264|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
1412265|NCT01115400|quality of life|quality of life
1412266|NCT01115387|Age-related macular degeneration|age-related macular degeneration
1412268|NCT01115387|Genetic risk|genetic risk
1412269|NCT01115387|Environmental risk factors|environmental risk factors
1412270|NCT01115387|Complex genetic disorder|complex genetic disorder
1412271|NCT01115387|Age-related maculopathy|age-related maculopathy
1412272|NCT01115387|Risk modeling|risk modeling
1412273|NCT01115387|Smoking|smoking
1412274|NCT01115387|Light exposure|light exposure
1412275|NCT01115387|Sleep apnea|sleep apnea
1412276|NCT01115387|Fundus Photography|fundus photography
1412277|NCT01115387|Macula|macula
1412278|NCT01115387|Drusen|drusen
1412279|NCT01115387|Wet AMD|wet amd
1412280|NCT01115387|Dry AMD|dry amd
1412281|NCT01115387|Geographic atrophy|geographic atrophy
1412282|NCT01115387|Vitamins & supplements|vitamins & supplements
1412283|NCT01115361|family planning|family planning
1412284|NCT01115361|postpartum|postpartum
1412285|NCT01115361|immunization|immunization
1412286|NCT01115361|integration|integration
1412287|NCT01115361|Contraceptive behavior|contraceptive behavior
1412288|NCT01115335|neonatal male circumcision|neonatal male circumcision
1412289|NCT01115335|Gomco|gomco
1412290|NCT01115335|Plastibell|plastibell
1412291|NCT01115335|Mogen|mogen
1412292|NCT01115335|Safety|safety
1412293|NCT01115335|Uptake|uptake
1412294|NCT01115335|Acceptability|acceptability
1412295|NCT01115335|Feasibility|feasibility
1412296|NCT01115335|Zambia|zambia
1412297|NCT01115322|Healthy volunteer study|healthy volunteer study
1412298|NCT01115322|phototoxicity|phototoxicity
1412299|NCT01115309|Sinusitis|sinusitis
1412300|NCT01115296|Helicobacter Pylori|helicobacter pylori
1412301|NCT01115296|gastritis|gastritis
1412302|NCT01115296|Probiotics|probiotics
1412303|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
1412304|NCT01115283|amblyopia treatment|amblyopia treatment
1412305|NCT01115283|neural plasticity|neural plasticity
1412306|NCT01115283|perceptual learning|perceptual learning
1412307|NCT01115283|vision therapy|vision therapy
1412308|NCT01115283|spatial vision|spatial vision
1412309|NCT01115283|video games|video games
1412310|NCT01115283|occlusion therapy|occlusion therapy
1412311|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1412312|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
1412313|NCT01115257|vitrectomy|vitrectomy
1412314|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
1412315|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
1412316|NCT01115244|Dapsone|dapsone
1412317|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
1412318|NCT01115231|Age-Related Maculopathies|age-related maculopathies
1412319|NCT01115231|Age-Related Maculopathy|age-related maculopathy
1412320|NCT01115231|Macular Dystrophy|macular dystrophy
1412321|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
1412322|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
1412323|NCT01115218|Glaucoma|glaucoma
1412324|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
1412325|NCT01115179|propofol|propofol
1412326|NCT01115179|inflammation|inflammation
1412327|NCT01115179|perioperative|perioperative
1412328|NCT01115179|lipids|lipids
1412329|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
1412330|NCT01115166|blood volume|blood volume
1412331|NCT01115153|Acute appendicitis|acute appendicitis
1412332|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
1412333|NCT01115153|Wound infection|wound infection
1412334|NCT01115153|Nosocomial infection|nosocomial infection
1412335|NCT01115140|Folate|folate
1412336|NCT01115140|Metformin|metformin
1412337|NCT01115140|PCOS|pcos
1412338|NCT01115140|Pregnancy|pregnancy
1412339|NCT01115140|Trophoblastic invasion|trophoblastic invasion
1412340|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
1412341|NCT01115127|pre-menopause|pre-menopause
1412342|NCT01115127|melatonin|melatonin
1412343|NCT01115127|myo-inositol|myo-inositol
1412344|NCT01115101|pain after cesarean|pain after cesarean
1412345|NCT01115101|visual analog scale|visual analog scale
1412346|NCT01115101|oxycodon|oxycodon
1412347|NCT01115101|piritramid|piritramid
1412348|NCT01115075|Leptin|leptin
1412349|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
1412350|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
1412351|NCT01115062|Pain|pain
1412352|NCT01115062|Children|children
1412353|NCT01115062|Local anesthetics|local anesthetics
1412354|NCT01115036|glioblastoma|glioblastoma
1412355|NCT01115036|recurrent|recurrent
1412356|NCT01115036|surgical resection|surgical resection
1412357|NCT01115023|iron deficiency anemia|iron deficiency anemia
1412358|NCT01115023|dietary intervention|dietary intervention
1412359|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
1412360|NCT01115010|intubation rate|intubation rate
1412361|NCT01115010|intubation time|intubation time
1412362|NCT01115010|stiffening device|stiffening device
1412363|NCT01115010|stiffening wire|stiffening wire
1412364|NCT01114997|Lidocaine Infusion|lidocaine infusion
1412365|NCT01114997|Esmolol Infusion|esmolol infusion
1412366|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
1412367|NCT01114997|Abdominal surgery|abdominal surgery
1412368|NCT01114997|Pain management|pain management
1542569|NCT00610909|IBS|ibs
1412369|NCT01114997|Hemodynamic stability|hemodynamic stability
1412370|NCT01114997|Perioperative outcomes|perioperative outcomes
1412371|NCT01114984|Pain management|pain management
1412372|NCT01114984|Radical mastectomy|radical mastectomy
1412373|NCT01114984|Breast surgery|breast surgery
1412374|NCT01114984|post-operative pain|post-operative pain
1412375|NCT01114971|Labetalol|labetalol
1412376|NCT01114971|Esmolol|esmolol
1412377|NCT01114971|Fentanyl|fentanyl
1412378|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
1412379|NCT01114971|Ambulatory surgery|ambulatory surgery
1412380|NCT01114971|Outpatient surgery|outpatient surgery
1412381|NCT01114971|Pain management|pain management
1412382|NCT01114971|Hemodynamic stability|hemodynamic stability
1412383|NCT01114971|Perioperative outcomes|perioperative outcomes
1412384|NCT01114958|Lung cancer|lung cancer
1412385|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
1412386|NCT01114958|Small-cell lung cancer|small-cell lung cancer
1412387|NCT01114958|Lung metastases|lung metastases
1412388|NCT01114958|Metastatic cancer|metastatic cancer
1412389|NCT01114958|Stage IIIA|stage iiia
1412390|NCT01114958|Stage IIIB|stage iiib
1412391|NCT01114958|Stage III|stage iii
1412392|NCT01114958|Stage 3|stage 3
1412393|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
1412394|NCT01114945|Video-Mac|video-mac
1412395|NCT01114945|GlideScope|glidescope
1412396|NCT01114945|McGrath|mcgrath
1412397|NCT01114945|Laryngoscopy|laryngoscopy
1412398|NCT01114945|Bariatrics|bariatrics
1412399|NCT01114945|Glottic view|glottic view
1412400|NCT01114945|Airway intubating devices|airway intubating devices
1412401|NCT01114945|Tracheal intubation|tracheal intubation
1412402|NCT01114932|pre-oxygenation|pre-oxygenation
1412403|NCT01114932|body mass index|body mass index
1412404|NCT01114932|end-tidal O2|end-tidal o2
1412405|NCT01114932|anesthesia induction|anesthesia induction
1412406|NCT01114919|Problem drinking|problem drinking
1412407|NCT01114919|Alcohol dependence|alcohol dependence
1412408|NCT01114919|Alcohol abuse|alcohol abuse
1412409|NCT01114919|Internet based intervention|internet based intervention
1412410|NCT01114919|Treatment|treatment
1412411|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
1412412|NCT01114906|Asthma|asthma
1412413|NCT01114906|Resource use|resource use
1412414|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
1412415|NCT01114880|China|china
1412416|NCT01114867|ultrasound|ultrasound
1412417|NCT01114867|penis length|penis length
1412418|NCT01114867|corpus cavernosum|corpus cavernosum
1412419|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
1412420|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
1412421|NCT01114828|Cirrhosis|cirrhosis
1412422|NCT01114828|ascites|ascites
1412423|NCT01114828|Tolvaptan|tolvaptan
1412424|NCT01114828|OPC-41061|opc-41061
1412425|NCT01114815|CADASIL|cadasil
1412426|NCT01114815|cerebral|cerebral
1412427|NCT01114815|autosomal dominant|autosomal dominant
1412428|NCT01114815|arteriopathy|arteriopathy
1412429|NCT01114815|subcortical infarcts|subcortical infarcts
1412430|NCT01114815|leukoencephalopathy|leukoencephalopathy
1412431|NCT01114802|Cancer survivors|cancer survivors
1412432|NCT01114802|Anxiety|anxiety
1412433|NCT01114802|Depression|depression
1412434|NCT01114802|Technology Assisted|technology assisted
1412435|NCT01114802|Internet|internet
1412436|NCT01114789|chronic renal failure|chronic renal failure
1412437|NCT01114789|hemodialysis|hemodialysis
1412439|NCT01114789|proteolysis|proteolysis
1412440|NCT01114763|Metabolic Syndrome|metabolic syndrome
1412441|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
1412442|NCT01114763|Arterial Elasticity|arterial elasticity
1412443|NCT01114763|Diabetes Mellitus|diabetes mellitus
1412444|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
1412445|NCT01114750|blood glucose|blood glucose
1412446|NCT01114750|blood insulin|blood insulin
1412447|NCT01114750|dextran|dextran
1412448|NCT01114750|diabetes|diabetes
1412449|NCT01114750|hyperglycemia|hyperglycemia
1412450|NCT01114750|hypoglycemia|hypoglycemia
1412451|NCT01114750|oral delivery|oral delivery
1412452|NCT01114750|portal delivery|portal delivery
1412453|NCT01114737|Phenylketonuria|phenylketonuria
1412455|NCT01114737|Kuvan|kuvan
1412456|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
1412457|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
1412458|NCT01114737|ADHD|adhd
1412459|NCT01114724|Thoracic dissection|thoracic dissection
1412460|NCT01114724|Endovascular aortic repair|endovascular aortic repair
1412461|NCT01114711|Menstrual Migraine|menstrual migraine
1412462|NCT01114711|Frova|frova
1412463|NCT01114711|Imaging|imaging
1412464|NCT01114711|fMRI|fmri
1412465|NCT01114711|Pain|pain
1412466|NCT01114698|Depression|depression
1412467|NCT01114698|Major Depressive Disorder|major depressive disorder
1412468|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
1412469|NCT01114698|26489112|26489112
1412470|NCT01114698|JNJ26489112|jnj26489112
1412471|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
1412472|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
1412473|NCT01114646|Hemiarthroplasty|hemiarthroplasty
1412474|NCT01114646|Cemented|cemented
1412475|NCT01114646|Press Fit|press fit
1412476|NCT01114646|Mortality|mortality
1412477|NCT01114646|Morbidity|morbidity
1412478|NCT01114646|Functional Status|functional status
1412479|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
1412480|NCT01114633|PCOS|pcos
1412481|NCT01114633|Acne|acne
1412482|NCT01114633|Hirsutism|hirsutism
1412483|NCT01114620|elderly|elderly
1412484|NCT01114620|post-marketing|post-marketing
1412485|NCT01114620|H1N1|h1n1
1412486|NCT01114620|Clinical trial|clinical trial
1412487|NCT01114620|pandemic influenza|pandemic influenza
1412488|NCT01114607|GSK1605786|gsk1605786
1412489|NCT01114607|relative bioavailability|relative bioavailability
1412490|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
1412491|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1412492|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
1412493|NCT01114581|Acute Respiratory Infection|acute respiratory infection
1412494|NCT01114581|Mucociliary|mucociliary
1412495|NCT01114581|Cough Clearance|cough clearance
1412496|NCT01114581|Guaifenesin|guaifenesin
1412497|NCT01114568|Relative Bioavailability|relative bioavailability
1412498|NCT01114568|Pharmacokinetics|pharmacokinetics
1412499|NCT01114568|Pharmacodynamics|pharmacodynamics
1412500|NCT01114555|Bevacizumab|bevacizumab
1412501|NCT01114555|Irinotecan|irinotecan
1412502|NCT01114555|Temozolomide|temozolomide
1412503|NCT01114555|10-015|10-015
1412504|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
1412505|NCT01114529|renal allograft function|renal allograft function
1412506|NCT01114529|CNI-free regimen|cni-free regimen
1412507|NCT01114516|cervical insufficiency|cervical insufficiency
1412508|NCT01114503|GSK2136525|gsk2136525
1412509|NCT01114503|Pharmacodynamics|pharmacodynamics
1412510|NCT01114503|Safety|safety
1412511|NCT01114503|Otelixizumab|otelixizumab
1412512|NCT01114503|Thyroid eye disease|thyroid eye disease
1412513|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
1412514|NCT01114503|Repeat dose|repeat dose
1412515|NCT01114503|Intravenous infusion|intravenous infusion
1412516|NCT01114503|Tolerability|tolerability
1412517|NCT01114503|EUGOGO|eugogo
1412518|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
1412519|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
1412520|NCT01114477|TMS|tms
1412521|NCT01114477|Observational study|observational study
1412522|NCT01114477|Major Depression|major depression
1412523|NCT01114464|Breast cancer|breast cancer
1412524|NCT01114464|Ovarian reserve|ovarian reserve
1412525|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
1412526|NCT01114464|Chemotherapy|chemotherapy
1412527|NCT01114451|Cesarean delivery|cesarean delivery
1412528|NCT01114451|Obesity|obesity
1412529|NCT01114451|Skin staples|skin staples
1412530|NCT01114451|Wound complications|wound complications
1412531|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
1412532|NCT01114412|focus groups|focus groups
1412533|NCT01114412|overactive bladder|overactive bladder
1412534|NCT01114412|bladder sensations|bladder sensations
1412535|NCT01114399|Cardiovascular Disease|cardiovascular disease
1412536|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
1412537|NCT01114399|Cholesterol|cholesterol
1412538|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
1412539|NCT01114399|Arterial Stiffness|arterial stiffness
1412540|NCT01114386|Smoking|smoking
1412541|NCT01114386|Dyspnea|dyspnea
1412542|NCT01114386|Cough|cough
1412543|NCT01114386|Exercise|exercise
1412544|NCT01114373|Melatonin|melatonin
1412545|NCT01114373|Hypertension|hypertension
1412546|NCT01114373|Blood Pressure|blood pressure
1412547|NCT01114373|Cardiovascular|cardiovascular
1412548|NCT01114373|Sleep|sleep
1412549|NCT01114373|Nighttime|nighttime
1412550|NCT01114373|Nocturnal|nocturnal
1412551|NCT01114373|Catecholamines|catecholamines
1412552|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
1412553|NCT01114373|Endothelial Function|endothelial function
1412554|NCT01114373|African American|african american
1412555|NCT01114360|Melatonin|melatonin
1412556|NCT01114360|Hypertension|hypertension
1412557|NCT01114360|Blood Pressure|blood pressure
1412558|NCT01114360|Cardiovascular|cardiovascular
1412559|NCT01114360|Sleep|sleep
1412560|NCT01114360|Nighttime|nighttime
1412561|NCT01114360|Nocturnal|nocturnal
1412562|NCT01114360|Catecholamines|catecholamines
1412563|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
1412564|NCT01114360|Endothelial function|endothelial function
1412565|NCT01114360|African American|african american
1412566|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1412567|NCT01114321|Glucose intolerance|glucose intolerance
1412568|NCT01114321|Diabetes|diabetes
1412569|NCT01114321|OGTT|ogtt
1412570|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
1412571|NCT01114308|opioid dependence|opioid dependence
1412572|NCT01114308|opioid addiction|opioid addiction
1412573|NCT01114308|buprenorphine|buprenorphine
1412574|NCT01114308|implant|implant
1412575|NCT01114308|methadone|methadone
1412576|NCT01114308|heroin|heroin
1412577|NCT01114308|suboxone|suboxone
1412578|NCT01114308|opioid pain medication|opioid pain medication
1412579|NCT01114308|opioid withdrawal|opioid withdrawal
1412580|NCT01114295|overt|overt
1412581|NCT01114295|obscure|obscure
1412582|NCT01114295|gastrointestinal|gastrointestinal
1412583|NCT01114295|bleeding|bleeding
1412584|NCT01114295|hemorrhage|hemorrhage
1412585|NCT01114269|Coronary Artery Disease|coronary artery disease
1412586|NCT01114269|Sudden Cardiac Death|sudden cardiac death
1412587|NCT01114269|Myocardial Infarction|myocardial infarction
1412588|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
1412589|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
1412590|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1412591|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
1412592|NCT01114230|AGS-16M8F|ags-16m8f
1412593|NCT01114217|Iron deficiency anemia|iron deficiency anemia
1412594|NCT01114217|Feraheme|feraheme
1412595|NCT01114217|Ferumoxytol|ferumoxytol
1412597|NCT01114204|Iron deficiency anemia|iron deficiency anemia
1412598|NCT01114204|Feraheme|feraheme
1412599|NCT01114204|ferumoxytol|ferumoxytol
1412600|NCT01114204|iron sucrose|iron sucrose
1412601|NCT01114204|Venofer|venofer
1412602|NCT01114204|IDA|ida
1412603|NCT01114178|questionnaire|questionnaire
1412604|NCT01114178|peripheral artery disease|peripheral artery disease
1412605|NCT01114178|exercise|exercise
1412606|NCT01114165|Neutropenia|neutropenia
1412607|NCT01114165|Febrile Neutropenia|febrile neutropenia
1412608|NCT01114165|Sepsis|sepsis
1412609|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
1412610|NCT01114152|AZD9742|azd9742
1412611|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
1412612|NCT01114152|Phase I|phase i
1412613|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
1412614|NCT01114139|Iron deficiency anemia|iron deficiency anemia
1412615|NCT01114139|Feraheme|feraheme
1412616|NCT01114139|ferumoxytol|ferumoxytol
1412617|NCT01114139|IDA|ida
1412618|NCT01114126|Neu-P11|neu-p11
1412619|NCT01114126|Insomnia|insomnia
1412620|NCT01114126|PSG|psg
1412621|NCT01114126|safety|safety
1412622|NCT01114113|IBS-D|ibs-d
1412623|NCT01114113|Post meal Diarrhea|post meal diarrhea
1412624|NCT01114113|Trigger meals|trigger meals
1412625|NCT01114100|chest pain|chest pain
1412626|NCT01114100|panic attacks|panic attacks
1412627|NCT01114100|palpitations|palpitations
1412628|NCT01114100|depression|depression
1412629|NCT01114100|panic disorder|panic disorder
1412630|NCT01114100|depressive disorder|depressive disorder
1412631|NCT01114100|non cardiac chest pain|non cardiac chest pain
1412632|NCT01114087|Spermatogenesis|spermatogenesis
1412633|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
1412634|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
1412635|NCT01114074|Thrombosis|thrombosis
1412636|NCT01114074|Blood coagulation|blood coagulation
1412637|NCT01114074|Perfusion flow experiments|perfusion flow experiments
1412638|NCT01114074|Factor XII|factor xii
1412639|NCT01114074|Factor XI|factor xi
1412640|NCT01114074|Prekallikrein|prekallikrein
1412641|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
1412642|NCT01114061|diabetes|diabetes
1412643|NCT01114061|postprandial glucose level|postprandial glucose level
1412644|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
1412645|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
1412646|NCT01114048|age under 65|age under 65
1412647|NCT01114048|Previous untreated|previous untreated
1412648|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
1412649|NCT01114035|characterization phenotypic|characterization phenotypic
1412650|NCT01114035|genetic study|genetic study
1412651|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
1412652|NCT01114022|Acute respiratory failure|acute respiratory failure
1412653|NCT01114009|recruitment maneuvers|recruitment maneuvers
1412654|NCT01114009|ARDS|ards
1412655|NCT01114009|lung protective strategy|lung protective strategy
1412656|NCT01114009|ARDS, Human|ards, human
1412657|NCT01113996|Obesity|obesity
1412658|NCT01113996|Gastric by-pass|gastric by-pass
1412659|NCT01113996|Body composition|body composition
1412660|NCT01113996|Nutrition|nutrition
1412661|NCT01113996|Physical activity|physical activity
1412662|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
1412663|NCT01113970|breast cancer|breast cancer
1412664|NCT01113970|Indibulin|indibulin
1412665|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
1412666|NCT01113957|Ovarian Cancer|ovarian cancer
1412667|NCT01113931|Chlamydia|chlamydia
1412668|NCT01113918|Obesity,|obesity,
1412669|NCT01113918|PCOS,|pcos,
1412670|NCT01113918|HA,|ha,
1412671|NCT01113918|CVD|cvd
1412672|NCT01113905|Fatigue|fatigue
1412673|NCT01113905|Breast Cancer|breast cancer
1412674|NCT01113879|rehabilitation|rehabilitation
1412675|NCT01113879|aphasia|aphasia
1412676|NCT01113879|exercise|exercise
1412678|NCT01113879|BDNF|bdnf
1412679|NCT01113853|asthma|asthma
1412680|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
1412681|NCT01113853|lung function|lung function
1412682|NCT01113840|elderly|elderly
1412683|NCT01113840|heart failure|heart failure
1412684|NCT01113840|exercise|exercise
1412685|NCT01113840|diastolic dysfunction|diastolic dysfunction
1412686|NCT01113827|Olive|olive
1412687|NCT01113827|antioxidant|antioxidant
1412688|NCT01113827|exercise|exercise
1412689|NCT01113827|inflammation|inflammation
1412690|NCT01113827|recovery|recovery
1412691|NCT01113827|Healthy men|healthy men
1412692|NCT01113801|Chronic Kidney Disease|chronic kidney disease
1412693|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
1412694|NCT01113801|End-Stage Renal Disease|end-stage renal disease
1412695|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
1412696|NCT01113801|Type 1 Diabetes|type 1 diabetes
1412697|NCT01113801|Type 2 Diabetes|type 2 diabetes
1412698|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
1412699|NCT01113775|pulmonary embolism|pulmonary embolism
1412700|NCT01113775|computed tomography|computed tomography
1412701|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1412702|NCT01113762|Bone Density|bone density
1412703|NCT01113762|Rehabilitation|rehabilitation
1412704|NCT01113762|T-Lymphocytes|t-lymphocytes
1412705|NCT01113762|Chromium Alloys|chromium alloys
1412706|NCT01113749|Dementia|dementia
1412707|NCT01113749|Nutrition|nutrition
1412708|NCT01113749|Feeding|feeding
1412709|NCT01113736|Ileostomy|ileostomy
1412710|NCT01113736|Stenosis|stenosis
1412711|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
1412712|NCT01113736|Peritoneal|peritoneal
1412713|NCT01113736|Colorectal Surgery|colorectal surgery
1412714|NCT01113723|C-MAC|c-mac
1412715|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
1412716|NCT01113723|Laryngoscopy|laryngoscopy
1412717|NCT01113723|Cervical spine injury|cervical spine injury
1412718|NCT01113723|Glottic view|glottic view
1412719|NCT01113723|Tracheal intubation|tracheal intubation
1412720|NCT01113710|Rotigotine|rotigotine
1412721|NCT01113710|Neupro®|neupro®
1412722|NCT01113710|Restless Legs Syndrome|restless legs syndrome
1412723|NCT01113697|allergen challenge|allergen challenge
1412724|NCT01113697|blood draw|blood draw
1412725|NCT01113697|gene expression analysis|gene expression analysis
1412726|NCT01113697|protein analysis|protein analysis
1412727|NCT01113697|genetics|genetics
1412728|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
1412729|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
1412730|NCT01113671|Vitamin E|vitamin e
1412731|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
1412732|NCT01113658|NPWT|npwt
1412733|NCT01113658|Spiracur|spiracur
1412734|NCT01113658|SNaP Wound Care System|snap wound care system
1412735|NCT01113645|Decompressive craniectomy|decompressive craniectomy
1412736|NCT01113645|Cranioplasty|cranioplasty
1412737|NCT01113645|Cerebral blood flow|cerebral blood flow
1412738|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
1412739|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
1412839|NCT01113268|Echography|echography
1412740|NCT01113645|Transcranial Doppler|transcranial doppler
1412741|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1412742|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1412743|NCT01113632|Ofatumumab|ofatumumab
1412744|NCT01113619|lactose maldigestion|lactose maldigestion
1412745|NCT01113619|dairy intolerance|dairy intolerance
1412746|NCT01113619|intolerance to milk|intolerance to milk
1412747|NCT01113619|intolerance to dairy|intolerance to dairy
1412748|NCT01113619|milk intolerance|milk intolerance
1412749|NCT01113619|GI disorder|gi disorder
1412750|NCT01113619|lactose metabolism|lactose metabolism
1412751|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
1412956|NCT01112865|Dyads|dyads
1412752|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
1412753|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
1412754|NCT01113593|COPD|copd
1412755|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
1412756|NCT01113567|Liver Cirrhosis|liver cirrhosis
1412757|NCT01113567|Disaccharides|disaccharides
1412758|NCT01113567|Lactose|lactose
1412759|NCT01113567|Quality of Life|quality of life
1412760|NCT01113541|Ziprasidone|ziprasidone
1412761|NCT01113541|Bipolar Disorder|bipolar disorder
1412762|NCT01113541|Metabolic Syndrome|metabolic syndrome
1412763|NCT01113528|Bone allograft|bone allograft
1412764|NCT01113528|IL-1|il-1
1412765|NCT01113528|IL-10|il-10
1412766|NCT01113528|periodontal regeneration|periodontal regeneration
1412767|NCT01113528|omega-3|omega-3
1412768|NCT01113528|aspirin|aspirin
1412769|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
1412770|NCT01113515|Diabetic wound|diabetic wound
1412771|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
1412772|NCT01113476|Advanced Malignancies|advanced malignancies
1412773|NCT01113476|Nab-paclitaxel|nab-paclitaxel
1412774|NCT01113476|Gemcitabine|gemcitabine
1412775|NCT01113476|Bevacizumab|bevacizumab
1412776|NCT01113463|Brain Tumor|brain tumor
1412777|NCT01113463|Central Nervous System|central nervous system
1412778|NCT01113463|CNS|cns
1412779|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
1412780|NCT01113463|GBM|gbm
1412781|NCT01113463|TPI 287|tpi 287
1412782|NCT01113463|Radiation Therapy|radiation therapy
1412783|NCT01113463|Temozolomide|temozolomide
1412784|NCT01113463|Chemotherapy|chemotherapy
1412785|NCT01113463|taxanes|taxanes
1412786|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
1412787|NCT01113437|Bronchial Asthma|bronchial asthma
1412788|NCT01113437|Allergy|allergy
1412789|NCT01113424|Smoking Cessation|smoking cessation
1412790|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
1412791|NCT01113411|humerus fracture|humerus fracture
1412792|NCT01113411|locked plate|locked plate
1412793|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
1412794|NCT01113398|gliosarcoma|gliosarcoma
1412795|NCT01113398|malignant glioma|malignant glioma
1412796|NCT01113398|glioma|glioma
1412797|NCT01113398|Avastin|avastin
1412798|NCT01113398|bevacizumab|bevacizumab
1412799|NCT01113398|AMG 102|amg 102
1412800|NCT01113398|rilotumumab|rilotumumab
1412801|NCT01113398|recurrent|recurrent
1412802|NCT01113398|Duke|duke
1412803|NCT01113398|Pro00022491|pro00022491
1412804|NCT01113385|Nephrotic syndrome|nephrotic syndrome
1412805|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
1412806|NCT01113385|FSGS|fsgs
1412807|NCT01113385|Minimal change|minimal change
1412808|NCT01113385|Steroid resistant|steroid resistant
1412809|NCT01113385|Pediatric|pediatric
1412810|NCT01113385|Proteinuria|proteinuria
1412811|NCT01113385|Galactose|galactose
1412812|NCT01113385|FSPF|fspf
1412813|NCT01113372|Coronary, Disease|coronary, disease
1412814|NCT01113359|HCMV infection|hcmv infection
1412815|NCT01113359|Hypertension|hypertension
1412816|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
1412817|NCT01113346|enterosorbent|enterosorbent
1412818|NCT01113346|sorbent|sorbent
1412819|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
1412820|NCT01113346|viral diarrhea|viral diarrhea
1412821|NCT01113346|rotavirus|rotavirus
1412822|NCT01113346|Filtrum|filtrum
1412823|NCT01113346|Filtrum-STI|filtrum-sti
1412824|NCT01113346|lignin|lignin
1412825|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
1412826|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
1412827|NCT01113307|Chronic ulcers|chronic ulcers
1412828|NCT01113307|pressure ulcers|pressure ulcers
1412829|NCT01113307|venous ulcers|venous ulcers
1412830|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
1412831|NCT01113307|post operative ulcers|post operative ulcers
1412832|NCT01113307|hard to heal ulcers|hard to heal ulcers
1412833|NCT01113281|Tuberculosis|tuberculosis
1412834|NCT01113281|Vaccine|vaccine
1412835|NCT01113281|Live Vaccine|live vaccine
1412836|NCT01113281|rBCG|rbcg
1412837|NCT01113268|Patient collection|patient collection
1412838|NCT01113268|Cardiac remodelling|cardiac remodelling
1412840|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
1412841|NCT01113268|Gene polymorphisms|gene polymorphisms
1412842|NCT01113268|Biomarkers|biomarkers
1412843|NCT01113255|VENTILATORS|ventilators
1412844|NCT01113255|BENCH EVALUATION|bench evaluation
1412845|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
1412846|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
1412847|NCT01113242|Observational|observational
1412848|NCT01113242|Case control|case control
1412849|NCT01113242|Neuropsychological assessment|neuropsychological assessment
1412850|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
1412851|NCT01113229|oxytocin,|oxytocin,
1412957|NCT01112865|Adults|adults
1412852|NCT01113229|misoprostol,|misoprostol,
1412853|NCT01113229|prevention,|prevention,
1412854|NCT01113229|delivery.|delivery.
1412855|NCT01113216|CF|cf
1412856|NCT01113216|CFRD|cfrd
1412857|NCT01113216|Diabetes|diabetes
1412858|NCT01113216|Genetic Modifiers|genetic modifiers
1412859|NCT01113203|resistance training|resistance training
1412860|NCT01113203|blood pressure|blood pressure
1412861|NCT01113203|hemodynamics|hemodynamics
1412862|NCT01113203|autonomic|autonomic
1412863|NCT01113203|Elderly Subjects|elderly subjects
1412864|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
1412865|NCT01113164|ondansetron|ondansetron
1412866|NCT01113164|sertraline|sertraline
1412867|NCT01113164|lab studies|lab studies
1412868|NCT01113164|alcoholism|alcoholism
1412869|NCT01113164|alcohol dependence|alcohol dependence
1412870|NCT01113151|Steroid-resistant|steroid-resistant
1412871|NCT01113151|Severe asthmatics|severe asthmatics
1412872|NCT01113151|Annual symptoms|annual symptoms
1412873|NCT01113151|Daily magnesium supplement|daily magnesium supplement
1412874|NCT01113151|ACT (asthma control test)|act (asthma control test)
1412875|NCT01113138|Clearance|clearance
1412876|NCT01113138|Half-life|half-life
1412877|NCT01113138|Absorption fraction|absorption fraction
1412878|NCT01113138|Pharmacokinetics|pharmacokinetics
1412879|NCT01113125|hypertrophic scar|hypertrophic scar
1412880|NCT01113125|keloid|keloid
1412881|NCT01113125|central venous catheter|central venous catheter
1412882|NCT01113125|children|children
1412883|NCT01113125|cancer|cancer
1412884|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
1412885|NCT01113086|Parkinson|parkinson
1412886|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
1412887|NCT01113086|Motor function|motor function
1412888|NCT01113086|Cognitive function|cognitive function
1412889|NCT01113086|Affective function|affective function
1412890|NCT01113073|pulse pressure variation|pulse pressure variation
1412891|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
1412892|NCT01113073|fluid responsiveness|fluid responsiveness
1412893|NCT01113073|mechanical ventilation|mechanical ventilation
1412894|NCT01113073|fluid therapy|fluid therapy
1412895|NCT01113060|Coronary Artery Disease|coronary artery disease
1412896|NCT01113060|Aspirin|aspirin
1412897|NCT01113060|Secondary Prevention|secondary prevention
1412898|NCT01113047|Hypertension|hypertension
1412899|NCT01113047|Aliskiren|aliskiren
1412900|NCT01113047|Amlodipine|amlodipine
1412901|NCT01113034|Asthma|asthma
1412902|NCT01113034|Bronchiectasis|bronchiectasis
1412903|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
1412904|NCT01113008|Coronary angioplasty|coronary angioplasty
1412905|NCT01113008|Reperfusion|reperfusion
1412906|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
1412907|NCT01112995|Probiotic|probiotic
1412908|NCT01112995|Lactobacillus|lactobacillus
1412909|NCT01112995|Antibiotic resistance|antibiotic resistance
1412910|NCT01112982|Gout|gout
1412911|NCT01112982|Synovial pannus|synovial pannus
1412912|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
1412913|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
1412914|NCT01112969|guided self-help|guided self-help
1412915|NCT01112969|Caregivers|caregivers
1412916|NCT01112969|Brain Injury|brain injury
1412917|NCT01112969|Caregiver Burden|caregiver burden
1412918|NCT01112969|Coping|coping
1412919|NCT01112969|Stress|stress
1412920|NCT01112969|Depression|depression
1412921|NCT01112956|HSV-2|hsv-2
1412922|NCT01112956|HSV-1|hsv-1
1412923|NCT01112956|Sensitivity|sensitivity
1412924|NCT01112956|Specificity|specificity
1412925|NCT01112956|Testing algorithm|testing algorithm
1412926|NCT01112956|Test evaluation|test evaluation
1412927|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
1412928|NCT01112930|essential fatty acids|essential fatty acids
1412929|NCT01112930|DHA|dha
1412930|NCT01112930|preschool children|preschool children
1412931|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
1412932|NCT01112904|essential fatty acids|essential fatty acids
1412933|NCT01112904|DHA status|dha status
1412934|NCT01112904|preschool children|preschool children
1412935|NCT01112904|gestation|gestation
1412936|NCT01112891|Vitamin D|vitamin d
1412937|NCT01112891|Infant|infant
1412938|NCT01112891|Lactation|lactation
1412939|NCT01112891|Dose-Response|dose-response
1412940|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
1412941|NCT01112878|Knee arthroscopy|knee arthroscopy
1412942|NCT01112878|Clonidine|clonidine
1412943|NCT01112878|Gabapentin|gabapentin
1412944|NCT01112878|Pain management|pain management
1412945|NCT01112878|Ambulatory surgery|ambulatory surgery
1412946|NCT01112878|Perioperative outcome|perioperative outcome
1412947|NCT01112878|Analgesia|analgesia
1412948|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
1412949|NCT01112865|Somatropin|somatropin
1412950|NCT01112865|Injection Pen|injection pen
1412951|NCT01112865|Medical Device|medical device
1412952|NCT01112865|Cross Over Study|cross over study
1412953|NCT01112865|Preference|preference
1412958|NCT01112852|control of bleed|control of bleed
1412959|NCT01112839|Overweight|overweight
1412960|NCT01112839|Obese|obese
1412961|NCT01112839|Breast cancer survivors|breast cancer survivors
1412962|NCT01112839|Weight loss|weight loss
1412963|NCT01112839|Exercise|exercise
1412964|NCT01112839|Physical activity|physical activity
1412965|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
1412966|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
1412967|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
1412968|NCT01112813|Stroke|stroke
1412969|NCT01112813|lithium|lithium
1412970|NCT01112813|MRI|mri
1412971|NCT01112813|gray matter|gray matter
1412972|NCT01112800|Anthracycline|anthracycline
1412973|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
1412974|NCT01112800|Doxorubicin|doxorubicin
1412975|NCT01112800|Doppler Imaging|doppler imaging
1412976|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
1412977|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
1412978|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
1412979|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
1412980|NCT01112774|Spinal cord injury|spinal cord injury
1412981|NCT01112774|Chronic pain|chronic pain
1412982|NCT01112774|Brain excitability|brain excitability
1412983|NCT01112761|Athletes|athletes
1412984|NCT01112761|Multiple Concussions|multiple concussions
1412985|NCT01112761|Transcranial Stimulation|transcranial stimulation
1412986|NCT01112748|Focal neuropathic pain|focal neuropathic pain
1412987|NCT01112735|Abdominoplasty|abdominoplasty
1412988|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
1412989|NCT01112722|honeybee toxin|honeybee toxin
1412990|NCT01112722|Apitox|apitox
1412991|NCT01112722|pain|pain
1412992|NCT01112722|inflammation|inflammation
1412993|NCT01112722|osteoarthritis|osteoarthritis
1412994|NCT01112722|Apitoxin|apitoxin
1412995|NCT01112709|Diabetes|diabetes
1412996|NCT01112709|Prediabetes|prediabetes
1412997|NCT01112709|Resistance training|resistance training
1412998|NCT01112709|behavior|behavior
1412999|NCT01112709|behavioral change theory|behavioral change theory
1413000|NCT01112696|diabetes|diabetes
1413001|NCT01112696|glucose sensor|glucose sensor
1413002|NCT01112696|CGM|cgm
1413003|NCT01112683|Down syndrome|down syndrome
1413004|NCT01112683|Trisomy 21|trisomy 21
1413005|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
1413006|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
1413007|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
1413008|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
1413009|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
1413010|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
1413011|NCT01112670|Healthy volunteers|healthy volunteers
1413012|NCT01112657|Multiple Sclerosis|multiple sclerosis
1413013|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
1413014|NCT01112657|Demyelination|demyelination
1413015|NCT01112631|NSCLC,|nsclc,
1413016|NCT01112631|PORT,|port,
1413017|NCT01112631|Quality of Life,|quality of life,
1413018|NCT01112631|Pulmonary function after RT|pulmonary function after rt
1413019|NCT01112618|Infertility|infertility
1413020|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
1413021|NCT01112618|r-hFSH|r-hfsh
1413022|NCT01112618|r-hLH|r-hlh
1413023|NCT01112618|Pergoveris|pergoveris
1413024|NCT01112605|achilles tendon|achilles tendon
1413025|NCT01112605|sural nerve|sural nerve
1413026|NCT01112605|distance|distance
1413027|NCT01112605|US|us
1413028|NCT01112605|ultrasound|ultrasound
1413029|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
1413030|NCT01112592|NETs|nets
1413031|NCT01112592|Infections|infections
1413032|NCT01112592|Neutrophil function|neutrophil function
1413033|NCT01112553|Acute Migraine|acute migraine
1413034|NCT01112553|Treximet|treximet
1413035|NCT01112553|Imaging|imaging
1413036|NCT01112553|fMRI|fmri
1413037|NCT01112553|Pain|pain
1413038|NCT01112553|Heat Stimulus|heat stimulus
1413039|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
1413040|NCT01112527|PF-00299804|pf-00299804
1413041|NCT01112514|ICG|icg
1413042|NCT01112514|indocyanine green|indocyanine green
1413043|NCT01112501|Diagnosis|diagnosis
1413044|NCT01112501|Dementia|dementia
1413045|NCT01112501|Imaging|imaging
1413046|NCT01112488|stroke|stroke
1413047|NCT01112488|patient engagement programme|patient engagement programme
1413048|NCT01112488|community rehabilitation|community rehabilitation
1413049|NCT01112488|new carer|new carer
1413050|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
1413051|NCT01112449|selenium|selenium
1413052|NCT01112449|oxidative stress|oxidative stress
1413053|NCT01112449|prostate cancer|prostate cancer
1413055|NCT01112449|glucose|glucose
1413056|NCT01112436|Pain|pain
1413057|NCT01112436|preemptive|preemptive
1413058|NCT01112436|Postoperative|postoperative
1413059|NCT01112436|delirium|delirium
1413060|NCT01112410|Bronchiectasis|bronchiectasis
1413061|NCT01112410|Hypertonic saline|hypertonic saline
1413062|NCT01112397|Jak2|jak2
1543417|NCT00607633|ARB|arb
1413063|NCT01112397|cancer|cancer
1413064|NCT01112397|jak 1|jak 1
1413065|NCT01112397|stat 3|stat 3
1413066|NCT01112397|Phase 1|phase 1
1413067|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
1413068|NCT01112358|Lutropin alfa|lutropin alfa
1413069|NCT01112358|Fertilization in vitro|fertilization in vitro
1413070|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1413071|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
1413072|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1413073|NCT01112345|Interferon-beta|interferon-beta
1413074|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
1413075|NCT01112306|Open-label|open-label
1413076|NCT01112306|PAH|pah
1413077|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1413078|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
1413079|NCT01112280|Colorectal neoplasm|colorectal neoplasm
1413080|NCT01112280|Colonoscopy|colonoscopy
1413081|NCT01112280|chromoendoscopy|chromoendoscopy
1413082|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
1413083|NCT01112267|Chronic low back pain|chronic low back pain
1413084|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
1413085|NCT01112267|acetaminophen|acetaminophen
1413086|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
1413087|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
1413088|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
1413089|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
1413090|NCT01112241|Lung volumes|lung volumes
1413091|NCT01112215|SLE|sle
1413092|NCT01112215|non-renal manifestations|non-renal manifestations
1413093|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
1413094|NCT01112202|Dabigatran|dabigatran
1413095|NCT01112202|Coagulation parameters|coagulation parameters
1413096|NCT01112189|Lymphedema|lymphedema
1413097|NCT01112189|Stem cells|stem cells
1413098|NCT01112189|Mastectomy|mastectomy
1413099|NCT01112189|Breast Cancer|breast cancer
1413100|NCT01112176|Strain|strain
1413101|NCT01112176|Ejection fraction|ejection fraction
1413102|NCT01112176|Diastolic function|diastolic function
1413103|NCT01112163|ischemic heart disease|ischemic heart disease
1413104|NCT01112150|Edema|edema
1413105|NCT01112150|Heart failure|heart failure
1413106|NCT01112150|Pulmonary hypertension|pulmonary hypertension
1413107|NCT01112150|Edema in legs|edema in legs
1413108|NCT01112124|Typical|typical
1413109|NCT01112124|Development|development
1413110|NCT01112124|Microwave|microwave
1413111|NCT01112124|Children|children
1413112|NCT01112124|Behavior|behavior
1413113|NCT01112085|Diabetic macular edema|diabetic macular edema
1413114|NCT01112085|Ranibizumab|ranibizumab
1413115|NCT01112072|keratoconus|keratoconus
1413116|NCT01112072|corneal ectasia|corneal ectasia
1413117|NCT01112072|collagen crosslinking|collagen crosslinking
1413118|NCT01112072|riboflavin|riboflavin
1413119|NCT01112072|cornea|cornea
1413120|NCT01112072|ultraviolet|ultraviolet
1413121|NCT01112059|cystic fibrosis|cystic fibrosis
1413122|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
1413123|NCT01112033|biliverdin reductase|biliverdin reductase
1413124|NCT01112033|BLVRA|blvra
1413125|NCT01112033|hepatitis C|hepatitis c
1413126|NCT01112033|HCV|hcv
1413127|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
1413128|NCT01112033|PBMC|pbmc
1413129|NCT01112033|liver|liver
1413130|NCT01112033|genetic polymorphisms|genetic polymorphisms
1413131|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
1413132|NCT01112020|Biopatch Protective Disk|biopatch protective disk
1413133|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
1413134|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
1413135|NCT01112020|No condition being studied.|no condition being studied.
1413136|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
1413137|NCT01112007|Insulin Resistance|insulin resistance
1413138|NCT01112007|Hypertension|hypertension
1413139|NCT01112007|Blood pressure|blood pressure
1413140|NCT01112007|Aldosterone|aldosterone
1413141|NCT01112007|Renin|renin
1413142|NCT01111994|hyperpigmentation|hyperpigmentation
1413143|NCT01111981|alopecia|alopecia
1413144|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
1413145|NCT01111968|vaccine|vaccine
1413146|NCT01111968|pandemic influenza A|pandemic influenza a
1413147|NCT01111968|adjuvant|adjuvant
1413148|NCT01111968|safety|safety
1413149|NCT01111942|head and neck cancer|head and neck cancer
1413150|NCT01111942|chemotherapy|chemotherapy
1413151|NCT01111942|radiation|radiation
1413152|NCT01111929|Emergency contraception|emergency contraception
1413153|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
1413154|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
1413155|NCT01111929|unplanned pregnancy|unplanned pregnancy
1413156|NCT01111877|ear tubes|ear tubes
1413157|NCT01111877|ear drainage|ear drainage
1413158|NCT01111877|ear infection|ear infection
1413159|NCT01111877|ear drops|ear drops
1413160|NCT01111877|tympanostomy tubes|tympanostomy tubes
1413161|NCT01111877|Pediatric patients|pediatric patients
1413162|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
1413163|NCT01111838|STA-9090|sta-9090
1413164|NCT01111838|colon|colon
1413165|NCT01111838|rectal|rectal
1413166|NCT01111838|10-029|10-029
1413167|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
1413168|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
1413169|NCT01111825|HER2-Amplified|her2-amplified
1413170|NCT01111825|Triple-negative|triple-negative
1413171|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
1413172|NCT01111825|10-005|10-005
1413173|NCT01111825|Nerlynx|nerlynx
1413174|NCT01111825|PB-272|pb-272
1413175|NCT01111812|overweight|overweight
1413176|NCT01111812|obese|obese
1413177|NCT01111812|children|children
1413178|NCT01111812|weighing|weighing
1413179|NCT01111812|weight|weight
1413180|NCT01111799|endometrial biopsy|endometrial biopsy
1413181|NCT01111799|implantation|implantation
1413182|NCT01111799|uterine receptivity|uterine receptivity
1413183|NCT01111799|infertility|infertility
1413184|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
1413185|NCT01111799|intra uterine insemination|intra uterine insemination
1413186|NCT01111786|scleroderma|scleroderma
1413187|NCT01111786|skin|skin
1413188|NCT01111786|tightness|tightness
1413189|NCT01111786|durometer|durometer
1413190|NCT01111773|Patellar tendonitis|patellar tendonitis
1413191|NCT01111760|cardiovascular disease|cardiovascular disease
1413192|NCT01111760|heart CT scan|heart ct scan
1413193|NCT01111760|CT scan|ct scan
1413194|NCT01111760|pulmonary embolisms|pulmonary embolisms
1413195|NCT01111760|aortography|aortography
1413196|NCT01111747|platelet-rich plasma|platelet-rich plasma
1413197|NCT01111747|patellar ligament|patellar ligament
1413198|NCT01111747|regeneration|regeneration
1413199|NCT01111747|growth substances|growth substances
1413200|NCT01111734|self harm|self harm
1413201|NCT01111734|self injury|self injury
1413202|NCT01111734|self mutilation|self mutilation
1413203|NCT01111734|N-Acetylcysteine|n-acetylcysteine
1413204|NCT01111734|adolescents|adolescents
1413205|NCT01111734|impulse control disorder|impulse control disorder
1413206|NCT01111734|borderline personality disorder|borderline personality disorder
1413207|NCT01111734|fMRI|fmri
1413208|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
1413209|NCT01111721|HIV Infections|hiv infections
1413210|NCT01111721|Genital Diseases, Female|genital diseases, female
1413211|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1413212|NCT01111721|Risk Reduction Behavior|risk reduction behavior
1413213|NCT01111721|HIV prevention|hiv prevention
1413214|NCT01111695|wound healing|wound healing
1413215|NCT01111695|granulation tissue|granulation tissue
1413216|NCT01111695|Varicose Ulcer|varicose ulcer
1413217|NCT01111682|traumatic brain injury|traumatic brain injury
1413218|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
1413219|NCT01111682|intracranial pressure|intracranial pressure
1413220|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
1413221|NCT01111669|Tranexamic Acid|tranexamic acid
1413222|NCT01111656|Multi-center|multi-center
1413223|NCT01111656|randomized|randomized
1413224|NCT01111656|prospective|prospective
1413225|NCT01111656|parallel-group|parallel-group
1413226|NCT01111656|rater-blinded|rater-blinded
1413227|NCT01111656|RR-MS|rr-ms
1413228|NCT01111630|chronic renal failure|chronic renal failure
1413229|NCT01111630|Anaemia|anaemia
1413230|NCT01111604|Colonic Neoplasms|colonic neoplasms
1413231|NCT01111604|Rectal Neoplasms|rectal neoplasms
1413232|NCT01111604|Adenocarcinoma|adenocarcinoma
1413233|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
1413234|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
1413235|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
1413622|NCT01109992|regadenoson|regadenoson
1413236|NCT01111591|Pancreas cancer|pancreas cancer
1413237|NCT01111565|Major Depressive Disorder|major depressive disorder
1413238|NCT01111565|MDD|mdd
1413239|NCT01111565|Depression|depression
1413240|NCT01111552|Major Depressive Disorder|major depressive disorder
1413241|NCT01111552|MDD|mdd
1413242|NCT01111552|Depression|depression
1413243|NCT01111539|Major Depressive Disorder|major depressive disorder
1413244|NCT01111539|MDD|mdd
1413245|NCT01111539|Depression|depression
1413246|NCT01111526|Graft versus host disease|graft versus host disease
1413247|NCT01111526|GVHD|gvhd
1413248|NCT01111526|allogeneic transplant|allogeneic transplant
1413249|NCT01111526|acute GVHD|acute gvhd
1413250|NCT01111526|chronic GVHD|chronic gvhd
1413251|NCT01111513|knee surgery|knee surgery
1413252|NCT01111513|total knee arthroplasty|total knee arthroplasty
1413253|NCT01111513|total knee replacement|total knee replacement
1413254|NCT01111513|ropivacaine|ropivacaine
1413255|NCT01111513|femoral nerve block|femoral nerve block
1413256|NCT01111487|COPD|copd
1413257|NCT01111487|Electromyography|electromyography
1413258|NCT01111487|Inspiratory muscles|inspiratory muscles
1413259|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
1413260|NCT01111474|cyanoacrylate|cyanoacrylate
1413261|NCT01111474|laser|laser
1413262|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
1413263|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
1413264|NCT01111422|Antioxidant|antioxidant
1413265|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
1413266|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
1413267|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
1413268|NCT01111396|ALL|all
1413269|NCT01111396|GMALL 2003|gmall 2003
1413270|NCT01111396|Chemotherapy|chemotherapy
1413271|NCT01111396|Hippocampus|hippocampus
1413272|NCT01111383|cystic fibrosis|cystic fibrosis
1413273|NCT01111383|P. aeruginosa|p. aeruginosa
1413274|NCT01111383|tobramycin|tobramycin
1413275|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
1413276|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
1413277|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
1413278|NCT01111344|Dietary supplement|dietary supplement
1413279|NCT01111344|Anogenital warts|anogenital warts
1413280|NCT01111344|Viusid|viusid
1413281|NCT01111344|Glizigen|glizigen
1413282|NCT01111305|Filariasis|filariasis
1413283|NCT01111305|Post-Treatment Reactions|post-treatment reactions
1413284|NCT01111305|Monoclonal Antibody|monoclonal antibody
1413285|NCT01111305|Loa Loa|loa loa
1413286|NCT01111305|Loiasis|loiasis
1413287|NCT01111266|in vivo KUF|in vivo kuf
1413288|NCT01111266|ß2M|ß2m
1413289|NCT01111266|leptin|leptin
1413290|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
1413291|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
1413292|NCT01111253|treatment strategies|treatment strategies
1413293|NCT01111253|management of diverticulitis|management of diverticulitis
1413294|NCT01111253|antibiotics|antibiotics
1413295|NCT01111253|observation and supportive care|observation and supportive care
1413296|NCT01111253|cost analysis|cost analysis
1413297|NCT01111253|economic evaluation|economic evaluation
1413298|NCT01111240|Humira|humira
1413299|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
1413300|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
1413301|NCT01111227|cytokines|cytokines
1413302|NCT01111227|propofol|propofol
1413303|NCT01111227|isoflurane|isoflurane
1413304|NCT01111227|flow cytometry|flow cytometry
1413305|NCT01111227|Types of General Anesthesia|types of general anesthesia
1413306|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
1413307|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
1413308|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
1413309|NCT01111201|Breast|breast
1413310|NCT01111201|Lymphoma|lymphoma
1413311|NCT01111201|International travel|international travel
1413312|NCT01111201|questionnaire|questionnaire
1413313|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
1413314|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
1413315|NCT01111162|HIV|hiv
1413316|NCT01111162|H1N1 vaccination|h1n1 vaccination
1413317|NCT01111162|HIV infected individuals|hiv infected individuals
1413318|NCT01111149|Schizophrenia|schizophrenia
1413319|NCT01111149|Smoking cessation|smoking cessation
1413320|NCT01111149|Varenicline|varenicline
1413321|NCT01111149|Bupropion|bupropion
1413322|NCT01111136|Urticaria|urticaria
1413323|NCT01111136|Hives|hives
1413324|NCT01111136|Stress|stress
1413325|NCT01111123|plaque psoriasis|plaque psoriasis
1413326|NCT01111123|lac-hydrin|lac-hydrin
1413327|NCT01111123|ammonium lactate|ammonium lactate
1413328|NCT01111123|Ultravate|ultravate
1413329|NCT01111123|halobetasol propionate|halobetasol propionate
1413330|NCT01111123|weekend only application|weekend only application
1413331|NCT01111123|topical therapy|topical therapy
1413332|NCT01111123|topical corticosteroid|topical corticosteroid
1413333|NCT01111123|class I steroid|class i steroid
1413334|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
1413335|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
1413336|NCT01111084|Ovulation induction|ovulation induction
1413337|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
1413338|NCT01111084|Pregnancy|pregnancy
1413339|NCT01111084|Fertility|fertility
1413340|NCT01111071|hospital variation|hospital variation
1413341|NCT01111071|30 day mortality|30 day mortality
1413342|NCT01111071|in hospital mortality|in hospital mortality
1413343|NCT01111071|acute coronary syndrome|acute coronary syndrome
1413344|NCT01111071|myocardial infarction|myocardial infarction
1413345|NCT01111071|unstable angina|unstable angina
1413346|NCT01111071|hospital performance|hospital performance
1413347|NCT01111071|trends|trends
1413348|NCT01111058|Squamous Cell Cancer|squamous cell cancer
1413349|NCT01111032|Treadmill|treadmill
1543770|NCT00605982|MRI|mri
1413350|NCT01111032|Exercise|exercise
1413351|NCT01111032|Cancer|cancer
1413352|NCT01111032|Validity|validity
1413353|NCT01111032|Reliability|reliability
1413354|NCT01111019|Hypochondroplasia|hypochondroplasia
1413355|NCT01111019|Skeletal dysplasia|skeletal dysplasia
1413356|NCT01111019|Growth|growth
1413357|NCT01111019|Growth Hormone|growth hormone
1413358|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
1413359|NCT01111006|Electronic toilet|electronic toilet
1413360|NCT01111006|Bidet|bidet
1413361|NCT01111006|Anorectal resting pressure|anorectal resting pressure
1413362|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
1413363|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
1413364|NCT01110980|Radiotherapy|radiotherapy
1413365|NCT01110980|Diet counselling|diet counselling
1413366|NCT01110980|Swallow therapy|swallow therapy
1413367|NCT01110980|Food intake|food intake
1413368|NCT01110941|S-1|s-1
1413369|NCT01110941|leucovorin|leucovorin
1413370|NCT01110941|oxaliplatin|oxaliplatin
1413371|NCT01110941|colorectal cancer|colorectal cancer
1413372|NCT01110941|SOL|sol
1413373|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
1413374|NCT01110902|Agomelatine|agomelatine
1413375|NCT01110902|Major Depressive Disorder|major depressive disorder
1413376|NCT01110902|MDD|mdd
1413377|NCT01110902|depression|depression
1413378|NCT01110889|Agomelatine|agomelatine
1413379|NCT01110889|Major Depressive Disorder|major depressive disorder
1413380|NCT01110889|MDD|mdd
1413381|NCT01110889|depression|depression
1413382|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1413383|NCT01110876|GBM|gbm
1413384|NCT01110876|Brain|brain
1413385|NCT01110876|Central Nervous Center|central nervous center
1413386|NCT01110876|Malignant glioma|malignant glioma
1413387|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
1413388|NCT01110876|Gliosarcoma|gliosarcoma
1413389|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
1413390|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1413391|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1413392|NCT01110876|Vorinostat|vorinostat
1413393|NCT01110876|SAHA|saha
1413394|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1413395|NCT01110876|MSK-390|msk-390
1413396|NCT01110876|Zolinza|zolinza
1413397|NCT01110876|Erlotinib|erlotinib
1413398|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
1413399|NCT01110876|OSI-774|osi-774
1413400|NCT01110876|Tarceva|tarceva
1413401|NCT01110876|Temozolomide|temozolomide
1413402|NCT01110876|Temodar|temodar
1413403|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1413404|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1413405|NCT01110837|Allergic rhinitis|allergic rhinitis
1413406|NCT01110837|Allergen|allergen
1413407|NCT01110824|Prevention|prevention
1413408|NCT01110824|ventricular dysfunction|ventricular dysfunction
1413409|NCT01110824|chemotherapy|chemotherapy
1413410|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
1413411|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
1413412|NCT01110824|multiple myeloma|multiple myeloma
1413413|NCT01110824|lymphoma|lymphoma
1413414|NCT01110824|ejection fraction|ejection fraction
1413415|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1413416|NCT01110811|GERD|gerd
1413417|NCT01110811|Esophagitis|esophagitis
1413418|NCT01110811|Fundoplication|fundoplication
1413419|NCT01110811|Anti-reflux surgery|anti-reflux surgery
1413420|NCT01110811|PPI dependent|ppi dependent
1413421|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
1413422|NCT01110798|gastrointestinal complications|gastrointestinal complications
1413423|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1413424|NCT01110798|stage I rectal cancer|stage i rectal cancer
1413425|NCT01110798|stage II rectal cancer|stage ii rectal cancer
1413426|NCT01110798|stage III rectal cancer|stage iii rectal cancer
1413427|NCT01110785|recurrent colon cancer|recurrent colon cancer
1413428|NCT01110785|stage III colon cancer|stage iii colon cancer
1413429|NCT01110785|stage IV colon cancer|stage iv colon cancer
1413430|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
1413431|NCT01110785|stage III rectal cancer|stage iii rectal cancer
1413432|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
1413433|NCT01110772|Surgical site infection|surgical site infection
1413434|NCT01110772|Skin preparation|skin preparation
1413435|NCT01110772|Cost analysis|cost analysis
1413436|NCT01110759|pain management|pain management
1413437|NCT01110759|ambulatory surgery|ambulatory surgery
1413438|NCT01110759|opioid|opioid
1413439|NCT01110759|local anesthesia|local anesthesia
1413440|NCT01110759|hand surgery|hand surgery
1413441|NCT01110759|postoperative pain|postoperative pain
1413442|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1413443|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1413444|NCT01110733|Lymphoma|lymphoma
1568389|NCT00506038|Calcific Tendinitis|calcific tendinitis
1413445|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
1413446|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
1413447|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
1413448|NCT01110707|Ovulation induction|ovulation induction
1413449|NCT01110707|Infertility|infertility
1413450|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1413451|NCT01110694|Interstitial lung disease|interstitial lung disease
1413452|NCT01110694|Prognosis|prognosis
1413453|NCT01110694|Biomarkers|biomarkers
1413454|NCT01110694|Mortality|mortality
1413455|NCT01110694|Acute exacerbations|acute exacerbations
1413456|NCT01110668|Unresectable|unresectable
1413457|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
1413458|NCT01110668|disease progression|disease progression
1413459|NCT01110668|progression-free survival|progression-free survival
1413460|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
1413461|NCT01110655|Randomized treatment trial|randomized treatment trial
1413462|NCT01110655|Endurance runners|endurance runners
1413463|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
1413464|NCT01110629|Lanthanum carbonate|lanthanum carbonate
1413465|NCT01110616|EEG Standardization|eeg standardization
1413466|NCT01110603|Cancer|cancer
1413467|NCT01110603|Advanced Solid Tumors|advanced solid tumors
1413468|NCT01110590|Erectile Dysfunction|erectile dysfunction
1413469|NCT01110577|MRI|mri
1413470|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
1413471|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1413472|NCT01110564|daily symptom variability|daily symptom variability
1413473|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
1413474|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
1413475|NCT01110525|Phase I|phase i
1413476|NCT01110525|Drug-drug interaction|drug-drug interaction
1413477|NCT01110525|Oral contraceptives|oral contraceptives
1413478|NCT01110525|AZD 1981|azd 1981
1413479|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
1413480|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
1413481|NCT01110421|Doripenem|doripenem
1413482|NCT01110421|Child, Hospitalized|child, hospitalized
1413483|NCT01110421|Cefepime|cefepime
1413484|NCT01110421|Infusions, Intravenous|infusions, intravenous
1413485|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
1413486|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
1413487|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
1413488|NCT01110408|Antibiotic|antibiotic
1413489|NCT01110408|Child, Hospitalized|child, hospitalized
1413490|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
1413491|NCT01110408|Pyelonephritis|pyelonephritis
1413492|NCT01110408|Doripenem|doripenem
1413493|NCT01110408|Cefepime|cefepime
1413494|NCT01110382|Anti-Infective Agents|anti-infective agents
1413495|NCT01110382|Doripenem|doripenem
1413496|NCT01110382|Meropenem|meropenem
1413497|NCT01110382|Child, Hospitalized|child, hospitalized
1413498|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
1413499|NCT01110369|sarcopenia|sarcopenia
1413500|NCT01110369|frail elderly|frail elderly
1413501|NCT01110369|protein drink|protein drink
1413502|NCT01110369|resistance exercise|resistance exercise
1413503|NCT01110369|Skeletal muscle mass|skeletal muscle mass
1413504|NCT01110369|muscle mass in elderly|muscle mass in elderly
1413505|NCT01110343|parent stress|parent stress
1413506|NCT01110343|parent coping|parent coping
1413507|NCT01110343|parent anxiety|parent anxiety
1413508|NCT01110343|parent health|parent health
1413509|NCT01110343|parent depression|parent depression
1413510|NCT01110330|Tinea Pedis|tinea pedis
1413511|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
1413512|NCT01110330|Antifungal Agents|antifungal agents
1413513|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
1413514|NCT01110317|Paliperidone palmitate|paliperidone palmitate
1413515|NCT01110317|R092670PSY1001|r092670psy1001
1413516|NCT01110317|Pharmacokinetics|pharmacokinetics
1413517|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
1413518|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
1413519|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
1413520|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
1413521|NCT01110304|joint dislocation|joint dislocation
1413522|NCT01110304|clavicle hook plate|clavicle hook plate
1413523|NCT01110291|docetaxel toxicity|docetaxel toxicity
1413524|NCT01110291|CYP3A activity|cyp3a activity
1413525|NCT01110291|CYP3A5|cyp3a5
1413526|NCT01110291|MDR1|mdr1
1413527|NCT01110291|peroral midazolam|peroral midazolam
1413528|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
1413529|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
1413530|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
1413531|NCT01110278|Brain Connectivity|brain connectivity
1413532|NCT01110278|Bladder Control|bladder control
1413533|NCT01110278|fMRI|fmri
1568390|NCT00506025|Pregnancy|pregnancy
1413534|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1413535|NCT01110252|Emphysema|emphysema
1413536|NCT01110252|Cell therapy|cell therapy
1413537|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
1413538|NCT01110252|stem cells|stem cells
1413539|NCT01110239|limb preconditioning|limb preconditioning
1413540|NCT01110239|remote preconditioning|remote preconditioning
1413541|NCT01110239|ischemic preconditioning|ischemic preconditioning
1413542|NCT01110226|non small cell lung cancer|non small cell lung cancer
1413543|NCT01110226|small cell lung cancer|small cell lung cancer
1413544|NCT01110226|Platinum Responsive|platinum responsive
1413545|NCT01110226|solid tumor malignancies|solid tumor malignancies
1413547|NCT01110213|physical activity|physical activity
1413548|NCT01110213|diet|diet
1413549|NCT01110213|goal setting|goal setting
1413550|NCT01110200|Hospitalization|hospitalization
1413551|NCT01110200|Exacerbations of COPD|exacerbations of copd
1413552|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1413553|NCT01110187|Lacosamide|lacosamide
1413554|NCT01110187|Fosphenytoin|fosphenytoin
1413555|NCT01110187|traumatic brain injury|traumatic brain injury
1413556|NCT01110187|Glasgow coma scale|glasgow coma scale
1413557|NCT01110187|Disability Rating Scale|disability rating scale
1413558|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
1413559|NCT01110187|Continuous EEG|continuous eeg
1413560|NCT01110187|seizures|seizures
1413561|NCT01110161|Abdominal Fat|abdominal fat
1413562|NCT01110161|Visceral Fat|visceral fat
1413563|NCT01110161|Subcutaneous Fat|subcutaneous fat
1413564|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1413565|NCT01110161|DXA|dxa
1413566|NCT01110161|Computed Tomography|computed tomography
1413567|NCT01110161|CT|ct
1413568|NCT01110161|Body Mass Index|body mass index
1413569|NCT01110161|Body composition|body composition
1413570|NCT01110161|Percent fat|percent fat
1413571|NCT01110161|Waist circumference|waist circumference
1413572|NCT01110161|Hip circumference|hip circumference
1413573|NCT01110148|skin biopsy|skin biopsy
1413574|NCT01110148|informed consent|informed consent
1413575|NCT01110148|patient education|patient education
1413576|NCT01110148|video education|video education
1413577|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
1413578|NCT01110122|Muscle recovery|muscle recovery
1413579|NCT01110122|Intermittent exercise|intermittent exercise
1413580|NCT01110122|Whey protein|whey protein
1413581|NCT01110122|Soccer|soccer
1413582|NCT01110109|Adult|adult
1413583|NCT01110109|Surgery|surgery
1413584|NCT01110109|Endotracheal Tube|endotracheal tube
1413585|NCT01110109|Ventilator|ventilator
1413586|NCT01110109|Pneumonia|pneumonia
1413587|NCT01110109|Suctioning|suctioning
1413588|NCT01110096|Obesity|obesity
1413589|NCT01110096|Child|child
1413590|NCT01110096|Parent|parent
1413591|NCT01110096|Family|family
1413592|NCT01110083|Phase 1|phase 1
1413593|NCT01110083|advanced solid tumors|advanced solid tumors
1413594|NCT01110083|refractory to standard therapy|refractory to standard therapy
1413595|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
1413596|NCT01110070|articular|articular
1413597|NCT01110070|cartilage|cartilage
1413598|NCT01110070|microfracture|microfracture
1413599|NCT01110070|knee pain|knee pain
1413600|NCT01110070|cartilage repair|cartilage repair
1413601|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
1413602|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
1413603|NCT01110057|male and female|male and female
1413604|NCT01110057|patients|patients
1413605|NCT01110044|Neonatal vaccination|neonatal vaccination
1413606|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1413607|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
1413608|NCT01110018|Tolerability|tolerability
1413609|NCT01110018|COPD|copd
1413610|NCT01110018|Safety|safety
1413611|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
1413612|NCT01110018|GSK573719|gsk573719
1413613|NCT01110018|Healthy subjects|healthy subjects
1413614|NCT01110018|Pharmacokinetics|pharmacokinetics
1413615|NCT01110018|IV study|iv study
1413616|NCT01110005|D5LR|d5lr
1413617|NCT01110005|glucose containing IV solution|glucose containing iv solution
1413618|NCT01110005|LR|lr
1413619|NCT01110005|non glucose IV solution|non glucose iv solution
1413620|NCT01109992|coronary artery disease|coronary artery disease
1413621|NCT01109992|exercise|exercise
1413623|NCT01109992|positron emission tomography|positron emission tomography
1413624|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
1413625|NCT01109966|Allergy|allergy
1413626|NCT01109966|Cow's Milk|cow's milk
1413627|NCT01109966|Infants|infants
1413628|NCT01109966|Food Allergy|food allergy
1413629|NCT01109953|Lung|lung
1413630|NCT01109953|PET/CT scan|pet/ct scan
1413631|NCT01109953|10-054|10-054
1413632|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
1413922|NCT01108757|catheter|catheter
1413633|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
1413634|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
1413635|NCT01109914|Renal transplantation|renal transplantation
1413636|NCT01109914|Immunosuppression|immunosuppression
1413637|NCT01109914|ETEC|etec
1413638|NCT01109914|Dukoral|dukoral
1413639|NCT01109914|Vaccination|vaccination
1413640|NCT01109914|Immunity, Humoral|immunity, humoral
1413641|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
1413642|NCT01109862|Femoral neck fractures|femoral neck fractures
1413643|NCT01109862|Hip fractures|hip fractures
1413644|NCT01109862|Elderly|elderly
1413645|NCT01109862|Total hip arthroplasty|total hip arthroplasty
1413646|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
1413647|NCT01109849|ADHD|adhd
1413648|NCT01109849|growth|growth
1413649|NCT01109849|BMI|bmi
1413650|NCT01109849|stimulant medication|stimulant medication
1413651|NCT01109836|prevention|prevention
1413652|NCT01109836|cognitive decline|cognitive decline
1413653|NCT01109836|post-stroke dementia|post-stroke dementia
1413654|NCT01109836|life-style intervention|life-style intervention
1413655|NCT01109836|vascular risk factors|vascular risk factors
1413656|NCT01109836|polyintervention|polyintervention
1413657|NCT01109836|multifactorial treatment|multifactorial treatment
1413658|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
1413659|NCT01109784|coronary angioplasty|coronary angioplasty
1413660|NCT01109784|clopidogrel resistance|clopidogrel resistance
1413661|NCT01109784|prasugrel|prasugrel
1413662|NCT01109771|Ventral hernia|ventral hernia
1413663|NCT01109758|Fenofibrate|fenofibrate
1413664|NCT01109758|Gene Expression|gene expression
1413665|NCT01109758|DNA methylation|dna methylation
1413666|NCT01109745|Asthma|asthma
1413667|NCT01109745|health-related quality of life|health-related quality of life
1413668|NCT01109745|patient-centred care|patient-centred care
1413669|NCT01109719|Protocol|protocol
1413670|NCT01109719|Critical pathway|critical pathway
1413671|NCT01109719|Intensive care units|intensive care units
1413672|NCT01109706|Acute coronary syndrome|acute coronary syndrome
1413673|NCT01109706|PCSK9|pcsk9
1413674|NCT01109706|cardiovascular safety|cardiovascular safety
1413675|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
1413676|NCT01109654|Fertilization in Vitro|fertilization in vitro
1413677|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
1413678|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
1413679|NCT01109654|Cetrotide|cetrotide
1413680|NCT01109654|Gonal-f|gonal-f
1413681|NCT01109628|sarcopenia|sarcopenia
1413682|NCT01109628|frail elderly|frail elderly
1413683|NCT01109628|protein drink|protein drink
1413684|NCT01109628|skeletal muscle mass|skeletal muscle mass
1413685|NCT01109628|muscle mass in elderly|muscle mass in elderly
1413686|NCT01109615|Colorectal cancer|colorectal cancer
1413687|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
1413688|NCT01109615|Treatment resistant|treatment resistant
1413689|NCT01109615|Chemotherapy refractory|chemotherapy refractory
1413690|NCT01109615|KRAS mutation|kras mutation
1413691|NCT01109602|Stroke|stroke
1413692|NCT01109602|accidental falls|accidental falls
1413693|NCT01109602|Yoga|yoga
1413694|NCT01109602|Blood pressure|blood pressure
1413695|NCT01109602|Range of Motion|range of motion
1413696|NCT01109602|Rehabilitation|rehabilitation
1413697|NCT01109602|Exercise|exercise
1413698|NCT01109602|balance|balance
1413699|NCT01109602|quality of life|quality of life
1413700|NCT01109602|mobility|mobility
1413701|NCT01109589|antibiotics|antibiotics
1413702|NCT01109589|prescriptions|prescriptions
1413703|NCT01109589|pregnancy|pregnancy
1413704|NCT01109589|children|children
1413705|NCT01109576|deafness-blindness|deafness-blindness
1413706|NCT01109576|pilot study|pilot study
1413707|NCT01109576|self management education|self management education
1413708|NCT01109576|dual sensory loss|dual sensory loss
1413709|NCT01109576|rehabilitation|rehabilitation
1413710|NCT01109576|peer support groups|peer support groups
1413711|NCT01109576|age related|age related
1413712|NCT01109563|cannabis use disorder|cannabis use disorder
1413713|NCT01109563|marijuana|marijuana
1413714|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
1413715|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
1413716|NCT01109563|continuing care|continuing care
1413717|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
1413718|NCT01109537|GABA|gaba
1413719|NCT01109537|Glutamate|glutamate
1413720|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1413722|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
1413723|NCT01109498|Chylomicronaemia|chylomicronaemia
1413724|NCT01109498|Genetherapy|genetherapy
1413725|NCT01109498|AAV|aav
1413726|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
1544345|NCT00603304|BPH|bph
1413727|NCT01109498|AMT-011|amt-011
1413728|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
1414205|NCT01107431|glucose|glucose
1413729|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
1413730|NCT01109459|preschool|preschool
1413731|NCT01109459|screening|screening
1413732|NCT01109459|cluster randomized|cluster randomized
1413733|NCT01109459|physician practice patterns|physician practice patterns
1413734|NCT01109459|behavior|behavior
1413735|NCT01109459|knowledge|knowledge
1413736|NCT01109459|attitudes|attitudes
1413737|NCT01109459|guideline adherence|guideline adherence
1413738|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
1413739|NCT01109446|Tennis Elbow|tennis elbow
1413740|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
1413741|NCT01109433|Behcet's Disease|behcet's disease
1413742|NCT01109433|Intermediate Uveitis|intermediate uveitis
1413743|NCT01109433|Uveitis|uveitis
1413744|NCT01109433|Immunogenetics|immunogenetics
1413745|NCT01109420|Hereditary Cancer|hereditary cancer
1413746|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
1413747|NCT01109420|Screening at Risk Family Members|screening at risk family members
1413748|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
1413749|NCT01109420|Thyroid Cancer|thyroid cancer
1413750|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
1413751|NCT01109407|Natural History|natural history
1413752|NCT01109407|Translational Studies|translational studies
1413753|NCT01109407|Gene Expression Profiling|gene expression profiling
1413754|NCT01109407|Protein Markers|protein markers
1413755|NCT01109407|Smoldering Myeloma|smoldering myeloma
1413756|NCT01109407|SMM|smm
1413757|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
1413758|NCT01109407|MGUS|mgus
1413759|NCT01109394|Genomics|genomics
1413760|NCT01109394|Proteomics|proteomics
1413761|NCT01109394|Tissue Repository|tissue repository
1413762|NCT01109394|Omics|omics
1413763|NCT01109394|Cell Lines|cell lines
1413764|NCT01109394|Pediatric Cancer|pediatric cancer
1413765|NCT01109394|Solid Tumor|solid tumor
1413766|NCT01109394|Sarcoma|sarcoma
1413767|NCT01109394|Kidney Cancer|kidney cancer
1413768|NCT01109394|Neuroblastoma|neuroblastoma
1413769|NCT01109381|bacterial infections|bacterial infections
1413770|NCT01109381|anti-infective agents|anti-infective agents
1413771|NCT01109381|gastrointestinal agents|gastrointestinal agents
1413772|NCT01109381|antibacterial agents|antibacterial agents
1413773|NCT01109381|omeprazole|omeprazole
1413774|NCT01109381|lauric acid|lauric acid
1413775|NCT01109381|n-acetylcysteine|n-acetylcysteine
1413776|NCT01109381|helicobacter infections|helicobacter infections
1413777|NCT01109381|helicobacter pylori|helicobacter pylori
1413778|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
1413779|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
1413780|NCT01109355|PEEP|peep
1413781|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
1413782|NCT01109342|HIV Prevention|hiv prevention
1413783|NCT01109342|Vaccine|vaccine
1413784|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
1413785|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
1413786|NCT01109329|Vaccine|vaccine
1413787|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
1413788|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
1413789|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1413914|NCT01108783|Nasal Congestion|nasal congestion
1413790|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
1413791|NCT01109264|Chlorambucil|chlorambucil
1413792|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
1413793|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
1413794|NCT01109225|aldosterone|aldosterone
1413795|NCT01109225|myocardial infarction|myocardial infarction
1413796|NCT01109225|cardiac remodeling|cardiac remodeling
1413797|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
1413798|NCT01109212|bindarit|bindarit
1413799|NCT01109212|albuminuria|albuminuria
1413800|NCT01109212|MCP-1|mcp-1
1413801|NCT01109199|viscous|viscous
1413802|NCT01109199|fibre|fibre
1413803|NCT01109199|polysaccharide|polysaccharide
1413804|NCT01109199|appetite|appetite
1413805|NCT01109199|hunger|hunger
1413806|NCT01109199|satiety|satiety
1413807|NCT01109199|weight management|weight management
1413808|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
1413809|NCT01109160|azithromycin|azithromycin
1413810|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
1413811|NCT01109160|lung transplantation|lung transplantation
1413812|NCT01109160|acute allograft rejection|acute allograft rejection
1413813|NCT01109160|chronic allograft rejection|chronic allograft rejection
1413814|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1413815|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
1413816|NCT01109147|Schizophrenia|schizophrenia
1413817|NCT01109147|Affect|affect
1544408|NCT00603018|PET|pet
1413818|NCT01109147|Emotional Blunting|emotional blunting
1413819|NCT01109134|primary angioplasty|primary angioplasty
1413820|NCT01109134|tirofiban|tirofiban
1413821|NCT01109134|microcirculation|microcirculation
1413822|NCT01109121|Moderate to severe gout|moderate to severe gout
1413823|NCT01109121|Hyperuricemia|hyperuricemia
1413824|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
1413825|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
1413826|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
1413827|NCT01109095|HER2|her2
1413828|NCT01109095|CMV|cmv
1413829|NCT01109095|Brain Cancer|brain cancer
1413830|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
1413831|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
1413832|NCT01109082|Scoliosis|scoliosis
1413833|NCT01109082|gait|gait
1413834|NCT01109082|posture|posture
1413835|NCT01109082|balance|balance
1413836|NCT01109069|PCI-32765|pci-32765
1413837|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
1413838|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
1413839|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
1413840|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1413841|NCT01109043|Hypertension|hypertension
1413842|NCT01109043|Bisoprolol|bisoprolol
1413843|NCT01109043|Antihypertensive drugs|antihypertensive drugs
1413844|NCT01109043|Blood pressure|blood pressure
1413845|NCT01109043|Quality of life|quality of life
1413846|NCT01109043|Diabetes|diabetes
1413847|NCT01109043|Ketohexokinase|ketohexokinase
1413848|NCT01109030|Major depressive disorder|major depressive disorder
1413849|NCT01109030|pioglitazone|pioglitazone
1413850|NCT01109030|double blind|double blind
1413851|NCT01109030|placebo controlled|placebo controlled
1413852|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
1413853|NCT01109004|Lenalidomide|lenalidomide
1413854|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
1413855|NCT01109004|Hematologic Disorders|hematologic disorders
1413856|NCT01109004|Maintenance Therapy|maintenance therapy
1413857|NCT01109004|Progression|progression
1413858|NCT01109004|Autologous Transplant|autologous transplant
1413859|NCT01109004|RVD Consolidation|rvd consolidation
1413860|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1413861|NCT01108991|Randomized controlled trial|randomized controlled trial
1413862|NCT01108991|Self-management support|self-management support
1413863|NCT01108991|Physical activity|physical activity
1413864|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1413865|NCT01108978|Cardiovascular Disease|cardiovascular disease
1413866|NCT01108978|hypercholesterolemia|hypercholesterolemia
1413867|NCT01108965|Hydrocephalus|hydrocephalus
1413868|NCT01108965|Shunt Dysfunction|shunt dysfunction
1413869|NCT01108965|Shunt Flow|shunt flow
1413870|NCT01108952|Chemotherapy|chemotherapy
1413871|NCT01108952|Memory|memory
1413872|NCT01108952|Methotrexate|methotrexate
1413873|NCT01108952|Glucocorticoids|glucocorticoids
1413874|NCT01108952|Trauma|trauma
1413875|NCT01108952|pediatric oncology|pediatric oncology
1413876|NCT01108952|traumatization|traumatization
1413877|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
1413878|NCT01108913|COPD|copd
1413879|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
1413880|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1413881|NCT01108887|RebiSmart|rebismart
1413882|NCT01108887|Rebif|rebif
1413883|NCT01108887|Interferon beta-1a|interferon beta-1a
1413884|NCT01108874|Cesarean section|cesarean section
1413885|NCT01108874|Hypotension|hypotension
1413886|NCT01108874|Metaraminol|metaraminol
1413887|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
1413888|NCT01108874|Adult|adult
1413889|NCT01108874|Female|female
1413890|NCT01108874|Pregnancy|pregnancy
1413891|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
1413892|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
1413893|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
1413894|NCT01108874|Nausea|nausea
1413895|NCT01108874|Vomiting|vomiting
1413896|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
1413897|NCT01108861|In-stent restenosis|in-stent restenosis
1413898|NCT01108861|Endoprosthesis|endoprosthesis
1413899|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
1413900|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
1413901|NCT01108848|Hereditary angioedema|hereditary angioedema
1413902|NCT01108848|Acute HAE attack|acute hae attack
1413903|NCT01108835|COPD|copd
1413904|NCT01108835|Comprehensive care|comprehensive care
1413905|NCT01108783|Rhinitis|rhinitis
1413906|NCT01108783|Allergic|allergic
1413907|NCT01108783|Seasonal|seasonal
1413908|NCT01108783|Hay Fever|hay fever
1413909|NCT01108783|Pollen Allergy|pollen allergy
1413910|NCT01108783|Pollinosis|pollinosis
1413911|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
1413912|NCT01108783|Sneezing|sneezing
1413913|NCT01108783|Nasal itching|nasal itching
1413915|NCT01108783|Rhinorrhea|rhinorrhea
1413916|NCT01108783|Ocular itching|ocular itching
1413917|NCT01108783|Ocular redness|ocular redness
1413918|NCT01108783|Tearing|tearing
1413919|NCT01108770|HED|hed
1413920|NCT01108770|XLHED|xlhed
1413921|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
1413923|NCT01108757|urinary tract infection|urinary tract infection
1413924|NCT01108744|clinical trial|clinical trial
1413925|NCT01108744|mannitol|mannitol
1413926|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
1413927|NCT01108744|hypertonic saline|hypertonic saline
1413928|NCT01108744|cerebral edema|cerebral edema
1413929|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
1413930|NCT01108718|Mattress|mattress
1413931|NCT01108718|Tempur-Pedic|tempur-pedic
1413932|NCT01108718|Fibromyalgia|fibromyalgia
1413933|NCT01108718|Sleep patterns|sleep patterns
1413934|NCT01108692|atrial fibrillation|atrial fibrillation
1413935|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
1413936|NCT01108692|antithrombotic treatment|antithrombotic treatment
1413937|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
1413938|NCT01108692|medical reaction time|medical reaction time
1413939|NCT01108692|telecardiology|telecardiology
1413940|NCT01108692|early detection|early detection
1413941|NCT01108692|holters memories|holters memories
1413942|NCT01108692|Pacemaker|pacemaker
1413943|NCT01108666|Adult subjects with a confirmed diagnosis of Stage IIIA or IIIB NSCLC, with adequate bone marrow, liver and renal function.|adult subjects with a confirmed diagnosis of stage iiia or iiib nsclc, with adequate bone marrow, liver and renal function.
1413944|NCT01108653|Cardiovascular diseases|cardiovascular diseases
1413945|NCT01108653|Heart diseases|heart diseases
1413946|NCT01108653|Myocardial infarction|myocardial infarction
1413947|NCT01108653|Rehabilitation|rehabilitation
1413948|NCT01108653|Health Economy|health economy
1413949|NCT01108653|Randomized controlled trials|randomized controlled trials
1413950|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
1413951|NCT01108653|Cost analysis|cost analysis
1413952|NCT01108653|Sick-leave|sick-leave
1413953|NCT01108653|Quality of Life|quality of life
1413954|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
1413955|NCT01108614|drug users|drug users
1413956|NCT01108614|heroin|heroin
1413957|NCT01108614|HIV|hiv
1413958|NCT01108614|HCV|hcv
1413959|NCT01108614|Syphilis|syphilis
1413960|NCT01108614|HSV-2|hsv-2
1413961|NCT01108601|Ringer's|ringer's
1413962|NCT01108601|lactate|lactate
1413963|NCT01108601|cisplatin|cisplatin
1413964|NCT01108601|ototoxicity|ototoxicity
1413965|NCT01108601|hearing loss|hearing loss
1413966|NCT01108575|Mechanical ventilation|mechanical ventilation
1413967|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
1413968|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
1413969|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
1413970|NCT01108562|postoperative pain management|postoperative pain management
1413971|NCT01108549|Fibromyalgia|fibromyalgia
1413972|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
1413973|NCT01108549|D-ribose|d-ribose
1413974|NCT01108549|fatigue|fatigue
1413975|NCT01108536|prosthetics|prosthetics
1413976|NCT01108536|socket comfort|socket comfort
1413977|NCT01108536|amputation stump|amputation stump
1413978|NCT01108536|amputee rehabilitation|amputee rehabilitation
1413979|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
1413980|NCT01108510|Treatment Naive|treatment naive
1413981|NCT01108510|HIV 1 Infected|hiv 1 infected
1413982|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
1413983|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
1413984|NCT01108445|cancer|cancer
1413985|NCT01108445|kidney cancer|kidney cancer
1413986|NCT01108445|sutent|sutent
1413987|NCT01108445|everolimus|everolimus
1413988|NCT01108445|renal cancer|renal cancer
1413989|NCT01108445|papillary renal cell|papillary renal cell
1413990|NCT01108445|chromophobe renal cell|chromophobe renal cell
1413991|NCT01108445|papillary|papillary
1413992|NCT01108445|chromophobe|chromophobe
1413993|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
1413994|NCT01108419|healthy adults|healthy adults
1413995|NCT01108406|Hearing Loss|hearing loss
1413996|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
1413997|NCT01108406|Single Sided Deafness|single sided deafness
1413998|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
1413999|NCT01108393|Agomelatine|agomelatine
1414000|NCT01108380|Liver cirrhosis|liver cirrhosis
1414001|NCT01108380|liver regeneration|liver regeneration
1414002|NCT01108380|liver volume|liver volume
1414003|NCT01108380|liver function|liver function
1414004|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
1414005|NCT01108380|hepatectomy|hepatectomy
1414006|NCT01108328|viscous|viscous
1414007|NCT01108328|fibre|fibre
1414008|NCT01108328|polysaccharide|polysaccharide
1414009|NCT01108328|blood glucose|blood glucose
1414010|NCT01108328|postprandial|postprandial
1414011|NCT01108328|appetite|appetite
1414012|NCT01108328|hunger|hunger
1414013|NCT01108328|satiety|satiety
1414014|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
1414015|NCT01108315|Web-based|web-based
1414016|NCT01108315|Phone-based|phone-based
1414017|NCT01108315|Breast Cancer|breast cancer
1414018|NCT01108302|uterotonic|uterotonic
1414019|NCT01108302|oxytocin|oxytocin
1414020|NCT01108302|randomized trial|randomized trial
1414021|NCT01108302|India|india
1414022|NCT01108302|community|community
1414023|NCT01108302|hemorrhage|hemorrhage
1414024|NCT01108289|hemorrhage|hemorrhage
1414025|NCT01108289|uterotonic|uterotonic
1414026|NCT01108289|oxytocin|oxytocin
1414027|NCT01108289|blood loss|blood loss
1414028|NCT01108289|community|community
1414029|NCT01108289|Ghana|ghana
1414030|NCT01108289|randomized trial|randomized trial
1414031|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
1414032|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
1414033|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
1414034|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
1414035|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
1414036|NCT01108237|Knee Replacement, Total|knee replacement, total
1414037|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
1414038|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
1414039|NCT01108237|Replacement, Total Knee|replacement, total knee
1414040|NCT01108237|Total Knee Replacement|total knee replacement
1414041|NCT01108224|Quality of life|quality of life
1414042|NCT01108224|Coping|coping
1414043|NCT01108224|Social relations|social relations
1414044|NCT01108224|Survival|survival
1414045|NCT01108224|Psychotherapy|psychotherapy
1414046|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1414047|NCT01108211|AIS|ais
1414048|NCT01108211|Vibration Therapy|vibration therapy
1414049|NCT01108211|Low bone mass|low bone mass
1414050|NCT01108211|osteopenia|osteopenia
1414051|NCT01108198|phimosis,|phimosis,
1414052|NCT01108198|non-retractable foreskin|non-retractable foreskin
1414053|NCT01108198|topical steroids|topical steroids
1414054|NCT01108198|children|children
1414055|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
1414056|NCT01108185|tracheitis|tracheitis
1414057|NCT01108185|tracheobronchitis|tracheobronchitis
1414058|NCT01108185|bronchitis|bronchitis
1414059|NCT01108185|chronic bronchitis|chronic bronchitis
1414060|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
1414061|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
1414062|NCT01108133|Traumatic Memories|traumatic memories
1414063|NCT01108133|fMRI|fmri
1414064|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
1414065|NCT01108120|artery mini-pump|artery mini-pump
1414066|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
1414067|NCT01108120|femoral artery|femoral artery
1414068|NCT01108107|Colon cancer|colon cancer
1414069|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
1414070|NCT01108107|KRAS mutation|kras mutation
1414071|NCT01108107|BRAF mutation|braf mutation
1414072|NCT01108107|PIK3CA mutation|pik3ca mutation
1414073|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
1414074|NCT01108081|Sleep apnea|sleep apnea
1414075|NCT01108081|Sleep symptoms|sleep symptoms
1414076|NCT01108081|Quality of Life|quality of life
1414077|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
1414078|NCT01108029|Parkinson's disease|parkinson's disease
1414079|NCT01108029|Freezing of Gait|freezing of gait
1414080|NCT01108029|Memantine|memantine
1414081|NCT01108029|NMDA receptor|nmda receptor
1414082|NCT01108029|glutamate|glutamate
1414083|NCT01108029|No Dementia|no dementia
1414084|NCT01107964|Dry Eye Syndrome|dry eye syndrome
1414085|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
1414086|NCT01107951|Rituximab|rituximab
1414087|NCT01107951|Dexamethasone|dexamethasone
1414088|NCT01107951|Low-dose|low-dose
1414089|NCT01107951|ITP|itp
1414090|NCT01107938|GERD|gerd
1414091|NCT01107925|Platelet function|platelet function
1414092|NCT01107912|Platelet function|platelet function
1414093|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
1414094|NCT01107899|Angina|angina
1414095|NCT01107899|Platelet Function|platelet function
1414096|NCT01107899|Coronary Angiography|coronary angiography
1414097|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
1414098|NCT01107899|Positive Stress Test|positive stress test
1414099|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
1414100|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
1414101|NCT01107847|electrical impedance tomography|electrical impedance tomography
1414102|NCT01107847|EIT|eit
1414103|NCT01107847|acute lung injury|acute lung injury
1414104|NCT01107847|regional lung opening pressure|regional lung opening pressure
1414105|NCT01107847|regional lung closing pressure|regional lung closing pressure
1414106|NCT01107834|HIV|hiv
1414107|NCT01107834|heart function|heart function
1414108|NCT01107834|HAART|haart
1414109|NCT01107834|in utero|in utero
1414110|NCT01107834|children|children
1414111|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
1414206|NCT01107431|insulin|insulin
1414112|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
1414113|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
1414114|NCT01107821|Abdominal wounds|abdominal wounds
1414115|NCT01107808|Adolescents|adolescents
1414116|NCT01107808|African American|african american
1414117|NCT01107808|Female|female
1414118|NCT01107782|sildenafil|sildenafil
1414119|NCT01107782|FGR|fgr
1414120|NCT01107743|Hypertension|hypertension
1414121|NCT01107743|Angina pectoris|angina pectoris
1414122|NCT01107743|Hypercholesterolemia|hypercholesterolemia
1414123|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
1414124|NCT01107743|Japanese|japanese
1414125|NCT01107743|caduet|caduet
1414126|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1414127|NCT01107730|Atrial fibrillation|atrial fibrillation
1414128|NCT01107730|Cardiac valve repair|cardiac valve repair
1414129|NCT01107730|Aneurysm repair|aneurysm repair
1414130|NCT01107730|CABG|cabg
1414131|NCT01107730|On-pump|on-pump
1414132|NCT01107730|Cardiac surgery|cardiac surgery
1414133|NCT01107730|Vitamin C|vitamin c
1414134|NCT01107717|type 2 diabetes|type 2 diabetes
1414135|NCT01107717|new onset|new onset
1414136|NCT01107717|combination therapy|combination therapy
1414137|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
1414138|NCT01107704|Intensive Care Units|intensive care units
1414139|NCT01107704|Surrogates|surrogates
1414140|NCT01107704|Family Members|family members
1414141|NCT01107704|Physicians|physicians
1414142|NCT01107704|Critically Ill|critically ill
1414143|NCT01107704|Depression|depression
1414144|NCT01107704|Anxiety|anxiety
1414145|NCT01107704|Emotional|emotional
1414146|NCT01107704|Support|support
1414147|NCT01107704|Multi-faceted communication|multi-faceted communication
1414148|NCT01107704|Grief|grief
1414149|NCT01107704|Prognosis|prognosis
1414150|NCT01107704|Family Support Counselor|family support counselor
1414151|NCT01107691|resistance and weight loss training|resistance and weight loss training
1414152|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
1414153|NCT01107665|pazopanib|pazopanib
1414154|NCT01107665|paclitaxel|paclitaxel
1414155|NCT01107665|melanoma|melanoma
1414156|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
1414157|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1414158|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1414159|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1414160|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
1414161|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
1414162|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
1414163|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1414164|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1414165|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1414166|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
1414167|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1414168|NCT01107626|large cell lung cancer|large cell lung cancer
1414169|NCT01107613|opinion leader|opinion leader
1414170|NCT01107613|COPD|copd
1414171|NCT01107613|Emergency Department|emergency department
1414172|NCT01107613|relapse|relapse
1414173|NCT01107613|follow-up|follow-up
1414174|NCT01107613|evidence-based guidelines|evidence-based guidelines
1414175|NCT01107613|Exacerbation of COPD|exacerbation of copd
1414176|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
1414177|NCT01107600|Bone Regeneration|bone regeneration
1414178|NCT01107600|Dental Restoration|dental restoration
1414179|NCT01107600|Socket preservation|socket preservation
1414180|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
1414181|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
1414182|NCT01107561|cricothyroidotomy|cricothyroidotomy
1414183|NCT01107561|intubation|intubation
1414184|NCT01107561|airway|airway
1414185|NCT01107561|emergency medicine|emergency medicine
1414186|NCT01107561|education|education
1414187|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
1414188|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
1414189|NCT01107535|Preterm infants|preterm infants
1414190|NCT01107509|Renal cell carcinoma|renal cell carcinoma
1414191|NCT01107509|Metastatic|metastatic
1414192|NCT01107509|everolimus|everolimus
1414193|NCT01107509|neo-adjuvant|neo-adjuvant
1414194|NCT01107509|biomarkers|biomarkers
1414195|NCT01107509|nephrectomy|nephrectomy
1414196|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
1414400|NCT01106625|Placebo|placebo
1414197|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
1414198|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
1414199|NCT01107483|endotoxaemia|endotoxaemia
1414200|NCT01107470|Infertility IVF ART|infertility ivf art
1414201|NCT01107457|Moderate|moderate
1414202|NCT01107457|Severe|severe
1414203|NCT01107457|Plaque|plaque
1414204|NCT01107457|Chronic|chronic
1414207|NCT01107431|L-arabinose|l-arabinose
1414208|NCT01107431|Chromium|chromium
1414209|NCT01107366|lupiae techinque|lupiae techinque
1414210|NCT01107366|aortic aneurism|aortic aneurism
1414211|NCT01107366|aortic dissection|aortic dissection
1414212|NCT01107327|cancer|cancer
1414213|NCT01107301|ADHD|adhd
1414214|NCT01107288|Aged|aged
1414215|NCT01107288|Balance|balance
1414216|NCT01107288|Dual-task|dual-task
1414217|NCT01107288|Exercise|exercise
1414218|NCT01107288|Falls|falls
1414219|NCT01107288|Gait|gait
1414220|NCT01107288|Music|music
1414221|NCT01107275|Rabies|rabies
1414222|NCT01107275|PCECV|pcecv
1414223|NCT01107275|pre-exposure immunization|pre-exposure immunization
1414224|NCT01107275|intradermal|intradermal
1414225|NCT01107275|children|children
1414226|NCT01107262|H5N1 Subtype|h5n1 subtype
1414227|NCT01107262|Avian viruses|avian viruses
1414228|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
1414229|NCT01107249|esophageal|esophageal
1414230|NCT01107249|stenting|stenting
1414231|NCT01107249|perforations|perforations
1414232|NCT01107249|gastric|gastric
1414233|NCT01107249|esophageal stenting|esophageal stenting
1414234|NCT01107236|Healthy subjects|healthy subjects
1414235|NCT01107223|Antibiotic|antibiotic
1414236|NCT01107223|Prescribing behaviour|prescribing behaviour
1414237|NCT01107223|Guidelines|guidelines
1414238|NCT01107223|Respiratory tract infections|respiratory tract infections
1414239|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
1414240|NCT01107210|stroke|stroke
1414241|NCT01107210|physical fitness|physical fitness
1414242|NCT01107210|evolution|evolution
1414243|NCT01107210|determinants|determinants
1414244|NCT01107197|Pressure ulcers|pressure ulcers
1414245|NCT01107197|Healing|healing
1414246|NCT01107197|Malnutrition|malnutrition
1414247|NCT01107197|Nutritional support|nutritional support
1414248|NCT01107197|Micronutrients|micronutrients
1414249|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
1414250|NCT01107184|CABG surgery|cabg surgery
1414251|NCT01107184|Atrial fibrillation|atrial fibrillation
1414252|NCT01107184|Coronary Artery Bypass|coronary artery bypass
1414253|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
1414254|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
1414255|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
1414256|NCT01107171|blood glucose|blood glucose
1414257|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
1414258|NCT01107171|Clinical Trial|clinical trial
1414259|NCT01107171|Intervention Studies|intervention studies
1414260|NCT01107145|Plasmodium|plasmodium
1414261|NCT01107145|Vivax|vivax
1414262|NCT01107145|Malaria|malaria
1414263|NCT01107145|Pregnancy|pregnancy
1414264|NCT01107145|Brazil|brazil
1414265|NCT01107145|Treatment|treatment
1414266|NCT01107119|Frail elderly|frail elderly
1414267|NCT01107119|Chronic illness|chronic illness
1414268|NCT01107119|Integrated care model|integrated care model
1414269|NCT01107119|Clinical pathways|clinical pathways
1414270|NCT01107119|Home care services|home care services
1414271|NCT01107106|Contraceptive Methods|contraceptive methods
1414272|NCT01107106|Female Contraception|female contraception
1414273|NCT01107080|breast cancer|breast cancer
1414274|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
1414275|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1414276|NCT01107080|invasive carcinoma|invasive carcinoma
1414277|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
1414278|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
1414279|NCT01107067|hypogonadism|hypogonadism
1414280|NCT01107067|paraoxonase|paraoxonase
1414281|NCT01107067|Hipogonadism|hipogonadism
1414283|NCT01107041|Depression|depression
1414284|NCT01107041|Technology Assisted|technology assisted
1414285|NCT01107041|Mobile Phone|mobile phone
1414286|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1414287|NCT01107028|Dyspnea|dyspnea
1414288|NCT01107028|Functional capacity|functional capacity
1414289|NCT01107028|Quality of life|quality of life
1414290|NCT01107015|Diabetes|diabetes
1414291|NCT01107015|Glucose control|glucose control
1414292|NCT01107015|Diabetes monitoring|diabetes monitoring
1414293|NCT01107015|Care management|care management
1414294|NCT01107015|Electronic communication|electronic communication
1414295|NCT01107015|Mobile phone technology|mobile phone technology
1414296|NCT01107015|Self care|self care
1414297|NCT01107002|infertility|infertility
1414298|NCT01107002|Embryo transfer|embryo transfer
1414300|NCT01106976|acetylcholine|acetylcholine
1414302|NCT01106963|tibial fractures|tibial fractures
1414303|NCT01106963|pain|pain
1414304|NCT01106963|osteosynthesis|osteosynthesis
1414305|NCT01106963|intramedullary nailing|intramedullary nailing
1414306|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
1414307|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
1414308|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
1414309|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
1414310|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
1414311|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
1414312|NCT01106911|baseline screening mammography|baseline screening mammography
1414313|NCT01106911|recall rates|recall rates
1414314|NCT01106885|Diabetes|diabetes
1414315|NCT01106885|Depression|depression
1414316|NCT01106885|Telephone Care Management|telephone care management
1414317|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
1414318|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1414319|NCT01106872|Sarcoma|sarcoma
1414320|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
1414321|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
1414322|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
1414323|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
1414324|NCT01106872|Valproic Acid|valproic acid
1414325|NCT01106872|Bevacizumab|bevacizumab
1414326|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1414327|NCT01106859|insomnia|insomnia
1414328|NCT01106846|Ketamine|ketamine
1414329|NCT01106846|Anesthesia|anesthesia
1414330|NCT01106846|Pain|pain
1414331|NCT01106846|Outpatient surgery|outpatient surgery
1414332|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
1414333|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1414334|NCT01106794|DIPG|dipg
1414335|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
1414336|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
1414337|NCT01106794|brainstem glioma|brainstem glioma
1414338|NCT01106794|BSG|bsg
1414339|NCT01106781|EGFR mutation test|egfr mutation test
1414340|NCT01106781|NSCLC|nsclc
1414341|NCT01106781|Non-Interventional Study|non-interventional study
1414342|NCT01106781|EGFR mutation status|egfr mutation status
1414343|NCT01106768|oral health needs|oral health needs
1414344|NCT01106768|children|children
1414345|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
1414346|NCT01106755|kinematic|kinematic
1414347|NCT01106755|hemiparesis|hemiparesis
1414348|NCT01106755|gait|gait
1414349|NCT01106755|Body weight support|body weight support
1414350|NCT01106755|Functional electrical stimulation|functional electrical stimulation
1414351|NCT01106742|Inflammatory|inflammatory
1414352|NCT01106742|AbM|abm
1414353|NCT01106742|IBD|ibd
1414354|NCT01106729|Flavonoids|flavonoids
1414355|NCT01106729|Anthocyanin|anthocyanin
1414356|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
1414357|NCT01106729|Acute feeding trial|acute feeding trial
1414358|NCT01106729|Stable isotope|stable isotope
1414359|NCT01106729|Metabolism|metabolism
1414360|NCT01106729|Clearance|clearance
1414361|NCT01106729|Bioavailability|bioavailability
1414362|NCT01106729|Pharmacokinetics|pharmacokinetics
1414363|NCT01106716|Lidocaine|lidocaine
1414364|NCT01106716|Lignocaine|lignocaine
1414365|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
1414366|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
1414367|NCT01106716|Pain|pain
1414368|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
1414369|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
1414370|NCT01106716|PHN|phn
1414371|NCT01106703|atopy, IgE|atopy, ige
1414372|NCT01106690|Canagliflozin|canagliflozin
1414373|NCT01106690|Placebo|placebo
1414374|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
1414375|NCT01106690|Metformin|metformin
1414376|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
1414377|NCT01106690|Hemoglobin A1c|hemoglobin a1c
1414378|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
1414379|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
1414380|NCT01106677|Canagliflozin|canagliflozin
1414381|NCT01106677|Placebo|placebo
1414382|NCT01106677|Sitagliptin|sitagliptin
1414383|NCT01106677|Januvia|januvia
1414384|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
1414385|NCT01106677|Hemoglobin A1c|hemoglobin a1c
1414386|NCT01106664|ONO-7746|ono-7746
1414387|NCT01106664|Healthy adult subjects|healthy adult subjects
1414388|NCT01106651|Canagliflozin|canagliflozin
1414389|NCT01106651|Placebo|placebo
1414390|NCT01106651|Hemoglobin A1c|hemoglobin a1c
1414391|NCT01106651|Bone|bone
1414392|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
1414393|NCT01106638|HIV|hiv
1414394|NCT01106638|AIDS|aids
1414395|NCT01106638|Smoking|smoking
1414396|NCT01106638|Tobacco|tobacco
1414397|NCT01106638|Cessation|cessation
1414398|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
1414399|NCT01106625|Canagliflozin|canagliflozin
1414401|NCT01106625|Metformin|metformin
1414402|NCT01106625|Sulphonylurea|sulphonylurea
1414403|NCT01106625|Hemoglobin A1c|hemoglobin a1c
1414404|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
1414405|NCT01106612|randomized controlled trial|randomized controlled trial
1414406|NCT01106612|controlled clinical trial|controlled clinical trial
1414407|NCT01106612|comparative effectiveness research|comparative effectiveness research
1414408|NCT01106612|chest pain|chest pain
1414409|NCT01106612|angina pectoris|angina pectoris
1414410|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
1414411|NCT01106612|nuclear stress testing|nuclear stress testing
1414412|NCT01106612|coronary CT angiography|coronary ct angiography
1414413|NCT01106612|coronary catheterization|coronary catheterization
1414414|NCT01106612|coronary revascularization|coronary revascularization
1414415|NCT01106586|HIV 1 Infection|hiv 1 infection
1414416|NCT01106586|Treatment Naive|treatment naive
1414417|NCT01106573|Diabetes Mellitus|diabetes mellitus
1414418|NCT01106573|Arteriosclerosis|arteriosclerosis
1414419|NCT01106573|Intima media thickness|intima media thickness
1414420|NCT01106573|arterial stiffness|arterial stiffness
1414421|NCT01106573|pulsewave velocity|pulsewave velocity
1414422|NCT01106573|fibulin-1|fibulin-1
1414423|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
1414424|NCT01106547|glucocorticoids|glucocorticoids
1414425|NCT01106547|rehabilitation|rehabilitation
1414426|NCT01106547|postoperative pain|postoperative pain
1414427|NCT01106547|analgetics|analgetics
1414428|NCT01106534|drug eluting stents|drug eluting stents
1414429|NCT01106534|Stents|stents
1414430|NCT01106534|Angioplasty|angioplasty
1414431|NCT01106534|Stent thrombosis|stent thrombosis
1414432|NCT01106534|antiplatelet treatment|antiplatelet treatment
1414433|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
1414434|NCT01106521|Brachytherapy|brachytherapy
1414435|NCT01106508|Advanced solid tumors|advanced solid tumors
1414436|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
1414437|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
1414438|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
1414439|NCT01106495|Atherosclerosis|atherosclerosis
1414440|NCT01106495|Vascular Endothelium|vascular endothelium
1414441|NCT01106495|Counterpulsation, External|counterpulsation, external
1414442|NCT01106482|TBE|tbe
1414443|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
1414444|NCT01106469|Healthy Volunteers|healthy volunteers
1414445|NCT01106469|Healthy|healthy
1414446|NCT01106469|JNJ-41443532|jnj-41443532
1414447|NCT01106469|Pharmacokinetics|pharmacokinetics
1414448|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
1414449|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
1414450|NCT01106443|thyroidectomy|thyroidectomy
1414451|NCT01106443|central lymph node dissection|central lymph node dissection
1414452|NCT01106430|ADHD|adhd
1414453|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
1414454|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
1414455|NCT01106417|Spinal Stenosis|spinal stenosis
1414456|NCT01106417|Stem cells|stem cells
1414457|NCT01106417|Adult Stem Cells|adult stem cells
1414458|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
1414459|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
1414460|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
1414461|NCT01106391|AAA|aaa
1414462|NCT01106391|Safety|safety
1414463|NCT01106391|Performance|performance
1414464|NCT01106391|Stent graft system|stent graft system
1414465|NCT01106391|First in Human|first in human
1414466|NCT01106391|Endovascular repair|endovascular repair
1414467|NCT01106378|Coronary artery disease|coronary artery disease
1414468|NCT01106378|drug-eluting stents|drug-eluting stents
1414469|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
1414470|NCT01106365|multiple sclerosis|multiple sclerosis
1414471|NCT01106365|fatigue|fatigue
1414472|NCT01106365|depressivity|depressivity
1414473|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
1414474|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
1414475|NCT01106339|humans|humans
1414476|NCT01106339|patients|patients
1414477|NCT01106339|somatoform disorders|somatoform disorders
1414478|NCT01106339|fibromyalgia|fibromyalgia
1414479|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
1414480|NCT01106339|depression|depression
1414481|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
1414482|NCT01106339|inflammation|inflammation
1414483|NCT01106339|inflammatory response|inflammatory response
1414484|NCT01106339|biomarkers|biomarkers
1414485|NCT01106339|cytokines|cytokines
1414486|NCT01106339|cell surface markers|cell surface markers
1414487|NCT01106339|functional polymorphisms|functional polymorphisms
1414488|NCT01106326|Asthma|asthma
1414489|NCT01106248|tumor|tumor
1414490|NCT01106209|premature infants|premature infants
1414491|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
1414492|NCT01106209|PMNs|pmns
1414493|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
1414494|NCT01106209|NET formation|net formation
1414495|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
1414496|NCT01106196|Influenza, Human|influenza, human
1414497|NCT01106196|Influenza, Human/complications|influenza, human/complications
1414498|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
1414499|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
1414500|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
1414501|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
1414502|NCT01106079|Tight control|tight control
1414503|NCT01106079|Intensive management|intensive management
1414504|NCT01106053|Binge eating disorder|binge eating disorder
1414505|NCT01106053|Food craving|food craving
1414506|NCT01106053|Obesity|obesity
1414507|NCT01106053|Pramipexole|pramipexole
1414508|NCT01106053|Mirapex|mirapex
1414509|NCT01106053|Binge|binge
1414510|NCT01106040|Lymphoseek|lymphoseek
1414511|NCT01106040|Breast Cancer|breast cancer
1414512|NCT01106040|Melanoma|melanoma
1414513|NCT01106040|Experimental|experimental
1414514|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
1414516|NCT01106001|total hip arthroplasty|total hip arthroplasty
1414517|NCT01106001|periarticular injection|periarticular injection
1414518|NCT01106001|pain|pain
1414519|NCT01105988|GBM|gbm
1414520|NCT01105988|PET scans|pet scans
1414521|NCT01105988|MRI scans|mri scans
1414522|NCT01105975|Dyslipidemias|dyslipidemias
1414523|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
1414524|NCT01105975|Hypercholesterolemia|hypercholesterolemia
1414525|NCT01105975|Atherosclerosis|atherosclerosis
1414526|NCT01105975|Atorvastatin|atorvastatin
1414527|NCT01105975|Simvastatin|simvastatin
1414528|NCT01105975|Rosuvastatin|rosuvastatin
1414529|NCT01105975|Metabolic Diseases|metabolic diseases
1414530|NCT01105975|Antilipemic Agents|antilipemic agents
1414531|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
1414532|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
1414533|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
1414534|NCT01105975|Cholesteryl Ester|cholesteryl ester
1414535|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
1414536|NCT01105962|traumatic|traumatic
1414537|NCT01105962|brain|brain
1414538|NCT01105962|injury|injury
1414539|NCT01105962|post-traumatic|post-traumatic
1414540|NCT01105962|stress|stress
1414541|NCT01105962|hyperbaric|hyperbaric
1414542|NCT01105962|oxygen|oxygen
1414543|NCT01105962|HBOT|hbot
1414544|NCT01105962|TBI|tbi
1414545|NCT01105962|PTSD|ptsd
1414546|NCT01105949|nasal patency|nasal patency
1414547|NCT01105949|acoustic rhinometry|acoustic rhinometry
1414548|NCT01105949|nasal strip|nasal strip
1414549|NCT01105936|osteoarthritis|osteoarthritis
1414550|NCT01105936|pain|pain
1414551|NCT01105936|paracetamol|paracetamol
1414552|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
1414553|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
1414554|NCT01105897|endometriosis|endometriosis
1414555|NCT01105897|deep endometriosis|deep endometriosis
1414556|NCT01105897|surgery|surgery
1414557|NCT01105897|laparoscopy|laparoscopy
1414558|NCT01105897|chronic pain|chronic pain
1414559|NCT01105897|quality of life|quality of life
1414560|NCT01105897|sexual function|sexual function
1414561|NCT01105897|complications|complications
1414562|NCT01105897|recurrence|recurrence
1414563|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
1414564|NCT01105871|Pain relief|pain relief
1414565|NCT01105858|Diabetes Mellitus|diabetes mellitus
1414566|NCT01105858|Obesity|obesity
1414567|NCT01105858|Diabetic Complications|diabetic complications
1414568|NCT01105858|Genetics|genetics
1414569|NCT01105858|Molecular Profiling|molecular profiling
1414570|NCT01105845|Motor Learning|motor learning
1414571|NCT01105845|Genetic Analysis|genetic analysis
1414572|NCT01105845|BDNF|bdnf
1414573|NCT01105845|Parkinson Disease|parkinson disease
1414574|NCT01105845|Movement Disorders|movement disorders
1414575|NCT01105845|Dystonia|dystonia
1414576|NCT01105845|Healthy Volunteer|healthy volunteer
1414577|NCT01105845|HV|hv
1414578|NCT01105832|Teriparatide|teriparatide
1414579|NCT01105832|fracture healing|fracture healing
1414580|NCT01105832|proximal humeral fractures|proximal humeral fractures
1414581|NCT01105819|Probiotics|probiotics
1414582|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
1414583|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
1414584|NCT01105819|Chlorhexidine|chlorhexidine
1414585|NCT01105819|Tracheal secretions|tracheal secretions
1568391|NCT00506025|Cranberry|cranberry
1414586|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
1414587|NCT01105806|advance directive|advance directive
1414588|NCT01105806|CPR Intervention|cpr intervention
1414589|NCT01105806|Video|video
1414590|NCT01105806|Narrative|narrative
1414591|NCT01105806|10-043|10-043
1414592|NCT01105793|cyclic mastalgia|cyclic mastalgia
1414593|NCT01105793|cyclic breast pain|cyclic breast pain
1414594|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
1414595|NCT01105780|Healthy Volunteers|healthy volunteers
1414596|NCT01105780|Healthy|healthy
1414597|NCT01105780|Japanese|japanese
1414598|NCT01105780|Pharmacokinetics|pharmacokinetics
1414599|NCT01105780|JNJ-41443532|jnj-41443532
1414600|NCT01105767|Staphylococcus aureus|staphylococcus aureus
1414601|NCT01105767|MRSA Skin Infection|mrsa skin infection
1414602|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
1414603|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
1414604|NCT01105741|Crohn's disease|crohn's disease
1414605|NCT01105741|Adalimumab|adalimumab
1414606|NCT01105741|Metabolome|metabolome
1414607|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
1414608|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
1414609|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
1414610|NCT01105715|cLDL|cldl
1414611|NCT01105715|Cardiovascular disease|cardiovascular disease
1414612|NCT01105702|brain tumor|brain tumor
1414613|NCT01105702|brain cancer|brain cancer
1414614|NCT01105702|glioma|glioma
1414615|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
1414616|NCT01105689|Hypocalciuria|hypocalciuria
1414617|NCT01105689|Infants|infants
1414618|NCT01105689|Toddlers|toddlers
1414619|NCT01105676|vascular malformation|vascular malformation
1414620|NCT01105676|vascular anomalies|vascular anomalies
1414621|NCT01105676|abnormalities of growth|abnormalities of growth
1414622|NCT01105676|overgrowth|overgrowth
1414623|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
1414624|NCT01105663|sedated|sedated
1414625|NCT01105663|intubated|intubated
1414626|NCT01105663|mechanically ventilated|mechanically ventilated
1414627|NCT01105663|pediatric|pediatric
1414628|NCT01105663|lung injury|lung injury
1414629|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
1414630|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1414631|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
1414632|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
1414633|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
1414634|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
1414635|NCT01105650|metastatic breast cancer|metastatic breast cancer
1414636|NCT01105637|burn injuries|burn injuries
1414637|NCT01105637|exercise|exercise
1414638|NCT01105611|HIV|hiv
1414639|NCT01105611|Hepatitis C|hepatitis c
1414640|NCT01105611|Co-infection|co-infection
1414641|NCT01105611|Intravenous drug users|intravenous drug users
1414642|NCT01105611|Treatment-naïve|treatment-naïve
1414643|NCT01105611|Methadone|methadone
1414644|NCT01105585|Cataracts|cataracts
1414645|NCT01105585|aspheric|aspheric
1414646|NCT01105585|IOL|iol
1414647|NCT01105585|ocular aberrations|ocular aberrations
1414648|NCT01105572|Congestive Heart Failure|congestive heart failure
1414649|NCT01105559|Diphtheria|diphtheria
1414650|NCT01105559|Tetanus|tetanus
1414651|NCT01105559|Whooping cough|whooping cough
1414652|NCT01105559|Hepatitis B|hepatitis b
1414653|NCT01105559|Poliomyelitis|poliomyelitis
1414894|NCT01104441|critical limb ischaemia|critical limb ischaemia
1414654|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
1414655|NCT01105546|hemophilia A|hemophilia a
1414656|NCT01105546|inhibitors|inhibitors
1414657|NCT01105546|prophylaxis|prophylaxis
1414658|NCT01105546|immune tolerance induction|immune tolerance induction
1414659|NCT01105533|VGEF inhibitor|vgef inhibitor
1414660|NCT01105533|Anti angiogenesis|anti angiogenesis
1414661|NCT01105533|Advanced Solid Tumors|advanced solid tumors
1414662|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
1414663|NCT01105507|Canakinumab|canakinumab
1414664|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
1414665|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
1414666|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
1414667|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
1414668|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
1414669|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
1414670|NCT01105507|Cutaneous|cutaneous
1414671|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
1414672|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
1414673|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
1414674|NCT01105481|clozapine|clozapine
1414675|NCT01105481|amisulpride|amisulpride
1545470|NCT00598286|PET|pet
1414676|NCT01105468|Breath gas analysis|breath gas analysis
1414677|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
1414678|NCT01105455|Randomized clinical trial|randomized clinical trial
1414679|NCT01105455|Gestational diabetes|gestational diabetes
1414680|NCT01105455|Carbohydrates|carbohydrates
1414681|NCT01105455|Glycemic index|glycemic index
1414970|NCT01104116|PET Scan|pet scan
1414682|NCT01105442|Post-operative pain treatment|post-operative pain treatment
1414683|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
1414684|NCT01105442|Surgery|surgery
1414685|NCT01105416|Pediatric Emergency Department|pediatric emergency department
1414686|NCT01105416|Parental monitoring|parental monitoring
1414687|NCT01105416|Adolescent|adolescent
1414688|NCT01105416|Parents|parents
1414689|NCT01105416|Communication|communication
1414690|NCT01105416|Alcohol Drinking|alcohol drinking
1414691|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
1414692|NCT01105403|Mobilisation|mobilisation
1414693|NCT01105403|Autologous transplantation|autologous transplantation
1414694|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
1414695|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
1414696|NCT01105364|liver metastases|liver metastases
1414697|NCT01105351|Folate|folate
1414698|NCT01105351|MTHFR|mthfr
1414699|NCT01105351|Homocysteine|homocysteine
1414700|NCT01105338|prostate cancer|prostate cancer
1414701|NCT01105325|acute coronary syndrome|acute coronary syndrome
1414702|NCT01105325|treatment compliance|treatment compliance
1414703|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
1414704|NCT01105325|secondary prevention|secondary prevention
1414705|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
1414706|NCT01105325|compliance|compliance
1414707|NCT01105325|intensive care|intensive care
1414708|NCT01105312|male breast cancer|male breast cancer
1414709|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1414710|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1414711|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
1414712|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
1414713|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1414714|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1414715|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
1414716|NCT01105312|recurrent breast cancer|recurrent breast cancer
1414717|NCT01105312|stage IV breast cancer|stage iv breast cancer
1414718|NCT01105299|bioequivalence|bioequivalence
1414719|NCT01105299|anastrozole|anastrozole
1414720|NCT01105299|Healthy subjects|healthy subjects
1414721|NCT01105299|Antineoplastic Agents|antineoplastic agents
1414722|NCT01105299|Therapeutic Uses|therapeutic uses
1414723|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
1414724|NCT01105273|Aplastic anemia|aplastic anemia
1414725|NCT01105273|Fludarabine|fludarabine
1414726|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
1414727|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1414728|NCT01105260|early reconditioning program|early reconditioning program
1414729|NCT01105260|spinal cord injury|spinal cord injury
1414730|NCT01105260|early rehabilitation|early rehabilitation
1414731|NCT01105260|wheelchair|wheelchair
1414732|NCT01105247|PCI-32765|pci-32765
1414733|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
1414734|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
1414735|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
1414736|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1414737|NCT01105234|Healthy volunteers|healthy volunteers
1414738|NCT01105221|Acupuncture|acupuncture
1414739|NCT01105221|Dry eye|dry eye
1414740|NCT01105221|Artificial tear drop|artificial tear drop
1414741|NCT01105221|Mixed method approach|mixed method approach
1414742|NCT01105221|Qualitative study|qualitative study
1414743|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
1414744|NCT01105221|Tear cytokine analysis|tear cytokine analysis
1414745|NCT01105195|DuraPrep|duraprep
1414746|NCT01105195|ChloraPrep|chloraprep
1414747|NCT01105195|Lumbar Spine|lumbar spine
1414748|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
1414749|NCT01105169|Personalized prevention|personalized prevention
1414750|NCT01105169|Colorectal cancer|colorectal cancer
1414751|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
1414752|NCT01105169|Magnesium|magnesium
1414753|NCT01105169|Gene polymorphism|gene polymorphism
1414754|NCT01105156|Gastric band|gastric band
1414755|NCT01105156|Questionnaire|questionnaire
1414756|NCT01105156|Post operative management|post operative management
1414757|NCT01105156|Adjustment|adjustment
1414758|NCT01105143|weight loss|weight loss
1414759|NCT01105143|muscle mass|muscle mass
1414760|NCT01105130|radiation toxicity|radiation toxicity
1414761|NCT01105130|male erectile disorder|male erectile disorder
1414762|NCT01105130|prostate cancer|prostate cancer
1414763|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1414764|NCT01105117|PAH|pah
1414765|NCT01105117|EPITOME-1|epitome-1
1414766|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1414767|NCT01105091|PAH|pah
1414768|NCT01105091|EPITOME-1|epitome-1
1414769|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
1414770|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
1414771|NCT01105052|Insomnia|insomnia
1414772|NCT01105052|Co-morbid|co-morbid
1414773|NCT01105052|CBT|cbt
1414774|NCT01105052|Self-help|self-help
1414775|NCT01105052|Bibliotherapy|bibliotherapy
1414776|NCT01105039|Pain pattern|pain pattern
1414777|NCT01105039|overall pain|overall pain
1414778|NCT01105039|incisional pain|incisional pain
1414779|NCT01105039|shoulder pain|shoulder pain
1414780|NCT01105039|visceral pain|visceral pain
1414781|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
1414782|NCT01105013|fungal infections|fungal infections
1414783|NCT01105013|tinea|tinea
1414784|NCT01105013|tonaftato|tonaftato
1414785|NCT01105000|HPV|hpv
1414786|NCT01105000|HPV vaccine|hpv vaccine
1414787|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
1414788|NCT01104987|spondarthritis|spondarthritis
1414789|NCT01104987|Osteoporosis|osteoporosis
1414790|NCT01104987|Bone mineral density|bone mineral density
1414791|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1414792|NCT01104987|Quantitative computed tomography|quantitative computed tomography
1414793|NCT01104974|HIV|hiv
1414794|NCT01104974|HIV providers|hiv providers
1414795|NCT01104974|Infectious Disease|infectious disease
1414796|NCT01104974|HIV and pregnancy|hiv and pregnancy
1414797|NCT01104961|Bacterial infection|bacterial infection
1414798|NCT01104961|Loss of epithelial cells|loss of epithelial cells
1414799|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
1414800|NCT01104909|Dry weight|dry weight
1414801|NCT01104909|Blood Pressure|blood pressure
1414802|NCT01104909|Chronic Kidney disease|chronic kidney disease
1414803|NCT01104896|Cigarette|cigarette
1414804|NCT01104896|tobacco|tobacco
1414805|NCT01104896|mechanical ventilation|mechanical ventilation
1414806|NCT01104896|nicotine|nicotine
1414807|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
1414808|NCT01104883|postoperative pain|postoperative pain
1414809|NCT01104883|US-guided nerve block|us-guided nerve block
1414810|NCT01104883|total knee arthroplasty|total knee arthroplasty
1414811|NCT01104857|Respiratory muscle|respiratory muscle
1414812|NCT01104857|Myosin|myosin
1414813|NCT01104857|Mechanical ventilation|mechanical ventilation
1414814|NCT01104844|dental pain|dental pain
1414815|NCT01104844|Analgesia|analgesia
1414816|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
1414817|NCT01104831|AO/OTA 41|ao/ota 41
1414818|NCT01104818|Sibling relationship quality|sibling relationship quality
1414819|NCT01104818|Foster Care|foster care
1414820|NCT01104818|Parent Management Training|parent management training
1414821|NCT01104818|Mental health outcomes|mental health outcomes
1414822|NCT01104805|Drug Abuse|drug abuse
1414823|NCT01104805|Substance Abuse|substance abuse
1414824|NCT01104805|Substance Use Disorder|substance use disorder
1414825|NCT01104805|Addiction|addiction
1414826|NCT01104805|Behavioral Treatment|behavioral treatment
1414827|NCT01104792|Schizophrenia|schizophrenia
1414828|NCT01104792|Acute Schizophrenia|acute schizophrenia
1414829|NCT01104792|Psychotropic Drugs|psychotropic drugs
1414830|NCT01104792|Antipsychotic Agents|antipsychotic agents
1414831|NCT01104792|Mental Disorders|mental disorders
1414832|NCT01104792|Dopamine Agents|dopamine agents
1414833|NCT01104792|Central Nervous System Agents|central nervous system agents
1414834|NCT01104779|Schizophrenia|schizophrenia
1414835|NCT01104779|Acute Schizophrenia|acute schizophrenia
1414836|NCT01104779|Psychotropic Drugs|psychotropic drugs
1414837|NCT01104779|Antipsychotic Agents|antipsychotic agents
1414838|NCT01104779|Mental Disorders|mental disorders
1414839|NCT01104779|Dopamine Agents|dopamine agents
1414840|NCT01104779|Central Nervous System Agents|central nervous system agents
1414841|NCT01104766|Schizophrenia|schizophrenia
1414842|NCT01104766|Acute Schizophrenia|acute schizophrenia
1414843|NCT01104766|Psychotropic Drugs|psychotropic drugs
1414844|NCT01104766|Aripiprazole|aripiprazole
1414845|NCT01104766|Antipsychotic Agents|antipsychotic agents
1414846|NCT01104766|Mental Disorders|mental disorders
1414847|NCT01104766|Dopamine Agents|dopamine agents
1414848|NCT01104766|Central Nervous System Agents|central nervous system agents
1414849|NCT01104727|SINGLE PORT SURGERY|single port surgery
1414850|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
1414851|NCT01104701|Exenatide|exenatide
1414852|NCT01104701|Amylin|amylin
1414853|NCT01104701|Lilly|lilly
1414854|NCT01104701|Byetta|byetta
1414855|NCT01104701|Exenatide Once Weekly|exenatide once weekly
1414856|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1414857|NCT01104688|Wall Stress|wall stress
1414858|NCT01104688|Shear Stress|shear stress
1414859|NCT01104688|Inflammation|inflammation
1414860|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
1414861|NCT01104675|ovarian|ovarian
1414862|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1414863|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
1414864|NCT01104649|Friedreich ataxia|friedreich ataxia
1414865|NCT01104623|ADHD|adhd
1414866|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
1414867|NCT01104584|Breast Cancer|breast cancer
1414868|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
1414869|NCT01104584|Mammography|mammography
1414870|NCT01104584|Diagnostic Imaging|diagnostic imaging
1414871|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
1414872|NCT01104571|stage IA breast cancer|stage ia breast cancer
1414873|NCT01104571|stage IB breast cancer|stage ib breast cancer
1414874|NCT01104571|stage II breast cancer|stage ii breast cancer
1414875|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
1414876|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1414877|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1414878|NCT01104558|Bisoprolol|bisoprolol
1414879|NCT01104558|Chronic Heart failure|chronic heart failure
1414880|NCT01104532|ASP1941|asp1941
1414881|NCT01104532|Januvia|januvia
1414882|NCT01104532|sitagliptin|sitagliptin
1414883|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
1414884|NCT01104480|Unremitting|unremitting
1414885|NCT01104480|Inflammation|inflammation
1414886|NCT01104480|IL6|il6
1414887|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
1414888|NCT01104467|Desmoteplase|desmoteplase
1414889|NCT01104467|Japan|japan
1414890|NCT01104467|Safety|safety
1414891|NCT01104467|Stroke|stroke
1414892|NCT01104467|Tolerability|tolerability
1414893|NCT01104454|healthy pregnant women|healthy pregnant women
1414895|NCT01104441|Aspirin resistance|aspirin resistance
1414896|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
1414897|NCT01104428|Renal damage|renal damage
1414898|NCT01104428|Relapse|relapse
1414899|NCT01104428|End event|end event
1414900|NCT01104428|TCM syndrome|tcm syndrome
1414901|NCT01104415|Carcinoid syndrome|carcinoid syndrome
1414902|NCT01104402|telemedicine|telemedicine
1414903|NCT01104402|spirometer|spirometer
1414904|NCT01104402|CF|cf
1414905|NCT01104402|pulmonary|pulmonary
1414906|NCT01104402|home monitoring|home monitoring
1414907|NCT01104376|Cytochrome P450|cytochrome p450
1414908|NCT01104376|CYP2B6|cyp2b6
1414909|NCT01104376|Voriconazole|voriconazole
1414910|NCT01104376|Efavirenz|efavirenz
1414911|NCT01104376|Pharmacokinetics|pharmacokinetics
1414912|NCT01104376|Drug-Interactions|drug-interactions
1414913|NCT01104376|Pharmacogenetics|pharmacogenetics
1414914|NCT01104376|Healthy volunteers|healthy volunteers
1414915|NCT01104363|Dental implants|dental implants
1414916|NCT01104350|Bladder|bladder
1414917|NCT01104350|Radiotherapy|radiotherapy
1414918|NCT01104350|Gemcitabine|gemcitabine
1414919|NCT01104350|Chemotherapy|chemotherapy
1414920|NCT01104350|10-031|10-031
1414921|NCT01104337|paracetamol|paracetamol
1414922|NCT01104337|warfarin|warfarin
1414923|NCT01104337|drug interaction|drug interaction
1414924|NCT01104337|pathogenic mechanism|pathogenic mechanism
1414925|NCT01104324|bone health|bone health
1414926|NCT01104324|Osteonecrosis|osteonecrosis
1414927|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1414928|NCT01104311|Blood Pressure|blood pressure
1414929|NCT01104311|Atherosclerosis|atherosclerosis
1414930|NCT01104311|Brain Ischemia|brain ischemia
1414931|NCT01104298|metastatic STS|metastatic sts
1414932|NCT01104298|Trabectedin|trabectedin
1414933|NCT01104298|doxorrubicin|doxorrubicin
1414934|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
1414935|NCT01104298|non operable sarcoma|non operable sarcoma
1414936|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
1414937|NCT01104246|Hypogonadism|hypogonadism
1414938|NCT01104246|Testosterone|testosterone
1414939|NCT01104246|Hormone replacement therapy|hormone replacement therapy
1414940|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
1414941|NCT01104233|Soft spreading|soft spreading
1414942|NCT01104233|LAP Protector|lap protector
1414943|NCT01104220|NAFLD|nafld
1414944|NCT01104220|Obesity|obesity
1414945|NCT01104220|Metabolic syndrome|metabolic syndrome
1414946|NCT01104207|tinnitus|tinnitus
1414947|NCT01104207|TMS|tms
1414948|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
1414949|NCT01104194|depression|depression
1414950|NCT01104194|cognition|cognition
1414951|NCT01104194|heart rate variability|heart rate variability
1414952|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
1414953|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
1414954|NCT01104181|Anal HPV|anal hpv
1414955|NCT01104181|Anal Dysplasia|anal dysplasia
1414956|NCT01104181|Ana Cancer|ana cancer
1414957|NCT01104168|diabetes|diabetes
1414958|NCT01104168|elderly|elderly
1414959|NCT01104168|nursing home resident|nursing home resident
1414960|NCT01104155|NSCLC|nsclc
1414961|NCT01104129|Pancreatic Cancer|pancreatic cancer
1414962|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
1414963|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
1414964|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
1414965|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
1414966|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
1414967|NCT01104116|Pancreatic Cancer|pancreatic cancer
1414968|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
1414969|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
1414971|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
1414972|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
1414973|NCT01104103|Disposable Equipment|disposable equipment
1414974|NCT01104103|Emergency Medical Technicians|emergency medical technicians
1414975|NCT01104103|Emergency Nursing|emergency nursing
1414976|NCT01104090|C-MAC|c-mac
1414977|NCT01104090|direct laryngoscopy|direct laryngoscopy
1414978|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
1414979|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
1414980|NCT01104077|Pancreatic Cancer|pancreatic cancer
1414981|NCT01104077|Family History|family history
1414982|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
1414983|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
1414984|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
1414985|NCT01104064|Stroke|stroke
1414986|NCT01104038|physical activity|physical activity
1414987|NCT01104038|cardiometabolic risk|cardiometabolic risk
1414988|NCT01104038|children|children
1414989|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1414990|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
1414991|NCT01104025|dexamethasone|dexamethasone
1414992|NCT01104025|Etoposide|etoposide
1414993|NCT01104025|ATG,rabbit|atg,rabbit
1414994|NCT01103999|spleen|spleen
1414995|NCT01103986|health literacy|health literacy
1414996|NCT01103986|consumer health information|consumer health information
1414997|NCT01103986|patient education as topics/methods|patient education as topics/methods
1414998|NCT01103986|patient participation|patient participation
1414999|NCT01103973|IVF, Mind/Body|ivf, mind/body
1415000|NCT01103947|Anesthesia induction|anesthesia induction
1415001|NCT01103947|Facemask|facemask
1415002|NCT01103947|surgery|surgery
1415003|NCT01103921|sugar|sugar
1415004|NCT01103921|fructose|fructose
1415005|NCT01103921|glucose|glucose
1415006|NCT01103921|HFCS|hfcs
1415007|NCT01103921|metabolism|metabolism
1415008|NCT01103908|cardiac output|cardiac output
1415009|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
1415010|NCT01103908|ultrasound dilution|ultrasound dilution
1415011|NCT01103895|cardiac output|cardiac output
1415012|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
1415013|NCT01103895|ultrasound dilution|ultrasound dilution
1415014|NCT01103856|HIV|hiv
1415015|NCT01103856|adherence to care|adherence to care
1415016|NCT01103856|retention in care|retention in care
1415017|NCT01103856|patient navigation|patient navigation
1415018|NCT01103843|Coronary artery disease|coronary artery disease
1415019|NCT01103843|clopidogrel|clopidogrel
1415020|NCT01103843|prasugrel|prasugrel
1415021|NCT01103843|Verify Now|verify now
1415022|NCT01103843|PRU measurements|pru measurements
1415023|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
1415025|NCT01103843|Platelet reactivity|platelet reactivity
1415026|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
1415027|NCT01103817|Type 1 Diabetes|type 1 diabetes
1415028|NCT01103817|Adolescents and Young Adults|adolescents and young adults
1415029|NCT01103817|Vitamin D|vitamin d
1415030|NCT01103817|Cardiovascular Disease|cardiovascular disease
1415031|NCT01103804|GerdQ questionnaire|gerdq questionnaire
1415032|NCT01103778|Chronic kidney disease|chronic kidney disease
1415033|NCT01103778|IgA nephropathy|iga nephropathy
1415034|NCT01103778|Velcade®|velcade®
1415035|NCT01103778|Proteinuria|proteinuria
1415036|NCT01103778|Bortezomib|bortezomib
1415037|NCT01103778|Proteasome inhibitor|proteasome inhibitor
1415038|NCT01103765|Post-dilatation|post-dilatation
1415039|NCT01103765|noncompliant balloon|noncompliant balloon
1415040|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
1415041|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
1415042|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
1415043|NCT01103739|pharmacokinetics|pharmacokinetics
1415044|NCT01103739|drug-drug interaction|drug-drug interaction
1415045|NCT01103726|FDG-PET|fdg-pet
1415046|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
1415047|NCT01103726|striatum|striatum
1415048|NCT01103726|PDE10 inhibitor|pde10 inhibitor
1415049|NCT01103713|P. falciparum malaria|p. falciparum malaria
1415050|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
1415051|NCT01103713|parasitological clearance|parasitological clearance
1415052|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
1415053|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
1415054|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
1415055|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1415056|NCT01103674|AF|af
1415057|NCT01103674|Atrial Fibrillation|atrial fibrillation
1415058|NCT01103674|RF ablation|rf ablation
1415059|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
1415060|NCT01103661|AF|af
1415061|NCT01103661|Chronic AF|chronic af
1415062|NCT01103661|RF Ablation|rf ablation
1415063|NCT01103661|nContact Surgical|ncontact surgical
1415064|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
1415065|NCT01103661|St. Jude Medical|st. jude medical
1415066|NCT01103648|Prediabetes|prediabetes
1415067|NCT01103648|Statin|statin
1415068|NCT01103648|Ezetimibe|ezetimibe
1415069|NCT01103648|Pleiotropic effects|pleiotropic effects
1415070|NCT01103648|Cardiometabolic risk|cardiometabolic risk
1415071|NCT01103622|Diabetes|diabetes
1415072|NCT01103622|Type 2|type 2
1415073|NCT01103622|Digoxin|digoxin
1415074|NCT01103622|drug-drug interaction|drug-drug interaction
1415075|NCT01103609|Diabetes|diabetes
1415076|NCT01103609|Type 2|type 2
1415077|NCT01103609|Warfarin|warfarin
1415078|NCT01103609|drug-drug interaction|drug-drug interaction
1415079|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
1415080|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1415081|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
1415082|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
1415083|NCT01103557|neck dissection|neck dissection
1415084|NCT01103544|TCCU|tccu
1415085|NCT01103544|advanced TCCU|advanced tccu
1415086|NCT01103544|metastatic TCCU|metastatic tccu
1415087|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
1415088|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
1415089|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
1415090|NCT01103544|Cisplatinum failure|cisplatinum failure
1415091|NCT01103544|Vinflunine|vinflunine
1415092|NCT01103544|Javlor|javlor
1415093|NCT01103544|daily routine|daily routine
1415094|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
1415095|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
1415096|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
1415097|NCT01103544|patient compliance|patient compliance
1415098|NCT01103544|quality of life|quality of life
1415099|NCT01103544|non-interventional study|non-interventional study
1415100|NCT01103544|Germany|germany
1415101|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
1415102|NCT01103531|Methamphetamine|methamphetamine
1415103|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
1415104|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
1415105|NCT01103531|Aerobic Exercise|aerobic exercise
1415106|NCT01103531|Resistance Exercise|resistance exercise
1415107|NCT01103531|Brain Imaging|brain imaging
1415108|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
1415109|NCT01103518|Menstrual irregularity|menstrual irregularity
1415110|NCT01103518|Menstruation disturbances|menstruation disturbances
1415111|NCT01103518|Hyperandrogenism|hyperandrogenism
1415112|NCT01103505|AMD|amd
1415113|NCT01103505|CNV|cnv
1415114|NCT01103492|prostate cancer|prostate cancer
1415115|NCT01103492|endometrial cancer|endometrial cancer
1415116|NCT01103492|radiation proctitis|radiation proctitis
1415117|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
1415118|NCT01103492|rectal bleeding|rectal bleeding
1415119|NCT01103479|Early Detection of Cancer|early detection of cancer
1415120|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
1415121|NCT01103466|Ileostomy base plate|ileostomy base plate
1415122|NCT01103453|MCI|mci
1415123|NCT01103453|Executive Function|executive function
1415124|NCT01103453|ADL|adl
1415125|NCT01103453|Virtual Supermarket|virtual supermarket
1415126|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
1415127|NCT01103440|MACE|mace
1415128|NCT01103440|Death|death
1415129|NCT01103440|MI|mi
1415130|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
1415131|NCT01103440|Urgent Revascularization|urgent revascularization
1415132|NCT01103440|Stent Thrombosis|stent thrombosis
1415133|NCT01103440|Bleeding|bleeding
1415134|NCT01103427|smoking cessation|smoking cessation
1415135|NCT01103427|telemedicine|telemedicine
1415136|NCT01103427|smoking|smoking
1415137|NCT01103427|prevention intervention|prevention intervention
1415138|NCT01103427|internet-based|internet-based
1415139|NCT01103427|text messages|text messages
1415140|NCT01103427|behavioral|behavioral
1415141|NCT01103414|Diabetes|diabetes
1415142|NCT01103388|Rituximab|rituximab
1415143|NCT01103388|Rituxan|rituxan
1415144|NCT01103388|Lymphoma|lymphoma
1415145|NCT01103388|High dose chemotherapy|high dose chemotherapy
1415146|NCT01103388|Autologous transplantation|autologous transplantation
1415147|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
1415148|NCT01103388|ASCT|asct
1415149|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
1415150|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
1415151|NCT01103310|Neoplasm|neoplasm
1415152|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
1415153|NCT01103310|PET tracer|pet tracer
1415154|NCT01103297|Distal radius fracture|distal radius fracture
1415155|NCT01103297|Double row plate|double row plate
1415156|NCT01103297|Volar approach|volar approach
1415157|NCT01103297|DVR plate|dvr plate
1415158|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
1415159|NCT01103284|beta-cells|beta-cells
1415160|NCT01103284|autoimmune|autoimmune
1415161|NCT01103284|Diabetes|diabetes
1415162|NCT01103284|immunomodulation|immunomodulation
1415163|NCT01103271|depression|depression
1415164|NCT01103271|placebo effect|placebo effect
1415165|NCT01103271|complementary therapies|complementary therapies
1415166|NCT01103271|alternative therapies|alternative therapies
1415167|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
1415168|NCT01103245|Glucose|glucose
1415169|NCT01103245|Insulin|insulin
1415170|NCT01103232|Cross education|cross education
1415171|NCT01103232|Muscle training|muscle training
1415172|NCT01103219|VLBW|vlbw
1415173|NCT01103219|nutrition|nutrition
1415174|NCT01103219|vitamin A|vitamin a
1415175|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
1415176|NCT01103219|growth|growth
1415177|NCT01103219|cognitive functions|cognitive functions
1415178|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
1415179|NCT01103206|Parathyroid hormone|parathyroid hormone
1415180|NCT01103206|Cinacalcet|cinacalcet
1415181|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
1415182|NCT01103206|Diagnosis|diagnosis
1415183|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
1415184|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
1415185|NCT01103180|Escitalopram|escitalopram
1415186|NCT01103180|Borderline Personality Disorder|borderline personality disorder
1415187|NCT01103180|Major Depressive Disorder|major depressive disorder
1415188|NCT01103180|Self-harm|self-harm
1415189|NCT01103167|body composition|body composition
1415190|NCT01103167|blood pressure|blood pressure
1415191|NCT01103167|hemodialysis|hemodialysis
1415192|NCT01103154|beta blocker|beta blocker
1415193|NCT01103154|variceal rebleeding|variceal rebleeding
1415194|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
1415195|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
1415196|NCT01103141|Angioplasty|angioplasty
1415197|NCT01103141|Radiology, Interventional|radiology, interventional
1415198|NCT01103128|Pancreatic Cancer|pancreatic cancer
1415199|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
1415200|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
1415201|NCT01103128|BRCA1/2|brca1/2
1415202|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
1415203|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
1415204|NCT01103115|AIS|ais
1415205|NCT01103115|low bone mass|low bone mass
1415206|NCT01103115|osteopenia|osteopenia
1415207|NCT01103115|bone health|bone health
1415208|NCT01103115|bone density|bone density
1415209|NCT01103102|Gingivitis|gingivitis
1415210|NCT01103102|Biological Markers|biological markers
1415211|NCT01103089|NSCLC|nsclc
1415212|NCT01103089|EGFR|egfr
1415213|NCT01103089|gefitinib|gefitinib
1415214|NCT01103089|observational|observational
1415215|NCT01103076|Immune dysfunction|immune dysfunction
1415216|NCT01103076|Hemodialysis|hemodialysis
1415217|NCT01103076|HBV|hbv
1415218|NCT01103076|Vaccination|vaccination
1415219|NCT01103076|Immune response|immune response
1415220|NCT01103063|P. falciparum malaria|p. falciparum malaria
1415221|NCT01103063|IPTp|iptp
1415222|NCT01103050|Allergic inflammation|allergic inflammation
1415223|NCT01103050|Seasonal rhinitis|seasonal rhinitis
1415224|NCT01103037|Mild|mild
1415225|NCT01103037|Moderate|moderate
1415226|NCT01103037|Asthma|asthma
1415227|NCT01103024|Active uveitis|active uveitis
1415228|NCT01103024|intermediate uveitis|intermediate uveitis
1415229|NCT01103024|panuveitis|panuveitis
1415230|NCT01103024|posterior uveitis|posterior uveitis
1415231|NCT01103024|uveitis|uveitis
1415232|NCT01102998|Sleep complaints|sleep complaints
1415233|NCT01102998|Brain Tumor Survivors|brain tumor survivors
1415234|NCT01102985|exercise|exercise
1415235|NCT01102985|physical activity|physical activity
1415236|NCT01102985|intervention|intervention
1415237|NCT01102985|cancer survivor|cancer survivor
1415238|NCT01102972|HIV-1|hiv-1
1415239|NCT01102972|HIV|hiv
1415240|NCT01102959|EDUCATION|education
1415241|NCT01102959|DIABETES MELLITUS|diabetes mellitus
1415242|NCT01102959|ADOLESCENT|adolescent
1415243|NCT01102959|DIABETIC DIET|diabetic diet
1415244|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1415245|NCT01102946|retinal neovascularization|retinal neovascularization
1415246|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
1415247|NCT01102946|ranibizumab|ranibizumab
1415249|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
1415250|NCT01102920|Obesity|obesity
1415251|NCT01102920|Behavioural medicine|behavioural medicine
1415252|NCT01102920|Physical therapy|physical therapy
1415253|NCT01102920|Health behaviour change|health behaviour change
1415254|NCT01102920|Physical activity|physical activity
1415255|NCT01102920|Eating habits|eating habits
1415256|NCT01102907|Appetite|appetite
1415257|NCT01102907|Satiety|satiety
1415258|NCT01102907|Gastric Emptying Time|gastric emptying time
1415259|NCT01102907|Food Intake|food intake
1415260|NCT01102907|Food Form|food form
1415261|NCT01102881|Healthy adults|healthy adults
1415262|NCT01102829|Knee Joint|knee joint
1415263|NCT01102829|Arthroplasty|arthroplasty
1415264|NCT01102829|Replacement|replacement
1415265|NCT01102829|Knee|knee
1415266|NCT01102816|hemodialysis|hemodialysis
1415267|NCT01102816|end-stage renal disease|end-stage renal disease
1415268|NCT01102816|pain|pain
1415269|NCT01102816|acupuncture|acupuncture
1415270|NCT01102803|Phobias|phobias
1415271|NCT01102803|Anxiety Disorders|anxiety disorders
1415272|NCT01102803|D-Cycloserine|d-cycloserine
1415273|NCT01102803|Phobic Disorders|phobic disorders
1415274|NCT01102803|Mental Disorders|mental disorders
1415275|NCT01102803|Heights|heights
1415276|NCT01102803|Acrophobia|acrophobia
1415278|NCT01102777|internet|internet
1415279|NCT01102777|walking|walking
1415280|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
1415281|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
1415282|NCT01102764|Telemedicine|telemedicine
1415283|NCT01102764|cost effectiveness|cost effectiveness
1415284|NCT01102764|deployment related problems|deployment related problems
1415285|NCT01102764|mental health care delivery|mental health care delivery
1415286|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
1415287|NCT01102751|Osteomalacia|osteomalacia
1415288|NCT01102751|vitamin D|vitamin d
1415289|NCT01102725|Colon Surgery|colon surgery
1415290|NCT01102725|Rectal Surgery|rectal surgery
1415291|NCT01102725|Colorectal Surgery|colorectal surgery
1415292|NCT01102712|Emphysema|emphysema
1415293|NCT01102712|COPD|copd
1415294|NCT01102712|Lung Volume Reduction|lung volume reduction
1415295|NCT01102712|BTVA|btva
1415296|NCT01102699|Diabetes|diabetes
1415297|NCT01102699|stem cells|stem cells
1415298|NCT01102699|bone marrow|bone marrow
1415299|NCT01102699|mobilization|mobilization
1415300|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
1415301|NCT01102686|pyrimethamine|pyrimethamine
1415302|NCT01102673|phase 1|phase 1
1415303|NCT01102673|safety and tolerability|safety and tolerability
1415304|NCT01102673|PK|pk
1415305|NCT01102673|T2DM|t2dm
1415306|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
1415307|NCT01102660|Knee osteoarthritis|knee osteoarthritis
1415308|NCT01102660|clinical trial|clinical trial
1415309|NCT01102660|cross-over|cross-over
1415310|NCT01102621|hearing loss|hearing loss
1415311|NCT01102621|head and neck cancer|head and neck cancer
1415312|NCT01102621|radiotherapy|radiotherapy
1415313|NCT01102621|hearing complaint|hearing complaint
1415314|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
1415315|NCT01102608|sarcoma|sarcoma
1415316|NCT01102608|ifosfamide|ifosfamide
1415317|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
1415318|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
1415319|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
1415320|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
1415321|NCT01102569|BRCA1/2|brca1/2
1415322|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
1415323|NCT01102556|Pancreatic Cancer|pancreatic cancer
1415324|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
1415325|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
1415326|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
1415327|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
1415328|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
1415329|NCT01102543|pulmonary surfactant|pulmonary surfactant
1415330|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
1415331|NCT01102543|Newborn|newborn
1415332|NCT01102543|prophylaxis|prophylaxis
1415333|NCT01102517|NSCLC|nsclc
1415334|NCT01102517|Clinical|clinical
1415335|NCT01102517|Early-stage|early-stage
1415336|NCT01102504|carotid atheroma|carotid atheroma
1415337|NCT01102504|plaque vulnerability|plaque vulnerability
1415338|NCT01102504|stroke risk|stroke risk
1415339|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
1415340|NCT01102439|Clopidogrel|clopidogrel
1415342|NCT01102439|Interaction|interaction
1415343|NCT01102426|Multiple Myeloma|multiple myeloma
1415344|NCT01102426|Aplidin|aplidin
1415345|NCT01102426|plitidepsin|plitidepsin
1415346|NCT01102426|dexamethasone|dexamethasone
1415347|NCT01102400|cancer|cancer
1415348|NCT01102400|tumor|tumor
1415349|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
1415350|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
1415351|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
1415352|NCT01102374|Respiratory Infection|respiratory infection
1415353|NCT01102374|Nursing Home Residents|nursing home residents
1415354|NCT01102374|Geriatrics|geriatrics
1415355|NCT01102374|Immunosenescence|immunosenescence
1415356|NCT01102374|Prevention|prevention
1415357|NCT01102348|Critically Ill|critically ill
1415358|NCT01102348|Nutrition Therapy|nutrition therapy
1415359|NCT01102348|Enteral Nutrition|enteral nutrition
1415360|NCT01102335|hepatitis B virus|hepatitis b virus
1415361|NCT01102335|Antiviral Agents|antiviral agents
1415362|NCT01102335|Liver Neoplasms|liver neoplasms
1415363|NCT01102335|Drug Toxicity|drug toxicity
1415364|NCT01102335|Survival|survival
1415365|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
1415366|NCT01102309|cerebrovascular accident|cerebrovascular accident
1415367|NCT01102309|hemiparesis|hemiparesis
1415368|NCT01102309|recovery of function|recovery of function
1415369|NCT01102309|rehabilitation|rehabilitation
1415370|NCT01102309|robotics|robotics
1415371|NCT01102309|subacute therapy|subacute therapy
1415372|NCT01102309|training|training
1415373|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
1415374|NCT01102296|male homosexual|male homosexual
1415375|NCT01102296|HIV infection|hiv infection
1415376|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
1415377|NCT01102283|Colonic obstruction|colonic obstruction
1415378|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
1415379|NCT01102270|Arousal threshold|arousal threshold
1415380|NCT01102270|Sedative medication|sedative medication
1415381|NCT01102270|upper airway|upper airway
1415382|NCT01102257|Dry Eye Disease|dry eye disease
1415383|NCT01102257|DED|ded
1415384|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1415385|NCT01102257|Omega-3|omega-3
1415386|NCT01102244|blepharitis|blepharitis
1415387|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
1415388|NCT01102218|Anemia, ESRD|anemia, esrd
1415389|NCT01102192|Myasthenia gravis|myasthenia gravis
1415390|NCT01102192|Thymoma|thymoma
1415391|NCT01102192|T-cells|t-cells
1415392|NCT01102192|Thymectomy|thymectomy
1415393|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
1415394|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
1415395|NCT01102153|Hypothermia|hypothermia
1415396|NCT01102153|Coolgard|coolgard
1415397|NCT01102153|arctic sun|arctic sun
1415398|NCT01102153|neurological outcome|neurological outcome
1415399|NCT01102153|neuron specific enolase|neuron specific enolase
1415400|NCT01102140|Cardiomyopathy|cardiomyopathy
1415401|NCT01102140|Heart Failure|heart failure
1415402|NCT01102127|elastography|elastography
1415403|NCT01102127|thyroid nodule|thyroid nodule
1415404|NCT01102127|fine-needle aspiration|fine-needle aspiration
1415405|NCT01102114|Smoking Cessation|smoking cessation
1415406|NCT01102114|NicVAX|nicvax
1415407|NCT01102114|Smoking Vaccine|smoking vaccine
1415408|NCT01102114|Smoking Abstinence|smoking abstinence
1415409|NCT01102114|Smoking|smoking
1415410|NCT01102114|Tobacco Cessation|tobacco cessation
1415411|NCT01102101|Remifentanil|remifentanil
1415412|NCT01102101|Hyperalgesia|hyperalgesia
1415413|NCT01102101|Zoster|zoster
1415414|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
1415415|NCT01102088|Cancer|cancer
1415416|NCT01102088|Gastroesophageal|gastroesophageal
1415417|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
1415419|NCT01102088|5-Fluorouracil|5-fluorouracil
1415420|NCT01102088|5-FU|5-fu
1415421|NCT01102088|Adrucil|adrucil
1415422|NCT01102088|Efudex|efudex
1415423|NCT01102088|Docetaxel|docetaxel
1415424|NCT01102088|Taxotere|taxotere
1415425|NCT01102088|Radiation|radiation
1415426|NCT01102088|chemoradiation|chemoradiation
1415427|NCT01102075|Obesity|obesity
1415428|NCT01102075|Electroacupuncture|electroacupuncture
1415429|NCT01102075|Sham electroacupuncture|sham electroacupuncture
1415430|NCT01102075|Waist circumference|waist circumference
1415431|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
1415432|NCT01102036|Transit time|transit time
1415433|NCT01102036|constipation|constipation
1415434|NCT01102036|gut regularity|gut regularity
1415435|NCT01102036|defecation frequency|defecation frequency
1415436|NCT01102036|Colonic transit time|colonic transit time
1415437|NCT01102010|Blood transfusion|blood transfusion
1415438|NCT01102010|Hip fracture|hip fracture
1415439|NCT01102010|Elderly|elderly
1415440|NCT01102010|Geriatrics|geriatrics
1415441|NCT01102010|Hospitalization|hospitalization
1415442|NCT01102010|Frail elderly|frail elderly
1415443|NCT01101997|Lipolysis|lipolysis
1415444|NCT01101997|Cryolipolysis|cryolipolysis
1415445|NCT01101997|Fat Reduction|fat reduction
1415446|NCT01101971|Education, Medical|education, medical
1415447|NCT01101971|Students, Medical|students, medical
1415448|NCT01101971|Gynecology|gynecology
1415449|NCT01101971|Physical Examination|physical examination
1415450|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
1415451|NCT01101945|diabetes|diabetes
1415452|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
1415453|NCT01101945|dutogliptin|dutogliptin
1415454|NCT01101945|PHX1149|phx1149
1415455|NCT01101932|Safety|safety
1415456|NCT01101932|Tolerability|tolerability
1415457|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
1415458|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
1415459|NCT01101932|healthy volunteers|healthy volunteers
1415460|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
1415461|NCT01101906|OSI-906|osi-906
1415462|NCT01101906|HCC|hcc
1415463|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
1415464|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
1415465|NCT01101867|diabetes|diabetes
1415466|NCT01101867|glucose|glucose
1415467|NCT01101867|hospital|hospital
1415468|NCT01101854|gene expression in wounds|gene expression in wounds
1415469|NCT01101854|healing wounds|healing wounds
1415470|NCT01101854|non-healing wounds|non-healing wounds
1415471|NCT01101854|punch biopsy|punch biopsy
1415472|NCT01101854|debridement|debridement
1415473|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
1415474|NCT01101841|Menopause|menopause
1415475|NCT01101841|Hot Flashes|hot flashes
1415476|NCT01101841|Perimenopause|perimenopause
1415477|NCT01101841|Nonhormonal therapies|nonhormonal therapies
1415478|NCT01101841|Climacteric symptoms|climacteric symptoms
1415479|NCT01101841|Mesafem|mesafem
1415480|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
1415481|NCT01101815|Viral Loads|viral loads
1415482|NCT01101815|Naltrexone|naltrexone
1415483|NCT01101815|HIV Risk|hiv risk
1415484|NCT01101815|Substance Abuse|substance abuse
1415485|NCT01101802|SLE|sle
1415486|NCT01101802|Atherosclerosis|atherosclerosis
1415487|NCT01101802|Endothelial function|endothelial function
1415488|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
1415489|NCT01101789|surgical wound infection|surgical wound infection
1415490|NCT01101789|triclosan-coated suture|triclosan-coated suture
1415491|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
1415492|NCT01101776|Rebif New Formulation|rebif new formulation
1415493|NCT01101776|Interferon beta-1a|interferon beta-1a
1415494|NCT01101750|Gardasil|gardasil
1415495|NCT01101750|HPV|hpv
1415496|NCT01101750|transplant|transplant
1415497|NCT01101750|adolescent|adolescent
1415498|NCT01101750|prevention|prevention
1415499|NCT01101750|vaccine|vaccine
1415500|NCT01101750|immunogenicity|immunogenicity
1415501|NCT01101750|vaccination|vaccination
1415502|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
1415503|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
1415504|NCT01101724|Concussion|concussion
1415505|NCT01101724|postconcussive syndrome|postconcussive syndrome
1415506|NCT01101698|Vitamin K|vitamin k
1415507|NCT01101698|chronic kidney disease|chronic kidney disease
1415508|NCT01101698|coronary artery calcification|coronary artery calcification
1415509|NCT01101698|intima media thickness|intima media thickness
1415510|NCT01101685|non-dysphoric|non-dysphoric
1415511|NCT01101685|Dysphoric|dysphoric
1415512|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
1415513|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
1415514|NCT01101659|Challenge study|challenge study
1415515|NCT01101646|Rabeprazole sodium|rabeprazole sodium
1415516|NCT01101646|Pharmacokinetics|pharmacokinetics
1415517|NCT01101646|Biological Availability|biological availability
1415519|NCT01101646|Adult|adult
1415520|NCT01101633|Appetite|appetite
1415521|NCT01101633|Energy intake|energy intake
1415522|NCT01101633|gastric emptying|gastric emptying
1415523|NCT01101633|well being|well being
1415524|NCT01101633|Body weight|body weight
1415525|NCT01101607|Pediatrics|pediatrics
1415526|NCT01101607|Distal Forearm fractures|distal forearm fractures
1415527|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
1415528|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
1415529|NCT01101594|Treatment|treatment
1415530|NCT01101594|Multiple Myeloma|multiple myeloma
1415531|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
1415532|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
1415533|NCT01101581|Mantle cell NHL|mantle cell nhl
1415534|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
1415535|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
1415536|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
1415537|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
1546597|NCT00593398|Malaria|malaria
1415538|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
1415539|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
1415540|NCT01101555|repeat dose|repeat dose
1415541|NCT01101555|pharmacodynamics|pharmacodynamics
1415542|NCT01101555|pharmacokinetics|pharmacokinetics
1415543|NCT01101555|subcutaneous|subcutaneous
1415544|NCT01101555|safety|safety
1415545|NCT01101555|Otelixizumab|otelixizumab
1415546|NCT01101555|long term follow up|long term follow up
1415547|NCT01101555|tolerability|tolerability
1415548|NCT01101542|Post-marketing surveillance|post-marketing surveillance
1415549|NCT01101542|Human papillomavirus|human papillomavirus
1415550|NCT01101542|Korea|korea
1415551|NCT01101542|Safety|safety
1415552|NCT01101542|Prescribing Information|prescribing information
1415553|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
1415554|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
1415555|NCT01101503|Endothelial dysfunction|endothelial dysfunction
1415556|NCT01101503|Intensive therapy|intensive therapy
1415557|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
1415558|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
1415559|NCT01101477|Target-controlled infusion,|target-controlled infusion,
1415560|NCT01101477|bronchoscopy,|bronchoscopy,
1415561|NCT01101477|sedation,|sedation,
1415562|NCT01101477|propofol|propofol
1415563|NCT01101438|stage I breast cancer|stage i breast cancer
1415564|NCT01101438|stage II breast cancer|stage ii breast cancer
1415565|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
1415566|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
1415567|NCT01101438|male breast cancer|male breast cancer
1415568|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
1415569|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1415570|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
1415571|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1415572|NCT01101425|male|male
1415573|NCT01101425|breast cancer|breast cancer
1415574|NCT01101412|infection|infection
1415575|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1415576|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1415577|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
1415578|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1415579|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1415580|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1415581|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1415582|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1415583|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1415584|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1415585|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1415586|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1415587|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1415588|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1415589|NCT01101412|mast cell leukemia|mast cell leukemia
1415590|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1415591|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1415592|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
1415593|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1415594|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1415595|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1415596|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1415597|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
1415598|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1415599|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1415600|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1415601|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1415602|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1415603|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1415604|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1415605|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1415606|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1415607|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1415608|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1415609|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1415610|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1415611|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1415612|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
1415613|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1415614|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1415615|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1415616|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1415617|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1415618|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1415619|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1415620|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1415621|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1415622|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1415623|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1415624|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1415625|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1415626|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1415627|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1415628|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1415629|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1415630|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1415631|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1415632|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1415633|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1415634|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1415635|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1415636|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1415637|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1415638|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1415639|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1415640|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1415641|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1415642|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1415643|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1415644|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1415645|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1415646|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1415647|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1415648|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1415649|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1415650|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1415651|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1415652|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1415653|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1415654|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1415655|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1415656|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1415657|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1415658|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1415659|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1415660|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1415661|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1415662|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1415663|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1415664|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1415665|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1415666|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1415667|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1415668|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1415669|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1415670|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1415671|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1415672|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1415673|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1415674|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1415675|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1415676|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1415677|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1415678|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1415679|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1415680|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1415681|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1415682|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1415683|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1415764|NCT01101243|Vitamin D|vitamin d
1415684|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1415685|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1415686|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1415687|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1415688|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1415689|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1415690|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1415691|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1415692|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1415693|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1415694|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1415695|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1415696|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1415697|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1415698|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1415699|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1415700|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1415701|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1415702|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1415703|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1415704|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1415705|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1415706|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1415707|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1415831|NCT01100944|Thymic Cancer|thymic cancer
1415708|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1415709|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1415710|NCT01101412|intraocular lymphoma|intraocular lymphoma
1415711|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1415712|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1415713|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1415714|NCT01101412|primary myelofibrosis|primary myelofibrosis
1415715|NCT01101412|essential thrombocythemia|essential thrombocythemia
1415716|NCT01101412|polycythemia vera|polycythemia vera
1415717|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
1415718|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1415719|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
1415720|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
1415721|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
1415722|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
1415723|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
1415724|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1415725|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1415726|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1415727|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1415728|NCT01101399|Anemia|anemia
1547017|NCT00591526|APL|apl
1415729|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
1415730|NCT01101399|Chemotherapy|chemotherapy
1415731|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
1415732|NCT01101399|iron|iron
1415733|NCT01101386|Voriconazole|voriconazole
1415734|NCT01101386|SBECD|sbecd
1415735|NCT01101386|pharmacokinetics|pharmacokinetics
1415736|NCT01101386|Renal Failure|renal failure
1415737|NCT01101373|Limbic surgery|limbic surgery
1415738|NCT01101373|Stereotactic surgery|stereotactic surgery
1415739|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
1415740|NCT01101360|port wine stains|port wine stains
1415741|NCT01101360|radiofrequency|radiofrequency
1415742|NCT01101360|Pulse Dye Laser|pulse dye laser
1415743|NCT01101334|NSCLC|nsclc
1415744|NCT01101321|Healthy subjects|healthy subjects
1415745|NCT01101321|Opioid|opioid
1415746|NCT01101321|Healthy volunteers|healthy volunteers
1415747|NCT01101308|Healthy subjects|healthy subjects
1415748|NCT01101308|Opioid|opioid
1415749|NCT01101308|Healthy volunteers|healthy volunteers
1415750|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
1415751|NCT01101295|Rituximab|rituximab
1415752|NCT01101295|side effects|side effects
1415753|NCT01101295|tolerance|tolerance
1415754|NCT01101295|safety|safety
1415755|NCT01101295|splenectomy|splenectomy
1415756|NCT01101295|serum sickness|serum sickness
1415757|NCT01101282|PEP|pep
1415758|NCT01101282|exacerbation|exacerbation
1415759|NCT01101282|physiotherapy|physiotherapy
1415760|NCT01101282|airway clearance|airway clearance
1415761|NCT01101282|sputum|sputum
1415762|NCT01101282|physical Therapy modalities|physical therapy modalities
1415763|NCT01101269|Diabetic nephropathy|diabetic nephropathy
1415765|NCT01101243|UVB|uvb
1415766|NCT01101243|Frequency|frequency
1415767|NCT01101243|Body surface area|body surface area
1415768|NCT01101243|Dose-Response|dose-response
1415769|NCT01101230|Cardiovascular disease|cardiovascular disease
1415770|NCT01101230|cholesterol|cholesterol
1415771|NCT01101230|low-density|low-density
1415772|NCT01101230|lipoprotein|lipoprotein
1415773|NCT01101230|high-density lipoprotein|high-density lipoprotein
1415774|NCT01101230|triglycerides|triglycerides
1415775|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
1415776|NCT01101191|Healthy subjects|healthy subjects
1415777|NCT01101191|Opioid|opioid
1415778|NCT01101191|Healthy volunteers|healthy volunteers
1415779|NCT01101178|Healthy subjects|healthy subjects
1415780|NCT01101178|Opioid|opioid
1415781|NCT01101178|Healthy volunteers|healthy volunteers
1415782|NCT01101165|Healthy subjects|healthy subjects
1415783|NCT01101165|Opioid|opioid
1415784|NCT01101165|Healthy volunteers|healthy volunteers
1415785|NCT01101152|Antidepressant|antidepressant
1415786|NCT01101152|healthy volunteers|healthy volunteers
1415787|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
1415788|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
1415789|NCT01101152|serotonin reuptake|serotonin reuptake
1415790|NCT01101152|tyramine test|tyramine test
1415791|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1415792|NCT01101126|Asthma|asthma
1415793|NCT01101113|peritoneal dialysis|peritoneal dialysis
1415794|NCT01101100|Psoriasis|psoriasis
1415795|NCT01101087|Dialysis|dialysis
1415796|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
1415797|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
1415798|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
1415799|NCT01101061|Amgen|amgen
1415800|NCT01101061|Phase 1|phase 1
1415801|NCT01101061|Postmenopausal|postmenopausal
1415802|NCT01101061|Japanese|japanese
1415803|NCT01101048|Amgen|amgen
1415804|NCT01101048|Phase 1b|phase 1b
1415805|NCT01101048|Postmenopausal|postmenopausal
1415806|NCT01101048|Bone Mineral Density|bone mineral density
1415807|NCT01101035|Cardiovascular Outcomes|cardiovascular outcomes
1415808|NCT01101035|Heart Attack|heart attack
1415809|NCT01101035|Stroke|stroke
1415810|NCT01101035|Drug Therapy|drug therapy
1415811|NCT01101035|Physiology|physiology
1415812|NCT01101035|Hyperuricemia|hyperuricemia
1415813|NCT01101035|Uric Acid|uric acid
1415814|NCT01101009|Sevikar®|sevikar®
1415815|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
1415816|NCT01100996|enteral nutrition|enteral nutrition
1415817|NCT01100996|endotoxemia|endotoxemia
1415818|NCT01100996|innate immunity|innate immunity
1415819|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
1415820|NCT01100996|intestinal damage|intestinal damage
1415821|NCT01100970|Caesarean section|caesarean section
1415822|NCT01100970|cortisol|cortisol
1415823|NCT01100970|stress|stress
1415824|NCT01100970|unipolar electric needle|unipolar electric needle
1415825|NCT01100970|bipolar electric needle|bipolar electric needle
1415826|NCT01100944|Gene Expression|gene expression
1415827|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
1415828|NCT01100944|Thymoma|thymoma
1415829|NCT01100944|Chemotherapy|chemotherapy
1415830|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
1415832|NCT01100931|NSCLC|nsclc
1415833|NCT01100931|Solid Tumors|solid tumors
1415834|NCT01100931|YM155|ym155
1415835|NCT01100931|Survivin|survivin
1415836|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
1415837|NCT01100931|Solid Tumor|solid tumor
1415838|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1415839|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
1415840|NCT01100918|Dyssynchrony|dyssynchrony
1415841|NCT01100905|Iron|iron
1415842|NCT01100905|Iron status|iron status
1415843|NCT01100905|Iron deficiency|iron deficiency
1415844|NCT01100905|Iron deficiency anemia|iron deficiency anemia
1415845|NCT01100892|Pediatrics|pediatrics
1415846|NCT01100892|Pancreas|pancreas
1415847|NCT01100879|Anemia|anemia
1415848|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
1415849|NCT01100879|Chemotherapy|chemotherapy
1415850|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
1415851|NCT01100879|iron|iron
1415852|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
1415853|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
1415854|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
1415855|NCT01100853|amphetamine dependence|amphetamine dependence
1415856|NCT01100853|amphetamine injection|amphetamine injection
1415857|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
1415858|NCT01100853|amphetamine craving|amphetamine craving
1415859|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
1415860|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
1415861|NCT01100801|advanced|advanced
1415862|NCT01100801|metastatic|metastatic
1415863|NCT01100775|Galantamine|galantamine
1415864|NCT01100775|Schizophrenia|schizophrenia
1415865|NCT01100775|working memory|working memory
1415866|NCT01100775|cognitive|cognitive
1415867|NCT01100762|Parkinson's Disease|parkinson's disease
1415868|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
1415869|NCT01100762|Gait|gait
1415870|NCT01100749|Hepatitis C|hepatitis c
1415871|NCT01100749|Genotype 3|genotype 3
1415872|NCT01100749|Demographics|demographics
1415873|NCT01100749|Genetics|genetics
1415874|NCT01100749|Metabolic status|metabolic status
1415875|NCT01100736|Forearm Blood Flow|forearm blood flow
1415876|NCT01100736|Vasodilation|vasodilation
1415877|NCT01100736|Vasoconstriction|vasoconstriction
1415878|NCT01100736|Endothelin System|endothelin system
1415879|NCT01100736|Endothelin-1|endothelin-1
1415880|NCT01100736|Endothelin-3|endothelin-3
1415881|NCT01100736|Endothelin antagonists|endothelin antagonists
1415882|NCT01100736|Bosentan|bosentan
1415883|NCT01100736|Sitaxsentan|sitaxsentan
1415884|NCT01100736|Endothelin|endothelin
1415885|NCT01100736|Regional Blood Flow|regional blood flow
1415886|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
1415887|NCT01100723|calcium|calcium
1415888|NCT01100723|phosphorus|phosphorus
1415889|NCT01100723|ESRD|esrd
1415890|NCT01100723|CKD|ckd
1415891|NCT01100723|mineral disorder|mineral disorder
1415892|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
1415893|NCT01100697|prenatal diagnosis|prenatal diagnosis
1415894|NCT01100697|ultrasound|ultrasound
1415895|NCT01100697|outcome|outcome
1415896|NCT01100697|spina bifida|spina bifida
1415897|NCT01100697|neural tube defect|neural tube defect
1415898|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
1415899|NCT01100671|atherosclerosis|atherosclerosis
1415900|NCT01100671|vascular inflammation|vascular inflammation
1415901|NCT01100671|MDCT|mdct
1415902|NCT01100671|18FDG-PET|18fdg-pet
1415903|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1415904|NCT01100606|Infants with CF|infants with cf
1415905|NCT01100593|Ultrasound|ultrasound
1415906|NCT01100593|IV catheters|iv catheters
1415907|NCT01100593|Extravasation|extravasation
1415908|NCT01100580|Low-salt diet|low-salt diet
1415909|NCT01100580|calciuria|calciuria
1415910|NCT01100580|blood pressure|blood pressure
1415911|NCT01100580|nephrolithiasis|nephrolithiasis
1415912|NCT01100580|hypertension|hypertension
1415913|NCT01100580|BMI|bmi
1415914|NCT01100580|urinary stone risk factors|urinary stone risk factors
1415915|NCT01100567|skeletal health|skeletal health
1415916|NCT01100567|bone turnover|bone turnover
1415917|NCT01100567|bone geometry|bone geometry
1415918|NCT01100567|malnutrition|malnutrition
1415919|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
1415920|NCT01100541|Thermotherapy|thermotherapy
1415921|NCT01100541|Polymers|polymers
1415922|NCT01100541|Castor Oil|castor oil
1415923|NCT01100515|intoxication|intoxication
1415924|NCT01100515|carbon monoxide|carbon monoxide
1415925|NCT01100515|adults|adults
1415926|NCT01100515|domestic accident|domestic accident
1415927|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
1415928|NCT01100502|Antigens, CD30|antigens, cd30
1415929|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
1415930|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
1415931|NCT01100502|Disease, Hodgkin|disease, hodgkin
1415932|NCT01100502|Drug Therapy|drug therapy
1415933|NCT01100502|Hematologic Diseases|hematologic diseases
1415934|NCT01100502|Immunotherapy|immunotherapy
1415935|NCT01100502|Lymphoma|lymphoma
1415936|NCT01100502|Monomethylauristatin E|monomethylauristatin e
1415937|NCT01100476|Closure Device|closure device
1415938|NCT01100476|endovascular procedures|endovascular procedures
1415939|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
1415940|NCT01100476|Mynx M5|mynx m5
1415941|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
1415942|NCT01100450|bariatric surgery|bariatric surgery
1415943|NCT01100450|class III obesity|class iii obesity
1415944|NCT01100450|resistance training|resistance training
1415945|NCT01100450|strength|strength
1415946|NCT01100450|fitness|fitness
1415947|NCT01100437|opioid|opioid
1415948|NCT01100437|morphine|morphine
1415949|NCT01100437|naltrexone|naltrexone
1415950|NCT01100437|withdrawal signs|withdrawal signs
1415951|NCT01100437|withdrawal symptoms|withdrawal symptoms
1415952|NCT01100424|Contact lenses|contact lenses
1415953|NCT01100424|Contact lens solution|contact lens solution
1415954|NCT01100424|Corneal staining|corneal staining
1415955|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
1415956|NCT01100398|Fatty liver disease|fatty liver disease
1415957|NCT01100385|Healthy adults|healthy adults
1415958|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1415959|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1415960|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1415961|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1415962|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1415963|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
1415964|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
1415965|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
1415966|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
1416069|NCT01099917|Maitake|maitake
1415967|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
1415968|NCT01100346|Ovulation induction|ovulation induction
1415969|NCT01100346|Intrauterine insemination|intrauterine insemination
1415970|NCT01100346|Gonal-f|gonal-f
1415971|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
1415972|NCT01100346|Infertility|infertility
1415973|NCT01100333|Infertility|infertility
1415974|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
1415975|NCT01100333|r-hFSH|r-hfsh
1415976|NCT01100333|Gonal-f|gonal-f
1415977|NCT01100320|Healthy subjects|healthy subjects
1415978|NCT01100320|Opioid|opioid
1415979|NCT01100307|diabetic macular edema|diabetic macular edema
1415980|NCT01100307|Macugen|macugen
1415981|NCT01100307|sham-controlled study|sham-controlled study
1415982|NCT01100294|Influenza|influenza
1415983|NCT01100294|Pandemic vaccine|pandemic vaccine
1415984|NCT01100294|Seasonal vaccine|seasonal vaccine
1415985|NCT01100294|Prevention|prevention
1415986|NCT01100294|Influenza vaccine|influenza vaccine
1415987|NCT01100294|Influenza in humans|influenza in humans
1415988|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
1415989|NCT01100294|Influenza vaccine for children|influenza vaccine for children
1415990|NCT01100281|prefrontal cortex|prefrontal cortex
1415991|NCT01100268|Hoarding|hoarding
1415993|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
1415994|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
1415995|NCT01100242|kidney cancer|kidney cancer
1415996|NCT01100216|smokeless tobacco|smokeless tobacco
1415997|NCT01100216|nicotine|nicotine
1415998|NCT01100216|snus|snus
1415999|NCT01100216|snuff|snuff
1416000|NCT01100216|chewing tobacco|chewing tobacco
1416001|NCT01100216|oral tobacco|oral tobacco
1416002|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
1416003|NCT01100203|arterial stiffness|arterial stiffness
1416004|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
1416005|NCT01100190|Facelift|facelift
1416006|NCT01100190|Rhytidectomy|rhytidectomy
1416007|NCT01100190|Ptosis|ptosis
1416008|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
1416009|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
1416010|NCT01100164|INSOMNIA|insomnia
1416011|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
1416012|NCT01100151|Opioid-induced constipation|opioid-induced constipation
1416013|NCT01100151|RDC-1036|rdc-1036
1416014|NCT01100151|ALKS 37|alks 37
1416015|NCT01100125|Diabetes|diabetes
1416016|NCT01100125|Sitagliptin|sitagliptin
1416017|NCT01100125|insulin|insulin
1416018|NCT01100125|C-peptide|c-peptide
1416019|NCT01100112|ulcerative colitis|ulcerative colitis
1416020|NCT01100112|Budesonide|budesonide
1416021|NCT01100099|Celiac disease.|celiac disease.
1416022|NCT01100099|Food intolerance.|food intolerance.
1416023|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
1416024|NCT01100086|Healthy subjects|healthy subjects
1416025|NCT01100086|Opioid|opioid
1416026|NCT01100060|Azithromycin|azithromycin
1416027|NCT01100060|chloroquine|chloroquine
1416028|NCT01100060|microsphere|microsphere
1416029|NCT01100060|pharmacokinetics|pharmacokinetics
1416030|NCT01100060|bioavailability|bioavailability
1416031|NCT01100047|Phase I|phase i
1416032|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
1416033|NCT01100047|AZD5069|azd5069
1416034|NCT01100034|pediatric psoriasis|pediatric psoriasis
1416035|NCT01100034|etanercept|etanercept
1416036|NCT01100034|PASS|pass
1416037|NCT01100034|safety|safety
1416038|NCT01100034|effectiveness|effectiveness
1416039|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
1416040|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
1416041|NCT01100008|severity|severity
1416042|NCT01100008|prognosis|prognosis
1416043|NCT01099995|domestic accident|domestic accident
1416044|NCT01099995|coma|coma
1416045|NCT01099995|carbon monoxide|carbon monoxide
1416046|NCT01099995|intoxication|intoxication
1416047|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
1416048|NCT01099982|Congestive Heart Failure|congestive heart failure
1416049|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
1416050|NCT01099982|LVAD|lvad
1416051|NCT01099982|Myocardium|myocardium
1416052|NCT01099982|Remodeling|remodeling
1416053|NCT01099982|Microvasculature|microvasculature
1416054|NCT01099982|Fibrosis|fibrosis
1416055|NCT01099982|Cardiac Transplant|cardiac transplant
1416056|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
1416057|NCT01099969|Regular endotracheal tube|regular endotracheal tube
1416058|NCT01099969|gliderite stylet|gliderite stylet
1416059|NCT01099969|McGrath videolaryngoscope|mcgrath videolaryngoscope
1416060|NCT01099969|Glidescope|glidescope
1416061|NCT01099956|type 1 diabetes|type 1 diabetes
1416062|NCT01099956|children|children
1416063|NCT01099956|low grade inflammation|low grade inflammation
1416064|NCT01099956|cytokine|cytokine
1416066|NCT01099930|immunoablation|immunoablation
1416067|NCT01099930|stem cell transplantation|stem cell transplantation
1416068|NCT01099917|MDS|mds
1416070|NCT01099917|mushroom|mushroom
1416071|NCT01099917|09-094|09-094
1416072|NCT01099878|Cycling Exercise|cycling exercise
1416073|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
1416074|NCT01099878|Stroke|stroke
1416075|NCT01099852|dengue|dengue
1416076|NCT01099852|fever|fever
1416077|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
1416078|NCT01099852|dengue virus|dengue virus
1416079|NCT01099852|Chikungunya virus|chikungunya virus
1416080|NCT01099852|Zika Virus|zika virus
1416081|NCT01099852|Joint pain|joint pain
1416082|NCT01099839|ASP1941|asp1941
1416083|NCT01099839|Miglitol|miglitol
1416084|NCT01099826|colorectal cancer screening|colorectal cancer screening
1416085|NCT01099826|tailored education|tailored education
1416086|NCT01099826|motivational interview|motivational interview
1416087|NCT01099826|patient education|patient education
1416088|NCT01099813|Critical Illness|critical illness
1416089|NCT01099813|Sepsis|sepsis
1416090|NCT01099813|Duration|duration
1416091|NCT01099813|Severity of Illness Scores|severity of illness scores
1416092|NCT01099813|Trajectory|trajectory
1416093|NCT01099800|asthma|asthma
1416094|NCT01099800|health disparities|health disparities
1416095|NCT01099800|illness representations|illness representations
1416096|NCT01099800|CAM|cam
1416097|NCT01099800|Latino|latino
1416098|NCT01099748|Drug interaction|drug interaction
1416099|NCT01099748|pharmacokinetics|pharmacokinetics
1416100|NCT01099748|lersivirine|lersivirine
1416101|NCT01099748|methadone|methadone
1416102|NCT01099735|Bariatric Surgery|bariatric surgery
1416103|NCT01099735|Sleep Apnea|sleep apnea
1416104|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1416105|NCT01099735|GERD|gerd
1416106|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
1416107|NCT01099709|healthy subjects|healthy subjects
1416108|NCT01099709|opioid|opioid
1416109|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
1416110|NCT01099644|Peritoneum|peritoneum
1416111|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
1416112|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
1416113|NCT01099644|131 I-8H9|131 i-8h9
1416114|NCT01099644|09-090|09-090
1416115|NCT01099631|Salmonella typhimurium|salmonella typhimurium
1416116|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
1416117|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
1416118|NCT01099631|IL-2|il-2
1547474|NCT00589667|pharynx|pharynx
1416119|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
1416120|NCT01099605|pain management|pain management
1416121|NCT01099579|HIV, Pediatric|hiv, pediatric
1416122|NCT01099566|human endotoxemia|human endotoxemia
1416123|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
1416124|NCT01099566|platelet activation|platelet activation
1416125|NCT01099566|thienopyridines|thienopyridines
1416126|NCT01099553|Educational video|educational video
1416127|NCT01099553|colonoscopy|colonoscopy
1416128|NCT01099553|bowel preparation|bowel preparation
1416129|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
1416130|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
1416131|NCT01099527|gastric cancer|gastric cancer
1416132|NCT01099527|refractory|refractory
1416133|NCT01099527|metastatic|metastatic
1416134|NCT01099501|Mechanical Ventilation|mechanical ventilation
1416135|NCT01099488|Immunological assays|immunological assays
1416136|NCT01099475|liver surgery|liver surgery
1416137|NCT01099475|pringle manoeuvre|pringle manoeuvre
1416138|NCT01099475|hepatocellular damage|hepatocellular damage
1416139|NCT01099475|surgical complications|surgical complications
1416140|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
1416141|NCT01099462|fever|fever
1416142|NCT01099462|Ibuprofen|ibuprofen
1416143|NCT01099449|neurotoxicity|neurotoxicity
1416144|NCT01099449|neuropathy|neuropathy
1416145|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1416146|NCT01099449|stage II colon cancer|stage ii colon cancer
1416147|NCT01099449|stage III colon cancer|stage iii colon cancer
1416148|NCT01099449|stage IV colon cancer|stage iv colon cancer
1416149|NCT01099449|stage II rectal cancer|stage ii rectal cancer
1416150|NCT01099449|stage III rectal cancer|stage iii rectal cancer
1416151|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
1416152|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
1416153|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1416154|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
1416155|NCT01099436|stage II breast cancer|stage ii breast cancer
1416259|NCT01099163|Antioxidant|antioxidant
1416156|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
1416157|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
1416158|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
1416159|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1416160|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
1416161|NCT01099410|macrophages, alveolar|macrophages, alveolar
1416162|NCT01099410|monocytes|monocytes
1416163|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
1416165|NCT01099410|Phagocytosis|phagocytosis
1416166|NCT01099410|Lung|lung
1416167|NCT01099410|in vitro|in vitro
1416168|NCT01099397|Glucose|glucose
1416169|NCT01099397|Glucose Tolerance Test|glucose tolerance test
1416170|NCT01099397|Insulin Resistance|insulin resistance
1416171|NCT01099397|Metabolic adverse effects|metabolic adverse effects
1416172|NCT01099397|Hypertension|hypertension
1416173|NCT01099397|Beta-blocker|beta-blocker
1416174|NCT01099397|Atenolol|atenolol
1416175|NCT01099397|Diuretic|diuretic
1416176|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
1416177|NCT01099397|Blood pressure|blood pressure
1416178|NCT01099371|Knee|knee
1416179|NCT01099371|Osteoarthritis|osteoarthritis
1416180|NCT01099371|Exercise|exercise
1416181|NCT01099358|Cancer of Head|cancer of head
1416182|NCT01099358|Cancer of Head and Neck|cancer of head and neck
1416183|NCT01099358|Cancer of Neck|cancer of neck
1416184|NCT01099358|Cancer of the Head|cancer of the head
1416185|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
1416186|NCT01099358|Cancer of the Neck|cancer of the neck
1416187|NCT01099358|Head and Neck Cancer|head and neck cancer
1416188|NCT01099358|Head Cancer|head cancer
1416189|NCT01099358|Head Neoplasms|head neoplasms
1416190|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
1416191|NCT01099358|Neck Cancer|neck cancer
1416192|NCT01099358|Neck Neoplasms|neck neoplasms
1416193|NCT01099358|Solid Neoplasm|solid neoplasm
1416194|NCT01099358|Carcinoma|carcinoma
1416195|NCT01099358|Sarcoma|sarcoma
1416196|NCT01099345|OAB|oab
1416197|NCT01099345|Nocturia|nocturia
1416198|NCT01099345|Bladder function|bladder function
1416199|NCT01099345|cystometry|cystometry
1416200|NCT01099345|polysomnography|polysomnography
1416201|NCT01099332|Alzheimer's disease|alzheimer's disease
1416202|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
1416203|NCT01099332|Copper metabolism|copper metabolism
1416204|NCT01099332|Zinc metabolism|zinc metabolism
1416205|NCT01099332|Ceruloplasmin|ceruloplasmin
1416206|NCT01099319|Dietary supplement|dietary supplement
1416207|NCT01099319|Renalof|renalof
1416208|NCT01099319|gallstones|gallstones
1416209|NCT01099319|elderly|elderly
1416210|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
1416211|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
1416212|NCT01099293|Critical Flicker Frequency|critical flicker frequency
1416213|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
1416214|NCT01099293|Endotoxemia|endotoxemia
1416215|NCT01099293|Transcranial Doppler|transcranial doppler
1416216|NCT01099293|Liver Cirrhosis|liver cirrhosis
1416217|NCT01099280|induction of labor in term|induction of labor in term
1416218|NCT01099280|premature rupture of membranes|premature rupture of membranes
1416219|NCT01099280|dinoprostone|dinoprostone
1416220|NCT01099280|oxytocin|oxytocin
1416221|NCT01099267|MDS|mds
1416222|NCT01099254|CVP|cvp
1416223|NCT01099254|US|us
1416224|NCT01099254|Trendelenburg position|trendelenburg position
1416225|NCT01099254|Ultrasound|ultrasound
1416226|NCT01099254|Head Down Tilt|head down tilt
1416227|NCT01099241|CVP|cvp
1416228|NCT01099241|US|us
1416229|NCT01099241|Ultrasonography|ultrasonography
1416230|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
1416231|NCT01099228|Imaging|imaging
1416232|NCT01099215|peripheral artery disease|peripheral artery disease
1416233|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1416234|NCT01099215|stent|stent
1416235|NCT01099215|balloon/stent|balloon/stent
1416236|NCT01099215|superficial femoral artery|superficial femoral artery
1416237|NCT01099202|Procrit|procrit
1416238|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1416239|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1416240|NCT01099202|Burkitt's|burkitt's
1416241|NCT01099202|Chemotherapy|chemotherapy
1416242|NCT01099202|Hyper-CVAD|hyper-cvad
1416243|NCT01099202|augmented BFM|augmented bfm
1416244|NCT01099202|Epoetin alfa|epoetin alfa
1416245|NCT01099202|Epogen|epogen
1416246|NCT01099202|Erythropoietin|erythropoietin
1416247|NCT01099189|Histology|histology
1416248|NCT01099189|Compliance|compliance
1416249|NCT01099189|Dialysis|dialysis
1416250|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
1416251|NCT01099189|vein|vein
1416252|NCT01099176|hyperlipidemia|hyperlipidemia
1416253|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
1416254|NCT01099176|adipokines|adipokines
1416255|NCT01099176|atorvastatin|atorvastatin
1416256|NCT01099176|fenofibrate|fenofibrate
1416257|NCT01099163|Diabetes mellitus|diabetes mellitus
1416258|NCT01099163|CLA|cla
1416260|NCT01099163|Glycemic control|glycemic control
1416261|NCT01099150|Platelets|platelets
1416262|NCT01099150|Platelet aggregation|platelet aggregation
1416263|NCT01099150|Platelet activation|platelet activation
1416264|NCT01099150|Platelet function|platelet function
1416265|NCT01099150|Light transmission aggregometry|light transmission aggregometry
1416266|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
1416267|NCT01099150|P-selectin|p-selectin
1416268|NCT01099150|Fibrinogen receptor|fibrinogen receptor
1416269|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
1416270|NCT01099150|Chocolate|chocolate
1416271|NCT01099150|Cocoa|cocoa
1416272|NCT01099150|Flavan-3-ols|flavan-3-ols
1416273|NCT01099150|Procyanidins|procyanidins
1416274|NCT01099137|Diabetes|diabetes
1416275|NCT01099137|Vildagliptin|vildagliptin
1416276|NCT01099137|insulin|insulin
1416277|NCT01099137|C-peptide|c-peptide
1416278|NCT01099124|M2ES|m2es
1416279|NCT01099124|NSCLC|nsclc
1416280|NCT01099124|Phase I Trial|phase i trial
1416281|NCT01099124|Advanced NSCLC|advanced nsclc
1416282|NCT01099124|Recurrent NSCLC|recurrent nsclc
1416283|NCT01099111|IBS|ibs
1416284|NCT01099111|UC|uc
1416285|NCT01099111|CD|cd
1416286|NCT01099111|CRAP/CRC|crap/crc
1416287|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
1416288|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
1416289|NCT01099072|ADHD|adhd
1416290|NCT01099072|carnitine|carnitine
1416291|NCT01099072|methylphenidate|methylphenidate
1416292|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1416293|NCT01099059|Clinical Trial|clinical trial
1416294|NCT01099059|Amantadine|amantadine
1416295|NCT01099059|Methylphenidate|methylphenidate
1416296|NCT01099046|Meniere's disease|meniere's disease
1416297|NCT01099046|stress management|stress management
1416298|NCT01099046|vasopressin|vasopressin
1416299|NCT01099046|V2 receptor|v2 receptor
1416300|NCT01099046|water intake|water intake
1416301|NCT01099046|tympanic tubing|tympanic tubing
1416302|NCT01099046|regular sleep under dark|regular sleep under dark
1416303|NCT01099033|hiatal hernia|hiatal hernia
1416304|NCT01099033|paraesophageal hernia|paraesophageal hernia
1416305|NCT01099033|biologic mesh|biologic mesh
1416306|NCT01099033|MMPs|mmps
1416307|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
1416308|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
1416309|NCT01099007|Women|women
1416310|NCT01099007|Menopause|menopause
1416311|NCT01099007|Cardiovascular Disease|cardiovascular disease
1416312|NCT01099007|Physical Activity|physical activity
1416313|NCT01099007|Weight Loss|weight loss
1416314|NCT01098994|Type 1 diabetes|type 1 diabetes
1416315|NCT01098994|Haptoglobin genotype|haptoglobin genotype
1416316|NCT01098994|HDL function|hdl function
1416317|NCT01098994|Heart disease|heart disease
1416318|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
1416319|NCT01098955|Cancer|cancer
1416320|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
1416321|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
1416322|NCT01098955|ACT Theory|act theory
1416323|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
1416324|NCT01098955|MBC|mbc
1416325|NCT01098955|abstinence|abstinence
1416326|NCT01098955|Varenicline|varenicline
1416327|NCT01098955|Chantix|chantix
1416328|NCT01098942|bariatric surgery|bariatric surgery
1416329|NCT01098929|genes|genes
1416330|NCT01098929|genetic|genetic
1416331|NCT01098929|chromosome|chromosome
1416332|NCT01098929|chromosome microarray|chromosome microarray
1416333|NCT01098916|hospital at home|hospital at home
1416334|NCT01098916|radiology at home|radiology at home
1416335|NCT01098916|frail elderly|frail elderly
1416336|NCT01098903|sunitinib|sunitinib
1416337|NCT01098903|cancer|cancer
1416338|NCT01098903|pharmacogenomics|pharmacogenomics
1416339|NCT01098903|pharmacokinetics|pharmacokinetics
1416340|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
1416341|NCT01098903|doseindividualism|doseindividualism
1416342|NCT01098877|Phase1|phase1
1416343|NCT01098877|pharmacokinetics|pharmacokinetics
1416344|NCT01098877|safety|safety
1416345|NCT01098877|toleration|toleration
1416346|NCT01098877|pharmacodynamics|pharmacodynamics
1416347|NCT01098864|Behavior|behavior
1416348|NCT01098864|Impulsivity|impulsivity
1416349|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1416350|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
1416351|NCT01098851|Pulse Oximetry|pulse oximetry
1416352|NCT01098838|Cancer|cancer
1416353|NCT01098838|adults|adults
1416354|NCT01098838|solid tumor|solid tumor
1416355|NCT01098838|apoptosis|apoptosis
1416356|NCT01098838|programmed cell death|programmed cell death
1416357|NCT01098838|LCL161|lcl161
1416358|NCT01098825|vaccine hesitancy|vaccine hesitancy
1416359|NCT01098825|vaccine refusal|vaccine refusal
1416360|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
1416361|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
1416362|NCT01098786|Influenza A|influenza a
1416363|NCT01098786|H1N1 subtype|h1n1 subtype
1416364|NCT01098786|Vaccine|vaccine
1416365|NCT01098786|Adjuvant|adjuvant
1416366|NCT01098786|Cell culture|cell culture
1416367|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
1416368|NCT01098773|BNP|bnp
1416369|NCT01098773|Lung ultrasound|lung ultrasound
1416370|NCT01098773|Echocardiography|echocardiography
1416371|NCT01098760|Sorafenib|sorafenib
1416372|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1416373|NCT01098747|Pain following third molar extraction|pain following third molar extraction
1416374|NCT01098734|non-steroid|non-steroid
1416375|NCT01098734|anti-inflammatory|anti-inflammatory
1416376|NCT01098734|skin disease|skin disease
1416377|NCT01098734|topical cream|topical cream
1416378|NCT01098734|small molecule|small molecule
1416379|NCT01098734|atopic dermatitis|atopic dermatitis
1416380|NCT01098734|eczema|eczema
1416381|NCT01098721|plaque psoriasis|plaque psoriasis
1416382|NCT01098721|skin diseases|skin diseases
1416383|NCT01098721|anti-inflammatory|anti-inflammatory
1416384|NCT01098721|non-steroid|non-steroid
1416385|NCT01098721|topical cream|topical cream
1416386|NCT01098708|DMD|dmd
1416387|NCT01098708|non ambulatory|non ambulatory
1416388|NCT01098695|parenting interventions|parenting interventions
1416389|NCT01098695|Family Check-Up|family check-up
1416390|NCT01098695|Early Intervention|early intervention
1416391|NCT01098695|Self-Regulation|self-regulation
1416392|NCT01098669|cancer survivor|cancer survivor
1416393|NCT01098669|lymphedema|lymphedema
1416394|NCT01098669|head and neck cancer|head and neck cancer
1416395|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1416396|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1416397|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1416398|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1416399|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1416400|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1416401|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1416402|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
1416403|NCT01098617|hemorrhage|hemorrhage
1416404|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
1416405|NCT01098617|antiaggregants|antiaggregants
1416406|NCT01098617|anticoagulants|anticoagulants
1416407|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
1416408|NCT01098591|meta-analysis|meta-analysis
1416409|NCT01098591|stem cell|stem cell
1416410|NCT01098591|cardiac|cardiac
1416411|NCT01098591|remodeling|remodeling
1416412|NCT01098591|MESS|mess
1416413|NCT01098578|Posterior Epistaxis|posterior epistaxis
1416414|NCT01098552|Prostate Cancer|prostate cancer
1416415|NCT01098539|sitagliptin|sitagliptin
1416416|NCT01098539|albiglutide|albiglutide
1416417|NCT01098539|renal impairment|renal impairment
1416418|NCT01098526|GSK1349572|gsk1349572
1416419|NCT01098526|efavirenz|efavirenz
1416420|NCT01098526|integrase|integrase
1416421|NCT01098526|pharmacokinetics|pharmacokinetics
1416423|NCT01098513|healthy|healthy
1416424|NCT01098513|GSK1349572|gsk1349572
1416425|NCT01098500|Liver function|liver function
1416426|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1416427|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
1416428|NCT01098487|bone marrow fibers|bone marrow fibers
1416429|NCT01098487|eltrombopag olamine|eltrombopag olamine
1416430|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
1416431|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
1416432|NCT01098461|dose-ranging|dose-ranging
1416433|NCT01098461|pharmacokinetics|pharmacokinetics
1416434|NCT01098461|GSK716155|gsk716155
1416435|NCT01098461|Japan|japan
1416436|NCT01098461|albiglutide|albiglutide
1416437|NCT01098448|Amoxicillin|amoxicillin
1416438|NCT01098448|antibiotics|antibiotics
1416439|NCT01098448|chronic periodontitis|chronic periodontitis
1416440|NCT01098448|local drug delivery|local drug delivery
1416441|NCT01098448|metronidazol|metronidazol
1416442|NCT01098448|randomized controlled trial|randomized controlled trial
1416443|NCT01098448|subgingival scaling|subgingival scaling
1416444|NCT01098448|surgery|surgery
1416445|NCT01098448|tetracycline|tetracycline
1416446|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
1416447|NCT01098435|Binge eating disorder|binge eating disorder
1416448|NCT01098435|RDC-0313|rdc-0313
1416449|NCT01098422|liver|liver
1416450|NCT01098422|colorectal|colorectal
1416451|NCT01098422|metastasis|metastasis
1416452|NCT01098422|carcinoma|carcinoma
1416453|NCT01098422|Yttrium-90|yttrium-90
1416454|NCT01098422|microspheres|microspheres
1416455|NCT01098409|sodium nitrite|sodium nitrite
1416456|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
1416457|NCT01098409|cardioprotection|cardioprotection
1416458|NCT01098409|myocardial injury|myocardial injury
1416459|NCT01098396|parkinson disease|parkinson disease
1416460|NCT01098396|gait|gait
1416461|NCT01098383|Autism|autism
1416462|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
1416463|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
1416464|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
1416465|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1416466|NCT01098331|stage I prostate cancer|stage i prostate cancer
1416467|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
1416468|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
1416469|NCT01098318|Depression|depression
1416470|NCT01098318|Antidepressant Therapy|antidepressant therapy
1416471|NCT01098318|Herbal Treatment|herbal treatment
1416472|NCT01098318|Rhodiola rosea|rhodiola rosea
1416473|NCT01098318|Alternative Therapy|alternative therapy
1416474|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
1416475|NCT01098292|Fibromyalgia|fibromyalgia
1416476|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
1416477|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
1416478|NCT01098292|Interstitial Cystitis|interstitial cystitis
1416479|NCT01098292|Chronic Prostatitis|chronic prostatitis
1416480|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
1416481|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
1416482|NCT01098279|Interstitial Cystitis|interstitial cystitis
1416483|NCT01098279|Chronic Prostatitis|chronic prostatitis
1416484|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
1416485|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
1416486|NCT01098266|MPM|mpm
1416487|NCT01098266|NGR-hTNF|ngr-htnf
1416488|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
1416489|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
1416490|NCT01098253|adherence|adherence
1416491|NCT01098253|diabetes mellitus|diabetes mellitus
1416492|NCT01098253|depression|depression
1416493|NCT01098253|primary health care|primary health care
1416494|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
1416495|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
1416496|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
1416497|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
1416498|NCT01098214|Normal pregnancy|normal pregnancy
1416499|NCT01098214|Amniotic fluid|amniotic fluid
1416500|NCT01098214|Cytokines|cytokines
1416501|NCT01098214|Biomarkers|biomarkers
1416502|NCT01098201|Certolizumab|certolizumab
1416503|NCT01098201|TNF|tnf
1416504|NCT01098201|RA|ra
1416505|NCT01098201|Cizmia|cizmia
1416506|NCT01098175|laparotomy|laparotomy
1416507|NCT01098175|thoracotomy|thoracotomy
1416508|NCT01098175|peritoneal conditioning|peritoneal conditioning
1416509|NCT01098175|humidification|humidification
1416510|NCT01098175|temperature control|temperature control
1547938|NCT00588341|TMZ|tmz
1416511|NCT01098162|Lacosamide|lacosamide
1416512|NCT01098162|Vimpat®|vimpat®
1416513|NCT01098162|Epilepsy|epilepsy
1416514|NCT01098162|Partial-Onset Seizures|partial-onset seizures
1416515|NCT01098162|Adjunctive therapy|adjunctive therapy
1416516|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
1416517|NCT01098149|acetate free biofiltration|acetate free biofiltration
1416518|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
1416519|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
1416520|NCT01098136|Pelvic girdle pain|pelvic girdle pain
1416521|NCT01098136|Chiropractic|chiropractic
1416522|NCT01098136|Single-blinded|single-blinded
1416523|NCT01098136|Outcome study|outcome study
1416524|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
1416525|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
1416526|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
1416527|NCT01098058|randomised controlled trial|randomised controlled trial
1416528|NCT01098045|HIV|hiv
1416529|NCT01098045|fat redistribution|fat redistribution
1416530|NCT01098045|brown adipose tissue|brown adipose tissue
1416531|NCT01098045|PET|pet
1416532|NCT01098032|Contrast media|contrast media
1416533|NCT01098032|Kidney|kidney
1416534|NCT01098032|Complication|complication
1416535|NCT01098019|Notalgia paresthetica|notalgia paresthetica
1416536|NCT01098019|Xeomin|xeomin
1416537|NCT01098019|Botulinum Toxin A|botulinum toxin a
1416538|NCT01098019|Pruritus|pruritus
1416539|NCT01098019|Upper Back|upper back
1416540|NCT01098019|Hyperpigmentation|hyperpigmentation
1416541|NCT01098006|Immunological assays|immunological assays
1416542|NCT01098006|Chronic hepatitis B|chronic hepatitis b
1416543|NCT01097980|trazodone|trazodone
1416544|NCT01097980|SSRI|ssri
1416545|NCT01097980|sexual dysfunction|sexual dysfunction
1416546|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
1416547|NCT01097967|Sleep disordered breathing|sleep disordered breathing
1416548|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
1416549|NCT01097967|Sleep apnoea|sleep apnoea
1416550|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
1416551|NCT01097954|Exercise induced asthma|exercise induced asthma
1416552|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
1416553|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
1416554|NCT01097941|Influenza|influenza
1416555|NCT01097941|H1N1|h1n1
1416556|NCT01097915|PROP taste sensitivity|prop taste sensitivity
1416557|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
1416558|NCT01097915|Salivary zinc|salivary zinc
1416559|NCT01097915|BMI|bmi
1416560|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
1416561|NCT01097889|United Nations World Food Programme|united nations world food programme
1416562|NCT01097889|blended food (CSB)|blended food (csb)
1416563|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
1416564|NCT01097889|Plumpy®|plumpy®
1416565|NCT01097876|healthy volunteer|healthy volunteer
1416566|NCT01097876|pharmacokinetic|pharmacokinetic
1416567|NCT01097876|safety|safety
1416568|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
1416569|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
1416570|NCT01097850|doxorubicin|doxorubicin
1416571|NCT01097850|capecitabine|capecitabine
1416572|NCT01097837|Epilepsy|epilepsy
1416573|NCT01097837|Contraceptive|contraceptive
1416574|NCT01097837|Birth Control|birth control
1416575|NCT01097837|Seizure|seizure
1416818|NCT01096771|ARDS|ards
1416576|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
1416577|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
1416578|NCT01097811|Hypertension, Portal|hypertension, portal
1416579|NCT01097811|Liver Cirrhosis|liver cirrhosis
1416580|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
1416581|NCT01097798|muscle injury|muscle injury
1416582|NCT01097772|abdominal|abdominal
1416583|NCT01097772|aortic|aortic
1416584|NCT01097772|aneurysm|aneurysm
1416585|NCT01097759|hemorrhoids|hemorrhoids
1416586|NCT01097759|prolapsed|prolapsed
1416587|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
1416588|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
1416589|NCT01097759|LigaSure|ligasure
1416590|NCT01097759|Stapled|stapled
1416591|NCT01097746|Cancer|cancer
1416592|NCT01097746|Fallopian Tube|fallopian tube
1416593|NCT01097746|Ovary|ovary
1416594|NCT01097746|Peritoneum|peritoneum
1416595|NCT01097746|Epithelial ovarian|epithelial ovarian
1416596|NCT01097746|Paclitaxel|paclitaxel
1416597|NCT01097746|Carboplatin|carboplatin
1416598|NCT01097746|Bevacizumab|bevacizumab
1416599|NCT01097746|Taxol|taxol
1416600|NCT01097746|Avastin|avastin
1416601|NCT01097746|Paraplatin|paraplatin
1416602|NCT01097746|Carcinoma|carcinoma
1416603|NCT01097746|Surgery|surgery
1416604|NCT01097720|Valproate|valproate
1416605|NCT01097720|Lamotrigine|lamotrigine
1416606|NCT01097720|Carbamazepine|carbamazepine
1416607|NCT01097720|Anticonvulsant|anticonvulsant
1416608|NCT01097720|Antiepileptic|antiepileptic
1416609|NCT01097720|Teratogen|teratogen
1416610|NCT01097720|Autism|autism
1416611|NCT01097720|Developmental Delay|developmental delay
1416612|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
1416613|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
1416614|NCT01097681|ASP1941|asp1941
1416615|NCT01097681|Diabetes mellitus|diabetes mellitus
1416616|NCT01097681|Urinary glucose excretion|urinary glucose excretion
1416617|NCT01097668|Multiple sclerosis|multiple sclerosis
1416618|NCT01097668|Immunomodulation|immunomodulation
1416619|NCT01097668|Phase 1|phase 1
1416620|NCT01097655|Tablets|tablets
1416621|NCT01097655|Infection|infection
1416622|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
1416623|NCT01097655|Tolerability|tolerability
1416624|NCT01097655|Viral load|viral load
1416625|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
1416626|NCT01097655|Effectiveness|effectiveness
1416627|NCT01097655|Treatment-naïve|treatment-naïve
1416628|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
1416629|NCT01097590|ulcerative colitis|ulcerative colitis
1416630|NCT01097590|leukapheresis treatment|leukapheresis treatment
1416631|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
1416632|NCT01097577|excimer laser|excimer laser
1416633|NCT01097577|PRK|prk
1416634|NCT01097577|pain, postoperative|pain, postoperative
1416635|NCT01097577|pregabalin|pregabalin
1416636|NCT01097564|Genetic|genetic
1416637|NCT01097564|Cerebral angiopathy|cerebral angiopathy
1416638|NCT01097564|Retinal angiopathy|retinal angiopathy
1416639|NCT01097564|COL4A1 gene|col4a1 gene
1416640|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
1416641|NCT01097564|Congenital porencephaly|congenital porencephaly
1416642|NCT01097564|Congenital cataract|congenital cataract
1416643|NCT01097564|Leukoencephalopathy|leukoencephalopathy
1416644|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
1416645|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
1416646|NCT01097551|Diabetic retinopathy|diabetic retinopathy
1416647|NCT01097551|Pathogenesis|pathogenesis
1416648|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
1416649|NCT01097551|Endothelial dysfunction|endothelial dysfunction
1416650|NCT01097538|exercise|exercise
1416651|NCT01097538|rehabilitation|rehabilitation
1416652|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
1416653|NCT01097538|functional ability|functional ability
1416654|NCT01097538|fatigue|fatigue
1416655|NCT01097538|quality of life|quality of life
1416656|NCT01097512|AS703569|as703569
1416657|NCT01097512|MSC1992371A|msc1992371a
1416658|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
1416659|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
1416660|NCT01097499|Dental implant initial stability|dental implant initial stability
1417394|NCT01094899|diabetes|diabetes
1416661|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
1416662|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
1416663|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
1416664|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
1416665|NCT01097486|Spinal Stenosis|spinal stenosis
1416666|NCT01097486|Stem cells|stem cells
1416667|NCT01097486|Adult Stem Cells|adult stem cells
1416668|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
1416669|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
1416670|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
1416671|NCT01097460|HER2/HER3|her2/her3
1416672|NCT01097460|Bispecific Antibody|bispecific antibody
1416673|NCT01097460|Breast Cancer|breast cancer
1416674|NCT01097460|Advanced Breast Cancer|advanced breast cancer
1416675|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
1416676|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
1416677|NCT01097460|Trastuzumab|trastuzumab
1416678|NCT01097460|Herceptin|herceptin
1416679|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
1416680|NCT01097395|ribavirin|ribavirin
1416681|NCT01097395|pharmacokinetics|pharmacokinetics
1416682|NCT01097395|Hepatitis C virus|hepatitis c virus
1416683|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
1416684|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
1416685|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
1416686|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
1416687|NCT01097330|Catheter Ablation|catheter ablation
1416688|NCT01097330|Amiodarone|amiodarone
1416689|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1416690|NCT01097317|musculoskeletal complications|musculoskeletal complications
1416691|NCT01097317|fatigue|fatigue
1416692|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1416693|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1416694|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1416819|NCT01096771|Parenteral|parenteral
1416695|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1416696|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1416697|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1416698|NCT01097278|breast cancer|breast cancer
1416699|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1416700|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1416701|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
1416702|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
1416703|NCT01097265|stage I colon cancer|stage i colon cancer
1416704|NCT01097265|stage II colon cancer|stage ii colon cancer
1416705|NCT01097252|Cervical Neoplasm|cervical neoplasm
1416706|NCT01097252|chemoradiation|chemoradiation
1416707|NCT01097252|compliance|compliance
1416708|NCT01097252|toxicity|toxicity
1416709|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
1416710|NCT01097239|HIFU|hifu
1416711|NCT01097239|Rectal Cancer|rectal cancer
1416712|NCT01097239|Sonablate 500|sonablate 500
1416713|NCT01097239|Transrectal|transrectal
1416714|NCT01097226|Dietary intervention|dietary intervention
1416715|NCT01097226|bioavailability|bioavailability
1416716|NCT01097226|Healthy volunteers|healthy volunteers
1416717|NCT01097200|sacrocolpopexy|sacrocolpopexy
1416718|NCT01097200|meshes|meshes
1416719|NCT01097200|sacrospinous ligament|sacrospinous ligament
1416720|NCT01097174|Glaucoma|glaucoma
1416721|NCT01097174|Glaucoma device|glaucoma device
1416722|NCT01097174|Glaucoma surgery|glaucoma surgery
1416723|NCT01097174|Intraocular pressure|intraocular pressure
1416724|NCT01097161|Stuttering|stuttering
1416725|NCT01097161|Apraxia of speech|apraxia of speech
1416726|NCT01097161|Motor control|motor control
1416727|NCT01097161|Prosody|prosody
1416728|NCT01097161|Pitch range|pitch range
1416729|NCT01097161|Speech rate|speech rate
1416730|NCT01097161|fluency disorders|fluency disorders
1416731|NCT01097148|Obese|obese
1416732|NCT01097148|Atracurium|atracurium
1416733|NCT01097148|Cefazolin|cefazolin
1416734|NCT01097148|Morfine|morfine
1416735|NCT01097148|Nadroparin|nadroparin
1416736|NCT01097122|bone|bone
1416737|NCT01097122|motor neuron excitability|motor neuron excitability
1416738|NCT01097122|forearm vibration|forearm vibration
1416739|NCT01097122|mechanical loading|mechanical loading
1416740|NCT01097122|muscle electrical activity|muscle electrical activity
1416741|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
1416742|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
1416743|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
1416744|NCT01097109|Weight-Bearing|weight-bearing
1416745|NCT01097096|Active immunization|active immunization
1416746|NCT01097096|Alzheimer disease|alzheimer disease
1416747|NCT01097096|Antibody|antibody
1416748|NCT01097096|Central Nervous System Diseases|central nervous system diseases
1416749|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
1416750|NCT01097096|Vaccine|vaccine
1416751|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
1416752|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
1416753|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
1416754|NCT01097044|EPP|epp
1416755|NCT01097044|Afamelanotide|afamelanotide
1416756|NCT01097031|blood pressure|blood pressure
1416757|NCT01097031|pediatric|pediatric
1416758|NCT01097031|nursing|nursing
1416759|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
1416760|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
1416761|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1416762|NCT01096992|CLL|cll
1416763|NCT01096992|Bendamustine|bendamustine
1416764|NCT01096992|Fludarabine|fludarabine
1416765|NCT01096992|Fludara|fludara
1416766|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
1416767|NCT01096992|Rituximab|rituximab
1416768|NCT01096992|Rituxan|rituxan
1416769|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
1416770|NCT01096966|chronic low back pain|chronic low back pain
1416771|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1416772|NCT01096953|ADHD|adhd
1416773|NCT01096953|attention deficit|attention deficit
1416774|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1416775|NCT01096940|Glucose lowering|glucose lowering
1416776|NCT01096927|Lower Abdominal Pain|lower abdominal pain
1416777|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
1416778|NCT01096927|Acute Appendicitis|acute appendicitis
1416779|NCT01096927|Antibiotic Therapy|antibiotic therapy
1416780|NCT01096927|Conservative Management|conservative management
1416781|NCT01096927|Appendectomy|appendectomy
1416782|NCT01096927|Recurrence|recurrence
1416783|NCT01096927|Length of hospital stay|length of hospital stay
1416784|NCT01096927|Sick leave time|sick leave time
1416785|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
1416786|NCT01096888|WIC|wic
1416787|NCT01096888|Weight loss|weight loss
1416788|NCT01096888|Overweight|overweight
1416789|NCT01096888|Post Partum|post partum
1416790|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
1416791|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
1416792|NCT01096875|Atorvastatin|atorvastatin
1416793|NCT01096875|Coronary surgery|coronary surgery
1416794|NCT01096862|Psoriasis|psoriasis
1416795|NCT01096862|ASP015K|asp015k
1416796|NCT01096849|urinary tract infection|urinary tract infection
1416797|NCT01096849|UTI|uti
1416798|NCT01096849|cUTI|cuti
1416799|NCT01096849|pyelonephritis|pyelonephritis
1416800|NCT01096849|AP|ap
1416801|NCT01096849|ACHN-490|achn-490
1416802|NCT01096836|resistance exercise|resistance exercise
1416803|NCT01096836|body mass index|body mass index
1416804|NCT01096836|hypertrophy|hypertrophy
1416805|NCT01096836|endothelial function|endothelial function
1416806|NCT01096836|blood lipids|blood lipids
1416807|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
1416808|NCT01096823|Yoga|yoga
1416809|NCT01096823|Adolescents|adolescents
1416810|NCT01096823|Young Adults|young adults
1416811|NCT01096810|Asymptomatic|asymptomatic
1416812|NCT01096784|insulin-like growth factor|insulin-like growth factor
1416813|NCT01096784|ROP|rop
1416814|NCT01096784|IGF-I|igf-i
1416815|NCT01096784|BPD|bpd
1416816|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1416817|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
1416820|NCT01096771|Pharmaconutrition|pharmaconutrition
1416821|NCT01096758|PKU|pku
1416822|NCT01096758|phenylketonuria|phenylketonuria
1416823|NCT01096758|adult|adult
1416824|NCT01096758|patient|patient
1416825|NCT01096758|development|development
1416826|NCT01096758|nutritional deficiencies|nutritional deficiencies
1416827|NCT01096758|neurological outcome|neurological outcome
1416828|NCT01096758|psychological and neurological development|psychological and neurological development
1416829|NCT01096758|comparison with healthy adults|comparison with healthy adults
1416830|NCT01096758|longitudinal development|longitudinal development
1416831|NCT01096758|quality of life|quality of life
1416832|NCT01096745|Gemcitabine|gemcitabine
1416833|NCT01096745|Cisplatin|cisplatin
1416834|NCT01096745|S-1|s-1
1416835|NCT01096745|bile duct cancer|bile duct cancer
1416836|NCT01096732|Pancreatic|pancreatic
1416837|NCT01096732|adenocarcinoma|adenocarcinoma
1416838|NCT01096732|cancer|cancer
1416839|NCT01096719|Weight|weight
1416840|NCT01096719|Dietary intake|dietary intake
1416841|NCT01096719|Energy Density|energy density
1416842|NCT01096719|Behavioral|behavioral
1416843|NCT01096719|Satiety|satiety
1416844|NCT01096719|Deprivation|deprivation
1416845|NCT01096719|Hunger|hunger
1416846|NCT01096719|Fruit|fruit
1416847|NCT01096719|Vegetable|vegetable
1416848|NCT01096706|Urocortin 2|urocortin 2
1416849|NCT01096706|Urocortin 3|urocortin 3
1416850|NCT01096706|Nitric Oxide|nitric oxide
1416851|NCT01096706|Plethysmography|plethysmography
1416852|NCT01096706|Forearm blood flow|forearm blood flow
1416853|NCT01096706|Vascular|vascular
1416854|NCT01096706|Heart failure|heart failure
1416855|NCT01096706|endothelium|endothelium
1416856|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
1416857|NCT01096706|EDHF|edhf
1416858|NCT01096693|Urocortin 2|urocortin 2
1416859|NCT01096693|Urocortin 3|urocortin 3
1416860|NCT01096693|Astressin 2B|astressin 2b
1416861|NCT01096693|forearm blood flow|forearm blood flow
1416862|NCT01096693|plethysmography|plethysmography
1416863|NCT01096693|vascular|vascular
1416864|NCT01096693|heart failure|heart failure
1416865|NCT01096667|type 2 diabetes|type 2 diabetes
1416866|NCT01096667|hypertension|hypertension
1416867|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1416868|NCT01096654|endocrine hypertension|endocrine hypertension
1416869|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
1416870|NCT01096654|aldosterone|aldosterone
1416871|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
1416872|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
1416873|NCT01096654|computed tomography|computed tomography
1416874|NCT01096654|adrenal vein sampling|adrenal vein sampling
1416875|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
1416876|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
1416877|NCT01096628|adolescent|adolescent
1416878|NCT01096628|low back pain|low back pain
1416879|NCT01096628|chiropractic|chiropractic
1416880|NCT01096628|exercise|exercise
1416881|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
1416882|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
1416883|NCT01096602|CT-011|ct-011
1416884|NCT01096589|lymphoedema|lymphoedema
1416885|NCT01096589|lymphedema|lymphedema
1416886|NCT01096563|Phase I|phase i
1416887|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
1416888|NCT01096563|AZD9164|azd9164
1416889|NCT01096550|opioid dependence|opioid dependence
1416890|NCT01096550|outpatient treatment|outpatient treatment
1416891|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
1416892|NCT01096537|incidence|incidence
1416893|NCT01096537|young workers|young workers
1416894|NCT01096537|occupations at risk|occupations at risk
1416895|NCT01096537|public health|public health
1416896|NCT01096537|epidemiology|epidemiology
1416897|NCT01096537|polymorphisms|polymorphisms
1416898|NCT01096537|gentic|gentic
1416899|NCT01096524|Kneehab|kneehab
1416900|NCT01096524|NMES|nmes
1416901|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
1416902|NCT01096524|Total Knee Replacement|total knee replacement
1416903|NCT01096524|TKA|tka
1416904|NCT01096524|Disuse atrophy|disuse atrophy
1416905|NCT01096524|muscle hypertrophy|muscle hypertrophy
1416906|NCT01096524|TKR|tkr
1416907|NCT01096524|Atrophy Prevention|atrophy prevention
1416908|NCT01096511|Moxifloxacin,|moxifloxacin,
1416909|NCT01096511|cIAI|ciai
1416910|NCT01096511|non-interventional|non-interventional
1416911|NCT01096472|Tinea pedis|tinea pedis
1416912|NCT01096459|spina|spina
1416913|NCT01096459|bifida|bifida
1416914|NCT01096459|restore|restore
1416915|NCT01096459|urinary|urinary
1416916|NCT01096459|function|function
1416917|NCT01096459|nerve|nerve
1416918|NCT01096459|reroute|reroute
1416919|NCT01096433|Sleep apnea|sleep apnea
1416920|NCT01096433|CPAP|cpap
1416921|NCT01096433|Prostaglandins|prostaglandins
1416922|NCT01096433|Circadian variations|circadian variations
1416923|NCT01096420|chronic migraine|chronic migraine
1416924|NCT01096420|acupuncture|acupuncture
1416925|NCT01096420|Topiramate|topiramate
1416926|NCT01096420|Randomized trial|randomized trial
1416927|NCT01096407|pain|pain
1416928|NCT01096407|arthralgia|arthralgia
1416929|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1416930|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1416931|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1416932|NCT01096381|cardiovascular complications|cardiovascular complications
1416933|NCT01096381|stage I breast cancer|stage i breast cancer
1416934|NCT01096381|stage II breast cancer|stage ii breast cancer
1416935|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
1416936|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
1416937|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
1416938|NCT01096381|stage IV breast cancer|stage iv breast cancer
1416939|NCT01096381|stage I colon cancer|stage i colon cancer
1416940|NCT01096381|stage II colon cancer|stage ii colon cancer
1416941|NCT01096381|stage III colon cancer|stage iii colon cancer
1416942|NCT01096381|stage IV colon cancer|stage iv colon cancer
1416943|NCT01096381|stage I rectal cancer|stage i rectal cancer
1416944|NCT01096381|stage II rectal cancer|stage ii rectal cancer
1416945|NCT01096381|stage III rectal cancer|stage iii rectal cancer
1416946|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
1416947|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1416948|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1417395|NCT01094899|osteopenia|osteopenia
1416949|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1416950|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1416951|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1416952|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1416953|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1416954|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1416955|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1416956|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1416957|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1416958|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1416959|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1416960|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1416961|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1416962|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1416963|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1416964|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1416965|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1416966|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1416967|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1416968|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1416969|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1416970|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1416971|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1416972|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1416973|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1416974|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1416975|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1416976|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1416977|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1416978|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1416979|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1416980|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1416981|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1416982|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1416983|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1416984|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1416985|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1416986|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1416987|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1416988|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1416989|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1416990|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1416991|NCT01096381|fallopian tube cancer|fallopian tube cancer
1416992|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
1416993|NCT01096329|postmenopausal|postmenopausal
1416994|NCT01096329|hormone replacement therapy|hormone replacement therapy
1416995|NCT01096316|mood disorders|mood disorders
1416996|NCT01096316|depressive disorder|depressive disorder
1416997|NCT01096316|women|women
1416998|NCT01096316|depression|depression
1416999|NCT01096303|COPD|copd
1417000|NCT01096303|pulmonary function|pulmonary function
1417001|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
1417002|NCT01096290|constipation|constipation
1417003|NCT01096290|lubiprostone|lubiprostone
1417004|NCT01096290|healthy volunteers|healthy volunteers
1417005|NCT01096264|Arterial stiffness|arterial stiffness
1417006|NCT01096264|Pulse wave velocity|pulse wave velocity
1417007|NCT01096264|Ultrafastecho|ultrafastecho
1417008|NCT01096264|Supersonic shear imaging|supersonic shear imaging
1417009|NCT01096251|Obesity|obesity
1417010|NCT01096251|Binge Eating Disorder|binge eating disorder
1417396|NCT01094899|neuropathy|neuropathy
1417011|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
1417012|NCT01096251|Brief Strategic Therapy|brief strategic therapy
1417013|NCT01096251|Telepsychology|telepsychology
1417014|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
1417015|NCT01096225|the antibody response|the antibody response
1417016|NCT01096225|T-cell response|t-cell response
1417017|NCT01096225|S-OIV|s-oiv
1417018|NCT01096225|vaccine|vaccine
1417019|NCT01096225|Immunogenicity assessment|immunogenicity assessment
1417020|NCT01096212|Efficacy|efficacy
1417021|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
1417022|NCT01096212|Safety|safety
1417023|NCT01096212|Sevoflurane|sevoflurane
1417024|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
1417025|NCT01096199|Objectives|objectives
1417026|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
1417027|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
1417028|NCT01096199|platinum refractory disease|platinum refractory disease
1417029|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
1417030|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
1417031|NCT01096186|motor Symptoms|motor symptoms
1417032|NCT01096186|efficacy|efficacy
1417033|NCT01096186|IPX066|ipx066
1417034|NCT01096186|Parkinson's Disease|parkinson's disease
1417035|NCT01096173|Sputum|sputum
1417036|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1417037|NCT01096160|Hypertension|hypertension
1417038|NCT01096147|FBSS|fbss
1417039|NCT01096147|chronic pain|chronic pain
1417040|NCT01096147|leg pain|leg pain
1417041|NCT01096147|low back pain|low back pain
1417042|NCT01096147|spinal cord stimulation|spinal cord stimulation
1417043|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
1417044|NCT01096121|Renal disease|renal disease
1417045|NCT01096121|Microalbuminemia|microalbuminemia
1417046|NCT01096108|Smoking cessation|smoking cessation
1417047|NCT01096108|Quit smoking|quit smoking
1417048|NCT01096108|Quit & Win|quit & win
1417049|NCT01096095|SCA|sca
1417050|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
1417051|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
1417052|NCT01096095|Machado-Joseph Disease|machado-joseph disease
1417053|NCT01096095|Treatment|treatment
1417054|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
1417055|NCT01096082|Treatment|treatment
1417056|NCT01096082|Lithium carbonate|lithium carbonate
1417057|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
1417058|NCT01096056|Children|children
1417059|NCT01096056|Influenza|influenza
1417060|NCT01096056|Safety|safety
1417061|NCT01096056|Immunogenicity|immunogenicity
1417062|NCT01096056|Vaccine|vaccine
1417063|NCT01096043|Heart Failure|heart failure
1417064|NCT01096043|ADHF|adhf
1417065|NCT01096030|Regorafenib|regorafenib
1417066|NCT01096030|Advanced|advanced
1417067|NCT01096030|Refractory solid tumors|refractory solid tumors
1417068|NCT01096017|Terbutaline|terbutaline
1417069|NCT01096017|Turbuhaler|turbuhaler
1417070|NCT01096017|Efficacy|efficacy
1417071|NCT01096017|Asthma|asthma
1417072|NCT01096017|Japanese|japanese
1417073|NCT01096017|salbutamol|salbutamol
1417074|NCT01096017|Bricanyl|bricanyl
1417075|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
1417076|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
1417077|NCT01095978|Klacid SR|klacid sr
1417078|NCT01095978|Clarithromycin|clarithromycin
1417079|NCT01095978|Respiratory tract infections|respiratory tract infections
1417080|NCT01095978|Bronchitis|bronchitis
1417081|NCT01095978|Pneumonia|pneumonia
1417082|NCT01095965|Nutrition education intervention|nutrition education intervention
1417083|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
1417084|NCT01095952|atrial fibrillation|atrial fibrillation
1417085|NCT01095952|inappropriate shock|inappropriate shock
1417086|NCT01095952|AV-node stimulation|av-node stimulation
1417087|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
1417088|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
1417089|NCT01095926|pharmacokinetic|pharmacokinetic
1417090|NCT01095926|doxorubicin|doxorubicin
1417091|NCT01095926|cancer|cancer
1417092|NCT01095926|troponin|troponin
1417093|NCT01095926|natriuretic peptide|natriuretic peptide
1417094|NCT01095926|cardiotoxicity|cardiotoxicity
1417095|NCT01095926|anthracyclines|anthracyclines
1417096|NCT01095926|Ewing|ewing
1417097|NCT01095926|ALL|all
1417098|NCT01095913|Near-Infrared Imaging|near-infrared imaging
1417099|NCT01095913|Fluorescent Dyes|fluorescent dyes
1417100|NCT01095913|Lymph Node Mapping|lymph node mapping
1417101|NCT01095913|Indocyanine green|indocyanine green
1417102|NCT01095913|IC-Green|ic-green
1417103|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
1417104|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
1417105|NCT01095913|ICG|icg
1417106|NCT01095913|lymph nodes|lymph nodes
1417107|NCT01095913|axillary nodal dissection|axillary nodal dissection
1417108|NCT01095900|Pain after treatment|pain after treatment
1417109|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
1417110|NCT01095900|continence scores after treatment|continence scores after treatment
1417111|NCT01095887|ABO incompatibility|abo incompatibility
1417112|NCT01095887|living donor kidney transplant|living donor kidney transplant
1417113|NCT01095887|kidney transplant|kidney transplant
1417114|NCT01095887|ABO blood type incompatible|abo blood type incompatible
1417115|NCT01095874|myelodysplasia|myelodysplasia
1417116|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1417117|NCT01095874|Survival|survival
1417118|NCT01095874|Transplantation|transplantation
1417119|NCT01095861|endotracheal tube|endotracheal tube
1417120|NCT01095848|vaccine|vaccine
1417121|NCT01095848|cancer|cancer
1417122|NCT01095848|ovarian|ovarian
1417123|NCT01095848|breast|breast
1417124|NCT01095848|prostate|prostate
1417125|NCT01095848|tumor|tumor
1417126|NCT01095848|Immunotherapy|immunotherapy
1417127|NCT01095822|Diabetes|diabetes
1417128|NCT01095822|Hypertension|hypertension
1417129|NCT01095822|Platelets|platelets
1417130|NCT01095822|Hemostasis|hemostasis
1417131|NCT01095822|Aliskiren|aliskiren
1417132|NCT01095822|Valsartan|valsartan
1417133|NCT01095796|Treatment Naive|treatment naive
1417134|NCT01095796|HIV 1 Infected|hiv 1 infected
1417135|NCT01095783|low back pain|low back pain
1417136|NCT01095783|physiotherapy|physiotherapy
1417137|NCT01095783|hemodialysis|hemodialysis
1417138|NCT01095783|end-stage renal disease|end-stage renal disease
1417139|NCT01095770|Atrial Fibrillation|atrial fibrillation
1417140|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
1417141|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
1417142|NCT01095770|Ablation Frontiers|ablation frontiers
1417143|NCT01095770|Reveal XT|reveal xt
1417144|NCT01095770|LASSO|lasso
1417145|NCT01095757|Myeloma|myeloma
1417146|NCT01095757|Lymphoma|lymphoma
1417147|NCT01095757|Stem cell transplantation|stem cell transplantation
1417148|NCT01095744|PIB imaging,|pib imaging,
1417149|NCT01095744|brain atrophy|brain atrophy
1417150|NCT01095744|cognitive impairment|cognitive impairment
1417151|NCT01095744|Pet imaging|pet imaging
1417152|NCT01095744|Alzheimer's disease|alzheimer's disease
1417153|NCT01095744|amyloid protein|amyloid protein
1417154|NCT01095731|aneurysm|aneurysm
1417155|NCT01095731|aneurysmal|aneurysmal
1417156|NCT01095731|subarachnoid|subarachnoid
1417157|NCT01095731|hemorrhage|hemorrhage
1417158|NCT01095731|haemorrhage|haemorrhage
1417159|NCT01095731|neuroprotection|neuroprotection
1417160|NCT01095731|3-aminopropanal|3-aminopropanal
1417161|NCT01095731|3AP|3ap
1417162|NCT01095731|polyamine oxidase|polyamine oxidase
1417163|NCT01095731|spermine|spermine
1417164|NCT01095731|spermidine|spermidine
1417165|NCT01095731|vasospasm|vasospasm
1417166|NCT01095731|cerebral ischemia|cerebral ischemia
1417167|NCT01095731|neurosurgery|neurosurgery
1417168|NCT01095731|neurological intensive care unit|neurological intensive care unit
1417169|NCT01095731|NICU|nicu
1417170|NCT01095731|Tiopronin|tiopronin
1417171|NCT01095731|Thiola|thiola
1417173|NCT01095731|Thiopronin|thiopronin
1417174|NCT01095731|Thiosol|thiosol
1417175|NCT01095731|Tioglis|tioglis
1417176|NCT01095731|Acadione|acadione
1417177|NCT01095731|Capen|capen
1417178|NCT01095731|Captimer|captimer
1417179|NCT01095731|Epatiol|epatiol
1417180|NCT01095731|Vincol|vincol
1417181|NCT01095731|Mucolysin|mucolysin
1417182|NCT01095731|Sutilan|sutilan
1417183|NCT01095731|Meprin|meprin
1417184|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
1417185|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
1417186|NCT01095731|2 MPG|2 mpg
1417187|NCT01095705|Hypnosis|hypnosis
1417188|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
1417189|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
1417190|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
1417191|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
1417192|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
1417193|NCT01095692|Postoperative incontinence,|postoperative incontinence,
1417196|NCT01095679|Periodic ventilation|periodic ventilation
1417197|NCT01095679|baclofen|baclofen
1417198|NCT01095679|hypoxia|hypoxia
1417199|NCT01095679|healthy subject|healthy subject
1417200|NCT01095640|acne|acne
1417201|NCT01095640|adapalene|adapalene
1417202|NCT01095640|Differin|differin
1417203|NCT01095614|Women|women
1417204|NCT01095614|Hormonal status|hormonal status
1417205|NCT01095614|Exercise|exercise
1417206|NCT01095614|Substrate utilization|substrate utilization
1417207|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
1417208|NCT01095601|avanafil|avanafil
1417209|NCT01095601|absoprion|absoprion
1417210|NCT01095601|bioavailability|bioavailability
1417211|NCT01095601|food effect|food effect
1417212|NCT01095601|dose-proportionality|dose-proportionality
1417213|NCT01095601|TA-1790|ta-1790
1417214|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
1417215|NCT01095588|ED|ed
1417216|NCT01095575|Epidural|epidural
1417217|NCT01095575|Morphine|morphine
1417218|NCT01095575|Preoperative|preoperative
1417219|NCT01095575|Postoperative|postoperative
1417220|NCT01095575|Analgesia|analgesia
1417221|NCT01095575|Tolerance|tolerance
1417222|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
1417223|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
1417224|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
1417225|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
1417226|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
1417227|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
1417228|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
1417229|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
1417230|NCT01095536|anesthesia, general|anesthesia, general
1417231|NCT01095536|shoulder pain|shoulder pain
1417232|NCT01095536|nausea|nausea
1417233|NCT01095536|vomiting|vomiting
1417234|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1417235|NCT01095536|general anesthesia|general anesthesia
1417236|NCT01095523|Colon Cancer|colon cancer
1417237|NCT01095523|Rectal Cancer|rectal cancer
1417238|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
1417239|NCT01095523|Metastatic Cancer|metastatic cancer
1417240|NCT01095523|Recurrence|recurrence
1417241|NCT01095523|Colorectal Cancer|colorectal cancer
1417242|NCT01095510|HAE|hae
1417243|NCT01095510|CINRYZE|cinryze
1417244|NCT01095510|C1 INH|c1 inh
1417245|NCT01095510|C1 inhibitor|c1 inhibitor
1417246|NCT01095510|Pediatric|pediatric
1417247|NCT01095510|PK/PD|pk/pd
1417248|NCT01095497|HAE|hae
1417249|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
1417250|NCT01095497|Subcutaneous|subcutaneous
1417251|NCT01095484|Rotigotine|rotigotine
1417252|NCT01095484|Neupro®|neupro®
1417253|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
1417254|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
1417255|NCT01095471|PCV13|pcv13
1417256|NCT01095471|PCV7|pcv7
1417257|NCT01095458|Obesity|obesity
1417258|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
1417259|NCT01095445|hepatitis C|hepatitis c
1417260|NCT01095445|genotype 3|genotype 3
1417261|NCT01095445|end of treatment response|end of treatment response
1417262|NCT01095445|relapse rate|relapse rate
1417263|NCT01095445|rapid virologic response|rapid virologic response
1417264|NCT01095445|complete early virologic response|complete early virologic response
1417265|NCT01095432|Colonoscopy|colonoscopy
1417266|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
1417267|NCT01095419|massage therapy|massage therapy
1417268|NCT01095419|sleep quality|sleep quality
1417269|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
1417270|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
1417271|NCT01095406|Weaning|weaning
1417272|NCT01095406|closed loop|closed loop
1417273|NCT01095406|mechanical ventilation|mechanical ventilation
1417274|NCT01095406|children|children
1417275|NCT01095393|Certolizumab Pegol|certolizumab pegol
1417276|NCT01095393|CZP|czp
1417277|NCT01095393|Cimzia®|cimzia®
1417278|NCT01095393|NDB|ndb
1417279|NCT01095393|registry|registry
1417280|NCT01095380|task-specific training|task-specific training
1417281|NCT01095380|walking|walking
1417282|NCT01095380|locomotion|locomotion
1417283|NCT01095380|function|function
1417284|NCT01095380|body weight support|body weight support
1417285|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
1417286|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
1417287|NCT01095367|ovarian cancer|ovarian cancer
1417288|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
1417291|NCT01095341|hyperthyroidism|hyperthyroidism
1417292|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
1417293|NCT01095341|palpation thyroiditis|palpation thyroiditis
1417294|NCT01095341|parathyroidectomy|parathyroidectomy
1417295|NCT01095341|thyroglobulin|thyroglobulin
1417296|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
1417297|NCT01095328|Q fever|q fever
1417298|NCT01095328|Pregnancy|pregnancy
1417299|NCT01095328|Screening|screening
1417300|NCT01095328|Cost-effectiveness|cost-effectiveness
1417301|NCT01095289|electromyography|electromyography
1417302|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
1417303|NCT01095289|masticatory muscles|masticatory muscles
1417304|NCT01095276|Mechanical Ventilation|mechanical ventilation
1417305|NCT01095276|Extubation|extubation
1417306|NCT01095276|dornase alpha|dornase alpha
1417307|NCT01095276|oxygenation|oxygenation
1417308|NCT01095276|chest x ray|chest x ray
1417309|NCT01095250|Active uveitis|active uveitis
1417310|NCT01095250|intermediate uveitis|intermediate uveitis
1417311|NCT01095250|panuveitis|panuveitis
1417312|NCT01095250|posterior uveitis|posterior uveitis
1417313|NCT01095250|uveitis|uveitis
1417314|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
1417315|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
1417317|NCT01095237|vascular prosthesis|vascular prosthesis
1417318|NCT01095237|revascularization|revascularization
1417319|NCT01095237|patency|patency
1417320|NCT01095237|blood vessel|blood vessel
1417321|NCT01095237|Rutherford|rutherford
1417322|NCT01095237|ABI|abi
1417323|NCT01095237|Ankle Brachial Index|ankle brachial index
1417324|NCT01095237|Vascular Graft|vascular graft
1417325|NCT01095237|Carbothane|carbothane
1417326|NCT01095237|ProEndoTecc|proendotecc
1417327|NCT01095237|implantation|implantation
1417328|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
1417329|NCT01095211|folic acid|folic acid
1417330|NCT01095211|homocysteine|homocysteine
1417331|NCT01095211|MMSE scores|mmse scores
1417332|NCT01095211|methyl malonic acid|methyl malonic acid
1417333|NCT01095211|betaine|betaine
1417334|NCT01095198|vaginal self collection|vaginal self collection
1417335|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
1417336|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1417337|NCT01095172|Immunosuppression|immunosuppression
1417338|NCT01095172|Rituximab|rituximab
1417339|NCT01095172|B cell|b cell
1417340|NCT01095159|TVTO|tvto
1417341|NCT01095159|TVTSecur|tvtsecur
1417342|NCT01095159|Mini sling|mini sling
1417343|NCT01095159|stress urinary incontinence|stress urinary incontinence
1417344|NCT01095146|MAS|mas
1417345|NCT01095146|Hemophagocytosis|hemophagocytosis
1417346|NCT01095146|Reactive HLH|reactive hlh
1417347|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
1417348|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
1417349|NCT01095146|SoJIA|sojia
1417350|NCT01095146|JIA|jia
1417351|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
1417352|NCT01095133|Heartburn|heartburn
1417353|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
1417354|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
1417355|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
1417356|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
1417357|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
1417358|NCT01095094|adult brain tumor|adult brain tumor
1417359|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1417360|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
1417361|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1417362|NCT01095094|adult brain stem glioma|adult brain stem glioma
1417363|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
1417364|NCT01095094|adult glioblastoma|adult glioblastoma
1417365|NCT01095094|adult gliosarcoma|adult gliosarcoma
1417366|NCT01095094|adult mixed glioma|adult mixed glioma
1417367|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
1417368|NCT01095042|HRV|hrv
1417369|NCT01095042|emotion|emotion
1417370|NCT01095042|cognition|cognition
1417371|NCT01095042|stress|stress
1417372|NCT01095042|cortisol|cortisol
1417373|NCT01095042|Autonomic nervous system|autonomic nervous system
1417374|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
1417375|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
1417376|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
1417377|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
1417378|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
1417379|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
1417380|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
1417381|NCT01094977|Craniosynostoses|craniosynostoses
1417382|NCT01094977|Tranexamic Acid|tranexamic acid
1417383|NCT01094977|Children|children
1417384|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
1417385|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
1417386|NCT01094964|stage I bladder cancer|stage i bladder cancer
1417387|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1417388|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1417389|NCT01094951|Depression|depression
1417390|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
1417391|NCT01094925|Cesarean section|cesarean section
1417392|NCT01094925|Gabapentin|gabapentin
1417393|NCT01094912|Cancer pain|cancer pain
1417397|NCT01094899|foot|foot
1417398|NCT01094899|AGE|age
1417399|NCT01094886|Total Hip Replacement|total hip replacement
1417400|NCT01094886|Total Knee Replacement|total knee replacement
1417401|NCT01094886|Hip Implant|hip implant
1417402|NCT01094886|Knee Implant|knee implant
1417403|NCT01094886|Joint Prosthesis|joint prosthesis
1417404|NCT01094886|Orthopedic Surgery|orthopedic surgery
1417405|NCT01094886|Rivaroxaban|rivaroxaban
1417406|NCT01094886|Xarelto|xarelto
1417407|NCT01094886|Blood Clot|blood clot
1417408|NCT01094873|Hepatitis C|hepatitis c
1417409|NCT01094873|HCV|hcv
1417410|NCT01094873|Adenovirus|adenovirus
1417411|NCT01094873|Vaccine|vaccine
1417531|NCT01094392|Echocardiography|echocardiography
1417412|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
1417413|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1417415|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
1417416|NCT01094860|SLL|sll
1417417|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
1417418|NCT01094860|Follicular lymphoma|follicular lymphoma
1417419|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
1417420|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
1417421|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
1417422|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
1417423|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
1417424|NCT01094860|mycosis fungoides|mycosis fungoides
1417425|NCT01094860|Sezary syndrome|sezary syndrome
1417426|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1417427|NCT01094860|Chemotherapy|chemotherapy
1417428|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
1417429|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
1417430|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
1417431|NCT01094860|Arranon|arranon
1417432|NCT01094821|Healthy volunteers|healthy volunteers
1417433|NCT01094821|ATI-7505|ati-7505
1417434|NCT01094821|Scintigraphy|scintigraphy
1417435|NCT01094821|Gastrointestinal transit|gastrointestinal transit
1417436|NCT01094808|pregabalin|pregabalin
1417437|NCT01094808|motor|motor
1417438|NCT01094808|sensation|sensation
1417439|NCT01094808|colon|colon
1417440|NCT01094808|pain|pain
1417441|NCT01094808|gas|gas
1417442|NCT01094782|Pain|pain
1417443|NCT01094782|Pain management|pain management
1417444|NCT01094756|Obesity|obesity
1417445|NCT01094717|psoriasis|psoriasis
1417446|NCT01094717|excimer|excimer
1417447|NCT01094717|acitretin|acitretin
1417448|NCT01094717|tazarotene|tazarotene
1417449|NCT01094704|cystic fibrosis|cystic fibrosis
1417450|NCT01094704|mucociliary clearance|mucociliary clearance
1417451|NCT01094704|hypertonic saline|hypertonic saline
1417452|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
1417453|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
1417454|NCT01094678|Drug-Eluting Stent|drug-eluting stent
1417455|NCT01094678|Drug-Coated Stent|drug-coated stent
1417456|NCT01094678|Vascular Diseases|vascular diseases
1417457|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
1417458|NCT01094652|Adolescent|adolescent
1417459|NCT01094652|Whole grain|whole grain
1417460|NCT01094652|Digestive health|digestive health
1417461|NCT01094652|Dietary fiber|dietary fiber
1417462|NCT01094652|Grain|grain
1417463|NCT01094652|Microbiota|microbiota
1417464|NCT01094652|Inflammation|inflammation
1417465|NCT01094652|Mucosal Immunity|mucosal immunity
1417466|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1417467|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
1417468|NCT01094626|Imaging techniques|imaging techniques
1417469|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
1417470|NCT01094626|Synthetic human secretin|synthetic human secretin
1417471|NCT01094613|Crohn's Disease|crohn's disease
1417472|NCT01094613|Delayed Release|delayed release
1417473|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
1417474|NCT01094600|Pancreatic cancer|pancreatic cancer
1417475|NCT01094600|Pancreatic resection|pancreatic resection
1417476|NCT01094600|Synthetic human secretin|synthetic human secretin
1417477|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
1417573|NCT01094223|Mindfulness|mindfulness
1417478|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
1417479|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
1417480|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
1417481|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1417482|NCT01094561|Imaging techniques|imaging techniques
1417483|NCT01094561|Synthetic human secretin|synthetic human secretin
1417484|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
1417485|NCT01094561|Early detection and prevention|early detection and prevention
1417486|NCT01094548|L-BLP25 liposome|l-blp25 liposome
1417487|NCT01094548|Multiple myeloma|multiple myeloma
1417488|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1417489|NCT01094535|Synthetic human secretin|synthetic human secretin
1417490|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
1417491|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
1417492|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
1417493|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
1417494|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
1417495|NCT01094496|bladder cancer|bladder cancer
1417496|NCT01094496|immunotherapy|immunotherapy
1417497|NCT01094496|cystectomy|cystectomy
1417498|NCT01094496|cancer vaccine|cancer vaccine
1417499|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
1417500|NCT01094496|hCG|hcg
1417501|NCT01094496|urogenital neoplasms|urogenital neoplasms
1417502|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
1417503|NCT01094496|muscle invasive|muscle invasive
1417504|NCT01094496|non-metastatic|non-metastatic
1417505|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
1417506|NCT01094483|Thromboxane B2|thromboxane b2
1417507|NCT01094470|gait|gait
1417508|NCT01094470|ambulation|ambulation
1417509|NCT01094470|kinematics|kinematics
1417510|NCT01094457|antiplatelet therapy|antiplatelet therapy
1417511|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
1417512|NCT01094457|acute coronary syndromes|acute coronary syndromes
1417513|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
1417514|NCT01094457|cilostazol|cilostazol
1417515|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
1417516|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
1417517|NCT01094431|Fever|fever
1417518|NCT01094431|Etiology|etiology
1417519|NCT01094431|Children under five years of age|children under five years of age
1417520|NCT01094431|IMCI|imci
1417521|NCT01094418|polyneuropathy|polyneuropathy
1417522|NCT01094418|Nerve conduction study|nerve conduction study
1417523|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
1417524|NCT01094418|Diabetes mellitus|diabetes mellitus
1417525|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
1417526|NCT01094392|ALL|all
1417527|NCT01094392|PEG-asparaginase|peg-asparaginase
1417528|NCT01094392|prolonged treatment|prolonged treatment
1417529|NCT01094392|Thrombosis|thrombosis
1417530|NCT01094392|Central venous line|central venous line
1417532|NCT01094379|cholecystectomy|cholecystectomy
1417533|NCT01094379|laparoscopic|laparoscopic
1417534|NCT01094379|pain|pain
1417535|NCT01094379|single incision|single incision
1417536|NCT01094366|Paracervical Block|paracervical block
1417537|NCT01094366|pain control|pain control
1417538|NCT01094366|abortion|abortion
1417539|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
1417540|NCT01094353|Minisling|minisling
1417541|NCT01094353|Ophira™|ophira™
1417542|NCT01094353|Unitape™|unitape™
1417543|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1417544|NCT01094301|electrical stimulation|electrical stimulation
1417545|NCT01094301|neurostimulation|neurostimulation
1417546|NCT01094301|neuromodulation|neuromodulation
1417547|NCT01094301|shoulder pain|shoulder pain
1417548|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
1417549|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
1417550|NCT01094275|drug resistance|drug resistance
1417551|NCT01094275|gene polymorphism|gene polymorphism
1417552|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
1417553|NCT01094262|Osteoarthritis|osteoarthritis
1417554|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
1417555|NCT01094262|Pain|pain
1417556|NCT01094262|Arthralgia|arthralgia
1417557|NCT01094262|Joint Pain|joint pain
1417558|NCT01094262|JNJ-42160443|jnj-42160443
1417559|NCT01094249|Paliperidone ER|paliperidone er
1417560|NCT01094249|INVEGA|invega
1417561|NCT01094249|Divalproex sodium|divalproex sodium
1417562|NCT01094249|Depakote ER|depakote er
1417563|NCT01094249|Valproic acid|valproic acid
1417564|NCT01094249|Pharmacokinetics|pharmacokinetics
1417565|NCT01094249|R076477BIM1004|r076477bim1004
1417566|NCT01094236|behavior management|behavior management
1417567|NCT01094236|academic performance|academic performance
1417568|NCT01094236|playground supervision|playground supervision
1417569|NCT01094236|harm reduction|harm reduction
1417570|NCT01094236|Behavioral Research|behavioral research
1417571|NCT01094223|Stimulant|stimulant
1417572|NCT01094223|Addiction|addiction
1417574|NCT01094223|Treatment|treatment
1417575|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
1417576|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
1417577|NCT01094197|Injuries|injuries
1417578|NCT01094197|Leukocytes|leukocytes
1417579|NCT01094171|poliomyelitis|poliomyelitis
1417580|NCT01094171|diphtheria|diphtheria
1417581|NCT01094171|Primary immunization|primary immunization
1417582|NCT01094171|pertussis|pertussis
1417583|NCT01094171|Children|children
1417585|NCT01094158|NAFLD|nafld
1417586|NCT01094158|NASH|nash
1417587|NCT01094158|Fatty Liver|fatty liver
1417588|NCT01094158|Metabolic Syndrome|metabolic syndrome
1417589|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
1417590|NCT01094158|Insulin Resistance|insulin resistance
1417591|NCT01094158|Liver Fat|liver fat
1417592|NCT01094145|(light to moderate)|(light to moderate)
1417593|NCT01094132|cervical cancer|cervical cancer
1417594|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1417595|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1417596|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1417597|NCT01094132|Nonmalignant Condition|nonmalignant condition
1417598|NCT01094119|heated blanket|heated blanket
1417599|NCT01094119|heated pad|heated pad
1417600|NCT01094106|postoperative pain|postoperative pain
1417601|NCT01094106|infiltration analgesia|infiltration analgesia
1417602|NCT01094106|ropivacaine|ropivacaine
1417603|NCT01094106|Caesarean Section|caesarean section
1417604|NCT01094093|Amgen|amgen
1417605|NCT01094093|AMG 139|amg 139
1417606|NCT01094080|fully formula fed|fully formula fed
1417607|NCT01094080|fully breast fed|fully breast fed
1417608|NCT01094041|Gluten|gluten
1417609|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
1417610|NCT01094041|Colonic permeability|colonic permeability
1417611|NCT01094041|Small bowel permeability|small bowel permeability
1417612|NCT01094041|Colonic inflammatory response|colonic inflammatory response
1417613|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
1417614|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
1417615|NCT01094015|hysteroscopy|hysteroscopy
1417616|NCT01094015|local anaesthetic|local anaesthetic
1417617|NCT01094015|pain relief|pain relief
1417618|NCT01094015|gynecological pathology|gynecological pathology
1417619|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
1417620|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
1417621|NCT01094002|AGED|aged
1417622|NCT01094002|PATIENT CARE|patient care
1417623|NCT01093976|Skin Picking|skin picking
1417624|NCT01093976|OCD|ocd
1417625|NCT01093976|Trichotillomania|trichotillomania
1417626|NCT01093976|Pathological Skin Picking|pathological skin picking
1417627|NCT01093950|anthropometric|anthropometric
1417628|NCT01093950|white light scanner|white light scanner
1417629|NCT01093950|extraction profiles|extraction profiles
1417630|NCT01093950|Body lipodystrophy|body lipodystrophy
1417631|NCT01093937|Bipolar disorder|bipolar disorder
1417632|NCT01093937|Bipolar-I|bipolar-i
1417633|NCT01093937|Varenicline|varenicline
1417634|NCT01093937|Champix|champix
1417635|NCT01093937|Chantix|chantix
1417636|NCT01093937|Nicotine|nicotine
1417637|NCT01093937|Nicotinic receptor|nicotinic receptor
1417638|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
1417639|NCT01093937|Dopamine|dopamine
1417640|NCT01093937|Acetylcholine|acetylcholine
1417641|NCT01093937|Cigarette|cigarette
1417642|NCT01093937|Smoking|smoking
1417643|NCT01093937|Tobacco|tobacco
1417644|NCT01093937|Dependence|dependence
1417645|NCT01093937|Neuropsychological function|neuropsychological function
1417646|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
1417647|NCT01093924|Weight loss|weight loss
1417648|NCT01093924|Weight loss maintenance|weight loss maintenance
1417649|NCT01093911|Lupus|lupus
1417650|NCT01093911|SLE|sle
1417651|NCT01093859|acetylcholinesterase|acetylcholinesterase
1417652|NCT01093846|uveitis|uveitis
1417653|NCT01093833|Diabetes|diabetes
1417654|NCT01093833|Type 1 diabetes|type 1 diabetes
1417655|NCT01093833|Type 2 diabetes|type 2 diabetes
1417656|NCT01093833|Diabetes mellitus|diabetes mellitus
1417657|NCT01093833|Blood glucose|blood glucose
1417658|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
1417659|NCT01093833|CGM|cgm
1417660|NCT01093820|acute myocardial infarction|acute myocardial infarction
1417661|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
1417662|NCT01093820|Mircera|mircera
1417663|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
1417664|NCT01093807|Hypertension|hypertension
1417665|NCT01093807|Lercanidipine|lercanidipine
1417666|NCT01093807|Calcium antagonist|calcium antagonist
1417667|NCT01093807|Enalapril|enalapril
1417668|NCT01093794|Type 2 Diabetes|type 2 diabetes
1417669|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
1417670|NCT01093768|Oxytocin|oxytocin
1417671|NCT01093768|Vasopressin|vasopressin
1417672|NCT01093768|Autism|autism
1417673|NCT01093768|Amygdala|amygdala
1417674|NCT01093768|Social Cognition|social cognition
1417675|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
1417676|NCT01093768|ASD|asd
1417677|NCT01093768|Healthy Volunteer|healthy volunteer
1417678|NCT01093768|HV|hv
1417679|NCT01093755|Barrett's Esophagus|barrett's esophagus
1417680|NCT01093755|Radiofrequency ablation|radiofrequency ablation
1417681|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
1417682|NCT01093742|Healthy|healthy
1417683|NCT01093729|Exendin-4|exendin-4
1417684|NCT01093716|Alcohol dependence|alcohol dependence
1417685|NCT01093716|Craving|craving
1417686|NCT01093716|rTMS|rtms
1417687|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1417688|NCT01093703|kidney transplantation|kidney transplantation
1417689|NCT01093703|hypertension|hypertension
1417690|NCT01093703|chronotherapy|chronotherapy
1417691|NCT01093703|graft function|graft function
1417692|NCT01093703|circadian pattern|circadian pattern
1417693|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
1417694|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
1417695|NCT01093599|Smoking|smoking
1417696|NCT01093599|Smoking cessation|smoking cessation
1417697|NCT01093599|Nicotine|nicotine
1417698|NCT01093599|Tobacco|tobacco
1417699|NCT01093599|Mindfulness|mindfulness
1417700|NCT01093599|Meditation|meditation
1417701|NCT01093599|MBSR|mbsr
1417702|NCT01093599|Mindfulness Training|mindfulness training
1417703|NCT01093599|Behavioral Intervention|behavioral intervention
1417704|NCT01093599|Nicotine Patch|nicotine patch
1417705|NCT01093599|Quit Line|quit line
1417706|NCT01093599|Phone counseling|phone counseling
1417707|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
1417708|NCT01093560|metabolic syndrome|metabolic syndrome
1417709|NCT01093560|premenopausal women|premenopausal women
1417710|NCT01093560|fat feeding|fat feeding
1417711|NCT01093534|Vesicare|vesicare
1417712|NCT01093534|Solifenacin|solifenacin
1417713|NCT01093534|Detrusor Overactivity|detrusor overactivity
1417714|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
1417715|NCT01093534|Overactive Bladder|overactive bladder
1417716|NCT01093534|Bladder wall thickness|bladder wall thickness
1417717|NCT01093521|IV Gallium|iv gallium
1417718|NCT01093521|Gallium|gallium
1417719|NCT01093521|Ganite|ganite
1417720|NCT01093521|Cystic Fibrosis|cystic fibrosis
1417721|NCT01093521|Gallium Infusion|gallium infusion
1417722|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
1417723|NCT01093495|Nasal Cannula|nasal cannula
1417724|NCT01093495|CPAP|cpap
1417725|NCT01093495|Premature|premature
1417726|NCT01093495|RDS|rds
1417727|NCT01093495|HMD|hmd
1417728|NCT01093495|NICU|nicu
1417729|NCT01093482|mechanical ventilation|mechanical ventilation
1417730|NCT01093482|epidemiology|epidemiology
1417731|NCT01093482|outcomes|outcomes
1417732|NCT01093482|mortality|mortality
1417733|NCT01093482|weaning|weaning
1417734|NCT01093482|sedation|sedation
1417735|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
1417736|NCT01093469|Atopic Dermatitis|atopic dermatitis
1417737|NCT01093469|Wake Forest|wake forest
1417738|NCT01093469|Dermatology|dermatology
1417739|NCT01093469|Skin|skin
1417740|NCT01093469|Over-the-counter|over-the-counter
1417741|NCT01093469|Moisturizer|moisturizer
1417742|NCT01093469|Children|children
1417743|NCT01093456|diurnal variation|diurnal variation
1417744|NCT01093456|peritoneal dialysis|peritoneal dialysis
1417745|NCT01093456|uremic retention solutes|uremic retention solutes
1417746|NCT01093456|phosphorous|phosphorous
1417747|NCT01093456|indoxyl sulfate|indoxyl sulfate
1417748|NCT01093456|p-cresol sulfate|p-cresol sulfate
1417749|NCT01093443|IVF|ivf
1417750|NCT01093443|ICSI|icsi
1417751|NCT01093443|GnRH antagonist|gnrh antagonist
1417752|NCT01093443|pretreatment|pretreatment
1417753|NCT01093430|Gynecological surgery|gynecological surgery
1417754|NCT01093430|laparoscopic ports|laparoscopic ports
1417755|NCT01093430|neuropathy|neuropathy
1417756|NCT01093417|Vitamin D|vitamin d
1417757|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1417758|NCT01093417|Complementary Therapies|complementary therapies
1417759|NCT01093404|Heart disease|heart disease
1417760|NCT01093404|Myocardial infarction|myocardial infarction
1417761|NCT01093404|Angioplasty|angioplasty
1417762|NCT01093404|Thrombus aspiration|thrombus aspiration
1417763|NCT01093391|coronary artery|coronary artery
1417764|NCT01093391|thrombosis|thrombosis
1417765|NCT01093391|stent|stent
1417766|NCT01093378|Infertility|infertility
1417767|NCT01093378|Obesity|obesity
1417768|NCT01093378|Dietary intake|dietary intake
1417769|NCT01093378|Fertility|fertility
1417770|NCT01093378|nutrition|nutrition
1417771|NCT01093378|diet|diet
1417772|NCT01093378|weight|weight
1417773|NCT01093365|Schizophrenia|schizophrenia
1418056|NCT01092208|HV|hv
1417774|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
1417775|NCT01093365|Varenicline|varenicline
1417776|NCT01093365|Champix|champix
1417777|NCT01093365|Chantix|chantix
1417778|NCT01093365|Nicotine|nicotine
1417779|NCT01093365|Nicotinic receptor|nicotinic receptor
1417780|NCT01093365|Dopamine|dopamine
1417781|NCT01093365|Acetylcholine|acetylcholine
1417782|NCT01093365|Cigarette|cigarette
1417783|NCT01093365|Smoking|smoking
1417784|NCT01093365|Tobacco|tobacco
1417785|NCT01093365|Executive function|executive function
1417786|NCT01093365|Working memory|working memory
1417787|NCT01093365|Verbal memory|verbal memory
1417788|NCT01093365|Cognitive function|cognitive function
1417789|NCT01093365|Neuropsychological function|neuropsychological function
1417790|NCT01093352|Alveolar-decortication|alveolar-decortication
1417791|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
1417792|NCT01093352|Palatally impacted canine|palatally impacted canine
1417793|NCT01093352|Surgical exposure of canines|surgical exposure of canines
1417794|NCT01093352|Velocity of tooth movement|velocity of tooth movement
1417795|NCT01093339|GERD|gerd
1417796|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
1417797|NCT01093339|APPETITE REGULATION|appetite regulation
1417798|NCT01093339|GHRELIN|ghrelin
1417799|NCT01093339|LEPTIN|leptin
1417800|NCT01093274|colonoscopy|colonoscopy
1417801|NCT01093274|Cathartics|cathartics
1417802|NCT01093274|Sodium picosulfate|sodium picosulfate
1417803|NCT01093274|Polyethylene Glycol|polyethylene glycol
1417804|NCT01093261|trauma|trauma
1417805|NCT01093261|trauma brain injury|trauma brain injury
1417806|NCT01093261|multiple trauma|multiple trauma
1417807|NCT01093261|head trauma|head trauma
1417808|NCT01093261|hydrocortisone|hydrocortisone
1417809|NCT01093261|fludrocortisone|fludrocortisone
1568392|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
1417810|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
1417811|NCT01093261|adrenal Insufficiency|adrenal insufficiency
1417812|NCT01093261|pneumonia|pneumonia
1417813|NCT01093261|intensive care unit|intensive care unit
1417814|NCT01093261|shock|shock
1417815|NCT01093261|neurological recovery|neurological recovery
1417816|NCT01093235|cardiac toxicity|cardiac toxicity
1417817|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
1417818|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
1417819|NCT01093235|male breast cancer|male breast cancer
1417820|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1417821|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1417822|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1417823|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1417824|NCT01093235|stage II breast cancer|stage ii breast cancer
1417825|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
1417826|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
1417827|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
1417828|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
1417829|NCT01093209|Interferential laser therapy|interferential laser therapy
1417830|NCT01093209|Low-level laser therapy|low-level laser therapy
1417831|NCT01093209|Neuropathic pain|neuropathic pain
1417832|NCT01093209|Median nerve compression|median nerve compression
1417833|NCT01093196|Multiple Myeloma|multiple myeloma
1417834|NCT01093196|Elderly Patients|elderly patients
1417835|NCT01093196|Diagnosis|diagnosis
1417836|NCT01093196|Lenalidomide|lenalidomide
1417837|NCT01093196|Prednisone|prednisone
1417838|NCT01093196|Melphalan|melphalan
1417839|NCT01093196|Dexamethasone|dexamethasone
1417840|NCT01093196|Cyclophosphamide|cyclophosphamide
1417841|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
1417842|NCT01093144|Delivery mode|delivery mode
1417843|NCT01093144|pelvic measurement|pelvic measurement
1417844|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
1417845|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1417846|NCT01093131|chronic kidney disease|chronic kidney disease
1417847|NCT01093131|Prevention|prevention
1417848|NCT01093131|Equivalence|equivalence
1417849|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
1417850|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
1417851|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
1417852|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
1417853|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
1417854|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
1417855|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
1417856|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
1417857|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
1417858|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
1417859|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
1417860|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
1417861|NCT01093105|Psychosine|psychosine
1417862|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
1417863|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
1417864|NCT01093105|Krabbe Disease|krabbe disease
1417865|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
1417866|NCT01093105|Krabbe's Disease|krabbe's disease
1417867|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
1417868|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
1417869|NCT01093066|urothelial carcinoma|urothelial carcinoma
1417870|NCT01093066|TURB|turb
1417871|NCT01093066|chemotherapy|chemotherapy
1417872|NCT01093053|Mind-Body Therapies|mind-body therapies
1417873|NCT01093027|Essential Tremor|essential tremor
1417874|NCT01093027|Cooling|cooling
1417875|NCT01093027|Temperature|temperature
1417876|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
1417877|NCT01093014|Quadriceps Muscle|quadriceps muscle
1417878|NCT01093014|RNA, Messenger|rna, messenger
1417879|NCT01093014|Hypertrophy|hypertrophy
1417880|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
1417881|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
1417882|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
1417883|NCT01093001|Lead position|lead position
1417884|NCT01093001|Lead size|lead size
1417885|NCT01092988|Uterine Fibroids|uterine fibroids
1417886|NCT01092988|Bleeding|bleeding
1417887|NCT01092988|Pain|pain
1417888|NCT01092988|Quality of life|quality of life
1417889|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
1417890|NCT01092975|radiotherapy|radiotherapy
1417891|NCT01092962|Children|children
1417892|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
1417893|NCT01092962|Cyclophosphamide|cyclophosphamide
1417894|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
1417895|NCT01092949|Placenta|placenta
1417896|NCT01092949|perfusion|perfusion
1417898|NCT01092949|spin tagging|spin tagging
1417899|NCT01092949|Gadolinium|gadolinium
1417900|NCT01092949|placental insufficiency|placental insufficiency
1417901|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
1417902|NCT01092936|Comparative fit index|comparative fit index
1417903|NCT01092936|Movement Disorders' Society|movement disorders' society
1417904|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
1417905|NCT01092923|Nitrous Oxide|nitrous oxide
1417906|NCT01092923|washin|washin
1417907|NCT01092923|washout|washout
1417908|NCT01092923|second gas effect|second gas effect
1417909|NCT01092923|sevoflurane|sevoflurane
1417910|NCT01092923|induction|induction
1417911|NCT01092923|emergence|emergence
1417912|NCT01092910|Sensorineural|sensorineural
1417913|NCT01092910|Hearing Loss|hearing loss
1417914|NCT01092884|melasma|melasma
1417915|NCT01092884|sunscreen|sunscreen
1417916|NCT01092884|polypodium leucotomos|polypodium leucotomos
1417917|NCT01092858|Testosterone undecanoate|testosterone undecanoate
1417918|NCT01092858|Hypogonadism|hypogonadism
1417919|NCT01092845|Double-Blind|double-blind
1417920|NCT01092845|Randomized|randomized
1417921|NCT01092845|Placebo-Controlled|placebo-controlled
1417922|NCT01092845|2-Way Crossover|2-way crossover
1417923|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
1417924|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
1417925|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
1417926|NCT01092806|tacrolimus|tacrolimus
1417927|NCT01092806|pharmacokinetics|pharmacokinetics
1417928|NCT01092806|formulations|formulations
1417929|NCT01092806|once daily|once daily
1417930|NCT01092806|twice daily|twice daily
1417931|NCT01092806|renal transplant recipients|renal transplant recipients
1417932|NCT01092806|Kidney transplantation|kidney transplantation
1417933|NCT01092793|Fish oil|fish oil
1417934|NCT01092793|Krill|krill
1417935|NCT01092793|CAD|cad
1417936|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
1417937|NCT01092767|Thoracic Transection|thoracic transection
1417938|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
1417939|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
1417940|NCT01092741|Leukemia|leukemia
1417941|NCT01092741|Gleevec|gleevec
1417942|NCT01092741|STI571|sti571
1417943|NCT01092741|CML|cml
1417944|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1417945|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
1417946|NCT01092728|Mucosal melanoma|mucosal melanoma
1417947|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
1417948|NCT01092728|Surgically removed tumor|surgically removed tumor
1417949|NCT01092728|biopsied|biopsied
1417950|NCT01092728|Sprycel|sprycel
1417951|NCT01092728|Dasatinib|dasatinib
1417952|NCT01092715|Neck pain|neck pain
1417953|NCT01092715|Spinal manipulation|spinal manipulation
1417954|NCT01092715|Massage|massage
1417955|NCT01092702|Tobacco Dependence|tobacco dependence
1417956|NCT01092702|Smoking|smoking
1417957|NCT01092702|Tobacco Cessation|tobacco cessation
1417958|NCT01092689|heterocyclic amines|heterocyclic amines
1417959|NCT01092689|PhIP|phip
1417960|NCT01092689|Meat|meat
1417961|NCT01092689|pancreas neoplasms|pancreas neoplasms
1417962|NCT01092676|Pediatrics|pediatrics
1417963|NCT01092676|Emergency|emergency
1417964|NCT01092663|Colesevelam|colesevelam
1417965|NCT01092663|type 2 diabetes|type 2 diabetes
1417966|NCT01092663|sitagliptin|sitagliptin
1417967|NCT01092663|glucose metabolism|glucose metabolism
1417968|NCT01092650|Tobacco toxicants|tobacco toxicants
1417969|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
1417970|NCT01092650|Smoking|smoking
1417971|NCT01092624|voiding dysfunction|voiding dysfunction
1417972|NCT01092624|defecatory dysfunction|defecatory dysfunction
1417973|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
1417974|NCT01092611|long-term follow-up study|long-term follow-up study
1417975|NCT01092611|HIV-infected subjects|hiv-infected subjects
1417976|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
1417977|NCT01092572|cystic fibrosis|cystic fibrosis
1417978|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
1417979|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1417980|NCT01092546|Amyloid|amyloid
1417981|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
1417982|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
1417983|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
1417984|NCT01092520|Gabapentin|gabapentin
1417985|NCT01092520|Burn Injuries in Children|burn injuries in children
1417986|NCT01092520|pruritus|pruritus
1417987|NCT01092507|Encephalitis|encephalitis
1417988|NCT01092507|Japanese Encephalitis|japanese encephalitis
1417989|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
1417990|NCT01092507|Infant|infant
1417991|NCT01092494|Endometrioma recurrence|endometrioma recurrence
1417992|NCT01092494|oral contraceptives|oral contraceptives
1417993|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
1417994|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
1417995|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
1417996|NCT01092481|Adjuvant Therapy|adjuvant therapy
1417997|NCT01092468|cancer|cancer
1417998|NCT01092468|reconstruction|reconstruction
1417999|NCT01092468|free flap|free flap
1418000|NCT01092468|surgery|surgery
1418001|NCT01092455|End Stage Renal Disease|end stage renal disease
1418002|NCT01092455|Renal Dialysis|renal dialysis
1418003|NCT01092455|Hemodialysis therapy|hemodialysis therapy
1418004|NCT01092455|Heparin|heparin
1418005|NCT01092455|Citrasate|citrasate
1418006|NCT01092455|Anticoagulant|anticoagulant
1418007|NCT01092442|Pulmonary Valve|pulmonary valve
1418008|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
1418009|NCT01092442|Ross Procedure|ross procedure
1418010|NCT01092429|CAD|cad
1418011|NCT01092416|CAD|cad
1418012|NCT01092416|Severely calcified lesion|severely calcified lesion
1418013|NCT01092390|randomized trial|randomized trial
1418014|NCT01092390|omega three fatty acids|omega three fatty acids
1418015|NCT01092364|Young adults|young adults
1418016|NCT01092351|urinary tract infection|urinary tract infection
1418017|NCT01092351|nitrofurantoin|nitrofurantoin
1418018|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
1418019|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1418020|NCT01092338|Vitamin D|vitamin d
1418021|NCT01092338|HIV|hiv
1418022|NCT01092338|Complementary therapies|complementary therapies
1418023|NCT01092325|Heart Failure|heart failure
1418024|NCT01092312|knee|knee
1418025|NCT01092312|arthroplasty|arthroplasty
1418026|NCT01092299|Phase I|phase i
1418027|NCT01092299|Relative bioavailability|relative bioavailability
1418028|NCT01092299|Pharmacokinetic study|pharmacokinetic study
1418029|NCT01092299|AZD1446|azd1446
1418030|NCT01092299|healthy volunteers|healthy volunteers
1418031|NCT01092286|Knee injury|knee injury
1418032|NCT01092286|ankle sprain|ankle sprain
1418033|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
1418034|NCT01092286|adolescent|adolescent
1418035|NCT01092286|soccer|soccer
1418036|NCT01092286|basketball|basketball
1418037|NCT01092286|prevention|prevention
1418038|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
1418039|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
1418040|NCT01092260|Kidney disease|kidney disease
1418041|NCT01092260|Child|child
1418042|NCT01092260|Iohexol|iohexol
1418043|NCT01092260|Cystatin C|cystatin c
1418044|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
1418045|NCT01092247|Patients with malignant tumors|patients with malignant tumors
1418046|NCT01092234|Observational units|observational units
1418047|NCT01092234|Length of stay (LOS)|length of stay (los)
1418048|NCT01092234|Readmission|readmission
1418049|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
1418050|NCT01092208|Autism|autism
1418051|NCT01092208|iPS Cells|ips cells
1418052|NCT01092208|Fibroblasts|fibroblasts
1418053|NCT01092208|Gene Networks|gene networks
1418054|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
1418055|NCT01092208|Healthy Volunteer|healthy volunteer
1418072|NCT01092182|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1418074|NCT01092156|Nipple pain during lactation|nipple pain during lactation
1418075|NCT01092130|Heart failure|heart failure
1418076|NCT01092130|Vitamin D|vitamin d
1418077|NCT01092130|Plasma renin activity|plasma renin activity
1418078|NCT01092130|Renin angiotensin system|renin angiotensin system
1418079|NCT01092117|abdominal|abdominal
1418080|NCT01092117|aortic|aortic
1418081|NCT01092117|aneurysm|aneurysm
1418082|NCT01092091|Neoplasm|neoplasm
1418083|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
1418084|NCT01092078|hypertension|hypertension
1418085|NCT01092078|colon cancer screening|colon cancer screening
1418086|NCT01092078|african american|african american
1418087|NCT01092078|men|men
1418088|NCT01092078|motivational interviewing|motivational interviewing
1418089|NCT01092078|patient navigation|patient navigation
1418184|NCT01091727|Spinal|spinal
1418090|NCT01092065|Parkinson's Disease|parkinson's disease
1418091|NCT01092065|Dyskinesia|dyskinesia
1418092|NCT01092065|Drug-induced|drug-induced
1418093|NCT01092065|Levodopa|levodopa
1418094|NCT01092065|L-dopa|l-dopa
1418095|NCT01092052|Phase I study|phase i study
1418096|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
1418097|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
1418098|NCT01092039|Common Cold|common cold
1418099|NCT01092039|Cold Virus|cold virus
1418100|NCT01092039|Feeling sick|feeling sick
1418101|NCT01092039|Influenza|influenza
1418102|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
1418103|NCT01091987|Insomnia|insomnia
1418104|NCT01091974|Insomnia|insomnia
1418105|NCT01091974|Fatigue|fatigue
1418106|NCT01091974|QOL|qol
1418107|NCT01091974|CBT|cbt
1418108|NCT01091974|Breast cancer|breast cancer
1418109|NCT01091974|Survivors|survivors
1418110|NCT01091974|Chemotherapy|chemotherapy
1418111|NCT01091961|ACE inhibitor|ace inhibitor
1418112|NCT01091961|ARB|arb
1418113|NCT01091961|Non-cardiac surgery|non-cardiac surgery
1418114|NCT01091961|Perioperative|perioperative
1418115|NCT01091961|Preoperative|preoperative
1418116|NCT01091961|Hypotension|hypotension
1418117|NCT01091961|Congestive heart failure|congestive heart failure
1418118|NCT01091961|Hypertension|hypertension
1418119|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1418120|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1418121|NCT01091961|Perioperative Care|perioperative care
1418122|NCT01091948|elective general surgery|elective general surgery
1418123|NCT01091948|orotracheal intubation|orotracheal intubation
1418124|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
1418125|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
1418126|NCT01091922|flavonoids|flavonoids
1418127|NCT01091922|flavanols|flavanols
1418128|NCT01091922|bacteria|bacteria
1418129|NCT01091909|type 2 diabetes|type 2 diabetes
1418130|NCT01091909|wound healing|wound healing
1418131|NCT01091909|neutrophil count|neutrophil count
1418132|NCT01091909|dental extraction|dental extraction
1418133|NCT01091896|bevacizumab|bevacizumab
1418134|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
1418135|NCT01091896|diabetes mellitus|diabetes mellitus
1418136|NCT01091883|Bone cancer|bone cancer
1418137|NCT01091883|Bone Metastases|bone metastases
1418138|NCT01091883|pain palliation|pain palliation
1418139|NCT01091883|metastasis|metastasis
1418140|NCT01091883|breast cancer|breast cancer
1418141|NCT01091883|lung cancer|lung cancer
1418142|NCT01091883|prostate cancer|prostate cancer
1418143|NCT01091883|cancer related pain|cancer related pain
1418144|NCT01091883|tumors|tumors
1418145|NCT01091870|Aneurysm|aneurysm
1418146|NCT01091870|Vasospasm|vasospasm
1418147|NCT01091870|sildenafil|sildenafil
1418148|NCT01091870|Viagra|viagra
1418149|NCT01091857|Exercise|exercise
1418150|NCT01091857|Transdisciplinary|transdisciplinary
1418151|NCT01091857|Physiology|physiology
1418152|NCT01091857|Mood|mood
1418153|NCT01091857|Motivation|motivation
1418154|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
1418526|NCT01090180|combat|combat
1418155|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
1418156|NCT01091831|Multiple Myeloma|multiple myeloma
1418157|NCT01091831|Lenalidomide|lenalidomide
1418158|NCT01091831|High dose melphalan|high dose melphalan
1418159|NCT01091831|Mobilization|mobilization
1418160|NCT01091831|CD 34|cd 34
1418161|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
1418162|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
1418163|NCT01091818|treatment|treatment
1418164|NCT01091792|GBM|gbm
1418165|NCT01091792|Grade IV|grade iv
1418166|NCT01091792|glioma|glioma
1418167|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
1418168|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
1418169|NCT01091766|heart arrhythmia|heart arrhythmia
1418170|NCT01091766|heart rate|heart rate
1418171|NCT01091766|heart conduction|heart conduction
1418172|NCT01091766|regional anaesthesia|regional anaesthesia
1418173|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
1418174|NCT01091766|cardio-vascular system|cardio-vascular system
1418175|NCT01091766|prevention|prevention
1418176|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
1418177|NCT01091740|Drug eluting stent|drug eluting stent
1418178|NCT01091740|Tomography, optical coherence|tomography, optical coherence
1418179|NCT01091727|Neurogenic|neurogenic
1418180|NCT01091727|Detrusor|detrusor
1418181|NCT01091727|Overactive|overactive
1418182|NCT01091727|Overactivity|overactivity
1418183|NCT01091727|Bladder|bladder
1418185|NCT01091727|Cord|cord
1418186|NCT01091727|Injury|injury
1418187|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
1418188|NCT01091688|neonatal|neonatal
1418189|NCT01091688|discharge planning|discharge planning
1418190|NCT01091688|health transition|health transition
1418191|NCT01091688|educational needs assessment|educational needs assessment
1418192|NCT01091688|Intensive care, neonatal|intensive care, neonatal
1418193|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
1418194|NCT01091675|biologic therapies|biologic therapies
1418195|NCT01091675|ASAS|asas
1418196|NCT01091675|ASASBIO|asasbio
1418197|NCT01091675|etoricoxib|etoricoxib
1418198|NCT01091675|NSAIDs|nsaids
1418199|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
1418200|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
1418201|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
1418202|NCT01091662|Seizures|seizures
1418203|NCT01091662|Epilepsy|epilepsy
1418204|NCT01091662|Anticonvulsant|anticonvulsant
1418205|NCT01091662|Monotherapy|monotherapy
1418206|NCT01091662|Historical control|historical control
1418207|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
1418208|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
1418209|NCT01091610|retrospective study|retrospective study
1418210|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
1418211|NCT01091610|emergency medical technicians|emergency medical technicians
1418212|NCT01091610|human|human
1418213|NCT01091610|emergency medical services|emergency medical services
1418214|NCT01091610|ambulance|ambulance
1418215|NCT01091610|health personnel|health personnel
1418216|NCT01091610|emergency medicine|emergency medicine
1418217|NCT01091610|risk factors|risk factors
1418218|NCT01091571|Adenosine|adenosine
1418219|NCT01091571|Endotoxin|endotoxin
1418220|NCT01091571|Innate Immunity|innate immunity
1418221|NCT01091571|Dipyridamole|dipyridamole
1418222|NCT01091558|ulcerative colitis|ulcerative colitis
1418223|NCT01091558|colon cancer|colon cancer
1418224|NCT01091558|endoscopy|endoscopy
1418225|NCT01091558|screening|screening
1418226|NCT01091545|breast cancer|breast cancer
1418227|NCT01091545|screening|screening
1418228|NCT01091545|sensitivity|sensitivity
1418229|NCT01091545|tomosynthesis|tomosynthesis
1418230|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
1418231|NCT01091506|L-methylfolate|l-methylfolate
1418232|NCT01091506|Deplin|deplin
1418233|NCT01091506|schizophrenia|schizophrenia
1418234|NCT01091506|folate|folate
1418235|NCT01091506|folic acid|folic acid
1418236|NCT01091506|homocysteine|homocysteine
1418237|NCT01091506|methionine|methionine
1418238|NCT01091506|MTHFR genotype|mthfr genotype
1418239|NCT01091506|C677T mutation|c677t mutation
1418240|NCT01091506|vitamin B6|vitamin b6
1418241|NCT01091506|vitamin B12|vitamin b12
1418242|NCT01091506|psychotic symptoms|psychotic symptoms
1418243|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
1418244|NCT01091493|COPD|copd
1418245|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1418246|NCT01091480|Observatory|observatory
1418247|NCT01091480|LVH|lvh
1418248|NCT01091467|Heart Failure|heart failure
1418249|NCT01091467|Ejection Fraction|ejection fraction
1418250|NCT01091467|Echocardiography|echocardiography
1418251|NCT01091454|stage IV breast cancer|stage iv breast cancer
1418731|NCT01089322|CONTROL|control
1418252|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
1418253|NCT01091454|male breast cancer|male breast cancer
1418254|NCT01091441|therapeutic education|therapeutic education
1418255|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
1418256|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
1418257|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
1418258|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
1418259|NCT01091428|Drug therapy|drug therapy
1418260|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
1418261|NCT01091389|Atrial Fibrillation|atrial fibrillation
1418262|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
1418263|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
1418264|NCT01091376|EGFR-TKI|egfr-tki
1418265|NCT01091376|Erlotinib|erlotinib
1418266|NCT01091376|Radiotherapy|radiotherapy
1418267|NCT01091363|smoking cessation|smoking cessation
1418268|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
1418269|NCT01091363|cultural adaptation|cultural adaptation
1418270|NCT01091363|Asian Americans|asian americans
1418271|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
1418272|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
1418273|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
1418274|NCT01091298|Safety of vaccine|safety of vaccine
1418275|NCT01091272|healthy volunteer|healthy volunteer
1418277|NCT01091272|pharmacokinetic|pharmacokinetic
1418278|NCT01091259|antibody therapy|antibody therapy
1418279|NCT01091259|chemotherapy|chemotherapy
1418280|NCT01091259|biologic therapy|biologic therapy
1418281|NCT01091259|combination therapy|combination therapy
1418282|NCT01091233|Critically ill patients|critically ill patients
1418283|NCT01091233|liver cirrhosis|liver cirrhosis
1418284|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
1418285|NCT01091220|certolizumab pegol|certolizumab pegol
1418286|NCT01091220|Cimzia®|cimzia®
1418287|NCT01091220|healthy male volunteers|healthy male volunteers
1418288|NCT01091220|sperm|sperm
1418289|NCT01091207|Sorafenib|sorafenib
1418290|NCT01091207|GIST|gist
1418291|NCT01091207|Refractory|refractory
1418292|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
1418293|NCT01091194|Heart Transplantation|heart transplantation
1418294|NCT01091194|Aerobic Exercise|aerobic exercise
1418295|NCT01091194|Exercise, Physical|exercise, physical
1418296|NCT01091194|Exercise Test|exercise test
1418297|NCT01091194|Treadmill Test|treadmill test
1418298|NCT01091194|VO2 peak|vo2 peak
1418299|NCT01091194|Muscle Strength|muscle strength
1418300|NCT01091194|Quality of Life|quality of life
1418301|NCT01091194|Reinnervation|reinnervation
1418302|NCT01091194|Heart Rate|heart rate
1418303|NCT01091194|Myocardial Function|myocardial function
1418304|NCT01091181|Caesarean|caesarean
1418305|NCT01091155|Colon Anastomosis|colon anastomosis
1418306|NCT01091155|Rectum Anastomosis|rectum anastomosis
1418307|NCT01091155|Intestine|intestine
1418308|NCT01091155|Colorectal Surgery|colorectal surgery
1418309|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
1418310|NCT01091129|hyperhidrosis|hyperhidrosis
1418311|NCT01091116|Injections, Intra-Articular|injections, intra-articular
1418312|NCT01091090|Smoking cessation|smoking cessation
1418313|NCT01091090|Nicotine dependence|nicotine dependence
1418314|NCT01091090|Chronic pain|chronic pain
1418315|NCT01091077|dietary supplement|dietary supplement
1418316|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
1418317|NCT01091038|Adverse drug events|adverse drug events
1418318|NCT01091038|medical errors|medical errors
1418319|NCT01091038|computerized physician order entry|computerized physician order entry
1418320|NCT01091038|clinical decision support|clinical decision support
1418321|NCT01091025|Adults|adults
1418322|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
1418323|NCT01091025|Screening|screening
1418324|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
1418325|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
1418326|NCT01090999|COPD|copd
1418327|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
1418328|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
1418329|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
1418330|NCT01090973|relapsed|relapsed
1418331|NCT01090973|refractory|refractory
1418332|NCT01090973|CLL|cll
1418333|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1418334|NCT01090973|MCL|mcl
1418335|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
1418336|NCT01090934|Diagnosis|diagnosis
1418337|NCT01090934|Partial Epilepsy|partial epilepsy
1418338|NCT01090921|Multiple Myeloma|multiple myeloma
1418339|NCT01090921|Bortezomib|bortezomib
1418340|NCT01090921|Newly diagnosed|newly diagnosed
1418341|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
1418342|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
1418343|NCT01090895|Vitamin C|vitamin c
1418344|NCT01090895|Biomarkers|biomarkers
1418345|NCT01090895|Magnetic Risonance|magnetic risonance
1418346|NCT01090882|Local anaesthetic|local anaesthetic
1418347|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
1418348|NCT01090882|Pain scores|pain scores
1418349|NCT01090882|Bupivocaine|bupivocaine
1418350|NCT01090882|Day case surgery|day case surgery
1418351|NCT01090856|Bifurcations|bifurcations
1418352|NCT01090856|Drug eluting-stents|drug eluting-stents
1418353|NCT01090856|Provisional stenting|provisional stenting
1418354|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
1418355|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
1418356|NCT01090843|Chronic diarrhoea|chronic diarrhoea
1418357|NCT01090830|Non small cell lung cancer|non small cell lung cancer
1418358|NCT01090830|Belinostat|belinostat
1418359|NCT01090830|carboplatin|carboplatin
1418360|NCT01090830|Paclitaxel|paclitaxel
1418361|NCT01090830|Bevacizumab|bevacizumab
1418362|NCT01090830|chemotherapy|chemotherapy
1418363|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
1418364|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
1418365|NCT01090830|Lung Cancer|lung cancer
1418366|NCT01090830|Event Free Survival|event free survival
1418367|NCT01090830|Disease free survival|disease free survival
1418368|NCT01090830|Progression Free Survival|progression free survival
1418369|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
1418370|NCT01090830|Treatment Efficacy|treatment efficacy
1418371|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
1418372|NCT01090817|ileitis|ileitis
1418373|NCT01090817|colitis|colitis
1418374|NCT01090804|BreatheMAX breathing device|breathemax breathing device
1418375|NCT01090804|Secretion clearance|secretion clearance
1418376|NCT01090804|Ventilatory dependence|ventilatory dependence
1418377|NCT01090804|Intubated patients|intubated patients
1418378|NCT01090791|critically ill patient|critically ill patient
1418379|NCT01090778|growth hormone deficiency|growth hormone deficiency
1418380|NCT01090778|circadian variation|circadian variation
1418381|NCT01090765|Prostate|prostate
1418382|NCT01090765|Tumor|tumor
1418383|NCT01090765|Cancer|cancer
1418384|NCT01090765|Hormone|hormone
1418385|NCT01090765|Androgen|androgen
1418386|NCT01090765|Prostate Cancer|prostate cancer
1418387|NCT01090752|diabetes|diabetes
1418388|NCT01090752|blood pressure|blood pressure
1418389|NCT01090752|pioglitazone|pioglitazone
1418390|NCT01090752|sodium|sodium
1418509|NCT01090245|contingency management|contingency management
1418391|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
1418392|NCT01090739|Fecal incontinence|fecal incontinence
1418393|NCT01090739|Accidental bowel leakage|accidental bowel leakage
1418394|NCT01090739|Failure conservative therapy|failure conservative therapy
1418395|NCT01090739|Women|women
1418396|NCT01090739|Class III medical device|class iii medical device
1418397|NCT01090739|Surgical mesh|surgical mesh
1418398|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
1418399|NCT01090700|TMC435-C112|tmc435-c112
1418400|NCT01090700|TMC435|tmc435
1418402|NCT01090700|Hepatitis C|hepatitis c
1418403|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
1418404|NCT01090674|Diaphragmatic force|diaphragmatic force
1418405|NCT01090674|mobility|mobility
1418406|NCT01090661|antisense|antisense
1418407|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
1418408|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
1418409|NCT01090661|thorough QT|thorough qt
1418410|NCT01090648|TMC125HIV1083|tmc125hiv1083
1418411|NCT01090648|TMC125|tmc125
1418412|NCT01090648|HIV|hiv
1418413|NCT01090648|Etravirine|etravirine
1418414|NCT01090648|ETR|etr
1418415|NCT01090648|Intelence|intelence
1418416|NCT01090648|HIV Infections|hiv infections
1418417|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1418418|NCT01090609|Coronary Stent|coronary stent
1418419|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
1418420|NCT01090583|Cytokines|cytokines
1418421|NCT01090583|Pregnancy|pregnancy
1418422|NCT01090583|Cesarean|cesarean
1418423|NCT01090544|COPD|copd
1418424|NCT01090544|TNI|tni
1418425|NCT01090544|PaCO2|paco2
1418426|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
1418427|NCT01090492|vasospasm|vasospasm
1418428|NCT01090492|scleroderma|scleroderma
1418429|NCT01090492|systemic sclerosis|systemic sclerosis
1418430|NCT01090492|CREST|crest
1418431|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
1418432|NCT01090479|Surgical site infections|surgical site infections
1418433|NCT01090479|Chlorhexidine|chlorhexidine
1418434|NCT01090479|Shoulder surgery|shoulder surgery
1418435|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1418436|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
1418437|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
1418438|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1418439|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
1418440|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1418441|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1418442|NCT01090466|distal urethral cancer|distal urethral cancer
1418443|NCT01090466|proximal urethral cancer|proximal urethral cancer
1418444|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1418445|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
1418446|NCT01090440|schizophrenia|schizophrenia
1418447|NCT01090440|GSK1144814|gsk1144814
1418448|NCT01090440|effect of food|effect of food
1418449|NCT01090440|healthy subjects|healthy subjects
1418450|NCT01090440|depressive disorder|depressive disorder
1418451|NCT01090440|pharmacokinetics|pharmacokinetics
1418452|NCT01090427|Ustekinumab|ustekinumab
1418453|NCT01090427|Injection|injection
1418454|NCT01090427|CNTO 1275|cnto 1275
1418455|NCT01090427|Stelara|stelara
1418456|NCT01090427|Pediatric psoriasis|pediatric psoriasis
1418457|NCT01090427|Adolescents|adolescents
1418458|NCT01090414|Idelalisib|idelalisib
1418459|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
1418460|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1418461|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
1418462|NCT01090388|Cross-sectional survey|cross-sectional survey
1418463|NCT01090388|Health-related quality of life|health-related quality of life
1418464|NCT01090388|Symptom management|symptom management
1418465|NCT01090375|osteoarthritis|osteoarthritis
1418466|NCT01090375|biochemical markers|biochemical markers
1418467|NCT01090375|cartilage|cartilage
1418468|NCT01090375|inflammation|inflammation
1418469|NCT01090375|microdialysis|microdialysis
1418470|NCT01090362|Atrial fibrillation|atrial fibrillation
1418471|NCT01090362|Anticoagulation|anticoagulation
1418472|NCT01090362|Stroke|stroke
1418473|NCT01090362|Stroke prevention|stroke prevention
1418474|NCT01090362|Health Economics|health economics
1418475|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
1418476|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
1418477|NCT01090336|prasugrel|prasugrel
1418478|NCT01090336|clopidogrel|clopidogrel
1418479|NCT01090336|ACS|acs
1418480|NCT01090323|Deferasirox|deferasirox
1418481|NCT01090323|ICL670A|icl670a
1418482|NCT01090323|Iron chelators|iron chelators
1418483|NCT01090323|Sickle Cell Disease|sickle cell disease
1418484|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
1418485|NCT01090310|Quiescent uveitis|quiescent uveitis
1418486|NCT01090310|intermediate uveitis|intermediate uveitis
1418487|NCT01090310|panuveitis|panuveitis
1418488|NCT01090310|posterior uveitis|posterior uveitis
1418489|NCT01090310|uveitis|uveitis
1418490|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
1418491|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
1418492|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
1418493|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
1418494|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1418495|NCT01090297|Blood pressure|blood pressure
1418496|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
1418497|NCT01090284|Inguinal hernia|inguinal hernia
1418498|NCT01090284|Immune system|immune system
1418499|NCT01090284|Cytokines|cytokines
1418500|NCT01090284|Prosthetic repair|prosthetic repair
1418501|NCT01090284|Oxidative Stress|oxidative stress
1418502|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
1418503|NCT01090271|Muscle Strength|muscle strength
1418504|NCT01090271|Resistance Training|resistance training
1418505|NCT01090258|cardiac surgery|cardiac surgery
1418506|NCT01090258|mechanical ventilation|mechanical ventilation
1418507|NCT01090258|automation|automation
1418508|NCT01090258|weaning|weaning
1418510|NCT01090245|substance abuse treatment|substance abuse treatment
1418511|NCT01090245|criminal justice populations|criminal justice populations
1418512|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
1418513|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
1418514|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
1418515|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
1418516|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
1418517|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
1418518|NCT01090219|Inguinal Hernia|inguinal hernia
1418519|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
1418520|NCT01090206|Hemophilia|hemophilia
1418521|NCT01090206|Vitamin D|vitamin d
1418522|NCT01090193|Obstructive jaundice|obstructive jaundice
1418523|NCT01090193|kidney histopathology|kidney histopathology
1418524|NCT01090193|lactulose|lactulose
1418525|NCT01090180|PTSD|ptsd
1418527|NCT01090180|stress disorders|stress disorders
1418528|NCT01090180|veteran|veteran
1418529|NCT01090154|Ulcerative colitis|ulcerative colitis
1418530|NCT01090154|UC|uc
1418531|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
1418532|NCT01090141|Micafungin|micafungin
1418533|NCT01090141|Body Weight|body weight
1418534|NCT01090141|Anti-Infective Agents|anti-infective agents
1418535|NCT01090141|Signs and Symptoms|signs and symptoms
1418536|NCT01090141|Mycoses|mycoses
1418537|NCT01090141|Therapeutic Uses|therapeutic uses
1418538|NCT01090141|Antifungal Agents|antifungal agents
1418539|NCT01090141|Overnutrition|overnutrition
1418540|NCT01090141|Pharmacologic Actions|pharmacologic actions
1418541|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
1418542|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
1418543|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
1418544|NCT01090050|Chronic Migraine|chronic migraine
1418545|NCT01090050|Migraine|migraine
1418546|NCT01090050|Treximet|treximet
1418547|NCT01090050|naproxen|naproxen
1418548|NCT01090050|sumatriptan|sumatriptan
1418549|NCT01090037|ESRD|esrd
1418550|NCT01090037|Chronic Renal Failure|chronic renal failure
1418551|NCT01090037|Prostaglandin|prostaglandin
1418552|NCT01090037|Prostacyclin|prostacyclin
1418553|NCT01090037|Asian Multinational Study|asian multinational study
1418554|NCT01089998|Neoplasm|neoplasm
1418555|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
1418556|NCT01089998|PET tracer|pet tracer
1418557|NCT01089998|Inflammation|inflammation
1418558|NCT01089972|radial artery|radial artery
1418559|NCT01089972|ulnar artery|ulnar artery
1418560|NCT01089972|catheterization|catheterization
1418561|NCT01089972|regional blood flow|regional blood flow
1418562|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
1418563|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
1418564|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
1418565|NCT01089946|Mobilization|mobilization
1418566|NCT01089946|Hip arthroplasty|hip arthroplasty
1418567|NCT01089946|cardiovascular|cardiovascular
1418568|NCT01089933|Anesthesia|anesthesia
1418569|NCT01089933|Local Anesthetics|local anesthetics
1418570|NCT01089933|Analgesia|analgesia
1418571|NCT01089933|Quality of life|quality of life
1418572|NCT01089933|Paravertebral blocks|paravertebral blocks
1418573|NCT01089933|Arm morbidity|arm morbidity
1418574|NCT01089907|genomic|genomic
1418575|NCT01089907|childhood|childhood
1418576|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1418577|NCT01089894|18F-FLT|18f-flt
1418578|NCT01089894|PET|pet
1418579|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
1418580|NCT01089894|cell proliferation|cell proliferation
1418581|NCT01089894|therapeutic response|therapeutic response
1418582|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
1418583|NCT01089881|prostate cancer|prostate cancer
1418584|NCT01089881|18F-fluorocholine|18f-fluorocholine
1418585|NCT01089881|PET|pet
1418586|NCT01089881|recurrence|recurrence
1418587|NCT01089881|metastases|metastases
1418588|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
1418589|NCT01089868|Microsurgery|microsurgery
1418590|NCT01089868|Stereotactic biopsy|stereotactic biopsy
1418591|NCT01089868|Radiochemotherapy|radiochemotherapy
1418592|NCT01089868|Temodar|temodar
1418593|NCT01089868|FET PET|fet pet
1418594|NCT01089868|Molecular imaging|molecular imaging
1418595|NCT01089855|Neuropathic Pain|neuropathic pain
1418596|NCT01089855|Brief Pain Inventory|brief pain inventory
1418597|NCT01089855|DN4 questionnaire|dn4 questionnaire
1418598|NCT01089855|ElectroCardioGram|electrocardiogram
1418599|NCT01089842|Secondary Prevention|secondary prevention
1418600|NCT01089842|Health Promotion|health promotion
1418601|NCT01089842|Behavioral Medicine|behavioral medicine
1418602|NCT01089842|Exercise Therapy|exercise therapy
1418603|NCT01089829|CKD|ckd
1418604|NCT01089829|Foot Ulceration|foot ulceration
1418605|NCT01089829|Diabetes|diabetes
1418606|NCT01089816|Influenza infections|influenza infections
1418607|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
1418608|NCT01089816|Influenza Human|influenza human
1418609|NCT01089803|laryngectomy|laryngectomy
1418610|NCT01089803|larynx|larynx
1418611|NCT01089803|hypopharynx|hypopharynx
1418612|NCT01089764|breast neoplasm|breast neoplasm
1418613|NCT01089764|breast cancer|breast cancer
1418614|NCT01089764|behavioral intervention|behavioral intervention
1418615|NCT01089764|online support|online support
1418616|NCT01089764|relationship distress|relationship distress
1418617|NCT01089764|dyadic coping|dyadic coping
1418618|NCT01089738|mulitple dose|mulitple dose
1418619|NCT01089738|pharmacokinetics|pharmacokinetics
1418620|NCT01089738|safety|safety
1418621|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
1418622|NCT01089725|safety|safety
1418623|NCT01089725|efficacy|efficacy
1418624|NCT01089725|parallel group|parallel group
1418625|NCT01089725|double-blind|double-blind
1418626|NCT01089725|multicenter|multicenter
1418627|NCT01089725|injection|injection
1418628|NCT01089725|infusion|infusion
1418629|NCT01089725|osteoarthritis|osteoarthritis
1418630|NCT01089725|bridging|bridging
1418631|NCT01089725|subcutaneous|subcutaneous
1418632|NCT01089725|intravenous|intravenous
1418633|NCT01089725|tanezumab|tanezumab
1418634|NCT01089712|Infection|infection
1418635|NCT01089712|Cardiac Surgery|cardiac surgery
1418636|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
1418637|NCT01089712|Management Practices|management practices
1418638|NCT01089699|breast cancer|breast cancer
1418639|NCT01089699|support groups|support groups
1418640|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
1418641|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
1418642|NCT01089673|retrospective data collection|retrospective data collection
1418643|NCT01089660|Influenza|influenza
1418644|NCT01089660|Pandemic Flu|pandemic flu
1418645|NCT01089660|Swine-origin Influenza|swine-origin influenza
1418646|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
1418647|NCT01089647|OSA|osa
1418648|NCT01089647|Medical treatment|medical treatment
1418649|NCT01089634|LV measurement|lv measurement
1418650|NCT01089634|CRT|crt
1418651|NCT01089634|Concerto|concerto
1418652|NCT01089634|LVCM|lvcm
1418653|NCT01089634|LV threshold|lv threshold
1418654|NCT01089634|new CRT|new crt
1418655|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
1418656|NCT01089595|Imatinib Resistance|imatinib resistance
1418657|NCT01089595|GIST|gist
1418658|NCT01089595|Advanced Disease|advanced disease
1418659|NCT01089595|Nilotinib|nilotinib
1418660|NCT01089582|non-interventional|non-interventional
1418763|NCT01089231|Hyperlipidemia|hyperlipidemia
1418661|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
1418662|NCT01089582|ARICEPT.|aricept.
1418663|NCT01089569|diabetes|diabetes
1418664|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
1418665|NCT01089569|exenatide|exenatide
1418666|NCT01089569|insulin glargine|insulin glargine
1418667|NCT01089543|dyspepsia|dyspepsia
1418668|NCT01089543|rabeprazole|rabeprazole
1418669|NCT01089543|Japan|japan
1418670|NCT01089530|Fibrinogen|fibrinogen
1418671|NCT01089530|Cholesterol|cholesterol
1418672|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
1418673|NCT01089530|Primary prevention|primary prevention
1418674|NCT01089530|High levels fibrinogen|high levels fibrinogen
1418675|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
1418676|NCT01089504|phenobarbital|phenobarbital
1418677|NCT01089504|neonate|neonate
1418678|NCT01089504|antiepileptic drugs|antiepileptic drugs
1418679|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
1418680|NCT01089504|seizure|seizure
1418681|NCT01089491|Low back pain|low back pain
1418682|NCT01089491|Epiduroscopy|epiduroscopy
1418683|NCT01089491|Cytology|cytology
1418684|NCT01089491|Electrical stimulation|electrical stimulation
1418685|NCT01089478|Back pain|back pain
1418686|NCT01089478|Low back pain|low back pain
1418687|NCT01089478|Cytology|cytology
1418688|NCT01089478|Epiduroscopy|epiduroscopy
1418689|NCT01089478|Pain|pain
1418690|NCT01089478|Radiculopathy|radiculopathy
1418691|NCT01089465|Bed bugs|bed bugs
1418692|NCT01089465|Cimex|cimex
1418693|NCT01089465|insects|insects
1418694|NCT01089465|bites|bites
1418695|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
1418696|NCT01089439|Nitric oxide|nitric oxide
1418697|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
1418698|NCT01089400|influenza|influenza
1418699|NCT01089400|H1N1|h1n1
1418700|NCT01089400|lymphocytes|lymphocytes
1418701|NCT01089400|T cell|t cell
1418702|NCT01089400|CD4|cd4
1418703|NCT01089400|CD8|cd8
1418704|NCT01089400|cytokine|cytokine
1418705|NCT01089400|serology|serology
1418706|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
1418707|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
1418708|NCT01089400|ventilation|ventilation
1418709|NCT01089400|intensive care unit|intensive care unit
1418710|NCT01089387|radical prostatectomy|radical prostatectomy
1418711|NCT01089374|Phyllodes|phyllodes
1418712|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
1418713|NCT01089361|sepsis syndrome|sepsis syndrome
1418714|NCT01089361|septic shock|septic shock
1418715|NCT01089361|Cytokine|cytokine
1418716|NCT01089361|Ketamine|ketamine
1418717|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
1418718|NCT01089348|Prebiotics|prebiotics
1418719|NCT01089348|Lactofiltrum|lactofiltrum
1418720|NCT01089348|Therapy|therapy
1418721|NCT01089335|Sentinel node|sentinel node
1418722|NCT01089335|Thyroid cancer|thyroid cancer
1418723|NCT01089335|Thyroid neoplasia|thyroid neoplasia
1418724|NCT01089335|Follicular neoplasia|follicular neoplasia
1418725|NCT01089322|SEVERE ASTHMA|severe asthma
1418726|NCT01089322|RISK FACTORS|risk factors
1418727|NCT01089322|CHARACTERIZATION|characterization
1418728|NCT01089322|CLINICAL CONTROL|clinical control
1418729|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
1418730|NCT01089322|SEVERE|severe
1418732|NCT01089309|Aldosterone Blockade|aldosterone blockade
1418733|NCT01089309|Arterial elasticity|arterial elasticity
1418734|NCT01089309|Glycemic control|glycemic control
1418735|NCT01089296|Infants born preterm|infants born preterm
1418736|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
1418737|NCT01089296|Motor development|motor development
1418738|NCT01089296|Parental participation|parental participation
1418739|NCT01089296|Parental competency|parental competency
1418740|NCT01089283|parkinson|parkinson
1418741|NCT01089283|fdg pet-ct|fdg pet-ct
1418742|NCT01089283|i123 dat scan|i123 dat scan
1418743|NCT01089283|LRRK2|lrrk2
1418744|NCT01089283|GBA|gba
1418745|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
1418746|NCT01089270|Parkinson|parkinson
1418747|NCT01089270|fdg pet-ct|fdg pet-ct
1418748|NCT01089270|i123 dat scan|i123 dat scan
1418749|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
1418750|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
1418751|NCT01089257|Cardiovascular risks|cardiovascular risks
1418752|NCT01089257|Oxidative stress|oxidative stress
1418753|NCT01089257|Systemic inflammation|systemic inflammation
1418754|NCT01089257|Endothelial function|endothelial function
1418755|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
1418756|NCT01089257|Positive Airway Pressure|positive airway pressure
1418757|NCT01089244|Low grade glioma|low grade glioma
1418758|NCT01089244|Astrocytoma|astrocytoma
1418759|NCT01089244|Molecular imaging|molecular imaging
1418760|NCT01089244|FET PET|fet pet
1418761|NCT01089244|Therapy monitoring|therapy monitoring
1418762|NCT01089244|Temodar|temodar
1418764|NCT01089231|coronary heart disease|coronary heart disease
1418765|NCT01089231|gene expression|gene expression
1418766|NCT01089231|fish oil|fish oil
1418767|NCT01089231|DHA, EPA|dha, epa
1418768|NCT01089218|bronchoscopy|bronchoscopy
1418769|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
1418770|NCT01089218|pneumonia|pneumonia
1418771|NCT01089218|cytokines|cytokines
1418772|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
1418773|NCT01089218|prophylaxis|prophylaxis
1418774|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
1418775|NCT01089140|pediatrics|pediatrics
1418776|NCT01089140|scoliosis|scoliosis
1418777|NCT01089140|tranexamic acid|tranexamic acid
1418778|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
1418779|NCT01089127|Indacaterol|indacaterol
1418780|NCT01089127|COPD|copd
1418781|NCT01089127|salmeterol|salmeterol
1418782|NCT01089114|Cardiac Imaging|cardiac imaging
1418783|NCT01089114|MR Spectroscopy|mr spectroscopy
1418784|NCT01089114|HIV|hiv
1418785|NCT01089114|Lipid Metabolism|lipid metabolism
1418786|NCT01089114|HIV Infection|hiv infection
1418787|NCT01089114|Cardiovascular Disease|cardiovascular disease
1418788|NCT01089114|HIV Infections|hiv infections
1418789|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
1418790|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1418791|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1418792|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1418793|NCT01089088|posterior urethral cancer|posterior urethral cancer
1418794|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1418795|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1418796|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
1418797|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
1418798|NCT01089088|anterior urethral cancer|anterior urethral cancer
1418799|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
1418800|NCT01089062|Healthy volunteers|healthy volunteers
1418801|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
1418802|NCT01089049|2-OH Estrone|2-oh estrone
1418803|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
1418804|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
1418805|NCT01089036|ECMO|ecmo
1418806|NCT01089036|cardiogenic shock|cardiogenic shock
1418807|NCT01089036|ROS|ros
1418808|NCT01089036|GPx|gpx
1418809|NCT01089036|cytokines|cytokines
1418810|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
1418811|NCT01088997|PPHN|pphn
1418812|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
1418813|NCT01088997|Pulmonary hypertension|pulmonary hypertension
1418814|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
1418815|NCT01088958|Kenya|kenya
1418816|NCT01088958|Child Nutrition Disorders|child nutrition disorders
1418817|NCT01088958|Social marketing|social marketing
1418818|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
1418819|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
1418820|NCT01088919|ASP1941|asp1941
1418821|NCT01088919|Actos|actos
1418822|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
1418823|NCT01088906|Phalcis|phalcis
1418824|NCT01088906|BRCA1|brca1
1418825|NCT01088906|RAP80|rap80
1418826|NCT01088906|TS|ts
1418827|NCT01088906|First line|first line
1418828|NCT01088906|Non-squamous|non-squamous
1418829|NCT01088893|everolimus|everolimus
1418830|NCT01088893|neoadjuvant|neoadjuvant
1418831|NCT01088893|m-TOR inhibitor|m-tor inhibitor
1418832|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
1418833|NCT01088880|canakinumab|canakinumab
1418834|NCT01088880|colchicine resistance|colchicine resistance
1418835|NCT01088867|Pain|pain
1418836|NCT01088867|Acupuncture|acupuncture
1418837|NCT01088867|DNIC|dnic
1418838|NCT01088867|Electroacupuncture|electroacupuncture
1418839|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
1418840|NCT01088815|Adenocarcinoma|adenocarcinoma
1418841|NCT01088815|Hedgehog|hedgehog
1418842|NCT01088815|Neoplasms|neoplasms
1418843|NCT01088815|Digestive System Diseases|digestive system diseases
1418844|NCT01088815|Neoplasms by Site|neoplasms by site
1418845|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
1418846|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
1418847|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
1418848|NCT01088815|Pancreatic Diseases|pancreatic diseases
1418849|NCT01088815|Carcinoma|carcinoma
1418850|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
1418851|NCT01088802|Oropharynx|oropharynx
1418852|NCT01088789|Adenocarcinoma|adenocarcinoma
1418853|NCT01088789|Cyclophosphamide|cyclophosphamide
1418854|NCT01088789|Immunotherapy|immunotherapy
1418855|NCT01088789|Neo-Adjuvant|neo-adjuvant
1418856|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
1418857|NCT01088789|GM-CSF|gm-csf
1418858|NCT01088789|Randomize|randomize
1418859|NCT01088776|CKD|ckd
1418860|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
1418861|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
1418862|NCT01088776|Children|children
1418863|NCT01088776|Omega-3|omega-3
1418864|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
1418865|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1418866|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1418867|NCT01088737|Lentigo maligna|lentigo maligna
1418868|NCT01088737|melanoma|melanoma
1418869|NCT01088737|imiquimod|imiquimod
1418870|NCT01088737|prevention|prevention
1418871|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
1418872|NCT01088698|psoriasis|psoriasis
1418873|NCT01088698|golimumab|golimumab
1418874|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
1418875|NCT01088698|phototherapy|phototherapy
1418876|NCT01088698|311-nm|311-nm
1418877|NCT01088672|Stroke|stroke
1418878|NCT01088672|Ischemic|ischemic
1418879|NCT01088672|Thrombus|thrombus
1418880|NCT01088672|Embolectomy|embolectomy
1418881|NCT01088672|Thrombectomy|thrombectomy
1418882|NCT01088672|Concentric|concentric
1418883|NCT01088672|Embolus|embolus
1418884|NCT01088672|Mechanical|mechanical
1418885|NCT01088672|Trevo|trevo
1418886|NCT01088646|capsule endoscopy|capsule endoscopy
1418887|NCT01088646|small bowel disease|small bowel disease
1418888|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
1418889|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
1418890|NCT01088633|COPD|copd
1418891|NCT01088620|NSCLC|nsclc
1418892|NCT01088620|Stage IIIb or IV|stage iiib or iv
1418893|NCT01088620|Nonsquamous|nonsquamous
1418894|NCT01088620|KRAS-Wildtype|kras-wildtype
1418895|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
1418896|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
1418897|NCT01088607|Cholestatic liver disease|cholestatic liver disease
1418898|NCT01088607|Cirrhosis|cirrhosis
1418899|NCT01088607|Children|children
1418900|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
1418901|NCT01088594|urinary sodium excretion|urinary sodium excretion
1418902|NCT01088594|Pioglitazone|pioglitazone
1418903|NCT01088594|Rosiglitazone|rosiglitazone
1418904|NCT01088594|Methodological study|methodological study
1418905|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
1418906|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
1418907|NCT01088581|5-fluorouracil|5-fluorouracil
1418908|NCT01088581|cisplatin|cisplatin
1418909|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
1418910|NCT01088581|hepatectomy|hepatectomy
1418911|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
1418912|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
1418913|NCT01088568|myopia|myopia
1418914|NCT01088568|astigmatism|astigmatism
1418915|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
1418916|NCT01088555|nephrolithiasis|nephrolithiasis
1418917|NCT01088555|calcium stones|calcium stones
1418918|NCT01088555|kidney stones|kidney stones
1418919|NCT01088555|hypercalciuria|hypercalciuria
1418920|NCT01088555|sodium thiosulfate|sodium thiosulfate
1419212|NCT01087411|children|children
1418921|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
1418922|NCT01088542|substance use|substance use
1418923|NCT01088542|delinquency|delinquency
1418924|NCT01088542|risky sexual behavior|risky sexual behavior
1418925|NCT01088542|risk factors|risk factors
1418926|NCT01088542|protective factors|protective factors
1418927|NCT01088542|prevention|prevention
1418928|NCT01088542|community coalitions|community coalitions
1418929|NCT01088542|systems transformation|systems transformation
1418930|NCT01088542|violence|violence
1418931|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
1418932|NCT01088529|Abiraterone Acetate|abiraterone acetate
1418933|NCT01088529|LHRHa|lhrha
1418934|NCT01088529|high risk prostate cancer|high risk prostate cancer
1418935|NCT01088529|Radical prostatectomy|radical prostatectomy
1418936|NCT01088529|Prednisone|prednisone
1418937|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
1418938|NCT01088529|LHRH analogue|lhrh analogue
1418939|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
1418940|NCT01088516|Vertical Transmission|vertical transmission
1418941|NCT01088516|Pregnancy|pregnancy
1418942|NCT01088516|Breastfeeding|breastfeeding
1418943|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
1418944|NCT01088516|HAART|haart
1418945|NCT01088516|Aluvia|aluvia
1418946|NCT01088516|Lopinavir|lopinavir
1418947|NCT01088516|Africa|africa
1418948|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
1418949|NCT01088490|Hydrogen sulfide|hydrogen sulfide
1418950|NCT01088490|critically ill|critically ill
1418951|NCT01088490|mortality|mortality
1418952|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
1418953|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
1418954|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
1418955|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1418956|NCT01088464|Advanced Solid Tumors|advanced solid tumors
1418957|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1418958|NCT01088451|Prandial Glycemia|prandial glycemia
1418959|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
1418960|NCT01088451|Human Insulin|human insulin
1418961|NCT01088438|medical education|medical education
1418962|NCT01088438|decision making|decision making
1418963|NCT01088438|diagnostic error|diagnostic error
1418964|NCT01088438|contextualization|contextualization
1418965|NCT01088425|vitrification|vitrification
1418966|NCT01088425|2PN oocyte|2pn oocyte
1418967|NCT01088425|maternal and infant health|maternal and infant health
1418968|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
1418969|NCT01088425|mode of delivery|mode of delivery
1418970|NCT01088425|injury during delivery|injury during delivery
1418971|NCT01088425|infant development|infant development
1418972|NCT01088425|infant morbidity|infant morbidity
1418973|NCT01088425|slow- rate freezing|slow- rate freezing
1418974|NCT01088347|TRAIL|trail
1418975|NCT01088347|TRM1|trm1
1418976|NCT01088347|advanced cervical cancer|advanced cervical cancer
1418977|NCT01088347|mapatumumab|mapatumumab
1418978|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
1418979|NCT01088347|Radiotherapy|radiotherapy
1418980|NCT01088347|Cisplatin|cisplatin
1418981|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
1418982|NCT01088334|Malignancy|malignancy
1418983|NCT01088334|screening|screening
1418984|NCT01088295|Metabolic|metabolic
1418986|NCT01088295|Fat accumulation|fat accumulation
1418987|NCT01088295|AIDS|aids
1418988|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
1418989|NCT01088295|HIV Infections|hiv infections
1418990|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
1418991|NCT01088269|Blood Pressure Measurement|blood pressure measurement
1418992|NCT01088269|Atrial Fibrillation|atrial fibrillation
1418993|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
1418994|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
1418995|NCT01088256|CRPS|crps
1418996|NCT01088256|Morbus Sudeck|morbus sudeck
1418997|NCT01088256|Causalgia|causalgia
1418998|NCT01088256|Etoricoxib|etoricoxib
1418999|NCT01088256|Polyneuropathy|polyneuropathy
1419000|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
1419001|NCT01088256|peripheral nerve injury|peripheral nerve injury
1419002|NCT01088256|radiculopathy|radiculopathy
1419003|NCT01088256|Nervenverletzung|nervenverletzung
1419004|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
1419005|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
1419006|NCT01088243|Berylliosis|berylliosis
1419007|NCT01088243|Beryllium Disease|beryllium disease
1419008|NCT01088230|hemiparesis|hemiparesis
1419009|NCT01088230|robotics|robotics
1419010|NCT01088230|stroke|stroke
1419011|NCT01088230|Botox®|botox®
1419012|NCT01088230|rehabilitation|rehabilitation
1419013|NCT01088230|wrist spasticity|wrist spasticity
1419014|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1419015|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
1419016|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
1419017|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
1419018|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
1419019|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
1419020|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
1419021|NCT01088191|Adult Stem Cells|adult stem cells
1419022|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
1419023|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
1419024|NCT01088178|Contraceptive Agents|contraceptive agents
1419025|NCT01088178|Therapeutic Uses|therapeutic uses
1419026|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
1419027|NCT01088178|Reproductive Control Agents|reproductive control agents
1419028|NCT01088178|Pharmacologic Actions|pharmacologic actions
1419029|NCT01088178|Levonorgestrel|levonorgestrel
1419030|NCT01088165|Psoriasis|psoriasis
1419031|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
1419032|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1419033|NCT01088165|Adalimumab|adalimumab
1419034|NCT01088165|Fumaric acid esters|fumaric acid esters
1419035|NCT01088152|Celiac disease|celiac disease
1419036|NCT01088152|Education|education
1419038|NCT01088152|Gluten-free diet|gluten-free diet
1419039|NCT01088139|Nutritional support|nutritional support
1419040|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
1419041|NCT01088113|Tai Chi|tai chi
1419042|NCT01088113|Qigong|qigong
1419043|NCT01088113|Heart rate variability|heart rate variability
1419044|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
1419045|NCT01088113|blood pressure|blood pressure
1419046|NCT01088100|POCD|pocd
1419047|NCT01088100|clock-gene genotypes|clock-gene genotypes
1419048|NCT01088100|HPER3|hper3
1419049|NCT01088074|Total Knee Replacement|total knee replacement
1419050|NCT01088074|Closure Methods|closure methods
1419051|NCT01088048|CLL|cll
1419052|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
1419053|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
1419054|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1419055|NCT01088048|bendamustine|bendamustine
1419056|NCT01088048|CD20 mAb|cd20 mab
1419057|NCT01088048|rituximab|rituximab
1419058|NCT01088048|CAL-101|cal-101
1419059|NCT01088048|Ofatumumab|ofatumumab
1419060|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
1419061|NCT01088048|fludarabine|fludarabine
1419062|NCT01088048|everolimus|everolimus
1419063|NCT01088048|bortezomib|bortezomib
1419064|NCT01088048|chlorambucil|chlorambucil
1419065|NCT01088048|lenalidomide|lenalidomide
1419066|NCT01088035|Childhood ependymoma|childhood ependymoma
1419067|NCT01088035|Ependymoma|ependymoma
1419068|NCT01088035|Survivin|survivin
1419069|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
1419070|NCT01088009|chronic hepatitis B|chronic hepatitis b
1419071|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
1419072|NCT01087983|Metastatic cancer|metastatic cancer
1419073|NCT01087983|Lapatinib|lapatinib
1419074|NCT01087983|Tykerb|tykerb
1419075|NCT01087983|Metformin|metformin
1419076|NCT01087983|Glucophage|glucophage
1419077|NCT01087983|Sirolimus|sirolimus
1419078|NCT01087983|Rapamune|rapamune
1419079|NCT01087970|Pharynx|pharynx
1419080|NCT01087970|Larynx|larynx
1419081|NCT01087970|Nose|nose
1419082|NCT01087970|Parathyroid|parathyroid
1419083|NCT01087931|Local anesthetic|local anesthetic
1419084|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
1419085|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
1419086|NCT01087918|ASIA C and D|asia c and d
1419087|NCT01087905|Smoking|smoking
1419088|NCT01087905|Smoking cessation|smoking cessation
1419089|NCT01087905|Medication adherence|medication adherence
1419090|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
1419091|NCT01087879|hormonal contraception|hormonal contraception
1419092|NCT01087879|androgens|androgens
1419093|NCT01087879|crp|crp
1419094|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
1419095|NCT01087866|treatment|treatment
1419096|NCT01087866|metformin|metformin
1419097|NCT01087853|Fluid Therapy|fluid therapy
1419098|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
1419099|NCT01087853|Acid Base Imbalance|acid base imbalance
1419100|NCT01087853|Renal Circulation|renal circulation
1419101|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
1419102|NCT01087840|HIV|hiv
1419103|NCT01087840|nonoccupational|nonoccupational
1419104|NCT01087840|postexposure|postexposure
1419105|NCT01087840|prophylaxis|prophylaxis
1419106|NCT01087840|HIV Seronegativity|hiv seronegativity
1419107|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
1419108|NCT01087827|cuff site|cuff site
1419109|NCT01087827|forearm blood pressure|forearm blood pressure
1419110|NCT01087827|upper arm blood pressure|upper arm blood pressure
1419111|NCT01087827|anthropometric measurements|anthropometric measurements
1419112|NCT01087827|tonometry|tonometry
1419113|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
1419114|NCT01087827|measurement accuracy|measurement accuracy
1419115|NCT01087814|efavirenz|efavirenz
1419116|NCT01087814|Sustiva|sustiva
1419117|NCT01087814|pharmacokinetics|pharmacokinetics
1419118|NCT01087801|Genetic End Marker|genetic end marker
1419119|NCT01087788|Certolizumab Pegol|certolizumab pegol
1419120|NCT01087788|Cimzia|cimzia
1419121|NCT01087762|Certolizumab Pegol|certolizumab pegol
1419122|NCT01087762|Cimzia|cimzia
1419123|NCT01087736|PTSD|ptsd
1419124|NCT01087736|Alcohol abuse|alcohol abuse
1419125|NCT01087736|Alcoholism|alcoholism
1419126|NCT01087736|Topiramate|topiramate
1419127|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
1419128|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
1419129|NCT01087723|EUROMAX|euromax
1419130|NCT01087723|STEMI|stemi
1419131|NCT01087723|STE-ACS|ste-acs
1419133|NCT01087723|bivalirudin|bivalirudin
1419134|NCT01087723|PCI|pci
1419135|NCT01087723|ambulance study|ambulance study
1419136|NCT01087723|STE-MI participants|ste-mi participants
1419137|NCT01087697|bladder cancer|bladder cancer
1419138|NCT01087697|radical cystectomy|radical cystectomy
1419139|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
1419140|NCT01087684|Glaucoma|glaucoma
1419141|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
1419142|NCT01087684|intraocular pressure|intraocular pressure
1568393|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
1419143|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
1419144|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
1419145|NCT01087619|Aged 66 years or older|aged 66 years or older
1419146|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
1419147|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
1419148|NCT01087619|Indication|indication
1419149|NCT01087619|Osteoporosis|osteoporosis
1419150|NCT01087619|Cognitive function|cognitive function
1419151|NCT01087619|Atherosclerosis|atherosclerosis
1419152|NCT01087619|Follow-up|follow-up
1419153|NCT01087619|Randomized trial|randomized trial
1419154|NCT01087593|estrogen|estrogen
1419155|NCT01087593|substitution|substitution
1419156|NCT01087593|pain|pain
1419157|NCT01087593|hormonal levels|hormonal levels
1419158|NCT01087593|quantitative sensory testing|quantitative sensory testing
1419159|NCT01087580|Prostate Cancer|prostate cancer
1419160|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
1419161|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
1419162|NCT01087567|diabetes|diabetes
1419163|NCT01087567|insulin|insulin
1419164|NCT01087567|rescue therapy|rescue therapy
1419165|NCT01087554|Advanced Cancer|advanced cancer
1419166|NCT01087554|Sirolimus|sirolimus
1419167|NCT01087554|Rapamune|rapamune
1419168|NCT01087554|mTOR Inhibitor|mtor inhibitor
1419169|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
1419170|NCT01087554|Vorinostat|vorinostat
1419171|NCT01087554|SAHA|saha
1419172|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1419173|NCT01087554|MSK-390|msk-390
1419174|NCT01087554|Zolinza|zolinza
1419175|NCT01087554|Everolimus|everolimus
1419176|NCT01087554|Afinitor|afinitor
1419177|NCT01087554|Zortress|zortress
1419178|NCT01087554|RAD001|rad001
1419179|NCT01087554|Temsirolimus|temsirolimus
1419180|NCT01087554|CCI-779|cci-779
1419181|NCT01087554|Torisel|torisel
1419182|NCT01087541|Patient's Safety|patient's safety
1419183|NCT01087541|Diabetes mellitus|diabetes mellitus
1419184|NCT01087541|Public Health for professionals|public health for professionals
1419185|NCT01087541|Safety|safety
1419186|NCT01087541|Public health|public health
1419187|NCT01087528|Colonic Diseases|colonic diseases
1419188|NCT01087528|bowel diseases|bowel diseases
1419189|NCT01087528|large bowel diseases|large bowel diseases
1419190|NCT01087489|pain|pain
1419191|NCT01087489|discomfort|discomfort
1419192|NCT01087489|anesthetic drugs|anesthetic drugs
1419193|NCT01087489|topical drug administration|topical drug administration
1419194|NCT01087489|injections, intraocular|injections, intraocular
1419195|NCT01087489|lidocaine|lidocaine
1419196|NCT01087489|intraocular pressure|intraocular pressure
1419197|NCT01087489|keratopathy|keratopathy
1419198|NCT01087476|oral mucositis|oral mucositis
1419199|NCT01087476|chemotherapy|chemotherapy
1419200|NCT01087476|acute leukemia|acute leukemia
1419201|NCT01087476|salivary flow.|salivary flow.
1419202|NCT01087450|Erythropoietin|erythropoietin
1419203|NCT01087450|Sepsis|sepsis
1419204|NCT01087450|Septic shock|septic shock
1419205|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
1419206|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
1419207|NCT01087437|Distraction osteogenesis|distraction osteogenesis
1419208|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1419209|NCT01087411|accelerometry|accelerometry
1419210|NCT01087411|physical activity|physical activity
1419211|NCT01087411|obesity|obesity
1419213|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
1419214|NCT01087411|metabolic risk markers|metabolic risk markers
1419215|NCT01087411|DXA|dxa
1419216|NCT01087411|obesity prevention|obesity prevention
1419217|NCT01087411|omega 3|omega 3
1419218|NCT01087411|fish liver oil|fish liver oil
1419219|NCT01087411|motivational interviewing|motivational interviewing
1419220|NCT01087398|Osteopetrosis|osteopetrosis
1419221|NCT01087398|HSCT|hsct
1419222|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
1419223|NCT01087385|mortality|mortality
1419224|NCT01087385|cardiovascular events|cardiovascular events
1419225|NCT01087385|amputation|amputation
1419226|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
1419227|NCT01087372|Stress hyperglycemia|stress hyperglycemia
1419228|NCT01087372|Incretins|incretins
1419229|NCT01087372|GLP-1|glp-1
1419230|NCT01087372|GIP|gip
1419231|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
1419232|NCT01087346|Parents|parents
1419233|NCT01087346|Family History|family history
1419234|NCT01087346|Healthy Volunteer|healthy volunteer
1419235|NCT01087346|HV|hv
1419236|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
1419237|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
1419238|NCT01087333|Apheresis|apheresis
1419239|NCT01087333|Flow Cytometry|flow cytometry
1419240|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
1419241|NCT01087333|Leukemia|leukemia
1419242|NCT01087333|Lymphoma|lymphoma
1419243|NCT01087333|Hairy Cell Leukemia|hairy cell leukemia
1419244|NCT01087333|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1419245|NCT01087333|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1419246|NCT01087333|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1419247|NCT01087333|Adult T Cell Lymphoma|adult t cell lymphoma
1419248|NCT01087320|Genetic Counseling|genetic counseling
1419249|NCT01087320|Genetic Disorders|genetic disorders
1419250|NCT01087320|Genetic Testing|genetic testing
1419251|NCT01087320|Genetic/Genomic Researchers|genetic/genomic researchers
1419252|NCT01087320|Human Genetic Variation|human genetic variation
1419253|NCT01087320|Congenital Disorders|congenital disorders
1419254|NCT01087320|Inherited Diseases|inherited diseases
1419255|NCT01087307|Biospecimen|biospecimen
1419256|NCT01087307|Registry|registry
1419257|NCT01087307|Assay Development|assay development
1419258|NCT01087307|Assay Validation|assay validation
1419259|NCT01087307|Specimen Collection|specimen collection
1419260|NCT01087294|CD19|cd19
1419261|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
1419262|NCT01087294|Gene Therapy|gene therapy
1419263|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
1419264|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1419265|NCT01087294|B Cell Cancer|b cell cancer
1419266|NCT01087294|Allogenic Stem Cell Transplant|allogenic stem cell transplant
1419267|NCT01087281|Visual Attention|visual attention
1419268|NCT01087281|Visual Cortex|visual cortex
1419269|NCT01087281|Focal Lesions|focal lesions
1419270|NCT01087281|Neurological Disorder|neurological disorder
1419271|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1419272|NCT01087281|Focal Brain Lesion|focal brain lesion
1419273|NCT01087281|Healthy Volunteer|healthy volunteer
1419275|NCT01087268|gastrointestinal complications|gastrointestinal complications
1419276|NCT01087268|radiation toxicity|radiation toxicity
1419277|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1419278|NCT01087268|stage I rectal cancer|stage i rectal cancer
1419279|NCT01087268|stage II rectal cancer|stage ii rectal cancer
1419280|NCT01087268|stage III rectal cancer|stage iii rectal cancer
1419281|NCT01087268|stage I prostate cancer|stage i prostate cancer
1419282|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
1419283|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
1419284|NCT01087268|stage III prostate cancer|stage iii prostate cancer
1419285|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
1419286|NCT01087268|stage I bladder cancer|stage i bladder cancer
1419287|NCT01087268|stage II bladder cancer|stage ii bladder cancer
1419288|NCT01087268|stage III bladder cancer|stage iii bladder cancer
1419289|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
1419290|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
1419291|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
1419292|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
1419293|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
1419294|NCT01087268|stage III cervical cancer|stage iii cervical cancer
1419295|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
1419296|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
1419297|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
1419298|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1419299|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1419300|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1419301|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
1419302|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
1419588|NCT01086059|TNF|tnf
1419303|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
1419304|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
1419305|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
1419306|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
1419307|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1419308|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1419309|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1419310|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1419311|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1419312|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1419313|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1419314|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1419315|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1419316|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
1419317|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
1419318|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
1419319|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
1419320|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
1419321|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
1419322|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1419323|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1419324|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1419325|NCT01087255|Caregiver-based interventions|caregiver-based interventions
1419326|NCT01087255|Chronic Kidney Disease|chronic kidney disease
1419327|NCT01087255|Medication Adherence|medication adherence
1419328|NCT01087242|Tang-min Lin pills|tang-min lin pills
1419329|NCT01087242|type 2 diabetes|type 2 diabetes
1419330|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
1419331|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
1419332|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1419333|NCT01087203|tanezumab|tanezumab
1419334|NCT01087203|diabetic neuropathies|diabetic neuropathies
1419335|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
1419336|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
1419337|NCT01087190|kidney|kidney
1419338|NCT01087190|transplantation|transplantation
1419339|NCT01087190|tuberculosis|tuberculosis
1419340|NCT01087190|ELISPOT|elispot
1419341|NCT01087190|isoniazid|isoniazid
1419342|NCT01087177|Smoking|smoking
1419343|NCT01087177|Tobacco|tobacco
1419344|NCT01087177|Pediatrics|pediatrics
1419345|NCT01087164|Vaccine acceptance|vaccine acceptance
1419346|NCT01087164|human papillomavirus|human papillomavirus
1419347|NCT01087164|brief messages|brief messages
1419348|NCT01087164|social compliance|social compliance
1419349|NCT01087164|Message sidedness|message sidedness
1419350|NCT01087151|Rituxan|rituxan
1419351|NCT01087151|Apoptosis|apoptosis
1419352|NCT01087151|BCl-2|bcl-2
1419353|NCT01087138|bone health|bone health
1419354|NCT01087138|bone density|bone density
1419355|NCT01087138|bone mass|bone mass
1419356|NCT01087112|MIP|mip
1419357|NCT01087112|RCT|rct
1419358|NCT01087112|postnatal depression|postnatal depression
1419359|NCT01087112|Mother-child relationship|mother-child relationship
1419360|NCT01087086|Metabolic syndrome|metabolic syndrome
1419361|NCT01087086|Oxidative stress|oxidative stress
1419362|NCT01087086|Proinflammatory state|proinflammatory state
1419363|NCT01087086|Insulin resistance|insulin resistance
1419364|NCT01087086|Hypertension|hypertension
1419365|NCT01087086|Dyslipidemia|dyslipidemia
1419366|NCT01087086|Mediterranean diet|mediterranean diet
1419367|NCT01087086|Glycemic index|glycemic index
1419368|NCT01087086|Hypocaloric diet|hypocaloric diet
1419369|NCT01087086|Hyperproteic diet|hyperproteic diet
1419370|NCT01087086|Macronutrient distribution|macronutrient distribution
1419371|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
1419372|NCT01087086|Crononutrition|crononutrition
1419373|NCT01087086|Dietary and psychological support|dietary and psychological support
1419374|NCT01087086|Waist circumference|waist circumference
1419375|NCT01087073|Healthcare Disparities|healthcare disparities
1419376|NCT01087073|Health Care Quality Improvement|health care quality improvement
1419377|NCT01087073|Shared Decision-Making|shared decision-making
1419378|NCT01087073|Patient Education|patient education
1419379|NCT01087073|Patient Activation|patient activation
1419380|NCT01087073|Community Outreach|community outreach
1419381|NCT01087073|Provider Training|provider training
1419382|NCT01087047|Pregnancy|pregnancy
1419383|NCT01087047|Upper airways|upper airways
1419384|NCT01087047|Acoustic reflection method|acoustic reflection method
1419385|NCT01087034|Infantile scoliosis|infantile scoliosis
1419386|NCT01087034|bracing|bracing
1419387|NCT01087034|acoustic reflection method|acoustic reflection method
1419388|NCT01087034|EOS™|eos™
1419389|NCT01087034|noninvasive|noninvasive
1419390|NCT01087034|upper airways|upper airways
1419391|NCT01087034|thoracic penetration index|thoracic penetration index
1420153|NCT01083667|ALS|als
1419392|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
1419393|NCT01087008|Multiple Myeloma|multiple myeloma
1419394|NCT01087008|Zoledronic acid|zoledronic acid
1419395|NCT01086995|extubation|extubation
1419397|NCT01086995|mechanical ventilation|mechanical ventilation
1419398|NCT01086969|Meningococcal Infection|meningococcal infection
1419399|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
1419400|NCT01086969|Menactra®|menactra®
1419401|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
1419402|NCT01086917|Malaria Challenge|malaria challenge
1419403|NCT01086917|Plasmodium falciparum|plasmodium falciparum
1419404|NCT01086917|Controlled human malaria infection|controlled human malaria infection
1419405|NCT01086917|PfSPZ Challenge|pfspz challenge
1419406|NCT01086904|renal transplantation|renal transplantation
1419407|NCT01086904|immunosuppression|immunosuppression
1419408|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
1419409|NCT01086904|vaccine|vaccine
1419410|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1419411|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1419412|NCT01086878|anemia|anemia
1419413|NCT01086878|neutropenia|neutropenia
1419414|NCT01086878|safety|safety
1419415|NCT01086878|hematologic toxicity|hematologic toxicity
1419416|NCT01086865|inappetence|inappetence
1419417|NCT01086865|apetiviton BC|apetiviton bc
1419418|NCT01086852|Factor X deficiency|factor x deficiency
1419419|NCT01086852|surgery|surgery
1419420|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
1419421|NCT01086839|Cystic Fibrosis|cystic fibrosis
1419422|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
1419423|NCT01086813|Safety|safety
1419424|NCT01086813|Tolerability|tolerability
1419425|NCT01086813|Pharmacokinetics|pharmacokinetics
1419426|NCT01086813|Sedation|sedation
1419427|NCT01086787|Heart failure|heart failure
1419428|NCT01086787|Bone marrow|bone marrow
1419429|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
1419430|NCT01086787|Surgery|surgery
1419431|NCT01086787|Orthopedic surgery|orthopedic surgery
1419432|NCT01086787|Cardiac surgery|cardiac surgery
1419433|NCT01086774|Dry eye|dry eye
1419434|NCT01086774|Tear Film Stability|tear film stability
1419435|NCT01086735|hematological malignancy|hematological malignancy
1419436|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1419437|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
1419438|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
1419439|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
1419440|NCT01086735|gene therapy|gene therapy
1419441|NCT01086735|relapse|relapse
1419442|NCT01086735|adult|adult
1419443|NCT01086709|Human Papillomavirus|human papillomavirus
1419444|NCT01086709|Vaccine|vaccine
1419445|NCT01086709|Crossover|crossover
1419446|NCT01086709|Hepatitis A|hepatitis a
1419447|NCT01086709|Hepatitis B|hepatitis b
1419448|NCT01086696|PET Imaging|pet imaging
1419449|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
1419450|NCT01086696|Breast Cancer|breast cancer
1419451|NCT01086696|Lung Cancer|lung cancer
1419452|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
1419453|NCT01086696|Kidney Cancer|kidney cancer
1419454|NCT01086696|Adrenal Cancer|adrenal cancer
1419455|NCT01086683|neoplasms|neoplasms
1419456|NCT01086683|rehabilitation|rehabilitation
1419457|NCT01086683|intervention|intervention
1419458|NCT01086683|quality of life|quality of life
1419459|NCT01086683|lifestyle|lifestyle
1419460|NCT01086670|Coordination|coordination
1419461|NCT01086670|Neuroimaging|neuroimaging
1419462|NCT01086670|Motion Analysis|motion analysis
1419463|NCT01086670|Locomotor|locomotor
1419464|NCT01086670|Cerebral Palsy|cerebral palsy
1419465|NCT01086670|Pediatrics|pediatrics
1419466|NCT01086657|Bird Flu|bird flu
1419467|NCT01086657|Avian Influenza|avian influenza
1419468|NCT01086657|Healthy|healthy
1419469|NCT01086657|Immunity|immunity
1419470|NCT01086657|Prevention|prevention
1419471|NCT01086657|Healthy Volunteer|healthy volunteer
1419472|NCT01086657|HV|hv
1419473|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
1419474|NCT01086631|RITUXAN|rituxan
1419475|NCT01086631|Rituximab|rituximab
1419476|NCT01086631|Immunosuppression|immunosuppression
1419477|NCT01086618|stage IV colon cancer|stage iv colon cancer
1419478|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
1419479|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
1419480|NCT01086605|male breast cancer|male breast cancer
1419481|NCT01086605|recurrent breast cancer|recurrent breast cancer
1419482|NCT01086605|stage IV breast cancer|stage iv breast cancer
1419483|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
1419484|NCT01086592|Aged|aged
1419485|NCT01086592|Strength|strength
1419486|NCT01086592|Balance|balance
1419487|NCT01086592|Electrotherapy|electrotherapy
1419488|NCT01086592|Quality of life|quality of life
1419489|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
1419490|NCT01086579|provisional spot stenting|provisional spot stenting
1419491|NCT01086579|coronary artery disease|coronary artery disease
1419492|NCT01086579|Late Lumen Loss|late lumen loss
1419493|NCT01086579|Minimal lumen diameter|minimal lumen diameter
1419494|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
1419495|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
1419496|NCT01086553|Crohn´s disease|crohn´s disease
1419497|NCT01086553|budesonide|budesonide
1419498|NCT01086553|induction of remission|induction of remission
1419499|NCT01086540|Systemic Sclerosis-Associated Pulmonary Arterial Hypertension|systemic sclerosis-associated pulmonary arterial hypertension
1419500|NCT01086540|Autoimmune Disease|autoimmune disease
1419501|NCT01086540|Systemic Scleroderma|systemic scleroderma
1419502|NCT01086540|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1419503|NCT01086527|Pharmacogenetics|pharmacogenetics
1419504|NCT01086527|Singulair|singulair
1419505|NCT01086527|montelukast|montelukast
1419506|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
1419507|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
1419508|NCT01086527|Intestinal Absorption|intestinal absorption
1419509|NCT01086527|pharmacokinetics|pharmacokinetics
1419510|NCT01086527|absorption|absorption
1419511|NCT01086527|biochemical transport|biochemical transport
1419512|NCT01086527|Membrane Transport Proteins|membrane transport proteins
1419513|NCT01086514|Breast|breast
1419514|NCT01086514|mammography|mammography
1419515|NCT01086514|MRI|mri
1419516|NCT01086514|Digital Mammography|digital mammography
1419517|NCT01086514|10-024|10-024
1419518|NCT01086501|open, non-interventional|open, non-interventional
1419519|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
1419520|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
1419521|NCT01086488|Foscan-PDT|foscan-pdt
1419522|NCT01086488|Brachytherapy|brachytherapy
1419523|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
1419524|NCT01086475|D-cycloserine|d-cycloserine
1419525|NCT01086475|Social Skills Training|social skills training
1419526|NCT01086462|GSK2239633|gsk2239633
1419527|NCT01086462|RADIOLABEL|radiolabel
1419528|NCT01086462|PHARMACOKINETICS|pharmacokinetics
1419529|NCT01086462|INTRAVENOUS|intravenous
1419530|NCT01086462|MICRODOSE|microdose
1419531|NCT01086449|safety|safety
1419532|NCT01086449|Japanese|japanese
1419533|NCT01086449|Herpes Zoster|herpes zoster
1419534|NCT01086449|immunogenicity|immunogenicity
1419535|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
1419536|NCT01086449|Vaccine|vaccine
1419537|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
1419538|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
1419539|NCT01086410|HPA axis|hpa axis
1419540|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
1419541|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
1419542|NCT01086371|Multiple Sclerosis|multiple sclerosis
1419543|NCT01086371|gait|gait
1419544|NCT01086358|Productivity|productivity
1419545|NCT01086358|Migraine|migraine
1419546|NCT01086358|Treximet|treximet
1419547|NCT01086358|Triptan|triptan
1419548|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
1419549|NCT01086345|adult gliosarcoma|adult gliosarcoma
1419550|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
1419551|NCT01086332|radiotherapy|radiotherapy
1419552|NCT01086332|gemcitabine|gemcitabine
1419553|NCT01086332|nelfinavir|nelfinavir
1419554|NCT01086332|neoplasms|neoplasms
1419555|NCT01086241|Tomography|tomography
1419556|NCT01086241|Mammography|mammography
1419557|NCT01086241|Breast Neoplasms|breast neoplasms
1419558|NCT01086241|Prevention and Control|prevention and control
1419559|NCT01086228|Drug eluting stents|drug eluting stents
1419560|NCT01086228|Stents|stents
1419561|NCT01086228|Angioplasty|angioplasty
1419562|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
1419563|NCT01086163|Omacor|omacor
1419564|NCT01086163|Simvastatin|simvastatin
1419565|NCT01086163|Aspirin|aspirin
1419566|NCT01086163|Platelet activity|platelet activity
1419567|NCT01086163|Coronary artery disease|coronary artery disease
1419568|NCT01086137|salivary biomarker|salivary biomarker
1419569|NCT01086137|metabolic syndrome|metabolic syndrome
1419570|NCT01086137|prediabetes|prediabetes
1419571|NCT01086137|diabetes hypertension|diabetes hypertension
1419572|NCT01086124|echocardiography|echocardiography
1419573|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
1419574|NCT01086124|Heart failure|heart failure
1419575|NCT01086124|Coronary artery disease|coronary artery disease
1419576|NCT01086124|Cardiovascular diseases|cardiovascular diseases
1419577|NCT01086111|type 2 diabetes|type 2 diabetes
1419578|NCT01086111|gastric bypass|gastric bypass
1419579|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
1419580|NCT01086111|clamp study|clamp study
1419581|NCT01086111|weight loss surgery|weight loss surgery
1419582|NCT01086098|Pacemakers|pacemakers
1419583|NCT01086098|Survival|survival
1419584|NCT01086059|Autoimmune diseases|autoimmune diseases
1419585|NCT01086059|adalimumab|adalimumab
1419586|NCT01086059|pregnancy|pregnancy
1419587|NCT01086059|birth defects|birth defects
1419589|NCT01086059|Tumor necrosis factor|tumor necrosis factor
1419590|NCT01086046|platelet|platelet
1419591|NCT01086046|thrombozyme|thrombozyme
1419593|NCT01086046|Heparin|heparin
1419594|NCT01086046|Enoxaparin|enoxaparin
1419595|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
1419596|NCT01086033|Adalimumab treatment|adalimumab treatment
1419597|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
1419598|NCT01086020|IVUS|ivus
1419599|NCT01086020|coronary plaque|coronary plaque
1419600|NCT01086020|regression|regression
1419601|NCT01086007|Groin hernia|groin hernia
1419602|NCT01086007|chronic pain|chronic pain
1419603|NCT01086007|Persistent postoperative pain|persistent postoperative pain
1419604|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
1419605|NCT01086007|Sexual dysfunction|sexual dysfunction
1419606|NCT01085994|antibiotics|antibiotics
1419607|NCT01085994|resistance|resistance
1419608|NCT01085994|bio-marker|bio-marker
1419609|NCT01085994|procalcitonin|procalcitonin
1419610|NCT01085994|algorithm|algorithm
1419611|NCT01085994|critically ill|critically ill
1419612|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
1419732|NCT01085565|lung cancer|lung cancer
1419613|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
1419614|NCT01085981|flow plethysmography|flow plethysmography
1419615|NCT01085968|Parkinson's disease|parkinson's disease
1419616|NCT01085968|Cognitive deficits|cognitive deficits
1419617|NCT01085968|fMRI|fmri
1419618|NCT01085968|neuro rehabilitation|neuro rehabilitation
1419619|NCT01085968|Age Matched Controls|age matched controls
1419620|NCT01085955|peripartum|peripartum
1419621|NCT01085955|cardiomyopathy|cardiomyopathy
1419622|NCT01085955|post pregnancy|post pregnancy
1419623|NCT01085955|myocardial recovery|myocardial recovery
1420196|NCT01083511|Influenza|influenza
1419624|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
1419625|NCT01085942|rotator cuff tear|rotator cuff tear
1419626|NCT01085942|asymptomatic|asymptomatic
1419627|NCT01085942|natural course|natural course
1419628|NCT01085942|tear characteristics|tear characteristics
1419629|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
1419630|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
1419631|NCT01085929|abscess|abscess
1419632|NCT01085929|infection|infection
1419633|NCT01085929|ultrasound guidance|ultrasound guidance
1419634|NCT01085929|incision and drainage|incision and drainage
1419635|NCT01085929|needle aspiration|needle aspiration
1419636|NCT01085929|skin|skin
1419637|NCT01085929|ultrasound|ultrasound
1419638|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
1419639|NCT01085903|Spatial Neglect|spatial neglect
1419640|NCT01085903|Dysphagia|dysphagia
1419641|NCT01085903|Arousal|arousal
1419642|NCT01085903|Modafinil|modafinil
1419643|NCT01085903|Stroke|stroke
1419644|NCT01085890|Blood Pressure|blood pressure
1419645|NCT01085890|Life Style|life style
1419646|NCT01085890|Body Mass Index|body mass index
1419647|NCT01085890|Obesity, Abdominal|obesity, abdominal
1419648|NCT01085890|Blood Chemical Analysis|blood chemical analysis
1419649|NCT01085864|Lung Nodules|lung nodules
1419650|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
1419651|NCT01085851|Sunburn|sunburn
1419652|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
1419653|NCT01085851|Lotion|lotion
1419654|NCT01085851|Cream|cream
1419655|NCT01085838|Erlotinib|erlotinib
1419656|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
1419657|NCT01085825|induced abortion|induced abortion
1419658|NCT01085825|termination of pregnancy|termination of pregnancy
1419659|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
1419660|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
1419661|NCT01085799|Educational activities|educational activities
1419662|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
1419663|NCT01085799|Albendazole|albendazole
1419664|NCT01085799|Deworming|deworming
1419665|NCT01085799|School-age children|school-age children
1419666|NCT01085799|Peru|peru
1419667|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
1419668|NCT01085799|Trichuris trichiura|trichuris trichiura
1419669|NCT01085799|Hookworm|hookworm
1419670|NCT01085799|STH infections|sth infections
1419671|NCT01085799|Intestinal helminth infections|intestinal helminth infections
1419672|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
1419673|NCT01085773|HbA1c|hba1c
1419674|NCT01085773|Type 2 Diabetes|type 2 diabetes
1419675|NCT01085773|Lifestyle changes|lifestyle changes
1419676|NCT01085773|Exercise|exercise
1419677|NCT01085747|Chronic pancreatitis|chronic pancreatitis
1419678|NCT01085747|Biliary stricture|biliary stricture
1419679|NCT01085747|Endoscopic treatment|endoscopic treatment
1419680|NCT01085747|SEMS|sems
1419681|NCT01085721|allergic rhinitis|allergic rhinitis
1419682|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
1419683|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
1419684|NCT01085721|pseudoephedrine|pseudoephedrine
1419685|NCT01085721|guaifenesin|guaifenesin
1419686|NCT01085708|Rabeprazole|rabeprazole
1419688|NCT01085708|healthy Japanese male|healthy japanese male
1419689|NCT01085695|Rabeprazole|rabeprazole
1419690|NCT01085695|Japan|japan
1419691|NCT01085695|healthy Japanese male|healthy japanese male
1419692|NCT01085682|Diabetes prevention|diabetes prevention
1419693|NCT01085682|Lifestyle modification|lifestyle modification
1419694|NCT01085682|Obesity|obesity
1419695|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
1419696|NCT01085682|Diet|diet
1419697|NCT01085682|Physical activity|physical activity
1419698|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
1419699|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
1419700|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
1419701|NCT01085643|IBS|ibs
1419702|NCT01085643|Lubiprostone|lubiprostone
1419703|NCT01085643|Small Bowel|small bowel
1419704|NCT01085643|High Resolution Manometry|high resolution manometry
1419705|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
1419706|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
1419707|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
1552082|NCT00569660|MF|mf
1419708|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
1419709|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
1419710|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
1419711|NCT01085617|oral complications|oral complications
1419712|NCT01085617|mucositis|mucositis
1419713|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1419714|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1419902|NCT01084824|Verruca vulgaris|verruca vulgaris
1419715|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1419716|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1419717|NCT01085604|low back pain|low back pain
1419718|NCT01085604|clinical instability|clinical instability
1419719|NCT01085604|neuromuscular control|neuromuscular control
1419720|NCT01085604|core stabilization|core stabilization
1419721|NCT01085604|physical therapy|physical therapy
1419722|NCT01085591|CDI|cdi
1419723|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
1419724|NCT01085591|Diarrhea|diarrhea
1419725|NCT01085578|healthy male volunteers|healthy male volunteers
1419726|NCT01085578|fasted and fed state|fasted and fed state
1419727|NCT01085565|Bone cancer|bone cancer
1419728|NCT01085565|Bone Metastases|bone metastases
1419729|NCT01085565|pain palliation|pain palliation
1419730|NCT01085565|metastasis|metastasis
1419731|NCT01085565|breast cancer|breast cancer
1419733|NCT01085565|prostate cancer|prostate cancer
1419734|NCT01085565|cancer related pain|cancer related pain
1419735|NCT01085565|tumors|tumors
1419736|NCT01085552|NeoRecormon®|neorecormon®
1419737|NCT01085552|Caucasian|caucasian
1419738|NCT01085552|Japanese|japanese
1419739|NCT01085552|Bioequivalence|bioequivalence
1419740|NCT01085552|Ethnic|ethnic
1419741|NCT01085539|neonatal intensive care|neonatal intensive care
1419742|NCT01085539|infant pulse oximetry|infant pulse oximetry
1419743|NCT01085526|basophil activity|basophil activity
1419744|NCT01085526|plasma cells|plasma cells
1419745|NCT01085526|IgE|ige
1419746|NCT01085526|IgG1|igg1
1419747|NCT01085526|IgG4|igg4
1419748|NCT01085526|mast cells|mast cells
1419749|NCT01085526|IgE receptor|ige receptor
1419750|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1419751|NCT01085526|grass pollen allergy|grass pollen allergy
1419752|NCT01085513|intestinal abnormalities|intestinal abnormalities
1419753|NCT01085500|laparoscopic|laparoscopic
1419754|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
1419755|NCT01085487|Menorrhagia|menorrhagia
1419756|NCT01085474|Asthma|asthma
1419757|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
1419758|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
1419759|NCT01085448|low back pain|low back pain
1419760|NCT01085448|core stabilization|core stabilization
1419761|NCT01085448|physical therapy|physical therapy
1419762|NCT01085435|ICD|icd
1419763|NCT01085435|defibrillator|defibrillator
1419764|NCT01085422|Prostate Cancer|prostate cancer
1419765|NCT01085409|experienced utility|experienced utility
1419766|NCT01085409|decision utility|decision utility
1419767|NCT01085409|subjective well-being|subjective well-being
1419768|NCT01085409|experience sampling method|experience sampling method
1419769|NCT01085409|day reconstruction method|day reconstruction method
1419770|NCT01085409|Quality of life|quality of life
1419771|NCT01085396|Fiber Optic|fiber optic
1419772|NCT01085396|Melanoma|melanoma
1419773|NCT01085396|UV Exposure|uv exposure
1419774|NCT01085383|Antipsychotic|antipsychotic
1419775|NCT01085383|hyperprolactinemia|hyperprolactinemia
1419776|NCT01085383|hypogonadism|hypogonadism
1419777|NCT01085383|aripiprazole|aripiprazole
1419778|NCT01085370|posttraumatic stress|posttraumatic stress
1419779|NCT01085370|prevention|prevention
1419780|NCT01085370|children|children
1419781|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
1419782|NCT01085357|Glaucoma|glaucoma
1419783|NCT01085357|Glaucoma device|glaucoma device
1419784|NCT01085357|Glaucoma surgery|glaucoma surgery
1419785|NCT01085357|Intraocular pressure|intraocular pressure
1419786|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
1419787|NCT01085331|Mek Inhibitor|mek inhibitor
1419788|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
1419789|NCT01085331|K-Ras Mutation|k-ras mutation
1419790|NCT01085331|Phase II|phase ii
1419791|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
1419792|NCT01085305|Behavior problems|behavior problems
1419793|NCT01085305|Parent-Child Interaction|parent-child interaction
1419794|NCT01085305|Locus of control|locus of control
1419795|NCT01085305|Psychiatric symptoms|psychiatric symptoms
1419796|NCT01085305|Depressive symptoms|depressive symptoms
1419797|NCT01085305|Attachment|attachment
1419798|NCT01085279|fractional laser|fractional laser
1419800|NCT01085279|topical bleaching|topical bleaching
1419801|NCT01085253|Parkinson's|parkinson's
1419802|NCT01085253|supranuclear palsy|supranuclear palsy
1419803|NCT01085253|substantia nigra|substantia nigra
1419804|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
1419805|NCT01085253|MRI|mri
1419806|NCT01085227|Parkinson's disease|parkinson's disease
1419807|NCT01085227|LRRK2|lrrk2
1419808|NCT01085227|asymptomatic carriers|asymptomatic carriers
1419809|NCT01085201|lexiscan|lexiscan
1419810|NCT01085175|Heart Failure,|heart failure,
1419811|NCT01085175|PET Imaging,|pet imaging,
1419812|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
1419813|NCT01085175|Sudden Cardiac Death|sudden cardiac death
1419814|NCT01085162|Coronary Artery Disease|coronary artery disease
1419815|NCT01085162|PET imaging|pet imaging
1419816|NCT01085162|SPECT imaging|spect imaging
1419817|NCT01085149|simvastatin|simvastatin
1419818|NCT01085149|alveolar bone|alveolar bone
1419819|NCT01085149|tooth extraction|tooth extraction
1419820|NCT01085149|remodeling|remodeling
1419821|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
1419822|NCT01085123|Migraine|migraine
1419823|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
1419824|NCT01085110|Groin hernia|groin hernia
1419825|NCT01085110|Chronic pain|chronic pain
1419826|NCT01085110|QST|qst
1419827|NCT01085110|Quantitative sensory testing|quantitative sensory testing
1419828|NCT01085110|Persistent postoperative pain|persistent postoperative pain
1419829|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
1419830|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
1419831|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
1419832|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1419833|NCT01085097|Lupus Nephritis|lupus nephritis
1419834|NCT01085097|Laquinimod|laquinimod
1419835|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1419836|NCT01085084|Lupus Arthritis|lupus arthritis
1419837|NCT01085084|Laquinimod|laquinimod
1419838|NCT01085071|intensive care unit|intensive care unit
1419839|NCT01085071|potassium|potassium
1419840|NCT01085071|atrial fibrillation|atrial fibrillation
1419841|NCT01085071|cardiac surgery|cardiac surgery
1419842|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
1419843|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
1419844|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
1419845|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
1419846|NCT01085045|COPD|copd
1419847|NCT01085032|Smoking Cessation|smoking cessation
1419848|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
1419849|NCT01085032|Depression|depression
1419850|NCT01085019|Endothelial function|endothelial function
1419851|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
1419852|NCT01085019|Spices|spices
1419853|NCT01085019|Herbs|herbs
1419854|NCT01085019|Antioxidant|antioxidant
1419855|NCT01085006|cesarean delivery|cesarean delivery
1419856|NCT01085006|Tranexamic acid|tranexamic acid
1419857|NCT01085006|hemorrhage|hemorrhage
1419858|NCT01085006|Spinal analgesia|spinal analgesia
1419859|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
1419860|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
1419861|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
1419862|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
1419863|NCT01084980|minimal change disease|minimal change disease
1419864|NCT01084980|tacrolimus|tacrolimus
1419865|NCT01084980|corticosteroid|corticosteroid
1419866|NCT01084967|obesity|obesity
1419867|NCT01084967|metabolic syndrome|metabolic syndrome
1419868|NCT01084967|genetic risk markers|genetic risk markers
1419869|NCT01084967|copy number variation|copy number variation
1419870|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
1419871|NCT01084941|pregnancy|pregnancy
1419872|NCT01084941|weight gain|weight gain
1419873|NCT01084941|obesity|obesity
1419874|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
1419875|NCT01084928|diabetes|diabetes
1419876|NCT01084928|obesity|obesity
1419877|NCT01084928|pre-diabetes|pre-diabetes
1419878|NCT01084928|South Asian|south asian
1419879|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
1419880|NCT01084902|POAG|poag
1419881|NCT01084902|OH|oh
1419882|NCT01084902|Xalatan|xalatan
1419883|NCT01084902|Azopt|azopt
1419884|NCT01084902|Primary Open Angle Study|primary open angle study
1419885|NCT01084889|polypropylene mesh|polypropylene mesh
1419886|NCT01084889|Prolapse|prolapse
1419887|NCT01084889|Cystocele|cystocele
1419888|NCT01084889|Surgical Mesh|surgical mesh
1419889|NCT01084876|Herceptin|herceptin
1419890|NCT01084876|metastatic breast cancer|metastatic breast cancer
1419891|NCT01084876|CT-P6|ct-p6
1419892|NCT01084863|Herceptin|herceptin
1419893|NCT01084863|Her 2-positive|her 2-positive
1419894|NCT01084863|metastatic breast cancer|metastatic breast cancer
1419895|NCT01084863|CT-P6|ct-p6
1419896|NCT01084850|Corneal endothelium|corneal endothelium
1419897|NCT01084850|diabetes mellitus|diabetes mellitus
1419898|NCT01084850|corneal thickness|corneal thickness
1419899|NCT01084837|Multiple myeloma|multiple myeloma
1419900|NCT01084837|Renal failure|renal failure
1419901|NCT01084824|Warts|warts
1419999|NCT01084382|Yaounde|yaounde
1419903|NCT01084824|Liquid Nitrogen|liquid nitrogen
1419904|NCT01084824|Cantharidin|cantharidin
1419905|NCT01084824|combination treatment|combination treatment
1419906|NCT01084798|Multiple sclerosis|multiple sclerosis
1419907|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
1419908|NCT01084798|Sclerosis|sclerosis
1419909|NCT01084785|Cancer|cancer
1419910|NCT01084785|genomics|genomics
1419911|NCT01084785|proteomics|proteomics
1419912|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
1419913|NCT01084746|Computer Interactive Intervention|computer interactive intervention
1419914|NCT01084746|Predictors|predictors
1419915|NCT01084746|Cost Effective Analysis|cost effective analysis
1419916|NCT01084746|Transtheoretical Model|transtheoretical model
1419917|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
1419918|NCT01084694|HSCT|hsct
1419919|NCT01084694|Caregiver|caregiver
1419920|NCT01084694|Caregiver Burden|caregiver burden
1419921|NCT01084694|Allogeneic Transplant|allogeneic transplant
1419922|NCT01084694|Autologous Transplant|autologous transplant
1419923|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1419924|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
1419925|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
1419926|NCT01084668|adalimumab|adalimumab
1419927|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
1419928|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
1419929|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
1419930|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
1419931|NCT01084668|antibodies|antibodies
1419932|NCT01084668|monoclonals|monoclonals
1419933|NCT01084642|Survey|survey
1419934|NCT01084642|Sexual Health Issues|sexual health issues
1419935|NCT01084642|10-034|10-034
1419936|NCT01084629|Barrett's Esophagus|barrett's esophagus
1419937|NCT01084629|Surveillance|surveillance
1419938|NCT01084603|Smoking Cessation|smoking cessation
1419939|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
1419940|NCT01084590|Prevention|prevention
1419941|NCT01084590|Obesity|obesity
1419942|NCT01084590|Safety|safety
1419943|NCT01084590|Unhealthy weight gain|unhealthy weight gain
1419944|NCT01084590|Injury prevention|injury prevention
1419945|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
1419946|NCT01084564|Colombia|colombia
1419947|NCT01084538|paricalcitol iv|paricalcitol iv
1419948|NCT01084538|vitamin D|vitamin d
1419949|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
1419950|NCT01084538|hemodialysis|hemodialysis
1419951|NCT01084525|Meniere's Disease|meniere's disease
1419952|NCT01084525|Vertigo|vertigo
1419953|NCT01084525|Definitive vertigo|definitive vertigo
1419954|NCT01084525|Vertigo episodes|vertigo episodes
1419955|NCT01084525|Vertigo frequency|vertigo frequency
1419956|NCT01084525|Tinnitus|tinnitus
1419957|NCT01084525|Hearing loss|hearing loss
1419958|NCT01084525|Aural Fullness|aural fullness
1419959|NCT01084512|kinematic analysis,|kinematic analysis,
1420252|NCT01083329|obese|obese
1419960|NCT01084512|three-compartment model,|three-compartment model,
1419961|NCT01084512|chest wall motion,|chest wall motion,
1419962|NCT01084512|spinal cord injury.|spinal cord injury.
1419963|NCT01084499|Healthy Subjects|healthy subjects
1419964|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1419965|NCT01084486|Pulse wave velocity|pulse wave velocity
1419966|NCT01084486|augmentation index|augmentation index
1419967|NCT01084486|metformin|metformin
1419968|NCT01084473|Dexmedetomidine|dexmedetomidine
1419969|NCT01084473|gastric emptying|gastric emptying
1419970|NCT01084473|oro-cecal transit time|oro-cecal transit time
1419971|NCT01084473|Sedation in intensive care|sedation in intensive care
1419972|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
1419973|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
1419975|NCT01084447|gastroplasty|gastroplasty
1419976|NCT01084447|respiratory muscle training|respiratory muscle training
1419977|NCT01084447|muscle strength|muscle strength
1419978|NCT01084447|physical therapy|physical therapy
1419979|NCT01084421|Adolescents|adolescents
1419980|NCT01084421|Parents|parents
1419981|NCT01084421|Computer Based|computer based
1419982|NCT01084421|Latino|latino
1419983|NCT01084421|Sexual Communication|sexual communication
1419984|NCT01084408|de-novo|de-novo
1419985|NCT01084408|coronary stenoses|coronary stenoses
1419986|NCT01084408|PEPCAD|pepcad
1419987|NCT01084408|DEBonly|debonly
1419988|NCT01084408|Paclitaxel|paclitaxel
1419989|NCT01084395|Parent|parent
1419990|NCT01084395|Adolescent|adolescent
1419991|NCT01084395|Mexico|mexico
1419992|NCT01084395|Safer Sex Communication|safer sex communication
1419993|NCT01084395|Randomized Controlled Trial|randomized controlled trial
1419994|NCT01084395|HIV/AIDS|hiv/aids
1419996|NCT01084395|Sexual Behavior|sexual behavior
1419997|NCT01084382|Arthrospira platensis|arthrospira platensis
1419998|NCT01084382|female HIV patient|female hiv patient
1420000|NCT01084382|Redox potential|redox potential
1420001|NCT01084382|Life quality|life quality
1420002|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
1420003|NCT01084369|Type 2 diabetes|type 2 diabetes
1420004|NCT01084369|Hypogonadism|hypogonadism
1420005|NCT01084369|Testosterone|testosterone
1420006|NCT01084369|Endothelial dysfunction|endothelial dysfunction
1420007|NCT01084356|CZT|czt
1420008|NCT01084356|sentinel node|sentinel node
1420009|NCT01084356|osseous processes|osseous processes
1420010|NCT01084343|vaccination|vaccination
1420011|NCT01084343|prophylaxis|prophylaxis
1420012|NCT01084330|gastric cancer|gastric cancer
1420013|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
1420014|NCT01084330|advanced gastric cancer|advanced gastric cancer
1420015|NCT01084317|asthma|asthma
1420016|NCT01084317|children|children
1420017|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
1420018|NCT01084304|Pregnancy|pregnancy
1420019|NCT01084304|Ovulation tests|ovulation tests
1420020|NCT01084304|stress|stress
1420021|NCT01084304|Wishing to become pregnant|wishing to become pregnant
1420022|NCT01084291|Vaccine|vaccine
1420023|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1420024|NCT01084265|Hypogonadism|hypogonadism
1420025|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
1420026|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
1420027|NCT01084239|acute chest pain|acute chest pain
1420028|NCT01084239|emergency department|emergency department
1420029|NCT01084239|cardiac computed tomography|cardiac computed tomography
1420030|NCT01084226|Rye fiber|rye fiber
1420031|NCT01084226|Alkylresorcinols|alkylresorcinols
1420032|NCT01084226|Plant sterols|plant sterols
1420033|NCT01084226|Cholesterol|cholesterol
1420034|NCT01084226|Antioxidant|antioxidant
1420035|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
1420036|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
1420037|NCT01084213|Low birth weight|low birth weight
1420038|NCT01084213|Placenta malaria|placenta malaria
1420039|NCT01084213|Anaemia|anaemia
1420040|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
1420041|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
1420042|NCT01084213|Rapid diagnostic test|rapid diagnostic test
1420043|NCT01084200|Postoperative pain|postoperative pain
1420044|NCT01084200|Sevoflurane|sevoflurane
1420045|NCT01084200|Propofol|propofol
1420046|NCT01084200|Female|female
1420047|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
1420048|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
1420049|NCT01084200|Female patients|female patients
1420050|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
1420051|NCT01084187|erectile dysfunction|erectile dysfunction
1420052|NCT01084187|arterial hypertension|arterial hypertension
1420053|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
1420054|NCT01084187|endothelial dysfunction|endothelial dysfunction
1420055|NCT01084187|carotid intima media thickness|carotid intima media thickness
1420056|NCT01084187|vardenafil|vardenafil
1420057|NCT01084174|Peanut Allergy|peanut allergy
1420058|NCT01084135|Clinical trial|clinical trial
1420059|NCT01084135|Down syndrome|down syndrome
1420060|NCT01084135|adolescents|adolescents
1420061|NCT01084135|cognitive|cognitive
1420062|NCT01084135|rivastigmine|rivastigmine
1420063|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
1420064|NCT01084122|Anemia|anemia
1420065|NCT01084122|Transfusion|transfusion
1420066|NCT01084109|Complementary feeding|complementary feeding
1420067|NCT01084109|Infant growth|infant growth
1420068|NCT01084109|Developing countries|developing countries
1420069|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
1420070|NCT01084083|human papilloma virus infection|human papilloma virus infection
1420071|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1420072|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1420073|NCT01084083|tongue cancer|tongue cancer
1420074|NCT01084070|early feeding|early feeding
1420075|NCT01084070|postoperative care|postoperative care
1420076|NCT01084070|emergency surgery|emergency surgery
1420077|NCT01084018|acute postoperative pain|acute postoperative pain
1420078|NCT01084018|nursing intervention|nursing intervention
1420079|NCT01083992|NAFLD|nafld
1420080|NCT01083992|Galvus|galvus
1420081|NCT01083992|vitamin D|vitamin d
1420082|NCT01083966|Vestibular|vestibular
1420083|NCT01083966|Schwannoma|schwannoma
1420084|NCT01083966|earing-loss|earing-loss
1420085|NCT01083966|brain-tumor|brain-tumor
1420086|NCT01083966|Acoustic|acoustic
1420087|NCT01083966|Neuroma|neuroma
1420088|NCT01083953|end tidal concentration|end tidal concentration
1420089|NCT01083927|Pterygium|pterygium
1420090|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
1420091|NCT01083888|Pharmacokinetics|pharmacokinetics
1420092|NCT01083888|Safety and tolerability|safety and tolerability
1420093|NCT01083888|Plasma concentration|plasma concentration
1420094|NCT01083888|ASP1517|asp1517
1420095|NCT01083888|FG-4592|fg-4592
1420096|NCT01083875|Radiation|radiation
1420097|NCT01083875|mucositis|mucositis
1420098|NCT01083875|head and neck carcinoma|head and neck carcinoma
1420099|NCT01083875|oral rinse|oral rinse
1420100|NCT01083875|amlexanox|amlexanox
1420101|NCT01083875|MuGard|mugard
1420102|NCT01083862|Health literacy|health literacy
1420103|NCT01083862|patient education|patient education
1420104|NCT01083862|health behaviors|health behaviors
1420105|NCT01083862|chronic disease management|chronic disease management
1420106|NCT01083862|shared decision-making|shared decision-making
1420107|NCT01083862|patient-centered decision making|patient-centered decision making
1420108|NCT01083849|Observational study|observational study
1420109|NCT01083849|Paricalcitol|paricalcitol
1420110|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
1420111|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
1420112|NCT01083849|Chronic Kidney Disease|chronic kidney disease
1420113|NCT01083849|Zemplar|zemplar
1420114|NCT01083849|sHPT|shpt
1420115|NCT01083849|Secondary|secondary
1420116|NCT01083823|Mental health telemetry|mental health telemetry
1420117|NCT01083823|Mood telemetry|mood telemetry
1420118|NCT01083823|Mood|mood
1420119|NCT01083823|Bipolar disorder|bipolar disorder
1420120|NCT01083823|Affective instability|affective instability
1420121|NCT01083823|Cyclothymia|cyclothymia
1420122|NCT01083823|Electronic diaries|electronic diaries
1420123|NCT01083823|Mood diaries|mood diaries
1420124|NCT01083823|Mood swings|mood swings
1420125|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
1420126|NCT01083810|Infection|infection
1420127|NCT01083810|Kaletra|kaletra
1420128|NCT01083810|Resistance|resistance
1420129|NCT01083810|Mutations|mutations
1420130|NCT01083810|alternative Therapy regimen|alternative therapy regimen
1420131|NCT01083797|Sedation|sedation
1420132|NCT01083797|Electroencephalography|electroencephalography
1420133|NCT01083797|Dexmedetomidine|dexmedetomidine
1420134|NCT01083797|Chloral hydrate|chloral hydrate
1420135|NCT01083784|Cardiac arrest|cardiac arrest
1420136|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
1420137|NCT01083719|Glioblastoma|glioblastoma
1420138|NCT01083719|FDG-PET|fdg-pet
1420139|NCT01083719|MRI|mri
1420140|NCT01083693|Monoclonals|monoclonals
1420141|NCT01083693|Antibodies|antibodies
1420142|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
1420143|NCT01083693|Antirheumatic Agents|antirheumatic agents
1420144|NCT01083693|Quality of Life|quality of life
1420145|NCT01083693|Adalimumab|adalimumab
1420146|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
1420147|NCT01083693|psoriatic arthritis|psoriatic arthritis
1420148|NCT01083680|Routine clinical setting|routine clinical setting
1420149|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
1420150|NCT01083680|Crohn's Disease|crohn's disease
1420151|NCT01083680|Humira®|humira®
1420152|NCT01083680|Adalimumab|adalimumab
1420154|NCT01083667|Familial ALS|familial als
1420155|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
1420156|NCT01083654|Smoking|smoking
1420157|NCT01083654|Smoking cessation|smoking cessation
1420158|NCT01083641|Breast Cancer|breast cancer
1420159|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
1420160|NCT01083615|CRPC|crpc
1420161|NCT01083615|HRPC|hrpc
1420162|NCT01083602|Multiple Myeloma|multiple myeloma
1420163|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
1420164|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
1420165|NCT01083589|Lung Cancer|lung cancer
1420166|NCT01083589|Metastatic NSCLC|metastatic nsclc
1420167|NCT01083589|Tumor|tumor
1420168|NCT01083589|Imatinib Mesylate|imatinib mesylate
1420169|NCT01083589|Gleevec|gleevec
1420170|NCT01083589|Docetaxel|docetaxel
1420171|NCT01083589|Taxotere|taxotere
1420172|NCT01083576|leishmaniasis|leishmaniasis
1420173|NCT01083576|cutaneous|cutaneous
1420174|NCT01083576|WR 279,396|wr 279,396
1420175|NCT01083576|paromomycin|paromomycin
1420176|NCT01083576|gentamicin|gentamicin
1552655|NCT00567411|Laser|laser
1420177|NCT01083576|pharmacokinetics|pharmacokinetics
1420178|NCT01083576|safety|safety
1420179|NCT01083576|efficacy|efficacy
1420180|NCT01083563|TNF|tnf
1420181|NCT01083563|CD20|cd20
1420182|NCT01083563|RA|ra
1420183|NCT01083550|thyroid carcinoma|thyroid carcinoma
1420184|NCT01083550|thyroid cancer|thyroid cancer
1420185|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
1420186|NCT01083550|radioactive iodine|radioactive iodine
1420187|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
1420188|NCT01083537|ovarian cancer|ovarian cancer
1420189|NCT01083537|Peritoneal cancer|peritoneal cancer
1420190|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
1420191|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
1420192|NCT01083524|Pulmonary hypertension|pulmonary hypertension
1420193|NCT01083524|Dichloroacetate|dichloroacetate
1420194|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
1420195|NCT01083524|DCA|dca
1420197|NCT01083511|Influenza A|influenza a
1420198|NCT01083511|Influenza B|influenza b
1420199|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
1420200|NCT01083511|Respiratory Virus|respiratory virus
1420201|NCT01083498|Becker's nevus|becker's nevus
1420202|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
1420203|NCT01083498|randomized controlled trial|randomized controlled trial
1420204|NCT01083498|split-lesion design|split-lesion design
1420205|NCT01083485|Oxycodone|oxycodone
1420206|NCT01083485|Naloxone|naloxone
1420207|NCT01083485|Postoperative pain|postoperative pain
1420208|NCT01083485|Arthroplasty|arthroplasty
1420209|NCT01083485|Efficacy|efficacy
1420210|NCT01083472|dehiscence|dehiscence
1420211|NCT01083472|laparotomy|laparotomy
1420212|NCT01083472|Hernia repair|hernia repair
1420213|NCT01083472|surgical wound|surgical wound
1420214|NCT01083472|surgical mesh|surgical mesh
1420215|NCT01083446|Encephalopathy|encephalopathy
1420216|NCT01083446|Cirrhotics|cirrhotics
1420217|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
1420218|NCT01083433|Adherence|adherence
1420219|NCT01083433|Adolescents|adolescents
1420220|NCT01083433|Diabetes Education|diabetes education
1420221|NCT01083420|Oral lichen planus|oral lichen planus
1420222|NCT01083420|Minocycline|minocycline
1420223|NCT01083420|Dexamethasone|dexamethasone
1420224|NCT01083407|Oral care.|oral care.
1420225|NCT01083407|Chlorhexidine.|chlorhexidine.
1420226|NCT01083407|Pediatric Nursing|pediatric nursing
1420227|NCT01083407|Intensive Care|intensive care
1420228|NCT01083407|Nosocomial infection|nosocomial infection
1420229|NCT01083407|Pneumonia|pneumonia
1420230|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
1420231|NCT01083407|Tracheal colonization|tracheal colonization
1420232|NCT01083394|PTA|pta
1420233|NCT01083394|paclitaxel|paclitaxel
1420234|NCT01083394|restenosis|restenosis
1420235|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
1420236|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1420237|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1420238|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
1420239|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
1420240|NCT01083355|Variable ventilation|variable ventilation
1420241|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
1420242|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
1420243|NCT01083342|primary CNS lymphoma|primary cns lymphoma
1420244|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
1420245|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
1420246|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
1420247|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
1420248|NCT01083329|nicotinic acid|nicotinic acid
1420249|NCT01083329|lipolysis|lipolysis
1420250|NCT01083329|training program|training program
1420251|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
1420253|NCT01083316|Amyloid|amyloid
1420254|NCT01083316|Amyloidosis|amyloidosis
1420255|NCT01083316|AL Amyloidosis|al amyloidosis
1420256|NCT01083316|Primary Amyloidosis|primary amyloidosis
1420257|NCT01083316|Stem Cell Transplant|stem cell transplant
1420258|NCT01083303|energy expenditure|energy expenditure
1420259|NCT01083303|hypothermia|hypothermia
1420260|NCT01083303|body temperature|body temperature
1420261|NCT01083303|weaning|weaning
1420262|NCT01083303|preterm infants|preterm infants
1420263|NCT01083290|spironolactone|spironolactone
1420264|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
1420265|NCT01083290|Healthy volunteers|healthy volunteers
1420266|NCT01083277|oxygenation|oxygenation
1420267|NCT01083277|ventilation|ventilation
1420268|NCT01083277|tidal volume|tidal volume
1420269|NCT01083277|patterns of breathing|patterns of breathing
1420270|NCT01083277|variable ventilation|variable ventilation
1420271|NCT01083277|mechanical ventilation|mechanical ventilation
1420272|NCT01083264|Pharmacokinetics|pharmacokinetics
1420273|NCT01083251|HBV|hbv
1420274|NCT01083251|VITAMIN D|vitamin d
1420275|NCT01083251|PEGITERFERON|pegiterferon
1420276|NCT01083251|Telbivudine|telbivudine
1420277|NCT01083238|pharmacokinetics|pharmacokinetics
1420278|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
1420279|NCT01083238|adult|adult
1420280|NCT01083238|elderly adult|elderly adult
1420281|NCT01083238|COPD|copd
1420282|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1420283|NCT01083212|Gemfibrozil|gemfibrozil
1420284|NCT01083199|Prostate Cancer|prostate cancer
1420285|NCT01083199|Radical Prostatectomy|radical prostatectomy
1420286|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
1420287|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1420288|NCT01083186|Chronic Kidney Failure|chronic kidney failure
1420289|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
1420290|NCT01083173|HIV-1 infection|hiv-1 infection
1420291|NCT01083173|Kaletra|kaletra
1420292|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
1420293|NCT01083160|Anti-TNF|anti-tnf
1420294|NCT01083160|Adalimumab|adalimumab
1420295|NCT01083160|Infliximab|infliximab
1420296|NCT01083160|Etanercept|etanercept
1420297|NCT01083147|Intermediate AMD|intermediate amd
1420298|NCT01083134|CAD|cad
1420299|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
1420300|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
1420301|NCT01083108|Bariatric Surgery|bariatric surgery
1420302|NCT01083108|Diabetes Type II|diabetes type ii
1420303|NCT01083108|Obesity|obesity
1420304|NCT01083108|Adult|adult
1420305|NCT01083108|Type 2 Diabetes|type 2 diabetes
1420306|NCT01083095|Malaria|malaria
1420307|NCT01083095|Sporozoite|sporozoite
1420308|NCT01083095|Challenge Model|challenge model
1420309|NCT01083095|Plasmodium vivax|plasmodium vivax
1420310|NCT01083095|Human Volunteers|human volunteers
1420311|NCT01083082|lifestyles|lifestyles
1420312|NCT01083082|diet|diet
1420313|NCT01083082|exercise|exercise
1420314|NCT01083082|central blood pressure|central blood pressure
1420315|NCT01083082|arterial stiffness|arterial stiffness
1420316|NCT01083082|endothelial dysfunction|endothelial dysfunction
1420317|NCT01083082|Healthy people|healthy people
1420318|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
1420319|NCT01083069|hypothermia|hypothermia
1420320|NCT01083069|neurological outcome|neurological outcome
1420321|NCT01083056|retina|retina
1420322|NCT01083056|gliosis|gliosis
1420323|NCT01083056|macula|macula
1420324|NCT01083056|membrane|membrane
1420325|NCT01083056|ILM|ilm
1420326|NCT01083043|Glycemic Variability|glycemic variability
1420327|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
1420328|NCT01083030|pAVK|pavk
1420329|NCT01083030|PTA|pta
1420330|NCT01083030|drug coated balloon|drug coated balloon
1420331|NCT01083004|dye|dye
1420332|NCT01083004|internal limiting membrane|internal limiting membrane
1420333|NCT01083004|macular hole|macular hole
1420334|NCT01083004|macular pucker|macular pucker
1420335|NCT01082978|Quality of Life|quality of life
1420336|NCT01082978|Health Care Quality and Safety|health care quality and safety
1420337|NCT01082978|Randomized controlled trial|randomized controlled trial
1420338|NCT01082965|ASL MRI|asl mri
1420339|NCT01082965|perfusion|perfusion
1420340|NCT01082965|cognition|cognition
1420341|NCT01082965|donepezil|donepezil
1420342|NCT01082965|alzheimer's disease|alzheimer's disease
1420343|NCT01082965|translational medicine|translational medicine
1420344|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1420345|NCT01082939|Refractory CLL|refractory cll
1420346|NCT01082939|CFAR|cfar
1420347|NCT01082939|Alemtuzumab|alemtuzumab
1420348|NCT01082939|Campath-1H|campath-1h
1420349|NCT01082939|Campath|campath
1420350|NCT01082939|Cyclophosphamide|cyclophosphamide
1420351|NCT01082939|Cytoxan|cytoxan
1420352|NCT01082939|Neosar|neosar
1420353|NCT01082939|Fludarabine|fludarabine
1420354|NCT01082939|Fludara|fludara
1420355|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
1420356|NCT01082939|Rituximab|rituximab
1420357|NCT01082939|Rituxan|rituxan
1420358|NCT01082939|CLL|cll
1420359|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1420360|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
1420361|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
1420362|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1420363|NCT01082926|adult brain stem glioma|adult brain stem glioma
1420364|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
1420365|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
1420366|NCT01082926|adult glioblastoma|adult glioblastoma
1420367|NCT01082926|adult gliosarcoma|adult gliosarcoma
1420368|NCT01082926|adult grade III meningioma|adult grade iii meningioma
1420369|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1420370|NCT01082926|adult mixed glioma|adult mixed glioma
1420371|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1420372|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
1420373|NCT01082926|Los Angeles|los angeles
1420374|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
1420375|NCT01082900|Elective Cesarean section|elective cesarean section
1420376|NCT01082900|Late preterm|late preterm
1420377|NCT01082900|CPAP|cpap
1420378|NCT01082900|Delivery Room|delivery room
1420379|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
1420380|NCT01082887|Intra-tumoral injection|intra-tumoral injection
1420381|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
1420382|NCT01082887|Metastatic melanoma|metastatic melanoma
1420383|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
1420384|NCT01082887|in transit metastasis|in transit metastasis
1420385|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
1420386|NCT01082887|visceral metastases|visceral metastases
1420387|NCT01082874|Randomized Controlled Trial|randomized controlled trial
1420388|NCT01082874|Blinded|blinded
1420389|NCT01082874|Clonidine|clonidine
1420390|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
1420391|NCT01082874|Perioperative vascular complications|perioperative vascular complications
1420392|NCT01082874|Noncardiac surgery|noncardiac surgery
1420393|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
1420394|NCT01082835|Chinese herbs|chinese herbs
1420395|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
1420396|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
1420397|NCT01082809|Sunitinib|sunitinib
1420398|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
1420399|NCT01082783|acute media infarct|acute media infarct
1420400|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
1420401|NCT01082783|leucocytes|leucocytes
1420402|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
1420403|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
1420404|NCT01082757|Colorectal neoplasms|colorectal neoplasms
1420405|NCT01082757|metastasis|metastasis
1420406|NCT01082757|colorectal cancer|colorectal cancer
1420407|NCT01082744|Paravertebral Block|paravertebral block
1420408|NCT01082744|Regional Anesthesia|regional anesthesia
1420409|NCT01082744|Anesthetics Local|anesthetics local
1420410|NCT01082744|Ropivacaine|ropivacaine
1420411|NCT01082744|Sufentanil|sufentanil
1420412|NCT01082744|Pain Postoperative|pain postoperative
1420413|NCT01082744|Chronic Pain|chronic pain
1420414|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
1420415|NCT01082731|Malaria|malaria
1420416|NCT01082731|Plasmodium falciparum|plasmodium falciparum
1420417|NCT01082731|Treatment|treatment
1420418|NCT01082731|Brazil|brazil
1420419|NCT01082718|Malaria|malaria
1420420|NCT01082718|Pregnancy|pregnancy
1420421|NCT01082718|Pharmacokinetics|pharmacokinetics
1420422|NCT01082718|Brazil|brazil
1420423|NCT01082705|malaria|malaria
1420424|NCT01082705|treatment|treatment
1420425|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
1420426|NCT01082705|Tanzania|tanzania
1420427|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
1420428|NCT01082692|HIV Infection|hiv infection
1420429|NCT01082692|DNA vaccine|dna vaccine
1420430|NCT01082692|Electroporation|electroporation
1420431|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
1420432|NCT01082679|opioid dependent|opioid dependent
1420433|NCT01082679|methadone|methadone
1420434|NCT01082679|Suboxone|suboxone
1420435|NCT01082679|buprenorphine|buprenorphine
1420436|NCT01082666|Cuff pressure|cuff pressure
1420437|NCT01082666|microaspiration|microaspiration
1420438|NCT01082666|pepsin|pepsin
1420439|NCT01082666|VAP|vap
1420440|NCT01082666|Mechanical ventilation|mechanical ventilation
1420441|NCT01082653|ALS|als
1420442|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
1420443|NCT01082640|Gout|gout
1420444|NCT01082640|physiology|physiology
1420445|NCT01082640|Hyperuricemia|hyperuricemia
1420446|NCT01082640|Uric Acid|uric acid
1420447|NCT01082640|Drug Therapy|drug therapy
1420448|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
1420449|NCT01082601|Catheter Ablation|catheter ablation
1420450|NCT01082601|Atrial Fibrillation|atrial fibrillation
1420451|NCT01082601|Congestive heart failure|congestive heart failure
1420452|NCT01082588|schizophrenia|schizophrenia
1420453|NCT01082588|pravastatin|pravastatin
1420454|NCT01082588|inflammation|inflammation
1420455|NCT01082588|cognition|cognition
1420456|NCT01082588|antipsychotics|antipsychotics
1420457|NCT01082588|cholesterol|cholesterol
1420458|NCT01082575|Post Op Patients|post op patients
1420459|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
1420460|NCT01082575|Major Surgery|major surgery
1420461|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
1420462|NCT01082536|Pediatrics|pediatrics
1420463|NCT01082536|Congenital heart disease|congenital heart disease
1420464|NCT01082536|NIRS|nirs
1420465|NCT01082536|Brain oxygenation|brain oxygenation
1420466|NCT01082510|UFT|uft
1420467|NCT01082510|BCG|bcg
1420468|NCT01082497|Mindfulness|mindfulness
1420469|NCT01082497|Stress|stress
1420470|NCT01082497|Burnout|burnout
1420471|NCT01082497|Ward atmosphere|ward atmosphere
1420472|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
1420473|NCT01082484|Healthy volunteers|healthy volunteers
1420474|NCT01082484|iontophoresis|iontophoresis
1420475|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
1420476|NCT01082471|Morphine|morphine
1420477|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
1420478|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
1420479|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
1420480|NCT01082445|stage C|stage c
1420481|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
1420482|NCT01082432|thumb|thumb
1420483|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
1420484|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
1420485|NCT01082432|stiffness|stiffness
1420486|NCT01082432|adhesions|adhesions
1420487|NCT01082419|Liver stiffness measurement|liver stiffness measurement
1420488|NCT01082419|ARFI|arfi
1420489|NCT01082419|fibrosis|fibrosis
1420490|NCT01082419|hepatopathy|hepatopathy
1420491|NCT01082393|vitiligo|vitiligo
1420492|NCT01082380|radiolabeled|radiolabeled
1420493|NCT01082380|healthy volunteers|healthy volunteers
1420494|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
1420495|NCT01082367|Cystic fibrosis|cystic fibrosis
1420496|NCT01082367|Lung disease|lung disease
1420497|NCT01082367|anti-bacterial agents|anti-bacterial agents
1420498|NCT01082354|Infant, Low birth weight|infant, low birth weight
1420499|NCT01082354|Infant, Low birth height|infant, low birth height
1420500|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
1420501|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
1420502|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
1420503|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
1420504|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
1420505|NCT01082341|RBC Red Blood Cells|rbc red blood cells
1420506|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
1420507|NCT01082341|TBS Thick blood smear|tbs thick blood smear
1420508|NCT01082341|P. Vivax|p. vivax
1420509|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
1420510|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
1420511|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
1420512|NCT01082328|Kuvan®|kuvan®
1420513|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
1420514|NCT01082328|Kuvan responder|kuvan responder
1420515|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
1420516|NCT01082315|Colorectal cancer|colorectal cancer
1420517|NCT01082315|Neoplasm metastasis|neoplasm metastasis
1420518|NCT01082315|Cetuximab|cetuximab
1420519|NCT01082315|Erbitux|erbitux
1420520|NCT01082315|EGFR|egfr
1420521|NCT01082302|green tea extract|green tea extract
1420522|NCT01082302|Polyphenon E|polyphenon e
1420523|NCT01082302|Pharmacokinetics|pharmacokinetics
1420524|NCT01082289|Lurasidone|lurasidone
1420525|NCT01082289|Schizophrenia|schizophrenia
1420526|NCT01082289|Latuda|latuda
1420527|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
1420528|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
1420529|NCT01082263|Male and Female|male and female
1420530|NCT01082250|Bioequivalence|bioequivalence
1420531|NCT01082250|Male/Female Patient|male/female patient
1420532|NCT01082250|Reference/Test Formulation|reference/test formulation
1420533|NCT01082250|Schizophrenia Patients|schizophrenia patients
1420534|NCT01082237|Major Depressive Disorder|major depressive disorder
1420535|NCT01082237|EEG|eeg
1420536|NCT01082237|SSRI|ssri
1420537|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1420538|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1420539|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1420540|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1420541|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1420542|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1420543|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1420544|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1420545|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1420546|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1420547|NCT01082211|recurrent breast cancer|recurrent breast cancer
1420548|NCT01082198|stage III melanoma|stage iii melanoma
1420549|NCT01082185|abdominal|abdominal
1420550|NCT01082185|aortic|aortic
1420551|NCT01082185|aneurysm|aneurysm
1420553|NCT01082172|thoracic|thoracic
1420554|NCT01082172|aortic|aortic
1420555|NCT01082172|aneurysm|aneurysm
1420557|NCT01082159|Spinal Stenosis|spinal stenosis
1420558|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
1420559|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
1420560|NCT01082133|Fanconi Anemia|fanconi anemia
1420561|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1420562|NCT01082120|Pioglitazone|pioglitazone
1420563|NCT01082094|Ischemic heart failure|ischemic heart failure
1420564|NCT01082094|Congestive heart failure|congestive heart failure
1420565|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
1420566|NCT01082094|SDF-1|sdf-1
1420567|NCT01082094|Gene therapy|gene therapy
1420568|NCT01082081|paracetamol|paracetamol
1420569|NCT01082081|dental pain|dental pain
1420570|NCT01082081|Post-surgical dental pain|post-surgical dental pain
1420571|NCT01082068|HER2 negative|her2 negative
1420572|NCT01082068|Hormone Receptor Positive|hormone receptor positive
1420573|NCT01082068|Breast Neoplasms|breast neoplasms
1420574|NCT01082055|Cardiac|cardiac
1420575|NCT01082055|Dysrhythmia|dysrhythmia
1420576|NCT01082055|Safety|safety
1420577|NCT01082042|Balance, postural|balance, postural
1420578|NCT01082042|Aged, over 70|aged, over 70
1420579|NCT01082042|Exercise|exercise
1420580|NCT01082042|Accidental falls|accidental falls
1420581|NCT01082016|Sleep|sleep
1420582|NCT01082016|Critical Illness|critical illness
1420583|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
1420584|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
1420585|NCT01081977|Delayed cord clamping|delayed cord clamping
1420586|NCT01081977|Ferritin|ferritin
1420587|NCT01081977|Hemoglobin|hemoglobin
1420588|NCT01081977|Neonatal anemia|neonatal anemia
1420589|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
1420590|NCT01081977|Neonatal jaundice|neonatal jaundice
1420591|NCT01081964|pneumonia|pneumonia
1420592|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
1420593|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
1420594|NCT01081951|polymerisation (PARP)|polymerisation (parp)
1420595|NCT01081951|Platinum sensitive|platinum sensitive
1420596|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
1420597|NCT01081951|olaparib|olaparib
1420598|NCT01081951|PARP inhibitors|parp inhibitors
1420599|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
1420600|NCT01081925|Congestive Heart Failure|congestive heart failure
1420601|NCT01081925|Cardiac Failure|cardiac failure
1420602|NCT01081912|chronic pain|chronic pain
1420603|NCT01081912|back pain|back pain
1420604|NCT01081899|dying patients|dying patients
1420605|NCT01081899|cancer|cancer
1420606|NCT01081899|hospital|hospital
1420607|NCT01081899|Liverpool Care Pathways|liverpool care pathways
1420608|NCT01081886|Total knee arthroplasty|total knee arthroplasty
1420609|NCT01081886|PlasmaBlade|plasmablade
1420610|NCT01081886|Electrosurgery|electrosurgery
1420611|NCT01081886|PEAK Surgical|peak surgical
1420612|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
1420613|NCT01081886|Medtronic|medtronic
1420614|NCT01081873|Multicenter study|multicenter study
1420615|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
1420616|NCT01081860|CTS|cts
1420617|NCT01081860|Skinstiffness|skinstiffness
1420618|NCT01081860|Jointstiffness|jointstiffness
1420619|NCT01081847|Malaria|malaria
1420620|NCT01081847|Synthetic peptides|synthetic peptides
1420621|NCT01081847|Plasmodium vivax|plasmodium vivax
1420622|NCT01081847|Human volunteers|human volunteers
1420623|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1420624|NCT01081834|Canagliflozin|canagliflozin
1420625|NCT01081834|Placebo|placebo
1420626|NCT01081834|Hemoglobin A1c|hemoglobin a1c
1420627|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
1420628|NCT01081821|JNJ 39758979|jnj 39758979
1420629|NCT01081821|Japanese descent|japanese descent
1420630|NCT01081808|PhaseI|phasei
1420631|NCT01081808|Solid Tumor|solid tumor
1420632|NCT01081808|biomarkers|biomarkers
1420633|NCT01081808|T cell|t cell
1420634|NCT01081808|Cetuximab|cetuximab
1420635|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1420636|NCT01081808|Aldesleukin|aldesleukin
1420637|NCT01081808|Lymphocytes|lymphocytes
1420638|NCT01081808|Autologous|autologous
1420639|NCT01081808|Recurrent|recurrent
1420640|NCT01081808|Refractory|refractory
1420641|NCT01081808|Metastatic|metastatic
1420642|NCT01081808|Immunotherapy|immunotherapy
1420643|NCT01081808|Antibodies|antibodies
1420644|NCT01081808|Neoplasms by Site|neoplasms by site
1420645|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
1420646|NCT01081808|Therapeutic Uses|therapeutic uses
1420647|NCT01081808|Anti-Infective Agents|anti-infective agents
1420648|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
1420649|NCT01081808|Antineoplastic Agents|antineoplastic agents
1420650|NCT01081808|Antiviral Agents|antiviral agents
1420651|NCT01081808|Pharmacologic Actions|pharmacologic actions
1420652|NCT01081808|Carcinoma|carcinoma
1420653|NCT01081808|Neoplasms|neoplasms
1420654|NCT01081795|Topiramate|topiramate
1420655|NCT01081795|Migraine|migraine
1420656|NCT01081782|Multiple Sclerosis|multiple sclerosis
1420657|NCT01081782|ONO-4641|ono-4641
1420658|NCT01081769|Schizophrenia|schizophrenia
1420659|NCT01081769|paliperidone palmitate|paliperidone palmitate
1420660|NCT01081769|Invega|invega
1420661|NCT01081769|Intramuscular injection|intramuscular injection
1420662|NCT01081769|Oral antipsychotics|oral antipsychotics
1420663|NCT01081769|Relapse|relapse
1420664|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
1420665|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
1420666|NCT01081743|Alzheimer|alzheimer
1420667|NCT01081743|Dementia|dementia
1420668|NCT01081743|Mild to moderately severe|mild to moderately severe
1420669|NCT01081743|New diagnosis|new diagnosis
1420670|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
1420671|NCT01081730|psoriasis|psoriasis
1420672|NCT01081730|ustekinumab|ustekinumab
1420673|NCT01081730|anti-TNF biologics|anti-tnf biologics
1420674|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
1420675|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
1420676|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
1420677|NCT01081717|psoriatic arthritis|psoriatic arthritis
1420678|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
1420679|NCT01081717|golimumab|golimumab
1420680|NCT01081717|anti-TNF biologics|anti-tnf biologics
1420681|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
1420682|NCT01081717|non-biological treatments|non-biological treatments
1420683|NCT01081704|Healthy volunteer|healthy volunteer
1420684|NCT01081704|Chinese male|chinese male
1420685|NCT01081704|Stelara|stelara
1420686|NCT01081691|CNTO 5825|cnto 5825
1420687|NCT01081691|Safety|safety
1420688|NCT01081691|Phase I|phase i
1420689|NCT01081691|Healthy adults|healthy adults
1420690|NCT01081691|Healthy Atopic adults|healthy atopic adults
1420691|NCT01081678|AMG 785|amg 785
1420692|NCT01081678|Proximal Femur|proximal femur
1420693|NCT01081678|Fracture Healing|fracture healing
1420694|NCT01081678|Hip Fracture|hip fracture
1420695|NCT01081665|Chronic Kidney Failure|chronic kidney failure
1420696|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1420697|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
1420698|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
1420699|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
1420700|NCT01081652|Embryo transfer|embryo transfer
1420701|NCT01081652|progesterone|progesterone
1420702|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
1420703|NCT01081639|Follitropin alfa|follitropin alfa
1420704|NCT01081639|Follitropin beta|follitropin beta
1420705|NCT01081639|Fertilization, in vitro|fertilization, in vitro
1420706|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1420707|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
1420708|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
1420709|NCT01081626|Infertility|infertility
1420710|NCT01081626|Ovulation induction|ovulation induction
1420711|NCT01081626|Gonal-f|gonal-f
1420712|NCT01081626|Follitropin alpha|follitropin alpha
1420713|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
1420714|NCT01081626|Anovulatory infertility|anovulatory infertility
1420715|NCT01081613|heat shock protein|heat shock protein
1420716|NCT01081613|breast cancer|breast cancer
1420717|NCT01081613|PET imaging|pet imaging
1420718|NCT01081613|bevacizumab|bevacizumab
1420719|NCT01081600|Heat shock protein|heat shock protein
1420720|NCT01081600|breast cancer|breast cancer
1420721|NCT01081600|PET imaging|pet imaging
1420722|NCT01081600|trastuzumab|trastuzumab
1420723|NCT01081587|Non MeSH terms:|non mesh terms:
1420724|NCT01081587|Children|children
1420725|NCT01081587|Malnutrition|malnutrition
1420726|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
1420727|NCT01081587|Cluster randomized trial|cluster randomized trial
1420728|NCT01081587|Healthcare workers|healthcare workers
1420729|NCT01081587|Guideline adherence|guideline adherence
1420730|NCT01081587|Patient safety|patient safety
1420731|NCT01081587|MeSH terms:|mesh terms:
1420732|NCT01081587|Nutrition Surveys|nutrition surveys
1420733|NCT01081587|Secondary Prevention|secondary prevention
1420734|NCT01081587|Pediatrics|pediatrics
1420735|NCT01081587|Child Care|child care
1420736|NCT01081587|Health Personnel|health personnel
1420737|NCT01081587|Reminder Systems|reminder systems
1421944|NCT01076790|Heart|heart
1420738|NCT01081587|Intervention Studies|intervention studies
1420739|NCT01081587|Quality of Health Care|quality of health care
1420740|NCT01081574|Allergic Rhinitis|allergic rhinitis
1420741|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1420742|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
1420743|NCT01081574|Urticaria|urticaria
1420744|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
1420745|NCT01081574|Allergy|allergy
1420746|NCT01081574|Sneezing|sneezing
1420747|NCT01081574|Nasal Itching|nasal itching
1420748|NCT01081574|Rhinorrhea|rhinorrhea
1420749|NCT01081574|Nasal Congestion|nasal congestion
1420750|NCT01081574|Wheals|wheals
1420751|NCT01081574|Hives|hives
1420752|NCT01081574|Skin itching|skin itching
1420753|NCT01081574|Flare|flare
1420754|NCT01081574|Erythema|erythema
1420755|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
1420756|NCT01081509|adherence|adherence
1420757|NCT01081509|early breast cancer|early breast cancer
1420758|NCT01081509|Arimidex|arimidex
1420759|NCT01081509|Therapy adherence|therapy adherence
1420760|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
1420761|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
1420762|NCT01081483|Healthy Volunteers|healthy volunteers
1420763|NCT01081483|HCV Infections|hcv infections
1420764|NCT01081457|Parkinson's disease|parkinson's disease
1420765|NCT01081457|deep brain stimulation|deep brain stimulation
1420766|NCT01081457|GI motility|gi motility
1420767|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
1420768|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
1420770|NCT01081431|deletion 5q|deletion 5q
1420771|NCT01081431|del 5q|del 5q
1420772|NCT01081431|IPSS|ipss
1420773|NCT01081431|low risk|low risk
1420774|NCT01081431|intermediate-1 risk|intermediate-1 risk
1420775|NCT01081431|GMIHO|gmiho
1420776|NCT01081431|ClinAssess|clinassess
1420777|NCT01081431|Germing|germing
1420778|NCT01081431|Düsseldorf|düsseldorf
1420779|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
1420780|NCT01081431|Lenalidomide|lenalidomide
1420781|NCT01081431|Revlimid|revlimid
1420782|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
1420783|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
1420784|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
1420785|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
1420786|NCT01081392|LPS|lps
1420787|NCT01081392|endotoxin|endotoxin
1420788|NCT01081392|inflammatory markers|inflammatory markers
1420789|NCT01081392|healthy volunteers|healthy volunteers
1420790|NCT01081392|neutrophils in sputum|neutrophils in sputum
1420791|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
1420792|NCT01081379|Pregnancy|pregnancy
1420793|NCT01081379|T-Lymphocytes|t-lymphocytes
1420794|NCT01081379|Transmission|transmission
1420795|NCT01081353|Aspirin|aspirin
1420796|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
1420797|NCT01081340|gestational weight gain|gestational weight gain
1420798|NCT01081340|postpartum weight loss|postpartum weight loss
1420799|NCT01081340|breastfeeding|breastfeeding
1420800|NCT01081340|overfeeding|overfeeding
1420801|NCT01081327|Atrial Fibrillation|atrial fibrillation
1420802|NCT01081327|Warfarin|warfarin
1420803|NCT01081327|Safety|safety
1420804|NCT01081301|hope|hope
1420805|NCT01081301|quality of life|quality of life
1420806|NCT01081301|caregivers|caregivers
1420807|NCT01081288|Breast cancer|breast cancer
1420808|NCT01081288|Breast screening|breast screening
1420809|NCT01081288|Mammography|mammography
1420810|NCT01081288|Routine screening programme|routine screening programme
1420811|NCT01081275|Multiple Sclerosis|multiple sclerosis
1420812|NCT01081275|MS|ms
1420813|NCT01081275|CI Therapy|ci therapy
1420814|NCT01081275|CIMT|cimt
1420815|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
1420816|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
1420817|NCT01081275|CAM|cam
1420818|NCT01081275|Physical Therapy|physical therapy
1420819|NCT01081275|Occupational Therapy|occupational therapy
1420820|NCT01081275|Relaxation|relaxation
1420821|NCT01081275|Exercise|exercise
1420822|NCT01081275|Massage|massage
1420823|NCT01081275|Yoga|yoga
1420824|NCT01081275|Pool Therapy|pool therapy
1420825|NCT01081275|Aquatherapy|aquatherapy
1420826|NCT01081275|Aquatic Therapy|aquatic therapy
1420827|NCT01081249|psychotherapy|psychotherapy
1420828|NCT01081236|liver cirrhosis|liver cirrhosis
1420829|NCT01081236|intestinal permeability|intestinal permeability
1420830|NCT01081236|microbiota|microbiota
1420831|NCT01081236|complications|complications
1420832|NCT01081223|Brain Neoplasms|brain neoplasms
1420833|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
1420834|NCT01081223|Brain Diseases|brain diseases
1420835|NCT01081223|Neoplasms|neoplasms
1420836|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
1420837|NCT01081223|Glioblastoma|glioblastoma
1420838|NCT01081223|Astrocytoma|astrocytoma
1420839|NCT01081223|Nervous System Diseases|nervous system diseases
1420840|NCT01081223|Central Nervous System Diseases|central nervous system diseases
1420841|NCT01081223|Glioma|glioma
1420842|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
1420843|NCT01081223|Recurrent glioma|recurrent glioma
1420844|NCT01081223|Cancer vaccine|cancer vaccine
1420845|NCT01081223|Immunotherapy|immunotherapy
1420846|NCT01081223|Killer T cells|killer t cells
1420847|NCT01081223|Activated T cells|activated t cells
1420848|NCT01081223|GM-CSF|gm-csf
1420849|NCT01081223|Low dose IL-2|low dose il-2
1420850|NCT01081223|Activated lymphocytes|activated lymphocytes
1420851|NCT01081210|Echocardiography|echocardiography
1420852|NCT01081210|Heart failure|heart failure
1420853|NCT01081210|Kidney|kidney
1420854|NCT01081210|Lung|lung
1420855|NCT01081210|Aorta|aorta
1420856|NCT01081197|heart failure|heart failure
1420857|NCT01081197|liver|liver
1420858|NCT01081197|depression|depression
1420859|NCT01081197|neuropathy|neuropathy
1420860|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
1420861|NCT01081184|neurotrophins|neurotrophins
1420862|NCT01081184|B cell|b cell
1420863|NCT01081184|sicca syndrome|sicca syndrome
1420864|NCT01081184|T cell|t cell
1420865|NCT01081119|adolescent|adolescent
1420866|NCT01081119|middle school|middle school
1420867|NCT01081119|prevention|prevention
1420868|NCT01081119|alcohol|alcohol
1420869|NCT01081119|cigarettes|cigarettes
1420870|NCT01081119|marijuana|marijuana
1420871|NCT01081106|Breast Cancer|breast cancer
1420872|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
1420873|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
1420874|NCT01081080|cardiac|cardiac
1420875|NCT01081080|muscle|muscle
1420876|NCT01081080|pediatric|pediatric
1420877|NCT01081080|dystrophy|dystrophy
1420878|NCT01081054|Diverticulitis|diverticulitis
1421071|NCT01080118|Video Scope|video scope
1420879|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
1420880|NCT01081028|Multiple Myeloma|multiple myeloma
1420881|NCT01081028|MM|mm
1420882|NCT01081028|disease registry|disease registry
1420883|NCT01081028|Connect®|connect®
1420884|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1420885|NCT01081015|CLL|cll
1420886|NCT01081015|disease registry|disease registry
1420887|NCT01081015|Connect™|connect™
1420888|NCT01081002|Propofol|propofol
1420889|NCT01081002|Conscious sedation|conscious sedation
1420890|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
1420891|NCT01081002|Anesthetics, Local|anesthetics, local
1420892|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
1420893|NCT01080989|solomon islands|solomon islands
1420894|NCT01080989|malaria|malaria
1420895|NCT01080989|flavivirus|flavivirus
1420896|NCT01080989|alphavirus|alphavirus
1420897|NCT01080989|parasite|parasite
1420898|NCT01080989|leptospirosis|leptospirosis
1420899|NCT01080963|Prophylaxis|prophylaxis
1420900|NCT01080963|Antibiotic|antibiotic
1420901|NCT01080963|Sternotomy|sternotomy
1420902|NCT01080963|Heart-Lung Machine|heart-lung machine
1420903|NCT01080950|zinc|zinc
1420904|NCT01080950|sepsis|sepsis
1420905|NCT01080950|fever|fever
1420906|NCT01080950|vitamin d|vitamin d
1420907|NCT01080937|acute heart failure|acute heart failure
1420908|NCT01080911|Spinal morphine|spinal morphine
1420909|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
1420910|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
1420911|NCT01080898|Optical Coherence Tomography|optical coherence tomography
1420912|NCT01080898|Choroidal neovascularization|choroidal neovascularization
1420913|NCT01080898|FLORESCEIN Angiography|florescein angiography
1420914|NCT01080898|Fundus photographs|fundus photographs
1420915|NCT01080885|Prevention|prevention
1420916|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
1420917|NCT01080872|acute coronary syndrome|acute coronary syndrome
1420918|NCT01080872|coronary flow reserve|coronary flow reserve
1420919|NCT01080872|OCT|oct
1420920|NCT01080872|healing|healing
1420921|NCT01080872|drug eluting stent|drug eluting stent
1420922|NCT01080859|titanium|titanium
1420923|NCT01080859|everolimus|everolimus
1420924|NCT01080859|oct|oct
1420925|NCT01080859|acute coronary syndrome|acute coronary syndrome
1420926|NCT01080859|stent|stent
1420927|NCT01080859|pci|pci
1420928|NCT01080859|stenting|stenting
1420929|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
1420930|NCT01080846|PPH|pph
1420931|NCT01080846|uterine atony|uterine atony
1420932|NCT01080846|high fever|high fever
1420933|NCT01080846|hyperpyrexia|hyperpyrexia
1420934|NCT01080833|EMS|ems
1420935|NCT01080833|ERCP|ercp
1420936|NCT01080833|Training|training
1420937|NCT01080833|Trainees|trainees
1420938|NCT01080820|Healthy adult volunteers|healthy adult volunteers
1420939|NCT01080820|Pharmacokinetics|pharmacokinetics
1420940|NCT01080794|Parkinson's Disease|parkinson's disease
1420941|NCT01080794|Depression|depression
1420942|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1420943|NCT01080781|Cardiomyopathy|cardiomyopathy
1420944|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
1420945|NCT01080781|cell-cell junctions|cell-cell junctions
1420946|NCT01080781|heart rate variability|heart rate variability
1420947|NCT01080781|right appendage|right appendage
1420948|NCT01080768|Pedal edema|pedal edema
1420949|NCT01080768|hypertension|hypertension
1420950|NCT01080768|aliskiren|aliskiren
1420951|NCT01080768|amlodipine|amlodipine
1420952|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
1420953|NCT01080755|Pituitary|pituitary
1420954|NCT01080755|Saizen|saizen
1420955|NCT01080755|Somatropin|somatropin
1420956|NCT01080755|Growth Hormone|growth hormone
1420957|NCT01080742|Hypertension|hypertension
1420958|NCT01080742|Lodoz|lodoz
1420959|NCT01080742|Bisoprolol|bisoprolol
1420960|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
1420961|NCT01080729|Ovulation induction|ovulation induction
1420962|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
1420963|NCT01080729|Multifollicular stimulation|multifollicular stimulation
1420964|NCT01080729|Pregnancy|pregnancy
1420965|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
1420966|NCT01080729|Fertility|fertility
1420967|NCT01080703|Lung Transplant|lung transplant
1420968|NCT01080703|Quadriceps Strength|quadriceps strength
1420969|NCT01080703|Quality of Life|quality of life
1420970|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
1420971|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
1420972|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
1420973|NCT01080664|AS703569|as703569
1420974|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
1420975|NCT01080664|Haematological malignancies|haematological malignancies
1420976|NCT01080638|abciximab|abciximab
1420977|NCT01080638|Myocardial Infarction|myocardial infarction
1420978|NCT01080638|angioplasty|angioplasty
1420979|NCT01080638|Platelet|platelet
1420980|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
1420981|NCT01080625|phenylephrine|phenylephrine
1420982|NCT01080625|epinephrine|epinephrine
1420983|NCT01080625|liver transplantation|liver transplantation
1420984|NCT01080612|pregabalin|pregabalin
1420985|NCT01080612|pharmacokinetics|pharmacokinetics
1420986|NCT01080612|bioavailability|bioavailability
1420987|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
1420988|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1420989|NCT01080573|Multiple sclerosis|multiple sclerosis
1420990|NCT01080573|Rebif|rebif
1420991|NCT01080573|Interferon beta-1a|interferon beta-1a
1420992|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1420993|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1420994|NCT01080508|pressure pattern|pressure pattern
1420995|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
1420996|NCT01080508|esophageal intubation.|esophageal intubation.
1420997|NCT01080495|left ventricular function|left ventricular function
1420998|NCT01080495|radial strain|radial strain
1420999|NCT01080495|fractional shortening|fractional shortening
1421000|NCT01080495|fractional area change|fractional area change
1421001|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1421002|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1421003|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1421004|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1421005|NCT01080430|vestibular|vestibular
1421006|NCT01080430|vertigo|vertigo
1421007|NCT01080430|rehabilitation|rehabilitation
1421008|NCT01080430|rotation|rotation
1421009|NCT01080430|balance|balance
1421010|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
1421011|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
1421012|NCT01080404|Obesity|obesity
1421013|NCT01080404|Metabolism|metabolism
1421014|NCT01080404|Bariatric surgery|bariatric surgery
1421015|NCT01080404|CPAP|cpap
1421016|NCT01080391|Multiple Myeloma|multiple myeloma
1421017|NCT01080352|Prostate cancer|prostate cancer
1421018|NCT01080352|palliative care|palliative care
1421019|NCT01080352|antioxidants|antioxidants
1421020|NCT01080352|ascorbic acid|ascorbic acid
1421021|NCT01080352|rna expression|rna expression
1421022|NCT01080339|insulin resistance|insulin resistance
1421023|NCT01080339|cardiovascular risk|cardiovascular risk
1421024|NCT01080339|physical activity|physical activity
1421025|NCT01080339|child|child
1421026|NCT01080326|ulcer repair surgery|ulcer repair surgery
1421027|NCT01080326|transluminal omental patch|transluminal omental patch
1421028|NCT01080300|Hot Flushes|hot flushes
1421029|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
1421030|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
1421031|NCT01080287|autonomic|autonomic
1421032|NCT01080287|orthostatic|orthostatic
1421033|NCT01080287|syncope|syncope
1421034|NCT01080287|biopsy|biopsy
1421945|NCT01076790|Heart rate|heart rate
1421035|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
1421036|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
1421037|NCT01080274|ergometry|ergometry
1421038|NCT01080274|vitamin d|vitamin d
1421039|NCT01080274|zinc|zinc
1421040|NCT01080261|Atherosclerosis|atherosclerosis
1421041|NCT01080261|Coronary Artery Disease|coronary artery disease
1421042|NCT01080248|Pancreas|pancreas
1421043|NCT01080235|quality improvement|quality improvement
1421044|NCT01080235|geriatric care|geriatric care
1421045|NCT01080235|residency training|residency training
1421046|NCT01080222|VX-950|vx-950
1421047|NCT01080196|Falling risk|falling risk
1421048|NCT01080196|muscle conditioning|muscle conditioning
1421049|NCT01080196|muscle size|muscle size
1421050|NCT01080196|isometric strength|isometric strength
1421051|NCT01080196|Incidence in falls|incidence in falls
1421052|NCT01080183|Health-related quality of life|health-related quality of life
1421053|NCT01080183|physical activity|physical activity
1421054|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
1421055|NCT01080170|Anastrazole|anastrazole
1421056|NCT01080170|Arimidex|arimidex
1421057|NCT01080170|Heart disease|heart disease
1421058|NCT01080170|Lipids|lipids
1421059|NCT01080170|Body composition|body composition
1421060|NCT01080170|Breast cancer.|breast cancer.
1421061|NCT01080157|Diabetes|diabetes
1421062|NCT01080157|Diabetes Screening|diabetes screening
1421063|NCT01080157|Experimental Medical Device|experimental medical device
1421064|NCT01080144|Cirrhosis|cirrhosis
1421065|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
1421066|NCT01080144|Encephalopathy|encephalopathy
1421067|NCT01080131|Frequent flares|frequent flares
1421068|NCT01080131|Gout|gout
1421069|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
1421070|NCT01080118|Teaching|teaching
1421072|NCT01080118|Intubation|intubation
1421073|NCT01080105|Depression Prevention|depression prevention
1421074|NCT01080105|Prevention|prevention
1421075|NCT01080105|Major Depressive Disorder|major depressive disorder
1421076|NCT01080105|Internet|internet
1421077|NCT01080105|Technology Assisted|technology assisted
1421078|NCT01080092|smokers|smokers
1421079|NCT01080079|Onychomycosis|onychomycosis
1421080|NCT01080066|Carcinoma|carcinoma
1421081|NCT01080066|Squamous cell|squamous cell
1421082|NCT01080066|Erbitux|erbitux
1421083|NCT01080066|cetuximab|cetuximab
1421084|NCT01080066|Head|head
1421085|NCT01080066|Neck|neck
1421086|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
1421087|NCT01080053|Sexual dysfunction|sexual dysfunction
1421088|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
1421089|NCT01080040|Quality of life|quality of life
1421090|NCT01080027|Multiple sclerosis|multiple sclerosis
1421091|NCT01080027|Relapsing remitting|relapsing remitting
1421092|NCT01080027|Rebif|rebif
1421093|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
1421094|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
1421095|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
1421096|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
1421097|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
1421098|NCT01080001|Multiple sclerosis|multiple sclerosis
1421099|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
1421100|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
1421101|NCT01080001|Fatigue|fatigue
1421102|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
1421103|NCT01080001|Depression|depression
1421104|NCT01079988|Psoriasis|psoriasis
1421105|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
1421106|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
1421107|NCT01079975|Multiple sclerosis|multiple sclerosis
1421108|NCT01079975|Depression|depression
1421109|NCT01079962|Bisoprolol|bisoprolol
1421110|NCT01079962|Atenolol|atenolol
1421111|NCT01079962|Hypertension|hypertension
1421112|NCT01079962|Blood pressure|blood pressure
1421113|NCT01079949|Infertility|infertility
1421114|NCT01079949|Ovulation induction|ovulation induction
1421115|NCT01079949|Luveris|luveris
1421116|NCT01079949|Lutropin alfa|lutropin alfa
1421117|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
1421118|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
1421119|NCT01079936|Multiple Myeloma|multiple myeloma
1421120|NCT01079936|Lenalidomide|lenalidomide
1421121|NCT01079936|Revlimid|revlimid
1421122|NCT01079936|Melphalan|melphalan
1421123|NCT01079936|Alkeran|alkeran
1421124|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
1421125|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
1421126|NCT01079923|healthy volunteers|healthy volunteers
1421127|NCT01079923|healthy subjects|healthy subjects
1421128|NCT01079923|vitamin D|vitamin d
1421129|NCT01079923|cholecalciferol|cholecalciferol
1421130|NCT01079923|vitamin D3|vitamin d3
1421131|NCT01079923|total vitamin D|total vitamin d
1421132|NCT01079910|Plaque|plaque
1421133|NCT01079910|Toothpaste|toothpaste
1421134|NCT01079910|Gingivitis|gingivitis
1553924|NCT00561912|RCC|rcc
1421135|NCT01079897|Atopic dermatitis|atopic dermatitis
1421136|NCT01079897|Ectoine|ectoine
1421137|NCT01079897|Treatment|treatment
1421138|NCT01079897|Atopiclair|atopiclair
1421139|NCT01079897|Medical device|medical device
1421140|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
1421141|NCT01079871|Dry Eye|dry eye
1421142|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
1421143|NCT01079858|Dry Eye|dry eye
1421144|NCT01079845|Diet|diet
1421145|NCT01079845|Nutrition|nutrition
1421146|NCT01079845|Adolescent|adolescent
1421147|NCT01079845|Young Adult|young adult
1421148|NCT01079845|Overweight|overweight
1421149|NCT01079845|Obesity|obesity
1421150|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1421151|NCT01079793|stage III prostate cancer|stage iii prostate cancer
1421152|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
1421153|NCT01079780|recurrent colon cancer|recurrent colon cancer
1421154|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
1421155|NCT01079780|stage III colon cancer|stage iii colon cancer
1421156|NCT01079780|stage IV colon cancer|stage iv colon cancer
1421157|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
1421158|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
1421159|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
1421160|NCT01079780|stage III rectal cancer|stage iii rectal cancer
1421161|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
1421162|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1421163|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
1421164|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1421165|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1421166|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
1421167|NCT01079754|Spinal morphine|spinal morphine
1421168|NCT01079741|Melanoma|melanoma
1421169|NCT01079741|Skin Cancer|skin cancer
1421170|NCT01079741|Adjuvant Therapy|adjuvant therapy
1421171|NCT01079741|Oncogenesis|oncogenesis
1421172|NCT01079741|LAGE|lage
1421173|NCT01079741|Cancer Immunity|cancer immunity
1421174|NCT01079741|Neoplasms|neoplasms
1421175|NCT01079741|Immunogenicity|immunogenicity
1421176|NCT01079741|Vaccine|vaccine
1421177|NCT01079741|Immunotherapy|immunotherapy
1421178|NCT01079728|ischemic stroke|ischemic stroke
1421179|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
1421180|NCT01079728|prediction|prediction
1421181|NCT01079728|immune and infection parameters|immune and infection parameters
1421182|NCT01079715|Newborn|newborn
1421183|NCT01079715|Retinal Diseases|retinal diseases
1421184|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
1421185|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1421186|NCT01079689|basic science|basic science
1421187|NCT01079689|healthy volunteers|healthy volunteers
1421188|NCT01079650|children|children
1421189|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
1421190|NCT01079624|Incretin hormones|incretin hormones
1421191|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
1421192|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
1421193|NCT01079624|Gastric emptying|gastric emptying
1421194|NCT01079624|Appetite|appetite
1421195|NCT01079624|Glucose disposal|glucose disposal
1421196|NCT01079624|Gut hormones|gut hormones
1421197|NCT01079598|IPV|ipv
1421198|NCT01079598|RadioFrequency|radiofrequency
1421199|NCT01079598|QOL|qol
1421200|NCT01079572|osteoarthritis|osteoarthritis
1421201|NCT01079572|arthroplasty|arthroplasty
1421202|NCT01079572|web-based|web-based
1421203|NCT01079572|electronic follow-up|electronic follow-up
1421204|NCT01079559|total knee arthroplasty|total knee arthroplasty
1421205|NCT01079559|infection|infection
1421206|NCT01079559|antibiotic bone cement|antibiotic bone cement
1421207|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
1421208|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
1421209|NCT01079533|Mass Screening|mass screening
1421210|NCT01079533|Patient Compliance|patient compliance
1421211|NCT01079533|Intervention Studies|intervention studies
1421212|NCT01079533|Clinical Trial|clinical trial
1421213|NCT01079520|Cancer|cancer
1421214|NCT01079520|Lung Cancer|lung cancer
1421215|NCT01079520|Ultrasound|ultrasound
1421216|NCT01079520|Surgery|surgery
1421217|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
1421218|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1421219|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
1421220|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
1421221|NCT01079481|Paclitaxel|paclitaxel
1421222|NCT01079481|Everolimus|everolimus
1422047|NCT01076179|Rilpivirine|rilpivirine
1421223|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
1421224|NCT01079455|Coxarthrosis|coxarthrosis
1421226|NCT01079455|Infiltration|infiltration
1421227|NCT01079455|Hyaluronic Acid|hyaluronic acid
1421228|NCT01079455|Corticosterone|corticosterone
1421229|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
1421230|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1421231|NCT01079429|MGUS|mgus
1421232|NCT01079429|Smoldering myeloma|smoldering myeloma
1421233|NCT01079429|SMM|smm
1421234|NCT01079429|Multiple myeloma|multiple myeloma
1421235|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
1421236|NCT01079390|acupuncture|acupuncture
1421237|NCT01079390|osteoarthritis|osteoarthritis
1421238|NCT01079390|fMRI|fmri
1421239|NCT01079377|Adolescents|adolescents
1421240|NCT01079377|Bariatric Surgery|bariatric surgery
1421241|NCT01079377|Psychological Symptoms|psychological symptoms
1421242|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
1421243|NCT01079377|Telemedicine|telemedicine
1421244|NCT01079377|Longitudinal|longitudinal
1421245|NCT01079351|Epilepsy|epilepsy
1421246|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
1421247|NCT01079351|Oral Carbamazepine|oral carbamazepine
1421248|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
1421249|NCT01079325|Diabetic neuropathy|diabetic neuropathy
1421250|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
1421251|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
1421252|NCT01079312|ERCP|ercp
1421253|NCT01079312|patient-controlled sedation|patient-controlled sedation
1421254|NCT01079312|propofol|propofol
1421255|NCT01079312|remifentanil|remifentanil
1421256|NCT01079312|sedation level|sedation level
1421257|NCT01079299|venous ulcer|venous ulcer
1421258|NCT01079299|secondary lymphedema|secondary lymphedema
1421259|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
1421260|NCT01079286|mTOR inhibition|mtor inhibition
1421261|NCT01079286|advanced malignancies|advanced malignancies
1421262|NCT01079286|pharmacokinetics|pharmacokinetics
1421263|NCT01079286|Akt inhibition|akt inhibition
1421264|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
1421265|NCT01079273|Influenza|influenza
1421266|NCT01079273|Vaccines|vaccines
1421267|NCT01079273|A/H1N1|a/h1n1
1421268|NCT01079273|Influenza Vaccines|influenza vaccines
1421269|NCT01079260|Malnourished|malnourished
1421270|NCT01079260|Elderly|elderly
1421271|NCT01079260|Nutrition support|nutrition support
1421272|NCT01079247|Burn|burn
1421273|NCT01079247|Transfusion|transfusion
1421274|NCT01079247|blood|blood
1421275|NCT01079247|hemoglobin|hemoglobin
1421276|NCT01079221|exercise|exercise
1421277|NCT01079221|Knee extensor|knee extensor
1421278|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
1421279|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
1421280|NCT01079195|Hypertensive patients|hypertensive patients
1421281|NCT01079195|Diabetes mellitus|diabetes mellitus
1421282|NCT01079195|Observational study|observational study
1421283|NCT01079182|Daily practice|daily practice
1421284|NCT01079182|Humira|humira
1421285|NCT01079182|Efficacy|efficacy
1421286|NCT01079182|Safety|safety
1421287|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
1421288|NCT01079169|urinary tract infection|urinary tract infection
1421289|NCT01079169|prevention|prevention
1421290|NCT01079169|rehabilitation|rehabilitation
1421291|NCT01079169|spinal cord injury|spinal cord injury
1421292|NCT01079143|De Novo renal transplantation|de novo renal transplantation
1421293|NCT01079130|Indacaterol|indacaterol
1421294|NCT01079130|asthma|asthma
1421295|NCT01079130|salmeterol|salmeterol
1421296|NCT01079117|Opiate|opiate
1421297|NCT01079117|Methadone|methadone
1421298|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
1421299|NCT01079117|Sevre-Long™|sevre-long™
1421300|NCT01079104|Liver failure|liver failure
1421301|NCT01079104|Hepatic insufficiency|hepatic insufficiency
1421302|NCT01079104|Artificial liver|artificial liver
1421303|NCT01079104|Albumin dialysis|albumin dialysis
1421304|NCT01079091|Liver failure|liver failure
1421305|NCT01079091|Hepatic insufficiency|hepatic insufficiency
1421306|NCT01079091|Liver Cirrhosis|liver cirrhosis
1421307|NCT01079091|Artificial liver|artificial liver
1421308|NCT01079091|Albumin dialysis|albumin dialysis
1421309|NCT01079078|Acetaminophen fed study|acetaminophen fed study
1421310|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
1421311|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
1421312|NCT01079026|biomarker|biomarker
1421313|NCT01079026|epidural steroid|epidural steroid
1421314|NCT01079026|radiculopathy|radiculopathy
1421315|NCT01079026|hnp|hnp
1421316|NCT01079000|asthma|asthma
1421317|NCT01079000|exacerbation|exacerbation
1421318|NCT01079000|emergency department|emergency department
1421319|NCT01079000|relapse|relapse
1421320|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
1421321|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
1421322|NCT01078974|WM|wm
1421323|NCT01078974|pomalidomide|pomalidomide
1421324|NCT01078974|dexamethasone|dexamethasone
1421325|NCT01078974|rituximab|rituximab
1421326|NCT01078961|bortezomib|bortezomib
1421327|NCT01078961|sorafenib|sorafenib
1421328|NCT01078961|advanced melanoma|advanced melanoma
1421329|NCT01078948|tDCS|tdcs
1421330|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
1421331|NCT01078948|major depression|major depression
1421332|NCT01078948|double-blind|double-blind
1421333|NCT01078948|randomized|randomized
1421334|NCT01078948|placebo-controlled|placebo-controlled
1421335|NCT01078948|treatment|treatment
1421336|NCT01078935|Crohn's disease activity index|crohn's disease activity index
1421337|NCT01078935|CDAI|cdai
1421338|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
1421339|NCT01078922|refractory DLBCL|refractory dlbcl
1421340|NCT01078922|relapsed DLBCL|relapsed dlbcl
1421341|NCT01078909|Cardiovascular disease|cardiovascular disease
1421342|NCT01078909|Inflammation|inflammation
1421343|NCT01078909|Fish Oil|fish oil
1421344|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
1421345|NCT01078909|LPS|lps
1421346|NCT01078909|Endotoxin|endotoxin
1421347|NCT01078883|Lung cancer|lung cancer
1421348|NCT01078883|Respiratory muscle strength|respiratory muscle strength
1421349|NCT01078883|Dyspnea|dyspnea
1421350|NCT01078883|Functional capacity|functional capacity
1421351|NCT01078870|Negative symptom|negative symptom
1421352|NCT01078857|Chronic kidney disease|chronic kidney disease
1421353|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
1421354|NCT01078857|Skin biopsy|skin biopsy
1421355|NCT01078857|Contact heat evoked potential|contact heat evoked potential
1421356|NCT01078857|Autonomic neuropathy|autonomic neuropathy
1421357|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
1421358|NCT01078844|Autism|autism
1421359|NCT01078844|Asperger's Disorder|asperger's disorder
1421360|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
1421361|NCT01078844|Adult|adult
1421362|NCT01078844|Memantine|memantine
1421363|NCT01078818|Cardiac surgery|cardiac surgery
1421364|NCT01078818|Extracorporeal circulation|extracorporeal circulation
1421365|NCT01078818|Anaemia|anaemia
1421366|NCT01078818|Intravenous iron|intravenous iron
1421367|NCT01078818|Oral Iron|oral iron
1421368|NCT01078779|Influenza|influenza
1421369|NCT01078779|Prevention|prevention
1421370|NCT01078779|Chloroquine|chloroquine
1421371|NCT01078779|Randomised controlled trial|randomised controlled trial
1421372|NCT01078779|Respiratory virus infection|respiratory virus infection
1421373|NCT01078766|cerebral palsy|cerebral palsy
1421374|NCT01078740|cystic fibrosis|cystic fibrosis
1421375|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
1421376|NCT01078740|biomarkers|biomarkers
1421377|NCT01078740|Intestinal Current Measurement|intestinal current measurement
1421378|NCT01078727|Thermal Stimulation|thermal stimulation
1421379|NCT01078727|Upper Extremity|upper extremity
1421380|NCT01078727|Motor Recovery|motor recovery
1421381|NCT01078727|Stroke|stroke
1421382|NCT01078714|Autism|autism
1421383|NCT01078714|Bumetanide|bumetanide
1421384|NCT01078714|GABA|gaba
1421385|NCT01078714|NKCC1|nkcc1
1421386|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
1421387|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
1421388|NCT01078701|intranasal application|intranasal application
1421389|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
1421390|NCT01078688|Limitations of activities|limitations of activities
1421391|NCT01078688|persistent asthma|persistent asthma
1421392|NCT01078688|general practitioner|general practitioner
1421393|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
1421394|NCT01078688|depending on gender and age-group|depending on gender and age-group
1421395|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
1421396|NCT01078675|pediatric|pediatric
1421397|NCT01078662|olaparib|olaparib
1421398|NCT01078662|PARP inhibitors|parp inhibitors
1421399|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
1421400|NCT01078662|BRCA2 mutation|brca2 mutation
1421401|NCT01078662|solid tumour refractory|solid tumour refractory
1421402|NCT01078649|cancer|cancer
1421403|NCT01078649|solid tumors|solid tumors
1421404|NCT01078649|lymphoma|lymphoma
1421405|NCT01078649|smac mimetic|smac mimetic
1421406|NCT01078649|IAP inhibitor|iap inhibitor
1421407|NCT01078649|Phase I|phase i
1421408|NCT01078649|Dose escalation|dose escalation
1421409|NCT01078636|amyloid|amyloid
1421410|NCT01078636|plaques|plaques
1421411|NCT01078636|imaging|imaging
1421412|NCT01078636|early detection|early detection
1421413|NCT01078636|Amnestic MCI|amnestic mci
1421414|NCT01078636|pre-dementia|pre-dementia
1421415|NCT01078623|Bronchitis|bronchitis
1421416|NCT01078623|Chronic|chronic
1421417|NCT01078623|Emphysema|emphysema
1421418|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
1422331|NCT01075152|AIDS|aids
1421419|NCT01078610|Long-term Observation|long-term observation
1421420|NCT01078610|Humira|humira
1421421|NCT01078610|Safety|safety
1421422|NCT01078610|Effectiveness|effectiveness
1421423|NCT01078610|Quality of Life|quality of life
1421424|NCT01078610|Work Productivity|work productivity
1421425|NCT01078597|anti-MCV|anti-mcv
1421426|NCT01078597|anti-CCP|anti-ccp
1421427|NCT01078597|Biomarkers|biomarkers
1421428|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
1421429|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
1421430|NCT01078584|trandolapril|trandolapril
1421431|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
1421432|NCT01078571|Biologic|biologic
1421433|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
1421434|NCT01078558|Multicenter study|multicenter study
1421435|NCT01078545|Prostate cancer|prostate cancer
1421436|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
1421437|NCT01078545|Hormonotherapy|hormonotherapy
1421438|NCT01078545|LHRH analogue|lhrh analogue
1421439|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
1421440|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
1421441|NCT01078519|Fever|fever
1421442|NCT01078519|anesthesia|anesthesia
1421443|NCT01078519|Labor|labor
1421444|NCT01078506|Chinese|chinese
1421445|NCT01078506|intracranial aneurysm|intracranial aneurysm
1421446|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
1421447|NCT01078493|Platelet rich plasma|platelet rich plasma
1421449|NCT01078493|wrinkles|wrinkles
1421450|NCT01078493|MyCells®|mycells®
1421451|NCT01078493|CREATE|create
1421452|NCT01078493|Life Source Medical Centre|life source medical centre
1421453|NCT01078493|Dr Tan Kok leong|dr tan kok leong
1421454|NCT01078480|Fracture|fracture
1421455|NCT01078480|Collar bone|collar bone
1421456|NCT01078467|Wound Healing|wound healing
1421457|NCT01078467|Oral Wounds|oral wounds
1421458|NCT01078467|Cutaneous Wounds|cutaneous wounds
1421459|NCT01078467|Gene Array Analysis|gene array analysis
1421460|NCT01078467|Proteomic Analysis|proteomic analysis
1421461|NCT01078467|Healthy Volunteer|healthy volunteer
1421462|NCT01078467|HV|hv
1421463|NCT01078454|Melphalan|melphalan
1421464|NCT01078454|Dexamethasone|dexamethasone
1421465|NCT01078454|Bortezomib|bortezomib
1421466|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
1421467|NCT01078441|Bortezomib|bortezomib
1421468|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
1421469|NCT01078441|Dexamethasone|dexamethasone
1421470|NCT01078441|Cyclophosphamide|cyclophosphamide
1421471|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
1421472|NCT01078428|Hypertrophic scars|hypertrophic scars
1421473|NCT01078428|Topical silicone gel|topical silicone gel
1421474|NCT01078428|Scar thickness|scar thickness
1421475|NCT01078428|Scar Color|scar color
1421476|NCT01078428|Scar pliability|scar pliability
1421477|NCT01078428|Scar appearance|scar appearance
1421478|NCT01078415|HCC|hcc
1421479|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
1421480|NCT01078415|Early Stage|early stage
1421481|NCT01078415|Prospective|prospective
1421482|NCT01078415|Multicenter|multicenter
1421483|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
1421484|NCT01078415|Electroporation|electroporation
1421485|NCT01078415|Low Energy Direct Current|low energy direct current
1421486|NCT01078415|LEDC|ledc
1421487|NCT01078415|Nonthermal ablation|nonthermal ablation
1421488|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
1421489|NCT01078415|Ablation|ablation
1421490|NCT01078415|Soft Tissue|soft tissue
1421491|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
1421492|NCT01078402|Eastern European countries|eastern european countries
1421493|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
1421494|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
1421495|NCT01078402|Adalimumab|adalimumab
1421496|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
1421497|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
1421498|NCT01078389|Gout|gout
1421499|NCT01078389|Hyperuricemia|hyperuricemia
1421500|NCT01078389|Uric Acid|uric acid
1421501|NCT01078389|Drug Therapy|drug therapy
1421502|NCT01078376|Pediatrics|pediatrics
1421503|NCT01078376|Blood Pressure, High|blood pressure, high
1421504|NCT01078376|Drug Therapy|drug therapy
1421505|NCT01078363|Heart Transplantation|heart transplantation
1421506|NCT01078350|Lymphoma|lymphoma
1421507|NCT01078350|Hodgkin Disease|hodgkin disease
1421508|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
1421509|NCT01078298|smoking|smoking
1421510|NCT01078298|smoking cessation|smoking cessation
1421511|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
1421512|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
1421513|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
1422332|NCT01075152|strategy|strategy
1421514|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
1421515|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
1421516|NCT01078272|Coronary Stenting|coronary stenting
1421517|NCT01078272|Coronary Stenosis|coronary stenosis
1421518|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
1421519|NCT01078246|HIV|hiv
1421520|NCT01078233|HIV|hiv
1421521|NCT01078233|antiretroviral treatment|antiretroviral treatment
1421522|NCT01078233|HIV Cohort|hiv cohort
1421523|NCT01078233|Treatment|treatment
1421524|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1421525|NCT01078194|Weight regain|weight regain
1421526|NCT01078194|Weight loss failure|weight loss failure
1421527|NCT01078194|Gastric bypass|gastric bypass
1421528|NCT01078181|gastric bypass|gastric bypass
1421529|NCT01078181|banded gastric bypass|banded gastric bypass
1421530|NCT01078181|weight loss|weight loss
1421531|NCT01078181|weight regain|weight regain
1421532|NCT01078181|bariatric surgery|bariatric surgery
1421533|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
1421534|NCT01078155|Bone mineral density|bone mineral density
1421535|NCT01078155|Bone turnover markers|bone turnover markers
1421536|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
1421537|NCT01078155|Osteoporosis|osteoporosis
1421538|NCT01078142|temsirolimus|temsirolimus
1421539|NCT01078142|bendamustine|bendamustine
1421540|NCT01078142|rituximab|rituximab
1421541|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
1421542|NCT01078142|follicular lymphoma|follicular lymphoma
1421543|NCT01078129|cognitive deficits|cognitive deficits
1421544|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
1421545|NCT01078116|Adalimumab treatment|adalimumab treatment
1421546|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
1421547|NCT01078116|Cost of the disease management|cost of the disease management
1421548|NCT01078103|Diabetes Mellitus|diabetes mellitus
1421549|NCT01078103|cornea endothelium|cornea endothelium
1421550|NCT01078103|cell loss|cell loss
1421551|NCT01078103|cataract surgery|cataract surgery
1421552|NCT01078090|Safety|safety
1421553|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
1421554|NCT01078090|Effectiveness|effectiveness
1421555|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
1421556|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
1421557|NCT01078051|chronic total occlusion|chronic total occlusion
1421558|NCT01078051|stent|stent
1421559|NCT01078051|medical therapy|medical therapy
1421560|NCT01078038|Coronary Artery Disease|coronary artery disease
1421561|NCT01078038|Stent|stent
1421562|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
1421563|NCT01077999|chemoradiation|chemoradiation
1421564|NCT01077999|panitumumab|panitumumab
1421565|NCT01077999|esophageal cancer|esophageal cancer
1421566|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
1421567|NCT01077986|mTOR inhibition|mtor inhibition
1421568|NCT01077986|EGFR inhibition|egfr inhibition
1421569|NCT01077986|pancreatic cancer|pancreatic cancer
1421570|NCT01077986|pharmacodynamics|pharmacodynamics
1421571|NCT01077973|Headache|headache
1421572|NCT01077960|Serostim|serostim
1421573|NCT01077960|HARS|hars
1421574|NCT01077947|low back pain|low back pain
1421575|NCT01077947|spinal fusion|spinal fusion
1421576|NCT01077947|Primarily axial low back pain|primarily axial low back pain
1421577|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
1421578|NCT01077921|sickle|sickle
1421579|NCT01077921|adhesion|adhesion
1421580|NCT01077921|propranolol|propranolol
1421581|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
1421582|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1421583|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
1421584|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
1421585|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
1421586|NCT01077856|congenital anomaly|congenital anomaly
1421587|NCT01077856|pregnancy|pregnancy
1421588|NCT01077856|GARDASIL®|gardasil®
1421589|NCT01077856|Nordic|nordic
1421590|NCT01077856|population-based|population-based
1421591|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
1421592|NCT01077830|New Incidence of Cancer|new incidence of cancer
1421593|NCT01077791|Schizophrenia|schizophrenia
1421594|NCT01077791|social cognition|social cognition
1421595|NCT01077791|theory of mind|theory of mind
1421596|NCT01077791|cognitive therapy|cognitive therapy
1421597|NCT01077791|therapeutic trial|therapeutic trial
1421598|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
1568394|NCT00506012|Essential Myoclonus|essential myoclonus
1421599|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
1421600|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
1421601|NCT01077778|Perfusion Imaging|perfusion imaging
1421602|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
1421603|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
1421604|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
1421605|NCT01077752|Pain, postoperative|pain, postoperative
1421606|NCT01077752|Local infiltration|local infiltration
1421607|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
1421608|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
1421609|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
1421610|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
1421611|NCT01077687|schizophrenia|schizophrenia
1421612|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
1421613|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
1421614|NCT01077687|Han Chinese population|han chinese population
1421615|NCT01077687|trio families|trio families
1421616|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
1421617|NCT01077674|Electroencephalogram|electroencephalogram
1421618|NCT01077674|Entropy|entropy
1421619|NCT01077674|BIS|bis
1421620|NCT01077674|Sevoflurane|sevoflurane
1421621|NCT01077661|Nebivolol|nebivolol
1421622|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
1421623|NCT01077648|Breast Cancer|breast cancer
1421624|NCT01077648|Treatment|treatment
1421625|NCT01077648|Brain metastases|brain metastases
1421626|NCT01077648|ErbB2 expression|erbb2 expression
1421627|NCT01077635|HIV|hiv
1421628|NCT01077635|Antiretroviral therapy|antiretroviral therapy
1421629|NCT01077635|protease inbitor|protease inbitor
1421630|NCT01077635|fosamprenavir|fosamprenavir
1421631|NCT01077635|paediatrics|paediatrics
1421632|NCT01077609|Intranasal steroids|intranasal steroids
1421633|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
1421634|NCT01077609|steroid-related outcomes|steroid-related outcomes
1421635|NCT01077596|Carcinogenicity|carcinogenicity
1421636|NCT01077596|Case control|case control
1421637|NCT01077596|Bupropion|bupropion
1421638|NCT01077583|Pregnancy test|pregnancy test
1421639|NCT01077583|Wishing to become pregnant|wishing to become pregnant
1421640|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
1421641|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
1421642|NCT01077557|Zidovudine|zidovudine
1421643|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
1421644|NCT01077557|Fracture|fracture
1421645|NCT01077557|Amprenavir|amprenavir
1421646|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
1421647|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
1421648|NCT01077557|Lamivudine|lamivudine
1421649|NCT01077557|incidence|incidence
1421650|NCT01077557|Abacavir|abacavir
1421651|NCT01077557|risk|risk
1421652|NCT01077557|Fosamprenavir|fosamprenavir
1421653|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
1421654|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1421655|NCT01077544|Ph+ CML|ph+ cml
1421656|NCT01077544|Ph+ ALL|ph+ all
1421657|NCT01077544|pediatric|pediatric
1421658|NCT01077544|nilotinib|nilotinib
1421659|NCT01077544|imatinib|imatinib
1421660|NCT01077544|chronic phase|chronic phase
1421661|NCT01077544|accelerated phase|accelerated phase
1421662|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
1421663|NCT01077544|dasatinib|dasatinib
1421664|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
1421665|NCT01077531|intravenous infusion|intravenous infusion
1421666|NCT01077531|long-term followup|long-term followup
1421667|NCT01077518|Refractory|refractory
1421668|NCT01077518|Safety|safety
1421669|NCT01077518|Efficacy|efficacy
1421670|NCT01077518|Rituximab refractory|rituximab refractory
1421671|NCT01077518|Oncology|oncology
1421672|NCT01077505|pharmacokinetics|pharmacokinetics
1421673|NCT01077505|GSK716155|gsk716155
1421674|NCT01077505|Brevicon|brevicon
1421675|NCT01077505|albiglutide|albiglutide
1421676|NCT01077505|healthy female volunteers|healthy female volunteers
1421677|NCT01077505|oral contraceptive|oral contraceptive
1421678|NCT01077492|lung cancer|lung cancer
1421679|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
1421680|NCT01077492|TBNA|tbna
1421681|NCT01077492|staging lung cancer|staging lung cancer
1421682|NCT01077479|body fat mass gain|body fat mass gain
1421683|NCT01077479|Insulin resistance|insulin resistance
1421684|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
1421685|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1421686|NCT01077466|Natalizumab|natalizumab
1421687|NCT01077466|Treatment|treatment
1421688|NCT01077466|Safety|safety
1421689|NCT01077466|Efficacy|efficacy
1421690|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
1421691|NCT01077466|Osteopontin|osteopontin
1421692|NCT01077440|cancer survivor|cancer survivor
1421693|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1421694|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1421843|NCT01077245|Anti-Infective Agents|anti-infective agents
1421695|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1421696|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1421697|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1421698|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1421699|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1421700|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1421701|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1421702|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1421703|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1421704|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1421705|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1421706|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1421707|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1421708|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1421709|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1421710|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1421711|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1421712|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1421713|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1421714|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1421715|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1421716|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1421717|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1421718|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1421719|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1421720|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1421721|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1421722|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1421723|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1421724|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1421725|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1421726|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1421727|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1421728|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1421729|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1421730|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1421731|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1421732|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1421733|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1421734|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1421735|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1421736|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1421737|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1421738|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1421739|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1421740|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1421741|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1421742|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1421743|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1421744|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1421745|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1421746|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1421747|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1421748|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1421749|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1421750|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1568395|NCT00506012|Inherited Myoclonus|inherited myoclonus
1421751|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1421752|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1421753|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1421754|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1421844|NCT01077245|Clostridium butyricum|clostridium butyricum
1421755|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1421756|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1421757|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1421758|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1421759|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1421760|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1421761|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1421762|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1421763|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1421764|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
1421765|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1421766|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1421767|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1421768|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1421769|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1421770|NCT01077440|primary myelofibrosis|primary myelofibrosis
1421771|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1421772|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1421773|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
1421774|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1421775|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1421776|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
1421777|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1421778|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1421779|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
1421780|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
1421781|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
1421782|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1421783|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
1421784|NCT01077427|pancreatic cancer|pancreatic cancer
1421785|NCT01077427|adjuvant treatment|adjuvant treatment
1421786|NCT01077427|hyperthermia|hyperthermia
1421787|NCT01077414|Psychosocial Functioning|psychosocial functioning
1421788|NCT01077414|Psychosocial Stress|psychosocial stress
1421789|NCT01077414|Palliative Care|palliative care
1421790|NCT01077414|Spirituality|spirituality
1421791|NCT01077414|Cancer|cancer
1421792|NCT01077401|Diabetic|diabetic
1421793|NCT01077401|edema|edema
1421794|NCT01077401|DME|dme
1421795|NCT01077388|CVD|cvd
1421796|NCT01077388|uncontrolled HTN|uncontrolled htn
1421797|NCT01077375|Milnacipran|milnacipran
1421798|NCT01077375|Duloxetine|duloxetine
1421799|NCT01077375|Switch|switch
1421800|NCT01077375|Forest Research Institute|forest research institute
1421801|NCT01077362|Ustekinumab|ustekinumab
1421802|NCT01077362|CNTO 1275|cnto 1275
1421803|NCT01077362|Stelara|stelara
1421804|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
1421805|NCT01077362|Psoriasis|psoriasis
1421806|NCT01077362|TNF alpha|tnf alpha
1421807|NCT01077349|Cardiac surgery|cardiac surgery
1421808|NCT01077349|Shock|shock
1421809|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
1421810|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1421811|NCT01077349|Renal Insufficiency|renal insufficiency
1421812|NCT01077349|Acute|acute
1421813|NCT01077336|susceptibility testing|susceptibility testing
1421814|NCT01077323|pancreatitis|pancreatitis
1421815|NCT01077323|exenatide|exenatide
1421816|NCT01077323|Byetta|byetta
1421817|NCT01077323|Amylin|amylin
1421818|NCT01077323|Lilly|lilly
1421819|NCT01077310|HIV|hiv
1421820|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1421821|NCT01077310|Alcohol dependence|alcohol dependence
1421822|NCT01077310|CD4|cd4
1421823|NCT01077310|HIV-1 RNA|hiv-1 rna
1421824|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
1421825|NCT01077284|Kidney Calculi|kidney calculi
1421826|NCT01077284|Kidney Stones|kidney stones
1421827|NCT01077284|Nephrolithiasis|nephrolithiasis
1421828|NCT01077284|Drug Therapy|drug therapy
1421829|NCT01077284|Uric Acid|uric acid
1421830|NCT01077271|Premature infants|premature infants
1421831|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1421832|NCT01077271|Compliance|compliance
1421833|NCT01077271|Palivizumab|palivizumab
1421834|NCT01077258|Safety|safety
1421835|NCT01077258|Long-term observation|long-term observation
1421836|NCT01077258|Routine Clinical Setting|routine clinical setting
1421837|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
1421838|NCT01077258|Effectiveness|effectiveness
1421839|NCT01077245|Clostridium difficile|clostridium difficile
1421840|NCT01077245|Clostridium Infections|clostridium infections
1421841|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
1421842|NCT01077245|Bacterial Infections|bacterial infections
1421845|NCT01077245|Metronidazole|metronidazole
1421846|NCT01077245|Vancomycin|vancomycin
1421847|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
1421848|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
1421849|NCT01077245|Colonic Diseases|colonic diseases
1421850|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
1421851|NCT01077245|Intestinal Diseases|intestinal diseases
1421852|NCT01077245|Enterocolitis|enterocolitis
1421853|NCT01077245|Pharmacologic Actions|pharmacologic actions
1421854|NCT01077245|Digestive System Diseases|digestive system diseases
1421855|NCT01077245|Therapeutic Uses|therapeutic uses
1421856|NCT01077245|Gastroenteritis|gastroenteritis
1421857|NCT01077245|Colitis|colitis
1421858|NCT01077245|Diarrhea|diarrhea
1421859|NCT01077245|Probiotics|probiotics
1421860|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
1421861|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
1421862|NCT01077232|Humira|humira
1421863|NCT01077232|Safety|safety
1421864|NCT01077232|Efficacy|efficacy
1421865|NCT01077232|Work Productivity|work productivity
1421866|NCT01077219|healthy female|healthy female
1421867|NCT01077206|Aneurysm|aneurysm
1421868|NCT01077206|statin|statin
1421869|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
1421870|NCT01077193|Bariatric|bariatric
1421871|NCT01077193|Obesity|obesity
1421872|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
1421873|NCT01077167|pharmacokinetics|pharmacokinetics
1421874|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
1421875|NCT01077154|Bone Metastasis|bone metastasis
1421876|NCT01077154|Adjuvant treatment|adjuvant treatment
1421877|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
1421878|NCT01077154|Denosumab|denosumab
1421879|NCT01077154|Stage II breast cancer|stage ii breast cancer
1421880|NCT01077154|Stage III breast cancer|stage iii breast cancer
1421881|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
1421882|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
1421883|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
1421884|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
1421885|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
1421886|NCT01077154|Early breast cancer|early breast cancer
1421887|NCT01077154|Breast Tumors|breast tumors
1421888|NCT01077154|Breast Neoplasms|breast neoplasms
1421889|NCT01077128|Psoriasis|psoriasis
1421890|NCT01077128|Quality of life|quality of life
1421891|NCT01077115|Cholecystectomy|cholecystectomy
1421892|NCT01077115|Cholecystitis|cholecystitis
1421893|NCT01077115|Laparoscopy|laparoscopy
1421894|NCT01077115|Cholelithiasis|cholelithiasis
1421895|NCT01077115|Operative trauma|operative trauma
1421896|NCT01077102|COPD|copd
1421897|NCT01077102|eccentric exercise training|eccentric exercise training
1421898|NCT01077102|cycle ergometer|cycle ergometer
1421899|NCT01077102|muscle function|muscle function
1421900|NCT01077089|traumatic brain injury|traumatic brain injury
1421901|NCT01077089|In-hospital transport|in-hospital transport
1421902|NCT01077076|Gastric Acid|gastric acid
1421903|NCT01077076|Human Experimentation|human experimentation
1421904|NCT01077063|Pleurx catheter|pleurx catheter
1421905|NCT01077063|malignant ascites|malignant ascites
1421906|NCT01077024|Stimulant treatment|stimulant treatment
1421907|NCT01077024|Smoking Cessation|smoking cessation
1421908|NCT01077011|Dry eye|dry eye
1421909|NCT01077011|artificial tears|artificial tears
1421910|NCT01076998|Dry eye|dry eye
1421911|NCT01076998|artificial tears|artificial tears
1421912|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
1421913|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
1421914|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
1421915|NCT01076946|ballooning|ballooning
1421916|NCT01076946|TLVBS|tlvbs
1421917|NCT01076933|Borderline Personality Disorder|borderline personality disorder
1421918|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1421919|NCT01076933|Neuropsychological Test|neuropsychological test
1421920|NCT01076933|Randomised Control Trial|randomised control trial
1421921|NCT01076907|colonoscopy|colonoscopy
1421922|NCT01076907|polyps|polyps
1421923|NCT01076894|pain|pain
1421924|NCT01076894|thoracotomy|thoracotomy
1421925|NCT01076894|pulmonary function|pulmonary function
1421926|NCT01076894|epidural anesthesia|epidural anesthesia
1421927|NCT01076894|intercostal nerve block|intercostal nerve block
1421928|NCT01076868|vivax|vivax
1421929|NCT01076868|malaria|malaria
1421930|NCT01076868|relapse|relapse
1421931|NCT01076842|Diabetes|diabetes
1421933|NCT01076829|Spice|spice
1421934|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
1421935|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
1421936|NCT01076790|Nociception|nociception
1421937|NCT01076790|Dexmedetomidine|dexmedetomidine
1421938|NCT01076790|Electroencephalogram|electroencephalogram
1421939|NCT01076790|Electromyogram|electromyogram
1421940|NCT01076790|Entropy Index|entropy index
1421941|NCT01076790|Bispectral Index|bispectral index
1421942|NCT01076790|Electrocardiogram|electrocardiogram
1421943|NCT01076790|Plethysmogram|plethysmogram
1421946|NCT01076790|Heart rate variability|heart rate variability
1421948|NCT01076777|Panic disorder|panic disorder
1421949|NCT01076777|Physical exercise|physical exercise
1421950|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
1421951|NCT01076777|Manualized|manualized
1421952|NCT01076725|ProSeal LMA|proseal lma
1421953|NCT01076725|standard insertion|standard insertion
1421954|NCT01076725|rotational insertion|rotational insertion
1421955|NCT01076699|abdominal pain|abdominal pain
1421956|NCT01076699|bloating|bloating
1421957|NCT01076699|diarrhea|diarrhea
1421958|NCT01076699|irritable bowel|irritable bowel
1421959|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
1421960|NCT01076686|Breast augmentation|breast augmentation
1421961|NCT01076686|Postoperative pain|postoperative pain
1421962|NCT01076686|Analgesia|analgesia
1421963|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
1421964|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
1421965|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1421966|NCT01076660|Sudden Cardiac Death|sudden cardiac death
1421967|NCT01076660|Ventricular tachycardia|ventricular tachycardia
1421968|NCT01076660|Ventricular fibrillation|ventricular fibrillation
1421969|NCT01076608|primary care patients|primary care patients
1421970|NCT01076595|Multiple sclerosis|multiple sclerosis
1421971|NCT01076595|BetaPlus program|betaplus program
1421972|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
1421973|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
1421974|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
1421975|NCT01076504|SCLC|sclc
1421976|NCT01076504|Amrubicin|amrubicin
1421977|NCT01076504|Carboplatin|carboplatin
1421978|NCT01076504|Pegfilgrastim|pegfilgrastim
1421979|NCT01076504|Neulasta|neulasta
1421980|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
1421981|NCT01076465|Heart failure|heart failure
1421982|NCT01076465|Elderly|elderly
1421983|NCT01076465|Disease management|disease management
1421984|NCT01076452|Parkinson's Disease|parkinson's disease
1421985|NCT01076452|levo-dopa|levo-dopa
1421986|NCT01076452|tremor|tremor
1421987|NCT01076452|dyskinesia|dyskinesia
1421988|NCT01076452|subthalamic nucleus|subthalamic nucleus
1421989|NCT01076452|globus pallidus|globus pallidus
1421990|NCT01076426|probiotic|probiotic
1421991|NCT01076426|peritoneal dialysis|peritoneal dialysis
1421992|NCT01076426|peritonitis|peritonitis
1421993|NCT01076426|nutrition status|nutrition status
1421994|NCT01076413|gait|gait
1421995|NCT01076413|exercise|exercise
1421996|NCT01076413|skill-based|skill-based
1421997|NCT01076413|aerobic|aerobic
1421998|NCT01076387|Bladder|bladder
1421999|NCT01076387|Cystectomy|cystectomy
1422000|NCT01076387|Robotic|robotic
1422001|NCT01076387|Open Radical|open radical
1422002|NCT01076387|10-016|10-016
1422003|NCT01076374|pacemaker|pacemaker
1422004|NCT01076361|Epicardial|epicardial
1422005|NCT01076361|Pacing Lead|pacing lead
1422006|NCT01076348|Epicardial|epicardial
1422007|NCT01076348|Pacing Lead|pacing lead
1422008|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
1422009|NCT01076335|Docetaxel|docetaxel
1422010|NCT01076335|Taxotere|taxotere
1422011|NCT01076335|Chemotherapy|chemotherapy
1422012|NCT01076335|Radical Prostatectomy|radical prostatectomy
1422013|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
1422014|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
1422015|NCT01076335|Lymph node metastases|lymph node metastases
1422016|NCT01076309|cataract surgery|cataract surgery
1422017|NCT01076309|tamsulosin|tamsulosin
1422018|NCT01076309|endothelium cell|endothelium cell
1422019|NCT01076283|baclofen|baclofen
1422020|NCT01076283|alcoholism|alcoholism
1422021|NCT01076283|urge|urge
1422022|NCT01076283|craving|craving
1422023|NCT01076283|alcohol drinking|alcohol drinking
1422024|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
1422025|NCT01076257|brain damage|brain damage
1422026|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
1422027|NCT01076257|kinematic|kinematic
1422028|NCT01076257|function|function
1422029|NCT01076257|outcome|outcome
1422030|NCT01076257|Quality of life|quality of life
1422031|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
1422032|NCT01076218|Accuracy|accuracy
1555090|NCT00556868|Fasting|fasting
1422033|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
1422034|NCT01076205|Work Productivity|work productivity
1422035|NCT01076205|Long-term Observation|long-term observation
1422036|NCT01076205|Humira|humira
1422037|NCT01076205|Quality of Life|quality of life
1422038|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
1422039|NCT01076192|Moderate Psoriasis|moderate psoriasis
1422040|NCT01076192|Psoriasis|psoriasis
1422041|NCT01076192|Severe Psoriasis|severe psoriasis
1422042|NCT01076192|Adalimumab|adalimumab
1422043|NCT01076192|Effectiveness|effectiveness
1422044|NCT01076192|Safety|safety
1422045|NCT01076192|Clinical practice|clinical practice
1422046|NCT01076179|Infection|infection
1422048|NCT01076179|CCR5 antagonists|ccr5 antagonists
1422049|NCT01076179|Etravirine|etravirine
1422050|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
1422051|NCT01076179|Maraviroc|maraviroc
1422052|NCT01076179|Safety and efficacy|safety and efficacy
1422053|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
1422054|NCT01076179|Integrase inhibitors|integrase inhibitors
1422055|NCT01076179|Raltegravir|raltegravir
1422056|NCT01076179|Kaletra|kaletra
1422057|NCT01076166|Post-marketing observational study|post-marketing observational study
1422058|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
1422059|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
1422060|NCT01076153|Post-marketing observational study|post-marketing observational study
1422061|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
1422062|NCT01076153|Klacid MR|klacid mr
1422063|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
1422065|NCT01076101|sister|sister
1422066|NCT01076101|autoimmune disease|autoimmune disease
1422067|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1422068|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
1422069|NCT01076062|Labor, Induced|labor, induced
1422070|NCT01076062|spontaneous labor|spontaneous labor
1422071|NCT01076062|cesarean delivery|cesarean delivery
1422072|NCT01076036|ischemia|ischemia
1422073|NCT01076036|stent|stent
1422074|NCT01076023|Diabetes|diabetes
1422075|NCT01076023|Cardiovascular disease|cardiovascular disease
1422076|NCT01076023|Observational study|observational study
1422077|NCT01076023|China|china
1422078|NCT01075997|Diabetes Mellitus|diabetes mellitus
1422079|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
1422080|NCT01075984|Mycoses prevention and control|mycoses prevention and control
1422081|NCT01075971|Buprenorphine tablet|buprenorphine tablet
1422082|NCT01075971|Fast dissolving tablet|fast dissolving tablet
1422083|NCT01075971|Opioid dependant patients|opioid dependant patients
1422084|NCT01075958|n-3 PUFAs|n-3 pufas
1422085|NCT01075958|Fish oil|fish oil
1422086|NCT01075958|Cognitive function|cognitive function
1422087|NCT01075958|Healthy young adults|healthy young adults
1422088|NCT01075945|antimalarials|antimalarials
1422089|NCT01075945|ACTs|acts
1422090|NCT01075945|Piperaquine|piperaquine
1422091|NCT01075945|uncomplicated|uncomplicated
1422092|NCT01075932|cerebral blood flow|cerebral blood flow
1422093|NCT01075932|NIRS|nirs
1422094|NCT01075932|n-3 PUFAs|n-3 pufas
1422095|NCT01075932|fish oil|fish oil
1422096|NCT01075932|cognitive function|cognitive function
1422097|NCT01075919|n-3 PUFAs|n-3 pufas
1422098|NCT01075919|Cognitive function|cognitive function
1422099|NCT01075919|Healthy young adults|healthy young adults
1422100|NCT01075919|Fish oil|fish oil
1422101|NCT01075919|Mood|mood
1422102|NCT01075906|pharmacokinetics|pharmacokinetics
1422103|NCT01075893|Colorectal cancer|colorectal cancer
1422104|NCT01075893|Stem cells|stem cells
1422105|NCT01075893|Ulcerative colitis|ulcerative colitis
1422106|NCT01075893|Polyps|polyps
1422107|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
1422108|NCT01075880|Rebif|rebif
1422109|NCT01075880|Interferon beta-1a|interferon beta-1a
1422110|NCT01075854|Gonal-F|gonal-f
1422111|NCT01075854|Multifollicular stimulation|multifollicular stimulation
1422112|NCT01075854|Pregnancy|pregnancy
1422113|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
1422114|NCT01075854|In vitro fertilization|in vitro fertilization
1422115|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
1422116|NCT01075854|Infertility|infertility
1422117|NCT01075841|Head and neck neoplasms|head and neck neoplasms
1422118|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
1422119|NCT01075841|Cetuximab|cetuximab
1422120|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
1422121|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
1422122|NCT01075828|Cetuximab|cetuximab
1422123|NCT01075815|Infertility|infertility
1422124|NCT01075815|Ovulation induction|ovulation induction
1422125|NCT01075815|Luveris|luveris
1422126|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
1422127|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
1422128|NCT01075802|Breast cancer|breast cancer
1422129|NCT01075802|Tamoxifen|tamoxifen
1422130|NCT01075802|Endoxifen|endoxifen
1422131|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
1422132|NCT01075789|Pain|pain
1422133|NCT01075789|Discomfort|discomfort
1422134|NCT01075789|Insertion|insertion
1422135|NCT01075789|Nasogastric tube|nasogastric tube
1422136|NCT01075763|Alzheimer's|alzheimer's
1422137|NCT01075763|Dementia|dementia
1422138|NCT01075763|Interferon beta-1a|interferon beta-1a
1422139|NCT01075763|Rebif|rebif
1422140|NCT01075750|hyperkalaemia|hyperkalaemia
1422141|NCT01075750|metabolic acidosis|metabolic acidosis
1422142|NCT01075750|renal transplantation|renal transplantation
1422143|NCT01075750|normal saline|normal saline
1422144|NCT01075750|elomel isoton|elomel isoton
1422145|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
1422146|NCT01075737|Multiple sclerosis|multiple sclerosis
1422147|NCT01075737|Sclerosis|sclerosis
1422148|NCT01075737|Quality of life|quality of life
1422149|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
1422150|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
1422151|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
1422152|NCT01075711|Prednisone|prednisone
1422153|NCT01075698|Type 2 Diabetes|type 2 diabetes
1422154|NCT01075698|Cerebrovascular disease|cerebrovascular disease
1422155|NCT01075698|Coronary Artery Disease|coronary artery disease
1422156|NCT01075698|Chronic Kidney Disease|chronic kidney disease
1422157|NCT01075698|Peripheral Artery Disease|peripheral artery disease
1422160|NCT01075672|Tourette syndrome|tourette syndrome
1422161|NCT01075672|trichotillomania|trichotillomania
1422162|NCT01075672|Compulsive Skin Picking|compulsive skin picking
1422163|NCT01075672|panic disorder|panic disorder
1422164|NCT01075672|social phobia|social phobia
1422165|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
1422166|NCT01075672|depression|depression
1422167|NCT01075672|PTSD|ptsd
1422168|NCT01075672|ADHD|adhd
1422169|NCT01075672|eating disorder|eating disorder
1422170|NCT01075672|Specific Phobia|specific phobia
1422171|NCT01075659|Smoking Cessation|smoking cessation
1422172|NCT01075659|VAS|vas
1422173|NCT01075659|Urges to smoke|urges to smoke
1422174|NCT01075646|postoperative pain|postoperative pain
1422175|NCT01075646|wound infusion|wound infusion
1422176|NCT01075646|local anesthesia|local anesthesia
1422177|NCT01075633|FOBT|fobt
1422178|NCT01075633|colonoscopy|colonoscopy
1422179|NCT01075633|familiar risk|familiar risk
1422180|NCT01075633|colorectal cancer|colorectal cancer
1422181|NCT01075633|advanced adenoma|advanced adenoma
1422182|NCT01075620|rotating platform|rotating platform
1422183|NCT01075620|posterior stabilized|posterior stabilized
1422184|NCT01075620|non-posterior stabilized|non-posterior stabilized
1422185|NCT01075607|Lymph fluid collection|lymph fluid collection
1422186|NCT01075594|Dyslipidemia|dyslipidemia
1422187|NCT01075594|Target cholesterol|target cholesterol
1422188|NCT01075594|Undertreatment|undertreatment
1422189|NCT01075581|Hemodynamic instability|hemodynamic instability
1422190|NCT01075581|Hemostasis|hemostasis
1422191|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1422192|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1422193|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
1422194|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1422195|NCT01075542|Corneal astigmatism|corneal astigmatism
1422196|NCT01075542|Intraocular lens|intraocular lens
1422197|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
1422198|NCT01075516|Remote Monitoring|remote monitoring
1422199|NCT01075516|ICD patients|icd patients
1422200|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
1422201|NCT01075516|remote follow up|remote follow up
1422202|NCT01075503|Supraclavicular|supraclavicular
1422203|NCT01075503|Interscalene|interscalene
1422204|NCT01075503|Infraclavicular|infraclavicular
1422205|NCT01075503|Brachial plexus block|brachial plexus block
1422206|NCT01075503|Ropivacaine|ropivacaine
1422207|NCT01075490|spinal anesthesia|spinal anesthesia
1422208|NCT01075490|neonates|neonates
1422209|NCT01075490|clonidine|clonidine
1422210|NCT01075490|post operative apnea|post operative apnea
1422211|NCT01075464|Solid Tumor|solid tumor
1422212|NCT01075451|Staphylococcus aureus|staphylococcus aureus
1422213|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
1422214|NCT01075451|Antibacterial resistance|antibacterial resistance
1422215|NCT01075451|Vancomycin|vancomycin
1422216|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
1422217|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
1422218|NCT01075425|leukemia|leukemia
1422219|NCT01075425|acute leukemia|acute leukemia
1422220|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
1422221|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
1422222|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
1555361|NCT00555698|DBS|dbs
1422223|NCT01075425|refractory acute leukemia|refractory acute leukemia
1422224|NCT01075425|belinostat|belinostat
1422225|NCT01075425|bortezomib|bortezomib
1422226|NCT01075425|Velcade|velcade
1422227|NCT01075425|PXD-101|pxd-101
1422228|NCT01075412|Positron-Emission Tomography|positron-emission tomography
1422229|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
1422230|NCT01075399|[F 18]HX4|[f 18]hx4
1422231|NCT01075399|HX4|hx4
1422232|NCT01075399|Hypoxia|hypoxia
1422233|NCT01075399|Head/Neck Cancer|head/neck cancer
1422234|NCT01075399|Lung Cancer|lung cancer
1422235|NCT01075399|Liver Cancer|liver cancer
1422236|NCT01075399|Rectal Cancer|rectal cancer
1422237|NCT01075399|Cervical Cancer|cervical cancer
1422238|NCT01075399|HIF1 alpha|hif1 alpha
1422239|NCT01075399|CAIX|caix
1422240|NCT01075386|Hysterectomy|hysterectomy
1422241|NCT01075386|Endometrial cancer|endometrial cancer
1422242|NCT01075386|Benign|benign
1422243|NCT01075386|Endocrine system|endocrine system
1422244|NCT01075386|Tissue collection|tissue collection
1422245|NCT01075373|early stage schizophrenia|early stage schizophrenia
1422246|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
1422247|NCT01075373|treatment response|treatment response
1422248|NCT01075373|Aripiprazole|aripiprazole
1422249|NCT01075373|pharmacogenetics|pharmacogenetics
1422250|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
1422251|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
1422252|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
1422253|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
1422254|NCT01075373|neurocognitive function|neurocognitive function
1422255|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
1422256|NCT01075373|Niacin skin test|niacin skin test
1422257|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
1422258|NCT01075373|plasma cytokine level|plasma cytokine level
1422259|NCT01075373|plasma signaling protein level|plasma signaling protein level
1422260|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
1422261|NCT01075373|16-45 y/o|16-45 y/o
1422262|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
1422263|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
1422264|NCT01075347|autoserum|autoserum
1422265|NCT01075347|ocular surgery|ocular surgery
1422266|NCT01075347|corneal epithelium healing|corneal epithelium healing
1422267|NCT01075334|sperm|sperm
1422268|NCT01075334|male infertility|male infertility
1422269|NCT01075334|Carnitine|carnitine
1422270|NCT01075334|food supplementation|food supplementation
1422271|NCT01075334|insemination|insemination
1422272|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1422273|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
1422274|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
1422275|NCT01075308|stage III prostate cancer|stage iii prostate cancer
1422276|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1422277|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
1422278|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
1422279|NCT01075295|Bipolar I Disorder|bipolar i disorder
1422280|NCT01075295|Bipolar II Disorder|bipolar ii disorder
1422281|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
1422282|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
1422283|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
1422284|NCT01075295|antipsychotic|antipsychotic
1422285|NCT01075295|weight gain|weight gain
1422286|NCT01075295|body mass index|body mass index
1422287|NCT01075295|BMI|bmi
1422288|NCT01075295|waist circumference|waist circumference
1422289|NCT01075295|WC|wc
1422290|NCT01075295|coronary heart disease|coronary heart disease
1422291|NCT01075295|CHD|chd
1422292|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
1422293|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
1422294|NCT01075256|sensitivity|sensitivity
1422295|NCT01075256|occlusion|occlusion
1422296|NCT01075243|dental pain|dental pain
1422297|NCT01075243|paracetamol|paracetamol
1422298|NCT01075243|Post-surgical dental pain|post-surgical dental pain
1422299|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
1422300|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
1422301|NCT01075204|Respiratory Tract Infection|respiratory tract infection
1422302|NCT01075204|Clarithromycin|clarithromycin
1422303|NCT01075204|Recovery|recovery
1422304|NCT01075191|Viral load|viral load
1422305|NCT01075191|Resistance|resistance
1422306|NCT01075191|Double protease inhibitors|double protease inhibitors
1422307|NCT01075191|Mutations|mutations
1422308|NCT01075191|Immune system|immune system
1422309|NCT01075191|Infection|infection
1422310|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
1422311|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
1422312|NCT01075178|Infection|infection
1422313|NCT01075178|Arrhythmia|arrhythmia
1422314|NCT01075178|Death|death
1422315|NCT01075178|Palivizumab|palivizumab
1422316|NCT01075178|Safety|safety
1422317|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
1422318|NCT01075178|Pediatric|pediatric
1422319|NCT01075178|Observational|observational
1422320|NCT01075165|silicone|silicone
1422321|NCT01075165|burn scar|burn scar
1422322|NCT01075165|hypertrophic scar|hypertrophic scar
1422323|NCT01075165|keloid|keloid
1422324|NCT01075165|scar assessment|scar assessment
1422325|NCT01075165|abnormal scarring|abnormal scarring
1422326|NCT01075165|Burn patients|burn patients
1422327|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
1422328|NCT01075152|cryptococcus|cryptococcus
1422329|NCT01075152|cryptococcosis|cryptococcosis
1422330|NCT01075152|HIV|hiv
1422333|NCT01075139|Motivational interviewing|motivational interviewing
1422334|NCT01075139|Physical activity|physical activity
1422335|NCT01075139|Diet|diet
1422336|NCT01075126|bipolar affective disorder|bipolar affective disorder
1422337|NCT01075126|African American|african american
1422338|NCT01075126|antimanic|antimanic
1422339|NCT01075126|lithium|lithium
1422340|NCT01075126|depakote|depakote
1422341|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1422342|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
1422343|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1422344|NCT01075100|metastatic|metastatic
1422345|NCT01075100|breast|breast
1422346|NCT01075100|cancer|cancer
1422347|NCT01075087|TAP Block|tap block
1422348|NCT01075087|Pain|pain
1422349|NCT01075087|Obesity|obesity
1422350|NCT01075087|Surgery|surgery
1422351|NCT01075087|Laparoscopic Banding|laparoscopic banding
1422352|NCT01075074|Pain|pain
1422353|NCT01075074|TAP block|tap block
1422354|NCT01075074|Laparoscopic|laparoscopic
1422355|NCT01075074|Gynecologic|gynecologic
1422356|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
1422357|NCT01075048|Colorectal cancer|colorectal cancer
1422358|NCT01075048|wild-type KRAS|wild-type kras
1422359|NCT01075048|irinotecan|irinotecan
1422360|NCT01075048|cetuximab|cetuximab
1422361|NCT01075048|second-line therapy|second-line therapy
1422362|NCT01075035|Traumatic Brain Injury|traumatic brain injury
1422363|NCT01075035|TBI|tbi
1422364|NCT01075035|Military|military
1422365|NCT01075035|Imaging|imaging
1422366|NCT01075035|MEG|meg
1422367|NCT01075035|PET/CT|pet/ct
1422368|NCT01075035|MRI|mri
1422369|NCT01075035|fMRI|fmri
1422370|NCT01075035|DTI|dti
1422371|NCT01075035|SANIC|sanic
1422372|NCT01075035|veteran|veteran
1422373|NCT01075009|Antibiotics|antibiotics
1422374|NCT01075009|Resistance|resistance
1422375|NCT01075009|Epidemiology|epidemiology
1422376|NCT01075009|Gram-negative bacteria|gram-negative bacteria
1422377|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
1422378|NCT01074996|Pancreatic cancer|pancreatic cancer
1422379|NCT01074996|S-1|s-1
1422380|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
1422381|NCT01074996|second-line therapy|second-line therapy
1422382|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
1422383|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
1422384|NCT01074970|breast cancer|breast cancer
1422385|NCT01074970|PARP inhibitor|parp inhibitor
1422386|NCT01074970|Triple negative|triple negative
1422387|NCT01074944|Gaucher disease|gaucher disease
1422388|NCT01074944|Genz-112638|genz-112638
1422389|NCT01074944|beta-glucosidase|beta-glucosidase
1422390|NCT01074944|acid β-glucosidase|acid β-glucosidase
1422391|NCT01074944|glucocerebrosidase|glucocerebrosidase
1422392|NCT01074944|glucosylceramide|glucosylceramide
1422393|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1422394|NCT01074944|substrate reduction therapy|substrate reduction therapy
1422395|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
1422396|NCT01074918|Pre-hypertension|pre-hypertension
1422397|NCT01074918|Hypertension|hypertension
1422398|NCT01074905|vivax malaria|vivax malaria
1422399|NCT01074905|artesunate|artesunate
1422400|NCT01074905|chloroquine|chloroquine
1422401|NCT01074905|primaquine|primaquine
1422402|NCT01074905|relapse|relapse
1422403|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
1422404|NCT01074879|Elderly|elderly
1422405|NCT01074879|protein consumption|protein consumption
1422406|NCT01074879|resistance exercise|resistance exercise
1422407|NCT01074879|muscle mass|muscle mass
1422408|NCT01074866|Mechanical ventilation|mechanical ventilation
1422409|NCT01074866|Non invasive Ventilation|non invasive ventilation
1568396|NCT00506012|Dyskinesia|dyskinesia
1422410|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
1422411|NCT01074866|Pressure support|pressure support
1422412|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1422413|NCT01074840|Food Hypersensitivity|food hypersensitivity
1422414|NCT01074840|Hypersensitivity|hypersensitivity
1422415|NCT01074840|Immune System Diseases|immune system diseases
1422416|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
1422417|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
1422418|NCT01074840|Food Allergy|food allergy
1422419|NCT01074827|Multiple Sclerosis|multiple sclerosis
1422420|NCT01074827|Walking ability|walking ability
1422421|NCT01074827|Strength|strength
1422422|NCT01074827|Balance|balance
1422423|NCT01074827|Treadmill walking|treadmill walking
1422424|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
1422425|NCT01074814|Molecular profiling|molecular profiling
1422426|NCT01074801|Closed-loop systems|closed-loop systems
1422427|NCT01074801|day-and-night glucose control|day-and-night glucose control
1422428|NCT01074788|rehabilitation|rehabilitation
1422429|NCT01074788|mind body therapy|mind body therapy
1422430|NCT01074788|integrative medicine|integrative medicine
1422431|NCT01074775|innate immunity|innate immunity
1422432|NCT01074775|mycobacterium bovis|mycobacterium bovis
1422433|NCT01074775|mucosal immunity|mucosal immunity
1422434|NCT01074775|adaptive immunity|adaptive immunity
1422435|NCT01074775|genomics|genomics
1422436|NCT01074762|Diabetes mellitus|diabetes mellitus
1422437|NCT01074762|Quality of health care|quality of health care
1422438|NCT01074762|Health services research|health services research
1422440|NCT01074749|Automatic Mode Switch|automatic mode switch
1422441|NCT01074749|FFRW|ffrw
1422442|NCT01074749|paroxysmal AF|paroxysmal af
1422443|NCT01074736|influenza A/H5N1|influenza a/h5n1
1422444|NCT01074736|host genetic susceptibility|host genetic susceptibility
1422445|NCT01074736|genotyping|genotyping
1422446|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
1422447|NCT01074723|cholesterol|cholesterol
1422448|NCT01074723|bone markers|bone markers
1422449|NCT01074723|Osteoporosis|osteoporosis
1422450|NCT01074723|cardiovascular risk|cardiovascular risk
1422451|NCT01074723|post-menopausal women|post-menopausal women
1422452|NCT01074697|Randomized Controlled Trial|randomized controlled trial
1422453|NCT01074697|Serotonin Agonists|serotonin agonists
1422454|NCT01074697|Dexamethasone|dexamethasone
1422455|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
1422456|NCT01074697|Radiotherapy|radiotherapy
1422457|NCT01074697|Cisplatin|cisplatin
1422458|NCT01074697|Prevention & control|prevention & control
1422459|NCT01074684|diagnosis|diagnosis
1422460|NCT01074684|nodules|nodules
1422461|NCT01074684|fine needle aspiration|fine needle aspiration
1422462|NCT01074658|Advance|advance
1422463|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
1422464|NCT01074658|International|international
1422465|NCT01074658|Interventional|interventional
1422466|NCT01074658|Post Market Study|post market study
1422467|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
1422468|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
1422469|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
1422470|NCT01074606|Cataract|cataract
1422471|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
1422472|NCT01074580|Crohn's disease|crohn's disease
1422473|NCT01074580|sonography|sonography
1422474|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
1422475|NCT01074554|sarcoidosis|sarcoidosis
1422476|NCT01074554|mycobacteria|mycobacteria
1422477|NCT01074554|cutaneous lesions|cutaneous lesions
1422478|NCT01074541|Vitamin D|vitamin d
1422479|NCT01074541|UVB|uvb
1422480|NCT01074541|Dose-Response|dose-response
1422481|NCT01074541|UV intensity|uv intensity
1422482|NCT01074541|Skin cancer|skin cancer
1422483|NCT01074528|cancer patients|cancer patients
1422484|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
1422485|NCT01074515|COPD|copd
1422486|NCT01074515|Depression|depression
1422487|NCT01074515|Inflammation|inflammation
1422488|NCT01074515|Genetics|genetics
1422489|NCT01074515|Functioning|functioning
1422490|NCT01074515|Dyspnea|dyspnea
1422491|NCT01074515|Physical activity|physical activity
1422492|NCT01074502|acne|acne
1422493|NCT01074489|GDM|gdm
1422494|NCT01074489|Gestational Diabetes|gestational diabetes
1422495|NCT01074489|GTT|gtt
1422496|NCT01074489|CGMS|cgms
1422497|NCT01074476|Knee osteoarthritis|knee osteoarthritis
1422498|NCT01074476|glucosamine|glucosamine
1422499|NCT01074476|synovial fluid|synovial fluid
1422500|NCT01074476|viscosity|viscosity
1422501|NCT01074476|viscoelasticity|viscoelasticity
1422502|NCT01074476|WOMAC|womac
1422503|NCT01074463|Bioequivalence|bioequivalence
1422504|NCT01074463|Healthy Subjects|healthy subjects
1422505|NCT01074450|Bioequivalence|bioequivalence
1422506|NCT01074450|Healthy Subjects|healthy subjects
1422507|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
1422508|NCT01074424|stage III cervical cancer|stage iii cervical cancer
1422509|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
1422510|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
1422511|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1422512|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1422513|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1422514|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1422515|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1422516|NCT01074398|fallopian tube cancer|fallopian tube cancer
1422517|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
1422518|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
1422519|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
1422520|NCT01074346|Multiple sclerosis|multiple sclerosis
1422521|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
1422522|NCT01074333|Colorectal cancer|colorectal cancer
1422523|NCT01074333|Metastasis|metastasis
1422524|NCT01074333|Cetuximab|cetuximab
1422525|NCT01074333|Erbitux|erbitux
1422526|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
1422527|NCT01074320|breast cancer|breast cancer
1422528|NCT01074320|aromatase inhibitors|aromatase inhibitors
1422529|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
1422530|NCT01074307|Systolic heart failure|systolic heart failure
1422531|NCT01074307|Bisoprolol|bisoprolol
1422532|NCT01074307|Concor|concor
1422533|NCT01074307|Echocardiogram|echocardiogram
1422534|NCT01074294|Inattention|inattention
1422535|NCT01074294|Hyperactivity|hyperactivity
1422536|NCT01074294|Impulsivity|impulsivity
1422537|NCT01074294|Distractibility|distractibility
1422538|NCT01074294|Procrastination|procrastination
1422539|NCT01074294|Disorganized|disorganized
1422540|NCT01074294|ADHD|adhd
1422541|NCT01074281|Hypertension|hypertension
1422542|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
1422543|NCT01074281|Eneas|eneas
1422544|NCT01074255|Nausea|nausea
1422545|NCT01074255|Vomiting|vomiting
1422546|NCT01074255|Chemotherapy|chemotherapy
1422547|NCT01074255|Post-chemotherapy|post-chemotherapy
1422548|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
1422549|NCT01074229|Pain|pain
1422550|NCT01074229|Post Operative|post operative
1422551|NCT01074229|Opioids|opioids
1422552|NCT01074229|Laparoscopic|laparoscopic
1422553|NCT01074229|Surgery|surgery
1422554|NCT01074229|Hysterectomy|hysterectomy
1422555|NCT01074216|Vitamin D|vitamin d
1422556|NCT01074216|Vitamin D3|vitamin d3
1422557|NCT01074216|colon cancer|colon cancer
1422558|NCT01074216|rectum cancer|rectum cancer
1422559|NCT01074216|Cholecalciferol|cholecalciferol
1422560|NCT01074216|09-143|09-143
1422561|NCT01074203|nitazoxanide|nitazoxanide
1422562|NCT01074203|liver transplantation|liver transplantation
1422563|NCT01074203|HCV recurrence|hcv recurrence
1422564|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
1422565|NCT01074190|Pain|pain
1422566|NCT01074190|Infant|infant
1422567|NCT01074190|Breastfeeding|breastfeeding
1422568|NCT01074177|BIBW 2992|bibw 2992
1422569|NCT01074177|NSCLC|nsclc
1422570|NCT01074164|eczema|eczema
1422571|NCT01074164|atopic dermatitis|atopic dermatitis
1422572|NCT01074164|itch|itch
1422573|NCT01074164|pruritus|pruritus
1422574|NCT01074164|acupressure|acupressure
1422575|NCT01074164|acupuncture|acupuncture
1422576|NCT01074151|Pregnancy|pregnancy
1422577|NCT01074151|pregnant|pregnant
1422578|NCT01074151|Cymbalta|cymbalta
1422579|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
1422580|NCT01074138|CPRC|cprc
1422581|NCT01074125|Hyperphosphatemia|hyperphosphatemia
1422582|NCT01074125|ESRD|esrd
1422583|NCT01074125|Dialysis|dialysis
1422584|NCT01074125|End Stage Renal Disease|end stage renal disease
1422585|NCT01074125|Phosphorus|phosphorus
1422586|NCT01074125|Renal|renal
1422587|NCT01074125|Kidney|kidney
1422588|NCT01074112|Ultrasound|ultrasound
1422589|NCT01074112|Prehospital|prehospital
1422590|NCT01074112|Trauma|trauma
1422592|NCT01074112|Paramedics|paramedics
1422593|NCT01074112|Sonography|sonography
1422594|NCT01074112|Ultrasonography|ultrasonography
1422595|NCT01074112|Ambulance|ambulance
1422596|NCT01074112|FAST|fast
1422597|NCT01074112|EFAST|efast
1422598|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
1422599|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
1422600|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
1422601|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
1422602|NCT01074047|Cytarabine|cytarabine
1422603|NCT01074047|Vidaza|vidaza
1422604|NCT01074047|azacitidine|azacitidine
1422605|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
1422606|NCT01074047|Low Dose Cytarabine|low dose cytarabine
1422607|NCT01074047|Celgene|celgene
1422608|NCT01074021|Nimotuzumab|nimotuzumab
1422609|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
1422610|NCT01074021|chemoradiation|chemoradiation
1422611|NCT01073995|Radiculopathy|radiculopathy
1422612|NCT01073995|Sciatica|sciatica
1422613|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
1422614|NCT01073995|Surgical Alternative|surgical alternative
1422615|NCT01073982|pain|pain
1422616|NCT01073982|inflammation|inflammation
1422617|NCT01073982|osteoarthritis|osteoarthritis
1422618|NCT01073969|prebiotic study|prebiotic study
1422619|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
1422620|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
1422621|NCT01073956|Shoulder Pain|shoulder pain
1422622|NCT01073956|Physical therapy|physical therapy
1422623|NCT01073956|Electrotherapy|electrotherapy
1422624|NCT01073956|Ultrasonic therapy|ultrasonic therapy
1422625|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
1422626|NCT01073943|Bowel Preparation|bowel preparation
1422627|NCT01073943|Colonoscopy|colonoscopy
1422628|NCT01073930|Bowel Preparation|bowel preparation
1422629|NCT01073930|Colonoscopy|colonoscopy
1422630|NCT01073917|Ventilation|ventilation
1422631|NCT01073917|General Anesthesia|general anesthesia
1422632|NCT01073917|electrical impedance tomography|electrical impedance tomography
1422633|NCT01073917|pressure support|pressure support
1422634|NCT01073917|spontaneous breathing|spontaneous breathing
1422635|NCT01073917|laryngeal mask|laryngeal mask
1422636|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
1422637|NCT01073891|Pharmacokinetics|pharmacokinetics
1422638|NCT01073891|Bioavailability|bioavailability
1422639|NCT01073891|Food effect|food effect
1422640|NCT01073891|Oral liquid formulation|oral liquid formulation
1422641|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
1422642|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
1422643|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
1422644|NCT01073865|ZOLADEX|zoladex
1422645|NCT01073865|Pre-menopausal|pre-menopausal
1422646|NCT01073865|Oestrogen Receptor|oestrogen receptor
1422647|NCT01073865|Advanced Breast Cancer|advanced breast cancer
1422648|NCT01073865|Progression Free Survival|progression free survival
1422649|NCT01073852|Chronic Urticaria|chronic urticaria
1422650|NCT01073852|Hives|hives
1422651|NCT01073852|Hydroxychloroquine|hydroxychloroquine
1422652|NCT01073813|Minocycline|minocycline
1422653|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
1422654|NCT01073813|Macular volume|macular volume
1422655|NCT01073813|Visual outcomes|visual outcomes
1422656|NCT01073800|atorvastatin|atorvastatin
1422657|NCT01073800|vascular occlusion|vascular occlusion
1422658|NCT01073800|myocardial infarction|myocardial infarction
1422660|NCT01073800|renal failure|renal failure
1422661|NCT01073800|critically ill|critically ill
1422662|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
1422663|NCT01073787|migraine|migraine
1422664|NCT01073787|headache|headache
1422665|NCT01073787|pediatric|pediatric
1422666|NCT01073787|children|children
1422667|NCT01073787|Emergency Department|emergency department
1422668|NCT01073774|breast cancer couples coping|breast cancer couples coping
1422669|NCT01073748|Asthma|asthma
1422670|NCT01073748|Acetaminophen|acetaminophen
1422671|NCT01073748|paracetamol|paracetamol
1422672|NCT01073748|FeNO|feno
1422673|NCT01073748|Spirometry|spirometry
1422674|NCT01073748|Lung function|lung function
1422675|NCT01073735|Needs assessment|needs assessment
1422676|NCT01073735|Health-related needs|health-related needs
1422677|NCT01073735|Childhood cancer survivors|childhood cancer survivors
1422678|NCT01073722|thoracic surgery|thoracic surgery
1422679|NCT01073722|one-lung ventilation|one-lung ventilation
1422680|NCT01073722|double lumen tube|double lumen tube
1422681|NCT01073722|endobronchial blocker|endobronchial blocker
1422682|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
1422683|NCT01073696|Sancuso|sancuso
1422684|NCT01073696|granisetron|granisetron
1422685|NCT01073696|Pharmacokinetics|pharmacokinetics
1422686|NCT01073683|TPF|tpf
1422687|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
1422688|NCT01073683|LARYNX PRESERVATION|larynx preservation
1422689|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
1422690|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
1422691|NCT01073670|NSAIDs|nsaids
1422692|NCT01073670|bleeding|bleeding
1422693|NCT01073670|thromboelastography|thromboelastography
1422694|NCT01073670|cardiac surgery|cardiac surgery
1422695|NCT01073670|Indomethacin|indomethacin
1422696|NCT01073670|acetaminophen|acetaminophen
1422697|NCT01073657|Rehabilitation|rehabilitation
1422698|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
1422699|NCT01073631|voriconazole|voriconazole
1422700|NCT01073631|Korea|korea
1422701|NCT01073631|invasive fungal infection|invasive fungal infection
1422702|NCT01073618|voriconazole|voriconazole
1422703|NCT01073618|Korea|korea
1422704|NCT01073618|invasive fungal infection|invasive fungal infection
1422705|NCT01073605|Short height|short height
1422706|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
1422707|NCT01073605|Genotonorm|genotonorm
1422708|NCT01073605|continuous treatment|continuous treatment
1422709|NCT01073605|intermittent treatment|intermittent treatment
1422710|NCT01073592|HMP|hmp
1422711|NCT01073592|CNV|cnv
1422712|NCT01073592|AMD|amd
1422713|NCT01073592|PHP|php
1422714|NCT01073592|HPHP|hphp
1422715|NCT01073592|FORESEE HOME|foresee home
1422716|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
1422717|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
1422718|NCT01073579|Hypsarrhythmia|hypsarrhythmia
1422719|NCT01073579|Infantile Spasms|infantile spasms
1422720|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
1422721|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
1422722|NCT01073579|West Syndrome|west syndrome
1422723|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
1422724|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
1422725|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
1422726|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
1422727|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
1422728|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
1422729|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
1422730|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
1422731|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
1422732|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
1422733|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
1422734|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
1422735|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
1422736|NCT01073566|Autoimmune Diseases|autoimmune diseases
1422737|NCT01073566|Diabetes Mellitus|diabetes mellitus
1422738|NCT01073566|Endocrine System Diseases|endocrine system diseases
1422739|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
1422740|NCT01073566|Immune System Diseases|immune system diseases
1422741|NCT01073566|Insulin|insulin
1422742|NCT01073566|Metabolic Diseases|metabolic diseases
1422743|NCT01073527|Child, preschool|child, preschool
1422744|NCT01073527|Pediatric emergency department|pediatric emergency department
1422745|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
1422746|NCT01073501|UREMIC PRURITUS|uremic pruritus
1422747|NCT01073501|PREGABALIN|pregabalin
1422748|NCT01073501|UP|up
1422749|NCT01073488|Pregnancy|pregnancy
1422750|NCT01073488|Maternal child health|maternal child health
1422751|NCT01073488|Developing countries|developing countries
1422752|NCT01073488|Stillbirth|stillbirth
1422753|NCT01073488|Neonatal mortality|neonatal mortality
1422754|NCT01073488|Maternal mortality|maternal mortality
1422755|NCT01073488|Community intervention|community intervention
1422756|NCT01073488|Community mobilization|community mobilization
1422757|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
1422758|NCT01073475|Pregnancy|pregnancy
1422759|NCT01073475|Maternal mortality|maternal mortality
1422760|NCT01073475|Neonatal mortality|neonatal mortality
1422761|NCT01073475|Stillbirth|stillbirth
1422762|NCT01073475|Maternal Near Miss|maternal near miss
1422763|NCT01073475|Maternal Cause of Death|maternal cause of death
1422764|NCT01073475|Neonatal Cause of Death|neonatal cause of death
1422765|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
1422766|NCT01073462|Paricalcitol|paricalcitol
1422767|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
1422768|NCT01073449|Cardiac devices|cardiac devices
1422769|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
1422770|NCT01073449|Analytical|analytical
1422771|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
1422772|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
1422773|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
1422774|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
1422775|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
1422776|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
1422777|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
1422778|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
1422779|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
1422780|NCT01073436|18 years of age or older|18 years of age or older
1422781|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
1422782|NCT01073436|Informed Consent|informed consent
1422783|NCT01073423|HIV|hiv
1422784|NCT01073423|sleep|sleep
1422785|NCT01073423|insomnia|insomnia
1422786|NCT01073423|yoga|yoga
1422787|NCT01073423|music|music
1422788|NCT01073397|Menopause|menopause
1422789|NCT01073397|Hot Flashes|hot flashes
1422790|NCT01073397|Vasomotor symptoms|vasomotor symptoms
1422791|NCT01073397|Yoga|yoga
1422792|NCT01073371|Liposome|liposome
1422793|NCT01073371|Prilocaine|prilocaine
1422794|NCT01073371|Dental anesthesia|dental anesthesia
1422795|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
1422796|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
1422797|NCT01073319|Methamphetamine|methamphetamine
1422798|NCT01073319|Rivastigmine|rivastigmine
1422799|NCT01073306|Vaccine|vaccine
1422800|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1422801|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
1422802|NCT01073280|flexible endoscopy|flexible endoscopy
1422803|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
1422804|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
1422805|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
1422806|NCT01073267|TSEBT|tsebt
1422807|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
1422808|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
1422809|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
1422810|NCT01073228|Alzheimer's disease|alzheimer's disease
1422811|NCT01073228|Central Nervous System diseases|central nervous system diseases
1422812|NCT01073228|Cognition|cognition
1422813|NCT01073215|Adolescents|adolescents
1422814|NCT01073215|Obesity|obesity
1422815|NCT01073215|Weight Management|weight management
1422816|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
1422817|NCT01073189|Acute kidney injury|acute kidney injury
1422818|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
1422819|NCT01073189|Benephit catheter|benephit catheter
1422820|NCT01073176|ADHD|adhd
1422821|NCT01073176|Executive function|executive function
1422822|NCT01073176|Preschool children|preschool children
1422823|NCT01073176|Treatment|treatment
1422824|NCT01073176|Memory|memory
1422825|NCT01073176|Attention|attention
1422826|NCT01073176|Training|training
1422827|NCT01073176|Cognitive enhancement|cognitive enhancement
1422828|NCT01073150|Tea Tree Oil|tea tree oil
1422829|NCT01073150|Chronic Blepharitis|chronic blepharitis
1422830|NCT01073137|diabetes|diabetes
1422831|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
1422832|NCT01073072|contamination|contamination
1422833|NCT01073072|hernia repair|hernia repair
1422834|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
1422835|NCT01073072|Tutomesh|tutomesh
1422836|NCT01073072|Tutopatch|tutopatch
1422837|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
1422838|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
1422839|NCT01073059|valproic acid|valproic acid
1422840|NCT01073059|ertapenem|ertapenem
1422841|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
1422842|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
1422843|NCT01073046|Gastric Cancer|gastric cancer
1422844|NCT01073046|Decompression|decompression
1422845|NCT01073046|Discomfort|discomfort
1422846|NCT01073046|Complications|complications
1422847|NCT01073033|pregnancy|pregnancy
1422848|NCT01073033|lactation|lactation
1422849|NCT01073033|oral supplement|oral supplement
1422850|NCT01073033|probiotics|probiotics
1422851|NCT01073033|early infections|early infections
1422852|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1422853|NCT01073020|Obesity|obesity
1422854|NCT01073020|Lifestyle|lifestyle
1422855|NCT01073020|Bariatric Surgery|bariatric surgery
1422856|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
1422857|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
1422858|NCT01073007|Acute Stroke|acute stroke
1422859|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
1422860|NCT01073007|simvastatin|simvastatin
1422861|NCT01072994|Myocardium|myocardium
1422862|NCT01072994|Phospholipid|phospholipid
1422863|NCT01072994|Fish oil|fish oil
1422864|NCT01072994|Cardiolipin|cardiolipin
1422865|NCT01072994|Transplantation|transplantation
1422866|NCT01072981|Pancreatic Cancer|pancreatic cancer
1422867|NCT01072981|Vaccine Therapy|vaccine therapy
1422868|NCT01072968|Multicenter|multicenter
1422869|NCT01072968|Randomized|randomized
1422870|NCT01072968|Double-blind|double-blind
1422871|NCT01072968|Efficacy and safety study|efficacy and safety study
1422872|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
1422873|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
1422874|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
1422875|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
1422876|NCT01072942|Chronic Obstructive|chronic obstructive
1422877|NCT01072942|Phase I|phase i
1422878|NCT01072942|Pharmacokinetics|pharmacokinetics
1422879|NCT01072942|Microbiology|microbiology
1422880|NCT01072929|Bipolar I Disorder|bipolar i disorder
1422881|NCT01072916|Colon, Irritable|colon, irritable
1422882|NCT01072916|Microbiota|microbiota
1422883|NCT01072903|inflammation|inflammation
1422884|NCT01072903|colon, irritable|colon, irritable
1422885|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
1422886|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
1422887|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
1422888|NCT01072877|Varicose Veins|varicose veins
1422889|NCT01072864|Postmenopausal|postmenopausal
1422890|NCT01072851|colorectal cancer screening|colorectal cancer screening
1422891|NCT01072851|multimedia education|multimedia education
1422892|NCT01072851|print education|print education
1422893|NCT01072851|culturally competent|culturally competent
1422894|NCT01072838|breast cancer|breast cancer
1422895|NCT01072838|APBI|apbi
1422896|NCT01072838|brachytherapy|brachytherapy
1422897|NCT01072838|Contura|contura
1422898|NCT01072812|Alzheimer's|alzheimer's
1422899|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
1422900|NCT01072812|Pharmacokinetics|pharmacokinetics
1422901|NCT01072812|Pharmacodynamics|pharmacodynamics
1422902|NCT01072812|Biomarkers|biomarkers
1422903|NCT01072799|A (H1N1)|a (h1n1)
1422904|NCT01072786|Dengue Virus|dengue virus
1422905|NCT01072786|Dengue Fever|dengue fever
1422906|NCT01072786|Dengue Vaccine|dengue vaccine
1422907|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1422908|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
1422909|NCT01072760|Mallet finger|mallet finger
1422910|NCT01072760|extensor tendon|extensor tendon
1422911|NCT01072760|Kirschner wire|kirschner wire
1422912|NCT01072760|Fracture Fixation|fracture fixation
1422917|NCT01072721|Fibrosis|fibrosis
1422918|NCT01072721|Elastometry|elastometry
1422919|NCT01072721|FIBROSCANN|fibroscann
1422920|NCT01072721|Children|children
1422921|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
1422922|NCT01072695|Hepatitis C|hepatitis c
1422923|NCT01072695|HCV|hcv
1422924|NCT01072695|GS-9256|gs-9256
1422925|NCT01072695|GS-9190|gs-9190
1422926|NCT01072695|Genotype 1|genotype 1
1422927|NCT01072682|Acute Renal Failure|acute renal failure
1422928|NCT01072682|Acute tubular necrosis|acute tubular necrosis
1422929|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1422930|NCT01072682|Selective cytopheretic device|selective cytopheretic device
1422931|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
1422932|NCT01072643|Sedation|sedation
1422933|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
1422934|NCT01072643|Pediatric|pediatric
1422935|NCT01072643|Cardiac Catheterization|cardiac catheterization
1422936|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
1422937|NCT01072630|Bipolar I Disorder|bipolar i disorder
1422938|NCT01072604|Aspirin|aspirin
1422939|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
1422940|NCT01072591|anti-NGF|anti-ngf
1422941|NCT01072591|OA|oa
1422942|NCT01072591|pain|pain
1422943|NCT01072578|Healthy volunteers|healthy volunteers
1422944|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
1422945|NCT01072578|diabetes|diabetes
1422946|NCT01072578|dapagliflozin|dapagliflozin
1422947|NCT01072565|Type 2 Diabetes|type 2 diabetes
1422948|NCT01072565|A1c|a1c
1422949|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
1422950|NCT01072565|Blood Glucose|blood glucose
1422951|NCT01072552|recurrent wheezing|recurrent wheezing
1422952|NCT01072552|asthma|asthma
1422953|NCT01072552|preterm infants|preterm infants
1422954|NCT01072552|palivizumab|palivizumab
1422955|NCT01072552|atopic diseases|atopic diseases
1422956|NCT01072539|infection|infection
1422957|NCT01072539|Tygacil|tygacil
1422958|NCT01072539|PMS|pms
1422959|NCT01072526|Dry Eye Syndromes|dry eye syndromes
1422960|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
1422961|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
1422962|NCT01072500|Aging|aging
1422963|NCT01072500|Physical Activity|physical activity
1422964|NCT01072500|Exercise|exercise
1422965|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
1422966|NCT01072500|Mobility|mobility
1422967|NCT01072500|Disability|disability
1422968|NCT01072500|Falls|falls
1422969|NCT01072500|Cost effectiveness|cost effectiveness
1422970|NCT01072500|Behavioral counseling|behavioral counseling
1422971|NCT01072487|Safety|safety
1422972|NCT01072487|Sedation|sedation
1422973|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
1422974|NCT01072487|Colonoscopy|colonoscopy
1422975|NCT01072474|Safety|safety
1422976|NCT01072474|Sedation|sedation
1422977|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
1422978|NCT01072474|Colonoscopy|colonoscopy
1422979|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
1422980|NCT01072461|Robotics|robotics
1422981|NCT01072461|Virtual Reality|virtual reality
1422982|NCT01072461|Rehabilitation|rehabilitation
1422983|NCT01072461|Neuroplasticity|neuroplasticity
1422984|NCT01072448|COPD|copd
1422985|NCT01072448|indacaterol|indacaterol
1422986|NCT01072435|ERCP|ercp
1422987|NCT01072435|patient-controlled sedation|patient-controlled sedation
1422988|NCT01072435|target-controlled infusion|target-controlled infusion
1422989|NCT01072435|propofol|propofol
1422990|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
1422991|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1422992|NCT01072422|Smoking|smoking
1422993|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1422994|NCT01072422|Questionnaires|questionnaires
1422995|NCT01072422|Nurses|nurses
1422996|NCT01072422|Primary Health Care|primary health care
1422997|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
1422998|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
1422999|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
1423000|NCT01072383|autoimmune disease|autoimmune disease
1423005|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
1423006|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
1423007|NCT01072357|Neovascularization|neovascularization
1423008|NCT01072357|Corneal Blood Vessels|corneal blood vessels
1423009|NCT01072357|Avastin|avastin
1423010|NCT01072357|Bevacizumab|bevacizumab
1423011|NCT01072357|Corneal Graft|corneal graft
1423012|NCT01072344|Anxiety|anxiety
1423013|NCT01072344|Chamomile|chamomile
1423014|NCT01072344|Herbal Remedy|herbal remedy
1423015|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
1423016|NCT01072331|insulin resistance|insulin resistance
1423017|NCT01072318|Breast cancer|breast cancer
1423018|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
1423019|NCT01072318|letrozole|letrozole
1423020|NCT01072318|Toremifene|toremifene
1423021|NCT01072305|fluid restriction|fluid restriction
1423022|NCT01072305|fluid therapy|fluid therapy
1423023|NCT01072305|intraoperative care|intraoperative care
1423024|NCT01072279|Malnutrition;|malnutrition;
1423025|NCT01072279|Infant nutrition;|infant nutrition;
1423026|NCT01072279|Fortified food|fortified food
1423027|NCT01072279|Linear growth|linear growth
1423028|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
1423029|NCT01072279|Effectiveness|effectiveness
1423030|NCT01072279|Impact evaluation studies|impact evaluation studies
1423031|NCT01072279|Burundi|burundi
1423032|NCT01072279|Guatemala|guatemala
1423033|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
1423034|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
1423035|NCT01072227|Acute Otitis Media|acute otitis media
1423036|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
1423037|NCT01072227|Etiology|etiology
1423038|NCT01072214|Pazopanib|pazopanib
1423039|NCT01072214|Tolerability|tolerability
1423040|NCT01072214|Pharmacokinetics|pharmacokinetics
1423041|NCT01072214|GW786034|gw786034
1423042|NCT01072214|Safety|safety
1423043|NCT01072175|drug-drug interaction|drug-drug interaction
1423044|NCT01072175|BRAF inhibitor|braf inhibitor
1423045|NCT01072175|expansion cohorts|expansion cohorts
1423046|NCT01072175|melanoma|melanoma
1423047|NCT01072175|dose escalation|dose escalation
1423048|NCT01072175|MEK inhibitor|mek inhibitor
1423049|NCT01072162|healthy|healthy
1423050|NCT01072162|powder for suspension|powder for suspension
1423051|NCT01072162|tablets|tablets
1423052|NCT01072162|bioavailibility|bioavailibility
1423053|NCT01072162|eltrombopag|eltrombopag
1423054|NCT01072149|COPD|copd
1423055|NCT01072149|Safety|safety
1423056|NCT01072149|FEV1|fev1
1423057|NCT01072149|Efficacy|efficacy
1423058|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
1423059|NCT01072110|Patients with diarrhea|patients with diarrhea
1423060|NCT01072097|PCOS|pcos
1423061|NCT01072097|Atorvastatin|atorvastatin
1423062|NCT01072097|Androgens|androgens
1423063|NCT01072097|Glucose metabolism|glucose metabolism
1423064|NCT01072097|Inflammatory markers|inflammatory markers
1423065|NCT01072084|food allergy|food allergy
1423066|NCT01072084|confocal laser endoscope|confocal laser endoscope
1423067|NCT01072084|diagnosis|diagnosis
1423068|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
1423069|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
1423070|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
1423071|NCT01072071|furosemide|furosemide
1423072|NCT01072071|fluid balance|fluid balance
1423073|NCT01072058|Infliximab|infliximab
1423074|NCT01072058|Adalimumab|adalimumab
1423075|NCT01072058|Etanercept|etanercept
1423076|NCT01072058|Heart failure|heart failure
1423077|NCT01072058|Diastolic disfunction|diastolic disfunction
1423078|NCT01072058|TNF blocker|tnf blocker
1423079|NCT01072058|Anti-TNF|anti-tnf
1423080|NCT01072058|Echocardiography|echocardiography
1423081|NCT01072058|Tissue doppler imaging|tissue doppler imaging
1423082|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
1423083|NCT01072058|NT-proBNP|nt-probnp
1423084|NCT01072045|Hemangioma|hemangioma
1423085|NCT01072045|Proliferative hemangioma|proliferative hemangioma
1423086|NCT01072045|Treatment|treatment
1423087|NCT01072045|Propranolol|propranolol
1423088|NCT01072045|Corticosteroid|corticosteroid
1423089|NCT01072032|EEG|eeg
1423090|NCT01072032|Robotics (ankle)|robotics (ankle)
1423091|NCT01072032|Motor-learning|motor-learning
1423092|NCT01072032|Brain Plasticity|brain plasticity
1423093|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1423094|NCT01072006|PTSD|ptsd
1423095|NCT01072006|fMRI|fmri
1423096|NCT01072006|attention|attention
1423097|NCT01071993|prevention|prevention
1423098|NCT01071993|nephropathy|nephropathy
1423099|NCT01071967|Community Health Nursing|community health nursing
1423100|NCT01071967|Nursing Care Management|nursing care management
1423101|NCT01071967|Aged|aged
1423102|NCT01071967|Aged, 80 and over|aged, 80 and over
1423103|NCT01071967|Health Services for the Aged|health services for the aged
1423104|NCT01071967|Geriatric Nursing|geriatric nursing
1423105|NCT01071967|Geriatric Assessment|geriatric assessment
1423106|NCT01071967|Longevity|longevity
1423107|NCT01071967|Mortality|mortality
1423108|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
1423109|NCT01071954|Pediatric|pediatric
1423110|NCT01071954|Thrombocytopenia|thrombocytopenia
1423111|NCT01071941|rRp450|rrp450
1423112|NCT01071941|Herpes virus|herpes virus
1423113|NCT01071941|Gene therapy|gene therapy
1423114|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
1423115|NCT01071902|ear tubes|ear tubes
1423116|NCT01071902|ear drainage|ear drainage
1423117|NCT01071902|ear infection|ear infection
1423118|NCT01071902|ear drops|ear drops
1423119|NCT01071902|acute otitis media|acute otitis media
1423120|NCT01071889|Healthy Volunteers|healthy volunteers
1423121|NCT01071876|Sleep disorder|sleep disorder
1423122|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
1423123|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
1423124|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
1423125|NCT01071850|ASP1941|asp1941
1423126|NCT01071850|Metformin|metformin
1423127|NCT01071850|Type 2 diabetes|type 2 diabetes
1423128|NCT01071850|diabetes|diabetes
1423129|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
1423130|NCT01071824|size|size
1423131|NCT01071824|limb|limb
1423132|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
1423133|NCT01071824|rectal resection|rectal resection
1423134|NCT01071824|mesorectal excision|mesorectal excision
1423135|NCT01071824|treatment outcome|treatment outcome
1423136|NCT01071811|Randomized controlled trial|randomized controlled trial
1423137|NCT01071811|Pedometer|pedometer
1423138|NCT01071811|Physical activity|physical activity
1423139|NCT01071811|Health measurement|health measurement
1423140|NCT01071811|Self-rated health|self-rated health
1423141|NCT01071811|Stress|stress
1423142|NCT01071811|Sleep quality|sleep quality
1423143|NCT01071785|Metabolic Syndrome|metabolic syndrome
1423144|NCT01071785|diet|diet
1423145|NCT01071785|fiber|fiber
1423146|NCT01071785|Serum lipids|serum lipids
1423147|NCT01071785|Albuminuria|albuminuria
1423148|NCT01071759|Pregnancy|pregnancy
1423149|NCT01071759|anemia|anemia
1423150|NCT01071759|Helicobacter pylori|helicobacter pylori
1423151|NCT01071759|Hemoglobin|hemoglobin
1423152|NCT01071759|Iron|iron
1423153|NCT01071759|Ferritin|ferritin
1423154|NCT01071720|Healthy subjects|healthy subjects
1423155|NCT01071707|IPF|ipf
1423156|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1423157|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
1423158|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
1423159|NCT01071694|Interferon beta-1b,|interferon beta-1b,
1423160|NCT01071694|Quality of life|quality of life
1423161|NCT01071681|Arterial hypertension|arterial hypertension
1423162|NCT01071668|onset of labor|onset of labor
1423163|NCT01071668|metabolomics|metabolomics
1423164|NCT01071668|vaginal secretions|vaginal secretions
1423165|NCT01071668|urine|urine
1423166|NCT01071668|blood|blood
1423167|NCT01071655|colorectal cancer|colorectal cancer
1423168|NCT01071655|Bevacizumab|bevacizumab
1423169|NCT01071655|Oxaliplatin|oxaliplatin
1423170|NCT01071655|Irinotecan|irinotecan
1423171|NCT01071655|5FU|5fu
1423172|NCT01071655|capecitabine|capecitabine
1423173|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
1423174|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
1423175|NCT01071642|Length of hospitalization.|length of hospitalization.
1423176|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
1423177|NCT01071629|interval training|interval training
1423178|NCT01071629|strength training|strength training
1423179|NCT01071629|exercise capacity|exercise capacity
1423180|NCT01071629|chronic heart failure|chronic heart failure
1423181|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
1423182|NCT01071616|Cannabinoids|cannabinoids
1423183|NCT01071616|Oral Fluid|oral fluid
1423184|NCT01071616|Pharmacokinetics|pharmacokinetics
1423185|NCT01071616|Stability|stability
1423186|NCT01071616|Smoked Cannabis|smoked cannabis
1423187|NCT01071603|Biomarkers|biomarkers
1423188|NCT01071603|Extrapulmonary TB|extrapulmonary tb
1423189|NCT01071603|NTM|ntm
1423190|NCT01071603|HRCT|hrct
1423191|NCT01071603|MDRTB|mdrtb
1423192|NCT01071603|Tuberculosis|tuberculosis
1423193|NCT01071590|Parkinson's Disease|parkinson's disease
1423194|NCT01071590|Sensory Input|sensory input
1423195|NCT01071590|Gait|gait
1423196|NCT01071590|Imagery|imagery
1423197|NCT01071590|Parkinson Disease|parkinson disease
1423198|NCT01071590|PD|pd
1423199|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
1423200|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
1423201|NCT01071577|Immune Modulation|immune modulation
1423202|NCT01071577|Tissue Regeneration|tissue regeneration
1423203|NCT01071577|Bone Marrow|bone marrow
1423204|NCT01071577|Healthy Volunteer|healthy volunteer
1423205|NCT01071577|HV|hv
1423206|NCT01071551|Children|children
1423207|NCT01071551|Obesity|obesity
1423208|NCT01071551|Lifestyle|lifestyle
1423209|NCT01071551|LSES|lses
1423210|NCT01071551|Caries|caries
1423211|NCT01071538|Depressive Disorder, Major|depressive disorder, major
1423804|NCT01068912|Influenza|influenza
1423212|NCT01071538|Late-Life Depression|late-life depression
1423213|NCT01071538|Geriatrics|geriatrics
1423214|NCT01071538|Buprenorphine|buprenorphine
1423215|NCT01071512|MRI|mri
1423216|NCT01071512|OCT|oct
1423217|NCT01071512|Tysabri|tysabri
1423218|NCT01071512|Multiple Sclerosis|multiple sclerosis
1423219|NCT01071512|cognition|cognition
1423220|NCT01071499|pharmacokinetics|pharmacokinetics
1423221|NCT01071499|pharmacogenetics|pharmacogenetics
1423222|NCT01071499|morphine|morphine
1423223|NCT01071499|children|children
1423224|NCT01071486|Busulfan|busulfan
1423225|NCT01071486|Glutathione S-transferase|glutathione s-transferase
1423226|NCT01071486|Genetic polymorphism|genetic polymorphism
1423227|NCT01071486|HVOD|hvod
1423228|NCT01071486|GVHD|gvhd
1423229|NCT01071473|Childhood cancer|childhood cancer
1423230|NCT01071473|Anthracyclines|anthracyclines
1423231|NCT01071473|Cardiomyopathy|cardiomyopathy
1423232|NCT01071460|PAD|pad
1423233|NCT01071447|Rheumatic diseases|rheumatic diseases
1423234|NCT01071447|Biologic treatment|biologic treatment
1423235|NCT01071447|Nurse-led|nurse-led
1423236|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
1423237|NCT01071421|community acquired pneumonia|community acquired pneumonia
1423238|NCT01071421|prevalence|prevalence
1423239|NCT01071408|chronic care model|chronic care model
1423240|NCT01071408|stroke prevention|stroke prevention
1423241|NCT01071408|health services research|health services research
1423242|NCT01071395|Parkinson's disease|parkinson's disease
1423243|NCT01071395|Dyskinesia|dyskinesia
1423244|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
1423245|NCT01071395|Amantadine|amantadine
1423246|NCT01071395|Placebo|placebo
1423247|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
1423248|NCT01071382|Repatriation|repatriation
1423249|NCT01071356|methamphetamine|methamphetamine
1423250|NCT01071356|motivational interviewing|motivational interviewing
1423251|NCT01071343|muscular atrophy|muscular atrophy
1423252|NCT01071343|recovery of function|recovery of function
1423253|NCT01071343|rehabilitation|rehabilitation
1423254|NCT01071343|Intensive care unit|intensive care unit
1423255|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
1423256|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
1423257|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
1423258|NCT01071252|AIN457|ain457
1423259|NCT01071252|dermatology|dermatology
1423260|NCT01071239|Fanconi Anemia|fanconi anemia
1423462|NCT01070316|RAD001|rad001
1423261|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1423262|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
1423263|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1423264|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
1423265|NCT01071226|CliniMACS device|clinimacs device
1423266|NCT01071226|T cell depletion|t cell depletion
1423267|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
1423268|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
1423269|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
1423270|NCT01071187|alcohol dependence|alcohol dependence
1423271|NCT01071187|addiction|addiction
1423272|NCT01071187|alcohol|alcohol
1423273|NCT01071187|relapse prevention|relapse prevention
1423274|NCT01071174|HIV infections|hiv infections
1423275|NCT01071174|Anti-HIV agents|anti-hiv agents
1423276|NCT01071174|HIV-1|hiv-1
1423277|NCT01071161|chronic cough|chronic cough
1423278|NCT01071161|COPD|copd
1423279|NCT01071161|Azithromycin|azithromycin
1423280|NCT01071161|Zithromax|zithromax
1423281|NCT01071161|LCQ|lcq
1423282|NCT01071148|Infertility|infertility
1423283|NCT01071148|Gonal-f|gonal-f
1423284|NCT01071148|Pergoveris|pergoveris
1423285|NCT01071148|Luveris|luveris
1423286|NCT01071122|Central blood pressure|central blood pressure
1423287|NCT01071122|Nifedipine|nifedipine
1423288|NCT01071122|Valsartan|valsartan
1423289|NCT01071109|Therapeutic massage|therapeutic massage
1423290|NCT01071109|massage|massage
1423291|NCT01071109|inflammation|inflammation
1423292|NCT01071109|fatigue|fatigue
1423293|NCT01071109|insomnia|insomnia
1423294|NCT01071109|radiation therapy|radiation therapy
1423295|NCT01071109|breast cancer|breast cancer
1423296|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
1423297|NCT01071096|Botox|botox
1423298|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
1423299|NCT01071096|Chronic Migraine|chronic migraine
1423300|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
1423301|NCT01071096|Saliva|saliva
1423302|NCT01071083|MS|ms
1423303|NCT01071070|Chronic Kidney Disease|chronic kidney disease
1423304|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
1423305|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
1423306|NCT01071057|naloxone|naloxone
1423307|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
1423308|NCT01071031|Safety|safety
1423309|NCT01071031|Tolerability|tolerability
1423902|NCT01068353|Dementia|dementia
1423310|NCT01071031|Immunogenicity|immunogenicity
1423311|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
1423312|NCT01071031|HIV-1|hiv-1
1423313|NCT01071031|Vaccine|vaccine
1423314|NCT01071031|CD4|cd4
1423315|NCT01071031|Viral Load|viral load
1423316|NCT01071031|HIV|hiv
1423317|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
1423318|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
1423319|NCT01070966|Atherosclerosis|atherosclerosis
1423320|NCT01070953|Hypercholesterolemia|hypercholesterolemia
1423321|NCT01070940|L-NMMA|l-nmma
1423322|NCT01070940|blood pressure|blood pressure
1423323|NCT01070940|arterial stiffness|arterial stiffness
1423324|NCT01070940|pulse wave velocity|pulse wave velocity
1423325|NCT01070940|augmentation index|augmentation index
1423326|NCT01070940|dose-response|dose-response
1423327|NCT01070940|healthy subjects|healthy subjects
1423328|NCT01070940|GFR|gfr
1423329|NCT01070914|Cilia|cilia
1423330|NCT01070914|Phenotyping|phenotyping
1423331|NCT01070914|Diagnosis|diagnosis
1423332|NCT01070914|Nitric Oxide|nitric oxide
1423333|NCT01070914|Bronchiectasis|bronchiectasis
1423334|NCT01070888|Asthma|asthma
1423335|NCT01070888|Exercise Induced Asthma|exercise induced asthma
1423336|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
1423337|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
1423338|NCT01070849|exercise|exercise
1423339|NCT01070849|physical activity|physical activity
1423340|NCT01070836|JCV|jcv
1423341|NCT01070836|Sample Collection|sample collection
1423342|NCT01070836|PML|pml
1423343|NCT01070836|Antibody|antibody
1423344|NCT01070823|Sample Collection|sample collection
1423345|NCT01070823|JCV|jcv
1423346|NCT01070823|PML|pml
1423347|NCT01070810|Septic Shock|septic shock
1423348|NCT01070810|Sepsis|sepsis
1423349|NCT01070797|Epstein-Barr virus|epstein-barr virus
1423350|NCT01070797|CTL|ctl
1423351|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
1423352|NCT01070797|CMV|cmv
1423353|NCT01070797|Adenovirus Infection|adenovirus infection
1423354|NCT01070797|viral infection|viral infection
1423355|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1423356|NCT01070784|Symbicort|symbicort
1423357|NCT01070784|Safety|safety
1423358|NCT01070784|Efficacy|efficacy
1423359|NCT01070784|COPD|copd
1423360|NCT01070784|Japanese|japanese
1423361|NCT01070771|Pressure wire|pressure wire
1423362|NCT01070771|Fractional flow reserve|fractional flow reserve
1423363|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
1423364|NCT01070758|Somatostatin analog|somatostatin analog
1423365|NCT01070758|Lanreotide autogel|lanreotide autogel
1423366|NCT01070758|Hypoglycemia|hypoglycemia
1423367|NCT01070745|PDA|pda
1423368|NCT01070745|Indomethacin|indomethacin
1423369|NCT01070745|Ibuprofen|ibuprofen
1423370|NCT01070732|Fever|fever
1423371|NCT01070732|Infectious diseases|infectious diseases
1423372|NCT01070732|Neoplasia|neoplasia
1423373|NCT01070732|Pain|pain
1423374|NCT01070732|cholecystectomy|cholecystectomy
1423375|NCT01070732|Colectomy|colectomy
1423376|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
1423377|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
1423378|NCT01070693|Inguinal hernia|inguinal hernia
1423379|NCT01070693|Open mesh repair|open mesh repair
1423380|NCT01070693|Long term outcome|long term outcome
1423381|NCT01070693|Recurrence|recurrence
1423382|NCT01070693|Discomfort|discomfort
1423383|NCT01070680|ERCP|ercp
1423384|NCT01070680|dexmedetomidine|dexmedetomidine
1423385|NCT01070680|propofol|propofol
1423386|NCT01070680|patient-controlled sedation|patient-controlled sedation
1423387|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
1423388|NCT01070667|PAF|paf
1423389|NCT01070667|AF|af
1423390|NCT01070667|Dronedarone|dronedarone
1423391|NCT01070667|AF Burden|af burden
1423392|NCT01070667|AFB|afb
1423393|NCT01070667|PPM|ppm
1423394|NCT01070667|Permanent Pacemaker|permanent pacemaker
1423395|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
1423396|NCT01070654|ARDS|ards
1423397|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
1423398|NCT01070654|PEEP|peep
1423399|NCT01070654|Cytokines|cytokines
1423400|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
1423401|NCT01070641|CARVEDILOL|carvedilol
1423402|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
1423403|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
1423404|NCT01070628|Pharmacokinetic|pharmacokinetic
1423405|NCT01070602|IFIS|ifis
1423406|NCT01070589|Obesity|obesity
1423407|NCT01070589|Growth hormone secretion|growth hormone secretion
1423408|NCT01070589|Anaerobic exercise|anaerobic exercise
1423409|NCT01070576|non union|non union
1423410|NCT01070576|fracture|fracture
1423411|NCT01070576|healing|healing
1423412|NCT01070576|arginine|arginine
1423413|NCT01070576|NO|no
1423414|NCT01070563|Brain death|brain death
1423415|NCT01070563|CT angiography|ct angiography
1423416|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
1423417|NCT01070537|Otolaryngology|otolaryngology
1423418|NCT01070537|Equipment and Supplies|equipment and supplies
1423419|NCT01070537|Intubation|intubation
1423420|NCT01070511|Muscular Dystrophy|muscular dystrophy
1423421|NCT01070511|Tadalafil|tadalafil
1423422|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
1423423|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
1423424|NCT01070498|allergy|allergy
1423425|NCT01070498|Trichuris suis|trichuris suis
1423426|NCT01070498|hygiene hypothesis|hygiene hypothesis
1423427|NCT01070498|treatment|treatment
1423428|NCT01070498|clinical trial|clinical trial
1423429|NCT01070498|food/adverse effect|food/adverse effect
1423430|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
1423431|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
1423432|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
1423433|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
1423434|NCT01070446|choline|choline
1423435|NCT01070446|cystic fibrosis|cystic fibrosis
1423436|NCT01070446|methyl metabolism|methyl metabolism
1423437|NCT01070446|fatty acids|fatty acids
1423438|NCT01070446|oxidative stress|oxidative stress
1423439|NCT01070446|pulmonary function|pulmonary function
1423440|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
1423441|NCT01070420|Adenosine|adenosine
1423442|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
1423443|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
1423444|NCT01070407|Hepatitis C virus|hepatitis c virus
1423445|NCT01070407|HCV|hcv
1423446|NCT01070407|Adenovirus|adenovirus
1423447|NCT01070407|Vaccine|vaccine
1423448|NCT01070394|ADHD|adhd
1423449|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
1423450|NCT01070394|Amphetamine|amphetamine
1423451|NCT01070368|skin test|skin test
1423452|NCT01070368|open wheat challenge|open wheat challenge
1423453|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
1423454|NCT01070355|Fish Oils|fish oils
1423455|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
1423456|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
1423457|NCT01070355|Liver Metastases|liver metastases
1423458|NCT01070355|Randomised Controlled Trial|randomised controlled trial
1423459|NCT01070316|Epilepsy|epilepsy
1423460|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
1423461|NCT01070316|Everolimus|everolimus
1423463|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
1423464|NCT01070303|HUMIRA|humira
1423465|NCT01070303|adalimumab|adalimumab
1423466|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
1423467|NCT01070290|gastric carcinoma|gastric carcinoma
1423468|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
1423469|NCT01070277|chronic diarrhea|chronic diarrhea
1423470|NCT01070277|travelers|travelers
1423471|NCT01070277|Parasites|parasites
1423472|NCT01070277|albendazole|albendazole
1423473|NCT01070277|tinidazole|tinidazole
1423474|NCT01070264|Osteoarthritis|osteoarthritis
1423475|NCT01070238|Isomaltulose|isomaltulose
1423476|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
1423477|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
1423478|NCT01070238|Type 2 diabetes|type 2 diabetes
1423479|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
1423480|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
1423481|NCT01070186|nephrectomy|nephrectomy
1423482|NCT01070186|T1b|t1b
1423484|NCT01070186|T3|t3
1423485|NCT01070186|T4|t4
1423486|NCT01070186|N1|n1
1423487|NCT01070186|Kidney Cancer|kidney cancer
1423488|NCT01070173|Ghrelin|ghrelin
1423489|NCT01070173|short stature|short stature
1423490|NCT01070173|failure to thrive|failure to thrive
1423491|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
1423492|NCT01070160|Metformin|metformin
1423493|NCT01070160|Endometrin|endometrin
1423494|NCT01070147|asthma|asthma
1423495|NCT01070147|emergency medicine|emergency medicine
1423496|NCT01070147|medical informatics|medical informatics
1423497|NCT01070147|computerized reminder systems|computerized reminder systems
1423498|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
1423499|NCT01070121|RA|ra
1423500|NCT01070121|Autoimmune Disease|autoimmune disease
1423501|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
1423502|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
1423503|NCT01070082|adult ICU patients|adult icu patients
1423504|NCT01070082|procedural pain|procedural pain
1423505|NCT01070082|pain intensity|pain intensity
1423506|NCT01070082|pain distress|pain distress
1423507|NCT01070082|pain behaviors|pain behaviors
1423508|NCT01070082|pain|pain
1423509|NCT01070082|ICU procedures|icu procedures
1423510|NCT01070069|Percutaneous|percutaneous
1423511|NCT01070069|Preclose|preclose
1423512|NCT01070069|Endologix|endologix
1423903|NCT01068353|TNF-alpha|tnf-alpha
1423513|NCT01070069|Abbott Vascular|abbott vascular
1423514|NCT01070069|Endovascular|endovascular
1423515|NCT01070069|PEVAR|pevar
1423516|NCT01070069|Stent graft|stent graft
1423517|NCT01070069|Suture mediated closure devices|suture mediated closure devices
1423518|NCT01070056|Blood Pressure|blood pressure
1423519|NCT01070056|Lifestyle Changes|lifestyle changes
1423520|NCT01070056|African American|african american
1423521|NCT01070043|Hypertension|hypertension
1423522|NCT01070043|valsartan|valsartan
1423523|NCT01070043|amlodipine|amlodipine
1423524|NCT01070043|high blood pressure|high blood pressure
1423525|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
1423526|NCT01070017|Peru|peru
1423527|NCT01070017|DOT|dot
1423528|NCT01070017|HIV|hiv
1423529|NCT01070017|AIDS|aids
1423530|NCT01070017|Community based|community based
1423531|NCT01070017|social capital|social capital
1423532|NCT01070004|sleepiness|sleepiness
1423533|NCT01070004|driving|driving
1423534|NCT01070004|countermeasures|countermeasures
1423535|NCT01070004|coffee|coffee
1423536|NCT01070004|blue light exposure|blue light exposure
1423537|NCT01070004|physical activity|physical activity
1423538|NCT01069991|Asthma|asthma
1423539|NCT01069991|Adolescents|adolescents
1423540|NCT01069991|Patient Education|patient education
1423541|NCT01069991|Schools|schools
1423542|NCT01069965|Type 2|type 2
1423543|NCT01069952|Deep Brain Stimulation|deep brain stimulation
1423544|NCT01069952|Treatment Refractory|treatment refractory
1423545|NCT01069952|Neurosurgery|neurosurgery
1423546|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
1423547|NCT01069952|Internal Capsule|internal capsule
1423548|NCT01069939|Gastric ulcer|gastric ulcer
1423549|NCT01069939|Duodenal ulcer|duodenal ulcer
1423550|NCT01069939|Low-dose aspirin|low-dose aspirin
1423551|NCT01069926|Diabetes|diabetes
1423552|NCT01069913|Healthy Volunteer|healthy volunteer
1423553|NCT01069900|Intra-abdominal infection|intra-abdominal infection
1423554|NCT01069900|Pediatric infection|pediatric infection
1423555|NCT01069887|febrile events|febrile events
1423556|NCT01069887|invasive fungal infections|invasive fungal infections
1423557|NCT01069887|hematological patients|hematological patients
1423558|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
1423559|NCT01069874|Cholecalciferol|cholecalciferol
1423560|NCT01069874|Communicable Diseases|communicable diseases
1423561|NCT01069874|Growth Substances|growth substances
1423562|NCT01069874|Housing for the Elderly|housing for the elderly
1423563|NCT01069874|Infection|infection
1423564|NCT01069874|Micronutrients|micronutrients
1423565|NCT01069874|Pharmacologic Actions|pharmacologic actions
1423566|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
1423567|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
1423568|NCT01069874|Vitamins|vitamins
1423569|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
1423570|NCT01069874|Vitamin D|vitamin d
1423571|NCT01069861|PPHN|pphn
1423572|NCT01069861|neonates|neonates
1423573|NCT01069861|sildanefil IV|sildanefil iv
1423574|NCT01069835|Non small cell lung cancer|non small cell lung cancer
1423575|NCT01069835|EGFR mutation|egfr mutation
1423576|NCT01069835|NSCLC|nsclc
1423577|NCT01069822|Midazolam|midazolam
1423578|NCT01069822|Pharmacokinetics|pharmacokinetics
1423579|NCT01069796|triple negative|triple negative
1423580|NCT01069796|metastatic|metastatic
1423581|NCT01069796|breast cancer|breast cancer
1423582|NCT01069796|First line chemotherapy|first line chemotherapy
1423583|NCT01069783|dyslipidemia|dyslipidemia
1423584|NCT01069783|cholesterol|cholesterol
1423585|NCT01069783|LDL|ldl
1423586|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
1423587|NCT01069770|Sunitinib|sunitinib
1423588|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
1423589|NCT01069770|Metastasis|metastasis
1423590|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
1423591|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
1423592|NCT01069705|Cystic fibrosis|cystic fibrosis
1423593|NCT01069705|Lung diseases|lung diseases
1423594|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
1423595|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
1423596|NCT01069692|Chronic Kidney Disease|chronic kidney disease
1423597|NCT01069692|Hemodialysis|hemodialysis
1423598|NCT01069692|Hyperphosphatemia|hyperphosphatemia
1423599|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
1423600|NCT01069666|atopic dermatitis|atopic dermatitis
1423601|NCT01069666|Thai pediatricians|thai pediatricians
1423602|NCT01069653|CDCA1|cdca1
1423603|NCT01069653|KIF20A|kif20a
1423604|NCT01069653|lung cancer|lung cancer
1423605|NCT01069653|vaccine|vaccine
1423606|NCT01069653|HLA-A*2402|hla-a*2402
1423607|NCT01069640|URLC10|urlc10
1423608|NCT01069640|lung cancer|lung cancer
1423609|NCT01069640|vaccine|vaccine
1423610|NCT01069640|HLA-A*0201|hla-a*0201
1423611|NCT01069640|HLA-A*0206|hla-a*0206
1423612|NCT01069614|Equipment and supplies|equipment and supplies
1423613|NCT01069601|solid organ transplantation|solid organ transplantation
1423614|NCT01069601|bone marrow transplantation|bone marrow transplantation
1423615|NCT01069601|adults|adults
1423616|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
1423617|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
1423618|NCT01069588|bioabsorbable screw|bioabsorbable screw
1423619|NCT01069588|acl reconstruction|acl reconstruction
1423620|NCT01069575|URLC10|urlc10
1423621|NCT01069575|CDCA1|cdca1
1423622|NCT01069575|KIF20A|kif20a
1423623|NCT01069575|lung cancer|lung cancer
1423624|NCT01069575|vaccine|vaccine
1423625|NCT01069575|HLA-A*2402|hla-a*2402
1423626|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
1423627|NCT01069562|isoflurane|isoflurane
1423628|NCT01069562|open heart surgery|open heart surgery
1423629|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1423630|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
1423631|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
1423632|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
1423633|NCT01069536|metoclopramide|metoclopramide
1423634|NCT01069536|akathisia|akathisia
1423635|NCT01069536|nausea|nausea
1423636|NCT01069536|vomiting|vomiting
1423637|NCT01069536|antiemetic|antiemetic
1423638|NCT01069536|improvement of nausea|improvement of nausea
1423639|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1423640|NCT01069523|Guanfacine|guanfacine
1423641|NCT01069523|Event Related Potentials|event related potentials
1423642|NCT01069497|Infection control|infection control
1423643|NCT01069497|Urinary Tract Infections|urinary tract infections
1423644|NCT01069497|Respiratory Tract Infections|respiratory tract infections
1423645|NCT01069484|Randomized controlled trial|randomized controlled trial
1423771|NCT01069042|Heart failure|heart failure
1423646|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
1423647|NCT01069484|Urinary incontinence|urinary incontinence
1423648|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
1423649|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
1423650|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
1423651|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
1423652|NCT01069471|S.dysenteriae|s.dysenteriae
1423653|NCT01069471|Healthy volunteers|healthy volunteers
1423654|NCT01069471|Conjugate vaccine|conjugate vaccine
1423655|NCT01069471|Safety|safety
1424239|NCT01067066|Stage IV|stage iv
1423656|NCT01069471|Immunogenicity|immunogenicity
1423657|NCT01069471|Dose scaling|dose scaling
1423658|NCT01069458|Dietary intervention|dietary intervention
1423659|NCT01069458|Smoking cessation|smoking cessation
1423660|NCT01069458|Body weight|body weight
1423661|NCT01069445|diet|diet
1423662|NCT01069445|probiotics|probiotics
1423663|NCT01069445|inflammaging|inflammaging
1423664|NCT01069445|oxidative stress|oxidative stress
1423665|NCT01069445|gut microbiota|gut microbiota
1423666|NCT01069445|food complements|food complements
1423667|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1423668|NCT01069432|CLL|cll
1423669|NCT01069432|Normal Volunteers|normal volunteers
1423670|NCT01069419|Certolizumab Pegol|certolizumab pegol
1423671|NCT01069419|Cimzia|cimzia
1423672|NCT01069406|notch|notch
1423673|NCT01069406|uterine|uterine
1423674|NCT01069406|first|first
1423675|NCT01069406|bleeding|bleeding
1423676|NCT01069380|resting metabolic rate|resting metabolic rate
1423677|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
1423678|NCT01069380|low conscious|low conscious
1423679|NCT01069380|minimal conscious state|minimal conscious state
1423680|NCT01069380|immobilized|immobilized
1423681|NCT01069380|resting energy expenditure|resting energy expenditure
1423682|NCT01069367|Influenza A|influenza a
1423683|NCT01069367|H1N1 subtype|h1n1 subtype
1423684|NCT01069367|Children/adolescent|children/adolescent
1423685|NCT01069367|Vaccine|vaccine
1423686|NCT01069367|Adjuvant|adjuvant
1423687|NCT01069367|Cell culture|cell culture
1423688|NCT01069354|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
1423689|NCT01069341|Rubeosis|rubeosis
1423690|NCT01069341|Neovascularization of iris|neovascularization of iris
1423691|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1423692|NCT01069341|PDR|pdr
1423693|NCT01069341|Cataract|cataract
1423694|NCT01069328|Lung|lung
1423695|NCT01069328|cancer|cancer
1423696|NCT01069328|NSCLC|nsclc
1423697|NCT01069315|open wound|open wound
1423698|NCT01069315|solution|solution
1423699|NCT01069315|pressure|pressure
1423700|NCT01069315|randomized|randomized
1423701|NCT01069302|Coronary artery disease|coronary artery disease
1423702|NCT01069289|Symbicort|symbicort
1423703|NCT01069289|Oxis|oxis
1423704|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1423705|NCT01069289|COPD|copd
1423706|NCT01069289|Efficacy|efficacy
1423707|NCT01069276|Stroke|stroke
1423708|NCT01069276|prehospital ultrasound|prehospital ultrasound
1423709|NCT01069263|Interstitial cystitis|interstitial cystitis
1423710|NCT01069263|Painful bladder syndrome|painful bladder syndrome
1423711|NCT01069263|Chronic pelvic pain|chronic pelvic pain
1423712|NCT01069263|DMSO|dmso
1423713|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1423714|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
1423715|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
1423716|NCT01069250|acute brain injury|acute brain injury
1423717|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
1423718|NCT01069250|critical care|critical care
1423719|NCT01069237|contact lens wear|contact lens wear
1423720|NCT01069237|multi-purpose solution|multi-purpose solution
1423721|NCT01069237|corneal staining|corneal staining
1423722|NCT01069224|rotator cuff|rotator cuff
1423723|NCT01069224|synovial fluid|synovial fluid
1423724|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
1423725|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
1423726|NCT01069211|postmenopause|postmenopause
1423727|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
1423728|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
1423729|NCT01069198|Kala-azar|kala-azar
1423730|NCT01069198|Bangladesh|bangladesh
1423731|NCT01069198|Malnutrition|malnutrition
1423732|NCT01069198|Asymptomatic|asymptomatic
1423733|NCT01069198|Albendazole|albendazole
1423734|NCT01069198|Iron|iron
1423735|NCT01069198|Zinc|zinc
1423736|NCT01069198|Vitamin A|vitamin a
1423737|NCT01069185|Unplanned extubation|unplanned extubation
1423738|NCT01069185|Length of stay in PICU|length of stay in picu
1423739|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
1423740|NCT01069172|Cataract|cataract
1423741|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
1423742|NCT01069172|Optical devices, laser|optical devices, laser
1423743|NCT01069159|Traumatic memory|traumatic memory
1423744|NCT01069159|Traumatic memories|traumatic memories
1423745|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
1423746|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
1423747|NCT01069159|PTSD|ptsd
1423748|NCT01069146|sepsis,|sepsis,
1423749|NCT01069146|septic shock,|septic shock,
1423750|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
1423751|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
1423752|NCT01069133|cirrhosis|cirrhosis
1423753|NCT01069133|complications|complications
1423754|NCT01069120|Uterine Fibroids|uterine fibroids
1423755|NCT01069107|community hospital|community hospital
1423756|NCT01069107|alternative acute admissions|alternative acute admissions
1423757|NCT01069094|Uterine fibroids|uterine fibroids
1423758|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
1423759|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
1423760|NCT01069081|Chemotherapy|chemotherapy
1423761|NCT01069081|Phase II study|phase ii study
1423762|NCT01069081|TTP|ttp
1423763|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
1423764|NCT01069055|inguinal hernia|inguinal hernia
1423765|NCT01069055|surgery|surgery
1423766|NCT01069055|general anesthesia|general anesthesia
1423767|NCT01069055|analgesia|analgesia
1423768|NCT01069055|pre-emptive|pre-emptive
1423769|NCT01069055|SF36|sf36
1423770|NCT01069042|Rho kinase activity|rho kinase activity
1423772|NCT01069042|ACE inhibitor|ace inhibitor
1423773|NCT01069042|LVEF change|lvef change
1423774|NCT01069042|Rho kinase activity change|rho kinase activity change
1423775|NCT01069029|Macular Hole|macular hole
1423776|NCT01069029|Cataract surgery|cataract surgery
1423777|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
1423778|NCT01069029|Combined surgery|combined surgery
1423779|NCT01069029|Idiopathic|idiopathic
1423780|NCT01069016|Fecal Incontinence|fecal incontinence
1423781|NCT01069016|Colorectal surgery|colorectal surgery
1423782|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
1423783|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
1423784|NCT01069003|Heart Disease|heart disease
1423785|NCT01069003|Cardiovascular Disease|cardiovascular disease
1423786|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1423787|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
1423788|NCT01069003|Clopidogrel|clopidogrel
1423789|NCT01069003|Prasugrel|prasugrel
1423790|NCT01069003|Vascular Disease|vascular disease
1423791|NCT01069003|Myocardial Ischemia|myocardial ischemia
1423792|NCT01068990|pneumonia|pneumonia
1423793|NCT01068951|type 1 diabetes|type 1 diabetes
1423794|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
1423795|NCT01068951|intervention|intervention
1423796|NCT01068938|visual field|visual field
1423797|NCT01068938|perimetry|perimetry
1423798|NCT01068938|glaucoma progression|glaucoma progression
1423799|NCT01068938|grid|grid
1423800|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
1423801|NCT01068925|healthy volunteer|healthy volunteer
1423802|NCT01068925|pharmacokinetics|pharmacokinetics
1423803|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
1423805|NCT01068899|healthy adults|healthy adults
1423806|NCT01068899|healthy children|healthy children
1423807|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
1423808|NCT01068873|HIV|hiv
1423809|NCT01068873|Protease Inhibitor|protease inhibitor
1423810|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
1423811|NCT01068873|treatment naive|treatment naive
1423812|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1423813|NCT01068860|canakinumab|canakinumab
1423814|NCT01068860|Pre diabetic|pre diabetic
1423815|NCT01068860|glucose intolerant|glucose intolerant
1423816|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
1423817|NCT01068860|insulin treatment|insulin treatment
1423818|NCT01068860|metabolic syndrome|metabolic syndrome
1423819|NCT01068847|Opioid dependence|opioid dependence
1423820|NCT01068847|methadone|methadone
1423821|NCT01068847|opioid|opioid
1423822|NCT01068834|Adherence|adherence
1423823|NCT01068834|Statins|statins
1423824|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
1423825|NCT01068821|Slide|slide
1423826|NCT01068821|Trendelenburg's position|trendelenburg's position
1423827|NCT01068821|Postoperative|postoperative
1423828|NCT01068821|neurologic complaints|neurologic complaints
1423829|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
1423830|NCT01068808|Allergic rhinitis|allergic rhinitis
1423831|NCT01068808|Development|development
1423832|NCT01068795|placental syndrome|placental syndrome
1423833|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
1423834|NCT01068795|enoxaparin|enoxaparin
1423835|NCT01068795|anti-factor Xa|anti-factor xa
1423836|NCT01068782|Glioblastoma|glioblastoma
1423837|NCT01068782|Glioma|glioma
1423838|NCT01068782|Brain Cancer|brain cancer
1423839|NCT01068782|Brain Tumor|brain tumor
1423840|NCT01068782|Astrocytoma|astrocytoma
1423841|NCT01068769|regorafenib|regorafenib
1423842|NCT01068769|GIST|gist
1423843|NCT01068691|aortic dissection|aortic dissection
1423844|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
1423845|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1423846|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
1423847|NCT01068613|COPD|copd
1423848|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
1423849|NCT01068600|COPD|copd
1423850|NCT01068600|Indacaterol|indacaterol
1423851|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1423852|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1424237|NCT01067066|cytotoxic agent|cytotoxic agent
1423853|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1423854|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1423855|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
1423856|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
1423857|NCT01068561|stem cell|stem cell
1423858|NCT01068561|bone marrow|bone marrow
1423859|NCT01068535|metabolic syndrome|metabolic syndrome
1423860|NCT01068535|MetS|mets
1423861|NCT01068535|premenopausal women|premenopausal women
1423862|NCT01068535|vascular risk|vascular risk
1423863|NCT01068535|atherosclerosis detection|atherosclerosis detection
1423864|NCT01068522|Intracranial pressure|intracranial pressure
1423865|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
1423866|NCT01068522|Head injury|head injury
1423867|NCT01068509|Cvac|cvac
1423868|NCT01068483|Advanced solid tumors|advanced solid tumors
1423869|NCT01068483|Breast Cancer|breast cancer
1423870|NCT01068483|Colon Cancer|colon cancer
1423871|NCT01068483|Ovarian Cancer|ovarian cancer
1423872|NCT01068483|Endometrium cancer|endometrium cancer
1423873|NCT01068470|Interleukin-2|interleukin-2
1423874|NCT01068470|Melanoma|melanoma
1423875|NCT01068470|Kidney Cancer|kidney cancer
1423876|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
1423877|NCT01068457|persistent pain|persistent pain
1423878|NCT01068457|neuropathic pain|neuropathic pain
1423879|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
1423880|NCT01068457|Chronic Pain|chronic pain
1423881|NCT01068444|NASH|nash
1423882|NCT01068444|Pioglitazone|pioglitazone
1423883|NCT01068444|Treatment|treatment
1423884|NCT01068431|lymphedema|lymphedema
1423885|NCT01068431|conservative treatment|conservative treatment
1423886|NCT01068431|compression therapy|compression therapy
1423887|NCT01068431|interface pressure|interface pressure
1423888|NCT01068418|Obesity|obesity
1423889|NCT01068418|Renin Angiotensin System|renin angiotensin system
1423890|NCT01068418|Vitamin D deficiency|vitamin d deficiency
1423891|NCT01068418|Hypertension|hypertension
1423892|NCT01068392|relapsed|relapsed
1423893|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
1423894|NCT01068392|oxaliplatin|oxaliplatin
1423895|NCT01068392|prednisolone|prednisolone
1423896|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1423897|NCT01068379|cryopexy|cryopexy
1423898|NCT01068379|photocoagulation|photocoagulation
1423899|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
1423900|NCT01068366|Septal Closure Devices|septal closure devices
1423901|NCT01068353|Alzheimer's disease|alzheimer's disease
1423904|NCT01068353|Etanercept|etanercept
1423905|NCT01068340|Adhesions|adhesions
1423906|NCT01068340|Small Bowel Obstruction|small bowel obstruction
1423907|NCT01068340|Ileus|ileus
1423908|NCT01068314|Endothelium|endothelium
1423909|NCT01068314|Vasodilatation|vasodilatation
1423910|NCT01068314|Vein|vein
1423911|NCT01068314|Compliance|compliance
1423912|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
1423913|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
1423914|NCT01068301|Plerixafor|plerixafor
1423915|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
1423916|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
1423917|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
1423918|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
1423919|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1423920|NCT01068301|Other Leukemia|other leukemia
1423921|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
1423922|NCT01068288|open appendectomy|open appendectomy
1423923|NCT01068288|expectant management|expectant management
1423924|NCT01068288|paediatric|paediatric
1423925|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
1423926|NCT01068275|pain, postoperative|pain, postoperative
1423927|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
1423928|NCT01068275|nerve block|nerve block
1423929|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
1423930|NCT01068249|Advanced|advanced
1423931|NCT01068249|Recurrent|recurrent
1423932|NCT01068249|Progressive|progressive
1423933|NCT01068249|Endometrial Cancer|endometrial cancer
1423934|NCT01068249|Letrozole|letrozole
1423935|NCT01068249|RAD001|rad001
1423936|NCT01068249|Afinitor|afinitor
1423937|NCT01068249|Everolimus|everolimus
1423938|NCT01068249|Femara|femara
1423939|NCT01068236|Teen girls|teen girls
1423940|NCT01068236|weightloss|weightloss
1423941|NCT01068236|healthy lifestyle|healthy lifestyle
1423942|NCT01068236|yoga|yoga
1423943|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
1423944|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
1423945|NCT01068210|Exercise Intervention|exercise intervention
1423946|NCT01068210|Lung Cancer|lung cancer
1423947|NCT01068210|15-215|15-215
1423948|NCT01068197|Low Glycemic Load diet|low glycemic load diet
1423949|NCT01068197|Low Glycemic Index diet|low glycemic index diet
1423950|NCT01068197|Low Fat diet|low fat diet
1423951|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
1423952|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
1423953|NCT01068184|AZD6553|azd6553
1423954|NCT01068184|Chronic|chronic
1423955|NCT01068184|obstructive|obstructive
1423956|NCT01068184|pulmonary|pulmonary
1423957|NCT01068184|lung|lung
1423958|NCT01068184|respiratory disease|respiratory disease
1423959|NCT01068184|placebo-controlled|placebo-controlled
1423960|NCT01068184|COPD|copd
1423961|NCT01068184|Healthy Volunteers|healthy volunteers
1423962|NCT01068184|COPD Patients|copd patients
1423963|NCT01068171|diabetes|diabetes
1423964|NCT01068171|foot ulcers|foot ulcers
1423965|NCT01068171|off-loading|off-loading
1423966|NCT01068171|collagen|collagen
1423967|NCT01068171|Wagner 1|wagner 1
1423968|NCT01068158|Head lice infestation|head lice infestation
1423969|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
1423970|NCT01068145|COPD|copd
1423971|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
1423972|NCT01068132|KRAS|kras
1423973|NCT01068132|PTEN|pten
1423974|NCT01068119|Acute coronary syndrome|acute coronary syndrome
1423975|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
1423976|NCT01068119|Troponin negative|troponin negative
1423977|NCT01068119|cardiac|cardiac
1423978|NCT01068080|fatty acid metabolism|fatty acid metabolism
1423979|NCT01068080|insulin resistance|insulin resistance
1423980|NCT01068080|cardiac death|cardiac death
1423981|NCT01068080|hemodialysis|hemodialysis
1423982|NCT01068080|normal coronary arteries|normal coronary arteries
1423983|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
1423984|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
1423985|NCT01068054|FK-506|fk-506
1423986|NCT01068054|tacrolimus|tacrolimus
1423987|NCT01068054|cyclosporine|cyclosporine
1423988|NCT01068054|children|children
1423989|NCT01068028|Healthy volunteer study|healthy volunteer study
1423990|NCT01068015|MSM|msm
1423991|NCT01068015|Intervention|intervention
1423992|NCT01068015|Popular Opinion Leader|popular opinion leader
1423993|NCT01068015|Male Circumcision|male circumcision
1423994|NCT01068015|HIV|hiv
1423995|NCT01068015|Syphilis|syphilis
1423996|NCT01068015|HSV-2|hsv-2
1423997|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
1423998|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
1423999|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
1424000|NCT01067989|Breast cancer|breast cancer
1424001|NCT01067976|Breast Cancer|breast cancer
1424002|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
1424003|NCT01067976|Mammography|mammography
1424004|NCT01067963|self-care|self-care
1424005|NCT01067963|self-management|self-management
1424006|NCT01067963|health behavior change|health behavior change
1424007|NCT01067963|motivational interviewing|motivational interviewing
1424008|NCT01067963|computer assisted learning|computer assisted learning
1424009|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
1424010|NCT01067950|intensive insulin therapy|intensive insulin therapy
1424011|NCT01067937|Appendicitis|appendicitis
1424012|NCT01067937|children|children
1424013|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
1424014|NCT01067911|Postprandial lipids|postprandial lipids
1424015|NCT01067911|test meal|test meal
1424016|NCT01067911|fatty acids|fatty acids
1424017|NCT01067898|vitamin D supplementation|vitamin d supplementation
1424018|NCT01067898|cholecalciferol|cholecalciferol
1424019|NCT01067898|PTH|pth
1424020|NCT01067898|bone turnover markers|bone turnover markers
1424021|NCT01067898|elderly women|elderly women
1424022|NCT01067885|Nitinol Stent|nitinol stent
1424023|NCT01067885|Superficial femoral artery|superficial femoral artery
1424024|NCT01067885|SFA|sfa
1424025|NCT01067885|Angioplasty|angioplasty
1424026|NCT01067885|peripheral artery disease|peripheral artery disease
1424027|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
1424028|NCT01067885|PAOD|paod
1424029|NCT01067885|PAD|pad
1424030|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
1424031|NCT01067859|Heart Failure|heart failure
1424032|NCT01067846|cocaine dependence|cocaine dependence
1424033|NCT01067846|relapse prevention|relapse prevention
1424034|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
1424035|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
1424036|NCT01067833|atrial fibrillation|atrial fibrillation
1424037|NCT01067833|AF|af
1424038|NCT01067820|ApolipoproteinA1|apolipoproteina1
1424039|NCT01067820|HDL-C|hdl-c
1424040|NCT01067820|Atherosclerosis|atherosclerosis
1424041|NCT01067807|Pharmacokinetics|pharmacokinetics
1424042|NCT01067794|Metastatic|metastatic
1424043|NCT01067794|Advanced|advanced
1424044|NCT01067794|Stage IIIB-IV|stage iiib-iv
1424045|NCT01067794|daily|daily
1424046|NCT01067794|hospital|hospital
1424047|NCT01067794|practice|practice
1424048|NCT01067794|setting|setting
1424345|NCT01066533|MTA|mta
1424049|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
1424050|NCT01067768|Urinary Tract Infections|urinary tract infections
1424051|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
1424052|NCT01067768|Prevention and control|prevention and control
1424053|NCT01067768|Controlled clinical trial|controlled clinical trial
1424054|NCT01067755|navigation|navigation
1424055|NCT01067755|bronchoscopy|bronchoscopy
1424056|NCT01067755|lymphadenopathy|lymphadenopathy
1424057|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
1424058|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
1424059|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
1424060|NCT01067729|Burn|burn
1424061|NCT01067729|Superficial burns|superficial burns
1424062|NCT01067729|Partial thickness burns|partial thickness burns
1424063|NCT01067729|Rate of healing|rate of healing
1424064|NCT01067729|Infection rate|infection rate
1424065|NCT01067729|Pain perception|pain perception
1424066|NCT01067729|Non adherence|non adherence
1424067|NCT01067729|Scarring|scarring
1424068|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
1424069|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
1424070|NCT01067690|chemotherapy|chemotherapy
1424071|NCT01067690|indinavir|indinavir
1424072|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
1424073|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
1424074|NCT01067677|PONV|ponv
1424075|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
1424076|NCT01067677|rescue emetic therapy|rescue emetic therapy
1424077|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
1424078|NCT01067599|Smokeless Tobacco|smokeless tobacco
1424079|NCT01067586|Smokeless Tobacco|smokeless tobacco
1424080|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
1424081|NCT01067573|MS|ms
1424082|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
1424083|NCT01067573|Multiple sclerosis|multiple sclerosis
1424084|NCT01067573|relapse|relapse
1424085|NCT01067560|Glucose|glucose
1424086|NCT01067560|CSF|csf
1424087|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
1424088|NCT01067560|Nova Stat Strip|nova stat strip
1424089|NCT01067560|Abbott Precision Xtra|abbott precision xtra
1424090|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
1424091|NCT01067547|Iron deficiency|iron deficiency
1424092|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
1424093|NCT01067547|Crohn's Disease|crohn's disease
1424094|NCT01067547|Ulcerative colitis|ulcerative colitis
1424095|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1424096|NCT01067521|Glatiramer Acetate|glatiramer acetate
1424097|NCT01067495|stroke|stroke
1424098|NCT01067495|rehabilitation|rehabilitation
1424099|NCT01067495|exercise|exercise
1424100|NCT01067495|walking|walking
1424101|NCT01067495|risk factors|risk factors
1424102|NCT01067482|OCT|oct
1424103|NCT01067482|spectral domain cirrus|spectral domain cirrus
1424104|NCT01067482|glaucoma|glaucoma
1424105|NCT01067482|glaucoma suspect|glaucoma suspect
1424106|NCT01067482|normal population|normal population
1424107|NCT01067469|CNS|cns
1424108|NCT01067469|Central Nervous System|central nervous system
1424109|NCT01067469|malignant brain tumor|malignant brain tumor
1424110|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1424111|NCT01067469|GBM|gbm
1424112|NCT01067469|Bevacizumab|bevacizumab
1424113|NCT01067469|Lomustine|lomustine
1424114|NCT01067469|CCNU|ccnu
1424115|NCT01067443|Phase II|phase ii
1424116|NCT01067443|Randomised clinical trial|randomised clinical trial
1424117|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
1424118|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
1424119|NCT01067430|Etoricoxib|etoricoxib
1424120|NCT01067430|Diclofenac|diclofenac
1424121|NCT01067430|Pain|pain
1424122|NCT01067430|Stiffness|stiffness
1424123|NCT01067417|Hydroxychloroquine|hydroxychloroquine
1424124|NCT01067417|Chloroquine|chloroquine
1424125|NCT01067417|HIV Infection|hiv infection
1424126|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1424127|NCT01067417|Immune Activation|immune activation
1424128|NCT01067417|inflammation|inflammation
1424129|NCT01067417|treatment naive|treatment naive
1424130|NCT01067417|disease progression|disease progression
1424131|NCT01067404|Influenza vaccines|influenza vaccines
1424132|NCT01067404|Infant|infant
1424133|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
1424134|NCT01067391|Hypotension in SCI males|hypotension in sci males
1424135|NCT01067391|Erectile Dysfunction|erectile dysfunction
1424136|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
1424137|NCT01067378|Training|training
1424138|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
1424139|NCT01067352|Infant, small for gestational age|infant, small for gestational age
1424140|NCT01067352|Growth hormone|growth hormone
1424141|NCT01067352|Saizen|saizen
1424238|NCT01067066|unresectable Stage III|unresectable stage iii
1424142|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
1424143|NCT01067339|coronary vasospasm|coronary vasospasm
1424144|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
1424145|NCT01067326|Endothelial Function|endothelial function
1424146|NCT01067326|Tekturna|tekturna
1424147|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
1424148|NCT01067326|Progenitor Cells|progenitor cells
1424149|NCT01067326|renin inhibition|renin inhibition
1424150|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
1424151|NCT01067326|early atherosclerosis|early atherosclerosis
1424152|NCT01067313|Intensive Care Unit|intensive care unit
1424153|NCT01067313|continuous hemodialysis|continuous hemodialysis
1424154|NCT01067313|continuous hemofiltration|continuous hemofiltration
1424155|NCT01067313|High Cut-off membrane|high cut-off membrane
1424156|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
1424157|NCT01067313|Septic shock|septic shock
1424158|NCT01067313|Acute kidney injury|acute kidney injury
1424159|NCT01067313|Blood purification|blood purification
1424160|NCT01067313|Renal replacement therapy|renal replacement therapy
1424162|NCT01067300|acute leukemia in remission|acute leukemia in remission
1424163|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
1424164|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
1424165|NCT01067287|CT-011|ct-011
1424166|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
1424167|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
1424168|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
1424169|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
1424170|NCT01067261|Nerve stimulation|nerve stimulation
1424171|NCT01067261|TMNS|tmns
1424172|NCT01067261|Prostatectomy|prostatectomy
1424173|NCT01067261|Prevention|prevention
1424174|NCT01067261|Restoration|restoration
1424175|NCT01067261|Treatment|treatment
1424176|NCT01067261|Vibration|vibration
1424177|NCT01067261|Non-invasive|non-invasive
1424178|NCT01067248|COPD|copd
1424179|NCT01067248|Osteoporosis|osteoporosis
1424180|NCT01067248|Pathophysiology|pathophysiology
1424181|NCT01067248|Mechanism|mechanism
1424182|NCT01067248|Bone markers|bone markers
1424183|NCT01067248|Bone turnover|bone turnover
1424184|NCT01067248|Protein turnover|protein turnover
1424185|NCT01067248|Ageing|ageing
1424186|NCT01067248|Endocrinology|endocrinology
1424187|NCT01067248|Vitamin D|vitamin d
1424188|NCT01067235|Narcolespy|narcolespy
1424189|NCT01067235|Cataplexy|cataplexy
1424486|NCT01066169|Antibodies|antibodies
1424190|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
1424191|NCT01067235|Sleep Disorders|sleep disorders
1424192|NCT01067235|Sleep attacks|sleep attacks
1424193|NCT01067235|Orphan Drug|orphan drug
1424194|NCT01067235|Pitolisant|pitolisant
1424195|NCT01067222|Narcolepsy|narcolepsy
1424196|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
1424197|NCT01067222|Cataplexy|cataplexy
1424198|NCT01067222|Sleep Disorders|sleep disorders
1424199|NCT01067222|Sleep attacks|sleep attacks
1424200|NCT01067222|Orphan Drug|orphan drug
1424201|NCT01067222|Pitolisant|pitolisant
1424202|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
1424203|NCT01067196|Proton Radiation|proton radiation
1424204|NCT01067196|Central Nervous System Tumors|central nervous system tumors
1424205|NCT01067196|Brain|brain
1424206|NCT01067196|Spine|spine
1424207|NCT01067196|Cancer|cancer
1424208|NCT01067183|stress reduction|stress reduction
1424209|NCT01067183|physician wellness|physician wellness
1424210|NCT01067170|Hemodialysis|hemodialysis
1424211|NCT01067170|Intradialytic hypotension|intradialytic hypotension
1424212|NCT01067157|Obesity|obesity
1424213|NCT01067157|overweight|overweight
1424214|NCT01067157|childhood|childhood
1424215|NCT01067157|adolescence|adolescence
1424216|NCT01067157|inpatient therapy|inpatient therapy
1424217|NCT01067157|lifestyle intervention|lifestyle intervention
1424218|NCT01067157|cardiovascular risk|cardiovascular risk
1424219|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
1424220|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
1424221|NCT01067157|health behaviour|health behaviour
1424222|NCT01067131|Candida albicans|candida albicans
1424223|NCT01067131|Fungal vaginal infection|fungal vaginal infection
1424224|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
1424225|NCT01067131|Candidose|candidose
1424226|NCT01067131|Vaccine|vaccine
1424227|NCT01067131|Virosome|virosome
1424228|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
1424229|NCT01067105|allergic rhinitis|allergic rhinitis
1424230|NCT01067105|ciclesonide|ciclesonide
1424231|NCT01067079|Rabies vaccine|rabies vaccine
1424232|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
1424233|NCT01067066|TPI 287|tpi 287
1424234|NCT01067066|microtubule inhibitor|microtubule inhibitor
1424235|NCT01067066|Temozolomide|temozolomide
1424236|NCT01067066|Temodar|temodar
1424240|NCT01067066|Metastatic Melanoma|metastatic melanoma
1424241|NCT01067053|Bevacizumab|bevacizumab
1424242|NCT01067053|Capecitabine|capecitabine
1424243|NCT01067053|Oxaliplatin|oxaliplatin
1424244|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
1424245|NCT01067027|Colic|colic
1424246|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
1424247|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
1424248|NCT01067014|Decompression|decompression
1424249|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
1424250|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
1424251|NCT01066988|lipid layer thickness|lipid layer thickness
1424252|NCT01066975|loaded backpack|loaded backpack
1424253|NCT01066975|unloaded backpack|unloaded backpack
1424254|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
1424255|NCT01066949|hemodialysis|hemodialysis
1424256|NCT01066949|behavior change|behavior change
1424257|NCT01066949|patient adherence|patient adherence
1424258|NCT01066949|self management|self management
1424259|NCT01066923|firefighter|firefighter
1424260|NCT01066923|heat stress|heat stress
1424261|NCT01066923|platelet activation|platelet activation
1424262|NCT01066923|aspirin|aspirin
1424263|NCT01066910|Obesity|obesity
1424264|NCT01066910|Childhood Obesity|childhood obesity
1424265|NCT01066910|Exercise|exercise
1424266|NCT01066910|Nutrition|nutrition
1424267|NCT01066871|Knee cartilage injury|knee cartilage injury
1424268|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
1424269|NCT01066871|FGF18|fgf18
1424270|NCT01066858|tenofovir|tenofovir
1424271|NCT01066858|renal and bone toxicity|renal and bone toxicity
1424272|NCT01066858|pregnancy|pregnancy
1424273|NCT01066858|breastfeeding|breastfeeding
1424274|NCT01066858|mother to child transmission|mother to child transmission
1424275|NCT01066832|Drug-eluting balloon|drug-eluting balloon
1424276|NCT01066832|Paclitaxel|paclitaxel
1424277|NCT01066832|DIOR|dior
1424278|NCT01066832|short term registry|short term registry
1424279|NCT01066832|Valentines Trial|valentines trial
1424280|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
1424281|NCT01066780|cochlear implant|cochlear implant
1424282|NCT01066780|adults|adults
1424283|NCT01066780|HiResolution|hiresolution
1424284|NCT01066780|Fidelity 120|fidelity 120
1424285|NCT01066780|listening benefits|listening benefits
1424286|NCT01066780|noise|noise
1424287|NCT01066780|cochlear implant benefit|cochlear implant benefit
1424487|NCT01066169|Replicaton|replicaton
1424290|NCT01066741|Oropharynx|oropharynx
1424291|NCT01066741|Oral cavity|oral cavity
1424292|NCT01066741|Oral mucosa|oral mucosa
1424293|NCT01066741|Cavum|cavum
1424294|NCT01066741|Severe Oral mucositis|severe oral mucositis
1424295|NCT01066741|Radiotherapy|radiotherapy
1424296|NCT01066741|Phytotherapy|phytotherapy
1424297|NCT01066728|apnea|apnea
1424298|NCT01066728|premature|premature
1424299|NCT01066728|infant|infant
1424300|NCT01066728|prematurity|prematurity
1424301|NCT01066715|Diabetes|diabetes
1424302|NCT01066715|Type 2|type 2
1424303|NCT01066715|Mellitus|mellitus
1424304|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
1424309|NCT01066650|TWENTE|twente
1424310|NCT01066650|randomized study|randomized study
1424311|NCT01066650|stent|stent
1424312|NCT01066650|coronary stent|coronary stent
1424313|NCT01066650|drug-eluting stent|drug-eluting stent
1424314|NCT01066650|Zotarolimus|zotarolimus
1424315|NCT01066650|Everolimus|everolimus
1424316|NCT01066650|Xience V|xience v
1424317|NCT01066650|Endeavor Resolute|endeavor resolute
1424318|NCT01066650|head to head comparison|head to head comparison
1424319|NCT01066650|real world patients|real world patients
1424320|NCT01066650|target vessel failure|target vessel failure
1424321|NCT01066650|investigator initiated study|investigator initiated study
1424322|NCT01066650|coronary artery disease|coronary artery disease
1424323|NCT01066650|coronary arteries|coronary arteries
1424324|NCT01066650|atherosclerosis|atherosclerosis
1424325|NCT01066650|non inferiority|non inferiority
1424326|NCT01066637|Heart transplant patients|heart transplant patients
1424327|NCT01066624|Mucositis|mucositis
1424328|NCT01066624|Multiple myeloma|multiple myeloma
1424329|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1424330|NCT01066611|Allergic Rhinitis|allergic rhinitis
1424331|NCT01066611|Allergy|allergy
1424332|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1424333|NCT01066598|graft versus host disease|graft versus host disease
1424334|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
1424335|NCT01066598|cGVHD|cgvhd
1424336|NCT01066585|Head lice|head lice
1424337|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
1424338|NCT01066546|Delirium|delirium
1424339|NCT01066546|Dementia|dementia
1424340|NCT01066546|Amnestic|amnestic
1424341|NCT01066546|Cognitive Disorders|cognitive disorders
1424342|NCT01066546|Mental Disorders|mental disorders
1424343|NCT01066546|Nervous System Diseases|nervous system diseases
1424344|NCT01066546|Central Nervous System Diseases|central nervous system diseases
1424346|NCT01066533|NEC|nec
1424347|NCT01066533|Immunohistochemistry|immunohistochemistry
1424348|NCT01066533|fibronectin|fibronectin
1424349|NCT01066533|tenascin|tenascin
1424350|NCT01066520|ankle sprain|ankle sprain
1424351|NCT01066520|traumeel|traumeel
1424352|NCT01066520|diclofenac|diclofenac
1424353|NCT01066520|antiinflammatory|antiinflammatory
1424354|NCT01066520|time to normal function|time to normal function
1424355|NCT01066507|Her2|her2
1424356|NCT01066507|FISH|fish
1424357|NCT01066507|Breast cancer|breast cancer
1424358|NCT01066507|Amplification|amplification
1424359|NCT01066494|AML|aml
1424360|NCT01066494|Pgp|pgp
1424361|NCT01066494|MDR|mdr
1424362|NCT01066494|sAML|saml
1424363|NCT01066494|AS1413|as1413
1424364|NCT01066494|Amonafide|amonafide
1424365|NCT01066481|Alzheimer's disease|alzheimer's disease
1424366|NCT01066481|clinical trial|clinical trial
1424367|NCT01066481|memory loss|memory loss
1424368|NCT01066481|investigational drug|investigational drug
1424369|NCT01066481|neurodegenerative disease|neurodegenerative disease
1424370|NCT01066481|dementia|dementia
1424371|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
1424372|NCT01066468|CML|cml
1424373|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
1424374|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1424375|NCT01066468|PhGlivec,|phglivec,
1424376|NCT01066468|Gleevec,|gleevec,
1424377|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
1424378|NCT01066468|HES,|hes,
1424379|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
1424380|NCT01066468|CEL,|cel,
1424381|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
1424382|NCT01066468|MDS,|mds,
1424383|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
1424384|NCT01066468|MPD+ ALL|mpd+ all
1424385|NCT01066455|Cardiac|cardiac
1424386|NCT01066455|Muscular Dystrophy|muscular dystrophy
1424387|NCT01066455|Prospective|prospective
1424388|NCT01066455|Pediatric|pediatric
1424389|NCT01066455|Echocardiogram|echocardiogram
1424390|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
1424391|NCT01066442|Parkinson's Disease|parkinson's disease
1424484|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
1424392|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
1424393|NCT01066429|dose-adjusted|dose-adjusted
1424394|NCT01066429|R-EDOCH-14|r-edoch-14
1424395|NCT01066429|rituximab|rituximab
1424396|NCT01066429|age-adjusted IPI|age-adjusted ipi
1424397|NCT01066429|toxicity|toxicity
1424398|NCT01066403|schizophrenia|schizophrenia
1424399|NCT01066403|cognitive deficits|cognitive deficits
1424400|NCT01066403|dopamine|dopamine
1424401|NCT01066403|dopamine agonists|dopamine agonists
1424402|NCT01066403|prefrontal cortex|prefrontal cortex
1424403|NCT01066403|D1 specific modulation|d1 specific modulation
1424404|NCT01066403|pergolide|pergolide
1424405|NCT01066403|executive control|executive control
1424406|NCT01066403|working memory|working memory
1424407|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
1424408|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
1424409|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
1424410|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
1424411|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
1424412|NCT01066377|prebiotic|prebiotic
1424413|NCT01066377|probiotic|probiotic
1424414|NCT01066377|influenza|influenza
1424415|NCT01066377|vaccination|vaccination
1424416|NCT01066377|ageing|ageing
1424417|NCT01066377|immunosenescence|immunosenescence
1424418|NCT01066364|NASH|nash
1424419|NCT01066364|NAFLD|nafld
1424420|NCT01066364|Steatohepatitis|steatohepatitis
1424421|NCT01066364|Nonalcoholic|nonalcoholic
1424422|NCT01066364|Fatty Liver Disease|fatty liver disease
1424423|NCT01066351|acute kidney injury|acute kidney injury
1424424|NCT01066351|erythropoietin|erythropoietin
1424425|NCT01066351|cardiac surgery|cardiac surgery
1424426|NCT01066338|SNP array|snp array
1424427|NCT01066338|prognosis|prognosis
1424428|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
1424429|NCT01066338|normal karyotype|normal karyotype
1424430|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
1424431|NCT01066325|Sit-n-Reach Test|sit-n-reach test
1424432|NCT01066325|Flexibility|flexibility
1424433|NCT01066325|Hamstring|hamstring
1424434|NCT01066325|Mindbody|mindbody
1424435|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
1424436|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
1424437|NCT01066312|Muscle testing|muscle testing
1424438|NCT01066312|Kinesiology|kinesiology
1424439|NCT01066312|Muscles|muscles
1424440|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
1424441|NCT01066312|Practitioner Experience|practitioner experience
1424442|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
1424539|NCT01065961|cervical|cervical
1424443|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
1424444|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
1424445|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
1424446|NCT01066299|oxytocin|oxytocin
1424447|NCT01066299|psychophysiology|psychophysiology
1424448|NCT01066299|startle|startle
1424449|NCT01066299|anxiety|anxiety
1424450|NCT01066299|emotion|emotion
1424451|NCT01066299|physiology|physiology
1424452|NCT01066286|genome wide SNP-array|genome wide snp-array
1424453|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
1424454|NCT01066286|KIT mutation|kit mutation
1424455|NCT01066286|core binding factor|core binding factor
1424456|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
1424457|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
1424458|NCT01066260|Probiotics|probiotics
1424459|NCT01066260|Energy balance|energy balance
1424460|NCT01066247|spinal anesthesia|spinal anesthesia
1424461|NCT01066247|heart rate variability|heart rate variability
1424462|NCT01066247|premedication|premedication
1424463|NCT01066247|heart rate|heart rate
1424464|NCT01066247|blood pressure|blood pressure
1424465|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
1424466|NCT01066234|Paclitaxel|paclitaxel
1424467|NCT01066234|Carboplatin|carboplatin
1424468|NCT01066234|Cisplatin|cisplatin
1424469|NCT01066221|clostridium difficile|clostridium difficile
1424470|NCT01066208|Classification criteria|classification criteria
1424471|NCT01066208|Diagnostic criteria|diagnostic criteria
1424472|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
1424473|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
1424474|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
1424475|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
1424476|NCT01066182|DHA|dha
1424477|NCT01066182|Learning|learning
1424478|NCT01066182|Reading|reading
1424479|NCT01066182|Memory|memory
1424480|NCT01066182|Children|children
1424481|NCT01066182|Omega 3|omega 3
1424482|NCT01066182|Education|education
1424483|NCT01066182|Learning and behaviour in children|learning and behaviour in children
1424485|NCT01066169|HIV|hiv
1424488|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
1424489|NCT01066156|PTSD|ptsd
1424490|NCT01066156|Seroquel|seroquel
1424491|NCT01066156|fMRI|fmri
1424492|NCT01066143|Seroquel|seroquel
1424493|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
1424494|NCT01066143|fMRI|fmri
1424495|NCT01066130|Diabetes Mellitus|diabetes mellitus
1424496|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
1424497|NCT01066130|psychosocial aspects|psychosocial aspects
1424498|NCT01066130|Patient Adherence|patient adherence
1424499|NCT01066130|Social Work|social work
1424500|NCT01066130|Coping Behavior|coping behavior
1424501|NCT01066130|Coping Skills|coping skills
1424502|NCT01066130|Adaptation, Psychological|adaptation, psychological
1424503|NCT01066117|urinary incontinent|urinary incontinent
1424504|NCT01066091|Inflammatory response|inflammatory response
1424505|NCT01066091|High-fat meal|high-fat meal
1424506|NCT01066091|cytokines|cytokines
1424507|NCT01066091|Body composition|body composition
1424508|NCT01066078|heart failure - congestive|heart failure - congestive
1424753|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
1424509|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
1424510|NCT01066078|Echocardiography|echocardiography
1424511|NCT01066078|Other diagnostic testing|other diagnostic testing
1424512|NCT01066078|Other Treatment|other treatment
1424513|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
1424514|NCT01066065|cardiovascular disease|cardiovascular disease
1424515|NCT01066065|HIV|hiv
1424516|NCT01066065|metabolic disorder|metabolic disorder
1424517|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
1424518|NCT01066052|Growth hormone|growth hormone
1424519|NCT01066052|Turner syndrome|turner syndrome
1424520|NCT01066052|r-hGH|r-hgh
1424521|NCT01066052|early treatment|early treatment
1424522|NCT01066039|Bisoprolol|bisoprolol
1424523|NCT01066039|Hypertension|hypertension
1424524|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
1424525|NCT01066039|Blood pressure|blood pressure
1424526|NCT01066039|Glycemic level|glycemic level
1424527|NCT01066026|metallic cannula|metallic cannula
1424528|NCT01066026|Hyaluronic acid|hyaluronic acid
1424529|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
1424530|NCT01066013|Meropenem|meropenem
1424531|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
1424532|NCT01066013|Medical patients|medical patients
1424533|NCT01066013|Appropriate use|appropriate use
1424534|NCT01066013|Cost savings|cost savings
1424535|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
1424536|NCT01065974|Nutritional Intake|nutritional intake
1424537|NCT01065974|Psychosocial Outcome|psychosocial outcome
1424538|NCT01065961|anterior|anterior
1424540|NCT01065961|fusion|fusion
1424541|NCT01065961|swallowing|swallowing
1424542|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
1424543|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
1424544|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
1424545|NCT01065948|diabetes|diabetes
1424546|NCT01065948|fluorescence|fluorescence
1424547|NCT01065948|affinity|affinity
1424548|NCT01065948|biosensor|biosensor
1424549|NCT01065948|type I Diabetes|type i diabetes
1424550|NCT01065948|type II diabetes|type ii diabetes
1424551|NCT01065935|ALN-RSV01|aln-rsv01
1424552|NCT01065935|RSV|rsv
1424553|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
1424554|NCT01065896|spinal cord injury|spinal cord injury
1424555|NCT01065896|coronary artery disease|coronary artery disease
1424556|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
1424557|NCT01065844|Nelfinavir|nelfinavir
1424558|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
1424559|NCT01065818|Esophageal cancer|esophageal cancer
1424560|NCT01065818|Non-small cell lung cancer|non-small cell lung cancer
1424561|NCT01065818|FLT-PET|flt-pet
1424562|NCT01065818|Chemoradiotherapy|chemoradiotherapy
1424563|NCT01065805|18F-FLT|18f-flt
1424564|NCT01065805|Positive Emission Tomography|positive emission tomography
1424565|NCT01065805|Cancer|cancer
1424566|NCT01065792|HIV Infection|hiv infection
1424567|NCT01065766|Diabetes Mellitus|diabetes mellitus
1424568|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
1424569|NCT01065753|Rho kinase|rho kinase
1424570|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
1424571|NCT01065740|Peripheral arterial disease|peripheral arterial disease
1424572|NCT01065740|Patient education|patient education
1424573|NCT01065740|Physical activity coaching|physical activity coaching
1424574|NCT01065740|Lifestyle modifications|lifestyle modifications
1424575|NCT01065740|Walking capacity|walking capacity
1424576|NCT01065740|6 minutes walking test|6 minutes walking test
1424577|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
1424578|NCT01065714|Transepidermal water loss|transepidermal water loss
1424873|NCT01064466|Oncology|oncology
1424579|NCT01065714|Epidermal barrier|epidermal barrier
1424580|NCT01065714|Skin hydration|skin hydration
1424581|NCT01065688|distal gastrectomy|distal gastrectomy
1424582|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
1424583|NCT01065688|gastric cancer|gastric cancer
1424584|NCT01065688|QOL|qol
1424585|NCT01065675|Medication Reconciliation|medication reconciliation
1424586|NCT01065675|Emergency Department|emergency department
1424587|NCT01065675|Nurse|nurse
1424588|NCT01065675|Pharmacist|pharmacist
1424589|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
1424590|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
1424591|NCT01065662|AZD2171|azd2171
1424592|NCT01065662|temsirolimus|temsirolimus
1424593|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
1424594|NCT01065649|reflux disease|reflux disease
1424595|NCT01065649|heartburn|heartburn
1424596|NCT01065623|Phase I|phase i
1424597|NCT01065623|Dose escalation|dose escalation
1424598|NCT01065623|Immunoconjugate|immunoconjugate
1424599|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
1424600|NCT01065597|seizure|seizure
1424601|NCT01065597|nonconvulsive|nonconvulsive
1424602|NCT01065597|subconvulsive|subconvulsive
1424603|NCT01065597|major depression|major depression
1424604|NCT01065597|bipolar disorder|bipolar disorder
1424605|NCT01065584|liver transplantation|liver transplantation
1424606|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
1424607|NCT01065571|relapse|relapse
1424608|NCT01065571|carrageenan|carrageenan
1424609|NCT01065571|inflammation|inflammation
1424610|NCT01065558|Ecopipam|ecopipam
1424611|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
1424612|NCT01065558|Safety|safety
1424613|NCT01065558|Self-Injurious Behavior|self-injurious behavior
1424614|NCT01065545|leukemia|leukemia
1424615|NCT01065532|Restenosis|restenosis
1424616|NCT01065532|PCI|pci
1424617|NCT01065532|Drug-eluting stent|drug-eluting stent
1424618|NCT01065532|Drug-eluting balloon|drug-eluting balloon
1424619|NCT01065532|Optical Coherence Tomography|optical coherence tomography
1424620|NCT01065519|Coronary stent|coronary stent
1424621|NCT01065519|Optical coherence tomography|optical coherence tomography
1424622|NCT01065519|Intravascular ultrasound|intravascular ultrasound
1424623|NCT01065480|Training|training
1424624|NCT01065480|Substance Abuse|substance abuse
1424625|NCT01065480|Counseling|counseling
1424626|NCT01065480|Motivational Interviewing|motivational interviewing
1424627|NCT01065467|LBH589|lbh589
1424628|NCT01065467|panobinostat|panobinostat
1424629|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
1424630|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
1424631|NCT01065441|breast cancer|breast cancer
1424632|NCT01065441|colorectal cancer|colorectal cancer
1424633|NCT01065441|prostate cancer|prostate cancer
1424634|NCT01065441|melanoma|melanoma
1424635|NCT01065441|ovarian cancer|ovarian cancer
1424636|NCT01065441|GI cancer|gi cancer
1424637|NCT01065441|Sarcoma|sarcoma
1424638|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
1424639|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
1424640|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
1424641|NCT01065428|weaning|weaning
1424642|NCT01065428|Respiration, Artificial|respiration, artificial
1424643|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
1424644|NCT01065415|Whole body imaging|whole body imaging
1424645|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
1424646|NCT01065415|staging|staging
1424647|NCT01065415|Diagnostic accuracy|diagnostic accuracy
1424648|NCT01065402|Diabetes mellitus|diabetes mellitus
1424649|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
1424650|NCT01065389|Intradialysis|intradialysis
1424651|NCT01065389|Resistance training|resistance training
1424652|NCT01065389|Protein Catabolic Rate|protein catabolic rate
1424653|NCT01065389|Urea kinetics|urea kinetics
1424654|NCT01065389|Quality of life|quality of life
1424655|NCT01065389|VO2 max|vo2 max
1424656|NCT01065376|IVF|ivf
1424657|NCT01065376|OHSS|ohss
1424658|NCT01065376|cabergoline|cabergoline
1424659|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
1424660|NCT01065363|Metabolic factor|metabolic factor
1424661|NCT01065363|Body mass index|body mass index
1424662|NCT01065363|Obesity|obesity
1424663|NCT01065363|Insulin resistance|insulin resistance
1424664|NCT01065363|Lifestyle factor|lifestyle factor
1424665|NCT01065363|Preventive Medicine|preventive medicine
1424666|NCT01065363|Health Promotion|health promotion
1424667|NCT01065350|ketofol|ketofol
1424668|NCT01065350|hemodynamics|hemodynamics
1424669|NCT01065350|propofol|propofol
1424670|NCT01065350|anesthesia|anesthesia
1424671|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
1424672|NCT01065337|diabetic foot|diabetic foot
1424673|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
1424674|NCT01065337|stem cell therapy|stem cell therapy
1424675|NCT01065324|balloon|balloon
1424676|NCT01065324|enteroscopy|enteroscopy
1424677|NCT01065324|bacteremia|bacteremia
1424874|NCT01064466|Genetics|genetics
1424678|NCT01065311|Depressive Disorder|depressive disorder
1424679|NCT01065311|Psychotherapy|psychotherapy
1424680|NCT01065285|Influenza|influenza
1424681|NCT01065285|autoimmune diseases|autoimmune diseases
1424682|NCT01065285|vaccination|vaccination
1424683|NCT01065285|H1N1|h1n1
1424684|NCT01065272|Dexamethasone|dexamethasone
1424685|NCT01065272|Bronchiolitis|bronchiolitis
1424686|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1424687|NCT01065259|executive function|executive function
1424688|NCT01065259|OROS MPH|oros mph
1424689|NCT01065259|atomoxetine|atomoxetine
1424690|NCT01065246|malignant ascites|malignant ascites
1424691|NCT01065246|second cycle|second cycle
1424692|NCT01065246|trifunctional|trifunctional
1424693|NCT01065220|Serotonin Transporter|serotonin transporter
1424694|NCT01065220|Hormone therapy|hormone therapy
1424695|NCT01065220|Gender Dysphoria|gender dysphoria
1424696|NCT01065220|Transsexualism|transsexualism
1424697|NCT01065181|shoulder|shoulder
1424698|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
1424699|NCT01065181|posterior capsule|posterior capsule
1424700|NCT01065181|capsular contracture|capsular contracture
1424701|NCT01065181|baseball|baseball
1424702|NCT01065181|throwing injury|throwing injury
1424703|NCT01065168|endometriosis|endometriosis
1424704|NCT01065168|endometrioma|endometrioma
1424705|NCT01065168|antimullerian hormone|antimullerian hormone
1424706|NCT01065168|cystectomy|cystectomy
1424707|NCT01065142|Heart Failure|heart failure
1424708|NCT01065142|Patient Education as Topic|patient education as topic
1424709|NCT01065142|Primary Health Care|primary health care
1424710|NCT01065142|Quality of Life|quality of life
1424711|NCT01065116|Malaria|malaria
1424712|NCT01065103|STEMI|stemi
1424713|NCT01065103|Primary angioplasty|primary angioplasty
1424714|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
1424715|NCT01065103|Fractional Flow Reserve|fractional flow reserve
1424716|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
1424717|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
1424718|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
1424719|NCT01065090|exercise|exercise
1424720|NCT01065090|AVONEX|avonex
1424721|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
1424722|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
1424723|NCT01065090|effects of exercise|effects of exercise
1424724|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
1424725|NCT01065077|Heart Failure|heart failure
1424726|NCT01065064|Multifocal IOL|multifocal iol
1424727|NCT01065064|ReSTOR IOL|restor iol
1424728|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
1424729|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
1424730|NCT01065025|4SC-205|4sc-205
1424731|NCT01065025|Solid tumors|solid tumors
1424732|NCT01065025|Lymphomas|lymphomas
1424733|NCT01065025|Phase I|phase i
1424734|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1424735|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
1424736|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1424737|NCT01064999|pathological complete response|pathological complete response
1424738|NCT01064986|Immune System|immune system
1424739|NCT01064973|autism|autism
1424740|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
1424741|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
1424742|NCT01064960|Neoplasms|neoplasms
1424743|NCT01064960|Myofibroma|myofibroma
1424744|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
1424745|NCT01064960|Connective Tissue Diseases|connective tissue diseases
1424746|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
1424747|NCT01064960|Leiomyoma|leiomyoma
1424748|NCT01064934|coronary heart disease|coronary heart disease
1424749|NCT01064934|cerebrovascular disease|cerebrovascular disease
1424750|NCT01064934|peripheral arterial disease|peripheral arterial disease
1424751|NCT01064934|atherosclerosis|atherosclerosis
1424752|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
1424754|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1424755|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
1424756|NCT01064908|Carotid stenosis|carotid stenosis
1424757|NCT01064908|Oxygen mask|oxygen mask
1424758|NCT01064895|Benephit|benephit
1424759|NCT01064895|Acute Kidney Injury|acute kidney injury
1424760|NCT01064895|Acute Renal Failure|acute renal failure
1424761|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
1424762|NCT01064895|Chronic Kidney Disease|chronic kidney disease
1424763|NCT01064869|Adherence|adherence
1424764|NCT01064869|Asthma|asthma
1424765|NCT01064869|medication|medication
1424766|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
1424767|NCT01064856|adalimumab|adalimumab
1424768|NCT01064856|humira|humira
1424769|NCT01064843|Edentulous|edentulous
1424770|NCT01064843|Edentulism|edentulism
1424771|NCT01064843|Lower denture|lower denture
1424772|NCT01064843|Mini dental implant|mini dental implant
1424773|NCT01064843|Imtec MDI|imtec mdi
1424774|NCT01064843|Denture stabilization|denture stabilization
1424775|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
1424776|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
1424777|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
1424778|NCT01064843|Cost estimates|cost estimates
1424779|NCT01064830|brittle nail|brittle nail
1424780|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
1424781|NCT01064791|Renal transplantation|renal transplantation
1424782|NCT01064778|Glycemic Index|glycemic index
1424783|NCT01064778|Brain|brain
1424784|NCT01064778|Intake Regulation|intake regulation
1424785|NCT01064778|Weight Loss|weight loss
1424786|NCT01064778|Hunger|hunger
1424787|NCT01064778|Diet|diet
1424788|NCT01064765|Heart failure|heart failure
1424789|NCT01064765|Self management|self management
1424790|NCT01064765|cognitive dysfunction|cognitive dysfunction
1424791|NCT01064765|Self management of heart failure|self management of heart failure
1424792|NCT01064752|Minocycline|minocycline
1424793|NCT01064752|HIV-1|hiv-1
1424794|NCT01064752|Immune activation|immune activation
1424795|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
1424796|NCT01064752|Observational|observational
1424797|NCT01064739|Healthy Volunteers|healthy volunteers
1424798|NCT01064739|Fava bean consumption|fava bean consumption
1424799|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
1424800|NCT01064739|Sodium|sodium
1424801|NCT01064739|Potassium|potassium
1424802|NCT01064739|Electrolyte Balance|electrolyte balance
1424803|NCT01064739|Natriuresis|natriuresis
1424804|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
1424805|NCT01064713|Tesetaxel|tesetaxel
1424806|NCT01064713|Second-line therapy|second-line therapy
1424807|NCT01064713|Metastatic melanoma|metastatic melanoma
1424808|NCT01064713|Normal serum LDH|normal serum ldh
1424809|NCT01064700|Anxiety|anxiety
1424810|NCT01064700|Phototherapy|phototherapy
1424811|NCT01064700|Psychic Anxiety|psychic anxiety
1424812|NCT01064674|renal transplantation|renal transplantation
1424813|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
1424814|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
1424815|NCT01064661|Probiotics|probiotics
1424816|NCT01064661|abdominal pain|abdominal pain
1424817|NCT01064661|abdominal discomfort|abdominal discomfort
1424818|NCT01064661|bloating|bloating
1424819|NCT01064661|Functional Bowel Disorders|functional bowel disorders
1424820|NCT01064635|stage IA breast cancer|stage ia breast cancer
1424821|NCT01064635|stage IB breast cancer|stage ib breast cancer
1424822|NCT01064635|stage II breast cancer|stage ii breast cancer
1424823|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
1424824|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
1424825|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
1424826|NCT01064596|obesity|obesity
1424827|NCT01064596|fondaparinux|fondaparinux
1424828|NCT01064596|surgery|surgery
1424829|NCT01064596|anti-Xa activity|anti-xa activity
1424830|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1424831|NCT01064570|APL|apl
1424832|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
1424833|NCT01064544|Sleep problems|sleep problems
1424834|NCT01064544|melatonin|melatonin
1424835|NCT01064544|mood|mood
1424836|NCT01064544|Hemodialysis|hemodialysis
1424837|NCT01064518|Lateral Canthal Lines|lateral canthal lines
1424838|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
1424839|NCT01064518|Facial Wrinkles|facial wrinkles
1424840|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
1424841|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
1424842|NCT01064505|NAION|naion
1424843|NCT01064505|NAAION|naaion
1424844|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
1424845|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
1424846|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
1424847|NCT01064505|optic nerve atrophy|optic nerve atrophy
1424848|NCT01064505|retinal degeneration|retinal degeneration
1424849|NCT01064505|optic neuritis|optic neuritis
1424850|NCT01064505|end stage glaucoma|end stage glaucoma
1424851|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
1424852|NCT01064479|SCCHN|scchn
1424853|NCT01064479|Oral cavity|oral cavity
1424854|NCT01064479|Oropharynx|oropharynx
1424855|NCT01064479|Hypopharynx|hypopharynx
1424856|NCT01064479|Larynx|larynx
1424857|NCT01064479|Tarceva|tarceva
1424858|NCT01064479|Erlotinib|erlotinib
1424859|NCT01064479|OSI-774|osi-774
1424860|NCT01064479|Docetaxel|docetaxel
1424861|NCT01064479|Taxotere|taxotere
1424862|NCT01064479|Cisplatin|cisplatin
1424863|NCT01064479|Platinol|platinol
1424864|NCT01064479|CDDP|cddp
1424865|NCT01064479|Placebo|placebo
1424866|NCT01064479|Chemotherapy|chemotherapy
1424867|NCT01064466|SCLC|sclc
1424868|NCT01064466|Etoposide|etoposide
1424869|NCT01064466|SNP|snp
1424870|NCT01064466|Topo|topo
1424871|NCT01064466|CYP|cyp
1424872|NCT01064466|Genotype|genotype
1424875|NCT01064466|Lung|lung
1424876|NCT01064466|Cancer|cancer
1424877|NCT01064453|Menopause|menopause
1424878|NCT01064453|Menopausal symptoms|menopausal symptoms
1425005|NCT01063907|Multiple Myeloma|multiple myeloma
1424879|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
1424880|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
1424881|NCT01064453|Hormone replacement therapy|hormone replacement therapy
1424882|NCT01064440|Painful legs|painful legs
1424883|NCT01064440|Ischemic legs|ischemic legs
1424884|NCT01064440|Treatment for Claudication|treatment for claudication
1424885|NCT01064440|Gene therapy|gene therapy
1424886|NCT01064427|breast cancer|breast cancer
1424887|NCT01064427|fatigue|fatigue
1424888|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
1424889|NCT01064427|quality of life|quality of life
1424890|NCT01064414|Canagliflozin|canagliflozin
1424891|NCT01064414|JNJ 28431754|jnj 28431754
1424892|NCT01064414|Placebo|placebo
1424893|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
1424894|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
1424895|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
1424896|NCT01064388|Safety|safety
1424897|NCT01064375|DNA vaccine|dna vaccine
1424898|NCT01064375|Electroporation|electroporation
1424899|NCT01064362|Haemorrhage|haemorrhage
1424900|NCT01064362|Thromboprophylaxis|thromboprophylaxis
1424901|NCT01064349|brain metastases|brain metastases
1424902|NCT01064349|ErbB2 treatment|erbb2 treatment
1424903|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
1424904|NCT01064336|Thrombocytopenia|thrombocytopenia
1424905|NCT01064336|Pregnancy|pregnancy
1424906|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
1424907|NCT01064323|nitric oxide|nitric oxide
1424908|NCT01064323|vascular endothelial cells|vascular endothelial cells
1424909|NCT01064323|IPC|ipc
1424910|NCT01064323|EECP|eecp
1424911|NCT01064323|atherosclerosis|atherosclerosis
1424912|NCT01064310|renal cell carcinoma|renal cell carcinoma
1424913|NCT01064310|Votrient|votrient
1424914|NCT01064310|cancer|cancer
1424915|NCT01064310|pazopanib|pazopanib
1424916|NCT01064310|patient preference|patient preference
1424917|NCT01064310|quality of life|quality of life
1424918|NCT01064297|Pregnancy registry|pregnancy registry
1424919|NCT01064297|Major congenital malformations|major congenital malformations
1424920|NCT01064297|Pregnancy outcomes|pregnancy outcomes
1424921|NCT01064297|Pregnancy|pregnancy
1424922|NCT01064297|First trimester|first trimester
1424923|NCT01064297|Lamotrigine|lamotrigine
1424924|NCT01064284|Hemophilia A|hemophilia a
1424925|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
1424926|NCT01064284|vWF/FVIII|vwf/fviii
1424927|NCT01064284|rFVIII|rfviii
1424928|NCT01064258|treatment|treatment
1424929|NCT01064258|CPAP|cpap
1424930|NCT01064258|sleep apnea|sleep apnea
1424931|NCT01064245|Asthma|asthma
1424932|NCT01064245|Cough Variant Asthma|cough variant asthma
1424933|NCT01064245|Mannitol|mannitol
1424934|NCT01064245|Methacholine|methacholine
1424935|NCT01064245|Cough|cough
1424936|NCT01064245|Hypersensitivity|hypersensitivity
1424937|NCT01064219|hCG|hcg
1424938|NCT01064219|Treg cells|treg cells
1424939|NCT01064219|implantation|implantation
1424940|NCT01064219|pinopodes|pinopodes
1424941|NCT01064219|endometrium|endometrium
1424942|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
1424943|NCT01064206|Buerger's disease|buerger's disease
1424944|NCT01064206|atheromatous arteritis|atheromatous arteritis
1424945|NCT01064206|psychiatric disorders|psychiatric disorders
1424946|NCT01064206|personality disorders|personality disorders
1424947|NCT01064206|addictive profile|addictive profile
1424948|NCT01064206|addiction|addiction
1424949|NCT01064206|tobacco|tobacco
1424950|NCT01064206|cannabis|cannabis
1424951|NCT01064193|In Vitro Fertilization|in vitro fertilization
1424952|NCT01064193|biopsy|biopsy
1424953|NCT01064193|pregnancy|pregnancy
1424954|NCT01064193|Implantation|implantation
1424955|NCT01064193|Embryo|embryo
1424956|NCT01064193|first or second IVF tentative|first or second ivf tentative
1424957|NCT01064167|Tranexamic Acid|tranexamic acid
1424958|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
1424959|NCT01064141|Dengue Fever|dengue fever
1424960|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1424961|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
1424962|NCT01064141|Toddlers|toddlers
1424963|NCT01064128|Single-port|single-port
1424964|NCT01064128|Laparoscopy|laparoscopy
1424965|NCT01064128|Hysterectomy|hysterectomy
1424966|NCT01064128|Pain|pain
1424967|NCT01064128|Cosmesis|cosmesis
1424968|NCT01064128|Analgesics|analgesics
1424969|NCT01064089|HSP990|hsp990
1424970|NCT01064089|HSP90|hsp90
1424971|NCT01064089|Japan/Korea|japan/korea
1424972|NCT01064089|Phase I|phase i
1424973|NCT01064089|advanced solid tumors|advanced solid tumors
1424974|NCT01064089|dose escalation|dose escalation
1424975|NCT01064089|maximum tolerated dose|maximum tolerated dose
1424976|NCT01064089|MTD|mtd
1424977|NCT01064089|Japanese paatients|japanese paatients
1424978|NCT01064089|Korean patients|korean patients
1424979|NCT01064076|ICD, defibrillator|icd, defibrillator
1424980|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
1424981|NCT01064050|bronchoscopy|bronchoscopy
1424982|NCT01064050|silicone stent|silicone stent
1424983|NCT01064037|Heart Failure|heart failure
1424984|NCT01064024|uUTI|uuti
1424985|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
1424986|NCT01063998|Renal cell|renal cell
1424987|NCT01063998|Carcinoma|carcinoma
1424988|NCT01063998|Biomarkers|biomarkers
1424989|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
1424990|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
1424991|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
1424992|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
1424993|NCT01063920|LT-NS001|lt-ns001
1424994|NCT01063920|Gastric Ulcers|gastric ulcers
1424995|NCT01063920|NSAID|nsaid
1424996|NCT01063920|Osteoarthritis|osteoarthritis
1424997|NCT01063920|Naproxen|naproxen
1424998|NCT01063907|Leukemia|leukemia
1424999|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
1425000|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
1425001|NCT01063907|Immune System Diseases|immune system diseases
1425002|NCT01063907|Hematologic Diseases|hematologic diseases
1425003|NCT01063907|Blood Protein Disorders|blood protein disorders
1425004|NCT01063907|Paraproteinemias|paraproteinemias
1425006|NCT01063907|Hematologic Disorders|hematologic disorders
1425007|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
1425008|NCT01063907|Leukemia, B-cell|leukemia, b-cell
1425009|NCT01063907|Leukemia, Chronic|leukemia, chronic
1425010|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
1425011|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
1425012|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
1425013|NCT01063881|R096769|r096769
1425014|NCT01063881|Dapoxetine|dapoxetine
1425015|NCT01063881|Phase 3b|phase 3b
1425016|NCT01063881|Premature Ejaculation|premature ejaculation
1425017|NCT01063868|Diabetic neuropathy|diabetic neuropathy
1425018|NCT01063868|Painful|painful
1425019|NCT01063868|Polyneuropathy|polyneuropathy
1425020|NCT01063868|Peripheral neuropathy|peripheral neuropathy
1425021|NCT01063855|Erectile Dysfunction|erectile dysfunction
1425022|NCT01063855|Sexual Dysfunction|sexual dysfunction
1425023|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
1425024|NCT01063855|PRILIGY|priligy
1425025|NCT01063855|Premature ejaculation|premature ejaculation
1425026|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1425027|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
1425324|NCT01062568|adolescents|adolescents
1425028|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
1425029|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
1425030|NCT01063842|Drop-out rate|drop-out rate
1425031|NCT01063842|Osteoarthritis|osteoarthritis
1425032|NCT01063842|Tolerability|tolerability
1425033|NCT01063842|Tramadol|tramadol
1425034|NCT01063842|Acetaminophen|acetaminophen
1425035|NCT01063829|HCMV|hcmv
1425036|NCT01063816|PARP Inhibitors|parp inhibitors
1425037|NCT01063803|Open-label|open-label
1425038|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
1425039|NCT01063790|Post-operative pain|post-operative pain
1425040|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
1425041|NCT01063790|Patient education|patient education
1425042|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
1425043|NCT01063764|Keppra|keppra
1425044|NCT01063764|Levetiracetam|levetiracetam
1425045|NCT01063764|Children|children
1425046|NCT01063764|Epilepsy|epilepsy
1425047|NCT01063764|Partial Seizures|partial seizures
1425048|NCT01063751|Osteoarthritis|osteoarthritis
1425049|NCT01063751|Traumatic arthritis|traumatic arthritis
1425050|NCT01063751|Avascular Necrosis|avascular necrosis
1425051|NCT01063738|Rehabilitation|rehabilitation
1425052|NCT01063738|Intensive Care|intensive care
1425053|NCT01063738|Critical illness|critical illness
1425054|NCT01063738|Physiotherapy|physiotherapy
1425055|NCT01063738|Nutritional supplementation|nutritional supplementation
1425056|NCT01063725|menopause|menopause
1425057|NCT01063725|hot flashes|hot flashes
1425058|NCT01063725|vasomotor symptoms|vasomotor symptoms
1425059|NCT01063725|femarelle|femarelle
1425060|NCT01063725|soy extract|soy extract
1425061|NCT01063725|SERM|serm
1425062|NCT01063712|Ductus|ductus
1425063|NCT01063712|Patent ductus Arterious|patent ductus arterious
1425064|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
1425065|NCT01063712|Interventional closure of PDA|interventional closure of pda
1425066|NCT01063712|Percutaneous closure|percutaneous closure
1425067|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
1425068|NCT01063686|Pregnancy|pregnancy
1425069|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
1425070|NCT01063660|Treosulfan|treosulfan
1425071|NCT01063660|Fludarabine|fludarabine
1425072|NCT01063660|ATG|atg
1425073|NCT01063660|AML|aml
1425074|NCT01063647|Treosulfan|treosulfan
1425075|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1425076|NCT01063647|Conditioning therapy|conditioning therapy
1425077|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
1425078|NCT01063634|viaduct|viaduct
1425079|NCT01063634|self-expandable metal stents|self-expandable metal stents
1425080|NCT01063595|Octaplas LG|octaplas lg
1425081|NCT01063595|Octaplas SD|octaplas sd
1425082|NCT01063582|echocardiogram|echocardiogram
1425083|NCT01063582|electrocardiographic|electrocardiographic
1425084|NCT01063582|risk factors|risk factors
1425085|NCT01063582|noise|noise
1425086|NCT01063569|Addison's disease|addison's disease
1425087|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
1425088|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
1425089|NCT01063569|CSHI|cshi
1425090|NCT01063569|Quality of Life|quality of life
1425091|NCT01063569|Sleep|sleep
1425092|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
1425093|NCT01063543|fondaparinux|fondaparinux
1425094|NCT01063543|orthopedic surgery|orthopedic surgery
1425095|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
1425096|NCT01063530|FLuoride|fluoride
1425097|NCT01063530|Dental Sensitivity|dental sensitivity
1425098|NCT01063530|Abfraction|abfraction
1425099|NCT01063530|Cervical lesions|cervical lesions
1425100|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
1425101|NCT01063517|polymerase (PARP)|polymerase (parp)
1425102|NCT01063517|Gastric cancer|gastric cancer
1425103|NCT01063517|olaparib|olaparib
1425104|NCT01063517|PARP inhibitor|parp inhibitor
1425105|NCT01063517|ATM AZD2281|atm azd2281
1425106|NCT01063517|Ku0059436|ku0059436
1425107|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
1425108|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
1425109|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
1425110|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
1425111|NCT01063491|bypass grafts|bypass grafts
1425112|NCT01063491|angiography|angiography
1425113|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
1425114|NCT01063491|coronary imaging|coronary imaging
1425115|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
1425116|NCT01063478|Non-Small Cell|non-small cell
1425117|NCT01063478|Lung Cancer|lung cancer
1425118|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
1425119|NCT01063465|Achilles|achilles
1425120|NCT01063465|Tendon|tendon
1425121|NCT01063465|weightbearing|weightbearing
1425122|NCT01063452|Urinary Catheterization|urinary catheterization
1425123|NCT01063452|Urinary Tract Infections|urinary tract infections
1425124|NCT01063439|DLBCL|dlbcl
1425126|NCT01063426|Statin|statin
1425127|NCT01063426|Vein|vein
1425128|NCT01063413|Behavioral Research|behavioral research
1425129|NCT01063413|Community-Based Participatory Research|community-based participatory research
1425130|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
1425131|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
1425132|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
1425133|NCT01063348|Picking|picking
1425134|NCT01063348|Impulse Control Disorder|impulse control disorder
1425135|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
1425136|NCT01063335|CB1 Receptor|cb1 receptor
1425137|NCT01063335|Schizophrenia|schizophrenia
1425138|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
1425139|NCT01063335|Healthy Volunteers|healthy volunteers
1425140|NCT01063335|HV|hv
1425141|NCT01063322|Mitral Regurgitation|mitral regurgitation
1425142|NCT01063322|Echocardiography|echocardiography
1425143|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
1425144|NCT01063322|Regurgitant Volume|regurgitant volume
1425145|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
1425146|NCT01063309|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
1425147|NCT01063309|Atherosclerosis|atherosclerosis
1425148|NCT01063309|Inflammatory Bowel Disease|inflammatory bowel disease
1425149|NCT01063309|Immune Deficiencies|immune deficiencies
1425150|NCT01063309|Immune System Deficiences|immune system deficiences
1425151|NCT01063309|Chronic Granulomatous Disease|chronic granulomatous disease
1425152|NCT01063309|CGD|cgd
1425153|NCT01063296|cervical cancer|cervical cancer
1425154|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
1425155|NCT01063283|Bevacizumab|bevacizumab
1425156|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1425157|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
1425158|NCT01063270|Antibiotics|antibiotics
1425159|NCT01063270|Laser|laser
1425160|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
1425161|NCT01063244|pregnancy|pregnancy
1425162|NCT01063244|induction of Labor|induction of labor
1425163|NCT01063244|Cervical ripening|cervical ripening
1425164|NCT01063244|Foley balloon|foley balloon
1425165|NCT01063231|Colonic Diseases|colonic diseases
1425166|NCT01063231|bowel diseases|bowel diseases
1425167|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
1425168|NCT01063218|Corticoids, topic|corticoids, topic
1425169|NCT01063218|Corticosteroids|corticosteroids
1425170|NCT01063205|Methamphetamine|methamphetamine
1425172|NCT01063205|N-acetylcysteine|n-acetylcysteine
1425173|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
1425174|NCT01063179|Elderly patients|elderly patients
1425175|NCT01063179|Bortezomib|bortezomib
1425176|NCT01063179|Thalidomide|thalidomide
1425177|NCT01063153|ADHD|adhd
1425178|NCT01063153|Adults|adults
1425179|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
1425180|NCT01063153|Concerta|concerta
1425181|NCT01063140|Rabies Immune Globulin|rabies immune globulin
1425182|NCT01063140|Source Plasma Donors|source plasma donors
1425183|NCT01063140|Booster Immunization|booster immunization
1425184|NCT01063127|Morbid obesity|morbid obesity
1425185|NCT01063127|Insulin resistance|insulin resistance
1425186|NCT01063127|Euglycemic clamp|euglycemic clamp
1425187|NCT01063114|proton beam radiation|proton beam radiation
1425188|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
1425189|NCT01063075|Cancer of Head|cancer of head
1425190|NCT01063075|Cancer of Head and Neck|cancer of head and neck
1425191|NCT01063075|Cancer of Neck|cancer of neck
1425192|NCT01063075|Head and Neck Cancer|head and neck cancer
1425193|NCT01063075|Head Cancer|head cancer
1425194|NCT01063075|Head Neoplasms|head neoplasms
1425195|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
1425196|NCT01063075|Neck Cancer|neck cancer
1425197|NCT01063075|Neck Neoplasms|neck neoplasms
1425198|NCT01063075|Solid Neoplasm|solid neoplasm
1425199|NCT01063075|Carcinoma|carcinoma
1425200|NCT01063075|Sarcoma|sarcoma
1425201|NCT01063010|sepsis|sepsis
1425202|NCT01063010|septic shock|septic shock
1425203|NCT01063010|Bevacizumab|bevacizumab
1425204|NCT01063010|Avastin|avastin
1425205|NCT01062984|Renal Replacement Therapy|renal replacement therapy
1425206|NCT01062971|Open-angle glaucoma|open-angle glaucoma
1425207|NCT01062971|Ocular hypertension|ocular hypertension
1425208|NCT01062971|POAG|poag
1425209|NCT01062971|Treatment|treatment
1425210|NCT01062958|Neevo|neevo
1425211|NCT01062958|Neevo DHA|neevo dha
1425212|NCT01062958|L-methylfolate|l-methylfolate
1425213|NCT01062958|anemia during pregnancy|anemia during pregnancy
1425214|NCT01062958|folic acid|folic acid
1425215|NCT01062958|vitamin B12|vitamin b12
1425216|NCT01062958|prenatal vitamins|prenatal vitamins
1425217|NCT01062958|hemoglobin|hemoglobin
1425218|NCT01062958|iron deficiency|iron deficiency
1425219|NCT01062958|Pregnancy|pregnancy
1425220|NCT01062945|Cocaine|cocaine
1425221|NCT01062945|Doxazosin|doxazosin
1425222|NCT01062932|Cycloserine|cycloserine
1425223|NCT01062932|Nicotine|nicotine
1425224|NCT01062932|Smoking|smoking
1425225|NCT01062906|intravenous lidocaine|intravenous lidocaine
1425226|NCT01062906|postoperative pain|postoperative pain
1425227|NCT01062906|laparoscopic surgery|laparoscopic surgery
1425228|NCT01062906|opioids|opioids
1425229|NCT01062906|opioids side-effects|opioids side-effects
1425230|NCT01062893|labor pain treatment|labor pain treatment
1425231|NCT01062893|duration analgesia|duration analgesia
1425232|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
1425233|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
1425234|NCT01062867|Anaesthetic|anaesthetic
1425235|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
1425236|NCT01062841|Long-Term Care|long-term care
1425237|NCT01062841|Nursing Homes|nursing homes
1425238|NCT01062841|Infection Control|infection control
1425239|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
1425240|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
1425241|NCT01062828|Prematurity|prematurity
1425242|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
1425243|NCT01062828|Feeding Intolerance|feeding intolerance
1425244|NCT01062815|PNALD|pnald
1425245|NCT01062815|PNAC|pnac
1425246|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
1425247|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
1425248|NCT01062789|lung biopsy|lung biopsy
1425249|NCT01062789|computed tomograph|computed tomograph
1425250|NCT01062789|respiratory motion|respiratory motion
1425251|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
1425252|NCT01062789|biopsy|biopsy
1425253|NCT01062776|dehydration|dehydration
1425254|NCT01062776|fluid therapy|fluid therapy
1425255|NCT01062776|pharmacokinetics|pharmacokinetics
1425256|NCT01062776|hemoglobin|hemoglobin
1425257|NCT01062763|hypertension|hypertension
1425258|NCT01062763|spironolactone|spironolactone
1425259|NCT01062763|antihypertensive treatment|antihypertensive treatment
1425260|NCT01062763|Type-2 diabetes|type-2 diabetes
1425261|NCT01062750|Liver Cirrhosis|liver cirrhosis
1425262|NCT01062724|Cholestasis|cholestasis
1425263|NCT01062724|TPN|tpn
1425264|NCT01062724|Neonates|neonates
1425265|NCT01062724|Primene|primene
1425266|NCT01062724|Trophamine|trophamine
1425267|NCT01062724|Methionine|methionine
1425268|NCT01062724|Cysteine|cysteine
1425269|NCT01062724|Taurine|taurine
1425270|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
1425271|NCT01062711|sarcopenia|sarcopenia
1425272|NCT01062711|muscle|muscle
1425273|NCT01062711|protein|protein
1425274|NCT01062711|muscle protein synthesis|muscle protein synthesis
1425275|NCT01062711|muscle protein breakdown|muscle protein breakdown
1425276|NCT01062711|whey|whey
1425277|NCT01062711|soy|soy
1425278|NCT01062711|casein|casein
1425279|NCT01062711|dose response|dose response
1425280|NCT01062711|resistance exercise|resistance exercise
1425281|NCT01062711|unilateral|unilateral
1425282|NCT01062711|knee extension|knee extension
1425283|NCT01062711|whole body protein|whole body protein
1425284|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
1425285|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1425286|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1425287|NCT01062685|septic shock|septic shock
1425288|NCT01062685|sepsis|sepsis
1425289|NCT01062685|St02|st02
1425290|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
1425291|NCT01062685|NIRS|nirs
1425292|NCT01062672|plasticity|plasticity
1425293|NCT01062672|reorganization|reorganization
1425294|NCT01062672|cortical|cortical
1425295|NCT01062672|fMRI|fmri
1425296|NCT01062672|rehabilitation|rehabilitation
1425297|NCT01062659|HCV|hcv
1425298|NCT01062659|hepatitis C virus|hepatitis c virus
1425299|NCT01062659|CHC|chc
1425300|NCT01062659|chronic hepatitis c|chronic hepatitis c
1425301|NCT01062659|interferon|interferon
1425302|NCT01062659|ribavirin|ribavirin
1425303|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
1425304|NCT01062659|Anti-Infective Agents|anti-infective agents
1425305|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
1425306|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
1425307|NCT01062646|music therapy|music therapy
1425308|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
1425309|NCT01062646|children|children
1425310|NCT01062646|anxiety disorders|anxiety disorders
1425311|NCT01062646|pediatric anxiety|pediatric anxiety
1425312|NCT01062633|dental caries|dental caries
1425313|NCT01062633|prevention|prevention
1425314|NCT01062633|dietary supplements|dietary supplements
1425315|NCT01062607|bipolar disorders|bipolar disorders
1425316|NCT01062607|everyday setting|everyday setting
1425317|NCT01062607|treatment adherence|treatment adherence
1425318|NCT01062607|global|global
1425319|NCT01062581|Recipient|recipient
1425320|NCT01062581|Donor|donor
1425321|NCT01062581|Organ Transplant|organ transplant
1425322|NCT01062581|Registry|registry
1425323|NCT01062581|University of Minnesota|university of minnesota
1425325|NCT01062568|puberty|puberty
1425326|NCT01062568|androgens|androgens
1425327|NCT01062568|hyperandrogenemia|hyperandrogenemia
1425328|NCT01062529|GH signalling|gh signalling
1425329|NCT01062529|insulin resistance|insulin resistance
1425330|NCT01062529|somatostatin|somatostatin
1425331|NCT01062529|acromegaly|acromegaly
1425332|NCT01062516|acute coronary syndrome|acute coronary syndrome
1425333|NCT01062516|acute myocardial infarction|acute myocardial infarction
1425334|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
1425335|NCT01062516|aspirin|aspirin
1425336|NCT01062516|clopidogrel|clopidogrel
1425337|NCT01062516|esomeprazole|esomeprazole
1425338|NCT01062516|famotidine|famotidine
1425339|NCT01062516|platelet function|platelet function
1425340|NCT01062503|Cancer|cancer
1425341|NCT01062503|Prostate|prostate
1425342|NCT01062503|metastatic|metastatic
1425343|NCT01062490|Treosulfan|treosulfan
1425344|NCT01062490|MDS|mds
1425345|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1425346|NCT01062490|leukemia|leukemia
1425347|NCT01062490|Conditioning|conditioning
1425348|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
1425349|NCT01062451|Methamphetamine|methamphetamine
1425350|NCT01062451|Perindopril|perindopril
1425351|NCT01062451|Candesartan|candesartan
1425352|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
1425353|NCT01062451|ACE Inhibitor|ace inhibitor
1425354|NCT01062438|localized osteosarcoma|localized osteosarcoma
1425355|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
1425356|NCT01062399|adult glioblastoma|adult glioblastoma
1425357|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
1425358|NCT01062399|adult gliosarcoma|adult gliosarcoma
1425359|NCT01062386|prevalence|prevalence
1425360|NCT01062386|transmission|transmission
1425361|NCT01062386|knowledge|knowledge
1425362|NCT01062386|attitude|attitude
1425363|NCT01062386|practice|practice
1425364|NCT01062373|Premature Newborns|premature newborns
1425365|NCT01062373|Human Milk|human milk
1425366|NCT01062373|DHA|dha
1425367|NCT01062373|Mother-child|mother-child
1425368|NCT01062360|Sore Throat|sore throat
1425568|NCT01061541|Pertussis|pertussis
1425369|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
1425370|NCT01062360|Nasal Congestion|nasal congestion
1425371|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
1425372|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
1425373|NCT01062321|Hepatitis E Virus|hepatitis e virus
1425374|NCT01062321|Cytokines|cytokines
1425375|NCT01062321|Pregnancy|pregnancy
1425376|NCT01062308|Stroke|stroke
1425377|NCT01062308|Taping|taping
1425378|NCT01062308|Pain|pain
1425379|NCT01062308|Shoulder Injury|shoulder injury
1425380|NCT01062295|passenger,|passenger,
1425381|NCT01062295|sleep,|sleep,
1425382|NCT01062295|rest,|rest,
1425383|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
1425384|NCT01062269|Bile acid sequestrant|bile acid sequestrant
1425385|NCT01062269|Resin|resin
1425386|NCT01062269|Cholesterol|cholesterol
1425387|NCT01062269|Diabetes mellitus|diabetes mellitus
1425388|NCT01062269|Lipids|lipids
1425389|NCT01062269|Glucose|glucose
1425390|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
1425391|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
1425392|NCT01062256|guaifenesin|guaifenesin
1425393|NCT01062256|honey|honey
1425394|NCT01062243|brain injury|brain injury
1425395|NCT01062243|family treatment|family treatment
1425396|NCT01062230|Cancer|cancer
1425397|NCT01062230|Hematologic malignancy|hematologic malignancy
1425398|NCT01062204|Skin Graft donor sites|skin graft donor sites
1425399|NCT01062191|hydrogel|hydrogel
1425400|NCT01062191|dressing|dressing
1425401|NCT01062191|burn|burn
1425402|NCT01062191|joint|joint
1425403|NCT01062178|Small renal Mass|small renal mass
1425404|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
1425405|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
1425406|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
1425407|NCT01062165|Echinocandin|echinocandin
1425408|NCT01062165|Obesity|obesity
1425409|NCT01062165|Pharmacokinetics|pharmacokinetics
1425410|NCT01062165|Pharmacodynamics|pharmacodynamics
1425411|NCT01062165|Fungal infection|fungal infection
1425412|NCT01062152|Hematology|hematology
1425413|NCT01062152|MDS|mds
1425414|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
1425415|NCT01062152|Low risk MDS|low risk mds
1425416|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
1425417|NCT01062152|Non-deletion 5q|non-deletion 5q
1425418|NCT01062152|Non del(5q)|non del(5q)
1425419|NCT01062152|Revlimid|revlimid
1425420|NCT01062152|lenalidomide|lenalidomide
1425421|NCT01062152|Telintra|telintra
1425422|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
1425423|NCT01062152|ezatiostat|ezatiostat
1425424|NCT01062152|TLK199|tlk199
1425425|NCT01062152|Glutathione|glutathione
1425426|NCT01062152|Glutathione analog|glutathione analog
1425427|NCT01062152|Glutathione Transferase|glutathione transferase
1425428|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
1425429|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
1425430|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
1425431|NCT01062152|Apoptosis|apoptosis
1425432|NCT01062152|Differentiation|differentiation
1425433|NCT01062152|Enzyme inhibitor|enzyme inhibitor
1425434|NCT01062126|Pacemaker|pacemaker
1425435|NCT01062126|Advanced Features|advanced features
1425436|NCT01062126|Clinical Outcomes|clinical outcomes
1425437|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
1425438|NCT01062100|breast cancer|breast cancer
1425439|NCT01062100|molecular breast imaging|molecular breast imaging
1425441|NCT01062100|gamma camera|gamma camera
1425442|NCT01062087|postoperative pain|postoperative pain
1425443|NCT01062087|tubal ligation|tubal ligation
1425444|NCT01062087|local anesthetic|local anesthetic
1425445|NCT01062061|Varicella|varicella
1425446|NCT01062035|Advanced colon polyp|advanced colon polyp
1425447|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
1425448|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
1425449|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
1425450|NCT01062035|Colonic neoplasms|colonic neoplasms
1425451|NCT01062035|High grade dysplasia|high grade dysplasia
1425452|NCT01062035|Telomere blood testing|telomere blood testing
1425453|NCT01062022|intervention|intervention
1425454|NCT01062022|combat wounded|combat wounded
1425455|NCT01062022|family|family
1425456|NCT01062022|Focus-CI|focus-ci
1425457|NCT01061996|Ulcerative Colitis|ulcerative colitis
1425458|NCT01061983|Deep brain stimulation|deep brain stimulation
1425459|NCT01061983|Treatment refractory|treatment refractory
1425460|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
1425461|NCT01061983|Neurosurgery|neurosurgery
1425462|NCT01061983|Neuroimaging|neuroimaging
1425463|NCT01061970|Hypogonadism|hypogonadism
1425464|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1425465|NCT01061970|COPD|copd
1425466|NCT01061957|Treatment outcome|treatment outcome
1425467|NCT01061957|HIV treatment|hiv treatment
1425468|NCT01061944|biopsy|biopsy
1425469|NCT01061944|tumor biopsy|tumor biopsy
1425470|NCT01061944|genetic studies|genetic studies
1425471|NCT01061931|MRI|mri
1425472|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
1425473|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1425474|NCT01061931|cryoballoon technique|cryoballoon technique
1425475|NCT01061931|mesh ablator catheter|mesh ablator catheter
1425476|NCT01061931|stroke|stroke
1425477|NCT01061931|silent stroke|silent stroke
1425478|NCT01061931|major complications|major complications
1425479|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
1425480|NCT01061905|health behavior|health behavior
1425481|NCT01061905|behavioral economics|behavioral economics
1425482|NCT01061905|calorie labeling|calorie labeling
1425483|NCT01061905|exercise|exercise
1425484|NCT01061879|umbilical cord|umbilical cord
1425485|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
1425486|NCT01061879|pregnancy|pregnancy
1425487|NCT01061866|Thalidomide|thalidomide
1425488|NCT01061866|Antiepileptic drugs|antiepileptic drugs
1425489|NCT01061866|Refractory epilepsy|refractory epilepsy
1425490|NCT01061866|Sedative drugs|sedative drugs
1425491|NCT01061853|Oral lichen planus|oral lichen planus
1425492|NCT01061853|chronic inflammatory|chronic inflammatory
1425493|NCT01061853|mucous membranes|mucous membranes
1425494|NCT01061853|erosive lesions|erosive lesions
1425495|NCT01061840|Ewings Sarcoma|ewings sarcoma
1425496|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
1425497|NCT01061840|Liver Cancer|liver cancer
1425498|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
1425499|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
1425500|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
1425501|NCT01061814|mipomersen|mipomersen
1425502|NCT01061814|ISIS301012|isis301012
1425503|NCT01061814|antisense|antisense
1425504|NCT01061801|caregivers|caregivers
1425505|NCT01061801|cancer|cancer
1425506|NCT01061801|emotion|emotion
1425507|NCT01061801|protective buffering|protective buffering
1425508|NCT01061788|Phase I|phase i
1425509|NCT01061788|Solid Tumor|solid tumor
1425510|NCT01061788|AMG 479|amg 479
1425511|NCT01061788|Panitumumab|panitumumab
1425512|NCT01061788|Everolimus|everolimus
1425513|NCT01061788|RAD001|rad001
1425514|NCT01061788|Duke|duke
1425515|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
1425516|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
1425517|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
1425518|NCT01061775|Exenatide|exenatide
1425519|NCT01061775|Byetta|byetta
1425520|NCT01061775|Craniopharyngioma|craniopharyngioma
1425915|NCT01060020|Sildenafil|sildenafil
1425521|NCT01061762|Treatment adherence|treatment adherence
1425522|NCT01061762|Low literacy skills|low literacy skills
1425523|NCT01061762|HIV treatment|hiv treatment
1425524|NCT01061710|Smoking|smoking
1425525|NCT01061710|smoking cessation|smoking cessation
1425526|NCT01061710|Japanese|japanese
1425527|NCT01061710|varenicline|varenicline
1425528|NCT01061710|retreatment|retreatment
1425529|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1425530|NCT01061684|fatty liver disease|fatty liver disease
1425531|NCT01061684|NASH|nash
1425532|NCT01061684|NAFLD|nafld
1425533|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1425534|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1425535|NCT01061671|COPD|copd
1425536|NCT01061671|Exacerbation|exacerbation
1425537|NCT01061671|Lung function|lung function
1425538|NCT01061671|Cardiovascular|cardiovascular
1425539|NCT01061671|Smoking|smoking
1425540|NCT01061671|Statins|statins
1425541|NCT01061671|Simvastatin|simvastatin
1425542|NCT01061645|MDT and DLT|mdt and dlt
1425543|NCT01061632|deadlift|deadlift
1425544|NCT01061632|motor control|motor control
1425545|NCT01061632|exercises|exercises
1425546|NCT01061632|pain|pain
1425547|NCT01061632|function|function
1425548|NCT01061632|functional capacity|functional capacity
1425549|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
1425550|NCT01061619|sentinel events|sentinel events
1425551|NCT01061619|pathway to diagnosis|pathway to diagnosis
1425552|NCT01061593|TB|tb
1425553|NCT01061593|MDR-TB|mdr-tb
1425554|NCT01061593|XDR-TB|xdr-tb
1425555|NCT01061593|TB/HIV|tb/hiv
1425556|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
1425557|NCT01061580|CABG|cabg
1425558|NCT01061580|Cardiac|cardiac
1425559|NCT01061580|Stem Cell|stem cell
1425560|NCT01061554|Bioavailability|bioavailability
1425561|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
1425562|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
1425563|NCT01061554|Soft gel capsules|soft gel capsules
1425564|NCT01061554|Gastric stable emulsion|gastric stable emulsion
1425565|NCT01061554|Omega-3|omega-3
1425566|NCT01061554|Tri-glycerides|tri-glycerides
1425567|NCT01061554|Marine phospholipids|marine phospholipids
1425569|NCT01061541|Tetanus|tetanus
1425570|NCT01061541|Hiberix™|hiberix™
1425571|NCT01061541|Hepatitis B|hepatitis b
1425572|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
1425573|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
1425574|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
1425575|NCT01061541|Diphtheria|diphtheria
1425576|NCT01061541|Hib vaccine|hib vaccine
1425577|NCT01061528|cigarette smoking|cigarette smoking
1425578|NCT01061528|smoking cessation|smoking cessation
1425579|NCT01061528|nicotine dependence|nicotine dependence
1425580|NCT01061502|Burns|burns
1425581|NCT01061502|Wounds and Injuries|wounds and injuries
1425582|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
1425583|NCT01061502|Grafting, skin|grafting, skin
1425584|NCT01061489|neuroplasticity|neuroplasticity
1425585|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1425586|NCT01061489|Alzheimer|alzheimer
1425587|NCT01061489|sensory-cognitive training|sensory-cognitive training
1425588|NCT01061489|physical fitness|physical fitness
1425589|NCT01061476|sleep apnea|sleep apnea
1425590|NCT01061476|treatment|treatment
1425591|NCT01061476|collapsibility|collapsibility
1425592|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
1425593|NCT01061463|Radiation cataracts|radiation cataracts
1425594|NCT01061463|Lens opacities|lens opacities
1425595|NCT01061463|X-rays|x-rays
1425596|NCT01061463|Interventional Cardiologists|interventional cardiologists
1425597|NCT01061463|Electrophysiologists|electrophysiologists
1425598|NCT01061450|Diastolic dysfunction|diastolic dysfunction
1425599|NCT01061450|hypertension|hypertension
1425600|NCT01061450|Statins|statins
1425601|NCT01061450|ACE inhibitor|ace inhibitor
1425602|NCT01061450|Echocardiography|echocardiography
1425603|NCT01061437|H. pylori|h. pylori
1425604|NCT01061424|pediatric asthma|pediatric asthma
1425605|NCT01061398|cardiac ct|cardiac ct
1425606|NCT01061398|stress testing|stress testing
1425607|NCT01061398|coronary artery disease|coronary artery disease
1425608|NCT01061372|RLS|rls
1425609|NCT01061359|Breast Cancer|breast cancer
1425610|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
1425611|NCT01061359|Chemotherapy|chemotherapy
1425612|NCT01061359|Adjuvant|adjuvant
1425613|NCT01061359|Epirubicin|epirubicin
1425614|NCT01061346|Fructose|fructose
1425615|NCT01061346|Glucose|glucose
1425616|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
1425617|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
1425618|NCT01061320|Chronic kidney disease|chronic kidney disease
1425619|NCT01061320|Coronary procedures|coronary procedures
1425620|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
1425621|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
1425718|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
1425622|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
1425623|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
1425625|NCT01061255|Cortisol|cortisol
1425626|NCT01061255|Clinical reasoning|clinical reasoning
1425627|NCT01061255|Ambulatory setting|ambulatory setting
1425628|NCT01061255|Medical students|medical students
1425629|NCT01061255|Year 6 medical students|year 6 medical students
1425630|NCT01061242|Neurocognitive function|neurocognitive function
1425631|NCT01061242|Sleep quality|sleep quality
1425632|NCT01061242|Critical care|critical care
1425633|NCT01061242|Quality Assurance, health care|quality assurance, health care
1425634|NCT01061216|Diabetes|diabetes
1425635|NCT01061216|Insulin Therapy|insulin therapy
1425636|NCT01061216|Blood Glucose|blood glucose
1425637|NCT01061216|Basal insulin|basal insulin
1425638|NCT01061216|Diabetics|diabetics
1425639|NCT01061203|Rhinitis|rhinitis
1425640|NCT01061203|allergic|allergic
1425641|NCT01061203|Seasonal|seasonal
1425642|NCT01061203|grass|grass
1425643|NCT01061203|Asthma|asthma
1425644|NCT01061190|Stroke|stroke
1425645|NCT01061177|Leukemia|leukemia
1425646|NCT01061177|myeloid|myeloid
1425647|NCT01061177|myelogenous|myelogenous
1425648|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
1425649|NCT01061177|Nilotinib|nilotinib
1425650|NCT01061177|Philadelphia chromosome|philadelphia chromosome
1425651|NCT01061177|CML in chronic phase|cml in chronic phase
1425652|NCT01061151|Mother to Child Transmission|mother to child transmission
1425653|NCT01061151|HIV Infection|hiv infection
1425654|NCT01061151|HAART|haart
1425655|NCT01061151|Maternal Health|maternal health
1425656|NCT01061151|Breastfeeding|breastfeeding
1425657|NCT01061151|Perinatal transmission|perinatal transmission
1425658|NCT01061138|breast cancer|breast cancer
1425659|NCT01061138|screening mammograms|screening mammograms
1425660|NCT01061138|breast biopsy|breast biopsy
1425661|NCT01061125|atrial fibrillation|atrial fibrillation
1425662|NCT01061125|implantable loop recorder|implantable loop recorder
1425663|NCT01061125|TTM|ttm
1425664|NCT01061112|drug interactions|drug interactions
1425665|NCT01061112|genetics|genetics
1425666|NCT01061112|healthy volunteers|healthy volunteers
1425667|NCT01061112|normal controls|normal controls
1425668|NCT01061112|CYP2C9|cyp2c9
1425669|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
1425670|NCT01061099|OI|oi
1425671|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
1425672|NCT01061099|MSC|msc
1425673|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
1425674|NCT01061086|Epidemiology|epidemiology
1425675|NCT01061086|Management of disease|management of disease
1425676|NCT01061086|Outcomes|outcomes
1425677|NCT01061086|Greece|greece
1425678|NCT01061060|Prostaglandin I2|prostaglandin i2
1425679|NCT01061060|Beraprost Na|beraprost na
1425680|NCT01061060|Endothelial cell function|endothelial cell function
1425681|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
1425682|NCT01061034|pharmacokinetics|pharmacokinetics
1425683|NCT01061034|aspirin|aspirin
1425684|NCT01061034|proton pump inhiditor|proton pump inhiditor
1425685|NCT01061021|HIV prevention|hiv prevention
1425686|NCT01061021|Treatment adherence|treatment adherence
1425687|NCT01061021|Treatment for Prevention|treatment for prevention
1425688|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
1425689|NCT01060995|Informed Consent|informed consent
1425690|NCT01060995|Oral Health|oral health
1425691|NCT01060995|Patient Decision-making|patient decision-making
1425692|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
1425693|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
1425694|NCT01060982|Parathyroid tumor|parathyroid tumor
1425695|NCT01060982|Parathyroid hormone|parathyroid hormone
1425696|NCT01060982|Calcium|calcium
1425697|NCT01060969|Acute Mountain Sickness|acute mountain sickness
1425698|NCT01060969|travellers|travellers
1425699|NCT01060969|Acetazolamide|acetazolamide
1425700|NCT01060969|Tadalafil|tadalafil
1425701|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
1425702|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
1425703|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
1425704|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
1425705|NCT01060943|injectable collagen filler|injectable collagen filler
1425706|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
1425707|NCT01060943|enrolled : 73|enrolled : 73
1425708|NCT01060943|withdrawal : 4|withdrawal : 4
1425709|NCT01060943|ongoing : 0|ongoing : 0
1425710|NCT01060943|completed : 69|completed : 69
1425711|NCT01060930|Nitric oxide|nitric oxide
1425712|NCT01060930|Diesel exhaust|diesel exhaust
1425713|NCT01060930|Air pollution|air pollution
1425714|NCT01060930|Cardiac output|cardiac output
1425715|NCT01060930|Healthy volunteers|healthy volunteers
1425716|NCT01060917|diabetes|diabetes
1425717|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
1425719|NCT01060904|Antigens, CD30|antigens, cd30
1425720|NCT01060904|Disease, Hodgkin|disease, hodgkin
1425721|NCT01060904|Hematologic Diseases|hematologic diseases
1425722|NCT01060904|Immunotherapy|immunotherapy
1425723|NCT01060904|Lymphoma|lymphoma
1425724|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
1425725|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
1425726|NCT01060878|Early-stage|early-stage
1425727|NCT01060865|hypertension|hypertension
1425728|NCT01060865|aliskiren|aliskiren
1425729|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1425730|NCT01060839|counseling|counseling
1425731|NCT01060826|acute pancreatits|acute pancreatits
1425732|NCT01060813|cirrhosis|cirrhosis
1425733|NCT01060813|exercise|exercise
1425734|NCT01060813|leucin|leucin
1425735|NCT01060813|glutamine synthetase|glutamine synthetase
1425736|NCT01060800|Chiari|chiari
1425737|NCT01060800|Chiari Type I|chiari type i
1425738|NCT01060800|Chiari Type I Malformation|chiari type i malformation
1425739|NCT01060800|Familial Chiari|familial chiari
1425740|NCT01060774|Bupivacaine|bupivacaine
1425741|NCT01060774|Inflammation|inflammation
1425742|NCT01060774|Pain|pain
1425743|NCT01060774|Local Anesthetic|local anesthetic
1425744|NCT01060774|peripheral sensitization|peripheral sensitization
1425745|NCT01060761|cancer|cancer
1425746|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
1425747|NCT01060761|counselling|counselling
1425748|NCT01060761|retreat weekend|retreat weekend
1425749|NCT01060748|Vaccination|vaccination
1425750|NCT01060748|Challenge|challenge
1425751|NCT01060748|Diarrhea|diarrhea
1425752|NCT01060748|ETEC illness|etec illness
1425753|NCT01060748|Travelers diarrhea|travelers diarrhea
1425754|NCT01060748|ETEC|etec
1425755|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
1425756|NCT01060735|Vitamin D|vitamin d
1425757|NCT01060735|pregnancy|pregnancy
1425758|NCT01060735|children|children
1425759|NCT01060735|bone|bone
1425760|NCT01060735|quantitative ultrasound|quantitative ultrasound
1425761|NCT01060735|Healthy pregnant women|healthy pregnant women
1427010|NCT01055548|Perinatal|perinatal
1425762|NCT01060722|Healthy Male Volunteers|healthy male volunteers
1425763|NCT01060709|Carbon dioxide|carbon dioxide
1425764|NCT01060709|TcC02|tcc02
1425765|NCT01060709|Hypoventilation|hypoventilation
1425766|NCT01060709|endoscopic|endoscopic
1425767|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
1425768|NCT01060696|Infertility|infertility
1425769|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
1425770|NCT01060696|Pain|pain
1425771|NCT01060696|Hyoscine|hyoscine
1425772|NCT01060696|Mefenamic acid|mefenamic acid
1425773|NCT01060696|women|women
1425774|NCT01060683|hemoglobin|hemoglobin
1425775|NCT01060683|Coagulation variables|coagulation variables
1425776|NCT01060683|blood chemistry|blood chemistry
1425777|NCT01060683|Blood gas analysis|blood gas analysis
1425778|NCT01060670|Foot Ulcer|foot ulcer
1425779|NCT01060670|Diabetic|diabetic
1425780|NCT01060670|Wound Healing|wound healing
1425781|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
1425782|NCT01060670|Full Thickness|full thickness
1425783|NCT01060670|Neuropathic|neuropathic
1425784|NCT01060670|Omnigraft|omnigraft
1425785|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
1425786|NCT01060657|Coronary vessels|coronary vessels
1425787|NCT01060657|Radiation dosage|radiation dosage
1425788|NCT01060644|Maxillary Sinus|maxillary sinus
1425789|NCT01060644|Bone Augmentation|bone augmentation
1425790|NCT01060644|Dental Implant|dental implant
1425791|NCT01060644|Sinus Membrane|sinus membrane
1425792|NCT01060631|bispectral index|bispectral index
1425793|NCT01060631|lesions|lesions
1425794|NCT01060631|consciousness|consciousness
1425795|NCT01060605|islet transplantation|islet transplantation
1425796|NCT01060605|insulin independence|insulin independence
1425797|NCT01060605|C-peptide secretion|c-peptide secretion
1425798|NCT01060592|Gastric Band|gastric band
1425799|NCT01060592|LapBand|lapband
1425800|NCT01060592|Bariatric Surgery|bariatric surgery
1425801|NCT01060579|Glaucoma|glaucoma
1425802|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
1425803|NCT01060553|Acupuncture|acupuncture
1425804|NCT01060553|Quality of life|quality of life
1425805|NCT01060553|sleep disorder|sleep disorder
1425806|NCT01060540|genetic screening|genetic screening
1425807|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
1425808|NCT01060514|Lung cancer|lung cancer
1425809|NCT01060514|Breast cancer|breast cancer
1425810|NCT01060501|rectal cancer|rectal cancer
1425811|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
1425812|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
1425813|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
1425814|NCT01060488|GH secretion tests|gh secretion tests
1425815|NCT01060488|adverse effects|adverse effects
1425816|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
1425817|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
1425818|NCT01060488|insulin tolerance test|insulin tolerance test
1425819|NCT01060488|GHRH + Arginine test|ghrh + arginine test
1425820|NCT01060475|Transplant|transplant
1425821|NCT01060462|Defervescence rate|defervescence rate
1425822|NCT01060462|Defervescence timing|defervescence timing
1425823|NCT01060462|Itraconazole|itraconazole
1425824|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
1425825|NCT01060449|congestive heart failure|congestive heart failure
1425826|NCT01060436|sleep apnea|sleep apnea
1425827|NCT01060436|sleep disordered breathing|sleep disordered breathing
1425828|NCT01060436|CPAP|cpap
1425829|NCT01060436|BiPAP|bipap
1425830|NCT01060436|treatment outcomes|treatment outcomes
1425831|NCT01060423|colorectal|colorectal
1425832|NCT01060423|liver metastasis|liver metastasis
1425833|NCT01060423|KRAS wildtype|kras wildtype
1425834|NCT01060423|chemoembolization|chemoembolization
1425835|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
1425836|NCT01060410|Myelosuppression|myelosuppression
1425837|NCT01060410|Infection|infection
1425838|NCT01060410|Nausea|nausea
1425839|NCT01060397|Alcohol|alcohol
1425840|NCT01060397|nurse|nurse
1425841|NCT01060397|alcohol dependence|alcohol dependence
1425842|NCT01060397|acute hospital|acute hospital
1425843|NCT01060397|brief interventions|brief interventions
1425844|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
1425845|NCT01060371|Natural History|natural history
1425846|NCT01060371|Genetic Modifiers|genetic modifiers
1425847|NCT01060371|DNA testing|dna testing
1425848|NCT01060358|lumbar spine|lumbar spine
1425849|NCT01060358|low back pain|low back pain
1425850|NCT01060345|DCIS|dcis
1425851|NCT01060293|Heart Failure|heart failure
1425852|NCT01060293|Dopamine|dopamine
1425853|NCT01060293|Furosemide|furosemide
1425854|NCT01060293|Worsening Renal Function|worsening renal function
1425855|NCT01060293|Hypokalemia|hypokalemia
1425856|NCT01060293|Outcomes|outcomes
1425857|NCT01060293|Prognosis|prognosis
1425858|NCT01060280|low back pain|low back pain
1425859|NCT01060280|physiotherapy|physiotherapy
1425860|NCT01060280|exercise|exercise
1427011|NCT01055548|Ultrasound|ultrasound
1425861|NCT01060280|active management|active management
1425862|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
1425863|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
1425864|NCT01060254|JNJ-42160443|jnj-42160443
1425865|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
1425866|NCT01060228|Paliperidone ER|paliperidone er
1425867|NCT01060228|INVEGA|invega
1425868|NCT01060228|Divalproex sodium|divalproex sodium
1425869|NCT01060228|Depakote ER|depakote er
1425870|NCT01060228|Pharmacokinetics|pharmacokinetics
1425871|NCT01060228|Valproic Acid|valproic acid
1425872|NCT01060228|Human Experimentation|human experimentation
1425873|NCT01060215|effusion|effusion
1425874|NCT01060215|osteoarthritis|osteoarthritis
1425875|NCT01060215|knee|knee
1425876|NCT01060202|Multiple Myeloma|multiple myeloma
1425877|NCT01060202|Bortezomib|bortezomib
1425878|NCT01060202|Velcade|velcade
1425879|NCT01060202|QoL|qol
1425880|NCT01060202|Proteasome inhibitor|proteasome inhibitor
1425881|NCT01060202|EORTC QLQ C30|eortc qlq c30
1425882|NCT01060202|EQ 5D|eq 5d
1425883|NCT01060189|ulinastatin|ulinastatin
1425884|NCT01060189|tranexamic acid|tranexamic acid
1425885|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
1425886|NCT01060189|hemostasis|hemostasis
1425887|NCT01060189|anti-inflammation|anti-inflammation
1425888|NCT01060176|tranexamic acid|tranexamic acid
1425889|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
1425890|NCT01060176|hemostasis|hemostasis
1425891|NCT01060176|anti-inflammation|anti-inflammation
1425892|NCT01060163|Clopidogrel|clopidogrel
1425893|NCT01060163|Tranexamic Acid|tranexamic acid
1425894|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
1425895|NCT01060163|Hemostasis|hemostasis
1425896|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1425897|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
1425898|NCT01060150|Methylphenidate|methylphenidate
1425899|NCT01060150|CONCERTA|concerta
1425900|NCT01060137|fentanyl matrix|fentanyl matrix
1425901|NCT01060124|Pain; Cancer|pain; cancer
1425902|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
1425903|NCT01060124|Durogesic D-trans|durogesic d-trans
1425904|NCT01060111|Migraine|migraine
1425905|NCT01060111|Topiramate|topiramate
1425906|NCT01060111|Propranolol|propranolol
1425907|NCT01060085|Breast Cancer|breast cancer
1425908|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
1425909|NCT01060046|biologic mesh|biologic mesh
1425910|NCT01060046|ventral hernia repair|ventral hernia repair
1425911|NCT01060046|breast reconstruction|breast reconstruction
1425912|NCT01060046|MMPs|mmps
1425913|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
1425914|NCT01060020|Aortic valve stenosis|aortic valve stenosis
1425916|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1425917|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
1425918|NCT01059994|fatigue|fatigue
1425919|NCT01059994|aging|aging
1425920|NCT01059968|bone density|bone density
1425921|NCT01059968|energy availability|energy availability
1425922|NCT01059968|menstrual status|menstrual status
1425923|NCT01059968|female|female
1425924|NCT01059968|adolescent|adolescent
1425925|NCT01059955|scleritis|scleritis
1425926|NCT01059955|anterior scleritis|anterior scleritis
1425927|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
1425928|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
1425929|NCT01059942|communication barriers|communication barriers
1425930|NCT01059942|clinical competence|clinical competence
1425931|NCT01059942|medical education|medical education
1425932|NCT01059942|internship and residency|internship and residency
1425933|NCT01059942|hospitalist|hospitalist
1425934|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
1425935|NCT01059942|Patient Care|patient care
1425936|NCT01059942|Internal Medicine|internal medicine
1425937|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
1425938|NCT01059929|Respiration, Artificial|respiration, artificial
1425939|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
1425940|NCT01059929|Critical care|critical care
1425941|NCT01059929|Intensive care|intensive care
1425942|NCT01059929|Physical therapy|physical therapy
1425943|NCT01059929|Occupational therapy|occupational therapy
1425944|NCT01059929|Sedative medications|sedative medications
1425945|NCT01059903|Rotigotine|rotigotine
1425946|NCT01059903|Neupro®|neupro®
1425947|NCT01059903|Transdermal Patch|transdermal patch
1425948|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
1425949|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
1425950|NCT01059864|cholesterol|cholesterol
1425951|NCT01059864|lipids|lipids
1425952|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
1425953|NCT01059864|CP-690|cp-690
1425954|NCT01059864|550|550
1425955|NCT01059838|pediatrics|pediatrics
1425956|NCT01059838|cochlear implant|cochlear implant
1425957|NCT01059825|Phase 2|phase 2
1427211|NCT01054599|epilepsy|epilepsy
1425958|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
1425959|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
1425960|NCT01059786|Monoclonal Antibody|monoclonal antibody
1425961|NCT01059786|Purine Analog|purine analog
1425962|NCT01059786|Soluble CD25|soluble cd25
1425963|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
1425964|NCT01059786|CD20|cd20
1425965|NCT01059786|Hairy Cell Leukemia|hairy cell leukemia
1425966|NCT01059773|Psoriasis|psoriasis
1425967|NCT01059773|Ustekinumab|ustekinumab
1425968|NCT01059773|Stelara|stelara
1425969|NCT01059773|Methotrexate|methotrexate
1425970|NCT01059773|Biologic|biologic
1425971|NCT01059760|Fasting|fasting
1425972|NCT01059760|Short-term starvation|short-term starvation
1425973|NCT01059760|Diet|diet
1425974|NCT01059760|Coronary artery disease|coronary artery disease
1425975|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1425976|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1425977|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1425978|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1425979|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1425980|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1425981|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1425982|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1425983|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1425984|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1425985|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1425986|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1425987|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1425988|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1425989|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1425990|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1425991|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1425992|NCT01059721|Centralisation|centralisation
1425993|NCT01059721|Patella dislocation|patella dislocation
1425994|NCT01059721|Open epiphyses|open epiphyses
1425995|NCT01059721|Malalignment syndrome|malalignment syndrome
1425996|NCT01059721|Relapse rate|relapse rate
1425997|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
1425998|NCT01059695|cervical cancer|cervical cancer
1425999|NCT01059695|retrospective|retrospective
1426000|NCT01059695|quality of life|quality of life
1426001|NCT01059695|treatment|treatment
1426396|NCT01058070|GERD|gerd
1426002|NCT01059669|Chronic pancreatitis|chronic pancreatitis
1426004|NCT01059669|Exocrine insufficiency|exocrine insufficiency
1426005|NCT01059669|Diabetes|diabetes
1426006|NCT01059669|Nutrition|nutrition
1426007|NCT01059669|Ultrasound|ultrasound
1426008|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
1426009|NCT01059656|Pazopanib¨|pazopanib¨
1426010|NCT01059656|Phase II|phase ii
1426011|NCT01059630|follicular|follicular
1426012|NCT01059630|follicular lymphoma|follicular lymphoma
1426013|NCT01059617|Pandemic|pandemic
1426014|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1426015|NCT01059617|H1N1|h1n1
1426016|NCT01059617|Influenza|influenza
1426017|NCT01059604|pregnancy outcomes|pregnancy outcomes
1426018|NCT01059604|pregnancy|pregnancy
1426019|NCT01059604|first trimester|first trimester
1426020|NCT01059604|Sumatriptan|sumatriptan
1426021|NCT01059604|major congenital malformations|major congenital malformations
1426022|NCT01059604|naratriptan|naratriptan
1426023|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
1426024|NCT01059604|pregnancy registry|pregnancy registry
1426025|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
1426026|NCT01059591|Healthy subjects|healthy subjects
1426027|NCT01059591|Safety|safety
1426028|NCT01059591|First time in Human|first time in human
1426029|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
1426030|NCT01059578|Safety|safety
1426031|NCT01059578|First Time in Humans|first time in humans
1426032|NCT01059578|Healthy Subjects|healthy subjects
1426033|NCT01059565|Cystic Fibrosis|cystic fibrosis
1426034|NCT01059565|Aztreonam Lysine|aztreonam lysine
1426035|NCT01059565|lung infection|lung infection
1426036|NCT01059565|Burkholderia|burkholderia
1426037|NCT01059565|CFQ-R|cfq-r
1426038|NCT01059565|inhaled antibiotic|inhaled antibiotic
1426039|NCT01059552|lung cancer|lung cancer
1426040|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
1426041|NCT01059539|mania|mania
1426042|NCT01059539|acute mania|acute mania
1426043|NCT01059539|bipolar I disorder|bipolar i disorder
1426044|NCT01059526|HAE|hae
1426045|NCT01059513|T1c|t1c
1426046|NCT01059513|T2a|t2a
1426047|NCT01059513|T2b|t2b
1427212|NCT01054599|memory|memory
1426048|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
1426049|NCT01059500|Overtesting|overtesting
1426050|NCT01059500|Radiation|radiation
1426051|NCT01059500|Intravenous Contrast|intravenous contrast
1426052|NCT01059500|Anticoagulation|anticoagulation
1426053|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
1426054|NCT01059487|Acupuncture|acupuncture
1426055|NCT01059474|DMPS|dmps
1426056|NCT01059474|mercury|mercury
1426057|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
1426058|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
1426059|NCT01059461|Nerve growth factor|nerve growth factor
1426060|NCT01059461|Cerebrolysin|cerebrolysin
1426061|NCT01059461|Cerebral palsy|cerebral palsy
1426062|NCT01059448|Amgen|amgen
1426063|NCT01059448|RA|ra
1426064|NCT01059448|AMG 827|amg 827
1426065|NCT01059448|20090061|20090061
1426066|NCT01059435|Amgen|amgen
1426067|NCT01059435|First in Human|first in human
1426068|NCT01059435|Postmenopausal|postmenopausal
1426069|NCT01059435|Phase 1|phase 1
1426070|NCT01059409|Meniscal Allografts|meniscal allografts
1426071|NCT01059409|Osteoarthritis|osteoarthritis
1426072|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
1426073|NCT01059383|GERD|gerd
1426074|NCT01059383|Nocturnal GERD|nocturnal gerd
1426075|NCT01059383|Heartburn|heartburn
1426076|NCT01059383|Nighttime Heartburn|nighttime heartburn
1426077|NCT01059370|Autonomic dysfunction|autonomic dysfunction
1426078|NCT01059370|Spinal cord injured|spinal cord injured
1426079|NCT01059370|Neurogenic bowel|neurogenic bowel
1426080|NCT01059370|Neurogenic bladder|neurogenic bladder
1426081|NCT01059344|Mesalamine|mesalamine
1426082|NCT01059344|Asacol|asacol
1426083|NCT01059344|Ulcerative colitis|ulcerative colitis
1426084|NCT01059344|induction therapy|induction therapy
1426085|NCT01059344|acute disease|acute disease
1426086|NCT01059344|mild to moderate|mild to moderate
1426087|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
1426088|NCT01059331|Kidney|kidney
1426089|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
1426090|NCT01059318|High Resolution CT scan,|high resolution ct scan,
1426091|NCT01059318|chest x-ray,|chest x-ray,
1426092|NCT01059318|6 minute walk test,|6 minute walk test,
1426093|NCT01059318|pulse oximetry,|pulse oximetry,
1426094|NCT01059318|renal MRI,|renal mri,
1426095|NCT01059318|Pikometer|pikometer
1426096|NCT01059305|Erlotinib|erlotinib
1426097|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
1426098|NCT01059305|OSI-774|osi-774
1426099|NCT01059305|Tarceva|tarceva
1426100|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1426101|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
1426102|NCT01059305|CSCC|cscc
1426103|NCT01059305|Local surgery|local surgery
1426104|NCT01059305|Radiation therapy|radiation therapy
1426500|NCT01057615|Asthma|asthma
1426105|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
1426106|NCT01059305|EGFR|egfr
1426107|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
1426108|NCT01059292|we have complieted party research|we have complieted party research
1426109|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
1426110|NCT01059279|Cytokines|cytokines
1426111|NCT01059279|Inflammatory proteins|inflammatory proteins
1426112|NCT01059279|MEFV|mefv
1426113|NCT01059279|mutations|mutations
1426114|NCT01059279|Heat Intolerance|heat intolerance
1426115|NCT01059279|Heat Tolerance Test|heat tolerance test
1426116|NCT01059266|immunotherapy|immunotherapy
1426117|NCT01059266|grass pollen|grass pollen
1426118|NCT01059266|seasonal allergy|seasonal allergy
1426119|NCT01059266|dose tolerability|dose tolerability
1426120|NCT01059253|Falls|falls
1426121|NCT01059253|Balance|balance
1426122|NCT01059253|Elderly|elderly
1426123|NCT01059253|Aged|aged
1426124|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
1426125|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
1426126|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
1426127|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
1426128|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
1426129|NCT01059240|SMA|sma
1426130|NCT01059227|Treatment|treatment
1426131|NCT01059227|Anxiety|anxiety
1426132|NCT01059227|Fear|fear
1426133|NCT01059227|Fear Potentiated Startle|fear potentiated startle
1426134|NCT01059227|Healthy Volunteer|healthy volunteer
1426135|NCT01059227|HV|hv
1426136|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
1426137|NCT01059214|Reperfusion|reperfusion
1426138|NCT01059214|MRI|mri
1426139|NCT01059214|Heart Attack|heart attack
1426140|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
1426141|NCT01059201|Cholesterol|cholesterol
1426142|NCT01059201|Exome Sequencing|exome sequencing
1426143|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
1426144|NCT01059201|ASD|asd
1426145|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1426146|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
1426147|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1426148|NCT01059188|large cell lung cancer|large cell lung cancer
1426149|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
1426150|NCT01059175|Heart failure|heart failure
1426151|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
1426152|NCT01059175|Biventricular stimulation|biventricular stimulation
1426153|NCT01059175|Multisite stimulation|multisite stimulation
1426154|NCT01059175|Non responders|non responders
1426155|NCT01059162|Glaucoma Surgery|glaucoma surgery
1426156|NCT01059162|Filtering Surgery|filtering surgery
1426157|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
1426158|NCT01059149|Rehabilitation|rehabilitation
1426159|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
1426160|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
1426161|NCT01059149|Repetitive|repetitive
1426162|NCT01059149|Stroke|stroke
1426163|NCT01059149|Subacute|subacute
1426164|NCT01059136|Myocardial infarction|myocardial infarction
1426165|NCT01059136|Outcome|outcome
1426166|NCT01059136|Aldosterone|aldosterone
1426167|NCT01059136|Spironolactone|spironolactone
1426168|NCT01059123|Amoxicillin|amoxicillin
1426169|NCT01059123|Erysipelas|erysipelas
1426170|NCT01059123|Short course|short course
1426171|NCT01059110|Occlusive dressings|occlusive dressings
1426172|NCT01059110|Salicylate ointment|salicylate ointment
1426173|NCT01059110|Cryotherapy|cryotherapy
1426174|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
1426175|NCT01059110|Imiquimod|imiquimod
1426176|NCT01059110|Randomized clinical trial|randomized clinical trial
1426177|NCT01059110|Plantar warts|plantar warts
1426178|NCT01059084|HIV|hiv
1426179|NCT01059084|Valacyclovir|valacyclovir
1426180|NCT01059084|Valtrex®|valtrex®
1426181|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
1426182|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
1426183|NCT01059058|MI Paste Plus|mi paste plus
1426184|NCT01059058|Fluoride Varnish|fluoride varnish
1426185|NCT01059058|CPP-ACP|cpp-acp
1426186|NCT01059058|White Spot Lesions|white spot lesions
1426187|NCT01059058|Remineralization|remineralization
1426188|NCT01059058|Orthodontic Treatment|orthodontic treatment
1426189|NCT01059019|Refractive Surgery|refractive surgery
1426190|NCT01059019|PRK|prk
1426191|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
1426192|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
1426194|NCT01059006|Reflective Surgery|reflective surgery
1426195|NCT01059006|Presbyopia|presbyopia
1426196|NCT01059006|PresbyLASIK|presbylasik
1426197|NCT01058993|neutropenia|neutropenia
1426198|NCT01058993|myelokathexis|myelokathexis
1426199|NCT01058993|WHIM syndrome|whim syndrome
1426200|NCT01058993|AMD 3100|amd 3100
1426201|NCT01058993|plerixafor|plerixafor
1426202|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
1426203|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
1426204|NCT01058980|catheter ablation|catheter ablation
1426205|NCT01058980|atrial fibrillation|atrial fibrillation
1426206|NCT01058980|adenosine|adenosine
1426207|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
1426208|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
1426209|NCT01058941|Alzheimer's disease|alzheimer's disease
1426210|NCT01058941|fish oil|fish oil
1426211|NCT01058941|lipoic acid|lipoic acid
1426212|NCT01058928|Tracheal tube|tracheal tube
1426213|NCT01058928|Size|size
1426214|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
1426215|NCT01058902|Non small cell lung cancer|non small cell lung cancer
1426216|NCT01058902|survival|survival
1426217|NCT01058902|aspirin|aspirin
1426218|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
1426219|NCT01058889|Telemedicine|telemedicine
1426220|NCT01058889|Insulin|insulin
1426221|NCT01058876|Smoking|smoking
1426222|NCT01058876|nicotine|nicotine
1426223|NCT01058837|Sudden Cardiac Death|sudden cardiac death
1426224|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1426225|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
1426226|NCT01058824|Bioequivalence|bioequivalence
1426227|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
1426228|NCT01058811|lung cancer|lung cancer
1426229|NCT01058798|Neuroblastoma|neuroblastoma
1426230|NCT01058798|B4GALNT3|b4galnt3
1426231|NCT01058798|Prognosis|prognosis
1426232|NCT01058785|Gene therapy|gene therapy
1426233|NCT01058785|Flow cytometry|flow cytometry
1426234|NCT01058785|Immunoenzyme technique|immunoenzyme technique
1426235|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
1426236|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
1426237|NCT01058772|Induced Labour|induced labour
1426238|NCT01058772|Expectant Management|expectant management
1426239|NCT01058772|C-section rate|c-section rate
1426240|NCT01058772|Maternal Outcomes|maternal outcomes
1426241|NCT01058772|Neonatal Outcomes|neonatal outcomes
1426242|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
1426243|NCT01058759|NSCLC|nsclc
1426244|NCT01058759|Enoxaparin|enoxaparin
1426368|NCT01058239|PTLD|ptld
1426369|NCT01058239|EBV|ebv
1427213|NCT01054599|memantine|memantine
1426245|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
1426246|NCT01058746|pancreas|pancreas
1426247|NCT01058746|surgery|surgery
1426248|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
1426249|NCT01058746|Central Pancreatectomy|central pancreatectomy
1426250|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
1426251|NCT01058746|resection|resection
1426252|NCT01058746|IV fluids|iv fluids
1426253|NCT01058746|09-185|09-185
1426254|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
1426255|NCT01058733|Diabetes Mellitus|diabetes mellitus
1426256|NCT01058733|Internet|internet
1426257|NCT01058733|ubiquitous health care system|ubiquitous health care system
1426258|NCT01058720|Vitamin D|vitamin d
1426259|NCT01058720|Supplementation|supplementation
1426260|NCT01058720|Adolescence|adolescence
1426261|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
1426262|NCT01058694|Mobile phones,|mobile phones,
1426263|NCT01058694|Medication Adherence|medication adherence
1426264|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
1426265|NCT01058694|HIV Infections|hiv infections
1426266|NCT01058681|LH pulsatility|lh pulsatility
1426267|NCT01058681|GnRH regulation|gnrh regulation
1426268|NCT01058681|isocaloric nutrition|isocaloric nutrition
1426269|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
1426270|NCT01058681|euglycemic clamps|euglycemic clamps
1426271|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
1426272|NCT01058681|testosterone|testosterone
1426273|NCT01058681|LH|lh
1426274|NCT01058681|leptine|leptine
1426275|NCT01058681|ghrelin|ghrelin
1426276|NCT01058681|PYY|pyy
1426277|NCT01058681|CCK|cck
1426278|NCT01058681|GLP-1|glp-1
1426279|NCT01058681|GIP|gip
1426280|NCT01058681|cortisol|cortisol
1426281|NCT01058668|Acute Mania|acute mania
1426282|NCT01058668|Bipolar I Disorder|bipolar i disorder
1426283|NCT01058655|Colorectal Cancer|colorectal cancer
1426284|NCT01058642|pain|pain
1426285|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
1426286|NCT01058629|Hybrid|hybrid
1426287|NCT01058629|contact lens|contact lens
1426288|NCT01058629|myopia|myopia
1426289|NCT01058629|hyperopia|hyperopia
1426290|NCT01058629|near sighted|near sighted
1426291|NCT01058629|astigmatism|astigmatism
1426292|NCT01058629|far sighted|far sighted
1426293|NCT01058603|Infertility|infertility
1426294|NCT01058603|Cell Culture|cell culture
1426295|NCT01058603|AECC|aecc
1426296|NCT01058603|Endocell|endocell
1426298|NCT01058590|Inflammation|inflammation
1426299|NCT01058590|Adenotonsillectomy|adenotonsillectomy
1426300|NCT01058577|diabetes|diabetes
1426301|NCT01058564|GERD|gerd
1426302|NCT01058551|Sleep Apnea|sleep apnea
1426303|NCT01058551|Atrial Fibrillation|atrial fibrillation
1426395|NCT01058096|Bipolar I Disorder|bipolar i disorder
1426304|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
1426305|NCT01058538|L19|l19
1426306|NCT01058512|hepatitis C|hepatitis c
1426307|NCT01058512|chronic HCV|chronic hcv
1426308|NCT01058512|viral HCV|viral hcv
1426309|NCT01058512|genotype 1|genotype 1
1426310|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
1426311|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1426312|NCT01058499|COPD|copd
1426313|NCT01058486|Chronic Disease Management|chronic disease management
1426314|NCT01058486|Physical Activity|physical activity
1426315|NCT01058486|Self-efficacy|self-efficacy
1426316|NCT01058486|Self management|self management
1426317|NCT01058473|Sickle Cell Disease|sickle cell disease
1426318|NCT01058473|Pain|pain
1426319|NCT01058473|Assessment|assessment
1426320|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
1426321|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
1426322|NCT01058447|ADME|adme
1426323|NCT01058447|Healthy volunteers|healthy volunteers
1426324|NCT01058434|Multiple myeloma|multiple myeloma
1426325|NCT01058434|relapsed|relapsed
1426326|NCT01058434|refractory|refractory
1426327|NCT01058434|t(4;14)|t(4;14)
1426328|NCT01058434|FGFR3|fgfr3
1426329|NCT01058421|mechanical ventilation|mechanical ventilation
1426330|NCT01058421|acute respiratory failure|acute respiratory failure
1426331|NCT01058421|physical therapy|physical therapy
1426332|NCT01058421|critical illness neuropathy|critical illness neuropathy
1426333|NCT01058421|critical illness myopathy|critical illness myopathy
1426334|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
1426335|NCT01058408|cisplatin|cisplatin
1426336|NCT01058408|RAD001|rad001
1426337|NCT01058408|radiation|radiation
1426338|NCT01058408|HNSCC|hnscc
1426339|NCT01058395|Traumatic Brain Injury|traumatic brain injury
1426340|NCT01058395|Minocycline|minocycline
1426341|NCT01058395|Outcome|outcome
1426342|NCT01058382|FET|fet
1426343|NCT01058382|Progesterone Support|progesterone support
1427310|NCT01054313|Prednisone|prednisone
1426344|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
1426345|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
1426346|NCT01058356|lactobacilli|lactobacilli
1426347|NCT01058356|probiotics|probiotics
1426348|NCT01058356|prevention|prevention
1426349|NCT01058356|pulmonary infection|pulmonary infection
1426350|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
1426351|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
1426352|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
1426353|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
1426354|NCT01058343|SLE|sle
1426355|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
1426356|NCT01058330|NF1|nf1
1426357|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
1426358|NCT01058304|osteoarthritis|osteoarthritis
1426359|NCT01058304|knee|knee
1426360|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
1426361|NCT01058304|veterans|veterans
1426362|NCT01058278|Glaucoma|glaucoma
1426363|NCT01058278|Ocular Hypertension|ocular hypertension
1426364|NCT01058278|Intraocular Pressure|intraocular pressure
1426365|NCT01058278|Trabeculectomy|trabeculectomy
1426366|NCT01058239|bortezomib|bortezomib
1426367|NCT01058239|rituximab|rituximab
1426370|NCT01058239|transplantation|transplantation
1426371|NCT01058226|Experimental malaria challenge|experimental malaria challenge
1426372|NCT01058213|COPD|copd
1426373|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
1426374|NCT01058213|Resistance Training|resistance training
1426375|NCT01058213|Aerobic Training|aerobic training
1426376|NCT01058213|Dyspnea|dyspnea
1426377|NCT01058174|Prophylaxis|prophylaxis
1426378|NCT01058174|Liver transplantation|liver transplantation
1426379|NCT01058174|Invasive Fungal Infection|invasive fungal infection
1426380|NCT01058174|Micafungin|micafungin
1426381|NCT01058174|Prevention|prevention
1426382|NCT01058174|Mycoses|mycoses
1426383|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
1426384|NCT01058148|Cervical Cancer Screening|cervical cancer screening
1426385|NCT01058148|Cervical Precancer|cervical precancer
1426386|NCT01058148|Self-Collection|self-collection
1426387|NCT01058148|Cytology|cytology
1426388|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1426389|NCT01058135|insulin resistance|insulin resistance
1426390|NCT01058135|dietary fiber|dietary fiber
1426391|NCT01058135|resistant starch|resistant starch
1426392|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
1426393|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
1426394|NCT01058096|Acute Mania|acute mania
1426397|NCT01058057|atorvastatin|atorvastatin
1426398|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
1426399|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
1426400|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1426401|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
1426402|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
1426403|NCT01058018|Cholesterol|cholesterol
1426404|NCT01058018|High density lipoprotein|high density lipoprotein
1426405|NCT01058018|Atherosclerosis|atherosclerosis
1426406|NCT01058018|ApolipoproteinA1|apolipoproteina1
1426407|NCT01058018|Stable angina artery disease|stable angina artery disease
1426408|NCT01058005|MS|ms
1426409|NCT01057979|exercise|exercise
1426410|NCT01057979|college students|college students
1426411|NCT01057979|Sedentary college students|sedentary college students
1426412|NCT01057966|Bioavailability|bioavailability
1426413|NCT01057966|Ocular Vitamins|ocular vitamins
1426414|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
1426415|NCT01057914|Randomized controlled trial|randomized controlled trial
1426416|NCT01057914|Malnutrition|malnutrition
1426417|NCT01057914|Aged|aged
1426418|NCT01057914|Aged 80 and over|aged 80 and over
1426419|NCT01057914|Nutrition therapy|nutrition therapy
1426420|NCT01057888|Immunization status for:|immunization status for:
1426421|NCT01057888|Tdap|tdap
1426422|NCT01057888|Menactra|menactra
1426423|NCT01057888|HPV (if female)|hpv (if female)
1426424|NCT01057888|Well child care visit|well child care visit
1426425|NCT01057862|Naltrexone|naltrexone
1426426|NCT01057862|Pathological Gambling|pathological gambling
1426427|NCT01057862|Opioid Antagonist|opioid antagonist
1426428|NCT01057849|schizophrenia|schizophrenia
1426429|NCT01057849|first episode|first episode
1426430|NCT01057849|atypical antipsychotics|atypical antipsychotics
1426431|NCT01057849|psychosocial intervention|psychosocial intervention
1426432|NCT01057849|outcome|outcome
1426433|NCT01057849|effectiveness|effectiveness
1426434|NCT01057823|aged|aged
1426435|NCT01057823|sleep deprivation|sleep deprivation
1426436|NCT01057823|actigraphy|actigraphy
1427409|NCT01053832|pacemaker|pacemaker
1426437|NCT01057823|ambulatory monitoring|ambulatory monitoring
1426438|NCT01057797|COPD|copd
1426439|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
1426440|NCT01057797|Self-efficacy|self-efficacy
1426441|NCT01057797|Muscle strength|muscle strength
1426442|NCT01057797|Dyspnea|dyspnea
1426443|NCT01057797|Exercise adherence|exercise adherence
1426444|NCT01057784|obesity|obesity
1426445|NCT01057784|bariatric|bariatric
1426446|NCT01057784|surgery|surgery
1426447|NCT01057784|sleeve|sleeve
1426448|NCT01057784|gastric bypass|gastric bypass
1426449|NCT01057784|vitamin D|vitamin d
1426450|NCT01057784|quality of life|quality of life
1426451|NCT01057784|body composition|body composition
1426452|NCT01057784|bone density|bone density
1426453|NCT01057784|adolescent|adolescent
1426454|NCT01057784|child|child
1426455|NCT01057784|teenager|teenager
1426456|NCT01057784|fertility|fertility
1426457|NCT01057784|offspring|offspring
1426458|NCT01057784|biomarker|biomarker
1426459|NCT01057784|epigenome|epigenome
1426460|NCT01057784|gene expression|gene expression
1426461|NCT01057771|meditation|meditation
1426462|NCT01057771|exercise|exercise
1426463|NCT01057771|immunity|immunity
1426464|NCT01057771|respiratory infection|respiratory infection
1426465|NCT01057771|influenza|influenza
1426466|NCT01057771|flu shot|flu shot
1426467|NCT01057771|immunomodulation|immunomodulation
1426468|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
1426469|NCT01057745|woman|woman
1426470|NCT01057745|chemotherapy|chemotherapy
1426471|NCT01057745|radiation|radiation
1426472|NCT01057745|fertility preservation|fertility preservation
1426473|NCT01057745|cryobank|cryobank
1426474|NCT01057719|cross-over design|cross-over design
1426475|NCT01057719|mixed model|mixed model
1426476|NCT01057719|multiple sclerosis|multiple sclerosis
1426477|NCT01057719|physical performance measures|physical performance measures
1426478|NCT01057719|physical therapy|physical therapy
1426479|NCT01057719|the Bobath concept|the bobath concept
1426480|NCT01057719|warm climate|warm climate
1426481|NCT01057719|6-minute walk test|6-minute walk test
1426482|NCT01057706|chiropractic|chiropractic
1426483|NCT01057706|exercise|exercise
1426484|NCT01057706|seniors|seniors
1426485|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
1426486|NCT01057693|Lyrica|lyrica
1426487|NCT01057693|pregabalin|pregabalin
1426488|NCT01057693|pain|pain
1426489|NCT01057680|Bone|bone
1426490|NCT01057680|Muscle|muscle
1426491|NCT01057680|Strength|strength
1426492|NCT01057680|Kidney|kidney
1426493|NCT01057680|Liver|liver
1426494|NCT01057680|Creatine|creatine
1426495|NCT01057654|Cholesterol|cholesterol
1426496|NCT01057641|PIDLSS, Spacer|pidlss, spacer
1426497|NCT01057628|ASP1941|asp1941
1426498|NCT01057628|Diabetes mellitus|diabetes mellitus
1426499|NCT01057628|Blood glucose|blood glucose
1426501|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
1426502|NCT01057615|Inflammation|inflammation
1426503|NCT01057615|Airway|airway
1426504|NCT01057615|Fish Oil|fish oil
1426505|NCT01057615|Ascorbic Acid|ascorbic acid
1426506|NCT01057602|Dementia|dementia
1426507|NCT01057602|Screening Tests|screening tests
1426508|NCT01057602|Cognition|cognition
1426509|NCT01057602|Memory|memory
1426510|NCT01057602|MOST|most
1426511|NCT01057589|Pharynx|pharynx
1426512|NCT01057589|Larynx|larynx
1426513|NCT01057589|Cervical esophagus|cervical esophagus
1426514|NCT01057589|Nose|nose
1426515|NCT01057589|Thyroid Gland|thyroid gland
1426516|NCT01057589|Parathyroid Gland|parathyroid gland
1426517|NCT01057576|bioactives|bioactives
1426518|NCT01057576|insulin|insulin
1426519|NCT01057576|botanicals|botanicals
1426520|NCT01057563|Coronary artery disease|coronary artery disease
1426521|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
1426522|NCT01057563|Drug-eluting balloon|drug-eluting balloon
1426523|NCT01057563|Optical coherence tomography|optical coherence tomography
1426524|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
1426525|NCT01057550|autologous slings|autologous slings
1426526|NCT01057550|slings|slings
1426527|NCT01057550|tvt|tvt
1426528|NCT01057550|grafts|grafts
1426529|NCT01057550|surgery|surgery
1426530|NCT01057537|Polypill|polypill
1426531|NCT01057537|Red Heart Pill|red heart pill
1426532|NCT01057537|Cardiovascular disease|cardiovascular disease
1426533|NCT01057537|Adherence|adherence
1426534|NCT01057537|Secondary prevention|secondary prevention
1426535|NCT01057524|Airway clearance|airway clearance
1426536|NCT01057524|Cystic fibrosis|cystic fibrosis
1426537|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
1426538|NCT01057511|Crinone|crinone
1426539|NCT01057511|progesterone|progesterone
1426540|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
1426541|NCT01057485|Atrial Fibrillation|atrial fibrillation
1426542|NCT01057485|Ablation|ablation
1426543|NCT01057472|Repeatability of measurements|repeatability of measurements
1426710|NCT01056757|metastatic breast cancer|metastatic breast cancer
1426544|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
1426545|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
1426546|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
1426547|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
1426548|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
1426549|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
1426550|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1426551|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1426552|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1426553|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1426554|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1426555|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1426556|NCT01057446|Colonoscopy preparation|colonoscopy preparation
1426557|NCT01057446|sennoside|sennoside
1426558|NCT01057446|sodium phosphate|sodium phosphate
1426559|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
1426560|NCT01057433|Healthy Volunteers|healthy volunteers
1426561|NCT01057407|Hyperphosphatemia|hyperphosphatemia
1426562|NCT01057407|hemodialysis|hemodialysis
1426563|NCT01057407|CKD|ckd
1426564|NCT01057407|ASP1585|asp1585
1426565|NCT01057394|Atrial Fibrillation|atrial fibrillation
1426566|NCT01057381|Adenotonsillectomy|adenotonsillectomy
1426567|NCT01057381|Postoperative analgesia|postoperative analgesia
1426568|NCT01057381|Pediatrics|pediatrics
1426569|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
1426570|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
1426571|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
1426572|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1426573|NCT01057355|Pancreatic cyst|pancreatic cyst
1426574|NCT01057355|Pancreas cyst|pancreas cyst
1426575|NCT01057355|Alcohol|alcohol
1426576|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1426577|NCT01057329|TDM|tdm
1426578|NCT01057329|Drug|drug
1426579|NCT01057329|Psychopharmacology|psychopharmacology
1426580|NCT01057329|children|children
1426581|NCT01057329|adolescents|adolescents
1426582|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1426583|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1426584|NCT01057277|Head and Neck Cancer|head and neck cancer
1426585|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
1426586|NCT01057264|Liver|liver
1426587|NCT01057264|Cancer|cancer
1426588|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
1426589|NCT01057264|HAI|hai
1426590|NCT01057264|Abraxane|abraxane
1426591|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
1426592|NCT01057264|Paclitaxel|paclitaxel
1426593|NCT01057264|ABI-007|abi-007
1426594|NCT01057264|Gemcitabine|gemcitabine
1426595|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1426596|NCT01057264|Gemzar|gemzar
1426597|NCT01057264|Bevacizumab|bevacizumab
1426598|NCT01057264|Avastin|avastin
1426599|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1426600|NCT01057264|rhuMAb-VEGF|rhumab-vegf
1426601|NCT01057264|Filgrastim|filgrastim
1426602|NCT01057264|G-CSF|g-csf
1426603|NCT01057264|Neupogen|neupogen
1426604|NCT01057251|Nebivolol|nebivolol
1426605|NCT01057251|Bystolic TM|bystolic tm
1426606|NCT01057251|Hypertension|hypertension
1426607|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
1426608|NCT01057238|mechanical ventilation|mechanical ventilation
1426609|NCT01057238|critical care|critical care
1426610|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
1426611|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
1426612|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1426613|NCT01057173|Heart Valve Disease|heart valve disease
1426614|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
1426615|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
1426616|NCT01057173|Randomized Controlled Trial|randomized controlled trial
1426617|NCT01057121|HIV Infections|hiv infections
1426618|NCT01057108|Hyperphosphatemia|hyperphosphatemia
1426619|NCT01057108|chronic kidney disease|chronic kidney disease
1426620|NCT01057108|salivary phosphorus|salivary phosphorus
1426621|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1426622|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1426623|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1426624|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1426625|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1426711|NCT01056757|ribavirin|ribavirin
1426626|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1426627|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1426628|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1426629|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1426630|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1426631|NCT01057082|Sarcopenia|sarcopenia
1426632|NCT01057082|Aging|aging
1426633|NCT01057082|Muscle|muscle
1426634|NCT01057082|Dietary Supplement|dietary supplement
1426635|NCT01057082|HMB|hmb
1426636|NCT01057082|Arginine|arginine
1426637|NCT01057082|Glutamine|glutamine
1426638|NCT01057069|Neo adjuvant|neo adjuvant
1426639|NCT01057069|Triple negative|triple negative
1426640|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
1426641|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
1426642|NCT01057043|Osteoarthritis|osteoarthritis
1426643|NCT01057017|colorectal cancer|colorectal cancer
1426644|NCT01057004|heart failure|heart failure
1426645|NCT01056978|palliative care unit|palliative care unit
1426646|NCT01056978|bleeding|bleeding
1426647|NCT01056978|thromboembolic|thromboembolic
1426648|NCT01056978|hemorrhagic risk|hemorrhagic risk
1426649|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
1426650|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
1426651|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
1426652|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
1426653|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
1426654|NCT01056965|FTLD|ftld
1426655|NCT01056965|FTD|ftd
1560783|NCT00534352|HIV|hiv
1426656|NCT01056965|PNFA|pnfa
1426657|NCT01056965|CBD|cbd
1426658|NCT01056965|PSP|psp
1426659|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
1426660|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
1426661|NCT01056965|(CBS)|(cbs)
1426662|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
1426663|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
1426664|NCT01056939|Children needing ventilatory care|children needing ventilatory care
1426665|NCT01056926|smoking|smoking
1426666|NCT01056926|nicotine|nicotine
1426667|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
1426668|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
1426669|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
1426670|NCT01056926|memory|memory
1426671|NCT01056913|anastomotic leakage|anastomotic leakage
1426672|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
1426673|NCT01056913|anastomotic stenosis|anastomotic stenosis
1426674|NCT01056900|articular cartilage defects|articular cartilage defects
1426675|NCT01056900|ACI|aci
1426676|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
1426677|NCT01056900|Knee joint|knee joint
1426678|NCT01056900|chondron|chondron
1426679|NCT01056887|diabetes insipidus|diabetes insipidus
1426680|NCT01056887|primary polydipsia|primary polydipsia
1426681|NCT01056887|copeptin|copeptin
1426682|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
1426683|NCT01056874|Maraviroc|maraviroc
1426684|NCT01056874|Digoxin|digoxin
1426685|NCT01056874|P-glycoprotein|p-glycoprotein
1426686|NCT01056874|Pharmacokinetics|pharmacokinetics
1426687|NCT01056874|Drug Interaction|drug interaction
1426688|NCT01056874|HIV|hiv
1426689|NCT01056861|cervical dystonia|cervical dystonia
1426690|NCT01056861|torticollis|torticollis
1426691|NCT01056861|Botulinum toxin|botulinum toxin
1426692|NCT01056861|magnetoencephalography|magnetoencephalography
1426693|NCT01056861|MEG|meg
1426694|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
1426695|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
1426696|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
1426697|NCT01056848|SIADH|siadh
1426698|NCT01056848|Serum Sodium|serum sodium
1426699|NCT01056809|Colorectal cancer|colorectal cancer
1426700|NCT01056809|Metastases|metastases
1426701|NCT01056809|Treatment strategies|treatment strategies
1426702|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
1426703|NCT01056796|compression anastomosis|compression anastomosis
1426704|NCT01056796|Colorectal cancer|colorectal cancer
1426705|NCT01056796|Low anterior resection|low anterior resection
1426706|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
1426707|NCT01056796|Radiotherapy|radiotherapy
1426708|NCT01056783|EoE|eoe
1426709|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
1426712|NCT01056757|eIF4E|eif4e
1426713|NCT01056744|coronary stent|coronary stent
1426714|NCT01056744|optical coherence tomography|optical coherence tomography
1426715|NCT01056744|drug-eluting|drug-eluting
1426716|NCT01056744|neointimal proliferation|neointimal proliferation
1426717|NCT01056731|high blood pressure|high blood pressure
1426718|NCT01056731|aliskiren|aliskiren
1426719|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
1426720|NCT01056731|control rate|control rate
1426721|NCT01056718|Diastolic Function|diastolic function
1426722|NCT01056718|Nebivolol|nebivolol
1426723|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
1426724|NCT01056705|Sabin Strains|sabin strains
1426725|NCT01056705|poliomyelitis|poliomyelitis
1426726|NCT01056692|Asthma|asthma
1426727|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
1426728|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
1426729|NCT01056653|father-child relations|father-child relations
1426730|NCT01056653|paternal behaviour|paternal behaviour
1426731|NCT01056653|early intervention|early intervention
1426732|NCT01056653|child-rearing|child-rearing
1426733|NCT01056640|telemonitoring|telemonitoring
1426734|NCT01056640|usual care|usual care
1426735|NCT01056640|elderly|elderly
1426736|NCT01056640|hospitalization|hospitalization
1426737|NCT01056640|Emergency room visits|emergency room visits
1426738|NCT01056601|insulinoma|insulinoma
1426739|NCT01056601|cancer of pancreas|cancer of pancreas
1426740|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
1426741|NCT01056601|alpha-cell tumor|alpha-cell tumor
1426742|NCT01056601|glucagonoma|glucagonoma
1426743|NCT01056601|beta-cell tumor|beta-cell tumor
1426744|NCT01056601|somatostatinoma|somatostatinoma
1426745|NCT01056588|adolescent smoking|adolescent smoking
1426746|NCT01056588|Contingency management|contingency management
1426747|NCT01056588|Quit smoking|quit smoking
1426748|NCT01056562|Prostate|prostate
1426750|NCT01056562|Urological Oncology|urological oncology
1426751|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
1426752|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
1426753|NCT01056549|Pancreatic clamp|pancreatic clamp
1426754|NCT01056549|GLP-1 agonist|glp-1 agonist
1426755|NCT01056536|Travel|travel
1426756|NCT01056536|casual sexual relationships|casual sexual relationships
1426757|NCT01056536|condoms|condoms
1426758|NCT01056536|Structured intervention|structured intervention
1426759|NCT01056523|AML|aml
1426760|NCT01056497|diabetes|diabetes
1426761|NCT01056497|alpha lipoic acid|alpha lipoic acid
1426762|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
1426763|NCT01056497|insulin secretion|insulin secretion
1426764|NCT01056497|insulin sensitivity|insulin sensitivity
1426765|NCT01056484|Alcohol Dependence|alcohol dependence
1426766|NCT01056484|Alcoholism|alcoholism
1426767|NCT01056484|Substance Use Disorders|substance use disorders
1426768|NCT01056484|Substance Abuse|substance abuse
1426769|NCT01056471|Multiple Sclerosis|multiple sclerosis
1427959|NCT01051726|Obstetrics|obstetrics
1426770|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
1426771|NCT01056471|Autologous|autologous
1426772|NCT01056458|acupressure|acupressure
1426773|NCT01056458|perimenopause|perimenopause
1426774|NCT01056458|menopause|menopause
1426775|NCT01056458|anxiety|anxiety
1426776|NCT01056458|life quality|life quality
1426777|NCT01056458|insomnia|insomnia
1426778|NCT01056445|Carotid artery stenting|carotid artery stenting
1426779|NCT01056445|Hemodynamic Instability|hemodynamic instability
1426780|NCT01056445|Valsalva Ratio|valsalva ratio
1426781|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
1426782|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
1426783|NCT01056419|Total thyroidectomy|total thyroidectomy
1426784|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
1426785|NCT01056419|Clinical activity score|clinical activity score
1426786|NCT01056406|Pregnancy|pregnancy
1426787|NCT01056406|Overweight|overweight
1426788|NCT01056406|Obese|obese
1426789|NCT01056406|Nutrition intervention|nutrition intervention
1426790|NCT01056393|HIV|hiv
1426791|NCT01056380|influenza|influenza
1426792|NCT01056380|influenza like illness|influenza like illness
1426793|NCT01056367|Resistant hypertension|resistant hypertension
1426794|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
1426795|NCT01056367|Arterial stiffness|arterial stiffness
1426796|NCT01056367|Ventricular function|ventricular function
1426797|NCT01056354|Influenza|influenza
1426798|NCT01056354|respiratory virus|respiratory virus
1426799|NCT01056354|pandemic|pandemic
1426800|NCT01056354|swine flu|swine flu
1426801|NCT01056354|infection|infection
1426802|NCT01056354|MERS-CoV|mers-cov
1426803|NCT01056354|SARS-CoV|sars-cov
1426804|NCT01056341|Infantile Hemangioma|infantile hemangioma
1426805|NCT01056341|Propranolol|propranolol
1426806|NCT01056315|Analgesia|analgesia
1426807|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
1426808|NCT01056315|Neuropathic pain|neuropathic pain
1426809|NCT01056315|Painful|painful
1426810|NCT01056315|Chronic pain|chronic pain
1426811|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
1426812|NCT01056302|visuohaptic|visuohaptic
1426813|NCT01056276|Multiple Myeloma|multiple myeloma
1426814|NCT01056276|Bendamustine|bendamustine
1426815|NCT01056276|Bortezomib|bortezomib
1426816|NCT01056276|Dexamethasone|dexamethasone
1426817|NCT01056263|retrospective trial|retrospective trial
1426818|NCT01056263|5-year survival|5-year survival
1426819|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
1426820|NCT01056250|cholelithiasis|cholelithiasis
1426821|NCT01056224|skull pin insertion|skull pin insertion
1426822|NCT01056224|remifentanil|remifentanil
1426823|NCT01056224|short acting opioid|short acting opioid
1426824|NCT01056224|craniotomy|craniotomy
1426825|NCT01056224|cervical spine surgery|cervical spine surgery
1426826|NCT01056224|hemodynamic changes|hemodynamic changes
1426827|NCT01056224|dose requirement|dose requirement
1426828|NCT01056224|age related|age related
1426829|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
1426830|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
1426831|NCT01056185|influenza|influenza
1426832|NCT01056185|flu|flu
1426833|NCT01056185|swine flu|swine flu
1426834|NCT01056185|respiratory virus|respiratory virus
1426835|NCT01056185|hospitalization|hospitalization
1426836|NCT01056185|MERS-CoV|mers-cov
1426837|NCT01056185|SARS-CoV|sars-cov
1426838|NCT01056172|Chronic hepatitis C|chronic hepatitis c
1426839|NCT01056172|Genotype 2|genotype 2
1426840|NCT01056172|Rapid virologic response|rapid virologic response
1426841|NCT01056172|Sustained virologic response|sustained virologic response
1426842|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
1426843|NCT01056172|Ribavirin|ribavirin
1426844|NCT01056159|asthma|asthma
1426845|NCT01056159|dry powder inhaler|dry powder inhaler
1426846|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
1426847|NCT01056159|SABA|saba
1426848|NCT01056159|bronchoconstriction|bronchoconstriction
1426849|NCT01056159|bronchodilation|bronchodilation
1426850|NCT01056159|bronchodilator|bronchodilator
1426851|NCT01056159|metered dose inhaler|metered dose inhaler
1426852|NCT01056146|TBI|tbi
1426853|NCT01056146|intracranial edema|intracranial edema
1426854|NCT01056146|brain edema|brain edema
1426855|NCT01056146|craniocerebral trauma|craniocerebral trauma
1426856|NCT01056146|head injury|head injury
1426857|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
1426858|NCT01056146|subdural hematoma|subdural hematoma
1426859|NCT01056146|brain concussion|brain concussion
1426860|NCT01056146|head injuries, closed|head injuries, closed
1426861|NCT01056146|epidural hematoma|epidural hematoma
1426862|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
1426863|NCT01056146|cortical contusion|cortical contusion
1426864|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
1426865|NCT01056146|Nervous System Diseases|nervous system diseases
1426866|NCT01056146|Wounds and Injuries|wounds and injuries
1426867|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
1426868|NCT01056146|Central Nervous System Diseases|central nervous system diseases
1426869|NCT01056146|Trauma, Nervous System|trauma, nervous system
1426870|NCT01056146|Brain Diseases|brain diseases
1426871|NCT01056146|Brain Injuries|brain injuries
1426872|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1426873|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1426874|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
1426875|NCT01056081|COPD|copd
1426876|NCT01056081|inspiratory muscles|inspiratory muscles
1426877|NCT01056081|diaphragm|diaphragm
1426878|NCT01056055|Ankle|ankle
1426879|NCT01056055|Chronic lateral instability|chronic lateral instability
1426880|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
1426881|NCT01056055|Suture anchor|suture anchor
1426882|NCT01056055|Bone tunnel|bone tunnel
1426883|NCT01056042|pelvic pain|pelvic pain
1426884|NCT01056042|postoperative|postoperative
1426885|NCT01056042|medical therapy|medical therapy
1426886|NCT01056029|Solid Tumors|solid tumors
1426887|NCT01056016|ADHD|adhd
1426888|NCT01056003|gastric inlet patch|gastric inlet patch
1426889|NCT01056003|prevalence|prevalence
1426890|NCT01056003|globus sensations|globus sensations
1426891|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
1426892|NCT01055990|blood fix treatment|blood fix treatment
1426893|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
1426894|NCT01055990|effectiveness|effectiveness
1426895|NCT01055990|immunogenicity|immunogenicity
1426896|NCT01055990|safety|safety
1426897|NCT01055977|statin therapy|statin therapy
1426898|NCT01055977|treatment goal|treatment goal
1426899|NCT01055977|dyslipidaemia|dyslipidaemia
1426900|NCT01055951|Insulin pumps|insulin pumps
1426901|NCT01055951|Diabetes|diabetes
1426902|NCT01055912|Congestive Heart Failure|congestive heart failure
1426903|NCT01055912|Volume Overload|volume overload
1426904|NCT01055899|RA|ra
1426905|NCT01055886|PTSD|ptsd
1426906|NCT01055886|smoking cessation|smoking cessation
1426907|NCT01055886|nicotine patch|nicotine patch
1426908|NCT01055873|immune status|immune status
1426909|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
1426910|NCT01055873|impact of viral replication|impact of viral replication
1426911|NCT01055860|uterine Prolapse|uterine prolapse
1426912|NCT01055860|vaginal prolapse|vaginal prolapse
1426913|NCT01055860|mesh erosion|mesh erosion
1426914|NCT01055860|urinary incontinence|urinary incontinence
1426915|NCT01055860|bowel symptoms|bowel symptoms
1426916|NCT01055847|cystic fibrosis|cystic fibrosis
1426918|NCT01055847|aztreonam|aztreonam
1426919|NCT01055847|lung infection|lung infection
1426920|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
1426921|NCT01055834|Insomnia|insomnia
1426922|NCT01055834|primary insomnia|primary insomnia
1426923|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
1426924|NCT01055821|Hepatitis C|hepatitis c
1426925|NCT01055821|Vaccine|vaccine
1426926|NCT01055821|HCVac|hcvac
1426927|NCT01055821|MVA-HCV|mva-hcv
1426928|NCT01055808|Insulin|insulin
1426929|NCT01055808|ITR-QOL|itr-qol
1426930|NCT01055808|DTSQ|dtsq
1426931|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1426932|NCT01055782|Colonoscopy|colonoscopy
1426933|NCT01055782|Endoguide|endoguide
1426934|NCT01055782|Pain perception|pain perception
1426935|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
1426936|NCT01055782|Patient's perception of pain|patient's perception of pain
1426937|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
1426938|NCT01055769|Bio-equivalence|bio-equivalence
1426939|NCT01055769|Linezolid OS|linezolid os
1426940|NCT01055769|Linezolid tablet|linezolid tablet
1426941|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
1426942|NCT01055756|Nasal Flow|nasal flow
1426943|NCT01055743|Fluorouracil Implants|fluorouracil implants
1426944|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
1426945|NCT01055743|Radical resection|radical resection
1426946|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
1426947|NCT01055730|Exercise therapy|exercise therapy
1426948|NCT01055730|Interstitial lung disease|interstitial lung disease
1426949|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
1426950|NCT01055730|Mobility limitation|mobility limitation
1426951|NCT01055730|Dyspnea|dyspnea
1426952|NCT01055730|Mental health|mental health
1426953|NCT01055717|avenanthramide|avenanthramide
1426954|NCT01055717|enriched|enriched
1426955|NCT01055717|oat|oat
1426956|NCT01055717|phytochemical|phytochemical
1426957|NCT01055717|bioavailability|bioavailability
1426958|NCT01055704|Methylnaltrexone|methylnaltrexone
1426959|NCT01055704|Codeine|codeine
1426960|NCT01055704|Gastrointestinal motility|gastrointestinal motility
1426961|NCT01055704|Colonic transit|colonic transit
1426962|NCT01055691|healthy volunteers|healthy volunteers
1426963|NCT01055691|bioequivalence|bioequivalence
1426964|NCT01055691|dapagliflozin|dapagliflozin
1426965|NCT01055691|metformin|metformin
1426966|NCT01055678|breast cancer|breast cancer
1426967|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1427960|NCT01051726|Labour|labour
1426968|NCT01055678|breast cancer in situ|breast cancer in situ
1426969|NCT01055678|invasive carcinoma|invasive carcinoma
1426970|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
1426971|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
1426972|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
1426973|NCT01055652|Japanese|japanese
1426974|NCT01055652|phase 1|phase 1
1426975|NCT01055652|safety|safety
1426976|NCT01055652|dapagliflozin|dapagliflozin
1426977|NCT01055652|Pharmacokinetics|pharmacokinetics
1426978|NCT01055652|Drug-drug Interaction|drug-drug interaction
1426979|NCT01055652|voglibose|voglibose
1426980|NCT01055639|Chronic Pain|chronic pain
1426981|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
1426982|NCT01055626|Body mass index|body mass index
1426983|NCT01055626|Body fat|body fat
1426984|NCT01055626|Obesity|obesity
1426985|NCT01055626|Overweight|overweight
1426986|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1426987|NCT01055626|Air displacement plethysmography|air displacement plethysmography
1426988|NCT01055600|eltrombopag|eltrombopag
1426989|NCT01055600|pharmacokinetics|pharmacokinetics
1426990|NCT01055600|PROMACTA|promacta
1426991|NCT01055600|lactation|lactation
1426992|NCT01055600|milk-only study|milk-only study
1426993|NCT01055587|major abdominal surgery|major abdominal surgery
1426994|NCT01055587|severe burn injury|severe burn injury
1426995|NCT01055587|infection|infection
1426996|NCT01055587|diagnostic|diagnostic
1426997|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
1426998|NCT01055574|total disc replacement|total disc replacement
1426999|NCT01055574|ProDisc L|prodisc l
1427000|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
1427001|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
1427002|NCT01055561|Acupuncture|acupuncture
1427003|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
1427004|NCT01055561|BPSD|bpsd
1427005|NCT01055561|MMSE|mmse
1427006|NCT01055561|BEHAVE-AD|behave-ad
1427007|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
1427008|NCT01055561|healthy volunteers|healthy volunteers
1427009|NCT01055548|Preterm|preterm
1427012|NCT01055548|Cerebral palsy|cerebral palsy
1427013|NCT01055548|Anxiety|anxiety
1427014|NCT01055548|Parents|parents
1427015|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
1427016|NCT01055522|, L19|, l19
1427017|NCT01055509|Social Adjustment|social adjustment
1427018|NCT01055509|Quality of life|quality of life
1427019|NCT01055509|Recurrence|recurrence
1427020|NCT01055509|Hospitalization|hospitalization
1427021|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1427022|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
1427023|NCT01055483|AML|aml
1427024|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
1427025|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
1427026|NCT01055431|iron|iron
1427027|NCT01055431|bioavailability|bioavailability
1427028|NCT01055431|status|status
1427029|NCT01055431|deficiency|deficiency
1427030|NCT01055431|anaemia|anaemia
1427031|NCT01055431|functional foods|functional foods
1427032|NCT01055431|child bearing|child bearing
1427033|NCT01055418|Vitamin C|vitamin c
1427034|NCT01055418|Cognitive performance|cognitive performance
1427035|NCT01055418|Cerebral blood flow|cerebral blood flow
1427036|NCT01055418|Trans cranial doppler|trans cranial doppler
1427037|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
1427038|NCT01055405|Exercise tolerance|exercise tolerance
1427039|NCT01055405|COPD|copd
1427040|NCT01055405|Pulmonary hypertension|pulmonary hypertension
1427041|NCT01055405|Sildenafil|sildenafil
1427042|NCT01055392|mild cognitive impairment|mild cognitive impairment
1427043|NCT01055392|Alzheimer's disease|alzheimer's disease
1427044|NCT01055392|Lithium|lithium
1427045|NCT01055392|disease-modification|disease-modification
1427046|NCT01055392|cognition|cognition
1427047|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
1427048|NCT01055379|Rasagiline|rasagiline
1427049|NCT01055379|Depressive Symptoms|depressive symptoms
1427050|NCT01055379|Cognition|cognition
1427051|NCT01055366|Open angle glaucoma|open angle glaucoma
1427052|NCT01055366|OAG|oag
1427053|NCT01055366|Elazop|elazop
1427054|NCT01055366|Azarga|azarga
1427055|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
1427056|NCT01055353|Target organs damage|target organs damage
1427057|NCT01055353|hypertensive patients|hypertensive patients
1427058|NCT01055340|Ketogenesis|ketogenesis
1427059|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
1427060|NCT01055340|Graded Glucose Infusion|graded glucose infusion
1427061|NCT01055340|Oxyntomodulin|oxyntomodulin
1427062|NCT01055327|Isolated oral clefts|isolated oral clefts
1427063|NCT01055327|lamotrigine|lamotrigine
1427064|NCT01055327|EUROCAT|eurocat
1427065|NCT01055327|congenital malformations|congenital malformations
1427066|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
1428547|NCT01049425|OncotypDX|oncotypdx
1427067|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
1427068|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
1427069|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
1427070|NCT01055275|iliac aneurysm|iliac aneurysm
1427071|NCT01055275|aortic aneurysm|aortic aneurysm
1427072|NCT01055275|endovascular grafts|endovascular grafts
1427073|NCT01055262|Safety|safety
1427074|NCT01055262|tolerability|tolerability
1427075|NCT01055262|heatwrap|heatwrap
1427076|NCT01055262|lower back|lower back
1427077|NCT01055262|healthy subjects|healthy subjects
1427078|NCT01055249|UVB|uvb
1427079|NCT01055249|pain|pain
1427080|NCT01055249|inflammation|inflammation
1427081|NCT01055249|model|model
1427082|NCT01055249|healthy volunteers|healthy volunteers
1427083|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
1427084|NCT01055236|sedation|sedation
1427085|NCT01055223|thiazolidinediones|thiazolidinediones
1427086|NCT01055223|rosiglitazone|rosiglitazone
1427087|NCT01055223|amiloride|amiloride
1427088|NCT01055223|pioglitazone|pioglitazone
1427089|NCT01055223|fracture|fracture
1427090|NCT01055223|Spironolactone|spironolactone
1427091|NCT01055210|Heart Failure|heart failure
1427092|NCT01055210|Pacemakers|pacemakers
1427093|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1427094|NCT01055184|Influenza|influenza
1427095|NCT01055184|H1N1|h1n1
1427096|NCT01055171|alcohol dependence|alcohol dependence
1427097|NCT01055171|PTSD|ptsd
1427098|NCT01055171|propanolol|propanolol
1427099|NCT01055171|craving|craving
1427100|NCT01055171|beta-block|beta-block
1427101|NCT01055171|cue exposure|cue exposure
1427102|NCT01055171|addiction|addiction
1427103|NCT01055171|memory|memory
1427104|NCT01055171|trauma|trauma
1427105|NCT01055171|addictive behavior|addictive behavior
1427106|NCT01055158|HIV|hiv
1427107|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
1427108|NCT01055106|bacterial vaginosis|bacterial vaginosis
1427109|NCT01055106|vaginal infection|vaginal infection
1427110|NCT01055106|vaginal discharge|vaginal discharge
1427111|NCT01055106|vaginal disease|vaginal disease
1427112|NCT01055093|diabetes mellitus|diabetes mellitus
1427113|NCT01055093|prospective observational study|prospective observational study
1427114|NCT01055093|diabetic complications|diabetic complications
1427115|NCT01055080|type 1 diabetes|type 1 diabetes
1427116|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
1427117|NCT01055080|cow's milk formula|cow's milk formula
1427118|NCT01055080|bovine insulin|bovine insulin
1427119|NCT01055054|bariatrics|bariatrics
1427120|NCT01055015|total knee arthroplasty|total knee arthroplasty
1427121|NCT01055002|Health male volunteers|health male volunteers
1427122|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
1427123|NCT01055002|Non-smokers and in good health|non-smokers and in good health
1427124|NCT01054989|Healthy adults|healthy adults
1427125|NCT01054989|Insulin sensitivity|insulin sensitivity
1427126|NCT01054976|Alzheimer's disease|alzheimer's disease
1427127|NCT01054976|Galantamine|galantamine
1427128|NCT01054976|Dementia|dementia
1427129|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
1427130|NCT01054963|chronic disease|chronic disease
1427131|NCT01054963|peer support|peer support
1427132|NCT01054963|peer mentor|peer mentor
1427133|NCT01054963|peer counselling|peer counselling
1427134|NCT01054937|4SC-203|4sc-203
1427135|NCT01054937|Phase I|phase i
1427136|NCT01054937|single dose|single dose
1427137|NCT01054937|healthy volunteers|healthy volunteers
1427138|NCT01054911|GIST|gist
1427139|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1427140|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
1427141|NCT01054911|Sunitinib|sunitinib
1427142|NCT01054898|depression|depression
1427143|NCT01054898|spouse abuse|spouse abuse
1427144|NCT01054898|intervention studies|intervention studies
1427145|NCT01054885|COPD|copd
1427146|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1427147|NCT01054885|Efficacy|efficacy
1427148|NCT01054885|FEV1|fev1
1427149|NCT01054885|Safety|safety
1427150|NCT01054872|HIV Seronegativity|hiv seronegativity
1427151|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
1427152|NCT01054846|Bicycle helmet|bicycle helmet
1427153|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
1427154|NCT01054820|acute back strain|acute back strain
1427155|NCT01054794|Gastroparesis|gastroparesis
1427156|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
1427157|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
1427158|NCT01054781|rituximab|rituximab
1427159|NCT01054781|CHOP|chop
1427160|NCT01054768|Antioxidant|antioxidant
1427161|NCT01054768|Inflammation|inflammation
1427162|NCT01054768|Sickle Cell Disease|sickle cell disease
1427163|NCT01054768|Oxidative Stress|oxidative stress
1427164|NCT01054768|Cytokines|cytokines
1427165|NCT01054768|anti-inflammatory|anti-inflammatory
1427166|NCT01054768|Acetylcarnitine|acetylcarnitine
1428548|NCT01049425|taxane|taxane
1427167|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
1427168|NCT01054729|HCV|hcv
1427169|NCT01054729|GT1|gt1
1427170|NCT01054729|GT 1|gt 1
1427171|NCT01054716|RhD negative|rhd negative
1427172|NCT01054716|RhD disease|rhd disease
1427173|NCT01054716|fetal nucleic acid|fetal nucleic acid
1427174|NCT01054716|fetal DNA|fetal dna
1427175|NCT01054716|cell free fetal DNA|cell free fetal dna
1427176|NCT01054716|Fetal RHD genotype|fetal rhd genotype
1427177|NCT01054690|Catheterization|catheterization
1427178|NCT01054690|Urinary Tract Infection|urinary tract infection
1427179|NCT01054690|Elective Surgery|elective surgery
1427180|NCT01054677|Infections in nursing homes|infections in nursing homes
1427181|NCT01054677|especially urinary tract infections|especially urinary tract infections
1427182|NCT01054664|liver enzymes|liver enzymes
1427183|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
1427184|NCT01054664|hemodialysis|hemodialysis
1427185|NCT01054664|hepatitis C|hepatitis c
1427186|NCT01054664|RNA|rna
1427187|NCT01054651|Schistosoma mansoni|schistosoma mansoni
1427188|NCT01054651|Praziquantel|praziquantel
1427189|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
1427190|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
1427191|NCT01054638|amprenavir|amprenavir
1427192|NCT01054638|fosamprenavir|fosamprenavir
1427193|NCT01054638|HIV|hiv
1427194|NCT01054638|HAART treatment|haart treatment
1427195|NCT01054638|Epzicom|epzicom
1427196|NCT01054638|Trizivir|trizivir
1427197|NCT01054638|Combivir|combivir
1427198|NCT01054638|zidovudine|zidovudine
1427199|NCT01054638|lamivudine|lamivudine
1427200|NCT01054638|cardiovascular disease|cardiovascular disease
1427201|NCT01054638|HIV Infections|hiv infections
1427202|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1427203|NCT01054625|Head and Neck Cancer|head and neck cancer
1427204|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
1427205|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
1427206|NCT01054625|Zalutumumab|zalutumumab
1427207|NCT01054612|Histology|histology
1427208|NCT01054612|Immunohistochemical|immunohistochemical
1427209|NCT01054612|Gene Expression|gene expression
1427210|NCT01054612|Tissue Sectioning|tissue sectioning
1427214|NCT01054599|localization related epilepsy|localization related epilepsy
1427215|NCT01054599|focal epilepsy|focal epilepsy
1427216|NCT01054586|antiretroviral therapy|antiretroviral therapy
1427217|NCT01054586|hepatic impairment|hepatic impairment
1427218|NCT01054586|HIV|hiv
1427219|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
1427220|NCT01054573|Telaprevir|telaprevir
1427221|NCT01054573|Roll-over study|roll-over study
1427222|NCT01054560|Ischemic Stroke|ischemic stroke
1427223|NCT01054560|SOLITAIRE™ Device|solitaire™ device
1427224|NCT01054560|SOLITAIRE™|solitaire™
1427225|NCT01054560|MERCI® Device|merci® device
1427226|NCT01054560|MERCI®|merci®
1427227|NCT01054560|Stroke|stroke
1427228|NCT01054560|Ischemic|ischemic
1427229|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
1427230|NCT01054560|Brain|brain
1427231|NCT01054560|Brain Clot|brain clot
1427232|NCT01054560|Brain Artery Revascularization|brain artery revascularization
1427233|NCT01054560|Recanalization|recanalization
1427234|NCT01054560|Brain Stroke|brain stroke
1427235|NCT01054560|Clot Retriever|clot retriever
1427236|NCT01054560|Device|device
1427237|NCT01054560|Neurosurgery|neurosurgery
1427238|NCT01054560|Neurovascular Intervention|neurovascular intervention
1427239|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
1427240|NCT01054560|Brain study|brain study
1427241|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
1427242|NCT01054547|topical anesthetic|topical anesthetic
1427243|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
1427244|NCT01054547|dentistry|dentistry
1427245|NCT01054534|urinary incontinence|urinary incontinence
1427246|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
1427247|NCT01054521|nasal obstruction|nasal obstruction
1427248|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
1427249|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
1427250|NCT01054521|chronic rhinitis.|chronic rhinitis.
1427251|NCT01054495|Acupuncture|acupuncture
1427252|NCT01054495|Sham acupuncture|sham acupuncture
1427253|NCT01054495|Laser|laser
1427254|NCT01054495|Methodology|methodology
1427255|NCT01054495|Control intervention|control intervention
1427256|NCT01054495|Pilot|pilot
1427257|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
1427258|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
1427259|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
1427260|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1427261|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
1427262|NCT01054469|nephrectomy|nephrectomy
1427263|NCT01054456|LEC|lec
1427264|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
1427265|NCT01054456|Nausea and Vomiting|nausea and vomiting
1427266|NCT01054456|Nausea|nausea
1427267|NCT01054456|Vomiting|vomiting
1427268|NCT01054456|Anti- emetic|anti- emetic
1427269|NCT01054443|Blood Platelet Disorders|blood platelet disorders
1427270|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
1427271|NCT01054443|Low Platelet Count|low platelet count
1427272|NCT01054443|Thrombocytopaenia|thrombocytopaenia
1427273|NCT01054443|S-888711|s-888711
1427274|NCT01054443|Splenectomy|splenectomy
1427275|NCT01054443|Thrombopoiesis|thrombopoiesis
1427276|NCT01054443|Hematologic Disease|hematologic disease
1427277|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
1427278|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
1427279|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1427280|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
1427281|NCT01054430|Avanafil|avanafil
1427282|NCT01054430|Hepatic|hepatic
1427283|NCT01054430|Erectile Dysfunction|erectile dysfunction
1427284|NCT01054430|Impairment|impairment
1427285|NCT01054417|Appendicitis|appendicitis
1427286|NCT01054417|Laparoscopy|laparoscopy
1427287|NCT01054417|Appendectomy|appendectomy
1427288|NCT01054404|Brain Swelling|brain swelling
1427289|NCT01054404|Brain Edema|brain edema
1427290|NCT01054404|Dehydration|dehydration
1427291|NCT01054352|Seasonal allergies|seasonal allergies
1427292|NCT01054352|Allergic rhinitis|allergic rhinitis
1427293|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1427294|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
1427295|NCT01054339|AAV|aav
1427296|NCT01054339|Gene therapy|gene therapy
1427297|NCT01054339|Human gene transfer|human gene transfer
1427298|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
1427299|NCT01054326|exercise|exercise
1427300|NCT01054326|physical therapy|physical therapy
1427301|NCT01054326|rotator cuff|rotator cuff
1427302|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
1427303|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
1427304|NCT01054313|Advanced Malignancies|advanced malignancies
1427305|NCT01054313|Taxotere|taxotere
1427306|NCT01054313|Docetaxel|docetaxel
1427307|NCT01054313|Rapamycin|rapamycin
1427308|NCT01054313|Sirolimus|sirolimus
1427309|NCT01054313|Rapamune|rapamune
1427311|NCT01054313|Resistant to standard therapy|resistant to standard therapy
1427312|NCT01054274|esophageal cancer|esophageal cancer
1427313|NCT01054274|dysphagia|dysphagia
1427314|NCT01054274|stent|stent
1427315|NCT01054274|brachytherapy|brachytherapy
1427316|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
1427317|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
1427318|NCT01054235|prenatal care|prenatal care
1427319|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
1427320|NCT01054235|perinatal mortality|perinatal mortality
1427321|NCT01054235|China|china
1427322|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
1427323|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
1427324|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
1427325|NCT01054209|Shivering|shivering
1427326|NCT01054209|Caesarean Section|caesarean section
1427327|NCT01054209|Elective|elective
1427328|NCT01054209|Warming Mattress|warming mattress
1427329|NCT01054209|Regional Anaesthesia|regional anaesthesia
1427330|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
1427331|NCT01054170|Chronic|chronic
1427332|NCT01054170|obstructive|obstructive
1427333|NCT01054170|pulmonary|pulmonary
1427334|NCT01054170|lung|lung
1427335|NCT01054170|respiratory disease|respiratory disease
1427336|NCT01054170|efficacy|efficacy
1427337|NCT01054170|placebo-controlled|placebo-controlled
1427338|NCT01054170|COPD|copd
1427339|NCT01054170|FEV1|fev1
1427340|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
1427341|NCT01054170|Computed Tomography|computed tomography
1427342|NCT01054170|MSCT|msct
1427343|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
1427344|NCT01054144|Senior Adults|senior adults
1427345|NCT01054131|peer support|peer support
1427346|NCT01054131|peer mentor|peer mentor
1427347|NCT01054131|self-management|self-management
1427348|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
1427349|NCT01054131|chronic disease|chronic disease
1427350|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1427351|NCT01054105|Pulmonary hypertension|pulmonary hypertension
1427353|NCT01054105|mutation|mutation
1427354|NCT01054105|drug therapy|drug therapy
1427355|NCT01054092|ASP1941|asp1941
1427356|NCT01054092|Diabetes mellitus|diabetes mellitus
1427357|NCT01054092|Blood glucose|blood glucose
1427358|NCT01054092|Food effect|food effect
1427359|NCT01054066|Chronic Kidney Disease|chronic kidney disease
1427360|NCT01054066|Cardiovascular Disease|cardiovascular disease
1427361|NCT01054066|Hypertension|hypertension
1427362|NCT01054066|Anemia|anemia
1427363|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
1427364|NCT01054053|Serum bactericidal activity|serum bactericidal activity
1427365|NCT01054053|Menbvac|menbvac
1427366|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
1427367|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
1427368|NCT01054027|Eye exams|eye exams
1427369|NCT01054027|Premature infants|premature infants
1427370|NCT01054027|cyclomydril|cyclomydril
1427371|NCT01054014|CR016795|cr016795
1427372|NCT01054001|prostate cancer|prostate cancer
1427373|NCT01054001|prostatectomy|prostatectomy
1427374|NCT01054001|erectile dysfunction|erectile dysfunction
1427375|NCT01053988|Safety|safety
1427376|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1427377|NCT01053988|Efficacy|efficacy
1427378|NCT01053988|FEV1|fev1
1427379|NCT01053988|COPD|copd
1427381|NCT01053975|SECG|secg
1427382|NCT01053975|SPECT|spect
1427383|NCT01053975|QCA|qca
1427384|NCT01053975|SCAD|scad
1427385|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
1427386|NCT01053962|Constipation|constipation
1427387|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
1427388|NCT01053949|Multiple myeloma|multiple myeloma
1427389|NCT01053949|dexamethasone|dexamethasone
1427390|NCT01053949|pomalidomide|pomalidomide
1427391|NCT01053949|response|response
1427392|NCT01053949|safety|safety
1427393|NCT01053936|Chronic Kidney Disease|chronic kidney disease
1427394|NCT01053936|Type 2 diabetes|type 2 diabetes
1427395|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
1427396|NCT01053923|Perianal Cancer|perianal cancer
1427397|NCT01053923|Anal Cancer|anal cancer
1427398|NCT01053923|MRI scan|mri scan
1427399|NCT01053897|GBT009|gbt009
1427400|NCT01053897|incisional scar|incisional scar
1427401|NCT01053897|breast reconstruction|breast reconstruction
1427402|NCT01053884|Invasive Candidiasis|invasive candidiasis
1427403|NCT01053884|invasive fungal disease|invasive fungal disease
1427404|NCT01053884|Anidulafungin|anidulafungin
1427405|NCT01053871|normal|normal
1427406|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
1427407|NCT01053845|Neuropathic pain|neuropathic pain
1427408|NCT01053832|ventricular pace suppression|ventricular pace suppression
1427410|NCT01053832|efficacy|efficacy
1427411|NCT01053832|safety|safety
1427412|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
1427413|NCT01053819|psoriasis|psoriasis
1427414|NCT01053819|melanoma|melanoma
1427415|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
1427416|NCT01053819|etanercept|etanercept
1427417|NCT01053819|Enbrel|enbrel
1427418|NCT01053806|MDS|mds
1427419|NCT01053806|Lenalidomide|lenalidomide
1427420|NCT01053806|5-Azacytidine.|5-azacytidine.
1427421|NCT01053806|ORR|orr
1427422|NCT01053806|PFS|pfs
1427423|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
1427424|NCT01053793|Glycemic index|glycemic index
1427425|NCT01053793|Anthocyanin|anthocyanin
1427426|NCT01053793|Potato|potato
1427427|NCT01053793|Polyphenol|polyphenol
1427428|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
1427429|NCT01053767|Group B streptococcus|group b streptococcus
1427430|NCT01053767|GBS|gbs
1427431|NCT01053767|Vaccine|vaccine
1427432|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
1427433|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
1427434|NCT01053715|Hemophilia|hemophilia
1427435|NCT01053715|Quality of Life|quality of life
1427436|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
1427437|NCT01053676|Hyperphosphatemia|hyperphosphatemia
1427438|NCT01053676|BE|be
1427439|NCT01053676|Granule|granule
1427440|NCT01053676|Healthy volunteers|healthy volunteers
1427441|NCT01053650|Healthy volunteers|healthy volunteers
1427442|NCT01053650|Open / hidden|open / hidden
1427443|NCT01053650|Placebo effect|placebo effect
1427444|NCT01053637|lacerations|lacerations
1427445|NCT01053637|sutures|sutures
1427446|NCT01053637|pediatrics|pediatrics
1427447|NCT01053637|child|child
1427448|NCT01053637|pain|pain
1427449|NCT01053637|Anxiety|anxiety
1427450|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
1427451|NCT01053624|postoperative complications|postoperative complications
1427452|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
1427453|NCT01053624|respiratory failure|respiratory failure
1427454|NCT01053611|composite variability index|composite variability index
1427455|NCT01053611|bispectral index|bispectral index
1427456|NCT01053611|pain|pain
1427457|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
1427458|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
1427459|NCT01053598|NRA|nra
1427460|NCT01053598|REMA|rema
1427461|NCT01053598|RETA|reta
1427462|NCT01053598|Rezazurine|rezazurine
1427463|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
1427464|NCT01053572|Chronic low back pain|chronic low back pain
1427465|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
1427466|NCT01053572|Lower extremity pain|lower extremity pain
1427467|NCT01053572|Local anesthetic|local anesthetic
1427468|NCT01053572|Steroid|steroid
1427469|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
1427470|NCT01053559|Crohn's|crohn's
1427471|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
1427472|NCT01053533|Chinese herbal medicines|chinese herbal medicines
1427473|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
1427474|NCT01053533|effectiveness|effectiveness
1427475|NCT01053533|safety|safety
1427476|NCT01053507|Headache|headache
1427477|NCT01053507|Post-traumatic headache|post-traumatic headache
1427478|NCT01053507|Brain injury|brain injury
1427479|NCT01053507|Cognitive impairment|cognitive impairment
1427480|NCT01053468|breast cancer|breast cancer
1427481|NCT01053468|physical activity|physical activity
1427482|NCT01053468|quality of life|quality of life
1427483|NCT01053468|theory of planned behavior|theory of planned behavior
1427484|NCT01053468|behavior change|behavior change
1427485|NCT01053468|health promotion|health promotion
1427486|NCT01053455|Non-invasive ventilation|non-invasive ventilation
1427487|NCT01053455|SiPAP|sipap
1427488|NCT01053455|CPAP|cpap
1427489|NCT01053455|low birth weight infants|low birth weight infants
1427490|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
1427491|NCT01053442|iron absorption|iron absorption
1427492|NCT01053442|stable isotopes|stable isotopes
1427493|NCT01053442|NaFeEDTA|nafeedta
1427494|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
1427495|NCT01053442|Hepcidin|hepcidin
1427496|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
1427497|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
1427498|NCT01053429|ziprasidone|ziprasidone
1427499|NCT01053416|glaucoma|glaucoma
1427500|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
1427501|NCT01053416|laser iridotomy|laser iridotomy
1427502|NCT01053403|MDMA|mdma
1427503|NCT01053403|Ecstasy|ecstasy
1427504|NCT01053403|MDMA effect on sleep|mdma effect on sleep
1427505|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
1427506|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
1427507|NCT01053403|Recreational Drug Use|recreational drug use
1427508|NCT01053403|Drug Abuse|drug abuse
1427509|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
1427510|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
1427511|NCT01053377|Influenza|influenza
1427512|NCT01053377|Tamiflu|tamiflu
1427513|NCT01053377|Osteltamivir|osteltamivir
1427514|NCT01053377|Transmission|transmission
1427515|NCT01053377|Prevention|prevention
1427516|NCT01053377|Resistance|resistance
1427517|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
1427518|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
1427519|NCT01053325|Malaria|malaria
1427520|NCT01053325|Pregnancy|pregnancy
1427521|NCT01053325|Prevention|prevention
1427522|NCT01053325|HIV|hiv
1427523|NCT01053325|Sub-Sahara Africa|sub-sahara africa
1427524|NCT01053312|Amyloid|amyloid
1427525|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
1427526|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
1427527|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
1427528|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
1427529|NCT01053299|newborn|newborn
1427530|NCT01053299|universal screening|universal screening
1427531|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
1427532|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
1427533|NCT01053286|Dysphagia|dysphagia
1427534|NCT01053286|Globus|globus
1427535|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
1427536|NCT01053273|Low back pain|low back pain
1427537|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
1427538|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
1427539|NCT01053273|Local anesthetic steroid|local anesthetic steroid
1427540|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
1427541|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
1427542|NCT01053273|Caudal epidural injection|caudal epidural injection
1427543|NCT01053260|Contingency Management|contingency management
1427544|NCT01053260|Weight Loss|weight loss
1427545|NCT01053247|Atopic Dermatitis|atopic dermatitis
1427546|NCT01053234|Hyperglycaemia|hyperglycaemia
1427547|NCT01053234|Postprandial|postprandial
1427548|NCT01053234|Type 2 diabetes|type 2 diabetes
1427549|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
1427550|NCT01053221|mycophenolate|mycophenolate
1427551|NCT01053221|living donor|living donor
1427552|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
1427553|NCT01053195|Diabetes|diabetes
1427554|NCT01053195|prevention|prevention
1427555|NCT01053195|intervention|intervention
1427556|NCT01053182|esophageal cancer|esophageal cancer
1427557|NCT01053182|postoperative complications|postoperative complications
1427558|NCT01053182|diaphragm|diaphragm
1427559|NCT01053182|pulmonary function|pulmonary function
1427560|NCT01053169|Coagulopathy|coagulopathy
1427561|NCT01053169|Perioperative bleeding|perioperative bleeding
1427562|NCT01053169|Prothrombin complex|prothrombin complex
1427563|NCT01053169|Liver disease|liver disease
1427564|NCT01053156|Fragile X syndrome|fragile x syndrome
1427565|NCT01053156|minocycline|minocycline
1427566|NCT01053156|targeted treatment|targeted treatment
1427567|NCT01053143|Influenza|influenza
1427568|NCT01053143|Pandemic Influenza|pandemic influenza
1427569|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
1427570|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
1427571|NCT01053143|Adults|adults
1427572|NCT01053130|obesity|obesity
1427573|NCT01053130|bariatric surgery|bariatric surgery
1427574|NCT01053130|chronic kidney disease|chronic kidney disease
1427575|NCT01053130|weight loss|weight loss
1427576|NCT01053130|exercise|exercise
1427577|NCT01053117|central venous catheter|central venous catheter
1427578|NCT01053117|arteriovenous fistula|arteriovenous fistula
1427579|NCT01053117|hemodialysis|hemodialysis
1427580|NCT01053117|vascular access|vascular access
1427581|NCT01053117|dialysis|dialysis
1427582|NCT01053104|Colorectal cancer|colorectal cancer
1427583|NCT01053104|Breast cancer|breast cancer
1427584|NCT01053104|Capecitabine|capecitabine
1427585|NCT01053104|Docetaxel|docetaxel
1427586|NCT01053104|Mobile phone|mobile phone
1427587|NCT01053104|Toxicity|toxicity
1427588|NCT01053104|Metastatic|metastatic
1427589|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
1427590|NCT01053091|diastolic heart failure|diastolic heart failure
1427591|NCT01053091|cardiovascular function|cardiovascular function
1427592|NCT01053091|aerobic fitness|aerobic fitness
1427593|NCT01053078|Type 1 diabetes|type 1 diabetes
1427594|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
1427595|NCT01053078|low blood sugar|low blood sugar
1427596|NCT01053065|Atherosclerosis|atherosclerosis
1427597|NCT01053065|Macrophages|macrophages
1427598|NCT01053065|Carotid arteries|carotid arteries
1427599|NCT01053065|Statin|statin
1427600|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
1427601|NCT01053052|Hysterosalpingography|hysterosalpingography
1428095|NCT01051193|child|child
1427602|NCT01053052|Sonography, Medical|sonography, medical
1427603|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
1427604|NCT01053013|macrobead|macrobead
1427605|NCT01053013|biological|biological
1427606|NCT01053013|mouse cells|mouse cells
1427607|NCT01053000|ACTINIC KERATOSES|actinic keratoses
1427608|NCT01053000|HAND|hand
1427609|NCT01053000|FOREARM|forearm
1427610|NCT01052987|Gout|gout
1427611|NCT01052987|Hyperuricemia|hyperuricemia
1427612|NCT01052974|femoral neck fracture|femoral neck fracture
1427613|NCT01052974|analgesia|analgesia
1427614|NCT01052961|severe influenza|severe influenza
1427615|NCT01052961|hospitalized adults|hospitalized adults
1427616|NCT01052961|oseltamivir treatment|oseltamivir treatment
1427617|NCT01052948|dopamine agonists|dopamine agonists
1427618|NCT01052948|cabergoline|cabergoline
1427619|NCT01052948|Parkinson's disease|parkinson's disease
1427620|NCT01052948|hyperprolactinemia|hyperprolactinemia
1427621|NCT01052948|epidemiology|epidemiology
1427622|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
1427623|NCT01052935|Group B streptococcus|group b streptococcus
1427624|NCT01052935|GBS|gbs
1427625|NCT01052935|Vaccine|vaccine
1427626|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
1427627|NCT01052922|Mass Screening|mass screening
1427628|NCT01052922|Population Surveillance|population surveillance
1427629|NCT01052922|Randomized controlled trial|randomized controlled trial
1427630|NCT01052922|Occult Blood|occult blood
1427631|NCT01052922|Colonoscopy|colonoscopy
1427632|NCT01052922|Sigmoidoscopy|sigmoidoscopy
1427633|NCT01052922|Health Behavior|health behavior
1427634|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
1427635|NCT01052896|Dyspepsia|dyspepsia
1427636|NCT01052896|Functional|functional
1427637|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
1427638|NCT01052883|TMC114-C182|tmc114-c182
1427639|NCT01052883|TMC114|tmc114
1427640|NCT01052883|HIV|hiv
1427641|NCT01052883|HIV Infections|hiv infections
1427642|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
1427643|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
1427644|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
1427645|NCT01052857|Induction|induction
1427646|NCT01052857|treatment|treatment
1427647|NCT01052857|posterm|posterm
1427648|NCT01052844|Vomiting|vomiting
1427649|NCT01052844|Antiemetics|antiemetics
1427650|NCT01052844|Dexamethasone|dexamethasone
1427651|NCT01052844|Cisplatin|cisplatin
1427652|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
1427653|NCT01052831|Compulsive Gambling|compulsive gambling
1427654|NCT01052831|Compulsive Buying|compulsive buying
1427655|NCT01052831|Compulsive Shopping|compulsive shopping
1427656|NCT01052831|Compulsive Eating|compulsive eating
1427657|NCT01052831|Hypersexuality|hypersexuality
1427658|NCT01052831|Dopamine Agonists|dopamine agonists
1427659|NCT01052831|Mirapex|mirapex
1427660|NCT01052831|Pramipexole|pramipexole
1427661|NCT01052831|Requip|requip
1427662|NCT01052831|Ropinirole|ropinirole
1427663|NCT01052831|Impulse Control Disorders|impulse control disorders
1427664|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
1427665|NCT01052818|Circulating tumor cells|circulating tumor cells
1427666|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
1427667|NCT01052818|Cytokeratin|cytokeratin
1427668|NCT01052805|nerve|nerve
1427669|NCT01052805|myelinated nerve|myelinated nerve
1427670|NCT01052805|unmyelinated nerve|unmyelinated nerve
1427671|NCT01052792|Bioequivalence|bioequivalence
1427672|NCT01052792|Naproxen|naproxen
1427673|NCT01052792|crossover|crossover
1427674|NCT01052779|Iron deficiency anemia|iron deficiency anemia
1427675|NCT01052779|Chronic kidney disease|chronic kidney disease
1427676|NCT01052779|Feraheme|feraheme
1427677|NCT01052779|Ferumoxytol|ferumoxytol
1427678|NCT01052779|Iron sucrose|iron sucrose
1427679|NCT01052779|IDA|ida
1427680|NCT01052779|CKD|ckd
1427681|NCT01052779|Venofer|venofer
1427682|NCT01052766|lung cancer|lung cancer
1427683|NCT01052766|PET Scan|pet scan
1427684|NCT01052766|CT Scan|ct scan
1427685|NCT01052766|BH-PET scan|bh-pet scan
1427686|NCT01052766|09-134|09-134
1427687|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1427688|NCT01052753|executive function|executive function
1427689|NCT01052753|endophenotype|endophenotype
1427690|NCT01052753|dopaminergic system|dopaminergic system
1427691|NCT01052753|noradrenergic system|noradrenergic system
1427692|NCT01052753|candidate gene|candidate gene
1427693|NCT01052753|Family-based association study|family-based association study
1427694|NCT01052740|Breast Cancer|breast cancer
1427695|NCT01052740|Mammography|mammography
1427696|NCT01052740|Screening|screening
1427697|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1427698|NCT01052727|quality of life|quality of life
1427699|NCT01052714|Antipsychotic|antipsychotic
1427700|NCT01052714|Bipolar|bipolar
1427701|NCT01052714|Diabetes|diabetes
1427702|NCT01052714|Mental Illness|mental illness
1427703|NCT01052714|Nutrition|nutrition
1427704|NCT01052714|Obesity|obesity
1427705|NCT01052714|Schizoaffective|schizoaffective
1427706|NCT01052714|Schizophrenia|schizophrenia
1427707|NCT01052714|Weight Gain|weight gain
1427708|NCT01052714|Weight Loss|weight loss
1427709|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
1427710|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
1427711|NCT01052662|Drug Abuse|drug abuse
1427712|NCT01052649|MNC subpopulations|mnc subpopulations
1427713|NCT01052649|Gene Expression|gene expression
1427714|NCT01052649|Metabolomics|metabolomics
1427715|NCT01052649|Immunological Status|immunological status
1427716|NCT01052636|Hip fracture|hip fracture
1427717|NCT01052636|Intervention program|intervention program
1427718|NCT01052636|Elderly|elderly
1427719|NCT01052623|GH/IGF-1|gh/igf-1
1427720|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
1427721|NCT01052623|IGF-1 Generation Test|igf-1 generation test
1427722|NCT01052623|Growth hormone|growth hormone
1427723|NCT01052610|SLIT|slit
1427724|NCT01052610|bronchial asthma|bronchial asthma
1427725|NCT01052610|allergic rhinitis|allergic rhinitis
1427726|NCT01052597|Type 2 diabetes|type 2 diabetes
1427727|NCT01052597|Metabolic syndrome|metabolic syndrome
1427728|NCT01052597|cardiovascular risk|cardiovascular risk
1427729|NCT01052584|malaria|malaria
1427730|NCT01052584|therapeutic efficacy|therapeutic efficacy
1427731|NCT01052584|in vivo|in vivo
1427732|NCT01052584|artemether lumefantrine|artemether lumefantrine
1427733|NCT01052584|coartem|coartem
1427734|NCT01052584|chloroquine|chloroquine
1427735|NCT01052584|Plasmodium falciparum|plasmodium falciparum
1427736|NCT01052584|Plasmodium vivax|plasmodium vivax
1427737|NCT01052571|Chronic low back pain|chronic low back pain
1427738|NCT01052571|Lumbar disc herniation|lumbar disc herniation
1427739|NCT01052571|Lower extremity pain|lower extremity pain
1427740|NCT01052571|Lumbar radiculitis|lumbar radiculitis
1427741|NCT01052571|Local anesthetic|local anesthetic
1427742|NCT01052571|Steroid|steroid
1427743|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
1427744|NCT01052558|Open angle|open angle
1427745|NCT01052558|Glaucoma|glaucoma
1427746|NCT01052558|Cataract|cataract
1427747|NCT01052558|Surgery|surgery
1427748|NCT01052558|Intraocular Pressure|intraocular pressure
1427749|NCT01052545|urinary tract infection|urinary tract infection
1427750|NCT01052545|urinary catheter|urinary catheter
1427751|NCT01052545|bacteriuria|bacteriuria
1427752|NCT01052545|clinical guidelines|clinical guidelines
1427753|NCT01052545|audit-feedback|audit-feedback
1427754|NCT01052545|guidelines implementation|guidelines implementation
1427755|NCT01052532|Mitral Regurgitation|mitral regurgitation
1428651|NCT01049061|Cancer|cancer
1427756|NCT01052532|LV remodeling|lv remodeling
1427757|NCT01052532|Reactive nitrogen species|reactive nitrogen species
1427758|NCT01052532|Cardiac MRI|cardiac mri
1427759|NCT01052532|Adrenergic overdrive|adrenergic overdrive
1427760|NCT01052519|Obesity|obesity
1427761|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
1427762|NCT01052519|tissue oxygen tension|tissue oxygen tension
1427763|NCT01052506|Human volunteers|human volunteers
1427764|NCT01052493|obesity|obesity
1427765|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
1427766|NCT01052493|gut hormones|gut hormones
1427767|NCT01052480|Antiviral|antiviral
1427768|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
1427769|NCT01052480|Emerging Infectious Disease|emerging infectious disease
1427770|NCT01052480|Swine Flu|swine flu
1427771|NCT01052454|hot flashes|hot flashes
1427772|NCT01052454|mindfulness|mindfulness
1427773|NCT01052454|stress|stress
1427774|NCT01052441|CCTA|ccta
1427775|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
1427776|NCT01052441|Iodinated Contrast|iodinated contrast
1427777|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
1427778|NCT01052428|Chronic MR|chronic mr
1427779|NCT01052428|Volume Overload|volume overload
1427780|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
1427781|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
1427782|NCT01052428|LV systolic function|lv systolic function
1427783|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
1427784|NCT01052428|Cardiac MRI|cardiac mri
1427786|NCT01052415|Stigma|stigma
1427787|NCT01052415|POL|pol
1427788|NCT01052415|Service providers|service providers
1427789|NCT01052415|China|china
1427790|NCT01052415|Universal precaution|universal precaution
1427791|NCT01052389|Schizophrenia|schizophrenia
1427792|NCT01052389|Pragmatic RCT|pragmatic rct
1427793|NCT01052389|Aripiprazole|aripiprazole
1427794|NCT01052389|Olanzapine|olanzapine
1427795|NCT01052389|Haloperidol|haloperidol
1427796|NCT01052389|Metabolic syndrome|metabolic syndrome
1427797|NCT01052389|Drug discontinuation|drug discontinuation
1427798|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
1427799|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
1427800|NCT01052363|CNS tumors|cns tumors
1427801|NCT01052350|Parkinson disease|parkinson disease
1427802|NCT01052350|PET imaging|pet imaging
1427803|NCT01052350|PIB|pib
1427804|NCT01052350|dementia|dementia
1427805|NCT01052311|Coronary artery disease|coronary artery disease
1427806|NCT01052311|Endothelial function|endothelial function
1427807|NCT01052311|Platelet function|platelet function
1427808|NCT01052311|Statins|statins
1427809|NCT01052311|Niacin|niacin
1427810|NCT01052298|Ciprofloxacin|ciprofloxacin
1427811|NCT01052298|Inhalation|inhalation
1427812|NCT01052298|Pharmacokinetics|pharmacokinetics
1427813|NCT01052298|Safety|safety
1427814|NCT01052298|Tolerability|tolerability
1427815|NCT01052298|COPD|copd
1427816|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
1427817|NCT01052272|Diabetes|diabetes
1427818|NCT01052272|Acute MI|acute mi
1427819|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
1427820|NCT01052272|LV remodeling|lv remodeling
1427821|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
1427822|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
1427823|NCT01052272|Systolic dysfunction|systolic dysfunction
1427824|NCT01052272|Diastolic dysfunction|diastolic dysfunction
1427825|NCT01052272|LV dimensions|lv dimensions
1427826|NCT01052272|Cardiac MRI|cardiac mri
1427827|NCT01052259|Chronic rejection|chronic rejection
1427828|NCT01052259|Kidney|kidney
1427829|NCT01052259|Transplantation|transplantation
1427830|NCT01052259|Immunosuppressive|immunosuppressive
1427831|NCT01052246|acne vulgaris|acne vulgaris
1427832|NCT01052246|laser surgery|laser surgery
1427833|NCT01052246|pulsed dye lasers|pulsed dye lasers
1427834|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
1427835|NCT01052246|clindamycin|clindamycin
1427836|NCT01052246|randomized controlled trial|randomized controlled trial
1427837|NCT01052233|Sham-surgery|sham-surgery
1427838|NCT01052233|Development of osteoarthritis|development of osteoarthritis
1427839|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
1427840|NCT01052220|Hypertension|hypertension
1427841|NCT01052220|Blood Pressure|blood pressure
1427842|NCT01052220|End Stage Renal Disease|end stage renal disease
1427843|NCT01052220|Hemodialysis|hemodialysis
1427844|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
1427845|NCT01052220|Self-Regulation|self-regulation
1427846|NCT01052207|Biological Response Modifiers|biological response modifiers
1427847|NCT01052207|Endocrinology|endocrinology
1427848|NCT01052207|Hormone Dysfunction|hormone dysfunction
1427849|NCT01052207|Hormones|hormones
1427850|NCT01052207|Neuroendocrinology|neuroendocrinology
1427851|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
1427852|NCT01052181|Vitamin D|vitamin d
1427853|NCT01052181|Insulin sensitivity|insulin sensitivity
1427854|NCT01052181|Centrally obese|centrally obese
1427855|NCT01052168|simulation|simulation
1427856|NCT01052168|simulators|simulators
1427857|NCT01052168|motion metrics|motion metrics
1427858|NCT01052168|performance metrics|performance metrics
1427859|NCT01052168|skills training|skills training
1427860|NCT01052168|proficiency|proficiency
1427861|NCT01052168|laparoscopic|laparoscopic
1427862|NCT01052155|Controlled substances|controlled substances
1427863|NCT01052155|Opioids|opioids
1427864|NCT01052155|Benzodiazepines|benzodiazepines
1427865|NCT01052155|Illicit drugs|illicit drugs
1427866|NCT01052155|Immunoassay drug testing|immunoassay drug testing
1427867|NCT01052155|Point of care (POC) testing|point of care (poc) testing
1427868|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
1427869|NCT01052142|Melanoma|melanoma
1427870|NCT01052142|Cancer vaccines|cancer vaccines
1427871|NCT01052129|Bioequivalence|bioequivalence
1427872|NCT01052129|Naproxen|naproxen
1427873|NCT01052129|crossover|crossover
1427874|NCT01052116|Asthma|asthma
1427875|NCT01052116|Soy|soy
1427876|NCT01052116|Supplement|supplement
1427877|NCT01052116|ACRC|acrc
1427878|NCT01052116|SOYA|soya
1427879|NCT01052090|HCV|hcv
1427880|NCT01052077|OPC-34712|opc-34712
1427881|NCT01052077|Major Depressive Disorder|major depressive disorder
1427882|NCT01052077|Adjunctive Treatment|adjunctive treatment
1427883|NCT01052064|Children|children
1427884|NCT01052064|ADHD|adhd
1427885|NCT01052064|rTMS|rtms
1427886|NCT01052064|Safety|safety
1427887|NCT01052038|Sore throat|sore throat
1427888|NCT01052038|Dexamethasone|dexamethasone
1427889|NCT01052038|Pain|pain
1427890|NCT01052012|Postoperative pain|postoperative pain
1427891|NCT01052012|Post-operative pain|post-operative pain
1427892|NCT01052012|Opioid|opioid
1427893|NCT01052012|Laparoscopic surgery|laparoscopic surgery
1427894|NCT01052012|Bupivacaine|bupivacaine
1427895|NCT01052012|Local anesthetic|local anesthetic
1427896|NCT01051999|Glutamine|glutamine
1427897|NCT01051986|coronary artery bypass|coronary artery bypass
1427898|NCT01051986|off-pump surgery|off-pump surgery
1427899|NCT01051986|composite graft|composite graft
1427900|NCT01051986|saphenous vein|saphenous vein
1427901|NCT01051986|internal thoracic artery|internal thoracic artery
1427902|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
1427903|NCT01051973|exposure|exposure
1427904|NCT01051973|stress management|stress management
1427905|NCT01051960|Systemic Sclerosis|systemic sclerosis
1427906|NCT01051960|connective tissue disease|connective tissue disease
1427907|NCT01051960|Shortness of breath|shortness of breath
1427908|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
1427909|NCT01051947|Nebivolol|nebivolol
1427910|NCT01051947|Metoprolol|metoprolol
1427911|NCT01051947|central aortic pressure|central aortic pressure
1427912|NCT01051947|hypertension|hypertension
1427913|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
1427914|NCT01051934|Monoclonal Antibody|monoclonal antibody
1427915|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
1427916|NCT01051934|Targeted Therapy|targeted therapy
1427917|NCT01051934|Lung Cancer|lung cancer
1427918|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
1427919|NCT01051921|HCV|hcv
1427920|NCT01051921|Null Responder|null responder
1427921|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
1427922|NCT01051895|Colposcopy|colposcopy
1427923|NCT01051895|HPV DNA testing|hpv dna testing
1427924|NCT01051895|treatment failure|treatment failure
1427925|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
1427926|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1427927|NCT01051882|Neuroprotection|neuroprotection
1427928|NCT01051882|Neurodegeneration|neurodegeneration
1427929|NCT01051882|Stem cells|stem cells
1427930|NCT01051882|ALS|als
1427931|NCT01051869|distal humerus|distal humerus
1427932|NCT01051869|fractures|fractures
1427933|NCT01051869|ulnar nerve|ulnar nerve
1427934|NCT01051869|simple decompression|simple decompression
1427935|NCT01051869|anterior transposition|anterior transposition
1427936|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
1427937|NCT01051843|Orofacial Difficulties|orofacial difficulties
1427938|NCT01051843|Rooming-in|rooming-in
1427939|NCT01051843|Speech and Language Therapy|speech and language therapy
1427940|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1427941|NCT01051817|RRMS|rrms
1427942|NCT01051804|Dry eye|dry eye
1427943|NCT01051804|Visual Performance|visual performance
1427944|NCT01051791|RAD001|rad001
1427945|NCT01051791|Everolimus|everolimus
1427946|NCT01051778|Recurrent abortion|recurrent abortion
1427947|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
1427948|NCT01051778|unfractionated heparin|unfractionated heparin
1427949|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
1427950|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
1427951|NCT01051752|pharmacokinetics|pharmacokinetics
1427952|NCT01051752|pharmacodynamics|pharmacodynamics
1427953|NCT01051739|vision testing|vision testing
1427954|NCT01051739|perimetry|perimetry
1427955|NCT01051739|glaucoma|glaucoma
1427956|NCT01051739|test variability|test variability
1427957|NCT01051726|aromatherapy|aromatherapy
1427958|NCT01051726|childbirth|childbirth
1427961|NCT01051726|Complementary Medicine|complementary medicine
1427962|NCT01051726|delivery, obstetric|delivery, obstetric
1427963|NCT01051713|obesity|obesity
1427964|NCT01051713|behavioraladherence|behavioraladherence
1427965|NCT01051713|weight loss|weight loss
1427966|NCT01051713|smartphone|smartphone
1427967|NCT01051700|repeat-dose|repeat-dose
1427968|NCT01051700|pharmacokinetics|pharmacokinetics
1427969|NCT01051700|choroidal neovascularization|choroidal neovascularization
1427970|NCT01051700|safety|safety
1427971|NCT01051700|GW786034|gw786034
1427972|NCT01051700|tolerability|tolerability
1427973|NCT01051700|age-related macular degeneration|age-related macular degeneration
1427974|NCT01051700|stem cell growth factor|stem cell growth factor
1427975|NCT01051700|pazopanib|pazopanib
1427976|NCT01051700|platelet derived growth factor|platelet derived growth factor
1427977|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
1427978|NCT01051687|vitiligo|vitiligo
1427979|NCT01051674|Obesity|obesity
1427980|NCT01051674|Type 2 diabetes|type 2 diabetes
1427981|NCT01051674|Fiber|fiber
1427982|NCT01051674|Dietary fiber|dietary fiber
1427983|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
1427984|NCT01051674|High protein diet|high protein diet
1427985|NCT01051661|Influenza|influenza
1427986|NCT01051661|H1N1|h1n1
1427987|NCT01051661|Pandemic|pandemic
1427988|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
1427989|NCT01051648|anterior vitrectomy|anterior vitrectomy
1427990|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
1427991|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
1427992|NCT01051635|DNA Repair|dna repair
1427993|NCT01051635|DNA Damage|dna damage
1427994|NCT01051635|Advanced Cancer|advanced cancer
1427995|NCT01051635|Advanced Malignancies|advanced malignancies
1427996|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
1427997|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
1427998|NCT01051622|Crohn's Disease|crohn's disease
1427999|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
1428000|NCT01051609|Post Menopausal|post menopausal
1428001|NCT01051609|Breast Cancer|breast cancer
1428002|NCT01051596|metastatic|metastatic
1428003|NCT01051596|colorectal cancer|colorectal cancer
1428004|NCT01051583|Neovascular glaucoma|neovascular glaucoma
1428005|NCT01051583|diode laser|diode laser
1428006|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
1428007|NCT01051583|Avastin|avastin
1428008|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1428009|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
1428010|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
1428011|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1428012|NCT01051544|ITI|iti
1428013|NCT01051544|HAEMOPHILIA A|haemophilia a
1428014|NCT01051544|INHIBITORS|inhibitors
1428015|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
1428016|NCT01051531|Schizophrenia|schizophrenia
1428017|NCT01051531|R092670|r092670
1428018|NCT01051531|Paliperidone palmitate|paliperidone palmitate
1428019|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
1428020|NCT01051531|Intramuscular injection|intramuscular injection
1428021|NCT01051505|Phase I|phase i
1428022|NCT01051505|multiple ascending dose|multiple ascending dose
1428023|NCT01051505|Safety|safety
1428024|NCT01051505|Tolerability|tolerability
1428025|NCT01051505|Healthy Volunteer|healthy volunteer
1428026|NCT01051479|PET Positron emission tomography|pet positron emission tomography
1428027|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
1428028|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
1428029|NCT01051440|lisdexamfetamine|lisdexamfetamine
1428030|NCT01051440|vyvanse|vyvanse
1428031|NCT01051440|bipolar disorder|bipolar disorder
1428032|NCT01051440|depression|depression
1428033|NCT01051440|stimulant|stimulant
1428034|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1428035|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
1428036|NCT01051440|neuropsychological testing|neuropsychological testing
1428037|NCT01051427|Nasal packing|nasal packing
1428038|NCT01051427|Haemostatic matrix|haemostatic matrix
1428039|NCT01051427|Epistaxis control|epistaxis control
1428040|NCT01051388|The efficacy of PPI|the efficacy of ppi
1428041|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
1428042|NCT01051375|anorexia nervosa|anorexia nervosa
1428043|NCT01051375|bulimia nervosa|bulimia nervosa
1428044|NCT01051375|EDNOS|ednos
1428045|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
1428046|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1428047|NCT01051362|Carboplatin|carboplatin
1428048|NCT01051362|Chemotherapy|chemotherapy
1428049|NCT01051349|MS|ms
1428050|NCT01051349|Multiple Sclerosis|multiple sclerosis
1428051|NCT01051336|TARIS Placebo|taris placebo
1428052|NCT01051336|Bladder|bladder
1428053|NCT01051336|Interstitial Cystitis|interstitial cystitis
1428652|NCT01049061|FRα|frα
1428054|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
1428055|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
1428056|NCT01051297|venous thrombosis|venous thrombosis
1428057|NCT01051297|pulmonary embolism|pulmonary embolism
1428058|NCT01051297|venous thromboembolism|venous thromboembolism
1428059|NCT01051284|Pancreas|pancreas
1428060|NCT01051284|Newly diagnosed|newly diagnosed
1428061|NCT01051284|Cyberknife|cyberknife
1428062|NCT01051284|Gemcitabine|gemcitabine
1428063|NCT01051271|metoclopramide|metoclopramide
1428064|NCT01051271|akathisia|akathisia
1428065|NCT01051271|midazolam|midazolam
1428066|NCT01051271|diphenhydramine|diphenhydramine
1428067|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
1428068|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
1428069|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
1428070|NCT01051258|AeriSeal|aeriseal
1428071|NCT01051258|treatment|treatment
1428072|NCT01051258|device|device
1428073|NCT01051258|breathing|breathing
1428074|NCT01051258|COPD|copd
1428075|NCT01051258|emphysema|emphysema
1428076|NCT01051258|heterogeneous|heterogeneous
1428077|NCT01051258|homogeneous|homogeneous
1428078|NCT01051258|Pathologic Processes|pathologic processes
1428079|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
1428080|NCT01051258|Lung Diseases|lung diseases
1428081|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1428082|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
1428083|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
1428084|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
1428085|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
1428086|NCT01051232|filibuvir|filibuvir
1428087|NCT01051232|pharmacokinetics|pharmacokinetics
1428088|NCT01051232|Japanese|japanese
1428089|NCT01051232|Asian|asian
1428090|NCT01051219|Losartan|losartan
1428091|NCT01051219|Liver fibrosis|liver fibrosis
1428092|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1428093|NCT01051193|Seizures|seizures
1428094|NCT01051193|oxcarbazepine|oxcarbazepine
1428096|NCT01051180|HEMORRHOIDS|hemorrhoids
1428097|NCT01051180|TREATMENT|treatment
1428098|NCT01051180|PILES|piles
1428099|NCT01051180|BLEEDING|bleeding
1428100|NCT01051180|HALO|halo
1428101|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
1428102|NCT01051154|Nutritional status|nutritional status
1428103|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1428104|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
1428105|NCT01051154|n-3 fatty acids|n-3 fatty acids
1428106|NCT01051154|Remission-induction phase|remission-induction phase
1428107|NCT01051141|alcohol use|alcohol use
1428108|NCT01051141|brief intervention|brief intervention
1428109|NCT01051141|risk behaviors|risk behaviors
1428110|NCT01051128|neurological disorders|neurological disorders
1428111|NCT01051128|multiple sclerosis|multiple sclerosis
1428112|NCT01051128|stroke|stroke
1428113|NCT01051128|cerebral palsy|cerebral palsy
1428114|NCT01051128|spinal cord|spinal cord
1428115|NCT01051128|brain injuries|brain injuries
1428116|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
1428117|NCT01051115|CLL|cll
1428118|NCT01051115|refractory|refractory
1428119|NCT01051115|dasatinib|dasatinib
1428120|NCT01051115|fludarabine|fludarabine
1428121|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
1428122|NCT01051089|lifestyle modification|lifestyle modification
1428123|NCT01051076|ITI|iti
1428124|NCT01051076|Haemophilia A|haemophilia a
1428125|NCT01051076|Inhibitors|inhibitors
1428126|NCT01051076|Failed ITI|failed iti
1428127|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
1428128|NCT01051063|adult|adult
1428129|NCT01051063|WT1|wt1
1428130|NCT01051063|ASCI|asci
1428131|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
1428132|NCT01051063|partial remission|partial remission
1428133|NCT01051063|post-induction therapy|post-induction therapy
1428134|NCT01051063|tumor antigen|tumor antigen
1428135|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
1428136|NCT01051063|Immunotherapy|immunotherapy
1428137|NCT01051050|Evidence based medicine|evidence based medicine
1428138|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
1428139|NCT01051037|lung tumors|lung tumors
1428140|NCT01051037|central airways|central airways
1428141|NCT01051024|Dietary supplement|dietary supplement
1428142|NCT01051024|Diamel|diamel
1428143|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
1428144|NCT01051024|Female Infertility|female infertility
1428145|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
1428146|NCT01050998|Mavrilimumab|mavrilimumab
1428147|NCT01050998|CAM-3001|cam-3001
1428148|NCT01050985|advanced cancer|advanced cancer
1428149|NCT01050985|temsirolimus|temsirolimus
1428150|NCT01050985|capecitabine|capecitabine
1428151|NCT01050972|Headache|headache
1428152|NCT01050972|Cervical Pain|cervical pain
1428153|NCT01050972|Cognitive treatment|cognitive treatment
1428154|NCT01050972|Relaxation|relaxation
1428155|NCT01050972|Exercise|exercise
1428156|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
1428157|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
1428158|NCT01050946|Haploidentical donor|haploidentical donor
1428159|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
1428160|NCT01050946|ALL|all
1428161|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
1428162|NCT01050946|AML|aml
1428163|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
1428164|NCT01050946|CML|cml
1428165|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
1428166|NCT01050946|NHL|nhl
1428167|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1428168|NCT01050946|HL|hl
1428169|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
1428170|NCT01050933|Healthy volunteer|healthy volunteer
1428171|NCT01050907|leishmaniasis|leishmaniasis
1428172|NCT01050907|cutaneous disease|cutaneous disease
1428173|NCT01050907|mucosal disease|mucosal disease
1428174|NCT01050907|miltefosine|miltefosine
1428175|NCT01050894|osteoarthritis|osteoarthritis
1428176|NCT01050881|blood donor notification|blood donor notification
1428177|NCT01050881|emotional response|emotional response
1428178|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
1428179|NCT01050855|Non-malignant diseases|non-malignant diseases
1428180|NCT01050855|Immune deficiencies|immune deficiencies
1428181|NCT01050855|Hemoglobinopathies|hemoglobinopathies
1428182|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
1428183|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
1428184|NCT01050829|Tumor|tumor
1428185|NCT01050829|Contrast media|contrast media
1428186|NCT01050829|Gadobutrol|gadobutrol
1428187|NCT01050816|articular cartilage defects|articular cartilage defects
1428188|NCT01050816|ACI|aci
1428189|NCT01050816|ankle joint|ankle joint
1428190|NCT01050816|chondron|chondron
1428191|NCT01050803|Diabetes Mellitus|diabetes mellitus
1428192|NCT01050803|Intervention studies|intervention studies
1428193|NCT01050803|Program effectiveness|program effectiveness
1428491|NCT01049568|HIV|hiv
1428194|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
1428195|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
1428196|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
1428197|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
1428198|NCT01050751|Bioavailability|bioavailability
1428199|NCT01050751|Bioequivalence|bioequivalence
1428200|NCT01050751|Lersivirine|lersivirine
1428201|NCT01050751|UK-453|uk-453
1428202|NCT01050751|061|061
1428203|NCT01050751|Pharmacokinetics|pharmacokinetics
1428204|NCT01050725|proteome|proteome
1428205|NCT01050725|biomarkers|biomarkers
1428206|NCT01050725|radiotherapy|radiotherapy
1428207|NCT01050725|cancer|cancer
1428208|NCT01050699|critical illness|critical illness
1428209|NCT01050699|sleep|sleep
1428210|NCT01050699|polysomnography|polysomnography
1428211|NCT01050699|inflammatory cytokines|inflammatory cytokines
1428212|NCT01050699|dexmedetomidine|dexmedetomidine
1428213|NCT01050699|acute lung injury|acute lung injury
1428214|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
1428215|NCT01050699|midazolam|midazolam
1428216|NCT01050699|fentanyl|fentanyl
1428217|NCT01050699|cytokines|cytokines
1428218|NCT01050686|ileostomy reversal|ileostomy reversal
1428219|NCT01050686|subcutaneous drain|subcutaneous drain
1428220|NCT01050686|hospital stay|hospital stay
1428221|NCT01050686|postoperative wound infection|postoperative wound infection
1428222|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
1428223|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
1428224|NCT01050673|traumatic wound|traumatic wound
1428225|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
1428226|NCT01050660|Direct bilirubin|direct bilirubin
1428227|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
1428228|NCT01050660|Very low birth weight infants|very low birth weight infants
1428229|NCT01050660|PNAC|pnac
1428230|NCT01050634|Aromatase inhibitor|aromatase inhibitor
1428231|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
1428232|NCT01050634|Quality of Life|quality of life
1428233|NCT01050634|Safety|safety
1428234|NCT01050621|ascorbic acid|ascorbic acid
1428235|NCT01050621|vitamin C|vitamin c
1428236|NCT01050621|antioxidants|antioxidants
1428237|NCT01050621|redox therapy|redox therapy
1428238|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
1428239|NCT01050608|Alcohol Rub|alcohol rub
1428240|NCT01050608|Hand Hygiene|hand hygiene
1428241|NCT01050608|Provider Feedback|provider feedback
1428242|NCT01050608|Health Care Associated Infections|health care associated infections
1428243|NCT01050595|Intensive Care Unit|intensive care unit
1428244|NCT01050595|Constipation|constipation
1428245|NCT01050595|Bowel Management|bowel management
1428246|NCT01050582|Schizophrenia|schizophrenia
1428247|NCT01050582|Bipolar Disorder|bipolar disorder
1428248|NCT01050582|Autistic Disorder|autistic disorder
1428249|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
1428250|NCT01050582|Risperidone|risperidone
1428251|NCT01050582|RISPERDAL|risperdal
1428252|NCT01050582|Antipsychotic Agents|antipsychotic agents
1428253|NCT01050582|Prolactin|prolactin
1428254|NCT01050582|Pediatrics|pediatrics
1428255|NCT01050569|Smoking Cessation|smoking cessation
1428256|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
1428257|NCT01050556|arsenic|arsenic
1428258|NCT01050556|folate|folate
1428259|NCT01050556|folic acid|folic acid
1428260|NCT01050556|creatine|creatine
1428261|NCT01050556|arsenicosis|arsenicosis
1428262|NCT01050556|nutrition|nutrition
1428263|NCT01050530|Cirrhosis|cirrhosis
1428264|NCT01050530|ascites|ascites
1428265|NCT01050530|Tolvaptan|tolvaptan
1428266|NCT01050530|OPC-41061|opc-41061
1428267|NCT01050491|asthma|asthma
1428268|NCT01050491|airway remodeling|airway remodeling
1428269|NCT01050491|airway obstruction|airway obstruction
1428270|NCT01050478|acute agitation|acute agitation
1428271|NCT01050478|aggression|aggression
1428272|NCT01050478|psychosis|psychosis
1428273|NCT01050478|paliperidone extended release|paliperidone extended release
1428274|NCT01050465|HIV|hiv
1428275|NCT01050465|Knee pain|knee pain
1428276|NCT01050465|Colonoscopy|colonoscopy
1428277|NCT01050465|Mammography|mammography
1428278|NCT01050465|Vaccination|vaccination
1428279|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1428280|NCT01050439|Unrelated donor|unrelated donor
1428281|NCT01050439|Cord blood donor|cord blood donor
1428282|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
1428283|NCT01050413|diagnosis|diagnosis
1428284|NCT01050413|prognosis|prognosis
1428285|NCT01050413|follow-up|follow-up
1428286|NCT01050400|CYP2D6|cyp2d6
1428287|NCT01050400|Genetic Polymorphism|genetic polymorphism
1428288|NCT01050400|codeine|codeine
1428289|NCT01050400|breastfeeding|breastfeeding
1428290|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
1428291|NCT01050387|VDD|vdd
1428292|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
1428293|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
1428294|NCT01050387|DBP|dbp
1428492|NCT01049568|Cell phone|cell phone
1428295|NCT01050387|Nutritional rickets|nutritional rickets
1428296|NCT01050387|rickets|rickets
1428297|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
1428298|NCT01050387|25OHD|25ohd
1428299|NCT01050387|1,25OH2D|1,25oh2d
1428300|NCT01050387|vitamin D metabolites|vitamin d metabolites
1428301|NCT01050387|PTH|pth
1428302|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
1428303|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
1428304|NCT01050322|receptor HER two positive|receptor her two positive
1428305|NCT01050322|lapatinib|lapatinib
1428306|NCT01050322|metastatic breast cancer|metastatic breast cancer
1428307|NCT01050296|Neuroblastoma|neuroblastoma
1428308|NCT01050296|Retinoblastoma|retinoblastoma
1428309|NCT01050296|Osteosarcoma|osteosarcoma
1428310|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
1428311|NCT01050296|Ewing sarcoma|ewing sarcoma
1428312|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
1428313|NCT01050296|Adrenocortical tumors|adrenocortical tumors
1428314|NCT01050296|Liver malignancies|liver malignancies
1428315|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
1428316|NCT01050244|Soy protein|soy protein
1428317|NCT01050244|Milk protein|milk protein
1428318|NCT01050244|Neuropathic pain|neuropathic pain
1428319|NCT01050231|stroke|stroke
1428320|NCT01050231|cerebrovascular accident|cerebrovascular accident
1428321|NCT01050231|robot|robot
1428322|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1428323|NCT01050205|Diabetes Prevention|diabetes prevention
1428324|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
1428325|NCT01050205|Lifestyle Intervention|lifestyle intervention
1428326|NCT01050205|Group Lifestyle Balance|group lifestyle balance
1428327|NCT01050192|Prematurity|prematurity
1428328|NCT01050192|Nutrition|nutrition
1428329|NCT01050192|Breast Feeding|breast feeding
1428330|NCT01050179|chemosensitivity|chemosensitivity
1428331|NCT01050166|islet transplantation|islet transplantation
1428332|NCT01050166|magnetic resonance|magnetic resonance
1428333|NCT01050166|Type 1 DM|type 1 dm
1428334|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
1428335|NCT01050140|fructose|fructose
1428336|NCT01050140|fatty liver disease|fatty liver disease
1428337|NCT01050140|diet|diet
1428338|NCT01050127|Pharmacokinetics|pharmacokinetics
1428339|NCT01050127|Pharmacodynamics|pharmacodynamics
1428340|NCT01050127|Drug Safety|drug safety
1428341|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
1428342|NCT01050114|Botulinum Toxin|botulinum toxin
1428343|NCT01050114|Oxybutynin|oxybutynin
1428344|NCT01050114|Overactive Bladder|overactive bladder
1428345|NCT01050114|Spinal Cord Injury|spinal cord injury
1428346|NCT01050114|Urinary Incontinence|urinary incontinence
1428347|NCT01050114|Nerve Growth Factor|nerve growth factor
1428348|NCT01050114|Urine Biomarkers|urine biomarkers
1428349|NCT01050101|Satiety|satiety
1428350|NCT01050101|Fiber|fiber
1428351|NCT01050101|Nutrition|nutrition
1428352|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
1428353|NCT01050101|overweight|overweight
1428354|NCT01050088|clubfoot|clubfoot
1428355|NCT01050088|casting|casting
1428356|NCT01050088|ponseti|ponseti
1428357|NCT01050088|discomfort|discomfort
1428358|NCT01050075|male breast cancer|male breast cancer
1428359|NCT01050075|neurotoxicity|neurotoxicity
1428360|NCT01050075|recurrent breast cancer|recurrent breast cancer
1428361|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
1428362|NCT01050036|Primary complete remission|primary complete remission
1428363|NCT01050036|Favorable karyotype|favorable karyotype
1428364|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
1428365|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
1428366|NCT01050023|venous stasis ulcer|venous stasis ulcer
1428367|NCT01050023|wound healing|wound healing
1428368|NCT01050023|Provant Wound Closure System|provant wound closure system
1428369|NCT01050023|radiofrequency|radiofrequency
1428370|NCT01050023|Provant|provant
1428371|NCT01050023|pain relief|pain relief
1428372|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
1428373|NCT01050010|clinical remission|clinical remission
1428374|NCT01050010|synovitis|synovitis
1428375|NCT01050010|dedicated extremity MRI|dedicated extremity mri
1428376|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
1428377|NCT01049997|Elderly|elderly
1428378|NCT01049997|Frailty|frailty
1428379|NCT01049984|Parkinson's Disease|parkinson's disease
1428380|NCT01049984|UPDRS|updrs
1428381|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
1428382|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
1428383|NCT01049984|B-SIT|b-sit
1428384|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
1428385|NCT01049984|PDQ -39|pdq -39
1428386|NCT01049984|SCOPA - Cognition|scopa - cognition
1428387|NCT01049984|Levodopa|levodopa
1428388|NCT01049984|rasagiline|rasagiline
1428389|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
1428493|NCT01049568|HAART|haart
1428390|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
1428391|NCT01049971|colorectal surgery|colorectal surgery
1428392|NCT01049971|wound infection|wound infection
1428393|NCT01049971|wound protector|wound protector
1428394|NCT01049971|laparoscopy|laparoscopy
1428395|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
1428396|NCT01049958|asynchrony|asynchrony
1428397|NCT01049958|mechanical ventilation|mechanical ventilation
1428398|NCT01049958|blunt trauma|blunt trauma
1428399|NCT01049932|HIV|hiv
1428400|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1428401|NCT01049932|HIV Seronegativity|hiv seronegativity
1428402|NCT01049919|Critical Limb Ischemia|critical limb ischemia
1428403|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
1428404|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
1428405|NCT01049919|CLI|cli
1428406|NCT01049919|PAD|pad
1428407|NCT01049919|PVD|pvd
1428408|NCT01049919|Angiogenesis|angiogenesis
1428409|NCT01049919|Stem Cells|stem cells
1428410|NCT01049919|Cell Therapy|cell therapy
1428411|NCT01049919|Limb Salvage|limb salvage
1428412|NCT01049919|Amputation|amputation
1428413|NCT01049919|Leg Pain|leg pain
1428414|NCT01049906|foot surgery|foot surgery
1428415|NCT01049906|ankle surgery|ankle surgery
1428416|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
1428417|NCT01049880|Ascorbic Acid|ascorbic acid
1428418|NCT01049880|Gemcitabine|gemcitabine
1428419|NCT01049854|unrelated donor transplant|unrelated donor transplant
1428420|NCT01049854|CD34 selection|cd34 selection
1428421|NCT01049841|pediatric|pediatric
1428422|NCT01049841|children|children
1428423|NCT01049841|perifosine|perifosine
1428424|NCT01049841|temsirolimus|temsirolimus
1428425|NCT01049841|recurrent|recurrent
1428426|NCT01049841|progressive|progressive
1428427|NCT01049841|09-124|09-124
1428428|NCT01049828|Tinnitus|tinnitus
1428429|NCT01049828|fcMRI|fcmri
1428430|NCT01049828|Neural Connectivity|neural connectivity
1428431|NCT01049828|Bother|bother
1428432|NCT01049815|hemodialysis|hemodialysis
1428433|NCT01049815|intimal media thickness|intimal media thickness
1428434|NCT01049802|stroke|stroke
1428435|NCT01049802|hemiplegia|hemiplegia
1428436|NCT01049802|TMS|tms
1428437|NCT01049789|youth|youth
1428438|NCT01049789|HIV|hiv
1428439|NCT01049789|Depression|depression
1428440|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
1428441|NCT01049789|Medication management|medication management
1428442|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
1428443|NCT01049763|obese adult|obese adult
1428444|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
1428445|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
1428446|NCT01049763|pharmacokinetics|pharmacokinetics
1428447|NCT01049763|healthy volunteers|healthy volunteers
1428448|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
1428449|NCT01049750|male|male
1428450|NCT01049750|erectile dysfunction|erectile dysfunction
1428451|NCT01049724|Myopia|myopia
1428452|NCT01049724|refractive surgery|refractive surgery
1428453|NCT01049724|LASIK|lasik
1428454|NCT01049724|PRK|prk
1428455|NCT01049724|Lacritin|lacritin
1428456|NCT01049724|Heparanase|heparanase
1428457|NCT01049711|erythropoietin|erythropoietin
1428458|NCT01049711|hemodialysis|hemodialysis
1428459|NCT01049711|cost utility|cost utility
1428460|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
1428461|NCT01049711|Quality adjusted life year|quality adjusted life year
1428462|NCT01049711|quality of life|quality of life
1428463|NCT01049698|Obesity|obesity
1428464|NCT01049698|Overweight|overweight
1428465|NCT01049698|Older adults|older adults
1428466|NCT01049698|resistance training|resistance training
1428467|NCT01049698|exercise|exercise
1428468|NCT01049685|HIV|hiv
1428469|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1428470|NCT01049685|Efavirenz|efavirenz
1428471|NCT01049685|Lopinavir|lopinavir
1428472|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
1428473|NCT01049685|Treatment Naive|treatment naive
1428474|NCT01049659|pregnancy|pregnancy
1428475|NCT01049659|iodine deficiency|iodine deficiency
1428476|NCT01049659|neuropsychological development|neuropsychological development
1428477|NCT01049646|renin-angiotensin system|renin-angiotensin system
1428478|NCT01049646|apelin|apelin
1428479|NCT01049646|systemic haemodynamics|systemic haemodynamics
1428480|NCT01049633|Insulin dependence|insulin dependence
1428481|NCT01049633|Hypoglycemia|hypoglycemia
1428482|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
1428483|NCT01049633|Islet transplantation|islet transplantation
1428484|NCT01049620|XELOX|xelox
1428485|NCT01049620|RAD001|rad001
1428486|NCT01049620|phase 1|phase 1
1428487|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
1428488|NCT01049581|Gross motor function performance|gross motor function performance
1428489|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
1428490|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
1428494|NCT01049555|alzheimer|alzheimer
1428495|NCT01049555|apathy|apathy
1428496|NCT01049555|actigraphy|actigraphy
1428497|NCT01049542|Astressin 2B|astressin 2b
1428498|NCT01049542|Forearm blood flow|forearm blood flow
1428499|NCT01049542|vascular|vascular
1428500|NCT01049542|plethysmography|plethysmography
1428501|NCT01049542|heart failure|heart failure
1428502|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
1428503|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
1563008|NCT00525486|PTL|ptl
1428504|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
1428505|NCT01049529|neonates|neonates
1428506|NCT01049529|clinical outcomes|clinical outcomes
1428507|NCT01049529|critically ill patients|critically ill patients
1428508|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
1428509|NCT01049529|Length of intensive care stay|length of intensive care stay
1428510|NCT01049516|Military|military
1428511|NCT01049516|Combat|combat
1428512|NCT01049516|Psychological Treatment|psychological treatment
1428513|NCT01049516|Psychotherapy|psychotherapy
1428514|NCT01049516|Trauma|trauma
1428515|NCT01049516|Posttraumatic Stress|posttraumatic stress
1428516|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
1428517|NCT01049516|PTSD|ptsd
1428518|NCT01049516|Prolonged Exposure|prolonged exposure
1428519|NCT01049516|Exposure therapy|exposure therapy
1428520|NCT01049516|Behavior Therapy|behavior therapy
1428521|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
1428522|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
1428523|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
1428524|NCT01049503|Dentifrices|dentifrices
1428525|NCT01049503|Fluoride|fluoride
1428526|NCT01049503|Nails|nails
1428527|NCT01049503|Plaque|plaque
1428528|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
1428529|NCT01049477|Pregnancy|pregnancy
1428530|NCT01049477|Cesarean Section|cesarean section
1428531|NCT01049464|Atrial fibrillation|atrial fibrillation
1428532|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
1428533|NCT01049464|Magnesium sulfate|magnesium sulfate
1428534|NCT01049464|Septic shock|septic shock
1428535|NCT01049464|Medical intensive care unit|medical intensive care unit
1428536|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
1428537|NCT01049464|Critically ill patients|critically ill patients
1428538|NCT01049451|Multiple Sclerosis|multiple sclerosis
1428539|NCT01049451|ACTH|acth
1428540|NCT01049451|Steroids|steroids
1428541|NCT01049438|MRSA|mrsa
1428542|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1428543|NCT01049438|Staphylococcus aureus|staphylococcus aureus
1428544|NCT01049438|Skin Infections|skin infections
1428545|NCT01049438|Body Decolonization|body decolonization
1428546|NCT01049425|anthracycline-free|anthracycline-free
1428549|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
1428550|NCT01049386|intestinal permeability|intestinal permeability
1428551|NCT01049386|health|health
1428552|NCT01049386|sugar absorption|sugar absorption
1428553|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
1428554|NCT01049373|low-back|low-back
1428555|NCT01049373|pain|pain
1428556|NCT01049373|chronic|chronic
1428557|NCT01049373|constitution|constitution
1428558|NCT01049373|diathesism|diathesism
1428559|NCT01049373|homoeopathy|homoeopathy
1428560|NCT01049373|fixed combination|fixed combination
1428561|NCT01049373|herbal preparation|herbal preparation
1428562|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
1428563|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1428564|NCT01049360|COPD|copd
1428565|NCT01049360|Chronic Bronchitis|chronic bronchitis
1428566|NCT01049360|Emphysema|emphysema
1428567|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
1428568|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
1428569|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1428570|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1428571|NCT01049347|depression|depression
1428572|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
1428573|NCT01049321|weight|weight
1428574|NCT01049321|coagulation|coagulation
1428575|NCT01049321|DASH eating pattern.|dash eating pattern.
1428576|NCT01049308|heart failure|heart failure
1428577|NCT01049308|cognitive disorders|cognitive disorders
1428578|NCT01049308|medication adherence|medication adherence
1428579|NCT01049308|patient readmissions|patient readmissions
1428580|NCT01049295|taxanes|taxanes
1428581|NCT01049295|breast cancer|breast cancer
1428582|NCT01049295|n3 fatty acids|n3 fatty acids
1428583|NCT01049295|inflammation|inflammation
1428584|NCT01049282|safety|safety
1428585|NCT01049282|immunogenicity|immunogenicity
1428586|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
1428587|NCT01049269|Body Scanning|body scanning
1428588|NCT01049269|Body Fat|body fat
1428589|NCT01049269|Body Volume|body volume
1428590|NCT01049269|Obesity|obesity
1428591|NCT01049269|No Conditions|no conditions
1428592|NCT01049256|Periodic breathing|periodic breathing
1428593|NCT01049256|Heart Failure|heart failure
1428594|NCT01049256|Chemoreflex|chemoreflex
1428595|NCT01049256|Chemosensitivity|chemosensitivity
1428596|NCT01049243|Atopic Dermatitis|atopic dermatitis
1428597|NCT01049243|Open-Label|open-label
1428598|NCT01049243|Topical|topical
1428599|NCT01049243|Cream|cream
1428600|NCT01049243|Eczema|eczema
1428601|NCT01049243|Vanos|vanos
1428602|NCT01049230|proton beam radiation|proton beam radiation
1428603|NCT01049230|CNS germ cell tumor|cns germ cell tumor
1428604|NCT01049217|neuropathy|neuropathy
1428605|NCT01049217|pain|pain
1428606|NCT01049217|HIV-1|hiv-1
1428607|NCT01049217|HIV Infections|hiv infections
1428608|NCT01049204|HIV|hiv
1428609|NCT01049204|HIV-1 Infections|hiv-1 infections
1428610|NCT01049191|Osteoporosis|osteoporosis
1428611|NCT01049191|Fracture|fracture
1428612|NCT01049191|microMRI|micromri
1428613|NCT01049191|Bone architecture|bone architecture
1428614|NCT01049191|Bone matrix|bone matrix
1428615|NCT01049191|Bone and Bones|bone and bones
1428616|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
1428617|NCT01049178|antioxidant enzymes|antioxidant enzymes
1428618|NCT01049178|asthma|asthma
1428619|NCT01049178|silymarin|silymarin
1428620|NCT01049178|RCT|rct
1428621|NCT01049152|Diabetes mellitus|diabetes mellitus
1428622|NCT01049152|ESRD|esrd
1428623|NCT01049152|CGM|cgm
1428624|NCT01049152|Inflammation markers|inflammation markers
1428625|NCT01049152|Hemodialysis|hemodialysis
1428626|NCT01049152|Diabetic patients|diabetic patients
1428627|NCT01049152|Nondiabetic patients|nondiabetic patients
1428628|NCT01049152|All with ESRD|all with esrd
1428629|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
1428630|NCT01049139|vaccination|vaccination
1428631|NCT01049139|HIV prevention|hiv prevention
1428632|NCT01049139|YMSM|ymsm
1428633|NCT01049139|youth|youth
1428634|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
1428635|NCT01049126|Late Stage|late stage
1428636|NCT01049113|Lymphoma|lymphoma
1428637|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
1428638|NCT01049113|ALL|all
1428639|NCT01049100|Surgical Staging|surgical staging
1428640|NCT01049100|Cervical Cancer|cervical cancer
1428641|NCT01049100|Chemoradiation|chemoradiation
1428642|NCT01049100|Outcome|outcome
1428643|NCT01049100|Toxicity|toxicity
1428644|NCT01049087|plasma volume|plasma volume
1428645|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
1428646|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
1428647|NCT01049087|Healthy volunteers|healthy volunteers
1428648|NCT01049074|Low Back Pain|low back pain
1428649|NCT01049074|Acupuncture|acupuncture
1428650|NCT01049074|RCT|rct
1428653|NCT01049048|Endothelial Function|endothelial function
1428654|NCT01049048|Arterial stiffness|arterial stiffness
1428655|NCT01049048|Vitamin D|vitamin d
1428656|NCT01049035|Meningitis|meningitis
1428657|NCT01049035|Meningococcal Infection|meningococcal infection
1428658|NCT01049035|Neisseria meningitidis|neisseria meningitidis
1428659|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
1428660|NCT01049022|Pharmacokinetics|pharmacokinetics
1428661|NCT01049009|Nitric Oxide|nitric oxide
1428662|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1428663|NCT01049009|Antihypertensive Agents|antihypertensive agents
1428664|NCT01049009|Vasodilator Agents|vasodilator agents
1428665|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
1428666|NCT01049009|Sympatholytics|sympatholytics
1428667|NCT01049009|Vascular Resistance|vascular resistance
1428668|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
1428669|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
1428670|NCT01049009|Metoprolol succinate|metoprolol succinate
1428671|NCT01049009|Therapeutic Uses|therapeutic uses
1428672|NCT01049009|Metoprolol|metoprolol
1428673|NCT01049009|Vascular Diseases|vascular diseases
1428674|NCT01049009|Nebivolol|nebivolol
1428675|NCT01049009|Cardiovascular Agents|cardiovascular agents
1428676|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
1428677|NCT01048996|Acute Lung Injury|acute lung injury
1428678|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1428679|NCT01048996|Genetic Variability|genetic variability
1428680|NCT01048996|Plasma Biomarkers|plasma biomarkers
1428681|NCT01048996|Pediatrics|pediatrics
1428682|NCT01048983|Lung Cancer|lung cancer
1428683|NCT01048983|NSCLC|nsclc
1428684|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
1428685|NCT01048983|Side Effects|side effects
1428686|NCT01048983|Armodafinil|armodafinil
1428687|NCT01048983|Nuvigil|nuvigil
1428688|NCT01048983|Bupropion|bupropion
1428689|NCT01048983|Wellbutrin|wellbutrin
1428690|NCT01048983|Wellbutrin SR|wellbutrin sr
1428691|NCT01048983|Zyban|zyban
1428692|NCT01048983|Curcumin|curcumin
1428693|NCT01048983|Minocycline|minocycline
1428694|NCT01048983|Dynacin|dynacin
1428695|NCT01048983|Minocin|minocin
1428696|NCT01048983|Minocin PAC|minocin pac
1428697|NCT01048983|Myrac|myrac
1428698|NCT01048983|Solodyn|solodyn
1428699|NCT01048970|Lung cancer|lung cancer
1568397|NCT00506012|Movement Disorder|movement disorder
1428700|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
1428701|NCT01048970|Weight loss|weight loss
1428702|NCT01048970|Toxicity|toxicity
1428703|NCT01048970|Body composition|body composition
1428704|NCT01048970|Inflammatory response|inflammatory response
1428705|NCT01048957|Nicotine|nicotine
1428706|NCT01048957|Craving|craving
1428707|NCT01048957|fMRI|fmri
1428708|NCT01048957|EEG|eeg
1428709|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
1428710|NCT01048944|Electroencephalography|electroencephalography
1428711|NCT01048944|nicotine|nicotine
1428712|NCT01048944|bupropion|bupropion
1428713|NCT01048944|attention|attention
1428714|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
1428715|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
1428716|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
1428717|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
1428718|NCT01048905|Sickle Cell Disease|sickle cell disease
1428719|NCT01048905|Thalassemia|thalassemia
1428720|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
1428721|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1428722|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1428723|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1428724|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
1428725|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1428726|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1428727|NCT01048879|oseltamivir|oseltamivir
1428728|NCT01048879|influenza|influenza
1428729|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
1428730|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1428731|NCT01048879|pharmacokinetics|pharmacokinetics
1428732|NCT01048866|pharyngitis|pharyngitis
1428733|NCT01048866|swollen throat|swollen throat
1428734|NCT01048866|difficulty swallowing|difficulty swallowing
1428735|NCT01048853|Cervix|cervix
1428736|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
1428737|NCT01048853|Conservative Surgery|conservative surgery
1428738|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
1428739|NCT01048853|Quality of Life Factors|quality of life factors
1428740|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
1428741|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
1428742|NCT01048853|parametrium|parametrium
1428743|NCT01048853|Cervical cone biopsy|cervical cone biopsy
1428744|NCT01048853|Endocervical curettage|endocervical curettage
1428745|NCT01048853|ECC|ecc
1428746|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
1428747|NCT01048827|AML|aml
1428748|NCT01048827|autologous transplant|autologous transplant
1428749|NCT01048801|History of fever|history of fever
1428750|NCT01048801|measured fever|measured fever
1428751|NCT01048788|Cirrhosis|cirrhosis
1428752|NCT01048788|ascites|ascites
1428753|NCT01048788|Tolvaptan|tolvaptan
1428754|NCT01048788|OPC-41061|opc-41061
1428755|NCT01048775|bispectral index|bispectral index
1428756|NCT01048775|cardiac surgery|cardiac surgery
1428757|NCT01048775|asymmetry|asymmetry
1428758|NCT01048762|pulmonary cancer|pulmonary cancer
1428759|NCT01048762|radically operated|radically operated
1428760|NCT01048762|exercise training|exercise training
1428761|NCT01048762|dyspnea counseling|dyspnea counseling
1428762|NCT01048762|quality of life|quality of life
1428763|NCT01048762|physical therapy|physical therapy
1428764|NCT01048749|Low back pain|low back pain
1428765|NCT01048749|nerve root compression|nerve root compression
1428766|NCT01048749|spinal height|spinal height
1428767|NCT01048736|obesity|obesity
1428768|NCT01048736|exercise|exercise
1428769|NCT01048736|intensity|intensity
1428770|NCT01048736|weight loss|weight loss
1428771|NCT01048736|diet|diet
1428772|NCT01048723|Soft Tissue|soft tissue
1428773|NCT01048723|Retroperitoneal|retroperitoneal
1428774|NCT01048723|resectable|resectable
1428775|NCT01048710|Knee osteoarthritis|knee osteoarthritis
1428776|NCT01048710|knee osteonecrosis|knee osteonecrosis
1428777|NCT01048710|osteotomy|osteotomy
1428778|NCT01048697|Obesity|obesity
1428779|NCT01048697|Pharmacokinetics|pharmacokinetics
1428780|NCT01048697|Pharmacodynamics|pharmacodynamics
1428781|NCT01048697|Dose individualization|dose individualization
1428782|NCT01048697|Tuberculosis|tuberculosis
1428783|NCT01048684|Brain tumor|brain tumor
1428784|NCT01048684|Intracranial pressure|intracranial pressure
1428785|NCT01048671|HIV|hiv
1428786|NCT01048658|Sevoflurane|sevoflurane
1428787|NCT01048658|anesthesia|anesthesia
1428788|NCT01048658|abortion|abortion
1428789|NCT01048658|blood loss|blood loss
1428790|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
1428791|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
1428792|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
1428793|NCT01048645|chemotherapy|chemotherapy
1428794|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
1428795|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
1428796|NCT01048619|MDS|mds
1428797|NCT01048606|Postmenopause|postmenopause
1428798|NCT01048606|Overweight|overweight
1428799|NCT01048606|Women|women
1428800|NCT01048606|Phytoestrogens|phytoestrogens
1428801|NCT01048606|Exercise|exercise
1428802|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
1428803|NCT01048606|Risk Factors|risk factors
1428804|NCT01048606|Aging|aging
1428805|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
1428806|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
1428807|NCT01048580|Perifosine|perifosine
1428808|NCT01048580|Capecitabine|capecitabine
1428809|NCT01048580|Colon Cancer|colon cancer
1428810|NCT01048567|Antibiotics|antibiotics
1428811|NCT01048567|Diarrhea|diarrhea
1428812|NCT01048567|Clostridium difficile|clostridium difficile
1428813|NCT01048567|Probiotics|probiotics
1428814|NCT01048567|Prevention & control|prevention & control
1428815|NCT01048554|Melanoma|melanoma
1428816|NCT01048554|Brain mets|brain mets
1428817|NCT01048554|Bevacizumab|bevacizumab
1428818|NCT01048554|Temozolomide|temozolomide
1428819|NCT01048554|Avastin|avastin
1428820|NCT01048554|Temodar|temodar
1428821|NCT01048554|Melanoma with brain mets|melanoma with brain mets
1428822|NCT01048528|immune response to vaccines|immune response to vaccines
1428823|NCT01048528|stress management|stress management
1428824|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
1428825|NCT01048515|Caffeine|caffeine
1428826|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
1428827|NCT01048515|Central Nervous System Agents|central nervous system agents
1428828|NCT01048502|healthy volunteer|healthy volunteer
1428829|NCT01048476|AMD|amd
1428830|NCT01048463|gastric cancer|gastric cancer
1428831|NCT01048463|colorectal cancer|colorectal cancer
1428832|NCT01048463|chemotherapy|chemotherapy
1428833|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
1428834|NCT01048463|enteral nutrition|enteral nutrition
1428835|NCT01048450|arthritis|arthritis
1428836|NCT01048450|degeneration|degeneration
1428837|NCT01048424|Urinary incontinence|urinary incontinence
1428838|NCT01048424|Paced respiration|paced respiration
1428839|NCT01048411|stroke rehabilitation|stroke rehabilitation
1428840|NCT01048411|outcome|outcome
1428841|NCT01048411|barthel-index|barthel-index
1428842|NCT01048411|geriatrics|geriatrics
1428843|NCT01048411|elderly|elderly
1428844|NCT01048398|ceophalic version|ceophalic version
1428845|NCT01048398|breech presentation|breech presentation
1428846|NCT01048398|pregnancy|pregnancy
1428847|NCT01048398|remifentanil|remifentanil
1428848|NCT01048398|paracetamol|paracetamol
1428849|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
1428850|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
1428851|NCT01048385|Aneuploidy|aneuploidy
1428852|NCT01048385|Meiotic Spindle|meiotic spindle
1428853|NCT01048385|Coenzyme Q10|coenzyme q10
1428854|NCT01048385|Electron transfer chain|electron transfer chain
1428855|NCT01048372|HIV|hiv
1428856|NCT01048372|monoclonal antibody|monoclonal antibody
1428857|NCT01048372|immune therapy|immune therapy
1428858|NCT01048372|pathogenesis|pathogenesis
1428859|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
1428860|NCT01048372|anti-CD4|anti-cd4
1428861|NCT01048372|anti-self|anti-self
1428862|NCT01048372|viral replication|viral replication
1428863|NCT01048372|Acute Infection|acute infection
1428864|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
1428865|NCT01048346|employment, disabilities|employment, disabilities
1428866|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1428867|NCT01048333|Onset of effect|onset of effect
1428868|NCT01048333|COPD|copd
1428869|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
1428870|NCT01048320|pancreatic cancer|pancreatic cancer
1428871|NCT01048320|toxicity|toxicity
1428872|NCT01048320|chemotherapy|chemotherapy
1428873|NCT01048320|dose finding|dose finding
1428874|NCT01048307|prontosan|prontosan
1428875|NCT01048307|wound cleansing|wound cleansing
1428876|NCT01048307|wound irrigation|wound irrigation
1428877|NCT01048307|phmb|phmb
1428878|NCT01048307|polihexanide|polihexanide
1428879|NCT01048307|betaine|betaine
1428880|NCT01048294|Seasonal affective disorder|seasonal affective disorder
1428881|NCT01048294|phototherapy|phototherapy
1428882|NCT01048294|circadian rhythms|circadian rhythms
1428883|NCT01048294|blue enriched light|blue enriched light
1428884|NCT01048294|melanopsin|melanopsin
1428885|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
1428886|NCT01048268|T1DM|t1dm
1428887|NCT01048268|T2DM|t2dm
1428888|NCT01048268|GIP|gip
1428889|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
1428890|NCT01048268|Incretin|incretin
1428891|NCT01048216|colorectal liver cancer|colorectal liver cancer
1428892|NCT01048216|metastatic|metastatic
1428893|NCT01048216|radiation therapy|radiation therapy
1428894|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
1428895|NCT01048203|tasquinimod|tasquinimod
1428896|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
1428897|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
1428898|NCT01048190|Sabin Strains|sabin strains
1428899|NCT01048190|poliomyelitis|poliomyelitis
1428900|NCT01048177|vulvodynia|vulvodynia
1428901|NCT01048177|interstitial cystitis|interstitial cystitis
1428902|NCT01048177|pelvic pain|pelvic pain
1428903|NCT01048164|Massage|massage
1428904|NCT01048164|Relaxation|relaxation
1428905|NCT01048151|Prostate|prostate
1428906|NCT01048151|TNFerade Biologic|tnferade biologic
1428907|NCT01048138|Biperiden|biperiden
1428908|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
1428909|NCT01048138|Traumatic Brain Injury|traumatic brain injury
1428910|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
1428911|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
1428912|NCT01048112|campylobacter|campylobacter
1428913|NCT01048112|gastroenteritis|gastroenteritis
1428914|NCT01048112|challenge models|challenge models
1428915|NCT01048099|Breast Cancer|breast cancer
1428916|NCT01048099|Metastatic|metastatic
1428917|NCT01048099|PRO Onc Assay|pro onc assay
1428918|NCT01048099|FISH Testing|fish testing
1428919|NCT01048099|HER Negative|her negative
1428920|NCT01048099|HER Overexpression|her overexpression
1428921|NCT01048099|HER Activation|her activation
1428922|NCT01048086|neuroblastoma|neuroblastoma
1428923|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
1428924|NCT01048086|NET|net
1428925|NCT01048086|retinoic acid|retinoic acid
1428926|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
1428927|NCT01048073|non influenza|non influenza
1428928|NCT01048073|PCR assay|pcr assay
1428929|NCT01048047|aliskiren|aliskiren
1428930|NCT01048047|amlodipine|amlodipine
1428931|NCT01048047|hypertension|hypertension
1428932|NCT01048047|ankle-foot volume|ankle-foot volume
1428933|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
1428934|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
1428935|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1428936|NCT01048034|Transfusion therapy|transfusion therapy
1428937|NCT01048034|Transfusion dependency|transfusion dependency
1428938|NCT01048034|Hypomethylating therapy|hypomethylating therapy
1428939|NCT01048034|Azacitidine|azacitidine
1428940|NCT01048034|DNA-methylation|dna-methylation
1428941|NCT01048034|Epigenetic modifications|epigenetic modifications
1428942|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
1428943|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
1428944|NCT01048008|Advanced cancers|advanced cancers
1428945|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
1428946|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
1428947|NCT01048008|Advanced cancer|advanced cancer
1428948|NCT01047982|gestational diabetes|gestational diabetes
1428949|NCT01047982|macrosomia|macrosomia
1428950|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
1428951|NCT01047982|HOMA-IR|homa-ir
1428952|NCT01047982|obesity|obesity
1428953|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
1428954|NCT01047956|Methadone|methadone
1428955|NCT01047956|NAC|nac
1428956|NCT01047956|opioids|opioids
1428957|NCT01047930|Insomnia|insomnia
1428958|NCT01047930|Smoking|smoking
1428959|NCT01047930|Cue reactivity|cue reactivity
1428960|NCT01047930|Exercise timing|exercise timing
1428961|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
1428962|NCT01047930|Mood disturbances|mood disturbances
1428963|NCT01047930|Smoking abstinence|smoking abstinence
1428964|NCT01047930|Exercise intensity|exercise intensity
1428965|NCT01047930|Altered sleep|altered sleep
1428966|NCT01047930|Exercise duration|exercise duration
1428967|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
1428968|NCT01047930|Smoking cessation|smoking cessation
1428969|NCT01047930|Exercise Test|exercise test
1428970|NCT01047930|Polysomnography|polysomnography
1428971|NCT01047917|Meditation|meditation
1428972|NCT01047917|Relaxation Therapy|relaxation therapy
1428973|NCT01047917|Quality of Life|quality of life
1428974|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
1428975|NCT01047865|Autoimmunity|autoimmunity
1428976|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
1428977|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
1428978|NCT01047852|noninvasive ventilation|noninvasive ventilation
1428979|NCT01047839|Pediatric|pediatric
1428980|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
1428981|NCT01047839|non-endemic countries|non-endemic countries
1428982|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
1428983|NCT01047826|Fractured Tibia|fractured tibia
1428984|NCT01047826|Expert Tibial Nail|expert tibial nail
1428985|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
1428986|NCT01047826|Intramedullary Nailing|intramedullary nailing
1428987|NCT01047826|Locked Plate|locked plate
1428988|NCT01047826|distal third|distal third
1428990|NCT01047813|Cognitive performance|cognitive performance
1428991|NCT01047813|Type 2 diabetes|type 2 diabetes
1428992|NCT01047813|Blood glucose|blood glucose
1428993|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
1428994|NCT01047800|GERD|gerd
1428995|NCT01047800|reflux|reflux
1428996|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
1428997|NCT01047800|Functional dyspepsia|functional dyspepsia
1428998|NCT01047800|postprandial fullness|postprandial fullness
1428999|NCT01047800|counseling|counseling
1429000|NCT01047800|service|service
1429001|NCT01047787|Sleep apnea|sleep apnea
1429002|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
1429003|NCT01047787|Congestive Heart Failure|congestive heart failure
1429004|NCT01047774|soy protein|soy protein
1429005|NCT01047774|diet|diet
1429006|NCT01047761|Myasthenia Gravis|myasthenia gravis
1429007|NCT01047761|Exercise|exercise
1429008|NCT01047761|Fitness|fitness
1429009|NCT01047761|Body Composition|body composition
1429010|NCT01047761|Physical Activity|physical activity
1429011|NCT01047761|Pulmonary Function|pulmonary function
1429012|NCT01047761|Balance|balance
1429013|NCT01047748|abortion|abortion
1429014|NCT01047735|21+ years old|21+ years old
1429015|NCT01047735|Address|address
1429016|NCT01047735|Adult|adult
1429017|NCT01047735|Amputation|amputation
1429018|NCT01047735|Area|area
1429019|NCT01047735|Arm|arm
1429020|NCT01047735|Atheroscleroses|atheroscleroses
1429021|NCT01047735|Atherosclerosis|atherosclerosis
1429022|NCT01047735|Atherosclerotic|atherosclerotic
1429023|NCT01047735|Cardiovascular Disease|cardiovascular disease
1429024|NCT01047735|Bariatrics|bariatrics
1429025|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
1429026|NCT01047735|Behavior Modification|behavior modification
1429027|NCT01047735|Behavior Therapy|behavior therapy
1429028|NCT01047735|Behavior Treatment|behavior treatment
1429029|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
1429030|NCT01047735|Behavioral|behavioral
1429031|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
1429032|NCT01047735|Behavioral Modification|behavioral modification
1429033|NCT01047735|Behavioral Therapy|behavioral therapy
1429034|NCT01047735|Behavioral Treatment|behavioral treatment
1429035|NCT01047735|Beta Cell|beta cell
1429036|NCT01047735|Blindness|blindness
1429037|NCT01047735|Blood Pressure, High|blood pressure, high
1429038|NCT01047735|Blood Vessels|blood vessels
1429039|NCT01047735|Body Composition|body composition
1429040|NCT01047735|Body Weight decreased|body weight decreased
1429041|NCT01047735|Cancers|cancers
1429042|NCT01047735|Cardiac infarction|cardiac infarction
1429043|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
1429044|NCT01047735|Care, Health|care, health
1429045|NCT01047735|Cause of Death|cause of death
1429046|NCT01047735|Cell Function|cell function
1429047|NCT01047735|Cell Process|cell process
1429048|NCT01047735|Cell physiology|cell physiology
1429049|NCT01047735|Cellular Function|cellular function
1429050|NCT01047735|Cellular Physiology|cellular physiology
1429051|NCT01047735|Cellular Process|cellular process
1429052|NCT01047735|Cessation of life|cessation of life
1429053|NCT01047735|Clinical|clinical
1429054|NCT01047735|Clinical Trials Design|clinical trials design
1429055|NCT01047735|Communities|communities
1429056|NCT01047735|Conditioning Therapy|conditioning therapy
1429057|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1429058|NCT01047735|Controlled Study|controlled study
1429059|NCT01047735|Country|country
1429060|NCT01047735|D-Glucose|d-glucose
1429061|NCT01047735|Death|death
1429062|NCT01047735|Decision Making|decision making
1429063|NCT01047735|Dextrose|dextrose
1429064|NCT01047735|Diabetes Mellitus|diabetes mellitus
1429065|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
1429066|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
1429067|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1429068|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
1429069|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
1429070|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
1429071|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1429072|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1429073|NCT01047735|Diet|diet
1429074|NCT01047735|Disease|disease
1429075|NCT01047735|Disease remission|disease remission
1429076|NCT01047735|Disorder|disorder
1429077|NCT01047735|Drugs|drugs
1429078|NCT01047735|Dysfunction|dysfunction
1429079|NCT01047735|Effectiveness|effectiveness
1429080|NCT01047735|Epidemic|epidemic
1429081|NCT01047735|Functional disorder|functional disorder
1429082|NCT01047735|Future|future
1429083|NCT01047735|Gastric Bypass|gastric bypass
1429084|NCT01047735|Glucose|glucose
1429085|NCT01047735|Health|health
1429086|NCT01047735|Healthcare|healthcare
1429087|NCT01047735|Hepatic Disorder|hepatic disorder
1429088|NCT01047735|Human, Adult|human, adult
1429089|NCT01047735|Hypertension|hypertension
1429090|NCT01047735|INFLM|inflm
1429091|NCT01047735|Incidence|incidence
1429092|NCT01047735|Inflammation|inflammation
1429093|NCT01047735|Insulin Cell|insulin cell
1429094|NCT01047735|Insulin Resistance|insulin resistance
1429095|NCT01047735|Insulin Secreting Cell|insulin secreting cell
1429096|NCT01047735|Intestinal|intestinal
1429097|NCT01047735|Intestines|intestines
1429098|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
1429099|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
1429100|NCT01047735|Kidney Failure|kidney failure
1429101|NCT01047735|Kidney Insufficiency|kidney insufficiency
1429102|NCT01047735|Learning|learning
1429103|NCT01047735|Life Style|life style
1429104|NCT01047735|Life Style Modification|life style modification
1429105|NCT01047735|Lifestyle|lifestyle
1429106|NCT01047735|Link|link
1429107|NCT01047735|Liver diseases|liver diseases
1429108|NCT01047735|Longitudinal Studies|longitudinal studies
1429109|NCT01047735|MODY|mody
1429110|NCT01047735|Malignant Neoplasms|malignant neoplasms
1429111|NCT01047735|Malignant Tumor|malignant tumor
1429112|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
1429113|NCT01047735|Measures|measures
1429114|NCT01047735|Medical|medical
1429115|NCT01047735|Medication|medication
1429116|NCT01047735|Metabolic|metabolic
1429117|NCT01047735|Methods|methods
1429118|NCT01047735|Modification|modification
1429119|NCT01047735|Morbid Obesity|morbid obesity
1429120|NCT01047735|Morbidity|morbidity
1429121|NCT01047735|Morbidity - disease rate|morbidity - disease rate
1429122|NCT01047735|Mortality|mortality
1429123|NCT01047735|Mortality Vital Statistics|mortality vital statistics
1429124|NCT01047735|Myocardial Infarct|myocardial infarct
1429125|NCT01047735|Myocardial Infarction|myocardial infarction
1429126|NCT01047735|NAFLD|nafld
1429127|NCT01047735|NASH|nash
1429128|NCT01047735|NIDDM|niddm
1429129|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
1429130|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
1429131|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1429132|NCT01047735|Obesity|obesity
1429133|NCT01047735|Obesity, Morbid|obesity, morbid
1429134|NCT01047735|Operation|operation
1429135|NCT01047735|Operative Procedures|operative procedures
1429136|NCT01047735|Operative Surgical Procedures|operative surgical procedures
1429137|NCT01047735|Outcome|outcome
1429138|NCT01047735|Outcome Measure|outcome measure
1429139|NCT01047735|PROV|prov
1429140|NCT01047735|Participant|participant
1429141|NCT01047735|Patients|patients
1429142|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
1429143|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
1429144|NCT01047735|Physical activity|physical activity
1429145|NCT01047735|Physiopathology|physiopathology
1429146|NCT01047735|Pilot Projects|pilot projects
1429147|NCT01047735|Population|population
1429148|NCT01047735|Procedures|procedures
1429149|NCT01047735|Programs (PT)|programs (pt)
1429150|NCT01047735|Programs [Publication Type]|programs [publication type]
1429151|NCT01047735|Provider|provider
1429152|NCT01047735|Psychosocial Factor|psychosocial factor
1429153|NCT01047735|Public Health|public health
1429154|NCT01047735|RMSN|rmsn
1429155|NCT01047735|Randomized|randomized
1429156|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
1429157|NCT01047735|Randomized Controlled Trials|randomized controlled trials
1429158|NCT01047735|Remission|remission
1429159|NCT01047735|Renal Failure|renal failure
1429160|NCT01047735|Renal Insufficiency|renal insufficiency
1429161|NCT01047735|Reporting|reporting
1429162|NCT01047735|Resolution|resolution
1429163|NCT01047735|Science|science
1429164|NCT01047735|Severe obesity|severe obesity
1429165|NCT01047735|Structure|structure
1429166|NCT01047735|Subcellular Process|subcellular process
1429167|NCT01047735|Surgical|surgical
1429168|NCT01047735|Surgical Interventions|surgical interventions
1429169|NCT01047735|Surgical Procedure|surgical procedure
1429170|NCT01047735|T2D|t2d
1429171|NCT01047735|T2DM|t2dm
1429172|NCT01047735|Testing|testing
1429173|NCT01047735|Type 2 diabetes|type 2 diabetes
1429174|NCT01047735|Type II diabetes|type ii diabetes
1429175|NCT01047735|United States|united states
1429176|NCT01047735|Upper arm|upper arm
1429177|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
1429178|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
1429179|NCT01047735|Weight|weight
1429180|NCT01047735|Weight Loss|weight loss
1429181|NCT01047735|Weight Reduction|weight reduction
1429182|NCT01047735|Work|work
1429183|NCT01047735|adiposity|adiposity
1429184|NCT01047735|adult human (21+)|adult human (21+)
1429185|NCT01047735|adult onset diabetes|adult onset diabetes
1429186|NCT01047735|atheromatosis|atheromatosis
1429187|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
1429188|NCT01047735|bariatric surgery|bariatric surgery
1429189|NCT01047735|behavior intervention|behavior intervention
1429190|NCT01047735|behavioral intervention|behavioral intervention
1429191|NCT01047735|blood glucose regulation|blood glucose regulation
1429192|NCT01047735|body weight loss|body weight loss
1429193|NCT01047735|bowel|bowel
1429194|NCT01047735|cardiac infarct|cardiac infarct
1429195|NCT01047735|cardiovascular disorder|cardiovascular disorder
1429196|NCT01047735|cardiovascular risk|cardiovascular risk
1429197|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
1429198|NCT01047735|clinical practice|clinical practice
1429199|NCT01047735|comparative effectiveness|comparative effectiveness
1429200|NCT01047735|coronary attack|coronary attack
1429201|NCT01047735|coronary infarct|coronary infarct
1429202|NCT01047735|coronary infarction|coronary infarction
1429203|NCT01047735|corpulence|corpulence
1429204|NCT01047735|corpulency|corpulency
1429205|NCT01047735|corpulentia|corpulentia
1429206|NCT01047735|design|design
1429207|NCT01047735|designing|designing
1429208|NCT01047735|diabetes|diabetes
1429209|NCT01047735|diabetic patient|diabetic patient
1429210|NCT01047735|disease/disorder|disease/disorder
1429211|NCT01047735|drug/agent|drug/agent
1429212|NCT01047735|effective therapy|effective therapy
1429213|NCT01047735|effectiveness research|effectiveness research
1429214|NCT01047735|fitness|fitness
1429215|NCT01047735|gastric banding|gastric banding
1429216|NCT01047735|gastric bypass surgery|gastric bypass surgery
1429217|NCT01047735|glucose control|glucose control
1429218|NCT01047735|glucose homeostasis|glucose homeostasis
1429219|NCT01047735|glucose metabolism|glucose metabolism
1429220|NCT01047735|glucose regulation|glucose regulation
1429221|NCT01047735|heart attack|heart attack
1429222|NCT01047735|heart infarct|heart infarct
1429223|NCT01047735|heart infarction|heart infarction
1429224|NCT01047735|hepatopathy|hepatopathy
1429225|NCT01047735|hyperpiesia|hyperpiesia
1429226|NCT01047735|hyperpiesis|hyperpiesis
1429227|NCT01047735|hypertensive disease|hypertensive disease
1429228|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
1429229|NCT01047735|insulin resistant|insulin resistant
1429230|NCT01047735|interest|interest
1429231|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
1429232|NCT01047735|life style intervention|life style intervention
1429233|NCT01047735|lifestyle intervention|lifestyle intervention
1429234|NCT01047735|liver disorder|liver disorder
1429235|NCT01047735|long-term study|long-term study
1429236|NCT01047735|malignancy|malignancy
1429237|NCT01047735|maturity onset diabetes|maturity onset diabetes
1429238|NCT01047735|moderate obesity|moderate obesity
1429239|NCT01047735|neoplasm/cancer|neoplasm/cancer
1429240|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
1429241|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
1429242|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
1429243|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
1429244|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
1429245|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
1429246|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
1429247|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1429248|NCT01047735|obese|obese
1429249|NCT01047735|obese people|obese people
1429250|NCT01047735|obese person|obese person
1429251|NCT01047735|obese population|obese population
1429252|NCT01047735|obesity surgery|obesity surgery
1429253|NCT01047735|obesity, extreme|obesity, extreme
1429254|NCT01047735|pathophysiology|pathophysiology
1429255|NCT01047735|pilot study|pilot study
1429256|NCT01047735|programs|programs
1429257|NCT01047735|psychosocial|psychosocial
1429258|NCT01047735|psychosocial variables|psychosocial variables
1429259|NCT01047735|public health medicine (field)|public health medicine (field)
1429260|NCT01047735|public health relevance|public health relevance
1429261|NCT01047735|randomisation|randomisation
1429262|NCT01047735|randomization|randomization
1429263|NCT01047735|randomized controlled study|randomized controlled study
1429264|NCT01047735|randomized trial|randomized trial
1429265|NCT01047735|randomly assigned|randomly assigned
1429266|NCT01047735|respiratory|respiratory
1429267|NCT01047735|response|response
1429268|NCT01047735|stomach bypass|stomach bypass
1429269|NCT01047735|stomach stapling|stomach stapling
1429270|NCT01047735|surgery|surgery
1429271|NCT01047735|trial comparing|trial comparing
1429272|NCT01047735|vascular|vascular
1429273|NCT01047735|weight loss intervention|weight loss intervention
1429274|NCT01047735|weight loss surgery|weight loss surgery
1429275|NCT01047735|wt-loss|wt-loss
1429276|NCT01047722|platelet function test|platelet function test
1429277|NCT01047722|platelets|platelets
1429278|NCT01047722|in vivo test|in vivo test
1429279|NCT01047722|aspirin|aspirin
1429280|NCT01047722|aspirin resistance|aspirin resistance
1429281|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
1429282|NCT01047722|in-vivo|in-vivo
1429283|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
1568398|NCT00505999|Multiple Myeloma|multiple myeloma
1429284|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
1429285|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
1429286|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
1429287|NCT01047683|statin|statin
1429288|NCT01047683|triglycerides|triglycerides
1429289|NCT01047683|lipids|lipids
1429290|NCT01047683|EPA|epa
1429291|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
1429292|NCT01047683|fish|fish
1429293|NCT01047683|fatty acids|fatty acids
1429294|NCT01047683|fibrates|fibrates
1429295|NCT01047683|niacin|niacin
1429296|NCT01047683|lipid|lipid
1429297|NCT01047683|atorvastatin|atorvastatin
1429298|NCT01047683|Lovaza|lovaza
1429299|NCT01047683|simvastatin|simvastatin
1429300|NCT01047683|lovastatin|lovastatin
1429301|NCT01047683|pravastatin|pravastatin
1429302|NCT01047683|fluvastatin|fluvastatin
1429303|NCT01047683|rosuvastatin|rosuvastatin
1429304|NCT01047683|Trilipix|trilipix
1429305|NCT01047683|Vytorin|vytorin
1429306|NCT01047683|Simcor|simcor
1429307|NCT01047683|Niaspan|niaspan
1429308|NCT01047683|ezetimibe|ezetimibe
1429309|NCT01047683|Zetia|zetia
1429310|NCT01047683|ethyl-EPA|ethyl-epa
1429311|NCT01047683|ethyl icosapentate|ethyl icosapentate
1429312|NCT01047683|Crestor|crestor
1429313|NCT01047683|Zocor|zocor
1429314|NCT01047683|Lipitor|lipitor
1429315|NCT01047683|LDL|ldl
1429316|NCT01047683|HDL|hdl
1429317|NCT01047683|cholesterol|cholesterol
1429318|NCT01047683|dyslipidemia|dyslipidemia
1429319|NCT01047683|VASCEPA|vascepa
1429320|NCT01047683|icosapent ethyl|icosapent ethyl
1429321|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
1429322|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
1429323|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
1429324|NCT01047670|PICU mortality|picu mortality
1429325|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
1429326|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
1429327|NCT01047657|Asthma|asthma
1429328|NCT01047657|Obesity|obesity
1429329|NCT01047657|weight loss|weight loss
1429330|NCT01047644|port|port
1429331|NCT01047644|catheter|catheter
1429332|NCT01047644|infusion|infusion
1429333|NCT01047644|flush|flush
1429334|NCT01047644|cleanse|cleanse
1429335|NCT01047644|chemotherapy|chemotherapy
1429336|NCT01047618|venous thromboembolism|venous thromboembolism
1429337|NCT01047605|qEEG|qeeg
1429338|NCT01047605|herbal medicine|herbal medicine
1429339|NCT01047605|cognitive function|cognitive function
1429340|NCT01047605|Neurapas balance|neurapas balance
1429341|NCT01047605|Pascoflair|pascoflair
1429342|NCT01047605|hypericum|hypericum
1429343|NCT01047605|passionflower|passionflower
1429344|NCT01047605|valerian|valerian
1429345|NCT01047605|Healthy volunteers|healthy volunteers
1429346|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
1429347|NCT01047592|Schizophrenia|schizophrenia
1429348|NCT01047592|cognitive function|cognitive function
1429349|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
1429350|NCT01047579|Alzheimer's Disease|alzheimer's disease
1429351|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
1429352|NCT01047579|caregiver preference|caregiver preference
1429353|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1429354|NCT01047553|COPD|copd
1429355|NCT01047553|Japanese|japanese
1429356|NCT01047553|Phase 3|phase 3
1429357|NCT01047553|Safety|safety
1429358|NCT01047553|OT|ot
1429359|NCT01047553|Oxis|oxis
1429360|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
1429361|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
1429362|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
1429363|NCT01047501|statin|statin
1429364|NCT01047501|triglycerides|triglycerides
1429365|NCT01047501|lipids|lipids
1429366|NCT01047501|EPA|epa
1429367|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
1429368|NCT01047501|fish|fish
1429369|NCT01047501|fatty acids|fatty acids
1429370|NCT01047501|fibrates|fibrates
1429371|NCT01047501|niacin|niacin
1429372|NCT01047501|lipid|lipid
1429373|NCT01047501|atorvastatin|atorvastatin
1429374|NCT01047501|Lovaza|lovaza
1429375|NCT01047501|simvastatin|simvastatin
1429376|NCT01047501|lovastatin|lovastatin
1429377|NCT01047501|pravastatin|pravastatin
1429378|NCT01047501|fluvastatin|fluvastatin
1429379|NCT01047501|rosuvastatin|rosuvastatin
1429380|NCT01047501|Trilipix|trilipix
1429381|NCT01047501|Vytorin|vytorin
1429382|NCT01047501|Simcor|simcor
1429383|NCT01047501|Niaspan|niaspan
1429384|NCT01047501|ezetimibe|ezetimibe
1429385|NCT01047501|Zetia|zetia
1429386|NCT01047501|ethyl-EPA|ethyl-epa
1429387|NCT01047501|ethyl icosapentate|ethyl icosapentate
1429388|NCT01047501|Crestor|crestor
1429389|NCT01047501|Zocor|zocor
1429390|NCT01047501|Lipitor|lipitor
1429391|NCT01047501|LDL|ldl
1429392|NCT01047501|HDL|hdl
1429393|NCT01047501|cholesterol|cholesterol
1429394|NCT01047501|dyslipidemia|dyslipidemia
1429395|NCT01047501|VASCEPA|vascepa
1429396|NCT01047501|icosapent ethyl|icosapent ethyl
1429397|NCT01047488|polyneuropathy|polyneuropathy
1429398|NCT01047488|neuropathic pain|neuropathic pain
1429399|NCT01047488|treatment|treatment
1429400|NCT01047475|MB-6|mb-6
1429401|NCT01047475|FOLFOX4|folfox4
1429402|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
1429403|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
1429404|NCT01047449|fish oil supplementation|fish oil supplementation
1429405|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
1429406|NCT01047449|coronary artery disease|coronary artery disease
1429407|NCT01047436|Plasmodium infections|plasmodium infections
1429408|NCT01047436|Remittent fever|remittent fever
1429409|NCT01047436|Artemether|artemether
1429410|NCT01047436|Artemisinins|artemisinins
1429411|NCT01047436|quinine|quinine
1429412|NCT01047436|Malaria|malaria
1429413|NCT01047436|Protozoan Infections|protozoan infections
1429414|NCT01047436|Anti-Infective Agents|anti-infective agents
1429415|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
1429416|NCT01047436|Schistosomicides|schistosomicides
1429417|NCT01047436|Pharmacologic Actions|pharmacologic actions
1429418|NCT01047436|Malaria, Falciparum|malaria, falciparum
1429419|NCT01047436|Antimalarials|antimalarials
1429420|NCT01047436|Antiparasitic Agents|antiparasitic agents
1429421|NCT01047436|Parasitic Diseases|parasitic diseases
1429422|NCT01047436|sublingual|sublingual
1429423|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
1429424|NCT01047410|physical exercise training|physical exercise training
1429425|NCT01047410|quality of life|quality of life
1429426|NCT01047410|exercise capacity|exercise capacity
1429427|NCT01047410|skeletal muscle strength|skeletal muscle strength
1429428|NCT01047410|physical activity level|physical activity level
1429429|NCT01047410|costeffectiveness|costeffectiveness
1429430|NCT01047410|renal transplantation|renal transplantation
1429431|NCT01047410|hemodialysis|hemodialysis
1429432|NCT01047410|peritoneal dialysis|peritoneal dialysis
1429433|NCT01047410|diet|diet
1429434|NCT01047397|hemodialysis|hemodialysis
1429435|NCT01047397|tolerability|tolerability
1429436|NCT01047397|pharmacokinetics|pharmacokinetics
1429437|NCT01047397|safety|safety
1429438|NCT01047397|anemia|anemia
1429439|NCT01047397|renal impairment|renal impairment
1429440|NCT01047397|repeat dose|repeat dose
1429441|NCT01047345|Cervical cancer|cervical cancer
1429442|NCT01047345|Genital warts|genital warts
1429443|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
1429444|NCT01047345|GARDASIL™|gardasil™
1429445|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1429446|NCT01047293|colorectal cancer|colorectal cancer
1429447|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
1429448|NCT01047280|Body weight|body weight
1429449|NCT01047280|Body composition|body composition
1429450|NCT01047280|Blood lipid profile|blood lipid profile
1429451|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
1429452|NCT01047267|candidiasis|candidiasis
1429453|NCT01047267|invasive fungal disease|invasive fungal disease
1429454|NCT01047267|critically ill|critically ill
1429455|NCT01047267|anidulafungin|anidulafungin
1429456|NCT01047267|pharmacokinetics|pharmacokinetics
1429457|NCT01047241|Painful medical procedures|painful medical procedures
1429458|NCT01047215|schizophrenia|schizophrenia
1429459|NCT01047215|bipolar|bipolar
1429460|NCT01047215|aripiprazole|aripiprazole
1429461|NCT01047215|quetiapine|quetiapine
1429462|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
1429463|NCT01047176|Statins|statins
1429464|NCT01047176|Coronary Heart Disease|coronary heart disease
1429465|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1429466|NCT01047163|Muscle soreness|muscle soreness
1429467|NCT01047163|Simvastatin|simvastatin
1429468|NCT01047163|Men|men
1429469|NCT01047163|Muscle Atrophy|muscle atrophy
1429470|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
1429471|NCT01047150|Repeat studies|repeat studies
1429472|NCT01047150|Tetrofosmin|tetrofosmin
1429473|NCT01047150|Sestamibi|sestamibi
1429474|NCT01047137|Urticaria|urticaria
1429475|NCT01047137|Hives|hives
1429476|NCT01047137|Stress|stress
1429477|NCT01047137|Immune dysregulation|immune dysregulation
1429478|NCT01047124|Depression|depression
1429479|NCT01047124|Collaborative Care|collaborative care
1429480|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
1429481|NCT01047124|Mental Health Services|mental health services
1429482|NCT01047124|Antidepressants|antidepressants
1429483|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
1429484|NCT01047111|Esophagectomy|esophagectomy
1429485|NCT01047098|Lactation|lactation
1429486|NCT01047098|Breastfeeding|breastfeeding
1429487|NCT01047098|Iron|iron
1429488|NCT01047098|Oxidative stress|oxidative stress
1568399|NCT00505999|Etiology|etiology
1429489|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
1429490|NCT01047085|cholecystolithiasis|cholecystolithiasis
1429491|NCT01047085|cholecystectomy|cholecystectomy
1429492|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
1429493|NCT01047085|impedance pH|impedance ph
1429592|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
1429494|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
1429495|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
1429496|NCT01047059|NSCLC|nsclc
1429497|NCT01047059|Lung Cancer|lung cancer
1429498|NCT01047046|SNM device|snm device
1429499|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
1429500|NCT01047033|Poverty|poverty
1429501|NCT01047033|Global health|global health
1429502|NCT01047033|International health|international health
1429503|NCT01047033|Latin America|latin america
1429504|NCT01047033|Peru|peru
1429505|NCT01047033|Child health|child health
1429506|NCT01047033|Microcredit|microcredit
1429507|NCT01047033|Microenterprise|microenterprise
1429508|NCT01047033|Microfinance|microfinance
1429509|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
1429510|NCT01047020|Physical activity;|physical activity;
1429511|NCT01047020|Motor Proficiency;|motor proficiency;
1429512|NCT01047007|Head and Neck Cancer|head and neck cancer
1429513|NCT01047007|Esophageal Cancer|esophageal cancer
1429514|NCT01047007|Gastric Cancer|gastric cancer
1429515|NCT01046981|Surgical site infections|surgical site infections
1429516|NCT01046981|Prevention|prevention
1429517|NCT01046981|Prophylaxis|prophylaxis
1429518|NCT01046981|Tumescent|tumescent
1429519|NCT01046981|Intravenous|intravenous
1429520|NCT01046981|Antibiotic|antibiotic
1429521|NCT01046981|Absorption|absorption
1429522|NCT01046981|Pharmacokinetics|pharmacokinetics
1429523|NCT01046981|Bioavailability|bioavailability
1429524|NCT01046968|Obesity|obesity
1429525|NCT01046968|metabolic syndrome|metabolic syndrome
1429526|NCT01046968|C-reactive protein|c-reactive protein
1429527|NCT01046968|Leptin|leptin
1429528|NCT01046955|ESRD|esrd
1429529|NCT01046942|Saphenous vein|saphenous vein
1429530|NCT01046942|Antiplatelet therapy|antiplatelet therapy
1429531|NCT01046942|Hypercoagulable|hypercoagulable
1429532|NCT01046942|Clopidogrel resistance|clopidogrel resistance
1429533|NCT01046942|Aspirin resistance|aspirin resistance
1429534|NCT01046942|Clopidogrel|clopidogrel
1429535|NCT01046942|Aspirin|aspirin
1429536|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
1429537|NCT01046942|TEG|teg
1429538|NCT01046942|Thrombelastography|thrombelastography
1429539|NCT01046942|Multiplate aggregometry|multiplate aggregometry
1429540|NCT01046942|Multislice CT|multislice ct
1429541|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1429542|NCT01046942|coagulation status|coagulation status
1429543|NCT01046942|graft patency|graft patency
1429544|NCT01046942|CABG|cabg
1429545|NCT01046929|limonene|limonene
1429546|NCT01046929|breast cancer|breast cancer
1429547|NCT01046929|cancer prevention|cancer prevention
1429548|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
1429549|NCT01046890|Darunavir|darunavir
1429550|NCT01046890|Echinacea purpurea|echinacea purpurea
1429551|NCT01046890|Interaction|interaction
1429552|NCT01046890|Complementary Therapies|complementary therapies
1429553|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
1429554|NCT01046838|Diastolic Heart Failure|diastolic heart failure
1429555|NCT01046825|Lymphoma|lymphoma
1429556|NCT01046825|Leukemia|leukemia
1429557|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1429558|NCT01046812|questionnaire|questionnaire
1429559|NCT01046812|halitosis|halitosis
1429560|NCT01046812|caphosol|caphosol
1429561|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
1429562|NCT01046799|hepatitis B|hepatitis b
1429563|NCT01046799|liver transplantation|liver transplantation
1429564|NCT01046799|shortterm HBIg|shortterm hbig
1429565|NCT01046799|lamivudine resistance|lamivudine resistance
1429566|NCT01046786|spinal cord injury|spinal cord injury
1429567|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
1429568|NCT01046786|Methylprednisolone|methylprednisolone
1429569|NCT01046786|Lithium Carbonate|lithium carbonate
1429570|NCT01046773|Children|children
1429571|NCT01046773|Crohn's disease|crohn's disease
1429572|NCT01046773|Vitamin D|vitamin d
1429573|NCT01046760|epilepsy|epilepsy
1429574|NCT01046760|language|language
1429575|NCT01046760|childhood|childhood
1429576|NCT01046760|praxis|praxis
1429577|NCT01046747|external fixation|external fixation
1429578|NCT01046747|pin tract infection|pin tract infection
1429579|NCT01046747|self drilling|self drilling
1429580|NCT01046734|Influenza|influenza
1429581|NCT01046734|virus shedding|virus shedding
1429582|NCT01046734|infection control|infection control
1429583|NCT01046734|swine flu|swine flu
1429584|NCT01046721|blood pressure|blood pressure
1429585|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
1429586|NCT01046721|cardiovascular effects|cardiovascular effects
1429587|NCT01046721|Exenatide|exenatide
1429588|NCT01046708|IUI|iui
1429589|NCT01046708|clomiphene citrate|clomiphene citrate
1429590|NCT01046708|utrogestan|utrogestan
1429591|NCT01046695|VATS|vats
1429593|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1429594|NCT01046682|HIV|hiv
1429595|NCT01046682|Endothelial dysfunction|endothelial dysfunction
1429596|NCT01046682|Inflammation|inflammation
1429597|NCT01046682|Insulin resistance|insulin resistance
1429598|NCT01046656|nosocomial infection|nosocomial infection
1429599|NCT01046656|diarrhea|diarrhea
1429600|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
1429601|NCT01046656|gastroenteritis|gastroenteritis
1429602|NCT01046656|rotavirus|rotavirus
1429603|NCT01046643|Women|women
1429604|NCT01046643|Healthy|healthy
1429605|NCT01046643|Menopausal|menopausal
1429606|NCT01046643|Hormone treatment|hormone treatment
1429607|NCT01046630|Phase I|phase i
1429608|NCT01046630|BOLD signal|bold signal
1429609|NCT01046630|fMRI|fmri
1429610|NCT01046630|AZD6765|azd6765
1429611|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
1429612|NCT01046617|infantile colic|infantile colic
1429613|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
1429614|NCT01046617|duration of crying|duration of crying
1429615|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
1429616|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
1429617|NCT01046604|fish oil|fish oil
1429618|NCT01046604|cardiac|cardiac
1429619|NCT01046604|mitochondria|mitochondria
1429620|NCT01046604|apoptosis|apoptosis
1429621|NCT01046604|human heart|human heart
1429622|NCT01046591|Cleft Palate|cleft palate
1429623|NCT01046591|Cleft Lip|cleft lip
1429624|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
1429625|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
1429626|NCT01046591|Behavior|behavior
1429627|NCT01046591|Learning|learning
1429628|NCT01046578|Folliculogenesis|folliculogenesis
1429629|NCT01046578|Letrozole|letrozole
1429630|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
1429631|NCT01046578|Estrogen|estrogen
1429632|NCT01046552|Choledocholithias|choledocholithias
1429633|NCT01046552|Common bile duct stones|common bile duct stones
1429634|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1429635|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
1429636|NCT01046552|Preoperative|preoperative
1429637|NCT01046552|intraoperative|intraoperative
1429638|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
1429639|NCT01046526|Psychopathology|psychopathology
1429640|NCT01046526|Nicotine Patch|nicotine patch
1429641|NCT01046526|Eye Tracking|eye tracking
1429642|NCT01046526|Attention|attention
1429643|NCT01046526|Schizophrenic Participants|schizophrenic participants
1429644|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
1429645|NCT01046513|Neuroimaging|neuroimaging
1429646|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
1429647|NCT01046513|Alpha4beta2|alpha4beta2
1429648|NCT01046513|Nicotine|nicotine
1429649|NCT01046513|Receptor Upregulation|receptor upregulation
1429650|NCT01046500|insulin resistance|insulin resistance
1429651|NCT01046500|body mass index|body mass index
1429652|NCT01046500|myo-inositol|myo-inositol
1429653|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
1429654|NCT01046500|blood pressure|blood pressure
1429655|NCT01046500|metformin|metformin
1429656|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
1429657|NCT01046487|cylindroma|cylindroma
1429658|NCT01046487|choroid melanoma|choroid melanoma
1429659|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
1429660|NCT01046487|chordoma|chordoma
1429661|NCT01046487|ocular melanoma|ocular melanoma
1429662|NCT01046487|conjunctival melanoma|conjunctival melanoma
1429663|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
1429664|NCT01046487|gastric melanoma|gastric melanoma
1429665|NCT01046487|desmoid tumor|desmoid tumor
1429666|NCT01046474|school children|school children
1429667|NCT01046474|body mass index|body mass index
1429668|NCT01046474|sugar intake|sugar intake
1429669|NCT01046474|beverage intake|beverage intake
1429670|NCT01046461|Ramosetron|ramosetron
1429671|NCT01046461|aprepitant|aprepitant
1429672|NCT01046461|dexamethasone|dexamethasone
1429673|NCT01046461|cancer|cancer
1429674|NCT01046461|chemotherapy|chemotherapy
1429675|NCT01046461|antiemetics|antiemetics
1429676|NCT01046461|cisplatin|cisplatin
1429677|NCT01046461|nausea|nausea
1429678|NCT01046461|vomiting|vomiting
1429679|NCT01046461|high dose cisplatin|high dose cisplatin
1429680|NCT01046448|Children|children
1429681|NCT01046448|chronic renal failure|chronic renal failure
1429682|NCT01046448|chronic kidney disease|chronic kidney disease
1429683|NCT01046448|cardiovascular disease|cardiovascular disease
1429684|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
1429685|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
1429686|NCT01046448|carotid intima media thickness|carotid intima media thickness
1429687|NCT01046448|arterial stiffness|arterial stiffness
1429688|NCT01046448|pulse wave velocity|pulse wave velocity
1429689|NCT01046448|augmentation index|augmentation index
1429690|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
1429691|NCT01046448|progression|progression
1429692|NCT01046448|genetic risk factors|genetic risk factors
1429693|NCT01046448|vasculopathy|vasculopathy
1429694|NCT01046448|cardiopathy|cardiopathy
1429695|NCT01046448|whole genome analysis|whole genome analysis
1429696|NCT01046448|haplotype analysis|haplotype analysis
1429697|NCT01046448|SNP-screening|snp-screening
1429698|NCT01046435|periodontitis|periodontitis
1429699|NCT01046435|cardiovascular disease|cardiovascular disease
1429700|NCT01046435|diabetes|diabetes
1429701|NCT01046409|Coronary artery disease|coronary artery disease
1429702|NCT01046409|Bifurcation|bifurcation
1429703|NCT01046409|Myocardial infarction|myocardial infarction
1429704|NCT01046409|Myocardial ischemia|myocardial ischemia
1429705|NCT01046409|Collateral|collateral
1429706|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
1429707|NCT01046383|WEIGHT LOSS|weight loss
1429708|NCT01046383|QUALITY OF LIFE|quality of life
1429709|NCT01046383|SURVIVAL|survival
1429710|NCT01046383|CHEMOTHERAPY|chemotherapy
1429711|NCT01046383|RADIOTHERAPY|radiotherapy
1429712|NCT01046383|SURGERY|surgery
1429713|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
1429714|NCT01046383|IMN1207|imn1207
1429715|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
1429716|NCT01046383|BODY WEIGHT|body weight
1429717|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
1429718|NCT01046357|First in human|first in human
1429719|NCT01046357|Safety|safety
1429720|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
1429721|NCT01046305|CML|cml
1429722|NCT01046305|Symptom Burden|symptom burden
1429723|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
1429724|NCT01046305|MDASI-CML|mdasi-cml
1429725|NCT01046305|Severity|severity
1429726|NCT01046305|Interference|interference
1429727|NCT01046305|Questionnaire|questionnaire
1429728|NCT01046305|Interview|interview
1429729|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
1429730|NCT01046253|Bioequivalence|bioequivalence
1429731|NCT01046253|Healthy Subjects|healthy subjects
1429732|NCT01046240|chemotherapy|chemotherapy
1429734|NCT01046240|palonosetron|palonosetron
1429735|NCT01046227|Serology|serology
1429736|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
1429737|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
1429738|NCT01046188|Education|education
1429739|NCT01046188|Internet|internet
1429740|NCT01046188|In vitro fertilization|in vitro fertilization
1429741|NCT01046175|Respiratory complications|respiratory complications
1429742|NCT01046175|respiratory insufficiency|respiratory insufficiency
1429743|NCT01046175|respiratory therapy|respiratory therapy
1429744|NCT01046162|Alprazolam|alprazolam
1429745|NCT01046162|Tafil|tafil
1429746|NCT01046162|Xanax|xanax
1429747|NCT01046162|Bioequivalence|bioequivalence
1429748|NCT01046162|Drug Kinetics|drug kinetics
1429749|NCT01046149|Depression|depression
1429750|NCT01046149|Depressive Symptoms|depressive symptoms
1429751|NCT01046149|postmenopause|postmenopause
1429752|NCT01046149|RSA biofeedback|rsa biofeedback
1429753|NCT01046136|common cold|common cold
1429754|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
1429755|NCT01046084|Bioequivalence|bioequivalence
1429756|NCT01046084|Healthy Subjects|healthy subjects
1429757|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
1429758|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
1429759|NCT01046058|TMC435-C113|tmc435-c113
1429760|NCT01046058|TMC435|tmc435
1429761|NCT01046058|HCV|hcv
1429762|NCT01046058|Protease Inhibitor|protease inhibitor
1429763|NCT01046058|Hepatitis C|hepatitis c
1429764|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
1429765|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
1429766|NCT01046045|everolimus|everolimus
1429767|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
1429768|NCT01046032|Polycystic ovaries|polycystic ovaries
1429769|NCT01046032|Ovarian stimulation|ovarian stimulation
1429770|NCT01046032|IVF|ivf
1429771|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
1429772|NCT01046032|Metformin|metformin
1429773|NCT01046019|DXA|dxa
1429774|NCT01046019|Hip|hip
1429775|NCT01046019|Arthroplasty|arthroplasty
1429776|NCT01046006|lymphoma|lymphoma
1429777|NCT01046006|Bortezomib|bortezomib
1429778|NCT01046006|Rituximab|rituximab
1429779|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
1429780|NCT01045980|Peritoneal dialysis|peritoneal dialysis
1429781|NCT01045980|Impedance, bioelectric|impedance, bioelectric
1564617|NCT00519545|one|one
1429782|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
1429783|NCT01045980|Fluid status|fluid status
1429784|NCT01045980|Volume overload|volume overload
1429785|NCT01045980|Congestive heart failure|congestive heart failure
1429786|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
1429787|NCT01045980|Randomized controlled trial|randomized controlled trial
1429788|NCT01045967|Bioequivalence|bioequivalence
1429789|NCT01045967|Healthy Subjects|healthy subjects
1429790|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
1429791|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
1429792|NCT01045941|Distal Pancreas|distal pancreas
1429793|NCT01045941|Adenocarcinoma|adenocarcinoma
1429794|NCT01045941|Laparoscopic|laparoscopic
1429795|NCT01045941|Gemcitabine|gemcitabine
1429796|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
1429797|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
1429798|NCT01045902|Pulmonary Abscess|pulmonary abscess
1429799|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
1429800|NCT01045889|HIV|hiv
1429801|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
1429802|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1429803|NCT01045876|Randomized controlled trial|randomized controlled trial
1429804|NCT01045876|Dexamethasone|dexamethasone
1429805|NCT01045876|Single dose|single dose
1429806|NCT01045876|Preoperative|preoperative
1429807|NCT01045876|Plasma Cortisol level|plasma cortisol level
1429808|NCT01045863|volunteer|volunteer
1429809|NCT01045850|coronary stents|coronary stents
1429810|NCT01045850|non cardiac surgery|non cardiac surgery
1429811|NCT01045850|cardiovascular complications|cardiovascular complications
1429812|NCT01045850|hemorrhagic complications|hemorrhagic complications
1429813|NCT01045850|antiplatelet agents|antiplatelet agents
1429814|NCT01045850|bare metal stent|bare metal stent
1429815|NCT01045850|drug eluting stent|drug eluting stent
1429816|NCT01045850|surgery|surgery
1429817|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
1429818|NCT01045824|Schizophrenia|schizophrenia
1429819|NCT01045824|DNA|dna
1429820|NCT01045824|MRI|mri
1429821|NCT01045811|Depression|depression
1429822|NCT01045811|Depressive Symptoms|depressive symptoms
1429823|NCT01045811|postmenopause|postmenopause
1429824|NCT01045811|RSA biofeedback|rsa biofeedback
1429825|NCT01045798|Candidiasis|candidiasis
1429826|NCT01045798|Invasive Candidiasis|invasive candidiasis
1429827|NCT01045798|Fungal Infection|fungal infection
1429828|NCT01045798|Empirical Therapy|empirical therapy
1429829|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
1429830|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
1429831|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
1429832|NCT01045759|ultrasonography|ultrasonography
1429833|NCT01045759|intensive care unit|intensive care unit
1429834|NCT01045746|whole-body vibration|whole-body vibration
1429835|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
1429836|NCT01045746|static balance|static balance
1429837|NCT01045746|balance, mobility|balance, mobility
1429838|NCT01045746|elderly, reaction time|elderly, reaction time
1429839|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
1429840|NCT01045733|Cataract|cataract
1429841|NCT01045733|Toric|toric
1429842|NCT01045733|IOL|iol
1429843|NCT01045733|AcrySof|acrysof
1429844|NCT01045733|LRI|lri
1429845|NCT01045733|Astigmatism|astigmatism
1429846|NCT01045720|Schizophrenia|schizophrenia
1429847|NCT01045720|clozapine|clozapine
1429848|NCT01045720|hypersalivation|hypersalivation
1429849|NCT01045720|Suo Quan Wan|suo quan wan
1429850|NCT01045720|Wu Lin San|wu lin san
1429851|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
1429852|NCT01045694|Osteoarthritis|osteoarthritis
1429853|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
1429854|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
1429855|NCT01045681|Multiple Myeloma|multiple myeloma
1429856|NCT01045681|Elderly patients|elderly patients
1429857|NCT01045681|first relapse|first relapse
1429858|NCT01045681|refractory to first line therapy|refractory to first line therapy
1429859|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
1429860|NCT01045655|Depression|depression
1429861|NCT01045655|Perinatal care|perinatal care
1429862|NCT01045655|Postpartum period|postpartum period
1429863|NCT01045655|Pregnancy|pregnancy
1429865|NCT01045655|Low-income population|low-income population
1429866|NCT01045642|Bioequivalence|bioequivalence
1429867|NCT01045642|Omeprazole|omeprazole
1429868|NCT01045642|Crossover|crossover
1429869|NCT01045629|schizophrenia|schizophrenia
1429870|NCT01045629|PANSS|panss
1429871|NCT01045603|Instanyl|instanyl
1429872|NCT01045603|non-interventional|non-interventional
1429873|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
1429874|NCT01045603|BTP|btp
1429875|NCT01045603|BTCP|btcp
1429876|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
1429877|NCT01045577|Severe Psoriasis|severe psoriasis
1429878|NCT01045577|Kinase Inhibitor|kinase inhibitor
1429879|NCT01045577|Masitinib|masitinib
1429880|NCT01045564|Immunogenicity|immunogenicity
1429881|NCT01045564|Vaccines|vaccines
1429882|NCT01045564|H5N1|h5n1
1429883|NCT01045564|Influenza|influenza
1429884|NCT01045564|Pandemic|pandemic
1429885|NCT01045564|Human|human
1429886|NCT01045564|Avian|avian
1429887|NCT01045564|Safety|safety
1429888|NCT01045551|Inflammatory rosacea|inflammatory rosacea
1429889|NCT01045551|Papules and pustules|papules and pustules
1429890|NCT01045551|Moderate to severe erythema|moderate to severe erythema
1429891|NCT01045551|Telangiectasia|telangiectasia
1429892|NCT01045538|gastric cancer|gastric cancer
1429893|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
1429894|NCT01045538|1st line chemotherapy|1st line chemotherapy
1429895|NCT01045525|Phlebotomy|phlebotomy
1429896|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
1429897|NCT01045525|Hepatic Iron overload|hepatic iron overload
1429898|NCT01045512|immunosenescence|immunosenescence
1429899|NCT01045512|heart rate variability|heart rate variability
1429900|NCT01045512|autonomic nervous system|autonomic nervous system
1429901|NCT01045512|ageing|ageing
1429902|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
1429903|NCT01045512|physical activity|physical activity
1429904|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
1429905|NCT01045499|bariatric surgery|bariatric surgery
1429906|NCT01045499|adjustable gastric banding|adjustable gastric banding
1429907|NCT01045486|Atopic dermatitis|atopic dermatitis
1429908|NCT01045486|Food allergy|food allergy
1429909|NCT01045486|Probiotics|probiotics
1429910|NCT01045473|MIS|mis
1429911|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
1429912|NCT01045473|Fusion|fusion
1429913|NCT01045473|Spine|spine
1429914|NCT01045473|SMISS|smiss
1429915|NCT01045460|Patients with active myeloma (Stage II/III) that have completed induction therapy and are eligible for an autologous stem cell transplant|patients with active myeloma (stage ii/iii) that have completed induction therapy and are eligible for an autologous stem cell transplant
1429916|NCT01045434|Bioequivalence|bioequivalence
1429917|NCT01045434|omeprazole|omeprazole
1429918|NCT01045434|crossover|crossover
1429919|NCT01045421|NSCLC|nsclc
1429920|NCT01045421|SCLC|sclc
1429921|NCT01045421|HNSCC|hnscc
1429922|NCT01045408|Helicobacter pylori|helicobacter pylori
1429923|NCT01045408|Berry extract|berry extract
1429924|NCT01045408|Triple therapy|triple therapy
1429925|NCT01045395|Algae|algae
1429926|NCT01045395|Psoriasis|psoriasis
1429927|NCT01045395|Lipid metabolism|lipid metabolism
1429928|NCT01045395|Inflammation|inflammation
1429929|NCT01045395|Oxidative stress|oxidative stress
1429930|NCT01045382|HSC transplantation|hsc transplantation
1429931|NCT01045382|HLA-mismatched|hla-mismatched
1429932|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
1429933|NCT01045382|GVHD|gvhd
1429934|NCT01045382|co-infusion|co-infusion
1429935|NCT01045369|HIV|hiv
1429936|NCT01045369|Treatment Naive|treatment naive
1429937|NCT01045343|heart failure|heart failure
1429938|NCT01045343|home monitoring|home monitoring
1429939|NCT01045343|integrated diagnostics|integrated diagnostics
1429940|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
1429941|NCT01045317|micro-dose|micro-dose
1430230|NCT01044121|mattress|mattress
1429942|NCT01045317|pharmacokinetics|pharmacokinetics
1429943|NCT01045317|open label|open label
1429944|NCT01045317|PF-04776548|pf-04776548
1429945|NCT01045278|Hepatitis C patients|hepatitis c patients
1429946|NCT01045278|Hepacivirus|hepacivirus
1429947|NCT01045252|hemodynamics|hemodynamics
1429948|NCT01045252|neonatal|neonatal
1429949|NCT01045239|Diabetic macular edema|diabetic macular edema
1429950|NCT01045239|Diabetic macular oedema|diabetic macular oedema
1429951|NCT01045239|micropulse laser|micropulse laser
1429952|NCT01045239|laser treatment|laser treatment
1429953|NCT01045239|macular thickness|macular thickness
1429954|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1429955|NCT01045213|COPD|copd
1429956|NCT01045200|rectal cancer|rectal cancer
1429957|NCT01045200|follow-up|follow-up
1429958|NCT01045200|specialist nurse|specialist nurse
1429959|NCT01045187|endometrial cancer|endometrial cancer
1429960|NCT01045187|Uterine cancer|uterine cancer
1429961|NCT01045187|electronic brachytherapy|electronic brachytherapy
1429962|NCT01045187|Xoft|xoft
1429963|NCT01045174|Asthma|asthma
1429964|NCT01045174|Pediatric|pediatric
1429965|NCT01045174|Emergency department|emergency department
1429966|NCT01045174|Nebulizer|nebulizer
1429967|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1429968|NCT01045161|COPD|copd
1429969|NCT01045161|Chronic Bronchitis|chronic bronchitis
1429970|NCT01045161|Emphysema|emphysema
1429971|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
1429972|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
1429973|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1429974|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1429975|NCT01045148|Prostatic Cancer|prostatic cancer
1429976|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
1429977|NCT01045148|Prostate Neoplasms|prostate neoplasms
1429978|NCT01045148|Cancer of the Prostate|cancer of the prostate
1429979|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
1429980|NCT01045135|Levator hiatus|levator hiatus
1429981|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
1429982|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
1429983|NCT01045109|prostate|prostate
1429984|NCT01045109|cancer|cancer
1429985|NCT01045109|vitamin D3|vitamin d3
1429986|NCT01045109|early stage|early stage
1429987|NCT01045109|active surveillance|active surveillance
1429988|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
1429989|NCT01045096|Erosive Esophagitis|erosive esophagitis
1429990|NCT01045096|Pharmacokinetics|pharmacokinetics
1429991|NCT01045096|Pediatrics|pediatrics
1429992|NCT01045096|Drug Therapy|drug therapy
1429993|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
1429994|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
1429995|NCT01045044|Breast cancer|breast cancer
1429996|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
1429997|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
1429998|NCT01045044|Tumor response|tumor response
1429999|NCT01045044|Cognitive Impairment|cognitive impairment
1430000|NCT01045044|Chemo Brain|chemo brain
1430001|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
1430002|NCT01045018|colitis|colitis
1430003|NCT01045018|ulcerative|ulcerative
1430004|NCT01045018|ulcerative colitis|ulcerative colitis
1430005|NCT01045005|Type 1 diabetes|type 1 diabetes
1430006|NCT01045005|Endothelial dysfunction|endothelial dysfunction
1430007|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
1430008|NCT01044992|Multi systemic atrophy|multi systemic atrophy
1430009|NCT01044992|Parkinson Disease|parkinson disease
1430010|NCT01044992|PET investigation|pet investigation
1430011|NCT01044992|Motor control|motor control
1430012|NCT01044992|levodopa|levodopa
1430013|NCT01044992|MSA|msa
1430014|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
1430015|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
1430016|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
1430017|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
1430018|NCT01044966|Glioblastoma|glioblastoma
1430019|NCT01044966|Subventricular|subventricular
1430020|NCT01044966|gliomagenesis|gliomagenesis
1430021|NCT01044966|temozolomide|temozolomide
1430022|NCT01044966|depocyt|depocyt
1430023|NCT01044953|injury incidence|injury incidence
1430024|NCT01044953|male professional soccer|male professional soccer
1430025|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
1430026|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
1430027|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
1430028|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
1430029|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1430030|NCT01044927|telemedicine|telemedicine
1430031|NCT01044927|COPD|copd
1430032|NCT01044901|Sickle Cell Disease|sickle cell disease
1430033|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1430034|NCT01044901|Coronary Disease|coronary disease
1430035|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
1430036|NCT01044888|Heparin responsiveness|heparin responsiveness
1430037|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
1430038|NCT01044888|Risk factors|risk factors
1430039|NCT01044888|Myocardial infarction|myocardial infarction
1430040|NCT01044875|Diabetic retinopathy|diabetic retinopathy
1430041|NCT01044875|Laser treatment|laser treatment
1430042|NCT01044875|Complications|complications
1430043|NCT01044875|Laser wavelength|laser wavelength
1430044|NCT01044862|Pregnancy|pregnancy
1430045|NCT01044862|Infertility|infertility
1430046|NCT01044862|Ovarian stimulation|ovarian stimulation
1430047|NCT01044862|Aromatase inhibitors|aromatase inhibitors
1430048|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
1430049|NCT01044849|Blood Pressure|blood pressure
1430050|NCT01044836|Healthy volunteer|healthy volunteer
1430051|NCT01044823|RA|ra
1430052|NCT01044823|JRA|jra
1430053|NCT01044810|HIV|hiv
1430054|NCT01044810|efavirenz|efavirenz
1430055|NCT01044810|nevirapine|nevirapine
1430056|NCT01044810|allergy|allergy
1430057|NCT01044810|rash|rash
1430058|NCT01044810|Cohort Studies, Historical|cohort studies, historical
1430059|NCT01044810|Retrospective Study|retrospective study
1430060|NCT01044810|exanthem|exanthem
1430061|NCT01044810|Antiretroviral Agents|antiretroviral agents
1430062|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1430063|NCT01044810|HAART|haart
1430064|NCT01044810|treatment failure|treatment failure
1430065|NCT01044797|Healthy Volunteer|healthy volunteer
1430066|NCT01044797|Given Capsule Manipulation|given capsule manipulation
1430067|NCT01044784|CRT|crt
1430068|NCT01044771|HIV|hiv
1430069|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
1430070|NCT01044771|tenofovir|tenofovir
1430071|NCT01044771|viread|viread
1430072|NCT01044771|truvada|truvada
1430073|NCT01044771|proteinuria|proteinuria
1430074|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
1430075|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
1430076|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1430077|NCT01044758|Levetiracetam|levetiracetam
1430078|NCT01044758|Keppra|keppra
1430079|NCT01044758|Medial Temporal Lobe|medial temporal lobe
1430080|NCT01044758|Memory Impairment|memory impairment
1430081|NCT01044758|Alzheimer's Disease|alzheimer's disease
1430082|NCT01044758|AD|ad
1430083|NCT01044732|Colorectal|colorectal
1430084|NCT01044732|Neoplasms|neoplasms
1430085|NCT01044732|Adenomas|adenomas
1430086|NCT01044732|Polyps|polyps
1430087|NCT01044732|Miss rates|miss rates
1430088|NCT01044732|Detection rates|detection rates
1430089|NCT01044732|Colonoscope|colonoscope
1430090|NCT01044732|Third Eye Retroscope|third eye retroscope
1430091|NCT01044706|Bioequivalency|bioequivalency
1430092|NCT01044693|supine Hypertension|supine hypertension
1430093|NCT01044693|autonomic failure|autonomic failure
1430094|NCT01044693|nitric oxide|nitric oxide
1430095|NCT01044693|nebivolol|nebivolol
1430096|NCT01044680|fiber|fiber
1430097|NCT01044680|metabolic syndrome|metabolic syndrome
1430098|NCT01044680|overweight|overweight
1430099|NCT01044680|satiety|satiety
1430100|NCT01044654|HIV|hiv
1430101|NCT01044654|Treatment Experienced|treatment experienced
1430102|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
1430103|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
1430104|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
1430105|NCT01044628|COPD|copd
1430106|NCT01044628|Oxygen therapy|oxygen therapy
1430107|NCT01044628|Nocturnal|nocturnal
1430108|NCT01044628|Desaturation|desaturation
1430109|NCT01044628|INOX|inox
1430110|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
1430111|NCT01044615|Concussion|concussion
1430112|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1430113|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
1430114|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
1430115|NCT01044602|Obesity|obesity
1430116|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1430117|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
1430118|NCT01044576|Multiple Sclerosis|multiple sclerosis
1430119|NCT01044563|Depression|depression
1430120|NCT01044563|Depressive Symptoms|depressive symptoms
1430121|NCT01044563|postmenopause|postmenopause
1430122|NCT01044563|RSA biofeedback|rsa biofeedback
1430123|NCT01044550|Diaphragm injury|diaphragm injury
1430124|NCT01044550|Herniation|herniation
1430125|NCT01044537|phase 1|phase 1
1430126|NCT01044537|safety and tolerability|safety and tolerability
1430127|NCT01044537|PK|pk
1430128|NCT01044537|PD|pd
1430129|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
1430130|NCT01044537|T2DM|t2dm
1430131|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
1430132|NCT01044524|Phase I|phase i
1430133|NCT01044511|Esophageal cancer|esophageal cancer
1430134|NCT01044511|Cardia cancer|cardia cancer
1430135|NCT01044511|Health Related quality of Life|health related quality of life
1430136|NCT01044511|SEMS|sems
1430137|NCT01044511|Home visits|home visits
1430138|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
1430139|NCT01044485|dose escalation study|dose escalation study
1430140|NCT01044485|lapatinib|lapatinib
1430141|NCT01044485|docetaxel|docetaxel
1430142|NCT01044472|CRT-D|crt-d
1430143|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1430144|NCT01044459|COPD|copd
1430145|NCT01044459|Chronic Bronchitis|chronic bronchitis
1430146|NCT01044459|Emphysema|emphysema
1430147|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
1430148|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
1430149|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1430150|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1430151|NCT01044446|peritoneal dialysis|peritoneal dialysis
1430152|NCT01044446|peritonitis|peritonitis
1430153|NCT01044446|CAPD|capd
1430154|NCT01044446|end-stage renal disease|end-stage renal disease
1430155|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
1430156|NCT01044407|respiration|respiration
1430157|NCT01044407|sleep apnea|sleep apnea
1430158|NCT01044407|pacemaker|pacemaker
1430159|NCT01044394|colonoscopy|colonoscopy
1430160|NCT01044394|bowel preparation|bowel preparation
1430161|NCT01044394|polyethylene glycol|polyethylene glycol
1430162|NCT01044394|Quality in endoscopy|quality in endoscopy
1430163|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
1430164|NCT01044381|Toenail|toenail
1430165|NCT01044381|Fungal Infections|fungal infections
1430166|NCT01044381|DSO|dso
1430167|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
1430168|NCT01044355|Resistant Hypertension|resistant hypertension
1430169|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
1430170|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
1430171|NCT01044355|Arterial Stiffness|arterial stiffness
1430172|NCT01044355|Insulin Resistance|insulin resistance
1430173|NCT01044355|CPAP|cpap
1430174|NCT01044355|APAP|apap
1430175|NCT01044342|Healthy Volunteers|healthy volunteers
1430176|NCT01044342|EEG|eeg
1430177|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
1430178|NCT01044316|Vaccine|vaccine
1430179|NCT01044316|Booster|booster
1430180|NCT01044303|Kidney Transplantation|kidney transplantation
1430181|NCT01044303|Mycophenolic Acid|mycophenolic acid
1430182|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
1430183|NCT01044303|Kidney Rejection|kidney rejection
1430184|NCT01044290|quality of life|quality of life
1430185|NCT01044290|end of life|end of life
1430186|NCT01044290|self-disclosure|self-disclosure
1430187|NCT01044290|palliative care|palliative care
1430188|NCT01044277|glutathione|glutathione
1430189|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
1430190|NCT01044277|GSH|gsh
1430191|NCT01044264|Acne Vulgaris|acne vulgaris
1430192|NCT01044264|bioequivalency|bioequivalency
1430193|NCT01044264|clindamycin|clindamycin
1430194|NCT01044264|benzoyl peroxide|benzoyl peroxide
1430195|NCT01044251|Medication overuse headache|medication overuse headache
1430196|NCT01044251|Rebound headache|rebound headache
1430197|NCT01044251|Analgesic overuse headache|analgesic overuse headache
1430198|NCT01044251|Transitional therapy|transitional therapy
1430199|NCT01044251|Frovatriptan|frovatriptan
1430200|NCT01044251|Migraine|migraine
1430201|NCT01044238|methamphetamine|methamphetamine
1430202|NCT01044238|methylphenidate|methylphenidate
1430203|NCT01044238|clinical trial|clinical trial
1430204|NCT01044238|random assignment|random assignment
1430205|NCT01044238|double blind|double blind
1430206|NCT01044238|abstinence|abstinence
1430207|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
1430208|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
1430209|NCT01044212|Urogynecology|urogynecology
1430210|NCT01044199|rabies|rabies
1430211|NCT01044199|rabies vaccine|rabies vaccine
1430212|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
1430213|NCT01044186|Deferasirox|deferasirox
1430214|NCT01044186|ICL670A|icl670a
1430215|NCT01044186|Iron chelators|iron chelators
1430216|NCT01044186|Deferiprone|deferiprone
1430217|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
1430218|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
1430219|NCT01044186|Red cell aplasia|red cell aplasia
1430220|NCT01044186|Thalassemia|thalassemia
1430221|NCT01044186|β thalassemia|β thalassemia
1430222|NCT01044173|acute abdomen|acute abdomen
1430223|NCT01044173|CT|ct
1430224|NCT01044173|MRI|mri
1430225|NCT01044173|fast imaging|fast imaging
1430226|NCT01044160|cancer as trauma in children|cancer as trauma in children
1430227|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
1430228|NCT01044147|Obesity|obesity
1430229|NCT01044147|Internet|internet
1430231|NCT01044121|pain|pain
1430232|NCT01044121|sleep|sleep
1430233|NCT01044121|low back pain|low back pain
1430234|NCT01044121|back|back
1430235|NCT01044121|neck|neck
1430236|NCT01044121|arousal|arousal
1430237|NCT01044121|pillow|pillow
1430238|NCT01044121|kingsdown|kingsdown
1430239|NCT01044121|sleep to live|sleep to live
1430240|NCT01044121|duke university|duke university
1430241|NCT01044121|sleep to live institute|sleep to live institute
1430242|NCT01044121|missouri|missouri
1430243|NCT01044121|springfield|springfield
1430244|NCT01044121|joplin|joplin
1430245|NCT01044121|body diagnostic|body diagnostic
1430246|NCT01044121|dormo diagnostic|dormo diagnostic
1430247|NCT01044121|morning pain|morning pain
1430248|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
1430249|NCT01044095|avian influenza H5N1|avian influenza h5n1
1430250|NCT01044095|cross reactivity|cross reactivity
1430251|NCT01044095|prime boost|prime boost
1430252|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
1430253|NCT01044082|Third stage of labour|third stage of labour
1430254|NCT01044082|Controlled cord traction|controlled cord traction
1430255|NCT01044082|Randomized controlled trial|randomized controlled trial
1430256|NCT01044082|Prevention|prevention
1430257|NCT01044069|Cyclophosphamide|cyclophosphamide
1430258|NCT01044069|T cell|t cell
1430259|NCT01044069|leukapheresis|leukapheresis
1430260|NCT01044069|stem cell transplant|stem cell transplant
1430261|NCT01044069|bone marrow transplant|bone marrow transplant
1430262|NCT01044069|09-114|09-114
1430263|NCT01044030|otitis media|otitis media
1430264|NCT01044030|ear infection|ear infection
1430265|NCT01043991|STEMI|stemi
1430266|NCT01043991|AMI,|ami,
1430267|NCT01043991|acute myocardial infarct|acute myocardial infarct
1430268|NCT01043991|Epo|epo
1430269|NCT01043991|Erythropoietin|erythropoietin
1430270|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
1430271|NCT01043991|apoptosis|apoptosis
1430272|NCT01043965|Diabetes Mellitus|diabetes mellitus
1430273|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
1430274|NCT01043965|Heart diseases|heart diseases
1430275|NCT01043965|Echocardiography|echocardiography
1430276|NCT01043965|Endothelium|endothelium
1430277|NCT01043952|Propofol|propofol
1430278|NCT01043952|Remifentanil|remifentanil
1430279|NCT01043952|Bispectral Index Monitor|bispectral index monitor
1430680|NCT01042288|Panitumumab|panitumumab
1430280|NCT01043939|childhood cancers|childhood cancers
1430281|NCT01043939|cardiovascular disease|cardiovascular disease
1430282|NCT01043939|childhood cancer survivor|childhood cancer survivor
1430283|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
1430284|NCT01043913|Fatigue|fatigue
1430285|NCT01043913|Breast Neoplasms|breast neoplasms
1430286|NCT01043913|Quality of Life|quality of life
1430287|NCT01043913|Paullinia|paullinia
1430288|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1430289|NCT01043900|rTMS|rtms
1430290|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1430291|NCT01043900|treatment|treatment
1430292|NCT01043900|randomized controlled trials|randomized controlled trials
1430293|NCT01043887|Healthy Volunteers|healthy volunteers
1430294|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
1430295|NCT01043874|Chronic phase|chronic phase
1430296|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
1430297|NCT01043874|CML|cml
1430298|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
1430299|NCT01043874|Ph+|ph+
1430300|NCT01043874|Nilotinib|nilotinib
1430301|NCT01043874|CML-CP|cml-cp
1430302|NCT01043874|Suboptimal molecular response|suboptimal molecular response
1430303|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
1430304|NCT01043848|neuromodulation|neuromodulation
1430305|NCT01043848|spinal cord injury|spinal cord injury
1430306|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
1430307|NCT01043848|videocystometry|videocystometry
1430308|NCT01043848|neurophysiology|neurophysiology
1430309|NCT01043848|neuroplasticity|neuroplasticity
1430310|NCT01043835|Stomach Neoplasm|stomach neoplasm
1430311|NCT01043835|Laparoscopy|laparoscopy
1430312|NCT01043835|gastrectomy|gastrectomy
1430313|NCT01043822|Autism|autism
1430314|NCT01043822|mental retardation|mental retardation
1430315|NCT01043822|pain|pain
1430316|NCT01043822|emotion|emotion
1430317|NCT01043822|sensory profile|sensory profile
1430318|NCT01043822|children|children
1430319|NCT01043809|schools|schools
1430320|NCT01043809|handwashing|handwashing
1430321|NCT01043809|prevention and control|prevention and control
1430322|NCT01043809|communicable diseases|communicable diseases
1430323|NCT01043809|absenteeism|absenteeism
1430324|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
1430325|NCT01043796|Insecticide treated nets|insecticide treated nets
1430326|NCT01043796|Incidence cohort|incidence cohort
1430327|NCT01043783|Obesity|obesity
1430328|NCT01043770|Metabolic syndrome|metabolic syndrome
1430329|NCT01043770|Primary prevention|primary prevention
1430330|NCT01043770|Diabetes|diabetes
1430331|NCT01043770|Cardiovascular disease|cardiovascular disease
1430332|NCT01043770|Patient education|patient education
1430333|NCT01043757|Sedentary lifestyle|sedentary lifestyle
1430334|NCT01043757|physical exercise|physical exercise
1430335|NCT01043757|behavioral economics|behavioral economics
1430336|NCT01043757|financial incentives|financial incentives
1430337|NCT01043757|obesity|obesity
1430338|NCT01043744|malaria|malaria
1430339|NCT01043744|presumptive treatment|presumptive treatment
1430340|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
1430341|NCT01043744|fever|fever
1430342|NCT01043718|Obesity|obesity
1430343|NCT01043718|Internet|internet
1430344|NCT01043705|Pacemaker infection|pacemaker infection
1430345|NCT01043705|Defibrillator infection|defibrillator infection
1430346|NCT01043705|ICD infection|icd infection
1430347|NCT01043705|CRT infection|crt infection
1430348|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
1430349|NCT01043705|Infection|infection
1430350|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
1430351|NCT01043705|Defibrillators|defibrillators
1430352|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
1430353|NCT01043692|Acupuncture|acupuncture
1430354|NCT01043692|Acceptability|acceptability
1430355|NCT01043692|Geriatrics|geriatrics
1430356|NCT01043679|Bipolar, Mania|bipolar, mania
1430357|NCT01043679|Utapine|utapine
1430358|NCT01043679|Seroquel|seroquel
1430359|NCT01043666|Micturition|micturition
1430360|NCT01043666|YM178|ym178
1430361|NCT01043666|Urinary incontinence|urinary incontinence
1430362|NCT01043666|Frequency|frequency
1430363|NCT01043666|Overactive Bladder|overactive bladder
1430364|NCT01043666|Urgency|urgency
1430365|NCT01043666|Urinary urge incontinence|urinary urge incontinence
1430366|NCT01043653|recovery|recovery
1430367|NCT01043653|serious mental illness|serious mental illness
1430368|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
1430369|NCT01043614|Obesity|obesity
1430370|NCT01043614|Obesity Prevention|obesity prevention
1430371|NCT01043614|Freshman women|freshman women
1430372|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
1430373|NCT01043614|Self efficacy|self efficacy
1430374|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
1430375|NCT01043614|Peer education|peer education
1430376|NCT01043588|Surgery|surgery
1430377|NCT01043588|Prostate|prostate
1430378|NCT01043588|Laser 532 nm|laser 532 nm
1430379|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
1430380|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
1430381|NCT01043588|Men health|men health
1430382|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
1430383|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
1430384|NCT01043549|Tics|tics
1430385|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
1430386|NCT01043536|IMRT|imrt
1430387|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
1430388|NCT01043536|glioblastoma|glioblastoma
1430389|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
1430390|NCT01043523|Liver neoplasms|liver neoplasms
1430391|NCT01043523|Adenoma|adenoma
1430392|NCT01043523|Liver cell carcinoma|liver cell carcinoma
1430393|NCT01043523|Hepatocellular|hepatocellular
1430394|NCT01043523|Liver abscess|liver abscess
1430395|NCT01043484|Resectable rectal cancer|resectable rectal cancer
1430396|NCT01043484|Radiotherapy|radiotherapy
1430397|NCT01043484|Bevacizumab|bevacizumab
1430398|NCT01043484|Capecitabine|capecitabine
1430399|NCT01043471|Obesity|obesity
1430400|NCT01043458|Pharmacokinetics|pharmacokinetics
1430401|NCT01043445|GPR 119|gpr 119
1430402|NCT01043445|GLP-1 secretion|glp-1 secretion
1430403|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
1430404|NCT01043445|Dietary supplementation|dietary supplementation
1430405|NCT01043432|Traumatic Brain Injury|traumatic brain injury
1430406|NCT01043432|Suicide|suicide
1430407|NCT01043432|Executive Function|executive function
1430408|NCT01043419|Xenon Anesthesia|xenon anesthesia
1430409|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
1430410|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
1430411|NCT01043419|Baroreflex reagibility|baroreflex reagibility
1430412|NCT01043406|Epilepsy|epilepsy
1430413|NCT01043406|Seizures|seizures
1430414|NCT01043406|Advisory|advisory
1430415|NCT01043406|Prediction|prediction
1430416|NCT01043393|Plaque psoriasis|plaque psoriasis
1430417|NCT01043380|Heart Diseases|heart diseases
1430418|NCT01043380|Hyperlipidemia|hyperlipidemia
1430419|NCT01043380|Atorvastatin|atorvastatin
1430420|NCT01043380|Ezetimibe|ezetimibe
1430421|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
1430422|NCT01043380|Hypercholesterolemia|hypercholesterolemia
1430423|NCT01043380|Coronary Artery Disease|coronary artery disease
1430424|NCT01043380|Dyslipidemias|dyslipidemias
1430425|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
1430426|NCT01043367|Depression|depression
1430427|NCT01043367|Dietary supplement|dietary supplement
1430428|NCT01043367|Deprexil|deprexil
1430429|NCT01043354|cholesterol|cholesterol
1430430|NCT01043354|diabetes|diabetes
1430431|NCT01043354|adherence|adherence
1430432|NCT01043341|HPV|hpv
1430433|NCT01043341|vaccines|vaccines
1430434|NCT01043341|knowledge|knowledge
1430435|NCT01043341|attitude|attitude
1430436|NCT01043328|human papillomavirus|human papillomavirus
1430437|NCT01043328|nested PCR|nested pcr
1430438|NCT01043328|saliva|saliva
1430439|NCT01043328|serum|serum
1430440|NCT01043328|oral tissues|oral tissues
1430441|NCT01043315|Cognitive Function|cognitive function
1430442|NCT01043315|Cognitive Impairment|cognitive impairment
1430443|NCT01043315|Hospitalization|hospitalization
1430444|NCT01043315|Cardiac Disease|cardiac disease
1430445|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
1430446|NCT01043289|light therapy|light therapy
1430447|NCT01043289|antepartum depression|antepartum depression
1430448|NCT01043289|controlled trial|controlled trial
1430449|NCT01043276|Healthy|healthy
1430450|NCT01043250|schizophrenia|schizophrenia
1430451|NCT01043250|atypical antipsychotics|atypical antipsychotics
1430452|NCT01043250|appetite|appetite
1430453|NCT01043250|eating behavior|eating behavior
1430454|NCT01043237|acoustic|acoustic
1430455|NCT01043237|digital|digital
1430456|NCT01043237|sound|sound
1430457|NCT01043237|vibration|vibration
1430458|NCT01043237|coronary|coronary
1430459|NCT01043237|auscultation|auscultation
1430460|NCT01043237|artery|artery
1430461|NCT01043237|diagnosis|diagnosis
1430462|NCT01043211|Back Pain|back pain
1430463|NCT01043211|Lidocaine|lidocaine
1430464|NCT01043198|CGH array technology|cgh array technology
1430465|NCT01043198|mental retardation|mental retardation
1430466|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
1430467|NCT01043198|syndromic obesity|syndromic obesity
1430468|NCT01043198|obesity|obesity
1430469|NCT01043185|GERD|gerd
1430470|NCT01043185|lesogaberan|lesogaberan
1430471|NCT01043185|impedance|impedance
1430472|NCT01043185|pH|ph
1430473|NCT01043185|pharmacokinetics|pharmacokinetics
1430474|NCT01043185|safety|safety
1430475|NCT01043185|tolerability|tolerability
1430476|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
1430477|NCT01043146|autoantibody|autoantibody
1430478|NCT01043146|cyclic peptide|cyclic peptide
1430479|NCT01043146|heart failure|heart failure
1430480|NCT01043133|electronic medical records|electronic medical records
1430481|NCT01043133|documentation templates|documentation templates
1430482|NCT01043133|clinical encounter notes|clinical encounter notes
1430483|NCT01043081|African American women who have sex with women|african american women who have sex with women
1430484|NCT01043081|Sexually transmitted infections|sexually transmitted infections
1430485|NCT01043081|Homosexuality|homosexuality
1430486|NCT01043081|Human papillomavirus|human papillomavirus
1430487|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1430488|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
1430489|NCT01043081|Chlamydia|chlamydia
1430490|NCT01043081|Gonorrhea|gonorrhea
1430491|NCT01043081|Trichomoniasis|trichomoniasis
1430492|NCT01043081|Bacterial vaginosis|bacterial vaginosis
1430493|NCT01043081|Syphilis|syphilis
1430494|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
1430495|NCT01043068|cancer pain|cancer pain
1430496|NCT01043068|opioid|opioid
1430497|NCT01043068|guideline|guideline
1430498|NCT01043055|Breast Cancer Screening|breast cancer screening
1430499|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
1430500|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
1430501|NCT01043016|skin cancer|skin cancer
1430502|NCT01043016|esophageal cancer|esophageal cancer
1430503|NCT01043016|photodynamic therapy|photodynamic therapy
1430504|NCT01042990|Stroke|stroke
1430505|NCT01042990|Exercise|exercise
1430506|NCT01042990|Balance|balance
1430507|NCT01042990|Dynamic Gait|dynamic gait
1430508|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
1430509|NCT01042977|dapagliflozin|dapagliflozin
1430510|NCT01042977|diabetes|diabetes
1430511|NCT01042977|cardiovascular disease|cardiovascular disease
1430512|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
1430513|NCT01042964|acute coronary syndrome|acute coronary syndrome
1430514|NCT01042964|myocardial infarction|myocardial infarction
1430515|NCT01042964|stroke|stroke
1430516|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
1430517|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
1430518|NCT01042951|safety|safety
1430519|NCT01042951|immunogenicity|immunogenicity
1430520|NCT01042951|Healthy Participants|healthy participants
1430521|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
1430522|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
1430523|NCT01042925|breast cancer|breast cancer
1430524|NCT01042925|breast tumors|breast tumors
1430525|NCT01042925|human mammary carcinoma|human mammary carcinoma
1430526|NCT01042912|diagnosis|diagnosis
1430527|NCT01042912|carotid|carotid
1430528|NCT01042912|artery|artery
1430529|NCT01042912|disease|disease
1430530|NCT01042912|auscultation|auscultation
1430531|NCT01042912|sound|sound
1430532|NCT01042899|TBI|tbi
1430533|NCT01042899|intracranial edema|intracranial edema
1430534|NCT01042899|brain edema|brain edema
1430535|NCT01042899|craniocerebral trauma|craniocerebral trauma
1430536|NCT01042899|head injury|head injury
1430537|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
1430538|NCT01042899|subdural hematoma|subdural hematoma
1430539|NCT01042899|brain concussion|brain concussion
1430540|NCT01042899|head injuries, closed|head injuries, closed
1430541|NCT01042899|epidural hematoma|epidural hematoma
1430542|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
1430543|NCT01042899|cortical contusion|cortical contusion
1430544|NCT01042899|wounds and injuries|wounds and injuries
1430545|NCT01042899|disorders of environmental origin|disorders of environmental origin
1430546|NCT01042899|trauma, nervous system|trauma, nervous system
1430547|NCT01042899|brain injuries|brain injuries
1430548|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
1430549|NCT01042886|Pilot study|pilot study
1430550|NCT01042873|Desensitization|desensitization
1430551|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
1430552|NCT01042873|Healthy subjects|healthy subjects
1430553|NCT01042860|macular pigment|macular pigment
1430554|NCT01042860|lutein|lutein
1430555|NCT01042860|age-related macular degeneration|age-related macular degeneration
1430556|NCT01042860|AMD|amd
1430557|NCT01042847|ovarian|ovarian
1430558|NCT01042834|air pollution|air pollution
1430559|NCT01042834|autonomic nervous system|autonomic nervous system
1430560|NCT01042834|sleep apnea|sleep apnea
1430561|NCT01042834|Heart rate variability|heart rate variability
1430562|NCT01042834|Healthy volunteers|healthy volunteers
1430563|NCT01042821|anal fistula|anal fistula
1430564|NCT01042821|advancement flap|advancement flap
1430565|NCT01042821|incontinence|incontinence
1430566|NCT01042795|sunitinib|sunitinib
1430567|NCT01042795|bladder neoplasm|bladder neoplasm
1430568|NCT01042795|adjuvant treatment|adjuvant treatment
1430569|NCT01042795|disease free survival|disease free survival
1430570|NCT01042795|cystectomy|cystectomy
1430571|NCT01042782|gastric cancer|gastric cancer
1430572|NCT01042782|RAD001|rad001
1430573|NCT01042782|Mitomycin C|mitomycin c
1430574|NCT01042782|MTD|mtd
1430575|NCT01042743|colon cancer|colon cancer
1430576|NCT01042743|robot|robot
1430577|NCT01042743|laparoscopy|laparoscopy
1430578|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
1430579|NCT01042743|robot-assisted surgery|robot-assisted surgery
1430580|NCT01042730|Pitavastatin|pitavastatin
1430581|NCT01042730|Coronary Artery Disease|coronary artery disease
1430582|NCT01042730|Cardiovascular Disease|cardiovascular disease
1430583|NCT01042717|plerixafor|plerixafor
1430584|NCT01042717|autologous transplantation|autologous transplantation
1430585|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
1430586|NCT01042717|multiple myeloma|multiple myeloma
1430587|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
1430588|NCT01042704|Relapsed Myeloma|relapsed myeloma
1430589|NCT01042704|Refractory Myeloma|refractory myeloma
1430590|NCT01042665|Glaucoma|glaucoma
1430591|NCT01042665|intraocular pressure|intraocular pressure
1430592|NCT01042665|latanoprost|latanoprost
1430593|NCT01042665|retinal ganglion cell|retinal ganglion cell
1430594|NCT01042665|pattern electroretinogram|pattern electroretinogram
1430595|NCT01042652|Methadone|methadone
1430596|NCT01042652|HIV|hiv
1430597|NCT01042652|Raltegravir|raltegravir
1430598|NCT01042652|Antiretroviral|antiretroviral
1430599|NCT01042652|Intravenous Drug User|intravenous drug user
1430600|NCT01042652|Methadone Maintenance|methadone maintenance
1430601|NCT01042652|Treatment Naive|treatment naive
1430602|NCT01042639|osteopenia|osteopenia
1430603|NCT01042639|very low birthweight infants|very low birthweight infants
1430604|NCT01042639|bone speed of sound|bone speed of sound
1430605|NCT01042639|quantitative ultrasound|quantitative ultrasound
1430606|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
1430607|NCT01042626|Parathyroid Hormone|parathyroid hormone
1430608|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
1430609|NCT01042613|Intravenous cannulation|intravenous cannulation
1430610|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
1430611|NCT01042600|Surfactant|surfactant
1430612|NCT01042600|Tracheal intubation|tracheal intubation
1430613|NCT01042600|Laryngeal mask airway|laryngeal mask airway
1430615|NCT01042587|bright light therapy|bright light therapy
1430616|NCT01042587|circadian rhythm,|circadian rhythm,
1430617|NCT01042587|entrainment|entrainment
1430618|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
1430619|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
1430620|NCT01042574|intracranial monitoring|intracranial monitoring
1430621|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
1430622|NCT01042574|hypertension|hypertension
1430623|NCT01042561|vitamin d|vitamin d
1430624|NCT01042561|prematurity|prematurity
1430625|NCT01042561|25(OH)D|25(oh)d
1430626|NCT01042561|infant|infant
1430627|NCT01042561|CRP|crp
1430628|NCT01042561|PTH|pth
1430629|NCT01042548|Proteomics|proteomics
1430630|NCT01042548|Breast Cancer Markers|breast cancer markers
1430915|NCT01041430|Aged|aged
1430631|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
1430632|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
1430633|NCT01042509|Alemtuzumab|alemtuzumab
1430634|NCT01042509|Rituximab|rituximab
1430635|NCT01042509|Low-dose|low-dose
1430636|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
1430637|NCT01042496|Bipolar|bipolar
1430638|NCT01042496|depression|depression
1430639|NCT01042483|active stage|active stage
1430640|NCT01042483|labor|labor
1430641|NCT01042483|progression|progression
1430642|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
1430643|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
1430644|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
1430645|NCT01042470|biomechanics|biomechanics
1430646|NCT01042470|aspiration device|aspiration device
1430647|NCT01042470|connective tissue|connective tissue
1430648|NCT01042457|trough level|trough level
1430649|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
1430650|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
1430651|NCT01042457|Mycophenolic acid|mycophenolic acid
1430652|NCT01042457|lupus nephritis|lupus nephritis
1430653|NCT01042444|Heart disease|heart disease
1430654|NCT01042444|Embolic Protection Device|embolic protection device
1430655|NCT01042444|PCI|pci
1430656|NCT01042444|SVG|svg
1430657|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
1430658|NCT01042418|satiety|satiety
1430659|NCT01042418|grain structure|grain structure
1430660|NCT01042418|rye|rye
1430661|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
1430662|NCT01042379|I-SPY 2|i-spy 2
1430663|NCT01042379|Neoadjuvant|neoadjuvant
1430664|NCT01042379|Breast|breast
1430665|NCT01042379|Cancer|cancer
1430666|NCT01042379|Neoplasm|neoplasm
1430667|NCT01042379|Adaptive|adaptive
1430668|NCT01042379|pCR|pcr
1430669|NCT01042379|Pathologic Complete Response|pathologic complete response
1430670|NCT01042379|Biomarkers signature|biomarkers signature
1430671|NCT01042379|MRI Volume|mri volume
1430672|NCT01042366|Melanoma|melanoma
1430673|NCT01042340|nutrition|nutrition
1430674|NCT01042340|geriatric|geriatric
1430675|NCT01042340|supplement|supplement
1430676|NCT01042340|energy|energy
1430677|NCT01042327|solute clearances|solute clearances
1430678|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1430679|NCT01042288|NSCLC|nsclc
1430681|NCT01042288|Vectibix|vectibix
1430682|NCT01042288|Pemetrexed|pemetrexed
1430683|NCT01042288|Alimta|alimta
1430684|NCT01042288|Carboplatin|carboplatin
1430685|NCT01042275|stress urinary incontinence|stress urinary incontinence
1430686|NCT01042275|retropubic sling|retropubic sling
1430687|NCT01042275|transobturator sling|transobturator sling
1430688|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
1430689|NCT01042275|transobturator tape|transobturator tape
1430690|NCT01042275|TVT|tvt
1430691|NCT01042275|TVT-O|tvt-o
1430692|NCT01042275|TOT|tot
1430693|NCT01042275|REMEEX|remeex
1430694|NCT01042275|IVS|ivs
1430695|NCT01042262|Superoxide dismutase|superoxide dismutase
1430696|NCT01042262|Oxygen|oxygen
1430697|NCT01042262|Oxygen free radicals|oxygen free radicals
1430698|NCT01042262|Labor and delivery|labor and delivery
1430699|NCT01042249|PFMT|pfmt
1430700|NCT01042249|Stroke|stroke
1430701|NCT01042249|LUTS|luts
1430702|NCT01042249|Men|men
1430703|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
1430704|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
1430705|NCT01042210|preeclampsia|preeclampsia
1430706|NCT01042210|agouti-related peptide|agouti-related peptide
1430707|NCT01042210|intrauterine growth|intrauterine growth
1430708|NCT01042210|birth weight|birth weight
1430709|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
1430710|NCT01042197|Vitamin D|vitamin d
1430711|NCT01042197|UVB|uvb
1430712|NCT01042197|Dose-Response|dose-response
1430713|NCT01042197|Body surface area|body surface area
1430714|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
1430715|NCT01042158|Tadalafil|tadalafil
1430716|NCT01042158|Ambrisentan|ambrisentan
1430717|NCT01042158|Quality of Life|quality of life
1430718|NCT01042145|Primary Care|primary care
1430719|NCT01042145|Treatment|treatment
1430720|NCT01042145|Croup|croup
1430721|NCT01042145|Corticosteroids|corticosteroids
1430722|NCT01042145|Prednisone|prednisone
1430723|NCT01042145|Dexamethasone|dexamethasone
1430724|NCT01042145|Randomized trial|randomized trial
1430725|NCT01042132|intramedullary reaming|intramedullary reaming
1430726|NCT01042132|inflammatory response|inflammatory response
1430727|NCT01042132|human|human
1430728|NCT01042132|femoral shaft fracture|femoral shaft fracture
1430729|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
1430730|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
1430731|NCT01042119|BoNT/A|bont/a
1430732|NCT01042119|Botox|botox
1431489|NCT01039311|cancer|cancer
1430733|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
1430734|NCT01042106|diabetes|diabetes
1430735|NCT01042093|Analgesia|analgesia
1430736|NCT01042093|postoperative pain|postoperative pain
1430737|NCT01042093|periarticular|periarticular
1430738|NCT01042093|arthroplasty|arthroplasty
1430739|NCT01042093|pain management|pain management
1430740|NCT01042080|Mechanical ventilation|mechanical ventilation
1430741|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
1430742|NCT01042080|Acute respiratory failure|acute respiratory failure
1430743|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1430744|NCT01042080|Weaning|weaning
1430745|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
1430746|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
1430747|NCT01042067|warfarin|warfarin
1430748|NCT01042067|genotyping|genotyping
1430749|NCT01042067|vitamin K|vitamin k
1430750|NCT01042067|dosing|dosing
1430751|NCT01042067|adverse events|adverse events
1430752|NCT01042067|initial phase of treatment|initial phase of treatment
1430753|NCT01042067|algorithm|algorithm
1430754|NCT01042054|Postoperative Care|postoperative care
1430755|NCT01042054|Enhanced|enhanced
1430756|NCT01042054|Recovery|recovery
1430757|NCT01042054|Hepatectomy|hepatectomy
1430758|NCT01042054|Analgesia|analgesia
1430759|NCT01042028|Pancreas cancer|pancreas cancer
1430760|NCT01042028|Everolimus|everolimus
1430761|NCT01042028|Irinotecan|irinotecan
1430762|NCT01042028|Cetuximab|cetuximab
1430763|NCT01042028|Capecitabine|capecitabine
1430764|NCT01042028|Oxaliplatin|oxaliplatin
1430765|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
1430766|NCT01042015|trauma|trauma
1430767|NCT01042015|cardiac arrest|cardiac arrest
1430768|NCT01042015|hemorrhagic shock|hemorrhagic shock
1430769|NCT01042002|High intensity exercise|high intensity exercise
1430770|NCT01042002|morbid obesity|morbid obesity
1430771|NCT01042002|gastric bypass|gastric bypass
1430772|NCT01041989|dementia|dementia
1430773|NCT01041989|cognitive impairment|cognitive impairment
1430774|NCT01041989|disability|disability
1430775|NCT01041989|intervention|intervention
1430776|NCT01041989|elderly|elderly
1430777|NCT01041989|lifestyle counseling|lifestyle counseling
1430778|NCT01041976|Veterans|veterans
1430779|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
1430780|NCT01041963|ACEI|acei
1430781|NCT01041963|ARB|arb
1430782|NCT01041963|CAPD|capd
1430868|NCT01041586|BTVA|btva
1430783|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
1430784|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
1430785|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
1430786|NCT01041950|hydrocephalus|hydrocephalus
1430787|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
1430788|NCT01041924|Sleep apnea|sleep apnea
1430789|NCT01041924|Periodic breathing|periodic breathing
1430790|NCT01041924|Heart Failure|heart failure
1430791|NCT01041911|Hemorrhoids|hemorrhoids
1430792|NCT01041898|osteocalcin|osteocalcin
1430793|NCT01041898|insulin|insulin
1430794|NCT01041898|body composition|body composition
1430795|NCT01041898|bone mineral density|bone mineral density
1430796|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
1430797|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
1430798|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
1430799|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
1430800|NCT01041885|cartilage lesion|cartilage lesion
1430801|NCT01041885|autologous chondrocyte|autologous chondrocyte
1430802|NCT01041885|scaffold|scaffold
1430803|NCT01041885|INSTRUCT|instruct
1430804|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1430805|NCT01041859|Painful|painful
1430806|NCT01041859|Polyneuropathy|polyneuropathy
1430807|NCT01041859|Peripheral neuropathy|peripheral neuropathy
1430808|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
1430809|NCT01041846|Dacogen|dacogen
1430810|NCT01041846|Decitabine|decitabine
1430811|NCT01041846|Epigenetic therapy|epigenetic therapy
1430812|NCT01041846|Hypomethylating agent|hypomethylating agent
1430813|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
1430814|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
1430815|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
1430816|NCT01041820|exercise|exercise
1430817|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
1430818|NCT01041820|bone mineral density|bone mineral density
1430819|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
1430820|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
1430821|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
1430822|NCT01041807|Hypertension|hypertension
1430823|NCT01041794|body composition|body composition
1430824|NCT01041794|fat distribution|fat distribution
1430825|NCT01041794|exercise|exercise
1430826|NCT01041794|diet|diet
1430827|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
1430828|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1430829|NCT01041781|large cell lung cancer|large cell lung cancer
1430830|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
1430831|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1430832|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1430833|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1430834|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1430835|NCT01041755|Encephalopathy|encephalopathy
1430836|NCT01041755|Cirrhosis|cirrhosis
1430837|NCT01041716|Carbapenem|carbapenem
1430838|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
1430839|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
1430840|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
1430841|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1430842|NCT01041690|Vitrectomy|vitrectomy
1430843|NCT01041690|Bevacizumab|bevacizumab
1430844|NCT01041677|Obesity|obesity
1430845|NCT01041677|Overweight|overweight
1430846|NCT01041677|Body Weight|body weight
1430847|NCT01041677|Body Size|body size
1430848|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
1430849|NCT01041664|nutrigenomics|nutrigenomics
1430850|NCT01041664|admixture|admixture
1430851|NCT01041664|Hispanic American|hispanic american
1430852|NCT01041664|body composition|body composition
1430853|NCT01041664|Association of diet and body composition|association of diet and body composition
1430854|NCT01041664|Association between genes and body composition|association between genes and body composition
1430855|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
1430856|NCT01041625|Lichen Planus|lichen planus
1430858|NCT01041612|HBD|hbd
1430859|NCT01041612|cancer of bile duct|cancer of bile duct
1430860|NCT01041612|pancreatic cancer|pancreatic cancer
1430861|NCT01041599|Diabetes Mellitus|diabetes mellitus
1430862|NCT01041599|Hypertension|hypertension
1430863|NCT01041599|Albuminuria|albuminuria
1430864|NCT01041599|vascular stiffness|vascular stiffness
1430865|NCT01041586|Emphysema|emphysema
1430866|NCT01041586|COPD|copd
1430867|NCT01041586|Lung Volume Reduction|lung volume reduction
1430869|NCT01041573|Pediatric|pediatric
1430870|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
1430871|NCT01041573|endemic countries|endemic countries
1430872|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
1430874|NCT01041560|Tone|tone
1430875|NCT01041560|Strength|strength
1430876|NCT01041547|Insulin sensitivity|insulin sensitivity
1430877|NCT01041547|Vascular function|vascular function
1430878|NCT01041547|Flow-mediated dilation|flow-mediated dilation
1430879|NCT01041547|Arterial stiffness|arterial stiffness
1430880|NCT01041547|Glucose tolerance|glucose tolerance
1430881|NCT01041547|Hypertension|hypertension
1430882|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
1430883|NCT01041521|HIV infection|hiv infection
1430884|NCT01041521|Dyslipidemia|dyslipidemia
1430885|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
1430886|NCT01041521|vascular function (BART)|vascular function (bart)
1430887|NCT01041521|arterial stiffness|arterial stiffness
1430888|NCT01041521|omega three fatty acids|omega three fatty acids
1430889|NCT01041521|complementary therapies|complementary therapies
1430890|NCT01041508|ALL|all
1430891|NCT01041508|AML|aml
1430892|NCT01041508|Recurrence|recurrence
1430893|NCT01041508|Relapsed|relapsed
1430894|NCT01041508|Stem Cell Transplant|stem cell transplant
1430895|NCT01041508|Non-myeloablastive|non-myeloablastive
1430896|NCT01041495|fibromyalgia|fibromyalgia
1430897|NCT01041495|Pain|pain
1430898|NCT01041495|Sleep|sleep
1430899|NCT01041495|Fatigue|fatigue
1430900|NCT01041482|sorafenib|sorafenib
1430901|NCT01041482|renal cell carcinoma|renal cell carcinoma
1430902|NCT01041482|disease free survival|disease free survival
1430903|NCT01041482|Hand food skin reaction|hand food skin reaction
1430904|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
1430905|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
1430906|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
1430907|NCT01041456|revision gastric bypass|revision gastric bypass
1430908|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
1430909|NCT01041456|revision bariatric surgery|revision bariatric surgery
1430910|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
1430911|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
1430912|NCT01041456|protein malnutrition|protein malnutrition
1430913|NCT01041456|metabolic bone disease|metabolic bone disease
1430914|NCT01041430|Ambulatory Surgery|ambulatory surgery
1430916|NCT01041417|claudication|claudication
1430917|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
1430918|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
1430919|NCT01041365|insulin sensitivity|insulin sensitivity
1430920|NCT01041365|vascular function|vascular function
1430921|NCT01041365|flow-mediated dilation|flow-mediated dilation
1430922|NCT01041365|arterial stiffness|arterial stiffness
1430923|NCT01041365|ethnicity|ethnicity
1430924|NCT01041365|adolescents|adolescents
1430925|NCT01041365|females|females
1430926|NCT01041365|glucose tolerance|glucose tolerance
1430927|NCT01041365|diabetes|diabetes
1430928|NCT01041365|hypertension|hypertension
1430929|NCT01041365|cardiovascular|cardiovascular
1430930|NCT01041352|anaesthesia|anaesthesia
1430931|NCT01041352|laryngeal mask|laryngeal mask
1430932|NCT01041352|prone position|prone position
1430933|NCT01041339|LpPLA2|lppla2
1430934|NCT01041339|ST elevation|st elevation
1430935|NCT01041339|acute pericarditis|acute pericarditis
1430936|NCT01041326|prostatectomy|prostatectomy
1430937|NCT01041326|radiation|radiation
1430938|NCT01041326|neoadjuvant|neoadjuvant
1430939|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
1430940|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
1430941|NCT01041313|Drug tolerance|drug tolerance
1430942|NCT01041313|Pain Measurement|pain measurement
1430943|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1430944|NCT01041300|TMS|tms
1430945|NCT01041300|Motor Threashold|motor threashold
1430946|NCT01041300|Multiway|multiway
1430947|NCT01041300|Magstim Rapid 2|magstim rapid 2
1430948|NCT01041300|Abductor policis brevis|abductor policis brevis
1430949|NCT01041300|Figure 8 coil|figure 8 coil
1430950|NCT01041300|Double cone coil|double cone coil
1430951|NCT01041300|Circular coil|circular coil
1430952|NCT01041300|Brainsway|brainsway
1430953|NCT01041300|Healthy participants.|healthy participants.
1430954|NCT01041274|Schizophrenia|schizophrenia
1430955|NCT01041274|Citalopram|citalopram
1430956|NCT01041274|First episode|first episode
1430957|NCT01041274|fMRI|fmri
1430958|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
1430959|NCT01041274|Psychoeducation|psychoeducation
1430960|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
1430961|NCT01041261|Medical food|medical food
1430962|NCT01041261|Body composition|body composition
1430963|NCT01041261|Dietary intervention|dietary intervention
1430964|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
1430965|NCT01041248|Single Patient Study|single patient study
1430966|NCT01041248|Tocilizumab|tocilizumab
1430967|NCT01041235|Solid Neoplasms|solid neoplasms
1430968|NCT01041235|Carcinoma|carcinoma
1430969|NCT01041235|Breast|breast
1430970|NCT01041235|Ovarian|ovarian
1430971|NCT01041235|Ovary|ovary
1430972|NCT01041235|Pancreas|pancreas
1430973|NCT01041235|Pancreatic|pancreatic
1430974|NCT01041235|Lung|lung
1430975|NCT01041235|NSCLC|nsclc
1430976|NCT01041235|Non Small Cell Lung|non small cell lung
1430977|NCT01041235|Prostate|prostate
1430978|NCT01041235|Gastric|gastric
1430979|NCT01041235|Head and Neck|head and neck
1430980|NCT01041222|Familial ALS|familial als
1430981|NCT01041222|ALS|als
1430982|NCT01041222|SOD1 Protein|sod1 protein
1430983|NCT01041222|ISIS 333611|isis 333611
1430984|NCT01041222|SOD1Rx|sod1rx
1430985|NCT01041209|Pneumonia|pneumonia
1430986|NCT01041209|Children|children
1430987|NCT01041196|obesity|obesity
1430988|NCT01041196|ulcer disease|ulcer disease
1430989|NCT01041196|marginal ulcer|marginal ulcer
1430990|NCT01041196|perforation|perforation
1430991|NCT01041196|abdominal pain|abdominal pain
1430992|NCT01041196|bariatric surgery|bariatric surgery
1430993|NCT01041196|weight loss surgery|weight loss surgery
1430994|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
1430995|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
1430996|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
1430997|NCT01041170|Rimonabant|rimonabant
1430998|NCT01041170|fMRI|fmri
1430999|NCT01041170|Alternative Matrices|alternative matrices
1431000|NCT01041170|Brain Imaging|brain imaging
1431001|NCT01041170|THC|thc
1431002|NCT01041157|Torticollis|torticollis
1431003|NCT01041157|Botulinum Toxins|botulinum toxins
1431004|NCT01041144|Diabetes|diabetes
1431005|NCT01041144|PDA|pda
1431006|NCT01041144|Internet|internet
1431007|NCT01041144|HbA1c|hba1c
1431008|NCT01041131|Obesity|obesity
1431009|NCT01041131|Obesity recidivism|obesity recidivism
1431010|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
1431011|NCT01041131|Technical bariatric complications|technical bariatric complications
1431012|NCT01041131|Complicated gastroplasty|complicated gastroplasty
1431013|NCT01041131|Failed gastroplasty|failed gastroplasty
1431014|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
1431015|NCT01041131|Revisional gastric bypass|revisional gastric bypass
1431691|NCT01038427|Rhinitis|rhinitis
1431016|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
1431017|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
1431018|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
1431019|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
1431020|NCT01041105|Obesity|obesity
1431021|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1431022|NCT01041105|Nissen funduplication|nissen funduplication
1431023|NCT01041105|Antireflux surgery|antireflux surgery
1431024|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
1431025|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
1431026|NCT01041105|Bariatric surgery|bariatric surgery
1431027|NCT01041105|Nissen|nissen
1431028|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
1566183|NCT00513422|NSAIDs|nsaids
1431029|NCT01041079|ulcer disease|ulcer disease
1431030|NCT01041079|marginal ulcer|marginal ulcer
1431031|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
1431032|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
1431033|NCT01041079|chronic abdominal pain|chronic abdominal pain
1431034|NCT01041079|GI hemorrhage|gi hemorrhage
1431035|NCT01041079|Perforation|perforation
1431036|NCT01041079|Penetration|penetration
1431037|NCT01041079|Obstruction|obstruction
1431038|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
1431039|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
1431040|NCT01041014|Limited English proficiency|limited english proficiency
1431041|NCT01041014|Cost-effectiveness|cost-effectiveness
1431042|NCT01041014|Emergency Departments|emergency departments
1431043|NCT01041014|Language Discordance|language discordance
1431044|NCT01041014|Satisfaction|satisfaction
1431045|NCT01041014|Limited English proficient patients|limited english proficient patients
1431046|NCT01041014|Spanish-speaking patients|spanish-speaking patients
1431047|NCT01041001|Umbilical Cord Blood|umbilical cord blood
1431048|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
1431049|NCT01041001|cartilage injury|cartilage injury
1431050|NCT01041001|osteoarthritis|osteoarthritis
1431051|NCT01040988|Pacemaker|pacemaker
1431052|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1431053|NCT01040962|neuropathy|neuropathy
1431054|NCT01040962|diabetes|diabetes
1431055|NCT01040949|smoking cessation|smoking cessation
1431056|NCT01040949|pregnant Latinas|pregnant latinas
1431057|NCT01040949|couples communication|couples communication
1431059|NCT01040949|couples communication in Latino couples|couples communication in latino couples
1431060|NCT01040936|acute coronary syndrome|acute coronary syndrome
1431062|NCT01040936|outcome|outcome
1431063|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
1431064|NCT01040936|patients received PCI therapy|patients received pci therapy
1431065|NCT01040923|CAD|cad
1431066|NCT01040923|Diagnostic|diagnostic
1431067|NCT01040910|cannabis|cannabis
1431068|NCT01040910|Crohn's disease|crohn's disease
1431069|NCT01040910|Ulcerative colitis|ulcerative colitis
1431070|NCT01040910|IBD|ibd
1431071|NCT01040897|Obesity prevention|obesity prevention
1431072|NCT01040897|Health Literacy|health literacy
1431073|NCT01040897|Health Communication|health communication
1431074|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
1431075|NCT01040858|cognitive disorders|cognitive disorders
1431076|NCT01040845|healthy|healthy
1431077|NCT01040845|pharmacokinetics|pharmacokinetics
1431078|NCT01040845|drug-interaction|drug-interaction
1431079|NCT01040832|Head and Neck Cancer|head and neck cancer
1431080|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
1431081|NCT01040832|Cetuximab|cetuximab
1431082|NCT01040832|EMD 1201081|emd 1201081
1431083|NCT01040819|Diabetes Mellitus|diabetes mellitus
1431084|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
1431085|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
1431086|NCT01040819|Thiazolidinediones|thiazolidinediones
1431087|NCT01040819|Pioglitazone|pioglitazone
1431088|NCT01040806|Diabetes|diabetes
1431089|NCT01040780|Efficacy|efficacy
1431090|NCT01040780|Safety|safety
1431091|NCT01040780|EGFR-TKI|egfr-tki
1431092|NCT01040780|phase III|phase iii
1431093|NCT01040780|NSCLC|nsclc
1431094|NCT01040767|Ultrasound education|ultrasound education
1431095|NCT01040767|Blended learning|blended learning
1431096|NCT01040767|Distance education|distance education
1431097|NCT01040767|Trauma ultrasound|trauma ultrasound
1431098|NCT01040767|FAST|fast
1431099|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
1431100|NCT01040741|Adjuvanted|adjuvanted
1431101|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
1431102|NCT01040715|anti-drug antibodies|anti-drug antibodies
1431103|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
1431104|NCT01040676|Diabetes Mellitus|diabetes mellitus
1431105|NCT01040676|Telephone|telephone
1431106|NCT01040676|Nutrition Support|nutrition support
1431107|NCT01040676|Automated|automated
1431108|NCT01040676|Low English Proficiency|low english proficiency
1431109|NCT01040676|Hispanic|hispanic
1431110|NCT01040676|Latino|latino
1431111|NCT01040637|Healthy subjects|healthy subjects
1431113|NCT01040611|music therapy|music therapy
1431114|NCT01040611|Tuberculosis|tuberculosis
1431115|NCT01040611|anxiety|anxiety
1431116|NCT01040611|physiological response|physiological response
1431117|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
1431118|NCT01040598|Xolair|xolair
1431119|NCT01040598|Omalizumab|omalizumab
1431120|NCT01040598|Esophagitis|esophagitis
1431121|NCT01040598|Eosinophils|eosinophils
1431122|NCT01040598|monoclonal antibody|monoclonal antibody
1431123|NCT01040585|cost effectiveness|cost effectiveness
1431124|NCT01040585|linezolid|linezolid
1431125|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
1431126|NCT01040585|central america|central america
1431127|NCT01040572|Obesity recidivism|obesity recidivism
1431128|NCT01040572|Weight Regain|weight regain
1431129|NCT01040572|Weight recidivism|weight recidivism
1431130|NCT01040572|Morbidity|morbidity
1431131|NCT01040572|Complication|complication
1431132|NCT01040572|Late complications|late complications
1431133|NCT01040572|Revisional gastric bypass|revisional gastric bypass
1431134|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
1431135|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
1431136|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
1431137|NCT01040546|Obesity|obesity
1431138|NCT01040546|Metabolic syndrome|metabolic syndrome
1431139|NCT01040546|Weight control educational intervention|weight control educational intervention
1431140|NCT01040546|Food intake|food intake
1431141|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
1431142|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
1431143|NCT01040533|Revision gastric bypass|revision gastric bypass
1431144|NCT01040533|Revisional surgery|revisional surgery
1431145|NCT01040533|Reoperations|reoperations
1431146|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
1431147|NCT01040520|CT-based autopsy|ct-based autopsy
1431148|NCT01040520|virtual autopsy|virtual autopsy
1431149|NCT01040520|medical autopsy|medical autopsy
1431150|NCT01040520|quality control|quality control
1431151|NCT01040507|severe obesity|severe obesity
1431152|NCT01040507|morbid obesity|morbid obesity
1431153|NCT01040507|gastric bypass|gastric bypass
1431154|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
1431155|NCT01040494|Aliskiren|aliskiren
1431156|NCT01040494|Congestive heart failure|congestive heart failure
1431157|NCT01040494|Central hemodynamics|central hemodynamics
1431158|NCT01040481|Failed gastric bypass|failed gastric bypass
1431159|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
1431160|NCT01040481|Distal gastric bypass|distal gastric bypass
1431161|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
1431162|NCT01040481|Adding malabsorption|adding malabsorption
1431163|NCT01040481|Increasing malabsorption|increasing malabsorption
1431164|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
1431165|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
1431166|NCT01040481|Revisional gastric bypass|revisional gastric bypass
1431167|NCT01040481|Reoperations|reoperations
1431168|NCT01040481|Conversions|conversions
1431169|NCT01040468|Type 2 Diabetes|type 2 diabetes
1431170|NCT01040468|Bariatric Surgery|bariatric surgery
1431171|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
1431172|NCT01040468|Gastric Banding|gastric banding
1431173|NCT01040468|Obesity|obesity
1431174|NCT01040468|Weight loss|weight loss
1431175|NCT01040468|Insulin sensitivity|insulin sensitivity
1431176|NCT01040468|GLP-1|glp-1
1431177|NCT01040468|Meal Challenge|meal challenge
1431178|NCT01040468|Euglycemic Clamp|euglycemic clamp
1431179|NCT01040455|functional dyspepsia|functional dyspepsia
1431180|NCT01040455|lansoprazole|lansoprazole
1431181|NCT01040455|placebo effect|placebo effect
1431182|NCT01040442|Postural Balance|postural balance
1431183|NCT01040442|Aging|aging
1431184|NCT01040442|Accidental Falls|accidental falls
1431185|NCT01040442|Vibration|vibration
1431186|NCT01040429|Adolescent|adolescent
1431187|NCT01040429|Clonidine|clonidine
1431188|NCT01040429|Autonomic nervous system|autonomic nervous system
1431189|NCT01040429|Stress|stress
1431190|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
1431191|NCT01040416|complex marginal ulcer|complex marginal ulcer
1431192|NCT01040416|complication after gastric bypass|complication after gastric bypass
1431193|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1431194|NCT01040390|Acne Vulgaris|acne vulgaris
1431195|NCT01040390|Homoeopathy|homoeopathy
1431196|NCT01040390|Lappa Arctium|lappa arctium
1431197|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
1431198|NCT01040377|Inadequate weight loss|inadequate weight loss
1431199|NCT01040377|Poor weight loss|poor weight loss
1431200|NCT01040377|Failed gastric bypass|failed gastric bypass
1431201|NCT01040377|Revision gastric bypass|revision gastric bypass
1431202|NCT01040364|Internal hernia|internal hernia
1431203|NCT01040364|Mesocolic hernia|mesocolic hernia
1431204|NCT01040364|Petersen´s hernia|petersen´s hernia
1431205|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
1431206|NCT01040364|Bowel obstruction|bowel obstruction
1431207|NCT01040364|Ischemic bowel|ischemic bowel
1431208|NCT01040364|Complication after gastric bypass|complication after gastric bypass
1431209|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
1431210|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
1431211|NCT01040351|Infertility|infertility
1431212|NCT01040351|Hydrosalpinx|hydrosalpinx
1431213|NCT01040351|IVF-ET|ivf-et
1431214|NCT01040338|Smoking|smoking
1431215|NCT01040338|Tobacco|tobacco
1431216|NCT01040338|Nicotine|nicotine
1431217|NCT01040338|Dependence|dependence
1431218|NCT01040338|Genetics|genetics
1431219|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
1431220|NCT01040299|GangTrainer|gangtrainer
1431221|NCT01040299|Gait Rehabilitation|gait rehabilitation
1431222|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
1431223|NCT01040299|Robot assisted|robot assisted
1431224|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
1431225|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
1431226|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
1431227|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
1431228|NCT01040260|tobacco use disorder|tobacco use disorder
1431229|NCT01040247|Infertility|infertility
1431230|NCT01040247|Low Responder|low responder
1431231|NCT01040247|IVF|ivf
1431232|NCT01040247|Embryo Transfer|embryo transfer
1431233|NCT01040234|postoperative pain|postoperative pain
1431234|NCT01040234|abdominal surgery|abdominal surgery
1431235|NCT01040234|bilateral dual TAP block|bilateral dual tap block
1431236|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
1431237|NCT01040221|ASD|asd
1431238|NCT01040221|Trichuris Suis Ova|trichuris suis ova
1431239|NCT01040221|TSO|tso
1431240|NCT01040221|Treatment|treatment
1431241|NCT01040221|Clinical Trial|clinical trial
1431242|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
1431243|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
1431244|NCT01040195|spondyloarthropathy|spondyloarthropathy
1431245|NCT01040195|inflammatory back pain|inflammatory back pain
1431246|NCT01040195|methotrexate|methotrexate
1431247|NCT01040195|sulfasalazine|sulfasalazine
1431248|NCT01040195|hydroxychloroquine|hydroxychloroquine
1431249|NCT01040182|ischemic stroke patients|ischemic stroke patients
1431250|NCT01040143|Pneumococci|pneumococci
1431251|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
1431252|NCT01040117|Equilibrium|equilibrium
1431253|NCT01040117|Rehabilitation|rehabilitation
1431254|NCT01040117|Randomized Controlled Trial|randomized controlled trial
1431255|NCT01040117|Postural instability|postural instability
1431256|NCT01040117|Sensory-motor integration|sensory-motor integration
1431257|NCT01040104|wound healing|wound healing
1431258|NCT01040104|hypertrophic scar|hypertrophic scar
1431259|NCT01040104|skin transplantation|skin transplantation
1431260|NCT01040104|diabetes mellitus|diabetes mellitus
1431261|NCT01040091|HIV Seronegativity|hiv seronegativity
1431262|NCT01040091|Treatment Experienced|treatment experienced
1431263|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
1431264|NCT01040065|distal clavicle resection|distal clavicle resection
1431265|NCT01040065|Mumford procedure|mumford procedure
1431266|NCT01040052|Diphtheria|diphtheria
1431267|NCT01040052|Tetanus|tetanus
1431268|NCT01040052|Pertussis|pertussis
1431269|NCT01040052|Adacel®|adacel®
1431270|NCT01040039|HCV|hcv
1431271|NCT01040039|HIV|hiv
1431272|NCT01040013|LAPAROSCOPY,|laparoscopy,
1431273|NCT01040013|LAPAROTOMY,|laparotomy,
1431274|NCT01040013|OXYGENATION,|oxygenation,
1431275|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
1431276|NCT01040000|NPC-1C|npc-1c
1431277|NCT01040000|Monoclonal antibody|monoclonal antibody
1431278|NCT01040000|Pancreatic Cancer|pancreatic cancer
1431279|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1431280|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
1431281|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
1431282|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
1431283|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
1431284|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
1431285|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
1431286|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
1431287|NCT01040000|Colorectal cancer|colorectal cancer
1431288|NCT01040000|Colorectal tumor|colorectal tumor
1431289|NCT01040000|Colorectal neoplasm|colorectal neoplasm
1431290|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1431291|NCT01039987|ADPKD|adpkd
1431292|NCT01039987|kidney|kidney
1431293|NCT01039987|Biomarker|biomarker
1431294|NCT01039987|MRI|mri
1431295|NCT01039974|ketoconazole|ketoconazole
1431296|NCT01039974|GSK962040|gsk962040
1431297|NCT01039974|Drug-Drug Interaction|drug-drug interaction
1431298|NCT01039974|Phase I|phase i
1431299|NCT01039961|healthy volunteers|healthy volunteers
1431300|NCT01039961|IV formulation study|iv formulation study
1431301|NCT01039948|Neoplasms|neoplasms
1431302|NCT01039948|Carcinoma|carcinoma
1431303|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1431304|NCT01039948|Lung Neoplasms|lung neoplasms
1431305|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
1431306|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1431307|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
1431308|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
1431309|NCT01039948|Neoplasms by Site|neoplasms by site
1431310|NCT01039948|Lung Diseases|lung diseases
1431311|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
1431312|NCT01039948|Gefitinib|gefitinib
1431313|NCT01039948|Antineoplastic Agents|antineoplastic agents
1431314|NCT01039948|Therapeutic Uses|therapeutic uses
1431315|NCT01039948|Pharmacologic Actions|pharmacologic actions
1431316|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
1431317|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
1431318|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1431319|NCT01039935|Odor Discrimination|odor discrimination
1431320|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
1431321|NCT01039922|Registries|registries
1431322|NCT01039883|Healthy Volunteers|healthy volunteers
1431323|NCT01039870|postthoracotomy pain|postthoracotomy pain
1431324|NCT01039857|Psychotherapy|psychotherapy
1431325|NCT01039857|Depression|depression
1431326|NCT01039857|Adjustment Disorders|adjustment disorders
1431327|NCT01039857|Neuropsychology|neuropsychology
1431328|NCT01039857|Rehabilitation|rehabilitation
1431329|NCT01039857|Coping Skills|coping skills
1431330|NCT01039857|Stroke|stroke
1431331|NCT01039857|Caregivers|caregivers
1431332|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
1431333|NCT01039844|metastatic Melanoma|metastatic melanoma
1431334|NCT01039831|PIGD|pigd
1431335|NCT01039831|tremor|tremor
1431336|NCT01039831|falls|falls
1431337|NCT01039831|white matter|white matter
1431338|NCT01039818|Graves Disease|graves disease
1431339|NCT01039818|Hyperthyroidism|hyperthyroidism
1431340|NCT01039818|Radioiodine|radioiodine
1431341|NCT01039818|Clinical trial|clinical trial
1431342|NCT01039805|GSK962040|gsk962040
1431343|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
1431344|NCT01039805|pharmacokinetics|pharmacokinetics
1431345|NCT01039805|critically ill patients|critically ill patients
1431346|NCT01039805|gut motility|gut motility
1431347|NCT01039805|pharmacodynamics|pharmacodynamics
1431348|NCT01039805|tolerability|tolerability
1431349|NCT01039805|single dose|single dose
1431350|NCT01039805|gastric emtpying|gastric emtpying
1431351|NCT01039792|Autism|autism
1431352|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
1431353|NCT01039779|older fallers|older fallers
1431354|NCT01039779|tai chi|tai chi
1431355|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
1431356|NCT01039766|prevention|prevention
1431357|NCT01039766|oxytocin|oxytocin
1431358|NCT01039753|acute kidney injury|acute kidney injury
1431359|NCT01039753|renal replacement therapy|renal replacement therapy
1431360|NCT01039753|biomarkers|biomarkers
1431361|NCT01039740|Pharmacogenomics|pharmacogenomics
1431362|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
1431363|NCT01039740|Depressed patients|depressed patients
1431364|NCT01039740|Mirtazapine response|mirtazapine response
1431365|NCT01039740|Adverse event|adverse event
1431366|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
1431367|NCT01039714|Hypocalcemia|hypocalcemia
1431368|NCT01039714|Hypoparathyroidism|hypoparathyroidism
1431369|NCT01039714|Vitamin D deficiency|vitamin d deficiency
1431370|NCT01039714|Total thyroidectomy|total thyroidectomy
1431371|NCT01039714|calcium|calcium
1431372|NCT01039714|PTH|pth
1431373|NCT01039701|safety|safety
1431374|NCT01039701|tolerability|tolerability
1431375|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
1431376|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
1431377|NCT01039688|oral JAK inhibitor|oral jak inhibitor
1431378|NCT01039688|MTX|mtx
1431379|NCT01039688|DMARD|dmard
1431380|NCT01039688|clinical trial|clinical trial
1431381|NCT01039688|joint diseases|joint diseases
1431382|NCT01039688|autoimmune diseases|autoimmune diseases
1431383|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
1431384|NCT01039688|rheumatic diseases|rheumatic diseases
1431385|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
1431386|NCT01039675|Safety and tolerability|safety and tolerability
1431387|NCT01039675|pharmacodynamics|pharmacodynamics
1431388|NCT01039675|pharmacokinetics|pharmacokinetics
1431389|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
1431390|NCT01039675|COPD|copd
1431391|NCT01039649|radiation|radiation
1431392|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
1431393|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
1431394|NCT01039649|Respiratory Function Tests|respiratory function tests
1431395|NCT01039636|Beta-thalassemia|beta-thalassemia
1431396|NCT01039636|Sickle cell anemia|sickle cell anemia
1431397|NCT01039636|Transfusional iron overload|transfusional iron overload
1431398|NCT01039636|Iron overload|iron overload
1431399|NCT01039636|Iron chelation|iron chelation
1431400|NCT01039623|Healthy volunteers|healthy volunteers
1431401|NCT01039610|single dose|single dose
1431402|NCT01039610|pharmacokinetics|pharmacokinetics
1431403|NCT01039610|GSK945237|gsk945237
1431404|NCT01039610|tolerability|tolerability
1431405|NCT01039610|safety|safety
1431406|NCT01039610|antibiotics|antibiotics
1431407|NCT01039610|linezolid|linezolid
1431408|NCT01039610|QTc|qtc
1431409|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
1431410|NCT01039610|moxifloxacin|moxifloxacin
1431411|NCT01039610|repeat dose|repeat dose
1431412|NCT01039597|IBD|ibd
1431413|NCT01039597|Ulcerative colitis|ulcerative colitis
1431414|NCT01039584|bioequivalence|bioequivalence
1431415|NCT01039584|butoconazole|butoconazole
1431416|NCT01039584|vulvovaginal|vulvovaginal
1431417|NCT01039584|candidiasis|candidiasis
1431418|NCT01039571|rotator cuff tear|rotator cuff tear
1431419|NCT01039571|arthroscopic repair|arthroscopic repair
1431420|NCT01039571|single row repair|single row repair
1431421|NCT01039571|double row repair|double row repair
1431422|NCT01039571|retear rate|retear rate
1431423|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
1431424|NCT01039558|lansoprazole|lansoprazole
1431425|NCT01039558|ecabet sodium|ecabet sodium
1431426|NCT01039545|Urinary tract infections|urinary tract infections
1431427|NCT01039545|Anti-bacterial agents|anti-bacterial agents
1431428|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
1431429|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
1431430|NCT01039532|Basal bolus insulin|basal bolus insulin
1431431|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
1431432|NCT01039519|GIST|gist
1431433|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
1431434|NCT01039480|pharmacological biomarker|pharmacological biomarker
1431435|NCT01039480|compliance monitoring|compliance monitoring
1431739|NCT01038206|Hispanic|hispanic
1431436|NCT01039480|platelet aggregometry|platelet aggregometry
1431437|NCT01039480|resistance|resistance
1431438|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1431439|NCT01039480|Medication Non-Compliance|medication non-compliance
1431440|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
1431441|NCT01039454|Food Reward|food reward
1431442|NCT01039454|fMRI|fmri
1431443|NCT01039454|Obese|obese
1431444|NCT01039454|Cognition|cognition
1431445|NCT01039454|Food Addiction|food addiction
1431446|NCT01039454|Behaviour|behaviour
1431447|NCT01039454|Overweight|overweight
1431448|NCT01039454|Food Reinforcement|food reinforcement
1431449|NCT01039454|Metabolic endpoints|metabolic endpoints
1431450|NCT01039428|hyperphosphatemia|hyperphosphatemia
1431451|NCT01039428|hemodialysis|hemodialysis
1431452|NCT01039428|chitosan|chitosan
1431453|NCT01039415|marijuana|marijuana
1431454|NCT01039415|marijuana abuse|marijuana abuse
1431455|NCT01039415|marijuana dependence|marijuana dependence
1431456|NCT01039415|cannabis|cannabis
1431457|NCT01039415|substance-related disorder|substance-related disorder
1431458|NCT01039415|abstinence|abstinence
1431459|NCT01039402|cardiovascular risk|cardiovascular risk
1431460|NCT01039402|France|france
1431461|NCT01039402|Observational, descriptive study|observational, descriptive study
1431462|NCT01039389|Coronary Artery Disease|coronary artery disease
1431463|NCT01039389|Stable|stable
1431464|NCT01039389|Coronary Collaterals|coronary collaterals
1431465|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
1431466|NCT01039389|Arteriogenesis|arteriogenesis
1431467|NCT01039389|Bradycardia|bradycardia
1431468|NCT01039376|maintenance therapy|maintenance therapy
1431469|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
1431470|NCT01039376|ofatumumab|ofatumumab
1431471|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
1431472|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
1431473|NCT01039337|osteoarthritis|osteoarthritis
1431474|NCT01039337|manual therapy|manual therapy
1431475|NCT01039337|manipulation|manipulation
1431476|NCT01039337|hip school|hip school
1431477|NCT01039337|chiropractic|chiropractic
1431478|NCT01039337|patient education|patient education
1431479|NCT01039324|Complex patients|complex patients
1431480|NCT01039324|Care transitions|care transitions
1431481|NCT01039324|Patient safety|patient safety
1431482|NCT01039324|Patient care|patient care
1431483|NCT01039324|Health Information Technology|health information technology
1431484|NCT01039324|Health Information Exchange|health information exchange
1431485|NCT01039324|Clinical Decision Support|clinical decision support
1431486|NCT01039324|Care coordination|care coordination
1431487|NCT01039324|Data sharing|data sharing
1431488|NCT01039311|Lung|lung
1431490|NCT01039311|bronchoscopy|bronchoscopy
1431491|NCT01039311|optical|optical
1431492|NCT01039311|coherence|coherence
1431493|NCT01039311|tomography|tomography
1431494|NCT01039298|Oral cancer|oral cancer
1431495|NCT01039298|fluorescence visualization|fluorescence visualization
1431496|NCT01039298|surgical margin|surgical margin
1431497|NCT01039298|recurrence|recurrence
1431498|NCT01039285|Very premature infant|very premature infant
1431499|NCT01039285|Surfactant|surfactant
1431500|NCT01039285|Respiratory Distress|respiratory distress
1431501|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1431502|NCT01039272|oral cancer|oral cancer
1431504|NCT01039272|PCR|pcr
1431505|NCT01039259|adolescent|adolescent
1431506|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
1431507|NCT01039259|tongue piercing|tongue piercing
1431508|NCT01039259|tongue/microbiology|tongue/microbiology
1431509|NCT01039181|Vitamin D|vitamin d
1431510|NCT01039181|Calcitriol|calcitriol
1431511|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
1431512|NCT01039181|Clinical trial|clinical trial
1431513|NCT01039168|Burnout|burnout
1431514|NCT01039168|Sick leave|sick leave
1431515|NCT01039168|Intervention study|intervention study
1431516|NCT01039168|Prospective study|prospective study
1431517|NCT01039168|Work|work
1431518|NCT01039142|Psoriasis|psoriasis
1431519|NCT01039129|Gallstones|gallstones
1431520|NCT01039129|Appendicitis|appendicitis
1431521|NCT01039129|Pelvic pain|pelvic pain
1431522|NCT01039129|Peritoneal mass|peritoneal mass
1431523|NCT01039116|obesity|obesity
1431524|NCT01039116|nutrition|nutrition
1431525|NCT01039116|type 2 diabetes|type 2 diabetes
1431526|NCT01039116|community-based.|community-based.
1431527|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
1431528|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
1431529|NCT01039090|Parkinsons's patients|parkinsons's patients
1431530|NCT01039038|prostate|prostate
1431531|NCT01039038|curietherapy|curietherapy
1431532|NCT01039038|radiotherapy|radiotherapy
1431533|NCT01039038|intermediate risk|intermediate risk
1431534|NCT01039025|Myeloma|myeloma
1431535|NCT01039025|Topotecan|topotecan
1431536|NCT01039025|Hycamtin|hycamtin
1431537|NCT01039025|Melphalan|melphalan
1431538|NCT01039025|Alkeran|alkeran
1431539|NCT01039025|Cyclophosphamide|cyclophosphamide
1431540|NCT01039025|Cytoxan|cytoxan
1431541|NCT01039025|Neosar|neosar
1431542|NCT01039025|Stem Cell Harvest|stem cell harvest
1431543|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
1431544|NCT01039012|bone mineral density|bone mineral density
1431545|NCT01039012|osteoporosis|osteoporosis
1431546|NCT01039012|exercise|exercise
1431547|NCT01039012|bone remodeling|bone remodeling
1431548|NCT01039012|biomotion analysis|biomotion analysis
1431549|NCT01038999|Complementary Therapies|complementary therapies
1431550|NCT01038986|chronic wound|chronic wound
1431551|NCT01038986|refractory wound|refractory wound
1431552|NCT01038986|CureXcell|curexcell
1431553|NCT01038986|activated cell suspension|activated cell suspension
1431554|NCT01038960|ICD, training|icd, training
1431555|NCT01038934|Buccal Mucosa|buccal mucosa
1431556|NCT01038934|DNA|dna
1431557|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
1431558|NCT01038921|Blood Pressure|blood pressure
1431559|NCT01038921|Glucose levels|glucose levels
1431560|NCT01038921|HDL levels|hdl levels
1431561|NCT01038921|Triglyceride levels|triglyceride levels
1431562|NCT01038921|Waist Circumference|waist circumference
1431563|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
1431564|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
1431565|NCT01038908|lymphatics|lymphatics
1431566|NCT01038908|blue dye|blue dye
1431567|NCT01038895|Hypertension|hypertension
1431568|NCT01038895|type 2 diabetes|type 2 diabetes
1431569|NCT01038895|aliskiren|aliskiren
1431570|NCT01038895|ramipril|ramipril
1431571|NCT01038895|microalbuminuria|microalbuminuria
1431572|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
1431573|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
1431574|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
1431575|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
1431576|NCT01038882|sedation|sedation
1431577|NCT01038882|midazolam|midazolam
1431578|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
1431579|NCT01038882|tolerance|tolerance
1431580|NCT01038843|VA106483|va106483
1431581|NCT01038843|Nocturia|nocturia
1431582|NCT01038843|males|males
1431583|NCT01038843|nocturnal voids|nocturnal voids
1431584|NCT01038843|anti-diuretic|anti-diuretic
1431585|NCT01038843|hyponatraemia|hyponatraemia
1431586|NCT01038817|tooth-decay|tooth-decay
1431587|NCT01038817|prevention|prevention
1431588|NCT01038817|fluoride-varnish|fluoride-varnish
1431589|NCT01038817|institutionalised elderly people|institutionalised elderly people
1431590|NCT01038804|Breast Cancer|breast cancer
1431591|NCT01038804|Metastatic|metastatic
1431592|NCT01038804|HER2 Negative|her2 negative
1431593|NCT01038804|YM155|ym155
1431594|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
1431595|NCT01038791|COPD|copd
1431596|NCT01038791|RTD|rtd
1431597|NCT01038791|sleep architecture|sleep architecture
1431598|NCT01038791|humidification|humidification
1431599|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
1431600|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1431601|NCT01038765|Randomized Controlled Trial|randomized controlled trial
1431602|NCT01038752|NSCLC|nsclc
1431603|NCT01038752|suramin|suramin
1431604|NCT01038752|lung cancer|lung cancer
1431605|NCT01038752|chemotherapy|chemotherapy
1431606|NCT01038726|Healthy Aging|healthy aging
1431607|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
1431608|NCT01038700|microparticles|microparticles
1431609|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
1431610|NCT01038700|circulating endothelial cells|circulating endothelial cells
1431611|NCT01038700|transcriptome|transcriptome
1431612|NCT01038700|aging|aging
1431613|NCT01038700|Healthy volunteers|healthy volunteers
1431614|NCT01038687|functional constipation|functional constipation
1431615|NCT01038687|bile acid|bile acid
1431616|NCT01038648|Sitagliptin|sitagliptin
1431617|NCT01038648|Type 2 diabetes|type 2 diabetes
1431618|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
1431619|NCT01038635|5-Azacytidine|5-azacytidine
1431620|NCT01038635|5-Aza|5-aza
1431621|NCT01038635|Lenalidomide|lenalidomide
1431622|NCT01038635|Revlimid|revlimid
1431623|NCT01038635|CC-5103|cc-5103
1431624|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
1431626|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
1431627|NCT01038635|AML|aml
1431628|NCT01038622|L-arginine|l-arginine
1431629|NCT01038622|Nasal NO|nasal no
1431630|NCT01038622|Nosocomial infection|nosocomial infection
1431631|NCT01038622|Immune function|immune function
1431632|NCT01038622|HLA-DR expression|hla-dr expression
1431633|NCT01038622|Critically ill|critically ill
1431634|NCT01038622|Medical ICU patients|medical icu patients
1431635|NCT01038609|Postoperative Pain|postoperative pain
1431740|NCT01038206|Adolescent|adolescent
1431741|NCT01038206|Familias Unidas|familias unidas
1431636|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
1431637|NCT01038583|Aspirin|aspirin
1431638|NCT01038583|Prevention|prevention
1431639|NCT01038583|Healthy|healthy
1431640|NCT01038583|Over 65 years old|over 65 years old
1431641|NCT01038583|ASPREE|aspree
1431642|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
1431643|NCT01038583|Australia|australia
1431644|NCT01038583|Functional disability|functional disability
1431645|NCT01038583|Dementia|dementia
1431646|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
1431647|NCT01038583|Cancer|cancer
1431648|NCT01038583|Bleeding|bleeding
1431649|NCT01038570|Prader Willi syndrome|prader willi syndrome
1431650|NCT01038570|adults|adults
1431651|NCT01038570|social behaviour|social behaviour
1431652|NCT01038570|stress|stress
1431653|NCT01038570|anxiety|anxiety
1431654|NCT01038570|psychological tests|psychological tests
1431655|NCT01038557|frozen|frozen
1431656|NCT01038557|red blood cells|red blood cells
1431657|NCT01038557|transfusion|transfusion
1431658|NCT01038557|trauma|trauma
1431659|NCT01038544|Esophageal Cancer|esophageal cancer
1431660|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
1431661|NCT01038544|Staging|staging
1431662|NCT01038544|EBUS|ebus
1431663|NCT01038544|EUS|eus
1431664|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
1431665|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
1431666|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
1431667|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
1431668|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
1431669|NCT01038531|ARDS Net|ards net
1431670|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
1431671|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
1431672|NCT01038518|epidemiology|epidemiology
1431673|NCT01038518|risk factors|risk factors
1431674|NCT01038518|micronutrients|micronutrients
1431675|NCT01038479|Xylitol|xylitol
1431676|NCT01038479|Mutans streptococci|mutans streptococci
1431677|NCT01038479|Maternal consumption|maternal consumption
1431678|NCT01038479|Early childhood tooth decay|early childhood tooth decay
1431679|NCT01038479|Early childhood caries|early childhood caries
1431680|NCT01038479|Childsmile|childsmile
1431681|NCT01038466|CHAT|chat
1431682|NCT01038466|breast cancer|breast cancer
1431683|NCT01038466|non interventional observational study|non interventional observational study
1431684|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
1431685|NCT01038440|Omega 3 Index|omega 3 index
1431686|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
1431687|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
1431688|NCT01038440|Red blood cells|red blood cells
1431689|NCT01038440|Lipids|lipids
1431690|NCT01038440|Inflammation markers|inflammation markers
1431692|NCT01038427|Allergic|allergic
1431693|NCT01038427|Seasonal|seasonal
1431694|NCT01038427|Mometasone Furoate|mometasone furoate
1431695|NCT01038427|Equivalence|equivalence
1431696|NCT01038401|HIV infection|hiv infection
1431697|NCT01038401|HAART|haart
1431698|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
1431699|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
1431700|NCT01038401|Treatment Experienced|treatment experienced
1431701|NCT01038388|Multiple Myeloma|multiple myeloma
1431702|NCT01038375|hypertension|hypertension
1431703|NCT01038375|stroke|stroke
1431704|NCT01038375|adherence|adherence
1431705|NCT01038362|endothelium|endothelium
1431706|NCT01038362|almonds|almonds
1431707|NCT01038362|dietary interventions|dietary interventions
1431708|NCT01038362|coronary artery disease|coronary artery disease
1431709|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
1431710|NCT01038336|Prevention|prevention
1431711|NCT01038336|Computer-assisted instruction|computer-assisted instruction
1431712|NCT01038323|Fibromyalgia|fibromyalgia
1431713|NCT01038323|FMS|fms
1431714|NCT01038310|Parkinson´s disease|parkinson´s disease
1431715|NCT01038310|FP-CIT-SPECT|fp-cit-spect
1431716|NCT01038297|Scarring|scarring
1431717|NCT01038284|Patient Education|patient education
1431718|NCT01038284|Drug Toxicity|drug toxicity
1431719|NCT01038271|palliative care|palliative care
1431720|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1431721|NCT01038245|Receptor Up-Regulation|receptor up-regulation
1431722|NCT01038245|Smoking|smoking
1431723|NCT01038245|Nicotine|nicotine
1431724|NCT01038245|Neuroimaging|neuroimaging
1431725|NCT01038232|Distress Tolerance|distress tolerance
1431726|NCT01038232|Cocaine Dependence|cocaine dependence
1431727|NCT01038232|Relapse|relapse
1431728|NCT01038232|Limbic System|limbic system
1431729|NCT01038232|Prefrontal Cortex|prefrontal cortex
1431730|NCT01038232|Healthy Volunteer|healthy volunteer
1431731|NCT01038232|HV|hv
1431732|NCT01038219|fever|fever
1431733|NCT01038219|children|children
1431734|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
1431735|NCT01038206|prevention|prevention
1431736|NCT01038206|HIV|hiv
1431737|NCT01038206|drugs|drugs
1431738|NCT01038206|smoking|smoking
1431742|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
1431743|NCT01038206|parent-centered|parent-centered
1431744|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
1431745|NCT01038206|efficacy|efficacy
1431746|NCT01038206|intervention|intervention
1431747|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
1431748|NCT01038180|pacemaker|pacemaker
1431749|NCT01038180|adverse effects|adverse effects
1431750|NCT01038167|VX-950|vx-950
1431751|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
1431752|NCT01038154|Pravastatin|pravastatin
1431753|NCT01038154|Survival|survival
1431754|NCT01038154|adverse effects|adverse effects
1431755|NCT01038128|Bulimia nervosa|bulimia nervosa
1431756|NCT01038128|Bulimia|bulimia
1431757|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
1431758|NCT01038128|Eating disorders|eating disorders
1431759|NCT01038128|Body image|body image
1431760|NCT01038128|Binge eating|binge eating
1431761|NCT01038128|purging|purging
1431762|NCT01038115|Catheter Ablation|catheter ablation
1431763|NCT01038102|Obesity|obesity
1431764|NCT01038102|Diabetes|diabetes
1431765|NCT01038102|Insulin resistance|insulin resistance
1431766|NCT01038102|Fatty liver|fatty liver
1431767|NCT01038102|NAFLD|nafld
1431768|NCT01038102|Steatosis|steatosis
1431769|NCT01038102|Dietary fatty acids|dietary fatty acids
1431770|NCT01038089|endothelium|endothelium
1431771|NCT01038089|resveratrol|resveratrol
1431772|NCT01038089|diabetes mellitus|diabetes mellitus
1431774|NCT01038076|AIDS|aids
1431775|NCT01038076|adherence|adherence
1431776|NCT01038076|antiretroviral|antiretroviral
1431777|NCT01038076|aCASI|acasi
1431778|NCT01038076|HAART|haart
1431779|NCT01038076|Complementary Therapies|complementary therapies
1431780|NCT01038076|Adherence Care Manager|adherence care manager
1431781|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
1431782|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
1431783|NCT01038050|Gingko Biloba Extract|gingko biloba extract
1431784|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1431785|NCT01038050|Stable coronary artery disease|stable coronary artery disease
1431786|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
1431787|NCT01038037|Lung Cancer|lung cancer
1431788|NCT01038037|Non small cell lung cancer|non small cell lung cancer
1431789|NCT01038037|Triple mutational status|triple mutational status
1431790|NCT01038037|KRAS|kras
1431791|NCT01038037|BRAF|braf
1431792|NCT01038037|PI3K|pi3k
1431793|NCT01038024|antioxidant supplement|antioxidant supplement
1431794|NCT01037998|adenocarcinoma|adenocarcinoma
1431795|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
1431796|NCT01037998|gefitinib|gefitinib
1431797|NCT01037998|UFUR|ufur
1431798|NCT01037985|Scarring|scarring
1431799|NCT01037972|Galileo|galileo
1431800|NCT01037972|Whole body vibration|whole body vibration
1431801|NCT01037972|Osteoarthritis|osteoarthritis
1431802|NCT01037972|Knee|knee
1431803|NCT01037972|Physiotherapy|physiotherapy
1431804|NCT01037959|severe cirrhosis|severe cirrhosis
1431805|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
1431806|NCT01037946|HIV|hiv
1431807|NCT01037946|Family interventions|family interventions
1431808|NCT01037946|Thailand|thailand
1431809|NCT01037933|Cancer|cancer
1431810|NCT01037933|Humor|humor
1431811|NCT01037933|Distraction|distraction
1431812|NCT01037933|Comedy|comedy
1431813|NCT01037933|Chemotherapy|chemotherapy
1431814|NCT01037907|Oral treatment for MS|oral treatment for ms
1431815|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
1431816|NCT01037907|Oral RRMS|oral rrms
1431817|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
1431818|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
1431819|NCT01037907|GLA|gla
1431820|NCT01037907|Fatty acid|fatty acid
1431821|NCT01037907|Triglyceride|triglyceride
1431822|NCT01037907|Structured lipid|structured lipid
1431823|NCT01037907|MRI|mri
1431824|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
1431825|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
1431826|NCT01037907|expanded disability status scale|expanded disability status scale
1431827|NCT01037907|EDSS|edss
1431828|NCT01037907|Demyelination|demyelination
1431829|NCT01037907|Remyelination|remyelination
1431830|NCT01037907|TGFB1|tgfb1
1431831|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
1431832|NCT01037907|cytokines|cytokines
1431833|NCT01037907|disease modifying therapy|disease modifying therapy
1431834|NCT01037907|immunomodulator|immunomodulator
1431835|NCT01037907|Anti inflammatory|anti inflammatory
1431836|NCT01037907|Pro inflammatory|pro inflammatory
1431837|NCT01037907|TNF alpha|tnf alpha
1431838|NCT01037907|interleukin 1 beta|interleukin 1 beta
1431839|NCT01037907|interferon gamma|interferon gamma
1431840|NCT01037907|Fayaz Master|fayaz master
1431841|NCT01037907|Omega 6|omega 6
1431842|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
1431843|NCT01037907|Cytokine balance|cytokine balance
1431844|NCT01037907|Pleneva TM|pleneva tm
1431845|NCT01037907|BGC20-0134|bgc20-0134
1431846|NCT01037907|RRMS|rrms
1431847|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
1431848|NCT01037868|depression|depression
1431849|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
1431850|NCT01037868|dual diagnosis|dual diagnosis
1431851|NCT01037868|SMS text messages|sms text messages
1431852|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
1431853|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
1431854|NCT01037816|Ankle Sprain|ankle sprain
1431855|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
1431856|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
1431857|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
1431858|NCT01037764|primary complete remission|primary complete remission
1431859|NCT01037764|secondary complete remission|secondary complete remission
1431860|NCT01037764|postremission therapy|postremission therapy
1431861|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1431862|NCT01037751|Cancer|cancer
1431863|NCT01037751|Symptom burden|symptom burden
1431864|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
1431865|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
1431866|NCT01037751|Symptoms|symptoms
1431867|NCT01037751|Daily functioning|daily functioning
1431868|NCT01037751|Symptom severity|symptom severity
1431869|NCT01037751|Questionnaire|questionnaire
1431870|NCT01037751|Interview|interview
1431871|NCT01037738|ACL reconstruction|acl reconstruction
1431872|NCT01037738|autologous conditioned serum|autologous conditioned serum
1431873|NCT01037738|Orthokine|orthokine
1431874|NCT01037738|osteoarthritis|osteoarthritis
1431875|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
1431876|NCT01037738|growth factors|growth factors
1431877|NCT01037738|WOMAC|womac
1431878|NCT01037738|IKDC|ikdc
1431879|NCT01037725|Healthy volunteer|healthy volunteer
1431880|NCT01037725|first time in human|first time in human
1431881|NCT01037725|food effect|food effect
1431882|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
1431883|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
1431884|NCT01037699|Ovarian stimulation|ovarian stimulation
1431885|NCT01037699|In Vitro Fertilization|in vitro fertilization
1431886|NCT01037699|Luteinizing Hormone|luteinizing hormone
1431887|NCT01037699|GnRH antagonist|gnrh antagonist
1431888|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
1431890|NCT01037686|DBS|dbs
1431891|NCT01037660|endothelium|endothelium
1431892|NCT01037660|cardiovascular disease|cardiovascular disease
1431893|NCT01037660|dietary fat|dietary fat
1431894|NCT01037660|insulin resistance|insulin resistance
1431895|NCT01037647|Type 2 diabetes|type 2 diabetes
1431896|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
1431897|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
1431898|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
1431899|NCT01037634|Avian Influenza|avian influenza
1431900|NCT01037634|H1N1 Influenza|h1n1 influenza
1431901|NCT01037634|Seasonal Influenza|seasonal influenza
1431902|NCT01037621|Herpes simplex type 2|herpes simplex type 2
1431903|NCT01037621|Hepatitis C virus|hepatitis c virus
1431904|NCT01037621|Valacyclovir|valacyclovir
1431905|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
1431906|NCT01037608|Sativex|sativex
1431907|NCT01037608|fMRI|fmri
1431908|NCT01037608|Alternative Matrices|alternative matrices
1431909|NCT01037608|Brain Imaging|brain imaging
1431910|NCT01037608|THC|thc
1431911|NCT01037595|hemodialysis|hemodialysis
1431912|NCT01037595|turmeric|turmeric
1431913|NCT01037595|pruritus|pruritus
1431914|NCT01037569|Toxicological Screening|toxicological screening
1431915|NCT01037569|Drugs|drugs
1431916|NCT01037569|Alternative Matrices|alternative matrices
1431917|NCT01037569|Urine|urine
1431918|NCT01037569|Children|children
1431919|NCT01037556|AML|aml
1431920|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
1431921|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
1431922|NCT01037556|Refractory AML|refractory aml
1431923|NCT01037556|Relapsed AML|relapsed aml
1431924|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
1431925|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
1431926|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
1431927|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
1431928|NCT01037556|ALL|all
1431929|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1431930|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
1431931|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
1431932|NCT01037556|Relapsed ALL|relapsed all
1431933|NCT01037556|Refractory ALL|refractory all
1431934|NCT01037530|ACE inhibitors|ace inhibitors
1431935|NCT01037530|Intermittent claudication|intermittent claudication
1431936|NCT01037530|Ramipril|ramipril
1431937|NCT01037517|Myeloma|myeloma
1431938|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
1431939|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
1431940|NCT01037504|safety|safety
1431941|NCT01037504|tolerability|tolerability
1431942|NCT01037504|healthy|healthy
1431943|NCT01037504|inhalation|inhalation
1431944|NCT01037504|Healthy volunteers|healthy volunteers
1431945|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
1431946|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
1431947|NCT01037478|HDAC|hdac
1431948|NCT01037478|4SC-201|4sc-201
1431949|NCT01037478|Resminostat|resminostat
1431950|NCT01037478|Phase II|phase ii
1431951|NCT01037465|endothelium|endothelium
1431952|NCT01037465|cell signaling|cell signaling
1431953|NCT01037465|N-acetylcysteine|n-acetylcysteine
1431954|NCT01037465|reactive oxygen species|reactive oxygen species
1431955|NCT01037452|Heartburn|heartburn
1431956|NCT01037452|antacid|antacid
1431957|NCT01037452|PPI|ppi
1431958|NCT01037452|Lansoprazole|lansoprazole
1431959|NCT01037452|calcium carbonate|calcium carbonate
1431960|NCT01037452|magnesium hydroxide|magnesium hydroxide
1431961|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
1431962|NCT01037426|SND Sinus Node Disease|snd sinus node disease
1431963|NCT01037426|Falls|falls
1431964|NCT01037426|Fractures|fractures
1431965|NCT01037413|Scarring|scarring
1431966|NCT01037400|Knee Replacement|knee replacement
1431967|NCT01037400|Arthroplasty|arthroplasty
1431968|NCT01037374|risk|risk
1431969|NCT01037374|assessment|assessment
1431970|NCT01037374|difficult|difficult
1431971|NCT01037374|endotracheal|endotracheal
1431972|NCT01037374|intubation|intubation
1431973|NCT01037361|Children and Adolescents|children and adolescents
1431974|NCT01037361|Motor Control|motor control
1431975|NCT01037361|Movement-Related Potential|movement-related potential
1431976|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
1431977|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
1431978|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
1431979|NCT01037348|Pathological Myopia|pathological myopia
1431980|NCT01037335|bone graft|bone graft
1431981|NCT01037335|pain|pain
1431982|NCT01037335|chronic|chronic
1431983|NCT01037322|crohn's disease|crohn's disease
1431984|NCT01037322|ulcerative colitis|ulcerative colitis
1431985|NCT01037322|cannabis|cannabis
1431986|NCT01037322|cannabidiol|cannabidiol
1431987|NCT01037296|catheter ablation|catheter ablation
1431988|NCT01037296|robotic navigation|robotic navigation
1431989|NCT01037283|Bipolar|bipolar
1431990|NCT01037283|Depressed|depressed
1431991|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
1431992|NCT01037231|hyperoxaluria|hyperoxaluria
1431993|NCT01037231|oxalate|oxalate
1431994|NCT01037231|PH|ph
1431995|NCT01037192|outpatient|outpatient
1431996|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
1431997|NCT01037192|vancomycin intravenous|vancomycin intravenous
1431998|NCT01037153|Intravenous|intravenous
1431999|NCT01037153|Rate of Delivery|rate of delivery
1432000|NCT01037153|Dose Responses|dose responses
1432001|NCT01037153|Variable Intervals|variable intervals
1432002|NCT01037153|Multiple Rapid Injections|multiple rapid injections
1432003|NCT01037127|GSK1120212|gsk1120212
1432004|NCT01037127|BRAF Inhibitor|braf inhibitor
1432005|NCT01037127|melanoma|melanoma
1432006|NCT01037127|MEK Inhibitor|mek inhibitor
1432007|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
1432008|NCT01037101|acrophobia|acrophobia
1432009|NCT01037101|virtual reality|virtual reality
1432010|NCT01037101|exposure therapy|exposure therapy
1432011|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
1432012|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
1432013|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
1432014|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
1432015|NCT01037101|Wait-List|wait-list
1432016|NCT01037088|cannabis|cannabis
1432017|NCT01037088|marijuana|marijuana
1432018|NCT01037088|neuropathy|neuropathy
1432019|NCT01037088|antinociception|antinociception
1432020|NCT01037088|mood|mood
1432021|NCT01037088|cognition|cognition
1432022|NCT01037088|neuropathic pain|neuropathic pain
1432023|NCT01037075|Schizophrenia|schizophrenia
1432024|NCT01037075|Dual Diagnosis|dual diagnosis
1432025|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
1432026|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
1432027|NCT01037075|Cognitive Processes|cognitive processes
1432028|NCT01037049|Rectal Cancer|rectal cancer
1432029|NCT01037049|6vs12|6vs12
1432030|NCT01037049|6 vs 12|6 vs 12
1432031|NCT01037049|Cancer|cancer
1432032|NCT01037049|CRM|crm
1432033|NCT01037049|Circumferential Resection Margin|circumferential resection margin
1432431|NCT01034839|cytarabine|cytarabine
1432034|NCT01037049|Quality of Life|quality of life
1432035|NCT01037049|MRI|mri
1432036|NCT01037049|Radiology|radiology
1432037|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
1432038|NCT01037049|Anterior Resection|anterior resection
1432039|NCT01037049|Surgery|surgery
1432040|NCT01037049|Pathology|pathology
1432041|NCT01037049|Radiotherapy|radiotherapy
1432042|NCT01037036|Ocular Hypertension|ocular hypertension
1432043|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
1432044|NCT01037036|Xalatan|xalatan
1432045|NCT01037036|IOP|iop
1432046|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
1432047|NCT01037023|Topotecan|topotecan
1432048|NCT01036971|Physical Examination|physical examination
1432049|NCT01036971|Medical Information|medical information
1432050|NCT01036971|Assessment|assessment
1432051|NCT01036971|Blood Work|blood work
1432052|NCT01036971|Screening|screening
1432053|NCT01036958|Pediatric cGVHD|pediatric cgvhd
1432054|NCT01036958|Response Criteria|response criteria
1432055|NCT01036958|Symptoms|symptoms
1432056|NCT01036958|Quality of Life|quality of life
1432057|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
1432058|NCT01036958|GVHD|gvhd
1432059|NCT01036958|Pediatric GVHD|pediatric gvhd
1432060|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
1432061|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
1432062|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
1432063|NCT01036802|sickle cell disease|sickle cell disease
1432064|NCT01036802|pulmonary hypertension|pulmonary hypertension
1432065|NCT01036802|coagulation activation|coagulation activation
1432066|NCT01036802|platelet activation|platelet activation
1432067|NCT01036802|endothelial activation|endothelial activation
1432068|NCT01036711|Attention|attention
1432069|NCT01036711|Working Memory|working memory
1432070|NCT01036711|Central Executive Processes|central executive processes
1432071|NCT01036711|Response Preparation|response preparation
1432072|NCT01036711|Cigarettes|cigarettes
1432073|NCT01036685|Children|children
1432074|NCT01036685|fMRI|fmri
1432075|NCT01036685|Task Development|task development
1432076|NCT01036685|Cognition|cognition
1432077|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
1432078|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
1432079|NCT01036633|mucositis|mucositis
1432080|NCT01036594|Ketoconazole|ketoconazole
1432081|NCT01036594|Dexamethasone|dexamethasone
1432082|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1432083|NCT01036581|Functional Brain Imaging|functional brain imaging
1432084|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1432085|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
1432086|NCT01036581|Drug Abuse|drug abuse
1432087|NCT01036568|Psychosis|psychosis
1432088|NCT01036568|Smooth Pursuit|smooth pursuit
1432089|NCT01036568|Motion Perception|motion perception
1432090|NCT01036568|Neurophysiology|neurophysiology
1432091|NCT01036568|fMRI|fmri
1432092|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
1432093|NCT01036529|Decompression|decompression
1432094|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
1432095|NCT01036529|Discectomy|discectomy
1432096|NCT01036529|Laminectomy|laminectomy
1432097|NCT01036529|Laminotomy|laminotomy
1432098|NCT01036529|Foraminotomy|foraminotomy
1432099|NCT01036516|Drug Cues|drug cues
1432100|NCT01036516|Dopamine Release|dopamine release
1432101|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
1432102|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
1432103|NCT01036516|Neuroimaging|neuroimaging
1432104|NCT01036412|Chlorhexidine|chlorhexidine
1432105|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
1432106|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
1432107|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
1432108|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
1432109|NCT01036412|caries-forming organisms|caries-forming organisms
1432110|NCT01036412|Radiation treatment|radiation treatment
1432111|NCT01036412|Mouth Cancer|mouth cancer
1432112|NCT01036412|Throat Cancer|throat cancer
1432113|NCT01036412|Tooth decay|tooth decay
1432114|NCT01036399|PTCL|ptcl
1432115|NCT01036360|Obesity|obesity
1432116|NCT01036360|Acute exercise|acute exercise
1432117|NCT01036360|Intensity of exercise|intensity of exercise
1432118|NCT01036360|Energy balance regulation|energy balance regulation
1432119|NCT01036360|Appetite|appetite
1432120|NCT01036308|dietary fibre|dietary fibre
1432121|NCT01036308|legumes|legumes
1432122|NCT01036308|lupin kernel fibre|lupin kernel fibre
1432123|NCT01036308|soy fibre|soy fibre
1432124|NCT01036308|bile acids|bile acids
1432125|NCT01036308|short-chain fatty acids|short-chain fatty acids
1432126|NCT01036308|cholesterol metabolism|cholesterol metabolism
1432127|NCT01036308|Subjects|subjects
1432128|NCT01036243|digestive tolerance|digestive tolerance
1432129|NCT01036243|night sleep|night sleep
1432130|NCT01036243|crying|crying
1432131|NCT01036243|growth|growth
1432132|NCT01036230|fMRI|fmri
1432133|NCT01036230|Methylphenidate|methylphenidate
1432134|NCT01036230|Taste|taste
1432135|NCT01036230|Olfaction|olfaction
1432136|NCT01036230|Addiction|addiction
1432137|NCT01036217|Recruitment|recruitment
1432138|NCT01036217|Adult|adult
1432139|NCT01036217|Telephone|telephone
1432140|NCT01036217|Selection|selection
1432141|NCT01036217|Testing|testing
1432142|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
1432143|NCT01036126|Nicotine|nicotine
1432144|NCT01036126|Cocaine|cocaine
1432145|NCT01036126|N-Back|n-back
1432146|NCT01036126|Craving|craving
1432147|NCT01036126|Dependence|dependence
1432148|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
1432149|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
1432150|NCT01036087|IBC|ibc
1432151|NCT01036087|Primary breast carcinoma|primary breast carcinoma
1432152|NCT01036087|HER2 negative overexpression|her2 negative overexpression
1432153|NCT01036087|Panitumumab|panitumumab
1432154|NCT01036087|Vectibix|vectibix
1432155|NCT01036087|Nab-paclitaxel|nab-paclitaxel
1432156|NCT01036087|Paclitaxel|paclitaxel
1432157|NCT01036087|Abraxane|abraxane
1432158|NCT01036087|Carboplatin|carboplatin
1432159|NCT01036087|Paraplatin|paraplatin
1432160|NCT01036087|PNC|pnc
1432161|NCT01036087|5-fluorouracil|5-fluorouracil
1432162|NCT01036087|5-FU|5-fu
1432163|NCT01036087|Adrucil|adrucil
1432164|NCT01036087|Efudex|efudex
1432165|NCT01036087|Epirubicin|epirubicin
1432166|NCT01036087|Ellence|ellence
1432167|NCT01036087|Cyclophosphamide|cyclophosphamide
1432168|NCT01036087|Cytoxan|cytoxan
1432169|NCT01036087|Neosar|neosar
1432170|NCT01036087|FEC|fec
1432171|NCT01036074|Drug Abuse|drug abuse
1432172|NCT01036074|Cocaine|cocaine
1432173|NCT01036074|Cocaine Dependence|cocaine dependence
1432174|NCT01036074|Functional MRI|functional mri
1432175|NCT01036074|Pharmalogical MRI|pharmalogical mri
1432176|NCT01036074|Conditioning|conditioning
1432177|NCT01036061|compulsive discorders|compulsive discorders
1432178|NCT01036061|addiction|addiction
1432179|NCT01036048|saphenous vein graft|saphenous vein graft
1432180|NCT01036048|stent|stent
1432181|NCT01036035|Tolterodine|tolterodine
1432182|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
1432183|NCT01036035|Incontinence|incontinence
1432184|NCT01036022|mesalazine|mesalazine
1432185|NCT01036022|ulcerative colitis|ulcerative colitis
1432186|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
1432187|NCT01036022|GSK1399686|gsk1399686
1432188|NCT01036009|Hematologic|hematologic
1432189|NCT01036009|Malignancy|malignancy
1432190|NCT01036009|Leukemia|leukemia
1432191|NCT01036009|Pre-leukemic|pre-leukemic
1432192|NCT01036009|Allogeneic|allogeneic
1432193|NCT01036009|Transplant|transplant
1432194|NCT01036009|Pediatric|pediatric
1432195|NCT01035996|Classical Conditioning|classical conditioning
1432196|NCT01035996|fMRI|fmri
1432197|NCT01035996|Schizophrenia|schizophrenia
1432198|NCT01035996|TD Model|td model
1432199|NCT01035996|Incentive Salience|incentive salience
1432200|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
1432201|NCT01035944|Chronic wounds|chronic wounds
1432202|NCT01035944|Chronic wound debridement|chronic wound debridement
1432203|NCT01035944|Debridement|debridement
1432204|NCT01035944|Bedside debridement|bedside debridement
1432205|NCT01035944|Surgical debridement|surgical debridement
1432206|NCT01035944|Wound debridement|wound debridement
1432207|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
1432208|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
1432209|NCT01035944|HemCon Dressings|hemcon dressings
1432210|NCT01035944|Chitosan-based dressings|chitosan-based dressings
1432211|NCT01035788|PTSD|ptsd
1432212|NCT01035788|mindfulness meditation|mindfulness meditation
1432213|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
1432214|NCT01035788|relationship function|relationship function
1432215|NCT01035788|couple therapy|couple therapy
1432216|NCT01035775|Colonoscopy|colonoscopy
1432217|NCT01035775|Adenoma detection|adenoma detection
1432218|NCT01035775|Colorectal polyps|colorectal polyps
1432219|NCT01035749|pandemic influenza|pandemic influenza
1432220|NCT01035749|Clinical trial|clinical trial
1432221|NCT01035749|H1N1|h1n1
1432222|NCT01035749|children|children
1432223|NCT01035723|Prefrontal Cortex|prefrontal cortex
1432224|NCT01035723|Hippocampus|hippocampus
1432225|NCT01035723|Amygdala|amygdala
1432226|NCT01035723|MRI|mri
1432227|NCT01035723|Cognitive Tasks|cognitive tasks
1432228|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
1432229|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1432230|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1432231|NCT01035697|Prematurity|prematurity
1432232|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
1432233|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
1432234|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
1432235|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
1432236|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
1432237|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
1432238|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
1432239|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
1432240|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
1432241|NCT01035658|Pazopanib|pazopanib
1432242|NCT01035658|Doxil|doxil
1432243|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
1432244|NCT01035658|Advanced relapsed|advanced relapsed
1432245|NCT01035658|platinum-sensitive|platinum-sensitive
1432246|NCT01035658|platinum-resistant|platinum-resistant
1432247|NCT01035645|First time in human|first time in human
1432248|NCT01035645|Interleukin-18|interleukin-18
1432249|NCT01035645|Healthy male subjects|healthy male subjects
1432250|NCT01035645|Obese male subjects|obese male subjects
1432251|NCT01035645|Monoclonal antibody|monoclonal antibody
1432252|NCT01035645|Pharmacokinetics|pharmacokinetics
1432253|NCT01035645|Tolerability|tolerability
1432254|NCT01035645|Safety|safety
1432255|NCT01035645|Pharmacodynamics|pharmacodynamics
1432256|NCT01035632|Craving|craving
1432257|NCT01035632|Incubation|incubation
1432258|NCT01035632|Relapse|relapse
1432259|NCT01035632|Smoking Cues|smoking cues
1432260|NCT01035632|Cortisol|cortisol
1432261|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
1432262|NCT01035606|attention|attention
1432263|NCT01035606|rehabilitation|rehabilitation
1432264|NCT01035606|training|training
1432265|NCT01035606|functional MRI|functional mri
1432266|NCT01035606|executive function|executive function
1432267|NCT01035606|brain injury|brain injury
1432268|NCT01035580|chemoprevention|chemoprevention
1432269|NCT01035580|curcumin|curcumin
1432270|NCT01035580|pharmacokinetics|pharmacokinetics
1432271|NCT01035580|safety|safety
1432272|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
1432273|NCT01035567|Hybrid revascularization|hybrid revascularization
1432274|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1432275|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
1432276|NCT01035567|Drug eluting stents|drug eluting stents
1432277|NCT01035554|high blood pressure|high blood pressure
1432278|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
1432279|NCT01035541|hemodynamic management,|hemodynamic management,
1432280|NCT01035541|PiCCO,|picco,
1432281|NCT01035541|acute kidney injury,|acute kidney injury,
1432282|NCT01035541|renal outcome|renal outcome
1432283|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
1432284|NCT01035515|Healthy subjects|healthy subjects
1432285|NCT01035502|Cancer|cancer
1432286|NCT01035502|CP-4055|cp-4055
1432287|NCT01035502|elacytarabine|elacytarabine
1432288|NCT01035502|combination|combination
1432289|NCT01035502|idarubicin|idarubicin
1432783|NCT01033097|Dermatitis|dermatitis
1432290|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
1432291|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
1432292|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
1432293|NCT01035489|DDD pacemakers|ddd pacemakers
1432295|NCT01035476|nasal ventilation|nasal ventilation
1432296|NCT01035476|data card recording|data card recording
1432297|NCT01035450|Coronary stent|coronary stent
1432298|NCT01035437|obstructing|obstructing
1432299|NCT01035424|Batten Disease|batten disease
1432300|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
1432301|NCT01035424|LINCL|lincl
1432302|NCT01035411|COPD|copd
1432303|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
1432304|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
1432305|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
1432306|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
1432307|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
1432308|NCT01035385|FOFLOX4|foflox4
1432309|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
1432310|NCT01035372|healthy older people|healthy older people
1432311|NCT01035359|radius|radius
1432312|NCT01035359|fracture|fracture
1432313|NCT01035359|wrist|wrist
1432314|NCT01035359|external|external
1432315|NCT01035359|fixation|fixation
1432316|NCT01035359|volar|volar
1432317|NCT01035359|plate|plate
1432318|NCT01035359|DASH|dash
1432319|NCT01035359|PRWE|prwe
1432320|NCT01035346|Fever|fever
1432321|NCT01035346|antipyretic|antipyretic
1432322|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
1432323|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
1432324|NCT01035333|gastric bypass surgery|gastric bypass surgery
1432325|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1432326|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1432327|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
1432328|NCT01035281|Neuropathic Pain|neuropathic pain
1432329|NCT01035281|Cannabinoids|cannabinoids
1432330|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
1432720|NCT01033370|aortic|aortic
1432331|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
1432332|NCT01035255|chronic heart failure|chronic heart failure
1432333|NCT01035255|cardiovascular death|cardiovascular death
1432334|NCT01035255|hospitalization|hospitalization
1432335|NCT01035255|outcome study|outcome study
1432336|NCT01035255|BNP|bnp
1432337|NCT01035255|KCCQ|kccq
1432338|NCT01035255|eGFR|egfr
1432339|NCT01035242|OCD|ocd
1432340|NCT01035242|obsessions|obsessions
1432341|NCT01035242|cognitive|cognitive
1432342|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
1432343|NCT01035229|randomized trial|randomized trial
1432344|NCT01035229|medical treatment|medical treatment
1432345|NCT01035229|RAD001|rad001
1432346|NCT01035229|placebo|placebo
1432347|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
1432348|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
1432349|NCT01035190|Preterm Infants|preterm infants
1432350|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
1432351|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1432352|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
1432353|NCT01035177|Cortical bone;|cortical bone;
1432354|NCT01035177|Hip fracture;|hip fracture;
1432355|NCT01035177|Osteoporosis;|osteoporosis;
1432356|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
1432357|NCT01035164|Alzheimer's Disease|alzheimer's disease
1432358|NCT01035164|Diagnostic Imaging|diagnostic imaging
1432359|NCT01035164|Neuroinflammation|neuroinflammation
1432360|NCT01035164|PET Diagnosis|pet diagnosis
1432361|NCT01035164|PET Tracer|pet tracer
1432362|NCT01035151|randomized cluster design|randomized cluster design
1432363|NCT01035151|tobacco cessation|tobacco cessation
1432364|NCT01035151|smoking cessation|smoking cessation
1432365|NCT01035151|African American|african american
1432366|NCT01035125|Self-management|self-management
1432367|NCT01035125|Self-efficacy|self-efficacy
1432368|NCT01035125|Coping|coping
1432369|NCT01035125|Health consumer|health consumer
1432370|NCT01035125|Patient education|patient education
1432371|NCT01035125|Health related quality of life|health related quality of life
1432372|NCT01035099|Letrozole|letrozole
1432373|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
1432374|NCT01035099|Cryopreservation|cryopreservation
1432375|NCT01035099|Fertility Preservation|fertility preservation
1432376|NCT01035099|Breast Cancer|breast cancer
1432377|NCT01035086|dietary fibre|dietary fibre
1432378|NCT01035086|lupin kernel fibre|lupin kernel fibre
1432379|NCT01035086|bile acids|bile acids
1432380|NCT01035086|cholesterol metabolism|cholesterol metabolism
1432381|NCT01035086|blood lipids|blood lipids
1432382|NCT01035086|hypercholesterolemia|hypercholesterolemia
1432383|NCT01035086|fibre-enriched food|fibre-enriched food
1432384|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
1432385|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
1432386|NCT01035047|Chest pain|chest pain
1432387|NCT01035047|Cardiac MRI|cardiac mri
1432388|NCT01035047|Risk Stratification|risk stratification
1432389|NCT01035047|Emergency Department|emergency department
1432390|NCT01035008|pancreatic cysts|pancreatic cysts
1432391|NCT01034982|COPD|copd
1432392|NCT01034969|Hereditary angioedema|hereditary angioedema
1432393|NCT01034956|Soft tissue filler|soft tissue filler
1432394|NCT01034956|Dermal filler|dermal filler
1432395|NCT01034956|Complications|complications
1432396|NCT01034956|Patient satisfaction|patient satisfaction
1432397|NCT01034943|radius|radius
1432398|NCT01034943|fracture|fracture
1432399|NCT01034943|wrist|wrist
1432400|NCT01034943|external|external
1432401|NCT01034943|fixation|fixation
1432402|NCT01034943|volar|volar
1432403|NCT01034943|plate|plate
1432404|NCT01034943|DASH|dash
1432405|NCT01034943|PRWE|prwe
1432406|NCT01034930|MANDIBLE|mandible
1432407|NCT01034930|IMPLANTS|implants
1432408|NCT01034930|OVERDENTURE|overdenture
1432409|NCT01034917|Active Comparator|active comparator
1432410|NCT01034917|Placebo Comparator|placebo comparator
1432411|NCT01034917|Sham Comparator|sham comparator
1432412|NCT01034917|No intervention|no intervention
1432413|NCT01034917|Other|other
1432414|NCT01034917|Treatment Experienced|treatment experienced
1432415|NCT01034904|Quality of Life|quality of life
1432416|NCT01034904|HRQoL|hrqol
1432417|NCT01034904|Hemophilia A|hemophilia a
1432418|NCT01034904|Helixate FS|helixate fs
1432419|NCT01034891|BRCA mutation|brca mutation
1432420|NCT01034891|benign breast disease|benign breast disease
1432421|NCT01034891|family history of breast cancer|family history of breast cancer
1432422|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
1432423|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
1432424|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
1432425|NCT01034891|high risk for breast cancer|high risk for breast cancer
1432426|NCT01034852|Atrial Fibrillation|atrial fibrillation
1432427|NCT01034852|Maze|maze
1432428|NCT01034852|Ablation|ablation
1432429|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
1432430|NCT01034839|prognosis|prognosis
1432432|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
1432433|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
1432434|NCT01034800|HIV Positive|hiv positive
1432435|NCT01034787|CP-675,206|cp-675,206
1432436|NCT01034787|Immunotherapy|immunotherapy
1432437|NCT01034787|AntiCTLA4|antictla4
1432438|NCT01034787|Clinical Trial|clinical trial
1432439|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
1432440|NCT01034774|Human volunteers|human volunteers
1432441|NCT01034761|Electronic prescribing|electronic prescribing
1432442|NCT01034761|Inappropriate medications|inappropriate medications
1432443|NCT01034761|Patient safety|patient safety
1432444|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
1432445|NCT01034748|Radiolabelled|radiolabelled
1432446|NCT01034748|Mass Balance|mass balance
1432447|NCT01034748|Healthy Volunteers|healthy volunteers
1432448|NCT01034748|Pharmacokinetics|pharmacokinetics
1432449|NCT01034735|Saizen®|saizen®
1432450|NCT01034735|bioequivalence|bioequivalence
1432451|NCT01034735|recombinant human|recombinant human
1432452|NCT01034735|Growth Hormone|growth hormone
1432453|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
1432454|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
1432455|NCT01034722|Breast Milk|breast milk
1432456|NCT01034722|Fat Globules|fat globules
1432457|NCT01034709|Cytomegalovirus|cytomegalovirus
1432459|NCT01034657|MDS|mds
1432460|NCT01034657|bone marrow|bone marrow
1432461|NCT01034657|anemia|anemia
1432462|NCT01034657|cytopenia|cytopenia
1432463|NCT01034657|transfusion dependance|transfusion dependance
1432464|NCT01034657|EPO|epo
1432465|NCT01034657|ESA|esa
1432466|NCT01034657|erythropoietin|erythropoietin
1432467|NCT01034657|LBH589|lbh589
1432468|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
1432469|NCT01034657|hematopoietic improvement|hematopoietic improvement
1432470|NCT01034657|IPSS Low|ipss low
1432471|NCT01034657|IPSS Int-1|ipss int-1
1432472|NCT01034657|HI-E|hi-e
1432473|NCT01034657|HDAC Inhibitor|hdac inhibitor
1432474|NCT01034657|HDAC-I|hdac-i
1432475|NCT01034657|DAC-I|dac-i
1432476|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
1432477|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
1432478|NCT01034657|red blood cell transfusions|red blood cell transfusions
1432479|NCT01034644|Biomarkers|biomarkers
1432480|NCT01034644|Genetic markers|genetic markers
1432481|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
1432482|NCT01034631|BNC105P|bnc105p
1432483|NCT01034618|Diabetes|diabetes
1432484|NCT01034618|protein|protein
1432485|NCT01034618|protein hydrolysate|protein hydrolysate
1432486|NCT01034579|Biomarkers|biomarkers
1432487|NCT01034579|Genetic markers|genetic markers
1432488|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
1432489|NCT01034527|Female Athlete|female athlete
1432490|NCT01034527|Sports Injuries|sports injuries
1432491|NCT01034527|Injury Prevention|injury prevention
1432492|NCT01034501|periodontitis|periodontitis
1432493|NCT01034501|photodynamic therapy|photodynamic therapy
1432494|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
1432495|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1432496|NCT01034475|multiple myeloma|multiple myeloma
1432497|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
1432498|NCT01034462|Depression|depression
1432499|NCT01034462|Major Depressive Disorder|major depressive disorder
1432500|NCT01034449|allo graft|allo graft
1432501|NCT01034449|cord blood|cord blood
1432502|NCT01034449|expansion|expansion
1432503|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
1432504|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
1432505|NCT01034410|AS1411|as1411
1432506|NCT01034410|AML|aml
1432507|NCT01034410|relapsed|relapsed
1432508|NCT01034410|refractory|refractory
1432509|NCT01034410|aptamer|aptamer
1432510|NCT01034410|nucleolin|nucleolin
1432511|NCT01034384|fMRI|fmri
1432512|NCT01034384|Smoking Withdrawal|smoking withdrawal
1432513|NCT01034384|Imaging|imaging
1432514|NCT01034384|Memory|memory
1432515|NCT01034384|Mood|mood
1432516|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
1432517|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
1432518|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
1432519|NCT01034358|Crohn disease|crohn disease
1432520|NCT01034358|ulcerative colitis|ulcerative colitis
1432521|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
1432522|NCT01034345|Sirolimus|sirolimus
1432523|NCT01034345|Liver Transplantation|liver transplantation
1432524|NCT01034345|Tolerance|tolerance
1432525|NCT01034345|Immune responses|immune responses
1432526|NCT01034345|Allograft tolerance|allograft tolerance
1432527|NCT01034332|Esophageal cancer|esophageal cancer
1432528|NCT01034332|Esophagectomy|esophagectomy
1432529|NCT01034332|Paclitaxel|paclitaxel
1432530|NCT01034332|Induction chemotherapy|induction chemotherapy
1432531|NCT01034319|type 2 diabetes|type 2 diabetes
1432532|NCT01034319|genetics|genetics
1432533|NCT01034319|genetic counseling|genetic counseling
1432534|NCT01034319|diabetes prevention|diabetes prevention
1432535|NCT01034293|feeding frequency|feeding frequency
1432536|NCT01034293|insulin metabolism|insulin metabolism
1432537|NCT01034293|glucose metabolism|glucose metabolism
1432538|NCT01034293|substrate partitioning|substrate partitioning
1432539|NCT01034280|Down Syndrome|down syndrome
1432540|NCT01034280|phenotype|phenotype
1432541|NCT01034280|genotype|genotype
1432542|NCT01034280|patient family|patient family
1432543|NCT01034267|Depression|depression
1432544|NCT01034267|Major Depressive Disorder|major depressive disorder
1432545|NCT01034254|influenza|influenza
1432546|NCT01034254|immunization|immunization
1432547|NCT01034254|pregnancy|pregnancy
1432548|NCT01034254|efficacy|efficacy
1432549|NCT01034254|pertussis|pertussis
1432550|NCT01034254|hepatitis E|hepatitis e
1432551|NCT01034241|milk protein|milk protein
1432552|NCT01034241|overweight|overweight
1432553|NCT01034241|insulin metabolism|insulin metabolism
1432554|NCT01034241|substrate partitioning|substrate partitioning
1432555|NCT01034228|Diarrhoea|diarrhoea
1432556|NCT01034228|L-isoleucine|l-isoleucine
1432557|NCT01034228|children|children
1432558|NCT01034228|ORS|ors
1432559|NCT01034228|Antibacterial peptide|antibacterial peptide
1432560|NCT01034215|Behavioral|behavioral
1432561|NCT01034215|Quality of Life|quality of life
1432562|NCT01034215|Breast Cancer|breast cancer
1432563|NCT01034189|Esophageal cancer|esophageal cancer
1432564|NCT01034189|Chemoradiotherapy|chemoradiotherapy
1432565|NCT01034189|Paclitaxel|paclitaxel
1432566|NCT01034189|Cetuximab|cetuximab
1432567|NCT01034176|BK viremia|bk viremia
1432568|NCT01034176|kidney transplantation|kidney transplantation
1432569|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
1432570|NCT01034163|Phase III randomized|phase iii randomized
1432571|NCT01034163|double blind|double blind
1432572|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
1432573|NCT01034163|panobinostat|panobinostat
1432574|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
1432575|NCT01034163|at risk for relapse|at risk for relapse
1432576|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
1432577|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
1432578|NCT01034124|warfarin|warfarin
1432579|NCT01034124|midazolam|midazolam
1432580|NCT01034124|cranberry juice|cranberry juice
1432581|NCT01034124|pharmacokinetics|pharmacokinetics
1432582|NCT01034098|Obesity|obesity
1432583|NCT01034098|Postmenopausal women|postmenopausal women
1432584|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
1432585|NCT01034098|Dynamic lung volume|dynamic lung volume
1432586|NCT01034098|Expiratory flow limitation|expiratory flow limitation
1432587|NCT01034085|Nicotine|nicotine
1432588|NCT01034085|Schizophrenia|schizophrenia
1432589|NCT01034085|Cognition|cognition
1432590|NCT01034085|Genes|genes
1432591|NCT01034085|Smoking|smoking
1432592|NCT01034085|Cigarette Smoking|cigarette smoking
1432593|NCT01034046|Obesity|obesity
1432594|NCT01034033|quality of life|quality of life
1432595|NCT01034020|Nasal Spray|nasal spray
1432596|NCT01034020|Attention Network Test|attention network test
1432597|NCT01034020|Continuous Performance Test|continuous performance test
1432598|NCT01034020|Attentional Blink Test|attentional blink test
1432599|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
1432600|NCT01033994|Knee osteoarthritis|knee osteoarthritis
1432601|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
1432602|NCT01033994|Sprifermin|sprifermin
1432603|NCT01033981|cost effectiveness|cost effectiveness
1432604|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
1432605|NCT01033968|lasers|lasers
1432606|NCT01033968|pain measurement|pain measurement
1432607|NCT01033968|photocoagulation|photocoagulation
1432608|NCT01033968|retina|retina
1432609|NCT01033955|critical care|critical care
1432610|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
1432611|NCT01033955|respiration|respiration
1432612|NCT01033955|ventilation, artificial|ventilation, artificial
1432613|NCT01033955|critically ill patients|critically ill patients
1432614|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
1432615|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
1432616|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
1432617|NCT01033942|HIV Prevention|hiv prevention
1432618|NCT01033942|Truvada|truvada
1432619|NCT01033942|Many Men, Many Voices|many men, many voices
1432620|NCT01033942|Emtricitabine|emtricitabine
1432621|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1432622|NCT01033942|Young men who have sex with men|young men who have sex with men
1432623|NCT01033942|HIV Seronegativity|hiv seronegativity
1432624|NCT01033929|tuberculosis|tuberculosis
1432625|NCT01033929|ESAT-6|esat-6
1432626|NCT01033929|CFP-10|cfp-10
1432627|NCT01033929|skin test|skin test
1432628|NCT01033929|diagnostic test|diagnostic test
1432629|NCT01033916|Blood Glucose|blood glucose
1432630|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
1432631|NCT01033916|Coronary Artery Bypass|coronary artery bypass
1432632|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
1432633|NCT01033903|Randomized Controlled Trial|randomized controlled trial
1432634|NCT01033890|local anesthesia|local anesthesia
1432635|NCT01033890|cochlear implant|cochlear implant
1432636|NCT01033890|sedation|sedation
1432637|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
1432638|NCT01033877|Immunisation, active|immunisation, active
1432639|NCT01033812|Networks|networks
1432640|NCT01033812|Index recruiter|index recruiter
1432641|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
1432642|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
1432643|NCT01033799|Common infectious diseases,|common infectious diseases,
1432644|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
1432645|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
1432646|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
1432647|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
1432648|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
1432649|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
1432650|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
1432651|NCT01033773|Emergency Department|emergency department
1432652|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
1432653|NCT01033760|antiretroviral treatment|antiretroviral treatment
1432654|NCT01033760|HIV reservoirs|hiv reservoirs
1432655|NCT01033760|HIV-DNA levels|hiv-dna levels
1432656|NCT01033760|randomized|randomized
1432657|NCT01033760|Treatment Naive|treatment naive
1432658|NCT01033747|iron overload|iron overload
1432659|NCT01033747|iron chelation therapy|iron chelation therapy
1432660|NCT01033747|B-thalassemia|b-thalassemia
1432661|NCT01033708|Psychotherapy|psychotherapy
1432662|NCT01033708|PTSD|ptsd
1432663|NCT01033708|Borderline personality disorders|borderline personality disorders
1432664|NCT01033695|Endoscopy|endoscopy
1432665|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
1432666|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
1432667|NCT01033695|Cancer|cancer
1432668|NCT01033695|Interobserver agreement|interobserver agreement
1432669|NCT01033669|Inhalation profiles|inhalation profiles
1432670|NCT01033669|asthma|asthma
1432671|NCT01033669|COPD|copd
1432672|NCT01033656|adult-onset Still's disease|adult-onset still's disease
1432673|NCT01033656|anakinra|anakinra
1432674|NCT01033656|prednisolone|prednisolone
1432675|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
1432676|NCT01033656|methotrexate|methotrexate
1432677|NCT01033656|efficacy|efficacy
1432678|NCT01033656|patients|patients
1432679|NCT01033617|Stem cells|stem cells
1432680|NCT01033617|Cellular therapy|cellular therapy
1432681|NCT01033617|Myocardial repair|myocardial repair
1432682|NCT01033591|Primary Health Care|primary health care
1432683|NCT01033591|Family PractiCe|family practice
1432684|NCT01033591|Hearth Failure|hearth failure
1432685|NCT01033591|Exercise|exercise
1432686|NCT01033591|Randomized Controlled Trials|randomized controlled trials
1432687|NCT01033591|Multicenter Study|multicenter study
1432688|NCT01033591|Quality of life|quality of life
1432689|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
1432690|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
1432691|NCT01033565|Pediatric|pediatric
1432692|NCT01033539|Survive|survive
1432693|NCT01033539|safety|safety
1432694|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
1432695|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
1432696|NCT01033487|Safety|safety
1432697|NCT01033487|Pharmacokinetics|pharmacokinetics
1432698|NCT01033487|Pharmacodynamics|pharmacodynamics
1432699|NCT01033487|PF-03635659|pf-03635659
1432700|NCT01033487|COPD|copd
1432701|NCT01033474|Infertile Patients|infertile patients
1432702|NCT01033461|probiotic|probiotic
1432703|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
1432704|NCT01033461|calcium|calcium
1432705|NCT01033461|faecal microbiota|faecal microbiota
1432706|NCT01033461|cholesterol metabolism|cholesterol metabolism
1432707|NCT01033435|Inflammation|inflammation
1432708|NCT01033435|Oxidative stress|oxidative stress
1432709|NCT01033435|HbA1c|hba1c
1432710|NCT01033435|Hemodialysis|hemodialysis
1432711|NCT01033422|Glaucoma|glaucoma
1432712|NCT01033422|Ocular hypertension|ocular hypertension
1432713|NCT01033422|Intraocular hypertension|intraocular hypertension
1432714|NCT01033409|Salmonella Typhi|salmonella typhi
1432715|NCT01033409|pneumonia|pneumonia
1432716|NCT01033409|oral|oral
1432717|NCT01033409|vaccine|vaccine
1432718|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
1432719|NCT01033370|acute|acute
1432721|NCT01033370|emergencies|emergencies
1432722|NCT01033370|Aortic dissection|aortic dissection
1432723|NCT01033357|dialysis|dialysis
1432724|NCT01033357|hemodialysis|hemodialysis
1432725|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
1432726|NCT01033344|Cat allergy|cat allergy
1432727|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
1432728|NCT01033344|Exposure chamber|exposure chamber
1432729|NCT01033344|Immunotherapy|immunotherapy
1432730|NCT01033344|Cat-PAD|cat-pad
1432731|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
1432732|NCT01033331|Valproic acid|valproic acid
1432733|NCT01033331|HMAS|hmas
1432734|NCT01033331|MRC scale|mrc scale
1432735|NCT01033318|Hypertension|hypertension
1432736|NCT01033305|UC|uc
1432737|NCT01033292|ovarian|ovarian
1432738|NCT01033292|cancer|cancer
1432739|NCT01033292|sensitive|sensitive
1432740|NCT01033292|PARP|parp
1432741|NCT01033292|recurrent|recurrent
1432742|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
1432743|NCT01033279|Coaguchek|coaguchek
1432744|NCT01033279|Portable coagulometer|portable coagulometer
1432745|NCT01033279|Self-monitoring|self-monitoring
1432746|NCT01033279|Coumadin|coumadin
1432747|NCT01033279|Warfarin|warfarin
1432748|NCT01033279|Quality of life|quality of life
1432749|NCT01033279|Pharmacist|pharmacist
1432750|NCT01033227|sickle cell disease|sickle cell disease
1432751|NCT01033227|sickle cell anemia|sickle cell anemia
1432752|NCT01033227|pain crisis|pain crisis
1432753|NCT01033227|nitric oxide|nitric oxide
1432754|NCT01033227|nitrite|nitrite
1432755|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
1432756|NCT01033227|pain medication|pain medication
1432757|NCT01033227|sickled cells|sickled cells
1432758|NCT01033227|blood flow|blood flow
1432759|NCT01033227|microcirculation|microcirculation
1432760|NCT01033214|TAA|taa
1432761|NCT01033214|Thoracic|thoracic
1432762|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
1432763|NCT01033214|TAArget|taarget
1432764|NCT01033201|Lung rejection|lung rejection
1432765|NCT01033188|double bundle|double bundle
1432766|NCT01033188|hamstring graft|hamstring graft
1432767|NCT01033188|ACL reconstruction|acl reconstruction
1432768|NCT01033188|single bundle|single bundle
1432769|NCT01033175|COPD|copd
1568373|NCT00506090|scar|scar
1432770|NCT01033175|anemia|anemia
1432771|NCT01033175|exercise|exercise
1432772|NCT01033175|cytokines|cytokines
1432773|NCT01033175|erythropoietin|erythropoietin
1432774|NCT01033123|ovarian|ovarian
1432775|NCT01033123|cancer|cancer
1432776|NCT01033123|sensitive|sensitive
1432777|NCT01033123|PARP|parp
1432778|NCT01033123|recurrent|recurrent
1432779|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
1432780|NCT01033110|inactive|inactive
1432781|NCT01033110|>45 years|>45 years
1432782|NCT01033110|female|female
1432784|NCT01033097|inflammatory skin disease|inflammatory skin disease
1432785|NCT01033097|itch|itch
1432786|NCT01033097|eczema|eczema
1432787|NCT01033084|Depressive Disorder, Major|depressive disorder, major
1432788|NCT01033071|Hypertensive|hypertensive
1432789|NCT01033071|Blood Pressure, High|blood pressure, high
1432790|NCT01033071|Cardiovascular disease|cardiovascular disease
1432791|NCT01033071|Vascular Disease|vascular disease
1432792|NCT01033071|Drug Therapy|drug therapy
1432793|NCT01033058|STEMI|stemi
1432794|NCT01033058|atorvastatin|atorvastatin
1432795|NCT01033058|PCI|pci
1432796|NCT01033045|Hepatitis C|hepatitis c
1432797|NCT01033045|Viral|viral
1432798|NCT01033045|Non-A|non-a
1432799|NCT01033045|Non-B|non-b
1432800|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
1432801|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
1432802|NCT01033032|Amrubicin|amrubicin
1432803|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
1432804|NCT01033019|sporadic,|sporadic,
1432805|NCT01033019|superficial and nodular,|superficial and nodular,
1432806|NCT01033019|skin|skin
1432807|NCT01033006|Peripheral Nerves|peripheral nerves
1432808|NCT01033006|Axillary Block|axillary block
1432809|NCT01033006|MRI|mri
1432810|NCT01032993|CoQ10|coq10
1432811|NCT01032993|Statins|statins
1432812|NCT01032993|Myalgia|myalgia
1432813|NCT01032993|Muscle Pain|muscle pain
1432814|NCT01032993|Muscle Weakness|muscle weakness
1432815|NCT01032980|HUMENZA|humenza
1432816|NCT01032980|PANENZA|panenza
1432817|NCT01032980|Influenza|influenza
1432818|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
1432819|NCT01032980|Influenza virus vaccines|influenza virus vaccines
1432820|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
1432821|NCT01032967|esophagectomy|esophagectomy
1432822|NCT01032967|chemoradiotherapy|chemoradiotherapy
1432823|NCT01032967|chemoradiation|chemoradiation
1432824|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
1432825|NCT01032954|Botulinum Toxin|botulinum toxin
1432826|NCT01032954|Rejuvenation|rejuvenation
1432827|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
1432828|NCT01032941|Portal Hypertension|portal hypertension
1432829|NCT01032941|Portal Pressure Measurement|portal pressure measurement
1432830|NCT01032941|VSL3|vsl3
1432831|NCT01032941|Cirrhosis|cirrhosis
1432832|NCT01032941|End Stage Liver Disease|end stage liver disease
1432833|NCT01032941|Probiotics|probiotics
1432834|NCT01032928|Swallowing|swallowing
1432835|NCT01032928|Dysphagia|dysphagia
1432836|NCT01032928|Breathing and swallowing|breathing and swallowing
1432837|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
1432838|NCT01032915|Quiescent uveitis|quiescent uveitis
1432839|NCT01032915|intermediate uveitis|intermediate uveitis
1432840|NCT01032915|panuveitis|panuveitis
1432841|NCT01032915|posterior uveitis|posterior uveitis
1432842|NCT01032915|uveitis|uveitis
1432843|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
1432844|NCT01032902|Rapid Test|rapid test
1432845|NCT01032902|HIV|hiv
1432846|NCT01032902|HIV Seronegativity|hiv seronegativity
1432847|NCT01032876|Congenital Heart disease|congenital heart disease
1432848|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
1432849|NCT01032876|Neonatal brain injury|neonatal brain injury
1432850|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
1432851|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
1432852|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
1432853|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
1432854|NCT01032863|Fibromyalgia|fibromyalgia
1432855|NCT01032850|INST 0820|inst 0820
1432856|NCT01032850|sorafenib|sorafenib
1432857|NCT01032850|capecitabine|capecitabine
1432858|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
1432859|NCT01032850|lung|lung
1432860|NCT01032850|nexavar|nexavar
1432861|NCT01032850|xeloda|xeloda
1432862|NCT01032850|liver cancer|liver cancer
1432863|NCT01032824|Complementary Therapies|complementary therapies
1432864|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
1432865|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
1432866|NCT01032785|Patent Foramen Ovale|patent foramen ovale
1432867|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
1432868|NCT01032785|PFO|pfo
1432869|NCT01032785|PDA|pda
1432870|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
1432871|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
1432872|NCT01032772|alcohol|alcohol
1432873|NCT01032772|contraception|contraception
1432874|NCT01032772|smoking|smoking
1432875|NCT01032772|pregnancy|pregnancy
1432876|NCT01032746|colon cancer|colon cancer
1432877|NCT01032746|rectal cancer|rectal cancer
1432878|NCT01032733|Weight Loss|weight loss
1432879|NCT01032733|Physical Function|physical function
1432880|NCT01032733|Oxidative Stress|oxidative stress
1432881|NCT01032733|Inflammation|inflammation
1432882|NCT01032720|ultrasound|ultrasound
1432883|NCT01032720|osteoarthritis|osteoarthritis
1432884|NCT01032720|knee|knee
1432885|NCT01032720|corticosteroids|corticosteroids
1432886|NCT01032720|intra-articular|intra-articular
1432887|NCT01032720|injections|injections
1432888|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
1432889|NCT01032694|Azithromycin SR|azithromycin sr
1432890|NCT01032694|Amoxiclav|amoxiclav
1432891|NCT01032681|Solid tumor|solid tumor
1432892|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
1432893|NCT01032681|Immunocytokine|immunocytokine
1432894|NCT01032681|interleukin-2|interleukin-2
1432895|NCT01032681|immunotherapy|immunotherapy
1432896|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
1432897|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
1432898|NCT01032655|Helicobacter pylori|helicobacter pylori
1432899|NCT01032655|sequential therapy|sequential therapy
1432900|NCT01032655|susceptibility-driven|susceptibility-driven
1432901|NCT01032655|rescue|rescue
1432902|NCT01032655|levofloxacin|levofloxacin
1432903|NCT01032655|clarithromycin|clarithromycin
1432904|NCT01032655|salvage|salvage
1432905|NCT01032655|treatment failure|treatment failure
1432906|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
1432907|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
1432908|NCT01032629|Diabetes|diabetes
1432909|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
1432910|NCT01032629|Cardiovascular risk|cardiovascular risk
1432911|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
1432912|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
1432913|NCT01032629|Placebo|placebo
1432914|NCT01032616|splanchnic bed|splanchnic bed
1432915|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
1432916|NCT01032616|isotopes|isotopes
1432917|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
1432919|NCT01032603|Exotropia|exotropia
1432920|NCT01032603|Strabismus|strabismus
1432921|NCT01032603|Intermittent exotropia|intermittent exotropia
1432922|NCT01032590|weight changes|weight changes
1432923|NCT01032590|cancer survivor|cancer survivor
1432924|NCT01032590|stage I colon cancer|stage i colon cancer
1432925|NCT01032590|stage II colon cancer|stage ii colon cancer
1432926|NCT01032590|stage III colon cancer|stage iii colon cancer
1432927|NCT01032590|stage I rectal cancer|stage i rectal cancer
1432928|NCT01032590|stage II rectal cancer|stage ii rectal cancer
1432929|NCT01032590|stage III rectal cancer|stage iii rectal cancer
1432930|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
1432931|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
1432932|NCT01032577|implant|implant
1432933|NCT01032577|bipolar sensing|bipolar sensing
1432934|NCT01032577|extended bipolar sensing|extended bipolar sensing
1432935|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
1432936|NCT01032551|Coronary Angiogram|coronary angiogram
1432937|NCT01032551|Decision Aid|decision aid
1432938|NCT01032551|Vascular Access|vascular access
1432939|NCT01032551|Radial|radial
1432940|NCT01032551|Femoral|femoral
1432941|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
1432942|NCT01032525|Crohn's Disease|crohn's disease
1432943|NCT01032525|Ulcerative Colitis|ulcerative colitis
1432944|NCT01032525|IBD|ibd
1432945|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
1432946|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
1432947|NCT01032512|GLUTAMINE|glutamine
1432948|NCT01032512|ARGININE|arginine
1432949|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
1432950|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
1432951|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
1432952|NCT01032499|Acne Vulgaris|acne vulgaris
1432953|NCT01032499|Boil|boil
1432954|NCT01032499|Taro Elixir|taro elixir
1432955|NCT01032486|Rasagiline|rasagiline
1432956|NCT01032486|Sleep|sleep
1432957|NCT01032486|Sleepiness|sleepiness
1432958|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
1432959|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
1432960|NCT01032460|airway|airway
1432961|NCT01032460|airway device|airway device
1432962|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
1432963|NCT01032434|sertraline|sertraline
1432964|NCT01032434|Polysomnograph|polysomnograph
1432965|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
1432966|NCT01032408|Influenza A Virus|influenza a virus
1432967|NCT01032408|Virus Diseases|virus diseases
1432968|NCT01032408|Influenza, Human|influenza, human
1432969|NCT01032408|HIV-1|hiv-1
1432970|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
1432971|NCT01032408|H1N1|h1n1
1432972|NCT01032408|HIV Infection|hiv infection
1432973|NCT01032408|Immunogenicity|immunogenicity
1432974|NCT01032408|safety|safety
1432975|NCT01032408|tolerability|tolerability
1432976|NCT01032395|H1N1|h1n1
1432977|NCT01032395|Pulmonary Disease|pulmonary disease
1432978|NCT01032395|Heart Disease|heart disease
1432979|NCT01032395|Diabetes|diabetes
1432980|NCT01032395|Influenza|influenza
1432981|NCT01032395|immunogenicity|immunogenicity
1432982|NCT01032395|safety|safety
1432983|NCT01032395|tolerability|tolerability
1432984|NCT01032382|leishmaniasis|leishmaniasis
1432985|NCT01032382|cutaneous|cutaneous
1432986|NCT01032382|WR 279,396|wr 279,396
1432987|NCT01032382|paromomycin|paromomycin
1432988|NCT01032382|gentamicin|gentamicin
1432989|NCT01032382|pharmacokinetics|pharmacokinetics
1432990|NCT01032382|safety|safety
1432991|NCT01032382|efficacy|efficacy
1432992|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
1432993|NCT01032356|Distal Radius fracture|distal radius fracture
1432994|NCT01032343|Immunosuppression|immunosuppression
1432995|NCT01032343|Ultraviolet radiation|ultraviolet radiation
1432996|NCT01032343|Nickel|nickel
1432997|NCT01032343|Contact hypersensitivity|contact hypersensitivity
1432998|NCT01032330|intermittent exotropia|intermittent exotropia
1432999|NCT01032330|IXT|ixt
1433000|NCT01032330|natural history|natural history
1433001|NCT01032330|occlusion therapy|occlusion therapy
1433002|NCT01032330|occlusion|occlusion
1433003|NCT01032330|patching|patching
1433004|NCT01032330|strabismus|strabismus
1433005|NCT01032330|strabismus treatment|strabismus treatment
1433006|NCT01032330|stereoacuity|stereoacuity
1433007|NCT01032330|motor alignment|motor alignment
1433008|NCT01032317|Arrhythmia|arrhythmia
1433009|NCT01032317|Electrophysiology|electrophysiology
1433010|NCT01032317|Fibrillation|fibrillation
1433011|NCT01032317|Tachycardia|tachycardia
1433012|NCT01032317|Ablation|ablation
1433013|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
1433014|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
1433015|NCT01032291|Colorectal cancer|colorectal cancer
1433016|NCT01032291|Revlimid|revlimid
1433017|NCT01032291|Lenalidomide|lenalidomide
1433018|NCT01032291|Cetuximab|cetuximab
1433019|NCT01032291|Erbitux|erbitux
1433020|NCT01032291|KRAS|kras
1433021|NCT01032278|cardiac toxicity|cardiac toxicity
1433022|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1433023|NCT01032265|female|female
1433024|NCT01032265|stress urinary incontinence|stress urinary incontinence
1433025|NCT01032265|treatment|treatment
1433026|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
1433027|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
1433028|NCT01032265|internet|internet
1433029|NCT01032265|life style|life style
1433030|NCT01032265|pamphlet|pamphlet
1433031|NCT01032265|eHealth|ehealth
1433032|NCT01032252|fall prevention|fall prevention
1433033|NCT01032252|general practitioners setting|general practitioners setting
1433034|NCT01032252|implementation|implementation
1433035|NCT01032252|network|network
1433036|NCT01032252|community dwelling older adults|community dwelling older adults
1433037|NCT01032252|exercise intervention|exercise intervention
1433038|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
1433039|NCT01032200|fatigue|fatigue
1433040|NCT01032200|cognitive/functional effects|cognitive/functional effects
1433041|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
1433042|NCT01032200|adult glioblastoma|adult glioblastoma
1433043|NCT01032200|adult gliosarcoma|adult gliosarcoma
1433044|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1433045|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1433046|NCT01032200|adult mixed glioma|adult mixed glioma
1433047|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
1433048|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1433049|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1433050|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1433051|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
1433052|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
1433053|NCT01032200|adult ependymoma|adult ependymoma
1433054|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1433055|NCT01032200|adult subependymoma|adult subependymoma
1433056|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
1433057|NCT01032200|adult grade I meningioma|adult grade i meningioma
1433058|NCT01032200|adult grade II meningioma|adult grade ii meningioma
1433059|NCT01032200|adult grade III meningioma|adult grade iii meningioma
1433060|NCT01032200|adult papillary meningioma|adult papillary meningioma
1433061|NCT01032200|adult brain stem glioma|adult brain stem glioma
1433062|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
1433063|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
1433064|NCT01032187|Meglumine antimoniate|meglumine antimoniate
1433065|NCT01032187|Children|children
1433066|NCT01032187|Brazil|brazil
1433067|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
1433068|NCT01032161|Delirium|delirium
1433069|NCT01032161|Postoperative|postoperative
1433263|NCT01031537|FSME-Immun|fsme-immun
1433070|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
1433071|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
1433072|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
1433073|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
1433074|NCT01032161|under general anesthesia|under general anesthesia
1433075|NCT01032161|surgery|surgery
1433076|NCT01032161|general anesthesia|general anesthesia
1433077|NCT01032148|Recurrent|recurrent
1433078|NCT01032148|Refractory|refractory
1433079|NCT01032122|melanoma|melanoma
1433080|NCT01032122|rituximab|rituximab
1433081|NCT01032122|metastatic|metastatic
1433082|NCT01032122|stage IIIc/IV|stage iiic/iv
1433083|NCT01032122|stem cell|stem cell
1433084|NCT01032122|overall survival|overall survival
1433085|NCT01032122|disease free interval|disease free interval
1433086|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
1433087|NCT01032083|SSRI antidepressant|ssri antidepressant
1433088|NCT01032083|Negative symptoms|negative symptoms
1433089|NCT01032083|Schizophrenia|schizophrenia
1433090|NCT01032070|phase 2|phase 2
1433091|NCT01032070|erlotinib|erlotinib
1433092|NCT01032070|pediatric|pediatric
1433093|NCT01032070|etoposide|etoposide
1433094|NCT01032070|ependymoma|ependymoma
1433095|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1433096|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
1433097|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
1433098|NCT01032044|Barrett's esophagus|barrett's esophagus
1433099|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
1433100|NCT01032044|Barrett's carcinoma|barrett's carcinoma
1433101|NCT01032044|adenocarcinoma|adenocarcinoma
1433102|NCT01032044|Cellvizio|cellvizio
1433103|NCT01032044|endomicroscopy|endomicroscopy
1433104|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
1433105|NCT01032044|pCLE|pcle
1433106|NCT01032044|Radio-frequency ablation|radio-frequency ablation
1433107|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
1433108|NCT01032044|Photodynamic therapy|photodynamic therapy
1433109|NCT01032031|Green tea|green tea
1433110|NCT01032031|Vitamin C|vitamin c
1433111|NCT01032031|Ultraviolet radiation|ultraviolet radiation
1433112|NCT01032031|Inflammation|inflammation
1433113|NCT01032031|Photoageing|photoageing
1433114|NCT01032018|Acute coronary syndrome|acute coronary syndrome
1433115|NCT01032018|Depression|depression
1433116|NCT01032018|Satisfaction with care|satisfaction with care
1433117|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1433118|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
1433119|NCT01031992|Epistaxis|epistaxis
1433120|NCT01031992|Nosebleeds|nosebleeds
1433121|NCT01031992|Anemia|anemia
1433122|NCT01031992|Tranexamic acid|tranexamic acid
1433123|NCT01031992|Antifibrinolytics|antifibrinolytics
1433124|NCT01031979|PTSD|ptsd
1433125|NCT01031979|Prolonged Exposure|prolonged exposure
1433126|NCT01031979|extinction|extinction
1433127|NCT01031979|habituation|habituation
1433128|NCT01031979|psychophysiology|psychophysiology
1433129|NCT01031966|ESRD|esrd
1433130|NCT01031953|nausea and vomiting|nausea and vomiting
1433131|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1433132|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
1433133|NCT01031927|sarcosine|sarcosine
1433134|NCT01031927|glycine transporter I|glycine transporter i
1433135|NCT01031927|NMDA receptor|nmda receptor
1433136|NCT01031914|Paced Breathing|paced breathing
1433137|NCT01031914|OSA|osa
1433138|NCT01031914|sleep/wake detection|sleep/wake detection
1433139|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
1433140|NCT01031901|Neurofibromatoses|neurofibromatoses
1433141|NCT01031901|Angiofibroma|angiofibroma
1433142|NCT01031901|Neurofibroma|neurofibroma
1433143|NCT01031901|Sirolimus|sirolimus
1433144|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
1433145|NCT01031888|Topical insulin application|topical insulin application
1433146|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
1433147|NCT01031888|diabetic retinopathy|diabetic retinopathy
1433148|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
1433149|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
1433150|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
1433151|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
1433152|NCT01031875|distal urethral cancer|distal urethral cancer
1433153|NCT01031875|proximal urethral cancer|proximal urethral cancer
1433154|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1433155|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1433156|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1433157|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
1433158|NCT01031862|healthy volunteer|healthy volunteer
1433159|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
1433160|NCT01031862|RCT|rct
1433161|NCT01031862|3H|3h
1433162|NCT01031849|HIV 1 patients|hiv 1 patients
1433264|NCT01031537|TBEV|tbev
1433163|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
1433164|NCT01031836|Japanese|japanese
1433165|NCT01031836|phase 2|phase 2
1433166|NCT01031836|safety|safety
1433167|NCT01031836|tolerability|tolerability
1433168|NCT01031836|MEDI-545|medi-545
1433169|NCT01031836|Autoimmune Disease|autoimmune disease
1433170|NCT01031836|Immune System Diseases|immune system diseases
1433171|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
1433172|NCT01031810|Treatment Resistant depression|treatment resistant depression
1433173|NCT01031810|Major Depression|major depression
1433174|NCT01031810|MDD|mdd
1433175|NCT01031810|Depression|depression
1433176|NCT01031797|SLE|sle
1433177|NCT01031797|Disease activity score|disease activity score
1433178|NCT01031797|QT dispersion|qt dispersion
1433179|NCT01031784|liver metastasis|liver metastasis
1433180|NCT01031784|Liver tumors|liver tumors
1433181|NCT01031784|microspheres|microspheres
1433182|NCT01031784|holmium|holmium
1433183|NCT01031784|toxicity|toxicity
1433184|NCT01031771|Cerebral Palsy|cerebral palsy
1433185|NCT01031771|Deglutition|deglutition
1433186|NCT01031771|Deglutition disorders|deglutition disorders
1433187|NCT01031771|Endoscopy|endoscopy
1433188|NCT01031758|Low HDL|low hdl
1433189|NCT01031758|High HDL|high hdl
1433190|NCT01031758|HDL|hdl
1433191|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
1433192|NCT01031758|RCT|rct
1433193|NCT01031758|healthy volunteer|healthy volunteer
1433194|NCT01031758|3H|3h
1433195|NCT01031758|Average HDL|average hdl
1433196|NCT01031745|Complementary Therapies|complementary therapies
1433197|NCT01031745|Drug Users|drug users
1433198|NCT01031732|Minimally invasive|minimally invasive
1433199|NCT01031732|Total hip arthroplasty|total hip arthroplasty
1433200|NCT01031732|Functional outcome|functional outcome
1433201|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
1433202|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
1433203|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
1433204|NCT01031719|Influenza A Virus|influenza a virus
1433205|NCT01031719|Virus Diseases|virus diseases
1433304|NCT01031420|bladder|bladder
1433206|NCT01031719|Influenza, Human|influenza, human
1433207|NCT01031719|H1N1|h1n1
1433208|NCT01031719|Immunogenicity|immunogenicity
1433209|NCT01031719|safety|safety
1433210|NCT01031719|tolerability|tolerability
1433211|NCT01031719|tumors|tumors
1433212|NCT01031719|oncology|oncology
1433213|NCT01031706|Hypertonic Saline|hypertonic saline
1433214|NCT01031706|Pediatrics|pediatrics
1433215|NCT01031706|Cystic Fibrosis|cystic fibrosis
1433216|NCT01031706|Mucociliary Clearance|mucociliary clearance
1433217|NCT01031706|Lung Clearance Index|lung clearance index
1433218|NCT01031693|Nicotine|nicotine
1433219|NCT01031693|Cigarettes|cigarettes
1433220|NCT01031693|Tobacco|tobacco
1433221|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1433222|NCT01031693|Cue-Induced Craving|cue-induced craving
1433223|NCT01031693|Smoking|smoking
1433224|NCT01031680|dapagliflozin|dapagliflozin
1433225|NCT01031680|diabetes|diabetes
1433226|NCT01031680|cardiovascular disease|cardiovascular disease
1433227|NCT01031680|hypertension|hypertension
1433228|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
1433229|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
1433230|NCT01031641|Symptoms|symptoms
1433231|NCT01031641|Instrument Development|instrument development
1433232|NCT01031641|Adverse Events|adverse events
1433233|NCT01031641|Questionnaire|questionnaire
1433234|NCT01031641|Patient Reported Outcomes|patient reported outcomes
1433235|NCT01031628|GIST|gist
1433236|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1433237|NCT01031628|Exon 9|exon 9
1433238|NCT01031628|Gleevec|gleevec
1433239|NCT01031628|Imatinib blood levels|imatinib blood levels
1433240|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
1433241|NCT01031602|Cancer|cancer
1433242|NCT01031602|Gynecology|gynecology
1433243|NCT01031602|Sexual Dysfunction|sexual dysfunction
1433244|NCT01031602|Depression|depression
1433245|NCT01031602|Anxiety|anxiety
1433246|NCT01031602|Underserved|underserved
1433247|NCT01031602|Minority|minority
1433248|NCT01031602|Psychological distress|psychological distress
1433249|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
1433250|NCT01031589|TMC278-C158|tmc278-c158
1433251|NCT01031589|TMC278|tmc278
1433253|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1433254|NCT01031589|HIV Seronegativity|hiv seronegativity
1433255|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
1433256|NCT01031563|Risk Taking|risk taking
1433257|NCT01031563|Schizophrenia|schizophrenia
1433258|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
1433259|NCT01031563|Comorbidity|comorbidity
1433260|NCT01031563|Impulsivity|impulsivity
1433261|NCT01031563|Drug Abuse|drug abuse
1433262|NCT01031550|liver resection for liver disease|liver resection for liver disease
1433265|NCT01031537|TBE Researcher|tbe researcher
1433266|NCT01031537|Plavivirus|plavivirus
1433267|NCT01031537|Anti-TBEV Levels|anti-tbev levels
1433268|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
1433269|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
1433270|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
1433271|NCT01031511|Anxiety|anxiety
1433272|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
1433273|NCT01031511|Social Recreational|social recreational
1433274|NCT01031511|Parent Stress|parent stress
1433275|NCT01031498|Nausea|nausea
1433276|NCT01031498|Vomiting|vomiting
1433277|NCT01031498|CINV|cinv
1433278|NCT01031498|Leukemia|leukemia
1433279|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
1433281|NCT01031498|Hematologic malignancies|hematologic malignancies
1433282|NCT01031498|Hematologic Disorder|hematologic disorder
1433283|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
1433284|NCT01031498|High-dose cytarabine|high-dose cytarabine
1433285|NCT01031498|Palonosetron|palonosetron
1433286|NCT01031498|Aloxi|aloxi
1433287|NCT01031498|Ondansetron|ondansetron
1433288|NCT01031498|Zofran|zofran
1433289|NCT01031485|hypertension|hypertension
1433290|NCT01031485|blood pressure|blood pressure
1433291|NCT01031485|milk peptides|milk peptides
1433292|NCT01031485|bioactive peptides|bioactive peptides
1433293|NCT01031485|randomized controlled trial|randomized controlled trial
1433294|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
1433295|NCT01031472|HIV Seronegativity|hiv seronegativity
1433296|NCT01031446|stage IV breast cancer|stage iv breast cancer
1433297|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
1433298|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
1433299|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
1433300|NCT01031433|Tobacco Craving|tobacco craving
1433301|NCT01031433|Virtual Reality|virtual reality
1433302|NCT01031433|Schizophrenia|schizophrenia
1433303|NCT01031433|Smoking|smoking
1433305|NCT01031420|cancer|cancer
1433306|NCT01031420|invasive|invasive
1433307|NCT01031407|Adolescents and Adults|adolescents and adults
1433308|NCT01031407|Autism|autism
1433309|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1433310|NCT01031407|MEG|meg
1433311|NCT01031407|Structural MRI|structural mri
1433312|NCT01031407|HV|hv
1433313|NCT01031407|Autism Spectrum Disorder|autism spectrum disorder
1433314|NCT01031407|ASD|asd
1433315|NCT01031407|Autistic Disorder|autistic disorder
1433316|NCT01031407|Asperger Syndrome|asperger syndrome
1433317|NCT01031407|Mental Retardation|mental retardation
1433318|NCT01031407|Healthy Volunteer|healthy volunteer
1433319|NCT01031394|exercise|exercise
1433320|NCT01031394|resistance training|resistance training
1433321|NCT01031381|Recurrent|recurrent
1433322|NCT01031381|ovarian|ovarian
1433323|NCT01031381|fallopian tube|fallopian tube
1433324|NCT01031381|primary peritoneal|primary peritoneal
1433325|NCT01031381|cancer|cancer
1433326|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
1433327|NCT01031355|Female Contraception|female contraception
1433328|NCT01031355|Contraceptives, Oral|contraceptives, oral
1433329|NCT01031342|Colonoscopy|colonoscopy
1433330|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
1433331|NCT01031316|Echocardiography|echocardiography
1433332|NCT01031316|Infant, Premature|infant, premature
1433333|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
1433334|NCT01031303|Diphtheria|diphtheria
1433335|NCT01031303|Tetanus|tetanus
1433336|NCT01031303|Pertussis|pertussis
1433337|NCT01031303|Poliomyelitis|poliomyelitis
1433338|NCT01031303|PENTAXIM™|pentaxim™
1433339|NCT01031303|TETRAXIM™|tetraxim™
1433340|NCT01031290|Cue-Induced Craving|cue-induced craving
1433341|NCT01031290|Cannabis|cannabis
1433342|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1433343|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
1433344|NCT01031290|Cannabis Craving|cannabis craving
1433345|NCT01031277|Hypercholesterolemia|hypercholesterolemia
1433346|NCT01031277|Update NCEP ATP111|update ncep atp111
1433347|NCT01031277|Survey|survey
1433348|NCT01031264|social drinkers|social drinkers
1433349|NCT01031238|PEM Uptake Value|pem uptake value
1433351|NCT01031238|Standardized Uptake Value|standardized uptake value
1433352|NCT01031238|SUV|suv
1433353|NCT01031238|Malignancies of the Breast|malignancies of the breast
1433354|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
1433355|NCT01031238|Tumor|tumor
1433356|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
1433357|NCT01031238|PET/CT scan|pet/ct scan
1433358|NCT01031225|Synta|synta
1433359|NCT01031225|STA 9090|sta 9090
1433360|NCT01031225|ganetespib)|ganetespib)
1433361|NCT01031225|Lung Cancer|lung cancer
1433362|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
1433363|NCT01031225|NSCLC|nsclc
1433364|NCT01031212|cancer|cancer
1433365|NCT01031212|neoplasms|neoplasms
1433366|NCT01031212|adult solid tumor|adult solid tumor
1433367|NCT01031212|antineoplastic agents|antineoplastic agents
1433368|NCT01031199|Multiple sclerosis|multiple sclerosis
1433369|NCT01031199|Diagnostic imaging|diagnostic imaging
1433370|NCT01031199|Neuroinflammation|neuroinflammation
1433371|NCT01031199|PET diagnosis|pet diagnosis
1433372|NCT01031199|PET tracer|pet tracer
1433373|NCT01031186|healthy male volunteers|healthy male volunteers
1433374|NCT01031186|GSK356278|gsk356278
1433375|NCT01031186|first time in man|first time in man
1433376|NCT01031186|major depressive disorder|major depressive disorder
1433377|NCT01031173|α galactosidase A|α galactosidase a
1433378|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
1433379|NCT01031173|agalsidase alfa|agalsidase alfa
1433380|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
1433381|NCT01031173|Replagal|replagal
1433382|NCT01031173|agalsidase beta|agalsidase beta
1433383|NCT01031173|Fabrazyme|fabrazyme
1433384|NCT01031160|Adolescence|adolescence
1433385|NCT01031160|Obesity|obesity
1433386|NCT01031160|Substance Abuse|substance abuse
1433387|NCT01031160|Etiology|etiology
1433388|NCT01031160|Social and Environmental Contexts|social and environmental contexts
1433389|NCT01031160|Health Behaviors|health behaviors
1433390|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
1433391|NCT01031147|Intracranial aneurysm|intracranial aneurysm
1433392|NCT01031147|Digital subtraction angiography|digital subtraction angiography
1433393|NCT01031147|Volume rendering|volume rendering
1433394|NCT01031121|Cigarette Smoking|cigarette smoking
1433395|NCT01031121|Biomarkers|biomarkers
1433396|NCT01031121|Nicotine|nicotine
1433397|NCT01031121|Cotinine|cotinine
1433398|NCT01031121|Metabolites|metabolites
1433399|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
1433400|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
1433401|NCT01031069|Cervarix|cervarix
1433402|NCT01031069|Gardasil|gardasil
1433403|NCT01031069|Immunogenicity|immunogenicity
1433404|NCT01031069|Cervical cancer|cervical cancer
1433405|NCT01031069|Safety|safety
1433406|NCT01031069|HPV vaccine|hpv vaccine
1433407|NCT01031043|IEM|iem
1433408|NCT01031030|stage I breast cancer|stage i breast cancer
1433409|NCT01031030|stage II breast cancer|stage ii breast cancer
1433410|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
1433411|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
1433412|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
1433413|NCT01031017|twin pregnancies|twin pregnancies
1433414|NCT01031017|preterm delivery|preterm delivery
1433415|NCT01031017|progesterone|progesterone
1433416|NCT01030991|Heart failure|heart failure
1433417|NCT01030991|Ejection fraction|ejection fraction
1433418|NCT01030991|Diastolic heart failure|diastolic heart failure
1433419|NCT01030991|Diastolic dysfunction|diastolic dysfunction
1433420|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
1433421|NCT01030991|Exercise testing|exercise testing
1433422|NCT01030991|Echocardiography|echocardiography
1433423|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
1433424|NCT01030991|Arterial tonometry|arterial tonometry
1433425|NCT01030991|Genetics|genetics
1433426|NCT01030991|Epidemiology|epidemiology
1433427|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
1433428|NCT01030978|PreDiabetes|prediabetes
1433429|NCT01030978|Diabetes Prevention|diabetes prevention
1433430|NCT01030965|Chronic Bronchitis|chronic bronchitis
1433431|NCT01030965|Anticholinergic|anticholinergic
1433432|NCT01030965|Emphysema|emphysema
1433433|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
1433434|NCT01030965|COPD|copd
1433435|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1433436|NCT01030952|Nateglinide|nateglinide
1433437|NCT01030952|Acarbose|acarbose
1433438|NCT01030952|glucose fluctuation|glucose fluctuation
1433439|NCT01030939|Healthy volunteers|healthy volunteers
1433440|NCT01030939|Men and women|men and women
1433441|NCT01030939|adults and elderly|adults and elderly
1433442|NCT01030939|repeat dose|repeat dose
1433443|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1433444|NCT01030900|Immunosuppression|immunosuppression
1433445|NCT01030900|Microenvironment|microenvironment
1433446|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
1433447|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
1433448|NCT01030900|Microarray|microarray
1433449|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1433450|NCT01030887|Cancer|cancer
1433451|NCT01030887|Exercise|exercise
1433452|NCT01030887|Physical Activity|physical activity
1433453|NCT01030887|Randomized controlled trial|randomized controlled trial
1433454|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
1433455|NCT01030874|falls|falls
1433456|NCT01030874|rehabilitation|rehabilitation
1433457|NCT01030874|blood pressure|blood pressure
1433458|NCT01030874|aging|aging
1433459|NCT01030861|type 1 diabetes|type 1 diabetes
1433460|NCT01030861|pre-diabetic|pre-diabetic
1433461|NCT01030861|autoantibody positive|autoantibody positive
1433462|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
1433463|NCT01030861|glucose intolerance|glucose intolerance
1433464|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
1433465|NCT01030835|Screening Protocol|screening protocol
1433466|NCT01030835|Comorbidity|comorbidity
1433467|NCT01030835|Normal Controls|normal controls
1433468|NCT01030835|Substance Use Disorders|substance use disorders
1433469|NCT01030835|Substance Abuse Disorders|substance abuse disorders
1433470|NCT01030822|Catch-up vaccination|catch-up vaccination
1433471|NCT01030822|Safety|safety
1433472|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
1433473|NCT01030822|Pneumococcal disease|pneumococcal disease
1433474|NCT01030822|Booster vaccination|booster vaccination
1433475|NCT01030822|Immunogenicity|immunogenicity
1433476|NCT01030809|Crohn's disease|crohn's disease
1433477|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
1433478|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
1433479|NCT01030809|Remission|remission
1433480|NCT01030809|Corticosteroids|corticosteroids
1433481|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
1433482|NCT01030770|Diabetes|diabetes
1433483|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
1433484|NCT01030757|Liver Cancer|liver cancer
1433485|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
1433486|NCT01030757|Tomotherapy|tomotherapy
1433487|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1433488|NCT01030744|Gestational Diabetes|gestational diabetes
1433489|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
1433490|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
1433491|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
1433492|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
1433493|NCT01030731|Streptococcal Infection|streptococcal infection
1433494|NCT01030705|Bradycardia|bradycardia
1433495|NCT01030705|pacemaker|pacemaker
1433496|NCT01030692|Cocaine|cocaine
1433497|NCT01030692|Rivastigmine|rivastigmine
1433498|NCT01030692|Huperzine A|huperzine a
1433499|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
1433500|NCT01030679|Glitazone|glitazone
1433501|NCT01030666|periodontal regeneration|periodontal regeneration
1433502|NCT01030666|radiographic bone fill|radiographic bone fill
1433503|NCT01030666|infrabony defects|infrabony defects
1433504|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
1433505|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
1433506|NCT01030653|Voriconazole|voriconazole
1433507|NCT01030653|Pharmacokinetics|pharmacokinetics
1433508|NCT01030653|Obese|obese
1433509|NCT01030653|Healthy Volunteer|healthy volunteer
1433510|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
1433511|NCT01030640|IENF|ienf
1433512|NCT01030640|tanezumab|tanezumab
1433513|NCT01030640|subcutaneous|subcutaneous
1433514|NCT01030640|healthy volunteers|healthy volunteers
1433515|NCT01030627|Eclampsia|eclampsia
1433516|NCT01030627|Preeclampsia|preeclampsia
1433517|NCT01030627|Magnesium sulfate|magnesium sulfate
1433518|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
1433519|NCT01030601|Diabetic|diabetic
1433520|NCT01030601|Macular Edema|macular edema
1433521|NCT01030601|Pseudophakic|pseudophakic
1433522|NCT01030601|Dexamethasone|dexamethasone
1433523|NCT01030601|Intravitreal|intravitreal
1433524|NCT01030601|Cataract surgery|cataract surgery
1433525|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
1433526|NCT01030575|Pharmacokinetics|pharmacokinetics
1433527|NCT01030575|Inositol|inositol
1433528|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1433529|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1433530|NCT01030575|Prematurity|prematurity
1433531|NCT01030562|adolescent, vaccine, human papillomavirus, HPV|adolescent, vaccine, human papillomavirus, hpv
1433532|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
1433533|NCT01030549|ventricular volumes|ventricular volumes
1433534|NCT01030549|ventricular function|ventricular function
1433535|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
1433537|NCT01030536|CLL|cll
1433538|NCT01030497|Cancer|cancer
1433539|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
1433540|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
1433541|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
1433542|NCT01030497|Head|head
1433543|NCT01030497|Neck|neck
1433544|NCT01030497|HR PET Imaging System|hr pet imaging system
1433545|NCT01030497|High-Resolution PET|high-resolution pet
1433546|NCT01030497|PET/CT|pet/ct
1433547|NCT01030497|PEMFlex Solo II|pemflex solo ii
1433548|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
1433549|NCT01030484|NAFLD|nafld
1433550|NCT01030484|NASH|nash
1433551|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1433552|NCT01030484|fatty liver disease|fatty liver disease
1433553|NCT01030471|adolescents|adolescents
1433554|NCT01030471|depression|depression
1433555|NCT01030471|adherence|adherence
1434050|NCT01028508|lithium|lithium
1433556|NCT01030471|family functioning|family functioning
1433557|NCT01030471|intervention|intervention
1433558|NCT01030458|Blood pressure|blood pressure
1433559|NCT01030458|Hypertension|hypertension
1433560|NCT01030458|Blacks|blacks
1433561|NCT01030458|Africa|africa
1433562|NCT01030458|Blood pressure control|blood pressure control
1433563|NCT01030458|Side-effects|side-effects
1433564|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
1433565|NCT01030445|electrical velocimetry|electrical velocimetry
1433566|NCT01030445|Aesculon|aesculon
1433567|NCT01030445|Icon|icon
1433568|NCT01030445|pediatrics|pediatrics
1433569|NCT01030445|normal reference|normal reference
1433570|NCT01030419|Aging|aging
1433571|NCT01030419|Quality of Life|quality of life
1433572|NCT01030419|Functional fitness|functional fitness
1433573|NCT01030406|Abuse Liability|abuse liability
1433574|NCT01030406|Abuse Prevention|abuse prevention
1433575|NCT01030406|Abuse Resistance|abuse resistance
1433576|NCT01030406|Abuse Deterrence|abuse deterrence
1433577|NCT01030393|hCG|hcg
1433578|NCT01030393|pregnancy|pregnancy
1433579|NCT01030393|implantation|implantation
1433580|NCT01030393|ICSI|icsi
1433581|NCT01030393|IVF|ivf
1433582|NCT01030380|Facial toning|facial toning
1433583|NCT01030380|Facial lift|facial lift
1433584|NCT01030380|Improve facial complexion|improve facial complexion
1433585|NCT01030380|Improve facial tone|improve facial tone
1433586|NCT01030380|Improve radiance of the face|improve radiance of the face
1433587|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
1433588|NCT01030380|firming, lift, tone face|firming, lift, tone face
1433589|NCT01030367|Coronary artery disease|coronary artery disease
1433590|NCT01030354|Satiety|satiety
1433591|NCT01030354|Meal Replacements|meal replacements
1433592|NCT01030354|High Protein|high protein
1433593|NCT01030354|Standard Protein|standard protein
1433594|NCT01030341|Diabetes|diabetes
1433595|NCT01030341|Gastroparesis|gastroparesis
1433596|NCT01030315|Erythropoietin|erythropoietin
1433597|NCT01030315|Long-acting|long-acting
1433598|NCT01030315|EPO|epo
1433599|NCT01030302|Bortezomib retreatment|bortezomib retreatment
1433600|NCT01030302|Velcade|velcade
1433601|NCT01030302|Proteasome inhibitor|proteasome inhibitor
1433602|NCT01030302|Bortezomib|bortezomib
1433603|NCT01030289|food cravings|food cravings
1433604|NCT01030250|Breast Cancer|breast cancer
1433605|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
1433606|NCT01030237|Dry eye|dry eye
1433607|NCT01030237|artificial tears|artificial tears
1433608|NCT01030224|Healthy volunteer|healthy volunteer
1433609|NCT01030224|First time in human|first time in human
1433610|NCT01030211|Dengue|dengue
1433611|NCT01030211|Platelet transfusion|platelet transfusion
1433612|NCT01030211|Bleeding|bleeding
1433613|NCT01030211|Prevention|prevention
1433614|NCT01030185|ascites|ascites
1433615|NCT01030185|liver cirrhosis|liver cirrhosis
1433616|NCT01030159|Cancer Anemia Survey|cancer anemia survey
1433617|NCT01030159|Thai National Cancer Institute|thai national cancer institute
1433618|NCT01030133|pain|pain
1433619|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
1433620|NCT01030120|etanercept|etanercept
1433621|NCT01030107|sleep|sleep
1433622|NCT01030107|obesity|obesity
1433623|NCT01030107|children|children
1433624|NCT01030107|eating behaviors|eating behaviors
1433625|NCT01030107|activity|activity
1433626|NCT01030107|leptin|leptin
1433627|NCT01030107|ghrelin|ghrelin
1433628|NCT01030094|Topiramate|topiramate
1433629|NCT01030094|Carbamazepine|carbamazepine
1433630|NCT01030094|Valproic acid|valproic acid
1433631|NCT01030094|Epilepsy|epilepsy
1433632|NCT01030094|Bone mineral density|bone mineral density
1433633|NCT01030094|Monotherapy|monotherapy
1433634|NCT01030081|24 hour blood pressure|24 hour blood pressure
1433635|NCT01030081|morning blood pressure surge|morning blood pressure surge
1433636|NCT01030081|amlodipine|amlodipine
1433637|NCT01030081|nifedipine GITS|nifedipine gits
1433638|NCT01030068|Smoking Cessation|smoking cessation
1433639|NCT01030068|Yoga|yoga
1433640|NCT01030068|Wellness|wellness
1433641|NCT01030068|Feasibility|feasibility
1433642|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
1433643|NCT01030055|Neoplasms|neoplasms
1433644|NCT01030055|Cancer|cancer
1433645|NCT01030055|Tumors|tumors
1433646|NCT01030055|Administration, oral|administration, oral
1433647|NCT01030055|Capsules|capsules
1433648|NCT01030055|CHIR258|chir258
1433649|NCT01030055|CHIR-258|chir-258
1433650|NCT01030055|CHIR 258|chir 258
1433651|NCT01030055|TKI258|tki258
1433652|NCT01030055|TKI-258|tki-258
1433653|NCT01030055|TKI 258|tki 258
1433654|NCT01030055|Bioavailability|bioavailability
1433655|NCT01030055|Food|food
1433656|NCT01030042|metastatic|metastatic
1433657|NCT01030042|colorectal cancer|colorectal cancer
1433658|NCT01030042|two sequences therapy|two sequences therapy
1433659|NCT01030029|auricular acupuncture|auricular acupuncture
1433660|NCT01030029|postoperative pain|postoperative pain
1433661|NCT01030029|opioid consumption|opioid consumption
1433662|NCT01030029|laparoscopic surgery|laparoscopic surgery
1433663|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
1433664|NCT01030016|resistance exercise|resistance exercise
1433665|NCT01030016|beta-blockers|beta-blockers
1433666|NCT01030016|blood pressure|blood pressure
1433667|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
1433668|NCT01030003|Snoring|snoring
1433669|NCT01030003|Pregnancy|pregnancy
1433670|NCT01030003|Fetal Growth Retardation|fetal growth retardation
1433671|NCT01030003|Pre-Eclampsia|pre-eclampsia
1433672|NCT01029990|participation|participation
1433673|NCT01029990|mass screening|mass screening
1433674|NCT01029990|cervical neoplasia|cervical neoplasia
1433675|NCT01029990|health economics|health economics
1433676|NCT01029990|cost-benefit|cost-benefit
1433677|NCT01029964|Childhood obesity|childhood obesity
1433678|NCT01029964|Age-dependent|age-dependent
1433679|NCT01029964|Long-term treatment|long-term treatment
1433680|NCT01029964|BMI SDS|bmi sds
1433681|NCT01029964|Dropouts|dropouts
1433682|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
1433683|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
1433684|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
1433685|NCT01029938|Covered stent;|covered stent;
1433686|NCT01029938|Coil embolization|coil embolization
1433687|NCT01029925|metastatic breast cancer|metastatic breast cancer
1433688|NCT01029925|lung cancer|lung cancer
1433689|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
1433690|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
1433691|NCT01029925|stage IV lung cancer|stage iv lung cancer
1433692|NCT01029912|Stroke|stroke
1433693|NCT01029912|Hemiplegia|hemiplegia
1433694|NCT01029912|Footdrop|footdrop
1433695|NCT01029912|Electrical Stimulation|electrical stimulation
1433696|NCT01029912|Motor Relearning|motor relearning
1433697|NCT01029912|Neuroplasticity|neuroplasticity
1433698|NCT01029899|Colonoscopy|colonoscopy
1433699|NCT01029899|Force|force
1433700|NCT01029899|Monitor|monitor
1433701|NCT01029899|Endoscopist|endoscopist
1433702|NCT01029899|Trainee|trainee
1433703|NCT01029886|diabetes|diabetes
1433704|NCT01029886|exenatide once weekly|exenatide once weekly
1433705|NCT01029886|Byetta|byetta
1433706|NCT01029886|liraglutide|liraglutide
1433707|NCT01029886|Victoza|victoza
1433708|NCT01029886|Amylin|amylin
1433709|NCT01029886|Lilly|lilly
1433710|NCT01029873|cancer|cancer
1433711|NCT01029873|immunotherapy|immunotherapy
1433712|NCT01029873|targeted|targeted
1433713|NCT01029873|metastatic|metastatic
1433714|NCT01029873|interleukin-2|interleukin-2
1433715|NCT01029873|IL-2|il-2
1433716|NCT01029873|Cisplatin|cisplatin
1433717|NCT01029873|antitumor|antitumor
1433718|NCT01029873|melanoma|melanoma
1433719|NCT01029873|TCR|tcr
1433720|NCT01029873|T-cell receptor|t-cell receptor
1433721|NCT01029873|p53|p53
1433722|NCT01029873|p53 gene|p53 gene
1433723|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
1433724|NCT01029860|Hypertension|hypertension
1433725|NCT01029860|Ambulatory measurement|ambulatory measurement
1433726|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
1433727|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
1433728|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
1433729|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
1433730|NCT01029821|Thromboprophylaxis|thromboprophylaxis
1433731|NCT01029808|carriers of hemophilia|carriers of hemophilia
1433732|NCT01029782|Cellulitis|cellulitis
1433733|NCT01029782|Emergency Department|emergency department
1433734|NCT01029782|Cefazolin|cefazolin
1433735|NCT01029782|Probenecid|probenecid
1433736|NCT01029782|Cephalexin|cephalexin
1433737|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
1433738|NCT01029756|Pentax AWS|pentax aws
1433739|NCT01029756|Macintosh|macintosh
1433740|NCT01029756|Laryngoscope|laryngoscope
1433741|NCT01029756|Video Laryngoscope|video laryngoscope
1433742|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
1433743|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
1433744|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
1433745|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
1433746|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
1433747|NCT01029730|Low grade lymphoma|low grade lymphoma
1433748|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
1433749|NCT01029730|Lymphoma first line|lymphoma first line
1433750|NCT01029730|bendamustine|bendamustine
1433751|NCT01029730|Treanda|treanda
1433752|NCT01029730|bortezomib|bortezomib
1433753|NCT01029730|Velcade|velcade
1433754|NCT01029730|rituximab|rituximab
1433755|NCT01029730|Rituxan|rituxan
1433756|NCT01029717|Central Venous Catheters|central venous catheters
1433757|NCT01029717|blood stream infection|blood stream infection
1433758|NCT01029717|children, intensive care|children, intensive care
1433759|NCT01029717|Heparin bonded|heparin bonded
1433760|NCT01029717|antibiotic coated|antibiotic coated
1434051|NCT01028508|venlafaxine|venlafaxine
1433761|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
1433762|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
1433763|NCT01029691|Sleep disordered breathing|sleep disordered breathing
1433764|NCT01029691|Preeclampsia|preeclampsia
1433765|NCT01029691|Positive Airway Pressure|positive airway pressure
1433766|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
1433767|NCT01029678|Elderly patients|elderly patients
1433768|NCT01029678|NSCLC|nsclc
1433769|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
1433770|NCT01029665|Asthma|asthma
1433771|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
1433772|NCT01029665|Growth & Development|growth & development
1433773|NCT01029652|frequent flares|frequent flares
1433774|NCT01029652|gout|gout
1433775|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
1433776|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
1433777|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
1433778|NCT01029639|Respiratory Quotients|respiratory quotients
1433779|NCT01029639|Hypoglycemia|hypoglycemia
1433780|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
1433781|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
1433782|NCT01029587|CAPS|caps
1433783|NCT01029587|Kidney transplant|kidney transplant
1433784|NCT01029587|Renal transplant|renal transplant
1433785|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
1433786|NCT01029574|Rotator cuff lesions|rotator cuff lesions
1433787|NCT01029574|Platelet rich plasma|platelet rich plasma
1433788|NCT01029574|Arthroscopic repair|arthroscopic repair
1433789|NCT01029561|Metabolic syndrome|metabolic syndrome
1433790|NCT01029561|Insulin Resistance|insulin resistance
1433791|NCT01029561|Adipokines|adipokines
1433792|NCT01029561|Proinflammatory markers|proinflammatory markers
1433793|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1433794|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
1433795|NCT01029561|Obesity|obesity
1433992|NCT01028742|Incidence|incidence
1433796|NCT01029561|Bariatric surgery|bariatric surgery
1433797|NCT01029548|HIV|hiv
1433798|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
1433799|NCT01029522|Dyslipidemia|dyslipidemia
1433800|NCT01029509|Advanced Leukemia|advanced leukemia
1433801|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
1433802|NCT01029509|ALL|all
1433803|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
1433804|NCT01029509|CMS|cms
1433805|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
1433806|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1433807|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
1433808|NCT01029509|MDS|mds
1433809|NCT01029509|OPB 31121|opb 31121
1433810|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
1433811|NCT01029496|Neonatal anemia|neonatal anemia
1433812|NCT01029496|Omphalitis|omphalitis
1433813|NCT01029483|Obesity|obesity
1433814|NCT01029483|Weight loss|weight loss
1433815|NCT01029483|low carbohydrate diets|low carbohydrate diets
1433816|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
1433817|NCT01029483|Healthy adults|healthy adults
1433818|NCT01029483|Body composition|body composition
1433819|NCT01029483|Energy Expenditure|energy expenditure
1433820|NCT01029470|Luveris|luveris
1433821|NCT01029470|hyporesponse|hyporesponse
1433822|NCT01029470|pituitary downregulation|pituitary downregulation
1433823|NCT01029470|IVF|ivf
1433824|NCT01029470|Infertility women|infertility women
1433825|NCT01029444|Diabetes|diabetes
1433826|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
1433827|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
1433828|NCT01029444|Respiratory Quotients|respiratory quotients
1433829|NCT01029444|Hypoglycemia|hypoglycemia
1433830|NCT01029444|Hyperglycemia|hyperglycemia
1433831|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
1433832|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
1433833|NCT01029431|pediatric|pediatric
1433834|NCT01029418|HCC|hcc
1433835|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
1433836|NCT01029418|liver cancer|liver cancer
1433837|NCT01029405|Topical|topical
1433838|NCT01029405|Plaque type psoriasis|plaque type psoriasis
1433839|NCT01029392|Diabetes|diabetes
1433840|NCT01029392|Type I|type i
1433841|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
1433842|NCT01029379|propofol|propofol
1433843|NCT01029379|depth of anesthesia|depth of anesthesia
1433844|NCT01029379|pharmacogenetics|pharmacogenetics
1433845|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
1433846|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
1433847|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1433848|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1433849|NCT01029353|Prematurity|prematurity
1433850|NCT01029353|Laparotomy|laparotomy
1433851|NCT01029353|Drainage|drainage
1433852|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
1433853|NCT01029353|Focal intestinal perforation|focal intestinal perforation
1433854|NCT01029340|Hemophilia A|hemophilia a
1433855|NCT01029340|Factor VIII|factor viii
1433856|NCT01029340|Prophylaxis|prophylaxis
1433857|NCT01029314|Thermometry|thermometry
1433858|NCT01029301|Skin aging|skin aging
1433859|NCT01029301|Skin Wrinkling|skin wrinkling
1433860|NCT01029288|Diabetes|diabetes
1433861|NCT01029288|Decision aid|decision aid
1433862|NCT01029288|Cardiovascular risk|cardiovascular risk
1433863|NCT01029288|Patient education|patient education
1433864|NCT01029275|Acromegaly|acromegaly
1433865|NCT01029275|pituitary adenoma|pituitary adenoma
1433866|NCT01029275|octreotide|octreotide
1433867|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
1433868|NCT01029275|GH|gh
1433869|NCT01029275|IGF-1|igf-1
1433870|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
1433871|NCT01029262|MDS|mds
1433872|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
1433873|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
1433874|NCT01029262|non-del 5q|non-del 5q
1433875|NCT01029236|obesity|obesity
1433876|NCT01029236|metabolism|metabolism
1433877|NCT01029236|weight loss|weight loss
1433878|NCT01029236|energy expenditure|energy expenditure
1433879|NCT01029236|thermogenesis|thermogenesis
1433880|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
1433881|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
1433882|NCT01029210|osteoporosis|osteoporosis
1433883|NCT01029210|temporomandibular disorders|temporomandibular disorders
1433884|NCT01029210|resonance magnetic|resonance magnetic
1433885|NCT01029184|weaning|weaning
1433886|NCT01029184|cereals|cereals
1433887|NCT01029184|allergy|allergy
1433888|NCT01029184|atopy|atopy
1433889|NCT01029184|open allergenic test|open allergenic test
1433890|NCT01029171|falls|falls
1433891|NCT01029171|balance training|balance training
1433892|NCT01029171|strength training|strength training
1433893|NCT01029158|Healthy volunteers|healthy volunteers
1434275|NCT01027351|Vaccination|vaccination
1433894|NCT01029158|Comparison of two formulations|comparison of two formulations
1433895|NCT01029158|Improvement of scar appearance|improvement of scar appearance
1433896|NCT01029145|Bipolar disorder|bipolar disorder
1433897|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
1433898|NCT01029132|Alzheimer's disease|alzheimer's disease
1433899|NCT01029132|Galantamine|galantamine
1433900|NCT01029132|Treatment response|treatment response
1433901|NCT01029132|Efficacy|efficacy
1433902|NCT01029132|Adverse Event|adverse event
1433903|NCT01029119|blood pressure|blood pressure
1433904|NCT01029106|SUI|sui
1433905|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
1433906|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
1433907|NCT01029093|extremity with immobilisation|extremity with immobilisation
1433908|NCT01029093|brain platicity|brain platicity
1433909|NCT01029093|deprivation|deprivation
1433910|NCT01029093|MRI|mri
1433911|NCT01029080|Brain, blood flow|brain, blood flow
1433912|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
1433913|NCT01029080|Monitoring, intensive care|monitoring, intensive care
1433914|NCT01029080|Sepsis|sepsis
1433915|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
1433916|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
1433917|NCT01029080|sepsis-associated delir|sepsis-associated delir
1433918|NCT01029067|schizophrenia|schizophrenia
1433919|NCT01029067|delusion|delusion
1433920|NCT01029067|paranoia|paranoia
1433921|NCT01029067|psychosis|psychosis
1433922|NCT01029054|Multiple Myeloma|multiple myeloma
1433923|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
1433924|NCT01029015|OAB|oab
1433925|NCT01029015|Insomnia|insomnia
1433926|NCT01029015|Bladder function|bladder function
1433927|NCT01029015|cystometry|cystometry
1433928|NCT01029015|polysomnography|polysomnography
1433929|NCT01029002|Vitamin D|vitamin d
1433930|NCT01029002|CKD|ckd
1433931|NCT01029002|proteinuria|proteinuria
1433932|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
1433933|NCT01028989|Insulin|insulin
1433934|NCT01028989|Diet|diet
1433935|NCT01028989|Glycemic Load|glycemic load
1433936|NCT01028976|randomized controlled trial|randomized controlled trial
1433937|NCT01028976|primary prevention|primary prevention
1433938|NCT01028976|Vitamin C|vitamin c
1433939|NCT01028976|Antioxidants|antioxidants
1433940|NCT01028976|C-reactive protein|c-reactive protein
1433941|NCT01028976|inflammation|inflammation
1433942|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
1433943|NCT01028976|obesity|obesity
1433944|NCT01028950|YM150|ym150
1433945|NCT01028950|Bleeding|bleeding
1433946|NCT01028950|VTE|vte
1433947|NCT01028950|FXa inhibitor|fxa inhibitor
1433948|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
1433949|NCT01028950|Venous thromboembolism|venous thromboembolism
1433950|NCT01028937|Hyperopia correction|hyperopia correction
1433951|NCT01028937|Laser vision correction|laser vision correction
1433952|NCT01028937|Optimal keratoplasty|optimal keratoplasty
1433953|NCT01028924|Thorough QTc-Study|thorough qtc-study
1433954|NCT01028924|Short Bowel Syndrome|short bowel syndrome
1433955|NCT01028924|Cardiac safety|cardiac safety
1433956|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
1433957|NCT01028898|IBS|ibs
1433958|NCT01028898|proteomics|proteomics
1433959|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
1433960|NCT01028898|Western blot|western blot
1433961|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
1433962|NCT01028898|ATP content|atp content
1433963|NCT01028898|micRNA|micrna
1433964|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
1433965|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
1433966|NCT01028859|CKD-516|ckd-516
1433967|NCT01028859|Phase I|phase i
1433968|NCT01028859|Vascular disrupting agent|vascular disrupting agent
1433969|NCT01028859|DCE MRI|dce mri
1433970|NCT01028846|Type 2 Diabetes|type 2 diabetes
1433971|NCT01028833|power wheelchairs|power wheelchairs
1433972|NCT01028833|power mobility|power mobility
1433973|NCT01028833|young children|young children
1433974|NCT01028820|autism|autism
1433975|NCT01028820|asperger's|asperger's
1433976|NCT01028820|repetitive|repetitive
1433977|NCT01028820|restricted|restricted
1433978|NCT01028820|compulsions|compulsions
1433979|NCT01028807|Early feeding|early feeding
1433980|NCT01028807|Bowel anastomosis|bowel anastomosis
1433981|NCT01028807|Children|children
1433982|NCT01028794|stroke|stroke
1433983|NCT01028794|bone marrow|bone marrow
1433984|NCT01028794|mononuclear cell|mononuclear cell
1433985|NCT01028794|angiogenesis|angiogenesis
1433986|NCT01028794|neurogenesis|neurogenesis
1433987|NCT01028768|Renal impairment|renal impairment
1433988|NCT01028768|Renal impairment study|renal impairment study
1433989|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
1433990|NCT01028742|Traumatic brain injury|traumatic brain injury
1433991|NCT01028742|Hypopituitarism|hypopituitarism
1433993|NCT01028703|Chronic kidney disease|chronic kidney disease
1433994|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
1433995|NCT01028703|diastolic dysfunction|diastolic dysfunction
1433996|NCT01028703|hypertension|hypertension
1433997|NCT01028690|Helicobacter pylori|helicobacter pylori
1433998|NCT01028690|Eradication therapy|eradication therapy
1433999|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
1434000|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
1434001|NCT01028677|oxytocin|oxytocin
1434002|NCT01028677|social cognition|social cognition
1434003|NCT01028677|social skill|social skill
1434004|NCT01028677|social functioning|social functioning
1434005|NCT01028677|paranoia|paranoia
1434006|NCT01028677|psychotic symptoms|psychotic symptoms
1434007|NCT01028677|schizophrenia|schizophrenia
1434008|NCT01028677|social deficits|social deficits
1434009|NCT01028677|intranasal administration|intranasal administration
1434010|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
1434011|NCT01028651|PAH|pah
1434012|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
1434013|NCT01028651|Remodulin|remodulin
1434014|NCT01028651|Treprostinil|treprostinil
1434015|NCT01028651|Quality of Life|quality of life
1434016|NCT01028638|VEGF imaging|vegf imaging
1434017|NCT01028638|everolimus|everolimus
1434018|NCT01028638|renal cell carcinoma|renal cell carcinoma
1434019|NCT01028638|PET|pet
1434020|NCT01028638|bevacizumab|bevacizumab
1434021|NCT01028625|Heart failure|heart failure
1434022|NCT01028625|Depression|depression
1434023|NCT01028625|Self Care|self care
1434024|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
1434025|NCT01028599|Heart transplantation|heart transplantation
1434026|NCT01028599|Exercise capacity|exercise capacity
1434027|NCT01028599|Endothelial function|endothelial function
1434028|NCT01028573|bowel preparation|bowel preparation
1434029|NCT01028573|colonoscopy|colonoscopy
1434030|NCT01028560|Wheezing|wheezing
1434031|NCT01028560|Asthma|asthma
1434032|NCT01028560|Allergy|allergy
1434033|NCT01028560|Immunotherapy|immunotherapy
1434034|NCT01028547|PONV|ponv
1434035|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
1434036|NCT01028534|Blood pressure|blood pressure
1434037|NCT01028534|Oxygen desaturation index|oxygen desaturation index
1434038|NCT01028534|Endothelial dysfunction|endothelial dysfunction
1434039|NCT01028534|Patient reported measurement|patient reported measurement
1434040|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
1434041|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
1434042|NCT01028508|Depression|depression
1434043|NCT01028508|ECT|ect
1434044|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
1434045|NCT01028508|mood disorders|mood disorders
1434046|NCT01028508|continuation ECT|continuation ect
1434047|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
1434048|NCT01028508|geriatric|geriatric
1434049|NCT01028508|elderly|elderly
1434052|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
1434053|NCT01028456|Seizures|seizures
1434054|NCT01028456|Light Therapy|light therapy
1434055|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1434056|NCT01028417|subcentimetre nodules|subcentimetre nodules
1434057|NCT01028365|Fertility|fertility
1434058|NCT01028365|Trying to Conceive|trying to conceive
1434059|NCT01028365|Trying to Get Pregnant|trying to get pregnant
1434060|NCT01028365|Pregnancy|pregnancy
1434061|NCT01028339|traumatic brain injury|traumatic brain injury
1434062|NCT01028339|PtiO2|ptio2
1434063|NCT01028339|Cerebral microdialysis|cerebral microdialysis
1434064|NCT01028339|Osmotherapy|osmotherapy
1434065|NCT01028339|hypertonic saline|hypertonic saline
1434066|NCT01028339|mannitol|mannitol
1434067|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
1434068|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
1434069|NCT01028313|GVHD|gvhd
1434070|NCT01028313|LBH589|lbh589
1434071|NCT01028313|Panobinostat|panobinostat
1434072|NCT01028300|DDD|ddd
1434073|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
1434074|NCT01028287|Nephrotic syndrome|nephrotic syndrome
1434075|NCT01028274|Hypercholesterolemia|hypercholesterolemia
1434076|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
1434077|NCT01028274|Fish Oil|fish oil
1434078|NCT01028274|Red Yeast Rice|red yeast rice
1434079|NCT01028261|Obese|obese
1434080|NCT01028261|Obesity|obesity
1434081|NCT01028261|Overweight|overweight
1434082|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
1434083|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
1434084|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
1434085|NCT01028222|Melanoma|melanoma
1434086|NCT01028222|AMN107|amn107
1434087|NCT01028222|c-Kit|c-kit
1434088|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
1434089|NCT01028196|schizophrenia|schizophrenia
1434090|NCT01028196|schizoaffective disorder|schizoaffective disorder
1434091|NCT01028196|recurrent depression|recurrent depression
1434092|NCT01028196|Bipolar disorders|bipolar disorders
1434093|NCT01028183|therapeutics|therapeutics
1434094|NCT01028183|safety|safety
1434095|NCT01028183|maternal|maternal
1434096|NCT01028183|neonatal|neonatal
1434097|NCT01028170|Congestive Heart Failure|congestive heart failure
1434098|NCT01028170|Renal Insufficiency|renal insufficiency
1434099|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
1434100|NCT01028157|HIV|hiv
1434101|NCT01028157|risk reduction|risk reduction
1434102|NCT01028157|behavioral intervention|behavioral intervention
1434103|NCT01028144|Exercise|exercise
1434104|NCT01028144|Physical Activity|physical activity
1434105|NCT01028144|Adolescent|adolescent
1434106|NCT01028144|Minority Health|minority health
1434107|NCT01028131|cigarette smoking|cigarette smoking
1434108|NCT01028131|pregnancy|pregnancy
1434109|NCT01028131|intervention|intervention
1434110|NCT01028131|efficacy|efficacy
1434111|NCT01028131|Motivational Interviewing|motivational interviewing
1434112|NCT01028131|Contingency Management|contingency management
1434113|NCT01028118|domestic and sexual violence|domestic and sexual violence
1434114|NCT01028118|menopause|menopause
1434115|NCT01028118|professional improvement|professional improvement
1434116|NCT01028118|social support network|social support network
1434117|NCT01028105|Preoperative screening|preoperative screening
1434118|NCT01028105|MRSA|mrsa
1434119|NCT01028105|Incidence|incidence
1434120|NCT01028105|Postoperative infection|postoperative infection
1434121|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
1434122|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
1434123|NCT01028079|Back Pain|back pain
1434124|NCT01028079|Acute low back pain|acute low back pain
1434125|NCT01028066|nutritional intervention|nutritional intervention
1434126|NCT01028066|nutritional counseling|nutritional counseling
1434127|NCT01028066|feeding behavior|feeding behavior
1434128|NCT01028066|food consumption|food consumption
1434129|NCT01028066|angioplasty|angioplasty
1434130|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
1434131|NCT01028053|Positron Emission Tomography|positron emission tomography
1434132|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
1434133|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
1434134|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
1434135|NCT01028040|Phase I|phase i
1434136|NCT01028040|AZD3043|azd3043
1434137|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
1434138|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
1434139|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
1434140|NCT01027988|Fundus|fundus
1434141|NCT01027988|mfERGs|mfergs
1434142|NCT01027988|CHF|chf
1434143|NCT01027988|Cardiovascular Disease|cardiovascular disease
1434144|NCT01027988|Coronarography|coronarography
1434145|NCT01027988|Macrovascularisation|macrovascularisation
1434146|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
1434147|NCT01027975|laparoscopy|laparoscopy
1434148|NCT01027975|fundoplication|fundoplication
1434149|NCT01027975|Nissen|nissen
1434150|NCT01027975|Thal|thal
1434151|NCT01027975|children|children
1434152|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
1434153|NCT01027962|Early Onset Psychosis|early onset psychosis
1434154|NCT01027962|Laptop Computer|laptop computer
1434155|NCT01027962|Brain Training|brain training
1434156|NCT01027936|Healthy Volunteers|healthy volunteers
1434157|NCT01027910|PCI-24781|pci-24781
1434158|NCT01027910|doxorubicin|doxorubicin
1434159|NCT01027897|Pharmacokinetics|pharmacokinetics
1434160|NCT01027897|Pharmacodynamics|pharmacodynamics
1434161|NCT01027897|Doripenem|doripenem
1434162|NCT01027897|Trauma|trauma
1434163|NCT01027897|sepsis|sepsis
1434164|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
1434165|NCT01027884|Idebenone|idebenone
1434166|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
1434167|NCT01027884|Respiratory function|respiratory function
1434168|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
1434169|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
1434170|NCT01027858|exercise|exercise
1434171|NCT01027858|aerobic exercise training|aerobic exercise training
1434172|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
1434173|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
1434174|NCT01027845|Pneumococcal disease|pneumococcal disease
1434175|NCT01027845|Immunogenicity|immunogenicity
1434176|NCT01027845|Booster vaccination|booster vaccination
1434177|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
1434654|NCT01025687|obesity|obesity
1434178|NCT01027845|Primary vaccination|primary vaccination
1434180|NCT01027832|tracheobronchitis|tracheobronchitis
1434181|NCT01027819|Total knee arthroplasty|total knee arthroplasty
1434182|NCT01027819|Mobile bearing|mobile bearing
1434183|NCT01027819|Fixed bearing|fixed bearing
1434184|NCT01027819|Range of motion|range of motion
1434185|NCT01027819|Knee Society Score|knee society score
1434186|NCT01027806|Children|children
1434187|NCT01027806|Sleep|sleep
1434188|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
1434189|NCT01027793|Stretch marks|stretch marks
1434190|NCT01027793|Striae|striae
1434191|NCT01027793|Tretinoin|tretinoin
1434192|NCT01027793|Superficial dermabrasion|superficial dermabrasion
1434193|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
1434194|NCT01027780|MBSR|mbsr
1434195|NCT01027780|Seniors|seniors
1434196|NCT01027780|immune system|immune system
1434197|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
1434198|NCT01027767|Breast|breast
1434200|NCT01027767|Molecular|molecular
1434201|NCT01027767|Molecular Breast Imaging|molecular breast imaging
1434202|NCT01027767|Dense breast tissue|dense breast tissue
1434203|NCT01027767|Surgery|surgery
1434204|NCT01027767|Radiation|radiation
1434205|NCT01027767|BCT|bct
1434206|NCT01027754|methadone maintenance|methadone maintenance
1434207|NCT01027715|Neonatal Seizures|neonatal seizures
1434208|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
1434209|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
1434210|NCT01027702|Immune Recovery|immune recovery
1434211|NCT01027702|T cell depleted transplant|t cell depleted transplant
1434212|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
1434213|NCT01027702|Unrelated donor transplants|unrelated donor transplants
1434214|NCT01027689|alprazolam|alprazolam
1434215|NCT01027689|bioequivalence|bioequivalence
1434216|NCT01027689|sublingual|sublingual
1434217|NCT01027676|Gefitinib|gefitinib
1434218|NCT01027676|Vorinostat|vorinostat
1434219|NCT01027663|anemia|anemia
1434220|NCT01027663|malaria|malaria
1434221|NCT01027637|breast reconstruction|breast reconstruction
1434222|NCT01027637|tissue expander|tissue expander
1434223|NCT01027637|Alloderm|alloderm
1434224|NCT01027637|tissue matrix|tissue matrix
1434225|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
1434226|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
1434227|NCT01027611|Eye discomfort|eye discomfort
1434228|NCT01027598|Lung Cancer|lung cancer
1434229|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
1434230|NCT01027598|Erlotinib|erlotinib
1434231|NCT01027598|Pazopanib|pazopanib
1434232|NCT01027572|Vegetative state|vegetative state
1434233|NCT01027572|Minimally conscious state|minimally conscious state
1434234|NCT01027572|Thalamic stimulation|thalamic stimulation
1434235|NCT01027559|Major Depression|major depression
1434333|NCT01027065|immune-based therapies|immune-based therapies
1434236|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1434237|NCT01027559|Emotional Circuitry|emotional circuitry
1434238|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
1434239|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
1434240|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
1434241|NCT01027533|visual acuity|visual acuity
1434242|NCT01027533|presbiopia|presbiopia
1434243|NCT01027520|Hand burn|hand burn
1434244|NCT01027520|skin graft|skin graft
1434245|NCT01027520|coban dressing|coban dressing
1434246|NCT01027520|range of motion|range of motion
1434247|NCT01027494|ear tubes|ear tubes
1434248|NCT01027494|ear drainage|ear drainage
1434249|NCT01027494|ear infection|ear infection
1434250|NCT01027494|ear drops|ear drops
1434251|NCT01027494|tympanostomy tubes|tympanostomy tubes
1434252|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
1434253|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
1434254|NCT01027442|Stereolithography|stereolithography
1434255|NCT01027442|Dental implants,|dental implants,
1434256|NCT01027442|Prosthetics|prosthetics
1434257|NCT01027442|positioning-errors|positioning-errors
1434258|NCT01027442|logistic regression analysis|logistic regression analysis
1434259|NCT01027429|infant|infant
1434260|NCT01027429|newborn|newborn
1434261|NCT01027429|sepsis|sepsis
1434262|NCT01027429|infection|infection
1434263|NCT01027429|community|community
1434264|NCT01027416|ER positive|er positive
1434265|NCT01027416|Tamoxifen|tamoxifen
1434266|NCT01027403|Heart failure|heart failure
1434267|NCT01027403|Adult stem cells|adult stem cells
1434268|NCT01027403|Circulating stem cells|circulating stem cells
1434269|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
1434270|NCT01027390|neck/shoulder|neck/shoulder
1434271|NCT01027351|Children|children
1434272|NCT01027351|Pre-school|pre-school
1434273|NCT01027351|Meningococcal disease|meningococcal disease
1434274|NCT01027351|Prevention|prevention
1434276|NCT01027325|Resistant Starch|resistant starch
1434277|NCT01027325|Amylose|amylose
1434278|NCT01027325|Amylopectin|amylopectin
1434279|NCT01027325|LDL subclasses|ldl subclasses
1434280|NCT01027325|Dietary carbohydrate|dietary carbohydrate
1434281|NCT01027325|Postprandial insulinemia|postprandial insulinemia
1434282|NCT01027312|Glaucoma|glaucoma
1434283|NCT01027312|quality of life|quality of life
1434284|NCT01027312|daily living activities|daily living activities
1434285|NCT01027312|visual fields|visual fields
1434286|NCT01027312|contrast sensitivity|contrast sensitivity
1434287|NCT01027299|cardiac failure|cardiac failure
1434288|NCT01027299|thoracic surgery|thoracic surgery
1434289|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
1434290|NCT01027273|Stroke|stroke
1434291|NCT01027273|Ischemic Stroke|ischemic stroke
1434292|NCT01027273|Transient Ischemic Attack|transient ischemic attack
1434293|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
1434294|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
1434295|NCT01027273|Brain Ischemia|brain ischemia
1434296|NCT01027273|Brain Infraction|brain infraction
1434297|NCT01027273|Brain Diseases|brain diseases
1434298|NCT01027273|Cerebral Infraction|cerebral infraction
1434299|NCT01027273|Self-management|self-management
1434300|NCT01027273|Peer-led|peer-led
1434301|NCT01027273|Community Based|community based
1434302|NCT01027247|Primary Glaucoma|primary glaucoma
1434303|NCT01027234|Healthy volunteers|healthy volunteers
1434304|NCT01027221|Low Dose Radiation|low dose radiation
1434305|NCT01027221|pancreatic cancer|pancreatic cancer
1434306|NCT01027221|Immunostimulation|immunostimulation
1434307|NCT01027182|HIV|hiv
1434308|NCT01027169|Hepatic impairment|hepatic impairment
1434309|NCT01027169|Liver diseases|liver diseases
1434310|NCT01027169|Pharmacokinetics|pharmacokinetics
1434311|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
1434312|NCT01027156|Public Health|public health
1434313|NCT01027156|Biochemistry|biochemistry
1434314|NCT01027156|Ecological|ecological
1434315|NCT01027143|Asthma|asthma
1434316|NCT01027143|Obesity|obesity
1434317|NCT01027143|Pharmacogenetics|pharmacogenetics
1434318|NCT01027143|Nutrigenetics|nutrigenetics
1434319|NCT01027117|Bioavailability|bioavailability
1434320|NCT01027117|Revatio|revatio
1434321|NCT01027117|Healthy Volunteers|healthy volunteers
1434322|NCT01027104|injury prevention|injury prevention
1434323|NCT01027104|firearms|firearms
1434324|NCT01027104|training|training
1434325|NCT01027104|counseling|counseling
1434326|NCT01027104|medical education|medical education
1434327|NCT01027104|safety|safety
1434328|NCT01027104|anticipatory guidance|anticipatory guidance
1434329|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
1434330|NCT01027091|hypocalcemia|hypocalcemia
1434331|NCT01027091|total thyroidectomy|total thyroidectomy
1434332|NCT01027065|interleukin-7|interleukin-7
1434334|NCT01027065|hepatitis B|hepatitis b
1434335|NCT01027065|HBe negative|hbe negative
1434336|NCT01027065|HBV vaccination|hbv vaccination
1434337|NCT01027065|entecavir|entecavir
1434338|NCT01027065|tenofovir|tenofovir
1434339|NCT01027065|chronic hepatitis|chronic hepatitis
1434340|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
1434341|NCT01027065|phase 1/2a|phase 1/2a
1434342|NCT01027065|viral disease|viral disease
1434343|NCT01027065|liver disease|liver disease
1434344|NCT01027052|MDA|mda
1434345|NCT01027052|Spice|spice
1434346|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
1434347|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
1434348|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
1434349|NCT01027039|angle closure glaucoma|angle closure glaucoma
1434350|NCT01027039|low tension glaucoma|low tension glaucoma
1434351|NCT01027026|Cost analysis|cost analysis
1434352|NCT01027026|Safety|safety
1434353|NCT01027026|Length of stay|length of stay
1434354|NCT01027026|Randomized controlled trials|randomized controlled trials
1434355|NCT01027026|Early discharge|early discharge
1434356|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1434357|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1434358|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1434359|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1434360|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1434361|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1434362|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1434363|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1434364|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1434365|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1434366|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1434465|NCT01026558|Skin Infections|skin infections
1434367|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1434368|NCT01026974|Children|children
1434369|NCT01026974|Pre-school|pre-school
1434370|NCT01026974|Meningococcal disease|meningococcal disease
1434371|NCT01026974|Prevention|prevention
1434372|NCT01026974|Vaccination|vaccination
1434373|NCT01026961|Safety|safety
1434374|NCT01026961|heart rate|heart rate
1434375|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
1434376|NCT01026961|arrhythmias|arrhythmias
1434377|NCT01026948|Induction of labour|induction of labour
1434378|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
1434379|NCT01026935|open mesh repair|open mesh repair
1434380|NCT01026935|sutured|sutured
1434381|NCT01026935|non-sutured|non-sutured
1434382|NCT01026935|pro-grip|pro-grip
1434383|NCT01026935|postoperative pain|postoperative pain
1434384|NCT01026922|antroduodenal manometry|antroduodenal manometry
1434385|NCT01026922|gastric dysmotility|gastric dysmotility
1434386|NCT01026922|intestinal dysmotility|intestinal dysmotility
1434387|NCT01026896|Mental practice|mental practice
1434388|NCT01026896|motor imagery|motor imagery
1434389|NCT01026896|stroke|stroke
1434390|NCT01026896|hemiplegia|hemiplegia
1434391|NCT01026896|motor recovery|motor recovery
1434392|NCT01026896|neuroplasticity|neuroplasticity
1434393|NCT01026883|hematocrit|hematocrit
1434394|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
1434395|NCT01026844|erlotinib|erlotinib
1434396|NCT01026844|tarceva|tarceva
1434397|NCT01026844|hydroxychloroquine|hydroxychloroquine
1434398|NCT01026844|NSCLC|nsclc
1434399|NCT01026818|Erectile Dysfunction|erectile dysfunction
1434400|NCT01026818|Radical Prostatectomy|radical prostatectomy
1434401|NCT01026805|morcellator|morcellator
1434402|NCT01026805|hysteroscope|hysteroscope
1434403|NCT01026805|myomectomy|myomectomy
1434404|NCT01026805|polypectomy|polypectomy
1434405|NCT01026805|uterine fibroids|uterine fibroids
1434406|NCT01026779|rotavirus|rotavirus
1434407|NCT01026779|gastroenteritis|gastroenteritis
1434408|NCT01026779|vaccine|vaccine
1434409|NCT01026779|case-control study|case-control study
1434410|NCT01026779|serotype|serotype
1434411|NCT01026766|Hypothermia|hypothermia
1434412|NCT01026766|Obesity|obesity
1434413|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
1434414|NCT01026766|Warming blanket|warming blanket
1434415|NCT01026766|Warming fluids|warming fluids
1434416|NCT01026766|Gynecological surgery|gynecological surgery
1434417|NCT01026766|Intravenous anesthesia|intravenous anesthesia
1434418|NCT01026766|Obese patients|obese patients
1434419|NCT01026766|Non obese patients|non obese patients
1434420|NCT01026753|colorectal cancer|colorectal cancer
1434421|NCT01026753|screening|screening
1434422|NCT01026753|fecal occult blood test|fecal occult blood test
1434423|NCT01026753|randomized control trial|randomized control trial
1434424|NCT01026753|primary care oncology|primary care oncology
1434425|NCT01026753|web site|web site
1434426|NCT01026753|provincial health contact center|provincial health contact center
1434427|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
1434428|NCT01026740|Streptococcal Infections|streptococcal infections
1434429|NCT01026727|HIV Infections|hiv infections
1434430|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1434431|NCT01026727|Virus Diseases|virus diseases
1434432|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
1434433|NCT01026727|RNA Virus Infections|rna virus infections
1434434|NCT01026727|Slow Virus Diseases|slow virus diseases
1434435|NCT01026727|Immune System Diseases|immune system diseases
1434436|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
1434437|NCT01026727|Lentivirus Infections|lentivirus infections
1434438|NCT01026727|Infection|infection
1434439|NCT01026727|Retroviridae Infections|retroviridae infections
1434440|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
1434441|NCT01026727|HIV|hiv
1434442|NCT01026727|treatment experienced|treatment experienced
1434443|NCT01026727|bevirimat|bevirimat
1434444|NCT01026701|Osteoblst effect|osteoblst effect
1434445|NCT01026701|Velcade|velcade
1434446|NCT01026701|Proteasome inhibitor|proteasome inhibitor
1434447|NCT01026701|Bortezomib|bortezomib
1434448|NCT01026701|Multjple Myeloma|multjple myeloma
1434449|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
1434450|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
1434451|NCT01026688|Knowledge translation|knowledge translation
1434452|NCT01026688|Clinical practice guidelines|clinical practice guidelines
1434453|NCT01026662|Aesthetic dermatology|aesthetic dermatology
1434454|NCT01026649|hematoma formation|hematoma formation
1434455|NCT01026649|success rate|success rate
1434456|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
1434457|NCT01026636|Skin Infections|skin infections
1434458|NCT01026636|Streptococcal Infections|streptococcal infections
1434459|NCT01026610|Chronic hepatitis B|chronic hepatitis b
1434460|NCT01026610|LB80380|lb80380
1434461|NCT01026610|treatment-naive|treatment-naive
1434462|NCT01026610|entecavir|entecavir
1434463|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
1434464|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
1434466|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
1434467|NCT01026558|Bacterial Skin Infections|bacterial skin infections
1434468|NCT01026558|Streptococcal Infection|streptococcal infection
1434469|NCT01026545|safety|safety
1434470|NCT01026545|tolerability|tolerability
1434471|NCT01026545|pharmacokinetics|pharmacokinetics
1434472|NCT01026545|multiple-dose|multiple-dose
1434473|NCT01026545|macrolide|macrolide
1434474|NCT01026506|c9,t11-CLA|c9,t11-cla
1434475|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
1434476|NCT01026506|children and adolescents|children and adolescents
1434477|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
1434478|NCT01026493|adult glioblastoma|adult glioblastoma
1434479|NCT01026493|adult gliosarcoma|adult gliosarcoma
1434480|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
1434481|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1434482|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
1434483|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1570569|NCT00499512|Survey|survey
1434484|NCT01026493|adult brain stem glioma|adult brain stem glioma
1434485|NCT01026493|adult mixed glioma|adult mixed glioma
1434486|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1434487|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
1434488|NCT01026480|IPAA|ipaa
1434489|NCT01026480|Pull through|pull through
1434490|NCT01026480|IBD|ibd
1434491|NCT01026480|Ulcerative colitis|ulcerative colitis
1434492|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
1434493|NCT01026480|FAP|fap
1434494|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
1434495|NCT01026480|HNPCC|hnpcc
1434496|NCT01026454|HSV|hsv
1434497|NCT01026454|HIV|hiv
1434498|NCT01026441|Aesthetic|aesthetic
1434499|NCT01026428|safinamide|safinamide
1434500|NCT01026428|levodopa|levodopa
1434501|NCT01026428|drug -drug interaction|drug -drug interaction
1434502|NCT01026428|pharmacokinetics|pharmacokinetics
1434503|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
1434504|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
1434505|NCT01026415|Antigens, CD30|antigens, cd30
1434506|NCT01026415|Disease, Hodgkin|disease, hodgkin
1434507|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1434508|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1434509|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
1434510|NCT01026415|Drug Therapy|drug therapy
1434511|NCT01026415|Immunotherapy|immunotherapy
1434512|NCT01026415|Hematologic Diseases|hematologic diseases
1434513|NCT01026415|Lymphoma|lymphoma
1434514|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
1434515|NCT01026402|Phase I|phase i
1434516|NCT01026402|cancer|cancer
1434517|NCT01026402|advanced solid malignancies|advanced solid malignancies
1434518|NCT01026402|dose escalation|dose escalation
1434519|NCT01026402|AZD2014|azd2014
1434520|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
1434521|NCT01026402|safety|safety
1434522|NCT01026402|pharmacokinetics|pharmacokinetics
1434523|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
1434524|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
1434525|NCT01026376|Decitabine|decitabine
1434526|NCT01026363|Vitamin D|vitamin d
1434527|NCT01026363|Chronic Kidney Disease|chronic kidney disease
1434528|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
1434529|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
1434530|NCT01026311|Coenzyme q10|coenzyme q10
1434531|NCT01026311|statins|statins
1434532|NCT01026311|myalgias|myalgias
1434533|NCT01026311|anaerobic threshold|anaerobic threshold
1434534|NCT01026311|athletic performance|athletic performance
1434535|NCT01026298|asthma|asthma
1434536|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
1434537|NCT01026298|severe asthma|severe asthma
1434538|NCT01026298|OSA|osa
1434539|NCT01026285|Risperdal Consta|risperdal consta
1434540|NCT01026272|Endocannabinoid|endocannabinoid
1434541|NCT01026272|Fish Oil|fish oil
1434542|NCT01026272|Multiple Sclerosis|multiple sclerosis
1434543|NCT01026272|Monocyte Migration|monocyte migration
1434544|NCT01026259|Surgical site infection|surgical site infection
1434545|NCT01026259|wound healing|wound healing
1434546|NCT01026259|tissue oxygen|tissue oxygen
1434547|NCT01026259|angiogenesis|angiogenesis
1434548|NCT01026259|flow cytometry|flow cytometry
1434549|NCT01026259|immunohistochemistry|immunohistochemistry
1434550|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
1434551|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
1434552|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
1434553|NCT01026233|Antigens, CD30|antigens, cd30
1434554|NCT01026233|Disease, Hodgkin|disease, hodgkin
1434555|NCT01026233|Drug Therapy|drug therapy
1434556|NCT01026233|Hematologic Diseases|hematologic diseases
1434557|NCT01026233|Immunotherapy|immunotherapy
1434558|NCT01026233|Lymphoma|lymphoma
1434559|NCT01026233|monomethylauristatin E|monomethylauristatin e
1434560|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1434561|NCT01026207|Diagnostic test|diagnostic test
1434562|NCT01026207|polysomnography|polysomnography
1434563|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1434564|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1434565|NCT01026194|insulin resistance|insulin resistance
1434566|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
1434567|NCT01026103|gastric bypass|gastric bypass
1434568|NCT01026103|Gastric bypass surgery|gastric bypass surgery
1434569|NCT01026077|Savella pregnant|savella pregnant
1434570|NCT01026077|savella pregnancy|savella pregnancy
1434571|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
1434572|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
1434573|NCT01026077|pregnancy registry savella|pregnancy registry savella
1434574|NCT01026064|Macrolides|macrolides
1434575|NCT01026064|Inflammation|inflammation
1434576|NCT01026064|Azithromycin|azithromycin
1434577|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
1434578|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
1434579|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
1434580|NCT01026025|lobectomy|lobectomy
1434581|NCT01026025|segmentectomy|segmentectomy
1434582|NCT01026025|pulmonary resection|pulmonary resection
1434583|NCT01026012|Regadenoson|regadenoson
1434584|NCT01026012|85% predicted heart rate|85% predicted heart rate
1434585|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
1434586|NCT01025999|RYGB|rygb
1434587|NCT01025999|Gastrostomy tube|gastrostomy tube
1434588|NCT01025999|DM|dm
1434589|NCT01025999|Gastric Bypass|gastric bypass
1434590|NCT01025960|colonoscopy|colonoscopy
1434591|NCT01025960|adenoma detection|adenoma detection
1434592|NCT01025960|polyps|polyps
1434593|NCT01025947|Atrial fibrillation|atrial fibrillation
1434594|NCT01025947|Cryptogenic stroke|cryptogenic stroke
1434595|NCT01025947|Implantable loop recorder|implantable loop recorder
1434596|NCT01025921|Tracheobronchitis|tracheobronchitis
1434597|NCT01025921|pneumonia|pneumonia
1434598|NCT01025921|inhaled antibiotics|inhaled antibiotics
1434599|NCT01025921|colistin|colistin
1434600|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
1434601|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
1434602|NCT01025908|psychotherapy|psychotherapy
1434603|NCT01025908|panic disorder|panic disorder
1434604|NCT01025908|anxiety|anxiety
1434605|NCT01025908|behavior|behavior
1434606|NCT01025908|cognition|cognition
1434607|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
1434608|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1434609|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
1434610|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
1434611|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
1434612|NCT01025856|liver fat|liver fat
1434613|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
1434614|NCT01025856|diet|diet
1434615|NCT01025856|exercise|exercise
1434912|NCT01024725|vaccination|vaccination
1434616|NCT01025856|type 2 diabetes|type 2 diabetes
1434617|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
1434618|NCT01025817|Kidney transplant|kidney transplant
1434619|NCT01025817|renal transplant|renal transplant
1434620|NCT01025817|immunosuppression|immunosuppression
1434621|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
1434622|NCT01025817|tacrolimus|tacrolimus
1434623|NCT01025817|everolimus|everolimus
1434624|NCT01025804|Interfant-06|interfant-06
1434625|NCT01025804|Infant ALL|infant all
1434626|NCT01025804|Asparaginase|asparaginase
1434627|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
1434628|NCT01025804|Antibody formation|antibody formation
1434629|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
1434630|NCT01025778|Graft versus host disease|graft versus host disease
1434631|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
1434632|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
1434633|NCT01025778|Immunological recovery|immunological recovery
1434634|NCT01025778|Bridge to transplant approach|bridge to transplant approach
1434635|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
1434636|NCT01025778|Hematological malignancy|hematological malignancy
1434637|NCT01025752|chronic pain|chronic pain
1434638|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
1434639|NCT01025752|low back pain|low back pain
1434640|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1434641|NCT01025739|EsophyX|esophyx
1434642|NCT01025713|Cystic Fibrosis|cystic fibrosis
1434643|NCT01025713|CF|cf
1434644|NCT01025713|Mucociliary Clearance|mucociliary clearance
1434645|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
1434646|NCT01025713|ENaC Inhibitor|enac inhibitor
1434647|NCT01025713|Airway Hydration|airway hydration
1434648|NCT01025713|Amiloride|amiloride
1434649|NCT01025700|Efficacy|efficacy
1434650|NCT01025700|Marijuana|marijuana
1434651|NCT01025700|Reduction|reduction
1434652|NCT01025700|Craving|craving
1434653|NCT01025687|girls|girls
1434655|NCT01025687|television viewing|television viewing
1434656|NCT01025687|puberty|puberty
1434657|NCT01025674|School health program|school health program
1434658|NCT01025674|Positive health behavior|positive health behavior
1434659|NCT01025674|School-wide climate|school-wide climate
1434660|NCT01025674|Mental health|mental health
1434661|NCT01025674|Self-esteem|self-esteem
1434662|NCT01025674|Social support|social support
1434663|NCT01025674|Exercise|exercise
1434664|NCT01025674|Nutrition|nutrition
1434665|NCT01025674|Parent involvement|parent involvement
1434666|NCT01025674|Community involvement|community involvement
1434667|NCT01025661|chiropractic|chiropractic
1434668|NCT01025661|hip osteoarthritis|hip osteoarthritis
1434669|NCT01025661|hip arthroplasty|hip arthroplasty
1434670|NCT01025661|pain|pain
1570873|NCT00498719|CNS|cns
1434671|NCT01025661|activities of daily living.|activities of daily living.
1434672|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
1434673|NCT01025648|Dyspnea|dyspnea
1434674|NCT01025648|Wheezing|wheezing
1434675|NCT01025648|Status Asthmaticus|status asthmaticus
1434676|NCT01025635|rosacea|rosacea
1434677|NCT01025635|papulopustular|papulopustular
1434678|NCT01025635|azelaic acid|azelaic acid
1434679|NCT01025635|foam|foam
1434680|NCT01025622|Stem Cells|stem cells
1434681|NCT01025622|Liver Cirrhosis|liver cirrhosis
1434682|NCT01025622|Cell Therapy|cell therapy
1434683|NCT01025609|spinal cord injury|spinal cord injury
1434684|NCT01025609|cardiovascular disease|cardiovascular disease
1434685|NCT01025609|dietary patterns|dietary patterns
1434686|NCT01025596|interleukin-7|interleukin-7
1434687|NCT01025596|immune-based therapies|immune-based therapies
1434688|NCT01025596|hepatitis C|hepatitis c
1434689|NCT01025596|chronic hepatitis|chronic hepatitis
1434690|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
1434691|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
1434692|NCT01025596|phase 1|phase 1
1434693|NCT01025596|viral disease|viral disease
1434694|NCT01025596|liver disease|liver disease
1434695|NCT01025583|acute gastroenteritis|acute gastroenteritis
1434696|NCT01025583|intestinal infection|intestinal infection
1434697|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
1434698|NCT01025583|intestinal microflora|intestinal microflora
1434699|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
1434700|NCT01025570|pancreas|pancreas
1434701|NCT01025570|pancreatic|pancreatic
1434702|NCT01025570|bosutinib|bosutinib
1434703|NCT01025570|SKI-606|ski-606
1434704|NCT01025570|gemcitabine|gemcitabine
1434705|NCT01025570|gemzar|gemzar
1434706|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
1434707|NCT01025557|Food intake|food intake
1434708|NCT01025557|Blood glucose|blood glucose
1434709|NCT01025557|Milk|milk
1434710|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
1434711|NCT01025544|Vaccine|vaccine
1434712|NCT01025544|Booster|booster
1434713|NCT01025531|Hepatitis C|hepatitis c
1434714|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
1434715|NCT01025518|Resistance training|resistance training
1434716|NCT01025518|Muscle mass|muscle mass
1434717|NCT01025518|Functional capacity|functional capacity
1434718|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
1434719|NCT01025492|high density lipoprotein|high density lipoprotein
1434720|NCT01025492|arterial compliance|arterial compliance
1434721|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
1434722|NCT01025479|Osteoporosis|osteoporosis
1434723|NCT01025479|Prostate cancer|prostate cancer
1434724|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
1434725|NCT01025479|Korean prostate cancer|korean prostate cancer
1434726|NCT01025453|thyroid|thyroid
1434727|NCT01025453|follicular cell|follicular cell
1434728|NCT01025453|papillary cell|papillary cell
1434729|NCT01025453|Hurthle cell|hurthle cell
1434730|NCT01025453|BAY 43-9006|bay 43-9006
1434731|NCT01025453|Temsirolimus|temsirolimus
1434732|NCT01025453|Sorafenib|sorafenib
1434733|NCT01025453|09-148|09-148
1434734|NCT01025427|HIV|hiv
1434735|NCT01025427|HIV persistence|hiv persistence
1434736|NCT01025427|HIV reservoirs|hiv reservoirs
1434737|NCT01025414|pancreatic fistula|pancreatic fistula
1434738|NCT01025401|epilepsy|epilepsy
1434739|NCT01025401|seizures|seizures
1434740|NCT01025401|movement|movement
1434741|NCT01025388|Hypercholesterolemia|hypercholesterolemia
1434742|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
1434743|NCT01025375|overweight|overweight
1434744|NCT01025349|bevacizumab|bevacizumab
1434745|NCT01025349|metastatic breast cancer|metastatic breast cancer
1434746|NCT01025349|docetaxel|docetaxel
1434747|NCT01025336|Antibody persistence|antibody persistence
1434748|NCT01025323|Pre hypertension|pre hypertension
1434749|NCT01025323|Lifestyle modification|lifestyle modification
1434750|NCT01025323|DASH diet|dash diet
1434751|NCT01025310|eye movements|eye movements
1434752|NCT01025310|saccades|saccades
1434753|NCT01025310|visual|visual
1434754|NCT01025310|stress|stress
1434755|NCT01025310|search coil|search coil
1434756|NCT01025310|environment|environment
1434757|NCT01025310|Saccadic eye movements|saccadic eye movements
1434758|NCT01025310|Urban environment|urban environment
1434759|NCT01025297|interleukin-7|interleukin-7
1434760|NCT01025297|immune-based therapies|immune-based therapies
1434761|NCT01025297|hepatitis C|hepatitis c
1434762|NCT01025297|chronic hepatitis|chronic hepatitis
1434763|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
1434764|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
1434765|NCT01025297|phase 1/2a|phase 1/2a
1434766|NCT01025297|viral disease|viral disease
1570925|NCT00498498|CSF|csf
1434767|NCT01025297|liver disease|liver disease
1434768|NCT01025271|meningitis|meningitis
1434769|NCT01025258|Cystic Fibrosis|cystic fibrosis
1434770|NCT01025258|Medication Adherence|medication adherence
1434771|NCT01025258|Multidisciplinary Team|multidisciplinary team
1434772|NCT01025258|Clinical Outcomes|clinical outcomes
1434773|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
1434774|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
1434775|NCT01025232|Immunologic Factors|immunologic factors
1434776|NCT01025232|Eye Diseases|eye diseases
1434777|NCT01025232|Retinal Degeneration|retinal degeneration
1434778|NCT01025232|Macular Degeneration|macular degeneration
1434779|NCT01025232|Pharmacologic Actions|pharmacologic actions
1434780|NCT01025232|Retinal Diseases|retinal diseases
1434781|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
1434782|NCT01025206|Multiple Myeloma|multiple myeloma
1434783|NCT01025206|monoclonal antibody|monoclonal antibody
1434784|NCT01025206|safety|safety
1434785|NCT01025206|pharmacokinetic|pharmacokinetic
1434786|NCT01025193|belimumab|belimumab
1434787|NCT01025193|Benlysta|benlysta
1434788|NCT01025193|LymphoStat B|lymphostat b
1434789|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
1434790|NCT01025180|safety|safety
1434791|NCT01025180|Procalcitonin|procalcitonin
1434792|NCT01025180|PCT|pct
1434793|NCT01025180|SOFA|sofa
1434794|NCT01025180|Sepsis|sepsis
1434795|NCT01025180|Antibiotic|antibiotic
1434796|NCT01025180|Strategy|strategy
1434797|NCT01025180|SIRS|sirs
1434798|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
1434799|NCT01025167|cancer|cancer
1434800|NCT01025167|enteral nutrition|enteral nutrition
1434801|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
1434802|NCT01025154|Leukemia|leukemia
1434803|NCT01025154|AML|aml
1434804|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
1434805|NCT01025154|Clofarabine|clofarabine
1434806|NCT01025154|Clofarex|clofarex
1434807|NCT01025154|Clolar|clolar
1434808|NCT01025154|Idarubicin|idarubicin
1434809|NCT01025154|Idamycin|idamycin
1434810|NCT01025154|Cytarabine|cytarabine
1434811|NCT01025154|Ara-C|ara-c
1434812|NCT01025154|Cytosar|cytosar
1434813|NCT01025154|DepoCyt|depocyt
1434913|NCT01024725|pandemic|pandemic
1434814|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1434815|NCT01025141|MINISCREW|miniscrew
1434816|NCT01025141|space extraction closure|space extraction closure
1434817|NCT01025141|anchorage|anchorage
1434818|NCT01025141|Orthodontic Treatment|orthodontic treatment
1434819|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
1434820|NCT01025141|closing of extraction space|closing of extraction space
1434821|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
1434822|NCT01025115|Dietary supplement|dietary supplement
1434823|NCT01025115|Diamel|diamel
1434824|NCT01025115|Metabolic Syndrome|metabolic syndrome
1434825|NCT01025089|Cetuximab|cetuximab
1434826|NCT01025089|Cisplatin|cisplatin
1434827|NCT01025089|Cyclophosphamide|cyclophosphamide
1434828|NCT01025089|09-038|09-038
1434829|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
1434830|NCT01025076|Post bariatric surgery|post bariatric surgery
1434831|NCT01025063|Spectral OCT|spectral oct
1434832|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
1434833|NCT01025063|Lucentis|lucentis
1434834|NCT01025063|Visudyne|visudyne
1434835|NCT01025063|PDT|pdt
1434836|NCT01025063|anti-VEGF|anti-vegf
1434837|NCT01025050|Presbyopia|presbyopia
1434838|NCT01025050|Intrastromal|intrastromal
1434839|NCT01025050|Femtosecond Laser|femtosecond laser
1434840|NCT01025050|minimal-invasive|minimal-invasive
1434841|NCT01025050|INTRACOR|intracor
1434842|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
1434843|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
1434844|NCT01025024|SNP|snp
1434845|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
1434846|NCT01025024|glaucoma|glaucoma
1434847|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
1434848|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
1434849|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
1434850|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
1434851|NCT01024998|AMD|amd
1434852|NCT01024998|Wet AMD|wet amd
1434853|NCT01024998|Neovascular AMD|neovascular amd
1434854|NCT01024998|Ocular|ocular
1434855|NCT01024998|Ocular gene therapy|ocular gene therapy
1434856|NCT01024998|Subretinal neovascularization|subretinal neovascularization
1434857|NCT01024985|optic neuritis|optic neuritis
1434858|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
1434859|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
1434860|NCT01024985|macular thickness|macular thickness
1434861|NCT01024959|Prostate Cancer|prostate cancer
1434862|NCT01024959|Prostate Biopsy|prostate biopsy
1434863|NCT01024959|PCA3|pca3
1434864|NCT01024946|mesothelioma|mesothelioma
1434865|NCT01024946|pleural|pleural
1434866|NCT01024946|RAD001|rad001
1434867|NCT01024946|Everolimus|everolimus
1434868|NCT01024946|09-142|09-142
1434869|NCT01024946|thoracic|thoracic
1434870|NCT01024946|lung|lung
1434871|NCT01024946|epithelioid|epithelioid
1434872|NCT01024946|sarcomatoid|sarcomatoid
1434873|NCT01024933|Hypertension|hypertension
1434874|NCT01024933|High Blood Pressure|high blood pressure
1434875|NCT01024894|interleukin-7|interleukin-7
1434876|NCT01024894|immune-based therapies|immune-based therapies
1434877|NCT01024894|hepatitis C|hepatitis c
1434878|NCT01024894|chronic hepatitis|chronic hepatitis
1434879|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
1434880|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
1434881|NCT01024894|taiwan|taiwan
1434882|NCT01024894|phase 1/2a|phase 1/2a
1434883|NCT01024894|viral disease|viral disease
1434884|NCT01024894|liver disease|liver disease
1434885|NCT01024881|catheterization success rate|catheterization success rate
1434886|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
1434887|NCT01024829|Non small cell lung cancer|non small cell lung cancer
1434888|NCT01024829|Inoperable|inoperable
1434889|NCT01024829|HX4|hx4
1434890|NCT01024816|Metabolic Syndrome|metabolic syndrome
1434891|NCT01024816|Restorative Yoga|restorative yoga
1434892|NCT01024816|Stretching|stretching
1434893|NCT01024816|Visceral adiposity|visceral adiposity
1434894|NCT01024816|Randomized controlled trial|randomized controlled trial
1434895|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
1434896|NCT01024803|Legal blindness|legal blindness
1434897|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
1434898|NCT01024803|Eye Diseases|eye diseases
1434899|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
1434900|NCT01024803|Retinitis|retinitis
1434901|NCT01024803|Retinal Degeneration|retinal degeneration
1434902|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
1434903|NCT01024803|Retinal Diseases|retinal diseases
1434904|NCT01024777|cholecalciferol|cholecalciferol
1434905|NCT01024777|multiple sclerosis|multiple sclerosis
1434906|NCT01024777|vitamin D|vitamin d
1434907|NCT01024777|D3|d3
1434908|NCT01024764|HIV|hiv
1434909|NCT01024764|Tat protein|tat protein
1434910|NCT01024764|Preventive vaccine|preventive vaccine
1434911|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
1434914|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1434915|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1434916|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1434917|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
1434918|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1434919|NCT01024712|large cell lung cancer|large cell lung cancer
1434920|NCT01024673|H1N1|h1n1
1434921|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
1434922|NCT01024634|Arterial stiffness|arterial stiffness
1434923|NCT01024634|Endothelial function|endothelial function
1434924|NCT01024634|Autonomic function|autonomic function
1434925|NCT01024634|Inflammation|inflammation
1434926|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
1434927|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
1434928|NCT01024595|HIV|hiv
1434929|NCT01024595|Tat protein|tat protein
1434930|NCT01024582|breast cancer|breast cancer
1434931|NCT01024582|invasive breast cancer|invasive breast cancer
1434932|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
1434933|NCT01024569|Severe Mental Illness|severe mental illness
1434934|NCT01024569|Recovery|recovery
1434935|NCT01024569|Psychiatric Disability|psychiatric disability
1434936|NCT01024569|Wellness|wellness
1434937|NCT01024569|Peer Service|peer service
1434938|NCT01024569|WRAP|wrap
1434939|NCT01024556|HIV, HAART|hiv, haart
1434940|NCT01024543|Angiotensin II|angiotensin ii
1434941|NCT01024530|hepatocellular carcinoma|hepatocellular carcinoma
1434942|NCT01024530|HCC|hcc
1434943|NCT01024530|NK|nk
1434944|NCT01024530|immune killer cells|immune killer cells
1434945|NCT01024517|Safety|safety
1434946|NCT01024517|Tolerability|tolerability
1434947|NCT01024517|Pharmacokinetics|pharmacokinetics
1434948|NCT01024504|Cancer|cancer
1434949|NCT01024504|Colorectal cancer|colorectal cancer
1434950|NCT01024504|Elderly|elderly
1434951|NCT01024504|Chemotherapy|chemotherapy
1434952|NCT01024504|Capecitabine|capecitabine
1434953|NCT01024504|Oxaliplatin|oxaliplatin
1434954|NCT01024504|Bevacizumab|bevacizumab
1434955|NCT01024491|premature ejaculation|premature ejaculation
1434956|NCT01024491|paroxetine|paroxetine
1434957|NCT01024491|daily treatment|daily treatment
1434958|NCT01024478|Coronary Artery|coronary artery
1434959|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
1434960|NCT01024478|Coronary Artery disease|coronary artery disease
1434961|NCT01024478|Multicenter Trial|multicenter trial
1434962|NCT01024478|Cardiac MRI|cardiac mri
1434963|NCT01024465|obesity|obesity
1434964|NCT01024465|intragastric balloon|intragastric balloon
1434965|NCT01024452|anticoagulation|anticoagulation
1434966|NCT01024452|warfarin|warfarin
1434967|NCT01024452|computer systems|computer systems
1434968|NCT01024452|international normalized ratio|international normalized ratio
1434969|NCT01024452|nomograms|nomograms
1434970|NCT01024426|Uganda|uganda
1434971|NCT01024426|malaria|malaria
1434972|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
1434973|NCT01024426|febrile illnesses|febrile illnesses
1434974|NCT01024426|health services|health services
1434975|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
1434976|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1434977|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
1434978|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
1434979|NCT01024413|Lung Neoplasms|lung neoplasms
1434980|NCT01024413|Erlotinib|erlotinib
1434981|NCT01024413|Gefitinib|gefitinib
1434982|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
1434983|NCT01024400|Influenza|influenza
1434984|NCT01024400|Vaccine|vaccine
1434985|NCT01024400|Pregnancy|pregnancy
1434986|NCT01024387|AMG 479|amg 479
1434987|NCT01024361|Preterm infants|preterm infants
1434988|NCT01024361|Nasal CPAP|nasal cpap
1434989|NCT01024361|Delivery room|delivery room
1434990|NCT01024361|Newborn|newborn
1434991|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
1434992|NCT01024348|Pain, postoperative|pain, postoperative
1434993|NCT01024348|tramadol, extended release|tramadol, extended release
1434994|NCT01024335|opioid dependence|opioid dependence
1434995|NCT01024335|naltrexone|naltrexone
1434996|NCT01024335|vivitrol|vivitrol
1434997|NCT01024335|dronabinol|dronabinol
1434998|NCT01024335|marinol|marinol
1434999|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
1435000|NCT01024309|total hip arthroplasty|total hip arthroplasty
1435001|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
1435002|NCT01024283|Pharmacodynamic|pharmacodynamic
1435003|NCT01024283|Blood|blood
1435004|NCT01024283|Biopsy|biopsy
1435005|NCT01024283|Solid malignancies|solid malignancies
1435006|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
1435007|NCT01024270|operative hysteroscopy|operative hysteroscopy
1435008|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
1435103|NCT01023776|Swine Flu|swine flu
1435104|NCT01023776|H1N1|h1n1
1435009|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
1435010|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1435011|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
1435012|NCT01024179|Optical Coherence Tomography|optical coherence tomography
1435013|NCT01024179|Coronary artery disease|coronary artery disease
1435014|NCT01024179|Chronic total occlusion|chronic total occlusion
1435015|NCT01024166|Cancer|cancer
1435016|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
1435017|NCT01024166|PRO|pro
1435018|NCT01024166|Palliative Care|palliative care
1435019|NCT01024166|Symptoms|symptoms
1435020|NCT01024166|Questionnaire|questionnaire
1435021|NCT01024166|Patients|patients
1435022|NCT01024166|Caregivers|caregivers
1435023|NCT01024166|Palliative Care Physicians|palliative care physicians
1435024|NCT01024166|Palliative Care Nurses|palliative care nurses
1435025|NCT01024153|active video games|active video games
1435026|NCT01024153|children|children
1435027|NCT01024153|physical activity|physical activity
1435028|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
1435029|NCT01024140|Escitalopram|escitalopram
1435030|NCT01024140|Efficacy|efficacy
1435031|NCT01024114|MBI|mbi
1435032|NCT01024114|Molecular Breast Imaging|molecular breast imaging
1435033|NCT01024114|Breast Cancer|breast cancer
1435034|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
1435035|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
1435036|NCT01024088|Swallowing disorders|swallowing disorders
1435037|NCT01024088|Respiratory failure|respiratory failure
1435038|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
1435039|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
1435040|NCT01024075|Sinufoam|sinufoam
1435041|NCT01024075|Dexamethasone|dexamethasone
1435164|NCT01023581|Hypoglycemia,|hypoglycemia,
1435042|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
1435043|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
1435044|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
1435045|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
1435047|NCT01024036|CNTO 328|cnto 328
1435048|NCT01024036|Best Supportive Care|best supportive care
1435049|NCT01024036|Tumor|tumor
1435050|NCT01024036|Symptomatic response|symptomatic response
1435051|NCT01024036|Pharmacokinetics|pharmacokinetics
1435052|NCT01024036|Interleukin-6|interleukin-6
1435053|NCT01024036|IL6|il6
1435054|NCT01024023|Early Walking Aid|early walking aid
1435055|NCT01024023|Amputee|amputee
1435056|NCT01024023|Trans-tibial|trans-tibial
1435057|NCT01024023|Quality of life|quality of life
1435058|NCT01023997|corneal thickness|corneal thickness
1435059|NCT01023997|exfoliation|exfoliation
1435060|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
1435061|NCT01023945|ASP1941|asp1941
1435062|NCT01023945|Diabetes mellitus|diabetes mellitus
1435063|NCT01023945|Blood glucose|blood glucose
1435064|NCT01023919|Optical coherence tomography|optical coherence tomography
1435065|NCT01023919|Drug eluting stent|drug eluting stent
1435066|NCT01023919|Coronary Artery Disease|coronary artery disease
1435067|NCT01023919|Diabetes Mellitus|diabetes mellitus
1435068|NCT01023906|Taste|taste
1435069|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
1435070|NCT01023906|Aging|aging
1435071|NCT01023906|Chronic Disease Risk|chronic disease risk
1435072|NCT01023906|Smell|smell
1435073|NCT01023867|Alzheimer's disease|alzheimer's disease
1435074|NCT01023867|Mixed Dementia|mixed dementia
1435075|NCT01023867|Donepezil|donepezil
1435076|NCT01023867|Efficacy|efficacy
1435077|NCT01023867|Adverse Event|adverse event
1435078|NCT01023854|Paravertebral block|paravertebral block
1435079|NCT01023854|loco regional anesthesia|loco regional anesthesia
1435080|NCT01023854|renal surgery|renal surgery
1435081|NCT01023854|PCA morphine|pca morphine
1435082|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
1435083|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
1435084|NCT01023828|WOOD SMOKE|wood smoke
1435085|NCT01023815|Immunosuppression|immunosuppression
1435086|NCT01023815|renal transplantation|renal transplantation
1435087|NCT01023815|once-a-day regimen|once-a-day regimen
1435088|NCT01023815|steroid withdrawal|steroid withdrawal
1435089|NCT01023815|drug minimization|drug minimization
1435090|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
1435091|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
1435092|NCT01023802|chemotherapy|chemotherapy
1435093|NCT01023802|hormone therapy|hormone therapy
1435094|NCT01023802|breast cancer|breast cancer
1435095|NCT01023802|MBI|mbi
1435096|NCT01023802|Molecular Breast Imaging|molecular breast imaging
1435097|NCT01023789|Drug eluting stent|drug eluting stent
1435098|NCT01023789|Stents|stents
1435099|NCT01023789|Angioplasty|angioplasty
1435100|NCT01023789|Bioabsorbable|bioabsorbable
1435101|NCT01023789|Bioresorbable|bioresorbable
1435102|NCT01023789|Scaffold|scaffold
1435105|NCT01023763|Nursing homes|nursing homes
1435106|NCT01023763|Intravenous|intravenous
1435107|NCT01023763|Treatment|treatment
1435108|NCT01023763|Patient trajectory|patient trajectory
1435109|NCT01023763|Hospital admissions|hospital admissions
1435110|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
1435111|NCT01023750|Triglycerides|triglycerides
1435112|NCT01023750|HDL|hdl
1435113|NCT01023750|Insulin resistance|insulin resistance
1435114|NCT01023737|Malignant Solid Tumor|malignant solid tumor
1435115|NCT01023737|Solid Tumor|solid tumor
1435116|NCT01023737|Hydroxychloroquine|hydroxychloroquine
1435117|NCT01023737|Vorinostat|vorinostat
1435118|NCT01023711|Influenza|influenza
1435119|NCT01023698|Diabetic retinopathy|diabetic retinopathy
1435120|NCT01023698|Diabetic macular edema|diabetic macular edema
1435121|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
1435122|NCT01023685|Active immunization|active immunization
1435123|NCT01023685|Alzheimer disease|alzheimer disease
1435124|NCT01023685|Antibody|antibody
1435125|NCT01023685|Central Nervous System diseases|central nervous system diseases
1435126|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
1435127|NCT01023685|Vaccine|vaccine
1435128|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
1435129|NCT01023672|hypersomnolence|hypersomnolence
1435130|NCT01023672|cognition|cognition
1435131|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
1435132|NCT01023672|quality of life|quality of life
1435133|NCT01023659|Smoking cessation|smoking cessation
1435134|NCT01023659|Bupropion|bupropion
1435135|NCT01023659|Varenicline|varenicline
1435136|NCT01023659|Population-level|population-level
1435137|NCT01023659|Mass distribution|mass distribution
1435138|NCT01023659|Drug Therapy|drug therapy
1435139|NCT01023646|Glycemic Index|glycemic index
1435140|NCT01023646|Glycemic Load|glycemic load
1435141|NCT01023646|Glucose|glucose
1435142|NCT01023646|Insulin|insulin
1435143|NCT01023646|Lipoproteins|lipoproteins
1435144|NCT01023646|Free fatty acids|free fatty acids
1435241|NCT01023373|Randomized controlled trials|randomized controlled trials
1435145|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
1435146|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
1571416|NCT00496678|PNRP|pnrp
1435147|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
1435148|NCT01023620|HIV|hiv
1435149|NCT01023620|Lipodystrophy|lipodystrophy
1435150|NCT01023620|Lipoatrophy|lipoatrophy
1435151|NCT01023620|Lipohypertrophy|lipohypertrophy
1435152|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
1435153|NCT01023607|optical coherence tomography|optical coherence tomography
1435154|NCT01023607|intravascular ultrasound|intravascular ultrasound
1435155|NCT01023607|Coronary artery disease|coronary artery disease
1435156|NCT01023607|Hyperlipidemia|hyperlipidemia
1435157|NCT01023594|Pancreatic fistula|pancreatic fistula
1435158|NCT01023594|Pancreatic leakage|pancreatic leakage
1435159|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
1435160|NCT01023594|Pancreatic stent|pancreatic stent
1435161|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1435162|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
1435163|NCT01023581|Drug Therapy|drug therapy
1435165|NCT01023581|Hyperglycemia|hyperglycemia
1435166|NCT01023568|intubation|intubation
1435167|NCT01023568|pediatric|pediatric
1435168|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
1435169|NCT01023555|Bacteremia|bacteremia
1435170|NCT01023555|Blood Cultures|blood cultures
1435171|NCT01023555|Sepsis|sepsis
1435172|NCT01023542|renal impairment|renal impairment
1435173|NCT01023542|MELD>25|meld>25
1435174|NCT01023542|Liver transplantation|liver transplantation
1435175|NCT01023542|CNI-free|cni-free
1435176|NCT01023542|Bottom-Up|bottom-up
1435177|NCT01023542|Everolimus|everolimus
1435178|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
1435179|NCT01023529|Rectal Neoplasms|rectal neoplasms
1435180|NCT01023529|Palliative treatment|palliative treatment
1435181|NCT01023529|Radiotherapy|radiotherapy
1435182|NCT01023529|Quality of life|quality of life
1435183|NCT01023516|Chronic|chronic
1435184|NCT01023516|obstructive|obstructive
1435185|NCT01023516|pulmonary|pulmonary
1435186|NCT01023516|lung|lung
1435187|NCT01023516|respiratory disease|respiratory disease
1435188|NCT01023516|efficacy|efficacy
1435189|NCT01023516|placebo-controlled|placebo-controlled
1435190|NCT01023516|COPD|copd
1435191|NCT01023516|FEV1|fev1
1435192|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
1435193|NCT01023503|Statins|statins
1435194|NCT01023503|Dyslipidemia|dyslipidemia
1435195|NCT01023503|Spain|spain
1435196|NCT01023503|Rosuvastatin|rosuvastatin
1435197|NCT01023503|Naive|naive
1435198|NCT01023503|Switching|switching
1435199|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
1435200|NCT01023490|back pain|back pain
1435201|NCT01023490|hypovitaminosis D|hypovitaminosis d
1435301|NCT01023165|Diabetes Mellitus|diabetes mellitus
1435202|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
1435203|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
1435204|NCT01023477|DCIS|dcis
1435205|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
1435206|NCT01023477|Breast Cancer|breast cancer
1435207|NCT01023477|Breast Tumors|breast tumors
1435208|NCT01023477|chloroquine|chloroquine
1435209|NCT01023477|autophagy|autophagy
1435210|NCT01023477|Autophagic Cell Death|autophagic cell death
1435211|NCT01023477|Autophagocytosis|autophagocytosis
1435212|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
1435213|NCT01023477|Autophagy, Cellular|autophagy, cellular
1435214|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
1435215|NCT01023464|tear film break-up time|tear film break-up time
1435216|NCT01023451|Pulmonary hypertension|pulmonary hypertension
1435217|NCT01023451|Sickle cell disease|sickle cell disease
1435218|NCT01023451|Pediatric patients|pediatric patients
1435219|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
1435220|NCT01023425|naive group|naive group
1435221|NCT01023425|switching group|switching group
1435222|NCT01023425|treatment response|treatment response
1435223|NCT01023425|Efficacy|efficacy
1435224|NCT01023425|Adverse event|adverse event
1435225|NCT01023412|Immunonutrition|immunonutrition
1435226|NCT01023412|cancer|cancer
1435227|NCT01023412|GI cancer surgery|gi cancer surgery
1435228|NCT01023386|YM155|ym155
1435229|NCT01023386|Mass-balance|mass-balance
1435230|NCT01023386|Phase I|phase i
1435231|NCT01023386|Pharmacokinetics|pharmacokinetics
1435232|NCT01023373|Angioplasty|angioplasty
1435233|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
1435234|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
1435235|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
1435236|NCT01023373|kidney diseases|kidney diseases
1435237|NCT01023373|High blood pressure|high blood pressure
1435238|NCT01023373|Hypertension|hypertension
1435239|NCT01023373|Ischemic nephropathy|ischemic nephropathy
1435240|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
1435242|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
1435243|NCT01023373|Renal insufficiency|renal insufficiency
1435244|NCT01023373|Vascular diseases|vascular diseases
1435245|NCT01023347|NSCLC|nsclc
1435246|NCT01023334|Topical analgesia|topical analgesia
1435247|NCT01023334|FlACC Pain Scale|flacc pain scale
1435248|NCT01023334|intracameral lignocaine|intracameral lignocaine
1435249|NCT01023334|Anesthetics|anesthetics
1435250|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
1435251|NCT01023334|Lidocaine|lidocaine
1435252|NCT01023321|Safety|safety
1435253|NCT01023321|Tolerability|tolerability
1435254|NCT01023321|Pharmacokinetics|pharmacokinetics
1435255|NCT01023308|Myeloma|myeloma
1435256|NCT01023308|DACi|daci
1435257|NCT01023308|Bortezomib|bortezomib
1435258|NCT01023308|Combination|combination
1435259|NCT01023308|Panobinostat|panobinostat
1435260|NCT01023308|LBH589D|lbh589d
1435261|NCT01023308|relapsed|relapsed
1435262|NCT01023308|Velcade®|velcade®
1435263|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
1435264|NCT01023295|PCV|pcv
1435265|NCT01023295|Polypoid|polypoid
1435266|NCT01023295|oxigene|oxigene
1435267|NCT01023295|VDA|vda
1435268|NCT01023295|vascular disrupting agent|vascular disrupting agent
1435269|NCT01023295|combretastatin|combretastatin
1435270|NCT01023295|fosbretabulin|fosbretabulin
1435271|NCT01023282|Parkinson's disease|parkinson's disease
1435272|NCT01023282|Levodopa|levodopa
1435273|NCT01023282|Dyskinesia|dyskinesia
1435274|NCT01023282|ACR325|acr325
1435275|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
1435276|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
1435277|NCT01023269|Neuromodulation|neuromodulation
1435278|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
1435279|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
1435280|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
1435281|NCT01023256|GM-CSF|gm-csf
1435282|NCT01023256|MOR103|mor103
1435283|NCT01023243|foot exam|foot exam
1435284|NCT01023243|health services|health services
1435285|NCT01023243|practice improvement|practice improvement
1435286|NCT01023243|quality|quality
1435287|NCT01023243|preventive services|preventive services
1435288|NCT01023243|Natural Language Processing|natural language processing
1435289|NCT01023230|DV-601|dv-601
1435290|NCT01023230|hepatitis B|hepatitis b
1435291|NCT01023230|entecavir|entecavir
1435292|NCT01023230|therapeutic vaccine|therapeutic vaccine
1435293|NCT01023217|Chronic hepatitis B|chronic hepatitis b
1435294|NCT01023217|lamivudine|lamivudine
1435295|NCT01023217|adefovir|adefovir
1435296|NCT01023217|entecavir|entecavir
1435297|NCT01023191|Dialysis|dialysis
1435298|NCT01023191|Peritoneal|peritoneal
1435299|NCT01023191|Catheter|catheter
1435300|NCT01023191|Surgery|surgery
1435302|NCT01023165|Metabolic Integrity|metabolic integrity
1435303|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
1435304|NCT01023139|Adolescent|adolescent
1435305|NCT01023139|Obesity|obesity
1435306|NCT01023139|Pharmacotherapy|pharmacotherapy
1435307|NCT01023139|Sibutramine|sibutramine
1435308|NCT01023126|Obesity|obesity
1435309|NCT01023126|Exercise|exercise
1435310|NCT01023126|Psychotherapy|psychotherapy
1435311|NCT01023113|Diabetic retinopathy|diabetic retinopathy
1435312|NCT01023113|laser|laser
1435313|NCT01023113|field loss|field loss
1435314|NCT01023113|macular edema|macular edema
1435315|NCT01023113|Visual field loss|visual field loss
1435316|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
1435317|NCT01023074|MS|ms
1435318|NCT01023074|CAP|cap
1435319|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
1435320|NCT01023022|CareLink|carelink
1435321|NCT01023022|Remote Monitoring|remote monitoring
1435322|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
1435323|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
1435324|NCT01023009|Occlusion|occlusion
1435325|NCT01023009|vitrectomy|vitrectomy
1435326|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
1435327|NCT01023009|Postoperative occlusion|postoperative occlusion
1435328|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
1435329|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
1435330|NCT01022996|Hodgkin's Disease|hodgkin's disease
1435331|NCT01022996|Hodgkin Disease|hodgkin disease
1435332|NCT01022996|Lymphoma|lymphoma
1435333|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
1435334|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
1435335|NCT01022996|Lymphatic Diseases|lymphatic diseases
1435336|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
1435337|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
1435338|NCT01022996|Refractory Lymphoma|refractory lymphoma
1435339|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
1435340|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
1435341|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
1435342|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
1435343|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
1435344|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
1435345|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
1435346|NCT01022970|Esophagitis|esophagitis
1435347|NCT01022970|Digestive System Diseases|digestive system diseases
1435348|NCT01022970|Esophageal disorder|esophageal disorder
1435349|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
1435350|NCT01022957|extra renal damages|extra renal damages
1435351|NCT01022944|Serous otitis media|serous otitis media
1435352|NCT01022944|Biofilm|biofilm
1435353|NCT01022944|Adenoidectomy|adenoidectomy
1435354|NCT01022944|Chronic otitis media|chronic otitis media
1435355|NCT01022931|Influenza A H1N1|influenza a h1n1
1435356|NCT01022931|Children|children
1435357|NCT01022931|Epidemiology|epidemiology
1435358|NCT01022931|Treatment|treatment
1435359|NCT01022931|Oseltamivir|oseltamivir
1435360|NCT01022931|Genetics|genetics
1435361|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
1435362|NCT01022905|HIV infection|hiv infection
1435363|NCT01022905|transplant|transplant
1435364|NCT01022905|rheumatic disease|rheumatic disease
1435365|NCT01022905|cancer|cancer
1435366|NCT01022905|children|children
1435367|NCT01022892|Endovascular|endovascular
1435368|NCT01022892|Abdominal|abdominal
1435369|NCT01022892|Aortic|aortic
1435370|NCT01022892|Aneurysm|aneurysm
1435371|NCT01022892|Repair|repair
1435372|NCT01022892|Surveillance|surveillance
1435373|NCT01022892|EVAR|evar
1435374|NCT01022892|CT|ct
1435375|NCT01022892|Scan|scan
1435376|NCT01022892|Endoleaks|endoleaks
1435377|NCT01022892|Contrast|contrast
1435378|NCT01022892|Enhanced|enhanced
1435379|NCT01022892|Ultrasound|ultrasound
1435380|NCT01022892|Definity|definity
1435381|NCT01022892|AAA|aaa
1435382|NCT01022892|imaging|imaging
1435383|NCT01022892|No Endoleaks|no endoleaks
1435384|NCT01022879|Pain scale of pain|pain scale of pain
1435385|NCT01022866|falls|falls
1435386|NCT01022866|older adults|older adults
1435387|NCT01022827|stiff shoulder|stiff shoulder
1435388|NCT01022827|massage|massage
1435389|NCT01022827|muscle stiffness|muscle stiffness
1435390|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
1435391|NCT01022775|Impingement syndrome|impingement syndrome
1435392|NCT01022775|Dynamic humeral centering|dynamic humeral centering
1435393|NCT01022775|Randomized clinical trial|randomized clinical trial
1435394|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1435395|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
1435396|NCT01022749|influenza vaccine|influenza vaccine
1435397|NCT01022749|antibody titers|antibody titers
1435398|NCT01022749|seroprotective titers|seroprotective titers
1435399|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
1435400|NCT01022736|gabapentin|gabapentin
1435401|NCT01022736|pharmacokinetics|pharmacokinetics
1435402|NCT01022736|visual analogue pain scale|visual analogue pain scale
1435403|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
1435404|NCT01022723|Circulating tumor cells|circulating tumor cells
1435405|NCT01022723|metastasis|metastasis
1435406|NCT01022723|cancer|cancer
1435407|NCT01022723|cell isolation|cell isolation
1435408|NCT01022723|mircofludics|mircofludics
1435409|NCT01022723|cell detection|cell detection
1435410|NCT01022710|hearing loss|hearing loss
1435411|NCT01022710|otoacoustic emissions|otoacoustic emissions
1435412|NCT01022684|atherosclerosis|atherosclerosis
1435413|NCT01022684|vascular inflammation|vascular inflammation
1435414|NCT01022684|LpPLA2|lppla2
1435415|NCT01022684|hsCRP|hscrp
1435416|NCT01022684|MCP-1|mcp-1
1435417|NCT01022684|18FDG-PET|18fdg-pet
1435418|NCT01022671|Belotecan|belotecan
1435419|NCT01022671|Camtobell inj|camtobell inj
1435420|NCT01022671|NSCLC|nsclc
1435421|NCT01022658|Insulin Therapy|insulin therapy
1435422|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
1435423|NCT01022658|arterial stiffness|arterial stiffness
1435424|NCT01022658|endothelial function|endothelial function
1435425|NCT01022645|Intrauterine device|intrauterine device
1435426|NCT01022645|Gestational diabetes|gestational diabetes
1435427|NCT01022645|Postpartum contraception|postpartum contraception
1435428|NCT01022645|Postpartum birth control|postpartum birth control
1435429|NCT01022632|Depression|depression
1435430|NCT01022619|Sleep apnea|sleep apnea
1435431|NCT01022619|high risk pregnancy|high risk pregnancy
1435432|NCT01022619|fetal outcome|fetal outcome
1435433|NCT01022619|cord blood|cord blood
1435434|NCT01022580|nitric oxide|nitric oxide
1435435|NCT01022580|surfactant|surfactant
1435436|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1435437|NCT01022580|BPD|bpd
1435438|NCT01022580|prematurity|prematurity
1435439|NCT01022580|neonates|neonates
1435440|NCT01022580|iNO|ino
1435441|NCT01022580|pulmonary outcome|pulmonary outcome
1435442|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
1435443|NCT01022580|Infasurf|infasurf
1435444|NCT01022580|lung function|lung function
1435445|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
1435446|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
1435447|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
1435448|NCT01022515|pheochromocytoma|pheochromocytoma
1435449|NCT01022515|paraganglioma|paraganglioma
1435450|NCT01022515|hypertension|hypertension
1435451|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
1435452|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
1435453|NCT01022476|Pharmacokinetics|pharmacokinetics
1435454|NCT01022476|Raltegravir|raltegravir
1435455|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
1435456|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
1435457|NCT01022476|Liver Transplantation|liver transplantation
1435458|NCT01022476|Additional Keywords|additional keywords
1435459|NCT01022476|HIV Infection|hiv infection
1435460|NCT01022476|Hepatocarcinoma|hepatocarcinoma
1435461|NCT01022476|Hepatitis C|hepatitis c
1435462|NCT01022476|Hepatitis B|hepatitis b
1435463|NCT01022450|rhabdomyolysis|rhabdomyolysis
1435464|NCT01022450|myopathy|myopathy
1435465|NCT01022450|acute renal failure|acute renal failure
1435466|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
1435467|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
1435468|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1435469|NCT01022450|fibrates|fibrates
1435470|NCT01022450|creatine kinase|creatine kinase
1435472|NCT01022424|Tolvaptan|tolvaptan
1435473|NCT01022424|OPC-41061|opc-41061
1435474|NCT01022411|brown rice|brown rice
1435475|NCT01022411|white rice|white rice
1435476|NCT01022411|diabetes risk|diabetes risk
1435477|NCT01022398|Vitamin D3|vitamin d3
1435478|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
1435479|NCT01022359|haemodialysis|haemodialysis
1435480|NCT01022359|vascular access|vascular access
1435481|NCT01022359|central venous catheter|central venous catheter
1435482|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1435483|NCT01022346|RO5217790|ro5217790
1435484|NCT01022333|BRCA1|brca1
1435485|NCT01022333|breast cancer|breast cancer
1435486|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
1435487|NCT01022333|dietary intervention|dietary intervention
1435488|NCT01022333|estrogen metabolites|estrogen metabolites
1435489|NCT01022333|mRNA expression|mrna expression
1435490|NCT01022333|BRCA1 protein|brca1 protein
1435491|NCT01022333|Estrogen|estrogen
1435492|NCT01022320|OSA|osa
1435493|NCT01022320|Blood pressure|blood pressure
1435494|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
1435495|NCT01022307|behavioral data acquisition|behavioral data acquisition
1435496|NCT01022307|MRI|mri
1435497|NCT01022294|children|children
1435498|NCT01022294|analgesia|analgesia
1435499|NCT01022294|dental treatment|dental treatment
1435500|NCT01022294|inhalation|inhalation
1435501|NCT01022281|Exfoliation|exfoliation
1435502|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
1435503|NCT01022281|Corneal Thickness|corneal thickness
1435504|NCT01022255|autologous vaccine|autologous vaccine
1435505|NCT01022255|follicular lymphoma|follicular lymphoma
1435506|NCT01022255|magnICON|magnicon
1435507|NCT01022255|plant-made vaccines|plant-made vaccines
1435508|NCT01022255|immune response|immune response
1435509|NCT01022242|Surgical Adhesions|surgical adhesions
1435510|NCT01022242|Post-surgical adhesions|post-surgical adhesions
1435511|NCT01022242|Flexor tendon|flexor tendon
1435512|NCT01022229|Attention Deficit Disorder|attention deficit disorder
1435513|NCT01022229|Pediatrics|pediatrics
1435514|NCT01022229|Attention|attention
1435515|NCT01022229|Impulsivity|impulsivity
1435516|NCT01022229|Complementary Therapies|complementary therapies
1435517|NCT01022216|Wound|wound
1435518|NCT01022216|Skin lesion|skin lesion
1435519|NCT01022216|Antimicrobial|antimicrobial
1435520|NCT01022216|Bioelectric|bioelectric
1435521|NCT01022216|Diabetic foot|diabetic foot
1435522|NCT01022216|Pressure Ulcer|pressure ulcer
1435523|NCT01022203|Couples Therapy|couples therapy
1435524|NCT01022203|PTSD|ptsd
1435525|NCT01022190|Arthroplasty|arthroplasty
1435526|NCT01022190|Hip|hip
1435527|NCT01022190|Cemented|cemented
1435528|NCT01022190|Heterotopic ossification|heterotopic ossification
1435529|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
1435530|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
1435531|NCT01022190|Hip Prosthesis|hip prosthesis
1435532|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
1435533|NCT01022164|fibrin glue|fibrin glue
1435534|NCT01022164|vitrectomy|vitrectomy
1435535|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
1435536|NCT01022151|Aminophylline|aminophylline
1435537|NCT01022151|sevoflurane|sevoflurane
1435538|NCT01022151|anaesthesia|anaesthesia
1435539|NCT01022151|recovery|recovery
1435540|NCT01022151|cognitive function|cognitive function
1435541|NCT01022151|entropy|entropy
1435542|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
1435543|NCT01022138|stage IV breast cancer|stage iv breast cancer
1435544|NCT01022138|recurrent breast cancer|recurrent breast cancer
1435545|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
1435546|NCT01022125|TMC435-C121|tmc435-c121
1435547|NCT01022125|TMC435|tmc435
1435548|NCT01022125|TMC435350|tmc435350
1435549|NCT01022125|Protease inhibitor|protease inhibitor
1435550|NCT01022125|HCV|hcv
1435551|NCT01022125|Hepatitis C|hepatitis c
1435552|NCT01022112|TA-7284|ta-7284
1435553|NCT01022112|JNJ-28431754|jnj-28431754
1435554|NCT01022112|Canagliflozin|canagliflozin
1435555|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
1435556|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
1435557|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
1435558|NCT01022099|Navigation|navigation
1435559|NCT01022086|Breast Cancer|breast cancer
1435560|NCT01022086|Cardiotoxicity|cardiotoxicity
1435561|NCT01022086|Trastuzumab|trastuzumab
1435562|NCT01022086|Cardiac MRI|cardiac mri
1435563|NCT01022073|Deep Brain Stimulation|deep brain stimulation
1435564|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
1435565|NCT01022073|Globus Pallidus|globus pallidus
1435566|NCT01022073|Parkinson Disease|parkinson disease
1435567|NCT01022060|Dietary supplement|dietary supplement
1435568|NCT01022060|Renalof|renalof
1435569|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
1435570|NCT01022060|Renal calculi|renal calculi
1435571|NCT01022034|Rectal prolapse|rectal prolapse
1435572|NCT01022034|mesh|mesh
1435573|NCT01022034|recurrence|recurrence
1435574|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1435575|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
1435576|NCT01022008|Exorbitism|exorbitism
1435577|NCT01022008|Upper respiratory airways|upper respiratory airways
1435578|NCT01022008|Osteodistraction|osteodistraction
1435579|NCT01022008|Polysomnography|polysomnography
1435580|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
1435581|NCT01021982|Pupillometer|pupillometer
1435582|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
1435583|NCT01021982|Glaucoma|glaucoma
1435584|NCT01021982|Objective perimetry|objective perimetry
1435585|NCT01021956|Macular Degeneration|macular degeneration
1435586|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
1435587|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
1435588|NCT01021956|AMD|amd
1435589|NCT01021956|CNV|cnv
1435590|NCT01021956|WST11|wst11
1435591|NCT01021956|Stakel|stakel
1435592|NCT01021956|Photodynamic therapy|photodynamic therapy
1435593|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
1435594|NCT01021956|VTP|vtp
1435595|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
1435596|NCT01021943|fibrosis|fibrosis
1435597|NCT01021943|spironolactone|spironolactone
1435695|NCT01021501|Pharmacokinetics|pharmacokinetics
1435696|NCT01021488|Thrombosis|thrombosis
1435697|NCT01021488|Vein|vein
1435598|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
1435599|NCT01021930|Optical coherence tomography|optical coherence tomography
1435600|NCT01021930|Drug eluting stent|drug eluting stent
1435601|NCT01021930|Coronary heart disease|coronary heart disease
1435602|NCT01021930|Diabetes mellitus|diabetes mellitus
1435603|NCT01021917|Obesity|obesity
1435604|NCT01021917|Weight Loss|weight loss
1435605|NCT01021917|Meal Replacements|meal replacements
1435606|NCT01021904|Primary prevention|primary prevention
1435607|NCT01021904|HPV Vaccination|hpv vaccination
1435608|NCT01021904|HPV Infection|hpv infection
1435609|NCT01021904|Cervical Cancer|cervical cancer
1435610|NCT01021904|HPV Related Diseases|hpv related diseases
1435611|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
1435612|NCT01021878|Peritoneal dialysis|peritoneal dialysis
1435613|NCT01021878|Renal replacement therapy|renal replacement therapy
1435614|NCT01021878|Dialysis solutions|dialysis solutions
1435615|NCT01021878|Icodextrin|icodextrin
1435616|NCT01021865|GLP-1|glp-1
1435617|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
1435618|NCT01021865|Myocardial perfusion|myocardial perfusion
1435619|NCT01021839|renal dialysis|renal dialysis
1435620|NCT01021839|bioprosthesis|bioprosthesis
1435621|NCT01021839|arteriovenous shunt|arteriovenous shunt
1435622|NCT01021839|surgical|surgical
1435623|NCT01021826|knee replacement|knee replacement
1435624|NCT01021826|hip replacement|hip replacement
1435625|NCT01021826|hyperglycemia|hyperglycemia
1435626|NCT01021826|diabetes|diabetes
1435627|NCT01021826|osteoarthritis|osteoarthritis
1435628|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
1435629|NCT01021787|Sun Protection|sun protection
1435630|NCT01021735|Rheumatoid|rheumatoid
1435631|NCT01021735|Outcome|outcome
1435632|NCT01021735|Cost effectiveness|cost effectiveness
1435633|NCT01021735|Safety|safety
1435634|NCT01021722|sphincter|sphincter
1435635|NCT01021722|obstetric tears|obstetric tears
1435636|NCT01021722|long-term follow-up|long-term follow-up
1435637|NCT01021709|depression|depression
1436308|NCT01018771|InductOs|inductos
1435638|NCT01021709|direct current stimulation|direct current stimulation
1435639|NCT01021709|extracephalic electrode|extracephalic electrode
1435640|NCT01021696|Dementia|dementia
1435641|NCT01021696|Nursing home|nursing home
1435642|NCT01021696|Pain treatment|pain treatment
1435643|NCT01021696|Pain assessment|pain assessment
1435644|NCT01021696|Agitation|agitation
1435645|NCT01021683|Hematological neoplasms|hematological neoplasms
1435646|NCT01021683|Neutropenia|neutropenia
1435647|NCT01021683|Fever|fever
1435648|NCT01021683|Itraconazole|itraconazole
1435649|NCT01021683|Sporanox|sporanox
1435650|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
1435651|NCT01021683|Defeverscence|defeverscence
1435652|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
1435653|NCT01021670|Priligy|priligy
1435654|NCT01021670|Premature ejaculation|premature ejaculation
1435655|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
1435656|NCT01021657|Glaucoma|glaucoma
1435657|NCT01021657|Tenon's Capsule|tenon's capsule
1435658|NCT01021657|Lipid profile|lipid profile
1435659|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
1435660|NCT01021644|APOE|apoe
1435661|NCT01021644|Apolipoprotein E|apolipoprotein e
1435662|NCT01021644|Cognition Disorders|cognition disorders
1435663|NCT01021644|Neurocognition|neurocognition
1435664|NCT01021631|Cardiac surgery|cardiac surgery
1435665|NCT01021631|Strategies of transfusion|strategies of transfusion
1435666|NCT01021631|Red blood cells|red blood cells
1435667|NCT01021631|Liberal|liberal
1435668|NCT01021631|Restrictive|restrictive
1435669|NCT01021631|Anemia|anemia
1435670|NCT01021592|Velcade|velcade
1435671|NCT01021592|QoL|qol
1435672|NCT01021592|Proteasome inhibitor|proteasome inhibitor
1435673|NCT01021592|Bortezomib|bortezomib
1435674|NCT01021592|EORTC QLQ C30|eortc qlq c30
1435675|NCT01021592|EQ 5D|eq 5d
1435676|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
1435677|NCT01021579|Metformin|metformin
1435678|NCT01021579|Simvastatin|simvastatin
1435679|NCT01021566|Opiate addiction|opiate addiction
1435680|NCT01021566|Withdrawal symptoms|withdrawal symptoms
1435681|NCT01021566|hemoperfusion|hemoperfusion
1435682|NCT01021566|hemodialysis|hemodialysis
1435683|NCT01021566|methadone|methadone
1435684|NCT01021553|Proof of Concept|proof of concept
1435685|NCT01021553|Double Blind|double blind
1435686|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
1435687|NCT01021514|sRAGE|srage
1435688|NCT01021514|SUV|suv
1435689|NCT01021514|TBR|tbr
1435690|NCT01021514|FDG PET CT|fdg pet ct
1435691|NCT01021514|Type 2 DM|type 2 dm
1435692|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
1435693|NCT01021501|hypertensive|hypertensive
1435694|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
1435698|NCT01021488|Statin|statin
1435699|NCT01021488|Prevention|prevention
1435700|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
1435701|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
1435702|NCT01021436|Pneumonia|pneumonia
1435703|NCT01021436|Gram-negative bacteria|gram-negative bacteria
1435704|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
1435705|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1435706|NCT01021423|CC-5013|cc-5013
1435707|NCT01021423|Revlimid|revlimid
1435708|NCT01021423|Lenalidomide|lenalidomide
1435709|NCT01021410|acetaminophen|acetaminophen
1435710|NCT01021410|paracetamol|paracetamol
1435711|NCT01021410|protein adduct|protein adduct
1435712|NCT01021410|healthy volunteer|healthy volunteer
1435713|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
1435714|NCT01021397|Respiratory Tract Infection|respiratory tract infection
1435715|NCT01021384|Depression,|depression,
1435716|NCT01021384|Early Intervention,|early intervention,
1435717|NCT01021384|Behavior Disorder,|behavior disorder,
1435718|NCT01021384|Parenting Skills,|parenting skills,
1435719|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
1435720|NCT01021384|Developmental Disabilities,|developmental disabilities,
1435721|NCT01021384|Family Support Programs|family support programs
1435722|NCT01021371|HRQOL|hrqol
1435723|NCT01021371|Rehabilitation|rehabilitation
1435724|NCT01021371|Cancer Patients|cancer patients
1435725|NCT01021371|General Practice|general practice
1435726|NCT01021332|Vesomni|vesomni
1435727|NCT01021332|Solifenacin succinate|solifenacin succinate
1435728|NCT01021332|EC905|ec905
1435729|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
1435730|NCT01021332|Treatment|treatment
1435731|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1435732|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1435733|NCT01021319|ischemic stroke|ischemic stroke
1435734|NCT01021319|thrombolysis|thrombolysis
1435735|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
1435736|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
1435737|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
1435738|NCT01021319|time window|time window
1435739|NCT01021293|Poliorix|poliorix
1435741|NCT01021280|Bartter syndrome,|bartter syndrome,
1435742|NCT01021280|parathyroid hormone,|parathyroid hormone,
1435743|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
1435744|NCT01021280|ROMK channel|romk channel
1435745|NCT01021280|Barttin gene|barttin gene
1435746|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
1435747|NCT01021267|sexual dysfunctions|sexual dysfunctions
1435748|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
1435749|NCT01021267|saw palmetto|saw palmetto
1435750|NCT01021228|Liver resection|liver resection
1435751|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
1435752|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
1435753|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
1435754|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
1435755|NCT01021215|Cancer Prevention|cancer prevention
1435756|NCT01021215|Smoking-related lung disease|smoking-related lung disease
1435757|NCT01021215|Smoking|smoking
1435758|NCT01021215|Celecoxib|celecoxib
1435759|NCT01021215|Celebrex|celebrex
1435760|NCT01021215|Zileuton|zileuton
1435761|NCT01021215|Zyflo CR|zyflo cr
1435762|NCT01021215|Prevention|prevention
1435763|NCT01021202|tracheostomy|tracheostomy
1435764|NCT01021202|tracheotomy|tracheotomy
1435765|NCT01021202|dilational|dilational
1435766|NCT01021202|dilatative|dilatative
1435767|NCT01021202|critical care|critical care
1435768|NCT01021202|intensive care|intensive care
1435769|NCT01021202|COPD|copd
1435770|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1435771|NCT01021202|lung disease|lung disease
1435772|NCT01021202|pneumonia|pneumonia
1435773|NCT01021202|prospective study|prospective study
1435774|NCT01021202|questionnaire|questionnaire
1435775|NCT01021202|quality of life|quality of life
1435776|NCT01021202|outcome|outcome
1435777|NCT01021202|mortality|mortality
1435778|NCT01021189|safety|safety
1435779|NCT01021189|tolerability|tolerability
1435780|NCT01021189|AZD1446|azd1446
1435781|NCT01021189|AD|ad
1435782|NCT01021189|Japanese|japanese
1435783|NCT01021176|Food Intake|food intake
1435784|NCT01021176|Hunger|hunger
1435785|NCT01021176|Lidocaine|lidocaine
1435786|NCT01021176|Nose|nose
1435787|NCT01021176|smell|smell
1435788|NCT01021137|vestibular function tests|vestibular function tests
1435789|NCT01021137|postural balance|postural balance
1435790|NCT01021137|neuroimaging|neuroimaging
1435791|NCT01021124|tuberculosis|tuberculosis
1435792|NCT01021124|bone marrow transplant|bone marrow transplant
1435793|NCT01021124|diagnosis|diagnosis
1435794|NCT01021098|influenza|influenza
1435795|NCT01021098|illness|illness
1435796|NCT01021098|active-duty|active-duty
1435797|NCT01021098|virus|virus
1435798|NCT01021098|flu|flu
1435799|NCT01021098|military|military
1435800|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
1435801|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
1435802|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
1435803|NCT01021085|First trimester|first trimester
1435804|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
1435805|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
1435806|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
1435807|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
1435808|NCT01021059|Kidney Cancer|kidney cancer
1435809|NCT01021059|Melanoma|melanoma
1435810|NCT01021059|Renal Cell Cancer|renal cell cancer
1435811|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
1435812|NCT01021046|rejection|rejection
1435813|NCT01021046|high risk patients|high risk patients
1435814|NCT01021046|acellular corneal tissue|acellular corneal tissue
1435815|NCT01021033|Ischemia|ischemia
1435816|NCT01021033|Hemorrhage|hemorrhage
1435817|NCT01021033|Rehabilitation|rehabilitation
1435818|NCT01021033|Stroke|stroke
1435819|NCT01021020|bioequivalence|bioequivalence
1435820|NCT01021020|fasting|fasting
1435821|NCT01021020|fed|fed
1435822|NCT01021020|healthy|healthy
1435823|NCT01020994|Superficial infected eczema|superficial infected eczema
1435824|NCT01020994|Superinfected eczema|superinfected eczema
1435825|NCT01020981|OEF/OIF|oef/oif
1435826|NCT01020981|Peer Group|peer group
1435827|NCT01020981|Veterans|veterans
1435828|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
1435829|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
1435830|NCT01020968|ixmyelocel-T|ixmyelocel-t
1435831|NCT01020955|GH and IGF-I|gh and igf-i
1435832|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
1435833|NCT01020942|ischemia|ischemia
1435834|NCT01020942|myocardial infarction|myocardial infarction
1435835|NCT01020942|prognosis|prognosis
1435836|NCT01020942|pretreatment|pretreatment
1435837|NCT01020942|electroacupuncture|electroacupuncture
1435838|NCT01020942|stents|stents
1435839|NCT01020942|troponin|troponin
1435840|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
1435841|NCT01020916|Induced hypothermia|induced hypothermia
1435842|NCT01020916|Mild induced hypothermia|mild induced hypothermia
1435843|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
1435844|NCT01020916|Cardiac arrest|cardiac arrest
1435845|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1435846|NCT01020916|Mortality|mortality
1435847|NCT01020916|Neurological function|neurological function
1435848|NCT01020916|Randomised clinical trial|randomised clinical trial
1435849|NCT01020890|GERD diagnosis|gerd diagnosis
1435850|NCT01020890|GERD-Q|gerd-q
1435851|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
1435852|NCT01020890|GERD|gerd
1435853|NCT01020877|Bioequivalence|bioequivalence
1435854|NCT01020877|Healthy Subjects|healthy subjects
1435855|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
1435856|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
1435857|NCT01020864|Cetuximab|cetuximab
1435858|NCT01020864|Carboplatin|carboplatin
1435859|NCT01020864|Navelbine|navelbine
1435860|NCT01020864|Phase II trial|phase ii trial
1435861|NCT01020864|Combination chemotherapy|combination chemotherapy
1435862|NCT01020851|hypertension|hypertension
1435863|NCT01020851|stroke|stroke
1435864|NCT01020851|cholesterol|cholesterol
1435865|NCT01020851|adherence|adherence
1435866|NCT01020838|Florbetaben|florbetaben
1435867|NCT01020838|Amyloid beta-protein|amyloid beta-protein
1435868|NCT01020838|Alzheimer's disease|alzheimer's disease
1435869|NCT01020825|Complex perianal fistula|complex perianal fistula
1435870|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
1435871|NCT01020825|Fibrin glue|fibrin glue
1435872|NCT01020799|Depression|depression
1435873|NCT01020786|Non-squamous|non-squamous
1435874|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
1435875|NCT01020760|Macular hole|macular hole
1435876|NCT01020760|Vitrectomy|vitrectomy
1435877|NCT01020760|Prone posturing|prone posturing
1435878|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1435879|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1435880|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1435881|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1435882|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1435883|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1435884|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1435885|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1435886|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1435887|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1435888|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1435889|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1435890|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1435891|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1435892|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1435893|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1435894|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1435895|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1435896|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1435897|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1435898|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1435899|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1435900|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1435901|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1435902|NCT01020721|CYP1B1 gene|cyp1b1 gene
1435903|NCT01020695|PTSD|ptsd
1435904|NCT01020695|EEG|eeg
1435905|NCT01020695|QEEG|qeeg
1435906|NCT01020695|LORETA|loreta
1435907|NCT01020682|apathy|apathy
1435908|NCT01020682|parkinson|parkinson
1435909|NCT01020682|agonist dopaminergic|agonist dopaminergic
1435910|NCT01020669|fMRI|fmri
1435911|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
1435912|NCT01020669|Decision Making|decision making
1435913|NCT01020669|Working Memory|working memory
1435914|NCT01020669|Vulnerability|vulnerability
1435915|NCT01020656|anticoagulant agents|anticoagulant agents
1435916|NCT01020656|antiplatelet agents|antiplatelet agents
1435917|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
1435918|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
1435919|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
1435920|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
1435921|NCT01020630|sunitinib|sunitinib
1435922|NCT01020630|FOLFIRI|folfiri
1435923|NCT01020604|BMI|bmi
1435924|NCT01020604|Prostate cancer|prostate cancer
1435925|NCT01020604|Recurrence|recurrence
1435926|NCT01020591|knee osteoarthritis|knee osteoarthritis
1435927|NCT01020591|manual therapy|manual therapy
1435928|NCT01020591|osteopathy|osteopathy
1435929|NCT01020552|APHIA II|aphia ii
1435930|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
1435931|NCT01020552|DCF|dcf
1435932|NCT01020552|data collection forms|data collection forms
1435933|NCT01020552|FDA|fda
1435934|NCT01020552|Federal Drug Administration|federal drug administration
1435935|NCT01020552|FP|fp
1435936|NCT01020552|family planning|family planning
1435937|NCT01020552|IRB|irb
1435938|NCT01020552|Institutional Review Board|institutional review board
1435939|NCT01020552|PAC|pac
1435940|NCT01020552|postabortion care|postabortion care
1435941|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
1435942|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
1435943|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
1435944|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1435945|NCT01020539|Targeted Immune Therapy|targeted immune therapy
1435946|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
1435947|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
1435948|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
1435949|NCT01020539|AML|aml
1435950|NCT01020539|MDS|mds
1435951|NCT01020539|JMML|jmml
1435952|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
1435953|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
1435954|NCT01020474|pregabalin|pregabalin
1435955|NCT01020474|and Lyrica|and lyrica
1435956|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
1435957|NCT01020435|Hypertension|hypertension
1435958|NCT01020422|breast hypertrophy|breast hypertrophy
1435959|NCT01020422|mammaplasty|mammaplasty
1435960|NCT01020422|sexuality|sexuality
1435961|NCT01020422|depression|depression
1435962|NCT01020409|cardiac surgery|cardiac surgery
1435963|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
1435964|NCT01020409|acute lung injury|acute lung injury
1435965|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
1435966|NCT01020409|acute kidney injury|acute kidney injury
1435967|NCT01020409|atrial fibrillation|atrial fibrillation
1435968|NCT01020409|postoperative psychosis|postoperative psychosis
1435969|NCT01020409|myocardial infarct|myocardial infarct
1435970|NCT01020409|sepsis|sepsis
1435971|NCT01020396|Bioequivalence|bioequivalence
1435972|NCT01020396|Metronidazole|metronidazole
1435973|NCT01020396|Vaginosis|vaginosis
1435974|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
1435975|NCT01020357|preterm infants|preterm infants
1435976|NCT01020357|very low birthweight|very low birthweight
1435977|NCT01020357|apnea of prematurity|apnea of prematurity
1435978|NCT01020357|methylxanthines|methylxanthines
1435979|NCT01020357|sleep disturbance|sleep disturbance
1435980|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1435981|NCT01020357|polysomnography|polysomnography
1435982|NCT01020357|sleep disruption|sleep disruption
1435983|NCT01020331|ALS|als
1435984|NCT01020318|Traumatic Brain Injury|traumatic brain injury
1435985|NCT01020318|TBI|tbi
1435986|NCT01020318|Brain Injuries|brain injuries
1435987|NCT01020279|muscle pain|muscle pain
1435988|NCT01020279|model|model
1435989|NCT01020266|brain protection|brain protection
1435990|NCT01020266|cardiac surgery|cardiac surgery
1435991|NCT01020266|heart valve replacement|heart valve replacement
1435992|NCT01020266|electroacupuncture|electroacupuncture
1435993|NCT01020266|pretreatment|pretreatment
1435994|NCT01020266|preconditioning|preconditioning
1435995|NCT01020266|Thoracic Surgery|thoracic surgery
1435996|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
1435997|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
1435998|NCT01020240|Immediate puerperium|immediate puerperium
1435999|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
1436000|NCT01020240|cesarean complications|cesarean complications
1436001|NCT01020227|Postoperative Care|postoperative care
1436002|NCT01020227|Quality of Life|quality of life
1436003|NCT01020227|Integrative Medicine|integrative medicine
1436004|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1436005|NCT01020201|Anesthesia, General|anesthesia, general
1436006|NCT01020201|Elective Gynecological Operation|elective gynecological operation
1436007|NCT01020201|Chinese female patient|chinese female patient
1436008|NCT01020201|Adult|adult
1436009|NCT01020175|allogeneic transplantation|allogeneic transplantation
1436010|NCT01020175|Leukemia|leukemia
1436012|NCT01020175|MDS|mds
1436013|NCT01020162|Chronic pelvic pain|chronic pelvic pain
1436014|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
1436015|NCT01020162|randomized study|randomized study
1436016|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
1436017|NCT01020149|Nerve transsection|nerve transsection
1436018|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
1436019|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
1436020|NCT01020123|metformin|metformin
1436021|NCT01020123|glipizide|glipizide
1436022|NCT01020110|perfusion chamber|perfusion chamber
1436023|NCT01020110|thrombus D-Dimer|thrombus d-dimer
1436024|NCT01020110|HUVEC|huvec
1436025|NCT01020084|Saliva|saliva
1436026|NCT01020084|Mastication|mastication
1436027|NCT01020084|Communication|communication
1436028|NCT01020071|iridotomy|iridotomy
1436029|NCT01020071|iridoplasty|iridoplasty
1436030|NCT01020071|angle closure glaucoma|angle closure glaucoma
1436031|NCT01020045|HIV|hiv
1436032|NCT01020045|Osteopenia|osteopenia
1436033|NCT01020045|Osteoporosis|osteoporosis
1436034|NCT01020032|Music therapy|music therapy
1436035|NCT01020032|Pain|pain
1436036|NCT01020032|Anxiety|anxiety
1436037|NCT01020032|Depression|depression
1436038|NCT01020032|Controlled randomized trial|controlled randomized trial
1436039|NCT01020019|Cannabis Dependence|cannabis dependence
1436040|NCT01020019|Marijuana Dependence|marijuana dependence
1436041|NCT01020019|Marinol|marinol
1436042|NCT01020019|Lofexidine|lofexidine
1436043|NCT01020006|PCI-27483|pci-27483
1436044|NCT01020006|Factor VIIa|factor viia
1436045|NCT01020006|Gemcitabine|gemcitabine
1436046|NCT01020006|4 months life expectancy|4 months life expectancy
1436047|NCT01020006|Pharmacyclics|pharmacyclics
1436048|NCT01020006|Locally Advanced|locally advanced
1436049|NCT01020006|Metastatic disease|metastatic disease
1436050|NCT01019993|Thoracotomy|thoracotomy
1436051|NCT01019993|one lung ventilation|one lung ventilation
1436052|NCT01019993|HFPPV|hfppv
1436053|NCT01019993|right ventricular function.|right ventricular function.
1436054|NCT01019980|Antipyretics|antipyretics
1436055|NCT01019980|fever|fever
1436056|NCT01019980|diclofenac|diclofenac
1436057|NCT01019980|acetaminophen|acetaminophen
1436058|NCT01019980|children|children
1436059|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
1436060|NCT01019967|Children and Adolescents|children and adolescents
1436061|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1436062|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1436063|NCT01019967|Autism|autism
1436064|NCT01019967|OCD|ocd
1436065|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
1436066|NCT01019941|Docetaxel|docetaxel
1436067|NCT01019941|CKD-810|ckd-810
1436068|NCT01019941|Taxotere inj.|taxotere inj.
1436069|NCT01019941|Advanced Solid cancer|advanced solid cancer
1436270|NCT01019044|Viral load|viral load
1436070|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
1436071|NCT01019928|GERD|gerd
1436072|NCT01019928|patient|patient
1436073|NCT01019928|esophagus|esophagus
1436074|NCT01019928|pain|pain
1436075|NCT01019915|CRT|crt
1436076|NCT01019915|heart failure|heart failure
1436077|NCT01019915|left bundle branch block|left bundle branch block
1436078|NCT01019915|skeletal muscle|skeletal muscle
1436079|NCT01019915|cytokines|cytokines
1436080|NCT01019915|VO2|vo2
1436081|NCT01019915|pgc1alpha|pgc1alpha
1436082|NCT01019902|iron|iron
1436083|NCT01019902|pregnancy|pregnancy
1436084|NCT01019902|adolescents|adolescents
1436085|NCT01019902|auditory brainstem responses|auditory brainstem responses
1436086|NCT01019902|anemia|anemia
1436087|NCT01019902|neonate|neonate
1436088|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
1436089|NCT01019889|herbal medicine|herbal medicine
1436090|NCT01019876|Bone marrow Failure|bone marrow failure
1436091|NCT01019876|Fanconi|fanconi
1436092|NCT01019876|SCID|scid
1436093|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
1436094|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1436095|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
1436096|NCT01019850|regional neuroblastoma|regional neuroblastoma
1436097|NCT01019837|Vaccine|vaccine
1436098|NCT01019824|nerve compression|nerve compression
1436099|NCT01019824|compression radiculopathy|compression radiculopathy
1436100|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
1436101|NCT01019811|Cross-finger flap|cross-finger flap
1436102|NCT01019811|finger injuries|finger injuries
1436103|NCT01019811|fingertip reconstruction|fingertip reconstruction
1436104|NCT01019811|proper digital artery|proper digital artery
1436105|NCT01019811|proper digital nerve.|proper digital nerve.
1436106|NCT01019798|non small cell lung cancer|non small cell lung cancer
1436107|NCT01019798|sunitinib|sunitinib
1436108|NCT01019798|docetaxel|docetaxel
1436109|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
1436110|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
1436111|NCT01019785|Thrombin generation|thrombin generation
1436112|NCT01019759|Atrial fibrillation|atrial fibrillation
1436113|NCT01019759|cardiac surgery|cardiac surgery
1436114|NCT01019759|ablation|ablation
1436115|NCT01019759|pulmonary veins|pulmonary veins
1436116|NCT01019746|Hypnosis with propofol|hypnosis with propofol
1436117|NCT01019733|Hypoxia|hypoxia
1436118|NCT01019733|Ischemia|ischemia
1436119|NCT01019733|Brain|brain
1436120|NCT01019733|Children|children
1436121|NCT01019733|Cerebral Palsy|cerebral palsy
1436122|NCT01019707|crystal meth|crystal meth
1436123|NCT01019707|methamphetamine|methamphetamine
1436124|NCT01019707|substance abuse|substance abuse
1436125|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
1436126|NCT01019668|chorioretinopathy|chorioretinopathy
1436127|NCT01019668|photodynamic therapy|photodynamic therapy
1436128|NCT01019668|reduced fluence|reduced fluence
1436129|NCT01019668|reduced dose|reduced dose
1436130|NCT01019655|thrombophilia|thrombophilia
1436131|NCT01019655|pregnancy|pregnancy
1436132|NCT01019655|heparin|heparin
1436133|NCT01019642|vitamin D|vitamin d
1436134|NCT01019642|diabetes|diabetes
1436135|NCT01019642|C-reactive protein|c-reactive protein
1436136|NCT01019642|insulin resistance|insulin resistance
1436137|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
1436138|NCT01019603|Acne|acne
1436139|NCT01019551|Controlled viremia|controlled viremia
1436140|NCT01019551|Viral reservoirs|viral reservoirs
1436141|NCT01019551|Virus eradication|virus eradication
1436142|NCT01019551|Therapeutic intensification|therapeutic intensification
1436143|NCT01019551|Immunointervention|immunointervention
1436144|NCT01019538|Oxygen|oxygen
1436145|NCT01019538|Hypoxemia|hypoxemia
1436146|NCT01019538|Air travel|air travel
1436147|NCT01019525|respiration|respiration
1436148|NCT01019525|respiratory disorders|respiratory disorders
1436149|NCT01019525|Otolaryngology|otolaryngology
1436150|NCT01019525|Otorhinolaryngology|otorhinolaryngology
1436151|NCT01019525|Posture|posture
1436152|NCT01019499|human|human
1436153|NCT01019499|intervention|intervention
1436154|NCT01019499|blood pressure|blood pressure
1436155|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
1436156|NCT01019499|polyphenols|polyphenols
1436157|NCT01019499|bioavailability|bioavailability
1436158|NCT01019486|Myocardial blood flow|myocardial blood flow
1436159|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1436160|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
1436161|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
1436162|NCT01019486|Regadenoson|regadenoson
1436163|NCT01019473|Huntington's disease|huntington's disease
1436164|NCT01019473|Chorea|chorea
1436165|NCT01019473|Dyskinesia|dyskinesia
1436166|NCT01019460|Small intestine|small intestine
1436167|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
1436168|NCT01019460|Computed tomography scanning|computed tomography scanning
1436169|NCT01019460|Capsule endoscopy|capsule endoscopy
1436170|NCT01019447|Surgical site infection|surgical site infection
1436171|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
1436172|NCT01019447|Length of hospital stay|length of hospital stay
1436173|NCT01019447|SSI|ssi
1436174|NCT01019434|adult glioblastoma|adult glioblastoma
1436175|NCT01019421|Cognition|cognition
1436176|NCT01019408|Clinical Trial|clinical trial
1436177|NCT01019408|Chloroquine|chloroquine
1436178|NCT01019408|Refugees|refugees
1436179|NCT01019408|Afghanistan|afghanistan
1436180|NCT01019408|Pakistan|pakistan
1436181|NCT01019395|Gram Positive Infection|gram positive infection
1436182|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
1436183|NCT01019382|pancreatic|pancreatic
1436184|NCT01019382|carcinoma|carcinoma
1436185|NCT01019382|cancer|cancer
1436186|NCT01019382|fish|fish
1436187|NCT01019382|alternative|alternative
1436188|NCT01019369|Contraception|contraception
1436189|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
1436190|NCT01019369|Self administration|self administration
1436191|NCT01019356|PCOS|pcos
1436192|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1436193|NCT01019343|Magnetoencephalogram|magnetoencephalogram
1436194|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
1436195|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1436196|NCT01019343|Motor Deficit|motor deficit
1436197|NCT01019343|Dystonia|dystonia
1436198|NCT01019343|Movement Disorder|movement disorder
1436199|NCT01019343|Parkinson Disease|parkinson disease
1436200|NCT01019343|PD|pd
1436201|NCT01019343|Tourette Syndrome|tourette syndrome
1436202|NCT01019343|TS|ts
1436203|NCT01019343|Tic Disorder|tic disorder
1436204|NCT01019330|radial vs femoral|radial vs femoral
1436205|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
1436206|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
1436207|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1436208|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
1436210|NCT01019317|Blast crisis|blast crisis
1436211|NCT01019317|Cytarabine|cytarabine
1436212|NCT01019317|Ara-C|ara-c
1436213|NCT01019317|Cytosar|cytosar
1436214|NCT01019317|DepoCyt|depocyt
1436215|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1436216|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
1436217|NCT01019317|Fludarabine|fludarabine
1436218|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
1436219|NCT01019317|Fludara|fludara
1436220|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
1436221|NCT01019317|Mylotarg|mylotarg
1436222|NCT01019291|Indoor pollutants|indoor pollutants
1436223|NCT01019265|Norspan patch|norspan patch
1436224|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
1436225|NCT01019265|efficacy|efficacy
1436226|NCT01019265|buprenorphine|buprenorphine
1436227|NCT01019252|Adolescent|adolescent
1436228|NCT01019252|ADHD|adhd
1436229|NCT01019239|Non-faeculant|non-faeculant
1436230|NCT01019239|Perforated|perforated
1436231|NCT01019239|Diverticulitis|diverticulitis
1436232|NCT01019226|myocardium|myocardium
1436233|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
1436234|NCT01019213|His-pacing|his-pacing
1436235|NCT01019200|psoriasis|psoriasis
1436236|NCT01019200|heart disease|heart disease
1436237|NCT01019200|cardiovascular disease|cardiovascular disease
1436238|NCT01019200|hyperlipidemia|hyperlipidemia
1436239|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
1436240|NCT01019161|AML|aml
1436241|NCT01019161|AZD1152|azd1152
1436242|NCT01019161|Pharmacokinetics|pharmacokinetics
1436243|NCT01019135|Women|women
1436244|NCT01019135|Cardiac Care Facilities|cardiac care facilities
1436245|NCT01019135|Patient satisfaction|patient satisfaction
1436246|NCT01019135|Patient participation|patient participation
1436247|NCT01019135|Patient compliance|patient compliance
1436248|NCT01019135|Randomized Control Trial|randomized control trial
1436249|NCT01019135|Coronary artery bypass|coronary artery bypass
1436250|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
1436251|NCT01019109|scoliosis|scoliosis
1436252|NCT01019096|iron|iron
1436253|NCT01019096|pregnancy|pregnancy
1436254|NCT01019096|heme iron|heme iron
1436255|NCT01019096|non-heme iron|non-heme iron
1436256|NCT01019096|stable isotopes|stable isotopes
1436257|NCT01019096|women/adolescents|women/adolescents
1436258|NCT01019083|Cholera|cholera
1436259|NCT01019083|Typhoid|typhoid
1436260|NCT01019083|Oral Vaccine|oral vaccine
1436261|NCT01019083|Immune response|immune response
1436262|NCT01019083|Vaccine Evaluation|vaccine evaluation
1436263|NCT01019083|Nutrition|nutrition
1436264|NCT01019083|Child Health|child health
1436265|NCT01019057|DDD|ddd
1436266|NCT01019057|decompression|decompression
1436267|NCT01019057|spinous process plate|spinous process plate
1436268|NCT01019044|HIV|hiv
1436269|NCT01019044|Viral reservoirs|viral reservoirs
1436271|NCT01019018|subtenon block|subtenon block
1436272|NCT01019005|post-operative analgesia|post-operative analgesia
1436273|NCT01019005|opioid|opioid
1436274|NCT01019005|catheter|catheter
1436275|NCT01019005|tibial nerve block|tibial nerve block
1436276|NCT01018992|PTSD|ptsd
1436277|NCT01018992|Anxiety Disorder|anxiety disorder
1436278|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
1436279|NCT01018992|Women|women
1436280|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
1436281|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
1436282|NCT01018927|Amyloid|amyloid
1436283|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
1436284|NCT01018927|Multiple Myeloma|multiple myeloma
1436285|NCT01018914|Prograf|prograf
1436286|NCT01018914|Advagraf|advagraf
1436287|NCT01018914|Myfortic|myfortic
1436288|NCT01018888|Cornea|cornea
1436289|NCT01018888|Transplantation, Cornea|transplantation, cornea
1436290|NCT01018888|Keratoplasty|keratoplasty
1436291|NCT01018888|Grafting, Corneal|grafting, corneal
1436292|NCT01018849|Vitamin D|vitamin d
1436293|NCT01018849|Cardiac Catheterization|cardiac catheterization
1436294|NCT01018849|Cardiovascular event|cardiovascular event
1436295|NCT01018849|Cardiovascular Disease|cardiovascular disease
1436296|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
1436297|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1436298|NCT01018810|Psoriasis|psoriasis
1436299|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
1436300|NCT01018797|ASTIGMATISM|astigmatism
1436301|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
1436302|NCT01018797|EYES|eyes
1436303|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
1436304|NCT01018784|Cancer|cancer
1436305|NCT01018784|Mesothelin-positive|mesothelin-positive
1436306|NCT01018771|actifuse|actifuse
1436307|NCT01018771|INFUSE|infuse
1436309|NCT01018771|DDD|ddd
1436310|NCT01018771|Degenerative disc disease|degenerative disc disease
1436311|NCT01018771|PLF|plf
1436312|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
1436313|NCT01018771|bone substitute|bone substitute
1436314|NCT01018771|bone graft|bone graft
1436315|NCT01018771|synthetic bone substitute|synthetic bone substitute
1436316|NCT01018771|spinal surgery|spinal surgery
1436317|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1436318|NCT01018758|Quality of life|quality of life
1436319|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
1436320|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
1436321|NCT01018732|Meningococcal|meningococcal
1436322|NCT01018732|ACWY|acwy
1436323|NCT01018732|Conjugate Vaccine|conjugate vaccine
1436324|NCT01018732|Meningitis|meningitis
1436325|NCT01018732|Adolescents|adolescents
1436326|NCT01018732|Persistence|persistence
1436327|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
1436328|NCT01018719|Radiotherapy|radiotherapy
1436329|NCT01018706|Primary pci|primary pci
1436330|NCT01018706|Stent|stent
1436331|NCT01018706|Medical Hystory|medical hystory
1436332|NCT01018706|Antiplatelet therapy|antiplatelet therapy
1436333|NCT01018706|Compliance|compliance
1436334|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
1436335|NCT01018693|late phase response,|late phase response,
1436336|NCT01018693|alutard avanz,|alutard avanz,
1436337|NCT01018693|immunotherapy,|immunotherapy,
1436338|NCT01018693|visual analogue scale,|visual analogue scale,
1436339|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
1436340|NCT01018693|immune modulation|immune modulation
1436341|NCT01018667|Heart Failure|heart failure
1436342|NCT01018667|clinical trial|clinical trial
1436343|NCT01018667|biventricular pacing|biventricular pacing
1436344|NCT01018667|cardiac device|cardiac device
1436345|NCT01018654|Substance Abuse|substance abuse
1436346|NCT01018654|Substance Addiction|substance addiction
1436347|NCT01020708|colitis|colitis
1436348|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
1436349|NCT01020708|ulcerative colitis|ulcerative colitis
1436350|NCT01020708|rectal administration|rectal administration
1436351|NCT01020708|enema|enema
1436352|NCT01020708|mesalamine|mesalamine
1436353|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
1436354|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
1436355|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
1436356|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
1436357|NCT01019122|cerebral palsy|cerebral palsy
1436358|NCT01019122|DEXA scan|dexa scan
1436359|NCT01019122|bone density|bone density
1436360|NCT01018641|Staphylococcus aureus|staphylococcus aureus
1436361|NCT01018641|Vaccine|vaccine
1436362|NCT01018615|chronic hepatitis C|chronic hepatitis c
1436363|NCT01018615|silymarin|silymarin
1436364|NCT01018615|green tea catechins|green tea catechins
1436365|NCT01018615|green tea extract|green tea extract
1436366|NCT01018615|pharmacokinetics|pharmacokinetics
1436367|NCT01018615|antioxidant activity|antioxidant activity
1436368|NCT01018589|Post surgical scars|post surgical scars
1436369|NCT01018589|Epidermic burn|epidermic burn
1436370|NCT01018589|Cicatrix cream|cicatrix cream
1436371|NCT01018576|delayed cord clamping|delayed cord clamping
1436372|NCT01018576|premature infants|premature infants
1436373|NCT01018576|hypothermia|hypothermia
1436374|NCT01018576|anemia|anemia
1436375|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
1436376|NCT01018576|Anemia in premature infants|anemia in premature infants
1436377|NCT01018563|Extension study|extension study
1436378|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
1436379|NCT01018537|Multiple Sclerosis|multiple sclerosis
1436380|NCT01018537|NARCOMS|narcoms
1436381|NCT01018537|Global Patient Registry|global patient registry
1436382|NCT01018524|position of the mesh|position of the mesh
1436383|NCT01018524|recurrence rate|recurrence rate
1436384|NCT01018524|surgical procedure|surgical procedure
1436385|NCT01018524|long time outcome|long time outcome
1436386|NCT01018511|EC905|ec905
1436387|NCT01018511|Solifenacin succinate|solifenacin succinate
1436388|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
1436389|NCT01018511|Treatment|treatment
1436390|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1436391|NCT01018511|Vesomni|vesomni
1436392|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1436393|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
1436394|NCT01018498|Children|children
1436395|NCT01018472|cyanotic heart disease|cyanotic heart disease
1436396|NCT01018472|congenital heart disease|congenital heart disease
1436397|NCT01018472|intestinal microbiota|intestinal microbiota
1436398|NCT01018472|probiotics|probiotics
1436593|NCT01017471|surgery|surgery
1436399|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
1436400|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
1436401|NCT01018433|self-injury|self-injury
1436402|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
1436403|NCT01018433|deliberate self-harm|deliberate self-harm
1436404|NCT01018433|self-mutilation|self-mutilation
1436405|NCT01018420|healthy|healthy
1436406|NCT01018394|tobacco dependence|tobacco dependence
1436407|NCT01018394|tobacco reduction|tobacco reduction
1436408|NCT01018394|chewing tobacco|chewing tobacco
1436409|NCT01018394|snuff|snuff
1436410|NCT01018394|moist snuff|moist snuff
1436411|NCT01018381|HCC|hcc
1436412|NCT01018381|HBV|hbv
1436413|NCT01018381|MGN-3|mgn-3
1436414|NCT01018381|BioBran|biobran
1436415|NCT01018381|Alternative Therapy|alternative therapy
1436416|NCT01018355|Patent foramen ovale|patent foramen ovale
1436417|NCT01018355|PFO|pfo
1436418|NCT01018355|Stroke|stroke
1436419|NCT01018355|TIA|tia
1436420|NCT01018355|Percutaneus closure|percutaneus closure
1436421|NCT01018355|Intervention|intervention
1436422|NCT01018329|Adult Brain Tumor|adult brain tumor
1436423|NCT01018316|preoxygenation|preoxygenation
1436424|NCT01018316|UMOX|umox
1436425|NCT01018303|cystic fibrosis|cystic fibrosis
1436426|NCT01018303|vitamins|vitamins
1436427|NCT01018303|antioxidants|antioxidants
1436428|NCT01018303|anthropometric measurements|anthropometric measurements
1436429|NCT01018303|pulmonary function|pulmonary function
1436430|NCT01018264|Overactive bladder|overactive bladder
1436431|NCT01018264|Urinary incontinence|urinary incontinence
1436432|NCT01018264|Urinary frequency|urinary frequency
1436433|NCT01018264|Parkinson's disease|parkinson's disease
1436434|NCT01018212|Cutaneous Groves|cutaneous groves
1436435|NCT01018199|C-reactive protein|c-reactive protein
1436436|NCT01018199|procalcitonin|procalcitonin
1436437|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
1436438|NCT01018199|antibiotic therapy|antibiotic therapy
1436439|NCT01018160|Rabeprazole sodium|rabeprazole sodium
1436440|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
1436441|NCT01018160|GERD|gerd
1436442|NCT01018160|Observational|observational
1436443|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1436444|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1436445|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1436446|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1436447|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1436448|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1436449|NCT01018134|Psoriasis|psoriasis
1436450|NCT01018134|Topical corticosteroids|topical corticosteroids
1436451|NCT01018134|Plaque psoriasis|plaque psoriasis
1436452|NCT01018121|Behavioral Treatment|behavioral treatment
1436453|NCT01018121|Preschool Children|preschool children
1436454|NCT01018121|Obesity Treatment|obesity treatment
1436455|NCT01018069|Acute|acute
1436456|NCT01018069|myeloid|myeloid
1436457|NCT01018069|leukemia|leukemia
1436458|NCT01018069|antisense|antisense
1436459|NCT01018069|chemotherapy|chemotherapy
1436460|NCT01018069|idarubicin|idarubicin
1436461|NCT01018069|cytarabine|cytarabine
1436462|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
1436463|NCT01018056|Tourette syndrome|tourette syndrome
1436464|NCT01018056|glutamatergic therapy|glutamatergic therapy
1436465|NCT01018056|D-serine|d-serine
1436466|NCT01018056|riluzole|riluzole
1436467|NCT01018056|glutamate|glutamate
1436468|NCT01018056|glutamate agonist|glutamate agonist
1436469|NCT01018056|glutamate antagonist|glutamate antagonist
1436470|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
1436471|NCT01018056|OCD|ocd
1436472|NCT01018056|tics|tics
1436473|NCT01018043|Cancer Anemia Survey|cancer anemia survey
1436474|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
1436475|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
1436476|NCT01018030|fluticasone furoate|fluticasone furoate
1436477|NCT01018030|sinusitis|sinusitis
1436478|NCT01018004|stage IB melanoma|stage ib melanoma
1436479|NCT01018004|stage II melanoma|stage ii melanoma
1436480|NCT01017991|infants|infants
1436481|NCT01017991|formula|formula
1436482|NCT01017991|probiotic|probiotic
1436483|NCT01017991|crying|crying
1436484|NCT01017965|Type 1 diabetes|type 1 diabetes
1436485|NCT01017952|Safety|safety
1436486|NCT01017952|COPD|copd
1436487|NCT01017952|FEV1|fev1
1436488|NCT01017952|Efficacy|efficacy
1436489|NCT01017939|Prostate neoplasms|prostate neoplasms
1436490|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
1436491|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
1436492|NCT01017939|Prostate cancer|prostate cancer
1436493|NCT01017939|Abiraterone acetate|abiraterone acetate
1436494|NCT01017939|CB7630|cb7630
1436495|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
1436496|NCT01017913|rehabilitation|rehabilitation
1436497|NCT01017913|electrotherapy|electrotherapy
1436498|NCT01017913|back pain|back pain
1436499|NCT01017900|surgery|surgery
1436500|NCT01017900|manual rupture|manual rupture
1436501|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
1436502|NCT01017887|laparoscopy|laparoscopy
1436503|NCT01017887|airseal|airseal
1436504|NCT01017887|carbon dioxide|carbon dioxide
1436505|NCT01017887|insufflation|insufflation
1436506|NCT01017887|pneumoperitoneum|pneumoperitoneum
1436507|NCT01017861|Temporal summation|temporal summation
1436508|NCT01017861|Venipuncture pain|venipuncture pain
1436509|NCT01017848|diabetes|diabetes
1436510|NCT01017848|urine pH|urine ph
1436511|NCT01017848|insulin resistance|insulin resistance
1436512|NCT01017848|metabolic syndrome|metabolic syndrome
1436513|NCT01017848|development of diabetes|development of diabetes
1436514|NCT01017835|statins|statins
1436515|NCT01017835|isolated hypertension|isolated hypertension
1436516|NCT01017835|atherosclerosis|atherosclerosis
1436517|NCT01017835|lipid profile|lipid profile
1436518|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1436519|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
1436520|NCT01017809|ovarian|ovarian
1436521|NCT01017809|chemotherapy|chemotherapy
1436522|NCT01017809|nausea|nausea
1436523|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
1436524|NCT01017770|Uncomplicated malaria|uncomplicated malaria
1436525|NCT01017757|Interstitial lung disease|interstitial lung disease
1436526|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
1436527|NCT01017757|Renal transplant|renal transplant
1436528|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
1436529|NCT01017744|Anaconda®|anaconda®
1436530|NCT01017744|Sevoflurane|sevoflurane
1436531|NCT01017744|Remifentanil|remifentanil
1436532|NCT01017744|Sedation|sedation
1436533|NCT01017744|Pressure support ventilation|pressure support ventilation
1436534|NCT01017744|Work of breathing|work of breathing
1436535|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
1436536|NCT01017744|Ventilatory dead space|ventilatory dead space
1436537|NCT01017744|Intensive care|intensive care
1436538|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
1436539|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
1436540|NCT01017744|No more in acute state|no more in acute state
1436541|NCT01017744|No respiratory distress|no respiratory distress
1436542|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
1436543|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
1436544|NCT01017731|Advanced Solid tumor|advanced solid tumor
1436545|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
1436546|NCT01017731|QTc|qtc
1436547|NCT01017731|Metastatic|metastatic
1436548|NCT01017731|Malignant|malignant
1436549|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
1436550|NCT01017718|nerve conduction velocity|nerve conduction velocity
1436551|NCT01017718|Young score|young score
1436552|NCT01017718|long term vascular complications|long term vascular complications
1436553|NCT01017666|Healthy Volunteer|healthy volunteer
1436554|NCT01017653|Panitumumab|panitumumab
1436555|NCT01017653|Vectibix|vectibix
1436556|NCT01017653|Irinotecan|irinotecan
1436557|NCT01017653|CPT-11|cpt-11
1436558|NCT01017653|Camptosar|camptosar
1436559|NCT01017653|Malignant glioma|malignant glioma
1436560|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
1436561|NCT01017653|Gliosarcoma|gliosarcoma
1436562|NCT01017653|Duke|duke
1436563|NCT01017653|Vredenburgh|vredenburgh
1436564|NCT01017653|Pro00015447|pro00015447
1436565|NCT01017627|ESRD|esrd
1436566|NCT01017627|Anemia|anemia
1436567|NCT01017627|Hospitalizations|hospitalizations
1436568|NCT01017627|Mortality|mortality
1436569|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
1436570|NCT01017614|Iron deficiency|iron deficiency
1436571|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
1436572|NCT01017614|Anaemia|anaemia
1436573|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1436574|NCT01017588|lumbar support|lumbar support
1436575|NCT01017588|rubber tapper|rubber tapper
1436576|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
1436577|NCT01017549|Stage I|stage i
1436578|NCT01017549|Stage II|stage ii
1436579|NCT01017549|Breast|breast
1436580|NCT01017549|Cancer|cancer
1436581|NCT01017536|HIV|hiv
1436582|NCT01017536|Tuberculosis|tuberculosis
1436583|NCT01017536|Vaccine|vaccine
1436584|NCT01017523|diabetes|diabetes
1436585|NCT01017523|relationship|relationship
1436586|NCT01017523|social support|social support
1436587|NCT01017523|telemedicine|telemedicine
1436588|NCT01017497|Brain Metastases|brain metastases
1436589|NCT01017484|blood pressure|blood pressure
1436590|NCT01017484|DASH diet|dash diet
1436591|NCT01017484|hypertension|hypertension
1436592|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
1436594|NCT01017471|PSU retractor|psu retractor
1436595|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
1436596|NCT01017458|Healthy Adults|healthy adults
1436597|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
1436598|NCT01017419|hearing aids|hearing aids
1436599|NCT01017419|counseling|counseling
1436600|NCT01017406|plantar fasciitis|plantar fasciitis
1436601|NCT01017406|heel cushion|heel cushion
1436602|NCT01017406|treatment|treatment
1436603|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
1436604|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
1436605|NCT01017380|preemptive analgesia|preemptive analgesia
1436606|NCT01017380|cruciate ligament|cruciate ligament
1436607|NCT01017367|RA|ra
1436608|NCT01017367|inflammatory joint disease|inflammatory joint disease
1436609|NCT01017354|vitamin D|vitamin d
1436610|NCT01017354|function|function
1436611|NCT01017354|falls|falls
1436612|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
1436613|NCT01017354|disability|disability
1436614|NCT01017341|hip fracture|hip fracture
1436615|NCT01017341|back support|back support
1436616|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
1436617|NCT01017315|baby talcum|baby talcum
1436618|NCT01017315|pruritus|pruritus
1436619|NCT01017315|cast|cast
1436620|NCT01017276|Hyperphosphatemia|hyperphosphatemia
1436621|NCT01017276|Peritoneal dialysis|peritoneal dialysis
1436622|NCT01017276|CKD|ckd
1436623|NCT01017276|ASP1585|asp1585
1436624|NCT01017263|ADHD|adhd
1436625|NCT01017263|Glucose Intolerance|glucose intolerance
1436626|NCT01017263|Obesity|obesity
1436627|NCT01017263|Vyvanse|vyvanse
1436628|NCT01017250|Recurrent|recurrent
1436629|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
1436630|NCT01017237|Oral surgery sedation|oral surgery sedation
1436631|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
1436632|NCT01017211|Pain|pain
1436633|NCT01017211|Electromyography|electromyography
1436634|NCT01017211|Acupuncture|acupuncture
1436635|NCT01017211|Randomized controlled trial|randomized controlled trial
1436636|NCT01017211|Rehabilitation|rehabilitation
1436637|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
1436638|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
1436639|NCT01017146|Ance|ance
1436640|NCT01017120|Acne|acne
1436641|NCT01017107|acute pancreatitis|acute pancreatitis
1436642|NCT01017107|treatment|treatment
1436643|NCT01017107|organ failure|organ failure
1436644|NCT01017107|activated protein c|activated protein c
1436645|NCT01017094|Pin-site infection|pin-site infection
1436646|NCT01017094|silversulfadiazine|silversulfadiazine
1436647|NCT01017094|open fracture|open fracture
1436648|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
1436649|NCT01017081|physiotherapy|physiotherapy
1436650|NCT01017081|children|children
1436651|NCT01017081|clinical trial|clinical trial
1436652|NCT01017068|GLAUCOMA|glaucoma
1436653|NCT01017042|healthy|healthy
1436654|NCT01017042|blood levels|blood levels
1436655|NCT01017003|healthy|healthy
1436656|NCT01017003|pharmacokinetics|pharmacokinetics
1436657|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1436658|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1436659|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1436660|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1436661|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1436662|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1436663|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1436664|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1568400|NCT00505999|Risk Factors|risk factors
1436665|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1436666|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1436667|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1436668|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1436669|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1436670|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1436671|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1436672|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1436673|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1436674|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1436675|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1436676|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1436677|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1436678|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
1436679|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
1436680|NCT01016964|Hair Loss|hair loss
1436681|NCT01016964|Female Pattern Baldness|female pattern baldness
1436682|NCT01016951|Phase I|phase i
1436683|NCT01016951|Safety study|safety study
1436684|NCT01016951|AZD9164|azd9164
1436685|NCT01016925|femoral perineural catheter|femoral perineural catheter
1436686|NCT01016925|tunnelization|tunnelization
1436687|NCT01016925|complication|complication
1436688|NCT01016925|colonization|colonization
1436689|NCT01016925|infection|infection
1436690|NCT01016899|Electronic|electronic
1436691|NCT01016899|Brachytherapy|brachytherapy
1436692|NCT01016899|Nonmelanoma|nonmelanoma
1436693|NCT01016899|cancer|cancer
1436694|NCT01016886|trastuzumab|trastuzumab
1436695|NCT01016886|cardiac MRI|cardiac mri
1436696|NCT01016886|beta-blocker|beta-blocker
1436697|NCT01016886|biomarkers|biomarkers
1436698|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1436699|NCT01016886|cardiotoxicity|cardiotoxicity
1436700|NCT01016886|HER2 positive|her2 positive
1436701|NCT01016873|Oraya|oraya
1436702|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
1436703|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
1436704|NCT01016873|radiotherapy|radiotherapy
1436705|NCT01016873|IRay|iray
1436706|NCT01016873|Ranibizumab|ranibizumab
1436707|NCT01016873|Lucentis|lucentis
1436708|NCT01016873|AMD|amd
1436709|NCT01016873|Macular Degeneration|macular degeneration
1436710|NCT01016873|xray|xray
1436711|NCT01016873|radiation|radiation
1436712|NCT01016873|x ray|x ray
1436713|NCT01016873|external beam radiation|external beam radiation
1436714|NCT01016873|radiosurgery|radiosurgery
1436715|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
1436716|NCT01016834|migraine|migraine
1436717|NCT01016834|treatment satisfaction|treatment satisfaction
1436718|NCT01016821|Oxycodone|oxycodone
1436719|NCT01016821|Labour pain|labour pain
1436720|NCT01016821|Pregnancy|pregnancy
1436721|NCT01016821|Pregnant women|pregnant women
1436722|NCT01016808|Bunionectomy|bunionectomy
1436723|NCT01016808|Opioids|opioids
1436724|NCT01016795|SCF|scf
1436725|NCT01016795|Priming|priming
1436726|NCT01016795|Mobilization|mobilization
1436727|NCT01016795|Lymphoma|lymphoma
1436728|NCT01016795|Clinical Trial|clinical trial
1436729|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
1436730|NCT01016782|Rosacea|rosacea
1436731|NCT01016769|Paclitaxel|paclitaxel
1436732|NCT01016769|Carboplatin|carboplatin
1436733|NCT01016769|Temsirolimus|temsirolimus
1436734|NCT01016769|Head and Neck|head and neck
1436735|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
1436736|NCT01016769|09-131|09-131
1436737|NCT01016756|PHACE syndrome|phace syndrome
1436738|NCT01016756|Hemangioma|hemangioma
1436739|NCT01016756|Coarctation of aorta|coarctation of aorta
1436740|NCT01016756|Dandy Walker|dandy walker
1436741|NCT01016756|Brain malformation|brain malformation
1436742|NCT01016756|Eye anomaly|eye anomaly
1436743|NCT01016756|Sternal malformation|sternal malformation
1436744|NCT01016756|Genetic analysis|genetic analysis
1436745|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
1436746|NCT01016743|parkinson|parkinson
1436747|NCT01016743|rTMS|rtms
1436748|NCT01016717|clopidogrel|clopidogrel
1436749|NCT01016717|platelet function|platelet function
1436750|NCT01016717|omeprazole|omeprazole
1436751|NCT01016717|pantoprazole|pantoprazole
1436752|NCT01016717|coronary disease|coronary disease
1436753|NCT01016665|Breast cancer|breast cancer
1436754|NCT01016665|Short Term|short term
1436755|NCT01016665|Homontherapy|homontherapy
1436756|NCT01016665|aromatase inhibitor|aromatase inhibitor
1436757|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
1436758|NCT01016639|Stomach cancer|stomach cancer
1436759|NCT01016639|Gall bladder cancer|gall bladder cancer
1436760|NCT01016639|Bile ductus cancer|bile ductus cancer
1436761|NCT01016639|Pancreas cancer|pancreas cancer
1436762|NCT01016639|Colorectal cancer|colorectal cancer
1436763|NCT01016639|Chemo radiotherapy|chemo radiotherapy
1436764|NCT01016639|Phase I-II|phase i-ii
1436765|NCT01016639|Oxaliplatin|oxaliplatin
1436766|NCT01016639|Capecitabine|capecitabine
1436767|NCT01016639|Response|response
1436768|NCT01016626|Pharmacokinetics|pharmacokinetics
1436769|NCT01016626|Healthy volunteers|healthy volunteers
1436770|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
1436771|NCT01016613|chronic kidney disease|chronic kidney disease
1436772|NCT01016613|glomerulonephritis|glomerulonephritis
1436773|NCT01016613|proteinuria|proteinuria
1436774|NCT01016613|nephrotic syndrome|nephrotic syndrome
1436775|NCT01016613|nephropathy|nephropathy
1436776|NCT01016613|biobank|biobank
1436777|NCT01016587|symptoms|symptoms
1436778|NCT01016587|dyspnea|dyspnea
1436779|NCT01016587|pain|pain
1436780|NCT01016587|fatigue|fatigue
1436781|NCT01016587|anxiety|anxiety
1436782|NCT01016587|depression|depression
1436783|NCT01016587|sleeplessness|sleeplessness
1436784|NCT01016587|genetic markers|genetic markers
1436785|NCT01016587|immune markers|immune markers
1436786|NCT01016587|COPD|copd
1436787|NCT01016587|Quality of Life|quality of life
1436788|NCT01016548|Lymphoma|lymphoma
1436789|NCT01016548|Multiple myeloma|multiple myeloma
1436790|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1436791|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
1436792|NCT01016548|Influenza Vaccines|influenza vaccines
1436793|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
1436794|NCT01016535|Family Health Program|family health program
1436795|NCT01016535|Hygiene|hygiene
1436796|NCT01016535|Child Health|child health
1436798|NCT01016522|Ketogenic Diet|ketogenic diet
1436799|NCT01016509|restenosis|restenosis
1436800|NCT01016509|insulin|insulin
1436801|NCT01016509|hyperglycemia|hyperglycemia
1436802|NCT01016496|Cerebral Palsy|cerebral palsy
1436803|NCT01016496|Mirror neurons|mirror neurons
1436804|NCT01016496|hemiplegia|hemiplegia
1436805|NCT01016496|action observation therapy|action observation therapy
1436806|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
1436807|NCT01016483|MEK inhibitor|mek inhibitor
1436808|NCT01016483|cancer|cancer
1436809|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1436810|NCT01016483|metastatic|metastatic
1436811|NCT01016483|chemo-naive|chemo-naive
1436812|NCT01016483|phase II|phase ii
1436813|NCT01016457|Diabetes Mellitus|diabetes mellitus
1436814|NCT01016444|asthma|asthma
1436815|NCT01016444|albuterol|albuterol
1436816|NCT01016444|B2AR receptors|b2ar receptors
1436817|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
1436818|NCT01016431|cardiac pacing|cardiac pacing
1436819|NCT01016431|heart failure|heart failure
1436820|NCT01016431|oxygen consumption|oxygen consumption
1436821|NCT01016431|ventricular dysfunction|ventricular dysfunction
1436822|NCT01016431|left, exercise tolerance|left, exercise tolerance
1436823|NCT01016431|chronotropic incompetence|chronotropic incompetence
1436824|NCT01016431|pacemaker programming|pacemaker programming
1436825|NCT01016418|NASH|nash
1436826|NCT01016418|fatty liver disease|fatty liver disease
1436827|NCT01016418|colostrum|colostrum
1436828|NCT01016405|Dry eye|dry eye
1436829|NCT01016405|incidence and severity|incidence and severity
1436830|NCT01016405|cataract surgery|cataract surgery
1436831|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
1436832|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1436833|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1436834|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
1436835|NCT01016366|FRDA|frda
1436836|NCT01016366|Neurodegenerative|neurodegenerative
1436837|NCT01016366|Erythropoietin|erythropoietin
1436838|NCT01016366|Carbamylated|carbamylated
1436839|NCT01016366|Neuroprotection|neuroprotection
1436840|NCT01016366|Frataxin|frataxin
1436841|NCT01016353|ABThera|abthera
1436842|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
1436843|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
1436845|NCT01016327|Phase I study|phase i study
1436846|NCT01016327|Advanced Solid Tumors|advanced solid tumors
1436847|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
1436848|NCT01016288|EUS-FNA|eus-fna
1436849|NCT01016288|22 Gauge Needle|22 gauge needle
1436850|NCT01016288|25 Gauge Needle|25 gauge needle
1436851|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
1436852|NCT01016262|Ulcerative proctitis|ulcerative proctitis
1436853|NCT01016262|Proctocolitis|proctocolitis
1436854|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
1436855|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
1436856|NCT01016262|Colonic Diseases|colonic diseases
1436857|NCT01016262|Mesalamine|mesalamine
1436858|NCT01016262|5-ASA|5-asa
1436859|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
1436860|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
1436861|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
1436862|NCT01016223|Beclomethasone|beclomethasone
1436863|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
1436864|NCT01016210|pregnancy|pregnancy
1436865|NCT01016210|IVF|ivf
1436866|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
1436867|NCT01016184|Quality of life|quality of life
1436868|NCT01016158|Umbilical cord serum|umbilical cord serum
1436869|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
1436870|NCT01016145|Schizophrenia|schizophrenia
1436871|NCT01016145|predictors of response|predictors of response
1436872|NCT01016145|antipsychotics|antipsychotics
1436873|NCT01016145|18-45 years old|18-45 years old
1436874|NCT01016145|non-refractory|non-refractory
1436875|NCT01016106|eczema|eczema
1436876|NCT01016106|atopic dermatitis|atopic dermatitis
1436877|NCT01016106|dry skin|dry skin
1436878|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
1436879|NCT01016093|Thalassemia|thalassemia
1436880|NCT01016093|BMT|bmt
1436881|NCT01016093|HSCT|hsct
1436882|NCT01016080|glutathione|glutathione
1436883|NCT01016080|melanin|melanin
1436884|NCT01016080|whitening|whitening
1436885|NCT01016080|UV spots|uv spots
1436886|NCT01016080|skin pigment|skin pigment
1436887|NCT01016067|Tibia|tibia
1436888|NCT01016067|Tibial|tibial
1436889|NCT01016067|Fracture|fracture
1436890|NCT01016067|Nonunion|nonunion
1436891|NCT01016067|delayed|delayed
1436892|NCT01016067|healing|healing
1436893|NCT01016067|iliac|iliac
1436894|NCT01016067|crest|crest
1436895|NCT01016067|autograft|autograft
1436896|NCT01016067|INFUSE|infuse
1436897|NCT01016067|MASTERGRAFT|mastergraft
1436898|NCT01016067|Fixation|fixation
1436899|NCT01016067|Internal|internal
1436900|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
1436901|NCT01016054|Combination Drug Therapy|combination drug therapy
1436902|NCT01016054|pharmacokinetics|pharmacokinetics
1436903|NCT01016054|safety|safety
1436904|NCT01016054|Ovarian|ovarian
1436905|NCT01016041|drug-eluting stent|drug-eluting stent
1436906|NCT01016041|stable angina|stable angina
1436907|NCT01016041|ACS|acs
1436908|NCT01016041|MACE|mace
1436909|NCT01016041|safety|safety
1436910|NCT01016041|stent thrombosis|stent thrombosis
1436911|NCT01016028|Cancer|cancer
1436912|NCT01016028|Colorectum Cancer|colorectum cancer
1436913|NCT01016028|Colorectal disease|colorectal disease
1436914|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
1436915|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1436916|NCT01016028|CIPN|cipn
1436917|NCT01016028|Pain|pain
1436918|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
1436919|NCT01016028|QST|qst
1436920|NCT01016028|symptom measurement tools|symptom measurement tools
1436921|NCT01016028|platinum agents|platinum agents
1436922|NCT01016028|cisplatin|cisplatin
1436923|NCT01016028|oxaliplatin|oxaliplatin
1436924|NCT01016028|taxanes|taxanes
1436925|NCT01016028|bortezomib|bortezomib
1436926|NCT01015989|HIV treatment|hiv treatment
1436927|NCT01015989|ART adherence|art adherence
1436928|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
1436929|NCT01015989|CARE+|care+
1436930|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
1436931|NCT01015976|Gastric Bypass|gastric bypass
1436932|NCT01015976|Sertraline|sertraline
1436933|NCT01015976|Pharmacokinetics|pharmacokinetics
1436934|NCT01015963|recurrent breast cancer|recurrent breast cancer
1436935|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
1436936|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
1436937|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
1436938|NCT01015963|stage IV breast cancer|stage iv breast cancer
1436939|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1436940|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
1436941|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1436942|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1436943|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1436944|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1436945|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
1436946|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
1436947|NCT01015963|stage III bladder cancer|stage iii bladder cancer
1436948|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1436949|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1436950|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1436951|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1436952|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1436953|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1436954|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1436955|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1436956|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1436957|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1436958|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1436959|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1436960|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1436961|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1436962|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1436963|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1436964|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1436965|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1436966|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1436967|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1437037|NCT01015846|low back|low back
1437038|NCT01015820|Pancreatic Cancer|pancreatic cancer
1436968|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1436969|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1436970|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1436971|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1436972|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1436973|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1436974|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1436975|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1436976|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1436977|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1436978|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1436979|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1436980|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1436981|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1436982|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1436983|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1436984|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1436985|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1436986|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1436987|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1436988|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1436989|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1436990|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1437112|NCT01015586|Affective disorder|affective disorder
1436991|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1436992|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1436993|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1436994|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1436995|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1436996|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1436997|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
1436998|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
1436999|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
1437000|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1437001|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1437002|NCT01015963|tongue cancer|tongue cancer
1437003|NCT01015937|diabetes|diabetes
1437004|NCT01015937|nephropathy|nephropathy
1437005|NCT01015937|turmeric|turmeric
1437006|NCT01015937|serum IL8|serum il8
1437007|NCT01015937|serum TGFb|serum tgfb
1437008|NCT01015937|serumINF|seruminf
1437009|NCT01015937|urinary IL8|urinary il8
1437010|NCT01015937|urine TGFb|urine tgfb
1437011|NCT01015924|clavicle|clavicle
1437012|NCT01015924|TEN|ten
1437013|NCT01015924|Plate osteosynthesis|plate osteosynthesis
1437014|NCT01015924|displaced|displaced
1437015|NCT01015924|ESIN|esin
1437016|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
1437017|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
1437018|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
1437019|NCT01015911|Antigens, CD70|antigens, cd70
1437020|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1437021|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
1437022|NCT01015911|Immunotherapy|immunotherapy
1437023|NCT01015911|Drug Therapy|drug therapy
1437024|NCT01015911|monomethylauristatin F|monomethylauristatin f
1437025|NCT01015898|basal cell carcinoma|basal cell carcinoma
1437026|NCT01015898|photodynamic therapy|photodynamic therapy
1437027|NCT01015898|photo chemotherapy|photo chemotherapy
1437028|NCT01015898|basal cell epithelioma|basal cell epithelioma
1437029|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
1437030|NCT01015872|CPAP|cpap
1437031|NCT01015872|prostanoids|prostanoids
1437032|NCT01015859|AV conduction|av conduction
1437033|NCT01015859|Atrial fibrillation|atrial fibrillation
1437034|NCT01015846|Core|core
1437035|NCT01015846|Redcord|redcord
1437036|NCT01015846|RUSI|rusi
1437039|NCT01015820|Duodenum|duodenum
1437040|NCT01015820|Spectroscopy|spectroscopy
1437041|NCT01015820|Fiberoptic probe|fiberoptic probe
1437042|NCT01015820|4D-ELF|4d-elf
1437043|NCT01015807|postoperative|postoperative
1437044|NCT01015807|hyperalgesia|hyperalgesia
1437045|NCT01015807|pain|pain
1437046|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
1437047|NCT01015807|TAP block|tap block
1437048|NCT01015807|cesarean section|cesarean section
1437049|NCT01015781|Tinnitus|tinnitus
1437050|NCT01015781|Counseling|counseling
1437051|NCT01015781|Education|education
1437052|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
1437053|NCT01015781|Triage|triage
1437054|NCT01015781|Evaluation studies|evaluation studies
1437055|NCT01015781|Quality of health care|quality of health care
1437056|NCT01015768|corneal staining|corneal staining
1437057|NCT01015768|barrier function|barrier function
1437058|NCT01015768|contact lenses|contact lenses
1437059|NCT01015768|contact lens care solutions|contact lens care solutions
1437060|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
1437061|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
1437062|NCT01015755|thirst intensity and distress|thirst intensity and distress
1437063|NCT01015755|predictors of thirst|predictors of thirst
1437064|NCT01015742|AML|aml
1437065|NCT01015742|ALL|all
1437066|NCT01015742|CML|cml
1437067|NCT01015729|Bioequivalence|bioequivalence
1437068|NCT01015729|ASA|asa
1437069|NCT01015729|Esomeprazole|esomeprazole
1437070|NCT01015729|peptic ulcer disease|peptic ulcer disease
1437071|NCT01015729|pH measurements|ph measurements
1437072|NCT01015716|Weight loss|weight loss
1437073|NCT01015716|Physical activity|physical activity
1437074|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
1437075|NCT01015703|Vaccine, hypertension|vaccine, hypertension
1437076|NCT01015690|unexplained infertility|unexplained infertility
1437077|NCT01015690|hCG|hcg
1437078|NCT01015690|early pregnancy loss|early pregnancy loss
1437079|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
1437080|NCT01015638|Healthy volunteers|healthy volunteers
1437081|NCT01015625|breast cancer|breast cancer
1437082|NCT01015625|ABCSG|abcsg
1437083|NCT01015625|POSYTIVE|posytive
1437084|NCT01015625|growth factor|growth factor
1437085|NCT01015625|median survival|median survival
1437086|NCT01015625|surgery on demand|surgery on demand
1437087|NCT01015625|surgical therapy|surgical therapy
1437088|NCT01015625|blood specimen|blood specimen
1437089|NCT01015625|tissue specimen|tissue specimen
1437090|NCT01015625|VEGF|vegf
1437091|NCT01015625|TGF|tgf
1437092|NCT01015625|circulating tumor cells|circulating tumor cells
1437093|NCT01015625|stem cells|stem cells
1437094|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
1437095|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
1437096|NCT01015599|Obesity prevention|obesity prevention
1437097|NCT01015599|after-school|after-school
1437098|NCT01015599|physical activity|physical activity
1437099|NCT01015599|fruit|fruit
1437100|NCT01015599|vegetable|vegetable
1437101|NCT01015599|children|children
1437102|NCT01015586|Alcohol|alcohol
1437103|NCT01015586|Bipolar Disorder|bipolar disorder
1437104|NCT01015586|Manic depression|manic depression
1437105|NCT01015586|Addiction|addiction
1437106|NCT01015586|Alcoholism|alcoholism
1437107|NCT01015586|Cognitive impairment|cognitive impairment
1437108|NCT01015586|Executive function|executive function
1437109|NCT01015586|Anxiety|anxiety
1437110|NCT01015586|Depression|depression
1437111|NCT01015586|Mania|mania
1437113|NCT01015586|Psychosis|psychosis
1437114|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
1437115|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
1437116|NCT01015586|California Verbal Learning Test|california verbal learning test
1437117|NCT01015586|Wisconsin Card Sort Test|wisconsin card sort test
1437118|NCT01015586|Stroop Color and Word Test|stroop color and word test
1437119|NCT01015586|Alcohol Stroop Test|alcohol stroop test
1437120|NCT01015586|Emotion Stroop Test|emotion stroop test
1437121|NCT01015586|Point Scoring Reaction Time Test|point scoring reaction time test
1437122|NCT01015586|Rey Osterrieth Complex Figure Test|rey osterrieth complex figure test
1437123|NCT01015586|Trail Making Test|trail making test
1437124|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
1437125|NCT01015586|Young Mania Rating Scale|young mania rating scale
1437126|NCT01015586|Timeline Follow Back|timeline follow back
1437127|NCT01015560|bone metastases|bone metastases
1437128|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1437129|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1437130|NCT01015547|polyarthritis|polyarthritis
1437131|NCT01015547|combination therapy|combination therapy
1437132|NCT01015547|biologic agents|biologic agents
1437133|NCT01015547|TNF antagonists|tnf antagonists
1437134|NCT01015547|infliximab|infliximab
1437135|NCT01015534|Brain metastases|brain metastases
1437136|NCT01015534|Temozolomide|temozolomide
1437137|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
1437138|NCT01015534|Phase II trial|phase ii trial
1437139|NCT01015521|breast cancer|breast cancer
1437140|NCT01015508|Weight loss and maintenance|weight loss and maintenance
1437141|NCT01015508|body composition|body composition
1437142|NCT01015508|energy expenditure|energy expenditure
1437143|NCT01015508|adipogenic capacity|adipogenic capacity
1437144|NCT01015508|physical activity|physical activity
1437145|NCT01015495|angioid streaks|angioid streaks
1437147|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
1437148|NCT01015482|Sunburn|sunburn
1437149|NCT01015482|Remifentanil|remifentanil
1437150|NCT01015482|Hyperalgesia|hyperalgesia
1437151|NCT01015469|bariatric|bariatric
1437152|NCT01015469|surgery|surgery
1437153|NCT01015469|obesity|obesity
1437154|NCT01015469|Roux-en-Y|roux-en-y
1437155|NCT01015469|gastric|gastric
1437156|NCT01015469|medical device|medical device
1437157|NCT01015469|bypass|bypass
1437158|NCT01015469|adiposity|adiposity
1437159|NCT01015469|GaBP-Ring|gabp-ring
1437160|NCT01015469|BMI|bmi
1437161|NCT01015469|banded|banded
1437162|NCT01015469|laparoscopic|laparoscopic
1437163|NCT01015456|lupus nephritis|lupus nephritis
1437164|NCT01015456|mycophenolate sodium|mycophenolate sodium
1437165|NCT01015456|cyclophosphamide|cyclophosphamide
1437166|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
1437167|NCT01015443|Tecemotide|tecemotide
1437168|NCT01015443|L-BLP25|l-blp25
1437169|NCT01015443|Cyclophosphamide|cyclophosphamide
1437170|NCT01015443|placebo controlled|placebo controlled
1437171|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
1437172|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
1437173|NCT01015417|Cholecystectomy|cholecystectomy
1437174|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
1437175|NCT01015417|Surgical site infection|surgical site infection
1437176|NCT01015417|Remote surgical site infection|remote surgical site infection
1437177|NCT01015404|Trafermin|trafermin
1437178|NCT01015404|Periodontitis|periodontitis
1437179|NCT01015391|T2|t2
1437180|NCT01015391|AZA|aza
1437181|NCT01015391|remission|remission
1437182|NCT01015391|Crohn's disease|crohn's disease
1437183|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
1437184|NCT01015378|diverticulitis|diverticulitis
1437185|NCT01015378|Colon|colon
1437186|NCT01015378|sigmoid|sigmoid
1437187|NCT01015378|recurrence|recurrence
1437188|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
1437189|NCT01015365|Fast-track|fast-track
1437190|NCT01015365|One-stage cementless revision|one-stage cementless revision
1437191|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
1437192|NCT01015326|EGFRI|egfri
1437193|NCT01015326|HRQL|hrql
1437194|NCT01015326|Quality of Life|quality of life
1437195|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
1437196|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
1437197|NCT01015300|Hemangioblastoma|hemangioblastoma
1437198|NCT01015300|Von Hippel Lindau|von hippel lindau
1437199|NCT01015300|VHL|vhl
1437200|NCT01015300|lesion|lesion
1437201|NCT01015300|EGFR|egfr
1437202|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
1437203|NCT01015287|Heart Disease|heart disease
1437204|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
1437205|NCT01015287|P2Y12|p2y12
1437206|NCT01015287|NSTEMI|nstemi
1437207|NCT01015261|ALL|all
1437208|NCT01015261|BMT|bmt
1437209|NCT01015261|Chemotherapy|chemotherapy
1437210|NCT01015261|Allogenic|allogenic
1437211|NCT01015248|CD 20 positive|cd 20 positive
1437212|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
1437213|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
1437214|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
1437215|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
1437216|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
1437217|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
1437218|NCT01015222|Advanced Malignancies|advanced malignancies
1437219|NCT01015222|Metastatic cancer|metastatic cancer
1437220|NCT01015222|Bevacizumab|bevacizumab
1437221|NCT01015222|Avastin|avastin
1437222|NCT01015222|Dasatinib|dasatinib
1437223|NCT01015222|Sprycel|sprycel
1437224|NCT01015222|Paclitaxel|paclitaxel
1437225|NCT01015222|Taxol|taxol
1437226|NCT01015209|Dry eye syndromes|dry eye syndromes
1437227|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
1437228|NCT01015183|Mucositis|mucositis
1437229|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
1437230|NCT01015183|BMT|bmt
1437231|NCT01015183|HSCT|hsct
1437232|NCT01015170|smoking cessation|smoking cessation
1437233|NCT01015170|nicotine addiction|nicotine addiction
1437234|NCT01015170|Zyban|zyban
1437235|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
1437236|NCT01015157|Gastric bypass|gastric bypass
1437237|NCT01015157|staple line reinforcement|staple line reinforcement
1437238|NCT01015157|outcomes|outcomes
1437239|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
1437240|NCT01015144|atorvastatin|atorvastatin
1437241|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
1437242|NCT01015144|heart failure|heart failure
1437243|NCT01015144|inflammation|inflammation
1437244|NCT01015105|patients with hip fracture|patients with hip fracture
1437245|NCT01015092|HIV|hiv
1437246|NCT01015092|Cardiovascular|cardiovascular
1437247|NCT01015092|Coronary hear disease|coronary hear disease
1437248|NCT01015092|HAART|haart
1437249|NCT01015092|antiretroviral|antiretroviral
1437250|NCT01015079|Pap smear screening|pap smear screening
1437251|NCT01015066|drug dependence|drug dependence
1437252|NCT01015066|substance abuse|substance abuse
1437253|NCT01015066|substance use disorders|substance use disorders
1437254|NCT01015066|buprenorphine|buprenorphine
1437255|NCT01015066|naltrexone|naltrexone
1437256|NCT01015066|adolescents|adolescents
1437257|NCT01015053|postoperative pain|postoperative pain
1437258|NCT01015053|pediatric|pediatric
1437259|NCT01015053|umbilical hernia|umbilical hernia
1437260|NCT01015053|ropivacaine|ropivacaine
1437261|NCT01015053|rectus sheath block|rectus sheath block
1437262|NCT01015053|regional block|regional block
1437263|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
1437264|NCT01015053|local infiltration|local infiltration
1437265|NCT01015053|ambulatory surgery|ambulatory surgery
1437266|NCT01015040|solifenacin succinate|solifenacin succinate
1437267|NCT01015040|VESIcare|vesicare
1437268|NCT01015040|Healthy Volunteers|healthy volunteers
1437269|NCT01015014|Gram negative|gram negative
1437270|NCT01015014|bacteria|bacteria
1437271|NCT01015014|infection|infection
1437272|NCT01015001|refractory schizophrenia|refractory schizophrenia
1437273|NCT01015001|rTMS|rtms
1437274|NCT01015001|auditory hallucinations|auditory hallucinations
1437275|NCT01014988|pandemic|pandemic
1437276|NCT01014988|seasonal influenza|seasonal influenza
1437277|NCT01014988|Influenza B virus|influenza b virus
1437278|NCT01014988|H1N1|h1n1
1437279|NCT01014988|zanamivir|zanamivir
1437280|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
1437281|NCT01014988|Relenza|relenza
1437282|NCT01014988|influenza|influenza
1437283|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
1437284|NCT01014975|stroke|stroke
1437285|NCT01014975|plasmin|plasmin
1437286|NCT01014975|thrombus|thrombus
1437287|NCT01014975|ischemic|ischemic
1437288|NCT01014975|middle cerebral artery|middle cerebral artery
1437289|NCT01014975|thrombolysis|thrombolysis
1437290|NCT01014975|intra-arterial|intra-arterial
1437291|NCT01014975|fibrin|fibrin
1437292|NCT01014962|Pharmacokinetic|pharmacokinetic
1437293|NCT01014962|tolerability|tolerability
1437294|NCT01014962|multiple escalating doses|multiple escalating doses
1437295|NCT01014936|Phase 1|phase 1
1437296|NCT01014936|advanced solid tumors|advanced solid tumors
1437297|NCT01014936|refractory to standard therapy|refractory to standard therapy
1437298|NCT01014923|motor vehicle|motor vehicle
1437299|NCT01014923|accidents, traffic|accidents, traffic
1437300|NCT01014923|prevention and control|prevention and control
1437301|NCT01014910|Bronchiolitis|bronchiolitis
1437302|NCT01014910|Hypoxia|hypoxia
1437303|NCT01014910|Pulse|pulse
1437304|NCT01014910|Oximetry|oximetry
1437305|NCT01014910|Hospitalized|hospitalized
1437306|NCT01014897|stroke|stroke
1437307|NCT01014897|recovery|recovery
1437308|NCT01014897|tDCS|tdcs
1437309|NCT01014897|direct current|direct current
1437310|NCT01014897|electric stimulation|electric stimulation
1437311|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
1437312|NCT01014858|Parkinson's disease|parkinson's disease
1437313|NCT01014858|mild dementia|mild dementia
1437314|NCT01014858|donepezil|donepezil
1437315|NCT01014858|NIHR HTA|nihr hta
1437316|NCT01014845|hepatitis E|hepatitis e
1437317|NCT01014845|vaccine|vaccine
1437318|NCT01014845|efficacy|efficacy
1437319|NCT01014832|Diabetes, insulin.|diabetes, insulin.
1437320|NCT01014819|Dermacorder|dermacorder
1437321|NCT01014819|Electric field|electric field
1437322|NCT01014819|basal cell carcinoma|basal cell carcinoma
1437323|NCT01014819|Gorlin Syndrome|gorlin syndrome
1437324|NCT01014793|Acromegaly resistant|acromegaly resistant
1437325|NCT01014793|combined-treatment|combined-treatment
1437326|NCT01014793|dopamine agonist|dopamine agonist
1437327|NCT01014780|dry eye|dry eye
1437328|NCT01014780|tear film|tear film
1437329|NCT01014780|thickness|thickness
1437330|NCT01014780|artificial tears|artificial tears
1437331|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
1437332|NCT01014767|Brain Tumor|brain tumor
1437333|NCT01014767|Chemotherapy|chemotherapy
1437334|NCT01014767|Etoposide|etoposide
1437335|NCT01014767|Carboplatin|carboplatin
1437336|NCT01014767|Vincristine|vincristine
1437337|NCT01014767|Cyclophosphamide|cyclophosphamide
1437338|NCT01014767|Methotrexate|methotrexate
1437339|NCT01014767|Doxorubicin|doxorubicin
1437340|NCT01014767|Cisplatin|cisplatin
1437341|NCT01014767|Dactinomycin|dactinomycin
1437342|NCT01014767|temozolomide|temozolomide
1437343|NCT01014767|irinotecan|irinotecan
1437344|NCT01014767|Pediatrics|pediatrics
1437345|NCT01014741|Atrial Fibrillation|atrial fibrillation
1437346|NCT01014741|Catheter Ablation|catheter ablation
1437347|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
1437348|NCT01014715|Breast Cancer|breast cancer
1437349|NCT01014702|Cataract|cataract
1437350|NCT01014702|Capsulotomy|capsulotomy
1437351|NCT01014702|Capsulorrhexis|capsulorrhexis
1437352|NCT01014702|lens fragmentation|lens fragmentation
1437353|NCT01014702|phacoemulsification|phacoemulsification
1437354|NCT01014689|acne vulgaris|acne vulgaris
1437355|NCT01014676|Costs and Cost Analysis|costs and cost analysis
1437356|NCT01014663|Parkinson's disease|parkinson's disease
1437357|NCT01014663|exercise|exercise
1437358|NCT01014663|training program|training program
1437359|NCT01014663|rehabilitation|rehabilitation
1437360|NCT01014663|boxing|boxing
1437361|NCT01014650|glycine site partial agonist|glycine site partial agonist
1437362|NCT01014650|normal volunteers|normal volunteers
1437363|NCT01014650|safety in normal volunteers|safety in normal volunteers
1437364|NCT01014637|Dermatomycoses|dermatomycoses
1437365|NCT01014637|Infection|infection
1437366|NCT01014637|Mycoses|mycoses
1437367|NCT01014637|Nail diseases|nail diseases
1437368|NCT01014637|Ski diseases|ski diseases
1437369|NCT01014637|Skin diseases/infectious|skin diseases/infectious
1437370|NCT01014624|thienopyridine|thienopyridine
1437371|NCT01014624|pharmacologic action|pharmacologic action
1437372|NCT01014624|prasugrel|prasugrel
1437373|NCT01014624|clopidogrel|clopidogrel
1437374|NCT01014611|Heart failure|heart failure
1437375|NCT01014611|Skeletal muscle|skeletal muscle
1437376|NCT01014611|Calcium|calcium
1437377|NCT01014611|Ryanodine receptor|ryanodine receptor
1437378|NCT01014611|Mitochondria|mitochondria
1437379|NCT01014611|Exercise training|exercise training
1437380|NCT01014611|Muscle biopsy|muscle biopsy
1437381|NCT01014611|Healthy volunteers|healthy volunteers
1437382|NCT01014585|Milnacipran|milnacipran
1437383|NCT01014585|Pain|pain
1437384|NCT01014585|Durability of Effect|durability of effect
1437385|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
1437386|NCT01014585|Fatigue|fatigue
1437387|NCT01014585|Forest Research Institute|forest research institute
1437388|NCT01014585|Savella ®|savella ®
1437389|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
1437390|NCT01014572|Exercise|exercise
1437391|NCT01014572|Exercise Tolerance|exercise tolerance
1437392|NCT01014572|Aging|aging
1437393|NCT01014559|Constipation|constipation
1437394|NCT01014559|Oxycodone|oxycodone
1437395|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
1437396|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
1437397|NCT01014559|Naloxone|naloxone
1437398|NCT01014533|Alcoholism|alcoholism
1437399|NCT01014533|Alcohol dependence|alcohol dependence
1437400|NCT01014533|Insomnia|insomnia
1437401|NCT01014533|Dim light melatonin onset|dim light melatonin onset
1437402|NCT01014533|Gabapentin|gabapentin
1437403|NCT01014520|Lumbar|lumbar
1437404|NCT01014520|Diskectomy|diskectomy
1437405|NCT01014520|Laminectomy|laminectomy
1437406|NCT01014481|HIV|hiv
1437407|NCT01014481|tuberculosis|tuberculosis
1437408|NCT01014481|antiretroviral treatment|antiretroviral treatment
1437409|NCT01014481|timing|timing
1437410|NCT01014468|ranibizumab|ranibizumab
1437411|NCT01014468|bevacizumab|bevacizumab
1437412|NCT01014468|AMD|amd
1437413|NCT01014468|Complications|complications
1437414|NCT01014468|Visual acuity|visual acuity
1437415|NCT01014468|OCt|oct
1437416|NCT01014468|Age Macular Degeneration|age macular degeneration
1437417|NCT01014455|surgery|surgery
1437418|NCT01014429|Phase I dose escalation study|phase i dose escalation study
1437419|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
1437420|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
1437421|NCT01014429|Adult patients|adult patients
1437422|NCT01014416|Healthy Korean male|healthy korean male
1437423|NCT01014403|venous thromboembolism|venous thromboembolism
1437424|NCT01014403|enoxaparin|enoxaparin
1437425|NCT01014403|traumatic brain injury|traumatic brain injury
1437426|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
1437427|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
1437428|NCT01014364|Acute lung injury|acute lung injury
1437429|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
1437430|NCT01014364|corticosteroids|corticosteroids
1437431|NCT01014364|inflammation|inflammation
1437432|NCT01014351|Metastatic Melanoma|metastatic melanoma
1437433|NCT01014351|Everolimus|everolimus
1437434|NCT01014351|Paclitaxel|paclitaxel
1437435|NCT01014351|Carboplatin|carboplatin
1437436|NCT01014312|Depression|depression
1437437|NCT01014299|Intubation|intubation
1437438|NCT01014299|Hypoxemia|hypoxemia
1437439|NCT01014299|Mechanical ventilation|mechanical ventilation
1437440|NCT01014299|Recruitment maneuver|recruitment maneuver
1437441|NCT01014299|Acute lung injury|acute lung injury
1437442|NCT01014299|Bacterial translocation|bacterial translocation
1437443|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
1437444|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
1437445|NCT01014273|PCI|pci
1437446|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
1437447|NCT01014273|Radial Access|radial access
1437448|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
1437449|NCT01014247|Moxifloxacin|moxifloxacin
1437450|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
1437451|NCT01014234|Immune system regulation|immune system regulation
1437452|NCT01014234|Regulatory T cells|regulatory t cells
1437453|NCT01014234|Rapamycin|rapamycin
1437454|NCT01014234|Tolerance|tolerance
1437455|NCT01014221|acupuncture|acupuncture
1437456|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
1437457|NCT01014221|CTS|cts
1437458|NCT01014221|steroid|steroid
1437459|NCT01014221|global symptom score (GSS)|global symptom score (gss)
1437460|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
1437461|NCT01014208|GELTAMO|geltamo
1437462|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
1437463|NCT01014208|Genmab|genmab
1437464|NCT01014208|ofatumumab|ofatumumab
1437465|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
1437466|NCT01014208|Oncology|oncology
1437467|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
1437468|NCT01014208|Salvage chemotherapy|salvage chemotherapy
1437469|NCT01014208|refractory|refractory
1437470|NCT01014208|HOVON|hovon
1437471|NCT01014208|DVD|dvd
1437472|NCT01014208|relapsed|relapsed
1437473|NCT01014208|safety|safety
1437474|NCT01014208|efficacy|efficacy
1437475|NCT01014208|DHAP|dhap
1437476|NCT01014208|rituximab|rituximab
1437477|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
1437478|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
1437479|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
1437480|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
1437481|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1437482|NCT01014195|Neurocognitive function|neurocognitive function
1437483|NCT01014195|ADHD|adhd
1437484|NCT01014195|brain imaging|brain imaging
1437485|NCT01014195|genetic polymorphisms|genetic polymorphisms
1437486|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
1437487|NCT01014182|Early PCI|early pci
1437488|NCT01014182|Myocardial Infarction|myocardial infarction
1437489|NCT01014182|Thrombolysis|thrombolysis
1437490|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
1437491|NCT01014169|Health education|health education
1437492|NCT01014169|Sudden Infant Death|sudden infant death
1437493|NCT01014169|Breast Feeding|breast feeding
1437494|NCT01014169|Infant Equipment|infant equipment
1437495|NCT01014156|pulmonary embolism|pulmonary embolism
1437496|NCT01014156|vasoconstriction|vasoconstriction
1437597|NCT01013688|Radiofrequency ablation|radiofrequency ablation
1437497|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
1437498|NCT01014156|epoprostenol|epoprostenol
1437499|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
1437500|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
1437501|NCT01014130|Hypofractionated|hypofractionated
1437502|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
1437503|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
1437504|NCT01014104|Methylprednisolone|methylprednisolone
1437505|NCT01014104|IVF|ivf
1437506|NCT01014091|influenza infection|influenza infection
1437507|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1437508|NCT01014065|sunitinib|sunitinib
1437509|NCT01014065|cardiac MRI|cardiac mri
1437510|NCT01014065|maximal exercise testing|maximal exercise testing
1437511|NCT01014065|biomarkers|biomarkers
1437512|NCT01014065|pharmacokinetics|pharmacokinetics
1437513|NCT01014026|Mass Screening|mass screening
1437514|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
1437515|NCT01014026|Vaginal Smears|vaginal smears
1437516|NCT01013987|HIV-1|hiv-1
1437517|NCT01013987|triple class failure|triple class failure
1437518|NCT01013987|Maraviroc|maraviroc
1437519|NCT01013987|Raltegravir|raltegravir
1437520|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
1437521|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
1437522|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1437523|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
1437524|NCT01013961|CLL|cll
1437525|NCT01013961|elderly|elderly
1437526|NCT01013961|low dose rituximab|low dose rituximab
1437527|NCT01013961|alemtuzumab|alemtuzumab
1437528|NCT01013961|monoclonal antibodies|monoclonal antibodies
1437529|NCT01013948|Spirometry|spirometry
1437530|NCT01013948|Bronchitis|bronchitis
1437531|NCT01013948|COPD|copd
1437532|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1437533|NCT01013948|Emphysema|emphysema
1437534|NCT01013948|Chronic Bronchitis|chronic bronchitis
1437535|NCT01013935|HIV treatment|hiv treatment
1437536|NCT01013935|ART adherence|art adherence
1437537|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
1437538|NCT01013935|CARE+|care+
1437539|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
1437540|NCT01013922|COPD|copd
1437541|NCT01013922|COPD-6|copd-6
1437542|NCT01013922|Spirometry|spirometry
1437543|NCT01013922|VC|vc
1437544|NCT01013922|FEV|fev
1437545|NCT01013922|FEV1|fev1
1437546|NCT01013909|Bifonazole|bifonazole
1437547|NCT01013909|Terbinafine|terbinafine
1437548|NCT01013909|Reduced treatment duration|reduced treatment duration
1437549|NCT01013909|Efficacy|efficacy
1437550|NCT01013909|Safety|safety
1437551|NCT01013909|Athlete's foot|athlete's foot
1437552|NCT01013909|Moderate severity|moderate severity
1437553|NCT01013883|systolic dysfunction|systolic dysfunction
1437554|NCT01013883|diastolic dysfunction|diastolic dysfunction
1437555|NCT01013883|mortality|mortality
1437556|NCT01013883|treatment|treatment
1437557|NCT01013883|heart rate|heart rate
1437558|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
1437559|NCT01013870|post-concussion syndrome|post-concussion syndrome
1437560|NCT01013870|acute stress disorder|acute stress disorder
1437561|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
1437562|NCT01013870|atorvastatin|atorvastatin
1437563|NCT01013844|skin self-examination|skin self-examination
1437564|NCT01013844|SSE|sse
1437565|NCT01013844|melanoma|melanoma
1437566|NCT01013805|Rectal Cancer|rectal cancer
1437567|NCT01013805|Chemotherapy|chemotherapy
1437568|NCT01013805|Radiotherapy|radiotherapy
1437569|NCT01013792|Diabetic|diabetic
1437570|NCT01013792|Foot|foot
1437571|NCT01013792|Ulcer|ulcer
1437572|NCT01013792|Neuropathic|neuropathic
1437573|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
1437574|NCT01013792|DFU|dfu
1437575|NCT01013792|Wound Care|wound care
1437576|NCT01013792|PHI|phi
1437577|NCT01013779|Merkel Cell Cancer|merkel cell cancer
1437578|NCT01013779|PET scanning|pet scanning
1437579|NCT01013766|GSK1362885|gsk1362885
1437580|NCT01013766|Pharmacodynamics|pharmacodynamics
1437581|NCT01013766|Safety|safety
1437582|NCT01013766|Pharmacokinetics|pharmacokinetics
1437583|NCT01013766|T2DM|t2dm
1437584|NCT01013766|Tolerability|tolerability
1437585|NCT01013740|Neoplasms, Breast|neoplasms, breast
1437586|NCT01013727|Volunteers|volunteers
1437587|NCT01013727|healthy subjects|healthy subjects
1437588|NCT01013714|Sudden cardiac death|sudden cardiac death
1437589|NCT01013714|Ventricular tachycardia|ventricular tachycardia
1437590|NCT01013714|Ventricular fibrillation|ventricular fibrillation
1437591|NCT01013714|Cardiomyopathy|cardiomyopathy
1437592|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
1437593|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
1437594|NCT01013701|nasal polyps|nasal polyps
1437595|NCT01013701|nasal steroid|nasal steroid
1437596|NCT01013701|fluticasone furoate|fluticasone furoate
1437598|NCT01013688|Maze|maze
1437599|NCT01013688|Atrial fibrillation|atrial fibrillation
1437600|NCT01013675|influenza|influenza
1437601|NCT01013675|active-controlled|active-controlled
1437602|NCT01013675|Phase 2|phase 2
1437603|NCT01013662|septic shock|septic shock
1437604|NCT01013662|glycemic control|glycemic control
1437606|NCT01013662|lipid metabolism|lipid metabolism
1437607|NCT01013662|septic patients|septic patients
1437608|NCT01013623|melanoma|melanoma
1437609|NCT01013623|stage IV|stage iv
1437610|NCT01013623|resectable|resectable
1437611|NCT01013623|surgery|surgery
1437612|NCT01013623|medical therapy|medical therapy
1437613|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
1437614|NCT01013597|thyroid|thyroid
1437615|NCT01013597|medullary|medullary
1437616|NCT01013597|differentiated|differentiated
1437617|NCT01013597|radioiodine-resistant|radioiodine-resistant
1437618|NCT01013597|LBH589|lbh589
1437619|NCT01013597|panobinostat|panobinostat
1437620|NCT01013584|vitamin D|vitamin d
1437621|NCT01013558|fetal pain|fetal pain
1437622|NCT01013558|intrauterine|intrauterine
1437623|NCT01013558|needling|needling
1437624|NCT01013545|joint engagement|joint engagement
1437625|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
1437626|NCT01013545|enhanced milieu training|enhanced milieu training
1437627|NCT01013545|autism spectrum disorder|autism spectrum disorder
1437628|NCT01013545|language|language
1437629|NCT01013532|Ischemic Stroke|ischemic stroke
1437630|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
1437631|NCT01013532|Cilostazol|cilostazol
1437632|NCT01013532|Probucol|probucol
1437633|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1437634|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1437635|NCT01013506|stage IV breast cancer|stage iv breast cancer
1437636|NCT01013506|recurrent breast cancer|recurrent breast cancer
1437637|NCT01013493|breastfeeding|breastfeeding
1437638|NCT01013493|myopia|myopia
1437639|NCT01013493|nearsightedness|nearsightedness
1437640|NCT01013493|children|children
1437641|NCT01013480|Fragile X Syndrome|fragile x syndrome
1437642|NCT01013467|blood pressure|blood pressure
1437643|NCT01013467|control|control
1437644|NCT01013467|adherence|adherence
1437645|NCT01013467|behaviour|behaviour
1437646|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
1437647|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1437648|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
1437649|NCT01013415|HIV-1|hiv-1
1437650|NCT01013402|Hypoglycemia|hypoglycemia
1437651|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
1437652|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
1437653|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
1437654|NCT01013389|actifuse|actifuse
1437655|NCT01013389|INFUSE|infuse
1437656|NCT01013389|InductOs|inductos
1437658|NCT01013389|degenerative disk disease|degenerative disk disease
1437659|NCT01013389|PLIF|plif
1437660|NCT01013389|PITF|pitf
1437661|NCT01013389|PLF|plf
1437662|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
1437663|NCT01013389|Bone substitute|bone substitute
1437664|NCT01013389|bone graft|bone graft
1437665|NCT01013389|synthetic bone substitute|synthetic bone substitute
1437666|NCT01013363|abortion|abortion
1437667|NCT01013363|first trimester|first trimester
1437668|NCT01013363|suction aspiration|suction aspiration
1437669|NCT01013363|vacuum aspiration|vacuum aspiration
1437670|NCT01013363|music|music
1437671|NCT01013363|anesthesia|anesthesia
1437672|NCT01013363|analgesia|analgesia
1437673|NCT01013363|anxiolytic|anxiolytic
1437674|NCT01013363|pain|pain
1437675|NCT01013363|anxiety|anxiety
1437676|NCT01013363|blood pressure|blood pressure
1437677|NCT01013363|heart rate|heart rate
1437678|NCT01013363|satisfaction|satisfaction
1437679|NCT01013350|Multiple Sclerosis|multiple sclerosis
1437680|NCT01013350|Cladribine|cladribine
1437681|NCT01013350|PREMIERE|premiere
1437682|NCT01013350|Observational study|observational study
1437683|NCT01013324|endometrial cancer|endometrial cancer
1437684|NCT01013324|endometrial carcinoma|endometrial carcinoma
1437685|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
1437686|NCT01013324|cancer of the endometrium|cancer of the endometrium
1437687|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
1437688|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
1437689|NCT01013298|paratracheal insertion|paratracheal insertion
1437690|NCT01013298|tracheal injury|tracheal injury
1437691|NCT01013298|transtracheal needle|transtracheal needle
1437692|NCT01013298|ventilatory parameters|ventilatory parameters
1437693|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
1437694|NCT01013285|adult gliosarcoma|adult gliosarcoma
1437695|NCT01013285|adult glioblastoma|adult glioblastoma
1437696|NCT01013272|entecavir|entecavir
1437697|NCT01013272|lamivudine|lamivudine
1437698|NCT01013272|sequential therapy|sequential therapy
1437700|NCT01013259|Mutaflor|mutaflor
1437701|NCT01013259|grass pollen|grass pollen
1437702|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
1437703|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
1437704|NCT01013246|Video games|video games
1437705|NCT01013246|Energy balance|energy balance
1437706|NCT01013246|Metabolism|metabolism
1437707|NCT01013246|Appetite control|appetite control
1437708|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
1437709|NCT01013220|depression|depression
1437710|NCT01013220|depression care management|depression care management
1437711|NCT01013220|financing|financing
1437712|NCT01013220|absenteeism|absenteeism
1437713|NCT01013220|presenteeism|presenteeism
1437714|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
1437715|NCT01013207|CPAP compliance|cpap compliance
1437716|NCT01013194|Liver cirrhosis|liver cirrhosis
1437717|NCT01013194|Fetal stem cells|fetal stem cells
1437718|NCT01013194|Stem cell transplantation|stem cell transplantation
1437719|NCT01013194|Liver transplant candidate|liver transplant candidate
1437720|NCT01013181|Immune Thrombopenia|immune thrombopenia
1437721|NCT01013181|Thrombocytopenia|thrombocytopenia
1437722|NCT01013181|romiplostim|romiplostim
1437723|NCT01013181|compassionate program|compassionate program
1437724|NCT01013168|OncoSorb|oncosorb
1437725|NCT01013168|immune apheresis|immune apheresis
1437726|NCT01013168|sTNF-R1|stnf-r1
1437727|NCT01013168|sTNF-R2|stnf-r2
1437728|NCT01013168|sIL-2R|sil-2r
1437729|NCT01013168|TNF|tnf
1437730|NCT01013142|COPD|copd
1437731|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
1437732|NCT01013129|prostate cancer|prostate cancer
1437733|NCT01013090|Epidural anesthesia|epidural anesthesia
1437734|NCT01013090|Spinal anesthesia|spinal anesthesia
1437735|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
1437736|NCT01013090|Fluid therapy|fluid therapy
1437737|NCT01013090|Crystalloid|crystalloid
1437738|NCT01013090|Colloid|colloid
1437739|NCT01013077|functional vision|functional vision
1437740|NCT01013077|contrast sensitivity|contrast sensitivity
1437741|NCT01013077|aberrometry|aberrometry
1437742|NCT01013077|reading ability|reading ability
1437743|NCT01013064|Erythropoietin|erythropoietin
1437744|NCT01013064|Long acting|long acting
1437745|NCT01013064|EPO|epo
1437746|NCT01013051|obesity|obesity
1437747|NCT01013051|gastric bypass|gastric bypass
1437748|NCT01013051|metformin|metformin
1437749|NCT01013051|pharmacokinetics|pharmacokinetics
1437750|NCT01013051|absorption|absorption
1437751|NCT01013038|myocardial infarction|myocardial infarction
1437752|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
1437753|NCT01013038|thrombus aspiration|thrombus aspiration
1437754|NCT01013025|prostate cancer|prostate cancer
1437755|NCT01013025|implant retrieval|implant retrieval
1437756|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
1437757|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
1437758|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
1437759|NCT01012973|Macular Edema|macular edema
1437760|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
1437761|NCT01012973|CRVO|crvo
1437762|NCT01012973|VEGF Trap-Eye|vegf trap-eye
1437763|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
1437764|NCT01012960|methylnaltrexone|methylnaltrexone
1437765|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
1437766|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
1437767|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
1437768|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
1437769|NCT01012947|MMSE|mmse
1437770|NCT01012947|activity|activity
1437771|NCT01012921|GBR|gbr
1437772|NCT01012921|GTR|gtr
1437773|NCT01012921|Dental Implant surgery|dental implant surgery
1437774|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
1437775|NCT01012856|depressive episode|depressive episode
1437776|NCT01012856|psychotherapy|psychotherapy
1437777|NCT01012856|cognitive therapy|cognitive therapy
1437778|NCT01012856|emotional processing|emotional processing
1437779|NCT01012856|RCT|rct
1437780|NCT01012856|exposure|exposure
1437781|NCT01012856|dual process model|dual process model
1437782|NCT01012856|Implicit Association Test|implicit association test
1437783|NCT01012856|mechanism of change|mechanism of change
1437784|NCT01012843|Perianal|perianal
1437785|NCT01012843|Abscess|abscess
1437786|NCT01012843|Fistulae in ano|fistulae in ano
1437787|NCT01012843|Antibiotic|antibiotic
1437788|NCT01012843|Anorectal|anorectal
1437789|NCT01012830|Schizophrenia|schizophrenia
1437790|NCT01012830|Cognitive Disorders|cognitive disorders
1437791|NCT01012830|Dementia|dementia
1437792|NCT01012830|Huperzine A|huperzine a
1437793|NCT01012830|HupA|hupa
1437794|NCT01012804|stage IV colon cancer|stage iv colon cancer
1437795|NCT01012804|recurrent colon cancer|recurrent colon cancer
1437796|NCT01012791|Zumba exercise|zumba exercise
1437797|NCT01012791|ApoE|apoe
1437798|NCT01012778|Performance impairment|performance impairment
1437799|NCT01012778|Yoga|yoga
1437800|NCT01012778|Meditation|meditation
1437801|NCT01012778|Peer mediated|peer mediated
1437802|NCT01012765|COPD|copd
1437803|NCT01012765|indacaterol|indacaterol
1437804|NCT01012765|QAB149|qab149
1437805|NCT01012765|inspiratory capacity|inspiratory capacity
1437806|NCT01012739|asthma|asthma
1437807|NCT01012739|QAB149|qab149
1437808|NCT01012739|indacaterol|indacaterol
1437809|NCT01012739|pulmonary function|pulmonary function
1437810|NCT01012713|Psoriasis|psoriasis
1437811|NCT01012713|Excimer|excimer
1437812|NCT01012713|Laser|laser
1437813|NCT01012713|Clobex|clobex
1437814|NCT01012713|Vectical|vectical
1437815|NCT01012713|clobetasol spray|clobetasol spray
1437816|NCT01012713|calcitriol|calcitriol
1437817|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
1437818|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
1437819|NCT01012674|Contrast agent|contrast agent
1437821|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
1437822|NCT01012635|spinal cord injury|spinal cord injury
1437823|NCT01012635|chronic pain|chronic pain
1437824|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1437825|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
1437826|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
1437827|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
1437828|NCT01012609|External beam radiation therapy|external beam radiation therapy
1437829|NCT01012609|cetuximab|cetuximab
1437830|NCT01012609|irinotecan|irinotecan
1437831|NCT01012609|POETIC|poetic
1437832|NCT01012596|Natural Family Planning Methods|natural family planning methods
1437833|NCT01012596|Ovulation Detection|ovulation detection
1437834|NCT01012596|Cervix Mucus|cervix mucus
1437835|NCT01012596|Intention|intention
1437836|NCT01012596|Behavior|behavior
1437837|NCT01012596|Birth Control|birth control
1437838|NCT01012596|Contraception|contraception
1437839|NCT01012596|Pregnancy|pregnancy
1437840|NCT01012596|Fertility|fertility
1437841|NCT01012583|Optical coherence tomography|optical coherence tomography
1437842|NCT01012583|Drug eluting stent|drug eluting stent
1437843|NCT01012583|Biodegradable polymer|biodegradable polymer
1437844|NCT01012583|Intimal|intimal
1437845|NCT01012583|Coverage|coverage
1437846|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
1437847|NCT01012557|H1N1v|h1n1v
1437848|NCT01012557|vaccine|vaccine
1437849|NCT01012557|pregnant|pregnant
1437850|NCT01012557|women|women
1437851|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
1437852|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
1437853|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
1437854|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
1437979|NCT01011972|Tumor|tumor
1437980|NCT01011972|Phase 1|phase 1
1437855|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
1437856|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
1437857|NCT01012544|clopidogrel|clopidogrel
1437858|NCT01012544|pharmacokinetics|pharmacokinetics
1437859|NCT01012544|platelet function tests|platelet function tests
1437860|NCT01012544|platelet reactivity|platelet reactivity
1437861|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
1437862|NCT01012518|paratracheal insertion|paratracheal insertion
1437863|NCT01012518|tracheal injury|tracheal injury
1437864|NCT01012518|transtracheal needle|transtracheal needle
1437865|NCT01012518|ventilatory parameters|ventilatory parameters
1437866|NCT01012492|cancer|cancer
1437867|NCT01012492|leukemia|leukemia
1437868|NCT01012492|transplant|transplant
1437869|NCT01012492|bone marrow|bone marrow
1437870|NCT01012479|Blood Pressure|blood pressure
1437871|NCT01012479|Blood Pressure, High|blood pressure, high
1437872|NCT01012479|Drug Therapy|drug therapy
1437873|NCT01012466|pregnancy|pregnancy
1437874|NCT01012466|birth|birth
1437875|NCT01012466|labor|labor
1437876|NCT01012466|labor pain|labor pain
1437877|NCT01012466|catastrophizing|catastrophizing
1437878|NCT01012453|Hand eczema|hand eczema
1437879|NCT01012453|Hand dermatitis|hand dermatitis
1437880|NCT01012453|Occupational skin disease|occupational skin disease
1437881|NCT01012453|skindisease in health care workers|skindisease in health care workers
1437882|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
1437883|NCT01012453|occupational hand eczema|occupational hand eczema
1437884|NCT01012427|Kidney|kidney
1437885|NCT01012427|Cryoablation|cryoablation
1437886|NCT01012427|09-108|09-108
1437887|NCT01012414|Vitamin D|vitamin d
1437888|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1437889|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1437890|NCT01012401|Lung cancer|lung cancer
1437891|NCT01012401|Quality of life|quality of life
1437892|NCT01012401|Communication with physician|communication with physician
1437893|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
1437894|NCT01012375|Adult ADHD|adult adhd
1437895|NCT01012362|Solid tumor malignancy|solid tumor malignancy
1437896|NCT01012362|breast cancer|breast cancer
1437897|NCT01012362|lung cancer|lung cancer
1437898|NCT01012362|colon cancer|colon cancer
1437899|NCT01012362|pancreatic cancer|pancreatic cancer
1437900|NCT01012362|head and neck cancer|head and neck cancer
1437901|NCT01012362|kidney cancer|kidney cancer
1437902|NCT01012362|sarcoma|sarcoma
1437903|NCT01012362|hepatocellular cancer|hepatocellular cancer
1437904|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
1437905|NCT01012323|PID|pid
1437906|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
1437907|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
1437908|NCT01012284|Tuberculosis|tuberculosis
1437909|NCT01012284|TMC207|tmc207
1437910|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
1437911|NCT01012271|Wrist abnormalities|wrist abnormalities
1437912|NCT01012258|antitumor activity|antitumor activity
1437913|NCT01012258|safety|safety
1437914|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
1437915|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
1437916|NCT01012245|Xchange|xchange
1437917|NCT01012245|Xalatan|xalatan
1437918|NCT01012245|Xalacom|xalacom
1437919|NCT01012245|Betablocker|betablocker
1437920|NCT01012245|observational|observational
1437921|NCT01012245|longterm|longterm
1437922|NCT01012232|total knee arthroplasty|total knee arthroplasty
1437923|NCT01012232|postoperative pain|postoperative pain
1437924|NCT01012206|Children|children
1437925|NCT01012206|Overweight|overweight
1437926|NCT01012206|Obesity|obesity
1437927|NCT01012206|Food habits|food habits
1437928|NCT01012206|Dietary assessment|dietary assessment
1437929|NCT01012206|Physical activity|physical activity
1437930|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
1437931|NCT01012193|high-MD clopidogrel|high-md clopidogrel
1437932|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
1437933|NCT01012193|high risk patients|high risk patients
1437934|NCT01012180|Bipolar Disorder|bipolar disorder
1437935|NCT01012180|Adaptation|adaptation
1437936|NCT01012180|Parents|parents
1437937|NCT01012180|Risk|risk
1437938|NCT01012180|Coping|coping
1437939|NCT01012180|Survey|survey
1437940|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
1437941|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
1437942|NCT01012128|Temperature|temperature
1437943|NCT01012128|Preterm Infants|preterm infants
1437944|NCT01012115|Histones|histones
1437945|NCT01012115|organ failure|organ failure
1437946|NCT01012115|sepsis|sepsis
1437947|NCT01012102|EMD 640744|emd 640744
1437948|NCT01012102|Montanide|montanide
1437949|NCT01012102|Advanced solid tumours|advanced solid tumours
1437950|NCT01012089|Hemodialysis|hemodialysis
1437951|NCT01012089|Peritoneal dialysis|peritoneal dialysis
1437952|NCT01012089|Daptomycin|daptomycin
1437953|NCT01012089|Pharmacokinetics|pharmacokinetics
1437954|NCT01012076|maternal synchrony|maternal synchrony
1437955|NCT01012076|parent-child|parent-child
1437956|NCT01012076|parent child play|parent child play
1437957|NCT01012076|social communication|social communication
1437958|NCT01012063|iron|iron
1437959|NCT01012063|erythropoietin|erythropoietin
1437960|NCT01012063|hemoglobin|hemoglobin
1437961|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
1437962|NCT01012050|Asthma|asthma
1437963|NCT01012050|status asthmatics|status asthmatics
1437964|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1437965|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
1437966|NCT01011998|CML|cml
1437967|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
1437968|NCT01011998|INST 0901|inst 0901
1437969|NCT01011998|imatinib|imatinib
1437970|NCT01011998|valproic acid|valproic acid
1437971|NCT01011998|Gleevec|gleevec
1437972|NCT01011985|end stage renal disease|end stage renal disease
1437973|NCT01011985|inflammation|inflammation
1437974|NCT01011985|vascular access|vascular access
1437975|NCT01011985|hemodialysis|hemodialysis
1437976|NCT01011972|Dose escalation|dose escalation
1437977|NCT01011972|XMT-1107|xmt-1107
1437978|NCT01011972|1107|1107
1437981|NCT01011972|Fumagillol|fumagillol
1437982|NCT01011972|PHF|phf
1437983|NCT01011972|Fleximer|fleximer
1437984|NCT01011972|cancer|cancer
1437985|NCT01011972|maximum tolerated dose|maximum tolerated dose
1437986|NCT01011972|MTD|mtd
1437987|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
1437988|NCT01011894|Lenalidomide|lenalidomide
1437989|NCT01011894|CLL|cll
1437990|NCT01011894|09-045|09-045
1437991|NCT01011881|pleuritis|pleuritis
1437992|NCT01011881|empyema|empyema
1437993|NCT01011881|procalcitonin|procalcitonin
1437994|NCT01011829|methamphetamine|methamphetamine
1437995|NCT01011829|crystal meth|crystal meth
1437996|NCT01011829|addiction|addiction
1437997|NCT01011829|los angeles|los angeles
1437998|NCT01011829|medication|medication
1437999|NCT01011829|meth|meth
1438000|NCT01011816|intervertebral disk|intervertebral disk
1438001|NCT01011803|Deglutition|deglutition
1438002|NCT01011803|Phonation|phonation
1438003|NCT01011790|Healing Rhythms™|healing rhythms™
1438004|NCT01011790|Meditation|meditation
1438005|NCT01011790|Biofeedback|biofeedback
1438006|NCT01011790|Stress|stress
1438007|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
1438008|NCT01011777|urinary incontinence|urinary incontinence
1438009|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
1438010|NCT01011777|stem cells|stem cells
1438011|NCT01011764|social networks|social networks
1438012|NCT01011764|friendships|friendships
1438013|NCT01011764|autism spectrum disorder|autism spectrum disorder
1438014|NCT01011751|Drug Therapy|drug therapy
1438015|NCT01011712|Genetics|genetics
1438016|NCT01011712|Virus|virus
1438017|NCT01011712|Defense|defense
1438018|NCT01011712|Immune Defects|immune defects
1438019|NCT01011712|Respiratory Viruses|respiratory viruses
1438020|NCT01011712|Herpesvirus|herpesvirus
1438021|NCT01011712|Cytomegalovirus|cytomegalovirus
1438022|NCT01011712|Human Papillomavirus|human papillomavirus
1438023|NCT01011712|Adenovirus|adenovirus
1438024|NCT01011699|nicotinamide|nicotinamide
1438025|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
1438026|NCT01011699|phosphatemia|phosphatemia
1438027|NCT01011699|cinacalcet|cinacalcet
1438028|NCT01011699|dyslipidemia|dyslipidemia
1438029|NCT01011699|vascular calcification|vascular calcification
1438030|NCT01011699|bone mass loss|bone mass loss
1438031|NCT01011673|headache|headache
1438032|NCT01011673|tension-type headache|tension-type headache
1438033|NCT01011660|hypertension|hypertension
1438034|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
1438035|NCT01011660|drugs intervention|drugs intervention
1438036|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
1438037|NCT01011660|50-79 years of age|50-79 years of age
1438038|NCT01011660|sign|sign
1438039|NCT01011660|the informed|the informed
1438040|NCT01011660|consent|consent
1438041|NCT01011660|forms|forms
1438042|NCT01011634|abortion|abortion
1438043|NCT01011634|uterine aspiration|uterine aspiration
1438044|NCT01011634|pain control|pain control
1438045|NCT01011621|Prednisolone acetate|prednisolone acetate
1438046|NCT01011621|Betamethasone valerate|betamethasone valerate
1438047|NCT01011595|lung cancer|lung cancer
1438048|NCT01011595|mediastinoscopy|mediastinoscopy
1438049|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
1438050|NCT01011595|staging|staging
1438051|NCT01011595|EBUS|ebus
1438052|NCT01011595|EUS|eus
1438053|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
1438054|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
1438055|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
1438056|NCT01011569|difference|difference
1438057|NCT01011556|Age Related Osteoporosis|age related osteoporosis
1438058|NCT01011556|Senile Osteoporosis|senile osteoporosis
1438059|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
1438060|NCT01011543|negative sputum exam|negative sputum exam
1438061|NCT01011543|induced sputum|induced sputum
1438062|NCT01011543|endoscopy|endoscopy
1438063|NCT01011530|Melanoma|melanoma
1438064|NCT01011517|muscadine grapes|muscadine grapes
1438065|NCT01011517|endothelial function|endothelial function
1438066|NCT01011491|Obesity|obesity
1438067|NCT01011491|Weight loss|weight loss
1438068|NCT01011491|meal replacements|meal replacements
1438069|NCT01011491|inflammation|inflammation
1438070|NCT01011491|oxidative stress|oxidative stress
1438071|NCT01011491|visceral fat|visceral fat
1438072|NCT01011478|adenomatous polyp|adenomatous polyp
1438073|NCT01011478|stage I colon cancer|stage i colon cancer
1438074|NCT01011478|stage II colon cancer|stage ii colon cancer
1438075|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
1438076|NCT01011465|Stress|stress
1438077|NCT01011465|Oxytocin|oxytocin
1438078|NCT01011465|Social Support|social support
1438079|NCT01011465|Resilience|resilience
1438080|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
1438081|NCT01011452|Montelukast|montelukast
1438082|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
1438083|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
1438084|NCT01011426|laxative|laxative
1438085|NCT01011426|postoperative care|postoperative care
1438086|NCT01011426|ob-Gyn population|ob-gyn population
1438087|NCT01011426|post-operative patients|post-operative patients
1438088|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
1438090|NCT01011413|ART|art
1438091|NCT01011413|Efavirenz|efavirenz
1438092|NCT01011413|Dose reduction|dose reduction
1438093|NCT01011400|clitoris|clitoris
1438094|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
1438095|NCT01011374|Retinal vein occlusion|retinal vein occlusion
1438096|NCT01011374|Ranibizumab|ranibizumab
1438097|NCT01011374|Lucentis|lucentis
1438098|NCT01011374|Depression|depression
1438099|NCT01011348|Gulf War Illness|gulf war illness
1438100|NCT01011348|Coenzyme Q10|coenzyme q10
1438101|NCT01011348|Quality of Life|quality of life
1438102|NCT01011348|Fatigue|fatigue
1438103|NCT01011348|oxidative stress|oxidative stress
1438104|NCT01011335|Staphylococcus aureus|staphylococcus aureus
1438105|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
1438106|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1438107|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
1438108|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
1438109|NCT01011309|Leishmaniasis|leishmaniasis
1438110|NCT01011309|vaccine|vaccine
1438111|NCT01011309|immunotherapy|immunotherapy
1438112|NCT01011283|MDS|mds
1438113|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
1438114|NCT01011270|Back pain|back pain
1438115|NCT01011270|postural balance|postural balance
1438116|NCT01011270|RDM|rdm
1438117|NCT01011270|industrial operators|industrial operators
1438118|NCT01011257|CAD|cad
1438119|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
1438120|NCT01011231|recurrent glioma|recurrent glioma
1438121|NCT01011231|MRI|mri
1438122|NCT01011231|Spectroscopy|spectroscopy
1438222|NCT01010841|Phytochemical|phytochemical
1438223|NCT01010841|Hops|hops
1438123|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
1438124|NCT01011218|quality of life|quality of life
1438125|NCT01011205|Immunosuppression|immunosuppression
1438127|NCT01011205|Transplant|transplant
1438128|NCT01011205|Advagraf|advagraf
1438129|NCT01011192|Intravenous anesthesia|intravenous anesthesia
1438130|NCT01011192|propofol|propofol
1438131|NCT01011192|pharmacokinetic model|pharmacokinetic model
1438132|NCT01011192|Monitoring|monitoring
1438133|NCT01011192|bispectral index.|bispectral index.
1438134|NCT01011179|Teens Taking Charge|teens taking charge
1438135|NCT01011179|Managing Arthritis Online|managing arthritis online
1438136|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1438137|NCT01011179|internet|internet
1438138|NCT01011179|self-management|self-management
1438139|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
1438140|NCT01011166|HepC|hepc
1438141|NCT01011166|Hep C|hep c
1438142|NCT01011140|Parenteral Hydration|parenteral hydration
1438143|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
1438144|NCT01011140|ALCP|alcp
1438145|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
1438146|NCT01011140|SECPAL|secpal
1438147|NCT01011140|Online survey|online survey
1438148|NCT01011140|Palliative care|palliative care
1438149|NCT01011140|Physicians' attitudes|physicians' attitudes
1438150|NCT01011140|End of life|end of life
1438151|NCT01011140|Latin America|latin america
1438152|NCT01011140|Spain|spain
1438153|NCT01011127|Statins|statins
1438154|NCT01011127|Insulin resistance|insulin resistance
1438155|NCT01011114|hypophosphatemia|hypophosphatemia
1438156|NCT01011114|hyperparathyroidism|hyperparathyroidism
1438157|NCT01011114|renal transplant|renal transplant
1438158|NCT01011101|Saccadic Eye Movements|saccadic eye movements
1438159|NCT01011101|Schizophrenia|schizophrenia
1438160|NCT01011101|Healthy Volunteer|healthy volunteer
1438161|NCT01011101|HV|hv
1438162|NCT01011088|Paternity|paternity
1438163|NCT01011088|Psychology|psychology
1438164|NCT01011088|Risk factor|risk factor
1438165|NCT01011075|Lung cancer,|lung cancer,
1438166|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
1438167|NCT01011075|NSCLC|nsclc
1438168|NCT01011075|Metastatic|metastatic
1438169|NCT01011075|Gleevec|gleevec
1438170|NCT01011075|elderly|elderly
1438171|NCT01011062|Adipose tissue|adipose tissue
1438172|NCT01011062|Adipokines|adipokines
1438173|NCT01011049|Influenza|influenza
1438174|NCT01011049|Fluzone Vaccine|fluzone vaccine
1438175|NCT01011049|Intradermal Injections|intradermal injections
1438176|NCT01011049|Adults|adults
1438177|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
1438178|NCT01011023|Bowel anastomosis|bowel anastomosis
1438179|NCT01011023|nasogastric tube|nasogastric tube
1438180|NCT01011023|children|children
1438181|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1438182|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1438384|NCT01010178|COPD|copd
1438183|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1438184|NCT01010997|AMD, CNV|amd, cnv
1438185|NCT01010984|metastatic melanoma|metastatic melanoma
1438186|NCT01010984|stage IV melanoma|stage iv melanoma
1438187|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
1438188|NCT01010971|Mountain Cedar|mountain cedar
1438189|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
1438190|NCT01010945|erlotinib|erlotinib
1438191|NCT01010945|gemcitabine|gemcitabine
1438192|NCT01010945|nab-paclitaxel|nab-paclitaxel
1438193|NCT01010945|Adenocarcinoma|adenocarcinoma
1438194|NCT01010945|Phase 1b|phase 1b
1438195|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
1438196|NCT01010932|Contrast agent|contrast agent
1438197|NCT01010932|MRA|mra
1438198|NCT01010893|pandemic|pandemic
1438199|NCT01010893|prevention|prevention
1438200|NCT01010893|influenza|influenza
1438201|NCT01010893|infection|infection
1438202|NCT01010893|influenza vaccine|influenza vaccine
1438203|NCT01010893|vaccine|vaccine
1438204|NCT01010893|influenza in humans|influenza in humans
1438205|NCT01010880|Multiple Myeloma|multiple myeloma
1438206|NCT01010880|CXCR4|cxcr4
1438207|NCT01010880|Stem Cells|stem cells
1438208|NCT01010880|Mobilization|mobilization
1438209|NCT01010880|Transplantation|transplantation
1438210|NCT01010880|Chemotherapy|chemotherapy
1438211|NCT01010867|Probiotics|probiotics
1438212|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1438213|NCT01010867|Pediatrics|pediatrics
1438214|NCT01010854|breast cancer|breast cancer
1438215|NCT01010854|advanced|advanced
1438216|NCT01010854|local|local
1438217|NCT01010841|Metabolic syndrome|metabolic syndrome
1438218|NCT01010841|Serum lipid|serum lipid
1438219|NCT01010841|Dietary intervention|dietary intervention
1438220|NCT01010841|Lifestyle modification|lifestyle modification
1438221|NCT01010841|Glycemic load|glycemic load
1438224|NCT01010841|Acacia|acacia
1438225|NCT01010841|Mediterranean diet|mediterranean diet
1438226|NCT01010841|Kinase modulator|kinase modulator
1438227|NCT01010815|ulcerative colitis|ulcerative colitis
1438228|NCT01010815|gut microbiome|gut microbiome
1438229|NCT01010815|metagenomics|metagenomics
1438230|NCT01010802|Neuroprotection|neuroprotection
1438231|NCT01010802|Parkinson Disease|parkinson disease
1438232|NCT01010802|Erythropoietin|erythropoietin
1438233|NCT01010776|Schizophrenia|schizophrenia
1438234|NCT01010776|Paliperidone|paliperidone
1438235|NCT01010750|ADHD|adhd
1438236|NCT01010737|Multimeric|multimeric
1438237|NCT01010737|Vaccine|vaccine
1438238|NCT01010737|Influenza|influenza
1438239|NCT01010737|elderly|elderly
1438240|NCT01010737|phase 1/2|phase 1/2
1438241|NCT01010737|safety|safety
1438242|NCT01010737|efficacy|efficacy
1438243|NCT01010737|tolerability|tolerability
1438244|NCT01010737|reactogenicity|reactogenicity
1438245|NCT01010737|Montanide|montanide
1438246|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
1438247|NCT01010737|HAI|hai
1438248|NCT01010737|TIV|tiv
1438249|NCT01010711|migraine|migraine
1438250|NCT01010711|children|children
1438251|NCT01010711|dietary supplement|dietary supplement
1438252|NCT01010711|q10|q10
1438253|NCT01010711|prevention|prevention
1438254|NCT01010698|cimetidine|cimetidine
1438255|NCT01010698|acyclovir|acyclovir
1438256|NCT01010698|pharmacokinetics|pharmacokinetics
1438257|NCT01010698|excipient|excipient
1438258|NCT01010698|formulation|formulation
1438259|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
1438260|NCT01010685|Transgastric surgery|transgastric surgery
1438261|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
1438262|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
1438263|NCT01010646|hepatitis C|hepatitis c
1438264|NCT01010646|viral kinetics|viral kinetics
1438265|NCT01010646|antiviral response|antiviral response
1438266|NCT01010646|Genotype 1 or 4|genotype 1 or 4
1438267|NCT01010620|screening|screening
1438268|NCT01010620|research participation|research participation
1438269|NCT01010620|substance abuse|substance abuse
1438270|NCT01010620|Schizophrenia|schizophrenia
1438271|NCT01010620|nicotine|nicotine
1438272|NCT01010620|Healthy|healthy
1438273|NCT01010620|cigarettes|cigarettes
1438274|NCT01010620|smoking|smoking
1438275|NCT01010620|marijuana|marijuana
1438276|NCT01010620|cocaine|cocaine
1438277|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
1438278|NCT01010581|SC12267|sc12267
1438279|NCT01010581|4SC-101|4sc-101
1438280|NCT01010581|Methotrexate|methotrexate
1438281|NCT01010581|Phase II|phase ii
1438282|NCT01010568|CLL|cll
1438283|NCT01010568|SLL|sll
1438284|NCT01010568|Bendamustine|bendamustine
1438285|NCT01010568|Ofatumumab|ofatumumab
1438286|NCT01010542|Single dose psoriasis study|single dose psoriasis study
1438287|NCT01010529|Occupational Therapy|occupational therapy
1438288|NCT01010529|Parkinson's Disease|parkinson's disease
1438289|NCT01010529|Feasibility|feasibility
1438290|NCT01010529|Effectiveness|effectiveness
1438291|NCT01010529|RCT|rct
1438385|NCT01010178|Macrolid|macrolid
1438292|NCT01010529|Activities of daily living|activities of daily living
1438293|NCT01010529|Participation|participation
1438294|NCT01010529|Caregiver's Burden|caregiver's burden
1438295|NCT01010490|PACHYMETRY|pachymetry
1438296|NCT01010490|CELL LOSS|cell loss
1438297|NCT01010490|SAFETY|safety
1438298|NCT01010490|EFFICACY|efficacy
1438299|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
1438300|NCT01010490|Intraoperative complications|intraoperative complications
1438301|NCT01010490|CLOCK TIME|clock time
1438302|NCT01010490|FLUID USED|fluid used
1438303|NCT01010490|CORNEAL THICKNESS|corneal thickness
1438304|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
1438305|NCT01010477|smoking cessation|smoking cessation
1438306|NCT01010477|schizophrenia|schizophrenia
1438307|NCT01010477|nicotine nasal spray|nicotine nasal spray
1438308|NCT01010477|behavioral counseling|behavioral counseling
1438309|NCT01010464|Adhesions|adhesions
1438310|NCT01010464|Open abdomen|open abdomen
1438311|NCT01010464|Laparotomy|laparotomy
1438312|NCT01010451|pulpotomy|pulpotomy
1438313|NCT01010451|pulpectomy|pulpectomy
1438314|NCT01010451|primary teeth|primary teeth
1438315|NCT01010451|dental care for children|dental care for children
1438316|NCT01010438|sleep studies|sleep studies
1438317|NCT01010438|sleep apnea|sleep apnea
1438318|NCT01010438|OSA|osa
1438319|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
1438320|NCT01010412|Ultrasound|ultrasound
1438321|NCT01010412|Nerve blocks|nerve blocks
1438322|NCT01010412|Upper extremity|upper extremity
1438323|NCT01010399|HIV|hiv
1438324|NCT01010399|triglycerides|triglycerides
1438325|NCT01010399|fosamprenavir|fosamprenavir
1438326|NCT01010386|Pregnancy|pregnancy
1438327|NCT01010386|Infertility|infertility
1438328|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
1438329|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
1438422|NCT01009957|Renal disease progression|renal disease progression
1438330|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
1438331|NCT01010360|celiac ganglia|celiac ganglia
1438332|NCT01010347|fractures|fractures
1438333|NCT01010347|casting|casting
1438334|NCT01010347|splinting|splinting
1438335|NCT01010347|pediatrics|pediatrics
1438336|NCT01010334|INST 0813|inst 0813
1438337|NCT01010334|Standard of Care|standard of care
1438338|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
1438339|NCT01010308|infantile hemangioma|infantile hemangioma
1438340|NCT01010308|nadolol|nadolol
1438341|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
1438342|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
1438343|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
1438344|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
1438345|NCT01010243|multiple myeloma|multiple myeloma
1438346|NCT01010243|anti-inflammatory|anti-inflammatory
1438347|NCT01010243|relapsed|relapsed
1438348|NCT01010243|refractory|refractory
1438349|NCT01010243|progressive|progressive
1438350|NCT01010230|Childhood cancer survivors|childhood cancer survivors
1438351|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
1438352|NCT01010217|Blood Disorders|blood disorders
1438353|NCT01010217|Blood Cancer|blood cancer
1438354|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
1438355|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
1438356|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
1438357|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
1438358|NCT01010217|Aplastic anemia|aplastic anemia
1438359|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
1438360|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1438361|NCT01010217|Myeloproliferative disease|myeloproliferative disease
1438362|NCT01010217|Hodgkin's disease|hodgkin's disease
1438363|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1438364|NCT01010217|Multiple myeloma|multiple myeloma
1438365|NCT01010217|Cyclophosphamide|cyclophosphamide
1438366|NCT01010217|Fludarabine|fludarabine
1438367|NCT01010217|Melphalan|melphalan
1438368|NCT01010217|Mesna|mesna
1438369|NCT01010217|Rituximab|rituximab
1438370|NCT01010217|Tacrolimus|tacrolimus
1438371|NCT01010217|Prograf|prograf
1438372|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
1575617|NCT00480610|Adult|adult
1438373|NCT01010217|MMF|mmf
1438374|NCT01010217|CellCept|cellcept
1438375|NCT01010217|G-CSF|g-csf
1438376|NCT01010217|Filgrastim|filgrastim
1438377|NCT01010217|Neupogen|neupogen
1438378|NCT01010204|Varenicline|varenicline
1438379|NCT01010204|Chantix|chantix
1438380|NCT01010204|Smoking|smoking
1438381|NCT01010204|Bipolar Disorder|bipolar disorder
1438382|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
1438383|NCT01010191|no organic digestive disease|no organic digestive disease
1438386|NCT01010178|reversibility|reversibility
1438387|NCT01010178|Theophylline|theophylline
1438388|NCT01010178|Corticosteroids|corticosteroids
1438389|NCT01010178|symptoms PFT|symptoms pft
1438390|NCT01010165|acute arthritis|acute arthritis
1438391|NCT01010165|bacteria|bacteria
1438392|NCT01010165|crystal arthritis|crystal arthritis
1438393|NCT01010165|proteomic|proteomic
1438394|NCT01010165|SELDI-TOF|seldi-tof
1438395|NCT01010113|infants|infants
1438396|NCT01010113|prebiotics|prebiotics
1438397|NCT01010113|probiotics|probiotics
1438398|NCT01010113|safety|safety
1438399|NCT01010100|Metabolic Disease|metabolic disease
1438400|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
1438401|NCT01010087|patients admitted to ICU|patients admitted to icu
1438402|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
1438403|NCT01010048|ESWL|eswl
1438404|NCT01010048|urinary calculus|urinary calculus
1438405|NCT01010048|drugs treat|drugs treat
1438406|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
1438407|NCT01010035|dyslipidemia|dyslipidemia
1438408|NCT01010035|kinetics|kinetics
1438409|NCT01010022|hypovolemia|hypovolemia
1438410|NCT01010022|surgical blood loss|surgical blood loss
1438411|NCT01010022|orthopedic procedures|orthopedic procedures
1438412|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
1438413|NCT01010009|resveratrol|resveratrol
1438414|NCT01010009|cerebral blood flow|cerebral blood flow
1438415|NCT01010009|NIRS|nirs
1438416|NCT01010009|cognitive performance|cognitive performance
1438417|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
1438418|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
1438419|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1438420|NCT01009957|ADPKD|adpkd
1438421|NCT01009957|CKD|ckd
1438423|NCT01009957|Everolimus|everolimus
1438424|NCT01009944|High blood pressure|high blood pressure
1438425|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
1438426|NCT01009931|Relapsed AML|relapsed aml
1438427|NCT01009931|Refractory AML|refractory aml
1438428|NCT01009918|cardiac toxicity|cardiac toxicity
1438429|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
1438430|NCT01009918|recurrent breast cancer|recurrent breast cancer
1438431|NCT01009918|stage IA breast cancer|stage ia breast cancer
1438432|NCT01009918|stage IB breast cancer|stage ib breast cancer
1438433|NCT01009918|stage II breast cancer|stage ii breast cancer
1438434|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
1438435|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
1438436|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
1438437|NCT01009918|male breast cancer|male breast cancer
1438438|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
1438439|NCT01009879|B lymphocytes|b lymphocytes
1438440|NCT01009866|Malignant brain tumor|malignant brain tumor
1438441|NCT01009866|GBM|gbm
1438442|NCT01009866|recurrent brain tumor|recurrent brain tumor
1438443|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
1438444|NCT01009866|astrocytomas|astrocytomas
1438445|NCT01009866|ependymomas|ependymomas
1438446|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
1438447|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
1438448|NCT01009840|Multiple Myeloma|multiple myeloma
1438449|NCT01009840|Bone marrow transplant|bone marrow transplant
1438450|NCT01009840|Stem cell transplant|stem cell transplant
1438451|NCT01009840|Busulfan|busulfan
1438452|NCT01009840|Bortezomib|bortezomib
1438453|NCT01009827|Medication adherence|medication adherence
1438454|NCT01009827|Substance use|substance use
1438455|NCT01009827|Sexual risk behaviors|sexual risk behaviors
1438456|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
1438457|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1438458|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1438459|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1438460|NCT01009788|ABT-888|abt-888
1438461|NCT01009788|temozolomide|temozolomide
1438462|NCT01009788|TMZ|tmz
1438463|NCT01009775|Melanoma, Stage III|melanoma, stage iii
1438464|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
1438465|NCT01009775|YM 155|ym 155
1438466|NCT01009775|Metastatic Melanoma|metastatic melanoma
1438467|NCT01009762|VACCINE|vaccine
1438468|NCT01009762|THERAPY|therapy
1438469|NCT01009762|CELLULAR IMMUNITY|cellular immunity
1438470|NCT01009762|IMMUNITY|immunity
1438471|NCT01009749|HAART|haart
1438473|NCT01009749|Adherence|adherence
1438474|NCT01009736|stage I prostate cancer|stage i prostate cancer
1438475|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
1438476|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
1438477|NCT01009736|stage III prostate cancer|stage iii prostate cancer
1438478|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
1438479|NCT01009723|Preterm delivery|preterm delivery
1438480|NCT01009723|preterm labor|preterm labor
1438481|NCT01009723|maternal-fetal care|maternal-fetal care
1438482|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
1438483|NCT01009723|alphafetoprotein|alphafetoprotein
1438484|NCT01009723|AFP|afp
1438485|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
1438486|NCT01009723|hCG|hcg
1438487|NCT01009723|unconjugated estriol|unconjugated estriol
1438488|NCT01009723|Inhibin A|inhibin a
1438489|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
1438490|NCT01009723|PAPP-A|papp-a
1438491|NCT01009723|maternal screening|maternal screening
1438492|NCT01009684|Contraception|contraception
1438493|NCT01009684|Estradiol valerate|estradiol valerate
1438494|NCT01009671|knee osteoarthritis|knee osteoarthritis
1438495|NCT01009658|Gastrointestinal motility|gastrointestinal motility
1438496|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
1438497|NCT01009658|Gastric emptying|gastric emptying
1438498|NCT01009658|Sodium glutamate|sodium glutamate
1438499|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
1438500|NCT01009645|education|education
1438501|NCT01009645|vaccination|vaccination
1438502|NCT01009645|preventive service|preventive service
1438503|NCT01009645|Prevention & Control|prevention & control
1438504|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1438505|NCT01009619|Acute allograft Rejection|acute allograft rejection
1438506|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
1438507|NCT01009619|Respiratory infection|respiratory infection
1438508|NCT01009619|Survival|survival
1438509|NCT01009619|Mortality|mortality
1438510|NCT01009619|Pulmonary function|pulmonary function
1438511|NCT01009619|FEV1|fev1
1438512|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
1438513|NCT01009619|Neutrophils|neutrophils
1438514|NCT01009619|Interleukin|interleukin
1438515|NCT01009619|Culture|culture
1438516|NCT01009619|Azithromycin|azithromycin
1438517|NCT01009606|Out-of-hospital|out-of-hospital
1438518|NCT01009606|Emergency|emergency
1438519|NCT01009606|Cardiac arrest|cardiac arrest
1438520|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
1438521|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1438522|NCT01009593|Antineoplastic Agents|antineoplastic agents
1438523|NCT01009593|Growth Substances|growth substances
1438524|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
1438525|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
1438526|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
1438527|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
1438528|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
1438529|NCT01009593|Pharmacologic Actions|pharmacologic actions
1438530|NCT01009593|Growth Inhibitors|growth inhibitors
1438531|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
1438532|NCT01009593|Sorafenib|sorafenib
1438533|NCT01009567|OHSS|ohss
1438534|NCT01009554|Mouthwashes|mouthwashes
1438535|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
1438536|NCT01009528|Quality of care|quality of care
1438537|NCT01009528|General Practice|general practice
1438538|NCT01009528|Electronic Feedback System|electronic feedback system
1438539|NCT01009515|metastatic|metastatic
1438540|NCT01009515|melanoma|melanoma
1438541|NCT01009515|skin cancer|skin cancer
1438542|NCT01009515|paclitaxel|paclitaxel
1438543|NCT01009515|carboplatin|carboplatin
1438544|NCT01009515|temozolomide|temozolomide
1438545|NCT01009476|Dementia|dementia
1438546|NCT01009476|Galantamine|galantamine
1438547|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
1438548|NCT01009476|Nootropic agents|nootropic agents
1438549|NCT01009476|Alzheimer|alzheimer
1438550|NCT01009476|Vascular dementia|vascular dementia
1438551|NCT01009476|Cognitive symptoms|cognitive symptoms
1438552|NCT01009476|Behavioural symptoms|behavioural symptoms
1438553|NCT01009476|Care giving times|care giving times
1438554|NCT01009463|COPD|copd
1438555|NCT01009463|Safety|safety
1438556|NCT01009463|FEV1|fev1
1438557|NCT01009463|Efficacy|efficacy
1438558|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
1438559|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
1438560|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
1438561|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1438562|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
1438563|NCT01009437|stage I breast cancer|stage i breast cancer
1438564|NCT01009437|stage II breast cancer|stage ii breast cancer
1438565|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
1438566|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
1438567|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
1438568|NCT01009437|stage IV breast cancer|stage iv breast cancer
1438569|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1438570|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
1438571|NCT01009398|Regional anesthesia|regional anesthesia
1438572|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
1438573|NCT01009398|Catheter location|catheter location
1438574|NCT01009385|cervical|cervical
1438575|NCT01009385|epidural|epidural
1438576|NCT01009385|epidural pressure|epidural pressure
1438577|NCT01009385|monitoring|monitoring
1438578|NCT01009372|surgeon's physiology|surgeon's physiology
1438579|NCT01009372|stress response|stress response
1438580|NCT01009372|break scheme|break scheme
1438581|NCT01009359|Alzheimers disease|alzheimers disease
1438582|NCT01009359|Diagnostic imaging|diagnostic imaging
1438583|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
1438584|NCT01009359|PET tracer|pet tracer
1438585|NCT01009333|urgency frequency|urgency frequency
1438586|NCT01009333|urinary urge incontinence|urinary urge incontinence
1438587|NCT01009333|InterStim Therapy|interstim therapy
1438588|NCT01009320|Pacemaker|pacemaker
1438589|NCT01009320|Magnets|magnets
1438590|NCT01009320|Drape|drape
1438591|NCT01009320|Ferrite|ferrite
1438592|NCT01009320|Magnetic field|magnetic field
1438593|NCT01009320|Pacemaker interference|pacemaker interference
1438594|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1438595|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
1438596|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1438597|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1438598|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
1438599|NCT01009307|adult ependymoma|adult ependymoma
1438600|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1438601|NCT01009307|adult subependymoma|adult subependymoma
1438602|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1438603|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
1438604|NCT01009307|adult brain stem glioma|adult brain stem glioma
1438605|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
1438606|NCT01009307|adult glioblastoma|adult glioblastoma
1438607|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
1438608|NCT01009307|adult gliosarcoma|adult gliosarcoma
1438609|NCT01009307|adult mixed glioma|adult mixed glioma
1438610|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1438611|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
1438612|NCT01009307|adult medulloblastoma|adult medulloblastoma
1438613|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1438614|NCT01009307|adult pineoblastoma|adult pineoblastoma
1438615|NCT01009307|adult pineocytoma|adult pineocytoma
1438616|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
1438617|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
1438618|NCT01009294|Nonsense mutation|nonsense mutation
1438619|NCT01009294|Premature stop codon|premature stop codon
1438621|NCT01009294|BMD|bmd
1438622|NCT01009294|Ataluren|ataluren
1438623|NCT01009294|PTC124|ptc124
1438624|NCT01009281|Crohn's Disease|crohn's disease
1438625|NCT01009281|Crohns|crohns
1438626|NCT01009281|Bowel disease|bowel disease
1438627|NCT01009281|digestive disorders|digestive disorders
1438628|NCT01009281|auto immune|auto immune
1438629|NCT01009281|diarrhea|diarrhea
1438630|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1438631|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
1438632|NCT01009281|digestive system diseases|digestive system diseases
1438633|NCT01009281|Antibody|antibody
1438634|NCT01009281|IL 17|il 17
1438635|NCT01009281|anti IL-17|anti il-17
1438636|NCT01009281|monoclonal antibody|monoclonal antibody
1438637|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
1438638|NCT01009255|Alzheimer's disease|alzheimer's disease
1438639|NCT01009255|placebo controlled|placebo controlled
1438640|NCT01009255|randomised|randomised
1438641|NCT01009255|Histamine|histamine
1438642|NCT01009255|H3 Antagonist|h3 antagonist
1438643|NCT01009255|double blind|double blind
1438644|NCT01009255|Cognition|cognition
1438645|NCT01009242|CDP6038|cdp6038
1438646|NCT01009216|Pharmacokinetics|pharmacokinetics
1438647|NCT01009216|Pharmacology|pharmacology
1438648|NCT01009216|Drug Safety|drug safety
1438649|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
1438650|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
1438651|NCT01009203|head|head
1438652|NCT01009203|neck|neck
1438653|NCT01009203|aerodigestive|aerodigestive
1438654|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
1438655|NCT01009177|Melanoma|melanoma
1438656|NCT01009177|Metastatic|metastatic
1438657|NCT01009177|DTIC|dtic
1438658|NCT01009177|Bosentan|bosentan
1438659|NCT01009151|telemonitoring|telemonitoring
1438660|NCT01009151|internet|internet
1438661|NCT01009151|home monitoring system|home monitoring system
1438662|NCT01009151|heart failure|heart failure
1438663|NCT01009151|self management plan|self management plan
1438664|NCT01009151|web portal|web portal
1438665|NCT01009138|Subthreshold Depression|subthreshold depression
1438666|NCT01009138|Diabetes-related Distress|diabetes-related distress
1438667|NCT01009138|Minor Depression|minor depression
1438668|NCT01009138|Light affective Disorder|light affective disorder
1438669|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
1438670|NCT01009138|Diabetes mellitus|diabetes mellitus
1438671|NCT01009138|Late Complications|late complications
1438672|NCT01009138|Markers of Inflammation|markers of inflammation
1438673|NCT01009125|questionnaires|questionnaires
1438674|NCT01009125|health care surveys/methods|health care surveys/methods
1438675|NCT01009125|motivation|motivation
1438676|NCT01009125|living donors|living donors
1438677|NCT01009125|living kidney donation|living kidney donation
1438678|NCT01009112|Sleep|sleep
1438679|NCT01009112|Sleep Disorder|sleep disorder
1438680|NCT01009112|Veterans|veterans
1438681|NCT01009112|Active Duty|active duty
1438682|NCT01009112|OEF|oef
1438683|NCT01009112|OIF|oif
1438684|NCT01009112|PTSD|ptsd
1438685|NCT01009099|pulmonary disease|pulmonary disease
1438686|NCT01009099|COPD|copd
1438687|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
1438688|NCT01009086|Ustekinumab|ustekinumab
1438689|NCT01009086|CNTO 1275|cnto 1275
1438690|NCT01009086|Stelara|stelara
1438691|NCT01009086|Psoriasis|psoriasis
1438692|NCT01009060|H3 Antagonist|h3 antagonist
1438693|NCT01009060|Schizophrenia|schizophrenia
1438694|NCT01009060|double blind|double blind
1438695|NCT01009060|Histamine|histamine
1438696|NCT01009060|randomised|randomised
1438697|NCT01009060|placebo controlled|placebo controlled
1438698|NCT01009060|Cognition|cognition
1438699|NCT01009047|Schizophrenia|schizophrenia
1438700|NCT01009047|Paliperidone|paliperidone
1438701|NCT01009047|Aripiprazole|aripiprazole
1438702|NCT01009021|pain|pain
1438703|NCT01009021|retinal photocoagulation|retinal photocoagulation
1438704|NCT01009021|potassium diclofenac|potassium diclofenac
1438705|NCT01009008|cancer|cancer
1438706|NCT01009008|breast cancer|breast cancer
1438707|NCT01009008|mastectomy|mastectomy
1438708|NCT01009008|breast reconstruction|breast reconstruction
1438709|NCT01009008|reconstruction|reconstruction
1438710|NCT01009008|tissue expansion|tissue expansion
1438711|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
1438712|NCT01009008|tissue expander|tissue expander
1438713|NCT01009008|AeroForm|aeroform
1438714|NCT01009008|AirXpander|airxpander
1438715|NCT01008995|psoriasis|psoriasis
1438716|NCT01008995|asian patients|asian patients
1438717|NCT01008995|Chinese|chinese
1438718|NCT01008995|ustekinumab|ustekinumab
1438719|NCT01008995|CNTO 1275|cnto 1275
1438720|NCT01008995|Stelara|stelara
1438721|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
1438722|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
1438723|NCT01008969|Prostate|prostate
1438724|NCT01008969|SPECT/CT|spect/ct
1438725|NCT01008956|Influenza|influenza
1438726|NCT01008956|H1N1|h1n1
1438727|NCT01008956|Pandemic|pandemic
1438728|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1438729|NCT01008930|Peripheral Tumors|peripheral tumors
1438730|NCT01008930|Arm|arm
1438731|NCT01008930|Leg|leg
1438732|NCT01008930|Head|head
1438733|NCT01008930|Neck|neck
1438734|NCT01008930|HR PET Imaging System|hr pet imaging system
1438735|NCT01008930|High-Resolution PET|high-resolution pet
1438736|NCT01008930|PET/CT|pet/ct
1438737|NCT01008930|PEMFlex Solo II|pemflex solo ii
1438738|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
1438739|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
1438740|NCT01008917|HCC|hcc
1438741|NCT01008917|Liver cancer|liver cancer
1438742|NCT01008917|Hepatoma|hepatoma
1438743|NCT01008904|cancer survivor|cancer survivor
1438744|NCT01008904|hot flashes|hot flashes
1438745|NCT01008904|breast cancer|breast cancer
1438746|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1438747|NCT01008891|arthritis|arthritis
1438748|NCT01008891|ankle pain|ankle pain
1438749|NCT01008891|foot pain|foot pain
1438750|NCT01008891|hindfoot fracture|hindfoot fracture
1438751|NCT01008891|ankle fracture|ankle fracture
1438752|NCT01008891|rheumatoid arthritis|rheumatoid arthritis
1438753|NCT01008891|arthrosis|arthrosis
1438754|NCT01008891|Foot/Hindfoot Fusion|foot/hindfoot fusion
1576138|NCT00478647|human|human
1438755|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
1438756|NCT01008852|seropositive|seropositive
1438757|NCT01008852|methotrexate|methotrexate
1438758|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
1438759|NCT01008826|sulforaphane|sulforaphane
1438760|NCT01008826|pharmacokinetics|pharmacokinetics
1438761|NCT01008813|HIV infection|hiv infection
1438762|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
1438763|NCT01008813|immunogenicity|immunogenicity
1438764|NCT01008813|safety|safety
1438765|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
1438766|NCT01008800|language|language
1438767|NCT01008800|social|social
1438768|NCT01008800|toddlers|toddlers
1438769|NCT01008787|Cancer Prevention|cancer prevention
1438770|NCT01008787|Focus Group|focus group
1438771|NCT01008787|Interview|interview
1438772|NCT01008787|Physical Activity|physical activity
1438773|NCT01008787|African American women|african american women
1438774|NCT01008787|Exercise|exercise
1438775|NCT01008787|Exercise habits|exercise habits
1438776|NCT01008787|Health behavior|health behavior
1438777|NCT01008761|Pre-school child|pre-school child
1438778|NCT01008761|Wheezy episode|wheezy episode
1438779|NCT01008748|Smoking|smoking
1438780|NCT01008748|Latinos|latinos
1438781|NCT01008748|Mexican American|mexican american
1438782|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
1438783|NCT01008748|Ecological momentary assessment|ecological momentary assessment
1438784|NCT01008748|Nicotine patch|nicotine patch
1438785|NCT01008748|Smoking cessation counseling|smoking cessation counseling
1438786|NCT01008748|Questionnaire|questionnaire
1438787|NCT01008748|EMA|ema
1438788|NCT01008722|Atrial Fibrillation|atrial fibrillation
1438789|NCT01008722|Ablation|ablation
1438790|NCT01008696|Reflux esophagitis|reflux esophagitis
1438791|NCT01008696|Rabeprazole|rabeprazole
1438792|NCT01008696|Lansoprazole|lansoprazole
1438793|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
1438794|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
1438795|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
1438796|NCT01008657|Recurrence|recurrence
1438797|NCT01008644|carbon dioxide|carbon dioxide
1438798|NCT01008644|ventilation|ventilation
1438799|NCT01008644|gender|gender
1438800|NCT01008644|osmolality|osmolality
1438801|NCT01008644|menstruation cycle|menstruation cycle
1438802|NCT01008631|renal failure|renal failure
1438803|NCT01008631|sodium Thiosulfate|sodium thiosulfate
1438804|NCT01008631|pharmakokinetic|pharmakokinetic
1438805|NCT01008618|Chronic pain|chronic pain
1438806|NCT01008618|Osteoarthritis|osteoarthritis
1438807|NCT01008618|Low back pain|low back pain
1438808|NCT01008618|Fentanyl|fentanyl
1438809|NCT01008618|JNS020QD|jns020qd
1438810|NCT01008618|Patch, transdermal|patch, transdermal
1438811|NCT01008618|Opioid analgesics|opioid analgesics
1438812|NCT01008605|Erectile Dysfunction|erectile dysfunction
1438813|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
1438814|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
1438815|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
1438816|NCT01008579|falls|falls
1438817|NCT01008579|older adults|older adults
1438818|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
1438819|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
1438820|NCT01008553|Postoperative Pain|postoperative pain
1438821|NCT01008553|Fentanyl|fentanyl
1438822|NCT01008553|Patch, transdermal|patch, transdermal
1438823|NCT01008553|Opioid analgesics|opioid analgesics
1438824|NCT01008540|cytomegalovirus|cytomegalovirus
1438825|NCT01008540|resistance|resistance
1438826|NCT01008540|transplantation|transplantation
1438827|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
1438828|NCT01008527|skin|skin
1438829|NCT01008527|cutaneous|cutaneous
1438830|NCT01008527|immunotherapy|immunotherapy
1438831|NCT01008527|immunology|immunology
1438832|NCT01008527|dose escalation|dose escalation
1438833|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1438834|NCT01008514|stage IA breast cancer|stage ia breast cancer
1438835|NCT01008514|stage IB breast cancer|stage ib breast cancer
1438836|NCT01008514|stage II breast cancer|stage ii breast cancer
1438837|NCT01008501|hydatidiform moles|hydatidiform moles
1438838|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
1438839|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
1438840|NCT01008501|Molar pregnancy|molar pregnancy
1438841|NCT01008501|NLRP7|nlrp7
1438842|NCT01008501|pregnancy wastage|pregnancy wastage
1438843|NCT01008501|imprinting|imprinting
1438844|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
1438845|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
1438846|NCT01008488|colonic diverticulitis|colonic diverticulitis
1438847|NCT01008488|diverticular disease|diverticular disease
1438848|NCT01008488|antibiotic therapy|antibiotic therapy
1438849|NCT01008475|EMD 525797|emd 525797
1438850|NCT01008475|Cetuximab|cetuximab
1438851|NCT01008475|Irinotecan|irinotecan
1438852|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
1438853|NCT01008449|Staples|staples
1438854|NCT01008449|Sutures|sutures
1438855|NCT01008449|Cesarean Delivery|cesarean delivery
1438856|NCT01008449|Wound|wound
1438857|NCT01008449|Skin Closure|skin closure
1438858|NCT01008449|Wound infection|wound infection
1438859|NCT01008449|Wound disruption|wound disruption
1438860|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
1438861|NCT01008423|Proctitis|proctitis
1438862|NCT01008423|Proctosigmoiditis|proctosigmoiditis
1438863|NCT01008423|Ulcerative|ulcerative
1438864|NCT01008423|Salix|salix
1438865|NCT01008423|Budesonide foam|budesonide foam
1438866|NCT01008423|Budesonide|budesonide
1438867|NCT01008423|Rectal|rectal
1438868|NCT01008423|Gastrointestinal|gastrointestinal
1438869|NCT01008423|Colitis|colitis
1438870|NCT01008423|UC|uc
1438871|NCT01008423|UP|up
1438872|NCT01008423|UPS|ups
1438873|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
1438874|NCT01008423|Proctocolitis|proctocolitis
1438875|NCT01008423|Ulcer|ulcer
1438876|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
1438877|NCT01008423|Gastroenteritis|gastroenteritis
1438878|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
1438879|NCT01008423|Digestive System Diseases|digestive system diseases
1438880|NCT01008423|Rectal Diseases|rectal diseases
1438881|NCT01008423|Intestinal Diseases|intestinal diseases
1438882|NCT01008423|Colonic Diseases|colonic diseases
1438883|NCT01008423|Sigmoid Diseases|sigmoid diseases
1438884|NCT01008423|Pathologic Processes|pathologic processes
1438885|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
1438886|NCT01008423|Bronchodilator Agents|bronchodilator agents
1438887|NCT01008423|Autonomic Agents|autonomic agents
1438888|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
1438889|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
1438890|NCT01008423|Pharmacologic Actions|pharmacologic actions
1438891|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
1438892|NCT01008423|Respiratory System Agents|respiratory system agents
1438893|NCT01008423|Therapeutic Uses|therapeutic uses
1438894|NCT01008423|Glucocorticoids|glucocorticoids
1438895|NCT01008423|Hormones|hormones
1438896|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1438897|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
1438898|NCT01008410|Proctitis|proctitis
1438899|NCT01008410|Proctosigmoiditis|proctosigmoiditis
1438900|NCT01008410|Ulcerative|ulcerative
1438901|NCT01008410|Salix|salix
1438902|NCT01008410|Budesonide foam|budesonide foam
1438903|NCT01008410|Budesonide|budesonide
1438904|NCT01008410|Rectal|rectal
1438905|NCT01008410|Gastrointestinal|gastrointestinal
1438906|NCT01008410|Colitis|colitis
1438907|NCT01008410|UC|uc
1438908|NCT01008410|UP|up
1438909|NCT01008410|UPS|ups
1438910|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
1438911|NCT01008410|Proctocolitis|proctocolitis
1438912|NCT01008410|Ulcer|ulcer
1438913|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
1438914|NCT01008410|Gastroenteritis|gastroenteritis
1438915|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
1438916|NCT01008410|Digestive System Diseases|digestive system diseases
1438917|NCT01008410|Rectal Diseases|rectal diseases
1438918|NCT01008410|Intestinal Diseases|intestinal diseases
1438919|NCT01008410|Colonic Diseases|colonic diseases
1438920|NCT01008410|Sigmoid Diseases|sigmoid diseases
1438921|NCT01008410|Pathologic Processes|pathologic processes
1438922|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
1438923|NCT01008410|Bronchodilator Agents|bronchodilator agents
1438924|NCT01008410|Autonomic Agents|autonomic agents
1438925|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
1438926|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
1438927|NCT01008410|Pharmacologic Actions|pharmacologic actions
1438928|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
1438929|NCT01008410|Respiratory System Agents|respiratory system agents
1438930|NCT01008410|Therapeutic Uses|therapeutic uses
1438931|NCT01008410|Glucocorticoids|glucocorticoids
1438932|NCT01008410|Hormones|hormones
1438933|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1438934|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
1438935|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
1438936|NCT01008371|Obesity|obesity
1438937|NCT01008371|Cholecystokinin|cholecystokinin
1438938|NCT01008371|Oxytocin|oxytocin
1438939|NCT01008371|Satiety|satiety
1438940|NCT01008371|Gastric emptying|gastric emptying
1438941|NCT01008371|Anxiety|anxiety
1576481|NCT00477399|QOL|qol
1438942|NCT01008371|Depression|depression
1438943|NCT01008371|Panic Disorder|panic disorder
1438944|NCT01008332|House Dust Mite Allergy|house dust mite allergy
1438945|NCT01008332|Immunotherapy|immunotherapy
1438946|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
1438947|NCT01008332|Toleromune HDM|toleromune hdm
1438948|NCT01008319|Anovulation|anovulation
1438949|NCT01008319|Ovulation induction|ovulation induction
1438950|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
1438951|NCT01008306|physical activity|physical activity
1438952|NCT01008306|hypertension|hypertension
1438953|NCT01008306|overweight and obesity|overweight and obesity
1438954|NCT01008306|metabolic syndrome|metabolic syndrome
1438955|NCT01008306|Body composition|body composition
1438956|NCT01008241|Hospice|hospice
1438957|NCT01008241|End of Life|end of life
1438958|NCT01008241|Knowledge|knowledge
1438959|NCT01008241|Attitudes|attitudes
1438960|NCT01008241|Opinions|opinions
1438961|NCT01008241|Advanced Care Planning|advanced care planning
1438962|NCT01008241|Death and Dying|death and dying
1438963|NCT01008241|Communication|communication
1438964|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
1438965|NCT01008228|spontaneous|spontaneous
1438966|NCT01008228|primary|primary
1438967|NCT01008228|first episode|first episode
1438968|NCT01008215|INR Control|inr control
1438969|NCT01008215|Warfarin dosing|warfarin dosing
1438970|NCT01008215|Family physicians|family physicians
1438971|NCT01008215|Cluster randomization|cluster randomization
1438972|NCT01008176|Hypertension|hypertension
1438973|NCT01008176|Sleep|sleep
1438974|NCT01008176|Blood Pressure|blood pressure
1438975|NCT01008176|Inflammatory Markers|inflammatory markers
1438976|NCT01008150|breast cancer|breast cancer
1438977|NCT01008150|neoadjuvant|neoadjuvant
1438978|NCT01008150|neratinib|neratinib
1438979|NCT01008150|paclitaxel|paclitaxel
1438980|NCT01008150|trastuzumab|trastuzumab
1438981|NCT01008150|doxorubicin|doxorubicin
1438982|NCT01008150|cyclophosphamide|cyclophosphamide
1438983|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
1438984|NCT01008124|BPPV|bppv
1438985|NCT01008124|PC|pc
1438986|NCT01008124|BPPN|bppn
1438987|NCT01008124|Vertigo|vertigo
1438988|NCT01008111|regeneration|regeneration
1438989|NCT01008111|tissue survival|tissue survival
1438990|NCT01008111|biological processes|biological processes
1438991|NCT01008111|connective tissue|connective tissue
1438992|NCT01008111|tissue|tissue
1438993|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
1438994|NCT01008098|Escitalopram|escitalopram
1438995|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
1438996|NCT01008098|BDNF|bdnf
1438997|NCT01008085|STEMI|stemi
1438998|NCT01008085|self-expandable|self-expandable
1438999|NCT01008085|balloon-expandable|balloon-expandable
1439000|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
1439001|NCT01008046|clomiphene resistance|clomiphene resistance
1439002|NCT01008046|metformin|metformin
1439003|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
1439004|NCT01008020|tea catechin extracts|tea catechin extracts
1439005|NCT01008020|influenza infection|influenza infection
1439006|NCT01008020|prophylaxis|prophylaxis
1439007|NCT01008020|supplements|supplements
1439008|NCT01008020|adults over 20 years old|adults over 20 years old
1439009|NCT01008020|both men and women|both men and women
1439010|NCT01008007|Viusid|viusid
1439011|NCT01008007|Dietary supplements|dietary supplements
1439012|NCT01008007|Acute fever|acute fever
1439013|NCT01008007|Viral etiology|viral etiology
1439014|NCT01007994|Nocturnal hypertension|nocturnal hypertension
1439015|NCT01007994|Pediatric|pediatric
1439016|NCT01007994|Renal Transplant|renal transplant
1439017|NCT01007994|Pulse Wave Velocity|pulse wave velocity
1439018|NCT01007994|Echocardiogram|echocardiogram
1439019|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
1439020|NCT01007968|solid tumors|solid tumors
1439021|NCT01007968|hepatic function|hepatic function
1439022|NCT01007968|advanced|advanced
1439023|NCT01007968|panobinostat|panobinostat
1439024|NCT01007929|ADME|adme
1439025|NCT01007929|safety|safety
1439026|NCT01007929|oral solution|oral solution
1439027|NCT01007890|ChemoFX|chemofx
1439028|NCT01007890|Operable|operable
1439029|NCT01007890|Breast|breast
1439030|NCT01007890|Cancer|cancer
1439031|NCT01007890|Measurable|measurable
1439032|NCT01007890|Disease|disease
1439033|NCT01008163|diabetes|diabetes
1439034|NCT01007942|Metastatic breast cancer|metastatic breast cancer
1439035|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
1439036|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
1439037|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
1439038|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
1439039|NCT01007942|over survival (OS)|over survival (os)
1439040|NCT01007942|bolero|bolero
1439041|NCT01007942|bolero 3|bolero 3
1439042|NCT01007942|Breast cancer|breast cancer
1439043|NCT01007942|everolimus|everolimus
1439044|NCT01007942|HER+|her+
1439045|NCT01007942|vinorelbine|vinorelbine
1439046|NCT01007942|herceptin|herceptin
1439047|NCT01007942|trastuzumab|trastuzumab
1439048|NCT01007942|RAD001|rad001
1439049|NCT01007877|sleepiness|sleepiness
1439050|NCT01007877|driving|driving
1439051|NCT01007864|Parkinson|parkinson
1439052|NCT01007864|piribedil|piribedil
1439053|NCT01007864|vigilance|vigilance
1439054|NCT01007864|dopamine agonist|dopamine agonist
1439055|NCT01007864|cognition|cognition
1439056|NCT01007851|GnRH agonist|gnrh agonist
1439057|NCT01007851|GnRH antagonist|gnrh antagonist
1439058|NCT01007851|IVF|ivf
1439059|NCT01007851|ICSI|icsi
1439060|NCT01007851|assisted reproduction|assisted reproduction
1439061|NCT01007851|luteal phase|luteal phase
1439062|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
1439063|NCT01007838|Muscle wasting|muscle wasting
1439064|NCT01007838|Chronic Kidney Disease|chronic kidney disease
1439065|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
1439066|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
1439067|NCT01007773|Dexmedetomidine|dexmedetomidine
1439068|NCT01007773|Intracranial Pressure|intracranial pressure
1439069|NCT01007773|Traumatic Brain Injury|traumatic brain injury
1439070|NCT01007760|Tobacco smoke|tobacco smoke
1439071|NCT01007760|Oxidative stress|oxidative stress
1439072|NCT01007760|Endothelial Function|endothelial function
1439073|NCT01007760|Atherosclerosis|atherosclerosis
1439074|NCT01007760|Arterial Stiffness|arterial stiffness
1439075|NCT01007760|Microvascular Function|microvascular function
1439076|NCT01007747|Geranium oil|geranium oil
1439077|NCT01007747|Neuropathy|neuropathy
1439078|NCT01007734|Quality of life|quality of life
1439079|NCT01007734|COPD patients|copd patients
1439080|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
1439081|NCT01007695|breast cancer|breast cancer
1439082|NCT01007682|intrusive memories|intrusive memories
1439083|NCT01007669|Physical activity|physical activity
1439084|NCT01007656|healthy adult subjects|healthy adult subjects
1439085|NCT01007656|safety evaluation|safety evaluation
1439086|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
1439087|NCT01007643|anterior knee pain|anterior knee pain
1439088|NCT01007643|adolescents|adolescents
1439089|NCT01007643|female|female
1439090|NCT01007643|interactive video games|interactive video games
1439091|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
1439092|NCT01007643|treatment|treatment
1439093|NCT01007643|compliance|compliance
1439094|NCT01007643|home exercises|home exercises
1439095|NCT01007630|Parkinson's|parkinson's
1439096|NCT01007630|Parkinsons|parkinsons
1439097|NCT01007630|Parkinson|parkinson
1439098|NCT01007630|Parkinson's Disease|parkinson's disease
1439099|NCT01007630|PD|pd
1439100|NCT01007630|Rasagiline|rasagiline
1439101|NCT01007630|Azilect|azilect
1439102|NCT01007630|Olfactory|olfactory
1439103|NCT01007630|Sense of Smell|sense of smell
1439104|NCT01007630|UPSIT|upsit
1439105|NCT01007617|Children|children
1439106|NCT01007617|Cancer|cancer
1439107|NCT01007617|Mucositis|mucositis
1439108|NCT01007617|Laser|laser
1439109|NCT01007617|Prevention|prevention
1439110|NCT01007617|Chemotherapy|chemotherapy
1439111|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
1439112|NCT01007604|claudication|claudication
1439113|NCT01007604|pneumatic compression device|pneumatic compression device
1439114|NCT01007578|Paclitaxel|paclitaxel
1439115|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
1439116|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
1439117|NCT01007578|Plasma levels|plasma levels
1439118|NCT01007578|Femoral artery|femoral artery
1439119|NCT01007578|Popliteal artery|popliteal artery
1439120|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
1439121|NCT01007565|periarticular injection|periarticular injection
1439122|NCT01007552|Biliary Duct Cancer|biliary duct cancer
1439123|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
1439124|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
1439125|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
1439126|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
1439127|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
1439128|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
1439129|NCT01007526|Natural killer cell|natural killer cell
1439130|NCT01007526|T cell|t cell
1439131|NCT01007526|Radiotherapy|radiotherapy
1439132|NCT01007526|Chemotherapy|chemotherapy
1439133|NCT01007513|Prematurity|prematurity
1439134|NCT01007513|Inflammation|inflammation
1439135|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
1439136|NCT01007513|Vaginal secretion|vaginal secretion
1439137|NCT01007513|Inflammatory process|inflammatory process
1439138|NCT01007513|Neonatal morbidity|neonatal morbidity
1439139|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
1439140|NCT01007487|Plastic wound protector|plastic wound protector
1439141|NCT01007487|Plastic wound retractor|plastic wound retractor
1439142|NCT01007487|Bacterial translocation|bacterial translocation
1439143|NCT01007487|Surgical site infection|surgical site infection
1439144|NCT01007487|Abdominal surgery|abdominal surgery
1439145|NCT01007487|Wound infection|wound infection
1439146|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1439147|NCT01007461|STEMI|stemi
1439148|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
1439149|NCT01007448|CTCL|ctcl
1439150|NCT01007448|bexarotene|bexarotene
1439151|NCT01007448|Targretin|targretin
1439152|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
1439153|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1439155|NCT01007448|Mycoses fungoides|mycoses fungoides
1439156|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1439157|NCT01007422|pain|pain
1439158|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
1439159|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
1439160|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
1439161|NCT01007370|tracheal intubation|tracheal intubation
1439162|NCT01007370|supraglottic airway devices|supraglottic airway devices
1439163|NCT01007344|flaxseed|flaxseed
1439164|NCT01007344|hypercholesterolemia|hypercholesterolemia
1439165|NCT01007344|children|children
1439166|NCT01007331|Infants|infants
1439167|NCT01007331|Atopic Dermatitis|atopic dermatitis
1439168|NCT01007331|SCORAD|scorad
1439169|NCT01007331|IgE|ige
1439170|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
1439171|NCT01007331|Calprotectin|calprotectin
1439172|NCT01007331|Intestinal microflora|intestinal microflora
1439173|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1439174|NCT01007292|relapsed|relapsed
1439175|NCT01007292|CD20-Positive|cd20-positive
1439176|NCT01007292|YM155|ym155
1439177|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
1439178|NCT01007279|Myocardial Infarction|myocardial infarction
1439179|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1439180|NCT01007266|Adolescents|adolescents
1439181|NCT01007266|Pediatric|pediatric
1439182|NCT01007266|Patient Partner|patient partner
1439183|NCT01007266|Buddy|buddy
1439184|NCT01007266|Obesity|obesity
1439185|NCT01007266|Type 2 Diabetes|type 2 diabetes
1439186|NCT01007240|head and neck carcinoma|head and neck carcinoma
1439187|NCT01007240|obturators|obturators
1439188|NCT01007240|maxillectomy|maxillectomy
1439189|NCT01007240|soft liner|soft liner
1439190|NCT01007240|nano particles|nano particles
1439191|NCT01007240|antibacterial properties|antibacterial properties
1439192|NCT01007240|patients post maxillectomy|patients post maxillectomy
1439193|NCT01007214|Prostate cancer|prostate cancer
1439194|NCT01007214|Prostatectomy|prostatectomy
1439195|NCT01007201|Influenza|influenza
1439196|NCT01007201|H1N1|h1n1
1439197|NCT01007201|vaccine|vaccine
1439198|NCT01007201|Immunogenicity|immunogenicity
1439199|NCT01007188|almond|almond
1439200|NCT01007188|nuts|nuts
1439201|NCT01007188|energy value|energy value
1439202|NCT01007188|cardiovascular disease|cardiovascular disease
1439203|NCT01007188|phytonutrient|phytonutrient
1439204|NCT01007188|gene expression|gene expression
1439205|NCT01007188|energy value of almonds|energy value of almonds
1439206|NCT01007188|energy|energy
1439207|NCT01007175|TNF inhibitor|tnf inhibitor
1439208|NCT01007175|Multiple ascending dose study|multiple ascending dose study
1439209|NCT01007149|Severe asthma,|severe asthma,
1439210|NCT01007149|non-atopic,|non-atopic,
1439211|NCT01007149|omalizumab|omalizumab
1439212|NCT01007136|tDCS|tdcs
1439213|NCT01007136|stroke|stroke
1439214|NCT01007136|functional MRI|functional mri
1439215|NCT01007136|TMS|tms
1439216|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
1439217|NCT01007123|A3309|a3309
1439218|NCT01007110|DHA|dha
1439219|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
1439220|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1439221|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1439222|NCT01007097|Drug Therapy|drug therapy
1439223|NCT01007084|pain|pain
1439224|NCT01007084|trauma|trauma
1439225|NCT01007084|propranolol|propranolol
1439226|NCT01007058|Urinary Bladder|urinary bladder
1439227|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
1439228|NCT01007058|Intact bladder|intact bladder
1439229|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
1439230|NCT01007058|Tumor Recurrence|tumor recurrence
1439231|NCT01007058|Surrogate markers of response|surrogate markers of response
1439232|NCT01007058|BCG|bcg
1439233|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
1439234|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
1439235|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
1439236|NCT01007058|Interferon|interferon
1439237|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
1439238|NCT01007058|FISH|fish
1439239|NCT01007045|deep vein thrombosis|deep vein thrombosis
1439240|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
1439241|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
1439242|NCT01007032|anti-IGF-IR|anti-igf-ir
1439243|NCT01007032|monoclonal|monoclonal
1439244|NCT01007032|solid tumor|solid tumor
1439245|NCT01007032|insulin-like growth factor|insulin-like growth factor
1439246|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
1439247|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
1439248|NCT01007006|Brain Injuries|brain injuries
1439249|NCT01007006|Stress Disorders|stress disorders
1439250|NCT01007006|Combat disorders|combat disorders
1439251|NCT01007006|Polytrauma|polytrauma
1439252|NCT01007006|Adherence|adherence
1439253|NCT01006967|balance|balance
1439254|NCT01006967|gait|gait
1439255|NCT01006967|physical therapy|physical therapy
1439256|NCT01006967|ActiveStep|activestep
1439257|NCT01006954|Poor responder|poor responder
1439258|NCT01006954|Flare up|flare up
1439259|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
1439260|NCT01006954|IVF/ICSI|ivf/icsi
1439261|NCT01006941|Multiple sclerosis|multiple sclerosis
1439262|NCT01006941|safety|safety
1439263|NCT01006941|MRI|mri
1439264|NCT01006941|immunological|immunological
1439265|NCT01006941|Helminths|helminths
1439266|NCT01006941|Trichuris suis|trichuris suis
1439267|NCT01006928|Subjective health feeling|subjective health feeling
1439268|NCT01006928|NICU|nicu
1439269|NCT01006928|team support|team support
1439270|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
1439271|NCT01006902|Elderly|elderly
1439272|NCT01006902|Function|function
1439273|NCT01006902|Oncologic therapy|oncologic therapy
1439274|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
1439275|NCT01006876|coumadin|coumadin
1439276|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
1439277|NCT01006876|RFCA|rfca
1439278|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
1439279|NCT01006863|Ephedrine|ephedrine
1439280|NCT01006863|phenylephrine|phenylephrine
1439281|NCT01006863|hypotension|hypotension
1439282|NCT01006863|propofol|propofol
1439283|NCT01006863|anesthesia|anesthesia
1439284|NCT01006863|cardiac valve surgery|cardiac valve surgery
1439285|NCT01006837|trauma patients|trauma patients
1439286|NCT01006837|severe injury|severe injury
1439287|NCT01006837|ISS ≥9|iss ≥9
1439288|NCT01006824|Capsule endoscopy|capsule endoscopy
1439289|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1439290|NCT01006811|West syndrome|west syndrome
1439291|NCT01006811|Hypsarrhythmia|hypsarrhythmia
1439292|NCT01006798|Virus Diseases|virus diseases
1439293|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
1439294|NCT01006798|Vaccine|vaccine
1439295|NCT01006785|Breast Cancer|breast cancer
1439296|NCT01006785|DLBS 1425|dlbs 1425
1439297|NCT01006785|Cancer|cancer
1439298|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
1439299|NCT01006772|Stroke|stroke
1439300|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
1439301|NCT01006772|Walking Speed|walking speed
1439302|NCT01006772|Gait|gait
1439303|NCT01006772|Rehabilitation|rehabilitation
1439304|NCT01006772|Hemiplegia|hemiplegia
1439305|NCT01006759|Leprosy|leprosy
1439306|NCT01006759|Disability Evaluation|disability evaluation
1439307|NCT01006759|Quality of Life|quality of life
1439308|NCT01006759|Sensation|sensation
1439309|NCT01006746|Remote monitoring|remote monitoring
1439310|NCT01006746|Defibrillators|defibrillators
1439311|NCT01006746|Survey|survey
1439312|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
1439313|NCT01006733|pharmacogenetics|pharmacogenetics
1439314|NCT01006733|arthroplasty|arthroplasty
1439315|NCT01006733|VKORC1|vkorc1
1439316|NCT01006733|thromboembolism|thromboembolism
1439317|NCT01006733|warfarin|warfarin
1439318|NCT01006720|Residual neuromuscular block|residual neuromuscular block
1439319|NCT01006720|post-operative residual curarization|post-operative residual curarization
1439320|NCT01006720|PORC|porc
1439321|NCT01006720|sugammadex|sugammadex
1439322|NCT01006720|neostigmine|neostigmine
1439323|NCT01006694|depression|depression
1439324|NCT01006694|collaborative care|collaborative care
1439325|NCT01006694|Vietnam|vietnam
1439326|NCT01006694|behavioral activation|behavioral activation
1439327|NCT01006681|rheumatoid|rheumatoid
1439328|NCT01006681|SLE|sle
1439329|NCT01006681|Psoriatic arthritis|psoriatic arthritis
1439330|NCT01006681|Ankylosing|ankylosing
1439331|NCT01006681|Influenza H1N1|influenza h1n1
1439332|NCT01006681|Vaccine|vaccine
1439333|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
1439334|NCT01006668|Neonates|neonates
1439335|NCT01006668|Intensive care|intensive care
1439336|NCT01006668|Endotracheal intubation|endotracheal intubation
1439337|NCT01006668|Neonates in intensive care|neonates in intensive care
1439338|NCT01006655|asthma|asthma
1439339|NCT01006655|preschool children|preschool children
1439340|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1439341|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
1439342|NCT01006655|Qvar|qvar
1439343|NCT01006655|Adenosine Challenge test|adenosine challenge test
1439344|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
1439345|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
1439346|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
1439347|NCT01006629|Preterm infants|preterm infants
1439469|NCT01006031|Liver cirrhosis|liver cirrhosis
1439348|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
1439349|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
1439350|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1439351|NCT01006603|elderly patients|elderly patients
1439352|NCT01006603|saxagliptin|saxagliptin
1439353|NCT01006603|randomised|randomised
1439354|NCT01006603|double-blind|double-blind
1439355|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1439356|NCT01006590|Saxagliptin|saxagliptin
1439357|NCT01006590|Randomised|randomised
1439358|NCT01006590|Double-blind|double-blind
1439359|NCT01006577|rectal cancer|rectal cancer
1439360|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
1439361|NCT01006577|colon J pouch|colon j pouch
1439362|NCT01006577|fecal incontinence|fecal incontinence
1439363|NCT01006577|anorectal function|anorectal function
1439364|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
1439365|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
1439366|NCT01006577|quality of life|quality of life
1439367|NCT01006577|postoperative complications|postoperative complications
1439368|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
1439369|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
1439370|NCT01006564|Prostate Cancer|prostate cancer
1439371|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1439372|NCT01006564|Radiotherapy planning|radiotherapy planning
1439373|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
1439374|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
1439375|NCT01006538|Predominantly classic|predominantly classic
1439376|NCT01006538|Minimally classic|minimally classic
1439377|NCT01006538|Occult with no classic|occult with no classic
1439378|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
1439379|NCT01006499|neonatal sepsis|neonatal sepsis
1439380|NCT01006499|pentoxyfilline|pentoxyfilline
1439381|NCT01006499|pentaglobin|pentaglobin
1439382|NCT01006499|biomarker|biomarker
1439383|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
1439384|NCT01006486|Oral anticoagulants|oral anticoagulants
1439385|NCT01006486|Warfarin|warfarin
1439386|NCT01006486|Anticoagulation clinic|anticoagulation clinic
1439387|NCT01006486|Thrombosis|thrombosis
1439388|NCT01006486|Hemorrhage|hemorrhage
1439389|NCT01006473|Chagas Disease|chagas disease
1439394|NCT01006447|exercise|exercise
1439395|NCT01006447|older adults|older adults
1439396|NCT01006447|exercise persistence|exercise persistence
1439397|NCT01006434|Stroke|stroke
1439398|NCT01006434|Thrombolysis|thrombolysis
1439399|NCT01006421|phototherapy|phototherapy
1439400|NCT01006421|Gingko biloba|gingko biloba
1439401|NCT01006421|repigmentation|repigmentation
1439402|NCT01006408|Neuropathy|neuropathy
1439403|NCT01006395|Prostate Cancer|prostate cancer
1439404|NCT01006395|Androgen deprivation|androgen deprivation
1439405|NCT01006395|Bone Health|bone health
1439406|NCT01006395|Insulin resistance|insulin resistance
1439407|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
1439408|NCT01006369|stage IV colon cancer|stage iv colon cancer
1439409|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
1439410|NCT01006369|recurrent colon cancer|recurrent colon cancer
1439411|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
1439412|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
1439413|NCT01006356|Jurnista|jurnista
1439414|NCT01006317|Maternal health services|maternal health services
1439415|NCT01006317|utilization|utilization
1439416|NCT01006317|education|education
1439417|NCT01006317|randomized controlled trial|randomized controlled trial
1439418|NCT01006317|cost|cost
1439419|NCT01006317|clinical skills|clinical skills
1439420|NCT01006317|rural China|rural china
1439421|NCT01006304|JNJ-39439335|jnj-39439335
1439422|NCT01006304|Placebo|placebo
1439423|NCT01006304|Pain|pain
1439424|NCT01006304|Pain Measurements|pain measurements
1439425|NCT01006304|Adults|adults
1439426|NCT01006304|Men|men
1439427|NCT01006278|biomarker|biomarker
1439428|NCT01006278|knee arthroscopy|knee arthroscopy
1439429|NCT01006278|pain|pain
1439430|NCT01006252|metastatic|metastatic
1439431|NCT01006252|second-line|second-line
1439432|NCT01006239|Cancer|cancer
1439433|NCT01006213|Motivational Intervention|motivational intervention
1439434|NCT01006200|granulation tissue|granulation tissue
1439435|NCT01006200|benign|benign
1439436|NCT01006200|tracheal stenosis|tracheal stenosis
1439437|NCT01006200|ultraflex|ultraflex
1439438|NCT01006200|COPD|copd
1439439|NCT01006187|Analgesics|analgesics
1439440|NCT01006187|Influenza|influenza
1439441|NCT01006187|Vapocoolant|vapocoolant
1439442|NCT01006187|vaccination|vaccination
1439443|NCT01006187|pain|pain
1439444|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
1439445|NCT01006122|Randomized|randomized
1439446|NCT01006122|double-blind|double-blind
1439447|NCT01006122|placebo-controlled|placebo-controlled
1439448|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
1439455|NCT01006096|Psoriasis|psoriasis
1439456|NCT01006096|double-blind|double-blind
1439457|NCT01006096|randomized|randomized
1439458|NCT01006096|placebo-controlled|placebo-controlled
1439459|NCT01006096|erlotinib|erlotinib
1439460|NCT01006096|efficacy|efficacy
1439461|NCT01006083|Aspirin|aspirin
1439462|NCT01006083|Plavix|plavix
1439463|NCT01006083|antiplatelet therapy|antiplatelet therapy
1439464|NCT01006083|Hemorrhage|hemorrhage
1439465|NCT01006083|ischemic events|ischemic events
1439466|NCT01006070|multiple myeloma|multiple myeloma
1439467|NCT01006070|spinal disease|spinal disease
1439468|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
1439470|NCT01006031|Hepatitis C virus|hepatitis c virus
1439471|NCT01006031|HIV infection|hiv infection
1439472|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
1439473|NCT01006031|Ribavirin|ribavirin
1439474|NCT01006031|Treatment experienced|treatment experienced
1439475|NCT01006018|Prediabetic State|prediabetic state
1439477|NCT01006005|Treatment experienced|treatment experienced
1439478|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
1439479|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1439480|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1439481|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
1439482|NCT01005979|Lymphoma|lymphoma
1439483|NCT01005979|Leukemia|leukemia
1439484|NCT01005966|remineralization|remineralization
1439485|NCT01005966|enamel|enamel
1439486|NCT01005966|in situ|in situ
1439487|NCT01005966|fluoride|fluoride
1439488|NCT01005966|caries|caries
1439489|NCT01005953|Autism|autism
1439490|NCT01005953|Behavioral Observations|behavioral observations
1439491|NCT01005953|Electronic diaries|electronic diaries
1439492|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
1439493|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
1439494|NCT01005940|Insulin Resistance|insulin resistance
1439495|NCT01005940|Mandibular advancement device|mandibular advancement device
1439496|NCT01005927|Calcium|calcium
1439497|NCT01005927|Bone and Bones|bone and bones
1439498|NCT01005927|Girls|girls
1439499|NCT01005927|Bone Mineralization|bone mineralization
1439500|NCT01005927|Fiber|fiber
1439501|NCT01005927|Fructooligosaccharide|fructooligosaccharide
1439502|NCT01005927|Female|female
1439503|NCT01005927|Healthy|healthy
1439504|NCT01005927|Adolescents|adolescents
1439505|NCT01005914|adults|adults
1439506|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
1439507|NCT01005914|T-cell ALL|t-cell all
1439508|NCT01005914|untreated ALL|untreated all
1439509|NCT01005901|COPD|copd
1439510|NCT01005901|NVA|nva
1439511|NCT01005901|FEV1|fev1
1439512|NCT01005888|Hereditary angioedema|hereditary angioedema
1439513|NCT01005888|HAE|hae
1439514|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
1439515|NCT01005888|C1INH-nf|c1inh-nf
1439516|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
1439517|NCT01005875|HCC|hcc
1439518|NCT01005875|Liver Cancer|liver cancer
1439519|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1439520|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
1439521|NCT01005849|Probiotics|probiotics
1439522|NCT01005849|Traveler's diarrhea|traveler's diarrhea
1439523|NCT01005849|Prevention|prevention
1439524|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
1439525|NCT01005836|Anxiety treatment|anxiety treatment
1439526|NCT01005836|Depression treatment|depression treatment
1439527|NCT01005836|Child treatment|child treatment
1439528|NCT01005836|Usual care|usual care
1439529|NCT01005797|Renal Cancer|renal cancer
1439530|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
1439531|NCT01005797|Solid Tumor|solid tumor
1439532|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
1439533|NCT01005797|Sorafenib|sorafenib
1439534|NCT01005797|Panobinostat|panobinostat
1439535|NCT01005784|GnRH antagonists|gnrh antagonists
1439536|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
1439537|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1439538|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1439539|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1439540|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1439541|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1439542|NCT01005745|skin|skin
1439543|NCT01005745|adoptive cell therapy|adoptive cell therapy
1439544|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
1439545|NCT01005745|lymphodepletion|lymphodepletion
1439546|NCT01005732|hypertrophic|hypertrophic
1439547|NCT01005732|scar|scar
1439548|NCT01005732|burn|burn
1439549|NCT01005732|cicatrix|cicatrix
1439550|NCT01005732|pressure|pressure
1439551|NCT01005732|garment|garment
1439552|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1439553|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
1439554|NCT01005654|Gene Expression|gene expression
1439555|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
1439556|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
1440824|NCT01000584|influenza|influenza
1439557|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
1439558|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
1439559|NCT01005654|Adrenal Cancer|adrenal cancer
1439560|NCT01005654|Endocrine Tumor|endocrine tumor
1439561|NCT01005654|Thyroid Cancer|thyroid cancer
1439562|NCT01005641|advanced breast cancer|advanced breast cancer
1439563|NCT01005641|hormone-responsive|hormone-responsive
1439564|NCT01005641|metastatic breast cancer|metastatic breast cancer
1439565|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
1439566|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
1439567|NCT01005602|Digoxin|digoxin
1439568|NCT01005602|Pharmacokinetics|pharmacokinetics
1439569|NCT01005602|Dosing|dosing
1439570|NCT01005602|Heart Failure|heart failure
1439571|NCT01005589|Neonatal sepsis|neonatal sepsis
1439572|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
1439573|NCT01005589|CD64 antigen|cd64 antigen
1439574|NCT01005589|Receptors, IgG|receptors, igg
1439575|NCT01005576|Thalassemia|thalassemia
1439576|NCT01005576|Alemtuzumab|alemtuzumab
1439577|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
1439578|NCT01005576|non-myeloablative|non-myeloablative
1439579|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
1439580|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
1439581|NCT01005550|Ropivacaine|ropivacaine
1439761|NCT01004874|gliosarcoma|gliosarcoma
1439582|NCT01005550|Traumatic hip surgery|traumatic hip surgery
1439583|NCT01005537|stage IV melanoma|stage iv melanoma
1439584|NCT01005524|brain computer interface|brain computer interface
1439585|NCT01005524|P3Speller|p3speller
1439586|NCT01005524|P300|p300
1439587|NCT01005524|Event Related potential|event related potential
1439588|NCT01005524|tetraplegia|tetraplegia
1439589|NCT01005524|Guillain barre syndrome|guillain barre syndrome
1439590|NCT01005524|Feasibility|feasibility
1439591|NCT01005524|Speed of spelling|speed of spelling
1439592|NCT01005524|Accuracy|accuracy
1439593|NCT01005511|Bruxism|bruxism
1439594|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
1439595|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
1439596|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
1439597|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
1439598|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
1439599|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
1439600|NCT01005472|stage III melanoma|stage iii melanoma
1439601|NCT01005472|stage IV melanoma|stage iv melanoma
1439602|NCT01005472|recurrent melanoma|recurrent melanoma
1439603|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1439604|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
1439605|NCT01005472|iris melanoma|iris melanoma
1439606|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
1439607|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
1439608|NCT01005459|labor pain|labor pain
1439609|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
1439610|NCT01005459|CSE analgesia|cse analgesia
1439611|NCT01005459|labor analgesia|labor analgesia
1439612|NCT01005433|dexmedetomidine|dexmedetomidine
1439613|NCT01005433|stress response|stress response
1439614|NCT01005433|cesarean delivery|cesarean delivery
1439615|NCT01005420|Insulin Sensitivity|insulin sensitivity
1439616|NCT01005420|Pre-diabetes|pre-diabetes
1439617|NCT01005420|Diabetes|diabetes
1439618|NCT01005420|Blueberries|blueberries
1439619|NCT01005420|Anthocyanins|anthocyanins
1439620|NCT01005407|HBV vaccine|hbv vaccine
1439621|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
1439622|NCT01005407|Hepatitis B|hepatitis b
1439623|NCT01005407|Hepatitis|hepatitis
1439624|NCT01005407|HBV|hbv
1439625|NCT01005407|Prevention & Control|prevention & control
1439626|NCT01005407|Healthy|healthy
1439627|NCT01005407|Healthy volunteers|healthy volunteers
1439628|NCT01005381|Calcium|calcium
1439629|NCT01005381|Vitamin D|vitamin d
1439630|NCT01005381|Particle Size|particle size
1439631|NCT01005381|Adolescents|adolescents
1439632|NCT01005381|Bone|bone
1439633|NCT01005381|Osteoporosis|osteoporosis
1439634|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1439635|NCT01005355|Solid tumor|solid tumor
1439636|NCT01005355|recombinant human IgG1|recombinant human igg1
1439637|NCT01005355|MAB|mab
1439638|NCT01005355|monoclonal antibody|monoclonal antibody
1439639|NCT01005355|VEGFR 2|vegfr 2
1439640|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
1439641|NCT01005342|gene expression|gene expression
1439642|NCT01005342|oats|oats
1439643|NCT01005342|rye|rye
1439644|NCT01005342|sugar beet fiber|sugar beet fiber
1439645|NCT01005342|glucose|glucose
1439646|NCT01005342|insulin|insulin
1439647|NCT01005342|triglyceride|triglyceride
1439648|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
1439649|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
1439650|NCT01005342|glycemic index|glycemic index
1439651|NCT01005316|cohort study|cohort study
1439652|NCT01005316|allo-antibodies|allo-antibodies
1439653|NCT01005316|allosensitization|allosensitization
1439654|NCT01005303|Heart Failure|heart failure
1439655|NCT01005303|Micronutrients|micronutrients
1439656|NCT01005303|Vitamin D|vitamin d
1439657|NCT01005303|Inflammation|inflammation
1439658|NCT01005303|Oxidative Stress|oxidative stress
1439659|NCT01005303|Quality of Life|quality of life
1439660|NCT01005303|Physical Functioning|physical functioning
1439661|NCT01005290|cardiovascular|cardiovascular
1439662|NCT01005290|fixed|fixed
1439663|NCT01005290|dose|dose
1439664|NCT01005290|combination|combination
1439665|NCT01005290|pill|pill
1439666|NCT01005290|hypertension|hypertension
1439667|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1439668|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1439669|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1439670|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1439671|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1439672|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1439673|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1439674|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1439675|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1439676|NCT01005264|diabetic foot|diabetic foot
1439677|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
1439678|NCT01005264|ulcer healing|ulcer healing
1439679|NCT01005264|non-removable total contact cast|non-removable total contact cast
1439680|NCT01005264|removable cast walker|removable cast walker
1439681|NCT01005251|GERD treatment|gerd treatment
1439682|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
1439683|NCT01005251|Heartburn|heartburn
1439684|NCT01005251|Regurgitation|regurgitation
1439685|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
1439686|NCT01005225|Solid tumor|solid tumor
1439687|NCT01005225|prostate cancer|prostate cancer
1439688|NCT01005225|colon cancer|colon cancer
1439689|NCT01005212|EVAR|evar
1439690|NCT01005212|Ultrasounds|ultrasounds
1439691|NCT01005212|AAA|aaa
1439692|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
1439693|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1439694|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1439695|NCT01005173|Acetaminophen|acetaminophen
1439696|NCT01005173|APAP|apap
1439697|NCT01005160|Mellitus, type 2|mellitus, type 2
1439698|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
1439699|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
1439700|NCT01005147|tranexamic acid|tranexamic acid
1439701|NCT01005147|upper GI bleeding|upper gi bleeding
1439702|NCT01005147|blood transfusion|blood transfusion
1439703|NCT01005147|GI bleeding|gi bleeding
1439704|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
1567288|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1439705|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
1439706|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
1439707|NCT01005069|diabetes mellitus|diabetes mellitus
1439708|NCT01005069|DLBS-32|dlbs-32
1439709|NCT01005069|fasting plasma glucose|fasting plasma glucose
1439710|NCT01005069|insulin resistance|insulin resistance
1439711|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
1439712|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
1439713|NCT01005043|particle therapy|particle therapy
1439714|NCT01005043|safety|safety
1439715|NCT01005043|toxicity|toxicity
1439716|NCT01005043|survival|survival
1439717|NCT01005043|radiotherapy|radiotherapy
1439718|NCT01005030|Parkinson Disease|parkinson disease
1439719|NCT01005030|blood|blood
1439720|NCT01005030|plasma|plasma
1439721|NCT01005030|metabolomics|metabolomics
1439722|NCT01005030|spectroscopy|spectroscopy
1439723|NCT01005030|oxidative stress.|oxidative stress.
1439724|NCT01005017|Radiofrequent ablation|radiofrequent ablation
1439725|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
1439726|NCT01005004|PMD|pmd
1439727|NCT01005004|stem cells|stem cells
1439728|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
1439729|NCT01005004|human stem cells|human stem cells
1439730|NCT01005004|central nervous system stem cells|central nervous system stem cells
1439731|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1439732|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1439733|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1439734|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1439735|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1441212|NCT00999115|Allogenic|allogenic
1439736|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1439737|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1439738|NCT01004952|Skin|skin
1439739|NCT01004952|Sunscreen|sunscreen
1439740|NCT01004952|UVR Protection|uvr protection
1439741|NCT01004952|09-137|09-137
1439742|NCT01004939|prophylaxis|prophylaxis
1439743|NCT01004939|venous thromboembolism|venous thromboembolism
1439744|NCT01004939|postpartum|postpartum
1439745|NCT01004939|fondaparinux|fondaparinux
1439746|NCT01004939|pregnancy|pregnancy
1439747|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
1439748|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
1439749|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
1439750|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
1439751|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
1439752|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
1439753|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
1439754|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1439755|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
1439756|NCT01004887|adult gliosarcoma|adult gliosarcoma
1439757|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1439758|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1439759|NCT01004874|malignant glioma|malignant glioma
1439760|NCT01004874|glioblastoma|glioblastoma
1439762|NCT01004874|Avastin|avastin
1439763|NCT01004874|bevacizumab|bevacizumab
1439764|NCT01004874|Topotecan|topotecan
1439765|NCT01004874|Hycamtin|hycamtin
1439766|NCT01004874|Temozolomide|temozolomide
1439767|NCT01004874|Temodar|temodar
1439768|NCT01004874|Pro00019960|pro00019960
1439769|NCT01004874|Vredenburgh|vredenburgh
1439770|NCT01004874|Duke|duke
1439771|NCT01004874|Desjardins|desjardins
1439772|NCT01004861|PVNS|pvns
1439773|NCT01004848|Pre-diabetes|pre-diabetes
1439774|NCT01004848|pre-diabetic state|pre-diabetic state
1439775|NCT01004848|community-based participatory research|community-based participatory research
1439776|NCT01004848|overweight|overweight
1439777|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
1439778|NCT01004835|migraine|migraine
1439779|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
1439780|NCT01004809|Dutasteride|dutasteride
1439781|NCT01004796|breast cancer|breast cancer
1439782|NCT01004783|stage I Wilms tumor|stage i wilms tumor
1439783|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
1439784|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
1439785|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
1439786|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
1439787|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
1439788|NCT01004770|Patient Safety|patient safety
1439789|NCT01004770|Tolerance|tolerance
1577491|NCT00473993|Heroin|heroin
1439790|NCT01004770|Pharmacokinetic|pharmacokinetic
1439791|NCT01004757|diastolic function|diastolic function
1439792|NCT01004757|postmeal glucose|postmeal glucose
1439793|NCT01004757|insulin resistance|insulin resistance
1439794|NCT01004757|low carb diet|low carb diet
1439795|NCT01004757|type 2 diabetes|type 2 diabetes
1439796|NCT01004744|Postmenopausal women|postmenopausal women
1439798|NCT01004744|Estrogen positive|estrogen positive
1439799|NCT01004744|PR+|pr+
1439800|NCT01004744|Progesterone positive|progesterone positive
1439801|NCT01004731|EGFr|egfr
1439802|NCT01004731|cetuximab|cetuximab
1439803|NCT01004731|gemcitabine|gemcitabine
1439804|NCT01004731|carboplatin|carboplatin
1439805|NCT01004731|NSCLC|nsclc
1439806|NCT01004705|cardiovascular|cardiovascular
1439807|NCT01004705|fixed|fixed
1439808|NCT01004705|dose|dose
1439809|NCT01004705|combination|combination
1439810|NCT01004705|pill|pill
1439811|NCT01004705|LDL|ldl
1439812|NCT01004705|cholesterol|cholesterol
1439813|NCT01004666|Breast cancer|breast cancer
1439814|NCT01004666|Scintimammography|scintimammography
1439815|NCT01004666|CZT|czt
1439816|NCT01004666|High-risk|high-risk
1439817|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
1439818|NCT01004627|fistula|fistula
1439819|NCT01004627|ultrasound|ultrasound
1439820|NCT01004627|angioaccess|angioaccess
1439821|NCT01004627|preoperative vein mapping|preoperative vein mapping
1439822|NCT01004627|Haemodialysis|haemodialysis
1439823|NCT01004627|Angioaccess surgery|angioaccess surgery
1439824|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
1439825|NCT01004588|elderly|elderly
1439826|NCT01004588|sarcopenia|sarcopenia
1439827|NCT01004588|protein drink|protein drink
1439828|NCT01004588|resistance training|resistance training
1439829|NCT01004575|stents|stents
1439830|NCT01004575|bare metal stents|bare metal stents
1439831|NCT01004562|breast cancer|breast cancer
1439925|NCT01004224|kinase inhibitor|kinase inhibitor
1441315|NCT00998686|dutogliptin|dutogliptin
1439832|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
1439833|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1439834|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1439835|NCT01004523|childhood mixed glioma|childhood mixed glioma
1439836|NCT01004523|adult mixed glioma|adult mixed glioma
1439837|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
1439838|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
1439839|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
1439840|NCT01004510|malignant pleural effusion|malignant pleural effusion
1439841|NCT01004510|non small cell lung cancer|non small cell lung cancer
1439842|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
1439843|NCT01004484|non-patients|non-patients
1439844|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
1439845|NCT01004471|Nasal dilator strip|nasal dilator strip
1439846|NCT01004471|Sleep disordered breathing|sleep disordered breathing
1439847|NCT01004458|fibromyalgia|fibromyalgia
1439848|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
1439849|NCT01004458|women|women
1439850|NCT01004458|pain|pain
1439851|NCT01004458|stress|stress
1439852|NCT01004458|type A behavior|type a behavior
1439853|NCT01004445|Pneumonia|pneumonia
1439854|NCT01004445|Adjunctive treatment|adjunctive treatment
1439855|NCT01004445|Gram-negative bacteria|gram-negative bacteria
1439856|NCT01004432|humira, remicade|humira, remicade
1439857|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
1439858|NCT01004432|enbrel failure|enbrel failure
1439859|NCT01004432|humira failure|humira failure
1439860|NCT01004432|arthritis|arthritis
1439861|NCT01004432|enbrel|enbrel
1439862|NCT01004419|non small cell lung cancer|non small cell lung cancer
1439863|NCT01004419|vandetanib|vandetanib
1439864|NCT01004419|ZD6474|zd6474
1439865|NCT01004419|fulvestrant|fulvestrant
1439866|NCT01004419|faslodex|faslodex
1439867|NCT01004419|phase 1|phase 1
1439868|NCT01004406|plaque|plaque
1439869|NCT01004406|LDL|ldl
1439870|NCT01004406|statin|statin
1439871|NCT01004406|endothelial|endothelial
1439872|NCT01004406|apheresis|apheresis
1439873|NCT01004406|acute coronary syndrome|acute coronary syndrome
1439874|NCT01004393|Methylnaltrexone|methylnaltrexone
1439875|NCT01004393|Constipation|constipation
1439876|NCT01004393|Narcotic Antagonists|narcotic antagonists
1439877|NCT01004393|Analgesics, Opioid|analgesics, opioid
1439878|NCT01004393|Neoplasms|neoplasms
1439879|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
1439880|NCT01004380|Ovarian Cancer|ovarian cancer
1439881|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
1439882|NCT01004354|Psychiatric illnesses|psychiatric illnesses
1439883|NCT01004354|Vitamin D deficiency|vitamin d deficiency
1439884|NCT01004354|Obesity|obesity
1439885|NCT01004341|pediatric obesity|pediatric obesity
1439886|NCT01004341|parenting style|parenting style
1439887|NCT01004341|feeding style|feeding style
1439888|NCT01004341|behavioral skills|behavioral skills
1439889|NCT01004341|parenting skills|parenting skills
1439890|NCT01004341|family meals|family meals
1439891|NCT01004328|patient safety|patient safety
1439892|NCT01004328|care transitions|care transitions
1439893|NCT01004328|therapeutic monitoring|therapeutic monitoring
1439894|NCT01004328|skilled nursing facilities|skilled nursing facilities
1439895|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
1439896|NCT01004315|Overactive bladder|overactive bladder
1439897|NCT01004315|Frequency|frequency
1439898|NCT01004315|Micturition|micturition
1439899|NCT01004315|Urgency|urgency
1439900|NCT01004315|Urge urinary incontinence|urge urinary incontinence
1439901|NCT01004315|OAB|oab
1439902|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
1439903|NCT01004302|Radiosurgery|radiosurgery
1439904|NCT01004302|Psychosurgery|psychosurgery
1439905|NCT01004302|Treatment outcome|treatment outcome
1439906|NCT01004302|Randomized Controlled Trials|randomized controlled trials
1439907|NCT01004289|Acute myocardial infarction|acute myocardial infarction
1439908|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
1439909|NCT01004289|Postconditioning|postconditioning
1439910|NCT01004276|primary health care|primary health care
1439911|NCT01004276|delivery of health care|delivery of health care
1439912|NCT01004276|smoking cessation|smoking cessation
1439913|NCT01004276|chronic disease|chronic disease
1439914|NCT01004276|disease management|disease management
1439915|NCT01004276|pilot projects|pilot projects
1439916|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
1439917|NCT01004237|insulin resistance|insulin resistance
1439918|NCT01004237|hypertensive|hypertensive
1439919|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
1439920|NCT01004224|advanced solid tumors|advanced solid tumors
1439921|NCT01004224|lung cancer|lung cancer
1439922|NCT01004224|bladder cancer|bladder cancer
1439923|NCT01004224|BGJ398|bgj398
1439924|NCT01004224|FGFR|fgfr
1439926|NCT01004224|advanced solid malignancies|advanced solid malignancies
1439927|NCT01004211|bladder cancer|bladder cancer
1439928|NCT01004211|recurrence|recurrence
1439929|NCT01004198|Trauma|trauma
1439930|NCT01004198|Hemorrhage|hemorrhage
1439931|NCT01004198|Hemorrhagic shock|hemorrhagic shock
1439932|NCT01004198|Lactic acidosis|lactic acidosis
1439933|NCT01004198|Oxygen carriers|oxygen carriers
1439934|NCT01004198|Oxygen therapeutics|oxygen therapeutics
1439935|NCT01004198|Hemoglobin solutions|hemoglobin solutions
1439936|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
1439937|NCT01004198|Red cell substitutes|red cell substitutes
1439938|NCT01004198|PEG-hemoglobin|peg-hemoglobin
1439939|NCT01004172|carboplatin|carboplatin
1439940|NCT01004172|bevacizumab|bevacizumab
1439941|NCT01004159|Colorectal cancer|colorectal cancer
1439942|NCT01004159|KRAS wild type tumors|kras wild type tumors
1439943|NCT01004146|incentive spirometry|incentive spirometry
1439944|NCT01004146|bariatric surgery|bariatric surgery
1439945|NCT01004146|obesity|obesity
1439946|NCT01004133|Age 80 or older|age 80 or older
1439947|NCT01004133|No chronic disease|no chronic disease
1439948|NCT01004094|children|children
1439949|NCT01004094|video games|video games
1439950|NCT01004094|internet|internet
1439951|NCT01004094|parents|parents
1439952|NCT01004094|fruit|fruit
1439953|NCT01004094|vegetable|vegetable
1439954|NCT01004094|implementation intention|implementation intention
1439955|NCT01004094|goal setting|goal setting
1439956|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
1440552|NCT01001689|Pregnancy|pregnancy
1439957|NCT01004094|obesity prevention|obesity prevention
1439958|NCT01004094|cancer prevention|cancer prevention
1439959|NCT01004081|Cancer of Breast|cancer of breast
1439960|NCT01004081|Cancer of the Breast|cancer of the breast
1439961|NCT01004068|Clomiphene|clomiphene
1439962|NCT01004068|Diet|diet
1439963|NCT01004068|Exercise|exercise
1439964|NCT01004068|Infertility|infertility
1439965|NCT01004068|PCOS|pcos
1439966|NCT01004068|Physical activity|physical activity
1439967|NCT01004068|Treatment|treatment
1439968|NCT01004055|Wound|wound
1439969|NCT01004055|Skin lesion|skin lesion
1439970|NCT01004055|Antimicrobial|antimicrobial
1439971|NCT01004055|Bioelectric|bioelectric
1439972|NCT01004042|Depression|depression
1439973|NCT01004042|Botulinum toxin|botulinum toxin
1439974|NCT01004042|Glabella|glabella
1439975|NCT01004042|Quality of life|quality of life
1439976|NCT01004042|Self-steem|self-steem
1439977|NCT01004029|17P|17p
1439978|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
1439979|NCT01004029|preterm birth|preterm birth
1439980|NCT01004029|progesterone|progesterone
1439981|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
1439982|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
1439983|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1439984|NCT01004016|SCD|scd
1439985|NCT01003990|Treatment experienced|treatment experienced
1439986|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
1439987|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
1439988|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
1439989|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
1439990|NCT01003964|Pemetrexed|pemetrexed
1439991|NCT01003964|Docetaxel|docetaxel
1439992|NCT01003964|advanced NSCLC|advanced nsclc
1439993|NCT01003951|Lymphedema|lymphedema
1439994|NCT01003951|Acupuncture|acupuncture
1439995|NCT01003951|09-136|09-136
1439996|NCT01003938|chemotherapy|chemotherapy
1439997|NCT01003938|combination therapy|combination therapy
1439998|NCT01003938|targeted therapy|targeted therapy
1439999|NCT01003938|second-line|second-line
1440000|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
1440001|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
1440002|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
1440003|NCT01003912|Krabbe|krabbe
1440004|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
1440005|NCT01003912|MLD|mld
1440006|NCT01003912|Tay Sachs|tay sachs
1440007|NCT01003912|Sandhoff|sandhoff
1440008|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
1440009|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
1440010|NCT01003912|PMD|pmd
1440011|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
1440012|NCT01003873|morbid obesity|morbid obesity
1440013|NCT01003873|bariatric surgery|bariatric surgery
1440014|NCT01003873|lifestyle intervention|lifestyle intervention
1440015|NCT01003873|endocannabinoids system|endocannabinoids system
1440016|NCT01003860|postoperative analgesia|postoperative analgesia
1440017|NCT01003847|Insulin resistance|insulin resistance
1440018|NCT01003834|substance use|substance use
1440019|NCT01003834|drug use|drug use
1440020|NCT01003834|drug abuse|drug abuse
1440021|NCT01003782|cholangitis|cholangitis
1440022|NCT01003782|antibiotic|antibiotic
1440023|NCT01003782|bacteriobilia|bacteriobilia
1440024|NCT01003782|bile|bile
1440025|NCT01003782|ERCP|ercp
1440026|NCT01003756|Preoperative|preoperative
1440027|NCT01003756|Exercise|exercise
1440028|NCT01003756|Joint Replacement|joint replacement
1440029|NCT01003756|Hip|hip
1440030|NCT01003756|Knee|knee
1440031|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
1440032|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
1440033|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
1440034|NCT01003678|Clofarabine|clofarabine
1440035|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
1440036|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
1440037|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
1440038|NCT01003652|goiter|goiter
1440039|NCT01003639|papilledema|papilledema
1440040|NCT01003639|vision loss|vision loss
1440041|NCT01003639|headache|headache
1440042|NCT01003639|obesity|obesity
1440043|NCT01003639|women|women
1440044|NCT01003639|diplopia|diplopia
1440045|NCT01003639|tinnitus|tinnitus
1440046|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
1440047|NCT01003626|Tumor Pressure|tumor pressure
1440048|NCT01003626|Tumor IFP|tumor ifp
1440049|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
1440050|NCT01003626|IFP|ifp
1440051|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
1440052|NCT01003626|Transducer Millar|transducer millar
1440053|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
1440054|NCT01003613|Tranilast|tranilast
1440055|NCT01003613|fibrin glue|fibrin glue
1440056|NCT01003613|primary pterygium|primary pterygium
1440057|NCT01003613|conjunctival autograft|conjunctival autograft
1440058|NCT01003600|Survivorship|survivorship
1440059|NCT01003600|Quality of Life|quality of life
1440060|NCT01003600|Questionnaire|questionnaire
1440061|NCT01003600|09-133|09-133
1440062|NCT01003587|India|india
1440063|NCT01003587|evidence-based policy|evidence-based policy
1440064|NCT01003587|knowledge translation|knowledge translation
1440065|NCT01003587|disease control priorities|disease control priorities
1440066|NCT01003587|decision-makers|decision-makers
1440067|NCT01003587|health spending|health spending
1440068|NCT01003587|health services delivery|health services delivery
1440069|NCT01003587|maternal and child health|maternal and child health
1440070|NCT01003587|policy making|policy making
1440071|NCT01003587|delivery of health care|delivery of health care
1440072|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
1440200|NCT01003106|RVO|rvo
1440073|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
1440074|NCT01003548|Embryo culture|embryo culture
1440075|NCT01003548|IVF|ivf
1440076|NCT01003548|Microfluidics|microfluidics
1440077|NCT01003548|infertility|infertility
1440078|NCT01003535|Parkinson´s disease|parkinson´s disease
1440079|NCT01003535|Acetylcholine receptors|acetylcholine receptors
1440080|NCT01003522|Bronchial stents|bronchial stents
1440081|NCT01003522|Airway obstruction|airway obstruction
1440082|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
1440083|NCT01003509|inguinal|inguinal
1440084|NCT01003509|hernia|hernia
1440085|NCT01003509|new|new
1440086|NCT01003509|repair|repair
1440087|NCT01003509|modified shouldice|modified shouldice
1440088|NCT01003509|double|double
1440089|NCT01003496|Cocaine|cocaine
1440090|NCT01003496|crack|crack
1440091|NCT01003496|heroin|heroin
1440092|NCT01003496|non-prescribed opioids|non-prescribed opioids
1440093|NCT01003496|contingency management|contingency management
1440094|NCT01003496|community reinforcement approach|community reinforcement approach
1440095|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
1440096|NCT01003496|chronic disease treatment models|chronic disease treatment models
1440097|NCT01003483|metformin|metformin
1440098|NCT01003483|orlistat|orlistat
1440099|NCT01003483|pcos|pcos
1440100|NCT01003483|obese|obese
1440101|NCT01003470|cerebral infarction|cerebral infarction
1440102|NCT01003470|Paralysis|paralysis
1440103|NCT01003470|acupuncture|acupuncture
1440104|NCT01003470|rehabilitation|rehabilitation
1440105|NCT01003470|trial|trial
1440106|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
1440107|NCT01003418|GSK2340272A|gsk2340272a
1440108|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
1440109|NCT01003405|Overactive bladder|overactive bladder
1440110|NCT01003405|Frequency|frequency
1440111|NCT01003405|Micturition|micturition
1440112|NCT01003405|Urgency|urgency
1440113|NCT01003405|Urge urinary incontinence|urge urinary incontinence
1440114|NCT01003405|OAB|oab
1440115|NCT01003392|Coronary artery disease|coronary artery disease
1440116|NCT01003392|Coffee|coffee
1440117|NCT01003392|Heart system|heart system
1440118|NCT01003379|cognitive dysfunction|cognitive dysfunction
1440119|NCT01003379|schizophrenia|schizophrenia
1440120|NCT01003379|Phase 2|phase 2
1440223|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
1440121|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
1440122|NCT01003353|Stroke|stroke
1440123|NCT01003353|Strength training|strength training
1440124|NCT01003353|exercise therapy|exercise therapy
1440125|NCT01003340|asthma|asthma
1440126|NCT01003340|children|children
1440127|NCT01003340|community health workers|community health workers
1440128|NCT01003340|home intervention|home intervention
1440129|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
1440130|NCT01003327|leak pressure|leak pressure
1440131|NCT01003314|Vaccine|vaccine
1440132|NCT01003314|Safety|safety
1440133|NCT01003314|Immunogenicity|immunogenicity
1440134|NCT01003314|Protection|protection
1440135|NCT01003314|Sporozoite challenge|sporozoite challenge
1440136|NCT01003301|cat allergy|cat allergy
1440137|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
1440138|NCT01003288|Health employees|health employees
1440139|NCT01003275|Chronic kidney disease|chronic kidney disease
1440140|NCT01003275|Vitamin D|vitamin d
1440141|NCT01003275|Paricalcitol|paricalcitol
1440142|NCT01003275|Placebo|placebo
1440143|NCT01003275|Kidney|kidney
1440144|NCT01003275|Renal|renal
1440145|NCT01003275|Oxidative Stress|oxidative stress
1440146|NCT01003275|Immune cell function|immune cell function
1440147|NCT01003275|Glucose|glucose
1440148|NCT01003275|Glucose tolerance|glucose tolerance
1440149|NCT01003262|Observation Unit|observation unit
1440150|NCT01003262|Emergency Department|emergency department
1440151|NCT01003249|over distention of bladder|over distention of bladder
1440152|NCT01003249|Dysfunctional voiding|dysfunctional voiding
1440153|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
1440154|NCT01003236|Diabetic nephropathy|diabetic nephropathy
1440155|NCT01003236|Type II Diabetes|type ii diabetes
1440156|NCT01003236|Milk Thistle extract|milk thistle extract
1440157|NCT01003236|Silymarin|silymarin
1440158|NCT01003223|phosphorus|phosphorus
1440159|NCT01003223|dialysis|dialysis
1440160|NCT01003223|PhosLo|phoslo
1440161|NCT01003223|CKD stage V|ckd stage v
1440162|NCT01003210|otitis media|otitis media
1440163|NCT01003210|children|children
1440164|NCT01003210|homeopathy|homeopathy
1440165|NCT01003197|Development|development
1440166|NCT01003197|Validation|validation
1440167|NCT01003197|Prediction Score|prediction score
1440168|NCT01003197|Complication|complication
1440169|NCT01003197|Liver resection|liver resection
1440170|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
1440171|NCT01003184|diabetes|diabetes
1440172|NCT01003184|exenatide once weekly|exenatide once weekly
1440173|NCT01003184|Byetta|byetta
1440174|NCT01003184|insulin detemir|insulin detemir
1440175|NCT01003184|Levemir|levemir
1440176|NCT01003184|Amylin|amylin
1440177|NCT01003184|Lilly|lilly
1440178|NCT01003171|Pharmacokinetics|pharmacokinetics
1440179|NCT01003171|PK|pk
1440180|NCT01003171|MCS|mcs
1440181|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1440182|NCT01003171|Multi-Carotenoids|multi-carotenoids
1440183|NCT01003171|Healthy subjects|healthy subjects
1440184|NCT01003158|Cancer|cancer
1440185|NCT01003158|tumour|tumour
1440186|NCT01003158|metastatic|metastatic
1440187|NCT01003158|breast cancer|breast cancer
1440188|NCT01003145|Influenza|influenza
1440189|NCT01003145|vaccine|vaccine
1440190|NCT01003145|Immunogenicity|immunogenicity
1440191|NCT01003132|Psychosis|psychosis
1440192|NCT01003132|Distress|distress
1440193|NCT01003132|Mindfulness|mindfulness
1440194|NCT01003132|Acceptance|acceptance
1440195|NCT01003132|Values|values
1440196|NCT01003119|Alcohol addiction|alcohol addiction
1440197|NCT01003119|Alcohol treatment|alcohol treatment
1440198|NCT01003119|Alcohol recovery|alcohol recovery
1440199|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
1440201|NCT01003106|BRVO|brvo
1440202|NCT01003106|CRVO|crvo
1440203|NCT01003106|Vein occlusion|vein occlusion
1440204|NCT01003093|Tuberculosis|tuberculosis
1440205|NCT01003093|Vaccine|vaccine
1440206|NCT01003093|Ag85B|ag85b
1440207|NCT01003093|ESAT-6|esat-6
1440208|NCT01003093|IC31|ic31
1440209|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
1440210|NCT01003054|Leukemia|leukemia
1440211|NCT01003054|CML|cml
1440212|NCT01003054|Busulfan|busulfan
1440213|NCT01003054|Busulfex|busulfex
1440214|NCT01003054|Myleran|myleran
1440215|NCT01003054|Cyclophosphamide|cyclophosphamide
1440216|NCT01003054|Cytoxan|cytoxan
1440217|NCT01003054|Neosar|neosar
1440218|NCT01003054|Imatinib Mesylate|imatinib mesylate
1440219|NCT01003054|Gleevec|gleevec
1440220|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1440221|NCT01003054|Stem Cell Transplant|stem cell transplant
1440222|NCT01003041|healthy normal infants|healthy normal infants
1440628|NCT01001377|Vectibix|vectibix
1440224|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
1440225|NCT01003015|HCC|hcc
1440226|NCT01003015|Safety|safety
1440227|NCT01003015|BAY73-4506|bay73-4506
1440228|NCT01003002|Parkinson's disease|parkinson's disease
1440229|NCT01003002|Dyskinesia|dyskinesia
1440230|NCT01003002|Movement Disorders|movement disorders
1440231|NCT01002989|ankle brachial index|ankle brachial index
1440232|NCT01002989|WatchBP Office|watchbp office
1440233|NCT01002989|oscillometric measurement|oscillometric measurement
1440234|NCT01002937|Biomarkers|biomarkers
1440235|NCT01002937|Prognosis response to treatment|prognosis response to treatment
1440236|NCT01002937|Renal cancer|renal cancer
1440237|NCT01002924|Cancer|cancer
1440238|NCT01002924|Adenocarcinoma|adenocarcinoma
1440239|NCT01002924|Phase II|phase ii
1440240|NCT01002924|Lung|lung
1440241|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
1440242|NCT01002924|NSCLC|nsclc
1440243|NCT01002924|extension|extension
1440244|NCT01002924|EC145|ec145
1440245|NCT01002924|Prior exposure to EC145|prior exposure to ec145
1440246|NCT01002911|Device procedure|device procedure
1440247|NCT01002911|pacemaker|pacemaker
1440248|NCT01002911|ICD|icd
1440249|NCT01002911|antibiotics|antibiotics
1440250|NCT01002898|HIV-1 RNA|hiv-1 rna
1440251|NCT01002898|Treatment experienced|treatment experienced
1440252|NCT01002885|Infertility|infertility
1440253|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
1440254|NCT01002872|FGF23|fgf23
1440255|NCT01002872|CKD|ckd
1440256|NCT01002872|Fosrenol|fosrenol
1440257|NCT01002872|Hyperphosphatemia|hyperphosphatemia
1440258|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
1440259|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1440260|NCT01002859|Cyclosporine|cyclosporine
1440261|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
1440262|NCT01002846|Efficacy|efficacy
1440263|NCT01002846|Acupuncture|acupuncture
1440264|NCT01002846|Hypertension|hypertension
1440265|NCT01002833|Plasmodium falciparum|plasmodium falciparum
1440266|NCT01002833|Malaria|malaria
1440267|NCT01002820|Epileptic Seizures|epileptic seizures
1440268|NCT01002820|Seizure Disorder|seizure disorder
1440269|NCT01002820|Seizures|seizures
1440270|NCT01002820|Convulsions|convulsions
1440271|NCT01002820|Anticonvulsant|anticonvulsant
1440272|NCT01002820|Anticonvulsive|anticonvulsive
1440273|NCT01002820|Antiepileptic|antiepileptic
1440274|NCT01002820|Ganaxolone|ganaxolone
1440275|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
1440276|NCT01002794|Arthroscopy|arthroscopy
1440277|NCT01002794|Exercise therapy|exercise therapy
1440278|NCT01002781|Tocilizumab Still|tocilizumab still
1440279|NCT01002755|Leukemia|leukemia
1440281|NCT01002755|SLL|sll
1440282|NCT01002755|Lenalidomide|lenalidomide
1440283|NCT01002755|Ofatumumab|ofatumumab
1440284|NCT01002742|GVHD|gvhd
1440285|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
1440286|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
1440287|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
1440288|NCT01002703|Lenalidomide|lenalidomide
1440289|NCT01002703|Bendamustine|bendamustine
1440290|NCT01002703|Multiple Myeloma|multiple myeloma
1440291|NCT01002703|Myeloma|myeloma
1440292|NCT01002703|Revlimid|revlimid
1440293|NCT01002703|Phase I/II|phase i/ii
1440294|NCT01002703|refractory Myeloma|refractory myeloma
1440295|NCT01002703|relapsed Myeloma|relapsed myeloma
1440296|NCT01002690|Asthma|asthma
1440297|NCT01002690|Allergen challenge|allergen challenge
1440298|NCT01002690|Airway responsiveness|airway responsiveness
1440299|NCT01002690|Prostaglandins|prostaglandins
1440300|NCT01002690|Eicosanoids|eicosanoids
1440301|NCT01002677|brain injury|brain injury
1440302|NCT01002677|traumatic brain injury|traumatic brain injury
1440303|NCT01002677|training|training
1440304|NCT01002677|teaching|teaching
1440305|NCT01002677|curriculum|curriculum
1440306|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1440307|NCT01002664|Multi-carotenoids|multi-carotenoids
1440308|NCT01002664|MCS-2|mcs-2
1440309|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1440310|NCT01002664|International prostate symptom scores|international prostate symptom scores
1440311|NCT01002651|gastrointestinal health|gastrointestinal health
1440312|NCT01002651|healthy subjects|healthy subjects
1440313|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
1440314|NCT01002612|Nutritional status|nutritional status
1440315|NCT01002612|Thai HIV-infected children|thai hiv-infected children
1440316|NCT01002599|bariatric surgery|bariatric surgery
1440317|NCT01002599|morbidly obese|morbidly obese
1440318|NCT01002599|BMI >35|bmi >35
1440319|NCT01002599|CPAP|cpap
1440320|NCT01002599|Venturi|venturi
1440321|NCT01002599|Boussignac|boussignac
1440322|NCT01002599|Ventilation|ventilation
1440323|NCT01002599|Pulmonary function|pulmonary function
1440324|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
1440325|NCT01002586|Alzheimer's dementia|alzheimer's dementia
1440326|NCT01002586|Wii-Fit|wii-fit
1440327|NCT01002586|Walking|walking
1440328|NCT01002586|Falls|falls
1440329|NCT01002573|Pediatric|pediatric
1440330|NCT01002573|Fever|fever
1440331|NCT01002560|Melanoma|melanoma
1440332|NCT01002560|Novel Prognostic Markers|novel prognostic markers
1440333|NCT01002547|steatohepatitis|steatohepatitis
1440334|NCT01002547|type 2 diabetes|type 2 diabetes
1440335|NCT01002547|fatty liver|fatty liver
1440336|NCT01002534|Cystic Fibrosis|cystic fibrosis
1440337|NCT01002534|Vardenafil|vardenafil
1440338|NCT01002534|Nasal instillation|nasal instillation
1440339|NCT01002534|Nasal Potential difference|nasal potential difference
1440340|NCT01002521|Diabetes|diabetes
1440341|NCT01002521|vascular|vascular
1440342|NCT01002521|haptoglobin|haptoglobin
1440343|NCT01002521|tumor|tumor
1440344|NCT01002521|necrosis|necrosis
1440345|NCT01002521|factor|factor
1440346|NCT01002521|alpha|alpha
1440347|NCT01002521|traps|traps
1440348|NCT01002521|impaired|impaired
1440349|NCT01002521|wound|wound
1440350|NCT01002521|healing|healing
1440351|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
1440352|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
1440353|NCT01002495|myocardial|myocardial
1440354|NCT01002495|ischemia|ischemia
1440355|NCT01002495|coronary disease|coronary disease
1440356|NCT01002495|angina|angina
1440357|NCT01002482|Hyperglycemia|hyperglycemia
1440358|NCT01002482|Hypoglycemia|hypoglycemia
1440359|NCT01002482|Intensive Care Unit|intensive care unit
1440360|NCT01002482|Glucose Control|glucose control
1440361|NCT01002482|Insulin|insulin
1440362|NCT01002482|Computer Protocol|computer protocol
1440363|NCT01002482|Metabolic Disorders|metabolic disorders
1440364|NCT01002469|isotope ratio measurement|isotope ratio measurement
1440365|NCT01002469|urea cycle|urea cycle
1440366|NCT01002469|13C acetate|13c acetate
1440367|NCT01002469|Healthy adults|healthy adults
1440368|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1440369|NCT01002456|Guideline Adherence|guideline adherence
1440370|NCT01002456|Drug Prescriptions|drug prescriptions
1440371|NCT01002456|target dose|target dose
1440372|NCT01002443|Helicobacter pylori|helicobacter pylori
1440373|NCT01002443|glandular atrophy|glandular atrophy
1440374|NCT01002443|intestinal metaplasia|intestinal metaplasia
1440375|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
1440376|NCT01002443|gastric cancer|gastric cancer
1440377|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
1578241|NCT00471107|HV|hv
1440378|NCT01002430|Myocardial ischemia|myocardial ischemia
1440379|NCT01002430|Refractory angina pectoris|refractory angina pectoris
1440380|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
1440381|NCT01002430|Gene therapy|gene therapy
1440382|NCT01002430|Perfusion|perfusion
1440383|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1440384|NCT01002417|Multi-carotenoids|multi-carotenoids
1440385|NCT01002417|MCS-2|mcs-2
1440386|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1440387|NCT01002417|International prostate symptom scores|international prostate symptom scores
1440388|NCT01002404|ERCP|ercp
1440389|NCT01002404|deep biliary cannulation|deep biliary cannulation
1440390|NCT01002404|guide wire cannulation|guide wire cannulation
1440391|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
1440392|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
1440393|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
1440394|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
1440395|NCT01002391|breast hypertrophy|breast hypertrophy
1440396|NCT01002391|mammaplasty|mammaplasty
1440397|NCT01002391|bandages|bandages
1440398|NCT01002391|surgical site infection|surgical site infection
1440399|NCT01002391|skin colonization|skin colonization
1440400|NCT01002352|obesity|obesity
1440401|NCT01002352|bariatric|bariatric
1440402|NCT01002352|BOLD|bold
1440403|NCT01002352|weightloss|weightloss
1440404|NCT01002352|database|database
1440405|NCT01002352|data registry|data registry
1440406|NCT01002326|Pediatric|pediatric
1440407|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
1440409|NCT01002326|CBT|cbt
1440410|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1440411|NCT01002300|Social Cognition|social cognition
1440412|NCT01002300|Oxytocin|oxytocin
1440413|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1440414|NCT01002274|BPH|bph
1440415|NCT01002274|MCS-2|mcs-2
1440416|NCT01002274|Multi-Carotenoids|multi-carotenoids
1440417|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1440418|NCT01002274|International prostate symptom score|international prostate symptom score
1440419|NCT01002261|Galactose|galactose
1440420|NCT01002261|PET/CT|pet/ct
1440421|NCT01002261|Liver physiology|liver physiology
1440422|NCT01002261|Liver pathophysiology|liver pathophysiology
1440423|NCT01002248|Multiple Myeloma|multiple myeloma
1440424|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
1440425|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
1440426|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
1440427|NCT01002235|Diabetic|diabetic
1440428|NCT01002235|Neuropathy|neuropathy
1440429|NCT01002235|peripheral|peripheral
1440430|NCT01002235|diabetes|diabetes
1440431|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1440432|NCT01002222|MCS-2|mcs-2
1440433|NCT01002222|Multi-Carotenoids|multi-carotenoids
1440434|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1440435|NCT01002222|International prostate symptom score|international prostate symptom score
1440436|NCT01002209|Diabetes|diabetes
1440437|NCT01002209|Vascular Surgery|vascular surgery
1440438|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
1440439|NCT01002209|Surgical complications|surgical complications
1440440|NCT01002209|Wound complication|wound complication
1440441|NCT01002209|Randomized|randomized
1440442|NCT01002209|Controlled|controlled
1440443|NCT01002196|Selective Mutism|selective mutism
1440444|NCT01002196|Intervention|intervention
1440445|NCT01002183|Malaria|malaria
1440446|NCT01002183|Plasmodium falciparum|plasmodium falciparum
1440447|NCT01002183|acute uncomplicated|acute uncomplicated
1440448|NCT01002170|Tuberculosis|tuberculosis
1440449|NCT01002170|Cycloserine|cycloserine
1440450|NCT01002170|Pharmacokinetics|pharmacokinetics
1440451|NCT01002157|Coronary Artery Calcification|coronary artery calcification
1440452|NCT01002157|Vitamin K|vitamin k
1440453|NCT01002157|Trial|trial
1440454|NCT01002157|Treatment|treatment
1440455|NCT01002131|Digital Volume Tomography|digital volume tomography
1440456|NCT01002131|Cone Beam CT|cone beam ct
1440457|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
1440458|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
1440459|NCT01002118|heart rate variability|heart rate variability
1440460|NCT01002118|Dialysis|dialysis
1440461|NCT01002105|Baclofen|baclofen
1440462|NCT01002105|Alcohol|alcohol
1440463|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
1440464|NCT01002092|Osteosarcoma|osteosarcoma
1440465|NCT01002092|Endostar|endostar
1440466|NCT01002092|Chemotherapy|chemotherapy
1440467|NCT01002066|Fever|fever
1440468|NCT01002066|Malaria|malaria
1440470|NCT01002066|IMCI|imci
1440471|NCT01002066|Children<5 years of age|children<5 years of age
1440473|NCT01002053|diabetes|diabetes
1440474|NCT01002053|neuropathy|neuropathy
1440475|NCT01002053|ankle block|ankle block
1440476|NCT01002053|regional anesthesia|regional anesthesia
1440477|NCT01002053|ultrasound|ultrasound
1440478|NCT01002053|nerve localization|nerve localization
1440479|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
1440480|NCT01002040|HIV|hiv
1440481|NCT01002040|vaccine,|vaccine,
1440482|NCT01002040|H1N1|h1n1
1440483|NCT01002040|influenza|influenza
1440484|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
1440485|NCT01002040|Arepanrix|arepanrix
1440486|NCT01002040|Pandemic|pandemic
1440487|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
1440488|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
1440489|NCT01002027|Postnatal Depression|postnatal depression
1440490|NCT01002027|CBT-Counselling|cbt-counselling
1440491|NCT01002027|Primary care|primary care
1440492|NCT01002014|Breast Cancer|breast cancer
1440493|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
1440494|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
1440495|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
1440496|NCT01002014|Nipple Areolar Complex|nipple areolar complex
1440497|NCT01002014|Mastectomy|mastectomy
1440498|NCT01002014|Breast Reconstruction|breast reconstruction
1440499|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
1440500|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
1440501|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
1440502|NCT01001988|Encephalitis|encephalitis
1440503|NCT01001988|Japanese Encephalitis|japanese encephalitis
1440504|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
1440505|NCT01001988|Toddlers|toddlers
1440506|NCT01001975|Sunscreens|sunscreens
1440507|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
1440508|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
1440509|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
1440510|NCT01001897|IUD insertion|iud insertion
1440511|NCT01001897|nulliparous women|nulliparous women
1440512|NCT01001897|contraception|contraception
1440513|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
1440514|NCT01001871|Iron deficiency anemia|iron deficiency anemia
1440515|NCT01001871|Sprinkles®|sprinkles®
1440516|NCT01001871|micronutrients|micronutrients
1440517|NCT01001871|malaria incidence|malaria incidence
1440518|NCT01001871|iron supplement|iron supplement
1440519|NCT01001858|OSA|osa
1440520|NCT01001858|CPAP compliance|cpap compliance
1440521|NCT01001858|nurse domiciliary led|nurse domiciliary led
1440522|NCT01001858|sleep disease|sleep disease
1440523|NCT01001845|hemodialysis|hemodialysis
1440524|NCT01001845|oxidative stress|oxidative stress
1440525|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
1440526|NCT01001845|Glutathion peroxidase|glutathion peroxidase
1440527|NCT01001780|Graft versus Host Disease|graft versus host disease
1440528|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1440529|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
1440530|NCT01001767|HIV|hiv
1440531|NCT01001767|Heart Disease|heart disease
1440532|NCT01001767|Treatment experienced|treatment experienced
1440533|NCT01001754|Hepatitis C|hepatitis c
1440534|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
1440535|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
1440536|NCT01001754|PEG-interferon lambda|peg-interferon lambda
1440537|NCT01001754|Interleukin 29|interleukin 29
1440538|NCT01001754|Virus|virus
1440539|NCT01001754|Infection|infection
1440540|NCT01001754|Liver Diseases|liver diseases
1440541|NCT01001741|HIV|hiv
1440542|NCT01001741|Antiretrovirals|antiretrovirals
1440543|NCT01001741|Adherence|adherence
1440544|NCT01001741|Text messaging|text messaging
1440545|NCT01001741|Antiretroviral adherence|antiretroviral adherence
1440546|NCT01001741|Treatment experienced|treatment experienced
1440547|NCT01001728|Breast Cancer|breast cancer
1440548|NCT01001728|Radiotherapy|radiotherapy
1440549|NCT01001728|Prone position|prone position
1440550|NCT01001702|Open Label|open label
1440551|NCT01001702|Aripiprazole|aripiprazole
1440553|NCT01001689|Preventive health care|preventive health care
1440554|NCT01001689|Fitness|fitness
1440555|NCT01001689|Nutrition|nutrition
1440556|NCT01001689|Obesity|obesity
1440557|NCT01001689|Diabetes|diabetes
1440558|NCT01001689|Weight gain|weight gain
1440559|NCT01001676|renal failure|renal failure
1440560|NCT01001676|Restenosis|restenosis
1440561|NCT01001676|Dialysis access|dialysis access
1440562|NCT01001676|Paclitaxel|paclitaxel
1440563|NCT01001676|Angioplasty|angioplasty
1440564|NCT01001676|Intimal hyperplasia|intimal hyperplasia
1440565|NCT01001663|CAG|cag
1440566|NCT01001650|Malaria Vaccine|malaria vaccine
1440567|NCT01001650|Plasmodium falciparum|plasmodium falciparum
1440568|NCT01001637|curcumin|curcumin
1440569|NCT01001637|alzheimer's|alzheimer's
1440570|NCT01001637|longVida|longvida
1440571|NCT01001637|dementia|dementia
1440572|NCT01001624|Cosmetic|cosmetic
1440573|NCT01001624|Facial cream|facial cream
1440574|NCT01001624|Melasma|melasma
1440575|NCT01001624|Melanil|melanil
1440576|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1440577|NCT01001611|glitazone|glitazone
1440578|NCT01001611|Type II Diabetes|type ii diabetes
1440579|NCT01001611|Hypolipidemic|hypolipidemic
1440580|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
1440581|NCT01001585|mitochondrial disease|mitochondrial disease
1440582|NCT01001585|sevoflurane|sevoflurane
1440583|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
1440584|NCT01001572|Blood pressure|blood pressure
1440585|NCT01001572|hypertension|hypertension
1440586|NCT01001572|Exforge|exforge
1440587|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
1440588|NCT01001559|Depression|depression
1440589|NCT01001559|Combination therapy|combination therapy
1440590|NCT01001559|antidepressant|antidepressant
1440591|NCT01001559|Deplin|deplin
1440592|NCT01001559|folate|folate
1440593|NCT01001559|methylfolate|methylfolate
1440594|NCT01001546|Veterans|veterans
1440595|NCT01001546|Smoking cessation|smoking cessation
1440596|NCT01001546|Operation Enduring Freedom|operation enduring freedom
1440597|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
1440598|NCT01001533|Electrical Cardiometry|electrical cardiometry
1440599|NCT01001533|Dexmedetomidine|dexmedetomidine
1440600|NCT01001533|ICON|icon
1440601|NCT01001533|bio-impedance|bio-impedance
1440602|NCT01001533|cardiac monitor|cardiac monitor
1440603|NCT01001520|Genetics|genetics
1440604|NCT01001520|Nicotine|nicotine
1440605|NCT01001520|Cognition|cognition
1440606|NCT01001520|fMRI|fmri
1440607|NCT01001507|Family planning|family planning
1440608|NCT01001507|HIV|hiv
1440609|NCT01001507|Integrated services|integrated services
1440610|NCT01001507|Unintended pregnancy|unintended pregnancy
1440611|NCT01001507|Kenya|kenya
1440612|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1440613|NCT01001494|antimuscarinic|antimuscarinic
1440614|NCT01001494|COPD|copd
1440615|NCT01001481|Treatment review|treatment review
1440616|NCT01001481|Schizophrenia|schizophrenia
1440617|NCT01001481|Observational|observational
1440618|NCT01001481|Prospective studies|prospective studies
1440619|NCT01001481|Australia|australia
1440620|NCT01001468|Psoriasis|psoriasis
1440621|NCT01001455|BP|bp
1440622|NCT01001442|Multiple myeloma|multiple myeloma
1440623|NCT01001442|Relapsed|relapsed
1440624|NCT01001442|Refractory|refractory
1440625|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
1440626|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
1440627|NCT01001377|Panitumumab|panitumumab
1440629|NCT01001377|Colon Cancer|colon cancer
1440630|NCT01001377|Colorectal Cancer|colorectal cancer
1440631|NCT01001377|Rectal Cancer|rectal cancer
1440632|NCT01001377|Cetuximab|cetuximab
1440633|NCT01001377|Erbitux|erbitux
1440634|NCT01001377|Metastatic|metastatic
1440635|NCT01001351|Chronic Kidney Disease|chronic kidney disease
1440636|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
1440637|NCT01001351|Hemodialysis|hemodialysis
1440638|NCT01001351|Vascular Access|vascular access
1440639|NCT01001351|Dialysis|dialysis
1440640|NCT01001351|Graft|graft
1440641|NCT01001351|Access|access
1440642|NCT01001351|vonapanitase|vonapanitase
1440643|NCT01001351|kidney|kidney
1440644|NCT01001351|renal|renal
1440645|NCT01001325|influenza|influenza
1440646|NCT01001325|vaccine|vaccine
1440647|NCT01001325|observer blind|observer blind
1440648|NCT01001312|Heart Failure|heart failure
1440649|NCT01001312|Therapeutics|therapeutics
1440650|NCT01001312|Blood volume|blood volume
1440651|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
1440652|NCT01001273|Pancreas Transplantation|pancreas transplantation
1440653|NCT01001273|Kidney Transplantation|kidney transplantation
1440654|NCT01001273|Organ Transplantation|organ transplantation
1440655|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
1440656|NCT01001260|Prostaglandins|prostaglandins
1440657|NCT01001260|vascular injury|vascular injury
1440658|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
1440659|NCT01001247|TMC278-C154|tmc278-c154
1440660|NCT01001247|TMC278|tmc278
1440661|NCT01001247|Healthy volunteers|healthy volunteers
1440662|NCT01001247|omeprazole|omeprazole
1440663|NCT01001247|proton pump inhibitor|proton pump inhibitor
1440664|NCT01001247|HIV|hiv
1440665|NCT01001208|Etanercept|etanercept
1440666|NCT01001208|Methotrexate|methotrexate
1440667|NCT01001208|Psoriasis|psoriasis
1440668|NCT01001182|observational|observational
1440669|NCT01001182|non-interventional|non-interventional
1440670|NCT01001182|prospective|prospective
1440671|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1440672|NCT01001169|influenza infection|influenza infection
1440673|NCT01001156|Aged|aged
1440674|NCT01001156|Breathing Muscles|breathing muscles
1440675|NCT01001156|Strength Muscles|strength muscles
1440676|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
1440677|NCT01001130|avamys|avamys
1440678|NCT01001130|Allergic Rhinitis|allergic rhinitis
1440679|NCT01001130|post marketing surveillance|post marketing surveillance
1440680|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1440681|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
1440682|NCT01001117|Cataract|cataract
1440683|NCT01001117|Capsulotomy|capsulotomy
1440684|NCT01001117|Capsulorrhexis|capsulorrhexis
1440685|NCT01001117|Phacoemulsification|phacoemulsification
1440686|NCT01001104|Metabolic Diseases|metabolic diseases
1440687|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
1440688|NCT01001104|Diabetes|diabetes
1440689|NCT01001104|GLP-1|glp-1
1440690|NCT01001104|Lilly|lilly
1440691|NCT01001091|Conjunctivitis|conjunctivitis
1440692|NCT01001091|conjunctival inflammation|conjunctival inflammation
1440693|NCT01001091|ocular allergies|ocular allergies
1440694|NCT01001078|supraglottic airway devices|supraglottic airway devices
1440695|NCT01001078|I-Gel|i-gel
1440696|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
1440697|NCT01001078|Airway leak pressure|airway leak pressure
1440698|NCT01001078|peak airway pressure|peak airway pressure
1440699|NCT01001052|Healthy|healthy
1440700|NCT01001052|bioavailability|bioavailability
1440701|NCT01001039|chronic sinusitis|chronic sinusitis
1440702|NCT01001039|facial pain|facial pain
1440703|NCT01001026|vaccine|vaccine
1440704|NCT01001026|H1N1|h1n1
1440705|NCT01001026|influenza|influenza
1440706|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
1440707|NCT01001026|pandemic|pandemic
1440709|NCT01000987|reactivity|reactivity
1440710|NCT01000987|smoking cessation medications|smoking cessation medications
1440711|NCT01000974|primary vaccination course|primary vaccination course
1440712|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
1440713|NCT01000974|infants, children|infants, children
1440714|NCT01000974|booster vaccination|booster vaccination
1440715|NCT01000974|immunogenicity|immunogenicity
1440716|NCT01000974|safety|safety
1440717|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
1440718|NCT01000974|vaccines, conjugate|vaccines, conjugate
1440719|NCT01000961|cystinosis|cystinosis
1440720|NCT01000961|cysteamine|cysteamine
1440721|NCT01000961|inheritable disease|inheritable disease
1440722|NCT01000961|orphan disease|orphan disease
1440723|NCT01000961|CTNS protein, human|ctns protein, human
1440724|NCT01000961|metabolic disease|metabolic disease
1440725|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
1440726|NCT01000948|Prostate cancer|prostate cancer
1440727|NCT01000948|Castration resistant|castration resistant
1440728|NCT01000948|Chemotherapy resistant|chemotherapy resistant
1440823|NCT01000584|H1N1|h1n1
1440729|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
1440730|NCT01000948|ZD4054|zd4054
1440731|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
1440732|NCT01000922|Mealtime Insulin|mealtime insulin
1440733|NCT01000922|Rapid acting insulin|rapid acting insulin
1440734|NCT01000922|Ultra fast VIAject|ultra fast viaject
1440735|NCT01000922|prandial insulin|prandial insulin
1440736|NCT01000896|Phase I|phase i
1440737|NCT01000896|cancer|cancer
1440738|NCT01000896|solid tumors|solid tumors
1440739|NCT01000896|advanced solid malignancies|advanced solid malignancies
1440740|NCT01000896|NSCLC|nsclc
1440741|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
1440742|NCT01000896|dose escalation|dose escalation
1440743|NCT01000896|combination treatment|combination treatment
1440744|NCT01000896|src inhibitor|src inhibitor
1440745|NCT01000896|Japanese|japanese
1440746|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
1440747|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
1440748|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
1440749|NCT01000883|stage IV breast cancer|stage iv breast cancer
1440750|NCT01000883|recurrent breast cancer|recurrent breast cancer
1440751|NCT01000857|controlled-release tablet|controlled-release tablet
1440752|NCT01000857|repeat dose|repeat dose
1440753|NCT01000857|immediate-release tablet|immediate-release tablet
1440754|NCT01000857|paroxetine|paroxetine
1440755|NCT01000857|safety|safety
1440756|NCT01000857|crossover|crossover
1440757|NCT01000857|pharmacokinetics|pharmacokinetics
1440758|NCT01000857|steady-state|steady-state
1440759|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
1440760|NCT01000857|tolerance|tolerance
1440761|NCT01000844|Hemophilia|hemophilia
1440762|NCT01000844|Joint|joint
1440763|NCT01000844|Cartilage|cartilage
1440764|NCT01000844|Damage|damage
1440765|NCT01000844|Prophylaxis|prophylaxis
1440766|NCT01000844|Factor VIII|factor viii
1440767|NCT01000844|FVIII|fviii
1440768|NCT01000844|Disease|disease
1440769|NCT01000844|Arthropathy|arthropathy
1440770|NCT01000831|vaccine|vaccine
1440771|NCT01000831|influenza|influenza
1440772|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
1440773|NCT01000831|influenza vaccine|influenza vaccine
1440774|NCT01000831|Arepanrix|arepanrix
1440775|NCT01000818|Treatment experienced|treatment experienced
1440776|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
1440777|NCT01000753|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
1440778|NCT01000753|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
1440779|NCT01000753|grade 1 follicular lymphoma|grade 1 follicular lymphoma
1440780|NCT01000753|grade 2 follicular lymphoma|grade 2 follicular lymphoma
1440781|NCT01000753|grade 3 follicular lymphoma|grade 3 follicular lymphoma
1440782|NCT01000753|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1440783|NCT01000753|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
1440784|NCT01000753|mantle cell lymphoma|mantle cell lymphoma
1440785|NCT01000753|marginal zone lymphoma|marginal zone lymphoma
1440786|NCT01000753|small lymphocytic lymphoma|small lymphocytic lymphoma
1440787|NCT01000753|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1440788|NCT01000753|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1440789|NCT01000753|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
1440790|NCT01000753|lymphoproliferative disorder|lymphoproliferative disorder
1440791|NCT01000740|EAP|eap
1440792|NCT01000740|Long term survival (3 years)|long term survival (3 years)
1440793|NCT01000740|Gefitinib|gefitinib
1440794|NCT01000740|efficacy|efficacy
1440795|NCT01000727|Atherosclerosis|atherosclerosis
1440796|NCT01000727|Heart disease|heart disease
1440797|NCT01000727|Cardiovascular disease|cardiovascular disease
1440798|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
1440799|NCT01000727|The TIMI Study Group|the timi study group
1440800|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
1440801|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1440802|NCT01000701|Inflammation|inflammation
1440803|NCT01000701|ACS|acs
1440804|NCT01000701|Prevention|prevention
1440805|NCT01000701|Education|education
1440806|NCT01000701|Clinical management|clinical management
1440807|NCT01000675|aneurysm|aneurysm
1440808|NCT01000675|coils|coils
1440809|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
1440810|NCT01000662|tumor bed boost|tumor bed boost
1440811|NCT01000649|V1a agonist|v1a agonist
1440812|NCT01000636|Renal transplant patients|renal transplant patients
1440813|NCT01000636|Actinic Keratoses|actinic keratoses
1440814|NCT01000636|Metvix PDT|metvix pdt
1440815|NCT01000636|Field cancerisation|field cancerisation
1440816|NCT01000636|Gene expression|gene expression
1440817|NCT01000597|pharmacokinetics|pharmacokinetics
1440818|NCT01000597|serum cortisol|serum cortisol
1440819|NCT01000597|pharmacodynamics|pharmacodynamics
1440820|NCT01000597|fluticasone furoate|fluticasone furoate
1440821|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
1440822|NCT01000584|vaccine|vaccine
1440825|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
1440826|NCT01000584|influenza vaccine|influenza vaccine
1440827|NCT01000584|seasonal Influenza|seasonal influenza
1440828|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
1440829|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
1440830|NCT01000545|Diabetes Mellitus|diabetes mellitus
1440831|NCT01000545|Chronic Kidney Disease|chronic kidney disease
1440832|NCT01000545|Glycosaminoglycans|glycosaminoglycans
1440833|NCT01000545|Sulodexide|sulodexide
1440834|NCT01000545|Macroalbuminuria|macroalbuminuria
1440835|NCT01000545|Safety and Efficacy|safety and efficacy
1440836|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
1440837|NCT01000519|Diabetes mellitus|diabetes mellitus
1440838|NCT01000519|Randomized control trial|randomized control trial
1440839|NCT01000519|Exercise|exercise
1440840|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1440841|NCT01000506|Dose-ranging|dose-ranging
1440842|NCT01000506|Safety|safety
1440843|NCT01000506|Pharmacodynamics|pharmacodynamics
1440844|NCT01000506|eosinophils|eosinophils
1440845|NCT01000506|SB-240563|sb-240563
1440846|NCT01000506|Efficacy|efficacy
1440847|NCT01000506|Severe refractory asthma|severe refractory asthma
1440848|NCT01000506|mepolizumab|mepolizumab
1440849|NCT01000506|Placebo|placebo
1440850|NCT01000493|efficacy|efficacy
1440851|NCT01000493|double-blind|double-blind
1440852|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
1440853|NCT01000493|placebo|placebo
1440854|NCT01000493|Sleep|sleep
1440855|NCT01000493|safety|safety
1440856|NCT01000493|CAPS|caps
1440857|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
1440858|NCT01000493|orvepitant|orvepitant
1440859|NCT01000493|PTSD|ptsd
1440860|NCT01000493|randomized|randomized
1440861|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
1440862|NCT01000493|Phase II|phase ii
1440863|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
1440864|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
1440865|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
1440866|NCT01000428|NSCLC|nsclc
1440868|NCT01000428|Positron emission technology|positron emission technology
1440869|NCT01000428|FLT|flt
1440870|NCT01000428|FDG|fdg
1440871|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
1440872|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1440873|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
1440874|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
1440875|NCT01000415|Quality of life|quality of life
1440876|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
1440877|NCT01000402|Bipolar Disorder|bipolar disorder
1440878|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1440879|NCT01000402|Genetics|genetics
1440880|NCT01000402|Environmental Factors|environmental factors
1440881|NCT01000402|Family Factors|family factors
1440882|NCT01000376|Cancer|cancer
1440883|NCT01000376|solid tumors|solid tumors
1440884|NCT01000350|orthostatic intolerance|orthostatic intolerance
1440885|NCT01000350|exercise capacity|exercise capacity
1440886|NCT01000350|tachycardia|tachycardia
1440887|NCT01000350|POTS|pots
1440888|NCT01000337|Liver Apoptosis|liver apoptosis
1440889|NCT01000324|Hepatitis A|hepatitis a
1440890|NCT01000324|Hepatitis B|hepatitis b
1440891|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
1440892|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
1440893|NCT01000311|MenACWY|menacwy
1440894|NCT01000246|mammacarcinoma|mammacarcinoma
1440895|NCT01000246|breastcancer|breastcancer
1440896|NCT01000246|chemotherapy|chemotherapy
1440897|NCT01000246|heart failure|heart failure
1440898|NCT01000246|influenza virus vaccine|influenza virus vaccine
1440899|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
1440900|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
1440901|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
1440902|NCT01000207|Influenza A|influenza a
1440903|NCT01000207|H1N1 subtype|h1n1 subtype
1440904|NCT01000207|Children/adolescent|children/adolescent
1440905|NCT01000207|Vaccine|vaccine
1440906|NCT01000207|Adjuvant|adjuvant
1440907|NCT01000194|postprandial|postprandial
1440908|NCT01000194|gene expression profiles|gene expression profiles
1440909|NCT01000194|microarray|microarray
1440910|NCT01000168|Brain Injury|brain injury
1440911|NCT01000168|Rehabilitation|rehabilitation
1440912|NCT01000168|Treadmill therapy|treadmill therapy
1440913|NCT01000155|fetal hemoglobin|fetal hemoglobin
1440914|NCT01000155|vorinostat|vorinostat
1440915|NCT01000155|HDAC inhibitor|hdac inhibitor
1440916|NCT01000155|SAHA|saha
1440917|NCT01000142|Osteopathic|osteopathic
1440918|NCT01000142|Manipulation|manipulation
1440919|NCT01000142|Preventative|preventative
1440920|NCT01000142|Elderly|elderly
1440921|NCT01000142|Nursing Home|nursing home
1440922|NCT01000142|Prevention: General Health Status|prevention: general health status
1440923|NCT01000129|Radiotherapy|radiotherapy
1440924|NCT01000129|Bladder cancer|bladder cancer
1440925|NCT01000129|Adaptive planning|adaptive planning
1440926|NCT01000116|Tapp|tapp
1440927|NCT01000116|Early pain|early pain
1440928|NCT01000116|well-being|well-being
1440929|NCT01000116|Seroma|seroma
1440930|NCT01000116|Haematoma|haematoma
1440931|NCT01000116|Fibrin glue|fibrin glue
1440932|NCT01000116|tacks|tacks
1440933|NCT01000103|Stroke|stroke
1440934|NCT01000103|Visuospatial neglect|visuospatial neglect
1440935|NCT01000103|Visuospatial extinction|visuospatial extinction
1440936|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1440937|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
1440938|NCT01000103|Neuromodulation|neuromodulation
1440939|NCT01000103|Brain parietal cortex|brain parietal cortex
1440940|NCT01000103|Neurological sequels|neurological sequels
1440941|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
1440942|NCT01000090|Acromegaly|acromegaly
1440943|NCT01000090|Somatostatin analogues|somatostatin analogues
1440944|NCT01000090|Treatment|treatment
1440945|NCT01000077|Regenerative Medicine|regenerative medicine
1440946|NCT01000077|Tissue Collection|tissue collection
1440947|NCT01000077|Cell Culture Systems|cell culture systems
1440948|NCT01000077|Routine Surgery|routine surgery
1440949|NCT01000064|Traumatic Brain Injury|traumatic brain injury
1440950|NCT01000064|Attention Deficit|attention deficit
1440951|NCT01000064|TBI|tbi
1440952|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
1440953|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
1440954|NCT01000051|HCT|hct
1440955|NCT01000051|Low platelet count|low platelet count
1440956|NCT01000051|Bleeding|bleeding
1440957|NCT01000051|Blood clot|blood clot
1440958|NCT01000051|Stem Cell Transplant|stem cell transplant
1440959|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
1440960|NCT01000051|Eltrombopag|eltrombopag
1440961|NCT01000051|Promacta|promacta
1440962|NCT01000038|Wii-Fit|wii-fit
1440963|NCT01000038|Assisted living|assisted living
1440964|NCT01000038|Alzheimer's dementia|alzheimer's dementia
1440965|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1440966|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1440967|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1440968|NCT00999999|Craniotomy outcome|craniotomy outcome
1440969|NCT00999999|CSF leakage|csf leakage
1440970|NCT00999999|Dural sealant|dural sealant
1440971|NCT00999960|Laparoscopy|laparoscopy
1440972|NCT00999960|Prostate|prostate
1440973|NCT00999960|Cancer|cancer
1440974|NCT00999960|Learning|learning
1440975|NCT00999960|Simulation|simulation
1440976|NCT00999960|Simulator|simulator
1440977|NCT00999947|genetics|genetics
1440978|NCT00999947|mutation screening|mutation screening
1440979|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
1440980|NCT00999947|desmosomal genes|desmosomal genes
1440981|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
1440982|NCT00999921|Fibroadenoma|fibroadenoma
1440983|NCT00999921|Mastalgia|mastalgia
1440984|NCT00999908|COPD|copd
1440985|NCT00999908|indacaterol|indacaterol
1440986|NCT00999908|tiotropium|tiotropium
1440987|NCT00999895|Schizophrenia|schizophrenia
1440988|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
1440989|NCT00999895|Outcome evaluation|outcome evaluation
1440990|NCT00999895|monotherapy|monotherapy
1440991|NCT00999895|Greece|greece
1440992|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
1440993|NCT00999882|Phase I/II|phase i/ii
1440994|NCT00999882|Dose escalation|dose escalation
1440995|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1440996|NCT00999882|Asia|asia
1440997|NCT00999882|HCC|hcc
1440998|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
1440999|NCT00999869|Newly diagnosed|newly diagnosed
1441000|NCT00999869|Alopecia areata|alopecia areata
1441001|NCT00999869|Botulinum toxin A|botulinum toxin a
1441002|NCT00999869|Corticosteroid|corticosteroid
1441003|NCT00999869|Intralesional injection|intralesional injection
1441004|NCT00999856|medical device,|medical device,
1441005|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
1441006|NCT00999856|photometer|photometer
1441007|NCT00999856|fluorescence|fluorescence
1441008|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
1441009|NCT00999856|non-invasive measurement|non-invasive measurement
1441010|NCT00999843|Sorafenib|sorafenib
1441011|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
1441012|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
1441013|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1441014|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
1441015|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
1441016|NCT00999778|Autism|autism
1441017|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
1441018|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
1441019|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
1441020|NCT00999778|ASD|asd
1441021|NCT00999765|Bipolar Disorder|bipolar disorder
1441022|NCT00999765|Bipolar Depression|bipolar depression
1441023|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1441024|NCT00999765|MBCT|mbct
1441025|NCT00999765|Maintenance|maintenance
1441026|NCT00999765|Euthymic|euthymic
1441027|NCT00999765|Efficacy|efficacy
1441028|NCT00999765|Feasibility|feasibility
1441029|NCT00999752|Hypertension|hypertension
1441030|NCT00999752|African Americans|african americans
1441031|NCT00999752|Arterial Stiffness|arterial stiffness
1441032|NCT00999752|Vascular Resistance|vascular resistance
1441033|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
1441034|NCT00999739|HIV|hiv
1441035|NCT00999739|antibody response|antibody response
1441036|NCT00999739|antibody affinity|antibody affinity
1441037|NCT00999739|Antibody formation|antibody formation
1441038|NCT00999739|Phagocytosis|phagocytosis
1441039|NCT00999713|Acute Lung Injury|acute lung injury
1441040|NCT00999713|Cancer|cancer
1441041|NCT00999713|Pediatrics|pediatrics
1441042|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
1441043|NCT00999700|Chemo-radiation|chemo-radiation
1441044|NCT00999700|Induction chemotherapy|induction chemotherapy
1441045|NCT00999700|Stage III/IV|stage iii/iv
1441046|NCT00999700|Unresectable disease|unresectable disease
1441640|NCT00997477|aerolizer|aerolizer
1441047|NCT00999687|Nail psoriasis|nail psoriasis
1441048|NCT00999687|Indigo naturalis|indigo naturalis
1441049|NCT00999674|Exercise|exercise
1441050|NCT00999648|Tinnitus|tinnitus
1441051|NCT00999648|Myofascial Trigger Points|myofascial trigger points
1441052|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
1441053|NCT00999648|Controlled Clinical Trial|controlled clinical trial
1441054|NCT00999635|Insoles|insoles
1441055|NCT00999635|Prevention of Ulceration|prevention of ulceration
1441056|NCT00999635|Diabetic Foot|diabetic foot
1441057|NCT00999635|Neuropathic|neuropathic
1441058|NCT00999622|infection|infection
1441059|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1441060|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1441061|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
1441062|NCT00999622|adult gliosarcoma|adult gliosarcoma
1441063|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
1441064|NCT00999622|adult glioblastoma|adult glioblastoma
1441065|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
1441066|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1441067|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1441068|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1441069|NCT00999609|Adeno-associated virus|adeno-associated virus
1441071|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
1441072|NCT00999609|RPE65|rpe65
1441073|NCT00999609|Gene therapy|gene therapy
1441074|NCT00999609|Gene transfer|gene transfer
1441075|NCT00999609|voretigene neparvovec-rzyl|voretigene neparvovec-rzyl
1441076|NCT00999609|Retinitis pigmentosa|retinitis pigmentosa
1441077|NCT00999596|Breast Cancer|breast cancer
1441078|NCT00999596|Digital Mammography|digital mammography
1441079|NCT00999583|Cardiac arrest|cardiac arrest
1441080|NCT00999583|erythropoietin|erythropoietin
1441081|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
1441082|NCT00999583|neuroprotective drugs|neuroprotective drugs
1441083|NCT00999570|outcome|outcome
1441084|NCT00999570|quality of life|quality of life
1441085|NCT00999570|total knee arthroplasty|total knee arthroplasty
1441086|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
1441087|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
1441088|NCT00999557|breast cancer|breast cancer
1441089|NCT00999557|male breast cancer|male breast cancer
1441090|NCT00999557|alopecia|alopecia
1441091|NCT00999544|opioid|opioid
1441092|NCT00999544|oxycodone|oxycodone
1441093|NCT00999544|NK1 antagonist|nk1 antagonist
1441094|NCT00999544|aprepitant|aprepitant
1441095|NCT00999544|intranasal|intranasal
1441096|NCT00999544|abuse|abuse
1441097|NCT00999531|Cystic Fibrosis|cystic fibrosis
1441098|NCT00999531|CF|cf
1441099|NCT00999531|Mucociliary Clearance|mucociliary clearance
1441100|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
1441101|NCT00999531|ENaC Inhibitor|enac inhibitor
1441102|NCT00999531|Airway Hydration|airway hydration
1441103|NCT00999531|Amiloride|amiloride
1441104|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
1441105|NCT00999505|Schizophrenia|schizophrenia
1441106|NCT00999505|Amantadine|amantadine
1441107|NCT00999505|Residual symptoms|residual symptoms
1441108|NCT00999492|Tecnis Multifocal|tecnis multifocal
1441109|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
1441110|NCT00999453|LDL-cholesterol|ldl-cholesterol
1441610|NCT00997620|Hay Fever|hay fever
1441111|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
1441112|NCT00999440|Chronic Pain|chronic pain
1441113|NCT00999440|Methadone|methadone
1441114|NCT00999440|Perceived Sleep|perceived sleep
1441115|NCT00999440|QTc|qtc
1441116|NCT00999427|Povidone-iodine|povidone-iodine
1441117|NCT00999427|prostate cancer|prostate cancer
1441118|NCT00999427|biopsy|biopsy
1441119|NCT00999427|transrectal ultrasound|transrectal ultrasound
1441120|NCT00999427|urinary tract infection|urinary tract infection
1441121|NCT00999427|fever|fever
1441122|NCT00999427|sepsis|sepsis
1441123|NCT00999427|antisepsis|antisepsis
1441124|NCT00999427|prevention|prevention
1441125|NCT00999427|complications|complications
1441126|NCT00999414|MM|mm
1441127|NCT00999388|Lifestyle|lifestyle
1441128|NCT00999388|Environment|environment
1441129|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
1441130|NCT00999388|Elderly|elderly
1441131|NCT00999388|Public Health|public health
1441132|NCT00999388|PD|pd
1441133|NCT00999388|Parkinson Disease|parkinson disease
1441134|NCT00999375|Type 1 Diabetes|type 1 diabetes
1441135|NCT00999375|Diet|diet
1441136|NCT00999375|Behavioral Intervention|behavioral intervention
1441137|NCT00999375|Children|children
1441138|NCT00999375|Adolescents|adolescents
1441139|NCT00999362|calcineurin activity|calcineurin activity
1441140|NCT00999362|real-time PCR|real-time pcr
1441141|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
1441142|NCT00999362|T-lymphocytes|t-lymphocytes
1441143|NCT00999362|interferon-gamma|interferon-gamma
1441144|NCT00999362|Pharmacodynamics|pharmacodynamics
1441145|NCT00999362|Pharmacokinetics|pharmacokinetics
1441146|NCT00999362|tacrolimus|tacrolimus
1441147|NCT00999362|western blot|western blot
1441148|NCT00999362|Hoechst|hoechst
1441149|NCT00999349|iron overload condition|iron overload condition
1441150|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
1441151|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
1441152|NCT00999336|Betrixaban|betrixaban
1441153|NCT00999336|Renal impairment|renal impairment
1441155|NCT00999336|Kidney dysfunction|kidney dysfunction
1441156|NCT00999310|Klinefelter syndrome|klinefelter syndrome
1441157|NCT00999310|Neuropsychology|neuropsychology
1441158|NCT00999310|Neuroradiology|neuroradiology
1441159|NCT00999310|Genetics|genetics
1441160|NCT00999297|thermogenesis|thermogenesis
1441161|NCT00999297|respiratory quotient|respiratory quotient
1441162|NCT00999297|fat oxidation|fat oxidation
1441163|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
1441164|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
1441165|NCT00999271|gastric emptying|gastric emptying
1441166|NCT00999271|appetite|appetite
1441167|NCT00999271|energy intake|energy intake
1441168|NCT00999271|lipid metabolism|lipid metabolism
1441169|NCT00999258|glomerular filtration rate|glomerular filtration rate
1441170|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
1441171|NCT00999258|Kidney transplantation|kidney transplantation
1441172|NCT00999258|African American|african american
1441173|NCT00999232|erythromycin|erythromycin
1441174|NCT00999232|prokinetics|prokinetics
1441175|NCT00999232|nasojejunal tubes|nasojejunal tubes
1441176|NCT00999232|Bengmark feeding tube|bengmark feeding tube
1441177|NCT00999232|post-pyloric feeding|post-pyloric feeding
1441178|NCT00999232|pancreatitis|pancreatitis
1441179|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
1441180|NCT00999219|FK199B|fk199b
1441181|NCT00999219|Zolpidem|zolpidem
1441182|NCT00999206|Influenza|influenza
1441183|NCT00999206|Vaccine|vaccine
1441184|NCT00999206|CHMP criteria|chmp criteria
1441185|NCT00999193|Shoulder|shoulder
1441186|NCT00999193|Fracture|fracture
1441187|NCT00999193|Locking Plate|locking plate
1441188|NCT00999193|Hemiarthroplasty|hemiarthroplasty
1441189|NCT00999193|Conservative|conservative
1441190|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
1441191|NCT00999180|Botulinum Toxin|botulinum toxin
1441192|NCT00999180|Rehabilitation|rehabilitation
1441193|NCT00999180|Stroke|stroke
1441194|NCT00999167|Cirrhosis|cirrhosis
1441195|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
1441197|NCT00999167|HPN-100|hpn-100
1441198|NCT00999167|GT4P|gt4p
1441199|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
1441200|NCT00999154|Energy Expenditure|energy expenditure
1441201|NCT00999154|Dietary Intake|dietary intake
1441202|NCT00999154|Physical Activity|physical activity
1441203|NCT00999154|Body Weight Regulation|body weight regulation
1441204|NCT00999154|Sedentary|sedentary
1441205|NCT00999154|HV|hv
1441206|NCT00999154|Healthy Volunteer|healthy volunteer
1441207|NCT00999128|PI3K inhibitor|pi3k inhibitor
1441208|NCT00999128|PI3 kinase|pi3 kinase
1441209|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
1441210|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
1441211|NCT00999115|Crohn Disease|crohn disease
1441213|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
1441214|NCT00999102|hypertension|hypertension
1441215|NCT00999102|beta blockers|beta blockers
1441216|NCT00999102|Metoprolol|metoprolol
1441217|NCT00999102|blood pressure, high|blood pressure, high
1441218|NCT00999102|antihypertensive agents|antihypertensive agents
1441219|NCT00999102|vascular resistance|vascular resistance
1441220|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
1441221|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
1441222|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
1441223|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
1441224|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
1441225|NCT00999102|Bystolic|bystolic
1441226|NCT00999102|Nebivolol|nebivolol
1441227|NCT00999102|Nebivololum|nebivololum
1441228|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
1441229|NCT00999102|R65,824|r65,824
1441230|NCT00999102|Beloc- Zok|beloc- zok
1441231|NCT00999102|H 93/26 succinate|h 93/26 succinate
1441232|NCT00999102|Metoprolol succinate|metoprolol succinate
1441233|NCT00999102|Seloken ZOC|seloken zoc
1441234|NCT00999102|Selozok|selozok
1441235|NCT00999102|Spesicor Dos|spesicor dos
1441236|NCT00999102|Toprol XL|toprol xl
1441237|NCT00999102|Toprol-XL|toprol-xl
1441238|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
1441239|NCT00999089|Coronary disease|coronary disease
1441240|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
1441241|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
1441242|NCT00999089|Extracorporeal circulation|extracorporeal circulation
1441243|NCT00999089|Cardioplegia|cardioplegia
1441244|NCT00999089|Off pump|off pump
1441245|NCT00999063|GerdQ|gerdq
1441246|NCT00999050|type two diabetes|type two diabetes
1441247|NCT00999050|gastric bypass surgery|gastric bypass surgery
1441248|NCT00999050|overweight or moderately obese|overweight or moderately obese
1441249|NCT00999011|critical care|critical care
1441250|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
1441251|NCT00999011|cytokines|cytokines
1441252|NCT00999011|mechanical ventilation|mechanical ventilation
1441253|NCT00999011|activity|activity
1441254|NCT00999011|mobility therapy|mobility therapy
1441255|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
1441256|NCT00998998|iron deficiency anemia|iron deficiency anemia
1441257|NCT00998998|infant behavior|infant behavior
1441258|NCT00998998|infant development|infant development
1441259|NCT00998972|kidney graft,|kidney graft,
1441260|NCT00998972|delayed graft function|delayed graft function
1441261|NCT00998972|N-acetylcysteine|n-acetylcysteine
1441262|NCT00998959|Depression|depression
1441263|NCT00998959|Major Depression|major depression
1441264|NCT00998946|Relapsed|relapsed
1441265|NCT00998946|Refractory|refractory
1441266|NCT00998946|Non-Hodgkin's|non-hodgkin's
1441267|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
1441268|NCT00998920|Healthy volunteers|healthy volunteers
1441269|NCT00998907|Open Abdominal Surgery|open abdominal surgery
1441270|NCT00998907|Fascial Closure|fascial closure
1441271|NCT00998894|BIS|bis
1441272|NCT00998894|MAC|mac
1441273|NCT00998894|MAP|map
1441274|NCT00998881|insulin resistance|insulin resistance
1441275|NCT00998868|Rotator Cuff|rotator cuff
1441276|NCT00998868|Tendinopathy|tendinopathy
1441277|NCT00998868|ultrasonography|ultrasonography
1441278|NCT00998855|Exercise in obesity|exercise in obesity
1441279|NCT00998842|ECG|ecg
1441280|NCT00998842|EKG|ekg
1441281|NCT00998842|healthy subjects|healthy subjects
1441282|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
1441283|NCT00998829|psoriasis|psoriasis
1441284|NCT00998829|psoriatic arthritis|psoriatic arthritis
1441285|NCT00998829|epidemiology|epidemiology
1441286|NCT00998829|prevalence|prevalence
1441287|NCT00998816|thoracotomy|thoracotomy
1441288|NCT00998816|chronic|chronic
1441289|NCT00998816|pain|pain
1441290|NCT00998816|pregabalin|pregabalin
1441291|NCT00998816|Lyrica|lyrica
1441292|NCT00998803|Influenza virus|influenza virus
1441293|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
1441294|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
1441295|NCT00998790|Secondary|secondary
1441296|NCT00998790|TUR|tur
1441297|NCT00998790|TURP|turp
1441298|NCT00998790|Radical prostatectomy|radical prostatectomy
1441299|NCT00998790|Open prostatectomy|open prostatectomy
1441300|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
1441301|NCT00998777|tubing program|tubing program
1441302|NCT00998777|shoulder strengthening|shoulder strengthening
1441303|NCT00998777|injury prevention|injury prevention
1441304|NCT00998764|antibody|antibody
1441305|NCT00998764|immunotherapy|immunotherapy
1441306|NCT00998751|cKIT inhibitor|ckit inhibitor
1441307|NCT00998751|GIST|gist
1441308|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
1441309|NCT00998712|pregnancy|pregnancy
1441310|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
1441311|NCT00998699|Diabetes|diabetes
1441312|NCT00998699|Type 1|type 1
1441313|NCT00998686|diabetes|diabetes
1441314|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
1441316|NCT00998673|Silica gel fiber|silica gel fiber
1441317|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
1441318|NCT00998673|Venous ulcer|venous ulcer
1441319|NCT00998673|Stasis ulcer|stasis ulcer
1441320|NCT00998673|Varicose ulcer|varicose ulcer
1441321|NCT00998660|Parkinson's disease|parkinson's disease
1441322|NCT00998660|Essential Tremor|essential tremor
1441323|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
1441324|NCT00998660|Deep brain stimulation|deep brain stimulation
1441325|NCT00998660|Activa RC|activa rc
1441326|NCT00998647|modified ultrafiltration|modified ultrafiltration
1441327|NCT00998647|cardiac surgery|cardiac surgery
1441328|NCT00998647|ROTEM|rotem
1441329|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
1441330|NCT00998634|SCA2|sca2
1441331|NCT00998634|Lithium|lithium
1441332|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
1441333|NCT00998621|HIV Infection|hiv infection
1441334|NCT00998621|Medication Adherence|medication adherence
1441335|NCT00998621|Questionnaire Design|questionnaire design
1441336|NCT00998621|Treatment experienced|treatment experienced
1441337|NCT00998595|Diabetes, Gestational|diabetes, gestational
1441338|NCT00998595|Postpartum Period|postpartum period
1441339|NCT00998595|Reproductive Health Services|reproductive health services
1441340|NCT00998595|Health Promotion|health promotion
1441341|NCT00998595|Health Personnel|health personnel
1441342|NCT00998582|Cardiovascular Disease|cardiovascular disease
1441343|NCT00998582|HIV Infection|hiv infection
1441344|NCT00998582|Abacavir|abacavir
1441345|NCT00998582|Artery Elasticity|artery elasticity
1441346|NCT00998582|Treatment experienced|treatment experienced
1441347|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
1441348|NCT00998556|Bromocriptine|bromocriptine
1441349|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
1441350|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
1441351|NCT00998530|trichomoniasis|trichomoniasis
1441352|NCT00998530|MLST|mlst
1441353|NCT00998530|Multilocus sequence typing|multilocus sequence typing
1441354|NCT00998517|Malnutrition|malnutrition
1441355|NCT00998517|Supplemental Food|supplemental food
1441356|NCT00998517|CSB++|csb++
1441357|NCT00998517|Supplementary Plumpy|supplementary plumpy
1441358|NCT00998504|impaired fat oxidation|impaired fat oxidation
1441359|NCT00998504|fat accumulation|fat accumulation
1441360|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
1441361|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
1441362|NCT00998465|Obesity|obesity
1441363|NCT00998465|Hypertension|hypertension
1441364|NCT00998465|Salt sensitivity|salt sensitivity
1441365|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
1441366|NCT00998465|Bariatric surgery|bariatric surgery
1441367|NCT00998452|Weight|weight
1441368|NCT00998452|Diet|diet
1441369|NCT00998452|Physical Activity|physical activity
1441370|NCT00998452|Veterans|veterans
1441371|NCT00998452|MOVE! Program|move! program
1441372|NCT00998439|in stent restenosis|in stent restenosis
1441373|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1441374|NCT00998439|pepcad|pepcad
1441375|NCT00998439|drug eluting balloon|drug eluting balloon
1441376|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
1441377|NCT00998426|HBIG|hbig
1441378|NCT00998426|HepaGam B|hepagam b
1441379|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
1441380|NCT00998413|asthma|asthma
1441381|NCT00998413|overweight|overweight
1441382|NCT00998413|obesity|obesity
1441383|NCT00998413|children|children
1441384|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
1441385|NCT00998400|Well-being therapy|well-being therapy
1441386|NCT00998400|Depression|depression
1441387|NCT00998400|Demoralization|demoralization
1441388|NCT00998400|Acute coronary syndrome|acute coronary syndrome
1441389|NCT00998361|Sarcoma|sarcoma
1441390|NCT00998361|allogeneic|allogeneic
1441391|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
1441392|NCT00998348|parenting|parenting
1441393|NCT00998348|diet|diet
1441394|NCT00998348|physical activity|physical activity
1441395|NCT00998348|family|family
1441396|NCT00998348|home|home
1441397|NCT00998348|child|child
1441398|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
1441399|NCT00998335|Insulin therapy|insulin therapy
1441400|NCT00998335|Detemir (Levemir)|detemir (levemir)
1441401|NCT00998335|Aspart (Novolog)|aspart (novolog)
1441402|NCT00998335|Hepatic steatosis|hepatic steatosis
1441403|NCT00998322|metastatic|metastatic
1441404|NCT00998322|pancreatic|pancreatic
1441405|NCT00998322|adenocarcinoma|adenocarcinoma
1441406|NCT00998322|REOLYSIN|reolysin
1441407|NCT00998322|chemotherapy|chemotherapy
1441408|NCT00998322|gemcitabine|gemcitabine
1441409|NCT00998309|skin infection|skin infection
1441410|NCT00998309|soft tissue infection|soft tissue infection
1441411|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
1441412|NCT00998309|infection oral|infection oral
1441413|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1441414|NCT00998270|MM|mm
1441415|NCT00998257|Contraception|contraception
1441416|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
1441417|NCT00998257|PMDD|pmdd
1441418|NCT00998257|Acne|acne
1441419|NCT00998244|low carbohydrate|low carbohydrate
1441420|NCT00998244|low fat|low fat
1441421|NCT00998244|diet|diet
1441422|NCT00998244|overweight|overweight
1441423|NCT00998244|GERD|gerd
1441424|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
1441425|NCT00998244|acid reflux|acid reflux
1441426|NCT00998244|heartburn|heartburn
1441427|NCT00998218|Sudden Cardiac Death|sudden cardiac death
1441428|NCT00998218|Arrythmias|arrythmias
1441429|NCT00998218|Triggered activity|triggered activity
1441430|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
1441431|NCT00998192|carcinoma|carcinoma
1441432|NCT00998192|squamous cell|squamous cell
1441433|NCT00998192|lung|lung
1441434|NCT00998192|REOLYSIN|reolysin
1441435|NCT00998192|chemotherapy|chemotherapy
1441436|NCT00998192|carboplatin|carboplatin
1441437|NCT00998192|paclitaxel|paclitaxel
1441438|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
1441439|NCT00998179|TENS|tens
1441440|NCT00998179|acupuncture|acupuncture
1441441|NCT00998179|FEV1|fev1
1441641|NCT00997477|formoterol|formoterol
1441442|NCT00998179|Normal Healthy subjects|normal healthy subjects
1441443|NCT00998166|NSCLC|nsclc
1441444|NCT00998153|substance use|substance use
1441445|NCT00998153|PTSD|ptsd
1441446|NCT00998153|risky behaviors|risky behaviors
1441447|NCT00998153|revictimization|revictimization
1441448|NCT00998140|resuscitation|resuscitation
1441449|NCT00998140|sudden death|sudden death
1441450|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1441451|NCT00998140|emergency medical services|emergency medical services
1441452|NCT00998140|termination of resuscitation|termination of resuscitation
1441453|NCT00998140|ventricular fibrillation|ventricular fibrillation
1441454|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1441455|NCT00998140|asystole|asystole
1441456|NCT00998140|medical futility|medical futility
1441457|NCT00998140|withdrawing treatment|withdrawing treatment
1441458|NCT00998140|transportation of patients|transportation of patients
1441459|NCT00998140|health expenditures|health expenditures
1441460|NCT00998140|healthcare costs|healthcare costs
1441461|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
1441462|NCT00998127|Non-adherence|non-adherence
1441463|NCT00998127|MACE|mace
1441464|NCT00998127|NACE|nace
1441465|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
1441466|NCT00998114|Aerobic Exercise|aerobic exercise
1441467|NCT00998114|Weight Reduction|weight reduction
1441468|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1441469|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1441470|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1441471|NCT00998088|Blood management|blood management
1441472|NCT00998088|Orthopedic surgery|orthopedic surgery
1441473|NCT00998088|elective|elective
1441474|NCT00998088|randomized study|randomized study
1441475|NCT00998088|adults|adults
1441476|NCT00998088|hip replacement|hip replacement
1441477|NCT00998088|knee replacement|knee replacement
1441478|NCT00998075|Bioequivalence|bioequivalence
1441479|NCT00998075|ASA|asa
1441480|NCT00998075|Esomeprazole|esomeprazole
1441481|NCT00998075|peptic ulcer disease|peptic ulcer disease
1441482|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
1441483|NCT00998075|healthy volunteers|healthy volunteers
1441484|NCT00998062|Dyslipaemia|dyslipaemia
1441485|NCT00998062|atherosclerosis risk|atherosclerosis risk
1441486|NCT00998062|increased hsCRP|increased hscrp
1441487|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
1441488|NCT00998036|TNBC|tnbc
1441489|NCT00998036|Temsirolimus|temsirolimus
1441490|NCT00998036|Erlotinib|erlotinib
1441491|NCT00998036|Cisplatin|cisplatin
1441492|NCT00998036|Breast Cancer|breast cancer
1441493|NCT00998023|Angiogram|angiogram
1441494|NCT00998023|Catheter Angiogram|catheter angiogram
1441495|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
1441496|NCT00998010|adult glioblastoma|adult glioblastoma
1441497|NCT00998010|adult gliosarcoma|adult gliosarcoma
1441498|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
1441499|NCT00997997|Product Surveillance|product surveillance
1441500|NCT00997997|Postmarketing|postmarketing
1441501|NCT00997984|ADHD|adhd
1441502|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
1441503|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
1441504|NCT00997971|Infant formula|infant formula
1441505|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
1441506|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
1441507|NCT00997945|advanced cancer|advanced cancer
1441508|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
1441509|NCT00997945|china|china
1441510|NCT00997945|PK|pk
1441511|NCT00997945|pharmacokinetics|pharmacokinetics
1441512|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
1441513|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
1441514|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
1441515|NCT00997932|postpartum contraception|postpartum contraception
1441516|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1441517|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1441518|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1441519|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1441520|NCT00997893|menopause|menopause
1441521|NCT00997893|hot flashes|hot flashes
1441522|NCT00997893|soy|soy
1441523|NCT00997893|estrogen|estrogen
1441524|NCT00997893|anxiety|anxiety
1441525|NCT00997880|rosuvastatin|rosuvastatin
1441526|NCT00997867|Pain|pain
1441527|NCT00997867|Surgery|surgery
1441528|NCT00997867|Catheter|catheter
1441529|NCT00997867|Nerve Block|nerve block
1441530|NCT00997867|Popliteal|popliteal
1441531|NCT00997867|Sciatic|sciatic
1441532|NCT00997867|Femoral|femoral
1441533|NCT00997867|Interscalene|interscalene
1441534|NCT00997867|UCSD|ucsd
1441535|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
1441536|NCT00997867|Perineural Catheter|perineural catheter
1441537|NCT00997867|Orthopedic Surgery|orthopedic surgery
1441538|NCT00997854|Feeding|feeding
1441539|NCT00997854|Intolerance|intolerance
1441540|NCT00997854|Preterm|preterm
1441541|NCT00997854|Bolus|bolus
1441542|NCT00997841|POC|poc
1441543|NCT00997841|ROTEM|rotem
1441544|NCT00997841|Multiplate|multiplate
1441545|NCT00997841|bleeding tendency|bleeding tendency
1441546|NCT00997841|coagulation management|coagulation management
1441547|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
1441548|NCT00997841|FFP|ffp
1441549|NCT00997841|platelet concentrates|platelet concentrates
1441550|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
1441551|NCT00997841|ventilation time|ventilation time
1441552|NCT00997828|Coronary Artery Disease|coronary artery disease
1441553|NCT00997828|stent|stent
1441554|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
1441555|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
1441556|NCT00997815|Recalcitrant|recalcitrant
1441557|NCT00997815|Alopecia totalis|alopecia totalis
1441558|NCT00997815|Alopecia universalis|alopecia universalis
1441559|NCT00997815|Botulinum toxin A|botulinum toxin a
1441560|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
1441561|NCT00997802|Colonic Polyps|colonic polyps
1441562|NCT00997802|Colonic Neoplasms|colonic neoplasms
1441563|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
1441564|NCT00997789|Rebamipide|rebamipide
1441565|NCT00997789|Bioequivalence|bioequivalence
1441566|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
1441567|NCT00997776|Hip Fracture|hip fracture
1441568|NCT00997776|Exercise|exercise
1441569|NCT00997776|Rehabilitation|rehabilitation
1441570|NCT00997776|Functional Performance|functional performance
1441571|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
1441572|NCT00997750|ACS|acs
1441573|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
1441574|NCT00997750|NSAID|nsaid
1441575|NCT00997750|Lornoxicam|lornoxicam
1441576|NCT00997750|Xefocam|xefocam
1441577|NCT00997737|incentive spirometry|incentive spirometry
1441578|NCT00997737|diaphragm mobility|diaphragm mobility
1441579|NCT00997737|ultrasound|ultrasound
1441580|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
1441581|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
1441582|NCT00997724|sleeve lobectomy|sleeve lobectomy
1441583|NCT00997724|bronchoplasty|bronchoplasty
1441584|NCT00997711|Diabetes|diabetes
1441585|NCT00997711|death|death
1441586|NCT00997711|MI|mi
1441587|NCT00997711|TVR|tvr
1441588|NCT00997698|Intracranial aneurysm|intracranial aneurysm
1441589|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
1441590|NCT00997698|Epidemiology|epidemiology
1441591|NCT00997685|XELOX|xelox
1441592|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
1441593|NCT00997672|MSA|msa
1441594|NCT00997672|Lithium|lithium
1441595|NCT00997672|Lithium carbonate|lithium carbonate
1441596|NCT00997672|MSA-P|msa-p
1441597|NCT00997672|MSA-C|msa-c
1441598|NCT00997659|chromium picolinate|chromium picolinate
1441599|NCT00997659|insulin resistance|insulin resistance
1441600|NCT00997659|obesity|obesity
1441601|NCT00997646|Performance|performance
1441602|NCT00997646|hospitalist|hospitalist
1441603|NCT00997646|ward|ward
1441604|NCT00997646|hospitalization|hospitalization
1441605|NCT00997633|Intraperitoneal volume|intraperitoneal volume
1441606|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
1441607|NCT00997633|cytoreductive surgery|cytoreductive surgery
1441608|NCT00997633|SPECT|spect
1441609|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1441611|NCT00997620|Daytime somnolence|daytime somnolence
1441612|NCT00997620|Cognition|cognition
1441613|NCT00997607|Vaccine|vaccine
1441614|NCT00997594|adrenal gland|adrenal gland
1441615|NCT00997581|Gout|gout
1441616|NCT00997568|transesophageal|transesophageal
1441617|NCT00997568|transducer|transducer
1441618|NCT00997568|TEE|tee
1441619|NCT00997555|inhalation|inhalation
1441620|NCT00997555|bronchoscopy|bronchoscopy
1441621|NCT00997555|burn|burn
1441622|NCT00997555|pneumonia|pneumonia
1441623|NCT00997529|Stem cell transplant|stem cell transplant
1441624|NCT00997529|Non-myeloablative|non-myeloablative
1441625|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
1441626|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
1441627|NCT00997516|Laparoscopy|laparoscopy
1441628|NCT00997516|Appendicitis|appendicitis
1441629|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
1441630|NCT00997516|SILS|sils
1441631|NCT00997490|depression|depression
1441632|NCT00997490|HAMD 21|hamd 21
1441633|NCT00997490|anxiety|anxiety
1441634|NCT00997490|HAMA|hama
1441635|NCT00997490|Hypericum|hypericum
1441636|NCT00997490|Valerian|valerian
1441637|NCT00997490|Passionflower|passionflower
1441638|NCT00997490|F32.0|f32.0
1441639|NCT00997490|F33.0|f33.0
1441642|NCT00997477|budesonide|budesonide
1441643|NCT00997477|asthma|asthma
1441644|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
1441645|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
1441646|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
1441647|NCT00997451|Self-management|self-management
1441648|NCT00997451|Primary care|primary care
1441649|NCT00997451|Nurses|nurses
1441650|NCT00997451|Economic analysis|economic analysis
1441651|NCT00997451|Cost effectiveness|cost effectiveness
1441652|NCT00997451|One year follow-up|one year follow-up
1441653|NCT00997425|wandering|wandering
1441654|NCT00997425|subjective exit barriers|subjective exit barriers
1441655|NCT00997399|Ph I|ph i
1441656|NCT00997399|panobinostat (DACi)|panobinostat (daci)
1441657|NCT00997399|PK & safety|pk & safety
1441658|NCT00997399|solid tumors|solid tumors
1441659|NCT00997399|varying renal function|varying renal function
1441660|NCT00997399|advanced|advanced
1441661|NCT00997386|Hematologic malignancies|hematologic malignancies
1441662|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
1441663|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
1441664|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
1441665|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
1441666|NCT00997373|Endometrial Cancer|endometrial cancer
1441667|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
1441668|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
1441669|NCT00997373|Letrozole|letrozole
1441670|NCT00997373|Femara|femara
1441671|NCT00997360|Phase 1|phase 1
1441672|NCT00997360|Maximum tolerated dose|maximum tolerated dose
1441673|NCT00997360|Solid tumors|solid tumors
1441674|NCT00997334|erlotinib|erlotinib
1441675|NCT00997334|EGFR mutation|egfr mutation
1441676|NCT00997334|NSCLC|nsclc
1441677|NCT00997321|ketamine|ketamine
1441678|NCT00997321|propofol|propofol
1441679|NCT00997321|procedural sedation|procedural sedation
1441680|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
1441681|NCT00997308|AZD1446|azd1446
1441682|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
1441683|NCT00997295|low flow gas|low flow gas
1441684|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
1441685|NCT00997295|Humidity|humidity
1441686|NCT00997295|Temperature|temperature
1441687|NCT00997295|Core temperature|core temperature
1441688|NCT00997295|Women|women
1441689|NCT00997269|CoQ-10|coq-10
1441690|NCT00997269|statin|statin
1441691|NCT00997269|muscle pain|muscle pain
1441692|NCT00997269|cardiovascular|cardiovascular
1441693|NCT00997256|sleep-EEG|sleep-eeg
1441694|NCT00997256|sleep architecture|sleep architecture
1441695|NCT00997256|sleep duration|sleep duration
1441696|NCT00997256|sleep continuity|sleep continuity
1441697|NCT00997256|REM-sleep|rem-sleep
1441698|NCT00997256|vigilance|vigilance
1441699|NCT00997256|well-being|well-being
1441700|NCT00997256|Healthy volunteers|healthy volunteers
1441701|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1441702|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1441703|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1441704|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1441705|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
1441706|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1441707|NCT00997243|refractory anemia|refractory anemia
1441708|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1441812|NCT00996736|Visual Acuity|visual acuity
1441709|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
1441710|NCT00997217|RIPC|ripc
1441711|NCT00997217|cardiac surgery|cardiac surgery
1441712|NCT00997217|ischemic preconditioning|ischemic preconditioning
1441713|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
1441714|NCT00997204|HAE|hae
1441715|NCT00997204|Type I HAE|type i hae
1441716|NCT00997204|Type II HAE|type ii hae
1441717|NCT00997191|Bevacizumab|bevacizumab
1441718|NCT00997191|Diabetes|diabetes
1441719|NCT00997191|Intravitreal|intravitreal
1441720|NCT00997191|Macular edema|macular edema
1441721|NCT00997191|triamcinolone|triamcinolone
1441722|NCT00997191|VEGF|vegf
1441723|NCT00997178|Diabetes|diabetes
1441724|NCT00997178|Diabetes Mellitus|diabetes mellitus
1441725|NCT00997178|Periodontal Disease|periodontal disease
1441726|NCT00997178|Periodontitis|periodontitis
1441727|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
1441728|NCT00997178|HbA1c|hba1c
1441729|NCT00997165|fatty liver|fatty liver
1441730|NCT00997165|adipose tissue|adipose tissue
1441731|NCT00997152|Diabetes|diabetes
1441732|NCT00997139|healthcare|healthcare
1441733|NCT00997139|staphylococcus aureus|staphylococcus aureus
1441734|NCT00997139|nasal|nasal
1441735|NCT00997126|propofol|propofol
1441736|NCT00997126|alfentanil|alfentanil
1441737|NCT00997126|nitrous oxide|nitrous oxide
1441738|NCT00997126|moderate procedural sedation|moderate procedural sedation
1441739|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
1441740|NCT00997113|propofol|propofol
1441741|NCT00997113|alfentanil|alfentanil
1441742|NCT00997113|procedural sedation|procedural sedation
1441743|NCT00997113|stress biomarkers|stress biomarkers
1441744|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
1441745|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1441746|NCT00997100|ABR-215757|abr-215757
1441747|NCT00997100|Change in Biomarkers|change in biomarkers
1441749|NCT00997074|pain after abortion|pain after abortion
1441750|NCT00997074|abortion|abortion
1441751|NCT00997035|Fungal Infections|fungal infections
1441752|NCT00997035|Eye Disease|eye disease
1441753|NCT00997035|Fungal Keratitis|fungal keratitis
1441754|NCT00997035|Visual Acuity|visual acuity
1441755|NCT00997022|HCC|hcc
1441756|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
1441757|NCT00997009|EGFR|egfr
1441758|NCT00997009|chemotherapy|chemotherapy
1441759|NCT00996996|Radioimmunotherapy|radioimmunotherapy
1441760|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
1441761|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
1441762|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1441763|NCT00996996|Bexxar|bexxar
1441764|NCT00996970|HIV|hiv
1441765|NCT00996970|H1N1|h1n1
1441766|NCT00996970|Influenza|influenza
1441767|NCT00996970|Vaccination|vaccination
1441768|NCT00996970|Seroresponse|seroresponse
1441769|NCT00996970|Immunogenicity|immunogenicity
1441770|NCT00996970|Vaccine|vaccine
1441771|NCT00996944|ropinirole|ropinirole
1441772|NCT00996944|haemodialysis|haemodialysis
1441773|NCT00996944|restless legs syndrome|restless legs syndrome
1441774|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
1441775|NCT00996931|lenalidomide|lenalidomide
1441776|NCT00996918|antibody|antibody
1441777|NCT00996905|Epidural Analgesia|epidural analgesia
1441778|NCT00996905|Ultrasound|ultrasound
1441779|NCT00996905|Training, Inservice|training, inservice
1441780|NCT00996892|GDC0941|gdc0941
1441781|NCT00996892|GDC0973|gdc0973
1441782|NCT00996892|MEK|mek
1441783|NCT00996892|MEK Inhibitor|mek inhibitor
1441784|NCT00996892|PI3K|pi3k
1441785|NCT00996892|PI3K Inhibitor|pi3k inhibitor
1441786|NCT00996892|PI3 Kinase|pi3 kinase
1441787|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
1441788|NCT00996879|Human Volunteers|human volunteers
1441789|NCT00996853|safety|safety
1441790|NCT00996853|Influenza|influenza
1441791|NCT00996853|vaccine|vaccine
1441792|NCT00996853|reactogenicity|reactogenicity
1441793|NCT00996853|swine flu|swine flu
1441794|NCT00996840|dilmapimod|dilmapimod
1441795|NCT00996840|p38|p38
1441796|NCT00996840|SB-681323|sb-681323
1441797|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
1441798|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
1441799|NCT00996827|Melanoma|melanoma
1441800|NCT00996827|Skin cancer|skin cancer
1441801|NCT00996827|Vitamin D|vitamin d
1441802|NCT00996827|Vitamin D receptor|vitamin d receptor
1441803|NCT00996827|Sunlight|sunlight
1441804|NCT00996827|Cytokine|cytokine
1441805|NCT00996814|Bioethics|bioethics
1441806|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
1441807|NCT00996775|Alcohol Consumption|alcohol consumption
1441808|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
1441809|NCT00996736|Fungal Infections|fungal infections
1441810|NCT00996736|Eye Disease|eye disease
1441811|NCT00996736|Fungal Keratitis|fungal keratitis
1441813|NCT00996710|Genome-wide|genome-wide
1441814|NCT00996710|09-068|09-068
1441815|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
1441816|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
1441817|NCT00996684|Wet AMD|wet amd
1441818|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
1441819|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
1441820|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
1441821|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
1441822|NCT00996671|healthy volunteers|healthy volunteers
1441823|NCT00996671|first time in human|first time in human
1441824|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1441825|NCT00996645|Coronary Artery Disease|coronary artery disease
1441826|NCT00996645|Primary Health Care|primary health care
1441827|NCT00996645|Feedback, Psychological|feedback, psychological
1441828|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
1441829|NCT00996632|breast cancer|breast cancer
1441830|NCT00996632|ultrasonic knife|ultrasonic knife
1441831|NCT00996632|volume drainage|volume drainage
1441832|NCT00996593|Tositumomab|tositumomab
1441833|NCT00996593|radioimmunotherapy|radioimmunotherapy
1441834|NCT00996593|rituximab|rituximab
1441835|NCT00996593|anti-B1|anti-b1
1441836|NCT00996593|I 131|i 131
1441837|NCT00996593|Bexxar|bexxar
1441838|NCT00996593|iodine|iodine
1441839|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1441840|NCT00996580|Contraception|contraception
1441841|NCT00996580|Oral contraceptives|oral contraceptives
1441842|NCT00996567|Malignant mesothelioma|malignant mesothelioma
1441843|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
1441844|NCT00996541|Runaway youth|runaway youth
1441845|NCT00996541|Homeless youth|homeless youth
1441846|NCT00996541|Family intervention|family intervention
1441847|NCT00996541|Family functioning|family functioning
1441848|NCT00996541|HIV risk behavior|hiv risk behavior
1441849|NCT00996541|HIV Seronegativity|hiv seronegativity
1441850|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
1441851|NCT00996528|alcohol abuse|alcohol abuse
1441852|NCT00996528|HIV|hiv
1441853|NCT00996528|malnutrition|malnutrition
1441854|NCT00996528|children|children
1441855|NCT00996528|mentor mother|mentor mother
1441856|NCT00996528|behavioral intervention|behavioral intervention
1441857|NCT00996528|South Africa|south africa
1441858|NCT00996528|Maternal alcohol use|maternal alcohol use
1441859|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
1441860|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
1441861|NCT00996528|HIV Seronegativity|hiv seronegativity
1441862|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
1441863|NCT00996515|Erlotinib|erlotinib
1441864|NCT00996515|Vidaza|vidaza
1441865|NCT00996515|Tarceva|tarceva
1441866|NCT00996515|5-azacytidine|5-azacytidine
1441867|NCT00996476|Hepatitis C|hepatitis c
1441868|NCT00996476|Hepatitis C virus|hepatitis c virus
1441869|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
1441870|NCT00996476|Ribavirin|ribavirin
1441871|NCT00996476|Viral RNA|viral rna
1441872|NCT00996450|brain tumour|brain tumour
1441873|NCT00996437|vitreous|vitreous
1441874|NCT00996437|hemorrhage|hemorrhage
1441875|NCT00996437|proliferative|proliferative
1441876|NCT00996437|diabetic|diabetic
1441877|NCT00996437|retinopathy|retinopathy
1441878|NCT00996437|intravitreal|intravitreal
1441879|NCT00996437|ranibizumab|ranibizumab
1441880|NCT00996437|Lucentis|lucentis
1441881|NCT00996437|saline|saline
1441882|NCT00996437|vitrectomy|vitrectomy
1441883|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
1441884|NCT00996398|Cryotherapy|cryotherapy
1441885|NCT00996398|Joint Position Sense|joint position sense
1441886|NCT00996398|Proprioception|proprioception
1441887|NCT00996398|Pre Cooling|pre cooling
1441888|NCT00996398|Knee Injury|knee injury
1441889|NCT00996398|Physical Therapy Modalities|physical therapy modalities
1441890|NCT00996398|Physical Therapy Techniques|physical therapy techniques
1441891|NCT00996398|Weightbearing|weightbearing
1441892|NCT00996398|NonWeightbearing|nonweightbearing
1441893|NCT00996398|Randomised Control Trial|randomised control trial
1441894|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
1441895|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
1441896|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1441897|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1441898|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1441899|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1441900|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1441901|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1441902|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1441903|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1441904|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1441905|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1441906|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1441907|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1441908|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1441909|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1441910|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1441911|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1441912|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1441913|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1441914|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1441915|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1441916|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1441917|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1441918|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1441919|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1441920|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1441921|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1441922|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1441923|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1441924|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1441925|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1441926|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1441927|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1441928|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1441929|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1441930|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1441931|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1441932|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1441933|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1441934|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1441935|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1441936|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1441937|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
1441938|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1441939|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1441940|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1441941|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1441942|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1441943|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1441944|NCT00996359|Burkitt lymphoma|burkitt lymphoma
1441945|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1441946|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1441947|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1441948|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1441949|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1441950|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1441951|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1441952|NCT00996346|INST 0909|inst 0909
1441953|NCT00996346|Irinotecan|irinotecan
1441954|NCT00996346|Temsirolimus|temsirolimus
1441955|NCT00996346|refractory sarcomas|refractory sarcomas
1441956|NCT00996346|3066K1|3066k1
1441957|NCT00996346|3066K1-1208|3066k1-1208
1441958|NCT00996346|20091334|20091334
1441959|NCT00996333|Stage IVB|stage ivb
1441960|NCT00996320|Internship and Residency|internship and residency
1441961|NCT00996320|Medical Errors|medical errors
1441962|NCT00996320|Burnout, Professional|burnout, professional
1441963|NCT00996320|Burnout|burnout
1441964|NCT00996320|Depression|depression
1441965|NCT00996320|Actigraphy|actigraphy
1441966|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
1441967|NCT00996320|Sleep Deprivation|sleep deprivation
1441968|NCT00996320|Workload|workload
1441969|NCT00996320|Humans|humans
1441970|NCT00996320|Adult|adult
1441971|NCT00996320|Male|male
1441972|NCT00996320|Female|female
1441973|NCT00996320|Intensive Care Units|intensive care units
1441974|NCT00996320|Prospective Studies|prospective studies
1441975|NCT00996320|Crossover Studies|crossover studies
1441976|NCT00996320|Work Schedule Tolerance|work schedule tolerance
1441977|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
1441978|NCT00996320|Guideline Adherence|guideline adherence
1441979|NCT00996320|Internal Medicine Education|internal medicine education
1441980|NCT00996307|Swine Flu|swine flu
1441982|NCT00996307|Vaccine|vaccine
1441983|NCT00996307|Children|children
1441984|NCT00996307|Adjuvant|adjuvant
1441985|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
1441986|NCT00996281|Hypertensive|hypertensive
1441987|NCT00996281|Blood Pressure, High|blood pressure, high
1441988|NCT00996281|Cardiovascular disease|cardiovascular disease
1441989|NCT00996281|Vascular Disease|vascular disease
1441990|NCT00996281|Drug Therapy|drug therapy
1441991|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
1441992|NCT00996268|GSK2212836|gsk2212836
1441993|NCT00996268|relative bioavailability|relative bioavailability
1441994|NCT00996242|Schizophrenia|schizophrenia
1441995|NCT00996242|L-lysine|l-lysine
1441996|NCT00996242|PANSS|panss
1441998|NCT00996229|elderly|elderly
1441999|NCT00996229|cognition|cognition
1442000|NCT00996229|prevention|prevention
1442001|NCT00996229|cognitive decline|cognitive decline
1442002|NCT00996229|Lifestyle|lifestyle
1442003|NCT00996216|Peginterferon|peginterferon
1442004|NCT00996216|Platelets|platelets
1442005|NCT00996216|Ribavirin|ribavirin
1442006|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
1442007|NCT00996216|Thrombocytopenia|thrombocytopenia
1442008|NCT00996216|Hepatitis C|hepatitis c
1442009|NCT00996216|Thrombopoietin|thrombopoietin
1442010|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
1442011|NCT00996190|noninvasive monitoring|noninvasive monitoring
1442012|NCT00996190|vasopressor|vasopressor
1442013|NCT00996190|blood pressure|blood pressure
1442014|NCT00996177|Pain|pain
1442015|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
1442016|NCT00996177|Postoperative pain|postoperative pain
1442017|NCT00996177|Transdermal fentanyl|transdermal fentanyl
1442018|NCT00996177|Surgical pain|surgical pain
1442019|NCT00996177|Opioid analgesics|opioid analgesics
1442020|NCT00996151|Hypergonadism|hypergonadism
1442021|NCT00996151|Testosterone Transfer|testosterone transfer
1442022|NCT00996138|Influenza A|influenza a
1442023|NCT00996138|H1N1 subtype|h1n1 subtype
1442024|NCT00996138|Adult|adult
1442025|NCT00996138|Vaccine|vaccine
1442026|NCT00996138|Adjuvant|adjuvant
1442027|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
1442028|NCT00996125|Immunogenicity|immunogenicity
1442029|NCT00996125|Safety|safety
1442030|NCT00996125|Human papillomavirus|human papillomavirus
1442031|NCT00996125|China|china
1442032|NCT00996125|HPV vaccine|hpv vaccine
1442033|NCT00996112|primary health care|primary health care
1442034|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
1442035|NCT00996099|intensive insulin therapy|intensive insulin therapy
1442036|NCT00996099|critically ill|critically ill
1442037|NCT00996099|cardiac surgery|cardiac surgery
1442038|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
1442039|NCT00996073|Degenerative disc disease|degenerative disc disease
1442040|NCT00996073|Spondylolisthesis|spondylolisthesis
1442041|NCT00996073|Spinal stenosis|spinal stenosis
1442042|NCT00996073|Stem cells|stem cells
1442043|NCT00996073|Adult Stem Cells|adult stem cells
1442044|NCT00996073|Spinal Fusion|spinal fusion
1442045|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
1442046|NCT00996073|TLIF|tlif
1442047|NCT00996073|PLIF|plif
1442048|NCT00996073|Mesoblast|mesoblast
1442049|NCT00996060|Lung Cancer|lung cancer
1442050|NCT00996060|Advanced Lung Cancer|advanced lung cancer
1442051|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
1442052|NCT00996060|Previously treated lung cancer|previously treated lung cancer
1442053|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1442054|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1442055|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
1442056|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1442057|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1442058|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1442059|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1442060|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1442061|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1442062|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1442063|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1442064|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1442065|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1442066|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1442067|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1442068|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1442069|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1442070|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1442071|NCT00996047|mast cell leukemia|mast cell leukemia
1442072|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1442073|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1442074|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
1442075|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1442076|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1442077|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1442078|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1442079|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1442080|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
1442081|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1442082|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1442176|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
1442083|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1442084|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1442085|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1442086|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1442087|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1442088|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1442089|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1442090|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1442091|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
1442092|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1442093|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1442094|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1442095|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1442096|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1442097|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
1442098|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
1442099|NCT00996021|GSK1349572|gsk1349572
1442100|NCT00996021|moxifloxacin|moxifloxacin
1442101|NCT00996021|Avelox|avelox
1442102|NCT00996021|QTc|qtc
1442103|NCT00995982|Influenza|influenza
1442104|NCT00995982|Healthy|healthy
1442105|NCT00995982|Immunity|immunity
1442106|NCT00995982|Preventive|preventive
1442107|NCT00995982|Flu|flu
1442108|NCT00995982|HV|hv
1442109|NCT00995982|Healthy Volunteer|healthy volunteer
1442110|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
1442111|NCT00995956|Albumin|albumin
1442112|NCT00995956|Mycophenolic acid|mycophenolic acid
1442113|NCT00995956|IMPDH|impdh
1442114|NCT00995956|Free fraction|free fraction
1442115|NCT00995930|Atherosclerosis,|atherosclerosis,
1442116|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
1442117|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
1442118|NCT00995917|acupuncture|acupuncture
1442119|NCT00995917|menstrual pain|menstrual pain
1442120|NCT00995917|dysmenorrhea|dysmenorrhea
1442121|NCT00995917|menstrual cramps|menstrual cramps
1442122|NCT00995917|vitamin K1|vitamin k1
1442123|NCT00995904|asthmatic children|asthmatic children
1442124|NCT00995891|Laboratory Research Specimens|laboratory research specimens
1442125|NCT00995891|Biologic Samples|biologic samples
1442126|NCT00995891|Sample Collection|sample collection
1442127|NCT00995891|Tissue Procurement|tissue procurement
1442128|NCT00995891|HV|hv
1442129|NCT00995891|Healthy Volunteer|healthy volunteer
1442130|NCT00995878|Uterine fibroids|uterine fibroids
1442131|NCT00995878|Fibroids|fibroids
1442132|NCT00995878|Uterine leiomyomas|uterine leiomyomas
1442133|NCT00995878|UAE|uae
1442134|NCT00995878|UFE|ufe
1442135|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
1442136|NCT00995878|MRgFUS|mrgfus
1442137|NCT00995878|Pelvic pain|pelvic pain
1442138|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
1442139|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
1442140|NCT00995852|emphysema|emphysema
1442141|NCT00995852|COPD|copd
1442142|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
1442143|NCT00995839|terlipressin|terlipressin
1442144|NCT00995839|vasopressin|vasopressin
1442145|NCT00995839|sepsis|sepsis
1442146|NCT00995839|septic shock|septic shock
1442147|NCT00995839|norepinephrine|norepinephrine
1442148|NCT00995813|Intestinal failure|intestinal failure
1442149|NCT00995813|Rotavirus vaccine|rotavirus vaccine
1442150|NCT00995813|Infants|infants
1442151|NCT00995800|Asthma|asthma
1442152|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
1442153|NCT00995787|metformin|metformin
1442154|NCT00995787|sulfonylurea|sulfonylurea
1442155|NCT00995774|stroke|stroke
1442156|NCT00995774|function|function
1442157|NCT00995774|arm|arm
1442158|NCT00995774|hand|hand
1442159|NCT00995774|robotic|robotic
1442160|NCT00995774|therapy|therapy
1442161|NCT00995774|motor|motor
1442162|NCT00995774|movement|movement
1442163|NCT00995774|treatment|treatment
1442164|NCT00995761|biweekly|biweekly
1442165|NCT00995761|docetaxel|docetaxel
1442166|NCT00995761|cisplatin|cisplatin
1442167|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
1442168|NCT00995735|NOTES|notes
1442169|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
1442170|NCT00995735|Cholecystectomy|cholecystectomy
1442171|NCT00995735|Appendectomy|appendectomy
1442172|NCT00995735|Endoscopy|endoscopy
1442173|NCT00995735|Laparoscopy|laparoscopy
1442174|NCT00995735|Minimally invasive surgery|minimally invasive surgery
1442175|NCT00995735|clinical trials|clinical trials
1442177|NCT00995722|Prednisone|prednisone
1442178|NCT00995722|Steroids|steroids
1442179|NCT00995709|Behçet's disease,|behçet's disease,
1442180|NCT00995709|intermediate uveitis|intermediate uveitis
1442181|NCT00995709|panuveitis|panuveitis
1442182|NCT00995709|posterior uveitis|posterior uveitis
1442183|NCT00995709|uveitis|uveitis
1442184|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
1442185|NCT00995696|Antidepressant|antidepressant
1442186|NCT00995683|intracranial hypertension|intracranial hypertension
1442187|NCT00995683|neurological outcome|neurological outcome
1442188|NCT00995683|osmotherapy|osmotherapy
1442189|NCT00995670|hyperglycemia|hyperglycemia
1442190|NCT00995670|statin|statin
1442191|NCT00995670|blood vessels|blood vessels
1442192|NCT00995670|ischemic preconditioning|ischemic preconditioning
1442193|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
1442194|NCT00995670|endothelium|endothelium
1442195|NCT00995670|5% dextrose|5% dextrose
1442196|NCT00995644|smoking|smoking
1442197|NCT00995644|smoking cessation|smoking cessation
1442198|NCT00995644|tobacco use cessation|tobacco use cessation
1442199|NCT00995644|tobacco use disorder|tobacco use disorder
1442200|NCT00995631|liposuction|liposuction
1442201|NCT00995631|adipose tissue|adipose tissue
1442202|NCT00995631|dietary fatty acids|dietary fatty acids
1442203|NCT00995631|triglyceride storage|triglyceride storage
1442204|NCT00995631|Normal healthy aging|normal healthy aging
1442205|NCT00995618|Gout|gout
1442206|NCT00995618|Hyperuricemia|hyperuricemia
1442207|NCT00995592|nutrition|nutrition
1442208|NCT00995592|child weight|child weight
1442209|NCT00995592|undernourishment|undernourishment
1442210|NCT00995592|mentor mother|mentor mother
1442211|NCT00995592|South Africa|south africa
1442212|NCT00995579|Physical Activity|physical activity
1442213|NCT00995579|Energy Expenditure|energy expenditure
1442214|NCT00995540|T1DM|t1dm
1442215|NCT00995540|Regeneration|regeneration
1442216|NCT00995540|Islet|islet
1442217|NCT00995540|Beta cell|beta cell
1442218|NCT00995540|INGAP Peptide|ingap peptide
1442219|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
1442220|NCT00995527|Biologic Sample Collection|biologic sample collection
1442221|NCT00995527|Laboratory Research Samples|laboratory research samples
1442222|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
1442223|NCT00995527|HV|hv
1442224|NCT00995527|Healthy Volunteer|healthy volunteer
1442225|NCT00995514|acute coronary syndrome|acute coronary syndrome
1442226|NCT00995514|cardiovascular death|cardiovascular death
1442227|NCT00995514|non-fatal MI|non-fatal mi
1442228|NCT00995514|non-fatal stroke|non-fatal stroke
1442229|NCT00995514|genetic testing|genetic testing
1442230|NCT00995514|CYP2C19|cyp2c19
1442231|NCT00995514|clopidogrel|clopidogrel
1442232|NCT00995514|prasugrel|prasugrel
1442233|NCT00995514|antiplatelet therapy|antiplatelet therapy
1442234|NCT00995514|genotyping|genotyping
1442235|NCT00995514|bleeding|bleeding
1442236|NCT00995501|steroid administration|steroid administration
1442237|NCT00995501|tight glucose control|tight glucose control
1442238|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
1442239|NCT00995501|a|a
1442240|NCT00995488|Urothelial Cancer|urothelial cancer
1442241|NCT00995488|ABI-007|abi-007
1442242|NCT00995488|Bladder Cancer|bladder cancer
1442243|NCT00995488|front-line|front-line
1442244|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
1442245|NCT00995449|Biologics-Inadequate|biologics-inadequate
1442246|NCT00995449|KB003|kb003
1442247|NCT00995449|GM-CSF|gm-csf
1442248|NCT00995436|Extractions|extractions
1442249|NCT00995436|Anchorage supplementation|anchorage supplementation
1442250|NCT00995423|Coronary Artery Disease|coronary artery disease
1442251|NCT00995423|stent|stent
1442252|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
1442354|NCT00995072|metoprolol|metoprolol
1442355|NCT00995072|nebivolol|nebivolol
1442253|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
1442254|NCT00995410|Gastric Ulcers|gastric ulcers
1442255|NCT00995397|Insect bites|insect bites
1442256|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
1442257|NCT00995397|Lotion|lotion
1442258|NCT00995397|Cream|cream
1442259|NCT00995371|Spinal Stenosis|spinal stenosis
1442260|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
1442261|NCT00995371|Laminotomy|laminotomy
1442262|NCT00995371|Laminectomy|laminectomy
1442263|NCT00995371|Spine Surgery|spine surgery
1442264|NCT00995358|Epitope peptide|epitope peptide
1442265|NCT00995358|CTL|ctl
1442266|NCT00995358|Esophageal cancer|esophageal cancer
1442267|NCT00995358|Vaccination|vaccination
1442268|NCT00995345|Type 2 Diabetes|type 2 diabetes
1442269|NCT00995345|Metformin|metformin
1442270|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
1442271|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
1442272|NCT00995332|valproic acid|valproic acid
1442273|NCT00995332|cytarabine|cytarabine
1442274|NCT00995332|Disease stabilization|disease stabilization
1442275|NCT00995332|survival|survival
1442276|NCT00995332|toxicity|toxicity
1442277|NCT00995319|mouth|mouth
1442278|NCT00995319|Mucositis|mucositis
1442279|NCT00995319|Dysphagia|dysphagia
1442280|NCT00995319|malnutrition|malnutrition
1442281|NCT00995319|Xerostomia|xerostomia
1442282|NCT00995319|saliva|saliva
1442283|NCT00995319|tooth injuries|tooth injuries
1442284|NCT00995306|Active comparator|active comparator
1442285|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
1442286|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
1442287|NCT00995280|follicle flushing|follicle flushing
1442288|NCT00995280|oocyte retrieval|oocyte retrieval
1442289|NCT00995280|needle|needle
1442290|NCT00995267|childhood obesity|childhood obesity
1442291|NCT00995267|nutrition|nutrition
1442292|NCT00995267|exercise|exercise
1442293|NCT00995267|Alfred Adler|alfred adler
1442294|NCT00995267|schoolchildren|schoolchildren
1442295|NCT00995267|intervention study|intervention study
1442296|NCT00995267|community-based trial|community-based trial
1442297|NCT00995267|parent-child interaction|parent-child interaction
1442298|NCT00995267|nutritional behaviors|nutritional behaviors
1442299|NCT00995254|secondhand smoke|secondhand smoke
1442300|NCT00995254|children|children
1442301|NCT00995254|Chinese|chinese
1442302|NCT00995254|respiratory symptoms|respiratory symptoms
1442303|NCT00995254|household smoking policy|household smoking policy
1442304|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
1442305|NCT00995241|Raltegravir|raltegravir
1442306|NCT00995241|intracellular concentration|intracellular concentration
1442307|NCT00995241|plasmatic concentration|plasmatic concentration
1442308|NCT00995241|HIV|hiv
1442309|NCT00995241|Treatment experienced|treatment experienced
1442310|NCT00995228|overhydration|overhydration
1442311|NCT00995228|fluid restriction|fluid restriction
1442312|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
1442313|NCT00995215|spinal cord injury|spinal cord injury
1442314|NCT00995215|SCI|sci
1442315|NCT00995215|paralysis|paralysis
1442316|NCT00995215|cough|cough
1442317|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
1442318|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
1442319|NCT00995202|stage II colon cancer|stage ii colon cancer
1442320|NCT00995202|stage II rectal cancer|stage ii rectal cancer
1442321|NCT00995202|stage III colon cancer|stage iii colon cancer
1442322|NCT00995202|stage III rectal cancer|stage iii rectal cancer
1442323|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
1442324|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1442325|NCT00995189|contact lens wear|contact lens wear
1442326|NCT00995189|multi-purpose solution|multi-purpose solution
1442327|NCT00995189|corneal staining|corneal staining
1442328|NCT00995176|Prevention|prevention
1442329|NCT00995176|HIV|hiv
1442330|NCT00995176|HIV seronegativity|hiv seronegativity
1442331|NCT00995163|outcomes study|outcomes study
1442332|NCT00995163|hemodialysis|hemodialysis
1442333|NCT00995163|CKD-MBD|ckd-mbd
1442334|NCT00995150|contraception|contraception
1442335|NCT00995150|intrauterine|intrauterine
1442336|NCT00995150|long-term|long-term
1442337|NCT00995150|reversible|reversible
1442338|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
1442339|NCT00995124|ovicide|ovicide
1442340|NCT00995124|head lice infestation|head lice infestation
1442341|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
1442342|NCT00995098|nutritional support|nutritional support
1442343|NCT00995098|enteral nutrition|enteral nutrition
1442344|NCT00995098|parenteral nutrition|parenteral nutrition
1442345|NCT00995085|ADHD|adhd
1442346|NCT00995085|ADD|add
1442347|NCT00995085|TOVA|tova
1442348|NCT00995085|METADOXINE|metadoxine
1442349|NCT00995072|sexual dysfunction|sexual dysfunction
1442350|NCT00995072|female|female
1442351|NCT00995072|hypertension|hypertension
1442352|NCT00995072|high blood pressure|high blood pressure
1442353|NCT00995072|beta blockers|beta blockers
1442356|NCT00995072|Bystolic|bystolic
1442357|NCT00995072|Toprol XL|toprol xl
1442358|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
1442359|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
1442360|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
1442361|NCT00995046|Hemophilia A|hemophilia a
1442362|NCT00995046|prophylaxis|prophylaxis
1442363|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
1442364|NCT00995033|Smoking cessation|smoking cessation
1442365|NCT00995033|Smoking lapse behavior|smoking lapse behavior
1442366|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
1442367|NCT00995033|Varenicline|varenicline
1442368|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
1442369|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
1442370|NCT00995020|Cone biopsy|cone biopsy
1442371|NCT00995020|Conization|conization
1442372|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
1442373|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
1442374|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
1442471|NCT00994526|Colorectal cancer|colorectal cancer
1442375|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
1442376|NCT00995020|Electrosurgery|electrosurgery
1442377|NCT00995007|Brain Tumor|brain tumor
1442378|NCT00995007|Chemotherapy|chemotherapy
1442379|NCT00995007|Antiangiogenesis|antiangiogenesis
1442380|NCT00995007|Radiation|radiation
1442381|NCT00995007|Progression|progression
1442383|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
1442384|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
1442385|NCT00994994|bleeding|bleeding
1442386|NCT00994994|tranexamic acid|tranexamic acid
1442387|NCT00994994|fibrinolysis|fibrinolysis
1442388|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
1442389|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
1442390|NCT00994968|stage II breast cancer|stage ii breast cancer
1442391|NCT00994968|stage III breast cancer|stage iii breast cancer
1442392|NCT00994955|SRT|srt
1442393|NCT00994955|laser|laser
1442394|NCT00994955|diabetic macular edema|diabetic macular edema
1442395|NCT00994955|diabetes|diabetes
1442396|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
1442397|NCT00994929|biologic effects|biologic effects
1442398|NCT00994929|von Willebrand disease|von willebrand disease
1442399|NCT00994929|hemophilia|hemophilia
1442400|NCT00994929|interleukin-11|interleukin-11
1442401|NCT00994929|DDAVp|ddavp
1442402|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
1442403|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
1442404|NCT00994903|Statin|statin
1442405|NCT00994903|Colon|colon
1442406|NCT00994903|Colorectal|colorectal
1442407|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
1442408|NCT00994903|ERAS|eras
1442409|NCT00994903|Perioperative Care|perioperative care
1442410|NCT00994890|Double-blind safety|double-blind safety
1442411|NCT00994825|levosimendan|levosimendan
1442412|NCT00994825|cardiac surgery|cardiac surgery
1442413|NCT00994825|cardiac anesthesia|cardiac anesthesia
1442414|NCT00994825|mortality|mortality
1442415|NCT00994825|survival|survival
1442416|NCT00994825|inotropic drugs|inotropic drugs
1442417|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
1442418|NCT00994812|PCOS|pcos
1442419|NCT00994812|Metformin|metformin
1442420|NCT00994812|Miscarriage|miscarriage
1442421|NCT00994812|Infertility|infertility
1442422|NCT00994812|Complications of pregnancy|complications of pregnancy
1442423|NCT00994786|treatment-resistant|treatment-resistant
1442424|NCT00994786|refractory|refractory
1442425|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
1442426|NCT00994786|Lyrica|lyrica
1442427|NCT00994786|pregabalin|pregabalin
1442428|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
1442429|NCT00994773|Hepatitis B|hepatitis b
1442430|NCT00994773|simvastatin|simvastatin
1442431|NCT00994773|HBV DNA|hbv dna
1442432|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
1442433|NCT00994747|infancy|infancy
1442434|NCT00994747|nutrition|nutrition
1442435|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
1442436|NCT00994747|flavor preferences|flavor preferences
1442437|NCT00994747|food preferences|food preferences
1442438|NCT00994747|growth|growth
1442439|NCT00994747|emotional development|emotional development
1442440|NCT00994747|mother-infant interaction|mother-infant interaction
1442441|NCT00994747|infant temperament|infant temperament
1442442|NCT00994747|feeding patterning|feeding patterning
1442443|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
1442444|NCT00994747|sensitive period|sensitive period
1442445|NCT00994721|Pancreatic Cancer|pancreatic cancer
1442446|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
1442447|NCT00994695|Children|children
1442448|NCT00994695|Safety|safety
1442449|NCT00994695|Immunogenicity|immunogenicity
1442547|NCT00994188|Renal transplantation|renal transplantation
1442450|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
1442451|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
1442452|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
1442453|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
1442454|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
1442455|NCT00994682|Pharmacologic Actions|pharmacologic actions
1442456|NCT00994682|Pioglitazone|pioglitazone
1442457|NCT00994656|invasive procedures|invasive procedures
1442458|NCT00994656|hypovolemia|hypovolemia
1580904|NCT00461500|Therapy|therapy
1442459|NCT00994643|NHL|nhl
1442460|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1442461|NCT00994643|Lymphoma|lymphoma
1442462|NCT00994591|Nicotine|nicotine
1442463|NCT00994591|Cotinine|cotinine
1442464|NCT00994591|CYP2A6|cyp2a6
1442465|NCT00994578|Advanced cancer|advanced cancer
1442466|NCT00994565|Physical activity|physical activity
1442467|NCT00994565|health behaviour|health behaviour
1442468|NCT00994565|lifestyle|lifestyle
1442469|NCT00994565|productivity|productivity
1442470|NCT00994565|outcomes|outcomes
1442472|NCT00994526|Processed meat|processed meat
1442473|NCT00994526|Calcium|calcium
1442474|NCT00994526|Vitamin E|vitamin e
1442475|NCT00994526|Preventive strategies|preventive strategies
1442476|NCT00994513|Antioxidant|antioxidant
1442477|NCT00994513|Obesity|obesity
1442478|NCT00994487|Childhood Obesity|childhood obesity
1442479|NCT00994487|Breastfeeding|breastfeeding
1442480|NCT00994487|Bottle Feeding|bottle feeding
1442481|NCT00994487|Dietary Intake|dietary intake
1442482|NCT00994487|Preload|preload
1442483|NCT00994487|Compensation|compensation
1442484|NCT00994487|Parental Feeding Style|parental feeding style
1442485|NCT00994474|Laser surgery|laser surgery
1442486|NCT00994474|Profilometry|profilometry
1442487|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
1442488|NCT00994474|Patient Benefit Index|patient benefit index
1442489|NCT00994474|Patient satisfaction|patient satisfaction
1442490|NCT00994461|Endoscopy|endoscopy
1442491|NCT00994448|Adolescents|adolescents
1442492|NCT00994448|Methamphetamine abuse|methamphetamine abuse
1442493|NCT00994448|Bupropion|bupropion
1442494|NCT00994448|Addiction|addiction
1442495|NCT00994448|Pharmacotherapy|pharmacotherapy
1442496|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
1442497|NCT00994448|Contingency Management|contingency management
1442498|NCT00994448|Teens|teens
1442499|NCT00994435|obesity|obesity
1442500|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
1442501|NCT00994422|Head Lice|head lice
1442502|NCT00994409|Stroke|stroke
1442503|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
1442504|NCT00994370|SIRT|sirt
1442505|NCT00994370|hepatic metastases|hepatic metastases
1442506|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
1442507|NCT00994357|Macrosomia|macrosomia
1442508|NCT00994344|Darunavir|darunavir
1442509|NCT00994344|Lopinavir|lopinavir
1442510|NCT00994344|Monotherapy|monotherapy
1442511|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
1442512|NCT00994344|HIV|hiv
1442513|NCT00994344|Treatment experienced|treatment experienced
1442514|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
1442515|NCT00994331|Magnetic Navigation|magnetic navigation
1442516|NCT00994331|Computed Tomography|computed tomography
1442517|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
1442518|NCT00994305|kidney transplantation|kidney transplantation
1442519|NCT00994305|oxidative stress|oxidative stress
1442520|NCT00994305|acetylcysteine|acetylcysteine
1442521|NCT00994305|graft rejection|graft rejection
1442522|NCT00994292|Factor Xa|factor xa
1442523|NCT00994292|Anticoagulant|anticoagulant
1442524|NCT00994292|YM150|ym150
1442525|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
1442526|NCT00994279|fatigue|fatigue
1442527|NCT00994279|depression|depression
1442528|NCT00994279|sleep disorders|sleep disorders
1442529|NCT00994279|stage IA breast cancer|stage ia breast cancer
1442530|NCT00994279|stage IB breast cancer|stage ib breast cancer
1442531|NCT00994279|stage II breast cancer|stage ii breast cancer
1442532|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
1442533|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
1442534|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
1442535|NCT00994279|recurrent breast cancer|recurrent breast cancer
1442536|NCT00994266|Type 2 diabetes|type 2 diabetes
1442537|NCT00994266|Diamel|diamel
1442538|NCT00994266|Dietary supplement|dietary supplement
1442539|NCT00994227|electron microscopy|electron microscopy
1442540|NCT00994227|internal limiting membrane|internal limiting membrane
1442541|NCT00994227|macular disease|macular disease
1442542|NCT00994227|optical coherence tomography|optical coherence tomography
1442543|NCT00994188|Renal tumor|renal tumor
1442544|NCT00994188|Ureteral tumor|ureteral tumor
1442545|NCT00994188|Ureteral stricture|ureteral stricture
1442546|NCT00994188|Restored kidney|restored kidney
1442963|NCT00993031|Uganda|uganda
1442548|NCT00994188|Family members|family members
1442549|NCT00994175|Pioglitazone|pioglitazone
1442550|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
1442551|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
1442552|NCT00994175|Airflow Obstruction|airflow obstruction
1442553|NCT00994175|Airway Inflammation|airway inflammation
1442554|NCT00994175|Asthma|asthma
1442555|NCT00994162|NPWT|npwt
1442556|NCT00994162|Gauze-based filler|gauze-based filler
1442557|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
1442558|NCT00994162|Efficacy|efficacy
1442559|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
1442560|NCT00994149|Hypoglycemia|hypoglycemia
1442561|NCT00994149|Diazoxide|diazoxide
1442562|NCT00994149|Large for Gestation Infants|large for gestation infants
1442563|NCT00994136|Catheters, indwelling|catheters, indwelling
1442564|NCT00994136|Catheterization, Central Venous|catheterization, central venous
1442565|NCT00994136|Withdrawal occlusion|withdrawal occlusion
1442566|NCT00994136|Heparin lock|heparin lock
1442567|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
1442568|NCT00994123|NSCLC|nsclc
1442569|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1442570|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
1442571|NCT00994123|Lung Cancer|lung cancer
1442572|NCT00994123|Erlotinib|erlotinib
1442573|NCT00994123|Tarceva|tarceva
1442574|NCT00994123|MM-121|mm-121
1442575|NCT00994123|ErbB3|erbb3
1442576|NCT00994123|Her3|her3
1442577|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1442578|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
1442579|NCT00994123|ErbB3 antagonist|erbb3 antagonist
1442580|NCT00994110|PANCREAS|pancreas
1442581|NCT00994110|Pasireotide|pasireotide
1442582|NCT00994110|SOM230|som230
1442583|NCT00994110|saline placebo|saline placebo
1442584|NCT00994110|09-039|09-039
1442585|NCT00994097|NGR-hTNF|ngr-htnf
1442586|NCT00994097|Randomized controlled trial|randomized controlled trial
1442587|NCT00994097|Gemcitabine|gemcitabine
1442588|NCT00994097|Cisplatin|cisplatin
1442589|NCT00994097|Pemetrexed|pemetrexed
1442590|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
1442591|NCT00994084|Obesity|obesity
1442592|NCT00994084|Minority children|minority children
1442593|NCT00994084|Community intervention program|community intervention program
1442594|NCT00994084|Lifestyle changes|lifestyle changes
1442595|NCT00994084|Physical activities|physical activities
1442596|NCT00994084|Nutrition lessons|nutrition lessons
1442597|NCT00994084|Behavior modification|behavior modification
1442598|NCT00994071|Brain Tumor|brain tumor
1442599|NCT00994071|CNC Tumor|cnc tumor
1442600|NCT00994071|Pediatric|pediatric
1442601|NCT00994071|PARP Inhibitor|parp inhibitor
1442602|NCT00994071|Oral Chemotherapy|oral chemotherapy
1442603|NCT00994058|Preterm Labor|preterm labor
1442604|NCT00994058|Uterine Inhibitor|uterine inhibitor
1442605|NCT00994058|Electro-Inhibition|electro-inhibition
1442606|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
1442607|NCT00994045|Coagulopathy|coagulopathy
1442608|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
1442609|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
1442610|NCT00994032|vertebroplasty|vertebroplasty
1442611|NCT00994032|disability evaluation|disability evaluation
1442612|NCT00994032|outcome assessment|outcome assessment
1442613|NCT00994032|pain measurement|pain measurement
1442614|NCT00994019|HPV|hpv
1442615|NCT00994019|oral cancer|oral cancer
1442616|NCT00994019|young adults|young adults
1442617|NCT00994006|Magnesium|magnesium
1442618|NCT00994006|nutrition|nutrition
1442619|NCT00994006|platelets|platelets
1442620|NCT00994006|aggregation|aggregation
1442621|NCT00993993|cleft palate|cleft palate
1442622|NCT00993980|qigong|qigong
1442623|NCT00993980|traditional chinese medicine|traditional chinese medicine
1442624|NCT00993980|exercise therapy|exercise therapy
1442625|NCT00993980|low back pain|low back pain
1442626|NCT00993967|FRDA|frda
1442627|NCT00993967|idebenone|idebenone
1442628|NCT00993967|FRDA disease|frda disease
1442629|NCT00993954|Nurse Treatment|nurse treatment
1442630|NCT00993954|Pulled Elbow|pulled elbow
1442631|NCT00993941|BMSC|bmsc
1442632|NCT00993941|Stem cells|stem cells
1442633|NCT00993941|Liver cirrhosis|liver cirrhosis
1442634|NCT00993941|Transplantation|transplantation
1442635|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1442636|NCT00993928|fatigue|fatigue
1442637|NCT00993928|sleep disorders|sleep disorders
1442638|NCT00993928|cancer survivor|cancer survivor
1442639|NCT00993915|Coronary Artery Disease|coronary artery disease
1442640|NCT00993915|Hyperlipidemia|hyperlipidemia
1442641|NCT00993915|Atorvastatin|atorvastatin
1442642|NCT00993902|Double IUI|double iui
1442643|NCT00993902|Intrauterine insemination|intrauterine insemination
1442644|NCT00993902|Unexplained infertility|unexplained infertility
1442645|NCT00993889|Virtual Reality Peds|virtual reality peds
1442646|NCT00993876|Depression|depression
1442647|NCT00993876|CREB|creb
1442648|NCT00993876|cognitive performance|cognitive performance
1442649|NCT00993876|psychotherapy|psychotherapy
1442650|NCT00993876|SSRI|ssri
1442651|NCT00993876|SNRI|snri
1442652|NCT00993863|delta opioid agonist|delta opioid agonist
1442653|NCT00993863|dental pain|dental pain
1442654|NCT00993850|Bipolar disorder|bipolar disorder
1442655|NCT00993850|Insomnia|insomnia
1442656|NCT00993850|Sleep disturbance|sleep disturbance
1442657|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
1442658|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
1442659|NCT00993837|thyroid carcinoma|thyroid carcinoma
1442660|NCT00993811|male circumcision|male circumcision
1442661|NCT00993811|HIV|hiv
1442662|NCT00993811|Africa|africa
1442663|NCT00993811|HIV Seronegativity|hiv seronegativity
1442664|NCT00993798|Post operative pain|post operative pain
1442665|NCT00993798|Local anaesthesia|local anaesthesia
1442666|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
1442667|NCT00993759|common cold|common cold
1442668|NCT00993759|rhinovirus|rhinovirus
1442669|NCT00993759|prevention|prevention
1442670|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
1442671|NCT00993746|Bupivacaine|bupivacaine
1442672|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
1442673|NCT00993746|End stage renal disease|end stage renal disease
1442674|NCT00993746|Arteriovenous fistula|arteriovenous fistula
1442675|NCT00993733|hemodiafiltration|hemodiafiltration
1442677|NCT00993733|dialysis solution|dialysis solution
1442678|NCT00993733|acute renal failure|acute renal failure
1442679|NCT00993733|intensive care unit|intensive care unit
1442680|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
1442681|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1442682|NCT00993694|methemoglobinemia|methemoglobinemia
1442683|NCT00993694|aplastic anemia|aplastic anemia
1442684|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1442685|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
1442686|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1442687|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1442688|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1442689|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1442690|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1442691|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1442692|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1442693|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1442694|NCT00993694|mast cell leukemia|mast cell leukemia
1442695|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1442696|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1442697|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
1442698|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1442699|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1442700|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1442701|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
1442702|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1442703|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1442704|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1442705|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1442706|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1442707|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1442708|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1442709|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1442710|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1442711|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1442712|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1442713|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1442714|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1442715|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1442716|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1442717|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1442718|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1442719|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1442720|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1442721|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1442722|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1442723|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1442724|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1443057|NCT00992745|imaging|imaging
1442725|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1442726|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1568401|NCT00505999|Healthy Controls|healthy controls
1581296|NCT00459992|Obesity|obesity
1442727|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1442728|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1442729|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1442730|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1442731|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1442732|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1442733|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1442734|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1442735|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1442736|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1442737|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1442738|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1443181|NCT00992186|Infusion|infusion
1442739|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1442740|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1442741|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1442742|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1442743|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1442744|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1442745|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1442746|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1442747|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1442748|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1442749|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1442750|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1442751|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1442752|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1442753|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1442754|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1442755|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1442756|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1442757|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1442758|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1442759|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1442760|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1442761|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1442762|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1442763|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1442764|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1442765|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1442766|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1442767|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1442768|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1442769|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1442770|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1442771|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1442772|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1442773|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1442774|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1442775|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1442776|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1442777|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1442778|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1442779|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1442780|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1442781|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1442782|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1442783|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1442784|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1442961|NCT00993031|Placental Malaria|placental malaria
1567289|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1442785|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1442786|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1442787|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1442788|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1442789|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1442790|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1442791|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1442792|NCT00993694|Burkitt lymphoma|burkitt lymphoma
1442793|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1442794|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1442795|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1442796|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1442797|NCT00993694|intraocular lymphoma|intraocular lymphoma
1442798|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1442799|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1442800|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1442801|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1442802|NCT00993694|primary myelofibrosis|primary myelofibrosis
1442803|NCT00993694|essential thrombocythemia|essential thrombocythemia
1442804|NCT00993694|polycythemia vera|polycythemia vera
1442805|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
1442806|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1442807|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
1442808|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
1442809|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
1442810|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
1442811|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
1442812|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1442813|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1442814|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1442815|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1442816|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1442817|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1442818|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1442819|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1442820|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1442821|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1442822|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1442823|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
1442824|NCT00993668|influenza|influenza
1442825|NCT00993668|vaccine|vaccine
1442826|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
1442827|NCT00993668|certolizumab pegol|certolizumab pegol
1442828|NCT00993668|Cimzia|cimzia
1442829|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
1442830|NCT00993655|fallopian tube cancer|fallopian tube cancer
1442831|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1442832|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1442833|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1442834|NCT00993655|malignant pleural effusion|malignant pleural effusion
1442835|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1442836|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
1442837|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
1442838|NCT00993629|PTSD|ptsd
1442839|NCT00993629|Depression|depression
1442840|NCT00993629|Neurosteroids|neurosteroids
1442841|NCT00993603|Lifestyle|lifestyle
1442842|NCT00993603|Diabetes Mellitus|diabetes mellitus
1442843|NCT00993603|prevention/onset delay.|prevention/onset delay.
1442844|NCT00993590|Persistent asthma|persistent asthma
1442845|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
1442846|NCT00993590|Asthma control, adolescents|asthma control, adolescents
1442847|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
1442848|NCT00993577|Stretching|stretching
1442849|NCT00993577|Pain|pain
1442850|NCT00993564|Therapeutic hypothermia|therapeutic hypothermia
1442851|NCT00993564|Head cooling|head cooling
1442852|NCT00993564|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1442853|NCT00993564|Newborn|newborn
1442854|NCT00993551|cleft palate|cleft palate
1442855|NCT00993551|paediatric|paediatric
1442856|NCT00993551|pediatric|pediatric
1442857|NCT00993551|surgery|surgery
1442858|NCT00993551|speech|speech
1442859|NCT00993551|velopharyngeal|velopharyngeal
1581531|NCT00459069|GM-CSF|gm-csf
1442860|NCT00993538|Leukaemia|leukaemia
1442861|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
1442862|NCT00993538|Cell growth|cell growth
1442863|NCT00993538|Cell differentiation|cell differentiation
1442864|NCT00993525|diabetic retinopathy|diabetic retinopathy
1442865|NCT00993525|ranibizumab|ranibizumab
1442866|NCT00993525|new vessels|new vessels
1442867|NCT00993525|intravitreal injection|intravitreal injection
1442868|NCT00993525|Persistent retina new vessels|persistent retina new vessels
1442869|NCT00993512|photochemical internalisation|photochemical internalisation
1442870|NCT00993512|photosensitiser|photosensitiser
1442871|NCT00993512|cutaneous tumour|cutaneous tumour
1442872|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
1442873|NCT00993512|dose escalation|dose escalation
1442874|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1442875|NCT00993486|Graft-versus-host disease|graft-versus-host disease
1442876|NCT00993486|Immune reconstitution|immune reconstitution
1442877|NCT00993486|Alloreactive T-cells|alloreactive t-cells
1442878|NCT00993486|Photodepletion|photodepletion
1442879|NCT00993486|TH9402|th9402
1442880|NCT00993486|Transplant related mortality|transplant related mortality
1442881|NCT00993486|Hematologic malignancy|hematologic malignancy
1442882|NCT00993460|Obesity|obesity
1442883|NCT00993460|Insulin sensitivity|insulin sensitivity
1442884|NCT00993460|Inflammation|inflammation
1442885|NCT00993447|Dengue|dengue
1442886|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
1442887|NCT00993447|Dengue virus|dengue virus
1442888|NCT00993447|Dengue fever|dengue fever
1442889|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
1442890|NCT00993434|Child|child
1442891|NCT00993395|addiction|addiction
1442892|NCT00993395|peer mentor|peer mentor
1442893|NCT00993395|adherence|adherence
1442894|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
1442895|NCT00993356|Acromegaly|acromegaly
1442896|NCT00993356|Macroadenomas|macroadenomas
1442897|NCT00993356|Lanreotide|lanreotide
1442898|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
1442899|NCT00993356|Preoperative|preoperative
1442900|NCT00993343|GVHD|gvhd
1442901|NCT00993343|tacrolimus|tacrolimus
1442902|NCT00993343|sirolimus|sirolimus
1442903|NCT00993343|cyclosporine|cyclosporine
1442904|NCT00993343|allogeneic|allogeneic
1442905|NCT00993343|stem cell transplantation|stem cell transplantation
1442906|NCT00993343|Relapse-free survival|relapse-free survival
1442907|NCT00993330|macular pigment|macular pigment
1442908|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
1442909|NCT00993317|CDP870|cdp870
1442910|NCT00993317|Korea|korea
1442911|NCT00993317|CIMZIA|cimzia
1442912|NCT00993291|Parkinson's Disease|parkinson's disease
1442913|NCT00993291|DBS|dbs
1442914|NCT00993291|Frequency|frequency
1442915|NCT00993291|Deep brain stimulation|deep brain stimulation
1442916|NCT00993265|Trichotillomania|trichotillomania
1442917|NCT00993265|Hair pulling|hair pulling
1442918|NCT00993265|glutamate|glutamate
1442919|NCT00993265|N-Acetylcysteine|n-acetylcysteine
1442920|NCT00993265|Children|children
1442921|NCT00993252|head injury|head injury
1442922|NCT00993252|radiography|radiography
1442923|NCT00993252|clinical impact|clinical impact
1442924|NCT00993252|dissemination|dissemination
1442925|NCT00993226|Postoperative pain|postoperative pain
1442926|NCT00993226|Local anaesthesia|local anaesthesia
1442927|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
1442928|NCT00993213|fat mass|fat mass
1442929|NCT00993213|body composition|body composition
1442930|NCT00993200|Warfarin|warfarin
1442931|NCT00993200|Pharmacogenetic|pharmacogenetic
1442932|NCT00993161|Neuromuscular disorders|neuromuscular disorders
1442933|NCT00993161|Evaluation|evaluation
1442934|NCT00993161|Strength|strength
1442935|NCT00993161|Upper limb|upper limb
1442936|NCT00993148|Treatment naive|treatment naive
1442937|NCT00993135|renal toxicity|renal toxicity
1442938|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1442939|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1442940|NCT00993122|pre treatment|pre treatment
1442941|NCT00993122|therapy compliance|therapy compliance
1442942|NCT00993122|SVR|svr
1442943|NCT00993122|sustained virological response|sustained virological response
1442944|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
1442945|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
1442946|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
1442947|NCT00993109|Hypertension|hypertension
1442948|NCT00993083|Influenza|influenza
1442949|NCT00993083|Vaccine|vaccine
1442950|NCT00993070|capsaicin|capsaicin
1442951|NCT00993070|placebo|placebo
1442952|NCT00993070|trial|trial
1442953|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
1442954|NCT00993070|neuropathic pain|neuropathic pain
1442955|NCT00993057|Euglycemia|euglycemia
1442956|NCT00993057|craniotomy|craniotomy
1442957|NCT00993057|neurosurgery|neurosurgery
1442958|NCT00993057|hypoglycemia|hypoglycemia
1442959|NCT00993057|insulin|insulin
1442960|NCT00993031|HIV|hiv
1442962|NCT00993031|Pregnancy|pregnancy
1442964|NCT00993031|Protease inhibitors|protease inhibitors
1442965|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1442966|NCT00993031|Treatment experienced|treatment experienced
1442967|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
1442968|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
1442969|NCT00993018|JNJ-42160443|jnj-42160443
1442970|NCT00993018|Neuropathic pain|neuropathic pain
1442971|NCT00993018|Pain|pain
1442972|NCT00993018|Pharmacokinetics|pharmacokinetics
1442973|NCT00993005|Hypertrophic scars|hypertrophic scars
1442974|NCT00993005|Keloids|keloids
1442975|NCT00993005|Asian Gotu Kola|asian gotu kola
1442976|NCT00993005|Asian Pennywort|asian pennywort
1442977|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
1442978|NCT00992992|Tositumomab|tositumomab
1442979|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
1442980|NCT00992992|Bexxar|bexxar
1442981|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
1442982|NCT00992992|Mantle Cell|mantle cell
1442983|NCT00992992|radioimmunotherapy|radioimmunotherapy
1442984|NCT00992979|Addiction|addiction
1442985|NCT00992979|Anxiety|anxiety
1442986|NCT00992979|Withdrawal|withdrawal
1442987|NCT00992979|Psychoactive Drugs|psychoactive drugs
1442988|NCT00992979|Therapeutic Massage|therapeutic massage
1443182|NCT00992186|Carlumab|carlumab
1442989|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
1442990|NCT00992953|Virtual Reality|virtual reality
1442991|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
1442992|NCT00992953|Combat|combat
1442993|NCT00992953|Military|military
1442994|NCT00992953|Major Depressive Disorder|major depressive disorder
1442995|NCT00992953|Anxiety|anxiety
1442996|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
1442997|NCT00992953|Treatment as Usual|treatment as usual
1442998|NCT00992940|awake craniotomy|awake craniotomy
1442999|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
1443000|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
1443001|NCT00992940|remifentanil-propofol|remifentanil-propofol
1443002|NCT00992940|tumour surgery|tumour surgery
1443003|NCT00992927|Injections, Intra-Articular|injections, intra-articular
1443004|NCT00992927|Range of Motion, Articular|range of motion, articular
1443005|NCT00992927|Pain|pain
1443006|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
1443007|NCT00992901|gastric bypass surgery|gastric bypass surgery
1443008|NCT00992901|glucose tolerance|glucose tolerance
1443009|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
1443010|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
1443011|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
1443012|NCT00992888|Alcohol|alcohol
1443013|NCT00992888|Endotoxin|endotoxin
1443014|NCT00992888|LPS|lps
1443015|NCT00992888|Liver dialysis|liver dialysis
1443016|NCT00992888|Innate immunity|innate immunity
1443017|NCT00992888|Toll Like receptors|toll like receptors
1443018|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
1443019|NCT00992849|Corneal neovascularization|corneal neovascularization
1443020|NCT00992849|bevacizumab|bevacizumab
1443021|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
1443022|NCT00992836|Vaccine|vaccine
1443023|NCT00992836|Children|children
1443024|NCT00992836|Adolescents|adolescents
1443025|NCT00992836|HIV-Infected|hiv-infected
1443026|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
1443027|NCT00992836|Treatment experienced|treatment experienced
1443028|NCT00992823|Iron|iron
1443029|NCT00992823|anemia|anemia
1443030|NCT00992823|supplementation|supplementation
1443031|NCT00992823|preschoolers|preschoolers
1443032|NCT00992823|prevalence|prevalence
1443033|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
1443034|NCT00992810|upper limb|upper limb
1443035|NCT00992810|hand|hand
1443036|NCT00992810|arm|arm
1443037|NCT00992810|surgery|surgery
1443038|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
1443039|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
1443040|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
1443041|NCT00992797|Insulin resistance|insulin resistance
1443042|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
1443043|NCT00992797|Inflammation|inflammation
1443044|NCT00992797|Vascular stiffness|vascular stiffness
1443045|NCT00992784|Influenza Vaccines|influenza vaccines
1443046|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
1443047|NCT00992784|influenza infection|influenza infection
1443048|NCT00992758|bone marrow|bone marrow
1443049|NCT00992758|Radioimmunotherapy|radioimmunotherapy
1443050|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1443051|NCT00992758|Bexxar|bexxar
1443052|NCT00992758|anti-B1 antibody|anti-b1 antibody
1443053|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
1443054|NCT00992758|NHL|nhl
1443055|NCT00992758|tositumomab|tositumomab
1443056|NCT00992745|prostate cancer|prostate cancer
1443058|NCT00992745|metastases|metastases
1443059|NCT00992745|PSMA|psma
1443060|NCT00992745|ProstaScint®|prostascint®
1443061|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
1443062|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1443063|NCT00992706|stage IV breast cancer|stage iv breast cancer
1443064|NCT00992706|male breast cancer|male breast cancer
1443065|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
1443066|NCT00992693|Lassa Fever|lassa fever
1443067|NCT00992693|CCHF|cchf
1443068|NCT00992693|LF|lf
1443069|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
1443070|NCT00992693|VHF|vhf
1443071|NCT00992693|Ribavirin|ribavirin
1443072|NCT00992680|Lung Disease|lung disease
1443073|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
1443074|NCT00992680|Chronic Bronchitis|chronic bronchitis
1443075|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
1443076|NCT00992680|Walk|walk
1443077|NCT00992667|apocynin|apocynin
1443078|NCT00992667|asthma|asthma
1443079|NCT00992654|Open Label Access Program|open label access program
1443080|NCT00992654|Treatment experienced|treatment experienced
1443081|NCT00992641|Systems biology|systems biology
1443082|NCT00992641|Nutrition|nutrition
1443083|NCT00992641|Nordic diet|nordic diet
1443084|NCT00992641|Dietary recommendations|dietary recommendations
1443085|NCT00992641|Metabolic syndrome|metabolic syndrome
1443086|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
1443087|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
1443088|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
1443089|NCT00992628|Intubation|intubation
1443090|NCT00992628|Applied Forces|applied forces
1443091|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
1443092|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
1443093|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1443094|NCT00992589|GERD|gerd
1443095|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
1443096|NCT00992589|PPI|ppi
1443097|NCT00992589|Regurgitation|regurgitation
1443098|NCT00992589|Infants|infants
1443099|NCT00992589|AcipHex, PARIET|aciphex, pariet
1443100|NCT00992589|ALFENCE|alfence
1443101|NCT00992576|Confirmatory|confirmatory
1443102|NCT00992576|Constipation|constipation
1443103|NCT00992576|Pain|pain
1443104|NCT00992576|Hydromorphone|hydromorphone
1443105|NCT00992576|Naloxone|naloxone
1443106|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
1443107|NCT00992550|hookah|hookah
1443108|NCT00992550|cigarette|cigarette
1443109|NCT00992550|smoking|smoking
1443110|NCT00992524|Misoprostol|misoprostol
1443111|NCT00992524|Labor, Obstetric|labor, obstetric
1443112|NCT00992524|Labor, Induced|labor, induced
1443113|NCT00992511|influenza infection|influenza infection
1443114|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1443115|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
1443116|NCT00992498|outpatients|outpatients
1443117|NCT00992498|rehabilitation|rehabilitation
1443118|NCT00992498|comorbidities|comorbidities
1443119|NCT00992498|patient-centered outcome|patient-centered outcome
1443120|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
1443121|NCT00992459|UCD|ucd
1443122|NCT00992459|hyperammonemia|hyperammonemia
1443123|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
1443124|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
1443125|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
1443126|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
1443127|NCT00992446|NHL|nhl
1443128|NCT00992446|maintenance therapy|maintenance therapy
1443129|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
1443130|NCT00992420|thienopyridine|thienopyridine
1443131|NCT00992420|platelets|platelets
1443132|NCT00992420|CYP2C19|cyp2c19
1443133|NCT00992420|clopidogrel|clopidogrel
1443134|NCT00992420|platelet function tests|platelet function tests
1443135|NCT00992420|platelet|platelet
1443136|NCT00992420|genes|genes
1443137|NCT00992420|cytochrome P450|cytochrome p450
1443138|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
1443139|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1443140|NCT00992407|Schizophrenia|schizophrenia
1443141|NCT00992407|Risperidone|risperidone
1443142|NCT00992407|Risperdal|risperdal
1443143|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
1443144|NCT00992381|GI Pain|gi pain
1443145|NCT00992381|healthy participants|healthy participants
1443146|NCT00992381|Safety|safety
1581935|NCT00457678|AMD|amd
1443147|NCT00992381|bioavailability|bioavailability
1443148|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
1443149|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
1443150|NCT00992368|Mammaplasty|mammaplasty
1443151|NCT00992368|QALY|qaly
1443152|NCT00992368|Health-related quality of life|health-related quality of life
1443153|NCT00992368|Cost-effectiveness|cost-effectiveness
1443154|NCT00992368|Breast|breast
1443155|NCT00992355|Cataract|cataract
1443156|NCT00992355|Phacoemulsification|phacoemulsification
1443157|NCT00992355|Treatment duration|treatment duration
1443158|NCT00992329|ciprofloxacin|ciprofloxacin
1443159|NCT00992329|pharmacokinetics|pharmacokinetics
1443160|NCT00992329|formulation|formulation
1443161|NCT00992316|Inflammatory pain|inflammatory pain
1443162|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1443163|NCT00992290|cirrhosis|cirrhosis
1443164|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
1443165|NCT00992290|complications|complications
1443166|NCT00992290|probiotic|probiotic
1443167|NCT00992290|lactobacillus GG|lactobacillus gg
1443168|NCT00992264|Cigarette Smoking|cigarette smoking
1443169|NCT00992264|Health Behavior|health behavior
1443170|NCT00992264|Intervention Studies|intervention studies
1443171|NCT00992264|Personal Communication|personal communication
1443172|NCT00992251|prostate cancer|prostate cancer
1443173|NCT00992225|Metastatic|metastatic
1443174|NCT00992212|Pandemic influenza|pandemic influenza
1443175|NCT00992212|vaccine|vaccine
1443176|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
1443177|NCT00992199|cisplatin|cisplatin
1443178|NCT00992199|fluorouracil|fluorouracil
1443179|NCT00992199|advanced gastric cancer|advanced gastric cancer
1443180|NCT00992186|Prostate cancer|prostate cancer
1443183|NCT00992186|CNTO 888|cnto 888
1443184|NCT00992173|Neuroblastoma|neuroblastoma
1443186|NCT00992173|Iobenguane|iobenguane
1443187|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
1443188|NCT00992160|Adults|adults
1443189|NCT00992160|Primary Insomnia|primary insomnia
1443190|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1443191|NCT00992134|Bendamustine|bendamustine
1443192|NCT00992134|Cytarabine|cytarabine
1443193|NCT00992134|Rituximab|rituximab
1443194|NCT00992134|Treatment|treatment
1443195|NCT00992134|Combination chemotherapy|combination chemotherapy
1443196|NCT00992121|pazopanib|pazopanib
1443197|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
1443198|NCT00992121|Kidney|kidney
1443199|NCT00992121|cancer|cancer
1443200|NCT00992121|bevacizumab|bevacizumab
1443201|NCT00992108|Bruxism|bruxism
1443202|NCT00992108|Myofascial pain|myofascial pain
1443203|NCT00992108|EMG|emg
1443204|NCT00992108|Ultrasound|ultrasound
1443205|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
1443206|NCT00992082|Postoperative pain|postoperative pain
1443207|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
1443208|NCT00992082|Knee arthroplasty|knee arthroplasty
1443209|NCT00992069|ARV|arv
1443210|NCT00992069|Pharmacokinetics|pharmacokinetics
1443211|NCT00992069|TMC207|tmc207
1443212|NCT00992069|Efavirenz|efavirenz
1443213|NCT00992043|creatine supplementation|creatine supplementation
1443214|NCT00992043|exercise training|exercise training
1443215|NCT00992017|Vaccine|vaccine
1443216|NCT00992017|Pregnant|pregnant
1443217|NCT00992017|Perinatal|perinatal
1443218|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
1443219|NCT00992004|Osteoarthritis|osteoarthritis
1443220|NCT00992004|Joint Diseases|joint diseases
1443221|NCT00992004|Arthritis|arthritis
1443222|NCT00992004|Rheumatic Diseases|rheumatic diseases
1443223|NCT00991991|stage I melanoma|stage i melanoma
1443224|NCT00991991|stage II melanoma|stage ii melanoma
1443225|NCT00991991|stage III melanoma|stage iii melanoma
1443226|NCT00991978|breast cancer|breast cancer
1443227|NCT00991978|VEGF|vegf
1443228|NCT00991978|Screening|screening
1443229|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
1443230|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
1443231|NCT00991965|Osseointegration|osseointegration
1443232|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
1443233|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
1443234|NCT00991939|ITP|itp
1443235|NCT00991939|Dexamethasone|dexamethasone
1443236|NCT00991939|Prednisone|prednisone
1443237|NCT00991926|obesity|obesity
1443238|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
1443239|NCT00991926|postprandial NEFA|postprandial nefa
1443240|NCT00991913|Delirium|delirium
1443241|NCT00991913|Postoperative|postoperative
1443242|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
1443243|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
1443244|NCT00991887|Heterotopic Ossification|heterotopic ossification
1443245|NCT00991887|Distal humerus Fracture-dislocations of the elbow|distal humerus fracture-dislocations of the elbow
1443246|NCT00991887|Radiation Therapy|radiation therapy
1443247|NCT00991874|Nitric oxide|nitric oxide
1443248|NCT00991874|Asthma|asthma
1443249|NCT00991874|Longitudinal studies|longitudinal studies
1443250|NCT00991874|Child|child
1443251|NCT00991861|Actinic Keratosis|actinic keratosis
1443252|NCT00991861|AK|ak
1443253|NCT00991861|NMSC|nmsc
1443254|NCT00991848|Lidocaine;|lidocaine;
1443255|NCT00991848|Fibromyalgia|fibromyalgia
1443256|NCT00991848|signs|signs
1443257|NCT00991848|symptoms|symptoms
1443258|NCT00991822|open angle glaucoma|open angle glaucoma
1443259|NCT00991822|timolol|timolol
1443260|NCT00991822|dorzolamide|dorzolamide
1443261|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
1443262|NCT00991783|Fimasartan|fimasartan
1443263|NCT00991783|Drug interaction|drug interaction
1443264|NCT00991770|Discomfort|discomfort
1443265|NCT00991770|Port-a-Catheters|port-a-catheters
1443266|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
1443267|NCT00991770|Massage|massage
1443268|NCT00991757|RWJ-333369|rwj-333369
1443269|NCT00991757|Anticonvulsants|anticonvulsants
1443270|NCT00991757|Antiepileptic drugs|antiepileptic drugs
1443271|NCT00991757|Epilepsy, Focal|epilepsy, focal
1443272|NCT00991757|Seizure Disorder|seizure disorder
1443273|NCT00991744|Leukemia|leukemia
1443274|NCT00991744|Central nervous system|central nervous system
1443275|NCT00991744|Neurotoxicity|neurotoxicity
1443276|NCT00991744|Liposomal cytarabine|liposomal cytarabine
1443277|NCT00991744|Children|children
1443278|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1443279|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1443280|NCT00991744|Intrathecal|intrathecal
1443281|NCT00991744|Efficacy|efficacy
1443282|NCT00991744|Safety|safety
1443283|NCT00991731|Physical Activity|physical activity
1443284|NCT00991731|Faith based|faith based
1443285|NCT00991731|Non faith based|non faith based
1443286|NCT00991731|African American|african american
1443287|NCT00991731|Female|female
1443288|NCT00991731|Pedometers|pedometers
1443289|NCT00991718|GDC0449|gdc0449
1443290|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
1443291|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
1443292|NCT00991692|ACQUIREc Therapy|acquirec therapy
1443293|NCT00991692|Dosage|dosage
1443294|NCT00991692|Occupational Therapy|occupational therapy
1443295|NCT00991692|Physical Therapy|physical therapy
1443296|NCT00991692|Cerebral Palsy|cerebral palsy
1443297|NCT00991692|Hemiparesis|hemiparesis
1443298|NCT00991679|Dry eye syndrome|dry eye syndrome
1443299|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
1443300|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
1443301|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
1443302|NCT00991679|CXCR3 receptor|cxcr3 receptor
1443303|NCT00991666|AMD|amd
1443304|NCT00991666|rigidity|rigidity
1443305|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
1443306|NCT00991666|Physiology of the eye|physiology of the eye
1443307|NCT00991653|Weight|weight
1443308|NCT00991653|Breast|breast
1443309|NCT00991653|Cancer|cancer
1443310|NCT00991627|Ephedrine|ephedrine
1443311|NCT00991627|Adrenergic Agents|adrenergic agents
1443312|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
1443313|NCT00991627|Sympathomimetics|sympathomimetics
1443314|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
1443315|NCT00991627|Bupivacaine|bupivacaine
1443316|NCT00991627|Anesthetics, Local|anesthetics, local
1443317|NCT00991627|Atropine|atropine
1443318|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
1443319|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
1443320|NCT00991627|Bronchodilator Agents|bronchodilator agents
1443321|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
1443322|NCT00991627|Mydriatics|mydriatics
1443323|NCT00991627|Parasympatholytics|parasympatholytics
1443324|NCT00991627|Morphine|morphine
1443325|NCT00991627|Analgesics, Opioid|analgesics, opioid
1443326|NCT00991627|Narcotics|narcotics
1443327|NCT00991627|Ringer's Lactate|ringer's lactate
1443328|NCT00991627|Isotonic Solutions|isotonic solutions
1443329|NCT00991627|Hypotension|hypotension
1443330|NCT00991627|Blood pressure|blood pressure
1443331|NCT00991627|Signs and Symptoms|signs and symptoms
1443332|NCT00991627|Pregnancy|pregnancy
1443333|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
1443334|NCT00991627|Inferior Vena Cava|inferior vena cava
1443335|NCT00991601|liver|liver
1443336|NCT00991601|pancreas|pancreas
1443337|NCT00991601|cancer|cancer
1443338|NCT00991601|tumor|tumor
1443339|NCT00991601|FNAC|fnac
1443340|NCT00991588|PCL|pcl
1443341|NCT00991588|Posterolateral|posterolateral
1443342|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
1443343|NCT00991575|cardiovascular disease|cardiovascular disease
1443344|NCT00991575|diabetes complications|diabetes complications
1443345|NCT00991575|Glycation end products, advanced|glycation end products, advanced
1443346|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
1443347|NCT00991549|overweight|overweight
1443348|NCT00991549|obesity|obesity
1443349|NCT00991549|glucose intolerance|glucose intolerance
1443350|NCT00991549|pre-diabetes|pre-diabetes
1443351|NCT00991523|resistance|resistance
1443352|NCT00991523|exercise|exercise
1443353|NCT00991523|protein|protein
1443354|NCT00991523|recovery|recovery
1443355|NCT00991510|renal transplantation|renal transplantation
1443356|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
1443357|NCT00991510|pharmacokinetics|pharmacokinetics
1443358|NCT00991510|immunosuppression|immunosuppression
1443359|NCT00991497|varicose veins|varicose veins
1443360|NCT00991497|foam sclerotherapy|foam sclerotherapy
1443361|NCT00991497|compression bandaging|compression bandaging
1443362|NCT00991497|duration|duration
1443363|NCT00991484|ventral|ventral
1443364|NCT00991484|inguinal|inguinal
1443365|NCT00991484|hernia|hernia
1443366|NCT00991484|inheritance|inheritance
1443367|NCT00991484|genetics|genetics
1443368|NCT00991471|Emergency Department Wait Times|emergency department wait times
1443369|NCT00991471|Physician Nurse at Triage|physician nurse at triage
1443370|NCT00991471|Overcrowding|overcrowding
1443371|NCT00991471|CostEffectiveness|costeffectiveness
1443372|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
1443373|NCT00991445|Surgical exposure|surgical exposure
1443374|NCT00991445|Minimal invasive surgery|minimal invasive surgery
1443375|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
1443376|NCT00991445|Knee Arthroplasty|knee arthroplasty
1443377|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
1443378|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
1443379|NCT00991432|Osseointegration|osseointegration
1443380|NCT00991432|Space Maintenance|space maintenance
1443381|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
1443382|NCT00991419|PET|pet
1443383|NCT00991419|Alzheimer's disease|alzheimer's disease
1443384|NCT00991419|diagnostic|diagnostic
1443385|NCT00991406|Electric Stimulation|electric stimulation
1443386|NCT00991406|Hemiplegia|hemiplegia
1443387|NCT00991406|walking|walking
1443388|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
1443389|NCT00991393|Dental Implantation|dental implantation
1443390|NCT00991393|Osseointegration|osseointegration
1443391|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
1443392|NCT00991367|Post-surgical scars|post-surgical scars
1443393|NCT00991367|Asian Gotu Kola|asian gotu kola
1443394|NCT00991367|Asian Pennywort|asian pennywort
1443395|NCT00991354|HIV Seronegativity|hiv seronegativity
1443396|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
1443397|NCT00991341|Cardiac surgery|cardiac surgery
1443398|NCT00991341|Red blood cell|red blood cell
1443399|NCT00991341|Transfusion|transfusion
1443400|NCT00991328|PD|pd
1443401|NCT00991328|POCD|pocd
1443402|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
1443403|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
1443404|NCT00991315|prostate cancer|prostate cancer
1443405|NCT00991302|Adherence|adherence
1443406|NCT00991302|Behavioral Intervention|behavioral intervention
1443407|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
1443408|NCT00991302|ART|art
1443409|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1443410|NCT00991302|HAART|haart
1443411|NCT00991302|Treatment experienced|treatment experienced
1443412|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
1443413|NCT00991289|HCV treatment naive|hcv treatment naive
1443414|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
1443415|NCT00991289|Antiretroviral|antiretroviral
1443416|NCT00991289|Ribavirin|ribavirin
1443417|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
1443418|NCT00991289|Nitazoxanide|nitazoxanide
1443419|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
1443420|NCT00991263|stage II breast cancer|stage ii breast cancer
1443421|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
1443422|NCT00991250|Malignant melanoma|malignant melanoma
1443423|NCT00991237|NRS|nrs
1443424|NCT00991237|GPE|gpe
1443425|NCT00991237|pain reduction|pain reduction
1443426|NCT00991237|quality of life|quality of life
1443427|NCT00991224|HIV|hiv
1443428|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
1443429|NCT00991211|Comparison|comparison
1443430|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
1443431|NCT00991211|CHOP + Rituximab|chop + rituximab
1443432|NCT00991211|Progression free survival|progression free survival
1443433|NCT00991211|Overall survival|overall survival
1443434|NCT00991211|Toxicity|toxicity
1443435|NCT00991211|Safety|safety
1443436|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
1443437|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
1443438|NCT00991198|rosacea|rosacea
1443439|NCT00991198|acne vulgaris|acne vulgaris
1443440|NCT00991198|atopic dermatitis|atopic dermatitis
1443441|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
1443442|NCT00991198|photodamage|photodamage
1443443|NCT00991185|Infections in Children|infections in children
1443444|NCT00991172|sciatica|sciatica
1443445|NCT00991172|sciatic pain|sciatic pain
1443446|NCT00991172|pain|pain
1443447|NCT00991172|back pain|back pain
1443448|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
1443449|NCT00991146|CAPS|caps
1443450|NCT00991146|FCAS|fcas
1443451|NCT00991146|MWS|mws
1443452|NCT00991146|NOMID|nomid
1443453|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
1443454|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
1443455|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
1443456|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
1443457|NCT00991146|canakinumab|canakinumab
1443458|NCT00991146|ACZ885|acz885
1443459|NCT00991146|children|children
1443460|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
1443461|NCT00991146|NALP-3|nalp-3
1443462|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
1443463|NCT00991146|autosomal dominant|autosomal dominant
1443464|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
1443465|NCT00991107|phase I|phase i
1443466|NCT00991107|safety|safety
1443467|NCT00991107|tolerance|tolerance
1443468|NCT00991107|insulin resistance|insulin resistance
1443469|NCT00991107|obese|obese
1443470|NCT00991094|Proton Therapy|proton therapy
1443471|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
1443472|NCT00991094|Proton Dose Distributions|proton dose distributions
1443473|NCT00991094|Side Effects|side effects
1443474|NCT00991094|Symptoms|symptoms
1443475|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
1443476|NCT00991094|Dose Response Relationship|dose response relationship
1443477|NCT00991081|pharmacogenetics|pharmacogenetics
1443478|NCT00991081|genetic counseling|genetic counseling
1443479|NCT00991081|genetic feedback|genetic feedback
1443480|NCT00991081|nicotine replacement|nicotine replacement
1443481|NCT00991081|bupropion|bupropion
1443482|NCT00991081|smoking cessation|smoking cessation
1443483|NCT00991081|primary care|primary care
1443484|NCT00991081|telehealth|telehealth
1443485|NCT00991081|motivational interviewing|motivational interviewing
1443487|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
1443488|NCT00991042|Cytokines|cytokines
1443489|NCT00991042|Low back pain|low back pain
1443490|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
1443491|NCT00991042|Interleukins|interleukins
1443492|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
1443493|NCT00991029|Transient Ischemic Attack|transient ischemic attack
1443494|NCT00991029|TIA|tia
1443495|NCT00991029|minor stroke|minor stroke
1443496|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
1443497|NCT00991003|Colorectal Cancer|colorectal cancer
1443498|NCT00991003|Colonoscopy|colonoscopy
1443499|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
1443500|NCT00990977|breast cancer|breast cancer
1443501|NCT00990977|supportive care|supportive care
1443502|NCT00990977|post-treatment|post-treatment
1443503|NCT00990977|intervention|intervention
1443504|NCT00990977|MBSR|mbsr
1443505|NCT00990977|mindfulness|mindfulness
1443506|NCT00990977|anxiety|anxiety
1443507|NCT00990977|depression|depression
1443508|NCT00990977|lifestyle|lifestyle
1443509|NCT00990977|diet|diet
1443510|NCT00990977|alcohol consumption|alcohol consumption
1443511|NCT00990977|smoking|smoking
1443512|NCT00990977|exercise|exercise
1443513|NCT00990977|spirituality|spirituality
1443514|NCT00990977|existential well-being|existential well-being
1443515|NCT00990977|physical symptoms|physical symptoms
1443516|NCT00990977|women|women
1443517|NCT00990925|Obesity|obesity
1443518|NCT00990925|Schizophrenia|schizophrenia
1443519|NCT00990925|Schizoaffective disorder|schizoaffective disorder
1443520|NCT00990925|weight loss|weight loss
1443521|NCT00990899|hypertension|hypertension
1443522|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
1443523|NCT00990899|pediatrics|pediatrics
1443524|NCT00990886|Oxybutynin|oxybutynin
1443525|NCT00990886|Ditropan|ditropan
1443526|NCT00990886|Menopause Treatment|menopause treatment
1443527|NCT00990886|Vasomotor symptoms|vasomotor symptoms
1443528|NCT00990886|Hot Flashes|hot flashes
1443529|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
1443530|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1443531|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
1443532|NCT00990834|Statin|statin
1443533|NCT00990834|Myopathy|myopathy
1443534|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1443535|NCT00990834|Atrogin-1|atrogin-1
1443536|NCT00990795|open heart surgery|open heart surgery
1443537|NCT00990795|cyclosporine|cyclosporine
1443538|NCT00990795|myocardial protection|myocardial protection
1443539|NCT00990769|Emergence delirium|emergence delirium
1443540|NCT00990769|Bispectral Index|bispectral index
1443541|NCT00990769|Depth of anesthesia|depth of anesthesia
1443542|NCT00990743|Ocular hypertension|ocular hypertension
1443543|NCT00990743|Glaucoma|glaucoma
1443544|NCT00990743|Beta-blocker|beta-blocker
1443545|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
1443546|NCT00990730|endothelial dysfunction|endothelial dysfunction
1443547|NCT00990730|lipoproteins|lipoproteins
1443548|NCT00990730|inflammation|inflammation
1443549|NCT00990730|oxidative stress|oxidative stress
1443550|NCT00990730|arterial stiffness|arterial stiffness
1443551|NCT00990717|natural killer cells|natural killer cells
1443552|NCT00990717|leukemia|leukemia
1443553|NCT00990717|lymphoma|lymphoma
1443554|NCT00990717|myeloma|myeloma
1443555|NCT00990717|Hodgkin's disease|hodgkin's disease
1443556|NCT00990717|cell therapy|cell therapy
1443557|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
1443558|NCT00990704|Hemodialysis|hemodialysis
1443559|NCT00990704|paricalcitol|paricalcitol
1443560|NCT00990704|maxacalcitol|maxacalcitol
1443561|NCT00990691|Rett syndrome|rett syndrome
1443562|NCT00990678|HIV-1|hiv-1
1443563|NCT00990678|humans|humans
1443564|NCT00990678|vitamin D|vitamin d
1443565|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
1443566|NCT00990678|Rocaltrol|rocaltrol
1443567|NCT00990678|calcium|calcium
1443568|NCT00990678|complementary therapies|complementary therapies
1443569|NCT00990665|CRT|crt
1443570|NCT00990665|Heart Failure|heart failure
1443571|NCT00990665|LV Leads|lv leads
1443572|NCT00990652|brain tumor|brain tumor
1443573|NCT00990639|hepatic fibrosis|hepatic fibrosis
1443574|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
1443575|NCT00990639|alcoholic liver disease|alcoholic liver disease
1443576|NCT00990626|Seroquel XR|seroquel xr
1443577|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
1443578|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
1443579|NCT00990600|adherence|adherence
1443580|NCT00990600|Qol|qol
1443581|NCT00990600|virologic efficacy|virologic efficacy
1443582|NCT00990600|immunologic efficacy|immunologic efficacy
1443583|NCT00990600|patients' preference|patients' preference
1443584|NCT00990600|once-daily|once-daily
1443585|NCT00990600|HAART|haart
1443586|NCT00990600|treatment experienced|treatment experienced
1443587|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
1443588|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
1443589|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
1443590|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
1443591|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
1443592|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
1443593|NCT00990548|Cardiac Caregivers|cardiac caregivers
1443594|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
1443595|NCT00990548|Prevention of CVD|prevention of cvd
1443596|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
1443597|NCT00990535|octreotide|octreotide
1443598|NCT00990535|somatostatin analogues|somatostatin analogues
1443599|NCT00990522|sharp debridment|sharp debridment
1443600|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
1443601|NCT00990509|Primary ICH|primary ich
1443602|NCT00990509|Albumin|albumin
1443603|NCT00990509|MRI|mri
1443604|NCT00990509|Neuroimaging outcome|neuroimaging outcome
1443605|NCT00990509|Placebo-controlled|placebo-controlled
1443606|NCT00990509|Phase II|phase ii
1443607|NCT00990509|Blinded|blinded
1443608|NCT00990509|Safety|safety
1443609|NCT00990509|Acute ICH|acute ich
1443610|NCT00990509|ICH|ich
1443611|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
1443612|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
1443613|NCT00990496|GBM|gbm
1443614|NCT00990496|Cytomegalovirus|cytomegalovirus
1443615|NCT00990496|CMV|cmv
1443616|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
1443617|NCT00990496|CTL|ctl
1443618|NCT00990470|Transplantation|transplantation
1443619|NCT00990470|Liver|liver
1443620|NCT00990470|Endoscopy|endoscopy
1443621|NCT00990470|Colonoscopy|colonoscopy
1443622|NCT00990470|Gastroscopy|gastroscopy
1443623|NCT00990457|Exercise|exercise
1443624|NCT00990457|Weight loss diet|weight loss diet
1443625|NCT00990457|Obesity|obesity
1443626|NCT00990457|Overweight|overweight
1443627|NCT00990457|Abdominal obesity|abdominal obesity
1443628|NCT00990457|Cardiovascular function|cardiovascular function
1443629|NCT00990457|Body composition|body composition
1443630|NCT00990444|blood glucose|blood glucose
1443631|NCT00990444|blood insulin|blood insulin
1443632|NCT00990444|dextran|dextran
1443633|NCT00990444|diabetes|diabetes
1443634|NCT00990444|hyperglycemia|hyperglycemia
1443635|NCT00990444|hypoglycemia|hypoglycemia
1443636|NCT00990444|oral delivery|oral delivery
1443637|NCT00990444|portal delivery|portal delivery
1443638|NCT00990431|skin aging|skin aging
1443639|NCT00990431|laser surgery|laser surgery
1443640|NCT00990431|fractional photothermolysis|fractional photothermolysis
1443641|NCT00990431|comparative study|comparative study
1443642|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
1443643|NCT00990418|Postoperative pain|postoperative pain
1443644|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
1443645|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
1443646|NCT00990418|Acute postoperative pain|acute postoperative pain
1443647|NCT00990405|Rome III criteria|rome iii criteria
1443648|NCT00990392|Blood stream infections|blood stream infections
1443649|NCT00990392|Catheter related infections|catheter related infections
1443746|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
1443650|NCT00990392|Central venous catheter related infections|central venous catheter related infections
1443651|NCT00990392|Line sepsis|line sepsis
1443652|NCT00990392|Topical antibiotics|topical antibiotics
1443653|NCT00990392|Bacitracin|bacitracin
1443654|NCT00990392|Polymixin|polymixin
1443655|NCT00990392|Gramicidin|gramicidin
1443656|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
1443657|NCT00990392|Intensive care unit|intensive care unit
1443658|NCT00990379|HIV|hiv
1443659|NCT00990379|brain diseases|brain diseases
1443660|NCT00990379|spinal fluid|spinal fluid
1443661|NCT00990379|HIV positive|hiv positive
1443662|NCT00990366|antireflux valve|antireflux valve
1443663|NCT00990366|biliary obstruction|biliary obstruction
1443664|NCT00990366|cholangitis|cholangitis
1443665|NCT00990366|biliary stent|biliary stent
1443666|NCT00990353|Spatial neglect|spatial neglect
1443667|NCT00990353|hemineglect|hemineglect
1443668|NCT00990353|stroke|stroke
1443669|NCT00990353|cognition|cognition
1443670|NCT00990353|prism adaptation|prism adaptation
1443671|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
1443672|NCT00990353|growth curve modeling|growth curve modeling
1443673|NCT00990327|Coronary artery disease|coronary artery disease
1443674|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
1443675|NCT00990301|Healthy Subjects|healthy subjects
1443676|NCT00990301|Bioequivalence|bioequivalence
1443677|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
1443678|NCT00990262|acute chest pain|acute chest pain
1443679|NCT00990262|emergency department|emergency department
1443680|NCT00990262|cardiac computed tomography|cardiac computed tomography
1443681|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1443682|NCT00990249|ALL|all
1443683|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
1443684|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
1443685|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1443686|NCT00990249|HCT|hct
1443687|NCT00990249|Stem Cell Transplant|stem cell transplant
1443688|NCT00990249|Treatment-related mortality|treatment-related mortality
1443689|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
1443690|NCT00990249|TKI|tki
1443691|NCT00990249|Busulfan|busulfan
1443692|NCT00990249|Busulfex|busulfex
1443693|NCT00990249|Myleran|myleran
1443694|NCT00990249|Clofarabine|clofarabine
1443695|NCT00990249|Clolar|clolar
1443696|NCT00990249|Clofarex|clofarex
1443697|NCT00990249|Gleevec|gleevec
1443698|NCT00990249|Imatinib Mesylate|imatinib mesylate
1443699|NCT00990236|deep vein thrombosis|deep vein thrombosis
1443700|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
1443701|NCT00990236|pulmonary embolus|pulmonary embolus
1443702|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
1443703|NCT00990197|Pilot study|pilot study
1443704|NCT00990197|Randomized clinical trial|randomized clinical trial
1443705|NCT00990197|Smoking cessation|smoking cessation
1443706|NCT00990197|Acute coronary syndrome|acute coronary syndrome
1443707|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
1443708|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
1443709|NCT00990184|PreDiabetes|prediabetes
1443710|NCT00990171|peritoneal Dialysis|peritoneal dialysis
1443711|NCT00990171|wasting and malnutrition|wasting and malnutrition
1443712|NCT00990171|nutrition status|nutrition status
1443713|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
1443714|NCT00990171|body composition|body composition
1443715|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
1443716|NCT00990158|Randomized controlled trial|randomized controlled trial
1443717|NCT00990158|Warfarin|warfarin
1443718|NCT00990158|Coagulopathy|coagulopathy
1443719|NCT00990158|Time in therapeutic range|time in therapeutic range
1443720|NCT00990158|Bleeding|bleeding
1443721|NCT00990158|Thrombosis|thrombosis
1443722|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
1443723|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
1443724|NCT00990132|COPD|copd
1443725|NCT00990132|Respiratory failure|respiratory failure
1443726|NCT00990132|Non-invasive ventilation|non-invasive ventilation
1443727|NCT00990132|Home mechanical ventilation|home mechanical ventilation
1443728|NCT00990119|high flow therapy|high flow therapy
1443729|NCT00990119|high flow nasal cannula|high flow nasal cannula
1443730|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1443731|NCT00990119|respiratory insufficiency|respiratory insufficiency
1443732|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
1443733|NCT00990106|PTSD|ptsd
1443734|NCT00990106|nightmares|nightmares
1443735|NCT00990106|prazosin|prazosin
1443736|NCT00990106|sleep disturbance|sleep disturbance
1443737|NCT00990106|combat trauma|combat trauma
1443738|NCT00990067|MDMA|mdma
1443739|NCT00990067|serotonin|serotonin
1443740|NCT00990067|norepinephrine|norepinephrine
1443741|NCT00990067|Ecstasy|ecstasy
1443742|NCT00990067|stimulant|stimulant
1443743|NCT00990054|Cytarabine,|cytarabine,
1443744|NCT00990054|Daunorubicin,|daunorubicin,
1443745|NCT00990054|De Novo,|de novo,
1443748|NCT00990041|periodontitis|periodontitis
1443749|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
1443750|NCT00990028|moderate head injury|moderate head injury
1443751|NCT00990028|rosuvastatin|rosuvastatin
1443752|NCT00990028|statin|statin
1443753|NCT00990028|amnesia|amnesia
1443754|NCT00990028|orientation|orientation
1443755|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
1443756|NCT00989989|DME|dme
1443757|NCT00989989|Diabetic|diabetic
1443758|NCT00989989|macula|macula
1443759|NCT00989989|edema|edema
1443760|NCT00989989|ranibizumab|ranibizumab
1443761|NCT00989989|REVEAL|reveal
1443762|NCT00989976|Sleep|sleep
1443763|NCT00989976|Diabetes Risk|diabetes risk
1443764|NCT00989963|PAH|pah
1443765|NCT00989950|daytrana|daytrana
1443766|NCT00989950|sleep latency|sleep latency
1443767|NCT00989950|adhd rating scales|adhd rating scales
1443768|NCT00989950|ADHD|adhd
1443769|NCT00989937|oxytocin|oxytocin
1443770|NCT00989924|Diabetes mellitus|diabetes mellitus
1443771|NCT00989924|Coronary heart disease|coronary heart disease
1443772|NCT00989924|Magnetocardiography|magnetocardiography
1443773|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
1443774|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
1443775|NCT00989885|Evaluation|evaluation
1443776|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
1443777|NCT00989885|Polysomnography|polysomnography
1443778|NCT00989872|Macrolides|macrolides
1443779|NCT00989872|Antibiotics|antibiotics
1443780|NCT00989872|Safety|safety
1443781|NCT00989872|Tolerability|tolerability
1443782|NCT00989872|Pharmacokinetics|pharmacokinetics
1443783|NCT00989872|Phase I|phase i
1443784|NCT00989872|MRSA/SSTI|mrsa/ssti
1443785|NCT00989859|monitoring|monitoring
1443786|NCT00989846|biomarker|biomarker
1443787|NCT00989846|lung disease|lung disease
1443788|NCT00989833|Exercise induced asthma|exercise induced asthma
1443789|NCT00989833|Mild intermittent asthma|mild intermittent asthma
1443790|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
1443791|NCT00989820|osteoradionecrosis|osteoradionecrosis
1443792|NCT00989820|mandible|mandible
1443793|NCT00989820|radiotherapy|radiotherapy
1443794|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1443795|NCT00989807|CF|cf
1443796|NCT00989807|Cystic fibrosis|cystic fibrosis
1443797|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
1443798|NCT00989807|EAP|eap
1443799|NCT00989807|Expanded access|expanded access
1443800|NCT00989807|AZLI|azli
1443801|NCT00989807|Aztreonam lysine|aztreonam lysine
1443802|NCT00989794|cartilage|cartilage
1443803|NCT00989794|implantation|implantation
1443804|NCT00989794|chondrocyte|chondrocyte
1443805|NCT00989794|condyle|condyle
1443806|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
1443807|NCT00989768|Botulinum toxin type A|botulinum toxin type a
1443808|NCT00989768|field effects|field effects
1443809|NCT00989768|dose-equivalence|dose-equivalence
1443810|NCT00989768|anhydrotic action halos|anhydrotic action halos
1443811|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
1443812|NCT00989755|Fax to Quit|fax to quit
1443813|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
1443814|NCT00989755|Fax referral|fax referral
1443815|NCT00989755|Quitline|quitline
1443816|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
1443817|NCT00989742|LAM|lam
1443818|NCT00989742|tuberous sclerosis|tuberous sclerosis
1443819|NCT00989742|doxycycline|doxycycline
1443820|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
1443821|NCT00989742|MMP|mmp
1443822|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
1443823|NCT00989729|Methylprednisolone|methylprednisolone
1443824|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
1443825|NCT00989703|Safety|safety
1443826|NCT00989703|Tolerability|tolerability
1443827|NCT00989703|Pharmacokinetics|pharmacokinetics
1443828|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1443829|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1443830|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1443831|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1443832|NCT00989664|radioimmunotherapy|radioimmunotherapy
1443833|NCT00989664|NHL|nhl
1443834|NCT00989664|Bexxar|bexxar
1443835|NCT00989664|lymphoma|lymphoma
1443836|NCT00989664|Tositumomab|tositumomab
1443837|NCT00989625|migraine|migraine
1443838|NCT00989625|single dose|single dose
1443839|NCT00989625|healthy volunteer|healthy volunteer
1443840|NCT00989625|adolescence|adolescence
1443841|NCT00989625|pharmacokinetics|pharmacokinetics
1443842|NCT00989612|influenza infection|influenza infection
1443843|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
1443844|NCT00989599|phlebitis|phlebitis
1443845|NCT00989599|Chamomilla recutita|chamomilla recutita
1443846|NCT00989599|Catheterization peripheral|catheterization peripheral
1443847|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1443848|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1443849|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1443850|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1443851|NCT00989586|MALT lymphoma|malt lymphoma
1443852|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1443853|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1443854|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1443855|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1443856|NCT00989534|shift work|shift work
1443857|NCT00989534|diabetes|diabetes
1443858|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
1443859|NCT00989521|Asthma|asthma
1443860|NCT00989521|bronchial diseases|bronchial diseases
1443861|NCT00989521|lung diseases|lung diseases
1443862|NCT00989521|bronchitis|bronchitis
1443863|NCT00989521|respiratory tract diseases|respiratory tract diseases
1443864|NCT00989508|Perhexiline|perhexiline
1443865|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
1443866|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
1443867|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
1443868|NCT00989508|Cardiac Output, Low|cardiac output, low
1443869|NCT00989508|Troponin|troponin
1443870|NCT00989495|AIS|ais
1443871|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1443872|NCT00989456|Heart failure|heart failure
1443873|NCT00989456|Stroke|stroke
1443874|NCT00989456|quality of life|quality of life
1443875|NCT00989456|self management education|self management education
1443876|NCT00989456|physical exercise|physical exercise
1443877|NCT00989456|primary health care|primary health care
1443878|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
1443879|NCT00989430|stroke|stroke
1443880|NCT00989430|CVA|cva
1443881|NCT00989430|cerebrovascular accident|cerebrovascular accident
1443882|NCT00989430|rehabilitation|rehabilitation
1443883|NCT00989417|Remote monitoring|remote monitoring
1443884|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
1443885|NCT00989417|Home monitoring|home monitoring
1443886|NCT00989417|Shock|shock
1443887|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
1443888|NCT00989404|pk|pk
1443889|NCT00989404|healthy subjects|healthy subjects
1443890|NCT00989404|influenza virus|influenza virus
1443891|NCT00989404|Safety|safety
1443892|NCT00989404|pandemic|pandemic
1443893|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
1443894|NCT00989378|sleep|sleep
1443895|NCT00989378|insulin|insulin
1443896|NCT00989378|diabetes|diabetes
1443897|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
1443898|NCT00989365|Aerobic Exercise|aerobic exercise
1443899|NCT00989365|Exercise|exercise
1443900|NCT00989352|PCNSL|pcnsl
1443901|NCT00989352|Lymphoma|lymphoma
1443902|NCT00989352|Methotrexate|methotrexate
1443903|NCT00989352|Lomustine|lomustine
1443904|NCT00989352|Procarbazine|procarbazine
1443905|NCT00989352|Rituximab|rituximab
1443906|NCT00989352|Elderly|elderly
1443907|NCT00989352|Chemotherapy|chemotherapy
1443908|NCT00989339|lipid emulsion|lipid emulsion
1443909|NCT00989339|endothelial function|endothelial function
1443910|NCT00989339|inflammatory markers|inflammatory markers
1443911|NCT00989339|oxidative stress|oxidative stress
1443912|NCT00989339|insulin sensitivity|insulin sensitivity
1443913|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
1443914|NCT00989326|Remote monitoring|remote monitoring
1443915|NCT00989326|Pacemaker|pacemaker
1443916|NCT00989326|Follow up|follow up
1443917|NCT00989326|Follow-up studies|follow-up studies
1443918|NCT00989313|Peplin|peplin
1443919|NCT00989313|Actinic keratosis|actinic keratosis
1443920|NCT00989313|PEP005|pep005
1443921|NCT00989300|Drug-Drug interaction|drug-drug interaction
1443922|NCT00989300|Clopidogrel|clopidogrel
1443923|NCT00989300|Rabeprazol|rabeprazol
1443924|NCT00989300|Omeprazol|omeprazol
1443925|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
1443926|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1443927|NCT00989287|influenza infection|influenza infection
1443928|NCT00989274|Influenza|influenza
1443929|NCT00989274|Vaccination|vaccination
1443930|NCT00989274|Immunology|immunology
1443931|NCT00989274|Immunogenicity|immunogenicity
1443932|NCT00989274|Reactogenicity|reactogenicity
1443933|NCT00989274|Safety|safety
1443934|NCT00989274|Influenza vaccine|influenza vaccine
1443935|NCT00989274|Immune response|immune response
1443936|NCT00989274|Adverse effects|adverse effects
1443937|NCT00989261|AML|aml
1443938|NCT00989261|AC220|ac220
1443939|NCT00989261|acute|acute
1443940|NCT00989261|FLT3|flt3
1443941|NCT00989261|inhibitor|inhibitor
1443942|NCT00989261|kinase|kinase
1443943|NCT00989261|leukemia|leukemia
1443944|NCT00989261|leukaemia|leukaemia
1443945|NCT00989261|myeloid|myeloid
1443946|NCT00989261|relapsed|relapsed
1443947|NCT00989261|refractory|refractory
1443948|NCT00989248|Ergospirometry|ergospirometry
1443949|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
1443950|NCT00989248|Exercises|exercises
1443951|NCT00989248|Immersion|immersion
1443952|NCT00989235|NOS|nos
1443953|NCT00989222|Distal radius fractures|distal radius fractures
1443954|NCT00989222|Fractures of the distal radius|fractures of the distal radius
1443955|NCT00989222|Volar plate|volar plate
1443956|NCT00989222|External fixation|external fixation
1443957|NCT00989209|facial paralysis|facial paralysis
1443958|NCT00989209|asymmetry|asymmetry
1443959|NCT00989209|myofunctional therapy|myofunctional therapy
1443960|NCT00989209|botulinum toxin|botulinum toxin
1443961|NCT00989209|facial evaluation|facial evaluation
1443962|NCT00989183|Ovaries|ovaries
1443963|NCT00989183|Reproductive Age|reproductive age
1443964|NCT00989183|Oophorectomy|oophorectomy
1443965|NCT00989157|Gastric Bypass|gastric bypass
1443966|NCT00989157|Duloxetine|duloxetine
1443967|NCT00989157|Cymbalta|cymbalta
1443968|NCT00989157|Pharmacokinetics|pharmacokinetics
1443969|NCT00989144|HIV seronegative|hiv seronegative
1443970|NCT00989144|acute infection|acute infection
1443971|NCT00989131|Ovarian Cancer|ovarian cancer
1443972|NCT00989105|stage I prostate cancer|stage i prostate cancer
1443973|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
1443974|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
1443975|NCT00989105|stage III prostate cancer|stage iii prostate cancer
1443976|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
1443977|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
1443978|NCT00989092|anemia of cancer|anemia of cancer
1443979|NCT00989092|darbepoetin alfa|darbepoetin alfa
1443980|NCT00989092|Aranesp|aranesp
1443981|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
1443982|NCT00989066|Xience V|xience v
1443983|NCT00989066|stent|stent
1443984|NCT00989066|coronary disease|coronary disease
1443985|NCT00989053|depression|depression
1443986|NCT00989053|anxiety|anxiety
1443987|NCT00989053|stress|stress
1443988|NCT00989053|antidepressant therapy|antidepressant therapy
1443989|NCT00989053|SSRI|ssri
1443990|NCT00989053|infertility|infertility
1443991|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
1443992|NCT00989053|immunological factors|immunological factors
1443993|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
1443994|NCT00989040|NPZ|npz
1443995|NCT00989040|Pain|pain
1443996|NCT00989027|Uterine contraction|uterine contraction
1443997|NCT00989027|Dose-response|dose-response
1443998|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
1443999|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
1444000|NCT00989014|Rosacea|rosacea
1444001|NCT00989001|Atrial Fibrillation|atrial fibrillation
1444002|NCT00989001|RSD1235|rsd1235
1444003|NCT00989001|Vernakalant|vernakalant
1444004|NCT00989001|conversion|conversion
1444005|NCT00988988|Multiple Sclerosis|multiple sclerosis
1444006|NCT00988988|AGEE|agee
1444007|NCT00988988|histamine response|histamine response
1444008|NCT00988962|pain|pain
1444009|NCT00988962|opioids|opioids
1444010|NCT00988949|Proof of mechanism study|proof of mechanism study
1444011|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
1444012|NCT00988936|RGD-K5|rgd-k5
1444013|NCT00988936|K5-101|k5-101
1444014|NCT00988936|Avastin|avastin
1444015|NCT00988936|angiogenesis|angiogenesis
1444016|NCT00988936|anti-angiogenesis|anti-angiogenesis
1444017|NCT00988936|chemotherapy|chemotherapy
1444018|NCT00988936|breast cancer|breast cancer
1444019|NCT00988936|colon cancer|colon cancer
1444020|NCT00988936|rectal cancer|rectal cancer
1444021|NCT00988936|lung cancer|lung cancer
1444022|NCT00988936|non-squamous|non-squamous
1444023|NCT00988936|non small cell|non small cell
1444024|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
1444025|NCT00988910|COC|coc
1444026|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
1444027|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
1444028|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
1444029|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
1444030|NCT00988871|agreement|agreement
1444031|NCT00988845|dietary supplement|dietary supplement
1444032|NCT00988845|indole 3 carbinol|indole 3 carbinol
1444033|NCT00988845|estrogen|estrogen
1444034|NCT00988806|Advanced heart failure|advanced heart failure
1444035|NCT00988806|Levosimendan|levosimendan
1444036|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
1444037|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
1444038|NCT00988780|CCR5 antagonist|ccr5 antagonist
1444039|NCT00988780|Maraviroc|maraviroc
1444040|NCT00988780|HIV|hiv
1444041|NCT00988780|treatment naive|treatment naive
1444042|NCT00988767|Hepatitis B|hepatitis b
1444043|NCT00988767|DNA vaccine|dna vaccine
1444044|NCT00988767|immunotherapy|immunotherapy
1444045|NCT00988754|Obesity|obesity
1444046|NCT00988754|childhood and adolescence|childhood and adolescence
1444047|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
1444048|NCT00988754|cardiovascular risk|cardiovascular risk
1444049|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
1444050|NCT00988754|health behaviour|health behaviour
1444051|NCT00988741|Unresectable|unresectable
1444052|NCT00988741|Hepatocellular|hepatocellular
1444053|NCT00988741|Carcinoma|carcinoma
1444054|NCT00988702|Dan Tian Breathing|dan tian breathing
1444055|NCT00988702|Physiological measurement|physiological measurement
1444056|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
1444057|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
1444058|NCT00988689|starch|starch
1444059|NCT00988689|carbohydrates|carbohydrates
1444060|NCT00988689|blood glucose|blood glucose
1444061|NCT00988689|food intake|food intake
1444062|NCT00988689|satiety|satiety
1444063|NCT00988689|appetite|appetite
1444064|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
1444065|NCT00988663|memantine|memantine
1444066|NCT00988663|cognitive function|cognitive function
1444067|NCT00988663|memory|memory
1444068|NCT00988650|Metabolic syndrome|metabolic syndrome
1444267|NCT00987896|polypectomy|polypectomy
1444069|NCT00988650|Mediterranean diet|mediterranean diet
1444070|NCT00988650|Blood lipids|blood lipids
1444071|NCT00988650|Coronary heart disease|coronary heart disease
1444072|NCT00988650|Apolipoprotein|apolipoprotein
1444073|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
1444074|NCT00988611|Reproductive aging|reproductive aging
1444075|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
1444076|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
1444077|NCT00988572|Wrist fractures|wrist fractures
1444078|NCT00988572|Vestibular asymmetry|vestibular asymmetry
1444079|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
1444080|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
1444081|NCT00988572|Patients 50 years or older|patients 50 years or older
1444082|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
1444083|NCT00988559|treatment vaccine|treatment vaccine
1444084|NCT00988559|therapeutic|therapeutic
1444085|NCT00988559|HPV|hpv
1444086|NCT00988559|DNA vaccine|dna vaccine
1444087|NCT00988559|gene therapy|gene therapy
1444088|NCT00988559|gene gun|gene gun
1444089|NCT00988559|pre-cancerous|pre-cancerous
1444090|NCT00988546|Disability Evaluation|disability evaluation
1444091|NCT00988546|Joint Diseases|joint diseases
1444092|NCT00988546|Joint Disability|joint disability
1444093|NCT00988533|Head Lice|head lice
1444094|NCT00988533|Pediculus|pediculus
1444095|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
1444096|NCT00988481|Bulimia Nervosa|bulimia nervosa
1444097|NCT00988481|Topiramate|topiramate
1444098|NCT00988481|Augmentation|augmentation
1444099|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
1444100|NCT00988468|Manual Therapy|manual therapy
1444101|NCT00988468|Therapeutic Exercise|therapeutic exercise
1444102|NCT00988468|Ultrasound|ultrasound
1444103|NCT00988468|Effusion|effusion
1444104|NCT00988455|basal cell carcinoma|basal cell carcinoma
1444105|NCT00988455|photodynamic therapy|photodynamic therapy
1444106|NCT00988455|photo chemotherapy|photo chemotherapy
1444107|NCT00988455|basal cell epithelioma|basal cell epithelioma
1444108|NCT00988442|Adherence|adherence
1444109|NCT00988442|Treatment|treatment
1444110|NCT00988442|Adherence Intervention|adherence intervention
1444111|NCT00988442|Telephone Intervention|telephone intervention
1444112|NCT00988442|treatment experienced|treatment experienced
1444113|NCT00988429|Refractory|refractory
1444114|NCT00988429|partial|partial
1444115|NCT00988429|epilepsy|epilepsy
1444116|NCT00988429|efficacy|efficacy
1444117|NCT00988429|eslicarbazepine|eslicarbazepine
1444118|NCT00988429|safety|safety
1444119|NCT00988416|IPMN|ipmn
1444120|NCT00988390|mothers living with HIV|mothers living with hiv
1444121|NCT00988390|family intervention|family intervention
1444122|NCT00988390|family functioning|family functioning
1444123|NCT00988390|conflict|conflict
1444124|NCT00988390|Mental health|mental health
1444125|NCT00988390|and physical health|and physical health
1444126|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
1444127|NCT00988377|whey protein|whey protein
1444128|NCT00988377|subjective appetite|subjective appetite
1444129|NCT00988377|shor-term food intake|shor-term food intake
1444130|NCT00988377|blood glucose|blood glucose
1444131|NCT00988364|Metabolic Syndrome|metabolic syndrome
1444132|NCT00988364|LDL subfraction L5|ldl subfraction l5
1444133|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
1444134|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
1444135|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
1444136|NCT00988351|sleep apnea|sleep apnea
1444137|NCT00988351|positive airway pressure|positive airway pressure
1444138|NCT00988351|portable monitoring|portable monitoring
1444139|NCT00988351|auto positive airway pressure|auto positive airway pressure
1444140|NCT00988338|Trinity Evolution|trinity evolution
1444141|NCT00988338|Arthrodesis|arthrodesis
1444142|NCT00988338|Foot Fusion|foot fusion
1444143|NCT00988338|Ankle Fusion|ankle fusion
1444144|NCT00988338|Allograft|allograft
1444145|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
1444146|NCT00988312|idiotype (Id)|idiotype (id)
1444147|NCT00988312|immunotherapy|immunotherapy
1444148|NCT00988299|older|older
1444149|NCT00988299|NEAT|neat
1444150|NCT00988299|exercise|exercise
1444151|NCT00988299|RMR|rmr
1444152|NCT00988299|energy expenditure|energy expenditure
1444153|NCT00988273|Crohn's disease|crohn's disease
1444154|NCT00988273|Ulcerative colitis|ulcerative colitis
1444155|NCT00988273|dysplasia|dysplasia
1444156|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
1444157|NCT00988247|BDP-HFA|bdp-hfa
1444158|NCT00988247|Hay fever|hay fever
1444159|NCT00988247|Allergic rhinitis|allergic rhinitis
1444160|NCT00988234|Lumbar plexus block|lumbar plexus block
1444161|NCT00988234|sciatic nerve block|sciatic nerve block
1444162|NCT00988234|position|position
1444163|NCT00988234|ultrasound guidance|ultrasound guidance
1444164|NCT00988234|elective lower limb surgery|elective lower limb surgery
1444165|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
1444166|NCT00988208|Revlimid|revlimid
1444167|NCT00988208|Lenalidomide|lenalidomide
1444168|NCT00988195|Neoplasm|neoplasm
1444169|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
1444170|NCT00988182|Whey protein|whey protein
1444171|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
1444172|NCT00988182|Blood glucose|blood glucose
1444173|NCT00988182|Insulin|insulin
1444174|NCT00988169|AT-101|at-101
1444175|NCT00988169|erlotinib|erlotinib
1444176|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
1444177|NCT00988169|09-026|09-026
1444178|NCT00988156|Epilepsy|epilepsy
1444179|NCT00988156|Partial|partial
1444180|NCT00988156|Refractory|refractory
1444181|NCT00988156|Children|children
1444182|NCT00988156|Adolescents|adolescents
1444183|NCT00988156|Adjunctive|adjunctive
1444184|NCT00988156|Randomised|randomised
1444185|NCT00988156|Double-blind|double-blind
1444186|NCT00988156|Placebo-controlled|placebo-controlled
1444187|NCT00988156|Parallel-group|parallel-group
1444188|NCT00988143|Influenza|influenza
1444189|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
1444190|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
1444191|NCT00988130|sexual dysfunction|sexual dysfunction
1444192|NCT00988130|stage I prostate cancer|stage i prostate cancer
1444193|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
1444194|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
1444195|NCT00988130|stage III prostate cancer|stage iii prostate cancer
1444196|NCT00988117|PDD|pdd
1444197|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
1444198|NCT00988117|rivastigmine|rivastigmine
1444199|NCT00988117|rivastigmine patch|rivastigmine patch
1444200|NCT00988117|open label|open label
1444201|NCT00988117|Parkinson's Disease|parkinson's disease
1444202|NCT00988117|Parkinsons Disease|parkinsons disease
1444203|NCT00988117|memory|memory
1444204|NCT00988117|Exelon|exelon
1444205|NCT00988117|Exelon Patch|exelon patch
1444206|NCT00988104|Behavior Therapy|behavior therapy
1444207|NCT00988104|Randomized Controlled Trial|randomized controlled trial
1444208|NCT00988078|metformin|metformin
1444209|NCT00988078|Hyperandrogenism|hyperandrogenism
1444210|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
1444211|NCT00988078|adolescents|adolescents
1444212|NCT00988078|melatonin|melatonin
1444213|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
1444214|NCT00988078|Insulin Resistance|insulin resistance
1444215|NCT00988078|Menstrual Cycle|menstrual cycle
1444216|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1444217|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
1444218|NCT00988039|second line therapy|second line therapy
1444219|NCT00988039|raltegravir|raltegravir
1444221|NCT00988039|monotherapy|monotherapy
1444222|NCT00988039|integrase inhibitor|integrase inhibitor
1444223|NCT00988039|protease inhibitor|protease inhibitor
1444224|NCT00988039|Randomized Controlled Trial|randomized controlled trial
1444225|NCT00988013|total marrow irradiation|total marrow irradiation
1444226|NCT00988013|intensity modulated radiation|intensity modulated radiation
1444227|NCT00988013|leukemia|leukemia
1444228|NCT00988013|hematologic diseases|hematologic diseases
1444229|NCT00988000|outpatients|outpatients
1444230|NCT00987987|hematological malignancy|hematological malignancy
1444231|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1444232|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
1444233|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
1444234|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
1444235|NCT00987987|regulatory T cells|regulatory t cells
1444237|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
1444238|NCT00987974|endothelial dysfunction|endothelial dysfunction
1444239|NCT00987974|statins|statins
1444240|NCT00987974|rosuvastatin|rosuvastatin
1444241|NCT00987974|atorvastatin|atorvastatin
1444242|NCT00987974|placebo|placebo
1444243|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
1444244|NCT00987974|flow mediated dilation|flow mediated dilation
1444245|NCT00987961|opioid dependence|opioid dependence
1444246|NCT00987961|suboxone|suboxone
1444247|NCT00987961|HIV risk behavior|hiv risk behavior
1444248|NCT00987948|HIV|hiv
1444249|NCT00987948|dementia|dementia
1444250|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
1444251|NCT00987948|treatment experienced|treatment experienced
1444252|NCT00987922|Stroke|stroke
1444253|NCT00987922|Acute|acute
1444254|NCT00987922|Infarction|infarction
1444255|NCT00987922|Ischemic|ischemic
1444256|NCT00987922|Thrombolysis|thrombolysis
1444257|NCT00987922|Mild|mild
1444258|NCT00987922|Hypothermia|hypothermia
1444259|NCT00987909|Cat|cat
1444260|NCT00987909|Allergy|allergy
1444261|NCT00987909|Immunotherapy|immunotherapy
1444262|NCT00987909|Sublingual|sublingual
1444263|NCT00987909|Exposure chamber|exposure chamber
1444264|NCT00987909|Safety|safety
1444265|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
1444266|NCT00987896|colonoscopy|colonoscopy
1444268|NCT00987896|NOTES|notes
1444269|NCT00987883|Nutritional Support|nutritional support
1444270|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
1444271|NCT00987870|inflammatory skin|inflammatory skin
1444272|NCT00987870|with or without arthritis|with or without arthritis
1444273|NCT00987857|esophageal cancer|esophageal cancer
1444274|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1444275|NCT00987857|Barrett esophagus|barrett esophagus
1444276|NCT00987831|SLE|sle
1444277|NCT00987831|lupus|lupus
1444278|NCT00987831|biomarkers|biomarkers
1444279|NCT00987831|depomedrol|depomedrol
1444280|NCT00987831|flare|flare
1444281|NCT00987831|disease activity|disease activity
1444282|NCT00987818|Biomarkers|biomarkers
1444283|NCT00987818|Antibiotic therapy|antibiotic therapy
1444284|NCT00987805|Functional dyspepsia|functional dyspepsia
1444285|NCT00987805|Banhasasim-tang|banhasasim-tang
1444286|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
1444287|NCT00987805|Visual Analogue Scale|visual analogue scale
1444288|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
1444289|NCT00987805|Electrogastrography|electrogastrography
1444290|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
1444291|NCT00987779|Bioequivalence study|bioequivalence study
1444292|NCT00987779|Food effect study|food effect study
1444293|NCT00987779|Pharmacokinetics|pharmacokinetics
1444294|NCT00987779|Gabapentin|gabapentin
1444295|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
1444296|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
1444297|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
1444298|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
1444299|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
1444300|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1444301|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1444302|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1444303|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
1444304|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
1444305|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
1444306|NCT00987714|Organ Donors|organ donors
1444307|NCT00987714|Recipients|recipients
1444308|NCT00987701|Neurobehavior|neurobehavior
1444309|NCT00987701|Development|development
1444310|NCT00987701|Fluid management|fluid management
1444311|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
1444312|NCT00987688|trauma|trauma
1444313|NCT00987688|Brain injury|brain injury
1444314|NCT00987688|Pre-hospital|pre-hospital
1444315|NCT00987688|cooling|cooling
1444316|NCT00987675|stage I prostate cancer|stage i prostate cancer
1444317|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
1444318|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
1444319|NCT00987675|stage III prostate cancer|stage iii prostate cancer
1444320|NCT00987662|irbesartan|irbesartan
1444321|NCT00987662|amlodipine|amlodipine
1444322|NCT00987662|obesity|obesity
1444323|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1444324|NCT00987662|new onset diabetes|new onset diabetes
1444325|NCT00987649|pelvic mass|pelvic mass
1444326|NCT00987649|ovarian cancer|ovarian cancer
1444327|NCT00987649|adnexal mass|adnexal mass
1444328|NCT00987649|CA125|ca125
1444329|NCT00987649|HE4|he4
1444330|NCT00987636|Ewing Sarcoma|ewing sarcoma
1444331|NCT00987636|localized|localized
1444332|NCT00987636|disseminated|disseminated
1444333|NCT00987636|metastases|metastases
1444334|NCT00987636|bone|bone
1444335|NCT00987636|soft tissue|soft tissue
1444336|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
1444337|NCT00987610|chronic total occlusion|chronic total occlusion
1444338|NCT00987610|guidewire|guidewire
1444339|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1444340|NCT00987610|Angioplasty|angioplasty
1444341|NCT00987610|Percutaneous Coronary|percutaneous coronary
1444342|NCT00987597|Smoking|smoking
1444343|NCT00987597|nicotine replacement|nicotine replacement
1444344|NCT00987597|psychological behaviour|psychological behaviour
1444345|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
1444346|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
1444347|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
1444348|NCT00987571|median nerve|median nerve
1444349|NCT00987571|ultrasound|ultrasound
1444350|NCT00987571|electrodiagnosis|electrodiagnosis
1444351|NCT00987571|Normal subjects|normal subjects
1444352|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
1444353|NCT00987558|simvastatin|simvastatin
1444355|NCT00987545|recurrence|recurrence
1444356|NCT00987532|preschool|preschool
1444357|NCT00987532|participatory intervention|participatory intervention
1444358|NCT00987532|cluster-randomization|cluster-randomization
1444359|NCT00987532|children|children
1444360|NCT00987532|obesity prevention|obesity prevention
1444361|NCT00987519|acute bronchiolitis|acute bronchiolitis
1444362|NCT00987519|acute gastroenteritis|acute gastroenteritis
1445263|NCT00984087|depression|depression
1444363|NCT00987519|febrile convulsion|febrile convulsion
1444364|NCT00987519|viral agents|viral agents
1444365|NCT00987519|molecular methods|molecular methods
1444366|NCT00987506|drug eluting stents|drug eluting stents
1444367|NCT00987506|Stents|stents
1444368|NCT00987506|Angioplasty|angioplasty
1444369|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
1444370|NCT00987506|Stent thrombosis|stent thrombosis
1444371|NCT00987506|Vascular disease|vascular disease
1444372|NCT00987506|Myocardial ischemia|myocardial ischemia
1444373|NCT00987506|Coronary artery stenosis|coronary artery stenosis
1444374|NCT00987506|Coronary Disease|coronary disease
1444375|NCT00987506|Coronary Artery Disease|coronary artery disease
1444376|NCT00987506|Coronary Restenosis|coronary restenosis
1444377|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1444378|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1444379|NCT00987480|Stem Cell Transplantation|stem cell transplantation
1444380|NCT00987480|Anemia|anemia
1444381|NCT00987480|Busulfan|busulfan
1444382|NCT00987480|Cyclophosphamide|cyclophosphamide
1444383|NCT00987480|Fludarabine|fludarabine
1444384|NCT00987480|08-031|08-031
1444385|NCT00987467|Atopic|atopic
1444386|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
1444387|NCT00987467|Restasis|restasis
1444388|NCT00987467|Cyclosporine|cyclosporine
1444389|NCT00987441|Neurobehavior|neurobehavior
1444390|NCT00987441|Epidural analgesia|epidural analgesia
1444391|NCT00987441|Local anesthetic|local anesthetic
1444392|NCT00987441|Opioid|opioid
1444393|NCT00987428|ERCP|ercp
1444394|NCT00987428|EUS|eus
1444395|NCT00987428|Pancreatitis biliary|pancreatitis biliary
1444396|NCT00987428|Severe|severe
1444397|NCT00987428|Interventional endoscopy|interventional endoscopy
1444398|NCT00987428|Choledocolithiasis|choledocolithiasis
1444399|NCT00987402|Surgery|surgery
1444400|NCT00987402|hand scrubbing|hand scrubbing
1444401|NCT00987402|post-operative infection|post-operative infection
1444402|NCT00987402|surgical site infection|surgical site infection
1444403|NCT00987402|surgical hand preparation|surgical hand preparation
1444404|NCT00987402|plain soap and water|plain soap and water
1444405|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
1444406|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
1444407|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
1444408|NCT00987389|Vasculitis|vasculitis
1444409|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
1444410|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
1444411|NCT00987389|Wegener's|wegener's
1444412|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
1444414|NCT00987389|MPA|mpa
1444415|NCT00987389|Treatment|treatment
1444416|NCT00987389|Plasma exchange|plasma exchange
1444417|NCT00987389|Glucocorticoids|glucocorticoids
1444418|NCT00987389|ANCA-Positive|anca-positive
1444419|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
1444420|NCT00987363|diabetic foot|diabetic foot
1444421|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
1444422|NCT00987363|cell therapy|cell therapy
1444423|NCT00987350|Jet Injector|jet injector
1444424|NCT00987350|Vaccine|vaccine
1444425|NCT00987350|Influenza|influenza
1444426|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
1444427|NCT00987311|Probiotics|probiotics
1444428|NCT00987311|intestinal immune system|intestinal immune system
1444429|NCT00987311|human|human
1444430|NCT00987311|healthy subjects|healthy subjects
1444431|NCT00987311|dairy drink|dairy drink
1444432|NCT00987311|Healthy adults|healthy adults
1444433|NCT00987298|Abdominal Fat|abdominal fat
1444434|NCT00987298|Visceral Fat|visceral fat
1444435|NCT00987298|Subcutaneous Fat|subcutaneous fat
1446066|NCT00981201|Celebrex|celebrex
1444436|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1444437|NCT00987298|DXA|dxa
1444438|NCT00987298|Computed Tomography|computed tomography
1444439|NCT00987298|CT|ct
1444440|NCT00987298|Body Mass Index|body mass index
1444441|NCT00987298|Body composition|body composition
1444442|NCT00987298|Percent fat|percent fat
1444443|NCT00987298|Waist circumference|waist circumference
1444444|NCT00987298|Hip circumference|hip circumference
1444445|NCT00987285|RE AIM model|re aim model
1444446|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1444447|NCT00987285|Interactive voice recognition|interactive voice recognition
1444448|NCT00987285|Computer Assisted Self Management|computer assisted self management
1444449|NCT00987272|Allergies|allergies
1444450|NCT00987272|Ocular|ocular
1444451|NCT00987259|Myocardial infarction|myocardial infarction
1444452|NCT00987259|Myocardial oedema|myocardial oedema
1444453|NCT00987259|Magnetic resonance|magnetic resonance
1444454|NCT00987246|Actinic Keratosis|actinic keratosis
1444455|NCT00987246|AK|ak
1444456|NCT00987246|NMSC|nmsc
1444457|NCT00987246|Combination|combination
1444458|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
1444459|NCT00987207|Postconditioning|postconditioning
1444460|NCT00987207|cyclosporine A|cyclosporine a
1445264|NCT00984087|TMS|tms
1444461|NCT00987207|myocardial ischemia|myocardial ischemia
1444462|NCT00987207|cardiac surgery|cardiac surgery
1444463|NCT00987207|aortic valvulopathy|aortic valvulopathy
1444464|NCT00987194|HIV|hiv
1444465|NCT00987194|rapid testing|rapid testing
1444466|NCT00987194|HIV seronegativity|hiv seronegativity
1444467|NCT00987181|Pulse wave velocity|pulse wave velocity
1444468|NCT00987181|Non contact|non contact
1444469|NCT00987181|Non-invasive|non-invasive
1444470|NCT00987181|Photoplethysmography|photoplethysmography
1444471|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
1444472|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
1444473|NCT00987168|Hypoglycemia,|hypoglycemia,
1444474|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
1444475|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
1444476|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
1444477|NCT00987155|arm crank|arm crank
1444478|NCT00987155|wheelchair|wheelchair
1444479|NCT00987155|ergometry|ergometry
1444480|NCT00987155|paraplegia|paraplegia
1444481|NCT00987155|spinal cord injury|spinal cord injury
1444482|NCT00987155|exercise testing|exercise testing
1444483|NCT00987129|DHA|dha
1444484|NCT00987129|EPA|epa
1444485|NCT00987129|AMD|amd
1444486|NCT00987129|drusen|drusen
1444487|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
1444488|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
1444489|NCT00987116|Myasthenia gravis|myasthenia gravis
1444490|NCT00987116|Steroids side effects|steroids side effects
1444491|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
1444492|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
1444493|NCT00987103|renal transplantation|renal transplantation
1444494|NCT00987103|tacrolimus|tacrolimus
1444495|NCT00987103|pharmacokinetics|pharmacokinetics
1444496|NCT00987103|rectal|rectal
1444497|NCT00987103|sublingual|sublingual
1444498|NCT00987103|rectal administration|rectal administration
1444499|NCT00987103|sublingual administration|sublingual administration
1444500|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
1444501|NCT00987077|CSC|csc
1444502|NCT00987077|SRT|srt
1444503|NCT00987064|Protexo|protexo
1444504|NCT00987064|Asthma|asthma
1444505|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
1444506|NCT00987064|Perennial allergy|perennial allergy
1444507|NCT00987064|Quality of life|quality of life
1444508|NCT00987064|MiniAQLQ|miniaqlq
1444509|NCT00987064|FeNO|feno
1444510|NCT00987064|FEV1|fev1
1444511|NCT00987064|PEF|pef
1444512|NCT00987051|sentinel node procedure|sentinel node procedure
1444513|NCT00987051|radiocolloid|radiocolloid
1444514|NCT00987051|patent blue|patent blue
1444515|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
1444516|NCT00987025|hypertension|hypertension
1444517|NCT00987025|telehealth|telehealth
1444518|NCT00987025|nurse monitor|nurse monitor
1444519|NCT00987025|nutrition center|nutrition center
1444520|NCT00986999|HIV infected|hiv infected
1444521|NCT00986999|treatment experienced|treatment experienced
1444522|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
1444523|NCT00986986|Low high density lipoprotein|low high density lipoprotein
1444524|NCT00986986|Endothelial function|endothelial function
1444525|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
1444526|NCT00986973|PKU|pku
1444527|NCT00986973|BH4|bh4
1444528|NCT00986973|KUVAN|kuvan
1444529|NCT00986973|PET scan|pet scan
1444530|NCT00986973|Neurodevelopment|neurodevelopment
1444531|NCT00986960|multiple sclerosis|multiple sclerosis
1444532|NCT00986960|relapsing remitting|relapsing remitting
1444533|NCT00986960|RRMS|rrms
1444534|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
1444535|NCT00986921|Need for additional dilation|need for additional dilation
1444536|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
1444537|NCT00986895|HPN-100|hpn-100
1444538|NCT00986895|GT4P|gt4p
1444539|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
1444540|NCT00986882|Postoperative pain|postoperative pain
1444541|NCT00986869|Safety|safety
1444542|NCT00986869|Bronchoscopy|bronchoscopy
1444543|NCT00986869|Pulmonary|pulmonary
1444544|NCT00986869|Hypertension|hypertension
1444545|NCT00986843|HM30181A|hm30181a
1444546|NCT00986843|Irinotecan|irinotecan
1444547|NCT00986843|MTD|mtd
1444548|NCT00986843|DLT|dlt
1444549|NCT00986830|Rhinosinusitis|rhinosinusitis
1444550|NCT00986830|Balloon catheters|balloon catheters
1444551|NCT00986830|Office treatment|office treatment
1444552|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
1444553|NCT00986830|Respiratory Tract Infections|respiratory tract infections
1444554|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
1444555|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
1444556|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
1444557|NCT00986817|Refractory ascites|refractory ascites
1445265|NCT00984087|adolescent|adolescent
1444558|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
1444559|NCT00986817|Paracentesis|paracentesis
1444560|NCT00986791|risk reduction|risk reduction
1444561|NCT00986765|Fetal growth restriction|fetal growth restriction
1444562|NCT00986765|Abruptio placentae|abruptio placentae
1444563|NCT00986765|Perinatal death|perinatal death
1444564|NCT00986752|stent|stent
1444565|NCT00986752|atherectomy|atherectomy
1444566|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
1444567|NCT00986739|Chronic pathologies|chronic pathologies
1444568|NCT00986739|elderly|elderly
1444569|NCT00986739|atmospheric pollution|atmospheric pollution
1444570|NCT00986739|unplanned hospitalization|unplanned hospitalization
1444571|NCT00986739|case-crossover|case-crossover
1444572|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
1444573|NCT00986687|vitrification|vitrification
1444574|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
1444575|NCT00986674|Carboplatin|carboplatin
1444576|NCT00986674|Paclitaxel|paclitaxel
1444577|NCT00986674|Cetuximab|cetuximab
1444578|NCT00986674|IMC-A12|imc-a12
1444579|NCT00986661|melanoma|melanoma
1444580|NCT00986661|uveal|uveal
1444581|NCT00986661|ocular|ocular
1444583|NCT00986661|mOM|mom
1444584|NCT00986661|OM|om
1444585|NCT00986661|UM|um
1444586|NCT00986661|pancreatic|pancreatic
1444587|NCT00986661|colon|colon
1444588|NCT00986661|colorectal|colorectal
1444589|NCT00986661|lung|lung
1444590|NCT00986661|metastatic|metastatic
1444591|NCT00986661|carcinoid|carcinoid
1444592|NCT00986661|neuroendocrine|neuroendocrine
1444593|NCT00986648|acute liver failure|acute liver failure
1444594|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
1444595|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
1444596|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
1444597|NCT00986635|Thrombin clotting Time|thrombin clotting time
1444598|NCT00986635|Anti-Xa-activity|anti-xa-activity
1444599|NCT00986635|Factor X-activity|factor x-activity
1444600|NCT00986635|Factor XIII-activity|factor xiii-activity
1444601|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
1444602|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
1444603|NCT00986596|vitamin D|vitamin d
1444604|NCT00986596|skeletal muscle|skeletal muscle
1444605|NCT00986596|vitamin D receptor|vitamin d receptor
1444606|NCT00986583|Succinylcholine|succinylcholine
1444607|NCT00986583|Statins|statins
1583713|NCT00451269|RDT|rdt
1444608|NCT00986583|myalgias|myalgias
1444609|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
1444610|NCT00986570|Botulinum Toxin A|botulinum toxin a
1444611|NCT00986570|Wrinkles|wrinkles
1444612|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
1444613|NCT00986557|graft versus host disease|graft versus host disease
1444614|NCT00986544|Laparoscopy|laparoscopy
1444615|NCT00986544|cholecystectomy|cholecystectomy
1444616|NCT00986544|drainage|drainage
1444617|NCT00986531|schizophrenia|schizophrenia
1444618|NCT00986531|early phase trials|early phase trials
1444619|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
1444620|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
1444621|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
1444622|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
1444623|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
1444624|NCT00986505|lidocaine|lidocaine
1444625|NCT00986505|fibromyalgia|fibromyalgia
1444626|NCT00986505|intravenous lidocaine|intravenous lidocaine
1444627|NCT00986505|manifestations|manifestations
1444628|NCT00986492|Sleep deprivation|sleep deprivation
1444629|NCT00986492|Food intake|food intake
1444630|NCT00986492|Motor activity|motor activity
1446067|NCT00981201|Placebo|placebo
1444631|NCT00986492|Normal, healthy subjects|normal, healthy subjects
1444632|NCT00986479|Patients|patients
1444633|NCT00986466|exercise|exercise
1444634|NCT00986466|falls|falls
1444635|NCT00986466|physical functioning|physical functioning
1444636|NCT00986466|vitamin D|vitamin d
1444637|NCT00986466|mobility function|mobility function
1444638|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
1444639|NCT00986466|quality of life|quality of life
1444640|NCT00986466|number of fallers|number of fallers
1444641|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
1444642|NCT00986466|bone mass|bone mass
1444643|NCT00986453|Breast Reduction|breast reduction
1444644|NCT00986453|PlasmaBlade|plasmablade
1444645|NCT00986453|Electrosurgery|electrosurgery
1444646|NCT00986453|PEAK Surgical|peak surgical
1444647|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
1444648|NCT00986453|Medtronic|medtronic
1444649|NCT00986414|Parkinson Disease|parkinson disease
1444650|NCT00986414|L-dopa|l-dopa
1444651|NCT00986414|Levodopa|levodopa
1444652|NCT00986414|dyskinesia|dyskinesia
1444653|NCT00986401|Adults|adults
1444654|NCT00986375|Randomized Controlled Trial|randomized controlled trial
1444655|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
1444656|NCT00986375|expert system|expert system
1444657|NCT00986375|stages of change|stages of change
1444658|NCT00986375|motivational interviewing|motivational interviewing
1444659|NCT00986375|tailoring|tailoring
1444660|NCT00986375|Self Care|self care
1444661|NCT00986375|Rehabilitation|rehabilitation
1444662|NCT00986375|Expert Systems|expert systems
1444663|NCT00986375|Behavior|behavior
1444664|NCT00986375|Motivation|motivation
1444665|NCT00986362|Safety in pediatrics|safety in pediatrics
1444666|NCT00986349|Diabetes|diabetes
1444667|NCT00986349|Weight Loss|weight loss
1444668|NCT00986349|GI Dynamics|gi dynamics
1444669|NCT00986349|EndoBarrier|endobarrier
1444670|NCT00986336|topiramate|topiramate
1444671|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
1444672|NCT00986323|Asthma|asthma
1444673|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
1444674|NCT00986323|TLA|tla
1444675|NCT00986323|Perennial allergy|perennial allergy
1444676|NCT00986323|Quality of life|quality of life
1444677|NCT00986323|Environmental control|environmental control
1444678|NCT00986310|fluoxetine|fluoxetine
1444679|NCT00986310|epilepsy|epilepsy
1444680|NCT00986310|Prozac|prozac
1444681|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1444682|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1444683|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1444684|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1444685|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1444686|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
1444687|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1444688|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1444689|NCT00986297|large cell lung cancer|large cell lung cancer
1444690|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
1444691|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
1444692|NCT00986284|Gefitinib|gefitinib
1444693|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
1444694|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
1444695|NCT00986258|pain assessment|pain assessment
1444696|NCT00986258|tapentadol|tapentadol
1444697|NCT00986258|centrally acting analgesic|centrally acting analgesic
1444698|NCT00986245|Parkinson disease|parkinson disease
1444699|NCT00986245|Ropinirole|ropinirole
1444700|NCT00986219|Asthma|asthma
1444701|NCT00986219|Language|language
1444702|NCT00986219|Symptoms,|symptoms,
1444703|NCT00986219|Limitation of Daily activities|limitation of daily activities
1444704|NCT00986219|Patients|patients
1444705|NCT00986219|Physicians|physicians
1444706|NCT00986219|Greece|greece
1444707|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
1444708|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
1444709|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
1444710|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1444711|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1444712|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1444713|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1444714|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1444715|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1444716|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1444717|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1444718|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1444719|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1444720|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
1444721|NCT00986193|Stent Valve|stent valve
1444722|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
1444723|NCT00986180|Acute Low Back Pain|acute low back pain
1444724|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
1444725|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
1444726|NCT00986180|Tapentadol|tapentadol
1444727|NCT00986180|NUCYNTA|nucynta
1444728|NCT00986167|Psychosis|psychosis
1444729|NCT00986167|Aggression|aggression
1444730|NCT00986167|Acute|acute
1444731|NCT00986167|Quetiapine XR|quetiapine xr
1444732|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
1444733|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
1444734|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
1444735|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
1444736|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
1444737|NCT00986128|Topiramate|topiramate
1444738|NCT00986128|Lithium|lithium
1444739|NCT00986128|Bipolar disorder|bipolar disorder
1444740|NCT00986115|epilepsy|epilepsy
1444741|NCT00986115|memory|memory
1444742|NCT00986115|cognition|cognition
1444743|NCT00986115|memantine|memantine
1444744|NCT00986102|Carbapenem|carbapenem
1444745|NCT00986102|Doripenem|doripenem
1444746|NCT00986102|Doribax|doribax
1444747|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
1444748|NCT00986102|Urinary tract infection|urinary tract infection
1444758|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
1444759|NCT00986063|Nevirapine induced rash|nevirapine induced rash
1444760|NCT00986063|Hepatitis|hepatitis
1444761|NCT00986063|Pharmacogenomics|pharmacogenomics
1444762|NCT00986063|AIDS|aids
1444763|NCT00986063|HIV|hiv
1444764|NCT00986063|treatment naive|treatment naive
1444765|NCT00986050|STEMI|stemi
1444766|NCT00986050|DES|des
1444767|NCT00986050|BMS|bms
1444768|NCT00986050|abciximab|abciximab
1444769|NCT00986037|Adverse events|adverse events
1444770|NCT00986037|Pharmacokinetics|pharmacokinetics
1444771|NCT00986024|Exercise therapy|exercise therapy
1444772|NCT00986011|obesity|obesity
1444773|NCT00986011|weight changes|weight changes
1444774|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
1444775|NCT00985998|nimotuzumab|nimotuzumab
1444776|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
1444777|NCT00985998|chemotherapy|chemotherapy
1444778|NCT00985985|smoking cessation|smoking cessation
1444779|NCT00985985|nicotine lozenge|nicotine lozenge
1444780|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
1444781|NCT00985972|PHYSICAL ACTIVITY|physical activity
1444782|NCT00985972|SCHOOL|school
1444783|NCT00985972|NUTRITION|nutrition
1444784|NCT00985972|EDUCATION|education
1444785|NCT00985972|OVERWEIGHT|overweight
1444786|NCT00985959|Multiple myeloma|multiple myeloma
1444787|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1444788|NCT00985959|HSCT|hsct
1444789|NCT00985959|Melphalan|melphalan
1444790|NCT00985959|Prednisolone|prednisolone
1444791|NCT00985959|Bortezomib|bortezomib
1444792|NCT00985959|JNJ-26866138|jnj-26866138
1444793|NCT00985933|Healthy normal volunteers|healthy normal volunteers
1444794|NCT00985920|blood loss|blood loss
1444795|NCT00985920|postoperative|postoperative
1444796|NCT00985907|myeloma|myeloma
1444797|NCT00985907|DMV|dmv
1444798|NCT00985894|Teledermatology|teledermatology
1444799|NCT00985894|Telemedicine|telemedicine
1444800|NCT00985894|Atopic Dermatitis|atopic dermatitis
1444806|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1444812|NCT00985829|basal cell carcinoma|basal cell carcinoma
1444813|NCT00985829|photodynamic therapy|photodynamic therapy
1444814|NCT00985829|photo chemotherapy|photo chemotherapy
1444815|NCT00985829|basal cell epithelioma|basal cell epithelioma
1444816|NCT00985816|Preterm|preterm
1444817|NCT00985816|newborns|newborns
1444818|NCT00985816|Gastric|gastric
1444819|NCT00985816|Motility|motility
1444820|NCT00985816|Mucosal|mucosal
1444821|NCT00985816|immunity|immunity
1444822|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
1444823|NCT00985803|Activity Physical|activity physical
1444824|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
1444825|NCT00985790|vaccine|vaccine
1444826|NCT00985790|Influenza|influenza
1444827|NCT00985777|pancreas|pancreas
1444828|NCT00985777|resectable|resectable
1444829|NCT00985777|pancreatic tumor|pancreatic tumor
1444830|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
1444831|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
1444832|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
1444833|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
1444834|NCT00985751|immunogenicity|immunogenicity
1444835|NCT00985751|toddlers|toddlers
1444836|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
1444837|NCT00985751|Haemophilus influenzae|haemophilus influenzae
1444838|NCT00985751|safety|safety
1444839|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
1444840|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
1444841|NCT00985738|Prostate Cancer|prostate cancer
1444842|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
1444843|NCT00985725|Major Depressive Disorder|major depressive disorder
1444844|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
1444845|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1444846|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1444847|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1444848|NCT00985686|e-mental health|e-mental health
1444849|NCT00985686|Adolescent mental health|adolescent mental health
1444850|NCT00985686|Spirituality|spirituality
1444851|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1444852|NCT00985673|influenza infection|influenza infection
1444853|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
1444854|NCT00985647|HIV|hiv
1444855|NCT00985647|HAART|haart
1444856|NCT00985647|ART|art
1444857|NCT00985647|Pharmacokinetic|pharmacokinetic
1444858|NCT00985647|Healthy volunteers|healthy volunteers
1444859|NCT00985647|3TC|3tc
1444860|NCT00985647|Lamivudine|lamivudine
1444861|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
1444862|NCT00985634|OPCAB|opcab
1444863|NCT00985621|monoclonal antibody|monoclonal antibody
1444864|NCT00985621|RN624|rn624
1444865|NCT00985621|PF-04383119|pf-04383119
1444866|NCT00985621|nerve growth factor|nerve growth factor
1444867|NCT00985621|OA|oa
1444868|NCT00985621|pain|pain
1444869|NCT00985621|arthritis|arthritis
1444870|NCT00985608|H pylori|h pylori
1444871|NCT00985608|eradication therapy|eradication therapy
1444872|NCT00985595|Adolescent|adolescent
1444873|NCT00985595|substance abuse|substance abuse
1444874|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
1444875|NCT00985569|Constipation|constipation
1444876|NCT00985569|Nursing Home|nursing home
1444877|NCT00985569|Quality Indicator|quality indicator
1444878|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
1444879|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1444880|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
1444881|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
1444882|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
1444883|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
1444884|NCT00985543|HIV|hiv
1444885|NCT00985543|ART|art
1444886|NCT00985543|HAART|haart
1444887|NCT00985543|Pharmacokinetics|pharmacokinetics
1444888|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
1444889|NCT00985543|Lower dose selection|lower dose selection
1444890|NCT00985517|Parkinson's disease|parkinson's disease
1444891|NCT00985517|Movement Disorders|movement disorders
1444892|NCT00985517|Gene Therapy|gene therapy
1444893|NCT00985517|Neurotrophic Factors|neurotrophic factors
1444894|NCT00985517|GDNF|gdnf
1444895|NCT00985517|Neurturin|neurturin
1444896|NCT00985517|DBS|dbs
1444897|NCT00985517|Dopamine|dopamine
1444898|NCT00985504|Major Depressive Disorder|major depressive disorder
1444899|NCT00985504|Apathy|apathy
1444900|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
1444901|NCT00985504|SSRI|ssri
1444902|NCT00985504|Escitalopram|escitalopram
1444903|NCT00985491|obesity|obesity
1444904|NCT00985478|First in Man|first in man
1444905|NCT00985478|SLV342|slv342
1444906|NCT00985478|Atherosclerosis|atherosclerosis
1444907|NCT00985465|Booster vaccination|booster vaccination
1444908|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
1444909|NCT00985465|Catch-up vaccination|catch-up vaccination
1444910|NCT00985465|Pneumococcal disease|pneumococcal disease
1444911|NCT00985465|Safety|safety
1444912|NCT00985465|Immunogenicity|immunogenicity
1444913|NCT00985452|Medication|medication
1444914|NCT00985452|Adherence|adherence
1444915|NCT00985452|Hypertension|hypertension
1444916|NCT00985426|chronic kidney disease|chronic kidney disease
1444917|NCT00985426|kidney failure|kidney failure
1444918|NCT00985426|kidney failure,chronic|kidney failure,chronic
1444919|NCT00985426|chronic kidney failure|chronic kidney failure
1444920|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
1444921|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
1444922|NCT00985426|hepatitis B|hepatitis b
1444923|NCT00985426|hepatitis|hepatitis
1444925|NCT00985426|prevention and control|prevention and control
1444926|NCT00985426|dialysis|dialysis
1444927|NCT00985413|Cockayne Syndrome|cockayne syndrome
1444928|NCT00985413|pediatrics|pediatrics
1444929|NCT00985413|growth|growth
1444930|NCT00985413|hearing|hearing
1444931|NCT00985413|Ageing|ageing
1444932|NCT00985400|recurrent colon cancer|recurrent colon cancer
1444933|NCT00985400|stage IV colon cancer|stage iv colon cancer
1444934|NCT00985400|Gastrointestinal|gastrointestinal
1444935|NCT00985400|Exercise|exercise
1444936|NCT00985400|Relaxation|relaxation
1444937|NCT00985400|Meditation|meditation
1444938|NCT00985387|Solifenacin|solifenacin
1444939|NCT00985387|Overactive bladder|overactive bladder
1444940|NCT00985387|persistency of the treatment|persistency of the treatment
1444941|NCT00985387|Vesicare|vesicare
1444942|NCT00985348|Levetiracetam|levetiracetam
1444943|NCT00985348|Healthy volunteers|healthy volunteers
1444944|NCT00985348|Healthy Subjects|healthy subjects
1444945|NCT00985322|Hemodialysis|hemodialysis
1444946|NCT00985309|unsatisfactory|unsatisfactory
1444947|NCT00985309|Pap smear|pap smear
1444948|NCT00985296|Allergic rhinitis|allergic rhinitis
1444949|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
1444950|NCT00985283|prevention|prevention
1444951|NCT00985283|older adults|older adults
1444952|NCT00985283|function|function
1444953|NCT00985283|participation|participation
1444954|NCT00985283|life satisfaction|life satisfaction
1444955|NCT00985283|self-rated health|self-rated health
1444957|NCT00985244|COPD exacerbation|copd exacerbation
1444958|NCT00985244|macrolide|macrolide
1444959|NCT00985244|diseae progression|diseae progression
1444960|NCT00985244|bacterial colonisation|bacterial colonisation
1444961|NCT00985218|infertility|infertility
1444962|NCT00985218|embryo development|embryo development
1444963|NCT00985205|Randomized Clinical Trial|randomized clinical trial
1444964|NCT00985205|Glutamine|glutamine
1444965|NCT00985205|Themal Burn Injuries|themal burn injuries
1444966|NCT00985205|Nutrition|nutrition
1444967|NCT00985205|Outcome Assessment|outcome assessment
1444968|NCT00985205|Critical Care|critical care
1444969|NCT00985205|Total Body Surface Area|total body surface area
1444970|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1444971|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1444972|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
1444973|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
1444974|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
1444975|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
1444976|NCT00985192|stage III gastric cancer|stage iii gastric cancer
1444977|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
1444978|NCT00985179|Randomized Controlled Trial|randomized controlled trial
1444979|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
1444980|NCT00985179|expert system|expert system
1444981|NCT00985179|stages of change|stages of change
1444982|NCT00985179|motivational interviewing|motivational interviewing
1444983|NCT00985179|tailoring|tailoring
1444984|NCT00985179|Self Care|self care
1444985|NCT00985179|Expert Systems|expert systems
1444986|NCT00985127|Hyperuricemia|hyperuricemia
1444987|NCT00985127|Gout|gout
1444988|NCT00985114|Type II Diabetes|type ii diabetes
1444989|NCT00985114|Obesity|obesity
1444990|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1444991|NCT00985088|influenza infection|influenza infection
1444992|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
1444993|NCT00985075|Allergic rhinitis|allergic rhinitis
1444994|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
1444995|NCT00985062|Folic Acid|folic acid
1444996|NCT00985062|Homocysteine|homocysteine
1444997|NCT00985062|Ovarian response|ovarian response
1444998|NCT00985062|In Vitro Fertilization|in vitro fertilization
1444999|NCT00985036|glioma|glioma
1445000|NCT00985036|meningioma|meningioma
1445001|NCT00985036|VEGF|vegf
1445002|NCT00985023|Unstable|unstable
1445003|NCT00985023|Lisfranc|lisfranc
1445004|NCT00985023|fracture|fracture
1445005|NCT00985023|dislocation|dislocation
1445006|NCT00985023|midfoot|midfoot
1445007|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
1445008|NCT00985010|hepatitis C|hepatitis c
1445009|NCT00985010|manganese|manganese
1445010|NCT00985010|mortality|mortality
1445011|NCT00985010|prognosis.|prognosis.
1445012|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
1445013|NCT00984997|Lung Cancer|lung cancer
1445014|NCT00984997|Non-Small Cell|non-small cell
1445015|NCT00984997|Multimodality Treatment|multimodality treatment
1445016|NCT00984997|Surgery|surgery
1445017|NCT00984997|Segmentectomy|segmentectomy
1445018|NCT00984997|Lobectomy|lobectomy
1445019|NCT00984997|Cisplatin|cisplatin
1445020|NCT00984997|CDDP|cddp
1445021|NCT00984997|Etoposide|etoposide
1445022|NCT00984997|VP-16|vp-16
1445023|NCT00984997|VePesid|vepesid
1445024|NCT00984997|Radiation Therapy|radiation therapy
1445025|NCT00984997|Radiotherapy|radiotherapy
1445026|NCT00984997|Chest Irradiation|chest irradiation
1445027|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1445028|NCT00984997|PCI|pci
1445029|NCT00984971|Microbicides|microbicides
1445030|NCT00984971|Tenofovir|tenofovir
1445031|NCT00984971|HIV seronegativity|hiv seronegativity
1445032|NCT00984945|pandemic vaccine|pandemic vaccine
1445033|NCT00984945|influenza|influenza
1445034|NCT00984945|H5N1|h5n1
1445035|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
1445036|NCT00984932|systemic sclerosis|systemic sclerosis
1445037|NCT00984932|pulmonary hypertension|pulmonary hypertension
1445038|NCT00984932|rosuvastatin|rosuvastatin
1445039|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
1445040|NCT00984919|stage I prostate cancer|stage i prostate cancer
1445041|NCT00984919|stage II prostate cancer|stage ii prostate cancer
1445042|NCT00984919|stage III prostate cancer|stage iii prostate cancer
1445043|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
1445044|NCT00984893|Osteoporosis|osteoporosis
1445045|NCT00984893|Bone Mineral density|bone mineral density
1445046|NCT00984893|fragility fractures|fragility fractures
1445047|NCT00984893|zoledronic acid.|zoledronic acid.
1445048|NCT00984893|Treatment|treatment
1445049|NCT00984880|Sedation|sedation
1445050|NCT00984880|anaesthesia|anaesthesia
1445051|NCT00984880|Safety|safety
1445052|NCT00984880|Tolerability|tolerability
1445053|NCT00984880|Pharmacokinetics|pharmacokinetics
1445054|NCT00984880|Pharmacodynamics|pharmacodynamics
1445055|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
1445056|NCT00984867|Inadequate control|inadequate control
1445057|NCT00984854|Cicatrix|cicatrix
1445058|NCT00984854|Scar|scar
1445059|NCT00984854|Wound-healing|wound-healing
1445060|NCT00984854|Re-epithelialisation|re-epithelialisation
1445061|NCT00984854|RN1004|rn1004
1445062|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
1445063|NCT00984854|M6P|m6p
1445064|NCT00984854|Juvidex|juvidex
1445065|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
1445066|NCT00984828|multiple myeloma|multiple myeloma
1445067|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
1445068|NCT00984828|velcade|velcade
1445069|NCT00984815|NSAID|nsaid
1445070|NCT00984815|Chronic Pain|chronic pain
1445071|NCT00984815|Osteoarthritis|osteoarthritis
1445072|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
1445073|NCT00984789|Transdermal Patch|transdermal patch
1445074|NCT00984789|Bleeding|bleeding
1445075|NCT00984789|Pregnancy|pregnancy
1445076|NCT00984776|coronary artery|coronary artery
1445077|NCT00984776|MRI|mri
1445078|NCT00984776|vessel wall imaging|vessel wall imaging
1445079|NCT00984763|Malaria|malaria
1445080|NCT00984763|Vaccine|vaccine
1445081|NCT00984724|Smoking|smoking
1445082|NCT00984724|Motivation and Problem Solving|motivation and problem solving
1445083|NCT00984724|MAPS|maps
1445084|NCT00984724|Low Income Smokers|low income smokers
1445085|NCT00984724|HCHD community clinics|hchd community clinics
1445086|NCT00984724|Telephone-based counseling|telephone-based counseling
1445087|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
1445088|NCT00984698|Depression|depression
1445089|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1445090|NCT00984698|Insomnia|insomnia
1445091|NCT00984698|Psychotherapy, Group|psychotherapy, group
1445092|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
1445093|NCT00984698|Randomized Controlled Trial|randomized controlled trial
1445094|NCT00984698|Veterans|veterans
1445095|NCT00984698|Social Rhythms|social rhythms
1445096|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
1445097|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
1445098|NCT00984672|TLIF|tlif
1445099|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1445100|NCT00984659|Dyspnea|dyspnea
1445101|NCT00984646|Cicatrix|cicatrix
1445102|NCT00984646|Scar|scar
1445103|NCT00984646|Wound-healing|wound-healing
1445104|NCT00984646|Prevascar|prevascar
1445105|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
1445106|NCT00984646|Ilodecakin|ilodecakin
1445107|NCT00984646|RN1003|rn1003
1445108|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
1445109|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
1445110|NCT00984607|LAP BAND system|lap band system
1445111|NCT00984594|allograft|allograft
1445112|NCT00984594|knee injury|knee injury
1445113|NCT00984594|cartilage injury|cartilage injury
1584347|NCT00448695|MRI|mri
1445114|NCT00984581|Cicatrix|cicatrix
1445115|NCT00984581|Scar|scar
1445116|NCT00984581|Wound healing|wound healing
1445117|NCT00984581|Avotermin|avotermin
1445118|NCT00984581|TGF beta 3|tgf beta 3
1445119|NCT00984581|Juvista|juvista
1445120|NCT00984581|RN1001|rn1001
1445121|NCT00984555|Biomarkers|biomarkers
1445122|NCT00984555|Semen Exposure|semen exposure
1445123|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
1445124|NCT00984529|Chronic heart failure|chronic heart failure
1445125|NCT00984529|candesartan cilexetil|candesartan cilexetil
1445126|NCT00984529|clinical signs|clinical signs
1445127|NCT00984529|symptoms|symptoms
1445128|NCT00984516|Cicatrix|cicatrix
1445129|NCT00984516|Scar|scar
1445130|NCT00984516|Wound-healing|wound-healing
1445131|NCT00984516|Juvidex|juvidex
1445132|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
1445133|NCT00984516|M6P|m6p
1445134|NCT00984516|RN1004|rn1004
1445135|NCT00984503|Cicatrix|cicatrix
1445136|NCT00984503|Scar|scar
1445137|NCT00984503|Wound healing|wound healing
1445138|NCT00984503|Avotermin|avotermin
1445139|NCT00984503|TGF beta 3|tgf beta 3
1445140|NCT00984503|Juvista|juvista
1445141|NCT00984503|RN1001|rn1001
1445142|NCT00984490|stage I breast cancer|stage i breast cancer
1445143|NCT00984490|stage II breast cancer|stage ii breast cancer
1445144|NCT00984477|Healthy volunteer|healthy volunteer
1445145|NCT00984477|healthy subjects|healthy subjects
1445146|NCT00984477|AZD5122|azd5122
1445147|NCT00984477|single oral dose|single oral dose
1445148|NCT00984477|phase 1|phase 1
1445149|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
1445150|NCT00984464|metastatic|metastatic
1445151|NCT00984464|melanoma|melanoma
1445152|NCT00984464|REOLYSIN|reolysin
1445153|NCT00984464|chemotherapy|chemotherapy
1445154|NCT00984464|carboplatin|carboplatin
1445155|NCT00984464|paclitaxel|paclitaxel
1445156|NCT00984451|Antibody Treatment|antibody treatment
1445157|NCT00984451|Immune Therapy|immune therapy
1445158|NCT00984451|Infectious Diseases|infectious diseases
1445159|NCT00984451|IVIG|ivig
1445160|NCT00984451|Plasma Apheresis|plasma apheresis
1445161|NCT00984451|Influenza A|influenza a
1445162|NCT00984451|Swine Flu|swine flu
1445163|NCT00984399|vaginitis|vaginitis
1445164|NCT00984399|Postmenopausal|postmenopausal
1445165|NCT00984399|17-β estradiol|17-β estradiol
1445166|NCT00984399|09-110|09-110
1445167|NCT00984386|Cicatrix|cicatrix
1445168|NCT00984386|Scar|scar
1445169|NCT00984386|Wound-healing|wound-healing
1445170|NCT00984386|Zesteem|zesteem
1445171|NCT00984386|17β-Estradiol|17β-estradiol
1445172|NCT00984386|RN1002|rn1002
1445173|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
1445174|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
1445175|NCT00984360|Meth|meth
1445176|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
1445177|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
1445178|NCT00984360|Naltrexone|naltrexone
1445179|NCT00984360|Vivitrol|vivitrol
1445180|NCT00984360|A118G|a118g
1445181|NCT00984360|OPRM1|oprm1
1445182|NCT00984347|nipple stimulation|nipple stimulation
1445183|NCT00984347|Oxytocin|oxytocin
1445184|NCT00984347|induction of labor|induction of labor
1445185|NCT00984347|term pregnancies|term pregnancies
1445186|NCT00984347|grandmultipara|grandmultipara
1445187|NCT00984347|VBAC|vbac
1445188|NCT00984347|PROM|prom
1445189|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
1445190|NCT00984334|pain|pain
1445191|NCT00984334|opioid|opioid
1445192|NCT00984334|constipation|constipation
1445193|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
1445194|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
1445195|NCT00984321|Geriatric|geriatric
1445196|NCT00984321|Elderly|elderly
1445197|NCT00984321|Counseling|counseling
1445198|NCT00984321|Depression|depression
1445199|NCT00984321|Anxiety|anxiety
1445200|NCT00984321|Intervention|intervention
1445201|NCT00984321|Psychoeducational|psychoeducational
1445202|NCT00984321|09-116|09-116
1445203|NCT00984308|sleep apnea|sleep apnea
1445204|NCT00984308|hypertension|hypertension
1445205|NCT00984308|brain ischemia|brain ischemia
1445206|NCT00984282|RAI-Refractory|rai-refractory
1445207|NCT00984282|Differentiated|differentiated
1445208|NCT00984282|Follicular|follicular
1445209|NCT00984282|Papillary|papillary
1445210|NCT00984282|Hurthle|hurthle
1445211|NCT00984256|Malaria|malaria
1445212|NCT00984256|Prophylaxis|prophylaxis
1445213|NCT00984256|Atovaquone|atovaquone
1445214|NCT00984256|Malarone|malarone
1445215|NCT00984256|Challenge|challenge
1445216|NCT00984243|lung cancer|lung cancer
1445217|NCT00984230|Infant Formula|infant formula
1445218|NCT00984230|Gut|gut
1445219|NCT00984217|panitumumab|panitumumab
1445220|NCT00984217|salivary gland malignancies|salivary gland malignancies
1445221|NCT00984217|radiotherapy|radiotherapy
1445222|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
1445223|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
1445224|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
1445225|NCT00984191|preoperative|preoperative
1445226|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
1445227|NCT00984191|cervical metastasis|cervical metastasis
1445228|NCT00984178|Reperfusion|reperfusion
1445229|NCT00984178|acute myocardial infarction|acute myocardial infarction
1445230|NCT00984178|stem cell therapy|stem cell therapy
1445231|NCT00984178|GCSF|gcsf
1445232|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
1445233|NCT00984178|magnetic resonance|magnetic resonance
1445234|NCT00984165|Allotransplant|allotransplant
1445235|NCT00984165|Relapse|relapse
1445236|NCT00984165|Radiation|radiation
1445237|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
1445238|NCT00984165|Hematologic Malignancies|hematologic malignancies
1445239|NCT00984165|Multiple Myeloma|multiple myeloma
1445240|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
1445241|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1445242|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1445243|NCT00984152|HIV|hiv
1445244|NCT00984152|Raltegravir|raltegravir
1445245|NCT00984152|Women|women
1445246|NCT00984152|Viral Suppression|viral suppression
1445247|NCT00984152|Viral Reservoir|viral reservoir
1445248|NCT00984152|Immune Parameters|immune parameters
1445249|NCT00984152|Gut|gut
1445250|NCT00984152|Genital Tract|genital tract
1445251|NCT00984139|persistence|persistence
1445252|NCT00984139|HBV|hbv
1445253|NCT00984139|Long-term|long-term
1445254|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
1445255|NCT00984139|Hepatitis B|hepatitis b
1445256|NCT00984139|adolescent|adolescent
1445257|NCT00984113|Elinogrel|elinogrel
1445258|NCT00984113|Renal impairment|renal impairment
1445259|NCT00984113|Healthy|healthy
1445260|NCT00984113|Kidney dysfunction|kidney dysfunction
1445261|NCT00984100|Cholelithiasis|cholelithiasis
1445262|NCT00984100|Biliary dyskinesia|biliary dyskinesia
1445266|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
1445267|NCT00984087|MDD|mdd
1445268|NCT00984087|Major depression|major depression
1445269|NCT00984087|mood disorders|mood disorders
1445270|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
1445271|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1445272|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1445273|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1445274|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1445275|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1445276|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1445277|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1445278|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1445279|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1445280|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1445281|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1445282|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1445283|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1445284|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1445285|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1445286|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1445287|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1445288|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1445289|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1445290|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1445291|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1445292|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1445293|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1445294|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1445295|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1445296|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1445297|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1445298|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1445299|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1445300|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1445301|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1445302|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1445303|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1445304|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1445305|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1445306|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1445307|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1445308|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1445309|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1445310|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1445311|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1445312|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1445313|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1445314|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1445315|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1445316|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1445317|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1445475|NCT00983671|cystic fibrosis|cystic fibrosis
1445318|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1445319|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1445320|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1445321|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1445322|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1445323|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1445324|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1445437|NCT00983762|Functional outcomes|functional outcomes
1445325|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1445326|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1445327|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1445328|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1445329|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1445330|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1445331|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1445332|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1445333|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1445334|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1445335|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1445336|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1445337|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1445338|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1445339|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
1445340|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1445341|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1445342|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1445343|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1445344|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1445345|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1445346|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1445347|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
1445348|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
1445349|NCT00984074|tongue cancer|tongue cancer
1445350|NCT00984061|healthy|healthy
1445351|NCT00984061|pharmacokinetics|pharmacokinetics
1445352|NCT00984061|drug-drug interaction|drug-drug interaction
1445353|NCT00984048|Colorectal cancer|colorectal cancer
1445354|NCT00984048|FOLFOX|folfox
1445355|NCT00984048|FOLFIRI|folfiri
1445356|NCT00984048|Avastin|avastin
1445357|NCT00984048|Metastases|metastases
1445358|NCT00984048|Liver|liver
1445359|NCT00984048|Colon cancer|colon cancer
1445360|NCT00984048|Biomarkers|biomarkers
1445361|NCT00984048|Resistance|resistance
1445362|NCT00984048|Biobanking|biobanking
1445363|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
1445364|NCT00984022|abscess|abscess
1445365|NCT00984022|MRSA|mrsa
1445366|NCT00984022|Aquacel dressing|aquacel dressing
1445367|NCT00984022|Iodoform dressing|iodoform dressing
1445368|NCT00984009|healthy|healthy
1445369|NCT00984009|pharmacokinetics|pharmacokinetics
1445370|NCT00984009|grapefruit juice|grapefruit juice
1445371|NCT00984009|furanocoumarins|furanocoumarins
1445372|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
1445373|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1445374|NCT00983983|ALS|als
1445375|NCT00983983|Motor Neuron Disease|motor neuron disease
1445376|NCT00983983|MND|mnd
1445377|NCT00983983|Fat|fat
1445378|NCT00983983|Lipid|lipid
1445379|NCT00983983|Cholesterol|cholesterol
1445380|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
1445381|NCT00983983|Diet|diet
1445382|NCT00983983|Tube feed|tube feed
1445383|NCT00983983|Gastrostomy|gastrostomy
1445384|NCT00983983|PEG|peg
1445385|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
1445386|NCT00983970|Adolescents|adolescents
1445387|NCT00983970|Obesity|obesity
1445388|NCT00983970|Exercise|exercise
1445389|NCT00983970|Music|music
1445390|NCT00983970|Virtual Reality|virtual reality
1445391|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1445392|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1445393|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1445394|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1445395|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1445976|NCT00981526|Cognition|cognition
1445396|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1445397|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1445398|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1445399|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1445400|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1445401|NCT00983931|healthy|healthy
1445402|NCT00983931|adult|adult
1445403|NCT00983931|colchicine|colchicine
1445404|NCT00983931|cyclosporine|cyclosporine
1445405|NCT00983931|blood levels over time|blood levels over time
1445406|NCT00983905|healthy;|healthy;
1445407|NCT00983905|adult;|adult;
1445408|NCT00983905|blood levels over time|blood levels over time
1445409|NCT00983892|Cancer|cancer
1445410|NCT00983892|caregiver|caregiver
1445411|NCT00983892|pain|pain
1445412|NCT00983892|symptom|symptom
1445413|NCT00983892|information technology|information technology
1445414|NCT00983892|palliative care|palliative care
1445415|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
1445416|NCT00983879|GLD|gld
1445417|NCT00983879|Krabbe disease|krabbe disease
1445418|NCT00983879|Natural History Study|natural history study
1445419|NCT00983853|VX-950|vx-950
1445420|NCT00983853|INCIVEK|incivek
1445421|NCT00983853|INCIVO|incivo
1445422|NCT00983840|diet|diet
1445423|NCT00983840|African-American families|african-american families
1445424|NCT00983840|web-based|web-based
1445425|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1445426|NCT00983814|ADHD|adhd
1445427|NCT00983814|Adult ADHD|adult adhd
1445428|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
1445429|NCT00983788|CPT II|cpt ii
1445430|NCT00983788|VLCAD|vlcad
1445431|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
1445432|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
1445433|NCT00983775|insulin|insulin
1445434|NCT00983775|jet injector|jet injector
1445435|NCT00983762|Knee osteoarthritis|knee osteoarthritis
1445436|NCT00983762|Leg strength|leg strength
1445438|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
1445439|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
1445440|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
1445441|NCT00983762|gait|gait
1445442|NCT00983762|knee arthroplasty|knee arthroplasty
1445443|NCT00983749|External Counterpulsation|external counterpulsation
1445444|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
1445445|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
1445446|NCT00983749|Blood Flow Velocity|blood flow velocity
1445447|NCT00983749|Neurologic Deficit|neurologic deficit
1445448|NCT00983723|Patient Foramen Ovale|patient foramen ovale
1445449|NCT00983723|PFO|pfo
1445450|NCT00983723|Stroke|stroke
1445451|NCT00983723|Ischemic Brain Injury|ischemic brain injury
1445452|NCT00983723|Neurovascular Disease|neurovascular disease
1445453|NCT00983710|prostate neoplasms|prostate neoplasms
1445454|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1445455|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1445456|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1445457|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1445458|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1445459|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1445460|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1445461|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1445462|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1445463|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1445464|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1445465|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1445466|NCT00983697|tongue cancer|tongue cancer
1445467|NCT00983684|Neoplasms by Site|neoplasms by site
1445468|NCT00983684|Breast Neoplasms|breast neoplasms
1445469|NCT00983684|Breast Diseases|breast diseases
1445470|NCT00983684|Breast Cancer|breast cancer
1445471|NCT00983684|Cancer of Breast|cancer of breast
1445472|NCT00983684|Cancer of the Breast|cancer of the breast
1445473|NCT00983684|Carcinoma|carcinoma
1445474|NCT00983671|Asthma|asthma
1445476|NCT00983671|chronic lung disease|chronic lung disease
1445477|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1445478|NCT00983671|pneumonia|pneumonia
1445479|NCT00983658|Anti-OX40L|anti-ox40l
1445480|NCT00983658|Mild Allergic Asthma|mild allergic asthma
1445481|NCT00983658|Allergies|allergies
1445482|NCT00983658|Allergic Asthma|allergic asthma
1445483|NCT00983658|Adult Asthma|adult asthma
1445484|NCT00983645|Kidney Transplantation|kidney transplantation
1445485|NCT00983645|Immunosuppression|immunosuppression
1445486|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
1445487|NCT00983632|heart rate|heart rate
1445488|NCT00983632|systolic arterial pressure|systolic arterial pressure
1445490|NCT00983593|Mind Body Bridging|mind body bridging
1445491|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
1445492|NCT00983593|Batterer Treatment|batterer treatment
1445493|NCT00983554|testosterone|testosterone
1445494|NCT00983554|insulin|insulin
1445495|NCT00983554|obesity|obesity
1445496|NCT00983554|aromatase|aromatase
1445497|NCT00983554|5 alpha reductase|5 alpha reductase
1445498|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
1445499|NCT00983541|liver cancer|liver cancer
1445500|NCT00983541|liver|liver
1445501|NCT00983541|HCC|hcc
1445502|NCT00983541|EHCC|ehcc
1445503|NCT00983528|cancer|cancer
1445504|NCT00983528|lymphoblastic|lymphoblastic
1445505|NCT00983528|leukemia|leukemia
1445506|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
1445507|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
1445508|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
1445509|NCT00983489|breast feeding|breast feeding
1445510|NCT00983489|counselling|counselling
1445511|NCT00983489|video demonstration|video demonstration
1445512|NCT00983476|Randomized controlled trial|randomized controlled trial
1445513|NCT00983476|Obesity|obesity
1445514|NCT00983476|Comparative Effectiveness|comparative effectiveness
1445515|NCT00983476|Clinical practice guidelines|clinical practice guidelines
1445516|NCT00983476|Medical Informatics Computing|medical informatics computing
1445517|NCT00983476|Services, Mental Health|services, mental health
1445518|NCT00983476|Self-care|self-care
1445519|NCT00983476|Psychotic disorders|psychotic disorders
1445520|NCT00983476|Mental Health Care|mental health care
1445521|NCT00983476|Veterans|veterans
1445522|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
1445523|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
1445524|NCT00983463|Obesity|obesity
1445525|NCT00983463|Lipidomics|lipidomics
1445526|NCT00983463|Proteomics|proteomics
1445527|NCT00983424|Breast Cancer|breast cancer
1445528|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
1445529|NCT00983411|work of breathing|work of breathing
1445530|NCT00983411|Pulse transit time|pulse transit time
1445531|NCT00983385|low back pain|low back pain
1445532|NCT00983385|pain|pain
1445533|NCT00983385|assessment|assessment
1445534|NCT00983385|tapentadol|tapentadol
1445535|NCT00983385|centrally acting analgesic|centrally acting analgesic
1445536|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
1445537|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
1445538|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1445539|NCT00983346|cancer|cancer
1445540|NCT00983346|myeloma|myeloma
1445541|NCT00983346|multiple myeloma|multiple myeloma
1445542|NCT00983346|smoldering myeloma|smoldering myeloma
1445543|NCT00983333|Health communication|health communication
1445544|NCT00983333|Health literacy|health literacy
1445545|NCT00983333|Patient|patient
1445546|NCT00983333|Health Care Professional|health care professional
1445547|NCT00983333|Satisfaction|satisfaction
1445548|NCT00983320|Fibromyalgia|fibromyalgia
1445549|NCT00983320|pain|pain
1445550|NCT00983320|quetiapine|quetiapine
1445551|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
1445552|NCT00983307|Radiation|radiation
1445553|NCT00983307|Erlotinib|erlotinib
1445554|NCT00983307|Tarceva|tarceva
1445555|NCT00983294|blood levels over time;|blood levels over time;
1445556|NCT00983294|colchicine;|colchicine;
1445557|NCT00983294|azithromycin;|azithromycin;
1445558|NCT00983294|healthy|healthy
1445559|NCT00983281|Combat casualty care|combat casualty care
1445560|NCT00983281|Hextend|hextend
1445561|NCT00983281|Colloid|colloid
1445562|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
1445563|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
1445564|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
1445565|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
1445566|NCT00983229|difficult airway|difficult airway
1445567|NCT00983229|fibreoptic intubation|fibreoptic intubation
1445568|NCT00983229|supraglottic airways|supraglottic airways
1445569|NCT00983229|laryngeal mask airway|laryngeal mask airway
1445570|NCT00983216|blood levels over time;|blood levels over time;
1445571|NCT00983216|pharmacokinetics;|pharmacokinetics;
1445572|NCT00983216|healthy adult;|healthy adult;
1445674|NCT00982826|Phase 1|phase 1
1445573|NCT00983216|cytochrome p450|cytochrome p450
1445574|NCT00983203|Dry eye|dry eye
1445575|NCT00983203|artificial tears|artificial tears
1445576|NCT00983190|HeartMate II|heartmate ii
1445577|NCT00983190|BeneMACS|benemacs
1445578|NCT00983190|LVAD|lvad
1445579|NCT00983190|Thoratec Corporation|thoratec corporation
1445580|NCT00983164|antiviral therapy|antiviral therapy
1445581|NCT00983164|antioxidant therapy|antioxidant therapy
1445582|NCT00983164|hepatitis C virus|hepatitis c virus
1445583|NCT00983164|oxidative stress|oxidative stress
1445584|NCT00983164|vitamin E|vitamin e
1445585|NCT00983125|Labour|labour
1445586|NCT00983125|Epidural analgesia|epidural analgesia
1445587|NCT00983125|Clonidine|clonidine
1445588|NCT00983125|Levobupivacaine|levobupivacaine
1445589|NCT00983125|Opiates|opiates
1445590|NCT00983125|Patient-controlled|patient-controlled
1445591|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
1445592|NCT00983112|Gonarthrosis|gonarthrosis
1445593|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
1445594|NCT00983112|Bleeding|bleeding
1445595|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
1445596|NCT00983112|knee prothesis surgery|knee prothesis surgery
1445597|NCT00983112|Knee arthrosis|knee arthrosis
1445598|NCT00983112|Thrombosis|thrombosis
1445599|NCT00983086|Flavanones and vascular function|flavanones and vascular function
1445600|NCT00983073|Osteoarthritis|osteoarthritis
1445601|NCT00983073|Pain|pain
1445602|NCT00983073|Assessment|assessment
1445603|NCT00983073|Tapentadol|tapentadol
1445604|NCT00983073|Centrally acting analgesic|centrally acting analgesic
1445605|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
1445606|NCT00983060|NIM811|nim811
1445607|NCT00983060|chronic hepatitis|chronic hepatitis
1445608|NCT00983060|chronic hepatitis C|chronic hepatitis c
1445609|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
1445610|NCT00983060|HCV|hcv
1445611|NCT00983060|HCV-1|hcv-1
1445612|NCT00983060|relapser|relapser
1445613|NCT00983047|Nimotuzumab|nimotuzumab
1445614|NCT00983047|NSCLC|nsclc
1445615|NCT00983047|Docetaxel|docetaxel
1445616|NCT00983034|nephrotic syndrome|nephrotic syndrome
1445617|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
1445618|NCT00983034|proteinuria|proteinuria
1445619|NCT00983034|membranous nephropathy|membranous nephropathy
1445620|NCT00983008|Signs and Symptoms|signs and symptoms
1445621|NCT00983008|Fatigue|fatigue
1445622|NCT00983008|Sleep Deprivation|sleep deprivation
1445623|NCT00983008|Internship and Residency|internship and residency
1445624|NCT00983008|Depression|depression
1445625|NCT00983008|Medical Errors|medical errors
1445626|NCT00983008|Burnout, Professional|burnout, professional
1445627|NCT00983008|Burnout|burnout
1445628|NCT00983008|Actigraphy|actigraphy
1445629|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
1445630|NCT00983008|Workload|workload
1445631|NCT00983008|Humans|humans
1445632|NCT00983008|Adult|adult
1445633|NCT00983008|Male|male
1445634|NCT00983008|Female|female
1445635|NCT00983008|Intensive Care Units|intensive care units
1445636|NCT00983008|Prospective Studies|prospective studies
1445637|NCT00983008|Work Schedule Tolerance|work schedule tolerance
1445638|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
1445639|NCT00983008|Guideline Adherence|guideline adherence
1445640|NCT00983008|Internal Medicine Education|internal medicine education
1445641|NCT00982982|Schizophrenia|schizophrenia
1445642|NCT00982982|Mental Disorders|mental disorders
1445643|NCT00982982|Psychotic Disorders|psychotic disorders
1445644|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1445645|NCT00982982|Cannabis|cannabis
1445646|NCT00982969|tuberculosis|tuberculosis
1445647|NCT00982969|pneumonia|pneumonia
1445648|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
1445649|NCT00982969|Tuberculin skin test|tuberculin skin test
1445650|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
1445651|NCT00982930|Cystic fibrosis|cystic fibrosis
1445652|NCT00982930|Lung diseases|lung diseases
1445653|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
1445654|NCT00982917|playground|playground
1445655|NCT00982917|injury prevention|injury prevention
1445656|NCT00982904|neglected disease|neglected disease
1445657|NCT00982904|africa|africa
1445658|NCT00982904|new drug|new drug
1445659|NCT00982904|oral drug|oral drug
1445660|NCT00982904|parasite|parasite
1445661|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1445662|NCT00982891|palliation|palliation
1445663|NCT00982891|opioids|opioids
1445664|NCT00982878|treatment experienced|treatment experienced
1445665|NCT00982865|MEK inhibitor|mek inhibitor
1445666|NCT00982865|Cancer|cancer
1445667|NCT00982865|Solid tumors|solid tumors
1445668|NCT00982852|Angioplasty|angioplasty
1445669|NCT00982852|Coronary Vessels|coronary vessels
1445670|NCT00982852|Heart Disease|heart disease
1445671|NCT00982852|Cardiology|cardiology
1445672|NCT00982852|Atherosclerosis|atherosclerosis
1445673|NCT00982852|Catheterization|catheterization
1445675|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
1445676|NCT00982826|Food Effect|food effect
1445677|NCT00982813|Periodontal disease|periodontal disease
1445678|NCT00982813|Per-term delivery|per-term delivery
1445679|NCT00982813|Sulcular bleeding index|sulcular bleeding index
1445680|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
1445681|NCT00982813|Cytokines|cytokines
1445682|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
1445683|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
1445684|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
1445685|NCT00982800|gabapentin|gabapentin
1445686|NCT00982800|opioid consumption|opioid consumption
1445687|NCT00982800|analgesic|analgesic
1445688|NCT00982800|anxiety|anxiety
1445689|NCT00982800|quality of life|quality of life
1445690|NCT00982787|Epilepsy|epilepsy
1445691|NCT00982787|Seizures|seizures
1445692|NCT00982787|Passiflora|passiflora
1445693|NCT00982774|PKDL|pkdl
1445694|NCT00982761|occupational drivers|occupational drivers
1445695|NCT00982761|health status|health status
1445696|NCT00982748|Fatigue|fatigue
1445697|NCT00982748|Chemotherapy|chemotherapy
1445698|NCT00982748|Yoga|yoga
1445699|NCT00982748|Breathing|breathing
1445700|NCT00982748|Cancer|cancer
1445701|NCT00982748|Anxiety|anxiety
1445702|NCT00982748|Pranayama|pranayama
1445703|NCT00982748|Stress|stress
1445704|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
1445705|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
1445706|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
1445707|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
1445708|NCT00982696|head and neck cancer|head and neck cancer
1445709|NCT00982696|opioid growth factor|opioid growth factor
1445710|NCT00982683|Surgery|surgery
1445711|NCT00982683|Moon phases|moon phases
1445712|NCT00982683|hemorrhage|hemorrhage
1445713|NCT00982670|Metabolic syndrome|metabolic syndrome
1445714|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
1445715|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
1445716|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
1445717|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
1445718|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
1445719|NCT00982553|Healthy Volunteers|healthy volunteers
1445720|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
1445721|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
1445722|NCT00982540|febrile neutropenia|febrile neutropenia
1445723|NCT00982540|risk stratification|risk stratification
1445724|NCT00982540|invasive fungal infection|invasive fungal infection
1445725|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
1445726|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
1445727|NCT00982527|acute renal failure|acute renal failure
1445728|NCT00982527|renal biomarkers|renal biomarkers
1445729|NCT00982527|fenoldopam|fenoldopam
1445730|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
1445731|NCT00982514|Asparaginase|asparaginase
1445732|NCT00982514|thrombosis|thrombosis
1445734|NCT00982514|central line|central line
1445735|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
1445736|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
1445737|NCT00982475|robotic navigation|robotic navigation
1445738|NCT00982475|atrial fibrillation|atrial fibrillation
1445739|NCT00982462|cognition|cognition
1445740|NCT00982462|vision|vision
1445741|NCT00982462|immunology|immunology
1445742|NCT00982462|DHA|dha
1445743|NCT00982462|ARA|ara
1445744|NCT00982462|infant|infant
1445745|NCT00982462|nutrition|nutrition
1445746|NCT00982449|EBV+ malignancies|ebv+ malignancies
1445747|NCT00982449|KSHV+ malignancies|kshv+ malignancies
1445748|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
1445749|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
1445750|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
1445751|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
1445752|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
1445753|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
1445754|NCT00982449|Gastric Cancer|gastric cancer
1445755|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
1445756|NCT00982436|Combined Modality Therapy|combined modality therapy
1445757|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
1445758|NCT00982436|Head and neck neoplasms|head and neck neoplasms
1445759|NCT00982423|heart failure|heart failure
1445760|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
1445761|NCT00982410|pain|pain
1445762|NCT00982410|alcohol|alcohol
1445763|NCT00982410|illicit drugs|illicit drugs
1445764|NCT00982410|pain management|pain management
1445765|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1445766|NCT00982384|Disease management|disease management
1445968|NCT00981565|CTS|cts
1445767|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
1445768|NCT00982384|Quality of life|quality of life
1445769|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
1445770|NCT00982371|osteoporosis|osteoporosis
1445771|NCT00982371|bone quality|bone quality
1445772|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
1445773|NCT00982371|fracture|fracture
1445977|NCT00981526|Metabolism|metabolism
1445774|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
1445775|NCT00982345|Depression|depression
1445776|NCT00982345|Anxiety|anxiety
1445777|NCT00982345|Seroquel|seroquel
1445778|NCT00982345|Quetiapine|quetiapine
1445779|NCT00982345|fMRI|fmri
1445780|NCT00982345|pictures|pictures
1445781|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
1445782|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
1445783|NCT00982319|Breast Cancer|breast cancer
1445784|NCT00982306|alcohol|alcohol
1445785|NCT00982306|brief interventions|brief interventions
1445786|NCT00982306|counseling|counseling
1445787|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
1445788|NCT00982280|Osteoarthritis|osteoarthritis
1445789|NCT00982280|pain assessment|pain assessment
1445790|NCT00982280|tapentadol|tapentadol
1445791|NCT00982280|centrally acting analgesic|centrally acting analgesic
1445792|NCT00982267|cancer|cancer
1445793|NCT00982254|Type 2 Diabetes|type 2 diabetes
1445794|NCT00982254|Oral Insulin|oral insulin
1445795|NCT00982254|Pharmacokinetics|pharmacokinetics
1445796|NCT00982254|Pharmacodynamics|pharmacodynamics
1445797|NCT00982241|OAB|oab
1445798|NCT00982241|urine|urine
1445799|NCT00982241|osmolality|osmolality
1445800|NCT00982241|urge|urge
1445801|NCT00982241|fluid intake|fluid intake
1445802|NCT00982241|PPIUS|ppius
1445803|NCT00982241|urge score|urge score
1445804|NCT00982241|bladder|bladder
1445805|NCT00982215|Paracetamol|paracetamol
1445806|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
1445807|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
1445808|NCT00982202|PPAR-gamma|ppar-gamma
1445809|NCT00982202|inflammation|inflammation
1445810|NCT00982189|treatment experienced|treatment experienced
1445811|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
1445812|NCT00982176|cognitive impairment|cognitive impairment
1445813|NCT00982176|coronary syndrome|coronary syndrome
1445814|NCT00982176|brain MRI|brain mri
1445815|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
1445816|NCT00982150|Talampanel|talampanel
1445817|NCT00982150|Open-Label Study|open-label study
1445818|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1445819|NCT00982137|Japanese Encephalitis|japanese encephalitis
1445820|NCT00982137|Yellow Fever|yellow fever
1445821|NCT00982137|ChimeriVax™-JE|chimerivax™-je
1445822|NCT00982137|STAMARIL®|stamaril®
1445823|NCT00982137|Adult|adult
1445824|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
1445825|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
1445826|NCT00982111|Nonsquamous|nonsquamous
1445827|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
1445828|NCT00982111|First line treatment|first line treatment
1445829|NCT00982111|Monoclonal|monoclonal
1445830|NCT00982111|Antibodies|antibodies
1445831|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1445832|NCT00982098|Prostatectomy|prostatectomy
1445833|NCT00982098|Prostatic cancer|prostatic cancer
1445834|NCT00982098|Urinary incontinence|urinary incontinence
1445835|NCT00982098|Exercise|exercise
1445836|NCT00982098|Electric stimulation therapy|electric stimulation therapy
1445837|NCT00982098|Counseling|counseling
1445838|NCT00982085|Asthma|asthma
1445839|NCT00982085|Allergic rhinitis|allergic rhinitis
1445840|NCT00982085|Military|military
1445841|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
1445842|NCT00982059|Colorectal cancer screening|colorectal cancer screening
1445843|NCT00982059|Cancer survivor|cancer survivor
1445844|NCT00982059|Radiation therapy|radiation therapy
1445845|NCT00982046|contact lenses|contact lenses
1445846|NCT00982046|disinfection solutions|disinfection solutions
1445847|NCT00982046|contact lens care|contact lens care
1445848|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1445849|NCT00982033|Elderly|elderly
1445850|NCT00982020|safety|safety
1445851|NCT00982020|schizophrenia|schizophrenia
1445852|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
1445853|NCT00982020|adolescents|adolescents
1445854|NCT00982020|weight management|weight management
1445855|NCT00982007|IDA|ida
1445856|NCT00981994|respiratory infection|respiratory infection
1445857|NCT00981994|antimicrobial drugs|antimicrobial drugs
1445858|NCT00981994|decision support|decision support
1445859|NCT00981994|Adult patients|adult patients
1445860|NCT00981981|humans|humans
1445861|NCT00981981|randomized clinical trial|randomized clinical trial
1445862|NCT00981981|dietary fiber|dietary fiber
1445863|NCT00981981|nutrition|nutrition
1445864|NCT00981981|beta-glucan|beta-glucan
1445865|NCT00981981|oats|oats
1446065|NCT00981201|Celecoxib|celecoxib
1445866|NCT00981981|LDL cholesterol|ldl cholesterol
1445867|NCT00981981|coronary heart disease|coronary heart disease
1445868|NCT00981955|Caffeine|caffeine
1445869|NCT00981955|Ltheanine|ltheanine
1445870|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
1445871|NCT00981955|Cerebral Blood Flow|cerebral blood flow
1445872|NCT00981955|Cognitive Function|cognitive function
1445873|NCT00981955|Mood|mood
1445975|NCT00981526|Schizophrenia|schizophrenia
1445874|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
1445875|NCT00981942|Imatinib mesylate|imatinib mesylate
1445876|NCT00981942|Glivec|glivec
1445877|NCT00981942|Gleevec|gleevec
1445878|NCT00981929|CYP2D6|cyp2d6
1445879|NCT00981929|CYP2C9|cyp2c9
1445880|NCT00981929|CYP2C19|cyp2c19
1445881|NCT00981929|CYP1A2|cyp1a2
1445882|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
1445883|NCT00981903|VTE in cancer patients|vte in cancer patients
1445884|NCT00981890|Brain Metastases|brain metastases
1445885|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
1445886|NCT00981890|Sunitinib|sunitinib
1445887|NCT00981890|Patients with Brain Metastases|patients with brain metastases
1445888|NCT00981877|acute diarrhea|acute diarrhea
1445889|NCT00981877|rotavirus|rotavirus
1445890|NCT00981877|probiotic|probiotic
1445891|NCT00981877|children|children
1445892|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
1445893|NCT00981864|concurrent radiation|concurrent radiation
1445894|NCT00981864|Breast cancer patients|breast cancer patients
1445895|NCT00981851|intervention study|intervention study
1445896|NCT00981851|interaction|interaction
1445897|NCT00981851|COPD|copd
1445898|NCT00981812|PET|pet
1445899|NCT00981812|PEM|pem
1445900|NCT00981812|Positron Emission Mammography|positron emission mammography
1445901|NCT00981812|Breast Biopsy|breast biopsy
1445902|NCT00981799|Relapse|relapse
1445903|NCT00981799|T cell|t cell
1445904|NCT00981799|Lymphoblastic|lymphoblastic
1445905|NCT00981799|Leukemia|leukemia
1445906|NCT00981799|Lymphoma|lymphoma
1445907|NCT00981799|Nelarabine|nelarabine
1445908|NCT00981799|TACL|tacl
1445909|NCT00981799|NECTAR|nectar
1445910|NCT00981786|24-hour IOP control|24-hour iop control
1445911|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
1445912|NCT00981786|brimonidine/timolol|brimonidine/timolol
1445913|NCT00981786|travoprost|travoprost
1445914|NCT00981773|HIV switch|hiv switch
1445915|NCT00981773|HIV|hiv
1445916|NCT00981773|treatment experienced|treatment experienced
1445917|NCT00981734|Aging|aging
1445918|NCT00981734|functionality|functionality
1445919|NCT00981734|life style|life style
1445920|NCT00981734|To have more than sixty years|to have more than sixty years
1445921|NCT00981721|Phase I|phase i
1445922|NCT00981721|Advanced solid malignancies|advanced solid malignancies
1445923|NCT00981721|Advanced solid tumour|advanced solid tumour
1445924|NCT00981721|Advanced cancer|advanced cancer
1445925|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
1445926|NCT00981721|China|china
1445927|NCT00981721|PK|pk
1445928|NCT00981721|pharmacokinetics|pharmacokinetics
1445929|NCT00981708|Amyloidosis|amyloidosis
1445930|NCT00981708|lenalidomide|lenalidomide
1445931|NCT00981708|newly diagnosed|newly diagnosed
1445932|NCT00981708|relapsed|relapsed
1445933|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
1445934|NCT00981695|HIV|hiv
1445935|NCT00981695|Vaccine|vaccine
1445936|NCT00981695|MVA|mva
1445937|NCT00981695|PMTCT|pmtct
1445938|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
1445939|NCT00981695|HIV seronegativity|hiv seronegativity
1445940|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
1445941|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
1445942|NCT00981669|safety|safety
1445943|NCT00981669|tolerability|tolerability
1445944|NCT00981669|immunogenicity|immunogenicity
1445945|NCT00981656|stage I bladder cancer|stage i bladder cancer
1445946|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1445947|NCT00981643|Meditation|meditation
1445948|NCT00981643|Multiple Sclerosis|multiple sclerosis
1445949|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
1445950|NCT00981630|Japanese Encephalitis|japanese encephalitis
1445951|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
1445952|NCT00981630|Adult|adult
1445953|NCT00981604|SILS|sils
1445954|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1445955|NCT00981604|Children|children
1445956|NCT00981591|Iloprost|iloprost
1445957|NCT00981591|Nitric oxide|nitric oxide
1445958|NCT00981591|Mechanical ventilator|mechanical ventilator
1445959|NCT00981578|bone cancer|bone cancer
1445960|NCT00981578|pain palliation|pain palliation
1445961|NCT00981578|metastasis|metastasis
1445962|NCT00981578|breast cancer|breast cancer
1445963|NCT00981578|lung cancer|lung cancer
1445964|NCT00981578|prostate cancer|prostate cancer
1445965|NCT00981578|cancer related pain|cancer related pain
1445966|NCT00981578|tumors|tumors
1445967|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
1445969|NCT00981565|medianus impingement|medianus impingement
1445970|NCT00981552|Cervix Cancer|cervix cancer
1445971|NCT00981552|IMRT|imrt
1445972|NCT00981552|Organ Motion|organ motion
1445973|NCT00981552|Target Definition|target definition
1445974|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
1445978|NCT00981526|Antipsychotics|antipsychotics
1445979|NCT00981526|Psychopathology|psychopathology
1445980|NCT00981500|obesity|obesity
1445981|NCT00981500|gastric bypass|gastric bypass
1445982|NCT00981500|gastric banding|gastric banding
1445983|NCT00981500|weight loss|weight loss
1445984|NCT00981500|insulin sensitivity|insulin sensitivity
1445985|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
1445986|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
1445987|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
1445988|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
1445989|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
1445990|NCT00981461|Hair Loss|hair loss
1445991|NCT00981461|Female Pattern Baldness|female pattern baldness
1445992|NCT00981448|zinc|zinc
1445993|NCT00981448|diabetes|diabetes
1445994|NCT00981448|genetics|genetics
1445995|NCT00981435|Glaucoma|glaucoma
1445996|NCT00981435|Trabeculoplasty|trabeculoplasty
1445997|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
1445998|NCT00981435|Intraocular pressure|intraocular pressure
1445999|NCT00981422|glaucoma|glaucoma
1446000|NCT00981422|immunology|immunology
1446001|NCT00981422|immunophenotype|immunophenotype
1446002|NCT00981409|Fondaparinux sodium|fondaparinux sodium
1446003|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
1446004|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
1446005|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
1446006|NCT00981396|smoking|smoking
1446007|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
1446008|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
1446009|NCT00981396|cravings|cravings
1446010|NCT00981396|trauma|trauma
1446011|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
1446012|NCT00981370|Sickle Cell Disease|sickle cell disease
1446013|NCT00981370|Sickle Cell Anemia|sickle cell anemia
1446014|NCT00981370|Iron Overload|iron overload
1446015|NCT00981370|Chelation Therapy|chelation therapy
1446016|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
1446017|NCT00981370|Heart rate variability|heart rate variability
1446018|NCT00981370|Autonomic dysfunction|autonomic dysfunction
1446019|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
1446020|NCT00981344|wheelchair|wheelchair
1446021|NCT00981344|mobility disability|mobility disability
1446022|NCT00981344|evidence based practice|evidence based practice
1446023|NCT00981344|self help devices|self help devices
1446024|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
1446025|NCT00981331|Subtalar joint|subtalar joint
1446026|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
1446027|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
1446028|NCT00981331|Ankle sprain|ankle sprain
1446029|NCT00981331|Inversion sprain|inversion sprain
1446030|NCT00981331|Range of motion, Articular|range of motion, articular
1446031|NCT00981331|Quaternion|quaternion
1446032|NCT00981331|Eigen analysis|eigen analysis
1446033|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1446035|NCT00981318|AIDS|aids
1446036|NCT00981318|treatment experienced|treatment experienced
1446037|NCT00981305|dyspareunia|dyspareunia
1446038|NCT00981305|breast cancer|breast cancer
1446039|NCT00981305|sexual dysfunction|sexual dysfunction
1446040|NCT00981305|vaginal lubricant|vaginal lubricant
1446041|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
1446042|NCT00981292|cerebral blood flow|cerebral blood flow
1446043|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
1446044|NCT00981292|Electroencephalography|electroencephalography
1446045|NCT00981292|cognitive function|cognitive function
1446046|NCT00981292|mood|mood
1446047|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
1446048|NCT00981279|Health Profile|health profile
1446049|NCT00981279|AIDS|aids
1446050|NCT00981279|Health Promotion|health promotion
1446051|NCT00981279|HIV|hiv
1446052|NCT00981279|treatment experienced|treatment experienced
1446053|NCT00981266|Augmentation|augmentation
1446054|NCT00981266|Augmentation Revision|augmentation revision
1446055|NCT00981253|Stress Management Training|stress management training
1446056|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
1446057|NCT00981253|Stress|stress
1446058|NCT00981253|Depression|depression
1446059|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
1446060|NCT00981214|Cystic fibrosis|cystic fibrosis
1446061|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1446062|NCT00981214|Zenpep-1009|zenpep-1009
1446063|NCT00981201|Smoking|smoking
1446064|NCT00981201|Cancer Prevention|cancer prevention
1446068|NCT00981175|Japanese Encephalitis|japanese encephalitis
1446069|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
1446070|NCT00981175|Adult|adult
1446071|NCT00981136|Appendicitis|appendicitis
1446072|NCT00981136|Appendectomy|appendectomy
1446073|NCT00981136|Children|children
1446074|NCT00981136|Laparoscopic|laparoscopic
1446076|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
1446077|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
1446078|NCT00981110|Hydrofibre dressing|hydrofibre dressing
1446079|NCT00981097|HIV infection|hiv infection
1446080|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1446081|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1446082|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1446083|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1446084|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1446085|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1446086|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1446087|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1446088|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1446089|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1446090|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1446091|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1446092|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1446093|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1446094|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1446095|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1446096|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1446097|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1446098|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1446099|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1446100|NCT00981071|Tuberculosis|tuberculosis
1446101|NCT00981071|QuantiFERON|quantiferon
1446102|NCT00981071|Outbreak|outbreak
1446103|NCT00981071|Conversion|conversion
1446104|NCT00981058|Squamous|squamous
1446105|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
1446106|NCT00981058|First line treatment|first line treatment
1446107|NCT00981058|Monoclonal|monoclonal
1446108|NCT00981058|Antibodies|antibodies
1446109|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
1446110|NCT00981045|IDA|ida
1446111|NCT00981032|Aspirin|aspirin
1446112|NCT00981032|Behavior|behavior
1446113|NCT00981032|Cardiovascular Disease|cardiovascular disease
1446114|NCT00981019|survival rates|survival rates
1446115|NCT00981019|risk communication|risk communication
1446116|NCT00981019|screening counselling|screening counselling
1446117|NCT00981019|screening recommendation|screening recommendation
1446118|NCT00981019|understanding of medical risk|understanding of medical risk
1446119|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
1446120|NCT00980993|Prostate|prostate
1446121|NCT00980993|Motion|motion
1446122|NCT00980993|Respiration|respiration
1446123|NCT00980980|MRSA infection|mrsa infection
1446124|NCT00980967|Lung transplantation|lung transplantation
1446125|NCT00980967|Chronic lung rejection|chronic lung rejection
1446126|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
1446127|NCT00980967|Predictive factors|predictive factors
1446128|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
1446129|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1446130|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1446131|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
1446132|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
1446133|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
1446134|NCT00980941|starch|starch
1446135|NCT00980941|carbohydrates|carbohydrates
1446136|NCT00980941|blood glucose|blood glucose
1446137|NCT00980941|food intake|food intake
1446138|NCT00980941|satiety|satiety
1446139|NCT00980941|appetite|appetite
1446140|NCT00980915|Acute Lung Injury|acute lung injury
1446141|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1446142|NCT00980915|Respiratory Distress|respiratory distress
1446143|NCT00980915|pneumonia|pneumonia
1446144|NCT00980915|sepsis|sepsis
1446145|NCT00980915|aspiration|aspiration
1446146|NCT00980915|pancreatitis|pancreatitis
1446147|NCT00980889|bile duct obstruction|bile duct obstruction
1446148|NCT00980889|jaundice|jaundice
1446149|NCT00980889|metal stent|metal stent
1446150|NCT00980850|Flu vaccine|flu vaccine
1446151|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
1446152|NCT00980850|Immunogenicity|immunogenicity
1446153|NCT00980850|Reactogenicity|reactogenicity
1446154|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
1446155|NCT00980824|self harm|self harm
1446156|NCT00980824|personality disorder|personality disorder
1446157|NCT00980824|complex comorbidity|complex comorbidity
1446158|NCT00980824|mental health|mental health
1446159|NCT00980798|Osteoarthritis|osteoarthritis
1446160|NCT00980798|Strong pain killer|strong pain killer
1446161|NCT00980798|Strong opioid|strong opioid
1446162|NCT00980798|Low starting dose|low starting dose
1446163|NCT00980798|Fewer side effects|fewer side effects
1446164|NCT00980798|Physical functioning|physical functioning
1446165|NCT00980798|Pain control|pain control
1446166|NCT00980798|Quality of life|quality of life
1446167|NCT00980798|Sleep quality|sleep quality
1446168|NCT00980785|Alzheimer's Disease|alzheimer's disease
1446169|NCT00980785|Hypertension|hypertension
1446170|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
1446171|NCT00980759|Cervical cancer|cervical cancer
1446172|NCT00980759|Hypoxia|hypoxia
1446173|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
1446174|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
1446175|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
1446176|NCT00980733|Micronutrients|micronutrients
1446177|NCT00980733|zinc|zinc
1446178|NCT00980733|iron|iron
1446179|NCT00980733|iodine|iodine
1446180|NCT00980733|fortification|fortification
1446181|NCT00980733|school children|school children
1446182|NCT00980707|versican|versican
1446183|NCT00980707|hyaluronan|hyaluronan
1446184|NCT00980707|sputum|sputum
1446185|NCT00980694|ubiquinol|ubiquinol
1446186|NCT00980694|coenzyme Q10|coenzyme q10
1446187|NCT00980694|Huntington disease|huntington disease
1446188|NCT00980681|Renal disease|renal disease
1446189|NCT00980681|Contrast agent|contrast agent
1446190|NCT00980681|MRA|mra
1446191|NCT00980642|surgery|surgery
1446192|NCT00980642|thermometer|thermometer
1446193|NCT00980642|non-invasive|non-invasive
1446194|NCT00980642|interoperative core temperature|interoperative core temperature
1446195|NCT00980642|anesthesia|anesthesia
1446196|NCT00980616|Arthroplasty, hip|arthroplasty, hip
1446197|NCT00980616|blood losses|blood losses
1446198|NCT00980616|pain|pain
1446199|NCT00980616|local analgesia|local analgesia
1446200|NCT00980616|epinephrine|epinephrine
1446201|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
1446202|NCT00980603|gastric cancer|gastric cancer
1446203|NCT00980603|metastatic|metastatic
1446204|NCT00980603|docetaxel|docetaxel
1446205|NCT00980603|cisplatin|cisplatin
1446206|NCT00980603|S-1|s-1
1446207|NCT00980590|supine emergency intubations|supine emergency intubations
1446208|NCT00980590|emergency intubations|emergency intubations
1446209|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
1446210|NCT00980538|TMC125-C239|tmc125-c239
1446211|NCT00980538|TMC125|tmc125
1446213|NCT00980538|Etravirine|etravirine
1446214|NCT00980538|Intelence|intelence
1446215|NCT00980538|IntelenceTM|intelencetm
1446216|NCT00980525|healthy|healthy
1446217|NCT00980512|behavior problems|behavior problems
1446218|NCT00980512|parent training|parent training
1446219|NCT00980512|foster care|foster care
1446220|NCT00980486|Antibiotic Concentration|antibiotic concentration
1446221|NCT00980486|Tissue|tissue
1446222|NCT00980486|Obesity|obesity
1446223|NCT00980486|Cesarean|cesarean
1446224|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
1446225|NCT00980447|H5N1|h5n1
1446226|NCT00980447|Vaccine|vaccine
1446227|NCT00980447|Influenza H5N1|influenza h5n1
1446228|NCT00980447|Avian influenza H5N1|avian influenza h5n1
1446229|NCT00980447|Pandemic|pandemic
1446230|NCT00980434|vertebral fracture|vertebral fracture
1446231|NCT00980434|spinal cord injury|spinal cord injury
1446232|NCT00980421|iron|iron
1446233|NCT00980421|iron toxicity markers|iron toxicity markers
1446234|NCT00980421|oxidative stress markers|oxidative stress markers
1446235|NCT00980421|iron supplementation|iron supplementation
1446236|NCT00980421|NTBI|ntbi
1446237|NCT00980421|iron over load|iron over load
1446238|NCT00980421|interleukin levels|interleukin levels
1446239|NCT00980421|iron status|iron status
1446240|NCT00980421|acut phase reactants|acut phase reactants
1446241|NCT00980421|preschool children|preschool children
1446242|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1446243|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1446244|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1446245|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1446246|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1446247|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1446248|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1446249|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1446250|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1446251|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1446252|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1446253|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1446254|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1446255|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1446256|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1446257|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1446258|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1446259|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1446260|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1446261|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
1446262|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
1446263|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1446264|NCT00980382|Stomach Neoplasms|stomach neoplasms
1446265|NCT00980382|phase I/II|phase i/ii
1446266|NCT00980382|Combination chemotherapy|combination chemotherapy
1446267|NCT00980382|S-1|s-1
1446268|NCT00980382|Docetaxel|docetaxel
1446269|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
1446270|NCT00980369|Anal fissure|anal fissure
1446271|NCT00980369|Surgical technique|surgical technique
1446272|NCT00980369|Incision|incision
1446273|NCT00980369|Wound healing|wound healing
1446274|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
1446275|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
1446276|NCT00980330|Hepatitis C|hepatitis c
1446277|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
1446278|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
1446279|NCT00980330|RBV|rbv
1446280|NCT00980330|Ribavirin|ribavirin
1446281|NCT00980330|Placebo|placebo
1446282|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
1446283|NCT00980330|TMC435-C206|tmc435-c206
1446284|NCT00980330|TMC435|tmc435
1446285|NCT00980330|HCV|hcv
1446286|NCT00980317|Renal tumor|renal tumor
1446287|NCT00980317|Restored kidney|restored kidney
1446288|NCT00980317|Renal transplantation|renal transplantation
1446289|NCT00980317|Third party|third party
1446290|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
1446291|NCT00980278|sinus lift|sinus lift
1446292|NCT00980278|tooth extraction|tooth extraction
1446293|NCT00980278|dental implant|dental implant
1446294|NCT00980252|Schizophrenia|schizophrenia
1446295|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
1446296|NCT00980252|Compliance|compliance
1446297|NCT00980252|Medication Adherence|medication adherence
1446298|NCT00980252|Psychotic Disorders|psychotic disorders
1446299|NCT00980252|Mental Disorders|mental disorders
1446300|NCT00980252|Outcomes|outcomes
1446301|NCT00980252|Psychoeducation|psychoeducation
1446302|NCT00980252|Adherence Attitudes|adherence attitudes
1446303|NCT00980252|Intervention|intervention
1446304|NCT00980252|Nonadherence|nonadherence
1446305|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1446306|NCT00980239|Solid Tumors|solid tumors
1446308|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
1446310|NCT00980239|Bevacizumab|bevacizumab
1446311|NCT00980239|Avastin|avastin
1446312|NCT00980239|Cetuximab|cetuximab
1446313|NCT00980239|Erbitux|erbitux
1446314|NCT00980239|Irinotecan|irinotecan
1446315|NCT00980239|Camptosar|camptosar
1446316|NCT00980239|Oxaliplatin|oxaliplatin
1446317|NCT00980239|Eloxatin|eloxatin
1446318|NCT00980213|renal cell cancer|renal cell cancer
1446319|NCT00980213|sunitinib|sunitinib
1446320|NCT00980213|costs|costs
1446321|NCT00980213|quality of life|quality of life
1446322|NCT00980200|GW642444|gw642444
1446323|NCT00980200|once daily dosing|once daily dosing
1446324|NCT00980200|asthma|asthma
1446325|NCT00980200|efficacy|efficacy
1446326|NCT00980200|safety|safety
1446327|NCT00980200|FEV1|fev1
1446328|NCT00980187|blood tests|blood tests
1446329|NCT00980187|cardiac function|cardiac function
1446330|NCT00980187|endothelial function|endothelial function
1446331|NCT00980187|arterial function|arterial function
1446332|NCT00980174|men|men
1446333|NCT00980174|male|male
1446334|NCT00980174|denosumab|denosumab
1446335|NCT00980174|BMD|bmd
1446336|NCT00980174|lumbar spine|lumbar spine
1446337|NCT00980174|ADAMO|adamo
1446338|NCT00980174|The ADAMO Trial|the adamo trial
1446339|NCT00980174|male osteoporosis|male osteoporosis
1446340|NCT00980174|osteoporosis in men|osteoporosis in men
1446341|NCT00980174|males with low bone mineral density|males with low bone mineral density
1446342|NCT00980161|Hepatitis C|hepatitis c
1446343|NCT00980161|Peginterferon|peginterferon
1446344|NCT00980161|Ribavirin|ribavirin
1446345|NCT00980161|MicroRNA|microrna
1446346|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
1446347|NCT00980135|Sinecort|sinecort
1446348|NCT00980135|Hydrocortison|hydrocortison
1446349|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
1446350|NCT00980135|Efficacy, safety|efficacy, safety
1446351|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
1446352|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
1446353|NCT00980109|Long Term|long term
1446354|NCT00980109|Oral Oseltamivir|oral oseltamivir
1446355|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
1446356|NCT00980083|GLP-1|glp-1
1446357|NCT00980083|exendin(9-39)|exendin(9-39)
1446358|NCT00980083|gastric emptying|gastric emptying
1446359|NCT00980083|incretin|incretin
1446360|NCT00980083|human|human
1446361|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
1446362|NCT00980031|Aldosterone Blockade|aldosterone blockade
1446363|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
1446364|NCT00980031|cardiac chamber size|cardiac chamber size
1446365|NCT00980031|wall thickness|wall thickness
1446366|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
1446367|NCT00980031|left atrial volumes|left atrial volumes
1446368|NCT00980031|diastolic function|diastolic function
1446369|NCT00980018|CML|cml
1446370|NCT00980018|Leukemia|leukemia
1446371|NCT00980018|Tasigna|tasigna
1446372|NCT00980018|nilotinib|nilotinib
1446373|NCT00980018|AMN107|amn107
1446374|NCT00980018|CML-CP|cml-cp
1446375|NCT00980018|Chronic Phase|chronic phase
1446376|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
1446377|NCT00980005|influenza infection|influenza infection
1446378|NCT00979979|Hepatitis C|hepatitis c
1446379|NCT00979979|Genotype|genotype
1446380|NCT00979979|Realtime PCR|realtime pcr
1446381|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
1446382|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
1446383|NCT00979953|osteoarthritis|osteoarthritis
1446384|NCT00979953|pain|pain
1446385|NCT00979940|atorvastatin|atorvastatin
1446386|NCT00979940|clopidogrel|clopidogrel
1446387|NCT00979940|percutaneous intervention|percutaneous intervention
1446388|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
1446389|NCT00979927|Antisense|antisense
1446390|NCT00979927|miR-122 antagonist|mir-122 antagonist
1446391|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
1446392|NCT00979927|Hepatitis C|hepatitis c
1446393|NCT00979914|osteoarthritis|osteoarthritis
1446394|NCT00979914|patient education|patient education
1446395|NCT00979914|function|function
1446396|NCT00979914|physio therapy|physio therapy
1446397|NCT00979888|dyspnea|dyspnea
1446398|NCT00979888|depression|depression
1446399|NCT00979888|fatigue|fatigue
1446400|NCT00979888|anxiety disorder|anxiety disorder
1446401|NCT00979888|small cell lung cancer|small cell lung cancer
1446402|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
1446403|NCT00979875|insulin|insulin
1446404|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
1446405|NCT00979875|Healthy volunteers|healthy volunteers
1446406|NCT00979849|safety|safety
1446407|NCT00979849|tolerability|tolerability
1446408|NCT00979849|healthy|healthy
1446409|NCT00979849|inhalation|inhalation
1446410|NCT00979836|venous|venous
1446411|NCT00979836|ulcer|ulcer
1446412|NCT00979836|phlebotonic|phlebotonic
1446413|NCT00979836|calcium dobesilate|calcium dobesilate
1446414|NCT00979836|clinical trial|clinical trial
1446415|NCT00979810|PET scan|pet scan
1446416|NCT00979810|CT scan|ct scan
1446417|NCT00979810|09-060|09-060
1446418|NCT00979810|CNS|cns
1446419|NCT00979797|Community IMCI|community imci
1446420|NCT00979797|C-IMCI|c-imci
1446421|NCT00979797|CHW|chw
1446422|NCT00979797|Children|children
1446423|NCT00979797|Evaluation|evaluation
1446424|NCT00979797|Behaviour|behaviour
1446425|NCT00979797|Counselling|counselling
1446426|NCT00979797|Under 5 mortality|under 5 mortality
1446427|NCT00979797|Under 5 Nutrition|under 5 nutrition
1446428|NCT00979784|obesity|obesity
1446429|NCT00979784|primary care|primary care
1446430|NCT00979771|GSK706769|gsk706769
1446431|NCT00979771|Enbrel|enbrel
1446432|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
1446433|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
1446434|NCT00979745|EPP|epp
1446435|NCT00979745|Afamelanotide|afamelanotide
1446436|NCT00979732|high blood pressure|high blood pressure
1446437|NCT00979732|dietary supplements|dietary supplements
1446438|NCT00979732|nutrition|nutrition
1446439|NCT00979719|Randomized Controlled Trial|randomized controlled trial
1446440|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
1446441|NCT00979719|expert system|expert system
1446442|NCT00979719|stages of change|stages of change
1446443|NCT00979719|motivational interviewing|motivational interviewing
1446444|NCT00979719|tailoring|tailoring
1446445|NCT00979719|Self Care|self care
1446446|NCT00979719|Rehabilitation|rehabilitation
1446447|NCT00979719|Expert Systems|expert systems
1446448|NCT00979693|anxiety|anxiety
1446449|NCT00979693|stage IV melanoma|stage iv melanoma
1446450|NCT00979693|depression|depression
1446451|NCT00979693|spirituality|spirituality
1446452|NCT00979693|pain|pain
1446453|NCT00979680|sphincter preservation|sphincter preservation
1446454|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
1446455|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
1446456|NCT00979667|Influenza A|influenza a
1446457|NCT00979667|Human Swine Influenza|human swine influenza
1446458|NCT00979654|Sifalimumab|sifalimumab
1446459|NCT00979654|MEDI-545|medi-545
1446460|NCT00979641|breast cancer|breast cancer
1446461|NCT00979641|metastatic|metastatic
1446462|NCT00979641|chemotherapy|chemotherapy
1446463|NCT00979641|bevacizumab|bevacizumab
1446464|NCT00979641|docetaxel|docetaxel
1446465|NCT00979641|Phase II|phase ii
1446466|NCT00979641|first line chemotherapy|first line chemotherapy
1446467|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
1446468|NCT00979628|Type 2 Diabetes|type 2 diabetes
1446469|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
1446470|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
1446471|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
1446472|NCT00979615|VMR|vmr
1446473|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1446474|NCT00979602|Influenza Vaccines|influenza vaccines
1446475|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
1446476|NCT00979602|influenza infection|influenza infection
1446477|NCT00979589|stroke|stroke
1446478|NCT00979589|transient ischemic attack|transient ischemic attack
1446479|NCT00979589|acute treatment|acute treatment
1446480|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
1446481|NCT00979589|clopidogrel|clopidogrel
1446482|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
1446483|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
1446484|NCT00979563|HM30181AK|hm30181ak
1446485|NCT00979563|Irinotecan tablet|irinotecan tablet
1446486|NCT00979563|MTD|mtd
1446487|NCT00979563|DLT|dlt
1446488|NCT00979550|laser|laser
1446489|NCT00979550|pediatric|pediatric
1446490|NCT00979550|skin pigmentation|skin pigmentation
1446491|NCT00979524|Depressive symptoms|depressive symptoms
1446492|NCT00979524|Mental health services|mental health services
1446493|NCT00979524|Adolescents|adolescents
1446494|NCT00979524|Young adults|young adults
1446495|NCT00979524|African-American|african-american
1446496|NCT00979511|osteoporosis|osteoporosis
1446497|NCT00979511|calcium|calcium
1446498|NCT00979511|weight-bearing exercise|weight-bearing exercise
1446499|NCT00979511|bone mass|bone mass
1446500|NCT00979511|prepubertal girls|prepubertal girls
1446501|NCT00979485|Pediatric IBD|pediatric ibd
1446502|NCT00979485|Microparticles|microparticles
1446503|NCT00979472|Solifenacin|solifenacin
1446504|NCT00979472|Overactive bladder|overactive bladder
1446505|NCT00979472|Micturition|micturition
1446506|NCT00979472|Urinary urgency|urinary urgency
1446507|NCT00979472|Vesicare|vesicare
1446508|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
1446509|NCT00979446|Older adults|older adults
1446510|NCT00979446|Physical activity|physical activity
1446511|NCT00979446|Cognitive stimulation|cognitive stimulation
1446512|NCT00979446|Social engagement|social engagement
1446513|NCT00979433|Extubation failure|extubation failure
1446514|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
1446515|NCT00979433|Bubble CPAP|bubble cpap
1446516|NCT00979420|treatment experienced|treatment experienced
1446517|NCT00979407|influenza infection|influenza infection
1446518|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
1446519|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
1446520|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
1446521|NCT00979381|sunitinib|sunitinib
1446522|NCT00979381|sorafenib|sorafenib
1446523|NCT00979381|immune response|immune response
1446524|NCT00979355|Whole body|whole body
1446525|NCT00979355|SPECT|spect
1446526|NCT00979342|morcellator|morcellator
1446527|NCT00979342|hysteroscope|hysteroscope
1446528|NCT00979342|myomectomy|myomectomy
1446529|NCT00979342|polypectomy|polypectomy
1446530|NCT00979342|uterine fibroids|uterine fibroids
1446531|NCT00979342|uterine polyps|uterine polyps
1446532|NCT00979342|local anesthetic|local anesthetic
1446533|NCT00979342|cervical block|cervical block
1446534|NCT00979342|pain management|pain management
1446535|NCT00979329|sunitinib|sunitinib
1446536|NCT00979329|sorafenib|sorafenib
1446537|NCT00979329|fatigue|fatigue
1446538|NCT00979329|depression|depression
1446539|NCT00979329|quality of life|quality of life
1446540|NCT00979329|metastatic RCC|metastatic rcc
1446541|NCT00979329|colorectal cancer|colorectal cancer
1446542|NCT00979329|GIST|gist
1446543|NCT00979303|Pediatric|pediatric
1446544|NCT00979303|Electrophysiology|electrophysiology
1446545|NCT00979303|Ablation|ablation
1446546|NCT00979303|Radiation|radiation
1446547|NCT00979303|Devices|devices
1446549|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
1446550|NCT00979290|adverse effect|adverse effect
1446551|NCT00979290|efficiency|efficiency
1446552|NCT00979264|Quality Improvement|quality improvement
1446553|NCT00979251|Influenza|influenza
1446554|NCT00979251|Immunocompromised|immunocompromised
1446555|NCT00979251|HIV|hiv
1446556|NCT00979251|History of transplant|history of transplant
1446557|NCT00979238|Hemophilia B|hemophilia b
1446558|NCT00979238|Factor IX Gene|factor ix gene
1446559|NCT00979238|Factor IX Protein|factor ix protein
1446560|NCT00979238|Vector|vector
1446561|NCT00979225|health information technology|health information technology
1446562|NCT00979225|clinical decision support|clinical decision support
1446563|NCT00979225|medication management|medication management
1446564|NCT00979225|medication adherence|medication adherence
1446565|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1446566|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
1446567|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1446568|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1446569|NCT00979212|large cell lung cancer|large cell lung cancer
1446570|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
1446571|NCT00979199|IHD|ihd
1446572|NCT00979199|CAD|cad
1446573|NCT00979199|Non invasive imaging|non invasive imaging
1446574|NCT00979199|SPECT|spect
1446575|NCT00979199|PET|pet
1446576|NCT00979199|CMR|cmr
1446577|NCT00979199|Echocardiography|echocardiography
1446578|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
1446579|NCT00979173|malignant glioma|malignant glioma
1446580|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
1446581|NCT00979173|gliosarcoma|gliosarcoma
1446582|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
1446583|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1446584|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
1446585|NCT00979173|Pro00018751|pro00018751
1446586|NCT00979173|Duke|duke
1446587|NCT00979173|Ambit|ambit
1446588|NCT00979173|AC480|ac480
1446589|NCT00979147|knee arthritis|knee arthritis
1446590|NCT00979147|total knee arthroplasty|total knee arthroplasty
1446591|NCT00979147|total knee replacement|total knee replacement
1446592|NCT00979147|metal backed tibial component|metal backed tibial component
1446593|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
1446594|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
1446595|NCT00979134|Cancer|cancer
1446596|NCT00979134|Tumour|tumour
1446597|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
1446598|NCT00979134|FGFR|fgfr
1446599|NCT00979134|Squamous NSCLC|squamous nsclc
1446600|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
1446601|NCT00979121|ALI|ali
1446602|NCT00979121|Sepsis|sepsis
1586015|NCT00444561|Symlin|symlin
1446603|NCT00979121|statin|statin
1446604|NCT00979108|Radiculopathy|radiculopathy
1446605|NCT00979108|Neck pain|neck pain
1446606|NCT00979108|Physical therapy modalities|physical therapy modalities
1446607|NCT00979108|Rehabilitation|rehabilitation
1446608|NCT00979095|multiple hernia|multiple hernia
1446609|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
1446610|NCT00979056|Prevention|prevention
1446611|NCT00979043|knee osteoarthritis|knee osteoarthritis
1446612|NCT00979043|weight-loss|weight-loss
1446613|NCT00979043|exercise|exercise
1446614|NCT00979043|obesity|obesity
1446615|NCT00979043|physical function|physical function
1446616|NCT00979043|total mortality|total mortality
1446617|NCT00979017|malignant glioma|malignant glioma
1446618|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
1446619|NCT00979017|gliosarcoma|gliosarcoma
1446620|NCT00979017|Avastin|avastin
1446621|NCT00979017|bevacizumab|bevacizumab
1446622|NCT00979017|Temodar|temodar
1446623|NCT00979017|temozolomide|temozolomide
1446624|NCT00979017|Irinotecan|irinotecan
1446625|NCT00979017|CPT-11|cpt-11
1446626|NCT00979017|Pro00019065|pro00019065
1446627|NCT00979017|Vredenburgh|vredenburgh
1446628|NCT00979017|Duke|duke
1446629|NCT00979004|Photosensitivity|photosensitivity
1446630|NCT00979004|Epilepsy|epilepsy
1446631|NCT00979004|Seizures|seizures
1446632|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
1446633|NCT00978991|Erectile dysfunction|erectile dysfunction
1446634|NCT00978965|kidney transplantation|kidney transplantation
1446635|NCT00978965|immunosuppression|immunosuppression
1446636|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
1446637|NCT00978965|IMPDH|impdh
1446638|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
1446639|NCT00978913|dendritic cell|dendritic cell
1446640|NCT00978913|cancervaccine|cancervaccine
1446641|NCT00978913|breast cancer|breast cancer
1446642|NCT00978913|malignant melanoma|malignant melanoma
1446643|NCT00978913|Cyclophosphamide|cyclophosphamide
1446644|NCT00978900|satiety peptides|satiety peptides
1446645|NCT00978900|GLP-1|glp-1
1446646|NCT00978900|PYY|pyy
1446647|NCT00978900|ghrelin|ghrelin
1446648|NCT00978900|appetite profile|appetite profile
1446649|NCT00978900|Sweetening Agents|sweetening agents
1446650|NCT00978887|Facial cream|facial cream
1446651|NCT00978887|natural product|natural product
1446652|NCT00978887|facial wrinkles|facial wrinkles
1446653|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
1446654|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
1446655|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
1446656|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
1447077|NCT00977327|Glioma|glioma
1446657|NCT00978874|stage III cervical cancer|stage iii cervical cancer
1446658|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
1446659|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
1446660|NCT00978848|trichomonas|trichomonas
1446661|NCT00978848|chlamydia|chlamydia
1446662|NCT00978848|gonorrhea|gonorrhea
1446663|NCT00978848|emergency contraception|emergency contraception
1446664|NCT00978848|emergency contraception use|emergency contraception use
1446665|NCT00978835|Diabetes|diabetes
1446666|NCT00978835|Hypertension|hypertension
1446667|NCT00978835|Physical Activity|physical activity
1446668|NCT00978835|Diet|diet
1446669|NCT00978835|Medication Adherence|medication adherence
1446670|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
1446671|NCT00978822|Hypertension|hypertension
1446672|NCT00978822|brain Aneurysm|brain aneurysm
1446673|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
1446674|NCT00978822|antihypertensive|antihypertensive
1446675|NCT00978822|calcium channel blockers|calcium channel blockers
1446676|NCT00978822|infusion|infusion
1446677|NCT00978822|neurocritical care|neurocritical care
1446678|NCT00978809|BPPV|bppv
1446679|NCT00978809|postural stability|postural stability
1446680|NCT00978809|Epley|epley
1446681|NCT00978809|Semont|semont
1446682|NCT00978796|Diabetes Mellitus|diabetes mellitus
1446683|NCT00978796|Type 1 diabetes|type 1 diabetes
1446684|NCT00978796|glucose variability|glucose variability
1446685|NCT00978783|Phonation|phonation
1446686|NCT00978783|Tracheostomy|tracheostomy
1446687|NCT00978783|phonation valve|phonation valve
1446688|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
1446689|NCT00978770|stage II breast cancer|stage ii breast cancer
1446690|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
1446691|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
1446692|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
1446693|NCT00978757|hepatectomy|hepatectomy
1446694|NCT00978757|IL 6|il 6
1446695|NCT00978757|organ failure|organ failure
1446696|NCT00978757|ketamine|ketamine
1446697|NCT00978757|Pringle|pringle
1446698|NCT00978744|Clinical Health Record|clinical health record
1446699|NCT00978744|Computerized Decision Support|computerized decision support
1446700|NCT00978744|Patient Safety|patient safety
1446701|NCT00978744|Resource Utilization|resource utilization
1446702|NCT00978718|prostate cancer|prostate cancer
1446703|NCT00978705|Keratinocyte Cell|keratinocyte cell
1446704|NCT00978705|severe burn wound|severe burn wound
1446705|NCT00978692|Myopia|myopia
1446706|NCT00978692|Astigmatism|astigmatism
1446707|NCT00978692|Orthokeratology|orthokeratology
1446708|NCT00978692|Corneal thickness|corneal thickness
1446709|NCT00978692|Corneal curvatures|corneal curvatures
1446710|NCT00978692|Corneal biomechanics|corneal biomechanics
1446711|NCT00978679|Children|children
1446712|NCT00978679|Peripheral refraction|peripheral refraction
1446713|NCT00978679|Aberration|aberration
1446714|NCT00978679|Eyeball length|eyeball length
1446715|NCT00978679|Myopic control|myopic control
1446716|NCT00978679|Myopia|myopia
1446717|NCT00978679|Corneal reshaping|corneal reshaping
1446718|NCT00978679|Orthokeratology|orthokeratology
1446719|NCT00978653|allopurinol|allopurinol
1446720|NCT00978653|chronic kidney disease|chronic kidney disease
1446721|NCT00978653|endothelial dysfunction|endothelial dysfunction
1446722|NCT00978653|hyperuricemia|hyperuricemia
1446723|NCT00978653|uric acid|uric acid
1446724|NCT00978653|vascular endothelium|vascular endothelium
1446725|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
1446726|NCT00978640|Sirt1 activity|sirt1 activity
1446727|NCT00978601|post-operative analgesia|post-operative analgesia
1446728|NCT00978601|early discharge,|early discharge,
1446729|NCT00978601|fast recovery,|fast recovery,
1446730|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
1446731|NCT00978601|laparoscopy,|laparoscopy,
1446732|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
1446733|NCT00978601|patient discharge|patient discharge
1446734|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
1446735|NCT00978575|Iron treatment|iron treatment
1446736|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
1446737|NCT00978549|pain|pain
1446738|NCT00978549|nausea and vomiting|nausea and vomiting
1446739|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1446740|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1446741|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1446742|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
1446743|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
1446744|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
1446745|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
1446746|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
1446747|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
1446748|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
1446749|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
1446750|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
1446751|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
1446752|NCT00978536|Multiple sclerosis|multiple sclerosis
1446753|NCT00978536|cognitive deterioration|cognitive deterioration
1446754|NCT00978536|biomarkers|biomarkers
1446755|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
1446756|NCT00978536|Alzheimer disease|alzheimer disease
1446757|NCT00978510|Tuberculosis|tuberculosis
1446761|NCT00978484|PTSD|ptsd
1446762|NCT00978484|Depression|depression
1446763|NCT00978484|Anxiety|anxiety
1446764|NCT00978484|Virtual Reality|virtual reality
1446765|NCT00978484|Computer Therapy|computer therapy
1446766|NCT00978484|Exposure Therapy|exposure therapy
1446767|NCT00978484|Prolonged Exposure|prolonged exposure
1446768|NCT00978484|Military Medicine|military medicine
1446769|NCT00978484|Combat|combat
1446770|NCT00978484|Iraq|iraq
1446771|NCT00978484|Afghanistan|afghanistan
1446772|NCT00978484|Air Force Personnel|air force personnel
1446773|NCT00978484|Armed Forces Personnel|armed forces personnel
1446774|NCT00978484|Army Personnel|army personnel
1446775|NCT00978484|Coast Guard|coast guard
1446776|NCT00978484|psychology|psychology
1446777|NCT00978484|military psychiatry|military psychiatry
1446778|NCT00978484|combat disorders|combat disorders
1446779|NCT00978484|combat neurosis|combat neurosis
1446780|NCT00978484|Marines|marines
1446781|NCT00978484|Military|military
1446782|NCT00978484|Navy Personnel|navy personnel
1446783|NCT00978484|Sailors|sailors
1446784|NCT00978484|Soldiers|soldiers
1446785|NCT00978471|Conventional chemotherapy|conventional chemotherapy
1446786|NCT00978471|cytapheresis|cytapheresis
1446787|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
1446788|NCT00978471|Surgical resection|surgical resection
1446789|NCT00978471|Thiotepa|thiotepa
1446790|NCT00978458|neurotoxicity|neurotoxicity
1446791|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
1446792|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
1446793|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
1446794|NCT00978458|adult mixed glioma|adult mixed glioma
1446795|NCT00978445|Systemic embolic events|systemic embolic events
1446796|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
1446797|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
1446798|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
1446799|NCT00978432|NHL|nhl
1446800|NCT00978432|DLBCL|dlbcl
1446801|NCT00978432|recurrent|recurrent
1446802|NCT00978432|refractory|refractory
1446803|NCT00978432|de novo|de novo
1446804|NCT00978419|Statins|statins
1446805|NCT00978419|Burns|burns
1446806|NCT00978419|Sedatives|sedatives
1446807|NCT00978419|Neurocognitive|neurocognitive
1446808|NCT00978419|Septic|septic
1446809|NCT00978419|Mortality|mortality
1446810|NCT00978419|C Reactive Protein|c reactive protein
1446811|NCT00978419|Septic shock|septic shock
1446812|NCT00978419|Sedation|sedation
1446813|NCT00978419|Neurocognitive function|neurocognitive function
1446814|NCT00978406|Dietary Assessment Methods|dietary assessment methods
1446815|NCT00978406|Measurement of Diet|measurement of diet
1446816|NCT00978406|24-Hour Diet Recall|24-hour diet recall
1446817|NCT00978406|Validation|validation
1446818|NCT00978406|Feeding Study|feeding study
1446819|NCT00978367|Cicatrix|cicatrix
1446820|NCT00978367|Scar|scar
1446821|NCT00978367|Avotermin|avotermin
1446822|NCT00978367|Juvista|juvista
1446823|NCT00978367|RN1001|rn1001
1446824|NCT00978367|TGF beta 3|tgf beta 3
1446825|NCT00978354|acute kidney injury|acute kidney injury
1446826|NCT00978354|acute renal failure|acute renal failure
1446827|NCT00978354|loop diuretic|loop diuretic
1446828|NCT00978354|critical illness|critical illness
1446829|NCT00978354|sepsis|sepsis
1446830|NCT00978354|renal replacement therapy|renal replacement therapy
1446831|NCT00978354|dialysis|dialysis
1446832|NCT00978354|renal recovery|renal recovery
1446833|NCT00978354|survival|survival
1446834|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
1446835|NCT00978328|Pain conditions|pain conditions
1446836|NCT00978328|Oxycodone immediate release|oxycodone immediate release
1446837|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
1446838|NCT00978328|Roxicodone®|roxicodone®
1446839|NCT00978328|Registry|registry
1446840|NCT00978328|Side effects|side effects
1446841|NCT00978328|Observational|observational
1446842|NCT00978328|Pain management|pain management
1446843|NCT00978302|Cicatrix|cicatrix
1446844|NCT00978302|Scar|scar
1446845|NCT00978302|Wound healing|wound healing
1446846|NCT00978302|Avotermin|avotermin
1446847|NCT00978302|TGF beta 3|tgf beta 3
1446848|NCT00978302|Juvista|juvista
1446849|NCT00978302|RN1001|rn1001
1446850|NCT00978289|obesity|obesity
1446851|NCT00978289|gastric bypass surgery|gastric bypass surgery
1446852|NCT00978276|Receptors|receptors
1446853|NCT00978276|Immunohistochemistry|immunohistochemistry
1446854|NCT00978276|Breast|breast
1446855|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
1446873|NCT00978211|somatostatin|somatostatin
1446874|NCT00978211|radiopeptide|radiopeptide
1446875|NCT00978211|Yttrium|yttrium
1446876|NCT00978211|Lutetium|lutetium
1446877|NCT00978211|neuroendocrine|neuroendocrine
1446878|NCT00978211|cancer|cancer
1446879|NCT00978198|Pharmacokinetics|pharmacokinetics
1446880|NCT00978198|Safety and tolerability|safety and tolerability
1446881|NCT00978198|Plasma concentration|plasma concentration
1446882|NCT00978198|ASP1517|asp1517
1446883|NCT00978198|FG-4592|fg-4592
1446884|NCT00978185|nausea and vomiting|nausea and vomiting
1446885|NCT00978185|anxiety disorder|anxiety disorder
1446886|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1446887|NCT00978159|esomeprazole|esomeprazole
1446888|NCT00978159|famotidine|famotidine
1446889|NCT00978159|aspirin|aspirin
1446890|NCT00978159|dyspepsia|dyspepsia
1446891|NCT00978133|Colectomy|colectomy
1446892|NCT00978133|Closure|closure
1446893|NCT00978133|Wound|wound
1446894|NCT00978133|Dermabond|dermabond
1446895|NCT00978133|Propen|propen
1446896|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
1446897|NCT00978120|Vaccine|vaccine
1446898|NCT00978107|Hepatic tumors|hepatic tumors
1446899|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
1446900|NCT00978081|precancerous condition|precancerous condition
1446901|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
1446902|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1446903|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1446904|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
1446905|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
1446906|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
1446907|NCT00978068|Pediatric HIV|pediatric hiv
1446908|NCT00978068|Malaria|malaria
1446909|NCT00978068|Uganda|uganda
1446910|NCT00978068|Nevirapine|nevirapine
1446911|NCT00978068|Zidovudine|zidovudine
1446912|NCT00978068|Lamivudine|lamivudine
1446913|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
1446914|NCT00978068|Stavudine|stavudine
1446915|NCT00978068|Efavirenz|efavirenz
1446917|NCT00978029|immunotherapy|immunotherapy
1446918|NCT00978016|GERD|gerd
1446919|NCT00978003|Vasti Medialis|vasti medialis
1446920|NCT00978003|Knee|knee
1446921|NCT00978003|MR Imaging|mr imaging
1446922|NCT00978003|Vasti Lateralis|vasti lateralis
1446923|NCT00978003|HV|hv
1446924|NCT00978003|Healthy Volunteer|healthy volunteer
1446925|NCT00977990|Skin Swab|skin swab
1446926|NCT00977990|Self-Sample|self-sample
1446927|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
1446928|NCT00977977|Renal Disease|renal disease
1446929|NCT00977977|Autoimmune Diseases|autoimmune diseases
1446930|NCT00977977|Clinical Trial|clinical trial
1446931|NCT00977977|Proteinuria|proteinuria
1446932|NCT00977964|Infant|infant
1446933|NCT00977951|Cicatrix|cicatrix
1446934|NCT00977951|Scar|scar
1446935|NCT00977951|Avotermin|avotermin
1446936|NCT00977951|Juvista|juvista
1446937|NCT00977951|RN1001|rn1001
1446938|NCT00977951|TGF beta 3|tgf beta 3
1446939|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
1446940|NCT00977938|Adverse event|adverse event
1446941|NCT00977938|Antiplatelet therapy|antiplatelet therapy
1446942|NCT00977938|Sirolimus|sirolimus
1446943|NCT00977938|Everolimus|everolimus
1446944|NCT00977938|Paclitaxel|paclitaxel
1446945|NCT00977938|Zotarolimus|zotarolimus
1446946|NCT00977938|Bare Metal Stent|bare metal stent
1446947|NCT00977938|Drug Eluting Stent|drug eluting stent
1446948|NCT00977938|Clinical Events Committee|clinical events committee
1446949|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
1446950|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
1446951|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
1446952|NCT00977938|Major Bleeding|major bleeding
1446953|NCT00977938|Myocardial infarction|myocardial infarction
1446954|NCT00977938|Myocardial ischemia|myocardial ischemia
1446955|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
1446956|NCT00977938|Stent placement|stent placement
1446957|NCT00977938|Stent Thrombosis|stent thrombosis
1446958|NCT00977938|Thienopyridine|thienopyridine
1446959|NCT00977938|Clopidogrel|clopidogrel
1446960|NCT00977938|Prasugrel|prasugrel
1446961|NCT00977925|Hemostasis|hemostasis
1446962|NCT00977912|B. lactis|b. lactis
1446963|NCT00977912|Preterm|preterm
1446964|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
1446965|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
1446966|NCT00977899|Alum Adsorbed|alum adsorbed
1446967|NCT00977899|Ookinete Surface Protein|ookinete surface protein
1446968|NCT00977899|Malaria Vaccine|malaria vaccine
1446969|NCT00977899|Healthy Volunteer|healthy volunteer
1446970|NCT00977899|HV|hv
1446971|NCT00977860|Prostate|prostate
1446972|NCT00977860|Stereotactic|stereotactic
1446973|NCT00977860|Radiosurgery|radiosurgery
1446974|NCT00977847|Family History|family history
1446975|NCT00977847|Electronic Health Record|electronic health record
1446976|NCT00977834|Geriatric Assessment|geriatric assessment
1446977|NCT00977808|Artificial pancreas|artificial pancreas
1446978|NCT00977808|Closed-Loop control|closed-loop control
1446979|NCT00977795|Brain Neoplasms|brain neoplasms
1446980|NCT00977795|5-ALA|5-ala
1446981|NCT00977795|Aminolevulinic acid|aminolevulinic acid
1446982|NCT00977795|Fluorescence|fluorescence
1446983|NCT00977795|Gliomas|gliomas
1446984|NCT00977795|Glioblastoma|glioblastoma
1446985|NCT00977795|Surgery|surgery
1446986|NCT00977769|cesarean delivery|cesarean delivery
1446987|NCT00977769|blood pressure|blood pressure
1446988|NCT00977769|cardiac output|cardiac output
1446989|NCT00977756|Treatment|treatment
1446990|NCT00977756|Children|children
1446991|NCT00977756|Integrase Inhibitors|integrase inhibitors
1446992|NCT00977756|Entry Inhibitors|entry inhibitors
1446993|NCT00977756|Treatment Experienced|treatment experienced
1446994|NCT00977730|Hepatitis|hepatitis
1446995|NCT00977730|Fatty Liver|fatty liver
1446996|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
1446997|NCT00977730|Protandim|protandim
1446998|NCT00977717|oxaliplatin|oxaliplatin
1446999|NCT00977717|neuropathy|neuropathy
1447000|NCT00977717|SNPs|snps
1447001|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
1447002|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1447003|NCT00977691|Anemia, Sickle Cell|anemia, sickle cell
1447004|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
1447005|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
1447006|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
1447007|NCT00977691|Thalassemia|thalassemia
1447008|NCT00977691|Sickle Cell Disease|sickle cell disease
1447009|NCT00977678|open access gastroscopy|open access gastroscopy
1447010|NCT00977652|fecal incontinence|fecal incontinence
1447011|NCT00977626|Safety|safety
1447012|NCT00977626|Tolerability|tolerability
1447013|NCT00977626|Healthy|healthy
1447014|NCT00977626|Pharmacokinetics|pharmacokinetics
1447015|NCT00977626|Healthy volunteers|healthy volunteers
1447016|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
1447017|NCT00977600|Ammonul|ammonul
1447018|NCT00977600|Sodium phenylacetate|sodium phenylacetate
1447019|NCT00977600|sodium benzoate|sodium benzoate
1447020|NCT00977600|Buphenyl|buphenyl
1586487|NCT00443313|HPV|hpv
1447021|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
1447022|NCT00977600|HPN-100|hpn-100
1447023|NCT00977600|GT4P|gt4p
1447024|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
1447025|NCT00977600|Healthy Volunteers|healthy volunteers
1447026|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
1447027|NCT00977587|faecal serine proteases|faecal serine proteases
1447028|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
1447029|NCT00977561|Extensive stage disease|extensive stage disease
1447030|NCT00977561|SCLC|sclc
1447031|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
1447032|NCT00977548|MDS|mds
1447033|NCT00977548|blood diseases|blood diseases
1447034|NCT00977548|bone marrow|bone marrow
1447035|NCT00977548|hematopoietic|hematopoietic
1447036|NCT00977548|leukemia|leukemia
1447037|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
1447038|NCT00977509|genes|genes
1447039|NCT00977509|mutation|mutation
1447040|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
1447041|NCT00977509|cancer cells|cancer cells
1447042|NCT00977496|hemodialysis|hemodialysis
1447043|NCT00977496|microbiota|microbiota
1447044|NCT00977496|Staphylococcus aureus|staphylococcus aureus
1447045|NCT00977470|NSCLC|nsclc
1447046|NCT00977470|HCQ|hcq
1447047|NCT00977470|erlotinib|erlotinib
1447048|NCT00977470|Tarceva|tarceva
1447049|NCT00977457|stage I prostate cancer|stage i prostate cancer
1447050|NCT00977457|stage II prostate cancer|stage ii prostate cancer
1447051|NCT00977457|stage III prostate cancer|stage iii prostate cancer
1447052|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
1447053|NCT00977444|knee|knee
1447054|NCT00977444|osteoarthritis|osteoarthritis
1447055|NCT00977418|Healthy Aging|healthy aging
1447056|NCT00977418|Exercise|exercise
1447057|NCT00977418|Cognition|cognition
1447058|NCT00977418|Cognitive Training|cognitive training
1447059|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
1447060|NCT00977405|Wound infection|wound infection
1447061|NCT00977405|Gentamicin|gentamicin
1447062|NCT00977405|Contaminated wounds|contaminated wounds
1447063|NCT00977392|human papilloma virus infection|human papilloma virus infection
1447064|NCT00977392|health status unknown|health status unknown
1447065|NCT00977353|Major depressive disorder|major depressive disorder
1447066|NCT00977353|Depression|depression
1447067|NCT00977353|Sarcosine|sarcosine
1447068|NCT00977353|N-methylglycine|n-methylglycine
1447069|NCT00977353|NMDA|nmda
1447070|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
1447071|NCT00977340|nightmares|nightmares
1447072|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
1447073|NCT00977340|sleep disturbance|sleep disturbance
1447074|NCT00977340|treatment of nightmares|treatment of nightmares
1447075|NCT00977340|confrontation|confrontation
1447076|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
1447078|NCT00977327|Intraoperative MR|intraoperative mr
1447079|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
1447080|NCT00977327|resection|resection
1447081|NCT00977327|Intraoperative navigation|intraoperative navigation
1447082|NCT00977327|Extent of resection|extent of resection
1447083|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
1447084|NCT00977301|HIV infection|hiv infection
1447085|NCT00977301|interaction|interaction
1447086|NCT00977301|pharmacokinetics|pharmacokinetics
1447087|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
1447088|NCT00977275|Partial breast irradiation|partial breast irradiation
1447089|NCT00977275|interstitial implant|interstitial implant
1447090|NCT00977262|fatty acids|fatty acids
1447091|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
1447092|NCT00977262|inflammation|inflammation
1447093|NCT00977262|nutrigenomics|nutrigenomics
1447094|NCT00977249|long term nicotine gum use|long term nicotine gum use
1447095|NCT00977249|varenicline|varenicline
1447096|NCT00977249|adverse effects|adverse effects
1447097|NCT00977236|children|children
1447098|NCT00977236|corneal reshaping|corneal reshaping
1447099|NCT00977236|myopia|myopia
1447100|NCT00977236|myopia control|myopia control
1447101|NCT00977236|orthokeratology|orthokeratology
1447102|NCT00977223|Aldosterone|aldosterone
1447103|NCT00977223|Substance P|substance p
1447104|NCT00977223|Cortisol|cortisol
1447105|NCT00977223|Aprepitant|aprepitant
1447106|NCT00977223|Adrenal glands|adrenal glands
1447107|NCT00977210|Phase 1|phase 1
1447108|NCT00977210|oxi4503|oxi4503
1447109|NCT00977210|oxigene|oxigene
1447110|NCT00977210|cruk|cruk
1447111|NCT00977210|solid tumors|solid tumors
1447112|NCT00977210|VDA|vda
1447113|NCT00977210|vascular disrupting agent|vascular disrupting agent
1447114|NCT00977184|Parkinson's Disease|parkinson's disease
1447115|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1447116|NCT00977184|Treatment Study|treatment study
1447117|NCT00977184|PD|pd
1447118|NCT00977184|Parkinson Disease|parkinson disease
1447119|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
1447120|NCT00977171|CFS|cfs
1447121|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
1447122|NCT00977171|NMH|nmh
1447123|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
1447124|NCT00977171|NOH|noh
1447125|NCT00977171|orthostatic hypotension|orthostatic hypotension
1447126|NCT00977171|droxidopa|droxidopa
1447127|NCT00977158|Cystic Fibrosis|cystic fibrosis
1447128|NCT00977158|Microbiota|microbiota
1447129|NCT00977158|upper respiratory tract|upper respiratory tract
1447130|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
1447131|NCT00977158|Staphylococcus aureus|staphylococcus aureus
1447132|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
1447133|NCT00977158|Burkholderia cepacia|burkholderia cepacia
1447134|NCT00977158|Haemophilus influenzae|haemophilus influenzae
1447135|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
1447136|NCT00977145|melanoma|melanoma
1447137|NCT00977145|peptide vaccine|peptide vaccine
1447138|NCT00977145|interferon gamma|interferon gamma
1447139|NCT00977145|immunotherapy|immunotherapy
1447140|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
1447141|NCT00977132|Valproic acid|valproic acid
1447142|NCT00977132|Lenalidomide|lenalidomide
1447143|NCT00977119|breast cancer|breast cancer
1447144|NCT00977119|capecitabine|capecitabine
1447145|NCT00977093|Coronary artery disease|coronary artery disease
1447146|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1447147|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
1447148|NCT00977093|invasive coronary angiography|invasive coronary angiography
1447149|NCT00977080|Zemplar|zemplar
1447150|NCT00977080|paricalcitol|paricalcitol
1447151|NCT00977080|IMPACT SHPT|impact shpt
1447152|NCT00977080|Hemodialysis|hemodialysis
1447153|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
1447154|NCT00977067|GDC0152|gdc0152
1447155|NCT00977067|IAP|iap
1447156|NCT00977067|IAP Antagonist|iap antagonist
1447157|NCT00977054|Hepatitis C|hepatitis c
1447158|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
1447159|NCT00977054|Ribavirin|ribavirin
1447160|NCT00977054|Plasmapheresis|plasmapheresis
1447161|NCT00977054|Genotype 1|genotype 1
1447162|NCT00977041|Neurofeedback|neurofeedback
1447163|NCT00977028|Tumescent|tumescent
1447164|NCT00977028|Local Anesthesia|local anesthesia
1447165|NCT00977028|Lidocaine|lidocaine
1447166|NCT00977028|Dosage Maximum|dosage maximum
1447167|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
1447168|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
1447169|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
1447170|NCT00977002|noninvasive ventilation|noninvasive ventilation
1447171|NCT00977002|extubation|extubation
1447172|NCT00977002|Respiratory failure|respiratory failure
1447173|NCT00977002|reintubation|reintubation
1447174|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
1447175|NCT00976963|UTI|uti
1447176|NCT00976924|blood glucose|blood glucose
1447559|NCT00975403|exercise|exercise
1447177|NCT00976898|proton beam radiation|proton beam radiation
1447178|NCT00976872|omega 3|omega 3
1447179|NCT00976872|inflammation|inflammation
1447180|NCT00976872|augmentation index|augmentation index
1447181|NCT00976872|endothelial function|endothelial function
1447182|NCT00976859|childhood sexual abuse|childhood sexual abuse
1447183|NCT00976859|CSA|csa
1447184|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
1447185|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
1447186|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
1447187|NCT00976859|feeling of being contaminated|feeling of being contaminated
1447188|NCT00976859|sexual assault|sexual assault
1447189|NCT00976859|disgust, shame|disgust, shame
1447190|NCT00976846|hemodialysis|hemodialysis
1447191|NCT00976846|on line|on line
1447192|NCT00976846|postdilution|postdilution
1447193|NCT00976846|high-flux dialyzer|high-flux dialyzer
1447194|NCT00976846|hemodiafiltration|hemodiafiltration
1447195|NCT00976833|Acute Respiratory Failure|acute respiratory failure
1447196|NCT00976833|Early ICU Mobility|early icu mobility
1447197|NCT00976833|Early Physical Therapy|early physical therapy
1447198|NCT00976833|Critical Care|critical care
1447199|NCT00976833|Intensive Care|intensive care
1447200|NCT00976833|ICU|icu
1447201|NCT00976820|influenza infection|influenza infection
1447202|NCT00976820|Influenza Vaccines|influenza vaccines
1447203|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
1447204|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
1447205|NCT00976807|critical care|critical care
1447206|NCT00976807|intensive care|intensive care
1447207|NCT00976807|weakness|weakness
1447208|NCT00976807|myopathy|myopathy
1447209|NCT00976807|paresis|paresis
1447210|NCT00976807|rehabilitation|rehabilitation
1447211|NCT00976794|BD I|bd i
1447212|NCT00976768|Advanced gastric cancer|advanced gastric cancer
1447213|NCT00976768|FOLFIRI|folfiri
1447214|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1586826|NCT00442806|AMI|ami
1447215|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1447216|NCT00976755|stage III prostate cancer|stage iii prostate cancer
1447217|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
1447218|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
1447219|NCT00976742|body composition|body composition
1447220|NCT00976742|glucose tolerance|glucose tolerance
1447221|NCT00976742|inflammation markers|inflammation markers
1447222|NCT00976742|insulin sensitivity|insulin sensitivity
1447223|NCT00976742|coagulation markers|coagulation markers
1447224|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
1447225|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
1447226|NCT00976729|Spiegelmer|spiegelmer
1447227|NCT00976716|posttraumatic pain|posttraumatic pain
1447228|NCT00976703|cervical foley catheter|cervical foley catheter
1447229|NCT00976690|Crohn's Disease|crohn's disease
1447230|NCT00976690|Ileocolic resection|ileocolic resection
1447231|NCT00976690|Endoscopic recurrence|endoscopic recurrence
1447232|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
1447233|NCT00976651|infertility|infertility
1447234|NCT00976651|ICSI|icsi
1447235|NCT00976651|hCG|hcg
1447236|NCT00976651|infertility treatment|infertility treatment
1447237|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
1447238|NCT00976638|Hospital acquired infections|hospital acquired infections
1447239|NCT00976638|Colonization|colonization
1447240|NCT00976638|Bacteremia|bacteremia
1447241|NCT00976638|MRSA|mrsa
1447242|NCT00976638|VRE|vre
1447243|NCT00976638|ESBL|esbl
1447244|NCT00976638|Intensive Care|intensive care
1447245|NCT00976638|ICU|icu
1447246|NCT00976625|diastolic function|diastolic function
1447247|NCT00976625|aortic regurgitation|aortic regurgitation
1447248|NCT00976625|aortic valve replacement|aortic valve replacement
1447249|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
1447250|NCT00976625|myocardial structure|myocardial structure
1447251|NCT00976625|LV remodeling|lv remodeling
1447252|NCT00976625|Muscular regression|muscular regression
1447253|NCT00976625|LV fibrous tissue|lv fibrous tissue
1447254|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1447255|NCT00976612|pharmacokinetics|pharmacokinetics
1447256|NCT00976612|nilotinib|nilotinib
1447257|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
1447849|NCT00974402|Therapy|therapy
1447258|NCT00976586|recombination|recombination
1447259|NCT00976586|IKBKG|ikbkg
1447260|NCT00976586|IKBKGP|ikbkgp
1447261|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
1447262|NCT00976573|recurrent melanoma|recurrent melanoma
1447263|NCT00976560|Lack of interest and energy|lack of interest and energy
1447264|NCT00976560|Psychomotor retardation|psychomotor retardation
1447265|NCT00976560|Cytokines|cytokines
1447266|NCT00976560|Major Depressive disorder|major depressive disorder
1447267|NCT00976547|tinnitus|tinnitus
1447268|NCT00976547|depression|depression
1447269|NCT00976547|audiometry|audiometry
1447270|NCT00976547|measurement|measurement
1447271|NCT00976534|Analgesic effect|analgesic effect
1448480|NCT00972101|Etoposide|etoposide
1447272|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
1447273|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
1447274|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
1447275|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
1447276|NCT00976482|Cardiovascular|cardiovascular
1447277|NCT00976482|Pacemaker|pacemaker
1447278|NCT00976482|Mortality|mortality
1447279|NCT00976482|Physiologic pacing|physiologic pacing
1447280|NCT00976456|lung cancer|lung cancer
1447281|NCT00976456|NSCLC|nsclc
1447282|NCT00976456|elderly|elderly
1447283|NCT00976456|non-squamous|non-squamous
1447284|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
1447285|NCT00976456|first line therapy|first line therapy
1447286|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
1447287|NCT00976443|Obesity|obesity
1447288|NCT00976443|Gastric Emptying|gastric emptying
1447289|NCT00976443|Satiation|satiation
1447290|NCT00976443|Endosonography|endosonography
1447291|NCT00976443|Endoscopy|endoscopy
1447292|NCT00976443|Feeding Behavior|feeding behavior
1447293|NCT00976430|Autologous Stem Cells.|autologous stem cells.
1447294|NCT00976404|HIV-1 infection|hiv-1 infection
1447295|NCT00976404|Treatment intensification|treatment intensification
1447296|NCT00976404|Immunomodulation|immunomodulation
1447297|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
1447298|NCT00976391|open-label|open-label
1447299|NCT00976391|albiglutide|albiglutide
1447300|NCT00976391|insulin glargine|insulin glargine
1447301|NCT00976391|preprandial insulin|preprandial insulin
1447302|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
1447303|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
1447304|NCT00976378|Spiegelmer|spiegelmer
1447305|NCT00976365|Breast Cancer|breast cancer
1447306|NCT00976352|Gene Therapy|gene therapy
1447307|NCT00976352|Pompe Disease|pompe disease
1447308|NCT00976352|Glycogen Storage Disease|glycogen storage disease
1447309|NCT00976339|Breast cancer|breast cancer
1447310|NCT00976339|Vitamin D|vitamin d
1447311|NCT00976339|Premenopausal|premenopausal
1447312|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
1447313|NCT00976313|urinary micturition|urinary micturition
1447314|NCT00976313|thoracotomy|thoracotomy
1447315|NCT00976300|SLE|sle
1447316|NCT00976300|lupus nephritis|lupus nephritis
1447317|NCT00976300|cyclosporine A|cyclosporine a
1447318|NCT00976300|cyclophosphamide|cyclophosphamide
1447319|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
1447320|NCT00976287|Stem cells|stem cells
1447321|NCT00976287|Liver cirrhosis|liver cirrhosis
1447322|NCT00976287|Radiology|radiology
1447323|NCT00976287|Interventional|interventional
1447324|NCT00976287|Transplantation|transplantation
1447325|NCT00976274|Korean red ginseng|korean red ginseng
1447326|NCT00976274|metabolic syndrome|metabolic syndrome
1447327|NCT00976274|blood pressure|blood pressure
1447328|NCT00976274|arterial stiffness|arterial stiffness
1447329|NCT00976274|inflammation|inflammation
1447330|NCT00976274|oxidative stress|oxidative stress
1447331|NCT00976261|type 2 diabetes|type 2 diabetes
1447332|NCT00976261|single dose|single dose
1447333|NCT00976261|3-O-methylglucose|3-o-methylglucose
1447334|NCT00976261|healthy volunteer|healthy volunteer
1447335|NCT00976261|repeat dose|repeat dose
1447336|NCT00976248|everolimus|everolimus
1447337|NCT00976248|RAD001|rad001
1447338|NCT00976248|WM|wm
1447339|NCT00976235|Macular Degeneration|macular degeneration
1447340|NCT00976235|Visual Impairment|visual impairment
1447341|NCT00976235|Quality of Life|quality of life
1447342|NCT00976235|Telescope Prosthesis|telescope prosthesis
1447343|NCT00976196|Aspirin|aspirin
1447344|NCT00976196|Blood platelets|blood platelets
1447345|NCT00976196|proteomics|proteomics
1447346|NCT00976196|Platelet reactivity|platelet reactivity
1447347|NCT00976183|ovarian cancer|ovarian cancer
1447348|NCT00976183|gynecologic oncology|gynecologic oncology
1447349|NCT00976183|vorinostat|vorinostat
1447350|NCT00976183|treatment|treatment
1447351|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
1447352|NCT00976157|STREM-1|strem-1
1447353|NCT00976157|BAL|bal
1447354|NCT00976157|VAP|vap
1447355|NCT00976144|safety|safety
1447356|NCT00976144|LAMA|lama
1447357|NCT00976144|pharmacodynamics|pharmacodynamics
1447358|NCT00976144|tolerability|tolerability
1447359|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
1447360|NCT00976144|anticholinergic,|anticholinergic,
1447361|NCT00976144|beta-2 agonist|beta-2 agonist
1447362|NCT00976144|healthy Japanese subjects|healthy japanese subjects
1447363|NCT00976144|LABA|laba
1447364|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1447365|NCT00976144|pharmacokinetics|pharmacokinetics
1447366|NCT00976131|Breast Cancer|breast cancer
1447367|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
1447368|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
1447370|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
1447371|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
1447372|NCT00976105|Pharmacokinetics|pharmacokinetics
1447373|NCT00976105|Pharmacodynamics|pharmacodynamics
1447374|NCT00976105|Safety and tolerability|safety and tolerability
1447375|NCT00976105|Repeat dose|repeat dose
1447376|NCT00976105|Personality traits|personality traits
1447377|NCT00976105|Fat mass|fat mass
1447378|NCT00976105|Healthy volunteers|healthy volunteers
1447379|NCT00976092|myocardial infarction|myocardial infarction
1447380|NCT00976092|clopidogrel|clopidogrel
1447381|NCT00976092|prasugrel|prasugrel
1447382|NCT00976092|bivalirudin|bivalirudin
1447383|NCT00976092|primary PCI|primary pci
1447384|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
1447385|NCT00976079|Osteoarthritis|osteoarthritis
1447386|NCT00976066|Obesity|obesity
1447387|NCT00976066|Naltrexone|naltrexone
1447388|NCT00976066|Carfentanil|carfentanil
1447389|NCT00976066|Receptor Occupancy|receptor occupancy
1447390|NCT00976066|mu-opioid Receptor|mu-opioid receptor
1447391|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
1447392|NCT00976066|BOLD-fMRI|bold-fmri
1447393|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
1447394|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
1447395|NCT00976053|Positron emission tomography|positron emission tomography
1447396|NCT00976040|HIV-1|hiv-1
1447397|NCT00976040|Africa|africa
1447398|NCT00976040|Botswana|botswana
1447399|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
1447400|NCT00976040|treatment naive|treatment naive
1447401|NCT00976027|Influenza|influenza
1447402|NCT00976027|Respiratory Tract Infections|respiratory tract infections
1447403|NCT00976027|Influenza-like illness|influenza-like illness
1447404|NCT00976027|Elderly|elderly
1447405|NCT00976027|Fluzone®|fluzone®
1447406|NCT00976027|Efficacy|efficacy
1447407|NCT00976001|Follow-up after stroke|follow-up after stroke
1447408|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
1447409|NCT00975988|TYKERB® tablets|tykerb® tablets
1447410|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1447411|NCT00975975|severe aplastic anemia|severe aplastic anemia
1447412|NCT00975975|Mantle cell|mantle cell
1447413|NCT00975962|Stroke|stroke
1447414|NCT00975962|Neuroprotection|neuroprotection
1447415|NCT00975962|remote preconditioning|remote preconditioning
1447416|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
1447417|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
1447418|NCT00975949|fungal colonization|fungal colonization
1447419|NCT00975949|fungal infection|fungal infection
1447420|NCT00975949|preterm infants|preterm infants
1447421|NCT00975949|long term outcomes|long term outcomes
1447422|NCT00975949|quality of life|quality of life
1447423|NCT00975936|Microdose|microdose
1447424|NCT00975936|Drug-Drug Interaction|drug-drug interaction
1447425|NCT00975936|Ketoconazole|ketoconazole
1447426|NCT00975936|Phase 0|phase 0
1447427|NCT00975923|Quality Improvement|quality improvement
1447428|NCT00975923|Critical Care|critical care
1447429|NCT00975923|Collaboratives|collaboratives
1447430|NCT00975923|Patient Safety|patient safety
1447431|NCT00975923|Tool Kit|tool kit
1447432|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
1447433|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
1447434|NCT00975897|recurrent colon cancer|recurrent colon cancer
1447435|NCT00975897|stage III colon cancer|stage iii colon cancer
1447436|NCT00975897|stage IV colon cancer|stage iv colon cancer
1447437|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1447438|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
1447439|NCT00975897|stage III rectal cancer|stage iii rectal cancer
1447440|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
1447441|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1447442|NCT00975884|influenza infection|influenza infection
1447443|NCT00975884|Influenza vaccine|influenza vaccine
1447444|NCT00975871|Livedo vasculitis|livedo vasculitis
1447445|NCT00975871|Genetic pleomorphism|genetic pleomorphism
1447446|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
1447448|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
1447449|NCT00975845|Torn tendon|torn tendon
1447450|NCT00975845|ACL Repair|acl repair
1447451|NCT00975845|ACL reconstruction|acl reconstruction
1447543|NCT00975429|Genital neoplasm, male|genital neoplasm, male
1447452|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
1447453|NCT00975793|Sepsis|sepsis
1447454|NCT00975793|Severe sepsis|severe sepsis
1447455|NCT00975793|Septic shock|septic shock
1447456|NCT00975780|Pneumonia|pneumonia
1447457|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
1447458|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
1447459|NCT00975754|Inhalation|inhalation
1447460|NCT00975754|lung deposition|lung deposition
1447461|NCT00975741|Asthma|asthma
1447462|NCT00975741|Mometasone furoate|mometasone furoate
1448579|NCT00971672|Infants|infants
1447463|NCT00975741|Inhalation devices|inhalation devices
1447464|NCT00975741|Forced expiratory volume|forced expiratory volume
1447465|NCT00975728|Anti-oxidant|anti-oxidant
1447466|NCT00975728|Açai|açai
1447467|NCT00975728|Food supplement|food supplement
1447468|NCT00975728|Sun protection|sun protection
1447469|NCT00975728|Skin erythema prevention|skin erythema prevention
1447470|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
1447471|NCT00975728|Anti-age efficacy|anti-age efficacy
1447472|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
1447473|NCT00975715|Seizures|seizures
1447474|NCT00975715|oxcarbazepine|oxcarbazepine
1447475|NCT00975715|child|child
1447476|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
1447477|NCT00975702|deceased organ donors|deceased organ donors
1447478|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
1447479|NCT00975702|Delayed graft function|delayed graft function
1447480|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
1447481|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
1447482|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
1447483|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
1447484|NCT00975689|Biomarkers|biomarkers
1447485|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
1447486|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
1447487|NCT00975689|Neurodegeneration|neurodegeneration
1447488|NCT00975689|NPC|npc
1447489|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1447490|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1447491|NCT00975676|stage IA breast cancer|stage ia breast cancer
1447492|NCT00975676|stage IB breast cancer|stage ib breast cancer
1447493|NCT00975676|stage II breast cancer|stage ii breast cancer
1447494|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
1447495|NCT00975663|Lung transplantation|lung transplantation
1447496|NCT00975663|heart-lung transplantation|heart-lung transplantation
1447497|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
1447498|NCT00975663|tacrolimus|tacrolimus
1447499|NCT00975663|mycophenolate|mycophenolate
1447500|NCT00975663|immunosuppressant|immunosuppressant
1447501|NCT00975663|pharmacokinetics|pharmacokinetics
1447502|NCT00975650|Primary Hypogonadism|primary hypogonadism
1447503|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
1447504|NCT00975611|schizophrenia|schizophrenia
1447505|NCT00975611|schizoaffective disorder|schizoaffective disorder
1447506|NCT00975611|paliperidone ER|paliperidone er
1447507|NCT00975611|risperidone Consta|risperidone consta
1447508|NCT00975611|prolactin|prolactin
1447509|NCT00975611|hyperprolactinemia|hyperprolactinemia
1447510|NCT00975572|Flu|flu
1447511|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
1447512|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
1447513|NCT00975572|Immunogenictiy|immunogenictiy
1447514|NCT00975572|Safety|safety
1447515|NCT00975546|fertility|fertility
1447516|NCT00975546|HIV discordant|hiv discordant
1447517|NCT00975546|HIV|hiv
1447518|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
1447519|NCT00975546|HIV seronegativity|hiv seronegativity
1447520|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
1447521|NCT00975533|obesity|obesity
1447522|NCT00975520|Neurotropic|neurotropic
1447523|NCT00975520|Melanoma|melanoma
1447524|NCT00975520|Observation|observation
1447525|NCT00975520|Radiation Therapy|radiation therapy
1447526|NCT00975520|Relapse|relapse
1447527|NCT00975494|pde5-inhibition|pde5-inhibition
1447528|NCT00975494|sildenafil|sildenafil
1447529|NCT00975494|LV diastolic function|lv diastolic function
1447530|NCT00975494|heart failure patients|heart failure patients
1447531|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
1447532|NCT00975468|pressure-controlled|pressure-controlled
1447533|NCT00975468|volume-controlled|volume-controlled
1447534|NCT00975468|one lung|one lung
1447535|NCT00975468|ventilation|ventilation
1447536|NCT00975468|lung injury|lung injury
1447537|NCT00975468|thoracotomy|thoracotomy
1447538|NCT00975442|Elbow|elbow
1447539|NCT00975442|Tendinitis|tendinitis
1447540|NCT00975442|Sports Medicine|sports medicine
1447541|NCT00975442|Athletic injuries|athletic injuries
1447542|NCT00975429|Prostatic Disease|prostatic disease
1447848|NCT00974402|Suicide|suicide
1447544|NCT00975429|Urogenital neoplasm|urogenital neoplasm
1447545|NCT00975429|Genital disease,male|genital disease,male
1447546|NCT00975429|Male urogenital disease|male urogenital disease
1447547|NCT00975429|Neoplasms|neoplasms
1447548|NCT00975429|Neoplasm by site|neoplasm by site
1447549|NCT00975429|Prostatic neoplasm|prostatic neoplasm
1447550|NCT00975429|Carcinoma|carcinoma
1447551|NCT00975416|Drug Dependence|drug dependence
1447552|NCT00975416|Cognitive Behavior|cognitive behavior
1447553|NCT00975416|Oxytocin|oxytocin
1447554|NCT00975416|Cocaine|cocaine
1447555|NCT00975416|Heroin|heroin
1447556|NCT00975416|fMRI|fmri
1447557|NCT00975403|mild COPD|mild copd
1447558|NCT00975403|dyspnea|dyspnea
1447560|NCT00975403|respiratory mechanics|respiratory mechanics
1447561|NCT00975403|COPD|copd
1447562|NCT00975390|Glycogen|glycogen
1447563|NCT00975390|Carbohydrate|carbohydrate
1447564|NCT00975390|Protein|protein
1447565|NCT00975390|Caffeine|caffeine
1447566|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
1447567|NCT00975390|Sports nutrition|sports nutrition
1447568|NCT00975377|hair removal|hair removal
1447569|NCT00975377|hair clipping|hair clipping
1447570|NCT00975377|surgical site infection|surgical site infection
1447571|NCT00975377|incisional infection|incisional infection
1447572|NCT00975377|wound infection|wound infection
1447573|NCT00975364|Folate|folate
1447574|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
1447575|NCT00975364|Speciation|speciation
1447576|NCT00975364|Nutrient status|nutrient status
1447577|NCT00975364|Bioavailability|bioavailability
1447578|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
1447579|NCT00975351|folates|folates
1447580|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
1447581|NCT00975351|pharmacokinetics|pharmacokinetics
1447582|NCT00975351|bioavailability|bioavailability
1447583|NCT00975351|biotransformation|biotransformation
1447584|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
1447585|NCT00975325|Bioequivalency|bioequivalency
1447586|NCT00975312|lentigo|lentigo
1447587|NCT00975312|hydroquinone|hydroquinone
1447588|NCT00975312|tretinoin|tretinoin
1447589|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
1447590|NCT00975299|Neoplasm|neoplasm
1447591|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
1447592|NCT00975299|PET tracer|pet tracer
1447593|NCT00975273|Asthma|asthma
1447594|NCT00975273|Dyspnea|dyspnea
1447595|NCT00975273|Paroxysmal|paroxysmal
1447596|NCT00975273|Pulmonary|pulmonary
1447597|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
1447598|NCT00975273|Airway inflammation|airway inflammation
1447599|NCT00975273|Airway obstruction|airway obstruction
1447600|NCT00975273|Wheezing|wheezing
1447601|NCT00975247|Quality Improvement|quality improvement
1447602|NCT00975247|Colonoscopy|colonoscopy
1447603|NCT00975247|Screening|screening
1447604|NCT00975247|Colon Cancer|colon cancer
1447605|NCT00975247|Polyp detection rates|polyp detection rates
1447606|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
1447607|NCT00975247|Scope Withdrawal time|scope withdrawal time
1447608|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
1447609|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
1447610|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
1447611|NCT00975221|Parathyroidectomy|parathyroidectomy
1447612|NCT00975221|Hypercalcemia|hypercalcemia
1447613|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
1447614|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
1447615|NCT00975182|PI3K|pi3k
1447616|NCT00975182|NSCLC|nsclc
1447617|NCT00975182|Tarceva|tarceva
1447618|NCT00975143|isotretinoin|isotretinoin
1447619|NCT00975143|dermatology|dermatology
1447620|NCT00975143|skin|skin
1447621|NCT00975117|Dietary supplement|dietary supplement
1447622|NCT00975117|male infertility|male infertility
1447623|NCT00975117|spermatogenesis|spermatogenesis
1447624|NCT00975104|Aging|aging
1447625|NCT00975104|Frailty|frailty
1447626|NCT00975104|Sedentary|sedentary
1447627|NCT00975104|Immobilization|immobilization
1447628|NCT00975104|Atrophy|atrophy
1447629|NCT00975104|Muscle Wasting|muscle wasting
1447630|NCT00975104|Physical Activity|physical activity
1447631|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
1447632|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
1447633|NCT00975078|Population at Risk|population at risk
1447634|NCT00975065|Galvus|galvus
1447635|NCT00975039|Inoperable|inoperable
1447636|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
1447637|NCT00975039|Non-resectable|non-resectable
1447638|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
1447639|NCT00975039|Carcinoma|carcinoma
1447640|NCT00975026|Massage|massage
1447641|NCT00975026|Chair Massage|chair massage
1447642|NCT00975026|Pain|pain
1447643|NCT00975026|Discomfort|discomfort
1447644|NCT00975026|Stretching|stretching
1447645|NCT00975026|Stretching Exercises|stretching exercises
1447646|NCT00975026|Sonographer|sonographer
1447647|NCT00975026|Cardiac Sonographer|cardiac sonographer
1447648|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
1447649|NCT00975013|Morbid Obesity|morbid obesity
1447650|NCT00975013|Bone Mineral Density|bone mineral density
1447651|NCT00975000|Intervention|intervention
1447652|NCT00975000|Cinacalcet|cinacalcet
1447653|NCT00975000|Sensipar|sensipar
1447655|NCT00975000|hyperparathyroidism|hyperparathyroidism
1447656|NCT00975000|calcium|calcium
1447657|NCT00975000|osteodystrophy|osteodystrophy
1447658|NCT00975000|hypercalcemia|hypercalcemia
1447659|NCT00975000|renal|renal
1447660|NCT00975000|transplant|transplant
1447661|NCT00975000|acute rejection|acute rejection
1447662|NCT00975000|kidney transplant failure|kidney transplant failure
1447663|NCT00975000|hypophosphatemia|hypophosphatemia
1447664|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
1447665|NCT00974987|adult glioblastoma|adult glioblastoma
1447666|NCT00974987|adult gliosarcoma|adult gliosarcoma
1447667|NCT00974974|Parkinson's Disease|parkinson's disease
1447668|NCT00974961|Levobupivacaine|levobupivacaine
1447669|NCT00974961|HRV|hrv
1447670|NCT00974961|Spinal Anesthesia|spinal anesthesia
1447671|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
1447672|NCT00974948|Pancreatic cancer|pancreatic cancer
1447673|NCT00974948|Therapy|therapy
1447674|NCT00974948|Neurolysis|neurolysis
1447675|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
1447676|NCT00974922|Vitamin D|vitamin d
1447677|NCT00974922|Hypertension|hypertension
1447678|NCT00974909|Fecal incontinence|fecal incontinence
1447679|NCT00974896|Advanced Solid Tumors|advanced solid tumors
1447680|NCT00974896|AMG 479|amg 479
1447681|NCT00974896|Amgen|amgen
1447682|NCT00974896|Oncology|oncology
1447683|NCT00974896|Phase 1b|phase 1b
1447684|NCT00974883|ultrasound|ultrasound
1447685|NCT00974883|GCA|gca
1447686|NCT00974883|temporal arteritis|temporal arteritis
1447687|NCT00974883|biopsy|biopsy
1447688|NCT00974857|Hemodialysis|hemodialysis
1447689|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
1447690|NCT00974857|Body Composition Monitor|body composition monitor
1447691|NCT00974844|posterior assisted levitation|posterior assisted levitation
1447692|NCT00974844|Pars Plana|pars plana
1447693|NCT00974844|Dropped nucleus|dropped nucleus
1447694|NCT00974844|cataract|cataract
1447695|NCT00974844|complication of|complication of
1447696|NCT00974844|surgery|surgery
1447697|NCT00974818|Bladder|bladder
1447698|NCT00974818|Mitomycin C|mitomycin c
1447699|NCT00974818|MMC|mmc
1447700|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
1447701|NCT00974818|BCG|bcg
1447702|NCT00974818|intravesical|intravesical
1447703|NCT00974818|09-118|09-118
1447704|NCT00974805|COPD|copd
1447705|NCT00974805|Emphysema|emphysema
1447706|NCT00974805|Bronchitis|bronchitis
1447707|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1447708|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1447709|NCT00974779|kidney failure chronic|kidney failure chronic
1447710|NCT00974779|renal dialysis|renal dialysis
1447711|NCT00974779|inflammation|inflammation
1447712|NCT00974779|monocytes|monocytes
1447713|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
1447714|NCT00974766|bronchial asthma|bronchial asthma
1447715|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
1447716|NCT00974753|epiretinal membrane|epiretinal membrane
1447717|NCT00974740|type 1 diabetes|type 1 diabetes
1447718|NCT00974727|Childhood overweight|childhood overweight
1447719|NCT00974727|Gardening|gardening
1447720|NCT00974727|Summer weight gain|summer weight gain
1447721|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
1447722|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
1447723|NCT00974688|Congenital|congenital
1447724|NCT00974688|physical activity participation|physical activity participation
1447725|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
1447726|NCT00974675|Asthma|asthma
1447727|NCT00974675|CAT-354|cat-354
1447728|NCT00974675|Tralokinumab|tralokinumab
1447729|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
1447730|NCT00974662|Lung Cancer|lung cancer
1447731|NCT00974662|NSCLC|nsclc
1447732|NCT00974649|drop-out|drop-out
1447733|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
1447734|NCT00974649|IVF/ICSI|ivf/icsi
1447735|NCT00974649|infertility|infertility
1447736|NCT00974649|counseling|counseling
1447737|NCT00974649|psychology|psychology
1447738|NCT00974649|Assisted Reproduction|assisted reproduction
1447739|NCT00974649|Counselling|counselling
1447740|NCT00974636|Kidney Disease|kidney disease
1447741|NCT00974636|Albuminuria|albuminuria
1447742|NCT00974636|Glomerular filtration rate|glomerular filtration rate
1447743|NCT00974636|Volume status|volume status
1447744|NCT00974636|Bioimpedance analysis|bioimpedance analysis
1447745|NCT00974623|Bone growth substitute|bone growth substitute
1447746|NCT00974623|Autograft|autograft
1447747|NCT00974623|Allograft|allograft
1447748|NCT00974623|Spine fusion|spine fusion
1447749|NCT00974610|stage IV melanoma|stage iv melanoma
1447750|NCT00974610|recurrent melanoma|recurrent melanoma
1447751|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1447752|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1447753|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1447754|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
1447755|NCT00974610|stage IV breast cancer|stage iv breast cancer
1447756|NCT00974610|recurrent breast cancer|recurrent breast cancer
1447757|NCT00974610|male breast cancer|male breast cancer
1447758|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
1447759|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
1447760|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
1447761|NCT00974610|stage IV colon cancer|stage iv colon cancer
1447762|NCT00974610|recurrent colon cancer|recurrent colon cancer
1447763|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
1447764|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
1447765|NCT00974597|burn|burn
1447766|NCT00974597|donor site|donor site
1447767|NCT00974597|treatment of burns|treatment of burns
1447768|NCT00974597|Treatment of Donor Sites|treatment of donor sites
1447769|NCT00974584|NSCLC|nsclc
1447770|NCT00974584|PI3K|pi3k
1447771|NCT00974584|Avastin|avastin
1447772|NCT00974558|dyspnea|dyspnea
1447774|NCT00974532|balance|balance
1447775|NCT00974532|chronic kidney disease|chronic kidney disease
1447776|NCT00974532|calcium|calcium
1447777|NCT00974532|phosphorus|phosphorus
1447778|NCT00974519|ADIS|adis
1447779|NCT00974519|complementary therapies|complementary therapies
1447780|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
1447781|NCT00974493|oral|oral
1447782|NCT00974493|intravenous|intravenous
1447783|NCT00974493|antibiotics|antibiotics
1447784|NCT00974493|bone|bone
1447785|NCT00974493|joint|joint
1447786|NCT00974493|infection|infection
1447787|NCT00974480|Skin|skin
1447788|NCT00974480|Aging|aging
1447789|NCT00974480|Rejuva-a|rejuva-a
1447790|NCT00974480|Redermic|redermic
1447791|NCT00974454|AIDS|aids
1447792|NCT00974454|complementary therapies|complementary therapies
1447793|NCT00974454|treatment experienced|treatment experienced
1447794|NCT00974441|Bioequivalence|bioequivalence
1447795|NCT00974428|Osteoarthritis|osteoarthritis
1447796|NCT00974428|Disease of joints|disease of joints
1447797|NCT00974428|Wobenzym® N|wobenzym® n
1447798|NCT00974428|WOMAC pain score|womac pain score
1447799|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
1447800|NCT00974415|BMI classification-overweight|bmi classification-overweight
1447801|NCT00974402|Active duty|active duty
1447802|NCT00974402|Afghanistan|afghanistan
1447803|NCT00974402|Anger|anger
1447804|NCT00974402|Anxiety|anxiety
1447805|NCT00974402|Avoidance|avoidance
1447806|NCT00974402|BAMC|bamc
1447807|NCT00974402|Brooke Army Medical Center|brooke army medical center
1447808|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
1447809|NCT00974402|Combat|combat
1447810|NCT00974402|Combat Disorder|combat disorder
1447811|NCT00974402|Coping|coping
1447812|NCT00974402|Counseling|counseling
1447813|NCT00974402|Counselor|counselor
1447814|NCT00974402|Deployment|deployment
1447815|NCT00974402|Depression|depression
1447816|NCT00974402|Exposure|exposure
1447817|NCT00974402|Fear|fear
1447818|NCT00974402|Feeling alone|feeling alone
1447819|NCT00974402|Flashbacks|flashbacks
1447820|NCT00974402|Guard|guard
1447821|NCT00974402|Guilt|guilt
1447822|NCT00974402|Hospitalization|hospitalization
1447823|NCT00974402|Iraq|iraq
1447824|NCT00974402|Mental Health|mental health
1447825|NCT00974402|Military|military
1447826|NCT00974402|Military member|military member
1447827|NCT00974402|Military personnel|military personnel
1447828|NCT00974402|Neuroses|neuroses
1447829|NCT00974402|Nightmares|nightmares
1447830|NCT00974402|OEF|oef
1447831|NCT00974402|OIF|oif
1447832|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
1447833|NCT00974402|Psychiatric|psychiatric
1447834|NCT00974402|Psychiatric medication|psychiatric medication
1447835|NCT00974402|Psychological distress|psychological distress
1447836|NCT00974402|Psychotherapy|psychotherapy
1447837|NCT00974402|Reserve|reserve
1447838|NCT00974402|Retired|retired
1447839|NCT00974402|Sadness|sadness
1447840|NCT00974402|Separated|separated
1447841|NCT00974402|Sleeplessness|sleeplessness
1447842|NCT00974402|Soldier|soldier
1447843|NCT00974402|Stress|stress
1447844|NCT00974402|Stress disorder|stress disorder
1447845|NCT00974402|Stress management|stress management
1447846|NCT00974402|STRONG STAR|strong star
1447847|NCT00974402|Suicidal|suicidal
1447850|NCT00974402|Trauma|trauma
1447851|NCT00974402|Traumatic Event|traumatic event
1447852|NCT00974402|Trouble Sleeping|trouble sleeping
1447853|NCT00974402|Veteran|veteran
1447854|NCT00974402|Veterans|veterans
1447855|NCT00974402|War|war
1447856|NCT00974402|WHMC|whmc
1447857|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
1447858|NCT00974402|PTSD|ptsd
1447859|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
1447860|NCT00974389|stage III colon cancer|stage iii colon cancer
1447861|NCT00974389|stage III rectal cancer|stage iii rectal cancer
1447862|NCT00974389|stage IV colon cancer|stage iv colon cancer
1447863|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
1447864|NCT00974389|recurrent colon cancer|recurrent colon cancer
1447865|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
1447866|NCT00974376|Cannabis Treatment|cannabis treatment
1447867|NCT00974376|Cannabis Use|cannabis use
1447868|NCT00974376|Cannabis Dependence|cannabis dependence
1447869|NCT00974376|Executive Functioning|executive functioning
1447870|NCT00974376|Cognitive Deficits|cognitive deficits
1447871|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
1447872|NCT00974350|Post-operative pain|post-operative pain
1447873|NCT00974350|hernia surgery|hernia surgery
1447874|NCT00974350|opioid|opioid
1447875|NCT00974337|Adrenal insufficiency|adrenal insufficiency
1447876|NCT00974337|cortisol|cortisol
1447877|NCT00974337|preterm|preterm
1447878|NCT00974337|shock|shock
1447879|NCT00974337|neonate|neonate
1447880|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
1447881|NCT00974324|chemotherapy|chemotherapy
1447882|NCT00974324|anti-angiogeneses|anti-angiogeneses
1447883|NCT00974311|Prostate Cancer|prostate cancer
1447884|NCT00974311|Castration-resistant|castration-resistant
1447885|NCT00974285|AIDS|aids
1447886|NCT00974285|complementary therapies|complementary therapies
1447887|NCT00974259|Hypoxia|hypoxia
1447888|NCT00974259|Ischemia|ischemia
1447889|NCT00974259|Intracranial hypertension|intracranial hypertension
1447890|NCT00974259|Neurocritical care|neurocritical care
1447891|NCT00974246|COPD|copd
1447892|NCT00974246|Depression|depression
1447893|NCT00974246|Nursing Home|nursing home
1447894|NCT00974233|CLL|cll
1447895|NCT00974233|SLL|sll
1447896|NCT00974220|inhaled fentanyl|inhaled fentanyl
1447897|NCT00974220|dyspnea|dyspnea
1447898|NCT00974220|exercise|exercise
1447899|NCT00974220|COPD|copd
1447900|NCT00974194|Cholecystolithiasis|cholecystolithiasis
1447901|NCT00974194|Cholecystectomy|cholecystectomy
1447902|NCT00974194|Laparoscopic surgery|laparoscopic surgery
1447903|NCT00974194|Single port|single port
1447904|NCT00974168|pain|pain
1447905|NCT00974168|radiation toxicity|radiation toxicity
1447906|NCT00974168|spinal cord compression|spinal cord compression
1447907|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1447908|NCT00974155|Major|major
1447909|NCT00974155|Depression|depression
1447910|NCT00974155|Disorder|disorder
1447911|NCT00974142|COPD|copd
1447912|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1447913|NCT00974142|Cyclosporine|cyclosporine
1447914|NCT00974142|Oral Immunotherapy|oral immunotherapy
1447915|NCT00974142|Advanced stage|advanced stage
1447916|NCT00974103|low back pain|low back pain
1447917|NCT00974103|pelvic pain|pelvic pain
1447918|NCT00974103|pelvic girdle pain|pelvic girdle pain
1447919|NCT00974103|post partum|post partum
1447920|NCT00974090|insulin resistance|insulin resistance
1447921|NCT00974077|recurrent depression,|recurrent depression,
1447922|NCT00974077|mindfulness training|mindfulness training
1447923|NCT00974077|attention|attention
1447924|NCT00974077|Evoked EEG potentials|evoked eeg potentials
1447925|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
1447926|NCT00974064|COPD|copd
1447927|NCT00974064|Lung disease|lung disease
1447928|NCT00974064|Chronic bronchitis|chronic bronchitis
1447929|NCT00974064|Emphysema|emphysema
1447930|NCT00974064|Smoking|smoking
1447931|NCT00974064|Smoking cessation|smoking cessation
1447932|NCT00974064|Quit smoking|quit smoking
1447933|NCT00974064|Healthy smoker|healthy smoker
1447934|NCT00974064|Smoker|smoker
1447935|NCT00974064|Non-smoker|non-smoker
1447936|NCT00974051|Children|children
1447937|NCT00974051|Exercise|exercise
1447938|NCT00974051|Hypoglycemia|hypoglycemia
1447939|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
1447940|NCT00974012|Bioequivalence|bioequivalence
1447941|NCT00973999|Botulinum Toxin|botulinum toxin
1447942|NCT00973999|Saliva|saliva
1447943|NCT00973999|Tracheostomy tube|tracheostomy tube
1447944|NCT00973986|atorvastatin|atorvastatin
1447945|NCT00973986|genetic polymorphisms|genetic polymorphisms
1447946|NCT00973986|coronary heart disease|coronary heart disease
1447947|NCT00973986|pharmacokinetics|pharmacokinetics
1447948|NCT00973986|CYP3A|cyp3a
1447949|NCT00973973|Pelvic Pain|pelvic pain
1447950|NCT00973973|NBI-56418|nbi-56418
1447951|NCT00973973|Endometriosis|endometriosis
1447952|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1447953|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1447954|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1447955|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1447956|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1447957|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1447958|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1447959|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1447960|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1447961|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1447962|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1447963|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1447964|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1447965|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1447966|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1447967|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1447968|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1447969|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1447970|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1447971|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1447972|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1447973|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1447974|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1447975|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1447976|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1447977|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1447978|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1447979|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1447980|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1447981|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1447982|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1447983|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1447984|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1447985|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1447986|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1447987|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1447988|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1447989|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1447990|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1447991|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1447992|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1447993|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1447994|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1447995|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1447996|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1447997|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1447998|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1447999|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1448000|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1448001|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1448002|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1448003|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1448004|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1448005|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1448006|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1448007|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1448008|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1448009|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1448010|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1448011|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1448012|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1448187|NCT00973362|APTIMA HPV Assay|aptima hpv assay
1448684|NCT00971165|treatment|treatment
1448013|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1448124|NCT00973609|drug holiday|drug holiday
1448014|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1448015|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1448016|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1448017|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1448018|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
1448019|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
1448020|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
1448021|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
1448022|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1448023|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1448024|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1448025|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1448026|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1448027|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1448028|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1448029|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1448030|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1448031|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1448032|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1448033|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1448034|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1448035|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1448036|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1448037|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1448038|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1448039|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
1448040|NCT00973921|Stent|stent
1448041|NCT00973921|under-expansion|under-expansion
1448042|NCT00973921|StentOp|stentop
1448043|NCT00973921|StentOptimizer|stentoptimizer
1448044|NCT00973921|IVUS|ivus
1448045|NCT00973921|IC-PRO|ic-pro
1448046|NCT00973921|image enhancement|image enhancement
1448047|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
1448048|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
1448049|NCT00973895|Influenza|influenza
1448050|NCT00973895|Healthy|healthy
1448051|NCT00973895|Immunity|immunity
1448052|NCT00973895|Preventive|preventive
1448053|NCT00973895|Pandemic|pandemic
1448054|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
1448055|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
1448056|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
1448057|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
1448058|NCT00973869|colon cancer|colon cancer
1448059|NCT00973869|rectal cancer|rectal cancer
1448060|NCT00973830|Changes in HbA1c|changes in hba1c
1448061|NCT00973817|Hepatitis|hepatitis
1448062|NCT00973817|AOCH|aoch
1448063|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
1448064|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
1448065|NCT00973804|Targeted Immune Depletion|targeted immune depletion
1448066|NCT00973804|Leukemia|leukemia
1448067|NCT00973804|Lymphoma|lymphoma
1448068|NCT00973804|Multiple Myeloma|multiple myeloma
1448069|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1448070|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
1448071|NCT00973791|Spinal anesthesia|spinal anesthesia
1448072|NCT00973791|Fluid therapy|fluid therapy
1448073|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1448074|NCT00973778|Capecitabine|capecitabine
1448075|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
1448076|NCT00973765|abcess|abcess
1448077|NCT00973765|MRSA|mrsa
1448078|NCT00973765|cellulitis|cellulitis
1448079|NCT00973765|antibiotics|antibiotics
1448080|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
1448081|NCT00973752|ALL|all
1448082|NCT00973739|NF-2|nf-2
1448083|NCT00973739|NF-2 related tumors|nf-2 related tumors
1448084|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
1448085|NCT00973739|schwannomas|schwannomas
1448188|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
1448086|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
1448087|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
1448088|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
1448089|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
1448090|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
1448091|NCT00973739|NF2 related gliomas|nf2 related gliomas
1448092|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
1448093|NCT00973700|Swine Flu|swine flu
1448094|NCT00973700|Flu|flu
1448095|NCT00973700|Vaccine|vaccine
1448096|NCT00973700|Adjuvant|adjuvant
1448097|NCT00973687|pediatric|pediatric
1448098|NCT00973687|dexamethasone|dexamethasone
1448099|NCT00973687|management|management
1448100|NCT00973687|corticosteroids|corticosteroids
1448101|NCT00973687|asthma|asthma
1448102|NCT00973661|Overweight|overweight
1448103|NCT00973661|Diagnosis|diagnosis
1448104|NCT00973661|Counseling|counseling
1448105|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
1448106|NCT00973648|Tinnitus|tinnitus
1448107|NCT00973648|Ringing in ears|ringing in ears
1448108|NCT00973648|Functional connectivity MRI|functional connectivity mri
1448109|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
1448110|NCT00973635|education|education
1448111|NCT00973635|web-based intervention|web-based intervention
1448112|NCT00973635|patient care|patient care
1448113|NCT00973622|Tobacco cessation|tobacco cessation
1448114|NCT00973622|Tobacco dependence|tobacco dependence
1448115|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1448116|NCT00973622|Nicotine Dependence|nicotine dependence
1448117|NCT00973622|Delayed Discounting|delayed discounting
1448118|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
1448119|NCT00973609|Bevacizumab|bevacizumab
1448120|NCT00973609|Avastin®|avastin®
1448121|NCT00973609|phase 3|phase 3
1448122|NCT00973609|maintenance treatment|maintenance treatment
1448123|NCT00973609|treatment pause|treatment pause
1448125|NCT00973609|stage IV|stage iv
1448126|NCT00973583|vitamin D|vitamin d
1448127|NCT00973583|infection|infection
1448128|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
1448129|NCT00973570|tobacco cessation|tobacco cessation
1448130|NCT00973570|evaluation|evaluation
1448131|NCT00973570|epidémiology|epidémiology
1448132|NCT00973570|adolescent|adolescent
1448133|NCT00973570|apprentices|apprentices
1448134|NCT00973557|bevacizumab|bevacizumab
1448135|NCT00973544|breast reconstruction complications|breast reconstruction complications
1448137|NCT00973544|silicone implant|silicone implant
1448138|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
1448139|NCT00973531|Sleep Apnea|sleep apnea
1448140|NCT00973531|Hypertension|hypertension
1448141|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
1448142|NCT00973518|Alzheimer's Disease|alzheimer's disease
1448143|NCT00973518|AD|ad
1448144|NCT00973518|Healthy Control|healthy control
1448145|NCT00973505|Breast neoplasms|breast neoplasms
1448146|NCT00973505|Aromatase inhibitors|aromatase inhibitors
1448147|NCT00973505|Genetic polymorphisms|genetic polymorphisms
1448148|NCT00973505|Arthralgia|arthralgia
1448149|NCT00973505|Arthritis|arthritis
1448150|NCT00973492|type 1 diabetes|type 1 diabetes
1448151|NCT00973492|functional insulinotherapy|functional insulinotherapy
1448152|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
1448153|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
1448154|NCT00973479|Golimumab|golimumab
1448155|NCT00973479|CNTO148|cnto148
1448156|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
1448157|NCT00973479|Methotrexate|methotrexate
1448158|NCT00973479|Intravenous|intravenous
1448159|NCT00973466|HIV-infection|hiv-infection
1448160|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
1448161|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
1448162|NCT00973466|Herpes simplex virus|herpes simplex virus
1448163|NCT00973466|prevalence|prevalence
1448164|NCT00973453|non-seasonal allergy|non-seasonal allergy
1448165|NCT00973453|house dust mite|house dust mite
1448166|NCT00973453|immunotherapy|immunotherapy
1448167|NCT00973453|dose tolerability|dose tolerability
1448168|NCT00973440|geriatric assessment|geriatric assessment
1448169|NCT00973427|NSCLC|nsclc
1448170|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
1448171|NCT00973414|Fluid therapy|fluid therapy
1448172|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
1448173|NCT00973388|VX-950-C136|vx-950-c136
1448175|NCT00973388|HEPATITIS|hepatitis
1448176|NCT00973388|Telaprevir|telaprevir
1448177|NCT00973388|Moxifloxacin|moxifloxacin
1448178|NCT00973388|ECG|ecg
1448179|NCT00973388|QT|qt
1448180|NCT00973388|QTc|qtc
1448181|NCT00973375|Drug-eluting stent|drug-eluting stent
1448182|NCT00973375|coronary restenosis|coronary restenosis
1448183|NCT00973375|coronary thrombosis|coronary thrombosis
1448184|NCT00973362|Cervix Cancer|cervix cancer
1448185|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1448186|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
1448189|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
1448190|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
1448191|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
1448192|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
1448193|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
1448194|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
1448195|NCT00973362|Relative Risk|relative risk
1448196|NCT00973349|Swine Flu|swine flu
1448197|NCT00973349|Flu|flu
1448198|NCT00973349|Vaccine|vaccine
1448199|NCT00973349|Adults|adults
1448200|NCT00973349|Elderly|elderly
1448201|NCT00973349|Non-Elderly|non-elderly
1448202|NCT00973349|Adjuvant|adjuvant
1448203|NCT00973336|postoperative follow-up|postoperative follow-up
1448204|NCT00973323|BAY59-7939|bay59-7939
1448205|NCT00973323|Rivaroxaban|rivaroxaban
1448206|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1448207|NCT00973323|Japanese Patients|japanese patients
1448208|NCT00973323|Phase II|phase ii
1448209|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
1448210|NCT00973310|Radiation therapy|radiation therapy
1448211|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
1448212|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1448213|NCT00973297|Falls|falls
1448214|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
1448215|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
1448216|NCT00973245|BAY59-7939|bay59-7939
1448217|NCT00973245|Rivaroxaban|rivaroxaban
1448218|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1448219|NCT00973245|Japanese Patients|japanese patients
1448220|NCT00973245|Phase II|phase ii
1448221|NCT00973232|Tramadol|tramadol
1448222|NCT00973232|Acetaminophen|acetaminophen
1448223|NCT00973232|combination|combination
1448224|NCT00973232|pharmacokinetics|pharmacokinetics
1448225|NCT00973232|bioavailability|bioavailability
1448226|NCT00973232|Zaldiar|zaldiar
1448227|NCT00973232|Ultracet|ultracet
1448228|NCT00973232|fed|fed
1448229|NCT00973232|fasted|fasted
1448230|NCT00973232|single-dose|single-dose
1448231|NCT00973232|multiple-dose|multiple-dose
1448232|NCT00973232|healthy|healthy
1448233|NCT00973232|volunteers|volunteers
1448234|NCT00973232|Healthy volunteers|healthy volunteers
1448235|NCT00973219|HBsAg loss|hbsag loss
1448236|NCT00973219|HBsAg seroconversion|hbsag seroconversion
1448237|NCT00973219|chronic hepatitis B|chronic hepatitis b
1448238|NCT00973219|low viral load|low viral load
1448239|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
1448240|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
1448241|NCT00973206|mortality community study|mortality community study
1448242|NCT00973193|rectum|rectum
1448243|NCT00973193|colorectal|colorectal
1448244|NCT00973193|cancer|cancer
1448245|NCT00973193|adenocarcinoma|adenocarcinoma
1448246|NCT00973193|anti-EGFR|anti-egfr
1448247|NCT00973193|monoclonal antibodies|monoclonal antibodies
1448248|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
1448249|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
1448250|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
1448251|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
1448252|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
1448253|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
1448254|NCT00973167|Fracture rate|fracture rate
1448255|NCT00973167|Fracture risks|fracture risks
1448256|NCT00973154|Pneumonia|pneumonia
1448257|NCT00973154|Corticosteroids|corticosteroids
1448258|NCT00973154|clinical stability|clinical stability
1448259|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
1448260|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
1448261|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
1448262|NCT00973141|JNJ-42160443|jnj-42160443
1448263|NCT00973089|Primary tooth|primary tooth
1448264|NCT00973089|Caries, Dental|caries, dental
1448265|NCT00973089|Alternative treatment|alternative treatment
1448266|NCT00973076|Phase I, cancer|phase i, cancer
1448267|NCT00973076|solid tumors|solid tumors
1448268|NCT00973076|advanced solid malignancies|advanced solid malignancies
1448269|NCT00973076|dose escalation|dose escalation
1448270|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
1448271|NCT00973076|Japanese|japanese
1448272|NCT00973063|bacteremia|bacteremia
1448273|NCT00973063|blood culture|blood culture
1448274|NCT00973063|contamination|contamination
1448275|NCT00973050|Bioequivalence|bioequivalence
1448276|NCT00973037|Breast neoplasms|breast neoplasms
1448277|NCT00973037|Tamoxifen|tamoxifen
1448278|NCT00973037|Genotype|genotype
1448279|NCT00973037|CYP2D6|cyp2d6
1448280|NCT00973024|JNJ-42160443|jnj-42160443
1448281|NCT00973024|Low back pain-related pain|low back pain-related pain
1448382|NCT00972582|adults|adults
1448282|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
1448284|NCT00972998|anal sphincter pressure|anal sphincter pressure
1448285|NCT00972998|phenyephrine|phenyephrine
1448286|NCT00972985|Healthy Control subjects|healthy control subjects
1448287|NCT00972972|fruit polyphenols|fruit polyphenols
1448288|NCT00972972|phytochemicals|phytochemicals
1448289|NCT00972972|neurocognition|neurocognition
1448290|NCT00972972|neuropsychology|neuropsychology
1448291|NCT00972972|psychopharmacology|psychopharmacology
1448292|NCT00972972|gene expression|gene expression
1448293|NCT00972972|biochemistry|biochemistry
1448294|NCT00972959|multiple myeloma|multiple myeloma
1448295|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
1448296|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
1448297|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
1448298|NCT00972959|Dexamethasone|dexamethasone
1448299|NCT00972959|bone mineral density|bone mineral density
1448300|NCT00972959|bone pain|bone pain
1448301|NCT00972959|bone metabolism|bone metabolism
1448302|NCT00972959|osteolytic lesions|osteolytic lesions
1448303|NCT00972959|DEXA-scans|dexa-scans
1448304|NCT00972959|X-ray radiography|x-ray radiography
1448305|NCT00972946|MRI|mri
1448306|NCT00972946|SPIO|spio
1448307|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
1448308|NCT00972933|Biomarker Analysis|biomarker analysis
1448309|NCT00972933|experimental|experimental
1448310|NCT00972920|Transversus abdominis plane|transversus abdominis plane
1448311|NCT00972920|Acute pain service|acute pain service
1448312|NCT00972920|Ultrasound|ultrasound
1448313|NCT00972907|anal fissure|anal fissure
1448314|NCT00972907|pain|pain
1448315|NCT00972907|nifedipine|nifedipine
1448316|NCT00972894|Group B streptococcus|group b streptococcus
1448317|NCT00972894|Polymerase chain reaction|polymerase chain reaction
1448318|NCT00972894|PCR|pcr
1448319|NCT00972894|Intrapartum screening|intrapartum screening
1448320|NCT00972894|Risk factors|risk factors
1448321|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
1448322|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1448323|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
1448324|NCT00972868|Unidirectional mask|unidirectional mask
1448325|NCT00972868|NPPV|nppv
1448326|NCT00972868|COPD|copd
1448327|NCT00972868|respiratory physiology|respiratory physiology
1448328|NCT00972855|Bioequivalence|bioequivalence
1448329|NCT00972842|PTCL|ptcl
1448330|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
1448331|NCT00972842|Vorinostat|vorinostat
1448332|NCT00972842|Lenalidomid|lenalidomid
1448333|NCT00972829|Hypercholesterolemia|hypercholesterolemia
1448334|NCT00972816|Swine Flu|swine flu
1448335|NCT00972816|Flu|flu
1448336|NCT00972816|Vaccine|vaccine
1448337|NCT00972816|Children|children
1448338|NCT00972816|Adjuvant|adjuvant
1448339|NCT00972803|gingivitis|gingivitis
1448340|NCT00972803|dental plaque|dental plaque
1448341|NCT00972803|mouthrinse|mouthrinse
1448342|NCT00972790|brain tumor|brain tumor
1448343|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
1448344|NCT00972790|arteriovenous malformation|arteriovenous malformation
1448345|NCT00972790|epileptic focus|epileptic focus
1448346|NCT00972790|supratentorial|supratentorial
1448347|NCT00972764|Laryngomalacia|laryngomalacia
1448348|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
1448349|NCT00972751|stage II rectal cancer|stage ii rectal cancer
1448350|NCT00972751|stage III rectal cancer|stage iii rectal cancer
1448351|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1448352|NCT00972725|Chloroquine|chloroquine
1448353|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
1448354|NCT00972712|Multiple Myeloma|multiple myeloma
1448355|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
1448356|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1448357|NCT00972699|Tuberculosis|tuberculosis
1448358|NCT00972699|Women|women
1448359|NCT00972699|Pregnancy|pregnancy
1448360|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
1448361|NCT00972699|South Africa|south africa
1448362|NCT00972699|Low Birth Weight|low birth weight
1448363|NCT00972686|solid tumors|solid tumors
1448364|NCT00972686|lymphoma|lymphoma
1448365|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
1448366|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
1448367|NCT00972660|Efficacy|efficacy
1448368|NCT00972660|Safety|safety
1448369|NCT00972647|fracture|fracture
1448370|NCT00972647|fixation|fixation
1448371|NCT00972647|fluoroscopy|fluoroscopy
1448372|NCT00972647|laser|laser
1448373|NCT00972647|radiation|radiation
1448374|NCT00972634|depression|depression
1448375|NCT00972634|cachexia|cachexia
1448376|NCT00972634|pain|pain
1448377|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1448378|NCT00972608|congenital heart disease|congenital heart disease
1448379|NCT00972608|surgical planning|surgical planning
1448380|NCT00972582|leucine intake|leucine intake
1448381|NCT00972582|tolerable upper limit|tolerable upper limit
1448383|NCT00972582|amino acid supplements|amino acid supplements
1448384|NCT00972582|Excessive Leucine Intake|excessive leucine intake
1448385|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
1448386|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
1448387|NCT00972556|Formocresol|formocresol
1448388|NCT00972556|pulpotomy|pulpotomy
1448389|NCT00972556|primary molar|primary molar
1448390|NCT00972556|treatment outcome|treatment outcome
1448391|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
1448392|NCT00972543|palms and/or soles|palms and/or soles
1448393|NCT00972543|with or without pustules|with or without pustules
1448394|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
1448395|NCT00972530|treatment|treatment
1448396|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1448397|NCT00972517|influenza infection|influenza infection
1448398|NCT00972504|Proof of concept|proof of concept
1448399|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
1448400|NCT00972452|Type II Diabetes|type ii diabetes
1448401|NCT00972452|Insulin Resistance|insulin resistance
1448402|NCT00972452|Exercise|exercise
1448403|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
1448404|NCT00972439|Oral Contraceptives|oral contraceptives
1448405|NCT00972439|Breast Tissue|breast tissue
1448406|NCT00972413|breast cancer|breast cancer
1448407|NCT00972413|cone beam computed tomography|cone beam computed tomography
1448408|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1448410|NCT00972400|cancer survivor|cancer survivor
1448411|NCT00972400|breast cancer|breast cancer
1448412|NCT00972387|carbohydrate-protein|carbohydrate-protein
1448413|NCT00972387|endurance exercise|endurance exercise
1448414|NCT00972387|supplement|supplement
1448415|NCT00972361|Adenoidectomy|adenoidectomy
1448416|NCT00972361|Tonsillectomy|tonsillectomy
1448417|NCT00972361|Ventilation Tubes|ventilation tubes
1448418|NCT00972361|Preoperational screening|preoperational screening
1448419|NCT00972361|Coagulation Profile|coagulation profile
1448420|NCT00972361|Lupus anticoagulant|lupus anticoagulant
1448421|NCT00972348|HIV|hiv
1448422|NCT00972348|Personal Health Record|personal health record
1448423|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
1448424|NCT00972348|Medication Reconciliation|medication reconciliation
1448425|NCT00972335|Avastin|avastin
1448426|NCT00972335|RAD001|rad001
1448427|NCT00972335|Meningioma|meningioma
1448428|NCT00972335|Bevacizumab|bevacizumab
1448429|NCT00972335|Everolimus|everolimus
1448430|NCT00972335|Brain|brain
1448431|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
1448432|NCT00972309|Prostate Cancer|prostate cancer
1448433|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
1448434|NCT00972309|PSADT|psadt
1448435|NCT00972309|HLA-A*0201|hla-a*0201
1448436|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
1448437|NCT00972270|Heart Diseases|heart diseases
1448438|NCT00972270|Myocardial Ischemia|myocardial ischemia
1448439|NCT00972270|Vascular Disease|vascular disease
1448440|NCT00972270|Arteriosclerosis|arteriosclerosis
1448441|NCT00972270|Ischemia|ischemia
1448442|NCT00972257|24-hour IOP control|24-hour iop control
1448443|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
1448444|NCT00972257|brimonidine/timolol|brimonidine/timolol
1448445|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
1448446|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
1448447|NCT00972244|Japanese|japanese
1448448|NCT00972244|phase 2|phase 2
1448449|NCT00972244|efficacy|efficacy
1448450|NCT00972244|safety|safety
1448451|NCT00972244|dapagliflozin|dapagliflozin
1448452|NCT00972231|Thalassemia Major|thalassemia major
1448453|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
1448454|NCT00972231|Sickle Cell Anemia|sickle cell anemia
1448455|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
1448456|NCT00972231|Iron Overload|iron overload
1448457|NCT00972231|Growth Velocity|growth velocity
1448458|NCT00972218|Spondyloarthritis|spondyloarthritis
1448459|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
1448460|NCT00972218|Crohn's disease|crohn's disease
1448461|NCT00972218|adalimumab|adalimumab
1448462|NCT00972218|treatment|treatment
1448463|NCT00972205|Pgp|pgp
1448464|NCT00972205|Solid Tumors|solid tumors
1448465|NCT00972205|Drug Resistance|drug resistance
1448466|NCT00972205|Sestamibi|sestamibi
1448467|NCT00972205|Cancer|cancer
1448468|NCT00972205|Solid Tumor|solid tumor
1448469|NCT00972192|HIV testing|hiv testing
1448470|NCT00972192|HIV risk behavior|hiv risk behavior
1448471|NCT00972192|access to care|access to care
1448472|NCT00972179|healthy volunteers|healthy volunteers
1448473|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
1448474|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
1448475|NCT00972140|Patients with stable COPD|patients with stable copd
1448476|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
1448477|NCT00972101|Leukemia|leukemia
1448478|NCT00972101|Lymphoma|lymphoma
1448479|NCT00972101|Pediatrics|pediatrics
1448481|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
1448482|NCT00972101|Filgrastim|filgrastim
1448483|NCT00972101|Fludarabine|fludarabine
1448484|NCT00972101|Melphalan|melphalan
1448485|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
1448486|NCT00972101|Rituximab|rituximab
1448487|NCT00972101|Tacrolimus|tacrolimus
1448488|NCT00972101|Thiotepa|thiotepa
1448489|NCT00972101|Thymoglobulin|thymoglobulin
1448490|NCT00972101|Total Body Irradiation|total body irradiation
1448491|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
1448492|NCT00972075|totally blind subjects|totally blind subjects
1448493|NCT00972062|Subcutaneous injections|subcutaneous injections
1448494|NCT00972062|Skin abnormalities|skin abnormalities
1448495|NCT00972049|safety|safety
1448496|NCT00972049|tolerability|tolerability
1448497|NCT00972049|AZD2516|azd2516
1448498|NCT00972049|pain|pain
1448499|NCT00972049|Japanese|japanese
1448500|NCT00972036|COLON|colon
1448501|NCT00972036|LIVER|liver
1448502|NCT00972036|RECTUM|rectum
1448503|NCT00972036|SIR-Spheres|sir-spheres
1448504|NCT00972036|09-030|09-030
1448505|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
1448506|NCT00972023|stage I breast cancer|stage i breast cancer
1448507|NCT00972023|stage II breast cancer|stage ii breast cancer
1448508|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
1448509|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
1448510|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
1448511|NCT00972010|Breast|breast
1448512|NCT00972010|Cancer|cancer
1448513|NCT00972010|Lumpectomies|lumpectomies
1448514|NCT00972010|PlasmaBlade|plasmablade
1448515|NCT00972010|Breast conservation therapy|breast conservation therapy
1448516|NCT00971971|Hypotension|hypotension
1448517|NCT00971971|Acute renal failure|acute renal failure
1448518|NCT00971971|acute kidney injury|acute kidney injury
1448519|NCT00971971|dialysis|dialysis
1448520|NCT00971971|ICU|icu
1448521|NCT00971958|HIV prevention|hiv prevention
1448522|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
1448523|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
1448524|NCT00971932|SCCHN|scchn
1448525|NCT00971919|pain|pain
1448526|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
1448527|NCT00971919|breast cancer in situ|breast cancer in situ
1448528|NCT00971919|stage IA breast cancer|stage ia breast cancer
1448529|NCT00971919|stage IB breast cancer|stage ib breast cancer
1448530|NCT00971919|stage II breast cancer|stage ii breast cancer
1448531|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
1448532|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
1448533|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
1448534|NCT00971906|Pandemic influenza|pandemic influenza
1448535|NCT00971906|Vaccine|vaccine
1448536|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
1448537|NCT00971880|Blood transfusions|blood transfusions
1448538|NCT00971880|Adverse events|adverse events
1448539|NCT00971880|Hepatitis C|hepatitis c
1448540|NCT00971880|HIV|hiv
1448541|NCT00971854|Dystonia|dystonia
1448542|NCT00971828|Myositis|myositis
1448543|NCT00971828|polymyositis|polymyositis
1448544|NCT00971828|dermatomyositis|dermatomyositis
1448545|NCT00971815|HPA-axis|hpa-axis
1448546|NCT00971815|fetal programming|fetal programming
1448547|NCT00971789|Sirolimus|sirolimus
1448548|NCT00971789|Cowden Syndrome|cowden syndrome
1448549|NCT00971789|PTEN Mutation|pten mutation
1448550|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
1448551|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
1448552|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1448553|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1448554|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1448555|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1448556|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1448557|NCT00971750|ultrasonography|ultrasonography
1448558|NCT00971750|gallbladder|gallbladder
1448559|NCT00971750|cholelithiasis|cholelithiasis
1448560|NCT00971750|laparoscopic|laparoscopic
1448561|NCT00971750|gastric bypass|gastric bypass
1448562|NCT00971750|obesity|obesity
1448563|NCT00971750|bariatric surgery|bariatric surgery
1448564|NCT00971737|stage IV breast cancer|stage iv breast cancer
1448565|NCT00971737|male breast cancer|male breast cancer
1448566|NCT00971724|Prednisolone|prednisolone
1448567|NCT00971724|Glucocorticoids|glucocorticoids
1448568|NCT00971711|IBS|ibs
1448569|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
1448570|NCT00971711|abdominal pain|abdominal pain
1448571|NCT00971711|urgency|urgency
1448572|NCT00971711|bloating|bloating
1448573|NCT00971711|diarrhea|diarrhea
1448574|NCT00971698|Splenectomy|splenectomy
1448575|NCT00971698|Thrombocytosis|thrombocytosis
1448576|NCT00971698|Infections|infections
1448577|NCT00971698|Spleen|spleen
1448578|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
1448580|NCT00971672|Iron Deficiency|iron deficiency
1448581|NCT00971672|Anemia|anemia
1448582|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
1448583|NCT00971659|type 2 diabetes|type 2 diabetes
1448584|NCT00971646|overactive bladder|overactive bladder
1448585|NCT00971646|self-consciousness|self-consciousness
1448586|NCT00971646|perceptual urge sensation|perceptual urge sensation
1448587|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
1448588|NCT00971620|Skin Pain|skin pain
1448589|NCT00971620|Botox Therapy|botox therapy
1448590|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
1448591|NCT00971620|Renal Cell Cancer|renal cell cancer
1448592|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
1448593|NCT00971607|Acute myocardial infarction|acute myocardial infarction
1448594|NCT00971607|Postconditioning|postconditioning
1448595|NCT00971607|Sevoflurane|sevoflurane
1448596|NCT00971594|weight loss|weight loss
1448597|NCT00971594|glucose metabolism|glucose metabolism
1448598|NCT00971568|Interstitial cystitis|interstitial cystitis
1448599|NCT00971568|Painful bladder syndrome|painful bladder syndrome
1448600|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
1448601|NCT00971555|Late Preterm Infants|late preterm infants
1448602|NCT00971555|Total T4|total t4
1448603|NCT00971555|TSH|tsh
1448604|NCT00971555|Illness severity|illness severity
1448605|NCT00971555|NICU|nicu
1448606|NCT00971542|Pandemic influenza|pandemic influenza
1448607|NCT00971542|Vaccine|vaccine
1448608|NCT00971529|Smoking cessation|smoking cessation
1448609|NCT00971529|tea filter|tea filter
1448610|NCT00971516|diabetes|diabetes
1448611|NCT00971516|implants|implants
1448612|NCT00971516|cytokines|cytokines
1448613|NCT00971503|Diabetes type 1|diabetes type 1
1448614|NCT00971503|Adult Stem cells|adult stem cells
1448615|NCT00971503|Local injection|local injection
1448616|NCT00971503|Catheter delivery|catheter delivery
1448617|NCT00971503|Bone marrow|bone marrow
1448618|NCT00971490|COPD|copd
1448619|NCT00971490|FEV1|fev1
1448620|NCT00971490|beta endorphin|beta endorphin
1448621|NCT00971490|SGRQ|sgrq
1448622|NCT00971490|Acu-TENS|acu-tens
1448623|NCT00971477|Teledermatology|teledermatology
1448624|NCT00971477|Telemedicine|telemedicine
1448625|NCT00971477|Psoriasis|psoriasis
1448626|NCT00971464|AMD|amd
1448627|NCT00971464|EV|ev
1448628|NCT00971464|CCTV|cctv
1448629|NCT00971464|Reading|reading
1448630|NCT00971464|vision|vision
1448631|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
1448632|NCT00971451|ACL|acl
1448633|NCT00971438|appendicitis|appendicitis
1448634|NCT00971438|diagnosis|diagnosis
1448635|NCT00971438|diagnostic imaging|diagnostic imaging
1448636|NCT00971438|clinical scoring system|clinical scoring system
1448637|NCT00971425|influenza infection|influenza infection
1448638|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1448639|NCT00971386|Heart Failure|heart failure
1448640|NCT00971373|antimicrobial|antimicrobial
1448641|NCT00971373|epidemiology|epidemiology
1448642|NCT00971373|bacteriology|bacteriology
1448643|NCT00971373|CFU|cfu
1448644|NCT00971360|conversion|conversion
1448645|NCT00971360|cytokine|cytokine
1448646|NCT00971360|inflammation|inflammation
1448647|NCT00971347|obesity|obesity
1448648|NCT00971347|overweight|overweight
1448649|NCT00971347|weight loss|weight loss
1448650|NCT00971347|randomized controlled trial|randomized controlled trial
1448651|NCT00971347|chewing gum|chewing gum
1448652|NCT00971334|Down Syndrome|down syndrome
1448653|NCT00971334|Aneuploidy|aneuploidy
1448654|NCT00971334|Amniocentesis|amniocentesis
1448655|NCT00971334|CVS|cvs
1448656|NCT00971321|influenza infection|influenza infection
1448657|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1448658|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
1448659|NCT00971295|zebinix|zebinix
1448660|NCT00971295|metformin|metformin
1448661|NCT00971256|Bladder|bladder
1448662|NCT00971256|Cancer|cancer
1448663|NCT00971256|Cytology|cytology
1448664|NCT00971243|Insulin resistance|insulin resistance
1448665|NCT00971230|HIV|hiv
1448666|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
1448667|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
1448668|NCT00971217|Exercise Intervention|exercise intervention
1448669|NCT00971217|Depression|depression
1448670|NCT00971217|Perceived Social Support|perceived social support
1448671|NCT00971217|Physical Self-Concept|physical self-concept
1448672|NCT00971204|atrial fibrillation|atrial fibrillation
1448673|NCT00971204|PAF|paf
1448674|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
1448675|NCT00971178|Analgesia|analgesia
1448676|NCT00971178|Dental pain|dental pain
1448677|NCT00971178|Dexmedetomidine|dexmedetomidine
1448678|NCT00971178|Pain|pain
1448679|NCT00971178|Peripheral effects|peripheral effects
1448680|NCT00971165|Hypertension|hypertension
1448681|NCT00971165|Chlorthalidone|chlorthalidone
1448682|NCT00971165|Amiloride|amiloride
1448683|NCT00971165|Losartan|losartan
1448685|NCT00971152|IVF|ivf
1448686|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
1448687|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
1448688|NCT00971139|Online patient-provider communication|online patient-provider communication
1448689|NCT00971139|Organizational change|organizational change
1448690|NCT00971139|Symptom management|symptom management
1448691|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
1448692|NCT00971100|Pandemic influenza|pandemic influenza
1448693|NCT00971100|Vaccine|vaccine
1448694|NCT00971087|Breast cancer|breast cancer
1448695|NCT00971087|breast cancer screening|breast cancer screening
1448696|NCT00971074|Arthralgia|arthralgia
1448697|NCT00971074|Viscosupplementation|viscosupplementation
1448698|NCT00971074|Knee|knee
1448699|NCT00971074|Menisci, Tibial|menisci, tibial
1448700|NCT00971074|Surgery, Outpatient|surgery, outpatient
1448701|NCT00971061|Ahmed valve|ahmed valve
1448702|NCT00971061|single-plate Molteno implant|single-plate molteno implant
1448703|NCT00971061|refractory glaucoma|refractory glaucoma
1448704|NCT00971061|surgical treatment|surgical treatment
1448705|NCT00971048|pressure ulcers|pressure ulcers
1448706|NCT00971048|PU|pu
1448707|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
1448708|NCT00971048|DFU|dfu
1448709|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
1448710|NCT00971035|MILR1444A|milr1444a
1448711|NCT00971022|Low-income populations|low-income populations
1448712|NCT00971022|Chronic health condition|chronic health condition
1448713|NCT00971022|Prescription medication|prescription medication
1448714|NCT00971022|Prescription drugs|prescription drugs
1448715|NCT00971022|Discount generic prescription programs|discount generic prescription programs
1448716|NCT00971022|Survey|survey
1448717|NCT00971022|Awareness|awareness
1448718|NCT00971022|Focus Group|focus group
1448719|NCT00971022|Houston|houston
1448720|NCT00971009|Symptom management|symptom management
1448721|NCT00971009|Interactive Health Communication Application|interactive health communication application
1448722|NCT00971009|Patient-provider communication|patient-provider communication
1448723|NCT00971009|Health care costs|health care costs
1448724|NCT00970996|Melanoma|melanoma
1448725|NCT00970996|Abraxane|abraxane
1448726|NCT00970996|Nab-paclitaxel|nab-paclitaxel
1448727|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
1448728|NCT00970996|ABI-007|abi-007
1448729|NCT00970996|Cisplatin|cisplatin
1448730|NCT00970996|Platinol-AQ|platinol-aq
1448731|NCT00970996|Platinol|platinol
1448732|NCT00970996|CDDP|cddp
1448733|NCT00970996|Interleukin 2|interleukin 2
1448734|NCT00970996|IL-2|il-2
1448735|NCT00970996|Proleukin|proleukin
1448736|NCT00970996|Intron A|intron a
1448737|NCT00970996|Interferon alpha 2b|interferon alpha 2b
1448738|NCT00970996|Interferon alfa-2b|interferon alfa-2b
1448739|NCT00970996|Temodar|temodar
1448740|NCT00970996|Temozolomide|temozolomide
1448741|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
1448742|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
1448743|NCT00970970|molecular imaging|molecular imaging
1448744|NCT00970970|biomarker|biomarker
1448745|NCT00970957|Macular edema|macular edema
1448746|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
1448747|NCT00970957|Bevacizumab|bevacizumab
1448748|NCT00970944|Traumatic Brain Injury|traumatic brain injury
1448749|NCT00970944|Rehabilitation|rehabilitation
1448750|NCT00970944|Disorders of Consciousness|disorders of consciousness
1448751|NCT00970944|Functional Outcome|functional outcome
1448752|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
1448753|NCT00970931|hypertension|hypertension
1448754|NCT00970931|diuretics|diuretics
1448755|NCT00970918|Cardiovascular disease|cardiovascular disease
1448756|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
1448757|NCT00970905|Radiation|radiation
1448758|NCT00970905|Nausea|nausea
1448759|NCT00970905|Vomiting|vomiting
1448760|NCT00970905|Ondansetron|ondansetron
1448761|NCT00970905|Aprepitant|aprepitant
1448762|NCT00970892|Anticoagulation|anticoagulation
1448763|NCT00970892|warfarin|warfarin
1448764|NCT00970892|VKORC1|vkorc1
1448765|NCT00970892|CYP2C9|cyp2c9
1448865|NCT00970515|Laparoscopy|laparoscopy
1448766|NCT00970892|thromboembolism|thromboembolism
1448767|NCT00970892|pharmacogenetics|pharmacogenetics
1448768|NCT00970879|malaria|malaria
1448769|NCT00970879|pregnancy|pregnancy
1448770|NCT00970879|HIV|hiv
1448771|NCT00970879|prevention|prevention
1448772|NCT00970879|cotrimoxazole|cotrimoxazole
1448773|NCT00970879|mefloquine|mefloquine
1448774|NCT00970866|multiple micronutrients|multiple micronutrients
1448775|NCT00970866|home fortification|home fortification
1448776|NCT00970866|complementary foods|complementary foods
1448777|NCT00970866|infant feeding|infant feeding
1448778|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
1448779|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
1448780|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
1448781|NCT00970840|Acceptability|acceptability
1448782|NCT00970840|Supplements|supplements
1448783|NCT00970840|Home-fortification|home-fortification
1448784|NCT00970827|Coronary artery disease|coronary artery disease
1448785|NCT00970827|PCI|pci
1448786|NCT00970827|Postconditioning|postconditioning
1448787|NCT00970827|Elective or urgent PCI|elective or urgent pci
1448788|NCT00970814|Alcoholism|alcoholism
1448789|NCT00970814|Alcohol Drinking|alcohol drinking
1448790|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
1448791|NCT00970814|Alcohol Abuse|alcohol abuse
1448792|NCT00970801|Atypical mycobacteria|atypical mycobacteria
1448793|NCT00970775|Phase I|phase i
1448794|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
1448795|NCT00970775|AZD2423|azd2423
1448796|NCT00970749|chlamydia|chlamydia
1448797|NCT00970749|healthy women|healthy women
1448798|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
1448799|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
1448800|NCT00970736|Motor cortex|motor cortex
1448801|NCT00970736|Motor control|motor control
1448802|NCT00970736|Neuroplasticity|neuroplasticity
1448803|NCT00970736|Aging|aging
1448804|NCT00970736|Swallowing|swallowing
1448805|NCT00970723|Diabetic retinopathy|diabetic retinopathy
1448806|NCT00970723|Macula edema|macula edema
1448807|NCT00970723|Sleep apnea|sleep apnea
1448808|NCT00970723|High blood pressure|high blood pressure
1448809|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
1448810|NCT00970697|hydrogel|hydrogel
1448811|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
1448812|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1448813|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1448814|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1448815|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
1448816|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1448817|NCT00970684|large cell lung cancer|large cell lung cancer
1448818|NCT00970671|scar|scar
1448819|NCT00970671|laser therapy|laser therapy
1448820|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
1448821|NCT00970658|Plaster|plaster
1448822|NCT00970658|injuries|injuries
1448823|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
1448824|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
1448825|NCT00970645|Non small cell lung cancer|non small cell lung cancer
1448826|NCT00970645|mediastinum|mediastinum
1448827|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
1448828|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
1448829|NCT00970645|mediastinoscopy|mediastinoscopy
1448830|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
1448831|NCT00970645|NSCLC|nsclc
1448832|NCT00970606|ARDS|ards
1448833|NCT00970606|H1N1|h1n1
1448834|NCT00970606|Influenza|influenza
1448835|NCT00970606|Statin|statin
1448836|NCT00970580|BIIB022|biib022
1448837|NCT00970580|Stage IV|stage iv
1448838|NCT00970580|Taxol|taxol
1448839|NCT00970580|Stage IIIB|stage iiib
1448840|NCT00970580|Carboplatin|carboplatin
1448841|NCT00970580|Paclitaxel|paclitaxel
1448842|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
1448843|NCT00970580|Treatment Naive|treatment naive
1448844|NCT00970580|Anti IGF1R|anti igf1r
1448845|NCT00970580|NSCLC|nsclc
1448846|NCT00970580|Open Label|open label
1448847|NCT00970580|IGF1R|igf1r
1448848|NCT00970580|Paraplatin|paraplatin
1448849|NCT00970580|Cytotoxic|cytotoxic
1448850|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
1448851|NCT00970580|Taxane|taxane
1448852|NCT00970580|Alkylating agent|alkylating agent
1448853|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
1448854|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
1448855|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
1448856|NCT00970554|Amblyopia|amblyopia
1448857|NCT00970554|Telescopic magnification|telescopic magnification
1448858|NCT00970554|Patching|patching
1448859|NCT00970541|Cinnamon|cinnamon
1448860|NCT00970541|PCOS|pcos
1448861|NCT00970541|low blood sugar|low blood sugar
1448862|NCT00970541|Insulin|insulin
1448863|NCT00970541|Glucose|glucose
1448864|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
1448866|NCT00970515|Incisional hernia|incisional hernia
1448867|NCT00970515|Umbilical hernia|umbilical hernia
1448868|NCT00970515|Mesh repair|mesh repair
1448869|NCT00970515|Postoperative complications|postoperative complications
1448870|NCT00970502|celecoxib|celecoxib
1448871|NCT00970502|erlotinib|erlotinib
1448872|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
1448873|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
1448874|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
1448875|NCT00970502|reirradiation|reirradiation
1448876|NCT00970489|atrial fibrillation|atrial fibrillation
1448877|NCT00970489|fish oil|fish oil
1448878|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
1448879|NCT00970450|Paracetamol|paracetamol
1448880|NCT00970450|Tropisetron|tropisetron
1448881|NCT00970450|Central analgesic effect|central analgesic effect
1448882|NCT00970450|Area of allodynia|area of allodynia
1448982|NCT00969852|Sertraline|sertraline
1448883|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
1448884|NCT00970398|Infant formula|infant formula
1448885|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
1448886|NCT00970398|growth|growth
1448887|NCT00970398|health|health
1448888|NCT00970398|immune functions|immune functions
1448889|NCT00970372|Coercion|coercion
1448890|NCT00970359|thyroid|thyroid
1448891|NCT00970359|metastases|metastases
1588999|NCT00434837|ACL|acl
1448892|NCT00970359|AZD6244|azd6244
1448893|NCT00970359|09-048|09-048
1448894|NCT00970346|Digestive System Diseases|digestive system diseases
1448895|NCT00970346|Genetic Diseases|genetic diseases
1448896|NCT00970346|Inborn|inborn
1448897|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
1448898|NCT00970346|Cystic Fibrosis|cystic fibrosis
1448899|NCT00970346|Lung Disease|lung disease
1448900|NCT00970346|Pancreatic Diseases|pancreatic diseases
1448901|NCT00970333|Alzheimer disease|alzheimer disease
1448902|NCT00970333|Parkinson disease|parkinson disease
1448903|NCT00970333|Multiple Sclerosis|multiple sclerosis
1448904|NCT00970320|Anal Incontinence|anal incontinence
1448905|NCT00970320|urinary incontinence|urinary incontinence
1448906|NCT00970320|primiparas|primiparas
1448907|NCT00970320|prevalence|prevalence
1448908|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
1448909|NCT00970320|Quality of Life (QoL)|quality of life (qol)
1448910|NCT00970294|diabetes|diabetes
1448911|NCT00970268|COPD|copd
1448912|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1448913|NCT00970268|Chronic Bronchitis|chronic bronchitis
1448914|NCT00970268|Emphysema|emphysema
1448915|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
1448916|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
1448917|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1448918|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1448919|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
1448920|NCT00970255|lingual frenulum|lingual frenulum
1448921|NCT00970255|labial frenulum|labial frenulum
1448922|NCT00970255|frenotomy|frenotomy
1448923|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
1448924|NCT00970203|Vaccine|vaccine
1448925|NCT00970203|Androgen Ablation|androgen ablation
1448926|NCT00970203|PSA Progression|psa progression
1448927|NCT00970190|sinusitis|sinusitis
1448928|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
1448929|NCT00970151|Fetal Inflammation|fetal inflammation
1448930|NCT00970151|Birth Outcome|birth outcome
1448931|NCT00970151|Pregnancy|pregnancy
1448932|NCT00970138|Progress free survival|progress free survival
1448933|NCT00970138|Toxicity|toxicity
1448934|NCT00970138|Response rate|response rate
1448935|NCT00970138|Overall survival|overall survival
1448936|NCT00970138|Quality of live|quality of live
1448937|NCT00970125|advance care planning|advance care planning
1448938|NCT00970125|cancer|cancer
1448939|NCT00970112|pain|pain
1448940|NCT00970112|pain assessment|pain assessment
1448941|NCT00970086|measure of postoperative pain|measure of postoperative pain
1448942|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
1448943|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
1448944|NCT00970073|Kidney|kidney
1448945|NCT00970060|neuropathy|neuropathy
1448946|NCT00970060|diabetes|diabetes
1448947|NCT00970047|pregnant|pregnant
1448948|NCT00970047|fetal sex determination|fetal sex determination
1448949|NCT00970047|gender determination|gender determination
1448950|NCT00970047|noninvasive test|noninvasive test
1448951|NCT00970047|fetal DNA|fetal dna
1448952|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
1448953|NCT00970008|Osteoarthritis|osteoarthritis
1448954|NCT00970008|Knee|knee
1448955|NCT00969995|inflammation|inflammation
1448956|NCT00969995|migraine|migraine
1448957|NCT00969995|headache|headache
1448958|NCT00969982|Pregnancy termination|pregnancy termination
1448959|NCT00969982|abortion|abortion
1448960|NCT00969982|medical abortion|medical abortion
1448961|NCT00969982|2nd trimester|2nd trimester
1448962|NCT00969982|mifepristone|mifepristone
1448963|NCT00969982|misoprostol|misoprostol
1448964|NCT00969969|First MTP Joint|first mtp joint
1448965|NCT00969969|Hallux Rigidus|hallux rigidus
1448966|NCT00969969|Hallux Limitus|hallux limitus
1448967|NCT00969969|Cartilage Replacement|cartilage replacement
1448968|NCT00969969|Osteoarthritis|osteoarthritis
1448969|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
1448970|NCT00969969|Big Toe Pain|big toe pain
1448971|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
1448972|NCT00969943|HPA axis|hpa axis
1448973|NCT00969930|COMT|comt
1448974|NCT00969930|ApoE|apoe
1448975|NCT00969930|BDNF|bdnf
1448976|NCT00969930|executive function|executive function
1448977|NCT00969930|bipolar|bipolar
1448978|NCT00969930|cognition|cognition
1448979|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
1448980|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
1448981|NCT00969865|Atherosclerosis|atherosclerosis
1448983|NCT00969852|PET|pet
1448984|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
1448985|NCT00969852|PK-PD Model|pk-pd model
1448986|NCT00969839|Fracture|fracture
1448987|NCT00969839|Humerus|humerus
1448988|NCT00969839|Intramedullary|intramedullary
1448989|NCT00969839|Fixation|fixation
1448990|NCT00969826|GCPGC|gcpgc
1448991|NCT00969826|Pharmacokinetics|pharmacokinetics
1448992|NCT00969826|Pharmacodynamics|pharmacodynamics
1448993|NCT00969813|Hepatic impairment|hepatic impairment
1448994|NCT00969800|Common cold|common cold
1448995|NCT00969800|Influenza|influenza
1448996|NCT00969800|Pneumonia|pneumonia
1448997|NCT00969774|Face|face
1448998|NCT00969774|Cephalometry|cephalometry
1448999|NCT00969774|Anthropometry|anthropometry
1449000|NCT00969774|Photography|photography
1449001|NCT00969774|Diagnosis|diagnosis
1449002|NCT00969774|Adult|adult
1449003|NCT00969774|Morphology|morphology
1449004|NCT00969774|Comparative Study|comparative study
1449005|NCT00969735|Atrial fibrillation|atrial fibrillation
1449006|NCT00969735|Catheter ablation|catheter ablation
1449007|NCT00969735|Cryoenergy|cryoenergy
1449008|NCT00969735|Implantable loop recorder|implantable loop recorder
1449009|NCT00969735|Pulmonary vein|pulmonary vein
1449010|NCT00969722|Neuroblastoma|neuroblastoma
1449011|NCT00969722|3F8|3f8
1449012|NCT00969722|Primary refractory|primary refractory
1449013|NCT00969709|Depression|depression
1449014|NCT00969709|Major Depressive Disorder|major depressive disorder
1449015|NCT00969696|ability to learn, working memory|ability to learn, working memory
1449016|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
1449017|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
1449018|NCT00969657|response prediction|response prediction
1449019|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
1449020|NCT00969631|clomiphene resistance|clomiphene resistance
1449021|NCT00969631|metformin|metformin
1449022|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
1449023|NCT00969618|ADHD|adhd
1449024|NCT00969605|weaning|weaning
1449025|NCT00969605|adaptive support ventilation|adaptive support ventilation
1449026|NCT00969605|COPD|copd
1449027|NCT00969592|diabetes|diabetes
1449028|NCT00969579|Cancer|cancer
1449029|NCT00969579|Psychosocial Stress|psychosocial stress
1449030|NCT00969579|Parenting|parenting
1449031|NCT00969566|Diabetes|diabetes
1449032|NCT00969566|Sitagliptin|sitagliptin
1449033|NCT00969566|C-peptide|c-peptide
1449034|NCT00969566|Glucagon|glucagon
1449035|NCT00969540|Back Pain|back pain
1449036|NCT00969540|Sleep|sleep
1449037|NCT00969527|Oncoxin|oncoxin
1449038|NCT00969527|Viusid|viusid
1449039|NCT00969527|dietary supplements|dietary supplements
1449040|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
1449041|NCT00969514|Robotic cystectomy|robotic cystectomy
1449042|NCT00969514|Bladder|bladder
1449043|NCT00969488|matern diet|matern diet
1449044|NCT00969488|obese|obese
1449045|NCT00969488|postpartum|postpartum
1449046|NCT00969488|body weight change|body weight change
1449047|NCT00969488|Women with overweight|women with overweight
1449048|NCT00969475|scar revision|scar revision
1449049|NCT00969475|intraoperative|intraoperative
1449050|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
1449051|NCT00969462|Doxorubicin|doxorubicin
1449052|NCT00969462|pharmacokinetics|pharmacokinetics
1449053|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1449054|NCT00969462|response|response
1449055|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
1449056|NCT00969462|myelosuppression degree|myelosuppression degree
1449057|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
1449058|NCT00969449|Naproxen Sodium|naproxen sodium
1449059|NCT00969436|Mumps|mumps
1449060|NCT00969436|Immunogenicity|immunogenicity
1449061|NCT00969436|Vaccines|vaccines
1449062|NCT00969436|Safety|safety
1449063|NCT00969436|Rubella|rubella
1449064|NCT00969436|Combined Vaccine|combined vaccine
1449065|NCT00969436|Varicella Vaccine|varicella vaccine
1449066|NCT00969436|Children|children
1449067|NCT00969436|Measles|measles
1449068|NCT00969436|Humans|humans
1449069|NCT00969423|persistent pain|persistent pain
1449070|NCT00969423|neuropathic pain|neuropathic pain
1449071|NCT00969423|Chronic Pain|chronic pain
1449073|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
1449074|NCT00969410|Neoplasms|neoplasms
1449075|NCT00969410|Neoplasm metastasis|neoplasm metastasis
1449076|NCT00969410|Liver neoplasms|liver neoplasms
1449077|NCT00969410|Neoplastic processes|neoplastic processes
1449078|NCT00969410|Pathologic processes|pathologic processes
1449079|NCT00969410|Digestive system neoplasms|digestive system neoplasms
1449080|NCT00969410|Neoplasms by site|neoplasms by site
1449081|NCT00969410|Digestive system diseases|digestive system diseases
1449082|NCT00969410|Liver diseases|liver diseases
1449083|NCT00969397|Birthmark|birthmark
1449084|NCT00969397|PWS|pws
1449085|NCT00969384|Physical health|physical health
1449086|NCT00969384|Mental illness|mental illness
1449087|NCT00969384|prevention|prevention
1449088|NCT00969384|Waist circumference|waist circumference
1449089|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
1449090|NCT00969371|PCIOL|pciol
1449091|NCT00969371|IOL|iol
1589201|NCT00434161|KGF|kgf
1449092|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
1449093|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
1449094|NCT00969345|Heart Rate Variability|heart rate variability
1449095|NCT00969345|Baroreflex|baroreflex
1449096|NCT00969345|Quality of Life|quality of life
1449097|NCT00969332|liver|liver
1449098|NCT00969332|Parenteral Nutrition|parenteral nutrition
1449099|NCT00969332|fish oil|fish oil
1449100|NCT00969332|Omegaven|omegaven
1449101|NCT00969332|children|children
1449102|NCT00969319|Octocog alfa|octocog alfa
1449103|NCT00969319|Hemophilia A|hemophilia a
1449104|NCT00969293|Macular Edema|macular edema
1449105|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
1449106|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
1449107|NCT00969293|CRVO|crvo
1449108|NCT00969280|Acupuncture|acupuncture
1449109|NCT00969280|Dry eye syndrome|dry eye syndrome
1449110|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
1449111|NCT00969280|Schirmer test|schirmer test
1449112|NCT00969280|Tear film Break-up time|tear film break-up time
1449113|NCT00969267|ear acupuncture|ear acupuncture
1449114|NCT00969267|obese|obese
1449115|NCT00969267|obese women|obese women
1449116|NCT00969267|women|women
1449117|NCT00969254|Pílulas de Lussen|pílulas de lussen
1449118|NCT00969254|Efficacy|efficacy
1449119|NCT00969254|Safety|safety
1449120|NCT00969254|Dysuria|dysuria
1449121|NCT00969254|Symptomatic control|symptomatic control
1449122|NCT00969241|saliva|saliva
1449123|NCT00969241|free-radicals|free-radicals
1449124|NCT00969241|periodontitis|periodontitis
1449125|NCT00969228|Gastroenteritis|gastroenteritis
1449126|NCT00969215|burn scar|burn scar
1449127|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
1449128|NCT00969215|scar revision|scar revision
1449129|NCT00969202|Prostate Cancer|prostate cancer
1449130|NCT00969202|Cancer of the Prostate|cancer of the prostate
1449131|NCT00969202|Prostate Tumor|prostate tumor
1449132|NCT00969202|Novalis Tx|novalis tx
1449133|NCT00969202|Novalis|novalis
1449134|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
1449135|NCT00969202|Radiosurgery|radiosurgery
1449136|NCT00969202|Radiation|radiation
1449137|NCT00969189|anesthesia|anesthesia
1449138|NCT00969189|child|child
1449139|NCT00969189|infant|infant
1449140|NCT00969189|laryngeal mask|laryngeal mask
1449141|NCT00969176|pain|pain
1449142|NCT00969176|fever|fever
1449143|NCT00969176|neonate|neonate
1449144|NCT00969176|preterm|preterm
1449145|NCT00969176|term|term
1449146|NCT00969176|newborn|newborn
1449147|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
1449148|NCT00969150|Major Depressive Disorder|major depressive disorder
1449149|NCT00969150|Depression|depression
1449150|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
1449151|NCT00969124|colonoscopy|colonoscopy
1449152|NCT00969124|polyps|polyps
1449153|NCT00969124|adenomas|adenomas
1449154|NCT00969124|miss rates|miss rates
1449155|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
1449156|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
1449157|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
1449158|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
1449159|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1449160|NCT00969085|Skin|skin
1449161|NCT00969085|Mycosis fungoides|mycosis fungoides
1449162|NCT00969085|MF|mf
1449163|NCT00969085|Sézary syndrome|sézary syndrome
1449164|NCT00969085|SS|ss
1449165|NCT00969085|Curcumin|curcumin
1449166|NCT00969085|Turmeric|turmeric
1449167|NCT00969072|GI198745|gi198745
1449168|NCT00969072|Long term extension study|long term extension study
1449169|NCT00969072|BPH|bph
1449170|NCT00969059|peripheral nerve injury|peripheral nerve injury
1449171|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
1449172|NCT00969059|neuropathic pain|neuropathic pain
1449173|NCT00969046|Colon cancer|colon cancer
1449174|NCT00969046|MTD|mtd
1449175|NCT00969046|DLT|dlt
1449176|NCT00969046|EPO906|epo906
1449177|NCT00969046|patupilone|patupilone
1449178|NCT00969020|Length of stay|length of stay
1449179|NCT00969020|Timed up and go|timed up and go
1449180|NCT00968994|Wound Healing|wound healing
1449181|NCT00968994|Wound Infection|wound infection
1449182|NCT00968981|Hedgehog|hedgehog
1449183|NCT00968981|BCC|bcc
1449184|NCT00968981|basal cell carcinoma|basal cell carcinoma
1449185|NCT00968955|Postoperative acute pain|postoperative acute pain
1449186|NCT00968955|Total hip arthroplasty|total hip arthroplasty
1449187|NCT00968955|Local infiltration analgesia|local infiltration analgesia
1449188|NCT00968942|Lateral Canthal Lines|lateral canthal lines
1449189|NCT00968942|Crow's Feet|crow's feet
1449190|NCT00968942|Facial Wrinkles|facial wrinkles
1449191|NCT00968929|pulmonary embolism|pulmonary embolism
1449192|NCT00968929|thrombolysis|thrombolysis
1449193|NCT00968929|massive|massive
1449194|NCT00968929|submassive|submassive
1449195|NCT00968929|recombinant streptokinase|recombinant streptokinase
1449196|NCT00968929|urokinase|urokinase
1449197|NCT00968903|Hip arthroplasty|hip arthroplasty
1449198|NCT00968903|Methylprednisolone|methylprednisolone
1449199|NCT00968903|Post-operative pain|post-operative pain
1449200|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1449201|NCT00968890|Influenza infection|influenza infection
1449202|NCT00968877|Renal Insufficiency|renal insufficiency
1449203|NCT00968877|Cholecalciferol|cholecalciferol
1449204|NCT00968877|Kidney Disease|kidney disease
1449205|NCT00968877|Kidney Failure|kidney failure
1449206|NCT00968877|Vitamin D|vitamin d
1449207|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
1449208|NCT00968877|Vitamin D3|vitamin d3
1449209|NCT00968864|T cell depleted|t cell depleted
1449210|NCT00968864|Matched unrelated donors|matched unrelated donors
1449211|NCT00968864|Haplocompatible donors|haplocompatible donors
1449212|NCT00968851|Schizophrenia|schizophrenia
1449213|NCT00968851|Central nervous System Diseases|central nervous system diseases
1449214|NCT00968851|Cognition|cognition
1449215|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
1449216|NCT00968838|Radiated Cells|radiated cells
1449217|NCT00968838|Unradiated Cells|unradiated cells
1449218|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
1449219|NCT00968838|Life-threatening Infections|life-threatening infections
1449220|NCT00968825|Lateral Canthal Lines|lateral canthal lines
1449221|NCT00968825|Crow's Feet|crow's feet
1449222|NCT00968825|Facial Wrinkles|facial wrinkles
1449223|NCT00968812|Diabetes|diabetes
1449224|NCT00968812|Metformin|metformin
1449225|NCT00968812|Glimepiride|glimepiride
1449226|NCT00968812|Hemoglobin A1c|hemoglobin a1c
1449227|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
1449228|NCT00968812|Canagliflozin|canagliflozin
1449229|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
1449230|NCT00968799|Recurrence|recurrence
1449231|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
1449232|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
1449233|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
1449234|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
1449235|NCT00968786|hypertension|hypertension
1449236|NCT00968786|type 2 diabetes|type 2 diabetes
1449237|NCT00968786|home monitoring|home monitoring
1449238|NCT00968773|inguinal hernia|inguinal hernia
1449239|NCT00968773|mesh|mesh
1449240|NCT00968773|hernia repair device|hernia repair device
1449241|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
1449242|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1449243|NCT00968760|NHL|nhl
1449244|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
1449245|NCT00968760|SLL|sll
1449246|NCT00968760|follicular lymphoma|follicular lymphoma
1449247|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
1449248|NCT00968760|gene cell transfer|gene cell transfer
1449249|NCT00968760|CD19-specific T cells|cd19-specific t cells
1449250|NCT00968760|Stem Cell Transplant|stem cell transplant
1449251|NCT00968760|T Cell Infusion|t cell infusion
1449252|NCT00968760|Chemotherapy|chemotherapy
1449253|NCT00968760|Leukapheresis|leukapheresis
1449254|NCT00968760|BCNU|bcnu
1449255|NCT00968760|carmustine|carmustine
1449256|NCT00968760|Cytarabine|cytarabine
1449257|NCT00968760|Etoposide|etoposide
1449258|NCT00968760|Interleukin-2|interleukin-2
1449259|NCT00968760|Proleukin|proleukin
1449260|NCT00968760|Melphalan|melphalan
1449261|NCT00968760|Rituximab|rituximab
1449262|NCT00968760|T cell therapy|t cell therapy
1449263|NCT00968747|Fasting|fasting
1449264|NCT00968747|Fast|fast
1449265|NCT00968747|healthy|healthy
1449266|NCT00968747|diet|diet
1449267|NCT00968747|study|study
1449268|NCT00968747|manipulation|manipulation
1449269|NCT00968747|dietary|dietary
1449270|NCT00968747|FGF21|fgf21
1449271|NCT00968747|Fibroblast growth factor|fibroblast growth factor
1449272|NCT00968747|PTRF|ptrf
1449273|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
1449274|NCT00968747|adipose|adipose
1449275|NCT00968747|fat|fat
1449276|NCT00968747|blood|blood
1449277|NCT00968747|inpatient|inpatient
1449278|NCT00968747|outpatient|outpatient
1449279|NCT00968747|NAFLD|nafld
1449280|NCT00968747|metabolism|metabolism
1449281|NCT00968734|Vitamin D|vitamin d
1449282|NCT00968734|colecalciferol|colecalciferol
1449283|NCT00968734|absorption by Vitamin D|absorption by vitamin d
1449284|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
1449285|NCT00968721|Crohn's disease|crohn's disease
1449286|NCT00968721|Ulcerative colitis|ulcerative colitis
1449287|NCT00968721|medication adherence|medication adherence
1449288|NCT00968721|Decisional influences|decisional influences
1449289|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
1449290|NCT00968708|Diabetes Mellitus|diabetes mellitus
1449291|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
1449292|NCT00968708|heart attack|heart attack
1449293|NCT00968708|stroke|stroke
1450509|NCT00964106|cocktail|cocktail
1449294|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
1449295|NCT00968708|metabolic disorders|metabolic disorders
1449296|NCT00968708|metabolic diseases|metabolic diseases
1449297|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
1449298|NCT00968682|cardiac toxicity|cardiac toxicity
1449299|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
1449300|NCT00968682|stage IA breast cancer|stage ia breast cancer
1449301|NCT00968682|stage IB breast cancer|stage ib breast cancer
1449302|NCT00968682|stage II breast cancer|stage ii breast cancer
1449303|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
1449304|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
1449305|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
1449306|NCT00968656|Breast cancer|breast cancer
1449307|NCT00968656|Head and Neck Cancer|head and neck cancer
1449308|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
1449309|NCT00968656|Cellular proliferation|cellular proliferation
1449310|NCT00968643|spinal cord compression|spinal cord compression
1449311|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1449312|NCT00968617|Anemia|anemia
1449313|NCT00968604|Pancreatic Cancer|pancreatic cancer
1449314|NCT00968604|Pancreas|pancreas
1449315|NCT00968604|Liver|liver
1449316|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
1449317|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
1449318|NCT00968604|C-VISA BikDD|c-visa bikdd
1449319|NCT00968591|Hepatic insufficiency|hepatic insufficiency
1449320|NCT00968591|liver disease|liver disease
1449321|NCT00968591|cirrhosis|cirrhosis
1449322|NCT00968591|pharmacokinetics|pharmacokinetics
1449323|NCT00968578|Knee arthroplasty|knee arthroplasty
1449324|NCT00968578|Methylprednisolone|methylprednisolone
1449325|NCT00968578|Post-operative pain|post-operative pain
1449326|NCT00968565|Heart Defects, Congenital|heart defects, congenital
1449327|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1449328|NCT00968565|Citric Acid|citric acid
1449329|NCT00968565|Heparin|heparin
1449330|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
1449331|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
1449332|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1449333|NCT00968539|influenza infection|influenza infection
1449334|NCT00968526|influenza infection|influenza infection
1449335|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1449336|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
1449337|NCT00968500|Grief|grief
1449338|NCT00968500|bereavement|bereavement
1449339|NCT00968500|questionnaires|questionnaires
1449340|NCT00968500|09-107|09-107
1449341|NCT00968487|Lyophilized Plasma|lyophilized plasma
1449342|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
1449343|NCT00968487|Hemorrhage|hemorrhage
1449344|NCT00968487|Coagulopathy|coagulopathy
1449345|NCT00968487|Autologous|autologous
1449346|NCT00968487|HemCon|hemcon
1449347|NCT00968487|Plasmapheresis|plasmapheresis
1449348|NCT00968487|Freeze Drying|freeze drying
1449349|NCT00968487|Transfusion|transfusion
1449350|NCT00968487|Resuscitation|resuscitation
1449351|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
1449352|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1449353|NCT00968461|CLL|cll
1449354|NCT00968461|PEITC|peitc
1449355|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
1449356|NCT00968461|Fludarabine|fludarabine
1449357|NCT00968448|respiratory muscle|respiratory muscle
1449358|NCT00968448|breathing pattern|breathing pattern
1449359|NCT00968448|exercise performance|exercise performance
1449360|NCT00968435|bevacizumab|bevacizumab
1449361|NCT00968435|cisplatin|cisplatin
1449362|NCT00968435|cetuximab|cetuximab
1449363|NCT00968435|radiation therapy|radiation therapy
1449364|NCT00968435|Phase II|phase ii
1449365|NCT00968435|09-083|09-083
1449366|NCT00968422|Pharmacology|pharmacology
1449367|NCT00968422|Drug Safety|drug safety
1449368|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
1449369|NCT00968422|Pharmacokinetics|pharmacokinetics
1449370|NCT00968409|Breast Cancer|breast cancer
1449371|NCT00968409|Hormone Receptor|hormone receptor
1449372|NCT00968396|Myeloma|myeloma
1449373|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
1449374|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
1449375|NCT00968396|PBPC|pbpc
1449376|NCT00968396|Stem Cell Transplant|stem cell transplant
1449377|NCT00968396|Bone marrow stem cells|bone marrow stem cells
1449378|NCT00968396|Melphalan|melphalan
1449379|NCT00968396|Alkeran|alkeran
1449380|NCT00968396|Apheresis|apheresis
1449381|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
1449382|NCT00968383|Myocardial infarction|myocardial infarction
1449383|NCT00968383|Infarct Related Artery|infarct related artery
1449384|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
1449385|NCT00968383|Medical treatment|medical treatment
1449386|NCT00968383|Tissue Viability|tissue viability
1449387|NCT00968383|Magnetic Resonance|magnetic resonance
1449388|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
1449389|NCT00968370|severe malnutrition|severe malnutrition
1449390|NCT00968370|children|children
1449391|NCT00968370|day-care management|day-care management
1449392|NCT00968370|hospital management|hospital management
1449393|NCT00968357|SCV-07|scv-07
1449394|NCT00968357|relapsers|relapsers
1449395|NCT00968357|Hepatitis C|hepatitis c
1449396|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
1449397|NCT00968318|Tissue expander|tissue expander
1449398|NCT00968318|seroma|seroma
1449399|NCT00968318|extrusion|extrusion
1449400|NCT00968318|lymphatics|lymphatics
1449401|NCT00968318|deep fascia|deep fascia
1449402|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
1449403|NCT00968305|African American children with stable asthma|african american children with stable asthma
1449404|NCT00968305|Asthma severity|asthma severity
1449405|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
1449406|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
1449407|NCT00968305|Total serum IgE|total serum ige
1449408|NCT00968305|Pediatrics|pediatrics
1449409|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
1449410|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
1449411|NCT00968266|Adherence|adherence
1449412|NCT00968266|Compliance|compliance
1449413|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
1449414|NCT00968266|Intervention|intervention
1449415|NCT00968266|Beliefs about medication|beliefs about medication
1449416|NCT00968266|Motivational Interviewing|motivational interviewing
1449417|NCT00968266|Medication adherence|medication adherence
1449418|NCT00968266|Patient compliance|patient compliance
1449419|NCT00968266|Intervention studies|intervention studies
1449420|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1449422|NCT00968253|Hyper-CVAD|hyper-cvad
1449423|NCT00968253|Everolimus|everolimus
1449424|NCT00968253|6-mercaptopurine|6-mercaptopurine
1449425|NCT00968253|Citrovorum|citrovorum
1449426|NCT00968253|Cyclophosphamide|cyclophosphamide
1449427|NCT00968253|Cytarabine|cytarabine
1449428|NCT00968253|Dexamethasone|dexamethasone
1449429|NCT00968253|Doxorubicin|doxorubicin
1449430|NCT00968253|G-CSF|g-csf
1449431|NCT00968253|Methotrexate|methotrexate
1449432|NCT00968253|MESNA|mesna
1449433|NCT00968253|Pegfilgrastim|pegfilgrastim
1449434|NCT00968253|Prednisone|prednisone
1449435|NCT00968253|RAD001|rad001
1449436|NCT00968253|Solumedrol|solumedrol
1449437|NCT00968253|Vincristine Sulfate|vincristine sulfate
1449438|NCT00968240|GBM|gbm
1449439|NCT00968240|AA|aa
1449440|NCT00968240|AO|ao
1449441|NCT00968240|Brain|brain
1449442|NCT00968240|Tumors|tumors
1449443|NCT00968240|Malignant|malignant
1449444|NCT00968240|Glioblastoma|glioblastoma
1449445|NCT00968240|Multiforme|multiforme
1449446|NCT00968240|Anaplastic|anaplastic
1449447|NCT00968240|Astrocytoma|astrocytoma
1449448|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
1449449|NCT00968227|vasospasm|vasospasm
1449450|NCT00968227|transfusion|transfusion
1449451|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
1449452|NCT00968227|hemoglobin|hemoglobin
1449453|NCT00968214|stage IA breast cancer|stage ia breast cancer
1449454|NCT00968214|stage IB breast cancer|stage ib breast cancer
1449455|NCT00968214|stage II breast cancer|stage ii breast cancer
1449456|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
1449457|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
1449458|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
1449459|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1449460|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1449461|NCT00968188|HIV Risk|hiv risk
1449462|NCT00968188|Internet Intervention|internet intervention
1449463|NCT00968188|Homosexuality, Male|homosexuality, male
1449464|NCT00968188|HIV Seronegativity|hiv seronegativity
1449465|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
1449466|NCT00968175|CPN|cpn
1449467|NCT00968175|Pancreatic Cancer|pancreatic cancer
1449468|NCT00968175|Pain Management|pain management
1449469|NCT00968162|Bone Marrow Transplant|bone marrow transplant
1449470|NCT00968162|Sickle Cell Disease|sickle cell disease
1449471|NCT00968136|refractory infantile spasms|refractory infantile spasms
1449472|NCT00968110|Milk Allergy|milk allergy
1449473|NCT00968097|Alzheimer' disease|alzheimer' disease
1449474|NCT00968097|SPECT imaging|spect imaging
1449475|NCT00968084|Diagnostic Work Up|diagnostic work up
1449476|NCT00968084|Normal Volunteers|normal volunteers
1449477|NCT00968084|HV|hv
1449478|NCT00968084|Inflammatory Disease|inflammatory disease
1449479|NCT00968084|Autoimmune Disease|autoimmune disease
1449480|NCT00968084|Immunologic Disease|immunologic disease
1449481|NCT00968084|Healthy Volunteer|healthy volunteer
1449482|NCT00968071|Leukemia|leukemia
1449483|NCT00968071|AML|aml
1449484|NCT00968071|MDS|mds
1449485|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1449486|NCT00968071|Decitabine|decitabine
1449487|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
1449488|NCT00968071|Dacogen|dacogen
1449489|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
1449490|NCT00968071|Mylotarg|mylotarg
1449491|NCT00968058|Leak Pressure|leak pressure
1449492|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
1449493|NCT00968058|Pediatric|pediatric
1449494|NCT00968058|Temporal Variation|temporal variation
1449495|NCT00968045|Fibrinogen|fibrinogen
1449496|NCT00968045|Postoperative bleeding|postoperative bleeding
1449497|NCT00968045|Transfusions|transfusions
1449498|NCT00968045|CABG|cabg
1449499|NCT00968032|PFO|pfo
1449500|NCT00968032|Patent Foramen Ovale|patent foramen ovale
1449501|NCT00968006|diabetes|diabetes
1449502|NCT00968006|endothelium|endothelium
1449503|NCT00968006|stem cells|stem cells
1449504|NCT00967993|hyperphosphatemia|hyperphosphatemia
1449505|NCT00967993|end-stage renal disease|end-stage renal disease
1449506|NCT00967993|ESRD|esrd
1449507|NCT00967993|hemodialysis|hemodialysis
1449508|NCT00967993|diabetes|diabetes
1449509|NCT00967993|dialysis|dialysis
1449510|NCT00967980|pain|pain
1449511|NCT00967980|Hip Resurfacing|hip resurfacing
1449512|NCT00967980|catheter|catheter
1449513|NCT00967980|nerve block|nerve block
1449514|NCT00967980|UCSD|ucsd
1449515|NCT00967980|hip surgery|hip surgery
1449516|NCT00967980|psoas|psoas
1449517|NCT00967980|femoral|femoral
1449518|NCT00967980|ambulation|ambulation
1449519|NCT00967980|hip flexion|hip flexion
1449520|NCT00967980|infusion|infusion
1449521|NCT00967967|control|control
1449522|NCT00967967|symptoms|symptoms
1449523|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
1449524|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
1449525|NCT00967954|stage III prostate cancer|stage iii prostate cancer
1449526|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
1449527|NCT00967941|Vascular Surgery|vascular surgery
1449528|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
1449529|NCT00967915|Ankyloglossia|ankyloglossia
1449530|NCT00967915|Tongue tie|tongue tie
1449531|NCT00967915|Frenotomy|frenotomy
1449532|NCT00967915|Frenulectomy|frenulectomy
1449533|NCT00967915|Breast feeding|breast feeding
1449534|NCT00967915|HATLFF|hatlff
1449535|NCT00967915|IBFAT|ibfat
1449536|NCT00967902|intracoronary stent|intracoronary stent
1449537|NCT00967902|drug eluting stent|drug eluting stent
1449538|NCT00967902|sirolimus|sirolimus
1449539|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
1449540|NCT00967889|stage III prostate cancer|stage iii prostate cancer
1449541|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
1449542|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
1449543|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
1449544|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1449545|NCT00967863|stage III prostate cancer|stage iii prostate cancer
1449546|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
1449547|NCT00967850|High Myopia|high myopia
1449548|NCT00967850|Bevacizumab|bevacizumab
1449549|NCT00967850|Photodynamic therapy|photodynamic therapy
1449550|NCT00967837|Diabetes with complications|diabetes with complications
1449551|NCT00967837|Wound healing|wound healing
1449552|NCT00967824|breast cancer|breast cancer
1449553|NCT00967798|cystic fibrosis|cystic fibrosis
1449554|NCT00967798|diabetes|diabetes
1449555|NCT00967798|inflammation|inflammation
1449556|NCT00967798|oxidative stress|oxidative stress
1449557|NCT00967798|redox balance|redox balance
1449558|NCT00967798|lung disease|lung disease
1449559|NCT00967785|WHIM|whim
1449560|NCT00967785|Mozobil (TM)|mozobil (tm)
1449561|NCT00967785|Neutrophil Disorder|neutrophil disorder
1449562|NCT00967785|Plerixafor|plerixafor
1449563|NCT00967772|Pharmacokinetics|pharmacokinetics
1449564|NCT00967772|Safety|safety
1449565|NCT00967772|tolerability|tolerability
1449566|NCT00967759|common cold|common cold
1449567|NCT00967759|treatment|treatment
1449674|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1449568|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
1449569|NCT00967694|Glaucoma|glaucoma
1449570|NCT00967694|Nitrous oxide|nitrous oxide
1449571|NCT00967668|Counseling|counseling
1449572|NCT00967668|Veterans|veterans
1449573|NCT00967668|Weight loss|weight loss
1449574|NCT00967668|Physical activity|physical activity
1449576|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1449577|NCT00967655|stage I rectal cancer|stage i rectal cancer
1449578|NCT00967655|stage II rectal cancer|stage ii rectal cancer
1449579|NCT00967655|stage III rectal cancer|stage iii rectal cancer
1449580|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
1449581|NCT00967629|Diabetic nephropathy|diabetic nephropathy
1449582|NCT00967629|CKD progression|ckd progression
1449583|NCT00967629|AGEs|ages
1450511|NCT00964106|omeprazole|omeprazole
1449584|NCT00967629|oxidative stress|oxidative stress
1449585|NCT00967629|dietary AGEs|dietary ages
1449586|NCT00967616|metastatic|metastatic
1449587|NCT00967616|colon|colon
1449588|NCT00967616|rectum|rectum
1449589|NCT00967616|combination|combination
1449590|NCT00967616|chemotherapy|chemotherapy
1449591|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1449592|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
1449593|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
1449594|NCT00967564|Quality of Life|quality of life
1449595|NCT00967564|Anemia|anemia
1449596|NCT00967564|Epoetin alfa|epoetin alfa
1449597|NCT00967564|Eprex|eprex
1449598|NCT00967551|Diarrhea|diarrhea
1449599|NCT00967551|Pneumonia|pneumonia
1449600|NCT00967551|Upper respiratory infections|upper respiratory infections
1449601|NCT00967551|Acute gastroenteritis|acute gastroenteritis
1449602|NCT00967538|psoriasis|psoriasis
1449603|NCT00967538|etanercept|etanercept
1449604|NCT00967538|efficacy|efficacy
1449605|NCT00967538|response|response
1449606|NCT00967538|anti-TNF alpha|anti-tnf alpha
1449607|NCT00967538|treatment efficacy|treatment efficacy
1449608|NCT00967525|AML|aml
1449609|NCT00967525|ALL|all
1449610|NCT00967525|leukemia|leukemia
1449611|NCT00967525|CML|cml
1449612|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
1449613|NCT00967525|malignancies|malignancies
1449614|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
1449615|NCT00967525|High risk malignancies|high risk malignancies
1449616|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
1449617|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
1449618|NCT00967512|idarubicin|idarubicin
1449619|NCT00967512|cytarabine|cytarabine
1449620|NCT00967499|PONV|ponv
1449621|NCT00967499|rescue|rescue
1449622|NCT00967473|Astigmatism|astigmatism
1449623|NCT00967473|cataract|cataract
1449624|NCT00967473|corneal astigmatism|corneal astigmatism
1449625|NCT00967473|IOL|iol
1449626|NCT00967473|AcrySof|acrysof
1449627|NCT00967460|Childhood obesity|childhood obesity
1449628|NCT00967460|Children|children
1449629|NCT00967460|Inactivity|inactivity
1449630|NCT00967460|Physical activity|physical activity
1449631|NCT00967460|Motor skills|motor skills
1449632|NCT00967460|Motor fitness|motor fitness
1449633|NCT00967460|Quality of life|quality of life
1449634|NCT00967460|Nutrition|nutrition
1449635|NCT00967460|Family|family
1449636|NCT00967434|infarction|infarction
1449637|NCT00967434|ischemia|ischemia
1449638|NCT00967434|surgery|surgery
1449639|NCT00967434|perioperative|perioperative
1449640|NCT00967434|statins|statins
1449641|NCT00967421|Driving|driving
1449642|NCT00967421|DUI|dui
1449643|NCT00967421|Driving simulation|driving simulation
1449644|NCT00967421|Drugs|drugs
1449645|NCT00967421|Ethanol|ethanol
1449646|NCT00967408|Stroke|stroke
1449647|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
1449648|NCT00967408|Treatment Outcome|treatment outcome
1449649|NCT00967408|Rehabilitation|rehabilitation
1449650|NCT00967382|Pregnancy|pregnancy
1449651|NCT00967382|Thrombophilia|thrombophilia
1449652|NCT00967382|High-risk pregnancy|high-risk pregnancy
1449653|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
1449654|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
1449655|NCT00967369|Lymphoma|lymphoma
1449656|NCT00967369|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
1449657|NCT00967369|Cancer|cancer
1449658|NCT00967369|Bortezomib|bortezomib
1449659|NCT00967369|Velcade|velcade
1449660|NCT00967369|Chemotherapy|chemotherapy
1449661|NCT00967369|ICE|ice
1449662|NCT00967369|Ifosfamide|ifosfamide
1449663|NCT00967369|Ifex|ifex
1449664|NCT00967369|Mesna|mesna
1449665|NCT00967369|Mesnex|mesnex
1449666|NCT00967369|Carboplatin|carboplatin
1449667|NCT00967369|Paraplatin|paraplatin
1449668|NCT00967369|Etoposide|etoposide
1449669|NCT00967369|VePesid|vepesid
1449670|NCT00967369|BICE|bice
1449671|NCT00967369|Pegfilgrastim|pegfilgrastim
1449672|NCT00967369|Neulasta|neulasta
1449673|NCT00967356|Healthy volunteers|healthy volunteers
1449675|NCT00967343|Graft-versus-host disease|graft-versus-host disease
1449676|NCT00967343|Immune reconstitution|immune reconstitution
1449677|NCT00967343|Alloreactive T-cells|alloreactive t-cells
1449678|NCT00967343|Photodepletion|photodepletion
1449679|NCT00967343|TH9402|th9402
1449680|NCT00967343|Transplant related mortality|transplant related mortality
1449681|NCT00967343|Hematologic malignancy|hematologic malignancy
1449682|NCT00967317|Auris-Sedina|auris-sedina
1449683|NCT00967317|Otitis|otitis
1449684|NCT00967317|Efficacy|efficacy
1449685|NCT00967317|Tolerability|tolerability
1449686|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
1449687|NCT00967304|Clinical decision rule|clinical decision rule
1449688|NCT00967304|Anticoagulants|anticoagulants
1449689|NCT00967304|Recurrence|recurrence
1449690|NCT00967304|Prognostic|prognostic
1449691|NCT00967304|Risk stratification|risk stratification
1449692|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
1449693|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1449694|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
1449695|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
1449696|NCT00967278|OPCAB|opcab
1449697|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
1449698|NCT00967278|esophageal doppler|esophageal doppler
1449699|NCT00967278|hemodynamics|hemodynamics
1449700|NCT00967265|Introduction seminar|introduction seminar
1449701|NCT00967265|Psychoeducation|psychoeducation
1449702|NCT00967265|Waiting list|waiting list
1449703|NCT00967265|Patient participation|patient participation
1449704|NCT00967265|Mental disorders|mental disorders
1449705|NCT00967252|surgery|surgery
1449706|NCT00967252|inflammation|inflammation
1449707|NCT00967252|infection|infection
1449708|NCT00967252|statins|statins
1449709|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1449710|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1449711|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1449712|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
1449713|NCT00967226|hemangioma|hemangioma
1449714|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1449715|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
1449716|NCT00967200|adult glioblastoma|adult glioblastoma
1449717|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
1449718|NCT00967200|adult gliosarcoma|adult gliosarcoma
1449719|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1449720|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1449721|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1449722|NCT00967200|adult brain stem glioma|adult brain stem glioma
1449723|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
1449724|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
1449725|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
1449726|NCT00967200|adult medulloblastoma|adult medulloblastoma
1449727|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1449728|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
1449729|NCT00967200|adult ependymoma|adult ependymoma
1449730|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1449731|NCT00967200|adult subependymoma|adult subependymoma
1449732|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
1449733|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1449734|NCT00967200|adult grade I meningioma|adult grade i meningioma
1449735|NCT00967200|adult grade II meningioma|adult grade ii meningioma
1449736|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
1449737|NCT00967200|adult papillary meningioma|adult papillary meningioma
1449738|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1449739|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
1449740|NCT00967200|adult pineoblastoma|adult pineoblastoma
1449741|NCT00967200|adult pineocytoma|adult pineocytoma
1449742|NCT00967200|adult mixed glioma|adult mixed glioma
1449743|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
1449744|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
1449745|NCT00967135|Thoracotomy|thoracotomy
1449746|NCT00967135|Neuropathic pain|neuropathic pain
1449747|NCT00967122|adjustment, hunger|adjustment, hunger
1449872|NCT00966550|Tomato|tomato
1449748|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
1449749|NCT00967109|Anemia|anemia
1449750|NCT00967109|Tissue oxygenation|tissue oxygenation
1449751|NCT00967109|Spine surgery|spine surgery
1449752|NCT00967096|rifaximin|rifaximin
1449753|NCT00967096|acute graft versus host disease|acute graft versus host disease
1449754|NCT00967096|bone marrow transplant|bone marrow transplant
1449755|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
1449756|NCT00967083|Quality of Life|quality of life
1449757|NCT00967083|Questionnaires|questionnaires
1449758|NCT00967083|Interviews|interviews
1449759|NCT00967083|family members|family members
1449760|NCT00967083|care givers|care givers
1449761|NCT00967083|09-104|09-104
1449858|NCT00966615|survival|survival
1449762|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1449763|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1449764|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
1449765|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
1449766|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1449768|NCT00967044|LBH589|lbh589
1449769|NCT00967044|Panobinostat|panobinostat
1449770|NCT00967044|RAD001|rad001
1449771|NCT00967044|Everolimus|everolimus
1449772|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
1449773|NCT00967031|male breast cancer|male breast cancer
1449774|NCT00967031|stage IV breast cancer|stage iv breast cancer
1449775|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
1449776|NCT00967018|Safety parameters|safety parameters
1449777|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
1449778|NCT00967018|general health state|general health state
1450512|NCT00964106|CYP|cyp
1449779|NCT00967005|N acetyl cysteine|n acetyl cysteine
1449780|NCT00967005|Pathological gambling|pathological gambling
1449781|NCT00967005|Nicotine dependence|nicotine dependence
1449782|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
1449783|NCT00966992|Cancer of Cervix|cancer of cervix
1449784|NCT00966992|Cervix Cancer|cervix cancer
1449785|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
1449786|NCT00966966|Alzheimer Disease|alzheimer disease
1449787|NCT00966940|Glaucoma|glaucoma
1449788|NCT00966940|IOP|iop
1449789|NCT00966940|Travoprost|travoprost
1449790|NCT00966927|quality of life|quality of life
1449791|NCT00966927|functional independence|functional independence
1449792|NCT00966927|spina bifid|spina bifid
1449793|NCT00966888|stage II breast cancer|stage ii breast cancer
1449794|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
1449795|NCT00966875|RA|ra
1449796|NCT00966849|Randomized Controlled Trial|randomized controlled trial
1449797|NCT00966849|Financial Support|financial support
1449798|NCT00966849|Poverty|poverty
1449799|NCT00966849|Child, Orphaned|child, orphaned
1449800|NCT00966849|HIV|hiv
1449801|NCT00966836|Heart Transplantation|heart transplantation
1449802|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
1449803|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
1449804|NCT00966836|Everolimus|everolimus
1449805|NCT00966836|Valganciclovir|valganciclovir
1449806|NCT00966836|Mycophenolate|mycophenolate
1449807|NCT00966823|Diaphragm|diaphragm
1449808|NCT00966823|Trachea|trachea
1449809|NCT00966823|Lung development|lung development
1449810|NCT00966823|Lung growth|lung growth
1449811|NCT00966823|Tracheal occlusion|tracheal occlusion
1449812|NCT00966823|ECMO|ecmo
1449813|NCT00966823|Neonatal death|neonatal death
1449814|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
1449815|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1449816|NCT00966810|T cell depletion|t cell depletion
1449817|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
1449818|NCT00966810|GvHD|gvhd
1449819|NCT00966810|transplant related mortality|transplant related mortality
1449820|NCT00966771|contraception|contraception
1449821|NCT00966771|emergency contraception|emergency contraception
1449822|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
1449823|NCT00966745|surgical field condition|surgical field condition
1449824|NCT00966719|Jaundice|jaundice
1449825|NCT00966719|Breastfeeding|breastfeeding
1449826|NCT00966719|Infants|infants
1449827|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1449828|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
1449829|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
1449830|NCT00966693|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
1449831|NCT00966693|RRMM|rrmm
1449832|NCT00966693|Lenalidomide|lenalidomide
1449833|NCT00966693|Revlimid|revlimid
1449834|NCT00966693|CC-5013|cc-5013
1449835|NCT00966693|Thalidomide|thalidomide
1449836|NCT00966693|Thalomid|thalomid
1449837|NCT00966693|Dexamethasone|dexamethasone
1449838|NCT00966693|Decadron|decadron
1449839|NCT00966680|general anesthesia|general anesthesia
1449840|NCT00966680|spinal anesthesia|spinal anesthesia
1449841|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
1449842|NCT00966667|cancer survivor|cancer survivor
1449843|NCT00966667|stage I colon cancer|stage i colon cancer
1449844|NCT00966667|stage II colon cancer|stage ii colon cancer
1449845|NCT00966667|stage III colon cancer|stage iii colon cancer
1449846|NCT00966667|stage I rectal cancer|stage i rectal cancer
1449847|NCT00966667|stage II rectal cancer|stage ii rectal cancer
1449848|NCT00966667|stage III rectal cancer|stage iii rectal cancer
1449849|NCT00966654|CABG|cabg
1449850|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
1449851|NCT00966628|pediatric|pediatric
1449852|NCT00966628|dengue|dengue
1449853|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
1449854|NCT00966628|fluid resuscitation|fluid resuscitation
1449855|NCT00966628|Ringer's lactate|ringer's lactate
1449856|NCT00966615|malnutrition|malnutrition
1449857|NCT00966615|fluid status|fluid status
1449859|NCT00966589|groin pain|groin pain
1449860|NCT00966589|sportsman hernia|sportsman hernia
1449861|NCT00966589|osteitis pubis|osteitis pubis
1449862|NCT00966589|laparoscopic surgery|laparoscopic surgery
1449863|NCT00966576|Glaucoma|glaucoma
1449864|NCT00966576|IOP|iop
1449865|NCT00966576|AZARGA|azarga
1449866|NCT00966563|Mangafodipir|mangafodipir
1449867|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
1449868|NCT00966563|Myocardial infarction|myocardial infarction
1449869|NCT00966563|Troponin|troponin
1449870|NCT00966563|CK-MB|ck-mb
1449871|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
1449873|NCT00966550|Nutrition|nutrition
1567290|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1449874|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
1449875|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
1449876|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
1449877|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
1449878|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
1449879|NCT00966524|Endotracheal intubation|endotracheal intubation
1449880|NCT00966511|lung cancer|lung cancer
1449881|NCT00966511|lung resection|lung resection
1449882|NCT00966511|lobectomy|lobectomy
1449883|NCT00966511|pneumonectomy|pneumonectomy
1449884|NCT00966511|lung function|lung function
1449885|NCT00966511|perfusion|perfusion
1449886|NCT00966498|malignancy|malignancy
1449887|NCT00966498|solid tumor|solid tumor
1449888|NCT00966498|recurrent|recurrent
1449889|NCT00966498|high risk|high risk
1449890|NCT00966485|ASA resistance|asa resistance
1449891|NCT00966485|coronary stenting|coronary stenting
1449892|NCT00966485|platelet function|platelet function
1449893|NCT00966485|laboratory ASA resistance|laboratory asa resistance
1449894|NCT00966485|MACE|mace
1449895|NCT00966485|Positive SPECT|positive spect
1449896|NCT00966472|Rosuvastatin|rosuvastatin
1449897|NCT00966472|Erlotinib|erlotinib
1449898|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
1449899|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
1449900|NCT00966459|COPD|copd
1449901|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
1449902|NCT00966433|Proseal™ LMA|proseal™ lma
1449903|NCT00966433|children|children
1449904|NCT00966433|ventilation|ventilation
1449905|NCT00966433|general anesthesia|general anesthesia
1449906|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
1449907|NCT00966407|Metabolic Syndrome|metabolic syndrome
1449908|NCT00966407|Obesity|obesity
1449909|NCT00966407|Genetic risk markers|genetic risk markers
1449910|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1449911|NCT00966407|Young adults|young adults
1449912|NCT00966407|Fitness testing|fitness testing
1449913|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
1449914|NCT00966381|breastfeeding|breastfeeding
1449915|NCT00966381|bone mineral density|bone mineral density
1449916|NCT00966381|exercise|exercise
1449917|NCT00966381|diet|diet
1449918|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
1449919|NCT00966342|vaccine|vaccine
1449920|NCT00966342|influenza|influenza
1449921|NCT00966342|influenza vaccine|influenza vaccine
1449922|NCT00966342|pandemic preparedness|pandemic preparedness
1449923|NCT00966329|Switching|switching
1449924|NCT00966329|Maraviroc|maraviroc
1449925|NCT00966329|Virological efficacy|virological efficacy
1449926|NCT00966329|Lipid profile|lipid profile
1449927|NCT00966329|Tropism|tropism
1449928|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
1449929|NCT00966303|rehabilitation|rehabilitation
1449930|NCT00966303|dyspnea|dyspnea
1449931|NCT00966303|strength|strength
1449932|NCT00966290|anticoagulants|anticoagulants
1449933|NCT00966290|management|management
1449934|NCT00966290|anticoagulation clinics|anticoagulation clinics
1449935|NCT00966290|randomized comparison|randomized comparison
1449936|NCT00966277|Pancreas|pancreas
1449937|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
1449938|NCT00966277|VTE|vte
1449939|NCT00966277|Chemotherapy|chemotherapy
1449940|NCT00966277|Deep venous thrombosis|deep venous thrombosis
1449941|NCT00966277|Pulmonary embolism|pulmonary embolism
1449942|NCT00966277|Dalteparin|dalteparin
1449943|NCT00966277|Fragmin|fragmin
1449944|NCT00966277|Thromboprophylaxis|thromboprophylaxis
1449945|NCT00966264|randomized controlled trial|randomized controlled trial
1449946|NCT00966264|menorrhagia|menorrhagia
1449947|NCT00966264|LNG-IUS|lng-ius
1449948|NCT00966264|hysterectomy|hysterectomy
1449949|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
1449950|NCT00966238|influenza|influenza
1449951|NCT00966238|vaccine|vaccine
1449952|NCT00966199|blood pressure|blood pressure
1449953|NCT00966199|aging|aging
1449954|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
1449955|NCT00966199|hypertension|hypertension
1449956|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
1449957|NCT00966186|Rotational technique|rotational technique
1449958|NCT00966186|Success rate|success rate
1449959|NCT00966186|Postoperative complications|postoperative complications
1449960|NCT00966160|treatment naive|treatment naive
1449961|NCT00966134|mountain medicine|mountain medicine
1449962|NCT00966134|ghrelin|ghrelin
1449963|NCT00966134|growth hormone|growth hormone
1449964|NCT00966134|hypoxia|hypoxia
1449965|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
1449966|NCT00966121|Cirrhosis|cirrhosis
1449967|NCT00966121|Esophagus Disorders|esophagus disorders
1449968|NCT00966121|Varicose Veins|varicose veins
1449969|NCT00966095|prostate cancer|prostate cancer
1449970|NCT00966082|Cirrhosis|cirrhosis
1449971|NCT00966082|Esophagus Disorders|esophagus disorders
1449972|NCT00966082|Varicose Veins|varicose veins
1450948|NCT00962728|heart rate|heart rate
1449973|NCT00966069|Respiratory tract infections|respiratory tract infections
1449974|NCT00966069|Viral infections|viral infections
1449975|NCT00966069|Pediatrics|pediatrics
1449976|NCT00966069|Specimen collection|specimen collection
1449977|NCT00966056|Nasal adhesions|nasal adhesions
1449978|NCT00966056|Nasal synechiae|nasal synechiae
1449979|NCT00966056|Mitomycin|mitomycin
1449980|NCT00966056|Mitomycin c|mitomycin c
1449981|NCT00966056|Teflon|teflon
1449982|NCT00966056|Splints|splints
1449983|NCT00966056|Septal splints|septal splints
1449984|NCT00966017|PET Scan|pet scan
1449985|NCT00966004|Urge incontinence|urge incontinence
1449986|NCT00966004|YM178|ym178
1449987|NCT00966004|Overactive Bladder|overactive bladder
1449988|NCT00966004|Urgency|urgency
1449989|NCT00966004|Urinary incontinence|urinary incontinence
1449990|NCT00966004|mirabegron|mirabegron
1449991|NCT00966004|Micturition|micturition
1449992|NCT00965991|Gestational diabetes|gestational diabetes
1449993|NCT00965991|Metformin|metformin
1449994|NCT00965991|Glyburide|glyburide
1449995|NCT00965991|oral agents|oral agents
1449996|NCT00965978|ONO-5920|ono-5920
1449997|NCT00965978|YM529|ym529
1449998|NCT00965978|Minodronic Acid|minodronic acid
1449999|NCT00965978|Food Effect|food effect
1450000|NCT00965965|health behavior|health behavior
1450001|NCT00965965|randomized controlled trials|randomized controlled trials
1450002|NCT00965965|self-efficacy|self-efficacy
1450003|NCT00965965|patient education|patient education
1450004|NCT00965965|comprehension|comprehension
1450005|NCT00965965|mass screening|mass screening
1450006|NCT00965965|prevention and control|prevention and control
1450007|NCT00965926|Overactive Bladder|overactive bladder
1450008|NCT00965926|Urinary incontinence|urinary incontinence
1450009|NCT00965926|YM178|ym178
1450010|NCT00965926|mirabegron|mirabegron
1450011|NCT00965900|Cirrhosis|cirrhosis
1450012|NCT00965900|Esophagus Disorders|esophagus disorders
1450013|NCT00965900|Varicose Veins|varicose veins
1450014|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
1450015|NCT00965874|Magnesium Sulfate|magnesium sulfate
1450016|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
1450017|NCT00965861|Tissue Registry|tissue registry
1450018|NCT00965861|Tissue Collection|tissue collection
1450019|NCT00965861|Unknown Primary|unknown primary
1450020|NCT00965861|Breast|breast
1450021|NCT00965861|Lung|lung
1450022|NCT00965861|Gastrointestinal|gastrointestinal
1450023|NCT00965861|Bone Marrow Transplant|bone marrow transplant
1450024|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1450025|NCT00965861|Central Nervous System|central nervous system
1450026|NCT00965861|Head and Neck|head and neck
1450027|NCT00965861|Melanoma|melanoma
1450028|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
1450029|NCT00965861|Multiple Myeloma|multiple myeloma
1450030|NCT00965861|Lymphoma|lymphoma
1450031|NCT00965861|Gynecologic|gynecologic
1450032|NCT00965861|Genitourinary|genitourinary
1450033|NCT00965861|Refractory Malignancy|refractory malignancy
1450034|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
1450035|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
1450036|NCT00965848|Urinary tract Infections|urinary tract infections
1450037|NCT00965848|Doripenem|doripenem
1450038|NCT00965848|Doribax|doribax
1450039|NCT00965835|PET Scan|pet scan
1450040|NCT00965822|URTI|urti
1450041|NCT00965822|Natural Health Products|natural health products
1450042|NCT00965796|Intravenous lidocaine|intravenous lidocaine
1450043|NCT00965796|postoperative analgesia|postoperative analgesia
1450044|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
1450045|NCT00965770|abortion|abortion
1450046|NCT00965770|intrauterine device|intrauterine device
1450047|NCT00965770|cost-effectiveness|cost-effectiveness
1450048|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
1450049|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
1450050|NCT00965744|Splenectomy|splenectomy
1450051|NCT00965744|Portal hypertension|portal hypertension
1450052|NCT00965731|Lung Neoplasms|lung neoplasms
1450053|NCT00965731|Crizotinib|crizotinib
1450054|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
1450055|NCT00965705|Binge Eating Disorder|binge eating disorder
1450056|NCT00965705|overeating|overeating
1450057|NCT00965705|binge eating|binge eating
1450058|NCT00965705|women|women
1450059|NCT00965705|overweight|overweight
1450060|NCT00965705|compulsive overeating|compulsive overeating
1450061|NCT00965679|Cardiac CT|cardiac ct
1450062|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
1450063|NCT00965679|Ionizing Radiation|ionizing radiation
1450064|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
1450065|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
1450066|NCT00965679|Heart Valve|heart valve
1450067|NCT00965666|Fanconi Anemia|fanconi anemia
1450068|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
1450069|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
1450070|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
1450071|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
1450072|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
1450073|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
1450074|NCT00965640|male pattern baldness|male pattern baldness
1450075|NCT00965640|androgenetic alopecia|androgenetic alopecia
1450076|NCT00965640|hair loss|hair loss
1450077|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
1450078|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
1450079|NCT00965601|Fibromyalgia|fibromyalgia
1450080|NCT00965588|Alzheimer's disease|alzheimer's disease
1450081|NCT00965588|amyloid beta|amyloid beta
1450082|NCT00965588|vaccine|vaccine
1450083|NCT00965575|epilepsy|epilepsy
1450084|NCT00965575|sleep|sleep
1450085|NCT00965575|seizures|seizures
1450086|NCT00965575|cognition|cognition
1450087|NCT00965562|Premenstrual syndrome|premenstrual syndrome
1450088|NCT00965562|PMS|pms
1450089|NCT00965562|calcium|calcium
1450090|NCT00965536|Schizophrenia|schizophrenia
1450091|NCT00965536|Bipolar Disorder|bipolar disorder
1450092|NCT00965536|Manic Disorder|manic disorder
1450093|NCT00965536|Register study|register study
1450094|NCT00965536|Quetiapine|quetiapine
1450095|NCT00965536|Quetiapine Prolong|quetiapine prolong
1450096|NCT00965536|Seroquel|seroquel
1450097|NCT00965536|Seroquel Prolong|seroquel prolong
1450098|NCT00965536|Seroquel XR|seroquel xr
1450099|NCT00965536|In-patient|in-patient
1450100|NCT00965523|Cancer|cancer
1450101|NCT00965523|breast cancer|breast cancer
1450102|NCT00965523|neoplasm|neoplasm
1450103|NCT00965523|E7389|e7389
1450104|NCT00965523|Eribulin|eribulin
1450105|NCT00965510|diabetes|diabetes
1450106|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1450107|NCT00965497|ALS|als
1450108|NCT00965497|Multiple Sclerosis|multiple sclerosis
1450109|NCT00965497|MS|ms
1450110|NCT00965497|Major Depression|major depression
1450111|NCT00965497|Depression|depression
1450112|NCT00965497|Major Depressive Disorder|major depressive disorder
1450113|NCT00965497|antidepressants|antidepressants
1450114|NCT00965497|Escitalopram|escitalopram
1450115|NCT00965497|Lexapro|lexapro
1450116|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
1450117|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
1450118|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
1450119|NCT00965471|acute coronary syndrome|acute coronary syndrome
1450120|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
1450121|NCT00965458|New-onset T1DM|new-onset t1dm
1450122|NCT00965458|New-onset T1D|new-onset t1d
1450123|NCT00965458|Alefacept|alefacept
1450124|NCT00965458|Amevive®|amevive®
1450125|NCT00965445|isoprostanes|isoprostanes
1450126|NCT00965445|mass spectrometry|mass spectrometry
1450127|NCT00965406|acute coronary syndrome|acute coronary syndrome
1450128|NCT00965406|glucose insulin potassium|glucose insulin potassium
1450129|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
1450130|NCT00965393|Platelet activation|platelet activation
1450131|NCT00965393|Endothelial function|endothelial function
1450132|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
1450133|NCT00965393|Bradykinin|bradykinin
1450134|NCT00965380|Trinity Evolution|trinity evolution
1450135|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
1450136|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
1450137|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
1450138|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
1450139|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
1450140|NCT00965354|severe|severe
1450141|NCT00965354|acute|acute
1450142|NCT00965354|influenza|influenza
1450143|NCT00965354|consortium|consortium
1450144|NCT00965354|swine|swine
1450146|NCT00965354|influenza A|influenza a
1450147|NCT00965354|H1N1|h1n1
1450148|NCT00965354|hospital|hospital
1450149|NCT00965354|admission|admission
1450150|NCT00965341|Cancer|cancer
1450151|NCT00965341|Fatigue|fatigue
1450152|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
1450153|NCT00965341|Depo-Testosterone|depo-testosterone
1450154|NCT00965341|Testosterone cypionate|testosterone cypionate
1450155|NCT00965341|Testosterone enanthate|testosterone enanthate
1450156|NCT00965341|Hypogonadic|hypogonadic
1450157|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
1450158|NCT00965341|FACIT-F|facit-f
1450159|NCT00965328|anticoagulation|anticoagulation
1450160|NCT00965328|hemofiltration|hemofiltration
1450161|NCT00965328|acute kidney injury|acute kidney injury
1450162|NCT00965328|heparin|heparin
1450163|NCT00965328|hemostasis|hemostasis
1450164|NCT00965328|nadroparin|nadroparin
1450165|NCT00965328|anti-Xa|anti-xa
1450166|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
1450167|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
1450168|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
1450169|NCT00965315|fenofibrate|fenofibrate
1450170|NCT00965315|rosuvastatin|rosuvastatin
1450171|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
1450172|NCT00965302|Obesity|obesity
1450173|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
1450174|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
1450175|NCT00965302|Metabolic surgery|metabolic surgery
1450176|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
1450177|NCT00965289|Intensive chemotherapy|intensive chemotherapy
1450178|NCT00965289|Rituximab|rituximab
1450179|NCT00965289|ASCT|asct
1450180|NCT00965276|Adjuvant Therapy|adjuvant therapy
1450181|NCT00965276|Paclitaxel|paclitaxel
1450182|NCT00965276|Chemoresistance|chemoresistance
1450183|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
1450184|NCT00965276|Cell Survival|cell survival
1450185|NCT00965276|Breast Cancer|breast cancer
1450186|NCT00965263|Cocaine|cocaine
1450187|NCT00965263|immunotherapy|immunotherapy
1450188|NCT00965263|vaccination|vaccination
1450189|NCT00965263|antibody|antibody
1450190|NCT00965263|addiction|addiction
1450191|NCT00965263|dependence|dependence
1450192|NCT00965250|Thymic Malignancies|thymic malignancies
1450193|NCT00965250|IMC-A12|imc-a12
1450194|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
1450195|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
1450196|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
1450197|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
1450198|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
1450199|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
1450200|NCT00965198|Catheters, Indwelling|catheters, indwelling
1450201|NCT00965198|Biofilms|biofilms
1450202|NCT00965185|Cardiovascular Disease|cardiovascular disease
1450203|NCT00965185|HIV|hiv
1450204|NCT00965185|Atherosclerosis|atherosclerosis
1450205|NCT00965185|Inflammation|inflammation
1450206|NCT00965185|Statins|statins
1450207|NCT00965185|treatment experienced|treatment experienced
1450208|NCT00965172|Cancer|cancer
1450209|NCT00965172|Mucositis|mucositis
1450210|NCT00965172|Chemotherapy|chemotherapy
1450211|NCT00965172|Caphosol|caphosol
1450212|NCT00965172|Calcium phosphate|calcium phosphate
1450213|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
1450214|NCT00965172|Baking Soda Solution|baking soda solution
1450215|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
1450216|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
1450217|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
1450218|NCT00965120|Bradykinin|bradykinin
1450219|NCT00965120|Platelet activation|platelet activation
1450220|NCT00965120|Endothelial function|endothelial function
1450221|NCT00965068|Autism|autism
1450222|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
1450223|NCT00965068|Cholesterol|cholesterol
1450224|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1450225|NCT00965068|ASD|asd
1450226|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
1450227|NCT00965068|PPD-NOS|ppd-nos
1450228|NCT00965042|Ceftobiprole|ceftobiprole
1450229|NCT00965042|ZEVTERA|zevtera
1450230|NCT00965042|ZEFTERA|zeftera
1450231|NCT00965042|Intestinal Microflora|intestinal microflora
1450232|NCT00965029|COPD|copd
1450233|NCT00965029|Spirometry|spirometry
1450234|NCT00965029|Weaning|weaning
1450235|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
1450236|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
1450237|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
1450238|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
1450239|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
1450240|NCT00964990|JNJ-42160443|jnj-42160443
1450241|NCT00964977|pN1|pn1
1450242|NCT00964977|head and neck cancer|head and neck cancer
1450243|NCT00964977|radiation|radiation
1450244|NCT00964977|prognosis|prognosis
1450245|NCT00964977|comprehensive cohort design|comprehensive cohort design
1450246|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
1450247|NCT00964938|Hemodynamic response|hemodynamic response
1450248|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
1450249|NCT00964886|chronic pain|chronic pain
1450250|NCT00964886|back pain|back pain
1450251|NCT00964886|antidepressants|antidepressants
1450253|NCT00964873|STA-9090|sta-9090
1450254|NCT00964873|ganetespib|ganetespib
1450255|NCT00964873|Hematologic Cancers|hematologic cancers
1450256|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
1450257|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1450258|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
1450261|NCT00964873|CML|cml
1450262|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
1450263|NCT00964847|hypertension|hypertension
1450264|NCT00964847|cardiovascular disease|cardiovascular disease
1450265|NCT00964847|yoga|yoga
1450510|NCT00964106|pioglitazone|pioglitazone
1450266|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1450267|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1450268|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1450269|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1450270|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1450271|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1450272|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1450273|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1450274|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1450275|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1450276|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1450277|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1450278|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1450279|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1450280|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1450281|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1450282|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1450283|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1450284|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1450285|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1450286|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1450287|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1450288|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1450289|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1450290|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1450291|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1450292|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1450293|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1450294|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1450295|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1450296|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1450297|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1450298|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1450299|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1450300|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1450301|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1450302|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1450303|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1450304|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1450305|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1450306|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1450307|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1450308|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1450309|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1450310|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1450311|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1450312|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1450313|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1450314|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1450315|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1450316|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1450317|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1450318|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1450319|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1450320|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1450321|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1450322|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1450323|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1450324|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1450325|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1450326|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1450327|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1450328|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1450329|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1450330|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1450331|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1450332|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1450333|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1450334|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1450335|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1450336|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1450337|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1450338|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
1450339|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1450340|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1450341|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1450342|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1450343|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1450344|NCT00964821|primary myelofibrosis|primary myelofibrosis
1450345|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1450346|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1450347|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1450348|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1450349|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1450350|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
1450351|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
1450352|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
1450353|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
1450354|NCT00964821|aplastic anemia|aplastic anemia
1450355|NCT00964808|Hip fractures|hip fractures
1450356|NCT00964808|Treatment Outcome|treatment outcome
1450357|NCT00964808|Painkiller|painkiller
1450358|NCT00964795|Eyes|eyes
1450359|NCT00964795|Neovascular|neovascular
1450360|NCT00964795|Macular Degeneration|macular degeneration
1450361|NCT00964795|Retina|retina
1450363|NCT00964795|VEGF Trap-Eye|vegf trap-eye
1450364|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
1450365|NCT00964782|Fontan|fontan
1450366|NCT00964782|sildenafil|sildenafil
1450367|NCT00964782|exercise capacity|exercise capacity
1450368|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
1450369|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
1450370|NCT00964769|Aged|aged
1450371|NCT00964756|ovarian cancer|ovarian cancer
1450372|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
1450373|NCT00964743|Neurologic Oncology|neurologic oncology
1450374|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
1450375|NCT00964743|Brain and Nervous System|brain and nervous system
1450376|NCT00964743|Breast Cancer|breast cancer
1450377|NCT00964730|Thorough QT Study|thorough qt study
1450378|NCT00964730|Talampanel|talampanel
1450379|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
1450380|NCT00964730|Healthy Volunteers|healthy volunteers
1450381|NCT00964717|back pain|back pain
1450382|NCT00964717|neck pain|neck pain
1450383|NCT00964717|anxiety|anxiety
1450384|NCT00964717|range of motion|range of motion
1450385|NCT00964691|malaria|malaria
1450386|NCT00964691|IPTp|iptp
1450387|NCT00964691|Fansidar|fansidar
1450388|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
1450389|NCT00964691|pregnancy|pregnancy
1450390|NCT00964691|prophylaxis|prophylaxis
1450391|NCT00964691|Chloroquine|chloroquine
1450392|NCT00964691|Anemia|anemia
1450393|NCT00964691|Prevention|prevention
1450394|NCT00964691|Placental malaria|placental malaria
1450395|NCT00964691|Solomon Islands|solomon islands
1450396|NCT00964691|Low birth weight|low birth weight
1450397|NCT00964665|Hepatitis B,|hepatitis b,
1450398|NCT00964665|Chronic,|chronic,
1450399|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
1590984|NCT00427843|hip|hip
1450400|NCT00964652|treadmill|treadmill
1450401|NCT00964652|body load|body load
1450402|NCT00964652|Parkinson's disease|parkinson's disease
1450403|NCT00964652|gait|gait
1450404|NCT00964639|Pain|pain
1450405|NCT00964639|Postoperative|postoperative
1450406|NCT00964639|Local infiltration analgesia|local infiltration analgesia
1450407|NCT00964639|Cerebral palsy|cerebral palsy
1450408|NCT00964639|r-FLACC|r-flacc
1450409|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1450410|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1450411|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1450412|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1450413|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1450414|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1450415|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1450416|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1450417|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1450418|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1450419|NCT00964613|Pars Plana|pars plana
1450420|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
1450421|NCT00964613|Posterior capsule opacification|posterior capsule opacification
1450422|NCT00964613|visual outcome|visual outcome
1450423|NCT00964613|Complications|complications
1450424|NCT00964600|transversus abdominis block|transversus abdominis block
1450425|NCT00964600|postoperative pain|postoperative pain
1450426|NCT00964600|cesarean|cesarean
1450427|NCT00964587|diabetes self management education|diabetes self management education
1450428|NCT00964587|problem-solving training|problem-solving training
1450429|NCT00964587|health behavior change|health behavior change
1450430|NCT00964587|health literacy|health literacy
1450431|NCT00964548|vasospasm|vasospasm
1450432|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
1450433|NCT00964548|neurocritical care|neurocritical care
1450434|NCT00964548|dantrolene|dantrolene
1450435|NCT00964548|vasorelaxation|vasorelaxation
1450436|NCT00964522|Quality of life|quality of life
1450437|NCT00964522|Breast Cancer|breast cancer
1450438|NCT00964522|Nursing Care|nursing care
1450439|NCT00964522|Education|education
1450440|NCT00964522|Chemotherapy|chemotherapy
1450441|NCT00964496|vascular malformation|vascular malformation
1450442|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
1450443|NCT00964496|thalidomide|thalidomide
1450444|NCT00964483|Hypertension|hypertension
1450445|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
1450446|NCT00964457|cetuximab|cetuximab
1450447|NCT00964457|rectum cancer|rectum cancer
1450448|NCT00964457|radiation|radiation
1450449|NCT00964457|MRI|mri
1450450|NCT00964444|Labor and delivery|labor and delivery
1450451|NCT00964444|Vaginal delivery|vaginal delivery
1450452|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
1450453|NCT00964353|coumadine|coumadine
1450454|NCT00964353|genotype|genotype
1450455|NCT00964353|genes|genes
1450456|NCT00964353|Warfarin|warfarin
1450457|NCT00964327|TMC114-C201|tmc114-c201
1450458|NCT00964327|TMC114|tmc114
1450459|NCT00964327|HIV|hiv
1450460|NCT00964327|darunavir|darunavir
1450461|NCT00964314|advanced cancer|advanced cancer
1450462|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
1450463|NCT00964314|quality of life (QOL)|quality of life (qol)
1450464|NCT00964301|Asthma|asthma
1450465|NCT00964301|Low-income|low-income
1450466|NCT00964301|Quality of life|quality of life
1450467|NCT00964301|Children|children
1450468|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
1450469|NCT00964288|threshold tracking|threshold tracking
1450470|NCT00964288|pain|pain
1450471|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1450472|NCT00964275|thromboembolism|thromboembolism
1450473|NCT00964262|diabetes|diabetes
1450474|NCT00964262|exenatide|exenatide
1450475|NCT00964262|SR exenatide|sr exenatide
1450476|NCT00964262|Peptron|peptron
1450477|NCT00964236|sapropterin|sapropterin
1450478|NCT00964236|Kuvan|kuvan
1450479|NCT00964236|cognition|cognition
1450480|NCT00964236|brain|brain
1450481|NCT00964223|Acne vulgaris|acne vulgaris
1450482|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1450483|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
1450484|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1450485|NCT00964210|Chronic Renal Disease|chronic renal disease
1450486|NCT00964210|Solid Organ Transplant|solid organ transplant
1450487|NCT00964197|FemmeJock|femmejock
1450488|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
1450489|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
1450490|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1450491|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
1591042|NCT00427674|Imaging|imaging
1450492|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
1450493|NCT00964158|influenza infection|influenza infection
1450494|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1450495|NCT00964145|Nulliparous women|nulliparous women
1450496|NCT00964145|ultrasound|ultrasound
1450497|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
1450498|NCT00964132|NSCLC|nsclc
1450499|NCT00964132|Rexinoid|rexinoid
1450500|NCT00964132|NRX194204|nrx194204
1450501|NCT00964132|Lung Cancer|lung cancer
1450502|NCT00964132|RXR|rxr
1450503|NCT00964106|inducer|inducer
1450504|NCT00964106|midazolam|midazolam
1450505|NCT00964106|inhibitor|inhibitor
1450506|NCT00964106|rosiglitazone|rosiglitazone
1450507|NCT00964106|dextromethorphan|dextromethorphan
1450508|NCT00964106|caffeine|caffeine
1450513|NCT00964106|rosuvastatin|rosuvastatin
1450514|NCT00964106|probe drug|probe drug
1450515|NCT00964106|drug interaction|drug interaction
1450516|NCT00964106|flurbiprofen|flurbiprofen
1450517|NCT00964093|premature|premature
1450518|NCT00964093|infection|infection
1450519|NCT00964093|central line|central line
1450520|NCT00964093|very low birth weight|very low birth weight
1450521|NCT00964093|silver alginate|silver alginate
1450522|NCT00964093|Algidex|algidex
1450523|NCT00964093|neonatal|neonatal
1450524|NCT00964093|NICU|nicu
1450525|NCT00964067|rehabilitation outcome|rehabilitation outcome
1450526|NCT00964067|cardiac patients|cardiac patients
1450527|NCT00964067|exercise intensity|exercise intensity
1450528|NCT00964054|adolescents|adolescents
1450529|NCT00964054|exercise|exercise
1450530|NCT00964054|depression|depression
1450531|NCT00964054|dose response|dose response
1450532|NCT00964054|pilot study|pilot study
1450533|NCT00964041|Cognitive Impairment|cognitive impairment
1450534|NCT00964041|Neuroplasticity|neuroplasticity
1450535|NCT00964041|D-cycloserine|d-cycloserine
1450536|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
1450537|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
1450538|NCT00964041|Mental Disorders|mental disorders
1450539|NCT00964041|Psychotic Disorders|psychotic disorders
1450540|NCT00964041|Antitubercular Agents|antitubercular agents
1450541|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1450542|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
1450543|NCT00964028|Combined vaccine|combined vaccine
1450544|NCT00964015|colloid fluid|colloid fluid
1450545|NCT00964015|crystalloid fluid|crystalloid fluid
1450546|NCT00964015|surgery|surgery
1450547|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
1450548|NCT00964015|renal function|renal function
1450549|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
1450550|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
1450551|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
1450552|NCT00963989|Acute stroke|acute stroke
1450553|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
1450554|NCT00963989|Core infarct volume|core infarct volume
1450555|NCT00963989|Penumbra System|penumbra system
1450556|NCT00963989|Revascularization|revascularization
1450557|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
1450558|NCT00963989|mRS|mrs
1450559|NCT00963989|NIHSS|nihss
1450560|NCT00963989|Procedural serious adverse events|procedural serious adverse events
1450561|NCT00963989|All cause mortality|all cause mortality
1450562|NCT00963976|Stroke|stroke
1450563|NCT00963976|Hypertension|hypertension
1450564|NCT00963976|Cerebral Blood Flow|cerebral blood flow
1450565|NCT00963976|CT Perfusion|ct perfusion
1450566|NCT00963963|sexual health|sexual health
1450567|NCT00963963|adolescent health|adolescent health
1450568|NCT00963963|parent education|parent education
1450569|NCT00963963|HIV Seronegativity|hiv seronegativity
1450570|NCT00963963|treatment experienced|treatment experienced
1450571|NCT00963950|cholecystectomy|cholecystectomy
1450572|NCT00963937|adolescent|adolescent
1450573|NCT00963937|sumatriptan|sumatriptan
1450574|NCT00963937|children|children
1450575|NCT00963937|migraine|migraine
1450576|NCT00963924|Cognitive Impairment|cognitive impairment
1450577|NCT00963924|Neuroplasticity|neuroplasticity
1450578|NCT00963924|D-cycloserine|d-cycloserine
1450579|NCT00963924|NMDA|nmda
1450580|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
1450581|NCT00963924|Mental Disorders|mental disorders
1450582|NCT00963924|Psychotic Disorders|psychotic disorders
1450583|NCT00963924|Antitubercular Agents|antitubercular agents
1450584|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1450585|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
1450586|NCT00963911|colon cancer|colon cancer
1450587|NCT00963911|rectal cancer|rectal cancer
1450588|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
1591166|NCT00427297|HIV-1|hiv-1
1450589|NCT00963911|small cell lung cancer|small cell lung cancer
1450835|NCT00963209|phenotyping|phenotyping
1450590|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
1450591|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
1450592|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
1450593|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
1450594|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
1450595|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
1450596|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
1450597|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
1450598|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1450599|NCT00963911|prostate cancer|prostate cancer
1450600|NCT00963911|breast cancer|breast cancer
1450601|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
1450602|NCT00963898|Intravenous sedation|intravenous sedation
1450603|NCT00963898|Target controlled infusion|target controlled infusion
1450604|NCT00963898|Bispectral index|bispectral index
1450605|NCT00963898|Dental treatment|dental treatment
1450606|NCT00963898|Mental Retardation|mental retardation
1450607|NCT00963898|Deep sedation|deep sedation
1450608|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
1450609|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
1450610|NCT00963859|RA-PLND|ra-plnd
1450611|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
1450612|NCT00963859|O-PLND|o-plnd
1450613|NCT00963859|Radical Cystectomy|radical cystectomy
1450614|NCT00963859|Urinary diversion|urinary diversion
1450615|NCT00963859|Bladder|bladder
1450616|NCT00963846|schizophrenia|schizophrenia
1450617|NCT00963846|cognition|cognition
1450618|NCT00963846|functioning|functioning
1450619|NCT00963833|Multiple Sclerosis|multiple sclerosis
1450620|NCT00963833|MS|ms
1450621|NCT00963833|Non-interventional|non-interventional
1450622|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
1450623|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
1450624|NCT00963820|Drug therapy|drug therapy
1450625|NCT00963794|Rectal cancer|rectal cancer
1450626|NCT00963794|Population screening|population screening
1450627|NCT00963794|Early detection|early detection
1450628|NCT00963781|Coronary Artery Disease|coronary artery disease
1450629|NCT00963781|Drug-Eluting Stents|drug-eluting stents
1450630|NCT00963781|Coronary Thrombosis|coronary thrombosis
1450631|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1450632|NCT00963781|Coronary Restenosis|coronary restenosis
1450633|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1450634|NCT00963768|JNJ-28431754|jnj-28431754
1450635|NCT00963768|Canagliflozin|canagliflozin
1450636|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
1450637|NCT00963768|Pharmacokinetics|pharmacokinetics
1450638|NCT00963768|Pharmacodynamics|pharmacodynamics
1450639|NCT00963755|Imaging|imaging
1450640|NCT00963755|Positron emission tomography|positron emission tomography
1450641|NCT00963755|F-18-FCH|f-18-fch
1450642|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
1450643|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1450644|NCT00963742|cataract surgery|cataract surgery
1450645|NCT00963742|IOL|iol
1450646|NCT00963742|Intraocular lens|intraocular lens
1450647|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1450648|NCT00963729|recurrent breast cancer|recurrent breast cancer
1450649|NCT00963729|stage II breast cancer|stage ii breast cancer
1450650|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
1450651|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
1450652|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
1450653|NCT00963716|endobronchial biopsy|endobronchial biopsy
1450654|NCT00963716|bronchoscopy|bronchoscopy
1450655|NCT00963716|interventional pulmonology|interventional pulmonology
1450656|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
1450657|NCT00963677|difficult airways|difficult airways
1450658|NCT00963677|intubation|intubation
1450659|NCT00963664|melanoma|melanoma
1450660|NCT00963664|malignant melanoma|malignant melanoma
1450661|NCT00963664|interferon|interferon
1450662|NCT00963664|interferon alfa-2b|interferon alfa-2b
1450663|NCT00963664|Intron-A|intron-a
1450664|NCT00963664|Intron A|intron a
1450665|NCT00963664|Intron|intron
1450666|NCT00963664|lovastatin|lovastatin
1450667|NCT00963664|mevinolin|mevinolin
1450668|NCT00963664|Mevacor|mevacor
1450669|NCT00963664|statin|statin
1450670|NCT00963664|HRI|hri
1450671|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
1450672|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
1450673|NCT00963625|Blastocyst transfer|blastocyst transfer
1450674|NCT00963625|endometrial receptivity|endometrial receptivity
1450675|NCT00963625|IVF|ivf
1450676|NCT00963625|in vitro fertilization|in vitro fertilization
1567291|NCT00509678|Rituximab|rituximab
1450677|NCT00963625|embryo cryopreservation|embryo cryopreservation
1450678|NCT00963612|Microvascular Invasion|microvascular invasion
1450679|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
1450680|NCT00963560|ReSTOR +3|restor +3
1450681|NCT00963547|Documented to be HER2+|documented to be her2+
1450682|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
1450683|NCT00963534|Lenalidomide|lenalidomide
1450684|NCT00963534|Bendamustine|bendamustine
1450685|NCT00963534|Rituximab|rituximab
1450686|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
1450687|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
1450688|NCT00963534|Untreated patients|untreated patients
1450689|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
1450690|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1450691|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1450692|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1450693|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1450694|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1450695|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1450696|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1450697|NCT00963508|Head Lice|head lice
1450698|NCT00963495|clioquinol|clioquinol
1450699|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
1450700|NCT00963495|ALL|all
1450701|NCT00963495|HD|hd
1450702|NCT00963495|CLL|cll
1450703|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
1450704|NCT00963495|CML blast crisis|cml blast crisis
1450705|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
1450706|NCT00963482|Smoking|smoking
1450707|NCT00963482|Alcohol|alcohol
1450708|NCT00963482|Outcome|outcome
1450709|NCT00963482|Harm reduction|harm reduction
1450710|NCT00963482|Alcohol drinking|alcohol drinking
1450711|NCT00963482|Treatment outcome|treatment outcome
1450712|NCT00963482|Treatment effectiveness|treatment effectiveness
1450713|NCT00963443|Aspirin Complex|aspirin complex
1450714|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
1450715|NCT00963443|Pseudoephedrine|pseudoephedrine
1450716|NCT00963443|Common Cold|common cold
1450717|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
1450718|NCT00963417|osteoporosis|osteoporosis
1450719|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1450720|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1450721|NCT00963417|stage IA breast cancer|stage ia breast cancer
1450722|NCT00963417|stage IB breast cancer|stage ib breast cancer
1450723|NCT00963417|stage II breast cancer|stage ii breast cancer
1450724|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
1450725|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
1450726|NCT00963404|Fiducial marker|fiducial marker
1450727|NCT00963404|Adverse effects|adverse effects
1450728|NCT00963391|Health Production|health production
1450729|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
1450730|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
1450731|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
1450732|NCT00963391|Respiratory Tract Infections|respiratory tract infections
1450733|NCT00963391|Diarrhea|diarrhea
1450734|NCT00963391|Ethanol|ethanol
1450735|NCT00963391|Child, Preschool|child, preschool
1450736|NCT00963391|Handwashing|handwashing
1450737|NCT00963365|Phase 1|phase 1
1450738|NCT00963365|Healthy volunteers|healthy volunteers
1450739|NCT00963352|Colon cancer|colon cancer
1450740|NCT00963352|Open surgery resection|open surgery resection
1450741|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
1450742|NCT00963352|Morbidity|morbidity
1450743|NCT00963352|Mortality|mortality
1450744|NCT00963352|Metastases|metastases
1450745|NCT00963352|Oncology|oncology
1450746|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
1450747|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
1450748|NCT00963352|Examination of adverse markers|examination of adverse markers
1450749|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
1450750|NCT00963339|AMD|amd
1450751|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1450752|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1450753|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1450754|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1450755|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1567292|NCT00509678|Rituxan|rituxan
1450756|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1450757|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1450758|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1450759|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1450760|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1450761|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1450762|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1450763|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1450764|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1450765|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1450766|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1450767|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1450768|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1450769|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1450949|NCT00962728|tachycardia|tachycardia
1450770|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1450771|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1450772|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1450773|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1450774|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1450775|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1450776|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1450777|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1450778|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1450779|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1450780|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1450781|NCT00963326|tongue cancer|tongue cancer
1450782|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
1450783|NCT00963313|Adalimumab|adalimumab
1450784|NCT00963313|Humira|humira
1450785|NCT00963313|anti-TNF|anti-tnf
1450786|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1450787|NCT00963300|stage I prostate cancer|stage i prostate cancer
1450788|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
1450789|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
1450790|NCT00963300|stage III prostate cancer|stage iii prostate cancer
1450791|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
1450792|NCT00963287|alternative medicine|alternative medicine
1450793|NCT00963287|traditional Chinese medicine|traditional chinese medicine
1450794|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1450795|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1450796|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1450797|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1450798|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1450799|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1450800|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1450920|NCT00962884|Blood pressure|blood pressure
1450801|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1450802|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1450803|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1450804|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1450805|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1450806|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1450807|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1450808|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1450809|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1450810|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1450811|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1450812|NCT00963261|melanoma|melanoma
1450813|NCT00963261|interferon-a|interferon-a
1450814|NCT00963261|quality of life|quality of life
1450815|NCT00963261|psychological distress|psychological distress
1450816|NCT00963261|depressive symptoms|depressive symptoms
1450817|NCT00963261|side effects|side effects
1450819|NCT00963248|PTLD|ptld
1450820|NCT00963248|RTx|rtx
1450821|NCT00963248|pediatric|pediatric
1450822|NCT00963235|vaccine|vaccine
1450823|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
1450824|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
1450825|NCT00963222|Atherosclerosis|atherosclerosis
1450826|NCT00963222|Coronary Artery Disease|coronary artery disease
1450827|NCT00963222|Vitamin A|vitamin a
1450828|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1450829|NCT00963222|Th1 Cells|th1 cells
1450830|NCT00963222|Th2 Cells|th2 cells
1450831|NCT00963209|endocrine sensitive|endocrine sensitive
1450832|NCT00963209|breast cancer|breast cancer
1450833|NCT00963209|tamoxifen|tamoxifen
1450834|NCT00963209|genotyping|genotyping
1450836|NCT00963209|Pharmacokinetics|pharmacokinetics
1450837|NCT00963209|Endoxifen|endoxifen
1450838|NCT00963183|Safety|safety
1450839|NCT00963183|Tolerability|tolerability
1450840|NCT00963183|Healthy|healthy
1450841|NCT00963183|Inhalation|inhalation
1450842|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
1450843|NCT00963144|Gerd Questionnaire|gerd questionnaire
1450844|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
1450845|NCT00963118|Angelica keiskei|angelica keiskei
1450846|NCT00963118|Glycine max|glycine max
1450847|NCT00963118|metabolic syndrome|metabolic syndrome
1450848|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1450849|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
1450850|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
1450851|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1450852|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1450853|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
1450854|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
1450855|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
1450856|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
1450857|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
1450858|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
1450859|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
1450860|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
1450861|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
1450862|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
1450863|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
1450864|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
1450866|NCT00963079|in vitro fertilization|in vitro fertilization
1450867|NCT00963079|blastocyst transfer|blastocyst transfer
1450868|NCT00963079|endometrial receptivity|endometrial receptivity
1450869|NCT00963079|embryo cryopreservation|embryo cryopreservation
1450870|NCT00963066|NAVA|nava
1450871|NCT00963066|Acute Lung Injury|acute lung injury
1450872|NCT00963066|Pressure Support Ventilation|pressure support ventilation
1450873|NCT00963066|Intubation|intubation
1450874|NCT00963066|Tracheostomy|tracheostomy
1450875|NCT00963066|Mechanical ventilation|mechanical ventilation
1450876|NCT00963053|dysmenorrhoea|dysmenorrhoea
1450877|NCT00963053|dysmenorrhea|dysmenorrhea
1450878|NCT00963053|pain|pain
1450879|NCT00963053|pre-emptive|pre-emptive
1450880|NCT00963040|intranasal oxytocin|intranasal oxytocin
1450881|NCT00963040|acute headache treatment|acute headache treatment
1450882|NCT00963040|chronic daily headache|chronic daily headache
1450883|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
1450884|NCT00963027|Treprostinil|treprostinil
1450885|NCT00963027|Pharmacokinetics|pharmacokinetics
1450886|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
1450887|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1450888|NCT00963027|Esomeprazole|esomeprazole
1450889|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
1450890|NCT00963001|Treprostinil|treprostinil
1450891|NCT00963001|Pharmacokinetics|pharmacokinetics
1450892|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
1450893|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1450894|NCT00962988|Cerebrovascular disease|cerebrovascular disease
1450895|NCT00962988|stroke|stroke
1450896|NCT00962988|Transient Ischemic Attack|transient ischemic attack
1450897|NCT00962988|smoking cessation|smoking cessation
1450898|NCT00962988|Pharmacotherapy|pharmacotherapy
1450899|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
1450900|NCT00962949|POTS|pots
1450901|NCT00962949|Orthostatic intolerance|orthostatic intolerance
1450902|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
1450903|NCT00962936|HCV Genotype I infection|hcv genotype i infection
1450904|NCT00962936|Liver disease|liver disease
1450905|NCT00962923|Systemic sclerosis|systemic sclerosis
1450906|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
1450907|NCT00962923|Transplantation|transplantation
1450908|NCT00962910|Femoral Fractures|femoral fractures
1450909|NCT00962910|Critical Pathway|critical pathway
1450910|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1450911|NCT00962910|Safety|safety
1450912|NCT00962910|Efficiency|efficiency
1450913|NCT00962897|atherosclerosis|atherosclerosis
1450914|NCT00962897|covered stent|covered stent
1450915|NCT00962897|percutaneous intervention|percutaneous intervention
1450916|NCT00962897|stent|stent
1450917|NCT00962897|angioplasty|angioplasty
1450918|NCT00962884|Orthostatic hypotension|orthostatic hypotension
1450919|NCT00962884|Breathing|breathing
1450921|NCT00962884|standing|standing
1450922|NCT00962845|stage III melanoma|stage iii melanoma
1450923|NCT00962845|stage IV melanoma|stage iv melanoma
1450924|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
1450925|NCT00962832|SLE|sle
1450926|NCT00962819|Mumps|mumps
1450927|NCT00962819|Immunity|immunity
1450928|NCT00962819|Vaccine|vaccine
1450929|NCT00962819|Mumps antibodies|mumps antibodies
1450930|NCT00962819|Mumps immunity|mumps immunity
1450931|NCT00962806|Pediatric obesity|pediatric obesity
1450932|NCT00962806|Insulin resistance|insulin resistance
1450933|NCT00962806|Diabetes|diabetes
1450934|NCT00962806|Mitochondria|mitochondria
1450935|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
1450936|NCT00962780|vaccine|vaccine
1450937|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
1450938|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
1450939|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
1450940|NCT00962767|Oncology comparison study|oncology comparison study
1450941|NCT00962754|recording fluid balance|recording fluid balance
1450942|NCT00962754|reliability|reliability
1450943|NCT00962754|utility|utility
1450944|NCT00962754|sick neonate|sick neonate
1450945|NCT00962754|fluid balance|fluid balance
1450946|NCT00962754|inpatient|inpatient
1450947|NCT00962754|sick|sick
1450950|NCT00962728|orthostatic intolerance|orthostatic intolerance
1450951|NCT00962715|Leukemia|leukemia
1450953|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
1450954|NCT00962715|TIV|tiv
1450955|NCT00962715|Flu|flu
1450956|NCT00962715|Pegasys|pegasys
1450957|NCT00962715|Pegylated interferon|pegylated interferon
1450958|NCT00962715|Roferon|roferon
1450959|NCT00962715|Interferon|interferon
1450960|NCT00962702|Exclusion|exclusion
1450961|NCT00962702|Left Atrial Appendage|left atrial appendage
1450962|NCT00962702|Surgical|surgical
1450963|NCT00962702|Open chest|open chest
1450964|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
1450965|NCT00962689|biofilm|biofilm
1450966|NCT00962689|sinus tissue|sinus tissue
1450967|NCT00962689|nasal secretions|nasal secretions
1450968|NCT00962689|proteomics|proteomics
1450969|NCT00962689|diagnosis|diagnosis
1450970|NCT00962689|decreased antibiotics|decreased antibiotics
1450971|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
1450972|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
1450973|NCT00962676|immunocompromised patients|immunocompromised patients
1450974|NCT00962650|abdominal adhesions|abdominal adhesions
1450975|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
1450976|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
1450977|NCT00962650|NOTES|notes
1450978|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
1450979|NCT00962624|Meningococcal|meningococcal
1450980|NCT00962624|Vaccine|vaccine
1450981|NCT00962624|Meningitis|meningitis
1450982|NCT00962611|Solid tumors|solid tumors
1450983|NCT00962611|Advanced cancer|advanced cancer
1450984|NCT00962598|Adolescents|adolescents
1450985|NCT00962598|Major Depressive Disorder|major depressive disorder
1450986|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
1450987|NCT00962598|Immune System Activation|immune system activation
1450988|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
1450989|NCT00962572|Outcomes|outcomes
1450990|NCT00962572|Cancer|cancer
1450991|NCT00962572|Radiotherapy|radiotherapy
1450992|NCT00962572|Socio-economic|socio-economic
1450993|NCT00962546|cerebral aneurysm|cerebral aneurysm
1450994|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
1450995|NCT00962546|cerebral vasospasm|cerebral vasospasm
1450996|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
1450997|NCT00962546|computed tomographic angiography|computed tomographic angiography
1450998|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
1450999|NCT00962520|pancreatic cancer|pancreatic cancer
1451000|NCT00962520|resectable|resectable
1451001|NCT00962520|Tarceva|tarceva
1451002|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1451003|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1451004|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1451005|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1451006|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1451007|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1451008|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1451009|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1451010|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1567293|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
1451011|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1451012|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1451013|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1451014|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1451015|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1451016|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1451017|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1451018|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1451019|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1451020|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1451021|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1451022|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1451023|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1451024|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1451025|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1451026|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1451027|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
1451028|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1451029|NCT00962468|Critical Pathway|critical pathway
1451030|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
1451031|NCT00962468|Safety|safety
1451032|NCT00962468|Efficiency|efficiency
1451033|NCT00962455|Spirometry|spirometry
1451034|NCT00962455|Family Practice|family practice
1451035|NCT00962455|Randomized Controlled Trial|randomized controlled trial
1451036|NCT00962455|Feedback|feedback
1451037|NCT00962455|Intervention Studies|intervention studies
1451038|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
1451039|NCT00962442|N-Acetylcysteine|n-acetylcysteine
1451040|NCT00962442|enteral nutrition|enteral nutrition
1451041|NCT00962442|oxidative stress|oxidative stress
1451042|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
1451043|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
1451044|NCT00962416|Drug eluting stent|drug eluting stent
1451045|NCT00962416|Biolimus|biolimus
1451046|NCT00962416|Biodegradable stent|biodegradable stent
1451047|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
1451048|NCT00962416|Coronary artery disease|coronary artery disease
1451049|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
1451050|NCT00962403|yoga|yoga
1451051|NCT00962403|meditation|meditation
1451052|NCT00962403|military|military
1451053|NCT00962403|veteran|veteran
1451054|NCT00962403|trauma|trauma
1451055|NCT00962403|stress|stress
1451056|NCT00962403|depression|depression
1451057|NCT00962403|anxiety|anxiety
1451058|NCT00962403|insomnia|insomnia
1451059|NCT00962403|autonomic|autonomic
1451060|NCT00962377|molecular expression testing|molecular expression testing
1451061|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
1451062|NCT00962351|total hip replacement|total hip replacement
1451063|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
1451064|NCT00962351|metal ion|metal ion
1451065|NCT00962351|metal-on-metal|metal-on-metal
1451066|NCT00962338|convalescence|convalescence
1451067|NCT00962338|pain|pain
1451068|NCT00962338|nausea|nausea
1451069|NCT00962338|vomiting|vomiting
1451070|NCT00962338|sexual dysfunction|sexual dysfunction
1451071|NCT00962325|Physical activity|physical activity
1451072|NCT00962325|Obesity|obesity
1451073|NCT00962325|Bariatric surgery|bariatric surgery
1451074|NCT00962325|Weight Loss|weight loss
1451075|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1451076|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
1451077|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
1451078|NCT00962299|Child|child
1451079|NCT00962299|Wheezing|wheezing
1451080|NCT00962299|Dyspnea|dyspnea
1451081|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
1451082|NCT00962286|Furosemide|furosemide
1451083|NCT00962286|obesity|obesity
1451084|NCT00962273|health personnel|health personnel
1451085|NCT00962273|communicable diseases|communicable diseases
1451086|NCT00962273|stress, psychological|stress, psychological
1451087|NCT00962273|resilience, psychological|resilience, psychological
1451088|NCT00962273|disaster planning|disaster planning
1451089|NCT00962273|education|education
1451090|NCT00962273|online|online
1451091|NCT00962260|glucocerebrosidase|glucocerebrosidase
1451092|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
1451093|NCT00962260|Gaucher disease|gaucher disease
1451094|NCT00962260|plant cell culture|plant cell culture
1451095|NCT00962260|splenomegaly|splenomegaly
1451096|NCT00962260|hepatomegaly|hepatomegaly
1451097|NCT00962260|anemia|anemia
1451098|NCT00962260|thrombocytopenia|thrombocytopenia
1451099|NCT00962247|physical activity|physical activity
1451100|NCT00962247|relative reinforcing value|relative reinforcing value
1451101|NCT00962247|sedentary behavior|sedentary behavior
1451102|NCT00962247|obesity|obesity
1451103|NCT00962234|Lipogenesis|lipogenesis
1451104|NCT00962234|Lipolysis|lipolysis
1451105|NCT00962234|Phospholipids|phospholipids
1451106|NCT00962234|Body Composition|body composition
1451107|NCT00962234|Nutritional Status|nutritional status
1451108|NCT00962234|Lipid Metabolism|lipid metabolism
1451109|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
1451110|NCT00962208|children|children
1451111|NCT00962208|corneal reshaping|corneal reshaping
1451112|NCT00962208|myopia|myopia
1451113|NCT00962208|myopia control|myopia control
1451114|NCT00962208|orthokeratology|orthokeratology
1451115|NCT00962195|health|health
1451116|NCT00962195|blood pressure|blood pressure
1451117|NCT00962195|liver enzymes|liver enzymes
1451118|NCT00962195|insulin resistance|insulin resistance
1451119|NCT00962182|celiac disease|celiac disease
1451120|NCT00962182|transglutaminase antibody|transglutaminase antibody
1451121|NCT00962169|Guideline adherence|guideline adherence
1451122|NCT00962169|Implementation|implementation
1451123|NCT00962169|Physical therapy|physical therapy
1451124|NCT00962169|Low back pain|low back pain
1451125|NCT00962169|Health plan implementation|health plan implementation
1451126|NCT00962156|Sepsis|sepsis
1451127|NCT00962156|Shock|shock
1451128|NCT00962156|Fluid therapy|fluid therapy
1451129|NCT00962156|Plasma expanders|plasma expanders
1451130|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
1451131|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
1451132|NCT00962130|tissue perfusion|tissue perfusion
1451133|NCT00962130|reconstructive surgery|reconstructive surgery
1451134|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
1451135|NCT00962117|Food Reinforcement|food reinforcement
1451136|NCT00962117|Energy Intake|energy intake
1451137|NCT00962117|Obesity|obesity
1451138|NCT00962117|Dopamine|dopamine
1451139|NCT00962104|ADHD|adhd
1451140|NCT00962091|Area under the plasma concentration versus time curve (AUC)|area under the plasma concentration versus time curve (auc)
1451141|NCT00962091|Maximum plasma concentration (Cmax)|maximum plasma concentration (cmax)
1451142|NCT00962091|Area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (AUC0-tlast)|area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (auc0-tlast)
1451143|NCT00962091|Confidence intervals (CI)|confidence intervals (ci)
1451144|NCT00962091|Time of first observed maximum plasma concentration (Tmax)|time of first observed maximum plasma concentration (tmax)
1451145|NCT00962078|COPD|copd
1451146|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
1451147|NCT00962078|Intervall versus continuous training|intervall versus continuous training
1451148|NCT00962078|6 MWD|6 mwd
1451149|NCT00962039|Abdominal Pain|abdominal pain
1451150|NCT00962039|Anxiety|anxiety
1451151|NCT00962026|Interleukin 1|interleukin 1
1451152|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
1451153|NCT00962026|Rilonacept|rilonacept
1451154|NCT00962026|Arcalyst|arcalyst
1451155|NCT00962000|Hemodialysis|hemodialysis
1451156|NCT00962000|Dialysis, Renal|dialysis, renal
1451157|NCT00961987|Maternity care|maternity care
1451158|NCT00961987|Interprofessional collaboration|interprofessional collaboration
1451159|NCT00961987|Continuity of Care|continuity of care
1451160|NCT00961987|Integration|integration
1451161|NCT00961974|type 1 diabetes|type 1 diabetes
1451162|NCT00961974|hemoglobin A1c|hemoglobin a1c
1451163|NCT00961974|family|family
1451164|NCT00961974|involvement|involvement
1451165|NCT00961974|responsibility|responsibility
1451166|NCT00961974|conflict|conflict
1451167|NCT00961974|quality of life|quality of life
1451168|NCT00961974|children|children
1451169|NCT00961961|Bipolar Disorder|bipolar disorder
1451170|NCT00961961|Manic Depression|manic depression
1451171|NCT00961961|Major Depressive Episode|major depressive episode
1451172|NCT00961961|Mania|mania
1451173|NCT00961961|Hypomania|hypomania
1451174|NCT00961961|Long Term Treatment|long term treatment
1451175|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
1451176|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
1451177|NCT00961948|Confocal Microscopy|confocal microscopy
1451178|NCT00961935|bipolar disorder|bipolar disorder
1451179|NCT00961935|child bipolar disorder|child bipolar disorder
1451180|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
1451181|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
1451182|NCT00961935|fMRI|fmri
1451183|NCT00961935|MRI|mri
1451184|NCT00961935|EEG|eeg
1451185|NCT00961935|neurocognitive tasks|neurocognitive tasks
1451186|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
1451187|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
1451188|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
1451189|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
1451190|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
1451191|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
1451192|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
1451193|NCT00961883|HIV|hiv
1451194|NCT00961883|Vaccine|vaccine
1451195|NCT00961883|HIV Seronegativity|hiv seronegativity
1451196|NCT00961883|Preventive Vaccine|preventive vaccine
1451197|NCT00961870|bone|bone
1451198|NCT00961870|motor neuron excitability|motor neuron excitability
1451199|NCT00961870|forearm vibration|forearm vibration
1451200|NCT00961870|Mechanical Loading|mechanical loading
1451201|NCT00961831|Neoplasm|neoplasm
1451202|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
1451203|NCT00961831|PET tracer|pet tracer
1451204|NCT00961818|Voice|voice
1451205|NCT00961818|Voice Quality|voice quality
1451206|NCT00961818|Voice Training|voice training
1451207|NCT00961818|Evaluation|evaluation
1451208|NCT00961805|Fibromyalgia|fibromyalgia
1451209|NCT00961805|Treatment|treatment
1451210|NCT00961805|Dance|dance
1451211|NCT00961805|Randomized controlled study|randomized controlled study
1451212|NCT00961805|Exercise|exercise
1451213|NCT00961753|PDA|pda
1451214|NCT00961753|Ibuprofen|ibuprofen
1451215|NCT00961753|Preterm|preterm
1451216|NCT00961753|Neonate|neonate
1451217|NCT00961740|Childhood Obesity|childhood obesity
1451218|NCT00961740|CBT|cbt
1451219|NCT00961740|Family|family
1451220|NCT00961740|Lifestyle change|lifestyle change
1451221|NCT00961727|Bedside Pews|bedside pews
1451222|NCT00961727|Credit Valley Hospital|credit valley hospital
1451223|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
1451224|NCT00961727|clinically deteriorating|clinically deteriorating
1451225|NCT00961714|VCF|vcf
1451226|NCT00961688|PCOS|pcos
1451227|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
1451228|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
1451229|NCT00961688|infertility|infertility
1451230|NCT00961688|ovulation|ovulation
1451231|NCT00961675|otitis|otitis
1451232|NCT00961675|acute|acute
1451233|NCT00961675|externa|externa
1451234|NCT00961675|ear|ear
1451235|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
1451236|NCT00961649|Ocular Hypertension|ocular hypertension
1451237|NCT00961649|Brinzolamide|brinzolamide
1451238|NCT00961649|Brimonidine|brimonidine
1451239|NCT00961649|Intraocular Pressure|intraocular pressure
1451240|NCT00961610|internet support|internet support
1451241|NCT00961610|cancer|cancer
1451242|NCT00961610|rehabilitation|rehabilitation
1451243|NCT00961597|Meniscus|meniscus
1451244|NCT00961597|Avascular region|avascular region
1451245|NCT00961597|Platelet rich plasma|platelet rich plasma
1451246|NCT00961571|colorectal cancer|colorectal cancer
1451247|NCT00961571|sunitinib|sunitinib
1451248|NCT00961571|capecitabine|capecitabine
1451249|NCT00961558|varicocelectomy|varicocelectomy
1451250|NCT00961558|male infertility|male infertility
1451251|NCT00961558|clinical varicoceles|clinical varicoceles
1451252|NCT00961558|randomized control trial|randomized control trial
1451253|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
1451254|NCT00961532|platelets|platelets
1451255|NCT00961506|cholecystectomy|cholecystectomy
1451256|NCT00961506|gallbladder|gallbladder
1451257|NCT00961506|laparoscopy|laparoscopy
1451258|NCT00961506|laparoendoscopic|laparoendoscopic
1451259|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
1451260|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
1451261|NCT00961441|Levetiracetam|levetiracetam
1451262|NCT00961441|Epilepsy|epilepsy
1451263|NCT00961441|Children|children
1451264|NCT00961441|Adults|adults
1451265|NCT00961428|Anorexia Nervosa|anorexia nervosa
1451266|NCT00961428|Eating Disorders|eating disorders
1451267|NCT00961428|Exercise|exercise
1451268|NCT00961428|Physical Activity|physical activity
1451269|NCT00961402|Exercise|exercise
1451270|NCT00961402|PostParum Depression|postparum depression
1451271|NCT00961389|delirium|delirium
1451272|NCT00961389|critical care|critical care
1451273|NCT00961389|risk factors|risk factors
1451274|NCT00961389|prediction|prediction
1451275|NCT00961389|inflammation|inflammation
1451276|NCT00961376|melanoma|melanoma
1451277|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
1451278|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
1451279|NCT00961337|school children|school children
1451280|NCT00961337|influenza vaccination|influenza vaccination
1451281|NCT00961337|vaccine effectiveness|vaccine effectiveness
1451282|NCT00961337|influenza attack rate|influenza attack rate
1451283|NCT00961337|absenteeism|absenteeism
1451284|NCT00961337|Influenza vaccine|influenza vaccine
1451285|NCT00961311|Balloon|balloon
1451286|NCT00961311|Angioplasty|angioplasty
1451287|NCT00961311|Coronary Artery|coronary artery
1451289|NCT00961311|PTCA|ptca
1451290|NCT00961311|Heart Disease|heart disease
1451291|NCT00961311|Myocardial Ischemia|myocardial ischemia
1451292|NCT00961298|IBS|ibs
1451293|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
1451295|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
1451296|NCT00961285|pharmacogenomics|pharmacogenomics
1451297|NCT00961285|genotyping|genotyping
1451298|NCT00961272|Pre-menopausal|pre-menopausal
1451299|NCT00961272|Pharmacokinetics|pharmacokinetics
1451300|NCT00961272|Raltegravir|raltegravir
1451301|NCT00961272|Women|women
1451302|NCT00961272|HIV-infected|hiv-infected
1451303|NCT00961259|healthy|healthy
1451304|NCT00961259|pharmacokinetics|pharmacokinetics
1451305|NCT00961259|therapeutic equivalency|therapeutic equivalency
1451306|NCT00961259|fenofibric acid|fenofibric acid
1451307|NCT00961246|web based intervention|web based intervention
1451308|NCT00961246|individually-tailored|individually-tailored
1451309|NCT00961246|Chinese-American children|chinese-american children
1451310|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
1451311|NCT00961246|changes in dietary intake|changes in dietary intake
1451312|NCT00961246|changes in coping strategy used|changes in coping strategy used
1451313|NCT00961246|changes in BMI|changes in bmi
1451314|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
1451315|NCT00961194|Ketamine|ketamine
1451316|NCT00961194|pain|pain
1451317|NCT00961194|neuropathic pain|neuropathic pain
1451318|NCT00961194|chronic|chronic
1451319|NCT00961181|paclitaxel|paclitaxel
1451320|NCT00961181|in-stent restenosis|in-stent restenosis
1451321|NCT00961181|BMS-ISR|bms-isr
1451322|NCT00961181|DES-ISR|des-isr
1451323|NCT00961181|drug eluting balloon|drug eluting balloon
1451324|NCT00961168|Mechanical Ventilation|mechanical ventilation
1451325|NCT00961155|asthma|asthma
1451326|NCT00961155|children|children
1451327|NCT00961155|EBC|ebc
1451328|NCT00961155|exposure to tabacco|exposure to tabacco
1451329|NCT00961155|antiasthma treatment|antiasthma treatment
1451532|NCT00960349|Japanese|japanese
1451330|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
1451331|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
1451332|NCT00961142|AML|aml
1451333|NCT00961142|ALL|all
1451334|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
1451335|NCT00961129|colorectal cancer|colorectal cancer
1451336|NCT00961129|needs|needs
1451337|NCT00961129|survivors|survivors
1451338|NCT00961129|any stage|any stage
1451339|NCT00961116|healthy|healthy
1451340|NCT00961116|pharmacokinetics|pharmacokinetics
1451341|NCT00961116|therapeutic equivalency|therapeutic equivalency
1451342|NCT00961116|fasting|fasting
1451343|NCT00961116|procetofen|procetofen
1451344|NCT00961116|fenofibric acid|fenofibric acid
1451345|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
1451346|NCT00961103|motor development|motor development
1451347|NCT00961103|orthoses|orthoses
1451348|NCT00961090|Brain tumor|brain tumor
1451349|NCT00961090|glioma|glioma
1451350|NCT00961090|surgical resection|surgical resection
1451351|NCT00961090|ALA|ala
1451352|NCT00961090|ultraviolet light|ultraviolet light
1451353|NCT00961077|elderly|elderly
1451354|NCT00961077|S-1|s-1
1451355|NCT00961077|Oxaliplatin|oxaliplatin
1451356|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
1451357|NCT00961064|Promacta|promacta
1451358|NCT00961064|Thrombocytopenia|thrombocytopenia
1451359|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
1451360|NCT00961064|MDS|mds
1451361|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
1451362|NCT00961038|Ciprofloxacin|ciprofloxacin
1451363|NCT00961038|Inhalation|inhalation
1451364|NCT00961038|Pharmacokinetics|pharmacokinetics
1451365|NCT00961038|Safety|safety
1451366|NCT00961038|Tolerability|tolerability
1451367|NCT00961038|COPD|copd
1451368|NCT00961012|Randomized control trial|randomized control trial
1451369|NCT00961012|pressure mapping|pressure mapping
1451370|NCT00961012|High Fowler's position|high fowler's position
1451371|NCT00961012|bed|bed
1451372|NCT00961012|ventilation|ventilation
1451373|NCT00961012|slow vital capacity|slow vital capacity
1451374|NCT00961012|older adult population|older adult population
1451375|NCT00961012|65 years and older|65 years and older
1451376|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1451377|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
1451378|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
1451379|NCT00960999|large cell lung cancer|large cell lung cancer
1451380|NCT00960973|vitamin K|vitamin k
1451381|NCT00960973|beta cell|beta cell
1451382|NCT00960973|glucose metabolism|glucose metabolism
1451383|NCT00960973|insulin resistance|insulin resistance
1451384|NCT00960960|MBC|mbc
1451385|NCT00960960|PI3K|pi3k
1451386|NCT00960960|Avastin|avastin
1451387|NCT00960960|Herceptin|herceptin
1451388|NCT00960934|Osteoporosis|osteoporosis
1451389|NCT00960934|Postmenopausal|postmenopausal
1451390|NCT00960934|MK-5442|mk-5442
1451391|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
1451392|NCT00960921|Hypoxia|hypoxia
1451393|NCT00960921|Iron|iron
1451394|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
1451395|NCT00960921|High altitude|high altitude
1451396|NCT00960908|Zotarolimus|zotarolimus
1451397|NCT00960908|Drug eluting stent|drug eluting stent
1451398|NCT00960908|Endeavor Resolute|endeavor resolute
1451399|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1451400|NCT00960895|Pulmonary hypertension|pulmonary hypertension
1451401|NCT00960882|Pharmacokinetics|pharmacokinetics
1451402|NCT00960882|Diabetes|diabetes
1451403|NCT00960882|gastric tolerability|gastric tolerability
1451404|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
1451405|NCT00960856|pharmacokinetics|pharmacokinetics
1451406|NCT00960843|Morbid Obesity|morbid obesity
1451407|NCT00960843|Gastric Banding|gastric banding
1451408|NCT00960843|Bariatric Banding|bariatric banding
1451409|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
1451410|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
1451412|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
1451413|NCT00960791|absorption|absorption
1451414|NCT00960791|distribution|distribution
1451415|NCT00960791|metabolism|metabolism
1451416|NCT00960791|excretion|excretion
1451417|NCT00960791|14C-labelled|14c-labelled
1451418|NCT00960778|gender|gender
1451419|NCT00960778|nicotine dependence|nicotine dependence
1451420|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
1451421|NCT00960778|extinction|extinction
1451422|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
1451423|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1451424|NCT00960765|Gastric Bypass|gastric bypass
1451425|NCT00960765|Gastric Banding|gastric banding
1451426|NCT00960765|Endotoxin|endotoxin
1451427|NCT00960752|gp100 peptide|gp100 peptide
1451428|NCT00960752|MAGE-3 peptide|mage-3 peptide
1451429|NCT00960752|R848|r848
1451430|NCT00960752|Resiquimod|resiquimod
1451431|NCT00960752|Toll Like Receptor|toll like receptor
1451432|NCT00960752|TLR|tlr
1451433|NCT00960752|T-cells|t-cells
1451434|NCT00960752|Tumor|tumor
1451435|NCT00960752|Metastatic|metastatic
1451436|NCT00960752|Lesions|lesions
1451437|NCT00960752|Injection Site|injection site
1451438|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
1451439|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1451440|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
1451441|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
1451442|NCT00960726|Leukemia|leukemia
1451443|NCT00960726|NOV-002|nov-002
1451444|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
1451445|NCT00960726|MDS|mds
1451446|NCT00960713|observational cohort|observational cohort
1451447|NCT00960713|rituximab|rituximab
1451448|NCT00960713|off-label use|off-label use
1451449|NCT00960713|auto-immunity|auto-immunity
1451450|NCT00960713|cytopenia|cytopenia
1451451|NCT00960700|MFlex|mflex
1451452|NCT00960700|Multifocal|multifocal
1451453|NCT00960700|630F|630f
1451454|NCT00960687|healthy|healthy
1451455|NCT00960687|pharmacokinetics|pharmacokinetics
1451456|NCT00960687|therapeutic equivalency|therapeutic equivalency
1451457|NCT00960661|diabetes|diabetes
1451458|NCT00960661|exenatide|exenatide
1451459|NCT00960661|Byetta|byetta
1451460|NCT00960661|insulin lispro|insulin lispro
1451461|NCT00960661|Humalog|humalog
1451462|NCT00960661|insulin glargine|insulin glargine
1451463|NCT00960661|Lantus|lantus
1451464|NCT00960661|Amylin|amylin
1451465|NCT00960661|Lilly|lilly
1451466|NCT00960648|Everolimus|everolimus
1451467|NCT00960648|Sirolimus|sirolimus
1451468|NCT00960648|Drug eluting stent|drug eluting stent
1451469|NCT00960635|new-onset|new-onset
1451470|NCT00960622|treatment experienced|treatment experienced
1451471|NCT00960609|Communicating veins|communicating veins
1451472|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
1451473|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
1451474|NCT00960609|hepatic resection|hepatic resection
1451475|NCT00960609|hepatic neoplasm|hepatic neoplasm
1451476|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
1451477|NCT00960596|educational intervention|educational intervention
1451478|NCT00960596|asthma|asthma
1451479|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
1451480|NCT00960596|children|children
1451481|NCT00960583|Chronic low back pain|chronic low back pain
1451482|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
1451483|NCT00960583|Exercise|exercise
1451484|NCT00960583|Cost-effectiveness|cost-effectiveness
1451485|NCT00960570|healthy|healthy
1451486|NCT00960570|adult|adult
1451487|NCT00960570|efavirenz|efavirenz
1451488|NCT00960570|fenofibric acid|fenofibric acid
1451489|NCT00960570|blood levels|blood levels
1451490|NCT00960557|hepatic tumor burden|hepatic tumor burden
1451491|NCT00960557|liver cancer|liver cancer
1451492|NCT00960557|liver carcinoma|liver carcinoma
1451493|NCT00960557|carcinoma|carcinoma
1451494|NCT00960557|hepatic cancer|hepatic cancer
1451495|NCT00960557|hepatic carcinoma|hepatic carcinoma
1451496|NCT00960557|VDA|vda
1451497|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
1451498|NCT00960544|Capecitabine|capecitabine
1451499|NCT00960544|Xeloda|xeloda
1451500|NCT00960544|Gene expression|gene expression
1451501|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
1451502|NCT00960544|PK sampling|pk sampling
1451503|NCT00960544|DNA analysis|dna analysis
1451504|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
1451505|NCT00960518|TACE|tace
1451506|NCT00960518|adefovir|adefovir
1451507|NCT00960518|recurrence rate|recurrence rate
1451508|NCT00960505|Diet|diet
1451509|NCT00960505|Coronary heart disease|coronary heart disease
1451510|NCT00960505|Obesity|obesity
1451511|NCT00960505|Weight loss|weight loss
1451512|NCT00960505|Weight maintenance|weight maintenance
1451513|NCT00960492|Astrocytic tumor|astrocytic tumor
1451514|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
1451515|NCT00960466|Stress, Psychological|stress, psychological
1451516|NCT00960466|Neoplasms/psychology|neoplasms/psychology
1451517|NCT00960466|Psychology|psychology
1451518|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
1451519|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1451520|NCT00960427|stage II rectal cancer|stage ii rectal cancer
1451521|NCT00960427|stage III rectal cancer|stage iii rectal cancer
1451522|NCT00960414|obesity|obesity
1451523|NCT00960414|randomized controlled trial|randomized controlled trial
1451524|NCT00960414|weight loss|weight loss
1451525|NCT00960414|metabolic syndrome|metabolic syndrome
1451526|NCT00960401|coronary calcium scoring|coronary calcium scoring
1451527|NCT00960401|breast cancer patients|breast cancer patients
1451528|NCT00960401|radiation treatment|radiation treatment
1451529|NCT00960375|smoking cessation|smoking cessation
1451530|NCT00960375|serious mental illness|serious mental illness
1451531|NCT00960349|Gastric cancer|gastric cancer
1451533|NCT00960349|PhI|phi
1451534|NCT00960349|Safety and tolerability|safety and tolerability
1451535|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
1451536|NCT00960349|Cediranib|cediranib
1451537|NCT00960349|Capecitabine|capecitabine
1451539|NCT00960349|Cisplatin|cisplatin
1451540|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
1451541|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
1451542|NCT00960336|recurrent breast cancer|recurrent breast cancer
1451543|NCT00960336|stage IV breast cancer|stage iv breast cancer
1451544|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1451545|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1451546|NCT00960323|pharmacokinetics|pharmacokinetics
1451547|NCT00960310|Treatment|treatment
1451548|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
1451549|NCT00960297|NSCLC|nsclc
1451550|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
1451551|NCT00960297|Bevacizumab|bevacizumab
1451552|NCT00960297|Avastin|avastin
1451553|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
1451554|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
1451555|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
1451556|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1451557|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
1451558|NCT00960271|mediastinal lymph node|mediastinal lymph node
1451559|NCT00960271|resectable|resectable
1451560|NCT00960271|EBUS|ebus
1451561|NCT00960271|stage IIIA|stage iiia
1451562|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
1451563|NCT00960258|Solid Tumors|solid tumors
1451564|NCT00960232|vitamin D|vitamin d
1451565|NCT00960232|blood pressure|blood pressure
1451566|NCT00960232|lipids|lipids
1451567|NCT00960232|infection|infection
1451568|NCT00960232|depression|depression
1451569|NCT00960193|blood levels over time|blood levels over time
1451570|NCT00960193|colchicine|colchicine
1451571|NCT00960193|seville orange juice|seville orange juice
1451572|NCT00960193|pharmacokinetics|pharmacokinetics
1451573|NCT00960167|HCC|hcc
1451574|NCT00960167|radiotherapy|radiotherapy
1451575|NCT00960167|dose escalation|dose escalation
1451576|NCT00960167|Toxicity|toxicity
1451577|NCT00960167|Local control|local control
1451578|NCT00960154|Lumpectomy|lumpectomy
1451579|NCT00960154|PlasmaBlade|plasmablade
1451580|NCT00960154|Electrosurgery|electrosurgery
1451581|NCT00960154|PEAK Surgical|peak surgical
1451582|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
1451583|NCT00960154|Medtronic|medtronic
1451584|NCT00960115|NSCLC|nsclc
1451585|NCT00960115|Stage III|stage iii
1451586|NCT00960115|EMD531444|emd531444
1451587|NCT00960115|L-BLP25|l-blp25
1451588|NCT00960115|Cyclophosphamide|cyclophosphamide
1451589|NCT00960115|Immunotherapy|immunotherapy
1451590|NCT00960115|Tecemotide|tecemotide
1451591|NCT00960102|cochlear implantation|cochlear implantation
1451592|NCT00960089|Toenail|toenail
1451593|NCT00960089|Fungus|fungus
1567294|NCT00509678|Arthritis|arthritis
1451594|NCT00960089|Onychomycosis|onychomycosis
1451595|NCT00960089|Dermatophyte|dermatophyte
1451596|NCT00960076|T2DM|t2dm
1451597|NCT00960076|Metformin|metformin
1451598|NCT00960076|A1c|a1c
1451599|NCT00960037|Vitamin D3|vitamin d3
1451600|NCT00960037|obesity|obesity
1451601|NCT00960037|cholecalciferol|cholecalciferol
1451602|NCT00960024|Vocational rehabilitation|vocational rehabilitation
1451603|NCT00960024|Severe mental illness|severe mental illness
1451604|NCT00960024|Psychosis|psychosis
1451605|NCT00960024|Mental Health|mental health
1451606|NCT00960011|Inguinal hernia|inguinal hernia
1451607|NCT00960011|mesh|mesh
1451608|NCT00960011|progrip|progrip
1451609|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
1451610|NCT00959985|compression sleeve|compression sleeve
1451611|NCT00959985|compression bandage|compression bandage
1451612|NCT00959972|Varenicline|varenicline
1452110|NCT00957788|ear|ear
1451613|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
1451614|NCT00959972|cardiovascular disease|cardiovascular disease
1451615|NCT00959972|prevention|prevention
1451616|NCT00959972|coronary heart disease|coronary heart disease
1451617|NCT00959972|Smoking cessation|smoking cessation
1451618|NCT00959959|CRPC|crpc
1451619|NCT00959959|HRPC|hrpc
1451620|NCT00959959|TOK-001|tok-001
1451621|NCT00959959|ARMOR|armor
1451622|NCT00959959|ARMOR1|armor1
1451623|NCT00959946|Phase 1/2|phase 1/2
1451624|NCT00959946|2-part study|2-part study
1451625|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
1451626|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
1451627|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
1451628|NCT00959920|Labor and Delivery|labor and delivery
1451629|NCT00959920|Time to delivery during labor|time to delivery during labor
1451630|NCT00959907|Muscular activity|muscular activity
1451631|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
1451632|NCT00959907|action halos|action halos
1451633|NCT00959894|HIV|hiv
1451634|NCT00959894|Infection|infection
1451635|NCT00959894|Treatment Naive|treatment naive
1451636|NCT00959894|Adults|adults
1451637|NCT00959894|Once|once
1451638|NCT00959894|Daily|daily
1451639|NCT00959894|Etravirine|etravirine
1451640|NCT00959894|HIV-1 Infection|hiv-1 infection
1451641|NCT00959881|Alzheimer Disease|alzheimer disease
1451642|NCT00959868|Bladder cancer|bladder cancer
1451643|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
1451644|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
1451645|NCT00959868|Transurethral resection|transurethral resection
1451646|NCT00959868|Radical cystectomy|radical cystectomy
1451647|NCT00959868|OGX-427|ogx-427
1451648|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
1451649|NCT00959868|Heat shock protein 27|heat shock protein 27
1451650|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
1451651|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
1451652|NCT00959855|COPD|copd
1451653|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
1451654|NCT00959855|Inflammation|inflammation
1451655|NCT00959855|Oxidative Stress|oxidative stress
1451656|NCT00959855|Steps|steps
1451657|NCT00959855|Free Living Activities|free living activities
1451658|NCT00959855|Exacerbation|exacerbation
1451659|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
1451660|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
1451661|NCT00959842|Lipoprotein|lipoprotein
1451662|NCT00959842|Statin|statin
1451663|NCT00959842|Lovaza|lovaza
1451664|NCT00959829|Communication|communication
1451665|NCT00959829|Complementary Therapies|complementary therapies
1451666|NCT00959829|Intensive Care|intensive care
1451667|NCT00959829|Ethics|ethics
1451668|NCT00959816|Volunteers|volunteers
1451669|NCT00959803|Phase 1|phase 1
1451670|NCT00959803|Pharmacokinetics|pharmacokinetics
1451671|NCT00959803|Healthy Young Adult|healthy young adult
1451672|NCT00959803|Japanese|japanese
1451673|NCT00959803|Healthy Elderly|healthy elderly
1451674|NCT00959803|Alzheimer disease|alzheimer disease
1451675|NCT00959790|Health|health
1451676|NCT00959790|Obesity|obesity
1451677|NCT00959790|Oxidative stress|oxidative stress
1451678|NCT00959790|Challenge concept|challenge concept
1451679|NCT00959790|Vegetables|vegetables
1451680|NCT00959751|migraine|migraine
1451681|NCT00959738|loop ileostomy|loop ileostomy
1451682|NCT00959738|quality of life|quality of life
1451683|NCT00959738|morbidity|morbidity
1451684|NCT00959738|Rectal Neoplasms|rectal neoplasms
1451685|NCT00959725|Infliximab|infliximab
1451686|NCT00959725|Diabetes|diabetes
1451687|NCT00959725|Macular Edema|macular edema
1451688|NCT00959699|coinfection|coinfection
1451689|NCT00959699|protease inhibitor|protease inhibitor
1451690|NCT00959699|HIV|hiv
1451691|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
1451692|NCT00959660|Diastolic heart failure|diastolic heart failure
1451693|NCT00959660|Heart Failure|heart failure
1451694|NCT00959660|Elderly|elderly
1451695|NCT00959660|Obesity|obesity
1451696|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
1451697|NCT00959621|Habitual abortion|habitual abortion
1451698|NCT00959621|recurrent abortion|recurrent abortion
1451699|NCT00959621|hereditary and acquired|hereditary and acquired
1451700|NCT00959621|thrombophilia|thrombophilia
1451701|NCT00959621|preeclampsia|preeclampsia
1451702|NCT00959621|premature birth|premature birth
1451703|NCT00959621|miscarriage|miscarriage
1451704|NCT00959621|stillbirth|stillbirth
1451705|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
1451706|NCT00959621|ASA|asa
1451707|NCT00959621|aspirin|aspirin
1451708|NCT00959608|Weight Management in adults|weight management in adults
1451709|NCT00959608|Reducing Health Disparities|reducing health disparities
1451710|NCT00959595|Diabetes mellitus|diabetes mellitus
1451711|NCT00959595|neuropathy|neuropathy
1451712|NCT00959595|foot|foot
1451713|NCT00959595|sensibility|sensibility
1451714|NCT00959595|brain plasticity|brain plasticity
1451715|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
1451716|NCT00959569|esmolol|esmolol
1451717|NCT00959569|cardiac surgery|cardiac surgery
1451718|NCT00959569|cardiac anesthesia|cardiac anesthesia
1451719|NCT00959569|mortality|mortality
1451720|NCT00959569|beta blockers|beta blockers
1451721|NCT00959569|beta-blockers|beta-blockers
1451722|NCT00959569|cardiac protection|cardiac protection
1451723|NCT00959556|recurrent breast cancer|recurrent breast cancer
1451724|NCT00959556|stage IA breast cancer|stage ia breast cancer
1451725|NCT00959556|stage IB breast cancer|stage ib breast cancer
1451726|NCT00959556|stage II breast cancer|stage ii breast cancer
1451727|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
1451728|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
1451729|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
1451730|NCT00959556|stage IV breast cancer|stage iv breast cancer
1451731|NCT00959530|complete dentures|complete dentures
1451732|NCT00959530|patient satisfaction|patient satisfaction
1451733|NCT00959530|treatment cost|treatment cost
1451734|NCT00959517|Placebo controlled|placebo controlled
1451735|NCT00959517|Efficacy|efficacy
1451736|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
1451737|NCT00959517|Primaquine|primaquine
1451738|NCT00959517|Gametocytes|gametocytes
1451739|NCT00959491|Colonoscopy|colonoscopy
1451740|NCT00959491|Occult Blood|occult blood
1451741|NCT00959491|Fecal|fecal
1451742|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
1451743|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
1451744|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
1451745|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
1451746|NCT00959478|Injury Prevention|injury prevention
1451747|NCT00959478|Emergency Department|emergency department
1451748|NCT00959452|Hypochondria|hypochondria
1451749|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
1451750|NCT00959452|Long term follow-up|long term follow-up
1451751|NCT00959452|Psychosomatics|psychosomatics
1451752|NCT00959452|Psychotherapy|psychotherapy
1451753|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
1451754|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
1451755|NCT00959400|Pain|pain
1451756|NCT00959400|Cancer|cancer
1451757|NCT00959387|head and neck cancer|head and neck cancer
1451758|NCT00959387|induction chemotherapy|induction chemotherapy
1451759|NCT00959374|Abdominoplasty|abdominoplasty
1451760|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
1451761|NCT00959374|Mastopexy|mastopexy
1451762|NCT00959361|patient compliance|patient compliance
1451763|NCT00959361|guidelines adherence|guidelines adherence
1451764|NCT00959361|advance directive adherence|advance directive adherence
1451765|NCT00959361|treatment refusal|treatment refusal
1451766|NCT00959361|directly observed therapy|directly observed therapy
1451767|NCT00959361|anti-retroviral agents|anti-retroviral agents
1451768|NCT00959361|HIV seropositivity|hiv seropositivity
1451769|NCT00959361|HIV infections|hiv infections
1451770|NCT00959361|HIV|hiv
1451771|NCT00959361|pharmaceutical services|pharmaceutical services
1451772|NCT00959361|HIV-positives patients|hiv-positives patients
1451773|NCT00959361|treatment experienced|treatment experienced
1451774|NCT00959348|Asthma|asthma
1451775|NCT00959348|Diabetes|diabetes
1451776|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
1451777|NCT00959348|Insulin resistance|insulin resistance
1451778|NCT00959335|treatment|treatment
1451779|NCT00959322|Capsulotomy|capsulotomy
1451780|NCT00959309|pediatrics|pediatrics
1451781|NCT00959309|media|media
1451782|NCT00959309|MUPS|mups
1451783|NCT00959296|Registry|registry
1451784|NCT00959296|Pain|pain
1451785|NCT00959296|Chronic Pain|chronic pain
1451786|NCT00959296|Back Pain|back pain
1451787|NCT00959296|Intractable Spasticity|intractable spasticity
1451788|NCT00959296|Parkinson's Disease|parkinson's disease
1451789|NCT00959296|Essential Tremor|essential tremor
1451790|NCT00959296|Dystonia|dystonia
1451791|NCT00959296|Implantable Pumps|implantable pumps
1451792|NCT00959296|Incontinence|incontinence
1451793|NCT00959283|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
1451795|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
1451796|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
1451797|NCT00959257|Systemic inflammation|systemic inflammation
1451798|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1451799|NCT00959244|stage I breast cancer|stage i breast cancer
1451800|NCT00959244|stage II breast cancer|stage ii breast cancer
1451801|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
1451802|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
1451803|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
1451804|NCT00959244|stage IV breast cancer|stage iv breast cancer
1451805|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1451806|NCT00959218|Dronabinol|dronabinol
1451807|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
1452111|NCT00957788|ringing|ringing
1451808|NCT00959218|central neuropathic pain|central neuropathic pain
1451809|NCT00959218|multiple sclerosis|multiple sclerosis
1451810|NCT00959218|analgesic|analgesic
1451811|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
1451812|NCT00959179|CHF|chf
1451813|NCT00959166|Acute hepatitis C|acute hepatitis c
1451814|NCT00959166|HIV|hiv
1451815|NCT00959166|Neurocognitive function|neurocognitive function
1451816|NCT00959166|Neuroinflammation|neuroinflammation
1451817|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
1451818|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
1451819|NCT00959140|Allo PBSC|allo pbsc
1451820|NCT00959140|HSCT|hsct
1451821|NCT00959140|Bone Marrow Transplant|bone marrow transplant
1451822|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
1451823|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
1451824|NCT00959140|MRD HSCT|mrd hsct
1451825|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
1451826|NCT00959127|Colon Cancer|colon cancer
1451827|NCT00959127|Rectal Cancer|rectal cancer
1451828|NCT00959114|Celiac Disease|celiac disease
1451829|NCT00959114|Coeliac Disease|coeliac disease
1451830|NCT00959114|Celiac Sprue|celiac sprue
1451831|NCT00959114|Keliakia|keliakia
1451832|NCT00959075|Thiamin supplementation|thiamin supplementation
1451833|NCT00959075|Thiamin deficiency|thiamin deficiency
1451834|NCT00959075|Heart failure|heart failure
1451835|NCT00959075|Improve heart function|improve heart function
1451836|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
1451837|NCT00959062|Pilot Study|pilot study
1451838|NCT00959062|Randomized Controlled Trial|randomized controlled trial
1451839|NCT00959062|Critically Ill|critically ill
1451840|NCT00959062|Child|child
1451841|NCT00959062|Pediatric|pediatric
1451842|NCT00959062|Clonidine|clonidine
1451843|NCT00959062|Sedation|sedation
1451844|NCT00959023|stage I prostate cancer|stage i prostate cancer
1451845|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
1451846|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
1451847|NCT00959023|stage III prostate cancer|stage iii prostate cancer
1451848|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
1451849|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
1451850|NCT00959010|Omega 3|omega 3
1451851|NCT00959010|Cystic Fibrosis|cystic fibrosis
1451852|NCT00959010|Inflammatory markers|inflammatory markers
1451853|NCT00958997|diabetes|diabetes
1451854|NCT00958997|islet|islet
1451855|NCT00958997|pancreas|pancreas
1451856|NCT00958997|beta cell mass|beta cell mass
1451857|NCT00958997|PET imaging|pet imaging
1451858|NCT00958997|FPDTBZ|fpdtbz
1451859|NCT00958997|arginine stimulus test|arginine stimulus test
1451860|NCT00958984|pediatric|pediatric
1451861|NCT00958984|solid organ transplant|solid organ transplant
1451862|NCT00958984|hemoglobin|hemoglobin
1451863|NCT00958971|Breast cancer|breast cancer
1451864|NCT00958971|HER2 negative|her2 negative
1451865|NCT00958971|FGFR1|fgfr1
1451866|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
1451867|NCT00958958|randomized cluster trial|randomized cluster trial
1451868|NCT00958958|quality improvement|quality improvement
1451869|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
1451870|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
1451871|NCT00958919|breathlessness intensity|breathlessness intensity
1451872|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
1451873|NCT00958919|endorphins|endorphins
1451874|NCT00958919|resistive breathing loads|resistive breathing loads
1451875|NCT00958906|Infliximab|infliximab
1451876|NCT00958906|Uveitis|uveitis
1451877|NCT00958906|Macular Edema|macular edema
1451878|NCT00958906|Intraocular Inflammation|intraocular inflammation
1451879|NCT00958893|Uterine fibroids|uterine fibroids
1451880|NCT00958867|Resistance exercise training|resistance exercise training
1451881|NCT00958867|aerobic exercise training|aerobic exercise training
1592773|NCT00421720|Germany|germany
1451882|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1451883|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
1451884|NCT00958841|NETs of the pancreatic|nets of the pancreatic
1451885|NCT00958841|Pituitary NETs|pituitary nets
1451886|NCT00958841|EAS Tumors|eas tumors
1451887|NCT00958841|Nelson's Syndrome|nelson's syndrome
1451888|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
1451889|NCT00958841|pituitary neoplasm|pituitary neoplasm
1451890|NCT00958841|Nelson Syndrome|nelson syndrome
1451891|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
1451892|NCT00958841|pasireotide LAR|pasireotide lar
1451893|NCT00958841|PNETs|pnets
1451894|NCT00958841|PiNETS|pinets
1451895|NCT00958815|vascular imaging|vascular imaging
1451896|NCT00958815|diabetes|diabetes
1451897|NCT00958815|rupture prone plaques|rupture prone plaques
1451898|NCT00958815|HIV|hiv
1451899|NCT00958815|treatment experienced|treatment experienced
1451900|NCT00958802|tissue engineering|tissue engineering
1451901|NCT00958776|Influenza|influenza
1451902|NCT00958776|Hospitalized|hospitalized
1451903|NCT00958776|Antiviral|antiviral
1451904|NCT00958776|Flu|flu
1451905|NCT00958763|HCV|hcv
1451906|NCT00958763|Alcohol|alcohol
1451907|NCT00958763|Methadone Maintained|methadone maintained
1451908|NCT00958750|Androgenetic alopecia|androgenetic alopecia
1451909|NCT00958750|female pattern hair loss|female pattern hair loss
1451910|NCT00958737|stage III colon cancer|stage iii colon cancer
1451911|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
1451912|NCT00958724|HKI-272|hki-272
1451913|NCT00958724|Vinorelbine|vinorelbine
1451914|NCT00958724|Combination|combination
1451915|NCT00958724|Solid Tumor|solid tumor
1451916|NCT00958724|Neratinib|neratinib
1451917|NCT00958724|Nerlynx|nerlynx
1451918|NCT00958724|PB-272|pb-272
1451919|NCT00958685|ginger extract|ginger extract
1451920|NCT00958685|ARDS|ards
1451921|NCT00958685|enteral feeding|enteral feeding
1451922|NCT00958685|mechanical ventilation|mechanical ventilation
1451924|NCT00958646|OMT|omt
1451925|NCT00958646|biomarker|biomarker
1451926|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
1451927|NCT00958633|Bipolar I disorder|bipolar i disorder
1451928|NCT00958633|Depression|depression
1451929|NCT00958633|Antidepressant|antidepressant
1451930|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
1451931|NCT00958607|Caregivers|caregivers
1451932|NCT00958607|Stroke|stroke
1451933|NCT00958607|Social support|social support
1451934|NCT00958607|Phase specific care|phase specific care
1451935|NCT00958581|antifibrinolytics|antifibrinolytics
1451936|NCT00958542|cerebral palsy|cerebral palsy
1451937|NCT00958542|scoliosis|scoliosis
1451938|NCT00958542|children|children
1451939|NCT00958529|fiber|fiber
1451940|NCT00958529|inulin|inulin
1451941|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
1451942|NCT00958516|volunteers|volunteers
1451943|NCT00958503|safety|safety
1451944|NCT00958503|biomarker|biomarker
1451945|NCT00958503|thiamphenicol|thiamphenicol
1451946|NCT00958503|EAAT2|eaat2
1451947|NCT00958477|Safety|safety
1451948|NCT00958477|tolerability|tolerability
1451949|NCT00958477|pharmacokinetics|pharmacokinetics
1451950|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
1451951|NCT00958477|prostate cancer patients|prostate cancer patients
1451952|NCT00958464|MRI|mri
1451953|NCT00958464|Perthes'disease|perthes'disease
1451954|NCT00958464|hip|hip
1451955|NCT00958464|cartilage|cartilage
1451956|NCT00958451|Calcium|calcium
1451957|NCT00958451|Vitamin D deficiency|vitamin d deficiency
1451958|NCT00958451|Chronic Kidney disease|chronic kidney disease
1451959|NCT00958438|Intercritical Gout|intercritical gout
1451960|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
1451961|NCT00958438|Allopurinol|allopurinol
1451962|NCT00958438|Metabolic Diseases|metabolic diseases
1451963|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
1451964|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
1451965|NCT00958438|Joint Diseases|joint diseases
1451966|NCT00958438|Arthritis|arthritis
1451967|NCT00958438|Rheumatic Diseases|rheumatic diseases
1451968|NCT00958438|Metabolic disorder|metabolic disorder
1451969|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
1451970|NCT00958438|Gout|gout
1451971|NCT00958412|Endometriosis|endometriosis
1451972|NCT00958412|Pelvic pain|pelvic pain
1451973|NCT00958412|Oral progesterone blocker|oral progesterone blocker
1451974|NCT00958399|satiety|satiety
1451975|NCT00958399|fiber|fiber
1451976|NCT00958399|food intake|food intake
1451977|NCT00958399|gut hormones|gut hormones
1451978|NCT00958399|visual analog scales|visual analog scales
1451979|NCT00958399|microflora|microflora
1451980|NCT00958386|colorectal cancer|colorectal cancer
1451981|NCT00958386|Panitumumab|panitumumab
1451982|NCT00958386|irinotecan|irinotecan
1451983|NCT00958373|Scoliosis|scoliosis
1451984|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1451985|NCT00958373|spine curve|spine curve
1451986|NCT00958373|pediatric|pediatric
1451987|NCT00958373|mental health|mental health
1451988|NCT00958373|screening|screening
1451989|NCT00958360|vision, low|vision, low
1451990|NCT00958334|Uterine fibroids|uterine fibroids
1451991|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
1451992|NCT00958321|large cell lung cancer|large cell lung cancer
1451993|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
1451994|NCT00958321|malignant pleural effusion|malignant pleural effusion
1451995|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1451996|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1451997|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1451998|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1451999|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1452000|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1452001|NCT00958308|Probiotic|probiotic
1452002|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
1452003|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
1452004|NCT00958295|urinary tract infection|urinary tract infection
1452005|NCT00958295|cystitis|cystitis
1452006|NCT00958282|cocaine|cocaine
1452007|NCT00958282|treatment|treatment
1452008|NCT00958282|lisdexamfetamine|lisdexamfetamine
1452009|NCT00958282|dependence|dependence
1452010|NCT00958282|addiction|addiction
1452011|NCT00958282|crack|crack
1452012|NCT00958269|diabetes|diabetes
1452013|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
1452014|NCT00958269|dutogliptin|dutogliptin
1452015|NCT00958269|PHX1149|phx1149
1452016|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
1452017|NCT00958256|Lymphoma|lymphoma
1452018|NCT00958256|Bortezomib|bortezomib
1452019|NCT00958256|Velcade|velcade
1452020|NCT00958256|Rituximab|rituximab
1452021|NCT00958256|Rituxan|rituxan
1452022|NCT00958256|Cyclophosphamide|cyclophosphamide
1452023|NCT00958256|Cytoxan|cytoxan
1452024|NCT00958256|Neosar|neosar
1452025|NCT00958256|Mesna|mesna
1452026|NCT00958256|Mesnex|mesnex
1452027|NCT00958256|G-CSF|g-csf
1452028|NCT00958256|Filgrastim|filgrastim
1452029|NCT00958256|Neupogen|neupogen
1452030|NCT00958230|endarterectomy|endarterectomy
1452031|NCT00958230|dCell|dcell
1452032|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
1452033|NCT00958230|TRL|trl
1452034|NCT00958230|Vascular Patch|vascular patch
1452035|NCT00958230|Treatment|treatment
1452036|NCT00958217|Depressive symptoms|depressive symptoms
1452037|NCT00958217|Substance-related disorders|substance-related disorders
1452038|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
1452039|NCT00958217|Psychotherapy|psychotherapy
1452040|NCT00958204|Depression|depression
1452041|NCT00958204|rating scales|rating scales
1452043|NCT00958204|combination treatment|combination treatment
1452044|NCT00958204|light therapy|light therapy
1452045|NCT00958204|negative ion therapy|negative ion therapy
1452046|NCT00958204|fluoxetine|fluoxetine
1452047|NCT00958204|antidepressants|antidepressants
1452048|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
1452049|NCT00958152|VX-950|vx-950
1452050|NCT00958152|VX-222|vx-222
1452051|NCT00958152|STAT-C|stat-c
1452052|NCT00958139|Lyme disease|lyme disease
1452053|NCT00958139|tick|tick
1452054|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
1452055|NCT00958100|treatment experienced|treatment experienced
1452056|NCT00958061|CVD|cvd
1452057|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1452058|NCT00958048|hypoventilation|hypoventilation
1452059|NCT00957996|influenza|influenza
1452060|NCT00957996|hospitalized|hospitalized
1452061|NCT00957996|flu|flu
1452062|NCT00957996|antiviral|antiviral
1452063|NCT00957970|Stress shielding|stress shielding
1452064|NCT00957970|Bone mineral density|bone mineral density
1452065|NCT00957970|stemless femoral component|stemless femoral component
1452066|NCT00957944|Rotigotine|rotigotine
1452067|NCT00957944|Neupro®|neupro®
1452068|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
1452069|NCT00957918|Parkinson's disease|parkinson's disease
1452070|NCT00957918|parkinsonian|parkinsonian
1452071|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
1452072|NCT00957892|Healthy Infants|healthy infants
1452073|NCT00957892|Satiation|satiation
1452074|NCT00957892|Satiety|satiety
1452075|NCT00957892|Intake Regulation|intake regulation
1452076|NCT00957892|Infant Feeding|infant feeding
1452077|NCT00957892|Infant Formula Feeding|infant formula feeding
1452078|NCT00957879|Vitamin D|vitamin d
1452079|NCT00957879|FGF23|fgf23
1452080|NCT00957879|FGF-23|fgf-23
1452081|NCT00957879|Phosphate|phosphate
1452082|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
1452083|NCT00957853|Head and Neck Cancer|head and neck cancer
1452084|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1452085|NCT00957853|HNSCC|hnscc
1452086|NCT00957853|Cetuximab|cetuximab
1452087|NCT00957853|IMC-A12|imc-a12
1452088|NCT00957853|Tumor|tumor
1452089|NCT00957853|Biomarkers|biomarkers
1452090|NCT00957853|Phospho-AKT|phospho-akt
1452091|NCT00957853|Surgical resection|surgical resection
1452092|NCT00957840|Omaya reservoirs|omaya reservoirs
1452093|NCT00957840|cerebral oxygenation|cerebral oxygenation
1452094|NCT00957840|VP shunt|vp shunt
1452095|NCT00957840|IVH|ivh
1452096|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
1452097|NCT00957814|nutritional education|nutritional education
1452098|NCT00957814|diet adherence|diet adherence
1452099|NCT00957814|nutritional knowledge|nutritional knowledge
1452100|NCT00957814|life quality|life quality
1452101|NCT00957814|nutritional status|nutritional status
1452102|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
1452103|NCT00957801|Sarcopenia|sarcopenia
1452104|NCT00957801|Aging muscle|aging muscle
1452105|NCT00957801|Androgen|androgen
1452106|NCT00957801|Cytokines|cytokines
1452107|NCT00957801|Muscle metabolism|muscle metabolism
1452108|NCT00957788|tinnitus|tinnitus
1452109|NCT00957788|acouphenes|acouphenes
1452112|NCT00957788|buzzing|buzzing
1452113|NCT00957788|roaring|roaring
1452114|NCT00957788|hissing|hissing
1452115|NCT00957788|clicking|clicking
1452116|NCT00957775|Substance Abuse Treatment|substance abuse treatment
1452117|NCT00957775|Adolescents|adolescents
1452118|NCT00957775|Substance-Related Disorders|substance-related disorders
1452119|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
1452120|NCT00957775|Marijuana Abuse|marijuana abuse
1452121|NCT00957762|Body Composition|body composition
1452122|NCT00957762|Glucose Tolerance|glucose tolerance
1452123|NCT00957762|Insulin Sensitivity|insulin sensitivity
1452124|NCT00957762|Metabolic Syndrome|metabolic syndrome
1452125|NCT00957736|graft versus host disease|graft versus host disease
1452126|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1452127|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1452128|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1452129|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1452130|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1452131|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1452132|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1452133|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1452134|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1452135|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1452136|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1452137|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1452138|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1452139|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1452140|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1452141|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1452142|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1452143|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1452144|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1452145|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1452146|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1452147|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1452148|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1452149|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1452150|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1452151|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1452152|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1452153|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1452154|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1452155|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1452156|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1452157|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1452158|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1452159|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1452160|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1452161|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1452162|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1452163|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1452164|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1452165|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1452166|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1452167|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1452168|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1452169|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1452170|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1452171|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1452172|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1452173|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
1452174|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
1452175|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
1452176|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
1452177|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
1452178|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
1452179|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
1452180|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
1452181|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
1452182|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
1452183|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
1452184|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
1452185|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1452186|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1452187|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1452188|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1452189|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1452190|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1452191|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1452192|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1452193|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1452194|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1452195|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1452196|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1452197|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1452198|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1452199|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1452200|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1452201|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1452202|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1452203|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1452204|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1452205|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1452206|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
1452207|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1452208|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1452209|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1452210|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1452211|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1452212|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1452213|NCT00957736|primary myelofibrosis|primary myelofibrosis
1452214|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1452215|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1452216|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
1452217|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1452218|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1452219|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1452220|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1452221|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1452222|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1452223|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
1452224|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1452225|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1452226|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1452227|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1452228|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
1452229|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
1452230|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
1452231|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1452232|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1452233|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1452234|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1452235|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
1452236|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
1452237|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
1452238|NCT00957736|stage IV breast cancer|stage iv breast cancer
1452239|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
1452240|NCT00957710|progressive aphasia|progressive aphasia
1452241|NCT00957710|semantic dementia|semantic dementia
1452242|NCT00957710|neuroimaging|neuroimaging
1452243|NCT00957710|treatment|treatment
1452244|NCT00957710|errorless learning|errorless learning
1452245|NCT00957697|Central Neuropathic Pain|central neuropathic pain
1452370|NCT00957164|PTSD|ptsd
1452246|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
1452247|NCT00957697|Stroke|stroke
1452248|NCT00957697|Pain|pain
1452262|NCT00957619|pentoxyfilline|pentoxyfilline
1452263|NCT00957619|liver regeneration|liver regeneration
1452264|NCT00957619|major liver resection|major liver resection
1452265|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
1452266|NCT00957606|Prostate cancer|prostate cancer
1452267|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
1452268|NCT00957606|osteoporosis|osteoporosis
1452269|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
1452270|NCT00957593|Term pregnancy|term pregnancy
1452271|NCT00957593|Cesarean delivery|cesarean delivery
1452272|NCT00957580|MEK Inhibitor|mek inhibitor
1452273|NCT00957580|Pimasertib|pimasertib
1452274|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
1452275|NCT00957580|Hematological Malignancies|hematological malignancies
1452276|NCT00957580|Elderly Patients|elderly patients
1452277|NCT00957580|Phase II|phase ii
1452278|NCT00957541|NYHA Class III or IV|nyha class iii or iv
1452279|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
1452280|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1452281|NCT00957528|Low Normal Testosterone|low normal testosterone
1452282|NCT00957528|Male|male
1452283|NCT00957528|Aging|aging
1452284|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
1452285|NCT00957476|Pregnancy|pregnancy
1452286|NCT00957476|Metabolic Diseases|metabolic diseases
1452287|NCT00957476|Obesity|obesity
1452288|NCT00957476|Fetal adiposity|fetal adiposity
1452289|NCT00957476|Omega-3|omega-3
1452290|NCT00957476|Inflammation|inflammation
1452291|NCT00957476|Insulin Resistance|insulin resistance
1452292|NCT00957463|endothelial function|endothelial function
1452293|NCT00957450|cervix cancer|cervix cancer
1452294|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
1452295|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
1452296|NCT00957437|Phase 1|phase 1
1452297|NCT00957437|healthy volunteer|healthy volunteer
1452298|NCT00957437|male|male
1452299|NCT00957437|pharmacokinetics|pharmacokinetics
1452300|NCT00957437|AZD1305|azd1305
1452301|NCT00957424|tobacco use disorder|tobacco use disorder
1452302|NCT00957424|bladder cancer|bladder cancer
1452303|NCT00957424|cervical cancer|cervical cancer
1452304|NCT00957424|esophageal cancer|esophageal cancer
1452305|NCT00957424|gastric cancer|gastric cancer
1452306|NCT00957424|renal cell carcinoma|renal cell carcinoma
1452307|NCT00957424|adult primary liver cancer|adult primary liver cancer
1452308|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
1452309|NCT00957424|small cell lung cancer|small cell lung cancer
1452310|NCT00957424|pancreatic cancer|pancreatic cancer
1452311|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
1452312|NCT00957424|laryngeal cancer|laryngeal cancer
1452313|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
1452314|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
1452315|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
1452316|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1452317|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
1452318|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
1452319|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
1452320|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
1452321|NCT00957411|stage III cervical cancer|stage iii cervical cancer
1452322|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
1452323|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1452324|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
1452325|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
1452326|NCT00957398|Motility|motility
1452327|NCT00957385|Leukemia|leukemia
1452328|NCT00957385|Remission|remission
1452329|NCT00957372|epilepsy|epilepsy
1452330|NCT00957359|Cancer|cancer
1452331|NCT00957359|Anxiety|anxiety
1452332|NCT00957359|Depression|depression
1452333|NCT00957359|Hallucinogens|hallucinogens
1452334|NCT00957346|Pregnancy termination|pregnancy termination
1452335|NCT00957346|abortion|abortion
1452336|NCT00957346|medical abortion|medical abortion
1452337|NCT00957346|2nd trimester|2nd trimester
1452338|NCT00957346|mifepristone|mifepristone
1452339|NCT00957346|misoprostol|misoprostol
1452340|NCT00957333|ketamine|ketamine
1452341|NCT00957333|bladder dysfunction|bladder dysfunction
1452342|NCT00957333|bladder mucosa|bladder mucosa
1452343|NCT00957333|mechanisms|mechanisms
1452344|NCT00957320|leukemia|leukemia
1452345|NCT00957320|cancer|cancer
1452346|NCT00957320|oncology|oncology
1452347|NCT00957320|sirolimus|sirolimus
1452348|NCT00957320|ALL|all
1452349|NCT00957281|Asthma|asthma
1452350|NCT00957281|Systemic inflammation|systemic inflammation
1452351|NCT00957281|Oxidative stress|oxidative stress
1452352|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
1452353|NCT00957281|Airway inflammation|airway inflammation
1452354|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
1452355|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
1452356|NCT00957268|Drug therapy|drug therapy
1452357|NCT00957268|Pediatrics|pediatrics
1452358|NCT00957255|rotator cuff tear|rotator cuff tear
1452359|NCT00957255|rotator cuff repair|rotator cuff repair
1452360|NCT00957242|IPF|ipf
1452361|NCT00957242|Warfarin|warfarin
1452362|NCT00957216|adult onset ataxia|adult onset ataxia
1452363|NCT00957203|Parkinson's disease|parkinson's disease
1452364|NCT00957203|levodopa|levodopa
1452365|NCT00957203|end of dose wearing off|end of dose wearing off
1452366|NCT00957203|OFF time|off time
1452367|NCT00957190|Ocular Hypertension|ocular hypertension
1452368|NCT00957190|Open Angle Glaucoma|open angle glaucoma
1452369|NCT00957164|Chronic pain|chronic pain
1452371|NCT00957151|chronic pancreatitis|chronic pancreatitis
1452372|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
1452373|NCT00957151|enzyme therapy|enzyme therapy
1452374|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
1452375|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
1452376|NCT00957125|Localized primary breast cancer|localized primary breast cancer
1452377|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
1452378|NCT00957112|anxiety disorder|anxiety disorder
1452379|NCT00957112|depression|depression
1452380|NCT00957112|fatigue|fatigue
1452381|NCT00957112|stage IA breast cancer|stage ia breast cancer
1452382|NCT00957112|stage IB breast cancer|stage ib breast cancer
1452383|NCT00957112|stage II breast cancer|stage ii breast cancer
1452384|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
1452385|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
1452386|NCT00957073|Heart Failure|heart failure
1452387|NCT00957073|Diastolic dysfunction|diastolic dysfunction
1452388|NCT00957047|refractory|refractory
1452389|NCT00957047|partial|partial
1452390|NCT00957047|epilepsy|epilepsy
1452391|NCT00957021|Knee|knee
1452392|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
1452393|NCT00956969|headaches|headaches
1452394|NCT00956969|stress management|stress management
1452395|NCT00956969|assertiveness training|assertiveness training
1452396|NCT00956969|relaxation training|relaxation training
1452397|NCT00956969|emotional expression|emotional expression
1452398|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
1452399|NCT00956956|multiple dose|multiple dose
1452400|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
1452401|NCT00956943|nicotine dependence|nicotine dependence
1452402|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
1452403|NCT00956943|transdermal nicotine|transdermal nicotine
1452404|NCT00956943|nicotine metabolism|nicotine metabolism
1452405|NCT00956943|high dose|high dose
1452406|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
1452407|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1452408|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1452409|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1452410|NCT00956904|Prostate Cancer|prostate cancer
1452411|NCT00956904|Prostatectomy|prostatectomy
1452412|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
1452413|NCT00956904|Tandem RALP|tandem ralp
1452414|NCT00956891|short-term effects|short-term effects
1452415|NCT00956891|long-term follow-up|long-term follow-up
1452416|NCT00956891|liver failure patients|liver failure patients
1452417|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
1452418|NCT00956878|Cancer|cancer
1452419|NCT00956878|Pain|pain
1452420|NCT00956878|SNP|snp
1452421|NCT00956865|Glaucoma|glaucoma
1452422|NCT00956865|Intervention|intervention
1452423|NCT00956865|Follow up|follow up
1452424|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
1452425|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
1452426|NCT00956839|Chronic pancreatitis|chronic pancreatitis
1452427|NCT00956839|Vitamin D|vitamin d
1452428|NCT00956839|Vitamin D deficiency|vitamin d deficiency
1452429|NCT00956839|Cholecalciferol|cholecalciferol
1452430|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
1452431|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
1452432|NCT00956813|menopausal symptoms|menopausal symptoms
1452433|NCT00956813|hot flashes|hot flashes
1452434|NCT00956813|breast cancer|breast cancer
1452435|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1452436|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
1452437|NCT00956774|HSG|hsg
1452438|NCT00956774|Cannula|cannula
1452439|NCT00956774|HSG procedure|hsg procedure
1452440|NCT00956774|infertility evaluation|infertility evaluation
1452441|NCT00956761|Influenza vaccine|influenza vaccine
1452442|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
1452443|NCT00956735|Cardiovascular Disease|cardiovascular disease
1452444|NCT00956735|Type II Diabetes|type ii diabetes
1452445|NCT00956735|Nutrition|nutrition
1452446|NCT00956735|Pistachios|pistachios
1452447|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
1452448|NCT00956696|Epilepsy|epilepsy
1452449|NCT00956696|mental retardation|mental retardation
1452450|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
1452451|NCT00956657|Randomised Controlled Trial|randomised controlled trial
1452452|NCT00956657|Adherence|adherence
1452453|NCT00956657|Patient Participation|patient participation
1452454|NCT00956631|Spinal Stenosis|spinal stenosis
1452455|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
1452456|NCT00956605|EEG-biofeedback|eeg-biofeedback
1452457|NCT00956605|neurofeedback|neurofeedback
1452458|NCT00956605|computer attention training systems|computer attention training systems
1452459|NCT00956605|ADHD|adhd
1452460|NCT00956605|ADD|add
1452461|NCT00956605|child|child
1452462|NCT00956605|children|children
1452463|NCT00956592|Video laryngoscopy|video laryngoscopy
1452464|NCT00956592|Intubation success|intubation success
1452465|NCT00956592|Difficult airway|difficult airway
1452466|NCT00956592|CMAC laryngoscope|cmac laryngoscope
1452467|NCT00956579|autism|autism
1452468|NCT00956579|autistic|autistic
1452469|NCT00956579|sensory|sensory
1452470|NCT00956579|MEG|meg
1452471|NCT00956579|connectivity|connectivity
1452472|NCT00956579|brain|brain
1452473|NCT00956579|MRI|mri
1452474|NCT00956579|language|language
1452475|NCT00956579|developmental|developmental
1452476|NCT00956579|neurodevelopmental|neurodevelopmental
1452477|NCT00956579|aspergers|aspergers
1452478|NCT00956579|asperger's|asperger's
1452479|NCT00956579|dyslexia|dyslexia
1452480|NCT00956579|coherence|coherence
1452481|NCT00956553|HPV|hpv
1452482|NCT00956553|Human Papilloma Virus|human papilloma virus
1452483|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
1452484|NCT00956540|Tracheostomy|tracheostomy
1452485|NCT00956540|decannulation|decannulation
1452486|NCT00956540|weaning|weaning
1452487|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
1452488|NCT00956527|Adolescent|adolescent
1452489|NCT00956527|Substance Use|substance use
1452490|NCT00956527|Early Intervention|early intervention
1452491|NCT00956527|Martial Arts|martial arts
1452492|NCT00956527|Karate|karate
1452493|NCT00956514|depression|depression
1452494|NCT00956514|major depressive disorder|major depressive disorder
1452495|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
1452496|NCT00956514|TMS|tms
1452497|NCT00956514|EEG|eeg
1452498|NCT00956514|electroencephalography|electroencephalography
1452499|NCT00956514|Major Depression,|major depression,
1452500|NCT00956501|fall|fall
1452501|NCT00956501|balance|balance
1452502|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
1452503|NCT00956475|anxiety disorder|anxiety disorder
1452504|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1452505|NCT00956475|fatigue|fatigue
1452506|NCT00956475|pain|pain
1452507|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1452508|NCT00956475|cancer survivor|cancer survivor
1452509|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1452510|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
1452511|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1452512|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1452513|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1452514|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1452515|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1452516|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1452517|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1452518|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1452519|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1452520|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1452521|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1452522|NCT00956475|mast cell leukemia|mast cell leukemia
1452523|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1452524|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1452525|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
1452657|NCT00956449|non-elderly|non-elderly
1452526|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1452527|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1452528|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1452529|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
1452530|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1452531|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1452532|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1452533|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1452534|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1452535|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1452536|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1452537|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1452538|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1452539|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1452540|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1452541|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1452542|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1452543|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1452544|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1452685|NCT00956371|ONO-7746|ono-7746
1452545|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1452546|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1452547|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1452548|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1452549|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1452550|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1452551|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1452552|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1452553|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1452554|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1452555|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1452556|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1452557|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1452558|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1452559|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1452560|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1452561|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1452562|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1452563|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1452564|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1452565|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1452566|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1452567|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1452568|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1452569|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1452570|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1452571|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1452572|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1452573|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1452574|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1452575|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1452576|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1452577|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1452578|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1452579|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1452580|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1452581|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1452582|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1452583|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1452584|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1452585|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1452586|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1452587|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1452588|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1452589|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1452590|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1452591|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1452592|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1452593|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1452594|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1452595|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1452596|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1452597|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1452598|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1452599|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1452600|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1452601|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1452602|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1452603|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1452604|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1452605|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1452606|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1452607|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1452608|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1452686|NCT00956371|Healthy adult subjects|healthy adult subjects
1452609|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1452610|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1452611|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1452612|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1452613|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1452614|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1452615|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1452616|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1452617|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1452618|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1452619|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1452620|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1452621|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1452622|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1452623|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1452624|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1452625|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1452626|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1452627|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1452628|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1452629|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1452630|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1452631|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1452632|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1452633|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1452634|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1452635|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1452636|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1452637|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1452638|NCT00956475|intraocular lymphoma|intraocular lymphoma
1452639|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
1452640|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1452641|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1452642|NCT00956475|small intestine lymphoma|small intestine lymphoma
1452643|NCT00956462|intraocular pressure|intraocular pressure
1452644|NCT00956462|Ahmed valve|ahmed valve
1452645|NCT00956462|NSAIDS|nsaids
1452646|NCT00956462|steroids|steroids
1452647|NCT00956449|flu|flu
1452648|NCT00956449|influenza|influenza
1452649|NCT00956449|seasonal influenza|seasonal influenza
1452650|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
1452651|NCT00956449|immunogenicity|immunogenicity
1452652|NCT00956449|safety|safety
1452653|NCT00956449|tolerability|tolerability
1452654|NCT00956449|antibody response|antibody response
1452655|NCT00956449|intra muscular|intra muscular
1452656|NCT00956449|elderly|elderly
1452658|NCT00956436|Liver Cancer|liver cancer
1452659|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
1452660|NCT00956436|Sorafenib|sorafenib
1452661|NCT00956436|HCC|hcc
1452662|NCT00956436|BIIB022|biib022
1452663|NCT00956436|Open-Label|open-label
1452664|NCT00956436|IGF-1R|igf-1r
1452665|NCT00956436|Nexavar|nexavar
1452666|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
1452667|NCT00956423|exercise training|exercise training
1452668|NCT00956423|aerobic exercise|aerobic exercise
1452669|NCT00956423|resistance exercise|resistance exercise
1452670|NCT00956410|Active immunization|active immunization
1452671|NCT00956410|Alzheimer disease|alzheimer disease
1452672|NCT00956410|Antibody|antibody
1452673|NCT00956410|Central Nervous System Diseases|central nervous system diseases
1452674|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
1452675|NCT00956410|Vaccine|vaccine
1452676|NCT00956397|Functional Dyspepsia|functional dyspepsia
1452677|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
1452678|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
1452679|NCT00956384|Breast reconstruction|breast reconstruction
1452680|NCT00956384|Early stage|early stage
1452681|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
1452682|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
1452683|NCT00956384|Acellular dermal matrix|acellular dermal matrix
1452684|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
1452687|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1452688|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
1452689|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
1452690|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
1452691|NCT00956332|Cell therapy|cell therapy
1452692|NCT00956332|Gene therapy|gene therapy
1452693|NCT00956332|Endothelial cells|endothelial cells
1452694|NCT00956332|Smooth muscle cells|smooth muscle cells
1452695|NCT00956332|Angiogenesis|angiogenesis
1452696|NCT00956332|Arteriogenesis|arteriogenesis
1452697|NCT00956332|amputation|amputation
1452698|NCT00956332|diabetic foot|diabetic foot
1452699|NCT00956319|Insomnia|insomnia
1452700|NCT00956319|Zolpidem|zolpidem
1452701|NCT00956319|Estazolam|estazolam
1452702|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
1452703|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
1452704|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
1452705|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
1452706|NCT00956267|clomiphene resistance|clomiphene resistance
1452707|NCT00956267|letrozole|letrozole
1452708|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
1452709|NCT00956254|mucositis|mucositis
1452710|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1452711|NCT00956254|pain|pain
1452712|NCT00956241|rectal cancer|rectal cancer
1452713|NCT00956241|colonic pouch|colonic pouch
1452714|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
1452715|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
1452716|NCT00956215|post operative|post operative
1452717|NCT00956215|obese|obese
1452718|NCT00956202|Influenza|influenza
1452719|NCT00956202|Pandemic Flu|pandemic flu
1452720|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
1452721|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
1452722|NCT00956202|Adjuvant|adjuvant
1452723|NCT00956189|Antipsychotic Agents|antipsychotic agents
1452724|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
1452725|NCT00956189|Identification|identification
1452726|NCT00956189|Prediction|prediction
1452727|NCT00956176|Cidofovir|cidofovir
1452728|NCT00956176|Vistide|vistide
1452729|NCT00956176|Adenovirus|adenovirus
1452730|NCT00956176|BK virus infections|bk virus infections
1452731|NCT00956176|HSCT|hsct
1452732|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
1452733|NCT00956176|Foley catheter|foley catheter
1452734|NCT00956176|Viral infection|viral infection
1452735|NCT00956176|Bladder instillation|bladder instillation
1452736|NCT00956176|Intravesical|intravesical
1452737|NCT00956176|Transurethral catheter|transurethral catheter
1452738|NCT00956176|Transplantation|transplantation
1452739|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
1452740|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
1452741|NCT00956150|Gulf War Syndrome|gulf war syndrome
1452742|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
1452743|NCT00956137|spinal anesthesia|spinal anesthesia
1452744|NCT00956137|ultrasound|ultrasound
1452745|NCT00956137|palpation|palpation
1452746|NCT00956137|knee|knee
1452747|NCT00956137|hip|hip
1452748|NCT00956137|surgery|surgery
1452749|NCT00956137|intervertebral space|intervertebral space
1452750|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
1452751|NCT00956111|Immunogenictiy|immunogenictiy
1452752|NCT00956111|Safety|safety
1452753|NCT00956085|OCD|ocd
1452754|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1452755|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1452756|NCT00956059|prednisone|prednisone
1452757|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
1452758|NCT00956059|FK506|fk506
1452759|NCT00956046|Influenza|influenza
1452760|NCT00956046|Pandemic Flu|pandemic flu
1452761|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
1452762|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
1452763|NCT00956046|Infants|infants
1452764|NCT00956033|Cancer|cancer
1452765|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
1452766|NCT00956033|Bortezomib|bortezomib
1452767|NCT00956020|platelet rich plasma|platelet rich plasma
1452768|NCT00956020|fibrin matrix|fibrin matrix
1452769|NCT00956020|dermal filler|dermal filler
1452770|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1452771|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1452772|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1452773|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1452774|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1452775|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1452867|NCT00955630|Lucentis|lucentis
1452776|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1452777|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1452778|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1452779|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1452780|NCT00956007|tongue cancer|tongue cancer
1452781|NCT00955968|HIV Infection|hiv infection
1452782|NCT00955968|HAART|haart
1452783|NCT00955968|Maternal Health|maternal health
1452784|NCT00955955|Depression|depression
1452785|NCT00955955|Medical food|medical food
1452786|NCT00955942|radiation toxicity|radiation toxicity
1452787|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1452788|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1452789|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1452790|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1452791|NCT00955929|Penis|penis
1452792|NCT00955929|PLACEBO|placebo
1452793|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
1452794|NCT00955929|TRIMIX|trimix
1452795|NCT00955929|Bimix|bimix
1452796|NCT00955929|Viagra|viagra
1452797|NCT00955929|09-005|09-005
1452798|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
1452799|NCT00955916|relapsed|relapsed
1452800|NCT00955916|refractory|refractory
1452801|NCT00955916|acute|acute
1452802|NCT00955916|myeloid|myeloid
1452803|NCT00955916|AML|aml
1452804|NCT00955916|CML|cml
1452805|NCT00955916|blast crisis|blast crisis
1452806|NCT00955903|glucose|glucose
1452807|NCT00955903|insulin|insulin
1452808|NCT00955903|lipids|lipids
1452809|NCT00955903|C-reactive protein|c-reactive protein
1452810|NCT00955903|adiponectin|adiponectin
1452811|NCT00955903|leptin|leptin
1452812|NCT00955903|TNF alpha|tnf alpha
1452813|NCT00955903|IL-6|il-6
1452814|NCT00955903|Quality of Life|quality of life
1452815|NCT00955903|functional status|functional status
1452816|NCT00955890|cardioprotection|cardioprotection
1452817|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
1452818|NCT00955890|breast cancer|breast cancer
1452819|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
1452820|NCT00955877|DepoDur|depodur
1452821|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
1452822|NCT00955864|Cervix|cervix
1452823|NCT00955864|Colposcope|colposcope
1452824|NCT00955864|Polarized Light|polarized light
1452825|NCT00955864|Cervix Structure|cervix structure
1452826|NCT00955864|Collagen|collagen
1452827|NCT00955864|HV|hv
1452828|NCT00955864|Healthy Volunteer|healthy volunteer
1452829|NCT00955864|Healthy Women|healthy women
1452830|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1452831|NCT00955812|OPB-31121|opb-31121
1452832|NCT00955812|Advanced Solid Tumor|advanced solid tumor
1452833|NCT00955812|STAT3|stat3
1452834|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
1452835|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
1452836|NCT00955786|Solid Tumors|solid tumors
1452837|NCT00955786|Lymphoma|lymphoma
1452838|NCT00955786|G-Quadruplex|g-quadruplex
1452839|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
1452840|NCT00955773|cancer|cancer
1452841|NCT00955760|Healthy subjects|healthy subjects
1452842|NCT00955734|wrist|wrist
1452843|NCT00955734|fracture|fracture
1452844|NCT00955734|motion|motion
1452845|NCT00955734|surgery|surgery
1452933|NCT00955305|cixutumumab|cixutumumab
1452846|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
1452847|NCT00955721|Biliary Tract Cancer|biliary tract cancer
1452848|NCT00955721|Gallbladder Cancer|gallbladder cancer
1452849|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
1452850|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1452851|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1452852|NCT00955695|large cell lung cancer|large cell lung cancer
1452853|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
1452854|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1452855|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1452856|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
1452857|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
1452858|NCT00955669|mononuclear cells|mononuclear cells
1452859|NCT00955656|Characteristics of medical practices|characteristics of medical practices
1452860|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
1452861|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
1452862|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
1452863|NCT00955656|Disadvantaged populations|disadvantaged populations
1452864|NCT00955643|periodontitis|periodontitis
1452865|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1452866|NCT00955630|Histoplasmosis|histoplasmosis
1452868|NCT00955630|Ranibizumab|ranibizumab
1452870|NCT00955617|Dotarem|dotarem
1452871|NCT00955617|Gadovist|gadovist
1452872|NCT00955617|Peripheral arterial disease|peripheral arterial disease
1452873|NCT00955617|MRA|mra
1452874|NCT00955604|Parkinson's Disease|parkinson's disease
1452875|NCT00955604|Serotonin Toxicity|serotonin toxicity
1452876|NCT00955604|Rasagiline|rasagiline
1452877|NCT00955604|Antidepressants|antidepressants
1452878|NCT00955604|Chart Review|chart review
1452879|NCT00955604|Retrospective|retrospective
1452880|NCT00955591|human papilloma virus infection|human papilloma virus infection
1452881|NCT00955591|anal cancer|anal cancer
1452882|NCT00955591|HIV infection|hiv infection
1452883|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
1452884|NCT00955552|knee|knee
1452885|NCT00955539|Heart Failure|heart failure
1452886|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
1452887|NCT00955539|Optimization|optimization
1452888|NCT00955539|Viability|viability
1452889|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
1452890|NCT00955526|Parkinson's disease|parkinson's disease
1452891|NCT00955526|levodopa|levodopa
1452892|NCT00955526|end of dose wearing off|end of dose wearing off
1452893|NCT00955526|OFF time|off time
1452894|NCT00955513|Ankle sprain|ankle sprain
1452895|NCT00955513|soft tissue injury|soft tissue injury
1452896|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
1452897|NCT00955500|Cirrhosis|cirrhosis
1452898|NCT00955500|Proteins of the diet|proteins of the diet
1452899|NCT00955500|Branched-chain amino acids|branched-chain amino acids
1452900|NCT00955487|Premature Newborns|premature newborns
1452901|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
1452902|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
1452903|NCT00955448|Surgical repair|surgical repair
1452904|NCT00955448|Pelvic floor surgery|pelvic floor surgery
1452905|NCT00955448|Randomized clinical trial|randomized clinical trial
1452906|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1452907|NCT00955435|stage I prostate cancer|stage i prostate cancer
1452908|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
1452909|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
1452910|NCT00955435|stage III prostate cancer|stage iii prostate cancer
1452911|NCT00955422|Diagnosis|diagnosis
1452912|NCT00955422|Alzheimer's Disease|alzheimer's disease
1452913|NCT00955422|Memory Disorder|memory disorder
1452914|NCT00955422|Dementia|dementia
1452915|NCT00955422|Alzheimer Disease|alzheimer disease
1452916|NCT00955422|Memory Loss|memory loss
1452917|NCT00955396|sodium channel blocker|sodium channel blocker
1452918|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
1452919|NCT00955383|Japanese|japanese
1452920|NCT00955370|Uncertainty|uncertainty
1452921|NCT00955370|Undiagnosed|undiagnosed
1452922|NCT00955370|Rare Diseases|rare diseases
1452923|NCT00955370|Parents|parents
1452924|NCT00955370|Multiple Abnormalities|multiple abnormalities
1452925|NCT00955357|Epilepsy Treatment|epilepsy treatment
1452926|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
1452927|NCT00955357|Seizures|seizures
1452928|NCT00955357|Vimpat|vimpat
1452929|NCT00955344|colorectal cancer screening|colorectal cancer screening
1452930|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
1453055|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1453056|NCT00954941|CML|cml
1452931|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
1452932|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
1452934|NCT00955292|Solid Tumors|solid tumors
1452935|NCT00955292|Lymphoma|lymphoma
1452936|NCT00955292|G-Quadruplex|g-quadruplex
1452937|NCT00955279|Ustekinumab|ustekinumab
1452938|NCT00955279|CNTO 1275|cnto 1275
1452939|NCT00955279|Stelara|stelara
1452940|NCT00955279|Golimumab|golimumab
1452941|NCT00955279|CNTO 148|cnto 148
1452942|NCT00955279|Simponi|simponi
1452943|NCT00955279|Sarcoidosis|sarcoidosis
1452944|NCT00955279|Sarcoid|sarcoid
1452945|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
1452946|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
1452947|NCT00955266|Separation|separation
1452948|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
1452949|NCT00955266|Calcium chloride|calcium chloride
1452950|NCT00955253|Neglect|neglect
1452951|NCT00955253|Attention|attention
1452952|NCT00955253|Vigilance|vigilance
1452953|NCT00955253|Stroke|stroke
1452954|NCT00955253|Hemineglect|hemineglect
1452955|NCT00955253|Unilateral Neglect|unilateral neglect
1452956|NCT00955253|Spatial Neglect|spatial neglect
1452957|NCT00955240|stage II anal cancer|stage ii anal cancer
1452958|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
1452959|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
1452960|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1452961|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
1452962|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
1452963|NCT00955227|Ezetimibe|ezetimibe
1452964|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
1452965|NCT00955214|TAXUS Liberté|taxus liberté
1452966|NCT00955214|Small coronary artery disease|small coronary artery disease
1452967|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
1452968|NCT00955201|diabetes mellitus|diabetes mellitus
1452969|NCT00955201|diabetic neuropathies|diabetic neuropathies
1452970|NCT00955201|Aerobic Exercise|aerobic exercise
1452971|NCT00955201|Exercise Therapy|exercise therapy
1452972|NCT00955201|electromyography|electromyography
1452973|NCT00955201|United States Veterans|united states veterans
1452974|NCT00955188|colon cancer|colon cancer
1452975|NCT00955188|rectal cancer|rectal cancer
1452976|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1452977|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1452978|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1452979|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1452980|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
1452981|NCT00955162|Buprenorphine|buprenorphine
1452982|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
1452983|NCT00955149|Trisomy 7|trisomy 7
1452984|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
1452985|NCT00955149|Chemoprevention|chemoprevention
1452986|NCT00955149|Erlotinib|erlotinib
1452987|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
1452988|NCT00955136|Acute coronary syndrome|acute coronary syndrome
1452989|NCT00955136|MRX 801|mrx 801
1452990|NCT00955136|Echocardiography|echocardiography
1452991|NCT00955123|Inflammation|inflammation
1452992|NCT00955123|Urea synthesis|urea synthesis
1452993|NCT00955123|Catabolism|catabolism
1452994|NCT00955123|Nitrogen balance|nitrogen balance
1452995|NCT00955110|Opioid|opioid
1452996|NCT00955110|Recreational|recreational
1452997|NCT00955110|Oxymorphone|oxymorphone
1452998|NCT00955110|Oxycodone|oxycodone
1452999|NCT00955110|Extended Release|extended release
1453000|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
1453001|NCT00955097|Definity|definity
1453002|NCT00955097|liver tumors|liver tumors
1453003|NCT00955097|intra operative contrast|intra operative contrast
1453004|NCT00955097|liver cancer|liver cancer
1453005|NCT00955097|hepatic tumors|hepatic tumors
1453006|NCT00955097|identify liver tumors|identify liver tumors
1453007|NCT00955097|surgery liver tumors|surgery liver tumors
1453008|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
1453009|NCT00955071|exercise|exercise
1453010|NCT00955071|physical activity|physical activity
1453011|NCT00955071|diet|diet
1453012|NCT00955071|metabolic risk|metabolic risk
1453013|NCT00955071|visceral fat|visceral fat
1453014|NCT00955071|Insulin Resistance|insulin resistance
1453015|NCT00955058|PSA|psa
1453016|NCT00955058|PCO|pco
1453017|NCT00955058|PCOS|pcos
1453018|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
1453019|NCT00955045|istradefylline treatment|istradefylline treatment
1453020|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
1453021|NCT00955032|Parkinson's disease|parkinson's disease
1453022|NCT00955032|Apathy|apathy
1453023|NCT00955032|rTMS|rtms
1453024|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1453025|NCT00955032|Depression|depression
1453026|NCT00955019|Barrett's|barrett's
1453027|NCT00955019|Esophagus|esophagus
1453028|NCT00955019|Reflux|reflux
1453029|NCT00955019|dysplasia|dysplasia
1453030|NCT00955019|adenocarcinoma|adenocarcinoma
1453031|NCT00955006|HIV Seronegativity|hiv seronegativity
1453032|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
1453138|NCT00954564|arthralgia|arthralgia
1453033|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
1453034|NCT00954993|Vaniprevir|vaniprevir
1453035|NCT00954993|MK-7009|mk-7009
1453036|NCT00954980|Varicose Veins|varicose veins
1453037|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
1453038|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
1453039|NCT00954980|Ulceration|ulceration
1453040|NCT00954980|leg pain|leg pain
1453041|NCT00954980|leg swelling|leg swelling
1453042|NCT00954967|Diabetes Mellitus|diabetes mellitus
1453043|NCT00954967|Smoking Cessation|smoking cessation
1453044|NCT00954967|Primary Health Care|primary health care
1453045|NCT00954967|Motivational Interview|motivational interview
1453046|NCT00954954|Arthroplasty|arthroplasty
1453047|NCT00954954|Replacement|replacement
1453048|NCT00954954|Knee|knee
1453049|NCT00954954|Range of Motion|range of motion
1453050|NCT00954941|Hematologic Disorder|hematologic disorder
1453051|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
1453052|NCT00954941|AML|aml
1453053|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
1453054|NCT00954941|HR-MDS|hr-mds
1453057|NCT00954941|Ondansetron|ondansetron
1453058|NCT00954941|Zofran|zofran
1453059|NCT00954941|Aprepitant|aprepitant
1453060|NCT00954941|Emend|emend
1453061|NCT00954941|L 754030|l 754030
1453062|NCT00954941|MK 869|mk 869
1453063|NCT00954941|Emesis|emesis
1453064|NCT00954941|Nausea|nausea
1453065|NCT00954941|Vomiting|vomiting
1453066|NCT00954928|hand|hand
1453067|NCT00954928|wrist|wrist
1453068|NCT00954928|anticoagulation|anticoagulation
1453069|NCT00954928|surgery|surgery
1453070|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
1453071|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
1453072|NCT00954915|psoriatic arthritis|psoriatic arthritis
1453073|NCT00954902|Spice|spice
1453074|NCT00954902|responses to stress|responses to stress
1453075|NCT00954902|Inflammatory|inflammatory
1453076|NCT00954837|Thyroid cancer|thyroid cancer
1453077|NCT00954837|thyroid FNA|thyroid fna
1453078|NCT00954837|repeat FNA|repeat fna
1453079|NCT00954837|thyroid screening|thyroid screening
1453080|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
1453081|NCT00954837|FNA screening|fna screening
1453082|NCT00954811|pregnancy|pregnancy
1453083|NCT00954798|Influenza|influenza
1453084|NCT00954798|Pandemic Flu|pandemic flu
1453085|NCT00954798|Swine-origin Influenza|swine-origin influenza
1453086|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
1453087|NCT00954798|Adjuvant|adjuvant
1453088|NCT00954798|Adult|adult
1453089|NCT00954785|ankle|ankle
1453090|NCT00954785|ligament|ligament
1453091|NCT00954785|sprain|sprain
1453092|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1453093|NCT00954785|treatment|treatment
1453094|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
1453095|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
1453096|NCT00954759|Infantile colic|infantile colic
1453097|NCT00954759|Chiropractic|chiropractic
1453098|NCT00954759|Manipulation|manipulation
1453099|NCT00954759|Randomized controlled trial|randomized controlled trial
1453100|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
1453101|NCT00954746|Muscular Diseases|muscular diseases
1453102|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
1453103|NCT00954746|Contracture Joint Diseases|contracture joint diseases
1453104|NCT00954746|Connective Tissue Diseases|connective tissue diseases
1453105|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
1453106|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
1453107|NCT00954733|Hypoventilation|hypoventilation
1453108|NCT00954733|Co2|co2
1453109|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
1453110|NCT00954720|AML|aml
1453111|NCT00954720|ALL|all
1453112|NCT00954720|MDS|mds
1453113|NCT00954720|iron overload|iron overload
1453114|NCT00954707|Atherosclerosis|atherosclerosis
1453115|NCT00954681|Cannabis|cannabis
1453116|NCT00954681|quetiapine|quetiapine
1453117|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
1453118|NCT00954668|angiography|angiography
1453119|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
1453120|NCT00954668|timing|timing
1453121|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1453122|NCT00954642|Solid Tumor|solid tumor
1453123|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
1453124|NCT00954642|Avastin|avastin
1453125|NCT00954629|Osteoarthritis|osteoarthritis
1453126|NCT00954629|Pain|pain
1453127|NCT00954629|Knee|knee
1453128|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
1453129|NCT00954616|Alzheimer's disease|alzheimer's disease
1453130|NCT00954603|delirium rating scale|delirium rating scale
1453131|NCT00954603|clinical global improvement|clinical global improvement
1453132|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
1453133|NCT00954577|obesity|obesity
1453134|NCT00954577|diabetes|diabetes
1453135|NCT00954577|exercise|exercise
1453136|NCT00954577|education|education
1453137|NCT00954577|child|child
1453144|NCT00954499|tactile stimulation|tactile stimulation
1453145|NCT00954499|pain|pain
1453146|NCT00954499|immunization|immunization
1453147|NCT00954499|infant|infant
1453148|NCT00954460|VPRIV|vpriv
1453149|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
1453150|NCT00954460|Gaucher disease|gaucher disease
1453151|NCT00954460|glucocerebrosidase|glucocerebrosidase
1453152|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
1453153|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
1453154|NCT00954460|glucosylceramidase|glucosylceramidase
1453155|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1453156|NCT00954460|gene activation|gene activation
1453157|NCT00954460|human|human
1453158|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
1453159|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
1453160|NCT00954382|Down syndrome|down syndrome
1453161|NCT00954382|IQ|iq
1453162|NCT00954382|mental age|mental age
1453163|NCT00954382|neuropsychological function|neuropsychological function
1453164|NCT00954369|Alzheimer's disease|alzheimer's disease
1453165|NCT00954369|AD|ad
1453166|NCT00954369|W372|w372
1453167|NCT00954369|W372000|w372000
1453168|NCT00954369|[F-18]W372|[f-18]w372
1453169|NCT00954369|exploratory|exploratory
1453170|NCT00954369|imaging|imaging
1453171|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
1453172|NCT00954343|Foot Ulcers|foot ulcers
1453173|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
1453174|NCT00954343|Chronic wound|chronic wound
1453175|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
1453176|NCT00954330|REturn to pre-injury level|return to pre-injury level
1453177|NCT00954317|epidural|epidural
1453178|NCT00954317|labour analgesia|labour analgesia
1453179|NCT00954304|Pgp inhibitor|pgp inhibitor
1453180|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
1453181|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
1453182|NCT00954278|non small cell lung cancer|non small cell lung cancer
1453183|NCT00954278|phase 1|phase 1
1453184|NCT00954278|sorafenib|sorafenib
1453185|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
1453186|NCT00954265|pregnancy occurence|pregnancy occurence
1453187|NCT00954265|OHSS|ohss
1453194|NCT00954161|First aid|first aid
1453195|NCT00954161|Helping behaviour|helping behaviour
1453196|NCT00954161|Health education|health education
1453197|NCT00954161|Myocardial infarction|myocardial infarction
1453198|NCT00954161|Emergencies|emergencies
1453199|NCT00954148|cancer|cancer
1453200|NCT00954148|colorectal|colorectal
1453201|NCT00954148|head/neck|head/neck
1453202|NCT00954148|lung|lung
1453203|NCT00954148|PET/CT|pet/ct
1453204|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
1453205|NCT00954122|Acute schizophrenia|acute schizophrenia
1453206|NCT00954109|Insulin Resistance|insulin resistance
1453207|NCT00954109|Type 2 Diabetes|type 2 diabetes
1453208|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
1453209|NCT00954057|TED|ted
1453210|NCT00954044|randomized clinical trial|randomized clinical trial
1453211|NCT00954044|prostate cancer|prostate cancer
1453212|NCT00954044|partnered exercise|partnered exercise
1453213|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
1453214|NCT00954005|gemcitabine|gemcitabine
1453215|NCT00954005|oxaliplatin|oxaliplatin
1453216|NCT00954005|rituximab|rituximab
1453217|NCT00953992|acute kidney disease|acute kidney disease
1453218|NCT00953992|prognosis|prognosis
1453219|NCT00953992|oxidative stress|oxidative stress
1453220|NCT00953992|inflammation|inflammation
1453221|NCT00953992|gene polymorphism|gene polymorphism
1453222|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
1453223|NCT00953979|treatment|treatment
1453224|NCT00953979|Sulfasalazine|sulfasalazine
1453225|NCT00953979|kunxian capsule|kunxian capsule
1453226|NCT00953914|pyridostigmine|pyridostigmine
1453227|NCT00953914|autonomic modulation|autonomic modulation
1453228|NCT00953914|diabetes mellitus|diabetes mellitus
1453229|NCT00953914|heart rate variability|heart rate variability
1453230|NCT00953888|Healthy volunteer|healthy volunteer
1453231|NCT00953888|Single ascending dose|single ascending dose
1453232|NCT00953888|Safety|safety
1453233|NCT00953888|Tolerability|tolerability
1453234|NCT00953888|Healthy volunteer study|healthy volunteer study
1453235|NCT00953862|ADHD|adhd
1453236|NCT00953862|Substance Use Disorder|substance use disorder
1453237|NCT00953862|Residential Treatment Facility|residential treatment facility
1453238|NCT00953849|Calcitriol|calcitriol
1453239|NCT00953849|Celecoxib|celecoxib
1453240|NCT00953849|Immunotherapy|immunotherapy
1453241|NCT00953836|kinetics|kinetics
1453242|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
1453243|NCT00953836|rye fiber|rye fiber
1453244|NCT00953823|Thiamin supplementation|thiamin supplementation
1453245|NCT00953823|Thiamin deficiency|thiamin deficiency
1453246|NCT00953823|Heart failure|heart failure
1453247|NCT00953823|Heart function|heart function
1453248|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
1453249|NCT00953810|heart failure|heart failure
1453250|NCT00953810|education|education
1453251|NCT00953810|non-pharmacological management|non-pharmacological management
1453252|NCT00953810|prognosis|prognosis
1453253|NCT00953797|Resistant Hypertension|resistant hypertension
1453254|NCT00953797|Endothelial dysfunction|endothelial dysfunction
1453255|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
1453256|NCT00953784|surgery|surgery
1453257|NCT00953784|wound infections|wound infections
1453258|NCT00953784|colorectal|colorectal
1453259|NCT00953771|TTP|ttp
1453260|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
1453261|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
1453262|NCT00953745|Depression|depression
1453263|NCT00953745|Neuroimaging|neuroimaging
1453264|NCT00953745|Aripiprazole|aripiprazole
1453265|NCT00953745|Mood disorder|mood disorder
1453266|NCT00953745|PET Scan|pet scan
1453267|NCT00953745|fMRI|fmri
1453268|NCT00953732|Peplin|peplin
1453269|NCT00953732|Actinic keratosis|actinic keratosis
1453270|NCT00953732|PEP005|pep005
1453271|NCT00953719|Hip arthroplasty|hip arthroplasty
1453272|NCT00953719|Acetabular cup|acetabular cup
1453273|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
1453274|NCT00953706|Fibrosis|fibrosis
1453275|NCT00953706|Pancreatic Diseases|pancreatic diseases
1453372|NCT00953199|lidocaine|lidocaine
1453276|NCT00953706|Digestive System Diseases|digestive system diseases
1453277|NCT00953706|Lung Diseases|lung diseases
1453278|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
1453279|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
1453280|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
1453281|NCT00953706|Pathologic Processes|pathologic processes
1453282|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
1453283|NCT00953693|Hepatic disorders|hepatic disorders
1453284|NCT00953693|Eye disorders|eye disorders
1453285|NCT00953693|Blood groups|blood groups
1453286|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
1453287|NCT00953654|Exercise Training|exercise training
1453288|NCT00953654|Strength Training|strength training
1453289|NCT00953654|Mental Health|mental health
1453290|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
1453291|NCT00953641|Cervical ripening|cervical ripening
1453292|NCT00953641|Endometrial biopsy|endometrial biopsy
1453293|NCT00953628|endometrium|endometrium
1453294|NCT00953628|histology|histology
1453295|NCT00953628|pregnancy|pregnancy
1453296|NCT00953615|PSC|psc
1453297|NCT00953615|Thalidomide|thalidomide
1453298|NCT00953589|treatment naive|treatment naive
1453299|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
1453300|NCT00953576|KHAD|khad
1453301|NCT00953563|Venous Leg Ulcers|venous leg ulcers
1453302|NCT00953537|stage IV breast cancer|stage iv breast cancer
1453303|NCT00953524|Influenza|influenza
1453304|NCT00953524|Pandemic Flu|pandemic flu
1453305|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
1453306|NCT00953524|Adult|adult
1453307|NCT00953511|esophagus|esophagus
1453308|NCT00953511|chemoradiation|chemoradiation
1453309|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
1453310|NCT00953511|polymorphism|polymorphism
1453311|NCT00953511|response prediction|response prediction
1453312|NCT00953498|diabetes|diabetes
1453313|NCT00953498|glitazones|glitazones
1453314|NCT00953498|HDL|hdl
1453315|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
1453316|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
1453317|NCT00953485|Transplantation|transplantation
1453318|NCT00953472|hypertension treatment|hypertension treatment
1453319|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1453320|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
1453321|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1453322|NCT00953446|ASL MRI|asl mri
1453323|NCT00953446|sunitinib|sunitinib
1453324|NCT00953446|AMG386|amg386
1453325|NCT00953433|Intratracheal|intratracheal
1453326|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1453327|NCT00953420|Carboplatin|carboplatin
1453328|NCT00953420|Docetaxel|docetaxel
1453329|NCT00953420|Epstein-Barr Virus|epstein-barr virus
1453330|NCT00953420|T Lymphocytes|t lymphocytes
1453331|NCT00953420|EBV-CTLs|ebv-ctls
1453332|NCT00953394|octreotide LAR|octreotide lar
1453333|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
1453528|NCT00952484|HPP|hpp
1453334|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
1453335|NCT00953381|Ilaprazole|ilaprazole
1453336|NCT00953381|Proton pump inhibitor|proton pump inhibitor
1453337|NCT00953381|Duodenal ulcer|duodenal ulcer
1453338|NCT00953381|Acid suppression|acid suppression
1453339|NCT00953381|Randomized trial|randomized trial
1453340|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
1453341|NCT00953368|cognitive function|cognitive function
1453342|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
1453343|NCT00953342|AEROBIC EXERCISE|aerobic exercise
1453344|NCT00953342|ASTHMA CONTROL|asthma control
1453345|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
1453346|NCT00953342|INFLAMMATION|inflammation
1453347|NCT00953342|TREATMENT|treatment
1453348|NCT00953303|heart failure|heart failure
1453349|NCT00953303|prednisone|prednisone
1453350|NCT00953303|cardiovascular mortality|cardiovascular mortality
1453351|NCT00953303|renal function|renal function
1453352|NCT00953290|Cellulite|cellulite
1453353|NCT00953290|Adipose tissue|adipose tissue
1453354|NCT00953290|Circumference|circumference
1453355|NCT00953290|Reduction|reduction
1453357|NCT00953277|Nerve Repair|nerve repair
1453358|NCT00953277|Erectile Function|erectile function
1453359|NCT00953277|Prostate Cancer|prostate cancer
1453360|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
1453361|NCT00953277|Continence|continence
1453362|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
1453363|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
1453364|NCT00953225|prostate cancer|prostate cancer
1453365|NCT00953225|vitamin D|vitamin d
1453366|NCT00953212|atrial fibrillation|atrial fibrillation
1453367|NCT00953212|cardiac surgery|cardiac surgery
1453368|NCT00953212|open heart surgery|open heart surgery
1453369|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1453370|NCT00953199|ERCP|ercp
1453371|NCT00953199|pancreatitis|pancreatitis
1453373|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
1453374|NCT00953186|Diabetes|diabetes
1453375|NCT00953186|Foot ulcer|foot ulcer
1453376|NCT00953186|Neuropathy|neuropathy
1453377|NCT00953186|Ischemia|ischemia
1453378|NCT00953160|Cellulite|cellulite
1453379|NCT00953160|Adipose tissue|adipose tissue
1453380|NCT00953160|Circumference|circumference
1453381|NCT00953160|Reduction|reduction
1453382|NCT00953160|Thigh|thigh
1453383|NCT00953160|Abdomen|abdomen
1453384|NCT00953160|Flank|flank
1453385|NCT00953134|periconceptional|periconceptional
1453386|NCT00953134|iron|iron
1453387|NCT00953134|folic acid|folic acid
1453388|NCT00953134|supplementation|supplementation
1453389|NCT00953121|irinotecan|irinotecan
1453390|NCT00953121|carboplatin|carboplatin
1453391|NCT00953121|bevacizumab|bevacizumab
1453392|NCT00953121|Avastin|avastin
1453393|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
1453394|NCT00953095|treatment|treatment
1453395|NCT00953095|joint attention|joint attention
1453396|NCT00953095|communication|communication
1453397|NCT00953095|language|language
1453398|NCT00953043|lubiprostone|lubiprostone
1453399|NCT00953043|colon|colon
1453400|NCT00953043|motility|motility
1453401|NCT00953043|sensation|sensation
1453402|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
1453403|NCT00953017|Patient tolerability|patient tolerability
1453404|NCT00953017|Amitiza|amitiza
1453405|NCT00953017|Dulcolax|dulcolax
1453406|NCT00953017|Miralax|miralax
1453407|NCT00953017|Colonoscopy preparation|colonoscopy preparation
1453408|NCT00953017|Bowel preparation|bowel preparation
1453409|NCT00953017|Screening colonoscopy|screening colonoscopy
1453410|NCT00953004|dietary fiber|dietary fiber
1453411|NCT00953004|obesity|obesity
1453412|NCT00953004|apparent energy digestibility|apparent energy digestibility
1453413|NCT00952978|Ilaprazole|ilaprazole
1453414|NCT00952978|Proton pump inhibitor|proton pump inhibitor
1453415|NCT00952978|Duodenal ulcer|duodenal ulcer
1453416|NCT00952978|Acid suppression|acid suppression
1453417|NCT00952978|Randomized trial|randomized trial
1453418|NCT00952965|BP|bp
1453419|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1453420|NCT00952939|iris melanoma|iris melanoma
1453421|NCT00952939|intraocular melanoma|intraocular melanoma
1453422|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1453423|NCT00952926|Watchful Waiting|watchful waiting
1453424|NCT00952926|Rectal cancer|rectal cancer
1453425|NCT00952926|Observation|observation
1453426|NCT00952926|Avoid operation|avoid operation
1453427|NCT00952900|TMJMD|tmjmd
1453428|NCT00952900|Acute Pain|acute pain
1453429|NCT00952900|RDC/TMD|rdc/tmd
1453430|NCT00952900|Community Treatment Clinics|community treatment clinics
1453431|NCT00952900|RCT|rct
1453432|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
1453433|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
1453434|NCT00952900|Biopsychosocial|biopsychosocial
1453435|NCT00952900|Assessment and Treatment|assessment and treatment
1453436|NCT00952900|Ability to read and write English|ability to read and write english
1453437|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
1453438|NCT00952900|No other pain-related conditions|no other pain-related conditions
1453439|NCT00952874|anal cancer|anal cancer
1453440|NCT00952874|Molecular biology|molecular biology
1453441|NCT00952874|HIV status|hiv status
1453442|NCT00952874|HPV infection|hpv infection
1453443|NCT00952874|Microsatellite instability|microsatellite instability
1453444|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
1453445|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
1453446|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1453447|NCT00952861|Infection|infection
1453448|NCT00952861|Antibiotics|antibiotics
1453449|NCT00952848|pain|pain
1453450|NCT00952848|neurotoxicity|neurotoxicity
1453451|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1453452|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1453453|NCT00952848|peripheral neuropathy|peripheral neuropathy
1453454|NCT00952835|Asthma|asthma
1453455|NCT00952835|rhinitis|rhinitis
1453456|NCT00952835|EIB|eib
1453457|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
1453458|NCT00952835|lung function|lung function
1453459|NCT00952835|vitamin d|vitamin d
1453460|NCT00952796|intra-abdominal infection|intra-abdominal infection
1453461|NCT00952796|moxifloxacin|moxifloxacin
1453462|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
1453463|NCT00952783|Peplin|peplin
1453464|NCT00952783|Actinic keratosis|actinic keratosis
1453465|NCT00952783|PEP005|pep005
1453466|NCT00952770|Coronary artery disease|coronary artery disease
1453467|NCT00952770|Coronary intervention|coronary intervention
1453468|NCT00952770|intima-media thickness|intima-media thickness
1453469|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
1453470|NCT00952757|Quetiapine|quetiapine
1453471|NCT00952757|Schizophrenia|schizophrenia
1453472|NCT00952757|Bipolar|bipolar
1453473|NCT00952744|acute myocardial infarction|acute myocardial infarction
1453474|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1453475|NCT00952744|STEMI|stemi
1453476|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
1453477|NCT00952744|NSTEMI|nstemi
1453478|NCT00952744|unstable angina|unstable angina
1453479|NCT00952744|unstable angina pectoris|unstable angina pectoris
1453480|NCT00952744|UA|ua
1453481|NCT00952744|UAP|uap
1453482|NCT00952692|breast cancer|breast cancer
1453483|NCT00952692|HER2|her2
1453484|NCT00952692|Lapatinib|lapatinib
1453485|NCT00952692|dHER2 ASCI|dher2 asci
1453486|NCT00952692|overexpressing HER2|overexpressing her2
1453487|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
1453488|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
1453489|NCT00952666|Prostate Cancer|prostate cancer
1453490|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
1453491|NCT00952666|Neurovascular Bundles|neurovascular bundles
1453492|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
1453493|NCT00952653|depression|depression
1453494|NCT00952640|vitamin A|vitamin a
1453495|NCT00952640|post-partum|post-partum
1453496|NCT00952640|infant|infant
1453497|NCT00952640|acute phase response|acute phase response
1453498|NCT00952627|Cardiac fibrosis|cardiac fibrosis
1453499|NCT00952627|Diastolic dysfunction|diastolic dysfunction
1453500|NCT00952627|Hypertension|hypertension
1453501|NCT00952614|retinal vein occlusion|retinal vein occlusion
1453502|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
1453503|NCT00952614|steroid|steroid
1453504|NCT00952614|macular edema|macular edema
1453505|NCT00952601|Tourette|tourette
1453506|NCT00952601|Atkins|atkins
1453507|NCT00952601|Ketosis|ketosis
1453508|NCT00952601|Tic|tic
1453509|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
1453510|NCT00952588|AML|aml
1453511|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
1453512|NCT00952562|vitamin d|vitamin d
1453513|NCT00952562|calcium|calcium
1453514|NCT00952562|blood pressure|blood pressure
1453515|NCT00952536|Randomised controlled trial|randomised controlled trial
1453516|NCT00952536|Double blind fully masked|double blind fully masked
1453517|NCT00952536|Dietary supplement|dietary supplement
1453518|NCT00952523|acne|acne
1453519|NCT00952523|irritation|irritation
1453520|NCT00952523|objective sensory methods|objective sensory methods
1453521|NCT00952510|Range of motion, articular|range of motion, articular
1453522|NCT00952510|Cervical spine|cervical spine
1453523|NCT00952497|Gastric Cancer|gastric cancer
1453524|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
1453525|NCT00952497|GE-Junction|ge-junction
1453526|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
1453527|NCT00952484|Hypophosphatasia|hypophosphatasia
1453529|NCT00952484|Bone Disease|bone disease
1453530|NCT00952484|Soft Bones|soft bones
1453531|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
1453532|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
1453533|NCT00952484|alkaline phosphatase|alkaline phosphatase
1453534|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1453535|NCT00952484|rickets|rickets
1453536|NCT00952484|osteomalacia|osteomalacia
1453537|NCT00952471|Asthma|asthma
1453538|NCT00952471|Children|children
1453539|NCT00952471|CPOE|cpoe
1453540|NCT00952471|Decision Support|decision support
1453541|NCT00952471|Framing|framing
1453542|NCT00952471|Heuristic|heuristic
1453543|NCT00952471|Order Sets|order sets
1453544|NCT00952458|Safety|safety
1453545|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
1453546|NCT00952458|ERCP|ercp
1453547|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
1453548|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
1453549|NCT00952432|Multiple Excitability Test|multiple excitability test
1453550|NCT00952432|Nerve Conduction Study|nerve conduction study
1453551|NCT00952432|QtracW|qtracw
1453552|NCT00952432|carbamazepine|carbamazepine
1453553|NCT00952432|Acupuncture|acupuncture
1453554|NCT00952419|Influenza|influenza
1453555|NCT00952419|Pandemic Flu|pandemic flu
1453556|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
1453557|NCT00952419|Children|children
1453558|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
1453559|NCT00952406|Sexual Function|sexual function
1453560|NCT00952406|Incontinence|incontinence
1453561|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
1453562|NCT00952393|receptors nicotinic|receptors nicotinic
1453564|NCT00952354|Down syndrome|down syndrome
1453566|NCT00952354|language development|language development
1453567|NCT00952354|language assessment|language assessment
1453568|NCT00952341|CINV|cinv
1453569|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
1453570|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
1453571|NCT00952328|infant weight loss|infant weight loss
1453572|NCT00952315|kidney stones|kidney stones
1453573|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
1453574|NCT00952315|kidney stone removal|kidney stone removal
1453575|NCT00952302|Hypoxia|hypoxia
1453576|NCT00952302|Iron|iron
1453577|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
1453578|NCT00952302|Chronic mountain sickness|chronic mountain sickness
1453579|NCT00952289|Myelofibrosis|myelofibrosis
1453580|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1453581|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1453582|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
1453583|NCT00952263|Hepatitis C|hepatitis c
1453584|NCT00952263|Phase I|phase i
1453585|NCT00952263|Infusion|infusion
1453586|NCT00952263|Pharmacokinetics|pharmacokinetics
1453587|NCT00952263|MBL-HCV1|mbl-hcv1
1453588|NCT00952263|Monoclonal antibody|monoclonal antibody
1453589|NCT00952263|Safety Assessment|safety assessment
1453590|NCT00952250|quality improvement|quality improvement
1453591|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
1453592|NCT00952237|IL-2|il-2
1453593|NCT00952237|GM-CSF|gm-csf
1453594|NCT00952224|myocardial salvage|myocardial salvage
1453595|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
1453596|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
1453597|NCT00952224|myocardial infarction|myocardial infarction
1453598|NCT00952224|prognosis|prognosis
1453599|NCT00952211|stroke|stroke
1453600|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
1453601|NCT00952211|fatigue|fatigue
1453602|NCT00952211|quality of life|quality of life
1453603|NCT00952185|viral infection|viral infection
1453604|NCT00952185|aplastic anemia|aplastic anemia
1453605|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1453606|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
1453607|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1453608|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1453609|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1453610|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1453611|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1453612|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1453613|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1453614|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1453615|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1453616|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1453617|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1453618|NCT00952185|mast cell leukemia|mast cell leukemia
1453619|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1453620|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1453621|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
1453622|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1453623|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1453624|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1453625|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1453626|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
1453627|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1453628|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1453629|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1453630|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1453631|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1453632|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1453633|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1453634|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1453635|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1453636|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1453637|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1453638|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1453639|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1453640|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1453641|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1453642|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1453643|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1453644|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1453645|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1453646|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1453877|NCT00951665|HER2|her2
1453647|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1453648|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1453649|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1453650|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1453651|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1453652|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1453653|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1453654|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1453655|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1453656|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1453657|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1453658|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1453659|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1453660|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1453661|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1453662|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1453663|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1453664|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1453665|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1453666|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1453667|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1453668|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1453669|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1453670|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1453671|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1453672|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1453673|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1453674|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1453675|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1453676|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1453677|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1453678|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1453679|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1453680|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1453985|NCT00951574|nadroparin|nadroparin
1453681|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1453682|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1453683|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1453684|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1453685|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1453686|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1453687|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1453688|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1453689|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1453690|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1453691|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1453692|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1453693|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1453694|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1453695|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1453696|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1453697|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1453698|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1453699|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1453700|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1453701|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1453702|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1453703|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1453704|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1453878|NCT00951665|HER2+|her2+
1453705|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1453706|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1453707|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1453708|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1453709|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1453710|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1453711|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1453712|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1453713|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1453714|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1453715|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1453716|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1453717|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1453718|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1453719|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1595289|NCT00413036|NHL|nhl
1453720|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1453721|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1453722|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1453723|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1453724|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1453725|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1453726|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1453727|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1453728|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1453729|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1453730|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1453731|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1453732|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1453733|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1453734|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1453735|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1453736|NCT00952185|intraocular lymphoma|intraocular lymphoma
1453737|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1453738|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1453739|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1453740|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1453741|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1453742|NCT00952185|primary myelofibrosis|primary myelofibrosis
1453743|NCT00952185|essential thrombocythemia|essential thrombocythemia
1453744|NCT00952185|polycythemia vera|polycythemia vera
1453745|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
1453746|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1453747|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
1453748|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
1453749|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
1453750|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
1453751|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
1453752|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1453753|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1453754|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1453755|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1453756|NCT00952172|Stair stepping training|stair stepping training
1453757|NCT00952172|OSAS|osas
1453758|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
1453759|NCT00952172|sleep disturbance|sleep disturbance
1453760|NCT00952172|Actigraphy|actigraphy
1453761|NCT00952159|tramadol|tramadol
1453762|NCT00952159|CYP2D6|cyp2d6
1453763|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
1453764|NCT00952159|poor metabolizer|poor metabolizer
1453765|NCT00952159|genotyping|genotyping
1453766|NCT00952159|phenotyping|phenotyping
1453767|NCT00952146|NOTES|notes
1453768|NCT00952146|Transgastric|transgastric
1453769|NCT00952146|Appendectomy|appendectomy
1453770|NCT00952146|Safety|safety
1453771|NCT00952146|Feasibility|feasibility
1453772|NCT00952133|PONV|ponv
1453773|NCT00952133|Outpatient surgery|outpatient surgery
1453774|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
1453775|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
1453776|NCT00952120|Wound healing|wound healing
1453777|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
1453778|NCT00952120|Skin graft|skin graft
1453779|NCT00952107|breast cancer|breast cancer
1454227|NCT00950677|Diabetes|diabetes
1453780|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
1453781|NCT00952107|flap assessment|flap assessment
1453782|NCT00952094|Healthy volunteer|healthy volunteer
1453783|NCT00952081|Hypertension|hypertension
1453784|NCT00952081|Neurosurgery|neurosurgery
1453785|NCT00952081|bloodpressure control|bloodpressure control
1453786|NCT00952081|brain tumor resection|brain tumor resection
1453787|NCT00952081|epilepsy focus resection|epilepsy focus resection
1453788|NCT00952068|Back Pain|back pain
1453789|NCT00952055|neopterin|neopterin
1453790|NCT00952055|macrophage|macrophage
1453791|NCT00952055|inflammation|inflammation
1453792|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
1453793|NCT00952029|stage IV colon cancer|stage iv colon cancer
1453794|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
1453795|NCT00952016|colorectal cancer|colorectal cancer
1453796|NCT00952016|MSH2|msh2
1453797|NCT00952016|metastatic|metastatic
1453798|NCT00952003|Avastin|avastin
1453799|NCT00952003|Campto|campto
1453800|NCT00952003|Oxaliplatin|oxaliplatin
1453801|NCT00952003|Taxotere|taxotere
1453802|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1453803|NCT00951977|Transplantation|transplantation
1453804|NCT00951977|Living Kidney Donation|living kidney donation
1453805|NCT00951977|Kidney Transplant|kidney transplant
1453806|NCT00951938|Trinity Evolution|trinity evolution
1453807|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
1453808|NCT00951938|Allograft|allograft
1453809|NCT00951925|diagnostic bone marrow biopsies|diagnostic bone marrow biopsies
1453810|NCT00951925|bone marrow harvesting for autologous BMT|bone marrow harvesting for autologous bmt
1453811|NCT00951912|genistein|genistein
1453812|NCT00951912|daidzein|daidzein
1453813|NCT00951912|impaired glucose regulation|impaired glucose regulation
1453814|NCT00951912|glucose metabolism|glucose metabolism
1453815|NCT00951912|lipids metabolism|lipids metabolism
1453816|NCT00951912|inflammation|inflammation
1453817|NCT00951912|women|women
1453818|NCT00951899|Incretins|incretins
1453819|NCT00951899|colesevelam|colesevelam
1453820|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
1453821|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
1453822|NCT00951886|Spirometry|spirometry
1453823|NCT00951886|Respiratory rare diseases|respiratory rare diseases
1453824|NCT00951860|Fullterm Birth|fullterm birth
1453825|NCT00951860|Neonate|neonate
1453826|NCT00951860|Prematurity|prematurity
1453827|NCT00951860|Neurodevelopment|neurodevelopment
1453828|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
1453829|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
1453830|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
1453831|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
1453832|NCT00951834|Neuroprotection|neuroprotection
1453833|NCT00951834|ADAS-COG|adas-cog
1453834|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
1453835|NCT00951821|Suicidal Ideation|suicidal ideation
1453836|NCT00951821|Suicide Attempts|suicide attempts
1454379|NCT00950118|Genes|genes
1453837|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
1453838|NCT00951808|Acute Chest Syndrome|acute chest syndrome
1453839|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
1453840|NCT00951795|HIV|hiv
1453841|NCT00951795|AIDS|aids
1453842|NCT00951795|CD4|cd4
1453843|NCT00951782|COPD|copd
1453844|NCT00951756|Dietary fat|dietary fat
1453845|NCT00951756|Microbiome composition|microbiome composition
1453846|NCT00951756|Controlled feeding experiment|controlled feeding experiment
1453847|NCT00951743|AIDS|aids
1453848|NCT00951743|HIV|hiv
1453849|NCT00951743|mDAPTA|mdapta
1453850|NCT00951730|Down Syndrome|down syndrome
1453851|NCT00951730|Adult|adult
1453852|NCT00951730|Children|children
1453853|NCT00951730|Sleep apnea|sleep apnea
1453854|NCT00951730|Sleep hypopnea|sleep hypopnea
1453855|NCT00951730|Polysomnography|polysomnography
1453856|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
1453857|NCT00951717|Physical Symptoms|physical symptoms
1453858|NCT00951717|Emotional Symptoms|emotional symptoms
1453859|NCT00951717|Infant Colic|infant colic
1453860|NCT00951717|Social Support|social support
1453861|NCT00951717|Breastfeeding|breastfeeding
1453862|NCT00951704|CPR|cpr
1453863|NCT00951704|Tissue Perfusion|tissue perfusion
1453864|NCT00951704|invasive arterial pressure|invasive arterial pressure
1453865|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
1453866|NCT00951704|Quality of life|quality of life
1453867|NCT00951704|Quality of chest compressions|quality of chest compressions
1453868|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
1453869|NCT00951691|Elderly|elderly
1453870|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
1453871|NCT00951678|ultrasound|ultrasound
1453872|NCT00951678|femoral vein|femoral vein
1453873|NCT00951678|internal jugular vein|internal jugular vein
1453874|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
1453875|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
1453876|NCT00951665|Armed Herceptin|armed herceptin
1453879|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
1453880|NCT00951652|CBT|cbt
1453881|NCT00951652|GAD|gad
1453882|NCT00951652|Interpersonal Therapy|interpersonal therapy
1453883|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
1453884|NCT00951639|Cassia|cassia
1453885|NCT00951639|Cinnamon|cinnamon
1453886|NCT00951639|Blood Glucose|blood glucose
1453887|NCT00951639|Endurance exercise|endurance exercise
1453888|NCT00951639|Acute exercise|acute exercise
1453889|NCT00951639|Overweight|overweight
1453890|NCT00951639|Obesity|obesity
1453891|NCT00951639|Women|women
1453892|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1453893|NCT00951626|therapy-related toxicity|therapy-related toxicity
1453894|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1453895|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1595485|NCT00412243|Clolar|clolar
1453896|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1453897|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1453898|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1453899|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1453900|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1453901|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1453902|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1453903|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1453904|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1453905|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1453906|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1453907|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1453908|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1453909|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1453910|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1453911|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1453912|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1453913|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1453914|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1453915|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1453916|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1453917|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1453918|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1453919|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1453920|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1453921|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1453922|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1453923|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1453924|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1453925|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1453926|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1453927|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1453928|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1453929|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1453930|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1453931|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1453932|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1453933|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1453934|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1453935|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1453936|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1453937|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1453938|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1453939|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1453940|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1453941|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1453942|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1453943|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1453944|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1453945|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1454228|NCT00950677|pramlintide|pramlintide
1453946|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1453947|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1453948|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1453949|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1453950|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1453951|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1453952|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1453953|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1453954|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1453955|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1453956|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1453957|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1453958|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1453959|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1453960|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1453961|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1453962|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1453963|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
1453964|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1453965|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1453966|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1453967|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1453968|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1453969|NCT00951626|primary myelofibrosis|primary myelofibrosis
1453970|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1453971|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1453972|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1453973|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1453974|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1453975|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
1453976|NCT00951613|small cell lung cancer|small cell lung cancer
1453977|NCT00951613|carcinoma, lung|carcinoma, lung
1453978|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
1453979|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
1453980|NCT00951587|Colonic Diseases|colonic diseases
1453981|NCT00951574|thromboembolism|thromboembolism
1453982|NCT00951574|cancer|cancer
1453983|NCT00951574|chemotherapy|chemotherapy
1453984|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
1453986|NCT00951561|Dysmenorrhea|dysmenorrhea
1453987|NCT00951548|Probiotics|probiotics
1453989|NCT00951548|Double-blind|double-blind
1453990|NCT00951548|Placebo controlled|placebo controlled
1453991|NCT00951535|stage I prostate cancer|stage i prostate cancer
1453992|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
1453993|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
1453994|NCT00951535|stage III prostate cancer|stage iii prostate cancer
1453995|NCT00951522|Cystic Fibrosis|cystic fibrosis
1453996|NCT00951522|CF|cf
1453997|NCT00951522|Mucociliary Clearance|mucociliary clearance
1453998|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
1453999|NCT00951522|ENaC Inhibitor|enac inhibitor
1454000|NCT00951522|Airway Hydration|airway hydration
1454001|NCT00951522|Amiloride|amiloride
1454002|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
1454003|NCT00951509|rehabilitation|rehabilitation
1454004|NCT00951509|driving assessments|driving assessments
1454005|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
1454006|NCT00951483|Depression|depression
1454007|NCT00951483|Quetiapine|quetiapine
1454008|NCT00951470|Head and neck lymphedema|head and neck lymphedema
1454009|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
1454010|NCT00951470|CDT|cdt
1454011|NCT00951470|Oral cavity cancer|oral cavity cancer
1454012|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
1454013|NCT00951457|CLL|cll
1454014|NCT00951457|pretreated|pretreated
1454015|NCT00951457|immune therapy|immune therapy
1454016|NCT00951457|dose escalation|dose escalation
1454017|NCT00951457|maintenance therapy|maintenance therapy
1454018|NCT00951457|Bendamustine|bendamustine
1454019|NCT00951457|Alemtuzumab|alemtuzumab
1454020|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1454021|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
1454022|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1454023|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1454024|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1454025|NCT00951431|Functional dyspepsia|functional dyspepsia
1454026|NCT00951431|PPI|ppi
1454027|NCT00951431|postprandial fullness|postprandial fullness
1454028|NCT00951431|delayed gastric emptying|delayed gastric emptying
1454029|NCT00951418|clozapine|clozapine
1454030|NCT00951418|schizophrenia|schizophrenia
1454031|NCT00951418|cognition|cognition
1454032|NCT00951418|t-wave morphology|t-wave morphology
1454033|NCT00951392|Insulin sensitivity|insulin sensitivity
1454034|NCT00951392|aging|aging
1454035|NCT00951392|lipid metabolism|lipid metabolism
1454036|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
1454037|NCT00951392|gene expression|gene expression
1454038|NCT00951392|sirtuins|sirtuins
1454039|NCT00951366|premature birth|premature birth
1454040|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
1454041|NCT00951366|chronic lung disease|chronic lung disease
1454042|NCT00951366|epidemiologicfactors|epidemiologicfactors
1454043|NCT00951366|genetic factors|genetic factors
1454044|NCT00951353|Transplantation|transplantation
1454045|NCT00951353|Kidney Failure|kidney failure
1454046|NCT00951353|End Stage Renal Disease|end stage renal disease
1454047|NCT00951353|Pediatric|pediatric
1454048|NCT00951340|CBT|cbt
1454049|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
1454050|NCT00951340|Interpersonal Therapy|interpersonal therapy
1454051|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
1454052|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
1454053|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
1454054|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
1454055|NCT00951314|Cocaine Dependence|cocaine dependence
1454056|NCT00951314|Cue-Induced Craving|cue-induced craving
1454057|NCT00951314|Drug Abuse|drug abuse
1454058|NCT00951288|AMD|amd
1454059|NCT00951288|Retinal Function|retinal function
1454060|NCT00951288|Neuroprotection|neuroprotection
1454061|NCT00951262|life review|life review
1454062|NCT00951262|quality of life|quality of life
1454063|NCT00951262|advanced cancer patients|advanced cancer patients
1454064|NCT00951249|MSM|msm
1454065|NCT00951249|HIV infections|hiv infections
1454066|NCT00951249|HIV Seronegativity|hiv seronegativity
1454067|NCT00951236|Trigger Finger|trigger finger
1454068|NCT00951236|Trigger Thumb|trigger thumb
1454069|NCT00951210|Peripheral Artery Disease|peripheral artery disease
1454070|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
1454071|NCT00951210|Critical limb ischemia|critical limb ischemia
1454072|NCT00951210|PAD|pad
1454073|NCT00951210|CLI|cli
1454074|NCT00951197|dementia|dementia
1454075|NCT00951197|Alzheimer's Disease|alzheimer's disease
1454076|NCT00951197|diagnostic|diagnostic
1454077|NCT00951197|biomarkers|biomarkers
1454078|NCT00951197|neuroimaging|neuroimaging
1454079|NCT00951197|PET|pet
1454080|NCT00951197|MRI|mri
1454081|NCT00951197|mild cognitive impairment|mild cognitive impairment
1454082|NCT00951184|depression|depression
1454083|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1454084|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
1454085|NCT00951158|Clarinol|clarinol
1454086|NCT00951158|S14 Expression|s14 expression
1454087|NCT00951132|Inflammation|inflammation
1454088|NCT00951132|Atherosclerosis|atherosclerosis
1454089|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1454090|NCT00951119|type 2 diabetes|type 2 diabetes
1454091|NCT00951119|hypertension|hypertension
1454092|NCT00951119|treatment|treatment
1454093|NCT00951119|non-medical|non-medical
1454095|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1454096|NCT00951106|Drug resistance|drug resistance
1454097|NCT00951093|GERD|gerd
1454098|NCT00951093|Gastric bypass|gastric bypass
1454099|NCT00951080|ulcer|ulcer
1454100|NCT00951080|venous|venous
1454101|NCT00951080|diabetic|diabetic
1454102|NCT00951080|wounds and injuries|wounds and injuries
1454103|NCT00951067|Lymphedema|lymphedema
1454104|NCT00951067|Breast Cancer|breast cancer
1454105|NCT00951067|Upper Extremity|upper extremity
1454106|NCT00951067|Arm|arm
1454107|NCT00951054|breast cancer|breast cancer
1454108|NCT00951054|triple negative|triple negative
1454109|NCT00951054|ER-negative|er-negative
1454110|NCT00951054|PR-negative|pr-negative
1454111|NCT00951054|HER2-negative|her2-negative
1454112|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
1454113|NCT00951041|influenza infection|influenza infection
1454114|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
1454115|NCT00951028|Adherence|adherence
1454116|NCT00951015|GSK1349572|gsk1349572
1454117|NCT00951015|emtricitabine|emtricitabine
1454118|NCT00951015|tenofovir|tenofovir
1454119|NCT00951015|efavirenz|efavirenz
1454120|NCT00951015|abacavir|abacavir
1454121|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
1454122|NCT00951015|dose selection|dose selection
1454123|NCT00951015|HIV-1 Infection|hiv-1 infection
1454124|NCT00951015|integrase inhibitor|integrase inhibitor
1454125|NCT00951015|HIV infection|hiv infection
1454126|NCT00951015|once daily|once daily
1454127|NCT00951015|lamivudine|lamivudine
1454128|NCT00951002|anal fistula|anal fistula
1454129|NCT00951002|acellular dermal matrix|acellular dermal matrix
1454130|NCT00951002|treatment|treatment
1454131|NCT00951002|postoperative complications|postoperative complications
1454132|NCT00951002|recurrence|recurrence
1454133|NCT00950989|Autoimmune Diseases|autoimmune diseases
1454134|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
1454135|NCT00950989|Joint Diseases|joint diseases
1454136|NCT00950989|Arthritis|arthritis
1454137|NCT00950989|Connective Tissue Diseases|connective tissue diseases
1454138|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
1454139|NCT00950989|Rheumatic Diseases|rheumatic diseases
1454140|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
1454141|NCT00950950|Amgen|amgen
1454142|NCT00950950|Postmenopausal|postmenopausal
1454143|NCT00950950|Bone Density|bone density
1454144|NCT00950924|Hyperopia|hyperopia
1454145|NCT00950924|Refractive Error|refractive error
1454146|NCT00950924|Ocular Biometrics|ocular biometrics
1454147|NCT00950924|Axial Length|axial length
1454148|NCT00950924|Contact Lenses|contact lenses
1454149|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
1454150|NCT00950911|Bone metastases|bone metastases
1454151|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
1454152|NCT00950911|Multiple myeloma|multiple myeloma
1454153|NCT00950911|Denosumab|denosumab
1454154|NCT00950911|Breast cancer|breast cancer
1454155|NCT00950911|20050103|20050103
1454156|NCT00950911|20050136|20050136
1454157|NCT00950911|20050244|20050244
1454158|NCT00950911|Advanced cancer|advanced cancer
1454159|NCT00950911|Tumor|tumor
1454160|NCT00950911|Prostate cancer|prostate cancer
1454161|NCT00950911|Zoledronic acid|zoledronic acid
1454162|NCT00950898|coffee|coffee
1454163|NCT00950898|caffeine|caffeine
1454164|NCT00950898|glucose metabolism|glucose metabolism
1454165|NCT00950898|insulin sensitivity|insulin sensitivity
1454166|NCT00950898|diabetes|diabetes
1454167|NCT00950885|sleep|sleep
1454168|NCT00950885|alertness|alertness
1454169|NCT00950885|performance|performance
1454170|NCT00950885|vigilance|vigilance
1454171|NCT00950885|circadian|circadian
1454172|NCT00950859|treatment experienced|treatment experienced
1454173|NCT00950859|HIV Infection|hiv infection
1454174|NCT00950859|raltegravir resistance|raltegravir resistance
1454175|NCT00950859|GSK1349572|gsk1349572
1454176|NCT00950859|optimized background regimen|optimized background regimen
1454177|NCT00950859|integrase inhibitor|integrase inhibitor
1454178|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
1454179|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
1454180|NCT00950846|Congenital Abnormalities|congenital abnormalities
1454181|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
1454182|NCT00950846|Busulfan|busulfan
1454183|NCT00950846|Cytoxan|cytoxan
1454184|NCT00950846|Cyclophosphamide|cyclophosphamide
1454185|NCT00950846|Fludarabine|fludarabine
1454186|NCT00950833|Catch-up vaccination|catch-up vaccination
1454187|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
1454188|NCT00950833|Immune memory|immune memory
1454189|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
1454190|NCT00950833|Immunogenicity|immunogenicity
1454191|NCT00950833|Pneumococcal disease|pneumococcal disease
1454192|NCT00950833|Safety|safety
1454193|NCT00950820|Open-label|open-label
1454194|NCT00950820|Phase-II-Study|phase-ii-study
1454195|NCT00950820|Randomized|randomized
1454196|NCT00950820|Metastatic|metastatic
1454197|NCT00950820|Colorectal|colorectal
1454198|NCT00950820|Cancer|cancer
1454199|NCT00950820|Panitumumab|panitumumab
1454200|NCT00950820|Vectibix®|vectibix®
1454201|NCT00950820|second-line-treatment|second-line-treatment
1454202|NCT00950820|KRAS|kras
1454203|NCT00950807|Dose ranging|dose ranging
1454204|NCT00950807|Chronic Bronchitis|chronic bronchitis
1454205|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
1454206|NCT00950807|cross-over|cross-over
1454207|NCT00950807|COPD|copd
1454208|NCT00950807|Emphysema|emphysema
1454209|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1454210|NCT00950807|anticholinergic|anticholinergic
1454211|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
1454212|NCT00950781|Menopause|menopause
1454213|NCT00950781|Cortisol|cortisol
1454214|NCT00950781|ACTH|acth
1454215|NCT00950768|Myeloma|myeloma
1454216|NCT00950768|Melphalan|melphalan
1454217|NCT00950768|Autologous transplantation|autologous transplantation
1454218|NCT00950729|car driving simulator|car driving simulator
1454219|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
1454220|NCT00950729|braking time|braking time
1454221|NCT00950729|braking force|braking force
1454222|NCT00950716|type II diabetes|type ii diabetes
1454223|NCT00950716|peer support|peer support
1454224|NCT00950716|empowerment|empowerment
1454225|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
1454226|NCT00950690|observational safety study|observational safety study
1454230|NCT00950677|exenatide|exenatide
1454231|NCT00950677|byetta|byetta
1454232|NCT00950677|glucagon|glucagon
1454233|NCT00950677|gastric emptying|gastric emptying
1454234|NCT00950664|cervical dystonia|cervical dystonia
1454235|NCT00950664|botulinum toxin|botulinum toxin
1454236|NCT00950638|AMD|amd
1454237|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
1454238|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1454239|NCT00950625|lignocaine|lignocaine
1454240|NCT00950625|bupevacaine|bupevacaine
1454241|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
1454242|NCT00950586|Drug interaction|drug interaction
1454243|NCT00950586|Saftey|saftey
1454244|NCT00950586|Pharmacokinetics|pharmacokinetics
1454245|NCT00950586|Cognition|cognition
1454246|NCT00950573|cardiovascular disease|cardiovascular disease
1454247|NCT00950573|endstage renal disease|endstage renal disease
1454248|NCT00950547|Blood Transfusion|blood transfusion
1454249|NCT00950547|Cell Saver|cell saver
1454250|NCT00950547|Cardiac Surgery|cardiac surgery
1454251|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
1454252|NCT00950521|Stroke|stroke
1454253|NCT00950521|Stem Cell|stem cell
1454254|NCT00950521|Cell Therapy|cell therapy
1454255|NCT00950521|CD34 Stem cell|cd34 stem cell
1454256|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
1454257|NCT00950495|Parallel design|parallel design
1454258|NCT00950495|Oral appliance|oral appliance
1454259|NCT00950495|Mandibular advancement device|mandibular advancement device
1454260|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
1454261|NCT00950495|Placebo|placebo
1454262|NCT00950495|Therapy|therapy
1454263|NCT00950495|Side-effects|side-effects
1454264|NCT00950495|Compliance|compliance
1454265|NCT00950482|Menopause|menopause
1454266|NCT00950482|Acupuncture|acupuncture
1454267|NCT00950482|Hotflash|hotflash
1454268|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
1454269|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
1454270|NCT00950443|Upper airway obstruction|upper airway obstruction
1454271|NCT00950443|child|child
1454272|NCT00950443|acoustic reflection method|acoustic reflection method
1454273|NCT00950443|endoscopy|endoscopy
1454274|NCT00950443|work of breathing|work of breathing
1454275|NCT00950443|sleep study|sleep study
1454276|NCT00950443|CT scan|ct scan
1454277|NCT00950430|Imaging|imaging
1454278|NCT00950430|PET|pet
1454279|NCT00950430|PiB|pib
1454280|NCT00950430|FDG|fdg
1454281|NCT00950430|MCI|mci
1454282|NCT00950430|Dementia|dementia
1454283|NCT00950430|Alzheimer's Disease|alzheimer's disease
1454284|NCT00950430|Brain Amyloid|brain amyloid
1454380|NCT00950118|Genetic|genetic
1454285|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
1454286|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
1454287|NCT00950391|peripheral nerve injury|peripheral nerve injury
1454288|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
1454289|NCT00950391|nerve repair|nerve repair
1454290|NCT00950391|nerve graft|nerve graft
1454291|NCT00950378|edema|edema
1454292|NCT00950378|blood supply|blood supply
1454293|NCT00950378|lower legs|lower legs
1454294|NCT00950378|venous stasis|venous stasis
1454295|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1454296|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1454297|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1454298|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
1454299|NCT00950352|methamphetamine|methamphetamine
1454300|NCT00950352|Citicoline|citicoline
1454301|NCT00950352|CDP-Choline|cdp-choline
1454302|NCT00950352|Neuroimaging|neuroimaging
1454303|NCT00950352|MRI|mri
1454304|NCT00950352|Brain|brain
1454305|NCT00950352|MRS|mrs
1454306|NCT00950352|DTI|dti
1454307|NCT00950339|GI bleeding|gi bleeding
1454308|NCT00950339|clopidogrel|clopidogrel
1454309|NCT00950339|aspirin|aspirin
1454310|NCT00950339|prevention|prevention
1454311|NCT00950339|angiography|angiography
1454312|NCT00950326|osteoarthritis|osteoarthritis
1454313|NCT00950326|hydrotherapy|hydrotherapy
1454314|NCT00950326|affusion|affusion
1454315|NCT00950326|conventional physiotherapy|conventional physiotherapy
1454316|NCT00950326|comparison|comparison
1454317|NCT00950313|Diabetes|diabetes
1454318|NCT00950313|Screening|screening
1454319|NCT00950313|Risk|risk
1454320|NCT00950313|Self assessment|self assessment
1454321|NCT00950287|apnea-bradycardias|apnea-bradycardias
1454322|NCT00950287|preterm infants|preterm infants
1454323|NCT00950274|Cell therapy|cell therapy
1454324|NCT00950274|Bone marrow|bone marrow
1454325|NCT00950274|CD133|cd133
1454326|NCT00950274|Bypass surgery|bypass surgery
1454327|NCT00950274|Stem cells|stem cells
1454328|NCT00950274|Myocardial infarction|myocardial infarction
1454329|NCT00950274|Myocardial ischemia|myocardial ischemia
1454330|NCT00950261|Cervical neoplasms|cervical neoplasms
1454331|NCT00950261|Cisplatin|cisplatin
1454332|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
1454333|NCT00950248|Idebenone|idebenone
1454334|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1454335|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1454336|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
1454337|NCT00950248|Multiple Sclerosis|multiple sclerosis
1454338|NCT00950248|MS|ms
1454339|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
1454340|NCT00950235|obese|obese
1454341|NCT00950235|pregnant|pregnant
1454342|NCT00950235|large for gestational age|large for gestational age
1454343|NCT00950235|large for gestational age baby|large for gestational age baby
1454344|NCT00950222|Intensive care unit|intensive care unit
1454345|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
1454346|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
1454347|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
1454348|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
1454349|NCT00950222|Imipenem|imipenem
1454350|NCT00950222|Amikacin|amikacin
1454351|NCT00950222|Gram negative bacilli|gram negative bacilli
1454352|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
1454353|NCT00950183|cryotherapy|cryotherapy
1454354|NCT00950183|postoperative pain|postoperative pain
1454355|NCT00950183|Iceman|iceman
1454356|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
1454357|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
1454358|NCT00950170|ReFacto AF|refacto af
1454359|NCT00950170|factor VIII|factor viii
1454360|NCT00950170|inhibitors|inhibitors
1454361|NCT00950170|antibodies|antibodies
1454362|NCT00950144|pain|pain
1454363|NCT00950144|depression|depression
1454364|NCT00950144|fatigue|fatigue
1454365|NCT00950144|stage III colon cancer|stage iii colon cancer
1454366|NCT00950144|stage IV colon cancer|stage iv colon cancer
1454367|NCT00950144|recurrent colon cancer|recurrent colon cancer
1454368|NCT00950144|stage III rectal cancer|stage iii rectal cancer
1454369|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
1454370|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
1454371|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
1454372|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
1454373|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
1454374|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1454375|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
1454376|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1454377|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1454378|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
1454381|NCT00950118|Genetic testing|genetic testing
1454382|NCT00950118|exome sequencing|exome sequencing
1454383|NCT00950118|genome sequencing|genome sequencing
1454384|NCT00950118|RNAseq|rnaseq
1454385|NCT00950105|CPSI2364|cpsi2364
1454386|NCT00950105|Semapimod|semapimod
1454387|NCT00950105|Anti TNF alpha|anti tnf alpha
1454388|NCT00950105|Crohn's Disease|crohn's disease
1454389|NCT00950105|Safety|safety
1454390|NCT00950105|Tolerability|tolerability
1454391|NCT00950105|Pharmacokinetics|pharmacokinetics
1454392|NCT00950092|AF|af
1454393|NCT00950092|atrial fibrillation|atrial fibrillation
1454394|NCT00950092|ablation|ablation
1454395|NCT00950092|surgical ablation|surgical ablation
1454396|NCT00950092|afib|afib
1454397|NCT00950092|coagulation|coagulation
1454398|NCT00950092|RF|rf
1454399|NCT00950092|epicardial|epicardial
1454400|NCT00950092|Arrhythmias|arrhythmias
1454401|NCT00950079|sodium bicarbonate|sodium bicarbonate
1454402|NCT00950079|diabetes mellitus|diabetes mellitus
1454403|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
1454404|NCT00950040|At-risk drinking|at-risk drinking
1454405|NCT00950040|Type 2 diabetes|type 2 diabetes
1454406|NCT00950040|Treatment adherence|treatment adherence
1454407|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
1454408|NCT00950014|Numeracy|numeracy
1454409|NCT00950001|Brain tumors|brain tumors
1454410|NCT00950001|Metastatic brain disease|metastatic brain disease
1454411|NCT00950001|Post-surgical|post-surgical
1454412|NCT00950001|Stereotactic radiosurgery|stereotactic radiosurgery
1454413|NCT00950001|SRS|srs
1454414|NCT00950001|Whole brain radiotherapy|whole brain radiotherapy
1454415|NCT00950001|MRI|mri
1454416|NCT00950001|Magnetic Resonance Imaging|magnetic resonance imaging
1454417|NCT00950001|Outpatient radiation procedure|outpatient radiation procedure
1454418|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1454419|NCT00949988|CLL|cll
1454420|NCT00949988|Dasatinib|dasatinib
1454421|NCT00949988|Rituximab|rituximab
1454422|NCT00949988|Relapsed|relapsed
1454423|NCT00949988|Refractory|refractory
1454424|NCT00949975|Chronic|chronic
1454425|NCT00949975|Obstructive|obstructive
1454426|NCT00949975|Pulmonary|pulmonary
1454427|NCT00949975|Lung|lung
1454428|NCT00949975|Respiratory disease|respiratory disease
1454429|NCT00949975|Efficacy|efficacy
1454430|NCT00949975|Safety and tolerability|safety and tolerability
1454431|NCT00949975|Placebo-controlled|placebo-controlled
1454432|NCT00949975|Pharmacokinetics|pharmacokinetics
1454433|NCT00949975|COPD|copd
1454434|NCT00949962|stage I prostate cancer|stage i prostate cancer
1454435|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
1454436|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
1454437|NCT00949962|stage III prostate cancer|stage iii prostate cancer
1454438|NCT00949936|Spine surgery|spine surgery
1454439|NCT00949923|Postmenopausal women|postmenopausal women
1454440|NCT00949923|Suspicious for breast ca|suspicious for breast ca
1454441|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
1454442|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
1454443|NCT00949897|Allograft Bone Wedge|allograft bone wedge
1454444|NCT00949871|stage I breast cancer|stage i breast cancer
1454445|NCT00949871|stage II breast cancer|stage ii breast cancer
1454446|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
1454447|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
1454448|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
1454449|NCT00949871|stage IV breast cancer|stage iv breast cancer
1454450|NCT00949871|cancer survivor|cancer survivor
1454451|NCT00949858|Sleep Disorders|sleep disorders
1454452|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
1454453|NCT00949858|Restless Leg Syndrome|restless leg syndrome
1454454|NCT00949858|Insomnia|insomnia
1454455|NCT00949858|Actigraphy|actigraphy
1454456|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
1454457|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
1454458|NCT00949832|rickets|rickets
1454459|NCT00949832|calcium|calcium
1454460|NCT00949832|vitamin D|vitamin d
1454461|NCT00949832|nutrition|nutrition
1454462|NCT00949832|child|child
1454463|NCT00949819|Prostate Cancer|prostate cancer
1454464|NCT00949819|Low risk|low risk
1454465|NCT00949819|Gleason 6|gleason 6
1454466|NCT00949819|Active surveillance|active surveillance
1454467|NCT00949806|Botulinum toxin|botulinum toxin
1454468|NCT00949793|Pathology|pathology
1454469|NCT00949793|Microscopy, Confocal|microscopy, confocal
1454470|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
1454471|NCT00949793|Intraoperative Procedures|intraoperative procedures
1454473|NCT00949780|Chloral Hydrate|chloral hydrate
1454474|NCT00949780|Sedation|sedation
1454475|NCT00949780|Children|children
1454476|NCT00949754|honeybee venom|honeybee venom
1454477|NCT00949754|osteoarthritis|osteoarthritis
1454478|NCT00949754|pain|pain
1454479|NCT00949754|knees|knees
1454480|NCT00949728|Pterygium|pterygium
1454481|NCT00949728|Autologous Transplantation|autologous transplantation
1454482|NCT00949728|Conjunctiva|conjunctiva
1454483|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
1454484|NCT00949728|Recurrence|recurrence
1454485|NCT00949715|Pacemaker|pacemaker
1454486|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
1454487|NCT00949715|AV Conduction Disturbance|av conduction disturbance
1454488|NCT00949715|Selective Site Pacing|selective site pacing
1454489|NCT00949689|adolescence|adolescence
1454490|NCT00949689|insomnia|insomnia
1454491|NCT00949689|depression|depression
1454492|NCT00949689|sleep problems|sleep problems
1454493|NCT00949689|cognitive therapy|cognitive therapy
1454494|NCT00949663|Diabetes|diabetes
1454495|NCT00949663|Blood Sugar|blood sugar
1454496|NCT00949663|Xenin-25|xenin-25
1454497|NCT00949663|GIP|gip
1454498|NCT00949663|Insulin|insulin
1454499|NCT00949637|obesity prevention|obesity prevention
1454500|NCT00949637|girl scouts|girl scouts
1454501|NCT00949637|physical activity|physical activity
1454502|NCT00949637|family meals|family meals
1454503|NCT00949637|fruits and vegetables|fruits and vegetables
1454504|NCT00949637|health promotion|health promotion
1454505|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
1454506|NCT00949624|VEGFr inhibition;|vegfr inhibition;
1454507|NCT00949624|targeted therapy|targeted therapy
1454508|NCT00949611|Decision Aid|decision aid
1454509|NCT00949611|Shared Decision Making|shared decision making
1454510|NCT00949611|Shared Medical Decision Making|shared medical decision making
1454511|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1454512|NCT00949598|stage IA breast cancer|stage ia breast cancer
1454513|NCT00949598|stage IB breast cancer|stage ib breast cancer
1454514|NCT00949598|stage II breast cancer|stage ii breast cancer
1454515|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
1454516|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
1454517|NCT00949585|crossover design|crossover design
1454518|NCT00949585|potassium intake|potassium intake
1454519|NCT00949572|mucosal immunity|mucosal immunity
1454520|NCT00949572|immunization|immunization
1454521|NCT00949572|sublingual|sublingual
1454522|NCT00949520|patients|patients
1454523|NCT00949520|functional evaluation|functional evaluation
1454524|NCT00949520|known coronary artery lesion|known coronary artery lesion
1454525|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
1454526|NCT00949481|postpartum|postpartum
1454527|NCT00949481|family planning|family planning
1454528|NCT00949481|job aid|job aid
1454529|NCT00949481|immunization|immunization
1454530|NCT00949481|pregnancy test|pregnancy test
1454531|NCT00949468|Keratitis|keratitis
1454532|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
1454533|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1454534|NCT00949429|postoperative pain|postoperative pain
1454535|NCT00949429|cardiac surgery|cardiac surgery
1454536|NCT00949429|risk factors|risk factors
1454538|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
1454539|NCT00949390|Advanced Cancer|advanced cancer
1454540|NCT00949390|Advanced Malignancy|advanced malignancy
1454541|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
1454542|NCT00949390|CAM|cam
1454543|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
1454544|NCT00949390|Phase I Clinical Trials|phase i clinical trials
1454545|NCT00949377|Constipation|constipation
1454546|NCT00949377|opioid|opioid
1454547|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
1454548|NCT00949364|Pomalidomide|pomalidomide
1454549|NCT00949364|Fibrotic Stage|fibrotic stage
1454550|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
1454551|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
1454552|NCT00949338|stage I prostate cancer|stage i prostate cancer
1454553|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
1454554|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
1454555|NCT00949338|stage III prostate cancer|stage iii prostate cancer
1454556|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
1454557|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
1454558|NCT00949325|osteosarcoma|osteosarcoma
1454559|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
1454560|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
1454561|NCT00949325|leiomyosarcoma|leiomyosarcoma
1454562|NCT00949325|Ewing's sarcoma|ewing's sarcoma
1454563|NCT00949325|chondrosarcoma|chondrosarcoma
1454564|NCT00949325|liposarcoma|liposarcoma
1454565|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
1454566|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
1454567|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
1454568|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
1454569|NCT00949325|synovial sarcoma|synovial sarcoma
1454570|NCT00949325|cancer stem cell|cancer stem cell
1454571|NCT00949312|stage II colon cancer|stage ii colon cancer
1454572|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1454573|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
1454574|NCT00949273|rectal cancer|rectal cancer
1454971|NCT00948298|vitamin D|vitamin d
1454575|NCT00949273|acellular dermal matrix|acellular dermal matrix
1454576|NCT00949273|pelvic reconstruction|pelvic reconstruction
1454577|NCT00949273|circumferential resection margin|circumferential resection margin
1454578|NCT00949273|overall survival|overall survival
1454579|NCT00949260|PIH|pih
1454580|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
1454581|NCT00949260|pregnancy|pregnancy
1454582|NCT00949260|bioimpedance|bioimpedance
1454583|NCT00949260|noninvasive monitoring|noninvasive monitoring
1454584|NCT00949260|Cardiac Output|cardiac output
1454585|NCT00949260|Blood Pressure|blood pressure
1454586|NCT00949247|stage I breast cancer|stage i breast cancer
1454587|NCT00949247|stage II breast cancer|stage ii breast cancer
1454588|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
1454589|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
1454590|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
1454591|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
1454592|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
1454593|NCT00949234|biomedical prevention|biomedical prevention
1454594|NCT00949234|HIV seronegativity|hiv seronegativity
1454595|NCT00949221|Type 1 diabetes|type 1 diabetes
1454596|NCT00949221|Paediatric|paediatric
1454597|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
1454598|NCT00949221|Glycemic control|glycemic control
1454599|NCT00949221|Therapeutic education|therapeutic education
1454600|NCT00949208|Healthy people|healthy people
1454601|NCT00949195|COPD|copd
1454602|NCT00949195|healthy patients|healthy patients
1454603|NCT00949195|PAP|pap
1454604|NCT00949195|CPX|cpx
1454605|NCT00949195|SSE|sse
1454606|NCT00949195|hsCRP|hscrp
1454607|NCT00949195|FMD|fmd
1454608|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1454609|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1454610|NCT00949169|Atherosclerosis|atherosclerosis
1454611|NCT00949169|Carotid IMT|carotid imt
1454612|NCT00949169|Multidetector CT|multidetector ct
1454613|NCT00949169|Type 2 diabetes|type 2 diabetes
1454614|NCT00949156|Craniopharyngiomas|craniopharyngiomas
1454615|NCT00949156|Classification|classification
1454616|NCT00949156|Membranous structure|membranous structure
1454617|NCT00949156|Pituitary stalk|pituitary stalk
1454618|NCT00949156|Obesity|obesity
1454619|NCT00949156|panhypopituitarism|panhypopituitarism
1454620|NCT00949143|wheelchair user|wheelchair user
1454621|NCT00949117|malnutrition|malnutrition
1454622|NCT00949117|weight changes|weight changes
1454623|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1454624|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1454625|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1454626|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1454627|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1454628|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
1454629|NCT00949117|other myeloid malignancies|other myeloid malignancies
1454630|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1454631|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1454632|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1454633|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1454634|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1454635|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1454636|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1454637|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1454638|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1454639|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1454640|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1454641|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1454642|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1454643|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1454644|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1454645|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1454646|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1454647|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1454648|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1454649|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1454650|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1454651|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1454652|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1454653|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1454654|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
1454655|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1454656|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1454657|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1454658|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1454659|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1454660|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1454661|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1454662|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1454663|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1454664|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1454665|NCT00949104|Sucrose|sucrose
1454666|NCT00949104|pain|pain
1454667|NCT00949104|neonate|neonate
1454668|NCT00949104|preterm|preterm
1454669|NCT00949104|orogastric tube|orogastric tube
1454670|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
1454671|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1454672|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1454673|NCT00949091|Drug Therapy|drug therapy
1454674|NCT00949078|peanut|peanut
1454675|NCT00949078|allergy|allergy
1454676|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
1454677|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
1454678|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
1454679|NCT00949065|autoimmune disease|autoimmune disease
1454680|NCT00949052|cancer survivor|cancer survivor
1454681|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1454682|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1454683|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1454684|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1454685|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1454686|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1454687|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1454688|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1454689|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1454690|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1454691|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1454692|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1454693|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1454694|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1454695|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1454696|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1454697|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1454698|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1454699|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1454700|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1454701|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1454702|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1454703|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1454704|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1454705|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1454706|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1454707|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1454708|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1454709|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1454710|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1454711|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1454712|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1454713|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1454714|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1454715|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1454716|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1454717|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1454718|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1454719|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1454720|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1454721|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1454722|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1455173|NCT00947609|HIV|hiv
1454723|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1454724|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1454725|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1454726|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1454727|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1454728|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1454729|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1454730|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1454731|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1454732|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1454733|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1454734|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1454735|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1454736|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1454737|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1454738|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1454739|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1454740|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1454741|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1454742|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1454743|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1567373|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1454744|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1454818|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
1454745|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1454746|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1454747|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1454748|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1454749|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1454750|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1454751|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1454752|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1454753|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1454754|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1454755|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1454756|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1454757|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1454758|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1454759|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1454760|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1454761|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1454762|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
1454763|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1454764|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1454765|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1454766|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1454767|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1454768|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1454769|NCT00949052|primary myelofibrosis|primary myelofibrosis
1454770|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1454771|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1454772|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
1454773|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1454774|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1454775|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1454776|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1454777|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1454778|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1454779|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
1454780|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1454781|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1454782|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1454783|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1454784|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
1454785|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
1454786|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
1454787|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1454788|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1454789|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1454790|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1454791|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
1454792|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
1454793|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
1454794|NCT00949052|stage IV breast cancer|stage iv breast cancer
1454795|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
1454796|NCT00949026|Brain Cancer|brain cancer
1454797|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
1454798|NCT00949013|stage IA breast cancer|stage ia breast cancer
1454799|NCT00949013|stage IB breast cancer|stage ib breast cancer
1454800|NCT00949013|stage II breast cancer|stage ii breast cancer
1454801|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
1454802|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
1454803|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
1454804|NCT00948987|aspirin resistance|aspirin resistance
1454805|NCT00948987|cardiovascular risk|cardiovascular risk
1454806|NCT00948987|prostaglandins|prostaglandins
1454807|NCT00948987|platelet inhibition|platelet inhibition
1454808|NCT00948974|social anxiety|social anxiety
1454809|NCT00948974|treatment|treatment
1454810|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
1454811|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
1454812|NCT00948974|Cognitive Therapy|cognitive therapy
1454814|NCT00948961|cancer vaccine|cancer vaccine
1454815|NCT00948961|immunotherapy|immunotherapy
1454816|NCT00948961|breast cancer|breast cancer
1454817|NCT00948961|ovarian cancer|ovarian cancer
1454819|NCT00948961|myeloma|myeloma
1454820|NCT00948961|sarcoma|sarcoma
1454821|NCT00948961|melanoma|melanoma
1454822|NCT00948961|Resiquimod|resiquimod
1454823|NCT00948961|Poly-ICLC|poly-iclc
1454824|NCT00948961|Hiltonol|hiltonol
1454825|NCT00948961|esophageal cancer|esophageal cancer
1454826|NCT00948961|bladder cancer|bladder cancer
1454827|NCT00948961|chondrosarcoma|chondrosarcoma
1454828|NCT00948961|adenocarcinoma|adenocarcinoma
1454829|NCT00948935|Biliary Cancer|biliary cancer
1454830|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
1454831|NCT00948935|Panitumumab|panitumumab
1454832|NCT00948922|multiple myeloma|multiple myeloma
1454833|NCT00948922|myeloma|myeloma
1454834|NCT00948922|myeloma proteins|myeloma proteins
1454835|NCT00948922|autologous|autologous
1454836|NCT00948922|allogeneic|allogeneic
1454837|NCT00948896|Chemoprevention|chemoprevention
1454838|NCT00948896|Uganda|uganda
1454839|NCT00948896|Malaria|malaria
1454840|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1454841|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1454842|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1454843|NCT00948883|organ transplant|organ transplant
1454844|NCT00948883|cancer|cancer
1454845|NCT00948883|biobank|biobank
1454846|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
1454847|NCT00948883|lymphoma|lymphoma
1454848|NCT00948870|alternative medicine|alternative medicine
1454849|NCT00948857|DHEA|dhea
1454851|NCT00948857|Pregnancy|pregnancy
1454852|NCT00948857|Ovarian Failure|ovarian failure
1454853|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
1454854|NCT00948857|Ovarian aging|ovarian aging
1454855|NCT00948844|falls|falls
1454856|NCT00948844|Missteps|missteps
1454857|NCT00948831|biologics|biologics
1454858|NCT00948831|fusion rates|fusion rates
1454859|NCT00948831|lumbar fusion|lumbar fusion
1454860|NCT00948831|ALIF|alif
1454861|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
1454862|NCT00948818|Constipation|constipation
1454863|NCT00948818|Linaclotide|linaclotide
1454864|NCT00948805|corpus luteum rescue|corpus luteum rescue
1454865|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
1454866|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
1454867|NCT00948805|infertility|infertility
1454868|NCT00948805|pregnancy rate|pregnancy rate
1454869|NCT00948792|platelets|platelets
1454870|NCT00948792|transfusion|transfusion
1454871|NCT00948792|thrombocytopenia|thrombocytopenia
1454872|NCT00948779|Patient education|patient education
1454873|NCT00948779|Antibiotic|antibiotic
1454874|NCT00948779|Child|child
1454875|NCT00948779|Respiratory tract infection|respiratory tract infection
1454876|NCT00948779|Patient satisfaction|patient satisfaction
1454877|NCT00948779|Parental knowledge|parental knowledge
1454878|NCT00948779|Adherence|adherence
1454879|NCT00948766|Alzheimer's disease|alzheimer's disease
1454880|NCT00948766|dementia|dementia
1454885|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
1454886|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1454888|NCT00948701|Breast cancer|breast cancer
1454889|NCT00948701|Exercise|exercise
1454890|NCT00948701|Physical activity|physical activity
1454891|NCT00948701|Community volunteers|community volunteers
1454892|NCT00948701|Peer mentors|peer mentors
1454893|NCT00948701|Peer coaches|peer coaches
1454894|NCT00948701|Social support|social support
1454895|NCT00948688|Zolinza|zolinza
1454900|NCT00948662|Safety|safety
1454901|NCT00948662|tolerability|tolerability
1454902|NCT00948662|ascending single doses|ascending single doses
1454903|NCT00948662|healthy subjects|healthy subjects
1454904|NCT00948649|Varenicline, Working memory|varenicline, working memory
1454905|NCT00948623|COPD|copd
1454906|NCT00948623|physical activity|physical activity
1454907|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
1454908|NCT00948623|counseling|counseling
1454909|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
1454910|NCT00948597|propofol|propofol
1454911|NCT00948597|elective surgical procedure|elective surgical procedure
1454912|NCT00948597|Obese subjects|obese subjects
1454913|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1454914|NCT00948584|Insulin dose titration system|insulin dose titration system
1454915|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
1454916|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
1454917|NCT00948558|citrate anticoagulation|citrate anticoagulation
1454918|NCT00948558|pharmacokinetic|pharmacokinetic
1454919|NCT00948558|critically ill|critically ill
1454920|NCT00948558|acute kidney failure|acute kidney failure
1454921|NCT00948545|Autonomic nervous system|autonomic nervous system
1454922|NCT00948545|Bariatric surgery|bariatric surgery
1454923|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
1454924|NCT00948532|degenerative disc disease|degenerative disc disease
1454925|NCT00948532|lumbar spine|lumbar spine
1454926|NCT00948532|XLIF|xlif
1454927|NCT00948532|Degenerative conditions|degenerative conditions
1454928|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
1454929|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
1454930|NCT00948493|diabetes|diabetes
1454931|NCT00948493|insulin therapy|insulin therapy
1454932|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
1454933|NCT00948480|metastatic melanoma|metastatic melanoma
1454934|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
1454935|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
1454936|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
1454937|NCT00948467|BRAF gene|braf gene
1454938|NCT00948454|smoking|smoking
1454939|NCT00948441|intestinal insufficiency|intestinal insufficiency
1454940|NCT00948441|central venous catheter|central venous catheter
1454941|NCT00948441|Catheter-Related Infections|catheter-related infections
1454942|NCT00948441|pediatrics|pediatrics
1454943|NCT00948441|ethanol|ethanol
1454944|NCT00948428|actinic keratoses|actinic keratoses
1454945|NCT00948428|imiquimod|imiquimod
1454946|NCT00948428|therapeutic equivalence|therapeutic equivalence
1454947|NCT00948428|bioequivalence|bioequivalence
1454948|NCT00948415|Obesity|obesity
1454949|NCT00948415|Weight loss|weight loss
1454950|NCT00948415|Internet|internet
1454951|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
1454952|NCT00948402|PCOS|pcos
1454953|NCT00948402|IR|ir
1454954|NCT00948402|metformin|metformin
1454955|NCT00948402|OCP|ocp
1454956|NCT00948402|Oral Contraceptive|oral contraceptive
1454957|NCT00948376|Natural history|natural history
1454958|NCT00948376|IFT80|ift80
1454959|NCT00948376|short ribs|short ribs
1454960|NCT00948376|multivisceral involvement|multivisceral involvement
1454961|NCT00948363|Kiwi fruits|kiwi fruits
1454962|NCT00948363|Blood pressure|blood pressure
1454963|NCT00948363|Endothelial function|endothelial function
1454964|NCT00948363|Antioxidant capacity|antioxidant capacity
1454965|NCT00948350|cervical instability|cervical instability
1454966|NCT00948350|awake intubation|awake intubation
1454967|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
1454968|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
1454969|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
1454970|NCT00948298|cardiovascular disease|cardiovascular disease
1454972|NCT00948298|african american|african american
1454973|NCT00948298|low vitamin D levels|low vitamin d levels
1454974|NCT00948285|breast cancer|breast cancer
1454975|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
1454976|NCT00948272|Rabies|rabies
1454977|NCT00948272|Rabies virus|rabies virus
1454978|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
1454979|NCT00948272|Serum Free|serum free
1454980|NCT00948259|safety|safety
1454981|NCT00948259|GSK inhibitor|gsk inhibitor
1454982|NCT00948259|Alzheimer|alzheimer
1454983|NCT00948233|Tobacco|tobacco
1454984|NCT00948233|Smoking Cessation|smoking cessation
1454985|NCT00948233|Prevention|prevention
1454986|NCT00948233|Smokeless tobacco|smokeless tobacco
1454987|NCT00948233|Habit|habit
1454988|NCT00948220|HCV|hcv
1454989|NCT00948220|hepatitis C virus|hepatitis c virus
1454990|NCT00948220|CHC|chc
1454991|NCT00948220|chronic hepatitis c|chronic hepatitis c
1454992|NCT00948220|interferon|interferon
1454993|NCT00948220|ribavirin|ribavirin
1454994|NCT00948220|DEXA|dexa
1454995|NCT00948220|BMD|bmd
1454996|NCT00948220|bone mineral density|bone mineral density
1454997|NCT00948220|osteoporosis|osteoporosis
1454998|NCT00948220|osteopenia|osteopenia
1454999|NCT00948220|osteodystrophy|osteodystrophy
1455000|NCT00948220|osteodensitometry|osteodensitometry
1455001|NCT00948220|Bone Density|bone density
1455002|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
1455003|NCT00948220|Anti-Infective Agents|anti-infective agents
1455004|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
1455005|NCT00948207|Metastatic Cancer|metastatic cancer
1455006|NCT00948207|Recurrent Cancer|recurrent cancer
1455007|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
1455008|NCT00948207|Advanced Cancer|advanced cancer
1455009|NCT00948207|Terminal Cancer|terminal cancer
1455010|NCT00948207|Stage III Cancer|stage iii cancer
1455011|NCT00948207|Stage IV Cancer|stage iv cancer
1455012|NCT00948194|Extended Donor Criteria|extended donor criteria
1455013|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
1455014|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
1455015|NCT00948168|T2DM|t2dm
1455016|NCT00948168|exenatide|exenatide
1455017|NCT00948168|HbA1c|hba1c
1455018|NCT00948168|weight|weight
1455019|NCT00948168|waist circumference|waist circumference
1455020|NCT00948168|insulin sensitivity|insulin sensitivity
1455021|NCT00948168|beta-cell function|beta-cell function
1455022|NCT00948155|smoking|smoking
1455023|NCT00948155|nicotine|nicotine
1455024|NCT00948155|varenicline|varenicline
1455150|NCT00947687|healthy subject|healthy subject
1455025|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
1455026|NCT00948129|Smoking Cessation|smoking cessation
1455027|NCT00948129|Low-Income|low-income
1455028|NCT00948129|Cigarette smoking|cigarette smoking
1455029|NCT00948129|Uninsured and underinsured|uninsured and underinsured
1455030|NCT00948129|NRT|nrt
1455031|NCT00948129|Nicoderm CQ|nicoderm cq
1455032|NCT00948129|Habits|habits
1455033|NCT00948116|Diabetes mellitus|diabetes mellitus
1455034|NCT00948116|Renal Impairment|renal impairment
1455035|NCT00948116|Acute Kidney Injury|acute kidney injury
1455036|NCT00948116|Coronary revascularisation|coronary revascularisation
1455037|NCT00948116|eGFR <60ml/min|egfr <60ml/min
1455038|NCT00948103|Nitrous Oxide|nitrous oxide
1455039|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
1455040|NCT00948103|Botulinum toxin|botulinum toxin
1455041|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
1455042|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1455043|NCT00948090|Bone marrow transplant|bone marrow transplant
1455044|NCT00948090|stem cell transplant|stem cell transplant
1455045|NCT00948090|busulfan|busulfan
1455046|NCT00948090|cyclophosphamide|cyclophosphamide
1455047|NCT00948090|etoposide|etoposide
1455048|NCT00948077|tuberculosis|tuberculosis
1455049|NCT00948077|pharmacokinetic|pharmacokinetic
1455050|NCT00948077|first-line drugs|first-line drugs
1455051|NCT00948064|Leukemia|leukemia
1455052|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
1455053|NCT00948064|AML|aml
1455054|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
1455055|NCT00948064|MDS|mds
1455056|NCT00948064|Vorinostat|vorinostat
1455057|NCT00948064|SAHA|saha
1455058|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1455059|NCT00948064|MSK-390|msk-390
1455060|NCT00948064|Zolinza|zolinza
1455061|NCT00948064|Azacitidine|azacitidine
1455062|NCT00948064|5-Azacitidine|5-azacitidine
1455063|NCT00948064|5-Aza|5-aza
1455064|NCT00948064|Vidaza|vidaza
1455065|NCT00948064|5-AZC|5-azc
1455066|NCT00948064|AZA-CR|aza-cr
1455067|NCT00948064|Ladakamycin|ladakamycin
1455068|NCT00948064|NSC-102816|nsc-102816
1455069|NCT00948038|Inflammation|inflammation
1455070|NCT00948038|Oxidative stress|oxidative stress
1455071|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
1455072|NCT00948025|Conduit|conduit
1455073|NCT00948025|AVANCE|avance
1455074|NCT00948025|Neuroma Resection|neuroma resection
1455075|NCT00948025|Nerve Gap Repair|nerve gap repair
1455076|NCT00948025|Digital Nerve Repair|digital nerve repair
1455077|NCT00948012|Sickle Cell Anemia|sickle cell anemia
1455078|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
1455079|NCT00948012|Exercise echocardiography|exercise echocardiography
1455080|NCT00948012|Echocardiography|echocardiography
1455081|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1455082|NCT00947973|ADHD|adhd
1455083|NCT00947973|School Based|school based
1455084|NCT00947973|Intervention|intervention
1455085|NCT00947973|Psychosocial|psychosocial
1455086|NCT00947973|Academic Intervention|academic intervention
1455087|NCT00947973|Behavioral|behavioral
1455088|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
1455089|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
1455090|NCT00947947|condom use|condom use
1455091|NCT00947947|HIV prevention|hiv prevention
1455092|NCT00947947|African American|african american
1455093|NCT00947947|Behavioral intervention|behavioral intervention
1455094|NCT00947947|HIV Seronegativity|hiv seronegativity
1455095|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
1455096|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
1455097|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
1455098|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
1455099|NCT00947895|ACTH|acth
1455100|NCT00947895|Acthar gel|acthar gel
1455101|NCT00947895|adrenocorticotropin|adrenocorticotropin
1455102|NCT00947895|methylprednisolone|methylprednisolone
1455103|NCT00947895|solumedrol|solumedrol
1455104|NCT00947895|MS|ms
1455105|NCT00947895|multiple|multiple
1455106|NCT00947895|sclerosis|sclerosis
1455107|NCT00947895|relapse|relapse
1455108|NCT00947895|exacerbation|exacerbation
1455109|NCT00947895|sub-responsive|sub-responsive
1455110|NCT00947895|IV|iv
1455111|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
1455112|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
1455113|NCT00947856|Antigens, CD30|antigens, cd30
1455114|NCT00947856|Drug Therapy|drug therapy
1455115|NCT00947856|Hematologic Diseases|hematologic diseases
1455116|NCT00947856|Immunotherapy|immunotherapy
1455117|NCT00947856|Monomethylauristatin E|monomethylauristatin e
1455118|NCT00947843|CHD|chd
1455119|NCT00947843|CHD equivalents|chd equivalents
1455120|NCT00947830|CML|cml
1455121|NCT00947830|intracellular imatinib level|intracellular imatinib level
1455122|NCT00947830|OCT-1|oct-1
1455123|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
1455124|NCT00947791|Bipolar Disorder|bipolar disorder
1455125|NCT00947791|Depression|depression
1455126|NCT00947791|Treatment-Resistant|treatment-resistant
1455127|NCT00947791|ketamine|ketamine
1455128|NCT00947791|antidepressant|antidepressant
1455129|NCT00947791|glutamate|glutamate
1455130|NCT00947765|Tennis Elbow|tennis elbow
1455131|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
1455132|NCT00947752|Multiple Sclerosis|multiple sclerosis
1455133|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
1455134|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
1455135|NCT00947739|CZ|cz
1455136|NCT00947739|Stehlin|stehlin
1455137|NCT00947739|Lymphomas|lymphomas
1455138|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
1455139|NCT00947713|Clomiphene citrate|clomiphene citrate
1455140|NCT00947713|chronic anovulation|chronic anovulation
1455141|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
1455142|NCT00947713|Follicolugenesis|follicolugenesis
1455143|NCT00947700|Infants|infants
1455144|NCT00947700|Risk markers|risk markers
1455145|NCT00947700|ERP|erp
1455146|NCT00947700|Parent child interaction|parent child interaction
1455147|NCT00947700|Promoting First Relations|promoting first relations
1455148|NCT00947700|Social Communication|social communication
1455149|NCT00947687|influenza|influenza
1455151|NCT00947687|virus inoculation|virus inoculation
1455152|NCT00947687|symptom scores|symptom scores
1455153|NCT00947687|viral shedding|viral shedding
1455154|NCT00947687|bioaerosol output|bioaerosol output
1455155|NCT00947674|Cellsorba EX|cellsorba ex
1455156|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
1455157|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
1455158|NCT00947648|AML|aml
1455159|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
1455160|NCT00947648|MDS|mds
1455161|NCT00947648|Neutropenia|neutropenia
1455162|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
1455163|NCT00947635|Type 1 diabetes|type 1 diabetes
1455164|NCT00947635|Transplants|transplants
1455165|NCT00947635|Immunosuppression|immunosuppression
1455166|NCT00947635|Hyperlipidemia|hyperlipidemia
1455167|NCT00947635|Nutrition Therapy|nutrition therapy
1455168|NCT00947622|Fibromyalgia|fibromyalgia
1455169|NCT00947622|Neuromodulation|neuromodulation
1455170|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1455171|NCT00947622|Occipital|occipital
1455172|NCT00947609|Latent tuberculosis|latent tuberculosis
1455174|NCT00947609|Children|children
1455175|NCT00947609|Interferon gamma release assays|interferon gamma release assays
1455176|NCT00947609|Thailand|thailand
1455177|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
1455178|NCT00947609|T-Spot.TB|t-spot.tb
1455179|NCT00947596|Atropine|atropine
1455181|NCT00947596|Inhaler|inhaler
1455182|NCT00947596|Dry Powder|dry powder
1455183|NCT00947583|fusion rates|fusion rates
1455184|NCT00947583|TLIF|tlif
1455185|NCT00947583|Osteocel Plus|osteocel plus
1455186|NCT00947583|biologics|biologics
1455187|NCT00947583|lumbar fusion|lumbar fusion
1455188|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
1455189|NCT00947570|Functional Brain Imaging|functional brain imaging
1455190|NCT00947570|Psychotherapy|psychotherapy
1455191|NCT00947570|Treatment|treatment
1455192|NCT00947570|Brain Imaging|brain imaging
1455193|NCT00947544|Urea Cycle Disorder|urea cycle disorder
1455194|NCT00947544|UCD|ucd
1455195|NCT00947544|GT4P|gt4p
1455196|NCT00947544|Buphenyl|buphenyl
1455197|NCT00947544|hyperammonemia|hyperammonemia
1455198|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
1455199|NCT00947518|chlorhexidine|chlorhexidine
1455200|NCT00947518|preterm|preterm
1455201|NCT00947518|newborn|newborn
1455202|NCT00947518|skin condition|skin condition
1455203|NCT00947518|temperature|temperature
1455204|NCT00947518|skin flora|skin flora
1455205|NCT00947505|Androgenetic alopecia|androgenetic alopecia
1455206|NCT00947505|Hair loss|hair loss
1455207|NCT00947505|Male Pattern baldness|male pattern baldness
1455208|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
1455209|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
1455210|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
1455211|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
1455212|NCT00947479|acute kidney injury|acute kidney injury
1455213|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
1455214|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
1455215|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
1455216|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
1455217|NCT00947466|Pharmacokinetic|pharmacokinetic
1455218|NCT00947453|asthma|asthma
1455219|NCT00947453|montelukast|montelukast
1455220|NCT00947440|Phase 1|phase 1
1455221|NCT00947440|Bioavailability|bioavailability
1455222|NCT00947427|type 1 diabetes|type 1 diabetes
1455223|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
1455224|NCT00947427|T1D|t1d
1455225|NCT00947427|canakinumab|canakinumab
1455226|NCT00947427|anti IL-1|anti il-1
1455227|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
1455228|NCT00947401|Surgery, elective|surgery, elective
1455229|NCT00947401|Fluids|fluids
1455230|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
1455231|NCT00947401|PACU|pacu
1455232|NCT00947401|Fluid management|fluid management
1455233|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
1455234|NCT00947388|Bendamustine|bendamustine
1455235|NCT00947388|Alemtuzumab|alemtuzumab
1455236|NCT00947388|Phase I|phase i
1455237|NCT00947388|CLL|cll
1455238|NCT00947375|schizophrenia|schizophrenia
1455239|NCT00947375|lamictal TM|lamictal tm
1455240|NCT00947375|haloperidol decanoate|haloperidol decanoate
1455241|NCT00947323|simvastatin|simvastatin
1455242|NCT00947323|endothelial dysfunction|endothelial dysfunction
1455243|NCT00947323|erectile dysfunction|erectile dysfunction
1455244|NCT00947310|Inappropriate therapy|inappropriate therapy
1455245|NCT00947310|ICD therapy|icd therapy
1455246|NCT00947310|Primary prevention|primary prevention
1455247|NCT00947297|Urea Cycle Disorder|urea cycle disorder
1455248|NCT00947297|UCD|ucd
1455249|NCT00947297|hyperammonemia|hyperammonemia
1455250|NCT00947297|Buphenyl|buphenyl
1455251|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
1455252|NCT00947271|STD|std
1455253|NCT00947271|STI|sti
1455254|NCT00947271|Sexual Behavior|sexual behavior
1455255|NCT00947271|Prevention|prevention
1455256|NCT00947271|HIV seronegativity|hiv seronegativity
1455257|NCT00947258|Muscle Strength|muscle strength
1455258|NCT00947258|Torque|torque
1455259|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
1455260|NCT00947258|Range of Motion|range of motion
1455261|NCT00947232|major depressive disorder|major depressive disorder
1455262|NCT00947232|physical activity|physical activity
1455263|NCT00947232|aging with physical disability|aging with physical disability
1455264|NCT00947232|motivational interviewing|motivational interviewing
1455265|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
1455266|NCT00947219|Hair Loss|hair loss
1455267|NCT00947219|Male Pattern Baldness|male pattern baldness
1455268|NCT00947206|Chinese Americans|chinese americans
1455269|NCT00947206|lay health worker outreach|lay health worker outreach
1455270|NCT00947206|colorectal cancer screening|colorectal cancer screening
1455271|NCT00947193|Hemophilia A|hemophilia a
1455272|NCT00947193|Hemophilia B|hemophilia b
1455273|NCT00947193|Factor VIII|factor viii
1455274|NCT00947193|Factor IX|factor ix
1455275|NCT00947193|FVIII|fviii
1455276|NCT00947193|FIX|fix
1455277|NCT00947193|Nonsense mutation|nonsense mutation
1455278|NCT00947193|Premature stop codon|premature stop codon
1455279|NCT00947193|HA|ha
1455280|NCT00947193|HB|hb
1455281|NCT00947193|PTC124|ptc124
1455282|NCT00947193|Ataluren|ataluren
1455283|NCT00947180|Biofeedback|biofeedback
1455284|NCT00947180|Pelvic floor|pelvic floor
1455285|NCT00947180|Levator ani syndrome|levator ani syndrome
1455286|NCT00947180|Chronic proctalgia|chronic proctalgia
1455287|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
1455288|NCT00947180|Massage|massage
1455289|NCT00947154|trichotillomania|trichotillomania
1455290|NCT00947154|aripiprazole|aripiprazole
1455291|NCT00947154|treatment|treatment
1455292|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
1455293|NCT00947128|Antiemetic|antiemetic
1455294|NCT00947115|Cervical cancer|cervical cancer
1455295|NCT00947115|HPV vaccine|hpv vaccine
1455296|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
1455297|NCT00947102|gemcitabine|gemcitabine
1455298|NCT00947102|gene expression|gene expression
1455299|NCT00947102|immunological status|immunological status
1455300|NCT00947102|serological status|serological status
1455301|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
1455302|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
1455303|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
1455304|NCT00947076|Antidepressant|antidepressant
1455305|NCT00947063|Antihistamine|antihistamine
1455306|NCT00947050|CAD|cad
1455307|NCT00947050|prompt physical exercise|prompt physical exercise
1455308|NCT00947050|collateral function|collateral function
1455309|NCT00947011|Healthy volunteers|healthy volunteers
1455310|NCT00947011|GLP-1|glp-1
1455311|NCT00947011|Januvia|januvia
1455312|NCT00947011|Sitagliptin|sitagliptin
1455313|NCT00946998|Chronic Kidney Disease|chronic kidney disease
1455314|NCT00946998|Depression|depression
1455315|NCT00946998|Antidepressants|antidepressants
1455316|NCT00946998|randomized controlled trial|randomized controlled trial
1455317|NCT00946998|treatment|treatment
1455318|NCT00946998|Sertraline|sertraline
1455319|NCT00946985|Schizophrenia|schizophrenia
1455320|NCT00946985|Risperidone|risperidone
1455321|NCT00946985|Risperdal|risperdal
1455322|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
1455323|NCT00946985|Invega Sustenna|invega sustenna
1455324|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1455325|NCT00946959|cardiac surgery|cardiac surgery
1455326|NCT00946959|angioplasty|angioplasty
1455327|NCT00946959|cognitive decline|cognitive decline
1455328|NCT00946946|Randomized|randomized
1455329|NCT00946946|Crohn's Disease|crohn's disease
1455330|NCT00946946|Prevention|prevention
1455331|NCT00946946|Azathioprine|azathioprine
1455332|NCT00946946|mesalazine|mesalazine
1455333|NCT00946946|mesalamine|mesalamine
1455334|NCT00946946|TPMT|tpmt
1455335|NCT00946933|acid-base balance|acid-base balance
1455336|NCT00946933|ventilatory control|ventilatory control
1455337|NCT00946933|dyspnea|dyspnea
1455338|NCT00946933|exercise|exercise
1455339|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
1455340|NCT00946933|Normal|normal
1455341|NCT00946933|older|older
1455342|NCT00946907|acute pericarditis|acute pericarditis
1455343|NCT00946907|treatment|treatment
1455344|NCT00946907|recurrence|recurrence
1455345|NCT00946894|Total thyroidectomy|total thyroidectomy
1455346|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
1455347|NCT00946894|Dunhill operation|dunhill operation
1455348|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
1455349|NCT00946894|Completion thyroidectomy|completion thyroidectomy
1455350|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
1455351|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
1455352|NCT00946894|Recurrent goiter|recurrent goiter
1455353|NCT00946881|Prostatic disease|prostatic disease
1455354|NCT00946881|genital neoplasm, male|genital neoplasm, male
1455355|NCT00946881|Urogenital neoplasm|urogenital neoplasm
1455356|NCT00946881|Genital disease|genital disease
1455357|NCT00946881|male|male
1455358|NCT00946881|Male urogenital disease|male urogenital disease
1455359|NCT00946881|Neoplasms|neoplasms
1455360|NCT00946881|Neoplasm by site|neoplasm by site
1455361|NCT00946881|prostatic neoplasm|prostatic neoplasm
1455362|NCT00946881|Carcinoma|carcinoma
1455363|NCT00946868|intermittent claudication|intermittent claudication
1455364|NCT00946868|metabolic syndrome|metabolic syndrome
1455365|NCT00946855|soccer|soccer
1455366|NCT00946855|laboratory|laboratory
1455367|NCT00946855|reference|reference
1455368|NCT00946855|exercise|exercise
1455369|NCT00946855|variability|variability
1455370|NCT00946855|season|season
1455371|NCT00946855|elite athletes|elite athletes
1455372|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
1455373|NCT00946842|Healthy|healthy
1455374|NCT00946842|Bioavailability|bioavailability
1455375|NCT00946842|Relative bioavailability|relative bioavailability
1455376|NCT00946842|TMC207|tmc207
1455377|NCT00946842|Fed condition|fed condition
1455378|NCT00946842|Fasted condition|fasted condition
1455379|NCT00946803|Pain|pain
1455380|NCT00946803|Fatigue|fatigue
1455381|NCT00946803|Sleep|sleep
1455382|NCT00946803|Cancer|cancer
1455383|NCT00946803|Complementary therapies|complementary therapies
1455384|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
1455385|NCT00946777|Dry Eye Signs|dry eye signs
1455386|NCT00946777|barrier function|barrier function
1455387|NCT00946764|Antidepressant|antidepressant
1455388|NCT00946751|Anticonvulsant|anticonvulsant
1455389|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
1455390|NCT00946738|biofeedback|biofeedback
1455391|NCT00946738|deep oscillation|deep oscillation
1455392|NCT00946738|systemic sclerosis|systemic sclerosis
1455393|NCT00946738|physiotherapy|physiotherapy
1455394|NCT00946725|Angina (Chest Pain)|angina (chest pain)
1455395|NCT00946725|Hypertension|hypertension
1455396|NCT00946660|Contingency Management|contingency management
1455397|NCT00946660|Drug Self-Administration|drug self-administration
1455398|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
1455399|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1455400|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
1455401|NCT00946647|hypomethylating therapy|hypomethylating therapy
1455402|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
1455403|NCT00946647|MDS|mds
1455404|NCT00946647|CMML|cmml
1455405|NCT00946647|AML|aml
1455406|NCT00946608|Antihistamine|antihistamine
1455407|NCT00946595|Undetectable|undetectable
1455408|NCT00946595|HIV infections|hiv infections
1455409|NCT00946595|Monotherapy|monotherapy
1455410|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
1455411|NCT00946595|Protease inhibitor|protease inhibitor
1455412|NCT00946595|Treatment experienced|treatment experienced
1455413|NCT00946582|parenting management program|parenting management program
1455414|NCT00946582|ADHD|adhd
1455415|NCT00946569|Asthma|asthma
1455416|NCT00946569|Persistent asthma|persistent asthma
1455417|NCT00946569|Adults with persistent asthma|adults with persistent asthma
1455418|NCT00946569|Chronic asthma|chronic asthma
1455419|NCT00946569|JNJ-39758979|jnj-39758979
1455420|NCT00946569|Placebo|placebo
1455421|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
1455422|NCT00946556|HIV|hiv
1455423|NCT00946556|genital immunology|genital immunology
1455424|NCT00946556|CD4+ T cell|cd4+ t cell
1455425|NCT00946556|valacyclovir|valacyclovir
1455426|NCT00946556|HIV seronegativity|hiv seronegativity
1455427|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
1455428|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
1455674|NCT00945906|Factor XIII|factor xiii
1455429|NCT00946543|stage III prostate cancer|stage iii prostate cancer
1455430|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
1455431|NCT00946491|Typical Antipsychotic|typical antipsychotic
1455432|NCT00946478|atopic dermatitis|atopic dermatitis
1455433|NCT00946478|elidel|elidel
1455434|NCT00946478|pimecrolimus|pimecrolimus
1455435|NCT00946478|CASM981|casm981
1455436|NCT00946478|immunity|immunity
1455437|NCT00946478|cathelicidin|cathelicidin
1455438|NCT00946478|antimicrobial peptide|antimicrobial peptide
1455439|NCT00946478|eczema|eczema
1455440|NCT00946452|Control|control
1455441|NCT00946452|Satisfaction|satisfaction
1455442|NCT00946439|training exercise gait|training exercise gait
1455443|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
1455444|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1455445|NCT00946400|HIT|hit
1455446|NCT00946400|4Ts|4ts
1455447|NCT00946400|Chong scale|chong scale
1455448|NCT00946400|interobserver variability|interobserver variability
1455449|NCT00946387|Antiemetic|antiemetic
1455450|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
1455451|NCT00946374|MCL|mcl
1455452|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
1455453|NCT00946374|NHL|nhl
1455454|NCT00946374|Immunochemotherapy|immunochemotherapy
1455455|NCT00946374|R-CHOP|r-chop
1455456|NCT00946374|CHOP|chop
1455457|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
1455458|NCT00946374|BEAM|beam
1455459|NCT00946374|HD-BEAM|hd-beam
1455460|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
1455461|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
1455462|NCT00946374|Unrelated donor|unrelated donor
1455463|NCT00946374|Sibling donor|sibling donor
1455464|NCT00946374|Total Body Irradiation|total body irradiation
1455465|NCT00946374|TBI|tbi
1455466|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
1455467|NCT00946374|ABSCT|absct
1455468|NCT00946374|ASCT|asct
1455469|NCT00946374|Fludarabine+TBI|fludarabine+tbi
1455470|NCT00946348|Dronabinol|dronabinol
1455471|NCT00946348|Schizophrenia|schizophrenia
1455472|NCT00946348|Dual Diagnosis|dual diagnosis
1455473|NCT00946348|Substance Abuse|substance abuse
1455474|NCT00946348|Cannabis Use Disorder|cannabis use disorder
1455475|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
1455476|NCT00946322|alcohol-related disorders|alcohol-related disorders
1455477|NCT00946322|substance use disorders|substance use disorders
1455478|NCT00946322|couple therapy|couple therapy
1455479|NCT00946296|Graves Disease|graves disease
1455480|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1455481|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1455482|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1455483|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1455484|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1455485|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1455486|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1455487|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1455488|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1455489|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1455490|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1455491|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1455492|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1455493|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1455494|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1455495|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1455496|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1455497|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1455498|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1455499|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1455500|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1455501|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1455502|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1455503|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1455504|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1455505|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1455506|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1455507|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1455508|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1455509|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1455510|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1455511|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1455675|NCT00945880|HCV|hcv
1455512|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1455513|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1455514|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1455515|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1455516|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1455517|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1455518|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1455519|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1455520|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1455521|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1455522|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1455523|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1455524|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1455525|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1455526|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1455527|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1455528|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1455529|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1455530|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1455531|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1455532|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1455533|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1455534|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1455535|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1455536|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1455537|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1455538|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1455722|NCT00945620|post-cesarean|post-cesarean
1455539|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1455540|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1455541|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1455542|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1455543|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1455544|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1455545|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1455546|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1455547|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1455548|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1455549|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1455550|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1455551|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
1455552|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1455553|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1455554|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1455555|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1455556|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1455557|NCT00946283|primary myelofibrosis|primary myelofibrosis
1455558|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1455559|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1455560|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
1455561|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1455562|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1455563|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
1455564|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1455565|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1455566|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1455567|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1455568|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
1455569|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
1455570|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1455571|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1455572|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1455676|NCT00945880|Hepatitis C|hepatitis c
1455573|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1455574|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
1455575|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
1455576|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
1455577|NCT00946283|stage IV breast cancer|stage iv breast cancer
1455578|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
1455579|NCT00946270|CC-4047|cc-4047
1455580|NCT00946270|Pomalidomide|pomalidomide
1455581|NCT00946270|polycythemia vera|polycythemia vera
1455582|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
1455583|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1455584|NCT00946244|Early intervention|early intervention
1455585|NCT00946244|Mother-child interaction|mother-child interaction
1455586|NCT00946244|Neurodevelopment|neurodevelopment
1455587|NCT00946244|Parenting|parenting
1455588|NCT00946244|Prematurity|prematurity
1455589|NCT00946244|Preschool age|preschool age
1455590|NCT00946231|Heart Failure|heart failure
1455591|NCT00946231|BNP|bnp
1455592|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
1455593|NCT00946231|home testing|home testing
1455594|NCT00946205|rectal prolapse|rectal prolapse
1455595|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
1455596|NCT00946205|obstructed defecation|obstructed defecation
1455597|NCT00946192|Amenorrhea|amenorrhea
1455598|NCT00946192|Adolescent|adolescent
1455599|NCT00946192|Endurance|endurance
1455600|NCT00946192|Athletes|athletes
1455601|NCT00946192|Females|females
1455602|NCT00946192|Osteopenia|osteopenia
1455603|NCT00946192|Osteoporosis|osteoporosis
1455604|NCT00946192|Estrogen|estrogen
1455605|NCT00946179|Influenza|influenza
1455606|NCT00946179|Influenza virus vaccine|influenza virus vaccine
1455607|NCT00946179|Split virion|split virion
1455608|NCT00946166|pneumonia|pneumonia
1455609|NCT00946166|statins|statins
1455610|NCT00946166|cytokines|cytokines
1455611|NCT00946153|Carcinoma|carcinoma
1455612|NCT00946153|Hepatocellular|hepatocellular
1455613|NCT00946140|Ovary|ovary
1455614|NCT00946140|MRI|mri
1455615|NCT00946140|08-132|08-132
1455616|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1455617|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
1455618|NCT00946127|Gait disorder|gait disorder
1455619|NCT00946127|Cognition|cognition
1455620|NCT00946127|Shunt|shunt
1455621|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
1455622|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
1455623|NCT00946062|low vision|low vision
1455624|NCT00946062|ophthalmology|ophthalmology
1455625|NCT00946062|randomised controlled trial|randomised controlled trial
1455626|NCT00946062|mobility|mobility
1455627|NCT00946062|orientation|orientation
1455628|NCT00946062|cane|cane
1455629|NCT00946062|aged|aged
1455630|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
1455631|NCT00946049|Bacteria|bacteria
1455632|NCT00946023|lymphoma|lymphoma
1455633|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
1455634|NCT00946023|allogeneic|allogeneic
1455635|NCT00946023|bone marrow transplantation|bone marrow transplantation
1455636|NCT00946023|nonmyeloablative|nonmyeloablative
1455637|NCT00946023|cyclophosphamide|cyclophosphamide
1455638|NCT00946023|rituximab|rituximab
1455639|NCT00946010|Hepatitis B|hepatitis b
1455640|NCT00946010|Hepatitis C|hepatitis c
1455641|NCT00946010|genotype|genotype
1455642|NCT00946010|DNA level|dna level
1455643|NCT00946010|RNA level|rna level
1455644|NCT00946010|Taiwan|taiwan
1455645|NCT00945997|misoprostol|misoprostol
1455646|NCT00945997|mifepristone|mifepristone
1455647|NCT00945997|medical abortion|medical abortion
1455648|NCT00945997|randomised controlled trial|randomised controlled trial
1455649|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
1455650|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1455651|NCT00945971|Catecholamine|catecholamine
1455652|NCT00945971|Children|children
1455653|NCT00945971|Physical Activity|physical activity
1455654|NCT00945958|Glaucoma|glaucoma
1455655|NCT00945958|Ocular hypertension|ocular hypertension
1455656|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
1455657|NCT00945945|Pain|pain
1455658|NCT00945932|asthma|asthma
1455659|NCT00945932|GW870086X|gw870086x
1455660|NCT00945932|Efficacy|efficacy
1455661|NCT00945932|FEV1|fev1
1455662|NCT00945932|repeat-dose|repeat-dose
1455663|NCT00945919|Oral morphine|oral morphine
1455664|NCT00945919|oxycodone|oxycodone
1455665|NCT00945919|OPANA|opana
1455666|NCT00945919|Oxymorphone|oxymorphone
1455667|NCT00945919|pain|pain
1455668|NCT00945919|nociceptive|nociceptive
1455669|NCT00945919|neuropathic|neuropathic
1455670|NCT00945919|rotation|rotation
1455671|NCT00945919|titration|titration
1455672|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
1455673|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
1455677|NCT00945880|Hepatitis|hepatitis
1455678|NCT00945867|flecainide|flecainide
1455679|NCT00945867|pharmacogenetics|pharmacogenetics
1455680|NCT00945854|wholegrain cereals|wholegrain cereals
1455681|NCT00945854|glycemic index|glycemic index
1455682|NCT00945854|metabolic syndrome|metabolic syndrome
1455683|NCT00945854|insulin sensitivity|insulin sensitivity
1455684|NCT00945841|influenza vaccine|influenza vaccine
1455685|NCT00945841|vaccine|vaccine
1455686|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
1455687|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1455688|NCT00945828|central nervous system tumors|central nervous system tumors
1455689|NCT00945828|lymphoma|lymphoma
1455690|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1455691|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1455692|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1455693|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1455694|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
1455695|NCT00945789|Infants|infants
1455696|NCT00945789|EEG|eeg
1455697|NCT00945789|Brain MRI|brain mri
1455698|NCT00945789|Nitric oxide|nitric oxide
1455699|NCT00945776|OSA|osa
1455700|NCT00945776|CPAP|cpap
1455701|NCT00945763|Dental Pain|dental pain
1455702|NCT00945737|hypercholesterolemia|hypercholesterolemia
1455703|NCT00945737|cholesterol|cholesterol
1455704|NCT00945737|soy|soy
1455705|NCT00945711|dual diagnosis|dual diagnosis
1455706|NCT00945698|Stunting|stunting
1455707|NCT00945698|Growth failure|growth failure
1455708|NCT00945698|Malnutrition|malnutrition
1455709|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
1455710|NCT00945698|LNS|lns
1455711|NCT00945698|Prevention|prevention
1455712|NCT00945698|Malawi|malawi
1455713|NCT00945698|Sub-Saharan Africa|sub-saharan africa
1455714|NCT00945698|Dietary supplementation|dietary supplementation
1455715|NCT00945698|Efficacy|efficacy
1455716|NCT00945685|Skin Aging|skin aging
1455717|NCT00945685|Skin Wrinkling|skin wrinkling
1455718|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
1455719|NCT00945633|Obesity|obesity
1455720|NCT00945633|unhealthy weight gain|unhealthy weight gain
1455721|NCT00945620|Trans-abdominis block|trans-abdominis block
1455723|NCT00945607|Complementary Medicine|complementary medicine
1455724|NCT00945607|Alternative Medicine|alternative medicine
1455725|NCT00945607|Breast Cancer|breast cancer
1455726|NCT00945594|flexible cystoscopy|flexible cystoscopy
1455727|NCT00945594|rigid cystoscopy|rigid cystoscopy
1455728|NCT00945594|bladder|bladder
1455729|NCT00945594|outcome assessment|outcome assessment
1455730|NCT00945594|pain measurement|pain measurement
1455731|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
1455732|NCT00945568|QOL|qol
1455733|NCT00945568|liver|liver
1455734|NCT00945555|Antibacterials|antibacterials
1455735|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
1455736|NCT00945555|Febrile neutropenia|febrile neutropenia
1455737|NCT00945555|Turkey|turkey
1455738|NCT00945542|Trauma|trauma
1455739|NCT00945542|Coagulopathy|coagulopathy
1455740|NCT00945542|Transfusion|transfusion
1455741|NCT00945542|Plasma|plasma
1455742|NCT00945542|Massive Transfusion|massive transfusion
1455743|NCT00945529|Fontan|fontan
1455744|NCT00945516|Metal stent|metal stent
1455745|NCT00945516|Bile duct stricture|bile duct stricture
1455746|NCT00945516|Stent migration|stent migration
1455747|NCT00945516|Feasibility|feasibility
1455749|NCT00945516|Removability|removability
1455750|NCT00945503|Glycine Tranporter|glycine tranporter
1455751|NCT00945503|MRI|mri
1455752|NCT00945503|PET|pet
1455753|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
1455754|NCT00945490|BPH|bph
1455755|NCT00945490|Enlarged prostate|enlarged prostate
1455756|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1455757|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1455758|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1455759|NCT00945438|Influenza|influenza
1455760|NCT00945438|Influenza virus vaccine|influenza virus vaccine
1455761|NCT00945438|Split virion|split virion
1455762|NCT00945438|Intradermal|intradermal
1455763|NCT00945425|Phase I|phase i
1455764|NCT00945425|Volunteer|volunteer
1455765|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
1455766|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
1455767|NCT00945386|children|children
1455768|NCT00945386|critically ill|critically ill
1455769|NCT00945386|furosemide|furosemide
1455770|NCT00945386|acoustic emission|acoustic emission
1455771|NCT00945373|rosacea|rosacea
1455772|NCT00945373|telangiectasias|telangiectasias
1455773|NCT00945373|topical treatment|topical treatment
1455774|NCT00945373|pulsed dye laser|pulsed dye laser
1455775|NCT00945360|Leiomyoma|leiomyoma
1455776|NCT00945360|perimenopause|perimenopause
1455777|NCT00945360|aromatase inhibitor|aromatase inhibitor
1455778|NCT00945347|Cystic fibrosis|cystic fibrosis
1455779|NCT00945347|miglustat|miglustat
1455780|NCT00945347|nasal instillation|nasal instillation
1455781|NCT00945347|nasal potential difference|nasal potential difference
1455782|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
1455783|NCT00945308|Primary PCI|primary pci
1455784|NCT00945308|Acute myocardial infarction|acute myocardial infarction
1455785|NCT00945308|Myocardial blush|myocardial blush
1455786|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
1455787|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
1455788|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
1455789|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
1455790|NCT00945308|blush|blush
1455791|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
1455792|NCT00945295|Muscle Spasticity|muscle spasticity
1455793|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
1455794|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
1455795|NCT00945282|IDX12899|idx12899
1455796|NCT00945282|adaptive|adaptive
1455797|NCT00945282|monotherapy|monotherapy
1455798|NCT00945282|pharmacokinetics|pharmacokinetics
1455799|NCT00945282|Treatment-naive|treatment-naive
1455800|NCT00945282|HIV-1|hiv-1
1455801|NCT00945282|GSK2248761|gsk2248761
1455802|NCT00945282|NNRTI|nnrti
1455803|NCT00945282|HIV Infections|hiv infections
1455804|NCT00945282|treatment naive|treatment naive
1455805|NCT00945256|metabolism|metabolism
1455806|NCT00945256|exercise|exercise
1455807|NCT00945256|sodium nitroprusside|sodium nitroprusside
1455808|NCT00945243|SCDD|scdd
1455809|NCT00945230|Neurosurgical outcome|neurosurgical outcome
1455810|NCT00945230|Actigraphy|actigraphy
1455811|NCT00945230|Treatment Response Measurement|treatment response measurement
1455812|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
1455813|NCT00945217|Non-HDL-C|non-hdl-c
1455814|NCT00945217|Postmenopausal women|postmenopausal women
1455815|NCT00945217|SAH gene family|sah gene family
1455816|NCT00945204|type 2 diabetes|type 2 diabetes
1455817|NCT00945204|intermediate care|intermediate care
1455818|NCT00945204|primary care|primary care
1455819|NCT00945204|randomised controlled trial|randomised controlled trial
1455820|NCT00945191|ovarian|ovarian
1455821|NCT00945191|cancer|cancer
1455822|NCT00945191|metastatic|metastatic
1455823|NCT00945191|locally|locally
1455824|NCT00945191|advanced|advanced
1455825|NCT00945191|chemotherapy|chemotherapy
1455826|NCT00945191|neoplasm|neoplasm
1455827|NCT00945178|Safety|safety
1455828|NCT00945178|Tolerability|tolerability
1455829|NCT00945178|Healthy|healthy
1455830|NCT00945178|Pharmacokinetics|pharmacokinetics
1455831|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
1455832|NCT00945165|Exercise|exercise
1455833|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
1455834|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
1455835|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
1455836|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
1455837|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
1455838|NCT00945113|pilot|pilot
1455839|NCT00945113|stammer|stammer
1455840|NCT00945113|stutter|stutter
1455841|NCT00945113|children|children
1455842|NCT00945113|randomised controlled trial|randomised controlled trial
1455843|NCT00945113|RCT|rct
1455844|NCT00945113|Speech and Language Therapy|speech and language therapy
1455845|NCT00945113|Stuttering|stuttering
1455846|NCT00945100|Amblyopia|amblyopia
1455847|NCT00945100|patching|patching
1598161|NCT00401726|Anxiety|anxiety
1455848|NCT00945100|occlusion|occlusion
1455849|NCT00945087|bacteriophage|bacteriophage
1455850|NCT00945087|bacteriophage preparation|bacteriophage preparation
1455851|NCT00945087|bacterial infection|bacterial infection
1455852|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
1455853|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
1455854|NCT00945087|MRSA|mrsa
1455855|NCT00945074|Acupuncture|acupuncture
1455856|NCT00945074|Moxibustion|moxibustion
1455857|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
1455858|NCT00945074|Complementary Medicine|complementary medicine
1455859|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
1455860|NCT00945074|IBS|ibs
1455861|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1455862|NCT00945061|recurrent breast cancer|recurrent breast cancer
1455863|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1455864|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1455865|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1455866|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1455867|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1455868|NCT00945061|male breast cancer|male breast cancer
1455869|NCT00945022|General Surgery|general surgery
1456069|NCT00944294|Ischemia|ischemia
1455870|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
1455871|NCT00944996|Major Depression|major depression
1455872|NCT00944996|Receptors|receptors
1455873|NCT00944996|Gene polymorphism|gene polymorphism
1455874|NCT00944996|PACAP signaling system|pacap signaling system
1455875|NCT00944996|Etiology of major depression|etiology of major depression
1455876|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
1455877|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
1455878|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
1455879|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
1455880|NCT00944983|Hypertension|hypertension
1455881|NCT00944983|Hypotension|hypotension
1455882|NCT00944983|Clinical Validation|clinical validation
1455883|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
1455884|NCT00944983|ISO 81600 Standard|iso 81600 standard
1455885|NCT00944983|British Hypertension Society|british hypertension society
1455886|NCT00944983|European Society of Hypertension|european society of hypertension
1455887|NCT00944983|International Protocol|international protocol
1455888|NCT00944970|Coronary artery disease|coronary artery disease
1455889|NCT00944970|Angina|angina
1455890|NCT00944970|Anginal symptoms|anginal symptoms
1455891|NCT00944970|Ischemic heart disease|ischemic heart disease
1455892|NCT00944970|Ischemia|ischemia
1455893|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
1455894|NCT00944970|Pharmacologic stress|pharmacologic stress
1455895|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
1455896|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
1455897|NCT00944970|known coronary artery disease|known coronary artery disease
1455898|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
1455899|NCT00944957|Raltegravir|raltegravir
1455900|NCT00944957|efavirenz|efavirenz
1455901|NCT00944957|anxiety|anxiety
1455902|NCT00944957|depression|depression
1455903|NCT00944957|sleep quality|sleep quality
1455904|NCT00944957|HIV|hiv
1455905|NCT00944957|NNRTI|nnrti
1455906|NCT00944957|Tritherapy|tritherapy
1455907|NCT00944957|compliance|compliance
1455908|NCT00944957|stocrin|stocrin
1455909|NCT00944957|treatment experienced|treatment experienced
1455910|NCT00944944|CORPUS UTERI,|corpus uteri,
1455911|NCT00944944|ENDOMETRIUM|endometrium
1455912|NCT00944944|FALLOPIAN TUBE|fallopian tube
1455913|NCT00944944|OVARY|ovary
1455914|NCT00944944|VAGINA|vagina
1455915|NCT00944944|Lymphedema|lymphedema
1455916|NCT00944944|Questionnaire|questionnaire
1455917|NCT00944944|Quality of Life|quality of life
1455918|NCT00944944|09-077|09-077
1455919|NCT00944944|Fallopian Tubes|fallopian tubes
1455920|NCT00944931|Cerebral Cortex|cerebral cortex
1455921|NCT00944931|Cognition|cognition
1455922|NCT00944931|Motor Cortex|motor cortex
1455923|NCT00944931|Cognitive Enhancement|cognitive enhancement
1455924|NCT00944931|Prefrontal Cortex|prefrontal cortex
1455925|NCT00944931|Healthy Volunteer|healthy volunteer
1455926|NCT00944918|Breast Cancer|breast cancer
1455927|NCT00944879|HIV|hiv
1455928|NCT00944879|vaccine|vaccine
1455929|NCT00944879|prevention|prevention
1455930|NCT00944879|HPV|hpv
1455931|NCT00944879|adolescents|adolescents
1455932|NCT00944853|zinc supplement|zinc supplement
1455933|NCT00944853|prevention|prevention
1455934|NCT00944853|zinc deficiency|zinc deficiency
1455935|NCT00944853|plasma zinc concentration|plasma zinc concentration
1455936|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
1455937|NCT00944840|Home based management of malaria|home based management of malaria
1455938|NCT00944827|Green Tea Extract|green tea extract
1455939|NCT00944827|Catechins|catechins
1455940|NCT00944827|Statin|statin
1455941|NCT00944827|atorvastatin|atorvastatin
1455942|NCT00944827|body composition|body composition
1455943|NCT00944827|visceral fat|visceral fat
1455944|NCT00944827|steatosis|steatosis
1455945|NCT00944827|oxidative stress|oxidative stress
1455946|NCT00944827|quality of life|quality of life
1455947|NCT00944827|OGTT|ogtt
1455948|NCT00944827|OGIS|ogis
1455949|NCT00944827|ISI matsuda|isi matsuda
1455950|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
1455951|NCT00944814|Prevention of malnutrition|prevention of malnutrition
1455952|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
1455953|NCT00944814|Zinc|zinc
1455954|NCT00944801|glioblastoma|glioblastoma
1455955|NCT00944801|first-line|first-line
1455956|NCT00944801|clinical trial|clinical trial
1455957|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
1455958|NCT00944801|temozolomide|temozolomide
1455959|NCT00944801|radiotherapy|radiotherapy
1455960|NCT00944801|phase 1|phase 1
1455961|NCT00944801|phase 2|phase 2
1455962|NCT00944788|physical activity|physical activity
1455963|NCT00944788|aging|aging
1455964|NCT00944788|inpatients|inpatients
1455965|NCT00944788|quality of life|quality of life
1455966|NCT00944788|depression|depression
1455967|NCT00944775|Exercise|exercise
1455968|NCT00944775|Dialysis|dialysis
1456068|NCT00944294|Ischemic heart disease|ischemic heart disease
1455969|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
1455970|NCT00944775|Exercise trained patients|exercise trained patients
1455971|NCT00944775|Controls|controls
1455972|NCT00944762|Stroke|stroke
1455973|NCT00944749|H- ATG|h- atg
1455974|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
1455975|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
1455976|NCT00944749|Aplastic Anemia|aplastic anemia
1455977|NCT00944736|Crohn's Disease|crohn's disease
1455978|NCT00944736|Pediatric|pediatric
1455979|NCT00944736|VSL#3|vsl#3
1455980|NCT00944736|Permeability|permeability
1455981|NCT00944736|Probiotic|probiotic
1455982|NCT00944736|Zonulin|zonulin
1455983|NCT00944723|zinc fortification|zinc fortification
1455984|NCT00944723|zinc supplementation|zinc supplementation
1455985|NCT00944723|plasma zinc concentration|plasma zinc concentration
1455986|NCT00944710|Amblyopia|amblyopia
1455987|NCT00944710|atropine|atropine
1455988|NCT00944710|Plano lens|plano lens
1455989|NCT00944684|Chronic hepatitis C|chronic hepatitis c
1455990|NCT00944684|Antiviral treatment|antiviral treatment
1455991|NCT00944684|Ribavirin|ribavirin
1455992|NCT00944684|Sustained virological response|sustained virological response
1455993|NCT00944684|Hemolytic anemia|hemolytic anemia
1455994|NCT00944684|Erythropoetin|erythropoetin
1455995|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
1455997|NCT00944580|MAGE-A1|mage-a1
1455998|NCT00944580|MAGE-A3|mage-a3
1455999|NCT00944580|NY-ESO-1|ny-eso-1
1456000|NCT00944580|antigen|antigen
1456001|NCT00944580|vaccine|vaccine
1456002|NCT00944580|dendritic cells|dendritic cells
1456003|NCT00944580|immunohistochemistry|immunohistochemistry
1456004|NCT00944580|immunology|immunology
1456005|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
1456006|NCT00944567|Positron emission tomography|positron emission tomography
1456007|NCT00944554|Relapse|relapse
1456008|NCT00944554|Smoking Cessation|smoking cessation
1456009|NCT00944554|Substance Abuse|substance abuse
1456010|NCT00944541|maraviroc|maraviroc
1456011|NCT00944541|immune restoration|immune restoration
1456012|NCT00944541|treatment intensification|treatment intensification
1456013|NCT00944528|Cancer of Breast|cancer of breast
1456014|NCT00944528|Cancer of the Breast|cancer of the breast
1456015|NCT00944528|Neoplasms, Breast|neoplasms, breast
1456016|NCT00944528|Single dose radiation|single dose radiation
1456017|NCT00944528|Radiotherapy|radiotherapy
1456018|NCT00944528|Preoperative|preoperative
1456019|NCT00944515|sinusitis|sinusitis
1456020|NCT00944515|azithromycin|azithromycin
1456021|NCT00944502|Neuralgy|neuralgy
1456022|NCT00944502|Dexamethasone|dexamethasone
1456023|NCT00944502|Complex Vitamins|complex vitamins
1456024|NCT00944502|Injection|injection
1456025|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
1456026|NCT00944489|Hypertension|hypertension
1456027|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
1456028|NCT00944489|Ambulatory Patients|ambulatory patients
1456029|NCT00944489|MINICHAL score|minichal score
1456030|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
1456031|NCT00944489|Quality of life|quality of life
1456032|NCT00944489|Adherence to treatment|adherence to treatment
1456034|NCT00944476|soft tissue|soft tissue
1456035|NCT00944476|MRI|mri
1456036|NCT00944476|Questionnaire|questionnaire
1456037|NCT00944476|09-078|09-078
1456038|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
1456039|NCT00944463|gemcitabine|gemcitabine
1456040|NCT00944463|simvastatin|simvastatin
1456041|NCT00944463|placebo|placebo
1456042|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
1456043|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
1456044|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
1456045|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
1456046|NCT00944398|Zinc fortification|zinc fortification
1456047|NCT00944398|Plasma zinc concentration|plasma zinc concentration
1456048|NCT00944398|Assessment of zinc status|assessment of zinc status
1456049|NCT00944372|Tumor|tumor
1456050|NCT00944372|somatostatin receptor|somatostatin receptor
1456051|NCT00944359|zinc supplementation|zinc supplementation
1456052|NCT00944359|diarrhea management|diarrhea management
1456053|NCT00944359|zinc deficiency|zinc deficiency
1456054|NCT00944359|malaria|malaria
1456055|NCT00944333|second generation DES|second generation des
1456056|NCT00944333|clopidogrel|clopidogrel
1456057|NCT00944333|dual platelet therapy|dual platelet therapy
1456058|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
1456059|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
1456060|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
1456061|NCT00944307|HIV|hiv
1456062|NCT00944307|antiretroviral|antiretroviral
1456063|NCT00944307|drug interaction|drug interaction
1456064|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
1456065|NCT00944294|Coronary artery disease|coronary artery disease
1456066|NCT00944294|Angina|angina
1456067|NCT00944294|Anginal symptoms|anginal symptoms
1456070|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
1456071|NCT00944294|Pharmacologic stress|pharmacologic stress
1456072|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
1456073|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
1456074|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
1456075|NCT00944294|known coronary artery disease|known coronary artery disease
1456076|NCT00944281|point-of-use fortification|point-of-use fortification
1456077|NCT00944281|zinc supplement|zinc supplement
1456078|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
1456079|NCT00944281|zinc deficiency|zinc deficiency
1456080|NCT00944281|micronutrient deficiency|micronutrient deficiency
1456081|NCT00944281|anemia|anemia
1456082|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
1456083|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
1456084|NCT00944268|Tablet|tablet
1456085|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
1456086|NCT00944229|Heart Failure|heart failure
1456087|NCT00944229|omega 3|omega 3
1456088|NCT00944229|lovaza|lovaza
1456089|NCT00944229|VO2 max|vo2 max
1456090|NCT00944216|keratosis pilaris|keratosis pilaris
1456091|NCT00944203|jellyfish|jellyfish
1456092|NCT00944203|jellyfish venom|jellyfish venom
1456093|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
1456094|NCT00944203|jellyfish stings|jellyfish stings
1456095|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
1456096|NCT00944190|pain|pain
1456097|NCT00944190|fatigue|fatigue
1456098|NCT00944190|depression|depression
1456099|NCT00944190|cognitive difficulties|cognitive difficulties
1456100|NCT00944190|self-management|self-management
1456101|NCT00944151|pain|pain
1456102|NCT00944151|UCSD|ucsd
1456103|NCT00944151|catheter|catheter
1456104|NCT00944151|nerve block|nerve block
1456105|NCT00944151|hernia|hernia
1456106|NCT00944151|post-surgery pain|post-surgery pain
1456107|NCT00944151|abdominal pain|abdominal pain
1456108|NCT00944151|pelvic pain|pelvic pain
1456109|NCT00944151|Transversus abdominal plane|transversus abdominal plane
1456110|NCT00944151|Hernia Repair|hernia repair
1456111|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
1456112|NCT00944138|Obesity|obesity
1456113|NCT00944138|meditation|meditation
1456114|NCT00944138|chronic kidney disease|chronic kidney disease
1456115|NCT00944112|Intensive care|intensive care
1456116|NCT00944112|Blood Transfusion|blood transfusion
1456117|NCT00944112|Anemia|anemia
1456118|NCT00944099|intervention studies|intervention studies
1456119|NCT00944099|feeding behavior|feeding behavior
1456120|NCT00944099|eating frequency|eating frequency
1456121|NCT00944099|weight loss|weight loss
1456122|NCT00944099|dietary intake|dietary intake
1456123|NCT00944086|Recruitment|recruitment
1456124|NCT00944086|Oxygen Concentration|oxygen concentration
1456125|NCT00944086|pneumoperitoneum|pneumoperitoneum
1456126|NCT00944086|laparoscopy|laparoscopy
1456127|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
1456128|NCT00944047|invasive breast cancer|invasive breast cancer
1456129|NCT00944047|HER2|her2
1456130|NCT00944047|primary breast cancer|primary breast cancer
1456131|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
1456132|NCT00944047|Trastuzumab|trastuzumab
1456133|NCT00944047|Nab-paclitaxel|nab-paclitaxel
1456134|NCT00944034|Meningococcal meningitis|meningococcal meningitis
1456135|NCT00944034|prevention|prevention
1456136|NCT00944034|vaccination|vaccination
1456137|NCT00944034|toddler|toddler
1456138|NCT00944021|Early Bactericidal Activity|early bactericidal activity
1456139|NCT00944021|EBA|eba
1456140|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
1456141|NCT00944021|PA-824|pa-824
1456142|NCT00944021|pretomanid|pretomanid
1456143|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1456144|NCT00944008|Depocyte®|depocyte®
1456145|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
1456146|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
1456147|NCT00944008|Standard risk|standard risk
1456148|NCT00943995|End Stage Kidney Disease|end stage kidney disease
1456149|NCT00943995|Kidney Failure|kidney failure
1456150|NCT00943995|Short stature|short stature
1456151|NCT00943995|Growth Hormone therapy|growth hormone therapy
1456152|NCT00943982|Cystoid Macular Edema|cystoid macular edema
1456153|NCT00943982|Intermediate Uveitis|intermediate uveitis
1456154|NCT00943982|Uveitis|uveitis
1456155|NCT00943982|OCT|oct
1456156|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
1456157|NCT00943969|obesity|obesity
1456158|NCT00943969|gastric bypass|gastric bypass
1456159|NCT00943969|morphine|morphine
1456160|NCT00943969|pharmacokinetic|pharmacokinetic
1456161|NCT00943969|absorption|absorption
1456162|NCT00943956|stage III prostate cancer|stage iii prostate cancer
1456163|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
1456164|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
1456165|NCT00943943|AML|aml
1456166|NCT00943943|Leukemia|leukemia
1456167|NCT00943943|myeloid leukemias|myeloid leukemias
1456369|NCT00943046|pacemaker|pacemaker
1456168|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
1456169|NCT00943943|FLT3 Mutations|flt3 mutations
1456170|NCT00943943|G-CSF|g-csf
1456171|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
1456172|NCT00943943|Filgrastim|filgrastim
1456173|NCT00943943|Neupogen|neupogen
1456174|NCT00943943|Plerixafor|plerixafor
1456175|NCT00943943|Mobozil|mobozil
1456176|NCT00943943|Sorafenib|sorafenib
1456177|NCT00943943|BAY 43-9006|bay 43-9006
1456178|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
1456179|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
1456180|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
1456181|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
1456182|NCT00943865|metabolic syndrome|metabolic syndrome
1456183|NCT00943865|lifestyle|lifestyle
1456184|NCT00943865|exercise|exercise
1456185|NCT00943865|endothelial dysfunction|endothelial dysfunction
1456186|NCT00943865|insulin sensitivity|insulin sensitivity
1456187|NCT00943865|lipids|lipids
1456188|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
1456189|NCT00943813|communication|communication
1456190|NCT00943813|survey|survey
1456191|NCT00943813|video|video
1456192|NCT00943813|09-043|09-043
1456193|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
1456194|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
1456195|NCT00943774|Physiology|physiology
1456196|NCT00943774|Phenotype|phenotype
1456197|NCT00943774|Genetics|genetics
1456198|NCT00943774|Genomics|genomics
1456199|NCT00943774|Stress|stress
1456200|NCT00943774|Baroreflex|baroreflex
1456201|NCT00943774|Blood Pressure|blood pressure
1456202|NCT00943774|Arterial stiffness|arterial stiffness
1456203|NCT00943761|hepatitis C|hepatitis c
1456204|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
1456205|NCT00943709|hyperglycemia|hyperglycemia
1456206|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1456207|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1456211|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1456212|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1456213|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1456214|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1456217|NCT00943670|Armed Herceptin|armed herceptin
1456218|NCT00943670|Herceptin|herceptin
1456219|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
1456220|NCT00943644|MBI|mbi
1456221|NCT00943644|Breast|breast
1456222|NCT00943644|Breast Cancer|breast cancer
1456223|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
1456224|NCT00943618|Smoking Cessation|smoking cessation
1456225|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
1456226|NCT00943618|Smoking Reduction|smoking reduction
1456227|NCT00943618|Varenicline|varenicline
1456228|NCT00943618|Chantix|chantix
1456229|NCT00943618|Bupropion|bupropion
1456230|NCT00943618|Zyban|zyban
1456231|NCT00943605|Mastectomy|mastectomy
1456232|NCT00943605|PlasmaBlade|plasmablade
1456233|NCT00943605|Electrosurgery|electrosurgery
1456234|NCT00943605|PEAK Surgical|peak surgical
1456235|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
1456236|NCT00943605|Medtronic|medtronic
1456237|NCT00943592|Melphalan|melphalan
1456238|NCT00943592|Alemtuzumab|alemtuzumab
1456239|NCT00943592|Clofarabine|clofarabine
1456240|NCT00943579|autism|autism
1456241|NCT00943579|autistic disorder|autistic disorder
1456242|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
1456243|NCT00943579|sapropterin|sapropterin
1456244|NCT00943579|treatment|treatment
1456245|NCT00943566|Pain|pain
1456246|NCT00943566|Cancer|cancer
1456247|NCT00943566|Morphine|morphine
1456248|NCT00943553|AML|aml
1456249|NCT00943540|pharmacokinetics|pharmacokinetics
1456250|NCT00943540|single dose|single dose
1456251|NCT00943540|raltegravir|raltegravir
1456252|NCT00943540|Treatment experienced|treatment experienced
1456253|NCT00943527|Breast|breast
1456254|NCT00943527|Menstrual Cycle|menstrual cycle
1456255|NCT00943527|Breast Cancer|breast cancer
1456256|NCT00943527|Hormone|hormone
1456257|NCT00943527|MBI|mbi
1456258|NCT00943527|Molecular Breast Imaging|molecular breast imaging
1456259|NCT00943527|Breast Imaging|breast imaging
1456260|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1456261|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
1456262|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
1456263|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
1456264|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
1456265|NCT00943514|Bronchiectasis|bronchiectasis
1456266|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
1456370|NCT00943046|efficacy|efficacy
1456267|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
1456268|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
1456269|NCT00943449|Sorafenib|sorafenib
1456270|NCT00943449|HDAC|hdac
1456271|NCT00943449|4SC-201|4sc-201
1456272|NCT00943449|Phase II|phase ii
1456273|NCT00943449|Resminostat|resminostat
1456281|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1456282|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1456283|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
1456284|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
1456285|NCT00943410|recurrent breast cancer|recurrent breast cancer
1456286|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
1456287|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
1456288|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
1456289|NCT00943410|stage IV breast cancer|stage iv breast cancer
1456290|NCT00943358|influenza|influenza
1456291|NCT00943358|immunogenicity|immunogenicity
1456292|NCT00943358|vaccine|vaccine
1456293|NCT00943345|GI|gi
1456294|NCT00943345|gastrointestinal|gastrointestinal
1456295|NCT00943345|permeability|permeability
1456296|NCT00943345|indometacin|indometacin
1456297|NCT00943345|indomethacin|indomethacin
1456298|NCT00943345|coeliac|coeliac
1456299|NCT00943332|Orthopedic Procedures|orthopedic procedures
1456300|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
1456301|NCT00943332|Fracture Fixation, External|fracture fixation, external
1456302|NCT00943332|femur fracture|femur fracture
1456303|NCT00943332|pediatrics|pediatrics
1456304|NCT00943319|Cancers of the blood|cancers of the blood
1456305|NCT00943306|Homozygous|homozygous
1456306|NCT00943306|Familial|familial
1456307|NCT00943306|Hypercholesterolemia|hypercholesterolemia
1456309|NCT00943306|Apheresis|apheresis
1456310|NCT00943306|lomitapide|lomitapide
1456311|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
1456312|NCT00943293|GVHD|gvhd
1456313|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
1456314|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
1456315|NCT00943267|Activated Protein C|activated protein c
1456316|NCT00943267|Lipopolysaccharides|lipopolysaccharides
1456317|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
1456318|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
1456319|NCT00943241|Breast|breast
1456320|NCT00943241|Breast Cancer|breast cancer
1456321|NCT00943241|MBI|mbi
1456322|NCT00943241|Molecular Breast Imaging|molecular breast imaging
1456323|NCT00943241|Molecular Imaging|molecular imaging
1456324|NCT00943228|Renal transplantation|renal transplantation
1456325|NCT00943228|Adequate exposure|adequate exposure
1456326|NCT00943228|Acute rejection|acute rejection
1456327|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
1456328|NCT00943228|immunosuppression|immunosuppression
1456329|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
1456330|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
1456331|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
1456332|NCT00943176|Fatigue|fatigue
1456333|NCT00943163|cyclorotation|cyclorotation
1456334|NCT00943163|pupil|pupil
1456335|NCT00943163|laser refractive surgery|laser refractive surgery
1456336|NCT00943150|Abdominoplasty|abdominoplasty
1456337|NCT00943150|PlasmaBlade|plasmablade
1456338|NCT00943150|Electrosurgery|electrosurgery
1456339|NCT00943150|PEAK Surgical|peak surgical
1456340|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
1456341|NCT00943150|Medtronic|medtronic
1456342|NCT00943111|Gaucher disease,|gaucher disease,
1456343|NCT00943111|Genz-112638,|genz-112638,
1456344|NCT00943111|beta-glucosidase,|beta-glucosidase,
1456345|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
1456346|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
1456347|NCT00943111|glucosylceramide,|glucosylceramide,
1456348|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
1456349|NCT00943111|substrate reduction therapy|substrate reduction therapy
1456350|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
1456351|NCT00943085|High Risk Youth|high risk youth
1456352|NCT00943085|Adolescence|adolescence
1456353|NCT00943085|Childhood|childhood
1456354|NCT00943072|Macular edema|macular edema
1456355|NCT00943072|Retinal vein occlusion|retinal vein occlusion
1456356|NCT00943072|CRVO|crvo
1456357|NCT00943072|VEGF Trap-Eye|vegf trap-eye
1456358|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
1456359|NCT00943072|Regeneron|regeneron
1456360|NCT00943072|COPERNICUS|copernicus
1456361|NCT00943059|Mitochondrial function|mitochondrial function
1456362|NCT00943059|Diabetes|diabetes
1456363|NCT00943059|Cardiomyopathy|cardiomyopathy
1456364|NCT00943059|insulin resistance|insulin resistance
1456365|NCT00943059|lipid lowering|lipid lowering
1456366|NCT00943059|triglycerides|triglycerides
1456367|NCT00943059|Acipimox|acipimox
1456368|NCT00943046|leads|leads
1456371|NCT00943046|safety|safety
1456372|NCT00943033|MBCT|mbct
1456373|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1456374|NCT00943033|Mindfulness|mindfulness
1456375|NCT00943033|Meditation|meditation
1456376|NCT00943033|Relapse Prevention|relapse prevention
1456377|NCT00943033|Recurrent Depression|recurrent depression
1456378|NCT00943033|Depression|depression
1456379|NCT00943033|Major Depressive Disorder|major depressive disorder
1456380|NCT00943020|Dietary supplement|dietary supplement
1456381|NCT00943020|Carbohydrate loading|carbohydrate loading
1456382|NCT00943020|Healthy volunteers|healthy volunteers
1456383|NCT00943020|Anaesthesia|anaesthesia
1456384|NCT00943020|Surgery|surgery
1456385|NCT00943020|Glutamine|glutamine
1456386|NCT00942994|Hypertension|hypertension
1456387|NCT00942994|Aliskiren|aliskiren
1456388|NCT00942994|Amlodipine|amlodipine
1456389|NCT00942994|HCTZ|hctz
1456390|NCT00942994|Systolic blood pressure|systolic blood pressure
1456391|NCT00942994|Diastolic blood pressure|diastolic blood pressure
1456392|NCT00942994|Stage II|stage ii
1456393|NCT00942994|Combination|combination
1456394|NCT00942981|PET Study|pet study
1456395|NCT00942981|(18F) Fallypride|(18f) fallypride
1456396|NCT00942981|(11C)NNC-112|(11c)nnc-112
1456397|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
1456398|NCT00942981|Schizophrenia|schizophrenia
1456399|NCT00942981|Healthy Volunteer|healthy volunteer
1456400|NCT00942981|HV|hv
1456401|NCT00942929|anorexia nervosa|anorexia nervosa
1456402|NCT00942929|adolescents|adolescents
1456403|NCT00942929|lung function tests|lung function tests
1456404|NCT00942929|refeeding|refeeding
1456405|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
1456406|NCT00942903|HME|hme
1456407|NCT00942903|Provox|provox
1456408|NCT00942903|voice prosthesis|voice prosthesis
1456409|NCT00942903|laryngectomy|laryngectomy
1456410|NCT00942890|Case Management|case management
1456411|NCT00942890|Amputation|amputation
1456412|NCT00942890|Muscle strength|muscle strength
1456413|NCT00942890|phantom limb pain|phantom limb pain
1456414|NCT00942877|VEGF|vegf
1456415|NCT00942877|Antiangiogenesis|antiangiogenesis
1456416|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1456417|NCT00942877|Advanced Cancer|advanced cancer
1456418|NCT00942877|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
1456419|NCT00942877|Sarcoma|sarcoma
1456420|NCT00942851|Dystonia|dystonia
1456421|NCT00942851|Blepharospasm|blepharospasm
1456422|NCT00942851|Botulinum Toxin|botulinum toxin
1456423|NCT00942851|Treatment|treatment
1456424|NCT00942851|Clinical Trial|clinical trial
1456425|NCT00942851|Focal Dystonia|focal dystonia
1456426|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
1456427|NCT00942838|Cancer|cancer
1456428|NCT00942825|NSCL|nscl
1456429|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
1456430|NCT00942825|Lung Cancer|lung cancer
1456431|NCT00942825|Lung|lung
1456432|NCT00942825|non-squamous|non-squamous
1456433|NCT00942825|metastatic|metastatic
1456434|NCT00942825|pleural effusion|pleural effusion
1456435|NCT00942825|Stage IIIb|stage iiib
1456436|NCT00942825|Stage IV|stage iv
1456437|NCT00942825|NSCLC|nsclc
1456438|NCT00942812|Children|children
1456439|NCT00942812|Recovery|recovery
1456440|NCT00942812|Diarrhea Pack|diarrhea pack
1456441|NCT00942812|Social Marketing|social marketing
1456442|NCT00942799|Genz-644282|genz-644282
1456443|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
1456444|NCT00942799|Top1|top1
1456445|NCT00942799|solid tumors|solid tumors
1456446|NCT00942799|dose-escalation|dose-escalation
1456447|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
1456448|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
1456449|NCT00942799|oncology|oncology
1456450|NCT00942799|cancer|cancer
1456451|NCT00942786|natriuretic peptides|natriuretic peptides
1456452|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
1456453|NCT00942773|Healthy volunteer|healthy volunteer
1456454|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
1456455|NCT00942734|Head and Neck|head and neck
1456456|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
1456457|NCT00942734|RAD001|rad001
1456458|NCT00942734|Erlotinib|erlotinib
1456459|NCT00942734|Everolimus|everolimus
1456460|NCT00942734|OSI-774|osi-774
1456461|NCT00942734|Tarceva|tarceva
1456462|NCT00942721|Web-based Intervention|web-based intervention
1456463|NCT00942721|CBT Treatment|cbt treatment
1456464|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1456465|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
1456466|NCT00942695|pistachio|pistachio
1456467|NCT00942695|nuts|nuts
1456468|NCT00942695|energy value|energy value
1456469|NCT00942695|cardiovascular disease|cardiovascular disease
1456470|NCT00942695|phytonutrient|phytonutrient
1456471|NCT00942695|gene expression|gene expression
1456472|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
1456473|NCT00942682|sorafenib|sorafenib
1456474|NCT00942682|RAD001|rad001
1456475|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
1456476|NCT00942669|SAS|sas
1456477|NCT00942669|SleepStrip OTC|sleepstrip otc
1456478|NCT00942656|trans fatty acids|trans fatty acids
1456479|NCT00942656|ruminant|ruminant
1456480|NCT00942656|cardiovascular disease|cardiovascular disease
1456481|NCT00942630|percutaneous|percutaneous
1456482|NCT00942630|transhepatic|transhepatic
1456483|NCT00942630|biliary|biliary
1456484|NCT00942630|drainage|drainage
1456485|NCT00942630|cholangioscopy|cholangioscopy
1456486|NCT00942617|platelet aggregation|platelet aggregation
1456487|NCT00942617|granule secretion|granule secretion
1456488|NCT00942617|thromboxane production|thromboxane production
1456489|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
1456490|NCT00942617|ATP release|atp release
1456491|NCT00942617|aspirin resistance|aspirin resistance
1456492|NCT00942617|platelet activation|platelet activation
1456493|NCT00942617|flow cytometry|flow cytometry
1456494|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
1456495|NCT00942604|Peplin|peplin
1456496|NCT00942604|Actinic keratosis|actinic keratosis
1456497|NCT00942604|PEP005|pep005
1456498|NCT00942591|multiple sclerosis|multiple sclerosis
1456499|NCT00942591|interferon beta|interferon beta
1456500|NCT00942591|atorvastatin|atorvastatin
1456501|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
1456502|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
1456503|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
1456504|NCT00942578|Correlative Measurements|correlative measurements
1456505|NCT00942578|Overall Survival Assessment|overall survival assessment
1456506|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
1456507|NCT00942578|Prostate Cancer|prostate cancer
1456508|NCT00942565|Open gynecological surgery|open gynecological surgery
1456509|NCT00942539|Neonates|neonates
1456510|NCT00942526|esophageal cancer|esophageal cancer
1456511|NCT00942526|anastomotic leakage|anastomotic leakage
1456512|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
1456513|NCT00942513|substrate absorption|substrate absorption
1456514|NCT00942513|substrate oxidation|substrate oxidation
1456515|NCT00942513|glucose regulation|glucose regulation
1456516|NCT00942513|whey protein|whey protein
1456517|NCT00942513|soy protein|soy protein
1456518|NCT00942513|sucrose|sucrose
1456519|NCT00942513|fructose|fructose
1456520|NCT00942513|lactose|lactose
1456521|NCT00942500|Post-conditioning|post-conditioning
1456522|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
1456523|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1456524|NCT00942487|arterial hypertension|arterial hypertension
1456525|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
1456526|NCT00942461|a-defensins|a-defensins
1456527|NCT00942461|TLRs|tlrs
1456528|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
1456529|NCT00942461|CRP|crp
1456530|NCT00942461|No metastases|no metastases
1456531|NCT00942461|No other obvious inflammation|no other obvious inflammation
1456532|NCT00942461|No chronic diseases|no chronic diseases
1456533|NCT00942435|YM150|ym150
1456534|NCT00942435|Bleeding|bleeding
1456535|NCT00942435|VTE|vte
1456536|NCT00942435|FXa inhibitor|fxa inhibitor
1456537|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
1456538|NCT00942435|Venous thromboembolism|venous thromboembolism
1456539|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1456540|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
1456541|NCT00942396|Mammography|mammography
1456542|NCT00942383|liver tumor|liver tumor
1456543|NCT00942383|liver tumors|liver tumors
1456544|NCT00942383|liver cancer|liver cancer
1456545|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
1456546|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
1456547|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
1456548|NCT00942383|metastatic cancer|metastatic cancer
1456549|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
1456550|NCT00942383|liver|liver
1456551|NCT00942383|liver surgery|liver surgery
1456552|NCT00942383|radiofrequency ablation|radiofrequency ablation
1456553|NCT00942383|microwave ablation|microwave ablation
1456554|NCT00942370|mechanography|mechanography
1456555|NCT00942370|electromyography|electromyography
1456556|NCT00942370|effort cough|effort cough
1456557|NCT00942344|Amlodipine|amlodipine
1456558|NCT00942344|Losartan|losartan
1456559|NCT00942344|Hypertension|hypertension
1456560|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1456561|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1456562|NCT00942318|Insulin external pump|insulin external pump
1456563|NCT00942318|Multiple daily injections|multiple daily injections
1456564|NCT00942318|Basal-bolus regimen|basal-bolus regimen
1456565|NCT00942318|Education|education
1456772|NCT00941837|Cholesterol|cholesterol
1456566|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
1456567|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
1456568|NCT00942305|transplant|transplant
1456569|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
1456570|NCT00942292|Hepatic|hepatic
1456571|NCT00942292|colorectal|colorectal
1456572|NCT00942292|metastases|metastases
1456573|NCT00942292|TPN|tpn
1456574|NCT00942292|Fish oil|fish oil
1456575|NCT00942253|RLS|rls
1456576|NCT00942253|Muscle|muscle
1456577|NCT00942253|Dialysis|dialysis
1456578|NCT00942253|exercise|exercise
1456579|NCT00942253|dopamine agonist|dopamine agonist
1456580|NCT00942253|Sleep|sleep
1456581|NCT00942227|Sciatica|sciatica
1456582|NCT00942227|Radiculopathy|radiculopathy
1456583|NCT00942227|Physical therapy modalities|physical therapy modalities
1456584|NCT00942227|Rehabilitation|rehabilitation
1456585|NCT00942214|Multiple sclerosis|multiple sclerosis
1456586|NCT00942214|natalizumab|natalizumab
1456587|NCT00942214|pharmacogenomics|pharmacogenomics
1456588|NCT00942201|Asthma|asthma
1456589|NCT00942201|Dexamethasone|dexamethasone
1456590|NCT00942201|Emergency Department|emergency department
1456591|NCT00942188|Diabetes|diabetes
1456592|NCT00942188|Type 2 Diabetes|type 2 diabetes
1456593|NCT00942175|Pharmacology|pharmacology
1456594|NCT00942175|Stomach Ulcer|stomach ulcer
1456701|NCT00941915|Calypso|calypso
1456595|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
1456596|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
1456597|NCT00942175|Platelet function|platelet function
1456598|NCT00942175|PPI|ppi
1456599|NCT00942175|clopidogrel|clopidogrel
1456600|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
1456601|NCT00942162|PREDICT|predict
1456602|NCT00942162|ASCI|asci
1456603|NCT00942162|Tumor antigen|tumor antigen
1456604|NCT00942162|Melanoma|melanoma
1456605|NCT00942162|Immunotherapeutic|immunotherapeutic
1456606|NCT00942149|Infants|infants
1456607|NCT00942149|Daptomycin|daptomycin
1456608|NCT00942136|HIV|hiv
1456609|NCT00942136|GSK1349572|gsk1349572
1456610|NCT00942136|omeprazole|omeprazole
1456611|NCT00942136|Prilosec|prilosec
1456612|NCT00942136|supratherapeutic dose|supratherapeutic dose
1456613|NCT00942136|pharmacokinetics|pharmacokinetics
1456614|NCT00942136|drug interaction|drug interaction
1456615|NCT00942136|HIV Infections|hiv infections
1456616|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
1456617|NCT00942110|humoral factors|humoral factors
1456618|NCT00942097|Homeopathy|homeopathy
1456619|NCT00942097|overweight|overweight
1456620|NCT00942097|obesity|obesity
1456621|NCT00942097|mental disorder|mental disorder
1456622|NCT00942097|pregnancy|pregnancy
1456623|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
1456624|NCT00942084|HSV|hsv
1456625|NCT00942084|Acyclovir|acyclovir
1456626|NCT00942084|Pharmacokinetics|pharmacokinetics
1456627|NCT00942084|Neonate|neonate
1456628|NCT00942084|Premature|premature
1456629|NCT00942084|Sepsis|sepsis
1456630|NCT00942071|Influenza|influenza
1456631|NCT00942071|Vaccine|vaccine
1456632|NCT00942058|biological markers|biological markers
1456633|NCT00942058|CA9 protein|ca9 protein
1456634|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
1456635|NCT00942058|kidney cancer|kidney cancer
1456636|NCT00942045|cervical spine|cervical spine
1456637|NCT00942045|ACDF|acdf
1456638|NCT00942045|biologics|biologics
1456639|NCT00942045|fusion rates|fusion rates
1456640|NCT00942019|BMI|bmi
1456641|NCT00942019|obesity|obesity
1456642|NCT00942019|CO|co
1456643|NCT00942019|tobacco smoking|tobacco smoking
1456644|NCT00942019|adolescents|adolescents
1456645|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
1456646|NCT00942006|Lyme borreliosis|lyme borreliosis
1456647|NCT00942006|erythema migrans|erythema migrans
1456648|NCT00942006|doxycycline treatment|doxycycline treatment
1456649|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
1456650|NCT00942006|outcome|outcome
1456651|NCT00942006|subjective symptoms|subjective symptoms
1456652|NCT00941980|biologics|biologics
1456653|NCT00941980|fusion rates|fusion rates
1456654|NCT00941980|PLIF|plif
1456655|NCT00941980|lumbar fusion|lumbar fusion
1456656|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1456657|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1456658|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1456659|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
1456660|NCT00941954|Physical activity|physical activity
1456661|NCT00941954|Diabetes|diabetes
1456662|NCT00941954|Prevention|prevention
1456663|NCT00941954|Pedometer|pedometer
1456664|NCT00941954|Walking|walking
1456665|NCT00941954|Structured education|structured education
1456666|NCT00941954|Randomized|randomized
1456667|NCT00941954|Risk score|risk score
1456668|NCT00941954|Impaired glucose regulation|impaired glucose regulation
1456669|NCT00941941|Inguinal|inguinal
1456670|NCT00941941|Hernia|hernia
1456671|NCT00941941|Hernia-repair|hernia-repair
1456672|NCT00941941|Non-mesh|non-mesh
1456673|NCT00941941|Mesh|mesh
1456674|NCT00941941|Desarda|desarda
1456675|NCT00941941|Lichtenstein|lichtenstein
1456676|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
1456677|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
1456678|NCT00941928|ALL|all
1456679|NCT00941928|Leukemia|leukemia
1456680|NCT00941928|Pediatrics|pediatrics
1456681|NCT00941928|Haploidentical NK cells|haploidentical nk cells
1456682|NCT00941928|Cyclophosphamide|cyclophosphamide
1456683|NCT00941928|Cytoxan|cytoxan
1456684|NCT00941928|Neosar|neosar
1456685|NCT00941928|Epratuzumab|epratuzumab
1456686|NCT00941928|Fludarabine|fludarabine
1456687|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
1456688|NCT00941928|Fludara|fludara
1456689|NCT00941928|Interleukin-2|interleukin-2
1456690|NCT00941928|IL-2|il-2
1456691|NCT00941928|Proleukin|proleukin
1456692|NCT00941928|Low-dose interleukin|low-dose interleukin
1456693|NCT00941928|Mesna|mesna
1456694|NCT00941928|Mesnex|mesnex
1456695|NCT00941928|Natural Killer Cells|natural killer cells
1456696|NCT00941928|NK Cells Transplant|nk cells transplant
1456697|NCT00941915|CaP|cap
1456698|NCT00941915|SBRT|sbrt
1456699|NCT00941915|Prostate|prostate
1456700|NCT00941915|ExacTrac|exactrac
1456702|NCT00941915|IMRT|imrt
1456703|NCT00941915|Radiation|radiation
1456704|NCT00941915|Cancer of Prostate|cancer of prostate
1456705|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
1456706|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
1456707|NCT00941902|hepatocytes|hepatocytes
1456708|NCT00941902|bariatric surgery|bariatric surgery
1456709|NCT00941889|HIV|hiv
1456710|NCT00941889|HPV|hpv
1456711|NCT00941889|Anal condylomata|anal condylomata
1456712|NCT00941889|Vaccine|vaccine
1456713|NCT00941889|HIV positive patients|hiv positive patients
1456714|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
1456715|NCT00941876|AE|ae
1456716|NCT00941876|adverse event|adverse event
1456717|NCT00941876|AIDS|aids
1456718|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1456719|NCT00941876|ALT (SGPT)|alt (sgpt)
1456720|NCT00941876|alanine aminotransferase|alanine aminotransferase
1456721|NCT00941876|ART|art
1456722|NCT00941876|antiretroviral therapy|antiretroviral therapy
1456723|NCT00941876|AST (SGOT)|ast (sgot)
1456724|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
1456725|NCT00941876|DCF|dcf
1456726|NCT00941876|data collection forms|data collection forms
1456727|NCT00941876|DMC|dmc
1456728|NCT00941876|Data Monitoring Committee|data monitoring committee
1456729|NCT00941876|FDA|fda
1456730|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
1456731|NCT00941876|GCP|gcp
1456732|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
1456733|NCT00941876|HB sAg|hb sag
1456734|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
1599262|NCT00397111|HV|hv
1456735|NCT00941876|ICH|ich
1456736|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
1456737|NCT00941876|IND|ind
1456738|NCT00941876|Investigational New Drug Application|investigational new drug application
1456739|NCT00941876|IRB|irb
1456740|NCT00941876|Institutional Review Board|institutional review board
1456741|NCT00941876|IU|iu
1456742|NCT00941876|International units|international units
1456743|NCT00941876|mg|mg
1456744|NCT00941876|milligram(s)|milligram(s)
1456745|NCT00941876|mm3|mm3
1456746|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
1456747|NCT00941876|PCR|pcr
1456748|NCT00941876|polymerase chain reaction|polymerase chain reaction
1456749|NCT00941876|SAE|sae
1456750|NCT00941876|serious adverse event|serious adverse event
1456751|NCT00941876|µg|µg
1456752|NCT00941876|microgram|microgram
1456753|NCT00941876|ULN|uln
1456754|NCT00941876|upper limit of the normal range|upper limit of the normal range
1456755|NCT00941876|WB|wb
1456756|NCT00941876|Western Blot|western blot
1456757|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
1456758|NCT00941876|HIV seronegativity|hiv seronegativity
1456759|NCT00941863|Sorafenib|sorafenib
1456760|NCT00941863|Advanced Solid Tumors|advanced solid tumors
1456761|NCT00941863|Maximum tolerated dose|maximum tolerated dose
1456762|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
1456763|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
1456764|NCT00941850|CRT|crt
1456765|NCT00941850|Heart failure|heart failure
1456766|NCT00941850|Dyssynchrony|dyssynchrony
1456767|NCT00941850|Echocardiography|echocardiography
1456768|NCT00941850|Pacemakers|pacemakers
1456769|NCT00941850|Nonresponders|nonresponders
1456770|NCT00941837|Palm olein|palm olein
1456771|NCT00941837|homocsyteine|homocsyteine
1456773|NCT00941837|lipoproteins|lipoproteins
1456774|NCT00941837|Interleukins|interleukins
1456775|NCT00941837|CRP|crp
1456776|NCT00941837|Blood Pressure|blood pressure
1456777|NCT00941837|Total homocystein|total homocystein
1456778|NCT00941837|Serum lipid profile|serum lipid profile
1456779|NCT00941837|Serum apolipoproteins|serum apolipoproteins
1456780|NCT00941837|Inflammatory markers|inflammatory markers
1456781|NCT00941824|pharmacokinetic|pharmacokinetic
1456782|NCT00941824|mycophénolate acid|mycophénolate acid
1456783|NCT00941824|kidney transplantation|kidney transplantation
1456784|NCT00941798|Asthma|asthma
1456785|NCT00941798|LABA|laba
1456786|NCT00941798|Safety|safety
1456787|NCT00941785|Malaria|malaria
1456788|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
1456789|NCT00941785|IPTc|iptc
1456790|NCT00941785|sIPTc|siptc
1456791|NCT00941785|Burkina Faso|burkina faso
1456792|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
1456793|NCT00941772|ultrasonography|ultrasonography
1456794|NCT00941759|Breast|breast
1456795|NCT00941759|Blood and tissue collection|blood and tissue collection
1456796|NCT00941759|Epidemiologic|epidemiologic
1456797|NCT00941759|Questionnaire|questionnaire
1456798|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
1456799|NCT00941759|09-056|09-056
1456800|NCT00941733|BTK|btk
1456801|NCT00941733|CLI|cli
1456802|NCT00941733|PTA|pta
1457000|NCT00940719|Vitamin D|vitamin d
1456803|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
1456804|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
1456805|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
1456806|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
1456807|NCT00941707|JNJ-38518168|jnj-38518168
1456808|NCT00941694|asthma|asthma
1456809|NCT00941694|aged|aged
1456810|NCT00941694|self care|self care
1456811|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
1456812|NCT00941655|Gastric Carcinoma|gastric carcinoma
1456813|NCT00941655|Chemotherapy|chemotherapy
1456814|NCT00941655|Liver Tumors|liver tumors
1456815|NCT00941655|Peritoneal Tumors|peritoneal tumors
1456816|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
1456817|NCT00941655|Stomach Cancer|stomach cancer
1456818|NCT00941655|Gastric Cancer|gastric cancer
1456819|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
1456820|NCT00941642|Lovaza|lovaza
1456821|NCT00941642|Steatosis|steatosis
1456822|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1456823|NCT00941629|PTSD|ptsd
1456824|NCT00941629|Telemedicine|telemedicine
1456825|NCT00941629|Clinical Trial|clinical trial
1456826|NCT00941629|Psychotherapy|psychotherapy
1456827|NCT00941616|Von Willebrand Disease|von willebrand disease
1456828|NCT00941590|tick borne encephalitis|tick borne encephalitis
1456829|NCT00941590|clinical outcome|clinical outcome
1456830|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
1456831|NCT00941577|Hypersensitivity|hypersensitivity
1456832|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
1456833|NCT00941577|Immune System Diseases|immune system diseases
1456834|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
1456835|NCT00941577|Bronchial Diseases|bronchial diseases
1456836|NCT00941577|Lung Diseases|lung diseases
1456837|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
1456839|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
1456840|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
1456841|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
1456842|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
1456843|NCT00941551|iodine deficiency,|iodine deficiency,
1456844|NCT00941551|long-term follow-up,|long-term follow-up,
1456845|NCT00941551|completion thyroidectomy|completion thyroidectomy
1456846|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
1456847|NCT00941538|screening|screening
1456848|NCT00941538|biomarker|biomarker
1456849|NCT00941538|early detection|early detection
1456850|NCT00941538|epidemiological survey|epidemiological survey
1456851|NCT00941525|Central corneal thickness|central corneal thickness
1456852|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
1456853|NCT00941525|Open angle glaucoma|open angle glaucoma
1456854|NCT00941525|Ocular hypertension|ocular hypertension
1456855|NCT00941512|Colposcopy|colposcopy
1456856|NCT00941499|Advanced Cancers|advanced cancers
1456857|NCT00941499|Liver|liver
1456858|NCT00941499|Oxaliplatin|oxaliplatin
1456859|NCT00941499|Eloxatin|eloxatin
1456860|NCT00941499|Bevacizumab|bevacizumab
1456861|NCT00941499|Avastin|avastin
1456862|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
1456863|NCT00941499|rhuMAb-VEGF|rhumab-vegf
1456864|NCT00941499|5-fluorouracil|5-fluorouracil
1456865|NCT00941499|5-FU|5-fu
1456866|NCT00941499|Adrucil|adrucil
1456867|NCT00941499|Efudex|efudex
1456868|NCT00941499|Leucovorin|leucovorin
1456869|NCT00941499|Citrovorum|citrovorum
1456870|NCT00941499|Wellcovorin|wellcovorin
1456871|NCT00941499|Cetuximab|cetuximab
1456872|NCT00941499|C225|c225
1456873|NCT00941499|Erbitux|erbitux
1456874|NCT00941499|IMC-C225|imc-c225
1456875|NCT00941473|Epidural Injection|epidural injection
1456876|NCT00941473|Bone Density|bone density
1456877|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
1456878|NCT00941460|temozolomide|temozolomide
1456879|NCT00941460|dose intensification|dose intensification
1456880|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
1456881|NCT00941447|Type 2 Diabetes|type 2 diabetes
1456882|NCT00941447|Obesity|obesity
1456883|NCT00941447|Self-Regulation|self-regulation
1456884|NCT00941447|Self-Efficacy|self-efficacy
1456885|NCT00941434|RUTF|rutf
1456886|NCT00941434|SAM|sam
1456887|NCT00941434|Nutributter|nutributter
1456888|NCT00941395|Cancer Prevention|cancer prevention
1456889|NCT00941395|College students|college students
1456890|NCT00941395|Prevention intervention|prevention intervention
1456891|NCT00941395|Smoking|smoking
1456892|NCT00941395|Tobacco|tobacco
1456893|NCT00941395|Internet-based|internet-based
1456894|NCT00941395|Cognitive Behavioral Therapy|cognitive behavioral therapy
1456895|NCT00941395|Nicotine lozenges|nicotine lozenges
1456896|NCT00941382|sibutramine|sibutramine
1456897|NCT00941382|metformin|metformin
1456898|NCT00941382|obesity|obesity
1456899|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
1456900|NCT00941356|Probiotics|probiotics
1456901|NCT00941330|Breast, Male|breast, male
1456902|NCT00941330|Breast, Female|breast, female
1457001|NCT00940719|Vitamin D3|vitamin d3
1456903|NCT00941317|onychomycosis|onychomycosis
1456904|NCT00941317|micro-drilling|micro-drilling
1456905|NCT00941291|idiopathic macular hole|idiopathic macular hole
1456906|NCT00941291|cataract|cataract
1456907|NCT00941291|edema|edema
1456908|NCT00941291|Reopening|reopening
1456909|NCT00941265|treatment of anomia|treatment of anomia
1456910|NCT00941265|levodopa|levodopa
1456911|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
1456912|NCT00941239|Metformin ER|metformin er
1456913|NCT00941239|Pharmacokinetics|pharmacokinetics
1456914|NCT00941239|Tolerability|tolerability
1456915|NCT00941239|Healthy volunteers|healthy volunteers
1456916|NCT00941226|Cerebral Palsy|cerebral palsy
1456917|NCT00941226|Caregivers|caregivers
1456918|NCT00941226|Quality of Life|quality of life
1456919|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
1456920|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
1456921|NCT00941187|pulmonary embolism|pulmonary embolism
1456922|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
1456923|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
1456924|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
1456925|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
1456926|NCT00941174|Folate Bioavailability|folate bioavailability
1456927|NCT00941122|MRSA, VRE|mrsa, vre
1456928|NCT00941109|MDS|mds
1456929|NCT00941096|Glaucoma|glaucoma
1456930|NCT00941096|Ocular Hypertension|ocular hypertension
1456931|NCT00941096|Lumigan|lumigan
1456932|NCT00941096|Ganfort|ganfort
1456933|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
1456934|NCT00941083|Treatment Experienced|treatment experienced
1456935|NCT00941083|HIV-1 Infections|hiv-1 infections
1456936|NCT00941044|non-invasive ventilation|non-invasive ventilation
1456937|NCT00941044|diaphragm|diaphragm
1456938|NCT00941044|electrical activity|electrical activity
1456939|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
1456940|NCT00941044|volunteers|volunteers
1456941|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
1456942|NCT00941031|AIN457|ain457
1456943|NCT00941031|dermatology|dermatology
1456944|NCT00941018|Resolvins|resolvins
1456945|NCT00941018|RvE1|rve1
1456946|NCT00941018|Healthy volunteers|healthy volunteers
1456947|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
1456948|NCT00940979|Infection prophylaxis|infection prophylaxis
1456949|NCT00940979|Postoperative wound infection|postoperative wound infection
1456950|NCT00940979|Arterial bypass surgery|arterial bypass surgery
1456951|NCT00940966|ADA diet|ada diet
1456952|NCT00940966|low carbohydrate diet|low carbohydrate diet
1456953|NCT00940966|Metabolic syndrome|metabolic syndrome
1456954|NCT00940927|Albuterol|albuterol
1456955|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
1456956|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
1456957|NCT00940927|Maximum effective dose|maximum effective dose
1456958|NCT00940927|Metered dose inhaler|metered dose inhaler
1456959|NCT00940927|Nebulizer|nebulizer
1456960|NCT00940914|Parkinson's disease|parkinson's disease
1456961|NCT00940914|pain|pain
1456962|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
1456963|NCT00940901|priapism|priapism
1456964|NCT00940901|sickle cell disease|sickle cell disease
1456965|NCT00940901|sildenafil|sildenafil
1456966|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
1456967|NCT00940888|ICD|icd
1456968|NCT00940888|CRTD|crtd
1456969|NCT00940888|Heart Failure|heart failure
1456970|NCT00940888|DF4|df4
1456971|NCT00940862|psoriasis|psoriasis
1456972|NCT00940862|vascular inflammation|vascular inflammation
1456973|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
1456974|NCT00940836|Anti-cold|anti-cold
1456975|NCT00940836|Cold preparation|cold preparation
1456976|NCT00940836|RCT|rct
1456977|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
1456978|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
1456979|NCT00940823|Ahmed Valve|ahmed valve
1456980|NCT00940823|Baerveldt Tube|baerveldt tube
1456981|NCT00940823|Refractory Glaucoma|refractory glaucoma
1456982|NCT00940797|diabetes|diabetes
1456983|NCT00940797|Type 2|type 2
1456984|NCT00940797|monotherapy|monotherapy
1456985|NCT00940797|antidiabetics|antidiabetics
1456986|NCT00940797|metformin|metformin
1456987|NCT00940771|HIV|hiv
1456988|NCT00940771|Lipids|lipids
1456989|NCT00940771|Atazanavir|atazanavir
1456990|NCT00940771|Pediatric|pediatric
1456991|NCT00940771|treatment experienced|treatment experienced
1456992|NCT00940745|HICH|hich
1456993|NCT00940745|Suction drainages|suction drainages
1456994|NCT00940745|TTAC|ttac
1456995|NCT00940732|Help-seeking|help-seeking
1456996|NCT00940732|Mental Health|mental health
1456997|NCT00940732|Athletes|athletes
1456998|NCT00940719|Multiple Sclerosis|multiple sclerosis
1456999|NCT00940719|Regulatory T cell function|regulatory t cell function
1457002|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
1457003|NCT00940706|Cerebral Palsy|cerebral palsy
1457004|NCT00940706|Activity monitoring|activity monitoring
1457005|NCT00940706|Treadmill|treadmill
1457006|NCT00940706|Group training|group training
1457007|NCT00940706|Physical active life style|physical active life style
1457008|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1457009|NCT00940693|Duloxetine|duloxetine
1457010|NCT00940693|Adult|adult
1457011|NCT00940693|ADDH|addh
1457012|NCT00940693|ADHD|adhd
1457013|NCT00940680|Amlodipine|amlodipine
1457014|NCT00940680|Losartan|losartan
1457015|NCT00940680|hypertension|hypertension
1457016|NCT00940667|Amlodipine|amlodipine
1457017|NCT00940667|Losartan|losartan
1457018|NCT00940667|hypertension|hypertension
1457019|NCT00940654|Fever|fever
1457020|NCT00940654|Antipyretic|antipyretic
1457021|NCT00940654|Infection|infection
1457022|NCT00940654|Mortality|mortality
1457023|NCT00940654|Cooling|cooling
1457024|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
1457025|NCT00940654|Acetaminophen|acetaminophen
1457026|NCT00940654|Steroid|steroid
1457027|NCT00940654|ICU|icu
1457028|NCT00940654|Intensive care|intensive care
1457029|NCT00940654|Critically ill|critically ill
1457030|NCT00940641|Healthy Volunteer|healthy volunteer
1457031|NCT00940615|traumatic brain injury|traumatic brain injury
1457032|NCT00940615|aerobic exercise|aerobic exercise
1457033|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
1457034|NCT00940615|Neuropsychology|neuropsychology
1457035|NCT00940615|Rehabilitation|rehabilitation
1457036|NCT00940602|TELESTO|telesto
1457037|NCT00940602|MDS Study|mds study
1457038|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
1457039|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
1457040|NCT00940589|Alzheimer's Disease|alzheimer's disease
1457041|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1457042|NCT00940589|cognitive function|cognitive function
1457043|NCT00940589|Circadin|circadin
1457044|NCT00940589|Sleep disturbances|sleep disturbances
1457045|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
1457046|NCT00940563|GIST|gist
1457047|NCT00940563|imatinib|imatinib
1457048|NCT00940563|advanced GIST|advanced gist
1457049|NCT00940537|Obese|obese
1457050|NCT00940537|MRS|mrs
1457051|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
1457052|NCT00940537|MR spectroscopy|mr spectroscopy
1457053|NCT00940524|Leukemia|leukemia
1457054|NCT00940524|ALL|all
1457055|NCT00940524|ALLOPURINOL|allopurinol
1457056|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
1457057|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1457058|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
1457059|NCT00940524|DACTINOMYCIN|dactinomycin
1457060|NCT00940524|DASATINIB|dasatinib
1457061|NCT00940524|DEXAMETHASONE|dexamethasone
1457062|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
1457063|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
1457064|NCT00940524|MERCAPTOPURINE|mercaptopurine
1457065|NCT00940524|METHOTREXATE|methotrexate
1457066|NCT00940524|MITOXANTRONE|mitoxantrone
1457067|NCT00940524|PEGASPERGASE|pegaspergase
1457068|NCT00940524|VINCRISTINE|vincristine
1457069|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
1457070|NCT00940498|Phase 1|phase 1
1457071|NCT00940498|Dose Finding|dose finding
1457072|NCT00940498|Solid Tumors|solid tumors
1457073|NCT00940498|Tumors|tumors
1457074|NCT00940498|PF-05212384|pf-05212384
1457075|NCT00940472|type 2 diabetes|type 2 diabetes
1457076|NCT00940472|monotherapy|monotherapy
1457077|NCT00940472|antidiabetics|antidiabetics
1457078|NCT00940472|metformin|metformin
1457079|NCT00940459|contact lenses|contact lenses
1457080|NCT00940459|conjunctival staining|conjunctival staining
1457081|NCT00940459|contact lens wear|contact lens wear
1457082|NCT00940446|Insorb staples|insorb staples
1457083|NCT00940446|Metal Staples|metal staples
1457084|NCT00940433|Minimally invasive|minimally invasive
1457085|NCT00940433|Inguinal hernia|inguinal hernia
1457086|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
1457087|NCT00940407|dry AMD|dry amd
1457088|NCT00940407|light treatment|light treatment
1457089|NCT00940407|ARMD|armd
1457090|NCT00940407|photobiomodulation|photobiomodulation
1457091|NCT00940407|macular|macular
1457092|NCT00940407|eye disease|eye disease
1457093|NCT00940407|ageing eye disease|ageing eye disease
1457094|NCT00940394|mutual support group|mutual support group
1457095|NCT00940394|psychoeducation group|psychoeducation group
1457096|NCT00940394|family caregivers|family caregivers
1457097|NCT00940394|schizophrenia|schizophrenia
1457098|NCT00940381|Advanced Malignancies|advanced malignancies
1457099|NCT00940381|Sirolimus|sirolimus
1457100|NCT00940381|Rapamune|rapamune
1457101|NCT00940381|Cetuximab|cetuximab
1457102|NCT00940381|C225|c225
1457103|NCT00940381|Erbitux|erbitux
1457104|NCT00940381|IMC-225|imc-225
1457105|NCT00940368|Nausea|nausea
1457106|NCT00940368|Vomiting|vomiting
1457107|NCT00940368|Chemotherapy|chemotherapy
1457108|NCT00940355|COPD|copd
1457109|NCT00940355|Health Status|health status
1457110|NCT00940355|Intervention|intervention
1457111|NCT00940355|Secondary prevention|secondary prevention
1457112|NCT00940355|patient-tailored treatment|patient-tailored treatment
1457113|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1457114|NCT00940342|Rituximab|rituximab
1457115|NCT00940342|Leukemia|leukemia
1457116|NCT00940342|Sargramostim|sargramostim
1457117|NCT00940342|GM-CSF|gm-csf
1457118|NCT00940329|Drug interactions|drug interactions
1457119|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
1457120|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
1457121|NCT00940329|Formoterol|formoterol
1457122|NCT00940329|Healthy subjects|healthy subjects
1457123|NCT00940329|Phase I study|phase i study
1457124|NCT00940329|Roflumilast|roflumilast
1457125|NCT00940316|recurrent colon cancer|recurrent colon cancer
1457126|NCT00940316|stage IV colon cancer|stage iv colon cancer
1457127|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
1457128|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
1457129|NCT00940290|practice guideline as topic|practice guideline as topic
1457130|NCT00940290|decision making|decision making
1457131|NCT00940290|evidence based medicine|evidence based medicine
1457132|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
1457133|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
1457134|NCT00940251|Ayurvedic formulation|ayurvedic formulation
1457135|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
1457136|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
1457137|NCT00940251|antidiabetic|antidiabetic
1457138|NCT00940225|Breast Cancer|breast cancer
1457139|NCT00940225|Melanoma|melanoma
1457140|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
1457141|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1457142|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
1457143|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1457144|NCT00940225|Ovarian Cancer|ovarian cancer
1457145|NCT00940225|Pancreatic Cancer|pancreatic cancer
1457146|NCT00940225|Prostate Cancer|prostate cancer
1457147|NCT00940212|Safety|safety
1457148|NCT00940212|tolerability|tolerability
1457149|NCT00940212|healthy|healthy
1457150|NCT00940212|pharmacokinetics|pharmacokinetics
1457151|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
1457152|NCT00940173|xenotransplantation|xenotransplantation
1457153|NCT00940173|type I diabetes|type i diabetes
1457154|NCT00940173|porcine islets|porcine islets
1457155|NCT00940160|Asthma|asthma
1457156|NCT00940134|obesity|obesity
1457157|NCT00940134|energy expenditure|energy expenditure
1457158|NCT00940134|incretins|incretins
1457159|NCT00940134|appetite regulation|appetite regulation
1457160|NCT00940134|GLP-1|glp-1
1457161|NCT00940134|PYY|pyy
1457162|NCT00940134|ad libitum energy intake|ad libitum energy intake
1457163|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
1457164|NCT00940121|pharmacokinetics|pharmacokinetics
1457165|NCT00940121|YM178|ym178
1457166|NCT00940121|mirabegron|mirabegron
1457167|NCT00940121|IV infusion|iv infusion
1457168|NCT00940121|oral administration|oral administration
1457169|NCT00940095|Subarachnoid|subarachnoid
1457170|NCT00940095|Aneurysmal|aneurysmal
1457171|NCT00940095|surgical clipping|surgical clipping
1457172|NCT00940095|PIVLAZ|pivlaz
1457173|NCT00940095|vasospasm|vasospasm
1457174|NCT00940095|cerebral vasospasm|cerebral vasospasm
1457175|NCT00940095|clazosentan|clazosentan
1457176|NCT00940095|Actelion|actelion
1457177|NCT00940095|Hemorrhage|hemorrhage
1457178|NCT00940082|Diabetes;|diabetes;
1457179|NCT00940082|Echocardiography;|echocardiography;
1457180|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
1457181|NCT00940082|homocysteine;|homocysteine;
1457182|NCT00940082|TNF-α|tnf-α
1457183|NCT00940069|TS|ts
1457184|NCT00940069|polymorphism|polymorphism
1457185|NCT00940069|lung cancer|lung cancer
1457186|NCT00940069|adenocarcinoma|adenocarcinoma
1457187|NCT00940069|pemetrexed|pemetrexed
1457188|NCT00940056|Atrial fibrillation|atrial fibrillation
1457189|NCT00940056|Ablation|ablation
1457190|NCT00940056|Thoracoscopy|thoracoscopy
1457191|NCT00940056|Atrial function|atrial function
1457192|NCT00940043|bedside test|bedside test
1457193|NCT00940043|interleukins|interleukins
1457194|NCT00940043|inflammation|inflammation
1457195|NCT00940043|vaginal secretions|vaginal secretions
1457196|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
1457197|NCT00940030|enema|enema
1457198|NCT00940017|PK|pk
1457199|NCT00940017|fungal infection|fungal infection
1457200|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
1457201|NCT00940004|melanoma|melanoma
1457202|NCT00940004|toll like receptor ligands|toll like receptor ligands
1457203|NCT00940004|vaccines|vaccines
1457204|NCT00939991|GBM|gbm
1457205|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1457206|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
1457207|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
1457208|NCT00939952|ertapenem|ertapenem
1457209|NCT00939952|CAPD|capd
1457210|NCT00939952|dialysis|dialysis
1457211|NCT00939913|contrast nephropathy|contrast nephropathy
1457212|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
1457213|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
1457214|NCT00939900|bisphosphonate|bisphosphonate
1457215|NCT00939900|collapse|collapse
1457216|NCT00939874|HIV+|hiv+
1457217|NCT00939874|Raltegravir|raltegravir
1457218|NCT00939874|Tenofovir|tenofovir
1457219|NCT00939874|osteopenia|osteopenia
1457220|NCT00939874|osteoporosis|osteoporosis
1457221|NCT00939874|bone markers|bone markers
1457222|NCT00939874|treatment experienced|treatment experienced
1457223|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
1457224|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
1457225|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
1457226|NCT00939861|morbidity|morbidity
1457227|NCT00939861|fertility|fertility
1457228|NCT00939848|Disease-Free Survival|disease-free survival
1457229|NCT00939770|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1457230|NCT00939770|recurrent neuroblastoma|recurrent neuroblastoma
1457231|NCT00939770|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1457232|NCT00939770|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1457233|NCT00939770|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1457234|NCT00939770|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1457235|NCT00939770|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1457236|NCT00939770|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
1457237|NCT00939770|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
1457238|NCT00939770|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
1457239|NCT00939770|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
1457240|NCT00939770|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
1457241|NCT00939770|recurrent childhood glioblastoma|recurrent childhood glioblastoma
1457242|NCT00939770|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
1457243|NCT00939770|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
1457244|NCT00939770|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
1457245|NCT00939770|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
1457246|NCT00939770|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
1457247|NCT00939770|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
1457248|NCT00939770|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
1457249|NCT00939770|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
1457250|NCT00939770|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1457251|NCT00939770|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1457252|NCT00939770|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1457253|NCT00939770|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1457254|NCT00939770|recurrent childhood ependymoma|recurrent childhood ependymoma
1457255|NCT00939770|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1457256|NCT00939770|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1457440|NCT00938977|Adipokines|adipokines
1457257|NCT00939770|childhood choroid plexus tumor|childhood choroid plexus tumor
1457258|NCT00939770|childhood craniopharyngioma|childhood craniopharyngioma
1457259|NCT00939770|childhood ependymoblastoma|childhood ependymoblastoma
1457260|NCT00939770|childhood medulloepithelioma|childhood medulloepithelioma
1457261|NCT00939770|childhood grade I meningioma|childhood grade i meningioma
1457262|NCT00939770|childhood grade II meningioma|childhood grade ii meningioma
1457263|NCT00939770|childhood grade III meningioma|childhood grade iii meningioma
1457264|NCT00939770|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1457265|NCT00939770|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
1457266|NCT00939770|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1457267|NCT00939770|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1457268|NCT00939770|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1457269|NCT00939770|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1457270|NCT00939770|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1457271|NCT00939770|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1457272|NCT00939770|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1457273|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
1457274|NCT00939757|pharmacokinetics|pharmacokinetics
1457276|NCT00939757|mirabegron|mirabegron
1457277|NCT00939757|food|food
1457278|NCT00939744|contractile activity|contractile activity
1457279|NCT00939744|eicosanoids|eicosanoids
1457280|NCT00939744|pregnant women|pregnant women
1457281|NCT00939744|obstetrics complications|obstetrics complications
1457282|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
1457283|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
1457284|NCT00939679|obesity|obesity
1457285|NCT00939679|bariatric surgery|bariatric surgery
1457286|NCT00939679|energy expenditure|energy expenditure
1457287|NCT00939679|incretins|incretins
1457288|NCT00939679|appetite regulation|appetite regulation
1457289|NCT00939679|body composition|body composition
1457290|NCT00939679|GLP-1|glp-1
1457291|NCT00939666|Rectal cancer|rectal cancer
1457292|NCT00939666|Chemoradiation|chemoradiation
1457293|NCT00939666|Response|response
1457294|NCT00939666|Wait-and-see policy|wait-and-see policy
1457295|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
1457296|NCT00939653|relapsed|relapsed
1457297|NCT00939653|relapse|relapse
1457298|NCT00939653|refractory|refractory
1457299|NCT00939653|AML|aml
1457300|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
1457301|NCT00939653|Relapsed AML|relapsed aml
1457302|NCT00939640|Diet|diet
1457303|NCT00939640|Sodium|sodium
1457304|NCT00939640|Hypertension|hypertension
1457305|NCT00939640|Potassium|potassium
1457306|NCT00939640|Antioxidants|antioxidants
1457307|NCT00939640|congestive heart failure|congestive heart failure
1457308|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1457309|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
1457310|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
1457311|NCT00939601|OSA|osa
1457312|NCT00939601|Adherence|adherence
1457313|NCT00939601|CPAP|cpap
1457314|NCT00939601|Cognition|cognition
1457315|NCT00939588|Aliskiren,|aliskiren,
1457316|NCT00939588|hypertension,|hypertension,
1457317|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1457318|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
1457319|NCT00939562|Bioequivalence|bioequivalence
1457320|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
1457321|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
1457322|NCT00939523|prolactinomas|prolactinomas
1457323|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
1457324|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
1457325|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
1457326|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1457327|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1457328|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
1457329|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
1457330|NCT00939432|incontinence|incontinence
1457331|NCT00939432|urinary|urinary
1457332|NCT00939432|taboo|taboo
1457333|NCT00939432|shame|shame
1457334|NCT00939432|embarrassment|embarrassment
1457335|NCT00939432|treatment|treatment
1457336|NCT00939432|depression|depression
1457337|NCT00939432|cancer|cancer
1457338|NCT00939419|Tuberculosis care|tuberculosis care
1457339|NCT00939419|community tuberculosis care|community tuberculosis care
1457340|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
1457341|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1457342|NCT00939380|bone marrow transplant|bone marrow transplant
1457343|NCT00939380|children|children
1457344|NCT00939380|parents|parents
1457345|NCT00939380|counseling|counseling
1457346|NCT00939380|depression|depression
1457637|NCT00938028|toddler|toddler
1457347|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
1457348|NCT00939341|Symbicort SMART|symbicort smart
1457349|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1457350|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1457351|NCT00939315|Glioma, diagnosis|glioma, diagnosis
1457352|NCT00939315|Imaging|imaging
1457353|NCT00939315|Positron emission tomography|positron emission tomography
1457354|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
1457355|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1457356|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
1457357|NCT00939276|cataract surgery|cataract surgery
1457358|NCT00939276|macular edema|macular edema
1457359|NCT00939276|prevention|prevention
1457360|NCT00939263|deglutition disorders|deglutition disorders
1457361|NCT00939263|esophageal diseases|esophageal diseases
1457362|NCT00939263|eosinophilia|eosinophilia
1457363|NCT00939250|Diabetes|diabetes
1457364|NCT00939250|Depression|depression
1457365|NCT00939250|Disease Self Management|disease self management
1457366|NCT00939250|Measurement Based Care|measurement based care
1457367|NCT00939237|Coronary heart disease|coronary heart disease
1457368|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
1457369|NCT00939237|Biomarkers|biomarkers
1457370|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
1457371|NCT00939224|Regional oxygen saturation|regional oxygen saturation
1457372|NCT00939224|Pediatrics|pediatrics
1457373|NCT00939224|Cardiac catheterization|cardiac catheterization
1457374|NCT00939224|Congenital heart disease|congenital heart disease
1457375|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1457376|NCT00939211|efficacy|efficacy
1457377|NCT00939211|safety|safety
1457378|NCT00939211|inhalation|inhalation
1457379|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
1457380|NCT00939198|Hookworm|hookworm
1457381|NCT00939198|Allergy|allergy
1457382|NCT00939198|Vaccine|vaccine
1457383|NCT00939198|Skin Test|skin test
1457384|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
1457385|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
1457386|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
1457387|NCT00939172|Solid tumor|solid tumor
1457388|NCT00939172|Lymphoma|lymphoma
1600137|NCT00393692|drusen|drusen
1457389|NCT00939172|TTP607|ttp607
1457390|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
1457391|NCT00939159|MDS|mds
1457392|NCT00939159|Cancer|cancer
1457393|NCT00939159|LBH589|lbh589
1457394|NCT00939146|self management|self management
1457395|NCT00939146|quality of life|quality of life
1457396|NCT00939146|end of life|end of life
1457397|NCT00939133|acne|acne
1457398|NCT00939133|tretinoin|tretinoin
1457399|NCT00939133|isotretinoin|isotretinoin
1457400|NCT00939133|recurrence|recurrence
1457401|NCT00939133|Retin A micro|retin a micro
1457402|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1457403|NCT00939120|dutasteride|dutasteride
1457404|NCT00939120|tolterodine ER|tolterodine er
1457405|NCT00939107|low back pain|low back pain
1457406|NCT00939107|Intervertebral disc|intervertebral disc
1457407|NCT00939107|McKenzie|mckenzie
1457408|NCT00939107|Physical Therapy|physical therapy
1457409|NCT00939107|Spinal manipulation|spinal manipulation
1457410|NCT00939107|Chiropractics|chiropractics
1457411|NCT00939107|Patient education|patient education
1457412|NCT00939107|Exercise therapy|exercise therapy
1457413|NCT00939107|Random allocation|random allocation
1457414|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
1457415|NCT00939094|Allodynia|allodynia
1457416|NCT00939094|Efficacy|efficacy
1457417|NCT00939094|analgesia|analgesia
1457418|NCT00939094|Neuropathic|neuropathic
1457419|NCT00939081|Obesity|obesity
1457420|NCT00939081|Women's health|women's health
1457421|NCT00939081|Minority health|minority health
1457422|NCT00939081|Obesity prevention|obesity prevention
1457423|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
1457424|NCT00939029|tobacco use|tobacco use
1457425|NCT00939029|smokeless tobacco|smokeless tobacco
1457426|NCT00939029|chewing tobacco|chewing tobacco
1457427|NCT00939029|snuff|snuff
1457428|NCT00939029|nicotine replacement|nicotine replacement
1457429|NCT00939029|tobacco dependence|tobacco dependence
1457430|NCT00939029|tobacco cessation|tobacco cessation
1457431|NCT00939029|tobacco abstinence|tobacco abstinence
1457432|NCT00939016|Dietary Assessment|dietary assessment
1457433|NCT00939016|24-hour dietary recall|24-hour dietary recall
1457434|NCT00939016|Dietary Restraint|dietary restraint
1457435|NCT00939016|Social Desirability|social desirability
1457436|NCT00939016|Portion estimation|portion estimation
1457437|NCT00939016|Underreporting|underreporting
1457438|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
1457439|NCT00938977|cytokines|cytokines
1457441|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
1457442|NCT00938977|bilevel support ventilation|bilevel support ventilation
1457443|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
1457444|NCT00938964|Cognition|cognition
1457445|NCT00938951|Dry Eye|dry eye
1457446|NCT00938951|Visual Performance|visual performance
1457447|NCT00938938|risk communication|risk communication
1457448|NCT00938938|medical reporting|medical reporting
1457449|NCT00938938|Mass media|mass media
1457450|NCT00938925|aggressive debridement|aggressive debridement
1457451|NCT00938925|nail lacquer|nail lacquer
1457452|NCT00938925|onychomycosis|onychomycosis
1457453|NCT00938925|podiatry|podiatry
1457454|NCT00938925|chiropody|chiropody
1457455|NCT00938925|podiatry care|podiatry care
1457456|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
1457457|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
1457458|NCT00938899|TMC435350-C101|tmc435350-c101
1457459|NCT00938899|TMC435350|tmc435350
1457460|NCT00938899|HCV|hcv
1457461|NCT00938873|MBCT|mbct
1457462|NCT00938873|identity|identity
1457463|NCT00938873|depression|depression
1457464|NCT00938873|recurrent|recurrent
1457465|NCT00938873|homework|homework
1457466|NCT00938860|Hepatitis C|hepatitis c
1457467|NCT00938860|liver transplantation|liver transplantation
1457468|NCT00938860|anti-viral therapy|anti-viral therapy
1457469|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
1457470|NCT00938847|myocardial infarction|myocardial infarction
1457471|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
1457472|NCT00938808|Osteoarthritis|osteoarthritis
1457473|NCT00938808|Obesity|obesity
1457474|NCT00938808|Weight loss|weight loss
1457475|NCT00938808|Dietary instruction|dietary instruction
1457476|NCT00938808|Formula diet|formula diet
1457477|NCT00938808|Attention|attention
1457478|NCT00938795|liver disease|liver disease
1457479|NCT00938795|uncertainty|uncertainty
1457480|NCT00938795|self management|self management
1457481|NCT00938769|cancer|cancer
1457482|NCT00938769|caregiver|caregiver
1457483|NCT00938769|symptom|symptom
1457484|NCT00938769|self management|self management
1457485|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
1457486|NCT00938756|male breast cancer|male breast cancer
1457487|NCT00938756|stage IV breast cancer|stage iv breast cancer
1457488|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
1457489|NCT00938756|adult meningioma|adult meningioma
1457490|NCT00938743|ADHD|adhd
1457491|NCT00938743|adults|adults
1457492|NCT00938743|driving performance|driving performance
1457493|NCT00938743|atomoxetine|atomoxetine
1457494|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
1457495|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
1457496|NCT00938730|Stroke|stroke
1457497|NCT00938730|Thromboembolism|thromboembolism
1457498|NCT00938730|Transient Ischemic attack|transient ischemic attack
1457499|NCT00938730|Anticoagulants|anticoagulants
1457500|NCT00938730|Prevention|prevention
1457501|NCT00938730|YM150|ym150
1457502|NCT00938730|Warfarin|warfarin
1457503|NCT00938717|IBS|ibs
1457504|NCT00938691|Scar|scar
1457505|NCT00938691|Appearance|appearance
1457506|NCT00938691|Spread|spread
1457507|NCT00938678|Healthy volunteers|healthy volunteers
1457508|NCT00938665|Alzheimer|alzheimer
1457509|NCT00938665|Memory disorder|memory disorder
1457510|NCT00938665|dementia|dementia
1457511|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
1457512|NCT00938665|vascular dementia|vascular dementia
1457513|NCT00938665|front temporal dementia|front temporal dementia
1457514|NCT00938652|triple negative breast cancer|triple negative breast cancer
1457515|NCT00938652|metastatic breast cancer|metastatic breast cancer
1457516|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
1457517|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
1457518|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
1457519|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
1457520|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
1457521|NCT00938613|SAR|sar
1457522|NCT00938600|pharmacokinetics|pharmacokinetics
1457523|NCT00938600|safety|safety
1457524|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
1457525|NCT00938561|Chronic Kidney Disease|chronic kidney disease
1457526|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
1457527|NCT00938561|Kidney function|kidney function
1457528|NCT00938561|Markers|markers
1457529|NCT00938548|mastectomy|mastectomy
1457530|NCT00938548|pain, postoperative|pain, postoperative
1457531|NCT00938548|pregabalin|pregabalin
1457532|NCT00938535|Obesity|obesity
1457533|NCT00938535|Women's health|women's health
1457534|NCT00938535|Minority health|minority health
1457535|NCT00938535|Obesity prevention|obesity prevention
1457536|NCT00938522|Cilostazol loading|cilostazol loading
1457537|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1457538|NCT00938509|IBUPROFEN|ibuprofen
1457539|NCT00938509|CHILDREN|children
1457540|NCT00938509|FEVER|fever
1457541|NCT00938483|infant formula|infant formula
1457542|NCT00938483|cow's milk allergy|cow's milk allergy
1457543|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1457544|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1457545|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
1457546|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
1457547|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
1457548|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
1457549|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
1457550|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
1457551|NCT00938457|protocol specific|protocol specific
1457552|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
1457553|NCT00938431|Lacosamide|lacosamide
1457554|NCT00938431|Vimpat|vimpat
1457555|NCT00938431|Children|children
1457556|NCT00938431|Epilepsy|epilepsy
1457557|NCT00938431|Seizures|seizures
1457558|NCT00938431|Anti-epileptic|anti-epileptic
1457559|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
1457560|NCT00938405|colesevelam|colesevelam
1457561|NCT00938405|LDL|ldl
1457562|NCT00938405|cholesterol|cholesterol
1457563|NCT00938405|A1c|a1c
1457564|NCT00938405|target range glucose values|target range glucose values
1457565|NCT00938392|influenza infection|influenza infection
1457566|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
1457567|NCT00938379|mosquito|mosquito
1457568|NCT00938379|repellent|repellent
1457569|NCT00938379|vector control|vector control
1457570|NCT00938379|malaria|malaria
1457836|NCT00937365|Mind body|mind body
1457571|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
1457572|NCT00938340|Cardiovascular Disease|cardiovascular disease
1457573|NCT00938327|Gastroenteritis|gastroenteritis
1457574|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
1457575|NCT00938288|Antithrombin|antithrombin
1457576|NCT00938288|Thrombosis|thrombosis
1457577|NCT00938288|Pharmacokinetics|pharmacokinetics
1457578|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
1457579|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
1457580|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
1457581|NCT00938236|lung transplant|lung transplant
1457582|NCT00938236|lung transplant recipient|lung transplant recipient
1457583|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1457584|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
1457585|NCT00938236|single lung transplant|single lung transplant
1457586|NCT00938236|double lung transplant|double lung transplant
1457587|NCT00938236|heart-lung transplant|heart-lung transplant
1457589|NCT00938223|melanoma|melanoma
1457590|NCT00938223|peptide|peptide
1457591|NCT00938223|vaccine|vaccine
1457592|NCT00938223|adjuvant|adjuvant
1457593|NCT00938223|advanced|advanced
1457594|NCT00938210|Colonic surgery|colonic surgery
1457595|NCT00938210|Postoperative care|postoperative care
1457596|NCT00938210|Fatigue|fatigue
1457597|NCT00938210|Physical function|physical function
1457598|NCT00938210|Quality of life|quality of life
1457599|NCT00938197|Fimasartan|fimasartan
1457600|NCT00938197|Drug interaction|drug interaction
1457601|NCT00938184|tolerance|tolerance
1457602|NCT00938184|single dose|single dose
1457603|NCT00938184|paroxetine|paroxetine
1457604|NCT00938184|controlled-release tablet|controlled-release tablet
1457605|NCT00938184|safety|safety
1457606|NCT00938184|pharmacokinetics|pharmacokinetics
1457607|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
1457608|NCT00938171|Cytokine|cytokine
1457609|NCT00938171|Anesthesia|anesthesia
1457610|NCT00938171|Local anesthesia|local anesthesia
1457611|NCT00938171|surgery|surgery
1457612|NCT00938171|breast cancer|breast cancer
1457613|NCT00938158|albiglutide|albiglutide
1457614|NCT00938158|hemodialysis|hemodialysis
1457615|NCT00938158|pharmacokinetics|pharmacokinetics
1457616|NCT00938158|renal|renal
1457617|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
1457618|NCT00938145|stage II bladder cancer|stage ii bladder cancer
1457619|NCT00938145|stage III bladder cancer|stage iii bladder cancer
1457620|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
1457621|NCT00938132|fimasartan|fimasartan
1457622|NCT00938132|drug interaction|drug interaction
1457623|NCT00938119|Cardiovascular disease|cardiovascular disease
1457624|NCT00938119|Diabetes|diabetes
1457625|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
1457626|NCT00938106|cervix cancer|cervix cancer
1457627|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
1457628|NCT00938067|Injuries, Trauma|injuries, trauma
1457629|NCT00938054|Outcome|outcome
1457630|NCT00938054|Autism|autism
1457631|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
1457632|NCT00938028|microbiome|microbiome
1457633|NCT00938028|metabolome|metabolome
1457634|NCT00938028|stool|stool
1457635|NCT00938028|fecal samples|fecal samples
1457636|NCT00938028|handling|handling
1457638|NCT00938015|postmarketing surveillance|postmarketing surveillance
1457639|NCT00938015|Enbrel|enbrel
1457640|NCT00938015|psoriatic arthritis|psoriatic arthritis
1457641|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1457642|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1457643|NCT00937989|male breast cancer|male breast cancer
1457644|NCT00937989|stage I breast cancer|stage i breast cancer
1457645|NCT00937989|stage II breast cancer|stage ii breast cancer
1457646|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
1457647|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
1457648|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
1457649|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
1457650|NCT00937963|cholesterol|cholesterol
1457651|NCT00937963|cardiovascular|cardiovascular
1457652|NCT00937963|CVD|cvd
1457653|NCT00937963|Triglycerides|triglycerides
1457654|NCT00937963|Heart|heart
1457655|NCT00937950|HPV|hpv
1457656|NCT00937950|Papillomavirus|papillomavirus
1457657|NCT00937950|Human papillomavirus|human papillomavirus
1457658|NCT00937950|Cervical cancer|cervical cancer
1457659|NCT00937950|HPV vaccine|hpv vaccine
1457660|NCT00937924|EUS|eus
1457661|NCT00937924|ERCP|ercp
1457662|NCT00937924|Sedation Level|sedation level
1457663|NCT00937924|Adverse Symptoms|adverse symptoms
1457664|NCT00937924|Recovery time|recovery time
1457665|NCT00937911|YM150|ym150
1457666|NCT00937911|Bleeding|bleeding
1457667|NCT00937911|Anticoagulant|anticoagulant
1457668|NCT00937911|Venous thromboembolism|venous thromboembolism
1457669|NCT00937911|FXa inhibitor|fxa inhibitor
1457670|NCT00937898|lean beef|lean beef
1457671|NCT00937898|cholesterol|cholesterol
1457672|NCT00937898|lipids|lipids
1457673|NCT00937898|diet intervention|diet intervention
1457674|NCT00937885|Reminiscence|reminiscence
1457675|NCT00937885|Nursing home staff|nursing home staff
1457676|NCT00937885|Nursing home residents|nursing home residents
1457677|NCT00937885|Elderly|elderly
1457678|NCT00937846|Cognitive impairment|cognitive impairment
1457679|NCT00937846|Schizophrenia|schizophrenia
1457680|NCT00937846|Alzheimer's Disease|alzheimer's disease
1457681|NCT00937846|PET|pet
1457682|NCT00937833|prostate cancer|prostate cancer
1457683|NCT00937833|prostatectomy|prostatectomy
1457684|NCT00937833|incontinence|incontinence
1457685|NCT00937820|YM150|ym150
1457686|NCT00937820|Bleeding|bleeding
1457687|NCT00937820|VTE|vte
1457688|NCT00937820|FXa inhibitor|fxa inhibitor
1457689|NCT00937820|Venous thromboembolism|venous thromboembolism
1457690|NCT00937807|hemodynamic stability|hemodynamic stability
1457691|NCT00937807|xenon|xenon
1457692|NCT00937807|carotid surgery|carotid surgery
1457693|NCT00937807|general anesthesia|general anesthesia
1457694|NCT00937781|stage III melanoma|stage iii melanoma
1457695|NCT00937781|recurrent melanoma|recurrent melanoma
1457696|NCT00937755|schizophrenia|schizophrenia
1457697|NCT00937755|antipsychotics|antipsychotics
1457698|NCT00937755|glucose homeostasis|glucose homeostasis
1457699|NCT00937755|metabolic disturbance|metabolic disturbance
1457700|NCT00937742|cardiovascular disease|cardiovascular disease
1457701|NCT00937742|Lycopene|lycopene
1457702|NCT00937742|Tomato|tomato
1457703|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
1457704|NCT00937729|Treatment experienced|treatment experienced
1457705|NCT00937716|schizophrenia|schizophrenia
1457706|NCT00937716|treatment response|treatment response
1457707|NCT00937716|risperidone|risperidone
1457708|NCT00937716|functional magnetic resonance|functional magnetic resonance
1457709|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
1457710|NCT00937690|melanoma|melanoma
1457711|NCT00937690|cutaneous|cutaneous
1457712|NCT00937690|imaging|imaging
1457713|NCT00937677|Tysabri|tysabri
1457714|NCT00937677|VWMTR|vwmtr
1457715|NCT00937664|Phase I|phase i
1457716|NCT00937664|cancer|cancer
1457717|NCT00937664|solid tumors|solid tumors
1457718|NCT00937664|advanced solid malignancies|advanced solid malignancies
1457719|NCT00937664|dose escalation|dose escalation
1457720|NCT00937664|combination treatment|combination treatment
1457721|NCT00937664|CHK inhibitor|chk inhibitor
1457722|NCT00937664|Japanese|japanese
1457723|NCT00937651|Fimasartan|fimasartan
1457724|NCT00937651|Essential Hypertension|essential hypertension
1457725|NCT00937638|Metabolic syndrome|metabolic syndrome
1457726|NCT00937638|Lean Beef|lean beef
1457727|NCT00937638|CVD|cvd
1457728|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
1457729|NCT00937612|Chemotherapy|chemotherapy
1457730|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
1457731|NCT00937612|Surgery|surgery
1457732|NCT00937599|obese|obese
1457733|NCT00937599|brazil nuts|brazil nuts
1457734|NCT00937599|oxidative stress|oxidative stress
1457735|NCT00937599|microcirculatory|microcirculatory
1457736|NCT00937599|metabolic profile|metabolic profile
1457737|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
1457738|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
1457739|NCT00937573|stents|stents
1457740|NCT00937573|mortality|mortality
1457741|NCT00937573|revascularization|revascularization
1457742|NCT00937573|stent thrombosis|stent thrombosis
1457743|NCT00937573|Drug-Eluting Stents|drug-eluting stents
1457744|NCT00937547|cervical cancer|cervical cancer
1457745|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
1457746|NCT00937534|Fimasartan|fimasartan
1457747|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
1457748|NCT00937534|pharmacokinetic|pharmacokinetic
1457749|NCT00937521|Immunogenicity|immunogenicity
1457750|NCT00937521|Meningitis|meningitis
1457751|NCT00937521|Antibody|antibody
1457752|NCT00937521|Infants|infants
1457753|NCT00937508|smoking|smoking
1457754|NCT00937508|quitting|quitting
1457755|NCT00937508|varenicline|varenicline
1457756|NCT00937508|preoperative|preoperative
1457757|NCT00937508|long term abstinence|long term abstinence
1457758|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
1457759|NCT00937469|Children with ADHD|children with adhd
1457760|NCT00937456|Esophagus|esophagus
1457761|NCT00937456|Cancer|cancer
1457762|NCT00937456|Surgery|surgery
1457763|NCT00937456|Laparoscopy|laparoscopy
1457764|NCT00937456|Randomized trial|randomized trial
1457765|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
1457766|NCT00937443|Physical Activity|physical activity
1457767|NCT00937443|Cardiac Heart Failure|cardiac heart failure
1457768|NCT00937443|Exercise Regimen|exercise regimen
1457769|NCT00937443|Cardioreparative Factors|cardioreparative factors
1457770|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
1457771|NCT00937430|Bowel preparation|bowel preparation
1457772|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1457773|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1457774|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1457775|NCT00937417|stage IV breast cancer|stage iv breast cancer
1457776|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1567374|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
1457777|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1457778|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1457779|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1457780|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1457781|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1457782|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1457783|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1457784|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1457785|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1457786|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1457787|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1457788|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1457789|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1457790|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1457791|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1457792|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1457793|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1457794|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1457795|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1457796|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1457797|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1457798|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1457799|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1457800|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1457801|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1457802|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1457803|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1457804|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1457805|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1457806|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1457807|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1458678|NCT00934596|Air emboli|air emboli
1457808|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1457809|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
1457810|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
1457811|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
1457812|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1457813|NCT00937417|insular thyroid cancer|insular thyroid cancer
1457814|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1457815|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
1457816|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1457817|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
1457818|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
1457819|NCT00937417|recurrent breast cancer|recurrent breast cancer
1457820|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
1457821|NCT00937417|male breast cancer|male breast cancer
1457823|NCT00937391|MRI agents|mri agents
1457824|NCT00937391|Magnevist|magnevist
1457825|NCT00937365|Pregnancy|pregnancy
1457826|NCT00937365|Pain|pain
1457827|NCT00937365|Low back pain|low back pain
1457828|NCT00937365|Pubic symphysis pain|pubic symphysis pain
1457829|NCT00937365|CAM|cam
1457830|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
1457831|NCT00937365|Exercise|exercise
1457832|NCT00937365|Chiropractic|chiropractic
1457833|NCT00937365|Spinal manipulation|spinal manipulation
1457834|NCT00937365|Adjustments|adjustments
1457835|NCT00937365|Neuroemotional technique|neuroemotional technique
1457837|NCT00937365|Mind body therapy|mind body therapy
1457838|NCT00937365|Attachment|attachment
1457839|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
1457840|NCT00937365|Intrauterine attachment|intrauterine attachment
1457841|NCT00937365|Heart rate variability|heart rate variability
1457842|NCT00937365|VAS|vas
1457843|NCT00937365|Visual analog scale|visual analog scale
1457844|NCT00937365|Roland Morris Disability Index|roland morris disability index
1457845|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
1457846|NCT00937339|cerebrovascular accident|cerebrovascular accident
1457847|NCT00937339|bone|bone
1457848|NCT00937339|muscle|muscle
1457849|NCT00937339|vibration|vibration
1457851|NCT00937287|African American|african american
1457852|NCT00937287|Rural|rural
1457853|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
1457854|NCT00937274|phage therapy|phage therapy
1457855|NCT00937274|ORS|ors
1457856|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
1457857|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
1457858|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
1457859|NCT00937235|Smoking Cessation|smoking cessation
1457860|NCT00937235|Anxiety|anxiety
1457861|NCT00937235|Behavior Therapy|behavior therapy
1457862|NCT00937235|Varenicline|varenicline
1457863|NCT00937222|diabetes|diabetes
1457864|NCT00937222|cholesterol|cholesterol
1457865|NCT00937222|peanuts|peanuts
1457866|NCT00937222|peanut butter|peanut butter
1457867|NCT00937222|dietary intervention|dietary intervention
1457868|NCT00937222|HDL cholesterol|hdl cholesterol
1457869|NCT00937183|Waldenström macroglobulinemia|waldenström macroglobulinemia
1457870|NCT00937183|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1457871|NCT00937183|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1457872|NCT00937183|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1457873|NCT00937183|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1457874|NCT00937183|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1457875|NCT00937183|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1457876|NCT00937183|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1457877|NCT00937183|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1457878|NCT00937183|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1457879|NCT00937183|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1457880|NCT00937183|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1457881|NCT00937183|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1457882|NCT00937183|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1457883|NCT00937183|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1457884|NCT00937183|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1457885|NCT00937183|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1457886|NCT00937183|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1457887|NCT00937183|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1457888|NCT00937183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1457889|NCT00937183|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1457890|NCT00937183|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1457891|NCT00937183|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1457892|NCT00937183|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1457893|NCT00937183|stage I multiple myeloma|stage i multiple myeloma
1457894|NCT00937183|stage II multiple myeloma|stage ii multiple myeloma
1457895|NCT00937183|stage III multiple myeloma|stage iii multiple myeloma
1457896|NCT00937183|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1457897|NCT00937183|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1457898|NCT00937183|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1457899|NCT00937183|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1457900|NCT00937170|Total Knee Replacement|total knee replacement
1457901|NCT00937170|Gender Specific Design|gender specific design
1457902|NCT00937157|Inflammation|inflammation
1457903|NCT00937157|Multiple Sclerosis|multiple sclerosis
1457904|NCT00937157|Glatiramer Acetate|glatiramer acetate
1457905|NCT00937157|Gd enhancing lesions|gd enhancing lesions
1457906|NCT00937157|1.5T protocol|1.5t protocol
1457907|NCT00937157|3T protocol|3t protocol
1457908|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
1457909|NCT00937157|Lesion activity analysis|lesion activity analysis
1457910|NCT00937157|Copaxone|copaxone
1457911|NCT00937144|endothelial function|endothelial function
1457912|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
1457913|NCT00937118|laparotomy|laparotomy
1457914|NCT00937118|duodenal injury|duodenal injury
1457915|NCT00937118|pancreatic injury|pancreatic injury
1457916|NCT00937118|trauma|trauma
1457917|NCT00937092|Heart Failure|heart failure
1457918|NCT00937092|Dopamine|dopamine
1457919|NCT00937092|Furosemide|furosemide
1457920|NCT00937092|Worsening Renal Function|worsening renal function
1457921|NCT00937092|Hypokalemia|hypokalemia
1457922|NCT00937092|Outcomes|outcomes
1457923|NCT00937092|Prognosis|prognosis
1457924|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
1457925|NCT00937079|Insulinoma imaging|insulinoma imaging
1457926|NCT00937079|Exendin-4|exendin-4
1457927|NCT00937079|molecular imaging|molecular imaging
1457928|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
1457929|NCT00937066|Symbicort|symbicort
1457930|NCT00937053|Neutropenia|neutropenia
1457931|NCT00937053|Transfusions|transfusions
1457932|NCT00937053|Hemoglobin|hemoglobin
1457933|NCT00937053|Bone marrow transplant|bone marrow transplant
1457934|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1457935|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
1457936|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
1457937|NCT00937027|Antifolate|antifolate
1457938|NCT00937027|Psoriasis|psoriasis
1457939|NCT00937027|Antiinflammatory drug|antiinflammatory drug
1457940|NCT00937027|Autoimmune disease|autoimmune disease
1457941|NCT00937027|Treatment|treatment
1457942|NCT00937014|infant formula|infant formula
1457943|NCT00937014|growth|growth
1457944|NCT00937014|weight|weight
1457945|NCT00937001|myopathy|myopathy
1457946|NCT00937001|respiratory failure|respiratory failure
1457947|NCT00937001|cognitive impairment|cognitive impairment
1457948|NCT00937001|delirium|delirium
1457949|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
1457950|NCT00936988|cinacalcet|cinacalcet
1457951|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
1457952|NCT00936962|Meningitis study|meningitis study
1457953|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
1457954|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
1457955|NCT00936949|total hip arthroplasty|total hip arthroplasty
1457956|NCT00936949|posterolateral|posterolateral
1457957|NCT00936949|modified lateral|modified lateral
1457958|NCT00936936|Testis|testis
1457959|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
1457960|NCT00936936|Bevacizumab|bevacizumab
1457961|NCT00936936|Avastin|avastin
1457962|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1457963|NCT00936936|rhuMAb-VEGF|rhumab-vegf
1457964|NCT00936936|Carboplatin|carboplatin
1457965|NCT00936936|Paraplatin|paraplatin
1457966|NCT00936936|Docetaxel|docetaxel
1457967|NCT00936936|Taxotere|taxotere
1457968|NCT00936936|Etoposide|etoposide
1457969|NCT00936936|VePesid|vepesid
1457970|NCT00936936|Gemcitabine|gemcitabine
1457971|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1457972|NCT00936936|Gemzar|gemzar
1457973|NCT00936936|Ifosfamide|ifosfamide
1457974|NCT00936936|Ifex|ifex
1457975|NCT00936936|Melphalan|melphalan
1457976|NCT00936936|Alkeran|alkeran
1457977|NCT00936923|CAPD|capd
1457978|NCT00936923|Diuretics|diuretics
1457979|NCT00936923|Residual Renal Function|residual renal function
1457980|NCT00936923|furosemide|furosemide
1457981|NCT00936910|central line fungal infections|central line fungal infections
1457982|NCT00936910|antifungal lock therapy|antifungal lock therapy
1457983|NCT00936910|Ambisome lock therapy|ambisome lock therapy
1457984|NCT00936884|Opioid Induced Constipation|opioid induced constipation
1457985|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
1457986|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
1457987|NCT00936858|RAD001|rad001
1457988|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
1457989|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1457990|NCT00936832|liver metastases|liver metastases
1457991|NCT00936832|lung metastases|lung metastases
1457992|NCT00936819|Stent|stent
1457993|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
1457994|NCT00936819|nitric oxide|nitric oxide
1457995|NCT00936819|myocardial infarction|myocardial infarction
1457996|NCT00936819|MRI|mri
1457997|NCT00936806|Intracranial tumor patients|intracranial tumor patients
1457998|NCT00936793|Drug Interaction|drug interaction
1457999|NCT00936793|Asthma|asthma
1458000|NCT00936793|HIV|hiv
1458001|NCT00936793|Beclomethasone|beclomethasone
1458002|NCT00936793|Protease Inhibitors|protease inhibitors
1458003|NCT00936793|HV|hv
1458004|NCT00936793|Healthy Volunteer|healthy volunteer
1458005|NCT00936793|HIV Infections|hiv infections
1458006|NCT00936780|Coronary Artery Disease|coronary artery disease
1458007|NCT00936780|Restenosis|restenosis
1458008|NCT00936780|Stent thrombosis|stent thrombosis
1458009|NCT00936780|Coronary stents|coronary stents
1458010|NCT00936780|Angioplasty|angioplasty
1458011|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
1458012|NCT00936767|falciparum malaria|falciparum malaria
1458013|NCT00936767|artemisone|artemisone
1458014|NCT00936767|artesunate|artesunate
1458015|NCT00936767|resistance|resistance
1458016|NCT00936754|Glycemic index|glycemic index
1458017|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
1458018|NCT00936741|Cushing's Disease|cushing's disease
1458019|NCT00936741|Cushing's Syndrome|cushing's syndrome
1458020|NCT00936741|Cushings|cushings
1458021|NCT00936741|Pituitary|pituitary
1458022|NCT00936741|ACTH|acth
1458023|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
1600993|NCT00390559|Gender|gender
1458024|NCT00936741|Ectopic|ectopic
1458025|NCT00936741|Adrenal adenoma|adrenal adenoma
1458026|NCT00936741|Adrenal carcinoma|adrenal carcinoma
1458027|NCT00936741|Adrenal autonomy|adrenal autonomy
1458028|NCT00936741|Cortisol|cortisol
1458029|NCT00936741|Hypercortisolemia|hypercortisolemia
1458030|NCT00936741|Cushingoid|cushingoid
1458031|NCT00936741|Moon facies|moon facies
1458032|NCT00936741|Dorsocervical fat|dorsocervical fat
1458033|NCT00936741|Plethora|plethora
1458034|NCT00936741|Hirsutism|hirsutism
1458035|NCT00936741|Violaceous striae|violaceous striae
1458036|NCT00936741|Hormone|hormone
1458037|NCT00936741|Contraceptive|contraceptive
1458038|NCT00936741|Endocrine|endocrine
1458039|NCT00936741|Cushing Syndrome|cushing syndrome
1458040|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
1458041|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
1458042|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
1458043|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
1458044|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
1458045|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
1458046|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
1458047|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1458048|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
1458049|NCT00936689|Chemoembolization;|chemoembolization;
1458050|NCT00936689|DC-Beads.|dc-beads.
1458051|NCT00936676|parkinson's|parkinson's
1458052|NCT00936676|long-term effects|long-term effects
1458053|NCT00936676|adagio|adagio
1458054|NCT00936676|rasagiline|rasagiline
1458055|NCT00936676|delayed start|delayed start
1458056|NCT00936663|Diabetes|diabetes
1458057|NCT00936663|Kidney Transplant|kidney transplant
1458058|NCT00936663|Sitagliptin|sitagliptin
1458059|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
1458060|NCT00936650|cinacalcet|cinacalcet
1458061|NCT00936624|Persistent asthma|persistent asthma
1458062|NCT00936611|LBH589|lbh589
1458063|NCT00936611|WM|wm
1458064|NCT00936611|panobinostat|panobinostat
1458065|NCT00936611|relapsed|relapsed
1458066|NCT00936611|waldenstrom|waldenstrom
1458067|NCT00936611|macroglobulinemia|macroglobulinemia
1458068|NCT00936598|Sleep|sleep
1458069|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
1458070|NCT00936598|Pain|pain
1458071|NCT00936585|Crohn's Disease|crohn's disease
1458072|NCT00936585|Infusion|infusion
1458073|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
1458074|NCT00936585|Placebo|placebo
1458075|NCT00936585|Crohn Disease|crohn disease
1458076|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
1458077|NCT00936572|Probiotics|probiotics
1458078|NCT00936572|La1|la1
1458079|NCT00936572|BB536|bb536
1458080|NCT00936572|Colorectal surgery|colorectal surgery
1458081|NCT00936572|Intestinal immunity|intestinal immunity
1458082|NCT00936572|Dendritic cells|dendritic cells
1458083|NCT00936572|Lymphocyte|lymphocyte
1458084|NCT00936572|Microbiota|microbiota
1458085|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
1458086|NCT00936559|open surgical technique|open surgical technique
1458087|NCT00936559|safety|safety
1459169|NCT00932269|Immunity|immunity
1458088|NCT00936520|Diabetic Macular Edema|diabetic macular edema
1458089|NCT00936520|DME|dme
1458090|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
1458091|NCT00936520|Ocular Inflammation|ocular inflammation
1458092|NCT00936507|energy density|energy density
1458093|NCT00936507|portion size|portion size
1458094|NCT00936507|child feeding|child feeding
1458095|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
1458096|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
1458097|NCT00936494|snoring|snoring
1458098|NCT00936494|disturbed sleeping|disturbed sleeping
1458099|NCT00936494|open mouth breathing|open mouth breathing
1458100|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
1458101|NCT00936481|OSA|osa
1458102|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
1458103|NCT00936455|telemedicine|telemedicine
1458104|NCT00936455|telephone|telephone
1458105|NCT00936455|outcomes|outcomes
1458106|NCT00936442|Compliance|compliance
1458107|NCT00936442|Early Breast Cancer|early breast cancer
1458108|NCT00936429|Dengue fever|dengue fever
1458109|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
1458110|NCT00936429|Dengue shock syndrome|dengue shock syndrome
1458111|NCT00936429|Vaccine|vaccine
1458112|NCT00936429|Hawaii Biotech|hawaii biotech
1458113|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
1458114|NCT00936416|Renal Blood Flow|renal blood flow
1458115|NCT00936416|MRI|mri
1458116|NCT00936416|Inulin|inulin
1458117|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
1458118|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1458119|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
1458120|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
1458121|NCT00936351|schizophrenia|schizophrenia
1458122|NCT00936351|intervention studies|intervention studies
1458123|NCT00936351|mindfulness meditation|mindfulness meditation
1458124|NCT00936351|vocational rehabilitation|vocational rehabilitation
1458125|NCT00936351|schizoaffective disorder|schizoaffective disorder
1458126|NCT00936351|psychotic disorders|psychotic disorders
1458127|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
1458129|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
1458130|NCT00936299|Adolescents|adolescents
1458131|NCT00936299|Substance Use Disorder|substance use disorder
1458132|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1458133|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
1458134|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1458135|NCT00936286|Respiratory Muscle Training|respiratory muscle training
1458136|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
1458137|NCT00936286|SpiroTiger|spirotiger
1458138|NCT00936286|Polysomnography|polysomnography
1458139|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
1458141|NCT00936273|double loop gain|double loop gain
1458142|NCT00936273|DLI|dli
1458143|NCT00936273|double loop index|double loop index
1458144|NCT00936273|periodic breathing|periodic breathing
1458145|NCT00936273|polysomnography|polysomnography
1458146|NCT00936260|osteoporosis|osteoporosis
1458147|NCT00936260|postmenopausal|postmenopausal
1458148|NCT00936260|alendronate|alendronate
1458149|NCT00936234|CAD|cad
1458150|NCT00936234|diabetes|diabetes
1458151|NCT00936234|SDF-1|sdf-1
1458152|NCT00936234|endothelial function|endothelial function
1458153|NCT00936221|BRAF mutation positive|braf mutation positive
1458154|NCT00936221|advanced melanoma|advanced melanoma
1458155|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
1458156|NCT00936221|Unknown primary melanoma|unknown primary melanoma
1458157|NCT00936195|HIV|hiv
1458158|NCT00936195|pregnancy|pregnancy
1458159|NCT00936195|breastfeeding|breastfeeding
1458160|NCT00936195|PMTCT|pmtct
1458161|NCT00936195|ARV treatment|arv treatment
1458162|NCT00936195|treatment naive|treatment naive
1458163|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
1458164|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
1458165|NCT00936143|infliximab|infliximab
1458166|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
1458167|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
1458168|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
1458169|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
1458170|NCT00936130|Low calorie diet program|low calorie diet program
1458171|NCT00936117|Cancer of the Blood|cancer of the blood
1458172|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
1458173|NCT00936117|Acute Leukemia|acute leukemia
1458174|NCT00936117|AML|aml
1458175|NCT00936117|Fungal infection|fungal infection
1458176|NCT00936117|Prophylaxis|prophylaxis
1458177|NCT00936117|Posaconazole|posaconazole
1458178|NCT00936117|SCH 56592|sch 56592
1458179|NCT00936117|Noxafil|noxafil
1458180|NCT00936117|Chemotherapy|chemotherapy
1458181|NCT00936104|pancreas|pancreas
1458182|NCT00936104|cancer|cancer
1458183|NCT00936104|stem cell|stem cell
1458184|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
1458185|NCT00936091|malnutrition|malnutrition
1458186|NCT00936091|Anemia|anemia
1458187|NCT00936078|kidney transplantation|kidney transplantation
1458188|NCT00936078|cohort study|cohort study
1458189|NCT00936078|qualitative research|qualitative research
1458190|NCT00936078|health services research|health services research
1458191|NCT00936078|hypertension|hypertension
1458192|NCT00936065|Etanercept|etanercept
1458193|NCT00936065|Acitretin|acitretin
1458194|NCT00936065|Psoriasis|psoriasis
1458195|NCT00936052|glioblastomas|glioblastomas
1458196|NCT00936052|GBM|gbm
1458197|NCT00936052|gliosarcoma|gliosarcoma
1458198|NCT00936052|blastoma|blastoma
1458199|NCT00936052|sarcoma|sarcoma
1458200|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
1458201|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
1458202|NCT00936000|alcohol abuse|alcohol abuse
1458203|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
1458204|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
1458205|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
1458206|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
1458207|NCT00935987|CYT387|cyt387
1458208|NCT00935961|CISPLATIN|cisplatin
1458209|NCT00935961|RAD001|rad001
1458210|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
1458211|NCT00935961|09-028|09-028
1458212|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
1458213|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
1458214|NCT00935948|hemorrhoids|hemorrhoids
1458215|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
1458216|NCT00935948|water smartweed|water smartweed
1458217|NCT00935948|hamamelis|hamamelis
1458218|NCT00935948|RCT|rct
1458219|NCT00935935|Treatment experienced|treatment experienced
1458220|NCT00935922|Flaxseed|flaxseed
1458221|NCT00935922|Weight loss|weight loss
1458222|NCT00935922|Heart health|heart health
1458223|NCT00935922|Diabetes|diabetes
1458224|NCT00935909|IV cannulation|iv cannulation
1458225|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
1458226|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
1458227|NCT00935896|Interleukin-8|interleukin-8
1458228|NCT00935896|Mechanical ventilation|mechanical ventilation
1458229|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
1458230|NCT00935896|Normal lungs|normal lungs
1458231|NCT00935883|Age Related macular Degeneration|age related macular degeneration
1458232|NCT00935883|Macular Degeneration|macular degeneration
1458233|NCT00935883|Drusen|drusen
1458234|NCT00935883|Geographic atrophy|geographic atrophy
1458235|NCT00935883|Eculizumab|eculizumab
1458236|NCT00935883|Soliris|soliris
1458237|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
1458238|NCT00935857|Looping|looping
1458239|NCT00935844|Advanced solid tumors|advanced solid tumors
1458240|NCT00935844|Lymphoma|lymphoma
1458241|NCT00935831|Tolerability|tolerability
1458242|NCT00935831|Safety|safety
1458243|NCT00935831|Pharmacokinetics|pharmacokinetics
1458244|NCT00935831|Pharmacodynamics|pharmacodynamics
1458245|NCT00935818|smoking|smoking
1458246|NCT00935818|nicotine|nicotine
1458247|NCT00935818|tobacco|tobacco
1458248|NCT00935818|dependence|dependence
1458249|NCT00935818|cessation|cessation
1458250|NCT00935818|abstinence|abstinence
1458251|NCT00935805|Diabetes Mellitus|diabetes mellitus
1458252|NCT00935805|Arterial Hypertension|arterial hypertension
1458253|NCT00935805|Treatment|treatment
1458254|NCT00935805|Primary Care|primary care
1458255|NCT00935792|hematopoietic cancer|hematopoietic cancer
1458256|NCT00935792|lymphoid cancer|lymphoid cancer
1458257|NCT00935779|Stomach Neoplasms|stomach neoplasms
1458258|NCT00935779|Peritoneum|peritoneum
1458259|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
1458260|NCT00935766|Omega three Fatty Acids|omega three fatty acids
1458261|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
1458262|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
1458263|NCT00935753|self-mutilating behavior|self-mutilating behavior
1458264|NCT00935740|thromboembolic disease|thromboembolic disease
1458265|NCT00935740|thromboplastin|thromboplastin
1458266|NCT00935740|hypercoagulability|hypercoagulability
1458267|NCT00935740|congestive heart failure|congestive heart failure
1458268|NCT00935727|renal transplant|renal transplant
1458269|NCT00935727|ultrasound|ultrasound
1458270|NCT00935727|elastography|elastography
1458271|NCT00935714|Arm|arm
1458272|NCT00935714|Lymphedema|lymphedema
1458273|NCT00935714|Breast Cancer|breast cancer
1458274|NCT00935714|Exercise|exercise
1458275|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
1458276|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
1458277|NCT00935701|Acupressure|acupressure
1458278|NCT00935701|Acupuncture|acupuncture
1458279|NCT00935688|malaria|malaria
1458280|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
1458281|NCT00935688|afghanistan|afghanistan
1458282|NCT00935688|Non-specific fever|non-specific fever
1458283|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
1458284|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
1458285|NCT00935662|First time in man|first time in man
1458286|NCT00935662|Safety study|safety study
1458287|NCT00935662|AZD8329|azd8329
1458288|NCT00935649|Toenail Fungus|toenail fungus
1458289|NCT00935649|PinPointe|pinpointe
1458290|NCT00935649|FootLaser|footlaser
1458291|NCT00935649|Onychomycosis|onychomycosis
1458292|NCT00935649|Fungal nails|fungal nails
1458293|NCT00935636|Intubation|intubation
1458294|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
1458295|NCT00935610|Elderly persons|elderly persons
1458296|NCT00935610|Muscle function and strength|muscle function and strength
1458297|NCT00935610|Body composition|body composition
1458298|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
1458299|NCT00935610|Cognitive functions|cognitive functions
1458300|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
1458301|NCT00935610|Immunocal|immunocal
1458302|NCT00935610|Resistance training|resistance training
1458303|NCT00935610|Improved muscle function|improved muscle function
1458304|NCT00935610|Improved quality of life|improved quality of life
1458305|NCT00935610|Aging processes|aging processes
1458306|NCT00935610|Quality of life|quality of life
1458307|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
1458308|NCT00935597|Hodgkin's Disease|hodgkin's disease
1458309|NCT00935597|Multiple Myeloma|multiple myeloma
1458310|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
1458311|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
1458905|NCT00933426|Paclitaxel|paclitaxel
1458312|NCT00935584|Communication|communication
1458313|NCT00935584|Doctor-patient relations|doctor-patient relations
1458314|NCT00935584|medical informatics|medical informatics
1458315|NCT00935584|patient-centered care|patient-centered care
1458316|NCT00935584|medical records systems, computerized|medical records systems, computerized
1458317|NCT00935558|dendritic cell|dendritic cell
1458318|NCT00935558|cancer vaccine|cancer vaccine
1458319|NCT00935558|breast cancer|breast cancer
1458320|NCT00935558|aromatase inhibitor|aromatase inhibitor
1458322|NCT00935545|Brain Tumors|brain tumors
1458323|NCT00935545|High Grade|high grade
1458324|NCT00935545|CNS|cns
1458325|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
1458326|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
1458327|NCT00935493|guanfacine|guanfacine
1458328|NCT00935493|aging|aging
1458329|NCT00935493|cognitive aging|cognitive aging
1458330|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
1458331|NCT00935493|executive function|executive function
1458332|NCT00935493|prefrontal cortex|prefrontal cortex
1458333|NCT00935480|HIV|hiv
1458334|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
1458335|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
1458336|NCT00935480|Residual HIV replication|residual hiv replication
1458337|NCT00935480|treatment experienced|treatment experienced
1458338|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
1458339|NCT00935454|endstage liver disease|endstage liver disease
1458340|NCT00935454|liver cirrhosis|liver cirrhosis
1458341|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
1458342|NCT00935454|improvement of liver function|improvement of liver function
1458343|NCT00935441|Diabetes mellitus|diabetes mellitus
1458344|NCT00935441|chronic care|chronic care
1458345|NCT00935441|case management|case management
1458346|NCT00935441|telemedicine|telemedicine
1458347|NCT00935428|Equestrian injury|equestrian injury
1458348|NCT00935428|Horse injury|horse injury
1458349|NCT00935428|Trauma|trauma
1458350|NCT00935428|Horse|horse
1458351|NCT00935428|Equestrian|equestrian
1458352|NCT00935415|asthma|asthma
1458353|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1458354|NCT00935415|montelukast|montelukast
1458355|NCT00935415|clinical protection|clinical protection
1458356|NCT00935415|children|children
1458357|NCT00935415|time effect|time effect
1458358|NCT00935402|Energy balance|energy balance
1458359|NCT00935402|Weight management|weight management
1458360|NCT00935402|Food intake|food intake
1458361|NCT00935402|Energy expenditure|energy expenditure
1458362|NCT00935376|Sleep Management|sleep management
1458363|NCT00935376|Awareness Training Programs|awareness training programs
1458364|NCT00935376|Mindfulness Meditation|mindfulness meditation
1458365|NCT00935376|Mind Body Bridging|mind body bridging
1458366|NCT00935363|glyburide|glyburide
1458367|NCT00935363|pharmacokinetics|pharmacokinetics
1458368|NCT00935363|pharmacodynamics|pharmacodynamics
1458369|NCT00935363|drug interaction|drug interaction
1458370|NCT00935363|Healthy Volunteers|healthy volunteers
1458371|NCT00935350|viscous|viscous
1458372|NCT00935350|fibre|fibre
1458373|NCT00935350|polysaccharide|polysaccharide
1458374|NCT00935350|blood glucose|blood glucose
1458375|NCT00935350|postprandial|postprandial
1458376|NCT00935337|Sleep problems|sleep problems
1458377|NCT00935337|Awareness training program|awareness training program
1458378|NCT00935337|Mind body bridging|mind body bridging
1458379|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
1458380|NCT00935298|Renal Transplantation|renal transplantation
1458381|NCT00935298|Tacrolimus|tacrolimus
1458382|NCT00935298|CYP3A5|cyp3a5
1458383|NCT00935298|Genotyping|genotyping
1458384|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
1458385|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
1458386|NCT00935285|Toll-like receptors|toll-like receptors
1458387|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
1458388|NCT00935246|Genomic devices|genomic devices
1458389|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
1458390|NCT00935246|Depressed Patients|depressed patients
1458391|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1458392|NCT00935207|Pain|pain
1458393|NCT00935207|Pediatric Pain|pediatric pain
1458394|NCT00935207|Pain Diary|pain diary
1458395|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
1458396|NCT00935207|Pain Measurement|pain measurement
1458397|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
1458398|NCT00935194|Oseltamivir|oseltamivir
1458399|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
1458400|NCT00935181|COPD|copd
1458401|NCT00935181|diaphragm|diaphragm
1458402|NCT00935181|muscle|muscle
1458403|NCT00935181|stretching|stretching
1458404|NCT00935181|exercises|exercises
1601476|NCT00388752|amputee|amputee
1458405|NCT00935181|dyspnea|dyspnea
1458406|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
1458407|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
1458408|NCT00935181|exercise training|exercise training
1458906|NCT00933426|Taxol|taxol
1458409|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
1458410|NCT00935168|Intensive Care|intensive care
1458411|NCT00935168|Fluid Resuscitation|fluid resuscitation
1458412|NCT00935168|Saline|saline
1458413|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
1458414|NCT00935155|exercise therapy|exercise therapy
1458415|NCT00935155|Knee arthroplasty|knee arthroplasty
1458416|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
1458417|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1458418|NCT00935155|rehabilitation|rehabilitation
1458419|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
1458420|NCT00935142|non-curative|non-curative
1458421|NCT00935129|Treatment satisfaction|treatment satisfaction
1458422|NCT00935129|OmniPod|omnipod
1458423|NCT00935129|Insulin pump|insulin pump
1458424|NCT00935129|diabetes|diabetes
1458425|NCT00935103|Addiction|addiction
1458426|NCT00935103|Psychoeducation|psychoeducation
1458427|NCT00935103|Risk reduction behaviour|risk reduction behaviour
1458428|NCT00935103|Drop in center (DIC)|drop in center (dic)
1458429|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1458430|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1458431|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
1458432|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1458433|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1458434|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1458435|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1458436|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1458437|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1458438|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1458439|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1458440|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1458441|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1458442|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1458443|NCT00935090|mast cell leukemia|mast cell leukemia
1458444|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1458445|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1458446|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
1458447|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1458448|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1458449|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1458450|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1458451|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
1458452|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1458453|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1458454|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1458455|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1458456|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1458457|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1459270|NCT00931801|Raltegravir|raltegravir
1458458|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1458459|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1458460|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1458461|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1458462|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1458463|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1458464|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1458465|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
1458466|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1458467|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1458468|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1458469|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1458470|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1458471|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1458472|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1567375|NCT00509418|Nutritional supplement|nutritional supplement
1458473|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1458474|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1458475|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1458476|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1458477|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1458478|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1458479|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1458480|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1458481|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1458482|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1458483|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1458484|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1458485|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1458486|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1458487|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1458488|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1458489|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1458490|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1458491|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1458492|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1458493|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1458494|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1458495|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1458496|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1458497|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1458498|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1458499|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1458500|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1458501|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1458502|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1458503|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1458504|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1458505|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1458506|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1458507|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1458508|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1458509|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1458510|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1458511|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1458512|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1458513|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1458514|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1458515|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1458516|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1458517|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1458676|NCT00934596|Cardiac de-airing|cardiac de-airing
1458518|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1458519|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1458520|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1458521|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1458522|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1458523|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1458524|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1458525|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1458526|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1458527|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1458528|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1458529|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1567376|NCT00509418|Diet|diet
1458530|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1458531|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1458532|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1458533|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1458534|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1458535|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1458536|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1458537|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1458538|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1458539|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1458540|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1458541|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1458542|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1458543|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1458544|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1458545|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1458546|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1458547|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1458548|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1458549|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1458550|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1458551|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1458552|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1458553|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1458554|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1458555|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1458556|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1458557|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1458558|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1458559|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1458560|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1458561|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1458562|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1458563|NCT00935090|intraocular lymphoma|intraocular lymphoma
1458564|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1458565|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1458566|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1458567|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1458568|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1458569|NCT00935090|primary myelofibrosis|primary myelofibrosis
1458570|NCT00935090|essential thrombocythemia|essential thrombocythemia
1458571|NCT00935090|polycythemia vera|polycythemia vera
1458572|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
1458573|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1458574|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
1458575|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
1458576|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
1458577|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
1458578|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
1458579|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1458580|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1458581|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1458677|NCT00934596|CO2 insufflation|co2 insufflation
1458582|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1458583|NCT00935077|Hypertension|hypertension
1458584|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
1458585|NCT00935064|Diabetes|diabetes
1458586|NCT00935051|type 1 diabetes|type 1 diabetes
1458587|NCT00935051|type 2 diabetes|type 2 diabetes
1458588|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
1458589|NCT00935025|Phase I|phase i
1458590|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
1458591|NCT00935025|AZD1305|azd1305
1458592|NCT00935025|Japanese and Caucasian|japanese and caucasian
1458593|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1458594|NCT00934986|NK Cells|nk cells
1458595|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
1458596|NCT00934973|treatment|treatment
1458597|NCT00934960|vision|vision
1458598|NCT00934960|Intraocular lenses|intraocular lenses
1458599|NCT00934947|Burns|burns
1458600|NCT00934947|Pain|pain
1458601|NCT00934934|Candida|candida
1458602|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
1458603|NCT00934934|respiratory tract infection|respiratory tract infection
1458604|NCT00934934|antifungal|antifungal
1458605|NCT00934934|biomarker|biomarker
1458606|NCT00934921|Bioequivalence|bioequivalence
1458607|NCT00934908|Zyprexa®|zyprexa®
1458608|NCT00934908|Green Tea|green tea
1458609|NCT00934908|ALL|all
1458610|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
1458611|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
1458612|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
1458613|NCT00934895|stage IV breast cancer|stage iv breast cancer
1458614|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
1458615|NCT00934895|recurrent breast cancer|recurrent breast cancer
1458616|NCT00934882|Colorectal cancer|colorectal cancer
1458617|NCT00934882|Targeted therapy|targeted therapy
1458618|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
1458619|NCT00934882|FOLFOX|folfox
1458620|NCT00934882|FOLFIRI|folfiri
1458621|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
1458622|NCT00934843|System Inflammatory Response|system inflammatory response
1458623|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
1458624|NCT00934843|Methylprednisolone|methylprednisolone
1458625|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
1458626|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
1458627|NCT00934843|Steroid|steroid
1458628|NCT00934830|Antibiotic|antibiotic
1458629|NCT00934830|Ultrasound|ultrasound
1458630|NCT00934830|Efficacy|efficacy
1458631|NCT00934830|Treatment|treatment
1458632|NCT00934817|Volunteer|volunteer
1458633|NCT00934804|refractive surgery|refractive surgery
1458634|NCT00934791|Kidney Transplant|kidney transplant
1458635|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1458636|NCT00934791|Polycystic liver disease|polycystic liver disease
1458637|NCT00934778|Confocal microscopy|confocal microscopy
1458638|NCT00934778|Endocytoscopy|endocytoscopy
1458639|NCT00934778|Diffuse lung disease|diffuse lung disease
1458640|NCT00934778|Minimally invasive|minimally invasive
1458641|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
1458642|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
1458643|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
1458644|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
1458645|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
1458646|NCT00934726|Quality of Life|quality of life
1458647|NCT00934726|Patient satisfaction|patient satisfaction
1458648|NCT00934726|Schizophrenia|schizophrenia
1458649|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
1458650|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
1458651|NCT00934700|perinatal asphyxia|perinatal asphyxia
1458652|NCT00934700|encephalopathy|encephalopathy
1458653|NCT00934700|neuroprotection|neuroprotection
1458654|NCT00934687|depression|depression
1458655|NCT00934687|depressive|depressive
1458656|NCT00934687|botulinum|botulinum
1458657|NCT00934687|botox|botox
1458658|NCT00934674|Healthy Subjects|healthy subjects
1458659|NCT00934661|hip resurfacing|hip resurfacing
1458660|NCT00934661|hip arthroplasty|hip arthroplasty
1458661|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
1458662|NCT00934635|Antipsychotic drugs|antipsychotic drugs
1458663|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
1458664|NCT00934635|Dopamine|dopamine
1458665|NCT00934635|Fallypride|fallypride
1458666|NCT00934635|Plasma concentration|plasma concentration
1458667|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
1458668|NCT00934622|AcrySof|acrysof
1458669|NCT00934622|ReSTOR|restor
1458670|NCT00934622|Aspheric IOL|aspheric iol
1458671|NCT00934622|Cataract|cataract
1458672|NCT00934609|Exercise|exercise
1458673|NCT00934609|heart failure|heart failure
1458674|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
1458675|NCT00934609|Endurance training|endurance training
1458679|NCT00934596|Trans cranial doppler|trans cranial doppler
1458680|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
1458681|NCT00934583|Bulimia Nervosa|bulimia nervosa
1458682|NCT00934583|Binge Eating|binge eating
1458683|NCT00934583|Binge-Eating Disorder|binge-eating disorder
1458684|NCT00934570|Obesity|obesity
1458685|NCT00934570|Metformin|metformin
1458686|NCT00934570|Physical activity|physical activity
1458687|NCT00934570|Cardiovascular health|cardiovascular health
1458688|NCT00934544|Myelofibrosis|myelofibrosis
1458689|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
1458690|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
1458691|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1458692|NCT00934531|Falls|falls
1458693|NCT00934531|donepezil|donepezil
1458694|NCT00934531|gait variability|gait variability
1458695|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
1458696|NCT00934505|Positron-Emission Tomography|positron-emission tomography
1458697|NCT00934505|PET Scan|pet scan
1458699|NCT00934505|oesophageal cancer|oesophageal cancer
1458700|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
1458701|NCT00934505|SUV|suv
1458702|NCT00934492|Malnutrition|malnutrition
1458703|NCT00934492|Wasting|wasting
1458704|NCT00934492|Kwashiorkor|kwashiorkor
1458705|NCT00934492|Immune deficiency|immune deficiency
1458706|NCT00934492|Infection|infection
1458707|NCT00934492|Prophylaxis|prophylaxis
1458708|NCT00934492|Mortality|mortality
1458709|NCT00934492|Kenya|kenya
1458710|NCT00934479|Chronic Constipation|chronic constipation
1458907|NCT00933426|Taxanes|taxanes
1458711|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
1458712|NCT00934479|Intestinal Microecology|intestinal microecology
1458713|NCT00934453|Healthy adult volunteers|healthy adult volunteers
1458714|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
1458715|NCT00934453|probiotic|probiotic
1458716|NCT00934453|dietary supplement|dietary supplement
1458717|NCT00934453|safety|safety
1458718|NCT00934453|Safety Assessment|safety assessment
1458719|NCT00934440|kidney cancer|kidney cancer
1458720|NCT00934440|renal cell|renal cell
1458721|NCT00934427|Raynaud's|raynaud's
1458722|NCT00934427|scleroderma|scleroderma
1458723|NCT00934427|nitroglycerin|nitroglycerin
1458724|NCT00934427|MQX-503|mqx-503
1458725|NCT00934427|treatment|treatment
1458726|NCT00934401|FLT|flt
1458727|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
1458728|NCT00934401|breast cancer|breast cancer
1458729|NCT00934401|Positron-Emission Mammography|positron-emission mammography
1458730|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
1458731|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
1458732|NCT00934349|Comoro Island|comoro island
1458733|NCT00934349|vit B1 intake|vit b1 intake
1458734|NCT00934349|Thiamine status|thiamine status
1458735|NCT00934349|Genetic factor|genetic factor
1458736|NCT00934323|volunteer|volunteer
1458737|NCT00934310|Patient Safety|patient safety
1458738|NCT00934310|Team work|team work
1458739|NCT00934310|Communication|communication
1458740|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
1458741|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
1458742|NCT00934284|sciatic neuropathy|sciatic neuropathy
1458743|NCT00934284|physical therapy|physical therapy
1458744|NCT00934284|spinal injections|spinal injections
1458745|NCT00934271|acromegaly|acromegaly
1458746|NCT00934271|irradiation|irradiation
1458747|NCT00934271|remission|remission
1458748|NCT00934271|pituitary function|pituitary function
1458749|NCT00934258|genes|genes
1458750|NCT00934258|rosuvastatin|rosuvastatin
1458751|NCT00934258|fenofibrate|fenofibrate
1458752|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
1458753|NCT00934258|dyslipidemia|dyslipidemia
1458754|NCT00934258|metabolic syndrome|metabolic syndrome
1458755|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
1458756|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
1458757|NCT00934245|Influenza|influenza
1458758|NCT00934245|India|india
1458759|NCT00934245|Children|children
1458760|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
1458761|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
1458762|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
1458763|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
1458764|NCT00934232|cancer|cancer
1458765|NCT00934232|myeloma|myeloma
1458766|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
1458767|NCT00934219|triglycerides|triglycerides
1458768|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
1458769|NCT00934206|Exercise|exercise
1458770|NCT00934206|healthy subjects|healthy subjects
1458771|NCT00934180|Bioequivalence|bioequivalence
1458772|NCT00934154|multiple myeloma|multiple myeloma
1458773|NCT00934154|thalidomide|thalidomide
1458774|NCT00934154|melphalan|melphalan
1458775|NCT00934154|prednisolone|prednisolone
1458776|NCT00934154|newly diagnosed|newly diagnosed
1458777|NCT00934154|elderly|elderly
1458778|NCT00934154|not eligible for transplantation|not eligible for transplantation
1458779|NCT00934141|Organizational change|organizational change
1458780|NCT00934141|process improvement|process improvement
1458781|NCT00934141|addiction treatment|addiction treatment
1458782|NCT00934141|cost effectiveness study|cost effectiveness study
1458783|NCT00934128|Advanced Cancer|advanced cancer
1458784|NCT00934128|Persistent Dyspnea|persistent dyspnea
1458785|NCT00934128|Shortness of breath|shortness of breath
1458786|NCT00934128|Specialized breathing devices|specialized breathing devices
1458787|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
1458788|NCT00934128|BIPAP|bipap
1458789|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
1458790|NCT00934128|VapoTherm|vapotherm
1458791|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
1458792|NCT00934128|ESAS|esas
1458793|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
1458794|NCT00934037|Coronary Artery Disease|coronary artery disease
1458795|NCT00934037|Computed Tomography|computed tomography
1458796|NCT00934037|Myoperfusion|myoperfusion
1458797|NCT00934037|Angiography|angiography
1458798|NCT00934037|SPECT|spect
1458799|NCT00934024|nicotine dependence|nicotine dependence
1458800|NCT00934024|tobacco|tobacco
1458801|NCT00934024|smoking|smoking
1458802|NCT00934011|C-reactive protein|c-reactive protein
1458803|NCT00934011|procalcitonin|procalcitonin
1458804|NCT00934011|sepsis|sepsis
1458805|NCT00934011|antibiotic therapy|antibiotic therapy
1458806|NCT00933998|DPN|dpn
1458807|NCT00933959|Sleep problems|sleep problems
1458808|NCT00933959|Awareness training program|awareness training program
1458809|NCT00933959|Mind body bridging|mind body bridging
1458810|NCT00933920|Aliskiren,|aliskiren,
1458811|NCT00933920|hypertension,|hypertension,
1458812|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
1458813|NCT00933920|pharmacokinetics,|pharmacokinetics,
1458814|NCT00933920|pharmacodynamics|pharmacodynamics
1458815|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
1458816|NCT00933894|VX-950-C133|vx-950-c133
1458817|NCT00933894|VX950|vx950
1458818|NCT00933894|HCV|hcv
1458819|NCT00933894|telaprevir|telaprevir
1458820|NCT00933894|escitalopram|escitalopram
1458821|NCT00933881|GDM|gdm
1458822|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
1458823|NCT00933855|Training Workshop|training workshop
1458824|NCT00933855|Communication|communication
1458825|NCT00933855|Questionnaires|questionnaires
1458826|NCT00933855|Multiple Diseases|multiple diseases
1458827|NCT00933829|absorbable sutures|absorbable sutures
1458828|NCT00933829|non-absorbable sutures|non-absorbable sutures
1458829|NCT00933829|wound management|wound management
1458830|NCT00933816|sorafenib|sorafenib
1458831|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
1458832|NCT00933816|Low dose FP|low dose fp
1458833|NCT00933816|cisplatin|cisplatin
1458834|NCT00933816|fluorouracil|fluorouracil
1458835|NCT00933790|TB|tb
1458836|NCT00933790|HIV|hiv
1458837|NCT00933790|ARR|arr
1458838|NCT00933790|Short course chemotherapy|short course chemotherapy
1458839|NCT00933790|Drug resistance|drug resistance
1458840|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
1458841|NCT00933751|oxygen transport|oxygen transport
1458842|NCT00933751|physiologic monitoring|physiologic monitoring
1458843|NCT00933751|tissue oxygenation|tissue oxygenation
1458844|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
1458845|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
1458846|NCT00933725|menopausal syndrome|menopausal syndrome
1458847|NCT00933725|TCM intervention|tcm intervention
1458848|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
1458849|NCT00933673|DICE|dice
1458850|NCT00933673|L-asparaginase|l-asparaginase
1458851|NCT00933660|Education|education
1458852|NCT00933660|Retention|retention
1458853|NCT00933660|Retrieval|retrieval
1458854|NCT00933647|Camellia sinensis|camellia sinensis
1458855|NCT00933647|Ilex paraguariensis|ilex paraguariensis
1458856|NCT00933647|Green tea|green tea
1458857|NCT00933647|Yerba mate tea|yerba mate tea
1458858|NCT00933647|Maté|maté
1458859|NCT00933647|Dyslipidemia|dyslipidemia
1458860|NCT00933647|Inflammation|inflammation
1458861|NCT00933647|Obesity|obesity
1458862|NCT00933634|atrial fibrillation|atrial fibrillation
1458863|NCT00933634|electrical cardioversion|electrical cardioversion
1458864|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
1458865|NCT00933608|subjective memory complaints|subjective memory complaints
1458866|NCT00933608|cognitively healthy|cognitively healthy
1458867|NCT00933608|family history|family history
1458868|NCT00933608|AD|ad
1458869|NCT00933595|HIV|hiv
1458870|NCT00933595|Lung|lung
1458871|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
1458872|NCT00933582|Knee Pain|knee pain
1458873|NCT00933582|Pain Measurement|pain measurement
1458874|NCT00933582|Naproxen|naproxen
1458875|NCT00933582|Placebo|placebo
1458876|NCT00933582|Treatment Outcome|treatment outcome
1458877|NCT00933556|infection|infection
1458878|NCT00933556|probiotics|probiotics
1458879|NCT00933543|Acne Vulgaris|acne vulgaris
1458880|NCT00933543|Moderate to severe|moderate to severe
1458881|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
1458882|NCT00933491|healthy|healthy
1458883|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
1458884|NCT00933465|Fecal incontinence|fecal incontinence
1458885|NCT00933452|duloxetine|duloxetine
1458886|NCT00933452|pharmacokinetics|pharmacokinetics
1458887|NCT00933452|antidepressant|antidepressant
1458888|NCT00933452|antidepressive agents|antidepressive agents
1458889|NCT00933452|depression|depression
1458890|NCT00933452|psychotropic drugs|psychotropic drugs
1458891|NCT00933452|safety|safety
1458892|NCT00933452|Chinese|chinese
1458893|NCT00933452|HAN|han
1458894|NCT00933452|BDNF|bdnf
1458895|NCT00933439|Depression|depression
1458896|NCT00933439|Major Depressive Disorder|major depressive disorder
1458897|NCT00933439|Cognitive Function|cognitive function
1458898|NCT00933439|Psychosocial Function|psychosocial function
1458899|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1458900|NCT00933426|CRPC|crpc
1458901|NCT00933426|Prostate|prostate
1458902|NCT00933426|Lenalidomide|lenalidomide
1458903|NCT00933426|Revlimid|revlimid
1458904|NCT00933426|CC-5103|cc-5103
1458908|NCT00933400|Computed Tomography|computed tomography
1458909|NCT00933400|CTA|cta
1458910|NCT00933400|Cardiac CT|cardiac ct
1458911|NCT00933400|CT|ct
1458912|NCT00933400|Cardiac CTA|cardiac cta
1458913|NCT00933400|Chest Pain|chest pain
1458914|NCT00933400|Heart Attack|heart attack
1458915|NCT00933400|Emergency Department|emergency department
1458916|NCT00933400|Myocardial Infarction|myocardial infarction
1458917|NCT00933400|Cost Effectiveness|cost effectiveness
1458918|NCT00933400|Acute Coronary Event|acute coronary event
1458919|NCT00933400|Heart Imaging|heart imaging
1458920|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
1458921|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
1458922|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
1458923|NCT00933387|biomarker|biomarker
1458924|NCT00933374|bladder cancer|bladder cancer
1458925|NCT00933374|RAD001|rad001
1458926|NCT00933374|Paclitaxel|paclitaxel
1458927|NCT00933361|Adult|adult
1458928|NCT00933348|ulcer|ulcer
1458929|NCT00933348|venous|venous
1458930|NCT00933348|pressure|pressure
1458931|NCT00933348|wound|wound
1458932|NCT00933348|treatment|treatment
1458933|NCT00933322|ruminant|ruminant
1458934|NCT00933322|industrial|industrial
1458935|NCT00933322|endothelial function|endothelial function
1458936|NCT00933322|flow-mediated dilation|flow-mediated dilation
1458937|NCT00933322|blood lipids|blood lipids
1458938|NCT00933322|nutrition|nutrition
1458939|NCT00933322|trans fatty acids|trans fatty acids
1458940|NCT00933322|coronary disease|coronary disease
1458941|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
1458942|NCT00933322|inflammation|inflammation
1458943|NCT00933322|insulin resistancy|insulin resistancy
1458944|NCT00933322|coagulation|coagulation
1458945|NCT00933309|Breast|breast
1458946|NCT00933309|Obese|obese
1458947|NCT00933309|Obesity Treatment|obesity treatment
1458948|NCT00933309|Exemestane|exemestane
1458949|NCT00933309|Aromasin|aromasin
1458950|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
1458951|NCT00933309|Avandamet|avandamet
1458952|NCT00933309|Postmenopausal|postmenopausal
1458953|NCT00933309|Hormone-sensitive|hormone-sensitive
1458954|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
1458955|NCT00933296|Schnitzler syndrome|schnitzler syndrome
1458956|NCT00933296|Waldentsröm's disease|waldentsröm's disease
1458957|NCT00933296|anakinra|anakinra
1458958|NCT00933283|Healthy participants|healthy participants
1458959|NCT00933283|Pharmacokinetics|pharmacokinetics
1458960|NCT00933283|Pharmacodynamic|pharmacodynamic
1458961|NCT00933283|Potential interaction|potential interaction
1458962|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
1458963|NCT00933283|VX-950|vx-950
1458964|NCT00933283|Methadone|methadone
1458965|NCT00933283|Telaprevir|telaprevir
1458966|NCT00933283|Steady-state|steady-state
1458967|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
1458968|NCT00933244|Vitamin D|vitamin d
1458969|NCT00933244|Cholecalciferol|cholecalciferol
1458970|NCT00933244|Parathyroid Hormone|parathyroid hormone
1458971|NCT00933244|Calcium Absorption|calcium absorption
1458972|NCT00933244|Bone Mineral Density|bone mineral density
1458973|NCT00933244|Muscle Function|muscle function
1458974|NCT00933231|Tacrolimus|tacrolimus
1458975|NCT00933231|Kidney Transplantation|kidney transplantation
1458976|NCT00933231|Advagraf|advagraf
1458977|NCT00933231|Immunosuppression|immunosuppression
1458978|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1458979|NCT00933179|Prevention of pregnancy|prevention of pregnancy
1458980|NCT00933153|Elderly|elderly
1458981|NCT00933153|Malnutrition|malnutrition
1458982|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
1458983|NCT00933153|Meals on Wheels|meals on wheels
1458984|NCT00933140|HIV|hiv
1458985|NCT00933140|women|women
1458986|NCT00933140|anal cytology|anal cytology
1567377|NCT00509418|Exercise|exercise
1458987|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1458988|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1458989|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1458990|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1458991|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1458992|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1458993|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1458994|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1458995|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1458996|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1458997|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1458998|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1458999|NCT00933114|DCE MRI|dce mri
1459000|NCT00933114|PET|pet
1459001|NCT00933114|Perfusion|perfusion
1459002|NCT00933114|Permeability|permeability
1459302|NCT00931671|Walking|walking
1459003|NCT00933114|Cancer of the head and neck|cancer of the head and neck
1459004|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
1459005|NCT00933088|adolescent coping strategies|adolescent coping strategies
1459006|NCT00933088|stress response|stress response
1459007|NCT00933088|breast cancer|breast cancer
1459008|NCT00933049|Efficacy|efficacy
1459009|NCT00933049|children|children
1459010|NCT00933049|pneumonia|pneumonia
1459011|NCT00933049|cotrimoxazole|cotrimoxazole
1459012|NCT00933049|amoxicillin|amoxicillin
1459013|NCT00933036|Osteoporosis|osteoporosis
1459014|NCT00933036|VCF|vcf
1459015|NCT00933036|PVA|pva
1459016|NCT00933036|Vertebroplasty|vertebroplasty
1459017|NCT00933036|Kyphoplasty|kyphoplasty
1459018|NCT00933036|Vertebral fracture|vertebral fracture
1459019|NCT00933036|Pathologic fracture|pathologic fracture
1459020|NCT00933036|Vertebral augmentation|vertebral augmentation
1459021|NCT00933010|metabolic syndrome|metabolic syndrome
1459022|NCT00933010|lipids|lipids
1459023|NCT00933010|waist circumference|waist circumference
1459024|NCT00933010|HDL|hdl
1459025|NCT00933010|hypertension|hypertension
1459026|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1459027|NCT00932997|stage I breast cancer|stage i breast cancer
1459028|NCT00932997|stage II breast cancer|stage ii breast cancer
1459029|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
1459030|NCT00932997|cancer survivor|cancer survivor
1459031|NCT00932958|Myocardial Infarction|myocardial infarction
1459032|NCT00932919|Agoraphobia|agoraphobia
1459033|NCT00932919|Cognitive therapy|cognitive therapy
1459034|NCT00932919|Thought field therapy|thought field therapy
1459035|NCT00932919|Psychotherapy research|psychotherapy research
1459036|NCT00932906|Education|education
1459037|NCT00932906|Retention|retention
1459038|NCT00932906|Retrieval|retrieval
1459039|NCT00932906|Self training|self training
1459040|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
1459041|NCT00932867|Arterial Hypertension|arterial hypertension
1459042|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
1459043|NCT00932854|EBUS|ebus
1459044|NCT00932854|Bronchoscopy|bronchoscopy
1459045|NCT00932854|Sarcoidosis|sarcoidosis
1459046|NCT00932828|Peanut allergy|peanut allergy
1459047|NCT00932802|Non-Interventional|non-interventional
1459048|NCT00932802|Observational|observational
1459049|NCT00932802|NIS|nis
1459050|NCT00932802|Moxifloxacin|moxifloxacin
1459051|NCT00932802|MXF|mxf
1459052|NCT00932802|Avelox|avelox
1459053|NCT00932802|AECB|aecb
1459054|NCT00932750|Body composition|body composition
1459055|NCT00932750|Weight loss|weight loss
1459056|NCT00932750|Weight management|weight management
1459057|NCT00932750|Beverages|beverages
1459058|NCT00932750|Diet|diet
1459059|NCT00932724|Metastatic|metastatic
1459060|NCT00932724|Colorectal|colorectal
1459061|NCT00932724|Cancer|cancer
1459062|NCT00932724|refractory|refractory
1459063|NCT00932724|Phase II|phase ii
1459064|NCT00932724|randomised|randomised
1459065|NCT00932724|double-blind|double-blind
1459066|NCT00932724|controlled|controlled
1459067|NCT00932724|multicenter|multicenter
1459068|NCT00932724|CY-503|cy-503
1459069|NCT00932724|Cytavis|cytavis
1459070|NCT00932711|COPD|copd
1459071|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
1459072|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
1459073|NCT00932698|IXAZOMIB Proteasome inhibitor|ixazomib proteasome inhibitor
1459074|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
1459075|NCT00932672|Prostate Cancer|prostate cancer
1459076|NCT00932672|Atkins|atkins
1459077|NCT00932659|End-Stage Renal Disease|end-stage renal disease
1459078|NCT00932659|Hemodialysis|hemodialysis
1459079|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
1459080|NCT00932633|neonatal brain injury|neonatal brain injury
1459081|NCT00932633|congenital heart disease|congenital heart disease
1459082|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
1459083|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
1459084|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
1459085|NCT00932620|hypercholesterolemia|hypercholesterolemia
1459086|NCT00932620|statins|statins
1459087|NCT00932620|simvastatin|simvastatin
1459088|NCT00932620|ezetimibe|ezetimibe
1459089|NCT00932620|LDL particles|ldl particles
1459090|NCT00932607|seasonal|seasonal
1459091|NCT00932607|rhinitis|rhinitis
1459092|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
1459093|NCT00932607|birch pollen|birch pollen
1459094|NCT00932607|immunotherapy|immunotherapy
1459095|NCT00932607|sublingual|sublingual
1459096|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
1459097|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
1459098|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
1459099|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
1459100|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
1459101|NCT00932581|Parkinson's Disease|parkinson's disease
1459102|NCT00932581|Movement Disorders|movement disorders
1459103|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
1459104|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
1459105|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
1459106|NCT00932581|Motor Evaluation|motor evaluation
1459107|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
1459108|NCT00932581|Bradykinesia|bradykinesia
1459109|NCT00932581|psychometrics|psychometrics
1459110|NCT00932581|order effects|order effects
1459111|NCT00932581|hoehn yahr aging|hoehn yahr aging
1459112|NCT00932581|assessments|assessments
1459113|NCT00932555|Octocog alfa|octocog alfa
1459114|NCT00932555|Hemophilia A|hemophilia a
1459115|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
1459116|NCT00932529|Antipsychotic drugs|antipsychotic drugs
1459117|NCT00932529|Treatment effectiveness|treatment effectiveness
1459118|NCT00932529|Randomized controlled trial|randomized controlled trial
1459119|NCT00932516|South Beach Diet™|south beach diet™
1459120|NCT00932516|overweight|overweight
1459121|NCT00932516|obesity|obesity
1459122|NCT00932516|satiety|satiety
1459123|NCT00932516|weight loss|weight loss
1459124|NCT00932503|Vicryl plus|vicryl plus
1459125|NCT00932503|wound infection|wound infection
1459126|NCT00932503|coated suture material|coated suture material
1459127|NCT00932503|open abdominal surgery|open abdominal surgery
1459128|NCT00932503|transverse laparotomy|transverse laparotomy
1459129|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
1459130|NCT00932438|colon cancer|colon cancer
1459131|NCT00932438|liver metastases|liver metastases
1459132|NCT00932425|Stroke|stroke
1459133|NCT00932425|Cryptogenic|cryptogenic
1459134|NCT00932425|Cardioembolic|cardioembolic
1459135|NCT00932425|Atrial Fibrillation|atrial fibrillation
1459136|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
1459137|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
1459138|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
1459140|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
1459141|NCT00932373|Herceptin|herceptin
1459142|NCT00932373|T-DM1|t-dm1
1459143|NCT00932360|Fibromyalgia|fibromyalgia
1459144|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
1459145|NCT00932347|Camellia sinensis|camellia sinensis
1459146|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
1459147|NCT00932334|kidney|kidney
1459148|NCT00932334|transplant|transplant
1459149|NCT00932334|donation|donation
1459150|NCT00932321|Contraception|contraception
1459151|NCT00932295|tobacco|tobacco
1459152|NCT00932295|cigarette|cigarette
1459153|NCT00932295|nicotine|nicotine
1459154|NCT00932282|Peanut|peanut
1459155|NCT00932282|Allergy|allergy
1459156|NCT00932282|Hypersensitivity|hypersensitivity
1459157|NCT00932269|Diphtheria|diphtheria
1459158|NCT00932269|Tetanus|tetanus
1459159|NCT00932269|Pertussis|pertussis
1459160|NCT00932269|Polio|polio
1459161|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
1459162|NCT00932269|Hib|hib
1459163|NCT00932269|Measles|measles
1459164|NCT00932269|Mumps|mumps
1459165|NCT00932269|Rubella|rubella
1459166|NCT00932269|Hepatitis B|hepatitis b
1459167|NCT00932269|Vaccine|vaccine
1459168|NCT00932269|Vaccination|vaccination
1459170|NCT00932269|Vaccination program|vaccination program
1459171|NCT00932269|Sweden|sweden
1459172|NCT00932269|ELISA|elisa
1459173|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
1459174|NCT00932243|bacteremia|bacteremia
1459175|NCT00932243|sepsis|sepsis
1459176|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
1459177|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
1459178|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1459179|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
1459180|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
1459181|NCT00932191|Cataract|cataract
1459182|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
1459183|NCT00932191|Ultrasound power|ultrasound power
1459184|NCT00932191|Corneal endothelium|corneal endothelium
1459185|NCT00932178|Anxiety|anxiety
1459186|NCT00932178|Worry|worry
1459187|NCT00932178|nervousness|nervousness
1459188|NCT00932178|Older Adult|older adult
1459189|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1459190|NCT00932152|postmenopausal|postmenopausal
1459191|NCT00932152|bevacizumab|bevacizumab
1459192|NCT00932152|fulvestrant|fulvestrant
1459193|NCT00932152|anastrozole|anastrozole
1459194|NCT00932139|Hypertension|hypertension
1459195|NCT00932139|blood pressure|blood pressure
1459196|NCT00932139|arrhythmias|arrhythmias
1459197|NCT00932139|mild to moderate hypertension|mild to moderate hypertension
1459198|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
1459199|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
1459200|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
1459201|NCT00932113|Methotrexate|methotrexate
1459202|NCT00932113|treatment|treatment
1459203|NCT00932113|mechanism|mechanism
1459204|NCT00932113|psoriasis|psoriasis
1459205|NCT00932100|ACS|acs
1459206|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
1459207|NCT00932100|Catheterization|catheterization
1459208|NCT00932087|Platelet function|platelet function
1459209|NCT00932087|diabetes|diabetes
1459210|NCT00932087|metabolic syndrome|metabolic syndrome
1459211|NCT00932074|Atopic Dermatitis|atopic dermatitis
1459212|NCT00932061|Fibromyalgia|fibromyalgia
1459213|NCT00932061|Healthy controls|healthy controls
1459214|NCT00932061|Acupuncture|acupuncture
1459215|NCT00932061|Sham Acupuncture|sham acupuncture
1459216|NCT00932061|fMRI|fmri
1459217|NCT00932061|Biological marker|biological marker
1459218|NCT00932048|Diabetes Mellitus|diabetes mellitus
1459219|NCT00932048|Statins|statins
1459220|NCT00932048|PET|pet
1459221|NCT00932035|breast cancer|breast cancer
1459222|NCT00932035|axillary mapping|axillary mapping
1459223|NCT00932035|lymphedema|lymphedema
1459224|NCT00932009|Human papillomavirus infection|human papillomavirus infection
1459225|NCT00932009|Tanzanian men|tanzanian men
1459226|NCT00932009|Prevalence|prevalence
1459227|NCT00931996|schizophrenia|schizophrenia
1459228|NCT00931996|antipsychotic|antipsychotic
1459229|NCT00931996|risperidone|risperidone
1459230|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
1459231|NCT00931983|Walking|walking
1459232|NCT00931983|Treadmill|treadmill
1459233|NCT00931983|Training|training
1459234|NCT00931970|Hemodialysis|hemodialysis
1459235|NCT00931970|Peritoneal dialysis|peritoneal dialysis
1459236|NCT00931970|Mortality|mortality
1459237|NCT00931970|Prospective cohort|prospective cohort
1459238|NCT00931970|Clinical study|clinical study
1459239|NCT00931957|Etanercept|etanercept
1459240|NCT00931957|Behcet's syndrome|behcet's syndrome
1459241|NCT00931957|Behcet's Disease|behcet's disease
1459242|NCT00931957|Ocular Lesions|ocular lesions
1459243|NCT00931957|Uveitis|uveitis
1459244|NCT00931957|Retinal Vasculitis|retinal vasculitis
1459245|NCT00931944|ALS|als
1459246|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1459247|NCT00931944|Lou Gehrig|lou gehrig
1459248|NCT00931944|Lou Gehrig's|lou gehrig's
1459249|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
1459250|NCT00931944|Motor Neuron Disease|motor neuron disease
1459251|NCT00931944|Nervous System Diseases|nervous system diseases
1459252|NCT00931944|KNS-760704|kns-760704
1459253|NCT00931944|RTPB|rtpb
1459254|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
1459255|NCT00931892|celiac disease|celiac disease
1459256|NCT00931892|gluten challenge|gluten challenge
1459257|NCT00931866|diclofenac|diclofenac
1459258|NCT00931866|acute pain|acute pain
1459259|NCT00931866|topical|topical
1459260|NCT00931866|patch|patch
1459261|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
1459262|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
1459263|NCT00931827|Contraception|contraception
1459264|NCT00931814|Depression|depression
1459265|NCT00931814|physical function|physical function
1459266|NCT00931814|Quality of life|quality of life
1459267|NCT00931801|AIDS|aids
1459268|NCT00931801|HIV|hiv
1459269|NCT00931801|Atazanavir|atazanavir
1459271|NCT00931801|Tenofovir|tenofovir
1459272|NCT00931801|protease inhibitors|protease inhibitors
1459273|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
1459274|NCT00931788|stroke|stroke
1459275|NCT00931788|TIA|tia
1459276|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
1459277|NCT00931762|Bone marrow|bone marrow
1459278|NCT00931762|Myelofibrosis|myelofibrosis
1459279|NCT00931762|JAK2mutation|jak2mutation
1459280|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
1459281|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
1459282|NCT00931749|ultrasound therapy|ultrasound therapy
1459283|NCT00931749|knee cartilage thickness|knee cartilage thickness
1459284|NCT00931749|knee cartilage volume|knee cartilage volume
1459285|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
1459286|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
1459287|NCT00931736|Tuberculosis|tuberculosis
1459288|NCT00931723|Acute Mania|acute mania
1459289|NCT00931723|Mania, Adults|mania, adults
1459290|NCT00931723|Seroquel|seroquel
1459291|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
1459292|NCT00931710|Hypertension|hypertension
1459293|NCT00931710|combination therapy|combination therapy
1459294|NCT00931710|valsartan|valsartan
1459295|NCT00931710|cardiovascular diseases|cardiovascular diseases
1459296|NCT00931697|Mefloquine|mefloquine
1459297|NCT00931697|Malaria|malaria
1459298|NCT00931697|(+) Mefloquine|(+) mefloquine
1459299|NCT00931697|Pharmacokinetics|pharmacokinetics
1459300|NCT00931671|Physical fitness|physical fitness
1459301|NCT00931671|Cerebral circulation|cerebral circulation
1459303|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
1459304|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
1459305|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
1459306|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
1459307|NCT00931619|Epilepsy|epilepsy
1459308|NCT00931619|Epileptic Focus|epileptic focus
1459309|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
1459310|NCT00931619|Depression|depression
1459311|NCT00931619|Major Depressive Disorder|major depressive disorder
1459312|NCT00931619|Healthy Volunteer|healthy volunteer
1459313|NCT00931619|HV|hv
1459314|NCT00931606|anemia|anemia
1459315|NCT00931606|metastatic|metastatic
1459316|NCT00931606|breast|breast
1459317|NCT00931606|cancer|cancer
1459318|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
1459319|NCT00931593|high resolution manometry|high resolution manometry
1459320|NCT00931593|dentsleeve probe|dentsleeve probe
1459321|NCT00931593|healthy volunteers|healthy volunteers
1459322|NCT00931580|Vitamin D|vitamin d
1459323|NCT00931580|Adolescent|adolescent
1459324|NCT00931580|African American|african american
1459325|NCT00931580|White|white
1459326|NCT00931541|Safety|safety
1459327|NCT00931541|Tolerability|tolerability
1459328|NCT00931541|Healthy|healthy
1459329|NCT00931528|sexual dysfunction|sexual dysfunction
1459330|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
1459331|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
1459332|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1459333|NCT00931515|DDD|ddd
1459334|NCT00931502|Stent thrombosis|stent thrombosis
1459335|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
1459336|NCT00931502|ACS|acs
1459337|NCT00931502|Stenting|stenting
1459338|NCT00931502|Interventional Cardiology|interventional cardiology
1459339|NCT00931502|Cardiology|cardiology
1459340|NCT00931502|Cardiovascular Research|cardiovascular research
1459341|NCT00931502|Registry|registry
1459342|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
1459343|NCT00931489|Lucentis|lucentis
1459344|NCT00931489|Ranibizumab|ranibizumab
1459345|NCT00931489|Antibodies|antibodies
1459346|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
1459347|NCT00931463|second line therapy|second line therapy
1459348|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
1459349|NCT00931463|first-line failure|first-line failure
1459350|NCT00931463|AIDS|aids
1459351|NCT00931463|treatment experienced|treatment experienced
1459352|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1459353|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
1459354|NCT00931450|stage IA breast cancer|stage ia breast cancer
1459355|NCT00931450|stage IB breast cancer|stage ib breast cancer
1459356|NCT00931450|stage II breast cancer|stage ii breast cancer
1459357|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
1459358|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
1459359|NCT00931437|vitamin K|vitamin k
1459360|NCT00931437|Bio-availability|bio-availability
1459361|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
1459362|NCT00931424|surgery|surgery
1459363|NCT00931424|reconstruction|reconstruction
1459364|NCT00931424|valve|valve
1459365|NCT00931411|Atopic Dermatitis|atopic dermatitis
1459366|NCT00931411|Vitamin B3|vitamin b3
1459367|NCT00931372|Insulin release|insulin release
1459760|NCT00929708|Efficacy|efficacy
1459368|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
1459369|NCT00931372|GLP-1 agonist|glp-1 agonist
1459370|NCT00931359|axillary|axillary
1459371|NCT00931359|hyperhidrosis|hyperhidrosis
1459372|NCT00931359|primary focal|primary focal
1459373|NCT00931346|HIV|hiv
1459374|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
1459375|NCT00931333|Vertebroplasty|vertebroplasty
1459376|NCT00931333|spine|spine
1459377|NCT00931333|vertebra height|vertebra height
1459378|NCT00931333|adverse events|adverse events
1459379|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
1459380|NCT00931320|Ratio improvement|ratio improvement
1459381|NCT00931320|LDL-C|ldl-c
1459382|NCT00931320|HDL-C|hdl-c
1459383|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
1459384|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
1459385|NCT00931281|Multiple Ascending Doses|multiple ascending doses
1459386|NCT00931268|Lipoatrophy|lipoatrophy
1459387|NCT00931268|Buttock treatment|buttock treatment
1459388|NCT00931255|kidney transplant|kidney transplant
1459389|NCT00931255|tacrolimus|tacrolimus
1459390|NCT00931255|sirolimus|sirolimus
1459391|NCT00931255|delayed graft function|delayed graft function
1459392|NCT00931255|Graft survival|graft survival
1459393|NCT00931255|Acute rejection|acute rejection
1459394|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
1459395|NCT00931242|eczema|eczema
1459396|NCT00931242|dermatitis|dermatitis
1459397|NCT00931242|TNF blockade|tnf blockade
1459398|NCT00931242|PDE4 inhibitor|pde4 inhibitor
1459591|NCT00930384|psoriasis|psoriasis
1459399|NCT00931242|T cell inhibitor|t cell inhibitor
1459400|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
1459401|NCT00931216|PMTCT|pmtct
1459402|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
1459403|NCT00931216|Pregnant women|pregnant women
1459404|NCT00931216|Infant HIV testing|infant hiv testing
1459405|NCT00931216|Kenya|kenya
1459406|NCT00931216|AIDS|aids
1459407|NCT00931164|phase I/II study|phase i/ii study
1459408|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
1459409|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
1459410|NCT00931164|AHC|ahc
1459411|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
1459412|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
1459413|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
1459414|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
1459415|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
1459416|NCT00931112|Walking ability|walking ability
1459417|NCT00931112|Quality of life|quality of life
1459418|NCT00931112|Exercise training|exercise training
1459419|NCT00931099|pregnancy|pregnancy
1459420|NCT00931099|sleep disordered breathing|sleep disordered breathing
1459421|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
1459422|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
1459423|NCT00931086|RA|ra
1459424|NCT00931073|Drug Interactions|drug interactions
1459425|NCT00931073|pharmacokinetics|pharmacokinetics
1459426|NCT00931073|CYP2D6|cyp2d6
1459427|NCT00931073|CYP2C19|cyp2c19
1459428|NCT00931073|ketoconazole|ketoconazole
1459429|NCT00931073|omeprazole|omeprazole
1459430|NCT00931060|Ammonia|ammonia
1459431|NCT00931060|Citric acid cycle|citric acid cycle
1459432|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
1459433|NCT00931034|South Beach Diet™|south beach diet™
1459434|NCT00931034|overweight|overweight
1459435|NCT00931034|obesity|obesity
1459436|NCT00931034|satiety|satiety
1459437|NCT00931034|weight loss|weight loss
1459438|NCT00931034|diabetes|diabetes
1459439|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
1459440|NCT00930982|Ciprofloxacin|ciprofloxacin
1459441|NCT00930982|Airway infection|airway infection
1459442|NCT00930982|Bronchiectasis|bronchiectasis
1459443|NCT00930969|Cardiac Ischemia|cardiac ischemia
1459444|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
1459445|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
1459446|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1459447|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
1459448|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1459449|NCT00930956|Diabetes|diabetes
1459450|NCT00930956|Obesity|obesity
1459451|NCT00930956|Hyperglycemia|hyperglycemia
1459452|NCT00930956|Dietary Fiber|dietary fiber
1459453|NCT00930956|Wheat|wheat
1459454|NCT00930956|Grain|grain
1459455|NCT00930943|opioid tolerant|opioid tolerant
1459456|NCT00930943|chronic pain|chronic pain
1459457|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
1459458|NCT00930930|stage II breast cancer|stage ii breast cancer
1459459|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
1459460|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
1459461|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
1459462|NCT00930930|male breast cancer|male breast cancer
1567378|NCT00509405|Endogenous acid production|endogenous acid production
1459463|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
1459464|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
1459465|NCT00930878|registry|registry
1459466|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
1459467|NCT00930878|observational|observational
1459468|NCT00930878|prospective|prospective
1459469|NCT00930878|open-label|open-label
1459470|NCT00930852|Migraine|migraine
1459471|NCT00930852|Children|children
1459472|NCT00930852|Primary headache disorders|primary headache disorders
1459473|NCT00930852|Appetite|appetite
1459474|NCT00930852|Obesity|obesity
1459475|NCT00930852|Feeding Behavior|feeding behavior
1459476|NCT00930839|Niacin|niacin
1459477|NCT00930839|Prostaglandin D2|prostaglandin d2
1459478|NCT00930839|Flushing|flushing
1459479|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
1459480|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
1459481|NCT00930813|Drug coated balloon|drug coated balloon
1459482|NCT00930813|SFA disease|sfa disease
1459483|NCT00930813|Femoropopliteal disease|femoropopliteal disease
1459484|NCT00930813|Angioplasty|angioplasty
1459485|NCT00930813|PAD|pad
1459486|NCT00930813|Paclitaxel|paclitaxel
1459487|NCT00930813|Tubulin modulators|tubulin modulators
1459488|NCT00930813|Antineoplastic Agents|antineoplastic agents
1459489|NCT00930813|Mitosis Modulators|mitosis modulators
1459490|NCT00930813|Balloon angioplasty|balloon angioplasty
1459491|NCT00930813|Local drug delivery|local drug delivery
1459492|NCT00930813|Restenosis|restenosis
1459493|NCT00930813|Drug-coated balloon|drug-coated balloon
1459494|NCT00930800|Exercise capacity|exercise capacity
1459495|NCT00930800|Physical activity|physical activity
1459496|NCT00930800|Quality of life|quality of life
1459497|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
1459498|NCT00930774|traumatic brain injury|traumatic brain injury
1459499|NCT00930774|rehabilitation|rehabilitation
1459500|NCT00930774|auditory processing disorder|auditory processing disorder
1459501|NCT00930761|breast feeding|breast feeding
1459502|NCT00930761|music therapy|music therapy
1459503|NCT00930761|maternal welfare|maternal welfare
1459504|NCT00930761|infant, newborn|infant, newborn
1459505|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
1459506|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
1459507|NCT00930709|Exercise|exercise
1459508|NCT00930709|Randomized Controlled Trial|randomized controlled trial
1459509|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
1459510|NCT00930709|Strength Training|strength training
1459511|NCT00930709|Treatment Outcome|treatment outcome
1459512|NCT00930696|endometriosis|endometriosis
1459513|NCT00930696|abdominal lavage|abdominal lavage
1459514|NCT00930696|bowel perforation|bowel perforation
1459515|NCT00930696|discoid resection|discoid resection
1459516|NCT00930696|laparoscopy|laparoscopy
1459517|NCT00930670|ranitidine|ranitidine
1459518|NCT00930670|pantoprazole|pantoprazole
1459519|NCT00930670|esomeprazole|esomeprazole
1459520|NCT00930670|omeprazole|omeprazole
1459521|NCT00930670|atorvastatin|atorvastatin
1459522|NCT00930670|rosuvastatin|rosuvastatin
1459523|NCT00930670|statin|statin
1459524|NCT00930670|clopidogrel resistance|clopidogrel resistance
1459525|NCT00930670|antiplatelet therapy|antiplatelet therapy
1459526|NCT00930670|coronary artery disease|coronary artery disease
1459527|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
1459528|NCT00930670|stent|stent
1459529|NCT00930670|clopidogrel|clopidogrel
1459530|NCT00930670|proton pump inhibitors|proton pump inhibitors
1459531|NCT00930670|drug interactions|drug interactions
1459532|NCT00930670|drug resistance|drug resistance
1459533|NCT00930670|genetic polymorphism|genetic polymorphism
1459534|NCT00930657|Panic Disorder|panic disorder
1459535|NCT00930657|Separation Anxiety|separation anxiety
1459536|NCT00930657|Familial|familial
1459537|NCT00930657|Risk|risk
1459538|NCT00930657|Respiratory Physiology|respiratory physiology
1459539|NCT00930644|short bowel syndrome|short bowel syndrome
1459540|NCT00930644|parenteral nutrition|parenteral nutrition
1459541|NCT00930644|PN|pn
1459542|NCT00930644|HPN|hpn
1459543|NCT00930644|TPN|tpn
1459544|NCT00930644|SBS|sbs
1459545|NCT00930631|CAD|cad
1459546|NCT00930631|Pharmacokinetics|pharmacokinetics
1459547|NCT00930631|BMS747158|bms747158
1459548|NCT00930618|Prolonged pregnancy|prolonged pregnancy
1459549|NCT00930618|Nulliparity|nulliparity
1459550|NCT00930618|Cervical ripening|cervical ripening
1459551|NCT00930618|Induced labor|induced labor
1459552|NCT00930618|Cesarean section|cesarean section
1459553|NCT00930592|Psoriasis|psoriasis
1459554|NCT00930592|Metabolic Syndrome|metabolic syndrome
1459555|NCT00930592|Cardiovascular Risk|cardiovascular risk
1459556|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1459557|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
1459558|NCT00930553|Multiple Sclerosis|multiple sclerosis
1459559|NCT00930501|chemotherapy|chemotherapy
1459560|NCT00930501|cancer|cancer
1459561|NCT00930501|AMH|amh
1459562|NCT00930501|gonadotoxicity|gonadotoxicity
1459563|NCT00930501|ovarian reserve|ovarian reserve
1459564|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
1459565|NCT00930488|Moxifloxacin|moxifloxacin
1459566|NCT00930488|MXF|mxf
1459567|NCT00930488|Avelox|avelox
1459568|NCT00930488|Sinusitis|sinusitis
1459569|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
1459570|NCT00930462|colonoscopy|colonoscopy
1459571|NCT00930462|cap|cap
1459572|NCT00930462|hood|hood
1459573|NCT00930462|cecal intubation time|cecal intubation time
1459574|NCT00930462|polyp detection rate|polyp detection rate
1459575|NCT00930462|performance|performance
1459576|NCT00930449|Pediatrics|pediatrics
1459577|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
1459578|NCT00930449|Learning Disorder|learning disorder
1459579|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
1459580|NCT00930436|chronic kidney disease|chronic kidney disease
1459581|NCT00930410|pancreas neoplasms|pancreas neoplasms
1459582|NCT00930410|bile duct diseases|bile duct diseases
1459583|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1459584|NCT00930410|ERCP|ercp
1459585|NCT00930397|Pre-eclampsia|pre-eclampsia
1459586|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
1459587|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
1459588|NCT00930397|IUGR|iugr
1459589|NCT00930397|Screening|screening
1459590|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
1459592|NCT00930384|fatty liver|fatty liver
1459593|NCT00930384|metabolic syndrome|metabolic syndrome
1459594|NCT00930371|fatty liver|fatty liver
1459595|NCT00930371|insulin resistance|insulin resistance
1459596|NCT00930371|diet|diet
1459597|NCT00930371|inflammation|inflammation
1459598|NCT00930371|oxidative stress|oxidative stress
1459599|NCT00930358|Sedation|sedation
1459600|NCT00930358|Colonoscopy|colonoscopy
1459601|NCT00930358|General anesthesia|general anesthesia
1459602|NCT00930345|Renal cell carcinoma|renal cell carcinoma
1459603|NCT00930345|Antiangiogenics|antiangiogenics
1459604|NCT00930345|Biomarkers|biomarkers
1459605|NCT00930345|Imagery|imagery
1459606|NCT00930332|sleep disorders|sleep disorders
1459607|NCT00930332|nausea and vomiting|nausea and vomiting
1459608|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1459609|NCT00930332|pain|pain
1459610|NCT00930306|Chronic Pain|chronic pain
1459611|NCT00930306|AZD2066|azd2066
1459612|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
1459613|NCT00930280|stroke|stroke
1459614|NCT00930280|brain attack|brain attack
1459615|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
1459616|NCT00930280|risk factors|risk factors
1459617|NCT00930267|fever|fever
1459618|NCT00930267|children|children
1459619|NCT00930267|cancer|cancer
1459620|NCT00930267|leukemia|leukemia
1459621|NCT00930267|stem cell transplantation|stem cell transplantation
1459622|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
1459623|NCT00930254|pediatric nursing|pediatric nursing
1459624|NCT00930254|peripheral catheterization|peripheral catheterization
1459625|NCT00930254|ultrasonics|ultrasonics
1459626|NCT00930254|intravenous infusions|intravenous infusions
1459627|NCT00930241|Lung Transplantation|lung transplantation
1459628|NCT00930241|Tacrolimus|tacrolimus
1459629|NCT00930241|Deterioration of graft function|deterioration of graft function
1459630|NCT00930228|Luteinizing hormone|luteinizing hormone
1459631|NCT00930228|Testosterone|testosterone
1459632|NCT00930215|Healthy volunteer|healthy volunteer
1459633|NCT00930215|Japanese males|japanese males
1459634|NCT00930215|homo-EM|homo-em
1459635|NCT00930215|Bioequivalence study|bioequivalence study
1459636|NCT00930202|Traumatic Brain Injury|traumatic brain injury
1459637|NCT00930202|Conivaptan|conivaptan
1459638|NCT00930202|Vaprisol|vaprisol
1459639|NCT00930202|Sodium|sodium
1459640|NCT00930189|age related macular degeneration|age related macular degeneration
1459641|NCT00930163|Adult Asthma|adult asthma
1459642|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
1459643|NCT00930137|Cardiovascular disease|cardiovascular disease
1459644|NCT00930137|Trans fatty acids|trans fatty acids
1459645|NCT00930137|Ruminant|ruminant
1459646|NCT00930137|Blood lipids|blood lipids
1459647|NCT00930137|Lipoproteins|lipoproteins
1459648|NCT00930137|Women|women
1459649|NCT00930124|cleft lip and palate|cleft lip and palate
1459650|NCT00930124|distraction osteogenesis|distraction osteogenesis
1459651|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
1459652|NCT00930124|stability|stability
1459653|NCT00930124|morbidity|morbidity
1459654|NCT00930124|soft tissue changes|soft tissue changes
1459655|NCT00930124|psychological adjustment|psychological adjustment
1459656|NCT00930124|speech changes|speech changes
1459657|NCT00930124|velopharyngeal function|velopharyngeal function
1459658|NCT00930111|inpatient|inpatient
1459659|NCT00930111|hospitalists|hospitalists
1459660|NCT00930111|residency|residency
1459661|NCT00930111|job satisfaction|job satisfaction
1459662|NCT00930111|burnout, professional|burnout, professional
1459663|NCT00930111|professional practice|professional practice
1459664|NCT00930111|medical education|medical education
1459665|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1459666|NCT00930098|clolar|clolar
1459667|NCT00930098|evoltra|evoltra
1459668|NCT00930098|clofarabine|clofarabine
1459669|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
1459670|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
1459671|NCT00930085|sepsis|sepsis
1459672|NCT00930085|septic shock|septic shock
1459673|NCT00930059|Alzheimer's disease|alzheimer's disease
1459674|NCT00930059|PF-04447943|pf-04447943
1459675|NCT00930059|efficacy|efficacy
1459676|NCT00930059|safety|safety
1459677|NCT00930059|plasma concentrations|plasma concentrations
1459678|NCT00930046|ropivacaine|ropivacaine
1459679|NCT00930046|pediatric|pediatric
1459680|NCT00930046|children|children
1459681|NCT00930046|continuous|continuous
1459682|NCT00930046|wound|wound
1459683|NCT00930046|catheter|catheter
1459684|NCT00930046|infusion|infusion
1459685|NCT00930046|pyeloplasty|pyeloplasty
1459686|NCT00930033|Nephrectomy,|nephrectomy,
1459687|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
1459688|NCT00930033|sunitinib|sunitinib
1459689|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
1459690|NCT00930020|minocycline|minocycline
1459691|NCT00930020|neuroprotection|neuroprotection
1459692|NCT00930020|acute stroke|acute stroke
1459693|NCT00930007|Luteinizing hormone|luteinizing hormone
1459694|NCT00930007|Puberty|puberty
1459695|NCT00929994|cardiac rehab|cardiac rehab
1459696|NCT00929981|Contact Dermatitis|contact dermatitis
1459697|NCT00929981|Allergic Dermatitis|allergic dermatitis
1459698|NCT00929968|Allergic rhinitis,|allergic rhinitis,
1459699|NCT00929968|atopic patients,|atopic patients,
1459700|NCT00929968|seasonal allergy,|seasonal allergy,
1459701|NCT00929968|ragweed allergy|ragweed allergy
1459702|NCT00929955|Anti inflammatory|anti inflammatory
1459703|NCT00929955|Schizophrenia|schizophrenia
1459704|NCT00929955|Simvastatin|simvastatin
1459705|NCT00929955|ondansetron|ondansetron
1459706|NCT00929942|lung transplantation|lung transplantation
1459707|NCT00929942|bronchial stenosis|bronchial stenosis
1459708|NCT00929942|biodegradable stent|biodegradable stent
1459709|NCT00929929|Aging|aging
1459710|NCT00929929|Functionality|functionality
1459711|NCT00929929|Sarcopenia|sarcopenia
1459712|NCT00929929|Leucine|leucine
1459713|NCT00929929|Progressive resistance exercise|progressive resistance exercise
1459714|NCT00929916|colonoscopy|colonoscopy
1459715|NCT00929916|MoviPrep|moviprep
1459716|NCT00929890|Obesity|obesity
1459717|NCT00929890|Exercise|exercise
1459718|NCT00929890|Diet|diet
1459719|NCT00929890|Lifestyle|lifestyle
1459720|NCT00929890|Vascular reactivity|vascular reactivity
1459721|NCT00929890|Body composition|body composition
1459722|NCT00929890|Lipids|lipids
1459723|NCT00929890|Glucose|glucose
1459724|NCT00929890|Insulin resistance|insulin resistance
1459725|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1459726|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
1459727|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1459728|NCT00929838|African Americans|african americans
1459729|NCT00929838|Blacks|blacks
1459730|NCT00929838|Randomized Controlled Trial|randomized controlled trial
1459731|NCT00929838|Controlled Clinical Trial|controlled clinical trial
1459732|NCT00929838|Behavioral Research|behavioral research
1459733|NCT00929838|Behavioral Medicine|behavioral medicine
1459734|NCT00929825|Salivary stimulation|salivary stimulation
1459735|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
1459736|NCT00929825|Hyperboloid|hyperboloid
1459737|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
1459738|NCT00929812|obesity|obesity
1459739|NCT00929812|food intake|food intake
1459740|NCT00929812|glucagon|glucagon
1459741|NCT00929812|ghrelin|ghrelin
1459742|NCT00929812|glucose|glucose
1459743|NCT00929812|insulin|insulin
1459744|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
1459745|NCT00929760|Chronic Kidney disease|chronic kidney disease
1459746|NCT00929760|Nephrologists|nephrologists
1459747|NCT00929760|Primary Care|primary care
1459748|NCT00929760|Death|death
1459749|NCT00929760|Renal Replacement Therapy|renal replacement therapy
1459750|NCT00929760|Specialised renal care|specialised renal care
1459751|NCT00929747|Cataract|cataract
1459752|NCT00929747|Toric|toric
1459753|NCT00929747|IOL|iol
1459754|NCT00929747|AcrySof, LRI|acrysof, lri
1459755|NCT00929734|Inflammation|inflammation
1459756|NCT00929734|Atherosclerosis|atherosclerosis
1459757|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
1459758|NCT00929721|CAP|cap
1459759|NCT00929708|COPD|copd
1459761|NCT00929708|Safety|safety
1459762|NCT00929708|Inhalation|inhalation
1459763|NCT00929682|Labor|labor
1459764|NCT00929682|Epidural analgesia|epidural analgesia
1459765|NCT00929682|Local anesthetics|local anesthetics
1459766|NCT00929682|Levobupivacaine|levobupivacaine
1459767|NCT00929682|Opiates|opiates
1459768|NCT00929682|Patient-controlled|patient-controlled
1459769|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
1459770|NCT00929669|pituitary tumor|pituitary tumor
1459771|NCT00929669|endocrine|endocrine
1459772|NCT00929656|Rehabilitation|rehabilitation
1459773|NCT00929656|Neurophysiology|neurophysiology
1459774|NCT00929656|Upper Extremity|upper extremity
1459775|NCT00929643|health care costs|health care costs
1459776|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
1459777|NCT00929630|fibrin glue|fibrin glue
1459778|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
1459779|NCT00929630|seton|seton
1459780|NCT00929630|incontinence|incontinence
1459781|NCT00929630|prospective randomised trial|prospective randomised trial
1459782|NCT00929617|breast cancer|breast cancer
1459783|NCT00929617|physical activity|physical activity
1459784|NCT00929617|exercise|exercise
1459785|NCT00929617|quality of life|quality of life
1459786|NCT00929617|doubly labeled water|doubly labeled water
1459787|NCT00929604|HIV|hiv
1459788|NCT00929604|AIDS|aids
1459789|NCT00929604|Zambia|zambia
1459790|NCT00929604|viral load|viral load
1459791|NCT00929604|antiretroviral therapy|antiretroviral therapy
1459792|NCT00929604|cluster randomization|cluster randomization
1459793|NCT00929604|ART monitoring|art monitoring
1459794|NCT00929604|treatment failure|treatment failure
1459795|NCT00929604|randomized clinical trial|randomized clinical trial
1459796|NCT00929604|treatment naive|treatment naive
1459797|NCT00929591|stage II breast cancer|stage ii breast cancer
1459798|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
1459799|NCT00929578|Psoriasis|psoriasis
1459800|NCT00929578|T-lymphocytes|t-lymphocytes
1459801|NCT00929578|Fluphenazine|fluphenazine
1459802|NCT00929565|hemoptysis|hemoptysis
1459803|NCT00929552|Blood pressure|blood pressure
1459804|NCT00929552|Insulin sensitivity|insulin sensitivity
1459805|NCT00929552|Blood lipid profile|blood lipid profile
1459806|NCT00929539|Diabetes|diabetes
1459807|NCT00929526|HPV vaccine|hpv vaccine
1459808|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1459809|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
1459810|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
1459811|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
1459812|NCT00929487|contact lens wear|contact lens wear
1459813|NCT00929487|contact lens solution|contact lens solution
1459814|NCT00929487|corneal staining|corneal staining
1459815|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
1459816|NCT00929461|lactate|lactate
1459817|NCT00929461|surgery|surgery
1459818|NCT00929461|gastric cancer|gastric cancer
1459819|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
1459820|NCT00929448|Traumatic brain injury|traumatic brain injury
1459821|NCT00929435|MRSA|mrsa
1459822|NCT00929435|Contact isolation|contact isolation
1459823|NCT00929435|Incidence|incidence
1459824|NCT00929422|spinal cord injury|spinal cord injury
1459825|NCT00929422|PET|pet
1459826|NCT00929422|cerebral function|cerebral function
1459827|NCT00929422|cortical reorganization|cortical reorganization
1459828|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
1459829|NCT00929396|Tuberculosis|tuberculosis
1459830|NCT00929396|Vaccine|vaccine
1459831|NCT00929396|Ag85B|ag85b
1459832|NCT00929396|ESAT-6|esat-6
1459833|NCT00929396|IC31|ic31
1459834|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
1459835|NCT00929383|Stenosis|stenosis
1459836|NCT00929383|ICAD|icad
1459837|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
1459838|NCT00929383|stenting|stenting
1459839|NCT00929370|Schizophrenia|schizophrenia
1459840|NCT00929370|GSK1018921|gsk1018921
1459841|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
1459842|NCT00929370|Healthy Volunteers|healthy volunteers
1459843|NCT00929370|CSF|csf
1459844|NCT00929370|Patient|patient
1459845|NCT00929370|Midazolam|midazolam
1459846|NCT00929344|Alcohol|alcohol
1459847|NCT00929344|Alcohol treatment|alcohol treatment
1459848|NCT00929344|Alcoholism|alcoholism
1459849|NCT00929344|Alcohol Abuse|alcohol abuse
1459850|NCT00929344|Alcohol Dependence|alcohol dependence
1459851|NCT00929331|Influenza|influenza
1459852|NCT00929331|Fluviral®|fluviral®
1459853|NCT00929305|chronic pain|chronic pain
1459854|NCT00929305|neck|neck
1459855|NCT00929305|shoulder|shoulder
1459856|NCT00929305|musculoskeletal origin|musculoskeletal origin
1459857|NCT00929292|Infant formula|infant formula
1459858|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
1459859|NCT00929292|Protein composition|protein composition
1459860|NCT00929292|Colic|colic
1459861|NCT00929292|Probiotics|probiotics
1459862|NCT00929279|Acute coronary syndrome|acute coronary syndrome
1459863|NCT00929279|Abciximab|abciximab
1459864|NCT00929279|Bolus|bolus
1459865|NCT00929279|Infusion|infusion
1459866|NCT00929279|platelet inhibition|platelet inhibition
1459867|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
1459868|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
1459869|NCT00929266|cultured red blood cells|cultured red blood cells
1459870|NCT00929266|In vivo half life|in vivo half life
1459871|NCT00929253|Opioid Dependence|opioid dependence
1459872|NCT00929253|Opiates|opiates
1459873|NCT00929253|Hydrocodone|hydrocodone
1459874|NCT00929253|Oxycodone|oxycodone
1459875|NCT00929253|Oxycontin|oxycontin
1459876|NCT00929253|Narcotic Abuse|narcotic abuse
1459877|NCT00929227|Atherosclerosis|atherosclerosis
1459878|NCT00929227|Myocardial Ischemia|myocardial ischemia
1459879|NCT00929227|Diagnostic Testing|diagnostic testing
1459880|NCT00929227|Cardiac Commuted Tomography|cardiac commuted tomography
1459881|NCT00929227|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1459882|NCT00929227|Coronary Artery Disease|coronary artery disease
1459883|NCT00929214|Breast Cancer|breast cancer
1459884|NCT00929214|Metastasized|metastasized
1459885|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
1459886|NCT00929214|Local Therapy|local therapy
1459887|NCT00929214|Radiation|radiation
1459888|NCT00929214|Radiation Therapy|radiation therapy
1459890|NCT00929214|Surgery|surgery
1459891|NCT00929214|Standard Therapy|standard therapy
1459892|NCT00929214|Chemotherapy|chemotherapy
1459988|NCT00928902|peptides|peptides
1459893|NCT00929214|Endocrine Therapy|endocrine therapy
1459894|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
1459895|NCT00929188|Cancer-related pain|cancer-related pain
1459896|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
1459897|NCT00929188|JNJ-42160443|jnj-42160443
1459898|NCT00929175|Hypertension|hypertension
1459899|NCT00929175|Resistant Hypertension|resistant hypertension
1459900|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
1459901|NCT00929175|Treatment|treatment
1459902|NCT00929162|ovarian|ovarian
1459903|NCT00929162|cancer|cancer
1459904|NCT00929162|chemotherapy|chemotherapy
1459905|NCT00929162|sensitive|sensitive
1459906|NCT00929162|ZD4054|zd4054
1459907|NCT00929136|Endotoxin|endotoxin
1459908|NCT00929136|Insulin resistance|insulin resistance
1459909|NCT00929136|Lipolysis|lipolysis
1459910|NCT00929136|Proteolysis|proteolysis
1459911|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
1459912|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
1459913|NCT00929123|manual therapy|manual therapy
1459914|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
1459915|NCT00929123|central sensitization|central sensitization
1459916|NCT00929110|COPD|copd
1459917|NCT00929110|NVA237|nva237
1459918|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
1459919|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
1459920|NCT00929097|Guideline|guideline
1459921|NCT00929097|Health Plan Implementation|health plan implementation
1459922|NCT00929097|Decision Support Techniques|decision support techniques
1459923|NCT00929097|Risk assessment|risk assessment
1459924|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
1459925|NCT00929097|Risk assessment tool|risk assessment tool
1459926|NCT00929084|Race Disparities|race disparities
1459927|NCT00929084|Breast Cancer|breast cancer
1459928|NCT00929084|Quality of Life|quality of life
1459929|NCT00929084|Treatment Adherence|treatment adherence
1459930|NCT00929071|wrinkles|wrinkles
1459931|NCT00929071|dermal filler|dermal filler
1459932|NCT00929071|collagen|collagen
1459933|NCT00929071|soft tissue augmentation|soft tissue augmentation
1459934|NCT00929071|lidocaine|lidocaine
1459935|NCT00929071|aesthetic|aesthetic
1459936|NCT00929045|Growth Hormone replacement|growth hormone replacement
1459937|NCT00929045|subject 8 to 21|subject 8 to 21
1459938|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
1459939|NCT00929045|growth hormone deficient|growth hormone deficient
1459940|NCT00929032|Liver Transplantation|liver transplantation
1459941|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
1459942|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
1459943|NCT00929019|uveal melanoma|uveal melanoma
1459944|NCT00929019|chromosome 3|chromosome 3
1459945|NCT00929019|high risk|high risk
1459946|NCT00929019|immunotherapy|immunotherapy
1459947|NCT00929019|adjuvant|adjuvant
1459948|NCT00929019|high risk genetic profile|high risk genetic profile
1459949|NCT00929019|loss of chromosome 3|loss of chromosome 3
1459950|NCT00929006|hyperandrogenemia|hyperandrogenemia
1459951|NCT00929006|pubertal|pubertal
1459952|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
1459953|NCT00928993|actigraphy|actigraphy
1459954|NCT00928993|polysomnography|polysomnography
1459955|NCT00928993|pediatrics|pediatrics
1459956|NCT00928993|sleep|sleep
1460641|NCT00926146|HIV|hiv
1459957|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
1459958|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
1459959|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
1459960|NCT00928980|Cost-effectiveness|cost-effectiveness
1459961|NCT00928980|Antidepressant medication|antidepressant medication
1459962|NCT00928980|Randomized Controlled Trial|randomized controlled trial
1459963|NCT00928967|Multiple Sclerosis|multiple sclerosis
1459964|NCT00928967|Quality of life|quality of life
1459965|NCT00928954|gabapentin|gabapentin
1459966|NCT00928954|memantine|memantine
1459967|NCT00928954|nystagmus|nystagmus
1459968|NCT00928954|Drug treatment|drug treatment
1459969|NCT00928941|PTSD|ptsd
1459970|NCT00928941|rehabilitation|rehabilitation
1459971|NCT00928928|Lipid peroxidation|lipid peroxidation
1459972|NCT00928928|Protein peroxidation|protein peroxidation
1459973|NCT00928928|DNA peroxidation|dna peroxidation
1459974|NCT00928928|RNA peroxidation|rna peroxidation
1459975|NCT00928928|Cytokines|cytokines
1459976|NCT00928928|hsCRP|hscrp
1459977|NCT00928928|Oxidative stress markers|oxidative stress markers
1459978|NCT00928928|Open surgery|open surgery
1459979|NCT00928928|Laparoscopic surgery|laparoscopic surgery
1459980|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
1459981|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
1459982|NCT00928915|Hemostatic treatment|hemostatic treatment
1459983|NCT00928915|Prothrombin complex|prothrombin complex
1459984|NCT00928915|Fresh frozen plasma|fresh frozen plasma
1459985|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
1459986|NCT00928902|melanoma|melanoma
1459987|NCT00928902|vaccine|vaccine
1459989|NCT00928902|adjuvant|adjuvant
1459990|NCT00928902|immunogenicity|immunogenicity
1459991|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
1459992|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
1459993|NCT00928889|nateglinide|nateglinide
1459994|NCT00928889|acarbose|acarbose
1459995|NCT00928889|hyperglycemia|hyperglycemia
1459996|NCT00928889|dyslipidemias|dyslipidemias
1459997|NCT00928889|C-reactive protein|c-reactive protein
1459998|NCT00928876|anakinra|anakinra
1459999|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
1460000|NCT00928876|Insulin resistance|insulin resistance
1460001|NCT00928876|Interleukin-1beta|interleukin-1beta
1460002|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
1460003|NCT00928863|implementation guidelines|implementation guidelines
1460004|NCT00928863|maternal morbidity|maternal morbidity
1460005|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
1460006|NCT00928850|Prostate|prostate
1460007|NCT00928850|Radical Prostatectomy|radical prostatectomy
1460008|NCT00928850|urethral irrigation|urethral irrigation
1460009|NCT00928850|fascial suturing|fascial suturing
1460010|NCT00928850|09-051|09-051
1460011|NCT00928811|Simulect|simulect
1460012|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
1460013|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
1460014|NCT00928811|Prograf|prograf
1460015|NCT00928785|Tetanus Vaccine|tetanus vaccine
1460016|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
1460017|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
1460018|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
1460019|NCT00928772|Preoperative sedation|preoperative sedation
1460020|NCT00928772|Perioperative sedation|perioperative sedation
1460021|NCT00928759|Obesity|obesity
1460022|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
1460023|NCT00928733|Permeability|permeability
1460024|NCT00928733|tight junctions|tight junctions
1460025|NCT00928733|cytokines|cytokines
1460026|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
1460027|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
1460028|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
1460029|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
1460030|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
1460031|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
1567163|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
1567164|NCT00509691|infection|infection
1460032|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
1460033|NCT00928720|fibromyalgia|fibromyalgia
1460034|NCT00928720|pain|pain
1460035|NCT00928720|sleep disturbance|sleep disturbance
1460036|NCT00928720|fatigue|fatigue
1460037|NCT00928720|depression|depression
1460038|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
1460934|NCT00925093|teicoplanin|teicoplanin
1460039|NCT00928707|Polycythemia Vera|polycythemia vera
1460040|NCT00928707|GIVINOSTAT|givinostat
1460041|NCT00928707|ITF2357|itf2357
1460042|NCT00928655|apnea|apnea
1460043|NCT00928655|sleep|sleep
1460044|NCT00928655|altitude|altitude
1460045|NCT00928655|hypoxia|hypoxia
1460046|NCT00928655|treatment|treatment
1460047|NCT00928655|CPAP|cpap
1460048|NCT00928642|ovarian|ovarian
1460049|NCT00928642|cancer|cancer
1460050|NCT00928642|peritoneal|peritoneal
1460051|NCT00928642|endometrioid|endometrioid
1460052|NCT00928642|mucinous|mucinous
1460053|NCT00928642|serous|serous
1460054|NCT00928642|clear cell|clear cell
1460055|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
1460056|NCT00928629|Cardiovascular Disease|cardiovascular disease
1460057|NCT00928629|Vascular Disease|vascular disease
1460058|NCT00928616|hyperlipidemia|hyperlipidemia
1460059|NCT00928616|plant sterols|plant sterols
1460060|NCT00928616|monocytes|monocytes
1460061|NCT00928603|prostate cancer|prostate cancer
1460062|NCT00928603|therapy|therapy
1460063|NCT00928590|open-angle glaucoma|open-angle glaucoma
1460064|NCT00928590|ocular hypertension|ocular hypertension
1460065|NCT00928590|pseudoexfoliation|pseudoexfoliation
1460066|NCT00928590|pigment dispersion|pigment dispersion
1460067|NCT00928577|Smallpox|smallpox
1460068|NCT00928577|Smallpox Vaccine|smallpox vaccine
1460069|NCT00928577|Vaccinia virus|vaccinia virus
1460070|NCT00928577|Military|military
1460071|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
1460072|NCT00928564|Pelvic pain|pelvic pain
1460073|NCT00928564|physical therapy|physical therapy
1460074|NCT00928564|pudendal block|pudendal block
1460075|NCT00928538|Female Contraception|female contraception
1460076|NCT00928538|Home Visits|home visits
1460077|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
1460078|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
1460079|NCT00928525|PDGFr alpha|pdgfr alpha
1460080|NCT00928525|PDGFr beta|pdgfr beta
1460081|NCT00928525|KIT|kit
1460082|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
1460083|NCT00928499|urge/frequency|urge/frequency
1460084|NCT00928499|urge incontinence|urge incontinence
1460085|NCT00928499|Interstim|interstim
1460086|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
1460087|NCT00928460|Electrocardiogram|electrocardiogram
1460088|NCT00928460|Electrocardiography|electrocardiography
1460089|NCT00928460|Perioperative care|perioperative care
1460090|NCT00928460|Preoperative care|preoperative care
1460091|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
1460092|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
1460093|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
1460094|NCT00928460|Myocardial ischaemia|myocardial ischaemia
1460095|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
1460096|NCT00928460|Intraoperative complications|intraoperative complications
1460097|NCT00928460|Postoperative complications|postoperative complications
1460098|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
1460099|NCT00928447|rHuPH20|rhuph20
1460100|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
1460101|NCT00928421|Varicose Veins|varicose veins
1460102|NCT00928395|Urgent PC|urgent pc
1460103|NCT00928395|Overactive Bladder|overactive bladder
1460104|NCT00928395|SUmiT Trial|sumit trial
1460105|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
1460106|NCT00928382|Spinal Cord|spinal cord
1460107|NCT00928382|Healthy Volunteer|healthy volunteer
1460108|NCT00928382|Metastasis|metastasis
1460109|NCT00928382|Samples|samples
1460110|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
1460111|NCT00928382|Cancer|cancer
1460112|NCT00928382|HV|hv
1460113|NCT00928356|Coronary Artery Disease|coronary artery disease
1460114|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
1460115|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
1460116|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
1460117|NCT00928343|Safety|safety
1460118|NCT00928343|Tolerability|tolerability
1460119|NCT00928343|Pharmacokinetics|pharmacokinetics
1460120|NCT00928330|TDM-1|tdm-1
1460121|NCT00928330|HER2|her2
1460122|NCT00928330|HER2+|her2+
1460123|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
1460124|NCT00928330|HER-2|her-2
1460125|NCT00928330|MBC|mbc
1460126|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
1460127|NCT00928304|Amyloid beta-protein|amyloid beta-protein
1460128|NCT00928304|Down Syndrome|down syndrome
1460129|NCT00928291|procalcitonin|procalcitonin
1460130|NCT00928291|neutropenia|neutropenia
1460131|NCT00928291|febrile neutropenia|febrile neutropenia
1460132|NCT00928291|antibiotic therapy|antibiotic therapy
1460133|NCT00928291|neutropenic patients|neutropenic patients
1460134|NCT00928265|intracranial|intracranial
1460135|NCT00928265|stenting|stenting
1460136|NCT00928265|endovascular treatment|endovascular treatment
1460137|NCT00928265|stent-assisted coiling|stent-assisted coiling
1460138|NCT00928265|cerebrovascular disease|cerebrovascular disease
1460139|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1460140|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
1460141|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
1460142|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
1460143|NCT00928213|Preeclampsia|preeclampsia
1460144|NCT00928213|IUGR|iugr
1460145|NCT00928213|GH|gh
1460146|NCT00928213|PP13|pp13
1460147|NCT00928213|Doppler|doppler
1460148|NCT00928213|placenta|placenta
1460149|NCT00928213|PTD|ptd
1460150|NCT00928213|Preterm delivery|preterm delivery
1460151|NCT00928200|Relapsed|relapsed
1460152|NCT00928200|Allergy|allergy
1460153|NCT00928200|Erwinia|erwinia
1460154|NCT00928200|Acute|acute
1460155|NCT00928200|Lymphoblastic|lymphoblastic
1460156|NCT00928200|Leukemia|leukemia
1460157|NCT00928187|HIV|hiv
1460158|NCT00928187|Second line treatment|second line treatment
1460159|NCT00928187|WHO recommendations|who recommendations
1460160|NCT00928187|Africa|africa
1460161|NCT00928187|Treatment strategies|treatment strategies
1460162|NCT00928187|treatment experienced|treatment experienced
1460163|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
1460164|NCT00928161|Reflux Disease|reflux disease
1460165|NCT00928161|Acid-reflux|acid-reflux
1460166|NCT00928161|Head and Neck Cancer|head and neck cancer
1460167|NCT00928161|HNC|hnc
1460168|NCT00928161|Radiation Therapy|radiation therapy
1460169|NCT00928161|Mucositis|mucositis
1460170|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
1460171|NCT00928161|RIX|rix
1460172|NCT00928161|Dry Mouth|dry mouth
1460173|NCT00928161|Heartburn|heartburn
1460174|NCT00928161|Dexlansoprazole|dexlansoprazole
1460175|NCT00928161|Prevacid|prevacid
1460176|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
1460177|NCT00928161|GERD|gerd
1460178|NCT00928109|eating disorders|eating disorders
1460179|NCT00928109|couples therapy|couples therapy
1460180|NCT00928096|Lymphoma|lymphoma
1460181|NCT00928096|Radiotherapy|radiotherapy
1460182|NCT00928096|Positron-Emission Tomography|positron-emission tomography
1460183|NCT00928096|CT scan|ct scan
1460184|NCT00928083|Phase I|phase i
1460185|NCT00928083|Safety and tolerability|safety and tolerability
1460186|NCT00928083|Pharmacokinetic|pharmacokinetic
1460187|NCT00928083|synthetic peroxide|synthetic peroxide
1460188|NCT00928083|trioxolane|trioxolane
1460189|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
1460190|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
1460191|NCT00928057|Pen Needle|pen needle
1460192|NCT00928057|Diabetes|diabetes
1460193|NCT00928057|Insulin|insulin
1460194|NCT00928057|Glycemic|glycemic
1460195|NCT00928057|Pain|pain
1460196|NCT00928057|Fructosamine|fructosamine
1460197|NCT00928057|Leakage|leakage
1460198|NCT00928057|Hypoglycemia|hypoglycemia
1460199|NCT00928057|Hyperglycemia|hyperglycemia
1460200|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
1460201|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
1460202|NCT00928018|graft versus host disease|graft versus host disease
1460203|NCT00928018|GVHD|gvhd
1460204|NCT00928018|RIC transplantation|ric transplantation
1460205|NCT00928005|Weight loss diet|weight loss diet
1460206|NCT00928005|Exercise training|exercise training
1460207|NCT00928005|Type 2 diabetes|type 2 diabetes
1460208|NCT00928005|Prediabetes|prediabetes
1460209|NCT00928005|Cardiovascular health|cardiovascular health
1460210|NCT00927966|RAD001|rad001
1460211|NCT00927966|CP-751,871|cp-751,871
1460212|NCT00927966|advanced sarcoma|advanced sarcoma
1460213|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
1460214|NCT00927953|West Nile virus|west nile virus
1460215|NCT00927953|WNV|wnv
1460216|NCT00927953|Encephalitis|encephalitis
1460217|NCT00927953|Meningitis|meningitis
1460218|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
1460219|NCT00927953|Monoclonal Antibody|monoclonal antibody
1460220|NCT00927953|WNND|wnnd
1460221|NCT00927953|West Nile Fever|west nile fever
1460222|NCT00927953|WNF|wnf
1460223|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1460224|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1460225|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
1460226|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1460227|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1460228|NCT00927940|STENT THROMBOSIS|stent thrombosis
1460229|NCT00927940|RESTENOTIC LESION|restenotic lesion
1567379|NCT00509405|metabolic acidosis|metabolic acidosis
1460230|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1460231|NCT00927901|QAB149|qab149
1460232|NCT00927901|asthma|asthma
1460233|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
1460234|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
1460235|NCT00927901|persistent asthma|persistent asthma
1460236|NCT00927862|warfarin metabolism|warfarin metabolism
1460237|NCT00927862|CYP2C9|cyp2c9
1460238|NCT00927862|genotyping|genotyping
1460239|NCT00927862|VKORC1|vkorc1
1460240|NCT00927862|anticoagulation|anticoagulation
1460241|NCT00927862|atrial fibrillation|atrial fibrillation
1460242|NCT00927862|deep vein thrombosis|deep vein thrombosis
1460243|NCT00927862|pulmonary embolism|pulmonary embolism
1460244|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
1460245|NCT00927849|anal hypertonia|anal hypertonia
1460246|NCT00927849|sphincterotomy|sphincterotomy
1460247|NCT00927849|incontinence|incontinence
1460248|NCT00927849|manometry|manometry
1460249|NCT00927810|Gout|gout
1460250|NCT00927810|Gouty arthritis|gouty arthritis
1460251|NCT00927810|Gout flares|gout flares
1460252|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
1460253|NCT00927797|immunochemotherapy|immunochemotherapy
1460254|NCT00927797|Pentostatin|pentostatin
1460255|NCT00927797|Cyclophosphamide|cyclophosphamide
1460256|NCT00927797|Rituximab|rituximab
1460257|NCT00927797|Maintenance|maintenance
1460258|NCT00927797|indolent B-NHL|indolent b-nhl
1460259|NCT00927797|B-CLL|b-cll
1460260|NCT00927797|B-NHL|b-nhl
1460261|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
1460262|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
1460263|NCT00927784|LVAD|lvad
1460264|NCT00927784|Congestive Heart Failure|congestive heart failure
1460265|NCT00927784|Stem Cells|stem cells
1460266|NCT00927771|melanosis|melanosis
1460267|NCT00927771|melasma|melasma
1460268|NCT00927771|azelaic acid|azelaic acid
1460269|NCT00927771|hydroquinone|hydroquinone
1460270|NCT00927745|Respiration Artificial|respiration artificial
1460271|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
1460272|NCT00927745|Critical Care|critical care
1460273|NCT00927745|Intensive Care Units|intensive care units
1460274|NCT00927732|Brugada|brugada
1460275|NCT00927732|hydroquinidine|hydroquinidine
1460276|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
1460374|NCT00927355|adiponectin|adiponectin
1460375|NCT00927355|leptin|leptin
1460376|NCT00927355|CTX|ctx
1460277|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
1460278|NCT00927719|Smallpox|smallpox
1460279|NCT00927719|Smallpox Vaccine|smallpox vaccine
1460280|NCT00927719|Vaccinia virus|vaccinia virus
1460281|NCT00927719|Military|military
1460282|NCT00927706|Assistive Technology|assistive technology
1460283|NCT00927706|Mobility Limitation|mobility limitation
1460284|NCT00927706|Physical Disability|physical disability
1460285|NCT00927706|Caregiver|caregiver
1460286|NCT00927706|Participation|participation
1460287|NCT00927693|Atherosclerosis|atherosclerosis
1460288|NCT00927693|Coronary Artery Disease|coronary artery disease
1460289|NCT00927693|Cardiac Risk Factors|cardiac risk factors
1460290|NCT00927693|Coronary Calcium Scan|coronary calcium scan
1460291|NCT00927693|Prevention|prevention
1460292|NCT00927680|Colorectal Cancer|colorectal cancer
1460293|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
1460294|NCT00927680|Genetics|genetics
1460295|NCT00927680|Hispanics|hispanics
1460296|NCT00927667|Hemophilia A|hemophilia a
1460297|NCT00927667|Joint Status|joint status
1460298|NCT00927667|Bleeds|bleeds
1460299|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
1460300|NCT00927654|Iloprost|iloprost
1460301|NCT00927654|pulmonary hypertension|pulmonary hypertension
1460302|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
1460303|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
1460304|NCT00927641|Ankle Sprain|ankle sprain
1460305|NCT00927628|vitrectomy|vitrectomy
1460306|NCT00927628|macular hole|macular hole
1460307|NCT00927628|ILM peeling|ilm peeling
1460308|NCT00927615|myocardial infarction|myocardial infarction
1460309|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
1460310|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
1460311|NCT00927615|thrombus aspiration|thrombus aspiration
1460312|NCT00927615|myocardial perfusion|myocardial perfusion
1460313|NCT00927602|renal failure|renal failure
1460314|NCT00927602|medical patient|medical patient
1460315|NCT00927602|venous thromboembolism|venous thromboembolism
1460316|NCT00927602|prophylaxis|prophylaxis
1460317|NCT00927602|fondaparinux|fondaparinux
1460318|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
1460319|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
1460320|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
1460321|NCT00927576|cognitive training|cognitive training
1460322|NCT00927576|neuroplasticity|neuroplasticity
1460323|NCT00927576|cognitive impairment|cognitive impairment
1460324|NCT00927576|recovery of function|recovery of function
1460325|NCT00927576|memory|memory
1460326|NCT00927576|attention|attention
1460327|NCT00927563|Gambling|gambling
1460328|NCT00927563|Addiction|addiction
1460329|NCT00927550|resistant depression|resistant depression
1460330|NCT00927550|lithium|lithium
1460332|NCT00927550|lithium therapy|lithium therapy
1460333|NCT00927550|standard therapy|standard therapy
1460334|NCT00927537|Hypertension|hypertension
1460335|NCT00927524|Insulin analogs|insulin analogs
1460336|NCT00927524|diabetes|diabetes
1460337|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
1460338|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
1460339|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
1460340|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
1460341|NCT00927485|Curcumin|curcumin
1460342|NCT00927485|Colorectal polyps|colorectal polyps
1460343|NCT00927485|Duodenal polyps|duodenal polyps
1460344|NCT00927472|Head Lice|head lice
1460345|NCT00927459|cholesterol|cholesterol
1460346|NCT00927459|coronary artery disease|coronary artery disease
1460347|NCT00927446|esophageal cancer|esophageal cancer
1460348|NCT00927446|head and neck cancer|head and neck cancer
1460349|NCT00927446|narrow band imaging|narrow band imaging
1460350|NCT00927446|endoscopy|endoscopy
1460351|NCT00927446|screening|screening
1460352|NCT00927433|Fatigue|fatigue
1460353|NCT00927433|Cancer|cancer
1460354|NCT00927433|Radiation therapy|radiation therapy
1460355|NCT00927433|Chemotherapy|chemotherapy
1460356|NCT00927433|Hormones|hormones
1460357|NCT00927433|Surgery|surgery
1460358|NCT00927433|Breast cancer|breast cancer
1460359|NCT00927420|Bipolar disorder|bipolar disorder
1460360|NCT00927420|adherence|adherence
1460361|NCT00927420|treatment|treatment
1460362|NCT00927420|real life practice|real life practice
1460363|NCT00927407|Head Lice|head lice
1460364|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
1460365|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
1460366|NCT00927394|Stage II, Combination|stage ii, combination
1460368|NCT00927368|total knee replacement|total knee replacement
1460369|NCT00927355|pioglitazone|pioglitazone
1460370|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
1460371|NCT00927355|adipocytes|adipocytes
1460372|NCT00927355|osteoblasts|osteoblasts
1460373|NCT00927355|bone mineral density|bone mineral density
1460377|NCT00927355|P1NP|p1np
1460378|NCT00927355|Osteocalcin|osteocalcin
1460379|NCT00927342|Air leak|air leak
1460380|NCT00927342|Thoracic Surgery|thoracic surgery
1460381|NCT00927342|Sealants|sealants
1460382|NCT00927329|Dermatophagoides|dermatophagoides
1460383|NCT00927329|farinae|farinae
1460384|NCT00927329|allergen|allergen
1460385|NCT00927329|dust|dust
1460386|NCT00927329|allergic|allergic
1460387|NCT00927329|mite|mite
1460388|NCT00927329|allergy|allergy
1460389|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
1460390|NCT00927303|retinal thickness|retinal thickness
1460391|NCT00927303|threshold algorithm|threshold algorithm
1460392|NCT00927303|optical coherence tomography|optical coherence tomography
1460393|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
1460394|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
1460395|NCT00927251|heart failure|heart failure
1460396|NCT00927251|cardiac pacing|cardiac pacing
1460397|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
1460398|NCT00927251|left ventricular lead|left ventricular lead
1460399|NCT00927238|Single Level|single level
1460400|NCT00927238|Lumbar Disc Disease|lumbar disc disease
1460401|NCT00927238|DDD|ddd
1460402|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
1460403|NCT00927199|Flaxseed Oil|flaxseed oil
1460404|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
1460405|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
1460406|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
1460407|NCT00927199|Cardiovascular|cardiovascular
1460408|NCT00927199|Hypercholesterolemia|hypercholesterolemia
1460409|NCT00927199|Lipids|lipids
1460410|NCT00927199|Inflammation|inflammation
1460411|NCT00927199|Metabolism|metabolism
1460412|NCT00927186|osteoporosis|osteoporosis
1460413|NCT00927186|teriparatide|teriparatide
1460414|NCT00927186|zoledronic acid|zoledronic acid
1460415|NCT00927186|histomorphometry|histomorphometry
1460416|NCT00927186|bone biopsy|bone biopsy
1460417|NCT00927186|postmenopausal|postmenopausal
1460418|NCT00927173|TMS|tms
1460419|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1460420|NCT00927173|MDD|mdd
1460421|NCT00927173|Major Depressive Disorder|major depressive disorder
1460422|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
1460423|NCT00927160|Geriatric Models of Care|geriatric models of care
1460424|NCT00927147|head and neck cancer|head and neck cancer
1460425|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
1460426|NCT00927147|cetuximab|cetuximab
1460427|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
1460428|NCT00927147|safety|safety
1460429|NCT00927147|efficacy|efficacy
1460430|NCT00927147|survival|survival
1460431|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
1460432|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
1460433|NCT00927108|Alzheimer's disease|alzheimer's disease
1460434|NCT00927108|Parkinson's disease|parkinson's disease
1460935|NCT00925093|linezolid|linezolid
1460435|NCT00927108|Multiple sclerosis|multiple sclerosis
1460436|NCT00927095|PMDD|pmdd
1460437|NCT00927095|Oral contraceptives|oral contraceptives
1460438|NCT00927095|steroid hormones|steroid hormones
1460439|NCT00927095|neurosteroids|neurosteroids
1460440|NCT00927069|Adalimumab|adalimumab
1460441|NCT00927030|Autism|autism
1460442|NCT00927030|children|children
1460443|NCT00927030|sleep|sleep
1460444|NCT00927030|insomnia|insomnia
1460445|NCT00927017|Healthy volunteers|healthy volunteers
1460446|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
1460447|NCT00927004|cold hyperalgesia|cold hyperalgesia
1460448|NCT00927004|chronic pain|chronic pain
1460449|NCT00926978|Thyroid|thyroid
1460450|NCT00926978|I-124|i-124
1460451|NCT00926965|tardive dyskinesia|tardive dyskinesia
1460452|NCT00926965|neurocognitive function|neurocognitive function
1460453|NCT00926952|Actinic keratoses|actinic keratoses
1460454|NCT00926952|actinic keratosis|actinic keratosis
1460455|NCT00926952|methylamonolevulinate|methylamonolevulinate
1460456|NCT00926952|photodynamic therapy|photodynamic therapy
1460457|NCT00926952|without occlusion|without occlusion
1460458|NCT00926952|short incubation|short incubation
1460459|NCT00926939|Cigarette|cigarette
1460460|NCT00926939|Nicotine|nicotine
1460461|NCT00926939|Smoking|smoking
1460462|NCT00926939|Contingency Management|contingency management
1460463|NCT00926939|Voucher reinforcement|voucher reinforcement
1460464|NCT00926939|Smoking Abstinence|smoking abstinence
1460465|NCT00926939|Internet-based treatment|internet-based treatment
1460466|NCT00926926|Healthy volunteer|healthy volunteer
1460467|NCT00926913|Macular Degeneration|macular degeneration
1460468|NCT00926900|Alcoholism|alcoholism
1460469|NCT00926900|D-cycloserine|d-cycloserine
1460470|NCT00926900|extinction|extinction
1460471|NCT00926900|cue-exposure|cue-exposure
1460472|NCT00926874|ischaemic stroke|ischaemic stroke
1460473|NCT00926874|acute coronary syndrome|acute coronary syndrome
1460572|NCT00926458|stress echocardiography|stress echocardiography
1460474|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1460475|NCT00926874|brachial endothelial function|brachial endothelial function
1460476|NCT00926874|blood pressure|blood pressure
1460477|NCT00926874|aortic stiffness|aortic stiffness
1460478|NCT00926861|age-related macular degeneration|age-related macular degeneration
1460479|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
1460480|NCT00926861|AMD|amd
1460481|NCT00926848|coronary heart disease|coronary heart disease
1460482|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
1460483|NCT00926848|lifestyle change|lifestyle change
1460484|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
1460485|NCT00926848|social support|social support
1460486|NCT00926848|social cognitive learning theory|social cognitive learning theory
1460487|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
1460488|NCT00926809|iatrogenic|iatrogenic
1460489|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
1460490|NCT00926783|paroxysmal|paroxysmal
1460491|NCT00926783|persistent|persistent
1460492|NCT00926783|targeted|targeted
1460493|NCT00926783|generalized|generalized
1460494|NCT00926783|CFAE|cfae
1460495|NCT00926757|lymphoma|lymphoma
1460496|NCT00926757|CD20|cd20
1460497|NCT00926757|Hepatitis B virus|hepatitis b virus
1460498|NCT00926757|reactivation|reactivation
1460499|NCT00926757|Rituximab|rituximab
1460500|NCT00926744|physical activity|physical activity
1460501|NCT00926744|nutrition|nutrition
1460502|NCT00926744|cardiovascular diseases|cardiovascular diseases
1460503|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
1460504|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
1460505|NCT00926718|BIS monitor|bis monitor
1460506|NCT00926718|rocuronium|rocuronium
1460507|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
1460508|NCT00926705|Dexmedetomidine|dexmedetomidine
1460509|NCT00926705|Fentanyl|fentanyl
1460510|NCT00926705|Pain|pain
1460511|NCT00926705|Pediatrics|pediatrics
1460512|NCT00926692|B-cells|b-cells
1460513|NCT00926692|CD5+|cd5+
1460514|NCT00926692|B1 Cells|b1 cells
1460515|NCT00926692|Healthy Controls|healthy controls
1460516|NCT00926666|Ageing|ageing
1460517|NCT00926666|Pain|pain
1460518|NCT00926666|Pharmacology|pharmacology
1460519|NCT00926666|Imaging|imaging
1460520|NCT00926666|Anaesthesiology|anaesthesiology
1460521|NCT00926666|Musculoskeletal disease|musculoskeletal disease
1460522|NCT00926653|Geriatric Depression|geriatric depression
1460523|NCT00926640|Solid Tumors|solid tumors
1460524|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
1460525|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
1460526|NCT00926640|Phase I|phase i
1460527|NCT00926640|SCLC|sclc
1460528|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
1460529|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
1460530|NCT00926627|bosentan|bosentan
1460531|NCT00926614|GT1|gt1
1460532|NCT00926614|HCV|hcv
1460533|NCT00926614|non responder|non responder
1460534|NCT00926614|relapser|relapser
1460535|NCT00926588|Pain|pain
1460536|NCT00926588|Telecare|telecare
1460537|NCT00926588|Collaborative care|collaborative care
1460538|NCT00926575|BDP|bdp
1460539|NCT00926575|orBec|orbec
1460540|NCT00926575|GVHD|gvhd
1460541|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
1460542|NCT00926575|bone marrow transplant|bone marrow transplant
1460543|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
1460544|NCT00926575|HCT|hct
1460545|NCT00926575|stem cell transplant|stem cell transplant
1460546|NCT00926575|marrow transplant|marrow transplant
1460547|NCT00926575|SCT|sct
1460548|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
1460549|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
1460550|NCT00926562|CIN|cin
1460551|NCT00926562|Cardiac Catheterization|cardiac catheterization
1460552|NCT00926549|spectral domain-OCT|spectral domain-oct
1460553|NCT00926549|macular thickness|macular thickness
1460554|NCT00926549|myopia|myopia
1460555|NCT00926549|hypermetropia|hypermetropia
1460556|NCT00926549|normal|normal
1460557|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
1460558|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1460559|NCT00926523|Interstitial Lung Disease|interstitial lung disease
1460560|NCT00926523|MIF|mif
1460561|NCT00926497|antibiotic therapy|antibiotic therapy
1460562|NCT00926497|early-onset sepsis|early-onset sepsis
1460563|NCT00926497|interventions study|interventions study
1460564|NCT00926497|procalcitonin|procalcitonin
1460565|NCT00926497|term and near-term neonates|term and near-term neonates
1460566|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
1460567|NCT00926484|Tooth Mousse|tooth mousse
1460568|NCT00926484|fluoride varnish|fluoride varnish
1460569|NCT00926471|Autism|autism
1460570|NCT00926471|Anxiety|anxiety
1460571|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
1460764|NCT00925600|Bone Loss|bone loss
1460581|NCT00926419|Vaccine|vaccine
1460582|NCT00926419|Injector|injector
1460583|NCT00926419|Fractional dose|fractional dose
1460584|NCT00926419|Intradermal|intradermal
1460585|NCT00926419|Children|children
1460586|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
1460587|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
1460588|NCT00926393|inpatient|inpatient
1460589|NCT00926393|bipolar depression|bipolar depression
1460590|NCT00926393|quetiapine|quetiapine
1460591|NCT00926393|Seroquel IR|seroquel ir
1460592|NCT00926393|Seroquel XR|seroquel xr
1460593|NCT00926393|safety|safety
1460594|NCT00926393|tolerability|tolerability
1460603|NCT00926367|Acne|acne
1460604|NCT00926341|Metabolic syndrome|metabolic syndrome
1460605|NCT00926341|inflammatory markers|inflammatory markers
1460606|NCT00926341|Thiazolidinediones|thiazolidinediones
1460607|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
1460608|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
1460609|NCT00926315|Breast Neoplasms|breast neoplasms
1460610|NCT00926315|Calcitriol|calcitriol
1460611|NCT00926315|Postmenopausal|postmenopausal
1460612|NCT00926315|Cell Proliferation|cell proliferation
1460613|NCT00926315|Gene Expression Profiling|gene expression profiling
1460614|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
1460615|NCT00926302|volunteer|volunteer
1460616|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1460617|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
1460618|NCT00926276|Fundoplication|fundoplication
1460619|NCT00926263|Pharmacokinetics|pharmacokinetics
1460620|NCT00926263|Pharmacodynamics|pharmacodynamics
1460621|NCT00926263|QTc interval prolongation|qtc interval prolongation
1460622|NCT00926250|Sarcopenia|sarcopenia
1460623|NCT00926237|Tinnitus|tinnitus
1460624|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1460625|NCT00926237|TMS|tms
1460626|NCT00926237|rTMS|rtms
1460627|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
1460628|NCT00926198|Upper airway infections|upper airway infections
1460629|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
1460630|NCT00926198|GABHS|gabhs
1460631|NCT00926185|Dry Eye|dry eye
1460632|NCT00926185|ophthalmic delivery|ophthalmic delivery
1460633|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
1460634|NCT00926172|Intracranial aneurysm|intracranial aneurysm
1460635|NCT00926172|cerebral aneurysm|cerebral aneurysm
1460636|NCT00926172|unruptured aneurysm|unruptured aneurysm
1460637|NCT00926172|Epidemiology|epidemiology
1460638|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
1460639|NCT00926159|Cardiomyopathies|cardiomyopathies
1460640|NCT00926146|Hepatitis B and C|hepatitis b and c
1460642|NCT00926146|nurse case management|nurse case management
1460643|NCT00926146|HIV seronegativity|hiv seronegativity
1460644|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
1460645|NCT00926081|Peripheral Artery Disease|peripheral artery disease
1460646|NCT00926081|Quality of Life|quality of life
1460647|NCT00926081|Outcome|outcome
1460648|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
1460649|NCT00926081|Microcirculation|microcirculation
1460650|NCT00926068|Diabetes Mellitus|diabetes mellitus
1460651|NCT00926068|Foot Ulcer|foot ulcer
1460652|NCT00926068|DFU|dfu
1460653|NCT00926068|Wound healing|wound healing
1460654|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
1460655|NCT00926042|Healthy|healthy
1460656|NCT00926042|volunteer|volunteer
1460657|NCT00926042|Healthy controls|healthy controls
1460658|NCT00926042|Normal controls|normal controls
1460659|NCT00926016|Hepatitis C|hepatitis c
1460660|NCT00926003|HIV|hiv
1460661|NCT00926003|Children|children
1460662|NCT00926003|Africa|africa
1460663|NCT00926003|Neuropsychology|neuropsychology
1460664|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
1460665|NCT00926003|computers|computers
1460666|NCT00925990|HCV|hcv
1460667|NCT00925990|interferon-naive|interferon-naive
1460668|NCT00925977|treatment satisfaction|treatment satisfaction
1460669|NCT00925977|insulin Glargine|insulin glargine
1460670|NCT00925977|insulin Apidra|insulin apidra
1460671|NCT00925977|NPH insulin|nph insulin
1460672|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
1460673|NCT00925951|wet cupping|wet cupping
1460674|NCT00925951|cupping|cupping
1460675|NCT00925951|Numerical Rating Scale|numerical rating scale
1460676|NCT00925938|Hysteroscopy|hysteroscopy
1460677|NCT00925938|Cervical priming|cervical priming
1460678|NCT00925938|Cervical dilatation|cervical dilatation
1460679|NCT00925938|Misoprostol|misoprostol
1460680|NCT00925938|Endoscopy, uterine|endoscopy, uterine
1460681|NCT00925925|Low birth weight|low birth weight
1460682|NCT00925925|small for gestational age|small for gestational age
1460683|NCT00925925|B-cell function|b-cell function
1460684|NCT00925925|epigenetics|epigenetics
1460685|NCT00925925|B1a|b1a
1460686|NCT00925925|B1b|b1b
1460687|NCT00925925|CD19|cd19
1460688|NCT00925925|CD5|cd5
1460689|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
1460690|NCT00925912|perianal block|perianal block
1460691|NCT00925912|local anesthesia|local anesthesia
1460692|NCT00925912|spinal anesthesia|spinal anesthesia
1460693|NCT00925899|Melatonin|melatonin
1460694|NCT00925899|Palliative care|palliative care
1460695|NCT00925899|Advanced cancer|advanced cancer
1460696|NCT00925899|Symptoms|symptoms
1460697|NCT00925899|Quality of life|quality of life
1460698|NCT00925899|Randomized controlled trial|randomized controlled trial
1460699|NCT00925886|Astigmatism|astigmatism
1460700|NCT00925886|Cataract|cataract
1460701|NCT00925873|Fludarabine|fludarabine
1460702|NCT00925873|AML|aml
1460703|NCT00925873|elderly patients|elderly patients
1460704|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1460705|NCT00925847|Lithium|lithium
1460706|NCT00925847|Survival|survival
1460707|NCT00925834|Coronary angiography|coronary angiography
1460708|NCT00925834|Placebo effect|placebo effect
1460709|NCT00925834|Suggestion|suggestion
1460710|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1460711|NCT00925821|Lenalidomide|lenalidomide
1460712|NCT00925821|IMiD|imid
1460713|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
1460714|NCT00925808|VTE|vte
1460715|NCT00925808|Routine Computed Tomography|routine computed tomography
1460716|NCT00925808|CT Scans|ct scans
1460717|NCT00925795|HIV|hiv
1460718|NCT00925795|atherosclerosis|atherosclerosis
1460719|NCT00925795|extra virgin olive oil|extra virgin olive oil
1460720|NCT00925795|Alternative therapies|alternative therapies
1460721|NCT00925795|Treatment experienced+|treatment experienced+
1460722|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
1460723|NCT00925756|HIV|hiv
1460724|NCT00925756|low CD4 recovery|low cd4 recovery
1460725|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
1460726|NCT00925756|Treatment experienced|treatment experienced
1460727|NCT00925743|Phase 1|phase 1
1460728|NCT00925743|XRP6258|xrp6258
1460729|NCT00925743|cisplatin|cisplatin
1460730|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
1460731|NCT00925730|Atopic dermatitis|atopic dermatitis
1460733|NCT00925730|pimecrolimus|pimecrolimus
1460734|NCT00925730|blood|blood
1460735|NCT00925730|absorption|absorption
1460736|NCT00925730|systemic|systemic
1460737|NCT00925717|ADA recommendation|ada recommendation
1460738|NCT00925665|Intubation|intubation
1460739|NCT00925665|Glidescope|glidescope
1460740|NCT00925665|Macintosh|macintosh
1460741|NCT00925665|Abscess|abscess
1460742|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
1460743|NCT00925652|CM|cm
1460744|NCT00925652|bevacizumab|bevacizumab
1460745|NCT00925652|cyclophosphamide|cyclophosphamide
1460936|NCT00925093|intravenous|intravenous
1460746|NCT00925652|methotrexate|methotrexate
1460747|NCT00925652|exercise intervention|exercise intervention
1460748|NCT00925652|diet intervention|diet intervention
1460749|NCT00925639|phytoestrogen|phytoestrogen
1460750|NCT00925639|coagulation|coagulation
1460751|NCT00925639|menopause|menopause
1460752|NCT00925639|ddimer|ddimer
1460753|NCT00925639|antithrombin|antithrombin
1460754|NCT00925639|hypercoagulation|hypercoagulation
1460755|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
1460756|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
1460757|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
1460758|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
1460759|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
1460760|NCT00925613|postoperative cough|postoperative cough
1460761|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
1460762|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
1460763|NCT00925600|Lens Opacification|lens opacification
1460765|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
1460766|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
1460767|NCT00925587|CKD|ckd
1460768|NCT00925587|Anemia|anemia
1460769|NCT00925587|correction|correction
1460770|NCT00925587|darbepoetin alfa|darbepoetin alfa
1460771|NCT00925574|CNTO 1959|cnto 1959
1460772|NCT00925574|Healthy Volunteers|healthy volunteers
1460773|NCT00925574|Psoriasis|psoriasis
1460774|NCT00925561|Coronary Artery Calcification|coronary artery calcification
1460775|NCT00925548|Phase III trial|phase iii trial
1460776|NCT00925548|randomized|randomized
1460777|NCT00925548|cancer vaccine|cancer vaccine
1460778|NCT00925548|MUC1|muc1
1460779|NCT00925548|BLP25|blp25
1460780|NCT00925548|advanced breast cancer|advanced breast cancer
1460781|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
1460782|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
1460783|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
1460784|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
1460785|NCT00925535|061 Rifabutin|061 rifabutin
1460786|NCT00925535|HIV Infections|hiv infections
1460787|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
1460788|NCT00925509|implants|implants
1460789|NCT00925509|implants insertion|implants insertion
1460790|NCT00925509|radio-surgical guidance|radio-surgical guidance
1460791|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
1460792|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
1460793|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
1460794|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
1460795|NCT00925483|left ventricular mass|left ventricular mass
1460796|NCT00925483|cardiac MRI|cardiac mri
1460797|NCT00925483|long dialysis|long dialysis
1460798|NCT00925483|daily dialysis|daily dialysis
1460799|NCT00925470|Target organs impairment|target organs impairment
1460800|NCT00925470|High blood pressure|high blood pressure
1460801|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
1460802|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
1460803|NCT00925457|Sudden cardiac death|sudden cardiac death
1460804|NCT00925457|Domperidone|domperidone
1460805|NCT00925457|Case-control study|case-control study
1460806|NCT00925457|Saskatchewan residents|saskatchewan residents
1460807|NCT00925457|Observational Study|observational study
1460808|NCT00925444|Absorbable implants|absorbable implants
1460809|NCT00925444|Humans|humans
1460810|NCT00925444|Alginates|alginates
1460811|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
1460812|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
1460813|NCT00925444|Surgical Stapling|surgical stapling
1604640|NCT00377091|heparin|heparin
1460814|NCT00925444|Thoracic surgery|thoracic surgery
1460815|NCT00925444|Tissue Adhesives|tissue adhesives
1460816|NCT00925444|Prospective studies|prospective studies
1460817|NCT00925418|Neoplasm|neoplasm
1460818|NCT00925418|breast Neoplasm|breast neoplasm
1460819|NCT00925418|docetaxel|docetaxel
1460820|NCT00925418|Glove|glove
1460821|NCT00925405|Breast Cancer|breast cancer
1460822|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
1460823|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
1460824|NCT00925405|Mammogram|mammogram
1460825|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
1460826|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
1460827|NCT00925392|doripenem|doripenem
1460828|NCT00925392|epithelial lining fluid|epithelial lining fluid
1460829|NCT00925392|alveolar macrophages|alveolar macrophages
1460830|NCT00925392|pharmacokinetics|pharmacokinetics
1460831|NCT00925392|Healthy adult subjects|healthy adult subjects
1460832|NCT00925366|Shoulder|shoulder
1460833|NCT00925366|MRI|mri
1460834|NCT00925366|MR arthrography|mr arthrography
1460835|NCT00925366|CT arthrography|ct arthrography
1460836|NCT00925366|Rotator cuff tear|rotator cuff tear
1460837|NCT00925366|Arthroscopy|arthroscopy
1460838|NCT00925353|lidocaine|lidocaine
1460839|NCT00925353|pre-medication|pre-medication
1460840|NCT00925353|mammography|mammography
1460841|NCT00925353|pain|pain
1460842|NCT00925353|safety|safety
1460843|NCT00925340|Alcohol|alcohol
1460844|NCT00925340|Substance Abuse|substance abuse
1460845|NCT00925340|Adolescent|adolescent
1460846|NCT00925340|Family functioning|family functioning
1460847|NCT00925314|Stage III Melanoma|stage iii melanoma
1460848|NCT00925314|Melanoma|melanoma
1460849|NCT00925314|TLI|tli
1460850|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
1460851|NCT00925314|CB-10-01-02|cb-10-01-02
1460852|NCT00925301|AmicusTherapeutics|amicustherapeutics
1460853|NCT00925301|AT1001|at1001
1460854|NCT00925301|Migalastat|migalastat
1460855|NCT00925301|Pharmacokinetics|pharmacokinetics
1460856|NCT00925301|Substrate|substrate
1460857|NCT00925288|Female sex worker|female sex worker
1460858|NCT00925288|Peru|peru
1460859|NCT00925288|Cervical infection|cervical infection
1460860|NCT00925288|Cervical abnormality|cervical abnormality
1460861|NCT00925288|Serum antibody|serum antibody
1460862|NCT00925288|Vaccine acceptance|vaccine acceptance
1460863|NCT00925288|Alternative schedule|alternative schedule
1460864|NCT00925288|Viral infections|viral infections
1460865|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
1460866|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
1460867|NCT00925288|non inferiority|non inferiority
1460868|NCT00925275|Solid tumors|solid tumors
1460869|NCT00925275|Refractory|refractory
1460870|NCT00925275|Relapsed|relapsed
1460871|NCT00925275|Radiation|radiation
1460872|NCT00925275|Dosimetry|dosimetry
1460873|NCT00925275|Radiopharmaceutical|radiopharmaceutical
1460874|NCT00925275|Biodistribution|biodistribution
1460875|NCT00925275|Pharmacokinetics|pharmacokinetics
1460876|NCT00925275|Cancer|cancer
1460877|NCT00925275|Phase I|phase i
1460878|NCT00925262|mental health|mental health
1460879|NCT00925262|randomized controlled trial|randomized controlled trial
1460880|NCT00925262|torture|torture
1460881|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
1460882|NCT00925249|RA|ra
1460883|NCT00925249|TB|tb
1460884|NCT00925249|tuberculosis|tuberculosis
1460885|NCT00925249|anti-TNF therapy|anti-tnf therapy
1460886|NCT00925249|biologic therapy|biologic therapy
1460887|NCT00925249|quantiferon|quantiferon
1460888|NCT00925249|IGRA|igra
1460889|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
1460890|NCT00925236|MYH9 gene|myh9 gene
1460891|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
1460892|NCT00925236|leukocyte inclusions|leukocyte inclusions
1460893|NCT00925236|cataracts deafness|cataracts deafness
1460894|NCT00925236|nephritis|nephritis
1460895|NCT00925236|MYH9 Related Disorders|myh9 related disorders
1460896|NCT00925223|IBS|ibs
1460897|NCT00925223|BDNf|bdnf
1460898|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
1460899|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
1460900|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
1460901|NCT00925210|Bronchoscopy|bronchoscopy
1460902|NCT00925210|Ultrasonography|ultrasonography
1460903|NCT00925197|anticoagulation|anticoagulation
1460904|NCT00925197|fluindione|fluindione
1460905|NCT00925197|patient self-testing|patient self-testing
1460906|NCT00925197|coaguchek|coaguchek
1460907|NCT00925197|inratio|inratio
1460908|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
1460909|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
1460910|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1460911|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
1460912|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
1460913|NCT00925158|Rhytidoplasty|rhytidoplasty
1460914|NCT00925158|Video-Assisted Surgery|video-assisted surgery
1460915|NCT00925158|Surgical instruments|surgical instruments
1460916|NCT00925158|Dissection|dissection
1460917|NCT00925158|Innovative therapies|innovative therapies
1460918|NCT00925158|Face|face
1460919|NCT00925158|Aging|aging
1460920|NCT00925158|Premature aging|premature aging
1460921|NCT00925158|Rejuvenation|rejuvenation
1460922|NCT00925132|Metastatic|metastatic
1460923|NCT00925132|Melanoma|melanoma
1460924|NCT00925132|Epigenetic|epigenetic
1460925|NCT00925132|Temozolomide|temozolomide
1460926|NCT00925132|Decitabine|decitabine
1460927|NCT00925132|Panobinostat|panobinostat
1460928|NCT00925132|LBH589|lbh589
1460929|NCT00925119|Diabetes|diabetes
1460930|NCT00925119|Atenolol|atenolol
1460931|NCT00925119|Genetic|genetic
1460932|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
1460933|NCT00925093|vancomycin|vancomycin
1460937|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
1460938|NCT00925093|CSF|csf
1460939|NCT00925093|pharmacokinetics|pharmacokinetics
1460940|NCT00925093|penetration|penetration
1460941|NCT00925093|blood-brain barrier|blood-brain barrier
1460942|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
1460943|NCT00925067|Inguinal hernia|inguinal hernia
1460944|NCT00925067|Laparoscopic repair|laparoscopic repair
1460945|NCT00925067|Prostheses|prostheses
1460946|NCT00925067|Male fertility|male fertility
1460947|NCT00925054|PKU|pku
1460948|NCT00925054|PEG PAL|peg pal
1460949|NCT00925054|BioMarin|biomarin
1460950|NCT00924989|ACC|acc
1460951|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
1460952|NCT00924989|OSI-906|osi-906
1460953|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
1460954|NCT00924989|GALACCTIC|galacctic
1460955|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
1460956|NCT00924950|Psoriasis|psoriasis
1460957|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
1460958|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
1460959|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
1460960|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
1460961|NCT00924937|Cardiovascular events|cardiovascular events
1460962|NCT00924937|Blood pressure|blood pressure
1460963|NCT00924937|Incidence of Cancer|incidence of cancer
1460964|NCT00924937|Cognitive decline|cognitive decline
1460965|NCT00924937|Mediterranean Diet|mediterranean diet
1460966|NCT00924937|Secondary Prevention|secondary prevention
1460967|NCT00924937|Low fat diet|low fat diet
1460968|NCT00924924|health promotion|health promotion
1460969|NCT00924924|prevention|prevention
1460970|NCT00924924|worksite wellness|worksite wellness
1460971|NCT00924924|behavior change|behavior change
1460972|NCT00924924|healthy volunteers|healthy volunteers
1460973|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
1460974|NCT00924898|Acute HIV|acute hiv
1460975|NCT00924898|HIV|hiv
1460976|NCT00924898|Acute Infections|acute infections
1460977|NCT00924898|Acute Infection|acute infection
1460978|NCT00924885|Reproductive Medicine|reproductive medicine
1460979|NCT00924885|Fertilization in Vitro|fertilization in vitro
1460980|NCT00924885|Oocyte retrieval|oocyte retrieval
1460981|NCT00924885|Local anaesthesia|local anaesthesia
1460982|NCT00924885|Aspiration needle|aspiration needle
1460983|NCT00924872|stroke|stroke
1460984|NCT00924872|power wheelchair skills|power wheelchair skills
1460985|NCT00924872|training|training
1460986|NCT00924872|safety|safety
1460987|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
1460988|NCT00924859|stroke|stroke
1460989|NCT00924859|coagulation|coagulation
1460990|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
1460991|NCT00924846|respiratory failure|respiratory failure
1460992|NCT00924846|children|children
1460993|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
1460994|NCT00924833|hypoxia|hypoxia
1460995|NCT00924833|autonomic nervous system|autonomic nervous system
1460996|NCT00924833|blood pressure|blood pressure
1460997|NCT00924833|heart rate|heart rate
1460998|NCT00924833|exercise|exercise
1460999|NCT00924833|heart failure|heart failure
1461000|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
1461001|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
1461002|NCT00924820|NM|nm
1461003|NCT00924820|Advanced Cancers|advanced cancers
1461004|NCT00924820|Brain Cancer|brain cancer
1461005|NCT00924820|Advanced Cancer|advanced cancer
1461006|NCT00924820|Brain Diseases|brain diseases
1461007|NCT00924820|Central Nervous System Disorders|central nervous system disorders
1461008|NCT00924820|CNS|cns
1461009|NCT00924820|Bevacizumab|bevacizumab
1461010|NCT00924820|Avastin|avastin
1461011|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1461012|NCT00924820|rhuMAb-VEGF|rhumab-vegf
1461013|NCT00924820|Spinal Cord|spinal cord
1461014|NCT00924820|meninges|meninges
1461015|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
1461016|NCT00924820|CSF|csf
1461017|NCT00924807|Prostate Cancer|prostate cancer
1461018|NCT00924807|Combined Androgen Blockade|combined androgen blockade
1461019|NCT00924807|Radiotherapy|radiotherapy
1461020|NCT00924807|Sorafenib|sorafenib
1461021|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
1461022|NCT00924781|Hemodialysis|hemodialysis
1461023|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
1461024|NCT00924768|current cigarette smokers|current cigarette smokers
1461025|NCT00924755|Surgical mesh|surgical mesh
1461026|NCT00924742|The PK of Tapimycin|the pk of tapimycin
1461027|NCT00924742|volunteer|volunteer
1461028|NCT00924690|Colon|colon
1461029|NCT00924690|Cancer|cancer
1461030|NCT00924690|Screening|screening
1461031|NCT00924690|Prevention|prevention
1461032|NCT00924690|Information|information
1461033|NCT00924677|genicular nerve|genicular nerve
1461034|NCT00924677|osteoarthritis|osteoarthritis
1461035|NCT00924677|knee|knee
1461036|NCT00924677|neurotomy|neurotomy
1461037|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
1461038|NCT00924651|fatigue|fatigue
1461039|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1461040|NCT00924638|atrial fibrillation|atrial fibrillation
1461041|NCT00924638|cryptogenic stroke|cryptogenic stroke
1461042|NCT00924638|continuous monitoring|continuous monitoring
1461043|NCT00924638|implantable loop recorder|implantable loop recorder
1461044|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
1461045|NCT00924612|Primary hypogonadism|primary hypogonadism
1461046|NCT00924612|Secondary hypogonadism|secondary hypogonadism
1461047|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
1461048|NCT00924599|Prevention|prevention
1461049|NCT00924573|Glimepiride|glimepiride
1461050|NCT00924573|Metformin|metformin
1461051|NCT00924573|Combination Drug Therapy|combination drug therapy
1461052|NCT00924560|Adolescents|adolescents
1461053|NCT00924560|Bone Mineral Density|bone mineral density
1461054|NCT00924560|Oral Contraceptive|oral contraceptive
1461055|NCT00924547|Cystic Fibrosis|cystic fibrosis
1461056|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
1461057|NCT00924547|DHA|dha
1461058|NCT00924547|isoprostanes|isoprostanes
1461059|NCT00924547|fatty acid|fatty acid
1461060|NCT00924534|type 2 diabetes|type 2 diabetes
1461061|NCT00924534|interventional|interventional
1461062|NCT00924534|placebo|placebo
1461063|NCT00924534|controlled|controlled
1461064|NCT00924534|PK|pk
1461065|NCT00924534|PD|pd
1461066|NCT00924534|safety|safety
1461067|NCT00924521|grains|grains
1461068|NCT00924521|fiber|fiber
1461069|NCT00924521|metabolic syndrome|metabolic syndrome
1461070|NCT00924521|insulin|insulin
1461071|NCT00924508|eczema|eczema
1461072|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
1461073|NCT00924495|low back pain|low back pain
1461074|NCT00924495|motor control|motor control
1461075|NCT00924495|cortical regulation|cortical regulation
1461076|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
1461077|NCT00924482|cardiac output|cardiac output
1461078|NCT00924482|ECOM|ecom
1461079|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
1461080|NCT00924482|Perioperative medical care|perioperative medical care
1461081|NCT00924469|Prostate cancer|prostate cancer
1461082|NCT00924469|Abiraterone acetate|abiraterone acetate
1461083|NCT00924469|Leuprolide acetate|leuprolide acetate
1461084|NCT00924469|Prednisone|prednisone
1461085|NCT00924469|CB7630|cb7630
1461086|NCT00924469|Testosterone|testosterone
1461087|NCT00924456|Transcendental Meditation|transcendental meditation
1461088|NCT00924456|blood pressure|blood pressure
1461089|NCT00924456|psychological distress|psychological distress
1461090|NCT00924456|high psychological distress|high psychological distress
1461091|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
1461092|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
1461093|NCT00924443|clolar|clolar
1461094|NCT00924443|evoltra|evoltra
1461095|NCT00924443|clofarabine|clofarabine
1461096|NCT00924443|untreated acute leukemia|untreated acute leukemia
1461097|NCT00924443|adult acute leukemia|adult acute leukemia
1461098|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
1461099|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
1461100|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
1461101|NCT00924404|Xylitol vs. Saline|xylitol vs. saline
1461102|NCT00924404|nasal washes|nasal washes
1461103|NCT00924404|sinusitis|sinusitis
1461104|NCT00924391|cholesterol|cholesterol
1461105|NCT00924391|plant sterols|plant sterols
1461106|NCT00924391|cholesterol absorption|cholesterol absorption
1461107|NCT00924365|Children|children
1461108|NCT00924365|AIDS|aids
1461109|NCT00924365|Toxicity|toxicity
1461110|NCT00924365|Development|development
1461111|NCT00924365|Puberty|puberty
1461112|NCT00924365|HIV|hiv
1461113|NCT00924365|Pediatrics|pediatrics
1461114|NCT00924365|HIV Infections|hiv infections
1461115|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
1461116|NCT00924339|soy protein|soy protein
1461117|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
1461118|NCT00924339|children and adolescents|children and adolescents
1461119|NCT00924339|isoflavones|isoflavones
1461120|NCT00924339|FH|fh
1461121|NCT00924326|B Cell Malignancies|b cell malignancies
1461122|NCT00924326|T Cell Persistence|t cell persistence
1461123|NCT00924326|Immunotherapy|immunotherapy
1461124|NCT00924326|Cell Transfer|cell transfer
1461125|NCT00924326|Leukemia|leukemia
1461126|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1461127|NCT00924326|CLL|cll
1461128|NCT00924326|Lymphoma|lymphoma
1461129|NCT00924313|Prostate Cancer|prostate cancer
1461130|NCT00924313|MRI|mri
1461131|NCT00924313|C-11 Acetate|c-11 acetate
1461132|NCT00924313|PET|pet
1461133|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
1461134|NCT00924287|Metastatic Cancer|metastatic cancer
1461135|NCT00924287|Tumor Regression|tumor regression
1461136|NCT00924287|Immunotherapy|immunotherapy
1461137|NCT00924287|Safety|safety
1461138|NCT00924287|Cancer|cancer
1461139|NCT00924261|hip|hip
1461140|NCT00924261|gait|gait
1461141|NCT00924261|walking|walking
1461142|NCT00924261|falls|falls
1461143|NCT00924261|stretching|stretching
1461144|NCT00924261|Flexibility|flexibility
1461145|NCT00924261|Aged|aged
1461146|NCT00924248|Liver MRI|liver mri
1461147|NCT00924209|Neoadjuvant|neoadjuvant
1461148|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
1461149|NCT00924209|Cisplatin|cisplatin
1461150|NCT00924209|Gemcitabine|gemcitabine
1461151|NCT00924209|Bevacizumab|bevacizumab
1461152|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461153|NCT00924209|NSCLC|nsclc
1461154|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
1461155|NCT00924196|Optic Pathway Tumor|optic pathway tumor
1461156|NCT00924196|Neurofibroma|neurofibroma
1461259|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
1461157|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
1461158|NCT00924196|Volumetric MRI|volumetric mri
1461159|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
1461160|NCT00924196|NF1|nf1
1461161|NCT00924196|Optic Glioma|optic glioma
1461162|NCT00924183|Depression|depression
1461163|NCT00924183|Symptom scales|symptom scales
1461164|NCT00924183|Symptom measures|symptom measures
1461165|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
1461166|NCT00924183|V-SID|v-sid
1461167|NCT00924183|VSID|vsid
1461168|NCT00924183|treatment-as-usual|treatment-as-usual
1461169|NCT00924183|treatment as usual|treatment as usual
1461170|NCT00924183|open-label|open-label
1461171|NCT00924183|open label|open label
1461172|NCT00924183|Major Depressive Episode|major depressive episode
1461173|NCT00924183|MDE|mde
1461174|NCT00924170|Immunotoxin|immunotoxin
1461175|NCT00924170|CD25|cd25
1461176|NCT00924170|Immunogenicity|immunogenicity
1461177|NCT00924170|Neutralization|neutralization
1461178|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
1461179|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
1461180|NCT00924170|Leukemia|leukemia
1461181|NCT00924170|ATL|atl
1461182|NCT00924131|Late Effects|late effects
1461183|NCT00924131|Radiation|radiation
1461184|NCT00924131|Chemotherapy|chemotherapy
1461185|NCT00924131|Hodgkin's Disease|hodgkin's disease
1461186|NCT00924131|Lymphoma|lymphoma
1461187|NCT00924131|Hodgkin Disease|hodgkin disease
1461188|NCT00924118|Acute myocardial infarction|acute myocardial infarction
1461189|NCT00924118|Reperfusion injury|reperfusion injury
1461190|NCT00924118|Nitric oxide|nitric oxide
1461191|NCT00924092|Immunotherapy|immunotherapy
1461192|NCT00924092|Lung Cancer|lung cancer
1461193|NCT00924092|Colorectal Cancer|colorectal cancer
1461194|NCT00924092|Head and Neck Cancer|head and neck cancer
1461195|NCT00924092|Prostate|prostate
1461196|NCT00924092|Breast Cancer|breast cancer
1461197|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
1461198|NCT00924066|Ixabepilone|ixabepilone
1461199|NCT00924066|BMS-247550|bms-247550
1461200|NCT00924066|Ixempra|ixempra
1461201|NCT00924066|Cervical Cancer|cervical cancer
1461202|NCT00924066|Epothilone|epothilone
1461203|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
1461204|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
1461205|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
1461206|NCT00924040|Leukemia|leukemia
1461207|NCT00924027|Radiation|radiation
1461208|NCT00924027|Cancer|cancer
1461209|NCT00924027|HDR|hdr
1461210|NCT00924027|Brachytherapy|brachytherapy
1461211|NCT00924027|Training|training
1461212|NCT00924014|heart failure|heart failure
1461213|NCT00924001|Clinical Response|clinical response
1461214|NCT00924001|Immunotherapy|immunotherapy
1461215|NCT00924001|Cancer|cancer
1461216|NCT00924001|Cytokines|cytokines
1461217|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
1461218|NCT00924001|Melanoma|melanoma
1461219|NCT00924001|Metastatic Melanoma|metastatic melanoma
1461220|NCT00923988|Secondhand smoke|secondhand smoke
1461221|NCT00923988|passive smoking|passive smoking
1461222|NCT00923988|platelet function|platelet function
1461223|NCT00923988|endothelial function|endothelial function
1461224|NCT00923962|Basic science|basic science
1461225|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1461226|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
1461227|NCT00923962|Coronary Bloodflow|coronary bloodflow
1461228|NCT00923962|Metabolite uptake|metabolite uptake
1461229|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
1461230|NCT00923949|Resectable NSCLC|resectable nsclc
1461231|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461232|NCT00923949|NSCLC|nsclc
1461233|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
1461234|NCT00923936|HIV|hiv
1461235|NCT00923936|Doxil|doxil
1461236|NCT00923936|VEGF|vegf
1461237|NCT00923936|Bevacizumab|bevacizumab
1461238|NCT00923923|stress reactivity|stress reactivity
1461239|NCT00923923|PTSD|ptsd
1461240|NCT00923923|alcohol dependence|alcohol dependence
1461241|NCT00923923|drinking|drinking
1461242|NCT00923923|craving|craving
1461243|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
1461244|NCT00923910|Hematologic Malignancies|hematologic malignancies
1461245|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
1461246|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
1461247|NCT00923910|WT1-Positive|wt1-positive
1461248|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
1461249|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
1461250|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
1461251|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
1461252|NCT00923910|Leukemia|leukemia
1461253|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
1461254|NCT00923910|AML|aml
1461255|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1461256|NCT00923910|ALL|all
1461257|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1461258|NCT00923910|CML|cml
1461260|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1461261|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
1461262|NCT00923897|Hepatic Metastasis|hepatic metastasis
1461263|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
1461264|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
1461265|NCT00923884|NSCLC|nsclc
1461266|NCT00923884|Genotype|genotype
1461267|NCT00923884|SCLC|sclc
1461268|NCT00923884|Lung Cancer|lung cancer
1461269|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461270|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
1461271|NCT00923871|CBCT|cbct
1461272|NCT00923871|Breast Cancer|breast cancer
1461273|NCT00923858|Rotator Cuff|rotator cuff
1461274|NCT00923858|Ultrasound|ultrasound
1461275|NCT00923858|Pain|pain
1461276|NCT00923858|Tear Progression|tear progression
1461277|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1461278|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1461279|NCT00923845|Th2 Cells|th2 cells
1461280|NCT00923845|Sirolimus|sirolimus
1461281|NCT00923845|Pentostatin|pentostatin
1461282|NCT00923845|Kidney Cancer|kidney cancer
1461283|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
1461284|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1461285|NCT00923832|Fungal Infections|fungal infections
1461286|NCT00923832|PCR Assays|pcr assays
1461287|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
1461288|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
1461289|NCT00923832|Molecular Assays|molecular assays
1461290|NCT00923832|Lung Fungal Infection|lung fungal infection
1461291|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
1461292|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
1461293|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
1461294|NCT00923819|Adolescents|adolescents
1461295|NCT00923819|Gastric Bypass|gastric bypass
1461296|NCT00923819|Quality of Life|quality of life
1461297|NCT00923819|Mental Health|mental health
1461298|NCT00923819|Lifestyle|lifestyle
1461299|NCT00923806|Metastatic Cancer|metastatic cancer
1461300|NCT00923806|Tumor Regression|tumor regression
1461301|NCT00923806|Safety|safety
1461302|NCT00923806|Immunotherapy|immunotherapy
1461303|NCT00923793|skull defects|skull defects
1461304|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
1461305|NCT00923793|Titanium implant|titanium implant
1461306|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
1461307|NCT00923780|Tissue Acquisition|tissue acquisition
1461308|NCT00923780|Gene Expression|gene expression
1461309|NCT00923780|Class Predictor Model|class predictor model
1461310|NCT00923780|Endocrine Tumor|endocrine tumor
1461311|NCT00923741|Lung Cancer|lung cancer
1461312|NCT00923741|Immunity|immunity
1461313|NCT00923741|Clinical Response|clinical response
1461314|NCT00923741|Cytokines|cytokines
1461315|NCT00923741|Elispot Assay|elispot assay
1461316|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461317|NCT00923741|NSCLC|nsclc
1461318|NCT00923728|AVN - 944|avn - 944
1461319|NCT00923728|Phase I|phase i
1461320|NCT00923728|Adult Solid Tumors|adult solid tumors
1461321|NCT00923728|Cancer|cancer
1461322|NCT00923728|Solid Tumor|solid tumor
1461323|NCT00923676|Hyperlipidemia|hyperlipidemia
1461324|NCT00923676|LDL-cholesterol|ldl-cholesterol
1461325|NCT00923676|HDL-cholesterol|hdl-cholesterol
1461326|NCT00923676|triglycerides|triglycerides
1461327|NCT00923676|IIEF|iief
1461328|NCT00923676|FSFI|fsfi
1461329|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
1461330|NCT00923663|MALT lymphoma|malt lymphoma
1461331|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
1461332|NCT00923650|Informed Consent|informed consent
1461333|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
1461334|NCT00923650|Assent|assent
1461335|NCT00923650|Questionnaires|questionnaires
1461336|NCT00923650|Osteosarcoma|osteosarcoma
1461337|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
1461338|NCT00923650|Neuroblastoma|neuroblastoma
1461339|NCT00923650|Brain Tumors|brain tumors
1461340|NCT00923650|Leukemia|leukemia
1461341|NCT00923637|Non small cell lung cancer|non small cell lung cancer
1461342|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
1461343|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
1461344|NCT00923637|Pemetrexed|pemetrexed
1461345|NCT00923637|Oxaliplatin|oxaliplatin
1461346|NCT00923624|electronic medical record|electronic medical record
1461347|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
1461348|NCT00923611|Hypertension|hypertension
1461349|NCT00923611|Fimasartan|fimasartan
1461350|NCT00923598|TKA|tka
1461351|NCT00923598|Bilateral|bilateral
1461352|NCT00923598|Cleveland Clinic|cleveland clinic
1461353|NCT00923598|UCSD|ucsd
1461354|NCT00923598|Catheter|catheter
1461355|NCT00923598|Nerve block|nerve block
1461356|NCT00923598|Postoperative pain|postoperative pain
1461357|NCT00923598|Femoral Catheter|femoral catheter
1461358|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
1461359|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
1461360|NCT00923572|Oral contraceptive|oral contraceptive
1461361|NCT00923533|Fimasartan|fimasartan
1461362|NCT00923533|Drug interaction|drug interaction
1461363|NCT00923520|Solid Tumors|solid tumors
1461364|NCT00923520|Phase I|phase i
1461365|NCT00923520|Lymphoma|lymphoma
1461366|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
1461367|NCT00923520|Cancer|cancer
1461368|NCT00923520|Solid Tumor|solid tumor
1461369|NCT00923520|Renal Cell Cancer|renal cell cancer
1461370|NCT00923520|Kidney Cancer|kidney cancer
1461371|NCT00923520|Breast Cancer|breast cancer
1461372|NCT00923520|Colon Cancer|colon cancer
1461373|NCT00923520|Lung Disease|lung disease
1461374|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1461375|NCT00923520|NHL|nhl
1461376|NCT00923507|Gene Expression|gene expression
1461377|NCT00923507|Prognosis|prognosis
1461378|NCT00923507|Watch and Wait|watch and wait
1461379|NCT00923507|Molecular Genetics|molecular genetics
1461380|NCT00923507|Biologic Markers|biologic markers
1461381|NCT00923507|Leukemia|leukemia
1461382|NCT00923507|Lymphoma|lymphoma
1461383|NCT00923494|Anesthesia|anesthesia
1461384|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
1461385|NCT00923481|Neoplasms|neoplasms
1461386|NCT00923481|Advanced Cancer|advanced cancer
1461387|NCT00923481|Kidney Cancer|kidney cancer
1461388|NCT00923481|Liver Cancer|liver cancer
1461389|NCT00923481|Pheochromocytoma|pheochromocytoma
1461390|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461391|NCT00923481|Colorectal Cancer|colorectal cancer
1461392|NCT00923481|Head and Neck Cancer|head and neck cancer
1461393|NCT00923468|Pharmacokinetics|pharmacokinetics
1461394|NCT00923468|Phase I Trials|phase i trials
1461395|NCT00923468|Children|children
1461396|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
1461397|NCT00923468|Relapsed Leukemia|relapsed leukemia
1461398|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
1461399|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1461400|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1461401|NCT00923442|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1461402|NCT00923442|Hodgkins Lymphoma|hodgkins lymphoma
1461403|NCT00923442|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1461404|NCT00923429|Manual therapy|manual therapy
1461405|NCT00923429|Low back pain|low back pain
1461406|NCT00923429|Pain|pain
1461407|NCT00923429|Return to work|return to work
1461408|NCT00923416|Intra-Prostate Markers|intra-prostate markers
1461409|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
1605361|NCT00375219|CML|cml
1461410|NCT00923416|Prostate Cancer Patients|prostate cancer patients
1461411|NCT00923403|plant sterols|plant sterols
1461412|NCT00923403|diet|diet
1461413|NCT00923403|soymilk|soymilk
1461414|NCT00923403|cholesterol|cholesterol
1461415|NCT00923390|Renal Cancer|renal cancer
1461416|NCT00923390|Immunotherapy|immunotherapy
1461417|NCT00923390|Clinical Response|clinical response
1461418|NCT00923390|Toxicity|toxicity
1461419|NCT00923390|Gene Therapy|gene therapy
1461420|NCT00923390|Kidney Cancer|kidney cancer
1461421|NCT00923377|Breast Cancer|breast cancer
1461422|NCT00923377|Breast Cancer Prevention|breast cancer prevention
1461423|NCT00923377|High Risk|high risk
1461424|NCT00923377|Breast Stem Cells|breast stem cells
1461425|NCT00923377|Mammographic Density|mammographic density
1461426|NCT00923377|Breast Cancer Risk|breast cancer risk
1461427|NCT00923364|GATA2|gata2
1461428|NCT00923364|Transplant|transplant
1461429|NCT00923364|Immunodeficiency|immunodeficiency
1461430|NCT00923364|Myelodysplasia|myelodysplasia
1461431|NCT00923364|MonoMAC|monomac
1461432|NCT00923351|Vaccine|vaccine
1461433|NCT00923351|Immunotherapy|immunotherapy
1461434|NCT00923351|Cancer|cancer
1461435|NCT00923351|Chemotherapy|chemotherapy
1461436|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
1461437|NCT00923351|Neuroblastoma|neuroblastoma
1461438|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
1461439|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
1461440|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
1461441|NCT00923338|fistula|fistula
1461442|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
1461443|NCT00923325|Biomarker Analysis|biomarker analysis
1461444|NCT00923325|Sarcomas|sarcomas
1461445|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
1461446|NCT00923325|Osteosarcoma|osteosarcoma
1461447|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
1461448|NCT00923325|Synovial Sarcoma|synovial sarcoma
1461449|NCT00923325|Other Sarcoma|other sarcoma
1461450|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
1461451|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
1461452|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1461453|NCT00923273|Pemetrexed|pemetrexed
1461454|NCT00923273|Sirolimus|sirolimus
1461455|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
1461456|NCT00923273|Phase I/II|phase i/ii
1461457|NCT00923273|mTOR Inhibitor|mtor inhibitor
1461458|NCT00923273|NSCLC|nsclc
1461459|NCT00923273|Lung Cancer|lung cancer
1461460|NCT00923260|Omentectomy|omentectomy
1461461|NCT00923260|metabolic syndrome|metabolic syndrome
1461462|NCT00923260|acute phase reactants|acute phase reactants
1461463|NCT00923247|Vandetanib|vandetanib
1461464|NCT00923247|Bortezomib|bortezomib
1461465|NCT00923247|Medullary Thyroid|medullary thyroid
1461466|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
1461467|NCT00923247|Cancer|cancer
1461468|NCT00923247|Solid Tumor|solid tumor
1461469|NCT00923247|Thyroid Cancer|thyroid cancer
1461470|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
1461471|NCT00923234|monosomy 5|monosomy 5
1461472|NCT00923234|del5q|del5q
1461473|NCT00923234|lenalidomide|lenalidomide
1461474|NCT00923234|azacitidine|azacitidine
1461475|NCT00923221|Blood|blood
1461476|NCT00923221|Prostate Cancer|prostate cancer
1461477|NCT00923221|Genotyping|genotyping
1461478|NCT00923195|Metastatic Melanoma|metastatic melanoma
1461479|NCT00923195|Tumor Regression|tumor regression
1461480|NCT00923195|Safety|safety
1461481|NCT00923195|Immunotherapy|immunotherapy
1461611|NCT00922727|Probiotics|probiotics
1461482|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
1461483|NCT00923182|CLL|cll
1461484|NCT00923169|Renal Cell|renal cell
1461485|NCT00923169|Melanoma|melanoma
1461486|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
1461487|NCT00923169|Phase I|phase i
1461488|NCT00923169|TGF-B|tgf-b
1461489|NCT00923156|Heart failure|heart failure
1461490|NCT00923156|Systolic|systolic
1461491|NCT00923156|Aliskiren|aliskiren
1461492|NCT00923156|Ramipril|ramipril
1461493|NCT00923156|Angiotensin II|angiotensin ii
1461494|NCT00923156|Ang II|ang ii
1461495|NCT00923156|Plasma Renin Activity|plasma renin activity
1461496|NCT00923156|PRA|pra
1461497|NCT00923156|Plasma Renin Concentration|plasma renin concentration
1461498|NCT00923156|PR,|pr,
1461499|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
1461500|NCT00923156|BNP|bnp
1461501|NCT00923156|urinary aldosterone|urinary aldosterone
1461502|NCT00923156|Escape|escape
1461503|NCT00923156|Pharmacokinetic|pharmacokinetic
1461504|NCT00923156|PK|pk
1461505|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
1461506|NCT00923130|Bevacizumab|bevacizumab
1461507|NCT00923130|Ixabepilone|ixabepilone
1461508|NCT00923130|Phase II|phase ii
1461509|NCT00923117|Glioblastoma|glioblastoma
1461510|NCT00923117|Chemotherapy|chemotherapy
1461511|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
1461512|NCT00923117|Radiation|radiation
1461513|NCT00923117|Brain Tumor|brain tumor
1461514|NCT00923117|Malignant Glioma|malignant glioma
1461515|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
1461516|NCT00923104|Radiation|radiation
1461517|NCT00923104|Blister|blister
1461518|NCT00923104|Healthy Volunteer|healthy volunteer
1461519|NCT00923104|Samples|samples
1461520|NCT00923104|Prostate Cancer|prostate cancer
1461521|NCT00923104|Breast Cancer|breast cancer
1461522|NCT00923104|HV|hv
1461523|NCT00923091|triple combination|triple combination
1461524|NCT00923091|parallel group|parallel group
1461525|NCT00923091|dual combination|dual combination
1461526|NCT00923078|schizophrenia|schizophrenia
1461527|NCT00923078|cognitive remediation|cognitive remediation
1461528|NCT00923078|rehabilitation|rehabilitation
1461529|NCT00923078|electrophysiology|electrophysiology
1461530|NCT00923078|neuropsychology|neuropsychology
1461531|NCT00923065|Cancer|cancer
1461532|NCT00923065|Oncology|oncology
1461533|NCT00923065|Standard Care|standard care
1461534|NCT00923052|Cancer Stem Cells|cancer stem cells
1461535|NCT00923052|Biomarkers|biomarkers
1461536|NCT00923052|Surgery|surgery
1461537|NCT00923052|Solid Organ Cancers|solid organ cancers
1461538|NCT00923052|Natural History|natural history
1461539|NCT00923052|Cancer|cancer
1461540|NCT00923052|Solid Organ Cancer|solid organ cancer
1461541|NCT00923052|Liver Cancer|liver cancer
1461542|NCT00923052|Colorectal Cancer|colorectal cancer
1461543|NCT00923052|Breast Cancer|breast cancer
1461544|NCT00923052|Gastric Cancer|gastric cancer
1461545|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
1461546|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
1461547|NCT00923026|Gene Therapy|gene therapy
1461548|NCT00923026|Follow-Up|follow-up
1461549|NCT00923026|Delayed Toxicity|delayed toxicity
1461550|NCT00923026|Adenocarcinoma|adenocarcinoma
1461551|NCT00923026|Melanoma|melanoma
1461552|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
1461553|NCT00923026|Carcinoma|carcinoma
1461554|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
1461555|NCT00923013|Cladribine|cladribine
1461556|NCT00923013|Rituximab|rituximab
1461557|NCT00923013|Minimal Residual Disease|minimal residual disease
1461558|NCT00923013|Leukemia|leukemia
1461559|NCT00923000|Herb Drug|herb drug
1461560|NCT00923000|volunteers|volunteers
1461561|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
1461562|NCT00922974|spinal bone metastases|spinal bone metastases
1461563|NCT00922974|pain|pain
1461564|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
1461565|NCT00922948|Radiofrequency ablation|radiofrequency ablation
1461566|NCT00922948|Cryosurgery|cryosurgery
1461567|NCT00922948|Renal cancers|renal cancers
1461568|NCT00922896|Gemcitabine|gemcitabine
1461569|NCT00922896|Cisplatin|cisplatin
1461570|NCT00922896|Erlotinib|erlotinib
1461571|NCT00922883|Promacta|promacta
1461572|NCT00922883|SAA|saa
1461573|NCT00922883|Aplastic Anemia|aplastic anemia
1461574|NCT00922883|Thrombocytopenia|thrombocytopenia
1461575|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
1461576|NCT00922857|Muscular Atrophy|muscular atrophy
1461577|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
1461578|NCT00922844|hypotension|hypotension
1461579|NCT00922844|low blood pressure|low blood pressure
1461580|NCT00922844|vasopressor need|vasopressor need
1461581|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
1461582|NCT00922818|Perineal|perineal
1461583|NCT00922818|Prostatectomy|prostatectomy
1461584|NCT00922818|Nerve|nerve
1461585|NCT00922818|Anatomic|anatomic
1461586|NCT00922818|Surgery|surgery
1461587|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
1461588|NCT00922818|Prostate Cancer|prostate cancer
1461589|NCT00922818|Prostate Neoplasms|prostate neoplasms
1461590|NCT00922818|Prostatic Cancer|prostatic cancer
1461591|NCT00922818|Prostate|prostate
1461592|NCT00922818|Cancer|cancer
1461593|NCT00922818|Recurrent|recurrent
1461594|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
1461595|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
1461596|NCT00922753|Preoxygenation|preoxygenation
1461597|NCT00922753|Inspiratory|inspiratory
1461598|NCT00922753|Support|support
1461599|NCT00922753|Healthy|healthy
1461600|NCT00922753|EndtidalO2|endtidalo2
1461601|NCT00922740|Nocturia|nocturia
1461602|NCT00922740|Pharmacokinetics|pharmacokinetics
1461603|NCT00922740|Pharmacodynamics|pharmacodynamics
1461604|NCT00922740|Water-loading|water-loading
1461605|NCT00922740|Elderly|elderly
1461606|NCT00922740|Males|males
1461607|NCT00922727|L. reuteri|l. reuteri
1461608|NCT00922727|Cytokines|cytokines
1461609|NCT00922727|Toll like receptors|toll like receptors
1461610|NCT00922727|Healthy Adults|healthy adults
1461612|NCT00922714|Glutamine|glutamine
1461613|NCT00922714|ICU patients|icu patients
1461614|NCT00922714|Critically ill|critically ill
1461615|NCT00922714|Nutrition|nutrition
1461616|NCT00922701|Peritoneal dialysis|peritoneal dialysis
1461617|NCT00922701|L-carnitine|l-carnitine
1461618|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
1461619|NCT00922688|Insulin sensitivity|insulin sensitivity
1461620|NCT00922688|Intracellular signaling|intracellular signaling
1461621|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
1461622|NCT00922688|Lipolysis|lipolysis
1461623|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
1461624|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
1461625|NCT00922662|coronary artery disease|coronary artery disease
1461626|NCT00922662|chest pain|chest pain
1461628|NCT00922623|Nasolabial folds|nasolabial folds
1461629|NCT00922597|Continuous infusion|continuous infusion
1461630|NCT00922597|Surgery|surgery
1461631|NCT00922597|Severe haemophilia A|severe haemophilia a
1461632|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
1461633|NCT00922584|Sorafenib|sorafenib
1461634|NCT00922584|targeted therapy|targeted therapy
1461635|NCT00922571|Cataract|cataract
1461636|NCT00922571|Femtosecond laser|femtosecond laser
1461637|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
1461638|NCT00922558|postural control|postural control
1461639|NCT00922558|tetrax|tetrax
1461640|NCT00922558|children|children
1461641|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1461642|NCT00922545|Quality of life|quality of life
1461643|NCT00922545|Primary health care|primary health care
1461644|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
1461645|NCT00922519|Positron Emission Tomography|positron emission tomography
1461646|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
1461647|NCT00922519|99mTc-MDP|99mtc-mdp
1461648|NCT00922519|Bone Scan|bone scan
1461649|NCT00922506|Overactive bladder|overactive bladder
1461650|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
1461651|NCT00922506|Doxazosin|doxazosin
1461652|NCT00922506|Tolterodine|tolterodine
1461653|NCT00922493|weaning|weaning
1461654|NCT00922493|inspiratory muscle training|inspiratory muscle training
1461655|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
1461656|NCT00922493|index of Tobin (IT)|index of tobin (it)
1461657|NCT00922493|intubated|intubated
1461658|NCT00922493|intensive care unit|intensive care unit
1461659|NCT00922493|elderly|elderly
1461660|NCT00922480|Hypertension|hypertension
1461661|NCT00922480|Losartan|losartan
1461662|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
1461663|NCT00922441|Fimasartan|fimasartan
1461664|NCT00922441|Essential Hypertension|essential hypertension
1461670|NCT00922428|lumbago|lumbago
1461671|NCT00922428|homoeopathy|homoeopathy
1461672|NCT00922428|injection|injection
1461673|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
1461674|NCT00922428|efficacy|efficacy
1461675|NCT00922428|tolerability|tolerability
1461676|NCT00922428|acceptance|acceptance
1461677|NCT00922428|safety|safety
1461678|NCT00922415|Crohn's disease|crohn's disease
1461679|NCT00922415|calprotectin|calprotectin
1461680|NCT00922402|Acute|acute
1461681|NCT00922402|heart failure|heart failure
1461682|NCT00922402|hyperglycemia|hyperglycemia
1461683|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
1461684|NCT00922389|Diabetes Complications|diabetes complications
1461685|NCT00922389|Lower limb ischemia|lower limb ischemia
1461686|NCT00922389|Adult stem cells|adult stem cells
1461687|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
1461688|NCT00922376|Diabetes|diabetes
1461689|NCT00922376|self- management|self- management
1461690|NCT00922376|glycemic control|glycemic control
1461691|NCT00922376|telehealth|telehealth
1461692|NCT00922376|mhealth|mhealth
1461693|NCT00922363|safety|safety
1461694|NCT00922363|vaccine|vaccine
1461695|NCT00922363|tuberculosis|tuberculosis
1461696|NCT00922363|CAF01|caf01
1461697|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
1461698|NCT00922363|prevention|prevention
1461699|NCT00922350|asthma|asthma
1461700|NCT00922350|heliox|heliox
1461701|NCT00922350|bronchodilators|bronchodilators
1461702|NCT00922350|posture|posture
1461703|NCT00922337|distal embolization|distal embolization
1461704|NCT00922337|thrombotic lesions|thrombotic lesions
1461705|NCT00922337|AMI|ami
1461706|NCT00922337|ACS|acs
1461707|NCT00922337|SVG|svg
1461708|NCT00922324|Healthy volunteers|healthy volunteers
1461709|NCT00922311|Proteinuria|proteinuria
1461710|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1461711|NCT00922285|health status unknown|health status unknown
1461712|NCT00922272|Schizophrenia|schizophrenia
1461713|NCT00922259|Flu|flu
1461714|NCT00922259|Influenza|influenza
1461715|NCT00922259|Vaccine|vaccine
1461716|NCT00922259|Prevention|prevention
1461717|NCT00922246|overuse injuries|overuse injuries
1461718|NCT00922246|conscript|conscript
1461719|NCT00922246|prevention|prevention
1461720|NCT00922233|Contraception|contraception
1461721|NCT00922220|low back pain|low back pain
1461722|NCT00922220|spinal manipulation|spinal manipulation
1461723|NCT00922220|central sensitization|central sensitization
1461724|NCT00922220|manual therapy|manual therapy
1461725|NCT00922194|Type 2 diabetes|type 2 diabetes
1461726|NCT00922194|Obesity|obesity
1461727|NCT00922194|Extended Release Metformin|extended release metformin
1461728|NCT00922181|malignancy|malignancy
1461729|NCT00922181|liver|liver
1461730|NCT00922181|microwave|microwave
1461731|NCT00922181|surgery|surgery
1461732|NCT00922168|Sleep|sleep
1461733|NCT00922168|apnea|apnea
1461734|NCT00922168|obstructive|obstructive
1461735|NCT00922168|central|central
1461736|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
1461737|NCT00922155|guide sheath|guide sheath
1461738|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
1461739|NCT00922129|Sirolimus|sirolimus
1461740|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
1461741|NCT00922129|prostate cancer|prostate cancer
1461742|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
1461743|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
1461744|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
1461745|NCT00922103|Quality of Life|quality of life
1461746|NCT00922103|functional results|functional results
1461747|NCT00922103|reconstructive surgery|reconstructive surgery
1461748|NCT00922103|surgery|surgery
1461749|NCT00922090|Schizophrenia|schizophrenia
1461750|NCT00922090|Seroquel XR|seroquel xr
1461751|NCT00922090|CGI-CB|cgi-cb
1461752|NCT00922090|SWN-K|swn-k
1461753|NCT00922051|COPD|copd
1461754|NCT00922051|FEV1|fev1
1461755|NCT00922051|beta endorphin|beta endorphin
1461756|NCT00922051|TENS|tens
1461757|NCT00922051|acupuncture|acupuncture
1461758|NCT00922025|NSCLC|nsclc
1461759|NCT00922025|Male|male
1461760|NCT00922025|Smoking Pattern|smoking pattern
1461761|NCT00922025|Efficacy|efficacy
1461762|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
1461763|NCT00922012|Chronic Prostatitis|chronic prostatitis
1461764|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
1461765|NCT00921999|Chickenpox|chickenpox
1461766|NCT00921999|Shingles|shingles
1461767|NCT00921999|Varicella|varicella
1461768|NCT00921999|Zoster|zoster
1461769|NCT00921999|Vaccine|vaccine
1461795|NCT00921960|Prevention|prevention
1461796|NCT00921960|Screening|screening
1461797|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
1461798|NCT00921960|Echocardiography|echocardiography
1461799|NCT00921960|Natriuretic Peptides|natriuretic peptides
1461800|NCT00921947|influenza vaccine|influenza vaccine
1461801|NCT00921947|M2e|m2e
1461802|NCT00921947|Universal influenza vaccine|universal influenza vaccine
1461803|NCT00921934|Herpes|herpes
1461804|NCT00921934|Shingles|shingles
1461805|NCT00921934|virus disease|virus disease
1461806|NCT00921934|vitamin C|vitamin c
1461807|NCT00921934|ascorbic acid|ascorbic acid
1461808|NCT00921934|antioxidant|antioxidant
1461809|NCT00921934|oxidative stress|oxidative stress
1461810|NCT00921908|total hip arthroplasty|total hip arthroplasty
1461811|NCT00921895|Pink Eye,|pink eye,
1461812|NCT00921895|Viral conjunctivitis|viral conjunctivitis
1461813|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
1461814|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
1461815|NCT00921882|Type 2 diabetes|type 2 diabetes
1461816|NCT00921882|Post-partum screening|post-partum screening
1461817|NCT00921869|Cancer|cancer
1461818|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
1461819|NCT00921856|Acetylcholine|acetylcholine
1461820|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
1461821|NCT00921830|ibuprofen|ibuprofen
1461822|NCT00921830|healthy volunteers|healthy volunteers
1461823|NCT00921830|bioavailability|bioavailability
1461824|NCT00921830|pharmacokinetics|pharmacokinetics
1461825|NCT00921830|suppository|suppository
1461826|NCT00921817|healthy children|healthy children
1461827|NCT00921804|Schizophrenia|schizophrenia
1461828|NCT00921804|Hallucinations|hallucinations
1461829|NCT00921804|Paranoia|paranoia
1461830|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
1461831|NCT00921791|Hypertension|hypertension
1461832|NCT00921791|Blood pressure|blood pressure
1461833|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
1461834|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1461835|NCT00921791|Pharmaceutical care|pharmaceutical care
1461836|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
1461837|NCT00921778|Vaginal bleeding|vaginal bleeding
1461838|NCT00921778|Patient satisfaction|patient satisfaction
1461839|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
1461840|NCT00921765|Pain|pain
1461841|NCT00921765|Naloxone|naloxone
1461842|NCT00921765|Ketamine|ketamine
1461843|NCT00921765|Third Molar|third molar
1461844|NCT00921765|Surgery|surgery
1461845|NCT00921752|Lipid therapy|lipid therapy
1461846|NCT00921752|high CV risk|high cv risk
1605824|NCT00373438|ECMO|ecmo
1461847|NCT00921752|lipid goal attainment|lipid goal attainment
1461848|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
1461849|NCT00921739|Non small cell lung cancer|non small cell lung cancer
1461850|NCT00921739|Small cell lung cancer|small cell lung cancer
1461851|NCT00921739|Thymoma unresectable|thymoma unresectable
1461852|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
1461853|NCT00921726|Drug Interaction|drug interaction
1461854|NCT00921713|Early cancer care|early cancer care
1461855|NCT00921700|Paracetamol|paracetamol
1461856|NCT00921700|Acetaminophen|acetaminophen
1461857|NCT00921700|Ibuprofen|ibuprofen
1461858|NCT00921700|Pain|pain
1461859|NCT00921700|Postoperative pain|postoperative pain
1461860|NCT00921700|third molar|third molar
1461861|NCT00921674|therapeutic equivalency|therapeutic equivalency
1461862|NCT00921674|pharmacokinetics|pharmacokinetics
1461863|NCT00921674|food|food
1461864|NCT00921674|Healthy Volunteers|healthy volunteers
1461865|NCT00921661|oxaliplatin|oxaliplatin
1461866|NCT00921661|5-FU|5-fu
1461867|NCT00921661|Folinic Acid|folinic acid
1461868|NCT00921648|EEG|eeg
1461869|NCT00921648|general paresis|general paresis
1461870|NCT00921648|MRI|mri
1461871|NCT00921648|neurosyphilis|neurosyphilis
1461872|NCT00921635|Haemoglobin|haemoglobin
1461873|NCT00921622|Blood pressure|blood pressure
1461874|NCT00921622|Vitamin C|vitamin c
1461875|NCT00921622|Vitamin D|vitamin d
1461876|NCT00921609|Acromegaly|acromegaly
1461877|NCT00921609|OGTT|ogtt
1461878|NCT00921609|post-op|post-op
1461879|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
1461880|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
1461881|NCT00921596|Thoracoscopes|thoracoscopes
1461882|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
1461883|NCT00921583|survival rate|survival rate
1461884|NCT00921583|success rate|success rate
1461885|NCT00921570|TWEAK|tweak
1461886|NCT00921570|FMD|fmd
1461887|NCT00921570|PTX3|ptx3
1461888|NCT00921570|Valsartan|valsartan
1461889|NCT00921570|Amlodipine|amlodipine
1461890|NCT00921570|Renin Angiotensin System|renin angiotensin system
1461891|NCT00921557|Bone mineral density|bone mineral density
1461892|NCT00921544|ROP|rop
1461893|NCT00921544|sucrose|sucrose
1461894|NCT00921544|pain|pain
1461895|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
1461896|NCT00921531|thalidomide|thalidomide
1461897|NCT00921531|TACE|tace
1461898|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
1461899|NCT00921518|Cardiac surgery|cardiac surgery
1461900|NCT00921518|Sodium bicarbonate|sodium bicarbonate
1461901|NCT00921518|Acute kidney injury|acute kidney injury
1461902|NCT00921518|Saline|saline
1461903|NCT00921505|Acetaminophen|acetaminophen
1461904|NCT00921505|Ibuprofen|ibuprofen
1461905|NCT00921505|Platelets|platelets
1461906|NCT00921505|Leukocytes|leukocytes
1461907|NCT00921505|Oxygen species|oxygen species
1461908|NCT00921505|Humans|humans
1461909|NCT00921505|Blood Platelets|blood platelets
1461910|NCT00921505|Reactive Oxygen Species|reactive oxygen species
1461911|NCT00921505|Platelet Activation|platelet activation
1461912|NCT00921492|Luteinizing hormone|luteinizing hormone
1461913|NCT00921492|Cortisol|cortisol
1461914|NCT00921492|HPA axis|hpa axis
1461915|NCT00921492|HPO axis|hpo axis
1461916|NCT00921492|Ovulation|ovulation
1461917|NCT00921492|Heart rate variability|heart rate variability
1461918|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
1461919|NCT00921479|third molar|third molar
1461920|NCT00921479|quality of life|quality of life
1461921|NCT00921479|postoperative swelling|postoperative swelling
1461922|NCT00921479|postoperative pain|postoperative pain
1461923|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
1461924|NCT00921479|Postoperative Period|postoperative period
1461925|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
1461926|NCT00921453|Internet|internet
1461927|NCT00921453|Information supply|information supply
1461928|NCT00921453|Tailoring|tailoring
1461929|NCT00921453|Patient empowerment|patient empowerment
1461930|NCT00921453|Headaches|headaches
1461931|NCT00921453|Meta-search|meta-search
1461932|NCT00921453|Consumer Health Information|consumer health information
1461933|NCT00921453|Information Services|information services
1461934|NCT00921453|Information Storage and Retrieval|information storage and retrieval
1461935|NCT00921453|Information Systems|information systems
1461936|NCT00921440|coronary artery|coronary artery
1461937|NCT00921440|stenosis|stenosis
1461938|NCT00921427|Hemianopia|hemianopia
1461939|NCT00921427|Rehabilitation|rehabilitation
1461940|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
1461941|NCT00921427|Visual field|visual field
1461942|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
1461943|NCT00921414|R DHAP|r dhap
1461944|NCT00921414|ASCT|asct
1461945|NCT00921414|Rituximab Maintenance|rituximab maintenance
1461946|NCT00921388|Smoking Cessation|smoking cessation
1461947|NCT00921388|Exercise|exercise
1461948|NCT00921388|Postmenopausal women|postmenopausal women
1461949|NCT00921388|CHANTIX|chantix
1461950|NCT00921388|varenicline|varenicline
1461951|NCT00921362|Schizophrenia|schizophrenia
1461952|NCT00921349|Prophylaxis|prophylaxis
1461953|NCT00921349|ligation|ligation
1461954|NCT00921349|beta blockers|beta blockers
1461955|NCT00921349|First bleeding rate|first bleeding rate
1461956|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
1461957|NCT00921323|Obesity|obesity
1461958|NCT00921323|Physical activity|physical activity
1461959|NCT00921323|pedometers|pedometers
1461960|NCT00921323|children|children
1461961|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
1461962|NCT00921297|Alzheimer's Disease|alzheimer's disease
1461963|NCT00921297|vision impairment|vision impairment
1461964|NCT00921297|cataract|cataract
1461965|NCT00921297|quality of life|quality of life
1461966|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
1461967|NCT00921271|Compartment syndrome|compartment syndrome
1461968|NCT00921258|latent prostate cancer|latent prostate cancer
1462072|NCT00920920|Cervical Cancer|cervical cancer
1461969|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
1461970|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
1461971|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
1461972|NCT00921258|Patient who accept just be control|patient who accept just be control
1461973|NCT00921245|Overactive Bladder|overactive bladder
1461974|NCT00921232|Life-ending patient|life-ending patient
1461975|NCT00921232|caregiver|caregiver
1462080|NCT00920868|Colorectal|colorectal
1461976|NCT00921219|therapeutic equivalency|therapeutic equivalency
1461977|NCT00921219|pharmacokinetics|pharmacokinetics
1461978|NCT00921219|food|food
1461979|NCT00921219|Healthy volunteers|healthy volunteers
1461980|NCT00921206|influenza|influenza
1461981|NCT00921206|influenza vaccine|influenza vaccine
1461982|NCT00921206|universal influenza vaccine|universal influenza vaccine
1461983|NCT00921206|Matrix 2e protein|matrix 2e protein
1461984|NCT00921206|M2e|m2e
1461985|NCT00921206|Immune response|immune response
1461986|NCT00921193|Prostate|prostate
1461987|NCT00921193|fiducials|fiducials
1461988|NCT00921193|radiation Therapy|radiation therapy
1461989|NCT00921193|Tracking|tracking
1461990|NCT00921193|Localization|localization
1461991|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
1461992|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
1461993|NCT00921180|Entecavir|entecavir
1461994|NCT00921167|Glioblastoma|glioblastoma
1461995|NCT00921167|Astrocytoma|astrocytoma
1461996|NCT00921167|Chemotherapy|chemotherapy
1461997|NCT00921154|therapeutic equivalency|therapeutic equivalency
1461998|NCT00921154|pharmacokinetics|pharmacokinetics
1461999|NCT00921154|fasting|fasting
1462000|NCT00921154|Healthy Volunteers|healthy volunteers
1462001|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
1462002|NCT00921128|Muscimol|muscimol
1462003|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
1462004|NCT00921128|Parkinson's Disease|parkinson's disease
1462005|NCT00921128|Deep Brain Stimulation|deep brain stimulation
1462006|NCT00921128|Parkinson Disease|parkinson disease
1462008|NCT00921115|hormone receptor positive|hormone receptor positive
1462009|NCT00921115|invasive breast cancer|invasive breast cancer
1462010|NCT00921115|endocrine therapy|endocrine therapy
1462011|NCT00921115|Anastrazole|anastrazole
1462012|NCT00921115|Fulvestrant|fulvestrant
1462013|NCT00921115|breast tumors|breast tumors
1462014|NCT00921115|postmenopausal|postmenopausal
1462015|NCT00921102|Atropine|atropine
1462016|NCT00921102|Morphine|morphine
1462017|NCT00921102|Analgesics, Opioid|analgesics, opioid
1462018|NCT00921102|Antiemetics|antiemetics
1462019|NCT00921089|Atherosclerosis|atherosclerosis
1462020|NCT00921089|Cardiovascular disease|cardiovascular disease
1462021|NCT00921089|Hemodialysis|hemodialysis
1462022|NCT00921089|Inflammation|inflammation
1462023|NCT00921089|Vascular calcification|vascular calcification
1462024|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
1462025|NCT00921050|elderly|elderly
1462026|NCT00921050|mild cognitive impairment|mild cognitive impairment
1462027|NCT00921050|neuropsychological test|neuropsychological test
1462028|NCT00921050|NEUROPSI|neuropsi
1462029|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
1462030|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
1462031|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
1462032|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
1462033|NCT00921037|Vaporisation|vaporisation
1462034|NCT00921037|Thermal Necrosis|thermal necrosis
1462035|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
1462036|NCT00921024|Pyelonephritis|pyelonephritis
1462037|NCT00921024|Antimicrobial|antimicrobial
1462038|NCT00921024|Cephalosporin|cephalosporin
1462039|NCT00921024|Intravenous|intravenous
1462040|NCT00921011|hypertension|hypertension
1462041|NCT00921011|diabetes|diabetes
1462042|NCT00921011|smoking|smoking
1462043|NCT00921011|hyperlipidemia|hyperlipidemia
1462044|NCT00921011|atherosclerosis risk|atherosclerosis risk
1462045|NCT00920998|Z-338|z-338
1462046|NCT00920998|YM443|ym443
1462047|NCT00920998|healthy volunteers|healthy volunteers
1462048|NCT00920985|Pregnancy prevention|pregnancy prevention
1462049|NCT00920985|Female contraception|female contraception
1462050|NCT00920985|Patch|patch
1462051|NCT00920972|Bone marrow|bone marrow
1462052|NCT00920972|Transplant|transplant
1462053|NCT00920972|Transplantation|transplantation
1462054|NCT00920972|Hematopoietic|hematopoietic
1462055|NCT00920972|Umbilical cord|umbilical cord
1462056|NCT00920972|Related|related
1462057|NCT00920972|Unrelated|unrelated
1462058|NCT00920972|Reduced|reduced
1462059|NCT00920972|Non-myeloablative|non-myeloablative
1462060|NCT00920972|Nonmyeloablative|nonmyeloablative
1462061|NCT00920972|Non-malignant|non-malignant
1462062|NCT00920972|Nonmalignant|nonmalignant
1462063|NCT00920946|Huntington|huntington
1462064|NCT00920946|Dimebon|dimebon
1462065|NCT00920946|HD|hd
1462066|NCT00920946|Huntingtin|huntingtin
1462067|NCT00920933|Ozone challenge|ozone challenge
1462068|NCT00920933|airway neutrophilia|airway neutrophilia
1462069|NCT00920933|induced sputum|induced sputum
1462070|NCT00920933|Healthy volunteers|healthy volunteers
1462071|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
1462073|NCT00920920|Multicenter Clinical Study|multicenter clinical study
1462074|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
1462075|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
1462076|NCT00920881|Accuracy|accuracy
1462077|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
1462078|NCT00920868|Phase I|phase i
1462079|NCT00920868|Solid Tumor|solid tumor
1462081|NCT00920868|Dasatinib|dasatinib
1462082|NCT00920868|Sprycel|sprycel
1462083|NCT00920868|Bevacizumab|bevacizumab
1462084|NCT00920868|Avastin|avastin
1462085|NCT00920868|Oxaliplatin|oxaliplatin
1462086|NCT00920868|Eloxatin|eloxatin
1462087|NCT00920868|Capecitabine|capecitabine
1462088|NCT00920868|Xeloda|xeloda
1462089|NCT00920868|Duke|duke
1462090|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
1462091|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
1462092|NCT00920842|metabolic syndrome|metabolic syndrome
1462093|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1462094|NCT00920842|cardiovascular complications|cardiovascular complications
1462095|NCT00920842|cancer survivor|cancer survivor
1462096|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1462097|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1462098|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1462099|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1462100|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1462101|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1462102|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1462103|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1462104|NCT00920829|Alcohol Dependence|alcohol dependence
1462105|NCT00920829|Alcoholism|alcoholism
1462106|NCT00920829|Naltrexone|naltrexone
1462107|NCT00920829|Substance Abuse|substance abuse
1462108|NCT00920829|Genetics|genetics
1462109|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
1462110|NCT00920777|CBT|cbt
1462111|NCT00920777|Fukuda criteria|fukuda criteria
1462112|NCT00920777|Mental functioning|mental functioning
1462113|NCT00920777|Physical functioning|physical functioning
1462114|NCT00920764|CKD Stages 3&4|ckd stages 3&4
1462115|NCT00920764|Endothelin antagonist|endothelin antagonist
1462116|NCT00920764|Proteinuria|proteinuria
1462117|NCT00920751|water infusion|water infusion
1462118|NCT00920751|air insufflation|air insufflation
1462119|NCT00920751|colonoscopy|colonoscopy
1462120|NCT00920751|colorectal cancer screening|colorectal cancer screening
1462121|NCT00920738|metabolic syndrome|metabolic syndrome
1462122|NCT00920738|cancer survivor|cancer survivor
1462123|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1462124|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1462125|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1462126|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1462127|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
1462128|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
1462129|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1462130|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1462131|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
1462132|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
1462133|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
1462134|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
1462135|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
1462136|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
1462137|NCT00920738|childhood ependymoma|childhood ependymoma
1462138|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
1462139|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
1462140|NCT00920738|childhood mixed glioma|childhood mixed glioma
1462141|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
1462142|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
1462143|NCT00920725|DKA|dka
1462144|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
1462145|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
1462146|NCT00920686|Migraine|migraine
1462147|NCT00920686|aura|aura
1462148|NCT00920673|child|child
1462149|NCT00920647|hunters syndrome|hunters syndrome
1462150|NCT00920647|hunter's syndrome|hunter's syndrome
1462151|NCT00920647|hunter disease|hunter disease
1462152|NCT00920647|hunters disease|hunters disease
1462153|NCT00920647|hunter's disease|hunter's disease
1462154|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
1462155|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
1462156|NCT00920647|Mucopolysaccharidosis (MPS) 2|mucopolysaccharidosis (mps) 2
1462157|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
1462158|NCT00920647|mucopolysaccharides|mucopolysaccharides
1462159|NCT00920647|lysosomal storage disease|lysosomal storage disease
1462160|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
1462161|NCT00920647|chronic ear infection|chronic ear infection
1462162|NCT00920647|enlarged adenoids|enlarged adenoids
1462163|NCT00920647|mps symptoms|mps symptoms
1462164|NCT00920647|mps diagnosis|mps diagnosis
1462165|NCT00920647|ert treatment|ert treatment
1462166|NCT00920647|elaprase|elaprase
1462167|NCT00920647|idursulfase|idursulfase
1462168|NCT00920647|iduronate sulfatase|iduronate sulfatase
1462169|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
1462170|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
1462171|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
1462172|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
1462173|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
1462174|NCT00920647|hunter's disease treatment|hunter's disease treatment
1462175|NCT00920647|mps society|mps society
1462176|NCT00920621|Asthma|asthma
1462177|NCT00920621|Vitamin D|vitamin d
1462178|NCT00920621|Randomized Control Trial|randomized control trial
1462179|NCT00920608|AZD9056|azd9056
1462180|NCT00920608|Pharmacokinetics|pharmacokinetics
1462181|NCT00920608|interaction|interaction
1462182|NCT00920608|Methotrexate|methotrexate
1462183|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
1462184|NCT00920595|Cancer|cancer
1462185|NCT00920582|Teplizumab|teplizumab
1462186|NCT00920582|Protege|protege
1462187|NCT00920582|Protege Encore|protege encore
1462188|NCT00920582|MGA031|mga031
1462189|NCT00920582|Monoclonal antibody|monoclonal antibody
1462190|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1462191|NCT00920582|T1DM|t1dm
1462192|NCT00920582|MacroGenics|macrogenics
1462193|NCT00920582|Recent Onset Diabetes|recent onset diabetes
1462194|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
1462195|NCT00920582|Encore|encore
1462196|NCT00920569|cardiac output|cardiac output
1462197|NCT00920569|recirculation|recirculation
1462198|NCT00920569|oxygenator blood volume|oxygenator blood volume
1462199|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
1462200|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
1462201|NCT00920530|Screening|screening
1462202|NCT00920530|real time PCR|real time pcr
1462203|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
1462204|NCT00920530|Pregnant women|pregnant women
1462205|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
1462206|NCT00920504|Mesh: neoplasms|mesh: neoplasms
1462207|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
1462208|NCT00920504|pain self management|pain self management
1462209|NCT00920504|symptom management|symptom management
1462210|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
1462211|NCT00920491|Chief complaint|chief complaint
1462212|NCT00920491|non-specific symptoms|non-specific symptoms
1462213|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
1462214|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
1462215|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
1462216|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
1462217|NCT00920478|Synovitis|synovitis
1462218|NCT00920478|DMARD|dmard
1462219|NCT00920478|Etanercept|etanercept
1462220|NCT00920478|Biomarkers|biomarkers
1462221|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
1462222|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1462223|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
1462224|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
1462225|NCT00920439|IPV|ipv
1462226|NCT00920426|HIV|hiv
1462227|NCT00920426|naive|naive
1462228|NCT00920426|Phase II|phase ii
1462229|NCT00920426|integrase inhibitor|integrase inhibitor
1462230|NCT00920426|GSK1265744|gsk1265744
1462231|NCT00920426|newly diagnosed|newly diagnosed
1462232|NCT00920426|pharmacokinetics|pharmacokinetics
1462233|NCT00920426|AIDS|aids
1462234|NCT00920426|integrase|integrase
1462235|NCT00920426|HIV Infections|hiv infections
1462236|NCT00920426|Treatment naive|treatment naive
1462237|NCT00920387|Anxiety|anxiety
1462238|NCT00920387|quality of life|quality of life
1462239|NCT00920387|psychotherapy|psychotherapy
1462240|NCT00920387|potentially fatal illness|potentially fatal illness
1462241|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
1462242|NCT00920374|Influenza|influenza
1462243|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1462244|NCT00920348|COPD|copd
1462245|NCT00920348|Cohort study|cohort study
1462246|NCT00920348|prospective longitudinal study|prospective longitudinal study
1462247|NCT00920348|tissue bank|tissue bank
1462248|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
1462249|NCT00920322|Depression|depression
1462250|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1462251|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1462252|NCT00920309|rapamycin|rapamycin
1462253|NCT00920309|ADPKD|adpkd
1462254|NCT00920296|drug interaction|drug interaction
1462255|NCT00920296|integrase inhibitor|integrase inhibitor
1462256|NCT00920283|Stents|stents
1462257|NCT00920283|Bare Metal Stents|bare metal stents
1462258|NCT00920283|PCI|pci
1462259|NCT00920283|Coronary Artery Disease|coronary artery disease
1462260|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
1462261|NCT00920283|Stent Thrombosis|stent thrombosis
1462262|NCT00920283|Vascular Disease|vascular disease
1462263|NCT00920283|Myocardial Ischemia|myocardial ischemia
1462264|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
1462265|NCT00920270|Gram Negative Bacteria|gram negative bacteria
1462266|NCT00920257|oncology|oncology
1462267|NCT00920257|breast cancer|breast cancer
1462268|NCT00920257|AKT inhibitor|akt inhibitor
1462269|NCT00920257|first time in human|first time in human
1462270|NCT00920257|lymphoma|lymphoma
1462271|NCT00920257|endometrial cancer|endometrial cancer
1462272|NCT00920257|GSK2141795|gsk2141795
1462273|NCT00920257|solid tumors|solid tumors
1462274|NCT00920244|Resuscitation|resuscitation
1462275|NCT00920244|Cardiac arrest|cardiac arrest
1462276|NCT00920244|State-transitions|state-transitions
1462277|NCT00920244|Markov|markov
1462278|NCT00920218|Vaccine|vaccine
1462279|NCT00920218|Safety|safety
1462280|NCT00920218|Herpes Zoster|herpes zoster
1462281|NCT00920218|Immunogenicity|immunogenicity
1462282|NCT00920218|Stem cell transplantation|stem cell transplantation
1462283|NCT00920205|MPC-3100|mpc-3100
1462284|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
1462285|NCT00920205|oral drug|oral drug
1462286|NCT00920205|cancer|cancer
1462287|NCT00920192|c-MET|c-met
1462288|NCT00920192|VEGFR2|vegfr2
1462289|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1462290|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
1462291|NCT00920166|Infant formula|infant formula
1462292|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
1462293|NCT00920166|Symbiotic|symbiotic
1462294|NCT00920166|Allergy|allergy
1462295|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
1462296|NCT00920166|Bacterial colonization|bacterial colonization
1462297|NCT00920166|Faecal IgA analysis|faecal iga analysis
1462298|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1462299|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1462300|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1462301|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1462302|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
1462303|NCT00920140|CMML|cmml
1462304|NCT00920140|MDS|mds
1462305|NCT00920127|AKL1|akl1
1462306|NCT00920127|COPD|copd
1462307|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
1462308|NCT00920101|hypercholesterolemia|hypercholesterolemia
1462309|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
1462310|NCT00920101|statin|statin
1462311|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
1462312|NCT00920088|probes|probes
1462313|NCT00920088|NNRTI|nnrti
1462314|NCT00920088|drug interaction|drug interaction
1462315|NCT00920088|protease inhitibor|protease inhitibor
1462316|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
1462317|NCT00920075|Bone Mineral Density|bone mineral density
1462318|NCT00920075|Fosamax|fosamax
1462319|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
1462320|NCT00920075|Fracture|fracture
1462321|NCT00920062|recirculation|recirculation
1462322|NCT00920062|ultrasound dilution|ultrasound dilution
1462323|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
1462324|NCT00920049|Driving|driving
1462325|NCT00920049|Injury|injury
1462326|NCT00920049|Prevention|prevention
1462327|NCT00920049|Intervention|intervention
1462328|NCT00920049|Parents|parents
1462329|NCT00920036|PTSD|ptsd
1462330|NCT00920036|Combat|combat
1462331|NCT00920036|Biofeedback|biofeedback
1462332|NCT00920036|Psychophysiology|psychophysiology
1462333|NCT00920023|SPIO MRI|spio mri
1462334|NCT00920023|Feridex|feridex
1462335|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
1462336|NCT00920010|small cell lung cancer|small cell lung cancer
1462337|NCT00919997|human papilloma virus infection|human papilloma virus infection
1462338|NCT00919997|HIV infection|hiv infection
1462339|NCT00919997|HIV Infections|hiv infections
1462340|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
1462341|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
1462342|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
1462343|NCT00919971|Bi spectral Index|bi spectral index
1462344|NCT00919971|Sedation depth monitoring|sedation depth monitoring
1462345|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
1462346|NCT00919958|Peripheral Artery Disease|peripheral artery disease
1462347|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
1466763|NCT00902096|prenatal|prenatal
1462348|NCT00919958|Critical limb ischemia|critical limb ischemia
1462349|NCT00919945|Neonates|neonates
1462350|NCT00919945|Congenital Heart Disease|congenital heart disease
1462351|NCT00919945|Postoperative Feeding|postoperative feeding
1462352|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
1462353|NCT00919932|Depression|depression
1462355|NCT00919932|Texting|texting
1462356|NCT00919932|SMS|sms
1462357|NCT00919919|menopause|menopause
1462358|NCT00919919|Endometrial Thickness|endometrial thickness
1462359|NCT00919919|progesterone|progesterone
1462360|NCT00919906|haptic|haptic
1462361|NCT00919906|rehabilitation|rehabilitation
1462362|NCT00919906|fine-motor skill|fine-motor skill
1462363|NCT00919906|handwriting|handwriting
1462364|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
1462365|NCT00919893|male|male
1462366|NCT00919893|inflammatory|inflammatory
1462367|NCT00919893|CP-CPPS|cp-cpps
1462368|NCT00919893|Cernilton|cernilton
1462369|NCT00919893|pelvic pain|pelvic pain
1462370|NCT00919893|symptoms|symptoms
1462371|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
1462372|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
1462373|NCT00919854|HIV-1|hiv-1
1462374|NCT00919854|Darunavir|darunavir
1462375|NCT00919854|Ritonavir|ritonavir
1462376|NCT00919854|Norvir|norvir
1462377|NCT00919841|postpartum|postpartum
1462378|NCT00919841|involution|involution
1462379|NCT00919841|three-dimension sonography|three-dimension sonography
1462380|NCT00919841|size of the uterus|size of the uterus
1462381|NCT00919815|Leprosy|leprosy
1462382|NCT00919815|Type 1 Reactions|type 1 reactions
1462383|NCT00919815|Prednisolone|prednisolone
1462384|NCT00919815|Ciclosporin|ciclosporin
1462385|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
1462386|NCT00919802|Oxytocin|oxytocin
1462387|NCT00919802|Bladder|bladder
1462388|NCT00919802|Void|void
1462389|NCT00919776|Leprosy|leprosy
1462390|NCT00919776|ENL|enl
1462391|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
1462392|NCT00919776|Prednisolone|prednisolone
1462393|NCT00919776|Ciclosporin|ciclosporin
1462394|NCT00919763|Atopic Dermatitis|atopic dermatitis
1462395|NCT00919737|NPC-08|npc-08
1462396|NCT00919737|carmustine|carmustine
1462397|NCT00919737|nitrosourea|nitrosourea
1462398|NCT00919737|safety|safety
1462399|NCT00919724|AIDS|aids
1462400|NCT00919724|Endothelial Function|endothelial function
1462401|NCT00919724|Inflammation|inflammation
1462402|NCT00919724|Immune Activation|immune activation
1462403|NCT00919724|treatment naive|treatment naive
1462404|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
1462405|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
1462406|NCT00919698|Respiration, Artificial|respiration, artificial
1462407|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
1462408|NCT00919698|Critical care|critical care
1462409|NCT00919698|Intensive care|intensive care
1462410|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
1462411|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
1462412|NCT00919672|Motility|motility
1462413|NCT00919672|Pain perception|pain perception
1462414|NCT00919672|GSRS-IBS|gsrs-ibs
1462415|NCT00919672|IBS-IS|ibs-is
1462416|NCT00919659|parenteral nutrition|parenteral nutrition
1462417|NCT00919659|cancer cachexia|cancer cachexia
1462418|NCT00919659|pancreatic cancer|pancreatic cancer
1462419|NCT00919633|hepatitis C|hepatitis c
1462420|NCT00919633|HCV|hcv
1462421|NCT00919633|genotype|genotype
1462422|NCT00919633|sustained virological response|sustained virological response
1462423|NCT00919633|rapid virological response|rapid virological response
1462424|NCT00919633|interferon|interferon
1462425|NCT00919620|Psychotic disorders|psychotic disorders
1462426|NCT00919620|Psychoses|psychoses
1462427|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
1462428|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
1462429|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
1462430|NCT00919594|Depression|depression
1462431|NCT00919594|Mothers|mothers
1462432|NCT00919581|Spinal cord injury|spinal cord injury
1462433|NCT00919555|ALS Treatment|als treatment
1462434|NCT00919555|Tretinoin|tretinoin
1462435|NCT00919555|Pioglitazone HCL|pioglitazone hcl
1462436|NCT00919555|Actos|actos
1462437|NCT00919555|Tau levels|tau levels
1462438|NCT00919555|ALS|als
1462439|NCT00919542|Leprosy|leprosy
1462440|NCT00919542|ENL|enl
1462441|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
1462442|NCT00919542|Prednisolone|prednisolone
1462443|NCT00919542|Ciclosporin|ciclosporin
1462444|NCT00919516|Bone marrow transplantation|bone marrow transplantation
1462445|NCT00919516|Ischemia|ischemia
1462446|NCT00919516|Neoangiogenesis|neoangiogenesis
1462447|NCT00919516|Peripheral arterial disease|peripheral arterial disease
1462448|NCT00919516|Stem cell therapy|stem cell therapy
1462449|NCT00919503|nonmalignant diseases|nonmalignant diseases
1462450|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
1462522|NCT00919399|locally advanced|locally advanced
1462451|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
1462452|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
1462453|NCT00919503|chronic granulomatous|chronic granulomatous
1462454|NCT00919503|disease|disease
1462455|NCT00919503|IPEX syndrome|ipex syndrome
1462456|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1462457|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
1462626|NCT00918931|Leukemia|leukemia
1462458|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
1462459|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
1462460|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
1462461|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
1462462|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
1462463|NCT00919503|metabolic diseases|metabolic diseases
1462464|NCT00919503|hemoglobinopathies|hemoglobinopathies
1462465|NCT00919503|sickle cell disease|sickle cell disease
1462466|NCT00919503|thalassemia|thalassemia
1462467|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
1462468|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
1462469|NCT00919503|bone marrow transplantation|bone marrow transplantation
1462470|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
1462471|NCT00919490|Healthy Volunteers|healthy volunteers
1462472|NCT00919477|Prostate cancer|prostate cancer
1462473|NCT00919477|Casodex|casodex
1462474|NCT00919477|Monotherapy|monotherapy
1462475|NCT00919464|Compartment pressure|compartment pressure
1462476|NCT00919464|compartment syndrome|compartment syndrome
1462477|NCT00919464|femur fracture|femur fracture
1462478|NCT00919451|Leprosy|leprosy
1462479|NCT00919451|Type 1 Reaction|type 1 reaction
1462480|NCT00919451|Prednisolone|prednisolone
1462481|NCT00919451|Ciclosporin|ciclosporin
1462482|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1462483|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1462484|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1462485|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1462486|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1462487|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1462488|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1462489|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1462490|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1462491|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1462492|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1462493|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1462494|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1462495|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1462496|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1462497|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1462498|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1462499|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1462500|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1462501|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1462502|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1462503|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1462504|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1462505|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1462506|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1462507|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1462508|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1462509|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1462510|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1462511|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1462512|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1462513|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1462514|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1462515|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1462516|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1462517|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1462518|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1462519|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1462520|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
1462521|NCT00919399|breast cancer|breast cancer
1462523|NCT00919399|Menopausal patient|menopausal patient
1462524|NCT00919399|aromasin|aromasin
1462525|NCT00919399|tamoxifen|tamoxifen
1462526|NCT00919399|efficacy|efficacy
1462527|NCT00919386|Ureteric Measurement|ureteric measurement
1462528|NCT00919373|Catheter Ablation|catheter ablation
1462529|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
1462530|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
1462531|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
1462532|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
1462533|NCT00919334|Myopia progression|myopia progression
1462534|NCT00919334|Myopia control|myopia control
1462535|NCT00919334|Simultaneous vision|simultaneous vision
1462536|NCT00919334|Myopic defocus|myopic defocus
1462538|NCT00919321|PPV|ppv
1462539|NCT00919321|PCV|pcv
1462540|NCT00919308|Simulation|simulation
1462541|NCT00919308|Invasive procedures|invasive procedures
1462542|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
1462543|NCT00919295|mirtazapine|mirtazapine
1462544|NCT00919295|randomized controlled trial|randomized controlled trial
1462545|NCT00919295|pilot study|pilot study
1462546|NCT00919282|pancreatic cancer|pancreatic cancer
1462547|NCT00919282|gemcitabine|gemcitabine
1462548|NCT00919282|combination|combination
1462549|NCT00919243|prednisone|prednisone
1462550|NCT00919243|allopurinol|allopurinol
1462551|NCT00919243|heart failure|heart failure
1462552|NCT00919243|hyperuricemia|hyperuricemia
1462553|NCT00919230|Hip fracture|hip fracture
1462554|NCT00919230|iron therapy|iron therapy
1462555|NCT00919230|anaemia|anaemia
1462556|NCT00919217|Multiple Sclerosis|multiple sclerosis
1462557|NCT00919217|MS|ms
1462558|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1462559|NCT00919217|RR-MS|rr-ms
1462560|NCT00919217|Women|women
1462561|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
1462562|NCT00919191|acne|acne
1462563|NCT00919191|irritation|irritation
1462564|NCT00919191|objective sensory methods|objective sensory methods
1462565|NCT00919178|Dengue virus|dengue virus
1462566|NCT00919178|Vaccine|vaccine
1462567|NCT00919178|DEN4|den4
1462568|NCT00919178|Dengue|dengue
1462569|NCT00919165|carotid stenting|carotid stenting
1462570|NCT00919165|cognitive function|cognitive function
1462571|NCT00919165|pre and post stent|pre and post stent
1462572|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
1462573|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
1462574|NCT00919152|intensive care|intensive care
1462575|NCT00919152|Critically ill|critically ill
1462576|NCT00919152|proton pump inhibitors|proton pump inhibitors
1462577|NCT00919152|pharmacoeconomics|pharmacoeconomics
1462578|NCT00919139|multiple myeloma|multiple myeloma
1462579|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
1462580|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1462581|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
1462582|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
1462583|NCT00919113|Bladder Pain|bladder pain
1462584|NCT00919113|GAG replacement therapy|gag replacement therapy
1462585|NCT00919113|IC/PBS|ic/pbs
1462586|NCT00919100|pediatric|pediatric
1462587|NCT00919100|venipuncture|venipuncture
1462588|NCT00919100|pain|pain
1462589|NCT00919100|vibration|vibration
1462590|NCT00919100|vapocoolant|vapocoolant
1462591|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
1462592|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
1462593|NCT00919061|GALL BLADDER|gall bladder
1462594|NCT00919061|BILE DUCTS|bile ducts
1462595|NCT00919061|BAY 43-9006|bay 43-9006
1462596|NCT00919061|SORAFENIB|sorafenib
1462597|NCT00919061|CISPLATIN|cisplatin
1462598|NCT00919061|GEMCITABINE|gemcitabine
1462599|NCT00919061|09-029|09-029
1462600|NCT00919035|prostate cancer|prostate cancer
1462601|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
1462602|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
1462603|NCT00919022|Erectile Dysfunction|erectile dysfunction
1462604|NCT00919009|TACE|tace
1462605|NCT00919009|Sorafenib|sorafenib
1462606|NCT00918996|Cesarean Section|cesarean section
1462607|NCT00918996|Bladder Flap|bladder flap
1462608|NCT00918996|Operating time|operating time
1462609|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
1462610|NCT00918983|BPH|bph
1462611|NCT00918983|Enlarged prostate|enlarged prostate
1462612|NCT00918970|autonomous nervous system|autonomous nervous system
1462613|NCT00918970|brain death|brain death
1462614|NCT00918970|organs transplantation|organs transplantation
1462615|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
1462616|NCT00918957|Cystic fibrosis|cystic fibrosis
1462617|NCT00918957|Lung diseases|lung diseases
1462618|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
1462701|NCT00918710|Human papillomavirus.|human papillomavirus.
1462619|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
1462620|NCT00918944|clinical decision support tool|clinical decision support tool
1462621|NCT00918944|electronic health record|electronic health record
1462622|NCT00918944|control tool|control tool
1462623|NCT00918944|spirometry|spirometry
1462624|NCT00918944|quality of life survey|quality of life survey
1462625|NCT00918944|provider survey|provider survey
1462627|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
1462628|NCT00918931|SM|sm
1462629|NCT00918931|Obatoclax mesylate|obatoclax mesylate
1462630|NCT00918931|GX15-070MS|gx15-070ms
1462631|NCT00918918|Alcohol Consumption|alcohol consumption
1462632|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
1462633|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
1462634|NCT00918918|Apolipoproteins|apolipoproteins
1462635|NCT00918918|Inflammation|inflammation
1462636|NCT00918905|pervasive healthcare|pervasive healthcare
1462637|NCT00918905|telecare|telecare
1462638|NCT00918905|telemedicine|telemedicine
1462639|NCT00918905|COPD|copd
1462640|NCT00918892|breast cancer|breast cancer
1462641|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1462642|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1462643|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1462644|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1462645|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
1462646|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
1462647|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
1462648|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
1462649|NCT00918879|HbA1c|hba1c
1462650|NCT00918879|Incretins|incretins
1462651|NCT00918866|Phase 4|phase 4
1462652|NCT00918866|DEFINITY®|definity®
1462653|NCT00918866|hemodynamics|hemodynamics
1462654|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
1462655|NCT00918853|pancreas|pancreas
1462656|NCT00918853|adenocarcinoma|adenocarcinoma
1462657|NCT00918840|HIV|hiv
1462658|NCT00918840|Vaccine|vaccine
1462659|NCT00918840|Immune Therapy|immune therapy
1462660|NCT00918840|DermaVir|dermavir
1462661|NCT00918840|Treatment experienced|treatment experienced
1462662|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
1462663|NCT00918827|stage III colon cancer|stage iii colon cancer
1462664|NCT00918801|T1DM|t1dm
1462665|NCT00918801|MRI|mri
1462666|NCT00918788|breast cancer|breast cancer
1462667|NCT00918775|Renal Cell Carcinoma|renal cell carcinoma
1462668|NCT00918775|RCC|rcc
1462669|NCT00918775|Kidney|kidney
1462670|NCT00918775|Metastasectomy|metastasectomy
1462671|NCT00918775|Surgery|surgery
1462672|NCT00918775|Tumor Removal|tumor removal
1462673|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
1462674|NCT00918762|precancerous condition|precancerous condition
1462675|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1462676|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1462677|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1462678|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1462679|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1462680|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1462681|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1462682|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1462683|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1462684|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1462685|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1462686|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1462687|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1462688|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1462689|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1462690|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1462691|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1462692|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1462693|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1462694|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1462695|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1462696|NCT00918736|Ankle joint|ankle joint
1462697|NCT00918736|Balance|balance
1462698|NCT00918736|Hyaluronic acid|hyaluronic acid
1462699|NCT00918736|Osteoarthritis|osteoarthritis
1462700|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
1462702|NCT00918710|Biological prognostic markers.|biological prognostic markers.
1462703|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
1462704|NCT00918697|PRK|prk
1462705|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
1462706|NCT00918697|mechanical debridement|mechanical debridement
1462707|NCT00918697|confocal scan|confocal scan
1462708|NCT00918697|confocal microscopy|confocal microscopy
1462709|NCT00918684|Depression|depression
1462710|NCT00918671|Headache|headache
1462711|NCT00918671|Medication overuse|medication overuse
1462712|NCT00918671|chronic|chronic
1462713|NCT00918671|relapse|relapse
1462714|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1462715|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
1462716|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1462717|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1462718|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
1462719|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1462720|NCT00918658|multiple myeloma|multiple myeloma
1462721|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
1462722|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
1462723|NCT00918645|bone metastases|bone metastases
1462724|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
1462725|NCT00918619|randomized,|randomized,
1462726|NCT00918619|controlled,|controlled,
1462727|NCT00918619|haemostatic agents,|haemostatic agents,
1462728|NCT00918619|Sangustop,|sangustop,
1462729|NCT00918619|Tachosil,|tachosil,
1462730|NCT00918619|liver resection,|liver resection,
1462731|NCT00918619|haemostasis|haemostasis
1462732|NCT00918593|Metastases|metastases
1462733|NCT00918593|Cutaneous|cutaneous
1462734|NCT00918593|Ulcerating|ulcerating
1462735|NCT00918593|Palliative|palliative
1462736|NCT00918593|ulcerating metastases|ulcerating metastases
1462737|NCT00918567|ADHD|adhd
1462738|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
1462739|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
1462740|NCT00918554|Macular oedema|macular oedema
1462741|NCT00918554|Methotrexate|methotrexate
1462742|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
1462743|NCT00918541|atherosclerotic disease|atherosclerotic disease
1462744|NCT00918541|progression|progression
1462745|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
1462746|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
1462747|NCT00918528|Urethral stricture|urethral stricture
1462748|NCT00918528|Mitomycin C|mitomycin c
1462749|NCT00918528|Internal Urethrotomy|internal urethrotomy
1462750|NCT00918515|Sedation|sedation
1462751|NCT00918515|Anaesthesia|anaesthesia
1462752|NCT00918515|Safety|safety
1462753|NCT00918515|tolerability|tolerability
1462754|NCT00918515|pharmacokinetics|pharmacokinetics
1462755|NCT00918515|pharmacodynamics|pharmacodynamics
1462756|NCT00918515|healthy male volunteers|healthy male volunteers
1462757|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
1462758|NCT00918489|metastatic|metastatic
1462759|NCT00918489|vorinostat|vorinostat
1462760|NCT00918463|lymphoma|lymphoma
1462761|NCT00918463|diffuse|diffuse
1462762|NCT00918463|refractory|refractory
1462763|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
1462764|NCT00918437|postoperative pain|postoperative pain
1462765|NCT00918437|quality of life|quality of life
1462766|NCT00918411|diarrhea|diarrhea
1462767|NCT00918411|IBS|ibs
1462768|NCT00918411|Colonic diseases|colonic diseases
1462769|NCT00918411|YM060|ym060
1462770|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
1462771|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
1462772|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
1462773|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
1462774|NCT00918385|hormonal therapy|hormonal therapy
1462775|NCT00918385|antiandrogen therapy|antiandrogen therapy
1462776|NCT00918385|androgen receptor|androgen receptor
1462777|NCT00918385|nilutamide|nilutamide
1462778|NCT00918385|dasatinib|dasatinib
1462779|NCT00918385|genomics|genomics
1462780|NCT00918385|genomic signature|genomic signature
1462781|NCT00918385|genomic predictor|genomic predictor
1462782|NCT00918385|genomic analysis|genomic analysis
1462783|NCT00918385|genomic expression profile|genomic expression profile
1462784|NCT00918372|MSCTA|mscta
1462785|NCT00918372|Marathon runners|marathon runners
1462786|NCT00918346|Ocular hypertension|ocular hypertension
1462787|NCT00918320|Temozolomide|temozolomide
1462788|NCT00918320|Topotecan|topotecan
1462789|NCT00918320|paediatric solid tumours|paediatric solid tumours
1462790|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
1462791|NCT00918307|Tobacco Dependence|tobacco dependence
1462792|NCT00918307|HIV infection|hiv infection
1462793|NCT00918307|varenicline|varenicline
1462794|NCT00918294|CRT|crt
1462995|NCT00917332|relaxation|relaxation
1462795|NCT00918294|heart failure|heart failure
1462796|NCT00918294|optimization|optimization
1462797|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
1462798|NCT00918268|Influenza vaccine|influenza vaccine
1462799|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
1462800|NCT00918255|Adalimumab|adalimumab
1462801|NCT00918255|Nodule|nodule
1462802|NCT00918255|Abscess|abscess
1462803|NCT00918255|Fistula|fistula
1462804|NCT00918255|Physicians Global Assessment|physicians global assessment
1462805|NCT00918255|Hurley Stage|hurley stage
1462806|NCT00918255|Sartorius Scale|sartorius scale
1462807|NCT00918242|Coronary Heart Disease|coronary heart disease
1462808|NCT00918242|computed tomography|computed tomography
1462809|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
1462810|NCT00918229|Prostate|prostate
1462811|NCT00918229|cancer|cancer
1462812|NCT00918229|radiation|radiation
1462813|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
1462814|NCT00918229|intrarectal balloon|intrarectal balloon
1462815|NCT00918216|breast cancer|breast cancer
1462816|NCT00918203|Lung neoplasms|lung neoplasms
1462817|NCT00918203|IMC-3G3|imc-3g3
1462818|NCT00918203|carboplatin|carboplatin
1462819|NCT00918203|paclitaxel|paclitaxel
1462820|NCT00918203|PDGFr|pdgfr
1462821|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
1462822|NCT00918190|Pediatric|pediatric
1462823|NCT00918190|Strabismus|strabismus
1462824|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
1462825|NCT00918112|Parkinson's Disease|parkinson's disease
1462826|NCT00918099|Mesh|mesh
1462827|NCT00918099|vaginal prolapse|vaginal prolapse
1462828|NCT00918099|Recurrence rate|recurrence rate
1462829|NCT00918086|Vitamin D|vitamin d
1462830|NCT00918086|Tuberculosis|tuberculosis
1462831|NCT00918073|HIV infected smokers|hiv infected smokers
1462832|NCT00918073|HIV|hiv
1462833|NCT00918034|BPH|bph
1462834|NCT00918034|LUTS|luts
1462835|NCT00918034|talaporfin sodium|talaporfin sodium
1462836|NCT00918008|URINARY BLADDER|urinary bladder
1462837|NCT00918008|Bladder|bladder
1462838|NCT00918008|Blood sample|blood sample
1462839|NCT00918008|Lymph Nodes|lymph nodes
1462840|NCT00917995|parastomal hernia|parastomal hernia
1462841|NCT00917995|prophylactic mesh|prophylactic mesh
1462842|NCT00917995|colostomy|colostomy
1462843|NCT00917995|hernia|hernia
1462844|NCT00917956|Lithium|lithium
1462845|NCT00917956|IBM|ibm
1462846|NCT00917956|InclusionIBM|inclusionibm
1462847|NCT00917956|Myositis|myositis
1462848|NCT00917943|smoking|smoking
1462849|NCT00917943|pregnancy|pregnancy
1462850|NCT00917943|counseling|counseling
1462851|NCT00917943|prevention|prevention
1462852|NCT00917943|tailored intervention|tailored intervention
1462853|NCT00917943|postpartum|postpartum
1462854|NCT00917943|women|women
1462855|NCT00917943|cessation|cessation
1462856|NCT00917930|exercise training|exercise training
1462857|NCT00917930|functional recovery|functional recovery
1462858|NCT00917930|heart diseases|heart diseases
1462859|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
1462860|NCT00917930|non diabetes CAD patients|non diabetes cad patients
1462861|NCT00917930|glycometabolic state|glycometabolic state
1462862|NCT00917917|Metabolic syndrome|metabolic syndrome
1462863|NCT00917917|exercise training|exercise training
1462864|NCT00917917|abdominal fat mass|abdominal fat mass
1462865|NCT00917917|endothelial function|endothelial function
1462866|NCT00917917|diastolic function|diastolic function
1462867|NCT00917904|HIV Infections|hiv infections
1462868|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1462869|NCT00917904|Healthy|healthy
1462870|NCT00917904|HIV seronegativity|hiv seronegativity
1462871|NCT00917891|HIV Infections|hiv infections
1462872|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1462873|NCT00917891|Healthy|healthy
1462874|NCT00917891|HIV seronegativity|hiv seronegativity
1462875|NCT00917878|Milk|milk
1462876|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
1462877|NCT00917878|Postprandial inflammation|postprandial inflammation
1462878|NCT00917878|Overweight|overweight
1462879|NCT00917852|aorta|aorta
1462880|NCT00917852|trauma|trauma
1462881|NCT00917852|transection|transection
1462882|NCT00917839|neuroprotection|neuroprotection
1462883|NCT00917839|multiple sclerosis|multiple sclerosis
1462884|NCT00917839|brain atrophy|brain atrophy
1462885|NCT00917839|mr-spectroscopy|mr-spectroscopy
1462886|NCT00917813|HIV|hiv
1462887|NCT00917813|monoclonal antibody|monoclonal antibody
1462888|NCT00917813|KD-247|kd-247
1462889|NCT00917813|treatment naive|treatment naive
1462890|NCT00917800|angiography|angiography
1462891|NCT00917800|exercise testing|exercise testing
1462892|NCT00917800|high frequency ECG|high frequency ecg
1462893|NCT00917800|coronary artery disease|coronary artery disease
1462894|NCT00917787|Asthma|asthma
1462895|NCT00917774|gender specific knee|gender specific knee
1462896|NCT00917774|osteoarthritis|osteoarthritis
1462897|NCT00917774|total knee arthroplasty|total knee arthroplasty
1464375|NCT00911560|Vaccine|vaccine
1462898|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
1462899|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
1462900|NCT00917761|Entecavir|entecavir
1462901|NCT00917735|Green tea|green tea
1462902|NCT00917735|Breast cancer|breast cancer
1462903|NCT00917735|Prevention|prevention
1462904|NCT00917735|COMT genotype|comt genotype
1462905|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
1463108|NCT00916916|Lanreotide|lanreotide
1462906|NCT00917735|Mammographic density|mammographic density
1462907|NCT00917735|Reproductive hormones|reproductive hormones
1462908|NCT00917735|IGF axis proteins|igf axis proteins
1462909|NCT00917735|Oxidative stress|oxidative stress
1462910|NCT00917722|Parkinson's Disease|parkinson's disease
1462911|NCT00917722|STN DBS|stn dbs
1462912|NCT00917722|Deep Brain Stimulation|deep brain stimulation
1462913|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
1462914|NCT00917709|imaging|imaging
1462915|NCT00917709|acetylcholine|acetylcholine
1462916|NCT00917709|dopamine|dopamine
1462917|NCT00917709|IBVM|ibvm
1462918|NCT00917709|DATSCAN|datscan
1462919|NCT00917670|trabecular meshwork|trabecular meshwork
1462920|NCT00917670|electron microscopy|electron microscopy
1462921|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
1462922|NCT00917657|hyperopia|hyperopia
1462923|NCT00917657|radial keratotomy|radial keratotomy
1462924|NCT00917657|refractive surgery|refractive surgery
1462925|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
1462926|NCT00917631|Co-bedding|co-bedding
1462927|NCT00917631|Procedural pain|procedural pain
1462928|NCT00917631|Twin|twin
1462929|NCT00917631|Comfort|comfort
1462930|NCT00917631|RCT|rct
1462931|NCT00917618|osteoarthritis|osteoarthritis
1462932|NCT00917618|knee|knee
1462933|NCT00917618|exercise|exercise
1462934|NCT00917618|cycling|cycling
1462935|NCT00917592|Diverticulitis|diverticulitis
1462936|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
1462937|NCT00917566|Airtraq|airtraq
1462938|NCT00917566|Pediatric|pediatric
1462939|NCT00917553|diabetic retinopathy|diabetic retinopathy
1462940|NCT00917553|diabetes|diabetes
1462941|NCT00917553|diabetic eye studies|diabetic eye studies
1462942|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
1462943|NCT00917514|Dosing Tool|dosing tool
1462944|NCT00917514|Compliance|compliance
1462945|NCT00917514|User Friendly|user friendly
1462946|NCT00917514|Crohn's Disease|crohn's disease
1462947|NCT00917514|Ulcerative Colitis|ulcerative colitis
1462948|NCT00917501|Mania|mania
1462949|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
1462950|NCT00917488|Allergen extract Standardization|allergen extract standardization
1462951|NCT00917475|preterm infants|preterm infants
1462952|NCT00917462|ESOPHAGUS|esophagus
1462953|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
1462954|NCT00917462|09-016|09-016
1462955|NCT00917462|Nexavar®.|nexavar®.
1462956|NCT00917449|Metabolic Syndrome|metabolic syndrome
1462957|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
1462958|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
1462959|NCT00917449|Endothelial dysfunction|endothelial dysfunction
1462960|NCT00917449|L-arginine|l-arginine
1462961|NCT00917449|Insulin resistance|insulin resistance
1462962|NCT00917423|Anorexia Nervosa|anorexia nervosa
1462963|NCT00917423|Exercise|exercise
1462964|NCT00917423|Physical Activity|physical activity
1462965|NCT00917397|Traumatized refugee|traumatized refugee
1462966|NCT00917397|treatment|treatment
1462967|NCT00917397|antidepressants|antidepressants
1462968|NCT00917397|psychotherapy|psychotherapy
1462969|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
1462970|NCT00917384|IMC-1121B|imc-1121b
1462971|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
1462972|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1462973|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
1462974|NCT00917384|Platinum resistant|platinum resistant
1462975|NCT00917384|platinum refractory|platinum refractory
1462976|NCT00917384|Gastric|gastric
1462977|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1462978|NCT00917384|metastatic|metastatic
1462979|NCT00917384|Angiogenesis|angiogenesis
1462980|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
1462981|NCT00917371|atomoxetine|atomoxetine
1462982|NCT00917371|neuropsychological functioning|neuropsychological functioning
1462983|NCT00917371|brain imaging studies|brain imaging studies
1462984|NCT00917358|Hepatitis C|hepatitis c
1462985|NCT00917358|Dialysis|dialysis
1462986|NCT00917358|Interferon|interferon
1462987|NCT00917345|ARC|arc
1462988|NCT00917345|PRA|pra
1462989|NCT00917345|primary aldosteronism|primary aldosteronism
1462990|NCT00917345|captopril test|captopril test
1462991|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
1462992|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
1462993|NCT00917332|pain|pain
1462994|NCT00917332|childbirth|childbirth
1462996|NCT00917332|guided imagery|guided imagery
1462997|NCT00917332|VAS|vas
1462998|NCT00917332|epidural|epidural
1462999|NCT00917306|Peplin|peplin
1463000|NCT00917306|Actinic keratosis|actinic keratosis
1463001|NCT00917306|PEP005|pep005
1463002|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
1463003|NCT00917293|Schizophrenia|schizophrenia
1463004|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
1463005|NCT00917280|Parkinson's Disease|parkinson's disease
1463006|NCT00917267|diabetes|diabetes
1463007|NCT00917267|exenatide|exenatide
1463008|NCT00917267|once weekly|once weekly
1463009|NCT00917267|Byetta|byetta
1463010|NCT00917267|Amylin|amylin
1463011|NCT00917267|Lilly|lilly
1463012|NCT00917254|YM150|ym150
1463013|NCT00917254|Thrombosis|thrombosis
1463014|NCT00917254|VTE|vte
1463015|NCT00917254|Knee Replacement|knee replacement
1463016|NCT00917254|Anticoagulant|anticoagulant
1463017|NCT00917254|FXa inhibitor|fxa inhibitor
1463018|NCT00917241|Graves' disease|graves' disease
1463019|NCT00917241|dexamethasone|dexamethasone
1463020|NCT00917241|relapse|relapse
1463021|NCT00917241|methimazole|methimazole
1463022|NCT00917215|Asthma|asthma
1463023|NCT00917215|Acupuncture|acupuncture
1463024|NCT00917215|Pulmonary function|pulmonary function
1463025|NCT00917215|Quality of life|quality of life
1463026|NCT00917189|VCFS|vcfs
1463027|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
1463028|NCT00917189|Learning Disorders|learning disorders
1463029|NCT00917163|coronary artery disease|coronary artery disease
1463030|NCT00917163|restenosis|restenosis
1463031|NCT00917163|stent thrombosis|stent thrombosis
1463032|NCT00917163|coronary stents|coronary stents
1463033|NCT00917163|angioplasty|angioplasty
1463034|NCT00917163|drug eluting stents|drug eluting stents
1463035|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1463036|NCT00917150|COPD|copd
1463037|NCT00917150|emphysema|emphysema
1463038|NCT00917137|Lung cancer|lung cancer
1463039|NCT00917137|Lung nodule|lung nodule
1463040|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
1463041|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
1463042|NCT00917137|Bronchoscopy|bronchoscopy
1463043|NCT00917124|cerebral oximetry|cerebral oximetry
1463044|NCT00917124|NIRS|nirs
1463045|NCT00917124|INVOS|invos
1463046|NCT00917111|Randomized|randomized
1463047|NCT00917111|Double-Blind|double-blind
1463048|NCT00917111|Multi-Center|multi-center
1463049|NCT00917111|Placebo-Controlled|placebo-controlled
1463050|NCT00917111|Phase II|phase ii
1463051|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
1463052|NCT00917111|Carbon Dioxide|carbon dioxide
1463053|NCT00917111|Efficacy|efficacy
1463054|NCT00917111|Safety|safety
1463055|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
1463056|NCT00917098|Behavior Therapy|behavior therapy
1463057|NCT00917098|Supportive Counseling|supportive counseling
1463058|NCT00917098|Child|child
1463059|NCT00917098|Adolescent|adolescent
1463060|NCT00917098|Hair Pulling|hair pulling
1463061|NCT00917098|CBT|cbt
1463062|NCT00917085|Preterm infant|preterm infant
1463063|NCT00917085|Skin-to-skin contact|skin-to-skin contact
1463064|NCT00917085|kangaroo care|kangaroo care
1463065|NCT00917085|temperature|temperature
1463066|NCT00917085|behavioral state|behavioral state
1463067|NCT00917072|Clinical Handoff|clinical handoff
1463068|NCT00917072|Medical Education|medical education
1463069|NCT00917072|Simulation|simulation
1463070|NCT00917072|Residency and Internship|residency and internship
1463071|NCT00917059|Major Depressive Disorder|major depressive disorder
1463072|NCT00917059|SSRI|ssri
1463073|NCT00917059|EEG|eeg
1463074|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
1463075|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
1463076|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
1463077|NCT00917020|Randomized|randomized
1463078|NCT00917020|Double-Blind|double-blind
1463079|NCT00917020|Multi-Center|multi-center
1463080|NCT00917020|Phase II|phase ii
1463081|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
1463082|NCT00917020|Carbon Dioxide|carbon dioxide
1463083|NCT00917020|Efficacy|efficacy
1463084|NCT00917020|Safety|safety
1463085|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
1463086|NCT00917007|ABO incompatibility|abo incompatibility
1463087|NCT00917007|hemolysis|hemolysis
1463088|NCT00917007|jaundice|jaundice
1463089|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
1463090|NCT00917007|newborn|newborn
1463091|NCT00916994|Rotator Cuff Tear|rotator cuff tear
1463092|NCT00916981|pseudarthrosis|pseudarthrosis
1463093|NCT00916981|Treatment|treatment
1463094|NCT00916981|osteoblast grafting|osteoblast grafting
1463095|NCT00916981|cell therapy|cell therapy
1463096|NCT00916981|nonunion|nonunion
1463097|NCT00916968|Gender specific|gender specific
1463098|NCT00916968|cruciate retaining|cruciate retaining
1463099|NCT00916968|total knee arthroplasty|total knee arthroplasty
1463100|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
1464376|NCT00911560|05-075|05-075
1463101|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
1463102|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
1463103|NCT00916955|congenital anomalies|congenital anomalies
1463104|NCT00916955|mental illness|mental illness
1463105|NCT00916955|congenital heart disease|congenital heart disease
1463106|NCT00916942|Tolerability study|tolerability study
1463107|NCT00916916|Acromegaly|acromegaly
1463109|NCT00916903|Talus|talus
1463110|NCT00916903|Neuroserpin|neuroserpin
1463111|NCT00916903|mental retardation|mental retardation
1463112|NCT00916903|epilepsy|epilepsy
1463113|NCT00916903|FENIB|fenib
1463114|NCT00916903|XLMR|xlmr
1463115|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
1463116|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
1463117|NCT00916890|Long-term opioid treatment|long-term opioid treatment
1463118|NCT00916890|Cancer pain|cancer pain
1463119|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
1463120|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
1463121|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
1463122|NCT00916851|autism spectrum disorders|autism spectrum disorders
1463123|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
1463124|NCT00916851|cognitive functions|cognitive functions
1463125|NCT00916851|emotion/behaviors|emotion/behaviors
1463126|NCT00916851|brain imaging|brain imaging
1463127|NCT00916851|genotypes|genotypes
1463128|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
1463129|NCT00916838|MRI|mri
1463130|NCT00916825|breast cancer|breast cancer
1463131|NCT00916825|quality of life|quality of life
1463132|NCT00916825|children of somatically ill parents|children of somatically ill parents
1463133|NCT00916825|psychological adaptation|psychological adaptation
1463134|NCT00916812|Difficult intubation|difficult intubation
1463135|NCT00916812|Hyomental distance|hyomental distance
1463136|NCT00916812|Obstetric|obstetric
1463137|NCT00916812|Mallampati classification|mallampati classification
1463138|NCT00916812|Thyromental distance|thyromental distance
1463139|NCT00916812|Sternomental distance|sternomental distance
1463140|NCT00916799|telehealth|telehealth
1463141|NCT00916799|oximetry|oximetry
1463142|NCT00916799|copd|copd
1463143|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
1463144|NCT00916786|pharmacogenetics|pharmacogenetics
1463145|NCT00916786|molecular genetics|molecular genetics
1463146|NCT00916786|medication response|medication response
1463147|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
1463148|NCT00916773|Airway inflammation|airway inflammation
1463149|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
1567380|NCT00509405|potassium citrate|potassium citrate
1463150|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
1463151|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
1463152|NCT00916747|Progeria|progeria
1463153|NCT00916734|McKenzie|mckenzie
1463154|NCT00916734|thrust manipulation|thrust manipulation
1463155|NCT00916734|clinical prediction rule|clinical prediction rule
1463156|NCT00916721|Smoking cessation|smoking cessation
1463157|NCT00916721|propranolol|propranolol
1463158|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
1463159|NCT00916721|craving|craving
1463160|NCT00916708|endometrial cancer|endometrial cancer
1463161|NCT00916708|follow up|follow up
1463162|NCT00916708|relapse|relapse
1463163|NCT00916695|Stents|stents
1463164|NCT00916695|Angioplasty|angioplasty
1463165|NCT00916695|Coronary Artery Disease|coronary artery disease
1463166|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
1463167|NCT00916669|SCLC|sclc
1463168|NCT00916669|enoxaparin sodium|enoxaparin sodium
1463169|NCT00916669|cisplatin|cisplatin
1463170|NCT00916669|etoposide|etoposide
1463171|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
1463172|NCT00916643|Hypercholesterolemia|hypercholesterolemia
1463174|NCT00916643|LDL-C|ldl-c
1463175|NCT00916643|CHD|chd
1463176|NCT00916630|recurrent|recurrent
1463177|NCT00916630|alimta|alimta
1463178|NCT00916630|pemetrexed|pemetrexed
1463179|NCT00916630|CNS lymphoma|cns lymphoma
1463180|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
1463181|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
1463182|NCT00916617|open-label|open-label
1463183|NCT00916617|safety|safety
1463184|NCT00916617|antibody|antibody
1463185|NCT00916604|AZD1656|azd1656
1463186|NCT00916604|Safety|safety
1463187|NCT00916604|Pharmacokinetics|pharmacokinetics
1463188|NCT00916604|Pharmacodynamic|pharmacodynamic
1463189|NCT00916604|Multiple ascending doses|multiple ascending doses
1463190|NCT00916604|Japanese|japanese
1463191|NCT00916604|T2DM|t2dm
1463192|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
1463193|NCT00916591|respiratory aspiration|respiratory aspiration
1463194|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
1463195|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
1463196|NCT00916578|Capecitabine|capecitabine
1463197|NCT00916578|Xeloda|xeloda
1464765|NCT00910130|Nutrition|nutrition
1463198|NCT00916578|Concomitant Radiation|concomitant radiation
1463199|NCT00916578|Radiation Therapy|radiation therapy
1463200|NCT00916578|Radiotherapy|radiotherapy
1463201|NCT00916578|Women|women
1463202|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
1463203|NCT00916565|Infant|infant
1463204|NCT00916552|Erythropoietin|erythropoietin
1463206|NCT00916552|depression|depression
1463207|NCT00916552|bipolar disorder|bipolar disorder
1463208|NCT00916552|cognition|cognition
1463209|NCT00916552|cognitive function|cognitive function
1463210|NCT00916552|antidepressant|antidepressant
1463211|NCT00916526|Chronic cough|chronic cough
1463212|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
1463213|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
1463214|NCT00916526|Methacholine|methacholine
1463215|NCT00916513|Diabetes|diabetes
1463216|NCT00916513|Treatment Satisfaction|treatment satisfaction
1463217|NCT00916513|Quality of Life|quality of life
1463218|NCT00916513|HbA1c levels and goals|hba1c levels and goals
1463219|NCT00916513|Healthcare resources consumption|healthcare resources consumption
1463220|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
1463221|NCT00916461|First episode psychosis|first episode psychosis
1463222|NCT00916461|Schizophrenia|schizophrenia
1463223|NCT00916461|Minocycline|minocycline
1463224|NCT00916461|neuroprotection|neuroprotection
1463225|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
1463226|NCT00916461|With in first five years of illness|with in first five years of illness
1463227|NCT00916448|Endotoxin|endotoxin
1463228|NCT00916448|Bilirubin|bilirubin
1463229|NCT00916448|Inflammation|inflammation
1463230|NCT00916448|Sepsis|sepsis
1463231|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
1463232|NCT00916448|Oxidative Stress|oxidative stress
1463233|NCT00916448|Heme oxygenase|heme oxygenase
1463234|NCT00916435|Arrhythmia|arrhythmia
1463235|NCT00916435|Cardiac Arrest|cardiac arrest
1463236|NCT00916435|Cardiomyopathy|cardiomyopathy
1463237|NCT00916435|Heart Failure|heart failure
1463238|NCT00916422|Immunotherapy|immunotherapy
1463239|NCT00916422|Allergoid|allergoid
1463240|NCT00916422|Depigmented|depigmented
1463241|NCT00916422|Polymerized|polymerized
1463242|NCT00916422|Allergen-extract|allergen-extract
1463243|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
1463244|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
1463245|NCT00916409|Glioblastoma|glioblastoma
1463246|NCT00916409|GBM|gbm
1463247|NCT00916409|Brain tumor|brain tumor
1463248|NCT00916409|Treatment|treatment
1463249|NCT00916409|Minimal toxicity|minimal toxicity
1463250|NCT00916409|Newly Diagnosed|newly diagnosed
1463251|NCT00916409|TTFields|ttfields
1463252|NCT00916409|Tumor Treating Fields|tumor treating fields
1463253|NCT00916409|NovoCure|novocure
1463254|NCT00916383|Skin Irritation|skin irritation
1463255|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
1463256|NCT00916383|Elderly|elderly
1463257|NCT00916383|Alzheimer's subjects|alzheimer's subjects
1463258|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
1463259|NCT00916370|drug eluting stents|drug eluting stents
1463260|NCT00916370|stents|stents
1463261|NCT00916370|Angioplasty|angioplasty
1463262|NCT00916370|myocardial ischemia|myocardial ischemia
1463263|NCT00916370|coronary artery stenosis|coronary artery stenosis
1463264|NCT00916370|Coronary Disease|coronary disease
1463265|NCT00916370|Coronary Artery Disease|coronary artery disease
1463266|NCT00916370|Coronary Restenosis|coronary restenosis
1463267|NCT00916370|Long lesion|long lesion
1463268|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
1463269|NCT00916357|Insulin lispro|insulin lispro
1463270|NCT00916357|Regular human insulin|regular human insulin
1463271|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
1463272|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
1463273|NCT00916331|blood loss|blood loss
1463274|NCT00916331|complications|complications
1463275|NCT00916331|functional status|functional status
1463276|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
1463277|NCT00916292|Diabetes|diabetes
1463278|NCT00916292|dermal ulcers|dermal ulcers
1463279|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
1463280|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
1463281|NCT00916279|Drug Coated Balloon|drug coated balloon
1463282|NCT00916279|Coronary Artery Disease|coronary artery disease
1463283|NCT00916266|Seizure frequency|seizure frequency
1463284|NCT00916266|Hippocampal volume|hippocampal volume
1463285|NCT00916266|Adverse effects|adverse effects
1463286|NCT00916253|Sleep|sleep
1463287|NCT00916253|real driving|real driving
1463288|NCT00916253|simulated driving|simulated driving
1463289|NCT00916253|MWT|mwt
1463290|NCT00916240|Adolescents|adolescents
1463291|NCT00916240|African American|african american
1463292|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
1463293|NCT00916201|schizophrenia|schizophrenia
1463294|NCT00916188|Black Tea|black tea
1463295|NCT00916188|Oxidative Stress|oxidative stress
1463296|NCT00916188|Blood Lipids|blood lipids
1463297|NCT00916188|Insulin Sensitivity|insulin sensitivity
1463298|NCT00916175|hyperglycemia|hyperglycemia
1463299|NCT00916175|overweight|overweight
1463300|NCT00916175|functional food|functional food
1463301|NCT00916175|aloe vera|aloe vera
1463302|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
1463599|NCT00914953|depression|depression
1463303|NCT00916162|aromatase inhibitor|aromatase inhibitor
1463304|NCT00916149|Epilepsy|epilepsy
1463305|NCT00916149|Cognition|cognition
1463306|NCT00916149|Lamictal|lamictal
1463307|NCT00916149|Lamotrigine|lamotrigine
1463308|NCT00916149|Keppra|keppra
1463309|NCT00916149|Levetiracetam|levetiracetam
1463310|NCT00916136|Pre-operative Traction|pre-operative traction
1463311|NCT00916136|Traction|traction
1463312|NCT00916136|Proximal Femur Fracture|proximal femur fracture
1463313|NCT00916136|Femoral Fractures|femoral fractures
1463314|NCT00916136|Femoral Fracture|femoral fracture
1463315|NCT00916136|Skeletal Traction|skeletal traction
1463316|NCT00916136|Cutaneous Traction|cutaneous traction
1463317|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
1463318|NCT00916123|CRPC|crpc
1463319|NCT00916110|healthy subjects|healthy subjects
1463320|NCT00916071|Bulimia Nervosa|bulimia nervosa
1463321|NCT00916071|Eating Disorder NOS|eating disorder nos
1463322|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1463323|NCT00916071|ADHD|adhd
1463324|NCT00916058|Multiple Myeloma|multiple myeloma
1463325|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
1463326|NCT00916058|ASCT|asct
1463327|NCT00916058|MM|mm
1463328|NCT00916019|gene expression|gene expression
1463329|NCT00916019|skeletal muscle|skeletal muscle
1463330|NCT00916019|Healthy men|healthy men
1463331|NCT00916006|Peplin|peplin
1463332|NCT00916006|Actinic keratosis|actinic keratosis
1463333|NCT00916006|PEP005|pep005
1463334|NCT00915993|stage IV renal cell cancer|stage iv renal cell cancer
1463335|NCT00915993|recurrent renal cell cancer|recurrent renal cell cancer
1463336|NCT00915980|Meal-test|meal-test
1463337|NCT00915980|reduced OGTT|reduced ogtt
1463338|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
1463339|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
1463340|NCT00915980|Different OGTT|different ogtt
1463341|NCT00915980|New meal- test|new meal- test
1463342|NCT00915967|Infection|infection
1463343|NCT00915967|Vancomycin|vancomycin
1463344|NCT00915967|Neurosurgery|neurosurgery
1463345|NCT00915967|Stimulator|stimulator
1463346|NCT00915967|Pump|pump
1463347|NCT00915967|Deep Brain Stimulation|deep brain stimulation
1463348|NCT00915967|Intrathecal Pump|intrathecal pump
1463349|NCT00915954|Acromegaly|acromegaly
1463350|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
1463351|NCT00915954|recombinant human IGF1|recombinant human igf1
1463352|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
1463353|NCT00915915|Female contraception|female contraception
1463354|NCT00915915|Ovulation inhibition|ovulation inhibition
1463355|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1463356|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
1463357|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
1463358|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
1463359|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
1463360|NCT00915889|stage III cervical cancer|stage iii cervical cancer
1463361|NCT00915889|cancer survivor|cancer survivor
1463362|NCT00915876|chronic kidney disease|chronic kidney disease
1463363|NCT00915876|Vitamin D|vitamin d
1463364|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
1463365|NCT00915863|pancreatic fistula|pancreatic fistula
1463366|NCT00915863|reconstruction|reconstruction
1463367|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
1463368|NCT00915837|DME|dme
1463369|NCT00915824|Drug therapy|drug therapy
1463370|NCT00915824|Prescribing|prescribing
1463371|NCT00915824|Appropriateness|appropriateness
1463372|NCT00915824|Randomized controlled trial|randomized controlled trial
1463373|NCT00915824|STOPP/START criteria|stopp/start criteria
1463374|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
1463375|NCT00915824|Prescription Drugs|prescription drugs
1463376|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
1463377|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1463378|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
1463379|NCT00915811|Fludarabine|fludarabine
1463380|NCT00915811|Busulphan|busulphan
1463381|NCT00915811|Thymoglobuline|thymoglobuline
1463382|NCT00915759|ProKera|prokera
1463383|NCT00915759|Amniotic membrane|amniotic membrane
1463384|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
1463385|NCT00915759|PRK|prk
1463386|NCT00915759|time to re-epithelialization|time to re-epithelialization
1463387|NCT00915746|Phase I|phase i
1463388|NCT00915746|ketoconazole|ketoconazole
1463389|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
1463390|NCT00915746|drug interaction|drug interaction
1463391|NCT00915746|metabolism|metabolism
1463392|NCT00915746|Healthly Volunteer|healthly volunteer
1463393|NCT00915746|JNJ-31001074|jnj-31001074
1463394|NCT00915733|acute myocardial infarction|acute myocardial infarction
1463395|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
1463396|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
1463397|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
1463600|NCT00914953|loneliness|loneliness
1463398|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
1463399|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
1463400|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1463401|NCT00915733|CYP2C19, human|cyp2c19, human
1463402|NCT00915720|Atrial Fibrillation|atrial fibrillation
1463403|NCT00915720|Surgical Ablation|surgical ablation
1463404|NCT00915720|Implanted loop recorder|implanted loop recorder
1463405|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
1463406|NCT00915707|obesity|obesity
1463407|NCT00915707|diabetes, risk|diabetes, risk
1463408|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
1463409|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
1463410|NCT00915694|adult gliosarcoma|adult gliosarcoma
1463411|NCT00915694|adult glioblastoma|adult glioblastoma
1463412|NCT00915681|amatoxin|amatoxin
1463413|NCT00915681|amanita|amanita
1463414|NCT00915681|mushroom poisoning|mushroom poisoning
1463415|NCT00915681|hepatic failure|hepatic failure
1463416|NCT00915681|milk thistle|milk thistle
1463417|NCT00915681|Silibinin|silibinin
1463418|NCT00915681|Legalon|legalon
1463419|NCT00915668|Healthy women|healthy women
1463420|NCT00915668|Non-childbearing potential|non-childbearing potential
1463421|NCT00915668|Drug-drug interaction|drug-drug interaction
1463422|NCT00915668|Oral contraceptive|oral contraceptive
1463423|NCT00915668|OC|oc
1463424|NCT00915668|Ovral-L|ovral-l
1463425|NCT00915668|ethinyl estradiol|ethinyl estradiol
1463426|NCT00915668|EE|ee
1463427|NCT00915668|levonorgestrel|levonorgestrel
1463428|NCT00915668|JNJ-31001074|jnj-31001074
1463429|NCT00915655|HIV Infections|hiv infections
1463430|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
1463431|NCT00915655|TMC114-C230|tmc114-c230
1463432|NCT00915655|TMC114|tmc114
1463433|NCT00915655|HIV-1|hiv-1
1463434|NCT00915655|Darunavir|darunavir
1463435|NCT00915655|Ritonavir|ritonavir
1463436|NCT00915655|NRTI|nrti
1463437|NCT00915655|Treatment Naive|treatment naive
1463438|NCT00915642|Obesity|obesity
1463439|NCT00915642|Weight loss rate|weight loss rate
1607912|NCT00365339|HIV|hiv
1463440|NCT00915642|Sleep|sleep
1463441|NCT00915642|Vigil|vigil
1463442|NCT00915642|Metabolism|metabolism
1463443|NCT00915642|Actigraphy|actigraphy
1463444|NCT00915642|Normal|normal
1463445|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
1463446|NCT00915603|Paclitaxel|paclitaxel
1463447|NCT00915603|Bevacizumab|bevacizumab
1463448|NCT00915603|Everolimus|everolimus
1463449|NCT00915577|Multiple Sclerosis|multiple sclerosis
1463450|NCT00915577|interferon beta-1a|interferon beta-1a
1463451|NCT00915577|Avonex|avonex
1463452|NCT00915577|liquid Avonex|liquid avonex
1463453|NCT00915564|Hepatitis C|hepatitis c
1463454|NCT00915564|HCV|hcv
1463455|NCT00915564|Hepatitis C Virus|hepatitis c virus
1463456|NCT00915564|HCV negative|hcv negative
1463457|NCT00915564|Protease inhibitor|protease inhibitor
1463458|NCT00915564|Methadone|methadone
1463459|NCT00915564|TMC435|tmc435
1463460|NCT00915551|Peplin|peplin
1463461|NCT00915551|Actinic keratosis|actinic keratosis
1463462|NCT00915551|PEP005|pep005
1463463|NCT00915538|Asthma|asthma
1463464|NCT00915538|Formoterol|formoterol
1463465|NCT00915538|LABA|laba
1463466|NCT00915538|Symbicort|symbicort
1463467|NCT00915538|Aerochamber|aerochamber
1463468|NCT00915512|Schizophrenia|schizophrenia
1463469|NCT00915512|Paliperidone|paliperidone
1463470|NCT00915512|Invega|invega
1463471|NCT00915486|Diabetic|diabetic
1463472|NCT00915486|ulcer|ulcer
1463473|NCT00915486|topical|topical
1463474|NCT00915486|PDGF|pdgf
1463475|NCT00915486|GSoC|gsoc
1463476|NCT00915460|Multiple Sclerosis|multiple sclerosis
1463477|NCT00915460|Avonex|avonex
1463478|NCT00915460|Interferon beta-1a|interferon beta-1a
1463479|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
1463480|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
1463481|NCT00915434|Healthy volunteer|healthy volunteer
1463482|NCT00915434|Phase I|phase i
1463483|NCT00915434|Non-childbearing potential|non-childbearing potential
1463484|NCT00915434|JNJ-31001074|jnj-31001074
1463485|NCT00915434|Food|food
1463486|NCT00915434|Pharmacokinetics|pharmacokinetics
1463487|NCT00915421|cardiac arrest|cardiac arrest
1463488|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
1463489|NCT00915421|Postresuscitative disease|postresuscitative disease
1463490|NCT00915408|Multiple Myeloma|multiple myeloma
1463491|NCT00915408|Cyclophosphamide|cyclophosphamide
1463492|NCT00915408|Dexamethasone|dexamethasone
1463493|NCT00915408|Lenalidomide|lenalidomide
1463494|NCT00915356|AZD1305|azd1305
1463495|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
1464766|NCT00910117|HNSCC|hnscc
1463496|NCT00915343|Adrenal insufficiency|adrenal insufficiency
1463497|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
1463498|NCT00915343|Addison's disease|addison's disease
1463499|NCT00915343|Hydrocortisone|hydrocortisone
1463500|NCT00915343|Modified release|modified release
1463601|NCT00914953|happiness|happiness
1463501|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
1463502|NCT00915330|Bronchoscopy|bronchoscopy
1463503|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
1463504|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
1463505|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
1463506|NCT00915304|Clinical Decision Support System|clinical decision support system
1463507|NCT00915304|Automatic reminder|automatic reminder
1463508|NCT00915304|Primary care|primary care
1463509|NCT00915304|Evidence-Based Medicine|evidence-based medicine
1463510|NCT00915291|medical education|medical education
1463511|NCT00915291|clinical decisionmaking|clinical decisionmaking
1463512|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
1463513|NCT00915278|Neoplasms|neoplasms
1463514|NCT00915278|monoclonal antibody|monoclonal antibody
1463515|NCT00915278|PF-04605412|pf-04605412
1463516|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
1463517|NCT00915265|Epidural analgesia|epidural analgesia
1463518|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
1463519|NCT00915265|Surgery|surgery
1463520|NCT00915265|Open colorectal surgery|open colorectal surgery
1463521|NCT00915265|Fast-track surgery|fast-track surgery
1463522|NCT00915265|ERAS|eras
1463523|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
1463524|NCT00915252|azacitidine|azacitidine
1463525|NCT00915252|elderly|elderly
1463526|NCT00915252|demethylating agent|demethylating agent
1463527|NCT00915252|flt3|flt3
1463528|NCT00915252|AML|aml
1463529|NCT00915239|volunteers|volunteers
1463530|NCT00915226|Optic disk|optic disk
1463531|NCT00915226|Regional blood flow|regional blood flow
1463532|NCT00915226|Autoregulation|autoregulation
1463533|NCT00915213|E. Coli|e. coli
1463534|NCT00915213|Prostate Biopsy|prostate biopsy
1463535|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
1463536|NCT00915200|Proteinuria|proteinuria
1463537|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
1463538|NCT00915200|Monocytes|monocytes
1463539|NCT00915200|Oxidative stress|oxidative stress
1463540|NCT00915200|Inflammation|inflammation
1463541|NCT00915200|Antioxidants|antioxidants
1463542|NCT00915200|Glutathione|glutathione
1463543|NCT00915200|Silymarin|silymarin
1463544|NCT00915200|Acetylcysteine|acetylcysteine
1463545|NCT00915200|Dietary Supplements|dietary supplements
1463546|NCT00915200|Complementary Therapies|complementary therapies
1463547|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
1463548|NCT00915174|drug-drug interaction study|drug-drug interaction study
1463549|NCT00915161|ventilation|ventilation
1463550|NCT00915161|oxygenation|oxygenation
1463551|NCT00915148|Prolonged labor|prolonged labor
1463552|NCT00915148|Ultrasound|ultrasound
1463553|NCT00915148|Caeserian section|caeserian section
1463554|NCT00915135|Insomnia|insomnia
1463555|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1463556|NCT00915135|Drug Therapy|drug therapy
1463557|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
1463558|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
1463559|NCT00915122|cancer of the prostate|cancer of the prostate
1463560|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
1463561|NCT00915109|amputees|amputees
1463562|NCT00915109|lower limb|lower limb
1463563|NCT00915096|Follicular Lymphoma|follicular lymphoma
1463564|NCT00915096|PET|pet
1463565|NCT00915096|GELA|gela
1463566|NCT00915070|BQ-123|bq-123
1463567|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
1463568|NCT00915070|Intraocular Pressure|intraocular pressure
1463569|NCT00915070|Regional Blood Flow|regional blood flow
1463570|NCT00915070|Ocular Physiology|ocular physiology
1463571|NCT00915070|Optic Disk|optic disk
1463572|NCT00915044|IBD|ibd
1463573|NCT00915031|Robotic prostatectomy|robotic prostatectomy
1463574|NCT00915031|Hypothermia|hypothermia
1463575|NCT00915031|Potency|potency
1463576|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
1463577|NCT00915018|HKI-272|hki-272
1463578|NCT00915018|Neratinib|neratinib
1463579|NCT00915018|Nerlynx|nerlynx
1463580|NCT00915018|HER2|her2
1463581|NCT00915018|PB-272|pb-272
1463582|NCT00915018|metastatic breast cancer|metastatic breast cancer
1463583|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
1463584|NCT00915005|NSCLC|nsclc
1463585|NCT00915005|Lung Cancer|lung cancer
1463586|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
1463587|NCT00915005|Proton Therapy|proton therapy
1463588|NCT00915005|Chemotherapy|chemotherapy
1463589|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
1463590|NCT00914992|optic disk|optic disk
1463591|NCT00914992|regional blood flow|regional blood flow
1463592|NCT00914992|autoregulation|autoregulation
1463593|NCT00914979|Angiosculpt|angiosculpt
1463594|NCT00914979|Bifurcation Lesion|bifurcation lesion
1463595|NCT00914979|Side branch|side branch
1463596|NCT00914979|IVUS|ivus
1463597|NCT00914953|social isolation|social isolation
1463598|NCT00914953|cooperative behavior|cooperative behavior
1463602|NCT00914953|empathy|empathy
1463603|NCT00914940|graft versus host disease|graft versus host disease
1463604|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1463605|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1463606|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1463607|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1463608|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1463609|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1463610|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1463611|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1463612|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1463613|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1463614|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1463615|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1463616|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1463617|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1463618|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1463619|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
1463620|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1463621|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1463622|NCT00914927|Thrombocytopenia|thrombocytopenia
1463623|NCT00914927|chronic liver disease|chronic liver disease
1463624|NCT00914901|Asthma|asthma
1463625|NCT00914901|Doping|doping
1463626|NCT00914901|Salmeterol|salmeterol
1463627|NCT00914901|Beta-agonist|beta-agonist
1463628|NCT00914901|Urine concentrations|urine concentrations
1463629|NCT00914888|children|children
1463630|NCT00914888|pediatry|pediatry
1463631|NCT00914888|pneumonia|pneumonia
1463632|NCT00914888|intra-abdominal|intra-abdominal
1463633|NCT00914888|infection|infection
1463634|NCT00914875|kidney function tests|kidney function tests
1463635|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
1463636|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1463637|NCT00914875|adult|adult
1463638|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
1463639|NCT00914862|Drug Therapy|drug therapy
1463640|NCT00914836|shoulder|shoulder
1463641|NCT00914836|subacromion|subacromion
1463642|NCT00914836|corticosteroid|corticosteroid
1463643|NCT00914836|bursitis|bursitis
1463644|NCT00914836|tendinitis|tendinitis
1463645|NCT00914836|calcific tendonitis|calcific tendonitis
1463646|NCT00914836|subacromial bursitis|subacromial bursitis
1463647|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
1463648|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1463649|NCT00914810|Vitamin D|vitamin d
1463650|NCT00914810|Cholecalciferol|cholecalciferol
1463651|NCT00914810|Skeletal muscle|skeletal muscle
1463652|NCT00914797|Asthma|asthma
1463653|NCT00914797|Doping|doping
1463654|NCT00914797|Beta agonist|beta agonist
1463655|NCT00914797|Terbutaline|terbutaline
1463656|NCT00914797|Pharmacokinetics|pharmacokinetics
1463657|NCT00914784|TRALI|trali
1463658|NCT00914784|Transfusion|transfusion
1463659|NCT00914784|dyspnea|dyspnea
1463660|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
1463661|NCT00914771|Pandemic Influenza|pandemic influenza
1463662|NCT00914771|H5N1|h5n1
1463663|NCT00914771|Adults and Elderly|adults and elderly
1463664|NCT00914771|antigen dose|antigen dose
1463665|NCT00914758|multiple sclerosis|multiple sclerosis
1463666|NCT00914758|cognition|cognition
1463667|NCT00914758|cognitive functioning|cognitive functioning
1463668|NCT00914758|Campath|campath
1463669|NCT00914758|Rebif|rebif
1463670|NCT00914758|alemtuzumab|alemtuzumab
1463671|NCT00914758|interferon|interferon
1463672|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
1463673|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
1463674|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
1463675|NCT00914706|Diabetes|diabetes
1463676|NCT00914693|Fertility control|fertility control
1463677|NCT00914693|Contraception|contraception
1463678|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
1463679|NCT00914654|Asthma|asthma
1463680|NCT00914654|Doping|doping
1463681|NCT00914654|Formoterol|formoterol
1463682|NCT00914654|Urinary concentrations|urinary concentrations
1463683|NCT00914654|Beta-agonists|beta-agonists
1463684|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
1463685|NCT00914628|high risk acute leukemia|high risk acute leukemia
1463686|NCT00914628|HSV-TK|hsv-tk
1463687|NCT00914628|Haploidentical HCT|haploidentical hct
1463688|NCT00914628|GvHD|gvhd
1463689|NCT00914628|GvL|gvl
1463886|NCT00913744|AMD|amd
1463690|NCT00914628|Immunoreconstitution|immunoreconstitution
1463691|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1463692|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
1463817|NCT00914082|Self hypnosis|self hypnosis
1463693|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
1463694|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
1463695|NCT00914576|Retina|retina
1463696|NCT00914576|Regional Blood Flow|regional blood flow
1463697|NCT00914563|Burned shock|burned shock
1463698|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
1463699|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
1463700|NCT00914550|Pneumonia|pneumonia
1463701|NCT00914550|Lung Infiltrates|lung infiltrates
1463702|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
1463703|NCT00914550|De-escalation therapy|de-escalation therapy
1463704|NCT00914537|Anal Cancer|anal cancer
1463705|NCT00914537|AIN|ain
1463706|NCT00914537|HPV|hpv
1463707|NCT00914537|Cytology|cytology
1463708|NCT00914537|HIV|hiv
1463709|NCT00914537|HIV Positive|hiv positive
1463710|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
1463711|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
1463712|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
1463713|NCT00914524|Urinary Protein|urinary protein
1463714|NCT00914511|Semen|semen
1463715|NCT00914511|Sperm|sperm
1463716|NCT00914511|Avanafil|avanafil
1463717|NCT00914511|Pharmacokinetics|pharmacokinetics
1463718|NCT00914511|Elderly|elderly
1463719|NCT00914498|Xylocaine|xylocaine
1463720|NCT00914498|Casarean section|casarean section
1463721|NCT00914498|Post operative pain|post operative pain
1463722|NCT00914498|Scar quality|scar quality
1463723|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
1463724|NCT00914459|hemophilia A|hemophilia a
1463725|NCT00914446|Steatohepatitis|steatohepatitis
1463726|NCT00914433|COPD|copd
1463727|NCT00914420|OCT|oct
1463728|NCT00914420|Reendothelialisation|reendothelialisation
1463729|NCT00914420|Intrepide|intrepide
1463730|NCT00914420|Trapidil|trapidil
1463731|NCT00914420|Taxus|taxus
1463732|NCT00914407|Ocular physiology|ocular physiology
1463733|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
1463734|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
1463735|NCT00914394|Intraocular Pressure|intraocular pressure
1463736|NCT00914394|Regional Blood Flow|regional blood flow
1463737|NCT00914394|Ocular Physiology|ocular physiology
1463738|NCT00914394|Optic Disk|optic disk
1463739|NCT00914381|Community reinforcement approach|community reinforcement approach
1463740|NCT00914381|Contingency management|contingency management
1463741|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
1463742|NCT00914381|Cocaine dependence|cocaine dependence
1463743|NCT00914381|Women|women
1463744|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1463745|NCT00914368|Aspirin|aspirin
1463746|NCT00914368|Clopidogrel|clopidogrel
1463747|NCT00914368|Pathologic Processes|pathologic processes
1463748|NCT00914368|Disease|disease
1463749|NCT00914368|Therapeutic Uses|therapeutic uses
1463750|NCT00914368|Syndrome|syndrome
1463751|NCT00914368|Hematologic Agents|hematologic agents
1463752|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
1463753|NCT00914368|Pharmacologic Actions|pharmacologic actions
1463754|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
1463755|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
1463756|NCT00914355|Unresectable liver cancer|unresectable liver cancer
1463757|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
1463758|NCT00914342|Gerd|gerd
1463759|NCT00914342|GerdQ questionnaire|gerdq questionnaire
1463760|NCT00914342|work productivity|work productivity
1463761|NCT00914342|Greece|greece
1463762|NCT00914329|stress provoked|stress provoked
1463763|NCT00914329|healthy volunteers|healthy volunteers
1463764|NCT00914329|gelsemium|gelsemium
1463765|NCT00914329|homeopathy|homeopathy
1463766|NCT00914316|Lower leg claudication|lower leg claudication
1463767|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
1463768|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
1463769|NCT00914316|Lower leg pain|lower leg pain
1463770|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
1463771|NCT00914303|Safety|safety
1463772|NCT00914303|tolerability|tolerability
1463773|NCT00914303|healthy|healthy
1463774|NCT00914303|Healthy volunteer study|healthy volunteer study
1463775|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
1463776|NCT00914277|male impotence|male impotence
1463777|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
1463778|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
1464857|NCT00909805|suture|suture
1463779|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
1463780|NCT00914251|endothelial|endothelial
1463781|NCT00914251|metabolic syndrome|metabolic syndrome
1463782|NCT00914251|hesperidin|hesperidin
1463783|NCT00914238|Randomized clinical trial|randomized clinical trial
1463885|NCT00913757|Gene Expression Profiling|gene expression profiling
1463784|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
1463785|NCT00914238|rehabilitation|rehabilitation
1463786|NCT00914238|psychosocial|psychosocial
1463787|NCT00914238|health service research|health service research
1463788|NCT00914238|schizotypal Disorder|schizotypal disorder
1463789|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
1463790|NCT00914225|malaria|malaria
1463791|NCT00914225|plasmodium falciparum|plasmodium falciparum
1463792|NCT00914225|diarrhea|diarrhea
1463793|NCT00914225|helminth|helminth
1463795|NCT00914225|Treatment naive|treatment naive
1463796|NCT00914199|PCI|pci
1463797|NCT00914199|Bifurcation lesion|bifurcation lesion
1463798|NCT00914186|Atopic Dermatitis|atopic dermatitis
1463799|NCT00914186|Pruritus|pruritus
1463800|NCT00914160|Anti-inflammatory|anti-inflammatory
1463801|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1463802|NCT00914134|Parkinson's disease|parkinson's disease
1463803|NCT00914134|Autonomic nervous system|autonomic nervous system
1463804|NCT00914134|Levodopa infusion|levodopa infusion
1463805|NCT00914108|Preterm Infants|preterm infants
1463806|NCT00914108|Developmental Care|developmental care
1463807|NCT00914108|NIDCAP|nidcap
1463808|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
1463809|NCT00914108|APIB|apib
1463810|NCT00914108|EEG|eeg
1463811|NCT00914108|Neurobehavior|neurobehavior
1463812|NCT00914095|Parkinson's disease|parkinson's disease
1463813|NCT00914095|Freezing of Gait|freezing of gait
1463814|NCT00914095|Methylphenidate|methylphenidate
1463815|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
1463816|NCT00914095|Noradrenaline|noradrenaline
1463818|NCT00914082|Hypnosis|hypnosis
1463819|NCT00914082|mental training|mental training
1463820|NCT00914082|antenatal training|antenatal training
1463821|NCT00914082|pregnancy|pregnancy
1463822|NCT00914082|pain control|pain control
1463823|NCT00914082|Childbirth|childbirth
1463824|NCT00914082|Analgesia|analgesia
1463825|NCT00914043|fatigue|fatigue
1463826|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
1463827|NCT00914043|stage II breast cancer|stage ii breast cancer
1463828|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
1463829|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
1463830|NCT00914030|Visual perception|visual perception
1463831|NCT00914030|Local/global processing|local/global processing
1463832|NCT00914030|Attention|attention
1463833|NCT00914030|Visual priming|visual priming
1463834|NCT00914030|Collinearity|collinearity
1463835|NCT00914030|Grouping|grouping
1463836|NCT00914017|Breast Cancer|breast cancer
1463837|NCT00914017|Breast Cancer Prevention|breast cancer prevention
1463838|NCT00914017|Mammographic Density|mammographic density
1463839|NCT00914017|Breast Density|breast density
1463840|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
1463841|NCT00914004|Antidepressant|antidepressant
1463842|NCT00913991|Nitric Oxide|nitric oxide
1463843|NCT00913978|Normothermia|normothermia
1463844|NCT00913978|Colorectal Surgery|colorectal surgery
1463845|NCT00913978|Bair Huggers|bair huggers
1463846|NCT00913978|VitaHeat|vitaheat
1463847|NCT00913952|Antidepressant|antidepressant
1463848|NCT00913939|Prostate Cancer|prostate cancer
1463849|NCT00913939|HDR Brachytherapy|hdr brachytherapy
1463850|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
1463851|NCT00913926|Climacteric symptoms|climacteric symptoms
1463852|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
1463853|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
1463854|NCT00913900|Vascular Disease|vascular disease
1463855|NCT00913887|Anti-Inflammatory|anti-inflammatory
1463856|NCT00913861|endoscopy|endoscopy
1463857|NCT00913861|comfort|comfort
1463858|NCT00913861|non-pharmacological|non-pharmacological
1463859|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
1463860|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
1463861|NCT00913835|IMC-3G3|imc-3g3
1463863|NCT00913835|Platinum resistant|platinum resistant
1463864|NCT00913835|Platinum refractory|platinum refractory
1463865|NCT00913835|Ovary|ovary
1463866|NCT00913835|Neoplasm|neoplasm
1463867|NCT00913835|PDGFr|pdgfr
1463868|NCT00913822|Antidepressant|antidepressant
1463869|NCT00913809|Antidepressant|antidepressant
1463870|NCT00913796|Renal transplantation|renal transplantation
1463871|NCT00913796|Metabolic acidosis|metabolic acidosis
1463872|NCT00913796|Physical capacity|physical capacity
1463873|NCT00913796|Bone histology|bone histology
1463874|NCT00913796|Bone histomorphometry|bone histomorphometry
1463875|NCT00913796|Parathyroid function|parathyroid function
1463876|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
1463877|NCT00913783|Antidepressant|antidepressant
1463878|NCT00913770|opioid dependence|opioid dependence
1463879|NCT00913770|buprenorphine|buprenorphine
1463880|NCT00913770|brief intervention|brief intervention
1463881|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
1463882|NCT00913757|Liver Cancer|liver cancer
1463883|NCT00913757|Chronic Liver Disease|chronic liver disease
1463884|NCT00913757|Genome Wide Association Study|genome wide association study
1463887|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
1463888|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
1463889|NCT00913705|NATCH|natch
1463890|NCT00913705|LUNG|lung
1463891|NCT00913705|OPERABLE NSCLC|operable nsclc
1463892|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
1463893|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
1463894|NCT00913692|Glutamine|glutamine
1463895|NCT00913692|Herpes Labialis|herpes labialis
1463896|NCT00913692|Herpes Simplex Virus|herpes simplex virus
1463897|NCT00913692|Cold Sore|cold sore
1463898|NCT00913679|osteonecrosis|osteonecrosis
1463899|NCT00913679|femoral neck fracture|femoral neck fracture
1463900|NCT00913679|implant fixation|implant fixation
1463901|NCT00913679|implant failure|implant failure
1463902|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
1463903|NCT00913679|gait function|gait function
1463904|NCT00913679|gait analysis|gait analysis
1463905|NCT00913679|patient recovery|patient recovery
1463906|NCT00913666|Multiple Sclerosis|multiple sclerosis
1463907|NCT00913653|Heart failure|heart failure
1463908|NCT00913653|LCZ696|lcz696
1463909|NCT00913640|Prospective Memory Performance|prospective memory performance
1463910|NCT00913640|Prospective Memory Outcome|prospective memory outcome
1463911|NCT00913640|Parkinson's Disease|parkinson's disease
1463912|NCT00913627|Extended-release|extended-release
1463913|NCT00913627|ibuprofen|ibuprofen
1463914|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
1463915|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
1608483|NCT00363454|Phase I|phase i
1463916|NCT00913601|Fecal Incontinence|fecal incontinence
1463917|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
1463918|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
1463919|NCT00913575|neuromuscular training|neuromuscular training
1463920|NCT00913575|preoperative exercise|preoperative exercise
1463921|NCT00913575|physiotherapy|physiotherapy
1463922|NCT00913575|total knee replacement|total knee replacement
1463923|NCT00913575|knee osteoarthritis|knee osteoarthritis
1463924|NCT00913562|Ocular Physiology|ocular physiology
1463925|NCT00913562|Regional Blood Flow|regional blood flow
1463926|NCT00913549|Antihistamine|antihistamine
1463927|NCT00913536|Bladder Cancer|bladder cancer
1463928|NCT00913536|Cone Beam CT|cone beam ct
1463929|NCT00913536|On-line image guidance|on-line image guidance
1463930|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
1463931|NCT00913523|tampons|tampons
1463932|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
1463933|NCT00913523|vaginal microflora|vaginal microflora
1463934|NCT00913523|microbes|microbes
1463935|NCT00913523|Vaginal Tampon|vaginal tampon
1463936|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
1463937|NCT00913497|insulin glulisine|insulin glulisine
1463938|NCT00913497|insulin aspart|insulin aspart
1463939|NCT00913497|post prandial|post prandial
1463940|NCT00913484|Disulfiram|disulfiram
1463941|NCT00913484|Buprenorphine|buprenorphine
1463942|NCT00913484|Cocaine dependence|cocaine dependence
1463943|NCT00913484|Opioid dependence|opioid dependence
1463944|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
1463945|NCT00913471|Spinal cord injury|spinal cord injury
1463946|NCT00913471|SCI|sci
1463947|NCT00913471|Neuropathic pain|neuropathic pain
1463948|NCT00913471|Pain|pain
1463949|NCT00913445|Appendicitis|appendicitis
1463950|NCT00913445|appendicectomy|appendicectomy
1463951|NCT00913445|stitches|stitches
1463952|NCT00913445|wound healing|wound healing
1463953|NCT00913445|cosmetic results|cosmetic results
1463954|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
1463955|NCT00913432|methotrexate|methotrexate
1463956|NCT00913432|DMARD|dmard
1463957|NCT00913432|c-kit inhibitor|c-kit inhibitor
1463958|NCT00913419|Antidepressant|antidepressant
1463959|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
1463960|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1463961|NCT00913354|infertility|infertility
1463962|NCT00913354|ivf|ivf
1463963|NCT00913354|acupuncture|acupuncture
1463964|NCT00913328|Asthma|asthma
1463965|NCT00913328|Airway responsiveness|airway responsiveness
1463966|NCT00913328|Dose-response plateau|dose-response plateau
1463967|NCT00913328|Montelukast|montelukast
1463968|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
1463969|NCT00913315|prostatitis|prostatitis
1463970|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
1463971|NCT00913315|tolterodine|tolterodine
1463972|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
1463973|NCT00913302|Education|education
1463974|NCT00913302|Physical fitness|physical fitness
1463975|NCT00913289|Liver Cirrhosis|liver cirrhosis
1463976|NCT00913263|Prostate cancer|prostate cancer
1463977|NCT00913250|Multiple Sclerosis|multiple sclerosis
1463978|NCT00913250|Interferon beta-1a|interferon beta-1a
1463979|NCT00913237|Antidepressant|antidepressant
1463980|NCT00913224|Anti-inflammatory|anti-inflammatory
1463981|NCT00913198|Pancreas|pancreas
1464282|NCT00911898|Her3/ErbB3|her3/erbb3
1463982|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
1463983|NCT00913198|CP-4126|cp-4126
1463984|NCT00913185|Acne|acne
1463985|NCT00913172|TB|tb
1463986|NCT00913172|cost|cost
1463987|NCT00913172|HEWs|hews
1463988|NCT00913172|Cost-effectiveness|cost-effectiveness
1463989|NCT00913172|treatment success rate|treatment success rate
1463990|NCT00913159|Renal stones|renal stones
1463991|NCT00913159|lithotripsy|lithotripsy
1463992|NCT00913159|stone free rate|stone free rate
1463993|NCT00913146|Management of fever|management of fever
1463994|NCT00913146|Malaria|malaria
1463995|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
1463996|NCT00913146|Clinical trial|clinical trial
1463997|NCT00913133|Anticoagulation|anticoagulation
1463998|NCT00913133|Prophylaxis|prophylaxis
1463999|NCT00913133|Desirudin|desirudin
1464000|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
1464001|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1464002|NCT00913120|YM150|ym150
1464003|NCT00913120|FXa inhibitor|fxa inhibitor
1464004|NCT00913120|Thrombosis|thrombosis
1464005|NCT00913120|Anticoagulant|anticoagulant
1464006|NCT00913120|Venous thromboembolism|venous thromboembolism
1464007|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
1464008|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
1464009|NCT00913107|Lamotrigine|lamotrigine
1464010|NCT00913107|Carbamazepine|carbamazepine
1464011|NCT00913107|Lamictal®|lamictal®
1464012|NCT00913107|Tegretol®|tegretol®
1464013|NCT00913094|Hypertension|hypertension
1464014|NCT00913081|Skin|skin
1464015|NCT00913081|pharmacology|pharmacology
1464016|NCT00913081|metabolism|metabolism
1464017|NCT00913081|lipid|lipid
1464018|NCT00913068|radical prostatectomy|radical prostatectomy
1464019|NCT00913055|S-LAR|s-lar
1464020|NCT00913055|Octreotide|octreotide
1464021|NCT00913055|Implant|implant
1464022|NCT00913042|Febrile neutropenia|febrile neutropenia
1464023|NCT00913042|Blood culture|blood culture
1464024|NCT00913042|Bacteremia|bacteremia
1464025|NCT00913042|Bacterial DNA testing|bacterial dna testing
1464026|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
1464027|NCT00913029|OAG|oag
1464028|NCT00913029|glaucoma|glaucoma
1464029|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
1464030|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
1464031|NCT00913016|quality of life|quality of life
1464032|NCT00913003|Lidocaine|lidocaine
1464033|NCT00913003|Mastectomy|mastectomy
1464034|NCT00913003|Pain|pain
1464035|NCT00912990|Pediatric|pediatric
1464036|NCT00912977|Parkinsons disease|parkinsons disease
1464037|NCT00912977|dyskinesia|dyskinesia
1464038|NCT00912977|measurement|measurement
1464039|NCT00912964|Urgency|urgency
1464040|NCT00912964|YM178|ym178
1464041|NCT00912964|Urinary incontinence|urinary incontinence
1464042|NCT00912964|Mirabegron|mirabegron
1464043|NCT00912964|Micturition|micturition
1464044|NCT00912964|Frequency|frequency
1464045|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
1464046|NCT00912964|Overactive Bladder|overactive bladder
1464047|NCT00912938|metastatic breast cancer|metastatic breast cancer
1464048|NCT00912938|bone remodeling markers|bone remodeling markers
1464049|NCT00912938|zoledronic acid|zoledronic acid
1464050|NCT00912912|Genitourinary|genitourinary
1464051|NCT00912912|Testis|testis
1464052|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
1464053|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
1464054|NCT00912912|GCTs|gcts
1464055|NCT00912912|Sunitinib Malate|sunitinib malate
1464056|NCT00912912|Sutent|sutent
1464057|NCT00912912|SU011248|su011248
1464058|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
1464059|NCT00912899|CB3304|cb3304
1464060|NCT00912899|Noscapine HCl|noscapine hcl
1464061|NCT00912899|Multiple Myeloma|multiple myeloma
1464062|NCT00912886|alzheimer|alzheimer
1464063|NCT00912886|memory|memory
1464064|NCT00912886|neurosteroids|neurosteroids
1464065|NCT00912873|pain|pain
1464066|NCT00912873|catheter|catheter
1464067|NCT00912873|nerve block|nerve block
1464068|NCT00912873|UCSD|ucsd
1464069|NCT00912873|range of motion|range of motion
1464070|NCT00912873|hip surgery|hip surgery
1464071|NCT00912873|psoas compartment|psoas compartment
1464072|NCT00912860|multiple sclerosis|multiple sclerosis
1464073|NCT00912860|interferon beta-1a|interferon beta-1a
1464074|NCT00912860|avonex|avonex
1464075|NCT00912847|HBV carriers|hbv carriers
1464076|NCT00912834|hematuria|hematuria
1464077|NCT00912834|urinary tract infection|urinary tract infection
1464078|NCT00912821|Renal Replacement Therapy|renal replacement therapy
1464079|NCT00912821|Peritoneal dialysis|peritoneal dialysis
1464080|NCT00912808|parkinsons disease|parkinsons disease
1464081|NCT00912808|falling|falling
1464082|NCT00912795|Smoking Cessation|smoking cessation
1464083|NCT00912795|technology|technology
1464084|NCT00912795|developing countries|developing countries
1464085|NCT00912782|ESRD|esrd
1464086|NCT00912782|Vitamin D|vitamin d
1464087|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
1464672|NCT00910403|LASIK|lasik
1464088|NCT00912782|Dialysis Vascular Access|dialysis vascular access
1464089|NCT00912769|Total knee replacement|total knee replacement
1464090|NCT00912769|Subvastus|subvastus
1464091|NCT00912769|Midvastus|midvastus
1464092|NCT00912769|Isokinetic|isokinetic
1464093|NCT00912769|Quadriceps|quadriceps
1464094|NCT00912756|endovascular therapy|endovascular therapy
1464095|NCT00912756|restenosis|restenosis
1464096|NCT00912756|cilostazol|cilostazol
1464097|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
1464098|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
1464099|NCT00912743|Colorectal cancer|colorectal cancer
1464100|NCT00912743|Olaparib|olaparib
1464101|NCT00912743|MSI status|msi status
1464102|NCT00912743|Stage IV|stage iv
1464103|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
1464104|NCT00912743|Stratified by MSI Status|stratified by msi status
1464105|NCT00912730|melanoma|melanoma
1464106|NCT00912730|imaging|imaging
1464107|NCT00912730|sentinel node|sentinel node
1464108|NCT00912730|biopsy|biopsy
1464109|NCT00912704|Hemodialysis patients|hemodialysis patients
1464110|NCT00912704|Kidney|kidney
1464111|NCT00912704|Physician attitudes|physician attitudes
1464112|NCT00912704|Family wishes|family wishes
1464113|NCT00912704|30 numbers require maximum|30 numbers require maximum
1464114|NCT00912691|Autism|autism
1464115|NCT00912678|Kidney transplantation|kidney transplantation
1464116|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
1464117|NCT00912678|European senior program|european senior program
1464118|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
1464119|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
1464120|NCT00912665|Intraocular Pressure|intraocular pressure
1464121|NCT00912665|Regional Blood Flow|regional blood flow
1464122|NCT00912665|Ocular Physiology|ocular physiology
1464123|NCT00912665|Optic Disk|optic disk
1464124|NCT00912652|obesity|obesity
1464125|NCT00912652|rural health|rural health
1464126|NCT00912652|exercise|exercise
1464127|NCT00912639|recurrent breast cancer|recurrent breast cancer
1464128|NCT00912639|Genexol-PM|genexol-pm
1464129|NCT00912626|siblings|siblings
1464130|NCT00912626|family|family
1464131|NCT00912626|child behavior|child behavior
1464132|NCT00912626|critical illness|critical illness
1464133|NCT00912626|social support|social support
1464134|NCT00912613|Critical illness|critical illness
1464135|NCT00912613|ICU Diaries|icu diaries
1464136|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
1464137|NCT00912613|Incidence|incidence
1464138|NCT00912600|Intensive Care Units|intensive care units
1464139|NCT00912600|Triage|triage
1464140|NCT00912600|Aged, 80 and over|aged, 80 and over
1464141|NCT00912600|Death|death
1464142|NCT00912600|Activities of Daily Living|activities of daily living
1464143|NCT00912600|Health Services Research|health services research
1464144|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1464145|NCT00912574|Melanoma|melanoma
1464146|NCT00912574|adjuvant|adjuvant
1464147|NCT00912574|dendritic cells|dendritic cells
1464148|NCT00912574|vaccine|vaccine
1464149|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
1464150|NCT00912561|stroke prevention|stroke prevention
1464151|NCT00912561|exercise|exercise
1464152|NCT00912561|physical training|physical training
1464153|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
1464154|NCT00912548|premenopause|premenopause
1464155|NCT00912548|ovarian function suppression|ovarian function suppression
1464156|NCT00912548|tamoxifen|tamoxifen
1464157|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
1464158|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
1464159|NCT00912522|reward|reward
1464160|NCT00912522|TMS|tms
1464161|NCT00912522|cognition|cognition
1464162|NCT00912522|Motivation|motivation
1464163|NCT00912522|Perception|perception
1464164|NCT00912522|Decision making|decision making
1464165|NCT00912509|infectious keratitis|infectious keratitis
1464166|NCT00912509|cross linking|cross linking
1464167|NCT00912509|corneal ulcer|corneal ulcer
1464168|NCT00912509|corneal infection|corneal infection
1464169|NCT00912509|collagen cross linking|collagen cross linking
1464170|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
1464171|NCT00912483|VTE|vte
1464172|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
1464173|NCT00912470|ocular blood flow|ocular blood flow
1464174|NCT00912470|progressive glaucoma|progressive glaucoma
1464175|NCT00912457|sleep apnea|sleep apnea
1464176|NCT00912457|donepezil|donepezil
1464177|NCT00912457|pharmacological|pharmacological
1464178|NCT00912457|cholinergic|cholinergic
1464858|NCT00909805|children|children
1464179|NCT00912444|Breast Neoplasms|breast neoplasms
1464180|NCT00912444|Neoadjuvant|neoadjuvant
1464181|NCT00912444|Chemotherapy|chemotherapy
1464182|NCT00912444|Docetaxel|docetaxel
1464183|NCT00912444|Cyclophosphamide|cyclophosphamide
1464184|NCT00912444|Anthracycline|anthracycline
1464185|NCT00912431|Healthy Volunteers|healthy volunteers
1464186|NCT00912418|melanoma|melanoma
1464187|NCT00912418|vaccine|vaccine
1464188|NCT00912418|IL2 low dose|il2 low dose
1464189|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
1464190|NCT00912366|VATS|vats
1464191|NCT00912366|Lung cancer|lung cancer
1464192|NCT00912366|NSCLC|nsclc
1464193|NCT00912353|Phase I|phase i
1464194|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
1464195|NCT00912353|AZD7268|azd7268
1464196|NCT00912340|Breast Cancer|breast cancer
1464197|NCT00912327|Colorectal|colorectal
1464198|NCT00912327|KRAS mutation|kras mutation
1464199|NCT00912327|Stage IV|stage iv
1464200|NCT00912327|Imprime PGG|imprime pgg
1464201|NCT00912327|Cetuximab|cetuximab
1464202|NCT00912327|Immunotherapy|immunotherapy
1464203|NCT00912314|OAB|oab
1464204|NCT00912314|overactive bladder|overactive bladder
1464205|NCT00912314|ptns|ptns
1464206|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
1464207|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
1464208|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
1464209|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
1464210|NCT00912262|Analgesics|analgesics
1464211|NCT00912262|Capsaicin|capsaicin
1464212|NCT00912249|Horticulture Therapy|horticulture therapy
1464213|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
1464214|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
1464215|NCT00912249|Day Care|day care
1464216|NCT00912236|Obesity|obesity
1464217|NCT00912236|HDL|hdl
1464218|NCT00912236|HDL functionality|hdl functionality
1464219|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
1464220|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
1464221|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
1464222|NCT00912184|Kidney failure, acute|kidney failure, acute
1464223|NCT00912184|Shock|shock
1464224|NCT00912184|Toxins, biological|toxins, biological
1464225|NCT00912184|Hemofiltration|hemofiltration
1464226|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
1464227|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1464228|NCT00912171|snoring|snoring
1464229|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
1464230|NCT00912171|polysomnography|polysomnography
1464231|NCT00912171|intranasal steroids|intranasal steroids
1464232|NCT00912171|Anti-leukotrienes|anti-leukotrienes
1464233|NCT00912158|CPE|cpe
1464234|NCT00912158|CPAP|cpap
1464235|NCT00912158|BiPAP|bipap
1464236|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
1464237|NCT00912132|Fetal Growth|fetal growth
1464238|NCT00912132|Pregnancy|pregnancy
1464239|NCT00912119|craniofacial surgery|craniofacial surgery
1464240|NCT00912119|pharmacokinetics|pharmacokinetics
1464241|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
1464242|NCT00912119|homologous blood products|homologous blood products
1464243|NCT00912119|wide scalp dissections|wide scalp dissections
1464244|NCT00912119|transfusion requirements|transfusion requirements
1464245|NCT00912106|osteoarthritis|osteoarthritis
1464246|NCT00912106|HA|ha
1464247|NCT00912106|synovial fluid|synovial fluid
1464248|NCT00912106|lubrication|lubrication
1464249|NCT00912093|HAE|hae
1464250|NCT00912093|Type I HAE|type i hae
1464251|NCT00912093|Type II HAE|type ii hae
1464252|NCT00912080|genomic signature|genomic signature
1464253|NCT00912080|lymph nodes|lymph nodes
1464254|NCT00912080|no metastases|no metastases
1464255|NCT00912054|OAG|oag
1464256|NCT00912054|OH|oh
1464257|NCT00912041|Brain computer interface|brain computer interface
1464258|NCT00912041|Assistive device|assistive device
1464259|NCT00912041|Environmental control|environmental control
1464260|NCT00912041|Communication device|communication device
1464261|NCT00912041|quadriplegia|quadriplegia
1464262|NCT00912041|tetraplegia|tetraplegia
1464263|NCT00911989|Obesity|obesity
1464264|NCT00911989|Weight Loss|weight loss
1464265|NCT00911976|Coronary artery bypass|coronary artery bypass
1464266|NCT00911976|Stents|stents
1464267|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1464268|NCT00911976|Coronary Restenosis|coronary restenosis
1464269|NCT00911976|Everolimus|everolimus
1464270|NCT00911976|Saphenous vein grafts|saphenous vein grafts
1464271|NCT00911963|VX-222|vx-222
1464272|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
1464273|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
1464274|NCT00911924|OAG|oag
1464275|NCT00911924|glaucoma|glaucoma
1464276|NCT00911911|Breast cancer|breast cancer
1464277|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1464278|NCT00911911|Proteomic|proteomic
1464279|NCT00911911|Histological response|histological response
1464280|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
1464281|NCT00911898|Breast Cancer|breast cancer
1464283|NCT00911898|Bispecific Antibody|bispecific antibody
1464284|NCT00911885|Weight|weight
1464285|NCT00911885|Diet|diet
1464286|NCT00911885|Lipids|lipids
1464287|NCT00911872|wrinkles|wrinkles
1464288|NCT00911872|dermal filler|dermal filler
1464289|NCT00911872|collagen|collagen
1464290|NCT00911872|soft tissue augmentation|soft tissue augmentation
1464291|NCT00911872|aesthetic|aesthetic
1464292|NCT00911859|Multiple Myeloma|multiple myeloma
1464293|NCT00911859|CNTO328|cnto328
1464294|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1464295|NCT00911859|Monoclonal antibody|monoclonal antibody
1464296|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
1464297|NCT00911859|Bortezomib|bortezomib
1464298|NCT00911859|Velcade|velcade
1464299|NCT00911859|Melphalan|melphalan
1464300|NCT00911859|Prednisone|prednisone
1464301|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
1464302|NCT00911846|"substitution"|"substitution"
1464303|NCT00911833|Trust|trust
1464304|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
1464305|NCT00911807|Randomized Controlled Trial|randomized controlled trial
1464306|NCT00911807|Multicenter Study|multicenter study
1464307|NCT00911807|Cerebrolysin|cerebrolysin
1464308|NCT00911807|Donepezil|donepezil
1464309|NCT00911794|Dyspnea|dyspnea
1464310|NCT00911794|Written Disclosure Therapy|written disclosure therapy
1464311|NCT00911794|COPD|copd
1464312|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
1464313|NCT00911794|Chronic Lung Diseases|chronic lung diseases
1464314|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
1464315|NCT00911781|Infantile hemangioma|infantile hemangioma
1464316|NCT00911768|Xerostomia|xerostomia
1464317|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
1464318|NCT00911768|Visual Analogue Scale|visual analogue scale
1464319|NCT00911768|Salivary Flow Rates|salivary flow rates
1464320|NCT00911755|Laryngoscopy|laryngoscopy
1464321|NCT00911755|Glidescope|glidescope
1464322|NCT00911729|paraganglioma|paraganglioma
1464323|NCT00911729|pheochromocytoma|pheochromocytoma
1464324|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1464325|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1464326|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
1464327|NCT00911716|stage IA breast cancer|stage ia breast cancer
1464328|NCT00911716|stage IB breast cancer|stage ib breast cancer
1464329|NCT00911716|stage II breast cancer|stage ii breast cancer
1464330|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
1464331|NCT00911716|male breast cancer|male breast cancer
1464332|NCT00911690|Dementia|dementia
1464333|NCT00911690|Alzheimers Disease|alzheimers disease
1464334|NCT00911690|Cognitive Disorders|cognitive disorders
1464335|NCT00911690|Tissue Banking|tissue banking
1464336|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
1464337|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
1464338|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
1464339|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
1464340|NCT00911664|Vitamin D|vitamin d
1464341|NCT00911664|HIV-Infected children|hiv-infected children
1464342|NCT00911664|CD4 count|cd4 count
1464343|NCT00911651|COPD|copd
1464344|NCT00911651|salbutamol|salbutamol
1464345|NCT00911651|ipratropium bromide|ipratropium bromide
1464346|NCT00911651|computational fluid dynamics|computational fluid dynamics
1464347|NCT00911651|functional imaging|functional imaging
1464348|NCT00911651|central and peripheral airways|central and peripheral airways
1464349|NCT00911638|Patient decision aids|patient decision aids
1464350|NCT00911638|Patient preferences|patient preferences
1464351|NCT00911638|Osteoarthritis|osteoarthritis
1464352|NCT00911638|Joint replacement|joint replacement
1464353|NCT00911638|Waiting times|waiting times
1464354|NCT00911625|glargine|glargine
1464355|NCT00911625|glulisine|glulisine
1464356|NCT00911625|type 2 diabetes|type 2 diabetes
1464357|NCT00911625|renal insufficiency|renal insufficiency
1464358|NCT00911612|bile acid|bile acid
1464359|NCT00911612|malabsorption|malabsorption
1464360|NCT00911612|permeability|permeability
1464361|NCT00911612|diarrhea|diarrhea
1464362|NCT00911612|IBS|ibs
1464363|NCT00911612|stool|stool
1464364|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
1464365|NCT00911573|pediatry|pediatry
1464366|NCT00911573|children|children
1464367|NCT00911573|skin|skin
1464368|NCT00911573|bacteria|bacteria
1464369|NCT00911573|MRSA|mrsa
1464370|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
1464371|NCT00911560|OPT-821|opt-821
1464372|NCT00911560|GD2-KLH|gd2-klh
1464373|NCT00911560|GD3-KLH|gd3-klh
1464374|NCT00911560|QS 21|qs 21
1464377|NCT00911547|chronic asthma|chronic asthma
1464378|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1464379|NCT00911534|GERD|gerd
1464380|NCT00911521|human papillomavirus|human papillomavirus
1464381|NCT00911521|vaccine|vaccine
1464382|NCT00911521|lupus|lupus
1464673|NCT00910403|Hyperopes|hyperopes
1464383|NCT00911508|Atrial Fibrillation|atrial fibrillation
1464384|NCT00911508|Left Atrial Ablation|left atrial ablation
1464385|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
1464386|NCT00911508|Catheter Ablation|catheter ablation
1464387|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
1464388|NCT00911495|Sickle Cell Disease|sickle cell disease
1464389|NCT00911482|Type 2 Diabetes|type 2 diabetes
1464390|NCT00911482|Dyslipidemia|dyslipidemia
1464391|NCT00911482|FFA|ffa
1464392|NCT00911482|Triglycerides|triglycerides
1464393|NCT00911482|Tracers|tracers
1464394|NCT00911469|Knee osteoarthritis|knee osteoarthritis
1464395|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
1464396|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
1464397|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
1464398|NCT00911430|Atopic Dermatitis|atopic dermatitis
1464399|NCT00911430|Immunodeficiency|immunodeficiency
1464400|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
1464401|NCT00911430|Staphylococcal Infection|staphylococcal infection
1464402|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
1464403|NCT00911430|Staph Infection|staph infection
1464404|NCT00911417|peripheral arterial disease|peripheral arterial disease
1464405|NCT00911417|peripheral vascular disease|peripheral vascular disease
1464406|NCT00911404|Gestational diabetes|gestational diabetes
1464407|NCT00911404|Carbohydrate|carbohydrate
1464408|NCT00911404|Diet|diet
1464409|NCT00911404|Insulin|insulin
1464410|NCT00911391|Doppler|doppler
1464411|NCT00911391|Colectomy|colectomy
1464412|NCT00911391|ERAS|eras
1464413|NCT00911391|Fluid|fluid
1464414|NCT00911391|Perioperative Care|perioperative care
1464415|NCT00911378|weaning|weaning
1464416|NCT00911378|mechanical ventilation|mechanical ventilation
1464417|NCT00911365|voluntary participants|voluntary participants
1464418|NCT00911365|75 years old or less|75 years old or less
1464419|NCT00911352|Cryotherapy|cryotherapy
1464420|NCT00911352|Hand toxicity|hand toxicity
1464421|NCT00911352|Nail toxicity|nail toxicity
1464422|NCT00911352|Infection control|infection control
1464423|NCT00911326|HNSCC|hnscc
1464424|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
1464425|NCT00911313|clomiphene resistance|clomiphene resistance
1464426|NCT00911313|letrozole|letrozole
1464427|NCT00911300|Cardioversion, Electric|cardioversion, electric
1464428|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
1464429|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
1464430|NCT00911300|Heart Diseases|heart diseases
1464431|NCT00911300|Atrial Fibrillation|atrial fibrillation
1464432|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
1464433|NCT00911300|Pathologic Processes|pathologic processes
1464434|NCT00911300|Anticoagulants|anticoagulants
1464435|NCT00911287|Chronic pain|chronic pain
1464436|NCT00911287|Extended Release|extended release
1464437|NCT00911287|Long-Acting Opioid|long-acting opioid
1464438|NCT00911287|Opioid|opioid
1464439|NCT00911287|Opioid-Naive|opioid-naive
1464440|NCT00911287|Oxymorphone|oxymorphone
1464441|NCT00911274|Bioequivalence|bioequivalence
1464442|NCT00911274|Healthy Subjects|healthy subjects
1464443|NCT00911261|Cancer Pain|cancer pain
1464444|NCT00911261|Neuropathic Pain|neuropathic pain
1464445|NCT00911261|Extended Release|extended release
1464446|NCT00911261|Long-Acting Opioid|long-acting opioid
1464447|NCT00911261|Oxymorphone|oxymorphone
1464448|NCT00911248|Angiogenesis|angiogenesis
1464449|NCT00911248|Neurofibromatosis|neurofibromatosis
1464450|NCT00911248|Post-transcriptional control|post-transcriptional control
1464452|NCT00911248|VEGF|vegf
1464453|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
1464454|NCT00911222|antiemetic therapy|antiemetic therapy
1464455|NCT00911222|emesis|emesis
1464456|NCT00911222|vomiting|vomiting
1464457|NCT00911222|nausea|nausea
1464458|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
1464459|NCT00911222|cisplatin|cisplatin
1464460|NCT00911222|carboplatin|carboplatin
1464461|NCT00911222|oxaliplatin|oxaliplatin
1464462|NCT00911222|anthracycline|anthracycline
1464463|NCT00911222|cyclophosphamid|cyclophosphamid
1464464|NCT00911209|Heart Disease|heart disease
1464465|NCT00911209|Obesity|obesity
1464466|NCT00911196|Prognosis|prognosis
1464467|NCT00911196|Markers|markers
1464468|NCT00911196|Expression analysis|expression analysis
1464469|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
1464470|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1464471|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1464472|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1465150|NCT00908453|phenytoin|phenytoin
1464473|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1464474|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
1464475|NCT00911170|febrile neutropenia|febrile neutropenia
1464476|NCT00911170|Bevacizumab|bevacizumab
1464477|NCT00911170|Avastin|avastin
1464478|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
1464479|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
1464480|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
1464481|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
1464482|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
1464483|NCT00911157|Fondaparinux sodium|fondaparinux sodium
1464484|NCT00911144|Safety|safety
1464485|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
1464486|NCT00911144|Immunogenicity|immunogenicity
1464487|NCT00911144|Pneumococcal disease|pneumococcal disease
1464488|NCT00911144|Booster vaccination|booster vaccination
1464489|NCT00911131|Small grade esophageal varices|small grade esophageal varices
1464490|NCT00911131|capsule endoscopy|capsule endoscopy
1464491|NCT00911131|PillCam ESO|pillcam eso
1464492|NCT00911131|abdominal binder|abdominal binder
1464493|NCT00911118|prostate|prostate
1464494|NCT00911118|radiation|radiation
1464495|NCT00911118|09-035|09-035
1464496|NCT00911105|Multiple Myeloma|multiple myeloma
1464497|NCT00911105|Non-interventional study|non-interventional study
1464498|NCT00911105|Lenalidomide|lenalidomide
1464499|NCT00911105|Dexamethasone|dexamethasone
1464500|NCT00911105|Observational|observational
1464501|NCT00911105|Time to progression|time to progression
1464502|NCT00911105|Clinical routine|clinical routine
1464503|NCT00911105|Germany|germany
1464504|NCT00911105|Plasmacytoma|plasmacytoma
1464505|NCT00911092|Oesophageal cancer|oesophageal cancer
1464506|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
1464507|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
1464508|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
1464509|NCT00911053|melatonin|melatonin
1464510|NCT00911053|sleep|sleep
1464511|NCT00911053|blindness|blindness
1464512|NCT00911053|blind individuals|blind individuals
1464513|NCT00911027|Prostate|prostate
1464514|NCT00911027|Cancer|cancer
1464515|NCT00911027|Biopsy|biopsy
1464516|NCT00911027|Guided|guided
1464517|NCT00911027|Contrast|contrast
1464518|NCT00911027|Enhanced|enhanced
1464519|NCT00911027|SonoVue|sonovue
1464520|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
1464521|NCT00911001|Arthroplasty|arthroplasty
1464522|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
1464523|NCT00911001|Replacement|replacement
1464524|NCT00911001|Knee|knee
1464525|NCT00910988|healthy|healthy
1464526|NCT00910988|sedentary|sedentary
1464527|NCT00910988|men|men
1464528|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
1464529|NCT00910988|blood sugar|blood sugar
1464530|NCT00910988|insulin sensitivity|insulin sensitivity
1464531|NCT00910975|Hepatitis C virus|hepatitis c virus
1464532|NCT00910975|Real-time PCR|real-time pcr
1464533|NCT00910975|Treatment|treatment
1464534|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
1464535|NCT00910949|persistent pain|persistent pain
1464536|NCT00910949|neuropathic pain|neuropathic pain
1464537|NCT00910949|Thoracotomy|thoracotomy
1464538|NCT00910949|Chronic Pain|chronic pain
1464539|NCT00910936|HIV|hiv
1464540|NCT00910936|Exercise|exercise
1464541|NCT00910936|Inflammation|inflammation
1464542|NCT00910936|Quality of life|quality of life
1464543|NCT00910936|Lipodystrophia|lipodystrophia
1464544|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1464545|NCT00910897|Newly Diagnosed|newly diagnosed
1464546|NCT00910897|multiple myeloma|multiple myeloma
1464547|NCT00910897|induction|induction
1464548|NCT00910897|Thalidomide|thalidomide
1464549|NCT00910884|stage I breast cancer|stage i breast cancer
1464550|NCT00910884|stage II breast cancer|stage ii breast cancer
1464551|NCT00910884|stage IIIA breast cancer|stage iiia breast cancer
1464552|NCT00910884|male breast cancer|male breast cancer
1464553|NCT00910871|Tuberculosis|tuberculosis
1464554|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
1464555|NCT00910871|TMC207-C209|tmc207-c209
1464556|NCT00910871|TMC207|tmc207
1464557|NCT00910871|TB|tb
1464558|NCT00910871|MDR-TB|mdr-tb
1464559|NCT00910832|Dyschesia treatment|dyschesia treatment
1464560|NCT00910832|Rehabilitation|rehabilitation
1464561|NCT00910832|Dyschesia|dyschesia
1464562|NCT00910819|Colorectal Cancer|colorectal cancer
1464563|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
1464564|NCT00910819|Epidemiology|epidemiology
1464565|NCT00910819|Health Services Research|health services research
1464566|NCT00910819|Germany|germany
1464567|NCT00910819|Registry|registry
1464568|NCT00910819|Palliative Care|palliative care
1464569|NCT00910819|Palliative Treatment|palliative treatment
1464570|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
1464571|NCT00910819|Nutrition Assessment|nutrition assessment
1464572|NCT00910819|Physical Activity|physical activity
1464573|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
1464574|NCT00910806|TMC207-C110|tmc207-c110
1464575|NCT00910806|TMC207|tmc207
1464576|NCT00910806|drug-drug interaction|drug-drug interaction
1464577|NCT00910806|Tuberculosis|tuberculosis
1464579|NCT00910806|nevirapine|nevirapine
1464580|NCT00910806|open-label|open-label
1464581|NCT00910806|Pharmacokinetics|pharmacokinetics
1464582|NCT00910793|Asthma|asthma
1464583|NCT00910793|Formoterol|formoterol
1464584|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
1464585|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
1464586|NCT00910793|Functional Imaging|functional imaging
1464587|NCT00910793|Central and Peripheral Airways|central and peripheral airways
1464588|NCT00910754|Prostate neoplasms|prostate neoplasms
1464589|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
1464590|NCT00910754|Abiraterone acetate|abiraterone acetate
1464591|NCT00910754|CB7630|cb7630
1464592|NCT00910741|pancreatic cancer|pancreatic cancer
1464593|NCT00910741|Gemcitabine|gemcitabine
1464594|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
1464595|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
1464596|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
1464597|NCT00910728|Phase I|phase i
1464598|NCT00910728|Phase II|phase ii
1464599|NCT00910728|Bone marrow|bone marrow
1464600|NCT00910715|erythema migrans|erythema migrans
1464601|NCT00910715|Lyme borreliosis|lyme borreliosis
1464602|NCT00910715|doxycycline treatment|doxycycline treatment
1464603|NCT00910715|outcome|outcome
1464604|NCT00910715|subjective symptoms|subjective symptoms
1464605|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
1464606|NCT00910689|Migraine Headache|migraine headache
1464607|NCT00910689|Preventive Therapy|preventive therapy
1464608|NCT00910689|Beta Blocker Medication|beta blocker medication
1464609|NCT00910689|Behavior Therapy|behavior therapy
1464610|NCT00910689|Clinical Trial|clinical trial
1464611|NCT00910676|EGF-R inhibitors|egf-r inhibitors
1464612|NCT00910663|Bioequivalence|bioequivalence
1464613|NCT00910663|Healthy Subjects|healthy subjects
1464614|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
1464615|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
1464616|NCT00910637|Pregnancy prevention|pregnancy prevention
1464617|NCT00910637|Female contraception|female contraception
1464618|NCT00910637|Patch|patch
1464619|NCT00910611|pediatric|pediatric
1464620|NCT00910611|immunization|immunization
1464621|NCT00910611|pain|pain
1464622|NCT00910611|analgesia|analgesia
1464623|NCT00910611|Immunization pain|immunization pain
1464624|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
1464625|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1464626|NCT00910598|glatiramer acetate|glatiramer acetate
1464627|NCT00910598|Optical Coherence Tomography|optical coherence tomography
1464628|NCT00910585|childhood|childhood
1464629|NCT00910585|asthma|asthma
1464630|NCT00910572|Yttrium-90|yttrium-90
1464631|NCT00910572|Radiation|radiation
1464632|NCT00910572|Radioembolization|radioembolization
1464633|NCT00910572|Hepatoma|hepatoma
1464634|NCT00910572|BCLC classification|bclc classification
1464635|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
1464636|NCT00910572|Yttrium|yttrium
1464637|NCT00910572|Microspheres|microspheres
1464638|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
1464639|NCT00910559|Autism|autism
1464640|NCT00910559|Asperger Syndrome|asperger syndrome
1464641|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
1464642|NCT00910546|Lung Cancer|lung cancer
1464643|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
1464644|NCT00910546|Image guidance|image guidance
1464645|NCT00910546|breathing adaption|breathing adaption
1464646|NCT00910546|tumor motion|tumor motion
1464647|NCT00910546|implanted marker|implanted marker
1464648|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
1464649|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1464650|NCT00910507|Exercise|exercise
1464651|NCT00910507|Counseling|counseling
1464652|NCT00910507|Behavior|behavior
1464653|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
1464654|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
1464655|NCT00910481|Coronary Artery Disease|coronary artery disease
1464656|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1464657|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
1464658|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
1464659|NCT00910481|High Risk|high risk
1464660|NCT00910455|Phase 1|phase 1
1464661|NCT00910455|Safety|safety
1464662|NCT00910455|Tolerability|tolerability
1464663|NCT00910455|Pharmacokinetics|pharmacokinetics
1464664|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
1464665|NCT00910429|PH|ph
1465928|NCT00905177|coumadin|coumadin
1464666|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
1464668|NCT00910416|Anesthesia|anesthesia
1464669|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
1464670|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
1464671|NCT00910403|Presbyopia|presbyopia
1464674|NCT00910390|IVF|ivf
1464675|NCT00910390|embryo cryopreservation|embryo cryopreservation
1464676|NCT00910390|vitrification|vitrification
1464677|NCT00910390|Human Embryo|human embryo
1464678|NCT00910390|Embryonic development|embryonic development
1464679|NCT00910390|Pregnancy rate|pregnancy rate
1464680|NCT00910377|breastfeeding|breastfeeding
1464681|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
1464682|NCT00910377|lactation counseling|lactation counseling
1464683|NCT00910377|teenagers|teenagers
1464684|NCT00910377|complementary food|complementary food
1464685|NCT00910377|adolescent|adolescent
1464686|NCT00910377|caregivers|caregivers
1464687|NCT00910364|Lower extremity DVT|lower extremity dvt
1464688|NCT00910364|Clot|clot
1464689|NCT00910364|leg clot|leg clot
1464690|NCT00910364|Deep vein thrombosis|deep vein thrombosis
1464691|NCT00910364|Thrombosis|thrombosis
1464692|NCT00910364|Warfarin|warfarin
1464693|NCT00910351|Cystic Fibrosis|cystic fibrosis
1464694|NCT00910351|Pharmacokinetics|pharmacokinetics
1464695|NCT00910351|Pediatrics|pediatrics
1464696|NCT00910351|Inhalation|inhalation
1464697|NCT00910351|Sputum|sputum
1464698|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
1464699|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
1464700|NCT00910325|Female|female
1464701|NCT00910325|Cholelithiasis|cholelithiasis
1464702|NCT00910325|Natural Orifice Surgery|natural orifice surgery
1464703|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
1464704|NCT00910325|Transvaginal|transvaginal
1464705|NCT00910299|Clopidogrel|clopidogrel
1464706|NCT00910299|VerifyNow|verifynow
1464707|NCT00910299|PRU Measurements|pru measurements
1464708|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
1464709|NCT00910299|Heart Disease|heart disease
1464710|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1464711|NCT00910299|P2Y12|p2y12
1464712|NCT00910299|Platelets|platelets
1464713|NCT00910299|Platelet Reactivity|platelet reactivity
1464714|NCT00910286|Pressure support ventilation|pressure support ventilation
1464715|NCT00910286|cycling off criteria|cycling off criteria
1464716|NCT00910286|expiratory trigger|expiratory trigger
1464717|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
1464718|NCT00910286|patient comfort|patient comfort
1464719|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
1464720|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
1464721|NCT00910247|Seizures|seizures
1464722|NCT00910247|Epilepsy|epilepsy
1464723|NCT00910247|Anticonvulsant|anticonvulsant
1464724|NCT00910247|Monotherapy|monotherapy
1464725|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
1464726|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
1464727|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
1464728|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
1464729|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
1464730|NCT00910221|Cardiac surgery|cardiac surgery
1464731|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
1464732|NCT00910221|Oxidative stress|oxidative stress
1464733|NCT00910221|Acute renal dysfunction|acute renal dysfunction
1464734|NCT00910221|Atorvastatin|atorvastatin
1464735|NCT00910208|Pain|pain
1464736|NCT00910208|Analgesia|analgesia
1464737|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
1464738|NCT00910208|Emergency Medicine|emergency medicine
1464739|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
1464740|NCT00910195|CPAP|cpap
1464741|NCT00910195|Bi-Level|bi-level
1464742|NCT00910182|Splenic rupture|splenic rupture
1464743|NCT00910182|abdominal injuries|abdominal injuries
1464744|NCT00910182|Surgery|surgery
1464745|NCT00910182|Angiography|angiography
1464746|NCT00910182|Embolisation|embolisation
1464747|NCT00910182|Computed tomography|computed tomography
1464748|NCT00910182|Classification|classification
1464749|NCT00910169|Anorexia nervosa|anorexia nervosa
1464750|NCT00910169|treatment|treatment
1464751|NCT00910169|inpatient|inpatient
1464752|NCT00910169|efficacy|efficacy
1464753|NCT00910169|outcome|outcome
1464754|NCT00910143|Rectal cancer|rectal cancer
1464755|NCT00910143|Colorectal Surgery|colorectal surgery
1464756|NCT00910143|Surgery|surgery
1464757|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
1464758|NCT00910143|survival|survival
1464759|NCT00910143|Follow-up Study|follow-up study
1464760|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
1464761|NCT00910130|Insulin Resistance|insulin resistance
1464762|NCT00910130|Diabetes|diabetes
1464763|NCT00910130|End Stage Renal Disease|end stage renal disease
1464764|NCT00910130|Dialysis|dialysis
1464767|NCT00910117|induction chemotherapy|induction chemotherapy
1464768|NCT00910117|nimotuzumab|nimotuzumab
1464769|NCT00910104|PNALD|pnald
1464770|NCT00910104|Omegaven|omegaven
1464771|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
1464772|NCT00910104|Cholestasis|cholestasis
1464773|NCT00910104|Short Bowel Syndrome|short bowel syndrome
1464774|NCT00910091|Endometrial cancer|endometrial cancer
1464775|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
1464776|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
1464777|NCT00910078|Stem cell transplantation|stem cell transplantation
1464778|NCT00910078|Serum immunofixation|serum immunofixation
1464779|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
1464780|NCT00910065|ACS|acs
1464781|NCT00910065|Aspirin|aspirin
1464782|NCT00910052|randomised|randomised
1464783|NCT00910052|controlled|controlled
1464784|NCT00910052|double blinded|double blinded
1464785|NCT00910039|cognitive/functional effects|cognitive/functional effects
1464786|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
1464787|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1464788|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
1464789|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
1464790|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
1464791|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
1464792|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
1464793|NCT00910013|TKR|tkr
1464794|NCT00910013|Femoral block|femoral block
1464795|NCT00910013|Ropivacaïne|ropivacaïne
1464796|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
1464797|NCT00910013|post-operative analgesia|post-operative analgesia
1464798|NCT00910000|carboplatin|carboplatin
1464799|NCT00910000|gemcitabine|gemcitabine
1464800|NCT00910000|vorinostat|vorinostat
1464801|NCT00909987|rectum|rectum
1464802|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
1464803|NCT00909987|neoadjuvant|neoadjuvant
1464804|NCT00909974|multiple micronutrients|multiple micronutrients
1464805|NCT00909974|energy deficiency|energy deficiency
1464806|NCT00909961|Osteoporosis|osteoporosis
1464807|NCT00909961|Bone Mineral Density|bone mineral density
1464808|NCT00909961|Biomarkers|biomarkers
1464809|NCT00909948|Related stem cell transplant,|related stem cell transplant,
1464810|NCT00909948|TBI,|tbi,
1464811|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
1464812|NCT00909948|Fludarabine|fludarabine
1464813|NCT00909948|Non-myeloablative|non-myeloablative
1464814|NCT00909948|Lymphoma|lymphoma
1464815|NCT00909948|Multiple myeloma|multiple myeloma
1464816|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
1464817|NCT00909922|Amputation|amputation
1464818|NCT00909922|Amputees|amputees
1464819|NCT00909922|Artificial Limbs|artificial limbs
1464820|NCT00909922|Leg Length Inequality|leg length inequality
1464821|NCT00909922|Lower Extremity|lower extremity
1464822|NCT00909922|Pelvis|pelvis
1464823|NCT00909922|Posture|posture
1464824|NCT00909922|Prostheses|prostheses
1464825|NCT00909922|Range of Motion|range of motion
1464826|NCT00909922|Trunk Muscles|trunk muscles
1464827|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1464828|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1464829|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1464830|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1464831|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1464832|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1464833|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1464834|NCT00909909|stage I breast cancer|stage i breast cancer
1464835|NCT00909909|stage II breast cancer|stage ii breast cancer
1464836|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
1464837|NCT00909896|endometrial|endometrial
1464838|NCT00909896|pain|pain
1464839|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1464840|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
1464841|NCT00909883|Botulinum Toxin|botulinum toxin
1464842|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
1464843|NCT00909870|Venous leg ulcer|venous leg ulcer
1464844|NCT00909870|randomized trial|randomized trial
1464845|NCT00909870|clinical trial|clinical trial
1464846|NCT00909870|Dermagraft|dermagraft
1464847|NCT00909870|compression therapy|compression therapy
1464848|NCT00909870|surgical debridement|surgical debridement
1464849|NCT00909870|venous stasis|venous stasis
1464850|NCT00909870|chronic ulcer|chronic ulcer
1464851|NCT00909870|chronic wound|chronic wound
1464852|NCT00909870|fibroblasts|fibroblasts
1464853|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
1464854|NCT00909857|Oral Contraception|oral contraception
1464855|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1464856|NCT00909805|dermabond glue|dermabond glue
1464859|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1464860|NCT00909779|respiratory|respiratory
1464861|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
1464862|NCT00909753|Bioequivalence|bioequivalence
1464863|NCT00909753|Healthy Subjects|healthy subjects
1464864|NCT00909740|Solid Tumor|solid tumor
1464865|NCT00909740|Cancer|cancer
1464866|NCT00909727|Fibrosis|fibrosis
1464867|NCT00909727|Pancreatic Diseases|pancreatic diseases
1464868|NCT00909727|Digestive System Diseases|digestive system diseases
1464869|NCT00909727|Lung Diseases|lung diseases
1464870|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
1464871|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
1464872|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
1464873|NCT00909727|Pathologic Processes|pathologic processes
1464874|NCT00909714|stroke|stroke
1464875|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
1464876|NCT00909714|motor recovery|motor recovery
1464877|NCT00909714|cortical plasticity|cortical plasticity
1464878|NCT00909714|TDCS|tdcs
1464879|NCT00909701|Dietary supplement|dietary supplement
1464880|NCT00909701|healthy volunteers|healthy volunteers
1464881|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
1464882|NCT00909688|Healthy Subjects|healthy subjects
1464883|NCT00909662|cognitive/functional effects|cognitive/functional effects
1464884|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1464885|NCT00909662|fatigue|fatigue
1464886|NCT00909662|stage I breast cancer|stage i breast cancer
1464887|NCT00909662|stage II breast cancer|stage ii breast cancer
1464888|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
1464889|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
1464890|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
1464891|NCT00909649|fibrin glue|fibrin glue
1464892|NCT00909649|seroma|seroma
1464893|NCT00909649|mastectomy|mastectomy
1464894|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
1464895|NCT00909610|Bioequivalence|bioequivalence
1464896|NCT00909610|Healthy Subjects|healthy subjects
1464897|NCT00909584|Hematology|hematology
1464898|NCT00909584|Neutropenia|neutropenia
1464900|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
1464901|NCT00909584|Idiopathic|idiopathic
1464902|NCT00909584|Telintra|telintra
1464903|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
1464904|NCT00909584|ezatiostat|ezatiostat
1464905|NCT00909584|TLK199|tlk199
1464906|NCT00909584|Glutathione|glutathione
1464907|NCT00909584|Glutathione analog|glutathione analog
1464908|NCT00909584|Glutathione Transferase|glutathione transferase
1464909|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
1464910|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
1464911|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
1464912|NCT00909584|Apoptosis|apoptosis
1464913|NCT00909584|Differentiation|differentiation
1464914|NCT00909584|Enzyme inhibitor|enzyme inhibitor
1464915|NCT00909571|FK506E|fk506e
1464916|NCT00909571|MR4|mr4
1464917|NCT00909571|Prograf|prograf
1464918|NCT00909571|Tacrolimus|tacrolimus
1464919|NCT00909571|Living Liver Transplantation|living liver transplantation
1464920|NCT00909558|metastatic malignancies|metastatic malignancies
1464921|NCT00909558|tumor markers|tumor markers
1464922|NCT00909558|chemotherapy|chemotherapy
1464923|NCT00909558|cancer|cancer
1464924|NCT00909558|breast cancer|breast cancer
1464925|NCT00909558|glioma|glioma
1464926|NCT00909558|hepatocellular cancer|hepatocellular cancer
1464927|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
1464928|NCT00909558|pancreatic cancer|pancreatic cancer
1464929|NCT00909558|colon cancer|colon cancer
1464930|NCT00909558|prostate cancer|prostate cancer
1464931|NCT00909545|Early Parkinson disease|early parkinson disease
1464932|NCT00909532|Fibrosis|fibrosis
1464933|NCT00909532|Pancreatic Diseases|pancreatic diseases
1464934|NCT00909532|Lung Diseases|lung diseases
1464935|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
1464936|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
1464937|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
1464938|NCT00909532|Pathologic Processes|pathologic processes
1464939|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
1464940|NCT00909454|Vitamin D deficiency|vitamin d deficiency
1464941|NCT00909454|Adolescents|adolescents
1464942|NCT00909454|African Americans|african americans
1464943|NCT00909454|Overweight|overweight
1464944|NCT00909454|Obesity|obesity
1464945|NCT00909441|Breast Cancer|breast cancer
1464946|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
1464947|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1464948|NCT00909441|Breast Surgery|breast surgery
1464949|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
1464950|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1464951|NCT00909428|Bladder|bladder
1464952|NCT00909428|Urinary Urgency|urinary urgency
1464953|NCT00909428|Solifenacin|solifenacin
1464954|NCT00909428|Vesicare(R)|vesicare(r)
1464955|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
1464956|NCT00909376|Pregnancy|pregnancy
1464957|NCT00909376|Ultrasonography|ultrasonography
1464958|NCT00909376|outcome|outcome
1464959|NCT00909376|adverse|adverse
1464960|NCT00909350|Barrett's esophagus|barrett's esophagus
1464961|NCT00909350|BE|be
1464962|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
1464963|NCT00909350|Micro-RNA|micro-rna
1464964|NCT00909350|miR expression|mir expression
1464965|NCT00909324|Post LASIK dry eye|post lasik dry eye
1464966|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
1464967|NCT00909324|Hypromellose|hypromellose
1464968|NCT00909311|Food effect|food effect
1464969|NCT00909298|Left ventricular assist devices|left ventricular assist devices
1464970|NCT00909298|Cardiac Disease|cardiac disease
1464971|NCT00909298|Heart Failure|heart failure
1464972|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
1464973|NCT00909285|Alzheimer|alzheimer
1464974|NCT00909285|TMS|tms
1464975|NCT00909285|cognitive training|cognitive training
1464976|NCT00909272|ultrasound|ultrasound
1464977|NCT00909272|diagnostic|diagnostic
1609822|NCT00358501|Liver|liver
1464978|NCT00909272|lumbar|lumbar
1464979|NCT00909272|median branch|median branch
1464980|NCT00909272|block|block
1464981|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
1464982|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
1464983|NCT00909259|Periodic Breathing|periodic breathing
1464984|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
1464985|NCT00909259|Sleep Apnea|sleep apnea
1464986|NCT00909233|Erectile dysfunction,|erectile dysfunction,
1464987|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1464988|NCT00909220|Major Depressive Disorder, EEG, Negativity bias|major depressive disorder, eeg, negativity bias
1464989|NCT00909207|Advanced Cancers|advanced cancers
1464990|NCT00909207|Hematologic Disorders|hematologic disorders
1464991|NCT00909207|Solid Tumors|solid tumors
1464992|NCT00909207|Cognitive Interview|cognitive interview
1464993|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
1464994|NCT00909207|PRO|pro
1464995|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
1464996|NCT00909207|CTCAE|ctcae
1464997|NCT00909207|PRO-CTCAE|pro-ctcae
1464998|NCT00909207|Cancer Symptoms|cancer symptoms
1464999|NCT00909207|Interview|interview
1465000|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
1465001|NCT00909194|Adolescents|adolescents
1465002|NCT00909194|Psychiatry|psychiatry
1465003|NCT00909168|Induction chemotherapy|induction chemotherapy
1465004|NCT00909168|Fludarabine|fludarabine
1465005|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
1465006|NCT00909155|Major Depressive Disorder|major depressive disorder
1465007|NCT00909142|Breast cancer|breast cancer
1465008|NCT00909142|Prostate cancer|prostate cancer
1465009|NCT00909142|Multiple myeloma|multiple myeloma
1465010|NCT00909129|HIV-1|hiv-1
1465011|NCT00909129|Chronic hepatitis C|chronic hepatitis c
1465012|NCT00909129|Immune activation|immune activation
1465013|NCT00909129|HCV kinetics|hcv kinetics
1465014|NCT00909129|IP-10|ip-10
1465015|NCT00909116|ODS|ods
1465016|NCT00909116|chronic constipation|chronic constipation
1465017|NCT00909116|internal rectal prolapse|internal rectal prolapse
1465018|NCT00909116|rectocele|rectocele
1465019|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
1465020|NCT00909116|Contour Transtar|contour transtar
1465021|NCT00909116|STARR|starr
1465022|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
1465023|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1465024|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
1465025|NCT00909090|macular pigment|macular pigment
1465026|NCT00909090|glare disability|glare disability
1465027|NCT00909090|lutein|lutein
1465028|NCT00909090|photostress|photostress
1465029|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
1465030|NCT00909051|Diabetes Mellitus|diabetes mellitus
1465031|NCT00909012|phenylketonuria|phenylketonuria
1465032|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
1465033|NCT00909012|visually evoked potential|visually evoked potential
1465034|NCT00909012|choice-reaction time|choice-reaction time
1465035|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
1465036|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
1465037|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
1465038|NCT00908973|Obesity|obesity
1465039|NCT00908973|Gastric bypass|gastric bypass
1465040|NCT00908973|Gut hormone|gut hormone
1465041|NCT00908973|Intestinal transit time|intestinal transit time
1465042|NCT00908960|enoxaparin|enoxaparin
1465043|NCT00908947|SFA|sfa
1465044|NCT00908947|Stent|stent
1465045|NCT00908947|Popliteal|popliteal
1465046|NCT00908947|infrainguinal|infrainguinal
1465047|NCT00908947|LifeStent|lifestent
1465048|NCT00908947|Peripheral|peripheral
1465049|NCT00908947|Arterial|arterial
1465050|NCT00908934|Relative Bioavailability|relative bioavailability
1465051|NCT00908934|AZD9056|azd9056
1465052|NCT00908908|Advanced Solid Tumors|advanced solid tumors
1465053|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
1465054|NCT00908895|Radius fractures|radius fractures
1465055|NCT00908895|Radio-radial fixator|radio-radial fixator
1465056|NCT00908895|Percutaneous pinning|percutaneous pinning
1465057|NCT00908895|Grip strength|grip strength
1465058|NCT00908882|Nursing Care|nursing care
1465059|NCT00908882|Veterans|veterans
1465060|NCT00908869|advanced neoplasm|advanced neoplasm
1465061|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
1465062|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
1465063|NCT00908843|Contrast nephropathy|contrast nephropathy
1465064|NCT00908843|Renal failure|renal failure
1465065|NCT00908817|postoperative sore throat|postoperative sore throat
1465066|NCT00908817|tracheal intubation|tracheal intubation
1465067|NCT00908817|lubrication|lubrication
1465068|NCT00908817|triamcinolone|triamcinolone
1465069|NCT00908804|acute appendicitis|acute appendicitis
1465070|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
1465071|NCT00908791|Proof of Principle|proof of principle
1465072|NCT00908791|Lipogenic Pathway|lipogenic pathway
1465073|NCT00908791|Clarinol|clarinol
1465074|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
1465075|NCT00908765|Exercise Training COPD|exercise training copd
1465076|NCT00908752|HCC|hcc
1465077|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
1465078|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
1465079|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
1465080|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1465081|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
1465082|NCT00908713|Severe CAP|severe cap
1465083|NCT00908713|Adjuvant therapy|adjuvant therapy
1465084|NCT00908713|Glucocorticoids|glucocorticoids
1465085|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
1465086|NCT00908700|Atrial fibrillation|atrial fibrillation
1465087|NCT00908700|Stroke|stroke
1465088|NCT00908700|left atrial appendage|left atrial appendage
1465089|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
1465090|NCT00908661|Parastomal, hernia|parastomal, hernia
1465091|NCT00908648|screening colonoscopy|screening colonoscopy
1465092|NCT00908648|narrow band imaging|narrow band imaging
1465093|NCT00908635|sepsis|sepsis
1465094|NCT00908635|organ failure|organ failure
1465095|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
1465096|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
1465097|NCT00908609|Optical Imaging|optical imaging
1465098|NCT00908609|Ultrasound Imaging|ultrasound imaging
1465099|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
1465100|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
1465101|NCT00908596|Primovist / Eovist|primovist / eovist
1465102|NCT00908583|Alloantibody|alloantibody
1465103|NCT00908583|Desensitization|desensitization
1465104|NCT00908583|Kidney Transplantation|kidney transplantation
1465105|NCT00908583|Nephrology|nephrology
1465106|NCT00908583|Plasma Cells|plasma cells
1465107|NCT00908583|Translational Research/Science|translational research/science
1465108|NCT00908570|estrogen|estrogen
1465109|NCT00908570|estriol|estriol
1465110|NCT00908570|cream|cream
1465111|NCT00908570|vagina|vagina
1465112|NCT00908570|infection prevention|infection prevention
1465113|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
1465114|NCT00908557|phase II/III trials|phase ii/iii trials
1465115|NCT00908557|ethic|ethic
1465116|NCT00908557|Informed consent|informed consent
1465117|NCT00908544|HIV-infection|hiv-infection
1465118|NCT00908544|Primary HIV-infection|primary hiv-infection
1465119|NCT00908544|Proviral DNA|proviral dna
1465120|NCT00908544|Eradication|eradication
1465121|NCT00908544|Multi drug class HAART|multi drug class haart
1465122|NCT00908531|Breast neoplasms|breast neoplasms
1465123|NCT00908531|Randomised trial|randomised trial
1465124|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
1465125|NCT00908531|Preoperative care|preoperative care
1465126|NCT00908531|Age 60 or older|age 60 or older
1465127|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
1465128|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
1465129|NCT00908531|No distant metastasis|no distant metastasis
1465130|NCT00908518|Cognitive dysfunction|cognitive dysfunction
1465131|NCT00908518|Cardiac morbidity|cardiac morbidity
1465132|NCT00908518|anesthesia|anesthesia
1465133|NCT00908505|Cystic fibrosis|cystic fibrosis
1465134|NCT00908505|physiotherapy|physiotherapy
1465135|NCT00908505|pulmonary function test|pulmonary function test
1465136|NCT00908492|Randomized control trial|randomized control trial
1465137|NCT00908492|Dementia caregivers|dementia caregivers
1465138|NCT00908492|Occupational Therapy|occupational therapy
1465139|NCT00908492|Caregivers|caregivers
1465140|NCT00908479|Exercise|exercise
1465141|NCT00908479|Rehabilitation|rehabilitation
1465142|NCT00908479|leg function|leg function
1465143|NCT00908479|in patient|in patient
1465144|NCT00908479|RCT|rct
1465145|NCT00908466|Non-infectious|non-infectious
1465146|NCT00908466|Uveitis|uveitis
1465147|NCT00908466|Panuveitis|panuveitis
1465148|NCT00908453|NPC-06|npc-06
1465149|NCT00908453|fosphenytoin|fosphenytoin
1465151|NCT00908453|pharmacokinetics|pharmacokinetics
1465152|NCT00908453|safety|safety
1465153|NCT00908440|Decision Aid|decision aid
1465154|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
1465155|NCT00908440|evidence-based treatments|evidence-based treatments
1465156|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
1465157|NCT00908427|KTP laser|ktp laser
1465158|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
1465159|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
1465160|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
1465161|NCT00908414|PEPI-C104|pepi-c104
1465162|NCT00908414|PEPI|pepi
1465163|NCT00908414|TMC589337|tmc589337
1465164|NCT00908414|TMC589354|tmc589354
1465165|NCT00908414|TMC310911|tmc310911
1465166|NCT00908414|Healthy Volunteers|healthy volunteers
1465167|NCT00908401|breastmilk|breastmilk
1465168|NCT00908401|oral sucrose|oral sucrose
1465169|NCT00908401|analgesia|analgesia
1465170|NCT00908401|preterm neonates|preterm neonates
1465171|NCT00908401|Neonates|neonates
1465172|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
1465173|NCT00908375|Pregabalin|pregabalin
1465174|NCT00908375|Radicular pain|radicular pain
1465175|NCT00908375|Failed back surgery|failed back surgery
1465176|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
1465177|NCT00908362|Dendritic cells|dendritic cells
1465178|NCT00908362|Airway|airway
1465179|NCT00908362|Smoker|smoker
1465180|NCT00908362|COPD|copd
1465181|NCT00908336|Adenocarcinoma|adenocarcinoma
1465182|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
1465183|NCT00908336|Lung Neoplasms|lung neoplasms
1465184|NCT00908336|Docetaxel|docetaxel
1465185|NCT00908336|Erlotinib|erlotinib
1465186|NCT00908336|Chemotherapy|chemotherapy
1465187|NCT00908323|HIV Seronegativity|hiv seronegativity
1465188|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
1465189|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
1465190|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
1465191|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
1465192|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
1465193|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
1465194|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
1465195|NCT00908297|Cardiovascular disease|cardiovascular disease
1465196|NCT00908297|End stage renal disease|end stage renal disease
1465197|NCT00908297|Atherosclerosis|atherosclerosis
1465198|NCT00908297|Oxidative stress|oxidative stress
1465199|NCT00908297|Antioxidants|antioxidants
1465200|NCT00908284|AIDS|aids
1465201|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1465202|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
1465203|NCT00908284|Exercise Physiology|exercise physiology
1465204|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
1465205|NCT00908245|Preconditioning|preconditioning
1465206|NCT00908245|Hepatectomy|hepatectomy
1465207|NCT00908245|Clamping|clamping
1465208|NCT00908232|multiple myeloma|multiple myeloma
1465209|NCT00908232|bortezomib|bortezomib
1465210|NCT00908232|hematology|hematology
1465211|NCT00908232|bone marrow cancer|bone marrow cancer
1465212|NCT00908232|immunoglobulin|immunoglobulin
1465213|NCT00908232|refractory|refractory
1465214|NCT00908232|progression|progression
1465215|NCT00908232|dexamethasone|dexamethasone
1465216|NCT00908232|lenalidomide|lenalidomide
1465217|NCT00908232|cyclophosphamide|cyclophosphamide
1465218|NCT00908219|malignant ascites|malignant ascites
1465219|NCT00908219|bevacizumab|bevacizumab
1465220|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1465221|NCT00908219|paracentesis|paracentesis
1465222|NCT00908206|Alcoholism|alcoholism
1465223|NCT00908206|Craving|craving
1465224|NCT00908206|Dependence|dependence
1465225|NCT00908206|Alcohol|alcohol
1465226|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
1465227|NCT00908193|Digestive system disease|digestive system disease
1465228|NCT00908193|Coelioscopy|coelioscopy
1465229|NCT00908193|Assistance robotics|assistance robotics
1465230|NCT00908193|Medical device|medical device
1465231|NCT00908193|DA VINCI Robot|da vinci robot
1465232|NCT00908193|Pain patient|pain patient
1465233|NCT00908193|Morphine consumption|morphine consumption
1465234|NCT00908193|Comparative Randomized study|comparative randomized study
1465235|NCT00908193|patient over 18 years|patient over 18 years
1465236|NCT00908193|with ruptured abdominal|with ruptured abdominal
1465237|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
1465238|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1465239|NCT00908167|sorafenib|sorafenib
1465240|NCT00908167|cytarabine|cytarabine
1465241|NCT00908167|clofarabine|clofarabine
1465242|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
1465243|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
1466764|NCT00902096|predictor|predictor
1465244|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1465245|NCT00908154|sodium channel blocker|sodium channel blocker
1465246|NCT00908154|bipolar disorder|bipolar disorder
1465247|NCT00908154|repeat dose|repeat dose
1465248|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1465249|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
1465250|NCT00908128|Bioequivalence|bioequivalence
1465251|NCT00908128|Healthy Subjects|healthy subjects
1465252|NCT00908102|low back pain|low back pain
1465253|NCT00908102|recurrent|recurrent
1465254|NCT00908102|subacute|subacute
1465255|NCT00908102|secondary prevention|secondary prevention
1465256|NCT00908102|primary care|primary care
1465257|NCT00908102|occupational health|occupational health
1465258|NCT00908102|back book|back book
1465259|NCT00908102|rehabilitation|rehabilitation
1465260|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
1465261|NCT00908089|methotrexate|methotrexate
1465262|NCT00908089|sulfasalazine|sulfasalazine
1465263|NCT00908089|hydroxychloroquine|hydroxychloroquine
1465264|NCT00908089|infliximab|infliximab
1465265|NCT00908076|constipation|constipation
1465266|NCT00908076|Parkinson's disease|parkinson's disease
1465267|NCT00908063|TBI|tbi
1465268|NCT00908063|Traumatic Brain Injury|traumatic brain injury
1465269|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
1465270|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1465271|NCT00908037|ITP|itp
1465272|NCT00908037|pharmacokinetics|pharmacokinetics
1465273|NCT00908037|chronic ITP|chronic itp
1465274|NCT00908037|eltrombopag|eltrombopag
1465275|NCT00908037|thrombocytopenia|thrombocytopenia
1465276|NCT00908037|pharmacodynamics|pharmacodynamics
1465277|NCT00908037|pediatrics|pediatrics
1465278|NCT00908011|Hypercholesterolemia|hypercholesterolemia
1465279|NCT00908011|HIV|hiv
1465280|NCT00908011|Ezetimibe|ezetimibe
1465281|NCT00908011|Statin|statin
1465282|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
1465283|NCT00907998|Coronary heart disease|coronary heart disease
1465284|NCT00907998|APL180|apl180
1465285|NCT00907985|Healthy Volunteer|healthy volunteer
1465286|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
1465287|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1465288|NCT00907972|Parkinson's Disease|parkinson's disease
1465289|NCT00907972|Parkinson Disease|parkinson disease
1465290|NCT00907972|PD|pd
1465291|NCT00907972|Movement Disorder|movement disorder
1465292|NCT00907946|Renal stones|renal stones
1465293|NCT00907907|Bioequivalence|bioequivalence
1465294|NCT00907907|Subjects|subjects
1465295|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
1465296|NCT00907894|telbivudine,|telbivudine,
1465297|NCT00907894|pharmacokinetics,|pharmacokinetics,
1465298|NCT00907894|safety,|safety,
1465299|NCT00907894|tolerability,|tolerability,
1465300|NCT00907894|pediatric|pediatric
1465301|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1465302|NCT00907855|Ischemic Heart Disease|ischemic heart disease
1465303|NCT00907855|Duke Activity Status Index|duke activity status index
1465304|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
1465305|NCT00907842|stoma|stoma
1465306|NCT00907829|stroke|stroke
1465307|NCT00907829|fingertip force|fingertip force
1465308|NCT00907829|muscle coordination|muscle coordination
1465309|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
1465310|NCT00907803|Orthopoxvirus|orthopoxvirus
1465311|NCT00907803|Smallpox|smallpox
1465312|NCT00907803|This is a safety study only|this is a safety study only
1465313|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
1465314|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
1465315|NCT00907790|Cognitive Therapy|cognitive therapy
1465316|NCT00907790|Abdominal Pain|abdominal pain
1465317|NCT00907790|Quality of Life|quality of life
1465318|NCT00907777|Haemophilus influenzae|haemophilus influenzae
1465319|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
1465320|NCT00907777|safety|safety
1465321|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1465322|NCT00907777|immunogenicity|immunogenicity
1465323|NCT00907725|medical abortion|medical abortion
1465324|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
1465325|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
1465326|NCT00907725|follow-up methods|follow-up methods
1465327|NCT00907712|amputation|amputation
1465328|NCT00907712|vascular|vascular
1465329|NCT00907712|below knee|below knee
1465330|NCT00907712|above knee|above knee
1465331|NCT00907712|cardiovascular|cardiovascular
1465332|NCT00907712|echo|echo
1465333|NCT00907712|cardiovascular assessment|cardiovascular assessment
1465334|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1465335|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1465336|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1465337|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
1465338|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
1465339|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
1465340|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
1465341|NCT00907660|Obesity|obesity
1465342|NCT00907660|Weight loss|weight loss
1465343|NCT00907660|Meal replacements|meal replacements
1465344|NCT00907660|Health services research|health services research
1465345|NCT00907634|cervix|cervix
1465346|NCT00907634|cervical|cervical
1465347|NCT00907634|radiation|radiation
1465348|NCT00907621|Infant Colic|infant colic
1465349|NCT00907621|Acupuncture|acupuncture
1465350|NCT00907621|General Practice|general practice
1465351|NCT00907595|Huntington's chorea|huntington's chorea
1465352|NCT00907595|Huntington's Disease|huntington's disease
1465353|NCT00907595|Parkinson's Disease|parkinson's disease
1610307|NCT00357058|HV|hv
1465354|NCT00907595|Parkinsonism|parkinsonism
1465355|NCT00907595|Dementia|dementia
1465356|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
1465357|NCT00907595|Actigraphy|actigraphy
1465358|NCT00907595|Circadian dysregulation|circadian dysregulation
1465359|NCT00907595|Sleep Disorders|sleep disorders
1465360|NCT00907595|Circadian rhythm|circadian rhythm
1465361|NCT00907582|PCR negative|pcr negative
1465362|NCT00907569|Small cell lung cancer|small cell lung cancer
1465363|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
1465364|NCT00907543|esophageal carcinoma|esophageal carcinoma
1465365|NCT00907543|chemotherapy|chemotherapy
1465366|NCT00907543|radiation|radiation
1465367|NCT00907543|surgery|surgery
1465368|NCT00907543|randomized clinical trial|randomized clinical trial
1465369|NCT00907543|Clinical Trial|clinical trial
1465370|NCT00907543|Radiotherapy|radiotherapy
1465371|NCT00907491|Cough|cough
1465372|NCT00907491|Wheeze Rate|wheeze rate
1465373|NCT00907491|Respiratory Function Tests|respiratory function tests
1465374|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1465375|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
1465376|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1465377|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
1465378|NCT00907478|ITP|itp
1465379|NCT00907452|Pharmacogenomics|pharmacogenomics
1465380|NCT00907452|prediction response|prediction response
1465381|NCT00907452|prediction adverse event|prediction adverse event
1465382|NCT00907439|Diastole, physiopathology|diastole, physiopathology
1465383|NCT00907439|coronary artery disease|coronary artery disease
1465384|NCT00907439|volatile anesthetic|volatile anesthetic
1465385|NCT00907439|sevoflurane|sevoflurane
1465386|NCT00907426|eyelashes|eyelashes
1465387|NCT00907413|cancer|cancer
1465388|NCT00907413|bile duct|bile duct
1465389|NCT00907400|Phase 1|phase 1
1465390|NCT00907400|Healthy Volunteer|healthy volunteer
1465391|NCT00907400|Healthy Volunteer Study|healthy volunteer study
1465392|NCT00907387|Lateral Canthal Lines|lateral canthal lines
1465393|NCT00907387|Crow's Feet|crow's feet
1465394|NCT00907387|Facial Wrinkles|facial wrinkles
1465395|NCT00907374|Microalbuminuria|microalbuminuria
1465396|NCT00907374|Carotid intima media thickness|carotid intima media thickness
1465397|NCT00907374|Endothelial dysfunction|endothelial dysfunction
1465398|NCT00907374|Renin angiotensin system|renin angiotensin system
1465399|NCT00907374|Diabetic nephropathy|diabetic nephropathy
1465400|NCT00907361|pacemaker|pacemaker
1465401|NCT00907361|ICD|icd
1465402|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1465403|NCT00907361|MRI|mri
1465404|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
1465405|NCT00907348|NHL|nhl
1465406|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
1465407|NCT00907348|Follicular Lymphoma|follicular lymphoma
1465408|NCT00907335|acne|acne
1465409|NCT00907335|irritation|irritation
1465410|NCT00907335|objective sensory methods|objective sensory methods
1465411|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
1465412|NCT00907309|alcohol abuse|alcohol abuse
1465413|NCT00907309|marijuana abuse|marijuana abuse
1465414|NCT00907309|drug abuse|drug abuse
1465415|NCT00907309|tobacco use|tobacco use
1465416|NCT00907309|tobacco dependence|tobacco dependence
1465417|NCT00907296|Fracture Healing|fracture healing
1465418|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
1465419|NCT00907283|NBIA|nbia
1465420|NCT00907283|Iron overload AND brain|iron overload and brain
1465421|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
1465422|NCT00907283|Brain iron Overload|brain iron overload
1465423|NCT00907283|Neurodegeneration|neurodegeneration
1465424|NCT00907283|Brain iron Accumulation|brain iron accumulation
1465425|NCT00907257|acne|acne
1465426|NCT00907257|irritation|irritation
1465427|NCT00907257|objective sensory methods|objective sensory methods
1465428|NCT00907218|ADHD|adhd
1465429|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1465430|NCT00907218|ADHD medication|adhd medication
1465431|NCT00907218|Chantix|chantix
1465432|NCT00907218|varenicline|varenicline
1465433|NCT00907218|smoking|smoking
1465434|NCT00907218|smoking cessation|smoking cessation
1465435|NCT00907218|quit smoking|quit smoking
1465436|NCT00907205|Advanced Solid Tumors|advanced solid tumors
1465437|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
1465438|NCT00907205|PI3K|pi3k
1465439|NCT00907205|PI3K Inhibitors|pi3k inhibitors
1465440|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
1465441|NCT00907205|mTORC inhibitor|mtorc inhibitor
1465442|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
1465443|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
1465444|NCT00907205|vascular targeted|vascular targeted
1465445|NCT00907205|conjugate|conjugate
1465446|NCT00907192|Cancer|cancer
1465447|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
1465448|NCT00907192|Narcotic pain drugs|narcotic pain drugs
1465449|NCT00907192|Self-report|self-report
1465450|NCT00907192|Questionnaire|questionnaire
1465451|NCT00907192|Interview|interview
1465452|NCT00907192|Actual use|actual use
1465453|NCT00907192|Doctor-prescribed use|doctor-prescribed use
1465454|NCT00907192|Frequency of deviation|frequency of deviation
1465455|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
1465456|NCT00907166|CPI-613|cpi-613
1465457|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
1465458|NCT00907166|Phase I|phase i
1465459|NCT00907166|Phase II|phase ii
1465460|NCT00907166|Cancer|cancer
1465461|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
1465462|NCT00907166|Pancreatic Cancer|pancreatic cancer
1465463|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
1465464|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
1465465|NCT00907153|Vitamin D|vitamin d
1465466|NCT00907153|Insulin resistance|insulin resistance
1465467|NCT00907153|Inflammation|inflammation
1465468|NCT00907140|Cervical Cancer|cervical cancer
1465469|NCT00907140|Positron Emission Tomography|positron emission tomography
1465470|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
1465471|NCT00907127|Metabolic|metabolic
1465472|NCT00907127|Syndrome|syndrome
1465473|NCT00907127|CAN|can
1465474|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1465475|NCT00907114|macular edema|macular edema
1465476|NCT00907114|panphotocoagulation|panphotocoagulation
1465477|NCT00907114|topic ketorolac|topic ketorolac
1465478|NCT00907114|efficacy|efficacy
1465479|NCT00907114|treatment|treatment
1465480|NCT00907088|Iron depletion|iron depletion
1465481|NCT00907088|Children|children
1465482|NCT00907088|Educational intervention|educational intervention
1465483|NCT00907088|Office-based|office-based
1465484|NCT00907075|diabetes|diabetes
1465485|NCT00907075|nutrition|nutrition
1465486|NCT00907075|diet|diet
1465487|NCT00907075|foods|foods
1465488|NCT00907062|vitiligo|vitiligo
1465489|NCT00907062|leucoderma|leucoderma
1465490|NCT00907049|quality of sleep|quality of sleep
1465491|NCT00907049|neck pain|neck pain
1465492|NCT00907049|disability|disability
1465493|NCT00907049|catastrophizing|catastrophizing
1465494|NCT00907049|depression|depression
1465495|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1465496|NCT00907023|solid organ transplant|solid organ transplant
1465497|NCT00907023|hospital discharge|hospital discharge
1465498|NCT00907010|Ageing|ageing
1465499|NCT00907010|Sarcopenia|sarcopenia
1465500|NCT00907010|Muscular contraction|muscular contraction
1465501|NCT00906997|Colorectal cancer|colorectal cancer
1465502|NCT00906997|Screening|screening
1465503|NCT00906997|Prevention|prevention
1465504|NCT00906997|Fecal occult blood test|fecal occult blood test
1465505|NCT00906997|Colonoscopy|colonoscopy
1465506|NCT00906997|Colorectal neoplasm|colorectal neoplasm
1465507|NCT00906997|Randomized clinical trial|randomized clinical trial
1465508|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
1465509|NCT00906984|Liver cancer|liver cancer
1465510|NCT00906984|Primary liver cancer|primary liver cancer
1465511|NCT00906984|Unresectable liver cancer|unresectable liver cancer
1465512|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1465513|NCT00906984|TheraSphere|therasphere
1465514|NCT00906971|Physical Therapy|physical therapy
1465515|NCT00906971|Chronic Functional Constipation|chronic functional constipation
1465516|NCT00906971|Children|children
1465517|NCT00906945|stem cell mobilization|stem cell mobilization
1465518|NCT00906945|chemosensitization|chemosensitization
1465519|NCT00906945|CXCR4|cxcr4
1465520|NCT00906945|SDF-1|sdf-1
1465521|NCT00906945|CXCL-12|cxcl-12
1465522|NCT00906932|Fiberoptic intubation|fiberoptic intubation
1465523|NCT00906932|direct laryngoscopy|direct laryngoscopy
1465524|NCT00906932|Trachview|trachview
1465525|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
1465526|NCT00906919|self-efficacy|self-efficacy
1465527|NCT00906919|health behavior|health behavior
1465528|NCT00906919|patient education|patient education
1465529|NCT00906919|health education|health education
1465530|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
1465531|NCT00906893|Glioblastoma|glioblastoma
1465532|NCT00906893|Hypoxia|hypoxia
1465533|NCT00906893|tumours|tumours
1465534|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
1465535|NCT00906880|HAT|hat
1466765|NCT00902083|p53 gene|p53 gene
1465536|NCT00906880|sleeping sickness|sleeping sickness
1465537|NCT00906880|combination treatment|combination treatment
1465538|NCT00906880|nifurtimox|nifurtimox
1465539|NCT00906880|eflornithine|eflornithine
1465540|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
1465541|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
1465542|NCT00906867|Laryngoscopy|laryngoscopy
1465543|NCT00906867|Methacholine challenge|methacholine challenge
1465544|NCT00906867|Pulmonary function testing|pulmonary function testing
1465545|NCT00906854|urinary incontinence|urinary incontinence
1465546|NCT00906854|physical exercise|physical exercise
1465547|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
1465548|NCT00906841|first line treatment|first line treatment
1465549|NCT00906841|R CHOP|r chop
1465550|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
1465551|NCT00906841|Patients older than 60 years|patients older than 60 years
1465552|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
1465553|NCT00906828|entacapone|entacapone
1465554|NCT00906828|tolcapone|tolcapone
1465555|NCT00906828|efficacy|efficacy
1465556|NCT00906828|pharmacokinetic|pharmacokinetic
1465557|NCT00906828|pharmacodynamics|pharmacodynamics
1465558|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
1465559|NCT00906802|reconstruction|reconstruction
1465560|NCT00906789|Lung Cancer|lung cancer
1465561|NCT00906789|Chest Radiograph|chest radiograph
1465562|NCT00906789|Computer-aided Detection|computer-aided detection
1465563|NCT00906789|Image processing|image processing
1465564|NCT00906763|Parkinson's disease|parkinson's disease
1465565|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
1465566|NCT00906763|Biogenic amines|biogenic amines
1465567|NCT00906763|Chocolate|chocolate
1465568|NCT00906763|Cocoa|cocoa
1465569|NCT00906750|FLuMIST|flumist
1465570|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
1465571|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
1465572|NCT00906737|Multiple Sclerosis|multiple sclerosis
1465573|NCT00906737|Gait|gait
1465574|NCT00906737|foot-drop|foot-drop
1465575|NCT00906737|Ankle-Bot|ankle-bot
1465576|NCT00906737|Physical Therapy|physical therapy
1465577|NCT00906737|Gait Abnormalities|gait abnormalities
1465578|NCT00906711|Aging|aging
1465579|NCT00906711|Postural Balance|postural balance
1465580|NCT00906685|CRVO|crvo
1465581|NCT00906685|anti-VEGF|anti-vegf
1465582|NCT00906685|Macular edema|macular edema
1465583|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
1465584|NCT00906672|Flap|flap
1465585|NCT00906672|graft|graft
1465586|NCT00906672|traumatic wound|traumatic wound
1465587|NCT00906672|medico economic costs|medico economic costs
1465588|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
1465589|NCT00906659|center point thickness|center point thickness
1465590|NCT00906659|diabetic retinopathy|diabetic retinopathy
1465591|NCT00906659|diabetic macular edema|diabetic macular edema
1465592|NCT00906659|macular volume|macular volume
1465593|NCT00906659|visual capacity|visual capacity
1465594|NCT00906659|visual function|visual function
1465595|NCT00906646|cardiac|cardiac
1465596|NCT00906646|surgery|surgery
1465597|NCT00906646|metabolic|metabolic
1465598|NCT00906646|supplements|supplements
1465599|NCT00906646|antioxidant|antioxidant
1465600|NCT00906633|antifungal therapies|antifungal therapies
1465601|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
1465602|NCT00906607|Urinary Incontinence|urinary incontinence
1465603|NCT00906581|Depression|depression
1465604|NCT00906568|Cystic fibrosis|cystic fibrosis
1465605|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
1465606|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
1465607|NCT00906568|Induced Sputum|induced sputum
1465608|NCT00906568|Bronchial inflammation|bronchial inflammation
1465609|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
1465610|NCT00906542|acute stroke|acute stroke
1465611|NCT00906542|ischemic stroke|ischemic stroke
1465612|NCT00906542|pneumonia|pneumonia
1465613|NCT00906542|chest infection|chest infection
1465614|NCT00906542|brain lesion|brain lesion
1465615|NCT00906542|lesion topology|lesion topology
1465616|NCT00906542|dysphagia|dysphagia
1465617|NCT00906542|sympathetic activation|sympathetic activation
1465618|NCT00906542|immunosuppression|immunosuppression
1465619|NCT00906529|Type 2 Diabetes|type 2 diabetes
1465620|NCT00906529|Inpatient|inpatient
1465621|NCT00906529|Length of Stay|length of stay
1465622|NCT00906529|Blood Glucose Control|blood glucose control
1465623|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
1465624|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
1465625|NCT00906516|Recurrent Brain Disease|recurrent brain disease
1465626|NCT00906516|Neuradiab|neuradiab
1465627|NCT00906516|Avastin|avastin
1465628|NCT00906516|Bevacizumab|bevacizumab
1465629|NCT00906503|pulmonary nodule|pulmonary nodule
1465630|NCT00906490|Glucose Monitoring|glucose monitoring
1465631|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
1465632|NCT00906451|myocardial infarction|myocardial infarction
1465633|NCT00906451|inflammation|inflammation
1465634|NCT00906451|endothelial dysfunction|endothelial dysfunction
1465836|NCT00905593|nilotinib,|nilotinib,
1465635|NCT00906425|Dental Implant|dental implant
1465636|NCT00906412|Essential Tremor|essential tremor
1465637|NCT00906399|interferon|interferon
1465638|NCT00906399|injectable|injectable
1465640|NCT00906399|SC|sc
1465641|NCT00906399|PEGylated|pegylated
1465642|NCT00906399|Interferon beta-1a|interferon beta-1a
1465643|NCT00906399|relapsing|relapsing
1465644|NCT00906399|PEG|peg
1465645|NCT00906399|multiple sclerosis|multiple sclerosis
1465646|NCT00906399|subcutaneous|subcutaneous
1465647|NCT00906386|Varenicline|varenicline
1465648|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
1465649|NCT00906373|Liver Neoplasms|liver neoplasms
1465650|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
1465651|NCT00906347|Labor augmentation|labor augmentation
1465652|NCT00906347|Oral misoprostol|oral misoprostol
1465653|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
1465654|NCT00906334|Trisomy 8|trisomy 8
1465655|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
1465656|NCT00906334|High-Risk Group|high-risk group
1465657|NCT00906334|azacitidine|azacitidine
1465658|NCT00906334|azacytidine|azacytidine
1465659|NCT00906334|Vidaza|vidaza
1465660|NCT00906334|decitabine|decitabine
1465661|NCT00906334|Dacogen|dacogen
1465662|NCT00906321|Web-Based Decision Support|web-based decision support
1465663|NCT00906321|Breast Cancer Risk|breast cancer risk
1465664|NCT00906295|Hemoglobin|hemoglobin
1465665|NCT00906295|Ambulation|ambulation
1465666|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
1465667|NCT00906282|NSCLC|nsclc
1465668|NCT00906282|pemetrexed|pemetrexed
1465669|NCT00906269|impotence|impotence
1465670|NCT00906269|prostatic neoplasms|prostatic neoplasms
1465671|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
1465672|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1465673|NCT00906256|Hepatitis C|hepatitis c
1465674|NCT00906256|Pharmacokinetics|pharmacokinetics
1465675|NCT00906256|AZD7295|azd7295
1465676|NCT00906256|Healthy volunteers|healthy volunteers
1465677|NCT00906217|colonoscopy|colonoscopy
1465678|NCT00906217|preparation|preparation
1465679|NCT00906217|safety|safety
1465680|NCT00906217|elderly|elderly
1465681|NCT00906204|Renal transplantation|renal transplantation
1465682|NCT00906204|Kidney transplantation|kidney transplantation
1465683|NCT00906178|HIV prevention|hiv prevention
1465684|NCT00906178|technology|technology
1465685|NCT00906178|adolescent|adolescent
1465686|NCT00906178|developing countries|developing countries
1465687|NCT00906152|quality of sleep|quality of sleep
1465688|NCT00906152|low back pain|low back pain
1465689|NCT00906152|disability|disability
1465690|NCT00906152|catastrophizing|catastrophizing
1465691|NCT00906152|depression|depression
1465692|NCT00906139|Propofol|propofol
1465693|NCT00906139|Midazolam|midazolam
1465694|NCT00906139|Cirrhosis|cirrhosis
1465695|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
1465696|NCT00906139|Complications|complications
1465697|NCT00906139|Sedation|sedation
1465698|NCT00906126|oral misoprostol|oral misoprostol
1465699|NCT00906126|labor augmentation|labor augmentation
1465700|NCT00906126|arrest of dilation|arrest of dilation
1465701|NCT00906126|nulliparous|nulliparous
1465702|NCT00906113|Retinoblastoma|retinoblastoma
1465703|NCT00906100|Biventricular ICD|biventricular icd
1465704|NCT00906100|AV delay|av delay
1465705|NCT00906087|Myocilin gene|myocilin gene
1465706|NCT00906087|Glaucoma|glaucoma
1465707|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
1465708|NCT00906074|Surgical Wound Infection|surgical wound infection
1465709|NCT00906074|Surgical Site Infection|surgical site infection
1465710|NCT00906074|Abdominal Surgery|abdominal surgery
1465711|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
1465712|NCT00906061|Lung Neoplasms|lung neoplasms
1465713|NCT00906061|Docetaxel|docetaxel
1465714|NCT00906061|Gemcitabine|gemcitabine
1465715|NCT00906061|ECOG 2|ecog 2
1465716|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
1465717|NCT00906035|PAD|pad
1465718|NCT00906035|Claudication|claudication
1465719|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
1465720|NCT00906022|Below the Knee|below the knee
1465721|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
1465722|NCT00906022|nitinol|nitinol
1465723|NCT00906022|limb ischemia|limb ischemia
1465724|NCT00906022|claudication|claudication
1465725|NCT00906022|self-expanding stent|self-expanding stent
1465726|NCT00906022|duplex|duplex
1465727|NCT00906022|angiography|angiography
1465728|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
1465729|NCT00905983|Elderly patients|elderly patients
1465730|NCT00905983|Docetaxel|docetaxel
1465731|NCT00905983|Gemcitabine|gemcitabine
1465732|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
1465733|NCT00905957|relief|relief
1470167|NCT00895869|Pain|pain
1465734|NCT00905944|Left ventricular failure|left ventricular failure
1465735|NCT00905944|chronic heart failure|chronic heart failure
1465736|NCT00905944|Pacemaker|pacemaker
1465737|NCT00905944|Resynchronisation therapy|resynchronisation therapy
1465738|NCT00905944|Exercise|exercise
1465739|NCT00905944|Endurance exercise|endurance exercise
1465740|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
1465741|NCT00905931|Cerebral vasospasm|cerebral vasospasm
1465742|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
1465743|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
1465744|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
1465745|NCT00905918|colon cancer|colon cancer
1465746|NCT00905918|rectal cancer|rectal cancer
1465747|NCT00905905|myocardial infarction|myocardial infarction
1465748|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
1465749|NCT00905905|endothelial function|endothelial function
1465750|NCT00905892|overfeeding|overfeeding
1465751|NCT00905892|stable isotopes|stable isotopes
1465752|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
1465753|NCT00905892|lipid oxidation|lipid oxidation
1465754|NCT00905892|fat distribution|fat distribution
1465755|NCT00905892|gene expression|gene expression
1465756|NCT00905892|endotoxemia|endotoxemia
1465757|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
1465758|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1465759|NCT00905879|Observational study|observational study
1465760|NCT00905879|Gadobutrol|gadobutrol
1465761|NCT00905866|Quality of life|quality of life
1465762|NCT00905866|Hyperparathyroidism|hyperparathyroidism
1465763|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
1465764|NCT00905853|Catheter Ablation|catheter ablation
1465765|NCT00905853|ICD therapy|icd therapy
1465766|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
1465767|NCT00905853|Ischemic Heart Disease|ischemic heart disease
1465768|NCT00905827|suicide|suicide
1465769|NCT00905827|assessment|assessment
1465770|NCT00905827|management|management
1465771|NCT00905827|Provider Training|provider training
1465772|NCT00905827|health services|health services
1465773|NCT00905814|Bioequivalence|bioequivalence
1465774|NCT00905801|Non small cell lung cancer|non small cell lung cancer
1465775|NCT00905801|NSCLC|nsclc
1465776|NCT00905801|CTP|ctp
1465777|NCT00905801|Perfusion|perfusion
1465778|NCT00905801|Imaging|imaging
1465779|NCT00905788|Embryo transfer|embryo transfer
1465780|NCT00905788|IVF/ICSI|ivf/icsi
1465781|NCT00905788|Embryo expulsion|embryo expulsion
1465782|NCT00905775|Isoflurane;|isoflurane;
1465783|NCT00905775|Propofol|propofol
1465784|NCT00905775|Renal functions tests|renal functions tests
1465785|NCT00905775|Cardiovascular tests|cardiovascular tests
1465786|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
1465787|NCT00905775|extracorporeal circulation|extracorporeal circulation
1465788|NCT00905762|pharmacokinetics|pharmacokinetics
1465789|NCT00905736|tendon|tendon
1465790|NCT00905736|healing|healing
1465791|NCT00905736|microcurrent|microcurrent
1465792|NCT00905736|chronic tennis elbow|chronic tennis elbow
1465793|NCT00905723|climacterium|climacterium
1465794|NCT00905723|sexual life|sexual life
1465795|NCT00905723|isoflavone|isoflavone
1465796|NCT00905723|estrogen|estrogen
1465797|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
1465798|NCT00905723|Kupperman index|kupperman index
1465799|NCT00905710|colorectal adenomas|colorectal adenomas
1465800|NCT00905710|colorectal cancer|colorectal cancer
1465801|NCT00905710|Lynch syndrome|lynch syndrome
1465802|NCT00905710|chromoendoscopy|chromoendoscopy
1465803|NCT00905697|Living donor lung transplantation|living donor lung transplantation
1465804|NCT00905697|Health-related quality of life|health-related quality of life
1465805|NCT00905697|Prognosis|prognosis
1465806|NCT00905697|Patient reported outcome|patient reported outcome
1465807|NCT00905684|Compliance|compliance
1465808|NCT00905684|Hormonal Contraception|hormonal contraception
1465809|NCT00905671|Lipid Core Plaque|lipid core plaque
1465810|NCT00905671|LCP|lcp
1465811|NCT00905671|Bifurcation|bifurcation
1465812|NCT00905671|Stenosis|stenosis
1465813|NCT00905671|Lesion|lesion
1465814|NCT00905671|Angioplasty|angioplasty
1465815|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
1465816|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
1465817|NCT00905658|fallopian tube cancer|fallopian tube cancer
1465818|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1465819|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1465820|NCT00905658|ovarian sarcoma|ovarian sarcoma
1465821|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
1465822|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1465823|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
1465824|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
1465825|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
1465826|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
1465827|NCT00905645|Breast Augmentation|breast augmentation
1465828|NCT00905645|Breast Reconstruction|breast reconstruction
1465829|NCT00905645|Breast Revision|breast revision
1465830|NCT00905645|Silicone breast implants|silicone breast implants
1465831|NCT00905606|Bioequivalence|bioequivalence
1465832|NCT00905606|Healthy Subjects|healthy subjects
1465833|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
1465834|NCT00905593|blast crisis,|blast crisis,
1465835|NCT00905593|accelerated phase,|accelerated phase,
1465837|NCT00905593|imatinib,|imatinib,
1465838|NCT00905593|resistant,|resistant,
1465839|NCT00905593|intolerant,|intolerant,
1465840|NCT00905593|chronic phase|chronic phase
1465841|NCT00905580|thyroidectomy|thyroidectomy
1465842|NCT00905580|pain, postoperative|pain, postoperative
1465843|NCT00905580|pregabalin|pregabalin
1465844|NCT00905567|Bioequivalence|bioequivalence
1465845|NCT00905567|Healthy Subjects|healthy subjects
1465846|NCT00905554|sedation|sedation
1465847|NCT00905554|warm water|warm water
1465848|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
1465849|NCT00905528|endothelial function|endothelial function
1465850|NCT00905528|renal hemodynamics|renal hemodynamics
1465851|NCT00905515|Kidney Transplantation|kidney transplantation
1465852|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
1465853|NCT00905502|Obesity|obesity
1465854|NCT00905502|fluid management|fluid management
1465855|NCT00905502|postoperative complications|postoperative complications
1465856|NCT00905502|bariatric surgery|bariatric surgery
1465857|NCT00905502|hemostasis|hemostasis
1465858|NCT00905476|NPPV|nppv
1465859|NCT00905476|Prognosis|prognosis
1465860|NCT00905476|Health-related quality of life|health-related quality of life
1465861|NCT00905476|Patient reported outcomes|patient reported outcomes
1465862|NCT00905463|Lung transplant candidates|lung transplant candidates
1465863|NCT00905463|Health-related quality of life|health-related quality of life
1465864|NCT00905463|patient reported outcome|patient reported outcome
1465865|NCT00905463|Prognosis|prognosis
1465866|NCT00905450|Surgery|surgery
1465867|NCT00905437|perioperative|perioperative
1465868|NCT00905437|pregabalin|pregabalin
1465869|NCT00905437|total hip replacement|total hip replacement
1465870|NCT00905437|post-operative pain|post-operative pain
1465871|NCT00905411|Overweight|overweight
1465872|NCT00905411|blood pressure|blood pressure
1465873|NCT00905411|DASH diet|dash diet
1465874|NCT00905411|Pacific|pacific
1465875|NCT00905411|children|children
1465876|NCT00905398|Leukemia|leukemia
1465877|NCT00905398|Lymphoblastic|lymphoblastic
1465878|NCT00905398|Acute|acute
1465879|NCT00905398|Philadelphia|philadelphia
1465880|NCT00905398|BCR-ABL|bcr-abl
1465881|NCT00905398|Nilotinib|nilotinib
1465882|NCT00905398|Treatment|treatment
1465883|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
1465884|NCT00905346|Bioequivalence|bioequivalence
1465885|NCT00905346|Healthy Subjects|healthy subjects
1465886|NCT00905333|pharmacokinetics|pharmacokinetics
1465887|NCT00905333|candesartan|candesartan
1465888|NCT00905333|felodipine|felodipine
1465889|NCT00905333|test formulations|test formulations
1465890|NCT00905333|Atacand®|atacand®
1465891|NCT00905333|Splendil®|splendil®
1465892|NCT00905333|healthy volunteers|healthy volunteers
1465893|NCT00905333|blood samples|blood samples
1465894|NCT00905333|after meal intake interaction|after meal intake interaction
1465895|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
1465896|NCT00905320|Hernia repair|hernia repair
1465897|NCT00905307|Schizophrenia|schizophrenia
1465898|NCT00905307|Relapsed|relapsed
1465899|NCT00905281|Metastatic breast cancer|metastatic breast cancer
1465900|NCT00905281|Supportive care|supportive care
1465901|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
1465902|NCT00905281|Quality of life|quality of life
1465903|NCT00905281|Treatment preferences|treatment preferences
1465904|NCT00905268|FRDA|frda
1465905|NCT00905268|idebenone|idebenone
1465906|NCT00905268|FRDA disease|frda disease
1465907|NCT00905255|hyperglycemia|hyperglycemia
1465908|NCT00905255|GLP-1|glp-1
1465909|NCT00905242|Kidney Transplantation|kidney transplantation
1465910|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
1465911|NCT00905229|hip fracture|hip fracture
1465912|NCT00905229|warfarin|warfarin
1465913|NCT00905229|vitamin k|vitamin k
1465914|NCT00905229|Phytonadione|phytonadione
1465915|NCT00905229|INR level|inr level
1465916|NCT00905216|heparin|heparin
1465917|NCT00905203|Postmenopausal women|postmenopausal women
1465918|NCT00905203|Diabetes|diabetes
1465919|NCT00905203|Skin microcirculation|skin microcirculation
1465920|NCT00905203|Exercise capacity|exercise capacity
1465921|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
1465922|NCT00905203|Dose-response relationship|dose-response relationship
1465923|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
1465924|NCT00905177|Atrial Fibrillation|atrial fibrillation
1465925|NCT00905177|deep vein thrombosis|deep vein thrombosis
1465926|NCT00905177|anticoagulation|anticoagulation
1465927|NCT00905177|warfarin|warfarin
1465929|NCT00905164|Bioequivalence|bioequivalence
1465930|NCT00905164|Healthy Subjects|healthy subjects
1465931|NCT00905151|HIV positive|hiv positive
1465932|NCT00905151|AIDS|aids
1465933|NCT00905151|antiretroviral|antiretroviral
1465934|NCT00905151|Kidney disease|kidney disease
1465935|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
1465936|NCT00905138|Safety|safety
1465937|NCT00905138|Tolerability|tolerability
1465938|NCT00905138|Pharmacokinetics|pharmacokinetics
1465939|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
1465940|NCT00905112|Pregnancy|pregnancy
1465941|NCT00905112|Pain|pain
1465942|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
1465943|NCT00905112|Exercise|exercise
1465944|NCT00905086|cognitive/functional effects|cognitive/functional effects
1465945|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1465946|NCT00905086|stage I breast cancer|stage i breast cancer
1465947|NCT00905086|stage II breast cancer|stage ii breast cancer
1465948|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
1465949|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
1465950|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
1465951|NCT00905086|stage I colon cancer|stage i colon cancer
1465952|NCT00905086|stage II colon cancer|stage ii colon cancer
1465953|NCT00905086|stage III colon cancer|stage iii colon cancer
1465954|NCT00905086|stage I rectal cancer|stage i rectal cancer
1465955|NCT00905086|stage II rectal cancer|stage ii rectal cancer
1465956|NCT00905086|stage III rectal cancer|stage iii rectal cancer
1465957|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1465958|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1465959|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1465960|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1465961|NCT00905086|stage I prostate cancer|stage i prostate cancer
1465962|NCT00905086|stage II prostate cancer|stage ii prostate cancer
1465963|NCT00905086|stage III prostate cancer|stage iii prostate cancer
1465964|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1465965|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
1465966|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
1465967|NCT00905073|cyclosporin|cyclosporin
1465968|NCT00905073|methotrexate|methotrexate
1465969|NCT00905073|renal function|renal function
1465970|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
1465971|NCT00905047|colo-rectal cancer|colo-rectal cancer
1465972|NCT00905047|advanced|advanced
1465973|NCT00905047|metastatic|metastatic
1465974|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
1465975|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1465977|NCT00905034|Leukemia|leukemia
1465978|NCT00905034|Methotrexate|methotrexate
1465979|NCT00905034|Vincristine|vincristine
1465980|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
1465981|NCT00905034|PEG asparaginase|peg asparaginase
1465982|NCT00905034|Pegaspargase|pegaspargase
1465983|NCT00905034|Oncaspar|oncaspar
1465984|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
1465985|NCT00905034|Dexamethasone|dexamethasone
1465986|NCT00905034|Decadron|decadron
1465987|NCT00905034|Rituximab|rituximab
1465988|NCT00905034|Rituxan|rituxan
1465989|NCT00905021|Breast Cancer|breast cancer
1465990|NCT00905021|Metastatic|metastatic
1465991|NCT00905021|Hormone Receptor Positive|hormone receptor positive
1465992|NCT00905008|drug-eluting stent|drug-eluting stent
1465993|NCT00905008|bare-metal stent|bare-metal stent
1465994|NCT00905008|long-term safety|long-term safety
1465995|NCT00905008|mortality|mortality
1465996|NCT00905008|stent thrombosis|stent thrombosis
1465997|NCT00905008|Angioplasty|angioplasty
1465998|NCT00905008|Transluminal|transluminal
1465999|NCT00905008|Percutaneous Coronary|percutaneous coronary
1466000|NCT00904995|Leukemia|leukemia
1466001|NCT00904995|Cancer of the blood|cancer of the blood
1466002|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
1466003|NCT00904995|Hematologic malignancy|hematologic malignancy
1466004|NCT00904995|Invasive fungal infection|invasive fungal infection
1466005|NCT00904995|Voriconazole|voriconazole
1466006|NCT00904995|Vfend|vfend
1466007|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
1466008|NCT00904982|warfarin|warfarin
1466009|NCT00904982|coumadin|coumadin
1466010|NCT00904982|adherence|adherence
1466011|NCT00904982|mechanical heart valves|mechanical heart valves
1466012|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
1466013|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
1466014|NCT00904969|Secondary|secondary
1466015|NCT00904969|Transurethral Resection (TUR)|transurethral resection (tur)
1466016|NCT00904969|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
1466017|NCT00904969|Radical prostatectomy|radical prostatectomy
1466018|NCT00904969|Open prostatectomy|open prostatectomy
1466019|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
1466020|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
1466021|NCT00904956|High Resolution Scanners|high resolution scanners
1466022|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
1466023|NCT00904943|Bioequivalence|bioequivalence
1466024|NCT00904943|Healthy Subjects|healthy subjects
1466025|NCT00904930|Tooth mobility assessment|tooth mobility assessment
1466026|NCT00904930|Splinting|splinting
1466027|NCT00904930|Splint Rigidity|splint rigidity
1466028|NCT00904917|African American Mothers|african american mothers
1466029|NCT00904917|Children|children
1466030|NCT00904917|African American Families|african american families
1466031|NCT00904917|Parental Depression|parental depression
1466032|NCT00904917|Preventive Intervention|preventive intervention
1466033|NCT00904891|Adolescents|adolescents
1466034|NCT00904891|Prevention|prevention
1466035|NCT00904891|Bibliotherapy|bibliotherapy
1466036|NCT00904878|pregnant IBD patients|pregnant ibd patients
1466037|NCT00904865|Single port access|single port access
1466038|NCT00904865|Laparoscopy|laparoscopy
1466039|NCT00904865|cholecystectomy|cholecystectomy
1466040|NCT00904865|cholangiography|cholangiography
1466041|NCT00904865|cosmesis|cosmesis
1466042|NCT00904826|NMO|nmo
1466043|NCT00904826|Devic's disease|devic's disease
1466044|NCT00904826|Neuromyelitis optica|neuromyelitis optica
1466045|NCT00904826|NMO-IgG|nmo-igg
1466046|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
1466047|NCT00904826|Eculizumab|eculizumab
1466048|NCT00904826|Complement|complement
1466049|NCT00904813|Rectal cancer|rectal cancer
1466050|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
1466051|NCT00904813|Timing of Surgery|timing of surgery
1466052|NCT00904813|Prognosis|prognosis
1466053|NCT00904800|Phase I|phase i
1466054|NCT00904800|Healthy volunteers|healthy volunteers
1466055|NCT00904787|Leukemia|leukemia
1466056|NCT00904787|Hematologic neoplasms|hematologic neoplasms
1466057|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1466058|NCT00904774|neonates|neonates
1466059|NCT00904774|lung development|lung development
1466060|NCT00904774|prematurity|prematurity
1466061|NCT00904761|diabetes mellitus|diabetes mellitus
1466062|NCT00904761|autonomic neuropathy|autonomic neuropathy
1466063|NCT00904761|exercise training|exercise training
1466064|NCT00904761|exercise capacity|exercise capacity
1466065|NCT00904761|heart rate variability|heart rate variability
1466066|NCT00904748|Sildenafil|sildenafil
1466067|NCT00904748|Bio-equivalence|bio-equivalence
1466068|NCT00904735|adult grade I meningioma|adult grade i meningioma
1466069|NCT00904735|adult grade II meningioma|adult grade ii meningioma
1466070|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
1466071|NCT00904735|adult papillary meningioma|adult papillary meningioma
1466072|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
1466073|NCT00904722|Follicular lymphoma|follicular lymphoma
1466074|NCT00904722|Immunotherapy|immunotherapy
1466075|NCT00904722|CT-011|ct-011
1466076|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
1466077|NCT00904722|Rituximab|rituximab
1466078|NCT00904722|Rituxan|rituxan
1466079|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
1466080|NCT00904696|probiotics|probiotics
1466081|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
1466082|NCT00904670|ADHD|adhd
1466083|NCT00904670|Pediatric Patients|pediatric patients
1466084|NCT00904670|Quillivant|quillivant
1466085|NCT00904670|methylphenidate|methylphenidate
1466086|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
1466087|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
1466088|NCT00904644|HIV|hiv
1466089|NCT00904644|antiretroviral treatment|antiretroviral treatment
1466090|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
1466091|NCT00904644|drug resistance|drug resistance
1466092|NCT00904644|integrase inhibitor|integrase inhibitor
1466093|NCT00904644|Treatment|treatment
1466094|NCT00904618|Suburethral slings|suburethral slings
1466095|NCT00904618|Urethra|urethra
1466096|NCT00904618|Urinary incontinence|urinary incontinence
1466097|NCT00904618|Urinary stress incontinence|urinary stress incontinence
1466098|NCT00904592|diabetic retinopathy|diabetic retinopathy
1466099|NCT00904592|traditional chinese medicine|traditional chinese medicine
1466100|NCT00904579|Organ Transplants|organ transplants
1466101|NCT00904579|Immunosuppression|immunosuppression
1466102|NCT00904579|Cancer|cancer
1466103|NCT00904579|End Stage Renal Disease|end stage renal disease
1466104|NCT00904579|ESRD|esrd
1466105|NCT00904579|Cancer Risk|cancer risk
1466106|NCT00904566|microarray|microarray
1466107|NCT00904566|gene expression profiling|gene expression profiling
1466108|NCT00904566|MammaPrint|mammaprint
1466109|NCT00904566|breast cancer|breast cancer
1466110|NCT00904553|Brain|brain
1466111|NCT00904553|metastases|metastases
1466112|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
1466113|NCT00904527|Migraine|migraine
1466114|NCT00904527|antipain center|antipain center
1466115|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1466116|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1567381|NCT00509405|osteoporosis|osteoporosis
1466117|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1466118|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
1466119|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1466120|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1466267|NCT00904254|Antibodies|antibodies
1466121|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1466122|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1466123|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
1466124|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1466125|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1466126|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1466127|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1466128|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1466129|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1466130|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1466131|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1466132|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1466133|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1466134|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1466135|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1466136|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1466137|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1466138|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1466139|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
1466140|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1466141|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1466142|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1466143|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1466144|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1466145|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1466146|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1466147|NCT00904514|stage IV colon cancer|stage iv colon cancer
1466148|NCT00904514|stage IV breast cancer|stage iv breast cancer
1466149|NCT00904514|recurrent breast cancer|recurrent breast cancer
1466150|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
1466151|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
1466152|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1466153|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
1466154|NCT00904514|recurrent colon cancer|recurrent colon cancer
1466155|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
1466156|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
1466157|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
1466158|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
1466159|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1466160|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
1466161|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1466162|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
1466163|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1466164|NCT00904514|stage III cervical cancer|stage iii cervical cancer
1466165|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
1466166|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
1466167|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
1466168|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
1466169|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1466170|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1466171|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
1466172|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1466173|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1466174|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1466175|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1466176|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1466177|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1466178|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1466179|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1466180|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1466181|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1466182|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1466183|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1466368|NCT00903669|Rehabilitation|rehabilitation
1466184|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1466185|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1466186|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1466187|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1466188|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1466189|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1466190|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1466191|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1466192|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1466193|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1466194|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1466195|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1466196|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1466197|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1466198|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1466199|NCT00904514|fallopian tube cancer|fallopian tube cancer
1466200|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1466201|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
1466202|NCT00904514|Brenner tumor|brenner tumor
1466203|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1466204|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1466205|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
1466206|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
1466207|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
1466208|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
1466209|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1466210|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
1466211|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1466212|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1466213|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1466214|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1466215|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1466216|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1466217|NCT00904501|Limb ischemia|limb ischemia
1466218|NCT00904501|Cell Therapy|cell therapy
1466219|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
1466220|NCT00904488|Diuretics|diuretics
1466221|NCT00904436|Tetraplegia|tetraplegia
1466222|NCT00904436|Breathing Patterns|breathing patterns
1466223|NCT00904436|Dyspnea|dyspnea
1466224|NCT00904410|adenocarcinoma|adenocarcinoma
1466225|NCT00904410|breast|breast
1466226|NCT00904384|HIV+|hiv+
1466227|NCT00904384|COPD|copd
1466228|NCT00904384|emphysema|emphysema
1466229|NCT00904358|internal jugular vein|internal jugular vein
1466230|NCT00904358|cross sectional area|cross sectional area
1466231|NCT00904358|ultrasound|ultrasound
1466232|NCT00904358|central venous pressure|central venous pressure
1466233|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
1466234|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1466235|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
1466236|NCT00904332|Motor Learning|motor learning
1466237|NCT00904332|Health Volunteer|health volunteer
1466238|NCT00904332|HV|hv
1466239|NCT00904319|osteoarthritis|osteoarthritis
1466240|NCT00904319|knee pain|knee pain
1466241|NCT00904319|power training|power training
1466242|NCT00904319|rehabilitation|rehabilitation
1466243|NCT00904306|binge eating|binge eating
1466244|NCT00904306|chromium|chromium
1466245|NCT00904306|mood|mood
1466246|NCT00904306|glucose|glucose
1466247|NCT00904306|appetite|appetite
1466248|NCT00904293|warfarin|warfarin
1466249|NCT00904293|CYP2C9|cyp2c9
1466250|NCT00904293|VKOR|vkor
1466251|NCT00904293|Coumadin|coumadin
1466252|NCT00904293|pharmacogenetics|pharmacogenetics
1466253|NCT00904293|pharmacogenomics|pharmacogenomics
1466254|NCT00904293|anticoagulation|anticoagulation
1466255|NCT00904293|genotype-guided therapy|genotype-guided therapy
1466256|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
1466257|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
1466258|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
1466259|NCT00904254|monoclonal antibody|monoclonal antibody
1466260|NCT00904254|diagnostics|diagnostics
1466261|NCT00904254|molecular target|molecular target
1466262|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
1466263|NCT00904254|physiological effects of drugs|physiological effects of drugs
1466264|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
1466265|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
1466266|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
1466268|NCT00904228|hypothermia|hypothermia
1466269|NCT00904228|euthermia|euthermia
1466270|NCT00904228|hyperthermia|hyperthermia
1466271|NCT00904228|mortality|mortality
1466272|NCT00904228|morbidity|morbidity
1466273|NCT00904228|sepsis|sepsis
1466274|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1466275|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
1466276|NCT00904228|ventilator days|ventilator days
1466277|NCT00904150|menstruation|menstruation
1466278|NCT00904150|migraine|migraine
1466279|NCT00904150|menstrual migraine|menstrual migraine
1466280|NCT00904150|genetics|genetics
1466281|NCT00904137|Supracondylar fracture|supracondylar fracture
1466282|NCT00904137|humerus|humerus
1466283|NCT00904137|elbow|elbow
1466284|NCT00904124|Dietary fiber|dietary fiber
1466285|NCT00904124|guar gum|guar gum
1466286|NCT00904124|alginate|alginate
1466287|NCT00904124|cellulose|cellulose
1466288|NCT00904124|food intake|food intake
1466289|NCT00904124|eating behaviour|eating behaviour
1466290|NCT00904098|migraine|migraine
1466291|NCT00904072|CDSS|cdss
1466292|NCT00904072|prescribing error|prescribing error
1466293|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
1466294|NCT00904072|CPOE|cpoe
1466295|NCT00904046|Uric acid|uric acid
1466296|NCT00904046|Nephrolithiasis|nephrolithiasis
1466297|NCT00904007|Educational Technology|educational technology
1466298|NCT00904007|Hypertension|hypertension
1466299|NCT00904007|Education, Professional|education, professional
1466300|NCT00903994|Acute Pain|acute pain
1466301|NCT00903968|refractory|refractory
1466302|NCT00903968|relapsed|relapsed
1466303|NCT00903968|bortezomib|bortezomib
1466304|NCT00903968|AMD3100|amd3100
1466305|NCT00903968|plerixafor|plerixafor
1466306|NCT00903955|Mucus|mucus
1466307|NCT00903955|COPD|copd
1466308|NCT00903955|Chronic Bronchitis|chronic bronchitis
1466309|NCT00903916|antipsychotic|antipsychotic
1466310|NCT00903916|ghrelin|ghrelin
1466311|NCT00903916|PYY|pyy
1466312|NCT00903916|appetite|appetite
1466313|NCT00903916|weight gain|weight gain
1466314|NCT00903903|active synovitis|active synovitis
1466315|NCT00903838|Parkinson's disease|parkinson's disease
1466316|NCT00903825|femoral artery puncture|femoral artery puncture
1466317|NCT00903825|local anesthesia|local anesthesia
1466318|NCT00903825|ultrasound guided|ultrasound guided
1466319|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
1466320|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
1466321|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
1466322|NCT00903799|Long-term multicenter study|long-term multicenter study
1466323|NCT00903786|Seizure|seizure
1466324|NCT00903786|epilepsy|epilepsy
1466325|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
1466326|NCT00903773|VX-950-C132|vx-950-c132
1466327|NCT00903773|VX-950|vx-950
1466328|NCT00903773|HCV|hcv
1466329|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
1466330|NCT00903760|MDS|mds
1466331|NCT00903760|Leukemia|leukemia
1466332|NCT00903760|Decitabine|decitabine
1466333|NCT00903760|clofarabine|clofarabine
1466334|NCT00903760|Dacogen®|dacogen®
1466335|NCT00903760|Clolar®|clolar®
1466336|NCT00903747|Prucalopride|prucalopride
1466337|NCT00903747|safety study|safety study
1466338|NCT00903734|Metastatic Cancer|metastatic cancer
1466339|NCT00903734|Histology-independent|histology-independent
1466340|NCT00903734|EGFR Mutation|egfr mutation
1466341|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
1466342|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
1466343|NCT00903734|Tarceva|tarceva
1466344|NCT00903734|OSI-774|osi-774
1466345|NCT00903734|Cetuximab|cetuximab
1466346|NCT00903734|Bortezomib|bortezomib
1466347|NCT00903734|Dasatinib|dasatinib
1466348|NCT00903708|Advanced Cancers|advanced cancers
1466349|NCT00903708|LY2275796|ly2275796
1466350|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
1466351|NCT00903708|eIF-4E|eif-4e
1466352|NCT00903695|Memory XL|memory xl
1466353|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
1466354|NCT00903695|cognitive status|cognitive status
1466355|NCT00903682|HIV|hiv
1466356|NCT00903682|Intelence|intelence
1466357|NCT00903682|etravirine|etravirine
1466358|NCT00903682|ETR|etr
1466359|NCT00903682|TMC125|tmc125
1466360|NCT00903682|Sustiva|sustiva
1466361|NCT00903682|efavirenz|efavirenz
1466362|NCT00903682|EFV|efv
1611629|NCT00352352|Autism|autism
1466363|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
1466364|NCT00903682|NNRTI|nnrti
1466365|NCT00903682|treatment-naive|treatment-naive
1466366|NCT00903669|Facial paralysis|facial paralysis
1466367|NCT00903669|Muscle tonus|muscle tonus
1466761|NCT00902096|cord blood|cord blood
1466369|NCT00903669|Myofunctional|myofunctional
1466370|NCT00903669|Stomatognathic system|stomatognathic system
1466371|NCT00903656|metastatic breast cancer|metastatic breast cancer
1466372|NCT00903656|Her2|her2
1466373|NCT00903656|Lapatinib|lapatinib
1466374|NCT00903656|Caelyx|caelyx
1466375|NCT00903656|cardiotoxic|cardiotoxic
1466376|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
1466377|NCT00903643|Urinary Bladder|urinary bladder
1466378|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1466379|NCT00903630|fallopian tube cancer|fallopian tube cancer
1466380|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
1466381|NCT00903617|lipids|lipids
1466382|NCT00903617|HM74A|hm74a
1466383|NCT00903604|Cardiac surgery|cardiac surgery
1466384|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
1466385|NCT00903604|valve surgery|valve surgery
1466386|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
1466387|NCT00903604|Acute kidney injury|acute kidney injury
1466388|NCT00903591|Breast|breast
1466389|NCT00903591|cancer|cancer
1466390|NCT00903591|09-040|09-040
1466391|NCT00903591|blood sample|blood sample
1466392|NCT00903591|saliva sample|saliva sample
1466393|NCT00903591|WECARE|wecare
1466394|NCT00903591|GWA|gwa
1466395|NCT00903578|FGF-23|fgf-23
1466396|NCT00903578|vitamin D|vitamin d
1466397|NCT00903578|phosphate|phosphate
1466398|NCT00903578|allograft dysfunction|allograft dysfunction
1466399|NCT00903578|mortality|mortality
1466400|NCT00903565|genomic profiling|genomic profiling
1466401|NCT00903565|gene expression|gene expression
1466402|NCT00903565|ColoPrint|coloprint
1466403|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
1466404|NCT00903565|recurrence risk assessment|recurrence risk assessment
1466405|NCT00903565|prospective|prospective
1466406|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
1466407|NCT00903539|Central Venous Catheter|central venous catheter
1466408|NCT00903539|Intravenous Catheter|intravenous catheter
1466409|NCT00903539|StatLock|statlock
1466410|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
1466411|NCT00903526|fungal susceptibility|fungal susceptibility
1466412|NCT00903474|anxiety disorder|anxiety disorder
1466413|NCT00903474|depression|depression
1466414|NCT00903474|cognitive/functional effects|cognitive/functional effects
1466415|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1466416|NCT00903474|cancer survivor|cancer survivor
1466417|NCT00903474|breast cancer|breast cancer
1466418|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
1466419|NCT00903435|Cystitis|cystitis
1466420|NCT00903435|Urinary|urinary
1466421|NCT00903435|Bladder|bladder
1466422|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
1466423|NCT00903422|Thrombocytopenia|thrombocytopenia
1466424|NCT00903422|sAML/MDS|saml/mds
1466425|NCT00903422|Eltrombopag|eltrombopag
1466426|NCT00903422|TPO-R agonist|tpo-r agonist
1466427|NCT00903422|de novo AML|de novo aml
1466428|NCT00903422|Thrombopoietin|thrombopoietin
1466429|NCT00903422|MDS|mds
1466430|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
1466431|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
1466432|NCT00903422|Platelets|platelets
1466433|NCT00903409|High triglycerides|high triglycerides
1466434|NCT00903409|Lovaza|lovaza
1466435|NCT00903409|simvastatin|simvastatin
1466436|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
1466437|NCT00903396|nausea and vomiting|nausea and vomiting
1466438|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
1466439|NCT00903396|anal cancer|anal cancer
1466440|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
1466441|NCT00903396|colon cancer|colon cancer
1466442|NCT00903396|rectal cancer|rectal cancer
1466443|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
1466444|NCT00903396|gallbladder cancer|gallbladder cancer
1466445|NCT00903396|gastric cancer|gastric cancer
1466446|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1466447|NCT00903396|pancreatic cancer|pancreatic cancer
1466448|NCT00903396|small intestine cancer|small intestine cancer
1466449|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1466450|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
1466451|NCT00903370|Mitral Valve Surgery|mitral valve surgery
1466452|NCT00903370|Mitral Valve Disease|mitral valve disease
1466453|NCT00903370|Ablation, Catheter|ablation, catheter
1466454|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1466455|NCT00903357|Atopic dermatitis|atopic dermatitis
1466456|NCT00903357|Montelukast|montelukast
1466457|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1466458|NCT00903331|MUSIC|music
1466459|NCT00903318|Endocrine|endocrine
1466460|NCT00903318|Environmental Chemicals|environmental chemicals
1466461|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
1466462|NCT00903318|Phthalate Exposure|phthalate exposure
1466463|NCT00903318|Generational sex ratio trends|generational sex ratio trends
1466762|NCT00902096|IgE|ige
1466464|NCT00903318|Mexican American|mexican american
1466465|NCT00903318|Baytown|baytown
1466466|NCT00903318|Rio Grande Valley|rio grande valley
1466467|NCT00903318|Hidalgo County|hidalgo county
1466468|NCT00903318|Texas|texas
1466469|NCT00903305|pain|pain
1466470|NCT00903305|fatigue|fatigue
1466471|NCT00903305|nausea and vomiting|nausea and vomiting
1466472|NCT00903305|stage I breast cancer|stage i breast cancer
1466473|NCT00903305|stage II breast cancer|stage ii breast cancer
1466474|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
1466475|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
1466476|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
1466477|NCT00903292|EGFR|egfr
1466478|NCT00903292|NSCLC|nsclc
1466479|NCT00903292|EGFR mutation rate|egfr mutation rate
1466480|NCT00903279|MRSA colonization|mrsa colonization
1466481|NCT00903279|Orthopedic Surgery|orthopedic surgery
1466482|NCT00903279|Altabax|altabax
1466483|NCT00903279|Placebo|placebo
1466484|NCT00903266|Aphasia|aphasia
1466485|NCT00903266|Speech Impairment|speech impairment
1466486|NCT00903266|Stroke|stroke
1466487|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
1466488|NCT00903266|Cerebral Infarction|cerebral infarction
1466489|NCT00903266|Brain Ischemia|brain ischemia
1466490|NCT00903266|Brain Infarction|brain infarction
1466491|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
1466492|NCT00903227|Asthma|asthma
1466493|NCT00903227|Allergic rhinitis|allergic rhinitis
1466494|NCT00903227|fluticasone|fluticasone
1466495|NCT00903227|methacholine|methacholine
1466496|NCT00903214|stage I breast cancer|stage i breast cancer
1466497|NCT00903214|stage II breast cancer|stage ii breast cancer
1466498|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
1466499|NCT00903201|cystic fibrosis|cystic fibrosis
1466500|NCT00903188|Renal Transplantation|renal transplantation
1466501|NCT00903188|graft function|graft function
1466502|NCT00903188|cardiovascular events|cardiovascular events
1466503|NCT00903188|malignancy|malignancy
1466504|NCT00903188|cyclosporin|cyclosporin
1466505|NCT00903188|steroids|steroids
1466506|NCT00903188|mycophenolate|mycophenolate
1466507|NCT00903188|everolimus|everolimus
1466508|NCT00903188|renal biopsies|renal biopsies
1466509|NCT00903188|pharmacokinetics|pharmacokinetics
1466510|NCT00903175|RAD001|rad001
1466511|NCT00903175|everolimus|everolimus
1466512|NCT00903175|sunitinib|sunitinib
1466513|NCT00903175|renal cell carcinoma|renal cell carcinoma
1466514|NCT00903175|kidney cancer|kidney cancer
1466515|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
1466516|NCT00903175|advanced kidney cancer|advanced kidney cancer
1466517|NCT00903162|hormone-receptor positive|hormone-receptor positive
1466518|NCT00903162|tamoxifen|tamoxifen
1466519|NCT00903162|letrozole|letrozole
1466520|NCT00903162|zoledronic acid|zoledronic acid
1466521|NCT00903162|leuprolide|leuprolide
1466522|NCT00903149|Premature babies|premature babies
1466523|NCT00903149|Social interaction|social interaction
1466524|NCT00903149|Psychoeducative intervention|psychoeducative intervention
1466525|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
1466526|NCT00903149|Three years follow-up|three years follow-up
1466527|NCT00903149|Late preterm|late preterm
1466528|NCT00903149|Cognitive development|cognitive development
1466529|NCT00903149|Social development|social development
1466530|NCT00903149|Emotional development|emotional development
1466531|NCT00903149|Motor development|motor development
1466532|NCT00903149|Children born preterm and their parents|children born preterm and their parents
1466533|NCT00903136|Barrett esophagus|barrett esophagus
1466534|NCT00903136|esophageal cancer|esophageal cancer
1466535|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1466536|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
1466537|NCT00903084|Tenofovir|tenofovir
1466538|NCT00903084|Pharmacokinetics|pharmacokinetics
1466539|NCT00903084|Concentrations|concentrations
1466540|NCT00903084|Hair|hair
1466541|NCT00903071|Hypertension|hypertension
1466542|NCT00903071|Primary Care|primary care
1466543|NCT00903071|Physician Learning|physician learning
1466544|NCT00903045|Overactive bladder|overactive bladder
1466545|NCT00903045|Propiverin|propiverin
1466546|NCT00903032|compliance/adherence|compliance/adherence
1466547|NCT00903019|Homebound|homebound
1466548|NCT00903019|Older Adults|older adults
1466549|NCT00903019|Disability|disability
1466550|NCT00903019|Videoconferencing|videoconferencing
1466551|NCT00903006|Breast|breast
1466552|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
1466553|NCT00903006|Fulvestrant|fulvestrant
1466554|NCT00903006|Faslodex|faslodex
1466555|NCT00903006|MK-0646|mk-0646
1466556|NCT00903006|Dasatinib|dasatinib
1466557|NCT00903006|BMS-354825|bms-354825
1466558|NCT00903006|Sprycel|sprycel
1466559|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
1466560|NCT00902993|MAD|mad
1466561|NCT00902993|NNR|nnr
1466562|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
1466563|NCT00902993|AZD1446|azd1446
1466564|NCT00902980|Kidney transplantation|kidney transplantation
1466565|NCT00902980|Tacrolimus|tacrolimus
1466566|NCT00902980|Immunosuppression|immunosuppression
1466567|NCT00902967|Postoperative pain|postoperative pain
1466568|NCT00902967|atorvastatin|atorvastatin
1466569|NCT00902967|analgesic|analgesic
1466570|NCT00902967|antiinflammatory|antiinflammatory
1466571|NCT00902954|Disease free survival|disease free survival
1466572|NCT00902954|Distant disease free survival|distant disease free survival
1466573|NCT00902954|Toxicity|toxicity
1466574|NCT00902954|Overall survival|overall survival
1466575|NCT00902941|Parkinson´s disease|parkinson´s disease
1466576|NCT00902941|olfaction|olfaction
1466577|NCT00902941|rasagiline|rasagiline
1466578|NCT00902941|smell testing|smell testing
1466579|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
1466580|NCT00902928|Factor Xa|factor xa
1466581|NCT00902928|Venous Thromboembolism|venous thromboembolism
1466582|NCT00902928|Thrombosis|thrombosis
1466583|NCT00902928|Anticoagulants|anticoagulants
1466584|NCT00902928|Prevention|prevention
1466585|NCT00902928|YM150|ym150
1466586|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
1466587|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
1466588|NCT00902889|Globus pallidus|globus pallidus
1466589|NCT00902889|Huntington's Disease|huntington's disease
1466590|NCT00902889|Deep Brain Stimulation|deep brain stimulation
1466591|NCT00902889|Movement Disorders|movement disorders
1466592|NCT00902876|root coverage|root coverage
1466593|NCT00902876|gingival recession|gingival recession
1466594|NCT00902876|keratinized gingiva|keratinized gingiva
1466595|NCT00902863|chronic pain|chronic pain
1466596|NCT00902863|mindfulness|mindfulness
1466597|NCT00902863|yoga|yoga
1466598|NCT00902863|quality of life|quality of life
1466599|NCT00902863|stress|stress
1466600|NCT00902837|randomised|randomised
1466601|NCT00902837|double-blind|double-blind
1466602|NCT00902837|double-dummy|double-dummy
1466603|NCT00902837|parallel-group|parallel-group
1466604|NCT00902837|non-inferiority|non-inferiority
1466605|NCT00902837|pain locomotor function|pain locomotor function
1466606|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
1466607|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
1466608|NCT00902837|OXN PR|oxn pr
1466609|NCT00902837|OxyPR|oxypr
1466610|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
1466611|NCT00902824|HIV|hiv
1466612|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
1466613|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
1466614|NCT00902798|Autism|autism
1466615|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
1466616|NCT00902798|Asperger's Syndrome|asperger's syndrome
1466617|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
1466618|NCT00902798|Cognition|cognition
1466619|NCT00902798|Social Cognition|social cognition
1466620|NCT00902798|Psychosocial Treatment|psychosocial treatment
1466621|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
1466622|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
1466623|NCT00902798|Therapy|therapy
1466624|NCT00902798|Psychotherapy|psychotherapy
1466625|NCT00902785|exploratory|exploratory
1466626|NCT00902785|observational|observational
1466627|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
1466628|NCT00902772|Recreational CNS depressant|recreational cns depressant
1466629|NCT00902772|Abuse liability|abuse liability
1466630|NCT00902772|Abuse potential|abuse potential
1466631|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
1466632|NCT00902759|Surgery|surgery
1466633|NCT00902759|Chemotherapy|chemotherapy
1466634|NCT00902759|Radiation Therapy|radiation therapy
1466635|NCT00902759|Pancreatic cancer|pancreatic cancer
1466636|NCT00902759|Fatigue|fatigue
1466637|NCT00902733|pain|pain
1466638|NCT00902733|fatigue|fatigue
1466639|NCT00902733|nausea and vomiting|nausea and vomiting
1466640|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
1466641|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
1466642|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
1466643|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
1466644|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
1466645|NCT00902720|Ovarian|ovarian
1466646|NCT00902720|Tissue|tissue
1466647|NCT00902720|Cryopreservation|cryopreservation
1466648|NCT00902707|healthy nonsmokers|healthy nonsmokers
1466649|NCT00902694|Serious Mental Illness|serious mental illness
1466650|NCT00902694|Weight Loss|weight loss
1466651|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
1466652|NCT00902668|radiation toxicity|radiation toxicity
1466653|NCT00902668|stage IA breast cancer|stage ia breast cancer
1466654|NCT00902668|stage IB breast cancer|stage ib breast cancer
1466655|NCT00902668|stage II breast cancer|stage ii breast cancer
1466656|NCT00902668|breast cancer in situ|breast cancer in situ
1466657|NCT00902655|Nocturnal polyuria|nocturnal polyuria
1466658|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
1466659|NCT00902642|Physical therapy,|physical therapy,
1466660|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
1466661|NCT00902642|psychosocial factors,|psychosocial factors,
1466662|NCT00902642|dissimilation,|dissimilation,
1466663|NCT00902642|evidence based,|evidence based,
1466664|NCT00902642|education|education
1466665|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
1466666|NCT00902629|Macular Pucker|macular pucker
1466667|NCT00902616|Type 2 diabetes|type 2 diabetes
1466668|NCT00902616|Peripheral neuropathy|peripheral neuropathy
1466669|NCT00902616|Microcirculation|microcirculation
1466670|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
1466671|NCT00902603|Ventavis®|ventavis®
1466672|NCT00902603|iloprost|iloprost
1466673|NCT00902590|renal pelvis|renal pelvis
1466674|NCT00902590|ureter|ureter
1466675|NCT00902590|bladder|bladder
1466676|NCT00902590|09-025|09-025
1466677|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
1466678|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
1466679|NCT00902564|GAD|gad
1466680|NCT00902564|Antidepressant|antidepressant
1466681|NCT00902564|Anxiolytic|anxiolytic
1466682|NCT00902551|DNA cytometry|dna cytometry
1466683|NCT00902551|Cytology|cytology
1466684|NCT00902551|Diagnosis accuracy|diagnosis accuracy
1466685|NCT00902538|Add on treatment|add on treatment
1466686|NCT00902538|essential hypertension|essential hypertension
1466687|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
1466688|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
1466689|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
1466690|NCT00902473|Topiramate fed study|topiramate fed study
1466691|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
1466692|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
1466693|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
1466694|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1466695|NCT00902421|Overactive bladder|overactive bladder
1466696|NCT00902421|SSRI|ssri
1466697|NCT00902421|Antimuscarinics|antimuscarinics
1466698|NCT00902395|Preschool children|preschool children
1466699|NCT00902382|Infertility|infertility
1466700|NCT00902382|Ovulation stimulation|ovulation stimulation
1466701|NCT00902382|Pregnancy|pregnancy
1466702|NCT00902369|AK106-001616|ak106-001616
1466703|NCT00902356|Amgen|amgen
1466704|NCT00902356|Phase 1|phase 1
1466705|NCT00902356|First in Human|first in human
1466706|NCT00902356|Postmenopausal|postmenopausal
1466707|NCT00902343|Liver|liver
1466708|NCT00902343|Cancer|cancer
1466709|NCT00902343|Primary|primary
1466710|NCT00902343|Metastatic|metastatic
1466711|NCT00902343|transfusions|transfusions
1466712|NCT00902343|08-158|08-158
1466713|NCT00902330|depression|depression
1466714|NCT00902330|anxiety disorder|anxiety disorder
1466715|NCT00902330|fatigue|fatigue
1466716|NCT00902330|pain|pain
1466717|NCT00902330|sleep disorders|sleep disorders
1466718|NCT00902330|stage IA breast cancer|stage ia breast cancer
1466719|NCT00902330|stage IB breast cancer|stage ib breast cancer
1466720|NCT00902330|stage II breast cancer|stage ii breast cancer
1466721|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
1466722|NCT00902304|Hypertension|hypertension
1466723|NCT00902304|valsartan|valsartan
1466724|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
1466725|NCT00902291|Combination Drug Therapy|combination drug therapy
1466726|NCT00902291|Gemcitabine|gemcitabine
1466727|NCT00902291|AGS-1C4D4|ags-1c4d4
1466728|NCT00902291|Pancreatic Cancer|pancreatic cancer
1466729|NCT00902278|influenzavirus A|influenzavirus a
1466730|NCT00902278|influenzavirus B|influenzavirus b
1466731|NCT00902278|human influenza|human influenza
1466732|NCT00902278|T lymphocytes|t lymphocytes
1466733|NCT00902278|influenza vaccines|influenza vaccines
1466734|NCT00902226|Social Anxiety Disorder|social anxiety disorder
1466735|NCT00902226|SAD|sad
1466736|NCT00902226|Antidepressant|antidepressant
1466737|NCT00902226|Anxiolytic|anxiolytic
1466738|NCT00902200|Glaucoma|glaucoma
1466739|NCT00902200|Intraocular pressure|intraocular pressure
1466740|NCT00902187|Bioequivalence|bioequivalence
1466741|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
1466742|NCT00902174|Imatinib|imatinib
1466743|NCT00902174|6MWD|6mwd
1466744|NCT00902174|Borg scale|borg scale
1567382|NCT00509405|sarcopenia|sarcopenia
1466745|NCT00902174|Pulmonary hypertension|pulmonary hypertension
1466746|NCT00902148|Surgery|surgery
1466747|NCT00902148|Colectomy|colectomy
1466748|NCT00902148|Proctocolectomy|proctocolectomy
1466749|NCT00902148|Adhesions|adhesions
1466750|NCT00902135|Multiple Sclerosis|multiple sclerosis
1466751|NCT00902135|Interferon beta-1b|interferon beta-1b
1466752|NCT00902122|p53 gene|p53 gene
1466753|NCT00902122|thyroid|thyroid
1466754|NCT00902122|gene therapy|gene therapy
1466755|NCT00902122|malignant tumors|malignant tumors
1466756|NCT00902109|visual field|visual field
1466757|NCT00902109|perimetry|perimetry
1466758|NCT00902109|progression|progression
1466759|NCT00902109|POAG|poag
1466760|NCT00902109|glaucoma|glaucoma
1466766|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
1466767|NCT00902083|gene therapy|gene therapy
1466768|NCT00902083|malignant tumors|malignant tumors
1466769|NCT00902044|Refractory Sarcoma|refractory sarcoma
1466770|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
1466771|NCT00902044|Sarcoma|sarcoma
1466772|NCT00902044|HER2-positive|her2-positive
1466773|NCT00902044|Gene Therapy|gene therapy
1466774|NCT00902044|HER2-specific T cells|her2-specific t cells
1466775|NCT00902031|Docusate|docusate
1466776|NCT00902031|Constipation|constipation
1466777|NCT00902031|Colace|colace
1466778|NCT00902031|Palliative Care|palliative care
1466779|NCT00902031|Sennoside|sennoside
1466780|NCT00902031|Senokot|senokot
1466781|NCT00902031|Terminally Ill|terminally ill
1466782|NCT00902031|Stool|stool
1466783|NCT00902031|Randomized Trial|randomized trial
1466784|NCT00902018|ITP|itp
1466785|NCT00902005|Endothelial dysfunction|endothelial dysfunction
1466786|NCT00902005|Bone and cartilage markers|bone and cartilage markers
1466787|NCT00902005|Inflammatory disease activity|inflammatory disease activity
1466788|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
1466789|NCT00902005|Psoriatic arthritis|psoriatic arthritis
1466790|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
1466791|NCT00901992|type 2 diabetes|type 2 diabetes
1466792|NCT00901992|education|education
1466793|NCT00901992|self-management|self-management
1466794|NCT00901992|insulin therapy|insulin therapy
1466795|NCT00901979|Type 2 Diabetes|type 2 diabetes
1466796|NCT00901966|Melanoma|melanoma
1466797|NCT00901966|Sun Exposure History|sun exposure history
1466798|NCT00901966|Sun Exposure|sun exposure
1466799|NCT00901953|migraine|migraine
1466800|NCT00901953|migrainous vertigo|migrainous vertigo
1466801|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
1466802|NCT00901953|vestibular function test|vestibular function test
1466803|NCT00901953|vestibular disorders|vestibular disorders
1466804|NCT00901927|Lymphoma|lymphoma
1466805|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1466806|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
1466807|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
1466808|NCT00901927|Bendamustine HCI|bendamustine hci
1466809|NCT00901927|Bendamustine|bendamustine
1466810|NCT00901927|CEP-18083|cep-18083
1466811|NCT00901927|SDX-105|sdx-105
1466812|NCT00901927|Treanda|treanda
1466813|NCT00901927|Mitoxantrone|mitoxantrone
1466814|NCT00901927|Novantrone|novantrone
1466815|NCT00901927|Rituximab|rituximab
1466816|NCT00901927|Rituxan|rituxan
1466817|NCT00901914|Hypersensitivity|hypersensitivity
1466818|NCT00901914|Allergy|allergy
1466819|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
1466820|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
1466821|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
1466822|NCT00901901|First Line|first line
1466823|NCT00901901|HCC|hcc
1466824|NCT00901888|Renin Angiotensin System|renin angiotensin system
1466825|NCT00901875|Buprenorphine|buprenorphine
1466826|NCT00901875|Naloxone|naloxone
1466827|NCT00901875|Suboxone|suboxone
1466828|NCT00901862|Migraine|migraine
1466829|NCT00901862|therapy|therapy
1466830|NCT00901862|magnetic therapy|magnetic therapy
1466831|NCT00901862|prophylaxis|prophylaxis
1466832|NCT00901862|prevention|prevention
1466833|NCT00901836|Sarcoma|sarcoma
1466834|NCT00901810|Length Determination|length determination
1466835|NCT00901810|Working Length|working length
1466836|NCT00901810|Electronic Apex Locator|electronic apex locator
1466837|NCT00901810|Root Canal Therapy|root canal therapy
1466838|NCT00901810|Endodontics|endodontics
1466839|NCT00901797|ABD|abd
1466840|NCT00901797|ABDuction|abduction
1466841|NCT00901797|ABR|abr
1466842|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
1466843|NCT00901797|ACJ|acj
1466844|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
1466845|NCT00901797|AD|ad
1466846|NCT00901797|Anterior Drawer|anterior drawer
1466847|NCT00901797|ARIC|aric
1466848|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
1466849|NCT00901797|BL|bl
1466850|NCT00901797|Bankart Lesion|bankart lesion
1466851|NCT00901797|CHL|chl
1466852|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
1466853|NCT00901797|ER|er
1466854|NCT00901797|External Rotation|external rotation
1466855|NCT00901797|FF|ff
1466856|NCT00901797|Forward Flexion|forward flexion
1466857|NCT00901797|GHJ|ghj
1466858|NCT00901797|GlenoHumeral Joint|glenohumeral joint
1466859|NCT00901797|HSL|hsl
1466860|NCT00901797|HillSacs Lesion|hillsacs lesion
1466861|NCT00901797|IR|ir
1466862|NCT00901797|Internal Rotation|internal rotation
1466863|NCT00901797|ISP|isp
1466864|NCT00901797|InfraSPinatus|infraspinatus
1466865|NCT00901797|PD|pd
1466866|NCT00901797|Posterior Drawer|posterior drawer
1466867|NCT00901797|RI|ri
1466868|NCT00901797|Rotator Interval|rotator interval
1466869|NCT00901797|ROM|rom
1466870|NCT00901797|Range Of Motion|range of motion
1466871|NCT00901797|SGHL|sghl
1466872|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
1466873|NCT00901797|SSC|ssc
1466874|NCT00901797|SubSCapularis|subscapularis
1466875|NCT00901797|SSP|ssp
1466876|NCT00901797|SupraSPinatus|supraspinatus
1466877|NCT00901784|Topiramate fasting study|topiramate fasting study
1466878|NCT00901771|Sleep|sleep
1466879|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
1466880|NCT00901771|OSA|osa
1466881|NCT00901771|OSAH|osah
1466882|NCT00901745|Renin angiotensin system|renin angiotensin system
1466883|NCT00901745|Apelin|apelin
1466884|NCT00901745|Vasodilatation|vasodilatation
1466885|NCT00901745|Heart disease|heart disease
1466886|NCT00901745|Vascular biology|vascular biology
1466887|NCT00901732|Caphosol|caphosol
1466888|NCT00901732|Oral Mucositis|oral mucositis
1466889|NCT00901732|Eusa Pharma|eusa pharma
1466890|NCT00901732|Moffitt Cancer Center|moffitt cancer center
1466891|NCT00901719|Renin angiotensin system|renin angiotensin system
1466892|NCT00901719|Apelin|apelin
1466893|NCT00901719|Cardiac output|cardiac output
1466894|NCT00901719|Vasodilatation|vasodilatation
1466895|NCT00901706|Self-Neglect|self-neglect
1466896|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
1466897|NCT00901706|Geriatric Syndromes|geriatric syndromes
1466898|NCT00901706|Quality of Life|quality of life
1466899|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
1466900|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
1466901|NCT00901693|pink eye|pink eye
1466902|NCT00901693|eye infection|eye infection
1466903|NCT00901693|conjunctivitis|conjunctivitis
1466904|NCT00901680|Tissue Bank|tissue bank
1466905|NCT00901654|Vaccination|vaccination
1466906|NCT00901654|Diarrhea|diarrhea
1466907|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
1466908|NCT00901654|ETEC|etec
1466909|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
1466910|NCT00901641|cognitive training|cognitive training
1466911|NCT00901641|insomnia|insomnia
1466912|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
1466913|NCT00901615|lymphoma|lymphoma
1466914|NCT00901615|lenalidomide|lenalidomide
1466915|NCT00901615|gela|gela
1466916|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
1466917|NCT00901602|pneumococcus|pneumococcus
1466918|NCT00901602|pneumonia|pneumonia
1466919|NCT00901602|meningitis|meningitis
1466920|NCT00901602|serotypes|serotypes
1466921|NCT00901602|bacteremia|bacteremia
1466922|NCT00901602|sepsis|sepsis
1466923|NCT00901589|n-3 PUFAs|n-3 pufas
1466924|NCT00901589|menopause|menopause
1466925|NCT00901589|adipose tissue|adipose tissue
1466926|NCT00901589|estrogens|estrogens
1466927|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
1466928|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
1466929|NCT00901576|Healthy volunteers|healthy volunteers
1466930|NCT00901563|Gap Junctions|gap junctions
1466931|NCT00901563|Rotigaptide|rotigaptide
1466932|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
1466933|NCT00901563|t-PA|t-pa
1466934|NCT00901563|Fibrinolysis|fibrinolysis
1466935|NCT00901563|Endothelial function|endothelial function
1466936|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
1466937|NCT00901550|MTX|mtx
1466938|NCT00901550|anti-TNF|anti-tnf
1466939|NCT00901550|Early RA|early ra
1466940|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
1466941|NCT00901537|Head and Neck Cancer|head and neck cancer
1466942|NCT00901537|Azacitidine|azacitidine
1466943|NCT00901537|Vidaza|vidaza
1466944|NCT00901537|Cisplatin|cisplatin
1466945|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
1466946|NCT00901524|Virological response|virological response
1466947|NCT00901524|Ribavirin|ribavirin
1466948|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
1466949|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
1466950|NCT00901511|Whole lung lavage|whole lung lavage
1466951|NCT00901511|Pulmonary surfactant|pulmonary surfactant
1466952|NCT00901511|GM-CSF|gm-csf
1466953|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
1466954|NCT00901485|Respiratory insufficiency|respiratory insufficiency
1466955|NCT00901485|Hypercapnia|hypercapnia
1466956|NCT00901485|Hypoventilation|hypoventilation
1466957|NCT00901485|Sleep|sleep
1466958|NCT00901485|Polysomnography|polysomnography
1466959|NCT00901485|Hypoxia|hypoxia
1466960|NCT00901485|Titration|titration
1466961|NCT00901485|Non Invasive Ventilation|non invasive ventilation
1466962|NCT00901472|Type 2 diabetes,|type 2 diabetes,
1466963|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
1466964|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1466965|NCT00901459|Cigarette Smoker|cigarette smoker
1466966|NCT00901459|Cigarette Dependence|cigarette dependence
1466967|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
1466968|NCT00901433|Asthma|asthma
1466969|NCT00901433|Wheeze Rate|wheeze rate
1466970|NCT00901433|Respiratory Function Tests|respiratory function tests
1466971|NCT00901420|Prostate|prostate
1466972|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
1470468|NCT00894803|blood clot|blood clot
1466973|NCT00901420|Prostatectomy|prostatectomy
1466974|NCT00901420|Salvage prostatectomy|salvage prostatectomy
1466975|NCT00901420|Bladder compliance|bladder compliance
1466976|NCT00901420|Radiation Therapy|radiation therapy
1466977|NCT00901420|External beam radiation therapy|external beam radiation therapy
1466978|NCT00901420|Quality-of-life|quality-of-life
1466979|NCT00901407|augmentation|augmentation
1466980|NCT00901407|depression|depression
1466981|NCT00901407|resistance|resistance
1466982|NCT00901394|Nitrous oxide|nitrous oxide
1466983|NCT00901394|cobalamin|cobalamin
1466984|NCT00901394|homocysteine|homocysteine
1466985|NCT00901394|vitamin B12|vitamin b12
1466986|NCT00901394|folate|folate
1466987|NCT00901394|No specific diseases targeted|no specific diseases targeted
1466988|NCT00901381|Ischemic stroke|ischemic stroke
1466989|NCT00901381|Stem cells|stem cells
1466990|NCT00901381|Colony-stimulating factors|colony-stimulating factors
1466991|NCT00901381|Filgrastim|filgrastim
1466992|NCT00901381|Randomized controlled trial|randomized controlled trial
1466993|NCT00901355|Blood pressure|blood pressure
1466994|NCT00901355|Arterial stiffness|arterial stiffness
1466995|NCT00901355|Morbidity|morbidity
1466996|NCT00901355|Mortality|mortality
1466997|NCT00901355|Elderly|elderly
1466998|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
1466999|NCT00901342|CRPC|crpc
1467000|NCT00901342|prostate cancer|prostate cancer
1467001|NCT00901342|prostate|prostate
1467002|NCT00901342|immune therapy|immune therapy
1467003|NCT00901342|immunotherapy|immunotherapy
1467004|NCT00901342|vaccine|vaccine
1467005|NCT00901342|dendritic cells|dendritic cells
1467006|NCT00901342|antigen-presenting cells|antigen-presenting cells
1467007|NCT00901342|antigen presenting cells|antigen presenting cells
1467008|NCT00901342|cancer vaccine|cancer vaccine
1467009|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
1467010|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
1467011|NCT00901329|TKA|tka
1467012|NCT00901329|functional outcome|functional outcome
1467013|NCT00901329|pain|pain
1467014|NCT00901329|ROM|rom
1467015|NCT00901329|gait|gait
1467016|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
1467017|NCT00901316|Abscesses|abscesses
1467018|NCT00901316|Boils|boils
1467019|NCT00901316|Clorox Baths|clorox baths
1467020|NCT00901316|Colonization|colonization
1467021|NCT00901316|Staph|staph
1467022|NCT00901316|MRSA|mrsa
1467023|NCT00901316|MSSA|mssa
1467024|NCT00901316|Recurrent Infections|recurrent infections
1467025|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
1467026|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
1467027|NCT00901290|oral contraceptive|oral contraceptive
1467028|NCT00901277|Post MI|post mi
1467029|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
1467030|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
1467031|NCT00901251|OABSS|oabss
1467032|NCT00901238|retinoblastoma|retinoblastoma
1467033|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
1467034|NCT00901238|chemosurgery|chemosurgery
1467035|NCT00901238|melphalan|melphalan
1467036|NCT00901238|topotecan|topotecan
1467037|NCT00901225|NHL|nhl
1467038|NCT00901212|Heart Failure|heart failure
1467039|NCT00901212|resynchronisation|resynchronisation
1467040|NCT00901212|ICD|icd
1467041|NCT00901199|Thalassemia|thalassemia
1467042|NCT00901199|Chelation|chelation
1467043|NCT00901199|Iron Overload|iron overload
1467044|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
1467045|NCT00901186|Diabetic Macular Edema|diabetic macular edema
1467046|NCT00901186|Ranibizumab|ranibizumab
1467047|NCT00901186|Laser Treatment|laser treatment
1467048|NCT00901186|Visual impairment|visual impairment
1467049|NCT00901173|Case-Control Study|case-control study
1467050|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
1467051|NCT00901173|Risk Factors|risk factors
1467052|NCT00901160|thromboelastography|thromboelastography
1467053|NCT00901160|post-operative complications|post-operative complications
1467054|NCT00901160|anti-platelet agents|anti-platelet agents
1467055|NCT00901160|prospective|prospective
1467056|NCT00901160|pilot|pilot
1467057|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
1467058|NCT00901147|t-cell lymphoma|t-cell lymphoma
1467059|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
1467060|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
1467061|NCT00901147|bortezomib|bortezomib
1467062|NCT00901147|velcade|velcade
1467063|NCT00901147|panobinostat|panobinostat
1467064|NCT00901147|LBH589b|lbh589b
1467065|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
1467066|NCT00901147|proteasome inhibitor|proteasome inhibitor
1467067|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
1467068|NCT00901121|maxillary sinus lift|maxillary sinus lift
1467069|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
1467070|NCT00901121|bone graft|bone graft
1467071|NCT00901121|bone augmentation|bone augmentation
1467072|NCT00901108|open angle glaucoma|open angle glaucoma
1467073|NCT00901108|trabectome|trabectome
1467074|NCT00901108|trabeculectomy|trabeculectomy
1467075|NCT00901108|cataract|cataract
1467076|NCT00901082|chronic pain|chronic pain
1467077|NCT00901082|anxiety|anxiety
1467078|NCT00901082|intervention|intervention
1467079|NCT00901082|information|information
1467080|NCT00901082|relaxation|relaxation
1467081|NCT00901056|ED|ed
1467082|NCT00901056|Erectile Dysfunction|erectile dysfunction
1467083|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
1467084|NCT00901030|platelet function|platelet function
1467085|NCT00901030|perioperative complications|perioperative complications
1467086|NCT00901030|thromboelastography|thromboelastography
1467087|NCT00901030|coronary stents|coronary stents
1467088|NCT00901030|non-cardiac surgery|non-cardiac surgery
1467089|NCT00901004|Minimal Change|minimal change
1467090|NCT00901004|GERD|gerd
1467091|NCT00901004|GERDQ|gerdq
1467092|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
1467093|NCT00900991|Immunogenictiy|immunogenictiy
1467094|NCT00900991|Safety|safety
1467095|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
1467096|NCT00900978|carriage|carriage
1467097|NCT00900978|Resistance|resistance
1467098|NCT00900978|Serotype|serotype
1467099|NCT00900978|vaccination|vaccination
1467100|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
1467101|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
1467102|NCT00900965|IBS|ibs
1467103|NCT00900965|fMRI|fmri
1467104|NCT00900965|acupuncture|acupuncture
1467105|NCT00900965|functional|functional
1467106|NCT00900965|brain|brain
1467107|NCT00900900|Cigarette Smokers|cigarette smokers
1467108|NCT00900900|DHEA|dhea
1467109|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
1467110|NCT00900900|pregnenolone|pregnenolone
1467111|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
1467112|NCT00900887|diabetic retinopathy|diabetic retinopathy
1467113|NCT00900887|clinically significant macular edema|clinically significant macular edema
1467114|NCT00900887|selective photocoagulation|selective photocoagulation
1467115|NCT00900887|topic ketorolac|topic ketorolac
1467116|NCT00900887|topic nepafenac|topic nepafenac
1467117|NCT00900887|efficacy|efficacy
1467118|NCT00900887|treatment|treatment
1467119|NCT00900874|Formoterol|formoterol
1467120|NCT00900874|Rapid bronchodilation|rapid bronchodilation
1467121|NCT00900861|asthma control level|asthma control level
1467122|NCT00900861|visual analogue scale|visual analogue scale
1467123|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
1467124|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
1467125|NCT00900848|Shock|shock
1467126|NCT00900848|Reconstruction|reconstruction
1467127|NCT00900835|fatigue|fatigue
1467128|NCT00900835|pain|pain
1467129|NCT00900835|recurrent breast cancer|recurrent breast cancer
1467130|NCT00900835|stage I breast cancer|stage i breast cancer
1467131|NCT00900835|stage II breast cancer|stage ii breast cancer
1467132|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
1467133|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
1467134|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
1467135|NCT00900835|stage IV breast cancer|stage iv breast cancer
1467444|NCT00900302|stage IIA melanoma|stage iia melanoma
1467136|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
1467137|NCT00900835|stage I prostate cancer|stage i prostate cancer
1467138|NCT00900835|stage II prostate cancer|stage ii prostate cancer
1467139|NCT00900835|stage III prostate cancer|stage iii prostate cancer
1467140|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
1467141|NCT00900835|recurrent colon cancer|recurrent colon cancer
1467142|NCT00900835|stage I colon cancer|stage i colon cancer
1467143|NCT00900835|stage II colon cancer|stage ii colon cancer
1467144|NCT00900835|stage III colon cancer|stage iii colon cancer
1467145|NCT00900835|stage IV colon cancer|stage iv colon cancer
1467146|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1612649|NCT00348049|PRK|prk
1467147|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
1467148|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1467149|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
1467150|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1467151|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1467152|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1467153|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1467154|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1467155|NCT00900822|bone grafting|bone grafting
1467156|NCT00900822|sinus elevation|sinus elevation
1467157|NCT00900822|sinus augmentation|sinus augmentation
1467158|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
1467159|NCT00900809|Neukoplast™|neukoplast™
1467161|NCT00900809|Refractory|refractory
1467162|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
1467163|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
1467164|NCT00900783|herpes zoster|herpes zoster
1467165|NCT00900783|shingles|shingles
1467166|NCT00900783|Phase II|phase ii
1467167|NCT00900783|FV-100|fv-100
1467168|NCT00900783|Inhibitex|inhibitex
1467169|NCT00900770|dementia|dementia
1467170|NCT00900770|mild cognitive impairment|mild cognitive impairment
1467171|NCT00900770|beta amyloid|beta amyloid
1467172|NCT00900757|Primary Glioma|primary glioma
1467173|NCT00900757|Palonosetron|palonosetron
1467174|NCT00900757|Standard Radiotherapy|standard radiotherapy
1467175|NCT00900757|Temozolomide|temozolomide
1467176|NCT00900744|Tamoxifen|tamoxifen
1467177|NCT00900744|Breast Cancer|breast cancer
1467178|NCT00900731|COPD|copd
1467179|NCT00900731|indacaterol|indacaterol
1467180|NCT00900731|beta 2 agonist|beta 2 agonist
1467181|NCT00900731|tiotropium|tiotropium
1467182|NCT00900692|Excessive pronation|excessive pronation
1467183|NCT00900692|CVA|cva
1467184|NCT00900692|Forearm|forearm
1467185|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
1467186|NCT00900679|transitional care planning|transitional care planning
1467187|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1467188|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1467189|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1467190|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1467191|NCT00900666|Stiff knee gait|stiff knee gait
1467192|NCT00900666|Gait analysis|gait analysis
1467193|NCT00900666|Traumatic Brain Injury|traumatic brain injury
1467194|NCT00900666|Acquired Brain Injury|acquired brain injury
1467195|NCT00900653|urinary tract infections|urinary tract infections
1467196|NCT00900653|postmenopause|postmenopause
1467197|NCT00900653|lactobacillus|lactobacillus
1467198|NCT00900653|estriol|estriol
1467199|NCT00900627|Cancer|cancer
1467200|NCT00900627|Tumour|tumour
1467201|NCT00900627|Breast cancer|breast cancer
1467202|NCT00900627|Metastatic|metastatic
1467203|NCT00900627|Secondary|secondary
1467204|NCT00900614|Hematologic malignancy|hematologic malignancy
1467205|NCT00900614|Prostate carcinoma|prostate carcinoma
1467206|NCT00900614|Hematologic cancer|hematologic cancer
1467207|NCT00900614|Prostate cancer|prostate cancer
1467208|NCT00900601|Sacroiliac pain|sacroiliac pain
1467209|NCT00900601|Sacroiliac instability|sacroiliac instability
1467210|NCT00900601|Pelvic girdle pain|pelvic girdle pain
1467211|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
1467212|NCT00900601|Arthrodesis|arthrodesis
1467213|NCT00900601|Surgery|surgery
1467214|NCT00900588|immunogenictiy|immunogenictiy
1467215|NCT00900588|safety|safety
1467216|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
1467217|NCT00900575|cervical cancer|cervical cancer
1467218|NCT00900575|LEEP|leep
1467219|NCT00900575|colposcopy|colposcopy
1467220|NCT00900562|Zalypsis|zalypsis
1467221|NCT00900562|Cancer|cancer
1467222|NCT00900562|Endometrial|endometrial
1467223|NCT00900562|Uterine Cervical|uterine cervical
1467224|NCT00900562|PharmaMar|pharmamar
1467225|NCT00900549|Heart failure|heart failure
1467226|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
1467227|NCT00900549|ICD|icd
1467228|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1467229|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
1467230|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
1467231|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
1467232|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
1467233|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
1467234|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1467235|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1467236|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1467237|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1567383|NCT00509405|hypertension|hypertension
1467238|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1467239|NCT00900510|subcutaneous abscess|subcutaneous abscess
1467240|NCT00900510|Incision and drainage|incision and drainage
1467241|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
1467242|NCT00900497|granulocytes|granulocytes
1467243|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
1467244|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1467245|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1467246|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1467247|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1467248|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1467249|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1467250|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1467251|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1467252|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1467253|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1470860|NCT00892983|Obesity|obesity
1470861|NCT00892983|Sleep|sleep
1467254|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1467255|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1467256|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1467257|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1467258|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1467259|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1467260|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1467261|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1467262|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1467263|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1467264|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1467265|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1467266|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1467267|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1467268|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1467269|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1467270|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1467271|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1467272|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1467273|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1467274|NCT00900458|preeclampsia|preeclampsia
1467275|NCT00900458|low vs high plasma volume|low vs high plasma volume
1467276|NCT00900445|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1467277|NCT00900445|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1467278|NCT00900432|recurrent colon cancer|recurrent colon cancer
1467279|NCT00900432|stage I colon cancer|stage i colon cancer
1467280|NCT00900432|stage II colon cancer|stage ii colon cancer
1467281|NCT00900432|stage III colon cancer|stage iii colon cancer
1467282|NCT00900432|stage IV colon cancer|stage iv colon cancer
1467283|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
1467284|NCT00900419|small cell lung cancer|small cell lung cancer
1467285|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
1467286|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
1467287|NCT00900419|laryngeal cancer|laryngeal cancer
1467288|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
1467289|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1467290|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
1467291|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
1467292|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1467293|NCT00900419|salivary gland cancer|salivary gland cancer
1467294|NCT00900419|esophageal cancer|esophageal cancer
1467295|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1467296|NCT00900419|tongue cancer|tongue cancer
1467297|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1467298|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1467299|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1467300|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1467301|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1467302|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1467303|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1567472|NCT00509080|BNP|bnp
1467304|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1467305|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1467306|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1467307|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1467308|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1467309|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1467310|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1467311|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1467312|NCT00900367|breast cancer|breast cancer
1467313|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1467314|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
1467315|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1467316|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
1467317|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1467318|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1467319|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1467320|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1467321|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1467322|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1467323|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1467324|NCT00900302|male breast cancer|male breast cancer
1467325|NCT00900302|recurrent breast cancer|recurrent breast cancer
1467326|NCT00900302|stage IA breast cancer|stage ia breast cancer
1467327|NCT00900302|stage IB breast cancer|stage ib breast cancer
1467328|NCT00900302|stage II breast cancer|stage ii breast cancer
1467329|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
1467330|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
1467331|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
1467332|NCT00900302|stage IV breast cancer|stage iv breast cancer
1467333|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1467334|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1467335|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1467336|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1467337|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1467338|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
1467339|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1467340|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
1467341|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
1467342|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
1467343|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1467344|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1467345|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1467346|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1467347|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1467348|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1467349|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1467350|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1467351|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1467352|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1467353|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1467354|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1467355|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1467356|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1467357|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1467358|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1467359|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1467360|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1467361|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1467362|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1467363|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1467364|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1467365|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1467366|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1467367|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1467368|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1467369|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1467370|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1467371|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1467372|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1467373|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1467374|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1467375|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1467376|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1467377|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1467378|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1467379|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1467380|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1467533|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
1467381|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1467382|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1467383|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1467384|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1467385|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1467386|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1467387|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
1467388|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
1467389|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
1467390|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
1467391|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
1467392|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1467393|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1467394|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
1467395|NCT00900302|recurrent anal cancer|recurrent anal cancer
1467396|NCT00900302|stage I anal cancer|stage i anal cancer
1467397|NCT00900302|stage II anal cancer|stage ii anal cancer
1467398|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
1467399|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
1467400|NCT00900302|stage IV anal cancer|stage iv anal cancer
1467401|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
1467402|NCT00900302|stage I bladder cancer|stage i bladder cancer
1467403|NCT00900302|stage II bladder cancer|stage ii bladder cancer
1467404|NCT00900302|stage III bladder cancer|stage iii bladder cancer
1467405|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
1467406|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
1467407|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
1467408|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
1467409|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
1467410|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
1467411|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
1467412|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
1467413|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
1467414|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
1467415|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
1467416|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
1467417|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
1467418|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
1467419|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
1467420|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
1467421|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
1467422|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
1467423|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
1467424|NCT00900302|stage III cervical cancer|stage iii cervical cancer
1467425|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
1467426|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
1467427|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1467428|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1467429|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1467430|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1467431|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1467432|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1467433|NCT00900302|recurrent skin cancer|recurrent skin cancer
1467434|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1467435|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1467436|NCT00900302|recurrent penile cancer|recurrent penile cancer
1467437|NCT00900302|stage I penile cancer|stage i penile cancer
1467438|NCT00900302|stage II penile cancer|stage ii penile cancer
1467439|NCT00900302|stage III penile cancer|stage iii penile cancer
1467440|NCT00900302|stage IV penile cancer|stage iv penile cancer
1467441|NCT00900302|recurrent melanoma|recurrent melanoma
1467442|NCT00900302|stage IA melanoma|stage ia melanoma
1467443|NCT00900302|stage IB melanoma|stage ib melanoma
1467445|NCT00900302|stage IIB melanoma|stage iib melanoma
1467446|NCT00900302|stage IIC melanoma|stage iic melanoma
1467447|NCT00900302|stage IIIA melanoma|stage iiia melanoma
1467448|NCT00900302|stage IIIB melanoma|stage iiib melanoma
1467449|NCT00900302|stage IIIC melanoma|stage iiic melanoma
1467450|NCT00900302|stage IV melanoma|stage iv melanoma
1467451|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1467452|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1467453|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1467454|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1467455|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1467456|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1471255|NCT00891579|NSCLC|nsclc
1467457|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1467458|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1467459|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1467460|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1467461|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1467462|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1467463|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1467464|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
1467465|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
1467466|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
1467467|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
1467468|NCT00900276|stage I bladder cancer|stage i bladder cancer
1467469|NCT00900276|stage II bladder cancer|stage ii bladder cancer
1467470|NCT00900276|stage III bladder cancer|stage iii bladder cancer
1467471|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
1467472|NCT00900276|anterior urethral cancer|anterior urethral cancer
1467473|NCT00900276|posterior urethral cancer|posterior urethral cancer
1467474|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
1467475|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1467476|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
1467477|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1467478|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1467479|NCT00900237|Partial|partial
1467480|NCT00900237|Epilepsy|epilepsy
1467481|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
1467482|NCT00900237|Pharmacokinetics|pharmacokinetics
1467483|NCT00900237|Tolerability|tolerability
1467484|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1467485|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1467486|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1467487|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1467488|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1467489|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1467490|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1467491|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1467492|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1467493|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1467494|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1467495|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1467496|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
1467497|NCT00900211|adult angiosarcoma|adult angiosarcoma
1467498|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
1467499|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1613226|NCT00345839|CKD|ckd
1467500|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
1467501|NCT00900211|adult liposarcoma|adult liposarcoma
1467502|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1467503|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1467504|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
1467505|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
1467506|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
1467507|NCT00900198|Tissue Collection|tissue collection
1467508|NCT00900198|Biospecimen|biospecimen
1467509|NCT00900198|Assay Development|assay development
1467510|NCT00900198|Tissue Acquisition|tissue acquisition
1467511|NCT00900198|Tissue Biopsies|tissue biopsies
1467512|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
1467513|NCT00900185|stage I prostate cancer|stage i prostate cancer
1467514|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
1467515|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
1467516|NCT00900185|stage III prostate cancer|stage iii prostate cancer
1467517|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
1467518|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1467519|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1467520|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1467521|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
1467522|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1467523|NCT00900159|Shift-work|shift-work
1467524|NCT00900159|SWSD|swsd
1467525|NCT00900159|eszopiclone|eszopiclone
1467526|NCT00900159|MWT|mwt
1467527|NCT00900159|shiftworkers|shiftworkers
1467528|NCT00900146|type 2 diabetes|type 2 diabetes
1467529|NCT00900146|canakinumab|canakinumab
1467530|NCT00900133|stage I breast cancer|stage i breast cancer
1467531|NCT00900133|stage II breast cancer|stage ii breast cancer
1469503|NCT00897780|Headache|headache
1467532|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
1467534|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
1467535|NCT00900120|aplastic anemia|aplastic anemia
1467536|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1467537|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1467538|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1467539|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1467540|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1467541|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
1467542|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1467543|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1467544|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1467545|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1467546|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1467547|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1467548|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1467549|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1467550|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1467551|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1467552|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1467553|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1467554|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1467555|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1467556|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1467557|NCT00900120|mast cell leukemia|mast cell leukemia
1467558|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1467559|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1467560|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
1467561|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1467562|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1467563|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1467564|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1467565|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1467566|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1467567|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
1467568|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1467569|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1467570|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1467571|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1467572|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1467573|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1467574|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1467575|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1467576|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1467577|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1467578|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1467579|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1467580|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1467581|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1467582|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1467583|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1467584|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
1467585|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1467586|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1467587|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1467588|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1467589|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1467590|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1467591|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1467592|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1467593|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1467594|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1467595|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1468233|NCT00899626|colon cancer|colon cancer
1467596|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1467597|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1467598|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1467599|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1467600|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1467601|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1467602|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1467603|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1467604|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1467605|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1467606|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1467607|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1467608|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1467609|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1467610|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1467611|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1467612|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1467613|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1467614|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1467615|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1467616|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1467617|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1467618|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1467619|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1467620|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1467621|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1467622|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1467623|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1467624|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1467625|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1467626|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1467627|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1467628|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1467629|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1567473|NCT00509080|NT-proBNP|nt-probnp
1467630|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1467631|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1467632|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1467633|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1467634|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1467635|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1467636|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1467637|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1467638|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1467639|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1467640|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1467641|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1467642|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1467643|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1467644|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1467645|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1467646|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1467647|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1467648|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1467649|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1467650|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1467651|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1467652|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1467653|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1467654|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1467717|NCT00900120|intraocular lymphoma|intraocular lymphoma
1467655|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1468234|NCT00899626|esophageal cancer|esophageal cancer
1467656|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1467657|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1467658|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1467659|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1467660|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1467661|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1467662|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1467663|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1467664|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1467665|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1467666|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1467667|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1467668|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1467669|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1467670|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1467671|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1467672|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1467673|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1467674|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1467675|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1467676|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1467677|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1467678|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1467679|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1467680|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1467681|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1467682|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1467683|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1467684|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1467685|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1467686|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1467687|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1467688|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1467689|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1467690|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1467691|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1467692|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1467693|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1467694|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1467695|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1467696|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1467697|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1467698|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1467699|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1467700|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1467701|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1467702|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1467703|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1467704|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1467705|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1467706|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1467707|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1467708|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1467709|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1467710|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1467711|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1467712|NCT00900120|Burkitt lymphoma|burkitt lymphoma
1467713|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1467714|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1467715|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1467716|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1467718|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1467719|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1467720|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1467721|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1467722|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1467723|NCT00900120|primary myelofibrosis|primary myelofibrosis
1467724|NCT00900120|essential thrombocythemia|essential thrombocythemia
1467725|NCT00900120|polycythemia vera|polycythemia vera
1467726|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
1467727|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1467728|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
1467729|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
1467730|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
1467731|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
1467732|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
1467733|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1467734|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1467735|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1467736|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1467737|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1467738|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1467739|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1467740|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1467741|NCT00900094|stage I breast cancer|stage i breast cancer
1467742|NCT00900094|stage II breast cancer|stage ii breast cancer
1467743|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
1467744|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
1467745|NCT00900094|stage IV breast cancer|stage iv breast cancer
1467746|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
1467747|NCT00900094|stage I colon cancer|stage i colon cancer
1467748|NCT00900094|stage II colon cancer|stage ii colon cancer
1467749|NCT00900094|stage III colon cancer|stage iii colon cancer
1467750|NCT00900094|stage IV colon cancer|stage iv colon cancer
1467751|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1467752|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1467753|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
1467754|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
1467755|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
1467756|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
1467757|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1467758|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1467759|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1467760|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1467761|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1467762|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1467763|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1467764|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1467765|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1467766|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1467767|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
1467768|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1467769|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
1467770|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
1467771|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1467772|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
1467773|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
1467774|NCT00900094|recurrent breast cancer|recurrent breast cancer
1467775|NCT00900094|recurrent colon cancer|recurrent colon cancer
1467776|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
1467777|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1467778|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1467779|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1467780|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1467781|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
1467782|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1467783|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
1467784|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
1467785|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1467786|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1467787|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1467788|NCT00900068|nausea and vomiting|nausea and vomiting
1467789|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1469504|NCT00897780|Pediatric|pediatric
1467790|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1468235|NCT00899626|gastric cancer|gastric cancer
1467791|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1467792|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1467793|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1467794|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1467795|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1467796|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1467797|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1467798|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1467799|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1467800|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1467801|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1467802|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1467803|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1467804|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1467805|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1467806|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1467807|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1467808|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1467809|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1467810|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1467811|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1467812|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1467813|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1467814|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1467815|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1467816|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1467817|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1467818|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1467819|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1467820|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1467821|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1467822|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1467823|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1467824|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1467825|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1467826|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1467827|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1467828|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1467829|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1467830|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1467831|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1467832|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1467833|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1467834|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1467835|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1467836|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1467837|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1467838|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1467839|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1467840|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1467841|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1467842|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1467843|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1467844|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1467845|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1467846|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1467847|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1467848|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1467849|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1470143|NCT00895960|Gliosarcoma|gliosarcoma
1467850|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1467922|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1467851|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1467852|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1467853|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1467854|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1467855|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1467856|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1467857|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1467858|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1467859|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1467860|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
1467861|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1467862|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1467863|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1467864|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1467865|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1467866|NCT00900068|primary myelofibrosis|primary myelofibrosis
1467867|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1467868|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1467869|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
1467870|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1467871|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1467872|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1467873|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
1467874|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1467875|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1467876|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1467877|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1467878|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
1467879|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
1467880|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
1467881|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1467882|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1467883|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1467884|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1467885|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
1467886|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
1467887|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
1467888|NCT00900068|stage IV breast cancer|stage iv breast cancer
1467889|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
1467890|NCT00900055|Fanconi anemia|fanconi anemia
1467891|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
1467892|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
1467893|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
1467894|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
1467895|NCT00900029|Venous Leg Ulcer|venous leg ulcer
1467896|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
1467898|NCT00900029|VSU|vsu
1467899|NCT00900029|Leg Ulcer|leg ulcer
1467900|NCT00900029|Leg Wound|leg wound
1467901|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1467902|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
1467903|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
1467904|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
1467905|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
1467906|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
1467907|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
1467908|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
1467909|NCT00899977|refractory hypertension|refractory hypertension
1467910|NCT00899977|hypertension|hypertension
1467911|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1467912|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1467913|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
1467914|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1467915|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1467916|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1467917|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1467918|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1467919|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1467920|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1467921|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1467923|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1467924|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1467925|NCT00899951|mast cell leukemia|mast cell leukemia
1467926|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1467927|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1467928|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
1467929|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1467930|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1467931|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1467932|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1467933|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
1467934|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1467935|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1467936|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1467937|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1467938|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1467939|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1467940|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1467941|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1467942|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1467943|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1467944|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1467945|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1467946|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1467947|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1467948|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1467949|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1467950|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1467951|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1467952|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1467953|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1467954|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1467955|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1467956|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1467957|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1467958|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1467959|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1467960|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1467961|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1467962|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1467963|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1467964|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1467965|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1467966|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
1467967|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1467968|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1467969|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1467970|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1467971|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1467972|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1467973|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1467974|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1467975|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1467976|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1467977|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1467978|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1467979|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1467980|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1467981|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1467982|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1468380|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
1467983|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1467984|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1467985|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1467986|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1467987|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1467988|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1467989|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1467990|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1467991|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1467992|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1467993|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1467994|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1467995|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1467996|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1467997|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1467998|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1467999|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1468000|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1468001|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1468002|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1468003|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1468004|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1567474|NCT00509080|natriuretic peptides|natriuretic peptides
1468005|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1468006|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1468007|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1468008|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1468009|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1468010|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1468011|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1469040|NCT00898378|stage I rectal cancer|stage i rectal cancer
1468012|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1468013|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1468014|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1468015|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1468016|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1468017|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1468018|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1468019|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1468020|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1468021|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1468022|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1468023|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1468024|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1468025|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1468026|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1468027|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1468028|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1468029|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1468030|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1468031|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1468032|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1468033|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1468034|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1468035|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1468036|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1468037|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1468038|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1468039|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1468040|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1468041|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1468042|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1468043|NCT00899951|intraocular lymphoma|intraocular lymphoma
1468044|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1468045|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1468046|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1471256|NCT00891579|EGFR|egfr
1468047|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1468048|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1468049|NCT00899951|primary myelofibrosis|primary myelofibrosis
1468050|NCT00899951|essential thrombocythemia|essential thrombocythemia
1468051|NCT00899951|polycythemia vera|polycythemia vera
1468052|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
1468053|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1468054|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1468055|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
1468056|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
1468057|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
1468058|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
1468059|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
1468060|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1468061|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1468062|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1468063|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1468064|NCT00899951|pain|pain
1468065|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
1468066|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
1468067|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1567475|NCT00509080|valvular heart disease|valvular heart disease
1468068|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1468069|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1468070|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1468071|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468072|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1468073|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
1468074|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
1468075|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
1468076|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
1468077|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
1468078|NCT00899834|adult brain stem glioma|adult brain stem glioma
1468079|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
1468080|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468081|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1468082|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1468083|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1468084|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1468085|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1468086|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1468087|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1468088|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1468089|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1468090|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1468091|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1468092|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1468093|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468094|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1468095|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1468096|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1468097|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1468098|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1468099|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468100|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468101|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1468102|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468103|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468104|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468105|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468106|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468107|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468232|NCT00899639|male breast cancer|male breast cancer
1468108|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468109|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468110|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468111|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468112|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
1468113|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1468114|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
1468115|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
1468116|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
1468117|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
1468118|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1468119|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1468120|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1567476|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
1468121|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1468122|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1468123|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1468124|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1468125|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1468126|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1468127|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1468128|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1468129|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1468130|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1468131|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1468132|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1468133|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1468134|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468135|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468136|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468137|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468138|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468139|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468140|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1468141|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1468142|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1468143|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1468144|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1468145|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1468146|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1468147|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1468148|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1468149|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1468150|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1468151|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468152|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1468153|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1468154|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1468155|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1468156|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1468157|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468381|NCT00899301|stage IV breast cancer|stage iv breast cancer
1468158|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468159|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1468160|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468161|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468162|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468163|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468164|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1468165|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468166|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
1468167|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1468168|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
1468169|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
1468170|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
1468171|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
1468172|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1468173|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1468174|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1468175|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1468176|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1468177|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1468178|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1468179|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1468180|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1468181|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1468182|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1468183|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1468184|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1468185|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1468186|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1468187|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1469041|NCT00898378|stage II rectal cancer|stage ii rectal cancer
1468188|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1468189|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1468190|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
1468191|NCT00899717|Orofacial pain|orofacial pain
1468192|NCT00899717|Limited mouth opening|limited mouth opening
1468193|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
1468194|NCT00899717|Axiography|axiography
1468195|NCT00899717|Gnatography|gnatography
1468196|NCT00899717|Preferred chewing side|preferred chewing side
1468197|NCT00899717|Occlusal adjustment|occlusal adjustment
1468198|NCT00899717|Selective grinding|selective grinding
1468199|NCT00899717|Handedness|handedness
1468200|NCT00899717|Bruxism|bruxism
1468202|NCT00899717|Costen's Syndrome|costen's syndrome
1468203|NCT00899717|Myofascial pain|myofascial pain
1468204|NCT00899717|TMD treatment|tmd treatment
1468205|NCT00899717|Pain|pain
1468206|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1468207|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1468208|NCT00899704|tongue cancer|tongue cancer
1468209|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1468210|NCT00899678|Certolizumab Pegol|certolizumab pegol
1468211|NCT00899678|Cimzia ®|cimzia ®
1468212|NCT00899678|Crohn's Disease|crohn's disease
1468213|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
1468214|NCT00899665|bone metastases|bone metastases
1468215|NCT00899665|anemia|anemia
1468216|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1468217|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1468218|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1468219|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1468220|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1468221|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1468222|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1468223|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1468224|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1468225|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1468226|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468227|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1468228|NCT00899639|stage I breast cancer|stage i breast cancer
1468229|NCT00899639|stage II breast cancer|stage ii breast cancer
1468230|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
1468231|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1468236|NCT00899626|pancreatic cancer|pancreatic cancer
1468237|NCT00899626|adenomatous polyp|adenomatous polyp
1468238|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
1468239|NCT00899613|lung metastases|lung metastases
1468240|NCT00899613|malignant pleural effusion|malignant pleural effusion
1468241|NCT00899600|chronic pain|chronic pain
1468242|NCT00899600|back surgery|back surgery
1468243|NCT00899600|opioid dependent|opioid dependent
1468244|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
1468245|NCT00899600|Ketamine|ketamine
1468246|NCT00899600|Central sensitization|central sensitization
1468247|NCT00899574|toll-like receptor|toll-like receptor
1468248|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
1468249|NCT00899574|recurrent breast cancer|recurrent breast cancer
1468250|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
1468251|NCT00899574|immunomodulator|immunomodulator
1468252|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
1468253|NCT00899561|Computed tomography|computed tomography
1468254|NCT00899561|Histology|histology
1468255|NCT00899561|Middle turbinate|middle turbinate
1468256|NCT00899561|Morphometry|morphometry
1468257|NCT00899561|osteomyelitis|osteomyelitis
1468258|NCT00899561|polyps|polyps
1468259|NCT00899548|stage IV breast cancer|stage iv breast cancer
1468260|NCT00899548|recurrent breast cancer|recurrent breast cancer
1468261|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
1468262|NCT00899535|large cell lung cancer|large cell lung cancer
1468263|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
1468264|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1468265|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1468266|NCT00899522|Fanconi anemia|fanconi anemia
1468267|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1468268|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1468269|NCT00899509|stage II breast cancer|stage ii breast cancer
1468270|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
1468271|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
1468272|NCT00899496|stage IV colon cancer|stage iv colon cancer
1468273|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1468274|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
1468275|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
1468276|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
1468277|NCT00899496|stage IV melanoma|stage iv melanoma
1468278|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
1468279|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1468280|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1468281|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1468282|NCT00899496|stage IV breast cancer|stage iv breast cancer
1468283|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1468284|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
1468285|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1468286|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1468287|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
1468288|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
1468289|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1468290|NCT00899496|ovarian sarcoma|ovarian sarcoma
1468291|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1468292|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1468293|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1468294|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1468295|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1468296|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1468297|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1468298|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1468299|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1468300|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1468301|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1468302|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1468303|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1468304|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1468305|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1468306|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1468307|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1468308|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1468309|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1468310|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1468311|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1471257|NCT00891579|Pemetrexed|pemetrexed
1468312|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1468313|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1468314|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1468315|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1468316|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1468317|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1468318|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1567477|NCT00509067|Acetylcholine|acetylcholine
1468319|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1468320|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1468321|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1468322|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1468323|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1468324|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1468325|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1468326|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1468327|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1468328|NCT00899496|intraocular lymphoma|intraocular lymphoma
1468329|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
1468330|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
1468331|NCT00899457|small cell lung cancer|small cell lung cancer
1468332|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
1468333|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
1468334|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1468336|NCT00899431|Immunomanipulation|immunomanipulation
1468337|NCT00899431|Fludarabine|fludarabine
1468338|NCT00899431|Lenalidomide|lenalidomide
1468339|NCT00899431|Rituximab|rituximab
1468340|NCT00899431|Thymoglobulin|thymoglobulin
1468341|NCT00899431|Stem Cell Transplantation|stem cell transplantation
1468342|NCT00899418|recurrent breast cancer|recurrent breast cancer
1468343|NCT00899418|stage IV breast cancer|stage iv breast cancer
1468344|NCT00899405|lung cancer|lung cancer
1468345|NCT00899392|consent|consent
1468346|NCT00899392|Anxiety|anxiety
1468347|NCT00899392|Satisfaction|satisfaction
1468348|NCT00899392|Efficiency|efficiency
1468349|NCT00899392|Questions|questions
1468350|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
1468351|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
1468352|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
1468353|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
1468354|NCT00899392|Number of questions asked|number of questions asked
1468355|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1468356|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1468357|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1468358|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1468359|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1468360|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468361|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1468362|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1468363|NCT00899353|ES-CLL|es-cll
1468364|NCT00899353|MGUS|mgus
1468365|NCT00899353|SMM|smm
1468366|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
1468367|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468368|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1468369|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1468370|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1468371|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468372|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
1468373|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
1468374|NCT00899301|breast cancer|breast cancer
1468375|NCT00899301|stage IA breast cancer|stage ia breast cancer
1468376|NCT00899301|stage IB breast cancer|stage ib breast cancer
1468377|NCT00899301|stage II breast cancer|stage ii breast cancer
1468378|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
1468379|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
1470144|NCT00895960|GS|gs
1468382|NCT00899288|osteoporosis|osteoporosis
1468383|NCT00899288|stage I breast cancer|stage i breast cancer
1468384|NCT00899288|stage II breast cancer|stage ii breast cancer
1468385|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
1468386|NCT00899275|osteosarcoma|osteosarcoma
1468387|NCT00899262|lung cancer|lung cancer
1468388|NCT00899262|tobacco use disorder|tobacco use disorder
1468389|NCT00899210|liver metastases|liver metastases
1468390|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
1468391|NCT00899210|stage IV colon cancer|stage iv colon cancer
1468392|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1468393|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
1468394|NCT00899210|recurrent colon cancer|recurrent colon cancer
1468395|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
1468396|NCT00899197|stage I breast cancer|stage i breast cancer
1468397|NCT00899197|stage II breast cancer|stage ii breast cancer
1468398|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
1468399|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
1468400|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
1468401|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
1468402|NCT00899184|stage I prostate cancer|stage i prostate cancer
1468403|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
1468404|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
1468405|NCT00899184|stage III prostate cancer|stage iii prostate cancer
1468406|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1468407|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1468408|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1468409|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1468410|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1468411|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1468412|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1468413|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1468414|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1468415|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1468416|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1468417|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1468418|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1468419|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1468420|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1468421|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1468422|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1468423|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
1468424|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
1468425|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
1468426|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
1468427|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
1468428|NCT00899158|cachexia|cachexia
1468429|NCT00899132|skin cancer|skin cancer
1468430|NCT00899132|small intestine cancer|small intestine cancer
1468431|NCT00899132|pancreatic cancer|pancreatic cancer
1468432|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
1468433|NCT00899132|testicular teratoma|testicular teratoma
1468434|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
1468435|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
1468436|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
1468437|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
1468438|NCT00899041|Prosthesis|prosthesis
1468439|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1468440|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1468441|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1468442|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
1468443|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1468444|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1468445|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1468446|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1468447|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1468448|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1468449|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468450|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1468451|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1468452|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1468453|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1468454|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1468455|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1468456|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1468457|NCT00899002|childhood liver cancer|childhood liver cancer
1468458|NCT00899002|adult primary liver cancer|adult primary liver cancer
1468459|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1468460|NCT00898976|stage I breast cancer|stage i breast cancer
1468461|NCT00898976|stage II breast cancer|stage ii breast cancer
1468462|NCT00898976|stage IV breast cancer|stage iv breast cancer
1468463|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
1468464|NCT00898976|breast cancer in situ|breast cancer in situ
1468465|NCT00898976|recurrent breast cancer|recurrent breast cancer
1468466|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
1468467|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
1468468|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
1468469|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1468470|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1468471|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1468472|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1468473|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1468474|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1468475|NCT00898950|diabetes|diabetes
1468476|NCT00898950|aspirin|aspirin
1468477|NCT00898950|oxidative stress|oxidative stress
1468478|NCT00898950|insulin resistance|insulin resistance
1468479|NCT00898950|endothelial function|endothelial function
1468480|NCT00898950|inflammation|inflammation
1468481|NCT00898950|photoplethysmography|photoplethysmography
1468482|NCT00898950|dysglycaemia|dysglycaemia
1468483|NCT00898937|breast cancer|breast cancer
1468484|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1468485|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1468486|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468487|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468488|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1468489|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1468490|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468491|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1468492|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468493|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468494|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1468495|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1468496|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1468497|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468498|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468499|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468500|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468501|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468502|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468503|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468504|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
1468505|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1468506|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
1468507|NCT00898898|stage IA breast cancer|stage ia breast cancer
1468508|NCT00898898|stage IB breast cancer|stage ib breast cancer
1468509|NCT00898898|stage II breast cancer|stage ii breast cancer
1468510|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
1468511|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
1468512|NCT00898885|oral manifestations|oral manifestations
1468513|NCT00898885|bone marrow transplantation|bone marrow transplantation
1468514|NCT00898885|adverse effects|adverse effects
1468515|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1468516|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1468517|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1468518|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1468519|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1468520|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1468521|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1468522|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1468523|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1468524|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1468525|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1468526|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1468527|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1468660|NCT00898755|localized osteosarcoma|localized osteosarcoma
1567478|NCT00509067|Nicotinic Receptors|nicotinic receptors
1468528|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1468529|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1468530|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1468531|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
1468532|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1468533|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1468534|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1468535|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1468536|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1468537|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1468538|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1468539|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
1468540|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1468542|NCT00898859|epithelial|epithelial
1468543|NCT00898859|COPD|copd
1468544|NCT00898846|stage II colon cancer|stage ii colon cancer
1468545|NCT00898846|stage II rectal cancer|stage ii rectal cancer
1468546|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
1468547|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1468548|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
1468549|NCT00898833|stage III prostate cancer|stage iii prostate cancer
1468550|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
1468551|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1468552|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1468553|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1468554|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1468555|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
1468556|NCT00898807|aggression|aggression
1468557|NCT00898807|mood lability|mood lability
1468558|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1468559|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1468560|NCT00898781|male breast cancer|male breast cancer
1468561|NCT00898781|stage IV breast cancer|stage iv breast cancer
1468562|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1468563|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1468564|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
1468565|NCT00898781|stage IV colon cancer|stage iv colon cancer
1468566|NCT00898781|ovarian sarcoma|ovarian sarcoma
1468567|NCT00898768|Lynch syndrome|lynch syndrome
1468568|NCT00898768|HNPCC|hnpcc
1468569|NCT00898768|Capsule endoscopy|capsule endoscopy
1468570|NCT00898768|Small bowel cancer|small bowel cancer
1468571|NCT00898768|Double balloon endoscopy|double balloon endoscopy
1468572|NCT00898755|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1468573|NCT00898755|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1468574|NCT00898755|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1468575|NCT00898755|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1468576|NCT00898755|childhood choroid plexus tumor|childhood choroid plexus tumor
1468577|NCT00898755|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1468578|NCT00898755|childhood craniopharyngioma|childhood craniopharyngioma
1468579|NCT00898755|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1468580|NCT00898755|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1468581|NCT00898755|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1468582|NCT00898755|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1468583|NCT00898755|childhood teratoma|childhood teratoma
1468584|NCT00898755|childhood grade I meningioma|childhood grade i meningioma
1468585|NCT00898755|childhood grade II meningioma|childhood grade ii meningioma
1468586|NCT00898755|childhood grade III meningioma|childhood grade iii meningioma
1468587|NCT00898755|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1468588|NCT00898755|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1468589|NCT00898755|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1468590|NCT00898755|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1468591|NCT00898755|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1468592|NCT00898755|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1469501|NCT00897793|stage III prostate cancer|stage iii prostate cancer
1468593|NCT00898755|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1468594|NCT00898755|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1468595|NCT00898755|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468596|NCT00898755|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1567479|NCT00509067|Nicotine|nicotine
1615396|NCT00338585|PAO|pao
1468597|NCT00898755|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1468598|NCT00898755|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1471258|NCT00891579|Gefitinib|gefitinib
1468599|NCT00898755|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1468600|NCT00898755|recurrent childhood ependymoma|recurrent childhood ependymoma
1468601|NCT00898755|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1468602|NCT00898755|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1468603|NCT00898755|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1468604|NCT00898755|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1468605|NCT00898755|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1468606|NCT00898755|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1468607|NCT00898755|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1468608|NCT00898755|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1468609|NCT00898755|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1468610|NCT00898755|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1468611|NCT00898755|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1468612|NCT00898755|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1468613|NCT00898755|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1468614|NCT00898755|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1468615|NCT00898755|stage I childhood liver cancer|stage i childhood liver cancer
1468616|NCT00898755|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1468617|NCT00898755|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1468618|NCT00898755|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1468619|NCT00898755|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1468620|NCT00898755|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1468621|NCT00898755|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1468622|NCT00898755|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1468623|NCT00898755|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1468624|NCT00898755|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1468625|NCT00898755|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1468626|NCT00898755|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1468627|NCT00898755|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1468628|NCT00898755|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1468629|NCT00898755|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1468630|NCT00898755|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1468631|NCT00898755|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1468632|NCT00898755|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1468633|NCT00898755|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1468634|NCT00898755|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1468635|NCT00898755|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1468636|NCT00898755|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1468637|NCT00898755|childhood hepatoblastoma|childhood hepatoblastoma
1468638|NCT00898755|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
1468639|NCT00898755|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1468640|NCT00898755|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1468641|NCT00898755|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1468642|NCT00898755|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1468643|NCT00898755|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1468644|NCT00898755|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1468645|NCT00898755|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1468646|NCT00898755|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1468647|NCT00898755|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1468648|NCT00898755|childhood Burkitt lymphoma|childhood burkitt lymphoma
1468649|NCT00898755|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1468650|NCT00898755|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1468651|NCT00898755|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1468652|NCT00898755|disseminated neuroblastoma|disseminated neuroblastoma
1567480|NCT00509067|Galantamine|galantamine
1468653|NCT00898755|localized resectable neuroblastoma|localized resectable neuroblastoma
1468654|NCT00898755|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1468655|NCT00898755|recurrent neuroblastoma|recurrent neuroblastoma
1468656|NCT00898755|regional neuroblastoma|regional neuroblastoma
1468657|NCT00898755|stage 4S neuroblastoma|stage 4s neuroblastoma
1468658|NCT00898755|childhood germ cell tumor|childhood germ cell tumor
1468659|NCT00898755|recurrent childhood liver cancer|recurrent childhood liver cancer
1472250|NCT00888043|Phase I|phase i
1468661|NCT00898755|metastatic osteosarcoma|metastatic osteosarcoma
1468662|NCT00898755|recurrent osteosarcoma|recurrent osteosarcoma
1468663|NCT00898755|extraocular retinoblastoma|extraocular retinoblastoma
1468664|NCT00898755|intraocular retinoblastoma|intraocular retinoblastoma
1468665|NCT00898755|recurrent retinoblastoma|recurrent retinoblastoma
1468666|NCT00898755|stage I Wilms tumor|stage i wilms tumor
1468667|NCT00898755|stage II Wilms tumor|stage ii wilms tumor
1468668|NCT00898755|stage III Wilms tumor|stage iii wilms tumor
1468669|NCT00898755|stage IV Wilms tumor|stage iv wilms tumor
1468670|NCT00898755|stage II childhood liver cancer|stage ii childhood liver cancer
1468671|NCT00898755|stage III childhood liver cancer|stage iii childhood liver cancer
1468672|NCT00898755|stage IV childhood liver cancer|stage iv childhood liver cancer
1468673|NCT00898755|unusual cancers of childhood|unusual cancers of childhood
1468674|NCT00898755|stage V Wilms tumor|stage v wilms tumor
1468675|NCT00898755|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1468676|NCT00898755|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1468677|NCT00898755|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1468678|NCT00898755|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1468679|NCT00898755|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1468680|NCT00898755|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1468681|NCT00898755|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1468682|NCT00898755|childhood central nervous system germinoma|childhood central nervous system germinoma
1468683|NCT00898755|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1468684|NCT00898755|childhood central nervous system teratoma|childhood central nervous system teratoma
1468685|NCT00898755|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1468686|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468687|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468688|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1468689|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1468690|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468691|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1468692|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468693|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468694|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1468695|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1468696|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1468697|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468698|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468699|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468700|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468701|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468702|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468703|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468704|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
1468705|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1468706|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
1468707|NCT00898703|breast cancer|breast cancer
1468708|NCT00898690|stage I breast cancer|stage i breast cancer
1468709|NCT00898690|stage II breast cancer|stage ii breast cancer
1468710|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
1468711|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
1468712|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
1468713|NCT00898690|stage IV breast cancer|stage iv breast cancer
1468714|NCT00898690|recurrent breast cancer|recurrent breast cancer
1468715|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1468716|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1468717|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1468718|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468719|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468720|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1468721|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1468722|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1468723|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1472447|NCT00887211|stent|stent
1468724|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468725|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1468726|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1468727|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1468728|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468729|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468730|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1468731|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468732|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1468733|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1468734|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1468735|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1468736|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468737|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468738|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1468739|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1468740|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1468741|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468742|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468743|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1468744|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468745|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468746|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468747|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468748|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1468749|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
1468750|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
1468751|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
1468752|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
1468753|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
1468754|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1468755|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1468756|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1468757|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1468758|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1468759|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1468760|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1468761|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1468762|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1468763|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1468764|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1468765|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1468766|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1468767|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1468768|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1468769|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1468770|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1468771|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1469042|NCT00898378|stage III rectal cancer|stage iii rectal cancer
1468772|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1468773|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1468774|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1468775|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1468776|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1468888|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1468777|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1468778|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1468779|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1468780|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1468781|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1468782|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1468783|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1468784|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1468785|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1468786|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1468787|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1468788|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1468789|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1468790|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1468791|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1468792|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1468793|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1468794|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1468795|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1468796|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1468797|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1468798|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1468799|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1468800|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1468801|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1468802|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1468803|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1468804|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1468805|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1468806|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1468807|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1468808|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1468809|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1468810|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1468811|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1468812|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1468813|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1468814|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1468815|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1468816|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1468817|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1468818|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1567481|NCT00509067|negative symptoms|negative symptoms
1468819|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1468820|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1468821|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1468822|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1468823|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468824|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1468825|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1468826|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1468827|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1468828|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1468829|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1468830|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1468831|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1468832|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1468833|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1468834|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1468835|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1468836|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
1468837|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
1468838|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
1468839|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
1468840|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
1468841|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1468842|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1468843|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1468844|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1468845|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1468846|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1468847|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1468848|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1468849|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1468850|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1468851|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1468852|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1468853|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1468854|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1468855|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1468856|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1468857|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1468858|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1468859|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1468860|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1468861|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1468862|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1468863|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1468864|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1468865|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1468866|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1468867|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1468868|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1468869|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1468870|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1468871|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1468872|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1468873|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1468874|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1468875|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1468876|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1468877|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1468878|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1470651|NCT00893906|Africa|africa
1468879|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1468880|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1468881|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1468882|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1468883|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1468884|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1468885|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1468886|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1468887|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1468889|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1468890|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1468891|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1468892|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1468893|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1468894|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1468895|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1468896|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1468897|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1468898|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1468899|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1468900|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1468901|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1468902|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1468903|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1468904|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1468905|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1468906|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1468907|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1468908|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1468909|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1468910|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1468911|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1468912|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1468913|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1468914|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1468915|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1468916|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1468917|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1468918|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1468919|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1468920|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1468921|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1468922|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1468923|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
1468924|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1468925|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1468926|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1468927|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1468928|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1468929|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1468930|NCT00898612|primary myelofibrosis|primary myelofibrosis
1468931|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1567585|NCT00508807|RTA 402|rta 402
1468932|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1468933|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
1468934|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1468935|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1468936|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1468937|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1468938|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1470652|NCT00893893|Obesity|obesity
1468939|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1468940|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
1468941|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1468942|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1468943|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1468944|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1468945|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
1468946|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
1468947|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
1468948|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1468949|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1469331|NCT00897884|breast cancer|breast cancer
1468950|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1468951|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1468952|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
1468953|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
1468954|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
1468955|NCT00898612|stage IV breast cancer|stage iv breast cancer
1468956|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
1468957|NCT00898573|breast cancer|breast cancer
1468958|NCT00898560|Partial|partial
1468959|NCT00898560|Epilepsy|epilepsy
1468960|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
1468961|NCT00898560|Combined oral contraceptive|combined oral contraceptive
1468962|NCT00898560|Pharmacokinetics|pharmacokinetics
1468963|NCT00898560|Tolerability|tolerability
1468964|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
1468965|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1468966|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
1468967|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
1468968|NCT00898534|Pediatrics|pediatrics
1468969|NCT00898534|Hemoglobin A1c|hemoglobin a1c
1468970|NCT00898534|Point of Care testing|point of care testing
1468971|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1468972|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1468973|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1468974|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1468975|NCT00898508|stage I breast cancer|stage i breast cancer
1468976|NCT00898508|stage II breast cancer|stage ii breast cancer
1468977|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
1468978|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
1468979|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
1468980|NCT00898508|stage IV breast cancer|stage iv breast cancer
1468981|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1468982|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
1468983|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
1468984|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
1468985|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
1468986|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1468987|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
1468988|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
1468989|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
1468990|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
1468991|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
1468992|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1468993|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
1468994|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1468995|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1468996|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1468997|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1468998|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1468999|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1469000|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1469001|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1469002|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1469003|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1469004|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1469005|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1469006|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1469007|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
1469008|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1469009|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1469010|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469011|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1469012|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1469013|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469014|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1469015|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1469016|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469017|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1469018|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1469019|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1469332|NCT00897884|metformin|metformin
1469020|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1469021|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1469022|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1469023|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469024|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469025|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469026|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1469027|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1469028|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
1469029|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
1469030|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469031|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1469032|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469033|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
1469034|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1469035|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
1469036|NCT00898378|stage I colon cancer|stage i colon cancer
1469037|NCT00898378|stage II colon cancer|stage ii colon cancer
1469038|NCT00898378|stage III colon cancer|stage iii colon cancer
1469039|NCT00898378|stage IV colon cancer|stage iv colon cancer
1469043|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
1469044|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
1469045|NCT00898378|recurrent colon cancer|recurrent colon cancer
1469046|NCT00898378|adenomatous polyp|adenomatous polyp
1469047|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
1469048|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
1469049|NCT00898326|stage I prostate cancer|stage i prostate cancer
1469050|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
1469051|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
1469052|NCT00898313|lung cancer|lung cancer
1469053|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1469054|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1469055|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1469056|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469057|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1469058|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1469059|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1469060|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469061|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1469062|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1469063|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1469064|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1469065|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1469066|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1469067|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1469068|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1469069|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1469070|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1469071|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1469072|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1469073|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1469074|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1469075|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1469502|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
1469076|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1469077|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1469078|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1469079|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1469080|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1469081|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1469082|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1469083|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1469084|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469085|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1469086|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1469087|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1469088|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1469089|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1469090|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1469091|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1469092|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1469093|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1469094|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1469095|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1469096|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1469097|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1469098|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1469099|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1469100|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469101|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469102|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469103|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469104|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469105|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469106|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1469107|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1469108|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1469109|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1469110|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1469111|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1469112|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1469113|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1469114|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1469115|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469116|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469117|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1469118|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
1469119|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
1469120|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
1469121|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
1469122|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1469123|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1469124|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1469125|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1469126|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1469127|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1469128|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1469129|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1469130|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469131|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1469132|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1469133|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1469134|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1469333|NCT00897884|breast surgery|breast surgery
1469135|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1469136|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
1469137|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1469138|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1469139|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1469140|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
1469141|NCT00898274|prostate cancer|prostate cancer
1469142|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
1469143|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1469144|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
1469145|NCT00898222|healthy volunteers|healthy volunteers
1469146|NCT00898222|aspirin|aspirin
1469147|NCT00898222|Normal healthy subjects|normal healthy subjects
1469148|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1469149|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1469150|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1469151|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469152|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469153|NCT00898183|stage III melanoma|stage iii melanoma
1469154|NCT00898183|stage IV melanoma|stage iv melanoma
1469155|NCT00898183|recurrent melanoma|recurrent melanoma
1469156|NCT00898170|myoma|myoma
1469157|NCT00898170|hypertension|hypertension
1469158|NCT00898170|erythropoetin|erythropoetin
1469159|NCT00898170|blood pressure|blood pressure
1469160|NCT00898170|erythropoetin level|erythropoetin level
1469161|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1469162|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1469163|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1469164|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1469165|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1469166|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1469167|NCT00898144|cervical cancer|cervical cancer
1469168|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1469169|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1469170|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
1469171|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1469172|NCT00898131|breast cancer|breast cancer
1469173|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1469174|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1469175|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1469176|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1616596|NCT00333632|Sleep|sleep
1469177|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1469178|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1469179|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1469180|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1469181|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1469182|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1469183|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1469184|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1469185|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1469186|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1469187|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
1469188|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1469189|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1469190|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1469191|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
1469192|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
1469193|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
1469194|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
1469195|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
1469196|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
1469197|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
1469198|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
1469199|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1469200|NCT00898014|stage IV breast cancer|stage iv breast cancer
1469201|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1469202|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1469203|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1469204|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469205|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469206|NCT00897975|statin associated myalgias|statin associated myalgias
1469207|NCT00897975|hyperlipidemia|hyperlipidemia
1469208|NCT00897975|red yeast rice|red yeast rice
1469209|NCT00897975|phytosterols|phytosterols
1469210|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
1469211|NCT00897975|compliance|compliance
1469212|NCT00897962|stage IV breast cancer|stage iv breast cancer
1469213|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1469214|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1469215|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1469216|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1469217|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1469218|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1469219|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1469220|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1469221|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1469222|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1469223|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1469224|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1469225|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1469226|NCT00897923|intraocular lymphoma|intraocular lymphoma
1469227|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1469228|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1469229|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1469230|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1469231|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1469232|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1469233|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1469234|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1469235|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1469236|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1469237|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1469238|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1469239|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1469240|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1469241|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1469242|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1469243|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1469244|NCT00897923|small intestine lymphoma|small intestine lymphoma
1469245|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1469246|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1469247|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1469248|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1469249|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1469250|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1469251|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1469252|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1469253|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1469254|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1469255|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1469256|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1469257|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1469258|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1469259|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1469260|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1469261|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1469262|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1469263|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1469264|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1469265|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1469266|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1469267|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1469588|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
1469268|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1469269|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1469270|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1469271|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1469272|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1469273|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1469274|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1469275|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1469276|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
1469277|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1469278|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1469279|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1469280|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1469281|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1469282|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1469283|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1469284|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1469285|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1469286|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1469287|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1469288|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1469289|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1469290|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1469291|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1469292|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1469293|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1469294|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1469295|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1469296|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1469297|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1469298|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1469299|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1567586|NCT00508794|Breast Cancer|breast cancer
1469300|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1469301|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1469302|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1469303|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1469304|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1469305|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1469306|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1469307|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1469308|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1469309|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1469310|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1469311|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1469312|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1469313|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1469314|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1469315|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1469316|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1469317|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1469318|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1469319|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1469320|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1469321|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1469322|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
1469323|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
1469324|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
1469325|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
1469326|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
1469327|NCT00897897|Fibroids|fibroids
1469329|NCT00897897|Ablation|ablation
1469330|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
1469334|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1469335|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1469336|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
1469337|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
1469338|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
1469339|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
1469340|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1469341|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1469342|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1469343|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1469344|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1469345|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
1469346|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1469347|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1469348|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1469349|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1469350|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1469351|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1469352|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1469353|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1469354|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1469355|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
1469356|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1469357|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
1469358|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1469359|NCT00897845|stage II breast cancer|stage ii breast cancer
1469360|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
1469361|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
1469362|NCT00897832|pancreatic cancer|pancreatic cancer
1469363|NCT00897819|recurrent colon cancer|recurrent colon cancer
1469364|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
1469365|NCT00897819|stage III colon cancer|stage iii colon cancer
1469366|NCT00897819|stage III rectal cancer|stage iii rectal cancer
1469367|NCT00897819|stage IV colon cancer|stage iv colon cancer
1469368|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
1469369|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
1469370|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1469371|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1469372|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1469373|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
1469374|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1469375|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1469376|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1469377|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1469378|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469379|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1469380|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1469381|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1469382|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1469383|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1469384|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1469385|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1469386|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1469387|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469388|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1469389|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1469390|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1469391|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1469392|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1469393|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1469394|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1469395|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1469396|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1472699|NCT00886470|cytokines|cytokines
1469397|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1469398|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1469399|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1469400|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1469401|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1469402|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1469403|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1469404|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1469405|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1469406|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1469407|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469408|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1469409|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1469410|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1469411|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1469412|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1469413|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1469414|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1469415|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1469416|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1469417|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1469418|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1469419|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1617087|NCT00331201|NEC|nec
1469420|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1469421|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1469422|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1469423|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1469424|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1469425|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1469426|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1469427|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1469428|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1469429|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1469430|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1469431|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1469432|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1469433|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1469434|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469435|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1469436|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469437|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469438|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1469439|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1469440|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1469441|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469442|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1469443|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1469444|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1469445|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469446|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1469447|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1469589|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
1469448|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469449|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469450|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1469451|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1469452|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469453|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469454|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1469455|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1469456|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1469457|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1469458|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1469459|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
1469460|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1469461|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1469462|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1469463|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1469464|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1469465|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1469466|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1469467|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
1617247|NCT00330564|VHL|vhl
1469468|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
1469469|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
1469470|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
1469471|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
1469472|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1469473|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
1469474|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1469475|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1469476|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1469477|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469478|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469479|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1469480|NCT00897793|male breast cancer|male breast cancer
1469481|NCT00897793|recurrent breast cancer|recurrent breast cancer
1469482|NCT00897793|stage I breast cancer|stage i breast cancer
1469483|NCT00897793|stage II breast cancer|stage ii breast cancer
1469484|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
1469485|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
1469486|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
1469487|NCT00897793|stage IV breast cancer|stage iv breast cancer
1469488|NCT00897793|recurrent colon cancer|recurrent colon cancer
1469489|NCT00897793|stage I colon cancer|stage i colon cancer
1469490|NCT00897793|stage II colon cancer|stage ii colon cancer
1469491|NCT00897793|stage III colon cancer|stage iii colon cancer
1469492|NCT00897793|stage IV colon cancer|stage iv colon cancer
1469493|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
1469494|NCT00897793|stage I rectal cancer|stage i rectal cancer
1469495|NCT00897793|stage II rectal cancer|stage ii rectal cancer
1469496|NCT00897793|stage III rectal cancer|stage iii rectal cancer
1469497|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
1469498|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
1469499|NCT00897793|stage I prostate cancer|stage i prostate cancer
1469500|NCT00897793|stage II prostate cancer|stage ii prostate cancer
1469505|NCT00897780|Virtual Reality|virtual reality
1469506|NCT00897780|Biofeedback|biofeedback
1469507|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1469508|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1469509|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1469510|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1469511|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1469512|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1469513|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1469514|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1469515|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1469516|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1469517|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1469518|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1469519|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1469520|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1469521|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1469522|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
1469523|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1469524|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1469525|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1469526|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1469527|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1469528|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1469529|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1469530|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1469531|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1469532|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1469533|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1469534|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1469535|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1469536|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1469537|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1469538|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1469539|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1469540|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1469541|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1469542|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1469543|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1469544|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1469545|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
1469546|NCT00897767|mast cell leukemia|mast cell leukemia
1469547|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1469548|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1469549|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
1469550|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
1469551|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
1469552|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1469553|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
1469554|NCT00897754|stage III rectal cancer|stage iii rectal cancer
1469555|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
1469556|NCT00897754|recurrent colon cancer|recurrent colon cancer
1469557|NCT00897754|stage III colon cancer|stage iii colon cancer
1469558|NCT00897754|stage IV colon cancer|stage iv colon cancer
1469559|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
1469560|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
1469561|NCT00897728|stage IA breast cancer|stage ia breast cancer
1469562|NCT00897728|stage IB breast cancer|stage ib breast cancer
1469563|NCT00897728|stage II breast cancer|stage ii breast cancer
1469564|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
1469565|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
1469566|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
1469567|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
1469568|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
1469569|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1469571|NCT00897715|inflammation|inflammation
1469572|NCT00897715|CVD|cvd
1469573|NCT00897702|recurrent breast cancer|recurrent breast cancer
1469574|NCT00897702|male breast cancer|male breast cancer
1470844|NCT00893048|prednisone|prednisone
1469575|NCT00897702|stage IV breast cancer|stage iv breast cancer
1469576|NCT00897676|Hyperinsulinism|hyperinsulinism
1469577|NCT00897676|Hypoglycemia|hypoglycemia
1469578|NCT00897676|KATP channel|katp channel
1469579|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
1469580|NCT00897663|adult gliosarcoma|adult gliosarcoma
1469581|NCT00897663|adult glioblastoma|adult glioblastoma
1469582|NCT00897650|lung cancer|lung cancer
1469583|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
1469584|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1469585|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1469586|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1469587|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1469590|NCT00897611|adult glioblastoma|adult glioblastoma
1469591|NCT00897611|adult gliosarcoma|adult gliosarcoma
1469592|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1469593|NCT00897546|recurrent melanoma|recurrent melanoma
1469594|NCT00897546|stage IV melanoma|stage iv melanoma
1469595|NCT00897546|stage IA melanoma|stage ia melanoma
1469596|NCT00897546|stage IB melanoma|stage ib melanoma
1469597|NCT00897546|stage IIA melanoma|stage iia melanoma
1469598|NCT00897546|stage IIB melanoma|stage iib melanoma
1469599|NCT00897546|stage IIC melanoma|stage iic melanoma
1469600|NCT00897546|stage IIIA melanoma|stage iiia melanoma
1469601|NCT00897546|stage IIIB melanoma|stage iiib melanoma
1469602|NCT00897546|stage IIIC melanoma|stage iiic melanoma
1469603|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1469604|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469605|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469606|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
1469607|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
1469608|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1469609|NCT00897520|stage II melanoma|stage ii melanoma
1469610|NCT00897520|stage III melanoma|stage iii melanoma
1469611|NCT00897520|stage IV melanoma|stage iv melanoma
1469612|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1469613|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1469614|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
1469615|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
1469616|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
1469617|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
1469618|NCT00897481|stage IV melanoma|stage iv melanoma
1469619|NCT00897481|recurrent melanoma|recurrent melanoma
1469620|NCT00897481|stage IA melanoma|stage ia melanoma
1469621|NCT00897481|stage IB melanoma|stage ib melanoma
1469622|NCT00897481|stage IIA melanoma|stage iia melanoma
1469623|NCT00897481|stage IIB melanoma|stage iib melanoma
1469624|NCT00897481|stage IIC melanoma|stage iic melanoma
1469625|NCT00897481|stage IIIA melanoma|stage iiia melanoma
1469626|NCT00897481|stage IIIB melanoma|stage iiib melanoma
1469627|NCT00897481|stage IIIC melanoma|stage iiic melanoma
1469628|NCT00897468|breast cancer|breast cancer
1469629|NCT00897455|breast cancer|breast cancer
1469630|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
1469631|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
1469632|NCT00897429|stage IIA colon cancer|stage iia colon cancer
1469633|NCT00897429|stage IIB colon cancer|stage iib colon cancer
1469634|NCT00897429|stage IIC colon cancer|stage iic colon cancer
1469635|NCT00897416|breast cancer|breast cancer
1469636|NCT00897416|stage I breast cancer|stage i breast cancer
1469637|NCT00897416|stage II breast cancer|stage ii breast cancer
1469638|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
1469639|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
1469640|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
1469641|NCT00897416|stage IV breast cancer|stage iv breast cancer
1469642|NCT00897403|colon cancer|colon cancer
1469643|NCT00897403|health status unknown|health status unknown
1469644|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
1469645|NCT00897364|small cell lung cancer|small cell lung cancer
1469646|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
1469647|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
1469648|NCT00897338|stage IV breast cancer|stage iv breast cancer
1469649|NCT00897312|stage IV melanoma|stage iv melanoma
1469650|NCT00897312|hepatitis C infection|hepatitis c infection
1469651|NCT00897312|melanoma (skin)|melanoma (skin)
1469652|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
1469653|NCT00897299|estrogen receptor|estrogen receptor
1469654|NCT00897299|HER-2|her-2
1469656|NCT00897299|stage II breast cancer|stage ii breast cancer
1469657|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
1469658|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
1469659|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1469660|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
1469661|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
1469662|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1469977|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
1469663|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1469664|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1469665|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
1469666|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1469667|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1469668|NCT00897286|gliomas|gliomas
1469669|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1469670|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
1469671|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
1469672|NCT00897273|infection|infection
1469673|NCT00897273|precancerous condition|precancerous condition
1469674|NCT00897273|human papilloma virus infection|human papilloma virus infection
1469675|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
1469676|NCT00897260|Multiple cord blood|multiple cord blood
1469677|NCT00897247|malignant mesothelioma|malignant mesothelioma
1469678|NCT00897247|pulmonary complications|pulmonary complications
1469679|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1469680|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1469681|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1469682|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1469683|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469684|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469685|NCT00897221|Friedreich's ataxia|friedreich's ataxia
1469686|NCT00897208|breast cancer|breast cancer
1469687|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1469688|NCT00897208|breast cancer in situ|breast cancer in situ
1469689|NCT00897208|stage IA breast cancer|stage ia breast cancer
1469690|NCT00897208|stage IB breast cancer|stage ib breast cancer
1469691|NCT00897208|stage II breast cancer|stage ii breast cancer
1469692|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1469693|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1469694|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1567587|NCT00508794|Tibetan Yoga|tibetan yoga
1469695|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1469696|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1469697|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1469698|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1469699|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1469700|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1469701|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1469702|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
1469703|NCT00897143|malignant pleural effusion|malignant pleural effusion
1469704|NCT00897143|small cell lung cancer|small cell lung cancer
1469705|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
1469706|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1469707|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1469708|NCT00897091|stage II breast cancer|stage ii breast cancer
1469709|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
1469710|NCT00897078|cancer survivor|cancer survivor
1469711|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
1469712|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1469713|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1469714|NCT00897065|stage IA breast cancer|stage ia breast cancer
1469715|NCT00897065|stage IB breast cancer|stage ib breast cancer
1469716|NCT00897065|stage II breast cancer|stage ii breast cancer
1469717|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
1469718|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1469719|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1469720|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1469721|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1469722|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469723|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1469724|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469725|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469726|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1469727|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1469728|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469978|NCT00896610|At Risk Diabetes|at risk diabetes
1469729|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1469730|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1469731|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469732|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1469733|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1469734|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1469735|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1469736|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1469737|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1469738|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1469739|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1469740|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1470164|NCT00895869|Screening|screening
1469741|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1469742|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1469743|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1469744|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1469745|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1469746|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1469747|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1469748|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
1469749|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
1469750|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
1469751|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
1469752|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
1469753|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
1469754|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1469755|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1469756|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1469757|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1469758|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
1469759|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
1469760|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
1469761|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
1469762|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
1469763|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
1469764|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1469765|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1469766|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1469767|NCT00897026|stage II breast cancer|stage ii breast cancer
1469768|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
1469769|NCT00896987|Epilepsy|epilepsy
1469770|NCT00896987|lamotrigine|lamotrigine
1469771|NCT00896987|cognitive function|cognitive function
1469772|NCT00896948|head and neck cancer|head and neck cancer
1469773|NCT00896935|cancer|cancer
1469774|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1469775|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1469776|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1469777|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1469778|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1469779|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1469780|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1469781|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1469782|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1469783|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1469784|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1469785|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1469786|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1469787|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1469788|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1469789|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1469790|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1469791|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1469792|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469793|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1469794|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1469795|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1469876|NCT00896896|recurrent colon cancer|recurrent colon cancer
1469796|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1469797|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1469798|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1469799|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1469800|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469801|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1469802|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1469803|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1469804|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1469805|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1469806|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1469807|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1469808|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1469809|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1469810|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1469811|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1469812|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1469813|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1469814|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1469815|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1469816|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1469817|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1469818|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1469819|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1469820|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1469821|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1469822|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469823|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1469824|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1469825|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1469826|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1469827|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1469828|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1469829|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1469830|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1469831|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1469832|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1469833|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1469834|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1469835|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1469836|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1469837|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1469838|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1469839|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1469840|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1469841|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1469842|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1469843|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1469844|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1469845|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1469846|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1469847|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1469848|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469849|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1469850|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469851|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1469852|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1469853|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1469854|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469855|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1469856|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1469857|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1470165|NCT00895869|Retinopathy|retinopathy
1469858|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469859|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1469860|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1469861|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1469862|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469863|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1469864|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1469865|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1469866|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1469867|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1469868|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1469869|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1469870|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
1469871|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
1469872|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
1469873|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
1469874|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
1469875|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1469877|NCT00896896|stage IV colon cancer|stage iv colon cancer
1469878|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
1469879|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
1469880|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
1469881|NCT00896883|turbinate|turbinate
1469882|NCT00896883|implant|implant
1469883|NCT00896883|sinus surgery|sinus surgery
1469884|NCT00896883|Turbinates|turbinates
1469885|NCT00896857|breast cancer|breast cancer
1469886|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1469887|NCT00896844|emotional disclosure|emotional disclosure
1469888|NCT00896844|expressive writing|expressive writing
1469889|NCT00896844|students|students
1469890|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
1469891|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
1469892|NCT00896831|psychometric test|psychometric test
1469893|NCT00896831|critical flicker frequency|critical flicker frequency
1469894|NCT00896831|quality of life|quality of life
1469895|NCT00896831|Treatment|treatment
1469896|NCT00896831|Health-related quality of life|health-related quality of life
1469897|NCT00896818|breast cancer|breast cancer
1469898|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1469899|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1469900|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1469901|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1469902|NCT00896753|stage IV colon cancer|stage iv colon cancer
1469903|NCT00896753|liver metastases|liver metastases
1469904|NCT00896753|lung metastases|lung metastases
1469905|NCT00896753|recurrent colon cancer|recurrent colon cancer
1469906|NCT00896740|Fanconi anemia|fanconi anemia
1469907|NCT00896727|stage IA breast cancer|stage ia breast cancer
1469908|NCT00896727|stage IB breast cancer|stage ib breast cancer
1469909|NCT00896727|stage II breast cancer|stage ii breast cancer
1469910|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
1469911|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1469912|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1469913|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1469914|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1469915|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1469916|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1469917|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1469918|NCT00896688|cervical branch block|cervical branch block
1469919|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
1469920|NCT00896688|ultrasound guidance|ultrasound guidance
1469921|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1469922|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1469923|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1469924|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1469925|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1469926|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1469927|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1469928|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1469929|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1469930|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1469931|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1567588|NCT00508794|Stretching Program|stretching program
1469932|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1469933|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1469934|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1469935|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1469936|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
1469937|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
1469938|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1469939|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1469940|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1469941|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1469942|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1469943|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1469944|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1469945|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1469946|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1469947|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1469948|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1469949|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1469950|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1469951|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1469952|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1469953|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1469954|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1469955|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1469956|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1469957|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1469958|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1469959|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1469960|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1469961|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1469962|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1469963|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1469964|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1469965|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1469966|NCT00896649|breast cancer|breast cancer
1469967|NCT00896636|breast cancer|breast cancer
1469968|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
1469969|NCT00896623|stage I breast cancer|stage i breast cancer
1469970|NCT00896623|stage II breast cancer|stage ii breast cancer
1469971|NCT00896610|Diabetes Mellitus|diabetes mellitus
1469972|NCT00896610|Type 1 Diabetes|type 1 diabetes
1469973|NCT00896610|Complications|complications
1469974|NCT00896610|Anti Beta-Cell Autoantibodies|anti beta-cell autoantibodies
1469975|NCT00896610|T-Lymphocyte Assays|t-lymphocyte assays
1469976|NCT00896610|Type 2 Diabetes|type 2 diabetes
1469979|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1469980|NCT00896584|Hypoxemia|hypoxemia
1469981|NCT00896584|Pre-flight evaluation|pre-flight evaluation
1469982|NCT00896584|Hypobaria|hypobaria
1469983|NCT00896584|COPD|copd
1469984|NCT00896584|Pulseoximetry|pulseoximetry
1469985|NCT00896584|Air travel|air travel
1469986|NCT00896584|Exercise desaturation|exercise desaturation
1469987|NCT00896571|Fertility control|fertility control
1469988|NCT00896571|Contraception|contraception
1469989|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
1469990|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1469991|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1469992|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1469993|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1469994|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1469995|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1469996|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
1469997|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
1469998|NCT00896480|Malignant melanoma|malignant melanoma
1469999|NCT00896480|MAGE-A3|mage-a3
1470000|NCT00896467|anxiety disorder|anxiety disorder
1470001|NCT00896467|depression|depression
1470002|NCT00896467|stage IV breast cancer|stage iv breast cancer
1470003|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
1470004|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1470005|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1470006|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
1470007|NCT00896467|stage IV anal cancer|stage iv anal cancer
1470008|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
1470009|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
1470010|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
1470011|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
1470012|NCT00896467|small intestine cancer|small intestine cancer
1470013|NCT00896454|hypercalcemia|hypercalcemia
1470014|NCT00896454|calcium|calcium
1470015|NCT00896454|bisphosphonates|bisphosphonates
1470016|NCT00896454|denosumab|denosumab
1470017|NCT00896454|amgen|amgen
1470018|NCT00896454|malignancy|malignancy
1470019|NCT00896454|20070315|20070315
1470020|NCT00896454|HMC|hmc
1470021|NCT00896454|oncology|oncology
1470022|NCT00896454|hematology|hematology
1470023|NCT00896428|Asthma|asthma
1470024|NCT00896428|gallopamil|gallopamil
1470025|NCT00896428|airway remodelling|airway remodelling
1470026|NCT00896428|smooth muscle|smooth muscle
1470027|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
1470028|NCT00896402|chloraprep|chloraprep
1470029|NCT00896402|betadine|betadine
1470030|NCT00896402|colonization|colonization
1470031|NCT00896402|femoral catheter|femoral catheter
1470032|NCT00896389|hypertension|hypertension
1470033|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
1470034|NCT00896389|HCTZ|hctz
1470035|NCT00896389|Salt sensitivity|salt sensitivity
1470036|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
1470037|NCT00896376|stage IV breast cancer|stage iv breast cancer
1470038|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
1470039|NCT00896363|anti-depressant|anti-depressant
1470040|NCT00896363|Severe Depression|severe depression
1470041|NCT00896363|Efficacy|efficacy
1470042|NCT00896363|Major Depressive Disorder|major depressive disorder
1470043|NCT00896363|Major Depressive Episode|major depressive episode
1470044|NCT00896350|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1470045|NCT00896350|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1470046|NCT00896350|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1470047|NCT00896350|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1470048|NCT00896350|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1470049|NCT00896350|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1470050|NCT00896350|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1470051|NCT00896350|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1470052|NCT00896350|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1470053|NCT00896350|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1470054|NCT00896350|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1470055|NCT00896350|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1470056|NCT00896350|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1470057|NCT00896350|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1470058|NCT00896350|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1470059|NCT00896350|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1470060|NCT00896350|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1470061|NCT00896350|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1470062|NCT00896350|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1470063|NCT00896350|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1470064|NCT00896350|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1470065|NCT00896350|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1470066|NCT00896350|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1470166|NCT00895869|Prematurity|prematurity
1470067|NCT00896350|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1470068|NCT00896350|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1470069|NCT00896350|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1470070|NCT00896350|tongue cancer|tongue cancer
1470071|NCT00896337|iliac artery stenosis|iliac artery stenosis
1470072|NCT00896337|claudication|claudication
1470073|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
1470074|NCT00896337|peripheral vascular disease|peripheral vascular disease
1470075|NCT00896324|Quality of life|quality of life
1470076|NCT00896298|Lipodystrophy|lipodystrophy
1470077|NCT00896298|Insulin secretory response|insulin secretory response
1470078|NCT00896285|Pleural malignancy|pleural malignancy
1470079|NCT00896285|pleural effusion|pleural effusion
1470080|NCT00896285|pleurodesis|pleurodesis
1470081|NCT00896285|chest tube|chest tube
1470083|NCT00896285|cancer pain management|cancer pain management
1470084|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
1470085|NCT00896272|47,XXY|47,xxy
1470086|NCT00896272|XXY|xxy
1470087|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
1470088|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
1470089|NCT00896220|chronic critical illness|chronic critical illness
1470090|NCT00896220|mechanical ventilation|mechanical ventilation
1470091|NCT00896220|outcomes|outcomes
1470092|NCT00896220|weakness|weakness
1470093|NCT00896220|quality of life|quality of life
1470094|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
1470095|NCT00896194|Overweight|overweight
1470096|NCT00896194|Obesity|obesity
1470097|NCT00896194|Self-Efficacy|self-efficacy
1470098|NCT00896194|Treatment Adherence|treatment adherence
1470099|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
1470100|NCT00896168|Infliximab|infliximab
1470101|NCT00896168|Methotrexate|methotrexate
1470102|NCT00896155|Breast cancer|breast cancer
1470103|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
1470104|NCT00896155|tamoxifen|tamoxifen
1470105|NCT00896155|radiotherapy|radiotherapy
1470106|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
1470107|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
1470108|NCT00896142|LV structure and function|lv structure and function
1470109|NCT00896129|Health Outcomes Research|health outcomes research
1470110|NCT00896129|CML|cml
1470111|NCT00896077|healthy subjects|healthy subjects
1470112|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
1470113|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
1470114|NCT00896064|Young adults|young adults
1470115|NCT00896051|HIV Infections|hiv infections
1470116|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1470117|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
1470118|NCT00896051|TMC125-C238|tmc125-c238
1470119|NCT00896051|Etravirine|etravirine
1470120|NCT00896051|Intelence|intelence
1470121|NCT00896051|HIV|hiv
1470122|NCT00896051|HIV-1|hiv-1
1470123|NCT00896051|Pharmacokinetics|pharmacokinetics
1470124|NCT00896038|Alcohol Dependence|alcohol dependence
1470125|NCT00896038|Alcohol Treatment|alcohol treatment
1470126|NCT00896038|Alcoholics|alcoholics
1470127|NCT00896038|Alcoholism|alcoholism
1470128|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
1470129|NCT00896038|PTSD|ptsd
1470130|NCT00896025|Liver disease|liver disease
1470131|NCT00896012|Kidney Transplant|kidney transplant
1470132|NCT00896012|Immunosuppression drugs|immunosuppression drugs
1470133|NCT00896012|Rapamune|rapamune
1470134|NCT00896012|tacrolimus|tacrolimus
1470135|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
1470136|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
1470137|NCT00895986|Diabetes|diabetes
1470138|NCT00895986|Education|education
1470139|NCT00895960|Brain|brain
1470140|NCT00895960|CNS Disease|cns disease
1470141|NCT00895960|CNS|cns
1470142|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
1470145|NCT00895960|Glioblastoma|glioblastoma
1470146|NCT00895960|GBM|gbm
1470147|NCT00895960|Dasatinib|dasatinib
1470148|NCT00895960|Sprycel|sprycel
1470149|NCT00895960|Temozolomide|temozolomide
1470150|NCT00895960|TMZ|tmz
1470151|NCT00895960|Temodar|temodar
1470152|NCT00895960|Radiation Therapy|radiation therapy
1470153|NCT00895960|Radiotherapy|radiotherapy
1470154|NCT00895960|RT|rt
1470155|NCT00895947|Prophylaxis|prophylaxis
1470156|NCT00895947|Treatment|treatment
1470157|NCT00895947|Symptoms|symptoms
1470158|NCT00895947|Winter Colds and Flu|winter colds and flu
1470159|NCT00895921|Insulin Resistance|insulin resistance
1470160|NCT00895921|Antipsychotic Medications|antipsychotic medications
1470161|NCT00895908|ADHD|adhd
1470162|NCT00895908|Psychosocial Intervention|psychosocial intervention
1470163|NCT00895908|Social Skills Training|social skills training
1470168|NCT00895856|Physiotherapy|physiotherapy
1470169|NCT00895856|Aged|aged
1470170|NCT00895856|Functionality|functionality
1470171|NCT00895856|Physiotherapic assistance|physiotherapic assistance
1470172|NCT00895856|Functional capacity|functional capacity
1470173|NCT00895843|Third molar|third molar
1470174|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
1470175|NCT00895817|acid reflux|acid reflux
1470176|NCT00895804|MDMA|mdma
1470177|NCT00895804|beta adrenergic|beta adrenergic
1470178|NCT00895804|Ecstasy|ecstasy
1470179|NCT00895791|coronary bifurcation|coronary bifurcation
1470180|NCT00895791|stent implantation|stent implantation
1470182|NCT00895791|Optical Coherence Tomography|optical coherence tomography
1470183|NCT00895778|Neuromuscular blockade|neuromuscular blockade
1470184|NCT00895778|post-operative pain|post-operative pain
1470185|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
1470186|NCT00895765|Melamine|melamine
1470187|NCT00895765|Calculus|calculus
1470188|NCT00895765|Kidney|kidney
1470189|NCT00895765|Child|child
1470190|NCT00895739|aplastic anemia|aplastic anemia
1470191|NCT00895726|cachexia|cachexia
1470192|NCT00895726|neoplasms|neoplasms
1470193|NCT00895713|Hepatitis B|hepatitis b
1470194|NCT00895713|HBV|hbv
1470195|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
1470196|NCT00895713|Immunoglobulins|immunoglobulins
1470197|NCT00895713|liver transplantation|liver transplantation
1470198|NCT00895713|Protective levels|protective levels
1470199|NCT00895713|Recurrence|recurrence
1470200|NCT00895713|Intramuscular|intramuscular
1470201|NCT00895700|Anxiety|anxiety
1470202|NCT00895700|ICD concerns|icd concerns
1470203|NCT00895700|Quality of life|quality of life
1470204|NCT00895687|Metastatic Cancer|metastatic cancer
1470205|NCT00895687|Bortezomib|bortezomib
1470206|NCT00895687|Velcade|velcade
1470207|NCT00895687|Erlotinib|erlotinib
1470208|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
1470209|NCT00895687|Tarceva|tarceva
1470210|NCT00895687|EGFR|egfr
1470211|NCT00895687|EGFR mutations|egfr mutations
1470212|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1470213|NCT00895661|rituximab|rituximab
1470214|NCT00895648|Meso|meso
1470215|NCT00895648|mesothelioma|mesothelioma
1470216|NCT00895648|pleura|pleura
1470217|NCT00895648|pleural|pleural
1470218|NCT00895635|Claudication|claudication
1470219|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
1470220|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
1470221|NCT00895635|Cardiovascular Function|cardiovascular function
1470222|NCT00895622|adult grade I meningioma|adult grade i meningioma
1470223|NCT00895622|adult grade II meningioma|adult grade ii meningioma
1470224|NCT00895622|adult grade III meningioma|adult grade iii meningioma
1470225|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
1470226|NCT00895622|adult papillary meningioma|adult papillary meningioma
1470227|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
1470228|NCT00895609|Residual neuromuscular block|residual neuromuscular block
1470229|NCT00895609|post-operative residual curarization|post-operative residual curarization
1470230|NCT00895609|PORC|porc
1470231|NCT00895609|sugammadex|sugammadex
1470232|NCT00895609|neostigmine|neostigmine
1470233|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
1470234|NCT00895596|Chronic hepatitis B|chronic hepatitis b
1470235|NCT00895596|Lamivudine resistant|lamivudine resistant
1470236|NCT00895596|YMDD mutant type|ymdd mutant type
1470237|NCT00895583|renal transplant|renal transplant
1470238|NCT00895583|immunosuppression|immunosuppression
1470239|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
1470240|NCT00895583|planned transition|planned transition
1470241|NCT00895570|sleep restriction|sleep restriction
1470242|NCT00895570|glucose metabolism|glucose metabolism
1470243|NCT00895570|modafinil|modafinil
1470244|NCT00895570|euglycemic clamp|euglycemic clamp
1470245|NCT00895570|insulin sensitivity|insulin sensitivity
1470246|NCT00895570|insulin release|insulin release
1470247|NCT00895557|varenicline|varenicline
1470248|NCT00895557|cocaine|cocaine
1470249|NCT00895557|brain imaging|brain imaging
1470250|NCT00895531|Knee Replacement, Total|knee replacement, total
1470251|NCT00895531|Morphine|morphine
1470252|NCT00895518|PTSD|ptsd
1470253|NCT00895505|DVT|dvt
1470254|NCT00895505|Venous thromboembolism|venous thromboembolism
1470255|NCT00895505|D-Dimer|d-dimer
1470256|NCT00895505|thrombophilia|thrombophilia
1470257|NCT00895505|secondary prophylaxis|secondary prophylaxis
1470258|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
1470259|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
1470260|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
1470261|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
1470262|NCT00895492|diarrhea|diarrhea
1470263|NCT00895492|rotavirus|rotavirus
1470264|NCT00895492|genotype|genotype
1470265|NCT00895492|VP4|vp4
1470266|NCT00895492|VP7|vp7
1470267|NCT00895479|End Stage Renal Disease|end stage renal disease
1470268|NCT00895479|ESRD|esrd
1470269|NCT00895479|Hemodialysis|hemodialysis
1470270|NCT00895479|Access Graft|access graft
1470271|NCT00895466|prostatic diseases|prostatic diseases
1470272|NCT00895466|neoplasms|neoplasms
1470273|NCT00895466|prostatic neoplasms|prostatic neoplasms
1470274|NCT00895466|hormones|hormones
1470275|NCT00895466|androgen antagonists|androgen antagonists
1470276|NCT00895466|vaccines|vaccines
1470277|NCT00895466|peptide vaccines|peptide vaccines
1470278|NCT00895466|adjuvants, immunological|adjuvants, immunological
1470279|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
1470280|NCT00895453|itraconazole|itraconazole
1470281|NCT00895453|classic homeopathy|classic homeopathy
1470282|NCT00895440|Diabetes|diabetes
1470283|NCT00895440|Diabetic neuropathy|diabetic neuropathy
1470284|NCT00895440|neuropad|neuropad
1470285|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
1470286|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
1470287|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
1470288|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
1470289|NCT00895427|Coronary artery calcification|coronary artery calcification
1470290|NCT00895414|stage I breast cancer|stage i breast cancer
1470291|NCT00895414|stage II breast cancer|stage ii breast cancer
1470292|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
1470293|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
1470294|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
1470295|NCT00895414|stage IV breast cancer|stage iv breast cancer
1470296|NCT00895401|Nutritional supplement|nutritional supplement
1470297|NCT00895401|Malnutrition|malnutrition
1470298|NCT00895401|Hemodialysis|hemodialysis
1470299|NCT00895401|Nepro with Carb Steady|nepro with carb steady
1470300|NCT00895388|Urinary function|urinary function
1470301|NCT00895388|Anal function|anal function
1470302|NCT00895375|Dermatology|dermatology
1470303|NCT00895375|Skin|skin
1470304|NCT00895375|Psoriasis|psoriasis
1470305|NCT00895375|Sleep|sleep
1470306|NCT00895375|Wake Forest|wake forest
1470307|NCT00895375|Insomnia|insomnia
1470308|NCT00895362|Advanced Cancer|advanced cancer
1470309|NCT00895362|EGFR mutation|egfr mutation
1470310|NCT00895362|Erlotinib|erlotinib
1470311|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
1470312|NCT00895362|Tarceva|tarceva
1470313|NCT00895362|OSI-774|osi-774
1470314|NCT00895362|Cetuximab|cetuximab
1470315|NCT00895362|C225|c225
1470316|NCT00895362|Erbitux|erbitux
1470317|NCT00895362|IMC-C225|imc-c225
1470318|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
1470319|NCT00895349|Diagnostic Intervention|diagnostic intervention
1470320|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
1470321|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
1470322|NCT00895323|stage I colon cancer|stage i colon cancer
1470323|NCT00895323|stage II colon cancer|stage ii colon cancer
1470324|NCT00895323|stage III colon cancer|stage iii colon cancer
1470325|NCT00895323|stage IV colon cancer|stage iv colon cancer
1470326|NCT00895323|stage I rectal cancer|stage i rectal cancer
1470327|NCT00895323|stage II rectal cancer|stage ii rectal cancer
1470328|NCT00895323|stage III rectal cancer|stage iii rectal cancer
1470329|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
1470330|NCT00895323|recurrent colon cancer|recurrent colon cancer
1470331|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
1470332|NCT00895310|PSA|psa
1470333|NCT00895310|Ketoconazole|ketoconazole
1470334|NCT00895310|Prostate Cancer|prostate cancer
1470335|NCT00895310|Hormone Refractory|hormone refractory
1470336|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
1470337|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
1470338|NCT00895297|Dasatinib|dasatinib
1470339|NCT00895297|Sprycel|sprycel
1470340|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
1470341|NCT00895284|robotic|robotic
1470342|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
1470343|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
1470344|NCT00895271|Immunodysregulation|immunodysregulation
1470345|NCT00895271|Skin Biopsy|skin biopsy
1470346|NCT00895271|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
1470347|NCT00895271|Lymphocyte|lymphocyte
1470348|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
1470349|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
1470350|NCT00895271|Healthy Volunteer|healthy volunteer
1470351|NCT00895271|HV|hv
1470352|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
1470353|NCT00895258|Major Depressive Disorder|major depressive disorder
1470354|NCT00895258|Supported Employment|supported employment
1470355|NCT00895258|Work|work
1470356|NCT00895258|Rehabilitation|rehabilitation
1470357|NCT00895258|Severe Mental Illness|severe mental illness
1470358|NCT00895258|Cognitive Training|cognitive training
1470359|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
1470360|NCT00895258|Cognitive Remediation|cognitive remediation
1470361|NCT00895219|Hyperventilation|hyperventilation
1470362|NCT00895219|Dysfunctional breathing|dysfunctional breathing
1470363|NCT00895219|Physiotherapy|physiotherapy
1470364|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
1470365|NCT00895193|Niacin|niacin
1567589|NCT00508794|Yoga|yoga
1470366|NCT00895193|Hypercholesterolemia|hypercholesterolemia
1470367|NCT00895193|Flushing|flushing
1470368|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
1470369|NCT00895180|adult glioblastoma|adult glioblastoma
1470370|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
1470371|NCT00895180|adult gliosarcoma|adult gliosarcoma
1470372|NCT00895167|Heme Oxygenase|heme oxygenase
1470373|NCT00895167|Genetic Polymorphism|genetic polymorphism
1470374|NCT00895167|Healthy Subjects|healthy subjects
1470375|NCT00895154|Sickle Cell Disease|sickle cell disease
1470376|NCT00895154|Sickle Cell|sickle cell
1470377|NCT00895154|Memory|memory
1470378|NCT00895154|Learning|learning
1470379|NCT00895154|Achievement|achievement
1470380|NCT00895141|Saturated fat|saturated fat
1470381|NCT00895141|LDL size|ldl size
1470382|NCT00895141|Large LDL|large ldl
1470383|NCT00895141|Large HDL|large hdl
1470384|NCT00895128|Advanced Cancer|advanced cancer
1470385|NCT00895128|EGFR mutations|egfr mutations
1470386|NCT00895128|Dasatinib|dasatinib
1470387|NCT00895128|Sprycel|sprycel
1470388|NCT00895128|Erlotinib|erlotinib
1470389|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
1470390|NCT00895128|Tarceva|tarceva
1470391|NCT00895115|prostate cancer|prostate cancer
1470392|NCT00895102|Bioavailability (BA)|bioavailability (ba)
1470393|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
1470394|NCT00895089|liver abscess|liver abscess
1470395|NCT00895089|moxifloxacin|moxifloxacin
1470396|NCT00895089|ceftriaxone|ceftriaxone
1470397|NCT00895089|treatment|treatment
1470398|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
1470399|NCT00895063|Botulinum Toxin|botulinum toxin
1470400|NCT00895063|Vocal Exercise|vocal exercise
1470401|NCT00895024|Caregiver|caregiver
1470402|NCT00895024|Questionnaire|questionnaire
1470403|NCT00895024|Home Hospice Care|home hospice care
1470404|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
1470405|NCT00895024|FEHC|fehc
1470406|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
1470407|NCT00895024|TRIG|trig
1470408|NCT00895024|Cross-ethnic differences|cross-ethnic differences
1470409|NCT00895024|Parenteral Hydration|parenteral hydration
1470410|NCT00895024|Grief|grief
1470411|NCT00895011|Erectile Dysfunction|erectile dysfunction
1470412|NCT00895011|E.D.|e.d.
1470413|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
1470414|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
1470415|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
1470416|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
1470417|NCT00894933|Prostate Cancer|prostate cancer
1470418|NCT00894933|Radical Prostatectomy|radical prostatectomy
1470419|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
1470420|NCT00894920|biotin|biotin
1470421|NCT00894920|deficiency|deficiency
1470422|NCT00894920|pregnancy|pregnancy
1470423|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
1470424|NCT00894907|Severe pancreatitis|severe pancreatitis
1470425|NCT00894907|acute pancreatitis|acute pancreatitis
1470426|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
1470427|NCT00894907|PiCCO|picco
1470428|NCT00894894|MP470|mp470
1470429|NCT00894894|MP-470|mp-470
1470430|NCT00894894|SuperGen|supergen
1470431|NCT00894894|Tyrosine|tyrosine
1470432|NCT00894894|Kinase|kinase
1470433|NCT00894894|Inhibitor|inhibitor
1470434|NCT00894894|Solid Malignancies|solid malignancies
1470435|NCT00894894|Oncology|oncology
1470436|NCT00894881|colonoscopy|colonoscopy
1470437|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
1470438|NCT00894868|Congestive Heart Failure|congestive heart failure
1470439|NCT00894868|CHF, vildagliptin|chf, vildagliptin
1470440|NCT00894868|metabolic disease|metabolic disease
1470441|NCT00894868|cardiovascular disease|cardiovascular disease
1470442|NCT00894868|T2DM|t2dm
1470443|NCT00894855|skin cancer prevention|skin cancer prevention
1470444|NCT00894855|SHADE|shade
1470445|NCT00894855|Beach|beach
1470446|NCT00894842|Schizophrenia|schizophrenia
1470447|NCT00894842|Pregnenolone|pregnenolone
1470448|NCT00894842|Neurocognition|neurocognition
1470449|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
1470450|NCT00894816|Prevention|prevention
1470451|NCT00894816|Probiotics|probiotics
1470452|NCT00894816|Eczema|eczema
1470453|NCT00894816|Allergy|allergy
1470454|NCT00894816|Asthma|asthma
1470455|NCT00894816|Obesity|obesity
1470456|NCT00894816|Caries|caries
1470457|NCT00894816|Gut microbiota|gut microbiota
1470458|NCT00894803|acute ischemic stroke|acute ischemic stroke
1470459|NCT00894803|stroke|stroke
1470460|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
1470461|NCT00894803|t-PA|t-pa
1470462|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1470463|NCT00894803|Activase|activase
1470464|NCT00894803|eptifibatide|eptifibatide
1470465|NCT00894803|Integrilin|integrilin
1470466|NCT00894803|fibrinolytic agents|fibrinolytic agents
1470467|NCT00894803|clot dissolving|clot dissolving
1470469|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
1470470|NCT00894790|sprain|sprain
1470471|NCT00894790|Celecoxib|celecoxib
1470472|NCT00894790|NSAID|nsaid
1470473|NCT00894790|Diclofenac|diclofenac
1470474|NCT00894777|Psoriasis|psoriasis
1470475|NCT00894764|Childhood|childhood
1470476|NCT00894764|Pneumonia|pneumonia
1470477|NCT00894764|Pneumococcal|pneumococcal
1470478|NCT00894764|pneumococcus|pneumococcus
1470479|NCT00894764|Carriage|carriage
1470480|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
1470481|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
1470482|NCT00894738|pediatric|pediatric
1470483|NCT00894738|mental illness|mental illness
1470484|NCT00894738|antipsychotic|antipsychotic
1470485|NCT00894738|cardiometabolic risk|cardiometabolic risk
1470486|NCT00894738|Antipsychotic agents|antipsychotic agents
1470487|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
1470488|NCT00894725|left colon cancer|left colon cancer
1470489|NCT00894712|Radiation Therapy|radiation therapy
1470490|NCT00894699|procedural sedation|procedural sedation
1470491|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
1470492|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
1470493|NCT00894647|actinic keratosis|actinic keratosis
1470494|NCT00894647|skin disease|skin disease
1470495|NCT00894621|Shock|shock
1470496|NCT00894621|Respiration, artificial|respiration, artificial
1470497|NCT00894621|Norepinephrine|norepinephrine
1470498|NCT00894608|letrozole|letrozole
1470499|NCT00894608|ovarian stimulation|ovarian stimulation
1470500|NCT00894608|PCOS|pcos
1470501|NCT00894608|IVF-ET|ivf-et
1470502|NCT00894595|Incidence of ACL injury|incidence of acl injury
1470503|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
1470504|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
1470505|NCT00894582|massive ventral hernia|massive ventral hernia
1470506|NCT00894582|abdominal volume|abdominal volume
1470507|NCT00894582|pulmonary function|pulmonary function
1470508|NCT00894582|components separation|components separation
1470509|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
1470510|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
1470511|NCT00894569|cancer of unknown primary|cancer of unknown primary
1470513|NCT00894569|carboplatin|carboplatin
1470514|NCT00894569|paclitaxel|paclitaxel
1470515|NCT00894569|cetuximab|cetuximab
1470516|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
1470517|NCT00894543|Hot flashes|hot flashes
1470518|NCT00894543|Menopause|menopause
1470519|NCT00894543|Vasomotor symptoms|vasomotor symptoms
1470520|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
1470521|NCT00894504|Triple Negative|triple negative
1470522|NCT00894504|Panitumumab|panitumumab
1470523|NCT00894504|Vectibix|vectibix
1470524|NCT00894504|Gemcitabine|gemcitabine
1470525|NCT00894504|Gemzar|gemzar
1470526|NCT00894504|Carboplatin|carboplatin
1470527|NCT00894491|alternative medicine|alternative medicine
1470528|NCT00894491|complementary medicine|complementary medicine
1470529|NCT00894491|acupuncture|acupuncture
1470530|NCT00894491|Chinese herbals|chinese herbals
1470531|NCT00894478|MRI-Negative|mri-negative
1470532|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
1470533|NCT00894478|Localization-related epilepsy|localization-related epilepsy
1470534|NCT00894478|Partial Epilepsy|partial epilepsy
1470535|NCT00894478|Children|children
1470536|NCT00894465|Midazolam|midazolam
1470537|NCT00894465|VCUG|vcug
1470538|NCT00894465|Anxiety|anxiety
1470539|NCT00894452|Methadone|methadone
1470540|NCT00894452|CYP|cyp
1470541|NCT00894452|OPRM1|oprm1
1470542|NCT00894452|MDR1|mdr1
1470543|NCT00894452|COMT|comt
1470544|NCT00894452|Midazolam challenge|midazolam challenge
1470545|NCT00894426|COPD|copd
1470546|NCT00894426|Symptom|symptom
1470547|NCT00894426|Morning activity|morning activity
1470548|NCT00894426|Questionnaire|questionnaire
1470549|NCT00894400|AF|af
1470550|NCT00894400|catheter ablation|catheter ablation
1470551|NCT00894400|fractionated electrogram|fractionated electrogram
1470845|NCT00893048|cellulitis|cellulitis
1470552|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
1470553|NCT00894387|elevated BNP|elevated bnp
1470554|NCT00894387|reduced LVEF|reduced lvef
1470555|NCT00894387|Acute Heart Failure|acute heart failure
1470556|NCT00894387|Cardiovascular death|cardiovascular death
1470557|NCT00894387|CHF|chf
1470558|NCT00894387|hospitalization|hospitalization
1470559|NCT00894387|morbi-mortality trial|morbi-mortality trial
1470560|NCT00894387|outcome study|outcome study
1470561|NCT00894387|endpoint driven|endpoint driven
1470562|NCT00894387|plasma renin activity|plasma renin activity
1470563|NCT00894387|renin angiotensin|renin angiotensin
1470564|NCT00894387|aldosterone system|aldosterone system
1470565|NCT00894387|direct renin inhibitors|direct renin inhibitors
1470566|NCT00894387|BNP|bnp
1470567|NCT00894387|KCCQ|kccq
1470568|NCT00894387|eGFR|egfr
1470569|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
1470570|NCT00894361|knee arthritis|knee arthritis
1470571|NCT00894361|total knee arthroplasty|total knee arthroplasty
1470572|NCT00894361|total knee replacement|total knee replacement
1470573|NCT00894361|mobile bearing design|mobile bearing design
1470574|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
1470575|NCT00894348|ERCP|ercp
1470576|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
1470577|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
1470578|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
1470579|NCT00894322|diabetes|diabetes
1470580|NCT00894322|exenatide once weekly|exenatide once weekly
1470581|NCT00894322|Byetta|byetta
1470582|NCT00894322|Amylin|amylin
1470583|NCT00894322|Lilly|lilly
1470585|NCT00894296|schizophrenia|schizophrenia
1470586|NCT00894296|negative symptoms|negative symptoms
1470588|NCT00894283|PE|pe
1470589|NCT00894283|MRV|mrv
1470590|NCT00894283|bariatric surgery|bariatric surgery
1470591|NCT00894270|Diabetes|diabetes
1470592|NCT00894270|Injection|injection
1470593|NCT00894270|Needle|needle
1470594|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
1470595|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
1470596|NCT00894205|neuropsychological function|neuropsychological function
1470597|NCT00894205|cognitive function|cognitive function
1470598|NCT00894205|exercise|exercise
1470599|NCT00894205|older adult|older adult
1470600|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
1470601|NCT00894179|coronary artery disease|coronary artery disease
1470602|NCT00894179|stress echocardiography|stress echocardiography
1470603|NCT00894179|regadenoson|regadenoson
1470604|NCT00894179|atropine|atropine
1470605|NCT00894179|coronary angiogram|coronary angiogram
1470606|NCT00894166|Smoking Cessation|smoking cessation
1470607|NCT00894166|Chantix|chantix
1470608|NCT00894166|varenicline|varenicline
1470609|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
1470610|NCT00894166|Nicotine Patches|nicotine patches
1470611|NCT00894166|Zyban|zyban
1470612|NCT00894166|bupropion|bupropion
1470613|NCT00894166|Quit Smoking|quit smoking
1470614|NCT00894153|p53 gene|p53 gene
1470615|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
1470616|NCT00894153|gene therapy|gene therapy
1470617|NCT00894140|Hip|hip
1470618|NCT00894140|Cementless|cementless
1470619|NCT00894140|Conservative|conservative
1470620|NCT00894127|Lung Cancer|lung cancer
1470621|NCT00894127|Porphyrin|porphyrin
1470622|NCT00894127|Fluorescence|fluorescence
1470623|NCT00894127|Diagnostic|diagnostic
1470624|NCT00894127|Sputum Cytology|sputum cytology
1470625|NCT00894127|Early Detection|early detection
1470626|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
1470627|NCT00894075|alkaline phosphatase|alkaline phosphatase
1470628|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1470629|NCT00894075|rickets|rickets
1470630|NCT00894075|osteomalacia|osteomalacia
1470631|NCT00894036|esbl children Switzerland|esbl children switzerland
1470632|NCT00894036|Colonization|colonization
1470633|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
1470634|NCT00894036|Infection|infection
1470635|NCT00894023|Patients with AMI|patients with ami
1470636|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
1470637|NCT00894010|Photosensitivity|photosensitivity
1470638|NCT00894010|Seizures|seizures
1470639|NCT00894010|Epilepsy|epilepsy
1470640|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
1470641|NCT00893997|MDS|mds
1470642|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
1470643|NCT00893984|Intolerance|intolerance
1470644|NCT00893984|Beta blocker|beta blocker
1470645|NCT00893971|Healthy Volunteers|healthy volunteers
1470646|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
1470647|NCT00893906|influenza|influenza
1470648|NCT00893906|influenza vaccine|influenza vaccine
1470649|NCT00893906|vaccine effectiveness|vaccine effectiveness
1470650|NCT00893906|cluster randomized|cluster randomized
1470653|NCT00893893|Lipid metabolism|lipid metabolism
1470654|NCT00893893|VLDL|vldl
1470655|NCT00893880|Tinea Pedis|tinea pedis
1470656|NCT00893880|Athletes Foot|athletes foot
1470657|NCT00893880|Nitric Oxide|nitric oxide
1470658|NCT00893867|acute ischemic stroke|acute ischemic stroke
1470659|NCT00893867|neuroprotective agent|neuroprotective agent
1470660|NCT00893841|bipolar|bipolar
1470661|NCT00893841|bipolar depression|bipolar depression
1470662|NCT00893841|bipolar disorder|bipolar disorder
1470663|NCT00893841|depression|depression
1470664|NCT00893841|quetiapine|quetiapine
1470665|NCT00893841|pramipexole|pramipexole
1470666|NCT00893841|Seroquel XR|seroquel xr
1470667|NCT00893841|Mirapex|mirapex
1470668|NCT00893815|HIV|hiv
1470669|NCT00893815|Neurocognitive function|neurocognitive function
1619069|NCT00323882|PSA|psa
1470670|NCT00893802|periodontal disease|periodontal disease
1470671|NCT00893802|pregnancy|pregnancy
1470672|NCT00893802|periodontal treatment|periodontal treatment
1470673|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
1470674|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1470675|NCT00893763|Mechanical ventilation|mechanical ventilation
1470676|NCT00893763|Endotracheal intubation|endotracheal intubation
1470677|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
1470678|NCT00893750|Formerly Abducted Children|formerly abducted children
1470679|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
1470680|NCT00893750|Trauma Treatment|trauma treatment
1470681|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
1470682|NCT00893750|Reconciliation|reconciliation
1470683|NCT00893750|Revenge Feelings|revenge feelings
1470684|NCT00893737|Migraine|migraine
1470685|NCT00893737|Headache, Migraine|headache, migraine
1470686|NCT00893724|DME|dme
1470687|NCT00893724|NAMD|namd
1470688|NCT00893724|Oxidative damage|oxidative damage
1470689|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
1470690|NCT00893724|DNA repair|dna repair
1470691|NCT00893724|NAMD/wet AMD|namd/wet amd
1470692|NCT00893711|infantile colic|infantile colic
1470693|NCT00893711|lactobacillus|lactobacillus
1470694|NCT00893711|gut microflora|gut microflora
1470695|NCT00893711|FISH|fish
1470696|NCT00893711|toll like receptor|toll like receptor
1470697|NCT00893711|T reg|t reg
1470698|NCT00893685|Telemedicine|telemedicine
1470699|NCT00893672|Radiography, Thoracic|radiography, thoracic
1470700|NCT00893672|Intensive Care Units|intensive care units
1470701|NCT00893672|Ventilation, mechanical|ventilation, mechanical
1470702|NCT00893672|Matched-Pair Analysis|matched-pair analysis
1470703|NCT00893659|Beta-glucan|beta-glucan
1470704|NCT00893659|faecal microflora|faecal microflora
1470705|NCT00893659|polypectomized|polypectomized
1470706|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
1470707|NCT00893646|abdominal obesity|abdominal obesity
1470708|NCT00893646|weight reduction|weight reduction
1470709|NCT00893646|diet|diet
1470710|NCT00893646|exercise training|exercise training
1470711|NCT00893646|lifestyle activity|lifestyle activity
1470712|NCT00893646|health-related fitness|health-related fitness
1470713|NCT00893646|walking|walking
1470714|NCT00893646|actigraphy|actigraphy
1470715|NCT00893646|lifestyle modification|lifestyle modification
1470716|NCT00893646|sleep|sleep
1470717|NCT00893646|sleep hygiene|sleep hygiene
1470718|NCT00893646|alertness|alertness
1470719|NCT00893646|daytime sleepiness|daytime sleepiness
1470720|NCT00893646|metabolic syndrome|metabolic syndrome
1470721|NCT00893646|counselling|counselling
1470722|NCT00893646|health education|health education
1470723|NCT00893646|truck drivers|truck drivers
1470724|NCT00893646|bus drivers|bus drivers
1470725|NCT00893646|randomized controlled trial|randomized controlled trial
1470726|NCT00893633|neuromuscular diseases|neuromuscular diseases
1470727|NCT00893633|critical illness|critical illness
1470728|NCT00893633|mechanical ventilation|mechanical ventilation
1470729|NCT00893633|phrenic nerve|phrenic nerve
1470730|NCT00893633|nerve conduction studies|nerve conduction studies
1470731|NCT00893620|iliac aneurysm|iliac aneurysm
1470732|NCT00893620|endovascular repair|endovascular repair
1470733|NCT00893594|migraine|migraine
1470734|NCT00893594|migraine with aura|migraine with aura
1470735|NCT00893594|headache|headache
1470736|NCT00893581|mania|mania
1470737|NCT00893581|adolescent|adolescent
1470738|NCT00893581|bipolar|bipolar
1470739|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
1470740|NCT00893555|Invasive fungal infection|invasive fungal infection
1470741|NCT00893555|hematological malignancy|hematological malignancy
1470742|NCT00893555|voriconazole|voriconazole
1470743|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
1470744|NCT00893529|overweight|overweight
1470745|NCT00893529|children|children
1470746|NCT00893529|intervention|intervention
1470747|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
1470748|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
1470749|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1470846|NCT00893048|erysipelas|erysipelas
1470750|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1470751|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1470752|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1470753|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1470754|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1470755|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1470756|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1470757|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1470758|NCT00893451|renal disease|renal disease
1470759|NCT00893451|renal impairment|renal impairment
1470760|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
1470761|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
1470762|NCT00893451|cholecalciferol|cholecalciferol
1470763|NCT00893451|vitamin D deficiency|vitamin d deficiency
1470764|NCT00893451|insulin resistance|insulin resistance
1470765|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
1470766|NCT00893451|non-diabetic|non-diabetic
1470767|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
1470768|NCT00893438|Adolescence|adolescence
1470769|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
1470770|NCT00893438|Web-based|web-based
1470771|NCT00893438|Internet|internet
1470772|NCT00893438|Efficacy|efficacy
1470773|NCT00893425|CD95|cd95
1470774|NCT00893425|ADMA|adma
1470775|NCT00893425|proteinuria|proteinuria
1470776|NCT00893425|diabetic nephropathy|diabetic nephropathy
1470777|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
1470778|NCT00893412|HSG|hsg
1470779|NCT00893412|analgesia|analgesia
1470780|NCT00893412|tramadol|tramadol
1470781|NCT00893412|metal cannula|metal cannula
1470782|NCT00893412|balloon catheter|balloon catheter
1470783|NCT00893399|adult patients|adult patients
1470784|NCT00893399|NPM1 mutation|npm1 mutation
1470785|NCT00893386|Extraction|extraction
1470786|NCT00893386|Removal|removal
1470787|NCT00893386|Lead|lead
1470788|NCT00893386|Heart Failure|heart failure
1470789|NCT00893373|AML|aml
1470790|NCT00893373|sorafenib|sorafenib
1470791|NCT00893360|Adult Stem cells|adult stem cells
1470792|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
1470793|NCT00893360|Myocardial infarction|myocardial infarction
1470794|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
1470795|NCT00893347|Concussion|concussion
1470796|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
1470797|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
1470798|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
1470799|NCT00893334|muscular dystrophy|muscular dystrophy
1470800|NCT00893295|colon cancer|colon cancer
1470801|NCT00893295|rectal cancer|rectal cancer
1470802|NCT00893282|renal|renal
1470803|NCT00893282|calculi|calculi
1470804|NCT00893282|kidney|kidney
1470805|NCT00893282|stones|stones
1470806|NCT00893269|marijuana|marijuana
1470807|NCT00893269|cannabis|cannabis
1470808|NCT00893269|dependence|dependence
1470809|NCT00893269|withdrawal|withdrawal
1470810|NCT00893256|schizophrenia|schizophrenia
1470811|NCT00893256|risperidone|risperidone
1470812|NCT00893256|citalopram|citalopram
1470813|NCT00893256|secondary negative symptoms|secondary negative symptoms
1470814|NCT00893230|atopic dermatitis|atopic dermatitis
1470815|NCT00893230|chemokines|chemokines
1470816|NCT00893230|probiotics|probiotics
1470817|NCT00893178|eNOS Polymorphism|enos polymorphism
1470818|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
1470819|NCT00893178|pulmonary pressure|pulmonary pressure
1470820|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
1470821|NCT00893165|inflammation|inflammation
1470822|NCT00893165|cardiovascular disease|cardiovascular disease
1470823|NCT00893139|Dry Eye|dry eye
1470824|NCT00893126|psoriasis|psoriasis
1470825|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
1470826|NCT00893126|coronary events|coronary events
1470827|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
1470828|NCT00893126|arthritis|arthritis
1470829|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
1470830|NCT00893087|Children needing ventilatory care|children needing ventilatory care
1470831|NCT00893074|withdrawal|withdrawal
1470832|NCT00893074|acute effects|acute effects
1470833|NCT00893074|cognitive performance|cognitive performance
1470834|NCT00893074|Marijuana Use|marijuana use
1470835|NCT00893074|Marijuana Abstinence|marijuana abstinence
1470836|NCT00893061|stage IA breast cancer|stage ia breast cancer
1470837|NCT00893061|stage IB breast cancer|stage ib breast cancer
1470838|NCT00893061|stage II breast cancer|stage ii breast cancer
1470839|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
1470840|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
1470841|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
1470842|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1470843|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1470847|NCT00893048|steroids|steroids
1470848|NCT00893048|oral|oral
1470849|NCT00893035|Radiotherapy|radiotherapy
1470850|NCT00893035|Late side effects|late side effects
1470851|NCT00893035|Predictive assay|predictive assay
1470852|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
1470853|NCT00893009|Inspiratory capacity|inspiratory capacity
1470854|NCT00893009|endurance time|endurance time
1470855|NCT00893009|residual volume|residual volume
1619345|NCT00322673|AML|aml
1470856|NCT00892996|Intrathecal morphine|intrathecal morphine
1470857|NCT00892996|Cesarean section|cesarean section
1470858|NCT00892996|Nausea and vomiting|nausea and vomiting
1470859|NCT00892996|Prevention|prevention
1470862|NCT00892983|Physical activity|physical activity
1470863|NCT00892983|Breast feeding|breast feeding
1470864|NCT00892983|Depression|depression
1470865|NCT00892957|Vascular Surgery|vascular surgery
1470866|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
1470867|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
1470868|NCT00892944|Positron Emission Tomography|positron emission tomography
1470870|NCT00892944|Healthy volunteers|healthy volunteers
1470871|NCT00892944|AZD2516|azd2516
1470872|NCT00892931|Glioblastoma|glioblastoma
1470873|NCT00892931|Brain Neoplasms|brain neoplasms
1470874|NCT00892931|Recurrence|recurrence
1470875|NCT00892918|pterygium|pterygium
1470876|NCT00892918|gatifloxacin|gatifloxacin
1470877|NCT00892918|moxifloxacin|moxifloxacin
1470878|NCT00892918|corneal epithelial defect|corneal epithelial defect
1470879|NCT00892905|coagulation|coagulation
1470880|NCT00892905|INR|inr
1470881|NCT00892905|aPTT|aptt
1470882|NCT00892905|point of care|point of care
1470883|NCT00892905|laboratory|laboratory
1470884|NCT00892905|CABG|cabg
1470885|NCT00892905|surgery|surgery
1470886|NCT00892892|sympatholytic treatment|sympatholytic treatment
1470887|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
1470888|NCT00892853|calcification|calcification
1470889|NCT00892853|osteoporosis|osteoporosis
1470890|NCT00892827|Rituximab|rituximab
1470891|NCT00892827|Mabthera|mabthera
1470892|NCT00892827|FFP|ffp
1470893|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
1470894|NCT00892827|CLL|cll
1470895|NCT00892827|Complement|complement
1470896|NCT00892827|Response|response
1470897|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
1470898|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
1470899|NCT00892827|after the study treatment.|after the study treatment.
1470900|NCT00892827|Time to disease progression|time to disease progression
1470901|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
1470902|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
1470903|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
1470904|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1470905|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1470906|NCT00892788|Overweight|overweight
1470907|NCT00892788|Obesity|obesity
1470908|NCT00892788|Contingency Management|contingency management
1470909|NCT00892775|Working seed virus|working seed virus
1470910|NCT00892775|Rubella|rubella
1470911|NCT00892775|Mumps|mumps
1470912|NCT00892775|Varicella|varicella
1470913|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
1470914|NCT00892775|Pediatric immunization|pediatric immunization
1470915|NCT00892775|Measles|measles
1470916|NCT00892762|Open Angle Glaucoma|open angle glaucoma
1470917|NCT00892762|Ocular hypertension|ocular hypertension
1470918|NCT00892762|OAG|oag
1470919|NCT00892762|OH|oh
1470920|NCT00892749|hyperphosphatemia|hyperphosphatemia
1470921|NCT00892749|hemodialysis|hemodialysis
1470922|NCT00892749|CKD|ckd
1470923|NCT00892749|ASP1585|asp1585
1470924|NCT00892723|AZX100|azx100
1470925|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
1470926|NCT00892723|POSAS|posas
1470927|NCT00892723|Visual Analog Scale|visual analog scale
1470928|NCT00892723|VAS|vas
1470929|NCT00892723|Keloid|keloid
1470930|NCT00892723|Scarring|scarring
1470931|NCT00892723|Scar reduction|scar reduction
1470932|NCT00892723|Scar prevention|scar prevention
1470933|NCT00892710|Non small cell lung cancer|non small cell lung cancer
1470934|NCT00892710|NSCLC|nsclc
1470935|NCT00892710|Pemetrexed|pemetrexed
1470936|NCT00892710|Bevacizumab|bevacizumab
1470937|NCT00892710|Avastin|avastin
1470938|NCT00892710|Carboplatin|carboplatin
1470939|NCT00892710|Stage IIIB/IV|stage iiib/iv
1470940|NCT00892697|hepatitis C|hepatitis c
1470941|NCT00892697|FNA|fna
1470942|NCT00892697|intrahepatic|intrahepatic
1470943|NCT00892684|Randomized|randomized
1470944|NCT00892684|Placebo controlled|placebo controlled
1470945|NCT00892684|Double blind|double blind
1470946|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
1470947|NCT00892684|Pregnancy|pregnancy
1470948|NCT00892684|Childhood allergy|childhood allergy
1470949|NCT00892684|Cytokines|cytokines
1470950|NCT00892684|Eicosanoids|eicosanoids
1470951|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
1470952|NCT00892671|Perceived effectiveness|perceived effectiveness
1470953|NCT00892658|Sorafenib|sorafenib
1470954|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
1470955|NCT00892632|Biliary Strictures|biliary strictures
1470956|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
1470957|NCT00892632|ERCP|ercp
1470958|NCT00892619|Epiretinal Membrane|epiretinal membrane
1470959|NCT00892619|Vitreomacular traction|vitreomacular traction
1470960|NCT00892619|MVR blade|mvr blade
1470961|NCT00892619|Tano brush|tano brush
1470962|NCT00892619|ILM forceps|ilm forceps
1470963|NCT00892619|surgical technique|surgical technique
1470964|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
1470965|NCT00892606|Pain, Postoperative|pain, postoperative
1470966|NCT00892593|colon|colon
1470967|NCT00892593|neoplasia|neoplasia
1470968|NCT00892593|polyp|polyp
1470969|NCT00892593|adenoma|adenoma
1470970|NCT00892593|FIT|fit
1470971|NCT00892593|cancer|cancer
1470972|NCT00892580|fragile X syndrome|fragile x syndrome
1470973|NCT00892580|biomarkers|biomarkers
1470974|NCT00892567|breast cancer|breast cancer
1470975|NCT00892567|peptide vaccine|peptide vaccine
1470976|NCT00892567|immunotherapy|immunotherapy
1470977|NCT00892554|Phenylketonurias|phenylketonurias
1470978|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
1470979|NCT00892554|Neuropsychological Tests|neuropsychological tests
1470980|NCT00892554|Female|female
1470981|NCT00892554|Adolescent|adolescent
1470982|NCT00892554|Adult|adult
1470983|NCT00892541|Schizophrenia|schizophrenia
1470984|NCT00892541|Mood disorders|mood disorders
1470985|NCT00892541|Antipsychotic drugs|antipsychotic drugs
1470986|NCT00892541|Renal secretion|renal secretion
1470987|NCT00892541|ER OROS paliperidone|er oros paliperidone
1470988|NCT00892515|breast cancer|breast cancer
1470989|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
1470990|NCT00892502|haematology|haematology
1470991|NCT00892502|haematological|haematological
1470992|NCT00892502|hematology|hematology
1470993|NCT00892502|hematological|hematological
1470994|NCT00892502|malignancy|malignancy
1470995|NCT00892502|lymphoma|lymphoma
1470996|NCT00892502|myeloma|myeloma
1470997|NCT00892502|leukemia|leukemia
1470998|NCT00892502|blood diseases|blood diseases
1470999|NCT00892502|malignant|malignant
1471000|NCT00892502|bismuth|bismuth
1471001|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
1471002|NCT00892489|ER OROS Paliperidone|er oros paliperidone
1471003|NCT00892476|myopia|myopia
1471004|NCT00892476|calcium supplementation|calcium supplementation
1471005|NCT00892476|prematurity|prematurity
1471006|NCT00892463|Major Depressive Disorder|major depressive disorder
1471007|NCT00892463|Seroquel XR|seroquel xr
1471008|NCT00892463|Quetiapine|quetiapine
1471009|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
1471010|NCT00892450|Parkinson's disease|parkinson's disease
1471011|NCT00892450|darifenacin|darifenacin
1471012|NCT00892450|oxybutynin|oxybutynin
1471013|NCT00892450|cognition|cognition
1471014|NCT00892437|HIV|hiv
1471015|NCT00892437|HIV-1|hiv-1
1471016|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
1471017|NCT00892424|Liver metastasis|liver metastasis
1471018|NCT00892424|sorafenib|sorafenib
1471019|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
1471020|NCT00892411|Neuroplasticity|neuroplasticity
1471021|NCT00892411|Prognosis|prognosis
1471022|NCT00892398|Trabeculectomy|trabeculectomy
1471023|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1471024|NCT00892398|Wound Healing|wound healing
1471025|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
1471026|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1471027|NCT00892372|body weight|body weight
1471028|NCT00892372|glycohemoglobin|glycohemoglobin
1471029|NCT00892359|pharmacokinetics|pharmacokinetics
1471030|NCT00892359|renal replacement therapy|renal replacement therapy
1471031|NCT00892359|hemofiltration|hemofiltration
1471032|NCT00892359|anidulafungin|anidulafungin
1471033|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1471034|NCT00892346|maintenance|maintenance
1471035|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
1471036|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
1471037|NCT00892320|ER OROS paliperidone|er oros paliperidone
1471038|NCT00892307|Diagnostic Imaging|diagnostic imaging
1471039|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
1471040|NCT00892307|Computed Tomography|computed tomography
1471041|NCT00892307|CT|ct
1471042|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
1471043|NCT00892307|SPECT|spect
1471044|NCT00892307|Myocardial Perfusion|myocardial perfusion
1471045|NCT00892307|Atherosclerosis|atherosclerosis
1471046|NCT00892268|menopausal symptoms|menopausal symptoms
1471047|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1471048|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1471049|NCT00892268|breast cancer|breast cancer
1471050|NCT00892268|pain|pain
1471051|NCT00892255|Liver cancer|liver cancer
1471052|NCT00892255|Tumors|tumors
1471053|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
1619539|NCT00321711|MDS|mds
1471054|NCT00892229|First trimester missed abortion|first trimester missed abortion
1471055|NCT00892229|Misoprostol|misoprostol
1471056|NCT00892229|buccal|buccal
1471057|NCT00892229|vaginal|vaginal
1471058|NCT00892229|cervical ripening|cervical ripening
1471059|NCT00892229|first trimester|first trimester
1471060|NCT00892229|missed abortion|missed abortion
1471061|NCT00892216|PONV|ponv
1471062|NCT00892216|NUSS procedure|nuss procedure
1471063|NCT00892216|Acupressure|acupressure
1471064|NCT00892216|Pectus Excavatum|pectus excavatum
1471065|NCT00892203|Migraine|migraine
1471066|NCT00892203|Headache|headache
1471067|NCT00892190|AML|aml
1471068|NCT00892190|Dasatinib|dasatinib
1471069|NCT00892190|all trans retinoic acid|all trans retinoic acid
1471070|NCT00892190|relapsed AML|relapsed aml
1471071|NCT00892190|refractory AML|refractory aml
1471072|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
1471073|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
1471074|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
1471075|NCT00892190|MDS|mds
1471076|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
1471077|NCT00892177|adult glioblastoma|adult glioblastoma
1471078|NCT00892177|adult gliosarcoma|adult gliosarcoma
1471079|NCT00892177|adult mixed glioma|adult mixed glioma
1471080|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
1471081|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1471082|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
1471083|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1471084|NCT00892164|thyroid surgery|thyroid surgery
1471085|NCT00892164|total thyroidectomy|total thyroidectomy
1471086|NCT00892164|harmonic scalpel|harmonic scalpel
1471087|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
1471088|NCT00892164|hemostatic device|hemostatic device
1471089|NCT00892138|mindfulness training|mindfulness training
1471090|NCT00892138|medical students|medical students
1471091|NCT00892138|psychology students|psychology students
1471092|NCT00892138|stress management|stress management
1471093|NCT00892138|personal development|personal development
1471094|NCT00892138|stress|stress
1471095|NCT00892125|Schizophrenia|schizophrenia
1471096|NCT00892125|Bipolar I disorder|bipolar i disorder
1471097|NCT00892125|mood disorders|mood disorders
1471098|NCT00892125|antipsychotic drugs|antipsychotic drugs
1471099|NCT00892125|enzyme inducer|enzyme inducer
1471100|NCT00892125|Paliperidone ER|paliperidone er
1471101|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1471102|NCT00892112|Cardiomyopathies|cardiomyopathies
1471103|NCT00892112|Parvo B19, Human|parvo b19, human
1471104|NCT00892099|end stage renal disease|end stage renal disease
1471105|NCT00892099|hemodialysis|hemodialysis
1471106|NCT00892086|geriatric syndrome|geriatric syndrome
1471107|NCT00892086|immobility|immobility
1471108|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
1471109|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
1471110|NCT00892073|Children|children
1471111|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
1471112|NCT00892047|Depression|depression
1471113|NCT00892047|Aripiprazole|aripiprazole
1471114|NCT00892047|Venlafaxine|venlafaxine
1471115|NCT00892047|Partial Remission|partial remission
1471116|NCT00892047|Augmentation strategy|augmentation strategy
1471117|NCT00892047|Treatment resistance|treatment resistance
1471118|NCT00892047|Elderly|elderly
1471119|NCT00892047|Late-life|late-life
1471120|NCT00892008|pregabalin|pregabalin
1471121|NCT00892008|neuropathic pain|neuropathic pain
1471122|NCT00892008|safety|safety
1471123|NCT00891995|Type 1 Diabetes|type 1 diabetes
1471124|NCT00891995|Closed Loop Therapy|closed loop therapy
1471125|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
1471126|NCT00891982|Acne Vulgaris|acne vulgaris
1471127|NCT00891969|stage I breast cancer|stage i breast cancer
1471128|NCT00891969|stage II breast cancer|stage ii breast cancer
1471129|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
1471130|NCT00891956|Rett Syndrome|rett syndrome
1471131|NCT00891943|Obesity|obesity
1471132|NCT00891943|Overweight|overweight
1471133|NCT00891943|Randomised controlled trial|randomised controlled trial
1471134|NCT00891943|Primary Care|primary care
1471135|NCT00891943|Weight|weight
1471136|NCT00891943|Cardiovascular Risk|cardiovascular risk
1471137|NCT00891943|Diabetes|diabetes
1471138|NCT00891943|Quality of life|quality of life
1471139|NCT00891930|wild-type KRAS|wild-type kras
1471140|NCT00891930|panitumumab|panitumumab
1471141|NCT00891930|biomarker|biomarker
1471142|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
1471143|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
1471144|NCT00891917|Down syndrome|down syndrome
1471145|NCT00891917|coenzyme Q10|coenzyme q10
1471146|NCT00891917|language function|language function
1471147|NCT00891917|behavior|behavior
1567590|NCT00508794|Quality of Life|quality of life
1471148|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1471149|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1471150|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1471151|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1471152|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1471253|NCT00891592|Multiple Myeloma|multiple myeloma
1471254|NCT00891592|Hodgkin's|hodgkin's
1471153|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1471154|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
1471155|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1471156|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1471157|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
1471158|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
1471159|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
1471160|NCT00891865|lung transplant|lung transplant
1471161|NCT00891865|BOS|bos
1471162|NCT00891865|OB|ob
1471163|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
1471164|NCT00891865|Lung disease|lung disease
1471165|NCT00891826|Bipolar disorders|bipolar disorders
1471166|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
1471167|NCT00891826|Heart rate|heart rate
1471168|NCT00891800|Cancer|cancer
1471169|NCT00891800|Breast|breast
1471170|NCT00891800|Liver|liver
1471171|NCT00891787|Probiotics|probiotics
1471172|NCT00891787|Isoagglutinins|isoagglutinins
1471173|NCT00891787|Anti-A|anti-a
1471174|NCT00891787|Anti-B|anti-b
1471175|NCT00891787|Hemolysis|hemolysis
1471176|NCT00891787|Healthy Volunteer|healthy volunteer
1471177|NCT00891787|HV|hv
1471178|NCT00891761|cisplatin|cisplatin
1471179|NCT00891761|nausea|nausea
1471180|NCT00891761|vomiting|vomiting
1471181|NCT00891761|cancer|cancer
1471182|NCT00891761|lung cancer|lung cancer
1471183|NCT00891735|Lucentis|lucentis
1471184|NCT00891735|AMD|amd
1471185|NCT00891735|Age-related macular degeneration|age-related macular degeneration
1471186|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
1471187|NCT00891735|Wet AMD|wet amd
1471188|NCT00891735|Macular degeneration|macular degeneration
1471189|NCT00891735|Ranibizumab|ranibizumab
1471190|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1471191|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1471192|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1471193|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1471194|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1471195|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1471196|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
1471197|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1471198|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1471199|NCT00891722|childhood mixed glioma|childhood mixed glioma
1471200|NCT00891696|Sarcopenia|sarcopenia
1471201|NCT00891696|Aging|aging
1471202|NCT00891696|Metabolism|metabolism
1471203|NCT00891696|Muscle|muscle
1471204|NCT00891696|mTOR|mtor
1471205|NCT00891696|Essential Amino Acids|essential amino acids
1471206|NCT00891696|Exercise|exercise
1471207|NCT00891696|Rapamycin|rapamycin
1471208|NCT00891683|Diabetic|diabetic
1471209|NCT00891683|peripheral|peripheral
1471210|NCT00891683|neuropathy|neuropathy
1471211|NCT00891683|pain|pain
1471212|NCT00891683|hyperalgesia|hyperalgesia
1471213|NCT00891683|allodynia|allodynia
1471214|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
1471215|NCT00891670|platelet|platelet
1471216|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
1471217|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
1471218|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
1471219|NCT00891657|Adhesion|adhesion
1471220|NCT00891657|Fibroid|fibroid
1471221|NCT00891657|Myoma|myoma
1471222|NCT00891657|Leiomyoma|leiomyoma
1471223|NCT00891657|Myomectomy|myomectomy
1471224|NCT00891644|HIV|hiv
1471225|NCT00891644|Care-seeking|care-seeking
1471226|NCT00891631|tobacco|tobacco
1471227|NCT00891631|alcohol|alcohol
1471228|NCT00891631|marijuana|marijuana
1471229|NCT00891631|drug use|drug use
1471230|NCT00891631|seat-belt|seat-belt
1471231|NCT00891631|weapons|weapons
1471232|NCT00891631|depression|depression
1471233|NCT00891631|suicidality|suicidality
1471234|NCT00891631|sexual risk behaviors|sexual risk behaviors
1471235|NCT00891618|Lymphoma|lymphoma
1471236|NCT00891618|Myeloma|myeloma
1471237|NCT00891618|Multiple Myeloma|multiple myeloma
1471238|NCT00891618|MM|mm
1471239|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1471240|NCT00891618|NHL|nhl
1471241|NCT00891618|Acupuncture|acupuncture
1471242|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
1471243|NCT00891618|Thalidomide|thalidomide
1471244|NCT00891618|Bortezomib|bortezomib
1471245|NCT00891618|Neuropathy|neuropathy
1471246|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
1471247|NCT00891605|Paclitaxel|paclitaxel
1471248|NCT00891605|Solid Tumors|solid tumors
1471249|NCT00891592|AML|aml
1471250|NCT00891592|MDS|mds
1471251|NCT00891592|ALL|all
1471252|NCT00891592|NHL|nhl
1471259|NCT00891579|without EGFR mutations|without egfr mutations
1471260|NCT00891566|medium to large tear|medium to large tear
1471261|NCT00891566|rotator cuff tear|rotator cuff tear
1471262|NCT00891566|arthroscopic repair|arthroscopic repair
1471263|NCT00891566|repair integrity|repair integrity
1471264|NCT00891566|immobilization|immobilization
1471265|NCT00891553|bone mineral density|bone mineral density
1471266|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
1471267|NCT00891553|ronacaleret|ronacaleret
1471268|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
1471269|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
1471270|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
1471271|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
1471272|NCT00891514|Exercise|exercise
1471273|NCT00891514|Inflammation|inflammation
1471274|NCT00891514|Insulin Sensitivity|insulin sensitivity
1471275|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
1471276|NCT00891501|cartilage repair|cartilage repair
1471277|NCT00891501|osteoarthritis|osteoarthritis
1471278|NCT00891501|osteochondral defects|osteochondral defects
1471279|NCT00891488|VO2 max|vo2 max
1471280|NCT00891488|stress|stress
1471281|NCT00891488|cortisol|cortisol
1471282|NCT00891488|fitness|fitness
1471283|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1471284|NCT00891475|radiofrequency ablation|radiofrequency ablation
1471285|NCT00891462|COPD|copd
1471286|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1471287|NCT00891462|Chronic Bronchitis|chronic bronchitis
1471288|NCT00891462|Emphysema|emphysema
1471289|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
1471290|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
1471291|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1471292|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1471293|NCT00891449|space flight simulation study|space flight simulation study
1471294|NCT00891449|medical research study|medical research study
1471295|NCT00891449|bed rest|bed rest
1471296|NCT00891449|microgravity|microgravity
1471297|NCT00891449|weightlessness|weightlessness
1471298|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
1471299|NCT00891423|Meropenem|meropenem
1471300|NCT00891423|extended infusion|extended infusion
1471301|NCT00891423|prolonged infusion|prolonged infusion
1471302|NCT00891423|Time above MIC|time above mic
1471303|NCT00891397|CPRS|cprs
1471304|NCT00891397|stellate ganglion block|stellate ganglion block
1471305|NCT00891397|pregabalin|pregabalin
1471306|NCT00891397|pain|pain
1471307|NCT00891397|Type I|type i
1471308|NCT00891384|Multiple Myeloma|multiple myeloma
1471309|NCT00891384|maintenance therapy|maintenance therapy
1471310|NCT00891384|lenalidomide|lenalidomide
1471311|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
1471312|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
1471313|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
1471314|NCT00891358|HIV seronegativity|hiv seronegativity
1471315|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
1471316|NCT00891345|Immunotherapy|immunotherapy
1471317|NCT00891319|hand|hand
1471318|NCT00891319|stroke|stroke
1471319|NCT00891319|hemiplegia|hemiplegia
1471320|NCT00891319|electrical stimulation|electrical stimulation
1471321|NCT00891319|recovery|recovery
1471322|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
1471323|NCT00891306|Chylomicronemia|chylomicronemia
1471324|NCT00891306|Gene therapy|gene therapy
1471325|NCT00891306|AAV|aav
1471326|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
1471327|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
1471328|NCT00891306|AMT-011|amt-011
1471329|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
1471330|NCT00891293|Very high triglycerides|very high triglycerides
1471331|NCT00891293|Lovaza|lovaza
1471332|NCT00891293|fenofibrate|fenofibrate
1471333|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
1471334|NCT00891280|Castleman's Disease|castleman's disease
1471335|NCT00891280|Multiple Myeloma|multiple myeloma
1471336|NCT00891280|Breast cancer|breast cancer
1471337|NCT00891280|Solid tumors|solid tumors
1471338|NCT00891280|CK2 inhibitor|ck2 inhibitor
1471339|NCT00891267|Inflammatory markers|inflammatory markers
1471340|NCT00891267|Vascular protection|vascular protection
1471341|NCT00891267|OM Effect|om effect
1471342|NCT00891267|Metabolic syndrome|metabolic syndrome
1471343|NCT00891267|Hypertension|hypertension
1471344|NCT00891254|Incisional hernia|incisional hernia
1471345|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
1471346|NCT00891254|On-lay repair|on-lay repair
1471347|NCT00891254|Prosthetic mesh|prosthetic mesh
1471348|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
1471349|NCT00891254|Recurrence|recurrence
1471350|NCT00891254|Complications|complications
1471351|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
1471352|NCT00891228|Contraception|contraception
1471353|NCT00891228|Male Contraception|male contraception
1471354|NCT00891228|Suppression of Sperm Production|suppression of sperm production
1471355|NCT00891202|Gaucher,|gaucher,
1471356|NCT00891202|beta-glucosidase,|beta-glucosidase,
1471357|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
1471358|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
1471359|NCT00891202|glucosylceramide,|glucosylceramide,
1471360|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
1471361|NCT00891202|substrate reduction therapy|substrate reduction therapy
1471362|NCT00891189|Circadian Rhythm|circadian rhythm
1471363|NCT00891176|Conjugate vaccines|conjugate vaccines
1471364|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
1471365|NCT00891176|Antibody persistence|antibody persistence
1471366|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
1471367|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
1471368|NCT00891163|Topical anesthesia|topical anesthesia
1471369|NCT00891163|Analgesia|analgesia
1471370|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
1471371|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
1471372|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
1471373|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
1471374|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
1471375|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1471376|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1471377|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1471378|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1471379|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1471380|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1471381|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1471382|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1471383|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1471384|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1471385|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1471386|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
1471387|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
1471388|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1471389|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1471390|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1471391|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1471392|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1471393|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
1471394|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
1471395|NCT00891137|large cell lymphoma|large cell lymphoma
1471396|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1471397|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1471398|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1471399|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1471400|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1471401|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1471402|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1471403|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1471404|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1471405|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1471406|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1471407|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
1471408|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1471409|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1471410|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1471411|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1471412|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
1471413|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
1471414|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
1471415|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1471416|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1471417|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1471418|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1471419|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1471420|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1471421|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1471422|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
1471423|NCT00891137|refractory anemia|refractory anemia
1471424|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
1471425|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1471426|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1471427|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1471428|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1471429|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1471547|NCT00890747|HIV Infections|hiv infections
1471430|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1471431|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1471432|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1471433|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1471434|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1471435|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1471436|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1471437|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1471438|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1471439|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1471440|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1471441|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1471442|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1471443|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1471444|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1471445|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1471446|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1471447|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1471448|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1471449|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1471450|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1471451|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1471452|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1471453|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1471454|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1471455|NCT00891137|Burkitt lymphoma|burkitt lymphoma
1471456|NCT00891124|Hypertension|hypertension
1471457|NCT00891124|Type II DM|type ii dm
1471458|NCT00891124|Hyperlipidemia|hyperlipidemia
1471459|NCT00891124|Glycemia|glycemia
1471460|NCT00891124|ADA 2008 guideline|ada 2008 guideline
1471461|NCT00891124|Patient Consultation|patient consultation
1471462|NCT00891111|Health Risk Assessment|health risk assessment
1471463|NCT00891111|Incentives|incentives
1471464|NCT00891111|Preventative Healthcare|preventative healthcare
1471465|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
1471466|NCT00891085|ventilation|ventilation
1471467|NCT00891085|ards|ards
1471468|NCT00891085|ali|ali
1471469|NCT00891085|trauma|trauma
1471470|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
1471471|NCT00891059|Cognitive Impairment|cognitive impairment
1471472|NCT00891059|Diskus Inhaler|diskus inhaler
1471473|NCT00891059|Nursing Home|nursing home
1471474|NCT00891046|Flare|flare
1471475|NCT00891046|arthritis|arthritis
1471476|NCT00891046|IL-1beta antagonist|il-1beta antagonist
1471477|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
1471478|NCT00891046|CHAQ|chaq
1471479|NCT00891046|steroids|steroids
1471480|NCT00891046|ACR pediatric response|acr pediatric response
1471481|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
1471482|NCT00891033|cancer|cancer
1471483|NCT00891007|Measles|measles
1471484|NCT00891007|Virus Disease|virus disease
1471485|NCT00891007|Paediatric Diseases|paediatric diseases
1471664|NCT00890344|BIA|bia
1471486|NCT00891007|Paramyoxyviridae|paramyoxyviridae
1471487|NCT00890994|MBI|mbi
1471488|NCT00890994|Molecular Breast Imaging|molecular breast imaging
1471489|NCT00890994|Breast Cancer|breast cancer
1471490|NCT00890994|DCIS|dcis
1471491|NCT00890994|Breast|breast
1471492|NCT00890994|Calcifications|calcifications
1471493|NCT00890994|Microcalcifications|microcalcifications
1471494|NCT00890968|hand dermatitis|hand dermatitis
1471495|NCT00890968|hand eczema|hand eczema
1471496|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
1471497|NCT00890955|Solid tumors|solid tumors
1471498|NCT00890942|pruritus|pruritus
1471499|NCT00890942|intrathecal morphine|intrathecal morphine
1471500|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
1471501|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
1471502|NCT00890929|AML|aml
1471503|NCT00890916|spinal cord injury|spinal cord injury
1471504|NCT00890916|neuroprosthesis|neuroprosthesis
1471505|NCT00890916|functional electrical stimulation|functional electrical stimulation
1471506|NCT00890916|quadriplegia|quadriplegia
1471507|NCT00890903|NSCLC|nsclc
1471508|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
1471509|NCT00890903|metastatic breast cancer|metastatic breast cancer
1471510|NCT00890903|MBC|mbc
1471511|NCT00890903|advanced breast cancer|advanced breast cancer
1471512|NCT00890903|Navelbine|navelbine
1471513|NCT00890903|Navelbine-ORAL|navelbine-oral
1471514|NCT00890903|Vinorelbine|vinorelbine
1471515|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
1471516|NCT00890903|daily routine|daily routine
1471517|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
1471518|NCT00890903|patient compliance|patient compliance
1471519|NCT00890903|germany|germany
1471520|NCT00890903|non-interventional study|non-interventional study
1471521|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
1471522|NCT00890903|quality of life|quality of life
1471523|NCT00890877|asthma|asthma
1471524|NCT00890877|treatment|treatment
1471525|NCT00890877|placebo|placebo
1471526|NCT00890877|efficacy|efficacy
1471527|NCT00890877|safety|safety
1471528|NCT00890864|Breast screening|breast screening
1471529|NCT00890864|Mammogram|mammogram
1471530|NCT00890864|Routine screening programme|routine screening programme
1471531|NCT00890851|Radiofrequency|radiofrequency
1471532|NCT00890851|Mini invasin surgery|mini invasin surgery
1471533|NCT00890851|Outpatient treatment|outpatient treatment
1471534|NCT00890851|Men health|men health
1471535|NCT00890838|IVFO|ivfo
1471536|NCT00890838|Inflammation|inflammation
1471537|NCT00890838|Valvular surgery|valvular surgery
1471538|NCT00890838|Inflammatory status|inflammatory status
1471539|NCT00890838|Infectious complications|infectious complications
1471540|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
1471541|NCT00890825|KRAS mutation|kras mutation
1471542|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
1471543|NCT00890799|transcatheter closure|transcatheter closure
1471544|NCT00890799|ventricular septal defects|ventricular septal defects
1471545|NCT00890760|Malaria|malaria
1471546|NCT00890760|Vaccine|vaccine
1471548|NCT00890747|treatment experienced|treatment experienced
1471549|NCT00890721|Hemorrhoid|hemorrhoid
1471550|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
1471551|NCT00890721|Postoperative pain|postoperative pain
1471552|NCT00890721|Analgesia|analgesia
1471553|NCT00890695|supplementary feeding|supplementary feeding
1471554|NCT00890695|moderate malnutrition|moderate malnutrition
1471555|NCT00890695|acute infection|acute infection
1471556|NCT00890695|developing country|developing country
1471557|NCT00890695|children|children
1471558|NCT00890682|Bunion|bunion
1471559|NCT00890682|Bunionectomy|bunionectomy
1471560|NCT00890682|Osteotomy|osteotomy
1471561|NCT00890669|treadmill training|treadmill training
1471562|NCT00890669|body load|body load
1471563|NCT00890669|quality of life|quality of life
1471564|NCT00890669|Parkinson's disease|parkinson's disease
1471565|NCT00890669|Motor Symptoms|motor symptoms
1471566|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1471568|NCT00890656|Leukemia|leukemia
1471569|NCT00890656|Hyper-CVAD|hyper-cvad
1471570|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
1471571|NCT00890643|Combat Disorders|combat disorders
1471572|NCT00890643|prazosin|prazosin
1471573|NCT00890643|cognition|cognition
1471574|NCT00890643|neurophysiology|neurophysiology
1471575|NCT00890617|lung metastases|lung metastases
1471576|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1471577|NCT00890591|hypertension|hypertension
1471578|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
1471579|NCT00890591|olmesartan|olmesartan
1471580|NCT00890578|Histoacryl|histoacryl
1471581|NCT00890578|closure of surgical incisions|closure of surgical incisions
1471582|NCT00890565|Electrocardiogram|electrocardiogram
1471583|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
1471584|NCT00890565|Granisetron|granisetron
1471585|NCT00890565|Moxifloxacin|moxifloxacin
1471586|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
1471587|NCT00890565|Sancuso® patch|sancuso® patch
1471588|NCT00890565|Transdermal|transdermal
1471589|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
1471590|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
1471591|NCT00890461|ECG|ecg
1471592|NCT00890461|ICD|icd
1471593|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
1471594|NCT00890448|Genetic Markers|genetic markers
1471595|NCT00890448|DNA Markers|dna markers
1471596|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1471597|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1471598|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1471599|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1471600|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1471601|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1471602|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1471603|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
1471604|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1471605|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1471606|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1471607|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1471608|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1471609|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
1471610|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
1471611|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
1471612|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
1471613|NCT00890435|childhood meningioma|childhood meningioma
1471614|NCT00890435|childhood mixed glioma|childhood mixed glioma
1471615|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
1471616|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
1471617|NCT00890435|adult brain stem glioma|adult brain stem glioma
1471618|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
1471619|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
1471620|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
1471621|NCT00890435|adult medulloblastoma|adult medulloblastoma
1471622|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1471623|NCT00890435|adult ependymal tumors|adult ependymal tumors
1471624|NCT00890435|adult meningeal tumor|adult meningeal tumor
1471625|NCT00890435|adult mixed glioma|adult mixed glioma
1471626|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
1471627|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1471628|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
1471629|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1471630|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1471631|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1471632|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1471633|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1471634|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1471635|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1471636|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1471637|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1471638|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
1471639|NCT00890435|mast cell leukemia|mast cell leukemia
1471640|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1471641|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1471642|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1471643|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1471644|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1471645|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1471646|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
1471647|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
1471648|NCT00890422|encephalitis|encephalitis
1471649|NCT00890422|FSME|fsme
1471650|NCT00890422|central european encephalitis|central european encephalitis
1471651|NCT00890409|hypothermia|hypothermia
1471652|NCT00890409|neonate|neonate
1471653|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1471654|NCT00890409|efficacy|efficacy
1471655|NCT00890409|safety|safety
1471656|NCT00890396|Sickle Cell Anemia|sickle cell anemia
1471657|NCT00890396|Hydroxyurea|hydroxyurea
1471658|NCT00890383|trauma resuscitation|trauma resuscitation
1471659|NCT00890383|abdominal hypertension|abdominal hypertension
1471660|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
1471661|NCT00890370|Cystic fibrosis|cystic fibrosis
1471662|NCT00890370|Airway clearance|airway clearance
1471663|NCT00890344|PeaPod|peapod
1471665|NCT00890344|Anthropometry|anthropometry
1471666|NCT00890344|Body Composition|body composition
1471667|NCT00890344|Fat Mass|fat mass
1471668|NCT00890344|Total Body Water|total body water
1471669|NCT00890344|Neonatology|neonatology
1471670|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
1471671|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
1471672|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1471673|NCT00890292|ADHD|adhd
1471674|NCT00890292|JNJ-31001074|jnj-31001074
1471675|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1471676|NCT00890279|Hypertension|hypertension
1471677|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
1471678|NCT00890279|Calcium Channel Blocker|calcium channel blocker
1471679|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1471680|NCT00890279|Kidney Volume|kidney volume
1471681|NCT00890279|eGFR|egfr
1471682|NCT00890266|keratoconus|keratoconus
1471683|NCT00890266|collagen cross-linking|collagen cross-linking
1471684|NCT00890266|riboflavin|riboflavin
1471685|NCT00890266|UV light|uv light
1471686|NCT00890253|Renal impairment|renal impairment
1471687|NCT00890253|Liver transplantation|liver transplantation
1471688|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
1471689|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1471690|NCT00890240|ADHD|adhd
1471691|NCT00890240|JNJ-31001074|jnj-31001074
1471692|NCT00890227|scoliosis|scoliosis
1471693|NCT00890227|kyphosis|kyphosis
1471694|NCT00890227|Surgical treatment|surgical treatment
1471695|NCT00890214|Anticoagulation|anticoagulation
1471696|NCT00890214|Prostacyclin|prostacyclin
1471697|NCT00890214|Heparin|heparin
1471698|NCT00890214|Renal Replacement Therapy|renal replacement therapy
1471699|NCT00890214|Kidney failure acute|kidney failure acute
1471700|NCT00890214|Platelet aggregation|platelet aggregation
1471701|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
1471702|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
1471703|NCT00890201|Gallstones|gallstones
1471704|NCT00890201|Cholelithiasis|cholelithiasis
1471705|NCT00890201|Cholecystectomy|cholecystectomy
1471706|NCT00890188|THALIDOMIDE|thalidomide
1471707|NCT00890188|UFUR|ufur
1471708|NCT00890188|Colorectal cancer|colorectal cancer
1471709|NCT00890188|Oxaliplatin|oxaliplatin
1471710|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
1471711|NCT00890162|Omalizumab|omalizumab
1471712|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
1471713|NCT00890162|Serum Tryptase|serum tryptase
1471714|NCT00890162|Placebo-Controlled|placebo-controlled
1471715|NCT00890162|Adult|adult
1471716|NCT00890162|Anaphylaxis|anaphylaxis
1471717|NCT00890162|Allergic Reaction|allergic reaction
1471718|NCT00890149|alcohol abuse|alcohol abuse
1471719|NCT00890149|binge drinking|binge drinking
1471720|NCT00890149|severe drinking|severe drinking
1471721|NCT00890149|alcoholism|alcoholism
1471722|NCT00890149|heavy drinking|heavy drinking
1471723|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1471724|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
1471725|NCT00890123|Inflammation|inflammation
1471726|NCT00890123|Hip Surgery|hip surgery
1471727|NCT00890123|Inflammatory status|inflammatory status
1471728|NCT00890123|Infectious complications|infectious complications
1471729|NCT00890110|Renal cell cancer|renal cell cancer
1471730|NCT00890110|sunitinib|sunitinib
1471731|NCT00890110|autologous vaccine|autologous vaccine
1471732|NCT00890110|metastatic RCC|metastatic rcc
1471733|NCT00890097|Geographic Atrophy|geographic atrophy
1471734|NCT00890097|GA|ga
1471735|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
1471736|NCT00890097|AMD|amd
1471737|NCT00890071|Fluid responsiveness|fluid responsiveness
1471738|NCT00890071|Ultrasound|ultrasound
1471739|NCT00890071|Cardiac output|cardiac output
1471740|NCT00890058|Arthritis|arthritis
1471741|NCT00890058|Synovitis|synovitis
1471742|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
1471743|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
1471744|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
1471745|NCT00890045|ePTFE graft|eptfe graft
1471746|NCT00890045|Graft-eligible|graft-eligible
1471747|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
1471748|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
1471749|NCT00890032|adult glioblastoma|adult glioblastoma
1471750|NCT00890032|adult gliosarcoma|adult gliosarcoma
1471751|NCT00890032|adult astrocytoma|adult astrocytoma
1471752|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
1471753|NCT00890006|Prostate cancer|prostate cancer
1471754|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
1471755|NCT00889993|Food intake|food intake
1471756|NCT00889993|Gut hormones|gut hormones
1471757|NCT00889993|Fiber|fiber
1471758|NCT00889993|Visual analog scales|visual analog scales
1471759|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
1471760|NCT00889967|antimicrobial|antimicrobial
1471761|NCT00889967|inhalation|inhalation
1471762|NCT00889967|ciprofloxacin|ciprofloxacin
1471763|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
1471764|NCT00889954|EBV+|ebv+
1471765|NCT00889954|Her2|her2
1471766|NCT00889954|TGFBeta|tgfbeta
1471767|NCT00889954|EBV positive|ebv positive
1471768|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
1471769|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
1471770|NCT00889928|gallbladder disease|gallbladder disease
1471771|NCT00889928|cholecystectomy|cholecystectomy
1471772|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
1471773|NCT00889915|ADHD|adhd
1471774|NCT00889915|Methylphenidate|methylphenidate
1471775|NCT00889915|Amphetamine|amphetamine
1471776|NCT00889902|Molecular Markers|molecular markers
1471777|NCT00889902|Cervical Cancer|cervical cancer
1471778|NCT00889902|Screening|screening
1471779|NCT00889902|Makov|makov
1471780|NCT00889889|Influenza|influenza
1471781|NCT00889889|Phase II|phase ii
1471782|NCT00889889|Placebo-controlled|placebo-controlled
1471783|NCT00889876|Obesity|obesity
1471784|NCT00889876|Adolescents|adolescents
1471785|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
1471786|NCT00889876|Insulin metabolism|insulin metabolism
1471787|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
1471788|NCT00889876|Treatment|treatment
1471789|NCT00889876|Exercise|exercise
1471790|NCT00889876|Metformin|metformin
1471791|NCT00889876|Insulin|insulin
1471792|NCT00889876|Blood glucose|blood glucose
1471793|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
1471794|NCT00889863|Flare|flare
1471795|NCT00889863|arthritis|arthritis
1471796|NCT00889863|IL-1beta antagonist|il-1beta antagonist
1471797|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
1471798|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
1471799|NCT00889850|Healthy|healthy
1471800|NCT00889850|Bioavailability|bioavailability
1471801|NCT00889850|Bioequivalence|bioequivalence
1471802|NCT00889850|Esomeprazole|esomeprazole
1471803|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
1471804|NCT00889837|Staccato Loxapine|staccato loxapine
1471805|NCT00889837|COPD|copd
1471806|NCT00889837|pulmonary safety|pulmonary safety
1471807|NCT00889824|Chronic imbalance|chronic imbalance
1471808|NCT00889824|vestibular disorders|vestibular disorders
1471809|NCT00889824|balance prosthesis|balance prosthesis
1471810|NCT00889811|OPCAB|opcab
1471811|NCT00889811|RIPC|ripc
1471812|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
1471813|NCT00889798|therapy-reality|therapy-reality
1471814|NCT00889798|observation|observation
1471815|NCT00889798|registry|registry
1471816|NCT00889798|therapy sequences|therapy sequences
1471817|NCT00889798|NHL|nhl
1471818|NCT00889798|CLL|cll
1471819|NCT00889798|Germany|germany
1471820|NCT00889798|lenalidomide|lenalidomide
1471821|NCT00889798|alemtuzumab|alemtuzumab
1471822|NCT00889798|rituximab|rituximab
1471823|NCT00889798|bendamustin|bendamustin
1471824|NCT00889798|thalidomide|thalidomide
1471825|NCT00889798|bortezomib|bortezomib
1471826|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
1471827|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
1471828|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
1471829|NCT00889798|follicular lymphoma|follicular lymphoma
1471830|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
1471831|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
1471832|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
1471833|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1471834|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
1471835|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1471836|NCT00889785|Adolescents|adolescents
1471837|NCT00889785|Type 2 Diabetes|type 2 diabetes
1471838|NCT00889785|Behavioral Research|behavioral research
1471839|NCT00889772|Respiratory distress, adult|respiratory distress, adult
1471840|NCT00889772|risk|risk
1471841|NCT00889772|emergency room|emergency room
1471842|NCT00889772|high risk surgery|high risk surgery
1471843|NCT00889772|sepsis|sepsis
1471844|NCT00889772|trauma|trauma
1471845|NCT00889772|aspiration|aspiration
1471846|NCT00889772|pneumonia|pneumonia
1471847|NCT00889759|Tuberculosis|tuberculosis
1471848|NCT00889759|Outbreaks|outbreaks
1471849|NCT00889720|smoking cessation|smoking cessation
1471850|NCT00889720|varenicline|varenicline
1471851|NCT00889720|elective surgery|elective surgery
1471852|NCT00889720|wound infections|wound infections
1471853|NCT00889720|post-operative complications|post-operative complications
1471854|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1471855|NCT00889707|BPH|bph
1471856|NCT00889707|Enlarged Prostate|enlarged prostate
1471857|NCT00889668|Glucose monitoring|glucose monitoring
1471858|NCT00889668|GlucoTrack|glucotrack
1471859|NCT00889668|Self glucose monitoring|self glucose monitoring
1471860|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
1472029|NCT00889122|Obesity|obesity
1471861|NCT00889655|patient tolerability|patient tolerability
1471862|NCT00889655|Golytely|golytely
1471863|NCT00889655|MiraLax|miralax
1471864|NCT00889655|colonoscopy preparation|colonoscopy preparation
1471865|NCT00889655|bowel preparation|bowel preparation
1471866|NCT00889655|screening colonoscopy|screening colonoscopy
1471867|NCT00889629|kidney transplantation|kidney transplantation
1471868|NCT00889629|kidney transplant recipients|kidney transplant recipients
1471869|NCT00889616|Malaria|malaria
1471870|NCT00889616|Asexual Blood Stafe|asexual blood stafe
1471871|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
1471872|NCT00889616|Immunogenicity|immunogenicity
1471873|NCT00889616|Safety|safety
1471874|NCT00889616|Vaccine|vaccine
1471875|NCT00889603|Aricept® Evess|aricept® evess
1471876|NCT00889603|non-interventional study|non-interventional study
1471877|NCT00889603|Alzheimer's Disease|alzheimer's disease
1471878|NCT00889603|Vascular Dementia|vascular dementia
1471879|NCT00889603|efficacy|efficacy
1471880|NCT00889603|tolerability|tolerability
1471881|NCT00889603|safety.|safety.
1471882|NCT00889590|GCT|gct
1471883|NCT00889590|Bisfosfonates|bisfosfonates
1471884|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
1471885|NCT00889564|Catheter dependent patients|catheter dependent patients
1471886|NCT00889564|Access challenged patients|access challenged patients
1471887|NCT00889564|Bacteremia|bacteremia
1471888|NCT00889564|HeRO Vascular Access Device|hero vascular access device
1471889|NCT00889538|Autism|autism
1471890|NCT00889538|Severe Behavior Disorder|severe behavior disorder
1471891|NCT00889538|Glutathione|glutathione
1471892|NCT00889538|Antioxidants|antioxidants
1471893|NCT00889525|Cabergoline|cabergoline
1471894|NCT00889486|gastroparesis|gastroparesis
1471895|NCT00889486|diabetes mellitus|diabetes mellitus
1471896|NCT00889486|delayed gastric emptying|delayed gastric emptying
1471897|NCT00889473|larazotide acetate|larazotide acetate
1471898|NCT00889473|gluten|gluten
1471899|NCT00889460|rBet v 1|rbet v 1
1471900|NCT00889460|Birch pollen allergy|birch pollen allergy
1471901|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
1471902|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1471903|NCT00889434|Cystic fibrosis|cystic fibrosis
1471904|NCT00889434|splicing mutations|splicing mutations
1471905|NCT00889434|molecular therapy|molecular therapy
1471906|NCT00889434|EGCG|egcg
1471907|NCT00889434|Tocotrienol|tocotrienol
1471908|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
1471909|NCT00889421|uveitis|uveitis
1471910|NCT00889421|apremilast|apremilast
1471911|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1471912|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1471913|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1471914|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1471915|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1471916|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1471917|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1471918|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1471919|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1471920|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1471921|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1471922|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1471923|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1471924|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1471925|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1471926|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1471927|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1471928|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1471929|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1471930|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1471931|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1471932|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
1471933|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1471934|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1471935|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1471936|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1471937|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1471938|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1471939|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1471940|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1472030|NCT00889122|Exergames|exergames
1471941|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1471942|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1471943|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1471944|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1471945|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1471946|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1471947|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1471948|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1471949|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1472701|NCT00886470|scarring|scarring
1471950|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1471951|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1471952|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
1471953|NCT00889408|intraocular lymphoma|intraocular lymphoma
1471954|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1471955|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
1471956|NCT00889395|MISC|misc
1471957|NCT00889395|caregivers|caregivers
1471958|NCT00889395|children|children
1471959|NCT00889395|psychosocial gains|psychosocial gains
1471960|NCT00889395|cognitive benefits|cognitive benefits
1471961|NCT00889382|Ovarian Cancer|ovarian cancer
1471962|NCT00889382|Ovarian|ovarian
1471963|NCT00889382|Paclitaxel|paclitaxel
1471964|NCT00889382|OSI-906|osi-906
1471965|NCT00889382|IGF-1R|igf-1r
1471966|NCT00889382|Solid Tumors|solid tumors
1471967|NCT00889369|depression|depression
1471968|NCT00889369|duloxetine|duloxetine
1471969|NCT00889369|menopause|menopause
1471970|NCT00889369|imaging|imaging
1471971|NCT00889369|FMRI|fmri
1471972|NCT00889369|Menopausal staging|menopausal staging
1471973|NCT00889369|vasomotor symptoms|vasomotor symptoms
1471974|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
1471975|NCT00889343|Sorafenib|sorafenib
1471976|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
1471977|NCT00889343|palliative therapy|palliative therapy
1471978|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
1471979|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
1471980|NCT00889291|End stage renal disease|end stage renal disease
1471981|NCT00889291|Bacteremia|bacteremia
1471982|NCT00889291|HeRO Vascular Access Device|hero vascular access device
1471983|NCT00889291|Access challenged|access challenged
1471984|NCT00889291|Catheter dependent|catheter dependent
1471985|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
1471986|NCT00889278|Lymphoma|lymphoma
1471987|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
1471988|NCT00889278|APBSCT|apbsct
1471989|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
1471990|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
1471991|NCT00889265|Implant Surgery|implant surgery
1471992|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
1471993|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
1471994|NCT00889265|Bone Graft|bone graft
1471995|NCT00889265|Periodontal Surgery|periodontal surgery
1471996|NCT00889239|ceramic|ceramic
1471997|NCT00889239|wear rate|wear rate
1471998|NCT00889239|opposing enamel|opposing enamel
1471999|NCT00889226|pitavastatin|pitavastatin
1472000|NCT00889226|PWV|pwv
1472001|NCT00889226|ESPRIT|esprit
1472002|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
1472003|NCT00889226|Adiponectin|adiponectin
1472004|NCT00889226|fasting insulin|fasting insulin
1472005|NCT00889226|hs-CRP|hs-crp
1472006|NCT00889226|baPWV|bapwv
1472007|NCT00889213|pancreatectomy|pancreatectomy
1472008|NCT00889213|fistula|fistula
1472009|NCT00889213|fibrin glue|fibrin glue
1472010|NCT00889213|falciform patch|falciform patch
1472011|NCT00889213|surgery|surgery
1472012|NCT00889213|complications|complications
1472013|NCT00889187|radiation therapy|radiation therapy
1472014|NCT00889187|capecitabine|capecitabine
1472015|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
1472016|NCT00889174|Leukodystrophies|leukodystrophies
1472017|NCT00889174|Myelin|myelin
1472018|NCT00889174|White Matter Disorder|white matter disorder
1472019|NCT00889174|Genetic Disorder|genetic disorder
1472020|NCT00889161|Crohn's disease|crohn's disease
1472021|NCT00889161|ulcerative colitis|ulcerative colitis
1472022|NCT00889161|curcumin|curcumin
1472023|NCT00889161|pediatric|pediatric
1472024|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
1472026|NCT00889148|arthroplasty|arthroplasty
1472027|NCT00889148|postoperative pain|postoperative pain
1472028|NCT00889148|gabapentin|gabapentin
1472031|NCT00889122|Videogames|videogames
1472032|NCT00889122|Prevention|prevention
1472033|NCT00889122|Family|family
1472034|NCT00889122|Dance Dance Revolution|dance dance revolution
1472035|NCT00889122|Pedometer|pedometer
1472036|NCT00889096|memory|memory
1472037|NCT00889096|heart rate|heart rate
1472038|NCT00889096|skin conductance|skin conductance
1472039|NCT00889096|α-amylase|α-amylase
1472040|NCT00889096|propranolol|propranolol
1472041|NCT00889096|tolerability|tolerability
1472042|NCT00889083|Sepsis|sepsis
1472043|NCT00889083|Peritonitis|peritonitis
1472044|NCT00889083|Mitochondria|mitochondria
1472045|NCT00889083|Liver|liver
1472702|NCT00886470|vascularity|vascularity
1472046|NCT00889057|osteosarcoma|osteosarcoma
1472047|NCT00889057|sorafenib|sorafenib
1472048|NCT00889057|target therapy|target therapy
1472049|NCT00889031|CLL|cll
1472050|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
1472051|NCT00889018|chemotherapy|chemotherapy
1472052|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
1472053|NCT00889005|Acute Stress Disorder|acute stress disorder
1472054|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
1472055|NCT00889005|Secondary Prevention|secondary prevention
1472056|NCT00889005|Anxiety disorders|anxiety disorders
1472057|NCT00889005|Service Delivery|service delivery
1472058|NCT00888992|Smoking|smoking
1472059|NCT00888992|Cessation|cessation
1472060|NCT00888992|Quitline|quitline
1472061|NCT00888992|Counseling|counseling
1472062|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
1472063|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
1472064|NCT00888966|heart arrest|heart arrest
1472065|NCT00888966|oxidative stress|oxidative stress
1472066|NCT00888966|lactic acid|lactic acid
1472067|NCT00888966|outcome|outcome
1472068|NCT00888953|Falls|falls
1472069|NCT00888953|Nursing Homes|nursing homes
1472070|NCT00888953|Elderly|elderly
1472071|NCT00888953|Prevention|prevention
1472072|NCT00888953|Spain|spain
1472073|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
1472074|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
1472075|NCT00888927|PTCL|ptcl
1472076|NCT00888927|CTCL|ctcl
1472077|NCT00888914|Lateral Canthal Lines|lateral canthal lines
1472078|NCT00888914|Crow's Feet|crow's feet
1472079|NCT00888914|Facial Wrinkles|facial wrinkles
1472080|NCT00888901|ITP|itp
1472081|NCT00888901|eltrombopag|eltrombopag
1472082|NCT00888901|platelet function|platelet function
1472083|NCT00888901|thrombocytopenia|thrombocytopenia
1472084|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
1472085|NCT00888888|Acute appendicitis|acute appendicitis
1472086|NCT00888888|Colonic diverticulitis|colonic diverticulitis
1472087|NCT00888888|Colonic tumors|colonic tumors
1472088|NCT00888888|Colonic resections|colonic resections
1472089|NCT00888875|i-gel|i-gel
1472090|NCT00888875|Fastrach|fastrach
1472091|NCT00888875|intubation|intubation
1472092|NCT00888875|fiberoptic|fiberoptic
1472093|NCT00888875|difficult airway|difficult airway
1472094|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
1472095|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
1472096|NCT00888862|depression|depression
1472097|NCT00888862|desvenlafaxine|desvenlafaxine
1472098|NCT00888862|menopause|menopause
1472099|NCT00888862|imaging|imaging
1472100|NCT00888862|FMRI|fmri
1472101|NCT00888849|Stapling|stapling
1472102|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
1472103|NCT00888849|colorectal disease|colorectal disease
1472104|NCT00888836|bariatric surgery|bariatric surgery
1472105|NCT00888836|GBP|gbp
1472106|NCT00888836|BPD|bpd
1472107|NCT00888836|type 2 diabetes|type 2 diabetes
1472108|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
1472109|NCT00888823|Medically inoperable|medically inoperable
1472110|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
1472111|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
1472112|NCT00888771|Colorectal cancer|colorectal cancer
1472113|NCT00888771|polyps|polyps
1472114|NCT00888771|colonoscopy|colonoscopy
1472115|NCT00888771|advanced imaging|advanced imaging
1472116|NCT00888758|Stents|stents
1472117|NCT00888745|RA|ra
1472118|NCT00888732|Diabetes|diabetes
1472119|NCT00888680|Migraine|migraine
1472120|NCT00888680|Headaches|headaches
1472121|NCT00888680|Migraine headaches|migraine headaches
1472122|NCT00888680|Head pain|head pain
1472123|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
1472124|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1472125|NCT00888654|stage I prostate cancer|stage i prostate cancer
1472126|NCT00888654|stage II prostate cancer|stage ii prostate cancer
1472127|NCT00888628|Type I diabetes|type i diabetes
1472128|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
1472129|NCT00888628|Islet transplantation|islet transplantation
1472130|NCT00888589|MBI|mbi
1472131|NCT00888589|Molecular Breast Imaging|molecular breast imaging
1472132|NCT00888589|Breast|breast
1472133|NCT00888589|Breast Cancer|breast cancer
1472134|NCT00888589|Molecular Imaging|molecular imaging
1472135|NCT00888563|Fatigue|fatigue
1472136|NCT00888563|Depression|depression
1472137|NCT00888563|Healthy Volunteer|healthy volunteer
1472138|NCT00888563|HV|hv
1472139|NCT00888537|Decision aid|decision aid
1472140|NCT00888537|Heart attack|heart attack
1472141|NCT00888537|myocardial infarction|myocardial infarction
1472142|NCT00888524|head out water immersion,|head out water immersion,
1472143|NCT00888524|high intensity exercise,|high intensity exercise,
1472144|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
1472145|NCT00888524|aquatics;|aquatics;
1472146|NCT00888524|hydrotherapy|hydrotherapy
1472147|NCT00888524|aquatics therapy|aquatics therapy
1472148|NCT00888524|exercise therapy|exercise therapy
1472149|NCT00888511|Lung cancer|lung cancer
1472150|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
1472151|NCT00888511|Tarceva|tarceva
1472152|NCT00888511|Radiotherapy|radiotherapy
1472153|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
1472154|NCT00888498|Sprains and Strains|sprains and strains
1472155|NCT00888498|Ankle|ankle
1472156|NCT00888498|Manual Therapies|manual therapies
1472157|NCT00888498|Outcome Studies|outcome studies
1472158|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
1472159|NCT00888459|tobacco|tobacco
1472160|NCT00888459|chew|chew
1472161|NCT00888459|nrt|nrt
1472162|NCT00888459|nicotine lozenges|nicotine lozenges
1472163|NCT00888459|self-help|self-help
1472164|NCT00888446|HIV|hiv
1472165|NCT00888446|HIV seronegativity|hiv seronegativity
1472166|NCT00888446|preventative vaccine|preventative vaccine
1472167|NCT00888433|hypertension|hypertension
1472168|NCT00888433|renal denervation|renal denervation
1472169|NCT00888433|sympathetic nervous system|sympathetic nervous system
1472170|NCT00888433|RDN|rdn
1472171|NCT00888420|Chronic Pain|chronic pain
1472172|NCT00888407|Asian American Health|asian american health
1472173|NCT00888407|Cancer|cancer
1472174|NCT00888407|Hepatitis|hepatitis
1472175|NCT00888407|Hepatitis B|hepatitis b
1472176|NCT00888407|Liver Cancer|liver cancer
1472177|NCT00888394|chiropody|chiropody
1472178|NCT00888394|podiatry|podiatry
1472179|NCT00888394|insoles|insoles
1472180|NCT00888394|foot orthesis|foot orthesis
1472181|NCT00888342|Pulmonary Disease|pulmonary disease
1472182|NCT00888342|Chronic Obstructive|chronic obstructive
1472183|NCT00888342|Hypercapnia|hypercapnia
1472184|NCT00888342|Hypoxemia|hypoxemia
1472185|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
1472186|NCT00888342|Polysomnography|polysomnography
1472187|NCT00888342|Capnography|capnography
1472188|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
1472189|NCT00888329|Elective hysterectomy|elective hysterectomy
1472190|NCT00888316|iron overload|iron overload
1472191|NCT00888290|metabolic acidosis|metabolic acidosis
1472192|NCT00888290|chronic kidney disease|chronic kidney disease
1472193|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
1472194|NCT00888264|Antipsychotics|antipsychotics
1472195|NCT00888264|Bipolar Disorder|bipolar disorder
1472196|NCT00888264|Depressive episodes|depressive episodes
1472197|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
1472198|NCT00888251|Obesity|obesity
1472199|NCT00888251|Meal replacement|meal replacement
1472200|NCT00888251|Obesity treatment|obesity treatment
1472201|NCT00888251|Weight management|weight management
1472202|NCT00888225|Tennis elbow|tennis elbow
1472203|NCT00888225|Epicondylitis|epicondylitis
1472204|NCT00888225|Pain|pain
1472205|NCT00888225|Muscle strength|muscle strength
1472206|NCT00888225|Quality of life|quality of life
1472207|NCT00888225|RCT|rct
1472208|NCT00888225|Tendinitis|tendinitis
1472209|NCT00888225|Chronic tennis elbow|chronic tennis elbow
1472210|NCT00888199|amputation|amputation
1472211|NCT00888199|amputee|amputee
1472212|NCT00888199|prosthetic|prosthetic
1472213|NCT00888199|foot|foot
1472214|NCT00888199|prosthesis|prosthesis
1472215|NCT00888199|Tensegrity|tensegrity
1472216|NCT00888199|Prosthetics|prosthetics
1472217|NCT00888199|K3 Promoter|k3 promoter
1472218|NCT00888186|Dyskinesias|dyskinesias
1472219|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
1472220|NCT00888186|Dose optimization|dose optimization
1472221|NCT00888186|Pharmacokinetics|pharmacokinetics
1472222|NCT00888186|Pharmacodynamics|pharmacodynamics
1472223|NCT00888147|Tube feeding|tube feeding
1472224|NCT00888147|Fiber|fiber
1472225|NCT00888147|Constipation|constipation
1472226|NCT00888095|deep brain stimulation|deep brain stimulation
1472227|NCT00888095|caudal Zona incerta|caudal zona incerta
1472228|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
1472229|NCT00888095|Parkinson's disease|parkinson's disease
1472230|NCT00888095|randomized|randomized
1472231|NCT00888095|blinded|blinded
1472232|NCT00888095|Movement disorder|movement disorder
1472233|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
1472234|NCT00888082|breast cancer|breast cancer
1472235|NCT00888082|goserelin acetate|goserelin acetate
1472236|NCT00888082|ovarian function|ovarian function
1472237|NCT00888082|Chemotherapy|chemotherapy
1472238|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
1472239|NCT00888069|Parathyroid Diseases|parathyroid diseases
1472240|NCT00888069|Renal Insufficiency|renal insufficiency
1472241|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
1472242|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1472243|NCT00888069|Vitamin D|vitamin d
1472244|NCT00888069|Hyperparathyroidism|hyperparathyroidism
1472245|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
1472246|NCT00888069|Kidney Diseases|kidney diseases
1472247|NCT00888069|Kidney Failure|kidney failure
1472248|NCT00888043|solid tumors|solid tumors
1472249|NCT00888043|avastin|avastin
1472251|NCT00888043|combination therapy|combination therapy
1472252|NCT00888043|bevacizumab|bevacizumab
1472253|NCT00888030|p-cresol|p-cresol
1472254|NCT00888030|indoxyl sulfate|indoxyl sulfate
1472255|NCT00888030|chronic kidney disease|chronic kidney disease
1472257|NCT00888017|bone density|bone density
1472258|NCT00888017|proton pump inhibitors|proton pump inhibitors
1472259|NCT00888017|premature infants|premature infants
1472260|NCT00888004|Parkinson's|parkinson's
1472261|NCT00888004|L-dopa|l-dopa
1472262|NCT00888004|dyskinesia|dyskinesia
1472263|NCT00887991|Randomised trial|randomised trial
1472264|NCT00887991|breast pumps|breast pumps
1472265|NCT00887991|efficacy|efficacy
1472266|NCT00887991|preterm|preterm
1472267|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
1472268|NCT00887965|Low Bone Mass|low bone mass
1472269|NCT00887965|Low Bone Mineral Density|low bone mineral density
1472270|NCT00887965|Osteoporosis|osteoporosis
1472271|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1472272|NCT00887965|Bone Biopsy|bone biopsy
1472273|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
1472274|NCT00887965|Histomorphometry|histomorphometry
1472275|NCT00887952|Deep caries lesion|deep caries lesion
1472276|NCT00887952|dentine caries removal|dentine caries removal
1472277|NCT00887952|dental restoration|dental restoration
1472278|NCT00887952|stepwise excavation|stepwise excavation
1472279|NCT00887939|Physical Urticaria|physical urticaria
1472280|NCT00887939|Pathogenesis|pathogenesis
1472281|NCT00887939|Inflammasome|inflammasome
1472282|NCT00887939|IL-1|il-1
1472283|NCT00887939|Mast Cell|mast cell
1472284|NCT00887939|Urticaria|urticaria
1472285|NCT00887926|AML|aml
1472286|NCT00887926|Leukemia|leukemia
1472287|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
1472288|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
1472289|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
1472290|NCT00887900|keratoconus|keratoconus
1472291|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
1472292|NCT00887900|Visual acuity|visual acuity
1472293|NCT00887887|liver surgery|liver surgery
1472294|NCT00887887|gene polymorphisms|gene polymorphisms
1472295|NCT00887887|innate immune response|innate immune response
1472296|NCT00887887|infectious complications|infectious complications
1472297|NCT00887887|post-resectional liver failure|post-resectional liver failure
1472298|NCT00887887|mortality|mortality
1472299|NCT00887861|epilepsy|epilepsy
1472300|NCT00887861|seizure|seizure
1472301|NCT00887861|monotherapy trials|monotherapy trials
1472302|NCT00887861|partial seizure|partial seizure
1472303|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
1472304|NCT00887848|Child|child
1472305|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
1472306|NCT00887848|Rehabilitation|rehabilitation
1472307|NCT00887835|PERPOS fusion|perpos fusion
1472308|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
1472309|NCT00887809|Gemcitabine|gemcitabine
1472310|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
1472311|NCT00887809|09-015|09-015
1472312|NCT00887809|Soft tissue|soft tissue
1472313|NCT00887783|Induction chemotherapy|induction chemotherapy
1472314|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
1472315|NCT00887783|Randomized phase II study|randomized phase ii study
1472316|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
1472317|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
1472318|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
1472319|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
1472320|NCT00887770|QTcF|qtcf
1472321|NCT00887770|Crossover|crossover
1472322|NCT00887770|ICH E14|ich e14
1472323|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
1472324|NCT00887770|Moxifloxacin|moxifloxacin
1472325|NCT00887770|QT/QTc Interval|qt/qtc interval
1472326|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
1472327|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
1472328|NCT00887744|Interpinous Device|interpinous device
1472329|NCT00887744|Percutaneous|percutaneous
1472330|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
1472331|NCT00887731|premature infants|premature infants
1472332|NCT00887731|oxygen exposure|oxygen exposure
1472333|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
1472334|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
1472335|NCT00887718|PET scan|pet scan
1472336|NCT00887705|COPD|copd
1472337|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
1472338|NCT00887705|ADL-Training|adl-training
1472339|NCT00887705|COPD Rehabilitation|copd rehabilitation
1472340|NCT00887679|Escitalopram|escitalopram
1472341|NCT00887679|Anxiety Disorder|anxiety disorder
1472342|NCT00887679|HIV and AIDS|hiv and aids
1472343|NCT00887679|treatment experienced|treatment experienced
1472344|NCT00887640|metastatic|metastatic
1472345|NCT00887640|Temsirolimus|temsirolimus
1472346|NCT00887640|prostate|prostate
1472347|NCT00887640|cancer|cancer
1472348|NCT00887627|Pharmacokinetics|pharmacokinetics
1472349|NCT00887627|Protein Binding|protein binding
1472350|NCT00887627|Conivaptan|conivaptan
1472351|NCT00887627|Vaprisol|vaprisol
1472352|NCT00887627|Kidney Diseases|kidney diseases
1472353|NCT00887614|mindfulness|mindfulness
1472354|NCT00887614|meditation|meditation
1472355|NCT00887614|stress|stress
1472356|NCT00887614|rumination|rumination
1472357|NCT00887614|emotion regulation|emotion regulation
1472358|NCT00887614|sleep quality|sleep quality
1472359|NCT00887614|spirituality|spirituality
1472360|NCT00887614|quality of life|quality of life
1472361|NCT00887588|Chronic heart failure|chronic heart failure
1472362|NCT00887588|preserved ejection fraction|preserved ejection fraction
1472363|NCT00887588|cardiovascular disease|cardiovascular disease
1472364|NCT00887588|NT-proBNP|nt-probnp
1472365|NCT00887588|biomarkers|biomarkers
1472366|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
1472367|NCT00887588|fraction|fraction
1472368|NCT00887575|Breast Cancer|breast cancer
1472369|NCT00887575|Triple-Negative|triple-negative
1472370|NCT00887575|Paclitaxel|paclitaxel
1472371|NCT00887575|Carboplatin|carboplatin
1472372|NCT00887575|Sunitinib|sunitinib
1472373|NCT00887575|Sutent|sutent
1472374|NCT00887575|Neoadjuvant|neoadjuvant
1472375|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
1472376|NCT00887536|Taxotere|taxotere
1472377|NCT00887536|Docetaxel|docetaxel
1472378|NCT00887536|Doxorubicin|doxorubicin
1472379|NCT00887536|Cyclophosphamide|cyclophosphamide
1472380|NCT00887536|Bevacizumab|bevacizumab
1472381|NCT00887536|Breast Neoplasms|breast neoplasms
1472382|NCT00887536|Adenocarcinoma|adenocarcinoma
1472383|NCT00887536|Breast Diseases|breast diseases
1472384|NCT00887536|Carcinoma|carcinoma
1472385|NCT00887536|HER2 negative|her2 negative
1472386|NCT00887536|Node negative|node negative
1472387|NCT00887536|High risk node positive|high risk node positive
1472388|NCT00887536|Adjuvant Therapy|adjuvant therapy
1472389|NCT00887510|Metabolic Syndrome|metabolic syndrome
1472390|NCT00887510|High Blood Pressure|high blood pressure
1472391|NCT00887510|Abdominal Obesity|abdominal obesity
1472392|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
1472393|NCT00887484|Acne|acne
1472394|NCT00887484|Acne Vulgaris|acne vulgaris
1472395|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
1472396|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
1472397|NCT00887471|Polysomnography|polysomnography
1472398|NCT00887471|Tonsillectomy|tonsillectomy
1472399|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
1472400|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
1472401|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
1472402|NCT00887458|rising PSA|rising psa
1472403|NCT00887445|First in Man|first in man
1472404|NCT00887445|SLV341|slv341
1472405|NCT00887445|diabetes|diabetes
1472406|NCT00887419|chronic back pain|chronic back pain
1472407|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
1472408|NCT00887406|first time in human study|first time in human study
1472409|NCT00887406|COPD|copd
1472410|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
1472411|NCT00887393|morbid obesity|morbid obesity
1472412|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1472413|NCT00887393|bariatric surgery|bariatric surgery
1472414|NCT00887393|low fat diet|low fat diet
1472415|NCT00887393|low carbohydrate diet|low carbohydrate diet
1472416|NCT00887380|Breast Cancer|breast cancer
1472417|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
1472418|NCT00887380|Local control|local control
1472419|NCT00887367|Healthy volunteers|healthy volunteers
1472420|NCT00887367|Substance dependence|substance dependence
1472421|NCT00887367|Alcohol dependence|alcohol dependence
1472422|NCT00887354|Low bone mass|low bone mass
1472423|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
1472424|NCT00887328|ischemic stroke|ischemic stroke
1472425|NCT00887328|ischemic penumbra|ischemic penumbra
1472426|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
1472428|NCT00887328|diffusion imaging|diffusion imaging
1472429|NCT00887328|DWI|dwi
1472430|NCT00887328|perfusion imaging|perfusion imaging
1472431|NCT00887328|PWI|pwi
1472432|NCT00887328|thrombolysis|thrombolysis
1472433|NCT00887328|alteplase|alteplase
1472434|NCT00887328|tPA|tpa
1472435|NCT00887328|EPITHET|epithet
1472436|NCT00887315|NSCLC|nsclc
1472437|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
1472438|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
1472439|NCT00887276|Ampicillin|ampicillin
1472440|NCT00887276|Amoxicillin|amoxicillin
1472441|NCT00887276|Moxifloxacin|moxifloxacin
1472442|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
1472443|NCT00887237|Heart failure|heart failure
1472444|NCT00887237|Cardiac resynchronization|cardiac resynchronization
1472445|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
1472446|NCT00887224|Major Depressive Disorder|major depressive disorder
1472448|NCT00887211|coronary artery disease|coronary artery disease
1472449|NCT00887198|Prostate cancer|prostate cancer
1472450|NCT00887198|Abiraterone acetate|abiraterone acetate
1472452|NCT00887198|CRPC|crpc
1472453|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
1472454|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
1472455|NCT00887185|Surgical Simulation|surgical simulation
1472456|NCT00887185|Surgical skills training|surgical skills training
1472457|NCT00887185|Temporal bone surgery|temporal bone surgery
1472458|NCT00887185|Computer simulation|computer simulation
1472459|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
1472460|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1472461|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1472462|NCT00887146|adult mixed glioma|adult mixed glioma
1472463|NCT00887120|Second line treatment|second line treatment
1472464|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
1472465|NCT00887120|Asia|asia
1472466|NCT00887120|LPV|lpv
1472467|NCT00887120|children|children
1472468|NCT00887120|pharmacokinetic|pharmacokinetic
1472469|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
1472470|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
1472471|NCT00887094|Diabetes mellitus|diabetes mellitus
1472472|NCT00887094|Exercise|exercise
1472473|NCT00887094|Endurance|endurance
1472474|NCT00887094|Resistance|resistance
1472475|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
1472476|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
1472477|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
1472478|NCT00887081|antiviral treatment|antiviral treatment
1472479|NCT00887068|Leukemia|leukemia
1472480|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
1472481|NCT00887068|AML|aml
1472482|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
1472483|NCT00887068|MDS|mds
1472484|NCT00887068|Remission|remission
1472485|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
1472486|NCT00887068|Allotx|allotx
1472487|NCT00887068|Azacitidine|azacitidine
1472488|NCT00887068|5-Azacitidine|5-azacitidine
1472489|NCT00887068|5-aza|5-aza
1472490|NCT00887068|Vidaza|vidaza
1472491|NCT00887068|5-AZC|5-azc
1472492|NCT00887068|AZA-CR|aza-cr
1472493|NCT00887068|Ladakamycin|ladakamycin
1472494|NCT00887068|NSC-102816|nsc-102816
1472495|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
1472496|NCT00887042|Cord blood transplantation|cord blood transplantation
1472497|NCT00887042|Pediatric|pediatric
1472498|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
1472499|NCT00887029|glaucoma|glaucoma
1472500|NCT00887029|POAG|poag
1472501|NCT00887029|OHT|oht
1472502|NCT00887029|OAG|oag
1472503|NCT00887029|ocular hypertension|ocular hypertension
1472504|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
1472505|NCT00887029|DuoTrav|duotrav
1472506|NCT00887029|timolol|timolol
1472507|NCT00887029|travoprost|travoprost
1472508|NCT00887029|24 hour post dose|24 hour post dose
1472509|NCT00887029|IOP|iop
1472510|NCT00887029|dosing preference|dosing preference
1472511|NCT00887003|epidural|epidural
1472512|NCT00887003|volume|volume
1472513|NCT00887003|dose|dose
1472514|NCT00887003|pain relief|pain relief
1472515|NCT00887003|steroid|steroid
1472516|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
1472517|NCT00886990|second line regimen|second line regimen
1472518|NCT00886990|NNRTI failure|nnrti failure
1472519|NCT00886990|HIV-infected children|hiv-infected children
1472520|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
1472521|NCT00886990|treatment experienced|treatment experienced
1472522|NCT00886977|ALS|als
1472523|NCT00886964|HBV vaccine|hbv vaccine
1472524|NCT00886964|HIV children|hiv children
1472525|NCT00886964|immune recovery|immune recovery
1472526|NCT00886964|HBV antibody|hbv antibody
1472527|NCT00886964|Intradermal|intradermal
1472528|NCT00886964|Intramuscular|intramuscular
1472529|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
1472530|NCT00886964|treatment experienced|treatment experienced
1472531|NCT00886938|tinnitus|tinnitus
1472532|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
1472533|NCT00886925|Cirrhosis|cirrhosis
1472534|NCT00886925|Albumin|albumin
1472535|NCT00886912|mountain sickness|mountain sickness
1472536|NCT00886899|CTO|cto
1472537|NCT00886899|chronic total occlusion|chronic total occlusion
1472538|NCT00886899|CAD|cad
1472539|NCT00886899|coronary artery disease|coronary artery disease
1472540|NCT00886899|interventional cardiology|interventional cardiology
1472541|NCT00886899|revascularization|revascularization
1472542|NCT00886899|recanalization|recanalization
1472543|NCT00886886|MDMA|mdma
1472544|NCT00886886|norepinephrine|norepinephrine
1472545|NCT00886886|Ecstasy|ecstasy
1472546|NCT00886886|stimulant|stimulant
1472547|NCT00886873|Uterine fibroids|uterine fibroids
1472548|NCT00886873|Mifepristone|mifepristone
1472549|NCT00886873|Antiprogestins|antiprogestins
1472550|NCT00886860|Efficacy|efficacy
1472551|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
1472552|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
1472553|NCT00886860|Term pregnancy|term pregnancy
1472554|NCT00886847|Lung|lung
1472555|NCT00886847|Lymphadenopathy|lymphadenopathy
1472556|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
1472557|NCT00886847|Benign|benign
1472558|NCT00886847|Malignant|malignant
1472559|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
1472560|NCT00886847|Hilar lymph nodes|hilar lymph nodes
1472561|NCT00886847|Fine Needle Aspiration|fine needle aspiration
1472562|NCT00886847|FNA|fna
1472563|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
1472564|NCT00886847|FNC|fnc
1472565|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
1472566|NCT00886847|EBUS|ebus
1472567|NCT00886847|Tissue Sample|tissue sample
1472568|NCT00886847|Suction|suction
1472569|NCT00886834|IUD insertion|iud insertion
1472570|NCT00886834|Nulliparous women|nulliparous women
1472571|NCT00886834|Contraception|contraception
1472572|NCT00886834|Family Planning|family planning
1472573|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
1472574|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
1472575|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
1472576|NCT00886821|non-insulin dependent|non-insulin dependent
1472577|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
1472578|NCT00886795|hives|hives
1472579|NCT00886795|rash|rash
1472580|NCT00886795|pruritis|pruritis
1472581|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
1472582|NCT00886769|Flare|flare
1472583|NCT00886769|arthritis|arthritis
1472584|NCT00886769|IL-1beta antagonist|il-1beta antagonist
1472585|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
1472586|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
1472587|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
1472588|NCT00886756|Phase I|phase i
1472589|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
1472590|NCT00886756|AZD8529|azd8529
1472591|NCT00886730|Depressive disorder|depressive disorder
1472592|NCT00886730|Primary care|primary care
1472593|NCT00886730|Internet|internet
1472594|NCT00886730|Social support|social support
1472595|NCT00886730|Feasibility|feasibility
1472596|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1472597|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1472598|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1472599|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1472600|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1472601|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1472602|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1472603|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1472604|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
1472605|NCT00886704|dietary supplementation|dietary supplementation
1472606|NCT00886704|atherosclerosis|atherosclerosis
1472607|NCT00886691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1472608|NCT00886691|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1472609|NCT00886691|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1472610|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
1472611|NCT00886678|pemetrexed|pemetrexed
1472612|NCT00886678|radiation|radiation
1472613|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
1472614|NCT00886665|Nerve Conduction Studies|nerve conduction studies
1472615|NCT00886665|Clinical Trial|clinical trial
1472616|NCT00886652|Scoliosis|scoliosis
1472617|NCT00886652|Muscle Strength|muscle strength
1472618|NCT00886652|Respiratory function tests|respiratory function tests
1472619|NCT00886652|Exercise therapy|exercise therapy
1472620|NCT00886639|COPD III/IV|copd iii/iv
1472621|NCT00886639|Oxygen Supply|oxygen supply
1472622|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
1472623|NCT00886639|Oxygen Responder|oxygen responder
1472624|NCT00886626|Obesity|obesity
1472625|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
1472626|NCT00886626|Children|children
1472627|NCT00886587|eczema|eczema
1472628|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
1472629|NCT00886574|Anti-PLT drug|anti-plt drug
1472799|NCT00886080|Ablation|ablation
1472630|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
1472631|NCT00886574|Type 2 DM|type 2 dm
1472632|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
1472633|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
1472634|NCT00886561|HIV seronegativity|hiv seronegativity
1472635|NCT00886535|breast cancer|breast cancer
1472636|NCT00886535|hot flashes|hot flashes
1472637|NCT00886535|tamoxifen|tamoxifen
1472638|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
1472639|NCT00886522|Busulfan|busulfan
1472640|NCT00886522|Cord blood|cord blood
1472641|NCT00886522|Cyclophosphamide|cyclophosphamide
1472642|NCT00886522|Fludarabine|fludarabine
1472643|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
1472644|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
1472645|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1472646|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
1472647|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
1472648|NCT00886522|Intrabone infusion|intrabone infusion
1472649|NCT00886522|Thiotepa|thiotepa
1472650|NCT00886509|Coronary Artery Disease|coronary artery disease
1472651|NCT00886509|Stable|stable
1472652|NCT00886509|Coronary Collaterals|coronary collaterals
1472653|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
1472654|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1472655|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1472656|NCT00886496|neutropenia|neutropenia
1472657|NCT00886496|infection|infection
1472658|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1472659|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
1472660|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1472661|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1472662|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
1472663|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1472664|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1472665|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1472666|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
1472667|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1472668|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1472669|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
1472670|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1472671|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1472672|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
1472673|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1472674|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1472675|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1472676|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1472677|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1472678|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1472679|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1472680|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1472681|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1472682|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1472683|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1472684|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1472685|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1472686|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1472687|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1472688|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1472689|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1472690|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1472691|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1472692|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1472693|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1472694|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1472695|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
1472696|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1472697|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1472698|NCT00886483|Neurofeedback|neurofeedback
1472703|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
1472704|NCT00886431|IVF|ivf
1472705|NCT00886431|embryo cryopreservation|embryo cryopreservation
1472706|NCT00886431|vitrification|vitrification
1472707|NCT00886431|slow cooling|slow cooling
1472708|NCT00886431|slow freezing|slow freezing
1472709|NCT00886431|surplus embryos|surplus embryos
1472710|NCT00886431|Human Reproduction|human reproduction
1472711|NCT00886405|Nitroglycerin|nitroglycerin
1472712|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
1472713|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
1472714|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
1472715|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
1472716|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
1472717|NCT00886392|Diabetic Macular Edema|diabetic macular edema
1472718|NCT00886392|Optical Coherence Tomography|optical coherence tomography
1472719|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
1472720|NCT00886392|Severity|severity
1472721|NCT00886379|vitamin d|vitamin d
1472722|NCT00886379|children|children
1472723|NCT00886379|Mongolia|mongolia
1472724|NCT00886366|Type II Diabetes|type ii diabetes
1472725|NCT00886353|RAS|ras
1472726|NCT00886353|ACE2|ace2
1472727|NCT00886353|Cardiovascular|cardiovascular
1472728|NCT00886353|Pulmonary|pulmonary
1472729|NCT00886353|Angiotensin II|angiotensin ii
1472730|NCT00886353|Angiotensin 1-7|angiotensin 1-7
1472731|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
1472732|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
1472733|NCT00886327|Crohn's disease|crohn's disease
1472734|NCT00886327|Capsule endoscopy|capsule endoscopy
1472735|NCT00886314|children|children
1472736|NCT00886314|surgery|surgery
1472737|NCT00886314|anxiety|anxiety
1472738|NCT00886301|overweight|overweight
1472739|NCT00886301|obesity|obesity
1472740|NCT00886301|steatohepatitis|steatohepatitis
1472741|NCT00886301|ectopic fat|ectopic fat
1472742|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
1472743|NCT00886262|liver transplantation|liver transplantation
1472744|NCT00886262|vasopressin|vasopressin
1472745|NCT00886262|renal function|renal function
1472746|NCT00886262|hypotension|hypotension
1472747|NCT00886262|creatinine|creatinine
1472748|NCT00886262|urine output|urine output
1472749|NCT00886262|diuretics|diuretics
1472750|NCT00886262|vasopressors|vasopressors
1472751|NCT00886262|hemodynamic stability|hemodynamic stability
1472752|NCT00886249|Vision|vision
1472753|NCT00886249|Eye|eye
1472754|NCT00886249|Cataract|cataract
1472755|NCT00886236|Gastric Bypass|gastric bypass
1472756|NCT00886236|Gabapentin|gabapentin
1621904|NCT00312832|HIV|hiv
1472757|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1472758|NCT00886236|Analgesics, Opioids|analgesics, opioids
1472759|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
1472760|NCT00886236|Respiratory Depression|respiratory depression
1472761|NCT00886236|Oximetry|oximetry
1472762|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
1472763|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
1472764|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
1472765|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
1472766|NCT00886210|drain|drain
1472767|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1472768|NCT00886210|pneumoperitonum|pneumoperitonum
1472769|NCT00886197|reflux|reflux
1472770|NCT00886197|GERD|gerd
1472771|NCT00886184|Hypothermia|hypothermia
1472772|NCT00886184|Cardiac arrest|cardiac arrest
1472773|NCT00886184|Biomarkers|biomarkers
1472774|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
1472775|NCT00886171|social skills|social skills
1472776|NCT00886171|physical activity|physical activity
1472777|NCT00886171|peer relationships|peer relationships
1472778|NCT00886171|childhood obesity|childhood obesity
1472779|NCT00886171|changes in physical activity|changes in physical activity
1472780|NCT00886171|changes in social involvement|changes in social involvement
1472781|NCT00886158|Organ Transplants|organ transplants
1472782|NCT00886145|Spinal Cord Injuries|spinal cord injuries
1472783|NCT00886145|Mechanical Stimulation|mechanical stimulation
1472784|NCT00886145|Vibration Plate|vibration plate
1472785|NCT00886132|Phase 2 Study|phase 2 study
1472786|NCT00886132|Sunitinib|sunitinib
1472787|NCT00886132|Recurrent|recurrent
1472788|NCT00886132|Metastatic|metastatic
1472789|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
1472790|NCT00886132|Salivary Glands|salivary glands
1472791|NCT00886132|Metastasis|metastasis
1472792|NCT00886106|Capsaicin|capsaicin
1472793|NCT00886106|Remifentanil|remifentanil
1472794|NCT00886106|Hyperalgesia|hyperalgesia
1472795|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
1472796|NCT00886080|Atrial fibrillation|atrial fibrillation
1472797|NCT00886080|Health related Quality of Life|health related quality of life
1472798|NCT00886080|Add-on surgery|add-on surgery
1472800|NCT00886080|Randomised controlled trial|randomised controlled trial
1472801|NCT00886080|SF-36|sf-36
1472802|NCT00886080|EuroQoL|euroqol
1472803|NCT00886080|MFI-20|mfi-20
1472804|NCT00886067|AZD1446|azd1446
1472805|NCT00886067|PET examination|pet examination
1472806|NCT00886054|Transcranial Doppler|transcranial doppler
1472807|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
1472808|NCT00886054|Neurocritical patients|neurocritical patients
1472809|NCT00886041|laparoscopy|laparoscopy
1472810|NCT00886041|unexplained infertility|unexplained infertility
1472811|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
1472812|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
1472813|NCT00886028|Progression free survival|progression free survival
1472814|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
1472815|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
1472816|NCT00886015|Trachoma|trachoma
1472817|NCT00886015|trichiasis|trichiasis
1472818|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
1472819|NCT00886002|Healthy volunteers|healthy volunteers
1472820|NCT00885989|SLV338|slv338
1472821|NCT00885989|phase I|phase i
1472822|NCT00885989|healthy volunteers|healthy volunteers
1472823|NCT00885950|colorectal liver metastases|colorectal liver metastases
1472824|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1472825|NCT00885950|oxaliplatin|oxaliplatin
1472826|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
1472827|NCT00885950|anticoagulants|anticoagulants
1472828|NCT00885937|Dexpanthenol|dexpanthenol
1472829|NCT00885937|Safety,|safety,
1472830|NCT00885937|New formulation|new formulation
1472831|NCT00885937|Topical administration|topical administration
1472832|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
1472833|NCT00885924|Hemorrhage|hemorrhage
1472834|NCT00885924|Vasopressin|vasopressin
1472835|NCT00885924|Blood Loss, Surgical|blood loss, surgical
1472836|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
1472837|NCT00885911|pediatric|pediatric
1472838|NCT00885911|observational study|observational study
1472839|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
1472840|NCT00885898|Respiratory Failure|respiratory failure
1472841|NCT00885885|Colorectal Cancer|colorectal cancer
1472842|NCT00885885|Panitumumab|panitumumab
1472843|NCT00885885|FOLFOX-4|folfox-4
1472844|NCT00885885|FOLFIRI|folfiri
1472845|NCT00885846|Qigong|qigong
1472846|NCT00885846|Breathing management|breathing management
1472847|NCT00885846|Glucose|glucose
1622033|NCT00312351|AMD|amd
1472848|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
1472849|NCT00885833|HSCT|hsct
1472850|NCT00885820|Kidney Transplantation|kidney transplantation
1472851|NCT00885820|Tacrolimus|tacrolimus
1472852|NCT00885820|Immunosuppression|immunosuppression
1472853|NCT00885820|Graft Survival|graft survival
1472854|NCT00885807|ADHD|adhd
1472855|NCT00885807|WFIRS|wfirs
1472856|NCT00885807|WSR|wsr
1472857|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
1472858|NCT00885794|Focal Laser|focal laser
1472859|NCT00885794|GRID-Laser|grid-laser
1472860|NCT00885794|Ranibizumab|ranibizumab
1472861|NCT00885794|Lucentis|lucentis
1472862|NCT00885794|Microperimetry|microperimetry
1472863|NCT00885794|High-Definition OCT|high-definition oct
1472864|NCT00885794|Randomized|randomized
1472865|NCT00885794|Observer-Blinded|observer-blinded
1472866|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
1472867|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
1472868|NCT00885768|Atherosclerosis|atherosclerosis
1472869|NCT00885768|angiography|angiography
1472870|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
1472871|NCT00885742|Factor XIII|factor xiii
1472872|NCT00885729|Cartilage defect|cartilage defect
1472873|NCT00885729|chondrocytes|chondrocytes
1472874|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
1472875|NCT00885729|femoral condyle|femoral condyle
1472877|NCT00885703|CM|cm
1472878|NCT00885703|HIV|hiv
1472879|NCT00885703|Meningitis|meningitis
1472880|NCT00885690|Schizophrenia|schizophrenia
1472881|NCT00885690|Antipsychotic|antipsychotic
1472882|NCT00885690|Cognition|cognition
1472883|NCT00885664|HIV|hiv
1472884|NCT00885664|immune reconstitution|immune reconstitution
1472885|NCT00885664|treatment naive|treatment naive
1472886|NCT00885651|SNP|snp
1472887|NCT00885651|catecholamines|catecholamines
1472888|NCT00885651|metoprolole|metoprolole
1472889|NCT00885651|healthy subjects|healthy subjects
1472890|NCT00885651|physiological stress|physiological stress
1472891|NCT00885638|GLP-1|glp-1
1472892|NCT00885638|Insulin secretion|insulin secretion
1472893|NCT00885638|Macronutrients|macronutrients
1472894|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
1472895|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
1472896|NCT00885612|CHD-Risk|chd-risk
1472897|NCT00885612|Breast Cancer|breast cancer
1472898|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
1472899|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
1472900|NCT00885599|gingivitis|gingivitis
1472901|NCT00885599|natural remedy|natural remedy
1472902|NCT00885599|inflammation|inflammation
1472903|NCT00885599|C-reactive protein|c-reactive protein
1472904|NCT00885599|mouthwash|mouthwash
1472905|NCT00885586|herpes zoster|herpes zoster
1472906|NCT00885586|neuropathic pain|neuropathic pain
1472907|NCT00885586|acupuncture|acupuncture
1472908|NCT00885586|randomised controlled trial|randomised controlled trial
1472909|NCT00885586|acute herpes zoster|acute herpes zoster
1472910|NCT00885573|sleep apnea|sleep apnea
1472911|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
1472912|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
1472913|NCT00885573|diagnosis algorithm|diagnosis algorithm
1472914|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
1472915|NCT00885560|ADHD|adhd
1472916|NCT00885560|SNAP 25|snap 25
1472917|NCT00885560|amphetamine|amphetamine
1472918|NCT00885560|methylphenidate|methylphenidate
1472919|NCT00885534|skin cancer|skin cancer
1472920|NCT00885534|CISPLATIN|cisplatin
1472921|NCT00885534|TEMOZOLOMIDE|temozolomide
1472922|NCT00885534|VINBLASTINE|vinblastine
1472923|NCT00885534|09-017|09-017
1472924|NCT00885508|MDS|mds
1472925|NCT00885508|AML|aml
1472926|NCT00885508|deletion 5q|deletion 5q
1472927|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
1472928|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
1472929|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
1472930|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
1472931|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
1472932|NCT00885495|HIV|hiv
1472933|NCT00885495|dyslipidemia|dyslipidemia
1472934|NCT00885495|statins|statins
1472935|NCT00885495|protease inhibitors|protease inhibitors
1472936|NCT00885482|HIV/AIDS|hiv/aids
1472937|NCT00885482|HAART|haart
1472938|NCT00885482|Simplification|simplification
1472939|NCT00885482|Atazanavir|atazanavir
1472940|NCT00885482|Lamivudine|lamivudine
1472941|NCT00885482|treatment experienced|treatment experienced
1472942|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
1472943|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
1472944|NCT00885469|chronic GERD|chronic gerd
1472945|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
1472946|NCT00885456|stroke|stroke
1472947|NCT00885456|secondary prevention|secondary prevention
1472948|NCT00885456|vascular risk|vascular risk
1472949|NCT00885456|behavioral change|behavioral change
1472950|NCT00885456|exercise|exercise
1472951|NCT00885456|lifestyle modification|lifestyle modification
1472952|NCT00885443|propofol|propofol
1472953|NCT00885443|sevoflurane|sevoflurane
1472954|NCT00885443|pediatric|pediatric
1472955|NCT00885443|emergence delirium|emergence delirium
1472956|NCT00885443|Induction of sedation|induction of sedation
1472957|NCT00885430|colonoscopy|colonoscopy
1472958|NCT00885430|preparation|preparation
1472959|NCT00885417|Helicobacter pylori|helicobacter pylori
1472960|NCT00885417|sequential therapy|sequential therapy
1472961|NCT00885417|levofloxacin|levofloxacin
1472962|NCT00885417|clarithromycin|clarithromycin
1472963|NCT00885417|rescue|rescue
1472964|NCT00885417|salvage|salvage
1472965|NCT00885417|treatment failure|treatment failure
1472966|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
1472967|NCT00885404|chloride|chloride
1472968|NCT00885404|acidosis|acidosis
1472969|NCT00885391|Atrial Fibrillation|atrial fibrillation
1472970|NCT00885391|Cardioversion|cardioversion
1472971|NCT00885391|Direct Current Cardioversion|direct current cardioversion
1472972|NCT00885391|QT Interval|qt interval
1472973|NCT00885365|cystic fibrosis|cystic fibrosis
1472974|NCT00885365|P. aeruginosa|p. aeruginosa
1472975|NCT00885365|tobramycin|tobramycin
1472976|NCT00885339|Colonic Diseases|colonic diseases
1472977|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
1472978|NCT00885313|NAFLD|nafld
1472979|NCT00885313|NASH|nash
1472980|NCT00885313|fibrosis|fibrosis
1472981|NCT00885287|uncomplicated malaria|uncomplicated malaria
1472982|NCT00885287|HIV/AIDS|hiv/aids
1472983|NCT00885287|drug interactions|drug interactions
1473591|NCT00882869|sorafenib|sorafenib
1472984|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
1472985|NCT00885287|antiretrovirals|antiretrovirals
1472986|NCT00885287|pharmacovigilance|pharmacovigilance
1472987|NCT00885287|Tanzania|tanzania
1472988|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
1472989|NCT00885248|pancreatic cancer|pancreatic cancer
1472990|NCT00885248|integrated PET-CT|integrated pet-ct
1472991|NCT00885235|Bowel Diseases|bowel diseases
1472992|NCT00885222|Parkinson's disease|parkinson's disease
1472993|NCT00885222|Major depressive disorder|major depressive disorder
1472994|NCT00885222|Deep brain stimulation|deep brain stimulation
1472995|NCT00885209|Colonic Diseases|colonic diseases
1472996|NCT00885196|Psoriasis|psoriasis
1472997|NCT00885196|plaque psoriasis|plaque psoriasis
1472998|NCT00885196|inflammatory skin disease|inflammatory skin disease
1472999|NCT00885196|scaly patches|scaly patches
1473000|NCT00885196|AEB071|aeb071
1473001|NCT00885183|breast cancer|breast cancer
1473002|NCT00885183|chemotherapy|chemotherapy
1473003|NCT00885183|adjuvant therapy|adjuvant therapy
1473004|NCT00885183|acupuncture|acupuncture
1473005|NCT00885183|fatigue|fatigue
1473006|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
1473007|NCT00885157|Poliomyelitis|poliomyelitis
1473008|NCT00885157|intradermal|intradermal
1473009|NCT00885144|Stunting|stunting
1473010|NCT00885144|Growth failure|growth failure
1473011|NCT00885144|Malnutrition|malnutrition
1473012|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
1473013|NCT00885144|LNS|lns
1473014|NCT00885144|Prevention|prevention
1473015|NCT00885144|Malawi|malawi
1473016|NCT00885144|Sub-Saharan Africa|sub-saharan africa
1473017|NCT00885144|Dietary supplementation|dietary supplementation
1473018|NCT00885131|Reward Processing|reward processing
1473019|NCT00885131|Motor Cortex|motor cortex
1473020|NCT00885131|HV|hv
1473021|NCT00885131|Healthy Volunteer|healthy volunteer
1473022|NCT00885105|Fluzone® vaccine|fluzone® vaccine
1473023|NCT00885105|Influenza|influenza
1473024|NCT00885092|Contact lenses|contact lenses
1473025|NCT00885092|Disinfecting solutions|disinfecting solutions
1473026|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
1473027|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
1473028|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1473029|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
1473030|NCT00885053|Inflammation|inflammation
1473031|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
1473032|NCT00885053|Leukotrienes|leukotrienes
1473033|NCT00885053|Adiponectin|adiponectin
1473034|NCT00885053|Adipose tissue|adipose tissue
1473035|NCT00885053|RNA, Messenger|rna, messenger
1473036|NCT00885040|Neurofeedback|neurofeedback
1473037|NCT00885040|Tourette Syndrome|tourette syndrome
1473038|NCT00885040|Healthy Volunteer|healthy volunteer
1473039|NCT00885040|Movement Disorder|movement disorder
1473040|NCT00885040|Brain Activity|brain activity
1473041|NCT00885040|fMRI|fmri
1473042|NCT00885040|HV|hv
1473043|NCT00885014|Depressive disorder|depressive disorder
1622268|NCT00311298|hiv|hiv
1473044|NCT00885014|Behavior therapy|behavior therapy
1473045|NCT00885014|Workplace|workplace
1473046|NCT00885014|Subthreshold depression|subthreshold depression
1473047|NCT00884988|ankle fracture|ankle fracture
1473048|NCT00884988|edema|edema
1473049|NCT00884988|surgical repair|surgical repair
1473050|NCT00884988|homeopathy|homeopathy
1473051|NCT00884988|lymphomyosot|lymphomyosot
1473052|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1473053|NCT00884975|exacerbations|exacerbations
1473054|NCT00884975|quality of life|quality of life
1473055|NCT00884975|emphysema|emphysema
1473056|NCT00884962|emphysema|emphysema
1473057|NCT00884962|aeris|aeris
1473058|NCT00884962|PLVR|plvr
1473059|NCT00884962|BLVR|blvr
1473060|NCT00884962|germany|germany
1473061|NCT00884962|treatment|treatment
1473062|NCT00884962|device|device
1473063|NCT00884962|breathing|breathing
1473064|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
1473065|NCT00884949|MPS IV Type A|mps iv type a
1473066|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1473067|NCT00884949|MPS IVA|mps iva
1473068|NCT00884949|Morquio A Syndrome|morquio a syndrome
1473069|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
1473070|NCT00884949|LSD|lsd
1473071|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1473072|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
1473073|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
1473074|NCT00884949|GALNS|galns
1473075|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
1473076|NCT00884949|ERT|ert
1473077|NCT00884936|Skin|skin
1473078|NCT00884936|Aging|aging
1473079|NCT00884936|Dermogenomics|dermogenomics
1473080|NCT00884936|Genetic|genetic
1473081|NCT00884936|Biomarker|biomarker
1473082|NCT00884936|Dermatology|dermatology
1473083|NCT00884910|laryngectomy|laryngectomy
1473084|NCT00884910|Provox Vega|provox vega
1473085|NCT00884910|voice prosthesis|voice prosthesis
1473086|NCT00884897|Social Cognition|social cognition
1473087|NCT00884897|Schizophrenia|schizophrenia
1473088|NCT00884897|Oxytocin|oxytocin
1473089|NCT00884884|Alcohol dependence|alcohol dependence
1473090|NCT00884884|alcohol abuse|alcohol abuse
1473091|NCT00884884|topiramate|topiramate
1473092|NCT00884884|aripiprazole|aripiprazole
1473093|NCT00884871|pelvic floor disorders|pelvic floor disorders
1473094|NCT00884871|weight loss|weight loss
1473095|NCT00884858|HIV-1|hiv-1
1473096|NCT00884858|CD4|cd4
1473097|NCT00884858|INR|inr
1473098|NCT00884858|HIV-1 infection|hiv-1 infection
1473099|NCT00884858|extreme immunological compromission|extreme immunological compromission
1473100|NCT00884858|treatment experienced|treatment experienced
1473101|NCT00884845|PM2734|pm2734
1473102|NCT00884845|Tumors|tumors
1473103|NCT00884845|PharmaMar|pharmamar
1473104|NCT00884845|Erlotinib|erlotinib
1473105|NCT00884845|Tarceva|tarceva
1473106|NCT00884832|fecal incontinence|fecal incontinence
1473107|NCT00884832|stool leakage|stool leakage
1473108|NCT00884832|incontinence|incontinence
1473109|NCT00884832|FI|fi
1473110|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
1473111|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
1473112|NCT00884819|hepatic adiposity|hepatic adiposity
1473113|NCT00884819|diabetes|diabetes
1473114|NCT00884819|hormones|hormones
1473115|NCT00884819|cardiovascular disease|cardiovascular disease
1473116|NCT00884806|Contact lenses|contact lenses
1473117|NCT00884806|Disinfecting solutions|disinfecting solutions
1473118|NCT00884793|HIV|hiv
1473119|NCT00884793|persistence|persistence
1473120|NCT00884793|reservoirs|reservoirs
1473121|NCT00884793|residual replication|residual replication
1473122|NCT00884793|gut|gut
1473123|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
1473124|NCT00884793|treatment experienced|treatment experienced
1473125|NCT00884780|Electronic Diary|electronic diary
1473126|NCT00884780|Body Map|body map
1473127|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
1473128|NCT00884767|neurotoxicity|neurotoxicity
1473129|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1473130|NCT00884767|recurrent colon cancer|recurrent colon cancer
1473131|NCT00884767|stage I colon cancer|stage i colon cancer
1473132|NCT00884767|stage II colon cancer|stage ii colon cancer
1473133|NCT00884767|stage III colon cancer|stage iii colon cancer
1473134|NCT00884767|stage IV colon cancer|stage iv colon cancer
1473135|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
1473136|NCT00884767|stage I rectal cancer|stage i rectal cancer
1473137|NCT00884767|stage II rectal cancer|stage ii rectal cancer
1473138|NCT00884767|stage III rectal cancer|stage iii rectal cancer
1473139|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
1473140|NCT00884728|Scabies|scabies
1473141|NCT00884728|Impetigo|impetigo
1473142|NCT00884728|Pyoderma|pyoderma
1473143|NCT00884728|Streptococcal infections|streptococcal infections
1473144|NCT00884702|Sleep|sleep
1473145|NCT00884702|14C-Leucine|14c-leucine
1473146|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
1473147|NCT00884702|Memory|memory
1473148|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
1473149|NCT00884702|HV|hv
1473150|NCT00884702|Healthy Volunteer|healthy volunteer
1473151|NCT00884689|Symbicort SMART|symbicort smart
1473152|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
1473153|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1473154|NCT00884650|Pain|pain
1473155|NCT00884650|Pain management|pain management
1473156|NCT00884650|Cerebral Palsy|cerebral palsy
1473157|NCT00884637|HMP|hmp
1473158|NCT00884637|CNV|cnv
1473159|NCT00884637|AMD|amd
1473160|NCT00884637|PHP|php
1473161|NCT00884637|HPHP|hphp
1473162|NCT00884637|foresee home|foresee home
1473163|NCT00884624|Bowel Diseases|bowel diseases
1473164|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
1473165|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1473166|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1473167|NCT00884559|Leadership|leadership
1473168|NCT00884559|Team building|team building
1473169|NCT00884559|Resuscitation|resuscitation
1473170|NCT00884533|QTc|qtc
1473171|NCT00884533|pharmacokinetics|pharmacokinetics
1473172|NCT00884533|rosiglitazone XR|rosiglitazone xr
1473173|NCT00884533|cardiac conduction|cardiac conduction
1473174|NCT00884533|healthy volunteers|healthy volunteers
1473175|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
1473176|NCT00884520|VM4-037|vm4-037
1473177|NCT00884520|hypoxia|hypoxia
1473178|NCT00884520|CA-IX|ca-ix
1473179|NCT00884520|CAIX|caix
1473180|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
1473181|NCT00884520|hypoxia marker|hypoxia marker
1473182|NCT00884520|lung cancer|lung cancer
1473183|NCT00884520|renal carcinoma|renal carcinoma
1473184|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
1473185|NCT00884520|hepatic carcinoma|hepatic carcinoma
1473186|NCT00884520|head and neck cancer|head and neck cancer
1473187|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
1473188|NCT00884520|exploratory|exploratory
1473189|NCT00884494|Obesity|obesity
1473190|NCT00884494|Insulin resistance|insulin resistance
1473191|NCT00884494|Ghrelin|ghrelin
1473192|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
1473193|NCT00884455|tissue banking, research|tissue banking, research
1473194|NCT00884442|Healthy|healthy
1473195|NCT00884442|Bioavailability|bioavailability
1473196|NCT00884442|Nifedipine|nifedipine
1473197|NCT00884429|Chest physiotherapy|chest physiotherapy
1473198|NCT00884416|high grade glioma|high grade glioma
1473199|NCT00884416|glioblastoma|glioblastoma
1473200|NCT00884416|gliosarcoma|gliosarcoma
1473201|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
1473202|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1473203|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1473204|NCT00884416|phase I|phase i
1473205|NCT00884416|first line treatment|first line treatment
1473206|NCT00884416|sorafenib|sorafenib
1473207|NCT00884416|temozolomide|temozolomide
1473208|NCT00884416|radiation therapy|radiation therapy
1473209|NCT00884416|safety|safety
1473210|NCT00884416|tolerability|tolerability
1473211|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
1473212|NCT00884403|abortion|abortion
1473213|NCT00884403|pregnancy dating|pregnancy dating
1473214|NCT00884403|gestational age|gestational age
1473215|NCT00884403|ultrasound|ultrasound
1473216|NCT00884390|Hemophilia A|hemophilia a
1473217|NCT00884364|Lymphoma|lymphoma
1473218|NCT00884364|Leukemia|leukemia
1473219|NCT00884364|Multiple myeloma|multiple myeloma
1473220|NCT00884364|Hodgkin´s disease|hodgkin´s disease
1473221|NCT00884364|Exercise|exercise
1473222|NCT00884364|Sport|sport
1473223|NCT00884364|Fatigue|fatigue
1473224|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
1473225|NCT00884351|Epilepsy|epilepsy
1473226|NCT00884351|MEG|meg
1473227|NCT00884351|Seizures|seizures
1473228|NCT00884338|Fatigue|fatigue
1473229|NCT00884338|Cancer|cancer
1473230|NCT00884338|Cognitive impairment|cognitive impairment
1473231|NCT00884338|Exercise|exercise
1473232|NCT00884338|Sport|sport
1473233|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1473234|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
1473235|NCT00884325|Itching|itching
1473236|NCT00884325|Atopic Dermatitis|atopic dermatitis
1473237|NCT00884312|Multiple myeloma|multiple myeloma
1473238|NCT00884312|proteasome|proteasome
1473239|NCT00884312|Hematological|hematological
1473240|NCT00884312|carfilzomib|carfilzomib
1473241|NCT00884312|PR-171|pr-171
1473242|NCT00884299|Lung function|lung function
1473243|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1473244|NCT00884299|Antioxidants|antioxidants
1473245|NCT00884286|Aplidin|aplidin
1473246|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
1473247|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
1473248|NCT00884260|Contraception|contraception
1473249|NCT00884260|Intrauterine contraception system|intrauterine contraception system
1473250|NCT00884247|GERD|gerd
1473251|NCT00884247|Quality of life|quality of life
1473252|NCT00884247|Structured treatment|structured treatment
1473253|NCT00884234|Lateral Canthal Lines|lateral canthal lines
1473254|NCT00884234|Crow's Feet|crow's feet
1473255|NCT00884234|Facial Wrinkles|facial wrinkles
1473256|NCT00884234|Lateral Canthal Area|lateral canthal area
1473257|NCT00884195|Obesity|obesity
1473258|NCT00884182|Influenza|influenza
1473259|NCT00884182|Orthomyxoviruses|orthomyxoviruses
1473260|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
1473261|NCT00884182|A/H5N1|a/h5n1
1473262|NCT00884143|tamoxifen|tamoxifen
1473263|NCT00884143|arimidex|arimidex
1473264|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
1473265|NCT00884143|breast cancer|breast cancer
1473266|NCT00884143|post-menopausal|post-menopausal
1473267|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
1473268|NCT00884130|Laparoscopy|laparoscopy
1473269|NCT00884130|Colorectal surgery|colorectal surgery
1473270|NCT00884130|Quality of life|quality of life
1473271|NCT00884130|economic analysis|economic analysis
1473272|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
1473273|NCT00884104|Solifenacin|solifenacin
1473274|NCT00884104|Tamsulosin|tamsulosin
1473275|NCT00884104|OAB|oab
1473276|NCT00884091|Chinese|chinese
1473277|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
1473278|NCT00884091|Glucagon|glucagon
1473279|NCT00884091|Insulin|insulin
1473280|NCT00884091|Mixed meals|mixed meals
1473281|NCT00884091|Healthy Adults|healthy adults
1473282|NCT00884078|Self harm in south asian women|self harm in south asian women
1473283|NCT00884078|depression|depression
1473284|NCT00884078|suicidal ideations|suicidal ideations
1473285|NCT00884078|problem solving training|problem solving training
1473286|NCT00884065|Physiotherapy|physiotherapy
1473287|NCT00884065|Manual therapy|manual therapy
1473288|NCT00884065|Painful Shoulder|painful shoulder
1473289|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
1473290|NCT00884052|Neonatal seizures|neonatal seizures
1473291|NCT00884039|cornea|cornea
1473292|NCT00884039|transplant|transplant
1473293|NCT00884039|intraocular pressure|intraocular pressure
1473294|NCT00884039|steroid response|steroid response
1473295|NCT00884026|Cesarean delivery|cesarean delivery
1473296|NCT00884026|hypotension|hypotension
1473297|NCT00884026|Augmentation Index|augmentation index
1473298|NCT00884026|Pulse Wave analysis|pulse wave analysis
1473299|NCT00884026|spinal anesthesia|spinal anesthesia
1473300|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
1473301|NCT00884013|Pay for Quality|pay for quality
1473302|NCT00884013|Provider|provider
1473303|NCT00884013|Clinical Decision Support|clinical decision support
1473304|NCT00884013|Quality Reporting|quality reporting
1473305|NCT00884013|Quality Measurement|quality measurement
1473306|NCT00883974|preterm bith|preterm bith
1473307|NCT00883974|neurodevelopment|neurodevelopment
1473308|NCT00883974|sensitivity training|sensitivity training
1473309|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1473310|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
1473311|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
1473312|NCT00883961|Hematological neoplasties|hematological neoplasties
1473313|NCT00883961|Fatigue|fatigue
1473314|NCT00883961|Cancer|cancer
1473315|NCT00883961|Exercise|exercise
1473316|NCT00883961|Sport|sport
1473317|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
1473318|NCT00883948|Acute Lung Injury|acute lung injury
1473319|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1473320|NCT00883948|Feeding|feeding
1473321|NCT00883948|Critical Care|critical care
1473322|NCT00883948|Ventilator|ventilator
1473323|NCT00883935|GSK1349572|gsk1349572
1473324|NCT00883935|Atazanavir|atazanavir
1473325|NCT00883935|Ritonavir|ritonavir
1473326|NCT00883935|Reyataz|reyataz
1473327|NCT00883935|Norvir|norvir
1473328|NCT00883935|healthy|healthy
1473329|NCT00883935|pharmacokinetic|pharmacokinetic
1473330|NCT00883909|Prostate Cancer|prostate cancer
1473331|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1473332|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
1473333|NCT00883896|ACR|acr
1473334|NCT00883896|Methotrexate|methotrexate
1473335|NCT00883896|Interleukin-22|interleukin-22
1473336|NCT00883883|Antibiotic|antibiotic
1473337|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
1473338|NCT00883870|critical limb ischemia|critical limb ischemia
1473339|NCT00883844|Hepatitis B|hepatitis b
1473340|NCT00883844|sustained response|sustained response
1473341|NCT00883844|peginterferon|peginterferon
1473342|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
1473343|NCT00883831|Acupuncture|acupuncture
1473344|NCT00883831|Hemodialysis|hemodialysis
1473345|NCT00883831|Symptom|symptom
1473346|NCT00883831|end stage renal disease|end stage renal disease
1473347|NCT00883831|chronic kidney disease|chronic kidney disease
1473348|NCT00883831|supportive care|supportive care
1473349|NCT00883818|Overactive bladder|overactive bladder
1473350|NCT00883818|Mycoplasma|mycoplasma
1473351|NCT00883805|Metal Ion Concentration|metal ion concentration
1473352|NCT00883805|Osteolysis|osteolysis
1473353|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
1473354|NCT00883766|GnRH Antagonist|gnrh antagonist
1473355|NCT00883766|Long Agonist Protocol|long agonist protocol
1473356|NCT00883766|OHSS|ohss
1473357|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
1473358|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
1473359|NCT00883727|myocardial infarction|myocardial infarction
1473360|NCT00883714|Exercise|exercise
1473361|NCT00883714|sport|sport
1473362|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
1473363|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
1473364|NCT00883714|Fatigue|fatigue
1473365|NCT00883714|Cancer|cancer
1473366|NCT00883714|Physical performance|physical performance
1473367|NCT00883714|Mood|mood
1473368|NCT00883714|Complications|complications
1473369|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1473370|NCT00883701|exacerbations|exacerbations
1473371|NCT00883701|perforin|perforin
1473372|NCT00883701|granzymes|granzymes
1473373|NCT00883688|Brain Tumor|brain tumor
1473374|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
1473375|NCT00883688|Refractory Ependymoma|refractory ependymoma
1473376|NCT00883688|Intracranial ependymoma|intracranial ependymoma
1473377|NCT00883688|Ependymoblastoma|ependymoblastoma
1473378|NCT00883688|Subependymoma|subependymoma
1473379|NCT00883688|Myxopapillary|myxopapillary
1473380|NCT00883688|Clear cell|clear cell
1473381|NCT00883688|Anaplastic|anaplastic
1473382|NCT00883688|Bevacizumab|bevacizumab
1473383|NCT00883688|Avastin|avastin
1473384|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
1473385|NCT00883688|rhuMAb-VEGF|rhumab-vegf
1473386|NCT00883688|Lapatinib|lapatinib
1473387|NCT00883688|Tykerb|tykerb
1473388|NCT00883688|GW572016|gw572016
1473389|NCT00883675|Lung cancer|lung cancer
1473390|NCT00883675|Adjuvant therapy|adjuvant therapy
1473391|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1473392|NCT00883649|Dry Eyes|dry eyes
1473393|NCT00883649|Post-menopausal|post-menopausal
1473394|NCT00883636|Podocyte Protein|podocyte protein
1473395|NCT00883636|Podocyte Mutation|podocyte mutation
1473396|NCT00883623|AL-Amyloidosis|al-amyloidosis
1473397|NCT00883623|Lenalidomide|lenalidomide
1473398|NCT00883610|QT Interval|qt interval
1473399|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
1473400|NCT00883610|Atrial Fibrillation|atrial fibrillation
1473401|NCT00883584|Proof of Concept|proof of concept
1473402|NCT00883584|Inflammatory Markers|inflammatory markers
1473403|NCT00883584|Lung Function|lung function
1473404|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1473405|NCT00883584|COPD|copd
1473406|NCT00883571|anal stenosis|anal stenosis
1473407|NCT00883571|flaps|flaps
1473408|NCT00883571|anoplasty|anoplasty
1473409|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
1473410|NCT00883558|Insulin lispro|insulin lispro
1473411|NCT00883558|regular human insulin|regular human insulin
1473412|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
1473413|NCT00883532|Preterm infant|preterm infant
1473414|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
1473415|NCT00883532|chronic lung disease|chronic lung disease
1473416|NCT00883532|budesonide|budesonide
1473417|NCT00883532|surfactant|surfactant
1473418|NCT00883493|Acute bipolar depression|acute bipolar depression
1473419|NCT00883493|Lithium carbonate|lithium carbonate
1473420|NCT00883493|quetiapine fumarate|quetiapine fumarate
1473421|NCT00883493|MADRS|madrs
1473422|NCT00883480|NSCLC|nsclc
1473423|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
1473424|NCT00883467|functional MRI|functional mri
1473425|NCT00883467|BOLD|bold
1473426|NCT00883467|Reperfusion|reperfusion
1473427|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
1473428|NCT00883454|liver tumor|liver tumor
1473429|NCT00883454|cirrhosis|cirrhosis
1473430|NCT00883454|liver resection|liver resection
1473431|NCT00883454|tumor staging|tumor staging
1473432|NCT00883454|liver disease staging|liver disease staging
1473433|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
1473434|NCT00883441|AEDES|aedes
1473435|NCT00883441|VECTOR CONTROL|vector control
1473436|NCT00883428|low back pain|low back pain
1473437|NCT00883428|pelvic pain|pelvic pain
1473438|NCT00883428|pregnancy|pregnancy
1473439|NCT00883415|metabolism|metabolism
1473440|NCT00883415|myocardium|myocardium
1473441|NCT00883415|chronic kidney disease|chronic kidney disease
1473442|NCT00883402|Carotid stenosis|carotid stenosis
1473443|NCT00883402|CEA|cea
1473444|NCT00883402|CAS|cas
1473445|NCT00883402|Stenting|stenting
1473446|NCT00883389|patient safety|patient safety
1473447|NCT00883389|chronic kidney disease|chronic kidney disease
1473448|NCT00883389|med-alert|med-alert
1473449|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
1473450|NCT00883376|OSAS|osas
1473451|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
1473452|NCT00883363|precondition|precondition
1473453|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
1473454|NCT00883363|myocardial infarction|myocardial infarction
1473455|NCT00883350|Body weight changes|body weight changes
1473456|NCT00883350|Overweight|overweight
1473457|NCT00883350|Obesity|obesity
1473458|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1473459|NCT00883324|fFN|ffn
1473460|NCT00883324|fetal fibronectin|fetal fibronectin
1473461|NCT00883324|non-speculum|non-speculum
1473462|NCT00883324|risk of preterm delivery|risk of preterm delivery
1473463|NCT00883311|Efficacy|efficacy
1473464|NCT00883298|temozolomide|temozolomide
1473465|NCT00883298|bevacizumab|bevacizumab
1473466|NCT00883298|Temodar|temodar
1473467|NCT00883298|Avastin|avastin
1473468|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
1473469|NCT00883298|gliosarcoma|gliosarcoma
1473470|NCT00883298|glioma|glioma
1473471|NCT00883298|GBM|gbm
1473472|NCT00883298|brain tumor|brain tumor
1473473|NCT00883272|Menopause|menopause
1473474|NCT00883272|Thrombophilia|thrombophilia
1473475|NCT00883272|factor V Leiden|factor v leiden
1473476|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
1473477|NCT00883272|Hypercoagulability|hypercoagulability
1473478|NCT00883272|Venous Thrombosis|venous thrombosis
1473479|NCT00883259|High-risk patients|high-risk patients
1473480|NCT00883259|Metformin|metformin
1473481|NCT00883259|PCOS|pcos
1473482|NCT00883259|Pregnancy complications|pregnancy complications
1473483|NCT00883259|Previous gestational DM|previous gestational dm
1473484|NCT00883246|PAD|pad
1473485|NCT00883233|Acne|acne
1473486|NCT00883220|self management|self management
1473487|NCT00883220|chronic condition|chronic condition
1473488|NCT00883220|urinary catheter|urinary catheter
1473489|NCT00883207|Depression|depression
1473490|NCT00883207|family therapy|family therapy
1473491|NCT00883207|dialogical processes|dialogical processes
1473592|NCT00882856|Clozapine|clozapine
1473492|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
1473493|NCT00883194|Experimental Pain Model|experimental pain model
1473494|NCT00883155|Antidepressant|antidepressant
1473495|NCT00883142|Lokomat|lokomat
1473496|NCT00883142|Suspended walking|suspended walking
1473497|NCT00883142|Body Weight Supported|body weight supported
1473498|NCT00883142|Treadmill Training|treadmill training
1473499|NCT00883129|Systemic Sclerosis|systemic sclerosis
1473500|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
1473501|NCT00883129|Cyclophosphamide|cyclophosphamide
1473502|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
1473503|NCT00883129|Pulmonary Function|pulmonary function
1473504|NCT00883129|Dyspnea|dyspnea
1473505|NCT00883129|Health Related Quality of Life|health related quality of life
1473506|NCT00883103|female urethral catheterization|female urethral catheterization
1473507|NCT00883103|Lidocaine|lidocaine
1473508|NCT00883103|lubricant|lubricant
1473509|NCT00883103|Q-tip test|q-tip test
1473510|NCT00883103|Q tip test|q tip test
1473511|NCT00883103|K-Y jelly|k-y jelly
1473512|NCT00883103|pain perception|pain perception
1473513|NCT00883103|straight catheterization|straight catheterization
1473514|NCT00883090|Factor XIII|factor xiii
1473515|NCT00883077|permeability|permeability
1473516|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
1473517|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
1473518|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
1473519|NCT00883051|COL-144|col-144
1473520|NCT00883051|acute treatment|acute treatment
1473521|NCT00883051|migraine|migraine
1473522|NCT00883038|insulin resistance|insulin resistance
1473523|NCT00883038|vegetarian diet|vegetarian diet
1473524|NCT00883025|Friedman Classification|friedman classification
1473525|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
1473526|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1473527|NCT00883012|Viral-confirmed|viral-confirmed
1473528|NCT00882999|Relapsing|relapsing
1473529|NCT00882999|Remitting|remitting
1473530|NCT00882999|Multiple Sclerosis|multiple sclerosis
1473531|NCT00882999|Multiple|multiple
1473532|NCT00882999|Sclerosis|sclerosis
1473533|NCT00882999|MS|ms
1473534|NCT00882999|LY2127399|ly2127399
1473535|NCT00882986|insulin resistance|insulin resistance
1473536|NCT00882960|pre-hospital|pre-hospital
1473537|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
1473538|NCT00882960|patients requiring analgesia|patients requiring analgesia
1473539|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
1473540|NCT00882934|Placebo|placebo
1473541|NCT00882934|Placebo Effect|placebo effect
1473542|NCT00882934|Sexual Dysfunction|sexual dysfunction
1473543|NCT00882934|Erectile Dysfunction|erectile dysfunction
1473544|NCT00882934|Clinical Trial|clinical trial
1473545|NCT00882921|Hunter syndrome|hunter syndrome
1473546|NCT00882921|hunters syndrome|hunters syndrome
1473547|NCT00882921|hunter's syndrome|hunter's syndrome
1473548|NCT00882921|hunter disease|hunter disease
1473549|NCT00882921|hunters disease|hunters disease
1473550|NCT00882921|hunter's disease|hunter's disease
1473551|NCT00882921|MPS II|mps ii
1473552|NCT00882921|MPSII|mpsii
1473553|NCT00882921|MPS2|mps2
1473554|NCT00882921|MPS 2|mps 2
1473555|NCT00882921|mucopolysaccharides|mucopolysaccharides
1473556|NCT00882921|lysosomal storage disease|lysosomal storage disease
1473557|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
1473558|NCT00882921|chronic ear infection|chronic ear infection
1473559|NCT00882921|enlarged adenoids|enlarged adenoids
1473560|NCT00882921|mps symptoms|mps symptoms
1473561|NCT00882921|mps diagnosis|mps diagnosis
1473562|NCT00882921|mps ii therapy|mps ii therapy
1473563|NCT00882921|MPS II treatment|mps ii treatment
1473564|NCT00882921|ert treatment|ert treatment
1473565|NCT00882921|elaprase|elaprase
1473566|NCT00882921|idursulfase|idursulfase
1473567|NCT00882921|iduronate sulfatase|iduronate sulfatase
1473568|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
1473569|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
1473570|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
1473571|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
1473572|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
1473573|NCT00882921|hunter's disease treatment|hunter's disease treatment
1473574|NCT00882921|mps society|mps society
1473575|NCT00882908|Hepatitis C|hepatitis c
1473576|NCT00882908|TMC435|tmc435
1473577|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
1473578|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
1473579|NCT00882908|RBV|rbv
1473580|NCT00882908|Ribavirin|ribavirin
1473581|NCT00882908|Placebo|placebo
1473582|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1473583|NCT00882895|Transplantation, Autologous|transplantation, autologous
1473584|NCT00882895|Transplantation, Homologous|transplantation, homologous
1473585|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
1473586|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
1473587|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
1473588|NCT00882869|liver|liver
1473589|NCT00882869|cancer|cancer
1473590|NCT00882869|antisense|antisense
1473593|NCT00882856|Sinustachycardia|sinustachycardia
1473594|NCT00882856|Heartrate variability|heartrate variability
1473595|NCT00882856|Cardiomyopathy|cardiomyopathy
1473596|NCT00882843|Vibrating plate|vibrating plate
1473597|NCT00882843|Mechanical Stimulation|mechanical stimulation
1473598|NCT00882843|Osteoporosis|osteoporosis
1473599|NCT00882830|ICU|icu
1473600|NCT00882830|myopathy|myopathy
1473601|NCT00882830|neuropathy|neuropathy
1473602|NCT00882830|EMS|ems
1473603|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
1473604|NCT00882830|NIRS|nirs
1473605|NCT00882830|muscle biopsy|muscle biopsy
1473711|NCT00882232|rectal|rectal
1473606|NCT00882830|microdialysis|microdialysis
1473607|NCT00882830|CIPNM|cipnm
1473609|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
1473610|NCT00882791|Skin Cancer|skin cancer
1473611|NCT00882791|Basal Cell|basal cell
1473612|NCT00882791|Mohs surgery|mohs surgery
1473613|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1473614|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
1473615|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
1473616|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
1473617|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
1473618|NCT00882739|angiography|angiography
1473619|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
1473620|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1473621|NCT00882739|Platelet Function Tests|platelet function tests
1473622|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1473623|NCT00882726|CNTO 3649|cnto 3649
1473624|NCT00882726|safety|safety
1473625|NCT00882726|Phase I|phase i
1473626|NCT00882726|healthy adults|healthy adults
1473627|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1473628|NCT00882700|Antibiotic|antibiotic
1473629|NCT00882661|Neck Pain|neck pain
1473630|NCT00882661|Arm Pain|arm pain
1473631|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
1473632|NCT00882635|STEMI|stemi
1473633|NCT00882635|acute coronary syndromes|acute coronary syndromes
1473634|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1473635|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
1473636|NCT00882622|Cardiac Surgery|cardiac surgery
1473637|NCT00882609|bone metastasis|bone metastasis
1473638|NCT00882609|bone metastases|bone metastases
1473639|NCT00882609|Sodium Fluoride|sodium fluoride
1473640|NCT00882609|F18 Fluoride|f18 fluoride
1473641|NCT00882609|bone scan|bone scan
1473642|NCT00882596|Contura|contura
1473643|NCT00882596|Cancer|cancer
1473644|NCT00882596|Accelerated|accelerated
1473645|NCT00882596|Partial|partial
1473646|NCT00882596|Breast|breast
1473647|NCT00882596|Irradiation|irradiation
1473648|NCT00882583|HNSCC|hnscc
1473649|NCT00882583|Dasatinib|dasatinib
1473650|NCT00882583|Cetuximab|cetuximab
1473651|NCT00882583|Cisplatin|cisplatin
1473652|NCT00882570|Antibiotic|antibiotic
1473653|NCT00882557|End-stage renal disease|end-stage renal disease
1473654|NCT00882557|hemodialysis|hemodialysis
1473655|NCT00882557|chronic renal failure|chronic renal failure
1473656|NCT00882544|hydronephrosis|hydronephrosis
1473657|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
1473658|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
1473659|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
1473660|NCT00882518|qualified PANSS assessment|qualified panss assessment
1473661|NCT00882492|Cardiac|cardiac
1473662|NCT00882492|Surgery|surgery
1473663|NCT00882492|Glycemia|glycemia
1473664|NCT00882466|erythropoietin|erythropoietin
1473665|NCT00882453|Physical Activity|physical activity
1473666|NCT00882453|Fatigue|fatigue
1473667|NCT00882453|RRMS|rrms
1473668|NCT00882453|CIS|cis
1473669|NCT00882427|algorithm|algorithm
1473670|NCT00882427|tight glycemic control|tight glycemic control
1473671|NCT00882427|glucose control|glucose control
1473672|NCT00882427|intensive care|intensive care
1473673|NCT00882427|insulin|insulin
1473674|NCT00882427|ICU|icu
1473675|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
1473676|NCT00882414|platelet|platelet
1473677|NCT00882414|thrombocyte|thrombocyte
1473678|NCT00882414|ferritin|ferritin
1473679|NCT00882414|hemoglobin|hemoglobin
1473680|NCT00882414|transferrin|transferrin
1473681|NCT00882388|celecoxib|celecoxib
1473682|NCT00882388|platelet|platelet
1473683|NCT00882388|thrombosis|thrombosis
1473684|NCT00882388|Volunteers|volunteers
1473685|NCT00882375|Smoking Cessation|smoking cessation
1473686|NCT00882336|Cardiovascular risk management|cardiovascular risk management
1473687|NCT00882336|Hyperlipidemia|hyperlipidemia
1473688|NCT00882336|Hypertension|hypertension
1473689|NCT00882336|Diabetes|diabetes
1473690|NCT00882336|Obesity|obesity
1473691|NCT00882310|Pancreatic cancer|pancreatic cancer
1473692|NCT00882310|Gemzar|gemzar
1473693|NCT00882310|Taxotere|taxotere
1473694|NCT00882310|Xeloda|xeloda
1473695|NCT00882310|GTX|gtx
1473696|NCT00882297|Ultrasoundography|ultrasoundography
1473697|NCT00882297|catheterization|catheterization
1473887|NCT00881517|prevention|prevention
1473698|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
1473699|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
1473700|NCT00882284|Blood Pressure Management|blood pressure management
1473701|NCT00882271|Fibromyalgia|fibromyalgia
1473702|NCT00882271|Acupuncture|acupuncture
1473703|NCT00882271|Pain|pain
1473704|NCT00882258|Uterine fibroids|uterine fibroids
1473705|NCT00882232|prostate|prostate
1473706|NCT00882232|cancer|cancer
1473707|NCT00882232|cross-linked|cross-linked
1473708|NCT00882232|hyaluronan|hyaluronan
1473709|NCT00882232|gel|gel
1473710|NCT00882232|Hylaform|hylaform
1473712|NCT00882232|toxicity|toxicity
1473713|NCT00882219|Drug eluting stent|drug eluting stent
1473714|NCT00882219|Stents|stents
1473715|NCT00882219|Angioplasty|angioplasty
1473716|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
1473717|NCT00882219|Stent thrombosis|stent thrombosis
1473718|NCT00882219|Vascular disease|vascular disease
1473719|NCT00882219|Myocardial ischemia|myocardial ischemia
1473720|NCT00882219|Coronary artery stenosis|coronary artery stenosis
1473721|NCT00882219|Coronary Disease|coronary disease
1473722|NCT00882219|Coronary Artery Disease|coronary artery disease
1473723|NCT00882219|Coronary Restenosis|coronary restenosis
1473724|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1473725|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1473726|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1473727|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1473728|NCT00882193|Chronic hepatitis C|chronic hepatitis c
1473729|NCT00882193|Genotype 1|genotype 1
1473730|NCT00882193|Nonresponder|nonresponder
1473731|NCT00882193|Relapser|relapser
1473732|NCT00882193|Betaine|betaine
1473733|NCT00882193|Antiviral therapy|antiviral therapy
1473734|NCT00882180|Liver|liver
1473735|NCT00882180|Solid Tumors|solid tumors
1473736|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
1473737|NCT00882154|Antibiotic|antibiotic
1473738|NCT00882141|Exercise|exercise
1473739|NCT00882141|Obesity|obesity
1473740|NCT00882141|Insulin Sensitivity|insulin sensitivity
1473741|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
1473742|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
1473743|NCT00882115|DEP|dep
1473744|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
1473745|NCT00882115|Allergies|allergies
1473746|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
1473747|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1473748|NCT00882102|AML|aml
1473749|NCT00882102|MDS|mds
1473750|NCT00882102|Leukemia|leukemia
1473751|NCT00882102|Decitabine|decitabine
1473752|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
1473753|NCT00882102|Dacogen|dacogen
1473754|NCT00882102|Mylotarg|mylotarg
1473755|NCT00882089|Contura|contura
1473756|NCT00882089|Cancer|cancer
1473757|NCT00882089|Accelerated|accelerated
1473758|NCT00882089|Partial|partial
1473759|NCT00882089|Breast|breast
1473760|NCT00882089|Irradiation|irradiation
1473761|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1473762|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1473763|NCT00882063|Multiple Myeloma|multiple myeloma
1473764|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
1473765|NCT00882037|Substance Abuse Treatment|substance abuse treatment
1473766|NCT00882037|Rural and Urban|rural and urban
1473767|NCT00882037|Latino and Non-Latino|latino and non-latino
1473768|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
1473769|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
1473770|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
1473771|NCT00882011|Intensive chemotherapy|intensive chemotherapy
1473772|NCT00882011|Transplant|transplant
1473773|NCT00882011|Adult patients|adult patients
1473774|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
1473775|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
1473776|NCT00881985|resistant hypertension|resistant hypertension
1473777|NCT00881985|refractory hypertension|refractory hypertension
1473778|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
1473779|NCT00881985|blood pressure control|blood pressure control
1473780|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
1473781|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
1473782|NCT00881959|Miller Class II|miller class ii
1473783|NCT00881959|Gingival Margin|gingival margin
1473784|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1473785|NCT00881946|aggressive lymphoma|aggressive lymphoma
1473786|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1473787|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
1473788|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
1473789|NCT00881946|multiple myeloma|multiple myeloma
1473790|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1473791|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
1473792|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
1473793|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
1473794|NCT00881920|Lymphocytic|lymphocytic
1473795|NCT00881920|Leukemia|leukemia
1473796|NCT00881920|B Cell|b cell
1473797|NCT00881920|Non-Hodgkin|non-hodgkin
1473798|NCT00881920|Multiple Myeloma|multiple myeloma
1473799|NCT00881920|Lymphoma|lymphoma
1473800|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
1473801|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
1473802|NCT00881894|Rotigotine|rotigotine
1473803|NCT00881894|Neupro®|neupro®
1473804|NCT00881894|Transdermal Patch|transdermal patch
1473805|NCT00881855|Antibiotics|antibiotics
1473806|NCT00881842|Influenza|influenza
1473807|NCT00881842|Vaccine|vaccine
1473808|NCT00881842|CHMP criteria|chmp criteria
1473809|NCT00881829|Pulse Oximetry|pulse oximetry
1473810|NCT00881829|Temperature|temperature
1473811|NCT00881829|Respiratory Rate|respiratory rate
1473812|NCT00881829|Respiratory Gases|respiratory gases
1473813|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
1473814|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
1473815|NCT00881816|Capecitabine|capecitabine
1473816|NCT00881816|Maximum tolerated dose|maximum tolerated dose
1473817|NCT00881816|Dose limiting toxicity|dose limiting toxicity
1473818|NCT00881803|Spinal Cord Injuries|spinal cord injuries
1473819|NCT00881803|Ascorbic Acid|ascorbic acid
1473820|NCT00881803|Vitamin C|vitamin c
1473821|NCT00881803|Iron|iron
1473822|NCT00881803|Dietary Supplements|dietary supplements
1473823|NCT00881777|Heart Failure|heart failure
1473824|NCT00881777|Cardiomyopathy|cardiomyopathy
1473825|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
1473826|NCT00881777|Heart Disease|heart disease
1473827|NCT00881764|Anesthesia|anesthesia
1473828|NCT00881764|New York|new york
1473829|NCT00881764|Columbia|columbia
1473830|NCT00881764|Children|children
1473831|NCT00881764|Neurodevelopment|neurodevelopment
1473832|NCT00881764|Child development|child development
1473833|NCT00881764|Pediatric|pediatric
1473834|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1473835|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
1473836|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1623246|NCT00307398|AMD|amd
1473837|NCT00881738|Antibiotic|antibiotic
1473838|NCT00881725|Metformin|metformin
1473839|NCT00881725|Prostate Cancer|prostate cancer
1473840|NCT00881725|Radical Prostatectomy|radical prostatectomy
1473841|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
1473842|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
1473843|NCT00881725|Tumour Expression|tumour expression
1473844|NCT00881725|Ki67 Expression|ki67 expression
1473845|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
1473846|NCT00881712|Proton Radiation|proton radiation
1473847|NCT00881712|Stage III|stage iii
1473848|NCT00881699|HIV Information|hiv information
1473849|NCT00881699|HIV Prevention|hiv prevention
1473850|NCT00881699|Severe Mental Illness|severe mental illness
1473851|NCT00881699|HIV seronegativity|hiv seronegativity
1473852|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
1473853|NCT00881686|Adenosine|adenosine
1473854|NCT00881673|Conjunctivitis|conjunctivitis
1473855|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
1473856|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
1473857|NCT00881660|FETO plug-unplug|feto plug-unplug
1473858|NCT00881660|Goldvalve balloon|goldvalve balloon
1473859|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
1473860|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
1473861|NCT00881660|Goldbal balloon|goldbal balloon
1473862|NCT00881660|FETO|feto
1473863|NCT00881647|PTSD|ptsd
1473864|NCT00881647|Insomnia Disorder|insomnia disorder
1473865|NCT00881647|Insomnia|insomnia
1473866|NCT00881647|CBT|cbt
1473867|NCT00881621|Pancreas cancer|pancreas cancer
1473868|NCT00881621|lapatinib|lapatinib
1473869|NCT00881621|capecitabine|capecitabine
1473870|NCT00881608|Menstruation|menstruation
1473871|NCT00881595|Sarcomas|sarcomas
1473872|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
1473873|NCT00881582|Hepatitis c|hepatitis c
1473874|NCT00881582|Renal transplantation|renal transplantation
1473875|NCT00881582|Pegylated interferon|pegylated interferon
1473876|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1473877|NCT00881556|AlloSCT|allosct
1473878|NCT00881556|RDEB|rdeb
1473879|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
1473880|NCT00881543|Sitagliptin|sitagliptin
1473881|NCT00881543|Diets|diets
1473882|NCT00881543|Diabetes type 2|diabetes type 2
1473883|NCT00881543|Näive patients|näive patients
1473884|NCT00881517|human cytomegalovirus|human cytomegalovirus
1473885|NCT00881517|immune globulin|immune globulin
1473886|NCT00881517|congenital infection|congenital infection
1473888|NCT00881517|pregnancy|pregnancy
1473889|NCT00881504|Biliary|biliary
1473890|NCT00881504|Oxaliplatin|oxaliplatin
1473891|NCT00881504|Bevacizumab|bevacizumab
1473892|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
1473893|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
1473894|NCT00881478|Obesity|obesity
1473895|NCT00881478|Children|children
1473896|NCT00881478|Dyslipidemia|dyslipidemia
1473897|NCT00881478|Hypertension|hypertension
1473898|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
1473899|NCT00881452|Autism|autism
1473900|NCT00881439|Heart failure|heart failure
1473901|NCT00881439|Renal Failure|renal failure
1473902|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
1473903|NCT00881439|Renin inhibition|renin inhibition
1473904|NCT00881439|Aliskiren|aliskiren
1473905|NCT00881426|Antibiotic|antibiotic
1473906|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
1473907|NCT00881413|Proton pump inhibitor|proton pump inhibitor
1473908|NCT00881413|Esomeprazole|esomeprazole
1473909|NCT00881413|Pantoprazole|pantoprazole
1473910|NCT00881413|Recurrent bleeding|recurrent bleeding
1473911|NCT00881413|bleeding|bleeding
1473912|NCT00881400|Antibiotic|antibiotic
1473913|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1473914|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1473915|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1473916|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1473917|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1473918|NCT00881361|stage II breast cancer|stage ii breast cancer
1473919|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
1473920|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
1473921|NCT00881335|geriatric|geriatric
1473922|NCT00881335|pulmonary disease|pulmonary disease
1473923|NCT00881335|flutter|flutter
1473924|NCT00881335|sputum|sputum
1473925|NCT00881335|physical therapy techniques|physical therapy techniques
1473926|NCT00881296|Elder Patients|elder patients
1473927|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
1473928|NCT00881296|Previously Untreated|previously untreated
1473929|NCT00881296|Advanced|advanced
1473930|NCT00881283|Cushing's disease|cushing's disease
1473931|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
1473932|NCT00881257|Peripheral Artery Disease|peripheral artery disease
1473933|NCT00881257|Radiofrequency|radiofrequency
1473934|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
1473935|NCT00881205|Multiple Sclerosis|multiple sclerosis
1473936|NCT00881205|Cognition|cognition
1473937|NCT00881205|Rivastigmine|rivastigmine
1473938|NCT00881205|Patch|patch
1473939|NCT00881192|CABG|cabg
1473940|NCT00881192|coronary surgery|coronary surgery
1473941|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
1473942|NCT00881192|CABG operation|cabg operation
1473943|NCT00881179|Antibiotic|antibiotic
1473944|NCT00881166|MP-470|mp-470
1473945|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
1473946|NCT00881166|Malignant disease|malignant disease
1473947|NCT00881153|Antibiotic|antibiotic
1473948|NCT00881140|oral mifepristone|oral mifepristone
1473949|NCT00881140|vaginal tablets|vaginal tablets
1473950|NCT00881114|Head and neck cancer|head and neck cancer
1473951|NCT00881114|pharmacogenetics|pharmacogenetics
1473952|NCT00881114|chemoradiotherapy|chemoradiotherapy
1473953|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
1473954|NCT00881101|Maximum tolerated dose|maximum tolerated dose
1473955|NCT00881101|Dose limiting toxicity|dose limiting toxicity
1473956|NCT00881088|Deep vein trombosis|deep vein trombosis
1473957|NCT00881088|Profylaxis|profylaxis
1473958|NCT00881088|Below knee plaster cast|below knee plaster cast
1473959|NCT00881088|Ankle fracture|ankle fracture
1473960|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
1473961|NCT00881075|Heart diseases|heart diseases
1473962|NCT00881075|myocardial infarction|myocardial infarction
1473963|NCT00881075|contrast agents|contrast agents
1473964|NCT00881075|manganese|manganese
1473965|NCT00881062|ABSORPTION|absorption
1473966|NCT00881062|METABOLISM|metabolism
1473967|NCT00881062|EXCRETION|excretion
1473968|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
1473969|NCT00881036|Hepatitis B|hepatitis b
1473970|NCT00881010|Breast Cancer|breast cancer
1473971|NCT00881010|Pain Intervention|pain intervention
1473972|NCT00881010|Underserved minority patients|underserved minority patients
1473973|NCT00881010|African American|african american
1473974|NCT00881010|Hispanic|hispanic
1473975|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
1473976|NCT00881010|Interactive voice response|interactive voice response
1473977|NCT00881010|IVR|ivr
1473978|NCT00880997|Cocaine Dependence|cocaine dependence
1473979|NCT00880997|Substance Related Disorders|substance related disorders
1473980|NCT00880984|Colon Anastomosis|colon anastomosis
1474576|NCT00878709|neratinib|neratinib
1473981|NCT00880984|Rectum Anastomosis|rectum anastomosis
1473982|NCT00880984|Intestine|intestine
1473983|NCT00880984|Colorectal Surgery|colorectal surgery
1473984|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
1473985|NCT00880971|Lung|lung
1473986|NCT00880971|Carcinoma|carcinoma
1473987|NCT00880971|radiotherapy|radiotherapy
1473988|NCT00880971|Surgery|surgery
1473989|NCT00880945|FBS|fbs
1473990|NCT00880945|coin lesions|coin lesions
1473991|NCT00880945|ENB|enb
1473992|NCT00880945|ROSE|rose
1473993|NCT00880932|warfarin|warfarin
1473994|NCT00880932|NSAID|nsaid
1474390|NCT00879385|metastatic colorectal|metastatic colorectal
1473995|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
1473996|NCT00880919|Borderline Personality Disorder|borderline personality disorder
1473997|NCT00880919|BPD|bpd
1473998|NCT00880919|Seroquel|seroquel
1473999|NCT00880919|Seroquel XR|seroquel xr
1474000|NCT00880919|quetiapine|quetiapine
1474001|NCT00880919|quetiapine extended-release|quetiapine extended-release
1474002|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
1474003|NCT00880906|esophageal food impaction|esophageal food impaction
1474004|NCT00880906|dysphagia|dysphagia
1474005|NCT00880893|Dengue virus|dengue virus
1474006|NCT00880893|Dengue fever|dengue fever
1474007|NCT00880893|Dengue hemorrhagic fever|dengue hemorrhagic fever
1474008|NCT00880893|Dengue diseases|dengue diseases
1474009|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
1474010|NCT00880880|urinary incontinence|urinary incontinence
1474011|NCT00880880|fecal incontinence|fecal incontinence
1474012|NCT00880880|communication|communication
1474013|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
1474014|NCT00880854|bladder cancer|bladder cancer
1474015|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
1474016|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
1474017|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
1474018|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
1474019|NCT00880828|Radicular Pain|radicular pain
1474020|NCT00880828|Acute neck pain|acute neck pain
1474021|NCT00880828|Cervicobrachial pain|cervicobrachial pain
1474022|NCT00880828|Far-infrared ray|far-infrared ray
1474023|NCT00880828|FIR|fir
1474024|NCT00880828|Cervical collar|cervical collar
1474025|NCT00880828|Cervical device|cervical device
1474026|NCT00880828|FIR Device|fir device
1474027|NCT00880815|Leukemia|leukemia
1474028|NCT00880815|Lymphoma|lymphoma
1474029|NCT00880815|Lymphoid Malignancies|lymphoid malignancies
1474030|NCT00880815|Non-myeloablative Allogeneic Conditioning|non-myeloablative allogeneic conditioning
1474031|NCT00880815|Non-myeloablative Allogeneic Hematopoietic Transplantation|non-myeloablative allogeneic hematopoietic transplantation
1474032|NCT00880815|Stem Cell Transplant|stem cell transplant
1474033|NCT00880815|SCT|sct
1474034|NCT00880815|Bendamustine HCI|bendamustine hci
1474035|NCT00880815|Bendamustine|bendamustine
1474036|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride
1474037|NCT00880815|CEP-18083|cep-18083
1474038|NCT00880815|SDX-105|sdx-105
1474039|NCT00880815|Treanda|treanda
1474040|NCT00880815|Fludarabine|fludarabine
1474041|NCT00880815|Fludarabine Phosphate|fludarabine phosphate
1474042|NCT00880815|Fludara|fludara
1474043|NCT00880815|Rituximab|rituximab
1474044|NCT00880815|Rituxan|rituxan
1474045|NCT00880815|FBR|fbr
1474046|NCT00880815|Graft-versus-host disease|graft-versus-host disease
1474047|NCT00880815|GVHD|gvhd
1474048|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
1474049|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
1474050|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
1474051|NCT00880802|Unstable Angina|unstable angina
1474052|NCT00880789|Cord Blood Transplant|cord blood transplant
1474053|NCT00880789|cytomegalovirus|cytomegalovirus
1474054|NCT00880789|CMV|cmv
1474055|NCT00880789|Adenovirus|adenovirus
1474056|NCT00880789|ADV|adv
1474057|NCT00880750|End stage Renal disease|end stage renal disease
1474058|NCT00880724|COPD|copd
1474059|NCT00880724|Emphysema|emphysema
1474060|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
1474061|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
1474062|NCT00880711|Fiona|fiona
1474063|NCT00880711|Faslodex|faslodex
1474064|NCT00880711|Advanced Breast Cancer|advanced breast cancer
1474065|NCT00880711|Real life data|real life data
1474066|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
1474067|NCT00880698|Rotavirus|rotavirus
1474068|NCT00880698|Rotavirus vaccine|rotavirus vaccine
1474069|NCT00880685|Compulsive Stealing|compulsive stealing
1474070|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
1474071|NCT00880672|prostate, dutasteride|prostate, dutasteride
1474072|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
1474073|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
1474074|NCT00880659|Influenza|influenza
1474075|NCT00880659|secondary transmission|secondary transmission
1474076|NCT00880659|handwashing|handwashing
1474077|NCT00880633|EUS|eus
1474078|NCT00880633|periampullary neoplasms|periampullary neoplasms
1474079|NCT00880620|Parkinson's disease|parkinson's disease
1474080|NCT00880607|Pain|pain
1474081|NCT00880607|Pediatric|pediatric
1474082|NCT00880607|Spinal Fusion|spinal fusion
1474083|NCT00880607|pain management|pain management
1474084|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
1474085|NCT00880555|Alzheimer disease|alzheimer disease
1474086|NCT00880555|Mild cognitive impairment|mild cognitive impairment
1474087|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
1474088|NCT00880555|Semantic memory|semantic memory
1474089|NCT00880542|localized osteosarcoma|localized osteosarcoma
1474090|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1474091|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1474092|NCT00880529|rib fractures|rib fractures
1474093|NCT00880529|ventilator|ventilator
1474094|NCT00880529|ON-Q|on-q
1474095|NCT00880529|analgesia|analgesia
1474096|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
1474097|NCT00880490|COPD|copd
1474098|NCT00880464|autologous vaccination|autologous vaccination
1474099|NCT00880464|GM-CSF|gm-csf
1474100|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
1474101|NCT00880464|Stage IV breast cancer|stage iv breast cancer
1474102|NCT00880451|Children and Adolescents|children and adolescents
1474103|NCT00880451|Aging|aging
1474104|NCT00880451|Brain Imaging|brain imaging
1474105|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1474106|NCT00880412|safety|safety
1474107|NCT00880412|efficacy|efficacy
1474108|NCT00880412|Alzheimer's disease|alzheimer's disease
1474109|NCT00880412|treatment|treatment
1474110|NCT00880412|phase II|phase ii
1474111|NCT00880412|study|study
1474112|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
1474113|NCT00880399|depression|depression
1474114|NCT00880399|QIDS-SR|qids-sr
1474115|NCT00880399|HAMD-17|hamd-17
1474116|NCT00880399|orvepitant|orvepitant
1474117|NCT00880399|MDD|mdd
1474118|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
1474119|NCT00880399|double-blind|double-blind
1474120|NCT00880399|Phase II|phase ii
1474121|NCT00880399|randomized|randomized
1474122|NCT00880399|efficacy|efficacy
1474123|NCT00880399|placebo|placebo
1474124|NCT00880399|safety|safety
1474125|NCT00880386|dyspnea|dyspnea
1474126|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1474127|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1474128|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1474129|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1474130|NCT00880386|pulmonary complications|pulmonary complications
1474131|NCT00880386|radiation fibrosis|radiation fibrosis
1474132|NCT00880373|Sickle Cell Disease|sickle cell disease
1474133|NCT00880373|Pain|pain
1474134|NCT00880373|Ibuprofen|ibuprofen
1474135|NCT00880373|Morphine|morphine
1474136|NCT00880373|Diamorphine|diamorphine
1474137|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
1474138|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
1474139|NCT00880360|FIGO (International Fed of Gyn and Ob)Stage III or Stage IV|figo (international fed of gyn and ob)stage iii or stage iv
1474140|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
1474141|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
1474142|NCT00880347|Alzheimer's disease|alzheimer's disease
1474143|NCT00880347|Other dementia|other dementia
1474144|NCT00880347|Vascular dementia|vascular dementia
1474145|NCT00880347|Mixed dementia|mixed dementia
1474146|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
1474147|NCT00880347|Lewy bodies dementia|lewy bodies dementia
1474148|NCT00880347|Frontotemporal dementia|frontotemporal dementia
1474149|NCT00880347|Blood signature|blood signature
1474150|NCT00880347|Diagnosis|diagnosis
1474151|NCT00880347|SpliceArray (tm)|splicearray (tm)
1474152|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
1474153|NCT00880334|TCC|tcc
1474154|NCT00880334|Zactima|zactima
1474155|NCT00880334|docetaxel|docetaxel
1474156|NCT00880334|ZD6474|zd6474
1474157|NCT00880334|taxotere|taxotere
1474158|NCT00880321|first time in human|first time in human
1474159|NCT00880321|BRAF inhibitor|braf inhibitor
1474160|NCT00880321|dose escalation|dose escalation
1474161|NCT00880308|Advanced tumors|advanced tumors
1474162|NCT00880308|hedgehog|hedgehog
1474163|NCT00880308|smoothened inhibitor|smoothened inhibitor
1474164|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
1474165|NCT00880269|AML|aml
1474166|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
1474167|NCT00880269|refractory AML|refractory aml
1474168|NCT00880269|refractory de novo AML|refractory de novo aml
1474169|NCT00880269|refractory secondary AML|refractory secondary aml
1474170|NCT00880269|secondary AML|secondary aml
1474171|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
1474172|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
1474173|NCT00880269|AML resistant to therapy|aml resistant to therapy
1474174|NCT00880256|irritable bowel|irritable bowel
1474175|NCT00880256|mindfulness|mindfulness
1474176|NCT00880256|stress|stress
1474177|NCT00880256|meditation|meditation
1474178|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
1474179|NCT00880243|Priming|priming
1474180|NCT00880243|GM-CSF|gm-csf
1474181|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
1474182|NCT00880243|Prognosis|prognosis
1474183|NCT00880230|Iliac Artery Stenting|iliac artery stenting
1474184|NCT00880230|Peripheral Artery Disease|peripheral artery disease
1474185|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1474186|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1474187|NCT00880217|Adult ADHD|adult adhd
1474188|NCT00880217|JNJ-31001074|jnj-31001074
1474189|NCT00880204|Cluster Randomized Trial|cluster randomized trial
1474190|NCT00880204|ESS-EMCH|ess-emch
1474191|NCT00880204|Neonatal|neonatal
1474192|NCT00880204|Maternal|maternal
1474193|NCT00880204|Life threatening emergency event|life threatening emergency event
1474194|NCT00880191|nausea and vomiting|nausea and vomiting
1474195|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1474196|NCT00880178|Simvastatin|simvastatin
1474197|NCT00880178|Niacin|niacin
1474198|NCT00880178|Vascular Disease|vascular disease
1474199|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
1474200|NCT00880178|High Density Lipoprotein|high density lipoprotein
1474201|NCT00880178|Oxidation|oxidation
1474202|NCT00880178|Proteomics|proteomics
1474203|NCT00880178|Stroke|stroke
1474204|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
1474205|NCT00880165|Polysomnogram|polysomnogram
1474206|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
1474207|NCT00880152|stress|stress
1474208|NCT00880152|mindfulness|mindfulness
1474209|NCT00880152|trauma|trauma
1474210|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
1474211|NCT00880139|Inflammation|inflammation
1474212|NCT00880139|Cytokines|cytokines
1474213|NCT00880139|Vascular reactivity|vascular reactivity
1474214|NCT00880126|Individualized Implementation|individualized implementation
1474215|NCT00880126|Community Development Teams|community development teams
1474216|NCT00880113|CT-perfusion|ct-perfusion
1474217|NCT00880113|CT-angiography|ct-angiography
1474218|NCT00880100|Steatorrhea|steatorrhea
1474219|NCT00880100|Malabsorption of fat|malabsorption of fat
1474220|NCT00880100|Pancreatic enzymes|pancreatic enzymes
1474221|NCT00880100|Abdominal pain|abdominal pain
1474222|NCT00880100|Greasy stools|greasy stools
1474223|NCT00880087|Cardiac Arrest|cardiac arrest
1474224|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
1474225|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
1474226|NCT00880087|VABS|vabs
1474227|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
1474228|NCT00880087|POPC/PCPC|popc/pcpc
1474229|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1474230|NCT00880074|Advanced Cancers|advanced cancers
1474231|NCT00880074|FLT-PET|flt-pet
1474232|NCT00880074|Positron Emission Tomography|positron emission tomography
1474233|NCT00880074|PET|pet
1474234|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
1474235|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
1474236|NCT00880074|FLT|flt
1474237|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
1474238|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
1474239|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
1474240|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
1474241|NCT00880061|Brain Tumor|brain tumor
1474242|NCT00880061|Glioma|glioma
1474243|NCT00880048|depression|depression
1474244|NCT00880048|safety|safety
1474245|NCT00880048|HAMD|hamd
1474246|NCT00880048|QIDS-SR|qids-sr
1474247|NCT00880048|NK-1 antagonist|nk-1 antagonist
1474248|NCT00880048|efficacy|efficacy
1474249|NCT00880048|orvepitant|orvepitant
1474250|NCT00880048|placebo|placebo
1474251|NCT00880048|MDD|mdd
1474252|NCT00880048|video-rating|video-rating
1474253|NCT00880035|sedative drug|sedative drug
1474254|NCT00880035|stress|stress
1474255|NCT00880035|music|music
1474256|NCT00880035|mechanical ventilation|mechanical ventilation
1474257|NCT00880035|IL-6|il-6
1474258|NCT00880035|cortisol|cortisol
1474259|NCT00880035|prolactin|prolactin
1474260|NCT00880035|CRP|crp
1474261|NCT00880035|copeptin|copeptin
1474262|NCT00880022|compression|compression
1474263|NCT00880022|Flexitouch|flexitouch
1474264|NCT00880022|breast cancer|breast cancer
1474265|NCT00880022|lymphedema|lymphedema
1474266|NCT00879996|Opiate Addiction|opiate addiction
1474267|NCT00879996|Narcotic Addiction|narcotic addiction
1474268|NCT00879996|Drug Addiction|drug addiction
1474269|NCT00879996|Pain|pain
1474270|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
1474271|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
1474272|NCT00879957|Infant, Premature|infant, premature
1474273|NCT00879957|Infant|infant
1474274|NCT00879957|Central venous catheterization|central venous catheterization
1474275|NCT00879957|Anticoagulants|anticoagulants
1474276|NCT00879944|Psoriasis|psoriasis
1474277|NCT00879944|Obesity|obesity
1474278|NCT00879944|BMI|bmi
1474279|NCT00879944|Atopic Dermatitis|atopic dermatitis
1474280|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
1474281|NCT00879905|Phase I|phase i
1474282|NCT00879905|Adults|adults
1474283|NCT00879905|HSP990|hsp990
1474284|NCT00879905|Advanced Solid Tumors|advanced solid tumors
1474285|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
1474286|NCT00879905|Cancer|cancer
1474287|NCT00879892|xenon|xenon
1474288|NCT00879892|hypothermia|hypothermia
1474289|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1474290|NCT00879879|precancerous condition|precancerous condition
1474291|NCT00879866|NSCLC|nsclc
1474292|NCT00879866|immunocytokine|immunocytokine
1474293|NCT00879866|radiation|radiation
1474294|NCT00879866|interleukin-2|interleukin-2
1474295|NCT00879866|immunotherapy|immunotherapy
1474296|NCT00879866|maintenance therapy|maintenance therapy
1474297|NCT00879853|PTSD|ptsd
1474298|NCT00879853|Depression|depression
1474299|NCT00879853|Anger|anger
1474300|NCT00879853|Domestic Violence|domestic violence
1474301|NCT00879853|Refugee|refugee
1474302|NCT00879853|Asylum Seeker|asylum seeker
1474303|NCT00879853|Community Therapist|community therapist
1474304|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
1474305|NCT00879840|Screening|screening
1474306|NCT00879840|Modalities|modalities
1474307|NCT00879840|Gynecological Cancers|gynecological cancers
1474308|NCT00879801|prevention of diabetes|prevention of diabetes
1474309|NCT00879801|susceptibility genes|susceptibility genes
1474310|NCT00879801|type 2 diabetes|type 2 diabetes
1474311|NCT00879801|insulin resistance|insulin resistance
1474312|NCT00879801|beta-cell funtion|beta-cell funtion
1474313|NCT00879788|Ramipril fed condition|ramipril fed condition
1474314|NCT00879775|Pain|pain
1474315|NCT00879775|Cancer patients|cancer patients
1474316|NCT00879775|Caffeine|caffeine
1474317|NCT00879775|Adjuvant analgesics|adjuvant analgesics
1474318|NCT00879775|Sedation|sedation
1474319|NCT00879775|Confusion|confusion
1474320|NCT00879775|Quality of life|quality of life
1474321|NCT00879775|Fatigue|fatigue
1474322|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
1474323|NCT00879736|Doctor-patient communication|doctor-patient communication
1474324|NCT00879736|Encounters|encounters
1474325|NCT00879736|Patient education training|patient education training
1474326|NCT00879723|post-burn recovery|post-burn recovery
1474327|NCT00879723|oxidative stress|oxidative stress
1474328|NCT00879723|micronutrient protocol|micronutrient protocol
1474329|NCT00879710|Diabetes Mellitus|diabetes mellitus
1474330|NCT00879710|Hypercholesterolemia|hypercholesterolemia
1474331|NCT00879710|Simvastatin|simvastatin
1474332|NCT00879710|Ezetimibe.|ezetimibe.
1474333|NCT00879697|peripheral arterial disease|peripheral arterial disease
1474334|NCT00879697|exercise|exercise
1474335|NCT00879697|resistance training|resistance training
1474336|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
1474337|NCT00879684|Phase 1|phase 1
1474338|NCT00879684|Tumors|tumors
1474339|NCT00879684|CVX-060|cvx-060
1474340|NCT00879671|lutein|lutein
1474341|NCT00879671|nonexudative AMD|nonexudative amd
1474342|NCT00879671|MPOD|mpod
1474343|NCT00879671|Supplementary Concepts|supplementary concepts
1474344|NCT00879658|Multiple Sclerosis|multiple sclerosis
1474345|NCT00879658|Relapsing-Remitting|relapsing-remitting
1474346|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
1474347|NCT00879645|Renal Impairment|renal impairment
1474348|NCT00879645|Renal Disease|renal disease
1474349|NCT00879645|Sodium Sulfide|sodium sulfide
1474350|NCT00879606|Sepsis|sepsis
1474351|NCT00879606|Acute Lung Injury|acute lung injury
1474352|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1474353|NCT00879606|ALI/ARDS|ali/ards
1474354|NCT00879606|Lung Disease|lung disease
1474355|NCT00879580|aneurysm|aneurysm
1474356|NCT00879580|stent|stent
1474357|NCT00879580|intracranial aneurysm|intracranial aneurysm
1474358|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
1474359|NCT00879554|Phase 1|phase 1
1474360|NCT00879554|Solid Tumors|solid tumors
1474361|NCT00879554|CVX-045|cvx-045
1474362|NCT00879541|Hemophilia A|hemophilia a
1474363|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
1474364|NCT00879528|stem cell reinfusion|stem cell reinfusion
1474365|NCT00879515|Fragile X Premutation|fragile x premutation
1474366|NCT00879515|Fragile X Syndrome|fragile x syndrome
1474367|NCT00879515|Down Syndrome|down syndrome
1474368|NCT00879502|Fragile X Premutation|fragile x premutation
1474369|NCT00879502|FMR1|fmr1
1474370|NCT00879502|Premutation|premutation
1474371|NCT00879502|Fragile X|fragile x
1474372|NCT00879502|Brain Function|brain function
1474373|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
1474374|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
1474375|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
1474376|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
1474377|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
1474378|NCT00879437|brain tumor|brain tumor
1474379|NCT00879437|bevacizumab|bevacizumab
1474380|NCT00879437|valproic acid|valproic acid
1474381|NCT00879437|radiation therapy|radiation therapy
1474382|NCT00879424|vitamin D|vitamin d
1474383|NCT00879424|atopic dermatitis|atopic dermatitis
1474384|NCT00879424|eczema|eczema
1474385|NCT00879424|winter|winter
1474386|NCT00879385|KRAS wild-type|kras wild-type
1474387|NCT00879385|Colon|colon
1474388|NCT00879385|Cancer|cancer
1474389|NCT00879385|colorectal|colorectal
1474792|NCT00877838|Serotonin|serotonin
1474391|NCT00879385|advanced colorectal|advanced colorectal
1474392|NCT00879372|Bipolar Disorder|bipolar disorder
1474393|NCT00879372|cognitive impairment|cognitive impairment
1474394|NCT00879372|depression|depression
1474395|NCT00879346|Healthy Volunteers|healthy volunteers
1474396|NCT00879346|ADME|adme
1474397|NCT00879346|Healthy male volunteers|healthy male volunteers
1474398|NCT00879333|Gastric cancer,|gastric cancer,
1474399|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
1474400|NCT00879333|stomach neoplasm,|stomach neoplasm,
1474401|NCT00879333|stomach disease,|stomach disease,
1474402|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
1474403|NCT00879333|GI neoplasm|gi neoplasm
1474404|NCT00879320|ADHD|adhd
1474405|NCT00879320|health|health
1474406|NCT00879320|healthy lifestyle|healthy lifestyle
1474407|NCT00879294|Perforated appendicitis|perforated appendicitis
1474408|NCT00879294|Ruptured appendicitis|ruptured appendicitis
1474409|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
1474410|NCT00879281|COPD|copd
1474411|NCT00879281|emphysema|emphysema
1474412|NCT00879281|chronic bronchitis|chronic bronchitis
1474413|NCT00879268|Liver Transplantation|liver transplantation
1474414|NCT00879268|Organ Preservation|organ preservation
1474415|NCT00879268|Liver Preservation|liver preservation
1474416|NCT00879268|Machine Perfusion|machine perfusion
1474417|NCT00879268|Vasosol|vasosol
1474418|NCT00879268|Machine Preservation|machine preservation
1474419|NCT00879255|cognitive processing therapy|cognitive processing therapy
1474420|NCT00879255|combat|combat
1474421|NCT00879255|veterans|veterans
1474422|NCT00879255|PTSD|ptsd
1474423|NCT00879255|Telemental Health|telemental health
1474424|NCT00879255|Videoteleconference|videoteleconference
1474425|NCT00879255|outcome|outcome
1474426|NCT00879255|Rural|rural
1474427|NCT00879255|Remote|remote
1474428|NCT00879255|CPT|cpt
1474429|NCT00879255|VTC|vtc
1474430|NCT00879242|Thalassemia|thalassemia
1474431|NCT00879242|cardiac MRI T2*|cardiac mri t2*
1474432|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1474433|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
1474434|NCT00879229|PH|ph
1474435|NCT00879229|IPF|ipf
1474436|NCT00879229|Ambrisentan|ambrisentan
1474437|NCT00879229|ERA|era
1474438|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
1474439|NCT00879229|Cardiovascular|cardiovascular
1474440|NCT00879216|Nocturia|nocturia
1474441|NCT00879216|Hyptotension|hyptotension
1474442|NCT00879216|Elderly|elderly
1474443|NCT00879216|Males|males
1474444|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
1474445|NCT00879203|Youth|youth
1474446|NCT00879203|Hypoglycemia|hypoglycemia
1474447|NCT00879203|Hyperglycemia|hyperglycemia
1474448|NCT00879203|Cognition|cognition
1474449|NCT00879203|Memory|memory
1474450|NCT00879203|Brain Growth & Development|brain growth & development
1474451|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
1474452|NCT00879177|smoking|smoking
1474453|NCT00879177|varenicline|varenicline
1474454|NCT00879177|behavioral therapy|behavioral therapy
1474455|NCT00879177|ABPM|abpm
1474456|NCT00879177|hypertension|hypertension
1474457|NCT00879164|hot flashes|hot flashes
1474458|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
1474459|NCT00879112|Hyperlipidemia|hyperlipidemia
1474460|NCT00879099|Interaction|interaction
1474461|NCT00879099|healthy volunteers|healthy volunteers
1474462|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
1474463|NCT00879086|Breast Cancer|breast cancer
1474464|NCT00879086|Oncology|oncology
1474465|NCT00879073|Brain and Nervous System|brain and nervous system
1474466|NCT00879060|Fibrosis|fibrosis
1474467|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1474468|NCT00879060|MRI|mri
1474469|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
1474470|NCT00879047|HIV|hiv
1474471|NCT00879047|Hepatitis C|hepatitis c
1474472|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
1474473|NCT00879034|HGPS|hgps
1474474|NCT00879034|Progeria|progeria
1474475|NCT00879034|FTI|fti
1474476|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
1474477|NCT00879034|Lonafarnib|lonafarnib
1474478|NCT00879034|Zoledronic Acid|zoledronic acid
1474479|NCT00879034|Pravastatin|pravastatin
1474575|NCT00878709|adjuvant therapy|adjuvant therapy
1474480|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
1474481|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
1474482|NCT00879008|Disease Exacerbation|disease exacerbation
1474483|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
1474484|NCT00879008|AECB|aecb
1474485|NCT00879008|Avelox|avelox
1474486|NCT00879008|Bronchitis|bronchitis
1474487|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
1474488|NCT00878995|stage III cervical cancer|stage iii cervical cancer
1474489|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
1474490|NCT00878995|cachexia|cachexia
1474491|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
1474492|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
1474493|NCT00878969|Hemodialysis|hemodialysis
1474494|NCT00878969|fibrinolysis|fibrinolysis
1474495|NCT00878969|oxidative stress|oxidative stress
1474496|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
1474497|NCT00878969|endothelial dysfunction|endothelial dysfunction
1474498|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
1474499|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
1474500|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
1474501|NCT00878956|Cardiac surgery|cardiac surgery
1474502|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
1474503|NCT00878956|Oxidative stress|oxidative stress
1474504|NCT00878956|Acute renal dysfunction|acute renal dysfunction
1474505|NCT00878956|Sodium bicarbonate|sodium bicarbonate
1474506|NCT00878943|Open label access|open label access
1474507|NCT00878943|sildenafil|sildenafil
1474508|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
1474509|NCT00878930|Breast cancer|breast cancer
1474510|NCT00878930|Fulvestrant|fulvestrant
1474511|NCT00878930|Faslodex|faslodex
1474512|NCT00878930|Acceptability|acceptability
1474513|NCT00878930|Compliance|compliance
1474514|NCT00878930|Efficacy|efficacy
1474515|NCT00878917|Equivalence Study|equivalence study
1474516|NCT00878917|Eye Drops Solution|eye drops solution
1474517|NCT00878917|Dorzolamide|dorzolamide
1474518|NCT00878917|Open Angle Glaucoma|open angle glaucoma
1474519|NCT00878917|Ocular Hypertension|ocular hypertension
1474520|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1474521|NCT00878891|Microdialysis|microdialysis
1474522|NCT00878891|realtime|realtime
1474523|NCT00878891|glucose sensor|glucose sensor
1474524|NCT00878891|coronary artery bypass|coronary artery bypass
1474525|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
1474526|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
1474527|NCT00878878|Right Heart Catheterization|right heart catheterization
1474528|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
1474529|NCT00878865|Alprazolam|alprazolam
1474530|NCT00878865|bioequivalence|bioequivalence
1474531|NCT00878839|Cataract|cataract
1474532|NCT00878839|Toric IOL|toric iol
1474533|NCT00878839|Corneal Aberration|corneal aberration
1474534|NCT00878839|Astigmatism|astigmatism
1474535|NCT00878839|AcrySof|acrysof
1474536|NCT00878813|Copeptin|copeptin
1474537|NCT00878813|Vasopressin|vasopressin
1474538|NCT00878813|Stroke|stroke
1474539|NCT00878813|Transient ischemic attack|transient ischemic attack
1474540|NCT00878813|Thrombolytic therapy|thrombolytic therapy
1474541|NCT00878813|Prognosis|prognosis
1474542|NCT00878813|Complications|complications
1474543|NCT00878800|Phase I/II trial|phase i/ii trial
1474544|NCT00878800|Solid tumors|solid tumors
1474545|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
1474546|NCT00878800|PXD101|pxd101
1474547|NCT00878800|Doxorubicin|doxorubicin
1474548|NCT00878774|Ragweed allergy|ragweed allergy
1474549|NCT00878774|Immunotherapy|immunotherapy
1474550|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
1474551|NCT00878774|Toleromune Ragweed|toleromune ragweed
1474552|NCT00878761|Renal transplant|renal transplant
1474553|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
1474554|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
1474555|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
1474556|NCT00878761|kidney transplant|kidney transplant
1474557|NCT00878735|Meditation|meditation
1474558|NCT00878735|Mindfulness|mindfulness
1474559|NCT00878735|fMRI|fmri
1474560|NCT00878735|cancer|cancer
1474561|NCT00878735|stress|stress
1474562|NCT00878735|anxiety|anxiety
1474563|NCT00878735|depression|depression
1474564|NCT00878735|attention|attention
1474565|NCT00878735|Neuroscience|neuroscience
1474566|NCT00878735|Neuroimaging|neuroimaging
1474567|NCT00878735|Psychobiology|psychobiology
1474568|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
1474569|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
1474570|NCT00878722|PXD101|pxd101
1474571|NCT00878722|Belinostat|belinostat
1474572|NCT00878722|Idarubicin|idarubicin
1474573|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
1474574|NCT00878709|breast cancer|breast cancer
1474577|NCT00878709|HKI-272|hki-272
1474578|NCT00878709|Nerlynx|nerlynx
1474579|NCT00878709|PB-272|pb-272
1474580|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1474581|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
1474582|NCT00878644|Cardiac Arrest|cardiac arrest
1474583|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
1474584|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
1474585|NCT00878644|VABS|vabs
1474586|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
1474587|NCT00878644|POPC/PCPC|popc/pcpc
1474897|NCT00877409|Safety|safety
1474588|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
1474589|NCT00878631|emergency medical services|emergency medical services
1474590|NCT00878631|traumatic brain injury|traumatic brain injury
1474591|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
1474592|NCT00878631|fluid resuscitation|fluid resuscitation
1474593|NCT00878618|Healthy volunteers|healthy volunteers
1474594|NCT00878605|Diabetes|diabetes
1474595|NCT00878605|Cyclo-Z|cyclo-z
1474596|NCT00878592|Post liver transplant|post liver transplant
1474597|NCT00878592|weight reduction classes|weight reduction classes
1474598|NCT00878592|obesity|obesity
1474599|NCT00878592|weight management|weight management
1474600|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
1474601|NCT00878579|back pain|back pain
1474602|NCT00878579|Spine|spine
1474603|NCT00878579|Spinal|spinal
1474604|NCT00878579|Lower back pain|lower back pain
1474605|NCT00878579|Lumbar|lumbar
1474606|NCT00878579|Lumbar Pain|lumbar pain
1474607|NCT00878579|DDD|ddd
1474608|NCT00878579|Degenerative Disc Disease|degenerative disc disease
1474609|NCT00878566|hypertension|hypertension
1474610|NCT00878566|pharmacists|pharmacists
1474611|NCT00878566|rural health|rural health
1474612|NCT00878566|prescribing|prescribing
1474613|NCT00878553|insomnia|insomnia
1474614|NCT00878553|middle of the night|middle of the night
1474615|NCT00878553|sleep maintenance|sleep maintenance
1474616|NCT00878540|mirtazapine|mirtazapine
1474617|NCT00878540|metabolism|metabolism
1474618|NCT00878540|depression|depression
1474619|NCT00878540|Healthy males|healthy males
1474620|NCT00878527|Heart Failure|heart failure
1474621|NCT00878527|Partial Circulatory Assist|partial circulatory assist
1474622|NCT00878527|NYHA Class IIIb|nyha class iiib
1474623|NCT00878527|NYHA Class IV|nyha class iv
1474624|NCT00878527|Ventricular Assist Device|ventricular assist device
1474626|NCT00878514|Alprazolam|alprazolam
1474627|NCT00878514|Bioequivalence|bioequivalence
1474628|NCT00878501|Phase II|phase ii
1474629|NCT00878501|Pain|pain
1474630|NCT00878475|Quantitative Capnometry|quantitative capnometry
1474631|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
1474632|NCT00878475|Acute Heart Failure|acute heart failure
1474633|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
1474634|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
1474635|NCT00878436|hormone therapy|hormone therapy
1474636|NCT00878436|androgen-independent|androgen-independent
1474637|NCT00878436|PSA|psa
1474638|NCT00878436|androgen receptor|androgen receptor
1474639|NCT00878423|HSP90|hsp90
1474640|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
1474641|NCT00878423|refractory to standard therapy|refractory to standard therapy
1474642|NCT00878397|malaria|malaria
1474643|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
1474644|NCT00878397|anaemia|anaemia
1474645|NCT00878397|schools|schools
1474646|NCT00878384|Atrial Fibrillation|atrial fibrillation
1474647|NCT00878384|Heart Failure|heart failure
1474648|NCT00878384|Heart Rate Control|heart rate control
1474649|NCT00878384|Catheter Ablation|catheter ablation
1474650|NCT00878371|morphine|morphine
1474651|NCT00878371|blood brain barrier|blood brain barrier
1474652|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
1474653|NCT00878358|Osteoarthritis|osteoarthritis
1474654|NCT00878358|Total knee replacement|total knee replacement
1474655|NCT00878345|Pediatric sedation|pediatric sedation
1474656|NCT00878345|Pentobarbital|pentobarbital
1474657|NCT00878345|Dexmedetomidine|dexmedetomidine
1474658|NCT00878345|Procedural sedation in children|procedural sedation in children
1474659|NCT00878332|edentulous|edentulous
1474660|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
1474661|NCT00878332|insufficient bone height|insufficient bone height
1474662|NCT00878332|Partially edentulous patients|partially edentulous patients
1474663|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
1474664|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
1474665|NCT00878332|Adult patients|adult patients
1474666|NCT00878319|Humeral|humeral
1474667|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
1474668|NCT00878319|fracture|fracture
1474669|NCT00878319|operative|operative
1474670|NCT00878319|non-operative|non-operative
1474671|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
1474672|NCT00878306|HIV|hiv
1474673|NCT00878293|analgesic|analgesic
1474674|NCT00878293|diabetes mellitus|diabetes mellitus
1474675|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
1474676|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
1474677|NCT00878267|Cancer|cancer
1474678|NCT00878267|Computer Program|computer program
1474679|NCT00878267|Palliative Care|palliative care
1474680|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
1474681|NCT00878267|PRO|pro
1474682|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
1474683|NCT00878267|Electronic Health Record|electronic health record
1474685|NCT00878267|Interview|interview
1474686|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
1474687|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1474688|NCT00878254|MCL|mcl
1474689|NCT00878254|NHL|nhl
1474690|NCT00878241|Colon Anastomosis|colon anastomosis
1474691|NCT00878241|Rectum Anastomosis|rectum anastomosis
1474692|NCT00878241|Intestine|intestine
1474693|NCT00878241|Colorectal Surgery|colorectal surgery
1474694|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
1474695|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
1474696|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
1474697|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
1474698|NCT00878176|urinary retention|urinary retention
1474699|NCT00878176|screening|screening
1474700|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
1474701|NCT00878150|traumatic brain injury|traumatic brain injury
1474702|NCT00878150|TBI|tbi
1474703|NCT00878150|head injury|head injury
1474704|NCT00878150|brain injury|brain injury
1474705|NCT00878150|depression|depression
1474706|NCT00878150|major depressive disorder|major depressive disorder
1474707|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
1474708|NCT00878150|CBT|cbt
1474709|NCT00878150|counseling|counseling
1474710|NCT00878124|Poor ovarian response|poor ovarian response
1474711|NCT00878124|Chromosomal aberrations|chromosomal aberrations
1474712|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
1474713|NCT00878124|Late maternal age|late maternal age
1474714|NCT00878111|NGR-hTNF|ngr-htnf
1474715|NCT00878111|Solid tumours|solid tumours
1474716|NCT00878111|High doses|high doses
1474717|NCT00878098|DDT|ddt
1474718|NCT00878098|Malaria|malaria
1474719|NCT00878098|Pregnancy Outcome|pregnancy outcome
1474720|NCT00878098|Spontaneous Abortion|spontaneous abortion
1474721|NCT00878098|HIV|hiv
1474722|NCT00878098|Pregnancy|pregnancy
1474723|NCT00878085|Robot Therapy|robot therapy
1474724|NCT00878085|Upper Limb|upper limb
1474725|NCT00878085|Stroke|stroke
1474726|NCT00878085|Rehabilitation|rehabilitation
1474727|NCT00878085|fMRI|fmri
1474728|NCT00878085|DTI|dti
1474729|NCT00878072|Herpes labialis|herpes labialis
1474730|NCT00878072|cold sores|cold sores
1474731|NCT00878072|herpes simplex type 1|herpes simplex type 1
1474732|NCT00878046|Hip|hip
1474733|NCT00878046|Cementless|cementless
1474734|NCT00878046|Conservative|conservative
1474735|NCT00878007|Anaemia|anaemia
1474736|NCT00878007|Malaria|malaria
1474737|NCT00878007|Literacy|literacy
1474738|NCT00878007|Kenya|kenya
1474739|NCT00877994|Disordered Eating|disordered eating
1474740|NCT00877994|Parenting|parenting
1474741|NCT00877994|Mothers|mothers
1474742|NCT00877981|hyperparathyroidism|hyperparathyroidism
1474743|NCT00877981|surgery|surgery
1474744|NCT00877981|minimal invasive|minimal invasive
1474745|NCT00877981|videoassited|videoassited
1474746|NCT00877968|Pea flour|pea flour
1474747|NCT00877968|Glycemic response|glycemic response
1474748|NCT00877968|Diabetes|diabetes
1474749|NCT00877968|Sensory|sensory
1474750|NCT00877968|Functional food|functional food
1474751|NCT00877968|Diabetes control and prevention|diabetes control and prevention
1474752|NCT00877955|bioequivalence|bioequivalence
1474753|NCT00877955|pharmacokinetic|pharmacokinetic
1474754|NCT00877955|alprazolam|alprazolam
1474755|NCT00877955|sublingual|sublingual
1474756|NCT00877903|Acute myocardial infarction|acute myocardial infarction
1474757|NCT00877903|AMI|ami
1474758|NCT00877903|Myocardial infarction|myocardial infarction
1474759|NCT00877903|Heart attack|heart attack
1474760|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
1474761|NCT00877903|MSC|msc
1474762|NCT00877903|Adult human stem cells|adult human stem cells
1474763|NCT00877903|Osiris|osiris
1474764|NCT00877890|diabetes|diabetes
1474765|NCT00877890|exenatide once weekly|exenatide once weekly
1474766|NCT00877890|Byetta|byetta
1474767|NCT00877890|Amylin|amylin
1474768|NCT00877890|Lilly|lilly
1474769|NCT00877890|Bydureon|bydureon
1474770|NCT00877877|HPV vaccine|hpv vaccine
1474771|NCT00877877|cervical cancer|cervical cancer
1474772|NCT00877864|diabetes|diabetes
1474773|NCT00877864|exercise|exercise
1474774|NCT00877864|printed materials|printed materials
1474775|NCT00877851|Diet|diet
1474776|NCT00877851|Physical activity|physical activity
1474777|NCT00877851|Self management|self management
1474778|NCT00877851|Goal setting|goal setting
1474779|NCT00877838|Headache|headache
1474780|NCT00877838|Migraine|migraine
1474781|NCT00877838|Aura|aura
1474782|NCT00877838|Acute|acute
1474783|NCT00877838|Attack|attack
1474784|NCT00877838|Clinical|clinical
1474785|NCT00877838|Trial|trial
1474786|NCT00877838|Intervention|intervention
1474787|NCT00877838|Nitrogen Oxide|nitrogen oxide
1474788|NCT00877838|NOS|nos
1474789|NCT00877838|nNOS|nnos
1474790|NCT00877838|Triptan|triptan
1474791|NCT00877838|5HT|5ht
1474793|NCT00877825|Diet Therapy|diet therapy
1474794|NCT00877812|Vitamin B6|vitamin b6
1474795|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
1474796|NCT00877812|Amino acids|amino acids
1474797|NCT00877812|pyridoxine|pyridoxine
1474798|NCT00877799|pain|pain
1474799|NCT00877799|acute pain|acute pain
1474800|NCT00877799|visceral pain|visceral pain
1474801|NCT00877799|kappa agonist|kappa agonist
1474802|NCT00877799|opioid analgesics|opioid analgesics
1474803|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
1474804|NCT00877799|physiological effects of drugs|physiological effects of drugs
1474805|NCT00877799|surgery|surgery
1474806|NCT00877799|hysterectomy|hysterectomy
1474807|NCT00877799|post-operative|post-operative
1474808|NCT00877799|post-operative complications|post-operative complications
1474809|NCT00877773|Advanced cancer|advanced cancer
1474810|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
1474811|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
1474812|NCT00877773|PI3K|pi3k
1474813|NCT00877773|PIK3 mutations|pik3 mutations
1474814|NCT00877773|Temsirolimus|temsirolimus
1474815|NCT00877773|CCI-779|cci-779
1474816|NCT00877773|Torisel|torisel
1474817|NCT00877773|mTOR inhibitor|mtor inhibitor
1474818|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
1474820|NCT00877734|alcohol dependence|alcohol dependence
1474821|NCT00877734|baclofen|baclofen
1474822|NCT00877734|pharmacotherapy|pharmacotherapy
1474823|NCT00877734|women|women
1474824|NCT00877721|Postural Control|postural control
1474825|NCT00877721|Gait|gait
1474826|NCT00877721|Falls|falls
1474827|NCT00877721|Elderly|elderly
1474828|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
1474829|NCT00877708|E. Coli|e. coli
1474830|NCT00877708|isolates|isolates
1474832|NCT00877695|HIV Seronegativity|hiv seronegativity
1474833|NCT00877695|prevention|prevention
1474834|NCT00877695|Hispanic|hispanic
1474835|NCT00877695|Latino|latino
1474836|NCT00877695|MSM|msm
1474837|NCT00877695|men|men
1474838|NCT00877682|Prostate Cancer|prostate cancer
1474839|NCT00877682|Prostate Tumor|prostate tumor
1474840|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
1474841|NCT00877682|PCA|pca
1474842|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
1474843|NCT00877682|Cryotherapy|cryotherapy
1474844|NCT00877682|Cryoablation|cryoablation
1474845|NCT00877682|Health Related Quality of Life|health related quality of life
1474846|NCT00877682|HRQOL|hrqol
1474847|NCT00877617|Quality of Life|quality of life
1474848|NCT00877617|QOL|qol
1474849|NCT00877617|Questionnaire|questionnaire
1474850|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
1474851|NCT00877617|HRLPC|hrlpc
1474852|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
1474853|NCT00877617|Radical Prostatectomy|radical prostatectomy
1474854|NCT00877604|ALS|als
1474855|NCT00877604|Therapy|therapy
1474856|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
1474857|NCT00877604|TUDCA|tudca
1474858|NCT00877604|antioxidant|antioxidant
1474859|NCT00877604|antiapoptotic drug|antiapoptotic drug
1474860|NCT00877604|neuroprotective drug|neuroprotective drug
1474861|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
1474862|NCT00877578|elderly patient|elderly patient
1474863|NCT00877578|malnutrition|malnutrition
1474864|NCT00877578|new nutritional support|new nutritional support
1474865|NCT00877578|micronutrients|micronutrients
1474866|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
1474867|NCT00877565|LVF|lvf
1474868|NCT00877565|Left ventricular systolic function|left ventricular systolic function
1474869|NCT00877552|Schizophrenia|schizophrenia
1474870|NCT00877552|brain development|brain development
1474871|NCT00877552|MRI|mri
1474872|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
1474873|NCT00877513|Smoking|smoking
1474874|NCT00877513|Insulin resistance|insulin resistance
1474875|NCT00877513|Metabolic syndrome|metabolic syndrome
1474876|NCT00877513|Body fat distribution|body fat distribution
1474877|NCT00877513|Cigarette smoking|cigarette smoking
1474878|NCT00877500|HER2/neu-negative Breast Cancer|her2/neu-negative breast cancer
1474879|NCT00877500|Residual Breast Cancer|residual breast cancer
1474880|NCT00877500|Surgery|surgery
1474881|NCT00877500|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
1474883|NCT00877500|Ixabepilone|ixabepilone
1474884|NCT00877500|BMS-247550|bms-247550
1474885|NCT00877500|Epothilone B analogue|epothilone b analogue
1474886|NCT00877487|ADHD|adhd
1474887|NCT00877474|PM01183|pm01183
1474888|NCT00877474|Solid tumors|solid tumors
1474889|NCT00877474|PharmaMar USA|pharmamar usa
1474890|NCT00877448|INFLUENZA|influenza
1474891|NCT00877448|VACCINE|vaccine
1474892|NCT00877448|UNIVERSAL|universal
1474893|NCT00877448|SAFETY|safety
1474894|NCT00877422|vitamin deficiency|vitamin deficiency
1474895|NCT00877409|Acnase|acnase
1474896|NCT00877409|Acne Vulgaris|acne vulgaris
1474898|NCT00877409|Efficacy|efficacy
1474899|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1474900|NCT00877383|COPD|copd
1474901|NCT00877383|indacaterol|indacaterol
1474902|NCT00877383|tiotropium|tiotropium
1474903|NCT00877383|bronchodilation|bronchodilation
1474904|NCT00877370|ertapenem|ertapenem
1474905|NCT00877370|continuous hemodialysis|continuous hemodialysis
1474906|NCT00877370|pharmacokinetics|pharmacokinetics
1474907|NCT00877357|Vaccine|vaccine
1474908|NCT00877357|Prevention|prevention
1474909|NCT00877357|Diphtheria|diphtheria
1474910|NCT00877357|Tetanus|tetanus
1474911|NCT00877357|Pertussis|pertussis
1474912|NCT00877357|Hepatitis B|hepatitis b
1474913|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
1474914|NCT00877357|Lot Consistency|lot consistency
1474915|NCT00877357|Long Term Immunogenicity|long term immunogenicity
1474916|NCT00877357|Reactogenicity|reactogenicity
1474917|NCT00877357|Healthy infants|healthy infants
1474918|NCT00877344|Pregnancy|pregnancy
1474920|NCT00877344|abortion|abortion
1474921|NCT00877344|contraception|contraception
1474922|NCT00877331|Drug Abuse|drug abuse
1474923|NCT00877331|Drug Addiction|drug addiction
1474924|NCT00877331|Drug Dependence|drug dependence
1474925|NCT00877331|Drug Usage|drug usage
1474926|NCT00877331|Drug Use Disorders|drug use disorders
1474927|NCT00877331|Substance Abuse|substance abuse
1474928|NCT00877331|Substance Addiction|substance addiction
1474929|NCT00877331|Substance Dependence|substance dependence
1474930|NCT00877331|Substance Use Disorders|substance use disorders
1474931|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
1474932|NCT00877305|Cognitive function|cognitive function
1474933|NCT00877292|Down Syndrome|down syndrome
1474934|NCT00877292|trisomy 21|trisomy 21
1474935|NCT00877292|prenatal testing|prenatal testing
1474936|NCT00877292|pregnant women|pregnant women
1474937|NCT00877279|Facial wrinkles|facial wrinkles
1474938|NCT00877279|Nasolabial folds|nasolabial folds
1474939|NCT00877266|catheter|catheter
1474940|NCT00877266|ultrasound guidance|ultrasound guidance
1474941|NCT00877266|nerve stimulation|nerve stimulation
1474942|NCT00877266|electrical stimulation|electrical stimulation
1474943|NCT00877266|nerve block|nerve block
1474944|NCT00877266|UCSD|ucsd
1474945|NCT00877266|timed placement|timed placement
1474946|NCT00877266|surgery|surgery
1474947|NCT00877266|Catheter Placement Time|catheter placement time
1474948|NCT00877227|CVA|cva
1474949|NCT00877227|stroke|stroke
1474950|NCT00877227|newborns|newborns
1474951|NCT00877227|homocysteine|homocysteine
1474952|NCT00877227|folinic acid|folinic acid
1474953|NCT00877214|Bendamustine|bendamustine
1474954|NCT00877214|Rituximab|rituximab
1474955|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
1474956|NCT00877214|Efficacy and safety|efficacy and safety
1474957|NCT00877201|Accommodation|accommodation
1474958|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
1474959|NCT00877201|antioxidant|antioxidant
1474960|NCT00877188|breast cancer|breast cancer
1474961|NCT00877188|exercise|exercise
1474962|NCT00877188|upper extremity function|upper extremity function
1474963|NCT00877188|quality of life|quality of life
1474964|NCT00877175|preterm infants|preterm infants
1474965|NCT00877175|mydriasis|mydriasis
1474966|NCT00877175|pupil dilation|pupil dilation
1474967|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
1474968|NCT00877162|trial|trial
1474969|NCT00877162|group|group
1474970|NCT00877162|Behavioral sleep problems|behavioral sleep problems
1474971|NCT00877149|Chronic HBV|chronic hbv
1474972|NCT00877136|Liver tumors|liver tumors
1474973|NCT00877136|Liver cancer|liver cancer
1474974|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1474975|NCT00877136|HCC|hcc
1474976|NCT00877136|Hepatoma|hepatoma
1474977|NCT00877136|Neoplasms|neoplasms
1474978|NCT00877123|fasting glucose|fasting glucose
1474979|NCT00877123|obesity|obesity
1474980|NCT00877123|arab women|arab women
1474981|NCT00877123|interleukin|interleukin
1474982|NCT00877123|diabetes|diabetes
1474983|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
1474984|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
1474985|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1474986|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
1474987|NCT00877110|TOPOTECAN|topotecan
1474988|NCT00877110|VINCRISTINE|vincristine
1474989|NCT00877110|Neuroblastoma|neuroblastoma
1474990|NCT00877110|09-011|09-011
1474991|NCT00877097|osteoporosis|osteoporosis
1474992|NCT00877097|Bone mineral density|bone mineral density
1474993|NCT00877097|clodronate|clodronate
1474994|NCT00877097|HRT|hrt
1474995|NCT00877097|postmenopausal|postmenopausal
1474996|NCT00877084|exacerbation|exacerbation
1474997|NCT00877084|COPD|copd
1474998|NCT00877084|Resistance training|resistance training
1474999|NCT00877084|Muscle force|muscle force
1475000|NCT00877058|Frailty|frailty
1475001|NCT00877058|health promotion|health promotion
1475002|NCT00877058|prevention|prevention
1475003|NCT00877058|self management|self management
1475004|NCT00877058|intervention|intervention
1475005|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1475007|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1475008|NCT00877045|Imatinib|imatinib
1475009|NCT00877045|Gleevec|gleevec
1475010|NCT00877045|Suntinib|suntinib
1475011|NCT00877045|Sutent|sutent
1475012|NCT00877032|Phase 1|phase 1
1475013|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
1475014|NCT00877032|RN6G|rn6g
1475015|NCT00877019|sonic brushes|sonic brushes
1475016|NCT00877019|time effectiveness|time effectiveness
1475017|NCT00877019|brush head design|brush head design
1475018|NCT00877019|ADA-toothbrush|ada-toothbrush
1475019|NCT00877019|professional brushing|professional brushing
1475020|NCT00877019|time dependence|time dependence
1475021|NCT00877019|efficacy|efficacy
1475022|NCT00877019|toothbrush|toothbrush
1475023|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
1475024|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
1475025|NCT00876980|Randomized controlled trial|randomized controlled trial
1475026|NCT00876967|anesthesiology|anesthesiology
1475027|NCT00876967|randomized|randomized
1475028|NCT00876967|laryngoscope|laryngoscope
1475029|NCT00876967|intubation|intubation
1475030|NCT00876967|laryngeal exposition|laryngeal exposition
1475031|NCT00876967|laryngoscope blades|laryngoscope blades
1475032|NCT00876967|plastic single use blade|plastic single use blade
1475033|NCT00876967|metallic single use blade|metallic single use blade
1475034|NCT00876967|metallic reusable blade|metallic reusable blade
1475035|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
1475036|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
1475038|NCT00876941|Drug Use|drug use
1475039|NCT00876941|Screening|screening
1475040|NCT00876941|Brief Intervention|brief intervention
1475041|NCT00876941|Primary Care|primary care
1475042|NCT00876941|Utilization|utilization
1475043|NCT00876928|pre-diabetes|pre-diabetes
1475044|NCT00876928|minorities|minorities
1475045|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
1475046|NCT00876928|disposition index|disposition index
1475047|NCT00876928|insulin secretion|insulin secretion
1475048|NCT00876928|insulin sensitivity|insulin sensitivity
1475049|NCT00876928|diabetes|diabetes
1475050|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
1475051|NCT00876902|liver transplantation|liver transplantation
1475052|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
1475053|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
1475054|NCT00876902|primary non-function|primary non-function
1475055|NCT00876902|delayed non-Function|delayed non-function
1475056|NCT00876902|poor early graft function|poor early graft function
1475057|NCT00876902|YSPSL|yspsl
1475058|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
1475059|NCT00876889|spinal cord injury|spinal cord injury
1475060|NCT00876889|riluzole|riluzole
1475061|NCT00876889|pharmacokinetics|pharmacokinetics
1475062|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
1475063|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
1475064|NCT00876876|serum sodium|serum sodium
1475065|NCT00876876|fluid overload|fluid overload
1475066|NCT00876876|heartfailure|heartfailure
1475067|NCT00876876|acute heart failure|acute heart failure
1475068|NCT00876876|vasopressin antagonist|vasopressin antagonist
1475069|NCT00876863|Alzheimer's disease|alzheimer's disease
1475070|NCT00876863|Dementia|dementia
1475071|NCT00876863|Memory loss|memory loss
1475072|NCT00876863|Cognitive impairment|cognitive impairment
1475073|NCT00876863|Nerve growth factor|nerve growth factor
1475074|NCT00876863|NGF|ngf
1475075|NCT00876863|Neurotrophic factors|neurotrophic factors
1475076|NCT00876863|Gene therapy|gene therapy
1475077|NCT00876850|cSSI|cssi
1475078|NCT00876850|Abscess|abscess
1475079|NCT00876850|Would|would
1475080|NCT00876850|Cellulitis|cellulitis
1475081|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
1475082|NCT00876824|Black Fever|black fever
1475083|NCT00876824|Kala-Azar|kala-azar
1475084|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
1475085|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
1475086|NCT00876811|raspberry|raspberry
1475087|NCT00876811|fruit|fruit
1475088|NCT00876811|antioxidants|antioxidants
1475089|NCT00876811|polyphenols|polyphenols
1475090|NCT00876811|oxidative stress|oxidative stress
1475091|NCT00876811|dietary intervention|dietary intervention
1475092|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
1475093|NCT00876798|SIADH|siadh
1475094|NCT00876798|Serum Sodium|serum sodium
1475095|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
1475096|NCT00876772|ALS|als
1475097|NCT00876772|olanazapine|olanazapine
1475098|NCT00876772|Loss of Apptetite|loss of apptetite
1475099|NCT00876772|Appetite Loss|appetite loss
1475100|NCT00876772|Malnutrition|malnutrition
1475101|NCT00876772|Cachexia|cachexia
1475102|NCT00876772|Zyprexa|zyprexa
1475103|NCT00876759|cerebral metastases|cerebral metastases
1475104|NCT00876746|Pain|pain
1475105|NCT00876746|surgery|surgery
1475106|NCT00876746|catheter|catheter
1475107|NCT00876746|nerve block|nerve block
1475108|NCT00876746|supraclavicular|supraclavicular
1475109|NCT00876746|infraclavicular|infraclavicular
1475110|NCT00876746|UCSD|ucsd
1475111|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
1475112|NCT00876746|Supraclavicular catheter|supraclavicular catheter
1475113|NCT00876746|Infraclavicular catheter|infraclavicular catheter
1475114|NCT00876720|Tinnitus|tinnitus
1475115|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
1475116|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
1475117|NCT00876720|sensation disorders|sensation disorders
1475118|NCT00876720|hearing disorders|hearing disorders
1475119|NCT00876707|wavefront|wavefront
1475120|NCT00876707|multifocal IOL|multifocal iol
1475121|NCT00876707|modulation transfer function|modulation transfer function
1475122|NCT00876707|intraocular lenses|intraocular lenses
1475123|NCT00876707|wavefront data|wavefront data
1475124|NCT00876707|Visual performance|visual performance
1475125|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
1475126|NCT00876681|Catheter|catheter
1475127|NCT00876681|Ultrasound-guidance|ultrasound-guidance
1475128|NCT00876681|Nerve Stimulation|nerve stimulation
1475129|NCT00876681|Electrical stimulation|electrical stimulation
1475130|NCT00876681|nerve block|nerve block
1475132|NCT00876681|Orthopedic surgery|orthopedic surgery
1475133|NCT00876681|Foot/ankle pain|foot/ankle pain
1475134|NCT00876681|Foot/ankle numbness|foot/ankle numbness
1475135|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
1475136|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
1475137|NCT00876668|Microcirculation|microcirculation
1475138|NCT00876668|fluorescence angiography|fluorescence angiography
1475139|NCT00876642|Radiation dermatitis|radiation dermatitis
1475140|NCT00876642|best supportive care|best supportive care
1475141|NCT00876642|Aloe vera gel|aloe vera gel
1475142|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
1475143|NCT00876629|MR Elastography|mr elastography
1475144|NCT00876629|kidney|kidney
1475145|NCT00876629|fibrosis|fibrosis
1475146|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
1475147|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
1475148|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
1475149|NCT00876603|cervical laminoplasty|cervical laminoplasty
1475150|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
1475151|NCT00876577|Avelox|avelox
1475152|NCT00876577|Bronchitis|bronchitis
1475153|NCT00876564|Triage precision|triage precision
1475154|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
1475155|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
1475156|NCT00876551|Esophagectomy|esophagectomy
1475157|NCT00876551|Anastomotic leakage|anastomotic leakage
1475158|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
1475159|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
1475160|NCT00876538|TR019622|tr019622
1475161|NCT00876538|Trophos|trophos
1475162|NCT00876525|Heart diseases.|heart diseases.
1475163|NCT00876525|Aortic valve diseases.|aortic valve diseases.
1475164|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
1475165|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
1475166|NCT00876512|thienopyridine resistance|thienopyridine resistance
1475167|NCT00876512|stable effort angina|stable effort angina
1475168|NCT00876512|platelet activation|platelet activation
1475169|NCT00876512|ADAMTS13|adamts13
1475170|NCT00876512|von Willebrand Factor|von willebrand factor
1475171|NCT00876499|Primary Brain Tumor|primary brain tumor
1475172|NCT00876499|PBT|pbt
1475173|NCT00876499|Brain Cancer|brain cancer
1475174|NCT00876499|Primary glioma|primary glioma
1475175|NCT00876499|Astrocytoma|astrocytoma
1475176|NCT00876499|Oligodendroglioma|oligodendroglioma
1475177|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
1475178|NCT00876499|Ependymoma|ependymoma
1475179|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
1475180|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1475181|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
1475182|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
1475183|NCT00876499|Fatigue|fatigue
1475184|NCT00876499|Cytokines|cytokines
1475185|NCT00876499|Questionnaires|questionnaires
1475186|NCT00876499|Actigraphy|actigraphy
1475187|NCT00876499|Sleep Disturbance|sleep disturbance
1475188|NCT00876499|Radiation Therapy|radiation therapy
1475189|NCT00876473|CPAP|cpap
1475190|NCT00876473|Acute Respiratory Failure|acute respiratory failure
1475191|NCT00876434|Sirolimus|sirolimus
1475192|NCT00876434|Anterior Uveitis|anterior uveitis
1475193|NCT00876434|Autoimmune Disease|autoimmune disease
1475194|NCT00876434|Uveitis|uveitis
1475195|NCT00876421|ONO-8539|ono-8539
1475196|NCT00876421|Overactive bladder|overactive bladder
1475197|NCT00876421|OAB|oab
1475198|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
1475199|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
1475200|NCT00876408|Unknown Primary|unknown primary
1475201|NCT00876408|UPC|upc
1475202|NCT00876408|CUP|cup
1475203|NCT00876395|Breast Cancer|breast cancer
1475204|NCT00876395|HER2+|her2+
1475205|NCT00876395|mTOR|mtor
1475206|NCT00876395|everolimus|everolimus
1475207|NCT00876395|RAD001|rad001
1475208|NCT00876395|first line|first line
1475209|NCT00876395|metastatic|metastatic
1475210|NCT00876395|locally advanced|locally advanced
1475211|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
1475212|NCT00876382|renal cancer|renal cancer
1475213|NCT00876382|renal cell|renal cell
1475214|NCT00876382|Sorafenib|sorafenib
1475215|NCT00876382|Nexavar|nexavar
1475216|NCT00876382|Bevacizumab|bevacizumab
1475217|NCT00876382|Avastin|avastin
1475218|NCT00876382|Sunitinib|sunitinib
1475219|NCT00876382|Sutent|sutent
1475220|NCT00876369|urticaria|urticaria
1475221|NCT00876369|angioedema|angioedema
1475222|NCT00876369|vitamin D|vitamin d
1475223|NCT00876369|allergy|allergy
1475224|NCT00876356|Asthma|asthma
1475225|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
1475226|NCT00876356|dietary supplement|dietary supplement
1475227|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
1475228|NCT00876330|Hyperlipidemia|hyperlipidemia
1475229|NCT00876330|Hypertension|hypertension
1475230|NCT00876317|Tenosynovitis|tenosynovitis
1475231|NCT00876317|Bursitis|bursitis
1475232|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
1475233|NCT00876278|Cataract|cataract
1475234|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
1475235|NCT00876278|Mesotest II|mesotest ii
1475236|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
1475237|NCT00876265|Facial wrinkles|facial wrinkles
1475238|NCT00876265|Nasolabial fold|nasolabial fold
1475239|NCT00876226|Citalopram|citalopram
1475240|NCT00876226|Pharmacokinetics|pharmacokinetics
1475241|NCT00876226|Short Bowel Syndrome|short bowel syndrome
1475242|NCT00876213|Amylin|amylin
1475243|NCT00876213|GLP-1|glp-1
1475244|NCT00876213|gastric emptying|gastric emptying
1475245|NCT00876213|appetite and food intake|appetite and food intake
1475246|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
1475247|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
1475248|NCT00876200|Cardiovascular structure|cardiovascular structure
1475249|NCT00876187|randomized controlled trial|randomized controlled trial
1475250|NCT00876187|monoclonal antibody|monoclonal antibody
1475251|NCT00876187|nerve growth factor|nerve growth factor
1475252|NCT00876187|naproxen|naproxen
1475253|NCT00876174|Chronic hepatitis C|chronic hepatitis c
1475254|NCT00876174|Genotype 1|genotype 1
1475255|NCT00876161|Healthy Adults|healthy adults
1475256|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
1475257|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
1475258|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
1475259|NCT00876122|NHL|nhl
1475260|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
1475261|NCT00876122|PI3K Inhibitors|pi3k inhibitors
1475262|NCT00876122|PI3K|pi3k
1475263|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
1475264|NCT00876109|PI3K|pi3k
1475265|NCT00876109|PI3K Inhibitors|pi3k inhibitors
1475266|NCT00876096|Diagnosis, Differential|diagnosis, differential
1475267|NCT00876083|Drug utilization review|drug utilization review
1475268|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
1475269|NCT00876070|Breast Cancer|breast cancer
1475270|NCT00876070|MBC|mbc
1475271|NCT00876070|Abraxane|abraxane
1475272|NCT00876070|Paclitaxel|paclitaxel
1475273|NCT00876070|Taxol|taxol
1475274|NCT00876070|Docetaxel|docetaxel
1475275|NCT00876070|Taxotere|taxotere
1475276|NCT00876057|psychological well-being|psychological well-being
1475277|NCT00876057|recovery|recovery
1475278|NCT00876057|time in hospital|time in hospital
1475279|NCT00876057|sick-leave|sick-leave
1475280|NCT00876057|complications|complications
1475281|NCT00876057|Sexual well-being|sexual well-being
1475282|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
1475283|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
1475284|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
1475285|NCT00876031|synovial sarcoma|synovial sarcoma
1475286|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
1475287|NCT00876018|physical performance|physical performance
1475288|NCT00876018|micronutrients|micronutrients
1475289|NCT00876018|physical fitness|physical fitness
1475290|NCT00876018|healthy children|healthy children
1475291|NCT00876005|Wound infection|wound infection
1475292|NCT00875979|MBC|mbc
1475293|NCT00875979|Breast Cancer|breast cancer
1475294|NCT00875979|HER2+|her2+
1475295|NCT00875979|HER2+ breast cancer|her2+ breast cancer
1475296|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
1475297|NCT00875979|herceptin|herceptin
1475298|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
1475299|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
1475300|NCT00875953|head and neck cancer|head and neck cancer
1475301|NCT00875953|neck dissection|neck dissection
1475302|NCT00875927|Halitosis|halitosis
1475303|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
1475304|NCT00875914|radiofrequency ablation|radiofrequency ablation
1475305|NCT00875914|magnetic navigation system|magnetic navigation system
1475306|NCT00875901|Lung Cancer|lung cancer
1475307|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
1475308|NCT00875901|Proton Radiation|proton radiation
1475309|NCT00875901|HypoIGRT|hypoigrt
1475310|NCT00875875|Diarrhea, travelers|diarrhea, travelers
1475311|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
1475312|NCT00875862|UCSD|ucsd
1475313|NCT00875862|pain|pain
1475314|NCT00875862|quality-of-life|quality-of-life
1475315|NCT00875862|range-of-motion|range-of-motion
1475316|NCT00875862|interscalene catheter|interscalene catheter
1475317|NCT00875862|nerve block|nerve block
1475318|NCT00875862|shoulder|shoulder
1475319|NCT00875862|Shoulder Manipulation|shoulder manipulation
1475320|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1475321|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1475322|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1475323|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1475324|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1475325|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1475326|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1475327|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1475328|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1475329|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1475330|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1475331|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1475332|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1475333|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1475334|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1475335|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1475336|NCT00875849|tongue cancer|tongue cancer
1475337|NCT00875836|Marijuana|marijuana
1475338|NCT00875836|Buspirone|buspirone
1475339|NCT00875836|Contingency management|contingency management
1475340|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
1475341|NCT00875823|PH|ph
1475342|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
1475343|NCT00875823|Type I|type i
1475344|NCT00875823|Type II|type ii
1475345|NCT00875823|NonI-NonII|noni-nonii
1475346|NCT00875823|Kidney stones|kidney stones
1475347|NCT00875823|oxalate|oxalate
1475348|NCT00875823|oxalosis|oxalosis
1475349|NCT00875797|enteral|enteral
1475350|NCT00875797|parenteral|parenteral
1475351|NCT00875797|glutamine|glutamine
1475352|NCT00875797|intestinal permeability|intestinal permeability
1475353|NCT00875797|infection|infection
1475354|NCT00875784|Sumatriptan exposure|sumatriptan exposure
1475355|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
1475356|NCT00875771|BEVACIZUMAB|bevacizumab
1475357|NCT00875771|CAPECITABINE|capecitabine
1475358|NCT00875771|IRINOTECAN|irinotecan
1475359|NCT00875758|preterm infants|preterm infants
1475360|NCT00875758|IVH|ivh
1475361|NCT00875758|germinal matrix|germinal matrix
1475362|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
1475363|NCT00875758|hydrocephalus|hydrocephalus
1475364|NCT00875732|Resynchronization|resynchronization
1475365|NCT00875732|Device|device
1475366|NCT00875732|Bradycardia|bradycardia
1475367|NCT00875732|atrioventricular block|atrioventricular block
1475368|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
1475369|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
1475370|NCT00875706|Nursing Homes|nursing homes
1475371|NCT00875706|Implementation of innovative programs|implementation of innovative programs
1475372|NCT00875706|Nursing staff|nursing staff
1475373|NCT00875706|Nurses' aides|nurses' aides
1475374|NCT00875706|Educational models|educational models
1475375|NCT00875693|AML|aml
1475376|NCT00875693|leukemia|leukemia
1475377|NCT00875693|MDS|mds
1475378|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
1475379|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
1475380|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
1475381|NCT00875667|Lymphoma|lymphoma
1475382|NCT00875667|MCL|mcl
1475383|NCT00875654|Cell therapy|cell therapy
1475384|NCT00875654|Stroke|stroke
1475385|NCT00875654|Neuronal Plasticity|neuronal plasticity
1475386|NCT00875654|Recovery|recovery
1475387|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
1475388|NCT00875654|Transplantation|transplantation
1475389|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
1475390|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1475391|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1475392|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
1475393|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
1475394|NCT00875589|Traumatic Brain Injury|traumatic brain injury
1475395|NCT00875589|Eye movement recording|eye movement recording
1475396|NCT00875576|social influences|social influences
1475397|NCT00875576|meals|meals
1475398|NCT00875576|obesity|obesity
1475399|NCT00875576|amount of food consumed|amount of food consumed
1567591|NCT00508794|Questionnaire|questionnaire
1475400|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
1475401|NCT00875537|Burning mouth syndrome|burning mouth syndrome
1475402|NCT00875537|neuropathy|neuropathy
1475403|NCT00875537|inflammation|inflammation
1475404|NCT00875537|tongue mucosa|tongue mucosa
1475405|NCT00875537|tongue innervation|tongue innervation
1475406|NCT00875537|dysgeusia|dysgeusia
1475407|NCT00875524|Dengue virus|dengue virus
1475408|NCT00875524|Dengue fever|dengue fever
1475409|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
1475410|NCT00875524|Dengue diseases|dengue diseases
1475411|NCT00875524|Dengue vaccine|dengue vaccine
1475412|NCT00875511|peer rejection|peer rejection
1475413|NCT00875511|obesity|obesity
1475414|NCT00875511|amount of food chosen|amount of food chosen
1475415|NCT00875511|amount of social time chosen|amount of social time chosen
1475416|NCT00875498|iTBS|itbs
1475417|NCT00875498|Negative Symptoms|negative symptoms
1475418|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
1475419|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
1475420|NCT00875485|Belgium and Czech Republic|belgium and czech republic
1475421|NCT00875472|social influences|social influences
1475422|NCT00875472|food purchases|food purchases
1475423|NCT00875472|childhood obesity|childhood obesity
1475424|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
1475425|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
1475426|NCT00875420|hot flashes|hot flashes
1475427|NCT00875420|hot flushes|hot flushes
1475428|NCT00875420|vasomotor symptoms|vasomotor symptoms
1475429|NCT00875420|postmenopausal|postmenopausal
1475430|NCT00875381|Melanocytes|melanocytes
1475431|NCT00875368|HIV-1|hiv-1
1475432|NCT00875368|HAART|haart
1475433|NCT00875368|CD4 cell|cd4 cell
1475434|NCT00875368|Immunologic non-responders|immunologic non-responders
1475435|NCT00875368|Immunology|immunology
1475436|NCT00875368|treatment experienced|treatment experienced
1475437|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
1475438|NCT00875355|stage IV breast cancer|stage iv breast cancer
1475439|NCT00875342|Traumatic Event|traumatic event
1475440|NCT00875342|Trauma Survivor|trauma survivor
1475441|NCT00875342|Exposure Therapy|exposure therapy
1475442|NCT00875342|PTSD DCS|ptsd dcs
1475443|NCT00875342|Telemedicine|telemedicine
1475444|NCT00875342|Telepsychiatry|telepsychiatry
1475445|NCT00875342|Telemental health|telemental health
1475446|NCT00875329|Brain Injury|brain injury
1475447|NCT00875316|Parkinson's disease|parkinson's disease
1475448|NCT00875316|Phase I|phase i
1475449|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
1475450|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
1475451|NCT00875290|Children|children
1475452|NCT00875290|Insulin pump therapy|insulin pump therapy
1475453|NCT00875290|Continuous glucose monitor|continuous glucose monitor
1475454|NCT00875264|CEP-11981|cep-11981
1475455|NCT00875264|TIE-2|tie-2
1475456|NCT00875264|VEGF-R|vegf-r
1475457|NCT00875251|body composition|body composition
1475458|NCT00875251|preterm infant|preterm infant
1475459|NCT00875251|anthropometry|anthropometry
1475460|NCT00875238|cardiac toxicity|cardiac toxicity
1475461|NCT00875238|cardiovascular complications|cardiovascular complications
1475462|NCT00875238|stage I breast cancer|stage i breast cancer
1475463|NCT00875238|stage II breast cancer|stage ii breast cancer
1475464|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
1475465|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
1475466|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
1475467|NCT00875225|Hypertension|hypertension
1475468|NCT00875225|Adherence to medications|adherence to medications
1475469|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
1475470|NCT00875212|Fluoride|fluoride
1475471|NCT00875212|Dentifrice|dentifrice
1475472|NCT00875212|Biofilm|biofilm
1475473|NCT00875212|Dental caries|dental caries
1475474|NCT00875199|Overweight|overweight
1475475|NCT00875199|Obesity|obesity
1475476|NCT00875199|Contingency Management|contingency management
1475477|NCT00875186|bariatric surgery|bariatric surgery
1475478|NCT00875186|co-morbidities|co-morbidities
1475859|NCT00873574|JAK-STAT|jak-stat
1475479|NCT00875186|aerobic physical exercise|aerobic physical exercise
1475480|NCT00875173|Selenium|selenium
1475481|NCT00875173|Chagas disease|chagas disease
1475482|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
1475483|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1475484|NCT00875147|bevacizumab|bevacizumab
1475485|NCT00875121|Food reinforcement|food reinforcement
1475486|NCT00875121|social reinforcers|social reinforcers
1475487|NCT00875121|overweight|overweight
1475488|NCT00875121|children|children
1475489|NCT00875095|sperm DNA integrity|sperm dna integrity
1475490|NCT00875095|Toluidine blue staining|toluidine blue staining
1475491|NCT00875082|Asthma|asthma
1475492|NCT00875082|Children|children
1475493|NCT00875082|Remodelling|remodelling
1475494|NCT00875082|Metalloproteinases|metalloproteinases
1475495|NCT00875082|Montelukast|montelukast
1475496|NCT00875069|Nosocomial infection|nosocomial infection
1475497|NCT00875069|Catheterization|catheterization
1475498|NCT00875069|Central Venous Ethanol|central venous ethanol
1475499|NCT00875069|lock solution|lock solution
1475500|NCT00875069|intensive care units|intensive care units
1475501|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
1475502|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
1475503|NCT00875043|cortical blindness|cortical blindness
1475504|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
1475505|NCT00875004|anemia|anemia
1475506|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1475507|NCT00874991|Cardiac deformation|cardiac deformation
1475508|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
1475509|NCT00874991|TEE|tee
1475510|NCT00874991|Cardiac Surgery|cardiac surgery
1475511|NCT00874991|Left ventricular function|left ventricular function
1475512|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
1475513|NCT00874991|Tissue Doppler|tissue doppler
1475514|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
1475515|NCT00874978|Lenalidomide|lenalidomide
1475516|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
1475517|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1475518|NCT00874965|Electrostimulation|electrostimulation
1475519|NCT00874965|Muscle function|muscle function
1475520|NCT00874965|Exercise ventilation|exercise ventilation
1475521|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
1475522|NCT00874952|Metabolic syndrome|metabolic syndrome
1475523|NCT00874952|Lipids|lipids
1475524|NCT00874952|Waist Circumference|waist circumference
1475525|NCT00874952|HDL|hdl
1475526|NCT00874952|hypertension|hypertension
1475527|NCT00874926|Octocog alfa|octocog alfa
1475528|NCT00874926|Haemophilia A|haemophilia a
1475529|NCT00874913|blood flow|blood flow
1475530|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1475531|NCT00874913|normal tension glaucoma|normal tension glaucoma
1475532|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1475533|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1475534|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1475535|NCT00874874|adult angiosarcoma|adult angiosarcoma
1475536|NCT00874861|cancer|cancer
1475537|NCT00874861|brain|brain
1475538|NCT00874861|tumor|tumor
1475539|NCT00874861|vaccine|vaccine
1475540|NCT00874848|Imprime PGG|imprime pgg
1475541|NCT00874848|NSCLC|nsclc
1475542|NCT00874848|Cetuximab|cetuximab
1475543|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
1475544|NCT00874835|EK|ek
1475545|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
1475546|NCT00874835|Corneal Transplantation|corneal transplantation
1475547|NCT00874835|Keratoplasty|keratoplasty
1475548|NCT00874835|DSEK|dsek
1475549|NCT00874835|DSAEK|dsaek
1475550|NCT00874809|insulin pump|insulin pump
1475551|NCT00874809|DM Type 2|dm type 2
1475552|NCT00874809|CGMS|cgms
1475553|NCT00874809|basal rate|basal rate
1475554|NCT00874796|apoptosis|apoptosis
1475555|NCT00874796|liver inflammation|liver inflammation
1475556|NCT00874796|hepatitis C|hepatitis c
1475557|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1475558|NCT00874783|Familial Dysautonomia|familial dysautonomia
1475559|NCT00874783|Parkinson's Disease|parkinson's disease
1475560|NCT00874783|Alzheimer's Disease|alzheimer's disease
1475561|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
1475562|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
1475563|NCT00874783|Huntington's Disease|huntington's disease
1475564|NCT00874783|Machado - Joseph Disease|machado - joseph disease
1475565|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
1475566|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
1475567|NCT00874770|Antivirals|antivirals
1475568|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
1475569|NCT00874757|Healthy subjects study|healthy subjects study
1475570|NCT00874744|Diabetic macular edema|diabetic macular edema
1475571|NCT00874744|intravitreal injection|intravitreal injection
1475572|NCT00874744|Pharmacological treatment|pharmacological treatment
1475573|NCT00874718|repetitive strain injury|repetitive strain injury
1475574|NCT00874718|quality of life|quality of life
1475575|NCT00874718|functional capacity|functional capacity
1475576|NCT00874718|workers|workers
1475577|NCT00874692|tap water temperature|tap water temperature
1475578|NCT00874692|social housing|social housing
1475579|NCT00874692|scald reduction|scald reduction
1475580|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
1475581|NCT00874666|garlic|garlic
1475582|NCT00874666|allicin|allicin
1475583|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
1475584|NCT00874666|healthy persons|healthy persons
1475585|NCT00874640|Drug utilization review|drug utilization review
1567592|NCT00508794|Survey|survey
1475586|NCT00874627|children > 5 years old|children > 5 years old
1475587|NCT00874627|IgE-mediated|ige-mediated
1475588|NCT00874627|cow milk allergy|cow milk allergy
1475589|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
1475590|NCT00874614|radiotherapy|radiotherapy
1475591|NCT00874614|MIBG|mibg
1475592|NCT00874614|Azedra|azedra
1475593|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
1475594|NCT00874614|Iobenguane I 131|iobenguane i 131
1475595|NCT00874614|progenics|progenics
1475596|NCT00874601|acute ischemic stroke|acute ischemic stroke
1475597|NCT00874601|blood pressure|blood pressure
1475598|NCT00874601|valsartan|valsartan
1475599|NCT00874601|death|death
1475600|NCT00874601|dependancy|dependancy
1475601|NCT00874575|HMB|hmb
1475602|NCT00874575|Vitamin D|vitamin d
1475603|NCT00874575|Older Adults|older adults
1475604|NCT00874562|rapamycin|rapamycin
1475605|NCT00874562|corticosteroid|corticosteroid
1475606|NCT00874562|ALL|all
1475607|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
1475608|NCT00874549|Menactra®|menactra®
1475609|NCT00874549|Menomune®|menomune®
1475610|NCT00874536|ADHD|adhd
1475611|NCT00874536|methylphenidate|methylphenidate
1475612|NCT00874536|omega-3|omega-3
1475613|NCT00874523|raltegravir|raltegravir
1475614|NCT00874523|atazanavir|atazanavir
1475615|NCT00874523|HIV infections|hiv infections
1475616|NCT00874523|pharmacokinetics|pharmacokinetics
1475617|NCT00874523|antiretroviral agents|antiretroviral agents
1475618|NCT00874523|treatment experienced|treatment experienced
1475619|NCT00874510|sleep deprivation|sleep deprivation
1475620|NCT00874510|fatigue|fatigue
1475621|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1475622|NCT00874432|cardiovascular disease|cardiovascular disease
1475623|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1475624|NCT00874432|chronic kidney disease|chronic kidney disease
1475625|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
1475626|NCT00874419|EGFR mutation|egfr mutation
1475627|NCT00874419|EGFR-TKI|egfr-tki
1475628|NCT00874419|Chemotherapy|chemotherapy
1475629|NCT00874406|colorectal cancer|colorectal cancer
1475630|NCT00874406|liver metastasis|liver metastasis
1475631|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1475632|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
1475633|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1475634|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1475635|NCT00874393|Prematurity|prematurity
1475636|NCT00874393|Blood Pressure Management|blood pressure management
1475637|NCT00874393|Dopamine|dopamine
1475638|NCT00874393|Hydrocortisone|hydrocortisone
1475639|NCT00874380|Fiber|fiber
1475640|NCT00874380|Dialysis|dialysis
1475641|NCT00874380|Renal Replacement Therapy|renal replacement therapy
1475642|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
1475643|NCT00874380|FFQ|ffq
1475644|NCT00874380|Dietary counseling|dietary counseling
1475645|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
1475646|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1475647|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1475648|NCT00874367|Prematurity|prematurity
1475649|NCT00874367|Early Onset Sepsis|early onset sepsis
1475650|NCT00874354|Myocardial Infarction|myocardial infarction
1475651|NCT00874354|Heart Attack|heart attack
1475652|NCT00874354|Infarct|infarct
1475653|NCT00874354|Stem Cells|stem cells
1475654|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
1475655|NCT00874354|CHF|chf
1475656|NCT00874354|Congestive Heart Failure|congestive heart failure
1475657|NCT00874354|Stent|stent
1475658|NCT00874354|PCI|pci
1475659|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
1475660|NCT00874341|Fruit|fruit
1475661|NCT00874341|Vegetables|vegetables
1475662|NCT00874341|Intervention|intervention
1475663|NCT00874341|Insulin resistance|insulin resistance
1475664|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
1475665|NCT00874341|Dose response|dose response
1475666|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
1475667|NCT00874328|Non small cell lung cancer|non small cell lung cancer
1475668|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
1475669|NCT00874328|Phase I/II trial|phase i/ii trial
1475670|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
1475671|NCT00874302|Uterine fibroids|uterine fibroids
1475672|NCT00874289|NGAL|ngal
1475673|NCT00874289|Heart failure|heart failure
1475674|NCT00874276|DCA|dca
1475675|NCT00874276|Dichloroacetate|dichloroacetate
1475676|NCT00874276|Trichloroacetate|trichloroacetate
1475677|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
1475678|NCT00874237|Staccato loxapine|staccato loxapine
1475679|NCT00874237|QTc|qtc
1475680|NCT00874237|healthy volunteers|healthy volunteers
1475681|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
1475682|NCT00874224|Benign liver disease|benign liver disease
1475683|NCT00874211|bone metastases|bone metastases
1475684|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1475685|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
1475686|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
1475687|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
1475688|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
1475689|NCT00874211|male breast cancer|male breast cancer
1475690|NCT00874211|recurrent breast cancer|recurrent breast cancer
1475691|NCT00874211|stage IA breast cancer|stage ia breast cancer
1475692|NCT00874211|stage IB breast cancer|stage ib breast cancer
1475693|NCT00874211|stage II breast cancer|stage ii breast cancer
1475694|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
1475695|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
1475696|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
1475697|NCT00874211|stage IV breast cancer|stage iv breast cancer
1475698|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
1475699|NCT00874211|stage I prostate cancer|stage i prostate cancer
1475700|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
1475701|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
1475702|NCT00874211|stage III prostate cancer|stage iii prostate cancer
1475703|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
1475704|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1475705|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1475706|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1475707|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1475708|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1475709|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1475710|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1475711|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
1475712|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
1475713|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
1475714|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
1475715|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
1475716|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
1475717|NCT00874198|outcome|outcome
1475718|NCT00874198|shunt surgery|shunt surgery
1475719|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
1475720|NCT00874198|biomarkers|biomarkers
1475721|NCT00874198|shunt surgery selection|shunt surgery selection
1475722|NCT00874198|Outcome measures|outcome measures
1475723|NCT00874198|Outcomes assessment|outcomes assessment
1475724|NCT00874198|Outcome and process assessment|outcome and process assessment
1475725|NCT00874185|satisfaction|satisfaction
1475726|NCT00874172|Anemia|anemia
1475727|NCT00874172|Sickle Cell|sickle cell
1475728|NCT00874172|Analgesic|analgesic
1475729|NCT00874172|Pain|pain
1475730|NCT00874172|Emergency treatment|emergency treatment
1475731|NCT00874172|Quality of life|quality of life
1475732|NCT00874107|NSCLC|nsclc
1475733|NCT00874107|Phase 2|phase 2
1475734|NCT00874107|Randomized|randomized
1475735|NCT00874107|Efficacy|efficacy
1475736|NCT00874107|Safety|safety
1475737|NCT00874107|Imprime PGG|imprime pgg
1475738|NCT00874107|Bevacizumab|bevacizumab
1475739|NCT00874094|nasolabial folds|nasolabial folds
1475740|NCT00874094|platelet rich plasma|platelet rich plasma
1475741|NCT00874094|fibrin matrix|fibrin matrix
1475742|NCT00874094|facial rhytids|facial rhytids
1475743|NCT00874094|dermal filler|dermal filler
1475744|NCT00874068|term infants|term infants
1475745|NCT00874068|preterm infants|preterm infants
1475746|NCT00874068|bone strength|bone strength
1475747|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
1475748|NCT00874068|Ultrasound|ultrasound
1475749|NCT00874055|social influence|social influence
1475750|NCT00874055|friends|friends
1475751|NCT00874055|eating behavior|eating behavior
1475752|NCT00874055|childhood overweight|childhood overweight
1475753|NCT00874042|dose escalation|dose escalation
1475754|NCT00874042|safety|safety
1475755|NCT00874042|tolerability|tolerability
1475756|NCT00874042|tumor|tumor
1475757|NCT00874042|PK|pk
1475758|NCT00874029|Uterine Fibroids|uterine fibroids
1475759|NCT00874029|Myomas|myomas
1475760|NCT00874016|intubation|intubation
1475761|NCT00874016|Airtraq|airtraq
1475762|NCT00874016|pediatric|pediatric
1475763|NCT00874016|airway|airway
1475860|NCT00873574|V617|v617
1475764|NCT00874003|alcohol dependence|alcohol dependence
1475765|NCT00874003|anti-depressant|anti-depressant
1475766|NCT00874003|5-HT|5-ht
1475767|NCT00874003|NE|ne
1475768|NCT00873990|fissure sealant|fissure sealant
1475769|NCT00873990|self etch|self etch
1475770|NCT00873990|total etch|total etch
1475771|NCT00873977|Adherence|adherence
1475772|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
1475773|NCT00873964|Metabolic Syndrome|metabolic syndrome
1475774|NCT00873964|Obesity|obesity
1475775|NCT00873964|Elderly|elderly
1475776|NCT00873964|Insulin Resistance|insulin resistance
1475777|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
1475778|NCT00873938|Compliance|compliance
1475779|NCT00873938|Malaria|malaria
1475780|NCT00873925|Type 1 Diabetes|type 1 diabetes
1475781|NCT00873912|influenza|influenza
1475782|NCT00873912|FluMist|flumist
1475783|NCT00873899|Heart Failure|heart failure
1475784|NCT00873899|Implantable defibrillator|implantable defibrillator
1475785|NCT00873899|Remote Monitoring|remote monitoring
1475786|NCT00873873|Asthma Progression|asthma progression
1475787|NCT00873873|Airway Wall Thickness|airway wall thickness
1475788|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
1475789|NCT00873873|Biomarkers|biomarkers
1475790|NCT00873873|Pulmonary Physiology|pulmonary physiology
1475791|NCT00873860|CAT-354|cat-354
1475792|NCT00873860|Tralokinumab|tralokinumab
1475793|NCT00873860|Asthma|asthma
1475794|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
1475795|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1475796|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1475797|NCT00873847|Prematurity|prematurity
1475798|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
1475799|NCT00873834|autism|autism
1475800|NCT00873834|fluoxetine|fluoxetine
1475801|NCT00873834|Comparative|comparative
1475802|NCT00873834|double blind|double blind
1475803|NCT00873834|placebo|placebo
1475804|NCT00873834|controlled trial|controlled trial
1475805|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
1475806|NCT00873834|children|children
1475807|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
1475808|NCT00873808|breast cancer|breast cancer
1475809|NCT00873795|efficacy|efficacy
1475810|NCT00873795|tolerability|tolerability
1475811|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
1475812|NCT00873782|Limb Perfusion|limb perfusion
1475813|NCT00873782|Gene Therapy|gene therapy
1475814|NCT00873769|Staccato Loxapine|staccato loxapine
1475815|NCT00873769|pharmacokinetics|pharmacokinetics
1475816|NCT00873769|smokers|smokers
1475817|NCT00873769|non-smokers|non-smokers
1475818|NCT00873756|CRC|crc
1475819|NCT00873756|Colon Cancer|colon cancer
1475820|NCT00873756|Avastin|avastin
1475821|NCT00873756|Apo2L/TRAIL|apo2l/trail
1475822|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
1475823|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
1475824|NCT00873717|elderly|elderly
1475825|NCT00873717|long-term facilities|long-term facilities
1475826|NCT00873717|nutritional status|nutritional status
1475827|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
1475828|NCT00873678|Molar tooth|molar tooth
1475829|NCT00873678|AHI1 gene|ahi1 gene
1475830|NCT00873678|CEP290 gene|cep290 gene
1475831|NCT00873678|ciliopathies|ciliopathies
1475832|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
1475833|NCT00873652|Booster dose|booster dose
1475834|NCT00873652|Persistence|persistence
1475835|NCT00873652|Immune response|immune response
1475836|NCT00873652|Healthy children|healthy children
1475837|NCT00873626|Urinary tract infection|urinary tract infection
1475838|NCT00873626|treatment duration|treatment duration
1475839|NCT00873626|acute pyelonephritis|acute pyelonephritis
1475840|NCT00873626|good use of antibiotics|good use of antibiotics
1475841|NCT00873600|cognitive/functional effects|cognitive/functional effects
1475842|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1475843|NCT00873600|stage I breast cancer|stage i breast cancer
1475844|NCT00873600|stage II breast cancer|stage ii breast cancer
1475845|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
1475846|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
1475847|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
1475848|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
1475849|NCT00873600|stage I colon cancer|stage i colon cancer
1475850|NCT00873600|stage II colon cancer|stage ii colon cancer
1475851|NCT00873600|stage III colon cancer|stage iii colon cancer
1475852|NCT00873587|Thoracotomy|thoracotomy
1475853|NCT00873587|Inspiration|inspiration
1475854|NCT00873587|Expiration|expiration
1475855|NCT00873587|Chest Tube|chest tube
1475856|NCT00873587|pneumothorax|pneumothorax
1475857|NCT00873587|Method of chest tube removal|method of chest tube removal
1475858|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
1475861|NCT00873574|JAK2|jak2
1475862|NCT00873561|diabetes|diabetes
1475863|NCT00873561|type 1|type 1
1475864|NCT00873561|adult|adult
1475865|NCT00873561|adolescent|adolescent
1475866|NCT00873561|new onset|new onset
1475867|NCT00873535|Nicotine|nicotine
1475868|NCT00873535|Nicotine dependence|nicotine dependence
1475869|NCT00873535|Smoking cessation|smoking cessation
1475870|NCT00873535|Alcohol|alcohol
1475871|NCT00873535|Alcohol dependence|alcohol dependence
1475872|NCT00873535|Alcohol cessation|alcohol cessation
1475873|NCT00873535|Treatment|treatment
1475874|NCT00873535|Smoking|smoking
1475875|NCT00873535|Cigarette|cigarette
1475876|NCT00873535|Heavy drinkers|heavy drinkers
1475877|NCT00873535|Social drinkers|social drinkers
1475878|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
1475879|NCT00873535|Nicotine receptor|nicotine receptor
1475880|NCT00873535|Nicotinic receptor|nicotinic receptor
1475881|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
1475882|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
1475883|NCT00873535|Cholinergic receptor|cholinergic receptor
1475884|NCT00873535|Dopamine|dopamine
1475885|NCT00873535|Craving|craving
1475886|NCT00873535|Diary|diary
1475887|NCT00873535|Cue induced|cue induced
1475888|NCT00873535|Pharmacotherapy|pharmacotherapy
1475889|NCT00873535|Varenicline|varenicline
1475890|NCT00873535|Chantix|chantix
1475891|NCT00873535|Champix|champix
1475892|NCT00873522|pneumonia|pneumonia
1475893|NCT00873509|Autism|autism
1475894|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
1475895|NCT00873496|hyposalivation|hyposalivation
1475896|NCT00873496|mouth dryness|mouth dryness
1475897|NCT00873496|complications|complications
1475898|NCT00873483|Pregnancy prevention|pregnancy prevention
1475899|NCT00873483|female contraception|female contraception
1475900|NCT00873483|patch|patch
1475901|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1475902|NCT00873457|Leukemia|leukemia
1475904|NCT00873444|Cementless|cementless
1475905|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
1475906|NCT00873444|Metal-on-Metal|metal-on-metal
1475907|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
1475908|NCT00873418|Heart Failure|heart failure
1475909|NCT00873418|Intervention|intervention
1475910|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
1475911|NCT00873418|Quality of Life|quality of life
1475912|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
1475913|NCT00873405|Metabolic control|metabolic control
1475914|NCT00873405|Bariatric Surgery|bariatric surgery
1475915|NCT00873405|Weight Loss|weight loss
1475916|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
1475917|NCT00873405|BMI reduction|bmi reduction
1475918|NCT00873405|Waist circumference reduction|waist circumference reduction
1475919|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
1475920|NCT00873405|Glucose homeostasis|glucose homeostasis
1475921|NCT00873392|Parkinson's disease|parkinson's disease
1475922|NCT00873392|Motor fluctuation|motor fluctuation
1475923|NCT00873392|Nicotine|nicotine
1475924|NCT00873392|Drug treatment|drug treatment
1475925|NCT00873392|neuroprotection|neuroprotection
1475926|NCT00873366|stage I breast cancer|stage i breast cancer
1475927|NCT00873366|stage II breast cancer|stage ii breast cancer
1475928|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
1475929|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
1475930|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
1475931|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
1475932|NCT00873340|MS|ms
1475933|NCT00873340|Multiple Sclerosis|multiple sclerosis
1475934|NCT00873340|Betaferon|betaferon
1475935|NCT00873340|Colombia|colombia
1475936|NCT00873327|presumed sepsis|presumed sepsis
1475937|NCT00873301|vulvodynia|vulvodynia
1475938|NCT00873301|vestibulectomy|vestibulectomy
1475939|NCT00873301|surgery|surgery
1475940|NCT00873301|vestibulitis|vestibulitis
1475941|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1475942|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1475943|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1475944|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1475945|NCT00873275|stage IV colon cancer|stage iv colon cancer
1475946|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
1475947|NCT00873275|recurrent colon cancer|recurrent colon cancer
1475948|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
1475949|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
1475950|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1475951|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
1475952|NCT00873262|Hormones|hormones
1475953|NCT00873262|Skin tests|skin tests
1475954|NCT00873262|Desensitization|desensitization
1475955|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
1475956|NCT00873249|Schizophrenia|schizophrenia
1475957|NCT00873249|Therapeutic adherence|therapeutic adherence
1475958|NCT00873249|Short message system|short message system
1475959|NCT00873249|Mobile phone|mobile phone
1475960|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
1475961|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
1475962|NCT00873210|renal cell carcinoma|renal cell carcinoma
1475963|NCT00873210|sunitinib malate|sunitinib malate
1475964|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
1475965|NCT00873197|Granisetron|granisetron
1475966|NCT00873197|Healthy subjects|healthy subjects
1475967|NCT00873197|Intravenous|intravenous
1475968|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
1475969|NCT00873197|Sancuso® patch|sancuso® patch
1475970|NCT00873197|Transdermal|transdermal
1475971|NCT00873197|Pharmacokinetics|pharmacokinetics
1475972|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
1475973|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
1475974|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
1475975|NCT00873158|ROM|rom
1475976|NCT00873158|Dynasplint|dynasplint
1475977|NCT00873145|Survival|survival
1475978|NCT00873145|Function|function
1475979|NCT00873145|Infection|infection
1475980|NCT00873145|Revision|revision
1475981|NCT00873145|Loosening|loosening
1475982|NCT00873119|Belinostat|belinostat
1475983|NCT00873119|PXD101|pxd101
1475984|NCT00873119|Carboplatin|carboplatin
1475985|NCT00873119|Paclitaxel|paclitaxel
1475986|NCT00873119|CUP|cup
1475987|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
1475988|NCT00873119|Occult primary|occult primary
1475989|NCT00873080|reliability|reliability
1475990|NCT00873080|photogrammetry|photogrammetry
1475991|NCT00873067|Atrial fibrillation|atrial fibrillation
1475992|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
1475993|NCT00873067|CFAE|cfae
1475994|NCT00873041|Thalassemia|thalassemia
1475995|NCT00873041|thalassemia intermedia|thalassemia intermedia
1475996|NCT00873041|alpha-thalassemia|alpha-thalassemia
1475997|NCT00873041|beta-thalassemia|beta-thalassemia
1475998|NCT00873041|deferasirox|deferasirox
1475999|NCT00873041|iron overload|iron overload
1476000|NCT00873041|non-transfusion dependent|non-transfusion dependent
1476001|NCT00873028|Physical therapy|physical therapy
1476002|NCT00873028|Inspiratory muscles|inspiratory muscles
1476003|NCT00873028|Exercise|exercise
1476004|NCT00873015|Cerebral aneurysm|cerebral aneurysm
1476005|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
1476006|NCT00873015|Nitrite|nitrite
1476007|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1476008|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
1476009|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1476010|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1476011|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1476012|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1476013|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1476014|NCT00872963|malaria vaccine|malaria vaccine
1476015|NCT00872963|RTS,S,|rts,s,
1476016|NCT00872950|LEMS|lems
1476017|NCT00872950|CMS|cms
1476018|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
1476019|NCT00872950|3,4 DAP|3,4 dap
1476020|NCT00872924|Bioequivalence|bioequivalence
1476021|NCT00872911|Sarcopenia|sarcopenia
1476022|NCT00872911|nutrition|nutrition
1476023|NCT00872911|aging|aging
1476024|NCT00872911|metabolism|metabolism
1476025|NCT00872911|exercise|exercise
1476026|NCT00872898|autism|autism
1476027|NCT00872898|memantine|memantine
1476028|NCT00872898|pediatric|pediatric
1476029|NCT00872898|Forest Laboratories|forest laboratories
1476030|NCT00872898|Autism in pediatric patients|autism in pediatric patients
1476031|NCT00872885|analgesic|analgesic
1476032|NCT00872885|bunionectomy|bunionectomy
1476033|NCT00872885|surgery|surgery
1476034|NCT00872885|post operative pain|post operative pain
1476035|NCT00872885|single Hallux valgus repair|single hallux valgus repair
1476036|NCT00872872|NVP|nvp
1476037|NCT00872872|PMTCT|pmtct
1476038|NCT00872872|pregnancy|pregnancy
1476039|NCT00872872|resistance|resistance
1476040|NCT00872859|Breast Cancer|breast cancer
1476041|NCT00872859|Cancer of Breast|cancer of breast
1476042|NCT00872859|Reconstructive Surgery|reconstructive surgery
1476043|NCT00872846|Body weight|body weight
1476044|NCT00872846|Signs and symptoms|signs and symptoms
1476045|NCT00872846|Obesity|obesity
1476046|NCT00872846|Metabolic disease|metabolic disease
1476047|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
1476048|NCT00872846|Diabetes mellitus|diabetes mellitus
1476049|NCT00872846|Nutrition disorder|nutrition disorder
1476050|NCT00872846|Endocrine system diseases|endocrine system diseases
1476051|NCT00872846|Overweight|overweight
1476052|NCT00872846|Overnutrition|overnutrition
1476053|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
1476054|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
1476055|NCT00872833|Pain|pain
1476056|NCT00872833|Mild Pain|mild pain
1476057|NCT00872820|Social Anxiety|social anxiety
1476058|NCT00872820|Social Anxiety Treatment|social anxiety treatment
1476059|NCT00872820|Cognitive Therapy|cognitive therapy
1476060|NCT00872820|Mindfulness|mindfulness
1476061|NCT00872820|Social Phobia|social phobia
1476062|NCT00872820|Social Phobia Treatment|social phobia treatment
1476063|NCT00872807|childhood|childhood
1476064|NCT00872807|therapy|therapy
1476065|NCT00872807|life style|life style
1476066|NCT00872807|motor activity|motor activity
1476067|NCT00872807|obesity|obesity
1476068|NCT00872807|overweight|overweight
1476069|NCT00872807|body mass index|body mass index
1476070|NCT00872807|treatment|treatment
1476072|NCT00872794|Conservative|conservative
1476073|NCT00872794|Metal on Metal|metal on metal
1476074|NCT00872794|Resurfacing|resurfacing
1476075|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
1476076|NCT00872742|Impulse Control Disorders|impulse control disorders
1476077|NCT00872742|Behavior Therapy|behavior therapy
1476078|NCT00872742|Acceptance|acceptance
1476079|NCT00872742|Habit Reversal|habit reversal
1476080|NCT00872729|cystinosis|cystinosis
1476081|NCT00872729|cysteamine|cysteamine
1476082|NCT00872729|inheritable disease|inheritable disease
1476083|NCT00872729|orphan disease|orphan disease
1476084|NCT00872729|CTNS protein, human|ctns protein, human
1476085|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
1476086|NCT00872716|specific phobia|specific phobia
1476087|NCT00872716|simple phobia|simple phobia
1476088|NCT00872716|anxiety disorder|anxiety disorder
1476089|NCT00872703|CMV|cmv
1476090|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
1476091|NCT00872703|Ultrasound|ultrasound
1476092|NCT00872703|MRI|mri
1476093|NCT00872690|Multiple Trauma|multiple trauma
1476094|NCT00872690|Blast Injuries|blast injuries
1476095|NCT00872690|Brain Injuries|brain injuries
1476096|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
1476097|NCT00872690|Consumer participation|consumer participation
1476098|NCT00872677|weight changes|weight changes
1476099|NCT00872677|obesity|obesity
1476100|NCT00872677|stage I breast cancer|stage i breast cancer
1476101|NCT00872677|stage II breast cancer|stage ii breast cancer
1476102|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
1476103|NCT00872664|ROP|rop
1476104|NCT00872664|anti-oxidants|anti-oxidants
1476105|NCT00872664|carotenoids|carotenoids
1476106|NCT00872651|Glaucoma|glaucoma
1476107|NCT00872651|intraocular pressure|intraocular pressure
1476108|NCT00872651|travoprost/timolol|travoprost/timolol
1476109|NCT00872651|timolol|timolol
1476110|NCT00872638|wound edge eversion|wound edge eversion
1476111|NCT00872638|cosmetic outcomes|cosmetic outcomes
1476112|NCT00872638|surgical incisions|surgical incisions
1476113|NCT00872625|stage IA breast cancer|stage ia breast cancer
1476114|NCT00872625|stage IB breast cancer|stage ib breast cancer
1476115|NCT00872625|stage II breast cancer|stage ii breast cancer
1476116|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
1476117|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
1476118|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
1476119|NCT00872625|recurrent breast cancer|recurrent breast cancer
1476120|NCT00872612|Sarcoidosis|sarcoidosis
1476121|NCT00872612|Diagnosis|diagnosis
1476122|NCT00872612|Non-caseating granulomas|non-caseating granulomas
1476123|NCT00872612|BAL|bal
1476124|NCT00872612|EUS-FNA|eus-fna
1476125|NCT00872612|EBUS-TBNA|ebus-tbna
1476126|NCT00872612|TBLB|tblb
1476127|NCT00872599|Hypertension|hypertension
1476128|NCT00872599|Phenotyping|phenotyping
1476129|NCT00872599|High Salt intake|high salt intake
1476130|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
1476131|NCT00872599|fenofibrate|fenofibrate
1476132|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
1476133|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
1476134|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
1476135|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
1476136|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
1476137|NCT00872573|Hip|hip
1476138|NCT00872573|Cemented|cemented
1476139|NCT00872547|Hip|hip
1476140|NCT00872547|Resurfacing|resurfacing
1476141|NCT00872547|Metal-on-Metal|metal-on-metal
1476142|NCT00872547|Large Heads|large heads
1476143|NCT00872547|XL Head|xl head
1476144|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
1476145|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
1476146|NCT00872521|Multiple Myeloma|multiple myeloma
1476147|NCT00872521|transplant eligible|transplant eligible
1476148|NCT00872521|doxorubicin|doxorubicin
1476149|NCT00872521|dexamethasone|dexamethasone
1476150|NCT00872521|bortezomib|bortezomib
1476151|NCT00872521|bortezomib resistance|bortezomib resistance
1476152|NCT00872521|PAD induction|pad induction
1476153|NCT00872521|PIMMS Trial|pimms trial
1476154|NCT00872495|Urothelial Cancer|urothelial cancer
1476155|NCT00872495|Cancer|cancer
1476156|NCT00872495|Bladder Neoplasms|bladder neoplasms
1476157|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
1476158|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
1476159|NCT00872482|NSCLC|nsclc
1476160|NCT00872482|Brain metastases|brain metastases
1476161|NCT00872482|nimotuzumab|nimotuzumab
1476162|NCT00872482|TheraCIM|theracim
1476164|NCT00872482|Radiation|radiation
1476165|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
1476166|NCT00872469|randomised controlled trial|randomised controlled trial
1476167|NCT00872469|tranexamic acid|tranexamic acid
1476168|NCT00872469|antifibrinolytic|antifibrinolytic
1476169|NCT00872456|Diabetes Mellitus|diabetes mellitus
1476170|NCT00872456|Cardiovascular Disease|cardiovascular disease
1476171|NCT00872456|Haptoglobin|haptoglobin
1476172|NCT00872430|constipation|constipation
1476173|NCT00872430|RCT|rct
1476174|NCT00872430|phytotherapy|phytotherapy
1476175|NCT00872417|HIV/AIDS|hiv/aids
1476176|NCT00872417|antiretroviral therapy|antiretroviral therapy
1476177|NCT00872417|immune reconstitution|immune reconstitution
1476178|NCT00872404|CP-751,871|cp-751,871
1476179|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
1476180|NCT00872404|recurrent or metastatic|recurrent or metastatic
1476181|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
1476182|NCT00872378|Morbid Obesity|morbid obesity
1476183|NCT00872378|LAP Band|lap band
1476184|NCT00872378|Adjustable Gastric Band|adjustable gastric band
1476185|NCT00872378|Exenatide|exenatide
1476186|NCT00872378|Byetta|byetta
1476187|NCT00872378|Weight Loss|weight loss
1476188|NCT00872378|Bariatric Surgery|bariatric surgery
1476189|NCT00872365|Pregnancy|pregnancy
1476190|NCT00872365|Exercise|exercise
1476191|NCT00872365|Nutrition|nutrition
1476192|NCT00872365|Micronutrients|micronutrients
1476193|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
1476194|NCT00872365|Endothelium|endothelium
1476195|NCT00872352|Multiple Myeloma|multiple myeloma
1476196|NCT00872352|Bortezomib|bortezomib
1476197|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
1476198|NCT00872352|evaluation|evaluation
1476199|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
1476200|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
1476201|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
1476202|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
1476203|NCT00872326|Diabetes Complications|diabetes complications
1476204|NCT00872326|Lower limb ischemia|lower limb ischemia
1476205|NCT00872326|Adult stem cells|adult stem cells
1476206|NCT00872313|Labor|labor
1476207|NCT00872313|Psychology|psychology
1476208|NCT00872313|Postpartum Psychology|postpartum psychology
1476209|NCT00872287|minimally invasive surgery|minimally invasive surgery
1476210|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
1476211|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
1476212|NCT00872287|invisible scar|invisible scar
1476213|NCT00872287|single port access|single port access
1476214|NCT00872287|abdominal pain|abdominal pain
1476215|NCT00872287|shoulder pain|shoulder pain
1476216|NCT00872274|Bioequivalence|bioequivalence
1476217|NCT00872261|Clinical Trials as Topic|clinical trials as topic
1476218|NCT00872261|Adolescent Psychology|adolescent psychology
1476219|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
1476220|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
1476221|NCT00872261|Adolescents|adolescents
1476222|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
1476223|NCT00872261|Microbicide Acceptability|microbicide acceptability
1476224|NCT00872261|Ethics|ethics
1476225|NCT00872261|Mixed Methods|mixed methods
1476226|NCT00872261|HIV|hiv
1476227|NCT00872248|Restless leg syndrome|restless leg syndrome
1476228|NCT00872248|Spinal anesthesia|spinal anesthesia
1476229|NCT00872248|Epidural anesthesia|epidural anesthesia
1476230|NCT00872248|Neuraxial block|neuraxial block
1476231|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
1476232|NCT00872222|Hip|hip
1476233|NCT00872222|Cementless|cementless
1476234|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
1476235|NCT00872209|swimmer's ear|swimmer's ear
1476236|NCT00872209|ear drops|ear drops
1476237|NCT00872209|ear foam|ear foam
1476238|NCT00872209|otic foam|otic foam
1476239|NCT00872209|ear infection|ear infection
1476240|NCT00872209|ear pain|ear pain
1476241|NCT00872209|ear inflammation|ear inflammation
1476242|NCT00872183|Motor Learning|motor learning
1476243|NCT00872183|Mirror Neurons|mirror neurons
1476244|NCT00872183|Healthy Volunteer|healthy volunteer
1476245|NCT00872183|HV|hv
1476246|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
1476247|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
1476248|NCT00872157|Prostate|prostate
1476249|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
1476250|NCT00872157|BMTP-11|bmtp-11
1476251|NCT00872157|Prostate State Antigen|prostate state antigen
1476252|NCT00872157|PSA|psa
1476253|NCT00872131|Anxiety|anxiety
1476254|NCT00872131|Social Phobia|social phobia
1476255|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
1476256|NCT00872118|alcohol consumption|alcohol consumption
1476257|NCT00872118|social anxiety|social anxiety
1476258|NCT00872118|brief intervention|brief intervention
1476259|NCT00872118|motivational interviewing|motivational interviewing
1476260|NCT00872118|cognitive behavioral|cognitive behavioral
1476261|NCT00872105|clavicle|clavicle
1476262|NCT00872105|fractures|fractures
1476263|NCT00872105|distal|distal
1476264|NCT00872092|small bowel|small bowel
1476265|NCT00872092|bacterial overgrowth|bacterial overgrowth
1476266|NCT00872079|warfarin|warfarin
1476267|NCT00872079|pharmacokinetics|pharmacokinetics
1476268|NCT00872079|pharmacodynamics|pharmacodynamics
1476269|NCT00872066|Hip|hip
1476270|NCT00872066|Bone Cement|bone cement
1476271|NCT00872053|robot|robot
1476272|NCT00872053|treadmill|treadmill
1476273|NCT00872053|foot drop|foot drop
1476274|NCT00872053|rehabilitation|rehabilitation
1476275|NCT00872053|gait|gait
1476276|NCT00872040|Sexual function|sexual function
1476277|NCT00872040|Pelvic floor disorders|pelvic floor disorders
1476278|NCT00872040|Delivery mode|delivery mode
1476279|NCT00872027|Critical Illness|critical illness
1476280|NCT00872027|Intensive Care Unit|intensive care unit
1476281|NCT00872027|Acute Respiratory Failure|acute respiratory failure
1476282|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
1476283|NCT00871975|LUTS|luts
1476284|NCT00871975|OAB|oab
1476285|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
1476286|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
1476287|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
1476288|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
1476289|NCT00871923|NSCLC|nsclc
1476290|NCT00871923|Brain Metastases|brain metastases
1476291|NCT00871923|Brain Cancer|brain cancer
1476292|NCT00871923|Lung Cancer|lung cancer
1476293|NCT00871923|Tarceva|tarceva
1476294|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
1476295|NCT00871923|OSI-774|osi-774
1476296|NCT00871923|Radiation Therapy|radiation therapy
1476297|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
1476298|NCT00871923|WBRT|wbrt
1476299|NCT00871897|Neuropsychology|neuropsychology
1476300|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
1476301|NCT00871884|Post Concussion Syndrome|post concussion syndrome
1476302|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
1476303|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
1476304|NCT00871884|Mild Head Injury|mild head injury
1476305|NCT00871884|Psychotherapy|psychotherapy
1476306|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
1476307|NCT00871858|stage II breast cancer|stage ii breast cancer
1476308|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
1476309|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
1476310|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1476311|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1476312|NCT00871845|obesity|obesity
1476313|NCT00871845|hepatitis C|hepatitis c
1476314|NCT00871845|insulin resistance|insulin resistance
1476315|NCT00871845|metabolic syndrome|metabolic syndrome
1476316|NCT00871832|hyperglycemia|hyperglycemia
1476317|NCT00871832|HgA1c|hga1c
1476318|NCT00871832|mortality|mortality
1476319|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
1476320|NCT00871806|Pharmacokinetics|pharmacokinetics
1476321|NCT00871806|eletriptan|eletriptan
1476322|NCT00871806|bioavailability|bioavailability
1476323|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
1476324|NCT00871780|TYSABRI naive|tysabri naive
1476325|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
1476326|NCT00871767|AZD5672|azd5672
1476327|NCT00871767|relative bioavailability|relative bioavailability
1476328|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1476329|NCT00871754|Bladder Cancer|bladder cancer
1476330|NCT00871754|Cancer, bladder|cancer, bladder
1476331|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
1476332|NCT00871741|Combined vaccine|combined vaccine
1476333|NCT00871741|Primary vaccination|primary vaccination
1476334|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
1476335|NCT00871728|Itraconazole|itraconazole
1476336|NCT00871728|Sporanox|sporanox
1476337|NCT00871715|stroke|stroke
1476338|NCT00871715|hemiparesis|hemiparesis
1476339|NCT00871715|physical therapy|physical therapy
1476340|NCT00871715|occupational therapy|occupational therapy
1476341|NCT00871715|neurorehabilitation|neurorehabilitation
1476342|NCT00871715|patient focused|patient focused
1476343|NCT00871715|motor learning|motor learning
1476344|NCT00871715|motor control|motor control
1476345|NCT00871715|skill acquisition|skill acquisition
1476346|NCT00871715|skill training|skill training
1476347|NCT00871715|motor recovery|motor recovery
1476348|NCT00871715|task oriented training|task oriented training
1476349|NCT00871715|task specific training|task specific training
1476350|NCT00871715|arm function|arm function
1476351|NCT00871715|hand function|hand function
1476352|NCT00871715|upper extremity|upper extremity
1476353|NCT00871715|arm therapy|arm therapy
1476354|NCT00871715|physical rehabilitation|physical rehabilitation
1476355|NCT00871715|arm rehabilitation|arm rehabilitation
1476356|NCT00871715|motor function|motor function
1476357|NCT00871702|Leukemia|leukemia
1476358|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1476359|NCT00871702|Hodgkin Disease|hodgkin disease
1476360|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
1476361|NCT00871702|Multiple Myeloma|multiple myeloma
1476362|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1476363|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1476364|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1476365|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1476366|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1476367|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1476368|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1476369|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1476370|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
1476371|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
1476372|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
1476373|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
1476374|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
1476375|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
1476376|NCT00871650|PTSD|ptsd
1476377|NCT00871650|Brain|brain
1476378|NCT00871650|Imaging|imaging
1476379|NCT00871650|PET|pet
1476380|NCT00871650|Neural|neural
1476381|NCT00871650|Sleep|sleep
1476382|NCT00871650|REM Sleep|rem sleep
1476383|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1476384|NCT00871637|Airway macrophages|airway macrophages
1476385|NCT00871637|Sputum milieu|sputum milieu
1476386|NCT00871637|Airway inflammation|airway inflammation
1476387|NCT00871637|Occupational diseases|occupational diseases
1476388|NCT00871611|Hereditary|hereditary
1476389|NCT00871611|Anderson-Fabry|anderson-fabry
1476390|NCT00871611|prevalence|prevalence
1476391|NCT00871611|heart|heart
1476392|NCT00871611|hypertrophy|hypertrophy
1476393|NCT00871611|urine|urine
1476394|NCT00871611|globotriaosylceramide|globotriaosylceramide
1476395|NCT00871611|isoforms|isoforms
1476396|NCT00871611|α - Galactosidase|α - galactosidase
1476397|NCT00871598|plaque psoriasis|plaque psoriasis
1476398|NCT00871598|BTT1023|btt1023
1476399|NCT00871598|safety|safety
1476400|NCT00871598|pharmacokinetics|pharmacokinetics
1476401|NCT00871585|bicalutamide|bicalutamide
1476402|NCT00871585|PSA|psa
1476403|NCT00871585|advanced prostate cancer|advanced prostate cancer
1476404|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1476405|NCT00871533|Biochemical Marker|biochemical marker
1476406|NCT00871533|Biochemical Markers|biochemical markers
1476407|NCT00871533|Biologic Marker|biologic marker
1476408|NCT00871533|Biologic Markers|biologic markers
1476409|NCT00871533|Biomarkers|biomarkers
1476410|NCT00871533|Clinical Marker|clinical marker
1476411|NCT00871533|Clinical Markers|clinical markers
1476412|NCT00871533|Immune Marker|immune marker
1476413|NCT00871533|Immune Markers|immune markers
1476414|NCT00871533|Immunologic Marker|immunologic marker
1476415|NCT00871533|Immunologic Markers|immunologic markers
1476416|NCT00871533|Laboratory Marker|laboratory marker
1476417|NCT00871533|Laboratory Markers|laboratory markers
1476418|NCT00871533|Marker, Biochemical|marker, biochemical
1476419|NCT00871533|Marker, Biological|marker, biological
1476420|NCT00871533|Marker, Clinical|marker, clinical
1476421|NCT00871533|Marker, Immunologic|marker, immunologic
1476422|NCT00871533|Marker, Laboratory|marker, laboratory
1476423|NCT00871533|Marker, Serum|marker, serum
1476424|NCT00871533|Marker, Surrogate|marker, surrogate
1476425|NCT00871533|Markers, Biochemical|markers, biochemical
1476426|NCT00871533|Markers, Biological|markers, biological
1476427|NCT00871533|Markers, Clinical|markers, clinical
1476428|NCT00871533|Markers, Immunologic|markers, immunologic
1476429|NCT00871533|Markers, Laboratory|markers, laboratory
1476430|NCT00871533|Markers, Serum|markers, serum
1476431|NCT00871533|Markers, Surrogate|markers, surrogate
1476432|NCT00871533|Markers, Viral|markers, viral
1476433|NCT00871533|Serum Marker|serum marker
1476434|NCT00871533|Serum Markers|serum markers
1476435|NCT00871533|Surrogate End Point|surrogate end point
1476436|NCT00871533|Surrogate End Points|surrogate end points
1476646|NCT00870688|valproate|valproate
1476437|NCT00871533|Surrogate Endpoint|surrogate endpoint
1476438|NCT00871533|Surrogate Endpoints|surrogate endpoints
1476439|NCT00871533|Surrogate Marker|surrogate marker
1476440|NCT00871533|Surrogate Markers|surrogate markers
1476441|NCT00871533|Viral Marker|viral marker
1476442|NCT00871533|Viral Markers|viral markers
1476654|NCT00870675|fetus|fetus
1476443|NCT00871520|Palliative Care|palliative care
1476444|NCT00871520|Predictive Value of Tests|predictive value of tests
1476445|NCT00871520|Prospective Studies|prospective studies
1476446|NCT00871520|Survival Analysis|survival analysis
1476447|NCT00871520|Survival prediction|survival prediction
1476448|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1476449|NCT00871455|Spinal Cord Injury|spinal cord injury
1476450|NCT00871455|Baclofen|baclofen
1476451|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
1476452|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
1476453|NCT00871442|PCEA|pcea
1476454|NCT00871442|labor and delivery|labor and delivery
1476455|NCT00871442|pain|pain
1476456|NCT00871442|epidural|epidural
1476457|NCT00871442|anesthesia|anesthesia
1476458|NCT00871442|pregnant women|pregnant women
1476459|NCT00871429|skin toxicity|skin toxicity
1476460|NCT00871429|cancer patients|cancer patients
1476461|NCT00871429|adverse effects|adverse effects
1476462|NCT00871403|GW786034|gw786034
1476463|NCT00871403|pazopanib|pazopanib
1476464|NCT00871403|pemetrexed|pemetrexed
1476465|NCT00871403|cisplatin|cisplatin
1476466|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
1476467|NCT00871403|NSCLC|nsclc
1476468|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1476469|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
1476470|NCT00871377|epilepsy|epilepsy
1476471|NCT00871377|cardiac risk factors|cardiac risk factors
1476472|NCT00871377|memory|memory
1476473|NCT00871377|cognition|cognition
1476474|NCT00871377|n-3 fatty acids|n-3 fatty acids
1476475|NCT00871377|fish oil|fish oil
1476476|NCT00871377|EPA|epa
1476477|NCT00871377|DHA|dha
1476478|NCT00871377|seizures|seizures
1476479|NCT00871364|Bioequivalence|bioequivalence
1476480|NCT00871364|venlafaxine|venlafaxine
1476481|NCT00871364|Healthy subjects|healthy subjects
1476482|NCT00871338|combined|combined
1476483|NCT00871338|Vaccines|vaccines
1476484|NCT00871325|Gastric emptying|gastric emptying
1476485|NCT00871325|Small bowel transit|small bowel transit
1476486|NCT00871325|Colonic transit|colonic transit
1476487|NCT00871325|Whole gut transit|whole gut transit
1476488|NCT00871325|Postoperative Ileus|postoperative ileus
1476489|NCT00871312|diabetes|diabetes
1476490|NCT00871312|diabetic|diabetic
1476491|NCT00871312|wound|wound
1476492|NCT00871312|ulcer|ulcer
1476493|NCT00871312|lower extremity|lower extremity
1476494|NCT00871312|foot|foot
1476495|NCT00871312|oxygen|oxygen
1476496|NCT00871312|hyperbaric|hyperbaric
1476497|NCT00871312|topical wound oxygen|topical wound oxygen
1476498|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
1476499|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
1476500|NCT00871286|Chronic sinusitis|chronic sinusitis
1476501|NCT00871286|CRS|crs
1476502|NCT00871273|capecitabine|capecitabine
1476503|NCT00871273|total gastrectomy|total gastrectomy
1476504|NCT00871273|pharmacokinetic|pharmacokinetic
1476505|NCT00871260|Coronary Disease|coronary disease
1476506|NCT00871260|Stress Testing|stress testing
1476507|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
1476508|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1476509|NCT00871247|Bioequivalence|bioequivalence
1476510|NCT00871247|finasteride|finasteride
1476511|NCT00871247|Healthy subjects|healthy subjects
1476512|NCT00871234|HIV|hiv
1476513|NCT00871234|Endothelial function|endothelial function
1476514|NCT00871234|Etravirine|etravirine
1476515|NCT00871208|Atopic Dermatitis|atopic dermatitis
1476516|NCT00871208|pruritus|pruritus
1476517|NCT00871208|quality of life|quality of life
1476518|NCT00871195|Rhesus D|rhesus d
1476519|NCT00871195|RHD|rhd
1476520|NCT00871195|genotype|genotype
1476521|NCT00871195|phenotype|phenotype
1476522|NCT00871195|neonatal|neonatal
1476523|NCT00871195|noninvasive|noninvasive
1476524|NCT00871195|fetal|fetal
1476525|NCT00871195|MassARRAY|massarray
1476526|NCT00871195|DNA|dna
1476527|NCT00871182|COPD|copd
1476528|NCT00871182|obstructive lung diseases|obstructive lung diseases
1476529|NCT00871182|Tiotropium|tiotropium
1476530|NCT00871169|Irinotecan|irinotecan
1476531|NCT00871169|Oxaliplatin|oxaliplatin
1476532|NCT00871169|Cetuximab|cetuximab
1476533|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
1476534|NCT00871156|Drug-Drug Interaction|drug-drug interaction
1476535|NCT00871143|CBT|cbt
1476536|NCT00871143|BDD|bdd
1476537|NCT00871130|Thyroid gland|thyroid gland
1476538|NCT00871130|bariatric surgery|bariatric surgery
1476539|NCT00871130|weight loss|weight loss
1476540|NCT00871130|thyroid hormones|thyroid hormones
1476541|NCT00871130|adult|adult
1476542|NCT00871130|morbid obesity|morbid obesity
1476543|NCT00871130|cohort|cohort
1476544|NCT00871117|Co-administration|co-administration
1476545|NCT00871117|Immunization|immunization
1476546|NCT00871117|Preschool|preschool
1476547|NCT00871117|Booster|booster
1476548|NCT00871104|Infective endocarditis|infective endocarditis
1476549|NCT00871091|CAD/CAM|cad/cam
1476550|NCT00871091|orthodontics|orthodontics
1476551|NCT00871091|fixed appliance|fixed appliance
1476552|NCT00871091|tooth movement|tooth movement
1476553|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
1476554|NCT00871065|Vasospasm|vasospasm
1476555|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1476556|NCT00871065|Sildenafil citrate|sildenafil citrate
1476557|NCT00871065|Aneurysm|aneurysm
1476558|NCT00871065|Intracranial aneurysm|intracranial aneurysm
1476559|NCT00871052|Polymorphic light eruption|polymorphic light eruption
1476560|NCT00871052|UV radiation|uv radiation
1476561|NCT00871052|Vitamin D|vitamin d
1476562|NCT00871052|Immune suppression|immune suppression
1476563|NCT00871052|Prevention|prevention
1476564|NCT00871039|Alcoholism|alcoholism
1476565|NCT00871039|Mechanical ventilation|mechanical ventilation
1476566|NCT00871026|CAD/CAM|cad/cam
1476567|NCT00871026|orthodontics|orthodontics
1476568|NCT00871026|fixed appliance|fixed appliance
1476569|NCT00871026|tooth movement|tooth movement
1476570|NCT00871026|Adverse Effects|adverse effects
1476571|NCT00871026|Time Factors|time factors
1476572|NCT00871026|Treatment Outcome|treatment outcome
1476573|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
1476574|NCT00871000|Boostrix Polio|boostrix polio
1476575|NCT00871000|dTpa-IPV|dtpa-ipv
1476576|NCT00870987|Malaria|malaria
1476577|NCT00870987|Vaccine|vaccine
1476578|NCT00870974|Parkinson|parkinson
1476579|NCT00870974|Huntington's|huntington's
1476580|NCT00870974|Fragile X|fragile x
1476581|NCT00870974|Autistic Spectrum|autistic spectrum
1476582|NCT00870974|Alzheimer's|alzheimer's
1476583|NCT00870974|MCI|mci
1476584|NCT00870961|colon cancer|colon cancer
1476585|NCT00870961|rectal cancer|rectal cancer
1476586|NCT00870961|adenomatous polyp|adenomatous polyp
1476587|NCT00870948|Open Label|open label
1476588|NCT00870948|Healthy Volunteers|healthy volunteers
1476589|NCT00870935|Balloon catheter|balloon catheter
1476590|NCT00870935|Cervical vacuum cup|cervical vacuum cup
1476591|NCT00870935|Hysterosalpingography|hysterosalpingography
1476592|NCT00870935|Infertility|infertility
1476593|NCT00870935|Pain|pain
1476594|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
1476595|NCT00870935|Female Infertility|female infertility
1476596|NCT00870896|capsaicin|capsaicin
1476597|NCT00870896|COPD|copd
1476598|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
1476599|NCT00870870|Tumors|tumors
1476600|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
1476601|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
1476602|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
1476603|NCT00870857|Lungs|lungs
1476604|NCT00870857|antiretrovirals|antiretrovirals
1476605|NCT00870857|HIV|hiv
1476606|NCT00870857|COPD|copd
1476607|NCT00870844|Acute ischemic stroke|acute ischemic stroke
1476608|NCT00870844|Erythropoietin|erythropoietin
1476609|NCT00870844|Carbamylated|carbamylated
1476610|NCT00870844|Neuroprotection|neuroprotection
1476611|NCT00870831|diabetes|diabetes
1476612|NCT00870818|Teplizumab|teplizumab
1476613|NCT00870818|Protege|protege
1476614|NCT00870818|MGA031|mga031
1476615|NCT00870818|Monoclonal antibody|monoclonal antibody
1476616|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1476617|NCT00870818|T1DM|t1dm
1476618|NCT00870818|MacroGenics|macrogenics
1476619|NCT00870792|HIV|hiv
1476620|NCT00870792|antiretroviral therapy|antiretroviral therapy
1476621|NCT00870792|medication adherence|medication adherence
1476622|NCT00870792|Treatment Experienced|treatment experienced
1476623|NCT00870779|Fluorescence|fluorescence
1476624|NCT00870779|Brain Tumor|brain tumor
1476625|NCT00870779|Malignant Glioma|malignant glioma
1476626|NCT00870779|Pituitary Tumor|pituitary tumor
1476627|NCT00870779|Skull Base Tumor|skull base tumor
1476628|NCT00870779|Brain Lesions|brain lesions
1476629|NCT00870779|Brain Metastases|brain metastases
1476630|NCT00870779|Meningioma|meningioma
1476631|NCT00870753|Eating disorders|eating disorders
1476632|NCT00870753|yoga|yoga
1476633|NCT00870753|body awareness|body awareness
1476634|NCT00870753|depression|depression
1476635|NCT00870753|anxiety|anxiety
1476636|NCT00870740|MS|ms
1476637|NCT00870740|Multiple Sclerosis|multiple sclerosis
1476638|NCT00870727|PDD NOS|pdd nos
1476639|NCT00870714|Prostate Cancer|prostate cancer
1476640|NCT00870714|Neoadjuvant|neoadjuvant
1476641|NCT00870701|sarcoma|sarcoma
1476642|NCT00870701|soft tissue|soft tissue
1476643|NCT00870701|members|members
1476644|NCT00870701|radiotherapy|radiotherapy
1476645|NCT00870701|absence of radiotherapy|absence of radiotherapy
1476647|NCT00870688|epilepsy|epilepsy
1476648|NCT00870688|compliance|compliance
1476649|NCT00870688|sustained released minitablet|sustained released minitablet
1476650|NCT00870688|Orfiril long|orfiril long
1476651|NCT00870675|Ventriculomegaly|ventriculomegaly
1476652|NCT00870675|ultrasound|ultrasound
1476653|NCT00870675|MRI|mri
1476655|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
1476656|NCT00870649|therapeutic vaccine|therapeutic vaccine
1476657|NCT00870649|Bilhvax|bilhvax
1476658|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
1476659|NCT00870636|Safety|safety
1476660|NCT00870636|ROP|rop
1476661|NCT00870636|Bevacizumab|bevacizumab
1476662|NCT00870636|Avastin|avastin
1476663|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
1476664|NCT00870610|hypothermia|hypothermia
1476665|NCT00870597|Floaters|floaters
1476666|NCT00870597|multifocal IOL|multifocal iol
1476667|NCT00870597|visual complaints|visual complaints
1476668|NCT00870597|vitrectomy|vitrectomy
1476669|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
1476670|NCT00870571|Bioequivalence|bioequivalence
1476671|NCT00870571|amlodipine besylate|amlodipine besylate
1476672|NCT00870571|amlodipine|amlodipine
1476673|NCT00870571|Healthy subjects|healthy subjects
1476674|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1476675|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
1476676|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1476677|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1476678|NCT00870545|spouses|spouses
1476679|NCT00870545|social support|social support
1476680|NCT00870545|reintegration|reintegration
1476681|NCT00870545|families|families
1476682|NCT00870545|military|military
1476683|NCT00870545|post deployment|post deployment
1476684|NCT00870545|OEF/OIF|oef/oif
1476685|NCT00870532|Phase I|phase i
1476686|NCT00870532|Combination|combination
1476687|NCT00870532|Anti-angiogenic|anti-angiogenic
1476688|NCT00870532|Sorafenib|sorafenib
1476689|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
1476690|NCT00870519|Alzheimer disease|alzheimer disease
1476691|NCT00870506|Randomized Controlled Trial|randomized controlled trial
1476692|NCT00870506|Healthcare Disparities|healthcare disparities
1476693|NCT00870493|proteinuria|proteinuria
1476694|NCT00870493|renal failure|renal failure
1476695|NCT00870493|glomerulonephritis|glomerulonephritis
1476696|NCT00870480|Bioequivalence|bioequivalence
1476697|NCT00870480|finasteride|finasteride
1476698|NCT00870480|Healthy subjects|healthy subjects
1476699|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
1476700|NCT00870454|Diabetic neuropathies|diabetic neuropathies
1476701|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
1476702|NCT00870454|Carisbamate|carisbamate
1476703|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
1476704|NCT00870441|ASP2151|asp2151
1476705|NCT00870441|Valacyclovir|valacyclovir
1476706|NCT00870441|Healthy Volunteers|healthy volunteers
1476707|NCT00870428|Preeclampsia|preeclampsia
1476708|NCT00870428|proteinuria|proteinuria
1476709|NCT00870415|stage IA breast cancer|stage ia breast cancer
1476710|NCT00870415|stage IB breast cancer|stage ib breast cancer
1476711|NCT00870415|stage II breast cancer|stage ii breast cancer
1476712|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
1476713|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
1476714|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
1476715|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1476716|NCT00870402|aldosterone|aldosterone
1476717|NCT00870402|albuminuria|albuminuria
1476718|NCT00870402|diastolic disfunction|diastolic disfunction
1476719|NCT00870402|hyperkalemia|hyperkalemia
1476720|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
1476721|NCT00870376|biomarkers|biomarkers
1476722|NCT00870376|urodynamic studies|urodynamic studies
1476723|NCT00870363|HIV|hiv
1476724|NCT00870363|HIV positive|hiv positive
1476725|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
1476726|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
1476727|NCT00870363|treatment naive|treatment naive
1476728|NCT00870350|immunogenicity|immunogenicity
1476729|NCT00870350|safety|safety
1476730|NCT00870350|tetanus|tetanus
1476731|NCT00870350|diphtheria|diphtheria
1476732|NCT00870350|acellular|acellular
1476733|NCT00870350|pertussis|pertussis
1476734|NCT00870350|vaccine|vaccine
1476735|NCT00870350|booster|booster
1476736|NCT00870350|adverse event|adverse event
1476737|NCT00870350|adverse reaction|adverse reaction
1476738|NCT00870350|DT1aP|dt1ap
1476739|NCT00870350|DT5ap|dt5ap
1476740|NCT00870350|FHA|fha
1476741|NCT00870350|fimbriae|fimbriae
1476742|NCT00870350|pertactin|pertactin
1476743|NCT00870350|SMI|smi
1476744|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
1476745|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
1476746|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1476747|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1476748|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
1476749|NCT00870324|ICD|icd
1476750|NCT00870324|Tachyarrhythmias|tachyarrhythmias
1476751|NCT00870324|Atrial Fibrillation|atrial fibrillation
1476945|NCT00869557|treatment naive|treatment naive
1476752|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
1476753|NCT00870311|Lithium|lithium
1476754|NCT00870311|Neuroprotection|neuroprotection
1476755|NCT00870311|Neurotrophic|neurotrophic
1476756|NCT00870311|bcl2|bcl2
1476757|NCT00870311|gsk3|gsk3
1476758|NCT00870311|pkc|pkc
1476759|NCT00870311|MRI|mri
1476760|NCT00870311|myoinositol|myoinositol
1476761|NCT00870311|MRS|mrs
1476762|NCT00870311|Alzheimers Disease|alzheimers disease
1476763|NCT00870298|drug orders|drug orders
1476764|NCT00870285|Psoriasis|psoriasis
1476765|NCT00870285|Biologic|biologic
1476766|NCT00870285|Ustekinumab|ustekinumab
1476767|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
1476768|NCT00870285|phototherapy|phototherapy
1476769|NCT00870285|half-side comparison|half-side comparison
1476770|NCT00870272|Medical Abortion|medical abortion
1476771|NCT00870272|Mifepristone|mifepristone
1476772|NCT00870272|Misoprostol|misoprostol
1476773|NCT00870272|Sublingual administration|sublingual administration
1476774|NCT00870272|Buccal administration|buccal administration
1476775|NCT00870259|Weight loss|weight loss
1476776|NCT00870259|Weight maintenance|weight maintenance
1476777|NCT00870246|COPD|copd
1476778|NCT00870246|pulmonary emphysema|pulmonary emphysema
1476779|NCT00870233|Gynecologic cancers|gynecologic cancers
1476780|NCT00870233|Quality of Life|quality of life
1476781|NCT00870233|08-155|08-155
1476782|NCT00870233|Surgery|surgery
1476783|NCT00870220|Turner's Syndrome|turner's syndrome
1476784|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
1476785|NCT00870194|diabetes|diabetes
1476786|NCT00870194|exenatide|exenatide
1476787|NCT00870194|Byetta|byetta
1476788|NCT00870194|sitagliptin|sitagliptin
1476789|NCT00870194|Januvia|januvia
1476790|NCT00870194|Amylin|amylin
1476791|NCT00870194|Lilly|lilly
1476792|NCT00870168|stage IV breast cancer|stage iv breast cancer
1476793|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1476794|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1476795|NCT00870142|Bioequivalence|bioequivalence
1476796|NCT00870142|amlodipine besylate|amlodipine besylate
1476797|NCT00870142|amlodipine|amlodipine
1476798|NCT00870142|Healthy subjects|healthy subjects
1476799|NCT00870129|brain tumor|brain tumor
1476800|NCT00870129|radiation|radiation
1476801|NCT00870129|MRI|mri
1476802|NCT00870129|09-009|09-009
1476803|NCT00870116|SBRT|sbrt
1476804|NCT00870116|non-operated|non-operated
1476805|NCT00870116|non-metastatic|non-metastatic
1476806|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
1476807|NCT00870116|conformational radiotherapy|conformational radiotherapy
1476808|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
1476809|NCT00870103|Cataract|cataract
1476810|NCT00870077|Intrahepatic fat|intrahepatic fat
1476811|NCT00870077|obesity|obesity
1476812|NCT00870077|body fat|body fat
1476813|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
1476814|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
1476815|NCT00870064|Fractures, Open|fractures, open
1476816|NCT00870064|Fracture Fixation|fracture fixation
1476817|NCT00870051|Endurant|endurant
1476818|NCT00870051|Stent Graft|stent graft
1476819|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1476820|NCT00870038|PCI|pci
1476821|NCT00870038|stent|stent
1476822|NCT00870038|drug eluting stent|drug eluting stent
1476823|NCT00870038|reendothelialization|reendothelialization
1476824|NCT00870038|restenosis|restenosis
1476825|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
1476826|NCT00870025|androgens|androgens
1476827|NCT00870025|hCG|hcg
1476828|NCT00870025|low response|low response
1476829|NCT00870025|IVF|ivf
1476830|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
1476831|NCT00869999|rituximab|rituximab
1476832|NCT00869999|everolimus|everolimus
1476833|NCT00869999|DLBCL|dlbcl
1476834|NCT00869999|mTOR|mtor
1476835|NCT00869973|aprepitant|aprepitant
1476836|NCT00869973|delayed emesis|delayed emesis
1476837|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
1476838|NCT00869973|breast cancer|breast cancer
1476839|NCT00869973|antiemetic|antiemetic
1476840|NCT00869960|Healthy Volunteers|healthy volunteers
1476841|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
1476842|NCT00869934|Insomnia|insomnia
1476843|NCT00869934|Sleep disorders|sleep disorders
1476844|NCT00869934|Treatment|treatment
1476845|NCT00869934|Sleep disturbances|sleep disturbances
1476846|NCT00869895|Advanced solid tumors|advanced solid tumors
1476847|NCT00869882|Spondylolisthesis|spondylolisthesis
1476848|NCT00869882|degeneration|degeneration
1476849|NCT00869882|spinal fusion|spinal fusion
1476850|NCT00869869|Heart Failure|heart failure
1476851|NCT00869869|Sleep Disorders|sleep disorders
1476852|NCT00869869|Melatonin|melatonin
1476853|NCT00869869|Antioxidants|antioxidants
1476946|NCT00869544|HIV|hiv
1476854|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1476855|NCT00869869|Nervous System Diseases|nervous system diseases
1476856|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
1476857|NCT00869869|Vascular Diseases|vascular diseases
1476858|NCT00869869|Central Nervous System Depressants|central nervous system depressants
1476859|NCT00869869|Protective Agents|protective agents
1476860|NCT00869869|Pharmacologic Actions|pharmacologic actions
1476861|NCT00869869|Signs and Symptoms|signs and symptoms
1476862|NCT00869869|Mental Disorders|mental disorders
1476863|NCT00869869|Therapeutic Uses|therapeutic uses
1476864|NCT00869869|Neurologic Manifestations|neurologic manifestations
1476865|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
1476866|NCT00869869|Central Nervous System Agents|central nervous system agents
1476867|NCT00869856|Treatment associated with CRI|treatment associated with cri
1476868|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
1476869|NCT00869830|Biofeedback|biofeedback
1476870|NCT00869830|constipation|constipation
1476871|NCT00869830|Parkinson's disease|parkinson's disease
1476872|NCT00869817|Alzheimer's disease|alzheimer's disease
1476873|NCT00869817|antecedent biomarkers|antecedent biomarkers
1476874|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
1476875|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
1476876|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
1476877|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
1476878|NCT00869804|breast cancer|breast cancer
1476879|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
1476880|NCT00869804|exercise|exercise
1476881|NCT00869791|Parkinson's|parkinson's
1476882|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
1476883|NCT00869778|HBeAg positive|hbeag positive
1476884|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
1476885|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
1476886|NCT00869765|Depression|depression
1476887|NCT00869765|Treatment|treatment
1476888|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
1476889|NCT00869765|D-cycloserine|d-cycloserine
1476890|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
1476891|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
1476892|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
1476893|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
1476894|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1476895|NCT00869739|cancer survivor|cancer survivor
1476896|NCT00869739|depression|depression
1476897|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1476898|NCT00869739|male erectile disorder|male erectile disorder
1476899|NCT00869739|urinary complications|urinary complications
1476900|NCT00869739|gastrointestinal complications|gastrointestinal complications
1476901|NCT00869739|stage I prostate cancer|stage i prostate cancer
1476902|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
1476903|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
1476904|NCT00869739|stage III prostate cancer|stage iii prostate cancer
1476905|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
1476906|NCT00869713|Viral Infections|viral infections
1476907|NCT00869713|Neurologic diseases|neurologic diseases
1476908|NCT00869713|Arbovirus Infections|arbovirus infections
1476909|NCT00869713|RVF|rvf
1476910|NCT00869700|HIV|hiv
1476911|NCT00869700|Malaria|malaria
1476912|NCT00869700|Pharmacokinetics|pharmacokinetics
1476913|NCT00869700|Treatment Experienced|treatment experienced
1476914|NCT00869674|GeneSearch|genesearch
1476915|NCT00869674|Breast cancer|breast cancer
1476916|NCT00869648|Airway|airway
1476917|NCT00869648|Anaesthesia|anaesthesia
1476918|NCT00869648|Resuscitation|resuscitation
1476919|NCT00869648|Ventilation|ventilation
1476920|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
1476921|NCT00869635|Photodynamic therapy|photodynamic therapy
1476922|NCT00869635|S-1|s-1
1476923|NCT00869622|osteoporosis|osteoporosis
1476924|NCT00869622|bone mineral density|bone mineral density
1476925|NCT00869622|fracture|fracture
1476926|NCT00869622|antiepileptic drug|antiepileptic drug
1476927|NCT00869622|seizure|seizure
1476928|NCT00869622|Prevention of bone loss|prevention of bone loss
1476929|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
1476930|NCT00869622|Prevention of Fractures|prevention of fractures
1476931|NCT00869609|Diabetes Prevention|diabetes prevention
1476932|NCT00869609|CVD Risk Reduction|cvd risk reduction
1476933|NCT00869609|Lifestyle Intervention|lifestyle intervention
1476934|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
1476935|NCT00869583|Women|women
1476936|NCT00869583|Physical Activity|physical activity
1476937|NCT00869583|Hispanic|hispanic
1476938|NCT00869583|Overweight|overweight
1476939|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1476940|NCT00869570|stage II rectal cancer|stage ii rectal cancer
1476941|NCT00869570|stage III rectal cancer|stage iii rectal cancer
1476942|NCT00869557|HIV|hiv
1476943|NCT00869557|HIV-1|hiv-1
1476944|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
1476947|NCT00869544|smoker|smoker
1476948|NCT00869544|emphysema|emphysema
1476949|NCT00869544|antiretrovirals|antiretrovirals
1476950|NCT00869544|COPD|copd
1476951|NCT00869531|Obesity|obesity
1476952|NCT00869531|wholegrain|wholegrain
1476953|NCT00869531|wheat|wheat
1476954|NCT00869531|cardiovascular disease|cardiovascular disease
1476955|NCT00869518|Staphylococcus aureus|staphylococcus aureus
1476956|NCT00869518|colonization|colonization
1476957|NCT00869518|eradication|eradication
1476958|NCT00869518|HIV|hiv
1476959|NCT00869518|rifabutin|rifabutin
1476960|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
1476961|NCT00869492|Acne|acne
1476962|NCT00869492|Nadifloxacin|nadifloxacin
1476963|NCT00869492|benzoyl peroxide|benzoyl peroxide
1476964|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
1476965|NCT00869479|Screening|screening
1476966|NCT00869466|weight changes|weight changes
1476967|NCT00869466|stage IA breast cancer|stage ia breast cancer
1476968|NCT00869466|stage IB breast cancer|stage ib breast cancer
1476969|NCT00869466|stage II breast cancer|stage ii breast cancer
1476970|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
1476971|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
1476972|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
1476973|NCT00869453|Gut hormone|gut hormone
1476974|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
1476975|NCT00869453|glucose turnver|glucose turnver
1476976|NCT00869440|CNS 7056|cns 7056
1476977|NCT00869440|Procedural Sedation|procedural sedation
1476978|NCT00869440|Sedation|sedation
1476979|NCT00869440|Endoscopy|endoscopy
1476980|NCT00869427|UVI|uvi
1476981|NCT00869427|Spinal cord injury|spinal cord injury
1476982|NCT00869427|Prevention|prevention
1476983|NCT00869427|Vitamin C|vitamin c
1476984|NCT00869414|hypoglycemia|hypoglycemia
1476985|NCT00869414|type 1 diabetes|type 1 diabetes
1476986|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
1476987|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
1476988|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
1476989|NCT00869401|adult glioblastoma|adult glioblastoma
1476990|NCT00869401|adult gliosarcoma|adult gliosarcoma
1476991|NCT00869388|malignant|malignant
1476992|NCT00869388|resistant|resistant
1476993|NCT00869388|solid tumor|solid tumor
1476994|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
1476995|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
1476996|NCT00869349|IFS|ifs
1476997|NCT00869349|psychosocial|psychosocial
1476998|NCT00869349|social support|social support
1476999|NCT00869336|Tinea Pedis|tinea pedis
1477000|NCT00869336|Athlete's Foot|athlete's foot
1477001|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1477002|NCT00869310|aprepitant|aprepitant
1477003|NCT00869310|delayed emesis|delayed emesis
1477004|NCT00869310|cisplatin|cisplatin
1477005|NCT00869310|antiemetic|antiemetic
1477006|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
1477007|NCT00869284|aggressive NHL|aggressive nhl
1477008|NCT00869284|high-risk|high-risk
1477009|NCT00869284|PBSC|pbsc
1477010|NCT00869271|liver metastasis|liver metastasis
1477011|NCT00869271|colorectal cancer|colorectal cancer
1477012|NCT00869258|Pancreatic cancer|pancreatic cancer
1477013|NCT00869258|Gemcitabine|gemcitabine
1477014|NCT00869258|Docetaxel|docetaxel
1477015|NCT00869258|Capecitabine|capecitabine
1477016|NCT00869245|ACS|acs
1477017|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
1477018|NCT00869245|Chest pain|chest pain
1477019|NCT00869245|Cardiac MRI|cardiac mri
1477020|NCT00869245|CMR|cmr
1477021|NCT00869245|Risk Stratification|risk stratification
1477022|NCT00869245|Emergency Department|emergency department
1477023|NCT00869232|Multiple Myeloma|multiple myeloma
1477024|NCT00869219|Pain|pain
1477025|NCT00869219|Pain after eyedrops|pain after eyedrops
1477026|NCT00869206|pain|pain
1477027|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
1477028|NCT00869206|urinary complications|urinary complications
1477029|NCT00869206|stage IV breast cancer|stage iv breast cancer
1477030|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
1477031|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
1477032|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
1477033|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
1477034|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
1477035|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
1477036|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
1477037|NCT00869206|bone metastases|bone metastases
1477038|NCT00869193|Blood pressure|blood pressure
1477039|NCT00869193|Grape seed|grape seed
1477040|NCT00869180|diclofenac|diclofenac
1477041|NCT00869180|ankle sprain|ankle sprain
1477042|NCT00869180|acute pain|acute pain
1477043|NCT00869180|topical|topical
1477044|NCT00869180|patch|patch
1477736|NCT00866437|PMS|pms
1477045|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
1477046|NCT00869154|Mild TBI|mild tbi
1477047|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1477048|NCT00869154|Traumatic Brain Injury|traumatic brain injury
1477049|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
1477050|NCT00869154|Injuries, Acute Brain|injuries, acute brain
1477051|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
1477052|NCT00869154|Acute Brain Injuries|acute brain injuries
1477053|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
1477054|NCT00869128|melatonin|melatonin
1477055|NCT00869128|insomnia|insomnia
1477056|NCT00869128|diabetes|diabetes
1477058|NCT00869115|Digoxin|digoxin
1477059|NCT00869115|Inotropes|inotropes
1477060|NCT00869115|Lusitropic agents|lusitropic agents
1477061|NCT00869115|Istaroxime|istaroxime
1477062|NCT00869115|Debio 0614|debio 0614
1477063|NCT00869102|IGT|igt
1477064|NCT00869102|IFG|ifg
1477065|NCT00869089|PN|pn
1477066|NCT00869076|Diabetes Mellitus|diabetes mellitus
1477067|NCT00869076|Pharmacist|pharmacist
1477068|NCT00869063|wrist|wrist
1477069|NCT00869063|sprain|sprain
1477070|NCT00869063|strain|strain
1477071|NCT00869063|contusion|contusion
1477072|NCT00869063|diclofenac|diclofenac
1477073|NCT00869063|patch|patch
1477074|NCT00869063|acute pain|acute pain
1477075|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
1477076|NCT00869050|Pancreatic cancer|pancreatic cancer
1477077|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
1477078|NCT00869050|Carcinoid tumors|carcinoid tumors
1477079|NCT00869050|Pheochromocytomas|pheochromocytomas
1477080|NCT00869050|Gastrinomas|gastrinomas
1477081|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
1477082|NCT00869050|MEN Type I/II|men type i/ii
1477083|NCT00869050|Somatostatinomas|somatostatinomas
1477084|NCT00869050|VIPomas|vipomas
1477085|NCT00869050|Merkel cell tumors|merkel cell tumors
1477086|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
1477087|NCT00869037|Randomized controlled study|randomized controlled study
1477088|NCT00869037|Total knee arthroplasty|total knee arthroplasty
1477089|NCT00869037|Post operative pain|post operative pain
1477090|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
1477091|NCT00869037|Posterior Capsular injection|posterior capsular injection
1477092|NCT00869037|Periarticular injection|periarticular injection
1477093|NCT00869024|Heart failure|heart failure
1477094|NCT00869024|Left ventricular assist device|left ventricular assist device
1477095|NCT00869024|Stem cells|stem cells
1477096|NCT00869011|Cancer|cancer
1477097|NCT00869011|renal cell carcinoma|renal cell carcinoma
1477098|NCT00869011|fatigue|fatigue
1477099|NCT00869011|exercise|exercise
1477100|NCT00868998|Biliary Cancer|biliary cancer
1477101|NCT00868972|Renal Artery Obstruction|renal artery obstruction
1477102|NCT00868972|renovascular hypertension|renovascular hypertension
1477103|NCT00868972|stent|stent
1477104|NCT00868972|Kidney Failure|kidney failure
1477105|NCT00868972|embolic protection|embolic protection
1477106|NCT00868959|Bipolar|bipolar
1477107|NCT00868959|Depression|depression
1477108|NCT00868959|Lurasidone|lurasidone
1477109|NCT00868959|Latuda|latuda
1477110|NCT00868946|Ribavirin|ribavirin
1477111|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
1477112|NCT00868946|Dobrava Virus|dobrava virus
1477113|NCT00868946|Puumala Virus|puumala virus
1477114|NCT00868881|Hypertension|hypertension
1477115|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
1477116|NCT00868881|Blood pressure|blood pressure
1477117|NCT00868868|Pedometer|pedometer
1477118|NCT00868868|Prostate|prostate
1477119|NCT00868868|Cancer|cancer
1477120|NCT00868868|Hormonotherapy|hormonotherapy
1477121|NCT00868868|Exercise|exercise
1477122|NCT00868855|Coronary Artery Disease|coronary artery disease
1477123|NCT00868842|Penicillin|penicillin
1477124|NCT00868842|Allergy|allergy
1477125|NCT00868842|Prevention|prevention
1477126|NCT00868842|Anaphylaxis|anaphylaxis
1477127|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
1477128|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
1477129|NCT00868829|Stent|stent
1477130|NCT00868829|FireBird2|firebird2
1477131|NCT00868829|Coronary Heart Disease|coronary heart disease
1477132|NCT00868816|oxaliplatine|oxaliplatine
1477133|NCT00868816|colorectal cancer|colorectal cancer
1477134|NCT00868816|chemotherapy|chemotherapy
1477135|NCT00868803|prostate cancer|prostate cancer
1477136|NCT00868777|Implant site development|implant site development
1477137|NCT00868777|Bone grafting|bone grafting
1477138|NCT00868777|Dental implants|dental implants
1477139|NCT00868764|Effect of age|effect of age
1477521|NCT00867113|PERSIST|persist
1477140|NCT00868764|Effect of body fat|effect of body fat
1477141|NCT00868764|Granisetron|granisetron
1477142|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
1477143|NCT00868764|Sancuso® patch|sancuso® patch
1477144|NCT00868764|Transdermal|transdermal
1477145|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
1477146|NCT00868751|Interleukin 6|interleukin 6
1477147|NCT00868738|Calcium|calcium
1477148|NCT00868738|Vitamin D|vitamin d
1477149|NCT00868738|Magnesium|magnesium
1477150|NCT00868738|Zinc|zinc
1477151|NCT00868725|oral cavity|oral cavity
1477152|NCT00868725|carcinoma|carcinoma
1477153|NCT00868725|thermal imaging|thermal imaging
1477154|NCT00868712|coronary calcification|coronary calcification
1477155|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
1477156|NCT00868712|warfarin|warfarin
1477157|NCT00868699|Bipolar I, Depression|bipolar i, depression
1477158|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
1477159|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
1477160|NCT00868673|Low fructose diet study|low fructose diet study
1477161|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
1477162|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
1477163|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
1477164|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
1477165|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
1477166|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
1477167|NCT00868608|lymphoma|lymphoma
1477168|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
1477169|NCT00868569|liver metastasis|liver metastasis
1477170|NCT00868569|colorectal cancer|colorectal cancer
1477171|NCT00868569|oxaliplatine|oxaliplatine
1477172|NCT00868569|transartery chemotherapy|transartery chemotherapy
1477173|NCT00868569|embolision|embolision
1477174|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
1477175|NCT00868556|fMRI scans|fmri scans
1477176|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
1477177|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
1477178|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
1477179|NCT00868543|Gastric bypass|gastric bypass
1477180|NCT00868543|obesity|obesity
1477181|NCT00868543|superobese|superobese
1477182|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
1477183|NCT00868517|Veterans|veterans
1477184|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
1477185|NCT00868517|Operation Enduring Freedom|operation enduring freedom
1477186|NCT00868517|Combat Disorders|combat disorders
1477187|NCT00868517|Acupuncture|acupuncture
1477188|NCT00868517|Complementary Therapies|complementary therapies
1477189|NCT00868504|GI tract|gi tract
1477190|NCT00868504|Tumors|tumors
1477191|NCT00868504|Temperatures|temperatures
1477192|NCT00868491|head and neck cancer|head and neck cancer
1477193|NCT00868491|inoperable|inoperable
1477194|NCT00868491|induction chemotherapy|induction chemotherapy
1477195|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
1477196|NCT00868491|biological agent|biological agent
1477197|NCT00868491|efficacy|efficacy
1477198|NCT00868491|toxicity|toxicity
1477199|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
1477200|NCT00868452|Bipolar I|bipolar i
1477201|NCT00868452|Latuda|latuda
1477202|NCT00868452|Lurasidone|lurasidone
1477203|NCT00868439|HF|hf
1477204|NCT00868439|Heart failure|heart failure
1477205|NCT00868439|hyperkalemia|hyperkalemia
1477206|NCT00868439|chronic kidney disease|chronic kidney disease
1477207|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
1477208|NCT00868426|Healthy volunteer study|healthy volunteer study
1477209|NCT00868400|Preoperative care|preoperative care
1477210|NCT00868400|colorectal surgery|colorectal surgery
1477211|NCT00868400|carbohydrate|carbohydrate
1477212|NCT00868400|fasting|fasting
1477213|NCT00868387|weight reduction|weight reduction
1477214|NCT00868387|low-carbohydrate|low-carbohydrate
1477215|NCT00868387|body fat|body fat
1477216|NCT00868387|telemedicine|telemedicine
1477217|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
1477218|NCT00868361|Mass Balance|mass balance
1477219|NCT00868361|Talampanel|talampanel
1477220|NCT00868361|Pharmacokinetics|pharmacokinetics
1477221|NCT00868361|Metabolism|metabolism
1477222|NCT00868361|Metabolites|metabolites
1477223|NCT00868361|Healthy Volunteers|healthy volunteers
1477224|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
1477225|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
1477226|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
1477227|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
1477228|NCT00868335|Activ-C|activ-c
1477229|NCT00868335|Mobility|mobility
1477230|NCT00868335|Movement|movement
1477231|NCT00868309|Snake Bite|snake bite
1477232|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
1477233|NCT00868296|Safety|safety
1477234|NCT00868257|AIDS|aids
1477235|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
1477236|NCT00868257|Pediatric|pediatric
1477737|NCT00866437|Hormones|hormones
1477237|NCT00868257|Resource Limited Setting|resource limited setting
1477238|NCT00868257|Treatment experienced|treatment experienced
1477239|NCT00868244|facial patterns|facial patterns
1477240|NCT00868244|bruxism|bruxism
1477241|NCT00868244|masticatory muscles|masticatory muscles
1477242|NCT00868231|COPD|copd
1477243|NCT00868231|Antimuscarinic|antimuscarinic
1477244|NCT00868218|Influenza A|influenza a
1477245|NCT00868218|pandemic|pandemic
1477246|NCT00868218|vaccine|vaccine
1477247|NCT00868218|immunogenicity|immunogenicity
1477248|NCT00868218|Virus|virus
1477249|NCT00868218|H5N1|h5n1
1477250|NCT00868205|oxidative stress|oxidative stress
1477251|NCT00868205|Comet assay|comet assay
1477252|NCT00868205|antioxidants|antioxidants
1477253|NCT00868179|Thrombosis|thrombosis
1477254|NCT00868179|total knee replacement|total knee replacement
1477255|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1477256|NCT00868166|TRO19622|tro19622
1477257|NCT00868166|Trophos|trophos
1477258|NCT00868127|Hyperlipidemia|hyperlipidemia
1477259|NCT00868127|Drug Therapy|drug therapy
1477260|NCT00868127|Dyslipidemia|dyslipidemia
1477261|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
1477262|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
1477263|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
1477264|NCT00868101|ischemic|ischemic
1477265|NCT00868101|preconditioning|preconditioning
1477266|NCT00868101|congenital heart disease|congenital heart disease
1477268|NCT00868088|SCC|scc
1477269|NCT00868088|SCC-is|scc-is
1477270|NCT00868088|PDT|pdt
1477271|NCT00868088|Mohs|mohs
1477272|NCT00868075|Physiotherapy|physiotherapy
1477273|NCT00868075|Rehabilitation|rehabilitation
1477274|NCT00868075|Bronchiectasis|bronchiectasis
1477275|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
1477276|NCT00868049|chewing|chewing
1477277|NCT00868049|deglutition|deglutition
1477278|NCT00868049|orofacial motricity|orofacial motricity
1477279|NCT00868049|obesity|obesity
1477280|NCT00868036|urticaria|urticaria
1477281|NCT00868036|hives|hives
1477282|NCT00868036|dermatitis|dermatitis
1477283|NCT00868036|rash|rash
1477284|NCT00868036|contact dermatitis|contact dermatitis
1477285|NCT00868036|contact|contact
1477286|NCT00868036|contact sensitization|contact sensitization
1477287|NCT00868036|allergy|allergy
1477288|NCT00868036|allergen|allergen
1477289|NCT00868036|patch testing|patch testing
1477290|NCT00868036|IgG|igg
1477291|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
1477292|NCT00868036|hypersensitivity|hypersensitivity
1477293|NCT00868010|stroke|stroke
1477294|NCT00868010|donepezil|donepezil
1477295|NCT00868010|recovery|recovery
1477296|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
1477297|NCT00867997|Hypersensitivity|hypersensitivity
1477298|NCT00867997|Teeth|teeth
1477299|NCT00867997|Dentistry|dentistry
1477300|NCT00867997|Practice-based research network|practice-based research network
1477301|NCT00867984|CRT, resynchronization,|crt, resynchronization,
1477302|NCT00867958|Colon Anastomosis|colon anastomosis
1477303|NCT00867958|Rectum Anastomosis|rectum anastomosis
1477304|NCT00867958|Intestine|intestine
1477305|NCT00867958|Colorectal Surgery|colorectal surgery
1477306|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
1477307|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
1477308|NCT00867906|Cat allergy|cat allergy
1477309|NCT00867906|Immunotherapy|immunotherapy
1477310|NCT00867906|Cat-PAD|cat-pad
1477311|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
1477312|NCT00867867|Iron deficiency anemia|iron deficiency anemia
1477313|NCT00867867|Helicobacter pylori|helicobacter pylori
1477314|NCT00867867|Iron absorption|iron absorption
1477315|NCT00867867|Iron fortification|iron fortification
1477316|NCT00867867|ferrous sulphate|ferrous sulphate
1477317|NCT00867867|ferrous fumarate|ferrous fumarate
1477318|NCT00867854|de-intensification|de-intensification
1477319|NCT00867854|HAART|haart
1477320|NCT00867854|monotherapy|monotherapy
1477321|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
1477322|NCT00867854|treatment experienced|treatment experienced
1477323|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
1477324|NCT00867841|polymerase chain reaction|polymerase chain reaction
1477325|NCT00867841|pneumococcus|pneumococcus
1477326|NCT00867841|mycoplasma|mycoplasma
1477327|NCT00867841|chlamydophila|chlamydophila
1477328|NCT00867841|anti-bacterial agents|anti-bacterial agents
1477329|NCT00867828|Decline of global cognitive function|decline of global cognitive function
1477522|NCT00867113|PERSIS-5|persis-5
1477330|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
1477331|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
1477332|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
1477333|NCT00867815|NAION|naion
1477738|NCT00866437|Skin tests|skin tests
1477334|NCT00867815|PDE5 inhibitors|pde5 inhibitors
1477335|NCT00867815|vardenafil|vardenafil
1477336|NCT00867815|Levitra|levitra
1477337|NCT00867815|sildenafil|sildenafil
1477338|NCT00867815|Viagra|viagra
1477339|NCT00867815|Tadalafil|tadalafil
1477340|NCT00867815|Cialis|cialis
1477341|NCT00867815|acute vision loss|acute vision loss
1477342|NCT00867815|vision loss|vision loss
1477343|NCT00867815|blurred vision|blurred vision
1477344|NCT00867815|optic neuropathy|optic neuropathy
1477345|NCT00867815|erectile dysfunction.|erectile dysfunction.
1477346|NCT00867802|MICAS|micas
1477347|NCT00867802|MBSR|mbsr
1477348|NCT00867789|abscess|abscess
1477349|NCT00867789|outcomes|outcomes
1477350|NCT00867789|antibiotics|antibiotics
1477351|NCT00867789|incision and drainage|incision and drainage
1477352|NCT00867789|skin abscess|skin abscess
1477353|NCT00867776|Depression|depression
1477354|NCT00867776|African Americans|african americans
1477355|NCT00867776|Exercise|exercise
1477356|NCT00867776|Culturally tailored intervention|culturally tailored intervention
1477357|NCT00867776|Health disparities|health disparities
1477358|NCT00867763|Polycystic ovaries,|polycystic ovaries,
1477359|NCT00867763|Tubal occlusion|tubal occlusion
1477360|NCT00867763|Unexplained infertility|unexplained infertility
1477361|NCT00867763|Low ovarian reserve|low ovarian reserve
1477362|NCT00867763|Male factor infertility|male factor infertility
1477363|NCT00867750|HCC|hcc
1477364|NCT00867750|RE|re
1477365|NCT00867750|Yttrium-90|yttrium-90
1477366|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
1477367|NCT00867750|TACE|tace
1477368|NCT00867750|Radioembolisation|radioembolisation
1477369|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
1477370|NCT00867737|Asthma|asthma
1477371|NCT00867737|Forced Oscillation|forced oscillation
1477372|NCT00867737|Impulse Oscillometry|impulse oscillometry
1477373|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
1477374|NCT00867724|polyp|polyp
1477375|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
1477376|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
1477377|NCT00867698|HE|he
1477378|NCT00867698|MHE|mhe
1477379|NCT00867698|Cognitive impairment|cognitive impairment
1477380|NCT00867698|Cognitive dysfunction|cognitive dysfunction
1477381|NCT00867698|Liver Disease|liver disease
1477382|NCT00867698|Cirrhosis|cirrhosis
1477383|NCT00867685|Healthy Volunteers|healthy volunteers
1477384|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
1477385|NCT00867672|Low-dose Decitabine|low-dose decitabine
1477386|NCT00867672|Valproic acid|valproic acid
1477387|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
1477388|NCT00867672|Older Patients|older patients
1477389|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
1477390|NCT00867659|cetrotide acetate|cetrotide acetate
1477391|NCT00867659|GnRH antagonist|gnrh antagonist
1477392|NCT00867659|oocyte donors|oocyte donors
1477393|NCT00867646|PT|pt
1477394|NCT00867646|DVT|dvt
1477395|NCT00867633|urothelial carinoma|urothelial carinoma
1477396|NCT00867633|aristolochic acid|aristolochic acid
1477397|NCT00867633|DNA|dna
1477398|NCT00867633|adduct|adduct
1477399|NCT00867607|Contact dermatitis|contact dermatitis
1477400|NCT00867607|Eczema|eczema
1477401|NCT00867581|middle cerebral artery|middle cerebral artery
1477402|NCT00867581|infarction|infarction
1477403|NCT00867581|chronic stage|chronic stage
1477404|NCT00867581|hippocampal volume|hippocampal volume
1477405|NCT00867581|MRI|mri
1477406|NCT00867581|MRS|mrs
1477407|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
1477408|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
1477409|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
1477410|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
1477411|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
1477412|NCT00867542|past IUGR|past iugr
1477413|NCT00867542|ECC|ecc
1477414|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
1477415|NCT00867503|ovarian cancer|ovarian cancer
1477416|NCT00867503|bendamustine|bendamustine
1477417|NCT00867490|Hypertension|hypertension
1477418|NCT00867490|aliskiren|aliskiren
1477419|NCT00867490|cardiovascular diseases|cardiovascular diseases
1477420|NCT00867477|Cancer of esophagus|cancer of esophagus
1477421|NCT00867477|Gastrointestine|gastrointestine
1477422|NCT00867477|esophagus cancer|esophagus cancer
1477423|NCT00867477|Positron emission tomography|positron emission tomography
1477424|NCT00867477|PET scan|pet scan
1477425|NCT00867477|Nitric oxide|nitric oxide
1477426|NCT00867477|NO|no
1477427|NCT00867477|NO Breathing Test|no breathing test
1477428|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
1477429|NCT00867464|Vaccine Efficacy|vaccine efficacy
1477430|NCT00867464|Long-Term Protection|long-term protection
1477431|NCT00867464|Immune Response|immune response
1477432|NCT00867464|Human Papillomavirus|human papillomavirus
1477433|NCT00867464|HPV|hpv
1477434|NCT00867464|Vaccine|vaccine
1477435|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1477436|NCT00867438|ulcerative colitis|ulcerative colitis
1477437|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
1477438|NCT00867425|Diabetes|diabetes
1477439|NCT00867425|Internet|internet
1477440|NCT00867425|Obesity|obesity
1477441|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
1477442|NCT00867412|NSCLC|nsclc
1477443|NCT00867412|PET/CT|pet/ct
1477444|NCT00867412|Surgery|surgery
1477445|NCT00867412|FDG|fdg
1477446|NCT00867412|staging|staging
1477447|NCT00867373|Obesity|obesity
1477448|NCT00867373|Weight perceptions|weight perceptions
1477449|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1477450|NCT00867347|stage II bladder cancer|stage ii bladder cancer
1477451|NCT00867347|stage III bladder cancer|stage iii bladder cancer
1477452|NCT00867334|colorectal neoplasm|colorectal neoplasm
1477453|NCT00867334|colorectal cancer|colorectal cancer
1477454|NCT00867334|imatinib mesylate|imatinib mesylate
1477455|NCT00867334|Gleevec|gleevec
1477456|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
1477457|NCT00867334|panitumumab|panitumumab
1477458|NCT00867334|Vectibix|vectibix
1477459|NCT00867334|c-kit receptor|c-kit receptor
1477460|NCT00867334|Receptor|receptor
1477461|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
1477462|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1477463|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
1477464|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1477465|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1477466|NCT00867308|IPSS Int-2|ipss int-2
1477467|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
1477468|NCT00867308|MDS)|mds)
1477469|NCT00867308|5q31.1 deletions|5q31.1 deletions
1477470|NCT00867295|implantable catheters|implantable catheters
1477471|NCT00867295|Indwelling Catheters|indwelling catheters
1477472|NCT00867295|infection|infection
1477473|NCT00867295|cefazolin sodium|cefazolin sodium
1477474|NCT00867295|prophylactic|prophylactic
1477475|NCT00867295|antibiotic|antibiotic
1477476|NCT00867295|totally implantable venous access device|totally implantable venous access device
1477477|NCT00867295|cancer patients|cancer patients
1477478|NCT00867269|Idiopathic Lymphocytopenia|idiopathic lymphocytopenia
1477479|NCT00867269|Opportunistic Infection|opportunistic infection
1477480|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
1477481|NCT00867269|Autoimmune Disease|autoimmune disease
1477482|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
1477483|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
1477484|NCT00867243|Hepatitis C virus|hepatitis c virus
1477485|NCT00867243|HCV|hcv
1477486|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
1477487|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
1477488|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
1477489|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1477490|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
1477491|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1477492|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1477493|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1477494|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
1477495|NCT00867230|FTS|fts
1477496|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
1477497|NCT00867204|ERCP|ercp
1477498|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
1477499|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
1477500|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
1477501|NCT00867152|ritonavir|ritonavir
1477502|NCT00867152|GSK1349572|gsk1349572
1477503|NCT00867152|integrase|integrase
1477504|NCT00867152|lopinavir|lopinavir
1477505|NCT00867152|darunavir|darunavir
1477506|NCT00867152|etravirine|etravirine
1477507|NCT00867139|Influenza|influenza
1477508|NCT00867139|Immunocompromised|immunocompromised
1477509|NCT00867139|Antiviral|antiviral
1477510|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
1477511|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1477512|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
1477513|NCT00867113|Imatinib|imatinib
1477514|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
1477515|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1477516|NCT00867113|Digestive System Diseases|digestive system diseases
1477517|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
1477518|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
1477519|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1477520|NCT00867113|Adjuvant|adjuvant
1477523|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
1477524|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
1477525|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
1477526|NCT00867061|Myelodysplastic|myelodysplastic
1477527|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
1477528|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
1477529|NCT00867061|IPSS High risk|ipss high risk
1477530|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
1477531|NCT00867048|CD4 Count|cd4 count
1477532|NCT00867048|Early Intervention|early intervention
1477534|NCT00867048|HIV Infection|hiv infection
1477535|NCT00867048|HIV Infections|hiv infections
1477536|NCT00867048|treatment naive|treatment naive
1477537|NCT00867022|Inflammatory factors|inflammatory factors
1477538|NCT00867022|Coagulation factors|coagulation factors
1477539|NCT00867022|Sympathetic activity|sympathetic activity
1477540|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1477541|NCT00866996|Methylphenidate|methylphenidate
1477542|NCT00866996|Atomoxetine|atomoxetine
1477543|NCT00866996|Concerta|concerta
1477544|NCT00866983|Open label|open label
1477545|NCT00866983|sildenafil|sildenafil
1477546|NCT00866983|PAH|pah
1477547|NCT00866983|Brazil|brazil
1477548|NCT00866970|Lung Cancer|lung cancer
1477549|NCT00866970|Fatigue|fatigue
1477550|NCT00866970|Cachexia|cachexia
1477551|NCT00866944|Colorectal carcinoma|colorectal carcinoma
1477552|NCT00866944|Liver metastases (only)|liver metastases (only)
1477553|NCT00866944|R0 resection|r0 resection
1477554|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
1477555|NCT00866905|Breast Cancer|breast cancer
1477556|NCT00866905|Ixabepilone|ixabepilone
1477557|NCT00866905|Ixempra|ixempra
1477558|NCT00866905|Cyclophosphamide|cyclophosphamide
1477559|NCT00866905|Cytoxan|cytoxan
1477560|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
1477561|NCT00866879|Sirolimus|sirolimus
1477562|NCT00866879|Rapamune|rapamune
1477563|NCT00866879|Immunosuppression|immunosuppression
1477564|NCT00866879|Renal allograft function|renal allograft function
1477565|NCT00866879|Lymphocytes function|lymphocytes function
1477566|NCT00866853|TMC435350|tmc435350
1477567|NCT00866853|HCV|hcv
1477568|NCT00866853|Hepatitis C|hepatitis c
1477569|NCT00866853|TMC435|tmc435
1477570|NCT00866853|protease inhibitor|protease inhibitor
1477571|NCT00866853|CYP|cyp
1477572|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
1477573|NCT00866840|stage III melanoma|stage iii melanoma
1477574|NCT00866840|stage IV melanoma|stage iv melanoma
1477575|NCT00866840|recurrent melanoma|recurrent melanoma
1477576|NCT00866827|Airway|airway
1477577|NCT00866827|Hemangiomas|hemangiomas
1477578|NCT00866827|Venous Malformations|venous malformations
1477579|NCT00866827|Lymphatic Malformations|lymphatic malformations
1477580|NCT00866814|hernia|hernia
1477581|NCT00866814|open|open
1477582|NCT00866801|coronary blood flow|coronary blood flow
1477583|NCT00866801|coronary flow reserve|coronary flow reserve
1477584|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
1477585|NCT00866801|general anesthesia|general anesthesia
1477586|NCT00866801|thoracic epidural|thoracic epidural
1477587|NCT00866801|autonomic dysfunction|autonomic dysfunction
1477588|NCT00866801|autonomic neuropathy|autonomic neuropathy
1477589|NCT00866788|Xolair|xolair
1477590|NCT00866788|CIU|ciu
1477591|NCT00866775|Seizure|seizure
1477592|NCT00866775|Epilepsy|epilepsy
1477593|NCT00866775|Anticonvulsant|anticonvulsant
1477594|NCT00866775|Historical Control|historical control
1477595|NCT00866775|Monotherapy|monotherapy
1477596|NCT00866762|Polycythaemia Vera|polycythaemia vera
1477597|NCT00866762|Polycythemia Vera|polycythemia vera
1477598|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
1477599|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
1477600|NCT00866762|HDAC-inhibitor|hdac-inhibitor
1477601|NCT00866762|Haematology|haematology
1477602|NCT00866762|Hematology|hematology
1477603|NCT00866762|Haematological disorder|haematological disorder
1477604|NCT00866762|Haematological disease|haematological disease
1477605|NCT00866762|Hematological disorder|hematological disorder
1477606|NCT00866762|Hematological disease|hematological disease
1477607|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1477608|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
1477609|NCT00866749|Leukemia|leukemia
1477610|NCT00866749|ALL|all
1477611|NCT00866749|6-Thioguanine|6-thioguanine
1477612|NCT00866749|Cyclophosphamide|cyclophosphamide
1477613|NCT00866749|Cytarabine|cytarabine
1477614|NCT00866749|Daunorubicin|daunorubicin
1477615|NCT00866749|Doxorubicin|doxorubicin
1477616|NCT00866749|Methotrexate|methotrexate
1477617|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
1477618|NCT00866749|Vincristine|vincristine
1477619|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
1477620|NCT00866749|Mercaptopurine|mercaptopurine
1477621|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
1477622|NCT00866736|dasatinib|dasatinib
1477623|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
1477624|NCT00866723|Avastin|avastin
1477625|NCT00866723|bevacizumab|bevacizumab
1477626|NCT00866697|fallopian tube cancer|fallopian tube cancer
1477627|NCT00866697|pazopanib|pazopanib
1477628|NCT00866697|anti-angiogenesis|anti-angiogenesis
1477629|NCT00866697|ovarian cancer|ovarian cancer
1477630|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
1477631|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
1477632|NCT00866697|gynecologic cancer|gynecologic cancer
1477633|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
1477634|NCT00866671|T-ALL|t-all
1477635|NCT00866671|Safety|safety
1477636|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
1477637|NCT00866671|T-LBL|t-lbl
1477638|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1477639|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1477640|NCT00866658|hyperglycemia|hyperglycemia
1477641|NCT00866658|GLP-1|glp-1
1477642|NCT00866658|sulfonylurea|sulfonylurea
1477643|NCT00866658|insulin|insulin
1477644|NCT00866645|Agitation|agitation
1477645|NCT00866645|Schizophrenia|schizophrenia
1477646|NCT00866645|Randomized|randomized
1477647|NCT00866645|Blind|blind
1477648|NCT00866645|Parallel|parallel
1477649|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
1477650|NCT00866645|Controlled|controlled
1477651|NCT00866645|Multicenter|multicenter
1477652|NCT00866645|Clinical Trial|clinical trial
1477653|NCT00866645|Efficacy|efficacy
1477654|NCT00866645|Safety|safety
1477655|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
1477656|NCT00866645|Chinese|chinese
1477657|NCT00866645|PANSS-EC|panss-ec
1477658|NCT00866645|ACES|aces
1477659|NCT00866645|CGI|cgi
1477660|NCT00866645|BPRS|bprs
1477661|NCT00866645|PANSS|panss
1477662|NCT00866645|RSESE|rsese
1477663|NCT00866645|BAS|bas
1477664|NCT00866632|Depression|depression
1477665|NCT00866632|Anxiety|anxiety
1477666|NCT00866632|Brain Injury|brain injury
1477667|NCT00866632|Cognitive Therapy|cognitive therapy
1477668|NCT00866632|Coping Skills|coping skills
1477669|NCT00866606|On-demand treatment|on-demand treatment
1477670|NCT00866606|Hemostatic efficacy|hemostatic efficacy
1477671|NCT00866606|Factor IX activity|factor ix activity
1477672|NCT00866606|Factor IX recovery|factor ix recovery
1477673|NCT00866606|Factor IX inhibitor|factor ix inhibitor
1477674|NCT00866606|Chinese|chinese
1477675|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
1477676|NCT00866593|depression|depression
1477677|NCT00866593|antidepressant|antidepressant
1477678|NCT00866593|escitalpram oxalate|escitalpram oxalate
1477679|NCT00866593|generic|generic
1477680|NCT00866593|innovator|innovator
1477681|NCT00866593|Lexapro|lexapro
1477682|NCT00866593|efficacy|efficacy
1477683|NCT00866593|safety|safety
1477684|NCT00866593|multicenter|multicenter
1477685|NCT00866593|double-blind|double-blind
1477686|NCT00866593|randomized|randomized
1477687|NCT00866593|chinese|chinese
1477688|NCT00866593|HAMD|hamd
1477689|NCT00866593|MADRS|madrs
1477690|NCT00866593|HAMA|hama
1477691|NCT00866593|VAS-PI|vas-pi
1477692|NCT00866593|SDS|sds
1477693|NCT00866593|CGI|cgi
1477694|NCT00866580|Pandemic influenza|pandemic influenza
1477695|NCT00866567|prematurity|prematurity
1477696|NCT00866567|VLBW|vlbw
1477697|NCT00866567|sepsis|sepsis
1477698|NCT00866567|innate immunity|innate immunity
1477699|NCT00866554|Prostate|prostate
1477700|NCT00866554|Brachytherapy|brachytherapy
1477701|NCT00866554|Cytoreduction|cytoreduction
1477702|NCT00866554|Sexual function|sexual function
1477703|NCT00866554|Toxicity|toxicity
1477704|NCT00866541|resistance|resistance
1477705|NCT00866541|flow proportional pressure support|flow proportional pressure support
1477706|NCT00866541|pressure support ventilation|pressure support ventilation
1477707|NCT00866541|volunteers|volunteers
1477708|NCT00866541|assistant breathing|assistant breathing
1477709|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
1477710|NCT00866528|paclitaxel|paclitaxel
1477711|NCT00866528|NSCLC|nsclc
1477712|NCT00866528|pazopanib|pazopanib
1477713|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1477714|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
1477715|NCT00866528|Advanced Solid Tumor|advanced solid tumor
1477716|NCT00866528|GW786034|gw786034
1477717|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
1477718|NCT00866515|Healthy volunteer|healthy volunteer
1477719|NCT00866515|pharmacodynamics|pharmacodynamics
1477720|NCT00866515|Ketoconazole|ketoconazole
1477721|NCT00866515|Drug Interaction|drug interaction
1477722|NCT00866515|pharmacokinetcs|pharmacokinetcs
1477723|NCT00866515|GW642444M|gw642444m
1477724|NCT00866515|pharmacokinetics|pharmacokinetics
1477725|NCT00866502|Parkinson|parkinson
1477726|NCT00866502|Safety|safety
1477727|NCT00866502|PDGF|pdgf
1477728|NCT00866502|Intracerebroventricular|intracerebroventricular
1477729|NCT00866502|Infusion|infusion
1477730|NCT00866502|Device|device
1477731|NCT00866489|Experimental|experimental
1477732|NCT00866476|Shigella|shigella
1477733|NCT00866476|Vaccine|vaccine
1477734|NCT00866476|Mucosal immunity|mucosal immunity
1477735|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
1477739|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
1477740|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
1477741|NCT00866424|pain|pain
1477742|NCT00866424|HBO|hbo
1477743|NCT00866424|VAS|vas
1477744|NCT00866424|MGPQ|mgpq
1477745|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
1477746|NCT00866411|anxiety|anxiety
1477747|NCT00866411|depression|depression
1477748|NCT00866411|pain|pain
1477749|NCT00866411|sleep disturbance|sleep disturbance
1477750|NCT00866411|combat exposure|combat exposure
1477751|NCT00866411|post traumatic stress|post traumatic stress
1477752|NCT00866411|health status|health status
1477753|NCT00866411|medication use|medication use
1477754|NCT00866411|soldiers|soldiers
1477755|NCT00866398|coronary heart disease|coronary heart disease
1477756|NCT00866398|chd|chd
1477757|NCT00866398|stent|stent
1477758|NCT00866385|Healthy Volunteer|healthy volunteer
1477759|NCT00866385|AZD8566|azd8566
1477760|NCT00866385|Food Effect|food effect
1477761|NCT00866385|Microtracer|microtracer
1477762|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1477763|NCT00866346|CML|cml
1477764|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
1477765|NCT00866346|Bone Marrow Transplant|bone marrow transplant
1477766|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
1477767|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
1477768|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
1477769|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
1477770|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1477771|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
1477772|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
1477773|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
1477774|NCT00866294|HAM-D (17 items)|ham-d (17 items)
1477775|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
1477776|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
1477777|NCT00866281|AML|aml
1477778|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1477779|NCT00866281|ALL|all
1477780|NCT00866281|midostaurin|midostaurin
1477781|NCT00866281|PKC412|pkc412
1477782|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
1477783|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
1477784|NCT00866268|Blood loss|blood loss
1477785|NCT00866268|Total knee arthroplasty|total knee arthroplasty
1477786|NCT00866268|Adults|adults
1477787|NCT00866268|Drain|drain
1477788|NCT00866268|Drainage system|drainage system
1477789|NCT00866255|endotracheal tube|endotracheal tube
1477790|NCT00866255|endotracheal pressure|endotracheal pressure
1477791|NCT00866255|airway pressure|airway pressure
1477792|NCT00866255|pressure drop|pressure drop
1477793|NCT00866255|calculation|calculation
1477794|NCT00866255|continuous calculation|continuous calculation
1477795|NCT00866242|Shigella|shigella
1477796|NCT00866242|Vaccine|vaccine
1477797|NCT00866242|Mucosal immunity|mucosal immunity
1477798|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
1477799|NCT00866164|back pain|back pain
1477800|NCT00866164|intractable pain|intractable pain
1477801|NCT00866164|implantable infusion pump|implantable infusion pump
1477802|NCT00866164|morphine|morphine
1477803|NCT00866151|genetic biomarker|genetic biomarker
1477804|NCT00866151|biomarker|biomarker
1477805|NCT00866151|molecular diagnostics|molecular diagnostics
1477806|NCT00866151|genes|genes
1477807|NCT00866151|genetics|genetics
1477808|NCT00866151|overweight management|overweight management
1477809|NCT00866151|weight management|weight management
1477810|NCT00866151|weight reduction|weight reduction
1477811|NCT00866151|SNPs|snps
1477812|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
1477813|NCT00866138|multiple myeloma|multiple myeloma
1477814|NCT00866138|t(4/14)|t(4/14)
1477815|NCT00866138|relapsing|relapsing
1477816|NCT00866138|refractory|refractory
1477817|NCT00866125|Polymyositis|polymyositis
1477818|NCT00866125|Dermatomyositis|dermatomyositis
1477819|NCT00866125|Grip force|grip force
1477820|NCT00866125|Quality of life|quality of life
1477821|NCT00866125|Activity performance|activity performance
1477822|NCT00866112|Wheelchair use|wheelchair use
1477823|NCT00866112|Spinal cord injury|spinal cord injury
1477824|NCT00866112|Multiple sclerosis|multiple sclerosis
1477825|NCT00866112|Muscular dystrophy|muscular dystrophy
1477826|NCT00866112|Cerebral palsy|cerebral palsy
1477827|NCT00866112|Spina bifida|spina bifida
1477828|NCT00866112|Amputation|amputation
1477829|NCT00866112|Arthritis|arthritis
1477831|NCT00866099|Dementia|dementia
1477832|NCT00866099|primary care|primary care
1477833|NCT00866099|early diagnosis|early diagnosis
1477834|NCT00866099|psychosocial interventions|psychosocial interventions
1477835|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
1477836|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1477837|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1477838|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1477839|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1477840|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1477841|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1477842|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1477843|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1477844|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
1477845|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
1477847|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
1477848|NCT00866073|Decitabine|decitabine
1477849|NCT00866060|donepezil|donepezil
1477850|NCT00866060|memantine|memantine
1477851|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
1477852|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
1477853|NCT00866047|Antigens, CD30|antigens, cd30
1477854|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
1477855|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
1477856|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1477857|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1477858|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
1477859|NCT00866047|Drug Therapy|drug therapy
1477860|NCT00866047|Immunotherapy|immunotherapy
1477861|NCT00866047|Hematologic Diseases|hematologic diseases
1477862|NCT00866047|Lymphoma|lymphoma
1477863|NCT00866034|Cetrotide|cetrotide
1477864|NCT00866034|IVF|ivf
1477865|NCT00866034|ICSI|icsi
1477866|NCT00866034|Treatment protocol|treatment protocol
1477867|NCT00866021|HIV infection|hiv infection
1477868|NCT00866021|HCV infection|hcv infection
1477869|NCT00866021|treatment experienced|treatment experienced
1477870|NCT00866008|IVF|ivf
1477871|NCT00866008|In vitro implantation|in vitro implantation
1477872|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
1477873|NCT00866008|Aneuploidy|aneuploidy
1477874|NCT00865995|pepsin|pepsin
1477875|NCT00865995|aspiration|aspiration
1477876|NCT00865995|GE reflux|ge reflux
1477877|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
1477878|NCT00865982|gastric cancer|gastric cancer
1477879|NCT00865982|esophageal cancer|esophageal cancer
1477880|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
1477881|NCT00865982|docetaxel|docetaxel
1477882|NCT00865982|capecitabine|capecitabine
1477883|NCT00865982|cisplatin|cisplatin
1477884|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
1477885|NCT00865969|Belinostat|belinostat
1477886|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1477887|NCT00865969|PXD101|pxd101
1477888|NCT00865969|PTCL|ptcl
1477889|NCT00865969|HDAC inhibitor|hdac inhibitor
1477890|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
1477891|NCT00865956|disease management|disease management
1477892|NCT00865956|substance use disorders|substance use disorders
1477893|NCT00865956|behavioral incentives|behavioral incentives
1477894|NCT00865943|Bioequivalence|bioequivalence
1477895|NCT00865943|Citalopram|citalopram
1477896|NCT00865943|Healthy subjects|healthy subjects
1477897|NCT00865917|POTS|pots
1477898|NCT00865904|∆F508|∆f508
1477899|NCT00865904|F508del|f508del
1477900|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
1477901|NCT00865904|CFTR|cftr
1477902|NCT00865904|Pancreatic diseases|pancreatic diseases
1477903|NCT00865904|Lung diseases|lung diseases
1477904|NCT00865904|Genetic disease, inborn|genetic disease, inborn
1477905|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
1477906|NCT00865891|Bioequivalence|bioequivalence
1477907|NCT00865891|Nifedipine|nifedipine
1477908|NCT00865891|Healthy subjects|healthy subjects
1477909|NCT00865878|Actinic Keratoses|actinic keratoses
1477910|NCT00865878|Skin Neoplasms|skin neoplasms
1477911|NCT00865878|Photodynamic Therapy|photodynamic therapy
1477912|NCT00865878|Transplants|transplants
1477913|NCT00865865|Knee|knee
1477914|NCT00865865|Computer|computer
1477915|NCT00865865|Gap|gap
1477916|NCT00865865|Soft tissue|soft tissue
1477917|NCT00865865|Balancing|balancing
1477918|NCT00865865|Replacement|replacement
1477919|NCT00865865|Arthroplasty|arthroplasty
1477920|NCT00865852|Bioequivalence|bioequivalence
1477921|NCT00865852|Metformin|metformin
1477922|NCT00865852|Healthy subjects|healthy subjects
1477923|NCT00865839|Bioequivalence|bioequivalence
1477924|NCT00865839|Metformin|metformin
1477925|NCT00865839|Healthy subjects|healthy subjects
1477926|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
1477927|NCT00865826|Myobacterium Infections|myobacterium infections
1477928|NCT00865813|Punch biopsy,|punch biopsy,
1477929|NCT00865813|periocular|periocular
1477930|NCT00865813|tumors.|tumors.
1477931|NCT00865774|Trauma|trauma
1477932|NCT00865774|Alcohol|alcohol
1477933|NCT00865774|Brief Intervention|brief intervention
1477934|NCT00865761|Bioequivalence|bioequivalence
1477935|NCT00865761|Alprazolam|alprazolam
1477936|NCT00865761|Healthy subjects|healthy subjects
1477937|NCT00865748|Bioequivalence|bioequivalence
1477938|NCT00865748|Metformin|metformin
1477939|NCT00865748|Healthy subjects|healthy subjects
1477940|NCT00865722|Remote Postconditioning|remote postconditioning
1477941|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
1477942|NCT00865722|Myocardial Infarction|myocardial infarction
1477943|NCT00865722|Primary PCI|primary pci
1477944|NCT00865709|Colorectal Cancer|colorectal cancer
1477945|NCT00865709|Metastasis|metastasis
1477946|NCT00865709|Stage IV|stage iv
1477947|NCT00865709|Liver Metastasis|liver metastasis
1477948|NCT00865696|Bioequivalence|bioequivalence
1477949|NCT00865696|Mirtazapine|mirtazapine
1477950|NCT00865696|Healthy subjects|healthy subjects
1477951|NCT00865683|Gestational Diabetes|gestational diabetes
1477952|NCT00865683|Pregnancy|pregnancy
1477953|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
1477954|NCT00865683|DHA|dha
1477955|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
1477956|NCT00865657|Bioequivalence|bioequivalence
1477957|NCT00865657|Alprazolam|alprazolam
1477958|NCT00865657|Healthy subjects|healthy subjects
1477959|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
1477960|NCT00865631|Bioequivalence|bioequivalence
1477961|NCT00865631|Gabapentin|gabapentin
1477962|NCT00865631|Healthy subjects|healthy subjects
1477963|NCT00865605|bioequivalence|bioequivalence
1477964|NCT00865605|Vasoconstriction|vasoconstriction
1477965|NCT00865605|Halobetasol|halobetasol
1477966|NCT00865605|Healthy subjects|healthy subjects
1477967|NCT00865592|diabetes|diabetes
1477968|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
1477969|NCT00865592|dutogliptin|dutogliptin
1477970|NCT00865592|PHX1149|phx1149
1477971|NCT00865579|MAO inhibitors|mao inhibitors
1477972|NCT00865579|motor fluctuations|motor fluctuations
1477973|NCT00865579|dyskinesia|dyskinesia
1477974|NCT00865579|Parkinson's Disease|parkinson's disease
1477975|NCT00865566|HIV Seronegativity|hiv seronegativity
1477976|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
1477977|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
1477978|NCT00865566|Adenovirus|adenovirus
1477979|NCT00865553|tobacco use disorder|tobacco use disorder
1477980|NCT00865540|cataract|cataract
1477981|NCT00865540|pupillary dilation|pupillary dilation
1477982|NCT00865540|anti-inflammatory|anti-inflammatory
1477983|NCT00865540|therapeutic use|therapeutic use
1477984|NCT00865527|Colorectal cancer|colorectal cancer
1477985|NCT00865527|Colon cancer|colon cancer
1477986|NCT00865527|Adenomatous polyps|adenomatous polyps
1477987|NCT00865527|Screening|screening
1477988|NCT00865527|Fecal occult blood test|fecal occult blood test
1477989|NCT00865527|Computed tomographic colonography|computed tomographic colonography
1477990|NCT00865527|Colonoscopy|colonoscopy
1477991|NCT00865514|dichloroacetate|dichloroacetate
1477992|NCT00865514|tyrosine|tyrosine
1477993|NCT00865514|maleylacetoacetate|maleylacetoacetate
1477994|NCT00865514|trichloroethylene|trichloroethylene
1477995|NCT00865514|leucine|leucine
1477996|NCT00865514|haplotype|haplotype
1477997|NCT00865501|primary hypertension|primary hypertension
1477998|NCT00865501|aldosterone|aldosterone
1477999|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
1478000|NCT00865475|HIV infection|hiv infection
1478001|NCT00865475|Treatment Experienced|treatment experienced
1478002|NCT00865462|Bioequivalence|bioequivalence
1478003|NCT00865462|Bupropion|bupropion
1478004|NCT00865462|Healthy subjects|healthy subjects
1478005|NCT00865449|spironolactone|spironolactone
1478006|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
1478007|NCT00865449|peritoneal dialysis|peritoneal dialysis
1478008|NCT00865436|Bioequivalence|bioequivalence
1478009|NCT00865436|Metformin|metformin
1478010|NCT00865436|Glyburide|glyburide
1478011|NCT00865436|Healthy subjects|healthy subjects
1478012|NCT00865423|Bioequivalence|bioequivalence
1478013|NCT00865423|Gabapentin|gabapentin
1478014|NCT00865423|Healthy subjects|healthy subjects
1478015|NCT00865410|Bioequivalence|bioequivalence
1478016|NCT00865410|Bupropion|bupropion
1478017|NCT00865410|Healthy subjects|healthy subjects
1478018|NCT00865384|Bioequivalence|bioequivalence
1478019|NCT00865384|Mirtazapine|mirtazapine
1478020|NCT00865384|Healthy subjects|healthy subjects
1478021|NCT00865371|Bioequivalence|bioequivalence
1478022|NCT00865371|Bupropion|bupropion
1478023|NCT00865371|Healthy subjects|healthy subjects
1478024|NCT00865358|yoga|yoga
1478025|NCT00865358|complementary alternative medicine|complementary alternative medicine
1478026|NCT00865358|low back pain|low back pain
1478027|NCT00865358|minority health|minority health
1478028|NCT00865358|health care disparities|health care disparities
1478029|NCT00865358|community health centers|community health centers
1478030|NCT00865345|blood sugar|blood sugar
1478031|NCT00865345|glucose|glucose
1478032|NCT00865345|sensor|sensor
1478033|NCT00865332|PET|pet
1478034|NCT00865332|fMRI|fmri
1478035|NCT00865332|D-Amphetamine|d-amphetamine
1478036|NCT00865332|Cocaine Addiction|cocaine addiction
1478037|NCT00865332|Methylphenidate|methylphenidate
1478038|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
1478039|NCT00865319|Spect CT Imaging|spect ct imaging
1478040|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
1478041|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
1478043|NCT00865306|Preschoolers|preschoolers
1478044|NCT00865306|Young Children|young children
1478045|NCT00865306|Parents|parents
1478046|NCT00865306|At-risk|at-risk
1478047|NCT00865306|Behavioral Inhibition|behavioral inhibition
1478048|NCT00865293|Obesity|obesity
1478049|NCT00865293|expiratory flow limitation|expiratory flow limitation
1478050|NCT00865293|EFL|efl
1478051|NCT00865293|posture|posture
1478052|NCT00865293|small airways obstruction|small airways obstruction
1478053|NCT00865293|FOT|fot
1478054|NCT00865280|CSSI|cssi
1478055|NCT00865280|Abscess|abscess
1478056|NCT00865280|Wound|wound
1478057|NCT00865280|Cellulitis|cellulitis
1478058|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
1478059|NCT00865267|Vasoconstriction|vasoconstriction
1478060|NCT00865267|Halobetasol|halobetasol
1478061|NCT00865267|Healthy adult subjects|healthy adult subjects
1478062|NCT00865254|Nicotine Dependence|nicotine dependence
1478063|NCT00865254|Smoking|smoking
1478064|NCT00865254|Smoking Cessation|smoking cessation
1478065|NCT00865254|Contingency Management|contingency management
1478066|NCT00865241|Bioequivalence|bioequivalence
1478067|NCT00865241|Metformin|metformin
1478068|NCT00865241|Glyburide|glyburide
1478069|NCT00865241|Healthy subjects|healthy subjects
1478070|NCT00865228|Hyperlipidemia|hyperlipidemia
1478071|NCT00865228|Dyslipidemia|dyslipidemia
1478072|NCT00865228|High Cholesterol|high cholesterol
1478073|NCT00865228|Drug Therapy|drug therapy
1478074|NCT00865215|Bioequivalence|bioequivalence
1478075|NCT00865215|Propranolol|propranolol
1478076|NCT00865215|Healthy subjects|healthy subjects
1478077|NCT00865202|delirium|delirium
1478078|NCT00865202|surgery|surgery
1478079|NCT00865202|operation|operation
1478080|NCT00865202|geriatric|geriatric
1478081|NCT00865202|complication|complication
1478082|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
1478083|NCT00865163|anticoagulation|anticoagulation
1478084|NCT00865163|PCI|pci
1478085|NCT00865150|Prematurity|prematurity
1478086|NCT00865150|Neonatal screening|neonatal screening
1478087|NCT00865150|Parenteral nutrition|parenteral nutrition
1478088|NCT00865150|Amino acids|amino acids
1478089|NCT00865150|Acylcarnitine|acylcarnitine
1478090|NCT00865137|Kidney Transplantation|kidney transplantation
1478091|NCT00865137|Pharmacokinetics|pharmacokinetics
1478092|NCT00865137|Tacrolimus modified release|tacrolimus modified release
1478093|NCT00865137|FK506E|fk506e
1478094|NCT00865111|Bioequivalence|bioequivalence
1478095|NCT00865111|Bupropion|bupropion
1478096|NCT00865111|Healthy subjects|healthy subjects
1478097|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
1478098|NCT00865085|Bioequivalence|bioequivalence
1478099|NCT00865085|Citalopram|citalopram
1478100|NCT00865085|Healthy subjects|healthy subjects
1478101|NCT00865072|Bioequivalence|bioequivalence
1478102|NCT00865072|Metformin|metformin
1478103|NCT00865072|Healthy subjects|healthy subjects
1478104|NCT00865059|Bioequivalence|bioequivalence
1478105|NCT00865059|Gabapentin|gabapentin
1478106|NCT00865059|Healthy subjects|healthy subjects
1478107|NCT00865046|acupuncture|acupuncture
1478108|NCT00865020|Hypertension|hypertension
1478109|NCT00865020|ABPM|abpm
1478110|NCT00865020|systolic blood pressure|systolic blood pressure
1478111|NCT00865020|diastolic blood pressure|diastolic blood pressure
1478112|NCT00865020|cardiovascular disease|cardiovascular disease
1478113|NCT00865020|aliskiren|aliskiren
1478114|NCT00865020|telmisartan|telmisartan
1478115|NCT00865007|Lipodystrophy|lipodystrophy
1478116|NCT00865007|treatment experienced|treatment experienced
1478117|NCT00864994|COPD|copd
1478118|NCT00864994|Inflammation|inflammation
1478119|NCT00864994|Smoking|smoking
1478120|NCT00864994|Multiorgan pathology|multiorgan pathology
1478121|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
1478122|NCT00864968|Bioequivalence|bioequivalence
1478123|NCT00864968|Nabumetone|nabumetone
1478124|NCT00864968|Healthy subjects|healthy subjects
1478125|NCT00864955|UV-A irradiation|uv-a irradiation
1478126|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
1478127|NCT00864955|Oxidative lesions|oxidative lesions
1478128|NCT00864955|cutaneous phototype|cutaneous phototype
1478129|NCT00864955|UV-B irradiation|uv-b irradiation
1478130|NCT00864955|DNA damages|dna damages
1478131|NCT00864942|CLL|cll
1478132|NCT00864942|NHL|nhl
1478133|NCT00864942|lymphoma|lymphoma
1478134|NCT00864929|Non-interventional study|non-interventional study
1478135|NCT00864929|Vietnam|vietnam
1478136|NCT00864929|inappropriate treatment|inappropriate treatment
1478137|NCT00864929|nosocomial infection|nosocomial infection
1478138|NCT00864916|Endothelial Function|endothelial function
1478139|NCT00864916|Pentoxifylline|pentoxifylline
1478140|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
1478141|NCT00864916|Inflammation|inflammation
1478142|NCT00864903|enterovirus|enterovirus
1478143|NCT00864903|aseptic meningitis|aseptic meningitis
1478144|NCT00864903|real time PCR|real time pcr
1478145|NCT00864903|diagnostics|diagnostics
1478146|NCT00864890|Bioequivalence|bioequivalence
1478147|NCT00864890|Citalopram|citalopram
1478148|NCT00864890|Healthy subjects|healthy subjects
1478149|NCT00864877|retrospective|retrospective
1478150|NCT00864877|comparison|comparison
1478151|NCT00864877|biodegradable|biodegradable
1478152|NCT00864877|implant|implant
1478153|NCT00864877|ankle fracture|ankle fracture
1478154|NCT00864864|sunitinib|sunitinib
1478155|NCT00864838|intraocular pressure|intraocular pressure
1478156|NCT00864838|bevacizumab|bevacizumab
1478157|NCT00864838|acetazolamide|acetazolamide
1478158|NCT00864838|brimonidine|brimonidine
1478159|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
1478160|NCT00864825|Schizophrenia|schizophrenia
1478161|NCT00864825|Allopurinol|allopurinol
1478162|NCT00864825|Add-on-treatment|add-on-treatment
1478163|NCT00864799|Abortion|abortion
1478164|NCT00864799|Misoprostol|misoprostol
1478165|NCT00864799|Mifepristone|mifepristone
1478166|NCT00864799|Pregnancy|pregnancy
1478167|NCT00864799|Fetus|fetus
1478168|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
1478169|NCT00864760|Bioequivalence|bioequivalence
1478170|NCT00864760|Gabapentin|gabapentin
1478171|NCT00864760|Healthy subjects|healthy subjects
1478172|NCT00864747|Bioequivalence|bioequivalence
1478173|NCT00864747|Propranolol|propranolol
1478174|NCT00864747|Healthy subjects|healthy subjects
1478175|NCT00864734|Bioequivalence|bioequivalence
1478176|NCT00864734|Metformin|metformin
1478177|NCT00864734|Glyburide|glyburide
1478178|NCT00864734|Healthy subjects|healthy subjects
1478179|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
1478180|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
1478181|NCT00864695|Anesthesia|anesthesia
1478182|NCT00864695|Ethics|ethics
1478183|NCT00864695|Trends|trends
1478184|NCT00864695|Manpower|manpower
1478185|NCT00864695|Perioperative care|perioperative care
1478186|NCT00864682|propofol|propofol
1478187|NCT00864682|lidocaine|lidocaine
1478188|NCT00864682|injection pain|injection pain
1478189|NCT00864669|Bioequivalence|bioequivalence
1478190|NCT00864669|Metformin|metformin
1478191|NCT00864669|Healthy subjects|healthy subjects
1478192|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
1478193|NCT00864656|phenylephrine|phenylephrine
1478194|NCT00864656|drug effects|drug effects
1478195|NCT00864656|diagnostic use|diagnostic use
1478196|NCT00864643|Hyperlipidemia|hyperlipidemia
1478197|NCT00864643|Drug Therapy|drug therapy
1478198|NCT00864643|Dyslipidemia|dyslipidemia
1478199|NCT00864617|Bioequivalence|bioequivalence
1478200|NCT00864617|Nifedipine|nifedipine
1478201|NCT00864617|Healthy subjects|healthy subjects
1478202|NCT00864604|Bioequivalence|bioequivalence
1478203|NCT00864604|Nabumetone|nabumetone
1478204|NCT00864604|Healthy subjects|healthy subjects
1478205|NCT00864591|SPECT Imaging|spect imaging
1478206|NCT00864591|Stress adenosine CMR|stress adenosine cmr
1478207|NCT00864578|POAG|poag
1478209|NCT00864578|Forskolin|forskolin
1478210|NCT00864578|Food supplement|food supplement
1478211|NCT00864565|Bioequivalence|bioequivalence
1478212|NCT00864565|Fentanyl|fentanyl
1478213|NCT00864565|Healthy subjects|healthy subjects
1478214|NCT00864552|Hemophilia A|hemophilia a
1478215|NCT00864552|Recombinant Factor VIII|recombinant factor viii
1478216|NCT00864539|vitamin D fortification|vitamin d fortification
1478217|NCT00864539|milk|milk
1478218|NCT00864539|orange juice|orange juice
1478219|NCT00864539|supplement|supplement
1478220|NCT00864539|efficacy|efficacy
1478221|NCT00864526|Bioequivalence|bioequivalence
1478222|NCT00864526|Oxycodone|oxycodone
1478223|NCT00864526|Ibuprofen|ibuprofen
1478224|NCT00864526|Healthy subjects|healthy subjects
1478225|NCT00864513|pancreas|pancreas
1478226|NCT00864513|metastatic|metastatic
1478227|NCT00864513|recurrent|recurrent
1478228|NCT00864500|Bio-Equivalence|bio-equivalence
1478229|NCT00864500|Vasoconstriction|vasoconstriction
1478230|NCT00864500|Clobetasol|clobetasol
1478231|NCT00864500|Healthy adult females|healthy adult females
1478232|NCT00864461|Down syndrome|down syndrome
1478233|NCT00864461|Metabolic syndrome X|metabolic syndrome x
1478234|NCT00864461|Insulin resistance|insulin resistance
1478235|NCT00864448|Bioequivalence|bioequivalence
1478236|NCT00864448|Ramipril|ramipril
1478237|NCT00864448|Healthy subjects|healthy subjects
1478238|NCT00864435|Bioequivalence|bioequivalence
1478239|NCT00864435|Carvedilol|carvedilol
1478240|NCT00864435|Healthy subjects|healthy subjects
1478241|NCT00864422|low back pain|low back pain
1478242|NCT00864422|motor training|motor training
1478243|NCT00864422|motor cortex|motor cortex
1478244|NCT00864422|brain plasticity|brain plasticity
1478245|NCT00864409|postoperative pain|postoperative pain
1478246|NCT00864409|total hip arthroplasty|total hip arthroplasty
1478247|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
1478248|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
1478249|NCT00864396|GERD|gerd
1478250|NCT00864370|Psychiatry|psychiatry
1478251|NCT00864370|Pregnancy|pregnancy
1478252|NCT00864370|Bipolar Disorder|bipolar disorder
1478253|NCT00864357|Bioequivalence|bioequivalence
1478254|NCT00864357|Oxycodone|oxycodone
1478255|NCT00864357|Ibuprofen|ibuprofen
1478256|NCT00864357|Healthy subjects|healthy subjects
1478257|NCT00864344|Bioequivalence|bioequivalence
1478258|NCT00864344|Sertralin|sertralin
1478259|NCT00864344|Healthy subjectse|healthy subjectse
1478260|NCT00864331|lung cancer|lung cancer
1478261|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
1478262|NCT00864331|radiation therapy|radiation therapy
1478263|NCT00864331|chemotherapy|chemotherapy
1478264|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
1478265|NCT00864318|refractory|refractory
1478266|NCT00864318|germ cell tumors|germ cell tumors
1478267|NCT00864318|relapse|relapse
1478268|NCT00864318|bad prognosis|bad prognosis
1478269|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
1478270|NCT00864305|Bioequivalence|bioequivalence
1478271|NCT00864305|Gabapentin|gabapentin
1478272|NCT00864305|Healthy subjects|healthy subjects
1478273|NCT00864279|Bioequivalence|bioequivalence
1478274|NCT00864279|Cetirizine|cetirizine
1478275|NCT00864279|Healthy subjects|healthy subjects
1478276|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
1478277|NCT00864266|Chemotherapy|chemotherapy
1478278|NCT00864266|Response prediction|response prediction
1478279|NCT00864253|Melanoma|melanoma
1478280|NCT00864253|Malignant|malignant
1478281|NCT00864253|Abraxane|abraxane
1478282|NCT00864253|ABI-007|abi-007
1478283|NCT00864253|Dacarbazine|dacarbazine
1478284|NCT00864253|Dtic-Dome|dtic-dome
1478285|NCT00864240|Vasoconstriction|vasoconstriction
1478286|NCT00864240|Clobetasol|clobetasol
1478287|NCT00864240|Healthy adult females|healthy adult females
1478288|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
1478289|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
1478290|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
1478291|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
1478292|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
1478293|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
1478294|NCT00864214|bioidentical hormone|bioidentical hormone
1478295|NCT00864214|menopause|menopause
1478296|NCT00864214|estrogen|estrogen
1478297|NCT00864214|progesterone|progesterone
1478298|NCT00864188|skin health|skin health
1478299|NCT00864188|probiotics|probiotics
1478300|NCT00864188|dairy|dairy
1478301|NCT00864188|oral|oral
1478302|NCT00864162|Bioequivalence|bioequivalence
1478303|NCT00864162|Ramipril|ramipril
1478304|NCT00864162|Healthy subjects|healthy subjects
1478305|NCT00864149|Bioequivalence|bioequivalence
1478306|NCT00864149|Carvedilol|carvedilol
1478307|NCT00864149|Healthy subjects|healthy subjects
1478308|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
1478309|NCT00864110|Non small cell lung cancer|non small cell lung cancer
1478310|NCT00864110|SPECT CT imaging|spect ct imaging
1478311|NCT00864110|Pharmacokinetic|pharmacokinetic
1478312|NCT00864110|Radiation Dosimetry|radiation dosimetry
1478313|NCT00864110|PET CT comparison|pet ct comparison
1478314|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
1478315|NCT00864071|Bioequivalence|bioequivalence
1478316|NCT00864071|Griseofulvin|griseofulvin
1478317|NCT00864071|Healthy subjects|healthy subjects
1478318|NCT00864058|Bioequivalence|bioequivalence
1478319|NCT00864058|Gabapentin|gabapentin
1478320|NCT00864058|Healthy subjects|healthy subjects
1478321|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
1478322|NCT00864019|Bioequivalence|bioequivalence
1478323|NCT00864019|Sertraline|sertraline
1478324|NCT00864019|Healthy subjects|healthy subjects
1478325|NCT00863980|angiotensin|angiotensin
1478326|NCT00863980|receptor|receptor
1478327|NCT00863980|vulnerable plaque|vulnerable plaque
1478328|NCT00863980|coronary artery|coronary artery
1478329|NCT00863967|physical examination|physical examination
1478330|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
1478331|NCT00863967|diagnosis|diagnosis
1478332|NCT00863967|immunologic tests|immunologic tests
1478333|NCT00863967|diagnostic tests|diagnostic tests
1478334|NCT00863967|causality|causality
1478335|NCT00863967|genetic test|genetic test
1478336|NCT00863967|biomarker|biomarker
1478337|NCT00863941|Bioequivalence|bioequivalence
1478338|NCT00863941|Bupropion|bupropion
1478339|NCT00863941|Healthy subjects|healthy subjects
1478340|NCT00863915|Bioequivalence|bioequivalence
1478341|NCT00863915|Ramipril|ramipril
1478637|NCT00862784|CRC|crc
1478342|NCT00863915|Healthy subjects|healthy subjects
1478343|NCT00863902|Bioequivalence|bioequivalence
1478344|NCT00863902|Cetirizine|cetirizine
1478345|NCT00863902|Healthy subjects|healthy subjects
1478346|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
1478347|NCT00863863|Bioequivalence|bioequivalence
1478348|NCT00863863|Griseofulvin|griseofulvin
1478349|NCT00863863|Healthy subjects|healthy subjects
1478350|NCT00863837|Acute variceal bleeding|acute variceal bleeding
1478351|NCT00863837|banding ligation|banding ligation
1478352|NCT00863837|vasoconstrictor|vasoconstrictor
1478353|NCT00863837|proton pump inhibitor|proton pump inhibitor
1478354|NCT00863824|NNAL|nnal
1478355|NCT00863824|Cotinine|cotinine
1478356|NCT00863824|Second hand smoke|second hand smoke
1478477|NCT00863317|Bronchiolitis|bronchiolitis
1478478|NCT00863317|montelukast|montelukast
1478357|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
1478358|NCT00863811|POAG|poag
1478360|NCT00863811|Forskolin|forskolin
1478361|NCT00863811|beta-blockers|beta-blockers
1478362|NCT00863811|prostaglandins|prostaglandins
1478363|NCT00863798|Major Depressive Disorder|major depressive disorder
1478364|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
1478365|NCT00863785|Cirrhosis|cirrhosis
1478366|NCT00863785|Alcohol|alcohol
1478367|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
1478368|NCT00863759|intra-ocular lenses|intra-ocular lenses
1478369|NCT00863759|comparative study|comparative study
1478370|NCT00863759|Ocular aberrations|ocular aberrations
1478371|NCT00863759|Contrast Sensitivity|contrast sensitivity
1478372|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1478373|NCT00863746|Sorafenib|sorafenib
1478374|NCT00863707|regadenoson|regadenoson
1478375|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
1478376|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
1478377|NCT00863707|renal impairment|renal impairment
1478378|NCT00863707|coronary artery disease|coronary artery disease
1478379|NCT00863694|cystic fibrosis|cystic fibrosis
1478380|NCT00863694|calprotectin|calprotectin
1478381|NCT00863694|elastase|elastase
1478382|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
1478383|NCT00863681|PH|ph
1478384|NCT00863681|Stimulator|stimulator
1478385|NCT00863668|Infection|infection
1478386|NCT00863668|HIV 1|hiv 1
1478387|NCT00863668|HIV|hiv
1478388|NCT00863668|treatment naive|treatment naive
1478389|NCT00863655|Breast Cancer|breast cancer
1478390|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
1478391|NCT00863655|ER+|er+
1478392|NCT00863655|exemestane|exemestane
1478393|NCT00863655|mTOR|mtor
1478394|NCT00863655|everolimus|everolimus
1478395|NCT00863655|refractory|refractory
1478396|NCT00863655|NSAI|nsai
1478397|NCT00863642|Early cholecystectomy|early cholecystectomy
1478398|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
1478399|NCT00863629|myocardial infarction|myocardial infarction
1478400|NCT00863629|oxidative stress|oxidative stress
1478401|NCT00863629|stem cells|stem cells
1478402|NCT00863629|glycemic control|glycemic control
1478403|NCT00863616|COPD|copd
1478404|NCT00863616|Mucus hypersecretion|mucus hypersecretion
1478405|NCT00863616|HRQL|hrql
1478406|NCT00863616|ESWT|eswt
1478407|NCT00863616|HFCWO|hfcwo
1478408|NCT00863603|Supplemental oxygen|supplemental oxygen
1478409|NCT00863603|Intimal hyperplasia|intimal hyperplasia
1478410|NCT00863603|Graft patency|graft patency
1478411|NCT00863577|Healthy volunteers|healthy volunteers
1478412|NCT00863564|Postprandial Period|postprandial period
1478413|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
1478414|NCT00863564|Incretins|incretins
1478415|NCT00863564|Subclinical Inflammation|subclinical inflammation
1478416|NCT00863564|Obesity|obesity
1478417|NCT00863564|Atherosclerosis|atherosclerosis
1478418|NCT00863564|Triglyceride|triglyceride
1478419|NCT00863564|Lipoproteins|lipoproteins
1478420|NCT00863564|Postprandial inflammation|postprandial inflammation
1478421|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
1478422|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
1478423|NCT00863538|SCD|scd
1478424|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1478425|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1478426|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1478427|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
1478428|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1478429|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1478430|NCT00863512|large cell lung cancer|large cell lung cancer
1478431|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
1478432|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1478433|NCT00863499|Attention Deficit Disorder|attention deficit disorder
1478434|NCT00863499|ADHD|adhd
1478435|NCT00863499|ADD|add
1478436|NCT00863499|iSPOT|ispot
1478437|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
1479129|NCT00860717|Leprosy|leprosy
1478438|NCT00863421|Sleep disordered breathing|sleep disordered breathing
1478439|NCT00863421|Prevalence|prevalence
1478440|NCT00863421|Chronic heart failure|chronic heart failure
1478441|NCT00863421|Incidence|incidence
1478442|NCT00863421|Sleep apnea|sleep apnea
1478443|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
1478444|NCT00863408|Mosquito|mosquito
1478445|NCT00863408|Human Landing Collection|human landing collection
1478446|NCT00863408|Malaria|malaria
1478447|NCT00863395|pruritis|pruritis
1478448|NCT00863395|itch|itch
1478449|NCT00863395|CTCL|ctcl
1478450|NCT00863382|atrial fibrillation|atrial fibrillation
1478451|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1478452|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1478453|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1478454|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1478455|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1478456|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1478457|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1478458|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1478459|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1478460|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1478461|NCT00863356|Epistaxis|epistaxis
1478462|NCT00863356|Chitosan|chitosan
1478463|NCT00863356|Hemostatic|hemostatic
1478464|NCT00863356|Nose bleed|nose bleed
1478465|NCT00863356|Nasal bleeding|nasal bleeding
1478466|NCT00863356|Nasal pack|nasal pack
1478467|NCT00863356|Sealant|sealant
1478468|NCT00863356|ChitoFlex®|chitoflex®
1478469|NCT00863356|HemCon|hemcon
1478470|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
1478471|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
1478472|NCT00863356|Biocompatible dressing|biocompatible dressing
1478473|NCT00863343|Influenza infections|influenza infections
1478474|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
1478475|NCT00863330|stage IV melanoma|stage iv melanoma
1478476|NCT00863330|recurrent melanoma|recurrent melanoma
1478479|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
1478480|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
1478481|NCT00863291|Depression|depression
1478482|NCT00863291|suicidality|suicidality
1478483|NCT00863291|buprenorphine|buprenorphine
1478484|NCT00863265|Phytosterols|phytosterols
1478485|NCT00863265|Ezetimibe|ezetimibe
1478486|NCT00863265|Cholesterol Excretion|cholesterol excretion
1478487|NCT00863265|Cholesterol Absorption|cholesterol absorption
1478488|NCT00863265|Diet|diet
1478489|NCT00863265|Mass Spectrometry|mass spectrometry
1478490|NCT00863265|Deuterium|deuterium
1478491|NCT00863252|proteinuria|proteinuria
1478492|NCT00863252|creatinine|creatinine
1478493|NCT00863252|kidney survival|kidney survival
1478494|NCT00863252|ESRD|esrd
1478495|NCT00863239|treatment naive|treatment naive
1478496|NCT00863239|genotype 1|genotype 1
1478497|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
1478498|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1478499|NCT00863213|Atrial fibrillation|atrial fibrillation
1478500|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
1478501|NCT00863200|Depression|depression
1478502|NCT00863200|Cancer|cancer
1478503|NCT00863200|African Americans|african americans
1478504|NCT00863200|Latinos|latinos
1478505|NCT00863200|Hispanics|hispanics
1478506|NCT00863200|Interactive voice response|interactive voice response
1478507|NCT00863200|IVR|ivr
1478508|NCT00863200|Behavioral Intervention|behavioral intervention
1478509|NCT00863174|Multiple myeloma|multiple myeloma
1478510|NCT00863174|Bio-equivalence|bio-equivalence
1478511|NCT00863161|Safety|safety
1478512|NCT00863161|tolerability|tolerability
1478513|NCT00863161|exposure|exposure
1478514|NCT00863161|healthy|healthy
1478515|NCT00863161|renally impaired subjects|renally impaired subjects
1478516|NCT00863148|MDS|mds
1478517|NCT00863148|AML|aml
1478518|NCT00863148|ALL|all
1478519|NCT00863148|RIC|ric
1478520|NCT00863148|clofarabine|clofarabine
1478521|NCT00863148|allo-HSCT|allo-hsct
1478522|NCT00863148|high-risk MDS/AML|high-risk mds/aml
1478523|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
1478524|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
1478525|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
1478526|NCT00863122|Lapatinib|lapatinib
1478527|NCT00863122|Tykerb|tykerb
1478528|NCT00863122|EGFR inhibitor|egfr inhibitor
1478529|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
1478530|NCT00863122|Pharmacokinetics|pharmacokinetics
1478531|NCT00863096|HPV|hpv
1478532|NCT00863096|acceptability|acceptability
1478533|NCT00863083|pediatric obesity|pediatric obesity
1478534|NCT00863083|pediatric overweight|pediatric overweight
1478636|NCT00862784|Colorectal carcinoma|colorectal carcinoma
1478535|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
1478536|NCT00863083|financial rewards|financial rewards
1478537|NCT00863070|Bladder exstrophy|bladder exstrophy
1478538|NCT00863070|Abnormal gait|abnormal gait
1478540|NCT00863070|urinary bladder disease|urinary bladder disease
1478541|NCT00863070|urogenital abnormalities|urogenital abnormalities
1478542|NCT00863057|HIV Infections|hiv infections
1478543|NCT00863057|Neuropathy|neuropathy
1478544|NCT00863057|Pain|pain
1478545|NCT00863044|off pump coronary bypass|off pump coronary bypass
1478546|NCT00863044|high frequency ventilation|high frequency ventilation
1478547|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
1478548|NCT00863044|vasopressors used|vasopressors used
1478549|NCT00863044|right and left ventricular function|right and left ventricular function
1478550|NCT00863044|arterial blood pressure|arterial blood pressure
1478551|NCT00863044|heart rate|heart rate
1478552|NCT00863031|mental health|mental health
1478553|NCT00863031|problem-solving therapy|problem-solving therapy
1478554|NCT00863031|elderly|elderly
1478555|NCT00863031|health-related quality of life|health-related quality of life
1478556|NCT00863031|primary care|primary care
1478557|NCT00863031|Chinese|chinese
1478558|NCT00863018|Corneal endothelial cell|corneal endothelial cell
1478559|NCT00863018|Specular microscopy|specular microscopy
1478560|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
1478561|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
1478562|NCT00863018|Trabeculectomy|trabeculectomy
1478563|NCT00862992|schizophrenia|schizophrenia
1478564|NCT00862992|antipsychotics|antipsychotics
1478565|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
1478566|NCT00862979|Heart Transplantation|heart transplantation
1478567|NCT00862979|Cardiac Transplantation|cardiac transplantation
1478568|NCT00862979|CNI-sparing|cni-sparing
1478569|NCT00862979|renal function|renal function
1478570|NCT00862979|CNI|cni
1478571|NCT00862979|Cyclosporine A|cyclosporine a
1478572|NCT00862979|Everolimus|everolimus
1478573|NCT00862979|mycophenolic acid|mycophenolic acid
1478574|NCT00862953|low carbohydrate|low carbohydrate
1478575|NCT00862953|high protein diet|high protein diet
1478576|NCT00862940|Memantine|memantine
1478577|NCT00862940|Neuroimaging|neuroimaging
1478578|NCT00862940|MRI|mri
1478579|NCT00862940|Brain atrophy|brain atrophy
1478580|NCT00862927|Smoking Cessation|smoking cessation
1478581|NCT00862927|Cigarette Smoking|cigarette smoking
1478582|NCT00862927|Tobacco Smoking|tobacco smoking
1478583|NCT00862927|Cue Reactivity|cue reactivity
1478584|NCT00862927|Virtual Reality|virtual reality
1478585|NCT00862927|VR|vr
1478586|NCT00862927|Contextual Cues|contextual cues
1478587|NCT00862927|Explicit Smoking Cues|explicit smoking cues
1478588|NCT00862927|Craving|craving
1478589|NCT00862927|Physiological Arousal|physiological arousal
1478590|NCT00862927|Nicotine Dependence|nicotine dependence
1478591|NCT00862927|Breath Sample|breath sample
1478592|NCT00862927|Saliva Test|saliva test
1478593|NCT00862927|Questionnaire|questionnaire
1478594|NCT00862914|Skin|skin
1478595|NCT00862914|MicroRNA|microrna
1478596|NCT00862914|miRNA|mirna
1478597|NCT00862914|Dicer|dicer
1478598|NCT00862914|Malignant Melanoma|malignant melanoma
1478599|NCT00862901|cancer|cancer
1478600|NCT00862901|skin metastases|skin metastases
1478601|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
1478602|NCT00862901|malignant melanoma|malignant melanoma
1478603|NCT00862901|photodynamic therapy|photodynamic therapy
1478604|NCT00862901|photophrin|photophrin
1478731|NCT00862381|shock|shock
1478605|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
1478606|NCT00862901|skin cancer|skin cancer
1478607|NCT00862875|Insulin initiation|insulin initiation
1478608|NCT00862875|oral therapy failure|oral therapy failure
1478609|NCT00862862|infection|infection
1478610|NCT00862862|staphylococcus aureus|staphylococcus aureus
1478611|NCT00862862|vancomycin|vancomycin
1478612|NCT00862862|pharmacodynammics|pharmacodynammics
1478613|NCT00862849|rHuPH20|rhuph20
1478614|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
1478615|NCT00862849|Insulin Lispro|insulin lispro
1478616|NCT00862849|Regular Human Insulin|regular human insulin
1478617|NCT00862836|ZD6474|zd6474
1478618|NCT00862836|Vandetanib|vandetanib
1478619|NCT00862836|Zactima|zactima
1478620|NCT00862836|Ovarian Cancer|ovarian cancer
1478621|NCT00862836|Phase I|phase i
1478622|NCT00862836|Phase II|phase ii
1478623|NCT00862836|Randomized|randomized
1478624|NCT00862836|Safety|safety
1478625|NCT00862823|Healthy Volunteers|healthy volunteers
1478626|NCT00862810|Human papillomavirus|human papillomavirus
1478627|NCT00862810|Cervical cancer|cervical cancer
1478628|NCT00862810|Genital warts|genital warts
1478629|NCT00862810|Vaccine|vaccine
1478630|NCT00862810|Immunogenicity|immunogenicity
1478631|NCT00862797|endotracheal tube|endotracheal tube
1478632|NCT00862797|swallowing|swallowing
1478633|NCT00862797|aspiration|aspiration
1478634|NCT00862797|cuff pressure|cuff pressure
1478635|NCT00862797|pneumonia|pneumonia
1478638|NCT00862784|Colon Cancer|colon cancer
1478639|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1478640|NCT00862732|active suicidal ideation|active suicidal ideation
1478641|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
1478642|NCT00862732|Sri Lanka|sri lanka
1478643|NCT00862732|RCT|rct
1478644|NCT00862706|Chronic HBV|chronic hbv
1478645|NCT00862693|Immunoglobulin A|immunoglobulin a
1478646|NCT00862693|Antibodies|antibodies
1478647|NCT00862693|treatment|treatment
1478648|NCT00862680|Lung Colorectum|lung colorectum
1478649|NCT00862680|Colorectal cancer|colorectal cancer
1478650|NCT00862680|Lung Cancer|lung cancer
1478651|NCT00862680|Liver Cancer|liver cancer
1478652|NCT00862680|Non-small cell lung cancer|non-small cell lung cancer
1478653|NCT00862680|NSCLC|nsclc
1478654|NCT00862680|4D PET/CT Imaging|4d pet/ct imaging
1478655|NCT00862680|Positron emission tomography/computed tomography|positron emission tomography/computed tomography
1478656|NCT00862680|PET/CT scan|pet/ct scan
1478657|NCT00862680|Breathing motion|breathing motion
1478658|NCT00862667|Pharmacokinetics|pharmacokinetics
1478659|NCT00862641|regadenoson|regadenoson
1478660|NCT00862641|CVT 3146|cvt 3146
1478661|NCT00862641|asthma|asthma
1478662|NCT00862641|coronary artery disease|coronary artery disease
1478663|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1478664|NCT00862615|Ageing|ageing
1478665|NCT00862615|Inflammation|inflammation
1478666|NCT00862615|Muscle protein synthesis|muscle protein synthesis
1478667|NCT00862615|Osteopenia|osteopenia
1478668|NCT00862615|Sarcopenia|sarcopenia
1478669|NCT00862602|GDM|gdm
1478670|NCT00862602|gestational diabetes|gestational diabetes
1478671|NCT00862602|pregnancy|pregnancy
1478672|NCT00862602|diabetes|diabetes
1478673|NCT00862602|walking|walking
1478674|NCT00862602|exercise|exercise
1478675|NCT00862602|pedometer|pedometer
1478676|NCT00862602|online|online
1478677|NCT00862589|glucagon|glucagon
1478678|NCT00862589|GLP-1|glp-1
1478679|NCT00862589|hyperglycemia|hyperglycemia
1478680|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
1478681|NCT00862576|Sleep|sleep
1478682|NCT00862576|Neuropathic pain|neuropathic pain
1478683|NCT00862576|Glossodynia|glossodynia
1478684|NCT00862576|Chronic pain|chronic pain
1478685|NCT00862576|Orofacial pain|orofacial pain
1478686|NCT00862563|Alcoholism|alcoholism
1478687|NCT00862563|Alcohol Dependence|alcohol dependence
1478688|NCT00862563|Alcohol Abuse|alcohol abuse
1478689|NCT00862563|Substance Abuse|substance abuse
1478690|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
1478691|NCT00862550|Head and Neck Cancer|head and neck cancer
1478692|NCT00862550|HNC|hnc
1478693|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1478694|NCT00862550|Acupuncture|acupuncture
1478695|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
1478696|NCT00862550|Xerostomia|xerostomia
1478697|NCT00862550|Dry Mouth|dry mouth
1478698|NCT00862550|Radiation|radiation
1478699|NCT00862511|metal ion concentration|metal ion concentration
1478700|NCT00862511|total knee arthroplasty|total knee arthroplasty
1478701|NCT00862511|metal hypersensitivity|metal hypersensitivity
1478702|NCT00862498|PTSD|ptsd
1478703|NCT00862498|Written Disclosure|written disclosure
1478704|NCT00862498|Written Emotional Disclosure|written emotional disclosure
1478705|NCT00862498|Narrative Exposure|narrative exposure
1478706|NCT00862498|Narrative Writing|narrative writing
1478707|NCT00862498|Motor Vehicle Accident|motor vehicle accident
1478708|NCT00862472|open-angle glaucoma|open-angle glaucoma
1478709|NCT00862472|ocular hypertension|ocular hypertension
1478710|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
1478711|NCT00862459|Contrast Agents|contrast agents
1478712|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
1478713|NCT00862446|TPN cholestasis|tpn cholestasis
1478714|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
1478715|NCT00862433|Vitamin C|vitamin c
1478716|NCT00862433|Antioxidant|antioxidant
1478717|NCT00862433|Lipid Peroxidation|lipid peroxidation
1478718|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
1478719|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
1478720|NCT00862433|Health Volunteer|health volunteer
1478721|NCT00862433|HV|hv
1478722|NCT00862433|Normal Weight|normal weight
1478723|NCT00862433|Overweight|overweight
1478724|NCT00862433|Type 2 Diabetes|type 2 diabetes
1478725|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
1478726|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
1478727|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
1478728|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
1478729|NCT00862407|Pulsatile perfusion|pulsatile perfusion
1478730|NCT00862407|plasma proteins|plasma proteins
1478732|NCT00862381|Tracheal Intubation|tracheal intubation
1478733|NCT00862381|reanimation|reanimation
1478734|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
1478735|NCT00862381|Etomidate|etomidate
1478736|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
1478737|NCT00862381|hydrocortisone|hydrocortisone
1478738|NCT00862368|Motivational Interviewing|motivational interviewing
1478739|NCT00862368|Pediatric Asthma|pediatric asthma
1478740|NCT00862368|Smoking Cessation|smoking cessation
1478741|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
1478742|NCT00862368|Second hand smoke|second hand smoke
1478743|NCT00862368|Biomarker|biomarker
1478744|NCT00862368|Asthma|asthma
1478745|NCT00862368|Asthma Education|asthma education
1478746|NCT00862368|Family Intervention|family intervention
1478747|NCT00862368|Smoking|smoking
1478748|NCT00862368|Nicotine Patch|nicotine patch
1478749|NCT00862368|Parents|parents
1478750|NCT00862368|Caregivers|caregivers
1478751|NCT00862368|Child Wellness|child wellness
1478752|NCT00862355|Carcinoma|carcinoma
1478753|NCT00862355|Ovary|ovary
1478754|NCT00862355|Carcinoma Ovary|carcinoma ovary
1478755|NCT00862342|colorectal cancer|colorectal cancer
1478756|NCT00862342|Bevacizumab|bevacizumab
1478757|NCT00862329|Healthy subjects|healthy subjects
1478758|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
1478759|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
1478760|NCT00862303|dendritic cell|dendritic cell
1478761|NCT00862303|vaccine|vaccine
1478762|NCT00862303|renal cell carcinoma|renal cell carcinoma
1478763|NCT00862290|sepsis|sepsis
1478764|NCT00862290|microRNA|microrna
1478765|NCT00862277|Menactra®|menactra®
1478766|NCT00862277|Menomune®|menomune®
1478767|NCT00862277|Meningitis|meningitis
1478768|NCT00862277|Meningococcal Infections|meningococcal infections
1478769|NCT00862251|cardiovascular disorder|cardiovascular disorder
1478770|NCT00862225|rhinomanometry|rhinomanometry
1478771|NCT00862225|mode of action|mode of action
1478772|NCT00862225|grass pollen|grass pollen
1478773|NCT00862212|anxiety|anxiety
1478774|NCT00862212|social anxiety|social anxiety
1478775|NCT00862212|social anxiety disorder|social anxiety disorder
1478776|NCT00862212|coping behaviors|coping behaviors
1478777|NCT00862212|alcohol abuse|alcohol abuse
1478778|NCT00862186|Neoplasms|neoplasms
1478779|NCT00862186|Fatigue|fatigue
1478780|NCT00862186|Self Care|self care
1478781|NCT00862173|Gene-expression profile|gene-expression profile
1478782|NCT00862173|Central nervous system metastasis|central nervous system metastasis
1478783|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
1478784|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
1478785|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
1478786|NCT00862160|heart lung machine|heart lung machine
1478787|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
1478788|NCT00862160|intracranial embolism|intracranial embolism
1478789|NCT00862160|embolism, air|embolism, air
1478790|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
1478791|NCT00862160|neuropsychological tests|neuropsychological tests
1478792|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
1478793|NCT00862160|saccadic eye movement test|saccadic eye movement test
1478794|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
1478795|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1478796|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1478797|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
1478798|NCT00862108|ADRA2A protein, human|adra2a protein, human
1478799|NCT00862056|asymptomatic|asymptomatic
1478800|NCT00862056|coronary artery disease|coronary artery disease
1478801|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
1478802|NCT00862043|Valvular Heart Disease|valvular heart disease
1478803|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
1478804|NCT00862043|Sildenafil|sildenafil
1478805|NCT00862043|Outcomes Research|outcomes research
1478806|NCT00862030|Palliative radiotherapy|palliative radiotherapy
1478807|NCT00862030|Treatment planning|treatment planning
1478808|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
1478809|NCT00862017|Physiology|physiology
1478810|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
1478811|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
1478812|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1478813|NCT00861991|medical communication|medical communication
1478814|NCT00861991|empathy|empathy
1478815|NCT00861991|medical education|medical education
1478816|NCT00861991|standardized patients|standardized patients
1478817|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
1478818|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
1478819|NCT00861965|Leukemia|leukemia
1478820|NCT00861965|Lymphoma|lymphoma
1478821|NCT00861965|Multiple Myeloma|multiple myeloma
1478822|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
1478823|NCT00861952|Neuralgia|neuralgia
1478824|NCT00861952|Complementary medicine|complementary medicine
1478825|NCT00861952|Analgesia|analgesia
1478826|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
1478827|NCT00861887|Clostridium difficile|clostridium difficile
1478828|NCT00861887|colitis|colitis
1478829|NCT00861887|recurrence|recurrence
1478830|NCT00861887|relapse|relapse
1478831|NCT00861887|Vancomycin|vancomycin
1478832|NCT00861861|Pitavastatin|pitavastatin
1478833|NCT00861861|Atorvastatin|atorvastatin
1478834|NCT00861861|CAD|cad
1478835|NCT00861861|HDL-C|hdl-c
1478836|NCT00861861|Adiponectin|adiponectin
1478837|NCT00861822|Anemia|anemia
1478838|NCT00861822|Cardiac surgery|cardiac surgery
1478839|NCT00861822|RBC transfusion|rbc transfusion
1478840|NCT00861822|Acute Kidney Injury|acute kidney injury
1478841|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
1478842|NCT00861809|single dose|single dose
1478843|NCT00861809|gut motility|gut motility
1478844|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
1478845|NCT00861809|tolerability|tolerability
1478846|NCT00861809|phase II|phase ii
1478847|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
1478848|NCT00861809|pharmacodynamics|pharmacodynamics
1478849|NCT00861809|gastric emtpying|gastric emtpying
1478850|NCT00861809|pharmacokinetics|pharmacokinetics
1478851|NCT00861783|oxaliplatin|oxaliplatin
1478852|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
1478853|NCT00861783|oxalatoplatin|oxalatoplatin
1478854|NCT00861783|oxalatoplatinum|oxalatoplatinum
1478855|NCT00861783|Eloxatin|eloxatin
1478856|NCT00861770|Congestive Heart Failure|congestive heart failure
1478857|NCT00861770|Ultrafiltration|ultrafiltration
1478858|NCT00861770|Blood Volume Measurement|blood volume measurement
1478859|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
1478860|NCT00861744|Children|children
1478861|NCT00861744|Immunogenicity|immunogenicity
1478862|NCT00861744|Safety|safety
1478863|NCT00861744|Humans|humans
1478864|NCT00861744|Combined Vaccine|combined vaccine
1478865|NCT00861744|Vaccines|vaccines
1478866|NCT00861731|chronic renal failure|chronic renal failure
1478867|NCT00861731|proteinuria|proteinuria
1478868|NCT00861731|apolipoprotein|apolipoprotein
1478869|NCT00861731|c reactive protein|c reactive protein
1478870|NCT00861718|Phase 1|phase 1
1478871|NCT00861718|Healthy Volunteer|healthy volunteer
1478872|NCT00861692|Argatroban|argatroban
1478873|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
1478874|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
1478875|NCT00861679|HSCT|hsct
1478876|NCT00861679|ALL|all
1478877|NCT00861679|GvHD|gvhd
1478878|NCT00861666|Forgiveness|forgiveness
1478879|NCT00861666|Writing|writing
1478880|NCT00861666|PTSD|ptsd
1478881|NCT00861666|OEF|oef
1478882|NCT00861666|OIF|oif
1478883|NCT00861666|Veterans|veterans
1478884|NCT00861653|Atherosclerosis|atherosclerosis
1478885|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
1478886|NCT00861640|rabeprazole|rabeprazole
1478887|NCT00861640|omeprazole|omeprazole
1478888|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
1478889|NCT00861627|REOLYSIN|reolysin
1478890|NCT00861627|reovirus|reovirus
1478891|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
1478892|NCT00861627|carcinoma|carcinoma
1478893|NCT00861627|oncolytics virus|oncolytics virus
1478894|NCT00861627|chemotherapy|chemotherapy
1478895|NCT00861627|paclitaxel|paclitaxel
1478896|NCT00861627|carboplatin|carboplatin
1478897|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
1478898|NCT00861588|randomized control trial|randomized control trial
1478899|NCT00861588|uroflowmetry|uroflowmetry
1478900|NCT00861588|quality of life|quality of life
1478901|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
1478902|NCT00861575|Cardiovascular|cardiovascular
1478903|NCT00861562|constipation|constipation
1478904|NCT00861562|hemorrhoids|hemorrhoids
1478905|NCT00861562|water smartweed|water smartweed
1478906|NCT00861562|RCT|rct
1478907|NCT00861549|Bioavailability|bioavailability
1478908|NCT00861549|Pharmacokinetics|pharmacokinetics
1478909|NCT00861549|Safety Evaluation|safety evaluation
1478910|NCT00861536|risk factors|risk factors
1478911|NCT00861536|immunology|immunology
1478912|NCT00861523|nausea|nausea
1478913|NCT00861523|vomiting|vomiting
1478914|NCT00861523|pregnancy|pregnancy
1478915|NCT00861523|thiamine|thiamine
1478916|NCT00861523|promethazine|promethazine
1478917|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
1478918|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1478919|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
1478920|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
1478921|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
1478922|NCT00861510|MCL|mcl
1478923|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1478924|NCT00861510|CLL|cll
1478925|NCT00861510|Multiple Myeloma|multiple myeloma
1478926|NCT00861510|MM|mm
1478927|NCT00861497|Open-label|open-label
1478928|NCT00861497|Flexible-dose|flexible-dose
1478929|NCT00861497|Extension|extension
1478930|NCT00861497|Safety study|safety study
1478931|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
1478932|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1478933|NCT00861471|Gleevec|gleevec
1478935|NCT00861471|prostate specific antigen|prostate specific antigen
1478936|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
1478937|NCT00861471|androgen independent|androgen independent
1478938|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
1478939|NCT00861432|Life quality|life quality
1478940|NCT00861432|questionnaire|questionnaire
1478941|NCT00861432|tumor patients|tumor patients
1478942|NCT00861419|AMG 386|amg 386
1478943|NCT00861419|AMG 706|amg 706
1478944|NCT00861419|Bevacizumab|bevacizumab
1478945|NCT00861419|Sorafenib|sorafenib
1478946|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
1478947|NCT00861419|Combination Therapy|combination therapy
1478948|NCT00861419|Peptibody|peptibody
1478949|NCT00861419|Sunitinib|sunitinib
1478950|NCT00861406|Melanoma|melanoma
1478951|NCT00861406|Stage II melanoma|stage ii melanoma
1478952|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
1478953|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
1478954|NCT00861406|PEG Intron|peg intron
1478955|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
1478956|NCT00861406|GP100 Vaccine|gp100 vaccine
1478957|NCT00861406|gp100|gp100
1478958|NCT00861406|peptide vaccine|peptide vaccine
1478959|NCT00861406|Leukapheresis|leukapheresis
1478960|NCT00861406|Immune-cell response|immune-cell response
1478961|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1478962|NCT00861380|Invasive disease|invasive disease
1478963|NCT00861380|Respiratory tract infections|respiratory tract infections
1478964|NCT00861380|Haemophilus influenzae|haemophilus influenzae
1478965|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
1478966|NCT00861380|Acute otitis media|acute otitis media
1478967|NCT00861380|Pneumonia|pneumonia
1478968|NCT00861367|aspirin|aspirin
1478969|NCT00861367|blood loss|blood loss
1478970|NCT00861367|transurethral surgery|transurethral surgery
1478971|NCT00861354|atrial fibrillation|atrial fibrillation
1478972|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
1478973|NCT00861341|Pioglitazone|pioglitazone
1478974|NCT00861341|Thiazolidinediones|thiazolidinediones
1478975|NCT00861341|Platelet Function|platelet function
1478976|NCT00861341|Platelet aggregation|platelet aggregation
1478977|NCT00861341|Diabetic|diabetic
1478978|NCT00861341|Aspirin.|aspirin.
1478979|NCT00861328|Phase 1|phase 1
1478980|NCT00861328|maximum tolerated dose|maximum tolerated dose
1478981|NCT00861328|oxaliplatin|oxaliplatin
1478982|NCT00861328|irinotecan|irinotecan
1478983|NCT00861328|ON 01910.Na|on 01910.na
1478984|NCT00861315|Pneumonia|pneumonia
1478985|NCT00861315|Nebulization|nebulization
1478986|NCT00861315|Amikacin|amikacin
1478987|NCT00861276|Smoking Cessation|smoking cessation
1478988|NCT00861276|Nicotine|nicotine
1478989|NCT00861276|Administration and dosage|administration and dosage
1478990|NCT00861276|Randomized Controlled Trial|randomized controlled trial
1478991|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
1478992|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
1478993|NCT00861250|Molecular remission|molecular remission
1478994|NCT00861237|Nux vomica|nux vomica
1478995|NCT00861237|homeopathy|homeopathy
1478996|NCT00861237|heart lung machine|heart lung machine
1478997|NCT00861237|heart surgery|heart surgery
1478998|NCT00861237|postoperatively studied|postoperatively studied
1478999|NCT00861211|asthma|asthma
1479000|NCT00861211|inflammation|inflammation
1479001|NCT00861211|bronchoconstriction|bronchoconstriction
1479002|NCT00861211|allergen challenge|allergen challenge
1479003|NCT00861211|KCa3.1|kca3.1
1479004|NCT00861185|bronchospasm|bronchospasm
1479005|NCT00861185|exercise asthma|exercise asthma
1479006|NCT00861185|inflammation|inflammation
1479007|NCT00861185|KCa3.1|kca3.1
1479008|NCT00861172|Multiple sclerosis|multiple sclerosis
1479009|NCT00861172|Active plaque|active plaque
1479010|NCT00861172|Multimodal analysis|multimodal analysis
1479012|NCT00861172|Weekly follow-up|weekly follow-up
1479013|NCT00861172|Physiopathology|physiopathology
1479014|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
1479015|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
1479016|NCT00861146|nicotine dependence|nicotine dependence
1479017|NCT00861146|tobacco dependence|tobacco dependence
1479018|NCT00861146|smoking cessation|smoking cessation
1479019|NCT00861146|alcoholism|alcoholism
1479020|NCT00861146|self-efficacy|self-efficacy
1479021|NCT00861146|relapse|relapse
1479022|NCT00861133|cardiac monitor|cardiac monitor
1479023|NCT00861133|loop recorder|loop recorder
1479024|NCT00861133|stroke|stroke
1479025|NCT00861133|ECG|ecg
1479026|NCT00861133|Implantable Loop Recorder|implantable loop recorder
1479027|NCT00861133|cryptogenic|cryptogenic
1479028|NCT00861133|ILR|ilr
1479029|NCT00861120|Ovarian cancer|ovarian cancer
1479030|NCT00861120|KRAS wildtype|kras wildtype
1479031|NCT00861120|Platinum resistant|platinum resistant
1479032|NCT00861107|Colorectal cancer|colorectal cancer
1479033|NCT00861107|Breast Cancer|breast cancer
1479034|NCT00861107|Melanoma|melanoma
1479035|NCT00861107|GI cancer|gi cancer
1479036|NCT00861107|Prostate cancer|prostate cancer
1479037|NCT00861107|Kidney cancer|kidney cancer
1479038|NCT00861107|Lung cancer|lung cancer
1479039|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
1479040|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1479041|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1479042|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
1479043|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
1479044|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
1479045|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
1479046|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
1479047|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
1479048|NCT00861081|Group Clinics|group clinics
1479049|NCT00861081|Self Management|self management
1479050|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
1479051|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
1479052|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
1479053|NCT00861016|Post marketing study|post marketing study
1479054|NCT00861003|schizophrenia|schizophrenia
1479055|NCT00861003|adherence|adherence
1479056|NCT00860977|HIV|hiv
1479057|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
1479058|NCT00860977|Genital herpes|genital herpes
1479059|NCT00860977|Treatment Naive|treatment naive
1479060|NCT00860964|estradiol valerate|estradiol valerate
1479061|NCT00860964|Medroxyprogesterone|medroxyprogesterone
1479062|NCT00860964|menopause|menopause
1479063|NCT00860964|Lipid|lipid
1479064|NCT00860964|Bone mineral density|bone mineral density
1479065|NCT00860964|Body Composition|body composition
1479066|NCT00860951|Normal|normal
1479067|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
1479068|NCT00860938|COPD|copd
1479069|NCT00860938|mannitol|mannitol
1479070|NCT00860925|Randomized Controlled Trial|randomized controlled trial
1479071|NCT00860925|Blinded|blinded
1479072|NCT00860925|Clonidine|clonidine
1479073|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
1479074|NCT00860925|Perioperative vascular complications|perioperative vascular complications
1479075|NCT00860925|Noncardiac surgery|noncardiac surgery
1479076|NCT00860912|Veritas|veritas
1479077|NCT00860912|Cystocele|cystocele
1479078|NCT00860912|Prolapse|prolapse
1479079|NCT00860899|clonidine|clonidine
1479080|NCT00860899|levobupivacaine|levobupivacaine
1479081|NCT00860899|preoperative analgesia|preoperative analgesia
1479082|NCT00860899|postoperative pain|postoperative pain
1479083|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
1479084|NCT00860899|epidural analgesia|epidural analgesia
1479085|NCT00860899|Anesthetics, Local|anesthetics, local
1479086|NCT00860886|Mongolia|mongolia
1479087|NCT00860886|Asia|asia
1479088|NCT00860886|GROWTH FACTORS|growth factors
1479089|NCT00860886|Hormones|hormones
1479090|NCT00860886|Premenopausal|premenopausal
1479091|NCT00860886|Breast Cancer|breast cancer
1479092|NCT00860860|radioimmunotherapy|radioimmunotherapy
1479093|NCT00860860|pretargeting|pretargeting
1479094|NCT00860860|bispecific antibody|bispecific antibody
1479095|NCT00860860|lutetium 177|lutetium 177
1479096|NCT00860860|phase I clinical trial|phase i clinical trial
1479097|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
1479098|NCT00860847|Aged garlic extract|aged garlic extract
1479099|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
1479100|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
1629578|NCT00285441|HIV|hiv
1479101|NCT00860847|Vascular function|vascular function
1479102|NCT00860834|Consumer Participation|consumer participation
1479103|NCT00860834|Telephone Coaching Program|telephone coaching program
1479104|NCT00860821|Healthy subjects|healthy subjects
1479105|NCT00860821|LPS|lps
1479106|NCT00860821|Effect|effect
1479107|NCT00860821|Intranasally|intranasally
1479108|NCT00860808|tinnitus|tinnitus
1479109|NCT00860795|Echinacea|echinacea
1479110|NCT00860795|prevention|prevention
1479111|NCT00860795|immune modulation|immune modulation
1479112|NCT00860782|Sickle Cell Disease|sickle cell disease
1479113|NCT00860782|Educational Outcomes|educational outcomes
1479114|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
1479115|NCT00860756|sleep|sleep
1479116|NCT00860756|disturbance|disturbance
1479117|NCT00860756|deployment|deployment
1479118|NCT00860756|intervention|intervention
1479119|NCT00860756|actigraph|actigraph
1479120|NCT00860743|intermittent hypoxia|intermittent hypoxia
1479121|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
1479122|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
1479123|NCT00860730|Aortic valve replacement|aortic valve replacement
1479124|NCT00860730|Aortic stenosis|aortic stenosis
1479125|NCT00860730|Biological valve|biological valve
1479126|NCT00860730|Sutureless valve|sutureless valve
1479127|NCT00860730|Stented valve|stented valve
1479128|NCT00860730|Aortic Valve Disease|aortic valve disease
1479130|NCT00860717|Ulcers|ulcers
1479131|NCT00860717|Laser|laser
1479132|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
1479133|NCT00860704|lean patients|lean patients
1479134|NCT00860704|obese patients|obese patients
1479135|NCT00860704|crystalloids|crystalloids
1479136|NCT00860704|Esophageal Doppler|esophageal doppler
1479137|NCT00860704|tissue oxygenation|tissue oxygenation
1479138|NCT00860704|Fluid management during surgery|fluid management during surgery
1479139|NCT00860704|Fluid management|fluid management
1479140|NCT00860691|Curative surgical resection|curative surgical resection
1479141|NCT00860691|Laparoscopic technique|laparoscopic technique
1479142|NCT00860665|colorectal cancer|colorectal cancer
1479143|NCT00860665|prevention|prevention
1479144|NCT00860665|colonoscopy|colonoscopy
1479145|NCT00860665|screening|screening
1479146|NCT00860665|quality assessment|quality assessment
1479147|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
1479148|NCT00860652|Oncology|oncology
1479149|NCT00860652|Prostate Cancer|prostate cancer
1479150|NCT00860652|Radiotherapy|radiotherapy
1479151|NCT00860652|Radical Prostatectomy|radical prostatectomy
1479152|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
1479153|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
1479154|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
1479156|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
1479157|NCT00860613|gestational diabetes|gestational diabetes
1479158|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
1479159|NCT00860613|glucose monitoring|glucose monitoring
1479160|NCT00860613|metabolic control|metabolic control
1479161|NCT00860613|nutritional status|nutritional status
1479162|NCT00860613|cost effectiveness|cost effectiveness
1479163|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
1479164|NCT00860600|Platelet Response|platelet response
1479165|NCT00860600|PG2 Treatment|pg2 treatment
1479166|NCT00860600|Quality of Life|quality of life
1479167|NCT00860600|Fatigue|fatigue
1479168|NCT00860600|WHO Bleeding score|who bleeding score
1479169|NCT00860587|Antibiotic resistance|antibiotic resistance
1479170|NCT00860587|Antibiotic treatment|antibiotic treatment
1479171|NCT00860561|Efficacy profile|efficacy profile
1479172|NCT00860561|Safety profile|safety profile
1479173|NCT00860561|Faslodex|faslodex
1479174|NCT00860522|relapsed leukemia|relapsed leukemia
1479175|NCT00860522|refractory leukemia|refractory leukemia
1479176|NCT00860509|phytosterols|phytosterols
1479177|NCT00860509|cholesterol excretion|cholesterol excretion
1479178|NCT00860509|cholesterol absorption|cholesterol absorption
1479179|NCT00860509|diet|diet
1479180|NCT00860509|mass spectrometry|mass spectrometry
1479181|NCT00860509|deuterium|deuterium
1479182|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
1479183|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
1479184|NCT00860470|micronutrients|micronutrients
1479185|NCT00860470|deficiency|deficiency
1479186|NCT00860470|pregnancy|pregnancy
1479187|NCT00860470|birth outcomes|birth outcomes
1479188|NCT00860470|infant mortality|infant mortality
1479189|NCT00860470|neonatal mortality|neonatal mortality
1479190|NCT00860470|malnutrition|malnutrition
1479191|NCT00860470|antenatal|antenatal
1479192|NCT00860457|Leukemia|leukemia
1479193|NCT00860444|Primary Care|primary care
1479194|NCT00860444|Diet|diet
1479195|NCT00860444|Physical Activity|physical activity
1479196|NCT00860418|asthma|asthma
1479197|NCT00860418|feedback|feedback
1479198|NCT00860418|anti-inflammatory|anti-inflammatory
1479199|NCT00860418|ED visits|ed visits
1479200|NCT00860366|Acute ischemic stroke|acute ischemic stroke
1479201|NCT00860366|thrombolysis|thrombolysis
1479202|NCT00860366|alteplase|alteplase
1479203|NCT00860366|uric acid|uric acid
1479204|NCT00860366|neuroprotection|neuroprotection
1479205|NCT00860366|oxidative stress|oxidative stress
1479206|NCT00860353|Healthy Volunteer|healthy volunteer
1479207|NCT00860353|Single Ascending Dose|single ascending dose
1479208|NCT00860353|Safety|safety
1479209|NCT00860353|Tolerability|tolerability
1479210|NCT00860353|AZD2551|azd2551
1479211|NCT00860353|Healthy Volunteer Study|healthy volunteer study
1479212|NCT00860340|Congestive Heart Failure|congestive heart failure
1479213|NCT00860340|Hemodynamics|hemodynamics
1479214|NCT00860340|Echocardiographs|echocardiographs
1479215|NCT00860327|Pediatric Heart Disease|pediatric heart disease
1479216|NCT00860327|Congenital Heart Disease|congenital heart disease
1479217|NCT00860327|Congenital Heart Defects|congenital heart defects
1479218|NCT00860327|Developmental Biology|developmental biology
1479219|NCT00860327|Contractile Function|contractile function
1479220|NCT00860314|external electrical cardioversion|external electrical cardioversion
1479221|NCT00860314|typical atrial flutter|typical atrial flutter
1479222|NCT00860314|electrode position|electrode position
1479223|NCT00860314|antero-lateral|antero-lateral
1479224|NCT00860314|antero-posterior|antero-posterior
1479225|NCT00860314|biphasic cardioversion|biphasic cardioversion
1479226|NCT00860314|step-up protocol|step-up protocol
1479227|NCT00860301|infantile colic|infantile colic
1479228|NCT00860288|Type 2 Diabetes|type 2 diabetes
1479229|NCT00860288|vildagliptin|vildagliptin
1479230|NCT00860249|education|education
1479231|NCT00860249|preventive service|preventive service
1479232|NCT00860249|screening|screening
1479233|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
1479234|NCT00860249|Prevention & Control|prevention & control
1479235|NCT00860236|CFS|cfs
1479236|NCT00860236|Giardia|giardia
1479237|NCT00860236|Fatigue|fatigue
1479238|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
1479239|NCT00860236|CBT|cbt
1479240|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
1479241|NCT00860223|Healthy Subjects|healthy subjects
1479242|NCT00860197|Coffee|coffee
1479243|NCT00860197|Elderly|elderly
1479244|NCT00860197|Immune response|immune response
1479245|NCT00860197|Inflammatory status|inflammatory status
1479246|NCT00860184|carotid artery|carotid artery
1479247|NCT00860184|atherosclerosis|atherosclerosis
1479248|NCT00860184|stroke|stroke
1479249|NCT00860184|transient ischemic attack|transient ischemic attack
1479250|NCT00860184|MRI|mri
1479251|NCT00860184|software|software
1479252|NCT00860184|risk|risk
1479253|NCT00860145|epilepsy|epilepsy
1479254|NCT00860145|radiosurgery|radiosurgery
1479255|NCT00860145|temporal lobectomy|temporal lobectomy
1479256|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
1479257|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
1479258|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
1479259|NCT00860106|VTE|vte
1479260|NCT00860106|VKA treatment|vka treatment
1479261|NCT00860106|VKA treatment cessation|vka treatment cessation
1479262|NCT00860093|Kidney Calculi|kidney calculi
1479263|NCT00860093|Urolithiasis|urolithiasis
1479264|NCT00860093|Lithotripsy|lithotripsy
1479265|NCT00860093|potassium compounds|potassium compounds
1479266|NCT00860093|magnesium compounds|magnesium compounds
1479267|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
1479268|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
1479269|NCT00860054|phytosterols|phytosterols
1479270|NCT00860054|cholesterol excretion|cholesterol excretion
1479271|NCT00860054|cholesterol absorption|cholesterol absorption
1479272|NCT00860054|diet|diet
1479273|NCT00860054|mass spectrometry|mass spectrometry
1479274|NCT00860054|deuterium|deuterium
1479275|NCT00860041|pain|pain
1479276|NCT00860041|neurotoxicity|neurotoxicity
1479277|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1479278|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1479279|NCT00860028|Smoking cessation|smoking cessation
1479280|NCT00860028|Smoking|smoking
1479281|NCT00860028|Tobacco|tobacco
1479282|NCT00860028|Varenicline|varenicline
1479283|NCT00860028|Alcohol|alcohol
1479284|NCT00860002|myomectomy|myomectomy
1479285|NCT00860002|uterine artery occlusion|uterine artery occlusion
1479286|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
1479287|NCT00860002|fibroids|fibroids
1479288|NCT00860002|leiomyomas|leiomyomas
1479289|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
1479290|NCT00859989|breast cancer|breast cancer
1479291|NCT00859989|weight changes|weight changes
1479292|NCT00859989|obesity|obesity
1479293|NCT00859976|BoneMaster|bonemaster
1479294|NCT00859976|Total Hip Replacement|total hip replacement
1479295|NCT00859976|Bone Density|bone density
1479296|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
1479297|NCT00859963|Press fit tibial tray|press fit tibial tray
1479298|NCT00859950|Sleep Apnea|sleep apnea
1479299|NCT00859950|Vascular Occlusion|vascular occlusion
1479300|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
1479301|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
1479302|NCT00859911|micronutrients|micronutrients
1479303|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1479304|NCT00859898|Diabetes Mellitus|diabetes mellitus
1479305|NCT00859898|Endocrine System Diseases|endocrine system diseases
1479306|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
1479307|NCT00859898|Metabolic Diseases|metabolic diseases
1479308|NCT00859898|Metformin|metformin
1479309|NCT00859898|Dapagliflozin|dapagliflozin
1479310|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
1479311|NCT00859898|Pharmacologic Actions|pharmacologic actions
1479312|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
1479313|NCT00859885|patent foramen ovale|patent foramen ovale
1479314|NCT00859885|ischemic stroke|ischemic stroke
1479315|NCT00859885|transient ischemic attack|transient ischemic attack
1479316|NCT00859885|secondary prevention|secondary prevention
1479317|NCT00859885|medical treatment|medical treatment
1479318|NCT00859885|percutaneous device closure|percutaneous device closure
1479319|NCT00859872|acute psychotic agitation|acute psychotic agitation
1479320|NCT00859872|schizophrenia|schizophrenia
1479321|NCT00859872|risperidone oral solution|risperidone oral solution
1479322|NCT00859872|clonazepam|clonazepam
1479323|NCT00859872|haloperidol|haloperidol
1479324|NCT00859846|Arterial line|arterial line
1479325|NCT00859846|Ultrasound|ultrasound
1479326|NCT00859846|Anesthesia|anesthesia
1479327|NCT00859846|Pediatric|pediatric
1479328|NCT00859833|adenosine|adenosine
1479329|NCT00859833|regadenoson|regadenoson
1479330|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
1479331|NCT00859807|Amodiaquine suspension|amodiaquine suspension
1479332|NCT00859807|Flavoquine tablets|flavoquine tablets
1479333|NCT00859807|Bioequivalence study|bioequivalence study
1479334|NCT00859794|Epilepsy|epilepsy
1479335|NCT00859794|fMRI|fmri
1479336|NCT00859794|Electrophysiology|electrophysiology
1479337|NCT00859794|Cortical Mapping|cortical mapping
1479338|NCT00859794|Neurosurgery|neurosurgery
1479339|NCT00859781|Prostate|prostate
1479340|NCT00859768|Cancer|cancer
1479341|NCT00859729|DNA|dna
1479342|NCT00859729|Vaccine|vaccine
1479343|NCT00859729|Electroporation|electroporation
1479344|NCT00859729|xenogenic|xenogenic
1479345|NCT00859729|PSA|psa
1479346|NCT00859716|Vaccination|vaccination
1479347|NCT00859716|Diarrhea|diarrhea
1479348|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
1479349|NCT00859716|Campylobacter jejuni|campylobacter jejuni
1479350|NCT00859716|C. jejuni|c. jejuni
1479351|NCT00859716|Campylobacter|campylobacter
1479352|NCT00859716|Campy|campy
1479353|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
1479354|NCT00859703|osteoporosis|osteoporosis
1479355|NCT00859703|breast cancer|breast cancer
1479356|NCT00859703|bisphosphonates|bisphosphonates
1479357|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
1479358|NCT00859690|Thrombosis|thrombosis
1479359|NCT00859690|Adenosine Deaminase|adenosine deaminase
1479360|NCT00859690|Sleep Disorder|sleep disorder
1479361|NCT00859677|HIV|hiv
1479362|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1479363|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
1479364|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
1479365|NCT00859651|vitamin D|vitamin d
1479366|NCT00859651|breast density|breast density
1479367|NCT00859625|colonoscopy|colonoscopy
1479368|NCT00859625|adenoma detection rate|adenoma detection rate
1479369|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
1479370|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
1479371|NCT00859599|Wound healing|wound healing
1479372|NCT00859599|Bacterial colonisation|bacterial colonisation
1479373|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1479374|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1479375|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1479376|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1479377|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
1479378|NCT00859586|AML|aml
1479379|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1479380|NCT00859586|ALL|all
1479381|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
1479382|NCT00859586|MDS|mds
1479383|NCT00859560|Breast cancer|breast cancer
1479384|NCT00859560|post-menopausal women|post-menopausal women
1479385|NCT00859560|Arimidex|arimidex
1479386|NCT00859560|bone fracture|bone fracture
1479387|NCT00859534|Solar Urticaria|solar urticaria
1479388|NCT00859521|Bioequivalence|bioequivalence
1479389|NCT00859521|Healthy Subjects|healthy subjects
1479390|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
1479391|NCT00859482|natalizumab|natalizumab
1479392|NCT00859482|multiple sclerosis|multiple sclerosis
1479393|NCT00859469|Mesothelioma|mesothelioma
1479394|NCT00859430|Bioequivalence|bioequivalence
1479395|NCT00859430|Healthy Subjects|healthy subjects
1479396|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
1479397|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
1479398|NCT00859417|randomized study|randomized study
1479399|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
1479400|NCT00859391|Celiac Disease|celiac disease
1479401|NCT00859378|Hip|hip
1479402|NCT00859378|Hip endoprosthesis|hip endoprosthesis
1479403|NCT00859378|Hip fracture|hip fracture
1479404|NCT00859378|Femoral fracture|femoral fracture
1479405|NCT00859378|Bone cement|bone cement
1479406|NCT00859378|Non-cemented|non-cemented
1479407|NCT00859365|back pain|back pain
1479408|NCT00859365|neck pain|neck pain
1479409|NCT00859365|anxiety|anxiety
1479410|NCT00859365|range of motion|range of motion
1479411|NCT00859339|TCC|tcc
1479412|NCT00859300|myocardial infarction|myocardial infarction
1479413|NCT00859300|ventricular fibrillation|ventricular fibrillation
1479414|NCT00859300|sudden death|sudden death
1479415|NCT00859300|polymorphism|polymorphism
1479416|NCT00859287|Reflux esophagitis|reflux esophagitis
1479417|NCT00859287|Omepral®|omepral®
1479418|NCT00859287|QOLRAD|qolrad
1479419|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1479420|NCT00859235|peristomal wound infection|peristomal wound infection
1479421|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
1479422|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
1479423|NCT00859222|LBH589|lbh589
1479424|NCT00859222|bevacizumab|bevacizumab
1479425|NCT00859222|Avastin|avastin
1479426|NCT00859222|Panobinostat|panobinostat
1479427|NCT00859209|HVF|hvf
1479428|NCT00859209|Premature infants|premature infants
1479429|NCT00859209|ETCO2|etco2
1479430|NCT00859196|Wound healing|wound healing
1479431|NCT00859196|Cell proliferation|cell proliferation
1479432|NCT00859196|Gene expression|gene expression
1479433|NCT00859183|in-stent restenosis|in-stent restenosis
1479434|NCT00859183|stents|stents
1479435|NCT00859183|sirolimus|sirolimus
1479436|NCT00859170|kidney stones|kidney stones
1479437|NCT00859170|ureter|ureter
1479438|NCT00859170|laser lithotripsy|laser lithotripsy
1479439|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
1479440|NCT00859157|pain|pain
1479441|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1479442|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1479443|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1479444|NCT00859157|stage IA breast cancer|stage ia breast cancer
1479445|NCT00859157|stage IB breast cancer|stage ib breast cancer
1479446|NCT00859157|stage II breast cancer|stage ii breast cancer
1479447|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
1479448|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
1479449|NCT00859144|HIV Prevention|hiv prevention
1479450|NCT00859144|Youth|youth
1479451|NCT00859144|Adolescent|adolescent
1479452|NCT00859144|Community Collaboration|community collaboration
1479453|NCT00859144|Community Mentorship|community mentorship
1479454|NCT00859144|Minority|minority
1479455|NCT00859144|Urban|urban
1479456|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
1479457|NCT00859144|HIV seronegativity|hiv seronegativity
1479458|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
1479459|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
1479460|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
1479461|NCT00859027|Non-metastatic|non-metastatic
1479462|NCT00858975|renal tumor|renal tumor
1479463|NCT00858975|cryotherapy|cryotherapy
1479464|NCT00858975|cytokine|cytokine
1479465|NCT00858962|HIV|hiv
1479466|NCT00858962|Pharmacokinetics|pharmacokinetics
1479467|NCT00858962|Pharmacodynamics|pharmacodynamics
1479468|NCT00858962|Buprenorphine|buprenorphine
1479469|NCT00858962|Raltegravir|raltegravir
1479470|NCT00858962|HIV seronegativity|hiv seronegativity
1479471|NCT00858962|Interaction|interaction
1479472|NCT00858949|Outpatient surgery|outpatient surgery
1479473|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
1479474|NCT00858949|Costs|costs
1479475|NCT00858949|Observational|observational
1479476|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
1479477|NCT00858936|Ischemia|ischemia
1479478|NCT00858936|Heart surgery|heart surgery
1479479|NCT00858936|Heart damage|heart damage
1479480|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
1479481|NCT00858923|immuno-therapy|immuno-therapy
1479482|NCT00858923|treatment naive|treatment naive
1479483|NCT00858910|Motor imagery|motor imagery
1479484|NCT00858910|Motor skill|motor skill
1479485|NCT00858910|Performance improvement|performance improvement
1479486|NCT00858897|Glutathione|glutathione
1479487|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
1479488|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
1479489|NCT00858884|Stroke|stroke
1479490|NCT00858884|Transient ischemic attack|transient ischemic attack
1479491|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
1479492|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
1479493|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
1479494|NCT00858845|Leg Weakness|leg weakness
1479495|NCT00858845|Skeletal Myopathy|skeletal myopathy
1479496|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
1479497|NCT00858819|Osteoporosis|osteoporosis
1479498|NCT00858819|Fractures|fractures
1479499|NCT00858819|Bone Mineral Density|bone mineral density
1479500|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
1479501|NCT00858793|AIDS|aids
1479502|NCT00858793|HIV|hiv
1479503|NCT00858793|Lymphoma|lymphoma
1479504|NCT00858793|Stem Cell Transplantation|stem cell transplantation
1479505|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
1479506|NCT00858793|treatment experienced|treatment experienced
1479507|NCT00858767|vitamin K2|vitamin k2
1479508|NCT00858767|absorption|absorption
1479509|NCT00858767|efficacy|efficacy
1479510|NCT00858754|opioid induced constipation|opioid induced constipation
1479511|NCT00858754|Cancer patients|cancer patients
1479512|NCT00858754|methylnaltrexone|methylnaltrexone
1479513|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
1479514|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
1479515|NCT00858728|Antibody response|antibody response
1479516|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
1479517|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
1479518|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
1479519|NCT00858728|IgG subclasses|igg subclasses
1479520|NCT00858715|Clopidogrel|clopidogrel
1479521|NCT00858715|Aspirin|aspirin
1479522|NCT00858715|Antithrombotic therapy|antithrombotic therapy
1479523|NCT00858715|Platelet function testing|platelet function testing
1479524|NCT00858702|Essential hypertension|essential hypertension
1479525|NCT00858702|Combination therapy|combination therapy
1479526|NCT00858689|Clinical Drug Trial|clinical drug trial
1479527|NCT00858676|acarbose|acarbose
1479528|NCT00858676|diabetes mellitus|diabetes mellitus
1479529|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
1479530|NCT00858676|coronary artery disease|coronary artery disease
1479531|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
1479532|NCT00858663|Cisplatin|cisplatin
1479533|NCT00858663|08-138|08-138
1479534|NCT00858650|registry|registry
1479535|NCT00858650|natural history|natural history
1479536|NCT00858637|Chronic Kidney Disease|chronic kidney disease
1479537|NCT00858637|Dialysis|dialysis
1479538|NCT00858637|Dyslipidemia|dyslipidemia
1479539|NCT00858637|Bile acid sequestrant|bile acid sequestrant
1479540|NCT00858624|Cough|cough
1479541|NCT00858624|Cough reflex|cough reflex
1479542|NCT00858624|NMDA receptor|nmda receptor
1479543|NCT00858624|central sensitisation|central sensitisation
1479544|NCT00858611|Influenza|influenza
1479545|NCT00858611|Healthy|healthy
1479546|NCT00858611|Immunity|immunity
1479547|NCT00858611|Preventive|preventive
1479548|NCT00858611|Flu|flu
1479549|NCT00858611|Healthy Volunteer|healthy volunteer
1479550|NCT00858611|HV|hv
1479551|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
1479552|NCT00858598|Revision|revision
1479553|NCT00858598|Tibial|tibial
1479554|NCT00858598|Void|void
1479555|NCT00858598|Bone Filler|bone filler
1479556|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
1479557|NCT00858572|Synta|synta
1479558|NCT00858572|STA-9090|sta-9090
1479559|NCT00858572|AML|aml
1479560|NCT00858572|CML|cml
1479561|NCT00858572|MDS|mds
1479562|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
1479563|NCT00858572|hematologic malignancy|hematologic malignancy
1479564|NCT00858572|ganetespib|ganetespib
1479565|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1479566|NCT00858559|Remote monitoring|remote monitoring
1479567|NCT00858559|Follow-up|follow-up
1479568|NCT00858533|early intervention|early intervention
1479569|NCT00858533|sickness absence|sickness absence
1479570|NCT00858533|return to work|return to work
1479571|NCT00858533|primary care|primary care
1479572|NCT00858520|COPD|copd
1479573|NCT00858520|Lung cancer|lung cancer
1479574|NCT00858520|genes|genes
1479575|NCT00858520|DNA|dna
1479576|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
1479577|NCT00858494|children|children
1479578|NCT00858494|homeopathic|homeopathic
1479579|NCT00858481|Pediculosis capitis|pediculosis capitis
1479580|NCT00858481|Head Lice|head lice
1479581|NCT00858468|Influenza|influenza
1479582|NCT00858468|Influenza vaccine|influenza vaccine
1479583|NCT00858455|Healthy Volunteers|healthy volunteers
1479584|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
1479585|NCT00858442|Burn sequelae|burn sequelae
1479586|NCT00858442|PRP|prp
1479587|NCT00858442|Children|children
1479588|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
1479589|NCT00858429|liver metastases|liver metastases
1479590|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1479591|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
1479592|NCT00858377|Amgen|amgen
1479593|NCT00858377|Phase 1|phase 1
1479594|NCT00858377|First in Human|first in human
1479595|NCT00858377|Advanced Solid Tumors|advanced solid tumors
1479596|NCT00858377|Clinical Trial|clinical trial
1479597|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
1479598|NCT00858377|Open-label|open-label
1479599|NCT00858377|Oncology|oncology
1479600|NCT00858364|darbepoetin alfa|darbepoetin alfa
1479601|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
1479602|NCT00858364|Aranesp|aranesp
1479603|NCT00858364|chemotherapy|chemotherapy
1479604|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
1479605|NCT00858364|advanced lung cancer|advanced lung cancer
1479606|NCT00858364|malignant pleural effusion|malignant pleural effusion
1479607|NCT00858364|metastatic lung cancer|metastatic lung cancer
1479608|NCT00858364|NSCLC|nsclc
1479609|NCT00858364|anemia|anemia
1479610|NCT00858364|lung cancer|lung cancer
1479611|NCT00858364|pleural effusion|pleural effusion
1479612|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
1479613|NCT00858364|Stage IV lung cancer|stage iv lung cancer
1479614|NCT00858351|Diabetes|diabetes
1479615|NCT00858351|Neuropathy|neuropathy
1479616|NCT00858351|Peripheral|peripheral
1479617|NCT00858351|Painful|painful
1479618|NCT00858351|Thermal|thermal
1479619|NCT00858351|Temperature|temperature
1479620|NCT00858351|Biofeedback|biofeedback
1479621|NCT00858351|Relaxation|relaxation
1479622|NCT00858351|Diabetic|diabetic
1479623|NCT00858338|stomach cancer|stomach cancer
1479624|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
1479625|NCT00858338|GEJ cancer|gej cancer
1479626|NCT00858338|intraperitoneal|intraperitoneal
1479627|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
1479628|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
1479629|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
1479630|NCT00858325|Cubicin|cubicin
1479631|NCT00858325|PK|pk
1479632|NCT00858325|China Registration|china registration
1479633|NCT00858325|Pharmacokinetics|pharmacokinetics
1479634|NCT00858312|dairy foods|dairy foods
1479635|NCT00858312|weight loss|weight loss
1479636|NCT00858312|fat loss|fat loss
1479637|NCT00858312|metabolic regulation|metabolic regulation
1479638|NCT00858299|proteinuria|proteinuria
1479639|NCT00858299|chronic kidney disease|chronic kidney disease
1479640|NCT00858299|renin-angiotensin system|renin-angiotensin system
1479641|NCT00858299|angiotensinogen|angiotensinogen
1479642|NCT00858273|Glutathione|glutathione
1479643|NCT00858260|Klotho|klotho
1479644|NCT00858260|calcium|calcium
1479645|NCT00858260|phosphate|phosphate
1479646|NCT00858260|parathormone|parathormone
1479647|NCT00858260|survival|survival
1479648|NCT00858260|dialysis|dialysis
1479649|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
1479650|NCT00858247|vitamin D|vitamin d
1479651|NCT00858247|Obesity|obesity
1479652|NCT00858247|Insulin sensitivity|insulin sensitivity
1479653|NCT00858247|Adolescent Obesity|adolescent obesity
1479654|NCT00858221|obesity|obesity
1479655|NCT00858221|genes|genes
1479656|NCT00858221|polymorphisms|polymorphisms
1479657|NCT00858221|weight loss|weight loss
1479658|NCT00858221|haplotype|haplotype
1479659|NCT00858221|diplotype|diplotype
1479660|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
1479661|NCT00858195|Anti-inflammatory|anti-inflammatory
1479662|NCT00858182|L-Carnitine|l-carnitine
1479663|NCT00858182|Xylitol|xylitol
1479664|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
1479665|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
1479666|NCT00858169|wrist|wrist
1479667|NCT00858169|knee|knee
1479668|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
1479669|NCT00858156|Pharmacokinetics|pharmacokinetics
1479670|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
1479671|NCT00858130|Veinoplus|veinoplus
1479672|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
1479673|NCT00858130|deep vein thrombosis|deep vein thrombosis
1479674|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
1479675|NCT00858130|Venous stasis syndrome|venous stasis syndrome
1479676|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
1479677|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
1479678|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
1479679|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1479680|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1479681|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1479682|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1479683|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1479684|NCT00858078|Qualitative Research|qualitative research
1479685|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
1479686|NCT00858078|BRCA 1/2|brca 1/2
1479687|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
1479688|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
1479689|NCT00858078|BRCA|brca
1479690|NCT00858078|BRCA1 Gene|brca1 gene
1479691|NCT00858078|BRCA2 Gene|brca2 gene
1479692|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
1479693|NCT00858065|Choice|choice
1479694|NCT00858065|Family-based|family-based
1479695|NCT00858065|Prevention|prevention
1479696|NCT00858052|breast implants|breast implants
1479697|NCT00858052|saline|saline
1479698|NCT00858026|weaning|weaning
1479699|NCT00858026|breastfeeding|breastfeeding
1479700|NCT00858026|infant formula|infant formula
1479701|NCT00858026|fermented formula|fermented formula
1479702|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1479703|NCT00858013|Nateglinide|nateglinide
1479704|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
1479705|NCT00858000|markers|markers
1479706|NCT00858000|expression analysis|expression analysis
1479707|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
1479708|NCT00857974|Physical Activity|physical activity
1479709|NCT00857974|Renal Transplant Candidate|renal transplant candidate
1479710|NCT00857974|Physical Function|physical function
1479711|NCT00857974|Body Composition|body composition
1479712|NCT00857948|head lice|head lice
1479713|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
1479714|NCT00857948|ivermectin|ivermectin
1479715|NCT00857935|Pediculosis Capitis|pediculosis capitis
1479716|NCT00857935|Head Lice|head lice
1479717|NCT00857922|Neurological|neurological
1479718|NCT00857922|Neurosurgical|neurosurgical
1479719|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
1479720|NCT00857883|Obesity|obesity
1479721|NCT00857883|Food Effect|food effect
1479722|NCT00857883|Pharmacokinetics|pharmacokinetics
1479723|NCT00857883|First-Time-In-Humans|first-time-in-humans
1479724|NCT00857883|Pharmacodynamics|pharmacodynamics
1479725|NCT00857883|Healthy Volunteers|healthy volunteers
1479726|NCT00857857|asthma|asthma
1479727|NCT00857857|late phase response|late phase response
1479728|NCT00857857|allergen|allergen
1479729|NCT00857857|challenge|challenge
1479730|NCT00857857|GW870086X|gw870086x
1479731|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
1479732|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
1479733|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
1479734|NCT00857831|spinal cord injury|spinal cord injury
1479735|NCT00857831|Vitamin D deficiency|vitamin d deficiency
1479736|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
1479737|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
1479738|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1479739|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
1479740|NCT00857792|Coronary Disease|coronary disease
1479741|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
1479742|NCT00857792|Stress Testing|stress testing
1479743|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
1479744|NCT00857779|allergen immunotherapy|allergen immunotherapy
1479745|NCT00857779|allergy to grass pollen|allergy to grass pollen
1479746|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1479747|NCT00857766|arterial stiffness|arterial stiffness
1479748|NCT00857766|Computed Tomography|computed tomography
1479749|NCT00857766|pulse wave velocity|pulse wave velocity
1479750|NCT00857766|Pulse wave analysis|pulse wave analysis
1479751|NCT00857727|Dexmedetomidine|dexmedetomidine
1479752|NCT00857727|Emergence Delirium|emergence delirium
1479753|NCT00857727|Agitation|agitation
1479754|NCT00857727|Pediatric|pediatric
1479755|NCT00857727|Anesthesia|anesthesia
1479756|NCT00857714|DCIS|dcis
1479757|NCT00857714|breast|breast
1479758|NCT00857701|total knee arthroplasty|total knee arthroplasty
1479759|NCT00857701|Dynamic Splinting|dynamic splinting
1479760|NCT00857701|Knee extension|knee extension
1479761|NCT00857701|knee|knee
1479762|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
1479763|NCT00857688|aphtous|aphtous
1479764|NCT00857688|bismuth|bismuth
1479765|NCT00857688|procain|procain
1479766|NCT00857688|neomycin|neomycin
1479767|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
1479768|NCT00857675|HBV DNA suppression|hbv dna suppression
1479769|NCT00857675|ALT normalisation|alt normalisation
1479770|NCT00857675|Viral resistance|viral resistance
1479771|NCT00857675|HBeAg seroconversion|hbeag seroconversion
1479772|NCT00857662|US Multicenter|us multicenter
1479773|NCT00857662|Randomized|randomized
1479774|NCT00857662|Onyx|onyx
1479775|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
1479776|NCT00857649|Alzheimer's Disease|alzheimer's disease
1479777|NCT00857636|Ethnic minority women|ethnic minority women
1479778|NCT00857636|Cancer screening|cancer screening
1479779|NCT00857636|Health literacy|health literacy
1479780|NCT00857636|Behavioral intervention|behavioral intervention
1479781|NCT00857636|Breast Cancer screening|breast cancer screening
1479782|NCT00857636|Cervical Cancer screening|cervical cancer screening
1479783|NCT00857623|Pain|pain
1479784|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
1479785|NCT00857623|PDN|pdn
1479786|NCT00857623|Analgesia|analgesia
1479787|NCT00857623|Efficacy|efficacy
1479788|NCT00857610|Aged skin|aged skin
1479789|NCT00857610|Photoaged skin|photoaged skin
1479790|NCT00857610|Retinol|retinol
1479791|NCT00857610|Topical retinoids|topical retinoids
1479792|NCT00857597|GERD|gerd
1479793|NCT00857597|endoscopic|endoscopic
1479794|NCT00857597|fundoplication|fundoplication
1479795|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
1479796|NCT00857597|heartburn|heartburn
1479797|NCT00857597|anti-reflux surgery|anti-reflux surgery
1479798|NCT00857584|Bipolar disorder|bipolar disorder
1479799|NCT00857584|Bipolar depression|bipolar depression
1479800|NCT00857584|quetiapine|quetiapine
1479801|NCT00857584|sertraline|sertraline
1479802|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
1479803|NCT00857532|amyloid burden|amyloid burden
1479804|NCT00857532|Parkinson's disease|parkinson's disease
1479805|NCT00857532|florbetapir PET|florbetapir pet
1479806|NCT00857532|amyloid PET imaging|amyloid pet imaging
1479807|NCT00857519|retinoblastoma|retinoblastoma
1480200|NCT00856063|Atomoxetine|atomoxetine
1479808|NCT00857519|Intraarterial|intraarterial
1479809|NCT00857519|Chemotherapy|chemotherapy
1479810|NCT00857519|Melphalan|melphalan
1479811|NCT00857519|Carboplatin|carboplatin
1479812|NCT00857506|Cognitive outcome|cognitive outcome
1479813|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
1479814|NCT00857506|Amyloid PET scan|amyloid pet scan
1479815|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
1479816|NCT00857506|Normal cognition|normal cognition
1479817|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
1479818|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
1479819|NCT00857415|amyloid imaging|amyloid imaging
1479820|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
1479821|NCT00857402|Arginine|arginine
1479822|NCT00857402|Nitric oxide|nitric oxide
1479823|NCT00857402|Peanuts|peanuts
1479824|NCT00857402|Sedimentation rate|sedimentation rate
1479825|NCT00857389|Cancer|cancer
1479826|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
1479827|NCT00857389|Stem Cell|stem cell
1479828|NCT00857389|Leukemia|leukemia
1479829|NCT00857389|Lymphoma|lymphoma
1479830|NCT00857389|Pediatrics|pediatrics
1479831|NCT00857389|Bone marrow|bone marrow
1479832|NCT00857389|Lymph node system|lymph node system
1479833|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1479834|NCT00857389|ASCT|asct
1479835|NCT00857389|Busulfan|busulfan
1479836|NCT00857389|Busulfex|busulfex
1479837|NCT00857389|Myleran|myleran
1479838|NCT00857389|Clofarabine|clofarabine
1479839|NCT00857389|Clofarex|clofarex
1479840|NCT00857389|Clolar|clolar
1479841|NCT00857389|Thiotepa|thiotepa
1479842|NCT00857389|Antithymocyte globulin|antithymocyte globulin
1479843|NCT00857389|ATG|atg
1479844|NCT00857389|Thymoglobulin|thymoglobulin
1479845|NCT00857389|G-CSF|g-csf
1479846|NCT00857389|Filgrastim|filgrastim
1479847|NCT00857389|Neupogen|neupogen
1479848|NCT00857389|Cyclophosphamide|cyclophosphamide
1479849|NCT00857389|Cytoxan|cytoxan
1479850|NCT00857389|Neosar|neosar
1479851|NCT00857389|Mesna|mesna
1479852|NCT00857389|Mesnex|mesnex
1479853|NCT00857389|Tacrolimus|tacrolimus
1479854|NCT00857389|Prograf|prograf
1479855|NCT00857389|Methotrexate|methotrexate
1479856|NCT00857376|Heart disease risk factors|heart disease risk factors
1479857|NCT00857376|Risk factor management|risk factor management
1479858|NCT00857376|Pre-Diabetes|pre-diabetes
1479859|NCT00857376|Hypertension|hypertension
1479860|NCT00857376|obesity|obesity
1479861|NCT00857376|glucose intolerance|glucose intolerance
1479862|NCT00857376|high cholesterol|high cholesterol
1479863|NCT00857376|abdominal obesity|abdominal obesity
1479864|NCT00857376|enlarged waist|enlarged waist
1479865|NCT00857363|capsule|capsule
1479866|NCT00857363|constipation|constipation
1479867|NCT00857363|whole gut transit|whole gut transit
1479868|NCT00857363|colonic transit|colonic transit
1479869|NCT00857363|gastric emptying|gastric emptying
1479870|NCT00857363|small bowel transit|small bowel transit
1479871|NCT00857350|HIV|hiv
1479872|NCT00857350|resistance|resistance
1479873|NCT00857350|opioid dependence|opioid dependence
1479874|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
1479875|NCT00857324|dose-finding|dose-finding
1479876|NCT00857324|Vorinostat|vorinostat
1479877|NCT00857298|HIV|hiv
1479878|NCT00857298|Metabolic Syndrome|metabolic syndrome
1479879|NCT00857298|Obesity|obesity
1479880|NCT00857298|Treatment Experienced|treatment experienced
1479881|NCT00857272|colonoscopy|colonoscopy
1479882|NCT00857272|bowel preparation|bowel preparation
1479883|NCT00857259|AMD|amd
1479884|NCT00857259|macular degeneration|macular degeneration
1479885|NCT00857259|Everolimus|everolimus
1479886|NCT00857259|Lucentis|lucentis
1479887|NCT00857259|Ranibizumab|ranibizumab
1479888|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
1479889|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1479890|NCT00857246|stomach cancer|stomach cancer
1479891|NCT00857246|biologics|biologics
1479892|NCT00857246|antibody|antibody
1479893|NCT00857246|chemotherapy|chemotherapy
1479894|NCT00857246|chemoradiation|chemoradiation
1479895|NCT00857246|adjuvant therapy|adjuvant therapy
1479896|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
1479897|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
1479898|NCT00857246|combination therapy|combination therapy
1479899|NCT00857233|Alzheimer's Disease|alzheimer's disease
1479900|NCT00857220|Hypnotic|hypnotic
1479901|NCT00857220|Eszopiclone|eszopiclone
1479902|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1479903|NCT00857220|Insomnia|insomnia
1479904|NCT00857220|Children|children
1479905|NCT00857220|Adolescent|adolescent
1479906|NCT00857207|Cognitive Therapy|cognitive therapy
1479907|NCT00857207|Outcomes Assessment|outcomes assessment
1479908|NCT00857194|Coronary Heart Disease|coronary heart disease
1479909|NCT00857194|spinal cord injury|spinal cord injury
1479910|NCT00857194|risk factor|risk factor
1479911|NCT00857194|postprandial lipemia|postprandial lipemia
1479912|NCT00857181|Liver Cirrhosis|liver cirrhosis
1479913|NCT00857181|Infection|infection
1479914|NCT00857181|Inflammation|inflammation
1479915|NCT00857181|Cytokines|cytokines
1479916|NCT00857155|Coronary Artery Disease|coronary artery disease
1479917|NCT00857155|CABG|cabg
1479918|NCT00857155|Clopidogrel|clopidogrel
1479919|NCT00857155|Aspirin|aspirin
1479920|NCT00857155|Point of Care devices|point of care devices
1479921|NCT00857129|"normal birth"|"normal birth"
1479922|NCT00857129|"birth outcome"|"birth outcome"
1479923|NCT00857129|"low risk birth"|"low risk birth"
1479924|NCT00857129|"low risk units"|"low risk units"
1479925|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
1479926|NCT00857129|Apgar score|apgar score
1479927|NCT00857129|breast feeding frequency|breast feeding frequency
1479928|NCT00857129|patient satisfaction|patient satisfaction
1479929|NCT00857116|Deworming|deworming
1479930|NCT00857116|Tuberculosis|tuberculosis
1479931|NCT00857116|TB-score|tb-score
1479932|NCT00857116|Albendazole|albendazole
1479933|NCT00857116|Helminths|helminths
1479934|NCT00857103|computer support|computer support
1479935|NCT00857103|patient-provider communication|patient-provider communication
1479936|NCT00857103|patient-centered care|patient-centered care
1479937|NCT00857103|cancer|cancer
1479938|NCT00857090|Urinary Calculi|urinary calculi
1479939|NCT00857090|Urinary Stones|urinary stones
1479940|NCT00857090|Urinary Tract Stones|urinary tract stones
1479941|NCT00857090|Renal Calculi|renal calculi
1479942|NCT00857090|Kidney Stones|kidney stones
1479943|NCT00857090|Calculi|calculi
1479944|NCT00857090|Urolithotomy|urolithotomy
1479945|NCT00857090|Ureteroscopy|ureteroscopy
1479946|NCT00857077|incidence of anaemia|incidence of anaemia
1479947|NCT00857064|Schizophrenia|schizophrenia
1479948|NCT00857064|antipsychotics|antipsychotics
1479949|NCT00857064|social functioning|social functioning
1479950|NCT00857064|subjective well being|subjective well being
1479951|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
1479952|NCT00857051|Stress|stress
1479953|NCT00857038|COPD|copd
1479954|NCT00857038|Inflammation|inflammation
1479955|NCT00857038|Neutrophilic|neutrophilic
1479956|NCT00857038|Myeloperoxidase|myeloperoxidase
1479957|NCT00857038|Doxycycline|doxycycline
1479958|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1479959|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1479960|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1479961|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1479962|NCT00857012|Primary early MCa|primary early mca
1479963|NCT00857012|Arimidex|arimidex
1479964|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
1479965|NCT00856973|Hypnotic|hypnotic
1479966|NCT00856973|Eszopiclone|eszopiclone
1479967|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1479968|NCT00856973|Insomnia|insomnia
1479969|NCT00856973|Children|children
1479970|NCT00856973|Adolescent|adolescent
1479971|NCT00856973|Polysomnography|polysomnography
1479972|NCT00856973|Actigraphy|actigraphy
1479973|NCT00856947|wheeze|wheeze
1479974|NCT00856947|infections|infections
1479975|NCT00856947|allergy|allergy
1479976|NCT00856947|eczema|eczema
1479977|NCT00856947|vitamin D|vitamin d
1479978|NCT00856934|Skin graft donor site healing|skin graft donor site healing
1479979|NCT00856934|skin|skin
1479980|NCT00856934|wound|wound
1479981|NCT00856934|platelet concentrate|platelet concentrate
1479982|NCT00856934|keratinocytes|keratinocytes
1479983|NCT00856934|burns|burns
1479984|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
1479985|NCT00856908|Type II Diabetes|type ii diabetes
1479986|NCT00856895|Improved Life Quality|improved life quality
1479987|NCT00856856|Bioabsorbable|bioabsorbable
1479988|NCT00856856|Coronary Stent|coronary stent
1479989|NCT00856856|Everolimus|everolimus
1479990|NCT00856856|drug eluting stents|drug eluting stents
1479991|NCT00856856|stents|stents
1479992|NCT00856856|angioplasty|angioplasty
1479993|NCT00856856|coronary artery disease|coronary artery disease
1479994|NCT00856856|total coronary occlusion|total coronary occlusion
1479995|NCT00856856|coronary artery restenosis|coronary artery restenosis
1479996|NCT00856856|stent thrombosis|stent thrombosis
1479997|NCT00856856|vascular disease|vascular disease
1479998|NCT00856856|myocardial ischemia|myocardial ischemia
1479999|NCT00856856|coronary artery stenosis|coronary artery stenosis
1480000|NCT00856856|CAD|cad
1480001|NCT00856856|CAOD|caod
1480002|NCT00856843|colonoscopy|colonoscopy
1480003|NCT00856843|bowel preparation|bowel preparation
1480004|NCT00856830|Small cell lung cancer|small cell lung cancer
1480005|NCT00856830|Chemonaive|chemonaive
1480006|NCT00856830|Bendamustine|bendamustine
1480007|NCT00856830|Irinotecan|irinotecan
1480008|NCT00856830|Etoposide|etoposide
1480009|NCT00856830|Carboplatin|carboplatin
1480010|NCT00856804|Thalidomide|thalidomide
1480011|NCT00856804|Hepatitis C|hepatitis c
1480012|NCT00856804|Interferon resistance|interferon resistance
1480013|NCT00856804|Immunomodulators|immunomodulators
1480014|NCT00856791|Ovarian|ovarian
1480015|NCT00856791|Cancer|cancer
1480016|NCT00856791|Cisplatin|cisplatin
1480017|NCT00856791|Carboplatin|carboplatin
1480018|NCT00856778|Male sling|male sling
1480019|NCT00856778|stress urinary incontinence|stress urinary incontinence
1480020|NCT00856778|urinary incontinence|urinary incontinence
1480021|NCT00856739|obesity|obesity
1480022|NCT00856739|arthritis|arthritis
1480023|NCT00856700|GLP-1|glp-1
1480024|NCT00856700|Endothelial Function|endothelial function
1480025|NCT00856700|Metabolic Syndrome|metabolic syndrome
1480026|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
1480027|NCT00856674|IgA nephropathy|iga nephropathy
1480028|NCT00856674|chemokine fusion protein|chemokine fusion protein
1480029|NCT00856674|leukocyte population modulator|leukocyte population modulator
1480030|NCT00856674|phase-1|phase-1
1480031|NCT00856661|Acute ischemic stroke|acute ischemic stroke
1480032|NCT00856661|Angiography|angiography
1480033|NCT00856661|Desmoteplase|desmoteplase
1480034|NCT00856661|Thrombolytic|thrombolytic
1480035|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
1480036|NCT00856609|Weight Loss|weight loss
1480037|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
1480038|NCT00856609|Energy Expenditure|energy expenditure
1480039|NCT00856609|Food Intake|food intake
1480040|NCT00856609|Obesity|obesity
1480041|NCT00856596|Tinea pedis|tinea pedis
1480042|NCT00856596|Fungus|fungus
1480043|NCT00856596|Pruritus|pruritus
1480044|NCT00856596|Dermatophyte|dermatophyte
1480045|NCT00856596|Athlete's foot|athlete's foot
1480046|NCT00856596|Dermatomycosis|dermatomycosis
1480047|NCT00856596|Skin manifestation|skin manifestation
1480048|NCT00856596|Infectious skin disease|infectious skin disease
1480049|NCT00856596|Foot diseases|foot diseases
1480050|NCT00856570|YM178|ym178
1480051|NCT00856570|Mirabegron|mirabegron
1480052|NCT00856570|DDI|ddi
1480053|NCT00856570|Phase I|phase i
1480054|NCT00856570|Warfarin|warfarin
1480055|NCT00856570|Pharmacokinetics|pharmacokinetics
1480056|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
1480057|NCT00856544|Arthritis|arthritis
1480058|NCT00856544|Rheumatoid|rheumatoid
1480059|NCT00856544|Antirheumatic Agents|antirheumatic agents
1480060|NCT00856544|Clinical Trial|clinical trial
1480061|NCT00856531|Möbius syndrome|möbius syndrome
1480062|NCT00856531|Language|language
1480063|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
1480064|NCT00856518|Multiple Sclerosis|multiple sclerosis
1480065|NCT00856518|Parkinson's disease|parkinson's disease
1480066|NCT00856518|Dysphagia|dysphagia
1480067|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1480068|NCT00856505|Drug Therapy, Combination|drug therapy, combination
1480069|NCT00856505|Immunosuppression|immunosuppression
1480070|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
1480071|NCT00856492|stage II breast cancer|stage ii breast cancer
1480072|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
1480073|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
1480074|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
1480075|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1480076|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1480077|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1480078|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1480079|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
1480080|NCT00856479|Infuse|infuse
1480081|NCT00856479|cost analysis|cost analysis
1480082|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
1480083|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
1480084|NCT00856453|fatigue|fatigue
1480085|NCT00856453|depression|depression
1480086|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1480087|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1480088|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1480089|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1480090|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1480091|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1480092|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1480093|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1480094|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1480095|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1480096|NCT00856440|SCI|sci
1480097|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1480098|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1480099|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1480100|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1480397|NCT00855140|Insomnia|insomnia
1480101|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1480102|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1480103|NCT00856401|hypoparathyroidism|hypoparathyroidism
1480104|NCT00856401|hypopara|hypopara
1480106|NCT00856401|parathyroid hormone|parathyroid hormone
1480107|NCT00856401|CL-11-040|cl-11-040
1480108|NCT00856401|CL1-11 Study|cl1-11 study
1480109|NCT00856401|NPSP 558|npsp 558
1480110|NCT00856401|RELAY|relay
1480111|NCT00856401|RACE|race
1480112|NCT00856401|REPLACE|replace
1480113|NCT00856401|HEXT|hext
1480114|NCT00856401|c10-007|c10-007
1480115|NCT00856401|c10-008|c10-008
1480116|NCT00856401|NPSP558|npsp558
1480117|NCT00856401|Columbia study|columbia study
1480118|NCT00856401|Columbia studies|columbia studies
1480119|NCT00856401|HPTH|hpth
1480120|NCT00856401|PTH1-84|pth1-84
1480121|NCT00856375|colorectal cancer|colorectal cancer
1480122|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
1480123|NCT00856362|Healthy Subjects|healthy subjects
1480124|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1480125|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
1480126|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
1480127|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
1480128|NCT00856323|Methamphetamine|methamphetamine
1480129|NCT00856323|HIV|hiv
1480130|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
1480131|NCT00856323|HIV seronegativity|hiv seronegativity
1480132|NCT00856310|Healthy volunteers|healthy volunteers
1480133|NCT00856297|Meningococcal|meningococcal
1480134|NCT00856297|ACWY|acwy
1480135|NCT00856297|Conjugate Vaccine|conjugate vaccine
1480136|NCT00856297|Meningitis|meningitis
1480137|NCT00856297|Adolescents|adolescents
1480138|NCT00856297|Persistence|persistence
1480139|NCT00856284|Diabetes Mellitus|diabetes mellitus
1480140|NCT00856284|Drug Therapy|drug therapy
1480141|NCT00856284|Hyperinsulinism|hyperinsulinism
1480142|NCT00856284|Hyperglycemia|hyperglycemia
1480143|NCT00856284|Glucose Intolerance|glucose intolerance
1480144|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
1480145|NCT00856245|non-Hodgkins|non-hodgkins
1480146|NCT00856245|lymphoma|lymphoma
1480147|NCT00856245|stem cell transplant|stem cell transplant
1480148|NCT00856232|Headache|headache
1480149|NCT00856232|Cephalgia|cephalgia
1480150|NCT00856232|Migraine|migraine
1480151|NCT00856219|Immune System|immune system
1480152|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
1480153|NCT00856206|Allopurinol|allopurinol
1480154|NCT00856206|Metabolic Disease|metabolic disease
1480155|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
1480156|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
1480157|NCT00856206|Joint Diseases|joint diseases
1480158|NCT00856206|Arthritis|arthritis
1480159|NCT00856206|Rheumatic Diseases|rheumatic diseases
1480160|NCT00856206|Metabolic disorder|metabolic disorder
1480161|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
1480162|NCT00856206|Gout|gout
1480163|NCT00856206|Intercritical Gout|intercritical gout
1480164|NCT00856193|COPD|copd
1480165|NCT00856193|Bronchodilator|bronchodilator
1480166|NCT00856180|avastin|avastin
1480167|NCT00856180|bevacizumab|bevacizumab
1480168|NCT00856180|cyclophosphamide|cyclophosphamide
1480169|NCT00856180|cytoxan|cytoxan
1480170|NCT00856180|mullerian malignancies|mullerian malignancies
1480171|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
1480172|NCT00856167|TMD|tmd
1480173|NCT00856167|TMJ|tmj
1480174|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
1480175|NCT00856167|TCM|tcm
1480176|NCT00856154|HIV-1|hiv-1
1480177|NCT00856154|HLA-A2|hla-a2
1480178|NCT00856154|Therapeutic|therapeutic
1480179|NCT00856154|Vaccine|vaccine
1480180|NCT00856154|treatment vaccine|treatment vaccine
1480181|NCT00856154|treatment naive|treatment naive
1480182|NCT00856141|IOP measurement|iop measurement
1480183|NCT00856141|IOP fluctuation|iop fluctuation
1480184|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
1480185|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
1480186|NCT00856115|stage I colon cancer|stage i colon cancer
1480187|NCT00856115|stage II colon cancer|stage ii colon cancer
1480188|NCT00856115|stage III colon cancer|stage iii colon cancer
1480189|NCT00856115|stage IV colon cancer|stage iv colon cancer
1480190|NCT00856115|stage I rectal cancer|stage i rectal cancer
1480191|NCT00856115|stage II rectal cancer|stage ii rectal cancer
1480192|NCT00856115|stage III rectal cancer|stage iii rectal cancer
1480193|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
1480194|NCT00856076|Venous thromboembolism|venous thromboembolism
1480195|NCT00856076|Intrauterine fetal death|intrauterine fetal death
1480196|NCT00856076|Risk factor|risk factor
1480197|NCT00856076|Thrombophilia|thrombophilia
1480198|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
1480199|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1480201|NCT00856063|Electrodermal Response|electrodermal response
1480202|NCT00856063|Impulsivity|impulsivity
1480203|NCT00856063|Preschool Children|preschool children
1480204|NCT00856050|estrogen receptor positive|estrogen receptor positive
1480205|NCT00856050|progesterone receptor positive|progesterone receptor positive
1480206|NCT00856050|letrozole|letrozole
1480207|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
1480208|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
1480209|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
1480210|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
1480211|NCT00855985|Whipple operation|whipple operation
1480212|NCT00855959|Asthma|asthma
1480213|NCT00855959|Pulmicort Respules|pulmicort respules
1480214|NCT00855946|tumor response|tumor response
1480215|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
1480216|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
1480217|NCT00855946|Proteomic analysis|proteomic analysis
1480218|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
1480219|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
1480220|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
1480221|NCT00855920|Allopurinol|allopurinol
1480222|NCT00855920|Metabolic Diseases|metabolic diseases
1480223|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
1480224|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
1480225|NCT00855920|Joint Diseases|joint diseases
1480226|NCT00855920|Arthritis|arthritis
1480227|NCT00855920|Rheumatic Diseases|rheumatic diseases
1480228|NCT00855920|Metabolic disorder|metabolic disorder
1480229|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
1480230|NCT00855920|Gout|gout
1480231|NCT00855920|Flare|flare
1480233|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
1480234|NCT00855907|fatty liver|fatty liver
1480235|NCT00855894|Tarceva|tarceva
1480236|NCT00855894|NSCLC|nsclc
1480237|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
1480238|NCT00855868|Amyloid imaging|amyloid imaging
1480239|NCT00855868|Positron Emission Tomography|positron emission tomography
1480240|NCT00855868|18F-AV-45|18f-av-45
1480241|NCT00855868|florbetapir F 18|florbetapir f 18
1480242|NCT00855868|Diagnostic imaging|diagnostic imaging
1480243|NCT00855855|Diphtheria|diphtheria
1480244|NCT00855855|Tetanus|tetanus
1480245|NCT00855855|Pertussis|pertussis
1480246|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
1480247|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
1480248|NCT00855855|Pentacel®|pentacel®
1480249|NCT00855842|second trimester abortion|second trimester abortion
1480250|NCT00855842|labor induction abortion|labor induction abortion
1480251|NCT00855842|second trimester medical abortion|second trimester medical abortion
1480252|NCT00855842|pregnancy|pregnancy
1480253|NCT00855803|spinal cord metastases|spinal cord metastases
1480254|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1480255|NCT00855803|pain|pain
1480256|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
1480257|NCT00855777|third molar extraction|third molar extraction
1480258|NCT00855777|etoricoxib|etoricoxib
1480259|NCT00855777|ibuprofen|ibuprofen
1480260|NCT00855777|analgesic efficacy|analgesic efficacy
1480261|NCT00855777|pain|pain
1480262|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
1480263|NCT00855725|Epilepsy|epilepsy
1480264|NCT00855725|Depression|depression
1480265|NCT00855725|Neurology|neurology
1480266|NCT00855725|fMRI|fmri
1480267|NCT00855725|Healthy Controls|healthy controls
1480268|NCT00855712|Heart Failure|heart failure
1480269|NCT00855712|Transplant|transplant
1480270|NCT00855712|Warm Perfusion|warm perfusion
1480271|NCT00855712|Organ Care|organ care
1480272|NCT00855712|Resting Mode|resting mode
1480273|NCT00855699|Alcohol detoxification|alcohol detoxification
1480274|NCT00855686|Memantine|memantine
1480275|NCT00855686|Cognition|cognition
1480276|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
1480277|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
1480278|NCT00855673|Claudication|claudication
1480279|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
1480280|NCT00855673|Intermittent Compression|intermittent compression
1480281|NCT00855673|Mechanical Compression|mechanical compression
1480282|NCT00855673|Flowmedic|flowmedic
1480283|NCT00855660|Bone Metabolism|bone metabolism
1480284|NCT00855634|Pancreatic cancer|pancreatic cancer
1480285|NCT00855634|metastasis|metastasis
1480286|NCT00855634|venous infiltration|venous infiltration
1480287|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
1480288|NCT00855621|deep brain stimulation|deep brain stimulation
1480289|NCT00855621|subthalamic nucleus|subthalamic nucleus
1480290|NCT00855608|choroidal neovascularization|choroidal neovascularization
1480291|NCT00855608|diabetic retinopathy|diabetic retinopathy
1480292|NCT00855608|uveitis|uveitis
1480293|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
1480294|NCT00855595|Rosacea|rosacea
1480295|NCT00855582|Erectile Dysfunction|erectile dysfunction
1480296|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1480297|NCT00855569|allografting|allografting
1480298|NCT00855530|Depression|depression
1480299|NCT00855504|preeclampsia|preeclampsia
1480300|NCT00855504|periodontitis|periodontitis
1480301|NCT00855504|cytokines|cytokines
1480302|NCT00855491|PCO|pco
1480303|NCT00855491|POCO|poco
1480304|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1480305|NCT00855465|PH|ph
1480306|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
1480307|NCT00855465|sGC|sgc
1480308|NCT00855452|GVL|gvl
1480309|NCT00855452|rIL-2(LAK)|ril-2(lak)
1480310|NCT00855452|GVHD|gvhd
1480311|NCT00855452|MST|mst
1480312|NCT00855452|alloCT|alloct
1480313|NCT00855452|alloBMT|allobmt
1480314|NCT00855439|Diabetes|diabetes
1480315|NCT00855439|Neuropathy|neuropathy
1480316|NCT00855439|Glucose|glucose
1480317|NCT00855439|Control|control
1480318|NCT00855439|Peripheral|peripheral
1480319|NCT00855439|Autonomic|autonomic
1480320|NCT00855413|Acute HIV|acute hiv
1480321|NCT00855413|HIV|hiv
1480322|NCT00855413|Treatment Naive|treatment naive
1480323|NCT00855413|Acute Infections|acute infections
1480324|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1480325|NCT00855400|Bone marrow|bone marrow
1480326|NCT00855400|Stem cells|stem cells
1480327|NCT00855400|Autologous|autologous
1480328|NCT00855400|Safety|safety
1480329|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
1480330|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
1480331|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
1480332|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
1480333|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
1480334|NCT00855361|Endoscopy|endoscopy
1480335|NCT00855361|Pediatrics|pediatrics
1480336|NCT00855361|GERD|gerd
1480337|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
1480338|NCT00855361|AcipHex|aciphex
1480339|NCT00855348|colorectal cancer|colorectal cancer
1480340|NCT00855348|early detection|early detection
1480341|NCT00855348|methylation, biomarker|methylation, biomarker
1480342|NCT00855335|HIV-1|hiv-1
1480343|NCT00855335|HIV|hiv
1480344|NCT00855335|Pregnancy|pregnancy
1480345|NCT00855335|Postpartum|postpartum
1480346|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
1480347|NCT00855335|PREZISTA|prezista
1480348|NCT00855335|INTELENCE|intelence
1480349|NCT00855335|NORVIR|norvir
1480350|NCT00855335|TMC114|tmc114
1480351|NCT00855335|TMC125|tmc125
1480352|NCT00855335|darunavir|darunavir
1480353|NCT00855335|ritonavir|ritonavir
1480354|NCT00855335|etravirine|etravirine
1480355|NCT00855335|rilpivirine|rilpivirine
1480356|NCT00855335|TMC278|tmc278
1480357|NCT00855335|Cobicistat|cobicistat
1480358|NCT00855335|treatment experienced|treatment experienced
1480359|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
1480360|NCT00855322|Exercise|exercise
1480361|NCT00855322|Biological Therapy|biological therapy
1480362|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1480363|NCT00855309|renal toxicity|renal toxicity
1480364|NCT00855309|infection|infection
1480365|NCT00855309|neutropenia|neutropenia
1480366|NCT00855270|PTSD|ptsd
1480367|NCT00855257|Acid nicotinique|acid nicotinique
1480368|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
1480369|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
1480370|NCT00855244|Bone marrow transplantation|bone marrow transplantation
1480371|NCT00855231|Acute coronary syndrome|acute coronary syndrome
1480372|NCT00855231|Coronary artery disease|coronary artery disease
1480373|NCT00855231|cardiac imaging|cardiac imaging
1480374|NCT00855231|computed tomography|computed tomography
1480375|NCT00855218|Sorafenib|sorafenib
1480376|NCT00855218|TACE|tace
1480377|NCT00855218|DC bead|dc bead
1480378|NCT00855218|Combination|combination
1480379|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
1480380|NCT00855192|anxiety|anxiety
1480381|NCT00855192|depression|depression
1480382|NCT00855192|pregnancy|pregnancy
1480383|NCT00855192|antenatal|antenatal
1480384|NCT00855192|prenatal|prenatal
1480385|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
1480386|NCT00855192|interpersonal therapy|interpersonal therapy
1480387|NCT00855192|support groups|support groups
1480388|NCT00855166|Dapagliflozin|dapagliflozin
1480389|NCT00855166|Metformin|metformin
1480390|NCT00855166|Type 2 diabetes|type 2 diabetes
1480391|NCT00855166|body weight|body weight
1480392|NCT00855153|PTSD|ptsd
1480393|NCT00855153|burns|burns
1480394|NCT00855153|virtual reality exposure|virtual reality exposure
1480395|NCT00855153|D-Cycloserine|d-cycloserine
1480396|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
1480398|NCT00855140|Primary insomnia|primary insomnia
1480399|NCT00855140|Insomnia disorder|insomnia disorder
1480400|NCT00855140|Acupuncture|acupuncture
1480401|NCT00855127|Biological Markers|biological markers
1480402|NCT00855127|Renal Replacement Therapy|renal replacement therapy
1480403|NCT00855127|Mortality|mortality
1480404|NCT00855114|stage II breast cancer|stage ii breast cancer
1480405|NCT00855114|stage III breast cancer|stage iii breast cancer
1480406|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
1480407|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
1480408|NCT00855088|HIV seronegativity|hiv seronegativity
1480409|NCT00855075|Sedation|sedation
1480410|NCT00855075|Analgesia|analgesia
1480411|NCT00855075|Mechanical ventilation|mechanical ventilation
1480412|NCT00855075|Cerebral State Monitor|cerebral state monitor
1480413|NCT00855075|Cerebral State Index|cerebral state index
1480414|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1480415|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
1480416|NCT00855062|HIV dementia|hiv dementia
1480417|NCT00855062|Uganda|uganda
1480418|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
1480419|NCT00855062|Treatment Naive|treatment naive
1480420|NCT00855049|Pharmacokinetics|pharmacokinetics
1480421|NCT00855049|Acetaminophen|acetaminophen
1480422|NCT00855049|Intranasal|intranasal
1480423|NCT00855049|Absorption|absorption
1480424|NCT00855036|blunt renal injury|blunt renal injury
1480425|NCT00855036|kidney laceration|kidney laceration
1480426|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
1480427|NCT00855023|Knee Joint|knee joint
1480428|NCT00855010|Pioglitazone|pioglitazone
1480429|NCT00855010|prediabetes|prediabetes
1480430|NCT00855010|diabetes|diabetes
1480431|NCT00855010|obesity|obesity
1480432|NCT00855010|Pancreatic fat|pancreatic fat
1480433|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
1480434|NCT00854984|Depression|depression
1480435|NCT00854984|diabetes|diabetes
1480436|NCT00854984|Coronary heart disease|coronary heart disease
1480437|NCT00854984|CBT|cbt
1480438|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
1480439|NCT00854971|NKCell|nkcell
1480440|NCT00854971|FOLFOX-4|folfox-4
1480441|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
1480442|NCT00854958|Oral|oral
1480443|NCT00854958|Allergy|allergy
1480444|NCT00854958|Syndrome|syndrome
1480445|NCT00854958|Food|food
1480446|NCT00854958|Pollen|pollen
1480447|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
1480448|NCT00854945|Refractory Cytopenia|refractory cytopenia
1480449|NCT00854945|Refractory Anemia|refractory anemia
1480450|NCT00854945|Dysplasia|dysplasia
1480451|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
1480452|NCT00854932|procalcitonin|procalcitonin
1480453|NCT00854932|sepsis|sepsis
1480454|NCT00854932|newborn|newborn
1480455|NCT00854932|intervention study|intervention study
1480456|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
1480457|NCT00854919|augmentation treatment|augmentation treatment
1480458|NCT00854919|SSRI-refractory|ssri-refractory
1480459|NCT00854906|dry eye|dry eye
1480460|NCT00854906|keratometer|keratometer
1480461|NCT00854906|fluorescein|fluorescein
1480462|NCT00854893|stroke|stroke
1480463|NCT00854893|aphasia|aphasia
1480464|NCT00854893|aging|aging
1480465|NCT00854893|language learning|language learning
1480466|NCT00854880|Erosive Gastritis|erosive gastritis
1480467|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
1480468|NCT00854867|STNM|stnm
1480469|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
1480470|NCT00854867|DepoCyte|depocyte
1480471|NCT00854867|WBRT|wbrt
1480472|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
1480473|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
1480474|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
1480475|NCT00854854|NKCell|nkcell
1480476|NCT00854854|FOLFOX-4|folfox-4
1480477|NCT00854854|gastric cancer|gastric cancer
1480478|NCT00854841|CML|cml
1480479|NCT00854841|suboptimal response|suboptimal response
1480480|NCT00854841|dasatinib|dasatinib
1480481|NCT00854841|imatinib|imatinib
1480482|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
1480483|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
1480484|NCT00854815|Perforated appendicitis|perforated appendicitis
1480485|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
1480486|NCT00854815|children|children
1480487|NCT00854815|irrigation|irrigation
1480488|NCT00854802|Hepatitis|hepatitis
1480489|NCT00854802|Hepatitis C|hepatitis c
1480490|NCT00854789|Breast cancer|breast cancer
1480491|NCT00854776|aspirin|aspirin
1480492|NCT00854776|clopidogrel|clopidogrel
1480493|NCT00854776|proton pump inhibitor|proton pump inhibitor
1480494|NCT00854776|peptic ulcer|peptic ulcer
1480495|NCT00854776|ulcer complications|ulcer complications
1480496|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
1480592|NCT00854334|Appetite|appetite
1480593|NCT00854334|NEAT|neat
1480497|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
1480498|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
1480499|NCT00854737|bipolar disorder|bipolar disorder
1480500|NCT00854737|bipolar depression|bipolar depression
1480501|NCT00854737|bipolar mania|bipolar mania
1480502|NCT00854737|manic depression|manic depression
1480503|NCT00854737|depression|depression
1480504|NCT00854737|mania|mania
1480505|NCT00854737|hypomania|hypomania
1480506|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
1480507|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
1480508|NCT00854698|exercise training|exercise training
1480509|NCT00854672|Sarcoidosis|sarcoidosis
1480510|NCT00854672|muscle strength|muscle strength
1480511|NCT00854672|exercise intolerance|exercise intolerance
1480512|NCT00854672|QOL|qol
1480513|NCT00854646|ON 01910.Na|on 01910.na
1480514|NCT00854646|refractory|refractory
1480515|NCT00854646|leukemia|leukemia
1480516|NCT00854646|myelodysplastic|myelodysplastic
1480517|NCT00854646|cell cycle|cell cycle
1480518|NCT00854633|Pre-term infants|pre-term infants
1480519|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
1480520|NCT00854594|Diabetes|diabetes
1480521|NCT00854594|Telemedicine|telemedicine
1480522|NCT00854594|Shared Medical Appointments|shared medical appointments
1480523|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1480524|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1480525|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1480526|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1480527|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1480528|NCT00854581|HTLV-1 infection|htlv-1 infection
1480529|NCT00854568|B-cell lymphoma|b-cell lymphoma
1480530|NCT00854568|CHOP|chop
1480531|NCT00854568|CEOP|ceop
1480532|NCT00854568|Cardiotoxicity|cardiotoxicity
1480533|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
1480534|NCT00854555|locomotor activity|locomotor activity
1480535|NCT00854555|walking function|walking function
1480536|NCT00854555|gait|gait
1480537|NCT00854542|Telepsychiatry|telepsychiatry
1480538|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
1480539|NCT00854542|Chinese Americans|chinese americans
1480540|NCT00854542|Depression|depression
1480541|NCT00854529|bevacizumab|bevacizumab
1480542|NCT00854529|subconjunctival injection|subconjunctival injection
1480543|NCT00854529|trabeculectomy|trabeculectomy
1480544|NCT00854529|bleb|bleb
1480545|NCT00854529|mitomycin c|mitomycin c
1480546|NCT00854516|compression therapy|compression therapy
1480548|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
1480549|NCT00854477|capecitabine|capecitabine
1480550|NCT00854477|Post whipples|post whipples
1480551|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
1480552|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1480553|NCT00854477|pharmacokinetic|pharmacokinetic
1480554|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
1480555|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
1480556|NCT00854464|Cigarette Metabolites|cigarette metabolites
1480557|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
1480558|NCT00854464|DNA Repair Enzymes|dna repair enzymes
1480559|NCT00854464|Inflammatory Factors|inflammatory factors
1480560|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
1480561|NCT00854451|Helicobacter pylori|helicobacter pylori
1480562|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
1480563|NCT00854451|intragastric pH|intragastric ph
1480564|NCT00854451|dual therapy|dual therapy
1480565|NCT00854451|antibiotic resistance|antibiotic resistance
1480566|NCT00854438|anticholinergic drugs|anticholinergic drugs
1480567|NCT00854438|adverse events|adverse events
1480568|NCT00854438|elderly|elderly
1480569|NCT00854438|clinical pharmacist|clinical pharmacist
1480570|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
1480571|NCT00854412|Obesity|obesity
1480572|NCT00854412|Weight loss|weight loss
1480573|NCT00854412|Very low-calorie diet|very low-calorie diet
1480574|NCT00854412|Mannose-binding lectin|mannose-binding lectin
1480575|NCT00854412|Insulin resistance|insulin resistance
1480576|NCT00854386|fluid management|fluid management
1480577|NCT00854386|VATS|vats
1480578|NCT00854386|ALI|ali
1480579|NCT00854386|ARDS|ards
1480580|NCT00854373|Infertility|infertility
1480581|NCT00854373|Pregnancy|pregnancy
1480582|NCT00854373|in vitro fertilization|in vitro fertilization
1480583|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1480584|NCT00854360|Hayfever|hayfever
1480585|NCT00854347|hyperglycemia|hyperglycemia
1480586|NCT00854347|diabetes|diabetes
1480587|NCT00854347|intensive care|intensive care
1480588|NCT00854347|prevalence|prevalence
1480589|NCT00854334|Sleep|sleep
1480590|NCT00854334|Overweight|overweight
1480591|NCT00854334|Physical activity|physical activity
1480594|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
1480595|NCT00854321|rituximab|rituximab
1480596|NCT00854321|therapy|therapy
1480597|NCT00854308|Tarceva|tarceva
1480598|NCT00854308|Lung Cancer|lung cancer
1480599|NCT00854308|NSCLC|nsclc
1480600|NCT00854295|arthritis|arthritis
1480601|NCT00854295|osteoarthritis|osteoarthritis
1480602|NCT00854295|degenerative knee disease|degenerative knee disease
1480603|NCT00854295|avascular necrosis|avascular necrosis
1480604|NCT00854295|total knee replacement|total knee replacement
1480605|NCT00854295|TKA|tka
1480606|NCT00854256|glaucoma|glaucoma
1480607|NCT00854230|HIV|hiv
1480608|NCT00854230|alcohol|alcohol
1480609|NCT00854230|naltrexone|naltrexone
1480610|NCT00854230|Treatment Experienced|treatment experienced
1480611|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
1480612|NCT00854204|Innovation-C101|innovation-c101
1480613|NCT00854204|Innovation|innovation
1480614|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
1480615|NCT00854204|controlled-release coformulations|controlled-release coformulations
1480616|NCT00854204|immediate-release coformulation|immediate-release coformulation
1480617|NCT00854204|Pharmacokinetics|pharmacokinetics
1480618|NCT00854191|mechanical simulator|mechanical simulator
1480619|NCT00854191|ERCP|ercp
1480620|NCT00854191|training|training
1480621|NCT00854178|isoflurane|isoflurane
1480622|NCT00854178|propofol|propofol
1480623|NCT00854178|genotoxicity|genotoxicity
1480624|NCT00854178|gene expression|gene expression
1480625|NCT00854178|cytokines|cytokines
1480626|NCT00854178|apoptosis|apoptosis
1480627|NCT00854165|lung transplantation|lung transplantation
1480628|NCT00854165|respiratory failure|respiratory failure
1480629|NCT00854165|ECMO|ecmo
1480630|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
1480631|NCT00854152|NHL|nhl
1480632|NCT00854152|Tumors|tumors
1480633|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
1480634|NCT00854139|Multiple myeloma|multiple myeloma
1480635|NCT00854139|Renal failure|renal failure
1480636|NCT00854139|Kidney transplant|kidney transplant
1480637|NCT00854126|NHL|nhl
1480638|NCT00854126|Solid Tumors|solid tumors
1480639|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
1480640|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
1480641|NCT00854100|Adjunctive|adjunctive
1480642|NCT00854100|Depression|depression
1480643|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1480644|NCT00854087|Hepatitis C Virus|hepatitis c virus
1480645|NCT00854087|HCV|hcv
1480646|NCT00854087|Herbal treatment|herbal treatment
1480647|NCT00854087|Herbs|herbs
1480648|NCT00854087|San Diego|san diego
1480649|NCT00854087|Non responder|non responder
1480650|NCT00854087|Relapser|relapser
1480651|NCT00854087|Treatment failure|treatment failure
1480652|NCT00854087|Antifibrotic|antifibrotic
1480653|NCT00854087|Anti-fibrotic|anti-fibrotic
1480654|NCT00854087|Fibrosis|fibrosis
1480655|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
1480656|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
1480657|NCT00854087|Intolerance to Interferon|intolerance to interferon
1480658|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
1480659|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
1480660|NCT00854074|Neuromodulation|neuromodulation
1480661|NCT00854074|Neurostimulation|neurostimulation
1480662|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
1480663|NCT00854048|Pediatric|pediatric
1480664|NCT00854048|Oxygen Saturation|oxygen saturation
1480665|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
1480666|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
1480667|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
1480668|NCT00854009|Healthy Subjects|healthy subjects
1480669|NCT00853983|Healthy Volunteers|healthy volunteers
1480670|NCT00853983|ADME|adme
1480671|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
1480672|NCT00853957|Hypertension|hypertension
1480673|NCT00853957|African Americans|african americans
1480674|NCT00853957|Aliskiren|aliskiren
1480675|NCT00853957|Amlodipine|amlodipine
1480676|NCT00853957|Systolic blood pressure|systolic blood pressure
1480677|NCT00853957|Diastolic blood pressure|diastolic blood pressure
1480678|NCT00853957|Stage II|stage ii
1480679|NCT00853957|Combination|combination
1480680|NCT00853944|islet transplantation|islet transplantation
1480681|NCT00853944|type 1 diabetes|type 1 diabetes
1480682|NCT00853944|incretin|incretin
1480683|NCT00853931|KRAS wild type|kras wild type
1480684|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
1480685|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
1480686|NCT00853918|Physician survey|physician survey
1480687|NCT00853918|Mail survey|mail survey
1480688|NCT00853918|Response rate|response rate
1480689|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
1480690|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
1480691|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
1480692|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
1480693|NCT00853905|neovascular glaucoma|neovascular glaucoma
1480694|NCT00853905|traumatic glaucoma|traumatic glaucoma
1480695|NCT00853892|Healthy Subjects|healthy subjects
1480696|NCT00853892|Bioequivalence|bioequivalence
1480697|NCT00853866|stroke|stroke
1480698|NCT00853866|reboxetine|reboxetine
1480699|NCT00853866|noradrenaline|noradrenaline
1480700|NCT00853866|motor cortex|motor cortex
1480701|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
1480702|NCT00853866|motor function|motor function
1480703|NCT00853866|rehabilitation|rehabilitation
1480704|NCT00853866|Jebsen Taylor test|jebsen taylor test
1480705|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
1480706|NCT00853853|Hemorrhoids|hemorrhoids
1480831|NCT00853463|Venous thromboembolism|venous thromboembolism
1480707|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
1480708|NCT00853827|CAD|cad
1480709|NCT00853827|coronary artery disease|coronary artery disease
1480710|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
1480711|NCT00853827|coronary angiography|coronary angiography
1480712|NCT00853827|IVUS|ivus
1480713|NCT00853827|intravascular ultrasound|intravascular ultrasound
1480714|NCT00853827|plasma renin activity|plasma renin activity
1480715|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
1480716|NCT00853827|direct renin inhibitors|direct renin inhibitors
1480717|NCT00853827|coronary atheroma|coronary atheroma
1480718|NCT00853814|adolescence|adolescence
1480719|NCT00853814|obesity|obesity
1480720|NCT00853814|physical activity|physical activity
1480721|NCT00853814|built environment|built environment
1480722|NCT00853814|neighborhood environment|neighborhood environment
1480723|NCT00853814|children|children
1480724|NCT00853814|youth|youth
1480725|NCT00853814|increasing physical activity|increasing physical activity
1480726|NCT00853814|changing dietary intake|changing dietary intake
1480727|NCT00853814|reducing zBMI|reducing zbmi
1480728|NCT00853801|Pre-Diabetes|pre-diabetes
1480729|NCT00853801|Metabolic Syndrome|metabolic syndrome
1480730|NCT00853801|Type 2 Diabetes|type 2 diabetes
1480731|NCT00853801|Diabetes Prevention|diabetes prevention
1480732|NCT00853801|Lifestyle Modification|lifestyle modification
1480733|NCT00853801|Diet Therapy|diet therapy
1480734|NCT00853801|Provider Education|provider education
1480735|NCT00853788|systemic sclerosis|systemic sclerosis
1480736|NCT00853788|biomarkers|biomarkers
1480737|NCT00853788|microarray|microarray
1480738|NCT00853775|heart disease|heart disease
1480739|NCT00853775|cardiovascular disease|cardiovascular disease
1480740|NCT00853775|lipoproteins|lipoproteins
1480741|NCT00853775|lipoprotein(a)|lipoprotein(a)
1480742|NCT00853775|Lp(a)|lp(a)
1480743|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
1480744|NCT00853775|apo(a)|apo(a)
1480745|NCT00853775|fats|fats
1480746|NCT00853775|proteins|proteins
1480747|NCT00853775|metabolism|metabolism
1480748|NCT00853749|Immune response|immune response
1480749|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1480750|NCT00853749|polysaccharide|polysaccharide
1480751|NCT00853736|Healthy Subjects|healthy subjects
1480752|NCT00853736|Bioequivalence|bioequivalence
1480753|NCT00853723|osteoporosis|osteoporosis
1480754|NCT00853723|post-menopausal|post-menopausal
1480755|NCT00853723|bone anabolic agents|bone anabolic agents
1480756|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
1480757|NCT00853710|Prostate Cancer|prostate cancer
1480758|NCT00853710|Cancer|cancer
1480759|NCT00853710|Assay|assay
1480760|NCT00853697|Prostate|prostate
1480761|NCT00853697|DUTASTERIDE|dutasteride
1480762|NCT00853697|TESTOSTERONE|testosterone
1480763|NCT00853697|09-008|09-008
1480764|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
1480765|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
1480766|NCT00853684|Oxaliplatin|oxaliplatin
1480767|NCT00853684|Capecitabine|capecitabine
1480768|NCT00853684|Endostar|endostar
1480769|NCT00853684|efficacy|efficacy
1480770|NCT00853671|Coronary Artery Disease|coronary artery disease
1480771|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
1480772|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
1480773|NCT00853658|Chronic Heart Failure|chronic heart failure
1480774|NCT00853658|Cardiovascular death|cardiovascular death
1480775|NCT00853658|CHF hospitalization|chf hospitalization
1480776|NCT00853658|morbi-mortality trial|morbi-mortality trial
1480777|NCT00853658|outcome study|outcome study
1480778|NCT00853658|endpoint driven|endpoint driven
1480779|NCT00853658|plasma renin activity|plasma renin activity
1480780|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
1480781|NCT00853658|direct renin inhibitors|direct renin inhibitors
1480783|NCT00853658|KCCQ|kccq
1480784|NCT00853658|eGFR|egfr
1480785|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
1480786|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
1480787|NCT00853632|Mitral valve|mitral valve
1480788|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
1480789|NCT00853632|PERIMOUNT|perimount
1480790|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
1480791|NCT00853632|mitral valve replacement|mitral valve replacement
1480792|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
1480793|NCT00853632|Heart valve disease|heart valve disease
1480794|NCT00853619|clinical decision support|clinical decision support
1480795|NCT00853619|knowledge management|knowledge management
1480796|NCT00853619|knowledge representation|knowledge representation
1480797|NCT00853619|clinical guidelines|clinical guidelines
1480798|NCT00853619|coronary artery disease|coronary artery disease
1480799|NCT00853619|myocardial ischemia|myocardial ischemia
1480800|NCT00853619|diabetes mellitus|diabetes mellitus
1480801|NCT00853619|hypertension|hypertension
1480802|NCT00853606|ED|ed
1480803|NCT00853606|Erectile Dysfunction|erectile dysfunction
1480804|NCT00853606|Dysfunction|dysfunction
1480805|NCT00853606|Erectile|erectile
1480806|NCT00853593|heart failure|heart failure
1480807|NCT00853593|cardiac pacing|cardiac pacing
1480808|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
1480809|NCT00853593|left ventricular lead|left ventricular lead
1480810|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
1480811|NCT00853567|Uterine Fibroids|uterine fibroids
1480812|NCT00853554|Healthy Subjects|healthy subjects
1480813|NCT00853554|Bioequivalence|bioequivalence
1480814|NCT00853541|renal impairment|renal impairment
1480815|NCT00853541|heart failure|heart failure
1480816|NCT00853541|hyperphosphatemia|hyperphosphatemia
1480817|NCT00853541|coronary artery calcification|coronary artery calcification
1480818|NCT00853528|spinal cord metastases|spinal cord metastases
1480819|NCT00853502|anorexia nervosa|anorexia nervosa
1480820|NCT00853502|testosterone|testosterone
1480821|NCT00853502|disordered eating|disordered eating
1480822|NCT00853502|hypogonadism|hypogonadism
1480823|NCT00853502|bone|bone
1480824|NCT00853489|Open tibia fractures|open tibia fractures
1480825|NCT00853489|rhBMP-2|rhbmp-2
1480826|NCT00853489|critical size defects|critical size defects
1480827|NCT00853489|bone grafting|bone grafting
1480828|NCT00853463|Pulmonary Embolism|pulmonary embolism
1480829|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
1480830|NCT00853463|Prophylaxis|prophylaxis
1480832|NCT00853463|Prevention|prevention
1480833|NCT00853463|Medical patients|medical patients
1480834|NCT00853450|Antiplatelet|antiplatelet
1480835|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
1480836|NCT00853424|diabetic retinopathy|diabetic retinopathy
1480837|NCT00853424|diabetic macular edema|diabetic macular edema
1480838|NCT00853424|type 1 diabetes|type 1 diabetes
1480839|NCT00853424|intensive medical therapy|intensive medical therapy
1480840|NCT00853424|islet cell transplantation|islet cell transplantation
1480841|NCT00853424|visual acuity|visual acuity
1480842|NCT00853424|diabetic eye disease|diabetic eye disease
1480843|NCT00853411|Moderate to severe asthma|moderate to severe asthma
1480844|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
1480845|NCT00853385|oral DMARD|oral dmard
1480846|NCT00853385|JAK inhibitor|jak inhibitor
1480847|NCT00853385|clinical trial|clinical trial
1480848|NCT00853346|Depression|depression
1480849|NCT00853346|Parkinson's Disease|parkinson's disease
1480850|NCT00853346|Major Depression|major depression
1480851|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
1480852|NCT00853333|Pain|pain
1480853|NCT00853333|Propofol|propofol
1480854|NCT00853333|Dexmedetomidine|dexmedetomidine
1480855|NCT00853333|Midazolam|midazolam
1480856|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
1480857|NCT00853320|Healthy Subjects|healthy subjects
1480858|NCT00853320|Bioequivalence|bioequivalence
1480859|NCT00853307|Drug therapy|drug therapy
1480860|NCT00853294|Healthy Subjects|healthy subjects
1480861|NCT00853294|Bioequivalence|bioequivalence
1480862|NCT00853281|Forest malaria prevention|forest malaria prevention
1480863|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
1480864|NCT00853281|Cluster randomized trial|cluster randomized trial
1480865|NCT00853281|Central Vietnam|central vietnam
1480866|NCT00853268|Healthy Subjects|healthy subjects
1480867|NCT00853268|Bioequivalence|bioequivalence
1480868|NCT00853255|Bird Flu|bird flu
1480869|NCT00853242|Chronic Kidney Disease|chronic kidney disease
1480870|NCT00853242|Phosphate Binder|phosphate binder
1480871|NCT00853242|Phosphate|phosphate
1480872|NCT00853242|Hyperphosphatemia|hyperphosphatemia
1480873|NCT00853229|vulvodynia|vulvodynia
1480874|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
1480875|NCT00853229|chronic vulvar pain|chronic vulvar pain
1480876|NCT00853229|generalized vulvodynia|generalized vulvodynia
1480877|NCT00853229|localized vulvodynia|localized vulvodynia
1480976|NCT00852826|morbidity|morbidity
1480878|NCT00853216|Healthy Subjects|healthy subjects
1480879|NCT00853216|Bioequivalence|bioequivalence
1480880|NCT00853203|Colorectal Cancer|colorectal cancer
1480881|NCT00853203|Rectal Cancer|rectal cancer
1480882|NCT00853203|Psychosocial|psychosocial
1481167|NCT00852163|leukemia|leukemia
1480883|NCT00853203|Expressive Disclosure|expressive disclosure
1480884|NCT00853203|Questionnaires|questionnaires
1480885|NCT00853203|Quality of life|quality of life
1480886|NCT00853203|QOL|qol
1480887|NCT00853203|Electronically Activated Recorder|electronically activated recorder
1480888|NCT00853203|EAR|ear
1480889|NCT00853190|Healthy Subjects|healthy subjects
1480890|NCT00853177|Oocyte retrieval|oocyte retrieval
1480891|NCT00853177|pain|pain
1480892|NCT00853177|surgery|surgery
1480893|NCT00853177|anaesthesiology|anaesthesiology
1480894|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
1480895|NCT00853164|prostate cancer|prostate cancer
1480896|NCT00853164|aerobic exercise|aerobic exercise
1480897|NCT00853164|resistance training|resistance training
1480898|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
1480899|NCT00853138|chronic pain|chronic pain
1480900|NCT00853138|randomized controlled trial|randomized controlled trial
1480901|NCT00853138|pediatrics|pediatrics
1480902|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1480903|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
1480904|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
1480905|NCT00853099|Ulcerative Colitis|ulcerative colitis
1480906|NCT00853073|failing blebs|failing blebs
1480907|NCT00853073|failing express shunt|failing express shunt
1480908|NCT00853073|avastin|avastin
1480909|NCT00853073|bevacizumab|bevacizumab
1480910|NCT00853073|glaucoma|glaucoma
1480911|NCT00853073|prior trabeculectomy|prior trabeculectomy
1480912|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
1480913|NCT00853073|subsequent filtration failure|subsequent filtration failure
1480914|NCT00853060|energy expenditure|energy expenditure
1480915|NCT00853060|mechanical ventilation|mechanical ventilation
1480916|NCT00853060|weaning|weaning
1480917|NCT00853060|pressure support ventilation|pressure support ventilation
1480918|NCT00853060|T-tube|t-tube
1480919|NCT00853034|gastrointestinal effects|gastrointestinal effects
1480920|NCT00853034|prebiotic|prebiotic
1480921|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1480922|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
1480923|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
1480924|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1480925|NCT00853008|High-Risk (HR)|high-risk (hr)
1480926|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
1480927|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
1480928|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
1480929|NCT00852995|VLU|vlu
1480930|NCT00852995|VSU|vsu
1480931|NCT00852995|Leg Ulcer|leg ulcer
1480932|NCT00852995|Leg Wound|leg wound
1480933|NCT00852982|Exercise|exercise
1480934|NCT00852982|Risk factors|risk factors
1480935|NCT00852982|Primary health care|primary health care
1480936|NCT00852969|Chronic Kidney Disease|chronic kidney disease
1480937|NCT00852969|Niacin|niacin
1480938|NCT00852969|HDL|hdl
1480939|NCT00852969|Endothelial Function|endothelial function
1480940|NCT00852956|Betahistine|betahistine
1480941|NCT00852956|Olanzapine|olanzapine
1480942|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
1480943|NCT00852943|Mast Cells|mast cells
1480944|NCT00852943|Piebaldism|piebaldism
1480945|NCT00852943|Anaphylaxis|anaphylaxis
1480946|NCT00852943|Allergy|allergy
1480947|NCT00852943|Genetics|genetics
1480948|NCT00852930|lymphedema|lymphedema
1480949|NCT00852930|quality of life|quality of life
1480950|NCT00852930|breast cancer|breast cancer
1480951|NCT00852930|symptoms|symptoms
1480952|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
1480953|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
1480954|NCT00852904|Childhood Growth and Development|childhood growth and development
1480955|NCT00852904|Genetics|genetics
1480956|NCT00852904|Children|children
1480957|NCT00852904|Environment|environment
1480958|NCT00852904|Longitudinal Study|longitudinal study
1480959|NCT00852904|National Children's Study|national children's study
1480960|NCT00852891|weaning|weaning
1480961|NCT00852891|echocardiogram|echocardiogram
1480962|NCT00852891|diastolic dysfunction|diastolic dysfunction
1480963|NCT00852891|Mechanical ventilation|mechanical ventilation
1480964|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
1480965|NCT00852878|Biofeedback|biofeedback
1480966|NCT00852878|Heart Rate Variability|heart rate variability
1480967|NCT00852865|Inflammation|inflammation
1480968|NCT00852865|Pain|pain
1480969|NCT00852852|ESRA-C 2|esra-c 2
1480970|NCT00852852|computerized assessment|computerized assessment
1480971|NCT00852839|Dry mouth|dry mouth
1480972|NCT00852839|Sjogren's syndrome|sjogren's syndrome
1480973|NCT00852839|Xerostomia|xerostomia
1480974|NCT00852826|axillary seroma|axillary seroma
1480975|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
1480977|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
1480978|NCT00852826|Lymphadenectomy|lymphadenectomy
1480979|NCT00852813|tolerance|tolerance
1480980|NCT00852813|prebiotic|prebiotic
1481266|NCT00851695|COPD|copd
1480981|NCT00852813|gastrointestinal effects|gastrointestinal effects
1480982|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
1480983|NCT00852800|albumin|albumin
1480984|NCT00852800|renal impairment|renal impairment
1480985|NCT00852800|mortality|mortality
1480986|NCT00852787|Digoxin like substances|digoxin like substances
1480987|NCT00852787|digibind|digibind
1480988|NCT00852787|digoxin immune fab|digoxin immune fab
1480989|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
1480990|NCT00852787|marinobufagenin|marinobufagenin
1480991|NCT00852761|Psoriasis|psoriasis
1480992|NCT00852748|headache|headache
1480993|NCT00852735|Cardiovascular diseases|cardiovascular diseases
1480994|NCT00852735|Rapeseed oil|rapeseed oil
1480995|NCT00852735|Micronutriments|micronutriments
1480996|NCT00852735|HDL cholesterol|hdl cholesterol
1480997|NCT00852735|Oxidative stress|oxidative stress
1480998|NCT00852735|Tocopherols|tocopherols
1480999|NCT00852735|Sterols|sterols
1481000|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
1481001|NCT00852722|Multiple sclerosis|multiple sclerosis
1481002|NCT00852722|Diet|diet
1481003|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
1481004|NCT00852709|Treatment-related AML|treatment-related aml
1481005|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
1481006|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
1481007|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
1481008|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
1481009|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
1481010|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
1481011|NCT00852696|Overactive Bladder|overactive bladder
1481012|NCT00852696|Incontinence|incontinence
1481013|NCT00852696|Solifenacin|solifenacin
1481015|NCT00852696|Postoperative|postoperative
1481016|NCT00852657|Rotator cuff tear|rotator cuff tear
1481017|NCT00852657|surgical repair|surgical repair
1481018|NCT00852657|Physiotherapy|physiotherapy
1481019|NCT00852657|Treatment benefit|treatment benefit
1481020|NCT00852657|Surgery|surgery
1481021|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1481022|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1481023|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
1481024|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
1481025|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
1481026|NCT00852618|Treatment Naive|treatment naive
1481027|NCT00852618|Viral Load|viral load
1481028|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
1481029|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
1481030|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
1481031|NCT00852579|Asthma|asthma
1481032|NCT00852579|Smoker|smoker
1481033|NCT00852579|Macrolide|macrolide
1481034|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
1481035|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1481036|NCT00852566|stem cell|stem cell
1481037|NCT00852566|Philadelphia chromosome|philadelphia chromosome
1481038|NCT00852566|dasatinib|dasatinib
1481039|NCT00852553|intestinal|intestinal
1481040|NCT00852553|smooth|smooth
1481041|NCT00852553|muscle|muscle
1481042|NCT00852553|GI|gi
1481043|NCT00852553|motility|motility
1481044|NCT00852540|impetigo|impetigo
1481045|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1481046|NCT00852540|linezolid|linezolid
1481047|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
1481048|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
1481049|NCT00852540|retapamulin|retapamulin
1481050|NCT00852527|Traumatic Brain Injury|traumatic brain injury
1481051|NCT00852527|Screening|screening
1481052|NCT00852527|Diagnosis|diagnosis
1481053|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
1481054|NCT00852514|Bioimpedance|bioimpedance
1481055|NCT00852514|ultrafiltration|ultrafiltration
1481056|NCT00852514|blood pressure|blood pressure
1481057|NCT00852514|pulse pressure|pulse pressure
1481058|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
1481059|NCT00852501|RTPCR|rtpcr
1481060|NCT00852501|Hormonal receptors|hormonal receptors
1481061|NCT00852475|MUFA|mufa
1481062|NCT00852475|PUFA|pufa
1481063|NCT00852475|MOVE! program|move! program
1481064|NCT00852462|SAMI|sami
1481065|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
1481066|NCT00852449|Intraoperative fluid|intraoperative fluid
1481067|NCT00852449|Monitoring|monitoring
1481068|NCT00852449|Oesophageal Doppler|oesophageal doppler
1481069|NCT00852449|Abdominal surgery|abdominal surgery
1481070|NCT00852449|major abdominal surgery|major abdominal surgery
1481071|NCT00852436|neuropathic pain|neuropathic pain
1481072|NCT00852436|orofacial pain|orofacial pain
1481073|NCT00852436|clinical trials|clinical trials
1481074|NCT00852436|pregabalin|pregabalin
1481075|NCT00852436|randomized controlled trial|randomized controlled trial
1481076|NCT00852423|Malaria in pregnancy|malaria in pregnancy
1481077|NCT00852423|Sub-saharan Africa|sub-saharan africa
1481078|NCT00852423|Treatment|treatment
1481079|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
1481080|NCT00852423|Efficacy|efficacy
1481081|NCT00852423|Safety|safety
1481082|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
1481083|NCT00852384|Anesthesia induction|anesthesia induction
1481084|NCT00852384|Obese patients|obese patients
1481085|NCT00852384|Noninvasive ventilation|noninvasive ventilation
1481086|NCT00852384|Alveolar recruitment|alveolar recruitment
1481087|NCT00852371|Malaria|malaria
1481088|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
1481089|NCT00852371|Efficacy|efficacy
1481090|NCT00852371|Safety|safety
1481091|NCT00852371|Tolerability|tolerability
1481092|NCT00852371|Schoolchildren|schoolchildren
1481093|NCT00852371|Uganda|uganda
1481094|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
1481095|NCT00852358|Hurler-Scheie|hurler-scheie
1481096|NCT00852358|Scheie|scheie
1481097|NCT00852358|laronidase|laronidase
1481098|NCT00852358|cognitive decline|cognitive decline
1481099|NCT00852358|central nervous system|central nervous system
1481100|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
1481101|NCT00852358|intrathecal|intrathecal
1481102|NCT00852358|LA Biomed|la biomed
1481103|NCT00852345|multibacillary leprosy|multibacillary leprosy
1481104|NCT00852345|leprosy|leprosy
1481105|NCT00852345|clofazamine|clofazamine
1481106|NCT00852332|male breast cancer|male breast cancer
1481107|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
1481108|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
1481109|NCT00852332|stage IV breast cancer|stage iv breast cancer
1481110|NCT00852332|recurrent breast cancer|recurrent breast cancer
1481111|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
1481112|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
1481113|NCT00852319|Interpregnancy Care|interpregnancy care
1481114|NCT00852319|Preconceptual Care|preconceptual care
1481115|NCT00852319|Premature Birth|premature birth
1481116|NCT00852319|Preterm Delivery|preterm delivery
1481117|NCT00852306|oocyte freezing|oocyte freezing
1481118|NCT00852306|vitrification|vitrification
1481119|NCT00852306|slow freeze|slow freeze
1481120|NCT00852306|fertility preservation|fertility preservation
1481121|NCT00852293|liver disease|liver disease
1481122|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
1481123|NCT00852280|scars|scars
1481124|NCT00852280|late effect of burn|late effect of burn
1481125|NCT00852280|burn|burn
1481126|NCT00852280|pulsed-dye laser|pulsed-dye laser
1481127|NCT00852267|cholesterol|cholesterol
1481128|NCT00852267|diet|diet
1481129|NCT00852267|protein|protein
1481130|NCT00852267|carbohydrate|carbohydrate
1481131|NCT00852267|saturated fat|saturated fat
1481132|NCT00852267|LDL subclass|ldl subclass
1481133|NCT00852267|healthy volunteers|healthy volunteers
1481134|NCT00852254|Cardiac Index|cardiac index
1481135|NCT00852254|Ultrasound Dilution|ultrasound dilution
1481136|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
1481137|NCT00852228|colorectal cancer|colorectal cancer
1481138|NCT00852228|unresectable metastases|unresectable metastases
1481139|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1481140|NCT00852228|liver metastases|liver metastases
1481141|NCT00852228|chronotherapy|chronotherapy
1481142|NCT00852228|cetuximab|cetuximab
1481143|NCT00852228|irinotecan|irinotecan
1481144|NCT00852228|oxaliplatin|oxaliplatin
1481145|NCT00852228|5-fluorouracil|5-fluorouracil
1481146|NCT00852228|hepatic artery infusion|hepatic artery infusion
1481147|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
1481148|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
1481149|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1481150|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
1481151|NCT00852215|Vision stent|vision stent
1481152|NCT00852202|bipolar|bipolar
1481153|NCT00852202|depression|depression
1481154|NCT00852189|Cancer|cancer
1481155|NCT00852189|Phase 1|phase 1
1481156|NCT00852189|EC0489|ec0489
1481157|NCT00852189|EC20|ec20
1481158|NCT00852189|Refractory|refractory
1481159|NCT00852189|Metastatic|metastatic
1481160|NCT00852189|Experimental|experimental
1481161|NCT00852176|Coronary brachytherapy|coronary brachytherapy
1481162|NCT00852176|Coronary restenosis|coronary restenosis
1481532|NCT00850941|Hormones|hormones
1481163|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
1481164|NCT00852163|conditioning, preparative|conditioning, preparative
1481165|NCT00852163|clofarabine; transplant|clofarabine; transplant
1481166|NCT00852163|Busulfan|busulfan
1481168|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
1481169|NCT00852150|gastritis|gastritis
1481170|NCT00852150|duodenitis|duodenitis
1481171|NCT00852150|inter-rater reliability|inter-rater reliability
1481172|NCT00852150|intra-rater reliablity|intra-rater reliablity
1481173|NCT00852150|gastroscopy|gastroscopy
1481174|NCT00852150|duodenoscopy|duodenoscopy
1481175|NCT00852137|Peplin|peplin
1481176|NCT00852137|PEP005|pep005
1481177|NCT00852137|Actinic Keratosis|actinic keratosis
1481178|NCT00852124|Asthma|asthma
1481179|NCT00852124|Probiotic|probiotic
1481180|NCT00852124|VSL#3|vsl#3
1481181|NCT00852111|Fatigue|fatigue
1481182|NCT00852111|Radiotherapy|radiotherapy
1481183|NCT00852111|Cancer Therapy|cancer therapy
1481184|NCT00852111|Cancer|cancer
1481185|NCT00852098|Fundoplication|fundoplication
1481186|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
1481187|NCT00852098|gastric vessels|gastric vessels
1481188|NCT00852098|surgery|surgery
1481189|NCT00852085|Counseling|counseling
1481190|NCT00852085|Crime|crime
1481191|NCT00852085|Adolescent|adolescent
1481192|NCT00852072|common bile duct stones|common bile duct stones
1481193|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
1481194|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
1481195|NCT00852059|ADHD|adhd
1481196|NCT00852059|children|children
1481197|NCT00852059|adolescents|adolescents
1481198|NCT00852059|methylphenidate|methylphenidate
1481199|NCT00852059|adherence|adherence
1481200|NCT00852059|immediate release|immediate release
1481201|NCT00852059|extended release|extended release
1481202|NCT00852059|efficacy|efficacy
1481203|NCT00852046|Mechanical ventilation|mechanical ventilation
1481204|NCT00852033|alcoholism|alcoholism
1481205|NCT00852033|alcohol abuse|alcohol abuse
1481206|NCT00852033|prevention|prevention
1481207|NCT00852033|behavior modification|behavior modification
1481208|NCT00852033|parent offspring interaction|parent offspring interaction
1481209|NCT00852033|university student|university student
1567593|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
1481210|NCT00852033|substance abuse related behavior|substance abuse related behavior
1481211|NCT00852033|adolescence|adolescence
1481212|NCT00852007|prostate cancer|prostate cancer
1481213|NCT00852007|dendritic cells|dendritic cells
1481214|NCT00852007|MUC-1|muc-1
1481215|NCT00852007|immune therapy|immune therapy
1481216|NCT00851994|Patients having surgery|patients having surgery
1481217|NCT00851981|Alcohol Liver Disease|alcohol liver disease
1481218|NCT00851968|hepatectomy|hepatectomy
1481219|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
1481220|NCT00851942|Volunteer|volunteer
1481221|NCT00851942|Hypoadrenalism|hypoadrenalism
1481222|NCT00851942|Hypopituitarism|hypopituitarism
1481223|NCT00851942|Healthy volunteers|healthy volunteers
1481224|NCT00851929|sarcoidosis|sarcoidosis
1481225|NCT00851929|pulmonary hypertension|pulmonary hypertension
1481226|NCT00851929|dyspnea|dyspnea
1481227|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
1481228|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1481229|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1481230|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1481231|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1481232|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1481233|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1481234|NCT00851877|tongue cancer|tongue cancer
1481235|NCT00851864|anticoagulation|anticoagulation
1481236|NCT00851864|pregnancy|pregnancy
1481237|NCT00851851|Surgical patients|surgical patients
1481238|NCT00851838|Peritoneal dialysis|peritoneal dialysis
1481239|NCT00851838|L-carnitine|l-carnitine
1481240|NCT00851825|autonomic modulation|autonomic modulation
1481241|NCT00851825|heart rate|heart rate
1481242|NCT00851825|pressure support ventilation|pressure support ventilation
1481243|NCT00851825|T-tube|t-tube
1481244|NCT00851825|Mechanical ventilation|mechanical ventilation
1481245|NCT00851812|Exercise|exercise
1481246|NCT00851812|Breast cancer|breast cancer
1481247|NCT00851812|fatigue|fatigue
1481249|NCT00851799|Antiretroviral therapy|antiretroviral therapy
1481250|NCT00851799|Treatment naive|treatment naive
1481251|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
1481252|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
1481253|NCT00851786|Herpes Zoster Virus|herpes zoster virus
1481254|NCT00851786|HIV|hiv
1481255|NCT00851721|Hemophilia A|hemophilia a
1481256|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
1481257|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
1481258|NCT00851721|Hemophilia B|hemophilia b
1481259|NCT00851708|kidney|kidney
1481260|NCT00851708|deceased kidney transplant|deceased kidney transplant
1481261|NCT00851708|oxidative stress|oxidative stress
1481262|NCT00851708|renal function measurements|renal function measurements
1481263|NCT00851695|Lung Function Decline|lung function decline
1481264|NCT00851695|Lung Function|lung function
1481265|NCT00851695|Allergy|allergy
1481267|NCT00851695|Vitamin D|vitamin d
1481268|NCT00851682|Prostate Cancer|prostate cancer
1481269|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
1481270|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
1481271|NCT00851669|depression|depression
1481272|NCT00851669|alcohol dependence|alcohol dependence
1481273|NCT00851669|women|women
1481274|NCT00851669|psychotherapy|psychotherapy
1481275|NCT00851669|men|men
1481276|NCT00851630|HIV|hiv
1481277|NCT00851630|Tuberculosis|tuberculosis
1481278|NCT00851630|Treatment Naive|treatment naive
1481279|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
1481280|NCT00851617|Respiratory Muscle Training|respiratory muscle training
1481281|NCT00851617|Ventilator dependent|ventilator dependent
1481282|NCT00851604|ProGRP|progrp
1481283|NCT00851604|CgA|cga
1481284|NCT00851604|NSE|nse
1481285|NCT00851604|TUM2-PK|tum2-pk
1481286|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
1481287|NCT00851591|fenugreek|fenugreek
1481288|NCT00851591|galactogogue|galactogogue
1481289|NCT00851591|breastmilk|breastmilk
1481290|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
1481291|NCT00851591|Bird's Foot|bird's foot
1481292|NCT00851591|Greek Clover|greek clover
1481293|NCT00851591|Greek Hay|greek hay
1481294|NCT00851591|Hu Lu Ba|hu lu ba
1481295|NCT00851591|Trigonella|trigonella
1481296|NCT00851578|AF|af
1481297|NCT00851578|atrial fibrillation|atrial fibrillation
1481298|NCT00851578|LAA occlusion|laa occlusion
1481299|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1481300|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1481301|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1481302|NCT00851539|HIV|hiv
1481303|NCT00851539|Teenagers|teenagers
1481304|NCT00851539|Adolescent|adolescent
1481305|NCT00851539|HIV Testing|hiv testing
1481306|NCT00851539|HIV Seronegativity|hiv seronegativity
1481307|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
1481308|NCT00851526|Drug-eluting stent|drug-eluting stent
1481309|NCT00851513|Pudendal neuralgia|pudendal neuralgia
1481310|NCT00851513|pudendal nerve|pudendal nerve
1481311|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
1481312|NCT00851513|Canal syndrome|canal syndrome
1481313|NCT00851513|neuropathic pain|neuropathic pain
1481314|NCT00851513|infiltration|infiltration
1481315|NCT00851513|randomized protocol|randomized protocol
1481316|NCT00851513|pain scales|pain scales
1481317|NCT00851500|atherosclerosis|atherosclerosis
1481318|NCT00851500|carotid artery disease|carotid artery disease
1481319|NCT00851487|ARI|ari
1481320|NCT00851487|LRTI|lrti
1481321|NCT00851474|COstatus(R)|costatus(r)
1481322|NCT00851474|Ultrasound Dilution|ultrasound dilution
1481323|NCT00851474|Cardiac Output|cardiac output
1481324|NCT00851474|Blood Volumes|blood volumes
1481325|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
1481326|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
1481327|NCT00851461|Kennedy's disease|kennedy's disease
1481328|NCT00851461|Goserelin|goserelin
1481329|NCT00851461|Electrophysiologic study|electrophysiologic study
1481330|NCT00851461|Inclusion body|inclusion body
1481331|NCT00851435|Pneumonia|pneumonia
1481332|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
1481333|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
1481334|NCT00851435|Monoclonal antibody|monoclonal antibody
1481335|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
1481336|NCT00851422|Ultrasound Dilution|ultrasound dilution
1481337|NCT00851422|Cardiac Output|cardiac output
1481338|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
1481339|NCT00851396|Vitamin D deficiency|vitamin d deficiency
1481340|NCT00851396|Insulin resistance|insulin resistance
1481341|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
1481342|NCT00851396|Obese adolescents|obese adolescents
1481343|NCT00851383|HIV|hiv
1481344|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
1481345|NCT00851383|HIV Seronegativity|hiv seronegativity
1481346|NCT00851383|Preventive Vaccine|preventive vaccine
1481347|NCT00851370|COPD|copd
1481348|NCT00851370|Exacerbation|exacerbation
1481349|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
1481350|NCT00851357|Nicotine Patch|nicotine patch
1481351|NCT00851357|Smoking cessation|smoking cessation
1481352|NCT00851357|Telephone|telephone
1481353|NCT00851357|Tobacco cessation|tobacco cessation
1481354|NCT00851357|Counseling|counseling
1481355|NCT00851357|Nicotine|nicotine
1481356|NCT00851357|Self-Help|self-help
1481357|NCT00851357|Smoking abstinence|smoking abstinence
1481358|NCT00851357|Tobacco Use Disorder|tobacco use disorder
1481359|NCT00851344|Proof-of-Concept|proof-of-concept
1481360|NCT00851344|Allergic Rhinitis|allergic rhinitis
1481361|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
1481362|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
1481363|NCT00851318|Certolizumab Pegol|certolizumab pegol
1481365|NCT00851305|Stomach|stomach
1481366|NCT00851305|endoscopy|endoscopy
1481367|NCT00851305|neoplasms|neoplasms
1481368|NCT00851292|prostate cancer|prostate cancer
1481369|NCT00851292|biopsy|biopsy
1481370|NCT00851292|TRUS|trus
1481371|NCT00851292|diagnosis|diagnosis
1481372|NCT00851279|arrhythmia|arrhythmia
1481373|NCT00851279|ventricular tachycardia|ventricular tachycardia
1481374|NCT00851279|ablation|ablation
1481375|NCT00851279|mapping|mapping
1481376|NCT00851279|electrophysiology|electrophysiology
1481377|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1481378|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1481379|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1481380|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1481381|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1481382|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1481383|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1481384|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1481385|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1481386|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1481387|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1481388|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1481389|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1481390|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1481391|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1481392|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1481393|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1481394|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1481395|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1481396|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1481397|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1481398|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1481399|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1481400|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1481401|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1481402|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1481403|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1481404|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1481405|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1481406|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
1481407|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1481408|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1481409|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1481410|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1481411|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1481412|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1481413|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1481414|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
1481415|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
1481416|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1481417|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1481418|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1481419|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1481420|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
1481421|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1481422|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1481423|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1481424|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1481425|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1481426|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
1481427|NCT00851240|safety|safety
1481428|NCT00851227|Pharmacokinetics|pharmacokinetics
1481429|NCT00851227|Protein Binding|protein binding
1481430|NCT00851227|Conivaptan|conivaptan
1481431|NCT00851227|Vaprisol|vaprisol
1481432|NCT00851227|Liver Disease|liver disease
1482938|NCT00845130|Diabetes|diabetes
1481433|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
1481434|NCT00851214|Emergency Department patients|emergency department patients
1481435|NCT00851214|trauma with an ISS>15|trauma with an iss>15
1481436|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
1481437|NCT00851201|children|children
1481438|NCT00851201|obesity|obesity
1481439|NCT00851201|weight loss|weight loss
1481440|NCT00851201|prevention|prevention
1481441|NCT00851201|diabetes risk|diabetes risk
1481442|NCT00851201|cardiometabolic|cardiometabolic
1481443|NCT00851162|Bone defect|bone defect
1481444|NCT00851162|Benign bone lesions|benign bone lesions
1481445|NCT00851162|Stem cells|stem cells
1481446|NCT00851149|aorta|aorta
1481447|NCT00851149|disease|disease
1481448|NCT00851149|abdominal|abdominal
1481449|NCT00851149|surgery|surgery
1481450|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
1481451|NCT00851149|replacement|replacement
1481452|NCT00851149|blood|blood
1481453|NCT00851149|autolog|autolog
1481454|NCT00851149|transfusion|transfusion
1481455|NCT00851149|cytokines|cytokines
1481456|NCT00851136|CRC|crc
1481457|NCT00851136|Colon cancer|colon cancer
1481458|NCT00851136|Avastin|avastin
1481459|NCT00851136|APM4566g|apm4566g
1481460|NCT00851123|Stroke|stroke
1481461|NCT00851123|arm paresis|arm paresis
1481462|NCT00851123|mCIMT|mcimt
1481463|NCT00851123|bimanual training|bimanual training
1481464|NCT00851123|rehabilitation|rehabilitation
1481465|NCT00851110|high dose|high dose
1481466|NCT00851110|breast cancer|breast cancer
1481467|NCT00851110|adjuvant|adjuvant
1481468|NCT00851084|Angiogenesis|angiogenesis
1481469|NCT00851084|Colon cancer|colon cancer
1481470|NCT00851084|Rectal cancer|rectal cancer
1481471|NCT00851084|Oxaliplatin|oxaliplatin
1481472|NCT00851071|Anxiety|anxiety
1481473|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1481474|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
1481475|NCT00851058|Behavioral research|behavioral research
1481476|NCT00851058|Motivational counseling|motivational counseling
1481477|NCT00851058|Group Counseling|group counseling
1481478|NCT00851058|Motivational Interviewing|motivational interviewing
1481479|NCT00851058|Vicarious Learning|vicarious learning
1481480|NCT00851058|Risky alcohol use|risky alcohol use
1481481|NCT00851058|Recidivism|recidivism
1481482|NCT00851058|Motor Vehicles|motor vehicles
1481484|NCT00851032|Advanced Cancer|advanced cancer
1481485|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
1481486|NCT00851032|IMPACT|impact
1481487|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
1481488|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
1481489|NCT00851032|Molecular profiling|molecular profiling
1481490|NCT00851032|Phase I Therapies|phase i therapies
1481491|NCT00851032|Tissue Bank|tissue bank
1481492|NCT00851019|Exercise|exercise
1481493|NCT00851019|Video game|video game
1481494|NCT00851019|Type 2 diabetes|type 2 diabetes
1481495|NCT00851019|Dance|dance
1481496|NCT00851006|Depression|depression
1481497|NCT00851006|Females|females
1481498|NCT00851006|Adolescents|adolescents
1481499|NCT00850993|Hemolysis|hemolysis
1481500|NCT00850954|Lung Cancer|lung cancer
1481501|NCT00850954|Cancer|cancer
1481502|NCT00850954|Smoke|smoke
1481503|NCT00850954|Mexican American|mexican american
1481504|NCT00850954|Indoor Air Policy|indoor air policy
1481505|NCT00850954|Secondhand smoke|secondhand smoke
1481506|NCT00850954|SHS|shs
1481507|NCT00850954|Smoking cessation programs|smoking cessation programs
1481508|NCT00850954|Smokers|smokers
1481509|NCT00850954|Tobacco|tobacco
1481510|NCT00850954|Nicotine|nicotine
1481511|NCT00850954|Chronic diseases|chronic diseases
1481512|NCT00850954|Transtheoretical model of change|transtheoretical model of change
1481513|NCT00850954|TTM|ttm
1481514|NCT00850941|Registry|registry
1481515|NCT00850941|Research Database|research database
1481516|NCT00850941|Prostate cancer|prostate cancer
1481517|NCT00850941|Casodex|casodex
1481518|NCT00850941|Flutamide|flutamide
1481519|NCT00850941|Goserelin Acetate|goserelin acetate
1481520|NCT00850941|Leuprolide Acetate|leuprolide acetate
1481521|NCT00850941|Radiation|radiation
1481522|NCT00850941|PSA|psa
1481523|NCT00850941|Post-prostatectomy|post-prostatectomy
1481524|NCT00850941|Radiation Therapy|radiation therapy
1481525|NCT00850941|Prostate Specific Antigen|prostate specific antigen
1481526|NCT00850941|Adenocarcinoma|adenocarcinoma
1481527|NCT00850941|Radical Prostatectomy|radical prostatectomy
1481528|NCT00850941|Bicalutamide|bicalutamide
1481529|NCT00850941|Zoladex|zoladex
1481530|NCT00850941|Lupron Depot|lupron depot
1481531|NCT00850941|Tissue banking|tissue banking
1481533|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1481534|NCT00850928|MCI|mci
1481535|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
1481536|NCT00850928|Aβ40|aβ40
1481537|NCT00850928|Aβ42|aβ42
1481538|NCT00850928|Apolipoprotein E|apolipoprotein e
1481539|NCT00850928|Inflammatory Markers|inflammatory markers
1481540|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
1481541|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
1481542|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
1481543|NCT00850915|tuberculosis|tuberculosis
1481544|NCT00850915|community IPT|community ipt
1481545|NCT00850915|isoniazid adverse events|isoniazid adverse events
1481546|NCT00850915|tuberculosis incidence|tuberculosis incidence
1481547|NCT00850902|ELBW|elbw
1481548|NCT00850902|Humidity|humidity
1481549|NCT00850902|BPD|bpd
1481550|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
1481551|NCT00850863|COPD|copd
1481552|NCT00850863|Inflammation|inflammation
1481553|NCT00850863|Smoking|smoking
1481554|NCT00850863|Susceptibility|susceptibility
1481555|NCT00850850|PACU|pacu
1481556|NCT00850850|Physostigmine|physostigmine
1481557|NCT00850850|Recovery|recovery
1481558|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
1481559|NCT00850850|Wakefulness|wakefulness
1481560|NCT00850850|General anesthesia|general anesthesia
1481561|NCT00850850|General Anesthetics|general anesthetics
1481562|NCT00850850|Postoperative Period|postoperative period
1481563|NCT00850837|Microbicide|microbicide
1481564|NCT00850837|HIV Seronegativity|hiv seronegativity
1481565|NCT00850824|T2DM|t2dm
1481566|NCT00850811|Peplin|peplin
1481567|NCT00850811|PEP005|pep005
1481568|NCT00850798|Type 2 diabetes|type 2 diabetes
1481569|NCT00850798|Elder patients|elder patients
1481570|NCT00850798|Glycemic control|glycemic control
1481571|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
1481572|NCT00850798|Be able to walk by themselves|be able to walk by themselves
1481573|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
1481574|NCT00850772|Enteral nutrition|enteral nutrition
1481575|NCT00850772|Ovarian cancer|ovarian cancer
1481576|NCT00850772|Peritoneal cancer|peritoneal cancer
1481577|NCT00850772|Fallopian tube cancer|fallopian tube cancer
1481578|NCT00850772|Malnutrition|malnutrition
1481579|NCT00850772|Surgery|surgery
1481580|NCT00850772|Gynecological Cancer|gynecological cancer
1481581|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
1481582|NCT00850759|pedestrian safety|pedestrian safety
1481583|NCT00850759|street-crossing ability|street-crossing ability
1481584|NCT00850759|road-crossing|road-crossing
1481585|NCT00850759|children|children
1481586|NCT00850759|injury prevention|injury prevention
1481587|NCT00850746|QT interval|qt interval
1481588|NCT00850746|Cardiac Repolarization|cardiac repolarization
1481589|NCT00850746|Cardiac Conduction|cardiac conduction
1481590|NCT00850746|Healthy Subjects|healthy subjects
1481591|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
1481592|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
1481593|NCT00850720|Biological Response Modifiers|biological response modifiers
1481594|NCT00850720|Bypass Surgery|bypass surgery
1481595|NCT00850720|Cardiology|cardiology
1481596|NCT00850720|Congenital Heart Disease|congenital heart disease
1481597|NCT00850720|Endocrinology|endocrinology
1481598|NCT00850720|Hormone Dysfunction|hormone dysfunction
1481599|NCT00850720|Hormones|hormones
1481600|NCT00850720|Neuroendocrinology|neuroendocrinology
1481601|NCT00850720|Pediatric Surgery|pediatric surgery
1481602|NCT00850707|AVF|avf
1481603|NCT00850707|AVG|avg
1481604|NCT00850707|TCC|tcc
1481605|NCT00850707|inflammation|inflammation
1481606|NCT00850707|monocite senescence|monocite senescence
1481607|NCT00850694|Vitamin D deficiency|vitamin d deficiency
1481608|NCT00850694|Obesity|obesity
1481609|NCT00850694|Insulin resistance|insulin resistance
1481610|NCT00850694|Glucose tolerance|glucose tolerance
1481611|NCT00850681|Peplin|peplin
1481612|NCT00850681|PEP005|pep005
1481613|NCT00850668|Food Allergy|food allergy
1481614|NCT00850668|Peanut Allergy|peanut allergy
1481615|NCT00850642|Sputum cell counts|sputum cell counts
1481616|NCT00850642|Neutrophils|neutrophils
1481617|NCT00850642|Severe Asthma|severe asthma
1481618|NCT00850642|ICS|ics
1481619|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
1481620|NCT00850629|weight regain|weight regain
1481621|NCT00850629|endocrine counterregulation|endocrine counterregulation
1481622|NCT00850616|HIV|hiv
1481623|NCT00850616|HIV Seronegativity|hiv seronegativity
1481624|NCT00850616|Preventive Vaccine|preventive vaccine
1481625|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
1481626|NCT00850603|Meningococcal Infections|meningococcal infections
1481627|NCT00850603|Meningitis|meningitis
1481628|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
1481629|NCT00850551|Early Intervention|early intervention
1482330|NCT00847548|drug abuse|drug abuse
1481630|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
1481631|NCT00850551|Cystic Fibrosis|cystic fibrosis
1481632|NCT00850551|Lung Function|lung function
1481633|NCT00850551|Spirometry|spirometry
1481634|NCT00850551|Phillips Telemonitor|phillips telemonitor
1481635|NCT00850551|Home Spirometry|home spirometry
1481636|NCT00850551|PiKo-6|piko-6
1481637|NCT00850551|Home Monitoring|home monitoring
1481638|NCT00850538|Bone Marrow Lesion|bone marrow lesion
1481639|NCT00850538|BML|bml
1481640|NCT00850538|Arthroplasty|arthroplasty
1481641|NCT00850538|Replacement|replacement
1481642|NCT00850538|Knee|knee
1481643|NCT00850538|Discarded tissue|discarded tissue
1481644|NCT00850486|women|women
1481645|NCT00850486|ischemic heart disease|ischemic heart disease
1481646|NCT00850486|high frequency ECG|high frequency ecg
1481647|NCT00850486|exercise stress testing|exercise stress testing
1481648|NCT00850486|signal processing|signal processing
1481649|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
1481650|NCT00850473|PET|pet
1481651|NCT00850473|CT|ct
1481652|NCT00850473|Heart Attack|heart attack
1481653|NCT00850473|Coronary Artery disease|coronary artery disease
1481654|NCT00850473|Cardiac Catheterization|cardiac catheterization
1481655|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
1481656|NCT00850447|Cognition|cognition
1481657|NCT00850447|Neuropsychological Tests|neuropsychological tests
1481658|NCT00850421|migraine headache|migraine headache
1481659|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
1481660|NCT00850421|BOTOX|botox
1481661|NCT00850421|BTX-A|btx-a
1481662|NCT00850408|Stroke|stroke
1481663|NCT00850408|rTMS|rtms
1481664|NCT00850408|TMS|tms
1481665|NCT00850408|Rehabilitation|rehabilitation
1481666|NCT00850408|Upper Extremity|upper extremity
1481667|NCT00850395|HIV-1|hiv-1
1481668|NCT00850395|non-interventional|non-interventional
1481669|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
1481670|NCT00850395|therapy experienced patients|therapy experienced patients
1481671|NCT00850382|CBF AML|cbf aml
1481672|NCT00850382|Dasatinib|dasatinib
1481673|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
1481674|NCT00850369|Pulmonary hypertension|pulmonary hypertension
1481675|NCT00850369|Sickle cell disease|sickle cell disease
1481676|NCT00850356|Bariatric Surgery|bariatric surgery
1481677|NCT00850356|Body Weight|body weight
1481678|NCT00850356|Health care costs|health care costs
1481679|NCT00850356|Obesity|obesity
1481680|NCT00850356|Obesity Complications|obesity complications
1481681|NCT00850356|Prolonged wait times|prolonged wait times
1481682|NCT00850356|Quality of Life|quality of life
1481683|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
1481684|NCT00850343|Certolizumab Pegol|certolizumab pegol
1481685|NCT00850343|Cimzia|cimzia
1481686|NCT00850330|Drug interactions|drug interactions
1481687|NCT00850330|Drug interaction software|drug interaction software
1481688|NCT00850330|Older patients|older patients
1481689|NCT00850330|Hospitalization|hospitalization
1481690|NCT00850304|AML|aml
1481691|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
1481692|NCT00850278|Brain tumor|brain tumor
1481693|NCT00850278|[18F]FLT|[18f]flt
1481694|NCT00850278|[11C]MET|[11c]met
1481695|NCT00850278|TEP-imaging|tep-imaging
1481696|NCT00850278|tumor cell proliferation|tumor cell proliferation
1481697|NCT00850265|Asthma|asthma
1481698|NCT00850265|Formoterol|formoterol
1481699|NCT00850265|Beclomethasone|beclomethasone
1481700|NCT00850265|Extrafine formulation|extrafine formulation
1481701|NCT00850265|Spacer|spacer
1481702|NCT00850265|Moderate|moderate
1481703|NCT00850265|Severe|severe
1481704|NCT00850265|Stable|stable
1481705|NCT00850252|Lifeline|lifeline
1481706|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
1481707|NCT00850252|A-V shunt|a-v shunt
1481708|NCT00850239|diabetes|diabetes
1481709|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
1481710|NCT00850239|dutogliptin|dutogliptin
1481711|NCT00850226|test anxiety|test anxiety
1481712|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
1481713|NCT00850187|Knee cartilage diseases|knee cartilage diseases
1481714|NCT00850174|Bioequivalence|bioequivalence
1481715|NCT00850174|Healthy Subjects|healthy subjects
1481716|NCT00850161|Type 1 Diabetes|type 1 diabetes
1481717|NCT00850161|Nasal Insulin|nasal insulin
1481718|NCT00850161|Insulin Deficiency|insulin deficiency
1481719|NCT00850161|Insulin-Dependent|insulin-dependent
1481720|NCT00850148|Anwar|anwar
1481721|NCT00850148|Melles|melles
1481722|NCT00850148|Keratoconus|keratoconus
1481723|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
1481724|NCT00850083|Fever|fever
1481725|NCT00850083|Children|children
1481726|NCT00850070|autism|autism
1481727|NCT00850044|FIH|fih
1481728|NCT00850044|SAD|sad
1481729|NCT00850031|Presbyopia|presbyopia
1481730|NCT00850031|Accommodation|accommodation
1481731|NCT00850031|Near visual acuity|near visual acuity
1481732|NCT00850031|LASIK|lasik
1481733|NCT00850018|Sickle Cell Disease|sickle cell disease
1482331|NCT00847548|addiction|addiction
1481734|NCT00850018|Sickle Cell Anemia|sickle cell anemia
1481735|NCT00850018|Hemoglobin SS|hemoglobin ss
1481736|NCT00850018|Hemoglobin SB0|hemoglobin sb0
1481737|NCT00850005|neuropathic pain|neuropathic pain
1481738|NCT00850005|resistant|resistant
1481739|NCT00850005|neuroinflammation|neuroinflammation
1482939|NCT00845130|MR imaging|mr imaging
1481740|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
1481741|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
1481742|NCT00849992|Actinic cheilitis|actinic cheilitis
1481743|NCT00849992|Imiquimod 5%|imiquimod 5%
1481744|NCT00849992|Photodynamic therapy|photodynamic therapy
1481745|NCT00849979|Colorectal|colorectal
1481746|NCT00849979|Gastric|gastric
1481747|NCT00849979|Gastrointestinal|gastrointestinal
1481749|NCT00849979|Liver|liver
1481750|NCT00849979|Pancreas|pancreas
1481751|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
1481752|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
1481753|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
1481754|NCT00849979|MDASI-GI|mdasi-gi
1481755|NCT00849979|Medical Oncology|medical oncology
1481756|NCT00849966|Celebrex|celebrex
1481757|NCT00849966|celecoxib|celecoxib
1481758|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
1481759|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
1481760|NCT00849966|Adverse drug events|adverse drug events
1481761|NCT00849966|quality of life|quality of life
1481762|NCT00849966|Pain Postoperative|pain postoperative
1481763|NCT00849966|Tonsillectomy|tonsillectomy
1481764|NCT00849966|Adenotonsillectomy|adenotonsillectomy
1481765|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
1481766|NCT00849940|Spectroscopy|spectroscopy
1481767|NCT00849940|Near infrared|near infrared
1481768|NCT00849940|Oximetry|oximetry
1481769|NCT00849940|Hypoxemia|hypoxemia
1481770|NCT00849940|Tissue oxygenation|tissue oxygenation
1481771|NCT00849940|Pediatric|pediatric
1481772|NCT00849927|shoulder instability|shoulder instability
1481773|NCT00849927|labral lesions|labral lesions
1481774|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
1481775|NCT00849927|SLAP|slap
1481776|NCT00849927|triple labrum|triple labrum
1481777|NCT00849927|circumferential labrum|circumferential labrum
1481778|NCT00849927|Pan-labral lesion|pan-labral lesion
1481779|NCT00849888|Thymus Transplantation|thymus transplantation
1481780|NCT00849888|DiGeorge Anomaly|digeorge anomaly
1481781|NCT00849888|Athymia|athymia
1481782|NCT00849888|Low T cell numbers|low t cell numbers
1481783|NCT00849888|Immunoreconstitution|immunoreconstitution
1481784|NCT00849888|Immunodeficiency|immunodeficiency
1481785|NCT00849875|ASCI|asci
1481786|NCT00849875|Dacarbazine|dacarbazine
1481787|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
1481788|NCT00849875|MAGE-A3|mage-a3
1481789|NCT00849875|Malignant melanoma|malignant melanoma
1481790|NCT00849862|Bioequivalence|bioequivalence
1481791|NCT00849862|Healthy Subjects|healthy subjects
1481792|NCT00849849|postgestational diabetes|postgestational diabetes
1481793|NCT00849849|diabetes mellitus|diabetes mellitus
1481794|NCT00849849|OGTT|ogtt
1481795|NCT00849849|insulin sensitivity|insulin sensitivity
1481796|NCT00849849|insulin secretion|insulin secretion
1481797|NCT00849823|African American|african american
1481798|NCT00849823|Men|men
1481799|NCT00849823|Condoms|condoms
1481800|NCT00849823|Randomization|randomization
1481801|NCT00849823|Brief Intervention|brief intervention
1481802|NCT00849823|HIV|hiv
1481803|NCT00849823|HIV Seronegativity|hiv seronegativity
1481804|NCT00849810|Hypertension|hypertension
1481805|NCT00849810|Beta-blockers|beta-blockers
1481806|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
1481807|NCT00849810|Basal metabolic rate|basal metabolic rate
1481808|NCT00849810|Quality of life|quality of life
1481809|NCT00849797|Bioequivalence|bioequivalence
1481810|NCT00849797|Healthy Subjects|healthy subjects
1481811|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
1481812|NCT00849771|Scapula Fracture|scapula fracture
1481813|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
1481814|NCT00849771|Clavicle|clavicle
1481815|NCT00849758|breast cancer|breast cancer
1481816|NCT00849758|elderly|elderly
1481817|NCT00849758|biomarker|biomarker
1481818|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
1481819|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
1481820|NCT00849732|HIV Seronegativity|hiv seronegativity
1481821|NCT00849732|Preventive Vaccine|preventive vaccine
1481822|NCT00849719|visual analog scale|visual analog scale
1481823|NCT00849719|patient controlled analgesia|patient controlled analgesia
1481824|NCT00849719|post operative pain|post operative pain
1481825|NCT00849719|rescue drug|rescue drug
1481826|NCT00849706|sleep deprivation|sleep deprivation
1481827|NCT00849706|workload|workload
1481828|NCT00849706|increased workload|increased workload
1481829|NCT00849680|HIV Seronegativity|hiv seronegativity
1481830|NCT00849680|Preventive Vaccine|preventive vaccine
1481831|NCT00849667|ovarian cancer|ovarian cancer
1481832|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
1481833|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
1481834|NCT00849654|PCI-32765|pci-32765
1481835|NCT00849654|Lymphoma|lymphoma
1481836|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1481837|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
1481838|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
1481839|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
1481840|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
1481841|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
1481842|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
1481843|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
1481844|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
1481845|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1481846|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
1481847|NCT00849641|decompensation|decompensation
1481848|NCT00849641|septic shock|septic shock
1481849|NCT00849641|tissue oxygenation|tissue oxygenation
1481850|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
1481851|NCT00849628|Aged|aged
1481852|NCT00849628|Polypharmacy|polypharmacy
1481853|NCT00849628|Adverse effects|adverse effects
1481854|NCT00849628|Nursing homes|nursing homes
1481855|NCT00849589|Screening|screening
1481856|NCT00849589|Brief intervention|brief intervention
1481857|NCT00849589|Underage drinking|underage drinking
1481858|NCT00849563|predictive genomics|predictive genomics
1481859|NCT00849563|personalized medicine|personalized medicine
1481860|NCT00849563|personal genomics|personal genomics
1481861|NCT00849563|genetic knowledge|genetic knowledge
1481862|NCT00849563|genetic attitudes|genetic attitudes
1481863|NCT00849563|prevention|prevention
1481864|NCT00849563|health outcomes|health outcomes
1481865|NCT00849563|behavioral|behavioral
1481866|NCT00849550|Advanced Solid Tumors|advanced solid tumors
1481867|NCT00849550|Cancer|cancer
1481868|NCT00849550|Capecitabine|capecitabine
1481869|NCT00849550|XELOX|xelox
1481870|NCT00849550|Neoplasms|neoplasms
1481871|NCT00849550|Oxaliplatin|oxaliplatin
1481872|NCT00849550|Bevacizumab|bevacizumab
1481873|NCT00849550|RAD001|rad001
1481874|NCT00849537|Triamcinolon|triamcinolon
1481875|NCT00849537|Cataract|cataract
1481876|NCT00849537|Diabetic retinopathy|diabetic retinopathy
1481877|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
1481878|NCT00849511|Migraine prevention|migraine prevention
1481879|NCT00849511|Crossover|crossover
1481880|NCT00849511|Melatonin|melatonin
1481881|NCT00849485|Bioequivalence|bioequivalence
1481882|NCT00849485|Healthy Subjects|healthy subjects
1481883|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
1481884|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
1481885|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
1481886|NCT00849472|cyclophosphamide|cyclophosphamide
1481887|NCT00849472|Paclitaxel|paclitaxel
1481888|NCT00849472|Doxorubicin|doxorubicin
1481889|NCT00849459|recurrent breast cancer|recurrent breast cancer
1481890|NCT00849459|stage IV breast cancer|stage iv breast cancer
1481891|NCT00849433|Inflammation|inflammation
1481892|NCT00849433|epithelial|epithelial
1481893|NCT00849433|integrity|integrity
1481894|NCT00849433|ECIS|ecis
1481895|NCT00849394|bevacizumab|bevacizumab
1481896|NCT00849394|proteinuria|proteinuria
1481897|NCT00849381|HPV|hpv
1481898|NCT00849381|HPV vaccine|hpv vaccine
1481899|NCT00849381|papillomavirus|papillomavirus
1481900|NCT00849381|cervical cancer|cervical cancer
1481901|NCT00849381|human papillomavirus|human papillomavirus
1481902|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
1481903|NCT00849303|stroke|stroke
1481904|NCT00849303|rehabilitation|rehabilitation
1481905|NCT00849303|gait|gait
1481906|NCT00849303|timing|timing
1481907|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
1481908|NCT00849277|Respiratory Tract Infections|respiratory tract infections
1481909|NCT00849277|Influenza, Human|influenza, human
1481910|NCT00849277|Probiotics|probiotics
1481911|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
1481912|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
1481913|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
1481914|NCT00849212|Seizures|seizures
1481915|NCT00849212|epilepsy|epilepsy
1481916|NCT00849199|screening|screening
1481917|NCT00849199|early detection|early detection
1481918|NCT00849199|prevention|prevention
1481919|NCT00849199|cancer|cancer
1481920|NCT00849199|high risk|high risk
1481921|NCT00849199|ovarian cancer|ovarian cancer
1481922|NCT00849199|breast cancer|breast cancer
1481923|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
1481924|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
1481925|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
1481926|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
1481927|NCT00849173|Endometriosis|endometriosis
1481928|NCT00849173|Infertility|infertility
1481929|NCT00849173|Tubal Ligation|tubal ligation
1481930|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
1481931|NCT00849173|Quality of Life|quality of life
1481932|NCT00849160|Treatment Experienced|treatment experienced
1481933|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
1481934|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
1481935|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
1481936|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
1481937|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
1481938|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
1481939|NCT00849134|First-Time-in-Human|first-time-in-human
1481940|NCT00849134|Tolerability|tolerability
1481941|NCT00849134|Pharmacodynamics|pharmacodynamics
1481942|NCT00849134|Safety|safety
1481943|NCT00849134|Food Effect|food effect
1481944|NCT00849134|Pharmacokinetics|pharmacokinetics
1481945|NCT00849134|Healthy Volunteers|healthy volunteers
1481946|NCT00849121|Vaccine|vaccine
1481947|NCT00849121|pTVG-HP|ptvg-hp
1481948|NCT00849121|Prostate Cancer|prostate cancer
1481949|NCT00849121|Castrate Resistant|castrate resistant
1481950|NCT00849108|Myocardial Perfusion|myocardial perfusion
1481951|NCT00849108|PET imaging|pet imaging
1481952|NCT00849108|SPECT imaging|spect imaging
1481953|NCT00849108|Coronary artery disease|coronary artery disease
1481954|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
1481955|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
1481956|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
1481957|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
1481958|NCT00849095|Adult|adult
1481959|NCT00849095|Asthma|asthma
1481960|NCT00849095|Bronchodilator Agents|bronchodilator agents
1481961|NCT00849095|Budesonide|budesonide
1481962|NCT00849095|Double-Blind Method|double-blind method
1481963|NCT00849095|Drug Therapy, Combination|drug therapy, combination
1481964|NCT00849095|Ethanolamines|ethanolamines
1481965|NCT00849095|Female|female
1481966|NCT00849095|Forced Expiratory Volume|forced expiratory volume
1481967|NCT00849095|Humans|humans
1481968|NCT00849095|Male|male
1481969|NCT00849095|Terbutaline|terbutaline
1481970|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
1481971|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
1481972|NCT00849082|stage III prostate cancer|stage iii prostate cancer
1481973|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
1481974|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
1481975|NCT00849069|Vaccine|vaccine
1481976|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
1481977|NCT00849069|Adults and Elderly Adults|adults and elderly adults
1481978|NCT00849056|diabetes|diabetes
1481979|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
1481980|NCT00849043|OSA|osa
1481981|NCT00849043|OSAH|osah
1481982|NCT00849017|placebo|placebo
1481983|NCT00849017|albiglutide|albiglutide
1481984|NCT00849017|monotherapy|monotherapy
1481985|NCT00849017|diabetes|diabetes
1481986|NCT00849004|keloid|keloid
1481987|NCT00849004|silicone sheet|silicone sheet
1481988|NCT00849004|silicone gel|silicone gel
1481989|NCT00849004|paper tape|paper tape
1481990|NCT00849004|steri-strip|steri-strip
1481991|NCT00848991|precedex|precedex
1481992|NCT00848991|propofol|propofol
1481993|NCT00848978|Functional capacity|functional capacity
1481994|NCT00848978|Quality of life|quality of life
1481995|NCT00848978|Depression|depression
1481996|NCT00848978|Falls|falls
1481997|NCT00848978|Body composition|body composition
1481998|NCT00848978|Physical activity|physical activity
1481999|NCT00848965|fluticasone propionate|fluticasone propionate
1482000|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
1482001|NCT00848965|glucocorticosteroids|glucocorticosteroids
1482002|NCT00848965|allergic rhinitis|allergic rhinitis
1482003|NCT00848939|systemic sclerosis|systemic sclerosis
1482004|NCT00848939|scleroderma|scleroderma
1482005|NCT00848939|pharmacokinetics|pharmacokinetics
1482006|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
1482007|NCT00848926|Antigens, CD30|antigens, cd30
1482008|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
1482009|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
1482010|NCT00848926|Disease, Hodgkin|disease, hodgkin
1482011|NCT00848926|Hematologic Diseases|hematologic diseases
1482012|NCT00848926|Lymphoma|lymphoma
1482013|NCT00848926|monomethylauristatin E|monomethylauristatin e
1482014|NCT00848926|Drug Therapy|drug therapy
1482015|NCT00848926|Immunotherapy|immunotherapy
1482016|NCT00848913|strength deficit|strength deficit
1482017|NCT00848913|physical function|physical function
1482018|NCT00848887|Influenza|influenza
1482019|NCT00848887|Flu|flu
1482020|NCT00848887|Vaccine|vaccine
1482021|NCT00848887|Adjuvant|adjuvant
1482022|NCT00848861|propofol sedation|propofol sedation
1482023|NCT00848861|colonoscopy|colonoscopy
1482024|NCT00848861|recovery time|recovery time
1482025|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
1482026|NCT00848848|Influenza|influenza
1482027|NCT00848848|Flu|flu
1482028|NCT00848848|Vaccine|vaccine
1482029|NCT00848848|Intradermal|intradermal
1482030|NCT00848848|Adjuvant|adjuvant
1482031|NCT00848835|defibrillator|defibrillator
1482032|NCT00848822|Pediatrics|pediatrics
1482034|NCT00848822|Glucose regulation|glucose regulation
1482035|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1482036|NCT00848809|Acute kidney injury|acute kidney injury
1482037|NCT00848809|Vancomycin therapy|vancomycin therapy
1482038|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
1482039|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
1482040|NCT00848809|Kidney|kidney
1482041|NCT00848809|Vancomycin|vancomycin
1482042|NCT00848809|Hemofiltration|hemofiltration
1482043|NCT00848796|Heparin Leo|heparin leo
1482044|NCT00848796|Hepalean|hepalean
1482045|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
1482046|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
1482047|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
1482048|NCT00848783|gastric cancer|gastric cancer
1482049|NCT00848783|gastroesophageal junction|gastroesophageal junction
1482050|NCT00848783|stomach cancer|stomach cancer
1482051|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
1482052|NCT00848783|capecitabine|capecitabine
1482053|NCT00848783|irinotecan|irinotecan
1482054|NCT00848783|cisplatin|cisplatin
1482055|NCT00848783|floxuridine|floxuridine
1482056|NCT00848770|Stroke, Acute|stroke, acute
1482057|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
1482058|NCT00848757|Diabetes|diabetes
1482059|NCT00848757|Lifestyle Intervention|lifestyle intervention
1482060|NCT00848744|Acne|acne
1482061|NCT00848731|pulmonary hypertension|pulmonary hypertension
1482062|NCT00848731|venous thromboembolism|venous thromboembolism
1482063|NCT00848718|Tumors, cancer|tumors, cancer
1482064|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
1482065|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
1482067|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
1482068|NCT00848692|Rituximab|rituximab
1482069|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
1482070|NCT00848692|B-cell depletion|b-cell depletion
1482071|NCT00848679|Pre-eclampsia|pre-eclampsia
1482072|NCT00848679|Pregnancy|pregnancy
1482073|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
1482074|NCT00848679|Epidural|epidural
1482075|NCT00848679|Anesthesia|anesthesia
1482076|NCT00848627|Bladder cancer|bladder cancer
1482077|NCT00848627|Smokers|smokers
1482078|NCT00848627|Hematuria|hematuria
1482079|NCT00848601|SGI-1776|sgi-1776
1482081|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
1482082|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
1482083|NCT00848588|agonal breathing|agonal breathing
1482084|NCT00848588|cardiac arrest|cardiac arrest
1482085|NCT00848588|9-1-1 call taker|9-1-1 call taker
1482086|NCT00848588|survey|survey
1482087|NCT00848562|sudden cardiac death|sudden cardiac death
1482088|NCT00848549|Epilepsy|epilepsy
1482089|NCT00848549|Monotherapy|monotherapy
1482090|NCT00848536|OAG|oag
1482091|NCT00848536|OHT|oht
1482092|NCT00848523|LBH859|lbh859
1482093|NCT00848523|Panobinostat|panobinostat
1482094|NCT00848523|GBM|gbm
1482095|NCT00848523|Glioma|glioma
1482096|NCT00848523|Glioblastoma|glioblastoma
1482097|NCT00848523|Astrocytoma|astrocytoma
1482098|NCT00848523|oligodendroglioma|oligodendroglioma
1482099|NCT00848523|oligoastrocytoma|oligoastrocytoma
1482100|NCT00848523|gliosarcoma|gliosarcoma
1482101|NCT00848523|anaplastic|anaplastic
1482102|NCT00848497|hormone replacement therapy|hormone replacement therapy
1482103|NCT00848497|radical prostatectomy|radical prostatectomy
1482104|NCT00848497|erectile dysfunctions|erectile dysfunctions
1482105|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
1482106|NCT00848471|Indirect calorimeter|indirect calorimeter
1482107|NCT00848471|Validation|validation
1482108|NCT00848471|Energy expenditure|energy expenditure
1482109|NCT00848471|Healthy volunteers|healthy volunteers
1482110|NCT00848458|Azelaic Acid|azelaic acid
1482111|NCT00848458|Iontophoresis|iontophoresis
1482112|NCT00848432|Schizophrenia|schizophrenia
1482113|NCT00848432|Risperidone|risperidone
1482114|NCT00848432|Maintenance treatment|maintenance treatment
1482115|NCT00848432|Relapse|relapse
1482116|NCT00848419|Epidural|epidural
1482117|NCT00848419|Analgesia|analgesia
1482118|NCT00848419|Methadone|methadone
1482119|NCT00848419|Morphine|morphine
1482120|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
1482121|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
1482122|NCT00848406|bronchial|bronchial
1482123|NCT00848406|COPD|copd
1482124|NCT00848406|Asthma|asthma
1482125|NCT00848406|sputum|sputum
1482126|NCT00848406|biopsies|biopsies
1482127|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
1482128|NCT00848393|stress response|stress response
1482129|NCT00848393|early extubation|early extubation
1482130|NCT00848393|Dexmedetomidine|dexmedetomidine
1482131|NCT00848393|TOF|tof
1482132|NCT00848393|VSD|vsd
1482133|NCT00848393|AVSD|avsd
1482134|NCT00848380|Hypertension|hypertension
1482135|NCT00848380|hyperlipidemia|hyperlipidemia
1482136|NCT00848354|enbrel|enbrel
1482137|NCT00848354|moderate arthritis|moderate arthritis
1482138|NCT00848354|severe arthritis|severe arthritis
1482139|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
1482140|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1482940|NCT00845130|Vitamin C|vitamin c
1482141|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1482142|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1482143|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1482144|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
1482145|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
1482146|NCT00848302|peripheral vascular disease|peripheral vascular disease
1482147|NCT00848302|endothelial dysfunction|endothelial dysfunction
1482148|NCT00848302|intravascular ultrasound|intravascular ultrasound
1482149|NCT00848302|L-Arginine|l-arginine
1482150|NCT00848289|Bladder cancer|bladder cancer
1482151|NCT00848289|Genetic susceptibility|genetic susceptibility
1482152|NCT00848289|Increased Risk|increased risk
1482153|NCT00848276|PCSK9|pcsk9
1482154|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
1482155|NCT00848276|testosterone|testosterone
1482156|NCT00848276|estradiol|estradiol
1482157|NCT00848263|Fracture|fracture
1482158|NCT00848263|Radius|radius
1482159|NCT00848263|Surgery|surgery
1482160|NCT00848263|Osteosynthesis|osteosynthesis
1482161|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
1482162|NCT00848250|ACE inhibitor|ace inhibitor
1482163|NCT00848250|Pediatrics|pediatrics
1482164|NCT00848237|Barrett's Esophagus|barrett's esophagus
1482165|NCT00848237|Dysplasia|dysplasia
1482166|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
1482167|NCT00848224|coronary heart disease|coronary heart disease
1482168|NCT00848224|lipid lowering medication|lipid lowering medication
1482169|NCT00848224|NCEP guidelines|ncep guidelines
1482170|NCT00848211|HIV|hiv
1482171|NCT00848211|vaccine|vaccine
1482172|NCT00848211|lipopeptide|lipopeptide
1482173|NCT00848211|Tat|tat
1482174|NCT00848211|TUTI-16|tuti-16
1482175|NCT00848211|THYMON|thymon
1482176|NCT00848211|Treatment Naive|treatment naive
1482177|NCT00848198|Dry Eye Disease|dry eye disease
1482178|NCT00848198|Dry Eye Syndrome|dry eye syndrome
1482179|NCT00848198|Dry Eye|dry eye
1482180|NCT00848185|VEGF|vegf
1482181|NCT00848185|Trigger|trigger
1482182|NCT00848185|OHSS|ohss
1482183|NCT00848172|Essential Tremor|essential tremor
1482184|NCT00848172|Octanol|octanol
1482185|NCT00848172|Octanoic Acid|octanoic acid
1482186|NCT00848172|Ethanol|ethanol
1482187|NCT00848172|Accelerometry|accelerometry
1482188|NCT00848159|Osteoporosis|osteoporosis
1482189|NCT00848159|kyphosis|kyphosis
1482190|NCT00848159|photogrammetry|photogrammetry
1482191|NCT00848107|systemic sclerosis|systemic sclerosis
1482192|NCT00848107|scleroderma|scleroderma
1482193|NCT00848107|digital ulcers|digital ulcers
1482194|NCT00848107|vasculopathy|vasculopathy
1482195|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
1482196|NCT00848094|radiation therapy|radiation therapy
1482197|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
1482198|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
1482199|NCT00848094|active breathing control|active breathing control
1482200|NCT00848081|Prostate|prostate
1482202|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1482203|NCT00848081|BPH-LUTS|bph-luts
1482204|NCT00848081|LUTS|luts
1482205|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
1482206|NCT00848081|tadalafil|tadalafil
1482207|NCT00848081|alpha blockers|alpha blockers
1482208|NCT00848068|lipid layer thickness|lipid layer thickness
1482209|NCT00848042|cancer|cancer
1482210|NCT00848042|head and neck|head and neck
1482211|NCT00848042|laser|laser
1482212|NCT00848042|ablation|ablation
1482213|NCT00848029|Influenza vaccine|influenza vaccine
1482214|NCT00848003|Probiotics|probiotics
1482215|NCT00848003|BB-12|bb-12
1482216|NCT00848003|Yogurt|yogurt
1482217|NCT00848003|Antibiotics|antibiotics
1482218|NCT00847990|Down syndrome|down syndrome
1482219|NCT00847990|aneuploidy|aneuploidy
1482220|NCT00847990|chromosome abnormality|chromosome abnormality
1482221|NCT00847990|amniocentesis|amniocentesis
1482222|NCT00847990|chorionic villus sampling|chorionic villus sampling
1482223|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
1482224|NCT00847977|Acute head trauma|acute head trauma
1482225|NCT00847964|Heart Failure|heart failure
1482226|NCT00847951|renal|renal
1482227|NCT00847951|neonates|neonates
1482228|NCT00847938|neostigmine|neostigmine
1482229|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
1482230|NCT00847938|train of four|train of four
1482231|NCT00847938|anesthesia|anesthesia
1482232|NCT00847912|NMSC|nmsc
1482233|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
1482234|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
1482235|NCT00847912|Neoplasms|neoplasms
1482332|NCT00847522|melanoma|melanoma
1482236|NCT00847912|Antineoplastic Agents|antineoplastic agents
1482237|NCT00847912|Therapeutic Uses|therapeutic uses
1482238|NCT00847912|Dermatologic Agents|dermatologic agents
1482239|NCT00847912|Neoplasms by Site|neoplasms by site
1482240|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
1482241|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
1482242|NCT00847899|hypertension|hypertension
1482243|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
1482244|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
1482245|NCT00847899|pre-diabetes|pre-diabetes
1482246|NCT00847873|intimate partner violence|intimate partner violence
1482247|NCT00847873|domestic violence|domestic violence
1482248|NCT00847873|alcohol abuse|alcohol abuse
1482249|NCT00847873|alcohol dependence|alcohol dependence
1482250|NCT00847873|drug abuse|drug abuse
1482251|NCT00847873|drug dependence|drug dependence
1482252|NCT00847873|addiction|addiction
1482253|NCT00847860|cognition|cognition
1482254|NCT00847847|ALS|als
1482255|NCT00847847|Motor neuron|motor neuron
1482256|NCT00847847|Pathophysiology|pathophysiology
1482257|NCT00847847|Neuromuscular junction|neuromuscular junction
1482258|NCT00847847|Neuromuscular transmission|neuromuscular transmission
1482259|NCT00847847|Microelectrodes|microelectrodes
1482260|NCT00847808|Esophageal Reflux|esophageal reflux
1482261|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
1482262|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1482263|NCT00847808|GERD|gerd
1482264|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
1482265|NCT00847808|Heartburn|heartburn
1482266|NCT00847808|Drug Therapy|drug therapy
1482267|NCT00847769|Ankle Sprain|ankle sprain
1482268|NCT00847756|Otitis media|otitis media
1482269|NCT00847756|demography|demography
1482270|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
1482271|NCT00847756|Haemophilus influenzae|haemophilus influenzae
1482272|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
1482273|NCT00847756|rhinovirus|rhinovirus
1482274|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
1482275|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
1482276|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
1482277|NCT00847743|oxidative stress|oxidative stress
1482278|NCT00847743|aging|aging
1482279|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
1482280|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
1482281|NCT00847717|Oral|oral
1482282|NCT00847717|cancer|cancer
1482283|NCT00847717|surgery|surgery
1482284|NCT00847717|neck dissection|neck dissection
1482285|NCT00847717|spinal accessory nerve|spinal accessory nerve
1482286|NCT00847704|Stroke|stroke
1482287|NCT00847704|Rehabilitation|rehabilitation
1482288|NCT00847704|Robotics|robotics
1482289|NCT00847691|economic evaluation|economic evaluation
1482290|NCT00847691|diagnostics|diagnostics
1482291|NCT00847691|sarcoma|sarcoma
1482292|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
1482293|NCT00847665|Pressure ulcers|pressure ulcers
1482294|NCT00847665|Repositioning|repositioning
1482295|NCT00847665|Prevention|prevention
1482296|NCT00847665|Mechanical Ventilation|mechanical ventilation
1482297|NCT00847665|Critical care|critical care
1482298|NCT00847639|Multiple Myeloma|multiple myeloma
1482299|NCT00847639|lenalidomide|lenalidomide
1482300|NCT00847639|Revlimid|revlimid
1482301|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1482302|NCT00847626|Hypertensive|hypertensive
1482303|NCT00847626|Blood Pressure, High|blood pressure, high
1482304|NCT00847626|Vascular Disease|vascular disease
1482305|NCT00847626|Cardiovascular Disease|cardiovascular disease
1482306|NCT00847626|Drug Therapy|drug therapy
1482307|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
1482308|NCT00847600|Schizophrenia|schizophrenia
1482309|NCT00847600|Neurosteroids|neurosteroids
1482310|NCT00847600|Pregnenolone|pregnenolone
1482311|NCT00847600|Augmentation|augmentation
1482312|NCT00847587|Contraceptive|contraceptive
1482313|NCT00847587|Implant|implant
1482314|NCT00847587|Postpartum period|postpartum period
1482315|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
1482316|NCT00847587|lactogenesis|lactogenesis
1482317|NCT00847587|Breastfeeding|breastfeeding
1482318|NCT00847574|Weight loss|weight loss
1482319|NCT00847574|Weight maintenance|weight maintenance
1482320|NCT00847574|Weight management|weight management
1482321|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
1482322|NCT00847574|Dietary Guidelines|dietary guidelines
1482323|NCT00847574|Diet and exercise|diet and exercise
1482324|NCT00847574|Prevention|prevention
1482325|NCT00847561|Anxiety|anxiety
1482326|NCT00847548|intimate partner violence|intimate partner violence
1482327|NCT00847548|domestic violence|domestic violence
1482328|NCT00847548|substance abuse|substance abuse
1482329|NCT00847548|alcohol abuse|alcohol abuse
1482333|NCT00847522|skin cancer|skin cancer
1482334|NCT00847522|lymph node|lymph node
1482335|NCT00847522|sentinel lymph node|sentinel lymph node
1482336|NCT00847522|malignant melanoma|malignant melanoma
1482337|NCT00847522|mapping|mapping
1482338|NCT00847509|lung cancer|lung cancer
1482339|NCT00847509|head and neck cancer|head and neck cancer
1482340|NCT00847509|radiotherapy|radiotherapy
1482341|NCT00847509|chemoradiotherapy|chemoradiotherapy
1482342|NCT00847509|radiation|radiation
1482343|NCT00847509|chemoradiation|chemoradiation
1482344|NCT00847509|FLT|flt
1482345|NCT00847509|[F-18]FLT|[f-18]flt
1482346|NCT00847509|FDG|fdg
1482347|NCT00847509|[F-18]FDG|[f-18]fdg
1482348|NCT00847496|Partial Thickness burn|partial thickness burn
1482349|NCT00847496|Biological Dressing|biological dressing
1482350|NCT00847483|glaucoma|glaucoma
1482351|NCT00847483|ocular hypertension|ocular hypertension
1482352|NCT00847483|latanoprost|latanoprost
1482353|NCT00847483|travoprost|travoprost
1482354|NCT00847483|bimatoprost|bimatoprost
1482355|NCT00847470|Dental caries|dental caries
1482356|NCT00847470|Assessments|assessments
1482357|NCT00847470|dental materials|dental materials
1482358|NCT00847457|Exercise|exercise
1482359|NCT00847457|Stretching|stretching
1482360|NCT00847457|Adolescents|adolescents
1482361|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
1482362|NCT00847431|Deep Brain Stimulation|deep brain stimulation
1482363|NCT00847431|Depression|depression
1482364|NCT00847431|Anxiety|anxiety
1482365|NCT00847431|Parkinson's Disease|parkinson's disease
1482366|NCT00847418|pharmacokinetics|pharmacokinetics
1482367|NCT00847418|ketamine|ketamine
1482368|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
1482369|NCT00847405|Bioequivalence|bioequivalence
1482370|NCT00847405|Healthy Subjects|healthy subjects
1482371|NCT00847392|Urethral catheterization|urethral catheterization
1482372|NCT00847392|Emergency Department|emergency department
1482373|NCT00847392|Ultrasound|ultrasound
1482374|NCT00847392|Urinary tract infection|urinary tract infection
1482375|NCT00847392|Pediatric|pediatric
1482376|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
1482377|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
1482378|NCT00847379|Nonsense mutation|nonsense mutation
1482379|NCT00847379|Premature stop codon|premature stop codon
1482380|NCT00847379|DMD|dmd
1482381|NCT00847379|BMD|bmd
1482382|NCT00847379|Ataluren|ataluren
1482383|NCT00847379|PTC124|ptc124
1482384|NCT00847366|Perifosine|perifosine
1482385|NCT00847353|high frequency ECG|high frequency ecg
1482386|NCT00847353|normal values|normal values
1482387|NCT00847353|asymptomatic|asymptomatic
1482388|NCT00847353|obese|obese
1482389|NCT00847340|Genital warts|genital warts
1482390|NCT00847340|HPV typing|hpv typing
1482391|NCT00847340|HPV infections|hpv infections
1482392|NCT00847340|Condyloma Acuminata|condyloma acuminata
1482393|NCT00847327|Type 1 Diabetes|type 1 diabetes
1482394|NCT00847327|Parenting|parenting
1482395|NCT00847327|Young Children|young children
1482396|NCT00847314|Hypogonadism|hypogonadism
1482397|NCT00847314|Abdominal obesity|abdominal obesity
1482398|NCT00847314|Physical exercise|physical exercise
1482399|NCT00847314|Testosterone|testosterone
1482400|NCT00847288|Heart Failure|heart failure
1482401|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1482402|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
1482403|NCT00847288|OptiVol®|optivol®
1482404|NCT00847275|Elderly patients|elderly patients
1482405|NCT00847275|renal insufficiency|renal insufficiency
1482406|NCT00847275|gerontologic evaluation|gerontologic evaluation
1482407|NCT00847262|Hypertension|hypertension
1482408|NCT00847262|Abdominal obesity|abdominal obesity
1482409|NCT00847262|Diabetes|diabetes
1482410|NCT00847262|Treatment|treatment
1482411|NCT00847249|safety|safety
1482412|NCT00847249|tolerability|tolerability
1482413|NCT00847249|healthy|healthy
1482414|NCT00847249|inhalation|inhalation
1482415|NCT00847249|Healthy males|healthy males
1482416|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
1482417|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
1482418|NCT00847236|Rheumatic Disease|rheumatic disease
1482419|NCT00847236|PMR|pmr
1482420|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
1482421|NCT00847223|Lymphoma|lymphoma
1482422|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
1482423|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
1482424|NCT00847210|Esophageal Reflux|esophageal reflux
1482425|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
1482426|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1482427|NCT00847210|GERD|gerd
1482428|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
1482429|NCT00847210|Heartburn|heartburn
1482430|NCT00847210|Drug Therapy|drug therapy
1482431|NCT00847210|Adolescent|adolescent
1482432|NCT00847184|nasal intubation|nasal intubation
1482433|NCT00847184|Aitraq|aitraq
1482434|NCT00847184|difficult intubation|difficult intubation
1482435|NCT00847171|male breast cancer|male breast cancer
1482436|NCT00847171|stage II breast cancer|stage ii breast cancer
1482437|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
1482438|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
1482439|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
1482440|NCT00847171|stage IV breast cancer|stage iv breast cancer
1482441|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
1482442|NCT00847158|POAG|poag
1482443|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
1482444|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
1482445|NCT00847158|iStent|istent
1482446|NCT00847145|toddler|toddler
1482447|NCT00847145|Meningococcal disease|meningococcal disease
1482448|NCT00847145|prevention|prevention
1482449|NCT00847145|vaccination|vaccination
1482450|NCT00847132|Collaborative Care|collaborative care
1482451|NCT00847119|rectum|rectum
1482452|NCT00847119|adenocarcinoma|adenocarcinoma
1482453|NCT00847119|neoadjuvant|neoadjuvant
1482454|NCT00847119|bevacizumab|bevacizumab
1482455|NCT00847119|capecitabine|capecitabine
1482456|NCT00847119|radiotherapy|radiotherapy
1482457|NCT00847119|locally|locally
1482458|NCT00847119|advanced|advanced
1482459|NCT00847119|resectable|resectable
1482460|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
1482461|NCT00847119|xeberecto|xeberecto
1482462|NCT00847106|Dendritic Cells|dendritic cells
1482463|NCT00847106|Regulatory T cells|regulatory t cells
1482464|NCT00847106|CD25|cd25
1482465|NCT00847106|Melanoma|melanoma
1482466|NCT00847106|Immunotherapy|immunotherapy
1482467|NCT00847106|Daclizumab|daclizumab
1482468|NCT00847106|Stage IV Melanoma|stage iv melanoma
1482469|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
1482470|NCT00847080|Sitagliptin|sitagliptin
1482471|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
1482472|NCT00847080|Incretins|incretins
1482473|NCT00847080|Prediabetes|prediabetes
1482474|NCT00847054|Solid Tumor|solid tumor
1482475|NCT00847054|Endosialin|endosialin
1482476|NCT00847028|Newborn|newborn
1482477|NCT00847028|Pain|pain
1482478|NCT00847028|glucose solution|glucose solution
1482479|NCT00847028|venipuncture|venipuncture
1482480|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
1482481|NCT00847015|Bladder|bladder
1482482|NCT00847015|Urinary|urinary
1482483|NCT00847015|CISPLATIN|cisplatin
1482484|NCT00847015|GEMCITABINE|gemcitabine
1482485|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
1482486|NCT00847015|08-159|08-159
1482487|NCT00847002|Flexitouch system|flexitouch system
1482488|NCT00847002|FarrowWrap|farrowwrap
1482489|NCT00847002|venous stasis ulcer|venous stasis ulcer
1482490|NCT00846989|glaucoma,|glaucoma,
1482491|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
1482492|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
1482493|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
1482494|NCT00846976|Safety|safety
1482495|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
1482496|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
1482497|NCT00846963|Bile duct obstruction|bile duct obstruction
1482498|NCT00846963|biliary stasis|biliary stasis
1482499|NCT00846950|H1-antagonist|h1-antagonist
1482500|NCT00846950|Event Related Potentials|event related potentials
1482501|NCT00846950|Memory|memory
1482502|NCT00846950|Information processing|information processing
1482503|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
1482504|NCT00846937|Cholesterol|cholesterol
1482505|NCT00846937|Plant stanolester|plant stanolester
1482506|NCT00846937|Beverage|beverage
1482507|NCT00846937|Ileostoma|ileostoma
1482508|NCT00846937|Serum cholesterol level|serum cholesterol level
1482509|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
1482510|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
1482511|NCT00846924|Stroke|stroke
1482512|NCT00846924|Transient Ischemic Attack|transient ischemic attack
1482513|NCT00846924|Atrial fibrillation|atrial fibrillation
1482514|NCT00846924|Atrial flutter|atrial flutter
1482515|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
1482516|NCT00846898|blood sugar|blood sugar
1482517|NCT00846898|cholesterol|cholesterol
1482518|NCT00846898|cinnamon|cinnamon
1482519|NCT00846898|HbA1c|hba1c
1482520|NCT00846885|Bioequivalence|bioequivalence
1482521|NCT00846885|Healthy Subjects|healthy subjects
1482522|NCT00846872|GHRP-3|ghrp-3
1482523|NCT00846872|Insulin Resistance|insulin resistance
1482524|NCT00846872|Markers of inflammation|markers of inflammation
1482525|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
1482526|NCT00846872|Flow Mediated Dilation|flow mediated dilation
1482527|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
1482528|NCT00846872|Post menopausal|post menopausal
1482529|NCT00846859|alcohol dependence|alcohol dependence
1482530|NCT00846859|nicotine dependence|nicotine dependence
1482531|NCT00846859|alcohol abuse|alcohol abuse
1482532|NCT00846859|varenicline|varenicline
1482533|NCT00846859|Champix|champix
1482534|NCT00846859|Chantix|chantix
1482535|NCT00846859|smoking|smoking
1482536|NCT00846859|drinking|drinking
1482537|NCT00846859|snuffing|snuffing
1482538|NCT00846859|diary|diary
1482539|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
1482540|NCT00846859|PEth|peth
1482541|NCT00846833|Melanoma, Experimental|melanoma, experimental
1482542|NCT00846755|Thyroid|thyroid
1482543|NCT00846755|Pregnancy|pregnancy
1482544|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
1482545|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1482546|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
1482547|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
1482548|NCT00846716|pioglitazone|pioglitazone
1482549|NCT00846690|topical anesthetics|topical anesthetics
1482550|NCT00846690|topical anesthesia|topical anesthesia
1482551|NCT00846690|20% benzocaine|20% benzocaine
1482552|NCT00846690|TAC alternate gel|tac alternate gel
1482553|NCT00846690|combination topical anesthetics|combination topical anesthetics
1482554|NCT00846690|dental anesthesia|dental anesthesia
1482555|NCT00846677|Healthy|healthy
1482556|NCT00846677|Infants|infants
1482557|NCT00846677|Vitamin D|vitamin d
1482558|NCT00846651|spinal anesthesia|spinal anesthesia
1482559|NCT00846651|cesarean section|cesarean section
1482560|NCT00846638|Risk drinking|risk drinking
1482561|NCT00846638|Women|women
1482562|NCT00846638|Medical problems|medical problems
1482563|NCT00846625|Biomedical research|biomedical research
1482564|NCT00846625|Macular Edema|macular edema
1482565|NCT00846625|Uveitis|uveitis
1482566|NCT00846625|Ranibizumab|ranibizumab
1482567|NCT00846625|Steroids|steroids
1482568|NCT00846612|refractory|refractory
1482569|NCT00846612|avastin|avastin
1482570|NCT00846612|doxil|doxil
1482571|NCT00846612|relapsed|relapsed
1482572|NCT00846612|ovarian cancer|ovarian cancer
1482573|NCT00846612|platinum-resistant|platinum-resistant
1482574|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
1482575|NCT00846599|brachial artery reactivity|brachial artery reactivity
1482576|NCT00846599|HIV|hiv
1482577|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
1482578|NCT00846599|cardiovascular risk|cardiovascular risk
1482579|NCT00846599|omega three|omega three
1482580|NCT00846599|saturated fat|saturated fat
1482581|NCT00846599|sustiva|sustiva
1482582|NCT00846599|atripla|atripla
1482583|NCT00846599|kaletra|kaletra
1482584|NCT00846599|treatment naive|treatment naive
1482585|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1482586|NCT00846586|COPD|copd
1482587|NCT00846586|indacaterol|indacaterol
1482588|NCT00846586|tiotropium|tiotropium
1482589|NCT00846586|bronchodilation|bronchodilation
1482590|NCT00846573|Helium|helium
1482591|NCT00846573|MRI|mri
1482592|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
1482593|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
1482594|NCT00846547|Autism|autism
1482595|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
1482596|NCT00846547|irritability|irritability
1482597|NCT00846547|aberrant behavior|aberrant behavior
1482598|NCT00846534|Oxidative stress markers|oxidative stress markers
1482599|NCT00846534|Cardiac surgery|cardiac surgery
1482600|NCT00846534|Atrial Fibrillation|atrial fibrillation
1482601|NCT00846521|Pediatric Obesity|pediatric obesity
1482602|NCT00846521|Insulin Resistance|insulin resistance
1482603|NCT00846521|Glucose Tolerance|glucose tolerance
1482604|NCT00846521|Adolescents|adolescents
1482605|NCT00846521|Acarbose|acarbose
1482606|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
1482607|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
1482608|NCT00846508|cervical cancer|cervical cancer
1482609|NCT00846508|Cisplatin|cisplatin
1482610|NCT00846508|chemoradiation|chemoradiation
1482611|NCT00846495|Migraine|migraine
1482612|NCT00846495|Migraine prevention|migraine prevention
1482613|NCT00846495|Prodrome|prodrome
1482614|NCT00846495|Premonitory phase|premonitory phase
1482615|NCT00846495|Preemptive therapy|preemptive therapy
1482616|NCT00846482|Colorectal cancer|colorectal cancer
1482617|NCT00846482|Oxaliplatin|oxaliplatin
1482618|NCT00846482|ERCC-1|ercc-1
1482619|NCT00846456|Tumor setm cell|tumor setm cell
1482620|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
1482621|NCT00846430|Neurofibromas|neurofibromas
1482622|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
1482623|NCT00846430|Celecoxib|celecoxib
1482624|NCT00846430|Celebrex|celebrex
1482625|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
1482626|NCT00846430|PEG-Intron|peg-intron
1482627|NCT00846430|Temozolomide|temozolomide
1482628|NCT00846430|Temodar|temodar
1482629|NCT00846430|Vincristine Sulfate|vincristine sulfate
1482630|NCT00846430|Oncovin|oncovin
1482631|NCT00846417|myocardial infarction|myocardial infarction
1482632|NCT00846417|heart failure|heart failure
1482633|NCT00846417|arrhythmia|arrhythmia
1482634|NCT00846404|heart failure|heart failure
1482635|NCT00846404|cardiomyopathy|cardiomyopathy
1482636|NCT00846404|diastolic dysfunction|diastolic dysfunction
1482637|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
1482838|NCT00845611|URLC10|urlc10
1482638|NCT00846378|timed balloon inflations|timed balloon inflations
1482639|NCT00846378|post conditioning|post conditioning
1482640|NCT00846365|Essential Hypertension|essential hypertension
1482641|NCT00846365|Hypertensive|hypertensive
1482642|NCT00846365|Blood Pressure, High|blood pressure, high
1482643|NCT00846365|Vascular Disease|vascular disease
1482644|NCT00846365|Cardiovascular Disease|cardiovascular disease
1482645|NCT00846365|Drug Therapy|drug therapy
1482646|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
1482647|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1482648|NCT00846352|Bronchoscopy|bronchoscopy
1482649|NCT00846339|Smoking cessation|smoking cessation
1482650|NCT00846339|Bupropion|bupropion
1482651|NCT00846326|allergic rhinitis|allergic rhinitis
1482652|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
1482653|NCT00846326|imidazolines|imidazolines
1482654|NCT00846326|corticosteroid|corticosteroid
1482655|NCT00846313|Dietary intake|dietary intake
1482656|NCT00846313|Dietary counseling|dietary counseling
1482657|NCT00846313|Weight loss|weight loss
1482658|NCT00846313|Body composition|body composition
1482659|NCT00846313|Resting energy expenditure|resting energy expenditure
1482660|NCT00846313|Quality of life|quality of life
1482661|NCT00846300|Patient compliance|patient compliance
1482662|NCT00846300|Hispanics|hispanics
1482663|NCT00846300|Health Behavior|health behavior
1482664|NCT00846300|Family Physicians|family physicians
1482665|NCT00846300|Primary Healthcare|primary healthcare
1482666|NCT00846287|COPD|copd
1482667|NCT00846287|aformoterol|aformoterol
1482668|NCT00846287|Helium|helium
1482669|NCT00846287|Hyperpolarized helium|hyperpolarized helium
1482670|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
1482672|NCT00846274|Healthy Male subjects|healthy male subjects
1482673|NCT00846261|infected|infected
1482674|NCT00846261|Ilizarov|ilizarov
1482675|NCT00846248|diabetes|diabetes
1482676|NCT00846248|insulin resistance|insulin resistance
1482677|NCT00846248|chromium|chromium
1482678|NCT00846248|healthy volunteers|healthy volunteers
1482679|NCT00846235|Dermatitis|dermatitis
1482680|NCT00846235|Atopic|atopic
1482681|NCT00846235|Moisturising cream|moisturising cream
1482682|NCT00846235|Skin|skin
1482683|NCT00846209|prescription drug|prescription drug
1482684|NCT00846209|warnings|warnings
1482685|NCT00846209|health literacy|health literacy
1482686|NCT00846209|enhanced language|enhanced language
1482687|NCT00846183|local injury|local injury
1482688|NCT00846183|implantation rate|implantation rate
1482689|NCT00846183|endometrial receptivity|endometrial receptivity
1482690|NCT00846183|IVF|ivf
1482691|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
1482692|NCT00846157|natural killer cell|natural killer cell
1482693|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
1482694|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
1482695|NCT00846144|copper|copper
1482696|NCT00846144|cytokines|cytokines
1482697|NCT00846144|diabetes|diabetes
1482698|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
1482699|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
1482700|NCT00846118|Pitavastatin|pitavastatin
1482701|NCT00846118|Hemodialysis|hemodialysis
1482702|NCT00846118|Mortality|mortality
1482703|NCT00846118|Cardiovascular disease|cardiovascular disease
1482704|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1482705|NCT00846105|MRSA|mrsa
1482706|NCT00846105|cross-infection|cross-infection
1482707|NCT00846105|staphylococcal infection|staphylococcal infection
1482708|NCT00846105|infection control|infection control
1482709|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
1482710|NCT00846092|Diabetic Macular Edema|diabetic macular edema
1482711|NCT00846092|NIR|nir
1482712|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
1482713|NCT00846079|coronary artery disease|coronary artery disease
1482714|NCT00846079|stress testing|stress testing
1482715|NCT00846066|educational research,|educational research,
1482716|NCT00846066|instructional methods,|instructional methods,
1482717|NCT00846066|Hands on training,|hands on training,
1482718|NCT00846066|Web based training,|web based training,
1482719|NCT00846066|pediatric residents|pediatric residents
1482720|NCT00846066|preventive oral health,|preventive oral health,
1482721|NCT00846066|dental caries,|dental caries,
1482722|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
1482723|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
1482724|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
1482725|NCT00846040|Obesity|obesity
1482726|NCT00846040|Weight Loss|weight loss
1482727|NCT00846040|Carbohydrate|carbohydrate
1482728|NCT00846040|Fat|fat
1482729|NCT00846040|Macronutrient Balance|macronutrient balance
1482730|NCT00846040|Healthy Volunteer|healthy volunteer
1482731|NCT00846014|asthma|asthma
1482732|NCT00846014|exacerbation|exacerbation
1482733|NCT00846014|Helium|helium
1482734|NCT00846014|MRI|mri
1482735|NCT00846014|Lung imaging|lung imaging
1482736|NCT00846001|Resynchronization Therapy|resynchronization therapy
1482737|NCT00845988|Bipolar disorder|bipolar disorder
1482738|NCT00845988|metabolic complication|metabolic complication
1482739|NCT00845988|Aripiprazole|aripiprazole
1482740|NCT00845988|Weight gain|weight gain
1482741|NCT00845988|Clinical Trial|clinical trial
1482742|NCT00845988|Antipsychotic|antipsychotic
1482743|NCT00845988|Metabolic syndrome|metabolic syndrome
1482744|NCT00845988|Psychopharmacology|psychopharmacology
1482745|NCT00845988|Open Label|open label
1482746|NCT00845962|bupivacaine|bupivacaine
1482747|NCT00845962|chloroprocaine|chloroprocaine
1482748|NCT00845962|spinal|spinal
1482749|NCT00845962|anesthesia|anesthesia
1482750|NCT00845962|elective surgery|elective surgery
1482751|NCT00845962|ambulatory surgery|ambulatory surgery
1482752|NCT00845949|chemokines synovium|chemokines synovium
1482753|NCT00845936|Atypical antipsychotics|atypical antipsychotics
1482754|NCT00845936|Weight|weight
1482755|NCT00845936|adolecsents|adolecsents
1482756|NCT00845936|pediatric|pediatric
1482757|NCT00845936|Metformin|metformin
1482758|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
1482759|NCT00845897|Diabetes mellitus|diabetes mellitus
1482760|NCT00845897|plantar ulcers|plantar ulcers
1482761|NCT00845897|peripheral neuropathy|peripheral neuropathy
1482762|NCT00845884|Gastric|gastric
1482763|NCT00845884|Cancer|cancer
1482764|NCT00845884|Advanced|advanced
1482765|NCT00845884|Docetaxel|docetaxel
1482766|NCT00845884|Cisplatin|cisplatin
1482767|NCT00845884|Capecitabine|capecitabine
1482768|NCT00845884|Bevacizumab|bevacizumab
1482769|NCT00845871|Exjade|exjade
1482770|NCT00845871|deferasirox|deferasirox
1482771|NCT00845871|palatability|palatability
1482772|NCT00845871|tolerability|tolerability
1482773|NCT00845871|food|food
1482774|NCT00845871|iron overload|iron overload
1482775|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
1482776|NCT00845858|Gastroparesis|gastroparesis
1482777|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
1482778|NCT00845858|Diabetes|diabetes
1482779|NCT00845858|Diabetes Mellitus|diabetes mellitus
1482780|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
1482781|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1482782|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
1482783|NCT00845845|MRI|mri
1482784|NCT00845845|NASH|nash
1482785|NCT00845819|oral mucositis|oral mucositis
1482786|NCT00845819|intensive chemotherapy|intensive chemotherapy
1482787|NCT00845819|stem cell transplantation|stem cell transplantation
1482788|NCT00845819|epidermal growth factor|epidermal growth factor
1482789|NCT00845806|Diacritics|diacritics
1482790|NCT00845806|Neuronal Processing|neuronal processing
1482791|NCT00845806|fMRI|fmri
1482792|NCT00845806|Arabic|arabic
1482793|NCT00845793|Type 2 diabetes|type 2 diabetes
1482794|NCT00845793|Nutrition|nutrition
1482795|NCT00845793|Lifestyle modifications|lifestyle modifications
1482796|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
1482797|NCT00845780|amiodarone|amiodarone
1482798|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
1482799|NCT00845780|adverse events|adverse events
1482800|NCT00845767|Nitric Oxide|nitric oxide
1482801|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
1482802|NCT00845767|Air Pollution|air pollution
1482803|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
1482804|NCT00845767|Diesel Exhaust|diesel exhaust
1482805|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
1482806|NCT00845754|Post-operative pain management|post-operative pain management
1482807|NCT00845728|Indacaterol|indacaterol
1482808|NCT00845728|Tiotropium|tiotropium
1482809|NCT00845728|COPD|copd
1482810|NCT00845715|rotator cuff|rotator cuff
1482811|NCT00845715|rehabilitation|rehabilitation
1482812|NCT00845715|range of motion|range of motion
1482813|NCT00845702|Renal artery stenosis|renal artery stenosis
1482814|NCT00845702|Contrast agent|contrast agent
1482815|NCT00845702|MRA|mra
1482816|NCT00845689|liver surgery|liver surgery
1482817|NCT00845676|Hepatitis C virus|hepatitis c virus
1482818|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
1482819|NCT00845676|HIV|hiv
1482820|NCT00845676|HCV|hcv
1482821|NCT00845663|certolizumab pegol|certolizumab pegol
1482822|NCT00845663|Cimzia|cimzia
1482823|NCT00845663|bioequivalence|bioequivalence
1482824|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
1482825|NCT00845650|Anthrax|anthrax
1482826|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
1482827|NCT00845650|Safety|safety
1482828|NCT00845650|Pharmacokinetics|pharmacokinetics
1482829|NCT00845637|eggplant|eggplant
1482830|NCT00845637|dyslipidemia|dyslipidemia
1482831|NCT00845637|postprandial lipemia|postprandial lipemia
1482832|NCT00845624|oxygen saturation|oxygen saturation
1482833|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
1482834|NCT00845624|long term outcomes|long term outcomes
1482835|NCT00845624|hypoxia|hypoxia
1482836|NCT00845624|hyperoxia|hyperoxia
1482837|NCT00845611|peptide vaccine|peptide vaccine
1482839|NCT00845598|Allergic Rhinitis|allergic rhinitis
1482840|NCT00845585|arterial reconstruction|arterial reconstruction
1482841|NCT00845585|bypass|bypass
1482842|NCT00845585|below knee|below knee
1482843|NCT00845585|PZFE|pzfe
1482844|NCT00845585|Ovine graft|ovine graft
1482845|NCT00845585|Omniflow II|omniflow ii
1482846|NCT00845585|graft patency|graft patency
1482847|NCT00845572|Schizophrenia|schizophrenia
1482848|NCT00845572|Schizoaffective|schizoaffective
1482849|NCT00845572|Risperdal Consta|risperdal consta
1482850|NCT00845572|Medication Adherence|medication adherence
1482851|NCT00845572|Antipsychotic|antipsychotic
1482852|NCT00845559|Childhood Obesity|childhood obesity
1482853|NCT00845559|Insulin resistance|insulin resistance
1482854|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
1482855|NCT00845559|Cardiovascular Disease|cardiovascular disease
1482856|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1482857|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
1482858|NCT00845559|Exenatide|exenatide
1482859|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
1567165|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1482860|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
1482861|NCT00845507|weight gain|weight gain
1482862|NCT00845494|Medication history|medication history
1482863|NCT00845494|medication errors|medication errors
1482864|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
1482865|NCT00845468|coronary flow reserve|coronary flow reserve
1482866|NCT00845468|diabetes mellitus|diabetes mellitus
1482867|NCT00845468|acute myocardial infarction|acute myocardial infarction
1482868|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
1482869|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
1482870|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
1482871|NCT00845442|vocal cord opening|vocal cord opening
1482872|NCT00845442|pulmonary function tests|pulmonary function tests
1482873|NCT00845429|Influenza|influenza
1482874|NCT00845429|Orthomyxoviruses|orthomyxoviruses
1482875|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
1482876|NCT00845429|cell-based vaccine|cell-based vaccine
1482877|NCT00845429|Adults|adults
1482878|NCT00845416|TREC|trec
1482879|NCT00845416|T cell|t cell
1482880|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
1482882|NCT00845416|Navajo|navajo
1482883|NCT00845416|SCID|scid
1482884|NCT00845403|Hepatitis B carrier|hepatitis b carrier
1482885|NCT00845377|Depression|depression
1482886|NCT00845377|Aging|aging
1482887|NCT00845377|Psychological well-being|psychological well-being
1482888|NCT00845377|Psychosocial intervention|psychosocial intervention
1482889|NCT00845364|Perhexiline|perhexiline
1482890|NCT00845364|Coronary artery bypass|coronary artery bypass
1482891|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
1482892|NCT00845364|Cardiac output, low|cardiac output, low
1482893|NCT00845364|Troponin|troponin
1482894|NCT00845351|Cushing's|cushing's
1482895|NCT00845338|Darifenacin|darifenacin
1482896|NCT00845338|Multiple Sclerosis|multiple sclerosis
1482897|NCT00845338|Open Label Study|open label study
1482898|NCT00845325|Carpal tunnel release|carpal tunnel release
1482899|NCT00845325|Rehabilitation|rehabilitation
1482900|NCT00845325|Early motion|early motion
1482901|NCT00845312|Age|age
1482902|NCT00845312|Mortality|mortality
1482903|NCT00845299|glaucoma|glaucoma
1482904|NCT00845299|ocular hypertension|ocular hypertension
1482905|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
1482906|NCT00845286|polymorphism|polymorphism
1482907|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
1482908|NCT00845247|Case Management|case management
1482909|NCT00845234|behavioral intervention|behavioral intervention
1482910|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1482911|NCT00845234|psychosocial education|psychosocial education
1482912|NCT00845234|anxiety|anxiety
1482913|NCT00845234|depression|depression
1482914|NCT00845208|Network Support|network support
1482915|NCT00845208|AA|aa
1482916|NCT00845208|Contingency Management|contingency management
1482917|NCT00845195|Rhinitis|rhinitis
1482918|NCT00845195|Allergy|allergy
1482919|NCT00845195|Nasal Spray|nasal spray
1482920|NCT00845195|Antihistamine|antihistamine
1482921|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
1482922|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
1482923|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
1482924|NCT00845182|Incretins|incretins
1482925|NCT00845182|Insulin secretion|insulin secretion
1482926|NCT00845169|Air Pollution|air pollution
1482927|NCT00845169|Nitric Oxide|nitric oxide
1482928|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
1482929|NCT00845169|Diesel exhaust|diesel exhaust
1482930|NCT00845169|endothelial dysfunction|endothelial dysfunction
1482931|NCT00845156|Diabetes|diabetes
1482932|NCT00845156|Insulin resistance|insulin resistance
1482933|NCT00845156|healthy controls|healthy controls
1482934|NCT00845156|anti oxidants|anti oxidants
1482935|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
1482936|NCT00845143|surgery|surgery
1482937|NCT00845143|lung function|lung function
1482941|NCT00845117|Aniridia,|aniridia,
1482942|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
1482943|NCT00845117|Ocular burns,|ocular burns,
1482944|NCT00845117|Pterygium|pterygium
1482945|NCT00845091|Parasympathetic activity|parasympathetic activity
1482946|NCT00845091|Exercise|exercise
1482947|NCT00845091|Education|education
1482948|NCT00845091|Arrhythmias|arrhythmias
1482949|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
1482950|NCT00845078|Breast|breast
1482951|NCT00845078|Radiotherapy|radiotherapy
1482952|NCT00845078|Esthetics|esthetics
1482953|NCT00845078|Treatment Outcome|treatment outcome
1634317|NCT00266773|CBT|cbt
1482954|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
1482955|NCT00845052|Housestaff|housestaff
1482956|NCT00845052|Patient Safety|patient safety
1482957|NCT00845052|Patient Care|patient care
1482958|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
1482959|NCT00845039|Tumors|tumors
1482960|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
1482961|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
1482962|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
1482963|NCT00845013|HIV infection|hiv infection
1482964|NCT00845013|pulmonary hypertension|pulmonary hypertension
1482965|NCT00845013|endothelial function|endothelial function
1482966|NCT00845013|antiretroviral medication|antiretroviral medication
1482967|NCT00845013|Treatment Experienced|treatment experienced
1482968|NCT00844987|PDGF|pdgf
1482970|NCT00844987|VEGF|vegf
1482971|NCT00844987|ACS|acs
1482972|NCT00844987|markers of myocardial injury|markers of myocardial injury
1482973|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1482974|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
1482975|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
1482976|NCT00844987|Strategies in ACS|strategies in acs
1482977|NCT00844961|IBS|ibs
1482978|NCT00844961|CBT|cbt
1482979|NCT00844961|Internet treatment|internet treatment
1482980|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
1482981|NCT00844948|Depression|depression
1482982|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
1482983|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
1482984|NCT00844909|CNTO 136|cnto 136
1482985|NCT00844909|safety|safety
1482986|NCT00844909|pharmacokinetics|pharmacokinetics
1482987|NCT00844909|healthy Japanese|healthy japanese
1482988|NCT00844909|healthy Caucasian|healthy caucasian
1482989|NCT00844909|Phase I|phase i
1482990|NCT00844909|antibody|antibody
1482991|NCT00844909|male.|male.
1482992|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
1482993|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
1482994|NCT00844883|primary liver cancer|primary liver cancer
1482995|NCT00844883|sorafenib|sorafenib
1482996|NCT00844883|Nexavar|nexavar
1482997|NCT00844883|doxorubicin|doxorubicin
1482998|NCT00844883|drug eluting beads|drug eluting beads
1482999|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
1483000|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
1483001|NCT00844857|Bipolar I Depression|bipolar i depression
1483002|NCT00844844|aHUS|ahus
1483003|NCT00844831|Constipation|constipation
1483004|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
1483005|NCT00844831|stool bacteria|stool bacteria
1483006|NCT00844818|smoking cessation|smoking cessation
1483007|NCT00844818|parents|parents
1483008|NCT00844792|Male Urogenital Diseases|male urogenital diseases
1483009|NCT00844792|Antioxidants|antioxidants
1483010|NCT00844792|Vitamin E|vitamin e
1483011|NCT00844792|Vitamin D|vitamin d
1483012|NCT00844792|Lycopene|lycopene
1483013|NCT00844792|Selenium|selenium
1483014|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
1483015|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
1483016|NCT00844766|Lactose intolerance|lactose intolerance
1483017|NCT00844766|Lactose|lactose
1483018|NCT00844766|Home-screening test|home-screening test
1483019|NCT00844766|Validate|validate
1483020|NCT00844753|Autism|autism
1483021|NCT00844753|PDD NOS|pdd nos
1483022|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1483023|NCT00844753|Parent Management Training|parent management training
1483024|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
1483025|NCT00844740|Cinacalcet|cinacalcet
1483026|NCT00844740|hyperparathyroidism|hyperparathyroidism
1483027|NCT00844714|endothelial function|endothelial function
1486412|NCT00830609|Genotype 3|genotype 3
1483028|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
1483029|NCT00844714|cardiovascular risk|cardiovascular risk
1483030|NCT00844714|rituxan therapy|rituxan therapy
1483031|NCT00844701|nicotine|nicotine
1483032|NCT00844701|addiction|addiction
1483033|NCT00844701|fMRI|fmri
1483034|NCT00844701|neuroimaging|neuroimaging
1483035|NCT00844701|neurobiology|neurobiology
1483036|NCT00844701|craving|craving
1483037|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
1483038|NCT00844688|Sorafenib|sorafenib
1483039|NCT00844688|Gemcitabine|gemcitabine
1483040|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
1483041|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
1483042|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1483043|NCT00844675|rabeprazole|rabeprazole
1483044|NCT00844662|Hyperphosphataemia|hyperphosphataemia
1483045|NCT00844662|phosphate binder|phosphate binder
1483046|NCT00844636|Needlestick injuries|needlestick injuries
1483047|NCT00844636|Glove perforations|glove perforations
1483048|NCT00844636|Blunt Needles|blunt needles
1483049|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
1483050|NCT00844636|Needlestick injuries of same|needlestick injuries of same
1483051|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
1483052|NCT00844584|Atrial fibrillation|atrial fibrillation
1483053|NCT00844584|radiofrequency|radiofrequency
1483054|NCT00844584|totally thoracoscope|totally thoracoscope
1483055|NCT00844584|epicardial|epicardial
1483056|NCT00844571|child abuse and neglect|child abuse and neglect
1483057|NCT00844571|child maltreatment|child maltreatment
1483058|NCT00844571|non accidental injury|non accidental injury
1483059|NCT00844571|training|training
1483060|NCT00844571|educational program|educational program
1483061|NCT00844558|osteoarthritis|osteoarthritis
1483062|NCT00844558|knee pain|knee pain
1483063|NCT00844558|gait training|gait training
1483064|NCT00844558|power training|power training
1483065|NCT00844558|rehabilitation|rehabilitation
1483066|NCT00844558|physical therapy|physical therapy
1483067|NCT00844545|aHUS|ahus
1483068|NCT00844532|Atherosclerosis|atherosclerosis
1483069|NCT00844532|Peripheral artery disease|peripheral artery disease
1483070|NCT00844532|Peripheral vascular disease|peripheral vascular disease
1483071|NCT00844532|PAD|pad
1483072|NCT00844532|Claudication|claudication
1483073|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1483074|NCT00844532|Stent|stent
1483075|NCT00844532|PAOD|paod
1483076|NCT00844532|PVD|pvd
1483077|NCT00844519|Treatment Experienced|treatment experienced
1483078|NCT00844519|CCR5 receptor|ccr5 receptor
1483079|NCT00844519|maraviroc|maraviroc
1483080|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
1483081|NCT00844493|diarrhea|diarrhea
1483082|NCT00844493|vaccine|vaccine
1483083|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
1483084|NCT00844493|colonization factor antigen|colonization factor antigen
1483085|NCT00844493|volunteer study|volunteer study
1483086|NCT00844480|spinal cord injury|spinal cord injury
1483087|NCT00844480|osteoporosis|osteoporosis
1483088|NCT00844480|bone loss|bone loss
1483089|NCT00844480|zoledronic acid|zoledronic acid
1483090|NCT00844480|bisphosphonate|bisphosphonate
1483091|NCT00844467|Risk factors|risk factors
1483092|NCT00844467|Case fatality|case fatality
1483093|NCT00844467|disease burden|disease burden
1483094|NCT00844467|Resistance|resistance
1483095|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
1483096|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
1483097|NCT00844454|PEI|pei
1483098|NCT00844454|RF ablation|rf ablation
1483099|NCT00844454|tumor ablation|tumor ablation
1483100|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1483101|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1483102|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1483103|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1483104|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1483105|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1483106|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1483107|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1483108|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1483109|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1483110|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1483111|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1483112|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1483113|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1483114|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1483115|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1483207|NCT00843908|Surgical Treatments|surgical treatments
1483116|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1483117|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
1483118|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
1483490|NCT00842751|androgen|androgen
1483119|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1483120|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1483121|NCT00844402|Cholestasis|cholestasis
1483122|NCT00844402|Atherosclerosis|atherosclerosis
1483123|NCT00844402|Statins|statins
1483124|NCT00844402|Vascular function|vascular function
1483125|NCT00844389|Open Angle Glaucoma|open angle glaucoma
1483126|NCT00844389|Biophotomodulation|biophotomodulation
1483127|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
1483128|NCT00844389|Neuroprotection|neuroprotection
1483129|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
1483130|NCT00844350|Oxytocin|oxytocin
1483131|NCT00844350|Letrozole|letrozole
1483132|NCT00844350|Induction of ovulation|induction of ovulation
1483133|NCT00844337|antibiotic regimens|antibiotic regimens
1483134|NCT00844337|sepsis|sepsis
1483135|NCT00844337|young infants|young infants
1483136|NCT00844337|Bangladeshi|bangladeshi
1483137|NCT00844337|outpatient treatment|outpatient treatment
1483138|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
1483139|NCT00844324|Candesartan|candesartan
1483140|NCT00844324|Bioequivalence|bioequivalence
1483142|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
1483143|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1483144|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1483145|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
1483146|NCT00844285|Crohn's Disease|crohn's disease
1483147|NCT00844272|Opiate Dependence|opiate dependence
1483148|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
1483149|NCT00844259|Down syndrome|down syndrome
1483150|NCT00844259|Pragmatics|pragmatics
1483151|NCT00844259|Language Development|language development
1483152|NCT00844246|Developmental delays|developmental delays
1483153|NCT00844246|Early intervention services|early intervention services
1483154|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
1483155|NCT00844207|Bioavailability|bioavailability
1483156|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
1483157|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
1483158|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
1483159|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
1483160|NCT00844142|etanercept|etanercept
1483161|NCT00844142|sulfasalazine|sulfasalazine
1483162|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
1483163|NCT00844129|spinal abnormalities|spinal abnormalities
1483164|NCT00844129|scoliosis|scoliosis
1483165|NCT00844116|COPD|copd
1483166|NCT00844116|spirometry|spirometry
1483167|NCT00844116|Telematic spirometry|telematic spirometry
1483168|NCT00844103|Volunteer|volunteer
1483169|NCT00844103|Safety|safety
1483170|NCT00844103|Tolerability|tolerability
1483171|NCT00844103|AZD8566|azd8566
1483172|NCT00844090|Apathy|apathy
1483173|NCT00844090|Diabetes|diabetes
1483174|NCT00844090|Self-care behaviors|self-care behaviors
1483175|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
1483176|NCT00844064|Pancreatic cancer|pancreatic cancer
1483177|NCT00844064|Metastatic melanoma|metastatic melanoma
1483178|NCT00844064|Advanced tumor|advanced tumor
1483179|NCT00844064|Targeted therapy|targeted therapy
1483180|NCT00844064|Antisense|antisense
1483181|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
1483182|NCT00844064|Dose escalation|dose escalation
1483183|NCT00844051|Influenza|influenza
1483184|NCT00844051|influenza vaccination|influenza vaccination
1483185|NCT00844051|school-based vaccination|school-based vaccination
1483186|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
1483187|NCT00844038|erythema multiform|erythema multiform
1483188|NCT00844038|autoimmune disease|autoimmune disease
1483189|NCT00844025|Adverse drug reaction|adverse drug reaction
1483190|NCT00844025|Inappropriate medication|inappropriate medication
1483191|NCT00844025|Pharmacist|pharmacist
1483192|NCT00844025|Pharmaceutical care|pharmaceutical care
1483193|NCT00843986|hyponatremia|hyponatremia
1483194|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
1483195|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
1483196|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
1483197|NCT00843986|conivaptan|conivaptan
1483198|NCT00843986|Vaprisol|vaprisol
1483199|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
1483200|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
1483201|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1483202|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
1483203|NCT00843934|Epirubicin|epirubicin
1483204|NCT00843934|Cisplatin|cisplatin
1483205|NCT00843921|Hyperammonemia|hyperammonemia
1483206|NCT00843908|Stress incontinence|stress incontinence
1483208|NCT00843908|Minislings|minislings
1483209|NCT00843895|Laboratory based study|laboratory based study
1483210|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
1483211|NCT00843895|invasive strains|invasive strains
1483212|NCT00843843|Circadian Rhythms|circadian rhythms
1483213|NCT00843817|cystic fibrosis|cystic fibrosis
1635308|NCT00262574|BNP|bnp
1483214|NCT00843804|nosocomial infection|nosocomial infection
1483215|NCT00843804|bloodstream infection|bloodstream infection
1483216|NCT00843804|central venous catheter|central venous catheter
1483217|NCT00843804|invasive Aspergillosis|invasive aspergillosis
1483218|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
1483219|NCT00843791|obesity|obesity
1483220|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
1483221|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
1483222|NCT00843778|Certolizumab Pegol|certolizumab pegol
1483223|NCT00843765|Stroke|stroke
1483224|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
1483225|NCT00843765|Rehabilitation|rehabilitation
1483226|NCT00843739|Breathing|breathing
1483227|NCT00843739|Cough|cough
1483228|NCT00843739|Speech|speech
1483229|NCT00843739|Swallow|swallow
1483230|NCT00843739|Parkinson's disease|parkinson's disease
1483231|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1483232|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1483233|NCT00843713|HIV|hiv
1483234|NCT00843713|endothelium|endothelium
1483235|NCT00843713|inflammation|inflammation
1483236|NCT00843713|Treatment Experienced|treatment experienced
1483237|NCT00843687|Schizophrenia|schizophrenia
1483238|NCT00843687|Risperidone|risperidone
1483239|NCT00843687|Long-acting injectable|long-acting injectable
1483240|NCT00843687|Intramuscular injection|intramuscular injection
1483241|NCT00843687|Pharmacokinetics|pharmacokinetics
1483242|NCT00843661|Treatment Experienced|treatment experienced
1483243|NCT00843648|antibody immune profile|antibody immune profile
1483244|NCT00843648|preterm|preterm
1483245|NCT00843648|c-section|c-section
1483246|NCT00843648|breastfeeding|breastfeeding
1483247|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1483248|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1483249|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1483250|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1483251|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1483252|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1483253|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1483254|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1483255|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1483256|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1483257|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1483258|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1483259|NCT00843622|Smoking|smoking
1483260|NCT00843622|Smoking cessation|smoking cessation
1483261|NCT00843622|Smokeless tobacco|smokeless tobacco
1483262|NCT00843622|Snus|snus
1483263|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
1483264|NCT00843609|hypoglycemia|hypoglycemia
1483265|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
1483266|NCT00843609|HbA1c|hba1c
1483267|NCT00843609|glycemic variability|glycemic variability
1483268|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
1483269|NCT00843583|prevalence|prevalence
1483270|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
1483271|NCT00843583|resistant hypertension|resistant hypertension
1483272|NCT00843570|IVF|ivf
1483273|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
1483274|NCT00843557|critical illness|critical illness
1483275|NCT00843557|intensive care|intensive care
1483276|NCT00843557|nosocomial infection|nosocomial infection
1483277|NCT00843531|neuroendocrine|neuroendocrine
1483278|NCT00843531|islet cell|islet cell
1483279|NCT00843531|carcinoid|carcinoid
1483280|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
1483281|NCT00843531|paraganglioma|paraganglioma
1483282|NCT00843531|pheochromocytoma|pheochromocytoma
1483283|NCT00843531|RAD001|rad001
1483284|NCT00843531|everolimus|everolimus
1483285|NCT00843531|erlotinib|erlotinib
1483286|NCT00843531|Tarceva|tarceva
1483287|NCT00843518|Agitation and Aggression|agitation and aggression
1483288|NCT00843505|Smoking Cessation|smoking cessation
1483289|NCT00843505|Motivational Interviewing|motivational interviewing
1483290|NCT00843505|Quitline|quitline
1483291|NCT00843505|Telemedicine|telemedicine
1483292|NCT00843505|Stop Smoking Medication|stop smoking medication
1483293|NCT00843492|deep vein thrombosis|deep vein thrombosis
1483294|NCT00843492|immobilization|immobilization
1483295|NCT00843492|nadroparin|nadroparin
1483296|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
1483297|NCT00843492|plaster cast|plaster cast
1483298|NCT00843492|non-surgical leg injury|non-surgical leg injury
1483299|NCT00843492|venous thromboembolism|venous thromboembolism
1483300|NCT00843492|bleeding events|bleeding events
1483301|NCT00843492|fondaparinux|fondaparinux
1483302|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
1483303|NCT00843479|Insulin resistance|insulin resistance
1483305|NCT00843479|Incretins|incretins
1483306|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
1483307|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
1483308|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1483309|NCT00843479|insulin|insulin
1634715|NCT00265499|Length|length
1483310|NCT00843479|glucagon|glucagon
1483311|NCT00843479|ghrelin|ghrelin
1483312|NCT00843466|Hand dermatitis|hand dermatitis
1483313|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
1483314|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
1483315|NCT00843453|proton pump inhibitors|proton pump inhibitors
1483316|NCT00843453|omeprazole|omeprazole
1483317|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
1483318|NCT00843440|Bevacuzimab|bevacuzimab
1483319|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
1483320|NCT00843427|aphasia|aphasia
1483321|NCT00843427|stroke|stroke
1483322|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
1483323|NCT00843427|fMRI|fmri
1483324|NCT00843427|language recovery after stroke|language recovery after stroke
1483325|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
1483326|NCT00843427|CIAT|ciat
1483327|NCT00843414|Emphysema|emphysema
1483328|NCT00843414|Sarcoidosis|sarcoidosis
1483329|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
1483330|NCT00843401|Low oxygen saturation|low oxygen saturation
1483331|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
1483332|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
1483333|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
1483334|NCT00843401|Blood Gas Analyzer|blood gas analyzer
1483335|NCT00843349|Phosphorus|phosphorus
1483336|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
1483337|NCT00843349|Kidney Disease|kidney disease
1483338|NCT00843336|fertility monitoring|fertility monitoring
1483339|NCT00843336|contraception|contraception
1483340|NCT00843310|multiple myeloma|multiple myeloma
1483341|NCT00843310|frontline treatment|frontline treatment
1483342|NCT00843310|first-line treatment|first-line treatment
1483343|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
1483344|NCT00843297|Hypothermia|hypothermia
1483345|NCT00843297|Outcome, neurological|outcome, neurological
1483346|NCT00843297|Coolgard|coolgard
1483347|NCT00843297|ArcticSun|arcticsun
1483348|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
1483349|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
1483350|NCT00843258|therapy|therapy
1483351|NCT00843258|ultrasound|ultrasound
1483352|NCT00843258|mild dysplasia|mild dysplasia
1483353|NCT00843245|Heart Failure|heart failure
1483354|NCT00843245|Electric bioimpedance|electric bioimpedance
1483355|NCT00843245|Body composition|body composition
1483356|NCT00843245|Diagnosis|diagnosis
1483357|NCT00843245|monitoring|monitoring
1483358|NCT00843245|Prognosis|prognosis
1483359|NCT00843245|Total body water|total body water
1483360|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
1483361|NCT00843232|Insulin resistance|insulin resistance
1483362|NCT00843232|Aging|aging
1483363|NCT00843232|Incretins|incretins
1483364|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
1483365|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
1483366|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1483367|NCT00843232|insulin|insulin
1483368|NCT00843232|glucagon|glucagon
1483369|NCT00843232|ghrelin|ghrelin
1483370|NCT00843219|Lung|lung
1483371|NCT00843219|Lung Cancer|lung cancer
1483372|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
1483373|NCT00843219|NSCLC|nsclc
1483374|NCT00843219|Motion Correction|motion correction
1483375|NCT00843219|PET/CT Scan|pet/ct scan
1483376|NCT00843219|PET|pet
1483377|NCT00843219|Positron Emission Tomography|positron emission tomography
1483378|NCT00843219|CT|ct
1483379|NCT00843219|Computed Tomography|computed tomography
1483380|NCT00843219|Amplitude Gating|amplitude gating
1483381|NCT00843193|Asthma|asthma
1483382|NCT00843193|Asthma control questionnaire|asthma control questionnaire
1483383|NCT00843180|Bone Marrow Transplant|bone marrow transplant
1483384|NCT00843180|Massage|massage
1483385|NCT00843180|Pediatric Oncology|pediatric oncology
1483386|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
1483387|NCT00843167|mammography|mammography
1483388|NCT00843167|biopsy|biopsy
1483389|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1483390|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
1483391|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
1483778|NCT00841607|fistula|fistula
1483392|NCT00843154|Biological Markers|biological markers
1483393|NCT00843154|Biomarkers|biomarkers
1483394|NCT00843154|Cardiac Failure|cardiac failure
1483395|NCT00843154|Congestive Heart Failure|congestive heart failure
1483396|NCT00843154|Heart Decompensation|heart decompensation
1483397|NCT00843154|Drug Therapy|drug therapy
1483398|NCT00843141|ADHD|adhd
1483399|NCT00843141|Executive functions|executive functions
1483400|NCT00843141|Quality of life|quality of life
1483401|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
1483402|NCT00843102|atherosclerosis|atherosclerosis
1483403|NCT00843102|pulmonary hypertension|pulmonary hypertension
1483404|NCT00843089|coronary artery disease|coronary artery disease
1483405|NCT00843089|CABG|cabg
1483406|NCT00843063|pantoprazole|pantoprazole
1483407|NCT00843063|famotidine|famotidine
1483408|NCT00843063|aspirin|aspirin
1483409|NCT00843063|dyspepsia|dyspepsia
1483410|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
1483411|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
1483412|NCT00843050|CKD inhibitor|ckd inhibitor
1483413|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
1483414|NCT00843037|PARAGANGLIOMA|paraganglioma
1483415|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
1483416|NCT00843037|SUNITINIB|sunitinib
1483417|NCT00843037|PHASE II|phase ii
1483418|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
1483419|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
1483420|NCT00843024|Migraine with or without aura|migraine with or without aura
1483421|NCT00843024|Migraine efficacy|migraine efficacy
1483422|NCT00843024|Migraine|migraine
1483423|NCT00843024|Migraine headache|migraine headache
1483424|NCT00843024|Adolescent migraine|adolescent migraine
1483425|NCT00843024|TREXIMET|treximet
1483426|NCT00843024|Sumatriptan succinate|sumatriptan succinate
1483427|NCT00843024|Naproxen sodium|naproxen sodium
1483428|NCT00843024|Migraine, acute|migraine, acute
1483429|NCT00843011|formulation|formulation
1483430|NCT00843011|safety and tolerability|safety and tolerability
1483431|NCT00843011|pharmacokinetics|pharmacokinetics
1483432|NCT00843011|NK1 antagonist|nk1 antagonist
1483433|NCT00843011|effect of food|effect of food
1483434|NCT00842998|breast cancer|breast cancer
1483435|NCT00842998|HER2|her2
1483436|NCT00842998|Trastuzumab|trastuzumab
1483437|NCT00842998|Lapatinib|lapatinib
1483438|NCT00842998|HER2 gene-amplification|her2 gene-amplification
1483439|NCT00842985|Cannabis Abuse|cannabis abuse
1483440|NCT00842985|Cannabis Dependence|cannabis dependence
1483441|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
1483442|NCT00842985|Marijuana Dependence|marijuana dependence
1483443|NCT00842985|Marihuana Abuse|marihuana abuse
1483444|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
1483445|NCT00842933|Septic shock|septic shock
1483446|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
1483447|NCT00842920|amnestic MCI|amnestic mci
1483448|NCT00842907|Brazil|brazil
1483449|NCT00842907|isotretinoin|isotretinoin
1483450|NCT00842907|photodamage|photodamage
1483451|NCT00842907|photoaging|photoaging
1483452|NCT00842881|Healingstone|healingstone
1483453|NCT00842868|atherosclerosis|atherosclerosis
1483454|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
1483455|NCT00842868|renal impairment|renal impairment
1483456|NCT00842868|catheterization|catheterization
1483457|NCT00842855|GERD|gerd
1483458|NCT00842855|PPI|ppi
1483459|NCT00842855|partial responders|partial responders
1483460|NCT00842842|surgical fixation devices|surgical fixation devices
1483461|NCT00842842|postoperative pain|postoperative pain
1483462|NCT00842842|ventral hernia|ventral hernia
1483463|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
1483464|NCT00842842|laparoscopy|laparoscopy
1483465|NCT00842842|quality of life|quality of life
1483466|NCT00842842|fatigue|fatigue
1483467|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
1483468|NCT00842816|Dementia|dementia
1483469|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
1483470|NCT00842816|Cognitive impairment|cognitive impairment
1483471|NCT00842803|Liver|liver
1483472|NCT00842803|transplant|transplant
1483473|NCT00842803|albumin|albumin
1483474|NCT00842803|outcome|outcome
1483475|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
1483476|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
1483477|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
1483478|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
1483479|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
1483480|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
1483481|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
1483482|NCT00842777|Childhood obesity|childhood obesity
1483483|NCT00842777|Quality of life|quality of life
1483484|NCT00842777|Self-esteem|self-esteem
1483485|NCT00842777|BMI|bmi
1483486|NCT00842777|parental group treatment|parental group treatment
1483487|NCT00842777|Body image|body image
1483488|NCT00842764|eyelid fat pads|eyelid fat pads
1483489|NCT00842751|5α-reductase|5α-reductase
1483491|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
1483492|NCT00842751|drug delivery|drug delivery
1483493|NCT00842751|oestradiol|oestradiol
1483494|NCT00842738|Screening|screening
1483495|NCT00842738|Cervical cancer|cervical cancer
1483496|NCT00842738|Cervical dysplasia|cervical dysplasia
1483497|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
1483498|NCT00842738|Alternative treatment|alternative treatment
1483499|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
1483500|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
1483501|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
1483502|NCT00842686|rectal cancer|rectal cancer
1483503|NCT00842686|capecitabine|capecitabine
1483504|NCT00842686|bevacizumab|bevacizumab
1483505|NCT00842686|radiotherapy|radiotherapy
1483506|NCT00842673|Dementia|dementia
1483507|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
1483508|NCT00842673|Cognitive impairment|cognitive impairment
1483509|NCT00842660|Cervical cancer|cervical cancer
1483510|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1483511|NCT00842660|gemcitabine|gemcitabine
1483512|NCT00842647|Sensitivity|sensitivity
1483513|NCT00842647|specificity|specificity
1483514|NCT00842647|positive rate|positive rate
1483515|NCT00842647|negative rate|negative rate
1483516|NCT00842634|HIV|hiv
1483517|NCT00842634|Treatment Experienced|treatment experienced
1483518|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
1483519|NCT00842621|Hemolysis|hemolysis
1483520|NCT00842608|confusion|confusion
1483521|NCT00842608|dementia|dementia
1483522|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
1483523|NCT00842595|Chemotherapy|chemotherapy
1483524|NCT00842582|Ovarian cancer|ovarian cancer
1483525|NCT00842582|chemotherapy|chemotherapy
1483526|NCT00842582|azacitidine|azacitidine
1483527|NCT00842569|obesity|obesity
1483528|NCT00842569|cognitive process|cognitive process
1483529|NCT00842569|reward|reward
1483530|NCT00842569|P300|p300
1483531|NCT00842569|ERP|erp
1483532|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
1483533|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
1483534|NCT00842569|externalizing factor|externalizing factor
1483535|NCT00842543|Nutrition|nutrition
1483536|NCT00842543|Oxidative Stress|oxidative stress
1483537|NCT00842543|Insulin Resistance|insulin resistance
1483538|NCT00842543|Whole Food Supplement|whole food supplement
1483539|NCT00842543|Pediatric|pediatric
1483540|NCT00842543|Retinoids|retinoids
1483541|NCT00842543|Antioxidants|antioxidants
1483542|NCT00842543|Dietary Supplements|dietary supplements
1483543|NCT00842530|Dengue virus|dengue virus
1483544|NCT00842530|Dengue fever|dengue fever
1483545|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
1483546|NCT00842530|Dengue diseases|dengue diseases
1483547|NCT00842530|Dengue vaccine|dengue vaccine
1483548|NCT00842517|Cocaine Dependence|cocaine dependence
1483549|NCT00842517|Cocaine Abuse|cocaine abuse
1483550|NCT00842517|Substance Abuse|substance abuse
1483551|NCT00842517|Contingency Management|contingency management
1483552|NCT00842517|Drug Treatment|drug treatment
1483553|NCT00842504|Anti-fungal|anti-fungal
1483554|NCT00842504|Immunocompromised|immunocompromised
1483555|NCT00842504|Pharmacokinetic|pharmacokinetic
1483556|NCT00842504|Prophylaxis|prophylaxis
1483557|NCT00842504|Pharmacokinetics|pharmacokinetics
1483558|NCT00842465|Breast diseases,|breast diseases,
1483559|NCT00842465|human mutation,|human mutation,
1483560|NCT00842465|prolactin receptor;|prolactin receptor;
1483561|NCT00842465|breast cancer|breast cancer
1483562|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1483563|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1483564|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1483565|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1483566|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1483567|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1483568|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1483569|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
1483570|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1483571|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
1483572|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
1483573|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
1483574|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
1483575|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
1483576|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
1483577|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
1483578|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
1483579|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
1483580|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
1483581|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
1483582|NCT00842452|stage III cervical cancer|stage iii cervical cancer
1483583|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
1483584|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
1483585|NCT00842452|fallopian tube cancer|fallopian tube cancer
1483586|NCT00842452|ovarian sarcoma|ovarian sarcoma
1483587|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
1483588|NCT00842439|aggression|aggression
1483589|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
1483590|NCT00842426|Diabetes|diabetes
1483591|NCT00842426|Cardiovascular disease|cardiovascular disease
1483592|NCT00842426|Metabolic syndrome|metabolic syndrome
1483593|NCT00842426|Cardiometabolic|cardiometabolic
1483594|NCT00842413|Prefrontal cortex|prefrontal cortex
1483595|NCT00842413|visual consciousness|visual consciousness
1483596|NCT00842413|focal lesions|focal lesions
1483597|NCT00842413|action perception|action perception
1483598|NCT00842400|Obesity|obesity
1483599|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
1483600|NCT00842387|reflux, heartburn|reflux, heartburn
1483601|NCT00842387|regurgitation|regurgitation
1483602|NCT00842387|acid control|acid control
1483603|NCT00842387|PPI|ppi
1483604|NCT00842387|antiacid|antiacid
1483605|NCT00842387|primary care|primary care
1483606|NCT00842387|esophagitis|esophagitis
1483607|NCT00842348|Lanreotide|lanreotide
1483608|NCT00842348|Somatuline|somatuline
1483609|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
1483610|NCT00842348|NET|net
1483611|NCT00842335|solid tumors|solid tumors
1483612|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
1483613|NCT00842335|dose escalation|dose escalation
1483614|NCT00842335|maximum tolerated dose|maximum tolerated dose
1483615|NCT00842335|JI-101|ji-101
1483616|NCT00842322|chronic kidney disease|chronic kidney disease
1483617|NCT00842322|transplantation|transplantation
1483618|NCT00842322|kidney function|kidney function
1483619|NCT00842322|fluid intake|fluid intake
1483620|NCT00842322|osmolarity|osmolarity
1483621|NCT00842296|GSV|gsv
1483622|NCT00842296|RadioFrequency|radiofrequency
1483623|NCT00842283|dermatologic diseases|dermatologic diseases
1483624|NCT00842270|severe asthma|severe asthma
1483625|NCT00842270|corticosteroids dependent|corticosteroids dependent
1483626|NCT00842270|asthma exacerbation|asthma exacerbation
1483627|NCT00842270|weaning|weaning
1483628|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1483629|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
1483630|NCT00842257|panitumumab|panitumumab
1483631|NCT00842257|cetuximab|cetuximab
1483632|NCT00842257|KRAS wild-type|kras wild-type
1483633|NCT00842231|Corneal astigmatism|corneal astigmatism
1483634|NCT00842231|post-cataract surgery|post-cataract surgery
1483635|NCT00842231|visual performance|visual performance
1483636|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
1483637|NCT00842218|Gait|gait
1483638|NCT00842218|scoliosis|scoliosis
1483639|NCT00842218|energy|energy
1483640|NCT00842218|mechanics|mechanics
1483641|NCT00842205|hepatitis C|hepatitis c
1483642|NCT00842205|NASH|nash
1483643|NCT00842205|Hem Oxygenase|hem oxygenase
1483644|NCT00842205|Gene polymorphism|gene polymorphism
1483645|NCT00842179|Perclose|perclose
1483646|NCT00842153|Psoriasis|psoriasis
1483647|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
1483648|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
1483649|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
1483650|NCT00842140|Cardiovascular Disease|cardiovascular disease
1483651|NCT00842140|Endothelium|endothelium
1483652|NCT00842127|Methylphenidate|methylphenidate
1483653|NCT00842127|ADHD|adhd
1483654|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
1483655|NCT00842127|OROS methylphenidate|oros methylphenidate
1483656|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
1483657|NCT00842114|Follicular Lymphoma|follicular lymphoma
1483658|NCT00842114|Progression free survival|progression free survival
1483659|NCT00842101|Intramedullary nails|intramedullary nails
1483660|NCT00842101|Compartmental syndrome|compartmental syndrome
1483661|NCT00842101|Fractures|fractures
1483662|NCT00842075|type 1 diabetes|type 1 diabetes
1483663|NCT00842075|adolescents|adolescents
1483664|NCT00842075|post prandial glucose|post prandial glucose
1483665|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
1483666|NCT00842049|Aneurysm|aneurysm
1483667|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
1483668|NCT00842036|Family Therapy|family therapy
1483669|NCT00842036|Relationship Dysfunction|relationship dysfunction
1483670|NCT00842036|Family Dysfunction|family dysfunction
1483671|NCT00842036|Family Relations|family relations
1483672|NCT00842036|Stimulant Dependence|stimulant dependence
1483673|NCT00842036|Opiate Dependence|opiate dependence
1483674|NCT00842036|Alcohol Dependence|alcohol dependence
1483675|NCT00842036|Behavior Therapy|behavior therapy
1483676|NCT00842036|Drug Treatment|drug treatment
1483677|NCT00842036|Substance Abuse|substance abuse
1483678|NCT00842036|Drug Addiction|drug addiction
1483679|NCT00842023|Natriuretic peptides|natriuretic peptides
1483680|NCT00842023|BNP|bnp
1483681|NCT00842023|Heart Failure|heart failure
1483682|NCT00842023|Nitoglycerin|nitoglycerin
1483683|NCT00842023|Biomarkers|biomarkers
1483684|NCT00842010|Diabetes|diabetes
1483685|NCT00842010|Inpatient|inpatient
1483686|NCT00842010|Hospital|hospital
1483687|NCT00842010|Hyperglycemia|hyperglycemia
1483688|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1483689|NCT00841984|neurological diseases|neurological diseases
1483690|NCT00841984|metabolic|metabolic
1483691|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
1483692|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
1483693|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
1483694|NCT00841945|Chemotherapy|chemotherapy
1483695|NCT00841945|Radiotherapy|radiotherapy
1483696|NCT00841932|Fractional Flow Reserve|fractional flow reserve
1483697|NCT00841932|Without anticoagulation|without anticoagulation
1483698|NCT00841919|Diabetes|diabetes
1483699|NCT00841919|Inpatient|inpatient
1483700|NCT00841919|Insulin|insulin
1483701|NCT00841919|Insulin pen|insulin pen
1483702|NCT00841893|Thermogenesis|thermogenesis
1483703|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
1483704|NCT00841893|Energy expenditure|energy expenditure
1483705|NCT00841893|Fat oxidation|fat oxidation
1483706|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
1483707|NCT00841893|Bioactive ingredient|bioactive ingredient
1483708|NCT00841893|Spice|spice
1483709|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
1483710|NCT00841867|Diabetes|diabetes
1483711|NCT00841854|Helicobacter pylori|helicobacter pylori
1483712|NCT00841854|Bismuth|bismuth
1483713|NCT00841854|Salvage treatment|salvage treatment
1483714|NCT00841854|Metronidazole|metronidazole
1483715|NCT00841841|Analgesia|analgesia
1483716|NCT00841841|molar third|molar third
1483717|NCT00841841|acetaminophen|acetaminophen
1483718|NCT00841841|dipyrone|dipyrone
1483719|NCT00841815|Bioequivalence|bioequivalence
1483720|NCT00841815|Healthy Subjects|healthy subjects
1483721|NCT00841802|Chronic sinusitis|chronic sinusitis
1483722|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
1483723|NCT00841802|Nasal polyps|nasal polyps
1483724|NCT00841789|Etanercept|etanercept
1483725|NCT00841776|Acne Vulgaris|acne vulgaris
1483726|NCT00841776|Acne|acne
1483727|NCT00841763|virus|virus
1483728|NCT00841763|pandemic influenza|pandemic influenza
1483729|NCT00841763|vaccine|vaccine
1483730|NCT00841750|Chest Tubes|chest tubes
1483731|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
1483732|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
1483733|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
1483734|NCT00841737|Depressive Disorders;|depressive disorders;
1483735|NCT00841737|Primary Health Care;|primary health care;
1483736|NCT00841737|Nurses;|nurses;
1483737|NCT00841737|Health education.|health education.
1483738|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1483739|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
1483740|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
1483741|NCT00841724|Hematological malignancies|hematological malignancies
1483742|NCT00841724|IV Busulfan|iv busulfan
1483743|NCT00841711|HIV|hiv
1483744|NCT00841711|AIDS|aids
1483745|NCT00841711|Buprenorphine|buprenorphine
1483746|NCT00841711|Intensive Case Management|intensive case management
1483747|NCT00841711|Money Management|money management
1483748|NCT00841711|Rapid Testing|rapid testing
1483749|NCT00841711|Substance Abuse|substance abuse
1483750|NCT00841711|Opioid Dependance|opioid dependance
1483751|NCT00841711|Inmate Population|inmate population
1483752|NCT00841698|Bioequivalence|bioequivalence
1483753|NCT00841698|Healthy Subjects|healthy subjects
1483754|NCT00841672|Hypertension|hypertension
1483755|NCT00841672|systolic blood pressure|systolic blood pressure
1483756|NCT00841672|cardiovascular disease|cardiovascular disease
1483757|NCT00841672|aliskiren|aliskiren
1483758|NCT00841672|amlodipine|amlodipine
1483759|NCT00841659|Bioequivalence|bioequivalence
1483760|NCT00841659|Healthy Subjects|healthy subjects
1483761|NCT00841646|Influenza vaccine|influenza vaccine
1483762|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
1483763|NCT00841633|ischemia|ischemia
1483764|NCT00841633|vasospasm|vasospasm
1483765|NCT00841633|CT|ct
1483766|NCT00841633|perfusion|perfusion
1483767|NCT00841633|induced hypertension|induced hypertension
1483768|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
1483769|NCT00841620|Symptoms|symptoms
1483770|NCT00841620|Postoperative pain|postoperative pain
1483771|NCT00841620|Postoperative complications|postoperative complications
1483772|NCT00841620|Milligan|milligan
1483773|NCT00841620|Anopxy|anopxy
1483774|NCT00841607|whipple|whipple
1483775|NCT00841607|pancreas|pancreas
1483776|NCT00841607|reconstruction|reconstruction
1483777|NCT00841607|leak|leak
1483779|NCT00841594|healthy volunteers|healthy volunteers
1483780|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
1483781|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
1483782|NCT00841581|Intravitreal Detachment|intravitreal detachment
1483783|NCT00841581|Anti-VEGF|anti-vegf
1483784|NCT00841568|ADPKD|adpkd
1483785|NCT00841568|Tolvaptan|tolvaptan
1483786|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
1483787|NCT00841555|adult gliosarcoma|adult gliosarcoma
1483788|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1483789|NCT00841555|adult glioblastoma|adult glioblastoma
1483790|NCT00841555|GBM/AA|gbm/aa
1483791|NCT00841542|Bioequivalence|bioequivalence
1483792|NCT00841542|Healthy Subjects|healthy subjects
1483793|NCT00841529|left atrial appendage|left atrial appendage
1483795|NCT00841529|atrial fibrillation|atrial fibrillation
1483796|NCT00841529|AF|af
1483797|NCT00841516|Specific immunotherapy|specific immunotherapy
1483798|NCT00841516|SIT|sit
1483799|NCT00841516|SCIT|scit
1483800|NCT00841516|recombinant|recombinant
1483801|NCT00841516|Type 1 - Allergy|type 1 - allergy
1483802|NCT00841503|functional food study|functional food study
1483803|NCT00841490|Helicobacter pylori|helicobacter pylori
1483804|NCT00841490|Oral Health|oral health
1483805|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
1483806|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
1483807|NCT00841464|Parkinson's disease|parkinson's disease
1483808|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1483809|NCT00841451|Atrial Fibrillation|atrial fibrillation
1483810|NCT00841451|Persistent|persistent
1483811|NCT00841451|Paroxysmal|paroxysmal
1483812|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
1483813|NCT00841451|Omega three fatty acids|omega three fatty acids
1483814|NCT00841451|Fish Oils|fish oils
1483815|NCT00841438|Angioplasty|angioplasty
1483816|NCT00841438|Transluminal|transluminal
1483817|NCT00841438|Percutaneous Coronary|percutaneous coronary
1483818|NCT00841412|Usual Care Control Group|usual care control group
1483819|NCT00841399|Breast cancer|breast cancer
1483820|NCT00841386|Cornea|cornea
1483821|NCT00841386|Keratoconus|keratoconus
1483822|NCT00841386|Ectasia|ectasia
1483823|NCT00841386|Riboflavin|riboflavin
1483824|NCT00841386|Collagen cross-linking|collagen cross-linking
1483825|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
1483826|NCT00841360|Social network|social network
1483827|NCT00841360|Asymptomatic HIV|asymptomatic hiv
1483828|NCT00841347|Obesity|obesity
1483829|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
1483830|NCT00841347|Appetite regulation|appetite regulation
1483831|NCT00841347|Sleep|sleep
1483832|NCT00841347|Adolescent|adolescent
1483833|NCT00841347|Randomized controlled trials|randomized controlled trials
1483834|NCT00841334|Adolescent|adolescent
1483835|NCT00841334|Overweight|overweight
1483836|NCT00841334|Obesity|obesity
1483837|NCT00841334|Weight loss|weight loss
1483838|NCT00841334|Nutrition|nutrition
1483839|NCT00841334|Physical activity|physical activity
1483840|NCT00841334|Community-based participatory research|community-based participatory research
1483841|NCT00841334|School-based|school-based
1483842|NCT00841334|Primary Care|primary care
1483843|NCT00841334|Motivational interviewing|motivational interviewing
1483844|NCT00841321|Ginkgo biloba|ginkgo biloba
1483845|NCT00841321|Multiple Sclerosis|multiple sclerosis
1483846|NCT00841321|Cognition|cognition
1483847|NCT00841321|Neuropsychological Tests|neuropsychological tests
1483848|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
1483849|NCT00841321|Quality of life|quality of life
1483850|NCT00841321|Randomized Controlled Trials|randomized controlled trials
1483851|NCT00841321|Placebos|placebos
1483852|NCT00841321|Double-Blind Method|double-blind method
1483853|NCT00841282|Colorectal cancer screening|colorectal cancer screening
1483854|NCT00841282|Optical colonoscopy|optical colonoscopy
1483855|NCT00841282|Water method|water method
1483856|NCT00841282|Sedation|sedation
1483857|NCT00841269|Bipolar Manic Depression|bipolar manic depression
1483858|NCT00841256|specific immunotherapy|specific immunotherapy
1483859|NCT00841256|SIT|sit
1483860|NCT00841256|SLIT|slit
1483861|NCT00841256|sublingual|sublingual
1483862|NCT00841243|Hepatitis C|hepatitis c
1483863|NCT00841243|Antiviral therapy|antiviral therapy
1483864|NCT00841243|weight loss|weight loss
1483865|NCT00841243|dietary support|dietary support
1483866|NCT00841243|dietary advise|dietary advise
1483867|NCT00841230|Tinnitus|tinnitus
1483868|NCT00841217|Drug treatment|drug treatment
1483869|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
1483870|NCT00841191|Interleukin-6|interleukin-6
1483871|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
1483872|NCT00841191|Immunologic Factors|immunologic factors
1483873|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
1483874|NCT00841191|KRAS protein, human|kras protein, human
1483875|NCT00841191|CNTO 328|cnto 328
1483876|NCT00841178|Randomised controlled trial|randomised controlled trial
1483877|NCT00841178|Venous insufficiency|venous insufficiency
1483878|NCT00841178|Varicose veins|varicose veins
1483879|NCT00841178|Quality of Life|quality of life
1483880|NCT00841178|Clinical effectiveness|clinical effectiveness
1483881|NCT00841178|Cost effectiveness|cost effectiveness
1485326|NCT00835302|Thoracic|thoracic
1483882|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
1483884|NCT00841165|Monoxide|monoxide
1483885|NCT00841165|Poisoning|poisoning
1483886|NCT00841165|Toxicity|toxicity
1483887|NCT00841165|Treatment|treatment
1483888|NCT00841165|CPAP|cpap
1483889|NCT00841165|Hyperbaric|hyperbaric
1483890|NCT00841165|Oxygen|oxygen
1483891|NCT00841152|Bone tumors|bone tumors
1483892|NCT00841152|Surgery|surgery
1483893|NCT00841152|Bone graft substitutes|bone graft substitutes
1483894|NCT00841152|Bioactive glass|bioactive glass
1483895|NCT00841152|Bioceramics|bioceramics
1483896|NCT00841152|Bone autograft|bone autograft
1483897|NCT00841152|Bone allograft|bone allograft
1483898|NCT00841139|perhexiline|perhexiline
1483899|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
1483900|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1483901|NCT00841139|cardiac energetics|cardiac energetics
1483902|NCT00841126|Hyperphosphatemia|hyperphosphatemia
1483903|NCT00841126|Phosphate binder|phosphate binder
1483904|NCT00841113|Prostate cancer|prostate cancer
1483905|NCT00841113|Advanced|advanced
1483906|NCT00841113|Metastatic|metastatic
1483907|NCT00841100|PKU|pku
1483908|NCT00841100|Kuvan|kuvan
1483909|NCT00841100|BH4|bh4
1483910|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
1483911|NCT00841074|Pneumonia|pneumonia
1483912|NCT00841074|Elderly|elderly
1483913|NCT00841074|Chlorhexidine|chlorhexidine
1483914|NCT00841074|Respiratory pathogens|respiratory pathogens
1483915|NCT00841048|Safety and tolerability|safety and tolerability
1483916|NCT00841035|Pancreatic|pancreatic
1483917|NCT00841035|Cancer|cancer
1483918|NCT00841035|Assay|assay
1483919|NCT00841035|Biomarkers|biomarkers
1483920|NCT00841022|anxiety|anxiety
1483921|NCT00841022|anaesthesia|anaesthesia
1483922|NCT00841022|child|child
1483923|NCT00841022|RCT|rct
1483924|NCT00841022|Elective surgery|elective surgery
1483925|NCT00841009|gastric bypass|gastric bypass
1483926|NCT00841009|obesity|obesity
1483927|NCT00840996|Spine Surgery|spine surgery
1483928|NCT00840996|Intraocular pressure|intraocular pressure
1483929|NCT00840996|Lidocaine|lidocaine
1483930|NCT00840996|Epidural Anesthetic|epidural anesthetic
1483931|NCT00840983|delayed cord clamping|delayed cord clamping
1483932|NCT00840983|very low birthweight infant|very low birthweight infant
1483933|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1483934|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
1483935|NCT00840983|motor function|motor function
1483936|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
1483937|NCT00840944|growth hormone|growth hormone
1483938|NCT00840944|final height|final height
1483939|NCT00840944|bone density|bone density
1483940|NCT00840944|puberty|puberty
1483941|NCT00840931|Myeloid|myeloid
1483942|NCT00840931|Monocytic|monocytic
1483943|NCT00840931|Immunotherapy|immunotherapy
1483944|NCT00840931|Vaccine|vaccine
1483945|NCT00840931|MDS|mds
1483946|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
1483947|NCT00840918|Cardiac surgery|cardiac surgery
1483948|NCT00840918|Lidocaine|lidocaine
1483949|NCT00840918|Quality of life|quality of life
1483950|NCT00840905|HPV|hpv
1483951|NCT00840879|Bioequivalence|bioequivalence
1483952|NCT00840879|Healthy Subjects|healthy subjects
1483953|NCT00840866|Bioequivalence|bioequivalence
1483954|NCT00840866|Healthy Subjects|healthy subjects
1483955|NCT00840853|Stem cell transplant|stem cell transplant
1483956|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1483957|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1483958|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1483959|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
1483960|NCT00840853|CTL|ctl
1483961|NCT00840853|CD-19|cd-19
1483962|NCT00840853|chimeric receptor|chimeric receptor
1483963|NCT00840840|Bioequivalence|bioequivalence
1483964|NCT00840840|Healthy Subjects|healthy subjects
1483965|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
1483966|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
1483967|NCT00840827|non-del 5q MDS|non-del 5q mds
1483968|NCT00840814|lymphedema|lymphedema
1483969|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1483970|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1483971|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1483972|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1483973|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1483974|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1483975|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1567594|NCT00508768|Methotrexate|methotrexate
1635612|NCT00261001|HIV|hiv
1483976|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1483977|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1484061|NCT00840554|Cancer-related fatigue|cancer-related fatigue
1483978|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1483979|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1483980|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1483981|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1483982|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1483983|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1483984|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1483985|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1483986|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1483987|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1483988|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1483989|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1483990|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1483991|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1483992|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1483993|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1483994|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
1483995|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
1483996|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
1483997|NCT00840788|skin adhesive|skin adhesive
1483998|NCT00840788|tissue adhesive|tissue adhesive
1483999|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
1484000|NCT00840788|perineal repair|perineal repair
1484001|NCT00840788|labor and delivery|labor and delivery
1484002|NCT00840788|repair|repair
1484003|NCT00840775|Stent|stent
1484004|NCT00840775|interventional cardiology|interventional cardiology
1484005|NCT00840775|catheterization|catheterization
1484006|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
1484007|NCT00840762|HIV-1|hiv-1
1484008|NCT00840762|HIV|hiv
1484009|NCT00840762|HIV Genotypic testing|hiv genotypic testing
1484010|NCT00840762|resistance|resistance
1484011|NCT00840749|STARS|stars
1484012|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
1484013|NCT00840749|NSCLC|nsclc
1484014|NCT00840749|CyberKnife|cyberknife
1484015|NCT00840749|Surgery|surgery
1484016|NCT00840749|Accuray|accuray
1484017|NCT00840736|VBG|vbg
1484018|NCT00840736|LAGB|lagb
1484019|NCT00840736|long term results|long term results
1484020|NCT00840736|Weight loss|weight loss
1484021|NCT00840736|Complications|complications
1484022|NCT00840736|Reoperations|reoperations
1484023|NCT00840736|Conversion|conversion
1484024|NCT00840723|Healthy smokers|healthy smokers
1484025|NCT00840723|Current cigarette smokers|current cigarette smokers
1484026|NCT00840723|No lung disease|no lung disease
1484027|NCT00840710|women in active labor|women in active labor
1484028|NCT00840697|low back pain|low back pain
1484029|NCT00840697|neck pain|neck pain
1484030|NCT00840697|return to work|return to work
1484031|NCT00840697|exercises|exercises
1484032|NCT00840697|cognitive intervention|cognitive intervention
1484033|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1484034|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1484035|NCT00840671|Cerebrolysin|cerebrolysin
1484036|NCT00840671|Alteplase|alteplase
1484037|NCT00840671|Ischemic Stroke|ischemic stroke
1484038|NCT00840671|Modified Rankin Scale|modified rankin scale
1484039|NCT00840671|NIH Stroke Scale|nih stroke scale
1484040|NCT00840671|Barthel Index|barthel index
1484041|NCT00840671|Glasgow Outcome Score|glasgow outcome score
1484042|NCT00840658|HIV|hiv
1484043|NCT00840658|Injection drug users|injection drug users
1484044|NCT00840658|Female sex workers|female sex workers
1484045|NCT00840658|STIs|stis
1484046|NCT00840658|HIV Seronegativity|hiv seronegativity
1484047|NCT00840645|YM178|ym178
1484048|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
1484049|NCT00840645|Mirabegron|mirabegron
1484050|NCT00840632|Bioequivalence|bioequivalence
1484051|NCT00840632|Healthy Subjects|healthy subjects
1484052|NCT00840606|Bioequivalence|bioequivalence
1484053|NCT00840606|Healthy Subjects|healthy subjects
1484054|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
1484055|NCT00840593|Dislocation|dislocation
1635726|NCT00260598|COPD|copd
1484056|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
1484057|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
1484058|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
1484059|NCT00840567|Stem cells|stem cells
1484060|NCT00840554|Fatigue|fatigue
1487718|NCT00825682|Fatigue|fatigue
1484930|NCT00837070|Lumbar|lumbar
1484062|NCT00840554|High grade glioma|high grade glioma
1484063|NCT00840554|Quality of life|quality of life
1484064|NCT00840554|Exercise|exercise
1484065|NCT00840554|Physical Therapy|physical therapy
1484066|NCT00840554|HGG|hgg
1484067|NCT00840554|QOL|qol
1484068|NCT00840528|ozone|ozone
1484069|NCT00840502|malaria|malaria
1484070|NCT00840502|ultrasound|ultrasound
1484071|NCT00840502|pregnancy|pregnancy
1484072|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
1484073|NCT00840476|Bioequivalence|bioequivalence
1484074|NCT00840476|Healthy Subjects|healthy subjects
1484075|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
1484076|NCT00840463|Diastolic Heart Failure|diastolic heart failure
1484077|NCT00840450|ovarian cancer|ovarian cancer
1484078|NCT00840450|recurrent|recurrent
1484079|NCT00840450|Gleevec|gleevec
1484080|NCT00840450|Paclitaxel|paclitaxel
1484081|NCT00840450|Taxane|taxane
1484082|NCT00840450|mullerian|mullerian
1484083|NCT00840437|angina|angina
1484084|NCT00840437|health related quality of life|health related quality of life
1484085|NCT00840411|Bioequivalence|bioequivalence
1484086|NCT00840411|Healthy Subjects|healthy subjects
1484087|NCT00840398|Bioequivalence|bioequivalence
1484088|NCT00840398|Healthy Subjects|healthy subjects
1484089|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
1484090|NCT00840385|Fludarabine|fludarabine
1484091|NCT00840372|Blunt needles|blunt needles
1484092|NCT00840372|Semi-blunt needles|semi-blunt needles
1484093|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
1484094|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
1484095|NCT00840359|Photodynamic therapy|photodynamic therapy
1484096|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
1484097|NCT00840346|Panobinostat|panobinostat
1484098|NCT00840320|Safety|safety
1484099|NCT00840320|tolerability|tolerability
1484100|NCT00840307|Obesity|obesity
1484101|NCT00840307|Type 2 Diabetes|type 2 diabetes
1484102|NCT00840307|Gastric Banding|gastric banding
1484103|NCT00840294|Men with Elevated PSA|men with elevated psa
1484104|NCT00840281|Bioequivalence|bioequivalence
1484105|NCT00840281|Healthy Subjects|healthy subjects
1484106|NCT00840268|OSDI|osdi
1484107|NCT00840268|corneal staining|corneal staining
1484108|NCT00840268|Dry Eye|dry eye
1484109|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
1484110|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
1484111|NCT00840229|adhesive capsulitis|adhesive capsulitis
1484112|NCT00840229|corticosteroids|corticosteroids
1484113|NCT00840229|injection|injection
1484114|NCT00840229|pain|pain
1484115|NCT00840216|Bioequivalence|bioequivalence
1484116|NCT00840216|Healthy Subjects|healthy subjects
1484117|NCT00840203|Bioequivalence|bioequivalence
1484118|NCT00840203|Healthy Subjects|healthy subjects
1484119|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1484120|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1484121|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1484122|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1484123|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1484124|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1484125|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
1484126|NCT00840164|nerve pathology|nerve pathology
1484127|NCT00840164|vasculature pathology|vasculature pathology
1484128|NCT00840164|amputation|amputation
1484129|NCT00840164|diabetic foot wound|diabetic foot wound
1484130|NCT00840164|sensory neuropathy|sensory neuropathy
1484131|NCT00840164|below knee amputation|below knee amputation
1484132|NCT00840151|Substance Abuse|substance abuse
1484133|NCT00840151|Contingency Management|contingency management
1484134|NCT00840125|NSCLC|nsclc
1484135|NCT00840125|ERLOTINIB|erlotinib
1484136|NCT00840125|DOCETAXEL|docetaxel
1484137|NCT00840125|first line treatment|first line treatment
1484138|NCT00840125|Stage IIIB /IV|stage iiib /iv
1484139|NCT00840125|not previously treated|not previously treated
1484140|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
1484141|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
1484142|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
1484143|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
1484144|NCT00840099|Bioequivalence|bioequivalence
1484145|NCT00840099|Healthy Subjects|healthy subjects
1484146|NCT00840073|Bioequivalence|bioequivalence
1484147|NCT00840073|Healthy Subjects|healthy subjects
1484148|NCT00840047|Pediatric brain tumor|pediatric brain tumor
1484149|NCT00840047|Pediatric solid tumor|pediatric solid tumor
1484150|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
1484151|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
1484152|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
1484153|NCT00840008|adherence to guidelines|adherence to guidelines
1484154|NCT00840008|knowledge transfer|knowledge transfer
1484155|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
1484156|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
1484157|NCT00839969|voiding|voiding
1484158|NCT00839969|pressure flow studies|pressure flow studies
1484159|NCT00839969|urethral dilatation|urethral dilatation
1484160|NCT00839943|ozone|ozone
1484161|NCT00839943|clean air|clean air
1484162|NCT00839930|Bioequivalence|bioequivalence
1484163|NCT00839930|Healthy Subjects|healthy subjects
1484164|NCT00839917|Measles|measles
1484165|NCT00839917|Mumps|mumps
1484166|NCT00839917|Rubella|rubella
1484167|NCT00839917|Varicella|varicella
1484168|NCT00839904|children|children
1484169|NCT00839904|cancer|cancer
1484170|NCT00839904|exercise|exercise
1484171|NCT00839904|fitness|fitness
1484172|NCT00839904|body composition|body composition
1484173|NCT00839891|TQT, QTc|tqt, qtc
1484174|NCT00839865|Evidence-based evaluation|evidence-based evaluation
1484175|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
1484176|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
1484177|NCT00839865|therapy|therapy
1484178|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
1484179|NCT00839865|clinical trails|clinical trails
1484180|NCT00839839|infertility|infertility
1484181|NCT00839839|egg freezing|egg freezing
1484182|NCT00839839|fertility preservation|fertility preservation
1484183|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
1484184|NCT00839813|Yoga|yoga
1484185|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
1484186|NCT00839813|PTSD|ptsd
1484187|NCT00839813|women's health|women's health
1484188|NCT00839800|Asthma|asthma
1484189|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
1484190|NCT00839774|Peas|peas
1484191|NCT00839774|Cardiovascular|cardiovascular
1484192|NCT00839774|Diabetes|diabetes
1484193|NCT00839774|Insulin|insulin
1484194|NCT00839774|Insulin resistance|insulin resistance
1484195|NCT00839774|Abdominal fat|abdominal fat
1484196|NCT00839748|asthma|asthma
1484197|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
1484198|NCT00839748|questionnaires|questionnaires
1484199|NCT00839748|lung function tests|lung function tests
1484200|NCT00839735|COPD|copd
1484201|NCT00839722|Uterine embolization|uterine embolization
1484202|NCT00839722|leiomyomas|leiomyomas
1484203|NCT00839722|fertility|fertility
1484204|NCT00839722|myomectomies|myomectomies
1484205|NCT00839709|liver disease|liver disease
1484206|NCT00839709|liver transplantation|liver transplantation
1484207|NCT00839709|depletion immunosuppression|depletion immunosuppression
1484208|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
1484209|NCT00839696|Breast|breast
1484210|NCT00839696|Estrogens|estrogens
1484211|NCT00839696|Mammography|mammography
1484212|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
1484213|NCT00839670|2- Stroke|2- stroke
1484214|NCT00839670|3- Upper limb|3- upper limb
1484215|NCT00839670|4- Rehabilitation|4- rehabilitation
1484216|NCT00839670|5- Motor training|5- motor training
1484217|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
1484218|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
1484219|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
1484220|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
1484221|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
1484222|NCT00839657|Embolism|embolism
1484223|NCT00839657|Thrombosis|thrombosis
1484224|NCT00839644|cystic fibrosis|cystic fibrosis
1484225|NCT00839644|Chest Wall Oscillation|chest wall oscillation
1484226|NCT00839644|drainage, postural|drainage, postural
1484227|NCT00839644|Medication Adherence|medication adherence
1484228|NCT00839644|patient dropouts|patient dropouts
1484229|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
1484230|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
1484231|NCT00839605|airway reconstruction|airway reconstruction
1484232|NCT00839592|Insomnia|insomnia
1484233|NCT00839592|Acupuncture|acupuncture
1484234|NCT00839592|Electroacupuncture|electroacupuncture
1484235|NCT00839592|Randomized Clinical Trial|randomized clinical trial
1484236|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
1484237|NCT00839579|slightly overweight|slightly overweight
1484238|NCT00839579|males 35-45 years|males 35-45 years
1484239|NCT00839566|Atrial Fibrillation|atrial fibrillation
1484240|NCT00839566|Heart Failure|heart failure
1484241|NCT00839540|candidemia|candidemia
1484242|NCT00839540|echinocandin|echinocandin
1484243|NCT00839540|micafungin|micafungin
1484244|NCT00839540|caspofungin|caspofungin
1484245|NCT00839527|diabetes|diabetes
1484246|NCT00839514|Parkinson's disease|parkinson's disease
1488459|NCT00823173|ESBA105|esba105
1484247|NCT00839514|Trichloroethylene|trichloroethylene
1484248|NCT00839488|pantoprazole|pantoprazole
1484249|NCT00839488|famotidine|famotidine
1484250|NCT00839488|stomach ulcer|stomach ulcer
1484251|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
1484252|NCT00839475|colposcopy|colposcopy
1484253|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1484254|NCT00839475|cervical cancer|cervical cancer
1484255|NCT00839475|cervical precancer|cervical precancer
1484256|NCT00839462|Thermal Erythema|thermal erythema
1484257|NCT00839462|Dexpanthenol|dexpanthenol
1484258|NCT00839462|Erythema|erythema
1484259|NCT00839462|Efficacy|efficacy
1484260|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
1484261|NCT00839449|cerebral vasospasm|cerebral vasospasm
1484262|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
1484263|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
1484264|NCT00839436|Interleukin-7|interleukin-7
1484265|NCT00839436|Clinical Trial|clinical trial
1484266|NCT00839436|T-Lymphocytes|t-lymphocytes
1484267|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
1484269|NCT00839423|Major depressive disorder|major depressive disorder
1484270|NCT00839423|Placebo-controlled|placebo-controlled
1484271|NCT00839423|Active reference|active reference
1484272|NCT00839423|Multicenter study|multicenter study
1484273|NCT00839423|Randomised study|randomised study
1484274|NCT00839423|Acute treatment|acute treatment
1484275|NCT00839410|skin cancer|skin cancer
1484276|NCT00839410|melanoma|melanoma
1484277|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
1484278|NCT00839410|bio bank|bio bank
1484279|NCT00839410|genetic polymorphism|genetic polymorphism
1484280|NCT00839410|prospective cohort|prospective cohort
1484282|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
1484283|NCT00839410|tissue samples|tissue samples
1484284|NCT00839371|bispectral analysis|bispectral analysis
1484285|NCT00839371|bronchoscopy|bronchoscopy
1484286|NCT00839371|midazolam|midazolam
1484287|NCT00839371|propofol|propofol
1484288|NCT00839371|recovery|recovery
1484289|NCT00839371|sedation|sedation
1484290|NCT00839358|cirrhosis|cirrhosis
1484291|NCT00839358|renal failure|renal failure
1484292|NCT00839358|midodrine|midodrine
1484293|NCT00839358|albumine|albumine
1484294|NCT00839345|platelet|platelet
1484295|NCT00839345|clopidogrel|clopidogrel
1484296|NCT00839345|VerifyNow|verifynow
1484297|NCT00839345|ticlopidine|ticlopidine
1484298|NCT00839345|thrombosis|thrombosis
1484299|NCT00839332|Pancreas|pancreas
1484300|NCT00839332|metastatic cancer|metastatic cancer
1484301|NCT00839332|advanced cancer|advanced cancer
1484302|NCT00839332|Pancreatic cancer|pancreatic cancer
1484303|NCT00839319|hCG|hcg
1484304|NCT00839319|testosterone|testosterone
1484305|NCT00839319|Acyline|acyline
1484306|NCT00839319|Intratesticular hormone|intratesticular hormone
1484307|NCT00839306|Gastroesophageal|gastroesophageal
1484308|NCT00839306|Reflux|reflux
1484309|NCT00839306|Disease|disease
1484310|NCT00839306|GERD|gerd
1484311|NCT00839293|Bioavailability|bioavailability
1484312|NCT00839280|Dry skin|dry skin
1484313|NCT00839280|Dexpanthenol|dexpanthenol
1484314|NCT00839280|Moisturizing effect|moisturizing effect
1484315|NCT00839267|platelet|platelet
1484316|NCT00839267|VASP|vasp
1484317|NCT00839267|clopidogrel|clopidogrel
1484318|NCT00839267|cardiogenic shock|cardiogenic shock
1484319|NCT00839267|myocardial infarction|myocardial infarction
1484320|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
1484321|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
1484322|NCT00839254|acute otitis media|acute otitis media
1484323|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1484324|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
1484325|NCT00839254|Haemophilus influenzae|haemophilus influenzae
1484326|NCT00839254|immunogenicity|immunogenicity
1484327|NCT00839254|invasive disease|invasive disease
1484328|NCT00839228|diastolic dysfunction|diastolic dysfunction
1484329|NCT00839228|cardiac energetics|cardiac energetics
1484330|NCT00839228|perhexiline|perhexiline
1484331|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1484332|NCT00839202|factor VIII|factor viii
1484333|NCT00839202|hemophilia A|hemophilia a
1484334|NCT00839202|assay|assay
1484335|NCT00839189|CCRE|ccre
1484336|NCT00839189|endotoxin|endotoxin
1484337|NCT00839189|LPS|lps
1484338|NCT00839189|asthma|asthma
1484339|NCT00839189|allergies|allergies
1484340|NCT00839189|allergic rhinitis|allergic rhinitis
1484341|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1484342|NCT00839176|Serdaxin|serdaxin
1484343|NCT00839176|Rexahn|rexahn
1484344|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
1484345|NCT00839163|Pulmonary embolism|pulmonary embolism
1484346|NCT00839163|Embolism|embolism
1484347|NCT00839163|Thrombosis|thrombosis
1484348|NCT00839150|Diabetic retinopathy|diabetic retinopathy
1484349|NCT00839150|Color vision|color vision
1484350|NCT00839150|Contrast sensitivity|contrast sensitivity
1484351|NCT00839150|Electroretinogram|electroretinogram
1484352|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
1484353|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
1484354|NCT00839137|asthma|asthma
1484355|NCT00839137|exercise therapy|exercise therapy
1484356|NCT00839124|normal volunteer|normal volunteer
1484357|NCT00839124|healthy control volunteer|healthy control volunteer
1484358|NCT00839124|healthy subjects|healthy subjects
1484359|NCT00839124|asthma|asthma
1484360|NCT00839124|allergy|allergy
1484361|NCT00839124|allergic asthma|allergic asthma
1484362|NCT00839111|Progression free survival|progression free survival
1484363|NCT00839111|Toxicity|toxicity
1484364|NCT00839111|Response rate|response rate
1484365|NCT00839111|overall survival|overall survival
1484366|NCT00839098|power wheelchairs|power wheelchairs
1484367|NCT00839098|assistive technology|assistive technology
1484368|NCT00839098|rehabilitation|rehabilitation
1484369|NCT00839085|CABG|cabg
1484370|NCT00839085|on pump|on pump
1484371|NCT00839085|Grape seed extract|grape seed extract
1484372|NCT00839085|Vit C|vit c
1484373|NCT00839085|Oxidative stress|oxidative stress
1484374|NCT00839072|bioavailability|bioavailability
1484375|NCT00839072|pharmacokinetics|pharmacokinetics
1484376|NCT00839072|healthy|healthy
1484377|NCT00839072|crossover|crossover
1484378|NCT00839072|trazodone|trazodone
1484379|NCT00839059|AML|aml
1484380|NCT00839059|lenalidomide|lenalidomide
1484381|NCT00839046|Pediatric Asthma|pediatric asthma
1484382|NCT00839046|Air Filters|air filters
1484383|NCT00839046|Indoor Particulate Matter|indoor particulate matter
1484384|NCT00839033|Cough assisted device|cough assisted device
1484385|NCT00839033|Neuromuscular disease|neuromuscular disease
1484386|NCT00839033|Respiratory exacerbation|respiratory exacerbation
1484387|NCT00839033|Invasive ventilation,|invasive ventilation,
1484388|NCT00839033|Chest physiotherapy|chest physiotherapy
1484389|NCT00839033|Congenital myopathies|congenital myopathies
1484390|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
1484391|NCT00839020|Range of Motion|range of motion
1484392|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
1484393|NCT00839007|ADHF|adhf
1484394|NCT00839007|AHF|ahf
1484395|NCT00839007|HF|hf
1484396|NCT00838994|Insomnia|insomnia
1484397|NCT00838994|Depression|depression
1484398|NCT00838994|Electroacupuncture|electroacupuncture
1484399|NCT00838994|Acupuncture|acupuncture
1484400|NCT00838994|Randomized Clinical Trial|randomized clinical trial
1484401|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
1484402|NCT00838981|Treatment for addiction|treatment for addiction
1484403|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
1484404|NCT00838981|Cocaine|cocaine
1484405|NCT00838981|Opiates|opiates
1484406|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
1484407|NCT00838968|interferon-alpha|interferon-alpha
1484408|NCT00838968|p48|p48
1484409|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
1484410|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
1484411|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
1484412|NCT00838955|Temsirolimus|temsirolimus
1484413|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
1484414|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
1484415|NCT00838942|Visual hallucinations|visual hallucinations
1484416|NCT00838942|Visual acuity,|visual acuity,
1484417|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
1484418|NCT00838942|Improvement of behaviour,|improvement of behaviour,
1484419|NCT00838942|Improvement of autonomy|improvement of autonomy
1484420|NCT00838942|Improvement of mood|improvement of mood
1484421|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
1484422|NCT00838929|brain metastases|brain metastases
1484423|NCT00838929|radiation|radiation
1484424|NCT00838929|vorinostat|vorinostat
1484425|NCT00838929|lung cancer|lung cancer
1484426|NCT00838929|breast cancer|breast cancer
1484427|NCT00838916|diabetes|diabetes
1484428|NCT00838903|diabetes|diabetes
1484429|NCT00838877|Alzheimer's Disease|alzheimer's disease
1484430|NCT00838877|PET|pet
1484431|NCT00838877|Phase 1|phase 1
1484432|NCT00838877|Positron Emission Tomography|positron emission tomography
1484433|NCT00838864|variceal bleeding|variceal bleeding
1484434|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
1484435|NCT00838864|ceftrioxone|ceftrioxone
1484436|NCT00838851|endotoxin|endotoxin
1484437|NCT00838851|CCRE|ccre
1484438|NCT00838851|LPS|lps
1484439|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
1484440|NCT00838838|Hypogonadism|hypogonadism
1484441|NCT00838838|Osteoporosis|osteoporosis
1484442|NCT00838838|Immobilisation|immobilisation
1484443|NCT00838838|Paraplegia|paraplegia
1484444|NCT00838838|Testosterone|testosterone
1484445|NCT00838825|diabetes|diabetes
1484446|NCT00838825|chronic care management|chronic care management
1484447|NCT00838825|resource utilization|resource utilization
1484448|NCT00838825|outcome|outcome
1484449|NCT00838825|glycohemoglobin|glycohemoglobin
1484450|NCT00838825|hospitalization|hospitalization
1484451|NCT00838812|clindamycin|clindamycin
1484452|NCT00838812|tretinoin|tretinoin
1484453|NCT00838812|acne vulgaris|acne vulgaris
1484454|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
1484455|NCT00838799|diabetic|diabetic
1484456|NCT00838799|peripheral|peripheral
1484457|NCT00838799|neuropathic|neuropathic
1484458|NCT00838799|pain|pain
1484459|NCT00838799|chronic|chronic
1484460|NCT00838799|diabetes|diabetes
1484461|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
1484462|NCT00838760|PEPI-C103|pepi-c103
1484463|NCT00838760|PEPI|pepi
1484464|NCT00838760|TMC558445|tmc558445
1484465|NCT00838760|TMC310911|tmc310911
1484466|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
1484467|NCT00838760|Pharmacokinetics|pharmacokinetics
1484468|NCT00838760|HIV Infections|hiv infections
1484469|NCT00838747|folate receptor|folate receptor
1484470|NCT00838747|blood samples|blood samples
1484471|NCT00838747|ovarian cancer|ovarian cancer
1484472|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
1484473|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
1484474|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
1484475|NCT00838734|KERATOPLASTY|keratoplasty
1484476|NCT00838721|Open Angle Glaucoma|open angle glaucoma
1484477|NCT00838721|Ocular Hypertension|ocular hypertension
1484478|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
1484479|NCT00838695|Hand vein sensitivity|hand vein sensitivity
1484480|NCT00838695|phenylephrine|phenylephrine
1484481|NCT00838695|nitroglycerin|nitroglycerin
1484482|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
1484483|NCT00838682|rabeprazole|rabeprazole
1484484|NCT00838682|proton pump inhibitor|proton pump inhibitor
1484485|NCT00838669|Schizophrenia|schizophrenia
1484486|NCT00838669|Mood disorders|mood disorders
1484487|NCT00838669|Antipsychotic drugs|antipsychotic drugs
1484488|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
1484489|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
1484490|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1484491|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1484492|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1484493|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1484494|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1484495|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1484496|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1484497|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1484498|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1484499|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1484500|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1484501|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1484502|NCT00838643|allogeneic transplantation|allogeneic transplantation
1484503|NCT00838643|Invasive aspergillosis|invasive aspergillosis
1484504|NCT00838630|Bioequivalence|bioequivalence
1484505|NCT00838630|Healthy Subjects|healthy subjects
1484506|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1484507|NCT00838617|Ultrasonography|ultrasonography
1484508|NCT00838617|Atrophy|atrophy
1484509|NCT00838591|MN-221|mn-221
1484510|NCT00838591|Asthma|asthma
1484511|NCT00838591|Acute|acute
1484512|NCT00838591|Exacerbation|exacerbation
1484513|NCT00838578|KRN330|krn330
1484514|NCT00838578|Colorectal Cancer|colorectal cancer
1484515|NCT00838578|Antimetabolites|antimetabolites
1484516|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
1484517|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
1484518|NCT00838578|Immunologic Factors|immunologic factors
1484519|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1484520|NCT00838578|Antineoplastic Agents|antineoplastic agents
1484521|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
1484522|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
1484523|NCT00838578|Colonic Diseases|colonic diseases
1484524|NCT00838578|Irinotecan|irinotecan
1484525|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
1484526|NCT00838578|Intestinal Diseases|intestinal diseases
1484527|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
1484528|NCT00838578|Rectal Diseases|rectal diseases
1484529|NCT00838578|Pharmacologic Actions|pharmacologic actions
1484530|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
1484531|NCT00838578|Neoplasms by Site|neoplasms by site
1484532|NCT00838578|Digestive System Diseases|digestive system diseases
1484533|NCT00838578|Therapeutic Uses|therapeutic uses
1484534|NCT00838578|Fluorouracil|fluorouracil
1484535|NCT00838578|Neoplasms|neoplasms
1484536|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1484537|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1484538|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
1484728|NCT00837759|Type I Diabetes|type i diabetes
1488763|NCT00822068|aphasia|aphasia
1484539|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
1484540|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
1484541|NCT00838539|Neratinib|neratinib
1484542|NCT00838539|solid tumors|solid tumors
1484543|NCT00838539|phase 1|phase 1
1484544|NCT00838539|dose finding study|dose finding study
1484545|NCT00838539|HKI-272|hki-272
1484546|NCT00838539|Nerlynx|nerlynx
1484547|NCT00838539|Temsirolimus|temsirolimus
1484548|NCT00838539|PB-272|pb-272
1484549|NCT00838526|Gastroesophageal|gastroesophageal
1484550|NCT00838526|Reflux|reflux
1484551|NCT00838526|Disease|disease
1484552|NCT00838526|GERD|gerd
1484553|NCT00838513|aHUS|ahus
1484554|NCT00838500|Venous insufficiency|venous insufficiency
1484555|NCT00838500|Leg ulcer|leg ulcer
1484556|NCT00838500|balneology|balneology
1484557|NCT00838500|hydrotherapy|hydrotherapy
1484558|NCT00838500|Modified Rutherford score|modified rutherford score
1484559|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
1484560|NCT00838500|CIVIQ2 scale|civiq2 scale
1484561|NCT00838500|Visual analogic Scale|visual analogic scale
1484562|NCT00838500|SPA treatment|spa treatment
1484563|NCT00838487|chondroitin|chondroitin
1484564|NCT00838487|glucosamine|glucosamine
1484565|NCT00838487|osteoarthritis|osteoarthritis
1484566|NCT00838474|metabolic rate|metabolic rate
1484567|NCT00838474|music|music
1484568|NCT00838474|preterm infants|preterm infants
1484569|NCT00838474|energy expenditure|energy expenditure
1484570|NCT00838474|NIDCA|nidca
1484571|NCT00838448|exercise|exercise
1484572|NCT00838448|cannabis use|cannabis use
1484573|NCT00838448|visual cues|visual cues
1484574|NCT00838435|Phenylketonuria|phenylketonuria
1484575|NCT00838435|PKU|pku
1484576|NCT00838435|Kuvan|kuvan
1484577|NCT00838435|Phenoptin|phenoptin
1484578|NCT00838435|Biopten|biopten
1484579|NCT00838435|Neurocognitive Function|neurocognitive function
1484580|NCT00838435|Phenylalanine|phenylalanine
1484581|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
1484582|NCT00838370|Pharmacogenetics|pharmacogenetics
1484583|NCT00838370|cost-benefit analysis|cost-benefit analysis
1484584|NCT00838370|toxicity|toxicity
1484585|NCT00838370|antineoplastic drugs|antineoplastic drugs
1484586|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
1484587|NCT00838357|Mobilisation stem cells|mobilisation stem cells
1484588|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
1484589|NCT00838357|Lymphoma|lymphoma
1484590|NCT00838357|Multiple Myeloma|multiple myeloma
1484591|NCT00838344|medication adherence|medication adherence
1484592|NCT00838344|medication persistence|medication persistence
1484593|NCT00838344|pharmacist interventions|pharmacist interventions
1484594|NCT00838344|diabetes|diabetes
1484595|NCT00838344|persistence|persistence
1484596|NCT00838344|adherence|adherence
1484597|NCT00838331|Blood Transfusions|blood transfusions
1484598|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
1484599|NCT00838318|CRC|crc
1484600|NCT00838318|Hispanic|hispanic
1484601|NCT00838318|CRC Patients|crc patients
1484602|NCT00838318|First-Degree Relatives|first-degree relatives
1484603|NCT00838318|FDRs|fdrs
1484604|NCT00838318|Interviews|interviews
1484605|NCT00838318|Colorectal cancer screening|colorectal cancer screening
1484606|NCT00838318|CRCS|crcs
1484607|NCT00838318|Key Informants|key informants
1484608|NCT00838305|MDMA|mdma
1484609|NCT00838305|citalopram|citalopram
1484610|NCT00838305|serotonin|serotonin
1484611|NCT00838305|psychedelic|psychedelic
1484612|NCT00838292|food supplementation|food supplementation
1484613|NCT00838292|HIV|hiv
1484614|NCT00838292|malnutrition|malnutrition
1484615|NCT00838279|Bioequivalence|bioequivalence
1484616|NCT00838279|Healthy Subjects|healthy subjects
1484617|NCT00838266|mouthrinse|mouthrinse
1484618|NCT00838266|grape seed extract|grape seed extract
1484619|NCT00838266|fluor|fluor
1484620|NCT00838266|plaque index|plaque index
1484621|NCT00838253|Acute Heart Failure|acute heart failure
1484622|NCT00838253|Inotropes|inotropes
1484623|NCT00838253|Lusitropic agents|lusitropic agents
1484624|NCT00838253|Istaroxime|istaroxime
1484625|NCT00838253|Debio 0614|debio 0614
1484626|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1484627|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1484628|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1484629|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1484630|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1484631|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1484632|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1484633|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1484634|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1484635|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1484636|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1484637|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1484638|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1484639|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1484640|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1484641|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1484642|NCT00838227|Schizophrenia|schizophrenia
1484643|NCT00838227|Cognition|cognition
1484644|NCT00838227|Obesity|obesity
1484645|NCT00838227|Sedation|sedation
1484646|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
1484647|NCT00838188|Metabolic rate|metabolic rate
1484648|NCT00838188|indirect calorimetry|indirect calorimetry
1484649|NCT00838188|oral feeding|oral feeding
1484650|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
1484651|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
1484652|NCT00838162|HIV-1|hiv-1
1484653|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
1484654|NCT00838162|TMC310911|tmc310911
1484655|NCT00838162|Protease inhibitor|protease inhibitor
1484656|NCT00838162|Ritonavir|ritonavir
1484657|NCT00838162|Antiviral Activity|antiviral activity
1484658|NCT00838162|HIV Infections|hiv infections
1484659|NCT00838162|Treatment Naive|treatment naive
1484660|NCT00838136|Bioequivalence|bioequivalence
1484661|NCT00838136|Healthy Subjects|healthy subjects
1484662|NCT00838110|Alzheimer's Disease|alzheimer's disease
1484663|NCT00838110|Dimebon|dimebon
1484664|NCT00838110|Safety|safety
1484665|NCT00838110|Tolerability|tolerability
1484667|NCT00838097|Paediatric|paediatric
1484668|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
1484669|NCT00838071|Hepatitis B|hepatitis b
1484670|NCT00838071|HBV|hbv
1484671|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
1484672|NCT00838071|Immunoglobulins|immunoglobulins
1484673|NCT00838071|liver transplantation|liver transplantation
1484674|NCT00838071|Protective levels|protective levels
1484675|NCT00838071|Recurrence|recurrence
1484676|NCT00838071|Intravenous|intravenous
1484677|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
1484678|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
1484679|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
1484680|NCT00838006|post-deployment|post-deployment
1484681|NCT00838006|prediction|prediction
1484682|NCT00838006|prevention|prevention
1484683|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
1484684|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
1484685|NCT00837993|Ovary|ovary
1484686|NCT00837993|GOG Protocol 158|gog protocol 158
1484687|NCT00837993|Survival Analysis|survival analysis
1484688|NCT00837993|Pathology Slides|pathology slides
1484689|NCT00837993|Two-tier Grading System|two-tier grading system
1484690|NCT00837993|Ancillary Study|ancillary study
1484691|NCT00837980|head and neck cancer|head and neck cancer
1484692|NCT00837980|DW MRI|dw mri
1484693|NCT00837980|PET|pet
1484694|NCT00837980|DCE MRI|dce mri
1484695|NCT00837980|functional imaging|functional imaging
1484696|NCT00837980|IMRT|imrt
1484697|NCT00837967|Asthma|asthma
1484698|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
1484699|NCT00837954|PTFE Graft|ptfe graft
1484700|NCT00837954|Suture Hole Bleeding|suture hole bleeding
1484701|NCT00837954|Hemostasis|hemostasis
1484702|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1484703|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
1484704|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
1484705|NCT00837902|Atenolol|atenolol
1484706|NCT00837902|Exercise|exercise
1484707|NCT00837902|Genotype|genotype
1484708|NCT00837902|Healthy volunteers|healthy volunteers
1484709|NCT00837889|cognition|cognition
1484710|NCT00837889|decompensation|decompensation
1484711|NCT00837889|heart failure|heart failure
1484712|NCT00837889|recompensation|recompensation
1484713|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
1484714|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
1484715|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
1484716|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1484717|NCT00837850|total hip arthroplasty|total hip arthroplasty
1484718|NCT00837850|Charnley stem|charnley stem
1484719|NCT00837850|RSA|rsa
1484720|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
1484721|NCT00837837|pharmacokinetics|pharmacokinetics
1484722|NCT00837837|children|children
1484723|NCT00837837|adolescents|adolescents
1484724|NCT00837837|antihistamine|antihistamine
1484725|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
1484726|NCT00837811|Arthritis|arthritis
1484727|NCT00837772|Alignment|alignment
1484729|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
1484730|NCT00837759|Sitagliptin|sitagliptin
1484731|NCT00837759|Lansoprazole|lansoprazole
1484732|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
1484733|NCT00837759|Diabetes|diabetes
1484734|NCT00837759|Type 1 Diabetes|type 1 diabetes
1484735|NCT00837759|T1DM|t1dm
1484736|NCT00837733|Endometrial biopsy|endometrial biopsy
1484737|NCT00837733|IVF/ICSI|ivf/icsi
1484738|NCT00837733|Pregnancy outcome|pregnancy outcome
1484739|NCT00837733|Recurrent implantation failure|recurrent implantation failure
1484740|NCT00837720|hypertension|hypertension
1484741|NCT00837720|blood pressure|blood pressure
1484742|NCT00837720|Atacand®|atacand®
1484743|NCT00837720|candesartan|candesartan
1484744|NCT00837707|aripiprazole|aripiprazole
1484745|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
1484746|NCT00837694|BMI|bmi
1484747|NCT00837694|obesity|obesity
1484748|NCT00837694|sensitization|sensitization
1484749|NCT00837694|food reinforcement|food reinforcement
1484750|NCT00837694|snack food|snack food
1484751|NCT00837694|Portion size of daily snacks|portion size of daily snacks
1484752|NCT00837694|Weight status|weight status
1484753|NCT00837681|Bone Marrow Transplant|bone marrow transplant
1484754|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1484755|NCT00837668|sarcoidosis|sarcoidosis
1484756|NCT00837668|stromal gene expression|stromal gene expression
1484757|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
1484758|NCT00837668|bronchoscopy|bronchoscopy
1484759|NCT00837655|Chronic kidney disease|chronic kidney disease
1484760|NCT00837655|End-stage renal disease|end-stage renal disease
1484761|NCT00837655|phosphate binder|phosphate binder
1484762|NCT00837655|insulin resistance|insulin resistance
1484763|NCT00837655|glucose intolerance|glucose intolerance
1484764|NCT00837655|sevelamer|sevelamer
1484765|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
1484766|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1484767|NCT00837629|COPD|copd
1484768|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
1484769|NCT00837616|Turner Syndrome|turner syndrome
1484770|NCT00837616|Hypogonadism|hypogonadism
1484771|NCT00837616|GH|gh
1484772|NCT00837616|Estrogen|estrogen
1484773|NCT00837616|Estrogen Patches|estrogen patches
1484774|NCT00837616|IGF-I|igf-i
1484775|NCT00837616|Body Composition|body composition
1484776|NCT00837616|Protein Metabolism|protein metabolism
1484777|NCT00837616|Lipid Oxidation|lipid oxidation
1484778|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
1484779|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
1484780|NCT00837603|tga|tga
1484781|NCT00837603|atrial switch|atrial switch
1484782|NCT00837603|training|training
1484783|NCT00837590|Vascular function|vascular function
1484784|NCT00837590|Glucose tolerance|glucose tolerance
1484785|NCT00837590|Obesity|obesity
1484786|NCT00837590|Pre-diabetes|pre-diabetes
1484787|NCT00837564|chronic depression|chronic depression
1484788|NCT00837564|CBASP|cbasp
1484789|NCT00837564|Escitalopram|escitalopram
1484790|NCT00837564|depression|depression
1484791|NCT00837564|trauma|trauma
1484792|NCT00837551|Non-steroid|non-steroid
1484793|NCT00837551|Small molecule|small molecule
1484794|NCT00837551|Topical cream|topical cream
1484795|NCT00837551|Inflammatory disease|inflammatory disease
1484796|NCT00837551|Skin|skin
1484797|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
1484798|NCT00837538|Intersegmental range of motion|intersegmental range of motion
1484799|NCT00837538|Spinal Mouse|spinal mouse
1484800|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
1484801|NCT00837499|Breast|breast
1484802|NCT00837499|Breast Cancer|breast cancer
1484803|NCT00837499|Risk Factors|risk factors
1484804|NCT00837499|Mexican Women|mexican women
1484805|NCT00837499|Mexican-American Women|mexican-american women
1484806|NCT00837499|African-American Women|african-american women
1484807|NCT00837499|Epidemiological|epidemiological
1484808|NCT00837499|Questionnaire|questionnaire
1484809|NCT00837499|Survey|survey
1484810|NCT00837499|Interview|interview
1567595|NCT00508755|cerebrovascular accident|cerebrovascular accident
1484811|NCT00837486|Treatment Resistant Depression|treatment resistant depression
1484812|NCT00837486|Treatment Refractory Depression|treatment refractory depression
1484813|NCT00837486|Deep Brain Stimulation|deep brain stimulation
1484814|NCT00837486|Depression|depression
1484815|NCT00837473|Bone Void Filler|bone void filler
1484816|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
1484817|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
1484818|NCT00837473|Autograft Bone|autograft bone
1484819|NCT00837473|Allograft Bone|allograft bone
1484820|NCT00837460|Hand|hand
1484821|NCT00837460|Rehabilitation|rehabilitation
1484822|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
1484823|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
1484824|NCT00837421|sepsis|sepsis
1484825|NCT00837421|registry|registry
1484826|NCT00837408|Diabetes|diabetes
1484827|NCT00837408|Genetics|genetics
1484828|NCT00837408|Asians|asians
1485712|NCT00833469|women|women
1484931|NCT00837031|Pancreatic|pancreatic
1484831|NCT00837369|Stress echocardiography|stress echocardiography
1484832|NCT00837369|SPECT|spect
1484833|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
1484834|NCT00837343|Bipolar disorder|bipolar disorder
1484835|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1484836|NCT00837330|choroidal neovascularization|choroidal neovascularization
1484837|NCT00837330|ranibizumab|ranibizumab
1484838|NCT00837330|Lucentis|lucentis
1484839|NCT00837317|Phenols|phenols
1484840|NCT00837317|Laser-Doppler|laser-doppler
1484841|NCT00837317|Olive Oil|olive oil
1484842|NCT00837317|Sunflower Oil|sunflower oil
1484843|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
1484844|NCT00837317|Postprandial|postprandial
1484845|NCT00837317|Inflammation|inflammation
1484846|NCT00837317|Oxidative Stress|oxidative stress
1484847|NCT00837291|osteoarthritis|osteoarthritis
1484848|NCT00837291|knee|knee
1484849|NCT00837291|CF101|cf101
1484850|NCT00837278|IVF|ivf
1484851|NCT00837278|angiogenic factors|angiogenic factors
1484852|NCT00837278|cytokines|cytokines
1484853|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
1484854|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
1484855|NCT00837252|Finasteride|finasteride
1484856|NCT00837252|Proscar|proscar
1484857|NCT00837252|Retinal Eye Disease|retinal eye disease
1484858|NCT00837239|HuaChanSu|huachansu
1484859|NCT00837239|HCS|hcs
1484860|NCT00837239|Gastrointestinal|gastrointestinal
1484861|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
1484862|NCT00837239|Metastases|metastases
1484863|NCT00837239|Cancer|cancer
1484864|NCT00837239|Pancreatic cancer|pancreatic cancer
1484865|NCT00837239|Placebo|placebo
1484866|NCT00837239|Gemcitabine|gemcitabine
1484867|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
1484868|NCT00837239|Gemzar|gemzar
1484869|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
1484870|NCT00837213|Acne|acne
1484871|NCT00837200|lymphoma|lymphoma
1484872|NCT00837200|myeloma|myeloma
1484873|NCT00837187|dexmedetomidine|dexmedetomidine
1484874|NCT00837187|intranasal|intranasal
1484875|NCT00837187|pharmacokinetics|pharmacokinetics
1484876|NCT00837187|pharmacodynamics|pharmacodynamics
1484877|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
1484878|NCT00837174|aggressive lymphoma|aggressive lymphoma
1484879|NCT00837174|indolent lymphoma|indolent lymphoma
1484880|NCT00837174|B cell lymphoma|b cell lymphoma
1484881|NCT00837174|T cell lymphoma|t cell lymphoma
1484882|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1484883|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
1484884|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
1484885|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
1484886|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
1484887|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
1484888|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
1484889|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
1484890|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
1484891|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
1484892|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
1484893|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
1484894|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
1484895|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1484896|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
1484897|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1484898|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
1484899|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
1484900|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
1484901|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
1484902|NCT00837174|mycosis fungoides|mycosis fungoides
1484903|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
1484904|NCT00837161|Uterine Fibroids|uterine fibroids
1484905|NCT00837161|Leiomyomata|leiomyomata
1484906|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
1484907|NCT00837161|MRI-Guided|mri-guided
1484908|NCT00837161|Fibroids|fibroids
1484909|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
1484910|NCT00837148|Sarcoma|sarcoma
1484911|NCT00837148|Bone|bone
1484912|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
1484913|NCT00837148|DACARBAZINE|dacarbazine
1484914|NCT00837148|08-068|08-068
1484915|NCT00837135|Pancreatic Cancer|pancreatic cancer
1484919|NCT00837083|hypercholesterolemia|hypercholesterolemia
1484920|NCT00837083|cholesterol|cholesterol
1484921|NCT00837083|LDL-cholesterol|ldl-cholesterol
1484922|NCT00837083|rosuvastatin|rosuvastatin
1484923|NCT00837083|Crestor|crestor
1484924|NCT00837070|Zygapophyseal|zygapophyseal
1484925|NCT00837070|joint|joint
1484926|NCT00837070|cyst|cyst
1484927|NCT00837070|Fluoroscopy|fluoroscopy
1484928|NCT00837070|guided|guided
1484929|NCT00837070|percutaneous|percutaneous
1484932|NCT00837031|Pancreatic Cancer|pancreatic cancer
1484933|NCT00837031|Lenalidomide|lenalidomide
1484934|NCT00837031|Revlimid|revlimid
1484935|NCT00837031|Gemcitabine|gemcitabine
1484936|NCT00837018|OSAS|osas
1484937|NCT00837018|exercise|exercise
1484938|NCT00837018|metabolic|metabolic
1484939|NCT00837018|cardio-vascular|cardio-vascular
1484940|NCT00837005|dobutamine stress|dobutamine stress
1484941|NCT00837005|inducible ischemia|inducible ischemia
1484943|NCT00836992|anal cancer|anal cancer
1484944|NCT00836992|colon cancer|colon cancer
1484945|NCT00836992|rectal cancer|rectal cancer
1484946|NCT00836992|esophageal cancer|esophageal cancer
1484947|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
1484948|NCT00836992|gallbladder cancer|gallbladder cancer
1484949|NCT00836992|gastric cancer|gastric cancer
1484950|NCT00836992|adult primary liver cancer|adult primary liver cancer
1484951|NCT00836992|pancreatic cancer|pancreatic cancer
1484952|NCT00836992|small intestine cancer|small intestine cancer
1484953|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
1484954|NCT00836992|small cell lung cancer|small cell lung cancer
1484955|NCT00836992|head and neck cancer|head and neck cancer
1484956|NCT00836979|Urinary Incontinence|urinary incontinence
1484957|NCT00836979|Incontinence|incontinence
1484958|NCT00836979|bladder problems|bladder problems
1484959|NCT00836979|bladder dysfunction|bladder dysfunction
1484960|NCT00836953|Influenza|influenza
1484961|NCT00836953|Fluzone®|fluzone®
1484962|NCT00836953|Children|children
1484963|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
1484964|NCT00836940|GRC 8200|grc 8200
1484965|NCT00836914|Allergic Rhinitis|allergic rhinitis
1484966|NCT00836914|Allergy|allergy
1484967|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1484968|NCT00836901|Bioequivalence|bioequivalence
1484969|NCT00836901|Healthy Subjects|healthy subjects
1484970|NCT00836888|ONO-4538|ono-4538
1484971|NCT00836888|MDX-1106|mdx-1106
1484972|NCT00836888|solid tumors|solid tumors
1484973|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
1484974|NCT00836862|Hemodialysis|hemodialysis
1484975|NCT00836862|Vascular access|vascular access
1484976|NCT00836862|Arteriovenous fistula|arteriovenous fistula
1484977|NCT00836849|Bioequivalence|bioequivalence
1484978|NCT00836849|Healthy Subjects|healthy subjects
1484979|NCT00836836|Childhood epilepsy|childhood epilepsy
1484980|NCT00836836|ketogenic diet|ketogenic diet
1484981|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
1484982|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
1484983|NCT00836823|Medical treatment|medical treatment
1484984|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
1484985|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
1484986|NCT00836797|Alveolar Bone Loss|alveolar bone loss
1484987|NCT00836797|Alveolar ridge|alveolar ridge
1484988|NCT00836797|Alveolar Process|alveolar process
1484989|NCT00836784|Old tooth brush|old tooth brush
1484990|NCT00836784|Plaque removal|plaque removal
1484991|NCT00836771|Infant formula|infant formula
1484992|NCT00836771|Probiotic microorganisms|probiotic microorganisms
1484993|NCT00836771|prebiotic|prebiotic
1484994|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
1484995|NCT00836745|Non interventional study|non interventional study
1484996|NCT00836745|Renal Cancer|renal cancer
1484997|NCT00836745|Sutent|sutent
1484998|NCT00836745|Metastatic|metastatic
1484999|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1485000|NCT00836732|celle therapy|celle therapy
1485001|NCT00836732|cell culture|cell culture
1485002|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
1485003|NCT00836719|Multiple sclerosis|multiple sclerosis
1485004|NCT00836719|safety|safety
1485005|NCT00836719|open label|open label
1485006|NCT00836719|Polyphenon E|polyphenon e
1485007|NCT00836719|EGCG|egcg
1485008|NCT00836719|NAA|naa
1485009|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
1485010|NCT00836719|MRI|mri
1485011|NCT00836706|Bioequivalence|bioequivalence
1485012|NCT00836706|Healthy Subjects|healthy subjects
1485013|NCT00836693|Erectile Dysfunction|erectile dysfunction
1485014|NCT00836667|Bioequivalence|bioequivalence
1485015|NCT00836667|Healthy Subjects|healthy subjects
1485016|NCT00836654|EpCAM positive tumor|epcam positive tumor
1485017|NCT00836654|malignant ascites|malignant ascites
1485018|NCT00836654|intraperitoneal|intraperitoneal
1485019|NCT00836641|preschool asthma|preschool asthma
1485020|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
1485021|NCT00836641|immunogenicity|immunogenicity
1485022|NCT00836641|safety|safety
1486007|NCT00832312|Knee|knee
1485023|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
1485024|NCT00836576|Bioequivalence|bioequivalence
1485025|NCT00836576|Healthy Subjects|healthy subjects
1485026|NCT00836563|Hemodialysis|hemodialysis
1485027|NCT00836563|Arteriovenous Graft|arteriovenous graft
1485028|NCT00836550|HIV|hiv
1485029|NCT00836550|HIV knowledge measure|hiv knowledge measure
1485030|NCT00836550|Teen HIV testing|teen hiv testing
1485031|NCT00836550|HIV Seronegativity|hiv seronegativity
1485032|NCT00836537|Bioequivalence|bioequivalence
1485033|NCT00836537|Healthy Subjects|healthy subjects
1485034|NCT00836524|IUGR|iugr
1485035|NCT00836524|Preeclampsia|preeclampsia
1485036|NCT00836524|ultrasound|ultrasound
1485037|NCT00836524|YKL-40|ykl-40
1485038|NCT00836472|Bioequivalence|bioequivalence
1485039|NCT00836472|Healthy Subjects|healthy subjects
1485040|NCT00836459|Humans|humans
1485041|NCT00836459|Middle Aged|middle aged
1485042|NCT00836459|Behavior Therapy|behavior therapy
1485043|NCT00836459|Directive Counseling|directive counseling
1485044|NCT00836459|Health Behavior|health behavior
1485045|NCT00836459|Interview, Psychological|interview, psychological
1485046|NCT00836459|Motivation|motivation
1485047|NCT00836459|Exercise|exercise
1485048|NCT00836459|Physical Fitness|physical fitness
1485049|NCT00836459|Self Efficacy|self efficacy
1485050|NCT00836459|Life Style|life style
1485051|NCT00836459|Health Promotion|health promotion
1485052|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1485053|NCT00836459|Body Mass Index|body mass index
1485054|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
1485055|NCT00836459|Walking|walking
1485056|NCT00836446|school-aged|school-aged
1485057|NCT00836446|children|children
1485058|NCT00836446|obesity|obesity
1485059|NCT00836446|cardiovascular risk|cardiovascular risk
1485060|NCT00836446|physical activity|physical activity
1485061|NCT00836433|staff education|staff education
1485062|NCT00836433|complexity science|complexity science
1485063|NCT00836433|social constructivist theory|social constructivist theory
1485064|NCT00836420|ammonia|ammonia
1485065|NCT00836420|acute liver failure|acute liver failure
1485066|NCT00836420|brain edema|brain edema
1485067|NCT00836420|oxidative metabolism|oxidative metabolism
1485068|NCT00836420|intracranial pressure|intracranial pressure
1485069|NCT00836407|pancreatic cancer|pancreatic cancer
1485070|NCT00836407|vaccine|vaccine
1485071|NCT00836407|immunotherapy|immunotherapy
1485072|NCT00836407|antibody|antibody
1485073|NCT00836407|CTLA-4|ctla-4
1485074|NCT00836394|arthritis|arthritis
1485075|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1485076|NCT00836394|pediatric|pediatric
1485077|NCT00836394|intervention|intervention
1485078|NCT00836394|vibration therapy|vibration therapy
1485079|NCT00836394|JIA|jia
1485080|NCT00836381|Overactive bladder|overactive bladder
1485081|NCT00836381|Antimuscarinics|antimuscarinics
1485082|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
1485083|NCT00836368|Asthma|asthma
1485084|NCT00836368|Asthmatic|asthmatic
1485085|NCT00836368|Allergy|allergy
1485086|NCT00836368|Allergic|allergic
1485087|NCT00836368|Gamma-tocopherol|gamma-tocopherol
1485088|NCT00836368|Vitamin|vitamin
1485089|NCT00836368|Vitamin E|vitamin e
1485090|NCT00836355|stroke|stroke
1485091|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
1485092|NCT00836355|enoxaparin|enoxaparin
1485093|NCT00836355|minocycline|minocycline
1485094|NCT00836355|NIH stroke scale|nih stroke scale
1485095|NCT00836355|modified Rankin scale|modified rankin scale
1485096|NCT00836355|neuroprotection|neuroprotection
1485097|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
1485098|NCT00836342|Basal cell carcinoma|basal cell carcinoma
1485099|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
1485100|NCT00836329|Neurologic|neurologic
1485101|NCT00836329|Diabetes|diabetes
1485102|NCT00836329|Cardiac Surgery|cardiac surgery
1485103|NCT00836329|Stroke|stroke
1485104|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1485105|NCT00836290|risk reduction|risk reduction
1485106|NCT00836290|HIV prevention|hiv prevention
1485107|NCT00836290|HIV education|hiv education
1485108|NCT00836290|HIV Seronegativity|hiv seronegativity
1485109|NCT00836277|Panitumumab|panitumumab
1485110|NCT00836277|Irinotecan|irinotecan
1485111|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
1485112|NCT00836277|Phase II|phase ii
1485113|NCT00836264|Morphine|morphine
1485114|NCT00836264|Phenotype|phenotype
1485115|NCT00836264|Genotype|genotype
1485116|NCT00836264|Tonsillectomy|tonsillectomy
1485117|NCT00836264|Adenoidectomy|adenoidectomy
1485118|NCT00836264|Opioid Receptors|opioid receptors
1485119|NCT00836264|Genome-Wide Association|genome-wide association
1485120|NCT00836264|Pharmacokinetics|pharmacokinetics
1485121|NCT00836251|energy expenditure|energy expenditure
1485122|NCT00836251|schizophrenia|schizophrenia
1485123|NCT00836238|Prostate Cancer|prostate cancer
1485124|NCT00836238|Neural Functioning Assessment|neural functioning assessment
1485125|NCT00836238|Physical Assessment|physical assessment
1485126|NCT00836238|Questionnaire|questionnaire
1485374|NCT00835107|Slow Wave Sleep|slow wave sleep
1485127|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
1485128|NCT00836238|Physical Function|physical function
1485129|NCT00836238|Symptom Assessment Interview|symptom assessment interview
1485130|NCT00836238|Elderly|elderly
1485131|NCT00836225|diabetes|diabetes
1485132|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
1485133|NCT00836212|HIV|hiv
1485134|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
1485135|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
1485136|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
1485137|NCT00836212|HIV Geneva|hiv geneva
1485138|NCT00836212|lopinavir|lopinavir
1485139|NCT00836212|efavirenz|efavirenz
1485140|NCT00836212|Treatment Experienced|treatment experienced
1485141|NCT00836199|smoking cessation|smoking cessation
1485142|NCT00836199|NicVAX|nicvax
1485143|NCT00836199|smoking vaccine|smoking vaccine
1485144|NCT00836199|smoking abstinence|smoking abstinence
1485145|NCT00836199|smoking|smoking
1485146|NCT00836199|tobacco cessation|tobacco cessation
1485147|NCT00836173|CARBOPLATIN|carboplatin
1485148|NCT00836173|DEXAMETHASONE|dexamethasone
1485149|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
1485150|NCT00836173|ETOPOSIDE|etoposide
1485151|NCT00836173|GALLIUM NITRATE|gallium nitrate
1485152|NCT00836173|IFOSFAMIDE|ifosfamide
1485153|NCT00836173|PHASE II|phase ii
1485154|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
1485155|NCT00836173|RITUXIMAB|rituximab
1485156|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
1485157|NCT00836160|NSCLC|nsclc
1485158|NCT00836160|Efficacy|efficacy
1485159|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
1485160|NCT00836134|morphine consumption|morphine consumption
1485161|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
1485162|NCT00836121|Teratoma|teratoma
1485163|NCT00836121|Mediastinum|mediastinum
1485164|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
1485165|NCT00836108|Breathing Exercises|breathing exercises
1485166|NCT00836108|Exercise Tolerance|exercise tolerance
1485167|NCT00836108|Dyspnea|dyspnea
1485168|NCT00836108|Arm Exercise|arm exercise
1485169|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
1485170|NCT00836082|Healthy volunteers|healthy volunteers
1485171|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
1485172|NCT00836056|Bioequivalence|bioequivalence
1485173|NCT00836056|Healthy Subjects|healthy subjects
1485174|NCT00836043|CLL|cll
1485175|NCT00836043|alemtuzumab|alemtuzumab
1485176|NCT00836004|Bioequivalence|bioequivalence
1485177|NCT00836004|Healthy Subjects|healthy subjects
1485178|NCT00835991|Bioequivalence|bioequivalence
1485179|NCT00835991|Healthy Subjects|healthy subjects
1485180|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
1485181|NCT00835978|kidney cancer|kidney cancer
1485182|NCT00835965|Laparoscopic|laparoscopic
1485183|NCT00835965|Surgery|surgery
1485184|NCT00835965|Postoperative|postoperative
1485185|NCT00835965|Nausea|nausea
1485186|NCT00835965|Vomiting|vomiting
1485187|NCT00835965|Aprepitant|aprepitant
1485188|NCT00835965|Dexamethasone|dexamethasone
1485189|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
1485190|NCT00835939|Achilles|achilles
1485191|NCT00835939|Tendinopathy|tendinopathy
1485192|NCT00835939|Sclerotherapy|sclerotherapy
1485193|NCT00835939|Neovascularisation|neovascularisation
1485194|NCT00835939|sports medicine|sports medicine
1485195|NCT00835939|interventional radiology|interventional radiology
1485196|NCT00835926|Influenza|influenza
1485197|NCT00835926|Fluzone®|fluzone®
1485198|NCT00835913|Autonomic nervous system|autonomic nervous system
1485199|NCT00835913|Sepsis shock|sepsis shock
1485200|NCT00835913|severe sepsis|severe sepsis
1485201|NCT00835913|sinusal change|sinusal change
1485202|NCT00835913|Myocardiac fixing|myocardiac fixing
1485203|NCT00835913|NTproBNP|ntprobnp
1485204|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
1485205|NCT00835913|Sepsis|sepsis
1485206|NCT00835900|smoking cessation|smoking cessation
1485207|NCT00835900|varenicline|varenicline
1485208|NCT00835900|smoking cessation treatment|smoking cessation treatment
1485209|NCT00835874|probiotic|probiotic
1485210|NCT00835874|preterm|preterm
1485211|NCT00835874|lactation|lactation
1485212|NCT00835874|breast feeding|breast feeding
1485213|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
1485214|NCT00835874|sepsis|sepsis
1485215|NCT00835874|bacterial cultures|bacterial cultures
1485216|NCT00835874|lactating mother|lactating mother
1485217|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
1485218|NCT00835874|Infant, very low birth weight|infant, very low birth weight
1485219|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
1485220|NCT00835861|Pregnancy|pregnancy
1485221|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1485222|NCT00835848|Primary PCI|primary pci
1486213|NCT00831337|VSL3|vsl3
1485223|NCT00835848|Postconditioning|postconditioning
1485224|NCT00835835|Multiple Sclerosis|multiple sclerosis
1485225|NCT00835835|gait|gait
1485226|NCT00835835|falls|falls
1485227|NCT00835835|lokomat|lokomat
1485228|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
1485229|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
1485230|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
1485231|NCT00835809|Biomarkers|biomarkers
1485232|NCT00835809|Emergency|emergency
1485233|NCT00835809|Intensive care unit|intensive care unit
1485234|NCT00835809|Prospective|prospective
1485235|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
1485236|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
1485237|NCT00835796|Bioequivalence|bioequivalence
1485238|NCT00835796|Healthy Subjects|healthy subjects
1485239|NCT00835770|relapsing|relapsing
1485240|NCT00835770|multiple sclerosis|multiple sclerosis
1485241|NCT00835770|remitting|remitting
1485242|NCT00835770|oral|oral
1485243|NCT00835744|ovulation induction|ovulation induction
1485244|NCT00835744|clomiphene citrate|clomiphene citrate
1485245|NCT00835744|gonadotropins|gonadotropins
1485246|NCT00835731|induced abortion|induced abortion
1485247|NCT00835731|misoprostol|misoprostol
1485248|NCT00835731|cervical ripening|cervical ripening
1485375|NCT00835107|Ziprasidone|ziprasidone
1485249|NCT00835731|second trimester abortion|second trimester abortion
1485250|NCT00835731|Dilapan-S|dilapan-s
1485251|NCT00835705|Bioequivalence|bioequivalence
1485252|NCT00835705|Healthy Subjects|healthy subjects
1485253|NCT00835692|Bioequivalence|bioequivalence
1485254|NCT00835692|Healthy Subjects|healthy subjects
1485255|NCT00835666|Bioequivalence|bioequivalence
1485256|NCT00835666|Healthy Subjects|healthy subjects
1485257|NCT00835640|Bioequivalence|bioequivalence
1485258|NCT00835640|Healthy Subjects|healthy subjects
1485259|NCT00835627|Treatment|treatment
1485260|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
1485261|NCT00835627|pharmacotherapy|pharmacotherapy
1485262|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
1485263|NCT00835627|pseudoseizures|pseudoseizures
1485264|NCT00835627|dissociative seizures|dissociative seizures
1485265|NCT00835627|conversion disorder|conversion disorder
1485266|NCT00835614|Bioequivalence|bioequivalence
1485267|NCT00835614|Healthy Subjects|healthy subjects
1485268|NCT00835588|Bioequivalence|bioequivalence
1485269|NCT00835588|Healthy Subjects|healthy subjects
1485270|NCT00835575|Bioequivalence|bioequivalence
1485271|NCT00835575|Healthy Subjects|healthy subjects
1485272|NCT00835562|Shoulder fractures|shoulder fractures
1485273|NCT00835562|Proximal humeral fractures|proximal humeral fractures
1485274|NCT00835562|Randomised clinical trial|randomised clinical trial
1485275|NCT00835562|elderly|elderly
1485276|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
1485277|NCT00835549|Bioequivalence|bioequivalence
1485278|NCT00835549|Healthy Subjects|healthy subjects
1485279|NCT00835536|Bioequivalence|bioequivalence
1485280|NCT00835536|Healthy Subjects|healthy subjects
1485281|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
1485282|NCT00835523|GnRH agonist|gnrh agonist
1485283|NCT00835523|GnRH antagonist|gnrh antagonist
1485284|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
1485285|NCT00835510|Tinea pedis|tinea pedis
1485286|NCT00835497|Bioequivalence|bioequivalence
1485287|NCT00835497|Healthy Subjects|healthy subjects
1485288|NCT00835484|Bioequivalence|bioequivalence
1485289|NCT00835484|Healthy Subjects|healthy subjects
1485290|NCT00835471|Lung cancer|lung cancer
1485291|NCT00835471|non-small-cell|non-small-cell
1485292|NCT00835471|erlotinib|erlotinib
1485293|NCT00835471|chemotherapy|chemotherapy
1485294|NCT00835458|gastric fistula|gastric fistula
1485295|NCT00835458|perforation|perforation
1485296|NCT00835458|endoscopy|endoscopy
1485297|NCT00835458|closure|closure
1485298|NCT00835458|endolumenal|endolumenal
1485299|NCT00835432|Lateral augmentation|lateral augmentation
1485301|NCT00835432|BoneCeramic|boneceramic
1485302|NCT00835432|collagen membrane|collagen membrane
1485303|NCT00835432|histomorphometry|histomorphometry
1485304|NCT00835432|morphometry|morphometry
1485306|NCT00835432|biopsy|biopsy
1485307|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
1485308|NCT00835406|Bioequivalence|bioequivalence
1485309|NCT00835406|Healthy Subjects|healthy subjects
1485310|NCT00835393|Bioequivalence|bioequivalence
1485311|NCT00835393|Healthy Subjects|healthy subjects
1485312|NCT00835367|Bioequivalence|bioequivalence
1485313|NCT00835367|Healthy Subjects|healthy subjects
1485314|NCT00835354|Bioequivalence|bioequivalence
1485315|NCT00835354|Healthy Subjects|healthy subjects
1485316|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
1485317|NCT00835341|p16 methylation|p16 methylation
1485318|NCT00835341|prognosis|prognosis
1485319|NCT00835341|malignant transformation|malignant transformation
1485320|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
1485321|NCT00835328|hyperinsulinism|hyperinsulinism
1485322|NCT00835328|hypoglycemia|hypoglycemia
1485323|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
1485324|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
1485325|NCT00835302|Cervical|cervical
1485327|NCT00835302|Manipulation|manipulation
1485328|NCT00835302|Mobilization|mobilization
1485329|NCT00835302|Clinical prediction rule|clinical prediction rule
1485330|NCT00835302|Shoulder pain.|shoulder pain.
1485331|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
1485332|NCT00835276|Bioequivalence|bioequivalence
1485333|NCT00835276|Healthy Subjects|healthy subjects
1485334|NCT00835263|Bioequivalence|bioequivalence
1485335|NCT00835263|Healthy Subjects|healthy subjects
1485336|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
1485337|NCT00835250|NOTES|notes
1485338|NCT00835250|Minilaparoscopy|minilaparoscopy
1485339|NCT00835250|Endoscopic surgery|endoscopic surgery
1485340|NCT00835250|Cholecystectomy|cholecystectomy
1485341|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
1485342|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
1485343|NCT00835237|Boostrix®|boostrix®
1485344|NCT00835237|adults|adults
1485345|NCT00835224|Spinal Cord Injury|spinal cord injury
1485346|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
1485347|NCT00835224|Blood Pressure|blood pressure
1485348|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
1485349|NCT00835224|L-NAME|l-name
1485350|NCT00835211|Bioequivalence|bioequivalence
1485351|NCT00835211|Healthy Subjects|healthy subjects
1485352|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
1485353|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
1485354|NCT00835172|Bioequivalence|bioequivalence
1485355|NCT00835172|Healthy Subjects|healthy subjects
1485356|NCT00835159|Postoperative Delirium|postoperative delirium
1485357|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1485358|NCT00835159|Rivastigmine|rivastigmine
1485359|NCT00835159|Exelon|exelon
1485360|NCT00835159|Memory impairment|memory impairment
1485361|NCT00835159|Delirium|delirium
1485362|NCT00835159|Cognitive function|cognitive function
1485363|NCT00835146|Bioequivalence|bioequivalence
1485364|NCT00835146|Healthy Subjects|healthy subjects
1485365|NCT00835133|family|family
1485366|NCT00835133|history|history
1485367|NCT00835133|pancreas|pancreas
1485368|NCT00835133|cancer|cancer
1485369|NCT00835133|melanoma|melanoma
1485370|NCT00835133|genetic|genetic
1485371|NCT00835107|Bipolar Depression|bipolar depression
1485372|NCT00835107|Sleep|sleep
1485373|NCT00835107|Polysomnograph|polysomnograph
1485376|NCT00835107|Antipsychotic|antipsychotic
1485377|NCT00835107|Placebo|placebo
1485378|NCT00835081|Bioequivalence|bioequivalence
1485379|NCT00835081|Healthy Subjects|healthy subjects
1485380|NCT00835068|Hemophilia B|hemophilia b
1485381|NCT00835068|observational|observational
1485382|NCT00835068|post marketing study|post marketing study
1485383|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
1485384|NCT00835055|standardized clinical tests|standardized clinical tests
1485385|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
1485386|NCT00835042|Bioequivalence|bioequivalence
1485387|NCT00835042|Healthy Subjects|healthy subjects
1485388|NCT00835029|oral|oral
1485389|NCT00835029|candida|candida
1485390|NCT00835029|denture|denture
1485391|NCT00835029|clotrimazole|clotrimazole
1485392|NCT00835029|slow releases|slow releases
1485393|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
1485394|NCT00835003|Neonatal admission|neonatal admission
1485395|NCT00835003|Elective Caesarean Section|elective caesarean section
1485396|NCT00835003|Timing|timing
1485397|NCT00835003|Choice behavior|choice behavior
1485398|NCT00835003|Intraoperative complications|intraoperative complications
1485399|NCT00835003|Postoperative complications|postoperative complications
1485400|NCT00834990|Bioequivalence|bioequivalence
1485401|NCT00834990|Healthy Subjects|healthy subjects
1485402|NCT00834977|Bioequivalence|bioequivalence
1485403|NCT00834977|Healthy Subjects|healthy subjects
1485404|NCT00834964|Bioequivalence|bioequivalence
1485405|NCT00834964|Healthy Subjects|healthy subjects
1485406|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1485407|NCT00834951|Elderly patients|elderly patients
1485408|NCT00834951|Low dose total body irradiation|low dose total body irradiation
1485409|NCT00834951|RCHOP14|rchop14
1485410|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
1485411|NCT00834938|Insulin resistance|insulin resistance
1485412|NCT00834938|bariatric surgery|bariatric surgery
1485413|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
1485414|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1485415|NCT00834938|insulin|insulin
1485416|NCT00834938|glucagon|glucagon
1485417|NCT00834938|ghrelin|ghrelin
1485418|NCT00834938|adiponectin|adiponectin
1485419|NCT00834938|Cytokines|cytokines
1485420|NCT00834938|gastric bypass|gastric bypass
1485421|NCT00834938|Obesity|obesity
1485422|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
1485423|NCT00834912|Healthy Subjects|healthy subjects
1485424|NCT00834899|Sickle cell disease|sickle cell disease
1485425|NCT00834899|Pain crisis|pain crisis
1485426|NCT00834899|Acute pain episode|acute pain episode
1485427|NCT00834899|Eptifibatide|eptifibatide
1485428|NCT00834899|Antiplatelet therapy|antiplatelet therapy
1485429|NCT00834899|Safety|safety
1485430|NCT00834899|Treatment|treatment
1485431|NCT00834873|Bioequivalence|bioequivalence
1485432|NCT00834873|Healthy Subjects|healthy subjects
1485433|NCT00834860|chronic hepatitis C|chronic hepatitis c
1485434|NCT00834860|sustained virological response|sustained virological response
1485435|NCT00834860|peginterferon|peginterferon
1485436|NCT00834860|ribavirin|ribavirin
1485437|NCT00834860|neoplasm|neoplasm
1485438|NCT00834847|Bioequivalence|bioequivalence
1485439|NCT00834847|Healthy Subjects|healthy subjects
1485440|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
1485441|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1485442|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
1485443|NCT00834821|Inattention|inattention
1485444|NCT00834821|Psychosocial Intervention|psychosocial intervention
1485445|NCT00834821|Behavioral Intervention|behavioral intervention
1485446|NCT00834808|Healthy volunteers|healthy volunteers
1485447|NCT00834795|Bioequivalence|bioequivalence
1485448|NCT00834795|Healthy Subjects|healthy subjects
1485450|NCT00834782|IOP|iop
1485451|NCT00834756|Bioequivalence|bioequivalence
1485452|NCT00834756|Healthy Subjects|healthy subjects
1485453|NCT00834743|Bioequivalence|bioequivalence
1485454|NCT00834743|Healthy Subjects|healthy subjects
1485455|NCT00834717|Bioequivalence|bioequivalence
1485456|NCT00834717|Healthy Subjects|healthy subjects
1485457|NCT00834704|PEGPH20|pegph20
1485458|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
1485459|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
1485460|NCT00834691|Inflammation|inflammation
1485461|NCT00834691|Oxidative stress|oxidative stress
1485462|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
1485463|NCT00834678|male breast cancer|male breast cancer
1485464|NCT00834678|recurrent breast cancer|recurrent breast cancer
1485465|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
1485466|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
1485467|NCT00834678|stage IV breast cancer|stage iv breast cancer
1485468|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1485469|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
1485470|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1485471|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
1485472|NCT00834652|Metabolic Diseases|metabolic diseases
1485473|NCT00834652|Depressive Disorder, Major|depressive disorder, major
1485474|NCT00834652|Depressive Disorder|depressive disorder
1485475|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
1485476|NCT00834652|Depression Recurrence|depression recurrence
1485477|NCT00834639|Bioequivalence|bioequivalence
1485478|NCT00834639|Healthy Subjects|healthy subjects
1485479|NCT00834626|Ileal Interposition|ileal interposition
1485480|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
1485481|NCT00834626|Type-2 Diabetes|type-2 diabetes
1485482|NCT00834613|Bioequivalence|bioequivalence
1485483|NCT00834613|Healthy Subjects|healthy subjects
1485484|NCT00834587|Bioequivalence|bioequivalence
1485485|NCT00834587|Healthy Subjects|healthy subjects
1485486|NCT00834574|Bioequivalence|bioequivalence
1485487|NCT00834574|Healthy Subjects|healthy subjects
1485488|NCT00834561|Bioequivalence|bioequivalence
1485489|NCT00834561|Healthy Subjects|healthy subjects
1485490|NCT00834548|Magnetic resonance|magnetic resonance
1485491|NCT00834548|whole body|whole body
1485492|NCT00834548|angiography|angiography
1485493|NCT00834548|hybrid protocol|hybrid protocol
1485494|NCT00834548|MRI|mri
1485495|NCT00834535|Bioequivalence|bioequivalence
1485496|NCT00834535|Healthy Subjects|healthy subjects
1485497|NCT00834522|Bioequivalence|bioequivalence
1485498|NCT00834522|Healthy Subjects|healthy subjects
1485500|NCT00834483|Efficacy|efficacy
1485501|NCT00834483|Cost-savings|cost-savings
1485502|NCT00834483|Cosmesis|cosmesis
1485503|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
1485504|NCT00834483|Cost-savings potential|cost-savings potential
1485505|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
1485506|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
1485507|NCT00834457|antiretroviral therapy|antiretroviral therapy
1485508|NCT00834444|Bioequivalence|bioequivalence
1485509|NCT00834444|Healthy Subjects|healthy subjects
1485510|NCT00834431|Bioequivalence|bioequivalence
1485511|NCT00834431|Healthy Subjects|healthy subjects
1485512|NCT00834418|Bioequivalence|bioequivalence
1485513|NCT00834418|Healthy Subjects|healthy subjects
1485514|NCT00834405|Bioequivalence|bioequivalence
1485515|NCT00834405|Healthy Subjects|healthy subjects
1485516|NCT00834379|Bioequivalence|bioequivalence
1485517|NCT00834379|Healthy Subjects|healthy subjects
1485518|NCT00834366|Healthy volunteers|healthy volunteers
1485519|NCT00834340|Bioequivalence|bioequivalence
1485520|NCT00834340|Healthy Subjects|healthy subjects
1485521|NCT00834327|Restless Legs Syndrome|restless legs syndrome
1485522|NCT00834301|End Stage Renal Disease|end stage renal disease
1485523|NCT00834301|Inflammation|inflammation
1485524|NCT00834288|Healthy subjects|healthy subjects
1485525|NCT00834288|Pharmacokinetics|pharmacokinetics
1485526|NCT00834288|Bioavailability|bioavailability
1485527|NCT00834275|Bioequivalence|bioequivalence
1485528|NCT00834275|Healthy Subjects|healthy subjects
1485529|NCT00834249|Bioequivalence|bioequivalence
1485530|NCT00834249|Healthy Subjects|healthy subjects
1485531|NCT00834236|gastric cancer|gastric cancer
1485532|NCT00834236|proteomics|proteomics
1485533|NCT00834236|gastric juice|gastric juice
1485534|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
1485535|NCT00834223|OAG|oag
1485536|NCT00834223|glaucoma|glaucoma
1485537|NCT00834197|Bioequivalence|bioequivalence
1485538|NCT00834197|Healthy Subjects|healthy subjects
1485539|NCT00834184|nikkomycin Z|nikkomycin z
1485540|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
1485541|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
1485542|NCT00834158|Hepatitis B|hepatitis b
1485543|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
1485544|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
1485545|NCT00834158|Surgical resection|surgical resection
1485546|NCT00834158|Disease-free survival|disease-free survival
1485547|NCT00834158|Overall survival|overall survival
1485548|NCT00834145|Edema|edema
1485549|NCT00834145|Right heart failure|right heart failure
1485550|NCT00834145|Cor pulmonale|cor pulmonale
1485551|NCT00834145|Pump|pump
1485552|NCT00834145|Leg compression|leg compression
1485553|NCT00834132|Bioequivalence|bioequivalence
1485554|NCT00834132|Healthy Subjects|healthy subjects
1485555|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
1485556|NCT00834093|Epstein-Barr Virus|epstein-barr virus
1485557|NCT00834093|NPC|npc
1485558|NCT00834093|EBV|ebv
1485559|NCT00834093|immunotherapy|immunotherapy
1485560|NCT00834080|opioid dependence|opioid dependence
1485561|NCT00834080|VIVITROL|vivitrol
1485562|NCT00834080|opioid-related disorders|opioid-related disorders
1485563|NCT00834067|Bioequivalence|bioequivalence
1485564|NCT00834067|Healthy Subjects|healthy subjects
1485565|NCT00834041|aliskiren|aliskiren
1485566|NCT00834041|pediatric|pediatric
1485567|NCT00834041|hypertension|hypertension
1485568|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
1485569|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
1485570|NCT00834041|plasma renin activity|plasma renin activity
1485571|NCT00834041|mini-tablet formulation|mini-tablet formulation
1485572|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
1485573|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
1485574|NCT00834028|angiopoietin|angiopoietin
1485575|NCT00834028|cathepsin|cathepsin
1485576|NCT00834015|spinal fusion|spinal fusion
1485577|NCT00834015|pain|pain
1485578|NCT00834015|disability|disability
1485579|NCT00834015|muscle strength|muscle strength
1485580|NCT00834015|mobility|mobility
1485581|NCT00834015|quality of life|quality of life
1485582|NCT00834015|lumbar|lumbar
1485583|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
1485584|NCT00834002|AML in remission|aml in remission
1485585|NCT00833950|Tinnitus|tinnitus
1485586|NCT00833950|Phase Out|phase out
1485587|NCT00833937|Bioequivalence|bioequivalence
1485588|NCT00833937|Healthy Subjects|healthy subjects
1485589|NCT00833924|Low Profile|low profile
1485590|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1485591|NCT00833924|Endovascular|endovascular
1485592|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
1485593|NCT00833898|depression|depression
1485594|NCT00833898|stress|stress
1485595|NCT00833898|caregiving|caregiving
1485596|NCT00833898|anxiety|anxiety
1485597|NCT00833898|psychoeducation intervention|psychoeducation intervention
1485598|NCT00833898|psycho-oncology|psycho-oncology
1485599|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
1485600|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
1485601|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
1485602|NCT00833859|gastrointestinal|gastrointestinal
1485603|NCT00833859|pancreas|pancreas
1485604|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
1485605|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
1485606|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
1485607|NCT00833846|Diabetes|diabetes
1485608|NCT00833846|Insulin Resistance|insulin resistance
1485610|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
1485611|NCT00833807|Melanoma|melanoma
1485612|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
1485613|NCT00833807|Liver metastasis|liver metastasis
1485614|NCT00833807|Nab-paclitaxel|nab-paclitaxel
1485615|NCT00833807|Abraxane|abraxane
1485616|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
1485617|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
1485618|NCT00833807|Hepatic Artery|hepatic artery
1485619|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
1485620|NCT00833807|Hepatic Administration|hepatic administration
1485621|NCT00833781|HIV vaccine|hiv vaccine
1485622|NCT00833781|Dendritic cells|dendritic cells
1485623|NCT00833781|treatment experienced|treatment experienced
1485624|NCT00833755|Pain|pain
1485625|NCT00833755|Chronic pain|chronic pain
1485626|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
1485627|NCT00833755|Opioid therapy|opioid therapy
1485628|NCT00833742|somatization|somatization
1485629|NCT00833742|psychosomatic|psychosomatic
1485630|NCT00833742|short-term|short-term
1485631|NCT00833742|dynamic|dynamic
1485632|NCT00833742|psychotherapy|psychotherapy
1485633|NCT00833729|psoriasis|psoriasis
1485634|NCT00833729|etanercept|etanercept
1485635|NCT00833729|adalimumab|adalimumab
1485636|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1485637|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
1485638|NCT00833703|shunt palliation|shunt palliation
1485639|NCT00833703|thrombosis|thrombosis
1485640|NCT00833703|clopidogrel|clopidogrel
1485641|NCT00833690|Parkinson's disease|parkinson's disease
1485642|NCT00833690|Parkinson disease|parkinson disease
1485643|NCT00833690|PD|pd
1485644|NCT00833690|inosine|inosine
1485645|NCT00833690|urate|urate
1485646|NCT00833690|uric acid|uric acid
1485647|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
1485648|NCT00833677|Coping skills|coping skills
1485649|NCT00833677|Chinese|chinese
1485650|NCT00833677|Immigrant|immigrant
1485651|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1485652|NCT00833677|Family research|family research
1485653|NCT00833664|Bioequivalence|bioequivalence
1485654|NCT00833664|Healthy Subjects|healthy subjects
1485655|NCT00833651|Transplant|transplant
1485656|NCT00833651|Immunology|immunology
1485657|NCT00833651|Immunosuppression|immunosuppression
1485658|NCT00833638|Erectile Dysfunction|erectile dysfunction
1485659|NCT00833625|Gastrointestinal|gastrointestinal
1485660|NCT00833625|Esophagus|esophagus
1485661|NCT00833625|Cancer of the esophagus|cancer of the esophagus
1485662|NCT00833625|Biopsy|biopsy
1485663|NCT00833625|EGD|egd
1485664|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
1485665|NCT00833625|PET/CT|pet/ct
1485666|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
1485667|NCT00833625|Esophageal Cancer|esophageal cancer
1485668|NCT00833625|Chemoradiation|chemoradiation
1485669|NCT00833625|Chemotherapy|chemotherapy
1485670|NCT00833625|Radiation Therapy|radiation therapy
1485671|NCT00833612|IABC|iabc
1485672|NCT00833612|AMI|ami
1485673|NCT00833599|Lymphedema|lymphedema
1485674|NCT00833599|Genetic|genetic
1485675|NCT00833599|Lymphatic Disorder|lymphatic disorder
1485676|NCT00833599|Lipedema|lipedema
1485677|NCT00833599|Vascular Malformation|vascular malformation
1485678|NCT00833599|Vascular Anomaly|vascular anomaly
1485679|NCT00833599|Dercum Disease|dercum disease
1485680|NCT00833586|Bioequivalence|bioequivalence
1485681|NCT00833586|Healthy Subjects|healthy subjects
1485682|NCT00833573|GERD digestive expression|gerd digestive expression
1485683|NCT00833573|ages|ages
1485684|NCT00833560|Multiple Myeloma|multiple myeloma
1485685|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
1485686|NCT00833560|Bortezomib|bortezomib
1485687|NCT00833560|VELCADE|velcade
1485688|NCT00833560|Cyclophosphamide|cyclophosphamide
1485689|NCT00833560|Dexamethasone|dexamethasone
1485690|NCT00833560|Chemotherapy|chemotherapy
1485691|NCT00833560|Remission therapy|remission therapy
1485692|NCT00833560|Induction therapy|induction therapy
1485693|NCT00833560|Stem Cell Transplantation|stem cell transplantation
1485694|NCT00833547|sleep|sleep
1485695|NCT00833547|schizophrenia|schizophrenia
1485696|NCT00833547|procedural learning|procedural learning
1485697|NCT00833547|motor skill|motor skill
1485698|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1485699|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1485700|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1485701|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1485702|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1485703|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1485704|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1485705|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1485706|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1485707|NCT00833521|Bioequivalence|bioequivalence
1485708|NCT00833521|Healthy Subjects|healthy subjects
1485709|NCT00833508|Exercise capacity|exercise capacity
1485710|NCT00833508|Chemoradiotherapy|chemoradiotherapy
1485711|NCT00833508|Colorectal cancer|colorectal cancer
1485713|NCT00833469|postpartum depression|postpartum depression
1485714|NCT00833469|anxiety|anxiety
1485715|NCT00833456|schizophrenia|schizophrenia
1485716|NCT00833456|Seroquel SR|seroquel sr
1485717|NCT00833456|atypical antipsychotics|atypical antipsychotics
1485718|NCT00833456|assessment of functioning|assessment of functioning
1485719|NCT00833456|GAF scale|gaf scale
1485720|NCT00833443|Methamphetamine|methamphetamine
1485721|NCT00833443|Addiction|addiction
1485722|NCT00833443|Pharmacogenomics|pharmacogenomics
1485723|NCT00833443|Amphetamine|amphetamine
1485724|NCT00833443|Bupropion|bupropion
1485725|NCT00833443|Meth|meth
1485726|NCT00833443|Crank|crank
1485727|NCT00833443|Crystal|crystal
1485728|NCT00833430|AVN|avn
1485729|NCT00833430|Femoral Head Collapse|femoral head collapse
1485730|NCT00833417|BCC|bcc
1485731|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
1485732|NCT00833417|Hedgehog|hedgehog
1485733|NCT00833417|Basal Cell Cancer|basal cell cancer
1485734|NCT00833404|Smoking|smoking
1485735|NCT00833404|Smoking Cessation|smoking cessation
1485736|NCT00833404|Quit Smoking|quit smoking
1485737|NCT00833404|Stop Smoking|stop smoking
1485738|NCT00833404|Nicotine Patch|nicotine patch
1485739|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
1485740|NCT00833404|Sexual Functioning|sexual functioning
1485741|NCT00833404|Erectile Functioning|erectile functioning
1485742|NCT00833404|Sexual Health|sexual health
1485743|NCT00833391|healthy volunteer|healthy volunteer
1485744|NCT00833391|formulations|formulations
1485745|NCT00833391|bioavailability|bioavailability
1485746|NCT00833391|pharmacokinetics|pharmacokinetics
1485747|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
1485748|NCT00833365|premature infants|premature infants
1485749|NCT00833365|PDA|pda
1485750|NCT00833365|ibuprofen|ibuprofen
1485751|NCT00833313|Atrial fibrillation|atrial fibrillation
1485752|NCT00833313|Gene expression|gene expression
1485753|NCT00833313|Genetic|genetic
1485754|NCT00833300|Delirium|delirium
1485755|NCT00833300|Agitation|agitation
1485756|NCT00833300|Intensive Care|intensive care
1485757|NCT00833300|Critical Care|critical care
1485758|NCT00833300|Antipsychotics|antipsychotics
1485759|NCT00833300|Olanzapine|olanzapine
1485760|NCT00833300|Haloperidol|haloperidol
1485761|NCT00833287|immunoregulatory|immunoregulatory
1485762|NCT00833287|dysfunction|dysfunction
1485763|NCT00833287|obesity|obesity
1485764|NCT00833261|recurrent hypopharynx Cancer|recurrent hypopharynx cancer
1485765|NCT00833261|recurrent larynx Cancer|recurrent larynx cancer
1485766|NCT00833261|recurrent verrucous carcinoma|recurrent verrucous carcinoma
1485767|NCT00833261|squamous cell carcinoma|squamous cell carcinoma
1485768|NCT00833261|recurrent oral cavity cancer|recurrent oral cavity cancer
1485769|NCT00833261|recurrent metastatic occult primary cancer|recurrent metastatic occult primary cancer
1485770|NCT00833261|recurrent oropharynx cacner|recurrent oropharynx cacner
1485771|NCT00833261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1485772|NCT00833261|tongue cancer|tongue cancer
1485773|NCT00833222|premature birth|premature birth
1485774|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
1485775|NCT00833209|Medication Overuse Headache|medication overuse headache
1485776|NCT00833209|Chronic headache|chronic headache
1485777|NCT00833209|withdrawal|withdrawal
1485778|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
1485779|NCT00833170|multiple site study|multiple site study
1485780|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
1485781|NCT00833157|exercise|exercise
1485782|NCT00833157|strength training|strength training
1485783|NCT00833157|Glucosamine|glucosamine
1485784|NCT00833157|Dietary supplement|dietary supplement
1485785|NCT00833157|Ibuprofen|ibuprofen
1485786|NCT00833157|NSAID|nsaid
1485787|NCT00833144|heart failure|heart failure
1485789|NCT00833144|ultrasound|ultrasound
1485790|NCT00833131|Rectal cancer|rectal cancer
1485791|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
1485792|NCT00833118|Surgery|surgery
1485793|NCT00833118|General Anesthesia|general anesthesia
1485794|NCT00833118|Intubation|intubation
1485795|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
1485796|NCT00833105|Rehabilitation|rehabilitation
1485797|NCT00833105|Upper Extremity|upper extremity
1485798|NCT00833105|AMES device|ames device
1485799|NCT00833105|Incomplete SCI|incomplete sci
1485800|NCT00833105|Quadriplegia|quadriplegia
1485801|NCT00833092|magnesium|magnesium
1485802|NCT00833092|Nutritional Requirements|nutritional requirements
1485803|NCT00833092|Sleep|sleep
1485804|NCT00833079|Atopic Dermatitis|atopic dermatitis
1485805|NCT00833066|hay fever|hay fever
1485806|NCT00833066|grass pollen allergy|grass pollen allergy
1485807|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
1485808|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
1485809|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
1485812|NCT00832988|sensing|sensing
1485813|NCT00832988|impedance|impedance
1485814|NCT00832962|Rhesus D|rhesus d
1485815|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
1485816|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
1485817|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
1485818|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
1485933|NCT00832572|Pain|pain
1486634|NCT00829686|antibiotics|antibiotics
1485819|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
1485820|NCT00832949|Peer support|peer support
1485821|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
1485822|NCT00832949|Self-management|self-management
1485823|NCT00832949|Patient education|patient education
1485824|NCT00832923|parental empowerment|parental empowerment
1485825|NCT00832923|parent self-efficacy|parent self-efficacy
1485826|NCT00832910|Body image|body image
1485827|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
1485828|NCT00832897|Keratoconus|keratoconus
1485829|NCT00832897|riboflavin|riboflavin
1485830|NCT00832897|cornea|cornea
1485831|NCT00832897|crosslinking|crosslinking
1485832|NCT00832884|partial|partial
1485833|NCT00832884|onset|onset
1485834|NCT00832884|epilepsy|epilepsy
1485835|NCT00832884|pediatric|pediatric
1485836|NCT00832884|lacosamide|lacosamide
1485837|NCT00832884|partial onset epilepsy|partial onset epilepsy
1485838|NCT00832884|vimpat|vimpat
1485843|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
1485844|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
1485845|NCT00832845|Randomized|randomized
1485846|NCT00832832|Glaucoma|glaucoma
1485847|NCT00832832|Eye drop|eye drop
1485848|NCT00832832|Intraocular pressure|intraocular pressure
1485849|NCT00832832|Eyelid closure|eyelid closure
1485850|NCT00832819|Cancer|cancer
1485851|NCT00832819|Lung Cancer|lung cancer
1485852|NCT00832806|smoking|smoking
1485853|NCT00832806|Champix|champix
1485854|NCT00832806|Integrated Voice Response technology|integrated voice response technology
1485855|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
1485856|NCT00832793|Peer support|peer support
1485857|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
1485858|NCT00832793|Self-management|self-management
1485859|NCT00832793|Patient education|patient education
1485860|NCT00832780|Lung cancer|lung cancer
1485861|NCT00832780|radiation therapy|radiation therapy
1485862|NCT00832780|SBRT|sbrt
1485863|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1485864|NCT00832780|Tomotherapy|tomotherapy
1485865|NCT00832780|other solid tumors|other solid tumors
1485866|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
1485867|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
1485868|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
1485869|NCT00832754|malaria|malaria
1485870|NCT00832754|rapid diagnostic test|rapid diagnostic test
1485871|NCT00832754|artemisinin|artemisinin
1485872|NCT00832754|Ghana|ghana
1485873|NCT00832741|GLP-1|glp-1
1485874|NCT00832741|Type 1 diabetes|type 1 diabetes
1485875|NCT00832741|Glycemic control|glycemic control
1485876|NCT00832741|Incretin hormone|incretin hormone
1485877|NCT00832715|Lung|lung
1485878|NCT00832715|Lung Cancer|lung cancer
1485879|NCT00832715|NSCLC|nsclc
1485880|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
1485881|NCT00832715|Squamous Cell|squamous cell
1485882|NCT00832715|Adenocarcinoma|adenocarcinoma
1485883|NCT00832715|Large Cell|large cell
1485884|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
1485885|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
1485886|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
1485887|NCT00832715|EBUS-FNA|ebus-fna
1485888|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
1485889|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
1485890|NCT00832715|Biopsy|biopsy
1485891|NCT00832715|PET scan|pet scan
1485892|NCT00832715|Positron Emission Tomography|positron emission tomography
1485893|NCT00832715|CT Scans|ct scans
1485894|NCT00832715|Computed Tomography Scans|computed tomography scans
1485895|NCT00832715|Lymph node|lymph node
1485896|NCT00832715|Mediastinoscopy|mediastinoscopy
1485897|NCT00832715|Bronchoscope|bronchoscope
1485898|NCT00832702|Cardiac|cardiac
1485900|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
1485901|NCT00832689|toxicity|toxicity
1485902|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
1485903|NCT00832676|Peer support|peer support
1485904|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
1486214|NCT00831337|Probiotics|probiotics
1485911|NCT00832663|myogenic precursor cells|myogenic precursor cells
1485912|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
1485921|NCT00832611|Lung Disease|lung disease
1485922|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
1485923|NCT00832611|Chronic Bronchitis|chronic bronchitis
1485924|NCT00832611|Chronic Emphysema|chronic emphysema
1485925|NCT00832598|18F-FACBC|18f-facbc
1485926|NCT00832598|PET scan imaging|pet scan imaging
1485927|NCT00832598|08-142|08-142
1485928|NCT00832585|Atopic|atopic
1485929|NCT00832585|Dermatitis|dermatitis
1485930|NCT00832585|chronic|chronic
1485931|NCT00832585|skin|skin
1485932|NCT00832572|Coronary Artery Disease|coronary artery disease
1485934|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
1485935|NCT00832572|Polyneuropathy|polyneuropathy
1485936|NCT00832559|CAVATAK|cavatak
1485937|NCT00832559|Coxsackievirus A21|coxsackievirus a21
1485938|NCT00832559|CVA21|cva21
1485939|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
1485940|NCT00832533|Vitamin D|vitamin d
1485941|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
1485942|NCT00832533|UV exposure|uv exposure
1485943|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
1485944|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
1485945|NCT00832520|Advanced cancer|advanced cancer
1485946|NCT00832520|weight loss|weight loss
1485947|NCT00832520|Remeron|remeron
1485948|NCT00832520|body weight|body weight
1485949|NCT00832507|PAH|pah
1485950|NCT00832507|pulmonary hypertension|pulmonary hypertension
1485951|NCT00832507|cicletanine|cicletanine
1485952|NCT00832507|cicletanine HCL|cicletanine hcl
1485953|NCT00832507|cardiovascular|cardiovascular
1485954|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
1485955|NCT00832507|ERA|era
1485956|NCT00832507|monotherapy|monotherapy
1485957|NCT00832507|combination therapy|combination therapy
1485958|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
1485959|NCT00832507|PDE5i|pde5i
1485960|NCT00832507|parenteral prostanoid|parenteral prostanoid
1485961|NCT00832507|PH|ph
1485962|NCT00832507|pulmonary|pulmonary
1485963|NCT00832481|Repaglinide|repaglinide
1485964|NCT00832481|Metformin|metformin
1485965|NCT00832468|insomnia|insomnia
1485966|NCT00832468|ear acupressure|ear acupressure
1485967|NCT00832442|Beta blocker|beta blocker
1485968|NCT00832442|Heart Failure|heart failure
1485969|NCT00832442|Meta analysis|meta analysis
1485970|NCT00832442|Individual patient data|individual patient data
1485971|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
1485972|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
1485973|NCT00832429|Cancer of the eyelid|cancer of the eyelid
1485974|NCT00832429|Eye Cancer|eye cancer
1485975|NCT00832429|Tumors of the Eye|tumors of the eye
1485976|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
1485977|NCT00832429|SLN|sln
1485978|NCT00832429|Metastatic Disease|metastatic disease
1485979|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
1485980|NCT00832429|Lymphatic Mapping|lymphatic mapping
1485981|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
1485982|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
1485983|NCT00832429|SLN Biopsy|sln biopsy
1485984|NCT00832429|Lymph Nodes|lymph nodes
1485985|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
1485986|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
1485987|NCT00832429|Computed Tomography|computed tomography
1485988|NCT00832429|SPECT/CT|spect/ct
1485989|NCT00832403|atrophic rhinitis|atrophic rhinitis
1485990|NCT00832403|implants|implants
1485991|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
1485992|NCT00832364|Psoriasis|psoriasis
1485993|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
1485994|NCT00832351|Stroke|stroke
1485995|NCT00832351|Brain infarction|brain infarction
1485996|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
1485997|NCT00832351|Early Mobilisation|early mobilisation
1485998|NCT00832338|Breast cancer|breast cancer
1485999|NCT00832338|Tumors, Breast|tumors, breast
1486000|NCT00832338|Cancer of the breast|cancer of the breast
1486001|NCT00832325|Childhood Survivor|childhood survivor
1486002|NCT00832325|survivors|survivors
1486003|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
1486004|NCT00832325|Childhood cancers|childhood cancers
1486006|NCT00832312|Osteoarthritis|osteoarthritis
1486008|NCT00832312|Pain management|pain management
1486009|NCT00832312|Ozone therapy|ozone therapy
1486010|NCT00832312|Intraarticular injection|intraarticular injection
1486011|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
1486012|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
1486013|NCT00832247|Hepatitis C|hepatitis c
1486014|NCT00832247|Cirrhosis|cirrhosis
1486015|NCT00832247|Stem cell|stem cell
1486016|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
1486017|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
1486018|NCT00832234|Therapy|therapy
1486019|NCT00832234|Rituximab|rituximab
1486020|NCT00832234|Dexamethasone|dexamethasone
1486021|NCT00832234|Bortezomib|bortezomib
1486022|NCT00832221|PET|pet
1486023|NCT00832221|Phase 1|phase 1
1486024|NCT00832221|Depression|depression
1486025|NCT00832221|SEROQUEL|seroquel
1486026|NCT00832221|Positron Emission Tomography|positron emission tomography
1486027|NCT00832221|Drug profile comparison|drug profile comparison
1486028|NCT00832195|running|running
1486029|NCT00832195|injury|injury
1486030|NCT00832195|pronation|pronation
1486031|NCT00832195|footwear.|footwear.
1486032|NCT00832169|Pain|pain
1486033|NCT00832156|Burns|burns
1486034|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
1486035|NCT00832156|Wound healing|wound healing
1486036|NCT00832156|Wound closure|wound closure
1486037|NCT00832156|Scar quality|scar quality
1486038|NCT00832143|neonatal illness|neonatal illness
1486039|NCT00832143|qualified care seeking|qualified care seeking
1486040|NCT00832143|Behaviour change|behaviour change
1486041|NCT00832143|Urban slums|urban slums
1486042|NCT00832143|India|india
1486043|NCT00832143|Neonatal morbidity|neonatal morbidity
1486044|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
1486045|NCT00832143|Qualified medical care seeking|qualified medical care seeking
1486046|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
1486047|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
1486048|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
1486049|NCT00832091|venous insufficiency|venous insufficiency
1486050|NCT00832091|leg ulcers|leg ulcers
1486051|NCT00832091|Thymosin Beta 4|thymosin beta 4
1486052|NCT00832091|Laminin-5|laminin-5
1486053|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
1486054|NCT00832065|Sleep Apnea|sleep apnea
1486055|NCT00832065|CPAP|cpap
1486056|NCT00832065|Low testosterone|low testosterone
1486057|NCT00832065|Sexual Dysfunction|sexual dysfunction
1486058|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
1486059|NCT00832039|sepsis|sepsis
1486060|NCT00832039|adjunctive therapy|adjunctive therapy
1486061|NCT00832039|sodium-selenite|sodium-selenite
1486062|NCT00832039|procalcitonin|procalcitonin
1486063|NCT00832026|sleep apnea|sleep apnea
1486064|NCT00832026|snoring|snoring
1486065|NCT00832026|sleep apnea treatment|sleep apnea treatment
1486066|NCT00832026|TNI|tni
1486067|NCT00832026|Trans nasal insuflation|trans nasal insuflation
1486068|NCT00832026|Open CPAP|open cpap
1486069|NCT00832013|Propofol|propofol
1486070|NCT00832013|sedation|sedation
1486071|NCT00832013|pediatric|pediatric
1486072|NCT00832013|Induction of sedation|induction of sedation
1486073|NCT00831987|Fluzone®|fluzone®
1486074|NCT00831987|Influenza|influenza
1486075|NCT00831987|Adults|adults
1486076|NCT00831974|mastocytosis|mastocytosis
1486077|NCT00831974|indolent|indolent
1486078|NCT00831974|handicap|handicap
1486079|NCT00831974|wild-type|wild-type
1486080|NCT00831974|systemic|systemic
1486081|NCT00831974|not D816V mutated|not d816v mutated
1486082|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
1486083|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
1486084|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
1486085|NCT00831922|DMARD failure|dmard failure
1486086|NCT00831922|ACR|acr
1486087|NCT00831909|Lung Cancer|lung cancer
1486088|NCT00831909|NSCLC management|nsclc management
1486089|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
1486090|NCT00831883|Adolescent|adolescent
1486091|NCT00831883|Adolescent behavior|adolescent behavior
1486092|NCT00831883|Health behavior|health behavior
1486093|NCT00831883|Sexual Behavior|sexual behavior
1486094|NCT00831883|Incarceration|incarceration
1486095|NCT00831883|Behavioral Intervention|behavioral intervention
1486096|NCT00831883|Risk Reduction Behavior|risk reduction behavior
1486097|NCT00831870|EndoSure Sensor|endosure sensor
1486098|NCT00831870|s2 Sensor|s2 sensor
1486099|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
1486100|NCT00831831|perinatal|perinatal
1486101|NCT00831831|intimate partner violence|intimate partner violence
1486102|NCT00831831|randomized controlled trial|randomized controlled trial
1486103|NCT00831831|preterm|preterm
1486104|NCT00831831|hemorrhage|hemorrhage
1486105|NCT00831831|safety|safety
1486106|NCT00831818|breastfeeding|breastfeeding
1486107|NCT00831818|ghrelin|ghrelin
1486108|NCT00831818|PYY|pyy
1486109|NCT00831818|appetite-regulation|appetite-regulation
1486110|NCT00831805|geriatrics|geriatrics
1486111|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
1486112|NCT00831805|elderly|elderly
1486113|NCT00831805|mobile unit|mobile unit
1486114|NCT00831805|elderly patients|elderly patients
1486115|NCT00831792|Prostate Cancer|prostate cancer
1486116|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
1486117|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
1486118|NCT00831792|Prostate Specific Antigen|prostate specific antigen
1486119|NCT00831792|PSA|psa
1486120|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
1486121|NCT00831792|TK1258|tk1258
1486122|NCT00831792|CHIR-258|chir-258
1486123|NCT00831766|Hematopoietic|hematopoietic
1486124|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
1486125|NCT00831766|AML|aml
1486126|NCT00831753|Diphtheria|diphtheria
1486127|NCT00831753|Tetanus|tetanus
1486128|NCT00831753|Pertussis|pertussis
1486129|NCT00831753|whooping cough|whooping cough
1486130|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
1486131|NCT00831753|Hepatitis B|hepatitis b
1486132|NCT00831753|Poliomyelitis|poliomyelitis
1486133|NCT00831740|Stroke|stroke
1486134|NCT00831740|Communication|communication
1486135|NCT00831740|Speech and Language Therapy|speech and language therapy
1486345|NCT00830856|Africa|africa
1486136|NCT00831727|expressive writing|expressive writing
1486137|NCT00831727|trauma|trauma
1486138|NCT00831727|intervention|intervention
1486139|NCT00831727|posttraumatic stress|posttraumatic stress
1486140|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
1486141|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
1486142|NCT00831701|drug therapy|drug therapy
1486143|NCT00831701|tamsulosin|tamsulosin
1486144|NCT00831701|ureter|ureter
1486145|NCT00831688|Meniere|meniere
1486146|NCT00831688|vertigo|vertigo
1486147|NCT00831688|overpressure treatment|overpressure treatment
1486148|NCT00831688|caloric irrigation|caloric irrigation
1486149|NCT00831688|hearing levels|hearing levels
1486150|NCT00831688|vertigo severity|vertigo severity
1486151|NCT00831688|functional disability scale|functional disability scale
1486152|NCT00831675|Influenza|influenza
1486153|NCT00831675|Fluzone® vaccine|fluzone® vaccine
1486154|NCT00831675|Infants|infants
1486155|NCT00831675|Toddlers|toddlers
1486156|NCT00831636|CP-4055|cp-4055
1486157|NCT00831636|Cancer|cancer
1486158|NCT00831636|Metastatic|metastatic
1486159|NCT00831636|Solid tumors|solid tumors
1486160|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
1486161|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
1486162|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
1486163|NCT00831623|hypofractionation|hypofractionation
1486164|NCT00831623|proton beam radiation|proton beam radiation
1486165|NCT00831610|bariatric surgery|bariatric surgery
1486166|NCT00831610|plastic surgery|plastic surgery
1486167|NCT00831610|abdominal wall|abdominal wall
1486168|NCT00831610|skin|skin
1486169|NCT00831610|sensation|sensation
1486170|NCT00831610|abdominoplasty|abdominoplasty
1486171|NCT00831597|Lymphoma|lymphoma
1486172|NCT00831597|B-Cell|b-cell
1486173|NCT00831571|oxaliplatin|oxaliplatin
1486174|NCT00831571|hypersensitivity|hypersensitivity
1486175|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
1486176|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
1486177|NCT00831493|Pancreas|pancreas
1486178|NCT00831493|Pancreatic Cancer|pancreatic cancer
1486179|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
1486180|NCT00831493|LAPC|lapc
1486181|NCT00831493|Non-Metastatic|non-metastatic
1486182|NCT00831493|Unresectable|unresectable
1486183|NCT00831493|Vorinostat|vorinostat
1486184|NCT00831493|XRT|xrt
1486185|NCT00831493|RT|rt
1486186|NCT00831493|Radiation Therapy|radiation therapy
1486187|NCT00831493|SAHA|saha
1486188|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1486189|NCT00831493|MSK-390|msk-390
1486190|NCT00831480|Renal cell carcinoma|renal cell carcinoma
1486191|NCT00831480|Everolimus|everolimus
1486192|NCT00831480|Neoadjuvant|neoadjuvant
1486193|NCT00831480|advanced kidney cancer|advanced kidney cancer
1486194|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
1486195|NCT00831467|RNA vaccine|rna vaccine
1486196|NCT00831441|NOS|nos
1486197|NCT00831428|asthma|asthma
1486198|NCT00831428|rhinitis|rhinitis
1486199|NCT00831428|swimmers|swimmers
1486200|NCT00831428|mannitol|mannitol
1486201|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
1486202|NCT00831402|woman|woman
1486203|NCT00831376|Asthma|asthma
1486204|NCT00831376|Genotype|genotype
1486205|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
1486206|NCT00831376|Levosalbutamol|levosalbutamol
1486207|NCT00831363|gait analysis|gait analysis
1486208|NCT00831363|minimal invasive approach|minimal invasive approach
1486209|NCT00831363|transgluteal approach|transgluteal approach
1486210|NCT00831363|THA|tha
1486211|NCT00831350|RVO|rvo
1486212|NCT00831350|PVD|pvd
1486215|NCT00831337|Gut microbiota|gut microbiota
1486216|NCT00831337|Cytokines|cytokines
1486217|NCT00831337|Portal hypertension|portal hypertension
1486218|NCT00831337|Chemokines|chemokines
1486219|NCT00831337|Liver cirrhosis|liver cirrhosis
1486220|NCT00831311|Diphtheria|diphtheria
1486222|NCT00831311|Pertussis|pertussis
1486223|NCT00831311|Whooping cough|whooping cough
1486224|NCT00831311|Hepatitis B|hepatitis b
1486225|NCT00831311|Poliomyelitis|poliomyelitis
1486226|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
1486227|NCT00831298|alzheimer disease|alzheimer disease
1486228|NCT00831298|sleep disturbance|sleep disturbance
1486229|NCT00831298|apathy|apathy
1486230|NCT00831298|memory loss|memory loss
1486231|NCT00831285|Healthy volunteers|healthy volunteers
1486232|NCT00831259|stroke|stroke
1486233|NCT00831259|PFO|pfo
1486234|NCT00831259|embolism|embolism
1486235|NCT00831246|Ileus,|ileus,
1486236|NCT00831246|Gynecologic surgery,|gynecologic surgery,
1486237|NCT00831246|Post-operative,|post-operative,
1486238|NCT00831246|Flatus|flatus
1486239|NCT00831220|COPD|copd
1486240|NCT00831220|exacerbations|exacerbations
1486241|NCT00831220|EPCs|epcs
1486242|NCT00831220|Erythropoietin|erythropoietin
1486243|NCT00831220|C-RP|c-rp
1486244|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
1486245|NCT00831207|B-2 microglobulin|b-2 microglobulin
1486246|NCT00831207|Serum cytokines|serum cytokines
1486247|NCT00831207|HIV-1|hiv-1
1486248|NCT00831207|Resistance|resistance
1486249|NCT00831207|HAART|haart
1486250|NCT00831207|Therapeutic failure|therapeutic failure
1486251|NCT00831207|Genotyping.|genotyping.
1486252|NCT00831194|Type 2 Diabetes|type 2 diabetes
1486253|NCT00831194|Obesity|obesity
1486254|NCT00831194|Weight loss|weight loss
1486255|NCT00831194|PDA|pda
1486256|NCT00831194|Stress|stress
1486257|NCT00831194|Dietary lapse|dietary lapse
1486258|NCT00831194|salivary alpha amylase|salivary alpha amylase
1486259|NCT00831181|stage II rectal cancer|stage ii rectal cancer
1486260|NCT00831181|stage III rectal cancer|stage iii rectal cancer
1486261|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1486262|NCT00831168|neonatal|neonatal
1486263|NCT00831168|premature babies|premature babies
1486264|NCT00831168|healthcare research|healthcare research
1486265|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
1486266|NCT00831155|smoking|smoking
1486267|NCT00831155|nicotine patches|nicotine patches
1486268|NCT00831155|extinction based treatment|extinction based treatment
1486269|NCT00831142|Prostate Cancer|prostate cancer
1486270|NCT00831142|MRI|mri
1486271|NCT00831142|Prostatectomy|prostatectomy
1486272|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
1486273|NCT00831116|LipiScan|lipiscan
1486274|NCT00831116|lipid core|lipid core
1486275|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
1486276|NCT00831116|myocardial infarction|myocardial infarction
1486277|NCT00831116|NIRS|nirs
1486278|NCT00831116|intravascular imaging|intravascular imaging
1486279|NCT00831103|EPB348|epb348
1486280|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
1486281|NCT00831103|Valacyclovir|valacyclovir
1486282|NCT00831103|Herpes Zoster|herpes zoster
1486283|NCT00831103|Shingles|shingles
1486284|NCT00831077|Healthy volunteers|healthy volunteers
1486285|NCT00831064|bowel preparation quality|bowel preparation quality
1486286|NCT00831064|colonoscopy|colonoscopy
1486287|NCT00831051|Bunionectomy|bunionectomy
1486288|NCT00831038|pulmonary function tests|pulmonary function tests
1486289|NCT00831038|infants|infants
1486290|NCT00831038|chronic lung disease|chronic lung disease
1486291|NCT00831038|dysphagia|dysphagia
1486292|NCT00831038|chronic aspiration|chronic aspiration
1486293|NCT00831025|Immunotherapy|immunotherapy
1486294|NCT00831025|Allergoid|allergoid
1486295|NCT00831025|Depigmented|depigmented
1486296|NCT00831025|Polymerized|polymerized
1486297|NCT00831025|Allergen-extract|allergen-extract
1486298|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
1486299|NCT00831012|Dengue Vaccine|dengue vaccine
1486300|NCT00831012|Dengue Virus|dengue virus
1486301|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1486302|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
1486303|NCT00830999|fat metabolism|fat metabolism
1486304|NCT00830999|exercise|exercise
1486305|NCT00830999|liver|liver
1486306|NCT00830999|lipoproteins|lipoproteins
1486307|NCT00830999|triglycerides|triglycerides
1486308|NCT00830986|Mental Cognition Change|mental cognition change
1486309|NCT00830986|Fat Embolism|fat embolism
1486310|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
1486311|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
1486312|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
1486313|NCT00830973|Estrogen Antagonists|estrogen antagonists
1486314|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
1486315|NCT00830973|Hormone Antagonists|hormone antagonists
1486316|NCT00830973|Hormones|hormones
1486317|NCT00830973|Hormone Substitutes|hormone substitutes
1486318|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
1486319|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
1486320|NCT00830973|Neoplasms|neoplasms
1486321|NCT00830973|Neoplasms by Site|neoplasms by site
1486322|NCT00830947|Orthodontic|orthodontic
1486323|NCT00830947|Extraction|extraction
1486325|NCT00830947|Space Closure|space closure
1486326|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
1486327|NCT00830934|pelvic girdle pain|pelvic girdle pain
1486328|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
1486329|NCT00830934|group care|group care
1486330|NCT00830934|individual care|individual care
1486331|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
1486332|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
1486333|NCT00830895|Renal cell carcinoma|renal cell carcinoma
1486334|NCT00830895|Non-clear cell|non-clear cell
1486335|NCT00830895|RAD001|rad001
1486336|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
1486337|NCT00830882|asthma|asthma
1486338|NCT00830882|levosalbutamol|levosalbutamol
1486339|NCT00830882|genotype|genotype
1486340|NCT00830882|bronchoprotection|bronchoprotection
1486341|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
1486342|NCT00830856|HIV|hiv
1486343|NCT00830856|Fluconazole|fluconazole
1486344|NCT00830856|Antiretroviral therapy|antiretroviral therapy
1486346|NCT00830856|treatment naive|treatment naive
1486347|NCT00830843|SAH|sah
1486348|NCT00830843|sedation|sedation
1486349|NCT00830843|anesthesia|anesthesia
1486350|NCT00830817|Topical cream application|topical cream application
1486351|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
1486352|NCT00830804|Treatment Naive|treatment naive
1486353|NCT00830778|pancreas|pancreas
1486354|NCT00830778|surgery|surgery
1486355|NCT00830778|cancer|cancer
1486356|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
1486357|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
1486358|NCT00830778|pancreatic tumors|pancreatic tumors
1486359|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
1486360|NCT00830752|alexithymia|alexithymia
1486361|NCT00830739|Smoking Cessation|smoking cessation
1486362|NCT00830739|Dopamine|dopamine
1486363|NCT00830739|Cognitive Control|cognitive control
1486364|NCT00830739|Reward Processing|reward processing
1486365|NCT00830739|Varenicline|varenicline
1486366|NCT00830726|Aquaporin|aquaporin
1486367|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
1486368|NCT00830726|Heart Failure|heart failure
1486369|NCT00830726|Valvular heart disease|valvular heart disease
1486370|NCT00830726|Ischemic heart disease|ischemic heart disease
1486371|NCT00830713|vitiligo|vitiligo
1486372|NCT00830713|skin transplantation|skin transplantation
1486373|NCT00830713|non-cultured|non-cultured
1486374|NCT00830713|melanocyte|melanocyte
1486375|NCT00830713|surgery|surgery
1486376|NCT00830700|ADHD|adhd
1486377|NCT00830700|telemental health|telemental health
1486378|NCT00830700|TMH|tmh
1486379|NCT00830700|telepsychiatry|telepsychiatry
1486380|NCT00830700|rural mental health services for children|rural mental health services for children
1486381|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
1486382|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
1486383|NCT00830687|TARGON FN|targon fn
1486384|NCT00830674|XLH|xlh
1486385|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
1486386|NCT00830661|cryptoglandular origin|cryptoglandular origin
1486387|NCT00830661|anal fistula repair|anal fistula repair
1486388|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
1486389|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
1486390|NCT00830661|surgical repair|surgical repair
1486391|NCT00830648|varicella-zoster virus|varicella-zoster virus
1486392|NCT00830648|varicella|varicella
1486393|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
1486394|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1486395|NCT00830635|depression|depression
1486396|NCT00830635|stage IA breast cancer|stage ia breast cancer
1486397|NCT00830635|stage IB breast cancer|stage ib breast cancer
1486398|NCT00830635|stage II breast cancer|stage ii breast cancer
1486399|NCT00830635|stage I prostate cancer|stage i prostate cancer
1486400|NCT00830635|stage II prostate cancer|stage ii prostate cancer
1486401|NCT00830622|HIV/AIDS|hiv/aids
1486402|NCT00830622|Adherence|adherence
1486403|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
1486404|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
1486405|NCT00830622|Text message, SMS|text message, sms
1486406|NCT00830622|Telemedicine|telemedicine
1486407|NCT00830622|Africa|africa
1486408|NCT00830622|Resource-limited setting|resource-limited setting
1486409|NCT00830622|Counseling, support|counseling, support
1486410|NCT00830622|treatment experienced|treatment experienced
1486411|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
1486413|NCT00830609|High viral load|high viral load
1486414|NCT00830570|CYP2C9|cyp2c9
1486415|NCT00830570|VKORC1|vkorc1
1486416|NCT00830570|polymorphism|polymorphism
1486417|NCT00830570|warfarin|warfarin
1486418|NCT00830570|Coumadin|coumadin
1486419|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
1486420|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
1486421|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
1486422|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
1486423|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
1486424|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1486425|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
1486426|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
1486427|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
1486428|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
1486429|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
1486430|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
1486431|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1486432|NCT00830531|Neonatal stroke|neonatal stroke
1486433|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
1486434|NCT00830531|Perinatal asphyxia|perinatal asphyxia
1486435|NCT00830531|Neonatal Seizures|neonatal seizures
1486436|NCT00830518|Drug therapy|drug therapy
1486437|NCT00830505|fluticasone|fluticasone
1486438|NCT00830505|salmeterol|salmeterol
1486439|NCT00830505|bronchoprotection|bronchoprotection
1486440|NCT00830492|clomiphene citrate|clomiphene citrate
1486441|NCT00830492|GnRH agonist|gnrh agonist
1486442|NCT00830492|GnRH antagonist|gnrh antagonist
1486443|NCT00830492|in vitro fertilization|in vitro fertilization
1486444|NCT00830492|clinical pregnancy|clinical pregnancy
1486445|NCT00830492|pregnancy|pregnancy
1486446|NCT00830466|port wine stain|port wine stain
1486447|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
1486448|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
1486449|NCT00830414|Bioequivalence|bioequivalence
1486450|NCT00830414|Healthy Subjects|healthy subjects
1486451|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
1486452|NCT00830401|intracavitary pathology|intracavitary pathology
1486453|NCT00830401|hysteroscopy|hysteroscopy
1486454|NCT00830401|IVF|ivf
1486455|NCT00830401|ICSI|icsi
1486456|NCT00830401|polyp|polyp
1486457|NCT00830401|myoma|myoma
1486458|NCT00830401|adhesion|adhesion
1486459|NCT00830401|septum|septum
1486460|NCT00830401|endometritis|endometritis
1486461|NCT00830388|tinea versicolor|tinea versicolor
1486462|NCT00830388|ketoconazole|ketoconazole
1486463|NCT00830375|Buying|buying
1486464|NCT00830375|Shopping|shopping
1486465|NCT00830375|Impulse Control|impulse control
1486466|NCT00830362|cocaine|cocaine
1486467|NCT00830362|cocaine-dependent|cocaine-dependent
1486468|NCT00830362|propranolol|propranolol
1486469|NCT00830362|craving|craving
1486470|NCT00830362|beta-blockade|beta-blockade
1486471|NCT00830362|cue exposure|cue exposure
1486472|NCT00830362|drug|drug
1486473|NCT00830362|addiction|addiction
1486474|NCT00830362|memory|memory
1486475|NCT00830362|addictive behavior|addictive behavior
1486476|NCT00830349|Bioequivalence|bioequivalence
1486477|NCT00830349|Healthy Subjects|healthy subjects
1486478|NCT00830336|Bioequivalence|bioequivalence
1486479|NCT00830336|Healthy Subjects|healthy subjects
1486480|NCT00830310|Patient Non-Adherence|patient non-adherence
1486481|NCT00830310|Patient Non-Compliance|patient non-compliance
1486482|NCT00830310|Patient Nonadherence|patient nonadherence
1486483|NCT00830310|Patient Noncompliance|patient noncompliance
1486484|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
1486485|NCT00830310|Refusal of Treatment|refusal of treatment
1486486|NCT00830310|Treatment Refusal|treatment refusal
1486487|NCT00830297|TIP|tip
1486488|NCT00830297|NODAT|nodat
1486489|NCT00830297|hyperglycemia|hyperglycemia
1486490|NCT00830297|long-acting insulin|long-acting insulin
1486491|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
1486492|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
1486493|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
1486494|NCT00830271|surgical site infection|surgical site infection
1638656|NCT00249496|HIV|hiv
1486495|NCT00830271|wound complications|wound complications
1486496|NCT00830271|suture|suture
1486497|NCT00830271|antiseptic|antiseptic
1486498|NCT00830271|wound closure|wound closure
1486499|NCT00830258|Bioequivalence|bioequivalence
1486500|NCT00830258|Healthy Subjects|healthy subjects
1486501|NCT00830245|EGFR mutation|egfr mutation
1486502|NCT00830245|Erlotinib|erlotinib
1486503|NCT00830245|Lung cancer|lung cancer
1486504|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
1486505|NCT00830232|Stroke|stroke
1486506|NCT00830232|Carotid stenosis|carotid stenosis
1486507|NCT00830232|stents|stents
1486508|NCT00830219|Bioequivalence|bioequivalence
1486509|NCT00830219|Healthy Subjects|healthy subjects
1486510|NCT00830206|Bioequivalence|bioequivalence
1486511|NCT00830206|Healthy Subjects|healthy subjects
1486512|NCT00830193|N-acetylcysteine|n-acetylcysteine
1486513|NCT00830193|prevention|prevention
1486514|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
1486515|NCT00830193|critically ill adults|critically ill adults
1486516|NCT00830180|Cancer pain|cancer pain
1486517|NCT00830180|NGF|ngf
1486518|NCT00830180|open-label extension|open-label extension
1486519|NCT00830154|stutter|stutter
1486520|NCT00830154|stuttering|stuttering
1486521|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
1486522|NCT00830141|Ghrelin|ghrelin
1486523|NCT00830141|obesity|obesity
1486524|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
1486525|NCT00830115|PPI therapy|ppi therapy
1486526|NCT00830115|Pantoprazole|pantoprazole
1486527|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
1486528|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
1486529|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
1486530|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
1486531|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
1486532|NCT00830089|Analgesia|analgesia
1486533|NCT00830063|monoclonal antibody|monoclonal antibody
1486534|NCT00830063|RN624|rn624
1486535|NCT00830063|PF-04383119|pf-04383119
1486536|NCT00830063|nerve growth factor|nerve growth factor
1486537|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
1486538|NCT00830063|OA|oa
1486539|NCT00830063|pain|pain
1486540|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
1486541|NCT00830037|anemia|anemia
1486542|NCT00830037|iron|iron
1486543|NCT00830037|kidney disease|kidney disease
1486544|NCT00830037|progression|progression
1486545|NCT00830037|glomerular filtration rate|glomerular filtration rate
1486546|NCT00830024|Bioequivalence|bioequivalence
1486547|NCT00830024|Healthy Subjects|healthy subjects
1486548|NCT00830011|diabetes|diabetes
1486549|NCT00830011|neuropathy|neuropathy
1486550|NCT00830011|chronic pain|chronic pain
1486551|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
1486552|NCT00829998|Bioequivalence|bioequivalence
1486553|NCT00829998|Healthy Subjects|healthy subjects
1486554|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
1486555|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
1486556|NCT00829985|Immunotherapy|immunotherapy
1486557|NCT00829985|Asthma|asthma
1486558|NCT00829985|Nasal Allergies|nasal allergies
1486559|NCT00829985|Hypersensitivity|hypersensitivity
1486560|NCT00829959|Ovary, Cancer|ovary, cancer
1486561|NCT00829959|Ovarian Cancer|ovarian cancer
1486562|NCT00829959|Breast Cancer|breast cancer
1486563|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
1486564|NCT00829959|HBOC|hboc
1486565|NCT00829959|Genetic testing|genetic testing
1486566|NCT00829959|Pregnancy|pregnancy
1486567|NCT00829959|Fertility|fertility
1486568|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
1486569|NCT00829946|Strength training|strength training
1486570|NCT00829946|Anorexia|anorexia
1486571|NCT00829946|Girls|girls
1486572|NCT00829946|Quality of life|quality of life
1486573|NCT00829946|Functional mobility|functional mobility
1486574|NCT00829933|Atrial fibrillation|atrial fibrillation
1486575|NCT00829933|Factor Xa inhibition|factor xa inhibition
1486576|NCT00829920|Bladder cancer|bladder cancer
1486577|NCT00829907|Healthy volunteer study|healthy volunteer study
1486578|NCT00829894|Bioequivalence|bioequivalence
1486579|NCT00829894|Healthy Subjects|healthy subjects
1486580|NCT00829881|Attention|attention
1486581|NCT00829868|Bioequivalence|bioequivalence
1486582|NCT00829868|Healthy Subjects|healthy subjects
1486583|NCT00829855|pulmonary edema|pulmonary edema
1486584|NCT00829855|hypertension|hypertension
1486585|NCT00829855|echocardiography|echocardiography
1486586|NCT00829842|chlorexidine|chlorexidine
1486587|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
1486588|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
1486589|NCT00829842|heart surgery|heart surgery
1486590|NCT00829842|oral hygiene|oral hygiene
1638758|NCT00249197|skin|skin
1486591|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
1486592|NCT00829829|Allopurinol|allopurinol
1486593|NCT00829829|Metabolic Diseases|metabolic diseases
1486594|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
1486595|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
1486596|NCT00829829|Joint Diseases|joint diseases
1486597|NCT00829829|Arthritis|arthritis
1486598|NCT00829829|Rheumatic Diseases|rheumatic diseases
1486599|NCT00829829|Metabolic disorder|metabolic disorder
1486600|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
1486601|NCT00829829|Gout|gout
1486602|NCT00829816|Alzheimers disease|alzheimers disease
1486603|NCT00829816|donepezil|donepezil
1486604|NCT00829816|memantine|memantine
1486605|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
1486606|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
1486607|NCT00829790|Bioequivalence|bioequivalence
1486608|NCT00829790|Healthy Subjects|healthy subjects
1486609|NCT00829777|Naloxone|naloxone
1486610|NCT00829777|6β-Naltrexol|6β-naltrexol
1486611|NCT00829777|Opioid-dependent|opioid-dependent
1486612|NCT00829777|Pharmacokinetics|pharmacokinetics
1486613|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
1486614|NCT00829777|central effects of withdrawal|central effects of withdrawal
1486615|NCT00829764|Bioequivalence|bioequivalence
1486616|NCT00829764|Healthy Subjects|healthy subjects
1486617|NCT00829751|staining|staining
1486618|NCT00829751|toxicity|toxicity
1486619|NCT00829751|fluorometry|fluorometry
1486620|NCT00829751|dye diffusion|dye diffusion
1486621|NCT00829751|anterior chamber|anterior chamber
1486622|NCT00829738|PPI therapy|ppi therapy
1486623|NCT00829738|pantoprazole|pantoprazole
1486624|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
1486625|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
1486626|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
1486627|NCT00829725|TARGON FN|targon fn
1486628|NCT00829712|Bioequivalence|bioequivalence
1486629|NCT00829712|Healthy Subjects|healthy subjects
1486630|NCT00829699|endothelial function|endothelial function
1486631|NCT00829699|fibrinolytic balance|fibrinolytic balance
1486633|NCT00829686|cellulitis|cellulitis
1486635|NCT00829686|MRSA|mrsa
1486636|NCT00829673|Bioequivalence|bioequivalence
1486637|NCT00829673|Healthy Subjects|healthy subjects
1486638|NCT00829660|Acarbose|acarbose
1486639|NCT00829647|CLL|cll
1486640|NCT00829647|dasatinib|dasatinib
1486641|NCT00829647|lenalidomide|lenalidomide
1486642|NCT00829647|sprycel|sprycel
1486643|NCT00829647|revlimid|revlimid
1486644|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
1486645|NCT00829634|methamphetamine|methamphetamine
1486646|NCT00829634|inpatient|inpatient
1486647|NCT00829634|d-MA|d-ma
1486648|NCT00829634|l-MA|l-ma
1486649|NCT00829634|APRL|aprl
1486650|NCT00829634|San Francisco|san francisco
1486651|NCT00829634|metabolism|metabolism
1486652|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
1486653|NCT00829621|BMP-2|bmp-2
1486654|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
1486655|NCT00829608|RRP|rrp
1486656|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
1486657|NCT00829608|HPV vaccine|hpv vaccine
1486658|NCT00829608|HPV|hpv
1486659|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
1486660|NCT00829595|Crohn disease|crohn disease
1486661|NCT00829595|ulcerative colitis|ulcerative colitis
1486662|NCT00829595|immunosuppression|immunosuppression
1486663|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
1486664|NCT00829595|pneumovax|pneumovax
1486665|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
1486666|NCT00829569|Intralipid|intralipid
1486667|NCT00829569|Omegaven|omegaven
1486668|NCT00829569|fish oil|fish oil
1486669|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
1486670|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
1486671|NCT00829569|indirect calorimetry|indirect calorimetry
1486672|NCT00829569|F2-isoprostanes|f2-isoprostanes
1486673|NCT00829543|Spodyloarthropathy|spodyloarthropathy
1486674|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
1486675|NCT00829530|Bioequivalence|bioequivalence
1486676|NCT00829530|Healthy Subjects|healthy subjects
1486677|NCT00829517|Contraception|contraception
1486678|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
1486679|NCT00829504|Bioequivalence|bioequivalence
1486680|NCT00829504|Healthy Subjects|healthy subjects
1486681|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
1486682|NCT00829491|Behavior change|behavior change
1486683|NCT00829491|Risk Reduction|risk reduction
1486684|NCT00829478|Atrial fibrillation|atrial fibrillation
1486685|NCT00829478|Cerebrovascular accident|cerebrovascular accident
1486686|NCT00829478|Anticoagulation|anticoagulation
1486687|NCT00829478|Decision-making|decision-making
1486688|NCT00829452|Bioequivalence|bioequivalence
1486689|NCT00829452|Healthy Subjects|healthy subjects
1486690|NCT00829439|Angelman syndrome|angelman syndrome
1486691|NCT00829439|Levodopa|levodopa
1486692|NCT00829439|Carbidopa|carbidopa
1486693|NCT00829439|L-dopa|l-dopa
1486694|NCT00829426|Bioequivalence|bioequivalence
1486695|NCT00829426|Healthy Subjects|healthy subjects
1486696|NCT00829400|Neuropsychology|neuropsychology
1486697|NCT00829400|Cognitive Remediation|cognitive remediation
1486698|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
1486699|NCT00829400|Schizophrenia|schizophrenia
1486700|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
1486701|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
1486702|NCT00829387|Diabetes|diabetes
1486703|NCT00829387|Pain|pain
1486704|NCT00829387|Neuropathic Pain|neuropathic pain
1486705|NCT00829374|Alzheimer's disease|alzheimer's disease
1486706|NCT00829374|clinical trial|clinical trial
1486707|NCT00829374|mitochondria|mitochondria
1486708|NCT00829374|memory loss|memory loss
1486709|NCT00829374|neurodegenerative disease|neurodegenerative disease
1486710|NCT00829374|dementia|dementia
1486711|NCT00829374|investigational drug|investigational drug
1486712|NCT00829361|Telemedicine|telemedicine
1486713|NCT00829361|Acute stroke|acute stroke
1486714|NCT00829361|Rural|rural
1486715|NCT00829361|thrombosis|thrombosis
1486716|NCT00829361|consultation|consultation
1486717|NCT00829361|Stroke|stroke
1486718|NCT00829361|Cerebral Infarction|cerebral infarction
1486719|NCT00829361|Vascular diseases|vascular diseases
1486720|NCT00829361|brain ischemia|brain ischemia
1486721|NCT00829361|brain infarction|brain infarction
1486722|NCT00829361|brain diseases|brain diseases
1486723|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
1486724|NCT00829348|Compliance|compliance
1486725|NCT00829348|Chronic|chronic
1486726|NCT00829348|Pharmacotherapy|pharmacotherapy
1486727|NCT00829348|Statins|statins
1486728|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
1486729|NCT00829335|Segmentectomy|segmentectomy
1486730|NCT00829335|HCC|hcc
1486731|NCT00829309|Bioequivalence|bioequivalence
1486732|NCT00829309|Healthy Subjects|healthy subjects
1486733|NCT00829296|diabetes|diabetes
1486734|NCT00829296|hypertension|hypertension
1486735|NCT00829296|aortic impedance|aortic impedance
1486736|NCT00829283|Experimental|experimental
1486737|NCT00829283|Comparator|comparator
1486738|NCT00829244|Infertility|infertility
1486739|NCT00829244|Assisted reproductive technology|assisted reproductive technology
1486740|NCT00829231|Liver disease|liver disease
1486741|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
1486742|NCT00829218|Fibromyalgia|fibromyalgia
1486743|NCT00829218|Glutamate|glutamate
1486744|NCT00829218|Diet|diet
1486745|NCT00829218|Food additives|food additives
1486746|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1486747|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
1486748|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
1486749|NCT00829192|CUV1647|cuv1647
1486750|NCT00829192|Afamelanotide|afamelanotide
1486751|NCT00829192|Clinuvel|clinuvel
1486752|NCT00829192|Photoprotection|photoprotection
1486753|NCT00829192|Organ transplant|organ transplant
1486754|NCT00829179|Asthma|asthma
1486755|NCT00829153|Fistula patency|fistula patency
1486756|NCT00829127|volunteers|volunteers
1486757|NCT00829114|AE|ae
1486758|NCT00829114|AIDS|aids
1486759|NCT00829114|ALT|alt
1486760|NCT00829114|ART|art
1486761|NCT00829114|AST|ast
1486762|NCT00829114|DCF|dcf
1486763|NCT00829114|DMC|dmc
1486764|NCT00829114|FDA|fda
1486765|NCT00829114|GCP|gcp
1486766|NCT00829114|HB sAg|hb sag
1486767|NCT00829114|ICH|ich
1486768|NCT00829114|IND|ind
1486769|NCT00829114|IRB|irb
1486770|NCT00829114|IU|iu
1486771|NCT00829114|mg|mg
1486772|NCT00829114|mm3|mm3
1486773|NCT00829114|PCR|pcr
1486774|NCT00829114|SAE|sae
1486775|NCT00829114|ULN|uln
1486776|NCT00829114|WB|wb
1486777|NCT00829114|COC|coc
1486778|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
1486779|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
1486780|NCT00829101|primary palatal surgery|primary palatal surgery
1486781|NCT00829101|articulation|articulation
1486782|NCT00829101|phonology|phonology
1486783|NCT00829101|one stage palatal repair|one stage palatal repair
1486784|NCT00829101|two stage palatal repair|two stage palatal repair
1486785|NCT00829088|Mass balance|mass balance
1486786|NCT00829088|AZD2066|azd2066
1486787|NCT00829088|Pain|pain
1486788|NCT00829088|Pain conditions|pain conditions
1486789|NCT00829062|Type 1 diabetes|type 1 diabetes
1486790|NCT00829062|Insulin pump|insulin pump
1486791|NCT00829062|Glycemic variability|glycemic variability
1486792|NCT00829036|Rehabilitation|rehabilitation
1486793|NCT00829036|Sensory Aid|sensory aid
1486794|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
1639033|NCT00248469|HIV|hiv
1486795|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
1486796|NCT00829010|Booster vaccination|booster vaccination
1486797|NCT00829010|Safety|safety
1486798|NCT00829010|Primary vaccination|primary vaccination
1486799|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
1486800|NCT00829010|Immunogenicity|immunogenicity
1486801|NCT00829010|Pneumococcal disease|pneumococcal disease
1486802|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
1486803|NCT00828997|spondylarthropathy|spondylarthropathy
1486804|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
1486805|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
1486806|NCT00828971|cSSSI|csssi
1486807|NCT00828958|schizophrenia|schizophrenia
1486808|NCT00828958|Risperidone|risperidone
1486809|NCT00828958|Long acting injectable|long acting injectable
1486810|NCT00828958|Intradeltoidal injection|intradeltoidal injection
1486811|NCT00828919|VEGFR inhibitor|vegfr inhibitor
1486812|NCT00828919|angi-angiogenic|angi-angiogenic
1486813|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1486814|NCT00828906|Glaucoma|glaucoma
1486815|NCT00828906|IOP|iop
1486816|NCT00828906|DuoTrav|duotrav
1486817|NCT00828893|drain under scanner|drain under scanner
1486818|NCT00828867|healthy subjects|healthy subjects
1486819|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
1486820|NCT00828854|breast cancer|breast cancer
1486821|NCT00828854|estrogen receptor postive|estrogen receptor postive
1486822|NCT00828828|Influenza Vaccine|influenza vaccine
1486823|NCT00828828|Sarcoidosis|sarcoidosis
1486824|NCT00828828|Antibody|antibody
1486825|NCT00828815|HIV-negative|hiv-negative
1486826|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
1486827|NCT00828815|norbuprenorphine|norbuprenorphine
1486828|NCT00828815|opioid-dependent|opioid-dependent
1486829|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
1486830|NCT00828815|TMC125-C188|tmc125-c188
1486831|NCT00828815|TMC125|tmc125
1486832|NCT00828815|HIV Infections|hiv infections
1486833|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
1486834|NCT00828802|MDS|mds
1486835|NCT00828789|Hepatitis C|hepatitis c
1486836|NCT00828789|HCV|hcv
1486837|NCT00828789|HIV|hiv
1486838|NCT00828789|AIDS|aids
1486839|NCT00828789|Telaprevir|telaprevir
1486840|NCT00828789|Efavirenz|efavirenz
1486841|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
1487742|NCT00825591|melatonin|melatonin
1486842|NCT00828789|Healthy volunteer|healthy volunteer
1486843|NCT00828789|VX-950-C134|vx-950-c134
1486844|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
1486845|NCT00828789|HIV Infections|hiv infections
1486846|NCT00828776|TTPa|ttpa
1486847|NCT00828776|Anti-Xa|anti-xa
1486848|NCT00828776|Adverse Reactions|adverse reactions
1486849|NCT00828763|healthy volunteer|healthy volunteer
1486850|NCT00828763|radiolabelled|radiolabelled
1486851|NCT00828750|eltrombopag|eltrombopag
1486852|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
1486853|NCT00828750|ITP|itp
1486854|NCT00828750|blood platelet|blood platelet
1486855|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
1486856|NCT00828711|Induction of labor|induction of labor
1486857|NCT00828711|Cervical ripening|cervical ripening
1486858|NCT00828711|Rate of cesarean section|rate of cesarean section
1486859|NCT00828698|Death, sudden|death, sudden
1486860|NCT00828698|All cause mortality|all cause mortality
1486861|NCT00828685|Return to Work|return to work
1486862|NCT00828685|CRPP|crpp
1486863|NCT00828685|ORIF|orif
1486864|NCT00828685|Distal Radius|distal radius
1486865|NCT00828672|assess activity|assess activity
1486866|NCT00828672|bevacizumab|bevacizumab
1486867|NCT00828672|capecitabine|capecitabine
1486868|NCT00828672|radiation therapy|radiation therapy
1486869|NCT00828672|oxaliplatin|oxaliplatin
1486870|NCT00828672|pre-operative treatment|pre-operative treatment
1486871|NCT00828672|TME (total mesorectal excision).|tme (total mesorectal excision).
1486872|NCT00828659|Abuse potential|abuse potential
1486873|NCT00828646|Healthy Subjects|healthy subjects
1486874|NCT00828633|stage I prostate cancer|stage i prostate cancer
1486875|NCT00828633|stage II prostate cancer|stage ii prostate cancer
1486876|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
1486877|NCT00828607|Liver tumors|liver tumors
1486878|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
1486879|NCT00828607|Hemangioma|hemangioma
1486880|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
1486881|NCT00828607|Hepatic metastases|hepatic metastases
1486882|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
1486883|NCT00828594|dose-finding study|dose-finding study
1486884|NCT00828594|randomized trial|randomized trial
1486885|NCT00828594|medical treatment|medical treatment
1486886|NCT00828594|RAD001|rad001
1486887|NCT00828594|sorafenib|sorafenib
1486888|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
1486889|NCT00828568|Actinic Keratosis|actinic keratosis
1486890|NCT00828555|HPV vaccine|hpv vaccine
1486891|NCT00828555|Tdap vaccine|tdap vaccine
1639072|NCT00248391|supine|supine
1486892|NCT00828542|Adverse Effects|adverse effects
1486893|NCT00828542|Etonogestrel|etonogestrel
1486894|NCT00828542|Postpartum period|postpartum period
1486895|NCT00828542|Contraception|contraception
1486896|NCT00828542|Hemostasis|hemostasis
1486897|NCT00828542|Metabolism|metabolism
1486898|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
1486899|NCT00828529|TMC207-C110|tmc207-c110
1486900|NCT00828529|TMC207|tmc207
1486901|NCT00828529|Drug-drug interaction|drug-drug interaction
1486902|NCT00828529|Tuberculosis|tuberculosis
1486903|NCT00828529|HIV|hiv
1486904|NCT00828529|Kaletra|kaletra
1486905|NCT00828529|Lopinavir|lopinavir
1486906|NCT00828529|Ritonavir|ritonavir
1486907|NCT00828529|Open-label|open-label
1486908|NCT00828529|HIV Infections|hiv infections
1486909|NCT00828516|lymphedema|lymphedema
1486910|NCT00828516|male breast cancer|male breast cancer
1486911|NCT00828516|stage IA breast cancer|stage ia breast cancer
1486912|NCT00828516|stage IB breast cancer|stage ib breast cancer
1486913|NCT00828516|stage II breast cancer|stage ii breast cancer
1486914|NCT00828516|recurrent breast cancer|recurrent breast cancer
1489456|NCT00819234|Pramlintide|pramlintide
1486915|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1486916|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1486917|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1486918|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1486919|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1486920|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1486921|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1486922|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1486923|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1486924|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1486925|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1486926|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1486927|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1486928|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1486929|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1486930|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1486931|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1486932|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1486933|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1486934|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1486935|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1486936|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1486937|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1486938|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1486939|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1486940|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1486941|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1486942|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1486943|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1486944|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1486945|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1486946|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1486947|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1486948|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1486949|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1486950|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1486951|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1486952|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1486953|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1486954|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1486955|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1486956|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1486957|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1486958|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1486959|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1486960|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1486961|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1486962|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1486963|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1486964|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1486965|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
1486966|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1486967|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1486968|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1486969|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1486970|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1486971|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1486972|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1486973|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
1486974|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
1486975|NCT00828516|tongue cancer|tongue cancer
1486976|NCT00828503|Certi-CMV|certi-cmv
1486977|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
1486978|NCT00828503|renal transplant|renal transplant
1486979|NCT00828490|Fraud and Abuse|fraud and abuse
1486980|NCT00828490|opioids|opioids
1486981|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
1486982|NCT00828451|newborn|newborn
1486983|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
1486984|NCT00828451|genetics|genetics
1486985|NCT00828451|growth factors|growth factors
1486986|NCT00828451|metabolism|metabolism
1486987|NCT00828425|Diabetes Mellitus|diabetes mellitus
1486988|NCT00828425|retinopathy|retinopathy
1486989|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
1486990|NCT00828399|Radiotherapy|radiotherapy
1486991|NCT00828399|Diarrhoea|diarrhoea
1486992|NCT00828399|Glutamine|glutamine
1486993|NCT00828399|Oxydative stress|oxydative stress
1486994|NCT00828399|Calprotectin|calprotectin
1486995|NCT00828399|Citrulline|citrulline
1486996|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
1486997|NCT00828386|induction chemotherapy|induction chemotherapy
1486998|NCT00828386|radiochemotherapy|radiochemotherapy
1486999|NCT00828360|Heart Failure|heart failure
1487000|NCT00828360|CRT|crt
1487001|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
1487002|NCT00828334|transcatheter occlusion of patent ductus arteriosus|transcatheter occlusion of patent ductus arteriosus
1487003|NCT00828321|Bioequivalency|bioequivalency
1487004|NCT00828321|Healthy Volunteers|healthy volunteers
1487005|NCT00828308|localized|localized
1487006|NCT00828308|high risk|high risk
1487007|NCT00828308|prostate cancer|prostate cancer
1487008|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
1487009|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1487010|NCT00828295|palonosetron|palonosetron
1487011|NCT00828295|pediatric|pediatric
1487012|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1487013|NCT00828282|Simvastatin|simvastatin
1487014|NCT00828282|Zocor|zocor
1487015|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
1487016|NCT00828256|arthroscopic repair|arthroscopic repair
1487017|NCT00828256|rotator cuff|rotator cuff
1487018|NCT00828256|tears|tears
1487019|NCT00828256|shoulder|shoulder
1487020|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
1487021|NCT00828243|Pulmonary surfactants|pulmonary surfactants
1487022|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
1487023|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
1487024|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
1487025|NCT00828230|budesonide|budesonide
1487026|NCT00828230|placebo|placebo
1487027|NCT00828230|acute radiation proctitis|acute radiation proctitis
1487028|NCT00828230|late radiation proctitis|late radiation proctitis
1487029|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
1567596|NCT00508755|electrical stimulation|electrical stimulation
1487030|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
1487031|NCT00828217|adapted physical activity|adapted physical activity
1487032|NCT00828217|hospital|hospital
1487033|NCT00828217|health-related quality of life|health-related quality of life
1487034|NCT00828217|satisfaction with care|satisfaction with care
1487035|NCT00828217|child|child
1487036|NCT00828217|adolescent|adolescent
1487037|NCT00828217|randomized controlled trial|randomized controlled trial
1487038|NCT00828217|physical activity|physical activity
1487039|NCT00828217|quality of life|quality of life
1487040|NCT00828191|Luteal support in IVF|luteal support in ivf
1487042|NCT00828178|atherosclerosis|atherosclerosis
1487043|NCT00828178|omega-3|omega-3
1487044|NCT00828126|Metastatic Melanoma|metastatic melanoma
1487045|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
1487046|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
1487047|NCT00828126|PET-CT|pet-ct
1487048|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
1487049|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
1487050|NCT00828126|CT|ct
1487051|NCT00828126|Conventional Imaging|conventional imaging
1487052|NCT00828126|False Positive Rate|false positive rate
1487053|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
1487054|NCT00828126|FDG|fdg
1487055|NCT00828126|Surgery|surgery
1487056|NCT00828113|smoking|smoking
1487057|NCT00828113|relapse|relapse
1487058|NCT00828113|withdrawal|withdrawal
1487059|NCT00828087|acute myocardial infarction|acute myocardial infarction
1487060|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1487061|NCT00828087|drug-eluting stent|drug-eluting stent
1487062|NCT00828074|stage IV breast cancer|stage iv breast cancer
1487063|NCT00828074|recurrent breast cancer|recurrent breast cancer
1487064|NCT00828035|robotics|robotics
1487065|NCT00828035|laparoscopy|laparoscopy
1487066|NCT00828035|surgery|surgery
1487067|NCT00828035|computer assisted|computer assisted
1487068|NCT00828022|measles-positive NSCLC|measles-positive nsclc
1487069|NCT00828022|measles vaccine|measles vaccine
1487070|NCT00828022|consolidation|consolidation
1487071|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
1487072|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1487073|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1487074|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
1487075|NCT00828009|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1487076|NCT00828009|large cell lung cancer|large cell lung cancer
1487077|NCT00827996|Apocrine glands|apocrine glands
1487078|NCT00827996|abcesses|abcesses
1487079|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
1487080|NCT00827970|mass screening|mass screening
1487081|NCT00827957|Hypothermia|hypothermia
1487082|NCT00827957|Internal cooling|internal cooling
1487083|NCT00827957|External cooling|external cooling
1487084|NCT00827957|Cardiac arrest|cardiac arrest
1487085|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
1487086|NCT00827931|tranexamic acid|tranexamic acid
1487087|NCT00827931|major abdominal surgery|major abdominal surgery
1487088|NCT00827931|blood loss|blood loss
1487089|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
1487090|NCT00827905|Non-Contact|non-contact
1487091|NCT00827905|Radar|radar
1487092|NCT00827905|Respiratory|respiratory
1487093|NCT00827905|Respiration|respiration
1487094|NCT00827905|Breathing|breathing
1487095|NCT00827905|Rate|rate
1487096|NCT00827905|Frequency|frequency
1487097|NCT00827905|Respiratory Mechanics|respiratory mechanics
1487098|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
1487099|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
1487100|NCT00827892|Treatment|treatment
1487101|NCT00827892|MRI|mri
1487102|NCT00827879|Intimate partner aggression|intimate partner aggression
1487103|NCT00827879|Couples intervention|couples intervention
1487104|NCT00827879|PTSD|ptsd
1487105|NCT00827879|Veterans|veterans
1487106|NCT00827879|Prevention|prevention
1487107|NCT00827879|Violence Prevention|violence prevention
1487108|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
1487109|NCT00827866|Tobacco quitline|tobacco quitline
1487110|NCT00827866|Childhood cancer survivors|childhood cancer survivors
1487111|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
1487112|NCT00827853|Diabetes|diabetes
1487113|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
1487114|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
1487115|NCT00827853|Cryoplasty|cryoplasty
1487116|NCT00827853|Restenosis|restenosis
1487117|NCT00827827|Stroke|stroke
1487118|NCT00827827|Exercise|exercise
1487119|NCT00827827|Strength Training|strength training
1487120|NCT00827827|Skeletal Muscle|skeletal muscle
1487121|NCT00827827|Insulin Sensitivity|insulin sensitivity
1487122|NCT00827801|Cancer|cancer
1487123|NCT00827801|Heart Failure|heart failure
1487124|NCT00827801|HF|hf
1487125|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
1487126|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
1487127|NCT00827801|MDASI-HF|mdasi-hf
1487128|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
1487129|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
1487130|NCT00827801|Questionnaire|questionnaire
1487131|NCT00827801|Symptom Management Gap|symptom management gap
1487132|NCT00827788|contrast media|contrast media
1487133|NCT00827788|angiography|angiography
1487134|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
1487135|NCT00827775|Hypertension|hypertension
1487136|NCT00827775|Hemodialysis|hemodialysis
1487137|NCT00827762|phenylketonuria|phenylketonuria
1487138|NCT00827762|Kuvan|kuvan
1487139|NCT00827762|sapropterin|sapropterin
1487140|NCT00827762|behavior|behavior
1487141|NCT00827762|cognition|cognition
1487142|NCT00827762|executive abilities|executive abilities
1487143|NCT00827762|attention|attention
1487144|NCT00827749|swallowing disorders|swallowing disorders
1487145|NCT00827749|geriatrics|geriatrics
1487146|NCT00827736|anal fissure|anal fissure
1487147|NCT00827736|fissura ani|fissura ani
1487148|NCT00827736|botox|botox
1487149|NCT00827736|ISDN|isdn
1487150|NCT00827736|Nitric oxide donor|nitric oxide donor
1487151|NCT00827723|Hepatic functional reserve|hepatic functional reserve
1487152|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1487153|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
1487154|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
1487155|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
1487156|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
1487157|NCT00827723|Makuuchi criteria|makuuchi criteria
1487158|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
1487159|NCT00827723|Hepatic resection|hepatic resection
1487160|NCT00827710|diabetes|diabetes
1487161|NCT00827710|registry|registry
1487162|NCT00827710|computer|computer
1487163|NCT00827710|self management|self management
1487164|NCT00827697|Gonorrhea|gonorrhea
1487165|NCT00827697|Chlamydia|chlamydia
1487166|NCT00827697|Rectal|rectal
1487167|NCT00827684|KRAS mutation|kras mutation
1487168|NCT00827658|anesthesia, local|anesthesia, local
1487169|NCT00827658|ulnar nerve|ulnar nerve
1487170|NCT00827658|hand|hand
1487171|NCT00827658|surgery, plastic|surgery, plastic
1487172|NCT00827658|blinded|blinded
1487173|NCT00827658|randomized|randomized
1487174|NCT00827658|prospective|prospective
1487175|NCT00827658|local anesthesia|local anesthesia
1487176|NCT00827658|volar wrist block|volar wrist block
1487177|NCT00827658|hypothenar palm block|hypothenar palm block
1487178|NCT00827658|hand surgery|hand surgery
1487179|NCT00827632|Ovarian Suppression|ovarian suppression
1487847|NCT00825227|Taxanes|taxanes
1487180|NCT00827632|Oral Contraceptives|oral contraceptives
1487181|NCT00827632|Obese and Normal BMI|obese and normal bmi
1487182|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
1487183|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
1487185|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
1487186|NCT00827567|Breast cancer|breast cancer
1487187|NCT00827567|metastatic breast|metastatic breast
1487188|NCT00827567|triple negative|triple negative
1487189|NCT00827567|ER/PR negative|er/pr negative
1487190|NCT00827567|Her2 Neu negative|her2 neu negative
1487191|NCT00827554|Liver Neoplasms|liver neoplasms
1487192|NCT00827554|Liver Diseases|liver diseases
1487193|NCT00827554|Digestive System Diseases|digestive system diseases
1487194|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
1487195|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1487196|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
1487197|NCT00827554|Adenocarcinoma|adenocarcinoma
1487198|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
1487199|NCT00827554|Neoplasms|neoplasms
1487200|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
1487201|NCT00827554|Nadroparin|nadroparin
1487202|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
1487203|NCT00827554|chemoembolization|chemoembolization
1487204|NCT00827541|tigecycline|tigecycline
1487205|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
1487206|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
1487207|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
1487208|NCT00827528|Surgical Treatment|surgical treatment
1487209|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
1487210|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
1487211|NCT00827489|schizophrenia|schizophrenia
1487213|NCT00827476|human|human
1487214|NCT00827476|transplantaion|transplantaion
1487215|NCT00827476|ovarian failure|ovarian failure
1487216|NCT00827463|aneamia|aneamia
1487217|NCT00827463|aneamia during the maternity|aneamia during the maternity
1487218|NCT00827450|hepatic steatosis|hepatic steatosis
1487219|NCT00827450|coffee|coffee
1487220|NCT00827450|fructose|fructose
1487221|NCT00827450|lipids|lipids
1487222|NCT00827424|physical activity (PA)|physical activity (pa)
1487223|NCT00827424|obesity|obesity
1487224|NCT00827424|life style modification|life style modification
1487225|NCT00827424|physical activity|physical activity
1487226|NCT00827424|diet|diet
1487227|NCT00827424|BMI reduction|bmi reduction
1487228|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
1487229|NCT00827424|health expenditure|health expenditure
1487230|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
1487231|NCT00827411|Drug Eluting Stent|drug eluting stent
1487232|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
1487233|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
1487234|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
1487235|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
1487236|NCT00827398|MSC|msc
1487237|NCT00827398|GVHD|gvhd
1487238|NCT00827398|Adults|adults
1487239|NCT00827398|Children|children
1487240|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
1487241|NCT00827359|everolimus|everolimus
1487242|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1487243|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1487244|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1487245|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1487246|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1487247|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1487248|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
1487249|NCT00827294|Phantom limb pain|phantom limb pain
1487250|NCT00827294|Mirror therapy|mirror therapy
1487251|NCT00827294|amputation|amputation
1487252|NCT00827294|Limb loss|limb loss
1487253|NCT00827294|treatment|treatment
1487254|NCT00827281|DCS|dcs
1487255|NCT00827281|CBT|cbt
1487256|NCT00827281|smoking|smoking
1487257|NCT00827281|tobacco|tobacco
1487258|NCT00827268|Dyslexia|dyslexia
1487259|NCT00827268|Reading|reading
1487260|NCT00827268|Aphasia|aphasia
1487261|NCT00827268|Stroke|stroke
1487262|NCT00827242|Signs and Symptoms|signs and symptoms
1487263|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
1487264|NCT00827242|Hyperplasia|hyperplasia
1487265|NCT00827242|Genital Diseases, Male|genital diseases, male
1487266|NCT00827242|Prostatic Diseases|prostatic diseases
1487267|NCT00827242|BPH-LUTS|bph-luts
1487268|NCT00827229|Active labor|active labor
1487269|NCT00827229|Term pregnancy|term pregnancy
1487270|NCT00827229|Vertex presentation|vertex presentation
1487271|NCT00827229|Single fetus|single fetus
1487272|NCT00827216|Gastric emptying|gastric emptying
1488247|NCT00823641|HAM/TSP|ham/tsp
1487273|NCT00827216|emergency anesthesia|emergency anesthesia
1487274|NCT00827216|intravenous erythromycin|intravenous erythromycin
1487275|NCT00827203|cancer|cancer
1487276|NCT00827203|metastatic|metastatic
1487277|NCT00827203|Elesclomol Sodium|elesclomol sodium
1487278|NCT00827203|tumor|tumor
1487279|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
1487280|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
1487281|NCT00827177|dose escalation|dose escalation
1487282|NCT00827177|safety|safety
1487283|NCT00827177|tolerability|tolerability
1487284|NCT00827177|tumor|tumor
1487285|NCT00827177|PK|pk
1487286|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
1487287|NCT00827177|renal cell carcinoma|renal cell carcinoma
1487288|NCT00827177|melanoma|melanoma
1487289|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
1487290|NCT00827177|breast cancer|breast cancer
1487291|NCT00827164|head and neck cancer|head and neck cancer
1487292|NCT00827164|resistance training|resistance training
1487293|NCT00827164|nutrition counseling|nutrition counseling
1487294|NCT00827164|radiation therapy|radiation therapy
1487295|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
1487296|NCT00827151|amenorrhea|amenorrhea
1487297|NCT00827151|athletes|athletes
1487298|NCT00827151|bone loss|bone loss
1487299|NCT00827151|eumenorrhea|eumenorrhea
1487300|NCT00827125|active stage|active stage
1487301|NCT00827125|labor|labor
1487302|NCT00827125|progression|progression
1487303|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
1487304|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
1487305|NCT00827099|accelerated phase cml|accelerated phase cml
1487306|NCT00827099|adult ALL in remission|adult all in remission
1487307|NCT00827099|adult AML in remission|adult aml in remission
1487308|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
1487309|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
1567597|NCT00508755|gait training|gait training
1639689|NCT00246051|Fatigue|fatigue
1487310|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1487311|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1487312|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1487313|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1487314|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1487315|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1487316|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
1487317|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1487318|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1487319|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1487320|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1487321|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1487322|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1487323|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1487324|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1487325|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1487326|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1487327|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1487328|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1487329|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1487330|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1487331|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1487417|NCT00826748|inhaled steroids|inhaled steroids
1487332|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1487333|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1487334|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1487335|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1487336|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1487337|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1487338|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1487339|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1487340|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1487341|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1487342|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1487343|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1487344|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1487345|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1487346|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1487347|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1487348|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
1487349|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
1487350|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
1487351|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
1487352|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1487353|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1487354|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1487355|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
1487356|NCT00827060|primary care|primary care
1487357|NCT00827060|procalcitonin|procalcitonin
1487358|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
1487359|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
1487360|NCT00827047|Surgical resection|surgical resection
1487361|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
1487362|NCT00827047|occlusion|occlusion
1487363|NCT00827047|bleeding|bleeding
1487364|NCT00827047|overall survival|overall survival
1487365|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
1487366|NCT00826995|patient Education|patient education
1487367|NCT00826995|dermatology Patient Education|dermatology patient education
1487368|NCT00826995|melanoma|melanoma
1487369|NCT00826995|melanoma education|melanoma education
1487370|NCT00826995|malignant melanoma|malignant melanoma
1487371|NCT00826995|melanoma detection|melanoma detection
1487372|NCT00826969|Asthma|asthma
1487373|NCT00826969|Ciclesonide|ciclesonide
1487374|NCT00826943|Allergic Rhinitis|allergic rhinitis
1487375|NCT00826930|High Grade Glioma|high grade glioma
1487376|NCT00826930|Brain Tumor|brain tumor
1487377|NCT00826930|Solid Tumor|solid tumor
1487378|NCT00826930|Partial Debulking|partial debulking
1639825|NCT00245349|FLT|flt
1487379|NCT00826930|Tumor Resection|tumor resection
1487380|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
1487381|NCT00826930|Radiation Sensitizer|radiation sensitizer
1487382|NCT00826930|Cancerous Tumor|cancerous tumor
1487383|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
1487384|NCT00826904|Fetal programming|fetal programming
1487385|NCT00826904|Fetal macrosomia|fetal macrosomia
1487386|NCT00826904|Fetal health|fetal health
1487387|NCT00826904|Gestational diabetes|gestational diabetes
1487388|NCT00826904|Maternal health|maternal health
1487389|NCT00826904|Maternal obesity|maternal obesity
1487390|NCT00826878|tivozanib|tivozanib
1487391|NCT00826878|AV-951|av-951
1487392|NCT00826839|In vitro fertilization|in vitro fertilization
1487393|NCT00826839|Poor responder patients|poor responder patients
1487394|NCT00826839|Randomized clinical trial|randomized clinical trial
1487395|NCT00826839|Estrogen patch|estrogen patch
1487396|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
1487397|NCT00826839|Oral contraceptive pill|oral contraceptive pill
1487398|NCT00826839|Microdose lupron|microdose lupron
1487399|NCT00826826|Atrial fibrillation|atrial fibrillation
1487400|NCT00826826|Amiodarone|amiodarone
1487401|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
1487402|NCT00826826|Catheter ablation|catheter ablation
1487403|NCT00826813|Dysphagia|dysphagia
1487404|NCT00826813|esophageal cancer|esophageal cancer
1487405|NCT00826813|stent|stent
1487406|NCT00826813|brachytherapy|brachytherapy
1487407|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1487408|NCT00826800|FLUOROURACIL|fluorouracil
1487409|NCT00826800|LEUCOVORIN|leucovorin
1487410|NCT00826800|OXALIPLATIN|oxaliplatin
1487411|NCT00826800|Chemotherapy|chemotherapy
1487412|NCT00826774|Body Weight|body weight
1487413|NCT00826774|Overweight|overweight
1487414|NCT00826774|Hypertension|hypertension
1487415|NCT00826774|Hyperglycemia|hyperglycemia
1487416|NCT00826748|COPD|copd
1487418|NCT00826748|gene expression|gene expression
1487419|NCT00826748|smoker's lungs|smoker's lungs
1487420|NCT00826735|third stage of labor|third stage of labor
1487421|NCT00826735|bleeding|bleeding
1487422|NCT00826735|guided imagery|guided imagery
1487423|NCT00826735|childbirth|childbirth
1487424|NCT00826696|preeclampsia|preeclampsia
1487425|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
1487426|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
1487427|NCT00826683|Angiogenesis|angiogenesis
1487428|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
1487429|NCT00826683|Healthy control|healthy control
1487430|NCT00826683|COPD patients|copd patients
1487431|NCT00826683|NSCLC patients|nsclc patients
1487432|NCT00826670|Antibiotic resistance|antibiotic resistance
1487433|NCT00826670|ESBL carriage|esbl carriage
1487434|NCT00826657|B12 deficiency|b12 deficiency
1487435|NCT00826657|methylmalonic acid|methylmalonic acid
1487436|NCT00826657|homocystein|homocystein
1487437|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
1487438|NCT00826644|Small cell lung cancer|small cell lung cancer
1487439|NCT00826644|Camptothecin|camptothecin
1487440|NCT00826644|Response rate|response rate
1487441|NCT00826631|weight|weight
1487442|NCT00826631|metabolism|metabolism
1487443|NCT00826631|cholesterol|cholesterol
1487444|NCT00826631|insulin|insulin
1487445|NCT00826618|Uveitis|uveitis
1487446|NCT00826618|Cystoid Macular Edema|cystoid macular edema
1487447|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
1487448|NCT00826592|patient education|patient education
1487449|NCT00826592|dermatology patient education|dermatology patient education
1487450|NCT00826592|atopic dermatitis|atopic dermatitis
1487451|NCT00826592|atopic dermatitis education|atopic dermatitis education
1487452|NCT00826592|atopic eczema|atopic eczema
1487453|NCT00826592|infantile eczema|infantile eczema
1487454|NCT00826592|hand eczema|hand eczema
1487455|NCT00826579|Sentinel lymph node|sentinel lymph node
1487456|NCT00826579|Lymph node analysis|lymph node analysis
1487457|NCT00826579|Bone marrow analysis|bone marrow analysis
1487458|NCT00826566|COPD|copd
1487459|NCT00826566|caffeine|caffeine
1487460|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
1487461|NCT00826566|oxidative stress|oxidative stress
1487462|NCT00826566|supplementation|supplementation
1487463|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
1487464|NCT00826553|sedative|sedative
1487465|NCT00826553|GABA|gaba
1487466|NCT00826553|alpha 2 agonist|alpha 2 agonist
1487467|NCT00826553|propofol|propofol
1487468|NCT00826553|midazolam|midazolam
1487469|NCT00826553|lorazepam|lorazepam
1487470|NCT00826553|dexmedetomidine|dexmedetomidine
1487471|NCT00826553|sleep|sleep
1487472|NCT00826553|electroencephalogram|electroencephalogram
1487473|NCT00826553|polysomnogram|polysomnogram
1487474|NCT00826553|ICU|icu
1487475|NCT00826514|Chronic Prostatis|chronic prostatis
1487476|NCT00826488|Breast Cancer|breast cancer
1487477|NCT00826488|Mammography|mammography
1487478|NCT00826488|Benign masses|benign masses
1487479|NCT00826488|Breast Lump|breast lump
1487480|NCT00826488|Breast Biopsy|breast biopsy
1487481|NCT00826488|Breast Mass|breast mass
1487482|NCT00826475|Migraine|migraine
1487483|NCT00826475|Headache|headache
1487484|NCT00826462|Randomised|randomised
1487485|NCT00826462|Placebo-controlled|placebo-controlled
1487486|NCT00826462|double blind|double blind
1487487|NCT00826462|Intervention study|intervention study
1487488|NCT00826462|Primary health care|primary health care
1487489|NCT00826449|Advanced Solid Tumors|advanced solid tumors
1487490|NCT00826449|Advanced Cancer|advanced cancer
1487491|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
1487492|NCT00826449|NSCLC|nsclc
1487493|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
1487494|NCT00826449|Dasatinib|dasatinib
1487495|NCT00826449|BMS-354825|bms-354825
1487496|NCT00826449|Sprycel®|sprycel®
1487497|NCT00826449|Erlotinib|erlotinib
1487498|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
1487499|NCT00826449|Tarceva|tarceva
1487500|NCT00826449|OSI-774|osi-774
1487501|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
1487502|NCT00826410|Laparotomy|laparotomy
1487503|NCT00826410|Surgical site infection|surgical site infection
1487504|NCT00826410|Drainage|drainage
1487505|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
1487506|NCT00826397|Joint Pain|joint pain
1487507|NCT00826397|Symptoms Control|symptoms control
1487508|NCT00826397|Acupuncture|acupuncture
1487509|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
1487510|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1487511|NCT00826384|overall survival|overall survival
1487512|NCT00826371|AMD|amd
1487513|NCT00826371|Ranibizumab|ranibizumab
1487514|NCT00826358|Adverse events|adverse events
1487515|NCT00826358|Pharmacokinetic|pharmacokinetic
1487516|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
1487517|NCT00826345|Neuropathy|neuropathy
1487518|NCT00826345|HIV|hiv
1487519|NCT00826345|AIDS|aids
1487520|NCT00826345|DSP|dsp
1487521|NCT00826345|alternative therapies|alternative therapies
1487522|NCT00826332|ultrasound|ultrasound
1487523|NCT00826332|IVF|ivf
1487524|NCT00826332|Embryo transfer|embryo transfer
1487525|NCT00826332|Pregnancy rate|pregnancy rate
1487526|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
1487527|NCT00826319|Chronic Kidney Disease|chronic kidney disease
1487528|NCT00826319|Renal Insufficiency|renal insufficiency
1487529|NCT00826319|Biomarkers|biomarkers
1487530|NCT00826319|Observational|observational
1487531|NCT00826306|patient education|patient education
1487532|NCT00826306|dermatology patient education|dermatology patient education
1487533|NCT00826306|sunscreen|sunscreen
1487534|NCT00826306|sunscreen education|sunscreen education
1487535|NCT00826306|skin cancer|skin cancer
1487536|NCT00826280|pharmacologic stress|pharmacologic stress
1487537|NCT00826280|ischemia|ischemia
1487538|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
1487539|NCT00826254|vitamin K|vitamin k
1487540|NCT00826254|Bone Mineral Density|bone mineral density
1487541|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
1487542|NCT00826241|Brain Tumor|brain tumor
1487543|NCT00826241|Central Nervous System|central nervous system
1487544|NCT00826241|CNS|cns
1487545|NCT00826241|Spinal Cord Tumor|spinal cord tumor
1487546|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
1487547|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
1487548|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
1487549|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
1487550|NCT00826241|Lapatinib|lapatinib
1487551|NCT00826241|GW572016|gw572016
1487552|NCT00826241|Temozolomide|temozolomide
1487553|NCT00826241|Temodar|temodar
1487554|NCT00826215|mechanical|mechanical
1487555|NCT00826215|neck pain|neck pain
1487556|NCT00826215|chronic|chronic
1487557|NCT00826215|acupuncture|acupuncture
1487558|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
1487559|NCT00826202|schizophrenia|schizophrenia
1487560|NCT00826202|d-serine|d-serine
1487561|NCT00826202|prodrome|prodrome
1487562|NCT00826189|Probiotics|probiotics
1487563|NCT00826189|Asthma|asthma
1487564|NCT00826189|Allergic Rhinitis|allergic rhinitis
1487565|NCT00826150|ovarian cancer|ovarian cancer
1487566|NCT00826150|H19 gene|h19 gene
1487567|NCT00826150|plasmid|plasmid
1487568|NCT00826137|prebiotics|prebiotics
1487569|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
1487570|NCT00826124|low back pain|low back pain
1487571|NCT00826124|radiculopathy|radiculopathy
1487572|NCT00826124|sciatica|sciatica
1487573|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1487574|NCT00826111|Glutamate|glutamate
1487575|NCT00826111|Glutamine|glutamine
1487576|NCT00826111|GABA|gaba
1487577|NCT00826111|Lexapro|lexapro
1487578|NCT00826111|Lunesta|lunesta
1487579|NCT00826111|Escitalopram|escitalopram
1487580|NCT00826111|Eszopiclone|eszopiclone
1487581|NCT00826098|Total knee replacement|total knee replacement
1487582|NCT00826098|Platelet Rich Plasma|platelet rich plasma
1487584|NCT00826098|Biologic|biologic
1487585|NCT00826098|Randomized|randomized
1487586|NCT00826085|Breast Cancer|breast cancer
1487587|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
1487588|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
1487589|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
1487590|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
1487591|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
1487592|NCT00826072|cardiac surgery|cardiac surgery
1487593|NCT00826059|acute ischemic stroke|acute ischemic stroke
1487594|NCT00826059|randomized clinical trial|randomized clinical trial
1487595|NCT00826059|effectiveness|effectiveness
1487596|NCT00826059|safety|safety
1487597|NCT00826046|GVHD|gvhd
1487598|NCT00826046|Prochymal|prochymal
1487599|NCT00826046|Graft vs Host Disease|graft vs host disease
1487600|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
1487601|NCT00826033|Positron emission tomography|positron emission tomography
1487602|NCT00826033|Lung cancer|lung cancer
1487603|NCT00826033|chemotherapy|chemotherapy
1487604|NCT00826033|monitoring|monitoring
1487605|NCT00826020|PN|pn
1487606|NCT00826020|parenteral nutrition|parenteral nutrition
1487607|NCT00826020|fat emulsions|fat emulsions
1487608|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
1487609|NCT00826020|liver disease|liver disease
1487610|NCT00826020|fatty acid deficiency|fatty acid deficiency
1487611|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
1487612|NCT00826007|surgery|surgery
1487613|NCT00825994|menopause|menopause
1487614|NCT00825994|perimenopause|perimenopause
1487615|NCT00825994|postmenopause|postmenopause
1487616|NCT00825994|depression|depression
1487617|NCT00825994|mood|mood
1487618|NCT00825994|sleep|sleep
1487619|NCT00825994|hot flashes|hot flashes
1487620|NCT00825968|Electrophysiological|electrophysiological
1487621|NCT00825968|Heart Disease|heart disease
1487622|NCT00825968|Cardiology|cardiology
1487717|NCT00825682|Reflexology|reflexology
1487623|NCT00825968|Atrial Fibrillation|atrial fibrillation
1487624|NCT00825968|Risk Factors|risk factors
1487625|NCT00825968|Follow-up|follow-up
1487626|NCT00825968|Outcomes|outcomes
1487627|NCT00825942|Asteroid hyalosis|asteroid hyalosis
1487628|NCT00825942|Opthalmic Study|opthalmic study
1487629|NCT00825929|pharmacokinetics|pharmacokinetics
1487630|NCT00825929|pregnancy|pregnancy
1487631|NCT00825929|antiretrovirals|antiretrovirals
1487632|NCT00825929|neonates|neonates
1487633|NCT00825929|HIV|hiv
1487634|NCT00825929|treatment experienced|treatment experienced
1487635|NCT00825916|AZX100|azx100
1487636|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
1487637|NCT00825916|POSAS|posas
1487638|NCT00825916|Visual Analog Scale|visual analog scale
1487639|NCT00825916|VAS|vas
1487640|NCT00825916|Keloid|keloid
1487641|NCT00825916|Scarring|scarring
1487642|NCT00825916|Scar reduction|scar reduction
1487643|NCT00825916|Scar prevention|scar prevention
1487644|NCT00825903|aquatic exercise|aquatic exercise
1487645|NCT00825903|asthma|asthma
1487646|NCT00825890|high cup disc ratio|high cup disc ratio
1488248|NCT00823641|HTLV-I|htlv-i
1487647|NCT00825890|glaucoma suspect|glaucoma suspect
1487648|NCT00825877|Hepatitis C|hepatitis c
1487649|NCT00825877|Sustained Virological Response|sustained virological response
1487650|NCT00825877|HALT-C|halt-c
1487651|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
1487652|NCT00825877|HCV RNA|hcv rna
1487653|NCT00825838|Body weight|body weight
1487654|NCT00825838|Body composition|body composition
1487655|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
1487656|NCT00825838|class I obese|class i obese
1487657|NCT00825825|Citalopram|citalopram
1487658|NCT00825825|Escitalopram|escitalopram
1487659|NCT00825825|Celexa|celexa
1487660|NCT00825825|Lexapro|lexapro
1487661|NCT00825825|fMRI|fmri
1487662|NCT00825825|antidepressant|antidepressant
1487663|NCT00825825|healthy volunteers|healthy volunteers
1487664|NCT00825799|biomarker|biomarker
1487665|NCT00825799|depression|depression
1487666|NCT00825799|blood test|blood test
1487667|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
1487668|NCT00825786|mepivacaine|mepivacaine
1487669|NCT00825786|ropivacaine|ropivacaine
1487670|NCT00825786|hand surgery|hand surgery
1487671|NCT00825786|elbow surgery|elbow surgery
1487672|NCT00825786|forearm surgery|forearm surgery
1487673|NCT00825773|TVF|tvf
1487674|NCT00825773|TLF|tlf
1487675|NCT00825773|MACE|mace
1487676|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
1487677|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
1487678|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
1487679|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
1487680|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
1487681|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
1487682|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
1487683|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
1487684|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
1487685|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
1487686|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
1487687|NCT00825760|Photodynamic Therapy|photodynamic therapy
1487688|NCT00825760|PDT|pdt
1487689|NCT00825760|Red light|red light
1487690|NCT00825760|Visible light|visible light
1487691|NCT00825760|Antimicrobial|antimicrobial
1487692|NCT00825760|Antibacterial|antibacterial
1487693|NCT00825760|Wound healing|wound healing
1487694|NCT00825760|Wound management|wound management
1487695|NCT00825760|Leg ulcer|leg ulcer
1487696|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
1487697|NCT00825760|Chronic wound|chronic wound
1487698|NCT00825760|Wound therapy|wound therapy
1487699|NCT00825760|Antimicrobial therapy|antimicrobial therapy
1487700|NCT00825747|Cataract|cataract
1487701|NCT00825747|Cataract surgery|cataract surgery
1487702|NCT00825747|intraocular lens|intraocular lens
1487703|NCT00825747|Aspheric lens|aspheric lens
1487704|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
1487705|NCT00825734|Sorafenib|sorafenib
1487706|NCT00825734|Nexavar|nexavar
1487707|NCT00825734|Ixabepilone|ixabepilone
1487708|NCT00825734|Ixempra|ixempra
1487709|NCT00825721|Cataract Study|cataract study
1487710|NCT00825721|Ophthalmic Study|ophthalmic study
1487711|NCT00825721|Agerelated cataract|agerelated cataract
1487712|NCT00825721|Nuclear Cataract|nuclear cataract
1487713|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
1487714|NCT00825708|ADHD|adhd
1487715|NCT00825682|Breast cancer|breast cancer
1487716|NCT00825682|Radiation therapy|radiation therapy
1487719|NCT00825682|Quality of life|quality of life
1487720|NCT00825682|Sleep disturbance|sleep disturbance
1487721|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
1487722|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
1487723|NCT00825669|laser ablation|laser ablation
1487724|NCT00825656|Allergic Rhinitis|allergic rhinitis
1487725|NCT00825656|Capsaicin|capsaicin
1487726|NCT00825656|Homeopathic|homeopathic
1487727|NCT00825656|Sinol|sinol
1487728|NCT00825656|Sinol-M|sinol-m
1487729|NCT00825630|HP|hp
1487730|NCT00825630|UBT|ubt
1487731|NCT00825630|PPI|ppi
1487732|NCT00825617|TS|ts
1487733|NCT00825617|HRT|hrt
1487734|NCT00825617|Liver function tests|liver function tests
1487735|NCT00825604|stable coronary artery disease|stable coronary artery disease
1487736|NCT00825604|quality of life|quality of life
1487737|NCT00825604|target achievement|target achievement
1487738|NCT00825604|physical training|physical training
1487739|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
1487740|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
1487741|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
1487743|NCT00825591|circadian rhythm|circadian rhythm
1487744|NCT00825578|intrabronchial valve|intrabronchial valve
1487745|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
1487746|NCT00825578|non-upper lobe|non-upper lobe
1487747|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
1487748|NCT00825552|Risperidone|risperidone
1487749|NCT00825552|Severe mood dysregulation|severe mood dysregulation
1487750|NCT00825552|bipolar|bipolar
1487751|NCT00825552|children|children
1487752|NCT00825539|Schizophrenia|schizophrenia
1487753|NCT00825539|Manic depression|manic depression
1487754|NCT00825539|anxiety|anxiety
1487755|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
1487756|NCT00825526|Stress Reduction|stress reduction
1487757|NCT00825526|hypertension|hypertension
1487758|NCT00825526|high blood pressure|high blood pressure
1487759|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1487760|NCT00825500|Migraine headache|migraine headache
1487761|NCT00825500|Loxapine|loxapine
1487762|NCT00825500|Staccato|staccato
1487763|NCT00825487|metastatic|metastatic
1487764|NCT00825487|hematologic|hematologic
1487765|NCT00825487|malignancy|malignancy
1487766|NCT00825487|multiple|multiple
1487767|NCT00825487|myeloma|myeloma
1487768|NCT00825487|malignant|malignant
1487769|NCT00825487|lymphoma|lymphoma
1487770|NCT00825487|chronic|chronic
1487771|NCT00825487|lymphocytic|lymphocytic
1487772|NCT00825487|leukemia|leukemia
1487773|NCT00825487|acute|acute
1487774|NCT00825487|myelogenous|myelogenous
1487775|NCT00825487|promyelocytic|promyelocytic
1487776|NCT00825487|dose escalation|dose escalation
1487777|NCT00825487|safety|safety
1487778|NCT00825487|tolerability|tolerability
1487779|NCT00825487|pharmacodynamics|pharmacodynamics
1487780|NCT00825487|tumor|tumor
1487781|NCT00825487|PK|pk
1487782|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
1487783|NCT00825474|partial hepatectomy|partial hepatectomy
1487784|NCT00825474|TACE plus PEI|tace plus pei
1487785|NCT00825461|Anorexia Nervosa|anorexia nervosa
1487786|NCT00825448|alcohol addiction|alcohol addiction
1487787|NCT00825435|Coronary CT angiogram|coronary ct angiogram
1487788|NCT00825435|Cardiac imaging|cardiac imaging
1487789|NCT00825435|Cost analysis|cost analysis
1487790|NCT00825435|acute chest pain|acute chest pain
1487791|NCT00825435|risk stratification|risk stratification
1487792|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
1487793|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
1487794|NCT00825422|Degenerative spine|degenerative spine
1487795|NCT00825422|Postoperative analgesia|postoperative analgesia
1487796|NCT00825422|Local anesthesic|local anesthesic
1487797|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
1487798|NCT00825422|Pain|pain
1487799|NCT00825422|lumbar vertebrae|lumbar vertebrae
1487800|NCT00825422|Spinal fusion|spinal fusion
1487801|NCT00825383|Diabetes|diabetes
1487802|NCT00825383|lipids|lipids
1487803|NCT00825383|fiber|fiber
1487804|NCT00825370|Hydromorphone|hydromorphone
1487805|NCT00825370|acute pain|acute pain
1487806|NCT00825370|Protocolized|protocolized
1487807|NCT00825370|Efficacy|efficacy
1487808|NCT00825370|Safety|safety
1487809|NCT00825357|biological markers|biological markers
1487810|NCT00825357|sepsis|sepsis
1487811|NCT00825357|acute lung injury|acute lung injury
1487812|NCT00825344|postoperative pain|postoperative pain
1487813|NCT00825344|inguinal hernia|inguinal hernia
1487814|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
1487815|NCT00825344|cytokine|cytokine
1487816|NCT00825344|preemptive analgesia|preemptive analgesia
1487817|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
1487818|NCT00825331|guide wire|guide wire
1487819|NCT00825331|cardiac catheterization|cardiac catheterization
1487820|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
1487825|NCT00825318|Hemodialysis|hemodialysis
1487826|NCT00825305|vaccine|vaccine
1487827|NCT00825305|prevention|prevention
1487828|NCT00825305|rabies|rabies
1487829|NCT00825305|Rabies disease|rabies disease
1487830|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
1487831|NCT00825279|Biodegradable polymer|biodegradable polymer
1487832|NCT00825279|Drug Eluting Stent|drug eluting stent
1487833|NCT00825279|In stent restenosis|in stent restenosis
1487834|NCT00825279|stent thrombosis|stent thrombosis
1487835|NCT00825279|Bare Metal Stent|bare metal stent
1487836|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
1487837|NCT00825240|Colorectal Cancer|colorectal cancer
1487838|NCT00825240|Cancer Survivorship Study|cancer survivorship study
1487839|NCT00825240|Questionnaires|questionnaires
1487840|NCT00825240|Survivorship|survivorship
1487841|NCT00825240|Survivor Health|survivor health
1487842|NCT00825240|Health Promotion|health promotion
1487843|NCT00825240|Behavior Changes|behavior changes
1487844|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
1487845|NCT00825227|Cancer|cancer
1487846|NCT00825227|Fatigue|fatigue
1487848|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
1487849|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
1487850|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1487851|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1487852|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1487853|NCT00825175|Down syndrome|down syndrome
1487854|NCT00825175|Gait|gait
1487855|NCT00825175|Motor Development|motor development
1487856|NCT00825175|Orthoses|orthoses
1487857|NCT00825136|Panic Disorder|panic disorder
1487858|NCT00825136|Temperature Biofeedback|temperature biofeedback
1487859|NCT00825136|Internet|internet
1487860|NCT00825123|healthy individuals|healthy individuals
1487861|NCT00825110|colorectal|colorectal
1487862|NCT00825110|cancer|cancer
1487863|NCT00825110|gene expression|gene expression
1487864|NCT00825110|biomarker|biomarker
1487865|NCT00825110|genomic mismatch repair|genomic mismatch repair
1487866|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
1487867|NCT00825097|Stroke|stroke
1487868|NCT00825097|Tibial neurotomy|tibial neurotomy
1487869|NCT00825097|Botulinum toxin type A|botulinum toxin type a
1487870|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
1487871|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
1487872|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1487873|NCT00825071|Ondansetron|ondansetron
1487874|NCT00825071|Dexamethasone|dexamethasone
1487875|NCT00825058|Depression|depression
1487876|NCT00825045|dopamine|dopamine
1487877|NCT00825045|D2|d2
1487878|NCT00825045|D3|d3
1487879|NCT00825045|caudate|caudate
1487880|NCT00825045|putamen|putamen
1487881|NCT00825045|globus pallidus|globus pallidus
1487882|NCT00825045|antipsychotic|antipsychotic
1487883|NCT00825045|risperidone|risperidone
1487884|NCT00825045|geriatric|geriatric
1487885|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
1487886|NCT00825045|PET|pet
1487887|NCT00825045|radiotracer|radiotracer
1487888|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
1487889|NCT00825045|[11C]-raclopride|[11c]-raclopride
1487890|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
1487891|NCT00825032|Upper extremity|upper extremity
1487892|NCT00825032|Exercise therapy|exercise therapy
1487893|NCT00825019|Depression|depression
1487894|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
1487895|NCT00825006|Anodal stimulation|anodal stimulation
1487896|NCT00824993|Blood Cancer|blood cancer
1487897|NCT00824993|Calcium|calcium
1487898|NCT00824993|Vitamin D|vitamin d
1487899|NCT00824993|Ibandronate|ibandronate
1487900|NCT00824993|Boniva|boniva
1487901|NCT00824993|Hematological Malignancies|hematological malignancies
1487902|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
1487903|NCT00824993|BMT|bmt
1487904|NCT00824993|Osteoporosis|osteoporosis
1487905|NCT00824993|Bone Loss|bone loss
1487906|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
1487907|NCT00824954|0 to 30 years|0 to 30 years
1487908|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
1487915|NCT00824928|Prostate Cancer|prostate cancer
1487916|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
1487917|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
1487918|NCT00824928|Radiation Failure|radiation failure
1487919|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
1487920|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
1487921|NCT00824902|Prostate Cancer|prostate cancer
1487922|NCT00824902|Prostate|prostate
1487923|NCT00824902|Radical Prostatectomy|radical prostatectomy
1487924|NCT00824902|Tissue Elastography|tissue elastography
1487925|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
1487926|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
1487927|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
1487928|NCT00824902|Ultrasound|ultrasound
1487929|NCT00824876|Mammae cancer patients|mammae cancer patients
1487930|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
1487931|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
1487932|NCT00824850|Single site|single site
1487933|NCT00824850|single dose|single dose
1487934|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
1487935|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
1487936|NCT00824837|haemodialysis|haemodialysis
1487937|NCT00824837|albumin|albumin
1487938|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
1487939|NCT00824811|Epiphora|epiphora
1487940|NCT00824811|Breast Cancer|breast cancer
1487941|NCT00824811|Lung Cancer|lung cancer
1487942|NCT00824811|Prostate Cancer|prostate cancer
1487943|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
1487944|NCT00824811|Bladder Cancer|bladder cancer
1487945|NCT00824811|Esophageal Cancer|esophageal cancer
1487946|NCT00824811|Head and Neck Cancer|head and neck cancer
1487948|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
1487949|NCT00824811|SCLC|sclc
1487950|NCT00824811|Ovarian Cancer|ovarian cancer
1487951|NCT00824811|Stomach Cancer|stomach cancer
1487952|NCT00824811|Canalicular Stenosis|canalicular stenosis
1487953|NCT00824811|Excessive tearing|excessive tearing
1487954|NCT00824811|Eye inflammation|eye inflammation
1487955|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
1487956|NCT00824811|Docetaxel|docetaxel
1487957|NCT00824811|Taxotere|taxotere
1487958|NCT00824811|Restasis®|restasis®
1487959|NCT00824811|Cyclosporine|cyclosporine
1487960|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
1487961|NCT00824811|FML Forte®|fml forte®
1487962|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
1487963|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
1487964|NCT00824811|Fluorometholone|fluorometholone
1487965|NCT00824811|Refresh Endura™|refresh endura™
1487966|NCT00824811|Lubricant eye drops|lubricant eye drops
1487967|NCT00824811|Eye drops|eye drops
1487968|NCT00824798|gait|gait
1487969|NCT00824798|haemophilia|haemophilia
1487970|NCT00824798|arthropathy|arthropathy
1487971|NCT00824785|epirubicin|epirubicin
1487972|NCT00824785|oxaliplatin|oxaliplatin
1487973|NCT00824785|capecitabine|capecitabine
1487974|NCT00824785|panitumumab|panitumumab
1487975|NCT00824772|pharmacogenetics|pharmacogenetics
1487976|NCT00824759|Healthy subjects|healthy subjects
1487977|NCT00824759|CABG|cabg
1487978|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
1487979|NCT00824746|Gefitinib|gefitinib
1487980|NCT00824746|Recurrence|recurrence
1487981|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1487982|NCT00824733|recurrent breast cancer|recurrent breast cancer
1487983|NCT00824733|stage IV breast cancer|stage iv breast cancer
1487984|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
1487985|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
1487986|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
1487987|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
1487988|NCT00824733|male breast cancer|male breast cancer
1487989|NCT00824707|primary liver cancer|primary liver cancer
1487990|NCT00824707|hepatitis B virus|hepatitis b virus
1487991|NCT00824707|anti-virus therapy|anti-virus therapy
1487992|NCT00824694|Glucose|glucose
1487993|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1487994|NCT00824694|HbA1c|hba1c
1487995|NCT00824681|Psychological adjustment of family|psychological adjustment of family
1487996|NCT00824681|family of patients|family of patients
1487997|NCT00824681|children of patients|children of patients
1487998|NCT00824681|intensive care unit|intensive care unit
1487999|NCT00824681|burn|burn
1488000|NCT00824681|music therapy|music therapy
1488001|NCT00824681|music|music
1488002|NCT00824681|music program|music program
1488003|NCT00824681|anxiety|anxiety
1488004|NCT00824681|coping|coping
1488005|NCT00824681|adjustment|adjustment
1488006|NCT00824681|psychological stressor|psychological stressor
1488007|NCT00824681|emotional stressor|emotional stressor
1488008|NCT00824655|Healthy Subjects|healthy subjects
1488009|NCT00824655|Vaccines|vaccines
1488010|NCT00824655|Pneumococcal|pneumococcal
1488011|NCT00824642|Asthma|asthma
1488012|NCT00824642|Exercise training|exercise training
1488013|NCT00824642|TENS|tens
1488014|NCT00824642|Acupuncture|acupuncture
1488015|NCT00824642|FEV1|fev1
1488016|NCT00824629|Embryo transfer|embryo transfer
1488017|NCT00824629|IVF|ivf
1488018|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
1488019|NCT00824590|Dimebon|dimebon
1488020|NCT00824590|renal impairment|renal impairment
1488021|NCT00824590|pharmacokinetics|pharmacokinetics
1488022|NCT00824577|heart rate variability|heart rate variability
1488023|NCT00824577|autonomic function|autonomic function
1488024|NCT00824577|heart function|heart function
1488025|NCT00824564|Tranexamic Acid|tranexamic acid
1488026|NCT00824564|Blood Loss|blood loss
1488027|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
1488028|NCT00824551|Acute Thermal Burns|acute thermal burns
1488029|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
1488030|NCT00824551|Burns conversion|burns conversion
1488031|NCT00824538|stage IA breast cancer|stage ia breast cancer
1488032|NCT00824538|stage IB breast cancer|stage ib breast cancer
1488033|NCT00824538|stage II breast cancer|stage ii breast cancer
1488034|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
1488035|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
1488036|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
1488037|NCT00824486|child|child
1488038|NCT00824486|injury prevention|injury prevention
1488039|NCT00824460|Hemodialysis|hemodialysis
1488040|NCT00824447|randomised|randomised
1488041|NCT00824447|double-blind|double-blind
1488042|NCT00824447|placebo-controlled|placebo-controlled
1488043|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
1488044|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
1488045|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1488046|NCT00824447|Allergy|allergy
1488047|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
1488048|NCT00824447|Immunotherapy|immunotherapy
1488049|NCT00824447|Grass pollen extract|grass pollen extract
1488050|NCT00824434|Atherosclerosis|atherosclerosis
1488051|NCT00824434|Coronary Artery Disease|coronary artery disease
1488052|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
1488053|NCT00824421|HIV Infections|hiv infections
1488054|NCT00824421|treatment naive|treatment naive
1488055|NCT00824395|diabetes|diabetes
1488056|NCT00824395|type 1|type 1
1488057|NCT00824395|type 2|type 2
1488058|NCT00824395|metabolic syndrome|metabolic syndrome
1488059|NCT00824395|mitochondria|mitochondria
1488060|NCT00824369|HIV-1|hiv-1
1488061|NCT00824369|Rollover|rollover
1488062|NCT00824369|Safety.|safety.
1488063|NCT00824369|HIV Infections|hiv infections
1488064|NCT00824369|treatment experienced|treatment experienced
1488065|NCT00824356|Allergic Rhinitis|allergic rhinitis
1488066|NCT00824356|Proof-of-Concept|proof-of-concept
1488067|NCT00824330|Aging|aging
1488068|NCT00824330|Type 2 diabetes|type 2 diabetes
1488069|NCT00824330|exercise|exercise
1488070|NCT00824330|walking|walking
1488071|NCT00824330|glucose metabolism|glucose metabolism
1488072|NCT00824330|arterial baroreceptors|arterial baroreceptors
1488073|NCT00824330|heart rate variability|heart rate variability
1488074|NCT00824330|cerebral autoregulation|cerebral autoregulation
1488075|NCT00824330|tilt table study|tilt table study
1488076|NCT00824330|transcranial Doppler|transcranial doppler
1488077|NCT00824330|autonomic nervous system|autonomic nervous system
1488078|NCT00824304|cognitive performance|cognitive performance
1488079|NCT00824304|growth|growth
1488080|NCT00824304|iron|iron
1488081|NCT00824304|zinc|zinc
1488082|NCT00824291|Major Depressive Disorder|major depressive disorder
1488083|NCT00824278|Pediatrics|pediatrics
1488084|NCT00824278|Distresss Screening|distresss screening
1488085|NCT00824278|Cancer|cancer
1488086|NCT00824278|Neurofibromatosis|neurofibromatosis
1488087|NCT00824278|HIV|hiv
1488088|NCT00824278|Pediatric Cancer|pediatric cancer
1488089|NCT00824278|Distress Screening|distress screening
1488090|NCT00824265|Relapsed|relapsed
1488091|NCT00824265|Oncology|oncology
1488092|NCT00824265|Safety|safety
1488093|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1488094|NCT00824265|Ofatumumab|ofatumumab
1488095|NCT00824265|Efficacy|efficacy
1488096|NCT00824252|Head And Neck Cancer|head and neck cancer
1488097|NCT00824252|HNC|hnc
1488098|NCT00824252|Radiation Therapy|radiation therapy
1488099|NCT00824252|Spousal Support|spousal support
1488100|NCT00824252|Emotional Disclosure|emotional disclosure
1488101|NCT00824252|Observational|observational
1488102|NCT00824252|Social Constraints|social constraints
1488103|NCT00824252|Questionnaires|questionnaires
1488104|NCT00824252|Videotaped Interview|videotaped interview
1488105|NCT00824252|Quality of Life|quality of life
1488106|NCT00824239|critical care|critical care
1488107|NCT00824239|sedation|sedation
1488108|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
1488109|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
1488110|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
1488111|NCT00824226|magnesium|magnesium
1488112|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
1488113|NCT00824200|Sleep|sleep
1488114|NCT00824200|Quality of life|quality of life
1488115|NCT00824200|nocturia|nocturia
1488116|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
1488117|NCT00824187|Oral contraceptive|oral contraceptive
1489457|NCT00819234|Obese|obese
1488118|NCT00824174|Questionnaire|questionnaire
1488119|NCT00824174|Head and Neck Cancer|head and neck cancer
1488120|NCT00824174|Skin Cancer|skin cancer
1488121|NCT00824174|Body Image|body image
1488122|NCT00824174|Surgical Treatment|surgical treatment
1488123|NCT00824174|Oral Cavity Cancer|oral cavity cancer
1488124|NCT00824174|Cutaneous Cancer|cutaneous cancer
1488125|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
1488126|NCT00824148|HbA1c|hba1c
1488127|NCT00824148|Quality of life|quality of life
1488128|NCT00824148|Hypoglycemia|hypoglycemia
1488129|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
1488130|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1488131|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
1488132|NCT00824135|Clofarabine|clofarabine
1488133|NCT00824135|Hematological Malignancies|hematological malignancies
1488134|NCT00824135|Apheresis|apheresis
1488135|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
1488136|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
1488137|NCT00824096|endotracheal intubation|endotracheal intubation
1488138|NCT00824096|cuff-leak test|cuff-leak test
1488139|NCT00824096|post-extubation stridor|post-extubation stridor
1488140|NCT00824096|bronchoscopy|bronchoscopy
1488141|NCT00824096|corticosteroids|corticosteroids
1488142|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
1488143|NCT00824083|bone tumors|bone tumors
1488144|NCT00824083|long-term function|long-term function
1488145|NCT00824083|daily activity|daily activity
1488146|NCT00824083|late sequelae|late sequelae
1488147|NCT00824070|Bioavailability|bioavailability
1488148|NCT00824057|Phase I|phase i
1488149|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1488150|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1488151|NCT00824044|Escitalopram|escitalopram
1488152|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
1488153|NCT00824031|schizophrenia|schizophrenia
1488154|NCT00824031|medical mental care|medical mental care
1488155|NCT00824031|caregiver|caregiver
1488156|NCT00824031|Sapin|sapin
1488157|NCT00824005|Congestive Heart Failure|congestive heart failure
1488158|NCT00824005|Regional Wall Motion|regional wall motion
1488159|NCT00824005|Perfusion Defects|perfusion defects
1488160|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
1488161|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
1488162|NCT00823953|diabetes type 2|diabetes type 2
1488163|NCT00823940|FTIH|ftih
1488164|NCT00823940|Glucagon|glucagon
1488165|NCT00823940|Safety|safety
1488166|NCT00823940|GSK1362885|gsk1362885
1488167|NCT00823940|Pharmacokinetics|pharmacokinetics
1488168|NCT00823940|Tolerability|tolerability
1488169|NCT00823940|Pharmacodynamics|pharmacodynamics
1488170|NCT00823927|lung damage|lung damage
1488171|NCT00823927|cigarette smoking|cigarette smoking
1488172|NCT00823927|HIV-seropositive|hiv-seropositive
1488173|NCT00823927|emphysema|emphysema
1488174|NCT00823914|Psoriasis|psoriasis
1488175|NCT00823914|Quality of Life|quality of life
1488176|NCT00823901|rosacea|rosacea
1488177|NCT00823901|clindamycin|clindamycin
1488178|NCT00823901|tretinoin|tretinoin
1488179|NCT00823901|clinical study|clinical study
1488180|NCT00823901|treatment|treatment
1488181|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
1488182|NCT00823888|pneumatic bracing|pneumatic bracing
1488184|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
1488185|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
1488186|NCT00823862|interferon (IFN)|interferon (ifn)
1488187|NCT00823862|ribavirin|ribavirin
1488188|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
1488189|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
1488190|NCT00823823|Casting techniques|casting techniques
1488191|NCT00823823|Bivalved cast|bivalved cast
1488192|NCT00823823|Circumferential cast|circumferential cast
1488193|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
1488194|NCT00823823|Children|children
1488195|NCT00823810|Colorectal cancer|colorectal cancer
1488196|NCT00823810|Response to treatment|response to treatment
1488197|NCT00823810|FDG PET/CT|fdg pet/ct
1488198|NCT00823784|hemorrhoids|hemorrhoids
1488199|NCT00823784|stapler|stapler
1488200|NCT00823784|Doppler|doppler
1488201|NCT00823784|artery ligation|artery ligation
1488202|NCT00823784|outcome|outcome
1488203|NCT00823784|recurrence|recurrence
1488204|NCT00823758|Acetaminophen|acetaminophen
1488205|NCT00823758|Liver|liver
1488206|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
1488207|NCT00823758|CERTS|certs
1488208|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
1488209|NCT00823758|OTC|otc
1488210|NCT00823758|Self-administration|self-administration
1488211|NCT00823758|Parental administration|parental administration
1488212|NCT00823758|Houston|houston
1488213|NCT00823758|Texas|texas
1488214|NCT00823758|Liver toxicity|liver toxicity
1488215|NCT00823758|Qualitative study|qualitative study
1488216|NCT00823758|Pharmacists|pharmacists
1488217|NCT00823758|Adolescents|adolescents
1488218|NCT00823758|Primary care physicians|primary care physicians
1488219|NCT00823758|Family Practitioners|family practitioners
1488220|NCT00823758|General Internist|general internist
1488221|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1488222|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1488223|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1488224|NCT00823719|Salvage chemotherapy|salvage chemotherapy
1488225|NCT00823719|relapsed|relapsed
1488226|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
1488227|NCT00823719|efficacy|efficacy
1488228|NCT00823719|safety|safety
1488229|NCT00823719|DHAP|dhap
1488230|NCT00823719|ofatumumab|ofatumumab
1488231|NCT00823719|refractory|refractory
1488232|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1488233|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
1488234|NCT00823719|Oncology|oncology
1488235|NCT00823719|ICE|ice
1488236|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
1488237|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
1488238|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1488239|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1488240|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1488241|NCT00823654|Breast|breast
1488242|NCT00823654|Questionaires|questionaires
1488243|NCT00823654|Blood draw|blood draw
1488244|NCT00823654|BRCA1|brca1
1488245|NCT00823654|BRCA2|brca2
1488246|NCT00823654|08-156|08-156
1488249|NCT00823602|GnRH antagonist|gnrh antagonist
1488250|NCT00823602|GnRH agonist|gnrh agonist
1488251|NCT00823602|pregnancy rate|pregnancy rate
1488252|NCT00823602|Ovarian stimulation|ovarian stimulation
1488253|NCT00823589|ELDERLY POPULATION|elderly population
1488254|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
1488255|NCT00823576|Spinal Surgery|spinal surgery
1488256|NCT00823550|Chronic hepatitis B|chronic hepatitis b
1488257|NCT00823550|Advanced fibrosis|advanced fibrosis
1488258|NCT00823550|Lamivudine|lamivudine
1488259|NCT00823550|Entecavir|entecavir
1488260|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1488261|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
1488262|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1488263|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1488264|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1488265|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1488266|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1567598|NCT00508755|motor learning|motor learning
1488267|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1488268|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1488269|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1488270|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1488271|NCT00823524|mast cell leukemia|mast cell leukemia
1488272|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1488273|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1488274|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
1488275|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1488276|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1488277|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1488278|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1488279|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
1488280|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1488281|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1488282|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1488283|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1488284|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1488285|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1488286|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1488287|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1488288|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1488289|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1488290|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1488291|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1488292|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1488293|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1488294|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1488295|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1488296|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1488297|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1488298|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1488299|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1488300|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1488301|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1488302|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1488303|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1488304|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1488305|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1488306|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1488307|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1488308|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1488309|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1488310|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1488311|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1488312|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1488313|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1488314|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1488315|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1488316|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1488317|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1488318|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1488319|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1488320|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1488321|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1488322|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1488323|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1488324|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1488325|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1488326|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1488327|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1488328|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1640983|NCT00240682|Skin|skin
1488329|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1488330|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1488331|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1488332|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1488333|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1488334|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1488335|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1488336|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1488337|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1488338|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1488339|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1488340|NCT00823524|intraocular lymphoma|intraocular lymphoma
1488341|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1488342|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1488343|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1488344|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1488345|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1488346|NCT00823524|primary myelofibrosis|primary myelofibrosis
1488347|NCT00823524|essential thrombocythemia|essential thrombocythemia
1488348|NCT00823524|polycythemia vera|polycythemia vera
1488349|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
1488350|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1488351|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
1488352|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
1488353|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
1488354|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
1488355|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1488356|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1488357|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1488358|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1488359|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1488360|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
1488361|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1488362|NCT00823511|HPV|hpv
1488363|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
1488364|NCT00823511|Cervix Uteri|cervix uteri
1488365|NCT00823511|Cancer Control|cancer control
1488366|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
1488367|NCT00823511|Sexually Transmitted|sexually transmitted
1488368|NCT00823511|Neoplasia|neoplasia
1488369|NCT00823511|Carcinogenesis|carcinogenesis
1488370|NCT00823511|Cervix|cervix
1488371|NCT00823498|Cancer Prevention|cancer prevention
1488372|NCT00823498|African American|african american
1488373|NCT00823498|African American Parents|african american parents
1488374|NCT00823498|African American Youth|african american youth
1488375|NCT00823498|Public Housing|public housing
1488376|NCT00823498|Physical Activity|physical activity
1488377|NCT00823498|Focus Groups|focus groups
1488378|NCT00823498|Housing Developments|housing developments
1488379|NCT00823498|Houston Public Housing|houston public housing
1488380|NCT00823498|Photovoice Project|photovoice project
1488381|NCT00823498|Prevention|prevention
1488382|NCT00823472|embryonic structures|embryonic structures
1488383|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
1488384|NCT00823472|IVF|ivf
1488385|NCT00823472|GnRH antagonist|gnrh antagonist
1488386|NCT00823472|ovarian stimulation|ovarian stimulation
1488387|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
1488388|NCT00823459|Low-grade glioma|low-grade glioma
1488389|NCT00823459|astrocytoma|astrocytoma
1488390|NCT00823459|oligodendroglioma|oligodendroglioma
1488492|NCT00823056|Children|children
1488391|NCT00823459|mixed oligoastrocytoma|mixed oligoastrocytoma
1488392|NCT00823433|Penicillin|penicillin
1488393|NCT00823433|Group B Streptococcus|group b streptococcus
1488394|NCT00823433|Pregnancy|pregnancy
1488395|NCT00823433|Labor|labor
1488396|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
1488397|NCT00823420|aneuploidy|aneuploidy
1488398|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
1488399|NCT00823407|MDA|mda
1488400|NCT00823407|MDMA|mdma
1488401|NCT00823407|Ecstasy|ecstasy
1488402|NCT00823407|entactogen|entactogen
1488403|NCT00823407|pharmacokinetics|pharmacokinetics
1488404|NCT00823407|pharmacodynamics|pharmacodynamics
1488405|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
1488406|NCT00823394|African American|african american
1488407|NCT00823394|Adults|adults
1641110|NCT00239889|Pain|pain
1488408|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
1488409|NCT00823394|Health Disparities|health disparities
1488410|NCT00823394|Questionnaire|questionnaire
1488411|NCT00823394|Body Measurements|body measurements
1488412|NCT00823394|Self-help|self-help
1488413|NCT00823394|Cancer Rates|cancer rates
1488414|NCT00823394|Prevention|prevention
1488415|NCT00823381|obesity|obesity
1488416|NCT00823381|metabolic syndrome|metabolic syndrome
1488417|NCT00823381|diabetes|diabetes
1488418|NCT00823381|aging|aging
1488419|NCT00823381|calorie restriction|calorie restriction
1488420|NCT00823381|resveratrol|resveratrol
1488421|NCT00823381|antioxidant|antioxidant
1488422|NCT00823368|fragile X syndrome|fragile x syndrome
1488423|NCT00823368|biomarkers|biomarkers
1488424|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
1488425|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
1488426|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
1488427|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
1488428|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
1488429|NCT00823316|Engraftment|engraftment
1488430|NCT00823316|GvHD|gvhd
1488431|NCT00823316|Childhood|childhood
1488432|NCT00823316|unrelated HSCT|unrelated hsct
1488433|NCT00823303|PTH|pth
1488434|NCT00823303|Active Vitamin D|active vitamin d
1488435|NCT00823303|hypercalcemia|hypercalcemia
1488436|NCT00823303|Chronic Kidney Disease|chronic kidney disease
1488437|NCT00823290|HCC|hcc
1488438|NCT00823290|sorafenib|sorafenib
1488439|NCT00823290|HDAC|hdac
1488440|NCT00823290|LBH589|lbh589
1488441|NCT00823290|Panobinostat|panobinostat
1488442|NCT00823264|Anticonvulsants|anticonvulsants
1488443|NCT00823264|Toxicology|toxicology
1488444|NCT00823264|multidose charcoal|multidose charcoal
1488445|NCT00823264|phenytoin|phenytoin
1488446|NCT00823225|Diabetes|diabetes
1488447|NCT00823225|urokinase|urokinase
1488448|NCT00823225|ulcer healing|ulcer healing
1488449|NCT00823225|major amputation|major amputation
1488450|NCT00823225|survival|survival
1488451|NCT00823212|drug-eluting stents|drug-eluting stents
1488452|NCT00823212|DES|des
1488453|NCT00823212|atherosclerotic|atherosclerotic
1488454|NCT00823186|cervical carcinoma|cervical carcinoma
1488455|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1488456|NCT00823173|Uveitis|uveitis
1488457|NCT00823173|TNF-alpha|tnf-alpha
1488458|NCT00823173|Topical|topical
1488460|NCT00823173|scFv antibody fragment|scfv antibody fragment
1488461|NCT00823173|ocular inflammation|ocular inflammation
1488462|NCT00823160|Pericardial window|pericardial window
1488463|NCT00823160|Sternotomy|sternotomy
1488464|NCT00823160|Haemopericardium|haemopericardium
1488465|NCT00823147|Pain|pain
1488466|NCT00823147|Systemic Inflammation|systemic inflammation
1488467|NCT00823147|Pain Catastrophizing|pain catastrophizing
1488468|NCT00823121|Fresh embryo transfer|fresh embryo transfer
1488469|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
1488470|NCT00823121|vitrification|vitrification
1488471|NCT00823121|endometrial receptivity|endometrial receptivity
1488472|NCT00823121|implantation rate|implantation rate
1488473|NCT00823121|pregnancy|pregnancy
1488474|NCT00823121|ART|art
1488475|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
1488476|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
1488477|NCT00823095|Nitric Oxide|nitric oxide
1488478|NCT00823095|topically applied|topically applied
1488479|NCT00823095|Biofilm|biofilm
1488480|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
1488481|NCT00823082|antithrombin|antithrombin
1488482|NCT00823082|ATIII|atiii
1488483|NCT00823082|acquired deficiency|acquired deficiency
1488484|NCT00823082|anticoagulants|anticoagulants
1488485|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
1488486|NCT00823082|surgery|surgery
1488487|NCT00823082|complications|complications
1488488|NCT00823082|postoperative outcomes|postoperative outcomes
1488489|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
1488490|NCT00823056|Probiotics|probiotics
1488491|NCT00823056|Infections|infections
1488493|NCT00823030|Interstitial Cystitis|interstitial cystitis
1488494|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
1488495|NCT00823017|ICU environment|icu environment
1488496|NCT00823017|Auditory stimulation|auditory stimulation
1488497|NCT00823017|Properties of relaxation music|properties of relaxation music
1488498|NCT00823017|music|music
1488499|NCT00823017|music therapy|music therapy
1488500|NCT00823017|pain|pain
1488501|NCT00823017|anxiety|anxiety
1488502|NCT00823017|cortisol|cortisol
1488503|NCT00823017|IgA|iga
1488504|NCT00823017|biomarkers|biomarkers
1488505|NCT00823017|relaxation music|relaxation music
1488506|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
1488507|NCT00823004|pregnancy rate|pregnancy rate
1488508|NCT00823004|Poor responders|poor responders
1488509|NCT00823004|GnRH antagonist|gnrh antagonist
1488510|NCT00823004|GnRH agonist|gnrh agonist
1488511|NCT00823004|letrozole|letrozole
1488512|NCT00823004|in vitro fertilization|in vitro fertilization
1488513|NCT00822991|Sonazoid|sonazoid
1488514|NCT00822991|Early detection|early detection
1488515|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
1488516|NCT00822991|Liver cirrhosis|liver cirrhosis
1488517|NCT00822978|healthy|healthy
1488518|NCT00822978|volunteers|volunteers
1488519|NCT00822978|subjects|subjects
1488520|NCT00822965|Pacemakers|pacemakers
1488521|NCT00822965|PM|pm
1488522|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
1488523|NCT00822965|ICD|icd
1488524|NCT00822965|Implantable pulse generators|implantable pulse generators
1488525|NCT00822965|Educational Interventions|educational interventions
1488526|NCT00822913|Botulinum A toxin|botulinum a toxin
1488527|NCT00822913|Parkinson's disease|parkinson's disease
1488528|NCT00822900|Trauma|trauma
1488529|NCT00822900|Brain Injury|brain injury
1488530|NCT00822887|malignant|malignant
1488531|NCT00822887|gliomas|gliomas
1488532|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
1488533|NCT00822874|aneuploidy|aneuploidy
1488534|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
1488535|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1488536|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1488537|NCT00822822|Questionnaire|questionnaire
1488538|NCT00822822|Electronic Health History|electronic health history
1488539|NCT00822809|Cancer|cancer
1488540|NCT00822809|Neoplasms|neoplasms
1488541|NCT00822809|Carcinoma|carcinoma
1488542|NCT00822809|Malignant Ascites|malignant ascites
1488543|NCT00822809|Drug therapy|drug therapy
1488544|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
1488545|NCT00822809|Immunotherapy|immunotherapy
1488546|NCT00822809|Phase III|phase iii
1488547|NCT00822809|trifunctional antibody|trifunctional antibody
1488548|NCT00822809|monoclonal antibody|monoclonal antibody
1488549|NCT00822809|EpCAM|epcam
1488550|NCT00822796|Hypothermia|hypothermia
1488551|NCT00822796|Severe burns|severe burns
1488552|NCT00822796|Warming catheter|warming catheter
1488553|NCT00822796|Thermogard™|thermogard™
1488554|NCT00822796|Coagulopathy|coagulopathy
1488555|NCT00822783|Serum IgE levels|serum ige levels
1488556|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
1488557|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
1488558|NCT00822783|IgE|ige
1488559|NCT00822783|IgE depletion|ige depletion
1488560|NCT00822783|atopic dermatitis|atopic dermatitis
1488561|NCT00822783|atopic eczema|atopic eczema
1488562|NCT00822783|Omalizumab|omalizumab
1488563|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
1488564|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
1488565|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
1488566|NCT00822770|Stem Cell Transplantation|stem cell transplantation
1488567|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
1488568|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
1488569|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
1488570|NCT00822770|AML|aml
1488571|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
1488572|NCT00822770|MDS|mds
1488573|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
1488574|NCT00822770|CML|cml
1488575|NCT00822770|Graft Versus Host Disease|graft versus host disease
1488576|NCT00822770|GVHD|gvhd
1488577|NCT00822770|ATG|atg
1488578|NCT00822770|Busulfan|busulfan
1488579|NCT00822770|Busulfex™|busulfex™
1488580|NCT00822770|Myleran®|myleran®
1488581|NCT00822770|Filgrastim|filgrastim
1488582|NCT00822770|Neupogen|neupogen
1488583|NCT00822770|Fludarabine|fludarabine
1488584|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
1488585|NCT00822770|Fludara™|fludara™
1488586|NCT00822770|G-CSF|g-csf
1488587|NCT00822770|Plerixafor|plerixafor
1488588|NCT00822770|Antithymocyte globulin|antithymocyte globulin
1488589|NCT00822770|Thymoglobulin|thymoglobulin
1488590|NCT00822757|study in healthy subjects|study in healthy subjects
1488591|NCT00822744|Depression|depression
1488592|NCT00822744|Major Depressive Episode|major depressive episode
1488593|NCT00822744|Antidepressant|antidepressant
1488594|NCT00822731|Lymphoma|lymphoma
1488595|NCT00822731|prognosis|prognosis
1488596|NCT00822731|morbidity|morbidity
1488597|NCT00822718|obestatin|obestatin
1488598|NCT00822718|ghrelin|ghrelin
1488599|NCT00822718|stomach cancer|stomach cancer
1488600|NCT00822718|distal gastrectomy|distal gastrectomy
1488601|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
1488602|NCT00822692|Abscess|abscess
1488603|NCT00822692|Cellulitis|cellulitis
1488604|NCT00822692|Antibiotics|antibiotics
1488605|NCT00822692|MRSA|mrsa
1488606|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
1488607|NCT00822679|cytokines|cytokines
1488608|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
1488609|NCT00822679|sleep disorders|sleep disorders
1488610|NCT00822666|Platelet aggregation|platelet aggregation
1488611|NCT00822666|Platelet|platelet
1488612|NCT00822666|Thrombosis|thrombosis
1488613|NCT00822666|Clopidogrel|clopidogrel
1488614|NCT00822653|hemodialysis treatment|hemodialysis treatment
1488615|NCT00822653|pump stimulation|pump stimulation
1488616|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
1488617|NCT00822640|Prosthesis Design|prosthesis design
1488618|NCT00822640|Range of Motion, Articular|range of motion, articular
1488619|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1488620|NCT00822627|Influenza|influenza
1488621|NCT00822627|vaccination|vaccination
1488622|NCT00822627|Emergency Department|emergency department
1488623|NCT00822614|Pain|pain
1488624|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1488625|NCT00822601|Supplementary Motor Area|supplementary motor area
1488626|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1488627|NCT00822601|Sham rTMS|sham rtms
1488628|NCT00822601|Placebo-controlled|placebo-controlled
1488629|NCT00822601|Randomized|randomized
1488630|NCT00822601|Double-blind|double-blind
1488631|NCT00822601|fMRI|fmri
1488632|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
1488633|NCT00822575|mosquito bites|mosquito bites
1488634|NCT00822575|itching|itching
1488635|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
1488636|NCT00822562|surgery|surgery
1488637|NCT00822549|Morphine titration|morphine titration
1488638|NCT00822549|Sub acute pain|sub acute pain
1488639|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
1488640|NCT00822549|Pharmacokinetics|pharmacokinetics
1488641|NCT00822549|Pharmacodynamics|pharmacodynamics
1488642|NCT00822549|Genetic polymorphism|genetic polymorphism
1488643|NCT00822549|PACU|pacu
1488644|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
1488645|NCT00822536|Drug-eluting stent|drug-eluting stent
1488646|NCT00822536|Clopidogrel|clopidogrel
1488647|NCT00822536|Stent thrombosis|stent thrombosis
1488648|NCT00822536|Myocardial infarction|myocardial infarction
1488649|NCT00822510|Psychosocial Intervention|psychosocial intervention
1488650|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
1488651|NCT00822497|music therapy|music therapy
1488652|NCT00822497|pain|pain
1488653|NCT00822497|anxiety|anxiety
1488654|NCT00822497|muscle tension|muscle tension
1488655|NCT00822471|Diabetes|diabetes
1488656|NCT00822471|Self-Management Education|self-management education
1488657|NCT00822471|Library|library
1488658|NCT00822471|Emergency Department Visits|emergency department visits
1488659|NCT00822471|African American|african american
1488660|NCT00822471|CVD prevention|cvd prevention
1488661|NCT00822471|Prevention|prevention
1488662|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
1488663|NCT00822445|Biomarker|biomarker
1488664|NCT00822445|S100 protein|s100 protein
1488665|NCT00822445|Traumatic brain injury|traumatic brain injury
1488666|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
1488667|NCT00822445|Neurological sequelae|neurological sequelae
1488668|NCT00822432|biomarkers|biomarkers
1488669|NCT00822432|ABC transporters|abc transporters
1488670|NCT00822432|MRP2|mrp2
1488671|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
1488672|NCT00822419|sternotomy pain|sternotomy pain
1488673|NCT00822406|allergy|allergy
1488674|NCT00822406|rhinitis|rhinitis
1488675|NCT00822406|homeopathy|homeopathy
1488676|NCT00822406|double-blind|double-blind
1488677|NCT00822393|Treosulfan|treosulfan
1488678|NCT00822393|Busulfan|busulfan
1488679|NCT00822393|Conditioning|conditioning
1488680|NCT00822393|Allogeneic|allogeneic
1488681|NCT00822393|Transplantation|transplantation
1488682|NCT00822380|Anemia|anemia
1488683|NCT00822380|Iron|iron
1488684|NCT00822380|Children|children
1488685|NCT00822380|Micronutrients|micronutrients
1488686|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
1488687|NCT00822328|Probiotics|probiotics
1488688|NCT00822328|Lactobacillus|lactobacillus
1488689|NCT00822328|Intestine|intestine
1488690|NCT00822328|Flora|flora
1488692|NCT00822315|Tuberculosis|tuberculosis
1488693|NCT00822315|Pharmacokinetics|pharmacokinetics
1488694|NCT00822315|Raltegravir|raltegravir
1488695|NCT00822315|France|france
1488696|NCT00822315|Brazil|brazil
1488697|NCT00822315|treatment naive|treatment naive
1488698|NCT00822302|atherosclerosis|atherosclerosis
1488699|NCT00822302|stroke|stroke
1488700|NCT00822302|ischaemia|ischaemia
1488701|NCT00822289|radioactive iodine|radioactive iodine
1488702|NCT00822289|Helicobacter pylori|helicobacter pylori
1488703|NCT00822289|Thyroid diseases|thyroid diseases
1488704|NCT00822289|CagA|caga
1488705|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1488706|NCT00822276|MRSA|mrsa
1488707|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
1488708|NCT00822276|MSSA|mssa
1488709|NCT00822276|Atopic Dermatitis|atopic dermatitis
1488710|NCT00822276|Eczema Herpeticum|eczema herpeticum
1488711|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
1488712|NCT00822263|anti-oxidant|anti-oxidant
1488713|NCT00822263|early treatment|early treatment
1488714|NCT00822224|acute pain|acute pain
1488715|NCT00822224|MEOPA|meopa
1488716|NCT00822224|Dementia|dementia
1488717|NCT00822211|Diabetes Mellitus|diabetes mellitus
1488718|NCT00822211|HbA1c reduction|hba1c reduction
1488719|NCT00822211|vildagliptin|vildagliptin
1488720|NCT00822211|add-on to metformin|add-on to metformin
1488721|NCT00822211|Chinese patients|chinese patients
1488722|NCT00822198|peripheral neuropathy|peripheral neuropathy
1488723|NCT00822198|diabetes|diabetes
1488724|NCT00822198|plantar vibration|plantar vibration
1488725|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
1488726|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
1488727|NCT00822172|Intermittent Claudication|intermittent claudication
1488728|NCT00822172|Peak Walking Time|peak walking time
1488729|NCT00822172|Claudication Onset Time|claudication onset time
1488730|NCT00822172|Cilostazol|cilostazol
1488731|NCT00822172|Carnitine|carnitine
1488732|NCT00822159|Fixation failure|fixation failure
1488733|NCT00822159|Bone strength|bone strength
1488734|NCT00822159|DensiProbe|densiprobe
1488736|NCT00822133|ketamine|ketamine
1488737|NCT00822133|preemption|preemption
1488738|NCT00822133|postoperative|postoperative
1488739|NCT00822133|pain|pain
1488740|NCT00822133|safety|safety
1488741|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1488742|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1488743|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1488744|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1488745|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1488746|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1488747|NCT00822120|HIV infection|hiv infection
1488748|NCT00822107|Hypokalemia|hypokalemia
1488749|NCT00822107|Bartter Syndrome|bartter syndrome
1488750|NCT00822107|Salt Wasting|salt wasting
1488751|NCT00822094|Acute|acute
1488752|NCT00822094|Myeloid|myeloid
1488753|NCT00822094|Leukemia|leukemia
1488754|NCT00822094|Adult|adult
1488755|NCT00822094|First|first
1488756|NCT00822094|Relapse|relapse
1488757|NCT00822094|AML|aml
1488758|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
1488759|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
1488760|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1488761|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
1488762|NCT00822068|stroke|stroke
1488764|NCT00822068|rehabilitation|rehabilitation
1488765|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
1488766|NCT00822068|intensive training|intensive training
1488767|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
1488768|NCT00822042|Lipodystrophy|lipodystrophy
1488769|NCT00822042|Adipokines|adipokines
1488770|NCT00822042|Glucocorticoids|glucocorticoids
1488771|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
1488772|NCT00822016|Best Supportive Care|best supportive care
1488773|NCT00822016|Protocol of Standard Practice|protocol of standard practice
1488774|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
1488775|NCT00822003|GLP-1|glp-1
1488776|NCT00822003|insulin|insulin
1488777|NCT00822003|glucose|glucose
1488778|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
1488779|NCT00821977|Type 2 Diabetes|type 2 diabetes
1488780|NCT00821977|Vildagliptin|vildagliptin
1488781|NCT00821964|Breast Cancer|breast cancer
1488782|NCT00821964|Stage IV|stage iv
1488783|NCT00821964|cream|cream
1488784|NCT00821964|topical|topical
1488785|NCT00821938|Narrow QRS|narrow qrs
1488786|NCT00821938|CRT|crt
1488787|NCT00821925|osteoporosis|osteoporosis
1488788|NCT00821899|diabetes type 1|diabetes type 1
1488789|NCT00821899|bone marrow transplantation|bone marrow transplantation
1488790|NCT00821886|Breast Cancer|breast cancer
1488791|NCT00821886|Neoadjuvant|neoadjuvant
1488792|NCT00821886|Ixabepilone|ixabepilone
1488793|NCT00821886|Carboplatin|carboplatin
1488794|NCT00821886|Trastuzumab|trastuzumab
1488795|NCT00821873|Cartilage injury|cartilage injury
1488796|NCT00821873|OATS|oats
1488797|NCT00821873|Knee injury|knee injury
1488798|NCT00821873|allograft|allograft
1488799|NCT00821873|autograft|autograft
1488800|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
1488801|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1488802|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
1488803|NCT00821860|malignant pleural effusion|malignant pleural effusion
1488804|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1488805|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1488806|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
1488807|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
1488808|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
1488809|NCT00821847|HIV|hiv
1488810|NCT00821847|glomerular filtration rate|glomerular filtration rate
1488811|NCT00821847|cockcroft|cockcroft
1488812|NCT00821847|MDRD formula|mdrd formula
1488813|NCT00821847|creatinine|creatinine
1488814|NCT00821847|cystatin C|cystatin c
1488815|NCT00821847|isotopic clearance|isotopic clearance
1488816|NCT00821847|EDTA-51Cr|edta-51cr
1488817|NCT00821847|DEXA scan|dexa scan
1488818|NCT00821834|Old Myocardial infarction|old myocardial infarction
1488819|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1488820|NCT00821834|Angioplasty|angioplasty
1488821|NCT00821834|Transluminal|transluminal
1488822|NCT00821834|Percutaneous Coronary|percutaneous coronary
1488823|NCT00821834|Stents|stents
1488824|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1488825|NCT00821795|insulin|insulin
1488826|NCT00821795|therapy|therapy
1488827|NCT00821782|Bacteria|bacteria
1488828|NCT00821782|Oral flora bacteria|oral flora bacteria
1488829|NCT00821782|Resistance|resistance
1488830|NCT00821756|Suicidal behaviour|suicidal behaviour
1488831|NCT00821756|Attempted suicide|attempted suicide
1488832|NCT00821756|Self harm|self harm
1488833|NCT00821756|Suicide|suicide
1488834|NCT00821756|Health system contacts|health system contacts
1488835|NCT00821756|Contacts with health system|contacts with health system
1488836|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
1488837|NCT00821730|Peer support|peer support
1488838|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
1488839|NCT00821730|Self-management|self-management
1488840|NCT00821730|Patient education|patient education
1488841|NCT00821717|Chronic Heart Failure|chronic heart failure
1488842|NCT00821717|Iron deficiency|iron deficiency
1488843|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
1488844|NCT00821717|Anaemia|anaemia
1488845|NCT00821717|Heart disease|heart disease
1488846|NCT00821691|cerebral infarction|cerebral infarction
1488847|NCT00821678|telemedicine|telemedicine
1488848|NCT00821678|rural|rural
1488849|NCT00821678|veterans|veterans
1488850|NCT00821678|care management|care management
1488851|NCT00821678|psychotherapy|psychotherapy
1488852|NCT00821665|Type 2 diabetes|type 2 diabetes
1488853|NCT00821665|Glycemic control|glycemic control
1488854|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
1488855|NCT00821665|Sucrose|sucrose
1488856|NCT00821652|Tumor|tumor
1488857|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
1488858|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
1488859|NCT00821626|Influenza|influenza
1488860|NCT00821626|Rapid flu test|rapid flu test
1488861|NCT00821626|Returning travelers with fever|returning travelers with fever
1488862|NCT00821600|Risperidone|risperidone
1488863|NCT00821600|Antipsychotic|antipsychotic
1488864|NCT00821600|Pharmacokinetic|pharmacokinetic
1488865|NCT00821600|Long-acting Injectable|long-acting injectable
1488866|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
1488867|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
1488868|NCT00821561|Persistent|persistent
1488869|NCT00821561|cornea|cornea
1488870|NCT00821561|defect|defect
1488871|NCT00821561|Nexagon|nexagon
1488872|NCT00821561|Coda|coda
1488873|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
1488874|NCT00821548|electrostimulation|electrostimulation
1488875|NCT00821548|training|training
1488876|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
1488877|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
1488878|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
1488879|NCT00821522|Acute Kidney Injury|acute kidney injury
1488880|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
1488881|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
1488882|NCT00821509|virus infection|virus infection
1488883|NCT00821509|hygiene|hygiene
1488884|NCT00821509|transmission|transmission
1488885|NCT00821509|intervention|intervention
1488886|NCT00821496|Multiple dose administration|multiple dose administration
1488887|NCT00821496|Oral Contraceptives|oral contraceptives
1488888|NCT00821470|osteonecrosis|osteonecrosis
1488889|NCT00821470|bone marrow|bone marrow
1488890|NCT00821470|core decompression|core decompression
1488891|NCT00821470|femoral head|femoral head
1488892|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
1488893|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
1490026|NCT00817466|treatment|treatment
1488894|NCT00821405|Number : 250~300 patients|number : 250~300 patients
1488895|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
1488896|NCT00821379|PCOS|pcos
1488897|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
1488898|NCT00821379|Pregnancy Complications|pregnancy complications
1488899|NCT00821379|Gestational Diabetes|gestational diabetes
1488900|NCT00821379|Pre eclampsia|pre eclampsia
1488901|NCT00821379|Prediction Model|prediction model
1488902|NCT00821379|Pre conceptional|pre conceptional
1488903|NCT00821366|HIV/AIDS|hiv/aids
1488904|NCT00821366|Food security|food security
1488905|NCT00821366|treatment experienced|treatment experienced
1488906|NCT00821353|Atrial fibrillation|atrial fibrillation
1488907|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1488908|NCT00821353|RF ablation|rf ablation
1488909|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
1488910|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
1488911|NCT00821340|LCA|lca
1488912|NCT00821340|RPE65|rpe65
1488913|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
1488914|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
1488915|NCT00821301|Multiple myeloma|multiple myeloma
1488916|NCT00821288|cancer survivorship|cancer survivorship
1488917|NCT00821288|survivorship prescription|survivorship prescription
1488918|NCT00821288|cancer related anxiety|cancer related anxiety
1488919|NCT00821275|Uterine Artery Embolization|uterine artery embolization
1488920|NCT00821275|Leiomyoma|leiomyoma
1488921|NCT00821275|myomectomy|myomectomy
1488922|NCT00821275|hysterectomy|hysterectomy
1488923|NCT00821275|pregnancy|pregnancy
1488924|NCT00821275|complication|complication
1488925|NCT00821275|ovarian function|ovarian function
1488926|NCT00821275|quality of life|quality of life
1488927|NCT00821262|Sevoflurane|sevoflurane
1488928|NCT00821262|Anesthesia|anesthesia
1488929|NCT00821262|Troponin|troponin
1488930|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
1488931|NCT00821262|Surgery, Cardiac|surgery, cardiac
1488932|NCT00821262|Stents|stents
1488933|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
1488934|NCT00821262|Surgery|surgery
1488935|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
1488936|NCT00821249|plasmacytoma|plasmacytoma
1488937|NCT00821249|kinesin spindle protein|kinesin spindle protein
1488938|NCT00821249|anti-mitotic|anti-mitotic
1488939|NCT00821236|Myopia|myopia
1488940|NCT00821236|LASIK|lasik
1488941|NCT00821236|Astigmatism|astigmatism
1488942|NCT00821236|Laser Vision Correction|laser vision correction
1488943|NCT00821236|Excimer Laser|excimer laser
1488944|NCT00821223|phacoemulsification|phacoemulsification
1488945|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
1488946|NCT00821223|visual acuity|visual acuity
1488947|NCT00821223|contrast sensitivity|contrast sensitivity
1488948|NCT00821223|quality of vision|quality of vision
1488949|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
1488950|NCT00821210|myocardial infarction|myocardial infarction
1488951|NCT00821197|obesity|obesity
1488952|NCT00821197|laparoscopy|laparoscopy
1488953|NCT00821197|bariatric|bariatric
1488954|NCT00821197|super obesity|super obesity
1488955|NCT00821184|urinary incontinence|urinary incontinence
1488956|NCT00821184|overactive bladder|overactive bladder
1488957|NCT00821184|urinary frequency|urinary frequency
1489458|NCT00819234|Symlin|symlin
1488958|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
1488959|NCT00821132|FALS|fals
1488960|NCT00821132|ALS|als
1488961|NCT00821132|ALS/FTD|als/ftd
1488962|NCT00821132|SALS|sals
1488963|NCT00821132|MND|mnd
1488964|NCT00821132|PLS|pls
1488965|NCT00821119|non invasive ventilation|non invasive ventilation
1488966|NCT00821119|mechanical ventilation|mechanical ventilation
1488967|NCT00821119|pulmonary morbidity|pulmonary morbidity
1488968|NCT00821119|preterm infant|preterm infant
1488969|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
1488970|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
1488971|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
1488972|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1488973|NCT00821106|Coronary angiography|coronary angiography
1488974|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
1488975|NCT00821106|Transradial approach|transradial approach
1488976|NCT00821093|respiratory|respiratory
1488977|NCT00821093|dyspnea|dyspnea
1488978|NCT00821093|breathlessness|breathlessness
1488979|NCT00821093|COPD|copd
1488980|NCT00821093|indacaterol|indacaterol
1488981|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
1488982|NCT00821080|vandetanib|vandetanib
1488983|NCT00821080|sirolimus|sirolimus
1488984|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
1488985|NCT00019539|adult solid tumor|adult solid tumor
1488986|NCT00019539|body system/site cancer|body system/site cancer
1488987|NCT00019539|cancer|cancer
1488988|NCT00019539|kidney tumor|kidney tumor
1488989|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
1488990|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
1488991|NCT00019539|renal cell cancer|renal cell cancer
1488992|NCT00019539|solid tumor|solid tumor
1488993|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
1488994|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
1488995|NCT00821054|Phase I Food Effect|phase i food effect
1488996|NCT00821041|insomnia|insomnia
1488997|NCT00821041|online systems|online systems
1488998|NCT00821028|atherosclerosis|atherosclerosis
1488999|NCT00821028|angioplasty|angioplasty
1489000|NCT00821028|peripheral arterial disease|peripheral arterial disease
1489001|NCT00821015|cryoablation|cryoablation
1489002|NCT00821015|recurring arrhythmia|recurring arrhythmia
1489003|NCT00821015|stroke|stroke
1489004|NCT00821015|RF ablation|rf ablation
1489005|NCT00821015|LA ablation|la ablation
1489006|NCT00821015|nodal ablation|nodal ablation
1489007|NCT00821015|catheter ablation|catheter ablation
1489008|NCT00821002|Glaucoma|glaucoma
1489009|NCT00820989|Healthy Immune System|healthy immune system
1489010|NCT00820976|G-CSF|g-csf
1489011|NCT00820976|AML|aml
1489012|NCT00820976|survival|survival
1489013|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
1489014|NCT00820963|adult glioblastoma|adult glioblastoma
1489015|NCT00820963|adult gliosarcoma|adult gliosarcoma
1489016|NCT00820924|HER-2|her-2
1489017|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
1489018|NCT00820924|EGFR|egfr
1489019|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
1489020|NCT00820924|Breast Cancer|breast cancer
1489021|NCT00820911|Kidney transplant|kidney transplant
1489022|NCT00820911|AEB071|aeb071
1489023|NCT00820872|male breast cancer|male breast cancer
1489024|NCT00820872|stage I breast cancer|stage i breast cancer
1489025|NCT00820872|stage II breast cancer|stage ii breast cancer
1489026|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
1489027|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
1489028|NCT00820859|Cognition disorder|cognition disorder
1489029|NCT00820859|nursing home residents|nursing home residents
1489030|NCT00820859|agitation|agitation
1489031|NCT00820859|behavior disorder|behavior disorder
1489032|NCT00820846|HIV Seronegativity|hiv seronegativity
1489033|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
1489034|NCT00820833|infant formula|infant formula
1489035|NCT00820833|obesity|obesity
1489036|NCT00820833|growth|growth
1489037|NCT00820820|Atopic Dermatitis|atopic dermatitis
1489038|NCT00820820|immunosuppression|immunosuppression
1489039|NCT00820820|Measles vaccine|measles vaccine
1489040|NCT00820820|T lymphocytes|t lymphocytes
1489041|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
1489042|NCT00820807|dietary fiber|dietary fiber
1489043|NCT00820807|fiber|fiber
1489044|NCT00820807|insulin sensitivity|insulin sensitivity
1489045|NCT00820807|insulin resistance|insulin resistance
1489046|NCT00820807|glucose metabolism|glucose metabolism
1489047|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
1489048|NCT00820781|bleeding gastric varices|bleeding gastric varices
1489049|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
1489050|NCT00820781|portacaval shunt|portacaval shunt
1489051|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
1489052|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
1489053|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
1489054|NCT00820742|A5751025|a5751025
1489055|NCT00820729|interstitial lung disease|interstitial lung disease
1489056|NCT00820729|pulmonary hypertension|pulmonary hypertension
1489057|NCT00820729|biomarkers|biomarkers
1489058|NCT00820729|NT-pro-BNP|nt-pro-bnp
1489059|NCT00820729|von Willebrand factor|von willebrand factor
1489060|NCT00820729|D-dimer|d-dimer
1489061|NCT00820729|Exhaled NO|exhaled no
1489062|NCT00820729|Troponin-t|troponin-t
1489063|NCT00820716|Asthma|asthma
1489064|NCT00820716|Asthmatic subjects|asthmatic subjects
1489065|NCT00820716|Exercise training|exercise training
1489066|NCT00820716|Constant load|constant load
1489067|NCT00820716|Alternate load|alternate load
1489068|NCT00820703|Nexagon|nexagon
1489069|NCT00820703|CoDa|coda
1489070|NCT00820703|ulcer|ulcer
1489071|NCT00820703|diabetic|diabetic
1489072|NCT00820703|foot|foot
1489073|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1489074|NCT00820690|advanced breast cancer|advanced breast cancer
1489075|NCT00820690|microarray|microarray
1489076|NCT00820690|correlation analysis|correlation analysis
1489077|NCT00820690|oncoplastic surgery|oncoplastic surgery
1489078|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1489079|NCT00820651|Insulinresistance|insulinresistance
1489080|NCT00820651|Diet and exercise|diet and exercise
1489081|NCT00820651|Nutritional supplement|nutritional supplement
1489082|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1489083|NCT00820651|Lifestyle modifications|lifestyle modifications
1489084|NCT00820638|neurorobotics|neurorobotics
1489085|NCT00820638|occupational therapy|occupational therapy
1489086|NCT00820599|Sapien Valve|sapien valve
1489087|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
1489088|NCT00820599|Valvular Heart Disease|valvular heart disease
1489089|NCT00820599|Aortic Stenosis|aortic stenosis
1489090|NCT00820599|Heart Valve Therapy|heart valve therapy
1489091|NCT00820599|Transfemoral|transfemoral
1489092|NCT00820599|Transcatheter|transcatheter
1489093|NCT00820586|Intramyocardial|intramyocardial
1489094|NCT00820586|Autologous|autologous
1489095|NCT00820586|Bone|bone
1489096|NCT00820586|Marrow|marrow
1489097|NCT00820586|Randomized|randomized
1489098|NCT00820586|Percutaneous|percutaneous
1489099|NCT00820586|CD34+|cd34+
1489100|NCT00820586|Refractory|refractory
1489101|NCT00820586|Angina|angina
1489102|NCT00820586|Pectoris.|pectoris.
1489103|NCT00820573|Diabetes|diabetes
1489104|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
1489105|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
1489106|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
1489107|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
1489108|NCT00820547|male breast cancer|male breast cancer
1489109|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
1489110|NCT00820534|cold sore|cold sore
1489111|NCT00820508|Haematological disease|haematological disease
1489112|NCT00820508|Lymphoid malignancy|lymphoid malignancy
1489113|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
1489114|NCT00820508|dose escalation|dose escalation
1489115|NCT00820495|Smokeless tobacco|smokeless tobacco
1489116|NCT00820495|Chewing Tobacco|chewing tobacco
1489117|NCT00820495|Internet|internet
1489118|NCT00820495|Adolescent|adolescent
1489119|NCT00820469|Rituximab|rituximab
1489120|NCT00820469|Plasma exchange|plasma exchange
1489121|NCT00820469|Autoimmune diseases|autoimmune diseases
1489122|NCT00820456|colorectal cancer|colorectal cancer
1489123|NCT00820456|colorectal neoplasm|colorectal neoplasm
1489124|NCT00820456|colorectal neoplasms|colorectal neoplasms
1489125|NCT00820456|metastasis|metastasis
1489126|NCT00820456|metastases|metastases
1489127|NCT00820456|liver|liver
1489128|NCT00820456|hepatic metastasis|hepatic metastasis
1489129|NCT00820456|liver metastasis|liver metastasis
1489130|NCT00820456|perfusion imaging|perfusion imaging
1489131|NCT00820456|MRI|mri
1489132|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
1489133|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
1489134|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
1489135|NCT00820430|osteoarthritis|osteoarthritis
1489136|NCT00820430|knee|knee
1489137|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
1489138|NCT00820430|knee cartilage|knee cartilage
1489139|NCT00820430|reproducibility|reproducibility
1489140|NCT00820417|cetuximab|cetuximab
1489141|NCT00820417|monoclonal|monoclonal
1489142|NCT00820417|antibody|antibody
1489143|NCT00820417|epidermal|epidermal
1489144|NCT00820417|growth|growth
1489145|NCT00820417|factor|factor
1489146|NCT00820417|receptor|receptor
1489147|NCT00820417|EGFR|egfr
1489148|NCT00820417|Gefitinib|gefitinib
1489149|NCT00820417|tyrosine|tyrosine
1489150|NCT00820417|kinase|kinase
1489151|NCT00820417|inhibitor|inhibitor
1489152|NCT00820417|advanced|advanced
1489153|NCT00820417|cancer|cancer
1489154|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
1489155|NCT00820378|Aortic dimension|aortic dimension
1489156|NCT00820378|Atherosclerosis|atherosclerosis
1489157|NCT00820378|Vascular disease|vascular disease
1489158|NCT00820378|Risk factors|risk factors
1489459|NCT00819234|Amylin|amylin
1489159|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1489160|NCT00820365|Crohn's Disease|crohn's disease
1489161|NCT00820365|Ulcerative Colitis|ulcerative colitis
1489162|NCT00820365|SC12267|sc12267
1489163|NCT00820365|4SC-101|4sc-101
1489164|NCT00820365|Phase II|phase ii
1489165|NCT00820352|HFNEF|hfnef
1489166|NCT00820352|HFPEF|hfpef
1489167|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
1489168|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
1489169|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
1489170|NCT00820339|hepatic vein|hepatic vein
1489171|NCT00820339|Surgical resection|surgical resection
1489172|NCT00820339|occlusion|occlusion
1489173|NCT00820339|time to recurrence|time to recurrence
1489174|NCT00820339|overall survival|overall survival
1489175|NCT00820313|Coronary Heart Disease|coronary heart disease
1489176|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
1489177|NCT00820313|Health Related Quality of Life|health related quality of life
1489178|NCT00820313|Diabetes|diabetes
1489179|NCT00820313|Diet|diet
1489180|NCT00820287|Testicular cancer|testicular cancer
1489181|NCT00820287|incidence|incidence
1489182|NCT00820287|young men|young men
1489183|NCT00820261|Genotypes|genotypes
1489184|NCT00820261|Epidemiology|epidemiology
1489185|NCT00820261|Diarrhea|diarrhea
1489186|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1489187|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1489188|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1489189|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1489190|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1489191|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1489192|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1489193|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1567599|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
1489194|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1489195|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1489196|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1489197|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1489198|NCT00820222|ErbB2|erbb2
1489199|NCT00820222|HERCEPTIN|herceptin
1489200|NCT00820222|XELODA|xeloda
1489201|NCT00820222|ErbB1|erbb1
1489202|NCT00820222|TYKERB|tykerb
1489203|NCT00820222|metastatic breast cancer|metastatic breast cancer
1489204|NCT00820222|trastuzumab|trastuzumab
1489205|NCT00820222|breast cancer|breast cancer
1489206|NCT00820222|capecitabine|capecitabine
1489207|NCT00820222|lapatinib|lapatinib
1489208|NCT00820222|brain metastases|brain metastases
1489209|NCT00820222|HER2 positive|her2 positive
1489210|NCT00820222|TYVERB|tyverb
1489211|NCT00820196|Venous ulcer|venous ulcer
1489212|NCT00820196|Nexagon|nexagon
1489213|NCT00820196|CoDa|coda
1489214|NCT00820183|Hypertension|hypertension
1489215|NCT00820183|Intervention|intervention
1489216|NCT00820183|Primary Care|primary care
1489217|NCT00820183|Quality improvement|quality improvement
1489218|NCT00820170|Breast|breast
1489219|NCT00820170|Cancer|cancer
1489220|NCT00820170|DASATINIB|dasatinib
1489221|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1489222|NCT00820170|08-122|08-122
1489223|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1489224|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1489225|NCT00820157|Cytoreductive|cytoreductive
1489226|NCT00820144|immune response|immune response
1489227|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
1489228|NCT00820144|mucosal way|mucosal way
1489229|NCT00820144|healthy volonteers|healthy volonteers
1489230|NCT00820144|vaccine|vaccine
1489231|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
1489232|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
1489233|NCT00820118|treatment naive|treatment naive
1489234|NCT00820105|Migraine|migraine
1489235|NCT00820105|Aura|aura
1489236|NCT00820105|Migraine headache|migraine headache
1489237|NCT00820092|Xerecept|xerecept
1489238|NCT00820092|Pharmacokinetics|pharmacokinetics
1489239|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
1489240|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
1489241|NCT00820079|Heartburn|heartburn
1489242|NCT00820079|Regurgitation|regurgitation
1489243|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
1489244|NCT00820053|adjuvant therapy|adjuvant therapy
1489245|NCT00820053|TACE|tace
1489246|NCT00820053|time to recurrence|time to recurrence
1489247|NCT00820053|overall survival|overall survival
1489248|NCT00820014|ESBA105|esba105
1489249|NCT00820014|scFv antibody fragment|scfv antibody fragment
1489250|NCT00820014|cataract surgery|cataract surgery
1489251|NCT00820014|pharmacokinetics|pharmacokinetics
1489611|NCT00818948|Nephritis|nephritis
1489252|NCT00820014|biodistribution|biodistribution
1489253|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
1489254|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
1489255|NCT00820001|Multimodal Treatment|multimodal treatment
1489256|NCT00820001|Physiological Parameters|physiological parameters
1489257|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
1489258|NCT00820001|Treatment as usual comparison|treatment as usual comparison
1489259|NCT00819988|Postoperative|postoperative
1489260|NCT00819988|Perioperative|perioperative
1489261|NCT00819988|Orthopedic surgery|orthopedic surgery
1489262|NCT00819988|Vascular surgery|vascular surgery
1489263|NCT00819988|Gabapentinoid|gabapentinoid
1489264|NCT00819975|Casein|casein
1489265|NCT00819975|Whey|whey
1489266|NCT00819975|postprandial|postprandial
1489267|NCT00819975|Triglyceride|triglyceride
1489268|NCT00819975|Free fatty acids|free fatty acids
1489269|NCT00819975|Retinyl palmitate|retinyl palmitate
1489270|NCT00819975|Incretins|incretins
1489271|NCT00819975|Type 2 Diabetes|type 2 diabetes
1489272|NCT00819949|Robot|robot
1489273|NCT00819949|Treadmill|treadmill
1489274|NCT00819949|Rehabilitation|rehabilitation
1489275|NCT00819949|Freezing of gait|freezing of gait
1489276|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
1489277|NCT00819936|Physical Training|physical training
1489278|NCT00819936|backward walking|backward walking
1489279|NCT00819936|physiotherapy|physiotherapy
1489280|NCT00819923|Titanium|titanium
1489281|NCT00819923|everolimus|everolimus
1489282|NCT00819923|drug eluting stent|drug eluting stent
1489283|NCT00819923|stent thrombosis|stent thrombosis
1489284|NCT00819923|restenosis|restenosis
1489412|NCT00819429|Social Skills Training|social skills training
1489285|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
1489286|NCT00819923|acute coronary syndrome|acute coronary syndrome
1489287|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
1489288|NCT00819910|Rosiglitazone|rosiglitazone
1642158|NCT00236041|Cancer|cancer
1489289|NCT00819910|Fenofibrate|fenofibrate
1489290|NCT00819897|MS|ms
1489291|NCT00819897|CIS|cis
1489292|NCT00819897|IFN|ifn
1489293|NCT00819897|MRI|mri
1489294|NCT00819897|OCT|oct
1489295|NCT00819897|QOL|qol
1489296|NCT00819884|Type II Diabetes|type ii diabetes
1489297|NCT00819884|24 hour glucose profile|24 hour glucose profile
1489298|NCT00819858|weight loss|weight loss
1489299|NCT00819858|weight gain|weight gain
1489300|NCT00819858|malnutrition|malnutrition
1489301|NCT00819858|convalescence|convalescence
1489302|NCT00819858|malaria|malaria
1489303|NCT00819858|RUTF|rutf
1489304|NCT00819858|RUF|ruf
1489305|NCT00819858|supplementation|supplementation
1489306|NCT00819858|nutrition|nutrition
1489307|NCT00819845|Duchenne|duchenne
1489308|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
1489309|NCT00819845|cardioprotective therapy|cardioprotective therapy
1489310|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
1489311|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
1489312|NCT00819832|vertebral compression fractures|vertebral compression fractures
1489313|NCT00819832|VCF|vcf
1489314|NCT00819832|Spinal|spinal
1489315|NCT00819832|Broken spinal bones|broken spinal bones
1489316|NCT00819832|Kyphoplasty|kyphoplasty
1489317|NCT00819832|vertebroplasty|vertebroplasty
1489318|NCT00819832|Cavity SpineWand|cavity spinewand
1489319|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
1489320|NCT00819832|CTCB|ctcb
1489321|NCT00819832|Spine pain|spine pain
1489322|NCT00819832|Coblation|coblation
1489323|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
1489324|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
1489325|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
1489326|NCT00819832|medical cement|medical cement
1489327|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
1489328|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
1489329|NCT00819793|CentriMag|centrimag
1489330|NCT00819793|Levitronix|levitronix
1489331|NCT00819793|Thoratec Corporation|thoratec corporation
1489332|NCT00819780|Colon Cancer|colon cancer
1489333|NCT00819780|Colorectal Cancer|colorectal cancer
1489334|NCT00819780|Rectal Cancer|rectal cancer
1489335|NCT00819780|Panitumumab|panitumumab
1489336|NCT00819780|Vectibix|vectibix
1489337|NCT00819780|modified FOLFOX 6|modified folfox 6
1489338|NCT00819780|mFOLFOX 6|mfolfox 6
1489339|NCT00819780|FOLFOX|folfox
1489340|NCT00819780|Bevacizumab|bevacizumab
1489341|NCT00819780|Avastin|avastin
1489342|NCT00819780|First-Line|first-line
1489343|NCT00819780|metastatic|metastatic
1489344|NCT00819767|hypertension|hypertension
1489345|NCT00819767|systolic blood pressure|systolic blood pressure
1489346|NCT00819767|exercise test|exercise test
1489347|NCT00819767|cardiovascular disease|cardiovascular disease
1489348|NCT00819767|aliskiren|aliskiren
1489349|NCT00819767|valsartan|valsartan
1489350|NCT00819715|Preterm infants|preterm infants
1489351|NCT00819715|small for gestational age|small for gestational age
1489352|NCT00819715|electrogastrography|electrogastrography
1489612|NCT00818909|Dry eye|dry eye
1489353|NCT00819702|child abuse prevention|child abuse prevention
1489354|NCT00819702|primary care|primary care
1489355|NCT00819702|professional education in primary care|professional education in primary care
1489356|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
1489357|NCT00819650|adjuvant therapy|adjuvant therapy
1489358|NCT00819650|Licartin|licartin
1489359|NCT00819650|time to recurrence|time to recurrence
1489360|NCT00819650|overall survival|overall survival
1489361|NCT00819637|Acute asthma|acute asthma
1489362|NCT00819637|Arformoterol|arformoterol
1489363|NCT00819637|Long acting beta agonists|long acting beta agonists
1489364|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
1489365|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
1489366|NCT00819611|Working memory training|working memory training
1489367|NCT00819611|Placebo|placebo
1489368|NCT00819611|Behavioral symptoms|behavioral symptoms
1489369|NCT00819611|Neuropsychology|neuropsychology
1489370|NCT00819611|Electropsychophysiology|electropsychophysiology
1489371|NCT00819585|Gout|gout
1489372|NCT00819585|Chronic Gout|chronic gout
1489373|NCT00819585|Gouty arthritis|gouty arthritis
1489374|NCT00819585|Gout flares|gout flares
1489375|NCT00819572|Osteoarthritis|osteoarthritis
1489376|NCT00819572|TNF-alpha|tnf-alpha
1489377|NCT00819572|DLX105|dlx105
1489378|NCT00819572|scFv antibody fragment|scfv antibody fragment
1489379|NCT00819572|pain|pain
1489380|NCT00819572|fragment|fragment
1491291|NCT00813176|Thoracic|thoracic
1489381|NCT00819572|antibody fragment|antibody fragment
1489382|NCT00819559|Rectal neoplasm|rectal neoplasm
1489383|NCT00819559|Clinical stage|clinical stage
1489384|NCT00819559|T3N0|t3n0
1489385|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
1489386|NCT00819559|Laparoscopic|laparoscopic
1489387|NCT00819559|Open resection|open resection
1489388|NCT00819546|AML|aml
1489389|NCT00819546|MDS|mds
1489390|NCT00819520|pediculosis capitis|pediculosis capitis
1489391|NCT00819520|pediculus|pediculus
1489392|NCT00819507|Skin barrier|skin barrier
1489393|NCT00819507|Atopic Dermatitis|atopic dermatitis
1489394|NCT00819507|Corticosteroid|corticosteroid
1489395|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
1489396|NCT00819494|Contrast media skin test|contrast media skin test
1489397|NCT00819494|Skin test|skin test
1489398|NCT00819494|hypersensitivity|hypersensitivity
1489399|NCT00819494|contrast media|contrast media
1489400|NCT00819481|Total knee replacement|total knee replacement
1489401|NCT00819455|Diabetes|diabetes
1489402|NCT00819455|Prevention of Diabetes|prevention of diabetes
1489403|NCT00819455|Lifestyle Modification|lifestyle modification
1489404|NCT00819455|Text messages|text messages
1489405|NCT00819442|heart failure|heart failure
1489406|NCT00819442|desmin|desmin
1489407|NCT00819442|ubiquitin|ubiquitin
1489408|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1489409|NCT00819429|Conduct Disorder|conduct disorder
1489410|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
1489411|NCT00819429|Omega 3 Supplements|omega 3 supplements
1489413|NCT00819429|Dietary Intake|dietary intake
1489414|NCT00819429|Aggression|aggression
1489415|NCT00819429|Nutrition|nutrition
1489416|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
1489417|NCT00819416|randomized controlled trial|randomized controlled trial
1489418|NCT00819416|clinical trial|clinical trial
1489419|NCT00819403|triglycerides|triglycerides
1489420|NCT00819403|hypertension|hypertension
1489422|NCT00819403|obesity|obesity
1489423|NCT00819377|Valvular surgery|valvular surgery
1489424|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
1489425|NCT00819364|Autism|autism
1489426|NCT00819364|early intervention|early intervention
1489427|NCT00819364|BCRI model|bcri model
1489428|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1489429|NCT00819351|child|child
1489430|NCT00819351|PEG-Asparaginase|peg-asparaginase
1489431|NCT00819351|EFS|efs
1489432|NCT00819351|efficacy|efficacy
1489433|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1489434|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1489435|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
1489436|NCT00819338|Omega-3|omega-3
1489437|NCT00819325|diabetes|diabetes
1489438|NCT00819325|stents|stents
1489439|NCT00819325|restenosis|restenosis
1489440|NCT00819325|thiazolidinediones|thiazolidinediones
1489441|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
1489442|NCT00819312|Contraceptives,|contraceptives,
1489443|NCT00819312|Oral Hormonal;|oral hormonal;
1489444|NCT00819312|Contraceptive Methods;|contraceptive methods;
1489445|NCT00819312|Female|female
1489446|NCT00819299|Presbyopia|presbyopia
1489447|NCT00819299|accommodation|accommodation
1489448|NCT00819299|near visual acuity|near visual acuity
1489449|NCT00819299|LASIK|lasik
1489450|NCT00819286|open heart surgery|open heart surgery
1489451|NCT00819273|hsCRP|hscrp
1489452|NCT00819260|Mammaplasty|mammaplasty
1489453|NCT00819260|Electrocoagulation|electrocoagulation
1489454|NCT00819260|Breast|breast
1489455|NCT00819234|Leptin|leptin
1489460|NCT00819221|advanced tumors|advanced tumors
1489461|NCT00819221|solid tumors|solid tumors
1489462|NCT00819221|dose escalation|dose escalation
1489463|NCT00819221|combination|combination
1489464|NCT00819221|AZD2281|azd2281
1489465|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
1489466|NCT00819221|pharmacology|pharmacology
1489467|NCT00819221|phase I|phase i
1489468|NCT00819221|multicenter|multicenter
1489469|NCT00819208|fatigue|fatigue
1489470|NCT00819208|sleep disorders|sleep disorders
1489471|NCT00819208|depression|depression
1489472|NCT00819208|anxiety disorder|anxiety disorder
1489473|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1489474|NCT00819208|cognitive/functional effects|cognitive/functional effects
1489475|NCT00819208|stage II colon cancer|stage ii colon cancer
1489476|NCT00819208|stage III colon cancer|stage iii colon cancer
1489477|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
1489478|NCT00819195|relapsing-remitting|relapsing-remitting
1489479|NCT00819195|multiple sclerosis|multiple sclerosis
1489480|NCT00819195|Copaxone|copaxone
1489481|NCT00819195|glatiramer acetate|glatiramer acetate
1489482|NCT00819195|MS|ms
1489483|NCT00819182|Menopause|menopause
1489484|NCT00819182|Breast Cancer|breast cancer
1489485|NCT00819182|Hot Flash|hot flash
1489486|NCT00819182|Night Sweats|night sweats
1489487|NCT00819169|AMG 655|amg 655
1489488|NCT00819169|AMG 479|amg 479
1489489|NCT00819169|Apoptosis|apoptosis
1489490|NCT00819169|Monoclonal Antibody|monoclonal antibody
1489491|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
1489492|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
1489493|NCT00819143|Tissue Procurement|tissue procurement
1489494|NCT00819143|Sample Collection|sample collection
1489495|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1489496|NCT00819143|Laboratory Research|laboratory research
1489497|NCT00819117|Epicardial leads|epicardial leads
1489498|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1489499|NCT00819104|Primary hypertension|primary hypertension
1489500|NCT00819104|Metoprolol XL|metoprolol xl
1489501|NCT00819104|Amlodipine|amlodipine
1489502|NCT00819078|adolescent|adolescent
1489503|NCT00819078|bupropion|bupropion
1489504|NCT00819078|smoking|smoking
1489505|NCT00819078|cessation|cessation
1489506|NCT00819078|depression|depression
1489507|NCT00819065|Botulinum toxin A|botulinum toxin a
1489508|NCT00819065|Spasticity|spasticity
1489509|NCT00819065|Randomized Clinical Trial|randomized clinical trial
1489510|NCT00819000|Specialty Pharmacy|specialty pharmacy
1489511|NCT00819000|Therapy Management|therapy management
1489512|NCT00819000|Medication Compliance|medication compliance
1489513|NCT00819000|Medication Adherence|medication adherence
1489514|NCT00819000|Medication Persistence|medication persistence
1489515|NCT00819000|Health Outcomes|health outcomes
1489516|NCT00818987|Operative|operative
1489517|NCT00818987|Non operative|non operative
1489518|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1489519|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1489520|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1489521|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
1489522|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1489523|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1489524|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1489525|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
1489526|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1489527|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1489528|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1489529|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1489530|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1489531|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1489532|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1489533|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1489534|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1489535|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1489536|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1489537|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1489538|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1489539|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1489540|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1489541|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1489542|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
1489543|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
1489544|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
1489545|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
1489546|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
1489547|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
1489548|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1489549|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1489550|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
1489551|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
1489552|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
1489553|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
1489554|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
1489555|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
1489556|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
1489557|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
1489558|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
1489559|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1489560|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1489561|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1489562|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1489563|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1489564|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1489565|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1489566|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1489567|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1489568|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
1489569|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
1489570|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
1489571|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
1489572|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
1489573|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
1489574|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
1489575|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
1489576|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
1489577|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1489578|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1489579|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1489580|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1489581|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1489582|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1489583|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1489584|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1489585|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1489586|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1489587|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1489588|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1489589|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1489590|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1489591|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1489592|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1489593|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1489594|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1489595|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1489596|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1489597|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1489598|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
1489599|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1489600|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1489601|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1489602|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1489603|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1489604|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1489605|NCT00818961|de novo MDS|de novo mds
1489606|NCT00818961|previously treated MDS|previously treated mds
1489607|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1489608|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1489609|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
1489610|NCT00818948|Lupus|lupus
1489613|NCT00818909|Systane|systane
1489614|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
1489615|NCT00818896|thyroid deficiency|thyroid deficiency
1489616|NCT00818896|pregnancy|pregnancy
1489617|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
1489618|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
1489619|NCT00818883|Essential Hypertension|essential hypertension
1489620|NCT00818883|Hypertensive|hypertensive
1489621|NCT00818883|Blood Pressure, High|blood pressure, high
1489622|NCT00818883|Vascular Disease|vascular disease
1489623|NCT00818883|Cardiovascular Disease|cardiovascular disease
1489624|NCT00818883|Drug Therapy|drug therapy
1489625|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
1489626|NCT00818870|GERD|gerd
1489627|NCT00818870|Nocturnal GERD|nocturnal gerd
1489628|NCT00818870|Heartburn|heartburn
1489629|NCT00818870|Nighttime Heartburn|nighttime heartburn
1489630|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
1489631|NCT00818857|cancer screening|cancer screening
1489632|NCT00818857|screening disparities|screening disparities
1489633|NCT00818857|underserved populations|underserved populations
1489634|NCT00818844|Nepafenac|nepafenac
1489635|NCT00818844|vitrectomy surgery|vitrectomy surgery
1489636|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
1489637|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
1489638|NCT00818818|Leishmaniasis|leishmaniasis
1489639|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
1489640|NCT00818818|Leishmania braziliensis|leishmania braziliensis
1489641|NCT00818818|Pentavalent antimonial|pentavalent antimonial
1489642|NCT00818818|Glucantime|glucantime
1489643|NCT00818805|conjunctivitis|conjunctivitis
1489644|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
1489645|NCT00818792|Drug-eluting stent|drug-eluting stent
1489646|NCT00818792|Chronic kidney disease|chronic kidney disease
1489647|NCT00818792|Restenosis|restenosis
1489648|NCT00818779|diabetes|diabetes
1489649|NCT00818779|heart disease|heart disease
1489650|NCT00818779|atherosclerosis|atherosclerosis
1489651|NCT00818766|Thoracic Surgery|thoracic surgery
1489652|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
1489653|NCT00818766|Chest Tube|chest tube
1489654|NCT00818727|Bone density|bone density
1489655|NCT00818727|SSRI|ssri
1489656|NCT00818727|newborn infants|newborn infants
1489657|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
1489658|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
1489659|NCT00818701|Congestive Heart Failure|congestive heart failure
1489660|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
1489661|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
1489662|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
1489663|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
1489664|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
1489665|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
1489666|NCT00818662|Alzheimer´s|alzheimer´s
1489667|NCT00818662|Dementia|dementia
1489668|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
1489669|NCT00818662|Immunoglobulins|immunoglobulins
1489670|NCT00818662|Gammaglobulins|gammaglobulins
1489671|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
1489672|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
1489673|NCT00818662|Antibodies|antibodies
1489674|NCT00818662|Amyloid|amyloid
1489675|NCT00818662|Immunotherapy|immunotherapy
1489676|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1489677|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1489678|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1489679|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
1489680|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1489681|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1489682|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1489683|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1489684|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1489685|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1489686|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1489687|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1489688|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1489689|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1489690|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1489691|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1489692|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1489693|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1489694|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1489695|NCT00818636|expressive writing|expressive writing
1489696|NCT00818636|ruminating|ruminating
1489697|NCT00818636|ruminative thinking|ruminative thinking
1489698|NCT00818636|experiential avoidance|experiential avoidance
1489699|NCT00818636|depression|depression
1489700|NCT00818636|alcohol|alcohol
1489701|NCT00818636|drinking|drinking
1489702|NCT00818636|emotional processing|emotional processing
1489703|NCT00818610|Community-acquired infections|community-acquired infections
1489704|NCT00818610|Pneumonia|pneumonia
1489705|NCT00818610|Clinical Stability|clinical stability
1489706|NCT00818610|Antibiotics|antibiotics
1489707|NCT00818610|Combination therapy|combination therapy
1489708|NCT00818610|Atypical bacteria|atypical bacteria
1489709|NCT00818597|septic shock|septic shock
1489710|NCT00818597|immunoparalysis|immunoparalysis
1489711|NCT00818597|extracorporeal|extracorporeal
1489712|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
1489713|NCT00818597|plasmapheresis|plasmapheresis
1489714|NCT00818584|Micafungin|micafungin
1489715|NCT00818584|Candida|candida
1489716|NCT00818584|Neonates|neonates
1489717|NCT00818584|Mycamine|mycamine
1489718|NCT00818584|FK463|fk463
1489719|NCT00818571|Renal impairment|renal impairment
1489720|NCT00818571|Diabetes|diabetes
1489721|NCT00818571|vildagliptin|vildagliptin
1489722|NCT00818571|Galvus|galvus
1489723|NCT00818571|Eucreas|eucreas
1489724|NCT00818558|non small cell lung cancer|non small cell lung cancer
1489725|NCT00818545|aging|aging
1489726|NCT00818545|barrier function|barrier function
1489727|NCT00818545|transcriptomic|transcriptomic
1489728|NCT00818532|Corneal astigmatism|corneal astigmatism
1489729|NCT00818532|Low diopter|low diopter
1489730|NCT00818532|Corneal measurement|corneal measurement
1489731|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
1489732|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
1489733|NCT00818519|Oral contraceptive|oral contraceptive
1489734|NCT00818519|Female|female
1489735|NCT00818506|Depression|depression
1489736|NCT00818506|Major depressive disorder|major depressive disorder
1489737|NCT00818506|Coronary artery disease|coronary artery disease
1489738|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
1489739|NCT00818506|White Matter Lesions|white matter lesions
1489740|NCT00818506|Coronary artery calcification|coronary artery calcification
1489741|NCT00818493|total knee arthroplasty|total knee arthroplasty
1489742|NCT00818493|total hip arthroplasty|total hip arthroplasty
1489743|NCT00818480|prostate cancer|prostate cancer
1489744|NCT00818480|melanoma|melanoma
1489745|NCT00818480|lymphoma|lymphoma
1489746|NCT00818480|YM155|ym155
1489747|NCT00818467|Skin tone|skin tone
1489748|NCT00818467|Vitamin D|vitamin d
1489749|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
1489750|NCT00818428|Phonological Awareness|phonological awareness
1489751|NCT00818428|Speech Articulation Disorder|speech articulation disorder
1489752|NCT00818428|Development Articulation Disorder|development articulation disorder
1489753|NCT00818428|Phonological Impairment|phonological impairment
1489754|NCT00818428|Dyslexia|dyslexia
1489755|NCT00818428|Speech Therapy|speech therapy
1489756|NCT00818428|School Transition|school transition
1489757|NCT00818402|Quality of life|quality of life
1489758|NCT00818402|symptoms|symptoms
1489759|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1489761|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
1489762|NCT00818389|riluzole|riluzole
1489763|NCT00818389|lithium|lithium
1489764|NCT00818389|neurodegeneration|neurodegeneration
1489765|NCT00818376|Chlorhexidine|chlorhexidine
1489766|NCT00818376|adverse effects|adverse effects
1489767|NCT00818376|staining|staining
1489768|NCT00818376|dental calculus|dental calculus
1489769|NCT00818376|dental plaque|dental plaque
1489770|NCT00818363|Postoperative pain|postoperative pain
1489771|NCT00818363|shoulder surgery|shoulder surgery
1489772|NCT00818363|opioid|opioid
1489773|NCT00818311|Light emitting diode|light emitting diode
1489774|NCT00818311|tolerance|tolerance
1489775|NCT00818311|photomodulation|photomodulation
1489776|NCT00818298|schizophrenia|schizophrenia
1489777|NCT00818298|schizoaffective disorder|schizoaffective disorder
1489778|NCT00818298|PET Scan|pet scan
1489779|NCT00818298|ziprasidone|ziprasidone
1489780|NCT00818298|dopamine|dopamine
1489781|NCT00818298|D2|d2
1489782|NCT00818298|receptor|receptor
1489783|NCT00818298|antagonist|antagonist
1489784|NCT00818298|occupancy|occupancy
1489785|NCT00818298|dissociation|dissociation
1489786|NCT00818298|affinity|affinity
1489787|NCT00818298|constant|constant
1489788|NCT00818298|Ki|ki
1489789|NCT00818298|ligand|ligand
1489790|NCT00818298|raclopride|raclopride
1489791|NCT00818298|half-life|half-life
1489792|NCT00818298|striatal|striatal
1489793|NCT00818298|plasma dynamics|plasma dynamics
1489794|NCT00818298|central dynamics|central dynamics
1489795|NCT00818298|plasma drug level|plasma drug level
1489796|NCT00818298|compliance|compliance
1489797|NCT00818298|antipsychotic|antipsychotic
1489798|NCT00818298|pharmacotherapy|pharmacotherapy
1489799|NCT00818298|twice daily dosing|twice daily dosing
1489800|NCT00818298|BID dosing|bid dosing
1489801|NCT00818298|once daily dosing|once daily dosing
1489802|NCT00818298|od dosing|od dosing
1489803|NCT00818298|qd dosing|qd dosing
1489804|NCT00818298|dosing schedule|dosing schedule
1489805|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
1489806|NCT00818233|variability|variability
1489807|NCT00818233|pulse amplitude|pulse amplitude
1489808|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
1489809|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
1489810|NCT00818220|sepsis|sepsis
1489811|NCT00818220|motor function|motor function
1489812|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
1489813|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
1489814|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
1489815|NCT00818207|Smoking cessation|smoking cessation
1489816|NCT00818207|quit rates|quit rates
1489817|NCT00818207|reimbursement|reimbursement
1489818|NCT00818207|drug coverage|drug coverage
1489819|NCT00818207|effectiveness|effectiveness
1489820|NCT00818207|cost-effectiveness|cost-effectiveness
1489821|NCT00818207|health policy|health policy
1489822|NCT00818207|drug utilization|drug utilization
1489823|NCT00818207|adherence|adherence
1489824|NCT00818207|urine cotinine.|urine cotinine.
1489825|NCT00818194|Tacrolimus|tacrolimus
1489826|NCT00818194|cyclosporine A|cyclosporine a
1489827|NCT00818194|renal plasma flow|renal plasma flow
1489828|NCT00818194|glomerular filtration rate|glomerular filtration rate
1489829|NCT00818194|human|human
1489830|NCT00818194|pharmacodynamics|pharmacodynamics
1489831|NCT00818194|pharmacokinetics|pharmacokinetics
1489832|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
1489833|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
1489834|NCT00818129|Phase I|phase i
1489835|NCT00818129|Japan|japan
1489836|NCT00818129|Japanese|japanese
1489837|NCT00818129|oral solution|oral solution
1489838|NCT00818116|Cataract|cataract
1489839|NCT00818116|visual acuity|visual acuity
1489840|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
1489841|NCT00818116|Bilateral cataract|bilateral cataract
1489842|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
1489843|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
1489844|NCT00818090|paclitaxel|paclitaxel
1489845|NCT00818090|cisplatin|cisplatin
1489846|NCT00818090|thymic carcinoma|thymic carcinoma
1489847|NCT00818090|invasive thymoma|invasive thymoma
1489848|NCT00818051|stage IA breast cancer|stage ia breast cancer
1489849|NCT00818051|stage IB breast cancer|stage ib breast cancer
1489850|NCT00818051|stage II breast cancer|stage ii breast cancer
1489851|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
1489852|NCT00818038|RRMS|rrms
1489853|NCT00818038|Relapsing Remitting|relapsing remitting
1489854|NCT00818038|MS|ms
1489855|NCT00818025|Transplantation|transplantation
1489856|NCT00818025|Self-care agency|self-care agency
1489857|NCT00818025|Self-care behaviors|self-care behaviors
1489858|NCT00818025|Hand-held device|hand-held device
1489859|NCT00818012|atrial fibrillation|atrial fibrillation
1489860|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
1489861|NCT00818012|direct current cardioversion|direct current cardioversion
1489862|NCT00818012|pulse wave velocity|pulse wave velocity
1489863|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
1489864|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
1489865|NCT00817973|Whey protein|whey protein
1489866|NCT00817973|gluten|gluten
1489867|NCT00817973|casein|casein
1489868|NCT00817973|cod protein|cod protein
1489869|NCT00817973|GLP-1|glp-1
1489870|NCT00817973|postprandial|postprandial
1489871|NCT00817973|triglyceride|triglyceride
1489872|NCT00817973|free fatty acids|free fatty acids
1489873|NCT00817973|chylomicrons|chylomicrons
1489874|NCT00817973|retinyl palmitate|retinyl palmitate
1489875|NCT00817973|type 2 diabetes|type 2 diabetes
1489876|NCT00817973|GIP|gip
1489877|NCT00817973|Postprandial incretins|postprandial incretins
1489878|NCT00817960|Dual tasking|dual tasking
1489879|NCT00817960|Postural Control|postural control
1489880|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
1489881|NCT00817960|old adults|old adults
1489882|NCT00817947|Airway clearance|airway clearance
1489883|NCT00817947|Cystic fibrosis|cystic fibrosis
1489884|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
1489885|NCT00817934|Efficacy|efficacy
1489886|NCT00817934|patient's tolerance|patient's tolerance
1489887|NCT00817934|patient's safety|patient's safety
1489888|NCT00817921|premature renal function|premature renal function
1489889|NCT00817921|ibuprofen|ibuprofen
1489890|NCT00817921|blood pressure|blood pressure
1489891|NCT00817921|Renal function|renal function
1489892|NCT00817908|liver transplant|liver transplant
1489893|NCT00817908|lung transplant|lung transplant
1489894|NCT00817908|kidney transplant|kidney transplant
1489895|NCT00817908|heart transplant|heart transplant
1489896|NCT00817908|CMV CMI|cmv cmi
1489897|NCT00817908|Transplant|transplant
1489898|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
1489899|NCT00817895|liver resection|liver resection
1489900|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
1489901|NCT00817882|vocational|vocational
1489902|NCT00817882|rehabilitation|rehabilitation
1489903|NCT00817882|work|work
1489904|NCT00817882|ability|ability
1489905|NCT00817882|low back pain|low back pain
1489906|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
1489907|NCT00817869|Health Services for the Aged|health services for the aged
1489908|NCT00817869|Fractures, bone|fractures, bone
1489909|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
1489910|NCT00817869|Frail Elderly|frail elderly
1489911|NCT00817869|Aged, 80 and over|aged, 80 and over
1489912|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
1489913|NCT00817843|Metabolic syndrome|metabolic syndrome
1489914|NCT00817843|Endothelial function|endothelial function
1489915|NCT00817843|Flow mediated dilatation|flow mediated dilatation
1489916|NCT00817843|EndoPAT|endopat
1489917|NCT00817843|Simvastatin|simvastatin
1489918|NCT00817843|Ezetimibe|ezetimibe
1489919|NCT00817830|Coronaropathy|coronaropathy
1489920|NCT00817830|lodenafil carbonate|lodenafil carbonate
1489921|NCT00817830|Erectile dysfunction|erectile dysfunction
1489922|NCT00817830|Treatment|treatment
1489923|NCT00817830|QT interval|qt interval
1489924|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1489925|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
1489926|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
1489927|NCT00817830|Cardiovascular test|cardiovascular test
1489928|NCT00817804|noninvasive ventilation|noninvasive ventilation
1489929|NCT00817791|CABG|cabg
1489930|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
1489931|NCT00817791|preconditioning|preconditioning
1489932|NCT00817791|S100B|s100b
1489933|NCT00817791|NSE|nse
1489934|NCT00817791|Troponin I|troponin i
1489935|NCT00817791|CABG surgery|cabg surgery
1489936|NCT00817791|neuroprotection|neuroprotection
1489937|NCT00817778|Type II Diabetes|type ii diabetes
1489938|NCT00817765|interaction|interaction
1489939|NCT00817765|pharmacokinetics|pharmacokinetics
1489940|NCT00817765|boosting|boosting
1489941|NCT00817765|drug-drug interaction|drug-drug interaction
1489942|NCT00817765|safety|safety
1489943|NCT00817752|stress|stress
1489944|NCT00817752|inflammation|inflammation
1489945|NCT00817752|natural remedy|natural remedy
1489946|NCT00817752|cytokines|cytokines
1489947|NCT00817752|interleukin|interleukin
1489948|NCT00817752|inflammatory conditions|inflammatory conditions
1489949|NCT00817752|auto-immune disorders|auto-immune disorders
1489950|NCT00817739|Drug therapy|drug therapy
1489951|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
1489952|NCT00817726|Parkinson's Disease|parkinson's disease
1489953|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
1489954|NCT00817726|Atypical Parkinson's|atypical parkinson's
1489955|NCT00817726|RBD|rbd
1489956|NCT00817726|PD|pd
1489957|NCT00817726|fMRI|fmri
1489958|NCT00817726|PSP|psp
1489959|NCT00817726|MSA|msa
1489960|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
1489961|NCT00817713|Helminthiasis|helminthiasis
1489962|NCT00817713|treatment naive|treatment naive
1489963|NCT00817713|co-infection|co-infection
1489964|NCT00817713|immune modulation|immune modulation
1489965|NCT00817700|Sleep|sleep
1489966|NCT00817700|young adults|young adults
1489967|NCT00817700|middle-age adults|middle-age adults
1489968|NCT00817700|older adults|older adults
1489969|NCT00817674|CKD|ckd
1489970|NCT00817674|Kidney Disease|kidney disease
1489971|NCT00817674|poor sleep|poor sleep
1489972|NCT00817674|CKD progression|ckd progression
1489973|NCT00817661|vitamin A|vitamin a
1489974|NCT00817661|influenza vaccine|influenza vaccine
1489975|NCT00817661|passive immunity|passive immunity
1489976|NCT00817661|pregnant mothers|pregnant mothers
1489977|NCT00817661|vitamin A suplementation|vitamin a suplementation
1489978|NCT00817661|Influenza vaccination|influenza vaccination
1489979|NCT00817661|Infant immune responses|infant immune responses
1489980|NCT00817648|schizophrenia|schizophrenia
1489981|NCT00817648|antipsychotics|antipsychotics
1489982|NCT00817648|quetiapine|quetiapine
1489983|NCT00817648|risperidone|risperidone
1489984|NCT00817648|efficacy|efficacy
1489985|NCT00817648|safety|safety
1489986|NCT00817648|multicenter|multicenter
1489987|NCT00817648|rater-blind|rater-blind
1489988|NCT00817648|randomized|randomized
1489989|NCT00817648|chinese|chinese
1489990|NCT00817648|han|han
1489991|NCT00817635|Blood Pressure|blood pressure
1489992|NCT00817635|Hypertension|hypertension
1489993|NCT00817635|Resistant Hypertension|resistant hypertension
1489994|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
1489995|NCT00817622|EPA|epa
1489996|NCT00817622|leptin|leptin
1489997|NCT00817622|adiponectin|adiponectin
1489998|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
1489999|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
1490000|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
1490001|NCT00817583|NPC|npc
1490002|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1490003|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
1490004|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
1490005|NCT00817557|Contact lenses|contact lenses
1490006|NCT00817557|Loteprednol|loteprednol
1490007|NCT00817557|Effect on CL dryness|effect on cl dryness
1490008|NCT00817544|3098004|3098004
1490009|NCT00817544|Healthy volunteers|healthy volunteers
1490010|NCT00817531|Breast Cancer|breast cancer
1490011|NCT00817505|Type I diabetes|type i diabetes
1490012|NCT00817505|bioavailability|bioavailability
1490013|NCT00817492|Sleep|sleep
1490014|NCT00817492|CKD|ckd
1490015|NCT00817492|kidney|kidney
1490016|NCT00817492|PSG|psg
1490017|NCT00817492|polysomnography|polysomnography
1490018|NCT00817492|Decreased sleep time|decreased sleep time
1490019|NCT00817492|Decreased sleep quality|decreased sleep quality
1490020|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
1567600|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
1643245|NCT00230607|GL3|gl3
1490021|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
1490022|NCT00817466|bronchiolitis|bronchiolitis
1490023|NCT00817466|infants|infants
1490024|NCT00817466|racemic adrenaline|racemic adrenaline
1490025|NCT00817466|inhalations|inhalations
1490027|NCT00817453|Parkinson's Disease|parkinson's disease
1490028|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
1490029|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
1490030|NCT00817427|Chronic Kidney Disease|chronic kidney disease
1490031|NCT00817427|Poor sleep|poor sleep
1490032|NCT00817427|CKD|ckd
1490033|NCT00817427|Kidney Failure|kidney failure
1490034|NCT00817414|Blood Pressure|blood pressure
1490035|NCT00817414|Hypertension|hypertension
1490036|NCT00817414|Cortisol|cortisol
1490037|NCT00817401|asphyxia|asphyxia
1490038|NCT00817401|hypothermia|hypothermia
1490039|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1490040|NCT00817401|neonates|neonates
1490041|NCT00817388|Interstitial cystitis|interstitial cystitis
1490042|NCT00817388|pelvic pain|pelvic pain
1490043|NCT00817375|Pharmacogenomics|pharmacogenomics
1490044|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
1490045|NCT00817375|Depressed Patients|depressed patients
1490046|NCT00817362|Breast Cancer|breast cancer
1490047|NCT00817362|Advanced Breast Cancer|advanced breast cancer
1490048|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
1490049|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
1490050|NCT00817362|Cancer of the breast|cancer of the breast
1490051|NCT00817362|Trastuzumab|trastuzumab
1490052|NCT00817362|Herceptin|herceptin
1490053|NCT00817349|Angio-Seal|angio-seal
1490054|NCT00817349|Peripheral vascular disease|peripheral vascular disease
1490055|NCT00817349|Vascular closure device|vascular closure device
1490056|NCT00817349|Arterial closure|arterial closure
1490057|NCT00817349|Coronary artery disease|coronary artery disease
1490058|NCT00817349|Arterial hemostasis|arterial hemostasis
1490059|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
1490060|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
1490061|NCT00817349|Interventional catheterization|interventional catheterization
1490062|NCT00817349|Diagnostic catheterization|diagnostic catheterization
1490063|NCT00817349|Common femoral artery|common femoral artery
1490064|NCT00817349|Manual compression|manual compression
1490065|NCT00817349|Vascular intervention|vascular intervention
1490066|NCT00817349|Angiogram|angiogram
1490067|NCT00817349|Coronary intervention|coronary intervention
1490068|NCT00817349|Coronary angioplasty|coronary angioplasty
1490069|NCT00817349|Angiography|angiography
1490070|NCT00817349|Arteriotomy|arteriotomy
1490071|NCT00817349|Vascular access|vascular access
1490072|NCT00817336|biomarker|biomarker
1490073|NCT00817336|EEG|eeg
1490074|NCT00817336|schizophrenia|schizophrenia
1490075|NCT00817336|NMDA|nmda
1490076|NCT00817336|D-serine|d-serine
1490077|NCT00817323|bipolar depression|bipolar depression
1490078|NCT00817323|atypical antipsychotic|atypical antipsychotic
1490079|NCT00817323|remission|remission
1490080|NCT00817323|depletion|depletion
1490081|NCT00817323|mood|mood
1490082|NCT00817297|noninvasive ventilation|noninvasive ventilation
1490083|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
1490084|NCT00817284|Performance status 0-2.|performance status 0-2.
1490085|NCT00817271|Type II Diabetes|type ii diabetes
1490086|NCT00817271|Counter-regulatory response|counter-regulatory response
1490087|NCT00817271|Hypoglycemia|hypoglycemia
1490088|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
1490089|NCT00817258|NPC|npc
1490090|NCT00817258|radiation therapy|radiation therapy
1490091|NCT00817258|chemotherapy|chemotherapy
1490092|NCT00817245|CSR|csr
1490093|NCT00817245|Helicobacter pylori|helicobacter pylori
1490094|NCT00817232|tennis elbow|tennis elbow
1490095|NCT00817232|microcurrent|microcurrent
1490096|NCT00817232|tissue healing|tissue healing
1490097|NCT00817206|kidney transplantation|kidney transplantation
1490098|NCT00817206|renal transplantation|renal transplantation
1490099|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
1490100|NCT00817206|tacrolimus|tacrolimus
1490101|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
1490102|NCT00817193|Clinical trial|clinical trial
1490103|NCT00817193|Short Physical Performance Battery|short physical performance battery
1490104|NCT00817193|Disability|disability
1490105|NCT00817193|Senior Housing|senior housing
1490106|NCT00817193|Aging|aging
1490107|NCT00817180|physiotherapy|physiotherapy
1490108|NCT00817180|airway clearance techniques|airway clearance techniques
1490109|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
1490110|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
1490111|NCT00817180|vest|vest
1490112|NCT00817167|Known or suspected lung disease|known or suspected lung disease
1643342|NCT00230061|HIV|hiv
1490113|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
1490114|NCT00817154|Older persons with SMI|older persons with smi
1490115|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
1490116|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
1490117|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
1490118|NCT00817128|Pharmacological treatment|pharmacological treatment
1491391|NCT00812877|MTA|mta
1490119|NCT00817128|Functional recovery|functional recovery
1490120|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
1490121|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
1490122|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
1490123|NCT00817115|Radiation Dosage|radiation dosage
1490124|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
1490125|NCT00817115|Radiography, Interventional|radiography, interventional
1490126|NCT00817102|coronary artery stenoses|coronary artery stenoses
1490127|NCT00817063|retinoid treatment|retinoid treatment
1490128|NCT00817063|fingertip dermatitis|fingertip dermatitis
1490129|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
1490130|NCT00817063|vesicular hand eczema|vesicular hand eczema
1490131|NCT00817063|pompholyx|pompholyx
1490132|NCT00817037|Chronic kidney disease|chronic kidney disease
1490133|NCT00817037|Proteinuria|proteinuria
1490134|NCT00817037|Blood pressure|blood pressure
1490135|NCT00817037|Arterial stiffness|arterial stiffness
1490136|NCT00817037|Endothelin antagonist|endothelin antagonist
1490137|NCT00817037|Sitaxsentan|sitaxsentan
1490138|NCT00817024|Coronary Heart Disease|coronary heart disease
1490139|NCT00817024|PCI|pci
1490140|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
1490141|NCT00817024|Quality of Life|quality of life
1490142|NCT00817011|depression|depression
1490143|NCT00817011|pharmacogenomics|pharmacogenomics
1490144|NCT00817011|antidepressant response|antidepressant response
1490145|NCT00817011|biological markers|biological markers
1490146|NCT00817011|clinical variables|clinical variables
1490147|NCT00816998|Radius fractures|radius fractures
1490148|NCT00816985|Female|female
1490149|NCT00816985|Lymphedema|lymphedema
1490150|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
1490151|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
1490152|NCT00816946|malnutrition|malnutrition
1490153|NCT00816946|growth|growth
1490154|NCT00816933|pain|pain
1490155|NCT00816933|operative times|operative times
1490156|NCT00816933|complication|complication
1490157|NCT00816933|time to return for normal life|time to return for normal life
1490158|NCT00816933|pain using VAS score|pain using vas score
1490159|NCT00816920|distal DVT|distal dvt
1490160|NCT00816920|calf DVT|calf dvt
1490161|NCT00816920|DVT diagnosis|dvt diagnosis
1490162|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
1490163|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
1490164|NCT00816894|schizophrenia|schizophrenia
1490165|NCT00816894|treatment resistance|treatment resistance
1490166|NCT00816894|D-serine|d-serine
1490167|NCT00816894|Olanzapine|olanzapine
1490168|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
1490169|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1490170|NCT00816881|flutter|flutter
1490171|NCT00816881|airway clearance|airway clearance
1490172|NCT00816881|sputum|sputum
1490173|NCT00816881|Physical Therapy Techniques|physical therapy techniques
1490174|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
1490175|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
1490176|NCT00816855|NPC|npc
1490177|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1490178|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
1490179|NCT00816842|citrulline|citrulline
1490180|NCT00816842|malabsorption|malabsorption
1490181|NCT00816842|Villous atrophy|villous atrophy
1490182|NCT00816842|enteropathy|enteropathy
1490183|NCT00816829|Dyslipidemia|dyslipidemia
1490184|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
1490185|NCT00816829|Fenofibrate|fenofibrate
1490186|NCT00816829|Obese|obese
1490187|NCT00816829|Overweight or obese patients|overweight or obese patients
1490188|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
1490189|NCT00816816|NPC|npc
1491263|NCT00813254|Ovary|ovary
1490190|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1490191|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
1490192|NCT00816803|Spinal cord injury|spinal cord injury
1490193|NCT00816790|Septic shock|septic shock
1490194|NCT00816790|Acute Renal Failure|acute renal failure
1490195|NCT00816790|Antimicrobial|antimicrobial
1490196|NCT00816790|Drug Dosing|drug dosing
1490197|NCT00816790|Feasibility Study|feasibility study
1490198|NCT00816777|Cancer|cancer
1490199|NCT00816777|Carcinoma|carcinoma
1490200|NCT00816777|Colon Cancer|colon cancer
1490201|NCT00816777|Colorectal Cancer|colorectal cancer
1490202|NCT00816777|Gastric Cancer|gastric cancer
1490203|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
1490204|NCT00816777|Metastases|metastases
1490205|NCT00816777|Metastatic Cancer|metastatic cancer
1490206|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
1490207|NCT00816777|Oncology|oncology
1490208|NCT00816777|Rectal Cancer|rectal cancer
1490209|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
1490210|NCT00816764|carcinoma|carcinoma
1490211|NCT00816764|pharmacokinetics|pharmacokinetics
1490212|NCT00816764|safety|safety
1490213|NCT00816764|ovarian|ovarian
1490214|NCT00816751|Local anesthesia|local anesthesia
1490215|NCT00816751|Paracervical|paracervical
1490216|NCT00816751|Intracervical|intracervical
1490217|NCT00816751|Abortion|abortion
1490218|NCT00816751|Pain|pain
1490219|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
1490220|NCT00816738|Nd: YAG laser|nd: yag laser
1490221|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
1490222|NCT00816738|trauma|trauma
1490223|NCT00816738|anterior stromal puncture|anterior stromal puncture
1490224|NCT00816725|Postnatal Depression|postnatal depression
1490225|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
1490226|NCT00816725|Mood Management|mood management
1490227|NCT00816725|Self-help|self-help
1490228|NCT00816725|Internet|internet
1490229|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
1490230|NCT00816699|Anxiety|anxiety
1490231|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
1490232|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
1490233|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
1490234|NCT00816686|kidney|kidney
1490235|NCT00816686|pharmacokinetics|pharmacokinetics
1490236|NCT00816686|safety|safety
1490237|NCT00816686|AGS-16M18|ags-16m18
1490238|NCT00816673|Insomnia|insomnia
1490239|NCT00816673|Primary insomnia|primary insomnia
1490240|NCT00816673|sleep latency|sleep latency
1490241|NCT00816673|non restorative sleep|non restorative sleep
1490242|NCT00816673|sleep quality|sleep quality
1490243|NCT00816673|Double-Blind|double-blind
1490244|NCT00816673|Placebo Controlled|placebo controlled
1490245|NCT00816673|Parallel-Group|parallel-group
1490246|NCT00816673|Sleep Laboratory Study|sleep laboratory study
1490247|NCT00816647|Patella|patella
1490248|NCT00816647|Dislocation|dislocation
1490249|NCT00816647|Knee|knee
1490250|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
1490251|NCT00816634|First line chemotherapy|first line chemotherapy
1490252|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
1490253|NCT00816621|Internationally Adopted Children|internationally adopted children
1490254|NCT00816621|Adoption|adoption
1490255|NCT00816621|Attachment|attachment
1490256|NCT00816621|Inattention|inattention
1490257|NCT00816621|Prevention|prevention
1490258|NCT00816608|diabetes|diabetes
1490259|NCT00816608|prediabetes|prediabetes
1490260|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
1490261|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
1490262|NCT00816608|body weight|body weight
1490263|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1490264|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1490265|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1490266|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1490267|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1490268|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1490269|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1490270|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1490271|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1490272|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1490273|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1490274|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
1490275|NCT00816582|PET/CT|pet/ct
1490276|NCT00816582|Recurrent or metastatic|recurrent or metastatic
1490277|NCT00816569|Orthokeratology|orthokeratology
1490278|NCT00816569|Keratoconus|keratoconus
1490279|NCT00816530|breast|breast
1490280|NCT00816530|breast cancer|breast cancer
1490281|NCT00816530|breast screening|breast screening
1490282|NCT00816530|breast cancer screening|breast cancer screening
1490283|NCT00816530|ultrasound|ultrasound
1490284|NCT00816530|ultrasonography|ultrasonography
1490285|NCT00816530|mammogram|mammogram
1490286|NCT00816530|mammography|mammography
1490287|NCT00816530|breast density|breast density
1490288|NCT00816530|dense breasts|dense breasts
1490289|NCT00816530|early detection|early detection
1490291|NCT00816530|somo•v|somo•v
1490292|NCT00816530|U-Systems|u-systems
1490293|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
1490294|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
1490295|NCT00816530|Breast Neoplasms|breast neoplasms
1490296|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
1490297|NCT00816517|Psoriasis|psoriasis
1490298|NCT00816517|Botulinum toxin|botulinum toxin
1490300|NCT00816504|Permeability factor|permeability factor
1490301|NCT00816504|Galactose|galactose
1490302|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
1490303|NCT00816491|patient with long-standing UC|patient with long-standing uc
1490304|NCT00816478|FSGS|fsgs
1490305|NCT00816478|Permeability factor|permeability factor
1490306|NCT00816478|Galactose|galactose
1490375|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1490307|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
1490308|NCT00816465|Hoodia gordoni|hoodia gordoni
1490309|NCT00816465|NASH|nash
1490310|NCT00816465|NAFLD|nafld
1490311|NCT00816452|Osteoporosis|osteoporosis
1490312|NCT00816452|Prostate Cancer|prostate cancer
1490313|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
1490314|NCT00816439|Positron Emission Tomography|positron emission tomography
1490315|NCT00816439|Brain Imaging|brain imaging
1490316|NCT00816439|Alcoholism|alcoholism
1490317|NCT00816426|Tuberculosis|tuberculosis
1490318|NCT00816426|Lesions|lesions
1490319|NCT00816426|Pharmacokinetics|pharmacokinetics
1490320|NCT00816426|Maldistribution|maldistribution
1490321|NCT00816426|Histopathology|histopathology
1490322|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1490323|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1490324|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1490325|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1490326|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1490327|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1490328|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1490329|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1490330|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1490331|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1490332|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1490333|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1490334|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1490335|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1490336|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1490337|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1490338|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1490339|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1490340|NCT00816413|essential thrombocythemia|essential thrombocythemia
1490341|NCT00816413|polycythemia vera|polycythemia vera
1490342|NCT00816413|primary myelofibrosis|primary myelofibrosis
1490343|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1490344|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1490345|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1490346|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1490347|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1490348|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1490349|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1490350|NCT00816413|aplastic anemia|aplastic anemia
1490351|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1490352|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1490353|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1490354|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1490355|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1490356|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1490357|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1490358|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1490359|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1490360|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1490361|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1490362|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1490363|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1490364|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1490365|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1490366|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1490367|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1490368|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1490369|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1490370|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1490371|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1490372|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1490373|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1490374|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1490376|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1490377|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1490378|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1490379|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1490380|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1490381|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1490382|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1490383|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1490384|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1490385|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1490386|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1490387|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1490388|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
1490390|NCT00816374|total cutaneous examination|total cutaneous examination
1490391|NCT00816374|TCE|tce
1490392|NCT00816374|skin self-examination|skin self-examination
1490393|NCT00816374|SSE|sse
1490394|NCT00816374|first degree relatives|first degree relatives
1490395|NCT00816374|FDR|fdr
1490396|NCT00816374|skin cancer protection|skin cancer protection
1490397|NCT00816374|skin cancer screening|skin cancer screening
1490398|NCT00816348|Cholestasis|cholestasis
1490399|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
1490400|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1490401|NCT00816309|physiotherapy|physiotherapy
1490402|NCT00816309|bronchiectasis|bronchiectasis
1490403|NCT00816296|NAFLD|nafld
1490404|NCT00816296|Obesity|obesity
1490405|NCT00816296|Microbiome|microbiome
1490406|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1490407|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1490408|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1490409|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1490410|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1490411|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1490412|NCT00816270|Blepharoptosis|blepharoptosis
1490413|NCT00816270|Dermatochalasis|dermatochalasis
1490414|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
1490415|NCT00816270|Suture Techniques|suture techniques
1490416|NCT00816270|Tissue Adhesive|tissue adhesive
1490417|NCT00816257|lung tissue repository|lung tissue repository
1490418|NCT00816244|Breast cancer|breast cancer
1490419|NCT00816244|Postmenopausal|postmenopausal
1490420|NCT00816244|Neo-adjuvant|neo-adjuvant
1490421|NCT00816244|Tumor proliferation|tumor proliferation
1490422|NCT00816244|Statin|statin
1490423|NCT00816244|Atorvastatin|atorvastatin
1490424|NCT00816244|Ki67|ki67
1490425|NCT00816244|Translational research|translational research
1490426|NCT00816244|Cell cycle regulators|cell cycle regulators
1490427|NCT00816244|Gene expression|gene expression
1490428|NCT00816244|Genomic profiling|genomic profiling
1490429|NCT00816244|Apoptosis|apoptosis
1490430|NCT00816244|Window-of-opportunity|window-of-opportunity
1490431|NCT00816231|Prevention Intervention|prevention intervention
1490432|NCT00816231|Alcohol|alcohol
1490433|NCT00816231|Tobacco|tobacco
1490434|NCT00816231|Nicotine|nicotine
1490435|NCT00816231|Craving|craving
1490436|NCT00816231|Cue Reactivity|cue reactivity
1490437|NCT00816231|Cross Cue Reactions|cross cue reactions
1490438|NCT00816192|FA|fa
1490439|NCT00816192|Atrial fibrillation|atrial fibrillation
1490440|NCT00816192|Catheter|catheter
1490441|NCT00816192|Ablation|ablation
1490442|NCT00816192|RF|rf
1490443|NCT00816179|Pancreatic head mass|pancreatic head mass
1490444|NCT00816179|Pancreatic cancer|pancreatic cancer
1490445|NCT00816179|NOTES|notes
1490446|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
1490447|NCT00816179|Whipple|whipple
1490448|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
1490449|NCT00816166|Ischemic stroke|ischemic stroke
1490450|NCT00816166|Transient Ischemic Attack|transient ischemic attack
1490451|NCT00816166|Intracranial Stenting|intracranial stenting
1490452|NCT00816153|Pleth variability Index|pleth variability index
1490453|NCT00816153|Fluid management|fluid management
1490454|NCT00816153|Fluid management during surgery|fluid management during surgery
1490455|NCT00816140|Helicobacter pylori|helicobacter pylori
1490456|NCT00816140|levofloxacin|levofloxacin
1490457|NCT00816140|clarithromycin|clarithromycin
1490458|NCT00816140|ERADICATION RATE|eradication rate
1490459|NCT00816127|liver cirrhosis|liver cirrhosis
1490460|NCT00816127|coagulopathy|coagulopathy
1490461|NCT00816127|desmopressin|desmopressin
1490462|NCT00816127|blood transfusion|blood transfusion
1490463|NCT00816114|Imatinib|imatinib
1490464|NCT00816114|Gleevec|gleevec
1490465|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1490466|NCT00816114|CML|cml
1490467|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
1490468|NCT00816101|acute wounds|acute wounds
1490469|NCT00816101|partial thickness wounds|partial thickness wounds
1490470|NCT00816088|chemotherapy|chemotherapy
1490471|NCT00816088|Stem cell transplantation|stem cell transplantation
1490472|NCT00816075|distilled water|distilled water
1490473|NCT00816075|recurrent|recurrent
1490474|NCT00816075|bladder|bladder
1490475|NCT00816075|mitomycin|mitomycin
1490476|NCT00816062|Aortic Aneurysm|aortic aneurysm
1490477|NCT00816062|Aneurysm|aneurysm
1490478|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1490479|NCT00816062|Talent|talent
1490480|NCT00816062|Medtronic|medtronic
1490481|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1490482|NCT00816049|child|child
1490483|NCT00816049|6-mercaptopurine|6-mercaptopurine
1490484|NCT00816049|minimal residual disease|minimal residual disease
1490485|NCT00816049|efficacy|efficacy
1490486|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1490487|NCT00816036|Smoking Cessation|smoking cessation
1490488|NCT00816036|Practice Guidelines|practice guidelines
1490489|NCT00816036|Inpatient|inpatient
1490490|NCT00816036|Effectiveness Trial|effectiveness trial
1490491|NCT00816036|Veterans Administration|veterans administration
1490492|NCT00816036|Relapse prevention|relapse prevention
1490493|NCT00816010|drug compliance|drug compliance
1490494|NCT00816010|lifestyle modification|lifestyle modification
1490495|NCT00815997|radial artery|radial artery
1490496|NCT00815997|transradial intervention|transradial intervention
1490497|NCT00815997|stent|stent
1490498|NCT00815984|Asthma|asthma
1490499|NCT00815984|Allergic Rhinitis|allergic rhinitis
1490500|NCT00815984|Atopic Dermatitis|atopic dermatitis
1490501|NCT00815984|Children|children
1490502|NCT00815984|lung function|lung function
1490503|NCT00815984|skin prick tests|skin prick tests
1490504|NCT00815984|FeNO|feno
1490505|NCT00815971|EGFR mutations|egfr mutations
1490506|NCT00815971|EGFR inhibitor|egfr inhibitor
1490507|NCT00815971|erlotinib|erlotinib
1490508|NCT00815958|knee replacement surgery|knee replacement surgery
1490509|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
1490510|NCT00815958|femoral reaming|femoral reaming
1490511|NCT00815958|fat embolism|fat embolism
1490512|NCT00815945|leiomyosarcoma|leiomyosarcoma
1490513|NCT00815945|carcinosarcoma|carcinosarcoma
1490514|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
1490515|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
1490516|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
1490517|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
1490518|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
1490519|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
1490520|NCT00815919|cGVHD|cgvhd
1490521|NCT00815919|Velcade|velcade
1490522|NCT00815919|bortezomib|bortezomib
1490523|NCT00815893|Dexmedetomidine|dexmedetomidine
1490524|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
1490525|NCT00815893|satisfaction|satisfaction
1490526|NCT00815880|Heart Failure|heart failure
1490527|NCT00815880|Device|device
1490528|NCT00815880|Implantable|implantable
1490529|NCT00815880|Active|active
1490530|NCT00815880|Class III and Class IV|class iii and class iv
1490531|NCT00815880|Counterpulsation|counterpulsation
1490532|NCT00815867|kidney failure|kidney failure
1490533|NCT00815867|kidney transplant|kidney transplant
1490534|NCT00815867|graft function|graft function
1490535|NCT00815867|haemoglobin|haemoglobin
1490536|NCT00815867|epoetin|epoetin
1490537|NCT00815854|Antipsychotic|antipsychotic
1490538|NCT00815854|Metabolic Syndrome|metabolic syndrome
1490539|NCT00815854|Insulin Resistance|insulin resistance
1490540|NCT00815854|Endothelial Function|endothelial function
1490541|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
1490542|NCT00815828|Gestational Diabetes|gestational diabetes
1490543|NCT00815828|Resistance Exercise|resistance exercise
1490544|NCT00815828|Pregnancy|pregnancy
1490545|NCT00815828|Insulin|insulin
1490546|NCT00815815|Anorexia Nervosa|anorexia nervosa
1490547|NCT00815802|Children in day care centers|children in day care centers
1490548|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
1490549|NCT00815776|Temporomandibular disorders|temporomandibular disorders
1490550|NCT00815763|randomized trial|randomized trial
1490551|NCT00815763|ischemic stroke|ischemic stroke
1490552|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
1490553|NCT00815750|Prostate Cancer|prostate cancer
1490554|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
1490555|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
1490556|NCT00815737|Rhubarb|rhubarb
1490557|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
1490558|NCT00815724|Distributed Learning|distributed learning
1490559|NCT00815724|E-learning|e-learning
1490561|NCT00815698|pain|pain
1490562|NCT00815685|n-3 fatty acids|n-3 fatty acids
1490563|NCT00815685|nutritional treatment|nutritional treatment
1490564|NCT00815685|molecular pathogenesis|molecular pathogenesis
1490565|NCT00815672|Exercise|exercise
1490566|NCT00815672|Prostate cancer|prostate cancer
1490567|NCT00815672|Fatigue|fatigue
1490568|NCT00815659|plasma lipid profile|plasma lipid profile
1490569|NCT00815659|metabolic syndrome|metabolic syndrome
1490570|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
1490571|NCT00815646|Diving|diving
1490572|NCT00815646|Swimming|swimming
1490573|NCT00815646|Pulmonary edema|pulmonary edema
1490574|NCT00815646|Cold water immersion|cold water immersion
1490575|NCT00815633|PRP|prp
1490576|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
1490577|NCT00815633|Amevive|amevive
1490578|NCT00815633|Alefacept|alefacept
1490579|NCT00815633|Biologic|biologic
1490580|NCT00815633|Immunosuppressant|immunosuppressant
1490581|NCT00815633|Severe skin disease|severe skin disease
1490582|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
1490583|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1490584|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
1490585|NCT00815620|surgery|surgery
1490586|NCT00815620|radio-frequency ablation|radio-frequency ablation
1490587|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
1490588|NCT00815620|progression-free survival|progression-free survival
1490589|NCT00815620|quality of life|quality of life
1490590|NCT00815620|overall survival|overall survival
1490591|NCT00815620|weight|weight
1490592|NCT00815620|time of hospitalization|time of hospitalization
1490593|NCT00815607|melanoma|melanoma
1490594|NCT00815607|biologic|biologic
1490595|NCT00815607|immunotherapy|immunotherapy
1490596|NCT00815607|cancer|cancer
1490597|NCT00815594|bleb|bleb
1490598|NCT00815594|vascular change|vascular change
1490599|NCT00815594|bevacizumab|bevacizumab
1490600|NCT00815594|trabeculectomy|trabeculectomy
1490601|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
1490602|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
1490603|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
1490604|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
1490605|NCT00815581|amblyopy|amblyopy
1490606|NCT00815568|fludarabine|fludarabine
1490607|NCT00815568|busulfan|busulfan
1490608|NCT00815568|total body irradiation|total body irradiation
1490609|NCT00815568|conditioning regimen|conditioning regimen
1490610|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
1490611|NCT00815555|Tamoxifen treatment|tamoxifen treatment
1490612|NCT00815555|CYP2D6 status|cyp2d6 status
1490613|NCT00815555|relapse|relapse
1490614|NCT00815529|Acupuncture|acupuncture
1490615|NCT00815529|Chronic low back pain|chronic low back pain
1490616|NCT00815529|Qualitative study|qualitative study
1490617|NCT00815516|candidiasis|candidiasis
1490618|NCT00815516|candida|candida
1490619|NCT00815516|Neonate|neonate
1490620|NCT00815516|candidemia|candidemia
1490621|NCT00815516|Micafungin|micafungin
1490622|NCT00815516|Mycamine|mycamine
1490623|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
1490624|NCT00815503|Anesthetics|anesthetics
1490625|NCT00815503|Local infiltration|local infiltration
1490626|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
1490627|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
1490628|NCT00815490|Oximetry|oximetry
1490629|NCT00815490|Hypoxemia|hypoxemia
1490630|NCT00815490|Tissue oxygenation|tissue oxygenation
1490631|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
1490632|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
1490633|NCT00815464|Therapeutics|therapeutics
1490634|NCT00815464|Herbalist|herbalist
1490635|NCT00815464|Acupoint|acupoint
1490636|NCT00815438|Transvaginal|transvaginal
1644038|NCT00226694|Stress|stress
1490637|NCT00815438|Cholecystectomy|cholecystectomy
1490638|NCT00815438|NOTES|notes
1490639|NCT00815438|Endoscopic|endoscopic
1490640|NCT00815425|African American|african american
1490641|NCT00815386|mitral valve|mitral valve
1490642|NCT00815386|heart failure|heart failure
1490643|NCT00815386|mitral regurgitation|mitral regurgitation
1490644|NCT00815386|annuloplasty|annuloplasty
1490645|NCT00815386|coronary sinus|coronary sinus
1490646|NCT00815373|Ocular Blood flow|ocular blood flow
1490647|NCT00815373|Ocular hypertension|ocular hypertension
1490648|NCT00815373|POAG|poag
1490649|NCT00815373|Ocular hemodynamics|ocular hemodynamics
1490650|NCT00815373|Xalacom|xalacom
1490651|NCT00815373|Cosopt|cosopt
1490652|NCT00815360|diabetic macular edema|diabetic macular edema
1490653|NCT00815347|Asthma|asthma
1490654|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
1490655|NCT00815334|low compliant bladder|low compliant bladder
1490656|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
1490657|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
1490752|NCT00814970|PPA|ppa
1490658|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
1490659|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
1490660|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
1490661|NCT00815308|Therapeutic|therapeutic
1490662|NCT00815308|Drug Therapy, combination|drug therapy, combination
1490663|NCT00815308|Radiotherapy|radiotherapy
1490664|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
1490665|NCT00815269|Inhalant anesthetic|inhalant anesthetic
1490666|NCT00815269|Vasodilation|vasodilation
1490667|NCT00815269|General anesthesia|general anesthesia
1490668|NCT00815269|Ultrasonography|ultrasonography
1490669|NCT00815256|Cornea degeneration|cornea degeneration
1490670|NCT00815256|keratoconus|keratoconus
1490671|NCT00815256|collagen cross linking|collagen cross linking
1490672|NCT00815256|CXL|cxl
1490673|NCT00815256|Riboflavin|riboflavin
1490674|NCT00815243|fracture|fracture
1490675|NCT00815243|coxarthrosis|coxarthrosis
1490676|NCT00815243|complication|complication
1490677|NCT00815243|congenital abnormalities|congenital abnormalities
1490678|NCT00815243|bone|bone
1490679|NCT00815243|joint|joint
1490680|NCT00815243|telemedicine|telemedicine
1490681|NCT00815243|transportation|transportation
1490682|NCT00815243|decision making|decision making
1490683|NCT00815243|outcomes|outcomes
1490684|NCT00815230|radiation injury|radiation injury
1490685|NCT00815230|computed tomography|computed tomography
1490686|NCT00815230|reactive oxygen species|reactive oxygen species
1490687|NCT00815230|free radicals|free radicals
1490688|NCT00815217|Lipoaspirate|lipoaspirate
1490689|NCT00815217|Diabetes Mellitus|diabetes mellitus
1490690|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
1490691|NCT00815217|Fat grafts|fat grafts
1490692|NCT00815217|venous stasis|venous stasis
1490693|NCT00815204|PTSD|ptsd
1490694|NCT00815204|HPA axis|hpa axis
1490695|NCT00815204|Pituitary volume|pituitary volume
1490696|NCT00815191|temperature|temperature
1490697|NCT00815191|surgery|surgery
1490698|NCT00815191|heating device|heating device
1490699|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
1490700|NCT00815178|autonomic modulation|autonomic modulation
1490701|NCT00815178|diabetes mellitus|diabetes mellitus
1490702|NCT00815178|heart rate variability|heart rate variability
1490703|NCT00815178|functional capacity|functional capacity
1490704|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
1490705|NCT00815152|high grade glioma|high grade glioma
1490706|NCT00815152|Coping skills intervention|coping skills intervention
1490707|NCT00815152|caregivers|caregivers
1490708|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
1490709|NCT00815113|Gastric cancer|gastric cancer
1490710|NCT00815113|screening|screening
1490711|NCT00815113|high-risk|high-risk
1490712|NCT00815113|relatives|relatives
1490713|NCT00815113|gastroscopy|gastroscopy
1490714|NCT00815100|Ivabradine|ivabradine
1490715|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
1490716|NCT00815100|Inflammation|inflammation
1490717|NCT00815100|C-reactive protein|c-reactive protein
1490718|NCT00815100|Atherosclerosis|atherosclerosis
1490719|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1490720|NCT00815087|functional electrical stimulation|functional electrical stimulation
1490721|NCT00815074|Military Women|military women
1490722|NCT00815074|Women's Health|women's health
1490723|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
1490724|NCT00815074|Illness Behaviors|illness behaviors
1491751|NCT00811343|T-SPOT.TB|t-spot.tb
1490725|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
1490726|NCT00815061|prevalence|prevalence
1490727|NCT00815061|Incidence|incidence
1490728|NCT00815061|crohn's disease|crohn's disease
1490729|NCT00815061|ulcerative colitis|ulcerative colitis
1490730|NCT00815061|Epidemiology|epidemiology
1490731|NCT00815048|Remifentanil|remifentanil
1490732|NCT00815048|Endotracheal intubation|endotracheal intubation
1490733|NCT00815048|Premedication|premedication
1490734|NCT00815048|Sedation|sedation
1490735|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
1490736|NCT00815035|Peanut Allergy|peanut allergy
1490737|NCT00815022|Temperature|temperature
1490738|NCT00815022|Spinal anesthesia|spinal anesthesia
1490739|NCT00815022|Cesarean section|cesarean section
1490740|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
1490741|NCT00815022|Regional anesthesia|regional anesthesia
1490742|NCT00815009|NAFLD|nafld
1490743|NCT00815009|NASH|nash
1490744|NCT00814983|myeloablative|myeloablative
1490745|NCT00814983|stem cell|stem cell
1490746|NCT00814983|naive T-cell depleted|naive t-cell depleted
1490747|NCT00814983|allogeneic|allogeneic
1490748|NCT00814970|PAD|pad
1490749|NCT00814970|peripheral arterial disease|peripheral arterial disease
1490750|NCT00814970|stent|stent
1490751|NCT00814970|SFA|sfa
1490753|NCT00814957|positron emission tomography|positron emission tomography
1490754|NCT00814957|addiction|addiction
1490755|NCT00814944|dry eye|dry eye
1490756|NCT00814944|sirolimus|sirolimus
1490757|NCT00814944|rapamycin|rapamycin
1490758|NCT00814918|acne vulgaris|acne vulgaris
1490759|NCT00814918|acne|acne
1490760|NCT00814918|dermatalogy|dermatalogy
1490761|NCT00814905|chorioamnionitis|chorioamnionitis
1490762|NCT00814905|antibiotics|antibiotics
1490763|NCT00814905|cesarean|cesarean
1490764|NCT00814905|vaginal delivery|vaginal delivery
1490765|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1490766|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
1490767|NCT00814892|stage I prostate cancer|stage i prostate cancer
1490768|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
1490769|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
1490770|NCT00814892|stage III prostate cancer|stage iii prostate cancer
1490771|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
1490772|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1490773|NCT00814879|AIDS|aids
1490774|NCT00814879|Anti-Infective Agents|anti-infective agents
1490775|NCT00814879|Antiretroviral|antiretroviral
1490776|NCT00814879|Antiviral Agents|antiviral agents
1490777|NCT00814879|Atazanavir|atazanavir
1490778|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
1490779|NCT00814879|HIV|hiv
1490780|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
1490781|NCT00814879|NRTI|nrti
1490782|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
1490783|NCT00814879|Raltegravir|raltegravir
1490784|NCT00814879|Resistance|resistance
1490785|NCT00814879|treatment experienced|treatment experienced
1490786|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
1490787|NCT00814866|arthritis|arthritis
1490788|NCT00814866|osteoclasts|osteoclasts
1490789|NCT00814866|bone|bone
1490790|NCT00814853|Extubation|extubation
1490791|NCT00814853|testing|testing
1490792|NCT00814853|ventilator weaning|ventilator weaning
1490793|NCT00814853|Pediatric extubation|pediatric extubation
1490794|NCT00814840|Heart failure|heart failure
1490795|NCT00814840|Dyssynchrony|dyssynchrony
1490796|NCT00814840|Cardiac resynchronization|cardiac resynchronization
1490797|NCT00814840|Triple-site pacing|triple-site pacing
1490798|NCT00814827|Interferon-Gamma|interferon-gamma
1490799|NCT00814827|Autoantibodies|autoantibodies
1490800|NCT00814827|Mycobacteria|mycobacteria
1490801|NCT00814827|Opportunistic Infections|opportunistic infections
1490802|NCT00814827|Immunodeficiency|immunodeficiency
1490803|NCT00814801|Alzheimer's Disease|alzheimer's disease
1490804|NCT00814801|Cognitive dysfunction|cognitive dysfunction
1490805|NCT00814801|Dementia|dementia
1490806|NCT00814801|Galantamine|galantamine
1490807|NCT00814801|R113675|r113675
1490808|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
1490809|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1490810|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
1490811|NCT00814775|Laryngeal mask|laryngeal mask
1490812|NCT00814775|Difficult intubation|difficult intubation
1490813|NCT00814762|immunogenicity|immunogenicity
1490814|NCT00814762|HIV|hiv
1490815|NCT00814762|reactogenicity|reactogenicity
1490816|NCT00814762|safety|safety
1490817|NCT00814762|vaccine|vaccine
1490818|NCT00814762|HIV Infections|hiv infections
1490819|NCT00814749|stress urinary incontinence|stress urinary incontinence
1490820|NCT00814749|urodynamics|urodynamics
1490821|NCT00814749|randomized clinical trial|randomized clinical trial
1490822|NCT00814749|surgery|surgery
1490823|NCT00814710|Pneumococcal disease|pneumococcal disease
1490824|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
1490825|NCT00814710|Safety|safety
1490826|NCT00814710|Primary vaccination|primary vaccination
1490827|NCT00814710|Immunogenicity|immunogenicity
1490828|NCT00814697|Alzheimer|alzheimer
1490829|NCT00814697|Language|language
1490830|NCT00814697|Treatment|treatment
1490831|NCT00814697|TMS|tms
1490832|NCT00814697|rTMS|rtms
1490833|NCT00814671|Tuberculosis|tuberculosis
1490834|NCT00814671|Pharmacokinetics|pharmacokinetics
1490835|NCT00814658|Dementia|dementia
1490836|NCT00814658|Mixed Dementia|mixed dementia
1490837|NCT00814658|Galantamine|galantamine
1490838|NCT00814658|Reminyl ER|reminyl er
1490839|NCT00814658|Nimodipine|nimodipine
1490840|NCT00814632|vulvodynia|vulvodynia
1490841|NCT00814632|pelvic pain|pelvic pain
1490842|NCT00814632|vulvar pain|vulvar pain
1490843|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1490844|NCT00814619|stage III rectal cancer|stage iii rectal cancer
1490845|NCT00814619|stage II rectal cancer|stage ii rectal cancer
1490846|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
1490847|NCT00814606|hepatitis C|hepatitis c
1490848|NCT00814606|HCV|hcv
1490849|NCT00814606|liver|liver
1490850|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
1490851|NCT00814593|adult gliosarcoma|adult gliosarcoma
1490852|NCT00814593|adult glioblastoma|adult glioblastoma
1490853|NCT00814580|analgesia|analgesia
1490854|NCT00814580|postoperative pain|postoperative pain
1490855|NCT00814580|opioid|opioid
1490856|NCT00814580|rotator cuff repair|rotator cuff repair
1490857|NCT00814580|labral tear repair|labral tear repair
1490858|NCT00814580|Bankart procedure|bankart procedure
1490859|NCT00814580|oxycodone|oxycodone
1490860|NCT00814580|tapentadol|tapentadol
1490861|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
1490862|NCT00814567|recurrent breast cancer|recurrent breast cancer
1490863|NCT00814567|stage IA breast cancer|stage ia breast cancer
1490864|NCT00814567|stage II breast cancer|stage ii breast cancer
1490865|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1490866|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
1490867|NCT00814554|obesity|obesity
1490868|NCT00814554|nutrition|nutrition
1490869|NCT00814554|cluster randomized trial|cluster randomized trial
1490870|NCT00814554|high school|high school
1490871|NCT00814554|primary prevention|primary prevention
1490872|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
1490873|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
1490874|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
1490875|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
1490876|NCT00814528|actinic keratosis|actinic keratosis
1490877|NCT00814528|skin lesions|skin lesions
1490878|NCT00814528|5-ALA|5-ala
1490879|NCT00814528|AK|ak
1490880|NCT00814528|Blu-Light|blu-light
1490881|NCT00814515|Moderate|moderate
1490882|NCT00814515|Severe|severe
1490883|NCT00814515|Dry|dry
1490884|NCT00814515|Eye|eye
1490885|NCT00814515|Ciclosporin|ciclosporin
1490886|NCT00814515|Cyclosporine|cyclosporine
1490887|NCT00814502|Alzheimer disease|alzheimer disease
1490888|NCT00814502|Dementia, vascular|dementia, vascular
1490889|NCT00814502|Actigraphy|actigraphy
1490890|NCT00814502|Circadian dysregulation|circadian dysregulation
1490891|NCT00814502|Sleep Disorders|sleep disorders
1490892|NCT00814502|Circadian rhythm|circadian rhythm
1490893|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
1490894|NCT00814489|protein vaccine|protein vaccine
1490895|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
1490896|NCT00814489|young adults|young adults
1490897|NCT00814476|Medtronic CareLink|medtronic carelink
1490898|NCT00814476|therapy management|therapy management
1490899|NCT00814476|diabetes|diabetes
1490900|NCT00814476|insulin pump|insulin pump
1490901|NCT00814476|Blood glucose monitor|blood glucose monitor
1490902|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
1490903|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1490904|NCT00814450|Biopsy|biopsy
1490905|NCT00814450|Fine needle aspiration|fine needle aspiration
1490906|NCT00814424|EtCO2|etco2
1490907|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
1490908|NCT00814424|ERCP|ercp
1490909|NCT00814411|contraception|contraception
1490910|NCT00814411|noninferiority|noninferiority
1490911|NCT00814411|intention|intention
1490912|NCT00814411|family planning counseling|family planning counseling
1490913|NCT00814411|post abortion care|post abortion care
1490914|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
1490915|NCT00814398|Infertility|infertility
1490916|NCT00814398|IVF|ivf
1490917|NCT00814398|SET|set
1490918|NCT00814398|DET|det
1490919|NCT00814398|Blastocyst|blastocyst
1490920|NCT00814359|mucositis|mucositis
1490921|NCT00814359|radiation|radiation
1490922|NCT00814359|magic mouthwash|magic mouthwash
1490923|NCT00814359|sucralfate|sucralfate
1490924|NCT00814359|benzydamine|benzydamine
1490925|NCT00814359|diphenhydramine|diphenhydramine
1490926|NCT00814359|dexamethasone|dexamethasone
1490927|NCT00814359|nystatin|nystatin
1567601|NCT00508742|Healthy Infants|healthy infants
1490928|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
1490929|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
1490930|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
1490931|NCT00814333|epistaxis|epistaxis
1490932|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
1490933|NCT00814294|Type 2|type 2
1490934|NCT00814281|particulate air pollution|particulate air pollution
1490935|NCT00814281|leukotriene|leukotriene
1490936|NCT00814281|asthma|asthma
1490937|NCT00814281|montelukast|montelukast
1490938|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
1490939|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
1490940|NCT00814255|Primary FSGS|primary fsgs
1490941|NCT00814255|Steroid Resistant|steroid resistant
1490942|NCT00814255|Rosiglitazone|rosiglitazone
1490943|NCT00814255|Adalimumab|adalimumab
1490944|NCT00814255|Resistant primary FSGS|resistant primary fsgs
1490945|NCT00814255|GALACTOSE|galactose
1490946|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
1490947|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
1490948|NCT00814242|Surgical resection|surgical resection
1490949|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
1490950|NCT00814242|Time to recurrence|time to recurrence
1490951|NCT00814242|Disease-free survival|disease-free survival
1490952|NCT00814242|Overall survival|overall survival
1490953|NCT00814229|influenza|influenza
1490954|NCT00814229|H9N2|h9n2
1490955|NCT00814229|vaccine|vaccine
1490956|NCT00814216|Efficacy|efficacy
1490957|NCT00814216|safety|safety
1490958|NCT00814216|QAV680|qav680
1490959|NCT00814216|pharmacokinetics|pharmacokinetics
1490960|NCT00814216|corticosteroid|corticosteroid
1490961|NCT00814216|asthma|asthma
1490962|NCT00814203|COPD|copd
1490963|NCT00814190|Type 2 Diabetes|type 2 diabetes
1490964|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
1490965|NCT00814177|warfarin|warfarin
1490966|NCT00814177|dosing|dosing
1490967|NCT00814177|prothrombin time|prothrombin time
1490968|NCT00814177|Heart valve prosthesis|heart valve prosthesis
1490969|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1490970|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1490971|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1490972|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1490973|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1490974|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1490975|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1490976|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1490977|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1490978|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1490979|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1490980|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1490981|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1490982|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1490983|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1490984|NCT00814151|Blood culture|blood culture
1490985|NCT00814151|Staphylococcus aureus|staphylococcus aureus
1490986|NCT00814151|Bacteremia|bacteremia
1490987|NCT00814151|MRSA|mrsa
1490988|NCT00814151|MSSA|mssa
1490989|NCT00814151|MicroPhage|microphage
1490990|NCT00814138|myasthenia gravis|myasthenia gravis
1490991|NCT00814125|Endometrial|endometrial
1490992|NCT00814125|Endometrial histological findings|endometrial histological findings
1490993|NCT00814099|Acute Respiratory Failure|acute respiratory failure
1490994|NCT00814099|Acute Lung Injury|acute lung injury
1490995|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
1490996|NCT00814073|Mastocytosis|mastocytosis
1490997|NCT00814073|Smouldering systemic mastocytosis|smouldering systemic mastocytosis
1490998|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
1490999|NCT00814073|Cutaneous mastocytosis|cutaneous mastocytosis
1491000|NCT00814073|Mast cell|mast cell
1491001|NCT00814073|Mast cell infiltration|mast cell infiltration
1491002|NCT00814073|Skin|skin
1491003|NCT00814073|Bone marrow|bone marrow
1491004|NCT00814073|Pruritus|pruritus
1491005|NCT00814073|Flushes|flushes
1491006|NCT00814073|c-kit|c-kit
1491007|NCT00814073|c-kit mutation|c-kit mutation
1491008|NCT00814073|Wild Type|wild type
1491009|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
1491010|NCT00814047|ultrasonography|ultrasonography
1491011|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
1491012|NCT00814034|Coagulation parameters|coagulation parameters
1491013|NCT00814034|Tamoxifen|tamoxifen
1491014|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
1492032|NCT00810355|work|work
1491015|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
1491016|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
1491017|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
1491019|NCT00813969|Autologous|autologous
1491020|NCT00813969|Multiple Sclerosis|multiple sclerosis
1491021|NCT00813956|triple negative breast cancer|triple negative breast cancer
1491022|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
1491023|NCT00813943|Cilengitide|cilengitide
1491024|NCT00813943|Temozolomide|temozolomide
1491025|NCT00813943|Radiotherapy|radiotherapy
1491026|NCT00813930|Diabetes|diabetes
1491027|NCT00813930|Lifestyle Intervention|lifestyle intervention
1491028|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
1491029|NCT00813891|ranibizumab|ranibizumab
1491030|NCT00813891|verteporfin|verteporfin
1491031|NCT00813878|breast cancer|breast cancer
1491032|NCT00813878|breast cancer in situ|breast cancer in situ
1491033|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
1491034|NCT00813852|skeletal muscle|skeletal muscle
1491035|NCT00813852|magnetic stimulation|magnetic stimulation
1491036|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1491037|NCT00813852|inflammatory markers|inflammatory markers
1491038|NCT00813852|exercise|exercise
1491039|NCT00813839|SmartCare|smartcare
1491040|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
1491041|NCT00813839|Mechanical Ventilation|mechanical ventilation
1491042|NCT00813839|Weaning|weaning
1491043|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
1491044|NCT00813826|PHN|phn
1491045|NCT00813826|Pain after Shingles|pain after shingles
1491046|NCT00813800|Smoking|smoking
1491047|NCT00813800|Bipolar Disorder|bipolar disorder
1491048|NCT00813800|Depression|depression
1491049|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
1491050|NCT00813787|Glioma|glioma
1491051|NCT00813774|Cimzia|cimzia
1491052|NCT00813774|certolizumab pegol|certolizumab pegol
1491053|NCT00813774|Bioavailability|bioavailability
1491054|NCT00813774|Healthy volunteers|healthy volunteers
1491055|NCT00813748|Asthma|asthma
1491056|NCT00813748|Anaphylaxis|anaphylaxis
1491057|NCT00813735|Insomnia|insomnia
1491058|NCT00813735|Major Depression|major depression
1491059|NCT00813735|Geriatric|geriatric
1491060|NCT00813722|adherence|adherence
1491061|NCT00813722|blood pressure|blood pressure
1491062|NCT00813722|hypertension|hypertension
1491063|NCT00813722|compliance|compliance
1491064|NCT00813722|atenolol|atenolol
1491065|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
1491066|NCT00813722|amlodipine|amlodipine
1491067|NCT00813722|losartan|losartan
1491068|NCT00813709|Interferon 1-beta|interferon 1-beta
1491069|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
1491070|NCT00813696|chemotherapy|chemotherapy
1491071|NCT00813696|advanced cancer|advanced cancer
1491072|NCT00813696|inoperable|inoperable
1491073|NCT00813696|Stage II, III, IV|stage ii, iii, iv
1491074|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
1491075|NCT00813683|Cephalic version,|cephalic version,
1491076|NCT00813683|Breech presentation|breech presentation
1491077|NCT00813631|Malignant fungating wound|malignant fungating wound
1491078|NCT00813631|Head and neck|head and neck
1491079|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
1491080|NCT00813631|Wound care|wound care
1491081|NCT00813631|RCT|rct
1491082|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
1491083|NCT00813605|AMG 655|amg 655
1491084|NCT00813605|AMG 479|amg 479
1491085|NCT00813605|Colon Cancer|colon cancer
1491086|NCT00813605|Rectal Cancer|rectal cancer
1491087|NCT00813605|Monoclonal Antibody|monoclonal antibody
1491088|NCT00813605|Clinical Trial|clinical trial
1491089|NCT00813605|Colorectal Cancer|colorectal cancer
1491090|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
1491091|NCT00813605|metastatic cancer|metastatic cancer
1491092|NCT00813605|antibody-2nd line|antibody-2nd line
1491093|NCT00813605|KRAS|kras
1491094|NCT00813605|adenocarcinoma|adenocarcinoma
1491095|NCT00813592|meningioma|meningioma
1491096|NCT00813592|brain|brain
1491097|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
1491098|NCT00813566|cancer|cancer
1491099|NCT00813566|imaging|imaging
1491100|NCT00813566|PET scanning|pet scanning
1491101|NCT00813553|physical fitness|physical fitness
1491102|NCT00813553|exercise|exercise
1491103|NCT00813553|amino acid|amino acid
1491104|NCT00813540|Colonic Neoplasms|colonic neoplasms
1491105|NCT00813540|Aerobic Exercise|aerobic exercise
1491106|NCT00813540|Weight Lifting|weight lifting
1491107|NCT00813540|Body Composition|body composition
1491108|NCT00813527|Drug Therapy|drug therapy
1491109|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
1491110|NCT00813527|Hyperlipidemias|hyperlipidemias
1491111|NCT00813527|Hypercholesterolemia|hypercholesterolemia
1491112|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
1491113|NCT00813514|AMD|amd
1491114|NCT00813514|VEGF genotyping|vegf genotyping
1491115|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
1491116|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1491117|NCT00813501|graft versus host disease|graft versus host disease
1491118|NCT00813501|infection|infection
1491119|NCT00813501|therapy-related toxicity|therapy-related toxicity
1491120|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1491121|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1491122|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1491123|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1491124|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1491125|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1491126|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1491127|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1491128|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1491129|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1491130|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1491131|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1491132|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1491133|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1491134|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1491135|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1491136|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1491137|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1491138|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1491139|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1491140|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1491141|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1491142|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1491143|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1491144|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1491145|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1491146|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1491147|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1491148|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1491149|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1491150|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1491151|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1491152|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1491153|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1491154|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1491155|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1491156|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1491157|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1491158|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1491159|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1491160|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1491161|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1491162|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1491163|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1491164|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1491165|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1491166|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1491167|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1491168|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1491169|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1491170|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1491171|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1491172|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1491173|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1491174|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1491175|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1491176|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1491264|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
1491177|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1491178|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1491179|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1491180|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1491181|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1491182|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1491183|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1491184|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1491185|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1491186|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1491187|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1491188|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1491189|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1491190|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1491191|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
1491192|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1491290|NCT00813176|Anesthesia|anesthesia
1491193|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1491194|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1491195|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1491196|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1491197|NCT00813501|primary myelofibrosis|primary myelofibrosis
1491198|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1491199|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1491200|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
1491201|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1491202|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1491203|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1491204|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
1491205|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
1491206|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
1491207|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
1491208|NCT00813488|Breakthrough Pain|breakthrough pain
1491209|NCT00813488|Opioid-tolerant|opioid-tolerant
1491210|NCT00813488|Chronic Pain|chronic pain
1491211|NCT00813475|cardio vascular outcome|cardio vascular outcome
1491212|NCT00813449|Endostar|endostar
1491213|NCT00813449|advanced melanoma|advanced melanoma
1491214|NCT00813449|combined chemotherapy|combined chemotherapy
1491215|NCT00813436|ToM|tom
1491216|NCT00813436|Theory of Mind|theory of mind
1491217|NCT00813436|Simulation|simulation
1491218|NCT00813436|Empathy|empathy
1491219|NCT00813436|Oxytocin|oxytocin
1491220|NCT00813436|Schizophrenia|schizophrenia
1491221|NCT00813384|Cancer|cancer
1491222|NCT00813384|Solid Tumors|solid tumors
1491223|NCT00813384|Phase 1|phase 1
1491224|NCT00813384|C-met inhibitor|c-met inhibitor
1491225|NCT00813384|Clinical Trial|clinical trial
1491226|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1491227|NCT00813371|acute lung injury|acute lung injury
1491228|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
1491229|NCT00813371|ARDSnet|ardsnet
1491230|NCT00813371|Bi-level|bi-level
1491231|NCT00813371|respiratory failure|respiratory failure
1491232|NCT00813371|trauma|trauma
1491233|NCT00813371|APRV|aprv
1491234|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
1491235|NCT00813358|Aortic Aneurysm|aortic aneurysm
1491236|NCT00813358|Thoracic|thoracic
1491237|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
1491238|NCT00813332|Endostar|endostar
1491239|NCT00813332|NSCLC|nsclc
1491240|NCT00813332|Docetaxel|docetaxel
1491241|NCT00813332|Combined therapy|combined therapy
1491242|NCT00813332|second-line chemotherapy|second-line chemotherapy
1491243|NCT00813319|GARDASIL|gardasil
1491244|NCT00813319|HPV|hpv
1491245|NCT00813319|Vaccination|vaccination
1491246|NCT00813306|GERD|gerd
1491247|NCT00813306|TLESR|tlesr
1491248|NCT00813306|reflux|reflux
1491249|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
1491250|NCT00813293|HCC|hcc
1491251|NCT00813293|Liver Cancer|liver cancer
1491252|NCT00813293|radiofrequency ablation|radiofrequency ablation
1491253|NCT00813293|RFA|rfa
1491254|NCT00813293|sorafenib|sorafenib
1491255|NCT00813293|nexavaar|nexavaar
1491256|NCT00813293|liver directed therapy|liver directed therapy
1491257|NCT00813293|interventional radiology|interventional radiology
1491258|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
1491259|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
1491260|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
1491261|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
1491262|NCT00813254|Ovarian Cancer|ovarian cancer
1491265|NCT00813254|Quality of Life|quality of life
1491266|NCT00813254|Cost Utility Analysis|cost utility analysis
1491267|NCT00813254|Sexual functioning|sexual functioning
1491268|NCT00813254|Questionnaire|questionnaire
1491269|NCT00813254|Caregiver|caregiver
1491270|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
1491271|NCT00813228|Immune Function|immune function
1491273|NCT00813228|Sitagliptin|sitagliptin
1491274|NCT00813228|GLP-1|glp-1
1491275|NCT00813228|TGF Beta|tgf beta
1491276|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
1491277|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
1491278|NCT00813215|Postprandial inflammation|postprandial inflammation
1491279|NCT00813215|Relatives|relatives
1491280|NCT00813215|Meal challenge|meal challenge
1491281|NCT00813202|Nesiritide|nesiritide
1491282|NCT00813202|Natrecor|natrecor
1491283|NCT00813202|Quanke|quanke
1491284|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
1491285|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
1491286|NCT00813189|muscle function|muscle function
1491287|NCT00813189|growth hormone treatment|growth hormone treatment
1491288|NCT00813176|Obesity|obesity
1491289|NCT00813176|One-Lung Ventilation|one-lung ventilation
1491292|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
1491293|NCT00813163|Phase II study|phase ii study
1491294|NCT00813163|Second line|second line
1491295|NCT00813163|Pancreatic cancer|pancreatic cancer
1491296|NCT00813163|Metastatic|metastatic
1491297|NCT00813150|Multiple myeloma|multiple myeloma
1491298|NCT00813150|Bortezomib|bortezomib
1491299|NCT00813150|Dexamethasone|dexamethasone
1491300|NCT00813150|Cyclophosphamide|cyclophosphamide
1491301|NCT00813150|Oncology|oncology
1491302|NCT00813137|Colorectal Cancer|colorectal cancer
1491303|NCT00813137|chemotherapy|chemotherapy
1491304|NCT00813137|recombinant human endostatin|recombinant human endostatin
1491305|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1491307|NCT00813124|Donor stem cell transplant|donor stem cell transplant
1491308|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1491309|NCT00813124|Stem cell transplant|stem cell transplant
1491310|NCT00813124|ATG|atg
1491311|NCT00813124|Antithymocyte globulin|antithymocyte globulin
1491312|NCT00813124|Vidaza|vidaza
1491313|NCT00813124|Azacitidine|azacitidine
1491314|NCT00813124|5-Azacitidine|5-azacitidine
1491315|NCT00813124|5-Aza|5-aza
1491316|NCT00813124|5-AZC|5-azc
1491317|NCT00813124|Ladakamycin|ladakamycin
1491318|NCT00813124|NSC-102816|nsc-102816
1491319|NCT00813124|allotx|allotx
1491320|NCT00813124|Busulfan|busulfan
1491321|NCT00813124|Busulfex|busulfex
1491322|NCT00813124|Myleran|myleran
1491323|NCT00813124|Fludarabine|fludarabine
1491324|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
1491325|NCT00813124|Tacrolimus|tacrolimus
1491326|NCT00813124|Methotrexate|methotrexate
1491327|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
1491328|NCT00813124|molecular remission|molecular remission
1491329|NCT00813124|HLA compatible donor|hla compatible donor
1491330|NCT00813124|Engraftment|engraftment
1491331|NCT00813124|Chimerism|chimerism
1491332|NCT00813124|Graft vs host disease|graft vs host disease
1491333|NCT00813124|GVHD|gvhd
1491334|NCT00813111|Postsurgical pain|postsurgical pain
1491335|NCT00813111|Analgesia|analgesia
1491336|NCT00813111|Breast augmentation|breast augmentation
1491337|NCT00813085|Diabetes|diabetes
1491338|NCT00813085|Computerized clinical decision support|computerized clinical decision support
1491339|NCT00813085|shared care|shared care
1491340|NCT00813085|patient self-monitoring|patient self-monitoring
1491341|NCT00813085|quality of care|quality of care
1491342|NCT00813085|complex interventions|complex interventions
1491343|NCT00813085|composite outcomes|composite outcomes
1491344|NCT00813072|Gastric Cancer|gastric cancer
1491345|NCT00813072|Stomach Cancer|stomach cancer
1491346|NCT00813072|Gastroesophageal|gastroesophageal
1491347|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
1491348|NCT00813072|Esophageal Cancer|esophageal cancer
1491349|NCT00813072|phase II|phase ii
1491350|NCT00813072|PEP02|pep02
1491351|NCT00813072|randomization|randomization
1491352|NCT00813072|randomisation|randomisation
1491353|NCT00813072|adenocarcinoma|adenocarcinoma
1491354|NCT00813072|locally advanced|locally advanced
1491355|NCT00813072|metastatic|metastatic
1491356|NCT00813072|simon's two|simon's two
1491357|NCT00813059|NAION|naion
1491358|NCT00813059|bevacizumab|bevacizumab
1491359|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
1491360|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
1491361|NCT00813007|Cervical Cancer|cervical cancer
1491362|NCT00813007|Cervix|cervix
1491363|NCT00813007|Questionnaire|questionnaire
1491364|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
1491365|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
1491366|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
1491367|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
1491368|NCT00813007|Trachelectomy|trachelectomy
1491369|NCT00813007|Quality of life|quality of life
1491370|NCT00813007|Sexual functioning|sexual functioning
1491371|NCT00812994|Depression|depression
1491372|NCT00812994|BDNF|bdnf
1491373|NCT00812994|neurotrophic factor|neurotrophic factor
1491374|NCT00812994|neurosetroid|neurosetroid
1491375|NCT00812994|allopregnanolone|allopregnanolone
1491376|NCT00812981|Pandemic influenza|pandemic influenza
1491377|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
1491378|NCT00812968|Lenalidomide|lenalidomide
1491379|NCT00812955|Dyslipidemia|dyslipidemia
1491380|NCT00812955|Hypercholesterolemia|hypercholesterolemia
1491381|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
1491382|NCT00812942|average-risk subjects for|average-risk subjects for
1491383|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
1491384|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
1491385|NCT00812903|Neck|neck
1491386|NCT00812903|Pain|pain
1491387|NCT00812903|Exercise|exercise
1491388|NCT00812903|Pilots|pilots
1491389|NCT00812903|Crew|crew
1491390|NCT00812877|pulp capping|pulp capping
1491392|NCT00812877|CaOH|caoh
1491393|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
1491394|NCT00812877|Calcium Hydroxide|calcium hydroxide
1491395|NCT00812864|Capecitabine|capecitabine
1491396|NCT00812864|pharmacocinetics|pharmacocinetics
1491397|NCT00812864|Breast metastatic cancer|breast metastatic cancer
1491398|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
1491399|NCT00812864|Elderly patients|elderly patients
1491400|NCT00812851|ALS|als
1491401|NCT00812851|cramps|cramps
1491402|NCT00812851|THC|thc
1491403|NCT00812851|Dronabinol|dronabinol
1491404|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
1491405|NCT00812812|paroxetine|paroxetine
1491406|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1491407|NCT00812812|CDRS-R|cdrs-r
1491408|NCT00812812|children and adolescents|children and adolescents
1491409|NCT00812799|randomised|randomised
1491410|NCT00812799|double-blind|double-blind
1491411|NCT00812799|placebo-controlled|placebo-controlled
1491412|NCT00812799|efficacy and safety|efficacy and safety
1491413|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
1491414|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1491415|NCT00812799|allergy|allergy
1491416|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
1491417|NCT00812799|immunotherapy|immunotherapy
1491418|NCT00812799|grass pollen extract|grass pollen extract
1491419|NCT00812786|heart transplantation|heart transplantation
1491420|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
1491421|NCT00812786|individual dose adjustment|individual dose adjustment
1491422|NCT00812786|harmacokinetics|harmacokinetics
1491423|NCT00812786|modelling|modelling
1491424|NCT00812773|GSK2190915|gsk2190915
1491425|NCT00812773|Repeat|repeat
1491426|NCT00812773|Oral|oral
1491427|NCT00812773|Dose|dose
1491428|NCT00812773|Challenge|challenge
1491429|NCT00812773|Asthma|asthma
1491430|NCT00812773|Allergen|allergen
1491431|NCT00812760|Electroretinography|electroretinography
1491432|NCT00812760|levodopa|levodopa
1491433|NCT00812747|surgical wound infection|surgical wound infection
1491434|NCT00812747|risk factor|risk factor
1491435|NCT00812734|Neuropathic pain|neuropathic pain
1491436|NCT00812734|chronic pain|chronic pain
1491437|NCT00812734|postoperative|postoperative
1491438|NCT00812734|surgery|surgery
1491439|NCT00812734|anesthesiology|anesthesiology
1491440|NCT00812734|Scheduled surgery|scheduled surgery
1491441|NCT00812721|higher order aberrations|higher order aberrations
1491442|NCT00812721|tear blur|tear blur
1491443|NCT00812708|aniridia|aniridia
1491444|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
1491445|NCT00812708|modified capsule tension ring|modified capsule tension ring
1491446|NCT00812708|artificial iris|artificial iris
1491447|NCT00812708|iris reconstruction lens|iris reconstruction lens
1491448|NCT00812708|glare sensitivity|glare sensitivity
1491449|NCT00812708|photophobia|photophobia
1491450|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
1491451|NCT00812695|Refractory hypertension|refractory hypertension
1567602|NCT00508742|Vaccines|vaccines
1491452|NCT00812695|Heart remodeling|heart remodeling
1491453|NCT00812695|Arterial stiffness|arterial stiffness
1491454|NCT00812695|CPAP|cpap
1491455|NCT00812682|SYMBICORT AMD|symbicort amd
1491456|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1491457|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1491458|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1491459|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1491460|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1491461|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1491462|NCT00812643|pharmacokinetics|pharmacokinetics
1491463|NCT00812630|male hormonal contraception|male hormonal contraception
1491464|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
1491465|NCT00812578|Type 2 diabetes|type 2 diabetes
1491466|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
1491467|NCT00812578|Insulin secretion|insulin secretion
1491468|NCT00812578|Insulin sensitivity|insulin sensitivity
1491469|NCT00812578|Pulsatility|pulsatility
1491470|NCT00812539|Diabetes|diabetes
1491471|NCT00812539|Blood glucose monitoring|blood glucose monitoring
1491472|NCT00812539|Internet|internet
1491473|NCT00812526|Choroid|choroid
1491474|NCT00812526|Regional blood flow|regional blood flow
1491475|NCT00812526|Autoregulation|autoregulation
1491476|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
1491477|NCT00812513|rhPDGF-BB|rhpdgf-bb
1491478|NCT00812513|Platelet derived growth factor|platelet derived growth factor
1491479|NCT00812513|Burns|burns
1491480|NCT00812513|Thermal burns|thermal burns
1491481|NCT00812513|Electric burns|electric burns
1491482|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
1491483|NCT00812487|congestive heart failure|congestive heart failure
1491484|NCT00812487|diabetes mellitus|diabetes mellitus
1491485|NCT00812487|hyperglycemia|hyperglycemia
1491486|NCT00812474|cerebral blood flow|cerebral blood flow
1491487|NCT00812461|Pharmacologic Actions|pharmacologic actions
1491488|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
1491489|NCT00812461|Alcoholism|alcoholism
1491490|NCT00812461|Mental Disorders|mental disorders
1491491|NCT00812461|Central Nervous System Agents|central nervous system agents
1491492|NCT00812448|prophylaxis|prophylaxis
1491493|NCT00812448|influenza infection|influenza infection
1491494|NCT00812448|catechins|catechins
1491495|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
1491496|NCT00812435|STEMI|stemi
1491497|NCT00812435|Patients|patients
1491498|NCT00812435|male or female|male or female
1491499|NCT00812435|greater than 18 years of age|greater than 18 years of age
1491500|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
1491501|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
1491502|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
1491503|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
1491505|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
1491506|NCT00812370|UNBLOCK|unblock
1491507|NCT00812370|Bivalirudin|bivalirudin
1491508|NCT00812370|Angiomax|angiomax
1491509|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
1491510|NCT00812357|asthma|asthma
1491511|NCT00812357|cohort study|cohort study
1491512|NCT00812357|France|france
1491513|NCT00812344|pharmacokinetics|pharmacokinetics
1491514|NCT00812331|Hepatitis C|hepatitis c
1491515|NCT00812331|TMC435|tmc435
1491516|NCT00812318|HIV infected subjects|hiv infected subjects
1491517|NCT00812318|Healthy volunteer|healthy volunteer
1491518|NCT00812318|GSK1265744.|gsk1265744.
1491519|NCT00812292|TMC278|tmc278
1491520|NCT00812292|TMC278-C145|tmc278-c145
1491521|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
1491522|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
1491523|NCT00812292|HIV Infections|hiv infections
1491524|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
1491525|NCT00812266|SCLC|sclc
1491526|NCT00812266|Extensive disease|extensive disease
1491527|NCT00812266|topotecan|topotecan
1491528|NCT00812253|Heart failure|heart failure
1491529|NCT00812253|Hyperglycemia|hyperglycemia
1491530|NCT00812253|Hospital|hospital
1491531|NCT00812253|Diabetes Mellitus|diabetes mellitus
1491532|NCT00812240|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
1491533|NCT00812240|GIST|gist
1491534|NCT00812240|non resectable|non resectable
1491535|NCT00812240|recurrent post-surgery|recurrent post-surgery
1491536|NCT00812240|first line of treatment|first line of treatment
1491537|NCT00812240|metastatic|metastatic
1491538|NCT00812240|locally advanced|locally advanced
1491539|NCT00812227|Depression|depression
1491540|NCT00812227|Psychotherapy|psychotherapy
1491541|NCT00812227|Neuroimaging|neuroimaging
1491542|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
1645270|NCT00221351|cough|cough
1491543|NCT00812214|insomnia|insomnia
1491544|NCT00812214|migraine|migraine
1491545|NCT00812214|eszopiclone|eszopiclone
1491546|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
1491547|NCT00812201|Heart failure|heart failure
1491548|NCT00812201|auto threshold|auto threshold
1491549|NCT00812201|pacing|pacing
1491550|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
1491551|NCT00812188|Morphea|morphea
1491552|NCT00812188|Plaque morphea|plaque morphea
1491553|NCT00812188|Localized Scleroderma|localized scleroderma
1491750|NCT00811343|QFTB-G|qftb-g
1491554|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
1491556|NCT00812175|Sorafenib|sorafenib
1491557|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
1491558|NCT00812149|Genetic Polymorphism|genetic polymorphism
1491559|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
1491560|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
1491561|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
1491562|NCT00812123|kidney transplantation|kidney transplantation
1491563|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
1491564|NCT00812123|protocol biopsy|protocol biopsy
1491565|NCT00812123|Cyclosporin A|cyclosporin a
1491566|NCT00812123|Sirolimus|sirolimus
1491567|NCT00812110|Influenza prevention|influenza prevention
1491568|NCT00812097|Breast Augmentation|breast augmentation
1491569|NCT00812097|Breast Reconstruction|breast reconstruction
1491570|NCT00812097|Breast Revision|breast revision
1491571|NCT00812097|Silicone gel|silicone gel
1491572|NCT00812097|Contour Profile Gel|contour profile gel
1491573|NCT00812097|Siltex®|siltex®
1491574|NCT00812084|Quality of life|quality of life
1491575|NCT00812084|health resources|health resources
1491576|NCT00812084|costs|costs
1491577|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
1491578|NCT00812071|volunteers|volunteers
1491579|NCT00812058|Bipolar Depression|bipolar depression
1491580|NCT00812058|Bipolar Disease|bipolar disease
1491581|NCT00812058|Bipolar Disorder|bipolar disorder
1491582|NCT00812058|Bipolar|bipolar
1491583|NCT00812058|Manic Depression|manic depression
1491584|NCT00812058|Manic Depressive Disorder|manic depressive disorder
1491585|NCT00812045|Induced sputum|induced sputum
1491586|NCT00812045|cystic fibrosis|cystic fibrosis
1491587|NCT00812045|biomarker|biomarker
1491588|NCT00812045|CYBER|cyber
1491589|NCT00812032|NIDDM|niddm
1491590|NCT00812032|Aspirin|aspirin
1491591|NCT00812032|platelet inhibition|platelet inhibition
1491592|NCT00812032|Aspirin treatment|aspirin treatment
1491593|NCT00812019|H5N1 Influenza|h5n1 influenza
1491594|NCT00812019|Pandemic Flu|pandemic flu
1491595|NCT00812019|MF59 Adjuvant|mf59 adjuvant
1491596|NCT00812019|Cell Culture-Derived|cell culture-derived
1491597|NCT00812019|Safety|safety
1491598|NCT00812019|Immunogenicity|immunogenicity
1491599|NCT00812019|Vaccination|vaccination
1491600|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
1491601|NCT00811954|Treatment naive|treatment naive
1491602|NCT00811954|Treatment inexperienced|treatment inexperienced
1491603|NCT00811941|Pharmacologic Actions|pharmacologic actions
1491604|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
1491605|NCT00811941|Alcoholism|alcoholism
1491606|NCT00811941|Mental Disorders|mental disorders
1491607|NCT00811941|Central Nervous System Agents|central nervous system agents
1491608|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
1491609|NCT00811915|Sirolimus|sirolimus
1491610|NCT00811915|Tacrolimus|tacrolimus
1491611|NCT00811915|Kidney transplantation|kidney transplantation
1491612|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
1491613|NCT00811902|Multiple sclerosis|multiple sclerosis
1491614|NCT00811876|Prostate cancer|prostate cancer
1491615|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
1491616|NCT00811863|Renal Insufficiency|renal insufficiency
1491617|NCT00811863|Gadoversetamide|gadoversetamide
1491618|NCT00811863|OptiMARK|optimark
1491619|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
1491620|NCT00811837|Sunburn|sunburn
1491621|NCT00811837|Remifentanil|remifentanil
1491622|NCT00811837|Hyperalgesia|hyperalgesia
1491623|NCT00811824|Weight loss|weight loss
1491624|NCT00811824|Physical activity|physical activity
1491625|NCT00811824|Dietary change|dietary change
1491626|NCT00811811|Hypertension|hypertension
1491627|NCT00811811|Biofeedback|biofeedback
1491628|NCT00811811|Relaxation training|relaxation training
1491629|NCT00811798|Hong Kong|hong kong
1491630|NCT00811798|Human papillomavirus|human papillomavirus
1491631|NCT00811798|Safety|safety
1491632|NCT00811785|Copper Deficiency|copper deficiency
1491633|NCT00811785|Menkes Disease|menkes disease
1491634|NCT00811785|Neurodevelopment|neurodevelopment
1491635|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
1491636|NCT00811772|Randomized controlled trial|randomized controlled trial
1491637|NCT00811772|Bare metal stent|bare metal stent
1491638|NCT00811772|Drug eluting stent|drug eluting stent
1491639|NCT00811759|stage IV melanoma|stage iv melanoma
1491640|NCT00811759|stage III melanoma|stage iii melanoma
1491641|NCT00811759|recurrent melanoma|recurrent melanoma
1491642|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
1491643|NCT00811746|eszopiclone|eszopiclone
1491644|NCT00811746|ramelteon|ramelteon
1491645|NCT00811746|polysomnography|polysomnography
1491646|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1491647|NCT00811733|Ofatumumab|ofatumumab
1491648|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
1491649|NCT00811720|Alcoholism|alcoholism
1491650|NCT00811720|Mental Disorders|mental disorders
1491651|NCT00811720|Central Nervous System Agents|central nervous system agents
1491652|NCT00811707|ultrasound image|ultrasound image
1491653|NCT00811707|epidural space|epidural space
1491654|NCT00811694|glaucoma|glaucoma
1491655|NCT00811694|ficker stimulation|ficker stimulation
1491656|NCT00811694|ocular blood flow|ocular blood flow
1491657|NCT00811681|Friedreich's ataxia|friedreich's ataxia
1491658|NCT00811681|Pioglitazone|pioglitazone
1491659|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
1491660|NCT00811668|heart diseases|heart diseases
1491661|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
1491662|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1491663|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
1491664|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
1491665|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
1491666|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
1491667|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1491668|NCT00811629|Severe sepsis|severe sepsis
1491669|NCT00811629|Septic shock|septic shock
1491670|NCT00811629|Alveolar epithelium|alveolar epithelium
1491671|NCT00811629|Mechanical ventilation|mechanical ventilation
1491672|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
1491673|NCT00811616|Coronary artery disease|coronary artery disease
1491674|NCT00811616|Supralimus-Core™|supralimus-core™
1491675|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
1491676|NCT00811603|Antibiotic|antibiotic
1491677|NCT00811603|Prophylaxis|prophylaxis
1491678|NCT00811603|Cesarean|cesarean
1491679|NCT00811603|Infection|infection
1491680|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
1491682|NCT00811590|Polyps|polyps
1491683|NCT00811577|AZX100|azx100
1491684|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
1491685|NCT00811577|POSAS|posas
1491686|NCT00811577|Visual Analog Scale|visual analog scale
1491687|NCT00811577|VAS|vas
1491688|NCT00811577|Trocar|trocar
1491689|NCT00811577|Scarring|scarring
1491690|NCT00811577|Scar reduction|scar reduction
1491691|NCT00811577|Scar prevention|scar prevention
1491692|NCT00811551|Heart Failure|heart failure
1491693|NCT00811551|Impedance Monitoring|impedance monitoring
1491694|NCT00811551|Wedge Pressure|wedge pressure
1491695|NCT00811538|ischemic stroke|ischemic stroke
1491696|NCT00811538|endovascular treatment|endovascular treatment
1491697|NCT00811538|Thrombolysis|thrombolysis
1491698|NCT00811538|outcome|outcome
1491699|NCT00811525|Breast Augmentation|breast augmentation
1491700|NCT00811525|Breast Reconstruction|breast reconstruction
1491701|NCT00811525|Breast Revision|breast revision
1491702|NCT00811525|Silicone gel|silicone gel
1491703|NCT00811525|Contour Profile Gel|contour profile gel
1491704|NCT00811525|Siltex|siltex
1491705|NCT00811512|retina|retina
1491706|NCT00811512|fold|fold
1491707|NCT00811512|fovea|fovea
1491708|NCT00811473|Bipolar Depression|bipolar depression
1491709|NCT00811473|Depression|depression
1491710|NCT00811473|Children|children
1491711|NCT00811473|Adolescents|adolescents
1491712|NCT00811473|Seroquel|seroquel
1491713|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
1491714|NCT00811434|encephalopathy|encephalopathy
1491715|NCT00811434|pediatric liver disease|pediatric liver disease
1491716|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
1491717|NCT00811434|serum ammonia levels|serum ammonia levels
1491718|NCT00811421|Malaria|malaria
1491719|NCT00811421|Pregnancy|pregnancy
1491720|NCT00811421|HIV|hiv
1491721|NCT00811421|Prevention|prevention
1491722|NCT00811421|Malaria prevention|malaria prevention
1491723|NCT00811408|human papilloma virus infection|human papilloma virus infection
1491724|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1491725|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
1491726|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
1491727|NCT00811408|stage II cervical cancer|stage ii cervical cancer
1491728|NCT00811408|stage III cervical cancer|stage iii cervical cancer
1491729|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
1491730|NCT00811382|CRT|crt
1491731|NCT00811382|therapy of AF|therapy of af
1491732|NCT00811382|telecardiology|telecardiology
1491733|NCT00811382|home monitoring|home monitoring
1491734|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
1491735|NCT00811382|cardiovascular mortality|cardiovascular mortality
1491736|NCT00811369|Breast Cancer|breast cancer
1491737|NCT00811369|Bone Metastases|bone metastases
1491738|NCT00811369|Telopeptide|telopeptide
1491739|NCT00811369|Zactima|zactima
1491740|NCT00811369|Fulvestrant|fulvestrant
1491741|NCT00811356|Food Effect|food effect
1491742|NCT00811356|Drug-Drug Interaction|drug-drug interaction
1491743|NCT00811356|Antimalarial|antimalarial
1491744|NCT00811356|First Time In Human|first time in human
1491745|NCT00811356|Single Dose|single dose
1491746|NCT00811356|Repeat Dose|repeat dose
1491747|NCT00811343|anti TNF Therapy|anti tnf therapy
1491748|NCT00811343|Tuberculosis|tuberculosis
1491749|NCT00811343|Tuberculin test|tuberculin test
1491752|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
1491753|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
1491754|NCT00811330|Aortic valve stenosis|aortic valve stenosis
1491755|NCT00811330|Aortic valve replacement|aortic valve replacement
1491756|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
1491757|NCT00811330|Statins|statins
1491758|NCT00811330|Myocardial preconditioning|myocardial preconditioning
1491759|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
1491760|NCT00811317|diabetes|diabetes
1491761|NCT00811317|glucose|glucose
1491762|NCT00811317|hyperglycemia|hyperglycemia
1491763|NCT00811317|hypoglycemia|hypoglycemia
1491764|NCT00811317|insulin|insulin
1491765|NCT00811317|glucagon|glucagon
1491766|NCT00811317|counter-regulation|counter-regulation
1491767|NCT00811317|closed-loop|closed-loop
1491768|NCT00811317|feedback|feedback
1491769|NCT00811317|control|control
1491770|NCT00811317|dual-infusion|dual-infusion
1491771|NCT00811317|subcutaneous|subcutaneous
1491772|NCT00811317|automated|automated
1491773|NCT00811317|artificial pancreas|artificial pancreas
1491774|NCT00811317|intensive insulin therapy|intensive insulin therapy
1491775|NCT00811304|ultrasound|ultrasound
1491776|NCT00811304|labor epidural|labor epidural
1491777|NCT00811304|failed epidural|failed epidural
1491778|NCT00811304|outcome|outcome
1491779|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
1491780|NCT00811291|B-vitamins|b-vitamins
1491781|NCT00811291|Folic-Acid|folic-acid
1491782|NCT00811291|kindergarten kids|kindergarten kids
1491783|NCT00811291|cognitive tests|cognitive tests
1491784|NCT00811291|Healthy kids|healthy kids
1491785|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
1491786|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
1491787|NCT00811265|ExAblate MRgFUS|exablate mrgfus
1491788|NCT00811265|Focused ultrasound|focused ultrasound
1491789|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
1491790|NCT00811265|Prostate cancer|prostate cancer
1491791|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
1491792|NCT00811252|Depression|depression
1491793|NCT00811252|Elderly|elderly
1491794|NCT00811252|Acute treatment|acute treatment
1491795|NCT00811239|antivenom|antivenom
1491796|NCT00811239|snake bite|snake bite
1491797|NCT00811239|Bungarus multicinctus|bungarus multicinctus
1491798|NCT00811239|Vietnam|vietnam
1491799|NCT00811226|Hypertension Stage I|hypertension stage i
1491800|NCT00811226|Hypertension Stage II|hypertension stage ii
1491801|NCT00811200|radiation|radiation
1491802|NCT00811200|retinopathy|retinopathy
1491803|NCT00811200|maculopathy|maculopathy
1491804|NCT00811200|choroidopathy|choroidopathy
1491805|NCT00811200|uveal|uveal
1491806|NCT00811200|melanoma|melanoma
1491807|NCT00811200|lucentis|lucentis
1491808|NCT00811200|ranibizumab|ranibizumab
1491809|NCT00811200|kenalog|kenalog
1491810|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
1491811|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
1491812|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
1491813|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
1491814|NCT00811187|Hysteroscopy|hysteroscopy
1491815|NCT00811187|Pain medication|pain medication
1491816|NCT00811187|Lidocaine|lidocaine
1491817|NCT00811187|Office Procedures|office procedures
1491818|NCT00811161|Remodeling|remodeling
1491819|NCT00811161|Airgent|airgent
1491820|NCT00811161|Hyaluronic acid|hyaluronic acid
1491821|NCT00811161|Collagen formation|collagen formation
1491822|NCT00811148|Brain Neoplasms|brain neoplasms
1491823|NCT00811148|Central Nervous System Diseases|central nervous system diseases
1491824|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
1491825|NCT00811148|Brain Diseases|brain diseases
1491826|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
1491827|NCT00811122|Alzheimer's disease|alzheimer's disease
1491828|NCT00811122|AD|ad
1491829|NCT00811122|Frontotemporal dementia|frontotemporal dementia
1491830|NCT00811122|FTD|ftd
1491831|NCT00811109|Acute Kidney Injury|acute kidney injury
1491832|NCT00811109|Critical care|critical care
1491833|NCT00811109|Hypotension|hypotension
1491834|NCT00811109|Renal replacement therapy|renal replacement therapy
1491835|NCT00811109|Efficacy|efficacy
1491836|NCT00811109|Tolerance|tolerance
1491837|NCT00811109|Outcome|outcome
1491838|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
1491839|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
1491840|NCT00811096|Recurrence|recurrence
1491841|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
1491842|NCT00811083|autism|autism
1491843|NCT00811083|toxic metals|toxic metals
1491844|NCT00811083|DMSA|dmsa
1491845|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
1491846|NCT00811083|chelation|chelation
1491847|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
1491848|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
1491849|NCT00811044|diabetes|diabetes
1491850|NCT00811044|genetics|genetics
1491851|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
1491852|NCT00811044|family history of diabetes|family history of diabetes
1491853|NCT00811044|gestational diabetes|gestational diabetes
1491854|NCT00811031|Prostate|prostate
1491855|NCT00811031|prostate gland|prostate gland
1491856|NCT00811031|prostate cancer markers|prostate cancer markers
1491857|NCT00811031|Taxotere®|taxotere®
1491858|NCT00811031|Docetaxel|docetaxel
1491859|NCT00811031|Prednisone|prednisone
1491860|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
1491861|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1491862|NCT00811018|Open-label study|open-label study
1491863|NCT00811005|acitretin|acitretin
1491864|NCT00811005|fumaric acid ester|fumaric acid ester
1491865|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
1491866|NCT00811005|PUVA|puva
1491867|NCT00810992|dietary, behavior|dietary, behavior
1491868|NCT00810992|IDF criteria|idf criteria
1491869|NCT00810992|coronary artery disease|coronary artery disease
1491870|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
1491871|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
1491872|NCT00810940|TBI|tbi
1491873|NCT00810940|closed head injury|closed head injury
1491874|NCT00810940|severe head trauma|severe head trauma
1491875|NCT00810940|traumatic brain injury|traumatic brain injury
1491876|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
1491877|NCT00810914|Pain control in labor|pain control in labor
1491878|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
1491879|NCT00810901|designated organ donor|designated organ donor
1491880|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
1491881|NCT00810888|ICH|ich
1491882|NCT00810888|computed tomography angiography|computed tomography angiography
1491883|NCT00810888|CTA|cta
1491884|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
1491885|NCT00810888|rFVIIa|rfviia
1491886|NCT00810888|NovoSeven|novoseven
1491887|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
1491888|NCT00810875|pregnancy|pregnancy
1491889|NCT00810875|immunity|immunity
1491890|NCT00810875|cord blood|cord blood
1491891|NCT00810875|influenza vaccines|influenza vaccines
1491892|NCT00810875|disease transmission, vertical|disease transmission, vertical
1491893|NCT00810862|African American children|african american children
1491894|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
1491895|NCT00810823|Diabetes|diabetes
1491896|NCT00810823|gastric bypass|gastric bypass
1491897|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
1491898|NCT00810810|Blood Component Transfusion|blood component transfusion
1491899|NCT00810810|Leukoreduction|leukoreduction
1491900|NCT00810810|HLA antibody|hla antibody
1491901|NCT00810810|Immunosuppression|immunosuppression
1491902|NCT00810797|recurrent breast cancer|recurrent breast cancer
1491903|NCT00810797|stage IV breast cancer|stage iv breast cancer
1491904|NCT00810784|Venous Thromboembolism|venous thromboembolism
1491905|NCT00810784|Prevention|prevention
1491906|NCT00810784|Quality Improvement|quality improvement
1491907|NCT00810784|Education|education
1491908|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
1491909|NCT00810771|Hospitals, Veterans|hospitals, veterans
1491910|NCT00810771|Mass Screening/utilization|mass screening/utilization
1491911|NCT00810771|Patient Preference|patient preference
1491912|NCT00810771|Prevention & Control|prevention & control
1491913|NCT00810771|Epidemiology|epidemiology
1491914|NCT00810758|HCV|hcv
1491915|NCT00810758|Toll-like receptor 7|toll-like receptor 7
1491916|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
1491917|NCT00810745|ODS|ods
1491918|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
1567166|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1491919|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
1491920|NCT00810732|B1321005|b1321005
1491921|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
1491922|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
1491923|NCT00810706|Breast Cancer|breast cancer
1491924|NCT00810706|Aromatase inhibitors|aromatase inhibitors
1491925|NCT00810706|Exemestane|exemestane
1491926|NCT00810706|Tamoxifen|tamoxifen
1491927|NCT00810706|Lipids|lipids
1491928|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
1491930|NCT00810693|Stimulator|stimulator
1491931|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1491932|NCT00810680|relapsed|relapsed
1491933|NCT00810680|refractory|refractory
1491934|NCT00810680|valproic acid|valproic acid
1491935|NCT00810680|valproate|valproate
1491936|NCT00810667|Schizophrenia|schizophrenia
1491937|NCT00810667|Cognition|cognition
1491938|NCT00810667|BACS|bacs
1491939|NCT00810667|Risperidone|risperidone
1491940|NCT00810667|Augmentation therapy|augmentation therapy
1491941|NCT00810667|Add-on therapy|add-on therapy
1491942|NCT00810667|Lu AE58054|lu ae58054
1491943|NCT00810654|Celiac disease|celiac disease
1491944|NCT00810654|Coeliac disease|coeliac disease
1491945|NCT00810654|treatment|treatment
1491946|NCT00810654|AN-PEP|an-pep
1491947|NCT00810654|prolyl endoprotease|prolyl endoprotease
1491948|NCT00810654|gluten|gluten
1491949|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
1491950|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
1491951|NCT00810641|Nystagmus|nystagmus
1491952|NCT00810641|Treatment outcome|treatment outcome
1491953|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
1491954|NCT00810628|Parkinson's disease|parkinson's disease
1491955|NCT00810628|depression|depression
1491956|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
1491957|NCT00810615|chronic TBI|chronic tbi
1491958|NCT00810615|cognitive function|cognitive function
1491959|NCT00810615|PTSD|ptsd
1491960|NCT00810615|HBO|hbo
1491961|NCT00810615|hyperbaric|hyperbaric
1491962|NCT00810615|oxygen|oxygen
1491963|NCT00810615|chronic brain injury|chronic brain injury
1491964|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
1491965|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
1491966|NCT00810576|NHL|nhl
1491967|NCT00810576|T-cell NHL|t-cell nhl
1491968|NCT00810576|vorinostat|vorinostat
1491969|NCT00810576|SAHA|saha
1491970|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1491971|NCT00810576|MSK-390|msk-390
1491972|NCT00810576|Zolinza|zolinza
1491973|NCT00810576|Bortezomib|bortezomib
1491974|NCT00810576|Velcade|velcade
1491975|NCT00810576|LDP-341|ldp-341
1491976|NCT00810576|MLN341|mln341
1491977|NCT00810576|PS-341|ps-341
1491978|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
1491979|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
1491980|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1491981|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
1491982|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
1491983|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
1491984|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
1491985|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
1491986|NCT00810563|pain|pain
1491987|NCT00810563|tubal ligation|tubal ligation
1491988|NCT00810563|bupivacaine|bupivacaine
1491989|NCT00810563|laparoscopy|laparoscopy
1491990|NCT00810524|Chronic hepatitis B|chronic hepatitis b
1491991|NCT00810524|antiviral treatment|antiviral treatment
1491992|NCT00810524|long term prognosis|long term prognosis
1491993|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
1491994|NCT00810485|Proton pump inhibitor|proton pump inhibitor
1491995|NCT00810485|Heartburn|heartburn
1491996|NCT00810485|Regurgitation|regurgitation
1491997|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
1491998|NCT00810472|HLA matching|hla matching
1491999|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
1492000|NCT00810420|Hypoglycemia|hypoglycemia
1492001|NCT00810420|EEG|eeg
1492002|NCT00810420|type 1 diabetes|type 1 diabetes
1492003|NCT00810420|neuroglycopenia|neuroglycopenia
1492004|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
1492005|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
1492006|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
1492007|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1492008|NCT00810381|Nitrovasodilators|nitrovasodilators
1492009|NCT00810381|ONH blood flow|onh blood flow
1492010|NCT00810381|Choroidal blood flow|choroidal blood flow
1492011|NCT00810381|Nitroglycerin|nitroglycerin
1492012|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
1492013|NCT00810381|Sodium nitroprusside|sodium nitroprusside
1492014|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
1492015|NCT00810381|Regional Blood Flow|regional blood flow
1492016|NCT00810368|Carnosine|carnosine
1492017|NCT00810368|antioxidant|antioxidant
1492018|NCT00810368|Persian Gulf War|persian gulf war
1492019|NCT00810368|Gulf War Syndrome|gulf war syndrome
1492021|NCT00810368|Gulf War Illness|gulf war illness
1492022|NCT00810368|Exercise|exercise
1492023|NCT00810368|Chronic Fatigue|chronic fatigue
1492024|NCT00810368|Fibromyalgia|fibromyalgia
1492025|NCT00810368|Veterans|veterans
1492026|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
1492027|NCT00810368|Migraine headaches|migraine headaches
1492028|NCT00810368|Neuropathy|neuropathy
1492029|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
1492030|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
1492031|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
1492033|NCT00810342|physical activity standard|physical activity standard
1492034|NCT00810342|exercise|exercise
1492035|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
1492036|NCT00810316|Alprazolam|alprazolam
1492037|NCT00810316|Alprazolam extended release|alprazolam extended release
1492038|NCT00810316|Clonazepam|clonazepam
1492039|NCT00810316|Pharmacokinetics|pharmacokinetics
1492040|NCT00810316|Mexican population|mexican population
1492041|NCT00810316|Healthy|healthy
1492042|NCT00810290|Metabolic syndrome|metabolic syndrome
1492043|NCT00810290|Latino health|latino health
1492044|NCT00810290|Community participatory research|community participatory research
1492045|NCT00810290|Translational Research|translational research
1492046|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
1492047|NCT00810251|rib fracture|rib fracture
1492048|NCT00810251|flail chest|flail chest
1492049|NCT00810251|plate|plate
1492050|NCT00810251|chest trauma|chest trauma
1492051|NCT00810251|osteosynthesis|osteosynthesis
1492052|NCT00810251|mechanical ventilation|mechanical ventilation
1492053|NCT00810251|respirator|respirator
1492054|NCT00810238|Heart failure|heart failure
1492055|NCT00810238|Cell therapy|cell therapy
1492056|NCT00810225|CNDP1|cndp1
1492057|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
1492058|NCT00810225|Persian Gulf War|persian gulf war
1492059|NCT00810225|Gulf War Syndrome|gulf war syndrome
1492060|NCT00810225|GWI|gwi
1492158|NCT00809809|Cold sores|cold sores
1492061|NCT00810225|Gulf War Illness|gulf war illness
1492062|NCT00810225|Exercise|exercise
1492063|NCT00810225|Chronic Fatigue|chronic fatigue
1492064|NCT00810225|Fibromyalgia|fibromyalgia
1492065|NCT00810225|Veterans|veterans
1492066|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
1492067|NCT00810225|Migraine headaches|migraine headaches
1492068|NCT00810225|Neuropathy|neuropathy
1492069|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
1492070|NCT00810212|Degenerative disc disease|degenerative disc disease
1492071|NCT00810212|Spondylolisthesis|spondylolisthesis
1492072|NCT00810212|Spinal stenosis|spinal stenosis
1492073|NCT00810212|Stem cell|stem cell
1492074|NCT00810212|Spinal Fusion|spinal fusion
1492075|NCT00810173|type 2 diabetes|type 2 diabetes
1492076|NCT00810173|physical activity|physical activity
1492077|NCT00810173|behavior change|behavior change
1492078|NCT00810173|profile personality|profile personality
1492079|NCT00810173|phone call support|phone call support
1492080|NCT00810160|probiotic|probiotic
1492081|NCT00810160|prebiotic|prebiotic
1492082|NCT00810160|oligosaccharides|oligosaccharides
1492083|NCT00810160|GOS|gos
1492084|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
1492085|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
1492086|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
1492087|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
1492088|NCT00810108|HIV/AIDS|hiv/aids
1492089|NCT00810108|pediatrics|pediatrics
1492090|NCT00810108|resource-limited settings|resource-limited settings
1492091|NCT00810108|lopinavir|lopinavir
1492092|NCT00810108|ritonavir|ritonavir
1492093|NCT00810108|Kaletra®|kaletra®
1492094|NCT00810108|antiretroviral treatment|antiretroviral treatment
1492095|NCT00810108|crushed tablets|crushed tablets
1492096|NCT00810108|treatment experienced|treatment experienced
1492097|NCT00810095|Cerebral Infarction|cerebral infarction
1492098|NCT00810095|Stroke|stroke
1492099|NCT00810095|Vascular Diseases|vascular diseases
1492100|NCT00810095|Central Nervous System Diseases|central nervous system diseases
1492101|NCT00810095|Penumbra|penumbra
1492102|NCT00810095|Functional Outcome|functional outcome
1492103|NCT00810095|Aphasia|aphasia
1492104|NCT00810095|Hemiplegia|hemiplegia
1492105|NCT00810095|Left sided weakness|left sided weakness
1492106|NCT00810095|Right Sided weakness|right sided weakness
1492107|NCT00810069|Major Depressive Disorder|major depressive disorder
1492108|NCT00810069|MDD|mdd
1492109|NCT00810069|Depression|depression
1492110|NCT00810056|Child abuse and neglect|child abuse and neglect
1492111|NCT00810056|Out-of-home care|out-of-home care
1492112|NCT00810056|Mentoring|mentoring
1492113|NCT00810056|Skills groups|skills groups
1492114|NCT00810056|Assessment|assessment
1492115|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
1492116|NCT00810030|iron sucrose|iron sucrose
1492117|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
1492118|NCT00810030|Crohn's Disease|crohn's disease
1492119|NCT00810030|Ulcerative Colitis|ulcerative colitis
1492120|NCT00810030|Ferritin|ferritin
1492121|NCT00810030|Transferrin|transferrin
1492122|NCT00810017|Her2 Positive|her2 positive
1492123|NCT00810017|Breast Cancer|breast cancer
1492124|NCT00810017|Metastatic|metastatic
1492125|NCT00809991|Prostate Cancer|prostate cancer
1492126|NCT00809965|Rivaroxaban|rivaroxaban
1492127|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
1492128|NCT00809965|ACS|acs
1492129|NCT00809965|Aspirin|aspirin
1492130|NCT00809965|Thienopyridine|thienopyridine
1492131|NCT00809965|Unstable Angina|unstable angina
1493022|NCT00806663|DCE-MRI|dce-mri
1492132|NCT00809965|Myocardial Infarction|myocardial infarction
1492133|NCT00809965|Anticoagulation|anticoagulation
1492134|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
1492135|NCT00809939|preterm delivery|preterm delivery
1492136|NCT00809939|short cervical length|short cervical length
1492137|NCT00809939|progesterone|progesterone
1492138|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
1492139|NCT00809913|Urinary Tract Infection|urinary tract infection
1492140|NCT00809913|Fever|fever
1492141|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
1492142|NCT00809913|Treatment duration|treatment duration
1492143|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
1492144|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
1492145|NCT00809874|Postprandial Period|postprandial period
1492146|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
1492147|NCT00809874|Incretins|incretins
1492148|NCT00809874|Subclinical Inflammation|subclinical inflammation
1492149|NCT00809874|Obesity|obesity
1492150|NCT00809874|Atherosclerosis|atherosclerosis
1492151|NCT00809874|Triglyceride|triglyceride
1492152|NCT00809874|Lipoproteins|lipoproteins
1492153|NCT00809835|Cocaine|cocaine
1492154|NCT00809835|Methadone|methadone
1492155|NCT00809835|CBT|cbt
1492156|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
1492157|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
1492159|NCT00809809|Zinc|zinc
1492160|NCT00809809|HSL|hsl
1492161|NCT00809809|Herpes simple labialis|herpes simple labialis
1492162|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
1492163|NCT00809770|stimulant abuse|stimulant abuse
1492164|NCT00809770|drug abuse|drug abuse
1492165|NCT00809770|schizophrenia|schizophrenia
1492166|NCT00809770|bipolar disorder|bipolar disorder
1492167|NCT00809770|major depressive disorder|major depressive disorder
1492168|NCT00809770|contingency management|contingency management
1492169|NCT00809770|psychosocial treatment|psychosocial treatment
1492170|NCT00809757|Asthma|asthma
1492171|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
1492172|NCT00809718|Raltegravir|raltegravir
1492173|NCT00809718|Pharmacokinetics|pharmacokinetics
1492174|NCT00809718|Rifapentine|rifapentine
1492175|NCT00809718|Drug Kinetics|drug kinetics
1492176|NCT00809692|histamine biotransformation|histamine biotransformation
1492177|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
1492178|NCT00809692|pediatric pharmacology|pediatric pharmacology
1492179|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
1492180|NCT00809679|Varicella Zoster|varicella zoster
1492181|NCT00809679|Shingles|shingles
1492182|NCT00809679|Neuropathic pain|neuropathic pain
1492183|NCT00809679|Analgesia|analgesia
1492184|NCT00809679|Pain|pain
1492185|NCT00809666|pregnancy|pregnancy
1492186|NCT00809666|hypertension|hypertension
1492187|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
1492188|NCT00809666|blood pressure|blood pressure
1492189|NCT00809666|automated blood pressure|automated blood pressure
1492190|NCT00809666|pre eclampsia|pre eclampsia
1492191|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
1492192|NCT00809653|Air pollution|air pollution
1492193|NCT00809653|Face mask|face mask
1492194|NCT00809653|Myocardial ischaemia|myocardial ischaemia
1492195|NCT00809653|Heart rate variability|heart rate variability
1492196|NCT00809653|Angina pectoris|angina pectoris
1492197|NCT00809653|Coronary heart disease|coronary heart disease
1492198|NCT00809640|low back pain|low back pain
1492199|NCT00809640|prevention|prevention
1492200|NCT00809640|schoolchildren|schoolchildren
1492201|NCT00809640|education campaign|education campaign
1492202|NCT00809627|headache|headache
1492203|NCT00809627|caffeine|caffeine
1492204|NCT00809627|pain|pain
1492205|NCT00809614|Psoriatic arthritis|psoriatic arthritis
1492206|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
1492207|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
1492208|NCT00809588|vaccination|vaccination
1492209|NCT00809588|GM-CSF|gm-csf
1492210|NCT00809588|autologous|autologous
1492211|NCT00809588|irradiated|irradiated
1492212|NCT00809575|adult|adult
1492213|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1492214|NCT00809575|Quality of life|quality of life
1492215|NCT00809575|Patient reported outcomes|patient reported outcomes
1492216|NCT00809549|Stroke|stroke
1492217|NCT00809549|GCSF|gcsf
1492218|NCT00809549|Hematopoeitic|hematopoeitic
1492219|NCT00809549|Neupogen|neupogen
1492220|NCT00809549|Filgrastim|filgrastim
1492221|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
1492223|NCT00809523|winter depression|winter depression
1492224|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
1492225|NCT00809484|Arimidex|arimidex
1492226|NCT00809484|Bone Mineral density|bone mineral density
1492227|NCT00809484|Bisphosphonates|bisphosphonates
1492228|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
1492229|NCT00809471|ED|ed
1492230|NCT00809471|Erectile Dysfunction|erectile dysfunction
1492231|NCT00809471|Dysfunction|dysfunction
1492232|NCT00809471|Diabetic|diabetic
1492233|NCT00809471|Erectile|erectile
1492234|NCT00809458|Vitamin E|vitamin e
1492235|NCT00809458|Prostate Cancer|prostate cancer
1492236|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
1492237|NCT00809432|Air pollution|air pollution
1492238|NCT00809432|Heart rate|heart rate
1492239|NCT00809432|Heart rate variability|heart rate variability
1492240|NCT00809432|Blood pressure|blood pressure
1492241|NCT00809432|Face mask|face mask
1492242|NCT00809419|Brachytherapy|brachytherapy
1492243|NCT00809419|EpiRad|epirad
1492244|NCT00809419|Macular Degeneration|macular degeneration
1492245|NCT00809419|Ranibizumab|ranibizumab
1492246|NCT00809393|Antifibrinolytic|antifibrinolytic
1492247|NCT00809393|Tranexamic acid|tranexamic acid
1492248|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
1492249|NCT00809393|Transfusion|transfusion
1492250|NCT00809393|Hemorrhage|hemorrhage
1492251|NCT00809380|Conscious sedation|conscious sedation
1492252|NCT00809380|Parental presence|parental presence
1492253|NCT00809380|Invasive procedure|invasive procedure
1492254|NCT00809380|Children|children
1492255|NCT00809380|Anxiety|anxiety
1492256|NCT00809367|MDS|mds
1492257|NCT00809367|AML|aml
1492258|NCT00809367|banking study|banking study
1492259|NCT00809354|monoclonal antibody|monoclonal antibody
1492260|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
1492261|NCT00809354|anti-NGF|anti-ngf
1492262|NCT00809354|tanezumab|tanezumab
1492263|NCT00809354|PF-04383119|pf-04383119
1492264|NCT00809354|RN624|rn624
1492265|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
1492266|NCT00809341|B-Cell|b-cell
1492267|NCT00809341|non-Hodgkin's|non-hodgkin's
1492268|NCT00809341|Lymphoma|lymphoma
1492269|NCT00809315|Child abuse and neglect|child abuse and neglect
1492270|NCT00809315|Out-of-home care|out-of-home care
1492271|NCT00809315|Mentoring|mentoring
1492272|NCT00809315|Skills groups|skills groups
1492273|NCT00809315|Assessment|assessment
1492274|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
1492275|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
1492276|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
1492277|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1492278|NCT00809276|Acute Leukemia|acute leukemia
1492279|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
1492280|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1492281|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
1492282|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1492283|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
1492284|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1492512|NCT00808535|Endothelial dysfunction|endothelial dysfunction
1492285|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
1492286|NCT00809276|Hematologic Malignancies|hematologic malignancies
1492287|NCT00809276|Transplantation|transplantation
1492288|NCT00809276|Busulfan|busulfan
1492289|NCT00809276|Fludarabine|fludarabine
1492290|NCT00809276|Cytoxan|cytoxan
1492291|NCT00809276|Bone Marrow|bone marrow
1492292|NCT00809276|Allogeneic|allogeneic
1492293|NCT00809276|Related donor|related donor
1492294|NCT00809276|unrelated donor|unrelated donor
1492295|NCT00809263|homeopathy|homeopathy
1492296|NCT00809263|homeopathic drug proving|homeopathic drug proving
1492297|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
1492298|NCT00809250|vaccination|vaccination
1492300|NCT00809250|CMML|cmml
1492301|NCT00809250|MDS-RAEB|mds-raeb
1492302|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
1492303|NCT00809237|Gefitinib|gefitinib
1492304|NCT00809237|Hydroxychloroquine|hydroxychloroquine
1492305|NCT00809224|ALS|als
1492306|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1492307|NCT00809224|brain-computer interface|brain-computer interface
1492308|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
1492309|NCT00809224|radiology|radiology
1492310|NCT00809224|fMRI|fmri
1492311|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1492312|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1492313|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
1492314|NCT00809198|Refresh Plus|refresh plus
1492315|NCT00809198|Dry Eye|dry eye
1492316|NCT00809198|Cornea Staining|cornea staining
1492317|NCT00809198|TBUT|tbut
1492318|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1492319|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1492320|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1492321|NCT00809172|Atopic-dermatitis|atopic-dermatitis
1492322|NCT00809172|scorad|scorad
1492323|NCT00809172|methotrexate|methotrexate
1492324|NCT00809172|ciclosporin|ciclosporin
1492325|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
1492326|NCT00809146|Status Epilepticus|status epilepticus
1492327|NCT00809146|Emergency Medical Services|emergency medical services
1492328|NCT00809146|Anticonvulsants|anticonvulsants
1492329|NCT00809146|Drug Administration Routes|drug administration routes
1492330|NCT00809146|Seizures|seizures
1492331|NCT00809120|Electrostimulation|electrostimulation
1492332|NCT00809120|COPD|copd
1492333|NCT00809120|Tolerance|tolerance
1492334|NCT00809120|Muscle fatigue|muscle fatigue
1492335|NCT00809120|Cardio-respiratory response|cardio-respiratory response
1492336|NCT00809107|natural cycle|natural cycle
1492337|NCT00809107|FET|fet
1492338|NCT00809107|spontaneous LH pic|spontaneous lh pic
1492339|NCT00809107|HCG|hcg
1492340|NCT00809081|periampullar carcinoma|periampullar carcinoma
1492341|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
1492342|NCT00809081|Enteral feeding|enteral feeding
1492343|NCT00809081|Total Parenteral Support|total parenteral support
1492344|NCT00809068|Menopause|menopause
1492345|NCT00809068|menopausal symptoms|menopausal symptoms
1492346|NCT00809068|tibolone|tibolone
1492347|NCT00809068|HDL-C|hdl-c
1492348|NCT00809068|fenofibrate|fenofibrate
1492349|NCT00809042|Hydroxyurea|hydroxyurea
1492350|NCT00809042|magnesium chloride|magnesium chloride
1492351|NCT00809042|L-carnitine|l-carnitine
1492352|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
1492353|NCT00809029|GIP|gip
1492354|NCT00809029|OBESITY|obesity
1492355|NCT00809029|HSL|hsl
1492356|NCT00809029|LPL|lpl
1492357|NCT00809029|ADIPOCYTOKINES|adipocytokines
1492358|NCT00809029|BARIATRIC SURGERY|bariatric surgery
1492359|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1492360|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1492361|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1492362|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1492363|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1492364|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1492365|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1492366|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1492367|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1492368|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1492369|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1492370|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1492371|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1492372|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1492373|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1492374|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1492375|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1492376|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1492377|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1492378|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1492379|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1492380|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1492381|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1492382|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1492383|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1492384|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1492385|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1492386|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1492387|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1492388|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1492389|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1492390|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1492391|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1492392|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1492393|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1492394|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
1493023|NCT00806663|DCE-USI|dce-usi
1492395|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1492396|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1492397|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1492398|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1492399|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1492400|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1492401|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1492402|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
1492403|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
1492404|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
1492405|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
1492406|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
1492407|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
1492408|NCT00808990|Probiotics|probiotics
1492409|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
1492410|NCT00808964|CABG|cabg
1492411|NCT00808964|anticoagulant|anticoagulant
1492412|NCT00808964|Off-Pump CABG|off-pump cabg
1492413|NCT00808951|Uncomplicated malaria|uncomplicated malaria
1492414|NCT00808951|P falciparum|p falciparum
1492415|NCT00808951|Children|children
1492416|NCT00808951|National treatment protocol|national treatment protocol
1492417|NCT00808951|Burkina Faso|burkina faso
1492418|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
1492419|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
1492420|NCT00808951|In vivo efficacy|in vivo efficacy
1492421|NCT00808951|In vitro efficacy|in vitro efficacy
1492422|NCT00808925|acclimation|acclimation
1492423|NCT00808925|heat|heat
1492424|NCT00808925|cytokines|cytokines
1492425|NCT00808925|stress|stress
1492426|NCT00808925|inflammation|inflammation
1492427|NCT00808912|phosphodiesterase|phosphodiesterase
1492428|NCT00808912|sildenafil|sildenafil
1492429|NCT00808912|pulmonary hypertension|pulmonary hypertension
1492430|NCT00808912|exercise performance|exercise performance
1492431|NCT00808912|air pollution|air pollution
1492432|NCT00808899|Neuroblastoma|neuroblastoma
1492433|NCT00808886|cataract|cataract
1492434|NCT00808886|locs3|locs3
1492435|NCT00808886|pentacam|pentacam
1492436|NCT00808873|attempted suicide|attempted suicide
1492437|NCT00808873|socio-educational intervention|socio-educational intervention
1492438|NCT00808873|follow up study|follow up study
1492439|NCT00808860|Herbal medicine|herbal medicine
1492440|NCT00808860|Type 2 diabetes|type 2 diabetes
1492441|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
1492442|NCT00808860|Insulin sensitivity|insulin sensitivity
1492443|NCT00808860|add-on|add-on
1492444|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
1492445|NCT00808795|Acute kidney injury|acute kidney injury
1492446|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
1492447|NCT00808795|Chronic kidney disease|chronic kidney disease
1492448|NCT00808795|Diabetes mellitus|diabetes mellitus
1492449|NCT00808795|N-acetylcysteine|n-acetylcysteine
1492450|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
1492451|NCT00808782|Asperger Syndrome|asperger syndrome
1492452|NCT00808782|Autism|autism
1492453|NCT00808756|Carbohydrates|carbohydrates
1492454|NCT00808756|Infant|infant
1492455|NCT00808756|Intestine|intestine
1492456|NCT00808756|Faeces|faeces
1492458|NCT00808756|Diet|diet
1492459|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
1492460|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
1492461|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
1492462|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
1492463|NCT00808743|Intestinal disease|intestinal disease
1492464|NCT00808743|Intestinal neoplasms|intestinal neoplasms
1492465|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
1492466|NCT00808743|Polyps|polyps
1492467|NCT00808743|Adenoma|adenoma
1492468|NCT00808743|Adenomatous Polyps|adenomatous polyps
1492469|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
1492470|NCT00808743|Digestive System Diseases|digestive system diseases
1492471|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
1492472|NCT00808743|Chemoprevention|chemoprevention
1492473|NCT00808743|Celecoxib|celecoxib
1492474|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
1492475|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1492476|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
1492477|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
1492478|NCT00808717|Myocardial Infarction|myocardial infarction
1492479|NCT00808717|Coronary Angioplasty|coronary angioplasty
1492480|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
1492481|NCT00808704|asphyxia|asphyxia
1492482|NCT00808704|erythropoietin|erythropoietin
1492483|NCT00808704|neonates|neonates
1492484|NCT00808678|Adverse Events|adverse events
1492485|NCT00808665|Lumbar Fusion|lumbar fusion
1492486|NCT00808665|Inflammation|inflammation
1492487|NCT00808665|Dexmedetomidine|dexmedetomidine
1492488|NCT00808665|Length of Hospital Stay|length of hospital stay
1492489|NCT00808665|General Anesthesia|general anesthesia
1492490|NCT00808665|Anti-inflammatory|anti-inflammatory
1492492|NCT00808665|Cytokine|cytokine
1492493|NCT00808665|Immune Response|immune response
1492494|NCT00808639|pegfilgrastim|pegfilgrastim
1492495|NCT00808639|MVAC|mvac
1492496|NCT00808600|lung transplantation|lung transplantation
1492497|NCT00808600|heart-lung transplantation|heart-lung transplantation
1492498|NCT00808600|rehabilitation|rehabilitation
1492499|NCT00808600|resource-activating training|resource-activating training
1492500|NCT00808600|anaerobic exercise training|anaerobic exercise training
1492501|NCT00808587|Genomic Scan|genomic scan
1492502|NCT00808587|Personalized Medicine|personalized medicine
1492503|NCT00808587|Gene testing|gene testing
1492504|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
1492505|NCT00808574|Internet|internet
1492506|NCT00808574|Screening|screening
1492507|NCT00808574|Health belief model|health belief model
1492508|NCT00808548|stress|stress
1492509|NCT00808548|carer's experiences|carer's experiences
1492510|NCT00808548|Prader-willi syndrome|prader-willi syndrome
1492511|NCT00808548|personal experiences|personal experiences
1492513|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
1492514|NCT00808535|Vasomotor Stress|vasomotor stress
1492515|NCT00808535|Cold Pressor Test|cold pressor test
1492516|NCT00808535|Adenosine Stress|adenosine stress
1492517|NCT00808522|Breast Cancer|breast cancer
1492518|NCT00808522|Chemoprevention|chemoprevention
1492519|NCT00808522|Tamoxifen|tamoxifen
1492520|NCT00808522|Breast density|breast density
1492521|NCT00808522|Hcg|hcg
1492522|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
1492523|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
1492524|NCT00808496|Radiography|radiography
1492525|NCT00808496|Randomized controlled trial|randomized controlled trial
1492526|NCT00808496|Antirheumatic agents|antirheumatic agents
1492527|NCT00808483|total hip arthroplasty|total hip arthroplasty
1492528|NCT00808483|physical functioning|physical functioning
1492529|NCT00808483|training program|training program
1492530|NCT00808483|self-efficacy|self-efficacy
1492531|NCT00808483|exercise therapy|exercise therapy
1492532|NCT00808483|walking|walking
1492533|NCT00808470|Noise|noise
1492534|NCT00808470|Hearing Loss|hearing loss
1492535|NCT00808470|Tinnitus|tinnitus
1492536|NCT00808470|Antioxidant|antioxidant
1492537|NCT00808470|Vasodilator|vasodilator
1492538|NCT00808470|Beta-Carotene|beta-carotene
1492539|NCT00808470|Vitamin C|vitamin c
1492540|NCT00808470|Vitamin E|vitamin e
1492541|NCT00808470|Magnesium|magnesium
1492542|NCT00808457|chest ultrasound|chest ultrasound
1492543|NCT00808457|pneumonia|pneumonia
1492544|NCT00808457|X-ray|x-ray
1492545|NCT00808457|CT|ct
1492546|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
1492547|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
1492548|NCT00808444|Immunogenicity|immunogenicity
1492549|NCT00808444|Primary vaccination|primary vaccination
1492550|NCT00808444|Safety|safety
1492551|NCT00808444|Pneumococcal disease|pneumococcal disease
1492552|NCT00808431|Obesity|obesity
1492553|NCT00808431|Diabetes|diabetes
1492554|NCT00808431|Physical Activity|physical activity
1492555|NCT00808431|Child Feeding|child feeding
1492556|NCT00808431|Growth Trajectories|growth trajectories
1492557|NCT00808431|Family based|family based
1492558|NCT00808418|prostate|prostate
1492559|NCT00808418|cancer|cancer
1492560|NCT00808418|metastatic|metastatic
1492561|NCT00808418|castration|castration
1492562|NCT00808418|refractory|refractory
1492563|NCT00808418|elesclomol|elesclomol
1492564|NCT00808418|sodium|sodium
1492565|NCT00808418|docetaxel|docetaxel
1492566|NCT00808418|prednisone|prednisone
1492567|NCT00808405|herpes simplex virus|herpes simplex virus
1492568|NCT00808405|acyclovir|acyclovir
1492569|NCT00808405|HSV shedding|hsv shedding
1492570|NCT00808405|women|women
1492571|NCT00808405|Africa|africa
1492572|NCT00808392|vaccine|vaccine
1492573|NCT00808392|prevention|prevention
1492574|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
1492575|NCT00808392|children|children
1492576|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
1492578|NCT00808327|Cesarean section|cesarean section
1492579|NCT00808327|Spinal|spinal
1492580|NCT00808314|Lexiscan(TM)|lexiscan(tm)
1492581|NCT00808314|Dipyridamole|dipyridamole
1492582|NCT00808314|Myocardial Perfusion|myocardial perfusion
1492583|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
1492584|NCT00808301|Coeliac disease|coeliac disease
1492585|NCT00808301|Oat|oat
1492586|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
1492587|NCT00808275|dietary calcium|dietary calcium
1492588|NCT00808275|weight loss|weight loss
1492589|NCT00808262|anti-TNFa|anti-tnfa
1492590|NCT00808262|immunization|immunization
1492591|NCT00808262|kinoid|kinoid
1492592|NCT00808262|crohn's disease|crohn's disease
1492593|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
1492594|NCT00808249|GAD|gad
1492595|NCT00808249|Anxiety|anxiety
1492596|NCT00808236|Cardiac Arrest|cardiac arrest
1492597|NCT00808236|Pre-hospital|pre-hospital
1492598|NCT00808236|Mild hypothermia|mild hypothermia
1492599|NCT00808236|Resuscitation|resuscitation
1492600|NCT00808223|alefacept|alefacept
1492601|NCT00808223|adolescent|adolescent
1492602|NCT00808223|psoriasis|psoriasis
1492603|NCT00808210|RA|ra
1492604|NCT00808210|Arthritis|arthritis
1492605|NCT00808197|AMD|amd
1492606|NCT00808197|choroidal blood flow|choroidal blood flow
1492607|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
1492608|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
1492609|NCT00808171|lumbar punction|lumbar punction
1492610|NCT00808171|myelogram|myelogram
1492611|NCT00808171|pain assessment|pain assessment
1492612|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
1492613|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
1492614|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
1492615|NCT00808132|Postmenopausal Women|postmenopausal women
1492616|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
1492617|NCT00808106|Albinism|albinism
1492618|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
1492619|NCT00808106|Pigmentation|pigmentation
1492620|NCT00808106|Natural History|natural history
1492621|NCT00808106|Vesical Biology|vesical biology
1492622|NCT00808093|Food Effect|food effect
1492623|NCT00808093|GSK256073F|gsk256073f
1492624|NCT00808093|TRIS Salt|tris salt
1492625|NCT00808080|AML|aml
1492626|NCT00808054|Pain|pain
1492627|NCT00808054|preterm neonate|preterm neonate
1492628|NCT00808054|pain assessment|pain assessment
1492629|NCT00808054|EMLA|emla
1492630|NCT00808054|oral glucose|oral glucose
1492631|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
1492632|NCT00808041|Therapy Response|therapy response
1492633|NCT00808041|Breast Computed Tomography|breast computed tomography
1492634|NCT00808015|Observational non-interventional trial|observational non-interventional trial
1492635|NCT00808002|Maraviroc|maraviroc
1492636|NCT00808002|CCR5 antagonists|ccr5 antagonists
1492637|NCT00808002|Primary HIV Infection|primary hiv infection
1492638|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
1492639|NCT00808002|eradication|eradication
1492640|NCT00808002|treatment naive|treatment naive
1492641|NCT00807976|Diabetes mellitus|diabetes mellitus
1492642|NCT00807976|Elderly|elderly
1492643|NCT00807976|Orthostatic hypotension|orthostatic hypotension
1492644|NCT00807963|Pharmacokinetics|pharmacokinetics
1492645|NCT00807963|rHuPH20|rhuph20
1492646|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
1492647|NCT00807937|GAD|gad
1492648|NCT00807937|Anxiety|anxiety
1492649|NCT00807924|Fibroadenomas|fibroadenomas
1492650|NCT00807924|Papillomas|papillomas
1492651|NCT00807924|Breast|breast
1492652|NCT00807924|Minimally invasive|minimally invasive
1492653|NCT00807924|Interstitial laser therapy|interstitial laser therapy
1492654|NCT00807924|Laser ablation|laser ablation
1492655|NCT00807924|Benign|benign
1492656|NCT00807924|Non-cancerous|non-cancerous
1492657|NCT00807924|Breast lesion|breast lesion
1492658|NCT00807924|Breast tumor|breast tumor
1492659|NCT00807911|rectal cancer|rectal cancer
1492660|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
1492661|NCT00807911|FOLFOX|folfox
1492662|NCT00807898|Gardasil|gardasil
1492663|NCT00807898|HPV vaccine|hpv vaccine
1492664|NCT00807898|decision making|decision making
1492665|NCT00807898|mother|mother
1492666|NCT00807898|daughter|daughter
1492667|NCT00807885|dehydration|dehydration
1492668|NCT00807885|fluid therapy|fluid therapy
1492669|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1492670|NCT00807885|hyaluronidase|hyaluronidase
1492671|NCT00807885|hypodermoclysis|hypodermoclysis
1492672|NCT00807885|clysis|clysis
1492673|NCT00807885|subcutaneous hydration|subcutaneous hydration
1492674|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
1492675|NCT00807885|hyaluronan|hyaluronan
1492676|NCT00807885|rHuPH20|rhuph20
1492677|NCT00807872|Radioimmunoimaging|radioimmunoimaging
1492678|NCT00807872|AL Amyloidosis|al amyloidosis
1492679|NCT00807872|PET/CT|pet/ct
1492680|NCT00807859|AMG 386|amg 386
1492681|NCT00807859|Paclitaxel|paclitaxel
1492682|NCT00807859|Trastuzumab|trastuzumab
1492683|NCT00807859|Capecitabine|capecitabine
1492684|NCT00807859|Lapatinib|lapatinib
1492685|NCT00807859|HER2-positive|her2-positive
1492686|NCT00807859|metastatic breast cancer|metastatic breast cancer
1492687|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
1492688|NCT00807859|Taxol|taxol
1492689|NCT00807859|Herceptin|herceptin
1492690|NCT00807859|Xeloda|xeloda
1492691|NCT00807859|Tykerb|tykerb
1492692|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
1492693|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
1492695|NCT00807833|TBI|tbi
1492696|NCT00807820|Prostate Cancer|prostate cancer
1492697|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
1492698|NCT00807807|Folate|folate
1492699|NCT00807807|Homocysteine|homocysteine
1492700|NCT00807807|Supplements|supplements
1492701|NCT00807807|Folic Acid|folic acid
1492702|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1492703|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1492704|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
1492705|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
1492706|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
1492707|NCT00807742|Contingency Management|contingency management
1492708|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
1492709|NCT00807729|Laparoscopy|laparoscopy
1492710|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1492711|NCT00807729|Sphincterotomy|sphincterotomy
1492712|NCT00807729|Common bile duct stones|common bile duct stones
1492713|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
1492714|NCT00807729|Cost efficiency|cost efficiency
1492715|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
1492716|NCT00807716|physiotherapy|physiotherapy
1492717|NCT00807716|functional outcome|functional outcome
1492718|NCT00807716|activity level|activity level
1492719|NCT00807716|self efficacy|self efficacy
1492720|NCT00807716|task oriented exercises|task oriented exercises
1492721|NCT00807703|Parkinson|parkinson
1492722|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
1492723|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
1492724|NCT00807703|Parkinson patients|parkinson patients
1492725|NCT00807690|vitiligo|vitiligo
1492726|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
1492727|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
1492728|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
1492729|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
1492730|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
1492731|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
1492732|NCT00807651|Diabetes Mellitus|diabetes mellitus
1492733|NCT00807651|Stem cells|stem cells
1492734|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
1492735|NCT00807651|Autoimmune diseases|autoimmune diseases
1492736|NCT00807625|HIV/AIDS|hiv/aids
1492737|NCT00807625|Contraception|contraception
1492738|NCT00807625|Birth control|birth control
1492739|NCT00807625|CD4+|cd4+
1492740|NCT00807625|Viral Load|viral load
1492741|NCT00807625|T-cell activation|t-cell activation
1492742|NCT00807625|B-cell activation|b-cell activation
1492743|NCT00807625|Hormonal|hormonal
1492744|NCT00807625|Intrauterine device|intrauterine device
1492745|NCT00807625|Depo Provera|depo provera
1492746|NCT00807625|Women|women
1492747|NCT00807625|IUCD|iucd
1492748|NCT00807625|treatment naive|treatment naive
1492749|NCT00807612|AMG 479|amg 479
1492750|NCT00807612|IGF-1R|igf-1r
1492751|NCT00807612|Apoptosis|apoptosis
1492752|NCT00807612|Monoclonal Antibody|monoclonal antibody
1492753|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
1492754|NCT00807612|antibody 1st-line|antibody 1st-line
1492755|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1492756|NCT00807599|DEXAMETHASONE|dexamethasone
1492757|NCT00807599|G-CSF|g-csf
1492758|NCT00807599|Lenalidomide|lenalidomide
1492759|NCT00807599|MELPHALAN|melphalan
1492760|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
1492761|NCT00807599|08-121|08-121
1492762|NCT00807586|Atrial Fibrillation|atrial fibrillation
1492763|NCT00807586|Corticosteroid|corticosteroid
1492764|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
1492765|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1492766|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
1492767|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1492768|NCT00807573|08-109|08-109
1492769|NCT00807560|Overweight|overweight
1492770|NCT00807560|Obesity|obesity
1492771|NCT00807560|Adolescents|adolescents
1492772|NCT00807560|Family Therapy|family therapy
1492773|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1492774|NCT00807534|Exercise|exercise
1492775|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
1492776|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
1492777|NCT00807534|Bronchodilation|bronchodilation
1492778|NCT00807534|Ipratropium bromide|ipratropium bromide
1492779|NCT00807495|MLN8237|mln8237
1492780|NCT00807495|Alisertib|alisertib
1492781|NCT00807495|Drug therapy|drug therapy
1492782|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1492783|NCT00807482|Mucociliary Clearance|mucociliary clearance
1492784|NCT00807482|Genetic Mutation|genetic mutation
1492785|NCT00807469|COPD|copd
1492786|NCT00807469|smoking|smoking
1492787|NCT00807469|susceptibility|susceptibility
1492788|NCT00807469|inflammation|inflammation
1492789|NCT00807469|genetic|genetic
1492790|NCT00807443|HIV-1|hiv-1
1492791|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
1492792|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
1492793|NCT00807443|treatment experienced|treatment experienced
1492794|NCT00807430|Bruxism|bruxism
1492795|NCT00807430|EMG|emg
1492796|NCT00807430|Biofeedback|biofeedback
1492797|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
1492798|NCT00807391|lung cancer|lung cancer
1492799|NCT00807391|transbronchial biopsy|transbronchial biopsy
1492800|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
1492801|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
1492802|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
1492803|NCT00807391|bronchoscopy|bronchoscopy
1492804|NCT00807378|CNS viral infection|cns viral infection
1492805|NCT00807378|PCR|pcr
1492806|NCT00807378|HYBRIDIZATION|hybridization
1492807|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
1492808|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
1492809|NCT00807365|Aging|aging
1492810|NCT00807365|Growth Hormone|growth hormone
1492811|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
1492812|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
1492813|NCT00807365|Hormones|hormones
1492814|NCT00807352|Triage|triage
1492815|NCT00807352|Pediatrics|pediatrics
1492816|NCT00807352|Emergency Department|emergency department
1492817|NCT00807339|CyberKnife|cyberknife
1492818|NCT00807326|Antidiarrheals|antidiarrheals
1492819|NCT00807313|Oligometastatic disease|oligometastatic disease
1492820|NCT00807313|Colorectal cancer|colorectal cancer
1492821|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
1492822|NCT00807313|Tomotherapy|tomotherapy
1492823|NCT00807313|Metabolic response|metabolic response
1492824|NCT00807313|Stage IV|stage iv
1492825|NCT00807300|percutaneous treatment|percutaneous treatment
1492826|NCT00807287|jejunal tube placement|jejunal tube placement
1492827|NCT00807274|Adult congenital heart disease|adult congenital heart disease
1492828|NCT00807274|Heart failure|heart failure
1492829|NCT00807274|Renal failure|renal failure
1492830|NCT00807274|Proteinuria|proteinuria
1492831|NCT00807235|Lucinactant|lucinactant
1492832|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
1492833|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
1492834|NCT00807235|Pediatric|pediatric
1492835|NCT00807235|Premature|premature
1492836|NCT00807222|ADHD|adhd
1492837|NCT00807222|Vyvanse|vyvanse
1492838|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
1492839|NCT00807222|LDX|ldx
1492840|NCT00807222|sleep|sleep
1492841|NCT00807209|Pain|pain
1492842|NCT00807209|postoperative|postoperative
1492843|NCT00807209|thoracotomy|thoracotomy
1492844|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1492845|NCT00807196|Zevalin|zevalin
1492846|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1492847|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1492848|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
1492849|NCT00807170|metastasis|metastasis
1492850|NCT00807157|PROBIOSTICK®|probiostick®
1492851|NCT00807157|Probiotic|probiotic
1492852|NCT00807157|Anxiety|anxiety
1492853|NCT00807157|Daily stress|daily stress
1492854|NCT00807144|Kidney transplant|kidney transplant
1492855|NCT00807144|Rejection|rejection
1492856|NCT00807144|Adherence|adherence
1492857|NCT00807144|Quality of life|quality of life
1492858|NCT00807131|pharmacy care|pharmacy care
1492859|NCT00807131|hypertension|hypertension
1492860|NCT00807131|primary care|primary care
1492861|NCT00807131|adherence|adherence
1492862|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
1492863|NCT00807105|MOOD EVALUATION|mood evaluation
1492864|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
1492865|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
1492866|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
1492867|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
1492868|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1492869|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1492870|NCT00807066|QUALITY OF LIFE|quality of life
1492871|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1492872|NCT00807053|Ciclesonide|ciclesonide
1492873|NCT00807053|SAR|sar
1492874|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1492875|NCT00807040|Mitral Valve Disease|mitral valve disease
1492876|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
1492877|NCT00807027|Glioblastoma|glioblastoma
1492878|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
1492879|NCT00807014|Differin|differin
1492880|NCT00807014|quality of life|quality of life
1492881|NCT00807014|Acne|acne
1492882|NCT00807014|Duac|duac
1492883|NCT00807014|Acne Vulgaris|acne vulgaris
1492884|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
1492885|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1492886|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
1492887|NCT00806910|Heart Failure|heart failure
1492888|NCT00806910|conivaptan|conivaptan
1492889|NCT00806910|Diuresis|diuresis
1492890|NCT00806884|Cystic Fibrosis|cystic fibrosis
1492891|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
1492892|NCT00806884|Manual therapy|manual therapy
1492893|NCT00806884|Posture|posture
1492894|NCT00806884|Pain|pain
1492895|NCT00806845|HIV|hiv
1492896|NCT00806845|B-lymphocyte|b-lymphocyte
1492897|NCT00806832|Medical clowns|medical clowns
1492898|NCT00806832|Cataract surgery|cataract surgery
1492899|NCT00806832|Blood pressure|blood pressure
1492900|NCT00806832|Heart rate|heart rate
1492901|NCT00806806|pain management|pain management
1492902|NCT00806806|postoperative|postoperative
1492903|NCT00806780|gallstones|gallstones
1492904|NCT00806780|cholangiography|cholangiography
1492905|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1492906|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1492907|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1492908|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1492909|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1492910|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1492911|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1492912|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1492913|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1492914|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1492915|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1492916|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1492917|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1492918|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1492919|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1492920|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1492921|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1492922|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1492923|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1492924|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1492925|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1492926|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1492927|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1492928|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1492929|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1492930|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1492931|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1492932|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1492933|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1492934|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1492935|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1492936|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1492937|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1492938|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1492939|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1492940|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1492941|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1492942|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1492943|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1492944|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1492945|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1492946|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1492947|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1492948|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1492949|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1492950|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1492951|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1492952|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1492953|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1492954|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1492955|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1492956|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1492957|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1492958|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1492959|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1492960|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1492961|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1492962|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1492963|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1492964|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1492965|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1492966|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1492967|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1492968|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1493055|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
1492969|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1492970|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1492971|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1492972|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1492973|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1492974|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1492975|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1492976|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1492977|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1492978|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
1492979|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1492980|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1492981|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1492982|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1492983|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1492984|NCT00806767|primary myelofibrosis|primary myelofibrosis
1492985|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1492986|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1492987|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1492988|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1492989|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1492990|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
1492991|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
1492992|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
1492993|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
1492994|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
1492995|NCT00806754|Ciclesonide|ciclesonide
1492996|NCT00806754|PAR|par
1492997|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
1492998|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
1492999|NCT00806741|Intraocular Pressure|intraocular pressure
1493000|NCT00806741|Regional blood flow|regional blood flow
1493001|NCT00806741|Ocular Physiology|ocular physiology
1493002|NCT00806741|Optic Disk|optic disk
1493003|NCT00806715|hemochromatosis|hemochromatosis
1493004|NCT00806715|Iron overload|iron overload
1493005|NCT00806715|Stem cell transplant|stem cell transplant
1493006|NCT00806715|Pediatrics|pediatrics
1493007|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
1493008|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
1493009|NCT00806689|follow-up|follow-up
1493010|NCT00806689|atrial fibrillation success|atrial fibrillation success
1493011|NCT00806676|chronic kidney disease|chronic kidney disease
1493012|NCT00806676|children|children
1493013|NCT00806676|dialysis|dialysis
1493014|NCT00806676|kidney transplant|kidney transplant
1493015|NCT00806676|human papilloma virus|human papilloma virus
1493016|NCT00806676|Gardasil|gardasil
1493017|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
1493018|NCT00806663|mCRC|mcrc
1493019|NCT00806663|colorectal cancer|colorectal cancer
1493020|NCT00806663|FOLFIRI|folfiri
1493021|NCT00806663|sunitinib|sunitinib
1493024|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
1493025|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
1493026|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
1493027|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
1493028|NCT00806637|Vessel sealing system|vessel sealing system
1493029|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
1493030|NCT00806637|UPPP|uppp
1493031|NCT00806637|uvulopalatal flap|uvulopalatal flap
1493032|NCT00806637|bleeding|bleeding
1493033|NCT00806637|operative time|operative time
1493034|NCT00806637|adverse effects|adverse effects
1493035|NCT00806611|pancreatic cancer|pancreatic cancer
1493036|NCT00806611|periampullary cancer|periampullary cancer
1493037|NCT00806611|resectable|resectable
1493038|NCT00806611|unresectable|unresectable
1493039|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
1493040|NCT00806611|surgery|surgery
1493041|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
1493042|NCT00806598|Aplastic Anemia|aplastic anemia
1493043|NCT00806598|Thymoglobulin|thymoglobulin
1493044|NCT00806598|Cyclosporine|cyclosporine
1493045|NCT00806598|Methylprednisolone|methylprednisolone
1493046|NCT00806598|G-CSF|g-csf
1493047|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
1493048|NCT00806559|effects clinical space|effects clinical space
1493049|NCT00806559|follow-up appointments|follow-up appointments
1493050|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
1493051|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
1493052|NCT00806520|Januvia or|januvia or
1493053|NCT00806520|Actos|actos
1493054|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
1493155|NCT00806169|efficacy|efficacy
1493056|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
1493057|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
1493058|NCT00806507|Roche 2010 system|roche 2010 system
1493059|NCT00806507|Echocardiography|echocardiography
1493060|NCT00806507|Herceptin|herceptin
1493061|NCT00806494|Fesoterodine|fesoterodine
1493062|NCT00806494|Open Label|open label
1493063|NCT00806494|Flexible Dose|flexible dose
1493064|NCT00806494|OAB|oab
1493065|NCT00806481|Phosphate|phosphate
1493066|NCT00806468|nycturia|nycturia
1493067|NCT00806468|Parkinson syndrome|parkinson syndrome
1493068|NCT00806468|desmopressin|desmopressin
1493069|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
1493070|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
1493071|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
1493072|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
1493073|NCT00806442|Asthma|asthma
1493074|NCT00806442|Fatty acids|fatty acids
1493075|NCT00806442|Leukotrienes|leukotrienes
1493076|NCT00806442|Diet|diet
1493077|NCT00806429|appendicitis|appendicitis
1493078|NCT00806429|surgery|surgery
1493079|NCT00806429|laparoscopy|laparoscopy
1493080|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
1493081|NCT00806403|thrombolysis|thrombolysis
1493082|NCT00806403|primary PCI|primary pci
1493083|NCT00806403|abciximab|abciximab
1493084|NCT00806403|ST-segment resolution|st-segment resolution
1493085|NCT00806403|TIMI flow|timi flow
1493086|NCT00806390|ejection fraction|ejection fraction
1493087|NCT00806390|anthracyclines|anthracyclines
1493088|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
1493089|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
1493090|NCT00806377|Electromagnetic field|electromagnetic field
1493091|NCT00806377|Oversensing|oversensing
1493092|NCT00806377|Non-thoracic surgery|non-thoracic surgery
1493093|NCT00806364|Healthy Volunteers|healthy volunteers
1493094|NCT00806364|Allergy|allergy
1493095|NCT00806364|Bone Marrow|bone marrow
1493096|NCT00806364|Buccal Mucosa|buccal mucosa
1493097|NCT00806364|HV|hv
1493098|NCT00806364|Healthy Volunteer|healthy volunteer
1493099|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
1493100|NCT00806325|Severe Sepsis|severe sepsis
1493101|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
1493102|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
1493103|NCT00806312|MiRNA|mirna
1493104|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
1493105|NCT00806273|debridement|debridement
1493106|NCT00806273|root canal|root canal
1493107|NCT00806260|Overweight|overweight
1493108|NCT00806260|Obesity|obesity
1493109|NCT00806260|coordination|coordination
1493110|NCT00806260|psychomotor|psychomotor
1493111|NCT00806247|Tapentadol|tapentadol
1493112|NCT00806247|Bunionectomy|bunionectomy
1493113|NCT00806247|Analgesia|analgesia
1493114|NCT00806247|Acute pain|acute pain
1493115|NCT00806247|Postsurgical pain|postsurgical pain
1493116|NCT00806234|Weight Gain|weight gain
1493117|NCT00806234|Obesity|obesity
1493118|NCT00806234|IMPACT|impact
1493119|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
1493317|NCT00805298|third molar|third molar
1493120|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
1493121|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
1493122|NCT00806234|Reducing Weight Gain|reducing weight gain
1493123|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
1493124|NCT00806234|Aripiprazole|aripiprazole
1493125|NCT00806234|Metformin|metformin
1493126|NCT00806234|Risperdal|risperdal
1493127|NCT00806234|Seroquel|seroquel
1493128|NCT00806234|Quetiapine|quetiapine
1493129|NCT00806234|Olanzapine|olanzapine
1493130|NCT00806234|Zyprexa|zyprexa
1493131|NCT00806234|Geodon|geodon
1493132|NCT00806234|Risperidone|risperidone
1493133|NCT00806234|Abilify|abilify
1493134|NCT00806234|Trilafon|trilafon
1493135|NCT00806234|Perphenazine|perphenazine
1493136|NCT00806234|Glucophage|glucophage
1493137|NCT00806234|Paliperidone|paliperidone
1493138|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
1493139|NCT00806221|Atopic Dermatitis|atopic dermatitis
1493140|NCT00806221|Prevention|prevention
1493141|NCT00806221|Skin Barrier|skin barrier
1493142|NCT00806195|vaccine|vaccine
1493143|NCT00806195|infants|infants
1493144|NCT00806195|healthy|healthy
1493145|NCT00806195|meningitis|meningitis
1493146|NCT00806195|meningococcal|meningococcal
1493147|NCT00806182|paraneoplastic|paraneoplastic
1493148|NCT00806182|neuroblastoma|neuroblastoma
1493149|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
1493150|NCT00806182|autoimmune disease|autoimmune disease
1493151|NCT00806182|immunotherapy|immunotherapy
1493152|NCT00806182|ataxia|ataxia
1493153|NCT00806169|combined therapy|combined therapy
1493154|NCT00806169|DRP|drp
1493156|NCT00806169|safety|safety
1493157|NCT00806169|sustainability|sustainability
1493158|NCT00806169|macular edema due to DRP|macular edema due to drp
1493159|NCT00806143|Depression|depression
1493160|NCT00806143|TMS|tms
1493161|NCT00806117|Cervical cancer|cervical cancer
1493162|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
1493163|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
1493164|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
1493165|NCT00806078|Healthy|healthy
1493166|NCT00806078|Bioequivalence|bioequivalence
1493167|NCT00806078|Pharmacokinetics|pharmacokinetics
1493168|NCT00806039|Kidney Failure, Acute|kidney failure, acute
1493169|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
1493170|NCT00806039|Kidney Failure|kidney failure
1493171|NCT00806039|Renal Insufficiency|renal insufficiency
1493172|NCT00806026|RLS|rls
1493173|NCT00806013|genotype|genotype
1493174|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
1493175|NCT00805974|diapasom|diapasom
1493176|NCT00805974|sleep quality|sleep quality
1493177|NCT00805974|type I diabete|type i diabete
1493178|NCT00805974|blood pressure|blood pressure
1493179|NCT00805974|plasma glucose|plasma glucose
1493180|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
1493181|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
1493182|NCT00805961|Radiation Therapy|radiation therapy
1493183|NCT00805961|Temozolomide|temozolomide
1493184|NCT00805961|Bevacizumab|bevacizumab
1493185|NCT00805961|Everolimus|everolimus
1493186|NCT00805948|thoracic aneurysm|thoracic aneurysm
1493187|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
1493188|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
1493189|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
1493190|NCT00805935|pre-menopausal women|pre-menopausal women
1493191|NCT00805935|PCOS|pcos
1493192|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
1493193|NCT00805935|infertility|infertility
1493195|NCT00805935|in vitro fertilization|in vitro fertilization
1493196|NCT00805883|Prostate Neoplasm|prostate neoplasm
1493197|NCT00805883|Localized|localized
1493198|NCT00805883|Photothermal|photothermal
1493199|NCT00805883|Radical Prostatectomy|radical prostatectomy
1493200|NCT00805844|Spine|spine
1493201|NCT00805844|Motor Evoked Potentials|motor evoked potentials
1493202|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
1493203|NCT00805805|Copper|copper
1493204|NCT00805805|ceruloplasmin|ceruloplasmin
1493205|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
1493206|NCT00805792|Ischemic stroke|ischemic stroke
1493207|NCT00805792|treatment|treatment
1493208|NCT00805792|recovery|recovery
1493209|NCT00805792|donepezil|donepezil
1493210|NCT00805792|Aricept|aricept
1493211|NCT00805779|Overactive Bladder|overactive bladder
1493212|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
1493213|NCT00805779|Bladder, Overactive|bladder, overactive
1493214|NCT00805779|Overactive Detrusor|overactive detrusor
1493215|NCT00805779|Detrusor, Overactive|detrusor, overactive
1493216|NCT00805779|Overactive Detrusor Function|overactive detrusor function
1493217|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
1493218|NCT00805766|Infliximab|infliximab
1493219|NCT00805766|REMICADE|remicade
1493220|NCT00805766|Crohn's disease|crohn's disease
1493221|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
1493222|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1493223|NCT00805701|prostate|prostate
1493224|NCT00805701|cancer|cancer
1493225|NCT00805701|avodart|avodart
1493226|NCT00805701|dutasteride|dutasteride
1493227|NCT00805701|mitcheson|mitcheson
1493228|NCT00805688|Questionnaire|questionnaire
1493229|NCT00805688|Pancreas|pancreas
1493230|NCT00805688|Pancreatic Cancer|pancreatic cancer
1493231|NCT00805688|Metastatic Disease|metastatic disease
1493232|NCT00805688|symptom outcomes|symptom outcomes
1493233|NCT00805688|Biomarkers|biomarkers
1493234|NCT00805688|Pedometer|pedometer
1493235|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
1493236|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
1493237|NCT00805688|IVRS|ivrs
1493238|NCT00805675|Chronic HBV|chronic hbv
1493239|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
1493240|NCT00805662|IUI|iui
1493241|NCT00805662|oxytocin|oxytocin
1493242|NCT00805649|ARMD|armd
1493243|NCT00805649|combined therapy|combined therapy
1493244|NCT00805649|efficacy|efficacy
1493245|NCT00805649|safety|safety
1493246|NCT00805636|cell death|cell death
1493247|NCT00805636|PET imaging|pet imaging
1493248|NCT00805636|brain metastases|brain metastases
1493249|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
1493250|NCT00805623|sucrose|sucrose
1493251|NCT00805623|sucking|sucking
1493252|NCT00805623|pain relief|pain relief
1493253|NCT00805623|infant|infant
1493254|NCT00805623|require venous puncture|require venous puncture
1493255|NCT00805610|Liver Failure|liver failure
1493256|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
1493257|NCT00805610|Liver Transplantation|liver transplantation
1493258|NCT00805597|breast cancer|breast cancer
1493259|NCT00805597|mastectomy|mastectomy
1493260|NCT00805597|one to three positive nodes|one to three positive nodes
1493261|NCT00805597|radiotherapy|radiotherapy
1493262|NCT00805571|Rejection|rejection
1493263|NCT00805571|Infection|infection
1493264|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
1493265|NCT00805558|Chronic Periodontitis|chronic periodontitis
1493266|NCT00805558|antibiotics|antibiotics
1493267|NCT00805532|PTSD|ptsd
1493268|NCT00805532|depression|depression
1493269|NCT00805532|behavior therapy|behavior therapy
1493270|NCT00805532|veterans|veterans
1493271|NCT00805532|behavioral activation|behavioral activation
1493272|NCT00805532|usual care|usual care
1493273|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
1493274|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
1493275|NCT00805519|Prednisolone|prednisolone
1493276|NCT00805519|Chloroquine|chloroquine
1493277|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
1493278|NCT00805493|Mania|mania
1493279|NCT00805493|Bipolar|bipolar
1493280|NCT00805493|Bipolar Disorder|bipolar disorder
1493281|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
1493282|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
1493283|NCT00805480|Plaque|plaque
1493284|NCT00805480|psoriasis|psoriasis
1493285|NCT00805480|inflammatory skin disease|inflammatory skin disease
1493286|NCT00805480|skin condition, thickening|skin condition, thickening
1493287|NCT00805480|flaking|flaking
1493288|NCT00805480|scaly patches|scaly patches
1493289|NCT00805480|skin disease|skin disease
1493290|NCT00805467|RA|ra
1493291|NCT00805454|Healthy Volunteers|healthy volunteers
1493292|NCT00805454|Phase I|phase i
1493293|NCT00805454|Pet Scan|pet scan
1493294|NCT00805441|Alcoholic|alcoholic
1493295|NCT00805415|Oral Contraceptive|oral contraceptive
1493296|NCT00805415|Ovulation Inhibition|ovulation inhibition
1493297|NCT00805389|Adjuvant Systems|adjuvant systems
1493298|NCT00805389|Hepatitis B|hepatitis b
1493299|NCT00805376|Brain|brain
1493300|NCT00805376|Brain Cancer|brain cancer
1493301|NCT00805376|Central Nervous System Diseases|central nervous system diseases
1493302|NCT00805376|CNS|cns
1493303|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
1493304|NCT00805376|Delta-24-RGD|delta-24-rgd
1493305|NCT00805376|DNX-2401|dnx-2401
1493306|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
1493307|NCT00805376|malignant brain tumor|malignant brain tumor
1493308|NCT00805350|Insomnia|insomnia
1493309|NCT00805350|Sleep Maintenance|sleep maintenance
1493310|NCT00805350|Polysomnography|polysomnography
1493311|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
1493312|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
1493313|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
1493314|NCT00805311|Stroke|stroke
1493315|NCT00805311|Cerebrovascular|cerebrovascular
1493316|NCT00805311|Atherosclerosis|atherosclerosis
1493318|NCT00805298|postoperative pain|postoperative pain
1493319|NCT00805298|thermography|thermography
1493320|NCT00805298|postoperative inflammation|postoperative inflammation
1493321|NCT00805298|methylprednisolone|methylprednisolone
1493322|NCT00805298|local anaesthetic|local anaesthetic
1493323|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
1493324|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
1493325|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
1493326|NCT00805285|Ulcerative Colitis|ulcerative colitis
1493327|NCT00805285|Budesonide|budesonide
1493328|NCT00805285|Corticosteroids|corticosteroids
1493329|NCT00805272|HIV|hiv
1493330|NCT00805272|tuberculosis|tuberculosis
1493331|NCT00805272|IGRA|igra
1493332|NCT00805272|diagnosis|diagnosis
1493333|NCT00805272|treatment naive|treatment naive
1493334|NCT00805259|cognitive function|cognitive function
1493335|NCT00805259|elderly|elderly
1493336|NCT00805259|technology|technology
1493337|NCT00805259|financial incentives|financial incentives
1493338|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
1493339|NCT00805246|Pulmonary embolism|pulmonary embolism
1493340|NCT00805246|PE|pe
1493341|NCT00805246|CT|ct
1493342|NCT00805246|Biomarker|biomarker
1493343|NCT00805246|Prognosis|prognosis
1493344|NCT00805246|Risk Prediction|risk prediction
1493345|NCT00805233|Neovascular|neovascular
1493346|NCT00805233|AMD|amd
1493347|NCT00805233|Treatment|treatment
1493348|NCT00805233|Lucentis|lucentis
1493349|NCT00805233|Bromfenac|bromfenac
1493350|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
1493351|NCT00805207|PCOS|pcos
1493352|NCT00805207|sleep apnea|sleep apnea
1493353|NCT00805207|obese|obese
1493354|NCT00805207|VLDL metabolism|vldl metabolism
1493355|NCT00805207|isotope tracer|isotope tracer
1493356|NCT00805207|women|women
1493357|NCT00805155|Bioequivalence|bioequivalence
1493358|NCT00805155|Mometasone Furoate|mometasone furoate
1493359|NCT00805142|Pain|pain
1493360|NCT00805142|Cancer|cancer
1493361|NCT00805142|Tapentadol|tapentadol
1493362|NCT00805129|URETER|ureter
1493363|NCT00805129|URINARY BLADDER|urinary bladder
1493364|NCT00805129|RAD001|rad001
1493365|NCT00805129|Everolimus|everolimus
1493366|NCT00805129|Urothelium|urothelium
1493367|NCT00805129|08-123|08-123
1493368|NCT00805103|Brain Metastases|brain metastases
1493369|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
1493370|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
1493371|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
1493372|NCT00805090|Renal|renal
1493373|NCT00805090|Hepatic|hepatic
1493374|NCT00805090|Healthy|healthy
1493375|NCT00805077|interoperative care|interoperative care
1493376|NCT00805077|Tidal volume|tidal volume
1493377|NCT00805077|Postoperative complications|postoperative complications
1493378|NCT00805077|Pneumonectomy|pneumonectomy
1493379|NCT00805077|Lobectomy|lobectomy
1493380|NCT00805077|Mechanical ventilation|mechanical ventilation
1493381|NCT00805051|Aortic stenosis|aortic stenosis
1493382|NCT00805051|aortic valve replacement|aortic valve replacement
1493383|NCT00805051|von Willebrand disease|von willebrand disease
1493384|NCT00805051|blood loss|blood loss
1493385|NCT00805012|S-1|s-1
1493386|NCT00805012|docetaxel|docetaxel
1493387|NCT00805012|head and neck cancer|head and neck cancer
1493388|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
1493389|NCT00804999|confocal microscopy|confocal microscopy
1493390|NCT00804999|contact lens wear|contact lens wear
1493391|NCT00804999|contact lens solutions|contact lens solutions
1493392|NCT00804999|sodium fluorescein|sodium fluorescein
1493393|NCT00804973|Migraine|migraine
1493394|NCT00804973|Headache|headache
1493395|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
1493396|NCT00804960|Ovulation Induction|ovulation induction
1493397|NCT00804960|Letrozole|letrozole
1493398|NCT00804960|In Vitro Fertilization|in vitro fertilization
1493399|NCT00804947|Autologous transplantation|autologous transplantation
1493400|NCT00804947|Multiple Myeloma|multiple myeloma
1493401|NCT00804947|Intravenous Busulfan|intravenous busulfan
1493402|NCT00804921|bevacizumab|bevacizumab
1493403|NCT00804921|intra-ocular pressure|intra-ocular pressure
1493404|NCT00804921|acetazolamide|acetazolamide
1493405|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
1493406|NCT00804921|brimonidine|brimonidine
1493407|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
1493408|NCT00804908|Temozolomide|temozolomide
1493409|NCT00804908|Skin cancer|skin cancer
1493410|NCT00804908|Melanoma|melanoma
1493411|NCT00804908|Metastatic Melanoma|metastatic melanoma
1493412|NCT00804908|ABT-888|abt-888
1493413|NCT00804908|MM|mm
1493414|NCT00804895|cluster headache|cluster headache
1493415|NCT00804895|greater occipital nerve block|greater occipital nerve block
1493416|NCT00804895|cortivazol|cortivazol
1493417|NCT00804882|Metabolic syndrome|metabolic syndrome
1493418|NCT00804882|Heart failure|heart failure
1493419|NCT00804882|Mexican Americans|mexican americans
1493420|NCT00804882|Ethnic differences|ethnic differences
1493421|NCT00804882|Echocardiography|echocardiography
1493422|NCT00804830|adjuvant|adjuvant
1493423|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
1493424|NCT00804817|self management|self management
1493425|NCT00804817|adherence|adherence
1493426|NCT00804817|activity enhancement|activity enhancement
1493427|NCT00804817|oral mucositis prevention|oral mucositis prevention
1493428|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
1493429|NCT00804817|cancer|cancer
1493430|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1493431|NCT00804817|loss of activity|loss of activity
1493432|NCT00804804|Sleep|sleep
1493433|NCT00804804|aging|aging
1493434|NCT00804804|cognitives processes|cognitives processes
1493435|NCT00804804|constant routine|constant routine
1493436|NCT00804791|dry eye|dry eye
1493437|NCT00804791|autofluorescence|autofluorescence
1493438|NCT00804791|residence time|residence time
1493439|NCT00804778|CAD|cad
1493440|NCT00804778|CABG|cabg
1493441|NCT00804778|CO|co
1493442|NCT00804778|CI|ci
1493443|NCT00804778|thermodilution|thermodilution
1493444|NCT00804778|USCOM|uscom
1493445|NCT00804765|Prevention|prevention
1493446|NCT00804765|child obesity|child obesity
1493447|NCT00804765|pregnancy|pregnancy
1493448|NCT00804765|overweight women|overweight women
1493449|NCT00804765|obese women|obese women
1493450|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
1493451|NCT00804739|Major Depression|major depression
1493452|NCT00804739|Postpartum Depression|postpartum depression
1493453|NCT00804739|Perinatal Depression|perinatal depression
1493454|NCT00804739|Treatment Feasibility|treatment feasibility
1493455|NCT00804739|Treatment Engagement|treatment engagement
1493456|NCT00804739|Treatment Adherence|treatment adherence
1493457|NCT00804739|Postpartum|postpartum
1493458|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
1493459|NCT00804739|IPT|ipt
1493460|NCT00804739|Sertraline|sertraline
1493461|NCT00804739|Zoloft|zoloft
1493462|NCT00804726|Cataract extraction|cataract extraction
1493463|NCT00804726|Phacoemulsification|phacoemulsification
1493464|NCT00804713|TB|tb
1493465|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
1493466|NCT00804713|TB screening|tb screening
1493467|NCT00804700|synchronous|synchronous
1647880|NCT00208416|Hip|hip
1493468|NCT00804700|exercise|exercise
1493469|NCT00804700|music|music
1493470|NCT00804700|heartbeat|heartbeat
1493471|NCT00804700|tunes|tunes
1493472|NCT00804687|Allergy|allergy
1493473|NCT00804687|Rhinitis|rhinitis
1493474|NCT00804687|Allergic Rhinitis|allergic rhinitis
1493475|NCT00804687|JNJ-39220675|jnj-39220675
1493476|NCT00804687|Pseudoephedrine|pseudoephedrine
1493477|NCT00804674|bupivacain|bupivacain
1493478|NCT00804674|breast|breast
1493479|NCT00804674|reconstruction|reconstruction
1493480|NCT00804674|diep|diep
1493481|NCT00804674|pain|pain
1493482|NCT00804674|postoperative|postoperative
1493483|NCT00804674|catheter|catheter
1493484|NCT00804674|anesthesia|anesthesia
1493485|NCT00804661|sleep|sleep
1493486|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
1493487|NCT00804661|sleep quality|sleep quality
1493488|NCT00804661|lung function|lung function
1493489|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
1493490|NCT00804583|Cystic Fibrosis|cystic fibrosis
1493491|NCT00804583|Liver Disease|liver disease
1493492|NCT00804583|Genetic Modifiers|genetic modifiers
1493493|NCT00804557|Male Urinary Disorders|male urinary disorders
1493494|NCT00804557|Urinary catheterization|urinary catheterization
1493495|NCT00804557|Urinary retention|urinary retention
1493496|NCT00804544|Integrated SPECT/CT|integrated spect/ct
1493497|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
1493498|NCT00804544|Chemosensitivity|chemosensitivity
1493499|NCT00804531|Low back pain|low back pain
1493500|NCT00804531|steroid injection|steroid injection
1493501|NCT00804531|inter-vertebral disc|inter-vertebral disc
1493502|NCT00804531|randomized trial|randomized trial
1493503|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
1493504|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
1493505|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
1493506|NCT00804518|Aging|aging
1493507|NCT00804518|Diastolic dysfunction|diastolic dysfunction
1493508|NCT00804518|Systolic function|systolic function
1493509|NCT00804518|Exercise|exercise
1493510|NCT00804518|Echocardiography|echocardiography
1493511|NCT00804518|tissue Doppler imaging|tissue doppler imaging
1493512|NCT00804518|Cardiac function|cardiac function
1493513|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
1493514|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
1493515|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
1493983|NCT00802503|nutrition|nutrition
1493516|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
1493517|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
1493518|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
1493519|NCT00804466|Human Papillomavirus|human papillomavirus
1493520|NCT00804466|Natural History|natural history
1493521|NCT00804466|Cervical Cancer|cervical cancer
1493522|NCT00804466|Screening|screening
1493523|NCT00804453|Chronic Kidney Failure|chronic kidney failure
1493524|NCT00804453|Hemodialysis|hemodialysis
1493525|NCT00804453|Biocompatibility|biocompatibility
1493526|NCT00804440|bioequivalency|bioequivalency
1493527|NCT00804440|ibuprofen|ibuprofen
1493528|NCT00804427|Fish oil|fish oil
1493529|NCT00804427|Triglycerides|triglycerides
1493530|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
1493531|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
1493532|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
1493533|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
1493534|NCT00804414|Diabetes|diabetes
1493535|NCT00804414|Diabetic ulcer|diabetic ulcer
1493536|NCT00804414|Chronic ulcer|chronic ulcer
1493537|NCT00804414|SBG|sbg
1493538|NCT00804401|bioequivalency|bioequivalency
1493539|NCT00804401|Naproxen|naproxen
1493540|NCT00804388|Vitamine E|vitamine e
1493541|NCT00804388|E-poly|e-poly
1493542|NCT00804388|Hip|hip
1493543|NCT00804388|Degenerative joint disease|degenerative joint disease
1493544|NCT00804375|stump pain|stump pain
1493545|NCT00804349|Heart Decompensation|heart decompensation
1493546|NCT00804349|Heart Failure, Congestive|heart failure, congestive
1493547|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
1493548|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
1493549|NCT00804349|Apnea, Sleep|apnea, sleep
1493550|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
1493551|NCT00804349|Sleep Hypopnea|sleep hypopnea
1493552|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
1493553|NCT00804336|pasireotide|pasireotide
1493554|NCT00804336|SOM230|som230
1493555|NCT00804336|RAD001|rad001
1567603|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
1493556|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1493557|NCT00804297|Hypoglycemia|hypoglycemia
1493558|NCT00804297|Diabetes Mellitus|diabetes mellitus
1493559|NCT00804297|Octreotide|octreotide
1493560|NCT00804284|DAPTACEL®|daptacel®
1493561|NCT00804284|PENTACEL®|pentacel®
1493562|NCT00804284|Diphtheria|diphtheria
1493563|NCT00804284|Tetanus|tetanus
1493564|NCT00804284|Pertussis|pertussis
1493565|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
1493566|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1493567|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1493568|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1493569|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1493570|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1493571|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1493572|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1493573|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1493574|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1493575|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1493576|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1493577|NCT00804245|stage I prostate cancer|stage i prostate cancer
1493578|NCT00804245|stage II prostate cancer|stage ii prostate cancer
1493579|NCT00804245|stage III prostate cancer|stage iii prostate cancer
1493580|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
1493581|NCT00804232|Diabetes type1; children|diabetes type1; children
1493582|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
1493583|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
1493584|NCT00804206|Visual acuity|visual acuity
1493585|NCT00804206|central retinal thickness|central retinal thickness
1493586|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
1493587|NCT00804206|electroretinogram studies|electroretinogram studies
1493588|NCT00804193|Tinea Pedis|tinea pedis
1493589|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
1493590|NCT00804180|anxiety|anxiety
1493591|NCT00804180|injection|injection
1493592|NCT00804180|needle|needle
1493593|NCT00804180|pediatric|pediatric
1493594|NCT00804180|youth|youth
1493595|NCT00804180|children|children
1493596|NCT00804180|adolescents|adolescents
1493597|NCT00804180|cognitive behavioral|cognitive behavioral
1493598|NCT00804180|behavioral|behavioral
1493599|NCT00804180|exposure|exposure
1493600|NCT00804180|group|group
1493601|NCT00804180|treatment|treatment
1493602|NCT00804180|chronic illness|chronic illness
1493603|NCT00804180|adherence|adherence
1493604|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
1493605|NCT00804167|renal damage|renal damage
1494171|NCT00801697|Adenovirus|adenovirus
1493606|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
1493607|NCT00804154|Pain|pain
1493608|NCT00804154|Vanilloid|vanilloid
1493609|NCT00804154|Capsaicin|capsaicin
1493610|NCT00804154|Cancer Pain|cancer pain
1493611|NCT00804154|Resiniferatoxin|resiniferatoxin
1493612|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
1493613|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1493614|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
1493615|NCT00804115|Latanoprost|latanoprost
1493616|NCT00804115|Timolol|timolol
1493617|NCT00804115|Pilocarpine|pilocarpine
1493618|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
1493619|NCT00804102|Macula off|macula off
1493620|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
1493621|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
1493622|NCT00804102|Treated Retina detachment|treated retina detachment
1493623|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
1493624|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
1493625|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
1493626|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
1493627|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
1493628|NCT00804102|Ischemic Macula edema|ischemic macula edema
1493629|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
1493630|NCT00804089|Acupuncture|acupuncture
1493631|NCT00804089|Dry Needling|dry needling
1493632|NCT00804089|Acupressure|acupressure
1493633|NCT00804089|Acupuncture Points|acupuncture points
1493634|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
1493635|NCT00804076|gene therapy|gene therapy
1493636|NCT00804076|replication defective HSV vector|replication defective hsv vector
1493637|NCT00804076|pain|pain
1493638|NCT00804076|enkephalin|enkephalin
1493639|NCT00804076|intradermal|intradermal
1493640|NCT00804063|glaucoma|glaucoma
1493641|NCT00804063|citrate|citrate
1493642|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
1493643|NCT00804050|Erythropoietin|erythropoietin
1493644|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
1493645|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
1493646|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
1493647|NCT00804050|MDS low risk|mds low risk
1493648|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
1493649|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
1493650|NCT00804011|Snakebite|snakebite
1493651|NCT00804011|Weaning|weaning
1493652|NCT00804011|Mechanical ventilation|mechanical ventilation
1493653|NCT00803985|Inguinal hernia|inguinal hernia
1493654|NCT00803985|TEP|tep
1493655|NCT00803985|Lichtenstein|lichtenstein
1493656|NCT00803985|mesh|mesh
1493657|NCT00803985|Randomized|randomized
1493658|NCT00803985|Chronic pain|chronic pain
1493659|NCT00803985|Sexual dysfunction|sexual dysfunction
1493660|NCT00803972|Humalog|humalog
1493661|NCT00803972|Humulin R|humulin r
1493662|NCT00803972|rHuPH20|rhuph20
1493663|NCT00803972|Hylenex|hylenex
1493664|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
1493665|NCT00803946|bioequivalency|bioequivalency
1493666|NCT00803946|ibuprofen|ibuprofen
1493667|NCT00803933|first stage|first stage
1493668|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
1493669|NCT00803933|T. b. gambiense|t. b. gambiense
1493670|NCT00803933|sleeping sickness|sleeping sickness
1493671|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
1493672|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
1493673|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
1493674|NCT00803907|immunomodulator|immunomodulator
1493675|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
1493676|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
1493677|NCT00803855|single dose|single dose
1493678|NCT00803855|pharmacokinetics|pharmacokinetics
1493679|NCT00803855|safety|safety
1493680|NCT00803855|healthy volunteers|healthy volunteers
1493681|NCT00803855|food interaction|food interaction
1493682|NCT00803855|AZD1446|azd1446
1493683|NCT00803842|erlotinib|erlotinib
1493684|NCT00803842|rash|rash
1493685|NCT00803842|supportive care|supportive care
1493686|NCT00803816|endogoneous|endogoneous
1493687|NCT00803816|posterior|posterior
1493688|NCT00803816|intermediate|intermediate
1493689|NCT00803803|Pilocarpine|pilocarpine
1493690|NCT00803803|POAG|poag
1493691|NCT00803803|IOP|iop
1493692|NCT00803803|Concentration|concentration
1493693|NCT00803803|Frequency|frequency
1493694|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
1493695|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
1493696|NCT00803764|bioequivalency|bioequivalency
1493697|NCT00803764|naproxen|naproxen
1493698|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
1493699|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
1493700|NCT00803738|Terconazole|terconazole
1493701|NCT00803725|spinal anesthesia|spinal anesthesia
1493702|NCT00803725|mepivacaine|mepivacaine
1493703|NCT00803725|fentanyl|fentanyl
1493704|NCT00803725|duration of anesthesia|duration of anesthesia
1493705|NCT00803725|knee arthroscopy|knee arthroscopy
1493706|NCT00803725|regional anesthesia|regional anesthesia
1493707|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
1493708|NCT00803699|selenium|selenium
1493709|NCT00803673|Healthy volunteers|healthy volunteers
1493710|NCT00803673|New formulation|new formulation
1493711|NCT00803660|hypertension|hypertension
1493712|NCT00803660|BP|bp
1493713|NCT00803660|diabetes|diabetes
1493714|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
1493715|NCT00803660|ACE-I|ace-i
1493716|NCT00803660|ARB|arb
1493717|NCT00803647|NSABP|nsabp
1493718|NCT00803647|Cetuximab|cetuximab
1493719|NCT00803647|FOLFOX7|folfox7
1493720|NCT00803647|Oxaliplatin|oxaliplatin
1493721|NCT00803647|Leucovorin|leucovorin
1493722|NCT00803647|5-FU|5-fu
1493723|NCT00803647|colorectal cancer|colorectal cancer
1493724|NCT00803647|KRAS wild type|kras wild type
1493725|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
1493726|NCT00803647|Erbitux|erbitux
1493727|NCT00803647|Eloxatin|eloxatin
1493728|NCT00803647|Liver resection|liver resection
1493729|NCT00803647|Liver ablation|liver ablation
1493730|NCT00803647|Metastasectomy|metastasectomy
1493731|NCT00803634|Hypertension|hypertension
1493732|NCT00803634|Antihypertensive Agent|antihypertensive agent
1493733|NCT00803634|Calcium Channel Blocker|calcium channel blocker
1493734|NCT00803608|Plantar|plantar
1493735|NCT00803608|Ulcer|ulcer
1493736|NCT00803608|Diabetes|diabetes
1493737|NCT00803595|Influenza|influenza
1493738|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
1493739|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1493740|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1493741|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1493742|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1493743|NCT00803569|fallopian tube cancer|fallopian tube cancer
1493744|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
1493745|NCT00803543|HSV-2|hsv-2
1493746|NCT00803543|Herpes Simplex|herpes simplex
1493747|NCT00803543|HSV Type 2|hsv type 2
1493748|NCT00803543|HIV|hiv
1493749|NCT00803543|HIV/HSV|hiv/hsv
1493750|NCT00803543|treatment experienced|treatment experienced
1493751|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
1493752|NCT00803530|arsenic trioxide|arsenic trioxide
1493753|NCT00803530|ascorbic acid|ascorbic acid
1493754|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
1493755|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
1493756|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
1493757|NCT00803504|optic disc morphology|optic disc morphology
1493758|NCT00803504|ocular blood flow|ocular blood flow
1493759|NCT00803504|retina|retina
1493760|NCT00803504|ocular physiology|ocular physiology
1493761|NCT00803491|Rheumatic diseases|rheumatic diseases
1493762|NCT00803491|Problem based learning|problem based learning
1493763|NCT00803491|Health-related quality of life|health-related quality of life
1493764|NCT00803491|Empowerment|empowerment
1493765|NCT00803491|Self-care|self-care
1493766|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
1493767|NCT00803465|Bioequivalence|bioequivalence
1493768|NCT00803465|Fluticasone Propionate|fluticasone propionate
1493769|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
1493770|NCT00803452|Lid margin disease|lid margin disease
1493771|NCT00803452|doxycycline|doxycycline
1493772|NCT00803452|azithromycin|azithromycin
1493773|NCT00803452|essential fatty acid|essential fatty acid
1493774|NCT00803439|Bioequivalence|bioequivalence
1493775|NCT00803439|Clobetasol Propionate|clobetasol propionate
1493776|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
1493777|NCT00803426|nerve block|nerve block
1493778|NCT00803426|popliteal fossa|popliteal fossa
1493779|NCT00803426|sciatic nerve|sciatic nerve
1493780|NCT00803426|common peroneal nerve|common peroneal nerve
1493781|NCT00803426|tibial nerve|tibial nerve
1493782|NCT00803426|onset time|onset time
1493783|NCT00803426|ankle surgery|ankle surgery
1493784|NCT00803426|foot surgery|foot surgery
1493785|NCT00803413|Chronic low back pain|chronic low back pain
1493786|NCT00803413|Back School|back school
1493787|NCT00803413|Walking|walking
1493788|NCT00803413|Physical activity|physical activity
1493789|NCT00803400|Panic disorder|panic disorder
1493790|NCT00803400|Exercise|exercise
1493791|NCT00803400|Alprazolam|alprazolam
1493792|NCT00803400|Aerobic|aerobic
1493793|NCT00803387|ocular dryness|ocular dryness
1493794|NCT00803387|ocular irritation|ocular irritation
1493795|NCT00803387|open-angle glaucoma|open-angle glaucoma
1493796|NCT00803387|ocular hypertension|ocular hypertension
1493797|NCT00803387|TravatanZ|travatanz
1493798|NCT00803387|Xalatan|xalatan
1493799|NCT00803361|anxiety|anxiety
1494071|NCT00802113|Cord Blood Transplant|cord blood transplant
1493800|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
1493801|NCT00803348|knee arthroplasty|knee arthroplasty
1493802|NCT00803348|knee replacement|knee replacement
1493803|NCT00803348|regional anesthesia|regional anesthesia
1493804|NCT00803348|readiness to discharge|readiness to discharge
1493805|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
1493806|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
1493807|NCT00803335|vaginal atrophy|vaginal atrophy
1493808|NCT00803335|atrophic vaginitis|atrophic vaginitis
1493809|NCT00803335|postmenopausal|postmenopausal
1493810|NCT00803335|posthysterectomy|posthysterectomy
1493811|NCT00803335|vaginal health|vaginal health
1493812|NCT00803335|vaginal cytology|vaginal cytology
1493813|NCT00803335|vaginal maturity index|vaginal maturity index
1493814|NCT00803335|vaginal histology|vaginal histology
1493815|NCT00803335|quality of life questionnaires|quality of life questionnaires
1493816|NCT00803322|TB|tb
1493817|NCT00803322|community|community
1493818|NCT00803322|community health workers|community health workers
1493819|NCT00803322|Ethiopia|ethiopia
1493820|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
1493821|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
1493822|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
1493823|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
1493824|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
1493825|NCT00803309|PegIntron|pegintron
1493826|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
1493827|NCT00803309|Rebetol|rebetol
1493828|NCT00803309|ribavirin|ribavirin
1493829|NCT00803283|Pain|pain
1493830|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
1493831|NCT00803283|Morphine|morphine
1493832|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
1493833|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
1493835|NCT00803257|Hand exercises|hand exercises
1493836|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1493837|NCT00803218|Bioequivalence|bioequivalence
1493838|NCT00803218|Fluticasone Propionate|fluticasone propionate
1493839|NCT00803205|Cystic fibrosis|cystic fibrosis
1493840|NCT00803205|Nonsense mutation|nonsense mutation
1493841|NCT00803205|Premature stop codon|premature stop codon
1493842|NCT00803205|PTC124|ptc124
1493843|NCT00803205|Ataluren|ataluren
1493844|NCT00803192|bioavailability|bioavailability
1493845|NCT00803192|famotidine|famotidine
1493846|NCT00803179|CF|cf
1493847|NCT00803166|Bioequivalence|bioequivalence
1493848|NCT00803166|Halobetasol Propionate|halobetasol propionate
1493849|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
1493850|NCT00803153|Bruch rupture|bruch rupture
1493851|NCT00803153|Choroidal detachment|choroidal detachment
1493852|NCT00803153|complication rates|complication rates
1493853|NCT00803140|scarring|scarring
1493854|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
1493855|NCT00803114|Postpartum perineal pain|postpartum perineal pain
1493856|NCT00803114|Epidural morphine|epidural morphine
1493857|NCT00803114|Randomised clinical trial|randomised clinical trial
1493858|NCT00803101|Anticoagulant reversal|anticoagulant reversal
1493859|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
1493860|NCT00803101|Coagulopathy|coagulopathy
1493861|NCT00803101|Coumarin derivatives|coumarin derivatives
1493862|NCT00803101|Emergency surgery|emergency surgery
1493863|NCT00803101|Invasive procedures|invasive procedures
1493864|NCT00803101|Vitamin K|vitamin k
1493865|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
1493866|NCT00803101|Kcentra|kcentra
1493867|NCT00803049|Multiple Sclerosis|multiple sclerosis
1493868|NCT00803049|Oral treatment|oral treatment
1493869|NCT00803036|spreading cortical depression|spreading cortical depression
1493870|NCT00803036|electroencephalography|electroencephalography
1493871|NCT00803036|traumatic brain injury|traumatic brain injury
1493872|NCT00803036|intensive care|intensive care
1493873|NCT00803036|vascular hypotension|vascular hypotension
1493874|NCT00803036|intracranial hypertension|intracranial hypertension
1493875|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
1493876|NCT00803010|GVHD|gvhd
1493877|NCT00803010|graft-versus-host disease|graft-versus-host disease
1493878|NCT00803010|tacrolimus|tacrolimus
1493879|NCT00803010|sirolimus|sirolimus
1493880|NCT00803010|methotrexate|methotrexate
1493881|NCT00803010|combination therapy|combination therapy
1493882|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
1493883|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
1493884|NCT00802971|Fiber|fiber
1493885|NCT00802971|Prevalence|prevalence
1493886|NCT00802971|Randomised controlled trial|randomised controlled trial
1493887|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
1493888|NCT00802958|Bioequivalence|bioequivalence
1493889|NCT00802958|Halobetasol Propionate|halobetasol propionate
1493890|NCT00802932|breast cancer|breast cancer
1493891|NCT00802932|female|female
1493892|NCT00802932|metallic markers|metallic markers
1493893|NCT00802932|image guided radiation therapy|image guided radiation therapy
1493894|NCT00802932|IGRT|igrt
1493895|NCT00802919|schizophrenia|schizophrenia
1493896|NCT00802919|smoking|smoking
1493897|NCT00802919|nicotine|nicotine
1493898|NCT00802919|cognitive deficits|cognitive deficits
1493899|NCT00802919|nicotinic receptors|nicotinic receptors
1493900|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
1493901|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
1493902|NCT00802906|bevacizumab|bevacizumab
1493903|NCT00802906|CSC|csc
1493904|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
1493905|NCT00802867|DAPTACEL®|daptacel®
1493906|NCT00802867|PENTACEL™|pentacel™
1493907|NCT00802867|Diphtheria|diphtheria
1493908|NCT00802867|Tetanus|tetanus
1493909|NCT00802867|Pertussis|pertussis
1493910|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
1493911|NCT00802854|anidulafungin|anidulafungin
1493912|NCT00802854|safety|safety
1493913|NCT00802854|efficacy|efficacy
1493914|NCT00802841|Chronic|chronic
1493915|NCT00802841|Myelogenous|myelogenous
1493916|NCT00802841|Leukemia|leukemia
1493917|NCT00802841|CML|cml
1493918|NCT00802841|Chronic Phase|chronic phase
1493919|NCT00802841|Suboptimal Response|suboptimal response
1493920|NCT00802828|bioavailability|bioavailability
1493921|NCT00802828|famotidine|famotidine
1493922|NCT00802763|VAGINAL INFECTION|vaginal infection
1493923|NCT00802763|COLOR APPEARANCE|color appearance
1493924|NCT00802763|ELEVATED Ph|elevated ph
1493925|NCT00802737|Maintenance|maintenance
1493926|NCT00802737|Retreatment|retreatment
1493927|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1494394|NCT00800839|Leukemia|leukemia
1493928|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1493929|NCT00802737|Ofatumumab|ofatumumab
1493930|NCT00802724|low back pain|low back pain
1493931|NCT00802724|classification|classification
1493932|NCT00802724|spine|spine
1493933|NCT00802711|stage IA breast cancer|stage ia breast cancer
1493934|NCT00802711|stage IB breast cancer|stage ib breast cancer
1493935|NCT00802711|stage II breast cancer|stage ii breast cancer
1493936|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1493937|NCT00802698|Biphasic waveform|biphasic waveform
1493938|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
1493939|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
1493940|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
1493941|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
1493942|NCT00802685|Respiratory outcome|respiratory outcome
1493943|NCT00802672|Tinea Pedis|tinea pedis
1493944|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
1493945|NCT00802646|first-time mother|first-time mother
1493946|NCT00802646|epidural request|epidural request
1493947|NCT00802646|vaginal childbirth|vaginal childbirth
1493948|NCT00802633|Tissue sealing device|tissue sealing device
1493949|NCT00802633|Articulating stapling device|articulating stapling device
1493950|NCT00802633|Radical cystectomy|radical cystectomy
1493951|NCT00802620|Amniotic membrane|amniotic membrane
1493952|NCT00802620|Conjunctival autograft|conjunctival autograft
1493953|NCT00802620|Recurrent pterygia|recurrent pterygia
1493954|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
1493955|NCT00802607|Bone Diseases|bone diseases
1493956|NCT00802607|Connective Tissue Diseases|connective tissue diseases
1493957|NCT00802594|first stage|first stage
1493958|NCT00802594|T.b. gambiense|t.b. gambiense
1493959|NCT00802594|sleeping sickness|sleeping sickness
1493960|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
1493961|NCT00802581|sciatic nerve block|sciatic nerve block
1493962|NCT00802581|local anesthetic|local anesthetic
1493963|NCT00802581|lidocaine|lidocaine
1493964|NCT00802581|ankle surgery|ankle surgery
1493965|NCT00802581|foot surgery|foot surgery
1493966|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
1493967|NCT00802581|circumferential spread|circumferential spread
1493968|NCT00802581|anesthetic infiltration|anesthetic infiltration
1493969|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
1493970|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
1493971|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
1493972|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
1493973|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
1493975|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
1493976|NCT00802542|Hypertension|hypertension
1493977|NCT00802542|blood pressure|blood pressure
1493978|NCT00802542|Atacand|atacand
1493979|NCT00802529|Meniere's disease|meniere's disease
1493980|NCT00802529|transtympanic steroids|transtympanic steroids
1493981|NCT00802529|Randomised controlled trial|randomised controlled trial
1493982|NCT00802503|Critically ill|critically ill
1493984|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
1493985|NCT00802503|human|human
1493986|NCT00802503|adult|adult
1493987|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
1493988|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1493989|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
1493990|NCT00802490|Inattention|inattention
1493991|NCT00802490|Brain-Computer Interface System|brain-computer interface system
1493992|NCT00802477|mastectomy|mastectomy
1493993|NCT00802477|seroma|seroma
1493994|NCT00802477|lymph node dissection|lymph node dissection
1493995|NCT00802464|Cytokine|cytokine
1493996|NCT00802464|Vaccine|vaccine
1493997|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
1493998|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
1493999|NCT00802464|Antibody response|antibody response
1494000|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
1494001|NCT00802464|Shingles|shingles
1494002|NCT00802451|Bioavailability|bioavailability
1494003|NCT00802451|Mesalamine|mesalamine
1494004|NCT00802438|asthma|asthma
1494005|NCT00802438|allergic inflammation|allergic inflammation
1494006|NCT00802438|interleukin-5|interleukin-5
1494007|NCT00802425|Sudden hearing loss|sudden hearing loss
1494008|NCT00802425|Sudden deafness|sudden deafness
1494009|NCT00802425|Acoustic trauma|acoustic trauma
1494010|NCT00802425|Noise trauma|noise trauma
1494011|NCT00802412|tobacco use disorders|tobacco use disorders
1494012|NCT00802412|alcoholism|alcoholism
1494013|NCT00802399|Cornea|cornea
1494014|NCT00802399|Dry eye|dry eye
1494015|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
1494016|NCT00802399|lacrimal film|lacrimal film
1494017|NCT00802399|ocular surface|ocular surface
1494018|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
1494019|NCT00802386|IUD INSERTION|iud insertion
1494020|NCT00802373|Overactive Bladder|overactive bladder
1494021|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
1494022|NCT00802347|Delayed Graft Function|delayed graft function
1494023|NCT00802347|Kidney Transplant|kidney transplant
1494024|NCT00802347|Renal Transplant|renal transplant
1494025|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
1494026|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
1494027|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
1494028|NCT00802334|safety and efficacy|safety and efficacy
1494029|NCT00802321|steroid 5AReductase|steroid 5areductase
1494030|NCT00802321|genetic polymorphism|genetic polymorphism
1494031|NCT00802321|GABA receptor|gaba receptor
1494032|NCT00802295|Ovarian|ovarian
1494033|NCT00802295|hyperstimulation|hyperstimulation
1494034|NCT00802295|Embryo|embryo
1494035|NCT00802295|Aneuploidy|aneuploidy
1494036|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
1494037|NCT00802282|healthy volunteers|healthy volunteers
1494038|NCT00802282|spirituality|spirituality
1494039|NCT00802282|psilocybin|psilocybin
1494040|NCT00802282|meditation|meditation
1494041|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1494042|NCT00802269|Laser photocoagulation|laser photocoagulation
1494043|NCT00802269|Pain|pain
1494044|NCT00802256|pulpotomy|pulpotomy
1494045|NCT00802256|primary molar teeth|primary molar teeth
1494047|NCT00802256|NEC|nec
1494048|NCT00802256|CEM|cem
1494049|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
1494050|NCT00802243|Bullous pemphigoid|bullous pemphigoid
1494051|NCT00802243|leflunomide|leflunomide
1494052|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
1494053|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
1494054|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
1494055|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
1494056|NCT00802217|Pharmacokinetics|pharmacokinetics
1494057|NCT00802217|Safety|safety
1494058|NCT00802217|Tolerability|tolerability
1494059|NCT00802217|Healthy Volunteers|healthy volunteers
1494060|NCT00802204|Obesity|obesity
1494061|NCT00802204|Insulin Resistance|insulin resistance
1494062|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
1494063|NCT00802204|Eating behaviors|eating behaviors
1494064|NCT00802204|Dopamine signaling|dopamine signaling
1494065|NCT00802165|Asymptomatic normals|asymptomatic normals
1494066|NCT00802152|Diabetes|diabetes
1494067|NCT00802152|Hypertension|hypertension
1494068|NCT00802139|iron deficiency anemia|iron deficiency anemia
1494069|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
1494070|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
1494072|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1494073|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
1494074|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
1494075|NCT00802087|Hydrocodone|hydrocodone
1494076|NCT00802087|Pharmacokinetics|pharmacokinetics
1494077|NCT00802087|Safety & Tolerability|safety & tolerability
1494078|NCT00802074|Healthy Subjects|healthy subjects
1494079|NCT00802074|Pharmacokinetics study|pharmacokinetics study
1494080|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
1494081|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
1494082|NCT00802048|Sternotomy|sternotomy
1494083|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
1494084|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
1494085|NCT00802048|Ropivacaïne|ropivacaïne
1494086|NCT00802048|Chronic|chronic
1494087|NCT00802048|Postoperative pain|postoperative pain
1494088|NCT00802048|Cardiac surgery|cardiac surgery
1494089|NCT00802048|Sternum|sternum
1494090|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
1494091|NCT00802035|ALK29|alk29
1494092|NCT00802035|Alcohol Dependence|alcohol dependence
1494093|NCT00802035|Pharmacokinetics|pharmacokinetics
1494094|NCT00802022|diabetic neuropathies|diabetic neuropathies
1494095|NCT00802022|electric stimulation therapy|electric stimulation therapy
1494096|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
1494097|NCT00802009|nerve block|nerve block
1494098|NCT00802009|brachial plexus|brachial plexus
1494099|NCT00802009|mepivicaine|mepivicaine
1494100|NCT00802009|dexamethasone|dexamethasone
1494101|NCT00802009|hand wrist surgery|hand wrist surgery
1494102|NCT00802009|duration|duration
1494103|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
1494104|NCT00801996|prostate cancer|prostate cancer
1494105|NCT00801996|genetics|genetics
1494106|NCT00801970|Fear of childbirth|fear of childbirth
1494107|NCT00801970|Tokophobia|tokophobia
1494108|NCT00801970|Anxiety|anxiety
1494109|NCT00801970|Labor|labor
1494110|NCT00801970|Pregnancy|pregnancy
1494111|NCT00801970|Cognitive-behavioral|cognitive-behavioral
1494112|NCT00801970|Psychoanalysis|psychoanalysis
1494113|NCT00801970|Group Therapy|group therapy
1494114|NCT00801970|etiology|etiology
1494115|NCT00801957|atopic dermatitis|atopic dermatitis
1494116|NCT00801957|meningitis|meningitis
1494117|NCT00801957|vaccination|vaccination
1494118|NCT00801957|tacrolimus|tacrolimus
1494119|NCT00801957|steroids|steroids
1494120|NCT00801957|equivalence response|equivalence response
1494121|NCT00801957|meningococcal vaccine|meningococcal vaccine
1494122|NCT00801944|Overactive Bladder|overactive bladder
1494123|NCT00801931|Cord Blood Transplant|cord blood transplant
1494124|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1494125|NCT00801918|lymphoma|lymphoma
1494126|NCT00801918|pediatric|pediatric
1494127|NCT00801918|adolescent|adolescent
1494128|NCT00801918|relapsed|relapsed
1494129|NCT00801918|refractory|refractory
1494130|NCT00801918|denileukin diftitox|denileukin diftitox
1494131|NCT00801918|Ontak|ontak
1494132|NCT00801905|Macular thickening|macular thickening
1494133|NCT00801905|Macular edema|macular edema
1494134|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
1494135|NCT00801905|Nepafenac|nepafenac
1494136|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
1494137|NCT00801892|daytime sleepiness|daytime sleepiness
1494138|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
1494139|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
1494140|NCT00801892|diabetes management|diabetes management
1494141|NCT00801879|mupirocin|mupirocin
1494142|NCT00801879|Staphylococcus aureus|staphylococcus aureus
1494143|NCT00801879|colonization|colonization
1494144|NCT00801879|infection|infection
1494145|NCT00801879|HIV|hiv
1494146|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
1494147|NCT00801866|Macular Edema|macular edema
1494148|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
1494149|NCT00801853|asthma|asthma
1494150|NCT00801853|allergy|allergy
1494151|NCT00801853|atopy|atopy
1494152|NCT00801853|atopic|atopic
1494153|NCT00801853|wheeze|wheeze
1494154|NCT00801827|Obesity|obesity
1494155|NCT00801827|Addiction|addiction
1494156|NCT00801827|PET imaging|pet imaging
1494157|NCT00801814|viscous|viscous
1494158|NCT00801814|fibre|fibre
1494159|NCT00801814|polysaccharide|polysaccharide
1494160|NCT00801814|blood glucose|blood glucose
1494161|NCT00801814|post prandial|post prandial
1494162|NCT00801801|Docetaxel|docetaxel
1494163|NCT00801801|Sorafenib|sorafenib
1494164|NCT00801775|calorimetry|calorimetry
1494165|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1494166|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1494167|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1494168|NCT00801723|Ulcerative Colitis|ulcerative colitis
1494169|NCT00801697|HIV Seronegativity|hiv seronegativity
1494170|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
1494172|NCT00801684|COPD|copd
1494173|NCT00801684|pulmonary|pulmonary
1494174|NCT00801684|inhalation|inhalation
1494175|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
1494176|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1494177|NCT00801671|hypertension|hypertension
1494178|NCT00801671|systemic hypertension|systemic hypertension
1494179|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1494180|NCT00801658|glaucoma|glaucoma
1494181|NCT00801658|SLT|slt
1494182|NCT00801658|Laser treatment|laser treatment
1494183|NCT00801658|IOP|iop
1494184|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
1494185|NCT00801645|Obesity|obesity
1494186|NCT00801645|Cardiovascular disease|cardiovascular disease
1494187|NCT00801645|Endothelial function|endothelial function
1494188|NCT00801645|Blood pressure|blood pressure
1494189|NCT00801645|Exercise|exercise
1494190|NCT00801645|Physical activity|physical activity
1494191|NCT00801645|Metabolic syndrome|metabolic syndrome
1494192|NCT00801645|Children|children
1494193|NCT00801645|Pediatric|pediatric
1494194|NCT00801632|renal allograft tolerance|renal allograft tolerance
1494195|NCT00801632|mixed chimerism|mixed chimerism
1494196|NCT00801632|kidney transplant|kidney transplant
1494197|NCT00801632|bone marrow transplant|bone marrow transplant
1494198|NCT00801632|antirejection|antirejection
1494199|NCT00801632|immunosuppression|immunosuppression
1494200|NCT00801606|Micronutrient|micronutrient
1494201|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
1494202|NCT00801593|JIA|jia
1494203|NCT00801580|relapsed ALL|relapsed all
1494204|NCT00801580|refractory ALL|refractory all
1494205|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
1494206|NCT00801567|Bipolar disorder|bipolar disorder
1494207|NCT00801567|Schizophrenia|schizophrenia
1494208|NCT00801567|Healthy volunteer|healthy volunteer
1494209|NCT00801567|Brain imaging|brain imaging
1494210|NCT00801567|Photic stimulation|photic stimulation
1494211|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
1494212|NCT00801554|ASD|asd
1494213|NCT00801554|Autism|autism
1494214|NCT00801554|Asperger's Syndrome|asperger's syndrome
1494215|NCT00801554|PDD-NOS|pdd-nos
1494216|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
1494217|NCT00801554|Adults|adults
1494218|NCT00801554|Children|children
1494219|NCT00801541|AMD|amd
1494220|NCT00801528|ropivacaine|ropivacaine
1494221|NCT00801528|diclofenac|diclofenac
1494222|NCT00801528|local anesthetic instillation|local anesthetic instillation
1494223|NCT00801515|Compassionate|compassionate
1494224|NCT00801515|HIV|hiv
1494225|NCT00801515|CCR5|ccr5
1494226|NCT00801502|Omega-3|omega-3
1494227|NCT00801502|Oily fish|oily fish
1494228|NCT00801502|Antioxidant|antioxidant
1494229|NCT00801502|Selenium|selenium
1494230|NCT00801502|Atopic disease|atopic disease
1494231|NCT00801502|Pregnancy|pregnancy
1494232|NCT00801502|Nutrient status|nutrient status
1494233|NCT00801489|Leukemia|leukemia
1494234|NCT00801489|Acute Myelogenous Leukemia|acute myelogenous leukemia
1494235|NCT00801489|AML|aml
1494236|NCT00801476|Breast Cancer|breast cancer
1494237|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
1494238|NCT00801476|Preoperative MRI|preoperative mri
1494239|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1494240|NCT00801463|Prednisone|prednisone
1494241|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
1494242|NCT00801450|diabetes|diabetes
1494243|NCT00801450|macular edema|macular edema
1494244|NCT00801450|triamcinolone|triamcinolone
1494245|NCT00801450|cataract|cataract
1494246|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
1494247|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
1494248|NCT00801424|abdominal surgery|abdominal surgery
1494249|NCT00801424|hypothermia|hypothermia
1494250|NCT00801424|wound dessication|wound dessication
1494251|NCT00801424|warming|warming
1494252|NCT00801411|stage II breast cancer|stage ii breast cancer
1494253|NCT00801398|Opioid tolerant|opioid tolerant
1494254|NCT00801398|Pediatric|pediatric
1494255|NCT00801398|Pain|pain
1494256|NCT00801398|Non malignant|non malignant
1494257|NCT00801398|Malignant|malignant
1494258|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1494259|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1494260|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1494261|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
1494262|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
1494263|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
1494264|NCT00801359|cataract|cataract
1494360|NCT00800943|Leukemia|leukemia
1494265|NCT00801359|phacoemulsification|phacoemulsification
1494266|NCT00801359|irrigation solution|irrigation solution
1494267|NCT00801359|endothelial cell density|endothelial cell density
1494268|NCT00801359|corneal thickness|corneal thickness
1494269|NCT00801346|fatigue|fatigue
1494270|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1494271|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1494272|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1494273|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1494274|NCT00801333|ALS|als
1494275|NCT00801320|tumor harvest|tumor harvest
1494276|NCT00801320|tumor collection|tumor collection
1494277|NCT00801320|tumor storage|tumor storage
1494278|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
1494279|NCT00801281|Lymphoma|lymphoma
1494280|NCT00801281|Immunochemotherapy|immunochemotherapy
1494281|NCT00801281|Induction therapy|induction therapy
1494282|NCT00801281|Maintenance therapy|maintenance therapy
1494283|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
1494284|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
1494285|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
1494286|NCT00801268|polycystic kidney disease|polycystic kidney disease
1494287|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
1494288|NCT00801229|ADHD|adhd
1494289|NCT00801229|young adults|young adults
1494290|NCT00801229|driving|driving
1494291|NCT00801229|Vyvanse|vyvanse
1494292|NCT00801229|lisdexamfetamine|lisdexamfetamine
1494293|NCT00801216|B-cell lymphomas|b-cell lymphomas
1494294|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
1494295|NCT00801216|liposomal cytarabine|liposomal cytarabine
1494296|NCT00801216|autologous transplant|autologous transplant
1494297|NCT00801216|CNS involvement|cns involvement
1494298|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
1494299|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
1494300|NCT00801190|colloid|colloid
1494301|NCT00801190|CABG|cabg
1494302|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
1494303|NCT00801190|bleeding|bleeding
1494304|NCT00801177|Tumors|tumors
1494305|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
1494306|NCT00801164|Diabetes Type 2|diabetes type 2
1494307|NCT00801164|Periodontitis|periodontitis
1494308|NCT00801138|ropivacaine|ropivacaine
1494309|NCT00801138|bupivacaine|bupivacaine
1494310|NCT00801138|glucocorticoid|glucocorticoid
1494311|NCT00801112|Bioimpedance|bioimpedance
1494312|NCT00801112|Fluid status|fluid status
1494313|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
1494314|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
1494315|NCT00801099|Postoperative wound infection|postoperative wound infection
1494316|NCT00801099|surgical site infection|surgical site infection
1494666|NCT00799916|Crystalloids|crystalloids
1494317|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
1494318|NCT00801099|developing countries|developing countries
1494319|NCT00801099|Sub-Saharan Africa|sub-saharan africa
1494320|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
1494321|NCT00801086|Alopecia|alopecia
1494322|NCT00801086|Hair loss|hair loss
1494323|NCT00801086|Radiation|radiation
1494324|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
1494325|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
1494326|NCT00801073|Amniotic membrane|amniotic membrane
1494327|NCT00801073|Cornea|cornea
1494328|NCT00801073|Scleral thinning|scleral thinning
1494329|NCT00801060|Fludara|fludara
1494330|NCT00801060|CD23|cd23
1494331|NCT00801060|Cyclophosphamide|cyclophosphamide
1494332|NCT00801060|Antibody|antibody
1494333|NCT00801060|Fludarabine|fludarabine
1494334|NCT00801060|CLL|cll
1494335|NCT00801060|Rituximab|rituximab
1494336|NCT00801060|Mabthera|mabthera
1494337|NCT00801060|Biogen Idec|biogen idec
1494338|NCT00801060|Lumiliximab|lumiliximab
1494339|NCT00801060|Rituxan|rituxan
1494340|NCT00801060|Cytoxan|cytoxan
1494341|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1494342|NCT00801047|Epidural|epidural
1494343|NCT00801047|Labor|labor
1494344|NCT00801047|Remifentanil|remifentanil
1494345|NCT00801034|hypertension|hypertension
1494346|NCT00801034|potassium|potassium
1494347|NCT00801034|blood pressure|blood pressure
1494348|NCT00801021|Cystitis|cystitis
1494349|NCT00801021|Urinary Tract Infections|urinary tract infections
1494350|NCT00801008|young adult|young adult
1494351|NCT00801008|cancer|cancer
1494352|NCT00801008|exercise|exercise
1494353|NCT00801008|relaxation|relaxation
1494354|NCT00800995|ARMD|armd
1494355|NCT00800995|SOD|sod
1494356|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
1494357|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
1494358|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
1494359|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
1494361|NCT00800943|Chronic|chronic
1494362|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1494363|NCT00800943|CAMPATH|campath
1494364|NCT00800943|Alemtuzumab|alemtuzumab
1494365|NCT00800943|MabCampath|mabcampath
1494366|NCT00800943|Subcutaneous|subcutaneous
1494367|NCT00800943|CLL|cll
1494368|NCT00800943|C-CLL|c-cll
1494369|NCT00800943|Residual|residual
1494370|NCT00800930|Shigellosis|shigellosis
1494371|NCT00800930|sodium butyrate|sodium butyrate
1494372|NCT00800930|antimicrobial peptides|antimicrobial peptides
1494373|NCT00800930|LL-37|ll-37
1494374|NCT00800930|innate immunity|innate immunity
1494375|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
1494376|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
1494377|NCT00800930|endoscopic findings|endoscopic findings
1494378|NCT00800930|histological features|histological features
1494379|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
1494380|NCT00800904|Asthma|asthma
1494381|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
1494382|NCT00800904|Thai patient eligibility|thai patient eligibility
1494383|NCT00800904|Persistent asthma|persistent asthma
1494384|NCT00800878|Chronic Kidney Disease|chronic kidney disease
1494385|NCT00800878|Renal insufficiency|renal insufficiency
1494386|NCT00800852|adiponectin|adiponectin
1494387|NCT00800852|adiponectin receptor|adiponectin receptor
1494388|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
1494389|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
1494390|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
1494391|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
1494392|NCT00800839|GVHD|gvhd
1494393|NCT00800839|Hematologic malignancies|hematologic malignancies
1494395|NCT00800839|Lymphoma|lymphoma
1494396|NCT00800839|Myeloma|myeloma
1494397|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
1494398|NCT00800839|HLA|hla
1494399|NCT00800839|Busulfan|busulfan
1494400|NCT00800839|Cyclophosphamide|cyclophosphamide
1494401|NCT00800839|Fludarabine|fludarabine
1494402|NCT00800839|Mesna|mesna
1494403|NCT00800839|Cytoxan®|cytoxan®
1494404|NCT00800839|Neosar®|neosar®
1494405|NCT00800839|Busulfex|busulfex
1494406|NCT00800839|Myleran®|myleran®
1494407|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
1494408|NCT00800813|Prostate|prostate
1494409|NCT00800813|Erectile function|erectile function
1494410|NCT00800813|Peyronie's Plaque|peyronie's plaque
1494411|NCT00800813|08-135|08-135
1494412|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
1494413|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
1494414|NCT00800774|LASIK|lasik
1494415|NCT00800774|safety|safety
1494416|NCT00800774|efficacy|efficacy
1494417|NCT00800774|stability|stability
1494418|NCT00800774|high anisometropia|high anisometropia
1494419|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
1494420|NCT00800774|conventional treatments have failed|conventional treatments have failed
1494421|NCT00800722|hypervascular anomalies|hypervascular anomalies
1494422|NCT00800709|Alzheimer's Disease|alzheimer's disease
1494423|NCT00800709|tau protein|tau protein
1494424|NCT00800709|PET|pet
1494425|NCT00800709|Memantine|memantine
1494426|NCT00800696|antibiotics|antibiotics
1494427|NCT00800696|Hospitalization|hospitalization
1494428|NCT00800696|oral care|oral care
1494429|NCT00800670|tuberculosis|tuberculosis
1494430|NCT00800670|vaccine|vaccine
1494431|NCT00800670|adenovirus|adenovirus
1494432|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
1494433|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
1494434|NCT00800657|Stem Cells Therapy|stem cells therapy
1494435|NCT00800657|Heart Failure|heart failure
1494436|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
1494437|NCT00800644|Cervical Cancer|cervical cancer
1494438|NCT00800644|Endometrial Cancer|endometrial cancer
1494439|NCT00800644|Vaginal Cancer|vaginal cancer
1494440|NCT00800644|Cervix|cervix
1494441|NCT00800644|Endometrial|endometrial
1494442|NCT00800644|X-ray|x-ray
1494443|NCT00800644|Computed tomography|computed tomography
1494444|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
1494445|NCT00800644|Vagina|vagina
1494446|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
1494447|NCT00800644|Bone density|bone density
1494448|NCT00800644|Bone mineral density test|bone mineral density test
1494449|NCT00800644|Pelvic fractures|pelvic fractures
1494450|NCT00800644|Gynecologic Oncology|gynecologic oncology
1494451|NCT00800644|Bone turnover|bone turnover
1494452|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
1494453|NCT00800579|cystic fibrosis|cystic fibrosis
1494454|NCT00800579|CF|cf
1494455|NCT00800579|mucociliary clearance|mucociliary clearance
1494456|NCT00800579|amiloride|amiloride
1494457|NCT00800579|ENaC|enac
1494458|NCT00800579|ENaC Inhibitor|enac inhibitor
1494459|NCT00800579|airway hydration|airway hydration
1494460|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
1494461|NCT00800566|Clofarabine|clofarabine
1494462|NCT00800566|Leukemia|leukemia
1494463|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1494464|NCT00800553|sleep deprivation|sleep deprivation
1494465|NCT00800553|fMRI|fmri
1494466|NCT00800553|double blind crossover study|double blind crossover study
1494467|NCT00800540|glaucoma|glaucoma
1494468|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
1494469|NCT00800540|ocular blood flow|ocular blood flow
1494470|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
1494471|NCT00800527|sternotomy|sternotomy
1494472|NCT00800527|pain|pain
1494473|NCT00800527|paresthesia|paresthesia
1494474|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
1494475|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
1494476|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
1494477|NCT00800501|ALS|als
1494478|NCT00800501|VEGF165|vegf165
1494479|NCT00800501|Safety|safety
1494480|NCT00800501|Intracerebroventricular|intracerebroventricular
1494481|NCT00800501|Infusion|infusion
1494482|NCT00800501|Implantable|implantable
1494483|NCT00800488|Fever|fever
1494484|NCT00800488|Infant|infant
1494485|NCT00800488|Procalcitonin|procalcitonin
1494486|NCT00800488|Serious Bacterial Infection|serious bacterial infection
1494487|NCT00800475|bioavailability|bioavailability
1494488|NCT00800475|Gemfibrozil|gemfibrozil
1494489|NCT00800449|Haptoglobin|haptoglobin
1494490|NCT00800449|sepsis|sepsis
1494491|NCT00800449|premature babies|premature babies
1494492|NCT00800423|corneal edema|corneal edema
1494493|NCT00800423|postoperative corneal edema|postoperative corneal edema
1494494|NCT00800423|central corneal thickness|central corneal thickness
1494495|NCT00800423|visual acuity|visual acuity
1494496|NCT00800423|postoperative|postoperative
1494497|NCT00800423|brimonidine|brimonidine
1494498|NCT00800423|timolol|timolol
1494499|NCT00800423|cataract surgery|cataract surgery
1494500|NCT00800410|Randomized Controlled Trial|randomized controlled trial
1494501|NCT00800371|JIA|jia
1494502|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
1494503|NCT00800358|End stage renal disease|end stage renal disease
1494504|NCT00800358|Haemodialysis|haemodialysis
1494505|NCT00800358|Peritoneal dialysis|peritoneal dialysis
1494506|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
1494507|NCT00800358|Calcitriol|calcitriol
1494508|NCT00800345|Gynecologic tumors|gynecologic tumors
1494509|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
1494510|NCT00800319|Alcohol dependence|alcohol dependence
1494511|NCT00800319|Opioid antagonist|opioid antagonist
1494512|NCT00800319|RDC-0313|rdc-0313
1494513|NCT00800306|sepsis|sepsis
1494514|NCT00800306|septic shock|septic shock
1494515|NCT00800306|microcirculation|microcirculation
1494516|NCT00800306|levosimendan|levosimendan
1494517|NCT00800306|dobutamine|dobutamine
1494518|NCT00800306|inotropes|inotropes
1494519|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
1494520|NCT00800293|bioequivalence|bioequivalence
1494521|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
1494522|NCT00800293|Bioequivalency|bioequivalency
1494523|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
1494524|NCT00800267|glaucoma|glaucoma
1494525|NCT00800267|ocular hypertension|ocular hypertension
1494526|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
1494527|NCT00800267|latanoprost|latanoprost
1494528|NCT00800267|timolol|timolol
1494529|NCT00800254|electrical stimulation|electrical stimulation
1494530|NCT00800254|total knee arthroplasty|total knee arthroplasty
1494531|NCT00800254|quadriceps|quadriceps
1494532|NCT00800254|muscle|muscle
1494533|NCT00800254|arthroscopy|arthroscopy
1494534|NCT00800241|Asthma|asthma
1494535|NCT00800241|Symbicort SMART|symbicort smart
1494536|NCT00800241|Thai patient eligibility|thai patient eligibility
1494537|NCT00800241|Persistent asthma|persistent asthma
1494538|NCT00800228|salt|salt
1494539|NCT00800228|blood pressure|blood pressure
1494540|NCT00800228|breathing|breathing
1494541|NCT00800215|Epilepsy|epilepsy
1494542|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1494543|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1494544|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1494545|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1494546|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1494547|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1494548|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1494549|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1494550|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1494551|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1494552|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1494553|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1494554|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1494555|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1494556|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1494557|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1494558|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1494559|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1494791|NCT00799552|Dry eye|dry eye
1494560|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1494561|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1494562|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1494563|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1494564|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1494565|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1494566|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1494567|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1494568|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1494569|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1494570|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1494571|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1494572|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1494573|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1494574|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1494575|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1494576|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1494577|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1494578|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1494579|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1494580|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1494581|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1494582|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1494583|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1494584|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1494585|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1494586|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1494587|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1494588|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1494589|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1494590|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1494591|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1494592|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1494593|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1494594|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1494595|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1494596|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1494597|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1494598|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1494599|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1494600|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1494601|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1494602|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1494603|NCT00800150|intraocular lymphoma|intraocular lymphoma
1494604|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1494605|NCT00800150|primary myelofibrosis|primary myelofibrosis
1494606|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
1494607|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
1494608|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
1494609|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1494610|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1494611|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1494612|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1494613|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1494614|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1494615|NCT00800137|coumadin|coumadin
1494616|NCT00800137|device surgery|device surgery
1494617|NCT00800137|pocket hematoma|pocket hematoma
1494618|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
1494619|NCT00800124|hip fracture|hip fracture
1494620|NCT00800124|hemiprosthesis|hemiprosthesis
1494621|NCT00800124|bone cement|bone cement
1494622|NCT00800124|clinical outcome|clinical outcome
1494623|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
1494624|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
1494625|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
1494626|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
1494627|NCT00800059|Relapse|relapse
1494628|NCT00800059|Refractory|refractory
1494629|NCT00800046|Mitral valve|mitral valve
1494630|NCT00800046|Mitral regurgitation|mitral regurgitation
1494631|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
1494632|NCT00800046|MR|mr
1494633|NCT00800046|FMR|fmr
1494634|NCT00800046|Heart valve|heart valve
1494635|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
1494636|NCT00800046|Valve repair|valve repair
1494637|NCT00800046|Valve disorder|valve disorder
1494638|NCT00800046|Cardiac surgery|cardiac surgery
1494639|NCT00800033|metabolic syndrome|metabolic syndrome
1494641|NCT00800033|blood pressure|blood pressure
1494642|NCT00800033|body composition|body composition
1494643|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
1494644|NCT00799994|glaucoma|glaucoma
1494645|NCT00799994|intraocular pressure|intraocular pressure
1494646|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
1494647|NCT00799968|Thrombolytic therapy|thrombolytic therapy
1494648|NCT00799968|Urokinase|urokinase
1494649|NCT00799968|Efficacy|efficacy
1494650|NCT00799968|Safety|safety
1494651|NCT00799955|Cesarean delivery|cesarean delivery
1494953|NCT00798811|brain tumor|brain tumor
1494652|NCT00799955|post-operative analgesia|post-operative analgesia
1494653|NCT00799955|TAP block|tap block
1494654|NCT00799955|ultrasound|ultrasound
1494655|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
1494656|NCT00799929|IVF Research Study|ivf research study
1494657|NCT00799929|Infertility Sudy|infertility sudy
1494658|NCT00799929|in vitro fertilization|in vitro fertilization
1494659|NCT00799929|Mini IVF|mini ivf
1494660|NCT00799929|Conventional IVF|conventional ivf
1494661|NCT00799916|Sepsis|sepsis
1494662|NCT00799916|Fluid resuscitation|fluid resuscitation
1494663|NCT00799916|Voluven|voluven
1494664|NCT00799916|Colloids|colloids
1494665|NCT00799916|Saline solution|saline solution
1494667|NCT00799916|Sublingual microcirculation|sublingual microcirculation
1494668|NCT00799903|heart disease|heart disease
1494669|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
1494670|NCT00799903|cardiovascular disease|cardiovascular disease
1494671|NCT00799903|coronary heart disease|coronary heart disease
1494672|NCT00799903|CV risk|cv risk
1494673|NCT00799903|Atherosclerosis|atherosclerosis
1494674|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
1494675|NCT00799890|sunphenon egcg|sunphenon egcg
1494676|NCT00799890|brain atrophy|brain atrophy
1494677|NCT00799890|T2 lesions|t2 lesions
1494678|NCT00799877|Psoriasis|psoriasis
1494679|NCT00799877|Moderate Psoriasis|moderate psoriasis
1494680|NCT00799877|Severe Psoriasis|severe psoriasis
1494681|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
1494682|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
1494683|NCT00799877|Registry|registry
1494684|NCT00799864|HIV Infection|hiv infection
1494685|NCT00799864|Antiretroviral|antiretroviral
1494686|NCT00799864|HIV-1|hiv-1
1494687|NCT00799864|AIDS|aids
1494688|NCT00799864|Children|children
1494689|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
1494690|NCT00799864|Pediatric|pediatric
1494691|NCT00799851|advanced liver disease|advanced liver disease
1494692|NCT00799851|esophageal varices|esophageal varices
1494693|NCT00799851|band ligation|band ligation
1494694|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
1494695|NCT00799825|papillomavirus|papillomavirus
1494696|NCT00799825|HPV vaccine|hpv vaccine
1494697|NCT00799825|cervical cancer|cervical cancer
1494698|NCT00799825|HPV|hpv
1494699|NCT00799825|human papillomavirus|human papillomavirus
1494700|NCT00799812|antimicrobial|antimicrobial
1494701|NCT00799812|antisepsis|antisepsis
1494702|NCT00799799|Nk cells infusion|nk cells infusion
1494703|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
1494704|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
1494705|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
1494706|NCT00799773|TTP|ttp
1494707|NCT00799773|Rituximab|rituximab
1494708|NCT00799773|Plasma Exchange|plasma exchange
1494709|NCT00799760|influenza A|influenza a
1494710|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
1494711|NCT00799760|oseltamivir|oseltamivir
1494712|NCT00799760|zanamivir|zanamivir
1494713|NCT00799760|treatment outcome|treatment outcome
1494714|NCT00799760|resistance|resistance
1494715|NCT00799760|mutation|mutation
1494716|NCT00799760|combination therapy|combination therapy
1494717|NCT00799760|monotherapy|monotherapy
1494718|NCT00799760|pandemic|pandemic
1494719|NCT00799760|primary care|primary care
1494720|NCT00799760|randomized controlled trials|randomized controlled trials
1494721|NCT00799760|antiviral agent|antiviral agent
1494722|NCT00799747|safety|safety
1494723|NCT00799747|tolerability|tolerability
1494724|NCT00799747|pharmacokinetics|pharmacokinetics
1494725|NCT00799747|AZD4017Japanese|azd4017japanese
1494726|NCT00799734|hot flushes|hot flushes
1494727|NCT00799734|night sweats|night sweats
1494728|NCT00799734|menopausal symptoms|menopausal symptoms
1494729|NCT00799734|osteoporosis|osteoporosis
1494730|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
1494731|NCT00799721|ROP|rop
1494732|NCT00799721|VLBW|vlbw
1494733|NCT00799721|Epo|epo
1494734|NCT00799721|IUGR|iugr
1494735|NCT00799721|VEGF|vegf
1494736|NCT00799721|sFLT-1|sflt-1
1494737|NCT00799721|very low birth weight infants|very low birth weight infants
1494738|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
1494739|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
1494740|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
1494741|NCT00799695|diabetic retinopathy|diabetic retinopathy
1494742|NCT00799695|screening|screening
1494743|NCT00799695|annual|annual
1494744|NCT00799682|Dry Eye|dry eye
1494745|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
1494746|NCT00799682|Ocular Hypertension|ocular hypertension
1494747|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
1494748|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
1494749|NCT00799682|Iridotomy|iridotomy
1494750|NCT00799682|Iridectomy|iridectomy
1494751|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
1494752|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
1494753|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
1494754|NCT00799682|Hyperemia|hyperemia
1494755|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
1494756|NCT00799669|laryngeal cancer|laryngeal cancer
1494757|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
1494758|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
1494759|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
1494760|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1494761|NCT00799669|tobacco use disorder|tobacco use disorder
1494762|NCT00799656|Diabetic neuropathy|diabetic neuropathy
1494763|NCT00799656|painful pain|painful pain
1494764|NCT00799656|postoperative|postoperative
1494765|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
1494766|NCT00799643|Inflammation|inflammation
1494767|NCT00799643|Obesity|obesity
1494768|NCT00799643|Metabolic Syndrome|metabolic syndrome
1494769|NCT00799643|Salicylates|salicylates
1494770|NCT00799630|energy drink|energy drink
1494771|NCT00799630|exercise|exercise
1494772|NCT00799630|BCAA|bcaa
1494773|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
1494774|NCT00799617|Testosterone|testosterone
1494775|NCT00799617|Mobility disability|mobility disability
1494776|NCT00799617|Decreased libido|decreased libido
1494777|NCT00799617|Age associated memory impairment|age associated memory impairment
1494778|NCT00799617|Low vitality|low vitality
1494779|NCT00799617|Anemia|anemia
1494780|NCT00799604|Hypertension|hypertension
1494781|NCT00799604|Antihypertensive Agent|antihypertensive agent
1494782|NCT00799604|Calcium Channel Blocker|calcium channel blocker
1494783|NCT00799591|Registre MONTRAVERS|registre montravers
1494784|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
1494785|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
1494786|NCT00799565|echography|echography
1494787|NCT00799565|genetic study|genetic study
1494788|NCT00799565|study case-witness|study case-witness
1494789|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
1494790|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1494792|NCT00799552|Resolvin|resolvin
1494793|NCT00799539|Prednisone|prednisone
1494794|NCT00799539|Bortezomib|bortezomib
1494795|NCT00799539|Melphalan|melphalan
1494796|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
1494797|NCT00799526|Transplantation|transplantation
1494798|NCT00799513|Lenalidomide|lenalidomide
1494799|NCT00799513|revlimid|revlimid
1494800|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
1494801|NCT00799513|relapse|relapse
1494802|NCT00799487|ADHD|adhd
1494803|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1494804|NCT00799435|Diabetes|diabetes
1494805|NCT00799435|Diastolic Heart Failure|diastolic heart failure
1494806|NCT00799435|Aortic Stiffness|aortic stiffness
1494807|NCT00799435|Exenatide|exenatide
1494808|NCT00799422|Conjunctival Staining|conjunctival staining
1494809|NCT00799422|lens parameters|lens parameters
1494810|NCT00799422|lens fit|lens fit
1494811|NCT00799409|ADHD|adhd
1494812|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1494813|NCT00799383|Risperidone|risperidone
1494814|NCT00799383|hyperprolactinemia|hyperprolactinemia
1494815|NCT00799383|children|children
1494816|NCT00799383|adolescents|adolescents
1494817|NCT00799383|antipsychotics|antipsychotics
1494818|NCT00799383|prevention|prevention
1494819|NCT00799383|calcium|calcium
1494820|NCT00799383|vitamin D|vitamin d
1494821|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
1494822|NCT00799370|Osteotomy|osteotomy
1494823|NCT00799370|Weight bearing|weight bearing
1494824|NCT00799370|Opening wedge|opening wedge
1494825|NCT00799357|ultrasound|ultrasound
1494826|NCT00799344|Coronary Stent|coronary stent
1494827|NCT00799331|Healthy volunteers|healthy volunteers
1494828|NCT00799279|smoking|smoking
1494829|NCT00799279|cessation|cessation
1494830|NCT00799279|family medicine|family medicine
1494831|NCT00799279|evidence-based|evidence-based
1494832|NCT00799279|knowledge translation|knowledge translation
1649793|NCT00198601|Uniject|uniject
1494833|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
1494834|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
1494835|NCT00799266|Osteoporosis|osteoporosis
1494836|NCT00799266|chronic inflammatory conditions|chronic inflammatory conditions
1494837|NCT00799266|zoledronic acid|zoledronic acid
1494838|NCT00799240|lung cancer|lung cancer
1494839|NCT00799240|stage IIIb|stage iiib
1494840|NCT00799240|pleural effusion|pleural effusion
1494841|NCT00799240|stage IV|stage iv
1494842|NCT00799240|metastatic lung cancer|metastatic lung cancer
1494843|NCT00799240|non squamous lung cancer|non squamous lung cancer
1494844|NCT00799240|IGF-1R|igf-1r
1494845|NCT00799240|Pemetrexed|pemetrexed
1494846|NCT00799240|Cisplatin|cisplatin
1494847|NCT00799214|bacterial vaginosis|bacterial vaginosis
1494848|NCT00799214|intravaginal|intravaginal
1494849|NCT00799214|boric acid|boric acid
1494850|NCT00799214|metronidazole|metronidazole
1494851|NCT00799214|placebo controlled|placebo controlled
1494852|NCT00799214|double-blind|double-blind
1494853|NCT00799214|randomized|randomized
1494854|NCT00799214|multicenter|multicenter
1494855|NCT00799214|non-inferiority|non-inferiority
1494856|NCT00799201|Enteral nutrition|enteral nutrition
1494857|NCT00799201|Constipation|constipation
1494858|NCT00799201|Gastrointestinal motility|gastrointestinal motility
1494859|NCT00799201|Naloxone|naloxone
1494860|NCT00799201|Docusate|docusate
1494861|NCT00799201|Bowel stimulant|bowel stimulant
1494862|NCT00799201|Stool softener|stool softener
1494863|NCT00799188|Cardiac Transplantation|cardiac transplantation
1494864|NCT00799188|Skin cancer|skin cancer
1494865|NCT00799188|Everolimus|everolimus
1494866|NCT00799175|Postoperative pain|postoperative pain
1494867|NCT00799175|Local infiltration analgesia|local infiltration analgesia
1494868|NCT00799175|Knee arthroplasty|knee arthroplasty
1494869|NCT00799149|Post-operative pain|post-operative pain
1494870|NCT00799149|Knee arthroscopy|knee arthroscopy
1494871|NCT00799149|Gabapentin|gabapentin
1494872|NCT00799149|Etoricoxib|etoricoxib
1494873|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
1494874|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
1494875|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
1494876|NCT00799123|NT-proBNP|nt-probnp
1494877|NCT00799110|dendritic cells|dendritic cells
1494878|NCT00799110|fusion vaccines|fusion vaccines
1494879|NCT00799110|GM-CSF|gm-csf
1494880|NCT00799110|imiquimod|imiquimod
1494881|NCT00799084|symptom management|symptom management
1494882|NCT00799084|cancer|cancer
1494883|NCT00799084|chemotherapy treatment|chemotherapy treatment
1494884|NCT00799084|Behavioral Research|behavioral research
1494885|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
1494886|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
1494887|NCT00799071|prophylaxis|prophylaxis
1494888|NCT00799071|CGD|cgd
1494889|NCT00799071|pharmacokinetics|pharmacokinetics
1494890|NCT00799058|HIV-1 infections|hiv-1 infections
1494891|NCT00799045|Migraine|migraine
1494892|NCT00799045|atrial septal defects|atrial septal defects
1494893|NCT00799045|transcatheter|transcatheter
1494894|NCT00799045|clopidogrel|clopidogrel
1494895|NCT00799032|Coronary Stent|coronary stent
1494896|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
1494897|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
1494898|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
1494899|NCT00798993|Chronic kidney failure|chronic kidney failure
1494900|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
1494901|NCT00798993|falls|falls
1494902|NCT00798993|exercise|exercise
1494903|NCT00798993|quadriceps strength|quadriceps strength
1494904|NCT00798980|Mirena|mirena
1494905|NCT00798980|Nulliparous|nulliparous
1494906|NCT00798980|Intrauterine Devices|intrauterine devices
1494907|NCT00798967|SBS|sbs
1494908|NCT00798967|short bowel syndrome|short bowel syndrome
1494909|NCT00798967|TPN|tpn
1494910|NCT00798967|parenteral nutrition|parenteral nutrition
1494911|NCT00798967|PN|pn
1494912|NCT00798915|Diabetes|diabetes
1494913|NCT00798915|Blood Sugar|blood sugar
1494914|NCT00798915|Xenin-25|xenin-25
1494915|NCT00798915|GIP|gip
1494916|NCT00798915|Insulin|insulin
1494918|NCT00798902|Spondylolisthesis|spondylolisthesis
1494919|NCT00798902|Spine Fusion|spine fusion
1494920|NCT00798902|Lumbar Spine|lumbar spine
1494921|NCT00798902|Bone Graft|bone graft
1494922|NCT00798889|Solid tumors|solid tumors
1494923|NCT00798863|submandibular gland|submandibular gland
1494924|NCT00798863|video assisted neck surgery|video assisted neck surgery
1494925|NCT00798850|Claudication|claudication
1494926|NCT00798850|Vascular claudication|vascular claudication
1494927|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
1494928|NCT00798850|Peripheral arterial disease|peripheral arterial disease
1494929|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
1494930|NCT00798850|Angioplasty|angioplasty
1494931|NCT00798850|Femoral angioplasty|femoral angioplasty
1494932|NCT00798850|Superficial femoral artery|superficial femoral artery
1494933|NCT00798850|Femoral arterial disease|femoral arterial disease
1494934|NCT00798850|Exercise|exercise
1494935|NCT00798850|Supervised exercise|supervised exercise
1494936|NCT00798850|Exercise therapy|exercise therapy
1494937|NCT00798850|Exercise programme|exercise programme
1494938|NCT00798850|Infrainuginal|infrainuginal
1494939|NCT00798850|Quality of life|quality of life
1494941|NCT00798850|Questionnaire|questionnaire
1494942|NCT00798850|VascuQol|vascuqol
1494943|NCT00798850|Randomised|randomised
1494944|NCT00798850|Randomised trial|randomised trial
1494945|NCT00798850|Combination therapy|combination therapy
1494946|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
1494947|NCT00798837|prostate|prostate
1494948|NCT00798837|cancer|cancer
1494949|NCT00798837|IMRT|imrt
1494950|NCT00798837|radiation|radiation
1494951|NCT00798824|tube feeding|tube feeding
1494952|NCT00798824|premature infant|premature infant
1494954|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
1494955|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
1494956|NCT00798811|infant|infant
1494957|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
1494958|NCT00798785|pancreatic beta cell|pancreatic beta cell
1494959|NCT00798785|transplantation|transplantation
1494960|NCT00798772|HIV infection|hiv infection
1494961|NCT00798772|Micronutrients|micronutrients
1494962|NCT00798772|Antioxidants|antioxidants
1494963|NCT00798759|Open-angle glaucoma|open-angle glaucoma
1494964|NCT00798759|Ocular hypertension|ocular hypertension
1494965|NCT00798746|Esophageal cancer|esophageal cancer
1494966|NCT00798746|pyloric drainage|pyloric drainage
1494967|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
1494968|NCT00798746|reflux|reflux
1494969|NCT00798746|reflux symptoms|reflux symptoms
1494970|NCT00798746|esophagectomy|esophagectomy
1494971|NCT00798746|Quality of Life|quality of life
1494972|NCT00798746|Health-related quality of life|health-related quality of life
1494973|NCT00798746|HRQL|hrql
1494974|NCT00798720|non small cell lung cancer|non small cell lung cancer
1494975|NCT00798720|HDAC|hdac
1494976|NCT00798720|proteasome inhibitor|proteasome inhibitor
1494977|NCT00798707|Major Depressive Disorder|major depressive disorder
1494978|NCT00798694|glaucoma|glaucoma
1494979|NCT00798694|impression cytology|impression cytology
1494980|NCT00798694|ocular surface changes|ocular surface changes
1494981|NCT00798694|prostaglandins|prostaglandins
1494982|NCT00798681|parenteral nutrition|parenteral nutrition
1494983|NCT00798681|ready-to-use|ready-to-use
1494984|NCT00798681|customized nutrition formulation|customized nutrition formulation
1494985|NCT00798681|olive oil|olive oil
1494986|NCT00798681|soybean oil|soybean oil
1494987|NCT00798681|LCT/MCT|lct/mct
1494988|NCT00798681|Clinoleic|clinoleic
1494989|NCT00798681|oliclinomel|oliclinomel
1494990|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
1494991|NCT00798681|BSI|bsi
1494992|NCT00798681|Infection rates|infection rates
1494993|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
1494994|NCT00798655|panitumumab|panitumumab
1494995|NCT00798655|cisplatin|cisplatin
1494996|NCT00798655|radiation|radiation
1494997|NCT00798642|Hypnotherapy|hypnotherapy
1494998|NCT00798642|Ulcerative Colitis|ulcerative colitis
1494999|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
1495000|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
1495001|NCT00798642|Digestive System Diseases|digestive system diseases
1495002|NCT00798642|Intestinal Diseases|intestinal diseases
1495003|NCT00798642|Colonic Diseases|colonic diseases
1495004|NCT00798629|stage III melanoma|stage iii melanoma
1495005|NCT00798629|stage IV melanoma|stage iv melanoma
1495006|NCT00798629|recurrent melanoma|recurrent melanoma
1495007|NCT00798629|mucosal melanoma|mucosal melanoma
1495008|NCT00798616|bronchiolitis|bronchiolitis
1495009|NCT00798616|steroids|steroids
1495010|NCT00798616|corticosteroids|corticosteroids
1495011|NCT00798616|albuterol|albuterol
1495012|NCT00798616|child|child
1495013|NCT00798616|infant|infant
1495014|NCT00798616|pediatric|pediatric
1495015|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1495016|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1495017|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1495018|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
1495019|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1495020|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
1495021|NCT00798590|Insulin infusion|insulin infusion
1495022|NCT00798590|Tight glycemic control|tight glycemic control
1495023|NCT00798590|Intensive Care Units|intensive care units
1495024|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
1495025|NCT00798564|Exercise|exercise
1495026|NCT00798564|Mannitol|mannitol
1495027|NCT00798538|Buprenorphine|buprenorphine
1495029|NCT00798538|Drug Abuse|drug abuse
1495030|NCT00798538|Drug Addiction|drug addiction
1495031|NCT00798538|Drug Dependence|drug dependence
1495032|NCT00798538|Drug Use Disorders|drug use disorders
1495033|NCT00798538|Drug Use Disorder|drug use disorder
1495034|NCT00798538|Substance Abuse|substance abuse
1495035|NCT00798538|Opiate Addiction|opiate addiction
1495036|NCT00798538|Substance-related disorders|substance-related disorders
1495037|NCT00798525|thrombocytopenia|thrombocytopenia
1495038|NCT00798525|Heparin|heparin
1495039|NCT00798525|Lepirudin|lepirudin
1495040|NCT00798525|Argatroban|argatroban
1495041|NCT00798525|critically ill patients|critically ill patients
1495042|NCT00798512|carotid artery stenting|carotid artery stenting
1495043|NCT00798512|cerebral protection|cerebral protection
1495044|NCT00798512|stroke|stroke
1495045|NCT00798512|ischemic lesion|ischemic lesion
1495046|NCT00798512|DW-MRI|dw-mri
1495047|NCT00798499|haemophilia|haemophilia
1495048|NCT00798499|patients with haemophilia|patients with haemophilia
1495049|NCT00798473|Crohn's disease|crohn's disease
1495050|NCT00798473|Osteopenia|osteopenia
1495051|NCT00798473|Osteoporosis|osteoporosis
1495052|NCT00798473|Bisphosphonates|bisphosphonates
1495053|NCT00798473|Zoledronate|zoledronate
1495054|NCT00798460|Chronic hepatitis B|chronic hepatitis b
1495055|NCT00798460|lamivudine resistance|lamivudine resistance
1495056|NCT00798460|clevudine|clevudine
1495057|NCT00798447|post OP|post op
1495058|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
1495059|NCT00798434|fesoterodine|fesoterodine
1495060|NCT00798434|elderly|elderly
1495061|NCT00798434|flexible dose regimen|flexible dose regimen
1495062|NCT00798434|urgency|urgency
1495063|NCT00798434|frequency|frequency
1495064|NCT00798434|urge urinary incontinence|urge urinary incontinence
1495065|NCT00798434|anticholinergic|anticholinergic
1495066|NCT00798434|antimuscarinic|antimuscarinic
1495067|NCT00798421|Influenza, transmission|influenza, transmission
1495068|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
1495069|NCT00798369|Acute flares|acute flares
1495070|NCT00798369|Gout|gout
1495071|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
1495072|NCT00798369|Colchicine|colchicine
1495073|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
1495074|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
1495075|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
1495076|NCT00798330|Cancer|cancer
1495077|NCT00798330|Blood stream infections|blood stream infections
1495078|NCT00798330|Bacteremia|bacteremia
1495079|NCT00798330|Dental procedure|dental procedure
1495080|NCT00798330|Central venous catheters|central venous catheters
1495081|NCT00798330|Mediport|mediport
1495082|NCT00798330|PICC line|picc line
1495083|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
1495084|NCT00798304|infants|infants
1495085|NCT00798304|safety|safety
1495086|NCT00798304|immunogenicity|immunogenicity
1495087|NCT00798278|Empyema|empyema
1495088|NCT00798278|Urokinase|urokinase
1495089|NCT00798278|Thoracoscopic|thoracoscopic
1495090|NCT00798278|Childhood|childhood
1495091|NCT00798265|HPV Vaccination|hpv vaccination
1495092|NCT00798265|HPV Immunogenicity|hpv immunogenicity
1495093|NCT00798265|HIV Infection|hiv infection
1495094|NCT00798265|HIV Negative|hiv negative
1495095|NCT00798265|Adolescents and Young Adults|adolescents and young adults
1495096|NCT00798265|Healthy Volunteer|healthy volunteer
1495097|NCT00798265|HV|hv
1495098|NCT00798265|Adolescent|adolescent
1495099|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
1495100|NCT00798239|DDD|ddd
1495101|NCT00798239|Spondylolisthesis|spondylolisthesis
1495102|NCT00798239|Spine Fusion|spine fusion
1495103|NCT00798239|Lumbar Spine|lumbar spine
1495104|NCT00798239|Bone Graft|bone graft
1495105|NCT00798226|Asthma|asthma
1495106|NCT00798226|Eczema|eczema
1495107|NCT00798226|Sensitization|sensitization
1495108|NCT00798226|Allergy|allergy
1495109|NCT00798200|Cancer|cancer
1495110|NCT00798200|Oncology|oncology
1495111|NCT00798200|Rehabilitation|rehabilitation
1495112|NCT00798200|Endurance|endurance
1495113|NCT00798200|Strength|strength
1495114|NCT00798187|Prostate Cancer|prostate cancer
1495115|NCT00798187|Breast Cancer|breast cancer
1495116|NCT00798187|Behavioral Intervention|behavioral intervention
1495117|NCT00798187|Cancer Support Programs|cancer support programs
1495118|NCT00798187|Social Comparison|social comparison
1495119|NCT00798187|Heterogeneous support group|heterogeneous support group
1495120|NCT00798187|Homogeneous support group|homogeneous support group
1495121|NCT00798174|DFT|dft
1495122|NCT00798174|CHF|chf
1495123|NCT00798174|ICD|icd
1495124|NCT00798148|Neuroblastoma|neuroblastoma
1495125|NCT00798148|MIBG|mibg
1495126|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
1495127|NCT00798122|sex|sex
1495128|NCT00798122|acute coronary syndromes|acute coronary syndromes
1495129|NCT00798122|normal angiogram|normal angiogram
1495130|NCT00798122|no obstruction at angiography|no obstruction at angiography
1495131|NCT00798122|women|women
1495132|NCT00798109|Schizophrenia|schizophrenia
1495133|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
1495134|NCT00798109|Motivational interview|motivational interview
1495135|NCT00798109|Randomised open trial|randomised open trial
1495136|NCT00798096|T Cell Lymphoma|t cell lymphoma
1495137|NCT00798096|Lymphoma|lymphoma
1495138|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
1495139|NCT00798070|cancer|cancer
1495140|NCT00798057|Pituitary tumor|pituitary tumor
1495141|NCT00798057|Outcomes|outcomes
1495142|NCT00798057|Proton radiation|proton radiation
1495143|NCT00798044|quality improvement|quality improvement
1495144|NCT00798044|feedback|feedback
1495145|NCT00798044|substance use disorders|substance use disorders
1495146|NCT00798031|dental implant|dental implant
1495147|NCT00798031|upper jaw|upper jaw
1495148|NCT00798031|posterior tooth loss|posterior tooth loss
1495149|NCT00798031|short dental implant|short dental implant
1495150|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
1495245|NCT00797693|first trimester missed abortion|first trimester missed abortion
1495151|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
1495152|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
1495153|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
1495154|NCT00798018|lidocaine|lidocaine
1495155|NCT00798018|tetracaine|tetracaine
1495156|NCT00798018|tracheal intubation|tracheal intubation
1495157|NCT00798018|pharyngitis|pharyngitis
1495158|NCT00798005|NV1FGF|nv1fgf
1495159|NCT00798005|PAOD|paod
1495160|NCT00798005|CLI|cli
1495161|NCT00797992|Bevacizumab|bevacizumab
1495162|NCT00797992|Myopia|myopia
1495163|NCT00797992|Complications|complications
1495164|NCT00797992|Neovascularization|neovascularization
1495165|NCT00797992|OCT|oct
1495166|NCT00797979|Craniotomy|craniotomy
1495167|NCT00797979|Skull fixation|skull fixation
1495168|NCT00797979|Skull Grip|skull grip
1495169|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
1495170|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
1495171|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
1495172|NCT00797940|GBM|gbm
1495173|NCT00797940|Glioblastoma|glioblastoma
1495174|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
1495175|NCT00797940|Brain Tumor|brain tumor
1495176|NCT00797940|Brain Cancer|brain cancer
1495177|NCT00797940|Glioma|glioma
1495178|NCT00797927|schizophrenia|schizophrenia
1495179|NCT00797927|quetiapine|quetiapine
1495180|NCT00797927|conventional antipsychotics|conventional antipsychotics
1495181|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1495182|NCT00797914|Colonoscopy|colonoscopy
1495183|NCT00797914|Instrumentation|instrumentation
1495184|NCT00797914|Force Monitoring|force monitoring
1495185|NCT00797914|Quality Control|quality control
1495186|NCT00797914|Training|training
1495187|NCT00797888|diabetes|diabetes
1495188|NCT00797888|behavioral intervention|behavioral intervention
1495189|NCT00797888|HbA1c|hba1c
1495190|NCT00797888|health disparities|health disparities
1495191|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
1495192|NCT00797862|Aliskiren|aliskiren
1495193|NCT00797862|Amlodipine|amlodipine
1495194|NCT00797862|Hypertension|hypertension
1495195|NCT00797862|SPA1000|spa1000
1495196|NCT00797862|Norvasc|norvasc
1495197|NCT00797849|phantom limb pain|phantom limb pain
1495198|NCT00797849|amputees|amputees
1495199|NCT00797849|Farabloc|farabloc
1495200|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
1495201|NCT00797836|Occupational Diseases|occupational diseases
1495202|NCT00797836|Tuberculosis|tuberculosis
1495203|NCT00797836|Tuberculin Test|tuberculin test
1495204|NCT00797836|Immunoassay|immunoassay
1495205|NCT00797823|diabetes|diabetes
1495206|NCT00797823|pancreas|pancreas
1495207|NCT00797823|beta cell|beta cell
1495208|NCT00797823|glucagon|glucagon
1495209|NCT00797823|insulin|insulin
1495210|NCT00797823|hypoglycemia|hypoglycemia
1495211|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
1495310|NCT00797394|prostate|prostate
1495212|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
1495213|NCT00797797|fibromyalgia|fibromyalgia
1495214|NCT00797797|milnacipran|milnacipran
1495215|NCT00797797|pregabalin|pregabalin
1495216|NCT00797797|treatment|treatment
1495217|NCT00797797|Forest Research Institute|forest research institute
1495218|NCT00797771|Insulin delivery|insulin delivery
1495219|NCT00797758|Cord blood transplantation|cord blood transplantation
1495220|NCT00797758|Conditioning regimen|conditioning regimen
1495221|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
1495222|NCT00797758|SORROR comorbidity index|sorror comorbidity index
1495223|NCT00797758|Quality of life|quality of life
1495224|NCT00797758|Innate immunity|innate immunity
1495225|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
1495226|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
1495227|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1495228|NCT00797745|genotype 1 infection|genotype 1 infection
1495229|NCT00797732|acupuncture|acupuncture
1495230|NCT00797732|dysphagia|dysphagia
1495231|NCT00797732|chemoradiation related effects|chemoradiation related effects
1495232|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1495233|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
1495234|NCT00797732|oropharynx cancer|oropharynx cancer
1495235|NCT00797732|hypopharynx cancer|hypopharynx cancer
1495236|NCT00797732|larynx cancer|larynx cancer
1495237|NCT00797719|MPM|mpm
1495238|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
1495239|NCT00797693|First trimester|first trimester
1495240|NCT00797693|missed abortion|missed abortion
1495241|NCT00797693|misoprostol|misoprostol
1495242|NCT00797693|cervical ripening|cervical ripening
1495243|NCT00797693|oral|oral
1495244|NCT00797693|vaginal|vaginal
1495443|NCT00796783|Pituitary|pituitary
1495246|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
1495247|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
1495248|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
1495249|NCT00797641|bleeding|bleeding
1495250|NCT00797641|ulcer|ulcer
1495251|NCT00797641|hemorrhage|hemorrhage
1495252|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
1495253|NCT00797641|digestive system disease|digestive system disease
1495254|NCT00797641|peptic ulcer|peptic ulcer
1495255|NCT00797641|proton pump inhibitor|proton pump inhibitor
1495256|NCT00797602|Chordomas|chordomas
1495257|NCT00797602|Chondrosarcomas|chondrosarcomas
1495258|NCT00797602|Cancer|cancer
1495259|NCT00797602|Outcomes|outcomes
1495260|NCT00797602|Proton radiation|proton radiation
1495261|NCT00797589|aorta valve|aorta valve
1495262|NCT00797589|mitral valve|mitral valve
1495263|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
1495264|NCT00797589|perfusion|perfusion
1495265|NCT00797589|priming|priming
1495266|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
1495267|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
1495268|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1495269|NCT00797576|atrial fibrillation|atrial fibrillation
1495270|NCT00797576|cardioversion|cardioversion
1495271|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
1495272|NCT00797550|bone graft|bone graft
1495273|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
1495274|NCT00797511|Diphtheria|diphtheria
1495275|NCT00797511|Tetanus|tetanus
1495276|NCT00797511|Pertussis|pertussis
1495277|NCT00797511|Poliomyelitis|poliomyelitis
1495278|NCT00797498|Nasal Cavity|nasal cavity
1495279|NCT00797498|Paranasal Sinuses|paranasal sinuses
1495280|NCT00797498|Proton Radiation|proton radiation
1495281|NCT00797498|Outcomes|outcomes
1495282|NCT00797485|stage IV colon cancer|stage iv colon cancer
1495283|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
1495284|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
1495285|NCT00797472|R-mabHD|r-mabhd
1495286|NCT00797472|ABVD treatment|abvd treatment
1495287|NCT00797472|Hodgkin's Disease|hodgkin's disease
1495288|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
1495289|NCT00797446|Oropharyngeal|oropharyngeal
1495290|NCT00797446|cancer|cancer
1495291|NCT00797446|proton|proton
1495292|NCT00797446|radiation|radiation
1495293|NCT00797446|outcomes|outcomes
1495294|NCT00797433|testosterone|testosterone
1495295|NCT00797433|mechanical ventilation|mechanical ventilation
1495296|NCT00797420|fluconazole|fluconazole
1495297|NCT00797420|pharmacokinetic|pharmacokinetic
1495298|NCT00797420|candidiasis|candidiasis
1495299|NCT00797420|sepsis|sepsis
1495300|NCT00797420|pediatric|pediatric
1495301|NCT00797420|infants|infants
1495302|NCT00797420|antifungal|antifungal
1495303|NCT00797420|candidemia|candidemia
1495304|NCT00797420|fungemia|fungemia
1495305|NCT00797420|loading dose|loading dose
1495306|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1495307|NCT00797407|Creatine|creatine
1495308|NCT00797407|Adverse Effects|adverse effects
1495309|NCT00797407|Muscle Toxicity|muscle toxicity
1495311|NCT00797394|dietary supplements|dietary supplements
1495312|NCT00797394|saw palmetto|saw palmetto
1495313|NCT00797394|canada|canada
1495314|NCT00797381|MK-0518|mk-0518
1495315|NCT00797381|HIV|hiv
1495316|NCT00797381|AIDS|aids
1495317|NCT00797381|hemophilia|hemophilia
1495318|NCT00797381|treatment experienced|treatment experienced
1495319|NCT00797368|ankle sprain|ankle sprain
1495320|NCT00797368|manual therapy|manual therapy
1495321|NCT00797368|exercise|exercise
1495322|NCT00797368|physical therapy|physical therapy
1495323|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
1495324|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
1495325|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
1495326|NCT00797316|Hypertension|hypertension
1495327|NCT00797316|Metabolic Syndrome|metabolic syndrome
1495328|NCT00797316|aliskiren|aliskiren
1495329|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
1495330|NCT00797316|systolic blood pressure|systolic blood pressure
1495331|NCT00797316|diastolic blood pressure|diastolic blood pressure
1495333|NCT00797303|bevacizumab|bevacizumab
1495334|NCT00797303|cornea|cornea
1495335|NCT00797303|neovascularization|neovascularization
1495336|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
1495337|NCT00797277|schizophrenia|schizophrenia
1495338|NCT00797277|schizoaffective disorder|schizoaffective disorder
1495339|NCT00797277|olanzapine|olanzapine
1495340|NCT00797277|haloperidol|haloperidol
1495341|NCT00797277|lorazepam|lorazepam
1495342|NCT00797277|agitation|agitation
1495343|NCT00797264|Ketamine|ketamine
1495344|NCT00797264|Morphine|morphine
1495345|NCT00797264|PCA|pca
1495346|NCT00797264|Hyperalgesia|hyperalgesia
1495347|NCT00797264|Nor-ketamine|nor-ketamine
1495348|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
1495349|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
1495350|NCT00797251|liver surgery|liver surgery
1495351|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
1495352|NCT00797251|finger-compression|finger-compression
1495353|NCT00797238|Gene Expression|gene expression
1495354|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1495355|NCT00797238|Chemotherapy|chemotherapy
1495356|NCT00797225|bone mineral density|bone mineral density
1495357|NCT00797225|Endometriosis|endometriosis
1495358|NCT00797225|Pelvic Pain|pelvic pain
1495359|NCT00797199|Breast Cancer Risk|breast cancer risk
1495360|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
1495361|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1495362|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
1495363|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
1495364|NCT00797186|diabetes|diabetes
1495365|NCT00797186|dyslipidemia|dyslipidemia
1495366|NCT00797186|microvascular dysfunction|microvascular dysfunction
1495367|NCT00797186|imaging|imaging
1495368|NCT00797160|propofol|propofol
1495369|NCT00797160|midazolam|midazolam
1495370|NCT00797160|neonate|neonate
1495371|NCT00797160|tracheal intubation|tracheal intubation
1495372|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
1495373|NCT00797121|Drainage|drainage
1495374|NCT00797095|Adolescence|adolescence
1495375|NCT00797095|Obesity|obesity
1495376|NCT00797095|Substance use|substance use
1495377|NCT00797095|Prevalence|prevalence
1495378|NCT00797095|Social and Environmental Contexts|social and environmental contexts
1495379|NCT00797095|Survey|survey
1495380|NCT00797082|Diabetic|diabetic
1495381|NCT00797082|Coronary disease|coronary disease
1495382|NCT00797082|Atherosclerosis|atherosclerosis
1495383|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
1495384|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
1495385|NCT00797082|Coronary angiography|coronary angiography
1495386|NCT00797056|G-CSF|g-csf
1495387|NCT00797056|angiogenesis|angiogenesis
1495388|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
1495389|NCT00797056|limb ischemia|limb ischemia
1495390|NCT00797056|revascularization|revascularization
1495391|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
1495392|NCT00797043|Proton radiation|proton radiation
1495393|NCT00797043|Outcomes|outcomes
1495394|NCT00797030|dry eye syndromes|dry eye syndromes
1495395|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
1495396|NCT00797030|cyclosporine|cyclosporine
1495397|NCT00797030|ophthalmic solutions|ophthalmic solutions
1495398|NCT00797030|HIV seropositivity|hiv seropositivity
1495399|NCT00797017|Chronic Pain|chronic pain
1495400|NCT00797017|Fentanyl Matrix|fentanyl matrix
1495401|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
1495402|NCT00797004|olfactory dysfunction|olfactory dysfunction
1495403|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
1495404|NCT00796978|stage I breast cancer|stage i breast cancer
1495405|NCT00796978|stage II breast cancer|stage ii breast cancer
1495406|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
1495407|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
1495408|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
1495409|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
1495410|NCT00796965|Phase 1|phase 1
1495411|NCT00796952|Head/ neck cancer|head/ neck cancer
1495412|NCT00796952|Swallowing|swallowing
1495413|NCT00796952|behavioral treatment|behavioral treatment
1495414|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
1495415|NCT00796939|Sleep|sleep
1495416|NCT00796900|Hyperthermia|hyperthermia
1495417|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
1495418|NCT00796900|placebo controlled|placebo controlled
1495419|NCT00796900|double blinded|double blinded
1495420|NCT00796900|Dantrolene|dantrolene
1495421|NCT00796887|Ischemic Stroke|ischemic stroke
1495422|NCT00796887|Recovery of Function|recovery of function
1495423|NCT00796887|Extended-release niacin|extended-release niacin
1495424|NCT00796874|stage I prostate cancer|stage i prostate cancer
1495425|NCT00796874|stage II prostate cancer|stage ii prostate cancer
1495426|NCT00796861|malignant ascites|malignant ascites
1495427|NCT00796835|Schizophrenia|schizophrenia
1495428|NCT00796835|Mood disorders|mood disorders
1495429|NCT00796835|Antipsychotic drugs|antipsychotic drugs
1495430|NCT00796835|ER OROS Paliperidone|er oros paliperidone
1495431|NCT00796822|Endothelial Function|endothelial function
1495432|NCT00796822|Inflammation|inflammation
1495433|NCT00796809|TNF inhibitors|tnf inhibitors
1495434|NCT00796809|Biologic agents|biologic agents
1495435|NCT00796809|coccidioidomycosis|coccidioidomycosis
1495436|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
1495437|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
1495438|NCT00796796|temsirolimus|temsirolimus
1495439|NCT00796796|radiation therapy|radiation therapy
1495440|NCT00796783|Cushing's Disease|cushing's disease
1495441|NCT00796783|Cushing's Syndrome|cushing's syndrome
1495442|NCT00796783|Cushings|cushings
1495444|NCT00796783|ACTH|acth
1495445|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
1495446|NCT00796783|Ectopic|ectopic
1495447|NCT00796783|Adrenal adenoma|adrenal adenoma
1495448|NCT00796783|Adrenal carcinoma|adrenal carcinoma
1495449|NCT00796783|Adrenal autonomy|adrenal autonomy
1495450|NCT00796783|Cortisol|cortisol
1495451|NCT00796783|Hypercortisolemia|hypercortisolemia
1495452|NCT00796783|Cushinoid|cushinoid
1495453|NCT00796783|Moon facies|moon facies
1495454|NCT00796783|Dorsalcervical fat|dorsalcervical fat
1495455|NCT00796783|Plethora|plethora
1495456|NCT00796783|Hirsutism|hirsutism
1495457|NCT00796783|Violaceous striae|violaceous striae
1495458|NCT00796783|Hormone|hormone
1495459|NCT00796783|Contraceptive|contraceptive
1495460|NCT00796783|Endocrine|endocrine
1495461|NCT00796783|Cushing Syndrome|cushing syndrome
1495462|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
1495463|NCT00796770|HIV|hiv
1495464|NCT00796770|Vaccine|vaccine
1495465|NCT00796770|HAART|haart
1495466|NCT00796770|HIV-1|hiv-1
1495467|NCT00796770|AIDS|aids
1495468|NCT00796770|Dendritic Cells|dendritic cells
1495469|NCT00796770|DALIA|dalia
1495470|NCT00796744|Diabetes mellitus|diabetes mellitus
1495471|NCT00796744|Diabetic neuropathy|diabetic neuropathy
1495472|NCT00796744|Peripheral vascular disease|peripheral vascular disease
1495473|NCT00796744|Infection|infection
1495474|NCT00796744|Topical application|topical application
1495475|NCT00796744|plantar foot ulcers|plantar foot ulcers
1495476|NCT00796731|B-cell lymphoma|b-cell lymphoma
1495477|NCT00796731|NHL|nhl
1495478|NCT00796692|Heparin|heparin
1495479|NCT00796692|Low molecular weight heparin|low molecular weight heparin
1495480|NCT00796692|Safety|safety
1495481|NCT00796692|Efficacy|efficacy
1495482|NCT00796692|Cost effective|cost effective
1495483|NCT00796679|paricalcitol|paricalcitol
1495484|NCT00796679|chronic kidney disease|chronic kidney disease
1495485|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
1495486|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
1495487|NCT00796666|Sitaxsentan|sitaxsentan
1495488|NCT00796640|Schizophrenia|schizophrenia
1495489|NCT00796640|Mood disorders|mood disorders
1495490|NCT00796640|Antipsychotic drugs|antipsychotic drugs
1495491|NCT00796640|ER Paliperidone|er paliperidone
1495492|NCT00796627|Wound Healing|wound healing
1495493|NCT00796627|Burns|burns
1495494|NCT00796627|HIF-1|hif-1
1495495|NCT00796627|CAC|cac
1495496|NCT00796614|tamsulosin|tamsulosin
1495497|NCT00796614|pediatric|pediatric
1495498|NCT00796614|neurogenic bladder|neurogenic bladder
1495499|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
1495500|NCT00796588|preconditioning|preconditioning
1495501|NCT00796588|remote|remote
1495502|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
1495503|NCT00796575|pharmacokinetics|pharmacokinetics
1495504|NCT00796575|pharmacodynamics|pharmacodynamics
1495505|NCT00796562|Leukemia|leukemia
1495506|NCT00796562|Lymphoma|lymphoma
1495507|NCT00796562|Hematologic malignancies|hematologic malignancies
1495508|NCT00796562|ALL|all
1495509|NCT00796562|AML|aml
1495511|NCT00796562|Transplantation|transplantation
1495512|NCT00796562|Mismatched|mismatched
1495513|NCT00796562|Haploidentical|haploidentical
1495514|NCT00796562|Busulfan|busulfan
1495515|NCT00796562|Cyclophosphamide|cyclophosphamide
1495516|NCT00796562|Cellcept|cellcept
1495517|NCT00796562|Tacrolimus|tacrolimus
1495518|NCT00796562|TBI|tbi
1495519|NCT00796562|CMMOL|cmmol
1495520|NCT00796562|CML|cml
1495521|NCT00796562|JMML|jmml
1495522|NCT00796536|Acute Pain|acute pain
1495523|NCT00796536|Low Back Pain|low back pain
1495524|NCT00796536|Back Pain|back pain
1495525|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1495526|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
1495527|NCT00796536|Pain Education|pain education
1495528|NCT00796523|colic|colic
1495529|NCT00796523|crying|crying
1495530|NCT00796523|clinical trial|clinical trial
1495531|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
1495532|NCT00796510|sitaxsentan|sitaxsentan
1495533|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
1495534|NCT00796497|5-ht3|5-ht3
1495535|NCT00796497|ondansetron|ondansetron
1495536|NCT00796484|Cancer|cancer
1495537|NCT00796484|Solid Tumors|solid tumors
1495538|NCT00796471|Schizophrenia|schizophrenia
1495539|NCT00796471|Mood Disorders|mood disorders
1495540|NCT00796471|Antipsychotic drugs|antipsychotic drugs
1495541|NCT00796471|Paliperidone ER|paliperidone er
1495542|NCT00796458|pain|pain
1495543|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1495544|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
1495545|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
1495546|NCT00796458|stage III prostate cancer|stage iii prostate cancer
1495547|NCT00796445|DERMA|derma
1495548|NCT00796445|Tumor antigen|tumor antigen
1495549|NCT00796445|Immunotherapeutic|immunotherapeutic
1495550|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
1495551|NCT00796445|Melanoma|melanoma
1495552|NCT00796445|ASCI|asci
1495553|NCT00796432|Schizophrenia|schizophrenia
1495554|NCT00796432|mood disorders|mood disorders
1495555|NCT00796432|antipsychotic drugs|antipsychotic drugs
1495556|NCT00796432|dopamine|dopamine
1495557|NCT00796432|receptor occupancy|receptor occupancy
1495558|NCT00796432|OROS paliperidone|oros paliperidone
1495559|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
1495560|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1495561|NCT00796419|Respiratory failure|respiratory failure
1495562|NCT00796367|Obesity|obesity
1495563|NCT00796354|Constipation|constipation
1495564|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
1495565|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
1495566|NCT00796315|Pharmacokinetic study|pharmacokinetic study
1495567|NCT00796302|Conduct Disorder|conduct disorder
1495568|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
1495569|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
1495570|NCT00796276|Schizophrenia|schizophrenia
1495571|NCT00796276|Mood disorders|mood disorders
1495572|NCT00796276|Antipsychotics|antipsychotics
1495573|NCT00796276|Pharmacokinetics|pharmacokinetics
1495574|NCT00796276|Enantiomer|enantiomer
1495575|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
1495576|NCT00796276|ER OROS Paliperidone|er oros paliperidone
1495577|NCT00796263|Acute HIV infection|acute hiv infection
1495578|NCT00796263|Chronic HIV infection|chronic hiv infection
1495579|NCT00796237|stroke|stroke
1495580|NCT00796237|bone|bone
1495581|NCT00796237|gait|gait
1495582|NCT00796237|muscle|muscle
1495583|NCT00796237|vibration|vibration
1495584|NCT00796237|motor balance|motor balance
1495585|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
1495586|NCT00796211|Psoriasis|psoriasis
1495587|NCT00796211|CRx-197|crx-197
1495588|NCT00796211|nortriptyline|nortriptyline
1495589|NCT00796211|loratadine|loratadine
1495590|NCT00796211|CombinatoRx|combinatorx
1495591|NCT00796211|Dermatology|dermatology
1495592|NCT00796211|Erythema|erythema
1495593|NCT00796211|Pruritus|pruritus
1495594|NCT00796198|Glaucoma|glaucoma
1495595|NCT00796198|Intraocular pressure|intraocular pressure
1495596|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
1495597|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
1495598|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
1495599|NCT00796185|Schizophrenia|schizophrenia
1495600|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
1495601|NCT00796185|Mood Disorders|mood disorders
1495602|NCT00796185|Antipsychotic drugs|antipsychotic drugs
1495603|NCT00796185|Paliperidone ER|paliperidone er
1495604|NCT00796172|Hypertension|hypertension
1495605|NCT00796172|High Blood Pressure|high blood pressure
1495606|NCT00796172|Blood Lipid Management|blood lipid management
1495607|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
1495608|NCT00796133|NES/E2|nes/e2
1495609|NCT00796133|transdermal gel delivery|transdermal gel delivery
1495610|NCT00796133|contraception|contraception
1495611|NCT00796133|ovulation|ovulation
1495612|NCT00796133|bleeding patterns|bleeding patterns
1495613|NCT00796120|Sarcomas|sarcomas
1495614|NCT00796120|Trabectedin|trabectedin
1495615|NCT00796120|Doxorubicin|doxorubicin
1495616|NCT00796120|Ifosfamide|ifosfamide
1495617|NCT00796120|YONDELIS|yondelis
1495618|NCT00796081|Schizophrenia|schizophrenia
1495619|NCT00796081|Schizoaffective disorder|schizoaffective disorder
1495620|NCT00796081|Schizophreniform disorders|schizophreniform disorders
1495621|NCT00796081|Mood disorders|mood disorders
1495622|NCT00796081|Antipshychotic drugs|antipshychotic drugs
1495623|NCT00796081|Pediatrics|pediatrics
1495624|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
1495625|NCT00796042|Pressure Ulcer|pressure ulcer
1495626|NCT00796042|Bed Sores|bed sores
1495627|NCT00796042|Bedsore|bedsore
1495628|NCT00796042|Decubitus Ulcer|decubitus ulcer
1495629|NCT00796042|Pressure Sore|pressure sore
1495630|NCT00796042|Best rest|best rest
1495631|NCT00796042|mobility|mobility
1495632|NCT00796042|pressure management|pressure management
1495633|NCT00796029|Schizophrenia|schizophrenia
1495634|NCT00796029|Mood disorders|mood disorders
1495635|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
1495636|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
1495637|NCT00796003|MDS|mds
1495638|NCT00796003|Decitabine|decitabine
1495639|NCT00796003|JNJ-30979754|jnj-30979754
1495640|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
1495641|NCT00795977|preoperative|preoperative
1495642|NCT00795977|intratumor|intratumor
1495643|NCT00795977|dendritic cells|dendritic cells
1495644|NCT00795977|pancreatic cancer|pancreatic cancer
1495645|NCT00795977|OK-432|ok-432
1495646|NCT00795964|tidal volume|tidal volume
1495647|NCT00795964|predicted body weight|predicted body weight
1495648|NCT00795964|lung function|lung function
1495649|NCT00795964|respiratory outcome|respiratory outcome
1495650|NCT00795964|Respiratory Function Tests|respiratory function tests
1495651|NCT00795964|surgery|surgery
1495652|NCT00795951|allergic|allergic
1495653|NCT00795951|contact dermatitis|contact dermatitis
1495654|NCT00795951|contact allergy|contact allergy
1495655|NCT00795951|Type IV|type iv
1495656|NCT00795951|Children|children
1495657|NCT00795951|TRUE TEST|true test
1495658|NCT00795925|propiverine|propiverine
1495659|NCT00795925|anticholinergics|anticholinergics
1495660|NCT00795925|urinary incontinence|urinary incontinence
1495661|NCT00795925|overactive bladder|overactive bladder
1495662|NCT00795925|children|children
1495663|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
1495664|NCT00795912|Systolic heart failure|systolic heart failure
1495665|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
1495786|NCT00795379|Psychotherapy|psychotherapy
1495666|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
1495667|NCT00795912|Inflammation|inflammation
1495668|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
1495669|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
1495671|NCT00795886|Cancer|cancer
1495672|NCT00795886|Stem Cell Transplant|stem cell transplant
1495673|NCT00795873|Heart failure|heart failure
1495674|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
1495675|NCT00795860|Insulin sensitivity|insulin sensitivity
1495676|NCT00795860|fat metabolism|fat metabolism
1495677|NCT00795860|inflammation|inflammation
1495678|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
1495679|NCT00795834|polyphenolics|polyphenolics
1495680|NCT00795834|flavonols|flavonols
1495681|NCT00795834|lipids|lipids
1495682|NCT00795834|endothelial function|endothelial function
1495683|NCT00795834|vascular risk factors|vascular risk factors
1495684|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
1495685|NCT00795808|PCOS|pcos
1495686|NCT00795808|Anovulation|anovulation
1495687|NCT00795808|Infertility|infertility
1495688|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
1495689|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
1495690|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
1495691|NCT00795782|Lymph node dissection|lymph node dissection
1495692|NCT00795782|Lymph node metastasis|lymph node metastasis
1495693|NCT00795782|Prophylactic node dissection|prophylactic node dissection
1495694|NCT00795782|Central lymph node metastasis|central lymph node metastasis
1495695|NCT00795756|Adults|adults
1495696|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
1495697|NCT00795756|Minimal residual disease|minimal residual disease
1495698|NCT00795743|Central Venous Catheterization|central venous catheterization
1495699|NCT00795743|coagulopathy|coagulopathy
1495700|NCT00795743|thromboelastography|thromboelastography
1495701|NCT00795730|Alzheimer's Disease|alzheimer's disease
1495702|NCT00795730|schizophrenia|schizophrenia
1495703|NCT00795717|HIV|hiv
1495704|NCT00795717|cardiovascular risk|cardiovascular risk
1495705|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
1495706|NCT00795717|brachial artery reactivity|brachial artery reactivity
1495707|NCT00795717|omega three fatty acids|omega three fatty acids
1495708|NCT00795704|Herbal Supplement|herbal supplement
1495709|NCT00795704|Type 2 Diabetes|type 2 diabetes
1495710|NCT00795704|Mulberry|mulberry
1495711|NCT00795704|Hemoglobin A1C|hemoglobin a1c
1495712|NCT00795691|diabetes|diabetes
1495713|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
1495714|NCT00795691|weight loss|weight loss
1495715|NCT00795691|obesity|obesity
1495716|NCT00795691|dietary intervention|dietary intervention
1495717|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
1495718|NCT00795678|stage IV breast cancer|stage iv breast cancer
1495719|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1495720|NCT00795665|adult glioblastoma|adult glioblastoma
1495721|NCT00795665|adult gliosarcoma|adult gliosarcoma
1495722|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
1495723|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1495724|NCT00795665|adult mixed glioma|adult mixed glioma
1495725|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
1495726|NCT00795652|Postpartum depression|postpartum depression
1495727|NCT00795652|Distance therapy|distance therapy
1495728|NCT00795652|depression|depression
1495729|NCT00795652|Distance Treatment|distance treatment
1495730|NCT00795652|Barriers to care|barriers to care
1495731|NCT00795639|Sitaxsentan|sitaxsentan
1495732|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
1495733|NCT00795626|nursing education|nursing education
1495734|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
1495735|NCT00795626|coronary heart disease|coronary heart disease
1495736|NCT00795613|PET|pet
1495737|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
1495738|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
1495739|NCT00795561|nausea|nausea
1495740|NCT00795561|vomiting|vomiting
1495741|NCT00795561|pregnancy|pregnancy
1495742|NCT00795561|day care|day care
1495743|NCT00795561|inpatient management|inpatient management
1495744|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
1495745|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1495746|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1495747|NCT00795548|Stem cell transplantation|stem cell transplantation
1495748|NCT00795548|5-Azacitidine|5-azacitidine
1495749|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
1495750|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
1495751|NCT00795535|Injury|injury
1495752|NCT00795496|Atopic dermatitis|atopic dermatitis
1495753|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
1495754|NCT00795496|Skin prick tests|skin prick tests
1495755|NCT00795496|Serum IgE|serum ige
1495756|NCT00795496|Mantoux test|mantoux test
1495757|NCT00795483|Osteoporosis|osteoporosis
1495758|NCT00795483|HIV infection|hiv infection
1495759|NCT00795483|Bisphosphonates|bisphosphonates
1495760|NCT00795483|Zoledronic acid|zoledronic acid
1495761|NCT00795470|urinary tract infection|urinary tract infection
1495762|NCT00795470|critically ill|critically ill
1495763|NCT00795470|ICU|icu
1495764|NCT00795470|antimicrobial|antimicrobial
1495765|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
1495766|NCT00795457|vaccine|vaccine
1495767|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
1495768|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
1495769|NCT00795444|HIV-1|hiv-1
1495770|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
1495771|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
1495772|NCT00795418|Active immunization|active immunization
1495773|NCT00795418|Alzheimer's disease|alzheimer's disease
1495774|NCT00795418|Antibody|antibody
1495775|NCT00795418|Vaccine|vaccine
1495776|NCT00795418|Central Nervous System Diseases|central nervous system diseases
1495777|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
1495778|NCT00795405|sporting events|sporting events
1495779|NCT00795405|stress|stress
1495780|NCT00795405|myocardial ischemia|myocardial ischemia
1495781|NCT00795405|ST-segment depression|st-segment depression
1495782|NCT00795405|blood pressure|blood pressure
1495783|NCT00795392|Psychology|psychology
1495784|NCT00795392|Postoperative outcome|postoperative outcome
1495785|NCT00795392|Surgical Operation|surgical operation
1495787|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
1495788|NCT00795353|plaque psoriasis|plaque psoriasis
1495789|NCT00795353|psoriasis|psoriasis
1495790|NCT00795353|alefacept|alefacept
1495791|NCT00795353|Amevive|amevive
1495792|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1495793|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1495794|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1495795|NCT00795314|Opioids|opioids
1495796|NCT00795314|General anesthesia|general anesthesia
1495797|NCT00795301|tumor|tumor
1495798|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
1495799|NCT00795288|vasospasm|vasospasm
1495800|NCT00795288|cerebral blood flow|cerebral blood flow
1495801|NCT00795288|cerebral metabolism|cerebral metabolism
1495802|NCT00795288|autoregulation|autoregulation
1495804|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
1495805|NCT00795275|pre-diabetes|pre-diabetes
1495806|NCT00795275|isotopes|isotopes
1495807|NCT00795275|insulin secretion|insulin secretion
1495808|NCT00795275|insulin action|insulin action
1495809|NCT00795275|GLP-1|glp-1
1495810|NCT00795275|simple obesity|simple obesity
1495811|NCT00795275|impaired fasting glucose|impaired fasting glucose
1495812|NCT00795262|brachial artery reactivity|brachial artery reactivity
1495813|NCT00795236|melatonin|melatonin
1495814|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
1495815|NCT00795210|growth hormone|growth hormone
1495816|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
1495817|NCT00795197|Gaucher Disease,|gaucher disease,
1495818|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
1495819|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
1495820|NCT00795197|glucosylceramide,|glucosylceramide,
1495821|NCT00795184|Barrett's Esophagus|barrett's esophagus
1495822|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
1495823|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
1495824|NCT00795184|adenocarcinoma|adenocarcinoma
1495825|NCT00795184|Cellvizio|cellvizio
1495826|NCT00795184|endomicroscopy|endomicroscopy
1495827|NCT00795184|random biopsy|random biopsy
1495828|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
1495829|NCT00795132|cancer|cancer
1495830|NCT00795132|Hematologic Malignancies|hematologic malignancies
1495831|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
1495832|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
1495833|NCT00795119|Diagnosis|diagnosis
1495834|NCT00795119|Children|children
1495835|NCT00795106|Capsaicin|capsaicin
1495836|NCT00795106|hydrogel|hydrogel
1495837|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
1495838|NCT00795106|neck pain|neck pain
1495839|NCT00795093|GERD|gerd
1495841|NCT00795093|partial responders|partial responders
1495842|NCT00795080|CVJ malformations|cvj malformations
1495843|NCT00795054|Stem cell transplantation|stem cell transplantation
1495844|NCT00795054|Financial impact|financial impact
1495845|NCT00795041|vitrification|vitrification
1495846|NCT00795041|ovarian stimulation|ovarian stimulation
1495847|NCT00795041|reproductive medicine|reproductive medicine
1495848|NCT00795028|older women|older women
1495849|NCT00795028|hip fracture|hip fracture
1495850|NCT00795028|exercise intervention|exercise intervention
1495851|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
1495852|NCT00795015|IV insulin infusion|iv insulin infusion
1495853|NCT00794989|breast cancer|breast cancer
1495854|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
1495855|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1495856|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1495857|NCT00794989|breast cancer prevention|breast cancer prevention
1495858|NCT00794989|high risk breast cancer|high risk breast cancer
1495859|NCT00794950|Bladder Cancer|bladder cancer
1495860|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
1495861|NCT00794924|probiotics|probiotics
1495862|NCT00794924|elderly|elderly
1495863|NCT00794924|motility|motility
1495864|NCT00794924|diarrhea|diarrhea
1495865|NCT00794911|Liver Transplantation|liver transplantation
1495866|NCT00794911|Quality of Life|quality of life
1495867|NCT00794911|Chronic HCV|chronic hcv
1495868|NCT00794911|Hepatitis C Virus|hepatitis c virus
1495869|NCT00794911|Cirrhosis|cirrhosis
1495870|NCT00794911|Liver disease|liver disease
1495871|NCT00794885|hypertension|hypertension
1495872|NCT00794885|stroke|stroke
1495873|NCT00794885|cardiovascular events|cardiovascular events
1495874|NCT00794885|enalapril|enalapril
1495875|NCT00794885|folic acid|folic acid
1495876|NCT00794885|randomized controlled trial|randomized controlled trial
1495877|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
1495878|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
1495879|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
1495880|NCT00794872|Chronic kidney disease|chronic kidney disease
1495881|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
1495882|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1495883|NCT00794820|CLL|cll
1495884|NCT00794820|Leukemia|leukemia
1495885|NCT00794820|Fludarabine phosphate|fludarabine phosphate
1495886|NCT00794820|Cyclophosphamide|cyclophosphamide
1495887|NCT00794820|Rituximab|rituximab
1495888|NCT00794820|FCR|fcr
1495889|NCT00794820|Cytoxan®|cytoxan®
1495890|NCT00794820|Neosar®|neosar®
1495891|NCT00794820|Rituxan®|rituxan®
1495892|NCT00794807|Alefacept|alefacept
1495893|NCT00794807|Skin Diseases|skin diseases
1495894|NCT00794807|Psoriasis|psoriasis
1495895|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
1495896|NCT00794807|Therapeutic Uses|therapeutic uses
1495897|NCT00794807|Dermatologic Agents|dermatologic agents
1495898|NCT00794781|Cancer|cancer
1495899|NCT00794781|solid tumors|solid tumors
1495900|NCT00794755|Vitamin K|vitamin k
1495901|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
1495902|NCT00794755|Unstable INR|unstable inr
1495903|NCT00794755|VTE or Thrombosis|vte or thrombosis
1495904|NCT00794755|Warfarin|warfarin
1495905|NCT00794755|Anticoagulation Control|anticoagulation control
1495906|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
1495907|NCT00794742|Burn|burn
1495908|NCT00794742|Antimicrobial|antimicrobial
1495909|NCT00794742|Bacteria|bacteria
1495910|NCT00794742|Resistance|resistance
1495911|NCT00794742|Biofilm|biofilm
1495912|NCT00794742|Pathogen|pathogen
1495913|NCT00794729|Healthy Volunteers|healthy volunteers
1495914|NCT00794729|Consents|consents
1495915|NCT00794703|Antifungal|antifungal
1495916|NCT00794703|micafungin|micafungin
1495917|NCT00794703|itraconazole|itraconazole
1495918|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
1495919|NCT00794690|liver blood flow and functions|liver blood flow and functions
1495920|NCT00794677|Hypercholesterolemia|hypercholesterolemia
1495921|NCT00794677|Oxysterol|oxysterol
1495922|NCT00794677|Ezetimibe|ezetimibe
1495923|NCT00794677|Zetia|zetia
1495924|NCT00794651|osteoarthritis|osteoarthritis
1495925|NCT00794651|testing kit|testing kit
1495926|NCT00794651|knee|knee
1495927|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1495928|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1495929|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
1495930|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
1495931|NCT00794638|Follicular Lymphoma|follicular lymphoma
1495932|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1495933|NCT00794625|Aggressive Behavior|aggressive behavior
1495934|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
1495935|NCT00794625|Conduct Disorder|conduct disorder
1495936|NCT00794586|cystic fibrosis|cystic fibrosis
1495938|NCT00794586|inhaled antibiotic|inhaled antibiotic
1495939|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
1495940|NCT00794586|tobramycin|tobramycin
1495941|NCT00794586|fosfomycin|fosfomycin
1495942|NCT00794586|lung infection|lung infection
1495943|NCT00794586|pseudomonal infection|pseudomonal infection
1495944|NCT00794586|FTI|fti
1495945|NCT00794573|Smoking Cessation|smoking cessation
1495946|NCT00794573|Cardiac Population|cardiac population
1495947|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
1495948|NCT00794573|Varenicline|varenicline
1495949|NCT00794573|Champix|champix
1495950|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
1495951|NCT00794560|compliance|compliance
1495952|NCT00794560|drug safety|drug safety
1495953|NCT00794560|self-administration|self-administration
1495954|NCT00794560|ambulatory Care|ambulatory care
1495955|NCT00794560|Pharmaceutical Services|pharmaceutical services
1495956|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
1495957|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
1495958|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
1495959|NCT00794508|Gene Therapy|gene therapy
1495960|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
1495961|NCT00794508|Retroviral Vector|retroviral vector
1495962|NCT00794508|ADA-deficient SCID|ada-deficient scid
1495963|NCT00794469|Resting metabolic rate|resting metabolic rate
1495964|NCT00794456|Passiflora|passiflora
1495965|NCT00794456|Crataegus|crataegus
1495966|NCT00794456|Herbal|herbal
1495967|NCT00794456|Valeriana|valeriana
1495968|NCT00794456|anxiety|anxiety
1495969|NCT00794443|ONO-5920|ono-5920
1495970|NCT00794443|YM529|ym529
1495971|NCT00794443|Bone mineral density|bone mineral density
1495972|NCT00794443|Minodronic acid|minodronic acid
1495973|NCT00794430|Safety|safety
1495974|NCT00794430|Tolerability|tolerability
1495975|NCT00794430|Efficacy|efficacy
1495976|NCT00794430|Patients|patients
1495977|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
1495978|NCT00794417|advanced cancer|advanced cancer
1495979|NCT00794417|lung cancer|lung cancer
1495980|NCT00794417|NSCLC|nsclc
1495981|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
1495982|NCT00794417|aflibercept|aflibercept
1495983|NCT00794417|chemotherapy|chemotherapy
1495984|NCT00794391|Vulnerable Populations|vulnerable populations
1495985|NCT00794391|Injecting drug users|injecting drug users
1495986|NCT00794391|IDU|idu
1495987|NCT00794391|Risky injecting practices|risky injecting practices
1495988|NCT00794391|Psychotherapy, brief|psychotherapy, brief
1495989|NCT00794391|Motivational interviewing|motivational interviewing
1495990|NCT00794391|Educational activities|educational activities
1495991|NCT00794391|Clinical trial|clinical trial
1495992|NCT00794391|Risk behavior|risk behavior
1495993|NCT00794391|risk reduction behavior|risk reduction behavior
1567604|NCT00508716|Congestive Heart Failure|congestive heart failure
1495994|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
1495995|NCT00794352|Inflammation|inflammation
1495996|NCT00794352|Multiple Sclerosis|multiple sclerosis
1495997|NCT00794352|Neuroimmunology|neuroimmunology
1495998|NCT00794352|Immune Disorder|immune disorder
1495999|NCT00794352|Neuroimaging|neuroimaging
1496000|NCT00794352|Central Nervous System Disease|central nervous system disease
1496001|NCT00794352|Healthy Volunteers|healthy volunteers
1496003|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1496004|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
1496005|NCT00794339|stage III cervical cancer|stage iii cervical cancer
1496006|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
1496007|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
1496008|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
1496009|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
1496010|NCT00794326|Chronic Kidney Failure|chronic kidney failure
1496011|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
1496012|NCT00794326|Low sodium solution|low sodium solution
1496013|NCT00794326|Hypertension|hypertension
1496014|NCT00794326|Total Body Water|total body water
1496015|NCT00794313|Parkinsons disease|parkinsons disease
1496016|NCT00794313|dyskinesia|dyskinesia
1496017|NCT00794313|amantadine|amantadine
1496018|NCT00794313|efficacy|efficacy
1496019|NCT00794300|reproducibility|reproducibility
1496020|NCT00794300|contrast agent|contrast agent
1496021|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
1496022|NCT00794300|infarct size|infarct size
1496023|NCT00794300|myocardial salvage index|myocardial salvage index
1496024|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
1496025|NCT00794274|Sarcodiosis|sarcodiosis
1496026|NCT00794274|tumor necrosis factor|tumor necrosis factor
1496027|NCT00794261|Myeloma|myeloma
1496028|NCT00794261|lymphoma|lymphoma
1496029|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
1496030|NCT00794261|PSC infusion, autologous|psc infusion, autologous
1496031|NCT00794261|neutropenia|neutropenia
1496032|NCT00794261|thrombocytopenia|thrombocytopenia
1496033|NCT00794261|hospital stay|hospital stay
1496034|NCT00794261|infection|infection
1496134|NCT00793767|human muscle tissue|human muscle tissue
1496035|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
1496036|NCT00794222|Cellular phones|cellular phones
1496037|NCT00794222|mental health|mental health
1496038|NCT00794222|Early intervention|early intervention
1496039|NCT00794222|prevention|prevention
1496040|NCT00794222|momentary sampling|momentary sampling
1496041|NCT00794222|Adolescent|adolescent
1496042|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
1496043|NCT00794196|Medication adherence|medication adherence
1496044|NCT00794196|Antidepressive agents|antidepressive agents
1496045|NCT00794196|Primary care|primary care
1496046|NCT00794196|Pharmaceutical care|pharmaceutical care
1496047|NCT00794183|heart failure|heart failure
1496048|NCT00794183|CRT|crt
1496049|NCT00794183|CHF|chf
1496050|NCT00794170|Treatment Compliance|treatment compliance
1496051|NCT00794157|COPD|copd
1496052|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1496053|NCT00794157|indacaterol|indacaterol
1496054|NCT00794157|long acting β2-agonist|long acting β2-agonist
1496055|NCT00794144|Allergic Rhinitis|allergic rhinitis
1496056|NCT00794144|Pediatric|pediatric
1496057|NCT00794144|PATANASE|patanase
1496058|NCT00794131|cancer|cancer
1496059|NCT00794131|vaccinia virus|vaccinia virus
1496060|NCT00794131|vaccinia|vaccinia
1496061|NCT00794131|oncolytic|oncolytic
1496062|NCT00794131|oncolytic virus|oncolytic virus
1496063|NCT00794131|biological|biological
1496064|NCT00794131|imaging|imaging
1496065|NCT00794105|Gas|gas
1496066|NCT00794105|Middle ear|middle ear
1496067|NCT00794079|Healthy volunteers|healthy volunteers
1496068|NCT00794079|young adults|young adults
1496069|NCT00794079|Aged|aged
1496070|NCT00794066|PAD|pad
1496071|NCT00794066|Stroke|stroke
1496072|NCT00794066|ICH|ich
1496073|NCT00794066|prevalence|prevalence
1496074|NCT00794053|Sentinel lymph node|sentinel lymph node
1496075|NCT00794053|thyroid cancer|thyroid cancer
1496076|NCT00794053|neck dissection|neck dissection
1496077|NCT00794040|Irritability|irritability
1496078|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1496079|NCT00794040|Explosive|explosive
1496080|NCT00794040|Tantrums|tantrums
1496081|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
1496082|NCT00794040|Mood Disorder|mood disorder
1496083|NCT00794040|Childhood Mood Disorder|childhood mood disorder
1496084|NCT00794040|ADHD|adhd
1496085|NCT00794027|heart failure|heart failure
1496086|NCT00794027|yoga|yoga
1496087|NCT00794027|quality of life|quality of life
1496088|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1496089|NCT00794001|myocardial infarction|myocardial infarction
1496090|NCT00794001|angioplasty|angioplasty
1496091|NCT00794001|data feedback|data feedback
1496092|NCT00794001|continuous quality improvement|continuous quality improvement
1496093|NCT00794001|STEMI|stemi
1496094|NCT00794001|Feedback|feedback
1496095|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
1496096|NCT00794001|Emergency service hospital|emergency service hospital
1496097|NCT00793988|vibration|vibration
1496098|NCT00793988|local anaesthesia|local anaesthesia
1496099|NCT00793988|ptosis surgery|ptosis surgery
1496100|NCT00793988|blepharoplasty|blepharoplasty
1496101|NCT00793988|Upper eyelid surgery|upper eyelid surgery
1496102|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
1496104|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
1496105|NCT00793962|breast cancer|breast cancer
1496106|NCT00793962|mastectomy|mastectomy
1496107|NCT00793962|radiotherapy|radiotherapy
1496108|NCT00793962|fractionation|fractionation
1496109|NCT00793936|Right Double Lumen Tube|right double lumen tube
1496110|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
1496111|NCT00793910|Gabapentin|gabapentin
1496112|NCT00793910|PRK|prk
1496113|NCT00793910|pain|pain
1496114|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
1496115|NCT00793884|Diabetes|diabetes
1496116|NCT00793884|Latino population|latino population
1496117|NCT00793871|sunitinib|sunitinib
1496118|NCT00793871|Phase IV|phase iv
1496119|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
1496120|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
1496121|NCT00793871|Chinese|chinese
1496122|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
1496123|NCT00793832|weight loss|weight loss
1496124|NCT00793819|nocturia|nocturia
1496125|NCT00793819|BPH|bph
1496126|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
1496127|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
1496128|NCT00793806|chronic kidney disease|chronic kidney disease
1496129|NCT00793780|obesity|obesity
1496130|NCT00793780|schizophrenia|schizophrenia
1496131|NCT00793780|schizoaffective disorder|schizoaffective disorder
1496132|NCT00793780|weight loss|weight loss
1496133|NCT00793767|Erythropoietin|erythropoietin
1496135|NCT00793767|insulin sensitivity|insulin sensitivity
1496136|NCT00793767|substrate metabolism|substrate metabolism
1496137|NCT00793741|Type 1 diabetes|type 1 diabetes
1496138|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
1496139|NCT00793741|Islet transplant|islet transplant
1496140|NCT00793728|Morbid obesity|morbid obesity
1496141|NCT00793728|High risk|high risk
1496142|NCT00793715|acute pancreatitis|acute pancreatitis
1496143|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
1496144|NCT00793715|decompressive laparotomy|decompressive laparotomy
1496145|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
1496146|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
1496147|NCT00793702|tuberculosis|tuberculosis
1496148|NCT00793702|diagnosis|diagnosis
1496149|NCT00793702|ESAT-6|esat-6
1496150|NCT00793702|CFP-10|cfp-10
1496151|NCT00793702|skin test|skin test
1496152|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
1496153|NCT00793689|parathyroid|parathyroid
1496154|NCT00793689|thyroidectomy|thyroidectomy
1496155|NCT00793689|hypoparathyroidism|hypoparathyroidism
1496280|NCT00793104|cartilage injury|cartilage injury
1496156|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
1496157|NCT00793676|GPCR expression|gpcr expression
1496158|NCT00793676|transcriptomic|transcriptomic
1496159|NCT00793676|white blood cells|white blood cells
1496160|NCT00793676|diagnostic|diagnostic
1496161|NCT00793676|Control|control
1496162|NCT00793663|Xenon|xenon
1496163|NCT00793663|Sevoflurane|sevoflurane
1496164|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
1496165|NCT00793663|Depth of anaesthesia|depth of anaesthesia
1496166|NCT00793650|Cancer|cancer
1496167|NCT00793650|Multiple Myeloma|multiple myeloma
1496168|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1496169|NCT00793637|Angular stable locking system|angular stable locking system
1496170|NCT00793637|Handling test|handling test
1496171|NCT00793637|Complications|complications
1496172|NCT00793611|Overactive Bladder|overactive bladder
1496173|NCT00793611|Hypnotherapy|hypnotherapy
1496174|NCT00793598|CMX001|cmx001
1496175|NCT00793598|Kidney transplant|kidney transplant
1496176|NCT00793598|HSCT transplant|hsct transplant
1496177|NCT00793598|BK Virus|bk virus
1496178|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
1496179|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
1496180|NCT00793585|IgA nephropathy|iga nephropathy
1496181|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
1496182|NCT00793546|Bosutinib|bosutinib
1651563|NCT00187590|HIV|hiv
1496183|NCT00793546|Exemestane|exemestane
1496184|NCT00793546|postmenopausal|postmenopausal
1496185|NCT00793546|breast cancer|breast cancer
1496186|NCT00793520|fibromyalgia|fibromyalgia
1496187|NCT00793520|milnacipran|milnacipran
1496188|NCT00793520|Forest Laboratories|forest laboratories
1496189|NCT00793507|childhood caries|childhood caries
1496190|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
1496191|NCT00793494|Children|children
1496192|NCT00793494|Pediatrics|pediatrics
1496193|NCT00793494|Probiotics|probiotics
1496194|NCT00793481|Metabolic Syndrome|metabolic syndrome
1496195|NCT00793468|nicotine dependence|nicotine dependence
1496196|NCT00793468|smoking|smoking
1496197|NCT00793468|pharmacological treatment|pharmacological treatment
1496198|NCT00793468|relapse prevention|relapse prevention
1496199|NCT00793455|education|education
1496200|NCT00793455|preventive service|preventive service
1496201|NCT00793455|screening|screening
1496202|NCT00793442|sepsis|sepsis
1496203|NCT00793442|severe sepsis|severe sepsis
1496204|NCT00793442|septic shock|septic shock
1496205|NCT00793442|endothelium|endothelium
1496206|NCT00793442|microcirculation|microcirculation
1496207|NCT00793442|biomarkers|biomarkers
1496208|NCT00793429|electrocardiographic safety|electrocardiographic safety
1496209|NCT00793429|pharmacokinetics|pharmacokinetics
1496210|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1496211|NCT00793416|Valve Adjustment|valve adjustment
1496212|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
1496213|NCT00793416|Diagnosis of blockage|diagnosis of blockage
1496214|NCT00793403|Observational cohort|observational cohort
1496215|NCT00793403|prospectives|prospectives
1496216|NCT00793403|multicentre|multicentre
1496217|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
1496218|NCT00793390|aggressive breast cancer|aggressive breast cancer
1496219|NCT00793390|Inflammatory Breast Cancer|inflammatory breast cancer
1496220|NCT00793390|IBC|ibc
1496221|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
1496222|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
1496223|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
1496224|NCT00793338|Heart failure|heart failure
1496225|NCT00793338|Sildenafil|sildenafil
1496226|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
1496227|NCT00793338|quality of life|quality of life
1496228|NCT00793338|6 minute walk test|6 minute walk test
1496229|NCT00793286|inguinal hernia|inguinal hernia
1496230|NCT00793286|laparoscopy|laparoscopy
1496231|NCT00793286|mesh|mesh
1496232|NCT00793234|TKR|tkr
1496233|NCT00793234|VTE|vte
1496234|NCT00793234|DVT|dvt
1496235|NCT00793221|Coronary stent.|coronary stent.
1496236|NCT00793221|Restenosis.|restenosis.
1496237|NCT00793221|Coronary artery disease.|coronary artery disease.
1496238|NCT00793221|Chronic total occlusion.|chronic total occlusion.
1496239|NCT00793208|Lung cancer|lung cancer
1496240|NCT00793208|non small cell|non small cell
1496241|NCT00793208|vaccine|vaccine
1496242|NCT00793208|carcinoma|carcinoma
1496243|NCT00793208|immunization|immunization
1496244|NCT00793208|autologous Tumor|autologous tumor
1496245|NCT00793208|vaccination|vaccination
1496246|NCT00793195|Neonates|neonates
1496247|NCT00793195|Short Bowel Syndrome|short bowel syndrome
1496248|NCT00793195|Intestinal Failure|intestinal failure
1496249|NCT00793195|Liver Failure|liver failure
1496250|NCT00793195|Parenteral Nutrition|parenteral nutrition
1496251|NCT00793195|Intralipid|intralipid
1496252|NCT00793195|SMOF|smof
1496253|NCT00793182|Renal|renal
1496254|NCT00793182|Kidney|kidney
1496255|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
1496256|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
1496257|NCT00793156|uremic pruritus|uremic pruritus
1496258|NCT00793143|morbid obesity|morbid obesity
1496259|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
1496260|NCT00793143|LSG|lsg
1496261|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
1496262|NCT00793143|LGB|lgb
1496263|NCT00793143|comorbidities|comorbidities
1496264|NCT00793143|diabetes|diabetes
1496265|NCT00793143|excessive weight loss|excessive weight loss
1496266|NCT00793143|weight loss|weight loss
1496267|NCT00793130|Ulcerative|ulcerative
1496268|NCT00793130|Colitis|colitis
1496269|NCT00793130|Coltect|coltect
1496270|NCT00793130|Curcumin|curcumin
1496271|NCT00793130|Green tea|green tea
1496272|NCT00793130|Selenium|selenium
1496273|NCT00793130|inflammation|inflammation
1496274|NCT00793130|bowel|bowel
1496275|NCT00793117|chronic sinusitis|chronic sinusitis
1496276|NCT00793117|FESS|fess
1496277|NCT00793117|packing|packing
1496278|NCT00793104|allograft|allograft
1496279|NCT00793104|knee injury|knee injury
1567605|NCT00508716|Health Literacy|health literacy
1496281|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
1496282|NCT00793078|sepsis|sepsis
1496283|NCT00793078|arterial blood pressure|arterial blood pressure
1496284|NCT00793078|complexity|complexity
1496285|NCT00793078|variability|variability
1496286|NCT00793065|electronic health records|electronic health records
1496570|NCT00791687|Antioxidant enzymes|antioxidant enzymes
1496287|NCT00793065|health information technology|health information technology
1496288|NCT00793065|physician incentives|physician incentives
1496289|NCT00793065|quality of health care|quality of health care
1496290|NCT00793052|trismus|trismus
1496291|NCT00793052|Edema|edema
1496292|NCT00793052|pain|pain
1496293|NCT00793013|Acute Lung Injury|acute lung injury
1496294|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
1496295|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
1496296|NCT00793013|Acute Kidney Injury|acute kidney injury
1496297|NCT00793013|Pressure Trial|pressure trial
1496298|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
1496299|NCT00792974|Cognitive behavioral education|cognitive behavioral education
1496300|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
1496301|NCT00792961|Prostate cancer|prostate cancer
1496302|NCT00792961|Robotic surgery|robotic surgery
1496303|NCT00792961|Endomicroscopy|endomicroscopy
1496304|NCT00792922|Trachoma|trachoma
1496305|NCT00792922|Azithromycin|azithromycin
1496306|NCT00792922|Mass treatment|mass treatment
1496307|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
1496308|NCT00792909|Pneumococcal disease|pneumococcal disease
1496309|NCT00792909|Safety|safety
1496310|NCT00792909|Immunogenicity|immunogenicity
1496311|NCT00792883|PICU|picu
1496312|NCT00792883|BIA|bia
1496313|NCT00792883|Phase angle|phase angle
1496314|NCT00792883|RQ|rq
1496315|NCT00792883|EEM|eem
1496316|NCT00792883|Compliance|compliance
1496317|NCT00792883|Resistance|resistance
1496318|NCT00792883|Curves|curves
1496319|NCT00792883|Polymorphisms|polymorphisms
1496320|NCT00792883|NF-kappa B|nf-kappa b
1496321|NCT00792883|Scores|scores
1496322|NCT00792883|PIM 2|pim 2
1496323|NCT00792883|PRISM I|prism i
1496324|NCT00792870|Obesity|obesity
1496325|NCT00792870|Weight loss|weight loss
1496326|NCT00792870|Internet|internet
1496327|NCT00792857|Parathyroid Diseases|parathyroid diseases
1496328|NCT00792857|Renal Insufficiency|renal insufficiency
1496329|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
1496330|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1496331|NCT00792857|Vitamin D|vitamin d
1496332|NCT00792857|Hyperparathyroidism|hyperparathyroidism
1496333|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
1496334|NCT00792857|Kidney Diseases|kidney diseases
1496335|NCT00792857|Kidney Failure|kidney failure
1496336|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
1496337|NCT00792805|COPD|copd
1496338|NCT00792805|indacaterol|indacaterol
1496339|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
1496340|NCT00792805|adults|adults
1496341|NCT00792792|tissue transfer|tissue transfer
1496342|NCT00792779|Morbid obesity|morbid obesity
1496343|NCT00792779|General anaesthesia|general anaesthesia
1496344|NCT00792779|Propofol|propofol
1496345|NCT00792779|Sevoflurane|sevoflurane
1496346|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
1496347|NCT00792766|Angiolipoma|angiolipoma
1496348|NCT00792766|mTOR|mtor
1496349|NCT00792766|Everolimus|everolimus
1496350|NCT00792753|Coronary Artery Disease|coronary artery disease
1496351|NCT00792727|Pain|pain
1496352|NCT00792727|Knee|knee
1496353|NCT00792727|Arthritis|arthritis
1496354|NCT00792727|Knee pain|knee pain
1496355|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1496356|NCT00792688|burn wounds|burn wounds
1496357|NCT00792688|wound healing|wound healing
1496358|NCT00792675|exercise|exercise
1496359|NCT00792675|disease activity|disease activity
1496360|NCT00792675|inflammation|inflammation
1496361|NCT00792675|resistance training|resistance training
1496362|NCT00792675|rehabilitation|rehabilitation
1496363|NCT00792662|Diabetes Mellitus|diabetes mellitus
1496364|NCT00792662|Alzheimer's Disease|alzheimer's disease
1496365|NCT00792662|Apathy|apathy
1496366|NCT00792662|Methylphenidate|methylphenidate
1496367|NCT00792662|Dementia|dementia
1496368|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
1496369|NCT00792636|migraine with or without aura|migraine with or without aura
1496370|NCT00792636|naproxen sodium|naproxen sodium
1496371|NCT00792636|sumatriptan|sumatriptan
1496372|NCT00792636|blood pressure|blood pressure
1496373|NCT00792636|migraine headaches|migraine headaches
1496374|NCT00792623|Varicella|varicella
1496375|NCT00792623|VarilrixTM|varilrixtm
1496376|NCT00792610|youth|youth
1496377|NCT00792610|hepatitis B|hepatitis b
1496378|NCT00792610|vaccination|vaccination
1496379|NCT00792610|booster|booster
1496380|NCT00792610|immunity response|immunity response
1496381|NCT00792584|etravirine|etravirine
1496382|NCT00792584|efavirenz|efavirenz
1496383|NCT00792584|anxiety|anxiety
1496384|NCT00792584|depression|depression
1496385|NCT00792584|sleep quality|sleep quality
1496386|NCT00792584|HIV|hiv
1496387|NCT00792584|NNRTI|nnrti
1496388|NCT00792584|Tritherapy|tritherapy
1496389|NCT00792584|compliance|compliance
1496390|NCT00792584|stocrin|stocrin
1496571|NCT00791687|Glutathione|glutathione
1496391|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
1496392|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
1496393|NCT00792519|alcohol use|alcohol use
1496394|NCT00792519|HIV|hiv
1496395|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
1496396|NCT00792519|Kenya|kenya
1496397|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
1496398|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
1496399|NCT00792493|Healthy volunteer study|healthy volunteer study
1496400|NCT00792480|Obesity|obesity
1496401|NCT00792480|Pregnancy|pregnancy
1496402|NCT00792480|Exercise|exercise
1496403|NCT00792480|Nutrition|nutrition
1496404|NCT00792480|obesity in pregnancy|obesity in pregnancy
1496405|NCT00792454|Chronic kidney disease|chronic kidney disease
1496406|NCT00792454|End stage renal disease|end stage renal disease
1496407|NCT00792454|Exercise|exercise
1496408|NCT00792454|Cardiovascular disease|cardiovascular disease
1496409|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
1496410|NCT00792441|Loaded deep breathing|loaded deep breathing
1496411|NCT00792441|Weaning|weaning
1496412|NCT00792441|Mechanical ventilation|mechanical ventilation
1496413|NCT00792441|Respiratory muscle|respiratory muscle
1496414|NCT00792428|Stroke|stroke
1496415|NCT00792428|Ischemia|ischemia
1496416|NCT00792428|Infarction|infarction
1496417|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
1496418|NCT00792428|Central Nervous System Diseases|central nervous system diseases
1496419|NCT00792428|Brain Infarction|brain infarction
1496420|NCT00792428|Brain Ischemia|brain ischemia
1496421|NCT00792428|Rehabilitation|rehabilitation
1496422|NCT00792428|Recovery|recovery
1496423|NCT00792428|Neurorehabilitation|neurorehabilitation
1496424|NCT00792428|Plasticity|plasticity
1496425|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
1496426|NCT00792415|Withdrawal symptoms|withdrawal symptoms
1496427|NCT00792415|Opioid dependence|opioid dependence
1496428|NCT00792402|chronic heart failure|chronic heart failure
1496429|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
1496430|NCT00792402|Primary care|primary care
1496431|NCT00792389|Gallstones|gallstones
1496432|NCT00792389|Gallbladder|gallbladder
1496433|NCT00792389|Cholecystectomy|cholecystectomy
1496434|NCT00792389|Gallstone disease|gallstone disease
1496435|NCT00792376|NSAID|nsaid
1496436|NCT00792376|tendon|tendon
1496437|NCT00792376|pain|pain
1496438|NCT00792376|stiffness|stiffness
1496439|NCT00792376|Achilles|achilles
1496440|NCT00792363|KRAS|kras
1496441|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1496442|NCT00792350|Sorafenib|sorafenib
1496443|NCT00792311|Tsui test|tsui test
1496444|NCT00792311|Epidural Analgesia|epidural analgesia
1496445|NCT00792285|Colon cancer|colon cancer
1496446|NCT00792285|Prevention|prevention
1496447|NCT00792285|Screening|screening
1496448|NCT00792285|Telephone|telephone
1496449|NCT00792272|aspirin resistance|aspirin resistance
1496450|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
1496451|NCT00792246|pharmacokinetics|pharmacokinetics
1496452|NCT00792246|pediatric|pediatric
1496453|NCT00792246|bioavailability|bioavailability
1496454|NCT00792233|Poly JIA|poly jia
1496455|NCT00792233|TNF|tnf
1496456|NCT00792233|Remission|remission
1496457|NCT00792220|stroke|stroke
1496458|NCT00792220|mobile stroke unit|mobile stroke unit
1496459|NCT00792220|thrombolysis|thrombolysis
1496460|NCT00792220|stroke management|stroke management
1496461|NCT00792220|computerized tomography|computerized tomography
1496462|NCT00792194|Cystic fibrosis|cystic fibrosis
1496463|NCT00792194|Exercise training|exercise training
1496464|NCT00792194|Home training|home training
1496465|NCT00792194|Aerobic capacity|aerobic capacity
1496466|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
1496467|NCT00792155|PKD|pkd
1496468|NCT00792142|neurotoxicity|neurotoxicity
1496469|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
1496470|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
1496471|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
1496472|NCT00792129|MIS|mis
1496473|NCT00792129|Minimally invasive|minimally invasive
1496474|NCT00792129|Atavi|atavi
1496475|NCT00792129|Flex Posure|flex posure
1496476|NCT00792129|retractor|retractor
1496477|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
1496478|NCT00792129|for inclusion in the study.|for inclusion in the study.
1496479|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
1496572|NCT00791687|Oxidative stress|oxidative stress
1496573|NCT00791687|Prematurity|prematurity
1496574|NCT00791687|Respiratory distress|respiratory distress
1496480|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
1496481|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
1496482|NCT00792090|allergy|allergy
1496483|NCT00792090|cow's milk|cow's milk
1496484|NCT00792090|sensibilisation|sensibilisation
1496485|NCT00792090|fermented milk|fermented milk
1496486|NCT00792090|infant formula|infant formula
1496487|NCT00792077|Leukemia|leukemia
1496488|NCT00792077|Lenalidomide|lenalidomide
1496489|NCT00792077|Actigraph|actigraph
1496490|NCT00792077|Sleep Test Study|sleep test study
1496491|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1496492|NCT00792077|CC-5013|cc-5013
1496493|NCT00792077|Revlimid|revlimid
1496494|NCT00792064|quality of life|quality of life
1496495|NCT00792064|adverse effects|adverse effects
1496496|NCT00792051|influenza|influenza
1496497|NCT00792051|vaccination|vaccination
1496498|NCT00792051|children|children
1496499|NCT00792051|Influenza-like illness|influenza-like illness
1496500|NCT00792038|Psychological tests|psychological tests
1496501|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
1496502|NCT00792038|Cognitive therapy|cognitive therapy
1496503|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1496504|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1496505|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1496506|NCT00792025|stage III bladder cancer|stage iii bladder cancer
1496507|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
1496508|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1496509|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
1496510|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
1496511|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
1496512|NCT00791999|Certolizumab Pegol|certolizumab pegol
1496513|NCT00791999|Cimzia|cimzia
1496514|NCT00791986|Breathing exercise|breathing exercise
1496515|NCT00791986|blood pressure|blood pressure
1496516|NCT00791986|hypertension|hypertension
1496517|NCT00791960|Cesarean Section|cesarean section
1496518|NCT00791960|Dimenhydrinate|dimenhydrinate
1496519|NCT00791960|Gravol|gravol
1496520|NCT00791960|Antiemetics|antiemetics
1496521|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
1496522|NCT00791921|Certolizumab Pegol|certolizumab pegol
1496523|NCT00791921|Cimzia|cimzia
1496524|NCT00791869|bupropion|bupropion
1496525|NCT00791869|smoking|smoking
1496526|NCT00791869|pharmacokinetics|pharmacokinetics
1496527|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
1496528|NCT00791843|CHF|chf
1496529|NCT00791830|Residual renal function|residual renal function
1496530|NCT00791830|Haemodialysis|haemodialysis
1496531|NCT00791830|Applanation tonometry|applanation tonometry
1496532|NCT00791830|Cardiac output|cardiac output
1496533|NCT00791830|Quality of life|quality of life
1496534|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1496535|NCT00791817|pharmacokinetics study|pharmacokinetics study
1496536|NCT00791804|Pain|pain
1496537|NCT00791804|Post Op pain|post op pain
1496538|NCT00791804|Fentanyl|fentanyl
1496539|NCT00791804|Pain Control|pain control
1496540|NCT00791804|Surgery|surgery
1496541|NCT00791791|Anesthesia General|anesthesia general
1496542|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
1496543|NCT00791791|Stress measurement|stress measurement
1496544|NCT00791791|Surgical Stress|surgical stress
1496545|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
1496546|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
1496547|NCT00791765|Scalp|scalp
1496548|NCT00791765|Psoriasis|psoriasis
1496549|NCT00791765|Plaque Psoriasis|plaque psoriasis
1496550|NCT00791765|Skin Diseases|skin diseases
1496551|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1496552|NCT00791765|etanercept|etanercept
1496553|NCT00791752|Safety and Tolerability|safety and tolerability
1496554|NCT00791739|fibromyalgia|fibromyalgia
1496555|NCT00791739|trazodone|trazodone
1496556|NCT00791739|pregabalin|pregabalin
1496557|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
1496558|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
1496559|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
1496560|NCT00791726|microperimetry|microperimetry
1496561|NCT00791726|macular edema|macular edema
1496562|NCT00791726|uveitis|uveitis
1496563|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
1496564|NCT00791713|Paliperidone ER|paliperidone er
1496565|NCT00791713|Antipsychotic drugs|antipsychotic drugs
1496566|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
1496567|NCT00791713|Mood disorders|mood disorders
1496568|NCT00791713|Schizophrenia|schizophrenia
1496569|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
1496575|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
1496576|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
1496577|NCT00791674|Opiates|opiates
1496578|NCT00791674|sleep apnea|sleep apnea
1496579|NCT00791674|ventilatory failure|ventilatory failure
1496580|NCT00791648|aki|aki
1496581|NCT00791648|delirium|delirium
1496582|NCT00791648|statin|statin
1496583|NCT00791648|short-term|short-term
1496584|NCT00791648|cardiac|cardiac
1496585|NCT00791635|Cervical Cancer|cervical cancer
1496586|NCT00791635|Vaginal Cancer|vaginal cancer
1496587|NCT00791635|Endometrial Cancer|endometrial cancer
1496588|NCT00791635|Cervix|cervix
1496589|NCT00791635|Endometrial|endometrial
1496590|NCT00791635|Pelvic Exenteration|pelvic exenteration
1496591|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
1496592|NCT00791635|Questionnaire|questionnaire
1496593|NCT00791635|Gynecologic Cancer|gynecologic cancer
1496594|NCT00791635|Vagina|vagina
1496595|NCT00791635|Vulva|vulva
1496596|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
1496597|NCT00791622|Paliperidone ER|paliperidone er
1496598|NCT00791622|Schizophernia|schizophernia
1496599|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
1496600|NCT00791622|Cardiovascular|cardiovascular
1496601|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
1496602|NCT00791609|cancer|cancer
1496603|NCT00791596|Ergonomic intervention|ergonomic intervention
1496604|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
1496605|NCT00791596|Low back pain|low back pain
1496606|NCT00791596|Posture|posture
1496607|NCT00791596|Video display terminal|video display terminal
1496608|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
1496609|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
1496610|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
1496611|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
1496612|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
1496613|NCT00791531|Methotrexate|methotrexate
1496614|NCT00791531|Malaria|malaria
1496615|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1496616|NCT00791518|Spirometry|spirometry
1496617|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1496618|NCT00791505|pulmonary infection|pulmonary infection
1496619|NCT00791505|antibiotic|antibiotic
1496620|NCT00791492|FAP|fap
1496621|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
1496622|NCT00791492|ATTR-PN|attr-pn
1496623|NCT00791492|transthyretin|transthyretin
1496624|NCT00791492|TTR|ttr
1496625|NCT00791492|amyloid|amyloid
1496626|NCT00791492|polyneuropathy|polyneuropathy
1496627|NCT00791492|familial|familial
1496628|NCT00791492|hereditary|hereditary
1496629|NCT00791492|amyloidosis|amyloidosis
1496630|NCT00791492|FoldRx|foldrx
1496631|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
1496632|NCT00791466|Iodine deficiency|iodine deficiency
1496633|NCT00791466|Pregnancy|pregnancy
1496634|NCT00791466|Thyroid function|thyroid function
1496635|NCT00791466|Infant development|infant development
1496636|NCT00791466|Growth|growth
1496637|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
1496638|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
1496639|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
1496640|NCT00791440|Schizophrenia|schizophrenia
1496641|NCT00791440|Schizoaffective|schizoaffective
1496642|NCT00791440|Schizophreniform|schizophreniform
1496643|NCT00791440|Psychosis|psychosis
1496644|NCT00791440|Psychotic|psychotic
1496645|NCT00791440|Hallucinations|hallucinations
1496646|NCT00791440|Delusions|delusions
1496647|NCT00791440|Paranoia|paranoia
1496648|NCT00791440|Paranoid|paranoid
1496649|NCT00791440|Voices|voices
1496650|NCT00791440|CBT|cbt
1496651|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
1496652|NCT00791440|Cognitive Therapy|cognitive therapy
1496653|NCT00791401|Schizophrenia|schizophrenia
1496654|NCT00791401|Mood disorders|mood disorders
1496655|NCT00791401|Antipsychotic drugs|antipsychotic drugs
1496656|NCT00791401|ER OROS Paliperidone|er oros paliperidone
1496657|NCT00791388|Pharmacokinetics|pharmacokinetics
1496658|NCT00791375|young adult|young adult
1496659|NCT00791375|cancer|cancer
1496660|NCT00791375|exercise|exercise
1496661|NCT00791375|physical activity|physical activity
1496662|NCT00791362|accreditation|accreditation
1496663|NCT00791362|cardiovascular disease|cardiovascular disease
1496664|NCT00791362|primary care|primary care
1496665|NCT00791349|Schizophrenia|schizophrenia
1496666|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
1496667|NCT00791349|Mood Disorders|mood disorders
1496668|NCT00791349|Antipsychotic drugs|antipsychotic drugs
1496669|NCT00791349|Cardiovascular|cardiovascular
1496670|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
1496671|NCT00791336|NSCLC|nsclc
1496672|NCT00791336|chemotherapy|chemotherapy
1496673|NCT00791336|radiation therapy|radiation therapy
1496674|NCT00791336|nelfinavir|nelfinavir
1496675|NCT00791336|NFV|nfv
1496676|NCT00791310|Medical ICU|medical icu
1496677|NCT00791310|Severe sepsis|severe sepsis
1496678|NCT00791297|CDB-2914|cdb-2914
1496679|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
1496680|NCT00791297|ovulation|ovulation
1496681|NCT00791297|endometrial changes|endometrial changes
1496682|NCT00791297|bleeding patterns|bleeding patterns
1496683|NCT00791297|normal cycling women|normal cycling women
1496684|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
1496685|NCT00791284|Schizophrenia|schizophrenia
1496686|NCT00791284|Mood disorders|mood disorders
1496687|NCT00791284|Antipsychotic drugs|antipsychotic drugs
1496688|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
1496689|NCT00791271|Melanoma|melanoma
1496690|NCT00791271|Malignant melanoma|malignant melanoma
1496691|NCT00791271|Unresectable|unresectable
1496692|NCT00791271|Decitabine|decitabine
1496693|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
1496694|NCT00791271|PEG Intron|peg intron
1496695|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
1496696|NCT00791271|Dacogen|dacogen
1496697|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
1496698|NCT00791245|cartilage repair|cartilage repair
1496699|NCT00791245|arthroscopy|arthroscopy
1496700|NCT00791245|361 HCT/P|361 hct/p
1496701|NCT00791245|human tissue|human tissue
1496702|NCT00791245|biologic|biologic
1496703|NCT00791245|knee|knee
1496704|NCT00791232|Extended-release paliperidone|extended-release paliperidone
1496705|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
1496706|NCT00791232|ER OROS paliperidone|er oros paliperidone
1496707|NCT00791219|Onychomycosis|onychomycosis
1496708|NCT00791206|exercise|exercise
1496709|NCT00791206|ischemia|ischemia
1496710|NCT00791206|MRI|mri
1496711|NCT00791206|MRI spectroscopy|mri spectroscopy
1496712|NCT00791206|Ischemia preconditioning|ischemia preconditioning
1496713|NCT00791193|Paliperidone ER|paliperidone er
1496714|NCT00791193|Antipsychotic drugs|antipsychotic drugs
1496715|NCT00791193|Schizophrenia|schizophrenia
1496716|NCT00791193|Mood disorders|mood disorders
1496717|NCT00791180|dynamic stabilization|dynamic stabilization
1496718|NCT00791180|Dynesys|dynesys
1496719|NCT00791180|fusion success|fusion success
1496720|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
1496721|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
1496722|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
1496723|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
1496724|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
1496725|NCT00791167|Schizophrenia|schizophrenia
1496726|NCT00791167|Paliperidone ER|paliperidone er
1496727|NCT00791154|Extensive disease|extensive disease
1496728|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
1496729|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
1496730|NCT00791154|Malignant pleural effusion|malignant pleural effusion
1496731|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
1496732|NCT00791141|Head and Neck Cancer|head and neck cancer
1496733|NCT00791141|Radiation therapy|radiation therapy
1496734|NCT00791141|Chemotherapy|chemotherapy
1496735|NCT00791141|Chemoradiotherapy|chemoradiotherapy
1496736|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
1496737|NCT00791128|Type 2 Diabetes|type 2 diabetes
1496738|NCT00791115|Prostate cancer|prostate cancer
1496739|NCT00791115|prostatectomy|prostatectomy
1496740|NCT00791115|radiotherapy|radiotherapy
1496741|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
1496742|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
1496743|NCT00791089|atrial fibrillation|atrial fibrillation
1496744|NCT00791076|Insulin pump therapy|insulin pump therapy
1496745|NCT00791076|Type 1 diabetic|type 1 diabetic
1496746|NCT00791076|Chronic pancreatitis|chronic pancreatitis
1496747|NCT00791076|Pancreatic resection|pancreatic resection
1496748|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
1496749|NCT00791063|cell death|cell death
1496750|NCT00791063|Apoptosis|apoptosis
1496751|NCT00791063|PET imaging|pet imaging
1496752|NCT00791063|brain metastases|brain metastases
1496753|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
1496754|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
1496755|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
1496756|NCT00791024|Analgesia Tests|analgesia tests
1496757|NCT00791024|Analog Pain Scale|analog pain scale
1496758|NCT00791024|Pain Measurement|pain measurement
1496759|NCT00791011|Lymphoma|lymphoma
1496760|NCT00791011|AMG 655|amg 655
1496761|NCT00791011|Trail receptor|trail receptor
1496762|NCT00791011|Apoptosis|apoptosis
1496763|NCT00791011|Vorinostat|vorinostat
1496764|NCT00791011|Bortezomib|bortezomib
1496765|NCT00791011|SAHA|saha
1496766|NCT00791011|Velcade|velcade
1496767|NCT00790998|onchocerciasis|onchocerciasis
1496768|NCT00790998|river blindness|river blindness
1496769|NCT00790998|onchocerca volvulus|onchocerca volvulus
1496770|NCT00790998|moxidectin|moxidectin
1496771|NCT00790998|ivermectin|ivermectin
1496772|NCT00790972|MRSA|mrsa
1496773|NCT00790972|sinofresh|sinofresh
1496774|NCT00790972|nasal spray|nasal spray
1496775|NCT00790959|Intimate Partner Violence|intimate partner violence
1496776|NCT00790959|HIV/AIDS|hiv/aids
1496777|NCT00790959|Gender|gender
1496778|NCT00790959|Prevention|prevention
1496779|NCT00790959|Community mobilisation|community mobilisation
1496780|NCT00790959|Uganda|uganda
1496781|NCT00790946|valsartan|valsartan
1496782|NCT00790946|Metabolic syndrome|metabolic syndrome
1496783|NCT00790933|Drug therapy|drug therapy
1496784|NCT00790920|Acute ischemic stroke|acute ischemic stroke
1496785|NCT00790920|Angiography|angiography
1496786|NCT00790920|Desmoteplase|desmoteplase
1496787|NCT00790920|Thrombolytic|thrombolytic
1496788|NCT00790907|Unstable angina|unstable angina
1496789|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
1496790|NCT00790907|PCI|pci
1496791|NCT00790907|unfractionated heparin|unfractionated heparin
1496792|NCT00790907|fondaparinux|fondaparinux
1496793|NCT00790907|acute coronary syndrome|acute coronary syndrome
1496794|NCT00790881|malaria|malaria
1496795|NCT00790881|HIV|hiv
1496796|NCT00790881|AIDS|aids
1496797|NCT00790881|nevirapine|nevirapine
1496798|NCT00790881|lumefantrine|lumefantrine
1496799|NCT00790881|artemether|artemether
1496800|NCT00790881|drug interaction|drug interaction
1496801|NCT00790881|pharmacokinetics|pharmacokinetics
1496802|NCT00790868|Panic Disorder|panic disorder
1496803|NCT00790868|Anxiety|anxiety
1496804|NCT00790868|D-cycloserine|d-cycloserine
1496805|NCT00790868|DCS|dcs
1496806|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
1496807|NCT00790868|CBT|cbt
1496808|NCT00790855|Bendamustine|bendamustine
1496809|NCT00790855|Acute Leukemia|acute leukemia
1496810|NCT00790855|Leukemia|leukemia
1496811|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
1496812|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
1496813|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1496814|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
1496815|NCT00790855|MDS|mds
1496816|NCT00790855|ALL|all
1496817|NCT00790855|AML|aml
1496818|NCT00790855|CML|cml
1496819|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
1496820|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
1496821|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
1496822|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
1496823|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
1496824|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
1496825|NCT00790829|preemptive|preemptive
1496826|NCT00790829|Nicotine Patch|nicotine patch
1496827|NCT00790829|Open Abdominal Surgery|open abdominal surgery
1496828|NCT00790816|Cancer|cancer
1496829|NCT00790816|lapatinib|lapatinib
1496830|NCT00790816|Combination therapy|combination therapy
1496831|NCT00790816|Chronic administration|chronic administration
1496832|NCT00790803|uveitis|uveitis
1496833|NCT00790803|cystoid macular edema|cystoid macular edema
1496834|NCT00790777|Paliperidone ER|paliperidone er
1496835|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
1496836|NCT00790751|ED|ed
1496837|NCT00790751|Erectile Dysfunction|erectile dysfunction
1496838|NCT00790751|Dysfunction|dysfunction
1496839|NCT00790751|Erectile|erectile
1496840|NCT00790738|bipolar disorder|bipolar disorder
1496841|NCT00790738|depression|depression
1496842|NCT00790738|treatment|treatment
1496843|NCT00790738|randomized controlled trial|randomized controlled trial
1496844|NCT00790699|diabetes|diabetes
1496845|NCT00790699|Symlin|symlin
1496846|NCT00790699|pramlintide acetate|pramlintide acetate
1496847|NCT00790699|insulin|insulin
1496848|NCT00790699|multiple injection port|multiple injection port
1496849|NCT00790699|I-PORT|i-port
1496850|NCT00790686|Ureteral obstruction|ureteral obstruction
1496851|NCT00790686|Urologic surgical procedure|urologic surgical procedure
1496852|NCT00790686|Stents|stents
1496853|NCT00790686|Endoscopy|endoscopy
1496854|NCT00790686|Urology|urology
1496855|NCT00790673|Hepatitis C|hepatitis c
1496856|NCT00790673|Viral hepatitis|viral hepatitis
1496857|NCT00790660|ASP1941|asp1941
1496858|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1496859|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
1496860|NCT00790595|Prostatectomy|prostatectomy
1496861|NCT00790582|ALS|als
1496862|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1496863|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
1496864|NCT00790582|Lithium|lithium
1496865|NCT00790582|Lithium Carbonate|lithium carbonate
1496866|NCT00790569|bladder cancer|bladder cancer
1496867|NCT00790569|cervical cancer|cervical cancer
1496868|NCT00790569|esophageal cancer|esophageal cancer
1496869|NCT00790569|gastric cancer|gastric cancer
1496870|NCT00790569|renal cell carcinoma|renal cell carcinoma
1496871|NCT00790569|adult primary liver cancer|adult primary liver cancer
1496872|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
1496873|NCT00790569|small cell lung cancer|small cell lung cancer
1496874|NCT00790569|pancreatic cancer|pancreatic cancer
1496875|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
1496876|NCT00790569|laryngeal cancer|laryngeal cancer
1496877|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
1496878|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
1496879|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
1496880|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1496881|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
1496882|NCT00790569|tobacco use disorder|tobacco use disorder
1496883|NCT00790543|Crohn's Disease|crohn's disease
1496884|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
1496885|NCT00790530|Diabetes|diabetes
1496886|NCT00790530|Information Technology|information technology
1496887|NCT00790530|Health Plans|health plans
1496888|NCT00790517|Weight loss|weight loss
1496889|NCT00790517|Diabetes prevention|diabetes prevention
1496890|NCT00790517|Serious mental illness|serious mental illness
1496891|NCT00790517|Antipsychotic medications|antipsychotic medications
1496892|NCT00790517|Lifestyle intervention|lifestyle intervention
1496893|NCT00790517|Antipsychotic Agents|antipsychotic agents
1496894|NCT00790504|Pelvic floor|pelvic floor
1496895|NCT00790504|Transperineal ultrasound|transperineal ultrasound
1496896|NCT00790504|Multiple pregnancy|multiple pregnancy
1496897|NCT00790504|Singleton pregnancy|singleton pregnancy
1496898|NCT00790504|Female pelvic floor|female pelvic floor
1496899|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
1496900|NCT00790478|Ulcerative Colitis|ulcerative colitis
1496901|NCT00790478|Melatonin|melatonin
1496902|NCT00790478|Gastrointestinal|gastrointestinal
1496903|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
1496904|NCT00790478|Sleep|sleep
1496905|NCT00790478|Pilot Study|pilot study
1496906|NCT00790465|achalasia|achalasia
1496907|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
1496908|NCT00790465|nitric oxide|nitric oxide
1496909|NCT00790465|dark chocolate|dark chocolate
1496910|NCT00790465|flavanols|flavanols
1496911|NCT00790452|Brain|brain
1496912|NCT00790452|Hematologic Disorder|hematologic disorder
1496913|NCT00790452|Venous Thromboembolism|venous thromboembolism
1496914|NCT00790452|Glioblastoma|glioblastoma
1496915|NCT00790452|Aspirin|aspirin
1496916|NCT00790452|Placebo|placebo
1496918|NCT00790452|ASA|asa
1496919|NCT00790452|DVT|dvt
1496920|NCT00790439|Insulin dependence|insulin dependence
1496921|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
1496922|NCT00790413|Radiotherapy|radiotherapy
1496923|NCT00790413|Immunotherapy|immunotherapy
1496924|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1496925|NCT00790400|Angiomyolipoma|angiomyolipoma
1496926|NCT00790400|AML|aml
1496927|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
1496928|NCT00790400|TSC|tsc
1496929|NCT00790400|mTOR|mtor
1496930|NCT00790400|RAD001|rad001
1496931|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
1496932|NCT00790400|Everolimus|everolimus
1496933|NCT00790400|Afinitor|afinitor
1496934|NCT00790400|SEGA|sega
1496935|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
1496936|NCT00790400|Seizures|seizures
1496937|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
1496938|NCT00790400|Tuberous sclerosis|tuberous sclerosis
1496939|NCT00790400|benign tumors of brain|benign tumors of brain
1496940|NCT00790400|kidney|kidney
1496941|NCT00790400|heart|heart
1496942|NCT00790400|eyes|eyes
1496943|NCT00790400|lungs|lungs
1496944|NCT00790400|skinTSC1|skintsc1
1496945|NCT00790400|TSC2|tsc2
1496946|NCT00790400|hamaratin|hamaratin
1496947|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
1496948|NCT00790400|gyri|gyri
1496949|NCT00790400|tubers|tubers
1496950|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
1496951|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
1496952|NCT00790400|rare lung disease|rare lung disease
1496953|NCT00790387|enoxaparin|enoxaparin
1496954|NCT00790387|tirofiban|tirofiban
1496955|NCT00790387|percutaneous intervention|percutaneous intervention
1496956|NCT00790387|platelet inhibition|platelet inhibition
1496957|NCT00790387|CD40L|cd40l
1496958|NCT00790387|Mac-1|mac-1
1496959|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
1496960|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
1496961|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
1496962|NCT00790361|spinal cord compression|spinal cord compression
1496963|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1496964|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
1496965|NCT00790361|brain plasticity|brain plasticity
1496966|NCT00790335|deep vein thrombosis|deep vein thrombosis
1496967|NCT00790335|deep venous thrombosis|deep venous thrombosis
1496968|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
1496969|NCT00790335|blood clot|blood clot
1496970|NCT00790335|thrombolysis|thrombolysis
1496971|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
1496972|NCT00790335|rt-PA|rt-pa
1496973|NCT00790335|Activase|activase
1496974|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
1496975|NCT00790335|pharmacomechanical|pharmacomechanical
1496976|NCT00790335|ATTRACT|attract
1496977|NCT00790322|Cancer|cancer
1496978|NCT00790322|Radiation therapy|radiation therapy
1496979|NCT00790322|Radiotherapy|radiotherapy
1496980|NCT00790322|Oral Mucositis|oral mucositis
1496981|NCT00790322|SBG|sbg
1496982|NCT00790309|Obesity|obesity
1496983|NCT00790309|Diabetes|diabetes
1496984|NCT00790309|Bariatric surgery|bariatric surgery
1496985|NCT00790296|cancer fatigue|cancer fatigue
1496986|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
1496987|NCT00790270|Cervical strain|cervical strain
1496988|NCT00790270|whiplash|whiplash
1496989|NCT00790270|ibuprofen|ibuprofen
1496990|NCT00790270|cyclobenzaprine|cyclobenzaprine
1496991|NCT00790257|Diabetes|diabetes
1496992|NCT00790257|Islets transplantation|islets transplantation
1496993|NCT00790257|Encapsulation|encapsulation
1496994|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
1496995|NCT00790244|prognostic factors|prognostic factors
1496996|NCT00790244|adjuvant|adjuvant
1496997|NCT00790244|chemotherapy|chemotherapy
1496998|NCT00790244|radiotherapy|radiotherapy
1496999|NCT00790244|metastases-free survival|metastases-free survival
1497000|NCT00790244|toxicity|toxicity
1497001|NCT00790244|High malignancy grade|high malignancy grade
1497002|NCT00790244|High-risk for metastases|high-risk for metastases
1497003|NCT00790244|Adult|adult
1497004|NCT00790231|urinary bladder|urinary bladder
1497005|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
1497006|NCT00790231|urodynamics|urodynamics
1497007|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
1497103|NCT00789815|sedation|sedation
1497008|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
1497009|NCT00790218|Hepatoma|hepatoma
1497010|NCT00790218|HCC|hcc
1497011|NCT00790192|Schizophrenia|schizophrenia
1497012|NCT00790192|SM-13496|sm-13496
1497013|NCT00790192|Latuda|latuda
1497014|NCT00790192|Lurasidone|lurasidone
1497015|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
1497016|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
1497017|NCT00790140|Esophageal Cancer|esophageal cancer
1497018|NCT00790140|esophagectomy|esophagectomy
1497019|NCT00790140|enteral feeding|enteral feeding
1497020|NCT00790140|body composition|body composition
1497021|NCT00790140|immunology|immunology
1497022|NCT00790114|Phase I|phase i
1497023|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1497024|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
1497025|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
1497026|NCT00790075|agitation|agitation
1497027|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
1497028|NCT00790062|Uterine atony|uterine atony
1497029|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
1497030|NCT00790062|clinical trial|clinical trial
1497031|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
1497032|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1497033|NCT00790036|DLBCL|dlbcl
1497034|NCT00790036|poor risk|poor risk
1497035|NCT00790036|R-IPI 3-5|r-ipi 3-5
1497036|NCT00790036|adjuvant therapy|adjuvant therapy
1497037|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
1497038|NCT00790036|after R-CHOP|after r-chop
1497039|NCT00790036|B-cell lymphoma|b-cell lymphoma
1497040|NCT00790036|lymphoma|lymphoma
1497041|NCT00790036|b cells|b cells
1497042|NCT00790036|blood cancer|blood cancer
1497043|NCT00790036|lymph nodes|lymph nodes
1497044|NCT00790036|Hodgkin's|hodgkin's
1497045|NCT00790036|non-Hodgkin|non-hodgkin
1497046|NCT00790023|SAR|sar
1497047|NCT00790010|bevacizumab|bevacizumab
1497048|NCT00790010|ipilimumab|ipilimumab
1497049|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
1497050|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
1497051|NCT00789997|COPD Exacerbation|copd exacerbation
1497052|NCT00789997|Etanercept|etanercept
1497053|NCT00789997|TNF alpha|tnf alpha
1497054|NCT00789997|Randomized|randomized
1497055|NCT00789984|Keratic precipitates|keratic precipitates
1497056|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
1497057|NCT00789971|phacoemulsification|phacoemulsification
1497058|NCT00789971|post op inflammation|post op inflammation
1497059|NCT00789971|cmo|cmo
1497060|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1497061|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1497062|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1497063|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
1497064|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1497065|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
1497166|NCT00789555|nasal spray|nasal spray
1497066|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
1497067|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
1497068|NCT00789945|type 1 diabetes|type 1 diabetes
1497069|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
1497070|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
1497071|NCT00789919|Mild Preeclampsia|mild preeclampsia
1497072|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
1497073|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
1497074|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
1497075|NCT00789893|brachytherapy|brachytherapy
1497076|NCT00789880|Vitamin D3|vitamin d3
1497077|NCT00789880|Atopic Dermatitis|atopic dermatitis
1497078|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
1497079|NCT00789867|Single dose|single dose
1497080|NCT00789867|Pilot|pilot
1497081|NCT00789867|Safety|safety
1497082|NCT00789867|Gene expression|gene expression
1497083|NCT00789867|Tolerability|tolerability
1497084|NCT00789867|CFTR gene|cftr gene
1497085|NCT00789867|Cystic fibrosis|cystic fibrosis
1497086|NCT00789867|Non-viral|non-viral
1497087|NCT00789854|Depression|depression
1497088|NCT00789854|MDD|mdd
1497089|NCT00789854|TRD|trd
1497090|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
1497091|NCT00789841|Carcinoid syndrome|carcinoid syndrome
1497092|NCT00789841|Motility|motility
1497093|NCT00789841|Transit time|transit time
1497094|NCT00789828|SEGA|sega
1497095|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
1497096|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
1497097|NCT00789828|mTOR|mtor
1497098|NCT00789828|RAD001|rad001
1497099|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
1497100|NCT00789828|Everolimus|everolimus
1497101|NCT00789828|TSC|tsc
1497102|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
1497104|NCT00789815|bispectral index|bispectral index
1497105|NCT00789802|contraception|contraception
1497106|NCT00789802|progestin contraception|progestin contraception
1497107|NCT00789802|intrauterine contraception|intrauterine contraception
1497108|NCT00789802|unscheduled bleeding|unscheduled bleeding
1497109|NCT00789802|placebo|placebo
1497110|NCT00789789|Cohort|cohort
1497111|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
1497112|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
1497113|NCT00789789|Long term safety|long term safety
1497114|NCT00789763|pancreatic cancer|pancreatic cancer
1497115|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
1497116|NCT00789724|acute myocardial infarction|acute myocardial infarction
1497117|NCT00789698|Schizophrenia|schizophrenia
1497118|NCT00789698|SM-13496|sm-13496
1497119|NCT00789698|Latuda|latuda
1497120|NCT00789698|Lurasidone|lurasidone
1497121|NCT00789685|Open label|open label
1497122|NCT00789672|Amblyopia|amblyopia
1497123|NCT00789672|Patching|patching
1497124|NCT00789672|Levodopa|levodopa
1497125|NCT00789659|Fracture fixation, internal|fracture fixation, internal
1497126|NCT00789659|Obesity|obesity
1497127|NCT00789659|Pelvis|pelvis
1497128|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
1497129|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
1497130|NCT00789646|corneal ulcer|corneal ulcer
1497131|NCT00789646|painless|painless
1497132|NCT00789646|subconjunctival injection|subconjunctival injection
1497133|NCT00789646|antibiotics|antibiotics
1497134|NCT00789646|antifungal|antifungal
1497135|NCT00789646|lidocaine|lidocaine
1497136|NCT00789633|Pancreatic cancer|pancreatic cancer
1497137|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
1497138|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
1497139|NCT00789633|Gemcitabine|gemcitabine
1497140|NCT00789633|Chemo-naive|chemo-naive
1497141|NCT00789620|intravenous lidocaine|intravenous lidocaine
1497142|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
1497143|NCT00789620|hospital stay|hospital stay
1497144|NCT00789620|pain|pain
1497145|NCT00789620|fatigue|fatigue
1497146|NCT00789620|length of stay|length of stay
1497147|NCT00789607|prostate cancer|prostate cancer
1497148|NCT00789607|individualized radiotherapy|individualized radiotherapy
1497149|NCT00789607|fiducial markers|fiducial markers
1497151|NCT00789607|ultrasound|ultrasound
1497152|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
1497153|NCT00789594|Monitoring|monitoring
1497154|NCT00789594|Testing|testing
1497155|NCT00789594|Medications|medications
1497156|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
1497157|NCT00789581|Breast Cancer|breast cancer
1497158|NCT00789581|Adjuvant|adjuvant
1497159|NCT00789581|Doxorubicin|doxorubicin
1497160|NCT00789581|Cyclophosphamide|cyclophosphamide
1497161|NCT00789581|Paclitaxel|paclitaxel
1497162|NCT00789581|Ixabepilone|ixabepilone
1497163|NCT00789581|TITAN|titan
1497164|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
1497165|NCT00789555|nasal allergy|nasal allergy
1497167|NCT00789555|seasonal allergy|seasonal allergy
1497168|NCT00789555|perennial allergy|perennial allergy
1497169|NCT00789542|stroke|stroke
1497170|NCT00789542|deep vein thrombosis|deep vein thrombosis
1497171|NCT00789542|doppler|doppler
1497172|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
1497173|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
1497174|NCT00789503|dietary fortification|dietary fortification
1497175|NCT00789503|Vitamin D3|vitamin d3
1497176|NCT00789503|Osteomalacia|osteomalacia
1497177|NCT00789503|bread|bread
1497178|NCT00789503|bone mineral density|bone mineral density
1497179|NCT00789503|geriatrics|geriatrics
1497180|NCT00789503|cholecalciferol|cholecalciferol
1497181|NCT00789503|calcidiol|calcidiol
1497182|NCT00789503|osteoporosis|osteoporosis
1497183|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
1497184|NCT00789503|bread fortification|bread fortification
1497185|NCT00789490|pregnancy|pregnancy
1497186|NCT00789490|relative bioavailability|relative bioavailability
1497187|NCT00789490|iron|iron
1497188|NCT00789490|folic acid|folic acid
1497189|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
1497190|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
1497191|NCT00789464|Urinary Tract Infection|urinary tract infection
1497192|NCT00789464|Probiotics|probiotics
1497193|NCT00789464|Dietary Supplements|dietary supplements
1497194|NCT00789464|Bacteriuria|bacteriuria
1497195|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
1497196|NCT00789451|t-PA|t-pa
1497197|NCT00789451|Fibrinolysis|fibrinolysis
1497198|NCT00789451|Endothelial function|endothelial function
1497199|NCT00789438|Analgesia|analgesia
1497200|NCT00789438|Sedation|sedation
1497201|NCT00789438|Spinal|spinal
1497202|NCT00789438|Stress|stress
1497203|NCT00789438|Surgical|surgical
1497204|NCT00789438|Surgical Stress|surgical stress
1497205|NCT00789438|Pain|pain
1497206|NCT00789425|osteoporosis|osteoporosis
1497207|NCT00789425|osteopenia|osteopenia
1497208|NCT00789425|olive extract|olive extract
1497209|NCT00789425|oleuropein|oleuropein
1497210|NCT00789412|Analgesia|analgesia
1497211|NCT00789412|Sedation|sedation
1497212|NCT00789412|Critical Illness|critical illness
1497213|NCT00789412|Intensive Care|intensive care
1497214|NCT00789399|deep vein thrombosis|deep vein thrombosis
1497215|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
1497216|NCT00789399|Venous thromboembolism|venous thromboembolism
1497217|NCT00789386|Capsaicin|capsaicin
1497218|NCT00789386|Remifentanil|remifentanil
1497219|NCT00789386|Hyperalgesia|hyperalgesia
1497220|NCT00789360|Healthy volunteers|healthy volunteers
1497221|NCT00789347|Neuropathic pain|neuropathic pain
1497222|NCT00789347|Cortical excitability|cortical excitability
1497223|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
1497224|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
1497225|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
1497226|NCT00789347|neurotrophic factors|neurotrophic factors
1497227|NCT00789308|Insulin dependence|insulin dependence
1497228|NCT00789295|Mediterranean diet|mediterranean diet
1497229|NCT00789295|Postprandial lipids|postprandial lipids
1497230|NCT00789295|Postprandial glucose|postprandial glucose
1497231|NCT00789295|High fibre diet|high fibre diet
1497232|NCT00789295|Low- CHO diet|low- cho diet
1497233|NCT00789295|High MUFA diet|high mufa diet
1497234|NCT00789295|Dietary approach|dietary approach
1497235|NCT00789282|chronic disease|chronic disease
1497236|NCT00789282|Family Physician|family physician
1497237|NCT00789282|primary care network|primary care network
1497238|NCT00789282|practice-based model|practice-based model
1497239|NCT00789282|type 2 diabetes|type 2 diabetes
1497240|NCT00789282|complications|complications
1497241|NCT00789282|sequelae|sequelae
1497242|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
1497243|NCT00789269|prevention of pneumonia|prevention of pneumonia
1497244|NCT00789269|rhubarb|rhubarb
1497245|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
1497246|NCT00789256|AML|aml
1497247|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
1497248|NCT00789256|MDS|mds
1497249|NCT00789256|Melphalan|melphalan
1497250|NCT00789256|Bortezomib|bortezomib
1497251|NCT00789256|Velcade|velcade
1497252|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
1497253|NCT00789243|t-PA|t-pa
1497254|NCT00789243|Fibrinolysis|fibrinolysis
1497255|NCT00789243|Endothelial function|endothelial function
1497256|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
1497257|NCT00789230|umbilical|umbilical
1497258|NCT00789230|hernia|hernia
1497259|NCT00789230|mesh|mesh
1497260|NCT00789217|Penicillin|penicillin
1497261|NCT00789217|Beta-Lactams|beta-lactams
1497262|NCT00789217|Allergy|allergy
1497263|NCT00789217|Hypersensitivity|hypersensitivity
1497264|NCT00789204|exercise|exercise
1497265|NCT00789204|low back pain|low back pain
1497266|NCT00789204|posture|posture
1497267|NCT00789204|rehabilitation|rehabilitation
1497268|NCT00789178|memory disturbances|memory disturbances
1497269|NCT00789165|Brugada syndrome|brugada syndrome
1497270|NCT00789165|quinidine|quinidine
1497271|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
1497272|NCT00789113|lamotrigine|lamotrigine
1497273|NCT00789113|epilepsy|epilepsy
1497274|NCT00789113|metabolism|metabolism
1497275|NCT00789113|bipolar disorder|bipolar disorder
1497276|NCT00789113|bipolar depression|bipolar depression
1497277|NCT00789113|glucuronidation|glucuronidation
1497278|NCT00789100|telehealth|telehealth
1497279|NCT00789100|telemonitor|telemonitor
1497280|NCT00789100|telemedicine|telemedicine
1497281|NCT00789100|Co-morbidities|co-morbidities
1497282|NCT00789087|Pleural Effusion.|pleural effusion.
1497283|NCT00789087|Talc.|talc.
1497284|NCT00789087|Pleurodesis.|pleurodesis.
1497285|NCT00789087|Quality of Life.|quality of life.
1497286|NCT00789087|Thoracoscopy.|thoracoscopy.
1497287|NCT00789074|Smoking cessation|smoking cessation
1497288|NCT00789074|Tobacco dependence|tobacco dependence
1497289|NCT00789074|Varenicline|varenicline
1497290|NCT00789074|Preloading|preloading
1497291|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
1497292|NCT00789048|hip|hip
1497293|NCT00789048|arthroplasty|arthroplasty
1497294|NCT00789048|radiograph|radiograph
1497295|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
1497296|NCT00789022|Glutamatergic system|glutamatergic system
1497297|NCT00789022|Glycine|glycine
1497298|NCT00789022|D-Serine|d-serine
1497299|NCT00789022|Oxytocin|oxytocin
1497300|NCT00789022|Estrogen|estrogen
1497301|NCT00789009|HIV|hiv
1497302|NCT00789009|Natural History|natural history
1497303|NCT00789009|Stored Sample|stored sample
1497304|NCT00789009|AIDS|aids
1497650|NCT00787982|tumor|tumor
1497305|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
1497306|NCT00788996|Parent-Child Relations|parent-child relations
1497307|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
1497308|NCT00788983|Induced hypoxia|induced hypoxia
1497309|NCT00788983|Pulse oximeter|pulse oximeter
1497310|NCT00788983|Nonin Medical|nonin medical
1497311|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
1497312|NCT00788970|Acupressure|acupressure
1497313|NCT00788970|Shiatsu|shiatsu
1497314|NCT00788970|Schizophrenia|schizophrenia
1497315|NCT00788957|panitumumab|panitumumab
1497316|NCT00788957|vectibix|vectibix
1497317|NCT00788957|AMG 102|amg 102
1497318|NCT00788957|AMG 479|amg 479
1497319|NCT00788957|colon cancer|colon cancer
1497320|NCT00788957|rectal cancer|rectal cancer
1497321|NCT00788957|colorectal cancer|colorectal cancer
1497322|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
1497323|NCT00788957|EGFR inhibitor|egfr inhibitor
1497324|NCT00788957|IGF inhibitor|igf inhibitor
1497325|NCT00788957|c-MET inhibitor|c-met inhibitor
1497326|NCT00788931|Breast Cancer|breast cancer
1497327|NCT00788931|HER2 positive|her2 positive
1497328|NCT00788931|adult-female|adult-female
1497329|NCT00788931|LBH589|lbh589
1497330|NCT00788931|HDAC inhibitor|hdac inhibitor
1497331|NCT00788931|panobinostat|panobinostat
1497332|NCT00788931|metastatic breast|metastatic breast
1497333|NCT00788931|adult female patients|adult female patients
1497334|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
1497335|NCT00788918|cognitive dysfunction|cognitive dysfunction
1497336|NCT00788918|MRI|mri
1497337|NCT00788918|MR spectroscopy|mr spectroscopy
1497338|NCT00788918|interferon|interferon
1497339|NCT00788918|ribavirin|ribavirin
1497340|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
1497341|NCT00788905|Hemodialysis|hemodialysis
1497342|NCT00788892|Acute|acute
1497343|NCT00788892|Myeloid|myeloid
1497344|NCT00788892|Leukemia|leukemia
1497345|NCT00788892|elderly|elderly
1497346|NCT00788892|Newly|newly
1497347|NCT00788892|Diagnosed|diagnosed
1497348|NCT00788879|Behavioral Journalism|behavioral journalism
1497349|NCT00788879|Mexican-Americans|mexican-americans
1497350|NCT00788879|Obesity|obesity
1497351|NCT00788879|Nutrition|nutrition
1497352|NCT00788879|Physical Activity|physical activity
1497353|NCT00788879|Border Health|border health
1497354|NCT00788866|Neuroprotection|neuroprotection
1497355|NCT00788866|Antioxidants|antioxidants
1497356|NCT00788866|Neonatal brain injury|neonatal brain injury
1497357|NCT00788866|Pomegranate juice|pomegranate juice
1497358|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
1497359|NCT00788827|diabetes type I|diabetes type i
1497360|NCT00788827|diabetes type 2|diabetes type 2
1497361|NCT00788827|renal transplant|renal transplant
1497362|NCT00788827|stem cells|stem cells
1497363|NCT00788827|successful renal transplant|successful renal transplant
1497364|NCT00788788|Airway obstruction|airway obstruction
1497365|NCT00788788|Heliox|heliox
1497366|NCT00788788|Different Helium content|different helium content
1497367|NCT00788775|nilotinib|nilotinib
1497368|NCT00788762|glaucoma|glaucoma
1497369|NCT00788762|myocilin|myocilin
1497370|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
1497371|NCT00788749|nasal polyps|nasal polyps
1497372|NCT00788749|oral steroid|oral steroid
1497373|NCT00788749|intranasal steroid|intranasal steroid
1497374|NCT00788749|medical polypectomy|medical polypectomy
1497375|NCT00788736|venous thromboembolism|venous thromboembolism
1497376|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
1497377|NCT00788736|warfarin|warfarin
1497378|NCT00788736|bleeding risk|bleeding risk
1497379|NCT00788736|clinical prediction rule|clinical prediction rule
1497380|NCT00788736|predictors|predictors
1497381|NCT00788736|deep vein thrombosis|deep vein thrombosis
1497382|NCT00788736|pulmonary embolism|pulmonary embolism
1497383|NCT00788736|vitamin k antagonist|vitamin k antagonist
1497384|NCT00788736|side effect|side effect
1497385|NCT00788723|Severe Brain Injury|severe brain injury
1497386|NCT00788723|Excitability|excitability
1497387|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1497388|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1497389|NCT00788684|Rituximab|rituximab
1497390|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
1497391|NCT00788684|Hematological Malignancies|hematological malignancies
1497392|NCT00788684|ABT-263|abt-263
1497393|NCT00788684|Navitoclax|navitoclax
1497394|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
1497395|NCT00788671|Endometrioid Endometrial Carcinoma|endometrioid endometrial carcinoma
1497396|NCT00788671|Complex Atypical Hyperplasia|complex atypical hyperplasia
1497397|NCT00788671|Levonorgestrel Intrauterine Device|levonorgestrel intrauterine device
1497398|NCT00788671|Endometrial Biopsy|endometrial biopsy
1497399|NCT00788671|Endometrium|endometrium
1497400|NCT00788671|Hyperplasia of lining of the uterus (womb)|hyperplasia of lining of the uterus (womb)
1497401|NCT00788671|Questionnaires|questionnaires
1497402|NCT00788671|Progesterone|progesterone
1497403|NCT00788671|Estrogen|estrogen
1497404|NCT00788671|Postmenopausal|postmenopausal
1497405|NCT00788671|Endometrial|endometrial
1497406|NCT00788671|Mirena|mirena
1497407|NCT00788671|Intrauterine Device|intrauterine device
1497408|NCT00788671|Birth control|birth control
1497409|NCT00788671|IUD|iud
1497410|NCT00788671|LIUD|liud
1497411|NCT00788671|CAH|cah
1497412|NCT00788671|G1EEC|g1eec
1497413|NCT00788671|Grade 1 endometrial cancer|grade 1 endometrial cancer
1497414|NCT00788671|Early endometrial cancer|early endometrial cancer
1497415|NCT00788658|Obstructed constipation|obstructed constipation
1497416|NCT00788658|Quality of life|quality of life
1497417|NCT00788645|Smoking|smoking
1497418|NCT00788645|COPD|copd
1497419|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1497420|NCT00788645|COPD Exacerbations|copd exacerbations
1497421|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
1497422|NCT00788632|Osteoporosis|osteoporosis
1497423|NCT00788632|BMD|bmd
1497424|NCT00788632|Bisphosphonates|bisphosphonates
1497425|NCT00788632|Educational materials|educational materials
1497426|NCT00788632|Patient Stories|patient stories
1497427|NCT00788619|Infertility|infertility
1497428|NCT00788619|Assisted reproductive technology|assisted reproductive technology
1497429|NCT00788619|Nitric oxide|nitric oxide
1497430|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
1497431|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
1497432|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
1497433|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1497434|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1497435|NCT00788554|groin|groin
1497436|NCT00788554|inguinal|inguinal
1497437|NCT00788554|hernia|hernia
1497438|NCT00788554|lichtenstein|lichtenstein
1497439|NCT00788554|TEP|tep
1497440|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
1497441|NCT00788541|Intraocular Pressure|intraocular pressure
1497442|NCT00788541|Anecortave Acetate|anecortave acetate
1497443|NCT00788528|Obesity|obesity
1497444|NCT00788515|insomnia|insomnia
1497445|NCT00788515|sleep maintenance|sleep maintenance
1497446|NCT00788489|breast cancer|breast cancer
1497447|NCT00788489|FDG-PET|fdg-pet
1497448|NCT00788489|MRI|mri
1497449|NCT00788489|chemotherapy|chemotherapy
1497450|NCT00788489|ultrasonography|ultrasonography
1497451|NCT00788476|Needs Assessment Survey|needs assessment survey
1497452|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
1497453|NCT00788476|Parents|parents
1497454|NCT00788476|Primary Caregiver|primary caregiver
1497455|NCT00788476|Survey|survey
1497456|NCT00788463|administration, intranasal|administration, intranasal
1497457|NCT00788463|aerosol|aerosol
1497458|NCT00788463|beclomethasone|beclomethasone
1497459|NCT00788463|QVAR|qvar
1497460|NCT00788463|corticosteroids|corticosteroids
1497461|NCT00788463|nasal polyps|nasal polyps
1497462|NCT00788463|rhinomanometry|rhinomanometry
1498363|NCT00785551|male|male
1497463|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
1497464|NCT00788463|Quality of Life|quality of life
1497465|NCT00788424|AS101 Psoriasis|as101 psoriasis
1497466|NCT00788385|Hydrocephalus|hydrocephalus
1497467|NCT00788385|High Pressure|high pressure
1497468|NCT00788385|Shunt Blockage|shunt blockage
1497469|NCT00788372|Chronic pain|chronic pain
1497470|NCT00788372|Fentanyl Patch|fentanyl patch
1497471|NCT00788359|cystic fibrosis|cystic fibrosis
1497472|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
1497473|NCT00788359|biomarkers|biomarkers
1497474|NCT00788346|Heavily marketed medications|heavily marketed medications
1497475|NCT00788346|Prescribing|prescribing
1497476|NCT00788346|Health information technology|health information technology
1497477|NCT00788346|Education|education
1497478|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
1497479|NCT00788320|Tuberculosis|tuberculosis
1497480|NCT00788320|vitamin D|vitamin d
1497481|NCT00788320|immune system|immune system
1497482|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1497483|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
1497484|NCT00788307|stage I prostate cancer|stage i prostate cancer
1497485|NCT00788307|stage II prostate cancer|stage ii prostate cancer
1497486|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
1497487|NCT00788242|Cardiac surgery|cardiac surgery
1497488|NCT00788242|Cardioprotection|cardioprotection
1497489|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
1497490|NCT00788242|Aortic stenosis|aortic stenosis
1497491|NCT00788229|Dry Eye Syndromes|dry eye syndromes
1497492|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1497493|NCT00788229|artificial tears|artificial tears
1497494|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
1497495|NCT00788229|sodium hyaluronate|sodium hyaluronate
1498094|NCT00786643|5-FU|5-fu
1497496|NCT00788216|Radical hysterectomy|radical hysterectomy
1497497|NCT00788216|Whole pelvic radiation|whole pelvic radiation
1497498|NCT00788216|Brachytherapy|brachytherapy
1497499|NCT00788216|Chemoradiation|chemoradiation
1497500|NCT00788216|Complications|complications
1497501|NCT00788216|Quality of Life|quality of life
1497502|NCT00788190|Distal Radius Fracture|distal radius fracture
1497503|NCT00788190|Elderly|elderly
1497504|NCT00788190|Prospective randomized trial|prospective randomized trial
1497505|NCT00788190|Outcomes|outcomes
1497506|NCT00788190|Pain and Function|pain and function
1497507|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
1497508|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
1497509|NCT00788177|age-related macular degeneration|age-related macular degeneration
1497510|NCT00788177|subretinal injection|subretinal injection
1497511|NCT00788177|Pegaptanib|pegaptanib
1497512|NCT00788177|Macugen|macugen
1497513|NCT00788164|cervical cancer|cervical cancer
1497514|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1497515|NCT00788164|therapeutic vaccine|therapeutic vaccine
1497516|NCT00788164|treatment|treatment
1497517|NCT00788164|CIN|cin
1497518|NCT00788164|HPV|hpv
1497519|NCT00788164|vaccine|vaccine
1497520|NCT00788164|Hopkins|hopkins
1497521|NCT00788164|Trimble|trimble
1497522|NCT00788151|Dengue virus|dengue virus
1497523|NCT00788151|Dengue fever|dengue fever
1497524|NCT00788151|Dengue hemorrhagic fever|dengue hemorrhagic fever
1497525|NCT00788151|Dengue diseases|dengue diseases
1497526|NCT00788151|Dengue vaccine|dengue vaccine
1497527|NCT00788138|Cystic Fibrosis|cystic fibrosis
1497528|NCT00788138|Vitamin D|vitamin d
1497529|NCT00788138|Anti-microbial peptides|anti-microbial peptides
1497530|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1497531|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1497532|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1497533|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
1497534|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1497535|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1497536|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1497537|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
1497538|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1497539|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1497540|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
1497541|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
1497542|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1497543|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1497544|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1497545|NCT00788125|childhood teratoma|childhood teratoma
1497546|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1497547|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
1497548|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
1497549|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
1497550|NCT00788125|cystic nephroma|cystic nephroma
1497551|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
1497552|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1497553|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
1497554|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1497555|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1497556|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
1497557|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
1497558|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1497559|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1497560|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1497561|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1497562|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1497563|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1497564|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1497565|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1497566|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1497567|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1497568|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1497569|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1497570|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1497571|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1497572|NCT00788125|Burkitt lymphoma|burkitt lymphoma
1497573|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1497574|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1497575|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1497576|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1497577|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1497578|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1497579|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
1497580|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1497581|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
1497582|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1497583|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1497584|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
1497585|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
1497586|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
1497587|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
1497588|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1497589|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1497590|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
1497591|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
1497592|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
1497593|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
1497594|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
1497595|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1497596|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1497597|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
1497598|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1497599|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1497600|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1497601|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1497602|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
1497603|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1497604|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1497605|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1497606|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1497607|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1497608|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1497609|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1497610|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1497611|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1497707|NCT00787761|stage II CLL|stage ii cll
1497612|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1497613|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
1497614|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
1497615|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1497616|NCT00788099|Aplidin|aplidin
1497617|NCT00788099|Plitidepsin|plitidepsin
1497618|NCT00788099|Tumors|tumors
1497619|NCT00788099|Lymphomas|lymphomas
1497620|NCT00788073|fragile X syndrome|fragile x syndrome
1497621|NCT00788073|irritability|irritability
1497622|NCT00788073|behavior problems|behavior problems
1497623|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
1497624|NCT00788060|Rad001|rad001
1497625|NCT00788060|Sutent|sutent
1497626|NCT00788034|Relapse prevention|relapse prevention
1497627|NCT00788034|GAD|gad
1497628|NCT00788034|Maintenance|maintenance
1497629|NCT00788034|Double-blind|double-blind
1497630|NCT00788034|Multicentre|multicentre
1497631|NCT00788021|Transplant|transplant
1497632|NCT00788021|Immunity|immunity
1497633|NCT00788021|Immunosuppression|immunosuppression
1497634|NCT00788008|spinal, joint|spinal, joint
1497635|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
1497636|NCT00787995|MPS IV Type A|mps iv type a
1497637|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
1497638|NCT00787995|MPS IVA|mps iva
1497639|NCT00787995|Morquio A Syndrome|morquio a syndrome
1497640|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
1497641|NCT00787995|LSD|lsd
1497642|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
1497643|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
1497644|NCT00787995|GALNS|galns
1497645|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
1497646|NCT00787995|ERT|ert
1497647|NCT00787982|brain|brain
1497648|NCT00787982|metastasis|metastasis
1497649|NCT00787982|neoplasm|neoplasm
1497651|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
1497652|NCT00787982|laser therapy|laser therapy
1497653|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
1497654|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1497655|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
1497656|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
1497657|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
1497658|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
1497659|NCT00787943|Acne|acne
1497660|NCT00787930|BPD|bpd
1497661|NCT00787917|Cystic Fibrosis|cystic fibrosis
1497662|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
1497663|NCT00787917|omalizumab|omalizumab
1497664|NCT00787917|oral corticosteroid use|oral corticosteroid use
1497665|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
1497666|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
1497667|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1497668|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
1497669|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
1497670|NCT00787891|Endoscopy|endoscopy
1497671|NCT00787891|Pediatrics|pediatrics
1497672|NCT00787891|Rabeprazole|rabeprazole
1497673|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
1497674|NCT00787865|DTI|dti
1497675|NCT00787865|Newborn|newborn
1497676|NCT00787865|Krabbe Disease|krabbe disease
1497677|NCT00787865|Motor Development|motor development
1497678|NCT00787865|Motor Disability|motor disability
1497679|NCT00787852|dasatinib|dasatinib
1497680|NCT00787852|radiation|radiation
1497681|NCT00787852|paclitaxel|paclitaxel
1497682|NCT00787852|carboplatin|carboplatin
1497683|NCT00787852|NSCLC|nsclc
1497684|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
1497685|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
1497686|NCT00787839|prediabetic state|prediabetic state
1497687|NCT00787839|mass screening|mass screening
1497688|NCT00787839|glucose tolerance test|glucose tolerance test
1497689|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
1497690|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
1497691|NCT00787813|Cervical cerclage|cervical cerclage
1497692|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
1497693|NCT00787800|Shock prevention|shock prevention
1497694|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
1497695|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
1497696|NCT00787800|Atrial Fibrillation|atrial fibrillation
1497697|NCT00787800|Remote Monitoring|remote monitoring
1497698|NCT00787800|ICD|icd
1497699|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1497700|NCT00787774|HIV|hiv
1497701|NCT00787774|resistance|resistance
1497702|NCT00787774|integrase|integrase
1497703|NCT00787761|accelerated phase CML|accelerated phase cml
1497704|NCT00787761|blastic phase CML|blastic phase cml
1497705|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
1497706|NCT00787761|stage I CLL|stage i cll
1497708|NCT00787761|stage III CLL|stage iii cll
1497709|NCT00787761|stage IV CLL|stage iv cll
1497710|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
1497711|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
1497712|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
1497713|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
1497714|NCT00787761|adult CML in remission|adult cml in remission
1497715|NCT00787761|adult ALL in remission|adult all in remission
1497716|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
1497717|NCT00787761|de novo MDS|de novo mds
1497718|NCT00787761|previously treated MDS|previously treated mds
1497719|NCT00787761|secondary MDS|secondary mds
1497720|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
1497721|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1497722|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
1497723|NCT00787761|primary myelofibrosis|primary myelofibrosis
1497724|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1497725|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1497726|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1497727|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
1497728|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
1497729|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
1497730|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
1497731|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1497732|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
1497733|NCT00787761|Burkitt lymphoma|burkitt lymphoma
1497734|NCT00787761|chronic phase CML|chronic phase cml
1497735|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
1497736|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1498095|NCT00786643|LV|lv
1497737|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1497738|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1497739|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1497740|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1497741|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1497742|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1497743|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1497744|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1497745|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1497746|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1497747|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1497748|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1497749|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1497750|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1567606|NCT00508716|Health Education|health education
1497751|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1497752|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1497753|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1497754|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1497755|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1497756|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1497757|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1497758|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
1497759|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
1497760|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1497761|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1497762|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1497763|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1497764|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1497765|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1497766|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1497767|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1497768|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1497769|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1497770|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1497771|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1497772|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1497773|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1497774|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1497775|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1497776|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1497777|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1497778|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1497779|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1497780|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1497781|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1497782|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1497783|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1497784|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1497785|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1497786|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1497787|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1497788|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1497789|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1497790|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1497791|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1497792|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1497793|NCT00787748|Cardiovascular|cardiovascular
1497794|NCT00787748|COPD|copd
1497795|NCT00787748|Population|population
1497796|NCT00787748|Prevalence|prevalence
1497797|NCT00787748|Underdiagnosis|underdiagnosis
1497798|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
1497799|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
1497800|NCT00787709|Obesity prevention|obesity prevention
1497801|NCT00787709|Health promotion|health promotion
1497802|NCT00787709|School based curriculum|school based curriculum
1497803|NCT00787696|HIV prevention|hiv prevention
1497804|NCT00787696|female adolescent offenders|female adolescent offenders
1497805|NCT00787696|sexual risk reduction|sexual risk reduction
1497806|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
1497807|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
1497808|NCT00787670|Obese|obese
1497809|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1497810|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
1497811|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
1497812|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
1497813|NCT00787644|Asthma|asthma
1497814|NCT00787644|Adipose Tissue|adipose tissue
1497815|NCT00787644|Asthmatics|asthmatics
1497816|NCT00787644|Pioglitazone|pioglitazone
1497817|NCT00787644|Actos|actos
1497818|NCT00787644|Obesity|obesity
1497819|NCT00787644|Exacerbation|exacerbation
1497821|NCT00787644|Overweight|overweight
1497822|NCT00787644|Leptin|leptin
1497823|NCT00787644|Adiponectin|adiponectin
1497824|NCT00787644|Wheezing|wheezing
1497825|NCT00787644|Vermont|vermont
1497826|NCT00787644|Pulmonary|pulmonary
1497827|NCT00787644|Lung|lung
1497828|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
1497829|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
1497830|NCT00787631|cross reactivity|cross reactivity
1497831|NCT00787631|bet v 1|bet v 1
1497832|NCT00787631|mal d 1|mal d 1
1497833|NCT00787618|Renal impairment|renal impairment
1497834|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
1497835|NCT00787592|Burns|burns
1497836|NCT00787592|children|children
1497837|NCT00787592|collagenase|collagenase
1497838|NCT00787592|silver sulfadiazine|silver sulfadiazine
1497839|NCT00787592|Childhood burns|childhood burns
1497840|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
1497841|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
1497842|NCT00787553|hysterectomy|hysterectomy
1497843|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
1497844|NCT00787553|bacterial vaginosis|bacterial vaginosis
1497845|NCT00787553|tinidazole|tinidazole
1497846|NCT00787553|cefazolin|cefazolin
1497847|NCT00787540|Coronary disease|coronary disease
1497848|NCT00787540|Psychosocial|psychosocial
1497849|NCT00787540|Nursing|nursing
1497850|NCT00787527|Lymphoma|lymphoma
1497851|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1497852|NCT00787527|SAHA|saha
1497853|NCT00787527|Vorinostat|vorinostat
1497854|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1497855|NCT00787527|MSK-390|msk-390
1497856|NCT00787527|CHOP|chop
1497857|NCT00787527|Cyclophosphamide|cyclophosphamide
1497858|NCT00787527|Doxorubicin|doxorubicin
1497859|NCT00787527|AD|ad
1497860|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1497861|NCT00787527|Cytoxan|cytoxan
1497862|NCT00787527|Neosar|neosar
1497863|NCT00787527|Vincristine|vincristine
1497864|NCT00787527|Prednisone|prednisone
1497865|NCT00787527|Untreated T-cell|untreated t-cell
1497866|NCT00787527|T-cell NHL|t-cell nhl
1497867|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
1497868|NCT00787527|PTCL|ptcl
1497869|NCT00787527|CD 30|cd 30
1497870|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1497871|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1497872|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
1497873|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
1497874|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
1497875|NCT00787501|Major Depressive Disorder|major depressive disorder
1497876|NCT00787501|Depression|depression
1497877|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1497878|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
1497879|NCT00787501|Cognitive Therapy|cognitive therapy
1497880|NCT00787501|antidepressant medications|antidepressant medications
1497881|NCT00787488|Ovarian|ovarian
1497882|NCT00787488|debulked|debulked
1497883|NCT00787488|recurrent|recurrent
1497884|NCT00787488|Stage III|stage iii
1497885|NCT00787488|Stage IV|stage iv
1497886|NCT00787475|Diabetes|diabetes
1497887|NCT00787475|Community health worker|community health worker
1497888|NCT00787475|Community outreach|community outreach
1497889|NCT00787462|Neuropathic|neuropathic
1497890|NCT00787462|Neuropathic pain|neuropathic pain
1497891|NCT00787462|Nerve pain|nerve pain
1497892|NCT00787462|Pain|pain
1497893|NCT00787462|Chronic pain|chronic pain
1497894|NCT00787462|Pregabalin|pregabalin
1497895|NCT00787462|Lyrica|lyrica
1497896|NCT00787462|Small fiber neuropathy|small fiber neuropathy
1497897|NCT00787462|Neuropathy|neuropathy
1497898|NCT00787436|portal hypertension|portal hypertension
1497899|NCT00787436|Gastroesophageal|gastroesophageal
1497900|NCT00787436|Varices|varices
1498405|NCT00785356|Anemia|anemia
1497901|NCT00787436|Liver disease|liver disease
1497902|NCT00787436|cirrhosis|cirrhosis
1497903|NCT00787423|Field Tools|field tools
1497904|NCT00787423|Drug Use|drug use
1497905|NCT00787423|Psychological Stress|psychological stress
1497906|NCT00787423|Ecological Momentary Assessment|ecological momentary assessment
1497907|NCT00787423|Global Positioning Units|global positioning units
1497908|NCT00787410|malignant mesothelioma|malignant mesothelioma
1497909|NCT00787410|IRESSA|iressa
1497910|NCT00787410|ZD1839|zd1839
1497911|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
1497912|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
1497913|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
1497914|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
1497915|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
1497916|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
1497917|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
1497918|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
1497919|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
1497920|NCT00787384|Imatinib|imatinib
1497921|NCT00787384|Response|response
1497922|NCT00787384|Timing to response|timing to response
1497923|NCT00787371|alanine transaminase|alanine transaminase
1497924|NCT00787358|osteoporosis|osteoporosis
1497925|NCT00787358|intertrochanteric|intertrochanteric
1497926|NCT00787358|hip fracture|hip fracture
1497927|NCT00787358|compression hip screw|compression hip screw
1497928|NCT00787358|surgical fixation|surgical fixation
1497929|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
1497930|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
1497931|NCT00787319|Ophthalmology|ophthalmology
1497932|NCT00787319|Age-related macular degeneration|age-related macular degeneration
1497933|NCT00787319|outpatients|outpatients
1497934|NCT00787306|chronic disease management|chronic disease management
1497935|NCT00787306|decision aids|decision aids
1497936|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
1497937|NCT00787293|Heart Failure|heart failure
1497938|NCT00787293|Mitral Regurgitation|mitral regurgitation
1497939|NCT00787293|Percutaneous|percutaneous
1497940|NCT00787293|Coronary sinus|coronary sinus
1497941|NCT00787280|obese|obese
1497942|NCT00787280|overweight|overweight
1497943|NCT00787280|fMRI|fmri
1497944|NCT00787280|Diet|diet
1497945|NCT00787267|NSCLC|nsclc
1497946|NCT00787267|Lung Cancer|lung cancer
1497947|NCT00787267|Dasatinib|dasatinib
1497948|NCT00787267|Genomics|genomics
1497949|NCT00787267|Genomics analysis|genomics analysis
1497950|NCT00787267|Genomic signature|genomic signature
1497951|NCT00787254|Curling Ulcer|curling ulcer
1497952|NCT00787254|Gastric Ulcer|gastric ulcer
1497953|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
1497954|NCT00787254|Drug Therapy|drug therapy
1497955|NCT00787241|Platelets|platelets
1497956|NCT00787241|Labor|labor
1497957|NCT00787241|Preeclampsia|preeclampsia
1497958|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
1497959|NCT00787215|Hong Kong Chinese|hong kong chinese
1497960|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
1497961|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
1497962|NCT00787189|tinnitus|tinnitus
1497963|NCT00787189|word recognition|word recognition
1497964|NCT00787176|Oxytocin|oxytocin
1497965|NCT00787176|Labor, Obstetric|labor, obstetric
1497966|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
1497967|NCT00787176|epidural|epidural
1497968|NCT00787163|pPROM|pprom
1497969|NCT00787163|oligohydramnios|oligohydramnios
1497970|NCT00787163|amnioinfusion|amnioinfusion
1497971|NCT00787163|prematurity|prematurity
1497972|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
1497973|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
1497974|NCT00787098|therapeutic mobility|therapeutic mobility
1497975|NCT00787098|acute care|acute care
1497976|NCT00787098|nursing|nursing
1497977|NCT00787098|inflammatory markers|inflammatory markers
1497978|NCT00787085|Funguria|funguria
1497979|NCT00787085|Epidemiology|epidemiology
1497980|NCT00787085|Urinary Tract Infections|urinary tract infections
1497981|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
1497982|NCT00787059|AC6|ac6
1497983|NCT00787059|adenovirus|adenovirus
1497984|NCT00787059|gene therapy|gene therapy
1497985|NCT00787059|congestive heart failure|congestive heart failure
1497986|NCT00787059|intracoronary|intracoronary
1497987|NCT00787059|nitroprusside|nitroprusside
1497988|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
1497989|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
1497990|NCT00787020|Ventriculostomy|ventriculostomy
1497991|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
1497992|NCT00787020|vasospasm|vasospasm
1497993|NCT00787020|Human Subjects|human subjects
1497994|NCT00787007|healthy volunteers|healthy volunteers
1497995|NCT00787007|pharmacokinetics|pharmacokinetics
1497996|NCT00786994|Actinic Keratoses|actinic keratoses
1497997|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
1497998|NCT00786968|Hurler-Scheie|hurler-scheie
1497999|NCT00786968|Scheie|scheie
1498000|NCT00786968|laronidase|laronidase
1498001|NCT00786968|spinal cord compression|spinal cord compression
1498002|NCT00786968|central nervous system|central nervous system
1498003|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
1498004|NCT00786968|intrathecal|intrathecal
1498005|NCT00786942|osteotomy|osteotomy
1498006|NCT00786942|knee|knee
1498007|NCT00786942|varus deformity|varus deformity
1498008|NCT00786942|bone graft|bone graft
1498009|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
1498010|NCT00786916|pain|pain
1498011|NCT00786916|propofol|propofol
1498012|NCT00786916|lidocaine|lidocaine
1498013|NCT00786916|sedation|sedation
1498014|NCT00786916|pediatric|pediatric
1498015|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
1498016|NCT00786890|Hong Kong Chinese|hong kong chinese
1498017|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
1498018|NCT00786877|pneumonia|pneumonia
1498019|NCT00786864|Randomised controlled trial|randomised controlled trial
1498020|NCT00786864|low back pain|low back pain
1498021|NCT00786864|exercise|exercise
1498022|NCT00786864|children|children
1498023|NCT00786864|school-based|school-based
1498024|NCT00786864|prevalence|prevalence
1498025|NCT00786864|intensity|intensity
1498026|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
1498027|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
1498028|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
1498029|NCT00786838|Solid tumor|solid tumor
1498030|NCT00786838|Advanced solid tumor|advanced solid tumor
1498031|NCT00786838|Malignant tumors|malignant tumors
1498032|NCT00786838|Sarcoma|sarcoma
1498033|NCT00786838|Breast tumor|breast tumor
1498034|NCT00786838|Ovarian tumor|ovarian tumor
1498035|NCT00786838|QT interval|qt interval
1498036|NCT00786838|Trabectedin|trabectedin
1498037|NCT00786838|Yondelis|yondelis
1498038|NCT00786838|Ecteinascidin 743|ecteinascidin 743
1498039|NCT00786838|ET743|et743
1498040|NCT00786825|Type 1 diabetes|type 1 diabetes
1498041|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
1498042|NCT00786812|Leukemia|leukemia
1498043|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
1498044|NCT00786812|imatinib|imatinib
1498045|NCT00786812|nilotinib|nilotinib
1498046|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
1498047|NCT00786786|at least 18 years of age|at least 18 years of age
1498048|NCT00786773|GERD|gerd
1498049|NCT00786773|reflux symptom|reflux symptom
1498050|NCT00786773|heartburn|heartburn
1498051|NCT00786773|acid regurgitation|acid regurgitation
1498052|NCT00786773|PPI|ppi
1498053|NCT00786773|H2RA|h2ra
1498054|NCT00786773|antacid|antacid
1498055|NCT00786760|HPV|hpv
1498056|NCT00786760|Papillomavirus|papillomavirus
1498057|NCT00786760|Infection|infection
1498153|NCT00786422|Hematologic Agents|hematologic agents
1498058|NCT00786760|Sexually transmitted disease|sexually transmitted disease
1498059|NCT00786760|STD|std
1498060|NCT00786747|Computer-assisted instruction|computer-assisted instruction
1498061|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
1498062|NCT00786747|Mass screening|mass screening
1498063|NCT00786747|Patient acceptance of health care|patient acceptance of health care
1498064|NCT00786747|Patient education as topic|patient education as topic
1498065|NCT00786747|Primary health care|primary health care
1498066|NCT00786747|Self-efficacy|self-efficacy
1498067|NCT00786734|pitavastatin|pitavastatin
1498068|NCT00786734|PCI|pci
1498069|NCT00786734|stable angina|stable angina
1498070|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
1498071|NCT00786708|renal|renal
1498072|NCT00786708|kidney|kidney
1498073|NCT00786708|lipocalin|lipocalin
1498074|NCT00786708|urine|urine
1498075|NCT00786708|biomarker|biomarker
1498076|NCT00786708|Azotemia|azotemia
1498077|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
1498078|NCT00786708|Renal failure, acute|renal failure, acute
1498079|NCT00786708|Hydronephrosis|hydronephrosis
1498080|NCT00786695|noncardiac chest pain|noncardiac chest pain
1498081|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
1498082|NCT00786695|diagnostic test|diagnostic test
1498083|NCT00786695|proton pump inhibitor|proton pump inhibitor
1498084|NCT00786695|esomeprazole|esomeprazole
1498085|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
1498086|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
1498087|NCT00786656|Navigation|navigation
1498088|NCT00786656|Coordination|coordination
1498089|NCT00786656|Cancer Care|cancer care
1498090|NCT00786656|Patient Experience|patient experience
1498091|NCT00786656|Cancer|cancer
1498092|NCT00786656|Patient Survey|patient survey
1498093|NCT00786643|Gamma Interferon|gamma interferon
1498096|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
1498097|NCT00786630|Drug injection frequency|drug injection frequency
1498098|NCT00786630|HIV risk behaviors|hiv risk behaviors
1498099|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
1498100|NCT00786591|Acute pancreatitis|acute pancreatitis
1498101|NCT00786591|biological markers|biological markers
1498102|NCT00786591|substance P|substance p
1498103|NCT00786591|hydrogen sulfide|hydrogen sulfide
1498104|NCT00786591|disease severity index|disease severity index
1498105|NCT00786578|training|training
1498106|NCT00786578|intramyocellular lipid|intramyocellular lipid
1498107|NCT00786578|insulin resistance|insulin resistance
1498108|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
1498109|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
1498110|NCT00786539|mitochondrial|mitochondrial
1498111|NCT00786526|Mechanical ventilation|mechanical ventilation
1498112|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
1498113|NCT00786526|Weaning|weaning
1498114|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
1498115|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
1498116|NCT00786513|Cystic fibrosis|cystic fibrosis
1498117|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
1498118|NCT00786513|biofilm|biofilm
1498119|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
1498120|NCT00786513|pediatrics|pediatrics
1498121|NCT00786500|Herbal medicine|herbal medicine
1498122|NCT00786500|Type 2 diabetes|type 2 diabetes
1498123|NCT00786500|Insulin sensitivity|insulin sensitivity
1498124|NCT00786500|Insulin secretion|insulin secretion
1498125|NCT00786487|insulin resistance|insulin resistance
1498126|NCT00786487|lipid metabolism|lipid metabolism
1498127|NCT00786487|lipid infusion|lipid infusion
1498128|NCT00786487|glycerol infusion|glycerol infusion
1498129|NCT00786487|skeletal muscle|skeletal muscle
1498130|NCT00786487|diabetes|diabetes
1498131|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
1498132|NCT00786461|silver nitrate|silver nitrate
1498133|NCT00786461|marsupialisation|marsupialisation
1498134|NCT00786448|Overactive Bladder|overactive bladder
1498135|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
1498136|NCT00786422|Pulmonary Embolism|pulmonary embolism
1498137|NCT00786422|Embolism|embolism
1498138|NCT00786422|Venous Thrombosis|venous thrombosis
1498139|NCT00786422|Thrombosis|thrombosis
1498140|NCT00786422|Enzyme Inducers|enzyme inducers
1498141|NCT00786422|CYP Inducers|cyp inducers
1498142|NCT00786422|Cohort Study|cohort study
1498143|NCT00786422|Pharmacologic Actions|pharmacologic actions
1498144|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
1498145|NCT00786422|Lung Diseases|lung diseases
1498146|NCT00786422|Vascular Diseases|vascular diseases
1498147|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1498148|NCT00786422|Neurologic disease|neurologic disease
1498149|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
1498150|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
1498151|NCT00786422|Anticoagulants|anticoagulants
1498152|NCT00786422|Therapeutic Uses|therapeutic uses
1498154|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
1498155|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
1498156|NCT00786422|Cardiovascular Agents|cardiovascular agents
1498157|NCT00786409|Lupus|lupus
1498158|NCT00786396|HIV|hiv
1498159|NCT00786396|AIDS|aids
1498160|NCT00786396|substance abuse|substance abuse
1498161|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
1498162|NCT00786396|adherence|adherence
1498163|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
1498164|NCT00786383|Phase I|phase i
1498165|NCT00786383|cancer|cancer
1498166|NCT00786383|solid tumors|solid tumors
1498167|NCT00786383|1121B|1121b
1498168|NCT00786383|VEGFR-2|vegfr-2
1498169|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
1498170|NCT00786370|propofol|propofol
1498171|NCT00786370|dexmedetomidine|dexmedetomidine
1498172|NCT00786370|cataract|cataract
1498173|NCT00786370|respiratory|respiratory
1498174|NCT00786370|blood pressure|blood pressure
1498175|NCT00786370|Cataract surgery|cataract surgery
1498176|NCT00786357|shift-work|shift-work
1498177|NCT00786357|sleep|sleep
1498178|NCT00786357|nurse|nurse
1498179|NCT00786357|relaxation|relaxation
1498180|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
1498181|NCT00786344|Occupational Therapy|occupational therapy
1498182|NCT00786344|Quality of Life|quality of life
1498183|NCT00786344|Health|health
1498184|NCT00786344|Biomarkers|biomarkers
1498185|NCT00786331|second line treatment|second line treatment
1498186|NCT00786331|pemetrexed|pemetrexed
1498187|NCT00786331|carboplatin|carboplatin
1498188|NCT00786318|Psychosis|psychosis
1498189|NCT00786318|Agitation|agitation
1498190|NCT00786318|Delirium|delirium
1498191|NCT00786305|Nebulization|nebulization
1498192|NCT00786305|ceftazidime|ceftazidime
1498193|NCT00786305|amikacin|amikacin
1498194|NCT00786305|pneumonia|pneumonia
1498195|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
1498196|NCT00786305|mechanical ventilation|mechanical ventilation
1498197|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
1498198|NCT00786305|treatment|treatment
1498199|NCT00786279|atherosclerosis|atherosclerosis
1498200|NCT00786266|shift-work|shift-work
1498201|NCT00786266|sleep|sleep
1498202|NCT00786266|nurse|nurse
1498203|NCT00786266|relaxation|relaxation
1498204|NCT00786253|Erectile dysfunction|erectile dysfunction
1498205|NCT00786253|Vardenafil|vardenafil
1498206|NCT00786240|Bioequivalence|bioequivalence
1498207|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
1498208|NCT00786214|Functional Dyspepsia|functional dyspepsia
1498209|NCT00786214|Acupuncture|acupuncture
1498210|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
1498211|NCT00786201|CNTO 888|cnto 888
1498212|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1498213|NCT00786201|IPF|ipf
1498214|NCT00786188|Menopause|menopause
1498215|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
1498216|NCT00786188|Hot flash|hot flash
1498217|NCT00786188|Perimenopause|perimenopause
1498218|NCT00786188|Nonhormonal therapies|nonhormonal therapies
1498219|NCT00786188|Climacteric symptoms|climacteric symptoms
1498220|NCT00786188|Mesafem|mesafem
1498221|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
1498222|NCT00786149|Underserved populations|underserved populations
1498223|NCT00786149|Homelessness|homelessness
1498224|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
1498225|NCT00786149|Counseling|counseling
1498226|NCT00786149|Cancer Prevention and control|cancer prevention and control
1498227|NCT00786136|diabetes mellitus|diabetes mellitus
1498228|NCT00786136|chronic kidney disease|chronic kidney disease
1498229|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
1498230|NCT00786136|angiography|angiography
1498231|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
1498232|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
1498233|NCT00786123|probiotics|probiotics
1498234|NCT00786123|melatonin|melatonin
1498235|NCT00786123|brain-gut axis|brain-gut axis
1498236|NCT00786110|Sorafenib|sorafenib
1498237|NCT00786110|Paclitaxel|paclitaxel
1498238|NCT00786110|Disease free survival|disease free survival
1498239|NCT00786084|Hiatal hernia|hiatal hernia
1498240|NCT00786084|PEH|peh
1498241|NCT00786084|paraesophageal hernia|paraesophageal hernia
1498242|NCT00786084|synthetic mesh|synthetic mesh
1498243|NCT00786084|small intestine submucosa|small intestine submucosa
1498244|NCT00786071|Rett syndrome.|rett syndrome.
1498245|NCT00786071|Nutritional status.|nutritional status.
1498246|NCT00786071|Metabolic alterations.|metabolic alterations.
1498247|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
1498248|NCT00786058|gemcitabine|gemcitabine
1498249|NCT00786058|phase III|phase iii
1498250|NCT00786058|second line|second line
1498251|NCT00786045|stroke|stroke
1498252|NCT00786045|rehabilitation|rehabilitation
1498253|NCT00786045|walking|walking
1498254|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1498255|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
1498256|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
1498257|NCT00786019|Type|type
1498258|NCT00786019|2|2
1498259|NCT00786019|Diabetes|diabetes
1498260|NCT00786019|Blood|blood
1498261|NCT00786019|Vessel|vessel
1498262|NCT00786019|Function|function
1498263|NCT00786019|Exercise|exercise
1498264|NCT00786019|Program|program
1498265|NCT00786019|Intervention|intervention
1498266|NCT00786019|Vitamin|vitamin
1498267|NCT00786019|C|c
1498268|NCT00786019|Men|men
1498269|NCT00786019|Women|women
1498270|NCT00786019|Blood vessel function|blood vessel function
1498271|NCT00786006|pancreatic cancer|pancreatic cancer
1498272|NCT00786006|gemcitabine|gemcitabine
1498273|NCT00786006|oxaliplatin|oxaliplatin
1498274|NCT00786006|irinotecan|irinotecan
1498275|NCT00786006|fluorouracil|fluorouracil
1498276|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
1498277|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
1498278|NCT00785980|quinine sulfate|quinine sulfate
1498279|NCT00785980|ciprofloxacin|ciprofloxacin
1498280|NCT00785980|drug interactions|drug interactions
1498281|NCT00785980|cytochrome p450|cytochrome p450
1498282|NCT00785980|male|male
1498283|NCT00785980|female|female
1498284|NCT00785980|adult|adult
1498285|NCT00785980|pharmacokinetics|pharmacokinetics
1498286|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
1498287|NCT00785954|Heart Diseases|heart diseases
1498288|NCT00785954|Myocardial Ischemia|myocardial ischemia
1498289|NCT00785954|Infarction|infarction
1498290|NCT00785954|Myocardial Infarction|myocardial infarction
1498291|NCT00785941|Tumors|tumors
1498292|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
1498293|NCT00785928|Arthritis|arthritis
1498294|NCT00785915|AZD6765|azd6765
1498295|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
1498296|NCT00785915|Phase I study|phase i study
1498297|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
1498298|NCT00785915|Japanese volunteers|japanese volunteers
1498299|NCT00785889|Colorectal cancer screening|colorectal cancer screening
1498300|NCT00785889|optical colonoscopy|optical colonoscopy
1498301|NCT00785889|water method|water method
1498302|NCT00785889|sedation|sedation
1498303|NCT00785876|Paediatric|paediatric
1498304|NCT00785876|Emergency Department|emergency department
1498305|NCT00785876|Ankle|ankle
1498306|NCT00785876|Injury|injury
1498307|NCT00785876|Low risk ankle rule|low risk ankle rule
1498308|NCT00785863|hyperalgesia|hyperalgesia
1498309|NCT00785863|remifentanil|remifentanil
1498310|NCT00785863|ketorolac|ketorolac
1498311|NCT00785863|parecoxib|parecoxib
1498312|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
1498313|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
1498314|NCT00785837|Hydrotherapy|hydrotherapy
1498315|NCT00785837|Perinatal Care|perinatal care
1498316|NCT00785837|Neonatology|neonatology
1498317|NCT00785824|Lactation|lactation
1498318|NCT00785824|Endocrine System Diseases|endocrine system diseases
1498319|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
1498320|NCT00785824|Hormone|hormone
1498321|NCT00785824|Physiological Properties|physiological properties
1498322|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
1498323|NCT00785798|Refractory Lymphomas|refractory lymphomas
1498324|NCT00785785|Unresectable GIST|unresectable gist
1498325|NCT00785785|metastatic GIST|metastatic gist
1498326|NCT00785785|nilotinib|nilotinib
1498327|NCT00785785|AMN107|amn107
1498328|NCT00785785|imatinib|imatinib
1498329|NCT00785785|STI571|sti571
1498330|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
1498331|NCT00785759|Alzheimer's Disease|alzheimer's disease
1498332|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
1498333|NCT00785733|asthma|asthma
1498334|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
1498335|NCT00785707|cochlear implant|cochlear implant
1498336|NCT00785668|Asthma|asthma
1498337|NCT00785668|Allergy|allergy
1498338|NCT00785668|Interleukin-4|interleukin-4
1498339|NCT00785668|Interleukin-13|interleukin-13
1498340|NCT00785668|IL-4|il-4
1498341|NCT00785668|IL-13|il-13
1498342|NCT00785668|Pharmacokinetics|pharmacokinetics
1498343|NCT00785668|Safety|safety
1498344|NCT00785668|Tolerability|tolerability
1498345|NCT00785668|Aerovance|aerovance
1498346|NCT00785668|dry powder|dry powder
1498347|NCT00785629|phosphorus|phosphorus
1498348|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
1498349|NCT00785629|vascular calcification|vascular calcification
1498350|NCT00785616|HIV|hiv
1498351|NCT00785616|Adherence|adherence
1498352|NCT00785616|MEMS|mems
1498353|NCT00785603|Depression|depression
1498354|NCT00785603|pain|pain
1498355|NCT00785603|CYP2D6|cyp2d6
1498356|NCT00785603|interactions|interactions
1498357|NCT00785603|Pupillometry|pupillometry
1498358|NCT00785603|Tramadol|tramadol
1498359|NCT00785603|Paroxetine|paroxetine
1498360|NCT00785603|MR-ratio|mr-ratio
1498361|NCT00785564|T-wave memory|t-wave memory
1498362|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
1498364|NCT00785551|female|female
1498365|NCT00785551|pharmacokinetics|pharmacokinetics
1498366|NCT00785551|normal and impaired renal function|normal and impaired renal function
1498367|NCT00785538|Tumors|tumors
1498368|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
1498369|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
1498370|NCT00785512|nebivolol|nebivolol
1498371|NCT00785512|Bystolic®|bystolic®
1498372|NCT00785512|Hypertension|hypertension
1498373|NCT00785512|blood pressure|blood pressure
1498374|NCT00785512|withdrawal|withdrawal
1498375|NCT00785499|obesity|obesity
1498376|NCT00785499|metabolic syndrome|metabolic syndrome
1498377|NCT00785499|milk components|milk components
1498378|NCT00785499|casein|casein
1498379|NCT00785499|whey|whey
1498380|NCT00785499|children|children
1498381|NCT00785499|adolescent|adolescent
1498382|NCT00785486|midazolam|midazolam
1498383|NCT00785486|drug interactions|drug interactions
1498384|NCT00785486|cytochrome p450|cytochrome p450
1498385|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1498386|NCT00785447|Respiratory Physiology|respiratory physiology
1498387|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
1498388|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
1498389|NCT00785434|MDD|mdd
1498390|NCT00785434|escitalopram|escitalopram
1498391|NCT00785421|heparin|heparin
1498392|NCT00785421|LMWH|lmwh
1498393|NCT00785421|pancreatic cancer|pancreatic cancer
1498394|NCT00785408|obesity|obesity
1498395|NCT00785408|overweight|overweight
1498396|NCT00785408|weight loss|weight loss
1498397|NCT00785408|Amylin|amylin
1498398|NCT00785408|AC2307|ac2307
1498399|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
1498400|NCT00785369|skin disorders|skin disorders
1498401|NCT00785369|skin cancer|skin cancer
1498402|NCT00785369|melanoma|melanoma
1498403|NCT00785369|lentigo maligna|lentigo maligna
1498404|NCT00785356|Uterine fibroids|uterine fibroids
1498406|NCT00785343|stroke|stroke
1498407|NCT00785343|acute|acute
1498408|NCT00785343|arm|arm
1498409|NCT00785343|robot|robot
1498410|NCT00785343|therapy|therapy
1498411|NCT00785343|arm paresis|arm paresis
1498412|NCT00785330|rituximab|rituximab
1498413|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1498414|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
1498415|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
1498416|NCT00785330|graft-versus-host disease|graft-versus-host disease
1498417|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
1498418|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
1498419|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
1498420|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
1498421|NCT00785278|Wheelchair Set-Up|wheelchair set-up
1498422|NCT00785278|Shoulder Joint Forces|shoulder joint forces
1498423|NCT00785278|Manual Wheelchair Users|manual wheelchair users
1498424|NCT00785278|Paraplegia|paraplegia
1498425|NCT00785278|Upper Limb Pain|upper limb pain
1498426|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
1498427|NCT00785278|Biomechanics|biomechanics
1498428|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
1498429|NCT00785265|LDKT|ldkt
1498430|NCT00785265|African Americans|african americans
1498431|NCT00785265|Disparity|disparity
1498432|NCT00785265|Education|education
1498433|NCT00785252|Catheters, Indwelling|catheters, indwelling
1498434|NCT00785239|Malignant Airway Disease|malignant airway disease
1498435|NCT00785239|Benign Airway Disease|benign airway disease
1498436|NCT00785239|Lung Cancer|lung cancer
1498437|NCT00785239|Emphysema|emphysema
1498438|NCT00785239|Chronic Bronchitis|chronic bronchitis
1498439|NCT00785239|COPD|copd
1498440|NCT00785239|Asthma|asthma
1498441|NCT00785239|Sarcoidosis|sarcoidosis
1498442|NCT00785239|Mesothelioma|mesothelioma
1498443|NCT00785239|CryoSpray Ablation|cryospray ablation
1498444|NCT00785239|Cryotherapy|cryotherapy
1498445|NCT00785239|Cryospray|cryospray
1498446|NCT00785239|Cryo|cryo
1498447|NCT00785213|rosiglitazone|rosiglitazone
1498448|NCT00785213|quinine sulfate|quinine sulfate
1498449|NCT00785213|drug interactions|drug interactions
1498450|NCT00785213|cytochrome p450|cytochrome p450
1498451|NCT00785200|MRSA|mrsa
1498452|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1498453|NCT00785200|Chlorhexidine|chlorhexidine
1498454|NCT00785200|Asymptomatic colonization|asymptomatic colonization
1498455|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
1498456|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
1498457|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
1498458|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
1498459|NCT00785161|Penumbra System|penumbra system
1498460|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
1498461|NCT00785161|Ischemic Stroke|ischemic stroke
1498462|NCT00785161|Intervention|intervention
1498848|NCT00783627|sickle cell|sickle cell
1498463|NCT00785161|Neurovascular|neurovascular
1498464|NCT00785161|Thrombus|thrombus
1498465|NCT00785161|Imaging|imaging
1498466|NCT00785161|Ischemic Penumbra|ischemic penumbra
1498467|NCT00785161|Functional Outcome|functional outcome
1498468|NCT00785135|vision, binocular|vision, binocular
1498469|NCT00785135|vision disparity|vision disparity
1498470|NCT00785135|headache|headache
1498471|NCT00785135|dizziness|dizziness
1498472|NCT00785135|anxiety|anxiety
1498473|NCT00785135|neck pain|neck pain
1498474|NCT00785135|learning disorders|learning disorders
1498475|NCT00785135|asthenopia|asthenopia
1498476|NCT00785135|motion sickness|motion sickness
1498477|NCT00785135|depth perception|depth perception
1498478|NCT00785135|gait disorder|gait disorder
1498479|NCT00785135|diplopia|diplopia
1498480|NCT00785135|photophobia|photophobia
1498481|NCT00785135|agoraphobia|agoraphobia
1498482|NCT00785135|panic disorder|panic disorder
1498483|NCT00785122|cancer vaccine|cancer vaccine
1498484|NCT00785109|aortic valve calcification|aortic valve calcification
1498485|NCT00785109|vitamin K supplementation|vitamin k supplementation
1498486|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
1498487|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
1498488|NCT00785070|Perioperative|perioperative
1498489|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
1498490|NCT00785070|Screening|screening
1498491|NCT00785070|Home Sleep Testing|home sleep testing
1498492|NCT00785057|Hypertension|hypertension
1498493|NCT00785057|Stroke|stroke
1498494|NCT00785057|Neurology|neurology
1498495|NCT00785057|JNC7|jnc7
1498496|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
1498497|NCT00785057|survey|survey
1498498|NCT00785044|Heart Failure|heart failure
1498499|NCT00785044|MIBG|mibg
1498500|NCT00785044|123I-mIBG|123i-mibg
1498681|NCT00784446|0205|0205
1498501|NCT00785031|risk management|risk management
1498502|NCT00785031|Self Management|self management
1498503|NCT00785031|Self-Efficacy|self-efficacy
1498504|NCT00785031|Disease management|disease management
1498505|NCT00785031|nurse practitioner|nurse practitioner
1498506|NCT00785031|internet|internet
1498507|NCT00785031|risk factors|risk factors
1498508|NCT00785031|vascular diseases|vascular diseases
1498509|NCT00785031|economic evaluation|economic evaluation
1498510|NCT00785018|Endotoxin|endotoxin
1498511|NCT00785018|C1-inhibitor|c1-inhibitor
1498512|NCT00785018|Inflammation|inflammation
1498513|NCT00785018|Sepsis|sepsis
1498514|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
1498515|NCT00785018|Complement activation|complement activation
1498516|NCT00785005|Diabetes|diabetes
1498517|NCT00785005|Exercise|exercise
1498518|NCT00785005|Women|women
1498519|NCT00785005|Research|research
1498520|NCT00785005|Bike|bike
1498521|NCT00785005|Type|type
1498522|NCT00785005|Control|control
1498523|NCT00785005|Healthy|healthy
1498524|NCT00784992|NLDO|nldo
1498525|NCT00784992|DCR|dcr
1498526|NCT00784992|silicone tubes|silicone tubes
1498527|NCT00784992|stent|stent
1498528|NCT00784979|Renal|renal
1498529|NCT00784979|Transplant|transplant
1498530|NCT00784979|PRA|pra
1498531|NCT00784966|Islet transplantation|islet transplantation
1498532|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1498533|NCT00784966|Kidney Transplantation|kidney transplantation
1498534|NCT00784953|Symbicort SMART|symbicort smart
1498535|NCT00784953|budesonide|budesonide
1498536|NCT00784953|formoterol|formoterol
1498537|NCT00784953|ICS/LABA|ics/laba
1498538|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
1498539|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
1498540|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1498541|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1498542|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1498543|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1498544|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1498545|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1498546|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1498547|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1498548|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1498549|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1498550|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1498551|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1498552|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1498553|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1498554|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1498555|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1498849|NCT00783614|HIV|hiv
1498556|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1498557|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1498558|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1498559|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1498560|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1498561|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1498562|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1498563|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1498564|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1498565|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
1498566|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
1498567|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
1498568|NCT00784914|adult brain stem glioma|adult brain stem glioma
1498569|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
1498570|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
1498571|NCT00784914|adult gliosarcoma|adult gliosarcoma
1498572|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
1498573|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
1498574|NCT00784914|adult medulloblastoma|adult medulloblastoma
1498575|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1498576|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
1498577|NCT00784914|adult ependymoma|adult ependymoma
1498578|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1498579|NCT00784914|adult subependymoma|adult subependymoma
1498580|NCT00784914|adult mixed glioma|adult mixed glioma
1498581|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
1498582|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1498583|NCT00784914|adult grade I meningioma|adult grade i meningioma
1498584|NCT00784914|adult grade II meningioma|adult grade ii meningioma
1498585|NCT00784914|adult grade III meningioma|adult grade iii meningioma
1498586|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1498587|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
1498588|NCT00784914|adult pineoblastoma|adult pineoblastoma
1498589|NCT00784914|adult pineocytoma|adult pineocytoma
1498590|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
1498591|NCT00784888|aromatase inhibitor|aromatase inhibitor
1498592|NCT00784888|quality of life|quality of life
1498593|NCT00784888|safety|safety
1498594|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
1498595|NCT00784849|Breast cancer|breast cancer
1498596|NCT00784849|diagnostic|diagnostic
1498597|NCT00784849|lymph nodes|lymph nodes
1498598|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
1498599|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
1498600|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
1498601|NCT00784784|antiviral drugs|antiviral drugs
1498602|NCT00784784|influenza vaccines|influenza vaccines
1498603|NCT00784771|Hypnotherapy|hypnotherapy
1498604|NCT00784771|Hypnosis|hypnosis
1498605|NCT00784771|PTSD|ptsd
1498606|NCT00784758|Asthma|asthma
1498607|NCT00784758|Lung Diseases|lung diseases
1498608|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
1498609|NCT00784745|incretin effect|incretin effect
1498610|NCT00784745|type 2 diabetes|type 2 diabetes
1498611|NCT00784745|GLP-1|glp-1
1498612|NCT00784745|GIP|gip
1498613|NCT00784745|dexamethasone|dexamethasone
1498614|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1498615|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
1498616|NCT00784732|nasal lavage|nasal lavage
1498617|NCT00784719|Dry eye|dry eye
1498618|NCT00784706|stroke rehabilitation|stroke rehabilitation
1498619|NCT00784706|perceptual deficits|perceptual deficits
1498620|NCT00784706|kinematic analysis|kinematic analysis
1498621|NCT00784693|Endometriosis|endometriosis
1498622|NCT00784693|pain|pain
1498623|NCT00784693|tanezumab|tanezumab
1498624|NCT00784693|nerve growth factor|nerve growth factor
1498625|NCT00784693|questionnaires|questionnaires
1498626|NCT00784667|Colorectal neoplasm|colorectal neoplasm
1498627|NCT00784667|Metastasis|metastasis
1498628|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
1498629|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
1498630|NCT00784615|Adiponectin|adiponectin
1498631|NCT00784615|C Reactive Protein|c reactive protein
1498632|NCT00784602|prolapse|prolapse
1498633|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
1498634|NCT00784589|Corticothérapy|corticothérapy
1498635|NCT00784589|Rituximab|rituximab
1498636|NCT00784589|therapeutic efficacity|therapeutic efficacity
1498637|NCT00784589|therapeutic tolerance|therapeutic tolerance
1498638|NCT00784576|Delirium|delirium
1498639|NCT00784576|Cardiac Surgery|cardiac surgery
1498640|NCT00784576|Depression|depression
1498641|NCT00784576|Cognitive Impairment|cognitive impairment
1498642|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
1498643|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
1498644|NCT00784576|Delirium Index|delirium index
1498645|NCT00784563|Parkinson Disease|parkinson disease
1498646|NCT00784563|Exercise/*physiology|exercise/*physiology
1498647|NCT00784563|*Physical Fitness|*physical fitness
1498648|NCT00784563|Rehabilitation|rehabilitation
1498649|NCT00784563|Cognition|cognition
1498650|NCT00784550|Spirometry|spirometry
1498651|NCT00784550|COPD|copd
1498652|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
1498653|NCT00784537|ABVD|abvd
1498654|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
1498655|NCT00784537|Radiotherapy|radiotherapy
1498656|NCT00784524|stage IV breast cancer|stage iv breast cancer
1498657|NCT00784524|recurrent breast cancer|recurrent breast cancer
1498658|NCT00784524|metastatic breast cancer|metastatic breast cancer
1498659|NCT00784511|diabetes|diabetes
1498660|NCT00784511|vitamin D|vitamin d
1498661|NCT00784511|African Americans|african americans
1498662|NCT00784511|overweight|overweight
1498663|NCT00784511|insulin sensitivity|insulin sensitivity
1498664|NCT00784511|glucose control|glucose control
1498665|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
1498666|NCT00784498|Emergency Department|emergency department
1498667|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
1498668|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
1498669|NCT00784485|Asthma|asthma
1498670|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
1498671|NCT00784485|Lung Diseases|lung diseases
1498672|NCT00784485|Dyspnea|dyspnea
1498673|NCT00784472|PCNL|pcnl
1498674|NCT00784472|oxycodone|oxycodone
1498675|NCT00784472|morphine|morphine
1498676|NCT00784472|visceral pain|visceral pain
1498677|NCT00784459|Asthma|asthma
1498678|NCT00784459|Allergy|allergy
1498679|NCT00784446|AIO|aio
1498680|NCT00784446|colorectal cancer|colorectal cancer
1498682|NCT00784446|Capecitabine|capecitabine
1498683|NCT00784446|Oxaliplatin|oxaliplatin
1498684|NCT00784446|Bevacizumab|bevacizumab
1498685|NCT00784446|Imatinib|imatinib
1498686|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
1498687|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
1498688|NCT00784407|thyroid surgery|thyroid surgery
1498689|NCT00784407|total thyroidectomy|total thyroidectomy
1498690|NCT00784407|harmonic scalpel|harmonic scalpel
1498691|NCT00784381|Renal failure|renal failure
1498692|NCT00784381|Elderly|elderly
1498693|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
1498694|NCT00784381|Quality of care|quality of care
1498695|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
1498696|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
1498697|NCT00784368|Mycoses|mycoses
1498698|NCT00784368|Candidiasis|candidiasis
1498699|NCT00784368|Aspergillosis|aspergillosis
1498700|NCT00784368|Cryptococcosis|cryptococcosis
1498701|NCT00784368|Blastomycosis|blastomycosis
1498702|NCT00784368|Histoplasmosis|histoplasmosis
1498703|NCT00784368|Neutropenia|neutropenia
1498704|NCT00784368|Itraconazole|itraconazole
1498705|NCT00784368|JK1211|jk1211
1498706|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
1498707|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1498708|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
1498709|NCT00784342|COPD|copd
1498710|NCT00784329|Lung Cancer|lung cancer
1498711|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
1498712|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
1498713|NCT00784329|Central Airway Diseases|central airway diseases
1498714|NCT00784316|Prevention|prevention
1498715|NCT00784303|Thyroid Cancer|thyroid cancer
1498716|NCT00784277|Pain medication|pain medication
1498717|NCT00784277|Arthritis|arthritis
1498718|NCT00784277|Joint pain|joint pain
1498719|NCT00784277|Analgesia|analgesia
1498720|NCT00784277|Analgesics|analgesics
1498721|NCT00784277|tapentadol|tapentadol
1498722|NCT00784277|CG5503|cg5503
1498723|NCT00784277|Nucynta|nucynta
1498724|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
1498725|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
1498726|NCT00784264|central obesity|central obesity
1498727|NCT00784264|cardiovascular disease|cardiovascular disease
1498728|NCT00784251|Pain|pain
1498729|NCT00784251|Leg pain|leg pain
1498730|NCT00784251|Back pain|back pain
1498731|NCT00784251|PROMIS|promis
1498732|NCT00784238|Schizophrenia|schizophrenia
1498733|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
1498734|NCT00784238|Paliperidone|paliperidone
1498735|NCT00784238|R076477|r076477
1498736|NCT00784225|cataract|cataract
1498737|NCT00784225|advanced macular degeneration|advanced macular degeneration
1498738|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
1498739|NCT00784199|MDD|mdd
1498740|NCT00784199|Depression|depression
1498741|NCT00784186|Pregnancy termination|pregnancy termination
1498742|NCT00784186|abortion|abortion
1498743|NCT00784186|medical abortion|medical abortion
1498744|NCT00784186|2nd trimester|2nd trimester
1498745|NCT00784186|mifepristone|mifepristone
1498746|NCT00784186|misoprostol|misoprostol
1498747|NCT00784173|Syndrome|syndrome
1498748|NCT00784173|Velocardiofacial|velocardiofacial
1498749|NCT00784173|Middle ear|middle ear
1498750|NCT00784173|Inner ear|inner ear
1498751|NCT00784173|Malformation|malformation
1498752|NCT00784147|HIV|hiv
1498753|NCT00784147|CD4|cd4
1498754|NCT00784147|experienced|experienced
1498755|NCT00784147|resistant|resistant
1498756|NCT00784147|resistance|resistance
1498757|NCT00784147|monoclonal|monoclonal
1498758|NCT00784147|antibody|antibody
1498759|NCT00784147|infusion|infusion
1498760|NCT00784147|ibalizumab|ibalizumab
1498761|NCT00784147|TNX355|tnx355
1498762|NCT00784147|TNX-355|tnx-355
1498763|NCT00784147|TMB355|tmb355
1498764|NCT00784147|TMB-355|tmb-355
1498765|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
1498766|NCT00784095|quality of life|quality of life
1498767|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
1498768|NCT00784043|Cochlear implant|cochlear implant
1498769|NCT00784043|hearing loss|hearing loss
1498770|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1498771|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
1498772|NCT00784030|Water Loading|water loading
1498773|NCT00784030|Biomarkers|biomarkers
1498774|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
1498775|NCT00784004|breathing patterns,|breathing patterns,
1498776|NCT00784004|unidirectional breathing,|unidirectional breathing,
1498777|NCT00784004|mask ventilation,|mask ventilation,
1498778|NCT00784004|respiratory physiology|respiratory physiology
1498779|NCT00783991|IVF|ivf
1498780|NCT00783991|PDA|pda
1498781|NCT00783991|PC|pc
1498782|NCT00783991|CAT|cat
1498783|NCT00783991|COPD|copd
1498784|NCT00783991|MDD|mdd
1498785|NCT00783991|RA|ra
1498786|NCT00783978|Surfactant protein C|surfactant protein c
1498787|NCT00783978|Interstitial|interstitial
1498788|NCT00783978|lung|lung
1498789|NCT00783978|Children|children
1498790|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1498791|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1498792|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
1498793|NCT00783952|Tissue oxygenation|tissue oxygenation
1498794|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
1498795|NCT00783913|Direct Current Stimulation|direct current stimulation
1498796|NCT00783913|Rehabilitation|rehabilitation
1498797|NCT00783913|Motor Learning|motor learning
1498798|NCT00783913|Stroke|stroke
1498799|NCT00783900|Prevention|prevention
1498800|NCT00783887|Cilia|cilia
1498801|NCT00783887|Axoneme|axoneme
1498802|NCT00783887|Dynein|dynein
1498803|NCT00783887|Gene|gene
1498804|NCT00783887|Ultrastructure|ultrastructure
1498805|NCT00783887|Linkage analysis|linkage analysis
1498807|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1498808|NCT00783835|Methylphenidate|methylphenidate
1498809|NCT00783835|Concerta|concerta
1498810|NCT00783835|CONQoL|conqol
1498811|NCT00783822|breast neoplasms|breast neoplasms
1498812|NCT00783822|genetic counseling|genetic counseling
1498813|NCT00783809|intracranial pressure|intracranial pressure
1498814|NCT00783809|intracranial hypertension|intracranial hypertension
1498815|NCT00783809|ultrasound|ultrasound
1498816|NCT00783809|emergency|emergency
1498817|NCT00783809|traumatic brain injury|traumatic brain injury
1498818|NCT00783809|ocular ultrasound|ocular ultrasound
1498819|NCT00783796|Coronary artery disease|coronary artery disease
1498820|NCT00783796|Atherosclerosis|atherosclerosis
1498821|NCT00783796|Myocardial ischemia|myocardial ischemia
1498822|NCT00783783|Psychiatric disorders|psychiatric disorders
1498823|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
1498824|NCT00783783|Autism|autism
1498825|NCT00783783|Risperidone|risperidone
1498826|NCT00783783|Pharmacogenetics|pharmacogenetics
1498827|NCT00783783|Pharmacokinetics|pharmacokinetics
1498828|NCT00783770|Breastfeeding|breastfeeding
1498829|NCT00783770|Infant|infant
1498830|NCT00783770|Preterm|preterm
1498831|NCT00783770|Nutrition|nutrition
1498832|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
1498834|NCT00783757|breast imaging|breast imaging
1498835|NCT00783757|optical imaging|optical imaging
1498836|NCT00783731|intubation|intubation
1498837|NCT00783679|Cardiac output|cardiac output
1498838|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
1498839|NCT00783679|Thermodilution|thermodilution
1498840|NCT00783653|AML|aml
1498841|NCT00783653|FLT3|flt3
1498842|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
1498843|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
1498844|NCT00783653|FLT3 mutated AML|flt3 mutated aml
1498845|NCT00783627|Endothelium|endothelium
1498846|NCT00783627|progenitors|progenitors
1498847|NCT00783627|stem cells|stem cells
1498850|NCT00783614|Cardiovascular Disease|cardiovascular disease
1498851|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
1498852|NCT00783601|Chronic Asthma|chronic asthma
1498853|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1498854|NCT00783588|CLL|cll
1498855|NCT00783588|Leukemia|leukemia
1498856|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1498857|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
1498858|NCT00783588|Immune System Diseases|immune system diseases
1498859|NCT00783588|ISF35|isf35
1498860|NCT00783588|Ad-ISF35|ad-isf35
1498861|NCT00783588|Immunotherapy|immunotherapy
1498862|NCT00783588|Immune therapy|immune therapy
1498863|NCT00783588|Active immune therapy|active immune therapy
1498864|NCT00783575|Crohn's disease|crohn's disease
1498865|NCT00783575|Ulcerative colitis|ulcerative colitis
1498866|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
1498867|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
1498868|NCT00783562|Low back pain|low back pain
1498869|NCT00783562|Neck pain|neck pain
1498870|NCT00783562|Functional disability|functional disability
1498871|NCT00783562|Nursery school teachers|nursery school teachers
1498872|NCT00783562|Exercise program|exercise program
1498873|NCT00783562|Prevention|prevention
1498874|NCT00783549|tolerability|tolerability
1498875|NCT00783549|pharmacodynamics|pharmacodynamics
1498876|NCT00783549|pharmacokinetics|pharmacokinetics
1498877|NCT00783549|safety|safety
1498878|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
1498879|NCT00783510|JIA|jia
1498880|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1498881|NCT00783510|Juvenile Arthritis|juvenile arthritis
1498882|NCT00783510|Polyarticular JIA|polyarticular jia
1498883|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
1498884|NCT00783497|High Blood Pressure|high blood pressure
1498885|NCT00783497|Stress|stress
1498886|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
1499313|NCT00781807|Ergometry|ergometry
1498887|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
1498888|NCT00783445|Metabolic Syndrome|metabolic syndrome
1498889|NCT00783445|Obesity|obesity
1498890|NCT00783445|Hyperglycemia|hyperglycemia
1498891|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
1498893|NCT00783380|Influenza vaccination|influenza vaccination
1498894|NCT00783380|Subunit|subunit
1498895|NCT00783380|Virosomal|virosomal
1498896|NCT00783380|HIV/AIDS|hiv/aids
1498897|NCT00783380|Renal Dialysis|renal dialysis
1498898|NCT00783380|Kidney transplantation|kidney transplantation
1498899|NCT00783380|Rheumatologic diseases|rheumatologic diseases
1498900|NCT00783380|Immunogenicity|immunogenicity
1498901|NCT00783380|Reactogenicity|reactogenicity
1498902|NCT00783367|Revlimid|revlimid
1498903|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
1498904|NCT00783367|lenalidomide|lenalidomide
1498905|NCT00783367|Rituxan|rituxan
1498906|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
1498907|NCT00783367|rituximab|rituximab
1498908|NCT00783367|Follicular Lymphoma|follicular lymphoma
1498909|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
1498910|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
1498911|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1498912|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
1498913|NCT00783367|Antigens, CD20|antigens, cd20
1498914|NCT00783367|refractory|refractory
1498915|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
1498916|NCT00783367|Previously treated|previously treated
1498917|NCT00783367|Treated with rituximab|treated with rituximab
1498918|NCT00783328|solid tumor|solid tumor
1498919|NCT00783315|Hypertension|hypertension
1498920|NCT00783315|Diabetes|diabetes
1498921|NCT00783315|Hypercholesterolemia|hypercholesterolemia
1498922|NCT00783302|CAD|cad
1498923|NCT00783302|Visipaque|visipaque
1498924|NCT00783302|CCTA|ccta
1498925|NCT00783250|COPD|copd
1498926|NCT00783250|Respiratory Mechanics|respiratory mechanics
1498927|NCT00783250|Bronchodilators|bronchodilators
1498928|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
1498929|NCT00783185|psychotic disorders|psychotic disorders
1498930|NCT00783185|cannabis|cannabis
1498931|NCT00783185|intervention|intervention
1498932|NCT00783172|pancreas|pancreas
1498933|NCT00783172|pancreatic cancer|pancreatic cancer
1498934|NCT00783172|cancer|cancer
1498935|NCT00783172|Opioid Growth Factor|opioid growth factor
1498936|NCT00783172|OGF|ogf
1498937|NCT00783172|gemcitabine|gemcitabine
1498938|NCT00783172|chemotherapy|chemotherapy
1498939|NCT00783159|Muscle power|muscle power
1498940|NCT00783159|Frailty|frailty
1498941|NCT00783159|Exercise|exercise
1498942|NCT00783159|Vitamin D|vitamin d
1498943|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
1498944|NCT00783107|Gold Stage III COPD|gold stage iii copd
1499276|NCT00781950|PAD|pad
1498945|NCT00783081|Intermittent Claudication|intermittent claudication
1498946|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
1498947|NCT00783068|Endotoxin|endotoxin
1498948|NCT00783068|GTS-21|gts-21
1498949|NCT00783068|Vagal activity|vagal activity
1498950|NCT00783068|Autonomic balance|autonomic balance
1498951|NCT00783055|Autonomy|autonomy
1498952|NCT00783055|Older people|older people
1498953|NCT00783055|Physically frail|physically frail
1498954|NCT00783055|Nursing home|nursing home
1498955|NCT00783055|Intervention study|intervention study
1498956|NCT00783042|TTDE-CFR|ttde-cfr
1498957|NCT00783042|coronary artery function|coronary artery function
1498958|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
1498959|NCT00783042|rosuvastatin|rosuvastatin
1498960|NCT00783042|Crestor|crestor
1498961|NCT00783029|Vasodilation|vasodilation
1498962|NCT00783029|Vessel Reactivity|vessel reactivity
1498963|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
1498964|NCT00783029|Retina|retina
1498965|NCT00783016|appendicitis|appendicitis
1498966|NCT00783016|diagnosis|diagnosis
1498967|NCT00783003|Tolerability|tolerability
1498968|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
1498969|NCT00783003|Safety|safety
1498970|NCT00783003|Anticholinergic|anticholinergic
1498971|NCT00783003|ß2 agonist|ß2 agonist
1498972|NCT00783003|Pharmacokinetics|pharmacokinetics
1498973|NCT00782990|stress urinary incontinence|stress urinary incontinence
1498974|NCT00782990|female incontinence|female incontinence
1498975|NCT00782990|surgical treatment|surgical treatment
1498976|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
1498977|NCT00782977|Apneic oxygenation|apneic oxygenation
1498978|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
1498979|NCT00782964|Depression|depression
1498980|NCT00782964|Major Depressive Disorder|major depressive disorder
1498981|NCT00782964|SSRI resistant depression|ssri resistant depression
1498982|NCT00782964|strategies in depression|strategies in depression
1499410|NCT00781378|Efficacy|efficacy
1498983|NCT00782925|Low back pain|low back pain
1498984|NCT00782925|recurrence|recurrence
1498985|NCT00782925|chronic low back pain|chronic low back pain
1498986|NCT00782925|educational program|educational program
1498987|NCT00782925|physical therapy|physical therapy
1498988|NCT00782925|home exercise|home exercise
1498989|NCT00782925|compliance|compliance
1498990|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
1498991|NCT00782899|Schizophrenia|schizophrenia
1498992|NCT00782899|subjective well-being|subjective well-being
1498993|NCT00782899|depressive symptoms|depressive symptoms
1498994|NCT00782899|schizophrenia course|schizophrenia course
1498995|NCT00782886|Pathfinder|pathfinder
1498996|NCT00782886|Liver|liver
1498997|NCT00782886|Resection|resection
1498998|NCT00782886|Surgery|surgery
1498999|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
1499000|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
1499001|NCT00782873|propofol|propofol
1499002|NCT00782873|sedation|sedation
1499003|NCT00782873|safety|safety
1499004|NCT00782873|obesity|obesity
1499005|NCT00782860|Early pregnancy failure|early pregnancy failure
1499006|NCT00782860|Misoprostol|misoprostol
1499007|NCT00782860|Gestational sac volume|gestational sac volume
1499008|NCT00782847|diabetes mellitus|diabetes mellitus
1499009|NCT00782847|diabetic nephropathy|diabetic nephropathy
1499010|NCT00782847|hypertension|hypertension
1499011|NCT00782834|GIST|gist
1499012|NCT00782834|Nilotinib|nilotinib
1499013|NCT00782821|Kidney|kidney
1499014|NCT00782821|Renal|renal
1499015|NCT00782821|Rejection|rejection
1499016|NCT00782821|High risk|high risk
1499017|NCT00782821|Induction|induction
1499018|NCT00782821|Immunology|immunology
1499019|NCT00782821|Transplantation|transplantation
1499020|NCT00782821|B Cell|b cell
1499021|NCT00782821|Allograft|allograft
1499022|NCT00782821|Desensitization|desensitization
1499023|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
1499024|NCT00782795|Chronic pancreatitis|chronic pancreatitis
1499025|NCT00782795|Insulin resistance|insulin resistance
1499026|NCT00782756|Radiation|radiation
1499027|NCT00782756|BEVACIZUMAB|bevacizumab
1499028|NCT00782756|AVASTIN|avastin
1499029|NCT00782756|TEMOZOLOMIDE|temozolomide
1499030|NCT00782756|newly diagnosed|newly diagnosed
1499031|NCT00782756|Glioblastoma|glioblastoma
1499032|NCT00782756|GBM|gbm
1499033|NCT00782756|malignant glioma|malignant glioma
1499034|NCT00782756|Radiotherapy|radiotherapy
1499035|NCT00782756|08-126|08-126
1499036|NCT00782743|phenprocoumon|phenprocoumon
1499037|NCT00782743|anticoagulation|anticoagulation
1499038|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
1499039|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
1499040|NCT00782730|bladder volume measurement|bladder volume measurement
1499041|NCT00782730|pregnancy|pregnancy
1499042|NCT00782730|bladder function|bladder function
1499043|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
1499044|NCT00782730|Bladder volumes|bladder volumes
1499045|NCT00782717|diabetic retinopathy|diabetic retinopathy
1499046|NCT00782717|cystoid macular edema;|cystoid macular edema;
1499047|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
1499048|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
1499049|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
1499050|NCT00782691|Head-and-neck cancer|head-and-neck cancer
1499051|NCT00782691|Histological validation|histological validation
1499052|NCT00782665|postoperative|postoperative
1499053|NCT00782665|infection|infection
1499054|NCT00782665|c-section|c-section
1499055|NCT00782652|myocaridal infarction|myocaridal infarction
1499056|NCT00782652|right ventricular infarction|right ventricular infarction
1499057|NCT00782652|cardiogenic shock|cardiogenic shock
1499058|NCT00782652|RVAD|rvad
1499059|NCT00782652|Right ventricular assist device|right ventricular assist device
1499060|NCT00782652|cardiac disease|cardiac disease
1499061|NCT00782652|right ventricle|right ventricle
1499062|NCT00782652|cardiac shock|cardiac shock
1499063|NCT00782652|heart dysfunction|heart dysfunction
1499064|NCT00782626|RAD001|rad001
1499065|NCT00782613|Psoriasis|psoriasis
1499066|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
1499067|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
1499068|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
1499069|NCT00782613|subjects.|subjects.
1499070|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
1568402|NCT00505999|Questionnaire|questionnaire
1655413|NCT00167947|Kidney|kidney
1499411|NCT00781378|Safety|safety
1499071|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
1499072|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
1499073|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
1499074|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
1499075|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
1499076|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
1499077|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
1499078|NCT00782613|concentration.|concentration.
1499079|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
1499080|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
1499081|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
1499082|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
1499083|NCT00782587|rHuPH20|rhuph20
1499084|NCT00782587|Chemophase®|chemophase®
1499085|NCT00782587|Mitomycin|mitomycin
1499086|NCT00782574|Advanced solid tumours|advanced solid tumours
1499087|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1499088|NCT00782574|homologous deficiency|homologous deficiency
1499089|NCT00782574|BRCA1|brca1
1499090|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
1499091|NCT00782561|FSGS|fsgs
1499092|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
1499093|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1499094|NCT00782548|KADIAN|kadian
1499095|NCT00782548|morphine|morphine
1499096|NCT00782548|Avinza|avinza
1499097|NCT00782548|30 mg|30 mg
1499098|NCT00782548|bioequivalence|bioequivalence
1499100|NCT00782483|Diagnosis|diagnosis
1499101|NCT00782483|Port Wine Stain|port wine stain
1499103|NCT00782405|antidepressant action|antidepressant action
1499104|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
1499105|NCT00782392|Nutrition|nutrition
1499106|NCT00782392|Infant Formula|infant formula
1499107|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1499108|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1499109|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1499110|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1499111|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1499112|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1499113|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1499114|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1499115|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1499116|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1499117|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1499192|NCT00782275|temsirolimus|temsirolimus
1499118|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1499119|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1499120|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1499121|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1499122|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1499123|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1499124|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1499125|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1499126|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1499127|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1499128|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1499129|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1499130|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1499131|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1499132|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1499133|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1499134|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1499135|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1499136|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1499137|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1499138|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1499139|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1499140|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1499141|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1499142|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1499143|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1499144|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1499145|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1499146|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1499147|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1499148|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1499149|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1499150|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1499151|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1499152|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1499153|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1499154|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1499155|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1499156|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1499157|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1499158|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1499159|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1499160|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
1499161|NCT00782366|predictive genomics|predictive genomics
1499162|NCT00782366|personalized medicine|personalized medicine
1499163|NCT00782366|personal genomics|personal genomics
1499164|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
1499165|NCT00782366|genetic knowledge|genetic knowledge
1499166|NCT00782366|genetic attitudes|genetic attitudes
1499168|NCT00782340|NOH|noh
1499169|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
1499170|NCT00782340|Orthostatic hypotension|orthostatic hypotension
1499171|NCT00782340|PAF|paf
1499172|NCT00782340|Pure Autonomic Failure|pure autonomic failure
1499173|NCT00782340|MSA|msa
1499174|NCT00782340|Multiple System Atrophy|multiple system atrophy
1499175|NCT00782340|Neuropathy|neuropathy
1499176|NCT00782340|Autonomic Failure|autonomic failure
1499177|NCT00782340|Parkinson|parkinson
1499178|NCT00782340|Dopamine Deficiency|dopamine deficiency
1499179|NCT00782340|Dopamine|dopamine
1499180|NCT00782340|Droxidopa|droxidopa
1499181|NCT00782314|asthma|asthma
1499182|NCT00782314|SMART|smart
1499183|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
1499184|NCT00782314|asthma control|asthma control
1499185|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
1499186|NCT00782288|digitoxin|digitoxin
1499187|NCT00782288|inflammatory markers|inflammatory markers
1499188|NCT00782288|cytokines|cytokines
1499189|NCT00782288|gene expression|gene expression
1499190|NCT00782275|RCC|rcc
1499191|NCT00782275|avastin|avastin
1499193|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
1499194|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
1499195|NCT00782197|osteoarthritis|osteoarthritis
1499196|NCT00782197|knee|knee
1499197|NCT00782197|PRGF|prgf
1499198|NCT00782197|autologous plasma|autologous plasma
1499199|NCT00782197|plasma preparations|plasma preparations
1499200|NCT00782197|treatment|treatment
1499201|NCT00782171|Dental implants|dental implants
1499202|NCT00782158|HIV|hiv
1499203|NCT00782158|Hepatitis B|hepatitis b
1499204|NCT00782158|Coinfection|coinfection
1499205|NCT00782158|Liver Fibrosis|liver fibrosis
1499206|NCT00782158|Transient Elastography|transient elastography
1499207|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1499208|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1499209|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1499210|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1499211|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1499212|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1499213|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1499214|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1499215|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1655684|NCT00166933|UVB|uvb
1499216|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1499217|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1499218|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1499219|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1499312|NCT00781807|Exercise Capacity|exercise capacity
1499220|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1499221|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1499222|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1499223|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1499224|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1499225|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1499226|NCT00782145|primary myelofibrosis|primary myelofibrosis
1499227|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1499228|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
1499229|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1499230|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1499231|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1499232|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1499233|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
1499234|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1499235|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1499236|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
1499237|NCT00782093|AMD|amd
1499238|NCT00782080|ADHD|adhd
1499239|NCT00782080|children|children
1499240|NCT00782080|adolescents|adolescents
1499241|NCT00782080|St. John`s Wort|st. john`s wort
1499242|NCT00782080|Valerian extract|valerian extract
1499243|NCT00782080|Safety|safety
1499244|NCT00782080|Efficacy|efficacy
1499245|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
1499246|NCT00782067|mast cell leukemia|mast cell leukemia
1499247|NCT00782067|C-Findings|c-findings
1499248|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1499249|NCT00782067|KIT mutation|kit mutation
1499250|NCT00782067|AHNMD|ahnmd
1499251|NCT00782067|Systemic|systemic
1499252|NCT00782067|Aggressive|aggressive
1499253|NCT00782054|pruritus|pruritus
1499254|NCT00782054|itch|itch
1499255|NCT00782054|burn|burn
1499256|NCT00782054|endopeptidase|endopeptidase
1499257|NCT00782054|moisturizer|moisturizer
1499258|NCT00782054|randomized controlled|randomized controlled
1499259|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
1499260|NCT00782015|almonds|almonds
1499261|NCT00782015|heart disease|heart disease
1499262|NCT00782015|vascular reactivity|vascular reactivity
1499263|NCT00782015|inflammation|inflammation
1499264|NCT00782015|dyslipidemia|dyslipidemia
1499265|NCT00782015|oxidative stress|oxidative stress
1499266|NCT00782002|Solid Tumors|solid tumors
1499267|NCT00782002|VEGF-A|vegf-a
1499268|NCT00782002|stromal cells|stromal cells
1499269|NCT00782002|endothelial cells|endothelial cells
1499270|NCT00782002|malignant cells|malignant cells
1499271|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
1499272|NCT00781989|biomarkers|biomarkers
1499273|NCT00781989|ultrasound|ultrasound
1499274|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
1499275|NCT00781963|insomnia|insomnia
1499277|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
1499278|NCT00781950|Diabetes|diabetes
1499279|NCT00781950|Atherosclerosis|atherosclerosis
1499280|NCT00781950|Flax|flax
1499281|NCT00781950|Flaxseeds|flaxseeds
1499282|NCT00781950|Functional Foods|functional foods
1499283|NCT00781950|Essential Fatty Acids|essential fatty acids
1499284|NCT00781950|Winnipeg|winnipeg
1499285|NCT00781911|Islet Cell|islet cell
1499286|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
1499287|NCT00781911|Octreotide|octreotide
1499288|NCT00781911|depot octreotide acetate|depot octreotide acetate
1499289|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
1499290|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
1499291|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
1499292|NCT00781898|Depot naltrexone|depot naltrexone
1499293|NCT00781898|Parolees|parolees
1499294|NCT00781898|Opioid addiction prevention|opioid addiction prevention
1499295|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
1499296|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
1499297|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
1499298|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
1499299|NCT00781872|stem cells|stem cells
1499300|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
1499301|NCT00781833|Functional Electric Stimulation|functional electric stimulation
1568403|NCT00505999|Survey|survey
1499302|NCT00781833|Implantable Stimulator|implantable stimulator
1499303|NCT00781833|Muscle Strength|muscle strength
1499304|NCT00781833|Muscle Spasticity|muscle spasticity
1499305|NCT00781820|Bifonazole|bifonazole
1499307|NCT00781820|Urea|urea
1499308|NCT00781820|Nail fungus|nail fungus
1499309|NCT00781807|Heart-Assist-Devices|heart-assist-devices
1499310|NCT00781807|Rehabilitation|rehabilitation
1499311|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
1499314|NCT00781807|Social Support|social support
1499315|NCT00781807|Quality of Life|quality of life
1499316|NCT00781807|Nutrition Assessment|nutrition assessment
1499317|NCT00781807|Nutrition Therapy|nutrition therapy
1499318|NCT00781807|Neuropsychological Tests|neuropsychological tests
1499319|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
1499320|NCT00781768|Bone Marrow Transplant|bone marrow transplant
1499321|NCT00781768|Nausea|nausea
1499322|NCT00781768|Vomiting|vomiting
1499323|NCT00781768|NK-1 antagonist|nk-1 antagonist
1499324|NCT00781768|Nausea and vommitting in the stem cell/marrow transplant population.|nausea and vommitting in the stem cell/marrow transplant population.
1499325|NCT00781755|smoking cessation|smoking cessation
1499326|NCT00781755|varenicline|varenicline
1499327|NCT00781755|schizophrenia|schizophrenia
1499328|NCT00781755|serious mental illness|serious mental illness
1499329|NCT00781755|Nicotine addiction|nicotine addiction
1499330|NCT00781755|Smoking Behavior|smoking behavior
1499331|NCT00781742|Depression|depression
1499332|NCT00781742|Depressive Disorder|depressive disorder
1499334|NCT00781729|Kyphosis|kyphosis
1499335|NCT00781729|Yoga|yoga
1499336|NCT00781729|Aging|aging
1499337|NCT00781729|Physical performance|physical performance
1499338|NCT00781729|Quality of Life|quality of life
1499339|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
1499340|NCT00781716|Drug eluting stents|drug eluting stents
1499341|NCT00781690|Chronic kidney failure|chronic kidney failure
1499342|NCT00781690|Heparin|heparin
1499343|NCT00781690|Hemodialysis|hemodialysis
1499344|NCT00781690|Biocompatibility|biocompatibility
1499345|NCT00781677|Major Depressive Disorder|major depressive disorder
1499346|NCT00781677|Depression|depression
1499347|NCT00781677|Anxiety|anxiety
1499348|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
1499349|NCT00781625|probiotics|probiotics
1499350|NCT00781625|QoL|qol
1499351|NCT00781625|inflammation|inflammation
1499352|NCT00781625|nutritional factors|nutritional factors
1499353|NCT00781625|prophylactic aid|prophylactic aid
1499354|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
1499355|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
1499356|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
1499357|NCT00781599|African american|african american
1499358|NCT00781599|smokers|smokers
1499359|NCT00781599|smoking cessation|smoking cessation
1499360|NCT00781599|African American smokers|african american smokers
1499361|NCT00781586|Energy expenditure|energy expenditure
1499362|NCT00781586|Nutritional|nutritional
1499363|NCT00781586|Weight control|weight control
1499364|NCT00781573|Drug Eluting Stent|drug eluting stent
1499365|NCT00781573|Clopidogrel|clopidogrel
1499366|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
1499367|NCT00781560|Hyperlipidemia|hyperlipidemia
1499368|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
1499369|NCT00781560|Crestor®|crestor®
1499370|NCT00781547|growth hormone|growth hormone
1499371|NCT00781547|obesity|obesity
1499372|NCT00781547|abdominal obesity|abdominal obesity
1499373|NCT00781534|Health Supplements|health supplements
1499374|NCT00781534|Ginseng|ginseng
1499375|NCT00781534|Diabetes|diabetes
1499376|NCT00781508|heart failure, left sided|heart failure, left sided
1499377|NCT00781508|ventricular dysfunction|ventricular dysfunction
1499378|NCT00781508|diastolic dysfunction|diastolic dysfunction
1499379|NCT00781508|sildenafil|sildenafil
1499380|NCT00781495|insulin|insulin
1499381|NCT00781482|Positron Emission Tomography|positron emission tomography
1499382|NCT00781482|GABA receptor binding|gaba receptor binding
1499383|NCT00781482|Hypnotic Drugs|hypnotic drugs
1499384|NCT00781482|Eszopiclone|eszopiclone
1499385|NCT00781482|Zolpidem|zolpidem
1499386|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
1499387|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
1499388|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
1499390|NCT00781469|Synovium|synovium
1499391|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
1499392|NCT00781456|Migraine headache|migraine headache
1499393|NCT00781456|menstrual|menstrual
1499394|NCT00781456|oral contraceptive|oral contraceptive
1499395|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
1499396|NCT00781443|Asthma|asthma
1499397|NCT00781417|vitamin D|vitamin d
1499398|NCT00781417|Chronic Kidney Disease|chronic kidney disease
1499399|NCT00781417|parathyroid hormone|parathyroid hormone
1499400|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
1499401|NCT00781404|adenosine|adenosine
1499402|NCT00781404|angioplasty|angioplasty
1499403|NCT00781404|acute myocardial infarction|acute myocardial infarction
1499404|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
1499405|NCT00781404|infarct size|infarct size
1499406|NCT00781404|rescued myocardium|rescued myocardium
1499407|NCT00781391|Systemic embolic events|systemic embolic events
1499408|NCT00781378|Thrombolytic therapy|thrombolytic therapy
1499409|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1499412|NCT00781365|Hypertension|hypertension
1499413|NCT00781365|Telemonitoring|telemonitoring
1499414|NCT00781365|Pharmacy management|pharmacy management
1499415|NCT00781352|nitrous oxide|nitrous oxide
1499416|NCT00781352|cancer recurrence|cancer recurrence
1499417|NCT00781352|colorectal surgery|colorectal surgery
1499418|NCT00781339|Bacteriuria|bacteriuria
1499419|NCT00781339|Catheterized|catheterized
1499420|NCT00781339|Chronically Catheterized|chronically catheterized
1499421|NCT00781326|Depressive Disorder, Major|depressive disorder, major
1499422|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
1499423|NCT00781326|Risk Factors|risk factors
1499424|NCT00781326|Nimodipine|nimodipine
1499425|NCT00781300|Intraocular pressure|intraocular pressure
1499426|NCT00781300|Pterygium|pterygium
1499427|NCT00781300|Surgery|surgery
1499428|NCT00781300|Steroids|steroids
1499429|NCT00781300|Glaucoma|glaucoma
1499430|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
1499431|NCT00781287|raltegravir|raltegravir
1499432|NCT00781287|primary HIV infection|primary hiv infection
1499433|NCT00781287|HIV-1|hiv-1
1499435|NCT00781261|collapse femoral head|collapse femoral head
1499436|NCT00781261|bisphosphonates|bisphosphonates
1499437|NCT00781261|osteonecrosis|osteonecrosis
1499438|NCT00781248|enteral feeding|enteral feeding
1499439|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
1499440|NCT00781209|irradiation|irradiation
1499441|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
1499442|NCT00781209|posterior fossa|posterior fossa
1499443|NCT00781209|cerebellar metastases|cerebellar metastases
1499444|NCT00781196|phenytoin|phenytoin
1499445|NCT00781196|gum hyperplasia|gum hyperplasia
1499446|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
1499447|NCT00781196|plaque index|plaque index
1499448|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
1499449|NCT00781183|COPD|copd
1499450|NCT00781183|rehabilitation|rehabilitation
1499451|NCT00781183|walking|walking
1499452|NCT00781170|Multiple Myeloma|multiple myeloma
1499453|NCT00781170|Plasmocytoma|plasmocytoma
1499454|NCT00781170|Stem Cell Transplantation|stem cell transplantation
1499455|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
1499456|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
1499457|NCT00781118|ST Shift|st shift
1499458|NCT00781118|Coronary Occlusion|coronary occlusion
1499459|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
1499460|NCT00781105|Chronic hepatitis B|chronic hepatitis b
1499461|NCT00781105|Adult|adult
1499462|NCT00781105|HBV DNA suppression|hbv dna suppression
1499463|NCT00781105|Telbivudine|telbivudine
1499464|NCT00781092|Dry Eyes|dry eyes
1499465|NCT00781092|LASIK|lasik
1499466|NCT00781092|Laser Vision Correction|laser vision correction
1499467|NCT00781079|Organization Innovation|organization innovation
1499468|NCT00781079|Opinion Leaders|opinion leaders
1499469|NCT00781079|Schizophrenia|schizophrenia
1499470|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
1499471|NCT00781066|PREVENTION|prevention
1499472|NCT00781066|CORD TRACTION|cord traction
1499473|NCT00781066|THIRD STAGE LABOR|third stage labor
1499474|NCT00781053|skin fibrosis|skin fibrosis
1499475|NCT00781053|systemic scleroderma|systemic scleroderma
1499476|NCT00781053|systemic sclerosis|systemic sclerosis
1499477|NCT00781053|p144|p144
1499478|NCT00781053|orphan drug|orphan drug
1499479|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
1499480|NCT00781001|neuropathic pain|neuropathic pain
1499481|NCT00781001|diabetic neuropathy|diabetic neuropathy
1499482|NCT00781001|cannabis|cannabis
1499483|NCT00781001|marijuana|marijuana
1499484|NCT00780975|Aplidin|aplidin
1499485|NCT00780975|Plitidepsin|plitidepsin
1499486|NCT00780975|Prostate|prostate
1499487|NCT00780975|Cancer|cancer
1499488|NCT00780962|NAC|nac
1499489|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
1499490|NCT00780962|N-Acetylcysteine|n-acetylcysteine
1499491|NCT00780962|RCN|rcn
1499492|NCT00780962|RCIN|rcin
1499493|NCT00780962|Creatinine|creatinine
1499494|NCT00780962|Computerized Tomography|computerized tomography
1499495|NCT00780962|CT|ct
1499496|NCT00780962|Emergency Department|emergency department
1499497|NCT00780962|ED|ed
1499498|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
1499499|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
1499500|NCT00780897|GENETIC ANALYSIS|genetic analysis
1499501|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
1499502|NCT00780884|acupuncture|acupuncture
1499503|NCT00780884|schizophrenia|schizophrenia
1499504|NCT00780884|insomnia|insomnia
1499505|NCT00780858|GnRH antagonist|gnrh antagonist
1499507|NCT00780845|Acute Kidney failure|acute kidney failure
1499508|NCT00780845|Clinical outcomes|clinical outcomes
1499509|NCT00780845|On-pump|on-pump
1499510|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
1499511|NCT00780845|Morbidity|morbidity
1499512|NCT00780845|Mortality|mortality
1499513|NCT00780832|overactive bladder|overactive bladder
1499514|NCT00780832|dietary caffeine|dietary caffeine
1499515|NCT00780832|anticholinergic medication|anticholinergic medication
1499516|NCT00780832|lifestyle modification|lifestyle modification
1499517|NCT00780832|incontinence|incontinence
1499518|NCT00780832|urinary frequency|urinary frequency
1499519|NCT00780806|MnB|mnb
1499520|NCT00780806|rLP2086|rlp2086
1499521|NCT00780806|blood collection|blood collection
1499522|NCT00780806|vaccination|vaccination
1499523|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
1499524|NCT00780793|Remission|remission
1499525|NCT00780793|Therapeutic strategy|therapeutic strategy
1499526|NCT00780793|DMARDs|dmards
1499527|NCT00780793|Biological agents|biological agents
1499528|NCT00780780|triamcinolone|triamcinolone
1499529|NCT00780780|nepafenac|nepafenac
1499530|NCT00780780|DME|dme
1499531|NCT00780780|edema macular|edema macular
1499532|NCT00780767|angiojet|angiojet
1499533|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
1499534|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
1499535|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
1499536|NCT00780754|prostate cancer|prostate cancer
1499537|NCT00780754|chemoprevention|chemoprevention
1499538|NCT00780754|dutasteride|dutasteride
1499539|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
1499540|NCT00780741|Simple probing|simple probing
1499541|NCT00780715|Diabetes therapies|diabetes therapies
1499542|NCT00780715|Pharmacogenetics|pharmacogenetics
1499543|NCT00780702|Cocaine|cocaine
1499544|NCT00780702|Treatment|treatment
1499545|NCT00780702|Airpiprazole|airpiprazole
1499546|NCT00780702|Methadone|methadone
1499547|NCT00780702|Relapse|relapse
1499548|NCT00780702|HIV|hiv
1499549|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
1499550|NCT00780702|Contingency Management|contingency management
1499551|NCT00780676|Dasatinib|dasatinib
1499552|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
1499553|NCT00780676|Sprycel|sprycel
1499554|NCT00780676|BMS-354825|bms-354825
1499555|NCT00780676|Genetic testing|genetic testing
1499556|NCT00780676|AZD6244|azd6244
1499557|NCT00780676|Selumetinib|selumetinib
1499558|NCT00780663|Neuroendocrine|neuroendocrine
1499559|NCT00780663|Carcinoid|carcinoid
1499560|NCT00780663|NET|net
1499561|NCT00780663|MEN-1|men-1
1499562|NCT00780663|Islet cell|islet cell
1499563|NCT00780637|Heart Transplant|heart transplant
1499564|NCT00780637|Endothelial Function|endothelial function
1499565|NCT00780637|Fibrinolysis|fibrinolysis
1499566|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
1499567|NCT00780624|RDS|rds
1499568|NCT00780624|Infant, newborn|infant, newborn
1499569|NCT00780624|NIPPV|nippv
1499570|NCT00780624|CPAP|cpap
1499571|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
1499572|NCT00780598|AML|aml
1499573|NCT00780598|Cancer|cancer
1499574|NCT00780598|Hematological malignancies|hematological malignancies
1499575|NCT00780598|Elderly|elderly
1499576|NCT00780598|Refractory|refractory
1499577|NCT00780598|Relapsed|relapsed
1499578|NCT00780598|Blood disorder|blood disorder
1499579|NCT00780572|Safety Management|safety management
1499580|NCT00780572|Risk Management|risk management
1499581|NCT00780572|surveillance|surveillance
1499582|NCT00780572|triggers|triggers
1499583|NCT00780559|Neuropathy|neuropathy
1499584|NCT00780559|diabetes|diabetes
1499585|NCT00780546|tuberculosis|tuberculosis
1499586|NCT00780546|spatial epidemiology|spatial epidemiology
1499587|NCT00780546|geographic information system|geographic information system
1499588|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
1499589|NCT00780481|Obesity|obesity
1499590|NCT00780481|Endothelial Function|endothelial function
1499591|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
1499592|NCT00780481|Baseline|baseline
1499593|NCT00780468|Weight loss|weight loss
1499594|NCT00780468|Diet|diet
1499595|NCT00780468|Obesity|obesity
1499596|NCT00780455|KineSEP|kinesep
1499597|NCT00780455|Rehabilitation|rehabilitation
1499598|NCT00780455|Betaferon|betaferon
1499599|NCT00780442|substance related disorders|substance related disorders
1499600|NCT00780429|kidney|kidney
1499601|NCT00780429|transplant|transplant
1499602|NCT00780429|Mycophenolic acid|mycophenolic acid
1499603|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
1499604|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
1499605|NCT00780416|Protease Inhibitor|protease inhibitor
1499606|NCT00780416|Telaprevir|telaprevir
1499607|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
1499608|NCT00780416|Ribavirin|ribavirin
1499610|NCT00780390|SCS|scs
1499611|NCT00780390|CRPS|crps
1499612|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
1499613|NCT00780377|Heart Transplant|heart transplant
1499614|NCT00780377|Fibrinolysis|fibrinolysis
1499615|NCT00780377|Resting conditions|resting conditions
1499616|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
1499617|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
1499618|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
1499619|NCT00780325|Carbonic anhydrase|carbonic anhydrase
1499620|NCT00780325|Eicosanoids|eicosanoids
1499621|NCT00780325|Healthy volunteers|healthy volunteers
1499622|NCT00780312|radiotherapy|radiotherapy
1499623|NCT00780312|trismus|trismus
1499624|NCT00780312|physiotherapy|physiotherapy
1499625|NCT00780312|lymphoedema|lymphoedema
1499626|NCT00780312|late side effects|late side effects
1499627|NCT00780312|fibrosis|fibrosis
1499628|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
1499629|NCT00780312|quality of life|quality of life
1499630|NCT00780299|Plasma epuration|plasma epuration
1499631|NCT00780299|Hemofiltration|hemofiltration
1499632|NCT00780299|Cardiac arrest|cardiac arrest
1499633|NCT00780299|Shock|shock
1499634|NCT00780299|Inflammatory mediators|inflammatory mediators
1499635|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
1499636|NCT00780260|HIV/AIDS|hiv/aids
1499637|NCT00780260|African Americans|african americans
1499638|NCT00780260|Women|women
1499639|NCT00780260|Case Management|case management
1499640|NCT00780247|Vitamin D|vitamin d
1499641|NCT00780247|Sun|sun
1499642|NCT00780247|Latitude|latitude
1499643|NCT00780247|Vitamin D status|vitamin d status
1499644|NCT00780234|chemoprevention|chemoprevention
1499645|NCT00780234|lung cancer|lung cancer
1499646|NCT00780234|pioglitazone|pioglitazone
1499647|NCT00780221|CRP|crp
1499648|NCT00780221|coronary artery disease|coronary artery disease
1499649|NCT00780221|polymorphisms|polymorphisms
1499650|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
1499651|NCT00780195|hypoglycemia|hypoglycemia
1499652|NCT00780195|African Americans|african americans
1499653|NCT00780182|Bioavailability|bioavailability
1499654|NCT00780156|Drug eluting stent|drug eluting stent
1499655|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
1499656|NCT00780156|bleeding|bleeding
1499657|NCT00780156|stent thrombosis|stent thrombosis
1499658|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
1499659|NCT00780143|Tumor|tumor
1499660|NCT00780143|Leukemia|leukemia
1499661|NCT00780143|Plitidepsin|plitidepsin
1499662|NCT00780143|Aplidin|aplidin
1499663|NCT00780117|CURRARINO syndrome|currarino syndrome
1499664|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
1499665|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
1499666|NCT00780117|Alpha foeto protein|alpha foeto protein
1499667|NCT00780117|Prognosis factors|prognosis factors
1499668|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
1499669|NCT00780104|AML|aml
1499670|NCT00780104|Leukemia|leukemia
1499671|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
1499672|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
1499673|NCT00780104|MEC|mec
1499674|NCT00780104|Rapamycin|rapamycin
1499675|NCT00780104|Sirolimus|sirolimus
1499676|NCT00780091|optimization|optimization
1499677|NCT00780091|risk scale|risk scale
1499678|NCT00780091|non inferiority|non inferiority
1499679|NCT00780091|cluster randomization|cluster randomization
1499680|NCT00780091|monitoring strategies|monitoring strategies
1499681|NCT00780078|Intensive care unit|intensive care unit
1499682|NCT00780078|Extubation failure|extubation failure
1499683|NCT00780078|Physiotherapist|physiotherapist
1499684|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
1499685|NCT00780078|Swallowing disorders|swallowing disorders
1499686|NCT00780052|Hematologic Malignancies|hematologic malignancies
1499687|NCT00780052|c-myb|c-myb
1499688|NCT00780052|c-myb AS ODN|c-myb as odn
1499689|NCT00780026|liver|liver
1499690|NCT00780026|transplant|transplant
1499691|NCT00780026|blood sugar|blood sugar
1499692|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
1499693|NCT00779987|Dry eye|dry eye
1499694|NCT00779987|Autologous serum|autologous serum
1499695|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
1499696|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
1499697|NCT00779974|Osteoarthritis|osteoarthritis
1499698|NCT00779961|pediatric|pediatric
1499699|NCT00779961|cleft palate|cleft palate
1499700|NCT00779961|plastic surgery|plastic surgery
1499701|NCT00779961|palatoplasty|palatoplasty
1499702|NCT00779961|pharyngoplasty|pharyngoplasty
1499703|NCT00779948|Femoral Neck Fracture|femoral neck fracture
1499704|NCT00779948|Internal Fixation|internal fixation
1499705|NCT00779948|Dynamic Hip Screw|dynamic hip screw
1499706|NCT00779922|Multiple Myeloma|multiple myeloma
1499707|NCT00779922|impaired renal function|impaired renal function
1499708|NCT00779909|vitamin D|vitamin d
1499709|NCT00779909|gingivitis|gingivitis
1499710|NCT00779909|periodontal disease|periodontal disease
1499711|NCT00779909|inflammation|inflammation
1499712|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
1499713|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
1499714|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1499715|NCT00779883|CLL|cll
1499716|NCT00779883|Leukemia|leukemia
1499717|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1499718|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
1499719|NCT00779883|Immune System Diseases|immune system diseases
1499720|NCT00779883|ISF35|isf35
1499721|NCT00779883|Ad-ISF35|ad-isf35
1499722|NCT00779883|Immunotherapy|immunotherapy
1499723|NCT00779883|Immune therapy|immune therapy
1499724|NCT00779883|Active immune therapy|active immune therapy
1499725|NCT00779870|asthma severity|asthma severity
1499726|NCT00779870|airway smooth muscle|airway smooth muscle
1499727|NCT00779870|oxidative stress|oxidative stress
1499728|NCT00779857|left atrial appendage|left atrial appendage
1499729|NCT00779857|laa|laa
1499730|NCT00779857|atrial fibrillation|atrial fibrillation
1499731|NCT00779857|afib|afib
1499732|NCT00779857|af|af
1499733|NCT00779857|stroke|stroke
1499734|NCT00779857|tia|tia
1499735|NCT00779844|Anesthesia|anesthesia
1499736|NCT00779844|Obesity|obesity
1499737|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
1499738|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
1499739|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
1499740|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
1499741|NCT00779792|treatment|treatment
1499742|NCT00779792|efficacy|efficacy
1499743|NCT00779792|topical steroids|topical steroids
1499744|NCT00779792|topical immune modulators|topical immune modulators
1499745|NCT00779792|glycerol|glycerol
1499746|NCT00779779|Gastroenteritis|gastroenteritis
1499747|NCT00779766|Human papillomavirus|human papillomavirus
1499748|NCT00779766|vaccine|vaccine
1499749|NCT00779766|cervical cancer|cervical cancer
1499750|NCT00779766|cervical infection|cervical infection
1499751|NCT00779753|Parenteral Feeding|parenteral feeding
1499752|NCT00779753|Neonate|neonate
1499753|NCT00779753|Lysine|lysine
1499754|NCT00779727|women|women
1499755|NCT00779727|increased|increased
1499756|NCT00779727|risk|risk
1499757|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
1499758|NCT00779714|first-line chemotherapy|first-line chemotherapy
1499759|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
1499760|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
1499761|NCT00779701|Hyperglycemia|hyperglycemia
1499762|NCT00779701|Glycemic control|glycemic control
1499763|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1499764|NCT00779688|ERCP|ercp
1499765|NCT00779688|bile duct cancer|bile duct cancer
1499766|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
1499767|NCT00779688|gall bladder|gall bladder
1499768|NCT00779688|pancreas|pancreas
1499769|NCT00779688|duodenoscope|duodenoscope
1499770|NCT00779688|Cellvizio|cellvizio
1499771|NCT00779688|endomicroscopy|endomicroscopy
1499772|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
1499773|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
1499774|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
1499775|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
1499776|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
1499777|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
1499778|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
1499779|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
1499780|NCT00779662|Streptococcus|streptococcus
1499781|NCT00779662|Fiji|fiji
1499782|NCT00779649|Colonoscopy,|colonoscopy,
1499783|NCT00779649|Prep|prep
1499784|NCT00779649|MoviPrep|moviprep
1499785|NCT00779649|HalfLytely|halflytely
1499786|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
1499787|NCT00779597|self care|self care
1499788|NCT00779597|symptom management|symptom management
1499789|NCT00779597|pain|pain
1499790|NCT00779597|cancer|cancer
1499791|NCT00779597|nurse coaching|nurse coaching
1499792|NCT00779597|patient education|patient education
1499793|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
1499794|NCT00779571|Morbid Obesity|morbid obesity
1499795|NCT00779571|Type 2 DM|type 2 dm
1499796|NCT00779571|Coronary heart disease|coronary heart disease
1499797|NCT00779532|Electrocardiography|electrocardiography
1499798|NCT00779532|Pharmacokinetics|pharmacokinetics
1499799|NCT00779519|Obesity|obesity
1499800|NCT00779519|Class 1|class 1
1499801|NCT00779519|Class 2|class 2
1499802|NCT00779519|Weight Loss|weight loss
1499803|NCT00779519|AgRP|agrp
1499804|NCT00779519|TTP435|ttp435
1499805|NCT00779519|alphaMSH|alphamsh
1499806|NCT00779519|Agouti-Related Protein|agouti-related protein
1499807|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
1499808|NCT00779506|Acute schizophrenia|acute schizophrenia
1499809|NCT00779506|PANSS|panss
1499810|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
1499811|NCT00779493|constipation|constipation
1499812|NCT00779493|diarrhea|diarrhea
1499813|NCT00779493|gas|gas
1499814|NCT00779493|bloating|bloating
1499815|NCT00779493|abdominal pain|abdominal pain
1499816|NCT00779493|disturbance of defecation|disturbance of defecation
1499817|NCT00779493|irritable colon|irritable colon
1499818|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
1499819|NCT00779480|Safety|safety
1499820|NCT00779480|Dose Tolerance|dose tolerance
1499821|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
1499822|NCT00779480|FLT-3|flt-3
1499823|NCT00779467|non narcotic|non narcotic
1499824|NCT00779467|epidural|epidural
1499825|NCT00779467|labor pain|labor pain
1499826|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
1499827|NCT00779454|KRAS wild-type|kras wild-type
1499828|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
1499829|NCT00779454|Inoperable|inoperable
1499830|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
1499831|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
1499832|NCT00779415|Partial Thickness|partial thickness
1499833|NCT00779415|Rotator Cuff|rotator cuff
1499834|NCT00779402|cancer|cancer
1499835|NCT00779402|prostate cancer|prostate cancer
1499836|NCT00779402|prostatectomy|prostatectomy
1499837|NCT00779402|PSA|psa
1499838|NCT00779402|sipuleucel-T|sipuleucel-t
1499839|NCT00779402|PROVENGE|provenge
1499840|NCT00779402|APC8015|apc8015
1499841|NCT00779402|non-metastatic|non-metastatic
1499842|NCT00779402|nonmetastatic|nonmetastatic
1499843|NCT00779402|androgen-sensitive|androgen-sensitive
1499844|NCT00779402|androgen sensitive|androgen sensitive
1499845|NCT00779402|biochemical recurrence|biochemical recurrence
1499846|NCT00779402|biochemically recurrent|biochemically recurrent
1499847|NCT00779402|immune therapy|immune therapy
1499848|NCT00779402|immunotherapy|immunotherapy
1499849|NCT00779402|vaccine|vaccine
1499850|NCT00779402|dendritic cells|dendritic cells
1499851|NCT00779402|antigen-presenting cells|antigen-presenting cells
1499852|NCT00779402|antigen presenting cells|antigen presenting cells
1499853|NCT00779402|cancer vaccine|cancer vaccine
1499854|NCT00779402|therapeutic vaccine|therapeutic vaccine
1499855|NCT00779402|therapeutic cancer vaccine|therapeutic cancer vaccine
1499856|NCT00779402|biologic|biologic
1499857|NCT00779402|booster|booster
1499858|NCT00779389|Head and Neck cancer|head and neck cancer
1499859|NCT00779376|Bioequivalence|bioequivalence
1499860|NCT00779363|obese,|obese,
1499861|NCT00779363|Diabetes|diabetes
1499862|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
1499863|NCT00779337|Epstein-Barr virus|epstein-barr virus
1499864|NCT00779337|lymphoma|lymphoma
1499865|NCT00779337|immunotherapy|immunotherapy
1499866|NCT00779324|traumatic brain injury|traumatic brain injury
1499867|NCT00779324|irritability|irritability
1499868|NCT00779324|aggression|aggression
1499869|NCT00779324|amantadine|amantadine
1499870|NCT00779324|behavior|behavior
1499871|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
1499872|NCT00779298|rye whole-meal bread|rye whole-meal bread
1499873|NCT00779298|white-wheat bread|white-wheat bread
1499874|NCT00779298|gastric emptying rate|gastric emptying rate
1499875|NCT00779298|postprandial glucose response|postprandial glucose response
1499876|NCT00779298|healthy subjects|healthy subjects
1499877|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1499878|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
1499879|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
1499880|NCT00779259|quinine sulfate|quinine sulfate
1499881|NCT00779259|theophylline|theophylline
1499882|NCT00779259|drug interactions|drug interactions
1499883|NCT00779259|cytochrome p450|cytochrome p450
1499885|NCT00779259|male|male
1499886|NCT00779259|adult|adult
1499887|NCT00779246|Methicillin resistance|methicillin resistance
1499888|NCT00779246|Infection control|infection control
1499889|NCT00779246|Staphylococcus aureus|staphylococcus aureus
1499890|NCT00779246|Cross infection|cross infection
1499891|NCT00779246|Epidemiology|epidemiology
1499892|NCT00779246|Chlorhexidine|chlorhexidine
1499893|NCT00779233|Bioequivalence|bioequivalence
1499894|NCT00779207|obesity|obesity
1499895|NCT00779207|aging|aging
1499896|NCT00779207|exercise|exercise
1499897|NCT00779207|diet|diet
1499898|NCT00779207|weight loss|weight loss
1499899|NCT00779207|physical function|physical function
1499900|NCT00779207|Obesity in the Elderly|obesity in the elderly
1499901|NCT00779181|Hypertension|hypertension
1499902|NCT00779181|High blood pressure|high blood pressure
1499903|NCT00779181|Htn|htn
1499904|NCT00779181|Addrenex|addrenex
1499905|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
1499906|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1499907|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
1499908|NCT00779103|puberty|puberty
1499909|NCT00779103|precocious puberty|precocious puberty
1499910|NCT00779103|early puberty|early puberty
1499911|NCT00779103|early onset puberty|early onset puberty
1499912|NCT00779103|histrelin|histrelin
1499913|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
1499914|NCT00779103|implant therapy|implant therapy
1499915|NCT00779077|device characteristics|device characteristics
1499916|NCT00779064|Atrial Fibrillation|atrial fibrillation
1499917|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
1499918|NCT00779038|IONSYS|ionsys
1499919|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
1499920|NCT00779038|Postoperative pain|postoperative pain
1499921|NCT00778986|heart failure|heart failure
1499922|NCT00778986|remote patient monitoring|remote patient monitoring
1499923|NCT00778986|telemonitoring|telemonitoring
1499924|NCT00778986|home monitoring|home monitoring
1499925|NCT00778986|randomized controlled trial|randomized controlled trial
1499926|NCT00778986|self care|self care
1499927|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
1499928|NCT00778947|Breast Reconstruction|breast reconstruction
1499929|NCT00778947|Halmonic Scalpel|halmonic scalpel
1499930|NCT00778947|diathermy|diathermy
1499931|NCT00778947|Free Tissue Transfer|free tissue transfer
1499932|NCT00778921|Aliskiren|aliskiren
1499933|NCT00778921|Amlodipine|amlodipine
1499934|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
1499935|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1499936|NCT00778908|Locally advanced disease|locally advanced disease
1499937|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
1499938|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
1499939|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
1499940|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
1499941|NCT00778895|Flu|flu
1499942|NCT00778895|Safety|safety
1499943|NCT00778895|Immunogenicity|immunogenicity
1499944|NCT00778895|Flu vaccine|flu vaccine
1499945|NCT00778895|Influenza|influenza
1499946|NCT00778895|Virus|virus
1499947|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
1499948|NCT00778882|Retroviral Vector|retroviral vector
1499949|NCT00778882|Gene Therapy|gene therapy
1499950|NCT00778843|Chronic hepatitis C|chronic hepatitis c
1499951|NCT00778843|Oxidative stress|oxidative stress
1499952|NCT00778843|Antioxidant|antioxidant
1499953|NCT00778843|Cytokines|cytokines
1499954|NCT00778843|Nutritional supplement|nutritional supplement
1499955|NCT00778830|mCRC|mcrc
1499956|NCT00778804|CVD risk|cvd risk
1499957|NCT00778804|self monitoring|self monitoring
1499958|NCT00778804|Internet|internet
1499959|NCT00778804|telemedicine|telemedicine
1499960|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
1499961|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
1499962|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
1499963|NCT00778752|Multiple Myeloma|multiple myeloma
1499964|NCT00778752|Stem Cell Transplantation|stem cell transplantation
1499965|NCT00778752|Revlimid|revlimid
1499966|NCT00778752|Lenalidomide|lenalidomide
1499967|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
1499968|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
1499969|NCT00778713|Bioequivalence|bioequivalence
1499970|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
1499971|NCT00778661|Bioequivalence|bioequivalence
1499972|NCT00778648|Common cold|common cold
1499973|NCT00778648|prevention|prevention
1499974|NCT00778648|dietary supplement|dietary supplement
1499975|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
1499976|NCT00778609|Pelvic Pain|pelvic pain
1499977|NCT00778609|Headache|headache
1499978|NCT00778596|Hepatitis B|hepatitis b
1656641|NCT00161564|ITP|itp
1499979|NCT00778596|Telbivudine|telbivudine
1499980|NCT00778596|Prednisolone|prednisolone
1499981|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
1499982|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
1499983|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
1499984|NCT00778531|injectable implant|injectable implant
1499985|NCT00778531|nasolabial folds|nasolabial folds
1499986|NCT00778531|Correction of nasolabial folds|correction of nasolabial folds
1499987|NCT00778518|growth hormone|growth hormone
1499988|NCT00778518|growth hormone deficiency|growth hormone deficiency
1499989|NCT00778518|GHD|ghd
1499990|NCT00778518|PEG|peg
1499991|NCT00778518|pegylated|pegylated
1499992|NCT00778518|IGF-1|igf-1
1499993|NCT00778505|Anesthesia|anesthesia
1499994|NCT00778492|Thrombelastogram|thrombelastogram
1499995|NCT00778492|Microvascular bleeding|microvascular bleeding
1499996|NCT00778492|antiplatelet medication|antiplatelet medication
1499997|NCT00778492|cardiac surgery|cardiac surgery
1499998|NCT00778492|consumption of blood products|consumption of blood products
1499999|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
1500000|NCT00778492|postoperative bleeding|postoperative bleeding
1500001|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
1500002|NCT00778453|stroke rehabilitation|stroke rehabilitation
1500003|NCT00778453|kinematic analysis|kinematic analysis
1500004|NCT00778453|upper extremity training|upper extremity training
1500005|NCT00778453|predictors|predictors
1500006|NCT00778440|Injuries|injuries
1500007|NCT00778440|Traffic Injuries|traffic injuries
1500008|NCT00778440|Preventive medicine|preventive medicine
1500009|NCT00778440|Observational studies|observational studies
1500010|NCT00778440|Primary care|primary care
1500011|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
1500012|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
1500013|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
1500014|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1500015|NCT00778375|Leukemia|leukemia
1500016|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
1500017|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
1500018|NCT00778375|AML|aml
1500019|NCT00778375|MDS|mds
1500020|NCT00778375|Clofarabine|clofarabine
1500021|NCT00778375|Ara-C|ara-c
1500022|NCT00778375|Cytarabine|cytarabine
1500023|NCT00778375|Decitabine|decitabine
1500024|NCT00778362|OPSI|opsi
1500025|NCT00778362|Splenectomy|splenectomy
1500026|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
1500027|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
1500028|NCT00778336|DVT|dvt
1500029|NCT00778336|Limb Ischemia|limb ischemia
1500030|NCT00778336|AV Access|av access
1500031|NCT00778336|AngioJet|angiojet
1500032|NCT00778336|Thrombectomy|thrombectomy
1500033|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
1500034|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
1500035|NCT00778323|spinal cord|spinal cord
1500036|NCT00778323|neuron-specific enolase|neuron-specific enolase
1500037|NCT00778323|s-100B|s-100b
1500038|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1500039|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1500040|NCT00778310|ADHD|adhd
1500041|NCT00778297|prevention|prevention
1500042|NCT00778297|influenza|influenza
1500043|NCT00778297|infection|infection
1500044|NCT00778297|vaccine|vaccine
1500045|NCT00778297|Influenza vaccine|influenza vaccine
1500046|NCT00778297|Influenza in humans|influenza in humans
1500047|NCT00778284|Bioequivalence|bioequivalence
1500048|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
1500049|NCT00778258|Food Allergy|food allergy
1500050|NCT00778258|Milk Allergy|milk allergy
1500051|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
1500052|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
1500053|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
1500054|NCT00778206|Phenylketonuria|phenylketonuria
1500055|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
1500056|NCT00778206|PKU|pku
1500057|NCT00778206|Phenylalanine|phenylalanine
1500058|NCT00778193|NSAID|nsaid
1500059|NCT00778193|ulcer|ulcer
1500060|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
1500061|NCT00778193|naproxen|naproxen
1500062|NCT00778193|aspirin|aspirin
1500063|NCT00778193|ASA|asa
1500064|NCT00778193|celecoxib|celecoxib
1500065|NCT00778193|clopidogrel|clopidogrel
1500066|NCT00778193|healing|healing
1500067|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
1500068|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1500069|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1500070|NCT00778193|Wound Healing|wound healing
1500071|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
1500072|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
1500073|NCT00778128|CP-4126|cp-4126
1500074|NCT00778128|Cancer|cancer
1500075|NCT00778128|Metastatic|metastatic
1500076|NCT00778128|Solid tumours|solid tumours
1500077|NCT00778128|Gemzitabine|gemzitabine
1500078|NCT00778128|Gemzar|gemzar
1500079|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
1500080|NCT00778089|skin test|skin test
1500081|NCT00778089|ArteFill|artefill
1500082|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
1500083|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
1500084|NCT00778063|dexmedetomidine|dexmedetomidine
1500085|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
1500086|NCT00778063|myringotomy|myringotomy
1500087|NCT00778063|sevoflurane|sevoflurane
1500088|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
1500089|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
1500090|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
1500091|NCT00778011|Nausea|nausea
1500092|NCT00778011|Vomiting|vomiting
1500093|NCT00778011|Ondansetron|ondansetron
1500094|NCT00778011|Metoclopramide|metoclopramide
1500095|NCT00778011|Randomized|randomized
1500096|NCT00778011|Double-Blind|double-blind
1500097|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
1500098|NCT00777998|Multiple Myeloma|multiple myeloma
1500099|NCT00777998|Stem Cell Transplantation|stem cell transplantation
1500100|NCT00777998|Thalidomide|thalidomide
1500101|NCT00777998|DLI|dli
1500102|NCT00777985|Cardiovascular system|cardiovascular system
1500103|NCT00777985|Sleep|sleep
1500104|NCT00777985|Endothelial function|endothelial function
1500105|NCT00777985|Endothelin system|endothelin system
1500106|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
1500107|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
1500108|NCT00777907|neurovascular embolization|neurovascular embolization
1500109|NCT00777907|therapeutic embolization|therapeutic embolization
1500110|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
1500111|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1500112|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1500113|NCT00777855|warfarin|warfarin
1500114|NCT00777855|pharmacokinetics|pharmacokinetics
1500115|NCT00777855|drug transporter|drug transporter
1500116|NCT00777855|healthy volunteer|healthy volunteer
1500117|NCT00777855|drug interaction|drug interaction
1500118|NCT00777855|rifampin|rifampin
1500119|NCT00777829|Nap|nap
1500120|NCT00777829|Pharmacology|pharmacology
1500121|NCT00777829|Memory|memory
1500122|NCT00777829|Visual Learning|visual learning
1500123|NCT00777829|Verbal Memory|verbal memory
1500124|NCT00777829|Motor Learning|motor learning
1500125|NCT00777816|Rheumatoid|rheumatoid
1500126|NCT00777816|Arthritis|arthritis
1500127|NCT00777790|Meningitis|meningitis
1500128|NCT00777790|Meningococcemia|meningococcemia
1500129|NCT00777790|Neisseria meningitidis|neisseria meningitidis
1500130|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
1500131|NCT00777764|Xolair|xolair
1500132|NCT00777764|Asthma|asthma
1500133|NCT00777764|Skin Tests|skin tests
1500134|NCT00777751|Chest Tumor|chest tumor
1500135|NCT00777751|Heart|heart
1500136|NCT00777751|Lung Cancer|lung cancer
1500137|NCT00777751|Esophageal Cancer|esophageal cancer
1500138|NCT00777751|Thymoma|thymoma
1500139|NCT00777751|Radiation dose to the heart|radiation dose to the heart
1500140|NCT00777751|Cardiac Enzymes|cardiac enzymes
1500141|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
1500142|NCT00777751|Radiation Therapy|radiation therapy
1500143|NCT00777751|RT|rt
1500144|NCT00777751|Electrocardiograms|electrocardiograms
1500145|NCT00777751|ECG|ecg
1500146|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
1500147|NCT00777738|Bortezomib|bortezomib
1500148|NCT00777738|Dexamethasone|dexamethasone
1500149|NCT00777738|Safety|safety
1500150|NCT00777738|Efficacy|efficacy
1500151|NCT00777712|Wound healing|wound healing
1500152|NCT00777712|diabetes|diabetes
1500153|NCT00777712|inflammatory cell|inflammatory cell
1500154|NCT00777712|monocyte|monocyte
1500155|NCT00777712|leukocyte|leukocyte
1500156|NCT00777712|macrophage|macrophage
1500157|NCT00777699|Cancer|cancer
1500158|NCT00777699|Solid Tumors|solid tumors
1500159|NCT00777699|NSCLC|nsclc
1500160|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
1500161|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
1500162|NCT00777686|glioblastoma|glioblastoma
1500163|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
1500164|NCT00777686|gliosarcoma|gliosarcoma
1500165|NCT00777686|brain cancer|brain cancer
1500166|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1500167|NCT00777686|MRS|mrs
1500168|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
1500169|NCT00777686|MRI|mri
1500170|NCT00777686|MRI/MRS|mri/mrs
1500171|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
1500172|NCT00777686|contrast enhanced MRI|contrast enhanced mri
1500173|NCT00777686|DCE-MRI|dce-mri
1500174|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
1500175|NCT00777686|DSC|dsc
1500176|NCT00777686|DW-MRI|dw-mri
1500177|NCT00777673|Breast Cancer|breast cancer
1500178|NCT00777673|Triple Negative|triple negative
1500179|NCT00777673|Neoadjuvant|neoadjuvant
1500180|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
1500181|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
1500182|NCT00777634|Binge Eating Disorder|binge eating disorder
1500183|NCT00777634|Eating Disorder|eating disorder
1500184|NCT00777595|QTc|qtc
1500185|NCT00777595|CHF 4226 HFA|chf 4226 hfa
1500186|NCT00777595|pMDI|pmdi
1500187|NCT00777595|Carmoterol|carmoterol
1500188|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
1500189|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
1500190|NCT00777582|Advanced solid tumours|advanced solid tumours
1500191|NCT00777569|Smoking|smoking
1500192|NCT00777569|PREPS|preps
1500193|NCT00777569|Harm reduction|harm reduction
1500194|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
1500195|NCT00777569|Compensatory smoking|compensatory smoking
1500196|NCT00777543|Bioavailability|bioavailability
1500197|NCT00777543|Ferulic acid|ferulic acid
1500198|NCT00777543|Phenolic compounds|phenolic compounds
1500199|NCT00777543|Colonic metabolites|colonic metabolites
1500200|NCT00777543|Immunomodulatory effects|immunomodulatory effects
1500201|NCT00777543|No disease|no disease
1500202|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
1500203|NCT00777504|angiogenesis|angiogenesis
1500204|NCT00777504|inhibitor|inhibitor
1500205|NCT00777504|duration of therapy|duration of therapy
1500206|NCT00777504|GIST|gist
1500207|NCT00777491|stage II bladder cancer|stage ii bladder cancer
1500208|NCT00777491|stage III bladder cancer|stage iii bladder cancer
1500209|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1500210|NCT00777478|Sunitinib|sunitinib
1500211|NCT00777478|Capecitabine|capecitabine
1500212|NCT00777478|Irinotecan|irinotecan
1500213|NCT00777478|colorectal cancer|colorectal cancer
1500214|NCT00777465|Acute kidney injury|acute kidney injury
1500215|NCT00777465|Kidney failure|kidney failure
1500216|NCT00777465|Risk factors|risk factors
1500217|NCT00777465|Clinical outcomes|clinical outcomes
1500218|NCT00777465|Cardiac valve surgery|cardiac valve surgery
1500219|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
1500220|NCT00777465|Morbidity|morbidity
1500221|NCT00777465|Mortality|mortality
1500222|NCT00777452|quality of life|quality of life
1500223|NCT00777452|localized prostate cancer|localized prostate cancer
1500224|NCT00777452|FACT-P|fact-p
1500225|NCT00777439|Dopamine|dopamine
1500226|NCT00777439|Domperidone|domperidone
1500227|NCT00777439|Gastroparesis|gastroparesis
1500228|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
1500229|NCT00777439|Neurologic Manifestations|neurologic manifestations
1500230|NCT00777439|Stomach Diseases|stomach diseases
1500231|NCT00777439|Digestive System Diseases|digestive system diseases
1500232|NCT00777439|Esophagitis|esophagitis
1500233|NCT00777439|Esophageal Disorders|esophageal disorders
1500234|NCT00777439|Paralysis|paralysis
1500235|NCT00777426|HIV positive with HAD|hiv positive with had
1500236|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
1500237|NCT00777400|Kidney transplant|kidney transplant
1500238|NCT00777400|T regulatory cells|t regulatory cells
1500239|NCT00777400|Efalizumab|efalizumab
1500240|NCT00777400|Rejection|rejection
1500340|NCT00777062|substance abuse|substance abuse
1500241|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
1500242|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
1500243|NCT00777387|slow-freeze|slow-freeze
1500244|NCT00777387|vitrification|vitrification
1500245|NCT00777361|Mass balance|mass balance
1500246|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
1500247|NCT00777322|keratoconus|keratoconus
1500248|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
1500249|NCT00777322|corneal ectasia|corneal ectasia
1500250|NCT00777322|collagen cross-linking|collagen cross-linking
1500251|NCT00777322|riboflavin|riboflavin
1500252|NCT00777322|UV light|uv light
1500253|NCT00777322|excimer laser|excimer laser
1500254|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
1500255|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
1500256|NCT00777309|NSCLC|nsclc
1500257|NCT00777296|Cystic Fibrosis|cystic fibrosis
1500258|NCT00777296|Respiratory Infections|respiratory infections
1500259|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1500260|NCT00777296|CFTR|cftr
1500261|NCT00777270|episiotomy|episiotomy
1500262|NCT00777270|perineal lesion|perineal lesion
1500263|NCT00777270|vaginal trauma|vaginal trauma
1500264|NCT00777257|Meningitis|meningitis
1500265|NCT00777257|Meningococcemia|meningococcemia
1500266|NCT00777257|Pertussis|pertussis
1500267|NCT00777257|Neisseria meningitidis|neisseria meningitidis
1500268|NCT00777257|Tetanus|tetanus
1500269|NCT00777257|Diphtheria|diphtheria
1500270|NCT00777244|mitotane|mitotane
1500271|NCT00777244|adjuvant therapy|adjuvant therapy
1500272|NCT00777244|disease free survival|disease free survival
1500273|NCT00777231|Sickle Cell|sickle cell
1500274|NCT00777231|Stem Cell|stem cell
1500275|NCT00777231|Tolerance|tolerance
1500276|NCT00777231|Bone Marrow Transplant|bone marrow transplant
1500277|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
1500278|NCT00777231|Apheresis|apheresis
1500279|NCT00777231|Aplastic Anemia|aplastic anemia
1500280|NCT00777231|Hemoglobinopathies|hemoglobinopathies
1500281|NCT00777231|Non Malignant|non malignant
1500282|NCT00777218|migraine|migraine
1500283|NCT00777205|Peer Support|peer support
1500284|NCT00777205|Quality of Life|quality of life
1500285|NCT00777205|Telephone|telephone
1500286|NCT00777192|colon cancer|colon cancer
1500287|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
1500288|NCT00777192|Oxaliplatin|oxaliplatin
1500289|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
1500290|NCT00777192|inflammatory cytokines|inflammatory cytokines
1500291|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
1500292|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
1500293|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
1500294|NCT00777166|oxytocin|oxytocin
1500295|NCT00777166|ST depression|st depression
1500296|NCT00777166|cesarean section|cesarean section
1500297|NCT00777166|blood loss|blood loss
1500298|NCT00777153|Cancer|cancer
1500299|NCT00777153|Tumour|tumour
1500300|NCT00777153|Advanced Solid Tumour|advanced solid tumour
1500301|NCT00777153|GBM|gbm
1500302|NCT00777153|Glioblastoma|glioblastoma
1500303|NCT00777140|Stroke|stroke
1500304|NCT00777140|Ischemic Stroke|ischemic stroke
1500305|NCT00777140|Thrombolytic treatment|thrombolytic treatment
1500306|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
1500307|NCT00777140|Deferoxamine|deferoxamine
1500308|NCT00777140|Iron chelator|iron chelator
1500309|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
1500310|NCT00777127|actinic keratosis|actinic keratosis
1500311|NCT00777127|invasive SCC|invasive scc
1500312|NCT00777127|in situ SCC|in situ scc
1500313|NCT00777127|histological classification|histological classification
1500314|NCT00777127|histological progression|histological progression
1500315|NCT00777127|clinical clearance|clinical clearance
1500316|NCT00777127|cryotherapy|cryotherapy
1500317|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
1500318|NCT00777101|HER2|her2
1500319|NCT00777101|ErbB2|erbb2
1500320|NCT00777101|metastatic|metastatic
1500321|NCT00777101|neratinib|neratinib
1500322|NCT00777101|lapatinib|lapatinib
1500323|NCT00777101|capecitabine|capecitabine
1500324|NCT00777101|HKI-272|hki-272
1500325|NCT00777101|Nerlynx|nerlynx
1500326|NCT00777101|PB-272|pb-272
1500327|NCT00777088|neurovascular embolization|neurovascular embolization
1500328|NCT00777088|therapeutic embolization|therapeutic embolization
1500329|NCT00777075|nitrate|nitrate
1500330|NCT00777075|nitric oxide|nitric oxide
1500331|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
1500332|NCT00777075|blood pressure|blood pressure
1500333|NCT00777075|NOS|nos
1500334|NCT00777075|IIEF|iief
1500335|NCT00777062|alcohol|alcohol
1500336|NCT00777062|cocaine|cocaine
1500337|NCT00777062|addiction|addiction
1500338|NCT00777062|alcoholism|alcoholism
1500339|NCT00777062|substance dependence|substance dependence
1500341|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
1500342|NCT00777023|Hot Flashes|hot flashes
1500343|NCT00777023|Hot Flushes|hot flushes
1500344|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
1500345|NCT00777023|Vasomotor symptoms|vasomotor symptoms
1500346|NCT00777010|memory loss|memory loss
1500347|NCT00777010|mild cognitive impairment|mild cognitive impairment
1500348|NCT00777010|forgetfulness|forgetfulness
1500349|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
1500350|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
1500351|NCT00776958|Multi-Center Database Registry|multi-center database registry
1500352|NCT00776958|High Risk|high risk
1500353|NCT00776958|Cancer|cancer
1657072|NCT00160563|Xyzal|xyzal
1500354|NCT00776958|Breast|breast
1500355|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
1500356|NCT00776958|Ovary|ovary
1500357|NCT00776958|Questionnaire|questionnaire
1500358|NCT00776919|Acne Vulgaris|acne vulgaris
1500359|NCT00776919|Acne|acne
1500360|NCT00776880|Surgical operation|surgical operation
1500361|NCT00776867|Pediatric|pediatric
1500362|NCT00776867|solid tumors|solid tumors
1500363|NCT00776867|Pediatric solid tumors|pediatric solid tumors
1500364|NCT00776867|08-091|08-091
1500365|NCT00776841|Phase-I|phase-i
1500366|NCT00776841|Hypercholesterolemia|hypercholesterolemia
1500367|NCT00776841|Obesity|obesity
1500368|NCT00776841|fatty liver|fatty liver
1500369|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
1500370|NCT00776828|cilostazol|cilostazol
1500371|NCT00776828|clopidogrel|clopidogrel
1500372|NCT00776828|statin|statin
1500373|NCT00776828|drug-eluting stent|drug-eluting stent
1500374|NCT00776802|GCS-100|gcs-100
1500375|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
1500376|NCT00776802|DLBCL|dlbcl
1500377|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
1500378|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
1500379|NCT00776789|Skin to skin contact|skin to skin contact
1500380|NCT00776789|Salivary cortisol|salivary cortisol
1500381|NCT00776789|Breast feeding Behavior|breast feeding behavior
1500382|NCT00776776|BMI > 40|bmi > 40
1500383|NCT00776776|Obesity|obesity
1500384|NCT00776776|Adolescents|adolescents
1500385|NCT00776776|Weight Loss Surgery|weight loss surgery
1500386|NCT00776737|Attention Deficit Disorder|attention deficit disorder
1500387|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1500388|NCT00776737|Computer Aided Learning|computer aided learning
1500389|NCT00776737|Attention Deficits|attention deficits
1500390|NCT00776737|Healthy Volunteer|healthy volunteer
1500391|NCT00776737|HV|hv
1500392|NCT00776724|breast ca|breast ca
1500393|NCT00776724|phase III|phase iii
1500394|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
1500395|NCT00776724|stage II/III|stage ii/iii
1500396|NCT00776711|Healthy|healthy
1500397|NCT00776711|Avian Influenza|avian influenza
1500398|NCT00776711|Immunity|immunity
1500399|NCT00776711|Preventive|preventive
1500400|NCT00776711|Bird Flu|bird flu
1500401|NCT00776711|Healthy Volunteer|healthy volunteer
1500402|NCT00776711|HV|hv
1500403|NCT00776711|Influenza|influenza
1500404|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
1500405|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
1500406|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
1500407|NCT00776659|Aromasin|aromasin
1500408|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
1500409|NCT00776633|aspirin|aspirin
1500410|NCT00776633|clopidogrel|clopidogrel
1500411|NCT00776633|oral anticoagulation|oral anticoagulation
1500412|NCT00776633|warfarin|warfarin
1500413|NCT00776633|drug eluting stent|drug eluting stent
1500414|NCT00776633|phenprocoumon|phenprocoumon
1500415|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
1500416|NCT00776607|LADA|lada
1500417|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
1500418|NCT00776607|Type 1.5|type 1.5
1500419|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
1500420|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
1500421|NCT00776594|ADT|adt
1500422|NCT00776594|bevacizumab|bevacizumab
1500423|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
1500424|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
1500425|NCT00776581|Epidural analgesia|epidural analgesia
1500426|NCT00776555|Not required|not required
1500427|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
1500428|NCT00776529|sensorimotor training|sensorimotor training
1500429|NCT00776529|Strengthening|strengthening
1500430|NCT00776529|Balance|balance
1500431|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
1500432|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
1500433|NCT00776516|rifampin|rifampin
1500434|NCT00776516|drug interaction|drug interaction
1500435|NCT00776516|pharmacokinetics|pharmacokinetics
1500436|NCT00776516|YM178|ym178
1500437|NCT00776516|mirabegron|mirabegron
1500438|NCT00776503|Epigenetic|epigenetic
1500439|NCT00776503|Myelodysplasia|myelodysplasia
1500440|NCT00776503|Cytarabine|cytarabine
1500441|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
1500442|NCT00776451|AMD|amd
1500443|NCT00776438|Influenza|influenza
1500444|NCT00776438|Orthomyxoviruses|orthomyxoviruses
1500445|NCT00776438|Myxovirus Infection|myxovirus infection
1500446|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1500447|NCT00776438|Adults|adults
1500448|NCT00776438|Elderly|elderly
1500449|NCT00776412|Immunologic Non-Responder|immunologic non-responder
1500450|NCT00776412|Cardiovascular Disease|cardiovascular disease
1500451|NCT00776412|D-dimer|d-dimer
1500452|NCT00776412|Antiretroviral|antiretroviral
1500453|NCT00776412|Mortality|mortality
1500454|NCT00776412|HIV Positive|hiv positive
1500455|NCT00776412|HIV Negative|hiv negative
1500456|NCT00776412|Healthy Volunteer|healthy volunteer
1500457|NCT00776412|HV|hv
1500458|NCT00776399|Colorectal cancer|colorectal cancer
1500459|NCT00776399|lung metastasis|lung metastasis
1500460|NCT00776399|radiofrequency ablation|radiofrequency ablation
1500461|NCT00776399|metastasectomy|metastasectomy
1500462|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
1500463|NCT00776373|ALL|all
1500464|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
1500465|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1500466|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
1500467|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
1500468|NCT00776373|HiVAC|hivac
1500469|NCT00776373|Rapamycin|rapamycin
1500470|NCT00776360|oxytocin|oxytocin
1500471|NCT00776360|gastroparesis|gastroparesis
1500472|NCT00776360|diabetics|diabetics
1500473|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
1500474|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
1500475|NCT00776347|FDG-PET|fdg-pet
1500476|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
1500477|NCT00776321|hypercholesterolemia|hypercholesterolemia
1500478|NCT00776321|dyslipidemia|dyslipidemia
1500479|NCT00776321|thyroid|thyroid
1500480|NCT00776321|safety|safety
1500481|NCT00776308|molecular breast imaging|molecular breast imaging
1500482|NCT00776308|breast cancer|breast cancer
1500483|NCT00776308|mammography|mammography
1500484|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
1500485|NCT00776295|SCLC|sclc
1500486|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
1500487|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
1500488|NCT00776282|tablets fed conditions|tablets fed conditions
1500489|NCT00776269|Argon laser|argon laser
1500490|NCT00776269|Trichiasis|trichiasis
1500491|NCT00776269|Radiofrequency|radiofrequency
1500492|NCT00776269|Patients with trichiasis|patients with trichiasis
1500493|NCT00776256|satiety|satiety
1500494|NCT00776256|food intake|food intake
1500495|NCT00776243|incretin|incretin
1500496|NCT00776243|GLP-1|glp-1
1500497|NCT00776243|GIP|gip
1500498|NCT00776243|intensive insulin therapy|intensive insulin therapy
1500499|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
1500500|NCT00776204|Coronary Artery Disease|coronary artery disease
1500501|NCT00776204|Drug eluting stent|drug eluting stent
1500502|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
1500503|NCT00776204|Optical Coherence Tomography|optical coherence tomography
1500504|NCT00776191|Physioneal 35|physioneal 35
1500505|NCT00776191|Physioneal 40|physioneal 40
1500506|NCT00776191|children|children
1500507|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
1500508|NCT00776178|Survival Study|survival study
1500509|NCT00776178|Bladder Cancer|bladder cancer
1500510|NCT00776178|Cancer Recurrence|cancer recurrence
1500511|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
1500512|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
1500513|NCT00776126|Breast|breast
1500514|NCT00776126|3D Digital Mammography|3d digital mammography
1500515|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
1500516|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
1500517|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1500518|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1500519|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
1500520|NCT00776100|large cell lung cancer|large cell lung cancer
1500521|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
1500522|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1500523|NCT00776087|Medical costs|medical costs
1500524|NCT00776087|Telemonitoring|telemonitoring
1500525|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1500526|NCT00776074|Leiomyoma|leiomyoma
1500527|NCT00776074|Uterine Fibroids|uterine fibroids
1500528|NCT00776074|Drug Therapy|drug therapy
1500529|NCT00776074|Uterine Neoplasms|uterine neoplasms
1500530|NCT00776074|Fibroid Tumor|fibroid tumor
1500531|NCT00776035|Obesity|obesity
1500532|NCT00776035|Heart|heart
1500533|NCT00776035|Failure|failure
1500534|NCT00776035|PET|pet
1500535|NCT00776035|radiation|radiation
1500536|NCT00776035|metabolism|metabolism
1500537|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
1500538|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
1657348|NCT00158964|pacing|pacing
1500539|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
1500540|NCT00775970|Obesity|obesity
1500541|NCT00775970|Weight loss maintenance|weight loss maintenance
1500542|NCT00775970|Spontaneous physical activity|spontaneous physical activity
1500543|NCT00775970|Lipid oxydation|lipid oxydation
1500544|NCT00775970|Walking|walking
1500545|NCT00775944|Tobacco|tobacco
1500546|NCT00775944|Cigarette|cigarette
1500547|NCT00775944|Smoking|smoking
1500548|NCT00775944|Counselling|counselling
1500549|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
1500550|NCT00775944|Telephone|telephone
1500551|NCT00775944|Quitline|quitline
1500552|NCT00775944|Helpline|helpline
1500553|NCT00775931|osteopetrosis|osteopetrosis
1500554|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
1500555|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
1500556|NCT00775892|ACL|acl
1500557|NCT00775892|Ligament|ligament
1500558|NCT00775879|Général anesthesia|général anesthesia
1500559|NCT00775879|Gynecology|gynecology
1500560|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
1500561|NCT00775853|Biomarkers|biomarkers
1500562|NCT00775853|Catecholamines|catecholamines
1500563|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
1500564|NCT00775853|Fluorodopamine|fluorodopamine
1500565|NCT00775853|Parkinson's Disease|parkinson's disease
1500566|NCT00775853|Parkinson Disease|parkinson disease
1500567|NCT00775853|PD|pd
1500568|NCT00775840|Cardiac Failure|cardiac failure
1500569|NCT00775840|Congestive Heart Failure|congestive heart failure
1500570|NCT00775840|Drug Therapy|drug therapy
1500571|NCT00775840|Hypertension|hypertension
1500572|NCT00775840|Diabetes Mellitus|diabetes mellitus
1500573|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
1500574|NCT00775814|Hypertension|hypertension
1500575|NCT00775814|Drug Therapy|drug therapy
1500576|NCT00775814|Blood Pressure|blood pressure
1500577|NCT00775814|Insulin, Resistant|insulin, resistant
1500578|NCT00775788|Fat Injection to Breast|fat injection to breast
1500579|NCT00775788|Fat Grafting to Breast|fat grafting to breast
1500580|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
1500581|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
1500582|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
1500583|NCT00775749|gynecological surgery|gynecological surgery
1500584|NCT00775749|outpatient surgery|outpatient surgery
1500585|NCT00775749|nicotine patch|nicotine patch
1500586|NCT00775749|laparoscopic surgery|laparoscopic surgery
1500587|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
1500588|NCT00775723|preterm infants|preterm infants
1500589|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
1500590|NCT00775697|wheezing|wheezing
1500591|NCT00775697|children|children
1500592|NCT00775697|montelukast|montelukast
1500593|NCT00775697|bronchodilators|bronchodilators
1500594|NCT00775697|lung function|lung function
1500595|NCT00775697|Rint|rint
1500596|NCT00775684|Exenatide|exenatide
1500597|NCT00775684|Sitagliptin|sitagliptin
1500598|NCT00775684|Glimepiride|glimepiride
1500599|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
1500600|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
1500601|NCT00775684|Type 2 Diabetes|type 2 diabetes
1500602|NCT00775684|Beta-cell Function|beta-cell function
1500603|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
1500604|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
1500605|NCT00775658|allergy|allergy
1500606|NCT00775658|skin testing|skin testing
1500607|NCT00775658|eye drops|eye drops
1500608|NCT00775658|antihistamines|antihistamines
1500609|NCT00775645|neurotoxicity|neurotoxicity
1500610|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1500611|NCT00775645|fatigue|fatigue
1500612|NCT00775645|neuropathy|neuropathy
1500613|NCT00775645|stage IA breast cancer|stage ia breast cancer
1500614|NCT00775645|stage IB breast cancer|stage ib breast cancer
1500615|NCT00775645|stage II breast cancer|stage ii breast cancer
1500616|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
1500617|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
1500618|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
1500619|NCT00775632|Graft Versus Host Disease|graft versus host disease
1500620|NCT00775632|Alemtuzumab|alemtuzumab
1500621|NCT00775632|Campath|campath
1500622|NCT00775632|Bone Marrow Transplants|bone marrow transplants
1500623|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
1500624|NCT00775606|AIDS, HIV|aids, hiv
1500625|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1500626|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
1500627|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1500628|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1500629|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1500630|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1500631|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1500632|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1500633|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1500634|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1500635|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1500636|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1500637|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1500638|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1500639|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1500640|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1500641|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
1500642|NCT00775567|Fructose|fructose
1500643|NCT00775567|Intolerance|intolerance
1500644|NCT00775567|Adaptation|adaptation
1500645|NCT00775567|Prebiotic|prebiotic
1500646|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
1500647|NCT00775541|Diabetes|diabetes
1500648|NCT00775541|Type 2 Diabetes|type 2 diabetes
1500649|NCT00775528|Cystic Fibrosis|cystic fibrosis
1500650|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
1500652|NCT00775515|prostatitis|prostatitis
1500653|NCT00775515|prostate|prostate
1500654|NCT00775515|pain|pain
1500655|NCT00775515|pelvic|pelvic
1500656|NCT00775515|pelvis|pelvis
1500657|NCT00775515|inflamation|inflamation
1500658|NCT00775502|Multiple myeloma|multiple myeloma
1500659|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
1500660|NCT00775502|monoclonal antibody|monoclonal antibody
1500661|NCT00775502|Potelligent design|potelligent design
1500662|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
1500663|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
1500664|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
1500665|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
1500666|NCT00775463|Scleroderma, Limited|scleroderma, limited
1500667|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
1500668|NCT00775463|Ulcer|ulcer
1500669|NCT00775463|prostacyclin|prostacyclin
1500670|NCT00775450|Influenza|influenza
1500671|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
1500672|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1500673|NCT00775450|Elderly|elderly
1500674|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
1500675|NCT00775437|compassionate use|compassionate use
1500676|NCT00775437|open label|open label
1500677|NCT00775424|HIV infection|hiv infection
1500678|NCT00775424|DNA vaccine|dna vaccine
1500679|NCT00775424|IL-12 adjuvant|il-12 adjuvant
1500680|NCT00775424|IL-15 adjuvant|il-15 adjuvant
1500681|NCT00775398|Hemostasis|hemostasis
1500682|NCT00775398|Thrombin-JMI|thrombin-jmi
1500683|NCT00775398|Thrombin|thrombin
1500684|NCT00775398|Blood Coagulation|blood coagulation
1500685|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1500686|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
1500687|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
1500688|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
1500689|NCT00775333|Diabetes|diabetes
1500690|NCT00775333|APB strength|apb strength
1500691|NCT00775333|Sensory Function|sensory function
1500692|NCT00775333|Pillar Pain|pillar pain
1500693|NCT00775333|Cold Intolerance|cold intolerance
1500694|NCT00775333|Patient Satisfaction|patient satisfaction
1500695|NCT00775320|Brain scan|brain scan
1500696|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
1500697|NCT00775307|Stage I|stage i
1500698|NCT00775307|adjuvant therapy|adjuvant therapy
1500699|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
1500700|NCT00775281|Tachykinin receptors|tachykinin receptors
1500701|NCT00775281|Protein expression|protein expression
1500702|NCT00775281|Contractile proteins|contractile proteins
1500703|NCT00775281|Inflammatory proteins|inflammatory proteins
1500704|NCT00775268|18F Fluorothymidine|18f fluorothymidine
1500705|NCT00775268|PET/CT|pet/ct
1500706|NCT00775268|FLT|flt
1500707|NCT00775268|Lymphoma|lymphoma
1500708|NCT00775268|FDG|fdg
1500709|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
1500710|NCT00775242|Menopause|menopause
1501263|NCT00773123|RNFL|rnfl
1500711|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
1500712|NCT00775242|Microspheres|microspheres
1500713|NCT00775242|Progesterone|progesterone
1500714|NCT00775242|Estradiol|estradiol
1500715|NCT00775242|Hot flashes|hot flashes
1500716|NCT00775229|hair pulling|hair pulling
1500717|NCT00775203|Unipolar|unipolar
1500718|NCT00775190|birth control pills|birth control pills
1500719|NCT00775190|oral contraceptives|oral contraceptives
1500720|NCT00775190|brand name|brand name
1500721|NCT00775190|generic|generic
1500722|NCT00775190|side effects|side effects
1500723|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
1500724|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
1500725|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
1500726|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
1500727|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
1500728|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
1500729|NCT00775138|Bronchiectasis|bronchiectasis
1500730|NCT00775138|Respiratory Infections|respiratory infections
1500731|NCT00775138|Amikacin|amikacin
1500732|NCT00775138|Genetic Diseases, Inborn|genetic diseases, inborn
1500733|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
1500734|NCT00775138|Cystic Fibrosis|cystic fibrosis
1500735|NCT00775138|Respiratory Tract Infections|respiratory tract infections
1500736|NCT00775138|Lung Diseases|lung diseases
1500737|NCT00775138|Infant, Newborn, Diseases|infant, newborn, diseases
1500738|NCT00775138|Pancreatic Diseases|pancreatic diseases
1500739|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
1500740|NCT00775125|VX-950-C124|vx-950-c124
1500742|NCT00775125|DDI|ddi
1500743|NCT00775125|telaprevir|telaprevir
1500744|NCT00775125|darunavir|darunavir
1500745|NCT00775125|ritonavir|ritonavir
1500746|NCT00775125|fosamprenavir|fosamprenavir
1500747|NCT00775125|interaction|interaction
1500748|NCT00775125|pharmacokinetics|pharmacokinetics
1500749|NCT00775125|steady-state|steady-state
1500750|NCT00775112|supportive care|supportive care
1500751|NCT00775112|lumbar puncture|lumbar puncture
1500752|NCT00775112|childhood disease|childhood disease
1500753|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
1500754|NCT00775099|Air Pollution|air pollution
1500755|NCT00775099|Particles|particles
1500756|NCT00775099|Particulate Matter|particulate matter
1500757|NCT00775099|Vascular function|vascular function
1500758|NCT00775099|Endothelial function|endothelial function
1500759|NCT00775099|Thrombosis|thrombosis
1500760|NCT00775086|ORTHO EVRA|ortho evra
1500761|NCT00775086|contraception|contraception
1500762|NCT00775086|NGMN|ngmn
1500763|NCT00775086|contraceptive patch|contraceptive patch
1500764|NCT00775086|bioequivalence|bioequivalence
1500765|NCT00775086|EE|ee
1500766|NCT00775086|norelgestromin|norelgestromin
1500767|NCT00775086|ethinyl estradiol|ethinyl estradiol
1500768|NCT00775073|Liver cancer|liver cancer
1500769|NCT00775073|HCC|hcc
1500770|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
1500771|NCT00775047|Depo Provera|depo provera
1500772|NCT00775047|contraceptive compliance|contraceptive compliance
1500773|NCT00775047|pharmacists|pharmacists
1500774|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
1500775|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
1500776|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
1500777|NCT00774995|Engerix-B|engerix-b
1500778|NCT00774995|Hepatitis B|hepatitis b
1500779|NCT00774982|Crohns Disease|crohns disease
1500780|NCT00774982|Pharmacokinetics|pharmacokinetics
1500781|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
1500782|NCT00774982|Delayed Release|delayed release
1500783|NCT00774982|Immunology Measurements|immunology measurements
1500784|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
1500785|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
1500786|NCT00774943|ICOSL|icosl
1500787|NCT00774943|B7RP-1|b7rp-1
1500788|NCT00774943|Costimulation|costimulation
1500789|NCT00774930|Carcinoid tumor|carcinoid tumor
1500790|NCT00774930|Somatuline Depot|somatuline depot
1500791|NCT00774930|Lanreotide Autogel|lanreotide autogel
1500792|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
1500793|NCT00774930|NET|net
1500794|NCT00774930|Diarrhea|diarrhea
1500795|NCT00774930|Flushing|flushing
1500796|NCT00774930|Carcinoid tumour|carcinoid tumour
1500797|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
1500798|NCT00774930|Diarrhoea|diarrhoea
1500799|NCT00774917|numen|numen
1500800|NCT00774917|hyperplasia|hyperplasia
1500801|NCT00774904|Type 2 Diabetes|type 2 diabetes
1500802|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
1500803|NCT00774904|Glucose Metabolism|glucose metabolism
1500804|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1500805|NCT00774891|Echocardiography- exercise|echocardiography- exercise
1500806|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
1500807|NCT00774891|Wall stress|wall stress
1500808|NCT00774891|Ventricular volume-left|ventricular volume-left
1500809|NCT00774891|Ischemia|ischemia
1500810|NCT00774891|Angina|angina
1500811|NCT00774891|Heart diseases|heart diseases
1500812|NCT00774891|Stress echocardiography|stress echocardiography
1500813|NCT00774891|Ventricular volume|ventricular volume
1500814|NCT00774891|Vascular diseases|vascular diseases
1500815|NCT00774878|Breast cancer|breast cancer
1500816|NCT00774878|Breast Tumors|breast tumors
1500817|NCT00774878|Anti IGF-1R|anti igf-1r
1500818|NCT00774878|Hormonosensitivity|hormonosensitivity
1500819|NCT00774865|Robotic|robotic
1500820|NCT00774865|CABG|cabg
1500821|NCT00774865|LITA|lita
1500822|NCT00774865|Patency|patency
1500823|NCT00774865|Long|long
1500824|NCT00774865|Term|term
1500825|NCT00774852|lupus|lupus
1500826|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
1500827|NCT00774852|lupus nephritis|lupus nephritis
1500828|NCT00774852|SLE|sle
1500829|NCT00774852|abatacept|abatacept
1500830|NCT00774852|CTLA4|ctla4
1500831|NCT00774852|CTLA4Ig|ctla4ig
1500832|NCT00774852|glomerulonephritis|glomerulonephritis
1500833|NCT00774839|Newly Diagnosed|newly diagnosed
1500834|NCT00774839|Colon|colon
1500835|NCT00774839|Stage II|stage ii
1500836|NCT00774839|Stage III|stage iii
1500837|NCT00774826|Follicular lymphoma|follicular lymphoma
1500838|NCT00774826|Rituximab|rituximab
1500839|NCT00774813|Depression|depression
1500840|NCT00774813|Mild|mild
1500841|NCT00774813|Moderate|moderate
1500842|NCT00774813|Anxiety|anxiety
1500843|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
1500844|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
1500845|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1500846|NCT00774800|Humalog|humalog
1500847|NCT00774800|Humulin R|humulin r
1500848|NCT00774800|rHuPH20|rhuph20
1500849|NCT00774800|Hylenex|hylenex
1500850|NCT00774787|Combination treatment|combination treatment
1500851|NCT00774787|Imiquimod|imiquimod
1500852|NCT00774787|Cryotherapy|cryotherapy
1500853|NCT00774774|Influenza, human|influenza, human
1500854|NCT00774774|Masks|masks
1500855|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
1500856|NCT00774761|Chronic|chronic
1500857|NCT00774761|Obstructive|obstructive
1500858|NCT00774761|Pulmonary|pulmonary
1500859|NCT00774761|Disease|disease
1500860|NCT00774761|COPD|copd
1500861|NCT00774761|Pharmacodynamic|pharmacodynamic
1500862|NCT00774761|Pharmacokinetic|pharmacokinetic
1500863|NCT00774748|low molecular weight heparin|low molecular weight heparin
1500864|NCT00774748|enoxaparin|enoxaparin
1500865|NCT00774748|Lovenox|lovenox
1500866|NCT00774748|Insuflon|insuflon
1500867|NCT00774748|subcutaneous catheter|subcutaneous catheter
1500868|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
1500869|NCT00774735|healthy volunteer|healthy volunteer
1500870|NCT00774735|darunavir|darunavir
1500871|NCT00774735|lopinavir|lopinavir
1500872|NCT00774735|ritonavir|ritonavir
1500873|NCT00774735|GSK1349572|gsk1349572
1500874|NCT00774735|integrase|integrase
1500875|NCT00774735|pharmacokinetics|pharmacokinetics
1500876|NCT00774709|Heart failure|heart failure
1500877|NCT00774709|Preserved ejection fraction|preserved ejection fraction
1500878|NCT00774709|Diastolic dysfunction|diastolic dysfunction
1500879|NCT00774709|Dyssynchrony|dyssynchrony
1500880|NCT00774709|Echocardiography|echocardiography
1500881|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
1500882|NCT00774709|diagnosed|diagnosed
1500883|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
1501118|NCT00773747|Hematologic Diseases|hematologic diseases
1500884|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
1500885|NCT00774709|≥ 45%)|≥ 45%)
1500886|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
1500887|NCT00774683|Pilot|pilot
1500888|NCT00774683|Pharmacokinetics|pharmacokinetics
1500889|NCT00774683|Raltegravir|raltegravir
1500890|NCT00774683|Cervicovaginal|cervicovaginal
1500891|NCT00774683|HIV|hiv
1500892|NCT00774683|Women|women
1500893|NCT00774657|Aortic Stenosis|aortic stenosis
1500894|NCT00774657|Valvular heart disease|valvular heart disease
1500895|NCT00774657|Heart disease|heart disease
1500896|NCT00774657|Cardiovascular disease|cardiovascular disease
1500897|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
1500898|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
1500899|NCT00774631|Meningitis|meningitis
1500900|NCT00774631|Hypothermia|hypothermia
1500901|NCT00774631|Intensive care|intensive care
1500902|NCT00774618|Rib Fracture|rib fracture
1500903|NCT00774618|Thoracic Injuries|thoracic injuries
1500904|NCT00774618|Flail Chest|flail chest
1500905|NCT00774618|Rib Fracture Repair|rib fracture repair
1500906|NCT00774618|Rib Fracture ORIF|rib fracture orif
1500907|NCT00774618|Chronic rib fractures|chronic rib fractures
1501553|NCT00771927|Lacosamide|lacosamide
1500908|NCT00774618|Non-healing rib fractures|non-healing rib fractures
1500909|NCT00774618|Rib Fracture Non-union|rib fracture non-union
1500910|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
1500911|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
1500912|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
1500913|NCT00774592|Behavioral Change|behavioral change
1500914|NCT00774592|HIV|hiv
1500915|NCT00774579|growth hormone|growth hormone
1500916|NCT00774579|growth hormone deficiency|growth hormone deficiency
1500917|NCT00774579|liver fat|liver fat
1500918|NCT00774579|liver steatosis|liver steatosis
1500919|NCT00774579|growth hormone replacement|growth hormone replacement
1500920|NCT00774566|catheter ablation|catheter ablation
1500921|NCT00774566|randomized|randomized
1500922|NCT00774566|cryo|cryo
1500923|NCT00774566|radiofrequency|radiofrequency
1500924|NCT00774566|atrial fibrillation|atrial fibrillation
1500925|NCT00774566|cryo-balloon|cryo-balloon
1500926|NCT00774566|PV-Isolation|pv-isolation
1500927|NCT00774553|Type 2 diabetes|type 2 diabetes
1500928|NCT00774540|Acute pain|acute pain
1500929|NCT00774540|Inflammatory pain|inflammatory pain
1500930|NCT00774540|Inflammatory mediators|inflammatory mediators
1500931|NCT00774540|Pain relief|pain relief
1500932|NCT00774540|Microdialysis|microdialysis
1500933|NCT00774514|Air Pollution|air pollution
1500934|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
1500935|NCT00774514|NO2|no2
1500936|NCT00774514|Endothelial dysfunction|endothelial dysfunction
1500937|NCT00774501|Anesthesia|anesthesia
1500938|NCT00774501|suspended ventilation|suspended ventilation
1500939|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
1500940|NCT00774488|fat biopsies|fat biopsies
1500941|NCT00774488|microarray analysis|microarray analysis
1500942|NCT00774488|quantitative real time PCR|quantitative real time pcr
1500943|NCT00774488|overnutrition|overnutrition
1500944|NCT00774488|low grade-inflammation|low grade-inflammation
1500945|NCT00774475|Clopidogrel therapy|clopidogrel therapy
1500946|NCT00774475|platelet function inhibition|platelet function inhibition
1500947|NCT00774462|Myositis|myositis
1500948|NCT00774462|Anti-synthetase|anti-synthetase
1500949|NCT00774462|Anti-SRP|anti-srp
1500950|NCT00774462|Myasthenia gravis|myasthenia gravis
1500951|NCT00774462|Rituximab|rituximab
1500952|NCT00774449|lung transplantation|lung transplantation
1500953|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1500954|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
1500955|NCT00774449|high-resolution computertomography|high-resolution computertomography
1500956|NCT00774449|quality of life|quality of life
1500957|NCT00774436|focal cryotherapy|focal cryotherapy
1500958|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
1500959|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
1500960|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
1500961|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
1500962|NCT00774423|Riluzole|riluzole
1500963|NCT00774384|Neisseria meningitidis|neisseria meningitidis
1500964|NCT00774384|Mucosal|mucosal
1500965|NCT00774384|Vaccination|vaccination
1500966|NCT00774384|Immunity|immunity
1500967|NCT00774384|T cells|t cells
1500968|NCT00774384|T regulatory cells|t regulatory cells
1500969|NCT00774371|Overweight|overweight
1500970|NCT00774371|Obese|obese
1500971|NCT00774371|Breast cancer survivors|breast cancer survivors
1500972|NCT00774371|Weight loss|weight loss
1500973|NCT00774371|Physical activity|physical activity
1500974|NCT00774371|Exercise|exercise
1500975|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
1500976|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
1500977|NCT00774319|HNSCC|hnscc
1500978|NCT00774319|neo Adjuvant|neo adjuvant
1500979|NCT00774319|Chemoradiation therapy|chemoradiation therapy
1500980|NCT00774319|TPF|tpf
1500981|NCT00774306|vascular risk|vascular risk
1500982|NCT00774306|lipid fractions|lipid fractions
1500983|NCT00774306|lipoprotein(a)|lipoprotein(a)
1500984|NCT00774306|C-reactive protein|c-reactive protein
1500985|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
1500986|NCT00774306|antiepileptic drug|antiepileptic drug
1500987|NCT00774306|randomized|randomized
1500988|NCT00774306|seizure|seizure
1500989|NCT00774306|cholesterol|cholesterol
1500990|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
1500991|NCT00774293|heart surgery,|heart surgery,
1500992|NCT00774293|randomized clinical trial|randomized clinical trial
1500993|NCT00774254|Health Disparities|health disparities
1500994|NCT00774254|Risk Communication|risk communication
1500995|NCT00774254|Numeracy|numeracy
1500996|NCT00774254|Doctor-Patient Communication|doctor-patient communication
1500997|NCT00774254|Virtual Reality Technology|virtual reality technology
1500998|NCT00774254|Communication|communication
1500999|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
1501000|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
1501001|NCT00774215|Cystocele|cystocele
1501002|NCT00774215|Rectocele|rectocele
1501003|NCT00774215|Enterocele|enterocele
1501004|NCT00774215|Synthetic Mesh|synthetic mesh
1501005|NCT00774215|Vaginal Mesh|vaginal mesh
1501006|NCT00774215|Transobturator|transobturator
1501007|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
1501008|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
1501009|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1501010|NCT00774176|COPD|copd
1501011|NCT00774176|COPD Exacerbation|copd exacerbation
1501012|NCT00774176|Genetic markers COPD|genetic markers copd
1501013|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
1501014|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
1501015|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
1501016|NCT00774176|COPD Treatment|copd treatment
1501017|NCT00774176|Breathing disorders|breathing disorders
1501018|NCT00774176|Emphysema|emphysema
1501019|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
1501020|NCT00774163|probiotics|probiotics
1501021|NCT00774163|lactobacillus|lactobacillus
1501022|NCT00774163|reuteri|reuteri
1501023|NCT00774163|none (safety only)|none (safety only)
1501024|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
1501025|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
1501026|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
1501027|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
1501028|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
1501029|NCT00774137|Acute Kidney Injury|acute kidney injury
1501030|NCT00774137|IL-18|il-18
1501031|NCT00774137|NGAL|ngal
1501032|NCT00774137|Cystatin C|cystatin c
1501033|NCT00774137|Biomarkers|biomarkers
1501034|NCT00774137|Dialysis|dialysis
1501035|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
1501036|NCT00774111|healthy volunteer|healthy volunteer
1501037|NCT00774111|pharmacokinetics|pharmacokinetics
1501038|NCT00774111|GSK1349572|gsk1349572
1501039|NCT00774111|integrase|integrase
1501040|NCT00774111|etravirine|etravirine
1501041|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
1501042|NCT00774085|Schizophrenia|schizophrenia
1501043|NCT00774085|Risperidone|risperidone
1501044|NCT00774085|Risperdal Consta|risperdal consta
1501045|NCT00774085|Propective|propective
1501046|NCT00774085|Retrospective|retrospective
1501047|NCT00774085|Mental disorders|mental disorders
1501048|NCT00774085|Observational|observational
1501049|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
1501050|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
1501051|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
1501052|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
1501053|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
1501054|NCT00774033|Keratinocytes|keratinocytes
1501055|NCT00774033|Cell spray|cell spray
1501056|NCT00774033|Deep partial thickness burns|deep partial thickness burns
1501057|NCT00774033|Full thickness burns|full thickness burns
1501058|NCT00774020|Paget's Disease of Bone|paget's disease of bone
1501059|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
1501060|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
1501061|NCT00773994|anterior palatal eminence|anterior palatal eminence
1501062|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
1501063|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
1501064|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
1501065|NCT00773981|anastomotic leakage|anastomotic leakage
1501066|NCT00773942|Medication therapy management|medication therapy management
1501067|NCT00773942|Pharmacist|pharmacist
1501068|NCT00773942|Chronic care|chronic care
1501069|NCT00773942|Medicare|medicare
1501070|NCT00773942|Medicaid|medicaid
1501071|NCT00773942|Medication reconciliation|medication reconciliation
1501072|NCT00773942|Adverse drug events|adverse drug events
1501073|NCT00773942|Drug related problems|drug related problems
1501074|NCT00773916|Attention Deficit Disorder|attention deficit disorder
1501075|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1501076|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
1501077|NCT00773916|Family Function|family function
1501078|NCT00773916|Adverse Factors|adverse factors
1501079|NCT00773916|Parental Psychopathology|parental psychopathology
1501080|NCT00773877|RNFL thickness|rnfl thickness
1501081|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
1501082|NCT00773851|ventral hernia|ventral hernia
1501083|NCT00773851|laparoscopy|laparoscopy
1501084|NCT00773851|mesh|mesh
1501085|NCT00773851|recurrence|recurrence
1501086|NCT00773825|Genomic imprinting|genomic imprinting
1501554|NCT00771927|LCM|lcm
1501087|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
1501088|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
1501089|NCT00773825|Angelman syndrome|angelman syndrome
1501090|NCT00773812|Autistic Disorder|autistic disorder
1501091|NCT00773812|Autism|autism
1501092|NCT00773812|Mecamylamine|mecamylamine
1501093|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
1501094|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
1501095|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
1501096|NCT00773799|ESBL producers|esbl producers
1501097|NCT00773799|MRSA|mrsa
1501098|NCT00773786|COPD|copd
1501099|NCT00773786|Bronchodilator|bronchodilator
1501100|NCT00773786|arformoterol|arformoterol
1501101|NCT00773786|tiotropium|tiotropium
1501102|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
1501103|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
1501104|NCT00773773|08-114|08-114
1501105|NCT00773760|opioids|opioids
1501106|NCT00773760|COMT|comt
1501107|NCT00773760|SNP|snp
1501108|NCT00773760|analgesia|analgesia
1501109|NCT00773760|postoperative pain|postoperative pain
1501110|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
1501111|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
1501112|NCT00773747|Neoplasms|neoplasms
1501113|NCT00773747|Hemostatic Disorders|hemostatic disorders
1501114|NCT00773747|Vascular Diseases|vascular diseases
1501115|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
1501116|NCT00773747|Paraproteinemias|paraproteinemias
1501117|NCT00773747|Blood Protein Disorders|blood protein disorders
1501119|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
1501120|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
1501121|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
1501122|NCT00773747|Immune System Diseases|immune system diseases
1501123|NCT00773747|Vorinostat|vorinostat
1501124|NCT00773747|Bortezomib|bortezomib
1501125|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1501126|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
1501127|NCT00773747|Analgesics|analgesics
1501128|NCT00773747|Sensory System Agents|sensory system agents
1501129|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
1501130|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
1501131|NCT00773747|Pharmacologic Actions|pharmacologic actions
1501132|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
1501133|NCT00773747|Therapeutic Uses|therapeutic uses
1501134|NCT00773747|Antirheumatic Agents|antirheumatic agents
1501135|NCT00773747|Antineoplastic Agents|antineoplastic agents
1501136|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
1501137|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1501138|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
1501139|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
1501140|NCT00773708|HIV infection|hiv infection
1501141|NCT00773708|Discordant patient|discordant patient
1501142|NCT00773708|CD4 recovery|cd4 recovery
1501143|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
1501144|NCT00773708|raltegravir|raltegravir
1501145|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
1501146|NCT00773682|osteoarthritis|osteoarthritis
1501148|NCT00773682|mud-packs therapy|mud-packs therapy
1501149|NCT00773682|balneotherapy|balneotherapy
1501150|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
1501151|NCT00773669|male breast cancer|male breast cancer
1501152|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
1501153|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
1501154|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
1501155|NCT00773656|Radiotherapy|radiotherapy
1501156|NCT00773656|Biologically effective dose|biologically effective dose
1501157|NCT00773656|Radiation injury|radiation injury
1501158|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
1501159|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
1501160|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
1501161|NCT00773617|Bulimia Nervosa|bulimia nervosa
1501162|NCT00773617|Treatment Efficacy|treatment efficacy
1501163|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
1501164|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
1501165|NCT00773604|blepharospasm|blepharospasm
1501166|NCT00773604|Deep brain Stimulation|deep brain stimulation
1501555|NCT00771927|epilepsy|epilepsy
1501167|NCT00773604|cervical dystonia|cervical dystonia
1501168|NCT00773604|cranial dystonia|cranial dystonia
1501169|NCT00773604|generalized dystonia|generalized dystonia
1501170|NCT00773604|subthalamic nucleus|subthalamic nucleus
1501172|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
1501173|NCT00773591|Snoring|snoring
1501174|NCT00773578|Children|children
1501175|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
1501176|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
1501177|NCT00773578|Nasal lavage|nasal lavage
1501178|NCT00773578|Cytokines|cytokines
1501179|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
1501180|NCT00773552|OAB|oab
1501181|NCT00773552|overactive bladder|overactive bladder
1501182|NCT00773552|urinary urge|urinary urge
1501183|NCT00773552|urge incontinence|urge incontinence
1501184|NCT00773552|urge|urge
1501185|NCT00773539|atrial fibrillation|atrial fibrillation
1501186|NCT00773539|pulmonary veins|pulmonary veins
1501187|NCT00773539|ablation|ablation
1501188|NCT00773500|Medication Errors|medication errors
1501189|NCT00773487|Asthma GINA 1|asthma gina 1
1501190|NCT00773487|Mild intermittant asthma|mild intermittant asthma
1501191|NCT00773448|Cancer|cancer
1501192|NCT00773448|Screening|screening
1501193|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
1501194|NCT00773435|Children|children
1501195|NCT00773435|Echinacea|echinacea
1501196|NCT00773435|Prevention|prevention
1501197|NCT00773435|Immune modulation|immune modulation
1501198|NCT00773422|smoking lapse behavior|smoking lapse behavior
1501199|NCT00773422|smoking cessation|smoking cessation
1501200|NCT00773422|varenicline|varenicline
1501201|NCT00773422|naltrexone|naltrexone
1501202|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
1501203|NCT00773370|stroke|stroke
1501204|NCT00773370|exercise|exercise
1501205|NCT00773357|smoking lapse behavior|smoking lapse behavior
1501206|NCT00773357|smoking cessation|smoking cessation
1501207|NCT00773357|guanfacine|guanfacine
1501208|NCT00773357|carvedilol|carvedilol
1501209|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
1501604|NCT00771810|Cytopenia|cytopenia
1501210|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
1501211|NCT00773357|stress|stress
1501212|NCT00773357|gender differences|gender differences
1501213|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
1501214|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
1501215|NCT00773318|LM/SL|lm/sl
1501216|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
1501217|NCT00773305|seed implantation|seed implantation
1501218|NCT00773292|HAM/TSP|ham/tsp
1501219|NCT00773266|Aphakia|aphakia
1501220|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
1501221|NCT00773266|Iris-Fixated IOL|iris-fixated iol
1501222|NCT00773266|Artisan|artisan
1501223|NCT00773266|Anterior Segment OCT|anterior segment oct
1501224|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
1501225|NCT00773253|dystonia|dystonia
1501226|NCT00773253|cervical dystonia|cervical dystonia
1501227|NCT00773253|Botox|botox
1501228|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
1501229|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
1501230|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
1501231|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
1501232|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
1501233|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
1501234|NCT00773227|Autologous myoblasts|autologous myoblasts
1501235|NCT00773227|Autograft|autograft
1501236|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
1501237|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
1501238|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
1501239|NCT00773214|Obesity|obesity
1501240|NCT00773214|Appetite|appetite
1501241|NCT00773214|Body composition|body composition
1501242|NCT00773214|Energy compensation|energy compensation
1501243|NCT00773201|Long QT syndrome|long qt syndrome
1501244|NCT00773201|Cardiac repolarisation|cardiac repolarisation
1501245|NCT00773201|Genome-wide association|genome-wide association
1501246|NCT00773201|Electrophysiology|electrophysiology
1501247|NCT00773201|Drugs/adverse effects|drugs/adverse effects
1501248|NCT00773175|pediatric|pediatric
1501249|NCT00773175|hylenex|hylenex
1501250|NCT00773175|subcutaneous infusion|subcutaneous infusion
1501251|NCT00773175|hyaluronidase|hyaluronidase
1501252|NCT00773175|rHuPH20|rhuph20
1501253|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
1501254|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
1501255|NCT00773149|Alemtuzumab|alemtuzumab
1501256|NCT00773136|Bimatoprost|bimatoprost
1501257|NCT00773136|Eyelash lengthening|eyelash lengthening
1501258|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
1501259|NCT00773136|Cosmetics|cosmetics
1501260|NCT00773123|RT-View|rt-view
1501261|NCT00773123|Spectral domain OCT|spectral domain oct
1501262|NCT00773123|Ganglion cell layer|ganglion cell layer
1501264|NCT00773123|Visual field defect|visual field defect
1501265|NCT00773110|hemolysis|hemolysis
1501266|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1501267|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
1501268|NCT00773110|albumin|albumin
1501269|NCT00773097|Prevention|prevention
1501270|NCT00773097|Colorectal Cancer|colorectal cancer
1501271|NCT00773084|Diastolic Heart Failure|diastolic heart failure
1501272|NCT00773084|Hispanic Americans|hispanic americans
1501273|NCT00773084|Aliskiren|aliskiren
1501274|NCT00773084|Spironolactone|spironolactone
1501275|NCT00773084|Lisinopril|lisinopril
1501276|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
1501277|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
1501278|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
1501279|NCT00773058|glucocorticoid|glucocorticoid
1501280|NCT00773058|adrenal insufficiency|adrenal insufficiency
1501281|NCT00773045|pain scores|pain scores
1501282|NCT00773045|critically ill patients|critically ill patients
1501283|NCT00773045|ICU|icu
1501284|NCT00773045|pain management|pain management
1501285|NCT00773045|pain measurement|pain measurement
1501286|NCT00773019|infusion pump|infusion pump
1501287|NCT00773019|implantable|implantable
1501288|NCT00773019|performance|performance
1501289|NCT00773006|coronary artery disease|coronary artery disease
1501290|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
1501291|NCT00773006|anticoagulation|anticoagulation
1501292|NCT00772993|glaucoma|glaucoma
1501293|NCT00772993|myopia|myopia
1501294|NCT00772993|myopia with glaucoma|myopia with glaucoma
1501295|NCT00772993|normal control|normal control
1501296|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
1501297|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
1501298|NCT00772928|Pertussis|pertussis
1501299|NCT00772928|Whooping cough|whooping cough
1501300|NCT00772928|Diphtheria|diphtheria
1501301|NCT00772928|Tetanus|tetanus
1501302|NCT00772928|Haemophilus influenzae|haemophilus influenzae
1501303|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
1501304|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
1501305|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
1501306|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
1501307|NCT00772902|HIV-1|hiv-1
1501308|NCT00772902|LDL|ldl
1501309|NCT00772902|HDL|hdl
1501310|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
1501311|NCT00772902|triglycerides|triglycerides
1501312|NCT00772902|cholesterol|cholesterol
1501313|NCT00772889|Elderly|elderly
1501314|NCT00772889|Vaccine|vaccine
1501315|NCT00772889|Influenza|influenza
1501316|NCT00772876|P1446A-05|p1446a-05
1501317|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
1501318|NCT00772876|Phase I|phase i
1501319|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
1501320|NCT00772837|Functional Dyspepsia|functional dyspepsia
1501321|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
1501322|NCT00772837|Quality of Life|quality of life
1501323|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
1501324|NCT00772824|Breast cancer|breast cancer
1501325|NCT00772824|Chemotherapy|chemotherapy
1501326|NCT00772824|Epirubicin|epirubicin
1501327|NCT00772824|Glutamine|glutamine
1501328|NCT00772824|FEC chemotherapy|fec chemotherapy
1501329|NCT00772798|ovarian cancer|ovarian cancer
1501330|NCT00772798|HDAC inhibitor|hdac inhibitor
1501331|NCT00772798|vorinostat|vorinostat
1501332|NCT00772785|opioid dependence|opioid dependence
1501333|NCT00772785|opioid addiction|opioid addiction
1501334|NCT00772785|buprenorphine|buprenorphine
1501335|NCT00772785|methadone|methadone
1501336|NCT00772785|heroin|heroin
1501337|NCT00772785|implant|implant
1501338|NCT00772785|opioid withdrawal|opioid withdrawal
1501339|NCT00772785|opioid pain medication|opioid pain medication
1501340|NCT00772785|suboxone|suboxone
1501341|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
1501342|NCT00772772|levels of endotoxin|levels of endotoxin
1501343|NCT00772772|intestinal permeability|intestinal permeability
1501344|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
1501345|NCT00772759|AZD3199|azd3199
1501346|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
1501347|NCT00772759|Phase I study|phase i study
1501348|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
1501349|NCT00772759|safety|safety
1501350|NCT00772759|tolerability|tolerability
1501351|NCT00772759|PK|pk
1501352|NCT00772746|panic|panic
1501353|NCT00772746|respiration|respiration
1501354|NCT00772746|anxiety|anxiety
1501355|NCT00772746|exercise|exercise
1501356|NCT00772746|cognition|cognition
1501357|NCT00772733|Quality assurance|quality assurance
1501358|NCT00772733|rehabilitation|rehabilitation
1501359|NCT00772733|chronic care model|chronic care model
1501360|NCT00772733|COPD|copd
1501361|NCT00772707|contact lens solution|contact lens solution
1501362|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
1501363|NCT00772707|contact lenses|contact lenses
1501556|NCT00771927|epilepsies|epilepsies
1501364|NCT00772694|testicular cancer|testicular cancer
1501365|NCT00772694|germ cell cancer|germ cell cancer
1501366|NCT00772694|sorafenib|sorafenib
1501367|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1501368|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1501369|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1501370|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1501371|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1501372|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1501373|NCT00772655|Follicular Lymphoma|follicular lymphoma
1501374|NCT00772655|First line therapy|first line therapy
1501375|NCT00772655|Zevalin|zevalin
1501376|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
1501377|NCT00772655|Yttrium|yttrium
1501378|NCT00772655|Rituximab|rituximab
1501379|NCT00772655|Radio-immuno therapy|radio-immuno therapy
1501380|NCT00772642|Cross-Sectional|cross-sectional
1501381|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
1501382|NCT00772642|Cord Blood|cord blood
1501383|NCT00772642|Immunology|immunology
1501384|NCT00772642|Mali|mali
1501385|NCT00772642|Malaria|malaria
1501386|NCT00772629|Menactra®|menactra®
1501387|NCT00772629|Meningitis|meningitis
1501388|NCT00772629|Meningococcemia|meningococcemia
1501389|NCT00772629|Neisseria meningitidis|neisseria meningitidis
1501390|NCT00772616|Anesthesia|anesthesia
1501391|NCT00772616|Analgesia|analgesia
1501392|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
1501393|NCT00772616|Hyperalgesia|hyperalgesia
1501394|NCT00772603|Partial onset epilepsy|partial onset epilepsy
1501395|NCT00772603|Partial onset seizures|partial onset seizures
1501397|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
1501398|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
1501399|NCT00772590|virological suppression|virological suppression
1501400|NCT00772590|bovine colostrum|bovine colostrum
1501401|NCT00772590|raltegravir|raltegravir
1501497|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
1501498|NCT00772174|Type II Diabetes|type ii diabetes
1501603|NCT00771810|Thrombocytopenia|thrombocytopenia
1501402|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
1501403|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
1501404|NCT00772525|Visual acuity|visual acuity
1501405|NCT00772525|Contrast sensitivity|contrast sensitivity
1501406|NCT00772525|Visual Evoked Potentials|visual evoked potentials
1501407|NCT00772525|Optical Coherence Tomography|optical coherence tomography
1501408|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
1501409|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1501410|NCT00772486|Leukemia|leukemia
1501411|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1501412|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
1501413|NCT00772486|Immune System Diseases|immune system diseases
1501414|NCT00772486|Rituximab|rituximab
1501415|NCT00772486|Fludarabine|fludarabine
1501416|NCT00772486|Cyclophosphamide|cyclophosphamide
1501417|NCT00772486|ISF35|isf35
1501418|NCT00772486|Ad-ISF35|ad-isf35
1501419|NCT00772486|Refractory|refractory
1501420|NCT00772486|Resistant|resistant
1501421|NCT00772486|17p-|17p-
1501422|NCT00772486|del 17p|del 17p
1501424|NCT00772486|Resistant CLL|resistant cll
1501425|NCT00772486|Refractory CLL|refractory cll
1501426|NCT00772486|17p- CLL|17p- cll
1501427|NCT00772486|CLL|cll
1501428|NCT00772460|patient warming|patient warming
1501429|NCT00772460|convective warming|convective warming
1501430|NCT00772460|conductive warming|conductive warming
1501431|NCT00772460|intraoperative normothermia|intraoperative normothermia
1501432|NCT00772460|accidental hypothermia|accidental hypothermia
1501433|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
1501434|NCT00772447|Skin Infections|skin infections
1501435|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
1501436|NCT00772421|Epilepsy|epilepsy
1501437|NCT00772421|Recruitment rhythm|recruitment rhythm
1501438|NCT00772421|DBS|dbs
1501439|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
1501440|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
1501441|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
1501442|NCT00772408|systemic symptoms|systemic symptoms
1501443|NCT00772408|pleural effusion|pleural effusion
1501444|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
1501445|NCT00772382|Chronic Kidney Disease|chronic kidney disease
1501446|NCT00772382|Dialysis|dialysis
1501447|NCT00772382|Hyperphosphatemia|hyperphosphatemia
1501448|NCT00772382|Phosphate binder|phosphate binder
1501449|NCT00772369|Pertussis|pertussis
1501450|NCT00772369|Whooping cough|whooping cough
1501451|NCT00772369|Diphtheria|diphtheria
1501452|NCT00772369|Tetanus|tetanus
1501453|NCT00772369|Haemophilus influenzae|haemophilus influenzae
1501454|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
1501455|NCT00772343|Diarrhea|diarrhea
1501456|NCT00772343|Clostridium difficile infection|clostridium difficile infection
1501457|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
1501458|NCT00772330|MIDI Arrow|midi arrow
1501459|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
1501460|NCT00772330|GDD|gdd
1501461|NCT00772330|InnFocus|innfocus
1501462|NCT00772330|Glaucoma treatment|glaucoma treatment
1501463|NCT00772317|Recurrent|recurrent
1501464|NCT00772317|prostate cancer|prostate cancer
1501465|NCT00772317|ebrt|ebrt
1501466|NCT00772317|hifu|hifu
1501467|NCT00772304|rhinitis|rhinitis
1501468|NCT00772291|inguinal|inguinal
1501469|NCT00772291|hernia|hernia
1501470|NCT00772291|chronic|chronic
1501471|NCT00772291|pain|pain
1501472|NCT00772291|pregabalin|pregabalin
1501473|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
1501474|NCT00772278|carotid stenosis|carotid stenosis
1501475|NCT00772278|asymptomatic|asymptomatic
1501476|NCT00772278|carotid stenting|carotid stenting
1501477|NCT00772278|carotid endarterectomy|carotid endarterectomy
1501478|NCT00772265|Bioequivalence|bioequivalence
1501479|NCT00772265|pharmacokinetic|pharmacokinetic
1501480|NCT00772265|Pharmacodynamic|pharmacodynamic
1501481|NCT00772265|Isophane insulin|isophane insulin
1501482|NCT00772252|Liver support treatment|liver support treatment
1501483|NCT00772239|Coagulation Management|coagulation management
1501484|NCT00772239|Cardiac surgery|cardiac surgery
1501485|NCT00772239|Bleeding|bleeding
1501486|NCT00772239|Rotem|rotem
1501487|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1501488|NCT00772226|pain|pain
1501489|NCT00772226|PONV|ponv
1501490|NCT00772226|music|music
1501491|NCT00772226|therapy|therapy
1501492|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
1501493|NCT00772213|multiple trauma|multiple trauma
1501494|NCT00772213|outcome and process assessment|outcome and process assessment
1501495|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
1501496|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
1501499|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501500|NCT00772174|Dyslipidemia|dyslipidemia
1501501|NCT00772174|Drug Therapy|drug therapy
1501502|NCT00772161|ADHD|adhd
1501503|NCT00772161|Attention Deficit Disorder|attention deficit disorder
1501504|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
1501505|NCT00772161|Children|children
1501506|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
1501507|NCT00772161|Methylphenidate|methylphenidate
1501508|NCT00772161|Pharmacokinetics|pharmacokinetics
1501509|NCT00772161|Area Under Curve|area under curve
1501510|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
1501511|NCT00772161|Psychopharmacology|psychopharmacology
1501512|NCT00772148|Liver|liver
1501513|NCT00772148|Hepatic|hepatic
1501514|NCT00772148|Transplantation|transplantation
1501515|NCT00772148|Immunosuppression|immunosuppression
1501516|NCT00772148|Tacrolimus|tacrolimus
1501517|NCT00772148|Prograf|prograf
1501518|NCT00772135|pulmonary hypertension|pulmonary hypertension
1501519|NCT00772135|congenital heart defects|congenital heart defects
1501520|NCT00772135|exercise|exercise
1501521|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
1501522|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
1501523|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
1501524|NCT00772122|G-CSF|g-csf
1501525|NCT00772122|pregnancy outcome|pregnancy outcome
1501526|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
1501527|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
1501528|NCT00772109|Influenza|influenza
1501529|NCT00772109|Orthomyxoviruses|orthomyxoviruses
1501530|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1501531|NCT00772109|Fluzone®|fluzone®
1501532|NCT00772109|Adults|adults
1501533|NCT00772070|Menactra®|menactra®
1501534|NCT00772070|Menomune®|menomune®
1501535|NCT00772070|Meningitis|meningitis
1501536|NCT00772070|Meningococcemia|meningococcemia
1501537|NCT00772070|Neisseria meningitidis|neisseria meningitidis
1501538|NCT00772044|OSA|osa
1501539|NCT00772044|sleep apnea|sleep apnea
1501540|NCT00772044|apnea|apnea
1501541|NCT00772044|AHI|ahi
1501542|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
1501543|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
1501544|NCT00771992|Asthma GINA 1|asthma gina 1
1501545|NCT00771979|Healthy Volunteers|healthy volunteers
1501546|NCT00771979|Relative Bioavailability|relative bioavailability
1501547|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
1501548|NCT00771953|apricoxib|apricoxib
1501549|NCT00771953|docetaxel|docetaxel
1501550|NCT00771953|pemetrexed|pemetrexed
1501551|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
1501552|NCT00771927|Vimpat®|vimpat®
1501557|NCT00771927|seizure|seizure
1501558|NCT00771927|partial seizure|partial seizure
1501559|NCT00771927|partial onset|partial onset
1501560|NCT00771927|seizure disorder|seizure disorder
1501561|NCT00771927|single seizure|single seizure
1501562|NCT00771927|motor seizure|motor seizure
1501563|NCT00771927|convulsions|convulsions
1501564|NCT00771927|add-on|add-on
1501565|NCT00771927|AED|aed
1501566|NCT00771927|anti-epileptic|anti-epileptic
1501567|NCT00771927|anti-epileptic drug|anti-epileptic drug
1501568|NCT00771927|seizure control|seizure control
1501569|NCT00771927|open-label|open-label
1501570|NCT00771927|post authorization|post authorization
1501571|NCT00771927|PASS|pass
1501572|NCT00771927|late stage|late stage
1501573|NCT00771927|trial|trial
1501574|NCT00771927|study|study
1501575|NCT00771927|phase 4|phase 4
1501576|NCT00771927|phase IV|phase iv
1501577|NCT00771914|aspirin|aspirin
1501578|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
1501579|NCT00771914|Lovaza|lovaza
1501580|NCT00771914|myocardial infarction|myocardial infarction
1501581|NCT00771914|aspirin resistance|aspirin resistance
1501582|NCT00771914|cardiovascular disease|cardiovascular disease
1501583|NCT00771901|obesity|obesity
1501584|NCT00771901|insulin resistance|insulin resistance
1501585|NCT00771901|type II diabetes|type ii diabetes
1501586|NCT00771862|pain|pain
1501587|NCT00771862|amputation|amputation
1501588|NCT00771862|phantom limb|phantom limb
1501589|NCT00771862|stump pain|stump pain
1501590|NCT00771862|catheter|catheter
1501591|NCT00771862|nerve block|nerve block
1501592|NCT00771862|peripheral nerve block|peripheral nerve block
1501593|NCT00771862|ucsd|ucsd
1501594|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
1501595|NCT00771849|Meningitis|meningitis
1501596|NCT00771849|Meningococcemia|meningococcemia
1501597|NCT00771849|Neisseria meningitidis|neisseria meningitidis
1501598|NCT00771836|Stem cell transplantation|stem cell transplantation
1501599|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
1501600|NCT00771836|methacholine|methacholine
1501601|NCT00771836|pediatric|pediatric
1501602|NCT00771810|Ovarian Cancer|ovarian cancer
1501605|NCT00771810|Chemotherapy|chemotherapy
1501606|NCT00771797|PAOD|paod
1501607|NCT00771797|diabetis|diabetis
1501608|NCT00771797|vascular function|vascular function
1501609|NCT00771797|in diabetics with PAOD|in diabetics with paod
1501610|NCT00771784|Endotracheal intubation|endotracheal intubation
1501611|NCT00771784|tracheostomy|tracheostomy
1501612|NCT00771784|laryngeal mask|laryngeal mask
1501613|NCT00771771|Stroke|stroke
1501614|NCT00771771|Rehabilitation|rehabilitation
1501615|NCT00771771|Early Supported Discharge|early supported discharge
1501617|NCT00771771|RCT|rct
1501618|NCT00771758|Vertebral compression fracture|vertebral compression fracture
1501619|NCT00771758|Osteoporosis|osteoporosis
1501620|NCT00771758|Acute pain|acute pain
1501621|NCT00771758|Analgesic|analgesic
1501622|NCT00771758|Oxycodone|oxycodone
1501623|NCT00771758|Tapentadol|tapentadol
1501624|NCT00771732|toe nail fungus|toe nail fungus
1501625|NCT00771719|VAP|vap
1501626|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
1501627|NCT00771706|Drug (including placebo)|drug (including placebo)
1501628|NCT00771693|NIDDM|niddm
1501629|NCT00771693|Platelet Activation|platelet activation
1501630|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
1501631|NCT00771693|insulin|insulin
1501632|NCT00771667|Interleukin-12|interleukin-12
1501633|NCT00771667|Inflammation|inflammation
1501634|NCT00771667|Research study|research study
1501635|NCT00771667|Ustekinumab|ustekinumab
1501636|NCT00771667|CNTO1275|cnto1275
1501637|NCT00771667|Interleukin-23|interleukin-23
1501638|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1501639|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1501640|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1501641|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1501642|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1501643|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1501644|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1501645|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1501646|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1501647|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1501648|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1501649|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1501650|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1501651|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
1501652|NCT00771615|human|human
1501653|NCT00771615|Avian|avian
1501654|NCT00771615|safety|safety
1501655|NCT00771615|vaccines|vaccines
1501656|NCT00771615|influenza|influenza
1501657|NCT00771615|pandemic|pandemic
1501658|NCT00771615|immunogenicity|immunogenicity
1501659|NCT00771615|H5N1|h5n1
1501660|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1501661|NCT00771602|Leukemia|leukemia
1501662|NCT00771602|CLL|cll
1501663|NCT00771602|PLL|pll
1501664|NCT00771602|SLL|sll
1501665|NCT00771602|Rituximab|rituximab
1501666|NCT00771602|Rituxan|rituxan
1501667|NCT00771602|Alemtuzumab|alemtuzumab
1501668|NCT00771602|Campath|campath
1501669|NCT00771576|Diabetes Mellitus|diabetes mellitus
1501670|NCT00771576|T1DM|t1dm
1501671|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
1501672|NCT00771563|chemotherapy|chemotherapy
1501673|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
1501674|NCT00771537|HIV Testing|hiv testing
1501675|NCT00771537|Persuasion|persuasion
1501676|NCT00771537|Health Communication|health communication
1501677|NCT00771537|Clinical Trials Participation|clinical trials participation
1501678|NCT00771537|Attitudes toward Health|attitudes toward health
1501679|NCT00771537|Diagnostic Tests|diagnostic tests
1501680|NCT00771537|Behavioral Research|behavioral research
1501681|NCT00771537|Intervention Studies|intervention studies
1501682|NCT00771524|Pharmacokinetics|pharmacokinetics
1501683|NCT00771524|Hip replacement|hip replacement
1501684|NCT00771524|Ceftobiprole|ceftobiprole
1501685|NCT00771498|rifampin|rifampin
1501686|NCT00771498|lopinavir|lopinavir
1501687|NCT00771498|drug interaction|drug interaction
1501688|NCT00771498|pharmacokinetic|pharmacokinetic
1501689|NCT00771459|Local infiltration analgesia|local infiltration analgesia
1501690|NCT00771459|postoperative pain|postoperative pain
1501691|NCT00771459|ropivacaine|ropivacaine
1501692|NCT00771446|Hepatitis, acute|hepatitis, acute
1501693|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
1501694|NCT00771433|neutropenia|neutropenia
1501695|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1501696|NCT00771433|recurrent breast cancer|recurrent breast cancer
1501697|NCT00771433|stage I breast cancer|stage i breast cancer
1502536|NCT00768352|Resident|resident
1501698|NCT00771433|stage II breast cancer|stage ii breast cancer
1501699|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
1501700|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
1501701|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
1501702|NCT00771433|stage IV breast cancer|stage iv breast cancer
1501703|NCT00771407|Ostomy creation|ostomy creation
1501704|NCT00771407|Parastomal hernia|parastomal hernia
1501705|NCT00771394|Vesicare|vesicare
1501706|NCT00771394|Solifenacin succinate|solifenacin succinate
1501707|NCT00771394|Tamsulosin|tamsulosin
1501708|NCT00771394|Overactive Bladder|overactive bladder
1501709|NCT00771394|BPH|bph
1501710|NCT00771381|18F-FAZA|18f-faza
1501711|NCT00771381|18F-FDG|18f-fdg
1501712|NCT00771381|Positron Emission Tomography|positron emission tomography
1501713|NCT00771381|Cell Hypoxia|cell hypoxia
1501714|NCT00771303|Pregnancy|pregnancy
1501715|NCT00771303|Pulmonary embolism|pulmonary embolism
1501716|NCT00771303|MSCT|msct
1501717|NCT00771290|Rectal sparing|rectal sparing
1501718|NCT00771290|Colon cancer|colon cancer
1501719|NCT00771277|Brain Injuries|brain injuries
1501720|NCT00771277|Caregivers|caregivers
1501721|NCT00771277|Volunteer Workers|volunteer workers
1501722|NCT00771277|Social Networks|social networks
1501723|NCT00771264|Overactive Bladder|overactive bladder
1501724|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
1501725|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
1501726|NCT00771251|CNTO148|cnto148
1501727|NCT00771251|Golimumab|golimumab
1501728|NCT00771238|pressure ulcers|pressure ulcers
1501729|NCT00771238|Therapy mattresses|therapy mattresses
1501730|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
1501731|NCT00771225|genital prolapse|genital prolapse
1501732|NCT00771225|surgery|surgery
1501733|NCT00771225|fascial repair|fascial repair
1501734|NCT00771225|mesh|mesh
1501735|NCT00771225|prolift|prolift
1501736|NCT00771212|Pain|pain
1501737|NCT00771212|Observational|observational
1501738|NCT00771212|Taiwan|taiwan
1501739|NCT00771199|Cancer pain|cancer pain
1501740|NCT00771199|Pain|pain
1501741|NCT00771199|Fentanyl|fentanyl
1501742|NCT00771199|Durogesic|durogesic
1501743|NCT00771199|Cancer|cancer
1501744|NCT00771199|Transdermal|transdermal
1501745|NCT00771186|pediatric|pediatric
1501746|NCT00771186|Laryngeal EMG|laryngeal emg
1501747|NCT00771173|Phenazopyrdine|phenazopyrdine
1501748|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
1501749|NCT00771173|VAS scores|vas scores
1501750|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
1501751|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
1501752|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
1501753|NCT00771134|Depression|depression
1501754|NCT00771134|Bipolar I Disorder|bipolar i disorder
1501755|NCT00771134|Bipolar II Disorder|bipolar ii disorder
1501756|NCT00771134|Placebo-controlled|placebo-controlled
1501757|NCT00771134|Double-blind|double-blind
1501758|NCT00771134|Randomised controlled|randomised controlled
1501759|NCT00771134|Multicenter|multicenter
1501760|NCT00771134|Clinical study|clinical study
1501761|NCT00771134|Mania|mania
1501762|NCT00771108|NAFLD|nafld
1501763|NCT00771108|Obesity|obesity
1501764|NCT00771108|Metabolic Syndrome|metabolic syndrome
1501765|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
1501766|NCT00771095|weight loss|weight loss
1501767|NCT00771095|elaboration|elaboration
1501768|NCT00771095|self efficacy|self efficacy
1501769|NCT00771082|inflammatory markers|inflammatory markers
1501770|NCT00771082|bone markers|bone markers
1501772|NCT00771069|Hypertension|hypertension
1501773|NCT00771069|Type II DM|type ii dm
1501774|NCT00771069|DM related complication|dm related complication
1501775|NCT00771069|JNC7|jnc7
1501776|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
1501777|NCT00771069|survey|survey
1501778|NCT00771056|untreated|untreated
1501779|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1501780|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
1501781|NCT00771017|stage II prostate cancer|stage ii prostate cancer
1501782|NCT00771017|stage III prostate cancer|stage iii prostate cancer
1501783|NCT00771017|stage I prostate cancer|stage i prostate cancer
1501784|NCT00771004|drug effects|drug effects
1501785|NCT00771004|Type II Diabetes|type ii diabetes
1501786|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1501787|NCT00771004|Drug Therapy|drug therapy
1501788|NCT00771004|Heart|heart
1501789|NCT00771004|physiology|physiology
1501790|NCT00771004|function|function
1501791|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
1501793|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
1501794|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
1501795|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
1501796|NCT00770952|Type II Diabetes|type ii diabetes
1502537|NCT00768352|Depression|depression
1501797|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501798|NCT00770952|Dyslipidemia|dyslipidemia
1501799|NCT00770952|Drug Therapy|drug therapy
1501800|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
1501801|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
1501802|NCT00770939|Vivostat|vivostat
1501803|NCT00770939|Growth factor treatment|growth factor treatment
1501804|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
1501805|NCT00770926|risk reduction|risk reduction
1501806|NCT00770926|minority|minority
1501807|NCT00770926|diabetes prevention|diabetes prevention
1501808|NCT00770926|lifestyle program|lifestyle program
1501809|NCT00770926|behavior change|behavior change
1501810|NCT00770913|reflux esophagitis|reflux esophagitis
1501811|NCT00770913|rabeprazole|rabeprazole
1501812|NCT00770913|GERD|gerd
1501813|NCT00770913|Japan|japan
1501814|NCT00770887|Undesired fertility|undesired fertility
1501815|NCT00770861|nebivolol|nebivolol
1501816|NCT00770861|Bystolic ™|bystolic ™
1501817|NCT00770861|Hypertension|hypertension
1501818|NCT00770861|Hispanic|hispanic
1501819|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
1501820|NCT00770848|CRPC|crpc
1501821|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
1501822|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
1501823|NCT00770835|Type II Diabetes|type ii diabetes
1501824|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501825|NCT00770835|Dyslipidemia|dyslipidemia
1501826|NCT00770835|Drug Therapy|drug therapy
1501827|NCT00770822|Primary|primary
1501828|NCT00770822|Prostate|prostate
1501829|NCT00770822|Cancer|cancer
1501830|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
1501831|NCT00770822|organ-confined|organ-confined
1501832|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
1501833|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
1501834|NCT00770744|Schizophrenia|schizophrenia
1501835|NCT00770744|Antipsychotic|antipsychotic
1501836|NCT00770744|Olanzapine|olanzapine
1501837|NCT00770744|Lu 31-130|lu 31-130
1659054|NCT00150098|HIV|hiv
1501838|NCT00770731|Torisel|torisel
1501839|NCT00770731|Temsirolimus|temsirolimus
1501840|NCT00770731|Hycamtin|hycamtin
1501841|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
1501842|NCT00770731|Velcade|velcade
1501843|NCT00770731|Bortezomib|bortezomib
1501844|NCT00770731|FDG-PET Scans|fdg-pet scans
1501845|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
1501846|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
1501847|NCT00770718|warfarin|warfarin
1501848|NCT00770718|anticoagulant|anticoagulant
1501849|NCT00770718|Factor VII|factor vii
1501850|NCT00770718|Prothrombin|prothrombin
1501851|NCT00770692|insomnia|insomnia
1501852|NCT00770692|primary insomnia|primary insomnia
1501853|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
1501854|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
1501855|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
1501856|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
1501857|NCT00770653|Type II Diabetes|type ii diabetes
1501858|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501859|NCT00770653|Dyslipidemia|dyslipidemia
1501860|NCT00770653|Hyperlipidemias|hyperlipidemias
1501861|NCT00770653|Drug Therapy|drug therapy
1501862|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
1501863|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
1501864|NCT00770640|Type II Diabetes|type ii diabetes
1501865|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501866|NCT00770640|Dyslipidemia|dyslipidemia
1501867|NCT00770640|Drug Therapy|drug therapy
1501868|NCT00770627|160 children|160 children
1501869|NCT00770627|parallel group|parallel group
1501870|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
1501871|NCT00770601|NOMID|nomid
1501872|NCT00770601|CINCA Syndrome|cinca syndrome
1501873|NCT00770601|Canakinumab|canakinumab
1501874|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1501875|NCT00770588|Gefitinib|gefitinib
1501876|NCT00770575|Biological Markers|biological markers
1501877|NCT00770575|Biochemical Markers|biochemical markers
1501878|NCT00770575|Carotid Artery, Internal|carotid artery, internal
1501879|NCT00770575|Carotid Artery, Common|carotid artery, common
1501880|NCT00770575|Marker, Surrogate|marker, surrogate
1501881|NCT00770575|Vascular Diseases|vascular diseases
1501882|NCT00770575|Diabetes Mellitus|diabetes mellitus
1501883|NCT00770575|Drug Therapy|drug therapy
1501884|NCT00770536|fallopian tube cancer|fallopian tube cancer
1501885|NCT00770536|Gynecological Malignancy|gynecological malignancy
1501886|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
1501887|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
1501888|NCT00770523|patients without comorbidity|patients without comorbidity
1501889|NCT00770510|Primary insomnia|primary insomnia
1501890|NCT00770497|drug effects|drug effects
1501891|NCT00770497|Hypertension|hypertension
1501892|NCT00770497|Vascular Resistance|vascular resistance
1501893|NCT00770497|Drug Therapy|drug therapy
1501894|NCT00770497|physiopathology, vascular|physiopathology, vascular
1501895|NCT00770484|Exercise|exercise
1501896|NCT00770484|Propanolol|propanolol
1501897|NCT00770484|Beta blockers|beta blockers
1501898|NCT00770471|adult glioblastoma|adult glioblastoma
1501899|NCT00770471|adult gliosarcoma|adult gliosarcoma
1501900|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
1501901|NCT00770458|Down Syndrome|down syndrome
1501902|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
1501903|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
1501904|NCT00770445|Type II Diabetes|type ii diabetes
1501905|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1501906|NCT00770445|Dyslipidemia|dyslipidemia
1501907|NCT00770445|Drug Therapy|drug therapy
1501908|NCT00770432|Human Experimentation|human experimentation
1501909|NCT00770419|depression|depression
1501910|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1501911|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1501912|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
1501913|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1501914|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1501915|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1501916|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1501917|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1501918|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1501919|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1501920|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1501921|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1501922|NCT00770419|mast cell leukemia|mast cell leukemia
1501923|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1501924|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
1501925|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1501926|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1501927|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1501928|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1501929|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
1501930|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1501931|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1501932|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1502399|NCT00769028|Scleroderma|scleroderma
1501933|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1501934|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1501935|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1501936|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1501937|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1501938|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1501939|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1501940|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1501941|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1501942|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1501943|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1501944|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1501945|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1501946|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1501947|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1501948|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1501949|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1501950|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1501951|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1501952|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1501953|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1501954|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1501955|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1501956|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1501957|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1501958|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1501959|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1501960|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1501961|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1501962|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1501963|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1501964|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1501965|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1501966|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1501967|NCT00770419|intraocular lymphoma|intraocular lymphoma
1501968|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1501969|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1501970|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1501971|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1501972|NCT00770419|primary myelofibrosis|primary myelofibrosis
1501973|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
1501974|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
1501975|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1501976|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1501977|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1501978|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
1501979|NCT00770393|laryngeal preservation|laryngeal preservation
1501980|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
1501981|NCT00770380|smoking|smoking
1501982|NCT00770367|Cardiovascular risk|cardiovascular risk
1501983|NCT00770367|biological markers|biological markers
1501984|NCT00770354|Breast cancer|breast cancer
1501985|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
1501986|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
1501987|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
1501988|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
1501989|NCT00770302|HBA1c|hba1c
1501990|NCT00770302|Incretins|incretins
1501991|NCT00770302|Pharmacokinetics|pharmacokinetics
1501992|NCT00770276|obesity WHO I-III|obesity who i-iii
1501993|NCT00770276|metabolic syndrome|metabolic syndrome
1501994|NCT00770276|Framingham risk score|framingham risk score
1501995|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
1501996|NCT00770276|endothelial dysfunction|endothelial dysfunction
1501997|NCT00770263|any solid tumors|any solid tumors
1501998|NCT00770250|asthma symptoms|asthma symptoms
1501999|NCT00770250|words used by patients and physicians|words used by patients and physicians
1502000|NCT00770250|express asthma symptoms|express asthma symptoms
1502001|NCT00770237|Smoking|smoking
1502002|NCT00770237|Nicotine|nicotine
1502003|NCT00770237|Schizophrenia|schizophrenia
1502004|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1502005|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1502006|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1502007|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1502008|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1502009|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1502010|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1502011|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1502012|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1502013|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1502014|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1502015|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1502016|NCT00770198|liver|liver
1502017|NCT00770198|alcohol|alcohol
1502018|NCT00770198|HCV|hcv
1502019|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
1502020|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1502021|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1502022|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
1502023|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1502024|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
1502025|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1502026|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1502027|NCT00770172|neutropenia|neutropenia
1502028|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1502029|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1502030|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
1502031|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
1502345|NCT00769301|sleeplessness|sleeplessness
1502032|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
1502033|NCT00770094|LASIK|lasik
1502034|NCT00770094|Laser Vision correction|laser vision correction
1502035|NCT00770094|Myopia|myopia
1502036|NCT00770094|Myopia with astigmatism|myopia with astigmatism
1502037|NCT00770094|Nearsighted|nearsighted
1502038|NCT00770081|Type 2 diabetes|type 2 diabetes
1502039|NCT00770081|vildagliptin|vildagliptin
1502040|NCT00770068|Mood Disorders|mood disorders
1502041|NCT00770068|Major Depressive Disorder|major depressive disorder
1502042|NCT00770068|Bipolar Disorder|bipolar disorder
1502043|NCT00770068|Tree Pollen|tree pollen
1502044|NCT00770068|Ragweed Pollen|ragweed pollen
1502045|NCT00770068|Rhinitis|rhinitis
1502046|NCT00770068|Allergic|allergic
1502047|NCT00770068|Seasonal|seasonal
1502048|NCT00770068|Allergens|allergens
1502049|NCT00770055|stage IV breast cancer|stage iv breast cancer
1502050|NCT00770055|recurrent breast cancer|recurrent breast cancer
1502051|NCT00770016|insulin sensitivity|insulin sensitivity
1502052|NCT00770016|Substrate metabolism|substrate metabolism
1502053|NCT00770016|Fatty liver|fatty liver
1502054|NCT00770016|intramyocellular lipid|intramyocellular lipid
1502055|NCT00770016|intracellular signaling|intracellular signaling
1502056|NCT00770003|patients|patients
1502057|NCT00770003|allergic rhinitis|allergic rhinitis
1502058|NCT00770003|tolerability|tolerability
1502059|NCT00770003|safety|safety
1502060|NCT00770003|nasal symptoms|nasal symptoms
1502061|NCT00769990|bone metastases|bone metastases
1502062|NCT00769990|pain|pain
1502063|NCT00769990|recurrent breast cancer|recurrent breast cancer
1502064|NCT00769990|stage IV breast cancer|stage iv breast cancer
1502065|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
1502066|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
1502067|NCT00769990|recurrent melanoma|recurrent melanoma
1502068|NCT00769990|stage IV melanoma|stage iv melanoma
1502069|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
1502070|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
1502071|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1502072|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1502073|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1502074|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
1502075|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
1502076|NCT00769951|pain|pain
1502077|NCT00769951|depression|depression
1502078|NCT00769951|weight changes|weight changes
1502079|NCT00769951|cognitive/functional effects|cognitive/functional effects
1502080|NCT00769951|malnutrition|malnutrition
1502081|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1502082|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1502083|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1502084|NCT00769938|Atrial fibrillation|atrial fibrillation
1502085|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
1502086|NCT00769938|Bleeding complications|bleeding complications
1502087|NCT00769938|Triple therapy|triple therapy
1502088|NCT00769925|Generalized Anxiety|generalized anxiety
1502089|NCT00769925|Social Phobia|social phobia
1502090|NCT00769925|Separation Anxiety|separation anxiety
1502091|NCT00769925|Phobia|phobia
1502092|NCT00769899|AZD7325|azd7325
1502093|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
1502094|NCT00769899|Phase I study|phase i study
1502095|NCT00769899|Single Ascending Dose|single ascending dose
1502096|NCT00769873|anticoagulation|anticoagulation
1502097|NCT00769873|thrombosis|thrombosis
1502098|NCT00769873|portal vein thrombosis|portal vein thrombosis
1502099|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
1502100|NCT00769873|splenectomy|splenectomy
1502101|NCT00769873|randomized|randomized
1502102|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
1502103|NCT00769873|lovenox|lovenox
1502104|NCT00769860|myositis|myositis
1502105|NCT00769860|IBM|ibm
1502106|NCT00769860|inclusion body myositis|inclusion body myositis
1502107|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
1502108|NCT00769834|chronic kidney disease|chronic kidney disease
1502109|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
1502110|NCT00769834|uremia|uremia
1502111|NCT00769834|disc edema|disc edema
1502112|NCT00769834|papilledema|papilledema
1502113|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
1502114|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
1502115|NCT00769821|lymphedema|lymphedema
1502116|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
1502117|NCT00769821|cancer survivor|cancer survivor
1502118|NCT00769821|stage I breast cancer|stage i breast cancer
1502119|NCT00769821|stage II breast cancer|stage ii breast cancer
1502120|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
1502121|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
1502122|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
1502123|NCT00769821|stage IV breast cancer|stage iv breast cancer
1502124|NCT00769795|prostate cancer|prostate cancer
1502125|NCT00769795|prostatic neoplasm|prostatic neoplasm
1502126|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
1502127|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
1502128|NCT00769795|neoadjuvant|neoadjuvant
1502129|NCT00769795|prostatectomy|prostatectomy
1502130|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1502131|NCT00769782|liver metastases|liver metastases
1502132|NCT00769769|Health Status|health status
1502133|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
1502134|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
1502135|NCT00769730|hepatitis B virus|hepatitis b virus
1502136|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1502137|NCT00769717|obesity|obesity
1502138|NCT00769717|wellness|wellness
1502139|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
1502140|NCT00769717|health at every size|health at every size
1502141|NCT00769717|weight loss|weight loss
1502142|NCT00769704|Melanoma|melanoma
1502143|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
1502144|NCT00769704|GM-CSF|gm-csf
1502145|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
1502146|NCT00769704|oncolytic|oncolytic
1502147|NCT00769704|OncoVex|oncovex
1502148|NCT00769704|T-Vec|t-vec
1502149|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
1502150|NCT00769691|Cardiac surgery|cardiac surgery
1502151|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
1502152|NCT00769678|Biventricular Pacing|biventricular pacing
1502153|NCT00769665|Dry Eye|dry eye
1502154|NCT00769665|re-wetting drops|re-wetting drops
1502155|NCT00769652|malnutrition|malnutrition
1502156|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
1502157|NCT00769652|small cell lung cancer|small cell lung cancer
1502158|NCT00769652|stage III prostate cancer|stage iii prostate cancer
1502159|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
1502160|NCT00769652|pancreatic cancer|pancreatic cancer
1502161|NCT00769652|weight changes|weight changes
1502162|NCT00769626|Low Back Pain|low back pain
1502163|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
1502164|NCT00769626|Spinal Manipulation|spinal manipulation
1502165|NCT00769626|Physical Therapy Techniques|physical therapy techniques
1502166|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1502167|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1502168|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1502169|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1502170|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1502171|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1502172|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1502173|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1502174|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1502175|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1502176|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1502177|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1502178|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1502179|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1502180|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1502181|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1502182|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1502183|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1502184|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1502185|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1502186|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1502187|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1502188|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1502189|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1502190|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1502191|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1502192|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1502193|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1502194|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1502195|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1502196|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1502197|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1502198|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1502199|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1502200|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1502201|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1502535|NCT00768352|Pediatric|pediatric
1502202|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1502203|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1502204|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1502205|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1502206|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1502207|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1502208|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1502209|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1502210|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1502211|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1502212|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1502213|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1502214|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1502215|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1502216|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1502217|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1502218|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1502219|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1502220|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1502221|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1502222|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1502223|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1502224|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1502225|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1502226|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1502227|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1502228|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1502229|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1502230|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1502231|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1502232|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1502233|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1502234|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1502235|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1502236|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1502237|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1502238|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1502239|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1502240|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1502241|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1502242|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1502243|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1502244|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1502245|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1502246|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1502247|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
1502248|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1502249|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1502250|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1502251|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1502252|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1502253|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1502254|NCT00769613|primary myelofibrosis|primary myelofibrosis
1502255|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1502256|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1502257|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
1502258|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1502259|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1502260|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1502261|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1502262|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1502263|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1502264|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
1502265|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1502266|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1502267|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1502268|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1502269|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
1502270|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
1502271|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
1502272|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1502273|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1502274|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1502275|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1502276|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
1502277|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
1502278|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
1502279|NCT00769613|stage IV breast cancer|stage iv breast cancer
1502280|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
1502281|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
1502282|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
1502283|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
1502284|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
1502285|NCT00769561|Temporomandibular disorders|temporomandibular disorders
1502286|NCT00769561|Biofeedback|biofeedback
1502287|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
1502288|NCT00769561|Pain|pain
1502289|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1502290|NCT00769548|stage I prostate cancer|stage i prostate cancer
1502291|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
1502292|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
1502293|NCT00769548|stage III prostate cancer|stage iii prostate cancer
1502294|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
1502295|NCT00769535|heat shock protein70|heat shock protein70
1502296|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
1502297|NCT00769535|polymorphism|polymorphism
1502298|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1502299|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1502300|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1502301|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1502302|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1502303|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1502304|NCT00769509|energy expenditure|energy expenditure
1502305|NCT00769509|indirect calorimetry|indirect calorimetry
1502306|NCT00769509|human milk|human milk
1502307|NCT00769509|preterm formula|preterm formula
1502308|NCT00769509|premature infant|premature infant
1502309|NCT00769483|Pancreas|pancreas
1502310|NCT00769483|Pancreatic Cancer|pancreatic cancer
1502311|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
1502312|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1502314|NCT00769483|Gemcitabine|gemcitabine
1502315|NCT00769483|Gemzar|gemzar
1502316|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
1502317|NCT00769483|Erlotinib|erlotinib
1502318|NCT00769483|OSI-774|osi-774
1502319|NCT00769483|Tarceva|tarceva
1502320|NCT00769470|stage I breast cancer|stage i breast cancer
1502321|NCT00769470|stage II breast cancer|stage ii breast cancer
1502322|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
1502323|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
1502324|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
1502325|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
1502326|NCT00769431|stage I prostate cancer|stage i prostate cancer
1502327|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
1502328|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
1502329|NCT00769405|recurrent colon cancer|recurrent colon cancer
1502330|NCT00769405|stage IV colon cancer|stage iv colon cancer
1502331|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
1502332|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
1502333|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
1502334|NCT00769392|Macular Degeneration|macular degeneration
1502335|NCT00769392|Intravitreal injections|intravitreal injections
1502336|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
1502337|NCT00769392|Eye-surgical procedures|eye-surgical procedures
1502338|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
1502339|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1502340|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1502341|NCT00769301|Symptoms|symptoms
1502342|NCT00769301|pain|pain
1502343|NCT00769301|fatigue|fatigue
1502344|NCT00769301|depression|depression
1502346|NCT00769301|genetic markers|genetic markers
1502347|NCT00769301|caregiver burden.|caregiver burden.
1502348|NCT00769275|silent ischemia|silent ischemia
1502349|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
1502350|NCT00769275|screening|screening
1502351|NCT00769275|cardiac outcome|cardiac outcome
1502352|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
1502353|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
1502354|NCT00769262|Premature neonates|premature neonates
1502355|NCT00769262|Thermoregulation|thermoregulation
1502356|NCT00769262|Isolette|isolette
1502357|NCT00769262|Feeding status|feeding status
1502358|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1502359|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1502360|NCT00769223|radiation toxicity|radiation toxicity
1502361|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
1502362|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
1502363|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
1502364|NCT00769223|stage III prostate cancer|stage iii prostate cancer
1502365|NCT00769223|stage I prostate cancer|stage i prostate cancer
1502366|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
1502367|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1502368|NCT00769197|optic disc cupping|optic disc cupping
1502369|NCT00769197|cerebral palsy|cerebral palsy
1502370|NCT00769197|static encephalopathy|static encephalopathy
1502371|NCT00769197|optic disc|optic disc
1502372|NCT00769197|optic nerve|optic nerve
1502373|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
1502374|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
1502375|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
1502376|NCT00769158|Alcohol|alcohol
1502377|NCT00769158|Alcoholism|alcoholism
1502378|NCT00769158|Alcohol Dependence|alcohol dependence
1502379|NCT00769145|Corneal neovascularization|corneal neovascularization
1502380|NCT00769145|Ranibizumab|ranibizumab
1502381|NCT00769145|Corneal transplantation|corneal transplantation
1502382|NCT00769119|bronchiectasis|bronchiectasis
1502383|NCT00769119|Phase II|phase ii
1502384|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
1502385|NCT00769106|recurrent|recurrent
1502386|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
1502387|NCT00769093|ferumoxytol|ferumoxytol
1502388|NCT00769093|diagnostic imaging|diagnostic imaging
1502390|NCT00769080|Standard Treatment|standard treatment
1502391|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
1502392|NCT00769067|Lung cancer|lung cancer
1502393|NCT00769067|advanced|advanced
1502394|NCT00769067|second or third line|second or third line
1502395|NCT00769054|Postoperative pain|postoperative pain
1502396|NCT00769054|PONV|ponv
1502397|NCT00769028|Systemic sclerosis|systemic sclerosis
1502398|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
1502400|NCT00769028|Biological|biological
1502401|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
1502402|NCT00769028|Goat Serum|goat serum
1502403|NCT00769015|age-related macular degeneration|age-related macular degeneration
1502404|NCT00769015|depression|depression
1502405|NCT00769015|vision loss|vision loss
1502406|NCT00769002|influenza|influenza
1502407|NCT00769002|flu|flu
1502408|NCT00769002|vaccine|vaccine
1502409|NCT00769002|vaccination|vaccination
1502410|NCT00769002|immune response|immune response
1502411|NCT00769002|FluShield|flushield
1502412|NCT00769002|FluMist|flumist
1502413|NCT00769002|PET-CT|pet-ct
1502414|NCT00769002|Healthy Volunteers|healthy volunteers
1502415|NCT00768989|Combination Therapy|combination therapy
1502416|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
1502417|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
1502418|NCT00768963|ranibizumab|ranibizumab
1502419|NCT00768963|pterygium|pterygium
1502420|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
1502421|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
1502422|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
1502423|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
1502424|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
1502425|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
1502426|NCT00768937|sorafenib|sorafenib
1502427|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
1502428|NCT00768937|tumor angiogenesis|tumor angiogenesis
1502429|NCT00768937|angiogenic factors|angiogenic factors
1502430|NCT00768924|Bone Void Filler|bone void filler
1502431|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
1502432|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
1502433|NCT00768911|glioblastoma|glioblastoma
1502434|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
1502435|NCT00768898|conjunctival|conjunctival
1502436|NCT00768898|staining|staining
1502437|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
1502438|NCT00768859|breast cancer|breast cancer
1502439|NCT00768859|HER2 positive|her2 positive
1502440|NCT00768859|neo-adjuvant|neo-adjuvant
1502441|NCT00768859|trastuzumab|trastuzumab
1502442|NCT00768859|paclitaxel|paclitaxel
1502443|NCT00768859|carboplatin|carboplatin
1502444|NCT00768846|PCI|pci
1502445|NCT00768846|Stent|stent
1502446|NCT00768846|DES|des
1502447|NCT00768846|CAD|cad
1502448|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
1502449|NCT00768833|Healthy subjects|healthy subjects
1502450|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
1502451|NCT00768820|Williams syndrome|williams syndrome
1502452|NCT00768820|fragile X syndrome|fragile x syndrome
1502453|NCT00768820|cognitive phenotype|cognitive phenotype
1502454|NCT00768820|psychiatric phenotype|psychiatric phenotype
1502455|NCT00768794|thrush|thrush
1502456|NCT00768781|insomnia|insomnia
1502457|NCT00768781|hyperarousal|hyperarousal
1502458|NCT00768781|mindfulness meditation|mindfulness meditation
1502459|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
1502460|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
1502461|NCT00768768|iontophoresis|iontophoresis
1502462|NCT00768768|terbinafine|terbinafine
1502463|NCT00768768|onychomycosis|onychomycosis
1502464|NCT00768755|non-squamous NSCLC|non-squamous nsclc
1502465|NCT00768755|axitinib|axitinib
1502466|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
1502467|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
1502468|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
1502469|NCT00768742|VizAblate|vizablate
1502470|NCT00768729|End stage renal disease|end stage renal disease
1502471|NCT00768729|Kidney transplantation|kidney transplantation
1502472|NCT00768729|Renal transplantation|renal transplantation
1502473|NCT00768729|Kidney failure|kidney failure
1502474|NCT00768729|Children|children
1502475|NCT00768729|Adolescents|adolescents
1502476|NCT00768729|Sirolimus|sirolimus
1502477|NCT00768729|Rapamycin|rapamycin
1502478|NCT00768729|CellCept|cellcept
1502479|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
1502480|NCT00768729|Azathioprine|azathioprine
1502481|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
1502482|NCT00768703|lung-head ratio|lung-head ratio
1502483|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
1502484|NCT00768703|fetal intervention|fetal intervention
1502485|NCT00768677|binge eating behavior|binge eating behavior
1502486|NCT00768677|adolescents|adolescents
1502487|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
1502488|NCT00768638|Chronic kidney disease|chronic kidney disease
1502489|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
1502490|NCT00768599|Econazole|econazole
1502491|NCT00768599|Foam|foam
1502492|NCT00768599|Quinnova|quinnova
1502493|NCT00768573|taste test|taste test
1502494|NCT00768534|Acute Otitis Media|acute otitis media
1502495|NCT00768534|Serotype distribution|serotype distribution
1502496|NCT00768508|Alcohol|alcohol
1502497|NCT00768508|Alcohol Dependence|alcohol dependence
1502498|NCT00768508|Alcoholism|alcoholism
1502499|NCT00768495|revascularization|revascularization
1502500|NCT00768495|claudication|claudication
1502501|NCT00768495|hyperspectral|hyperspectral
1502502|NCT00768495|oxygenation|oxygenation
1502503|NCT00768495|limb ischemia|limb ischemia
1502504|NCT00768482|opioid dependence|opioid dependence
1502505|NCT00768482|opioid addiction|opioid addiction
1502506|NCT00768482|buprenorphine|buprenorphine
1502507|NCT00768482|methadone|methadone
1502508|NCT00768482|heroin|heroin
1502509|NCT00768482|implant|implant
1502510|NCT00768482|opioid withdrawal|opioid withdrawal
1502511|NCT00768482|opioid pain medication|opioid pain medication
1502512|NCT00768482|suboxone|suboxone
1502513|NCT00768469|HKI-272|hki-272
1502514|NCT00768469|Paclitaxel|paclitaxel
1502515|NCT00768469|Combination|combination
1502516|NCT00768469|Solid Tumor|solid tumor
1502517|NCT00768443|GERD|gerd
1502518|NCT00768443|PPI|ppi
1502519|NCT00768417|Nuts|nuts
1502520|NCT00768417|Lipids|lipids
1502521|NCT00768417|Mastication|mastication
1502522|NCT00768417|Bioaccessibility|bioaccessibility
1502523|NCT00768417|Satiety|satiety
1502524|NCT00768417|Hormones|hormones
1502525|NCT00768417|Human|human
1502526|NCT00768391|Tumors|tumors
1502527|NCT00768391|Lymphoma|lymphoma
1502528|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
1502529|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
1502530|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
1502531|NCT00768378|Vestibular|vestibular
1502532|NCT00768378|Rehabilitation|rehabilitation
1502533|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
1502534|NCT00768365|cardiovascular risk|cardiovascular risk
1502538|NCT00768352|Screening|screening
1502539|NCT00768352|Substance Abuse|substance abuse
1502540|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
1502541|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
1502542|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
1502543|NCT00768339|antisense|antisense
1502544|NCT00768339|AEG35156|aeg35156
1502545|NCT00768339|lymphocytic|lymphocytic
1502546|NCT00768339|lymphoma|lymphoma
1502547|NCT00768339|leukemia|leukemia
1502548|NCT00768339|B-cell|b-cell
1502549|NCT00768326|Schizophrenia|schizophrenia
1502550|NCT00768326|Antipsychotic|antipsychotic
1502551|NCT00768326|Lu 31-130|lu 31-130
1502552|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
1502553|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1502554|NCT00768300|interstitial lung disease|interstitial lung disease
1502555|NCT00768300|ambrisentan|ambrisentan
1502556|NCT00768274|Cholesterol|cholesterol
1502557|NCT00768274|High density lipoprotein|high density lipoprotein
1502558|NCT00768274|Dyslipidemia|dyslipidemia
1502559|NCT00768274|Atherosclerosis|atherosclerosis
1502560|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
1502561|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
1502562|NCT00768248|pain|pain
1502563|NCT00768248|phantom limb|phantom limb
1502564|NCT00768248|stump pain|stump pain
1502565|NCT00768248|catheter|catheter
1502566|NCT00768248|nerve block|nerve block
1502567|NCT00768248|peripheral nerve block|peripheral nerve block
1502568|NCT00768248|NMCSD|nmcsd
1502569|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
1502570|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
1502571|NCT00768222|wound healing|wound healing
1502572|NCT00768209|Pharmacokinetics|pharmacokinetics
1502573|NCT00768196|GERD|gerd
1502574|NCT00768196|Korea|korea
1502575|NCT00768196|typical symptom|typical symptom
1502576|NCT00768196|quality of life|quality of life
1502577|NCT00768196|Naturalistic|naturalistic
1502578|NCT00768196|epidemiological|epidemiological
1502579|NCT00768183|KADIAN|kadian
1502580|NCT00768183|morphine|morphine
1502581|NCT00768183|alcohol|alcohol
1502582|NCT00768183|water|water
1502583|NCT00768183|Ethanol|ethanol
1502584|NCT00768183|solution|solution
1502585|NCT00768183|fed|fed
1502586|NCT00768183|fasting|fasting
1502587|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
1502588|NCT00768157|hepatitis B virus|hepatitis b virus
1502589|NCT00768157|surgery|surgery
1502590|NCT00768157|anti-virus|anti-virus
1502591|NCT00768157|recurrence|recurrence
1502592|NCT00768144|Sutent|sutent
1502593|NCT00768144|sunitinib|sunitinib
1502594|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
1502595|NCT00768105|Type 2 diabetes|type 2 diabetes
1502596|NCT00768079|Benralizumab|benralizumab
1502597|NCT00768079|MEDI-563|medi-563
1502598|NCT00768079|Asthma|asthma
1502599|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
1502600|NCT00768053|EULAR-RAID|eular-raid
1502601|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
1502602|NCT00768053|etanercept|etanercept
1502603|NCT00768040|Diabetes|diabetes
1502604|NCT00768040|Macular edema|macular edema
1502605|NCT00768040|Aliskiren|aliskiren
1502606|NCT00768040|Diabetic retinopathy|diabetic retinopathy
1502607|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
1502608|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
1502609|NCT00768027|hyperspectral imaging|hyperspectral imaging
1502610|NCT00768027|tissue oxygenation|tissue oxygenation
1502611|NCT00768027|wounds|wounds
1502612|NCT00768027|wound healing|wound healing
1502613|NCT00768027|prevention|prevention
1502614|NCT00768027|hyperbaric|hyperbaric
1502615|NCT00767988|Probiotics|probiotics
1502616|NCT00767988|Spina Bifida|spina bifida
1502617|NCT00767988|Dietary Supplements|dietary supplements
1502618|NCT00767988|Bacteriuria|bacteriuria
1502619|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
1502620|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
1502621|NCT00767949|wet|wet
1502622|NCT00767949|AMD|amd
1502623|NCT00767923|hyperspectral imaging|hyperspectral imaging
1502624|NCT00767923|tissue oxygenation|tissue oxygenation
1502625|NCT00767923|foot amputation|foot amputation
1502626|NCT00767923|critical limb ischemia|critical limb ischemia
1502627|NCT00767923|tissue necrosis|tissue necrosis
1502628|NCT00767897|Dose response relationship|dose response relationship
1502629|NCT00767897|immunity|immunity
1502630|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
1502631|NCT00767884|diabetic retinopathy|diabetic retinopathy
1502632|NCT00767884|optic nerve head changes|optic nerve head changes
1502633|NCT00767871|Panic disorder|panic disorder
1502634|NCT00767871|PET|pet
1502635|NCT00767871|Escitaopram|escitaopram
1502636|NCT00767858|Genetic|genetic
1502637|NCT00767858|Genetic Literacy|genetic literacy
1502638|NCT00767858|Human Genetic Research|human genetic research
1502639|NCT00767858|Cultural Congruence|cultural congruence
1502640|NCT00767858|Interview|interview
1502641|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1502642|NCT00767845|stage I prostate cancer|stage i prostate cancer
1502643|NCT00767845|stage II prostate cancer|stage ii prostate cancer
1502644|NCT00767845|stage III prostate cancer|stage iii prostate cancer
1502645|NCT00767819|progressive GIST|progressive gist
1502646|NCT00767819|progressive sarcoma|progressive sarcoma
1502647|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
1502648|NCT00767754|panic disorder|panic disorder
1502649|NCT00767754|paroxetine|paroxetine
1502650|NCT00767754|PET|pet
1502651|NCT00767741|diabetes|diabetes
1502652|NCT00767741|post prandial glucose level|post prandial glucose level
1502653|NCT00767741|insulin|insulin
1502654|NCT00767741|pharmacokinetics|pharmacokinetics
1502655|NCT00767741|pharmacodynamics|pharmacodynamics
1502656|NCT00767728|UC|uc
1502657|NCT00767728|ulcerative colitis|ulcerative colitis
1502658|NCT00767728|IBD|ibd
1502659|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
1502660|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
1502661|NCT00767702|Human Genetic Variation|human genetic variation
1502662|NCT00767702|Interviews|interviews
1502663|NCT00767702|Research Design|research design
1502664|NCT00767702|Race/Ethnicity|race/ethnicity
1502665|NCT00767702|Interview|interview
1502666|NCT00767676|Contact sensitization|contact sensitization
1502667|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
1502668|NCT00767650|Aplastic Anemia|aplastic anemia
1502669|NCT00767650|Cyclosporine|cyclosporine
1502670|NCT00767650|Campath|campath
1502671|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
1502672|NCT00767611|Infertility|infertility
1502673|NCT00767611|Sperm|sperm
1502674|NCT00767611|Embryo Development|embryo development
1502675|NCT00767611|In Vitro Fertilization|in vitro fertilization
1502676|NCT00767598|CYP3A5|cyp3a5
1502677|NCT00767598|sildenafil|sildenafil
1502678|NCT00767598|udenafil|udenafil
1502679|NCT00767598|vardenafil|vardenafil
1502680|NCT00767585|breast cancer|breast cancer
1502681|NCT00767585|aromatase inhibitors|aromatase inhibitors
1502682|NCT00767585|bone mineral density|bone mineral density
1502683|NCT00767585|osteoporosis|osteoporosis
1502684|NCT00767572|Coarctation of the aorta|coarctation of the aorta
1502685|NCT00767572|cross over design|cross over design
1502686|NCT00767572|atorvastatin|atorvastatin
1502687|NCT00767572|endothelial function|endothelial function
1502688|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
1502689|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
1502690|NCT00767546|parkinson's disease|parkinson's disease
1502691|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
1502692|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
1502693|NCT00767494|OAG|oag
1502694|NCT00767494|OH|oh
1502695|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
1502696|NCT00767481|glaucoma|glaucoma
1502697|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
1502698|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1502699|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
1502700|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1502701|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1502702|NCT00767455|cumulative irritation|cumulative irritation
1502703|NCT00767455|healthy adult volunteers|healthy adult volunteers
1502704|NCT00767429|accelerometer|accelerometer
1502705|NCT00767429|fall risk|fall risk
1502706|NCT00767429|target group|target group
1502707|NCT00767429|field measurements|field measurements
1502708|NCT00767416|MEDI-559|medi-559
1502709|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
1502710|NCT00767416|RSV|rsv
1502711|NCT00767416|Pediatric|pediatric
1502712|NCT00767416|Vaccine|vaccine
1502713|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
1502714|NCT00767390|ACL Patch Placement|acl patch placement
1502715|NCT00767377|Time to Progression|time to progression
1502716|NCT00767377|Overall survival|overall survival
1502717|NCT00767377|Response rate|response rate
1502718|NCT00767377|Quality of Live|quality of live
1502719|NCT00767377|Toxicities|toxicities
1502720|NCT00767364|Infant|infant
1502721|NCT00767338|Infertility|infertility
1502722|NCT00767338|Pregnancy|pregnancy
1502723|NCT00767338|Men|men
1502724|NCT00767338|Palpable varicocele|palpable varicocele
1502725|NCT00767338|Abnormal semen analysis|abnormal semen analysis
1502726|NCT00767338|Intrauterine insemination|intrauterine insemination
1502727|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
1502728|NCT00767312|HIV|hiv
1502729|NCT00767312|Antiretrovial Therapy|antiretrovial therapy
1502730|NCT00767312|Viremia|viremia
1502731|NCT00767312|Genetic Analysis|genetic analysis
1502732|NCT00767312|Single Copy Assay|single copy assay
1502733|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
1502734|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
1502735|NCT00767286|stage III prostate cancer|stage iii prostate cancer
1502736|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
1502737|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
1502738|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
1502739|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
1502740|NCT00767247|Arterial Hypertension|arterial hypertension
1502741|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
1502742|NCT00767195|pulmonary edema|pulmonary edema
1502743|NCT00767195|cardiogenic|cardiogenic
1502744|NCT00767195|non-cardiogenic|non-cardiogenic
1502745|NCT00767195|mortality|mortality
1502746|NCT00767195|length of stay|length of stay
1502747|NCT00767182|preeclampsia|preeclampsia
1502748|NCT00767182|eclampsia|eclampsia
1502749|NCT00767182|retroplacental hematoma|retroplacental hematoma
1502750|NCT00767182|vascular IUGR|vascular iugr
1502751|NCT00767182|IUFD|iufd
1502752|NCT00767182|placental volume|placental volume
1502753|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
1502754|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
1502755|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
1502756|NCT00767117|TMC125-C197|tmc125-c197
1502757|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
1502758|NCT00767117|HIV|hiv
1502759|NCT00767117|DDI|ddi
1502760|NCT00767117|Lopinavir|lopinavir
1502761|NCT00767117|Intelence|intelence
1502762|NCT00767117|Kaletra|kaletra
1502763|NCT00767117|Ritonavir|ritonavir
1502764|NCT00767117|Etravirine|etravirine
1502765|NCT00767117|Interaction|interaction
1502766|NCT00767117|Pharmacokinetics|pharmacokinetics
1502767|NCT00767117|Steady-state|steady-state
1502768|NCT00767091|Parkinson's disease|parkinson's disease
1502769|NCT00767091|Apathy|apathy
1502770|NCT00767091|Rivastigmine|rivastigmine
1502771|NCT00767091|transdermal patch|transdermal patch
1502772|NCT00767091|anticholinesterasic|anticholinesterasic
1502773|NCT00767091|acetylcholine|acetylcholine
1502774|NCT00767052|Healthy Volunteer|healthy volunteer
1502775|NCT00767052|Safety|safety
1502776|NCT00767052|Tolerability|tolerability
1502777|NCT00767052|Pharmacokinetics|pharmacokinetics
1502778|NCT00767052|AZD1236|azd1236
1502779|NCT00767039|Very Premature|very premature
1502780|NCT00767039|RDS|rds
1502781|NCT00767039|Surfactant|surfactant
1502782|NCT00767026|Epilepsy|epilepsy
1502783|NCT00767026|Caregiver Burden|caregiver burden
1502784|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
1502785|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
1502786|NCT00766987|coronary artery disease|coronary artery disease
1502787|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
1502788|NCT00766987|morbidity and mortality|morbidity and mortality
1502789|NCT00766987|revascularization|revascularization
1502790|NCT00766987|resource utilization|resource utilization
1502791|NCT00766974|Chronic Venous Disease|chronic venous disease
1502792|NCT00766974|C3|c3
1502793|NCT00766974|Edema|edema
1502794|NCT00766974|Compression Garments|compression garments
1502795|NCT00766974|Compression Stockings|compression stockings
1502796|NCT00766974|Bioimpedance|bioimpedance
1502797|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
1502798|NCT00766935|Lymphedema|lymphedema
1502799|NCT00766935|Bioimpedance|bioimpedance
1502800|NCT00766909|Insulin pulsatility|insulin pulsatility
1502801|NCT00766909|Insulin secretion|insulin secretion
1502802|NCT00766909|Insulin sensitivity|insulin sensitivity
1502803|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
1502804|NCT00766909|Cyclosporine|cyclosporine
1502805|NCT00766909|Tacrolimus|tacrolimus
1502806|NCT00766896|Stroke|stroke
1502807|NCT00766896|Cerebral Infarction|cerebral infarction
1502808|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
1502809|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
1502810|NCT00766896|Vascular Diseases|vascular diseases
1502811|NCT00766896|Platelet Activation|platelet activation
1502812|NCT00766896|Platelets|platelets
1502813|NCT00766896|Platelet Function Tests|platelet function tests
1502814|NCT00766896|Aspirin|aspirin
1502815|NCT00766896|Atherosclerosis|atherosclerosis
1502816|NCT00766896|Ischemia|ischemia
1502817|NCT00766896|Thrombosis|thrombosis
1502818|NCT00766883|Allogeneic HSCT|allogeneic hsct
1502819|NCT00766883|Psychosocial Distress|psychosocial distress
1502820|NCT00766883|Coping|coping
1502821|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
1502822|NCT00766883|Self Efficacy|self efficacy
1502823|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1502824|NCT00766870|Efficacy|efficacy
1502825|NCT00766870|Safety|safety
1502826|NCT00766870|Depression|depression
1502827|NCT00766870|Interventional|interventional
1502828|NCT00766870|Placebo|placebo
1502829|NCT00766870|Short-term|short-term
1502830|NCT00766870|Major Depressive Disorder|major depressive disorder
1502831|NCT00766870|Major Depressive Episode|major depressive episode
1502832|NCT00766857|Exenatide|exenatide
1502833|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
1502834|NCT00766857|Congestive heart failure|congestive heart failure
1502835|NCT00766857|Incretin hormones|incretin hormones
1502836|NCT00766857|GLP-1 agonist|glp-1 agonist
1502837|NCT00766857|Cardiac metabolism|cardiac metabolism
1502838|NCT00766857|Insulin resistance|insulin resistance
1502839|NCT00766857|Cardiac MRI|cardiac mri
1502840|NCT00766844|vasospasm|vasospasm
1502841|NCT00766844|spinal cord stimulation|spinal cord stimulation
1502842|NCT00766844|aneurysm|aneurysm
1502843|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
1502844|NCT00766831|Cancer pain|cancer pain
1502845|NCT00766831|Hydromorphone OROS|hydromorphone oros
1502846|NCT00766831|Jurnista|jurnista
1502847|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
1502848|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
1502849|NCT00766779|first Complete Remission|first complete remission
1502850|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
1502851|NCT00766753|HLA-A2 positive|hla-a2 positive
1502852|NCT00766753|Malignant Gliomas|malignant gliomas
1502853|NCT00766753|Vaccine|vaccine
1502854|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
1502855|NCT00766740|thrombectomy|thrombectomy
1502856|NCT00766740|primary PCI|primary pci
1502857|NCT00766675|Pain|pain
1502858|NCT00766675|Fibromyalgia|fibromyalgia
1502859|NCT00766675|Ultracet|ultracet
1502860|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
1502861|NCT00766675|Acetaminophen|acetaminophen
1502862|NCT00766662|Malaria|malaria
1502863|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
1502864|NCT00766662|EPI vaccine coverage|epi vaccine coverage
1502865|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
1502866|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
1502867|NCT00766649|Geographic Atrophy|geographic atrophy
1502868|NCT00766649|Sirolimus|sirolimus
1502869|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
1502870|NCT00766649|AMD|amd
1502871|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
1502872|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
1503123|NCT00765648|Labetalol|labetalol
1502873|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
1502874|NCT00766636|Chemoradiation|chemoradiation
1502875|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
1502876|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
1502877|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
1502878|NCT00766636|EBRT|ebrt
1502879|NCT00766636|Gemcitabine|gemcitabine
1502880|NCT00766636|Erlotinib|erlotinib
1502881|NCT00766623|endothelium,|endothelium,
1502882|NCT00766623|postprandial|postprandial
1502883|NCT00766623|microvascular|microvascular
1502884|NCT00766623|macrovascular|macrovascular
1502885|NCT00766597|Treatment Experienced|treatment experienced
1502886|NCT00766584|Aging|aging
1502887|NCT00766584|Autonomic nervous system|autonomic nervous system
1502888|NCT00766584|stroke|stroke
1502889|NCT00766584|Myocardiac infarction|myocardiac infarction
1502890|NCT00766584|Prospective cohort|prospective cohort
1502891|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
1502892|NCT00766571|VACTERL Association|vacterl association
1502893|NCT00766571|VATER Association|vater association
1502894|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
1502895|NCT00766571|VACTERL|vacterl
1502896|NCT00766571|Congenital Defects|congenital defects
1502897|NCT00766571|Birth Defects|birth defects
1502898|NCT00766571|Congenital Abnormalities|congenital abnormalities
1502899|NCT00766558|anorexia|anorexia
1502900|NCT00766558|bulimia|bulimia
1502901|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
1502902|NCT00766519|fluid responsiveness|fluid responsiveness
1502903|NCT00766519|monitoring|monitoring
1502904|NCT00766519|arterial pulse pressure|arterial pulse pressure
1502905|NCT00766506|IONSYS|ionsys
1502906|NCT00766506|Fentanyl|fentanyl
1502907|NCT00766506|Morphine|morphine
1502909|NCT00766506|Postoperative pain|postoperative pain
1502910|NCT00766506|Mobilization|mobilization
1502911|NCT00766493|carotid artery stenosis|carotid artery stenosis
1502912|NCT00766493|embolic protection device|embolic protection device
1502913|NCT00766493|distal embolic filter|distal embolic filter
1502914|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
1502915|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1502916|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
1502917|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
1502918|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
1502919|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
1502920|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
1502921|NCT00766467|armodafinil|armodafinil
1502922|NCT00766467|Nuvigil|nuvigil
1502923|NCT00766467|fatigue|fatigue
1502924|NCT00766454|breast cancer|breast cancer
1502925|NCT00766441|diabetes|diabetes
1502926|NCT00766441|hypoglycemia|hypoglycemia
1502927|NCT00766441|ramadan|ramadan
1502928|NCT00766441|fasting|fasting
1502929|NCT00766415|COPD|copd
1502930|NCT00766415|Moderate to severe COPD|moderate to severe copd
1502931|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
1502932|NCT00766402|Pain|pain
1502933|NCT00766402|Ultracet|ultracet
1502934|NCT00766402|Diclofenac|diclofenac
1502935|NCT00766402|Voltaren|voltaren
1502936|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
1502937|NCT00766389|Glaucoma|glaucoma
1502938|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
1502939|NCT00766389|Cirrus OCT|cirrus oct
1502940|NCT00766389|Stratus OCT|stratus oct
1502941|NCT00766363|Alzheimer's Disease|alzheimer's disease
1502942|NCT00766363|Central Nervous System Diseases|central nervous system diseases
1502943|NCT00766363|Pharmacokinetics|pharmacokinetics
1502944|NCT00766363|Cognition|cognition
1502945|NCT00766350|fibromyalgia|fibromyalgia
1502946|NCT00766350|quetiapine|quetiapine
1502947|NCT00766350|amitriptyline|amitriptyline
1502948|NCT00766337|wet AMD|wet amd
1502949|NCT00766298|Exercise|exercise
1502950|NCT00766298|Weight Loss|weight loss
1502951|NCT00766298|Physical Activity|physical activity
1502952|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1502953|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
1502954|NCT00766272|Rehabilitation|rehabilitation
1502955|NCT00766272|Treadmill|treadmill
1502956|NCT00766272|MS|ms
1502957|NCT00766272|Gait|gait
1502958|NCT00766272|Robot|robot
1502959|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
1502960|NCT00766259|colonization|colonization
1502961|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
1502962|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1502963|NCT00766246|Lung Cancer|lung cancer
1502964|NCT00766233|Hyperthermia|hyperthermia
1502965|NCT00766233|superficial tumor treatment|superficial tumor treatment
1502966|NCT00766233|superficial tumors|superficial tumors
1502967|NCT00766220|Colon|colon
1502968|NCT00766220|Liver|liver
1502969|NCT00766220|Colorectal cancer|colorectal cancer
1502970|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
1502971|NCT00766220|Metastases to the liver|metastases to the liver
1502972|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
1502973|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
1502974|NCT00766220|Yttrium microspheres|yttrium microspheres
1502975|NCT00766220|SIR-Spheres|sir-spheres
1502976|NCT00766220|Yttrium-90|yttrium-90
1502977|NCT00766220|Cetuximab|cetuximab
1502978|NCT00766220|C225|c225
1502979|NCT00766220|Erbitux|erbitux
1502980|NCT00766220|IMC-C225|imc-c225
1502981|NCT00766220|Irinotecan|irinotecan
1502982|NCT00766220|CPT-11|cpt-11
1502983|NCT00766220|Liver directed therapy|liver directed therapy
1502984|NCT00766207|Teratogens|teratogens
1502985|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
1502986|NCT00766207|Contraception|contraception
1502987|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
1502988|NCT00766168|contact lens|contact lens
1502989|NCT00766168|rigid gas permeable|rigid gas permeable
1502990|NCT00766168|refractive index|refractive index
1502991|NCT00766155|stage II rectal cancer|stage ii rectal cancer
1502992|NCT00766155|stage III rectal cancer|stage iii rectal cancer
1502993|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1502994|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
1502995|NCT00766142|recurrent colon cancer|recurrent colon cancer
1502996|NCT00766142|stage IV colon cancer|stage iv colon cancer
1502997|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1502998|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
1502999|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
1503000|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
1503001|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
1503002|NCT00766116|AML|aml
1503003|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
1503004|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
1503005|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
1503006|NCT00766051|NBOTI|nboti
1503007|NCT00766051|NICU|nicu
1503008|NCT00766051|NCCU|nccu
1503009|NCT00766051|Developmental Biology|developmental biology
1503010|NCT00766051|Critical Period|critical period
1503011|NCT00766051|Brain Development|brain development
1503012|NCT00766051|Sensory Integration|sensory integration
1503013|NCT00766051|Neurodevelopment|neurodevelopment
1503014|NCT00766051|Sensitive Period|sensitive period
1503015|NCT00766038|Mood disorders|mood disorders
1503016|NCT00766038|Cognitive disorders|cognitive disorders
1503017|NCT00766038|Fatigue|fatigue
1503018|NCT00766038|Metabolic disorders|metabolic disorders
1503019|NCT00766025|Taiwanese Subjects|taiwanese subjects
1503020|NCT00766025|CYP2C19|cyp2c19
1503021|NCT00766025|Poor Metabolizers|poor metabolizers
1503022|NCT00766025|Extensive Metabolizers|extensive metabolizers
1503023|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
1503024|NCT00766012|safety|safety
1503025|NCT00766012|tolerability|tolerability
1503026|NCT00766012|pharmacokinetics|pharmacokinetics
1503027|NCT00766012|AZD2066|azd2066
1503028|NCT00766012|Japanese|japanese
1503029|NCT00765999|Constipation|constipation
1503030|NCT00765999|Chronic Constipation|chronic constipation
1503031|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
1503032|NCT00765999|Linaclotide|linaclotide
1503033|NCT00765986|18F-FAZA|18f-faza
1503034|NCT00765986|18F-FDG|18f-fdg
1503035|NCT00765986|Positron Emission Tomography|positron emission tomography
1503036|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
1503037|NCT00765960|Vision|vision
1503038|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
1503039|NCT00765934|Healthy|healthy
1503040|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
1503041|NCT00765921|macular edema|macular edema
1503042|NCT00765921|eye enucleation|eye enucleation
1503043|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
1503044|NCT00765921|radiation oncology|radiation oncology
1503045|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
1503046|NCT00765882|Constipation|constipation
1503047|NCT00765882|Chronic Constipation|chronic constipation
1503048|NCT00765882|Linaclotide|linaclotide
1503049|NCT00765869|Decision support techniques|decision support techniques
1503050|NCT00765856|Opioid tolerant|opioid tolerant
1503051|NCT00765856|Pediatric|pediatric
1503052|NCT00765856|Male 6-17 years of age|male 6-17 years of age
1503053|NCT00765856|Female 6-17 years of age|female 6-17 years of age
1503054|NCT00765856|Pain|pain
1503055|NCT00765856|Non malignant|non malignant
1503056|NCT00765856|Malignant|malignant
1503057|NCT00765843|heel pain|heel pain
1503058|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
1503059|NCT00765817|diabetes|diabetes
1503060|NCT00765817|exenatide|exenatide
1503061|NCT00765817|Amylin|amylin
1503062|NCT00765817|Lilly|lilly
1503063|NCT00765817|metformin|metformin
1503064|NCT00765817|pioglitazone|pioglitazone
1503065|NCT00765817|insulin glargine|insulin glargine
1503066|NCT00765804|Dry Eye|dry eye
1503067|NCT00765804|Iontophoresis|iontophoresis
1503068|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
1503069|NCT00765791|head and neck cancer|head and neck cancer
1503070|NCT00765791|oral cancer|oral cancer
1503071|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
1503072|NCT00765791|laryngeal cancer|laryngeal cancer
1503073|NCT00765791|selective neck dissection|selective neck dissection
1503074|NCT00765791|submuscular recess|submuscular recess
1503075|NCT00765791|level 2b|level 2b
1503076|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
1503077|NCT00765765|stage IV breast cancer|stage iv breast cancer
1503078|NCT00765765|recurrent breast cancer|recurrent breast cancer
1503079|NCT00765765|male breast cancer|male breast cancer
1503080|NCT00765752|Insomnia|insomnia
1503081|NCT00765752|depression|depression
1503082|NCT00765752|GABA|gaba
1503083|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1503084|NCT00765752|MRS|mrs
1503085|NCT00765752|Sleep|sleep
1503086|NCT00765752|antidepressant medication use|antidepressant medication use
1503087|NCT00765739|muscle fibers|muscle fibers
1503088|NCT00765739|aging|aging
1503089|NCT00765726|hemophilia|hemophilia
1503090|NCT00765726|hemophilia A|hemophilia a
1503091|NCT00765726|ReFacto|refacto
1503092|NCT00765726|Xyntha|xyntha
1503093|NCT00765726|moroctocog alfa|moroctocog alfa
1503094|NCT00765726|bleeding disorder|bleeding disorder
1503095|NCT00765713|Sleep apnea|sleep apnea
1503096|NCT00765713|CPAP|cpap
1503097|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
1503098|NCT00765713|Defibrillator therapies|defibrillator therapies
1503099|NCT00765700|Sprain|sprain
1503100|NCT00765700|Strain|strain
1503101|NCT00765700|Pain|pain
1503102|NCT00765700|Ankle Pain|ankle pain
1503103|NCT00765700|Shoulder Pain|shoulder pain
1503104|NCT00765700|Elbow Pain|elbow pain
1503105|NCT00765700|Tennis Elbow|tennis elbow
1503106|NCT00765700|Knee pain|knee pain
1503107|NCT00765700|Wrist Pain|wrist pain
1503108|NCT00765700|Hand Pain|hand pain
1503109|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
1503110|NCT00765674|aliskiren|aliskiren
1503111|NCT00765674|antihypertensive|antihypertensive
1503112|NCT00765674|hypertension|hypertension
1503113|NCT00765674|renin inhibitor|renin inhibitor
1503114|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
1503115|NCT00765661|Kidney|kidney
1503116|NCT00765661|Transplantation|transplantation
1503117|NCT00765661|Immunosuppression|immunosuppression
1503118|NCT00765661|Tacrolimus|tacrolimus
1503119|NCT00765661|Prograf|prograf
1503120|NCT00765648|hypertension|hypertension
1503121|NCT00765648|emergency department|emergency department
1503122|NCT00765648|Nicardipine|nicardipine
1503124|NCT00765648|hypertensive emergency|hypertensive emergency
1503125|NCT00765648|hypertensive urgency|hypertensive urgency
1503126|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
1503127|NCT00765622|Urinary incontinence|urinary incontinence
1503128|NCT00765622|pelvic floor|pelvic floor
1503129|NCT00765622|functional evaluation|functional evaluation
1503130|NCT00765609|Paediatric|paediatric
1503131|NCT00765609|Analgesic|analgesic
1503132|NCT00765609|Prescribing|prescribing
1503133|NCT00765609|Parents|parents
1503134|NCT00765596|Obesity|obesity
1503135|NCT00765596|Insulin resistance|insulin resistance
1503136|NCT00765596|Gastric tube|gastric tube
1503137|NCT00765596|Ghrelin|ghrelin
1503138|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
1503139|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
1503140|NCT00765557|To determine if laxative therapy can resolve Urge Syndrome, and if so, in which patients.|to determine if laxative therapy can resolve urge syndrome, and if so, in which patients.
1503141|NCT00765557|To determine usefulness of KUB, an abdominal X-ray of the kidneys, ureters, and bladder.|to determine usefulness of kub, an abdominal x-ray of the kidneys, ureters, and bladder.
1503142|NCT00765557|To predict the bowel activity of children with Urge Syndrome, who are most likely to respond to laxatives, with the use of the Bowel/Bladder questionnaire.|to predict the bowel activity of children with urge syndrome, who are most likely to respond to laxatives, with the use of the bowel/bladder questionnaire.
1503143|NCT00765544|MS|ms
1503144|NCT00765544|Rehabilitation|rehabilitation
1503145|NCT00765544|Treadmill|treadmill
1503146|NCT00765544|Robot|robot
1503147|NCT00765544|Foot-drop|foot-drop
1503148|NCT00765531|To determine the prevalence of genetic mutations in a population.|to determine the prevalence of genetic mutations in a population.
1503149|NCT00765531|To identify stone formers with significant family history of stones.|to identify stone formers with significant family history of stones.
1503150|NCT00765531|To follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.|to follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.
1503151|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
1503152|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
1503153|NCT00765518|ixmyelocel-T|ixmyelocel-t
1503154|NCT00765505|Insulin Resistance|insulin resistance
1503155|NCT00765505|Obesity|obesity
1503156|NCT00765505|Exercise Training|exercise training
1503157|NCT00765505|Physical Activity|physical activity
1503158|NCT00765492|Phase I|phase i
1503159|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
1503160|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
1503161|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
1503162|NCT00765453|Heart attack|heart attack
1503163|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
1503166|NCT00765453|bone marrow stem cells|bone marrow stem cells
1503167|NCT00765453|autologous|autologous
1503168|NCT00765453|left ventricular function|left ventricular function
1503169|NCT00765453|intracoronary injection|intracoronary injection
1503170|NCT00765440|infection|infection
1503171|NCT00765440|malnutrition|malnutrition
1503172|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1503173|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1503174|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1503175|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1503176|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1503177|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1503178|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1503179|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1503180|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1503181|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1503182|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1503183|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1503184|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1503185|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1503186|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1503187|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1503188|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1503189|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1503190|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1503191|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1503192|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1503374|NCT00764322|menopausal symptoms|menopausal symptoms
1503193|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1503194|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1503195|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1503196|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1503197|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1503198|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1503199|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1503200|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1503201|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1503202|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1503203|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1503204|NCT00765440|tongue cancer|tongue cancer
1503205|NCT00765401|Abdominal Pain|abdominal pain
1503206|NCT00765401|Cystic Fibrosis|cystic fibrosis
1503207|NCT00765401|H. pylori|h. pylori
1503208|NCT00765401|Children|children
1503209|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
1503213|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
1503214|NCT00765323|Octreotide|octreotide
1503215|NCT00765323|Sandostatin LAR|sandostatin lar
1503216|NCT00765323|Growth hormone|growth hormone
1503217|NCT00765323|IGF-1|igf-1
1503218|NCT00765310|atherosclerosis|atherosclerosis
1503219|NCT00765310|lipoic acid|lipoic acid
1503220|NCT00765310|thioctic acid|thioctic acid
1503221|NCT00765310|triglycerides|triglycerides
1503222|NCT00765310|overweight|overweight
1503223|NCT00765310|obesity|obesity
1503224|NCT00765310|oxidative stress|oxidative stress
1503225|NCT00765310|inflammation|inflammation
1503226|NCT00765297|fall risk|fall risk
1503227|NCT00765297|movement characteristics|movement characteristics
1503228|NCT00765297|stumble detection|stumble detection
1503229|NCT00765297|accelerometry|accelerometry
1503231|NCT00765284|RCT|rct
1503232|NCT00765284|Cholesterol|cholesterol
1503233|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1503234|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1503235|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1503236|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1503333|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
1503237|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1503238|NCT00765232|laparoscopic|laparoscopic
1503239|NCT00765232|donor|donor
1503240|NCT00765232|nephrectomy|nephrectomy
1503241|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
1503242|NCT00765219|Geriatric|geriatric
1503243|NCT00765180|colonoscopy|colonoscopy
1503244|NCT00765180|hood|hood
1503245|NCT00765180|NBI|nbi
1503246|NCT00765141|wound debridement|wound debridement
1503247|NCT00765141|removed orthopedic implants|removed orthopedic implants
1503248|NCT00765141|removed catheters or shunts|removed catheters or shunts
1503249|NCT00765141|excised tonsils|excised tonsils
1503250|NCT00765141|amputated tissue|amputated tissue
1503251|NCT00765141|sputum, stool|sputum, stool
1503252|NCT00765141|or other excretions.|or other excretions.
1503253|NCT00765128|Percutaneous|percutaneous
1503254|NCT00765128|Nephrolithotomy|nephrolithotomy
1503255|NCT00765128|Kidney stones|kidney stones
1503256|NCT00765102|Multiple Myelonoma|multiple myelonoma
1503257|NCT00765102|Romidepsin|romidepsin
1503258|NCT00765102|Bortezomib|bortezomib
1503259|NCT00765076|Vaccine|vaccine
1503260|NCT00765076|Elderly|elderly
1503261|NCT00765076|Influenza|influenza
1503262|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
1503263|NCT00765050|Cellular therapy|cellular therapy
1503264|NCT00765050|CD133+|cd133+
1503265|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
1503266|NCT00765011|Head and Neck Cancer|head and neck cancer
1503267|NCT00764998|Influenza|influenza
1503268|NCT00764998|HIV|hiv
1503269|NCT00764998|Influenza Vaccine|influenza vaccine
1503270|NCT00764998|Efficacy|efficacy
1503271|NCT00764985|Syncope|syncope
1503272|NCT00764985|Pre-Syncope|pre-syncope
1503273|NCT00764985|Fainting|fainting
1503274|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
1503275|NCT00764933|information programme|information programme
1503276|NCT00764933|anxiety reduction|anxiety reduction
1503277|NCT00764933|multicenter trial|multicenter trial
1503278|NCT00764933|intensive care|intensive care
1503279|NCT00764933|critical care|critical care
1503280|NCT00764920|human skin|human skin
1503281|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1503557|NCT00763633|vomiting|vomiting
1503282|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1503283|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1503284|NCT00764881|Oral contraceptive|oral contraceptive
1503285|NCT00764881|Sexual dysfunction|sexual dysfunction
1503286|NCT00764881|Libido|libido
1503287|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1503288|NCT00764829|fludarabine|fludarabine
1503289|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
1503290|NCT00764829|mycophenolic acid|mycophenolic acid
1503291|NCT00764829|biomarkers|biomarkers
1503292|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
1503293|NCT00764816|phosphaturia|phosphaturia
1503294|NCT00764816|phosphorus|phosphorus
1503295|NCT00764816|PTH|pth
1503296|NCT00764816|FGF23|fgf23
1503297|NCT00764816|Dietary protein source|dietary protein source
1503298|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
1503299|NCT00764777|Intermittent Claudication|intermittent claudication
1503300|NCT00764777|Critical limb Ischemia|critical limb ischemia
1503301|NCT00764777|TASC A|tasc a
1503302|NCT00764777|TASC B|tasc b
1503303|NCT00764777|TASC C|tasc c
1503304|NCT00764777|TASC D|tasc d
1503305|NCT00764777|balloon-expandable stent|balloon-expandable stent
1503306|NCT00764777|Self-expanding stent|self-expanding stent
1503307|NCT00764777|TASC|tasc
1503308|NCT00764764|shoulder pain|shoulder pain
1503309|NCT00764764|rotator cuff|rotator cuff
1503310|NCT00764764|impingement|impingement
1503311|NCT00764764|cervical referred pain|cervical referred pain
1503312|NCT00764764|neural tension|neural tension
1503313|NCT00764738|ARMD|armd
1503314|NCT00764738|AMD|amd
1503315|NCT00764738|exudative AMD|exudative amd
1503316|NCT00764712|Tight glycemia control|tight glycemia control
1503317|NCT00764712|cardiac surgery patients|cardiac surgery patients
1503318|NCT00764699|poor growth|poor growth
1503319|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
1503320|NCT00764686|Exercise|exercise
1503321|NCT00764686|Education|education
1503322|NCT00764686|Hydrotherapy|hydrotherapy
1503323|NCT00764686|Physical Therapy Modalities|physical therapy modalities
1503324|NCT00764647|family caregivers|family caregivers
1503325|NCT00764647|caregiver education|caregiver education
1503326|NCT00764647|caregiver burden|caregiver burden
1503327|NCT00764647|caregiver hardiness|caregiver hardiness
1503328|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
1503329|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
1503330|NCT00764621|Contrast media|contrast media
1503331|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
1503332|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
1503334|NCT00764621|Liver|liver
1503335|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1503336|NCT00764595|liver metastases|liver metastases
1503337|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
1503338|NCT00764569|oral tissue|oral tissue
1503339|NCT00764556|Glucose|glucose
1503340|NCT00764556|Insulin|insulin
1503341|NCT00764556|COPD|copd
1503342|NCT00764556|Exacerbations|exacerbations
1503343|NCT00764556|Tight glycaemic control|tight glycaemic control
1503344|NCT00764556|Acute hospital ward|acute hospital ward
1503464|NCT00764023|other excretions.|other excretions.
1503345|NCT00764543|To measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys|to measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys
1503346|NCT00764543|To compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.|to compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.
1503347|NCT00764465|Healthy Subjects|healthy subjects
1503348|NCT00764465|Pharmacokinetics study|pharmacokinetics study
1503349|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
1503350|NCT00764426|alcoholic beverages|alcoholic beverages
1503351|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
1503352|NCT00764426|inflammation|inflammation
1503353|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
1503354|NCT00764413|EDSS|edss
1503355|NCT00764413|methylprednisolone|methylprednisolone
1503356|NCT00764413|circadian rhythms|circadian rhythms
1503357|NCT00764413|MSFC|msfc
1503358|NCT00764400|aphasia|aphasia
1503359|NCT00764400|anomia|anomia
1503360|NCT00764400|speech therapy|speech therapy
1503361|NCT00764400|rehabilitation|rehabilitation
1503362|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
1503363|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
1503364|NCT00764387|Comparison|comparison
1503365|NCT00764374|YM443|ym443
1503366|NCT00764374|Z-338|z-338
1503367|NCT00764374|Acotiamide|acotiamide
1503368|NCT00764374|Rome III|rome iii
1503369|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
1503370|NCT00764361|Diabetic|diabetic
1503371|NCT00764361|Ulcer|ulcer
1503372|NCT00764361|Wound|wound
1503373|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
1503375|NCT00764322|recurrent breast cancer|recurrent breast cancer
1503376|NCT00764322|stage I breast cancer|stage i breast cancer
1503377|NCT00764322|stage II breast cancer|stage ii breast cancer
1503378|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
1503379|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
1503380|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
1503381|NCT00764322|stage IV breast cancer|stage iv breast cancer
1503382|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1503383|NCT00764322|breast cancer in situ|breast cancer in situ
1503384|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
1503385|NCT00764270|atherosclerosis|atherosclerosis
1503386|NCT00764270|lipoic acid|lipoic acid
1503387|NCT00764270|thioctic acid|thioctic acid
1503388|NCT00764270|triglycerides|triglycerides
1503389|NCT00764270|overweight|overweight
1503390|NCT00764270|obesity|obesity
1503391|NCT00764270|oxidative stress|oxidative stress
1503392|NCT00764270|inflammation|inflammation
1503393|NCT00764244|Diabetes|diabetes
1503394|NCT00764244|Macular edema|macular edema
1503395|NCT00764244|Optical Coherence tomography|optical coherence tomography
1503396|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
1503397|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
1503398|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
1503399|NCT00764231|exercise|exercise
1503400|NCT00764231|fatigue|fatigue
1503401|NCT00764231|quality of life|quality of life
1503402|NCT00764231|home-based|home-based
1503403|NCT00764231|AML|aml
1503404|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1503405|NCT00764218|Hypertension|hypertension
1503406|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
1503407|NCT00764205|ACS|acs
1503408|NCT00764205|non STEMI|non stemi
1503409|NCT00764205|ECG troponin|ecg troponin
1503410|NCT00764205|iSTAT|istat
1503411|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
1503412|NCT00764192|hemodialysis|hemodialysis
1503413|NCT00764192|Flow-mediated dilation|flow-mediated dilation
1503414|NCT00764192|nictric oxide|nictric oxide
1503415|NCT00764192|endothelial function|endothelial function
1503416|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
1503417|NCT00764166|PSA (biochemical)|psa (biochemical)
1503418|NCT00764166|Progression- free Survival|progression- free survival
1503419|NCT00764166|Clinical progress|clinical progress
1503420|NCT00764166|Overall survival|overall survival
1503421|NCT00764166|Tolerance to the treatment|tolerance to the treatment
1503422|NCT00764166|Quality of Live|quality of live
1503514|NCT00763828|Hypothermia, Induced|hypothermia, induced
1503423|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
1503424|NCT00764153|Treatment|treatment
1503425|NCT00764153|Function|function
1503426|NCT00764153|Pain|pain
1503427|NCT00764153|Quality of life|quality of life
1503428|NCT00764153|Complications|complications
1503429|NCT00764153|Reoperations|reoperations
1503430|NCT00764153|Internal Fixation|internal fixation
1503431|NCT00764153|Hemiarthroplasty|hemiarthroplasty
1503432|NCT00764153|Activities of Daily Living|activities of daily living
1503433|NCT00764140|tumor growth factor|tumor growth factor
1503434|NCT00764127|adolescent|adolescent
1503435|NCT00764127|obesity|obesity
1503436|NCT00764127|bariatric surgery|bariatric surgery
1503437|NCT00764127|eating|eating
1503438|NCT00764114|Spondylodiscitis|spondylodiscitis
1503439|NCT00764114|Duration treatment|duration treatment
1503440|NCT00764114|Antibiotic|antibiotic
1503441|NCT00764114|men or women more than 18 years|men or women more than 18 years
1503442|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
1503443|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
1503444|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
1503445|NCT00764114|Radiological|radiological
1503446|NCT00764114|microbiological criteria|microbiological criteria
1503447|NCT00764088|full Thickness wounds|full thickness wounds
1503448|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
1503449|NCT00764062|Amoxicillin|amoxicillin
1503450|NCT00764062|Drug resistance, microbial|drug resistance, microbial
1503451|NCT00764062|Streptococcus|streptococcus
1503452|NCT00764062|Surgery, oral|surgery, oral
1503453|NCT00764049|Albumin dialysis|albumin dialysis
1503454|NCT00764049|Artificial liver support|artificial liver support
1503455|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
1503456|NCT00764036|phase I|phase i
1503457|NCT00764036|safety|safety
1503458|NCT00764023|wound debridement|wound debridement
1503459|NCT00764023|removed orthopedic implants|removed orthopedic implants
1503460|NCT00764023|removed catheters or shunts|removed catheters or shunts
1503461|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
1503462|NCT00764023|sputum|sputum
1503463|NCT00764023|stool|stool
1503465|NCT00763997|dipyrone|dipyrone
1503466|NCT00763997|platelet aggregation|platelet aggregation
1503467|NCT00763997|neuraxial blockage|neuraxial blockage
1503468|NCT00763997|ibuprofen|ibuprofen
1503558|NCT00763633|pregnancy|pregnancy
1503469|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
1503470|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
1503471|NCT00763984|Bladder Control for Women|bladder control for women
1503472|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
1503473|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
1503474|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
1503475|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
1503476|NCT00763984|Pelvic Support Problems|pelvic support problems
1503477|NCT00763984|Pregnancy|pregnancy
1503478|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
1503479|NCT00763984|Urinary Incontinence|urinary incontinence
1503480|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
1503481|NCT00763958|opiates|opiates
1503483|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
1503484|NCT00763945|STEMI|stemi
1503485|NCT00763945|NSTEMI|nstemi
1503486|NCT00763945|Registry|registry
1503487|NCT00763919|Patient Non-Adherence|patient non-adherence
1503488|NCT00763919|Patient Non-Compliance|patient non-compliance
1503489|NCT00763919|Patient Nonadherence|patient nonadherence
1503490|NCT00763919|Patient Noncompliance|patient noncompliance
1503491|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
1503492|NCT00763919|Refusal of Treatment|refusal of treatment
1503493|NCT00763919|Treatment Refusal|treatment refusal
1503494|NCT00763906|septic shock|septic shock
1503495|NCT00763906|fuzzy logic|fuzzy logic
1503496|NCT00763906|norepinephrine weaning|norepinephrine weaning
1503497|NCT00763893|Marfan syndrome|marfan syndrome
1503498|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1503499|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
1503500|NCT00763880|Hematoma block|hematoma block
1503501|NCT00763880|Lidocaine|lidocaine
1503502|NCT00763880|Forearm fracture|forearm fracture
1503503|NCT00763880|Radius fracture|radius fracture
1503504|NCT00763880|Ulna fracture|ulna fracture
1503505|NCT00763880|Ketamine|ketamine
1503506|NCT00763880|Midazolam|midazolam
1503507|NCT00763880|Procedural sedation|procedural sedation
1503508|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
1503509|NCT00763867|Decompensated Heart Failure|decompensated heart failure
1503510|NCT00763867|Sildenafil|sildenafil
1503511|NCT00763867|Exercise Capacity|exercise capacity
1503512|NCT00763841|Auditory hallucinations|auditory hallucinations
1503513|NCT00763828|Myocardial Infarction|myocardial infarction
1503515|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
1503516|NCT00763789|conscious sedation|conscious sedation
1503517|NCT00763789|remifentanil|remifentanil
1503518|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
1503519|NCT00763789|anesthesia recovery period|anesthesia recovery period
1503520|NCT00763789|ambulatory surgery|ambulatory surgery
1503521|NCT00763789|patient satisfaction|patient satisfaction
1503522|NCT00763789|length of stay|length of stay
1503523|NCT00763776|Liver cirrhosis|liver cirrhosis
1503524|NCT00763776|Hepatectomy|hepatectomy
1503525|NCT00763776|Liver parenchyma transection|liver parenchyma transection
1503526|NCT00763776|Randomized controlled trial|randomized controlled trial
1503527|NCT00763763|Imatinib mesylate|imatinib mesylate
1503528|NCT00763763|Combination therapy|combination therapy
1503529|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
1503530|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
1503531|NCT00763763|Blast Crisis|blast crisis
1503532|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
1503533|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
1503534|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
1503535|NCT00763737|fetal surgery|fetal surgery
1503536|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
1503537|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
1503538|NCT00763737|liver position|liver position
1503539|NCT00763737|feto|feto
1503540|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
1503541|NCT00763737|standardized neonatal care|standardized neonatal care
1503542|NCT00763711|Urinary Incontinence|urinary incontinence
1503543|NCT00763711|ISD|isd
1503544|NCT00763698|Left heart pacing lead|left heart pacing lead
1503545|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1503546|NCT00763698|Heart failure|heart failure
1503547|NCT00763698|ICD|icd
1503548|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
1503549|NCT00763685|postoperative pain|postoperative pain
1503550|NCT00763672|Preeclampsia|preeclampsia
1503551|NCT00763672|Hypertension|hypertension
1503552|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
1503553|NCT00763672|Antiangiogenic factor|antiangiogenic factor
1503554|NCT00763672|Prevention|prevention
1503555|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
1503556|NCT00763633|nausea|nausea
1503559|NCT00763633|B6|b6
1503560|NCT00763620|Community acquired pneumonia|community acquired pneumonia
1503561|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
1503562|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
1503563|NCT00763620|Endotracheal aspirates|endotracheal aspirates
1503564|NCT00763620|Expectorated sputum|expectorated sputum
1503565|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
1503566|NCT00763594|Major Depression|major depression
1503567|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
1503568|NCT00763594|Brief Relational Therapy|brief relational therapy
1503569|NCT00763594|Outcome research|outcome research
1503570|NCT00763581|Patient Non-Adherence|patient non-adherence
1503571|NCT00763581|Patient Non-Compliance|patient non-compliance
1503572|NCT00763581|Patient Nonadherence|patient nonadherence
1503573|NCT00763581|Patient Noncompliance|patient noncompliance
1503574|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
1503575|NCT00763581|Treatment Refusal|treatment refusal
1503576|NCT00763581|Refusal of Treatment|refusal of treatment
1503577|NCT00763568|Chronic hepatitis C|chronic hepatitis c
1503578|NCT00763568|Viral hepatitis|viral hepatitis
1503579|NCT00763555|psoriasis|psoriasis
1503580|NCT00763555|spray|spray
1503581|NCT00763555|calcitriol|calcitriol
1503582|NCT00763516|Pancreatic Cancer|pancreatic cancer
1503583|NCT00763516|Proton radiation|proton radiation
1503584|NCT00763516|Chemotherapy|chemotherapy
1503585|NCT00763516|Xeloda|xeloda
1503586|NCT00763516|Gemzar|gemzar
1503587|NCT00763516|Resectable|resectable
1503588|NCT00763516|Surgery|surgery
1503589|NCT00763503|psoriasis|psoriasis
1503590|NCT00763503|PK|pk
1503591|NCT00763503|calcitriol|calcitriol
1503592|NCT00763490|umbilical cord blood|umbilical cord blood
1503593|NCT00763490|stem cell transplant|stem cell transplant
1503594|NCT00763490|leukemia|leukemia
1503595|NCT00763490|multiple myeloma|multiple myeloma
1503596|NCT00763490|lymphoma|lymphoma
1503597|NCT00763477|Cystic fibrosis|cystic fibrosis
1503598|NCT00763477|Weight|weight
1503599|NCT00763477|Appetite|appetite
1503600|NCT00763477|Ghrelin|ghrelin
1503601|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
1503602|NCT00763464|Coronary Artery Disease|coronary artery disease
1503603|NCT00763464|ischemia diagnostic|ischemia diagnostic
1503604|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
1503605|NCT00763438|Schizophrenia|schizophrenia
1503606|NCT00763438|Sertindole|sertindole
1503607|NCT00763438|Safety study|safety study
1503608|NCT00763425|polypectomy|polypectomy
1503609|NCT00763425|colonic polyp|colonic polyp
1503610|NCT00763425|colorectal polyp|colorectal polyp
1503611|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
1503612|NCT00763412|Cystic Fibrosis|cystic fibrosis
1503613|NCT00763412|Diabetes|diabetes
1503614|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
1503615|NCT00763412|Pre-diabetes|pre-diabetes
1503616|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
1503617|NCT00763412|Repaglinide|repaglinide
1503618|NCT00763412|treatment|treatment
1503619|NCT00763412|inflammatory markers|inflammatory markers
1503620|NCT00763412|Lung function|lung function
1503621|NCT00763412|nutrition|nutrition
1503622|NCT00763399|probiotics|probiotics
1503623|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
1503624|NCT00763386|Osteoarthritis|osteoarthritis
1503625|NCT00763386|Knee|knee
1503626|NCT00763373|Lower respiratory infection|lower respiratory infection
1503627|NCT00763373|Upper respiratory infection|upper respiratory infection
1503628|NCT00763373|Urinary tract infection|urinary tract infection
1503629|NCT00763373|Soft tissue infection|soft tissue infection
1503630|NCT00763373|Hepatobiliary infection|hepatobiliary infection
1503631|NCT00763360|Cataract|cataract
1503632|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
1503633|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
1503634|NCT00763347|Type II Diabetes|type ii diabetes
1503635|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503636|NCT00763347|Dyslipidemia|dyslipidemia
1503637|NCT00763347|Drug Therapy|drug therapy
1503638|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
1503639|NCT00763308|Weight|weight
1503640|NCT00763308|Blood Pressure|blood pressure
1503641|NCT00763308|Smoking Status|smoking status
1503642|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
1503643|NCT00763295|latent tuberculosis|latent tuberculosis
1503644|NCT00763295|HIV|hiv
1503645|NCT00763295|IFN-γ based assay|ifn-γ based assay
1503646|NCT00763282|Spinal cord injuries|spinal cord injuries
1503647|NCT00763282|Pressure ulcers|pressure ulcers
1503648|NCT00763282|Health behavior|health behavior
1503649|NCT00763282|self management|self management
1503650|NCT00763282|Rehabilitation|rehabilitation
1503651|NCT00763282|Outcome assessment|outcome assessment
1503652|NCT00763282|QUERI|queri
1503653|NCT00763282|Veterans|veterans
1503654|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
1503655|NCT00763230|Depression|depression
1503656|NCT00763230|Treatment|treatment
1503657|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
1503658|NCT00763217|inflammation|inflammation
1503659|NCT00763217|coagulation|coagulation
1503660|NCT00763217|neuroprotection|neuroprotection
1503661|NCT00763217|drugs|drugs
1503662|NCT00763217|clinical neurology|clinical neurology
1503663|NCT00763217|pharmacology|pharmacology
1503664|NCT00763217|biological factors|biological factors
1503665|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
1503666|NCT00763204|Topical|topical
1503667|NCT00763178|PTSD|ptsd
1503668|NCT00763152|prostate|prostate
1503669|NCT00763152|prostate bed|prostate bed
1503670|NCT00763152|periprostatic|periprostatic
1503671|NCT00763139|RA|ra
1503672|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
1503673|NCT00763126|parturient|parturient
1503674|NCT00763126|epidural analgesia|epidural analgesia
1503675|NCT00763126|labor|labor
1503676|NCT00763126|spouse|spouse
1503677|NCT00763126|Stress levels|stress levels
1503678|NCT00763126|Salivary amylase|salivary amylase
1503679|NCT00763100|Breast cancer|breast cancer
1503680|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
1503681|NCT00763100|Breast cancer surveillance|breast cancer surveillance
1503682|NCT00763100|Tomosynthesis|tomosynthesis
1503683|NCT00763087|diabetes mellitus|diabetes mellitus
1503684|NCT00763087|peripheral neuropathy|peripheral neuropathy
1503685|NCT00763087|exercise|exercise
1503686|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
1503687|NCT00763074|Adipokines|adipokines
1503688|NCT00763074|Exercise|exercise
1503689|NCT00763074|Diet therapy|diet therapy
1503690|NCT00763061|Glaucoma|glaucoma
1503691|NCT00763035|Coronary Artery Disease|coronary artery disease
1503692|NCT00763035|Coronary Vessels|coronary vessels
1503693|NCT00763035|Myocardial Ischemia|myocardial ischemia
1503694|NCT00763035|Coronary Disease|coronary disease
1503695|NCT00763035|Ischemic heart disease|ischemic heart disease
1503696|NCT00763035|asthma|asthma
1503697|NCT00763035|copd|copd
1503698|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
1503699|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
1503700|NCT00763022|Type II Diabetes|type ii diabetes
1503701|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503702|NCT00763022|Dyslipidemia|dyslipidemia
1503703|NCT00763022|Drug Therapy|drug therapy
1503704|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
1503705|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
1503706|NCT00762957|Type II Diabetes|type ii diabetes
1503707|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503708|NCT00762957|Dyslipidemia|dyslipidemia
1503709|NCT00762957|Drug Therapy|drug therapy
1503710|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
1503711|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
1503712|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
1503713|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
1503714|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
1503715|NCT00762944|Multiple operated joints|multiple operated joints
1503716|NCT00762931|bronchoconstriction|bronchoconstriction
1503717|NCT00762931|neuromodulation|neuromodulation
1503718|NCT00762931|neurostimulation|neurostimulation
1503719|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
1503720|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
1503721|NCT00762931|nVNS|nvns
1503722|NCT00762931|VNS|vns
1503723|NCT00762931|non invasive|non invasive
1503724|NCT00762931|gammacore|gammacore
1503725|NCT00762918|cystic fibrosis|cystic fibrosis
1503726|NCT00762918|vitamin d|vitamin d
1503727|NCT00762918|inflammation|inflammation
1503728|NCT00762905|cyanoacrylate|cyanoacrylate
1503729|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
1503730|NCT00762905|Dermabond|dermabond
1503731|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
1503732|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
1503733|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
1503734|NCT00762892|Raltegravir|raltegravir
1503735|NCT00762892|Integrase inhibitor|integrase inhibitor
1503736|NCT00762892|Protease inhibitor|protease inhibitor
1503737|NCT00762892|Naive patients|naive patients
1503738|NCT00762892|HIV disease|hiv disease
1503739|NCT00762892|Lipids|lipids
1503740|NCT00762892|Treatment Naïve|treatment naïve
1503741|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1503742|NCT00762879|JIA|jia
1503743|NCT00762879|Arthritis|arthritis
1503744|NCT00762879|Osteoporosis|osteoporosis
1503745|NCT00762879|Osteoporosis in Children|osteoporosis in children
1503746|NCT00762866|Major Depressive Disorder|major depressive disorder
1503747|NCT00762866|Depression|depression
1503748|NCT00762866|Bipolar I Disorder|bipolar i disorder
1503749|NCT00762866|Bipolar II Disorder|bipolar ii disorder
1503750|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
1503751|NCT00762866|Psychotic Disorder|psychotic disorder
1503752|NCT00762866|Schizophrenia|schizophrenia
1503753|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
1503754|NCT00762840|Periapical lesions|periapical lesions
1503854|NCT00762372|desflurane|desflurane
1503755|NCT00762840|Apical Periodontitis|apical periodontitis
1503756|NCT00762840|endodontic procedure|endodontic procedure
1503757|NCT00762840|root canal treatment|root canal treatment
1503758|NCT00762814|Parkinson disease|parkinson disease
1503759|NCT00762814|Individuals|individuals
1503760|NCT00762814|frequent|frequent
1503761|NCT00762814|freezing|freezing
1503762|NCT00762814|during|during
1503763|NCT00762814|gait|gait
1503764|NCT00762801|RLIP76|rlip76
1503765|NCT00762801|Cancer|cancer
1503766|NCT00762801|apoptosis|apoptosis
1503767|NCT00762775|Bone resorption|bone resorption
1503768|NCT00762775|Calcium homeostasis|calcium homeostasis
1503769|NCT00762775|Bone markers|bone markers
1503770|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
1503771|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
1503772|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
1503773|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
1503774|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
1503775|NCT00762736|Type II Diabetes|type ii diabetes
1503776|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503777|NCT00762736|Dyslipidemia|dyslipidemia
1503778|NCT00762736|Drug Therapy|drug therapy
1503779|NCT00762723|Degenerative Disc Disease|degenerative disc disease
1503780|NCT00762723|Spinal Stenosis|spinal stenosis
1503781|NCT00762723|Spondylolisthesis|spondylolisthesis
1503782|NCT00762723|ALIF|alif
1503783|NCT00762723|fusion success|fusion success
1503784|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
1503785|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
1503786|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
1503787|NCT00762710|Alcohol|alcohol
1503788|NCT00762710|Abuse|abuse
1503789|NCT00762710|Use|use
1503790|NCT00762710|Disorder|disorder
1503791|NCT00762710|Dependence|dependence
1503792|NCT00762710|Symptoms|symptoms
1503793|NCT00762710|Alcoholic|alcoholic
1503794|NCT00762710|Alcoholism|alcoholism
1503795|NCT00762710|Prazosin|prazosin
1503796|NCT00762710|Drug|drug
1503797|NCT00762710|Medicine|medicine
1503798|NCT00762710|Medication|medication
1503799|NCT00762710|Treatment|treatment
1503800|NCT00762710|Study|study
1503801|NCT00762710|Placebo|placebo
1503802|NCT00762710|Medical|medical
1503803|NCT00762710|Management|management
1503804|NCT00762710|Craving|craving
1503805|NCT00762710|Consumption|consumption
1503806|NCT00762710|Binge|binge
1503807|NCT00762710|Drinking|drinking
1503808|NCT00762710|Drink|drink
1503809|NCT00762710|Heavy|heavy
1503810|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
1503811|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
1503812|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
1503813|NCT00762684|Type II Diabetes|type ii diabetes
1503814|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503815|NCT00762684|Dyslipidemia|dyslipidemia
1503816|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
1503817|NCT00762658|Topical|topical
1503818|NCT00762645|IOP lowering efficacy|iop lowering efficacy
1503819|NCT00762645|CACG|cacg
1503820|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
1503821|NCT00762606|Cataract|cataract
1503822|NCT00762593|urinary stress incontinence|urinary stress incontinence
1503823|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
1503824|NCT00762580|rotator cuff|rotator cuff
1503825|NCT00762580|rehabilitation|rehabilitation
1503826|NCT00762554|analgesia|analgesia
1503827|NCT00762554|cesarean section|cesarean section
1503828|NCT00762554|fentanyl|fentanyl
1503829|NCT00762554|Depodur|depodur
1503830|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
1503831|NCT00762541|Myopia|myopia
1503832|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
1503833|NCT00762541|Laser Therapy|laser therapy
1503834|NCT00762541|Laser Corneal Surgery|laser corneal surgery
1503835|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
1503836|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
1503837|NCT00762541|Operative Surgical Procedures|operative surgical procedures
1503838|NCT00762541|Therapeutics|therapeutics
1503839|NCT00762489|Temporal artery thermometry|temporal artery thermometry
1503840|NCT00762489|Rectal temperature|rectal temperature
1503841|NCT00762489|Axillary temperature|axillary temperature
1503842|NCT00762489|Newborns|newborns
1503843|NCT00762489|Temperature measurement|temperature measurement
1503844|NCT00762476|cold, common|cold, common
1503845|NCT00762476|rhinovirus|rhinovirus
1503846|NCT00762424|Kidney stone|kidney stone
1503847|NCT00762424|Ureterolithiasis|ureterolithiasis
1661888|NCT00136422|MDS|mds
1503848|NCT00762424|Tamsulosin|tamsulosin
1503849|NCT00762424|Flowmax|flowmax
1503850|NCT00762424|Emergency Department|emergency department
1503851|NCT00762411|Alzheimer's Disease|alzheimer's disease
1503852|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
1503853|NCT00762372|anesthesia|anesthesia
1503855|NCT00762359|Curling Ulcer|curling ulcer
1503856|NCT00762359|Gastric Ulcer|gastric ulcer
1503857|NCT00762359|Aspirin|aspirin
1503858|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
1503859|NCT00762359|Drug Therapy|drug therapy
1503860|NCT00762346|non small cell lung cancer|non small cell lung cancer
1503862|NCT00762346|zometa|zometa
1503864|NCT00762320|Kaletra|kaletra
1503865|NCT00762320|treatment Experienced|treatment experienced
1503866|NCT00762294|breast cancer|breast cancer
1503867|NCT00762294|arimidex|arimidex
1503868|NCT00762294|femara|femara
1503869|NCT00762294|bone health|bone health
1503870|NCT00762281|Hyperopia|hyperopia
1503871|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
1503872|NCT00762281|Laser Therapy|laser therapy
1503873|NCT00762281|Laser Corneal Surgery|laser corneal surgery
1503874|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
1503875|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
1503876|NCT00762281|Operative Surgical Procedures|operative surgical procedures
1503877|NCT00762281|Therapeutics|therapeutics
1503878|NCT00762268|SAMe|same
1503879|NCT00762268|alternative treatments|alternative treatments
1503880|NCT00762268|bipolar disorder|bipolar disorder
1503881|NCT00762268|depression|depression
1503882|NCT00762268|bipolar depression|bipolar depression
1503883|NCT00762268|treatment-resistant depression|treatment-resistant depression
1503884|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
1503885|NCT00762255|multiple agents|multiple agents
1503886|NCT00762255|immunotherapy|immunotherapy
1503887|NCT00762255|chemotherapy|chemotherapy
1503888|NCT00762255|brain and nervous system|brain and nervous system
1503889|NCT00762242|metabolomics|metabolomics
1503890|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
1503891|NCT00762229|Cholesterol|cholesterol
1503892|NCT00762229|Ezetimibe|ezetimibe
1503893|NCT00762216|Cataract|cataract
1503894|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
1503895|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
1503896|NCT00762190|Type II Diabetes|type ii diabetes
1503897|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503898|NCT00762190|Dyslipidemia|dyslipidemia
1503899|NCT00762190|Drug Therapy|drug therapy
1503900|NCT00762164|Hypercholesterolemia|hypercholesterolemia
1503901|NCT00762164|Statins|statins
1503902|NCT00762164|Ezetimibe|ezetimibe
1503903|NCT00762151|Dental Plaque|dental plaque
1503904|NCT00762138|Platelet rich plasma|platelet rich plasma
1503905|NCT00762138|wounds|wounds
1503906|NCT00762138|leg ulcers|leg ulcers
1503907|NCT00762138|pressure ulcers|pressure ulcers
1503908|NCT00762138|diabetic ulcers|diabetic ulcers
1503909|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
1503910|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
1503911|NCT00762125|FMS|fms
1503912|NCT00762125|Physical Therapy|physical therapy
1503913|NCT00762125|Psychotherapy|psychotherapy
1503914|NCT00762125|Group Counseling|group counseling
1503915|NCT00762125|Individual Counseling|individual counseling
1503916|NCT00762125|Chronic Pain|chronic pain
1503917|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
1503918|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
1503919|NCT00762112|Type II Diabetes|type ii diabetes
1503920|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1503921|NCT00762112|Dyslipidemia|dyslipidemia
1503922|NCT00762112|Drug Therapy.|drug therapy.
1503923|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
1503924|NCT00762099|Hip replacement|hip replacement
1503925|NCT00762099|Pain Management|pain management
1503926|NCT00762099|Functional Rehabilitation|functional rehabilitation
1503927|NCT00762099|Anxiety|anxiety
1503928|NCT00762099|Perioperative|perioperative
1503929|NCT00762099|Pregabalin|pregabalin
1503930|NCT00762099|Arthroplasty|arthroplasty
1503931|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
1503932|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
1503933|NCT00762086|Initial claudication|initial claudication
1503934|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
1503935|NCT00762060|colorectal surgery|colorectal surgery
1503936|NCT00762047|Fecal Incontinence|fecal incontinence
1503937|NCT00762021|cataract|cataract
1503938|NCT00762008|biomarkers|biomarkers
1503939|NCT00761995|Raised IOP|raised iop
1503940|NCT00761969|peripheral arterial disease|peripheral arterial disease
1503941|NCT00761969|secondary prevention|secondary prevention
1503942|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
1503943|NCT00761969|European guidelines|european guidelines
1503944|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
1503945|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
1503946|NCT00761956|Osteoarthritis|osteoarthritis
1503947|NCT00761956|Knee|knee
1503948|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
1503949|NCT00761943|Bursitis|bursitis
1503950|NCT00761943|Frozen Shoulder|frozen shoulder
1503951|NCT00761904|hypertension|hypertension
1503952|NCT00761904|hyperlipidemia|hyperlipidemia
1503953|NCT00761904|free generic samples|free generic samples
1503954|NCT00761891|aspirin|aspirin
1503955|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
1503956|NCT00761891|aspirin resistance|aspirin resistance
1503957|NCT00761891|aspirin nonresponse|aspirin nonresponse
1503958|NCT00761891|platelet|platelet
1503959|NCT00761891|Normal volunteers|normal volunteers
1503960|NCT00761878|Skin aging|skin aging
1503961|NCT00761878|Skin wrinkling|skin wrinkling
1503962|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
1503963|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
1503964|NCT00761865|High Tide Fracture Boot|high tide fracture boot
1503965|NCT00761839|wound healing|wound healing
1503966|NCT00761839|self-management|self-management
1503967|NCT00761839|patient education|patient education
1503968|NCT00761826|Mixed Astigmatism|mixed astigmatism
1503969|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
1503970|NCT00761826|Laser Therapy|laser therapy
1503971|NCT00761826|Laser Corneal Surgery|laser corneal surgery
1503972|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
1503973|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
1503974|NCT00761826|Operative Surgical Procedures|operative surgical procedures
1503975|NCT00761826|Therapeutics|therapeutics
1503976|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
1503977|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
1503978|NCT00761787|allograft|allograft
1503979|NCT00761787|rejection|rejection
1503980|NCT00761787|biopsy|biopsy
1503981|NCT00761787|gene|gene
1503982|NCT00761787|expression|expression
1503983|NCT00761787|cardiology|cardiology
1503984|NCT00761787|heart|heart
1503985|NCT00761787|transplant|transplant
1503986|NCT00761774|Epilepsy|epilepsy
1503987|NCT00761774|Monotherapy|monotherapy
1503988|NCT00761774|Partial Onset Seizures|partial onset seizures
1503989|NCT00761761|Sensoril|sensoril
1503990|NCT00761761|Bipolar Illness|bipolar illness
1503991|NCT00761761|Cognitive enhancement|cognitive enhancement
1503992|NCT00761748|Urostomy,|urostomy,
1503993|NCT00761748|2-piece,|2-piece,
1503994|NCT00761748|preference,|preference,
1503995|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
1503996|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
1503997|NCT00761722|Lymphoma|lymphoma
1503998|NCT00761722|Multiple Myeloma|multiple myeloma
1503999|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
1504000|NCT00761709|Open Angle Glaucoma|open angle glaucoma
1504001|NCT00761709|Ocular Hypertension|ocular hypertension
1504002|NCT00761696|solid tumor malignancies|solid tumor malignancies
1504003|NCT00761683|Endometriosis|endometriosis
1504004|NCT00761657|Kidney|kidney
1504005|NCT00761657|Chronic Kidney Disease|chronic kidney disease
1504006|NCT00761657|CKD|ckd
1504007|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
1504008|NCT00761657|Renal|renal
1504009|NCT00761657|Anemia|anemia
1504010|NCT00761657|Oral anemia treatment|oral anemia treatment
1504011|NCT00761657|Hemoglobin levels|hemoglobin levels
1504012|NCT00761657|Blood count|blood count
1504013|NCT00761657|Erythropoietin|erythropoietin
1504014|NCT00761644|Metastatic cancer|metastatic cancer
1504015|NCT00761644|Doxil|doxil
1504016|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
1504017|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
1504018|NCT00761644|Avastin|avastin
1504019|NCT00761644|Bevacizumab|bevacizumab
1504020|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1504021|NCT00761644|rhuMAb-VEGF|rhumab-vegf
1504022|NCT00761644|Torisel|torisel
1504023|NCT00761644|Temsirolimus|temsirolimus
1504024|NCT00761644|CCI-779|cci-779
1504025|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
1504026|NCT00761644|DCE-MRI scan|dce-mri scan
1504027|NCT00761618|Intrapleural catheter|intrapleural catheter
1504028|NCT00761618|IPC|ipc
1504029|NCT00761618|Pleurodesis|pleurodesis
1504030|NCT00761618|PD|pd
1504031|NCT00761618|Pleural effusion|pleural effusion
1504032|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
1504033|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
1504034|NCT00761618|MPE|mpe
1504035|NCT00761618|Pleural inflammatory response|pleural inflammatory response
1504036|NCT00761605|Schizophrenia|schizophrenia
1504037|NCT00761605|Paliperidone|paliperidone
1504038|NCT00761605|Paliperidone extended-release|paliperidone extended-release
1504039|NCT00761605|Antipsychotics Agents|antipsychotics agents
1504040|NCT00761579|Schizophrenia|schizophrenia
1504041|NCT00761579|Paliperidone|paliperidone
1504042|NCT00761579|Antipsychotics Agents|antipsychotics agents
1504043|NCT00761566|Elite swimmers|elite swimmers
1504044|NCT00761566|Exercise|exercise
1504045|NCT00761566|Preconditioning|preconditioning
1504046|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
1504047|NCT00761501|Phase I|phase i
1504048|NCT00761501|Healthy Volunteer|healthy volunteer
1504049|NCT00761488|Visual acuity,|visual acuity,
1504050|NCT00761488|corneal and|corneal and
1504051|NCT00761488|refractive|refractive
1504052|NCT00761488|cylinder|cylinder
1504053|NCT00761488|following|following
1504054|NCT00761488|implantation of the|implantation of the
1504055|NCT00761488|AcrySof® Toric|acrysof® toric
1504056|NCT00761475|incisional hernia|incisional hernia
1504057|NCT00761462|Pediatrics|pediatrics
1504058|NCT00761462|Safety|safety
1504059|NCT00761462|Musculoskeletal System|musculoskeletal system
1504060|NCT00761462|Neurologic Manifestations|neurologic manifestations
1504061|NCT00761462|Joint Diseases|joint diseases
1504062|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
1504063|NCT00761449|MDS|mds
1504064|NCT00761449|AML|aml
1504065|NCT00761449|Lenalidomide|lenalidomide
1504066|NCT00761449|monosomy 5|monosomy 5
1504067|NCT00761449|del5q|del5q
1504068|NCT00761410|Arthroplasty|arthroplasty
1504069|NCT00761410|Knee|knee
1504070|NCT00761410|Replacement|replacement
1504071|NCT00761410|High Flexion|high flexion
1504072|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
1504073|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
1504074|NCT00761397|Dysphagic|dysphagic
1504075|NCT00761397|Swallowing exercises|swallowing exercises
1504076|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
1504077|NCT00761397|PREPARE|prepare
1504078|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
1504079|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
1504080|NCT00761384|B-cell lymphoma|b-cell lymphoma
1504081|NCT00761384|Refractory|refractory
1504082|NCT00761384|Recurrent|recurrent
1504083|NCT00761384|90Y-ibritumomab|90y-ibritumomab
1504084|NCT00761384|Stem cells support|stem cells support
1504085|NCT00761384|Dosimetry study|dosimetry study
1504086|NCT00761371|external genital and perianal warts|external genital and perianal warts
1504087|NCT00761358|Acotiamide|acotiamide
1504088|NCT00761345|pancreatic cancer|pancreatic cancer
1504089|NCT00761345|locally advanced|locally advanced
1504090|NCT00761345|unresectable|unresectable
1504091|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
1504092|NCT00761319|Open-angle glaucoma|open-angle glaucoma
1504093|NCT00761319|ocular hypertension|ocular hypertension
1504094|NCT00761306|Major Depressive Disorder|major depressive disorder
1504095|NCT00761306|Long-term|long-term
1504096|NCT00761306|Safety|safety
1504097|NCT00761306|Open-label|open-label
1504098|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
1504099|NCT00761280|Glioblastoma|glioblastoma
1504100|NCT00761280|Antisense|antisense
1504101|NCT00761280|Cancer|cancer
1504102|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
1504103|NCT00761280|Targeted therapy|targeted therapy
1504104|NCT00761280|Brain tumor|brain tumor
1504105|NCT00761280|Glioma|glioma
1504106|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
1504107|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
1504108|NCT00761280|Intratumoral administration|intratumoral administration
1504109|NCT00761267|Anidulafungin|anidulafungin
1504110|NCT00761267|pediatrics|pediatrics
1504111|NCT00761267|candidemia|candidemia
1504112|NCT00761267|invasive candidiasis|invasive candidiasis
1504113|NCT00761267|safety|safety
1504114|NCT00761254|Domperidone|domperidone
1504115|NCT00761254|Gastroparesis|gastroparesis
1504116|NCT00761241|pancreas cancer|pancreas cancer
1504117|NCT00761241|combined modality therapy|combined modality therapy
1504118|NCT00761228|Vegetative State|vegetative state
1504119|NCT00761228|Minimally Conscious State|minimally conscious state
1504120|NCT00761228|Coma|coma
1504121|NCT00761228|Traumatic Brain Injury|traumatic brain injury
1504122|NCT00761215|Skin|skin
1504123|NCT00761215|Infection|infection
1504124|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
1504125|NCT00761189|Paliperidone|paliperidone
1504126|NCT00761189|R076477|r076477
1504127|NCT00761189|Schizophrenia|schizophrenia
1504128|NCT00761176|Diabetes|diabetes
1504129|NCT00761176|Ulcers|ulcers
1504130|NCT00761176|Wounds|wounds
1504131|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
1504132|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
1504133|NCT00761137|sialorrhea|sialorrhea
1504134|NCT00761137|drooling|drooling
1504135|NCT00761137|excessive salivation|excessive salivation
1504136|NCT00761137|parkinson's disease|parkinson's disease
1504137|NCT00761124|PSA screening|psa screening
1662258|NCT00134667|Macugen|macugen
1504138|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
1504139|NCT00761111|information booklet|information booklet
1504140|NCT00761111|low back beliefs|low back beliefs
1504141|NCT00761111|education|education
1504142|NCT00761111|disc hernia|disc hernia
1504143|NCT00761111|discectomy|discectomy
1504144|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
1504145|NCT00761111|on a slipped disc|on a slipped disc
1504146|NCT00761111|with a clinical radio|with a clinical radio
1504147|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
1504148|NCT00761111|carried out|carried out
1504149|NCT00761111|one duration|one duration
1504150|NCT00761111|of evolution higher|of evolution higher
1504151|NCT00761111|than four weeks|than four weeks
1504152|NCT00761111|at naive subjects|at naive subjects
1504153|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
1504154|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
1504155|NCT00761098|Cirrhosis|cirrhosis
1504156|NCT00761098|SBP|sbp
1504157|NCT00761072|Propofol|propofol
1504158|NCT00761072|Remifentanil|remifentanil
1504159|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
1504160|NCT00761059|analgesia|analgesia
1504161|NCT00761059|infant, premature|infant, premature
1504162|NCT00761059|glucose|glucose
1504163|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
1504164|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
1504165|NCT00761020|Malaria|malaria
1504166|NCT00761020|Diagnosis|diagnosis
1504167|NCT00761020|Biomarker|biomarker
1504168|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
1504169|NCT00761007|Bowel disease|bowel disease
1504170|NCT00760994|Alcohol|alcohol
1504171|NCT00760994|Alcoholic|alcoholic
1504172|NCT00760994|Alcoholism|alcoholism
1504173|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
1504174|NCT00760994|PTSD|ptsd
1504175|NCT00760994|Experiential acceptance|experiential acceptance
1504176|NCT00760994|Mindfulness|mindfulness
1504177|NCT00760994|Meditation|meditation
1504178|NCT00760994|Meditate|meditate
1504179|NCT00760994|Cognitive restructuring|cognitive restructuring
1504180|NCT00760994|Cognitive|cognitive
1504181|NCT00760994|Behavioral|behavioral
1504182|NCT00760994|Therapy|therapy
1504183|NCT00760994|Treatment|treatment
1504184|NCT00760994|Study|study
1504185|NCT00760994|Intervention|intervention
1504186|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
1504187|NCT00760968|Drug Therapy|drug therapy
1504188|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
1504189|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
1504190|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
1504191|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
1504192|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
1504193|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
1504194|NCT00760955|Drug Therapy|drug therapy
1504195|NCT00760942|Low birth weight|low birth weight
1504196|NCT00760942|neonates|neonates
1504197|NCT00760942|premature infants|premature infants
1504198|NCT00760942|nutrition|nutrition
1504199|NCT00760942|human milk fortification|human milk fortification
1504200|NCT00760942|Infant|infant
1504201|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1504202|NCT00760903|Moderate brain trauma|moderate brain trauma
1504203|NCT00760890|Iron, breastfed infant|iron, breastfed infant
1504204|NCT00760877|MYELOGENOUS|myelogenous
1504205|NCT00760877|LEUKEMIA|leukemia
1504206|NCT00760877|Chronic Phase|chronic phase
1504208|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
1504209|NCT00760864|Drug Therapy|drug therapy
1504210|NCT00760851|Probiotics|probiotics
1504211|NCT00760851|Child, preschool|child, preschool
1504212|NCT00760851|Child Day Care Centers|child day care centers
1504213|NCT00760851|Health|health
1504214|NCT00760851|Immune system|immune system
1504215|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
1504216|NCT00760825|cholera|cholera
1504217|NCT00760825|vibrios|vibrios
1504218|NCT00760825|oral cholera vaccine|oral cholera vaccine
1504219|NCT00760812|Autism|autism
1504220|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
1504221|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
1504222|NCT00760812|Toddlers|toddlers
1504223|NCT00760812|Intervention|intervention
1504224|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
1504225|NCT00760786|IVUS-VH|ivus-vh
1504226|NCT00760786|Plaque characterization|plaque characterization
1504227|NCT00760786|Omega3-fatty acid|omega3-fatty acid
1504228|NCT00760786|Atorvastatin|atorvastatin
1504229|NCT00760773|Probiotic treatment|probiotic treatment
1504230|NCT00760773|Daycare attendance|daycare attendance
1504231|NCT00760773|Pediatric|pediatric
1504232|NCT00760773|Emergency department|emergency department
1504233|NCT00760747|ADHD|adhd
1504234|NCT00760747|Children|children
1504235|NCT00760747|Stimulant|stimulant
1504236|NCT00760747|Atomoxetine|atomoxetine
1504237|NCT00760747|Adolescents|adolescents
1504238|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
1504239|NCT00760734|Post concussion syndrome|post concussion syndrome
1504240|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
1504241|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
1504242|NCT00760721|Hepatitis B Screening|hepatitis b screening
1504243|NCT00760721|Korean Americans|korean americans
1504244|NCT00760708|nucleosides|nucleosides
1504245|NCT00760708|neurotransmitter|neurotransmitter
1504246|NCT00760708|myocardial ischemia|myocardial ischemia
1504247|NCT00760708|Adenosine|adenosine
1504248|NCT00760695|anorexia nervosa|anorexia nervosa
1504249|NCT00760695|chronic|chronic
1504250|NCT00760695|dronabinol|dronabinol
1504251|NCT00760695|weight gain|weight gain
1504252|NCT00760695|EDI|edi
1504253|NCT00760682|osteoradionecrosis|osteoradionecrosis
1504254|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
1504255|NCT00760682|sequestrectomy|sequestrectomy
1504256|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
1504257|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
1504258|NCT00760669|Psoriasis|psoriasis
1504259|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
1504260|NCT00760669|Infliximab|infliximab
1504261|NCT00760669|Remicade|remicade
1504262|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
1504263|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
1504264|NCT00760630|abnormal stress test|abnormal stress test
1504265|NCT00760630|fractional flow reserve|fractional flow reserve
1504266|NCT00760630|pressure drop coefficient|pressure drop coefficient
1504267|NCT00760630|lesion flow coefficient|lesion flow coefficient
1504268|NCT00760617|Influenza|influenza
1504269|NCT00760617|Elderly|elderly
1504270|NCT00760604|Esophageal neoplasms|esophageal neoplasms
1504271|NCT00760604|Esophagectomy|esophagectomy
1504272|NCT00760591|Acute kidney failure|acute kidney failure
1504273|NCT00760591|Colonoscopy|colonoscopy
1504274|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
1504275|NCT00760552|Hypertension|hypertension
1504276|NCT00760552|Adherence|adherence
1504277|NCT00760552|Pharmacist|pharmacist
1504278|NCT00760552|Interdisciplinary|interdisciplinary
1504279|NCT00760552|Randomized Controlled|randomized controlled
1504280|NCT00760552|Primary Care|primary care
1504281|NCT00760539|Glaucoma|glaucoma
1504282|NCT00760539|Hypertension|hypertension
1504283|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
1504284|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
1504285|NCT00760513|NAFLD|nafld
1504286|NCT00760513|fish oil|fish oil
1504287|NCT00760513|intervention|intervention
1504288|NCT00760513|RCT|rct
1504289|NCT00760513|biomarkers|biomarkers
1504290|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
1504291|NCT00760487|Bilateral cataract|bilateral cataract
1504292|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
1504293|NCT00760435|Kawasaki disease|kawasaki disease
1504294|NCT00760435|Infliximab|infliximab
1504295|NCT00760435|Remicade|remicade
1504296|NCT00760435|Pediatrics|pediatrics
1504297|NCT00760409|recurrent tumor|recurrent tumor
1504298|NCT00760396|healthy volunteers|healthy volunteers
1504299|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
1504300|NCT00760383|Osteoarthritis|osteoarthritis
1504301|NCT00760383|Muscle Metabolism|muscle metabolism
1504302|NCT00760383|Rehabilitation|rehabilitation
1504303|NCT00760383|Physical Therapy|physical therapy
1504304|NCT00760370|bone marker|bone marker
1504305|NCT00760370|bisphosphonate|bisphosphonate
1504306|NCT00760370|Zometa|zometa
1504307|NCT00760370|retention|retention
1504308|NCT00760370|breast cancer|breast cancer
1504309|NCT00760370|multiple myeloma|multiple myeloma
1504310|NCT00760370|CTX|ctx
1504311|NCT00760370|bone specific ALP|bone specific alp
1504312|NCT00760357|Critical Ischemia|critical ischemia
1504313|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
1504314|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
1504315|NCT00760344|Type II Diabetes|type ii diabetes
1504316|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1504317|NCT00760344|Dyslipidemia|dyslipidemia
1504318|NCT00760344|Drug Therapy|drug therapy
1504319|NCT00760331|HNF1B|hnf1b
1504320|NCT00760331|TCF2|tcf2
1504321|NCT00760331|MODY-5|mody-5
1504322|NCT00760331|CAKUT|cakut
1504323|NCT00760331|Anomaly of renal development|anomaly of renal development
1504324|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
1504325|NCT00760305|cancer pain|cancer pain
1504326|NCT00760305|bone metastasis|bone metastasis
1504327|NCT00760305|patient education|patient education
1504328|NCT00760305|psychoeducational education|psychoeducational education
1504329|NCT00760305|side effects|side effects
1504330|NCT00760305|analgesics|analgesics
1504331|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1504332|NCT00760292|Genetic Variants|genetic variants
1504333|NCT00760292|SNP|snp
1504334|NCT00760292|DNA microarray|dna microarray
1504335|NCT00760279|Bacterial infection|bacterial infection
1504336|NCT00760279|Azithromycin|azithromycin
1504337|NCT00760266|Hypertension|hypertension
1504338|NCT00760266|older population|older population
1504339|NCT00760266|aliskiren|aliskiren
1504340|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
1504341|NCT00760266|systolic blood pressure|systolic blood pressure
1504342|NCT00760266|diastolic blood pressure|diastolic blood pressure
1504343|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
1504344|NCT00760253|target control infusion|target control infusion
1504345|NCT00760253|alfentanyl|alfentanyl
1504346|NCT00760253|propofol|propofol
1504347|NCT00760253|BIS|bis
1504348|NCT00760240|compliance|compliance
1504349|NCT00760240|eyedrop instillation|eyedrop instillation
1504350|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
1504351|NCT00760214|Essential Hypertension|essential hypertension
1504352|NCT00760214|Hypertension|hypertension
1504353|NCT00760214|Drug Therapy|drug therapy
1504354|NCT00760214|Blood Pressure, High|blood pressure, high
1504355|NCT00760214|Vascular Disease|vascular disease
1504356|NCT00760214|Cardiovascular Disease|cardiovascular disease
1504357|NCT00760201|executive|executive
1504358|NCT00760201|administrator|administrator
1504359|NCT00760201|perceptions|perceptions
1504360|NCT00760201|legal counsel|legal counsel
1504361|NCT00760201|end of life|end of life
1504362|NCT00760188|knee replacement|knee replacement
1504363|NCT00760175|Lung transplant Recipients|lung transplant recipients
1504364|NCT00760175|Vaxigrip|vaxigrip
1504365|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
1504366|NCT00760162|Probiotics|probiotics
1504367|NCT00760162|Kibow Biotics|kibow biotics
1504368|NCT00760162|Enteric Dialysis|enteric dialysis
1504369|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
1504370|NCT00760149|tuberculosis|tuberculosis
1504371|NCT00760149|rifampicin|rifampicin
1504372|NCT00760149|pharmacokinetics|pharmacokinetics
1504373|NCT00760149|pharmacodynamics|pharmacodynamics
1504374|NCT00760136|patellofemoral pain|patellofemoral pain
1504375|NCT00760136|quadriceps contraction|quadriceps contraction
1504376|NCT00760123|Lymphedema|lymphedema
1504377|NCT00760123|Prevention|prevention
1504378|NCT00760123|Breast cancer|breast cancer
1504379|NCT00760123|Physical therapy|physical therapy
1504380|NCT00760110|Morning BP|morning bp
1504381|NCT00760110|Clinic BP|clinic bp
1504382|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
1504383|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
1504384|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
1504385|NCT00760084|Dacogen|dacogen
1504386|NCT00760084|Decitabine|decitabine
1504387|NCT00760071|cystic fibrosis,|cystic fibrosis,
1504388|NCT00760071|lung disease,|lung disease,
1504389|NCT00760071|MRI,|mri,
1504390|NCT00760071|morphology,|morphology,
1504391|NCT00760071|function|function
1504392|NCT00760071|morphological MRI|morphological mri
1504393|NCT00760071|functional MRI|functional mri
1504394|NCT00760071|correlation to clinical data|correlation to clinical data
1504395|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
1504396|NCT00760032|Cirrhosis|cirrhosis
1504397|NCT00760032|Ascites|ascites
1504498|NCT00759655|Xyntha|xyntha
1504399|NCT00760032|Infections|infections
1504400|NCT00760032|Cytokines|cytokines
1504401|NCT00760032|Ciprofloxacin|ciprofloxacin
1504402|NCT00760019|vascular inflammation|vascular inflammation
1504403|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
1504404|NCT00760006|cleft secondary palate|cleft secondary palate
1504405|NCT00760006|primary closure of secondary cleft palate|primary closure of secondary cleft palate
1504406|NCT00760006|Prophylactic Antibiotics|prophylactic antibiotics
1504407|NCT00760006|Unasyn|unasyn
1504408|NCT00760006|Cleft Palate|cleft palate
1504409|NCT00759993|weight gain|weight gain
1504410|NCT00759993|Obesity|obesity
1504411|NCT00759993|Psychiatry|psychiatry
1504412|NCT00759993|Medication|medication
1504413|NCT00759993|Induced|induced
1504414|NCT00759980|Thrombocytopenia|thrombocytopenia
1504415|NCT00759980|Platelet transfusion|platelet transfusion
1504416|NCT00759967|Randomized|randomized
1504417|NCT00759967|Cross-Over|cross-over
1504418|NCT00759967|Conventional|conventional
1504419|NCT00759967|Daily|daily
1504420|NCT00759967|Hemodialysis|hemodialysis
1504421|NCT00759954|bioequivalence|bioequivalence
1504422|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
1504423|NCT00759954|KADIAN capsules|kadian capsules
1504424|NCT00759954|200 mg|200 mg
1504425|NCT00759954|applesauce|applesauce
1504426|NCT00759941|Glaucoma|glaucoma
1504427|NCT00759928|Refractory Solid Tumors|refractory solid tumors
1504428|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
1504429|NCT00759928|Sorafenib|sorafenib
1504430|NCT00759928|Erlotinib|erlotinib
1504431|NCT00759928|Pharmacokinetics|pharmacokinetics
1504432|NCT00759915|10 mg|10 mg
1504433|NCT00759915|KADIAN capsules|kadian capsules
1504434|NCT00759915|20 mg|20 mg
1504435|NCT00759915|fed conditions|fed conditions
1504436|NCT00759915|bioequivalence|bioequivalence
1504437|NCT00759902|bioequivalence|bioequivalence
1504438|NCT00759902|10 mg|10 mg
1504439|NCT00759902|KADIAN capsules|kadian capsules
1504440|NCT00759902|20 mg|20 mg
1504441|NCT00759902|under fasted conditions|under fasted conditions
1504443|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
1504444|NCT00759876|Nonsense mutation|nonsense mutation
1504445|NCT00759876|Premature stop codon|premature stop codon
1504446|NCT00759876|DMD|dmd
1504447|NCT00759876|PTC124|ptc124
1504448|NCT00759876|Ataluren|ataluren
1504449|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
1504450|NCT00759850|Drug Eluting Stent|drug eluting stent
1504451|NCT00759850|Primary PCI|primary pci
1504452|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
1504453|NCT00759824|Valproic acid|valproic acid
1504454|NCT00759824|Adriamycin|adriamycin
1504455|NCT00759824|Cyclophosphamide|cyclophosphamide
1504456|NCT00759824|Vindesine|vindesine
1504457|NCT00759824|Second-line chemotherapy|second-line chemotherapy
1504458|NCT00759811|Heart Failure|heart failure
1504459|NCT00759811|Myocardial Ischemia|myocardial ischemia
1504460|NCT00759811|Methotrexate|methotrexate
1504461|NCT00759811|Inflammation|inflammation
1504462|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
1504463|NCT00759811|Inflammation Mediators|inflammation mediators
1504464|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1504465|NCT00759798|Leukemia|leukemia
1504466|NCT00759798|FCR|fcr
1504467|NCT00759798|Fludarabine|fludarabine
1504468|NCT00759798|Cyclophosphamide|cyclophosphamide
1504469|NCT00759798|Rituximab|rituximab
1504470|NCT00759772|Anorexia Nervosa|anorexia nervosa
1504471|NCT00759772|Disordered Eating|disordered eating
1504472|NCT00759772|Osteoporosis|osteoporosis
1504473|NCT00759772|Parathyroid Hormone|parathyroid hormone
1504474|NCT00759772|Bone|bone
1504475|NCT00759759|bioequivalence|bioequivalence
1504476|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
1504477|NCT00759759|KADIAN capsules|kadian capsules
1504478|NCT00759759|200 mg|200 mg
1504479|NCT00759746|Weight loss maintenance|weight loss maintenance
1504480|NCT00759733|pregnancy|pregnancy
1504481|NCT00759733|heart disease|heart disease
1504482|NCT00759733|heart function testing|heart function testing
1504483|NCT00759733|echocardiography|echocardiography
1504484|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
1504485|NCT00759733|obstetrical care|obstetrical care
1504486|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
1504487|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
1504488|NCT00759720|Type II Diabetes|type ii diabetes
1504489|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1504490|NCT00759720|Dyslipidemia|dyslipidemia
1504491|NCT00759720|Drug Therapy|drug therapy
1504492|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
1504493|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
1504494|NCT00759681|Arterial Surgery|arterial surgery
1504495|NCT00759681|Open vascular Surgery|open vascular surgery
1504496|NCT00759681|Sealant|sealant
1504497|NCT00759655|hemophilia A|hemophilia a
1504502|NCT00759642|breast cancer|breast cancer
1504503|NCT00759642|hormone receptor positive|hormone receptor positive
1504504|NCT00759642|HER-2 negative|her-2 negative
1504505|NCT00759616|Knee Replacement|knee replacement
1504506|NCT00759603|Leukemia|leukemia
1504507|NCT00759603|CLL|cll
1504508|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1504509|NCT00759603|SLL|sll
1504510|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1504511|NCT00759603|Lenalidomide|lenalidomide
1504512|NCT00759603|Revlimid|revlimid
1504513|NCT00759603|Rituximab|rituximab
1504514|NCT00759603|Rituxan|rituxan
1504515|NCT00759551|Blood Pressure|blood pressure
1504516|NCT00759551|Drug Therapy|drug therapy
1504517|NCT00759551|Systolic Pressure|systolic pressure
1504518|NCT00759551|Diastolic Pressure|diastolic pressure
1504519|NCT00759551|Vascular Diseases|vascular diseases
1504520|NCT00759538|Lung Transplantation|lung transplantation
1504521|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
1504522|NCT00759538|Exercise tolerance|exercise tolerance
1504523|NCT00759538|Quality of Life|quality of life
1504526|NCT00759486|craniofacial fracture|craniofacial fracture
1504527|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
1504528|NCT00759473|substance-related disorders|substance-related disorders
1504529|NCT00759460|Schizophrenia|schizophrenia
1504530|NCT00759434|Varicose veins|varicose veins
1504531|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
1504532|NCT00759434|Venous ulceration|venous ulceration
1504533|NCT00759434|Surgery|surgery
1504534|NCT00759434|Endovenous Laser|endovenous laser
1504535|NCT00759421|Schizophrenia|schizophrenia
1504536|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
1504537|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
1504538|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
1504539|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
1504540|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
1504541|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
1504542|NCT00759382|PET scan|pet scan
1504543|NCT00759382|Observational study|observational study
1504544|NCT00759382|Non metastatic|non metastatic
1504545|NCT00759382|treated|treated
1504546|NCT00759382|curative intent|curative intent
1504547|NCT00759369|ADPKD|adpkd
1504548|NCT00759356|bioavailability|bioavailability
1504549|NCT00759356|KADIAN|kadian
1504550|NCT00759356|200 mg|200 mg
1504551|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
1504552|NCT00759356|100 mg|100 mg
1504553|NCT00759356|fed conditions|fed conditions
1504554|NCT00759343|Kidney stones|kidney stones
1504555|NCT00759343|urinary stone disease|urinary stone disease
1504556|NCT00759343|urinary stones|urinary stones
1504557|NCT00759343|urine|urine
1504558|NCT00759343|serum|serum
1504559|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
1504560|NCT00759317|normal controls|normal controls
1504561|NCT00759304|Aging|aging
1504562|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
1504563|NCT00759304|Autonomic nervous system|autonomic nervous system
1504564|NCT00759304|stroke|stroke
1504565|NCT00759304|Myocardiac infarction|myocardiac infarction
1504566|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
1504567|NCT00759304|Prospective cohort|prospective cohort
1504568|NCT00759291|free fatty acids|free fatty acids
1504569|NCT00759291|insulin-mediated|insulin-mediated
1504570|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
1504571|NCT00759291|metabolic syndrome|metabolic syndrome
1504572|NCT00759278|pregnancy|pregnancy
1504573|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
1504574|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
1504575|NCT00759278|antihypertensive medication|antihypertensive medication
1504576|NCT00759265|Muscle strength|muscle strength
1504577|NCT00759265|Physical activity|physical activity
1504578|NCT00759265|Mobility|mobility
1504579|NCT00759265|Gait analysis|gait analysis
1504580|NCT00759252|diagnosis of dementia|diagnosis of dementia
1504581|NCT00759252|perceptions of risk|perceptions of risk
1504582|NCT00759252|dementia screening|dementia screening
1504583|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
1504584|NCT00759226|esophageal cancer|esophageal cancer
1504585|NCT00759226|Gemcitabine|gemcitabine
1504586|NCT00759226|Cisplatin|cisplatin
1504587|NCT00759226|5-FU|5-fu
1504588|NCT00759226|Folinic Acid|folinic acid
1504589|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
1504590|NCT00759213|Discharge planning|discharge planning
1504591|NCT00759213|Family needs|family needs
1504592|NCT00759213|Family concerns|family concerns
1504593|NCT00759213|NICU|nicu
1504594|NCT00759213|Infants|infants
1504595|NCT00759200|Chronic hepatitis C|chronic hepatitis c
1504596|NCT00759200|genotype 2|genotype 2
1504597|NCT00759200|genotype 3|genotype 3
1504598|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
1504599|NCT00759200|alb-interferon|alb-interferon
1504600|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
1504601|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
1504602|NCT00759161|Topical|topical
1504603|NCT00759148|pink eye|pink eye
1504604|NCT00759148|conjunctivitis|conjunctivitis
1504605|NCT00759148|moxifloxacin|moxifloxacin
1504606|NCT00759148|fluoroquinolone|fluoroquinolone
1504607|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1504609|NCT00759135|Enlarged Prostate|enlarged prostate
1504610|NCT00759122|mdd|mdd
1504611|NCT00759122|major depressive disorder|major depressive disorder
1504612|NCT00759122|depression|depression
1504613|NCT00759096|bilateral implantation|bilateral implantation
1504614|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
1504615|NCT00759096|uniocular unaided distance|uniocular unaided distance
1504616|NCT00759096|binocular unaided distance|binocular unaided distance
1504617|NCT00759096|intermediate visual acuity|intermediate visual acuity
1504618|NCT00759096|near visual acuity|near visual acuity
1504619|NCT00759083|HIT|hit
1504620|NCT00759083|HITTS|hitts
1504621|NCT00759070|Treatment Naïve|treatment naïve
1504622|NCT00759057|Spinal Stenosis|spinal stenosis
1504623|NCT00759057|Spinal Instability|spinal instability
1504624|NCT00759057|Leg Pain|leg pain
1504625|NCT00759018|GVHD|gvhd
1504626|NCT00759018|Prochymal|prochymal
1504627|NCT00759018|Graft vs Host Disease|graft vs host disease
1504628|NCT00758992|gene transfer|gene transfer
1504629|NCT00758966|OCD,|ocd,
1504630|NCT00758966|naltrexone,|naltrexone,
1504631|NCT00758966|fluoxetine,|fluoxetine,
1504632|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
1504633|NCT00758940|Clinical|clinical
1504634|NCT00758940|assessment|assessment
1504635|NCT00758940|of visual|of visual
1504636|NCT00758940|function|function
1504637|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
1504638|NCT00758940|multifocal IOL|multifocal iol
1504639|NCT00758927|diabetes mellitus|diabetes mellitus
1504640|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
1504641|NCT00758927|OMACOR|omacor
1504642|NCT00758927|small dense LDL|small dense ldl
1504643|NCT00758927|HDL subfraction|hdl subfraction
1504644|NCT00758914|Vitamin E|vitamin e
1504645|NCT00758849|NOH|noh
1504646|NCT00758849|Orthostatic hypotension|orthostatic hypotension
1504647|NCT00758849|PAF|paf
1504648|NCT00758849|MSA|msa
1504649|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
1504650|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
1504651|NCT00758849|Striatonigral degeneration|striatonigral degeneration
1504652|NCT00758849|Autonomic Failure|autonomic failure
1504653|NCT00758849|Parkinson|parkinson
1504654|NCT00758849|Fipamezole|fipamezole
1504655|NCT00758849|JP-1730|jp-1730
1504656|NCT00758823|head lice|head lice
1504657|NCT00758810|Health Education|health education
1504658|NCT00758810|Myocardial Infarction|myocardial infarction
1504659|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
1504660|NCT00758810|Quality of Life|quality of life
1504661|NCT00758797|metastatic melanoma|metastatic melanoma
1504662|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
1504663|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
1504664|NCT00758758|Cervical Spine,|cervical spine,
1504665|NCT00758758|Herniated Disc|herniated disc
1504666|NCT00758745|Cataract|cataract
1504667|NCT00758745|Patients|patients
1504668|NCT00758745|bilateral|bilateral
1504669|NCT00758745|age related|age related
1504670|NCT00758745|undergoing|undergoing
1504671|NCT00758745|phacoemulsification|phacoemulsification
1504672|NCT00758732|Cancer|cancer
1504673|NCT00758732|Ovarian cancer|ovarian cancer
1504674|NCT00758732|Chemotherapy|chemotherapy
1504675|NCT00758732|Docetaxel|docetaxel
1504676|NCT00758732|Carboplatin|carboplatin
1504677|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
1504678|NCT00758732|Platinum sensitive|platinum sensitive
1504679|NCT00758719|Spinal Fusion|spinal fusion
1504680|NCT00758719|DDD|ddd
1504681|NCT00758706|COPD|copd
1504682|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1504683|NCT00758693|Bendamustine|bendamustine
1504684|NCT00758693|Treanda|treanda
1504685|NCT00758693|Rituximab|rituximab
1504686|NCT00758693|Rituxan|rituxan
1504687|NCT00758667|capsular contracture|capsular contracture
1504688|NCT00758667|capsulectomy|capsulectomy
1504689|NCT00758667|mesna|mesna
1504690|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
1504691|NCT00758654|myocardial strain|myocardial strain
1504692|NCT00758654|Strain-Encoded MRI|strain-encoded mri
1504693|NCT00758654|dobutamine stress MRI|dobutamine stress mri
1504694|NCT00758654|ischemia|ischemia
1504695|NCT00758654|strain rate reserve|strain rate reserve
1504696|NCT00758641|plantar fasciitis|plantar fasciitis
1504697|NCT00758641|platelet rich plasma|platelet rich plasma
1504698|NCT00758641|GPS|gps
1504699|NCT00758615|Obesity|obesity
1504700|NCT00758615|Physical activity|physical activity
1504701|NCT00758615|Injury Prevention|injury prevention
1504702|NCT00758615|Pedestrian safety|pedestrian safety
1504703|NCT00758615|Self efficacy|self efficacy
1504704|NCT00758615|School|school
1504705|NCT00758615|Walking School Bus|walking school bus
1504706|NCT00758615|Safe Routes to School|safe routes to school
1504707|NCT00758589|Asthma|asthma
1504708|NCT00758576|Cataract|cataract
1504709|NCT00758550|Visual function;|visual function;
1504710|NCT00758550|Refractive cylinder;|refractive cylinder;
1504711|NCT00758550|AcrySof® Toric;|acrysof® toric;
1504712|NCT00758550|AcrySof® Natural|acrysof® natural
1504713|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
1504714|NCT00758524|Essential hypertension|essential hypertension
1504715|NCT00758524|phase 2 study|phase 2 study
1504716|NCT00758524|antihypertensive agent|antihypertensive agent
1504717|NCT00758511|cortisol|cortisol
1504718|NCT00758511|pain|pain
1504719|NCT00758511|pain management|pain management
1504720|NCT00758511|preterm infants|preterm infants
1504721|NCT00758511|sucrose|sucrose
1504722|NCT00758511|facilitated tucking|facilitated tucking
1504723|NCT00758459|COPD|copd
1504724|NCT00758433|Adverse Events|adverse events
1504725|NCT00758433|Erythema Rating|erythema rating
1504726|NCT00758433|Pharmacokinetics|pharmacokinetics
1504727|NCT00758433|Civamide|civamide
1504728|NCT00758433|Phase 1|phase 1
1662921|NCT00132327|HV|hv
1504729|NCT00758433|Pain|pain
1504730|NCT00758433|Patch|patch
1504731|NCT00758420|Varicose Veins|varicose veins
1504732|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
1504733|NCT00758381|pancreatic cancer|pancreatic cancer
1504734|NCT00758381|advanced or metastatic|advanced or metastatic
1504735|NCT00758381|sorafenib|sorafenib
1504736|NCT00758368|Parkinson's disease|parkinson's disease
1504737|NCT00758368|PD|pd
1504738|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
1504739|NCT00758368|dyskinesia|dyskinesia
1504740|NCT00758368|apomorphine|apomorphine
1504741|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
1504742|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
1504743|NCT00758316|Malignant|malignant
1504744|NCT00758316|Pleural|pleural
1504745|NCT00758316|Effusions|effusions
1504746|NCT00758316|Thoracoscopy|thoracoscopy
1504747|NCT00758316|Catheter|catheter
1504748|NCT00758303|Triglycerides|triglycerides
1504749|NCT00758303|Cholesterol|cholesterol
1505032|NCT00757068|Supportive|supportive
1504750|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
1504751|NCT00758264|Safety|safety
1504752|NCT00758264|Routine infancy vaccination|routine infancy vaccination
1504753|NCT00758264|Meningococcal vaccine|meningococcal vaccine
1504754|NCT00758264|Immunogenicity|immunogenicity
1504755|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
1504756|NCT00758251|Schizophrenia|schizophrenia
1504757|NCT00758251|Seroquel XR|seroquel xr
1504758|NCT00758251|CGI|cgi
1504759|NCT00758238|hypertension|hypertension
1504760|NCT00758238|self-management|self-management
1504761|NCT00758238|e-health|e-health
1504762|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1504763|NCT00758225|DMD|dmd
1504764|NCT00758225|Duchenne|duchenne
1504765|NCT00758225|Idebenone|idebenone
1504766|NCT00758212|Influenza in Humans|influenza in humans
1504767|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1504768|NCT00758212|Immunization, Active|immunization, active
1504769|NCT00758186|Colorectal cancer|colorectal cancer
1504770|NCT00758186|Endoscopic stent|endoscopic stent
1504771|NCT00758186|Intestinal obstruction|intestinal obstruction
1504772|NCT00758186|Laparoscopy|laparoscopy
1504773|NCT00758173|prostate cancer|prostate cancer
1504774|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
1504775|NCT00758160|Methylphenidate|methylphenidate
1504776|NCT00758160|Concerta|concerta
1504777|NCT00758147|force feedback joystick|force feedback joystick
1504778|NCT00758147|stroke|stroke
1504779|NCT00758147|haptics|haptics
1504780|NCT00758147|kinematics|kinematics
1504781|NCT00758147|rehabilitation|rehabilitation
1504782|NCT00758147|robotics|robotics
1504783|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
1504784|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
1504785|NCT00758108|Energy Homeostasis|energy homeostasis
1504786|NCT00758108|Nociception|nociception
1504787|NCT00758108|Obesity|obesity
1504788|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
1504789|NCT00758108|WAGR Syndrome|wagr syndrome
1504790|NCT00758108|Wilm's Tumor|wilm's tumor
1504791|NCT00758108|Aniridia|aniridia
1504792|NCT00758108|Mental Retardation|mental retardation
1504793|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
1504794|NCT00758108|Healthy Volunteer|healthy volunteer
1504795|NCT00758082|type 1 diabetes|type 1 diabetes
1504796|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
1504797|NCT00758082|HbA1c|hba1c
1504798|NCT00758056|endometrial cancer|endometrial cancer
1504799|NCT00758043|Genotype 1|genotype 1
1504800|NCT00758030|Schizophrenia|schizophrenia
1504801|NCT00758030|Paliperidone|paliperidone
1504802|NCT00758017|low back pain|low back pain
1504803|NCT00758017|acupuncture|acupuncture
1504804|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
1504805|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
1504806|NCT00757978|Schizophrenia|schizophrenia
1504807|NCT00757978|negative symptoms|negative symptoms
1504808|NCT00757978|clozapine|clozapine
1504809|NCT00757965|colon cancer|colon cancer
1504810|NCT00757965|rectal cancer|rectal cancer
1504811|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
1504812|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
1504813|NCT00757900|influenza, human|influenza, human
1504814|NCT00757887|malaria|malaria
1504815|NCT00757887|plasmodium|plasmodium
1504816|NCT00757887|falciparum|falciparum
1504817|NCT00757887|human|human
1504818|NCT00757887|experimental infection|experimental infection
1504819|NCT00757874|Female urogenital disease|female urogenital disease
1504820|NCT00757874|skin disease|skin disease
1504821|NCT00757848|cystic fibrosis|cystic fibrosis
1504822|NCT00757835|24-hour IOP|24-hour iop
1504823|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
1504824|NCT00757835|travoprost/timolol|travoprost/timolol
1504825|NCT00757835|latanoprost/timolol|latanoprost/timolol
1504826|NCT00757835|fixed combinations|fixed combinations
1504827|NCT00757783|HIV|hiv
1504828|NCT00757783|AIDS|aids
1504829|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
1504830|NCT00757783|PREZISTA|prezista
1504831|NCT00757783|darunavir|darunavir
1504832|NCT00757783|TMC114|tmc114
1504833|NCT00757783|Protease Inhibitor|protease inhibitor
1504834|NCT00757783|Truvada|truvada
1504835|NCT00757783|Atazanavir|atazanavir
1504836|NCT00757783|REYATAZ|reyataz
1504837|NCT00757783|HIV Infections|hiv infections
1504838|NCT00757783|Treatment Naïve|treatment naïve
1504839|NCT00757770|Gastroenteritis|gastroenteritis
1504840|NCT00757757|Prostate cancer|prostate cancer
1504841|NCT00757757|bone metastases|bone metastases
1504842|NCT00757757|anti-M-CSF|anti-m-csf
1504843|NCT00757757|M-CSF antibody|m-csf antibody
1504844|NCT00757757|M-CSF|m-csf
1504845|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
1504846|NCT00757744|drug counseling|drug counseling
1504847|NCT00757744|HIV risks|hiv risks
1504848|NCT00757744|methadone maintenance|methadone maintenance
1504849|NCT00757744|HIV Seronegativity|hiv seronegativity
1504850|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
1504851|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
1504852|NCT00757718|Gestational Hypertension|gestational hypertension
1504853|NCT00757718|Preeclampsia|preeclampsia
1504854|NCT00757705|Schizophrenia|schizophrenia
1504855|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
1504856|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
1504857|NCT00757692|Hormone|hormone
1504858|NCT00757692|Refractory|refractory
1504859|NCT00757692|Prostate Cancer|prostate cancer
1504860|NCT00757692|Chemotherapy|chemotherapy
1504861|NCT00757692|Naïve|naïve
1504862|NCT00757666|Pacemaker|pacemaker
1504863|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
1504864|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
1504865|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
1504866|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
1504867|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
1504868|NCT00757614|intraocular lymphoma|intraocular lymphoma
1504869|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1504870|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1504871|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1504872|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
1504873|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
1504874|NCT00757614|adult brain stem glioma|adult brain stem glioma
1504875|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
1504876|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
1504877|NCT00757614|adult embryonal tumor|adult embryonal tumor
1504878|NCT00757614|adult ependymal tumors|adult ependymal tumors
1504879|NCT00757614|adult meningeal tumor|adult meningeal tumor
1504880|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
1504881|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1504882|NCT00757614|adult brain tumor|adult brain tumor
1504883|NCT00757614|intraocular melanoma|intraocular melanoma
1504884|NCT00757614|bladder cancer|bladder cancer
1504885|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1504886|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
1504887|NCT00757614|esophageal cancer|esophageal cancer
1504888|NCT00757614|melanoma|melanoma
1504889|NCT00757614|pancreatic cancer|pancreatic cancer
1504890|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
1504891|NCT00757614|renal cell carcinoma|renal cell carcinoma
1504892|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1504893|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
1504894|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
1504895|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1504896|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1504897|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1504898|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1504899|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1504900|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1504901|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1504902|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1504903|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1504904|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1504905|NCT00757536|primary vitrectomy|primary vitrectomy
1504906|NCT00757536|encircling band|encircling band
1504907|NCT00757536|endolaser treatment|endolaser treatment
1504908|NCT00757523|Acne Vulgaris|acne vulgaris
1504909|NCT00757523|Akne|akne
1504910|NCT00757523|Acne|acne
1504911|NCT00757523|Akne Vulgaris|akne vulgaris
1504912|NCT00757510|Congenital Heart Disease|congenital heart disease
1504913|NCT00757497|Treatment Study|treatment study
1504914|NCT00757497|Psychosis|psychosis
1504915|NCT00757497|Electrical Stimulation|electrical stimulation
1504916|NCT00757497|Refractory|refractory
1504917|NCT00757497|Novel|novel
1504918|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
1504919|NCT00757497|Schizophrenia|schizophrenia
1504920|NCT00757471|Macular hole surgery|macular hole surgery
1504921|NCT00757471|membranepeeling|membranepeeling
1504922|NCT00757471|closure rate|closure rate
1504923|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
1504924|NCT00757458|Propofol|propofol
1504925|NCT00757458|Bacterial growth|bacterial growth
1504926|NCT00757458|Fungal growth|fungal growth
1504927|NCT00757458|EDTA|edta
1504928|NCT00757458|Target controlled infusion|target controlled infusion
1504929|NCT00757445|Antibiotic therapy|antibiotic therapy
1504930|NCT00757445|Microbiological diagnosis|microbiological diagnosis
1504931|NCT00757419|Safety|safety
1504932|NCT00757419|tolerability|tolerability
1504933|NCT00757419|healthy subjects|healthy subjects
1504934|NCT00757406|Lymphedema|lymphedema
1504935|NCT00757406|Bioimpedance|bioimpedance
1504936|NCT00757393|Growth hormone|growth hormone
1504937|NCT00757393|Pediatrics|pediatrics
1504938|NCT00757393|Vitamin D|vitamin d
1504939|NCT00757393|Calcium|calcium
1504940|NCT00757393|Exercise|exercise
1504941|NCT00757380|epiretinal membranes|epiretinal membranes
1504942|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
1504943|NCT00757380|membranepeeling|membranepeeling
1504944|NCT00757367|Healthy subjects|healthy subjects
1504945|NCT00757367|insulin|insulin
1504946|NCT00757367|bronchoscope|bronchoscope
1504947|NCT00757367|serum insulin|serum insulin
1504948|NCT00757367|serum C-Peptide|serum c-peptide
1504949|NCT00757367|BAL fluid|bal fluid
1504951|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
1504952|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
1504953|NCT00757315|NdYag laser|ndyag laser
1504954|NCT00757315|AKN|akn
1504955|NCT00757315|acne keloidalis|acne keloidalis
1504956|NCT00757315|AK|ak
1504957|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
1504958|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
1504959|NCT00757315|sycosis nuchae|sycosis nuchae
1504960|NCT00757315|acne keloid|acne keloid
1504961|NCT00757315|keloidal folliculitis|keloidal folliculitis
1504962|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
1504963|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
1504964|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
1504965|NCT00757302|breast cancer|breast cancer
1504966|NCT00757302|CarolIReS|carolires
1504967|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
1504968|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
1504969|NCT00757302|sentinel lymph node|sentinel lymph node
1504970|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
1504971|NCT00757289|Tennis Elbow|tennis elbow
1504972|NCT00757276|Copeptin|copeptin
1504973|NCT00757276|Diabetes insipidus|diabetes insipidus
1504974|NCT00757276|diagnostic marker|diagnostic marker
1504975|NCT00757276|Vasopressin|vasopressin
1504976|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
1504977|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
1504978|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
1504979|NCT00757263|ovarian sarcoma|ovarian sarcoma
1504980|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
1504981|NCT00757250|HIV|hiv
1504982|NCT00757250|AIDS|aids
1504983|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
1504984|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
1504985|NCT00757250|treatment Experienced|treatment experienced
1504986|NCT00757237|aztreonam lysine|aztreonam lysine
1504987|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
1504988|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
1504989|NCT00757237|cystic fibrosis|cystic fibrosis
1504990|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
1504991|NCT00757237|lung infection|lung infection
1504992|NCT00757237|CFQ-R|cfq-r
1504993|NCT00757237|inhaled antibiotic|inhaled antibiotic
1504994|NCT00757211|breast cancer|breast cancer
1504995|NCT00757211|male breast cancer|male breast cancer
1504996|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
1504997|NCT00757185|skin blood flow|skin blood flow
1504998|NCT00757185|microcirculation|microcirculation
1504999|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1505000|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1505001|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
1505002|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
1505003|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
1505004|NCT00757159|Periodontal disease|periodontal disease
1505005|NCT00757159|Hydroxyapatite|hydroxyapatite
1505006|NCT00757159|Enamel matrix protein|enamel matrix protein
1505007|NCT00757159|Regeneration|regeneration
1505008|NCT00757159|Human|human
1505009|NCT00757146|chronic lung disease|chronic lung disease
1505010|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1505011|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
1505012|NCT00757146|premature infants|premature infants
1505013|NCT00757120|COPD|copd
1505014|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
1505015|NCT00757120|EMMPRIN|emmprin
1505016|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
1505017|NCT00757107|Short femoral stem|short femoral stem
1505018|NCT00757107|Stress shielding|stress shielding
1505019|NCT00757107|Stem migration|stem migration
1505020|NCT00757107|Implant Survival|implant survival
1505021|NCT00757107|DEXA|dexa
1505022|NCT00757107|Radiostereometric analysis|radiostereometric analysis
1505023|NCT00757094|Fasting|fasting
1505024|NCT00757094|Chemotherapy|chemotherapy
1505025|NCT00757094|Cancer|cancer
1505026|NCT00757068|Non-smoking|non-smoking
1505027|NCT00757068|Women|women
1505028|NCT00757068|Pregnancy|pregnancy
1505029|NCT00757068|Treatment|treatment
1505030|NCT00757068|Mood|mood
1505031|NCT00757068|Weight|weight
1505033|NCT00757068|Adjustment|adjustment
1505034|NCT00757055|Heart failure|heart failure
1505035|NCT00757055|Diastolic heart failure|diastolic heart failure
1505036|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
1505037|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
1505038|NCT00757055|Ivabradine|ivabradine
1505039|NCT00757055|Diastolic dysfunction|diastolic dysfunction
1505040|NCT00757042|atopic dermatitis|atopic dermatitis
1505041|NCT00757042|skin diseases|skin diseases
1505042|NCT00757042|healthy volunteer|healthy volunteer
1505043|NCT00757029|ADHD,|adhd,
1505044|NCT00757029|norepinephrine transporter|norepinephrine transporter
1505045|NCT00757029|pharmacogenetics|pharmacogenetics
1505046|NCT00757016|low back pain|low back pain
1505047|NCT00757016|randomised controlled trial|randomised controlled trial
1505048|NCT00757016|slow release corticosteroid|slow release corticosteroid
1505049|NCT00757016|injection treatment|injection treatment
1505050|NCT00756977|Colonoscopy|colonoscopy
1505051|NCT00756977|screening|screening
1505052|NCT00756964|cardiac surgery|cardiac surgery
1505053|NCT00756964|hyperuricemia|hyperuricemia
1505054|NCT00756951|SCV-07|scv-07
1505055|NCT00756951|Oral Mucositis|oral mucositis
1505057|NCT00756925|cocaine|cocaine
1505058|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
1505059|NCT00756925|gender differences|gender differences
1505060|NCT00756912|ANC|anc
1505061|NCT00756912|BMT|bmt
1505062|NCT00756912|graft versus leukemia|graft versus leukemia
1505063|NCT00756912|graft vs. host disease|graft vs. host disease
1505064|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
1505065|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
1505066|NCT00756912|myeloablative|myeloablative
1505067|NCT00756912|conditioning|conditioning
1505068|NCT00756912|therapy|therapy
1505069|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
1505070|NCT00756873|Elective tonsillectomy|elective tonsillectomy
1505071|NCT00756847|Solid Tumors|solid tumors
1505072|NCT00756847|NSCLC|nsclc
1505073|NCT00756847|Ovarian Cancer|ovarian cancer
1505074|NCT00756847|Endometrial Cancer|endometrial cancer
1505179|NCT00756405|Supplements|supplements
1505075|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
1505076|NCT00756821|Blood Biomarkers|blood biomarkers
1505077|NCT00756821|Urine Biomarkers|urine biomarkers
1505078|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
1505079|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
1505080|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
1505081|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
1505082|NCT00756821|Disease severity|disease severity
1505083|NCT00756821|Biomarkers|biomarkers
1505084|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
1505085|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
1505086|NCT00756756|G-CSF|g-csf
1505087|NCT00756756|Myocardial infarction|myocardial infarction
1505088|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
1505089|NCT00756730|lopinavir|lopinavir
1505090|NCT00756730|ritonavir|ritonavir
1505091|NCT00756730|atazanavir|atazanavir
1505092|NCT00756730|fosamprenavir|fosamprenavir
1505093|NCT00756730|darunavir|darunavir
1505094|NCT00756730|anti-retroviral|anti-retroviral
1505095|NCT00756730|AIDS|aids
1505097|NCT00756730|LARD|lard
1505098|NCT00756730|triglyceride|triglyceride
1505099|NCT00756730|protease inhibitors|protease inhibitors
1505100|NCT00756730|treatment Experienced|treatment experienced
1505101|NCT00756717|MK-0752|mk-0752
1505102|NCT00756717|Tamoxifen|tamoxifen
1505103|NCT00756717|Letroxole|letroxole
1505104|NCT00756704|Smoking Cessation|smoking cessation
1505105|NCT00756704|Emergency Medicine|emergency medicine
1505106|NCT00756704|Emergency Nursing|emergency nursing
1505107|NCT00756704|Effectiveness Trial|effectiveness trial
1505108|NCT00756704|Implementation|implementation
1505109|NCT00756704|Relapse prevention|relapse prevention
1505110|NCT00756691|18F-FAZA|18f-faza
1505111|NCT00756691|Positron Emission Tomography|positron emission tomography
1505112|NCT00756691|Radiation dosimetry|radiation dosimetry
1505113|NCT00756691|Pharmacokinetics|pharmacokinetics
1505114|NCT00756665|prostate|prostate
1505115|NCT00756665|cancer|cancer
1505116|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
1505117|NCT00756639|urothelial carcinoma|urothelial carcinoma
1505118|NCT00756639|genitourinary bladder|genitourinary bladder
1505119|NCT00756639|urothelium|urothelium
1505120|NCT00756639|bladder|bladder
1505121|NCT00756639|bladder cancer|bladder cancer
1505122|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
1505124|NCT00756639|brain metastasis|brain metastasis
1505125|NCT00756639|genitourinary|genitourinary
1505126|NCT00756639|radiation|radiation
1505127|NCT00756639|TCC|tcc
1505128|NCT00756639|adenocarcinoma|adenocarcinoma
1505129|NCT00756626|Bottle Weaning|bottle weaning
1505130|NCT00756626|Bottle Feeding|bottle feeding
1505131|NCT00756626|Overweight in toddlers|overweight in toddlers
1505132|NCT00756626|Bottle use|bottle use
1505133|NCT00756626|excess weight for length|excess weight for length
1505134|NCT00756600|Infants|infants
1505135|NCT00756600|scheduled|scheduled
1505136|NCT00756600|unilateral|unilateral
1505137|NCT00756600|bilateral|bilateral
1505138|NCT00756600|repair|repair
1505139|NCT00756587|Cup Feeding|cup feeding
1505140|NCT00756587|late Preterm|late preterm
1505141|NCT00756574|N95|n95
1505142|NCT00756574|Respirator|respirator
1505143|NCT00756574|mask|mask
1505144|NCT00756574|influenza|influenza
1505145|NCT00756574|efficacy|efficacy
1505146|NCT00756561|Fine Needle Aspiration|fine needle aspiration
1505147|NCT00756561|Male Health|male health
1505148|NCT00756561|Male Contraception|male contraception
1505149|NCT00756548|colonoscopy|colonoscopy
1505150|NCT00756548|screening|screening
1505151|NCT00756535|Exercise Therapy|exercise therapy
1505152|NCT00756535|Length of Stay|length of stay
1505153|NCT00756535|Disability Evaluation|disability evaluation
1505154|NCT00756522|COPD|copd
1505155|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
1505156|NCT00756509|1st. line treatment|1st. line treatment
1505157|NCT00756483|Resistance|resistance
1505158|NCT00756483|Exercise|exercise
1505159|NCT00756470|Breast Cancer|breast cancer
1505160|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
1505161|NCT00756470|IBC|ibc
1505162|NCT00756470|ErbB2 overexpression|erbb2 overexpression
1505163|NCT00756470|Lapatinib|lapatinib
1505164|NCT00756470|Paclitaxel|paclitaxel
1505165|NCT00756470|5-Fluorouracil|5-fluorouracil
1505166|NCT00756470|Epirubicin|epirubicin
1505167|NCT00756470|Cyclophosphamide|cyclophosphamide
1505168|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1505169|NCT00756457|PTTD|pttd
1505170|NCT00756457|Tendinopathy|tendinopathy
1505171|NCT00756457|Tendon Injuries|tendon injuries
1505172|NCT00756457|Muscular Diseases|muscular diseases
1505173|NCT00756457|Foot Diseases|foot diseases
1505174|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
1505175|NCT00756405|Adults|adults
1505176|NCT00756405|Antioxidants|antioxidants
1505177|NCT00756405|Inflammatory markers|inflammatory markers
1505178|NCT00756405|Diet|diet
1505180|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
1505181|NCT00756392|Prostate Imaging|prostate imaging
1505182|NCT00756379|Cardiovascular disease|cardiovascular disease
1505183|NCT00756379|Atherosclerosis|atherosclerosis
1505184|NCT00756379|Coronary artery disease|coronary artery disease
1505185|NCT00756379|Coronary perfusion defect|coronary perfusion defect
1505186|NCT00756379|Absolute coronary flow|absolute coronary flow
1505187|NCT00756379|Lifestyle management|lifestyle management
1505188|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
1505189|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
1505190|NCT00756366|positron emission tomography|positron emission tomography
1505191|NCT00756366|myocardial energetics|myocardial energetics
1505192|NCT00756366|sympathetic nerve function|sympathetic nerve function
1505194|NCT00756353|Buprenorphine use|buprenorphine use
1505195|NCT00756327|pediatric eyes|pediatric eyes
1505196|NCT00756327|bilateral cataract|bilateral cataract
1505197|NCT00756327|IOL implantation|iol implantation
1505198|NCT00756327|Aqualase capsule wash|aqualase capsule wash
1505199|NCT00756327|posterior capsule opacification|posterior capsule opacification
1505200|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
1505201|NCT00756314|abortion care|abortion care
1505202|NCT00756314|contraception|contraception
1505203|NCT00756314|counseling|counseling
1505204|NCT00756314|outpatient clinic|outpatient clinic
1505205|NCT00756288|Actinic Keratoses|actinic keratoses
1505206|NCT00756288|Blue light therapy|blue light therapy
1505207|NCT00756288|photosensitizer|photosensitizer
1505208|NCT00756288|Retinoid|retinoid
1505209|NCT00756275|Tobacco Smoking|tobacco smoking
1505210|NCT00756275|Smoking Cessation|smoking cessation
1505211|NCT00756275|Nicotine Dependence|nicotine dependence
1505212|NCT00756275|Tobacco Use Disorder|tobacco use disorder
1505213|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
1505214|NCT00756262|Probiotics|probiotics
1505215|NCT00756262|LGG|lgg
1505216|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
1505217|NCT00756249|Acute ischemic stroke|acute ischemic stroke
1505218|NCT00756249|Erythropoietin|erythropoietin
1505219|NCT00756249|Carbamylated|carbamylated
1505220|NCT00756249|Neuroprotection|neuroprotection
1505221|NCT00756197|Radiation Proctitis|radiation proctitis
1505222|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
1505223|NCT00756184|Glaucoma|glaucoma
1505224|NCT00756184|Adherence|adherence
1505225|NCT00756184|Teaching|teaching
1505226|NCT00756171|Cholestatic|cholestatic
1505227|NCT00756171|pruritus|pruritus
1505228|NCT00756171|of any cause|of any cause
1505229|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1505230|NCT00756158|dopaminergic|dopaminergic
1505231|NCT00756158|noradrenergic|noradrenergic
1505232|NCT00756158|endophenotype|endophenotype
1505233|NCT00756158|molecular genetics|molecular genetics
1505234|NCT00756158|candidate gene|candidate gene
1505331|NCT00755768|dietetic advice|dietetic advice
1505235|NCT00756158|Family-based Association study|family-based association study
1505236|NCT00756145|stage V|stage v
1505237|NCT00756145|treated|treated
1505238|NCT00756145|hemodiafiltration|hemodiafiltration
1505239|NCT00756132|Breast|breast
1505240|NCT00756132|Neoplasm|neoplasm
1505241|NCT00756132|Locally Advanced|locally advanced
1505242|NCT00756132|Stage IV|stage iv
1505243|NCT00756132|Stage III|stage iii
1505244|NCT00756132|Cognitive Function|cognitive function
1505245|NCT00756132|Cytokines|cytokines
1505246|NCT00756132|Inflammatory|inflammatory
1505247|NCT00756132|Node positive|node positive
1505248|NCT00756106|adult glioblastoma|adult glioblastoma
1505249|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
1505250|NCT00756106|adult gliosarcoma|adult gliosarcoma
1505251|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1505252|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
1505253|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1505254|NCT00756106|adult mixed glioma|adult mixed glioma
1505255|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
1505256|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
1505257|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
1505258|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
1505259|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
1505260|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
1505261|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
1505262|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
1505263|NCT00756041|Drug Therapy|drug therapy
1505264|NCT00756028|OHSS|ohss
1505265|NCT00756028|quality of life|quality of life
1505266|NCT00756028|IVF|ivf
1505267|NCT00756028|ICSI|icsi
1505268|NCT00756028|GnRH-agonist|gnrh-agonist
1505269|NCT00756028|GnRH-antagonist|gnrh-antagonist
1505270|NCT00756015|rotator cuff|rotator cuff
1505271|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
1505272|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
1505273|NCT00756015|physical therapy|physical therapy
1505274|NCT00756015|cuff repair integrity|cuff repair integrity
1505275|NCT00756015|ultrasound|ultrasound
1505276|NCT00756002|Chronic Insomnia|chronic insomnia
1505277|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
1505278|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
1505279|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
1505280|NCT00756002|Transient Insomnia|transient insomnia
1505281|NCT00756002|Drug Therapy|drug therapy
1505282|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1505283|NCT00755976|stage IV melanoma|stage iv melanoma
1505284|NCT00755950|Acute|acute
1505285|NCT00755950|Hepatitis|hepatitis
1505286|NCT00755950|Silymarin|silymarin
1505287|NCT00755950|Global Health|global health
1505288|NCT00755911|dental|dental
1505289|NCT00755911|tooth|tooth
1505290|NCT00755911|implant|implant
1505291|NCT00755911|extraction|extraction
1505292|NCT00755911|Oral|oral
1505293|NCT00755911|Surgical|surgical
1505294|NCT00755911|Procedures|procedures
1505295|NCT00755898|cancer|cancer
1505296|NCT00755898|diagnostic test|diagnostic test
1505297|NCT00755898|urine|urine
1505298|NCT00755898|amantadine acetylation|amantadine acetylation
1505299|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
1505300|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
1505301|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
1505302|NCT00755885|stage IV breast cancer|stage iv breast cancer
1505303|NCT00755885|recurrent breast cancer|recurrent breast cancer
1505304|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1505305|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1505306|NCT00755859|IgA nephropathy|iga nephropathy
1505307|NCT00755859|steroids|steroids
1505308|NCT00755859|azathioprine|azathioprine
1505309|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
1505310|NCT00755859|proteinuria|proteinuria
1505311|NCT00755846|Diabetes Mellitus|diabetes mellitus
1505312|NCT00755846|Drug Therapy|drug therapy
1505313|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1505314|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1505315|NCT00755846|Hyperinsulinism|hyperinsulinism
1505316|NCT00755846|Insulin Resistance|insulin resistance
1505317|NCT00755807|Central Neuropathic Pain|central neuropathic pain
1505318|NCT00755807|Multiple Sclerosis|multiple sclerosis
1505319|NCT00755781|lung transplant|lung transplant
1505320|NCT00755781|lung transplant recipient|lung transplant recipient
1505321|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1505322|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
1505323|NCT00755781|single lung transplant|single lung transplant
1505324|NCT00755781|double lung transplant|double lung transplant
1505325|NCT00755781|heart-lung transplant|heart-lung transplant
1505327|NCT00755768|hemodialysis|hemodialysis
1505328|NCT00755768|phosphate|phosphate
1505329|NCT00755768|calcium phosphate product|calcium phosphate product
1505330|NCT00755768|dietician|dietician
1505332|NCT00755742|obesity|obesity
1505333|NCT00755742|insulin resistance|insulin resistance
1505334|NCT00755742|metabolic syndrome|metabolic syndrome
1505335|NCT00755742|hepatitis C|hepatitis c
1505336|NCT00755742|adipokine|adipokine
1505338|NCT00755742|leptin|leptin
1505339|NCT00755742|adiponectin|adiponectin
1505340|NCT00755742|fatigue|fatigue
1505341|NCT00755742|mood|mood
1505342|NCT00755742|depression|depression
1505343|NCT00755742|exercise|exercise
1505344|NCT00755742|diet|diet
1505345|NCT00755742|counseling|counseling
1505346|NCT00755742|behavior modification|behavior modification
1505347|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
1505348|NCT00755729|Insulin resistance|insulin resistance
1505349|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
1505350|NCT00755716|nicotine patch|nicotine patch
1505351|NCT00755716|smoking|smoking
1505352|NCT00755716|topiramate|topiramate
1505353|NCT00755703|Influenza|influenza
1505354|NCT00755703|Vaccine|vaccine
1505355|NCT00755703|Pandemic|pandemic
1505356|NCT00755703|Avian influenza|avian influenza
1505357|NCT00755703|Adenovirus strain 5|adenovirus strain 5
1505358|NCT00755703|Vectored vaccine|vectored vaccine
1505359|NCT00755703|Intranasal|intranasal
1505360|NCT00755703|Tissue-culture derived|tissue-culture derived
1505361|NCT00755703|Non-replicating|non-replicating
1505362|NCT00755690|Chronic Kidney Disease|chronic kidney disease
1505363|NCT00755690|CKD|ckd
1505364|NCT00755690|Diet|diet
1505365|NCT00755690|Dietary Phosphate|dietary phosphate
1505366|NCT00755690|Mineral Metabolism|mineral metabolism
1505367|NCT00755690|FGF-23|fgf-23
1505368|NCT00755664|homocysteine|homocysteine
1505369|NCT00755664|folate acid,|folate acid,
1505370|NCT00755664|vitamin B|vitamin b
1505371|NCT00755664|random controlled trail|random controlled trail
1505372|NCT00755651|Menorrhagia|menorrhagia
1505373|NCT00755651|Uterine fibroids|uterine fibroids
1505374|NCT00755651|Endometrial polyps|endometrial polyps
1505375|NCT00755651|Endometrial cancer|endometrial cancer
1505376|NCT00755599|Papanicolaou Smear|papanicolaou smear
1505377|NCT00755599|Vaginitis|vaginitis
1505378|NCT00755599|Patient Satisfaction|patient satisfaction
1505379|NCT00755586|Brachial plexus|brachial plexus
1505380|NCT00755586|Muscle denervation|muscle denervation
1505381|NCT00755586|Stem cell transplantation|stem cell transplantation
1505382|NCT00755586|Bone marrow cells|bone marrow cells
1505383|NCT00755586|Satellite cells|satellite cells
1505384|NCT00755586|Fibrosis|fibrosis
1505385|NCT00755573|Pain|pain
1505386|NCT00755573|Neuropathic pain|neuropathic pain
1505387|NCT00755560|Toxocara|toxocara
1505388|NCT00755560|Pediatrics|pediatrics
1505389|NCT00755560|Albendazole|albendazole
1505390|NCT00755560|eosinophilia|eosinophilia
1505391|NCT00755560|parasitology|parasitology
1505392|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
1505393|NCT00755547|Childhood|childhood
1505394|NCT00755547|insulin sensitivity|insulin sensitivity
1505395|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
1505396|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
1505397|NCT00755534|Second line|second line
1505398|NCT00755534|Irinotecan|irinotecan
1505399|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
1505400|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
1505401|NCT00755521|Fibromyalgia|fibromyalgia
1505402|NCT00755521|tenderness|tenderness
1505403|NCT00755521|widespread pain|widespread pain
1505404|NCT00755521|comrbidity|comrbidity
1505405|NCT00755508|Chronic Insomnia|chronic insomnia
1505406|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
1505407|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
1505408|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
1505409|NCT00755508|Transient Insomnia|transient insomnia
1505410|NCT00755508|Drug Therapy|drug therapy
1505411|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1505412|NCT00755495|Chronic Insomnia|chronic insomnia
1505413|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
1505414|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
1505415|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
1505416|NCT00755495|Transient Insomnia|transient insomnia
1505417|NCT00755495|Drug Therapy|drug therapy
1505418|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1505419|NCT00755482|Osteoarthritis|osteoarthritis
1505420|NCT00755482|Clinical trial|clinical trial
1505421|NCT00755482|Aquamin F|aquamin f
1505422|NCT00755482|NSAID|nsaid
1505423|NCT00755469|Reperfusion injury|reperfusion injury
1505424|NCT00755469|Post-Conditioning|post-conditioning
1505425|NCT00755469|Infarct size|infarct size
1505426|NCT00755456|Peritoneal dialysis|peritoneal dialysis
1505427|NCT00755456|L-carnitine|l-carnitine
1505428|NCT00755456|Insulin resistance|insulin resistance
1505429|NCT00755456|Glucose homeostasis|glucose homeostasis
1505430|NCT00755456|Dyslipidemia|dyslipidemia
1505431|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
1505665|NCT00754754|brain|brain
1505432|NCT00755430|structural and functional connectivity|structural and functional connectivity
1505433|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
1505434|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1505435|NCT00755430|siblings|siblings
1505436|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
1505437|NCT00755417|Hot flashes|hot flashes
1505438|NCT00755417|Hot flushes|hot flushes
1505439|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
1505440|NCT00755417|Vasomotor symptoms|vasomotor symptoms
1505441|NCT00755404|Peritoneal dialysis|peritoneal dialysis
1505442|NCT00755404|L-carnitine|l-carnitine
1505443|NCT00755404|Diabetes|diabetes
1505444|NCT00755404|Glucose homeostasis|glucose homeostasis
1505445|NCT00755404|Dyslipidemia|dyslipidemia
1505446|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
1505447|NCT00755378|Phase I|phase i
1505448|NCT00755365|pelvic fractures|pelvic fractures
1505449|NCT00755365|angioembolism|angioembolism
1505450|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
1505451|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
1505452|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
1505453|NCT00755339|Magnetoencephalogram|magnetoencephalogram
1505454|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1505455|NCT00755339|Tourette Syndrome|tourette syndrome
1505456|NCT00755339|Tic Disorder|tic disorder
1505457|NCT00755339|Tourete Syndrome|tourete syndrome
1505459|NCT00755313|cognitive/functional effects|cognitive/functional effects
1505460|NCT00755313|fatigue|fatigue
1505461|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1505462|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1505463|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1505464|NCT00755313|neurotoxicity|neurotoxicity
1505465|NCT00755313|stage IA breast cancer|stage ia breast cancer
1505466|NCT00755313|stage IB breast cancer|stage ib breast cancer
1505467|NCT00755313|stage II breast cancer|stage ii breast cancer
1505468|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
1505469|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
1505470|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
1505471|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1505472|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1505473|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1505474|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1505475|NCT00755300|Total knee replacement|total knee replacement
1505476|NCT00755300|esophageal echocardiography|esophageal echocardiography
1505477|NCT00755274|Influenza|influenza
1505478|NCT00755274|Orthomyxoviruses|orthomyxoviruses
1505479|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
1505480|NCT00755274|Influenza vaccine|influenza vaccine
1505481|NCT00755261|STS|sts
1505482|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
1505483|NCT00755248|outcome|outcome
1505484|NCT00755248|saphenous graft patency|saphenous graft patency
1505485|NCT00755248|biochemical factors|biochemical factors
1505486|NCT00755248|genomics|genomics
1505487|NCT00755235|Depression|depression
1505488|NCT00755235|Primary care|primary care
1505489|NCT00755235|Effectiveness|effectiveness
1505490|NCT00755235|Care management|care management
1505491|NCT00755222|Peyronie's disease|peyronie's disease
1505492|NCT00755222|penile plaque|penile plaque
1505493|NCT00755222|penile curvature|penile curvature
1505494|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
1505495|NCT00755209|Adults|adults
1505496|NCT00755209|Moderately severe TBI|moderately severe tbi
1505497|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
1505498|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
1505499|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
1505500|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
1505501|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
1505502|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
1505503|NCT00755209|Human|human
1505504|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
1505505|NCT00755196|Topical|topical
1505506|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
1505507|NCT00755183|Dry Eye Syndrome|dry eye syndrome
1505508|NCT00755170|Vinorelbine|vinorelbine
1505509|NCT00755170|Bevacizumab|bevacizumab
1505510|NCT00755170|Chemotherapy|chemotherapy
1505511|NCT00755157|Cancer|cancer
1505512|NCT00755157|SCLC|sclc
1505513|NCT00755157|Docetaxel|docetaxel
1505514|NCT00755157|Bevacizumab|bevacizumab
1505515|NCT00755157|Chemotherapy|chemotherapy
1505516|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
1505517|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
1505518|NCT00755131|Inflammatory markers|inflammatory markers
1505519|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
1505520|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
1505666|NCT00754754|surgery|surgery
1505521|NCT00755131|Echocardiography|echocardiography
1505522|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
1505523|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
1505524|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
1505525|NCT00755131|Left Atrium Remodeling|left atrium remodeling
1505526|NCT00755131|Cardiac Remodeling|cardiac remodeling
1505527|NCT00755131|Exercise Training|exercise training
1505528|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
1505529|NCT00755118|Second line|second line
1505530|NCT00755118|Irinotecan|irinotecan
1505531|NCT00755118|Cetuximab|cetuximab
1505532|NCT00755118|Bevacizumab|bevacizumab
1505533|NCT00755105|body iron excretion|body iron excretion
1505534|NCT00755105|Iron isotopes|iron isotopes
1505535|NCT00755092|Doula|doula
1505536|NCT00755092|Psychological care|psychological care
1505537|NCT00755092|Labor analgesia|labor analgesia
1505538|NCT00755079|spinal cord injury|spinal cord injury
1505539|NCT00755079|beta-2 agonist|beta-2 agonist
1505540|NCT00755079|respiratory muscle strength|respiratory muscle strength
1505541|NCT00755079|pulmonary function test|pulmonary function test
1505542|NCT00755053|Clotrimazole|clotrimazole
1505543|NCT00755053|Ovule|ovule
1505544|NCT00755053|Tablet|tablet
1505545|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
1505546|NCT00755053|Non-inferiority|non-inferiority
1505547|NCT00755040|graft versus host disease|graft versus host disease
1505548|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1505549|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1505550|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1505551|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1505552|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1505553|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1505554|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1506011|NCT00753233|Arrhythmias|arrhythmias
1505555|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1505556|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1505557|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1505558|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1505559|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1505560|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1505561|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1505562|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1505563|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1505564|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1505565|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1505566|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1505567|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1505568|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1505569|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1505570|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1505571|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1505572|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1505573|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1505574|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1505575|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1505576|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1505577|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1505578|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1505579|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1505580|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1505581|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1505582|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1505583|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1505584|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1505585|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1505586|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1505587|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1505588|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1505589|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1505590|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1505591|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1505592|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1505593|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1505594|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1505595|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1505596|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1505597|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1505598|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1505599|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1505600|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1505601|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1505602|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1505603|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1505604|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1505605|NCT00755040|primary myelofibrosis|primary myelofibrosis
1505606|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1505607|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1505608|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1505609|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1505610|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1505611|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
1505612|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
1505613|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
1505614|NCT00755027|Parkinson's disease|parkinson's disease
1505615|NCT00755027|Apathy|apathy
1505616|NCT00755027|Rasagiline|rasagiline
1505617|NCT00755001|Total Hip Replacement|total hip replacement
1506632|NCT00751088|treatment|treatment
1505618|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
1505619|NCT00754949|Ophthalmology|ophthalmology
1505620|NCT00754936|Depression|depression
1505621|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1505622|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1505623|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1505624|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
1505625|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1505626|NCT00754923|large cell lung cancer|large cell lung cancer
1505627|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1505628|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1505629|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1505630|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1505631|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1505632|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1505633|NCT00754897|Phone Interview|phone interview
1505634|NCT00754897|Anesthesia|anesthesia
1505635|NCT00754897|Siblings|siblings
1505636|NCT00754897|Inguinal Hernia|inguinal hernia
1505637|NCT00754897|Neurologic Examination|neurologic examination
1505638|NCT00754897|Developmental Delay Disorders|developmental delay disorders
1505639|NCT00754884|salmon calcitonin|salmon calcitonin
1505640|NCT00754884|endorphins|endorphins
1505641|NCT00754884|treatment|treatment
1505642|NCT00754884|fibromyalgia|fibromyalgia
1505643|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1505644|NCT00754845|stage I breast cancer|stage i breast cancer
1505645|NCT00754845|stage II breast cancer|stage ii breast cancer
1505646|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
1505647|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
1505648|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
1505649|NCT00754832|Multiple sclerosis|multiple sclerosis
1505650|NCT00754832|fatigue|fatigue
1505651|NCT00754832|ginseng|ginseng
1505652|NCT00754806|HALS|hals
1505653|NCT00754806|open splenectomy|open splenectomy
1505654|NCT00754806|splenomegaly|splenomegaly
1505655|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
1505778|NCT00754013|Down syndrome|down syndrome
1505656|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
1505657|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
1505658|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
1505659|NCT00754780|NF1|nf1
1505660|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
1505661|NCT00754767|neurotoxicity|neurotoxicity
1505662|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1505663|NCT00754767|stage IV breast cancer|stage iv breast cancer
1505664|NCT00754767|recurrent breast cancer|recurrent breast cancer
1505667|NCT00754754|retraction|retraction
1505668|NCT00754754|injury|injury
1505669|NCT00754754|monitoring|monitoring
1505670|NCT00754741|medication adherence|medication adherence
1505671|NCT00754741|motivational interviewing|motivational interviewing
1505672|NCT00754715|Multiple dosing study,|multiple dosing study,
1505673|NCT00754715|safety|safety
1505674|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
1505675|NCT00754702|Chemotherapy|chemotherapy
1505676|NCT00754702|Targeted therapy|targeted therapy
1505677|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
1505678|NCT00754663|exercise|exercise
1505679|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1505680|NCT00754663|arrhythmia|arrhythmia
1505681|NCT00754637|Joint|joint
1505682|NCT00754637|Osteoarthritis|osteoarthritis
1505683|NCT00754637|Avascular Necrosis|avascular necrosis
1505684|NCT00754546|exercise;|exercise;
1505685|NCT00754546|treadmill;|treadmill;
1505686|NCT00754546|cycle ergometer;|cycle ergometer;
1505687|NCT00754546|breathlessness;|breathlessness;
1505688|NCT00754546|leg discomfort|leg discomfort
1505689|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
1505690|NCT00754533|coronary heart disease|coronary heart disease
1505691|NCT00754533|interval training|interval training
1505692|NCT00754533|continuous training|continuous training
1505693|NCT00754533|ventilatory threshold|ventilatory threshold
1505694|NCT00754481|Paediatrics|paediatrics
1505695|NCT00754468|Barrett's Esophagus|barrett's esophagus
1505696|NCT00754468|Esophageal Cancer|esophageal cancer
1505697|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
1505698|NCT00754468|Low Grade Dysplasia|low grade dysplasia
1505699|NCT00754468|High Grade Dysplasia|high grade dysplasia
1505700|NCT00754442|hyperparathyroidism|hyperparathyroidism
1505701|NCT00754442|parathyroid|parathyroid
1505702|NCT00754442|vitamin D|vitamin d
1505703|NCT00754442|vitamin D deficiency|vitamin d deficiency
1505704|NCT00754416|Shoulder Replacement|shoulder replacement
1505705|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
1505706|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
1505707|NCT00754403|Type II Diabetes|type ii diabetes
1505708|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1505709|NCT00754403|Dyslipidemia|dyslipidemia
1505710|NCT00754403|Drug Therapy|drug therapy
1505711|NCT00754390|dietary zinc absorption|dietary zinc absorption
1505712|NCT00754390|dietary phytic acid|dietary phytic acid
1505713|NCT00754390|dietary calcium|dietary calcium
1505714|NCT00754377|Education|education
1505715|NCT00754377|Program Evaluation|program evaluation
1505716|NCT00754377|Quality of Health Care|quality of health care
1505717|NCT00754377|Medical Residents|medical residents
1505718|NCT00754351|docetaxel|docetaxel
1505719|NCT00754351|gemcitabine|gemcitabine
1505720|NCT00754351|bevacizumab|bevacizumab
1505721|NCT00754351|chemotherapy|chemotherapy
1505722|NCT00754338|comfort|comfort
1505723|NCT00754338|wetability|wetability
1505724|NCT00754338|protein deposit|protein deposit
1505725|NCT00754338|lipid deposit|lipid deposit
1664291|NCT00127270|OAB|oab
1505726|NCT00754312|breast cancer|breast cancer
1505727|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
1505728|NCT00754299|nicotine dependent|nicotine dependent
1505729|NCT00754299|chronic osseous infection|chronic osseous infection
1505730|NCT00754299|infected osseous nonunions|infected osseous nonunions
1505731|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
1505732|NCT00754286|Aromatherapy|aromatherapy
1505733|NCT00754247|Keloid|keloid
1505734|NCT00754247|Hypertrophic scar|hypertrophic scar
1505735|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
1505736|NCT00754247|HSE|hse
1505737|NCT00754247|Onion extract gel|onion extract gel
1505738|NCT00754247|OE|oe
1505739|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
1505740|NCT00754247|CEA|cea
1505741|NCT00754234|iron absorption|iron absorption
1505742|NCT00754234|iron requirements|iron requirements
1505743|NCT00754234|dietary guidelines|dietary guidelines
1505744|NCT00754234|MyPyramid|mypyramid
1505745|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
1505746|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1505747|NCT00754208|Stimulant Treatment|stimulant treatment
1505748|NCT00754208|Young Children|young children
1505749|NCT00754195|Thoracotomy|thoracotomy
1505750|NCT00754182|thyroidectomy|thyroidectomy
1505751|NCT00754182|surgery|surgery
1505752|NCT00754182|synthetic glue|synthetic glue
1505753|NCT00754182|subcuticular suture|subcuticular suture
1505754|NCT00754169|Traumatic Brain Injury|traumatic brain injury
1505755|NCT00754169|Brain Imaging|brain imaging
1505756|NCT00754169|Brain Plasticity|brain plasticity
1505757|NCT00754169|Neuroplasticity|neuroplasticity
1505758|NCT00754169|Neuropsychological Testing|neuropsychological testing
1505759|NCT00754169|Head Injury|head injury
1505760|NCT00754169|Healthy Volunteer|healthy volunteer
1505761|NCT00754156|Closure, Wounds|closure, wounds
1505762|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
1505763|NCT00754143|proteinuria|proteinuria
1507974|NCT00746408|Internet|internet
1505764|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
1505765|NCT00754117|newly diagnosed|newly diagnosed
1505766|NCT00754078|tomotherapy|tomotherapy
1505767|NCT00754065|Oral contraceptive|oral contraceptive
1505768|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
1505769|NCT00754065|EV/DNG|ev/dng
1505770|NCT00754065|comparative tolerability|comparative tolerability
1505771|NCT00754052|Pediatric|pediatric
1505772|NCT00754052|Down syndrome|down syndrome
1505773|NCT00754052|Downs|downs
1505774|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
1505775|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
1505776|NCT00754026|Shoulder surgery|shoulder surgery
1505777|NCT00754013|pediatric|pediatric
1505779|NCT00754013|cognitive dysfunction|cognitive dysfunction
1505780|NCT00754013|Downs|downs
1505781|NCT00754013|Aricept|aricept
1505782|NCT00754013|children with Down syndrome|children with down syndrome
1505783|NCT00753987|Cystic Fibrosis|cystic fibrosis
1505784|NCT00753987|Hypertonic Saline|hypertonic saline
1505785|NCT00753987|Infants|infants
1505786|NCT00753961|Shiftworkers|shiftworkers
1505787|NCT00753961|volunteers|volunteers
1505788|NCT00753948|Tetraplegia|tetraplegia
1505789|NCT00753948|Mild asthma|mild asthma
1505790|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
1505791|NCT00753948|NOS inhibitor|nos inhibitor
1505792|NCT00753948|Spinal cord injury|spinal cord injury
1505793|NCT00753948|Pulmonary Function|pulmonary function
1505794|NCT00753935|aspirin|aspirin
1505795|NCT00753935|aspirin resistance|aspirin resistance
1505796|NCT00753935|aspirin nonresponse|aspirin nonresponse
1505797|NCT00753935|cyclooxygenase|cyclooxygenase
1505798|NCT00753935|thromboxane|thromboxane
1505799|NCT00753935|oxidative stress|oxidative stress
1505800|NCT00753922|Breast Reconstruction|breast reconstruction
1505801|NCT00753922|Breast Augmentation|breast augmentation
1505802|NCT00753922|Revision|revision
1505803|NCT00753922|Silicone breast implants|silicone breast implants
1505804|NCT00753922|Round low-bleed|round low-bleed
1506838|NCT00750126|malignancy|malignancy
1505805|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
1505806|NCT00753909|Paclitaxel|paclitaxel
1505807|NCT00753909|Carboplatin|carboplatin
1505808|NCT00753909|Bevacizumab|bevacizumab
1505809|NCT00753896|Amylin|amylin
1505810|NCT00753896|Lilly|lilly
1505811|NCT00753896|exenatide once weekly|exenatide once weekly
1505812|NCT00753896|thiazolidinedione|thiazolidinedione
1505813|NCT00753896|metformin|metformin
1505814|NCT00753870|current|current
1505815|NCT00753870|no health problems|no health problems
1505816|NCT00753870|no daily cough from smoking|no daily cough from smoking
1505817|NCT00753857|risk communication|risk communication
1505818|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
1505819|NCT00753844|peptide vaccine|peptide vaccine
1505820|NCT00753844|URLC10|urlc10
1505821|NCT00753831|Blepharoptosis|blepharoptosis
1505822|NCT00753831|Ophthalmoplegia|ophthalmoplegia
1505823|NCT00753831|Blepharospasm|blepharospasm
1505824|NCT00753818|infant formula|infant formula
1505825|NCT00753818|visual development|visual development
1505826|NCT00753805|mare's milk|mare's milk
1505827|NCT00753805|atopic dermatitis|atopic dermatitis
1505828|NCT00753805|endogenous eczema|endogenous eczema
1505829|NCT00753805|SCORAD|scorad
1505830|NCT00753805|Bifidobacteria|bifidobacteria
1505831|NCT00753792|multiple sclerosis|multiple sclerosis
1505832|NCT00753792|relapse|relapse
1505833|NCT00753792|methylprednisolone|methylprednisolone
1505834|NCT00753766|A1c|a1c
1505835|NCT00753766|Blood Glucose Management|blood glucose management
1505836|NCT00753766|Blood Pressure|blood pressure
1505837|NCT00753766|Case Management|case management
1505838|NCT00753766|Diabetes Mellitus|diabetes mellitus
1505839|NCT00753766|Intervention study|intervention study
1505840|NCT00753766|Multifactorial|multifactorial
1505841|NCT00753766|Peri-operative complications|peri-operative complications
1505842|NCT00753766|Pre-operative|pre-operative
1505843|NCT00753753|stent thrombosis|stent thrombosis
1505844|NCT00753753|clopidogrel|clopidogrel
1505845|NCT00753753|aspirin|aspirin
1505846|NCT00753753|bleeding|bleeding
1505847|NCT00753753|coronary|coronary
1505848|NCT00753753|angioplasty|angioplasty
1505849|NCT00753740|Cancer|cancer
1505850|NCT00753740|Neoplasms|neoplasms
1505851|NCT00753740|Solid Tumor|solid tumor
1505852|NCT00753740|Ovarian Cancer|ovarian cancer
1505853|NCT00753740|Solid Malignancies|solid malignancies
1505854|NCT00753727|soft tissue|soft tissue
1505855|NCT00753727|Sarcoma|sarcoma
1505856|NCT00753727|Sunitinib|sunitinib
1505857|NCT00753727|neoadjuvant|neoadjuvant
1505858|NCT00753727|radiotherapy|radiotherapy
1505859|NCT00753714|ZD6474|zd6474
1505860|NCT00753714|VANDETANIB|vandetanib
1505861|NCT00753714|ZACTIMA|zactima
1505862|NCT00753714|ADVANCED|advanced
1505863|NCT00753714|NSCLC|nsclc
1505864|NCT00753714|LUNG CANCER|lung cancer
1505865|NCT00753714|ELDERLY PATIENTS|elderly patients
1505866|NCT00753714|GEMCITABINE|gemcitabine
1505867|NCT00753714|PHASE II|phase ii
1505868|NCT00753714|RANDOMIZED|randomized
1505869|NCT00753714|DOUBLE-BLIND|double-blind
1505870|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
1505871|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
1505872|NCT00753688|pazopanib|pazopanib
1505873|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
1505874|NCT00753688|placebo|placebo
1505875|NCT00753675|Intrahepatic|intrahepatic
1505876|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
1505877|NCT00753675|Vandetanib|vandetanib
1505878|NCT00753675|Zactima|zactima
1505879|NCT00753675|Advanced|advanced
1505880|NCT00753675|Biliary|biliary
1505881|NCT00753675|Tract|tract
1505882|NCT00753675|Gallbladder|gallbladder
1505883|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
1505884|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
1505885|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
1505886|NCT00753662|TMS AD H2 coil|tms ad h2 coil
1505887|NCT00753649|Infant|infant
1505888|NCT00753649|First nation|first nation
1505889|NCT00753649|Aboriginal|aboriginal
1505890|NCT00753649|Canada|canada
1505891|NCT00753636|Parkinson's disease|parkinson's disease
1505892|NCT00753636|Isradipine|isradipine
1505893|NCT00753636|Neuroprotection|neuroprotection
1505894|NCT00753623|Pain|pain
1505895|NCT00753623|Neuropathic pain|neuropathic pain
1505896|NCT00753623|Pain scores|pain scores
1505897|NCT00753610|EPC|epc
1505898|NCT00753610|CCRT|ccrt
1505899|NCT00753610|Cervical cancer|cervical cancer
1505900|NCT00753597|B cell depletion|b cell depletion
1505901|NCT00753597|steroidogenesis|steroidogenesis
1505902|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1505903|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
1505904|NCT00753571|Randomized Control Trial Study|randomized control trial study
1505905|NCT00753545|Serous,|serous,
1505906|NCT00753545|Ovarian cancer,|ovarian cancer,
1505907|NCT00753545|PARP,|parp,
1505908|NCT00753545|BRCA1,|brca1,
1505909|NCT00753545|BRCA2,|brca2,
1507216|NCT00749489|Analgesics|analgesics
1505910|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
1505911|NCT00753545|Platinum sensitive,|platinum sensitive,
1505912|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
1505913|NCT00753532|Carotid artery stenoses|carotid artery stenoses
1505914|NCT00753532|Brain ischaemia|brain ischaemia
1505915|NCT00753532|stroke|stroke
1505916|NCT00753532|Lipid abnormalities|lipid abnormalities
1505917|NCT00753532|Fatty Liver|fatty liver
1505918|NCT00753519|Parkinson's Disease|parkinson's disease
1505919|NCT00753519|Brain Stimulation|brain stimulation
1505920|NCT00753519|Motor Cortex|motor cortex
1505921|NCT00753519|Bradykinesia|bradykinesia
1505922|NCT00753519|Parkinson Disease|parkinson disease
1505923|NCT00753519|PD|pd
1505924|NCT00753480|EOC|eoc
1505925|NCT00753480|PPC|ppc
1505926|NCT00753480|FTC|ftc
1505927|NCT00753467|HBV|hbv
1505928|NCT00753467|Treatment|treatment
1505929|NCT00753467|Interferon-gamma|interferon-gamma
1505930|NCT00753467|combination|combination
1505931|NCT00753467|Hepsera|hepsera
1505932|NCT00753467|Actimmune|actimmune
1505933|NCT00753467|HBV DNA|hbv dna
1505934|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
1505935|NCT00753454|Joint Disease|joint disease
1505936|NCT00753454|Arthritis|arthritis
1505937|NCT00753454|Certolizumab pegol|certolizumab pegol
1505938|NCT00753454|Cimzia|cimzia
1505939|NCT00753441|Pancreatic cancer|pancreatic cancer
1505940|NCT00753441|Bile duct obstruction|bile duct obstruction
1505941|NCT00753441|Stent|stent
1505942|NCT00753441|Bypass|bypass
1505943|NCT00753428|HIV-free survival|hiv-free survival
1505944|NCT00753428|Community based evaluation|community based evaluation
1505945|NCT00753428|Pregnancy|pregnancy
1505946|NCT00753428|Under 2 child survival|under 2 child survival
1505947|NCT00753428|PMTCT|pmtct
1505948|NCT00753428|Pediatric HIV infection|pediatric hiv infection
1505949|NCT00753428|HAART|haart
1505950|NCT00753428|Routine ART|routine art
1505951|NCT00753428|HIV Seronegativity|hiv seronegativity
1505952|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
1505953|NCT00753415|Breast Neoplasms|breast neoplasms
1505954|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
1505955|NCT00753415|Melanoma|melanoma
1505956|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
1505957|NCT00753415|Colonic Neoplasms|colonic neoplasms
1505958|NCT00753415|Urologic Neoplasms|urologic neoplasms
1505959|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
1505960|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
1505961|NCT00753415|Urologic Diseases|urologic diseases
1505962|NCT00753415|Breast Diseases|breast diseases
1505963|NCT00753415|Skin Diseases|skin diseases
1505964|NCT00753415|Neoplasms|neoplasms
1505965|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
1505966|NCT00753415|Adenocarcinoma|adenocarcinoma
1505967|NCT00753415|Kidney Neoplasms|kidney neoplasms
1505968|NCT00753415|Kidney Diseases|kidney diseases
1505969|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
1505970|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
1505971|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
1505972|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
1505973|NCT00753415|Nevi and Melanomas|nevi and melanomas
1505974|NCT00753415|Genital Neoplasms|genital neoplasms
1505975|NCT00753415|Male Genital Diseases|male genital diseases
1505976|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
1505977|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
1505978|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
1505979|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
1505980|NCT00753389|muscle relaxants,|muscle relaxants,
1505981|NCT00753389|morbidity mortality|morbidity mortality
1505982|NCT00753363|Glucose Metabolism|glucose metabolism
1505983|NCT00753350|obesity|obesity
1505984|NCT00753324|PMTCT|pmtct
1505985|NCT00753324|HAART|haart
1505986|NCT00753324|Pregnancy|pregnancy
1505987|NCT00753324|HIV Infection|hiv infection
1505988|NCT00753324|HIV Transmission|hiv transmission
1505989|NCT00753324|HIV Seronegativity|hiv seronegativity
1505990|NCT00753311|migraine|migraine
1505991|NCT00753311|rizatriptan|rizatriptan
1505992|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
1505993|NCT00753311|Migraine with or without aura|migraine with or without aura
1505994|NCT00753272|Efficacy|efficacy
1505995|NCT00753272|Influenza Vaccines|influenza vaccines
1505996|NCT00753272|Influenza|influenza
1505997|NCT00753272|Vaccine|vaccine
1505998|NCT00753272|Elderly|elderly
1505999|NCT00753259|atrial fibrillation|atrial fibrillation
1506000|NCT00753259|disease management program|disease management program
1506001|NCT00753259|integrated chronic care program|integrated chronic care program
1506002|NCT00753259|guideline|guideline
1506003|NCT00753259|stroke|stroke
1506004|NCT00753259|heart failure|heart failure
1506005|NCT00753259|quality of life|quality of life
1506006|NCT00753259|costs|costs
1506007|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
1506008|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1506009|NCT00753233|Children|children
1506010|NCT00753233|Sudden Death|sudden death
1506012|NCT00753233|Electrophysiology Study|electrophysiology study
1506013|NCT00753220|Metastatic|metastatic
1506014|NCT00753220|Androgen|androgen
1506015|NCT00753220|Independent|independent
1506016|NCT00753220|Prostate Cancer|prostate cancer
1506017|NCT00753220|(AIPC),|(aipc),
1506018|NCT00753220|Hormone-refractory|hormone-refractory
1506019|NCT00753220|(HRPC),|(hrpc),
1506020|NCT00753220|cryotherapy,|cryotherapy,
1506021|NCT00753220|dendritic cell,|dendritic cell,
1506022|NCT00753220|immunotherapy|immunotherapy
1506023|NCT00753220|Chemo-naïve|chemo-naïve
1506024|NCT00753220|lymph nodes|lymph nodes
1506025|NCT00753220|bone|bone
1506026|NCT00753207|stage IV breast cancer|stage iv breast cancer
1506027|NCT00753207|recurrent breast cancer|recurrent breast cancer
1506028|NCT00753194|hearing|hearing
1664715|NCT00125645|AMI|ami
1506029|NCT00753194|newborn|newborn
1506030|NCT00753194|otoacoustic emissions|otoacoustic emissions
1506031|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
1506032|NCT00753155|HRQoL;|hrqol;
1506033|NCT00753155|exercise|exercise
1506034|NCT00753155|capacity|capacity
1506035|NCT00753142|Hyperglycemia|hyperglycemia
1506036|NCT00753129|Prone position|prone position
1506037|NCT00753129|ALI/ARDS|ali/ards
1506038|NCT00753129|Head elevation|head elevation
1506039|NCT00753103|Infliximab|infliximab
1506040|NCT00753103|Vasculitis|vasculitis
1506041|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
1506042|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
1506043|NCT00753064|Composite clinical scoring system|composite clinical scoring system
1506044|NCT00753064|AScVS|ascvs
1506045|NCT00753064|Prazosin|prazosin
1506046|NCT00753064|Superiority|superiority
1506047|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
1506048|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
1506049|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
1506050|NCT00753038|carcinoma|carcinoma
1506051|NCT00753038|squamous cell|squamous cell
1506052|NCT00753038|head|head
1506053|NCT00753038|neck|neck
1506054|NCT00753038|REOLYSIN|reolysin
1506055|NCT00753038|chemotherapy|chemotherapy
1506056|NCT00753038|Carboplatin|carboplatin
1506057|NCT00753038|Paclitaxel|paclitaxel
1506058|NCT00753025|lower extremity ischemia|lower extremity ischemia
1506059|NCT00753025|Bone marrow|bone marrow
1506060|NCT00753025|Progenitor cells|progenitor cells
1506061|NCT00753025|Neoangiogenesis|neoangiogenesis
1506062|NCT00753012|cardiovascular testing|cardiovascular testing
1506063|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
1506064|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
1506065|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
1506066|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
1506067|NCT00753012|Lisdexamfetamine|lisdexamfetamine
1506068|NCT00753012|Vyvanse|vyvanse
1508076|NCT00746018|ovary|ovary
1506069|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
1506070|NCT00753012|ADHD medication.|adhd medication.
1506071|NCT00752999|SLE|sle
1506072|NCT00752999|Lupus|lupus
1506073|NCT00752986|ZD6474|zd6474
1506074|NCT00752986|Vandetanib|vandetanib
1506075|NCT00752986|Zactima|zactima
1506076|NCT00752986|Fulvestrant|fulvestrant
1506077|NCT00752986|Faslodex|faslodex
1506078|NCT00752986|Breast Cancer|breast cancer
1506079|NCT00752986|Advanced, Metastatic|advanced, metastatic
1506080|NCT00752986|Hormone Receptor Positive|hormone receptor positive
1506081|NCT00752986|Post-Menopausal Patients|post-menopausal patients
1506082|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
1506083|NCT00752973|Head Lice|head lice
1506084|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
1506085|NCT00752934|nursing homes|nursing homes
1506086|NCT00752934|children|children
1506087|NCT00752934|ages 1-18 years|ages 1-18 years
1506088|NCT00752934|spastic quadriplegia|spastic quadriplegia
1506089|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
1506090|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1506091|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1506092|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1506093|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1506094|NCT00752882|Ceftazidime|ceftazidime
1506095|NCT00752882|Pharmacokinetics|pharmacokinetics
1506096|NCT00752882|Pseudomonas|pseudomonas
1506097|NCT00752882|aeruginosa|aeruginosa
1506098|NCT00752882|Meningitis|meningitis
1506099|NCT00752882|Patients|patients
1506100|NCT00752882|hospitalised|hospitalised
1506101|NCT00752882|cerebrolesion|cerebrolesion
1506102|NCT00752882|acquired|acquired
1506103|NCT00752882|pneumopathy|pneumopathy
1506104|NCT00752882|mechanic|mechanic
1506105|NCT00752882|ventilation|ventilation
1507217|NCT00749489|Opioid|opioid
1506106|NCT00752869|low testosterone|low testosterone
1506107|NCT00752856|HIV treatment|hiv treatment
1506108|NCT00752856|Treatment-naive|treatment-naive
1506109|NCT00752856|Adult|adult
1506110|NCT00752843|mifepristone|mifepristone
1506111|NCT00752843|CORLUX|corlux
1506112|NCT00752843|fluvastatin|fluvastatin
1506113|NCT00752843|Lescol|lescol
1506114|NCT00752843|drug-drug interaction|drug-drug interaction
1506115|NCT00752843|DDI|ddi
1506116|NCT00752843|pharmacokinetics|pharmacokinetics
1506117|NCT00752830|AZD0328|azd0328
1506118|NCT00752830|Food Effect|food effect
1506119|NCT00752817|Virtual Reality|virtual reality
1664791|NCT00125398|ICU|icu
1506120|NCT00752817|Simulator|simulator
1506121|NCT00752817|Proficiency|proficiency
1506122|NCT00752817|Laparoscopic|laparoscopic
1506123|NCT00752817|Colectomy|colectomy
1506124|NCT00752817|Education|education
1506125|NCT00752817|Surgical Training|surgical training
1506126|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
1506127|NCT00752791|Anemia|anemia
1506128|NCT00752791|Drug Therapy|drug therapy
1506129|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
1506130|NCT00752778|MRI, PET scan|mri, pet scan
1506131|NCT00752765|knee osteoarthritis|knee osteoarthritis
1506132|NCT00752765|bariatric surgery|bariatric surgery
1506133|NCT00752765|weight loss|weight loss
1506134|NCT00752765|knee pain|knee pain
1506135|NCT00752752|Marathon Running|marathon running
1506136|NCT00752752|Cardiac Ischemia|cardiac ischemia
1506137|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
1506138|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1506139|NCT00752739|stage I prostate cancer|stage i prostate cancer
1506140|NCT00752739|stage II prostate cancer|stage ii prostate cancer
1506141|NCT00752739|stage III prostate cancer|stage iii prostate cancer
1506142|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
1506143|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
1506144|NCT00752713|AMI,|ami,
1506145|NCT00752713|Reperfusion|reperfusion
1506146|NCT00752713|successful|successful
1506147|NCT00752700|Patients|patients
1506148|NCT00752700|radically|radically
1506149|NCT00752700|treated|treated
1506150|NCT00752687|Phase 1|phase 1
1506151|NCT00752674|Low back pain|low back pain
1506152|NCT00752674|physical therapy|physical therapy
1506153|NCT00752674|pain|pain
1506154|NCT00752661|osteoarthritis|osteoarthritis
1506155|NCT00752661|low back pain|low back pain
1506156|NCT00752661|oral drug|oral drug
1506157|NCT00752661|tramadol|tramadol
1506158|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
1506159|NCT00752648|TMC435350-C106|tmc435350-c106
1506160|NCT00752648|Bioavailability|bioavailability
1506161|NCT00752648|Pharmacokinetics|pharmacokinetics
1506162|NCT00752635|TriCilest|tricilest
1506163|NCT00752635|acne vulgaris|acne vulgaris
1506164|NCT00752609|Anemia|anemia
1506165|NCT00752609|Drug Therapy|drug therapy
1506166|NCT00752609|Hemodialysis|hemodialysis
1506167|NCT00752609|Kidney Failure|kidney failure
1506168|NCT00752596|patients|patients
1506169|NCT00752596|with ICD|with icd
1506170|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
1506171|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
1506172|NCT00752570|colorectal cancer|colorectal cancer
1506173|NCT00752570|colon cancer|colon cancer
1506174|NCT00752557|Bone mineral density|bone mineral density
1506175|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
1506176|NCT00752557|osteoporosis|osteoporosis
1506177|NCT00752544|TMC435350|tmc435350
1506178|NCT00752544|HCV|hcv
1506179|NCT00752544|Hepatitis C|hepatitis c
1506180|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
1506181|NCT00752544|TMC435350-C109|tmc435350-c109
1506182|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1506183|NCT00752531|COPD|copd
1506184|NCT00752518|bolus|bolus
1506185|NCT00752518|intravenous|intravenous
1506186|NCT00752518|proteasome inhibitor|proteasome inhibitor
1506187|NCT00752518|multiple myeloma|multiple myeloma
1506188|NCT00752518|refractory|refractory
1506189|NCT00752518|relapse|relapse
1506190|NCT00752505|Fibromyalgia|fibromyalgia
1506191|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
1506192|NCT00752492|obesity|obesity
1506193|NCT00752492|isoflurane|isoflurane
1506194|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
1506195|NCT00752479|living|living
1506196|NCT00752479|related|related
1506197|NCT00752466|Healthy volunteers|healthy volunteers
1506198|NCT00752466|drug interaction|drug interaction
1506199|NCT00752466|Flunarizine|flunarizine
1506200|NCT00752466|Topiramate|topiramate
1506201|NCT00752466|Migraine|migraine
1506202|NCT00752453|ICU|icu
1506203|NCT00752453|patients|patients
1506204|NCT00752453|lactate|lactate
1506205|NCT00752453|acidosis|acidosis
1506206|NCT00752440|Diabetes Mellitus|diabetes mellitus
1506207|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
1506208|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
1507218|NCT00749489|Nerve Block|nerve block
1506209|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
1506210|NCT00752414|COPD|copd
1506211|NCT00752414|Patients|patients
1506212|NCT00752401|Vitamin D|vitamin d
1506213|NCT00752401|Cholecalciferol|cholecalciferol
1506214|NCT00752401|Vitamin D3|vitamin d3
1506215|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
1506216|NCT00752401|Immunomodulation|immunomodulation
1506217|NCT00752401|Vitamin D deficiency|vitamin d deficiency
1506218|NCT00752401|Kidney transplantation|kidney transplantation
1506219|NCT00752401|Renal transplantation|renal transplantation
1506220|NCT00752401|Graft function|graft function
1506221|NCT00752401|Acute rejection|acute rejection
1506222|NCT00752401|Renal osteodystrophy|renal osteodystrophy
1506223|NCT00752401|Posttransplant bone loss|posttransplant bone loss
1506224|NCT00752375|pyelonephritis|pyelonephritis
1506225|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
1506226|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
1506227|NCT00752375|DMSA scan|dmsa scan
1506228|NCT00752362|Supralimus®,|supralimus®,
1506229|NCT00752362|Infinnium®,|infinnium®,
1506230|NCT00752362|Matrix®,|matrix®,
1506231|NCT00752362|Restenosis|restenosis
1506232|NCT00752362|Percutaneous|percutaneous
1506233|NCT00752362|Revascularization|revascularization
1506234|NCT00752362|Techniques|techniques
1506235|NCT00752362|Metallic|metallic
1506236|NCT00752362|Platform|platform
1506237|NCT00752362|Agents|agents
1506238|NCT00752362|Antiproliferative|antiproliferative
1506239|NCT00752362|Properties|properties
1506240|NCT00752349|Videofluoroscopic|videofluoroscopic
1506241|NCT00752349|swallowing|swallowing
1506242|NCT00752349|study|study
1506243|NCT00752349|(VFSS)|(vfss)
1506244|NCT00752349|ultrasound|ultrasound
1506245|NCT00752336|HRQoL|hrqol
1506246|NCT00752336|exercise capacity|exercise capacity
1506247|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
1506248|NCT00752323|adult glioblastoma|adult glioblastoma
1506249|NCT00752323|adult gliosarcoma|adult gliosarcoma
1506250|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
1506251|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
1506252|NCT00752310|TMC114-C169|tmc114-c169
1506253|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
1506254|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
1506255|NCT00752297|Botulinum Toxin|botulinum toxin
1506256|NCT00752297|Glabellar Rhytides|glabellar rhytides
1506257|NCT00752297|Rhytides|rhytides
1506258|NCT00752297|Frown Lines|frown lines
1506259|NCT00752297|Neuromuscular Agents|neuromuscular agents
1506260|NCT00752297|Neurotoxin|neurotoxin
1506261|NCT00752297|Forehead|forehead
1506262|NCT00752297|Eyebrow|eyebrow
1506263|NCT00752297|Wrinkle|wrinkle
1506264|NCT00752284|coronectomy|coronectomy
1506265|NCT00752284|neurosensory deficit|neurosensory deficit
1506266|NCT00752284|third molar surgery|third molar surgery
1506267|NCT00752271|Arthroscopic|arthroscopic
1506268|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
1506269|NCT00752258|Botulinum Toxin|botulinum toxin
1506270|NCT00752258|Glabellar Rhytides|glabellar rhytides
1506271|NCT00752258|Rhytides|rhytides
1506272|NCT00752258|Frown Lines|frown lines
1506273|NCT00752258|Neuromuscular Agents|neuromuscular agents
1506274|NCT00752258|Neurotoxin|neurotoxin
1506275|NCT00752258|Forehead|forehead
1506276|NCT00752258|Eyebrow|eyebrow
1506277|NCT00752258|Wrinkle|wrinkle
1506278|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
1506279|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
1506280|NCT00752232|Phase IIa|phase iia
1506281|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
1506282|NCT00752206|AZD0530|azd0530
1506283|NCT00752206|Saracatinib|saracatinib
1506284|NCT00752206|Osteosarcoma|osteosarcoma
1506285|NCT00752206|Recurrent|recurrent
1506286|NCT00752206|Localized|localized
1506287|NCT00752206|to the Lung|to the lung
1506288|NCT00752180|pharmacokinetics|pharmacokinetics
1506289|NCT00752180|pharmacodynamics|pharmacodynamics
1506290|NCT00752180|type 1 diabetics|type 1 diabetics
1506291|NCT00752180|recombinant human insulin|recombinant human insulin
1506292|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
1506293|NCT00752167|asthma|asthma
1506294|NCT00752167|athlete|athlete
1506295|NCT00752167|sports|sports
1506296|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
1506297|NCT00752167|albuterol|albuterol
1506298|NCT00752154|Subjects|subjects
1506299|NCT00752154|active|active
1506300|NCT00752154|Rheumatoid|rheumatoid
1506301|NCT00752154|Arthritis|arthritis
1506302|NCT00752154|revised|revised
1506303|NCT00752154|American|american
1506304|NCT00752154|College|college
1506305|NCT00752154|Rheumatology|rheumatology
1506306|NCT00752154|Criteria|criteria
1506307|NCT00752128|Drug Eluting Stent|drug eluting stent
1506308|NCT00752128|Interventional Cardiology|interventional cardiology
1506309|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
1506310|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
1507219|NCT00749489|Geriatric|geriatric
1506311|NCT00752115|previously untreated|previously untreated
1506312|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
1506313|NCT00752102|Chronic Kidney Disease|chronic kidney disease
1506314|NCT00752102|Vitamin D|vitamin d
1506315|NCT00752102|Coronary Calcification|coronary calcification
1506316|NCT00752102|Bone metabolism|bone metabolism
1506317|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
1506318|NCT00752089|erosion|erosion
1506319|NCT00752089|enamel remineralization|enamel remineralization
1506320|NCT00752076|EGFR mutation|egfr mutation
1506321|NCT00752076|NSCLC cell line|nsclc cell line
1506322|NCT00752076|Malignant pleural effusion|malignant pleural effusion
1506323|NCT00752063|Sorafenib|sorafenib
1506324|NCT00752063|Capecitabine|capecitabine
1506325|NCT00752063|Oxaliplatin|oxaliplatin
1506326|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
1506327|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
1506328|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
1506329|NCT00752050|Botulinum Toxin|botulinum toxin
1506330|NCT00752050|Glabellar Rhytides|glabellar rhytides
1506331|NCT00752050|Rhytides|rhytides
1506332|NCT00752050|Frown Lines|frown lines
1506333|NCT00752050|Neuromuscular Agents|neuromuscular agents
1506334|NCT00752050|Neurotoxin|neurotoxin
1506335|NCT00752050|Forehead|forehead
1506336|NCT00752050|Eyebrow|eyebrow
1506337|NCT00752050|Wrinkle|wrinkle
1506338|NCT00752037|HIV|hiv
1506339|NCT00752037|Protease Inhibitor|protease inhibitor
1506340|NCT00752037|Integrase Inhibitor|integrase inhibitor
1506341|NCT00752037|Treatment Experienced|treatment experienced
1506342|NCT00752037|Naive|naive
1506343|NCT00752024|HICH|hich
1506344|NCT00752024|Suction drainages|suction drainages
1506345|NCT00752024|TTAC|ttac
1506346|NCT00752011|Cancer|cancer
1506347|NCT00752011|Solid Tumors|solid tumors
1506348|NCT00752011|Advanced Cancer|advanced cancer
1506349|NCT00752011|Carboplatin|carboplatin
1506350|NCT00752011|Paraplatin|paraplatin
1506351|NCT00752011|TAS-106|tas-106
1506352|NCT00752011|Antitumor Activity|antitumor activity
1506353|NCT00752011|Biomarkers|biomarkers
1506354|NCT00751998|biliary|biliary
1506355|NCT00751998|ERCP|ercp
1506356|NCT00751998|cholangioscopy|cholangioscopy
1506357|NCT00751998|pancreatic|pancreatic
1506358|NCT00751985|Heavy drinking|heavy drinking
1506359|NCT00751985|Ultra-brief intervention|ultra-brief intervention
1506360|NCT00751985|Brief intervention|brief intervention
1506361|NCT00751985|Alcohol prevention|alcohol prevention
1506362|NCT00751985|Randomized trial|randomized trial
1506363|NCT00751985|Personal normative feedback|personal normative feedback
1506364|NCT00751985|Self-help material|self-help material
1506365|NCT00751985|Web-based|web-based
1506366|NCT00751985|Intervention Studies|intervention studies
1506367|NCT00751985|prevention & control|prevention & control
1506368|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1506369|NCT00751959|extremely preterm infant|extremely preterm infant
1506370|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
1506371|NCT00751959|Surfactant|surfactant
1506372|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
1506373|NCT00751946|PTSD|ptsd
1506374|NCT00751946|psychotherapy|psychotherapy
1506375|NCT00751946|adolescents|adolescents
1506376|NCT00751946|clinical trial|clinical trial
1506377|NCT00751933|Ulcerative colitis|ulcerative colitis
1506378|NCT00751933|Vaccines|vaccines
1506379|NCT00751933|Oats|oats
1506380|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
1506381|NCT00751920|Pediatrics|pediatrics
1506382|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
1506383|NCT00751920|Computed Tomography|computed tomography
1506384|NCT00751920|Detection|detection
1506385|NCT00751907|Cerebral blood flow|cerebral blood flow
1506386|NCT00751894|Children|children
1506387|NCT00751894|cancer|cancer
1506388|NCT00751894|Bone marrow transplantation|bone marrow transplantation
1506389|NCT00751894|Stem cell mobilization|stem cell mobilization
1506390|NCT00751894|G-CSF|g-csf
1506391|NCT00751894|Children with solid malignancies|children with solid malignancies
1506392|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
1506393|NCT00751868|breast cancer|breast cancer
1506394|NCT00751842|Diabetes|diabetes
1506395|NCT00751842|Juvenile Diabetes|juvenile diabetes
1506396|NCT00751842|Diabetes type 1|diabetes type 1
1506397|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
1506398|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
1506399|NCT00751842|Type 1 diabetes|type 1 diabetes
1506400|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
1506401|NCT00751842|Diamyd|diamyd
1506402|NCT00751842|rhGAD65|rhgad65
1506403|NCT00751842|GAD|gad
1506404|NCT00751842|GAD-alum|gad-alum
1506405|NCT00751816|musculoskeletal complications|musculoskeletal complications
1506406|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1506407|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1506408|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1507708|NCT00747513|prevention|prevention
1506409|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1506410|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1506411|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1506412|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1506413|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1506414|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1506415|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1506416|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1506417|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1506418|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1506419|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1506420|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1506421|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1506422|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1506423|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1506424|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1506425|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1506426|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1506427|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1506428|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1506429|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1506430|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1506431|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1506432|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1506433|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1506434|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1506435|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1506436|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1506437|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1506438|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1506439|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1508077|NCT00746018|uterus|uterus
1506440|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1506441|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1506442|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1506443|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1506444|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1506445|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1506446|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1506447|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1506448|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1506449|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1506450|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1506451|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1506452|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1506453|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1506454|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1506455|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1506456|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1506457|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1506458|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1506459|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1506460|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1506461|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1506633|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
1506462|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1568404|NCT00505947|macular edema|macular edema
1506463|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1506464|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1506465|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1506466|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1506467|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1506468|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1506469|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1506470|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1506471|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1506472|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1506473|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1506474|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1506475|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1506476|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1506477|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1506478|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1506479|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
1506480|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
1506481|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
1506482|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
1506483|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
1506484|NCT00751712|Aortic Arch|aortic arch
1506485|NCT00751699|Pharmacokinetics|pharmacokinetics
1506486|NCT00751686|Gastroenteritis|gastroenteritis
1506487|NCT00751686|Burden|burden
1506488|NCT00751686|Rotavirus|rotavirus
1506489|NCT00751686|< 5 years|< 5 years
1506490|NCT00751686|Greece|greece
1506491|NCT00751686|Children|children
1506492|NCT00751660|small cell lung cancer|small cell lung cancer
1506493|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
1506494|NCT00751660|tobacco use disorder|tobacco use disorder
1506495|NCT00751647|CF|cf
1506496|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
1506497|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
1506498|NCT00751634|fever|fever
1506499|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
1506500|NCT00751621|SCIG|scig
1506501|NCT00751621|primary immunodeficiency|primary immunodeficiency
1506502|NCT00751621|PID|pid
1506503|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
1506504|NCT00751595|HIV|hiv
1506505|NCT00751595|Tat protein|tat protein
1506506|NCT00751595|Therapeutic vaccine|therapeutic vaccine
1506507|NCT00751595|HAART|haart
1506508|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1506509|NCT00751595|Treatment Experienced|treatment experienced
1506510|NCT00751582|nutrition|nutrition
1506511|NCT00751582|education|education
1506512|NCT00751582|supplementation|supplementation
1506513|NCT00751569|umbilical cord blood|umbilical cord blood
1506514|NCT00751556|Naproxen Sodium|naproxen sodium
1506515|NCT00751556|Bioavailability|bioavailability
1506516|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
1506517|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
1506518|NCT00751530|HIV|hiv
1506519|NCT00751530|AIDS|aids
1506520|NCT00751530|raltegravir|raltegravir
1506521|NCT00751530|BRAVO|bravo
1506522|NCT00751530|protease inhibitor|protease inhibitor
1506523|NCT00751530|treatment Experienced|treatment experienced
1506524|NCT00751517|Vasculitis|vasculitis
1506525|NCT00751517|Cyclophosphamide|cyclophosphamide
1506526|NCT00751517|Methotrexate|methotrexate
1506527|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
1506528|NCT00751504|Quetiapine|quetiapine
1506529|NCT00751504|Psychotic depression|psychotic depression
1506530|NCT00751491|Stable angina|stable angina
1506531|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
1506532|NCT00751491|Myonecrosis|myonecrosis
1506533|NCT00751478|ALO-01|alo-01
1506534|NCT00751478|morphine|morphine
1506734|NCT00750568|Bronchial asthma|bronchial asthma
1506535|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
1506536|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
1506537|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
1506538|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
1506539|NCT00751465|Social Anxiety Disorder|social anxiety disorder
1506540|NCT00751465|Social Phobia|social phobia
1506541|NCT00751465|Fear of blushing|fear of blushing
1506542|NCT00751465|attention|attention
1506543|NCT00751465|attention training|attention training
1506544|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
1506545|NCT00751452|Children|children
1506546|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1506547|NCT00751452|Intestinal damage|intestinal damage
1506548|NCT00751452|Citrulline|citrulline
1506549|NCT00751452|Graft versus Host Disease|graft versus host disease
1506550|NCT00751452|0 to 18 years old|0 to 18 years old
1506551|NCT00751439|Oximeter|oximeter
1506552|NCT00751439|Arterial blood gas|arterial blood gas
1506553|NCT00751439|comparison|comparison
1506554|NCT00751426|Interferon-alpha|interferon-alpha
1506555|NCT00751426|hepatitis c|hepatitis c
1506556|NCT00751426|Drug addiction|drug addiction
1506557|NCT00751426|methadone|methadone
1506558|NCT00751426|psychiatric disorder|psychiatric disorder
1506559|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
1506560|NCT00751400|Non-prescription|non-prescription
1506561|NCT00751361|Rheopheresis|rheopheresis
1506562|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
1506563|NCT00751361|AMD|amd
1506564|NCT00751361|apheresis|apheresis
1506565|NCT00751361|microcirculation|microcirculation
1506566|NCT00751348|second year of life|second year of life
1506567|NCT00751348|one-dose schedule|one-dose schedule
1506568|NCT00751348|varicella|varicella
1506569|NCT00751348|rubella|rubella
1506570|NCT00751348|measles|measles
1506571|NCT00751348|mumps|mumps
1506572|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
1506573|NCT00751335|Humidification|humidification
1506574|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
1506575|NCT00751322|Pulmonary|pulmonary
1506576|NCT00751322|Protein|protein
1506577|NCT00751309|allograft|allograft
1506578|NCT00751309|rejection|rejection
1506579|NCT00751309|biopsy|biopsy
1506580|NCT00751309|gene|gene
1506581|NCT00751309|expression|expression
1506582|NCT00751309|pulmonary|pulmonary
1506583|NCT00751309|lung|lung
1506584|NCT00751309|transplant|transplant
1506585|NCT00751296|Lenalidomide|lenalidomide
1506586|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
1506587|NCT00751296|Thalidomide analogues|thalidomide analogues
1506588|NCT00751270|Immunotherapy|immunotherapy
1506589|NCT00751270|Gene therapy|gene therapy
1506590|NCT00751270|Tumor Vaccine|tumor vaccine
1506591|NCT00751270|Cytotoxicity|cytotoxicity
1506592|NCT00751270|Radiation|radiation
1506593|NCT00751257|Nicotine|nicotine
1506594|NCT00751257|N-acetylcysteine|n-acetylcysteine
1506595|NCT00751257|smoking reduction|smoking reduction
1506596|NCT00751244|women|women
1506597|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
1506598|NCT00751244|PTSD|ptsd
1506599|NCT00751244|psychotherapy|psychotherapy
1506600|NCT00751244|clinical trial|clinical trial
1506601|NCT00751244|emotion regulation|emotion regulation
1506602|NCT00751231|PCI|pci
1506603|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
1506604|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
1506605|NCT00751205|Prostate Carcinoma|prostate carcinoma
1506606|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
1506607|NCT00751192|Men who have sex with men|men who have sex with men
1506608|NCT00751192|Peru|peru
1506609|NCT00751192|HIV testing|hiv testing
1506610|NCT00751192|video|video
1506611|NCT00751192|online|online
1506612|NCT00751192|Internet|internet
1506613|NCT00751192|HIV Seronegativity|hiv seronegativity
1506614|NCT00751153|drug substitution|drug substitution
1506615|NCT00751153|Raltegravir|raltegravir
1506616|NCT00751153|Atazanavir|atazanavir
1506617|NCT00751153|treatment Experienced|treatment experienced
1506618|NCT00751140|surgical candidates|surgical candidates
1506619|NCT00751140|upper urinary tract|upper urinary tract
1506620|NCT00751140|urothelial carcinoma|urothelial carcinoma
1506621|NCT00751140|lymph node dissection|lymph node dissection
1506622|NCT00751127|open angle glaucoma|open angle glaucoma
1506623|NCT00751127|ocular hypertension|ocular hypertension
1506624|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1506625|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1506626|NCT00751101|stage IV breast cancer|stage iv breast cancer
1506627|NCT00751101|recurrent breast cancer|recurrent breast cancer
1506628|NCT00751088|single-incision|single-incision
1506629|NCT00751088|sling|sling
1506630|NCT00751088|stress incontinence|stress incontinence
1506631|NCT00751088|surgery|surgery
1506634|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
1506635|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
1506636|NCT00751036|GIST|gist
1506637|NCT00751023|Methamphetamine|methamphetamine
1506638|NCT00751023|Modafinil|modafinil
1506639|NCT00751023|Addiction|addiction
1506640|NCT00751023|Craving|craving
1506641|NCT00751023|Cognitive|cognitive
1506642|NCT00751010|Vulvar pain|vulvar pain
1506643|NCT00751010|Vulvodynia|vulvodynia
1506644|NCT00751010|Interstitial cystitis|interstitial cystitis
1506645|NCT00750971|ASSIST|assist
1506646|NCT00750971|SLE|sle
1506647|NCT00750971|Stem Cell Transplantation|stem cell transplantation
1506648|NCT00750971|Tolerance|tolerance
1506649|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
1506650|NCT00750945|Parkinson's disease|parkinson's disease
1506651|NCT00750945|Cueing training|cueing training
1506652|NCT00750945|Treadmill training|treadmill training
1506653|NCT00750945|Music|music
1506654|NCT00750893|Gastroenteritis|gastroenteritis
1506655|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
1506656|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
1506657|NCT00750854|arthritis|arthritis
1506658|NCT00750854|osteoarthritis|osteoarthritis
1506659|NCT00750854|fibromyalgia|fibromyalgia
1506660|NCT00750854|connective tissue disorder|connective tissue disorder
1506661|NCT00750841|advanced cancer|advanced cancer
1506662|NCT00750841|metastatic|metastatic
1506663|NCT00750841|rifampicin|rifampicin
1506664|NCT00750841|pharmacokinetics|pharmacokinetics
1506665|NCT00750841|Phase I|phase i
1506666|NCT00750841|Advanced solid tumours|advanced solid tumours
1506667|NCT00750828|Saliva|saliva
1506668|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
1506669|NCT00750828|GCF|gcf
1506670|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
1506671|NCT00750815|B Cell|b cell
1506672|NCT00750815|hematologic malignancy|hematologic malignancy
1506673|NCT00750815|plasma|plasma
1506674|NCT00750815|bone marrow|bone marrow
1506675|NCT00750802|Phase I|phase i
1506676|NCT00750776|Quality assurance|quality assurance
1506677|NCT00750776|medical treatment|medical treatment
1506678|NCT00750776|Patient satisfaction|patient satisfaction
1506679|NCT00750763|Mucosal inflammation|mucosal inflammation
1506680|NCT00750763|Fleet|fleet
1506681|NCT00750763|Picoprep|picoprep
1506682|NCT00750763|Colonlytely|colonlytely
1506683|NCT00750763|Colonoscopy|colonoscopy
1506684|NCT00750763|tolerability|tolerability
1506685|NCT00750763|efficacy|efficacy
1506686|NCT00750737|Hematologic Malignancies|hematologic malignancies
1506687|NCT00750737|Blood Cancer|blood cancer
1506688|NCT00750737|Lymphatic Cancer|lymphatic cancer
1506689|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
1508078|NCT00746018|cervix|cervix
1506690|NCT00750737|Amphotericin B|amphotericin b
1506691|NCT00750737|ABLC|ablc
1506692|NCT00750737|Fungizone|fungizone
1506693|NCT00750737|Noxafil|noxafil
1506694|NCT00750737|SCH56592|sch56592
1506695|NCT00750737|Posaconazole|posaconazole
1506696|NCT00750737|Invasive fungal infections|invasive fungal infections
1506697|NCT00750737|IFI|ifi
1506698|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1506699|NCT00750737|HSCT|hsct
1506700|NCT00750737|Bone Marrow Transplant|bone marrow transplant
1506701|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
1506702|NCT00750724|Hyaluronic acid,|hyaluronic acid,
1506703|NCT00750724|OA knee,|oa knee,
1506704|NCT00750724|MRI|mri
1506705|NCT00750698|lung cancer|lung cancer
1506706|NCT00750698|non small cell lung cancer|non small cell lung cancer
1506707|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
1506708|NCT00750672|Endometrial neoplasia|endometrial neoplasia
1506709|NCT00750672|Follow-up care|follow-up care
1506710|NCT00750672|survivorship|survivorship
1506711|NCT00750672|Primary care provider|primary care provider
1506712|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
1506713|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
1506714|NCT00750659|stem cell transplantation|stem cell transplantation
1506715|NCT00750659|nilotinib|nilotinib
1506716|NCT00750646|compliance|compliance
1506717|NCT00750646|eye drop administration|eye drop administration
1506718|NCT00750646|MEMS|mems
1506719|NCT00750646|adherence|adherence
1506720|NCT00750633|swimmer's ear|swimmer's ear
1506721|NCT00750633|ear drops|ear drops
1506722|NCT00750633|ear infection|ear infection
1506723|NCT00750633|ear pain|ear pain
1506724|NCT00750633|ear inflammation|ear inflammation
1506725|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
1506726|NCT00750620|normal renal function subjects|normal renal function subjects
1506727|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
1506728|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
1506729|NCT00750620|YM178|ym178
1506730|NCT00750620|pharmacokinetics|pharmacokinetics
1506731|NCT00750594|Children|children
1506732|NCT00750594|Migraine headaches|migraine headaches
1506733|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
1506735|NCT00750568|Asthma, bronchial|asthma, bronchial
1506736|NCT00750568|Status Asthmaticus|status asthmaticus
1506737|NCT00750568|Terbutaline sulfate|terbutaline sulfate
1506738|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
1506740|NCT00750529|sleep|sleep
1506741|NCT00750529|Alzheimer|alzheimer
1506742|NCT00750529|old patients|old patients
1506743|NCT00750516|Lactic acid|lactic acid
1506744|NCT00750516|hypotension|hypotension
1506745|NCT00750516|sepsis|sepsis
1506746|NCT00750503|tobacco cessation|tobacco cessation
1506747|NCT00750503|behavioral therapy|behavioral therapy
1506748|NCT00750503|pharmacotherapy|pharmacotherapy
1506749|NCT00750503|workplace|workplace
1506750|NCT00750503|oral cancer screening|oral cancer screening
1506751|NCT00750503|Tobacco Quit rates|tobacco quit rates
1506752|NCT00750477|osteoarthritis|osteoarthritis
1506753|NCT00750477|arthritis|arthritis
1506754|NCT00750477|knee|knee
1506755|NCT00750477|eggshell|eggshell
1506756|NCT00750477|membrane|membrane
1506757|NCT00750477|OPTION|option
1506758|NCT00750451|fertilization in vitro|fertilization in vitro
1506759|NCT00750451|assisted reproduction|assisted reproduction
1506760|NCT00750451|recurrent implantation failure|recurrent implantation failure
1506761|NCT00750451|low molecular weight heparin|low molecular weight heparin
1506762|NCT00750451|heparin|heparin
1506763|NCT00750451|luteal phase|luteal phase
1506764|NCT00750438|Obesity|obesity
1506765|NCT00750438|Short chain fatty acids|short chain fatty acids
1506766|NCT00750438|Appetite|appetite
1506767|NCT00750438|Body weight|body weight
1506768|NCT00750438|Insulin sensitivity|insulin sensitivity
1506769|NCT00750438|Propionate|propionate
1506770|NCT00750438|Propionate ester|propionate ester
1506771|NCT00750425|advanced cancer,|advanced cancer,
1506772|NCT00750425|metastatic|metastatic
1506773|NCT00750425|ketoconazole|ketoconazole
1506774|NCT00750425|pharmacokinetics|pharmacokinetics
1506775|NCT00750425|Phase I|phase i
1506776|NCT00750412|TeenScreen|teenscreen
1506777|NCT00750412|Mental Health|mental health
1506778|NCT00750412|Adolescent Mental Health|adolescent mental health
1506779|NCT00750412|Social Work|social work
1506780|NCT00750399|radiation|radiation
1506781|NCT00750399|retinopathy|retinopathy
1506782|NCT00750399|ranibizumab|ranibizumab
1506783|NCT00750399|melanoma|melanoma
1506784|NCT00750399|choroid|choroid
1506785|NCT00750386|Cancer|cancer
1506786|NCT00750386|Ovarian cancer|ovarian cancer
1506787|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
1506788|NCT00750373|Endocarditis|endocarditis
1506789|NCT00750360|Influenza|influenza
1506790|NCT00750360|Korea|korea
1506791|NCT00750360|FluarixTM|fluarixtm
1506792|NCT00750347|pain,|pain,
1506793|NCT00750347|analgesia|analgesia
1506794|NCT00750347|Healthy volunteers|healthy volunteers
1506795|NCT00750334|Oral Clofarabine,|oral clofarabine,
1506796|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
1506797|NCT00750334|Myelodysplastic|myelodysplastic
1506798|NCT00750295|Chronic kidney disease,|chronic kidney disease,
1506799|NCT00750295|hemodialysis,|hemodialysis,
1506800|NCT00750295|serum phosphorus,|serum phosphorus,
1506801|NCT00750295|phosphate binders|phosphate binders
1506802|NCT00750282|Alzheimer Disease|alzheimer disease
1506803|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
1506804|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1506805|NCT00750256|tolerability|tolerability
1506806|NCT00750256|Safety|safety
1506807|NCT00750256|pharmacokinetics|pharmacokinetics
1506808|NCT00750230|arthritis|arthritis
1506809|NCT00750230|osteoarthritis|osteoarthritis
1506810|NCT00750230|fibromyalgia|fibromyalgia
1506811|NCT00750230|connective tissue disorder|connective tissue disorder
1506812|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
1506813|NCT00750204|Acute Lung Injury|acute lung injury
1506814|NCT00750204|ALI|ali
1506815|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1506816|NCT00750204|Mechanical Ventilation|mechanical ventilation
1506817|NCT00750204|Sedation|sedation
1506818|NCT00750204|Critical Illness|critical illness
1506819|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
1506820|NCT00750204|VILI|vili
1506821|NCT00750204|Cytokines|cytokines
1506822|NCT00750204|Protective Ventilation|protective ventilation
1506823|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
1506824|NCT00750204|APRV|aprv
1506825|NCT00750204|Breathing Comfort|breathing comfort
1506826|NCT00750204|Dyssynchrony|dyssynchrony
1506827|NCT00750204|Asynchrony|asynchrony
1506828|NCT00750191|Lower Back Pain|lower back pain
1506829|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
1506830|NCT00750165|Humidification|humidification
1506831|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
1506832|NCT00750152|tinea cruris|tinea cruris
1506833|NCT00750152|jock itch|jock itch
1506834|NCT00750139|Tinea Pedis|tinea pedis
1506835|NCT00750139|Athlete's foot|athlete's foot
1506836|NCT00750126|Allograft|allograft
1506837|NCT00750126|Children|children
1506839|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
1506840|NCT00750126|Fludarabin|fludarabin
1506841|NCT00750126|Busulfex|busulfex
1506842|NCT00750126|Thymoglobulin|thymoglobulin
1506843|NCT00750100|infertility|infertility
1506844|NCT00750100|IVF|ivf
1506845|NCT00750100|hCG|hcg
1506846|NCT00750100|primary infertility|primary infertility
1506847|NCT00750100|secondary infertility|secondary infertility
1506848|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
1506849|NCT00750087|Schizophrenia|schizophrenia
1506850|NCT00750074|mechanical ventilation|mechanical ventilation
1506851|NCT00750061|Spinal Cord Injury|spinal cord injury
1506852|NCT00750048|pain,|pain,
1506853|NCT00750048|sensitization,|sensitization,
1506854|NCT00750048|analgesia|analgesia
1506855|NCT00750035|Total hysterectomy|total hysterectomy
1506856|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
1506857|NCT00750035|urinary function|urinary function
1506858|NCT00750035|bowel function|bowel function
1506859|NCT00750035|sexual function|sexual function
1506860|NCT00750035|Quality of life|quality of life
1506861|NCT00750035|Psychological function|psychological function
1506862|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1506863|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1506864|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
1506865|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1506866|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1506958|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1506867|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1506868|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1506869|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1506870|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1506871|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1506872|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1506873|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1506874|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1506875|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1506876|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1506877|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1506878|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1506879|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1506880|NCT00750009|mast cell leukemia|mast cell leukemia
1506881|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1506882|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1506883|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
1506884|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1506885|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1506886|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1506887|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1506888|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1506889|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1506890|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
1506891|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1506892|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1506893|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1506894|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1506895|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1506896|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1506897|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1506898|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1506899|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1506900|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1506901|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1506902|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1506903|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1506904|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1506905|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1506906|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1506907|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
1506908|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1506909|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1506910|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1506911|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1506912|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1506913|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1506914|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1506915|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1506916|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1506917|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1506918|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1506919|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1506920|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1506921|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1506922|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1506923|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1506924|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1506925|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1506926|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1506927|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1506928|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1506929|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1506930|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1506931|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1506932|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1506933|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1506934|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1506935|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1506936|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1506937|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1506938|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1506939|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1506940|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1506941|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1506942|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1507003|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1508079|NCT00746018|08-092|08-092
1506943|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1506944|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1506945|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1506946|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1506947|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1506948|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1506949|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1506950|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1506951|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1506952|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1506953|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1506954|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1506955|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1506956|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1506957|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1506959|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1506960|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1506961|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1506962|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1506963|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1506964|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1506965|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1506966|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1506967|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1506968|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1506969|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1506970|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1506971|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1506972|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1506973|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1506974|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1506975|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1506976|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1506977|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1506978|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1506979|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1506980|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1506981|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1506982|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1506983|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1506984|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1506985|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1506986|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1506987|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1506988|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1506989|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1506990|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1506991|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1506992|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1506993|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1506994|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1506995|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1506996|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1506997|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1506998|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1506999|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1507000|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1507001|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1507002|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1507069|NCT00749957|AAV|aav
1507004|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1507005|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1507006|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1507007|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1507008|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1507009|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1507010|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1507011|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1507012|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1507013|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1507014|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1507015|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1507016|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1507017|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1507018|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1507019|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1507020|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1507021|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1507022|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1507023|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1507024|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1567607|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
1507025|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1507026|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1507027|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1507028|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1507029|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1507030|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1507031|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1507032|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1507033|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1507034|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1507035|NCT00750009|Burkitt lymphoma|burkitt lymphoma
1507036|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1507037|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1507038|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1507039|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1507040|NCT00750009|intraocular lymphoma|intraocular lymphoma
1507041|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1507042|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1507043|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1507044|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1507045|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1507046|NCT00750009|primary myelofibrosis|primary myelofibrosis
1507047|NCT00750009|essential thrombocythemia|essential thrombocythemia
1507048|NCT00750009|polycythemia vera|polycythemia vera
1507049|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
1507050|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1507051|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
1507052|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
1507053|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
1507054|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
1507055|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
1507056|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1507057|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1507058|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1507059|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1507060|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1507061|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1507062|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1507063|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1507064|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1507065|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1507066|NCT00749970|schizophrenia|schizophrenia
1507067|NCT00749970|subjective well-being|subjective well-being
1507068|NCT00749970|psychometric validation|psychometric validation
1507070|NCT00749957|adeno-associated virus|adeno-associated virus
1507071|NCT00749957|RPE65|rpe65
1507072|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
1507073|NCT00749957|LCA|lca
1507074|NCT00749957|gene therapy|gene therapy
1507075|NCT00749957|human gene transfer|human gene transfer
1507076|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
1507077|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
1507078|NCT00749918|vitamin D|vitamin d
1507079|NCT00749918|Cholecalciferol|cholecalciferol
1507080|NCT00749918|Insulin sensitivity|insulin sensitivity
1507081|NCT00749918|MinMod Millennium|minmod millennium
1507082|NCT00749918|FSIGT|fsigt
1507083|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
1507084|NCT00749892|Transitional Cell Carcinoma|transitional cell carcinoma
1507085|NCT00749892|Bladder Cancer|bladder cancer
1507086|NCT00749892|Urothelial Cancer|urothelial cancer
1507087|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride
1507088|NCT00749892|Tarceva|tarceva
1507089|NCT00749892|OSI-774|osi-774
1507090|NCT00749892|TCC|tcc
1507091|NCT00749879|PK|pk
1507092|NCT00749879|Pharmacokinetics|pharmacokinetics
1507093|NCT00749866|Nebulised antibiotics|nebulised antibiotics
1507094|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
1507095|NCT00749866|Bacterial Load|bacterial load
1507096|NCT00749866|Inflammation|inflammation
1507097|NCT00749866|Quality of Life|quality of life
1507098|NCT00749866|Side Effects|side effects
1507099|NCT00749853|ovarian stimulation|ovarian stimulation
1507100|NCT00749853|FSH|fsh
1507101|NCT00749853|genotyping|genotyping
1507102|NCT00749853|polymorphism|polymorphism
1507103|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1507104|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
1507105|NCT00749840|Questionnaire|questionnaire
1507107|NCT00749840|HIV|hiv
1507108|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1507109|NCT00749840|HAART|haart
1507110|NCT00749840|Steps of HIV Care|steps of hiv care
1507111|NCT00749840|CDC|cdc
1507112|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
1507113|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
1507220|NCT00749489|Nerve Stimulation|nerve stimulation
1507114|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
1507115|NCT00749801|drug naive|drug naive
1507116|NCT00749801|Dyslipidemic|dyslipidemic
1507117|NCT00749801|nattokinase|nattokinase
1507118|NCT00749801|fibrinolytic|fibrinolytic
1507119|NCT00749775|Eplerenone|eplerenone
1507120|NCT00749775|Selara|selara
1507121|NCT00749775|Hypertension|hypertension
1507122|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
1507123|NCT00749775|Drug use Investigation|drug use investigation
1507124|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
1507125|NCT00749775|ESSENCE|essence
1507126|NCT00749762|DURING|during
1507127|NCT00749762|PRONE|prone
1507128|NCT00749762|SUPINE|supine
1507129|NCT00749762|POSITIONING|positioning
1507130|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
1507131|NCT00749749|Postoperative pain|postoperative pain
1507132|NCT00749736|vitamin D|vitamin d
1507133|NCT00749736|determine|determine
1507134|NCT00749736|normal|normal
1507135|NCT00749736|intrapatient|intrapatient
1507136|NCT00749736|interpatient|interpatient
1507137|NCT00749736|variability|variability
1507138|NCT00749736|measures|measures
1507139|NCT00749736|immune system|immune system
1507140|NCT00749723|brain tumor|brain tumor
1507141|NCT00749723|relapse|relapse
1507142|NCT00749723|children|children
1507143|NCT00749723|etoposide|etoposide
1507144|NCT00749723|intraventricular|intraventricular
1507145|NCT00749723|temozolomide|temozolomide
1507146|NCT00749710|femoral neck fractures|femoral neck fractures
1507147|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
1507148|NCT00749710|antiaggregant therapy|antiaggregant therapy
1507149|NCT00749710|clopidogrel|clopidogrel
1507150|NCT00749710|plavix|plavix
1507151|NCT00749697|radioiodine|radioiodine
1507152|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
1507153|NCT00749697|dosimetry|dosimetry
1507154|NCT00749697|metastases|metastases
1507155|NCT00749684|interferon-alpha|interferon-alpha
1507156|NCT00749658|Tobacco|tobacco
1507157|NCT00749658|Nicotine|nicotine
1507158|NCT00749658|Smoking|smoking
1507159|NCT00749658|Varenicline|varenicline
1507160|NCT00749658|Bupropion|bupropion
1507161|NCT00749658|Human laboratory study|human laboratory study
1507162|NCT00749658|Stress tolerance|stress tolerance
1507163|NCT00749658|Startle response|startle response
1507164|NCT00749658|Cognitive assessment|cognitive assessment
1507165|NCT00749658|Progressive ratio|progressive ratio
1507166|NCT00749658|Motivation|motivation
1507167|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
1507168|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
1507169|NCT00749632|urinary urge incontinence|urinary urge incontinence
1507170|NCT00749632|urge incontinence|urge incontinence
1507171|NCT00749632|over active bladder|over active bladder
1507172|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
1507173|NCT00749619|Catheter Lock Solution|catheter lock solution
1507174|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
1507176|NCT00749606|Metabolic syndrome|metabolic syndrome
1507177|NCT00749606|Weight loss|weight loss
1507178|NCT00749606|Diabetes prevention|diabetes prevention
1507179|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1507180|NCT00749593|Quality of Life|quality of life
1507181|NCT00749593|Genotype|genotype
1507182|NCT00749593|Metabolic outcomes|metabolic outcomes
1507183|NCT00749580|Safety|safety
1507184|NCT00749567|NSCLC|nsclc
1507185|NCT00749567|TKI's|tki's
1507186|NCT00749567|Anti-VEGF|anti-vegf
1507187|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
1507188|NCT00749554|Disc biacuplasty|disc biacuplasty
1507189|NCT00749554|TransDiscal system|transdiscal system
1507190|NCT00749554|Discogenic pain|discogenic pain
1507191|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
1507192|NCT00749528|Wheezing|wheezing
1507193|NCT00749528|Hair trace elements|hair trace elements
1507194|NCT00749528|Hair toxic metals|hair toxic metals
1507195|NCT00749528|Oxidative stress|oxidative stress
1507196|NCT00749515|Thalassemia|thalassemia
1507197|NCT00749515|Iron|iron
1507198|NCT00749515|Chelation|chelation
1507199|NCT00749502|Neoplasms|neoplasms
1507200|NCT00749502|Ovarian neoplasms|ovarian neoplasms
1507201|NCT00749502|Prostatic neoplasms|prostatic neoplasms
1507202|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
1507203|NCT00749502|Ovarian diseases|ovarian diseases
1507204|NCT00749502|Adnexal diseases|adnexal diseases
1507205|NCT00749502|Genital diseases, female|genital diseases, female
1507206|NCT00749502|Genital diseases, male|genital diseases, male
1507207|NCT00749502|Genital neoplasms, female|genital neoplasms, female
1507208|NCT00749502|Urogenital neoplasms|urogenital neoplasms
1507209|NCT00749502|Endocrine system diseases|endocrine system diseases
1507210|NCT00749502|Gonadal disorders|gonadal disorders
1507211|NCT00749502|Genital neoplasms, male|genital neoplasms, male
1507212|NCT00749502|Prostatic diseases|prostatic diseases
1507213|NCT00749489|Pain|pain
1507214|NCT00749489|Hip Fractures|hip fractures
1507215|NCT00749489|Femoral Fractures|femoral fractures
1507221|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
1507222|NCT00749450|stage II colon cancer|stage ii colon cancer
1507223|NCT00749450|stage III colon cancer|stage iii colon cancer
1507224|NCT00749450|stage II rectal cancer|stage ii rectal cancer
1507225|NCT00749450|stage III rectal cancer|stage iii rectal cancer
1507226|NCT00749437|stage I breast cancer|stage i breast cancer
1507227|NCT00749437|stage II breast cancer|stage ii breast cancer
1507228|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1507229|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1507230|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1507231|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1507232|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1507233|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1507234|NCT00749437|breast cancer in situ|breast cancer in situ
1507235|NCT00749411|COPD|copd
1507236|NCT00749411|long-acting beta agonist|long-acting beta agonist
1507237|NCT00749411|Emphysema|emphysema
1507238|NCT00749411|Chronic Bronchitis|chronic bronchitis
1507239|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1507240|NCT00749411|bronchodilator|bronchodilator
1507241|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
1507242|NCT00749359|healthy volunteers|healthy volunteers
1507243|NCT00749359|paroxetine|paroxetine
1507244|NCT00749346|TTFields|ttfields
1507245|NCT00749346|NSCLC|nsclc
1507246|NCT00749346|Alimta|alimta
1507247|NCT00749346|Pemetrexed|pemetrexed
1507248|NCT00749333|Healthy Volunteer|healthy volunteer
1507249|NCT00749333|Safety|safety
1507250|NCT00749333|Tolerability|tolerability
1507251|NCT00749333|AZD8566|azd8566
1507252|NCT00749333|study|study
1507253|NCT00749320|MRI|mri
1507254|NCT00749320|Sunitinib|sunitinib
1507255|NCT00749320|Pazopanib|pazopanib
1507256|NCT00749307|Heart rate variability|heart rate variability
1507257|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
1507258|NCT00749307|DHA|dha
1507259|NCT00749307|Long chain fatty acids|long chain fatty acids
1507260|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
1507261|NCT00749307|Algal fatty acids|algal fatty acids
1507262|NCT00749307|Schizochytrium|schizochytrium
1507263|NCT00749307|Omega 3|omega 3
1507264|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
1507265|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
1507266|NCT00749281|atherosclerosis|atherosclerosis
1507267|NCT00749281|ngal|ngal
1507268|NCT00749281|coronary artery disease|coronary artery disease
1507269|NCT00749268|hernia|hernia
1507270|NCT00749255|Breast Cancer|breast cancer
1507271|NCT00749255|Digital archiver software|digital archiver software
1507272|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
1507273|NCT00749242|Vertebroplasty|vertebroplasty
1507274|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
1507275|NCT00749242|Bohler bracing|bohler bracing
1507276|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
1507277|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
1507278|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
1507279|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1507280|NCT00749203|PTSD|ptsd
1507281|NCT00749203|anxiety disorder|anxiety disorder
1507282|NCT00749203|ketamine|ketamine
1507283|NCT00749203|depression|depression
1507284|NCT00749203|depressed mood|depressed mood
1507285|NCT00749177|traditional healing|traditional healing
1507286|NCT00749177|anxiety|anxiety
1507287|NCT00749177|depression|depression
1507288|NCT00749177|aboriginal|aboriginal
1507289|NCT00749177|children|children
1507290|NCT00749177|youth|youth
1507291|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
1507292|NCT00749164|Umbilical cord|umbilical cord
1507293|NCT00749164|graft-vs-host disease|graft-vs-host disease
1507294|NCT00749164|Steroid resistant|steroid resistant
1507295|NCT00749151|smoking cessation|smoking cessation
1507296|NCT00749151|telephone help line|telephone help line
1507297|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
1507298|NCT00749125|Emotional Circuitry|emotional circuitry
1507299|NCT00749125|fMRI|fmri
1507300|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1507301|NCT00749112|Anemia|anemia
1507302|NCT00749112|Hemolytic|hemolytic
1507303|NCT00749112|Autoimmune|autoimmune
1507304|NCT00749112|Alemtuzumab|alemtuzumab
1507305|NCT00749112|Rituximab|rituximab
1507306|NCT00749086|Osteoporosis|osteoporosis
1507307|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
1507308|NCT00749086|Vertebral compression|vertebral compression
1507309|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
1507310|NCT00749086|Vertebroplasty|vertebroplasty
1507311|NCT00749073|Spinal Stenosis|spinal stenosis
1507312|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
1507313|NCT00749073|Laminotomy|laminotomy
1507314|NCT00749073|Laminectomy|laminectomy
1507315|NCT00749073|Spine Surgery|spine surgery
1507316|NCT00749060|osteoporosis|osteoporosis
1507606|NCT00747851|response|response
1507317|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
1507318|NCT00749060|vertebral compression|vertebral compression
1507319|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
1507320|NCT00749060|vertebroplasty|vertebroplasty
1507321|NCT00749047|Pioglitazone|pioglitazone
1507322|NCT00749047|Open study|open study
1507323|NCT00749047|Proteinuria|proteinuria
1507324|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
1507325|NCT00749034|Safety|safety
1507326|NCT00749034|Immunogenicity|immunogenicity
1507327|NCT00749034|Tuberculosis|tuberculosis
1507328|NCT00749034|Vaccination|vaccination
1507329|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
1507330|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
1507331|NCT00749021|choroidal neovascularization|choroidal neovascularization
1507332|NCT00749021|vascularized|vascularized
1507333|NCT00749008|Cerebral palsy|cerebral palsy
1507334|NCT00749008|Generalized movements|generalized movements
1507335|NCT00749008|Fidgety movements|fidgety movements
1507336|NCT00749008|Prechtl|prechtl
1507337|NCT00748982|AZD1305|azd1305
1507338|NCT00748982|anti-arrhythmics|anti-arrhythmics
1507339|NCT00748982|safety|safety
1507340|NCT00748969|MPS I|mps i
1507341|NCT00748969|MPS II|mps ii
1507342|NCT00748969|MPS VI|mps vi
1507343|NCT00748969|growth hormone|growth hormone
1507344|NCT00748969|short stature|short stature
1507345|NCT00748956|Mood Disorder|mood disorder
1507346|NCT00748956|Anxiety Disorders|anxiety disorders
1507347|NCT00748943|chlorine|chlorine
1507348|NCT00748943|dioxide|dioxide
1507349|NCT00748943|mouthwash|mouthwash
1507350|NCT00748943|halitosis|halitosis
1507351|NCT00748943|bacteria|bacteria
1507352|NCT00748943|saliva|saliva
1507353|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
1507354|NCT00748891|Cancer|cancer
1507355|NCT00748891|tumour|tumour
1507356|NCT00748891|advanced sold tumour|advanced sold tumour
1507357|NCT00748891|imaging|imaging
1507358|NCT00748891|DCE-CT Scan|dce-ct scan
1507359|NCT00748891|DCE-MRI scan|dce-mri scan
1507360|NCT00748891|Cediranib|cediranib
1507361|NCT00748891|Recentin|recentin
1507362|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
1507363|NCT00748865|Dry Eye|dry eye
1507364|NCT00748865|Artificial Tears|artificial tears
1507365|NCT00748839|HIT|hit
1507366|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1507367|NCT00748839|heparin treatment|heparin treatment
1507368|NCT00748839|venous thrombosis|venous thrombosis
1507369|NCT00748839|arterial thrombosis|arterial thrombosis
1507972|NCT00746421|bipolar|bipolar
1507370|NCT00748839|predictive clinical score|predictive clinical score
1507371|NCT00748839|biological test|biological test
1507372|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
1507373|NCT00748813|Influenza vaccine|influenza vaccine
1507374|NCT00748800|HIV prevention|hiv prevention
1507375|NCT00748800|HIV seronegativity|hiv seronegativity
1507376|NCT00748774|Primary Brain Tumor|primary brain tumor
1507377|NCT00748774|Caregivers|caregivers
1507378|NCT00748774|Symptom Severity|symptom severity
1507379|NCT00748774|Questionnaire|questionnaire
1507380|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
1507381|NCT00748774|MDASI-BT|mdasi-bt
1507382|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1507383|NCT00748761|OCD|ocd
1507384|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1507385|NCT00748761|CBT|cbt
1507386|NCT00748761|MRSI|mrsi
1507387|NCT00748761|Glutamate|glutamate
1507388|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
1507389|NCT00748735|echocardiography|echocardiography
1507390|NCT00748735|heart failure|heart failure
1507391|NCT00748735|left ventricular function|left ventricular function
1507392|NCT00748735|pacing|pacing
1507393|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
1567167|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1507394|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
1507395|NCT00748722|Breast reconstruction|breast reconstruction
1507396|NCT00748722|Perforator flaps|perforator flaps
1507397|NCT00748722|CT Angiography|ct angiography
1507398|NCT00748696|sarcopenia|sarcopenia
1507399|NCT00748696|elderly|elderly
1507400|NCT00748696|resistance training|resistance training
1507401|NCT00748696|oral nutritional supplement|oral nutritional supplement
1507402|NCT00748683|elderly|elderly
1507403|NCT00748683|longterm care|longterm care
1507404|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
1507405|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
1507406|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
1507407|NCT00748644|rituximab,|rituximab,
1507408|NCT00748644|azathioprine|azathioprine
1507409|NCT00748631|Vertebral fracture|vertebral fracture
1507410|NCT00748631|Vertebral compression fracture|vertebral compression fracture
1507411|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
1507412|NCT00748631|Vertebral metastases|vertebral metastases
1507413|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
1507414|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
1507415|NCT00748618|Vitamin D deficiency|vitamin d deficiency
1507416|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1507417|NCT00748618|Vascular risk|vascular risk
1507418|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
1507419|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
1507420|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
1507421|NCT00748605|Obesity|obesity
1507422|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
1507423|NCT00748566|Ziprasidone|ziprasidone
1507424|NCT00748566|metabolic syndrome|metabolic syndrome
1507425|NCT00748566|risk factors|risk factors
1507426|NCT00748566|schizophrenia|schizophrenia
1507427|NCT00748566|psychotic disorders.|psychotic disorders.
1507428|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
1507429|NCT00748540|conductive hearing loss|conductive hearing loss
1507430|NCT00748540|mixed hearing loss|mixed hearing loss
1507431|NCT00748527|fallopian tube cancer|fallopian tube cancer
1507432|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1507433|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1507434|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1507435|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
1507436|NCT00748514|capsular incision|capsular incision
1507437|NCT00748514|biochemical recurrence|biochemical recurrence
1507438|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
1507439|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
1507440|NCT00748501|ALS,|als,
1507441|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
1507442|NCT00748488|Parkinson|parkinson
1507443|NCT00748488|Physical Therapy|physical therapy
1507444|NCT00748488|Physical Activity|physical activity
1507445|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
1507446|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
1507447|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
1507448|NCT00748449|Colectomy|colectomy
1507449|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
1507450|NCT00748449|CT-colonography|ct-colonography
1507451|NCT00748436|Obese females|obese females
1507452|NCT00748436|Weight loss|weight loss
1507453|NCT00748436|Betahistine|betahistine
1507454|NCT00748423|Inhaled drug|inhaled drug
1507455|NCT00748423|Acute lung injury|acute lung injury
1507456|NCT00748423|Nitric oxide|nitric oxide
1507457|NCT00748423|Sickle cell|sickle cell
1507458|NCT00748410|CD11b|cd11b
1507459|NCT00748410|Ulcerative colitis|ulcerative colitis
1507460|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
1507461|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
1507462|NCT00748371|platelet aggregation|platelet aggregation
1507463|NCT00748371|granule secretion|granule secretion
1507464|NCT00748371|thromboxane production|thromboxane production
1507465|NCT00748371|prostacyclin production|prostacyclin production
1507466|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
1507467|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
1507468|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
1507469|NCT00748345|Caspofungin,|caspofungin,
1507470|NCT00748345|burn patients,|burn patients,
1507471|NCT00748345|pharmacokinetics,|pharmacokinetics,
1507472|NCT00748345|optimal dose,|optimal dose,
1507473|NCT00748345|antifungal treatment|antifungal treatment
1507474|NCT00748319|Receptors KIR|receptors kir
1507475|NCT00748319|Polymerase chain reaction|polymerase chain reaction
1507476|NCT00748319|Diagnosis|diagnosis
1507477|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
1507478|NCT00748319|Mycosis fungicides|mycosis fungicides
1666747|NCT00117858|FTP|ftp
1507479|NCT00748319|Sezary syndrome|sezary syndrome
1507480|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
1507481|NCT00748306|challenge|challenge
1507482|NCT00748306|early asthmatic response|early asthmatic response
1507483|NCT00748306|mild asthmatics|mild asthmatics
1507484|NCT00748306|Allergen|allergen
1507485|NCT00748306|methacholine|methacholine
1507486|NCT00748293|Colonoscopy|colonoscopy
1507487|NCT00748293|Colon cleansing|colon cleansing
1507488|NCT00748293|Low-reside diet|low-reside diet
1507489|NCT00748293|Compliance|compliance
1507490|NCT00748293|PEG-ELS|peg-els
1507491|NCT00748280|Endodontics|endodontics
1507492|NCT00748280|CEM cement|cem cement
1507493|NCT00748280|Calcium enriched mixture|calcium enriched mixture
1507495|NCT00748280|Root Canal Therapy|root canal therapy
1507496|NCT00748280|Pain|pain
1507497|NCT00748280|Pulpotomy|pulpotomy
1507498|NCT00748280|Human|human
1507499|NCT00748280|Permanent|permanent
1507500|NCT00748280|Molar teeth|molar teeth
1507501|NCT00748267|anxiety disorder|anxiety disorder
1507502|NCT00748267|pain|pain
1507503|NCT00748267|nausea and vomiting|nausea and vomiting
1507504|NCT00748267|breast cancer|breast cancer
1507505|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
1507506|NCT00748215|diarrhea|diarrhea
1507507|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1507508|NCT00748215|recurrent colon cancer|recurrent colon cancer
1507509|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
1507510|NCT00748215|stage IV colon cancer|stage iv colon cancer
1507511|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
1507512|NCT00748202|Hereditary angioedema|hereditary angioedema
1507513|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
1507514|NCT00748202|intravenous|intravenous
1507515|NCT00748202|subcutaneous|subcutaneous
1507516|NCT00748202|pharmacokinetic|pharmacokinetic
1507517|NCT00748189|Safety|safety
1507518|NCT00748189|Untreated|untreated
1507519|NCT00748189|Efficacy|efficacy
1507520|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1507521|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
1507522|NCT00748189|Ofatumumab|ofatumumab
1507523|NCT00748189|Oncology|oncology
1507524|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1507525|NCT00748150|flu|flu
1507526|NCT00748150|influenza|influenza
1507527|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
1507528|NCT00748150|immunogenicity|immunogenicity
1507529|NCT00748150|antibody response|antibody response
1507530|NCT00748150|intra muscular|intra muscular
1507531|NCT00748150|elderly|elderly
1507532|NCT00748150|non-elderly|non-elderly
1507533|NCT00748137|Type 1 Diabetes|type 1 diabetes
1507534|NCT00748137|Youth|youth
1507535|NCT00748137|Insulin dose|insulin dose
1507536|NCT00748111|Sudden death|sudden death
1507537|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
1507538|NCT00748111|Acute myocardial infarction|acute myocardial infarction
1507539|NCT00748111|Acute coronary syndrome|acute coronary syndrome
1507540|NCT00748098|PSG|psg
1507541|NCT00748098|Restless Legs Syndrome|restless legs syndrome
1507542|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
1507543|NCT00748098|XP13512|xp13512
1507544|NCT00748098|GSK1838262|gsk1838262
1507545|NCT00748098|sleep disturbance|sleep disturbance
1507546|NCT00748098|RLS|rls
1507547|NCT00748098|polysomnography|polysomnography
1507548|NCT00748085|Malignant Airway Disease|malignant airway disease
1507549|NCT00748085|Lung Cancer|lung cancer
1507550|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
1507551|NCT00748085|Mesothelioma|mesothelioma
1507552|NCT00748085|Endoluminal Tumor|endoluminal tumor
1507553|NCT00748072|Vasopressin|vasopressin
1507554|NCT00748072|bleeding|bleeding
1507555|NCT00748072|biopsy|biopsy
1507556|NCT00748072|ultrasonography|ultrasonography
1507557|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
1507558|NCT00748059|blood pressure|blood pressure
1507559|NCT00748059|congenital|congenital
1507560|NCT00748059|orthostasis|orthostasis
1507561|NCT00748059|catecholamines|catecholamines
1507562|NCT00748046|Biodistribution|biodistribution
1507563|NCT00748046|Radiation dosimetry|radiation dosimetry
1507564|NCT00748046|Pharmacokinetics|pharmacokinetics
1507565|NCT00748046|Safety|safety
1507566|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
1507567|NCT00747994|Paget's disease of bone|paget's disease of bone
1507568|NCT00747994|Relatives|relatives
1507569|NCT00747994|Mutations screening|mutations screening
1507570|NCT00747994|Haplotypes analysis|haplotypes analysis
1507571|NCT00747994|Linkage analysis|linkage analysis
1507572|NCT00747994|< 55 years|< 55 years
1507573|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
1507574|NCT00747994|bone deformity|bone deformity
1507575|NCT00747981|CT Scan|ct scan
1507576|NCT00747981|Endoscopy|endoscopy
1507577|NCT00747981|Aspiration|aspiration
1507578|NCT00747981|Foreign Bodies|foreign bodies
1507579|NCT00747955|Human Performance|human performance
1507580|NCT00747955|Physical Disability|physical disability
1507581|NCT00747955|Functional Outcome Measures|functional outcome measures
1507582|NCT00747955|Health Volunteer|health volunteer
1507583|NCT00747955|HV|hv
1507584|NCT00747942|overweight|overweight
1507585|NCT00747942|physical inactivity|physical inactivity
1507586|NCT00747942|physical fitness|physical fitness
1507587|NCT00747942|lifestyle change|lifestyle change
1507588|NCT00747929|Obesity|obesity
1507589|NCT00747916|Parietal pleura|parietal pleura
1507590|NCT00747916|Neoplasms|neoplasms
1507591|NCT00747916|Pleural Surface|pleural surface
1507592|NCT00747916|Pleural Neoplasms|pleural neoplasms
1507593|NCT00747916|Lung Cancer|lung cancer
1507594|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1507595|NCT00747903|recurrent skin cancer|recurrent skin cancer
1507596|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
1507597|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
1507598|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
1507599|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
1507600|NCT00747864|Gestational Age|gestational age
1507601|NCT00747864|Urine|urine
1507602|NCT00747864|Concentration|concentration
1507603|NCT00747864|of S100B|of s100b
1507604|NCT00747851|protein|protein
1507605|NCT00747851|synthesis|synthesis
1507607|NCT00747851|PAF-stimulated|paf-stimulated
1507609|NCT00747851|collected|collected
1507610|NCT00747838|Afib|afib
1507611|NCT00747838|Atrial Fibrillation|atrial fibrillation
1507612|NCT00747838|Maze|maze
1507613|NCT00747838|Mini-Maze|mini-maze
1507614|NCT00747825|cancer|cancer
1507615|NCT00747825|oncology|oncology
1507616|NCT00747825|melanoma|melanoma
1507617|NCT00747825|tumor|tumor
1507618|NCT00747812|Headache|headache
1507619|NCT00747812|Migraine|migraine
1507620|NCT00747812|Refractory|refractory
1507621|NCT00747812|Chronic|chronic
1507622|NCT00747812|Pain|pain
1507623|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
1507624|NCT00747773|Lung Cancer|lung cancer
1507625|NCT00747773|CryoPsray Ablation|cryopsray ablation
1507626|NCT00747773|CSA therapy|csa therapy
1507627|NCT00747773|CSA treatment|csa treatment
1507628|NCT00747773|Lobectomy|lobectomy
1507629|NCT00747773|lung resection|lung resection
1507630|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
1507631|NCT00747747|Sinusitis|sinusitis
1507632|NCT00747734|Neuropilin-1|neuropilin-1
1507633|NCT00747734|NRP1|nrp1
1507634|NCT00747734|anti-NRP1|anti-nrp1
1507635|NCT00747734|anti-angiogenic|anti-angiogenic
1507636|NCT00747708|heart failure|heart failure
1507637|NCT00747708|coronary heart disease|coronary heart disease
1507638|NCT00747708|adult stem cells|adult stem cells
1507639|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
1507640|NCT00747708|bone marrow stem cells|bone marrow stem cells
1507641|NCT00747708|autologous|autologous
1507642|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
1507643|NCT00747708|left ventricular function|left ventricular function
1507644|NCT00747708|intracoronary injection|intracoronary injection
1507645|NCT00747708|intramyocardial injection|intramyocardial injection
1507646|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
1507647|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
1507648|NCT00747695|Rabeprazole|rabeprazole
1507649|NCT00747695|Pediatric GERD|pediatric gerd
1507650|NCT00747695|Aciphex|aciphex
1507651|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
1507652|NCT00747682|Oxygenation,|oxygenation,
1507653|NCT00747682|Electrical|electrical
1507654|NCT00747682|Activity|activity
1507655|NCT00747656|Electrocardiography|electrocardiography
1507656|NCT00747656|Emergency medical services|emergency medical services
1507657|NCT00747656|Emergency medicine|emergency medicine
1507658|NCT00747656|Health services|health services
1507973|NCT00746421|disability|disability
1507659|NCT00747656|Cost effectiveness|cost effectiveness
1507660|NCT00747643|tobacco|tobacco
1507661|NCT00747643|nicotine|nicotine
1507662|NCT00747643|smoking|smoking
1507663|NCT00747643|reward|reward
1507664|NCT00747643|reinforcement|reinforcement
1507665|NCT00747643|craving|craving
1507666|NCT00747643|cues|cues
1507667|NCT00747643|conditioned stimuli|conditioned stimuli
1507668|NCT00747643|cue reactivity|cue reactivity
1507669|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
1507670|NCT00747630|Teen pregnancy|teen pregnancy
1507671|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
1507672|NCT00747617|androgens|androgens
1507673|NCT00747617|ovary|ovary
1507674|NCT00747617|LH|lh
1507675|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
1507676|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
1507677|NCT00747604|Short Stature|short stature
1507678|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
1507679|NCT00747604|Growth|growth
1507680|NCT00747591|urine|urine
1507681|NCT00747591|concentration|concentration
1507682|NCT00747591|of S100B|of s100b
1507683|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
1507684|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
1507685|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
1507686|NCT00747578|health-related|health-related
1507687|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
1507688|NCT00747578|compare|compare
1507689|NCT00747578|utility|utility
1507690|NCT00747578|patients|patients
1507691|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
1507692|NCT00747552|IAP measurements|iap measurements
1507693|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
1507694|NCT00747552|NICU patients|nicu patients
1507695|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
1507696|NCT00747539|Hepatitis C Virus|hepatitis c virus
1507698|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
1507699|NCT00747539|Coinfection|coinfection
1507700|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1507701|NCT00747526|Pediatrics|pediatrics
1507702|NCT00747526|Pharmacokinetics|pharmacokinetics
1507703|NCT00747526|Pharmacodynamics|pharmacodynamics
1507704|NCT00747526|Rabeprazole|rabeprazole
1507705|NCT00747526|GERD|gerd
1507706|NCT00747526|Aciphex|aciphex
1507707|NCT00747513|school|school
1507709|NCT00747513|overweight|overweight
1507710|NCT00747513|children|children
1507711|NCT00747513|diet|diet
1507712|NCT00747513|physical activity|physical activity
1507713|NCT00747513|fitness|fitness
1507714|NCT00747487|Leber|leber
1507715|NCT00747487|LHON|lhon
1507716|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
1507717|NCT00747487|Idebenone|idebenone
1507718|NCT00747461|Benign Airway Disease|benign airway disease
1507719|NCT00747461|Airway Injury|airway injury
1507720|NCT00747461|Sarcoidosis|sarcoidosis
1507721|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
1507722|NCT00747461|Rhinoscleroma|rhinoscleroma
1507723|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
1507724|NCT00747448|Barrett's Esophagus|barrett's esophagus
1507725|NCT00747448|High Grade Dysplasia|high grade dysplasia
1507726|NCT00747448|Low Grade Dysplasia|low grade dysplasia
1507727|NCT00747448|Squamous Dysplasia|squamous dysplasia
1507728|NCT00747448|Esophageal Cancer|esophageal cancer
1507729|NCT00747448|CryoSpray Ablation|cryospray ablation
1507730|NCT00747448|Cryotherapy|cryotherapy
1507731|NCT00747448|Cryospray|cryospray
1507732|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
1507733|NCT00747435|ski slope audiogram|ski slope audiogram
1507734|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
1507735|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
1507736|NCT00747396|Romania,|romania,
1507737|NCT00747396|children,|children,
1507738|NCT00747396|foster care,|foster care,
1507739|NCT00747396|institutionalization,|institutionalization,
1507740|NCT00747396|brain function,|brain function,
1507741|NCT00747396|MRI,|mri,
1507742|NCT00747396|attachment,|attachment,
1507743|NCT00747396|language,|language,
1507744|NCT00747396|growth,|growth,
1507745|NCT00747396|IQ,|iq,
1507746|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
1507747|NCT00747396|early intervention|early intervention
1507748|NCT00747383|Diabetes Mellitus|diabetes mellitus
1507749|NCT00747383|GLP1|glp1
1507750|NCT00747383|DPP4|dpp4
1507751|NCT00747370|stress urinary incontinence|stress urinary incontinence
1507752|NCT00747370|Tension free vaginal tape|tension free vaginal tape
1507753|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
1507754|NCT00747370|genital prolapse|genital prolapse
1507755|NCT00747344|Psoriasis|psoriasis
1507756|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
1507757|NCT00747344|Ustekinumab|ustekinumab
1507758|NCT00747344|CNTO 1275|cnto 1275
1507759|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
1507760|NCT00747331|Lactic acidosis|lactic acidosis
1507761|NCT00747331|Oxygen delivery|oxygen delivery
1507762|NCT00747331|Acute renal failure|acute renal failure
1507763|NCT00747331|outcome|outcome
1507764|NCT00747331|cardiac|cardiac
1507765|NCT00747331|surgery|surgery
1507766|NCT00747318|Moderate to Severe|moderate to severe
1507767|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
1507768|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1507769|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
1507770|NCT00747292|laparoscopic|laparoscopic
1507771|NCT00747292|colon|colon
1507772|NCT00747292|analgesia|analgesia
1507773|NCT00747292|fluid optimised|fluid optimised
1507774|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
1507775|NCT00747253|laser therapy|laser therapy
1507776|NCT00747253|thermal therapy|thermal therapy
1507777|NCT00747253|brain tumors|brain tumors
1507778|NCT00747253|recurrent brain tumor|recurrent brain tumor
1507779|NCT00747253|progressive brain tumor|progressive brain tumor
1507780|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
1507781|NCT00747240|Ile198Thr|ile198thr
1507782|NCT00747240|Ala379Val|ala379val
1507783|NCT00747240|variants|variants
1507784|NCT00747240|PAF-AH|paf-ah
1507785|NCT00747227|cataract|cataract
1507786|NCT00747227|monofocal|monofocal
1507787|NCT00747227|intraocular lens|intraocular lens
1507788|NCT00747227|acrylic|acrylic
1507789|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
1507790|NCT00747214|RA|ra
1507791|NCT00747214|DMARD|dmard
1507793|NCT00747201|Replicating Effective Programs|replicating effective programs
1507794|NCT00747201|Care Management|care management
1507795|NCT00747201|Implementation|implementation
1507796|NCT00747201|Intervention|intervention
1507797|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
1507798|NCT00747188|lecture|lecture
1507799|NCT00747188|nursing|nursing
1507800|NCT00747188|education|education
1507801|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
1507802|NCT00747175|Type 2 diabetes|type 2 diabetes
1507803|NCT00747162|Compartment Syndrome|compartment syndrome
1507804|NCT00747162|Muscle Oxygenation|muscle oxygenation
1507805|NCT00747162|Skin Pigmentation|skin pigmentation
1507806|NCT00747149|diabetes|diabetes
1507807|NCT00747149|type 2|type 2
1507808|NCT00747136|Barrett's|barrett's
1507809|NCT00747136|Dysplasia|dysplasia
1507810|NCT00747136|esophageal cancer|esophageal cancer
1507811|NCT00747136|Patients|patients
1507812|NCT00747110|5-ASA|5-asa
1507813|NCT00747110|mesalamine|mesalamine
1507814|NCT00747110|mesalazine|mesalazine
1507815|NCT00747110|budesonide|budesonide
1507816|NCT00747110|ulcerative colitis|ulcerative colitis
1507817|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
1507818|NCT00747071|Clostridium difficile|clostridium difficile
1507819|NCT00747071|diarrhea|diarrhea
1507820|NCT00747071|colostrum|colostrum
1507821|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
1507822|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
1507823|NCT00747045|Lung Injury|lung injury
1507824|NCT00747045|Ventilation Strategies|ventilation strategies
1507825|NCT00746993|Contraception|contraception
1507826|NCT00746993|Counseling|counseling
1507827|NCT00746980|alopecia|alopecia
1507828|NCT00746980|areata|areata
1507829|NCT00746980|universalis|universalis
1507830|NCT00746980|severe|severe
1507831|NCT00746980|ophiasis|ophiasis
1507832|NCT00746980|variants|variants
1507833|NCT00746954|buspirone|buspirone
1507834|NCT00746954|acetazolamide|acetazolamide
1507836|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
1507837|NCT00746941|HIV|hiv
1507838|NCT00746941|Central Nervous System Disease|central nervous system disease
1507839|NCT00746941|Mefloquine|mefloquine
1507840|NCT00746941|JC Virus|jc virus
1507841|NCT00746928|Blood pressure|blood pressure
1507842|NCT00746928|Hypertension|hypertension
1507843|NCT00746928|sympathetic control|sympathetic control
1507844|NCT00746928|chemosensitivity|chemosensitivity
1507845|NCT00746928|baroreflex|baroreflex
1507846|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
1507847|NCT00746902|Refractory hypertension|refractory hypertension
1507848|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1507849|NCT00746902|Obesity|obesity
1507850|NCT00746902|Leptinemia|leptinemia
1507851|NCT00746902|RHOOSAS study|rhoosas study
1507852|NCT00746889|osteoarthritis|osteoarthritis
1507853|NCT00746889|knee|knee
1507854|NCT00746889|corticosteroids|corticosteroids
1507855|NCT00746889|ultrasound|ultrasound
1507856|NCT00746876|Hip|hip
1507857|NCT00746876|Fracture|fracture
1507858|NCT00746876|Femoral neck|femoral neck
1507859|NCT00746876|Hemiarthroplasty|hemiarthroplasty
1507860|NCT00746876|Bipolar|bipolar
1507861|NCT00746876|Unipolar|unipolar
1507862|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
1507863|NCT00746863|mid-urethral sling|mid-urethral sling
1507864|NCT00746863|pubovaginal sling|pubovaginal sling
1507865|NCT00746863|postoperative pain|postoperative pain
1507866|NCT00746863|visual analog scale|visual analog scale
1507867|NCT00746863|suprapubic approach|suprapubic approach
1507868|NCT00746863|SPARC sling|sparc sling
1507869|NCT00746850|acute cholecystitis|acute cholecystitis
1507870|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1507871|NCT00746850|conversion rate|conversion rate
1507872|NCT00746850|morbidity|morbidity
1507873|NCT00746850|mortality|mortality
1507874|NCT00746850|postoperative pain|postoperative pain
1507875|NCT00746850|hospital stay|hospital stay
1507876|NCT00746837|AZD5672|azd5672
1507877|NCT00746824|Obesity|obesity
1507878|NCT00746824|weight loss|weight loss
1507879|NCT00746824|7TM Pharma|7tm pharma
1507880|NCT00746824|TM30339|tm30339
1507881|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
1507882|NCT00746811|cholesterol|cholesterol
1507883|NCT00746811|hypercholesterolemia|hypercholesterolemia
1507884|NCT00746811|omega 3|omega 3
1507885|NCT00746798|West Nile Fever|west nile fever
1507886|NCT00746798|ChimeriVax|chimerivax
1507887|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
1507888|NCT00746785|Olanzapine|olanzapine
1507889|NCT00746772|antioxidant|antioxidant
1507890|NCT00746772|oral lichen planus|oral lichen planus
1507891|NCT00746772|treatment|treatment
1507892|NCT00746772|purslane|purslane
1507893|NCT00746759|Lung Cancer|lung cancer
1507894|NCT00746759|Smoker|smoker
1507895|NCT00746759|Former Smoker|former smoker
1507896|NCT00746759|Gene Expression|gene expression
1507897|NCT00746759|Bronchoscopy|bronchoscopy
1507898|NCT00746746|Advanced Melanoma|advanced melanoma
1507899|NCT00746733|Drug|drug
1507900|NCT00746733|Interaction|interaction
1507901|NCT00746733|Study|study
1507902|NCT00746720|hip replacement|hip replacement
1507903|NCT00746720|osteoarthritis|osteoarthritis
1507904|NCT00746720|etoricoxib|etoricoxib
1507905|NCT00746720|pain|pain
1507906|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
1507907|NCT00746720|pharmacokinetics|pharmacokinetics
1507908|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
1507909|NCT00746668|Reading|reading
1507910|NCT00746668|Macular Degeneration|macular degeneration
1507911|NCT00746668|Rehabilitation|rehabilitation
1507912|NCT00746668|Vision, Low|vision, low
1507913|NCT00746655|Hepatocellular|hepatocellular
1507914|NCT00746642|glucose measurements|glucose measurements
1507915|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
1507916|NCT00746616|Acetabular Cup,|acetabular cup,
1507917|NCT00746616|Hip Resurfacing|hip resurfacing
1507919|NCT00746616|active|active
1507920|NCT00746616|patients|patients
1507921|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
1507922|NCT00746590|liver cancer|liver cancer
1507923|NCT00746590|Prolarix|prolarix
1507924|NCT00746590|tretazicar|tretazicar
1507925|NCT00746590|caricotamide|caricotamide
1507926|NCT00746590|Phase 2|phase 2
1507927|NCT00746590|tumor|tumor
1507928|NCT00746590|chemotherapy|chemotherapy
1507929|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
1507930|NCT00746564|Arrhythmias|arrhythmias
1507931|NCT00746564|Atrial Fibrillation|atrial fibrillation
1507932|NCT00746551|iron deficiency anemia|iron deficiency anemia
1507933|NCT00746551|pregnancy|pregnancy
1507934|NCT00746551|third trimester|third trimester
1507935|NCT00746551|intravenous iron|intravenous iron
1507936|NCT00746551|efficacy|efficacy
1507937|NCT00746551|a randomized trial|a randomized trial
1507938|NCT00746551|Female|female
1507939|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
1507940|NCT00746551|Infusions, Intravenous|infusions, intravenous
1507941|NCT00746551|Hematologic/therapy*|hematologic/therapy*
1507942|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
1507943|NCT00746538|biliary stent|biliary stent
1507944|NCT00746538|plastic stent|plastic stent
1507945|NCT00746538|metallic stent|metallic stent
1507946|NCT00746538|quality of life|quality of life
1507947|NCT00746525|stroke|stroke
1507948|NCT00746525|motor learning|motor learning
1507949|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
1507950|NCT00746525|functional electrical stimulation|functional electrical stimulation
1507951|NCT00746525|FES|fes
1507952|NCT00746525|brain computer interface|brain computer interface
1507953|NCT00746525|BCI|bci
1507954|NCT00746525|coordination|coordination
1507955|NCT00746525|motor control|motor control
1507956|NCT00746460|primary prevention|primary prevention
1507957|NCT00746460|patient knowledge|patient knowledge
1507958|NCT00746460|nurse|nurse
1507959|NCT00746460|exercise|exercise
1507960|NCT00746460|smoking cessation|smoking cessation
1507961|NCT00746460|weight loss|weight loss
1507962|NCT00746447|maintenance|maintenance
1507963|NCT00746447|5-ASA|5-asa
1507964|NCT00746447|mesalamine|mesalamine
1507965|NCT00746447|mesalazine|mesalazine
1507966|NCT00746447|ulcerative colitis|ulcerative colitis
1507967|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
1507968|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
1507969|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
1507970|NCT00746421|Cognition|cognition
1507971|NCT00746421|attention|attention
1507975|NCT00746408|Information supply|information supply
1507976|NCT00746408|Tailoring|tailoring
1507977|NCT00746408|Patient empowerment|patient empowerment
1507978|NCT00746408|Headaches|headaches
1507979|NCT00746408|Consumer Health Information|consumer health information
1507980|NCT00746408|Information Services|information services
1507981|NCT00746408|Information Storage and Retrieval|information storage and retrieval
1507982|NCT00746408|Information Systems|information systems
1507983|NCT00746395|capsule|capsule
1507984|NCT00746395|endoscopy|endoscopy
1507985|NCT00746395|prokinetic|prokinetic
1507986|NCT00746395|lubiprostone|lubiprostone
1507987|NCT00746395|Normal|normal
1507988|NCT00746395|volunteers|volunteers
1507989|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
1507990|NCT00746369|HIV|hiv
1507991|NCT00746369|Prevention|prevention
1507992|NCT00746369|Adolescents|adolescents
1507993|NCT00746369|HIV Seronegativity|hiv seronegativity
1507994|NCT00746356|heart failure|heart failure
1507995|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
1507996|NCT00746356|autocapture|autocapture
1507997|NCT00746356|Current RF|current rf
1507998|NCT00746356|Promote RF|promote rf
1507999|NCT00746343|Bipolar I Disorder|bipolar i disorder
1508000|NCT00746343|Medical Risks|medical risks
1508001|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
1508002|NCT00746343|Currently in Remission|currently in remission
1508003|NCT00746343|BMI|bmi
1508004|NCT00746330|Asthma|asthma
1508005|NCT00746330|Children|children
1508006|NCT00746330|Persistent asthma|persistent asthma
1508007|NCT00746304|botulinum|botulinum
1508008|NCT00746304|esotropia|esotropia
1508009|NCT00746278|Ovarian Cysts|ovarian cysts
1508010|NCT00746278|Electrocoagulation|electrocoagulation
1508011|NCT00746278|Ovarian Function Tests|ovarian function tests
1508012|NCT00746278|Laparoscopy|laparoscopy
1508013|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
1508014|NCT00746252|bipolar|bipolar
1508015|NCT00746252|children|children
1508016|NCT00746252|antipsychotic|antipsychotic
1508017|NCT00746252|side effect|side effect
1508018|NCT00746239|insomnia|insomnia
1508019|NCT00746239|sleep difficulty|sleep difficulty
1508020|NCT00746239|panic disorder|panic disorder
1508021|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
1508022|NCT00746239|anxiety|anxiety
1508023|NCT00746226|birch pollen|birch pollen
1508024|NCT00746213|Thoracotomy|thoracotomy
1508025|NCT00746213|Chronic Pain|chronic pain
1508026|NCT00746200|chronic constipation|chronic constipation
1508027|NCT00746200|electroacupuncture|electroacupuncture
1508028|NCT00746200|randomized controlled trial|randomized controlled trial
1508029|NCT00746174|insulin sensitivity|insulin sensitivity
1508030|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1508031|NCT00746174|lipotoxicity|lipotoxicity
1508032|NCT00746174|lipid oxidation|lipid oxidation
1508033|NCT00746174|thiazolidinediones|thiazolidinediones
1508034|NCT00746174|intracellular|intracellular
1508035|NCT00746174|triglyceride|triglyceride
1508036|NCT00746174|content|content
1508037|NCT00746161|total gastrectomy|total gastrectomy
1508038|NCT00746161|double tract reconstruction|double tract reconstruction
1508039|NCT00746161|gastric cancer|gastric cancer
1508040|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
1508041|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
1508042|NCT00746148|Reflexology|reflexology
1508043|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
1508044|NCT00746148|Endocrinopathy|endocrinopathy
1508045|NCT00746148|Oligo|oligo
1508046|NCT00746148|Amenorrhoea|amenorrhoea
1508173|NCT00745589|peritoneal dialysis|peritoneal dialysis
1508047|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
1508048|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
1508049|NCT00746109|randomized|randomized
1508050|NCT00746109|clinical trial|clinical trial
1508051|NCT00746109|ultrasound|ultrasound
1508052|NCT00746109|prospective|prospective
1508053|NCT00746109|abscess|abscess
1508054|NCT00746109|packing|packing
1508055|NCT00746109|incision and drainage|incision and drainage
1508056|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
1508057|NCT00746083|pediatric|pediatric
1508058|NCT00746083|obesity|obesity
1508059|NCT00746083|African American|african american
1508060|NCT00746083|adolescents|adolescents
1508061|NCT00746083|intervention|intervention
1508062|NCT00746083|home-based|home-based
1508063|NCT00746083|community-based|community-based
1508064|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
1508065|NCT00746057|Renal graft|renal graft
1508066|NCT00746057|chronic rejection|chronic rejection
1508067|NCT00746057|tolerance|tolerance
1508068|NCT00746057|DNA chip|dna chip
1508069|NCT00746057|biopsy|biopsy
1508070|NCT00746044|Healthy|healthy
1508071|NCT00746031|MTI|mti
1508072|NCT00746031|Fibroids|fibroids
1508073|NCT00746031|Novel|novel
1508074|NCT00746031|MR imaging|mr imaging
1508075|NCT00746031|techniques|techniques
1508080|NCT00746005|mild cognitive impairment|mild cognitive impairment
1508081|NCT00745992|Voriconazole|voriconazole
1508082|NCT00745992|Antifungal Agents|antifungal agents
1508083|NCT00745992|Invasive fungal infections|invasive fungal infections
1508084|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
1508085|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
1508086|NCT00745966|Bipolar|bipolar
1508087|NCT00745966|atypical antipsychotics|atypical antipsychotics
1508088|NCT00745966|quality of life|quality of life
1508089|NCT00745966|observational|observational
1508090|NCT00745953|Metabolic syndrome|metabolic syndrome
1508091|NCT00745953|Lipotoxicity|lipotoxicity
1508092|NCT00745953|Insulin sensitivity|insulin sensitivity
1508093|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
1508094|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
1508095|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1508096|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1508097|NCT00745940|MBCT|mbct
1508098|NCT00745940|Depression|depression
1508099|NCT00745940|Traumatic Brain Injury|traumatic brain injury
1508100|NCT00745940|TBI|tbi
1508101|NCT00745927|Colorectal neoplasm|colorectal neoplasm
1508102|NCT00745927|Colorectal cancer|colorectal cancer
1508103|NCT00745927|Screening colonoscopy|screening colonoscopy
1508104|NCT00745927|CO2 insufflations|co2 insufflations
1508105|NCT00745927|Colonoscopy|colonoscopy
1508106|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
1508107|NCT00745901|contraception|contraception
1508108|NCT00745901|bleeding|bleeding
1508109|NCT00745901|cycle control|cycle control
1508110|NCT00745888|oxidative stress|oxidative stress
1508111|NCT00745888|intensive care|intensive care
1508112|NCT00745888|Postoperative intensive care|postoperative intensive care
1508113|NCT00745875|NSCLC|nsclc
1508114|NCT00745875|Phase II|phase ii
1508115|NCT00745875|ZD4054|zd4054
1508116|NCT00745875|Pemetrexed|pemetrexed
1508117|NCT00745875|Lung Cancer|lung cancer
1508118|NCT00745862|Skin|skin
1508217|NCT00745446|Thrombosis|thrombosis
1508119|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
1508120|NCT00745836|insulin sensitivity|insulin sensitivity
1508121|NCT00745823|HIV Infections|hiv infections
1508122|NCT00745823|Treatment Naïve|treatment naïve
1508123|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
1508124|NCT00745810|oxidative injuries|oxidative injuries
1508125|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
1508126|NCT00745797|brain metastasis|brain metastasis
1508127|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
1508128|NCT00745784|Young Bereaved Spouses|young bereaved spouses
1508129|NCT00745771|pharmacokinetics|pharmacokinetics
1508130|NCT00745771|of Diractin®|of diractin®
1508131|NCT00745771|safety|safety
1508132|NCT00745771|efficacy|efficacy
1508133|NCT00745771|exercise|exercise
1508134|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
1508135|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
1508136|NCT00745732|Lung Cancer|lung cancer
1508137|NCT00745732|NSCLC|nsclc
1508138|NCT00745732|ZD6474|zd6474
1508139|NCT00745732|ZACTIMA|zactima
1508140|NCT00745732|Vandetanib|vandetanib
1508141|NCT00745732|Inoperable NSCLC|inoperable nsclc
1508142|NCT00745732|Unresectable NSCLC|unresectable nsclc
1508143|NCT00745732|Radiation Therapy|radiation therapy
1508144|NCT00745732|Palliative radiation therapy|palliative radiation therapy
1508145|NCT00745732|Angiogenesis|angiogenesis
1508146|NCT00745719|parathyroidectomy|parathyroidectomy
1508147|NCT00745719|cardiovascular|cardiovascular
1508148|NCT00745719|bone|bone
1508149|NCT00745719|endstage renal disease|endstage renal disease
1508150|NCT00745693|Endothelin|endothelin
1508151|NCT00745693|Air pollution|air pollution
1508152|NCT00745693|Diesel exhaust|diesel exhaust
1508153|NCT00745693|Vascular function|vascular function
1508154|NCT00745693|exposure|exposure
1508155|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
1508156|NCT00745667|laparoscopic|laparoscopic
1508157|NCT00745667|peptic ulcer|peptic ulcer
1508158|NCT00745654|Lung Transplantation|lung transplantation
1508159|NCT00745654|Chronic pain|chronic pain
1508160|NCT00745654|Thoracotomy|thoracotomy
1508161|NCT00745641|radiation injury|radiation injury
1508162|NCT00745641|computed tomography|computed tomography
1508163|NCT00745641|reactive oxygen species|reactive oxygen species
1508164|NCT00745641|free radicals|free radicals
1508165|NCT00745628|coronary heart disease|coronary heart disease
1508166|NCT00745628|secondary prevention|secondary prevention
1508167|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
1508168|NCT00745589|vascular,|vascular,
1508169|NCT00745589|valvular calcification,|valvular calcification,
1508170|NCT00745589|phosphate binder,|phosphate binder,
1508171|NCT00745589|sevelamer,|sevelamer,
1508172|NCT00745589|endstage renal disease|endstage renal disease
1508174|NCT00745563|infertility|infertility
1508175|NCT00745563|insemination|insemination
1508176|NCT00745563|slow release|slow release
1508177|NCT00745550|SB1518|sb1518
1508178|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
1508179|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
1508180|NCT00745550|Polycythemia Vera|polycythemia vera
1508181|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
1508182|NCT00745550|JAK2 inhibitor|jak2 inhibitor
1508183|NCT00745537|postpartum major depression|postpartum major depression
1508184|NCT00745537|adolescent mothers|adolescent mothers
1508185|NCT00745537|telephone depression care management|telephone depression care management
1508186|NCT00745537|barriers to depression care|barriers to depression care
1508187|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
1508188|NCT00745524|adolescent|adolescent
1508190|NCT00745524|high risk population|high risk population
1508191|NCT00745524|functional impairment|functional impairment
1508192|NCT00745524|quality of life|quality of life
1508193|NCT00745511|AMD|amd
1508194|NCT00745511|Avastin|avastin
1508195|NCT00745511|ORA102|ora102
1508196|NCT00745511|macular degeneration|macular degeneration
1508197|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
1508198|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1508199|NCT00745498|vitrectomy|vitrectomy
1508200|NCT00745498|bevacizumab|bevacizumab
1508201|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
1508202|NCT00745485|Osteoporosis|osteoporosis
1508203|NCT00745485|zoledronic acid|zoledronic acid
1508204|NCT00745485|postmenopausal women|postmenopausal women
1508205|NCT00745472|AEP|aep
1508206|NCT00745472|experimental pain|experimental pain
1508207|NCT00745472|healthy volunteers|healthy volunteers
1508208|NCT00745459|Patients|patients
1508209|NCT00745459|undergoing|undergoing
1508210|NCT00745459|gastric|gastric
1508211|NCT00745459|endoscopy|endoscopy
1508212|NCT00745446|Air pollution|air pollution
1508213|NCT00745446|Diesel exhaust|diesel exhaust
1508214|NCT00745446|Endothelial function|endothelial function
1508215|NCT00745446|Vascular function|vascular function
1508216|NCT00745446|Particle trap|particle trap
1508218|NCT00745446|effects|effects
1508219|NCT00745446|inhalation|inhalation
1508220|NCT00745420|Sickle Cell Disease|sickle cell disease
1508221|NCT00745420|Sickle Cell Anemia|sickle cell anemia
1508222|NCT00745407|adipocytokines|adipocytokines
1508223|NCT00745407|insulin sensitivity|insulin sensitivity
1508224|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
1508225|NCT00745394|NIRS|nirs
1508226|NCT00745394|bypass|bypass
1508227|NCT00745394|cardiopulmonary|cardiopulmonary
1508228|NCT00745394|CPB|cpb
1508229|NCT00745394|monitoring|monitoring
1508230|NCT00745394|system|system
1508231|NCT00745381|PANCREAS|pancreas
1508232|NCT00745381|STOMACH|stomach
1508233|NCT00745381|Questionnaire|questionnaire
1508234|NCT00745381|08-105|08-105
1508235|NCT00745368|HIV|hiv
1508236|NCT00745368|Raltegravir|raltegravir
1508237|NCT00745368|pharmacokinetics|pharmacokinetics
1508238|NCT00745368|Treatment Experienced|treatment experienced
1508239|NCT00745355|Quality of Life|quality of life
1508240|NCT00745355|Questionnaires|questionnaires
1508241|NCT00745355|08-076|08-076
1508242|NCT00745342|type 1 diabetes|type 1 diabetes
1508243|NCT00745342|glycemic control|glycemic control
1508244|NCT00745342|family conflict|family conflict
1508245|NCT00745342|quality of life|quality of life
1508246|NCT00745342|parental involvement|parental involvement
1508247|NCT00745316|Heart Failure|heart failure
1508248|NCT00745316|Renal Insufficiency|renal insufficiency
1508249|NCT00745316|Congestive Heart Failure|congestive heart failure
1508250|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
1508251|NCT00745290|Total knee arthroplasty|total knee arthroplasty
1508252|NCT00745290|Pain|pain
1508253|NCT00745290|Analgesia|analgesia
1508254|NCT00745277|carbidopa|carbidopa
1508255|NCT00745277|levodopa|levodopa
1508256|NCT00745277|Parkinson's disease|parkinson's disease
1508257|NCT00745264|heat|heat
1508258|NCT00745264|exercise|exercise
1508259|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
1508260|NCT00745238|endothelial function|endothelial function
1508261|NCT00745238|peripheral arterial tone|peripheral arterial tone
1508262|NCT00745238|systemic inflammation|systemic inflammation
1508263|NCT00745238|oxidative stress|oxidative stress
1508264|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
1508265|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
1508266|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
1508267|NCT00745212|placental vascular pathologies|placental vascular pathologies
1508268|NCT00745212|antithrombotic treatment|antithrombotic treatment
1508269|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
1508270|NCT00745212|pregnant women|pregnant women
1508271|NCT00745212|score|score
1508272|NCT00745212|therapeutic strategies|therapeutic strategies
1508273|NCT00745212|heparin|heparin
1508274|NCT00745212|aspirin|aspirin
1508275|NCT00745212|pregnancy pathology|pregnancy pathology
1508276|NCT00745199|End Stage Renal Disease|end stage renal disease
1508277|NCT00745199|Cromolyn Sodium|cromolyn sodium
1508278|NCT00745199|Pruritus|pruritus
1508279|NCT00745199|Tryptase|tryptase
1508280|NCT00745160|Questionaires|questionaires
1508281|NCT00745147|constipation|constipation
1508282|NCT00745147|traditional Chinese medicine|traditional chinese medicine
1508283|NCT00745147|Chinese herbal formula|chinese herbal formula
1508284|NCT00745147|lactulose|lactulose
1667762|NCT00114517|CAD|cad
1508285|NCT00745147|cost-effective|cost-effective
1508286|NCT00745147|long-term care|long-term care
1508287|NCT00745134|Rectum|rectum
1508288|NCT00745134|Rectal Cancer|rectal cancer
1508289|NCT00745134|Colon Cancer|colon cancer
1508290|NCT00745134|Curcumin|curcumin
1508291|NCT00745134|Diferuloylmethane|diferuloylmethane
1508292|NCT00745134|Capecitabine|capecitabine
1508293|NCT00745134|Radiation Therapy|radiation therapy
1508294|NCT00745134|RT|rt
1508295|NCT00745134|XRT|xrt
1508296|NCT00745134|Surgery for Rectal Cancer|surgery for rectal cancer
1508297|NCT00745095|Safety|safety
1508298|NCT00745095|Efficacy|efficacy
1508299|NCT00745095|Colonoscopy|colonoscopy
1508300|NCT00745095|PIEE|piee
1508301|NCT00745095|MoviPrep|moviprep
1508302|NCT00745095|Neostigmine|neostigmine
1508303|NCT00745095|Glycopyrrolate|glycopyrrolate
1508304|NCT00745069|Tapentadol|tapentadol
1508305|NCT00745069|Osteoarthritis|osteoarthritis
1508306|NCT00745069|Analgesia|analgesia
1508307|NCT00745069|Chronic pain|chronic pain
1508308|NCT00745056|Cognition|cognition
1508309|NCT00745056|Memory|memory
1508310|NCT00745056|Hormone Therapy|hormone therapy
1508311|NCT00745056|HT|ht
1508312|NCT00745043|COPD|copd
1508313|NCT00745043|Betablockers|betablockers
1508314|NCT00745043|bronchodilator|bronchodilator
1508315|NCT00745043|exercise capacity|exercise capacity
1508316|NCT00745043|methacholine challenge|methacholine challenge
1508317|NCT00745030|Parkinson's disease|parkinson's disease
1508318|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
1508319|NCT00745030|Lewy Body Dementia|lewy body dementia
1508320|NCT00745017|recurrent depression|recurrent depression
1508321|NCT00745017|major depressive disorder|major depressive disorder
1508322|NCT00745017|interpersonal therapy|interpersonal therapy
1508323|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
1508324|NCT00745017|antidepressant therapies|antidepressant therapies
1508325|NCT00745017|outome predictors|outome predictors
1508326|NCT00745017|personality dimensions|personality dimensions
1508327|NCT00745004|IBS D|ibs d
1508328|NCT00744978|Efficacy|efficacy
1508329|NCT00744978|Safety|safety
1508330|NCT00744978|Pharmacokinetics|pharmacokinetics
1508331|NCT00744978|Alzheimer's disease|alzheimer's disease
1508332|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
1508333|NCT00744939|Gadolinium|gadolinium
1508334|NCT00744939|NSF|nsf
1508335|NCT00744939|Renal Impairment|renal impairment
1508336|NCT00744939|chemically induced|chemically induced
1508337|NCT00744939|adverse effects|adverse effects
1508338|NCT00744939|Contrast Media|contrast media
1508339|NCT00744939|complications|complications
1508340|NCT00744913|Pregnancy|pregnancy
1508341|NCT00744913|Women|women
1508342|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
1508343|NCT00744913|Smoking cessation|smoking cessation
1508344|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
1508345|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
1508346|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
1508347|NCT00744874|atrial fibrillation|atrial fibrillation
1508348|NCT00744861|Lumbar Fusion|lumbar fusion
1508349|NCT00744861|exospine|exospine
1508350|NCT00744861|Exo-Spine|exo-spine
1508351|NCT00744848|hemorrhoids|hemorrhoids
1508352|NCT00744835|atrial fibrillation|atrial fibrillation
1508353|NCT00744822|Lung Transplantation|lung transplantation
1508354|NCT00744822|Infections|infections
1508355|NCT00744822|Graft Rejection|graft rejection
1508356|NCT00744809|TMC278-C152|tmc278-c152
1508357|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
1508358|NCT00744809|Healthy Volunteers|healthy volunteers
1508359|NCT00744809|QT/QTc interval|qt/qtc interval
1508360|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
1508361|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
1508362|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
1508363|NCT00744770|TMC278-C121|tmc278-c121
1508364|NCT00744770|open-label|open-label
1508365|NCT00744770|drug-drug interaction|drug-drug interaction
1508366|NCT00744770|methadone|methadone
1508367|NCT00744770|TMC278|tmc278
1508368|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
1508369|NCT00744757|decitabine|decitabine
1508370|NCT00744757|dacogen|dacogen
1508371|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
1508372|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
1508373|NCT00744731|Partial-onset Seizures|partial-onset seizures
1508374|NCT00744731|Simple Partial Seizures|simple partial seizures
1508375|NCT00744731|Complex Partial Seizures|complex partial seizures
1508376|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
1508377|NCT00744705|Glaucoma|glaucoma
1508378|NCT00744705|Myopia|myopia
1508379|NCT00744692|Immunodeficiencies|immunodeficiencies
1508380|NCT00744692|Congenital Marrow Failures|congenital marrow failures
1508381|NCT00744692|Hemoglobinopathies|hemoglobinopathies
1508382|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
1508383|NCT00744692|SCIDS|scids
1508384|NCT00744692|Wiskott Aldrich|wiskott aldrich
1508385|NCT00744692|FEL|fel
1508386|NCT00744692|HLH|hlh
1508387|NCT00744692|IPEX|ipex
1508388|NCT00744692|LAD|lad
1508389|NCT00744692|Sickle Cell|sickle cell
1508390|NCT00744692|Thalassemia|thalassemia
1508391|NCT00744692|Omenn's Syndrome|omenn's syndrome
1508392|NCT00744692|Hurler's Syndrome|hurler's syndrome
1508393|NCT00744692|MLD|mld
1508394|NCT00744692|ALD|ald
1508395|NCT00744692|Sanfilippo|sanfilippo
1508396|NCT00744692|Krabbe|krabbe
1508397|NCT00744692|Hunter's syndrome|hunter's syndrome
1508398|NCT00744692|TaySachs|taysachs
1508399|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
1508400|NCT00744692|transplant|transplant
1508401|NCT00744692|MPS|mps
1508402|NCT00744692|Gaucher|gaucher
1508403|NCT00744679|MS|ms
1508404|NCT00744679|Multiple Sclerosis|multiple sclerosis
1508405|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
1508406|NCT00744666|Side-effects|side-effects
1508407|NCT00744666|Ocular hypertension|ocular hypertension
1508408|NCT00744666|Glaucoma|glaucoma
1508409|NCT00744666|Prevention|prevention
1508410|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
1508411|NCT00744653|Breast Cancer|breast cancer
1508412|NCT00744653|Recurrence|recurrence
1508413|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
1508414|NCT00744640|palliative chemotherapy|palliative chemotherapy
1508415|NCT00744640|first-line therapy|first-line therapy
1508416|NCT00744640|capecitabine|capecitabine
1508417|NCT00744640|oxaliplatin|oxaliplatin
1508418|NCT00744640|gemcitabine|gemcitabine
1508419|NCT00744640|dose-finding study|dose-finding study
1508420|NCT00744640|Phase II|phase ii
1508421|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
1508422|NCT00744627|Anxiety Disorders|anxiety disorders
1508423|NCT00744627|Drug Therapy|drug therapy
1508424|NCT00744614|PC02|pc02
1508425|NCT00744614|Respiratory Rate|respiratory rate
1508426|NCT00744614|Arterial blood gas|arterial blood gas
1508427|NCT00744614|Intubation|intubation
1508428|NCT00744614|Capnography|capnography
1508429|NCT00744601|impulsivity|impulsivity
1508430|NCT00744601|cocaine dependence|cocaine dependence
1508431|NCT00744601|relapse|relapse
1508432|NCT00744601|neuroimaging|neuroimaging
1508433|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1508434|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
1508435|NCT00744588|substance abuse|substance abuse
1508436|NCT00744588|alcohol dependence|alcohol dependence
1508437|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
1508438|NCT00744588|cosyntropin|cosyntropin
1508439|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
1508440|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
1508441|NCT00744588|stress|stress
1508442|NCT00744588|trauma|trauma
1508443|NCT00744588|neurosteroids|neurosteroids
1508444|NCT00744588|cortisol|cortisol
1508445|NCT00744588|relapse|relapse
1508446|NCT00744575|back pain|back pain
1508448|NCT00744575|chronic pain|chronic pain
1508449|NCT00744562|Phase 1,|phase 1,
1508450|NCT00744562|dose escalation,|dose escalation,
1508451|NCT00744562|histologically|histologically
1508452|NCT00744562|confirmed|confirmed
1508453|NCT00744562|malignancy|malignancy
1508454|NCT00744562|metastatic|metastatic
1508455|NCT00744549|Male Urogenital Diseases|male urogenital diseases
1508456|NCT00744549|Antioxidants|antioxidants
1508457|NCT00744549|Vitamin E|vitamin e
1508458|NCT00744549|Vitamin D|vitamin d
1508459|NCT00744549|Lycopene|lycopene
1508460|NCT00744549|Selenium|selenium
1508461|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
1508462|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1508463|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
1508464|NCT00744536|Angiogenesis|angiogenesis
1508465|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
1508466|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
1508467|NCT00744523|carotid artery stenting|carotid artery stenting
1508468|NCT00744523|stroke|stroke
1508469|NCT00744523|cerebral protection|cerebral protection
1508470|NCT00744523|high surgical risk|high surgical risk
1508471|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
1508472|NCT00744510|Reflexology|reflexology
1508473|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
1508474|NCT00744510|Endocrinopathy|endocrinopathy
1508475|NCT00744510|Oligo|oligo
1508476|NCT00744510|Amenorrhoea|amenorrhoea
1508477|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1508478|NCT00744484|COPD|copd
1508479|NCT00744484|Physical group training|physical group training
1508480|NCT00744484|Water exercise|water exercise
1508481|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
1508482|NCT00744484|Functional exercise capacity|functional exercise capacity
1508483|NCT00744484|Health related quality of life|health related quality of life
1567608|NCT00508703|Uterine Cancer|uterine cancer
1508484|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
1508485|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
1508486|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
1508487|NCT00744458|Patient Compliance|patient compliance
1508488|NCT00744458|Treatment adherence|treatment adherence
1508489|NCT00744445|hemodialysis|hemodialysis
1508490|NCT00744445|erythropoietin|erythropoietin
1508492|NCT00744419|pharmacokinetics|pharmacokinetics
1508493|NCT00744419|pantoprazole|pantoprazole
1508494|NCT00744419|neonates|neonates
1508495|NCT00744419|infants|infants
1508496|NCT00744406|recurrent depression|recurrent depression
1508497|NCT00744406|major depressive disorder|major depressive disorder
1508498|NCT00744406|interpersonal therapy|interpersonal therapy
1508499|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
1508500|NCT00744406|antidepressant treatment|antidepressant treatment
1508501|NCT00744406|outcome predictors|outcome predictors
1508502|NCT00744406|personality dimensions|personality dimensions
1508503|NCT00744393|sleep|sleep
1508504|NCT00744393|critically ill|critically ill
1508505|NCT00744393|mechanical ventilation|mechanical ventilation
1508506|NCT00744380|Analgesia|analgesia
1508507|NCT00744380|Mechanical ventilation|mechanical ventilation
1508508|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
1508509|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
1508510|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
1508511|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
1508512|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
1508513|NCT00744328|Postpartum depression|postpartum depression
1508514|NCT00744328|estradiol|estradiol
1508613|NCT00743990|URI|uri
1508515|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
1508516|NCT00744315|myocardial revascularization|myocardial revascularization
1508517|NCT00744315|myocardial ischemia|myocardial ischemia
1508518|NCT00744315|genetics, medical|genetics, medical
1508519|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
1508520|NCT00744302|Dialysate calcium|dialysate calcium
1508521|NCT00744302|Mineral metabolism|mineral metabolism
1508522|NCT00744302|Parathyroid hormone|parathyroid hormone
1508523|NCT00744302|Calcification|calcification
1508524|NCT00744302|Cardiovascular disease|cardiovascular disease
1508525|NCT00744302|Haemodialysis|haemodialysis
1508526|NCT00744289|Hepatitis B|hepatitis b
1508527|NCT00744289|People who inject drugs|people who inject drugs
1508528|NCT00744289|Financial incentive|financial incentive
1508529|NCT00744289|Vaccine completion|vaccine completion
1508530|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
1508531|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
1508532|NCT00744276|breast pain|breast pain
1508533|NCT00744276|mastalgia|mastalgia
1508534|NCT00744276|cyclic mastalgia|cyclic mastalgia
1508535|NCT00744276|cystic breast disease|cystic breast disease
1508536|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1508537|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
1508538|NCT00744250|Cystic fibrosis|cystic fibrosis
1508539|NCT00744250|Pancrelipase|pancrelipase
1508540|NCT00744250|Pancrecarb|pancrecarb
1508541|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
1508542|NCT00744250|Bioavailability|bioavailability
1508543|NCT00744237|nebivolol|nebivolol
1508544|NCT00744237|Bystolic ™|bystolic ™
1508545|NCT00744237|Hypertension|hypertension
1508546|NCT00744237|Diabetes|diabetes
1508547|NCT00744198|Autologous|autologous
1508548|NCT00744198|Biological|biological
1508549|NCT00744198|Mesh|mesh
1508550|NCT00744198|Polypropylene|polypropylene
1508551|NCT00744198|Sling|sling
1508552|NCT00744198|Synthetic|synthetic
1508553|NCT00744198|Stress incontinence|stress incontinence
1508554|NCT00744198|Surgery|surgery
1508555|NCT00744198|TOT|tot
1508556|NCT00744198|Treatment|treatment
1508557|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
1508558|NCT00744185|propranolol|propranolol
1508559|NCT00744185|ultrasonography|ultrasonography
1508560|NCT00744172|hysterectomy|hysterectomy
1508561|NCT00744172|vaginal|vaginal
1508562|NCT00744172|laparoscopy|laparoscopy
1508563|NCT00744172|abdominal|abdominal
1508564|NCT00744172|complication|complication
1508565|NCT00744172|quality of life|quality of life
1508566|NCT00744172|cost-effectiveness|cost-effectiveness
1508567|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
1508568|NCT00744159|colon cancer|colon cancer
1508569|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
1508570|NCT00744159|cellular immunity|cellular immunity
1508571|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
1508572|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
1508573|NCT00744120|cancer|cancer
1508574|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
1508575|NCT00744107|Single stent|single stent
1508576|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
1508577|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
1508578|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
1508579|NCT00744094|resistance training|resistance training
1508580|NCT00744094|protein supplementation|protein supplementation
1508581|NCT00744094|hypertrophy|hypertrophy
1508582|NCT00744068|Stimulant|stimulant
1508583|NCT00744068|Drug treatment|drug treatment
1508584|NCT00744068|Continuing care|continuing care
1508585|NCT00744068|Telephone support|telephone support
1508586|NCT00744068|Aftercare|aftercare
1508587|NCT00744055|alcohol dependence|alcohol dependence
1508588|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
1508589|NCT00744055|treatment|treatment
1508590|NCT00744055|prazosin|prazosin
1508591|NCT00744042|Hypophosphatasia|hypophosphatasia
1508592|NCT00744042|HPP|hpp
1508593|NCT00744042|Bone Disease|bone disease
1508594|NCT00744042|Soft Bones|soft bones
1508595|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
1508596|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
1508597|NCT00744042|alkaline phosphatase|alkaline phosphatase
1508598|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1508599|NCT00744042|rickets|rickets
1508600|NCT00744042|osteomalacia|osteomalacia
1508601|NCT00744029|prehospital delays|prehospital delays
1508602|NCT00744029|intervention|intervention
1508603|NCT00744029|population-based|population-based
1508604|NCT00744029|stroke|stroke
1508605|NCT00744016|UC|uc
1508606|NCT00744016|Ulcerative colitis|ulcerative colitis
1508607|NCT00744016|IBD|ibd
1508608|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
1508609|NCT00743990|Cough symptoms|cough symptoms
1508610|NCT00743990|Cold symptoms|cold symptoms
1508611|NCT00743990|Congestion|congestion
1508612|NCT00743990|Children|children
1508628|NCT00743912|midazolam|midazolam
1508629|NCT00743912|pharmacokinetics|pharmacokinetics
1508630|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1508631|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
1508632|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
1508633|NCT00743860|darapladib|darapladib
1508634|NCT00743860|pharmacokinetics|pharmacokinetics
1508635|NCT00743860|metabolite|metabolite
1508636|NCT00743860|SB-480848|sb-480848
1508637|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
1508638|NCT00743808|hypertension|hypertension
1508639|NCT00743808|diabetes|diabetes
1508640|NCT00743808|quality improvement|quality improvement
1508641|NCT00743808|blood pressure|blood pressure
1508642|NCT00743795|Hepatitis C|hepatitis c
1508643|NCT00743795|HCV|hcv
1508644|NCT00743795|Rapid Virologic Response|rapid virologic response
1508645|NCT00743795|Sustained Virologic Response|sustained virologic response
1508646|NCT00743795|HCV RNA|hcv rna
1508647|NCT00743795|Polymerase inhibitor|polymerase inhibitor
1508648|NCT00743795|GS-9190|gs-9190
1508649|NCT00743782|Hypoparathyroidism|hypoparathyroidism
1508650|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
1508651|NCT00743769|Myocardial Infarction|myocardial infarction
1508652|NCT00743769|Myocardial Ischemia|myocardial ischemia
1508653|NCT00743769|Myocardial Diseases|myocardial diseases
1508654|NCT00743769|Infarction|infarction
1508655|NCT00743756|obesity|obesity
1508656|NCT00743756|diabetes|diabetes
1508657|NCT00743756|endothelial function|endothelial function
1508658|NCT00743756|insulin sensitivity|insulin sensitivity
1508659|NCT00743743|dementia|dementia
1508660|NCT00743743|Alzheimer disease|alzheimer disease
1508661|NCT00743743|cognition|cognition
1508662|NCT00743743|function|function
1508663|NCT00743743|behavior|behavior
1508664|NCT00743743|treatment|treatment
1508680|NCT00743717|total knee arthroplasty|total knee arthroplasty
1508681|NCT00743717|osteoarthritis|osteoarthritis
1508682|NCT00743717|ceramic bearing|ceramic bearing
1508683|NCT00743717|zirconia|zirconia
1508684|NCT00743691|Ethiopia|ethiopia
1508685|NCT00743691|Community|community
1508686|NCT00743691|Community based|community based
1508687|NCT00743691|Health extension Worker|health extension worker
1508688|NCT00743691|Health Extension Program|health extension program
1508689|NCT00743678|Colorectal Cancer|colorectal cancer
1508690|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
1508691|NCT00743678|FOLFOX6|folfox6
1508692|NCT00743678|Cetuximab|cetuximab
1508693|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
1508694|NCT00743665|Youth|youth
1508695|NCT00743665|consensus|consensus
1508696|NCT00743665|criteria|criteria
1508697|NCT00743665|CVS|cvs
1508698|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
1508699|NCT00743652|Antibody Response|antibody response
1508700|NCT00743652|safety|safety
1508701|NCT00743652|Alaskan Native Children|alaskan native children
1508702|NCT00743639|Cardiomyopathy|cardiomyopathy
1508703|NCT00743639|stem cell|stem cell
1508704|NCT00743639|cardiac failure|cardiac failure
1508705|NCT00743626|Pap test|pap test
1508706|NCT00743626|HPV|hpv
1508707|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
1508708|NCT00743613|Erectile Dysfunction|erectile dysfunction
1508709|NCT00743613|ED|ed
1508710|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
1508711|NCT00743613|PAD|pad
1508712|NCT00743613|Ankle-Brachial Index|ankle-brachial index
1508713|NCT00743613|ABI|abi
1508714|NCT00743600|ultrasound|ultrasound
1508715|NCT00743600|rotator cuff|rotator cuff
1508716|NCT00743561|MSA|msa
1508717|NCT00743561|sleep apnea|sleep apnea
1508718|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
1508719|NCT00743561|polysomnography|polysomnography
1508720|NCT00743548|interdental self-care aids|interdental self-care aids
1508721|NCT00743548|plaque|plaque
1508722|NCT00743548|bleeding gums|bleeding gums
1508723|NCT00743535|Cystocele|cystocele
1508724|NCT00743535|Mesh|mesh
1508725|NCT00743535|Prolapse|prolapse
1508726|NCT00743535|Sling|sling
1508727|NCT00743535|Stress incontinence|stress incontinence
1508728|NCT00743535|Surgery|surgery
1508729|NCT00743535|TOT|tot
1508730|NCT00743535|TVT|tvt
1508731|NCT00743535|Treatment|treatment
1508732|NCT00743522|Reducing shocks|reducing shocks
1508733|NCT00743509|sarcoma|sarcoma
1508734|NCT00743509|Cyclophosphamide|cyclophosphamide
1508735|NCT00743509|Sirolimus|sirolimus
1508736|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
1508737|NCT00743483|cystic fibrosis|cystic fibrosis
1508738|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
1508739|NCT00743483|bucelipase alfa|bucelipase alfa
1508740|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
1508741|NCT00743483|BSSL|bssl
1508742|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
1508743|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
1508744|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
1508745|NCT00743457|vomiting|vomiting
1508746|NCT00743457|lethargy|lethargy
1508747|NCT00743457|VPS failure|vps failure
1508748|NCT00743444|GERD|gerd
1508749|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
1508750|NCT00743444|reflux|reflux
1508751|NCT00743405|schizophrenia|schizophrenia
1508752|NCT00743405|M1 receptor agonist|m1 receptor agonist
1508753|NCT00743405|safety|safety
1508754|NCT00743405|pharmacokinetics|pharmacokinetics
1508755|NCT00743405|GSK1034702|gsk1034702
1508756|NCT00743379|Phase 1/2|phase 1/2
1508757|NCT00743379|Advanced Solid Tumors|advanced solid tumors
1508758|NCT00743379|Hypoxia|hypoxia
1508759|NCT00743379|Prodrug|prodrug
1508760|NCT00743379|Dose-Escalation|dose-escalation
1508761|NCT00743379|Evofosfamide|evofosfamide
1508762|NCT00743366|quetiapine|quetiapine
1508763|NCT00743366|smoked marijuana|smoked marijuana
1508764|NCT00743366|marijuana use|marijuana use
1508765|NCT00743353|laryngeal|laryngeal
1508766|NCT00743353|squamous cell|squamous cell
1508767|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
1508768|NCT00743353|oligodendroglioma|oligodendroglioma
1508769|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
1508770|NCT00743340|HIV-1 infection|hiv-1 infection
1508771|NCT00743340|emtricitabine|emtricitabine
1508772|NCT00743340|pediatrics|pediatrics
1508773|NCT00743340|pediatric patients|pediatric patients
1508774|NCT00743327|hormone therapy|hormone therapy
1508775|NCT00743314|lymphedema|lymphedema
1508776|NCT00743314|stage I breast cancer|stage i breast cancer
1508777|NCT00743314|stage II breast cancer|stage ii breast cancer
1508778|NCT00743301|CVD|cvd
1508779|NCT00743301|Palm olein|palm olein
1508780|NCT00743301|Olive oil|olive oil
1508781|NCT00743301|Lard|lard
1508782|NCT00743301|healthy men|healthy men
1508783|NCT00743301|metabolic syndrome|metabolic syndrome
1508784|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
1508785|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
1508786|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
1508787|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
1508788|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
1508789|NCT00743275|Influenza|influenza
1508790|NCT00743262|laryngectomy|laryngectomy
1508791|NCT00743262|larynx cancer|larynx cancer
1508792|NCT00743249|Dry eye|dry eye
1508793|NCT00743249|Tear duct|tear duct
1508794|NCT00743249|Punctal plug|punctal plug
1508795|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
1508796|NCT00743236|urinary complications|urinary complications
1508797|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1508798|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
1508799|NCT00743223|temporomandibular disorder|temporomandibular disorder
1508800|NCT00743223|orofacial pain|orofacial pain
1508801|NCT00743223|posture of the head|posture of the head
1508802|NCT00743210|pregnancy|pregnancy
1508803|NCT00743210|obesity|obesity
1508804|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
1508805|NCT00743210|L-arginine|l-arginine
1508806|NCT00743210|L-citrulline|l-citrulline
1508807|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
1508808|NCT00743197|chest pain|chest pain
1508809|NCT00743197|myocardial ischemia|myocardial ischemia
1508810|NCT00743197|endothelial function|endothelial function
1508811|NCT00743184|BPH|bph
1508812|NCT00743184|LUTS|luts
1508813|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
1508814|NCT00743171|Lung transplantation|lung transplantation
1508815|NCT00743171|Home spirometry|home spirometry
1508816|NCT00743171|non-adherence|non-adherence
1508817|NCT00743171|outcomes|outcomes
1508818|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
1508819|NCT00743158|ztr|ztr
1508820|NCT00743158|transfer impedance|transfer impedance
1508821|NCT00743158|cystic fibrosis|cystic fibrosis
1508822|NCT00743158|pulmonary function test|pulmonary function test
1508823|NCT00743158|pft|pft
1508824|NCT00743145|naltrexone|naltrexone
1508825|NCT00743145|smoked marijuana|smoked marijuana
1508826|NCT00743145|marijuana use|marijuana use
1508827|NCT00743132|evaluation|evaluation
1508828|NCT00743132|incidence|incidence
1508829|NCT00743132|liver surgery|liver surgery
1508830|NCT00743132|resection|resection
1508831|NCT00743132|impact|impact
1508832|NCT00743132|postoperative|postoperative
1508833|NCT00743132|mortality|mortality
1508834|NCT00743119|oral thc|oral thc
1508835|NCT00743119|cannabis|cannabis
1508836|NCT00743119|pain|pain
1508837|NCT00743119|analgesic effects|analgesic effects
1508838|NCT00743119|dronabinol|dronabinol
1508839|NCT00743106|nephrectomy|nephrectomy
1508840|NCT00743106|fenoldopam|fenoldopam
1508841|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
1508842|NCT00743093|acetaminophen|acetaminophen
1508843|NCT00743093|protein adducts|protein adducts
1508844|NCT00743093|drug safety|drug safety
1508845|NCT00743093|alanine aminotransferase|alanine aminotransferase
1508846|NCT00743093|Alanine Amino Transferase|alanine amino transferase
1508847|NCT00743080|laparoscopy|laparoscopy
1508848|NCT00743080|myomectomy|myomectomy
1508849|NCT00743080|myomas|myomas
1508850|NCT00743080|morcellator|morcellator
1508851|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
1508852|NCT00743080|surgery|surgery
1508853|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
1508854|NCT00743067|XL880|xl880
1508855|NCT00743067|MET inhibitor|met inhibitor
1508856|NCT00743067|GSK1363089|gsk1363089
1508857|NCT00743067|Solid Tumors|solid tumors
1508858|NCT00743067|c-Met|c-met
1508859|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
1508860|NCT00743054|MicroRNAs|micrornas
1508861|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
1508862|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
1508863|NCT00743002|TT223|tt223
1508864|NCT00742989|osteopathic|osteopathic
1508865|NCT00742989|lymphatic|lymphatic
1508866|NCT00742989|treatment|treatment
1508867|NCT00742989|OLT|olt
1508868|NCT00742989|normal|normal
1508869|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
1508870|NCT00742976|extracellular volume|extracellular volume
1508871|NCT00742976|insulin treatment|insulin treatment
1508872|NCT00742976|sodium retention|sodium retention
1508873|NCT00742963|TH-302|th-302
1508874|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
1508875|NCT00742963|Doxorubicin|doxorubicin
1508876|NCT00742963|Phase 1/2|phase 1/2
1508877|NCT00742950|Corneal incision|corneal incision
1508878|NCT00742950|Cataract surgery|cataract surgery
1508879|NCT00742950|Phacoemulsification|phacoemulsification
1508880|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
1508881|NCT00742950|Corneal Topography|corneal topography
1508882|NCT00742937|Hypovitaminosis A|hypovitaminosis a
1508883|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
1508884|NCT00742911|Solid Tumors, Liver|solid tumors, liver
1508885|NCT00742898|Quasi-experimental design|quasi-experimental design
1508886|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
1508887|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
1508888|NCT00742898|Emergency department|emergency department
1508889|NCT00742898|Effectiveness|effectiveness
1508890|NCT00742898|Efficiency|efficiency
1508891|NCT00742898|Health services research|health services research
1508892|NCT00742898|Program evaluation|program evaluation
1508893|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
1508894|NCT00742885|Immunogenicity|immunogenicity
1508895|NCT00742885|Safety|safety
1508896|NCT00742885|Pandemic Influenza|pandemic influenza
1508897|NCT00742872|Mosapride|mosapride
1508898|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
1508899|NCT00742872|Constipation|constipation
1508900|NCT00742859|Atrial Fibrillation|atrial fibrillation
1508901|NCT00742859|Betrixaban|betrixaban
1508902|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
1508903|NCT00742859|Warfarin|warfarin
1508904|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
1508905|NCT00742846|Subacromial injection|subacromial injection
1508906|NCT00742846|Intraarticular injection|intraarticular injection
1508907|NCT00742833|Overactive bladder|overactive bladder
1508908|NCT00742833|Frequency|frequency
1508909|NCT00742833|Micturition|micturition
1508910|NCT00742833|Urgency|urgency
1508911|NCT00742833|Urge urinary incontinence|urge urinary incontinence
1508912|NCT00742833|β3-agonist|β3-agonist
1508913|NCT00742820|bioequivalence|bioequivalence
1508914|NCT00742807|sensation|sensation
1508915|NCT00742807|relief|relief
1508916|NCT00742807|during|during
1508917|NCT00742807|surgery|surgery
1508918|NCT00742781|Crohn's|crohn's
1508919|NCT00742781|vitamin D|vitamin d
1508920|NCT00742768|absorption|absorption
1508921|NCT00742768|encapsulation|encapsulation
1508922|NCT00742768|menaquinone|menaquinone
1508923|NCT00742768|Bio-availability|bio-availability
1508924|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
1508925|NCT00742755|Korean American immigrants|korean american immigrants
1508926|NCT00742742|Walnut|walnut
1508927|NCT00742742|Lipids|lipids
1508928|NCT00742742|Blood Glucose|blood glucose
1508929|NCT00742729|Colorectal cancer screening|colorectal cancer screening
1508930|NCT00742729|Fecal occult blood test|fecal occult blood test
1508931|NCT00742729|Endoscopies|endoscopies
1508932|NCT00742729|Filipino American immigrants|filipino american immigrants
1508933|NCT00742729|Community based organizations and churches|community based organizations and churches
1508934|NCT00742716|Parathyroid Diseases|parathyroid diseases
1508935|NCT00742716|Renal Insufficiency|renal insufficiency
1508936|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
1508937|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1508938|NCT00742716|Vitamin D|vitamin d
1508939|NCT00742716|Hyperparathyroidism|hyperparathyroidism
1508940|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
1508941|NCT00742716|Kidney Diseases|kidney diseases
1508942|NCT00742716|Kidney Failure|kidney failure
1508943|NCT00742690|cirrhosis|cirrhosis
1508944|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
1508945|NCT00742690|terlipressin|terlipressin
1508946|NCT00742690|albumin|albumin
1508947|NCT00742690|effective circulating volume|effective circulating volume
1508948|NCT00742690|Patients|patients
1508949|NCT00742690|with|with
1508950|NCT00742677|female reproductive cancer|female reproductive cancer
1508951|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
1508952|NCT00742664|Compulsive behavior|compulsive behavior
1508953|NCT00742664|Hoarding|hoarding
1508954|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
1508955|NCT00742664|Children|children
1508956|NCT00742664|Treatment|treatment
1508957|NCT00742664|genetically|genetically
1508958|NCT00742664|confirmed|confirmed
1508959|NCT00742664|diagnosis|diagnosis
1508960|NCT00742638|CCMD-3,|ccmd-3,
1508961|NCT00742638|CRF,|crf,
1508962|NCT00742638|EPS,|eps,
1508963|NCT00742638|GCP,|gcp,
1508964|NCT00742638|ICH,|ich,
1508965|NCT00742638|ITT,|itt,
1508966|NCT00742638|LOCF,|locf,
1508967|NCT00742638|MADRS,|madrs,
1508968|NCT00742638|PANSS,|panss,
1508969|NCT00742638|YMRS.|ymrs.
1508970|NCT00742638|Acute|acute
1508971|NCT00742638|manic|manic
1508972|NCT00742638|patients|patients
1508973|NCT00742638|with|with
1508974|NCT00742638|bipolar|bipolar
1508975|NCT00742638|disorder|disorder
1508976|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
1508977|NCT00742612|von Willebrand Factor|von willebrand factor
1508978|NCT00742612|Microembolic Signal|microembolic signal
1508979|NCT00742599|Stomach Diseases|stomach diseases
1508980|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
1508981|NCT00742586|RNA|rna
1508982|NCT00742586|Pure Autonomic Failure|pure autonomic failure
1508983|NCT00742586|Multiply System Atrophy|multiply system atrophy
1508984|NCT00742586|Parkinson's Plus|parkinson's plus
1508985|NCT00742573|Major Depressive Disorder|major depressive disorder
1508986|NCT00742573|Mood Disorders|mood disorders
1508987|NCT00742573|Hispanic|hispanic
1508988|NCT00742560|Multiple Myeloma|multiple myeloma
1508989|NCT00742547|prevention|prevention
1508990|NCT00742547|health services research|health services research
1508991|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1508992|NCT00742534|Prematurity|prematurity
1508993|NCT00742534|Lung Disease|lung disease
1508994|NCT00742534|preterm infants|preterm infants
1508995|NCT00742521|cortisol|cortisol
1508996|NCT00742521|catecholamines|catecholamines
1508997|NCT00742521|Type 1 DM|type 1 dm
1508998|NCT00742508|carvedilol phosphate|carvedilol phosphate
1508999|NCT00742508|ß-blocker|ß-blocker
1509000|NCT00742508|SK&F-105517-D|sk&f-105517-d
1509001|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
1509002|NCT00742469|TD|td
1509003|NCT00742469|traveller's diarrhea|traveller's diarrhea
1509004|NCT00742469|campylobacter|campylobacter
1509005|NCT00742469|shigella|shigella
1509006|NCT00742469|salmonella|salmonella
1509007|NCT00742469|E. coli|e. coli
1509008|NCT00742469|diarrhea|diarrhea
1509009|NCT00742456|Microcirculation|microcirculation
1509010|NCT00742456|Insulin|insulin
1509011|NCT00742456|Hypertension|hypertension
1509012|NCT00742456|Obesity|obesity
1509013|NCT00742443|Scar Revision|scar revision
1509014|NCT00742430|aspirin resistance|aspirin resistance
1509015|NCT00742430|coronary artery disease|coronary artery disease
1509016|NCT00742430|clopidogrel resistance|clopidogrel resistance
1509017|NCT00742430|major adverse cardiac events|major adverse cardiac events
1509116|NCT00742144|GSK1841157|gsk1841157
1509018|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
1509019|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
1509020|NCT00742417|Alzheimer's|alzheimer's
1509021|NCT00742417|Dementia|dementia
1509022|NCT00742417|Senile|senile
1509023|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
1509024|NCT00742417|Old age|old age
1509025|NCT00742417|Elderly|elderly
1509026|NCT00742417|Aging|aging
1509027|NCT00742417|Albumin|albumin
1509028|NCT00742417|Caregiver|caregiver
1509029|NCT00742417|amyloid|amyloid
1509030|NCT00742417|beta amyloid|beta amyloid
1509031|NCT00742417|Central Nervous System Diseases|central nervous system diseases
1509032|NCT00742417|Brain Disease|brain disease
1509033|NCT00742417|Mental Disorders|mental disorders
1509034|NCT00742417|Plasma Exchange|plasma exchange
1509035|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
1509036|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
1509037|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
1509038|NCT00742391|Peplin|peplin
1509039|NCT00742391|Actinic keratosis|actinic keratosis
1509040|NCT00742391|PEP005|pep005
1509041|NCT00742378|Glaucoma|glaucoma
1509042|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
1509043|NCT00742378|Cirrus OCT|cirrus oct
1509044|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
1509045|NCT00742365|Light Therapy|light therapy
1509046|NCT00742365|Seasonal Depression|seasonal depression
1509047|NCT00742365|Psychiatric Disorder|psychiatric disorder
1509048|NCT00742365|Bright Light|bright light
1509049|NCT00742365|Major Depressive Disorder|major depressive disorder
1509050|NCT00742365|Bipolar Disorder|bipolar disorder
1509051|NCT00742339|cirrhosis|cirrhosis
1509052|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
1509053|NCT00742339|terlipressin|terlipressin
1509054|NCT00742339|midodrine|midodrine
1509055|NCT00742339|octreotide|octreotide
1509056|NCT00742339|human albumin|human albumin
1509057|NCT00742339|effective circulating volume|effective circulating volume
1509058|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
1509059|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
1509060|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
1509062|NCT00742326|Hepatitis C|hepatitis c
1509063|NCT00742326|Liver Disease|liver disease
1509064|NCT00742326|Fatty Liver|fatty liver
1509065|NCT00742326|Steatosis|steatosis
1509066|NCT00742313|Endoscopic|endoscopic
1509067|NCT00742313|saphenous|saphenous
1509068|NCT00742313|vein|vein
1509069|NCT00742313|harvest|harvest
1509070|NCT00742300|ASCT|asct
1509071|NCT00742300|Tolerance induction|tolerance induction
1509072|NCT00742300|SLE|sle
1509073|NCT00742300|Transplantation|transplantation
1509074|NCT00742300|Autoimmune diseases|autoimmune diseases
1509075|NCT00742287|smoking|smoking
1509076|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
1509077|NCT00742287|polyphenols|polyphenols
1509078|NCT00742287|supplementation|supplementation
1509079|NCT00742287|vascular function|vascular function
1509080|NCT00742287|oxidative stress|oxidative stress
1509081|NCT00742287|inflammation|inflammation
1509082|NCT00742261|Pharmacokinetics|pharmacokinetics
1509083|NCT00742261|Safety|safety
1509084|NCT00742261|MET|met
1509085|NCT00742261|Bioavailability|bioavailability
1509086|NCT00742261|Patients|patients
1509087|NCT00742261|GSK1363089A|gsk1363089a
1509088|NCT00742261|GSK1363089G|gsk1363089g
1509089|NCT00742261|GSK1363089|gsk1363089
1509090|NCT00742261|Relative|relative
1509091|NCT00742248|COPD|copd
1509092|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
1509093|NCT00742222|Multi-society registry|multi-society registry
1509094|NCT00742222|Breast cancer registry|breast cancer registry
1509095|NCT00742209|migraine|migraine
1509096|NCT00742209|prophylaxis|prophylaxis
1509097|NCT00742209|prevention|prevention
1509098|NCT00742196|Parapapillary atrophy|parapapillary atrophy
1509099|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
1509100|NCT00742196|Glaucoma|glaucoma
1509101|NCT00742196|Cirrus OCT|cirrus oct
1509102|NCT00742170|opioid dependence|opioid dependence
1509103|NCT00742170|opioid detoxification|opioid detoxification
1509104|NCT00742170|electroacupuncture|electroacupuncture
1509105|NCT00742170|adjunctive treatment|adjunctive treatment
1509106|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
1509107|NCT00742157|Growth Hormone|growth hormone
1509108|NCT00742157|TPN|tpn
1509109|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
1509110|NCT00742157|Glutamine|glutamine
1509111|NCT00742157|Short Bowel Syndrome|short bowel syndrome
1509112|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
1509113|NCT00742144|CD20 positive|cd20 positive
1509114|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1509115|NCT00742144|Follicular lymphoma|follicular lymphoma
1509117|NCT00742144|Japanese patient|japanese patient
1509118|NCT00742144|Ofatumumab|ofatumumab
1509119|NCT00742131|MET inhibitor|met inhibitor
1509120|NCT00742131|c-Met|c-met
1509121|NCT00742131|XL880|xl880
1509122|NCT00742131|GSK1363089|gsk1363089
1509123|NCT00742131|Solid Tumors|solid tumors
1509124|NCT00742105|PI3K|pi3k
1509125|NCT00742105|mTOR|mtor
1509126|NCT00742105|Advanced solid tumor|advanced solid tumor
1509127|NCT00742105|Adult|adult
1509128|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
1509129|NCT00742079|Paranoid Delusions|paranoid delusions
1509130|NCT00742079|CBT|cbt
1509131|NCT00742079|D-Cycloserine|d-cycloserine
1509132|NCT00742066|Hypertension|hypertension
1509133|NCT00742066|Insulin resistance|insulin resistance
1509134|NCT00742066|Microcirculation|microcirculation
1509135|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
1509136|NCT00742053|ECG PICC|ecg picc
1509137|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
1509138|NCT00742040|up-titration|up-titration
1509139|NCT00742040|captopril|captopril
1509140|NCT00742040|pediatric|pediatric
1509141|NCT00742040|cardiac patients|cardiac patients
1509142|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
1509143|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
1509144|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
1509145|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
1509146|NCT00742027|Nodular sclerosing|nodular sclerosing
1509147|NCT00742027|Mixed-cellularity|mixed-cellularity
1509148|NCT00742027|Lymphocyte-rich|lymphocyte-rich
1509149|NCT00742027|Lymphocyte depleted|lymphocyte depleted
1509150|NCT00742027|HL|hl
1509151|NCT00742027|Classical HL|classical hl
1509152|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
1509153|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
1509154|NCT00742027|Refractory HL|refractory hl
1509155|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
1509156|NCT00742014|Pediatrics|pediatrics
1509157|NCT00742014|Sildenafil|sildenafil
1509158|NCT00742014|Catheterization|catheterization
1509159|NCT00742014|Right ventricular contractility|right ventricular contractility
1509160|NCT00742001|red blood cells|red blood cells
1509161|NCT00742001|transfusion|transfusion
1509162|NCT00742001|recovery|recovery
1509163|NCT00742001|feasibility|feasibility
1509164|NCT00742001|white blood cell inactivation|white blood cell inactivation
1509165|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
1509166|NCT00741988|Advanced Disease|advanced disease
1509167|NCT00741988|Untreated|untreated
1509168|NCT00741988|Ixabepilone|ixabepilone
1509169|NCT00741988|Carboplatin|carboplatin
1509170|NCT00741988|Bevacizumab|bevacizumab
1509171|NCT00741975|HIV prevention|hiv prevention
1509172|NCT00741949|Respiratory failure|respiratory failure
1509173|NCT00741949|Target Controlled Infusion|target controlled infusion
1509174|NCT00741949|TCI|tci
1509175|NCT00741949|Propofol|propofol
1509176|NCT00741949|Noninvasive ventilation|noninvasive ventilation
1509177|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
1509178|NCT00741936|Functional Constipation|functional constipation
1509179|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
1509180|NCT00741936|MaZiRenWan|mazirenwan
1509181|NCT00741936|Hemp Seed Pill|hemp seed pill
1509182|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
1509183|NCT00741936|Herbal Medicine|herbal medicine
1509184|NCT00741923|beans|beans
1509185|NCT00741923|pulses|pulses
1509186|NCT00741923|satiety|satiety
1509187|NCT00741923|appetite|appetite
1509188|NCT00741923|obesity|obesity
1509189|NCT00741923|overweight|overweight
1509190|NCT00741923|diabetes|diabetes
1509191|NCT00741923|metabolic syndrome|metabolic syndrome
1509192|NCT00741923|hypertension|hypertension
1509193|NCT00741923|blood glucose|blood glucose
1509194|NCT00741923|insulin|insulin
1509195|NCT00741923|cholesterol|cholesterol
1509196|NCT00741923|HDL|hdl
1509197|NCT00741923|LDL|ldl
1509198|NCT00741923|leptin|leptin
1509199|NCT00741923|GLP-1|glp-1
1509200|NCT00741923|adiponectin|adiponectin
1509201|NCT00741923|Peptide YY|peptide yy
1509202|NCT00741923|diet|diet
1509203|NCT00741910|Crohn's Disease|crohn's disease
1509204|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
1509205|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
1509206|NCT00741910|CNI-1493|cni-1493
1509207|NCT00741871|Lymphoid malignancies|lymphoid malignancies
1509208|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
1509309|NCT00741546|Vitamin D|vitamin d
1509209|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1509210|NCT00741858|Chiari malformation;|chiari malformation;
1509211|NCT00741858|Duraplasty;|duraplasty;
1509212|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
1509213|NCT00741858|Duragen;|duragen;
1509214|NCT00741858|Duraguard|duraguard
1509215|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1509216|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
1509218|NCT00741832|recovery|recovery
1509219|NCT00741832|positive expiratory pressure|positive expiratory pressure
1509220|NCT00741832|exercise|exercise
1509221|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
1509222|NCT00741819|PAH|pah
1509223|NCT00741819|treprostinil sodium|treprostinil sodium
1509224|NCT00741819|inhalation|inhalation
1509225|NCT00741819|ventavis|ventavis
1509226|NCT00741819|iloprost|iloprost
1509227|NCT00741806|vaccination|vaccination
1509228|NCT00741806|avian|avian
1509229|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
1509230|NCT00741793|Remicade®|remicade®
1509231|NCT00741793|Simponi®|simponi®
1509232|NCT00741793|Simponi® I.V|simponi® i.v
1509233|NCT00741793|Stelara®|stelara®
1509234|NCT00741793|Registry|registry
1509235|NCT00741793|BioTRAC|biotrac
1509236|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1509237|NCT00741767|COPD|copd
1509238|NCT00741767|Sleep|sleep
1509239|NCT00741767|Sleep quality|sleep quality
1509240|NCT00741767|Lung hyperinflation|lung hyperinflation
1509241|NCT00741754|salivary flow|salivary flow
1509242|NCT00741754|oral neoplasm|oral neoplasm
1509243|NCT00741754|calcium hydroxide|calcium hydroxide
1509244|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
1509245|NCT00741754|radiotherapy.|radiotherapy.
1509246|NCT00741741|TMC278-C150|tmc278-c150
1509247|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
1509248|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
1509249|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
1509250|NCT00741741|Nanosuspension|nanosuspension
1509251|NCT00741741|Therapy|therapy
1509252|NCT00741741|Prevention|prevention
1509253|NCT00741741|Healthy volunteers|healthy volunteers
1509254|NCT00741741|HIV Infections|hiv infections
1509255|NCT00741728|epidemiology|epidemiology
1509256|NCT00741728|risk factors|risk factors
1509257|NCT00741728|heart rate|heart rate
1509258|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
1509259|NCT00741728|sudden death|sudden death
1509260|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
1509261|NCT00741702|Hypertension|hypertension
1509262|NCT00741702|Type 2 diabetes|type 2 diabetes
1509263|NCT00741702|First Nations populations|first nations populations
1509264|NCT00741689|Japanese|japanese
1509265|NCT00741689|healthy|healthy
1509266|NCT00741689|volunteers|volunteers
1509267|NCT00741663|cirrhosis|cirrhosis
1509268|NCT00741663|ascites|ascites
1509269|NCT00741663|diuretic therapy|diuretic therapy
1509270|NCT00741663|potassium canrenoate|potassium canrenoate
1509271|NCT00741663|furosemide|furosemide
1509272|NCT00741663|hyperkalemia|hyperkalemia
1509273|NCT00741663|plasma renin activity|plasma renin activity
1509274|NCT00741663|nitric oxide|nitric oxide
1509275|NCT00741663|serum sodium concentration|serum sodium concentration
1509276|NCT00741663|refractory ascites|refractory ascites
1509277|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
1509278|NCT00741650|Musculoskeletal pain|musculoskeletal pain
1509279|NCT00741650|Brief cognitive intervention|brief cognitive intervention
1509280|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
1509281|NCT00741650|Intervention Study|intervention study
1509282|NCT00741650|Health prevention|health prevention
1509283|NCT00741650|workplace intervention|workplace intervention
1509284|NCT00741637|Vibrio Cholerae|vibrio cholerae
1509285|NCT00741637|Diarrhea|diarrhea
1509286|NCT00741637|Live oral Vaccines|live oral vaccines
1509287|NCT00741637|Immunogenicity|immunogenicity
1509288|NCT00741637|Safety|safety
1509289|NCT00741637|HIV|hiv
1509290|NCT00741624|refractive surgery|refractive surgery
1509291|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1509292|NCT00741585|Chronotherapy|chronotherapy
1509293|NCT00741585|Circadian|circadian
1509294|NCT00741585|Non-dipper|non-dipper
1509295|NCT00741585|Type 2 diabetes|type 2 diabetes
1509296|NCT00741585|Resistant hypertension|resistant hypertension
1509297|NCT00741585|Total mortality|total mortality
1509298|NCT00741572|sarcoidosis|sarcoidosis
1509299|NCT00741572|fibrosis|fibrosis
1509300|NCT00741572|oxidative stress|oxidative stress
1509301|NCT00741572|inflammation|inflammation
1509302|NCT00741572|triggers|triggers
1509303|NCT00741572|individual sensitivity|individual sensitivity
1509304|NCT00741559|epilepsy|epilepsy
1509305|NCT00741559|pediatrics|pediatrics
1509306|NCT00741559|magnetoencephalography|magnetoencephalography
1509307|NCT00741559|electroencephalography|electroencephalography
1509308|NCT00741559|positron emission tomography|positron emission tomography
1509310|NCT00741546|malnutrition|malnutrition
1509311|NCT00741546|cardiac surgery|cardiac surgery
1509312|NCT00741546|study|study
1509313|NCT00741546|emphasize|emphasize
1509314|NCT00741546|importance|importance
1509315|NCT00741546|significant|significant
1509316|NCT00741546|high risk patient|high risk patient
1509317|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
1509318|NCT00741520|Blood Pressure|blood pressure
1509319|NCT00741520|PreHypertension|prehypertension
1509320|NCT00741520|Masked Hypertension|masked hypertension
1509321|NCT00741507|Anesthetics|anesthetics
1509322|NCT00741507|Sedatives|sedatives
1509323|NCT00741507|Analgesics|analgesics
1509324|NCT00741494|infertility|infertility
1509326|NCT00741494|hyaluronan binding|hyaluronan binding
1509327|NCT00741494|sperm|sperm
1509328|NCT00741494|sperm selection|sperm selection
1509329|NCT00741494|male factor|male factor
1509330|NCT00741494|hyaluronan|hyaluronan
1509331|NCT00741494|sperm maturity|sperm maturity
1509332|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
1509333|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
1509334|NCT00741494|HBA|hba
1509335|NCT00741494|PICSI|picsi
1509336|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
1509337|NCT00741481|fdg pet|fdg pet
1509338|NCT00741481|response evaluation|response evaluation
1509339|NCT00741468|Drug-drug interactions|drug-drug interactions
1509340|NCT00741468|DDI|ddi
1509341|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
1509342|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1509343|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
1509344|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1509345|NCT00741455|Multiple Myeloma|multiple myeloma
1509346|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1509347|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
1509348|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1509349|NCT00741455|Hodgkin's Disease|hodgkin's disease
1509350|NCT00741416|Heart Disease|heart disease
1509351|NCT00741416|Biorepository|biorepository
1509352|NCT00741416|Biobank|biobank
1509353|NCT00741403|Phase I|phase i
1509354|NCT00741403|malignancies|malignancies
1509355|NCT00741403|refractory|refractory
1509356|NCT00741403|relapsed|relapsed
1509357|NCT00741390|Diabetes|diabetes
1509358|NCT00741390|Lancets|lancets
1509359|NCT00741390|Pain|pain
1509360|NCT00741377|Multiple myeloma|multiple myeloma
1509361|NCT00741377|bone disease|bone disease
1509362|NCT00741377|antibody|antibody
1509363|NCT00741364|vitamin D|vitamin d
1509364|NCT00741364|prostate cancer|prostate cancer
1509365|NCT00741364|prostatectomy|prostatectomy
1509366|NCT00741364|pathology|pathology
1509367|NCT00741364|immunohistochemistry|immunohistochemistry
1509368|NCT00741351|Anesthesia|anesthesia
1509369|NCT00741351|Craniotomy|craniotomy
1509370|NCT00741351|Neurosurgery|neurosurgery
1509371|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
1509372|NCT00741312|pregnancy|pregnancy
1509373|NCT00741312|preeclampsia|preeclampsia
1509374|NCT00741312|exercise|exercise
1509375|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
1509376|NCT00741286|Cerebral infarction|cerebral infarction
1509377|NCT00741286|Cilostazol|cilostazol
1509378|NCT00741286|Aspirin|aspirin
1509379|NCT00741286|Transcranial Doppler|transcranial doppler
1509380|NCT00741286|Pulsatile Index|pulsatile index
1509381|NCT00741260|Solid Tumor|solid tumor
1509382|NCT00741260|erbB2+ Breast Cancer|erbb2+ breast cancer
1509383|NCT00741260|Prior trastuzumab|prior trastuzumab
1509384|NCT00741260|Metastatic|metastatic
1509385|NCT00741260|Neratinib|neratinib
1509386|NCT00741260|HKI-272|hki-272
1509387|NCT00741260|Nerlynx|nerlynx
1509388|NCT00741260|HER2|her2
1509389|NCT00741260|PB-272|pb-272
1509390|NCT00741247|staging|staging
1509391|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
1509392|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
1509393|NCT00741234|SB939|sb939
1509394|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
1509395|NCT00741234|Combination with azacitidine|combination with azacitidine
1509396|NCT00741234|Solid malignancies|solid malignancies
1509397|NCT00741234|Hematologic malignancies|hematologic malignancies
1509398|NCT00741234|HDAC inhibitor|hdac inhibitor
1509399|NCT00741234|Refractory to standard therapy|refractory to standard therapy
1509400|NCT00741221|Cancer|cancer
1509401|NCT00741221|NSCLC|nsclc
1509402|NCT00741221|Docetaxel|docetaxel
1509403|NCT00741221|Bevacizumab|bevacizumab
1509404|NCT00741208|asthma|asthma
1509405|NCT00741208|soy isoflavone|soy isoflavone
1509406|NCT00741208|genistein|genistein
1509407|NCT00741208|soy|soy
1509408|NCT00741195|Cancer|cancer
1509409|NCT00741195|NSCLC|nsclc
1509410|NCT00741195|Docetaxel|docetaxel
1509411|NCT00741195|Bevacizumab|bevacizumab
1509412|NCT00741182|Fracture|fracture
1509413|NCT00741182|Osteoporosis|osteoporosis
1509414|NCT00741182|Forsteo|forsteo
1509415|NCT00741182|Teriparatide|teriparatide
1509416|NCT00741182|Fracture healing|fracture healing
1509417|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
1509418|NCT00741169|TMC435350-C105|tmc435350-c105
1509419|NCT00741169|Hepatitis C|hepatitis c
1509420|NCT00741169|HCV|hcv
1509421|NCT00741169|Rifampin|rifampin
1509422|NCT00741156|pediatric|pediatric
1509423|NCT00741156|hypertension|hypertension
1509424|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
1509425|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
1509426|NCT00741156|cardiac catheterization|cardiac catheterization
1509427|NCT00741143|Food Fortification|food fortification
1509428|NCT00741143|Iron deficiency|iron deficiency
1509429|NCT00741143|NaFeEdta|nafeedta
1509430|NCT00741143|Iron deficiency anemia|iron deficiency anemia
1509431|NCT00741143|Cognition|cognition
1509432|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
1509433|NCT00741130|optic nerve head|optic nerve head
1509434|NCT00741130|Cirrus OCT|cirrus oct
1509435|NCT00741117|Pulse Oximetry|pulse oximetry
1509436|NCT00741117|Blood Gas Analysis|blood gas analysis
1509437|NCT00741117|Liver Disease|liver disease
1509438|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
1509439|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
1509440|NCT00741091|Carotid Stent|carotid stent
1509442|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
1509443|NCT00741078|endothelial|endothelial
1509444|NCT00741078|function|function
1509445|NCT00741078|insulin|insulin
1509446|NCT00741078|sensitivity|sensitivity
1509447|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1509448|NCT00741065|Myocardial Regeneration|myocardial regeneration
1509449|NCT00741052|V. cholerae,|v. cholerae,
1509450|NCT00741052|ciprofloxacin,|ciprofloxacin,
1509451|NCT00741052|azithromycin,|azithromycin,
1509452|NCT00741052|randomized|randomized
1509453|NCT00741039|Breast|breast
1509454|NCT00741039|Lung|lung
1509455|NCT00741039|Prostate|prostate
1509456|NCT00741039|Vaccine|vaccine
1509457|NCT00741026|Insulin Resistance|insulin resistance
1509458|NCT00741026|Diabetes mellitus|diabetes mellitus
1509459|NCT00741026|Antipsychotic|antipsychotic
1509460|NCT00741013|randomized|randomized
1509461|NCT00741013|positron emission tomography|positron emission tomography
1509462|NCT00741013|lung inflammation|lung inflammation
1509463|NCT00741013|lovastatin|lovastatin
1509464|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
1509465|NCT00741013|endotoxin|endotoxin
1509466|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
1509467|NCT00740987|Mechanical device|mechanical device
1509468|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
1509469|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1509470|NCT00740987|Intensive care unit|intensive care unit
1509471|NCT00740987|Hospitalization|hospitalization
1509472|NCT00740987|Intensive|intensive
1509473|NCT00740987|Care|care
1509474|NCT00740987|Unit|unit
1509475|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1509476|NCT00740961|cognitive/functional effects|cognitive/functional effects
1509477|NCT00740961|breast cancer|breast cancer
1509478|NCT00740961|colon cancer|colon cancer
1509479|NCT00740948|Sjogren's disease|sjogren's disease
1509480|NCT00740948|Rituximab|rituximab
1509481|NCT00740948|Treatment|treatment
1509482|NCT00740948|anti CD20|anti cd20
1509483|NCT00740935|prevention|prevention
1509484|NCT00740935|rotavirus vaccine|rotavirus vaccine
1509485|NCT00740935|gastroenteritis|gastroenteritis
1509486|NCT00740935|systematic vaccination|systematic vaccination
1509487|NCT00740935|infants|infants
1509488|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
1509489|NCT00740922|Becaplermin gel|becaplermin gel
1509490|NCT00740922|Target Ulcer|target ulcer
1509491|NCT00740922|Retrospective Studies|retrospective studies
1509492|NCT00740922|Diabetic Foot|diabetic foot
1509493|NCT00740922|Neoplasms|neoplasms
1509494|NCT00740922|Long-Term Safety|long-term safety
1509495|NCT00740922|Topical Administration|topical administration
1509496|NCT00740909|Trich|trich
1509497|NCT00740909|Hair Pulling|hair pulling
1509498|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
1509499|NCT00740909|Behavioral Therapy|behavioral therapy
1509500|NCT00740896|Cigarette Smoking|cigarette smoking
1509501|NCT00740896|Airway dendritic cells|airway dendritic cells
1509502|NCT00740883|venous thromboembolism|venous thromboembolism
1509503|NCT00740883|warfarin|warfarin
1509504|NCT00740883|duration of anticoagulation|duration of anticoagulation
1509505|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
1509506|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
1509507|NCT00740857|Dental pain analgesia|dental pain analgesia
1509508|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
1509509|NCT00740844|Hospitalization|hospitalization
1509510|NCT00740844|Intensive care unit|intensive care unit
1509511|NCT00740844|High bleeding risk|high bleeding risk
1509512|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
1509513|NCT00740831|Uterine Myomas|uterine myomas
1509514|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
1509515|NCT00740766|Perinatal Outcomes|perinatal outcomes
1509516|NCT00740766|Obesity|obesity
1509517|NCT00740766|Pregnant women|pregnant women
1509518|NCT00740753|liver tumor|liver tumor
1509519|NCT00740753|cancer|cancer
1509520|NCT00740753|hepatoma|hepatoma
1509521|NCT00740753|yttrium|yttrium
1509522|NCT00740740|Aneurysm|aneurysm
1509523|NCT00740740|Rupture|rupture
1509524|NCT00740727|Disaster|disaster
1509525|NCT00740727|Mass casualty incident|mass casualty incident
1509526|NCT00740727|Prehospital|prehospital
1509527|NCT00740727|Rehydration|rehydration
1509528|NCT00740727|Intravascular access|intravascular access
1509529|NCT00740714|Parkinson disease|parkinson disease
1509530|NCT00740714|PD|pd
1509531|NCT00740714|Coenzyme Q10|coenzyme q10
1509532|NCT00740714|CoQ|coq
1509533|NCT00740701|TMS|tms
1509534|NCT00740701|fMRI|fmri
1509535|NCT00740701|verbal working memory|verbal working memory
1509536|NCT00740701|classical conditioning|classical conditioning
1509537|NCT00740701|eyeblink|eyeblink
1509538|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
1509539|NCT00740701|Healthy subjects|healthy subjects
1509540|NCT00740701|Memory|memory
1509541|NCT00740675|adverse drug events|adverse drug events
1509542|NCT00740675|outpatient|outpatient
1509543|NCT00740662|morbid obesity|morbid obesity
1509544|NCT00740662|small bowel|small bowel
1509545|NCT00740662|gastric bypass|gastric bypass
1509546|NCT00740662|weight loss|weight loss
1509547|NCT00740636|TEMOZOLOMIDE|temozolomide
1509548|NCT00740636|Lung|lung
1509549|NCT00740623|Partial Onset Seizures|partial onset seizures
1509550|NCT00740623|Simple Partial Seizures|simple partial seizures
1509551|NCT00740623|Complex Partial Seizures|complex partial seizures
1509552|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1509553|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1509554|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1509555|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1509556|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1509557|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
1509558|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1509559|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
1509560|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
1509561|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1509562|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1509563|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
1509564|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
1509565|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1509566|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
1509567|NCT00740584|Prevention|prevention
1509568|NCT00740571|neuralgia|neuralgia
1509569|NCT00740571|off-label|off-label
1509570|NCT00740571|cancer|cancer
1509571|NCT00740558|HRV|hrv
1509572|NCT00740558|Activator|activator
1509573|NCT00740558|Chiropractic|chiropractic
1509574|NCT00740558|VLF|vlf
1509575|NCT00740558|HF|hf
1509576|NCT00740558|LF|lf
1509577|NCT00740558|LF/HF|lf/hf
1509578|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
1509579|NCT00740506|Behavioral|behavioral
1509580|NCT00740506|Environmental|environmental
1509581|NCT00740506|Delivery|delivery
1509582|NCT00740506|Pregnancy|pregnancy
1509583|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
1509584|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
1509585|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
1509586|NCT00740480|Evaluation|evaluation
1509587|NCT00740480|ENTact™|entact™
1509588|NCT00740480|Septal|septal
1509589|NCT00740480|Staple|staple
1509590|NCT00740480|System|system
1509591|NCT00740480|tissue|tissue
1509592|NCT00740480|approximation|approximation
1509593|NCT00740480|during|during
1509594|NCT00740480|septoplasties|septoplasties
1509595|NCT00740467|graft versus host disease|graft versus host disease
1509596|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1509597|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1509598|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1509599|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1509600|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1509601|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1509602|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1509603|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1509604|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1509605|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1509606|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1509607|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
1509608|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1509609|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1509610|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1509611|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1509612|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1509613|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1509614|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1509615|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1509616|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1509617|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1509618|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1509619|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1509620|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1509621|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1509622|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1509623|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1509624|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1509625|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1509626|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1509627|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
1509628|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
1509629|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1509630|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1509631|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1509632|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1509633|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1509634|NCT00740454|pregnancy|pregnancy
1509635|NCT00740454|postpartum|postpartum
1509636|NCT00740454|deep vein thrombosis|deep vein thrombosis
1509637|NCT00740454|venous thromboembolism|venous thromboembolism
1509638|NCT00740454|diagnosis|diagnosis
1509639|NCT00740454|compression ultrasonography|compression ultrasonography
1509640|NCT00740441|renal cell carcinoma|renal cell carcinoma
1509641|NCT00740441|rcc|rcc
1509642|NCT00740441|kidney cancer|kidney cancer
1509643|NCT00740428|Pelvic floor,|pelvic floor,
1509644|NCT00740428|muscular dysfunction,|muscular dysfunction,
1509645|NCT00740428|urinary incontinence|urinary incontinence
1509646|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1509647|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1509648|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1509649|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1509650|NCT00740389|TMC125-C187|tmc125-c187
1509651|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
1509652|NCT00740389|HIV|hiv
1509653|NCT00740389|AIDS|aids
1509654|NCT00740389|Fungal Infection|fungal infection
1509655|NCT00740389|Pharmacokinetics|pharmacokinetics
1509656|NCT00740376|osteoarthritis|osteoarthritis
1509657|NCT00740363|renal transplantation|renal transplantation
1509658|NCT00740363|diabetes|diabetes
1509659|NCT00740363|glucose intolerance|glucose intolerance
1509660|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
1509661|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1509662|NCT00740337|COPD|copd
1509663|NCT00740337|Emphysema|emphysema
1509664|NCT00740337|Natural Killer T-cell|natural killer t-cell
1509665|NCT00740337|Interleukin-13|interleukin-13
1509666|NCT00740337|Innate Immune Signaling|innate immune signaling
1509667|NCT00740324|During|during
1509668|NCT00740324|Endoscopy|endoscopy
1509669|NCT00740324|Gastric|gastric
1509670|NCT00740324|Peristalsis|peristalsis
1509671|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
1509672|NCT00740298|infants|infants
1509673|NCT00740298|undergoing|undergoing
1509674|NCT00740298|vaccinations|vaccinations
1509675|NCT00740285|scleroderma|scleroderma
1509676|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
1509677|NCT00740285|lidocaine|lidocaine
1509678|NCT00740285|effectiveness|effectiveness
1509679|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
1509680|NCT00740272|AF ablation|af ablation
1509681|NCT00740259|flunarizine|flunarizine
1509682|NCT00740259|schizophrenia|schizophrenia
1509683|NCT00740259|antipsychotic|antipsychotic
1509684|NCT00740233|fibromyalgia|fibromyalgia
1669364|NCT00109772|CRPS|crps
1509685|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
1509686|NCT00740233|interstitial cystitis|interstitial cystitis
1509687|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
1509688|NCT00740233|vulvodynia|vulvodynia
1509689|NCT00740233|chronic stress|chronic stress
1509690|NCT00740233|chronic pain|chronic pain
1509691|NCT00740233|stress-related conditions|stress-related conditions
1509692|NCT00740233|functional GI disorders|functional gi disorders
1509693|NCT00740220|hypoxemia|hypoxemia
1509694|NCT00740220|anoxia|anoxia
1509695|NCT00740220|oxygen|oxygen
1509696|NCT00740220|dyspnea|dyspnea
1509697|NCT00740220|pulmonary disease|pulmonary disease
1509698|NCT00740220|chronic obstructive|chronic obstructive
1509699|NCT00740194|Physiology|physiology
1509700|NCT00740194|males|males
1509701|NCT00740181|myelodysplasia|myelodysplasia
1509702|NCT00740181|refractory leukemia|refractory leukemia
1509703|NCT00740181|acute leukemia|acute leukemia
1509704|NCT00740168|bevacizumab|bevacizumab
1509705|NCT00740168|cancer|cancer
1509706|NCT00740155|Dengue virus|dengue virus
1509707|NCT00740155|Dengue fever|dengue fever
1509708|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
1509709|NCT00740155|Dengue diseases|dengue diseases
1509710|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
1509711|NCT00740142|Lactulose|lactulose
1509712|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
1509713|NCT00740142|LOLA|lola
1509714|NCT00740129|Paget's Disease|paget's disease
1509715|NCT00740129|Zoledronic acid|zoledronic acid
1509716|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
1509717|NCT00740129|infusion|infusion
1509718|NCT00740129|re-treatment|re-treatment
1509719|NCT00740129|re-lapse|re-lapse
1509720|NCT00740116|Tumor of ovary|tumor of ovary
1509721|NCT00740116|Surgical blood loss|surgical blood loss
1509722|NCT00740116|Postoperative blood loss|postoperative blood loss
1509723|NCT00740116|Preventive therapy|preventive therapy
1509724|NCT00740116|Thromboembolism|thromboembolism
1509725|NCT00740103|Semapimod|semapimod
1509726|NCT00740103|Crohn's Disease|crohn's disease
1509727|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
1509728|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
1509729|NCT00740103|CNI-1493|cni-1493
1509730|NCT00740090|Malaria|malaria
1509731|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
1509732|NCT00740090|Maleria Endemic|maleria endemic
1509733|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
1509734|NCT00740090|Dose Escalating|dose escalating
1509735|NCT00740077|cranberry|cranberry
1509736|NCT00740077|flavonoid|flavonoid
1509737|NCT00740077|phenolic acid|phenolic acid
1509738|NCT00740077|phytochemical|phytochemical
1509739|NCT00740077|bioavailability|bioavailability
1509740|NCT00740064|HIV infections|hiv infections
1509741|NCT00740038|Stress Management|stress management
1509742|NCT00740038|Quality of Life|quality of life
1509743|NCT00740038|Exercise|exercise
1509744|NCT00740038|Cancer|cancer
1509745|NCT00740038|Chemotherapy|chemotherapy
1509746|NCT00740025|QD dose|qd dose
1509747|NCT00740025|BID dosing|bid dosing
1509748|NCT00740025|peak estradiol|peak estradiol
1509749|NCT00740025|oocytes|oocytes
1509750|NCT00740025|implantation rate|implantation rate
1509751|NCT00740025|pregnancy rate|pregnancy rate
1509752|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
1509753|NCT00740012|continuous glucose profiles|continuous glucose profiles
1509754|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
1509755|NCT00739986|Crohn's Disease|crohn's disease
1509756|NCT00739986|TNF-alpha|tnf-alpha
1509757|NCT00739986|IL-6|il-6
1509758|NCT00739986|MAP Kinase|map kinase
1509759|NCT00739986|CNI-1493|cni-1493
1509760|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
1509761|NCT00739947|Observational|observational
1509762|NCT00739947|rotator cuff tear|rotator cuff tear
1509763|NCT00739947|arthroscopic|arthroscopic
1509764|NCT00739947|surgical|surgical
1509765|NCT00739947|outcome study|outcome study
1509766|NCT00739934|Open-Label|open-label
1509767|NCT00739934|Pharmacokinetics|pharmacokinetics
1509768|NCT00739934|Intravenous to oral switch|intravenous to oral switch
1509769|NCT00739934|Safety|safety
1509770|NCT00739934|Voriconazole|voriconazole
1509771|NCT00739934|Immunocompromise|immunocompromise
1509772|NCT00739934|Children|children
1509773|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
1509774|NCT00739921|PCR Analysis|pcr analysis
1509775|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
1509776|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
1509777|NCT00739921|Nasal Polyps|nasal polyps
1509778|NCT00739908|MDD|mdd
1509779|NCT00739895|athletes|athletes
1509780|NCT00739882|Efalizumab,|efalizumab,
1509781|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
1509782|NCT00739882|moderate to severe|moderate to severe
1509783|NCT00739882|involving|involving
1509784|NCT00739882|hands|hands
1509785|NCT00739882|feet|feet
1509786|NCT00739869|Silent Infarcts|silent infarcts
1509787|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
1509788|NCT00739869|MRI|mri
1509789|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
1509790|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
1509791|NCT00739869|Total Brain Volume|total brain volume
1509792|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
1509793|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
1509794|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
1509795|NCT00739869|CVD|cvd
1509796|NCT00739869|Subclinical CVD|subclinical cvd
1509797|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
1509798|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
1509799|NCT00739856|medication refractoriness|medication refractoriness
1509800|NCT00739843|Dementia,|dementia,
1509801|NCT00739843|Cognitive Disorders,|cognitive disorders,
1509802|NCT00739843|Hemodialysis|hemodialysis
1509803|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1509804|NCT00739791|stage I prostate cancer|stage i prostate cancer
1509805|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
1509806|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
1509807|NCT00739765|Trauma|trauma
1509808|NCT00739765|Psychotherapy|psychotherapy
1509809|NCT00739765|Anxiety|anxiety
1509810|NCT00739752|Attitude to Health|attitude to health
1509811|NCT00739752|Communication|communication
1509812|NCT00739752|Intervention Studies|intervention studies
1509813|NCT00739752|Health Promotion|health promotion
1509814|NCT00739752|Psychology, Medical|psychology, medical
1509815|NCT00739752|Sexual Behavior|sexual behavior
1509816|NCT00739752|Behavioral Research|behavioral research
1509817|NCT00739752|Vaccination|vaccination
1509818|NCT00739713|dry eye|dry eye
1509819|NCT00739713|sea buckthorn|sea buckthorn
1509820|NCT00739713|Hippophaë|hippophaë
1509821|NCT00739700|hemodynamics|hemodynamics
1509822|NCT00739700|blood pressure|blood pressure
1509823|NCT00739700|blood pressure monitors|blood pressure monitors
1509824|NCT00739687|Chronic Heart Failure|chronic heart failure
1509825|NCT00739661|Systemic Hedgehog|systemic hedgehog
1509826|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
1509827|NCT00739648|COPD|copd
1509828|NCT00739648|Patients|patients
1509829|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
1509830|NCT00739622|TMC278-C136|tmc278-c136
1509831|NCT00739622|Healthy Volunteer|healthy volunteer
1509832|NCT00739596|Hypertension|hypertension
1509833|NCT00739596|African American|african american
1509834|NCT00739596|aliskiren|aliskiren
1509835|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
1509836|NCT00739596|systolic blood pressure|systolic blood pressure
1509837|NCT00739596|diastolic blood pressure|diastolic blood pressure
1509838|NCT00739596|amlodipine|amlodipine
1509839|NCT00739596|stage 2|stage 2
1509840|NCT00739583|Skin preparation|skin preparation
1509841|NCT00739583|Skin marking|skin marking
1509842|NCT00739583|site marking|site marking
1509843|NCT00739583|Site identification|site identification
1509844|NCT00739570|Activator|activator
1509846|NCT00739570|Thermography|thermography
1509847|NCT00739570|Diagnostic|diagnostic
1509848|NCT00739570|X-Rays|x-rays
1509849|NCT00739557|elective TAAA repair|elective taaa repair
1509850|NCT00739544|Reference Values|reference values
1509851|NCT00739544|Sensory Thresholds|sensory thresholds
1509852|NCT00739544|Pain Threshold|pain threshold
1509853|NCT00739544|Breast Neoplasms|breast neoplasms
1509854|NCT00739531|Asthma|asthma
1509855|NCT00739531|nitric oxide|nitric oxide
1509856|NCT00739531|eNO|eno
1509857|NCT00739531|FENO|feno
1509858|NCT00739531|Apieron INSIGHT|apieron insight
1509859|NCT00739531|Aerocrine NIOX|aerocrine niox
1509860|NCT00739518|Neurological|neurological
1509861|NCT00739518|MRI|mri
1509862|NCT00739505|Hypophosphatasia|hypophosphatasia
1509863|NCT00739505|Bone Disease|bone disease
1509864|NCT00739505|Soft Bones|soft bones
1509865|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
1509866|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
1509867|NCT00739505|alkaline phosphatase|alkaline phosphatase
1509868|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
1509869|NCT00739505|rickets|rickets
1509870|NCT00739505|osteomalacia|osteomalacia
1509871|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
1509872|NCT00739479|Metabolic Syndrome|metabolic syndrome
1509873|NCT00739479|METS|mets
1509874|NCT00739479|Obesity|obesity
1509875|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
1509876|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
1509877|NCT00739479|PHWP|phwp
1509878|NCT00739479|PHG|phg
1509879|NCT00739479|Weight Loss|weight loss
1509880|NCT00739466|Liposomal Alendronate|liposomal alendronate
1509881|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
1509882|NCT00739466|Coronary stenting|coronary stenting
1509883|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
1509884|NCT00739466|Native coronary arteries|native coronary arteries
1509885|NCT00739466|Restenosis|restenosis
1509886|NCT00739466|Bare metal stent|bare metal stent
1509887|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
1509888|NCT00739453|Advanced cancer|advanced cancer
1509889|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
1509890|NCT00739453|Pancreatic cancer|pancreatic cancer
1509891|NCT00739453|Colorectal cancer|colorectal cancer
1509892|NCT00739453|Prostate cancer|prostate cancer
1509893|NCT00739414|Histone Deacetylases|histone deacetylases
1509894|NCT00739414|HDAC inhibitor|hdac inhibitor
1509895|NCT00739414|LBH589|lbh589
1509896|NCT00739414|Advanced solid tumor|advanced solid tumor
1509897|NCT00739414|Adult|adult
1509898|NCT00739401|AAA|aaa
1509899|NCT00739401|Aneurysm|aneurysm
1509900|NCT00739401|Suprarenal|suprarenal
1509901|NCT00739401|Proximal|proximal
1509902|NCT00739401|Cuff|cuff
1509903|NCT00739401|Extension|extension
1509904|NCT00739401|Endograft|endograft
1509905|NCT00739401|Endovascular repair|endovascular repair
1509906|NCT00739401|EVAR|evar
1509907|NCT00739401|Endoleak|endoleak
1509909|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1509910|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1509911|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1509912|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1509913|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1509914|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1509915|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1509916|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1509917|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1509918|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1509919|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1509920|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1509921|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1509922|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1509923|NCT00739375|Influence|influence
1509924|NCT00739375|of av access|of av access
1509925|NCT00739375|flow|flow
1509926|NCT00739375|development|development
1509927|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
1509928|NCT00739362|Obesity|obesity
1509929|NCT00739362|Appetite Control|appetite control
1509930|NCT00739362|Weight Loss|weight loss
1509931|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
1509932|NCT00739349|Dry Eye|dry eye
1509933|NCT00739349|Cyclosporine|cyclosporine
1509934|NCT00739336|diabetes mellitus|diabetes mellitus
1509935|NCT00739336|obesity|obesity
1509936|NCT00739336|prevention|prevention
1509937|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
1509938|NCT00739310|Cerebral Palsy|cerebral palsy
1509939|NCT00739310|Restrictive lung disease|restrictive lung disease
1509940|NCT00739297|Chronic asthma|chronic asthma
1509941|NCT00739284|preferred|preferred
1509942|NCT00739284|procedure|procedure
1509943|NCT00739284|drainage|drainage
1509944|NCT00739284|obstructed|obstructed
1509945|NCT00739284|kidney|kidney
1509946|NCT00739284|stone|stone
1509947|NCT00739258|HIV-infected person|hiv-infected person
1509948|NCT00739258|Entamoeba|entamoeba
1509949|NCT00739258|Cryptosporidium|cryptosporidium
1509950|NCT00739258|Giardia|giardia
1509951|NCT00739258|ELISA|elisa
1509952|NCT00739258|PCR|pcr
1509953|NCT00739258|IDU|idu
1509954|NCT00739258|Gonorrhea|gonorrhea
1509955|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
1509956|NCT00739258|Syphilis|syphilis
1509957|NCT00739258|Genital warts|genital warts
1509958|NCT00739258|Herpes simplex virus|herpes simplex virus
1509959|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
1509960|NCT00739219|Asthma|asthma
1509961|NCT00739219|inflammation|inflammation
1509962|NCT00739219|nitric oxide|nitric oxide
1509963|NCT00739219|eNO|eno
1509964|NCT00739219|FENO|feno
1509965|NCT00739206|uncomplicated|uncomplicated
1509966|NCT00739206|severe|severe
1509967|NCT00739206|treatment|treatment
1509968|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
1509969|NCT00739193|Blood Pressure|blood pressure
1509970|NCT00739180|Childhood obesity|childhood obesity
1509971|NCT00739180|Abdominal obesity|abdominal obesity
1509972|NCT00739180|Visceral fat|visceral fat
1509973|NCT00739180|Insulin resistance|insulin resistance
1509974|NCT00739180|Liver fat|liver fat
1509975|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
1509976|NCT00739180|Fitness|fitness
1509977|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1509978|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
1509979|NCT00739167|liver metastases|liver metastases
1509980|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1509981|NCT00739154|glaucoma|glaucoma
1509982|NCT00739154|Phenytoin|phenytoin
1509983|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
1509984|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
1509985|NCT00739154|visual acuity|visual acuity
1509986|NCT00739154|optic disc cupping|optic disc cupping
1509987|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1509988|NCT00739141|CYCLOSPORINE A|cyclosporine a
1509989|NCT00739141|FLUDARABINE|fludarabine
1509990|NCT00739141|G-CSF|g-csf
1509991|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
1509992|NCT00739141|THI0TEPA|thi0tepa
1509993|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
1509994|NCT00739141|08-087|08-087
1509995|NCT00739128|celiac disease|celiac disease
1509996|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
1509997|NCT00739115|Respiratory|respiratory
1509998|NCT00739115|Distress|distress
1509999|NCT00739115|Prematurity|prematurity
1510000|NCT00739115|Heliox|heliox
1510001|NCT00739115|CPAP|cpap
1510002|NCT00739102|Superficial Femoral Artery|superficial femoral artery
1510003|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
1510004|NCT00739089|hemodynamics|hemodynamics
1510005|NCT00739089|oxygen|oxygen
1510006|NCT00739089|renal dialysis|renal dialysis
1510007|NCT00739089|shock|shock
1510008|NCT00739089|sepsis|sepsis
1510009|NCT00739089|hypotension|hypotension
1510010|NCT00739089|lactic acidosis|lactic acidosis
1510011|NCT00739063|Breast cancer|breast cancer
1510012|NCT00739063|Carcinoma of the breast|carcinoma of the breast
1510013|NCT00739063|Stage IV|stage iv
1510014|NCT00739063|Triple receptor-negative|triple receptor-negative
1510015|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
1510016|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
1510017|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
1510018|NCT00739063|EGFR|egfr
1510019|NCT00739063|EGFR-overexpressing|egfr-overexpressing
1510020|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
1510021|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
1510022|NCT00739063|Erlotinib|erlotinib
1510023|NCT00739063|Tarceva|tarceva
1510024|NCT00739063|OSI-774|osi-774
1510025|NCT00739024|Migraine|migraine
1510026|NCT00739024|Headache|headache
1510027|NCT00738998|Breast Cancer|breast cancer
1510028|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
1510029|NCT00738998|Symptom Assessment|symptom assessment
1510030|NCT00738998|Questionnaire|questionnaire
1510031|NCT00738998|Survey|survey
1510032|NCT00738998|Phone Call|phone call
1510033|NCT00738998|Arimidex|arimidex
1510034|NCT00738998|Anastrozole|anastrozole
1510035|NCT00738959|AZD0328|azd0328
1510036|NCT00738959|Japanese|japanese
1510037|NCT00738959|Caucasian|caucasian
1510038|NCT00738959|pharmacokinetics|pharmacokinetics
1510039|NCT00738959|safety|safety
1510040|NCT00738959|tolerability|tolerability
1510041|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
1510042|NCT00738946|insecticide treated bednets|insecticide treated bednets
1510043|NCT00738946|malaria|malaria
1510044|NCT00738933|Atherosclerosis|atherosclerosis
1510045|NCT00738933|Plant sterols|plant sterols
1510046|NCT00738933|Plant stanols|plant stanols
1510047|NCT00738933|Aortic valve|aortic valve
1510048|NCT00738907|Type 1 diabetes|type 1 diabetes
1510049|NCT00738894|cryptogenic|cryptogenic
1510050|NCT00738894|stroke|stroke
1510051|NCT00738894|transient ischemic attack|transient ischemic attack
1510053|NCT00738894|PFO|pfo
1510054|NCT00738894|Patent foramen ovale|patent foramen ovale
1510055|NCT00738894|HELEX|helex
1510056|NCT00738894|Septal Occluder|septal occluder
1510057|NCT00738894|PFO Occluder|pfo occluder
1510058|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1510059|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1510060|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1510061|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1510062|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1510063|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1510064|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1510065|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1510066|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1510067|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1510068|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1510069|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1510070|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1510071|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1510072|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1510073|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1510074|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
1510075|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1510076|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
1510077|NCT00738855|Adhesions|adhesions
1510078|NCT00738855|Oral contrast|oral contrast
1510079|NCT00738855|Exploration|exploration
1510081|NCT00738842|Acid|acid
1510082|NCT00738842|Level|level
1510083|NCT00738829|CLL|cll
1510084|NCT00738829|untreated|untreated
1510085|NCT00738829|immune therapy|immune therapy
1510086|NCT00738829|dose escalation|dose escalation
1510087|NCT00738829|maximum tolerated dose|maximum tolerated dose
1510088|NCT00738829|maintenance therapy|maintenance therapy
1510089|NCT00738829|Lenalidomide|lenalidomide
1510090|NCT00738829|Rituximab|rituximab
1510091|NCT00738829|Fludarabine|fludarabine
1510092|NCT00738816|Medication review|medication review
1510093|NCT00738816|Patient|patient
1510094|NCT00738816|Safety|safety
1510095|NCT00738816|Drug|drug
1510096|NCT00738816|Prescriptions|prescriptions
1510097|NCT00738816|Drug-use|drug-use
1510098|NCT00738803|leg length|leg length
1510099|NCT00738803|hip arthroplasty|hip arthroplasty
1510100|NCT00738803|offset|offset
1510101|NCT00738790|rectal cancer|rectal cancer
1510102|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
1510103|NCT00738777|pre-operative|pre-operative
1510104|NCT00738777|endocrine treatment|endocrine treatment
1510105|NCT00738777|drug resistance|drug resistance
1510106|NCT00738764|cancer|cancer
1510107|NCT00738764|antibody|antibody
1510108|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
1510109|NCT00738751|NSCLC|nsclc
1510110|NCT00738751|Metastatic|metastatic
1510111|NCT00738751|erlotinib|erlotinib
1510112|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
1510113|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
1510114|NCT00738751|H&N cancer|h&n cancer
1510115|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
1510116|NCT00738725|High risk plaque|high risk plaque
1510117|NCT00738725|High-risk plaque|high-risk plaque
1510118|NCT00738725|Vulnerable plaque|vulnerable plaque
1510119|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
1510120|NCT00738725|Heart Disease|heart disease
1510121|NCT00738725|Stroke|stroke
1510122|NCT00738712|Vascular MRI|vascular mri
1510123|NCT00738712|Abdominal MRI|abdominal mri
1510124|NCT00738712|Pelvic MRI|pelvic mri
1510125|NCT00738712|Breast MRI|breast mri
1510126|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1510127|NCT00738699|ovarian cancer|ovarian cancer
1510128|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
1510129|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
1510130|NCT00738686|coronary artery disease|coronary artery disease
1510131|NCT00738686|drug-eluting stent|drug-eluting stent
1510132|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
1510133|NCT00738686|major adverse cardiac event|major adverse cardiac event
1510134|NCT00738686|in-stent restenosis|in-stent restenosis
1510135|NCT00738686|stent thrombosis|stent thrombosis
1510136|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
1510137|NCT00738673|Agonist treatment failure|agonist treatment failure
1510138|NCT00738660|type1 DM|type1 dm
1510139|NCT00738660|microalbuminuria|microalbuminuria
1510140|NCT00738660|nephropathy|nephropathy
1510141|NCT00738660|albumin excretion rate|albumin excretion rate
1510142|NCT00738660|dual blockade|dual blockade
1510143|NCT00738660|ACEI|acei
1510144|NCT00738660|ARB|arb
1510145|NCT00738647|Filling materials|filling materials
1510146|NCT00738647|Restorative materials|restorative materials
1510147|NCT00738647|clinical trial|clinical trial
1510148|NCT00738647|Resin based composite|resin based composite
1510149|NCT00738634|Depression|depression
1510150|NCT00738634|Motor Activity|motor activity
1510151|NCT00738634|Adolescent|adolescent
1510152|NCT00738621|PONV|ponv
1510153|NCT00738621|breast surgery|breast surgery
1510154|NCT00738621|prevention|prevention
1510155|NCT00738621|antiemetics|antiemetics
1510156|NCT00738608|morphine|morphine
1510157|NCT00738608|consumption|consumption
1510158|NCT00738608|postoperative|postoperative
1510159|NCT00738608|pain|pain
1510160|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
1510161|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
1510162|NCT00738595|Smoking Cessation|smoking cessation
1510163|NCT00738569|Chronic inflammation|chronic inflammation
1510164|NCT00738569|memory cells|memory cells
1669923|NCT00107965|AK|ak
1510165|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
1510166|NCT00738543|Antiseptics|antiseptics
1510167|NCT00738543|Administration, cutaneous|administration, cutaneous
1510168|NCT00738543|Iodophors|iodophors
1510169|NCT00738543|Chlorine compounds|chlorine compounds
1510170|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
1510171|NCT00738517|heart failure|heart failure
1510172|NCT00738517|coronary heart disease|coronary heart disease
1510173|NCT00738517|autoantibodies|autoantibodies
1510174|NCT00738517|immunoadsorption|immunoadsorption
1510175|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
1510176|NCT00738504|Intensive insulin therapy|intensive insulin therapy
1510177|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
1510178|NCT00738504|RIFLE Criteria|rifle criteria
1510179|NCT00738504|Acute Kidney Injury|acute kidney injury
1510180|NCT00738504|Critically ill patients|critically ill patients
1510181|NCT00738504|Acute|acute
1510182|NCT00738491|Angina pectoris|angina pectoris
1510183|NCT00738491|Exercise capacity|exercise capacity
1510184|NCT00738491|Myocardial ischaemia|myocardial ischaemia
1510185|NCT00738491|Air pollution|air pollution
1510186|NCT00738478|distal gastrectomy|distal gastrectomy
1510187|NCT00738478|quality of life|quality of life
1510188|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1510285|NCT00738062|Neuropathy|neuropathy
1510189|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1510190|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1510191|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1510192|NCT00738439|scoliosis|scoliosis
1510193|NCT00738439|kyphosis|kyphosis
1510194|NCT00738439|treatment outcomes|treatment outcomes
1510195|NCT00738439|spinal deformity|spinal deformity
1510196|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
1510197|NCT00738413|Iron chelation|iron chelation
1510198|NCT00738413|Iron balance|iron balance
1510199|NCT00738413|Secondary iron overload|secondary iron overload
1510200|NCT00738413|deferoxamine|deferoxamine
1510201|NCT00738413|deferasirox|deferasirox
1510202|NCT00738400|Vardenafil|vardenafil
1510203|NCT00738400|Erectile Dysfunction|erectile dysfunction
1510204|NCT00738400|Double-blind study|double-blind study
1510205|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
1510206|NCT00738387|VDA|vda
1510207|NCT00738387|ASA404|asa404
1510208|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
1510209|NCT00738387|NSCLC|nsclc
1510210|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1510211|NCT00738361|iris melanoma|iris melanoma
1510212|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
1510213|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
1510214|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
1510215|NCT00738348|surgery|surgery
1510216|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1510217|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
1510218|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1510219|NCT00738322|AZD1305|azd1305
1510220|NCT00738322|safety|safety
1510221|NCT00738322|pharmacokinetics|pharmacokinetics
1510222|NCT00738322|single ascending doses|single ascending doses
1510223|NCT00738322|Japanese|japanese
1510224|NCT00738322|male|male
1510225|NCT00738309|Treatment Outcomes|treatment outcomes
1510226|NCT00738309|Spinal Deformity|spinal deformity
1510227|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
1510228|NCT00738283|Zinc|zinc
1510229|NCT00738283|Copper|copper
1510230|NCT00738283|Neonate|neonate
1510231|NCT00738257|Renal|renal
1510232|NCT00738257|transplant,|transplant,
1510233|NCT00738257|pamidronate,|pamidronate,
1510234|NCT00738257|ciclosporin,|ciclosporin,
1510235|NCT00738257|Ciclosporin A,|ciclosporin a,
1510236|NCT00738257|steroids,|steroids,
1510237|NCT00738257|bone mineral density,|bone mineral density,
1510238|NCT00738257|fracture rates|fracture rates
1510239|NCT00738257|immunosuppressive|immunosuppressive
1510240|NCT00738257|regimen|regimen
1510241|NCT00738244|hearing aid algorithm|hearing aid algorithm
1510242|NCT00738244|wind-noise suppression|wind-noise suppression
1510243|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
1510244|NCT00738218|Coronary Artery Disease|coronary artery disease
1510245|NCT00738218|Computed Tomography|computed tomography
1510246|NCT00738218|Angiography|angiography
1510247|NCT00738205|Electronic device|electronic device
1510248|NCT00738205|Growth hormone treatment|growth hormone treatment
1510249|NCT00738192|Postoperative analgesia|postoperative analgesia
1510250|NCT00738192|Opioids|opioids
1510251|NCT00738192|Laparoscopic surgery|laparoscopic surgery
1510252|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
1510253|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
1510254|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
1510255|NCT00738179|Cardiovascular Disease|cardiovascular disease
1510256|NCT00738179|Clinical Trial|clinical trial
1510257|NCT00738166|diet, organic, health|diet, organic, health
1510258|NCT00738166|healthy people|healthy people
1510259|NCT00738140|insulin sensitivity|insulin sensitivity
1510260|NCT00738140|Diabetes Prevention Program|diabetes prevention program
1510261|NCT00738140|lifestyle intervention|lifestyle intervention
1510262|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
1510263|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
1510264|NCT00738127|Kirschner-wire|kirschner-wire
1510265|NCT00738127|Range of motion|range of motion
1510266|NCT00738114|non-cardiac|non-cardiac
1510268|NCT00738114|mortality|mortality
1510269|NCT00738114|morbidity|morbidity
1510270|NCT00738114|perioperative|perioperative
1510271|NCT00738114|period|period
1510272|NCT00738101|Omega-3|omega-3
1510273|NCT00738101|Omegaven|omegaven
1510274|NCT00738101|Cholestasis|cholestasis
1510275|NCT00738101|Liver damage|liver damage
1510276|NCT00738088|Sulphonylurea|sulphonylurea
1510277|NCT00738088|Pharmacogenetics|pharmacogenetics
1510278|NCT00738062|NOH|noh
1510279|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
1510280|NCT00738062|Orthostatic hypotension|orthostatic hypotension
1510281|NCT00738062|PAF|paf
1510282|NCT00738062|Pure Autonomic Failure|pure autonomic failure
1510283|NCT00738062|MSA|msa
1510284|NCT00738062|Multiple System Atrophy|multiple system atrophy
1510286|NCT00738062|Autonomic Failure|autonomic failure
1510287|NCT00738062|Parkinson|parkinson
1510288|NCT00738062|Dopamine Deficiency|dopamine deficiency
1510289|NCT00738062|Dopamine|dopamine
1510290|NCT00738062|Droxidopa|droxidopa
1510291|NCT00738049|atherosclerosis|atherosclerosis
1510292|NCT00738049|coronary artery disease|coronary artery disease
1510293|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
1510294|NCT00738049|endothelial dysfunction|endothelial dysfunction
1510295|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
1510296|NCT00738036|Analgesics|analgesics
1510298|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
1510299|NCT00738036|Acute pain|acute pain
1510300|NCT00738023|diabetes,|diabetes,
1510301|NCT00738023|hypertension,|hypertension,
1510302|NCT00738023|free-fatty acids|free-fatty acids
1510303|NCT00738010|NMES|nmes
1510304|NCT00738010|ACL|acl
1510305|NCT00738010|Atrophy Prevention|atrophy prevention
1510306|NCT00738010|Accelerated Recovery|accelerated recovery
1510307|NCT00738010|Knee Surgery|knee surgery
1510308|NCT00737997|Pediatrics|pediatrics
1510309|NCT00737997|Scoliosis|scoliosis
1510310|NCT00737997|Morphine|morphine
1510311|NCT00737997|Surgery|surgery
1510312|NCT00737997|Analgesia|analgesia
1510313|NCT00737984|Infertility|infertility
1510314|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
1510315|NCT00737971|avastin|avastin
1510316|NCT00737971|bevacizumab|bevacizumab
1510317|NCT00737971|triamcinolone|triamcinolone
1510318|NCT00737971|diabetic macular edema|diabetic macular edema
1510319|NCT00737971|macular edema|macular edema
1510320|NCT00737971|intravitreal injection|intravitreal injection
1510321|NCT00737958|Angina pectoris|angina pectoris
1510322|NCT00737958|Air pollution|air pollution
1510323|NCT00737958|Diesel exhaust|diesel exhaust
1510324|NCT00737958|Myocardial ischaemia|myocardial ischaemia
1510325|NCT00737958|Exercise capacity|exercise capacity
1510326|NCT00737919|Cholesterol|cholesterol
1510327|NCT00737919|Plant sterols|plant sterols
1510328|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
1510329|NCT00737906|Chronic rhinitis|chronic rhinitis
1510330|NCT00737906|Nasal Obstruction|nasal obstruction
1510331|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
1510332|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
1510333|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
1510334|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
1510335|NCT00737906|Coblation|coblation
1510336|NCT00737906|Arthrocare|arthrocare
1510337|NCT00737906|ENT|ent
1510338|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
1510339|NCT00737906|Turbinate|turbinate
1510340|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
1510341|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
1510342|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
1510343|NCT00737906|Inferior Turbinate|inferior turbinate
1510344|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
1510345|NCT00737893|Erythropoietin|erythropoietin
1510346|NCT00737893|Radical Prostatectomy|radical prostatectomy
1510347|NCT00737893|Erectile Dysfunction|erectile dysfunction
1510348|NCT00737893|Prostate Cancer|prostate cancer
1510349|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
1510350|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
1510351|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
1510352|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
1510353|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
1510354|NCT00737867|lung cancer|lung cancer
1510355|NCT00737867|chemotherapy|chemotherapy
1510356|NCT00737867|vinorelbine|vinorelbine
1510357|NCT00737867|gemcitabine|gemcitabine
1510358|NCT00737867|carboplatin|carboplatin
1510359|NCT00737867|advanced lung cancer|advanced lung cancer
1510360|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
1510361|NCT00737854|OLP|olp
1510362|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
1510363|NCT00737854|Treatment|treatment
1510364|NCT00737841|stress|stress
1510365|NCT00737841|brain-gut interactions|brain-gut interactions
1510366|NCT00737841|visceral perception|visceral perception
1510367|NCT00737841|gastrointestinal motility|gastrointestinal motility
1510368|NCT00737841|emotion|emotion
1510369|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
1510370|NCT00737828|CPX|cpx
1510371|NCT00737828|CPEX|cpex
1510372|NCT00737828|surgical outcome|surgical outcome
1510373|NCT00737828|colorectal surgery|colorectal surgery
1510374|NCT00737828|risk stratification|risk stratification
1510375|NCT00737815|Randomized Controlled Trial|randomized controlled trial
1510376|NCT00737815|Magnesium|magnesium
1510377|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1510378|NCT00737815|Inflammation|inflammation
1510379|NCT00737802|GERD|gerd
1510380|NCT00737802|Heartburn|heartburn
1510381|NCT00737802|Esophageal reflux|esophageal reflux
1510382|NCT00737802|Barretts esophagus|barretts esophagus
1510383|NCT00737802|Normal subjects|normal subjects
1510384|NCT00737763|efalizumab|efalizumab
1510385|NCT00737763|Raptiva|raptiva
1510386|NCT00737763|Diabetes|diabetes
1510387|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1510388|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
1510389|NCT00737750|Knee Surgery|knee surgery
1510390|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
1510391|NCT00737750|Atrophy Prevention|atrophy prevention
1510392|NCT00737750|Accelerated Recovery|accelerated recovery
1510393|NCT00737737|Analgesia|analgesia
1510394|NCT00737737|Chronic Pain|chronic pain
1510395|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
1510396|NCT00737737|Degenerative Diseases|degenerative diseases
1510397|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
1510398|NCT00737724|Deferred treatment|deferred treatment
1510399|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
1510400|NCT00737698|COPD|copd
1510401|NCT00737698|exercise|exercise
1510402|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
1510403|NCT00737698|quadriceps strength|quadriceps strength
1510404|NCT00737685|Pediatric|pediatric
1510405|NCT00737685|UBMT|ubmt
1510406|NCT00737685|Severe|severe
1510407|NCT00737672|Hemodialysis|hemodialysis
1510408|NCT00737672|Stent Graft|stent graft
1510409|NCT00737672|Venous Anastomosis|venous anastomosis
1510410|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
1510411|NCT00737659|Renal Transplant|renal transplant
1510412|NCT00737659|Renal|renal
1510413|NCT00737659|Transplant|transplant
1510414|NCT00737659|MMF|mmf
1510415|NCT00737659|MPA|mpa
1510416|NCT00737659|Recipients|recipients
1510417|NCT00737646|Cancer|cancer
1510418|NCT00737646|Colorectal cancer|colorectal cancer
1510419|NCT00737646|Patient education|patient education
1510420|NCT00737646|Physician education|physician education
1510421|NCT00737633|Diabetes|diabetes
1510422|NCT00737633|Type 2 Diabetes|type 2 diabetes
1510423|NCT00737633|Diabetes Mellitus|diabetes mellitus
1510424|NCT00737633|Metabolic Diseases|metabolic diseases
1510425|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
1510426|NCT00737633|Glycemic Control|glycemic control
1510427|NCT00737620|Renal Failure, End Stage|renal failure, end stage
1510428|NCT00737620|Blood Vessel Grafting|blood vessel grafting
1510429|NCT00737620|Hemodialysis|hemodialysis
1510430|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
1510431|NCT00737607|outcome|outcome
1510432|NCT00737607|surgery|surgery
1510433|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
1510434|NCT00737607|minimally invasive|minimally invasive
1510435|NCT00737581|Subject's|subject's
1510436|NCT00737581|response|response
1510437|NCT00737581|changes|changes
1510438|NCT00737581|in spinal|in spinal
1510439|NCT00737581|cord|cord
1510440|NCT00737581|stimulation|stimulation
1510441|NCT00737581|during|during
1510442|NCT00737581|postural|postural
1510443|NCT00737568|Tenofovir DF|tenofovir df
1510444|NCT00737568|Emtricitabine|emtricitabine
1510445|NCT00737568|Chronic hepatitis B|chronic hepatitis b
1510446|NCT00737568|Combination therapy|combination therapy
1510447|NCT00737555|Solid tumour|solid tumour
1510448|NCT00737555|Solid tumor|solid tumor
1510449|NCT00737555|Pharmacokinetic|pharmacokinetic
1510450|NCT00737555|Interaction|interaction
1510451|NCT00737555|dose escalation|dose escalation
1510452|NCT00737555|cancer|cancer
1510453|NCT00737555|paclitaxel|paclitaxel
1510454|NCT00737542|management|management
1510455|NCT00737542|post|post
1510456|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
1510457|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1510458|NCT00737529|CC-5013|cc-5013
1510459|NCT00737529|Revlimid|revlimid
1510460|NCT00737529|Lenalidomide|lenalidomide
1510461|NCT00737516|Registry|registry
1510462|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
1510463|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
1510464|NCT00737516|Center for Cord Blood|center for cord blood
1510465|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
1510466|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
1510467|NCT00737451|urticaria|urticaria
1510468|NCT00737451|goiter|goiter
1510469|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1510470|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
1510471|NCT00737438|CISPLATIN|cisplatin
1510472|NCT00737438|EPIRUBICIN|epirubicin
1510473|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1510474|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
1510475|NCT00737438|ESOPHAGUS|esophagus
1510476|NCT00737438|STOMACH|stomach
1510477|NCT00737438|08-081|08-081
1510478|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
1510479|NCT00737425|abdominal|abdominal
1510480|NCT00737425|pain relief|pain relief
1510481|NCT00737425|wound healing|wound healing
1510482|NCT00737425|low intensity ultrasound|low intensity ultrasound
1510483|NCT00737412|Bio-K+CL1285|bio-k+cl1285
1510484|NCT00737412|Probiotics|probiotics
1510485|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
1510784|NCT00736489|Asthma|asthma
1510486|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
1510487|NCT00737412|Lactobacillus Casei|lactobacillus casei
1510488|NCT00737399|depression|depression
1510489|NCT00737399|anxiety|anxiety
1510490|NCT00737399|pain|pain
1510491|NCT00737399|insomnia|insomnia
1510492|NCT00737399|cancer|cancer
1510493|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
1510494|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
1510495|NCT00737386|Leishmania tropica|leishmania tropica
1510496|NCT00737386|Hyrax|hyrax
1510497|NCT00737386|Sandfly|sandfly
1510498|NCT00737347|type 2 diabetes|type 2 diabetes
1510499|NCT00737347|obesity|obesity
1510500|NCT00737347|weight gain|weight gain
1510501|NCT00737347|thiazolidinediones|thiazolidinediones
1510502|NCT00737334|Carotid stenosis|carotid stenosis
1510503|NCT00737334|EEGo|eego
1510504|NCT00737334|nonlinear EEG|nonlinear eeg
1510505|NCT00737334|BIS|bis
1510506|NCT00737334|cerebral oximetry|cerebral oximetry
1510507|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
1510508|NCT00737334|cerebral monitoring|cerebral monitoring
1510509|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
1510510|NCT00737334|cerebral ischemia|cerebral ischemia
1510511|NCT00737334|carotid endarterectomy|carotid endarterectomy
1510512|NCT00737321|Impact of ischemia|impact of ischemia
1510513|NCT00737321|Impact of stress and|impact of stress and
1510514|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
1510515|NCT00737308|crowns|crowns
1510516|NCT00737308|ceramics|ceramics
1510517|NCT00737295|Biliary|biliary
1510518|NCT00737295|Dyskinesia|dyskinesia
1510519|NCT00737295|Gallbladder|gallbladder
1510520|NCT00737295|Cholecystitis|cholecystitis
1510521|NCT00737282|Uterine Fibroids|uterine fibroids
1510522|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
1510523|NCT00737269|Skin Infection|skin infection
1510524|NCT00737269|Skin Infection Registry|skin infection registry
1510525|NCT00737269|cSSTI Registry|cssti registry
1510526|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
1510527|NCT00737243|Molecular profiling assay|molecular profiling assay
1510528|NCT00737243|Bevacizumab|bevacizumab
1510529|NCT00737243|Erlotinib|erlotinib
1510530|NCT00737243|Paclitaxel|paclitaxel
1510531|NCT00737243|Carboplatin|carboplatin
1510532|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1510533|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1510534|NCT00737230|gastrointestinal complications|gastrointestinal complications
1510535|NCT00737230|radiation toxicity|radiation toxicity
1510536|NCT00737230|prostate cancer|prostate cancer
1510537|NCT00737230|bladder cancer|bladder cancer
1510538|NCT00737230|vulvar cancer|vulvar cancer
1510539|NCT00737230|vaginal cancer|vaginal cancer
1510540|NCT00737230|cervical cancer|cervical cancer
1510541|NCT00737230|endometrial cancer|endometrial cancer
1510542|NCT00737230|anal cancer|anal cancer
1510543|NCT00737230|rectal cancer|rectal cancer
1510544|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
1510545|NCT00737204|HIV|hiv
1510546|NCT00737204|AIDS|aids
1510547|NCT00737204|Armodafinil|armodafinil
1510548|NCT00737204|Depression|depression
1510549|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1510550|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1510551|NCT00737191|pain|pain
1510552|NCT00737178|IUD|iud
1510553|NCT00737178|Intrauterine device|intrauterine device
1510554|NCT00737178|Intrauterine contraception|intrauterine contraception
1510555|NCT00737178|Medication abortion|medication abortion
1510556|NCT00737178|Medical abortion|medical abortion
1510557|NCT00737165|Suicide, Prevention|suicide, prevention
1510558|NCT00737165|Community|community
1510559|NCT00737152|RAS 130|ras 130
1510560|NCT00737152|Exercise|exercise
1510561|NCT00737152|Diabetes Mellitus|diabetes mellitus
1510562|NCT00737152|Type II Diabetes|type ii diabetes
1510563|NCT00737152|Diabetes|diabetes
1510564|NCT00737152|Aerobic|aerobic
1510565|NCT00737139|Hip|hip
1510566|NCT00737139|Knee|knee
1510567|NCT00737139|Arthroplasty|arthroplasty
1510568|NCT00737139|Epinephrine|epinephrine
1510569|NCT00737139|Hemostasis|hemostasis
1510570|NCT00737126|Diabetic nephropathies|diabetic nephropathies
1510571|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
1510572|NCT00737126|Folic acid|folic acid
1510573|NCT00737126|Endothelial dysfunction|endothelial dysfunction
1510574|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1510575|NCT00737113|Engrafted|engrafted
1510576|NCT00737113|subjects|subjects
1510577|NCT00737087|total shoulder replacement|total shoulder replacement
1510578|NCT00737087|rotator cuff|rotator cuff
1510579|NCT00737087|osteoarthritis|osteoarthritis
1510580|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
1510581|NCT00737087|Delta Extend|delta extend
1510582|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
1510583|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
1510584|NCT00737074|Macular detachment|macular detachment
1510585|NCT00737074|Macular hole|macular hole
1510586|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
1510587|NCT00737061|Female|female
1510588|NCT00737061|Sterilization|sterilization
1510589|NCT00737048|Pain|pain
1510590|NCT00737048|Tooth extraction|tooth extraction
1510591|NCT00737048|Oral surgery|oral surgery
1510592|NCT00737048|Postoperative pain|postoperative pain
1510593|NCT00737048|JNS013|jns013
1510594|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
1510595|NCT00737048|Acetaminophen|acetaminophen
1510596|NCT00737035|Intimate Partner Homicide|intimate partner homicide
1510597|NCT00737035|Parental Homicide|parental homicide
1510598|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
1510599|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1510600|NCT00737035|Uxoricide Project|uxoricide project
1510601|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
1510602|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
1510603|NCT00737022|Macular appearance|macular appearance
1510604|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
1510605|NCT00737022|Visual function|visual function
1510606|NCT00737009|Breast cancer|breast cancer
1510607|NCT00737009|adherence|adherence
1510608|NCT00737009|anastrozole|anastrozole
1510609|NCT00737009|post-menopausal women|post-menopausal women
1510610|NCT00736996|Metabolic Syndrome|metabolic syndrome
1510611|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
1510612|NCT00736996|Insulin Resistance|insulin resistance
1510613|NCT00736996|Endurance Exercise|endurance exercise
1510614|NCT00736983|Perianal fistulas|perianal fistulas
1510615|NCT00736983|Crohn's disease|crohn's disease
1510616|NCT00736970|ridaforolimus|ridaforolimus
1510617|NCT00736970|deforolimus|deforolimus
1510618|NCT00736970|AP23573|ap23573
1510619|NCT00736970|breast cancer|breast cancer
1510620|NCT00736957|Chronic Pain|chronic pain
1510621|NCT00736957|Acetaminophen|acetaminophen
1510622|NCT00736957|Tramadol|tramadol
1510623|NCT00736957|JNS013|jns013
1510624|NCT00736931|Brivaracetam|brivaracetam
1510625|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
1510626|NCT00736931|Neuropsychological assessments|neuropsychological assessments
1510627|NCT00736918|Suicide Attempt|suicide attempt
1510628|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
1510629|NCT00736905|TMC278-C130|tmc278-c130
1510630|NCT00736905|healthy volunteer|healthy volunteer
1510631|NCT00736905|hepatic impairment|hepatic impairment
1510632|NCT00736905|HIV Infections|hiv infections
1510633|NCT00736892|Acute lung injury|acute lung injury
1510634|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
1510635|NCT00736892|Mechanical ventilation|mechanical ventilation
1510636|NCT00736892|Prognosis|prognosis
1510637|NCT00736892|Definitions|definitions
1510638|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1510639|NCT00736879|Diabetes Mellitus|diabetes mellitus
1510640|NCT00736879|Endocrine System Diseases|endocrine system diseases
1510641|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
1510642|NCT00736879|Metabolic Diseases|metabolic diseases
1510643|NCT00736866|acetylcysteine|acetylcysteine
1510644|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
1510645|NCT00736866|angiography|angiography
1510646|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
1510647|NCT00736853|Chronic pain|chronic pain
1510648|NCT00736853|Acetoaminophen|acetoaminophen
1510649|NCT00736853|Tramadol|tramadol
1510650|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
1510651|NCT00736853|Low back pain|low back pain
1510652|NCT00736840|Methacetin|methacetin
1510653|NCT00736840|Breath|breath
1510654|NCT00736840|Test|test
1510655|NCT00736840|Cirrhosis|cirrhosis
1510656|NCT00736827|BK virus|bk virus
1510657|NCT00736827|acute renal failure|acute renal failure
1510658|NCT00736827|hemodiafiltration|hemodiafiltration
1510659|NCT00736827|humans|humans
1510660|NCT00736827|patients|patients
1510661|NCT00736827|polytrauma|polytrauma
1510662|NCT00736827|surgery|surgery
1510663|NCT00736827|complement|complement
1510664|NCT00736827|inflammation|inflammation
1510665|NCT00736827|inflammatory response|inflammatory response
1510666|NCT00736827|biomarkers|biomarkers
1510667|NCT00736827|cytokines|cytokines
1510668|NCT00736827|cell surface markers|cell surface markers
1510669|NCT00736827|functional polymorphisms|functional polymorphisms
1510670|NCT00736827|infections|infections
1510671|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1510672|NCT00736827|SIRS|sirs
1510673|NCT00736827|sepsis|sepsis
1510674|NCT00736827|severe sepsis|severe sepsis
1510675|NCT00736827|shock|shock
1510676|NCT00736827|organ dysfunctions|organ dysfunctions
1510677|NCT00736827|SOFA|sofa
1510678|NCT00736827|severity of disease|severity of disease
1510679|NCT00736827|APACHEII|apacheii
1510680|NCT00736827|SAPSII|sapsii
1510681|NCT00736827|SPAPS3|spaps3
1510682|NCT00736827|length of stay|length of stay
1510683|NCT00736827|outcome|outcome
1510684|NCT00736827|mortality|mortality
1510785|NCT00736489|airway obstruction|airway obstruction
1510685|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1510686|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1510687|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
1510688|NCT00736788|AZD1704,|azd1704,
1510689|NCT00736788|Japanese|japanese
1510690|NCT00736788|Healthy|healthy
1510691|NCT00736788|Volunteers,|volunteers,
1510692|NCT00736788|Phase I study,|phase i study,
1510693|NCT00736788|Single Ascending Dose|single ascending dose
1510694|NCT00736788|Safety,|safety,
1510695|NCT00736788|Tolerability|tolerability
1510696|NCT00736788|Pharmacokinetics|pharmacokinetics
1510697|NCT00736775|AD|ad
1510698|NCT00736775|Alzheimer's|alzheimer's
1510699|NCT00736775|Alzheimers|alzheimers
1510700|NCT00736762|Global postural re-education|global postural re-education
1510701|NCT00736762|Balance|balance
1510702|NCT00736762|Physical therapy|physical therapy
1510703|NCT00736762|older people|older people
1510704|NCT00736723|NT-proBNP|nt-probnp
1510705|NCT00736723|myocardial dysfunction|myocardial dysfunction
1510706|NCT00736723|humans|humans
1510707|NCT00736723|patients|patients
1510708|NCT00736723|polytrauma|polytrauma
1510709|NCT00736723|complement|complement
1510710|NCT00736723|inflammation|inflammation
1510711|NCT00736723|inflammatory response|inflammatory response
1510712|NCT00736723|biomarkers|biomarkers
1510713|NCT00736723|cytokines|cytokines
1510714|NCT00736723|cell surface markers|cell surface markers
1510715|NCT00736723|functional polymorphisms|functional polymorphisms
1510716|NCT00736723|infections|infections
1510717|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1510718|NCT00736723|SIRS|sirs
1510719|NCT00736723|sepsis|sepsis
1510720|NCT00736723|severe sepsis|severe sepsis
1510721|NCT00736723|shock|shock
1510722|NCT00736723|organ dysfunctions|organ dysfunctions
1510723|NCT00736723|SOFA|sofa
1510724|NCT00736723|severity of disease|severity of disease
1510725|NCT00736723|APACHEII|apacheii
1510726|NCT00736723|SAPSII|sapsii
1510727|NCT00736723|SPAPS3|spaps3
1510728|NCT00736723|length of stay|length of stay
1510729|NCT00736723|outcome|outcome
1510730|NCT00736723|mortality|mortality
1510731|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1510732|NCT00736710|Cigarette smoking|cigarette smoking
1510733|NCT00736710|Schizophrenia|schizophrenia
1510734|NCT00736710|Randomized|randomized
1510735|NCT00736710|Double-blind|double-blind
1510736|NCT00736710|Placebo-controlled|placebo-controlled
1510737|NCT00736710|longitudinal|longitudinal
1510738|NCT00736710|nicotine patch|nicotine patch
1510739|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
1510740|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
1510741|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
1510742|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
1510743|NCT00736684|complex femoral fractures|complex femoral fractures
1510744|NCT00736684|femoral nail|femoral nail
1510745|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
1510746|NCT00736684|complications|complications
1510747|NCT00736658|Japanese|japanese
1510748|NCT00736658|MAD|mad
1510749|NCT00736658|Multiple ascending dose|multiple ascending dose
1510750|NCT00736658|Chronic pain|chronic pain
1510751|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1510752|NCT00736645|stage I prostate cancer|stage i prostate cancer
1510753|NCT00736645|stage II prostate cancer|stage ii prostate cancer
1510754|NCT00736632|Vitamin D|vitamin d
1510755|NCT00736632|Insulin Resistance|insulin resistance
1510756|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1510757|NCT00736632|Cardiovascular Disease|cardiovascular disease
1510758|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
1510759|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1510760|NCT00736619|Radiation Therapy|radiation therapy
1510761|NCT00736619|08-084|08-084
1510762|NCT00736606|simvastatin|simvastatin
1510763|NCT00736606|AZD5672|azd5672
1510764|NCT00736593|Wound|wound
1510765|NCT00736593|Healing|healing
1510766|NCT00736580|Cesarean delivery|cesarean delivery
1510767|NCT00736580|Surgical Needles|surgical needles
1510768|NCT00736580|blunt-tip needles|blunt-tip needles
1510769|NCT00736580|surgical glove perforation|surgical glove perforation
1510770|NCT00736567|Diarrhea|diarrhea
1510771|NCT00736567|Diagnostic|diagnostic
1510772|NCT00736567|Pediatric|pediatric
1510773|NCT00736554|Staphylococcus aureus|staphylococcus aureus
1510774|NCT00736554|CA-MRSA|ca-mrsa
1510775|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
1510776|NCT00736554|resistance|resistance
1510777|NCT00736554|emergency department|emergency department
1510778|NCT00736541|ARF|arf
1510779|NCT00736541|OLT|olt
1510780|NCT00736541|NAC|nac
1510781|NCT00736541|I/R injury|i/r injury
1510782|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
1510783|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
1510786|NCT00736489|beta2-agonist|beta2-agonist
1510787|NCT00736489|efficacy|efficacy
1510788|NCT00736489|inhalation|inhalation
1510912|NCT00735852|endometriosis|endometriosis
1510789|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
1510790|NCT00736476|vaccination|vaccination
1510791|NCT00736476|adults|adults
1510792|NCT00736463|HDL cholesterol|hdl cholesterol
1510793|NCT00736463|statin|statin
1510794|NCT00736463|inflammation|inflammation
1510795|NCT00736463|atherosclerosis|atherosclerosis
1510796|NCT00736463|prevention|prevention
1510797|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
1510798|NCT00736437|UV-induced|uv-induced
1510799|NCT00736437|Herpes labialis|herpes labialis
1510800|NCT00736437|time to healing|time to healing
1510801|NCT00736424|Epilepsy|epilepsy
1510802|NCT00736424|SUDEP|sudep
1510804|NCT00736411|infertility|infertility
1510805|NCT00736411|IVF|ivf
1510806|NCT00736411|acupuncture|acupuncture
1510807|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1510808|NCT00736372|cancer|cancer
1510809|NCT00736372|metastatic cancer|metastatic cancer
1510810|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
1510811|NCT00736346|Panic Disorder|panic disorder
1510812|NCT00736346|anxiety|anxiety
1510813|NCT00736346|chest pain|chest pain
1510814|NCT00736346|emergency department|emergency department
1510815|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
1510816|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
1510817|NCT00736320|early stage|early stage
1510818|NCT00736320|PET|pet
1510819|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
1510820|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
1510821|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1510822|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
1510823|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
1510824|NCT00736268|Lung Disease|lung disease
1510825|NCT00736268|Chronic Bronchitis|chronic bronchitis
1510826|NCT00736268|Emphysema|emphysema
1510827|NCT00736268|Caregiver stress|caregiver stress
1510828|NCT00736268|COPD|copd
1510829|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1510830|NCT00736255|ADHD|adhd
1510831|NCT00736255|Smoking|smoking
1510832|NCT00736242|HIV|hiv
1510833|NCT00736229|hyperglycemia|hyperglycemia
1510834|NCT00736229|acute coronary syndromes|acute coronary syndromes
1510835|NCT00736229|myocardial infarction|myocardial infarction
1510836|NCT00736216|cervical cancer|cervical cancer
1510837|NCT00736216|human papilloma virus infection|human papilloma virus infection
1510838|NCT00736203|fMRI|fmri
1510839|NCT00736203|non-smokers|non-smokers
1510840|NCT00736190|Hepatitis B|hepatitis b
1510841|NCT00736190|Hepatitis|hepatitis
1510842|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1510843|NCT00736190|Tenofovir DF|tenofovir df
1510844|NCT00736190|Asian-American|asian-american
1510845|NCT00736177|IVF|ivf
1510846|NCT00736177|blastocyst transfer|blastocyst transfer
1510847|NCT00736177|endometrium|endometrium
1510848|NCT00736177|embryo cryopreservation|embryo cryopreservation
1510849|NCT00736164|stage I prostate cancer|stage i prostate cancer
1510850|NCT00736164|stage II prostate cancer|stage ii prostate cancer
1510851|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1510852|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
1510853|NCT00736125|total knee arthroplasty|total knee arthroplasty
1510854|NCT00736125|cerebral emboli|cerebral emboli
1510855|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
1510856|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
1510857|NCT00736112|Food Allergy in Children|food allergy in children
1510858|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
1510859|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
1510860|NCT00736112|Middle Ear Fluid|middle ear fluid
1510861|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
1510862|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
1510863|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
1510864|NCT00736086|femoral artery|femoral artery
1510865|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
1510866|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
1510867|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
1510868|NCT00736086|early ambulation|early ambulation
1510971|NCT00735618|HRV|hrv
1510869|NCT00736086|vascular closure|vascular closure
1510870|NCT00736073|pancreatitis|pancreatitis
1510871|NCT00736060|Fever|fever
1510872|NCT00736060|Blood cultures|blood cultures
1510873|NCT00736047|Smokers|smokers
1510874|NCT00736047|smoking cessation|smoking cessation
1510875|NCT00736047|vaccine|vaccine
1510876|NCT00736047|antibodies|antibodies
1510877|NCT00736047|anti-nicotine|anti-nicotine
1510878|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
1510879|NCT00736021|PTSD|ptsd
1510880|NCT00736021|Pharmacological Treatment|pharmacological treatment
1510881|NCT00736021|SSRI|ssri
1510882|NCT00736021|Escitalopram|escitalopram
1510883|NCT00736021|Anxiety Disorders|anxiety disorders
1510884|NCT00736008|Factor V Leiden|factor v leiden
1510885|NCT00736008|Prothrombin Mutation|prothrombin mutation
1510886|NCT00736008|Hypercoagulability|hypercoagulability
1510887|NCT00736008|Pediatrics|pediatrics
1510888|NCT00735969|Non-Responder|non-responder
1510889|NCT00735969|Relapser|relapser
1510890|NCT00735969|High Dose Ribavirin|high dose ribavirin
1510891|NCT00735969|Peginterferon|peginterferon
1510892|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
1510893|NCT00735956|Screening|screening
1510894|NCT00735956|Brief Intervention|brief intervention
1510895|NCT00735943|Pegaptanib|pegaptanib
1510896|NCT00735943|macular degeneration|macular degeneration
1510897|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
1510898|NCT00735904|AG-013736|ag-013736
1510899|NCT00735904|axitinib|axitinib
1510900|NCT00735904|cisplatin|cisplatin
1510901|NCT00735904|gemcitabine|gemcitabine
1510902|NCT00735904|NSCLC|nsclc
1510903|NCT00735904|squamous cell|squamous cell
1510904|NCT00735904|lung cancer|lung cancer
1510905|NCT00735878|Lung Cancer|lung cancer
1510906|NCT00735878|Advanced Lung Cancer|advanced lung cancer
1510907|NCT00735878|NSCLC|nsclc
1510908|NCT00735865|Dry Eye Syndrome|dry eye syndrome
1510909|NCT00735865|Punctal Occlusion|punctal occlusion
1510910|NCT00735865|Punctal Plugs|punctal plugs
1510911|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
1510913|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
1510914|NCT00735826|resectable|resectable
1510915|NCT00735826|stage I-III|stage i-iii
1510916|NCT00735826|NSCLC|nsclc
1510917|NCT00735826|non-small cell lung cancer|non-small cell lung cancer
1510918|NCT00735826|vorinostat|vorinostat
1510919|NCT00735826|proof of principle|proof of principle
1510920|NCT00735826|resectable stage I to III NSCLC|resectable stage i to iii nsclc
1510921|NCT00735813|Catheterization, Central|catheterization, central
1510922|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
1510923|NCT00735813|Infection|infection
1510924|NCT00735813|Methods|methods
1510925|NCT00735813|Sepsis|sepsis
1510926|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
1510927|NCT00735813|Sonication|sonication
1510928|NCT00735813|Taurolidine|taurolidine
1510929|NCT00735813|Catheters, Indwelling|catheters, indwelling
1510930|NCT00735813|Pediatrics|pediatrics
1510931|NCT00735800|Dementia|dementia
1510932|NCT00735800|Caregivers|caregivers
1510933|NCT00735800|Alzheimer's disease|alzheimer's disease
1510934|NCT00735774|Healthy volunteer study|healthy volunteer study
1510935|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
1510936|NCT00735735|low back pain|low back pain
1510937|NCT00735735|chronic|chronic
1510938|NCT00735735|Substance P|substance p
1510939|NCT00735722|AF|af
1510940|NCT00735722|CAD|cad
1510941|NCT00735709|Depression|depression
1510942|NCT00735709|Depressive Disorder|depressive disorder
1510943|NCT00735709|Mood Disorder|mood disorder
1510944|NCT00735709|Mental Disorder|mental disorder
1510945|NCT00735709|Melancholia, Involutional|melancholia, involutional
1510946|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
1510947|NCT00735709|Drug Therapy|drug therapy
1510948|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
1510949|NCT00735696|Lung|lung
1510950|NCT00735696|NSCLC|nsclc
1510951|NCT00735683|Weight loss|weight loss
1510952|NCT00735683|Weight-loss drugs|weight-loss drugs
1510953|NCT00735683|Obesity|obesity
1510954|NCT00735683|Overweight|overweight
1510955|NCT00735683|Body weight|body weight
1510956|NCT00735683|Diet|diet
1510957|NCT00735683|Metabolic Disorder|metabolic disorder
1510958|NCT00735683|Nutrition Disorder|nutrition disorder
1510959|NCT00735670|SCI|sci
1510960|NCT00735657|Efficiency|efficiency
1510961|NCT00735657|Pars|pars
1510962|NCT00735657|Plana|plana
1510963|NCT00735657|Vitrectomy|vitrectomy
1510964|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
1510965|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
1510966|NCT00735618|Advanced Cancer|advanced cancer
1510967|NCT00735618|Cancer Patients|cancer patients
1510968|NCT00735618|Relaxation Therapy|relaxation therapy
1510969|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
1510970|NCT00735618|Guided Relaxation|guided relaxation
1510972|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
1510973|NCT00735605|obstructed defecation|obstructed defecation
1510974|NCT00735605|constipation|constipation
1510975|NCT00735605|puborectalis|puborectalis
1510976|NCT00735592|X rays findings|x rays findings
1510977|NCT00735579|major abdominal surgery|major abdominal surgery
1510978|NCT00735579|coagulation|coagulation
1510979|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
1510980|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
1510981|NCT00735566|gastric cancer|gastric cancer
1510982|NCT00735566|antiangiogenic factors|antiangiogenic factors
1510983|NCT00735566|TNM stage|tnm stage
1510984|NCT00735553|Uterine Fibroids|uterine fibroids
1510985|NCT00735527|seizures|seizures
1510986|NCT00735527|status epilepticus|status epilepticus
1510987|NCT00735527|lorazepam|lorazepam
1510988|NCT00735527|intra-nasal|intra-nasal
1510989|NCT00735514|radiation toxicity|radiation toxicity
1510990|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
1510991|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
1510992|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
1510993|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
1510994|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
1510995|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
1510996|NCT00735514|stage III cervical cancer|stage iii cervical cancer
1510997|NCT00735488|Thalassemia|thalassemia
1510998|NCT00735488|Sickle cell anemia|sickle cell anemia
1510999|NCT00735488|Carrier detection|carrier detection
1511000|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
1511001|NCT00735488|Genetic counseling|genetic counseling
1511002|NCT00735462|external genital warts|external genital warts
1511003|NCT00735462|perianal warts|perianal warts
1511004|NCT00735462|condylomata acuminata|condylomata acuminata
1511005|NCT00735462|human papilloma virus|human papilloma virus
1511006|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
1511007|NCT00735436|Malignant glioma|malignant glioma
1511008|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
1511009|NCT00735436|GBM|gbm
1511010|NCT00735436|Gliosarcoma|gliosarcoma
1511011|NCT00735436|Gliadel|gliadel
1511012|NCT00735436|Carmustine|carmustine
1511013|NCT00735436|Irinotecan|irinotecan
1511014|NCT00735436|CPT-11|cpt-11
1511015|NCT00735436|Camptosar|camptosar
1511016|NCT00735436|Avastin|avastin
1511017|NCT00735436|Bevacizumab|bevacizumab
1511018|NCT00735423|Healthy children|healthy children
1511019|NCT00735423|Brain Function|brain function
1511020|NCT00735423|Diet|diet
1511021|NCT00735423|Nutrition|nutrition
1511022|NCT00735423|Language|language
1511023|NCT00735423|fMRI|fmri
1511024|NCT00735423|ERP|erp
1511025|NCT00735423|Behavior|behavior
1511026|NCT00735410|Influenza vaccine|influenza vaccine
1511027|NCT00735410|Seasonal|seasonal
1511028|NCT00735410|Split|split
1511029|NCT00735397|Partial onset seizures|partial onset seizures
1511030|NCT00735384|sepsis|sepsis
1511031|NCT00735384|critical illness|critical illness
1511032|NCT00735384|muscle, skeletal|muscle, skeletal
1511033|NCT00735384|myopathy|myopathy
1511034|NCT00735384|isometric contraction|isometric contraction
1511035|NCT00735384|intensive care units|intensive care units
1511036|NCT00735384|torque|torque
1511037|NCT00735384|muscular atrophy|muscular atrophy
1511038|NCT00735384|malignant hyperthermia|malignant hyperthermia
1511039|NCT00735384|skin resistance|skin resistance
1511040|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
1511041|NCT00735358|cyanoacrylate|cyanoacrylate
1511042|NCT00735358|rebleeding|rebleeding
1511043|NCT00735358|complication|complication
1511044|NCT00735358|survival|survival
1511045|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
1511046|NCT00735345|Esophageal cancer|esophageal cancer
1511047|NCT00735345|Pre-operative|pre-operative
1511048|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
1511049|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
1511050|NCT00735345|EGFR|egfr
1511051|NCT00735345|Radiosensitivity|radiosensitivity
1511052|NCT00735345|Resection|resection
1511053|NCT00735332|Melanoma|melanoma
1511054|NCT00735332|Metastatic Melanoma|metastatic melanoma
1511055|NCT00735332|Phase II|phase ii
1511056|NCT00735332|Skin Cancer|skin cancer
1511057|NCT00735319|Neonatal Jaundice|neonatal jaundice
1511058|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
1511059|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
1511060|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
1511061|NCT00735306|Locally advanced|locally advanced
1511062|NCT00735306|Unresectable|unresectable
1511063|NCT00735293|hyperhidrosis|hyperhidrosis
1511064|NCT00735293|bromidrosis|bromidrosis
1511065|NCT00735293|bromhidrosis|bromhidrosis
1511066|NCT00735293|osmidrosis|osmidrosis
1511067|NCT00735293|hircismus|hircismus
1511068|NCT00735293|excessive|excessive
1511069|NCT00735293|underarm|underarm
1511070|NCT00735293|sweat|sweat
1511071|NCT00735293|perspiration|perspiration
1511072|NCT00735293|Body Odor|body odor
1511329|NCT00734630|lisinopril|lisinopril
1511073|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
1511074|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
1511075|NCT00735254|post|post
1511076|NCT00735254|surgical|surgical
1511077|NCT00735241|colon cancer|colon cancer
1511078|NCT00735241|colorectal cancer|colorectal cancer
1511079|NCT00735241|liver metastases|liver metastases
1511080|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
1511081|NCT00735241|yttrium-90|yttrium-90
1511082|NCT00735241|FOLFOX|folfox
1511083|NCT00735241|Bevacizumab|bevacizumab
1511084|NCT00735241|chemo-radiation|chemo-radiation
1511085|NCT00735228|surgery|surgery
1511086|NCT00735228|artificial pancreas|artificial pancreas
1511087|NCT00735228|tight glycemic control|tight glycemic control
1511088|NCT00735228|Liver|liver
1511089|NCT00735215|Breast cancer,|breast cancer,
1511090|NCT00735215|fulvestrant,|fulvestrant,
1511091|NCT00735215|postmenopausal,|postmenopausal,
1511092|NCT00735215|women|women
1511093|NCT00735215|locally advanced,|locally advanced,
1511094|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
1511095|NCT00735189|warfarin|warfarin
1511096|NCT00735189|anticoagulation|anticoagulation
1511097|NCT00735189|anticoagulation clinics|anticoagulation clinics
1511098|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
1511099|NCT00735176|Nerve Root Compression|nerve root compression
1511100|NCT00735176|Disc, intervertebral|disc, intervertebral
1511101|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
1511102|NCT00735176|Spondylosis|spondylosis
1511103|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
1511104|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
1511105|NCT00735176|Diskectomy|diskectomy
1511106|NCT00735176|Spinal Fusion|spinal fusion
1511107|NCT00735163|algorithm|algorithm
1511108|NCT00735163|tight glycemic control|tight glycemic control
1511109|NCT00735163|glucose control|glucose control
1511110|NCT00735163|intensive care|intensive care
1511111|NCT00735163|insulin|insulin
1511112|NCT00735163|ICU|icu
1511113|NCT00735150|Breast|breast
1511114|NCT00735150|Ovary|ovary
1511115|NCT00735150|Mutation carrier|mutation carrier
1511116|NCT00735137|Twins|twins
1511117|NCT00735137|Short cervix|short cervix
1511118|NCT00735137|Preterm birth|preterm birth
1511119|NCT00735137|Vaginal pessary|vaginal pessary
1511120|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
1511121|NCT00735111|QOL|qol
1511122|NCT00735111|Quality of Life|quality of life
1511123|NCT00735111|KPS|kps
1511124|NCT00735111|Karnofsky Performance Status|karnofsky performance status
1511125|NCT00735111|Cancer|cancer
1511126|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
1511127|NCT00735098|arthritis|arthritis
1511128|NCT00735085|Brain Injury|brain injury
1511129|NCT00735072|HIV infection|hiv infection
1511130|NCT00735072|T cell activation|t cell activation
1511131|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
1511132|NCT00735072|CCR5|ccr5
1511133|NCT00735072|Maraviroc|maraviroc
1511134|NCT00735059|dialysis membrane|dialysis membrane
1511135|NCT00735059|Polynephron|polynephron
1511136|NCT00735059|Elisio H|elisio h
1511137|NCT00735059|Polyethersulfone|polyethersulfone
1511138|NCT00735059|Diapes|diapes
1511139|NCT00735059|PES-DS|pes-ds
1511140|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
1511141|NCT00735059|hemodialysis|hemodialysis
1511142|NCT00735059|protein-bound toxins|protein-bound toxins
1511143|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
1511144|NCT00735059|hemodialysis patients|hemodialysis patients
1511145|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
1511146|NCT00735033|Physical therapy|physical therapy
1511147|NCT00735033|Physical therapy modalities|physical therapy modalities
1511148|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
1511149|NCT00735020|influenza|influenza
1511150|NCT00735020|vaccine|vaccine
1511151|NCT00735020|adjuvants|adjuvants
1511152|NCT00735020|flu|flu
1511153|NCT00735007|Multiple Sclerosis|multiple sclerosis
1511154|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
1511155|NCT00734968|suburethral sling|suburethral sling
1511156|NCT00734968|Prevention|prevention
1511157|NCT00734968|Nitrofurantoin|nitrofurantoin
1511158|NCT00734968|Prophylaxis|prophylaxis
1511159|NCT00734955|Partial Mastectomy|partial mastectomy
1511160|NCT00734955|Lumpectomy|lumpectomy
1511161|NCT00734955|Mastectomy|mastectomy
1511162|NCT00734942|young carers|young carers
1511163|NCT00734942|family support|family support
1511164|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
1511165|NCT00734929|PONV|ponv
1511166|NCT00734929|nausea|nausea
1511167|NCT00734929|emesis|emesis
1511168|NCT00734929|antiemetics|antiemetics
1511169|NCT00734929|aprepitant|aprepitant
1511170|NCT00734929|ondansetron|ondansetron
1511171|NCT00734929|dexamethasone|dexamethasone
1511172|NCT00734916|total parenteral nutrition|total parenteral nutrition
1511173|NCT00734916|infections|infections
1511239|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1511174|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
1511175|NCT00734903|Women|women
1511176|NCT00734903|Substance Use Disorders|substance use disorders
1511177|NCT00734903|Treatment Efficacy|treatment efficacy
1511178|NCT00734903|Women's Health|women's health
1511179|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
1511180|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1511181|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1511182|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1511183|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1511184|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1511185|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1511186|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1511187|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1511188|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1511189|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1511190|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1511191|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1511192|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1511193|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1511194|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1511195|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1511196|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1511197|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1511198|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1511199|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1511200|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1511201|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1511202|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1511203|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1511204|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1511205|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1511206|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1511207|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1511208|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1511209|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
1511210|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1511211|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1511212|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1511213|NCT00734890|intraocular lymphoma|intraocular lymphoma
1511214|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1511215|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1511216|NCT00734890|small intestine lymphoma|small intestine lymphoma
1511217|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
1511218|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1511219|NCT00734890|large cell lung cancer|large cell lung cancer
1511220|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1567609|NCT00508703|Cervical Cancer|cervical cancer
1671231|NCT00103025|HV|hv
1511221|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1511222|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1511223|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1511224|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1511225|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1511226|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1511227|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1511228|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1511229|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1511230|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1511231|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1511232|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1511233|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1511234|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1511235|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1511236|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1511237|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1511238|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1511240|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1511241|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1511242|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1511243|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1511244|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1511245|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1511246|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1511341|NCT00734552|Low Protein Diet|low protein diet
1511247|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1511248|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1511249|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1511250|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1511251|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1511252|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1511253|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1511254|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1511255|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1511256|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1511257|NCT00734864|Dasatinib|dasatinib
1511258|NCT00734864|Sprycel|sprycel
1511259|NCT00734864|Temozolomide|temozolomide
1511260|NCT00734864|Temodar|temodar
1511261|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
1511262|NCT00734864|Malignant Glioma|malignant glioma
1511263|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
1511264|NCT00734864|gliosarcoma|gliosarcoma
1511265|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
1511266|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1511267|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
1511268|NCT00734864|glioma|glioma
1511269|NCT00734851|prostate cancer|prostate cancer
1511270|NCT00734851|sunitinib|sunitinib
1511271|NCT00734851|docetaxel|docetaxel
1511272|NCT00734851|PSA|psa
1511273|NCT00734851|radiation|radiation
1511274|NCT00734851|PSA recurrence|psa recurrence
1511275|NCT00734851|No metastatic disease|no metastatic disease
1511276|NCT00734838|Breast Cancer|breast cancer
1511277|NCT00734838|Breast Biopsy|breast biopsy
1511278|NCT00734838|Reduction mammoplasty|reduction mammoplasty
1511279|NCT00734825|Appendicitis|appendicitis
1511280|NCT00734825|IV Contrast|iv contrast
1511281|NCT00734825|Oral Contrast|oral contrast
1511282|NCT00734825|CT scan|ct scan
1511283|NCT00734812|Hysterectomy|hysterectomy
1511284|NCT00734812|Laparoscopic|laparoscopic
1511285|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
1511286|NCT00734799|Insomnia,|insomnia,
1511287|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
1511288|NCT00734799|IRT,|irt,
1511289|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
1511290|NCT00734799|CBTI.|cbti.
1511291|NCT00734786|gonyautoxin|gonyautoxin
1511292|NCT00734773|neurotoxicity|neurotoxicity
1511293|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1511294|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1511295|NCT00734760|patient education|patient education
1511296|NCT00734760|acute coronary syndrome|acute coronary syndrome
1511297|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
1511298|NCT00734747|GERD|gerd
1511299|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
1511300|NCT00734747|Fundoplication|fundoplication
1511301|NCT00734747|Endoluminal|endoluminal
1511302|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
1511303|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
1511304|NCT00734734|Influenza Vaccines|influenza vaccines
1511305|NCT00734734|MF59C.1|mf59c.1
1511306|NCT00734721|intravitreal injection|intravitreal injection
1511307|NCT00734695|BURN|burn
1511308|NCT00734695|EYE|eye
1511309|NCT00734695|VITAMIN C|vitamin c
1511310|NCT00734695|ASCORBIC ACID|ascorbic acid
1511311|NCT00734682|Glioblastoma|glioblastoma
1511312|NCT00734682|Gliosarcoma|gliosarcoma
1511313|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
1511314|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
1511315|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
1511316|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
1511317|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
1511318|NCT00734682|liposomal irinotecan|liposomal irinotecan
1511319|NCT00734669|Diabetes|diabetes
1511320|NCT00734669|Hypoglycemia|hypoglycemia
1511321|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
1511322|NCT00734656|dutasteride|dutasteride
1511323|NCT00734656|neuroactive steroid|neuroactive steroid
1511324|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1511325|NCT00734643|Family coping|family coping
1511326|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
1511327|NCT00734630|nebivolol|nebivolol
1511328|NCT00734630|Bystolic ™|bystolic ™
1511330|NCT00734630|losartan|losartan
1511331|NCT00734630|Hypertension|hypertension
1511332|NCT00734617|Cigarette|cigarette
1511333|NCT00734617|Nicotine|nicotine
1511334|NCT00734591|Observational Study Exubera|observational study exubera
1511335|NCT00734565|vaccine|vaccine
1511336|NCT00734565|prevention|prevention
1511337|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
1511338|NCT00734565|children|children
1511339|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
1511340|NCT00734552|α-Keto Acid|α-keto acid
1511342|NCT00734552|Residual Renal Function|residual renal function
1511344|NCT00734539|Neonate|neonate
1511345|NCT00734539|Fluconazole|fluconazole
1511346|NCT00734539|Prophylaxis|prophylaxis
1511347|NCT00734539|Colonization|colonization
1511348|NCT00734539|Resistance|resistance
1511349|NCT00734526|Glioblastoma|glioblastoma
1511350|NCT00734526|Gliosarcoma|gliosarcoma
1511351|NCT00734526|Brain Cancer|brain cancer
1511352|NCT00734526|Sorafenib|sorafenib
1511353|NCT00734526|Temozolomide|temozolomide
1511354|NCT00734526|Radiation|radiation
1511355|NCT00734526|Radiotherapy|radiotherapy
1511356|NCT00734526|XRT|xrt
1511357|NCT00734513|GI Cancer|gi cancer
1511358|NCT00734513|Emotional Disclosure|emotional disclosure
1511359|NCT00734513|Behavioral Intervention|behavioral intervention
1511360|NCT00734513|Partner|partner
1511361|NCT00734513|Couples|couples
1511362|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
1511363|NCT00734487|Optical Coherence Tomography|optical coherence tomography
1511364|NCT00734487|AREDS2|areds2
1511365|NCT00734487|AMD|amd
1511366|NCT00734487|Age-related macular degeneration|age-related macular degeneration
1511367|NCT00734487|Drusen|drusen
1511368|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
1511369|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
1511370|NCT00734461|history of opioid abuse|history of opioid abuse
1511371|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
1511372|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
1511373|NCT00734448|myo-inositol|myo-inositol
1511374|NCT00734448|insulin resistance|insulin resistance
1511375|NCT00734435|schizophrenia|schizophrenia
1511376|NCT00734435|schizophreniform|schizophreniform
1511377|NCT00734435|schizoaffective disorder|schizoaffective disorder
1511378|NCT00734435|Zyprexa|zyprexa
1511379|NCT00734435|olanzapine|olanzapine
1511380|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
1511381|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1511382|NCT00734422|Fear extinction|fear extinction
1511383|NCT00734422|Yohimbine|yohimbine
1511384|NCT00734409|Mechanical ventilation|mechanical ventilation
1511385|NCT00734409|Human|human
1511386|NCT00734409|conscious sedation|conscious sedation
1511387|NCT00734409|bispectral index|bispectral index
1511388|NCT00734409|monitoring|monitoring
1511389|NCT00734409|critical care|critical care
1511390|NCT00734409|propofol|propofol
1511391|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
1511392|NCT00734396|Allograft rejection|allograft rejection
1511393|NCT00734396|Subclinical rejection|subclinical rejection
1511394|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
1511395|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
1511396|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
1511397|NCT00734383|diabetes|diabetes
1511398|NCT00734383|myocardial injury markers,|myocardial injury markers,
1511399|NCT00734383|sex differences|sex differences
1511400|NCT00734383|cardiac anesthesia|cardiac anesthesia
1511401|NCT00734383|inhalational anesthetics|inhalational anesthetics
1511402|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
1511403|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
1511404|NCT00734357|contrast|contrast
1511406|NCT00734357|cat scan|cat scan
1511407|NCT00734357|kidney|kidney
1511408|NCT00734357|nephrotoxicity|nephrotoxicity
1511409|NCT00734357|Computerized Emission Tomography|computerized emission tomography
1511410|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
1511411|NCT00734331|micro RNA|micro rna
1511412|NCT00734331|cholinergic tone|cholinergic tone
1511413|NCT00734331|inflammation|inflammation
1511414|NCT00734318|Severe asthma|severe asthma
1511415|NCT00734318|Fluticasone|fluticasone
1511416|NCT00734318|Formoterol|formoterol
1511417|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
1511418|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
1511419|NCT00734292|Asthma|asthma
1511420|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
1511421|NCT00734279|Puberty|puberty
1511422|NCT00734279|Delayed|delayed
1511423|NCT00734279|Early|early
1511424|NCT00734279|Precocious|precocious
1511425|NCT00734279|Peripubertal|peripubertal
1511426|NCT00734279|Gonadotropin|gonadotropin
1511427|NCT00734279|FSH|fsh
1511428|NCT00734279|LH|lh
1511429|NCT00734266|COPD|copd
1511430|NCT00734266|CPB|cpb
1511431|NCT00734266|Leukotrienes|leukotrienes
1511432|NCT00734253|Nephropathy|nephropathy
1511433|NCT00734253|Kidney Disease|kidney disease
1511434|NCT00734253|Diabetes|diabetes
1511435|NCT00734253|Pyridoxamine|pyridoxamine
1511436|NCT00734253|Pyridorin|pyridorin
1511437|NCT00734253|NephroGenex|nephrogenex
1511438|NCT00734253|PYR-210|pyr-210
1511439|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
1511440|NCT00734214|Parenteral Fluids|parenteral fluids
1511441|NCT00734214|Isotonic|isotonic
1511442|NCT00734214|Hypotonic|hypotonic
1511443|NCT00734214|Pediatric|pediatric
1511444|NCT00734214|Fluid overload|fluid overload
1511445|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
1511446|NCT00734175|Vaccine|vaccine
1511447|NCT00734175|Influenza|influenza
1511448|NCT00734162|tenofovir|tenofovir
1511449|NCT00734162|adolescents|adolescents
1511450|NCT00734162|chronic hepatitis B|chronic hepatitis b
1511451|NCT00734149|Multiple myeloma|multiple myeloma
1511452|NCT00734136|Angiogenic Factors|angiogenic factors
1511453|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
1511454|NCT00734136|Liver Disease|liver disease
1511455|NCT00734136|Renal Failure|renal failure
1511456|NCT00734136|Liver Cirrhosis|liver cirrhosis
1511457|NCT00734136|Ascites|ascites
1511458|NCT00734123|Atherosclerosis|atherosclerosis
1511459|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
1511460|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
1511461|NCT00734123|Ankle-Brachial Index|ankle-brachial index
1511462|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
1511463|NCT00734097|heartburn|heartburn
1511464|NCT00734097|reflux|reflux
1511465|NCT00734097|proton|proton
1511466|NCT00734097|pump|pump
1511467|NCT00734097|inhibitor|inhibitor
1511468|NCT00734084|Arthroplasty|arthroplasty
1511469|NCT00734084|Knee|knee
1511471|NCT00734084|Partial|partial
1511472|NCT00734084|Preservation|preservation
1511473|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
1511474|NCT00734071|Mood Disorder|mood disorder
1511475|NCT00734071|Affective Disorder|affective disorder
1511476|NCT00734071|Anxiety Disorder|anxiety disorder
1511477|NCT00734071|Drug Therapy|drug therapy
1511478|NCT00734058|Ablation|ablation
1511479|NCT00734058|AF|af
1511480|NCT00734058|Atrial Fibrillation|atrial fibrillation
1511481|NCT00734058|Cardiac|cardiac
1511482|NCT00734058|Endocardial|endocardial
1511483|NCT00734058|Endocardium|endocardium
1511484|NCT00734058|EP|ep
1511485|NCT00734058|Electrophysiology|electrophysiology
1511486|NCT00734058|Epicardial|epicardial
1511487|NCT00734058|Epicardium|epicardium
1511488|NCT00734058|Heart|heart
1511489|NCT00734058|Interventional|interventional
1511490|NCT00734058|Lesion|lesion
1511491|NCT00734058|PVI|pvi
1511492|NCT00734058|Pulmonary Vein|pulmonary vein
1511493|NCT00734058|MAZE|maze
1511494|NCT00734058|Surgery|surgery
1511495|NCT00734058|Surgical|surgical
1511496|NCT00734058|Treatment|treatment
1511497|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
1511498|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
1511499|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
1511500|NCT00734045|NT-proBNP|nt-probnp
1511501|NCT00734032|SB-480848|sb-480848
1511502|NCT00734032|Dyslipidaemia|dyslipidaemia
1511503|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
1511504|NCT00734006|Cortico-cortical|cortico-cortical
1511505|NCT00734006|connectivity|connectivity
1511506|NCT00734006|Transcranial|transcranial
1511507|NCT00734006|Magnetic|magnetic
1511508|NCT00734006|Stimulation|stimulation
1511509|NCT00733993|substance abuse|substance abuse
1511511|NCT00733993|caffeine|caffeine
1511512|NCT00733993|impulsivity|impulsivity
1511513|NCT00733980|Depressive Disorder, Major|depressive disorder, major
1511514|NCT00733967|Methamphetamine|methamphetamine
1511515|NCT00733967|Chantix|chantix
1511516|NCT00733967|Varenicline|varenicline
1511517|NCT00733941|Exercise test|exercise test
1511518|NCT00733941|Running|running
1511519|NCT00733941|Arterial diameter|arterial diameter
1511520|NCT00733941|Monitoring, physiologic|monitoring, physiologic
1511521|NCT00733941|Oxygen Consumption|oxygen consumption
1511522|NCT00733928|Arthroplasty,|arthroplasty,
1511523|NCT00733928|Replacement,|replacement,
1511524|NCT00733928|Knee,|knee,
1511525|NCT00733928|P.F.C.|p.f.c.
1511526|NCT00733928|Sigma|sigma
1511527|NCT00733928|all-polyethylene|all-polyethylene
1511528|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
1511529|NCT00733902|monoclonal antibody|monoclonal antibody
1511530|NCT00733902|RN624|rn624
1511531|NCT00733902|PF-04383119|pf-04383119
1511532|NCT00733902|nerve growth factor|nerve growth factor
1511533|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
1511534|NCT00733902|OA|oa
1511535|NCT00733902|pain|pain
1511536|NCT00733889|esophageal carcinoma|esophageal carcinoma
1511537|NCT00733889|cetuximab|cetuximab
1511538|NCT00733889|docetaxel|docetaxel
1511539|NCT00733889|cisplatin|cisplatin
1511540|NCT00733889|5-fluorouracil|5-fluorouracil
1511541|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
1511542|NCT00733863|Active immunization|active immunization
1511543|NCT00733863|Alzheimer disease|alzheimer disease
1511544|NCT00733863|Antibody|antibody
1511545|NCT00733863|Central Nervous System Diseases|central nervous system diseases
1511546|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
1511547|NCT00733863|Vaccine|vaccine
1511548|NCT00733824|Plerixafor|plerixafor
1511549|NCT00733824|Lymphoma|lymphoma
1511550|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
1511551|NCT00733824|Transplantation, Autologous|transplantation, autologous
1511552|NCT00733824|Receptors, CXCR4|receptors, cxcr4
1511553|NCT00733811|thalassemia major|thalassemia major
1511554|NCT00733811|chelation treatment|chelation treatment
1511555|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
1511556|NCT00733798|Melanoma|melanoma
1511557|NCT00733798|Malignant melanoma|malignant melanoma
1511558|NCT00733798|metastatic melanoma|metastatic melanoma
1511559|NCT00733798|Phase 1|phase 1
1511560|NCT00733798|Phase 2|phase 2
1511561|NCT00733785|Rosiglitazone XR|rosiglitazone xr
1511562|NCT00733785|Pharmacokinetics|pharmacokinetics
1511563|NCT00733785|Strength Equivalence.|strength equivalence.
1511564|NCT00733785|Alzheimers Disease|alzheimers disease
1511565|NCT00733785|Repeat dose|repeat dose
1511566|NCT00733785|Dose proportionality|dose proportionality
1511567|NCT00733772|flaxseed|flaxseed
1511568|NCT00733772|lignans|lignans
1511569|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
1511570|NCT00733772|LDL Cholesterol|ldl cholesterol
1511571|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1511572|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
1511573|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
1511574|NCT00733733|kidney|kidney
1511575|NCT00733733|transplantation|transplantation
1511576|NCT00733733|non-heart-beating donor|non-heart-beating donor
1511577|NCT00733733|delayed graft function|delayed graft function
1511578|NCT00733733|Antithymocyte globulin|antithymocyte globulin
1511579|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
1511580|NCT00733707|adherence|adherence
1511581|NCT00733707|oral contraceptive pills|oral contraceptive pills
1511582|NCT00733707|contraception|contraception
1511583|NCT00733707|text messaging|text messaging
1511584|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
1511585|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1511586|NCT00733681|Prosthesis Failure|prosthesis failure
1511587|NCT00733681|Revision surgery|revision surgery
1511588|NCT00733668|considered|considered
1511589|NCT00733668|entry|entry
1511590|NCT00733668|into|into
1511591|NCT00733668|the study|the study
1511592|NCT00733668|SSRI|ssri
1511593|NCT00733668|Seroquel|seroquel
1511594|NCT00733668|Quetiapine|quetiapine
1511595|NCT00733668|fumarate|fumarate
1511596|NCT00733668|antipsychotic|antipsychotic
1511597|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
1511598|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
1511599|NCT00733616|docetaxel|docetaxel
1511600|NCT00733616|oxaliplatin|oxaliplatin
1511601|NCT00733616|capecitabine|capecitabine
1511602|NCT00733616|intermediate general status|intermediate general status
1511603|NCT00733603|Interstitial Cystitis|interstitial cystitis
1511604|NCT00733603|IC|ic
1511605|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
1511606|NCT00733603|PBS|pbs
1511607|NCT00733603|Bladder Pain|bladder pain
1511608|NCT00733603|Pelvic Pain|pelvic pain
1511609|NCT00733590|defibrillator, implanted|defibrillator, implanted
1511610|NCT00733590|genomics|genomics
1511611|NCT00733590|electrocardiography|electrocardiography
1511612|NCT00733590|electrophysiological study|electrophysiological study
1511613|NCT00733590|proteomics|proteomics
1511614|NCT00733577|diabetes|diabetes
1511615|NCT00733577|pharmacodynamics|pharmacodynamics
1511616|NCT00733577|safety|safety
1511617|NCT00733577|pharmacokinetics|pharmacokinetics
1511618|NCT00733564|Local anesthetic|local anesthetic
1511619|NCT00733564|Propofol|propofol
1511620|NCT00733564|Sevoflurane|sevoflurane
1511621|NCT00733551|motilin|motilin
1511622|NCT00733551|gastric emptying|gastric emptying
1511623|NCT00733551|GSK962040|gsk962040
1511624|NCT00733551|oral dose|oral dose
1511625|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
1511626|NCT00733525|Bulimia Nervosa|bulimia nervosa
1511627|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
1511628|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
1511629|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
1511630|NCT00733473|Wheezing|wheezing
1511631|NCT00733473|Acute asthma|acute asthma
1511632|NCT00733473|Children|children
1511633|NCT00733460|BFPET|bfpet
1511634|NCT00733460|Coronary Artery Disease|coronary artery disease
1511635|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
1511636|NCT00733460|Radiation Dosimetry|radiation dosimetry
1511637|NCT00733447|Biventricular failure|biventricular failure
1511638|NCT00733434|Microsurgery|microsurgery
1511639|NCT00733434|Head and neck|head and neck
1511640|NCT00733434|Prostaglandin E1|prostaglandin e1
1511641|NCT00733434|Thrombosis|thrombosis
1511642|NCT00733434|Complication|complication
1511643|NCT00733421|Day surgery|day surgery
1511644|NCT00733421|Hallux Valgus|hallux valgus
1511645|NCT00733421|Pain|pain
1511646|NCT00733421|Analgesics|analgesics
1511647|NCT00733395|Muscle pain|muscle pain
1511648|NCT00733382|migraine|migraine
1511649|NCT00733382|dexamethasone|dexamethasone
1511650|NCT00733382|dihydroergotamine|dihydroergotamine
1511651|NCT00733369|Arthroplasty|arthroplasty
1511652|NCT00733369|Replacement|replacement
1511653|NCT00733369|Knee|knee
1511654|NCT00733369|PFC Sigma RPF|pfc sigma rpf
1511655|NCT00733369|PFC Sigma RP|pfc sigma rp
1511656|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1511657|NCT00733356|ADHD|adhd
1511659|NCT00733356|reading|reading
1511660|NCT00733356|brain hemodynamics|brain hemodynamics
1511661|NCT00733356|brain imaging|brain imaging
1511662|NCT00733356|attention|attention
1511663|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
1511664|NCT00733356|NIRS|nirs
1511665|NCT00733356|MSIT|msit
1511666|NCT00733343|heart failure|heart failure
1511667|NCT00733343|sleep disordered breathing|sleep disordered breathing
1511668|NCT00733343|sleep apnea|sleep apnea
1511669|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
1511670|NCT00733343|SBAS|sbas
1511671|NCT00733343|HF|hf
1511672|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
1511673|NCT00733317|Wheezing|wheezing
1511674|NCT00733317|Acute asthma|acute asthma
1511675|NCT00733317|Children|children
1511676|NCT00733317|Budesonide|budesonide
1511677|NCT00733317|Emergency room|emergency room
1511678|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1511679|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1511680|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1511681|NCT00733304|pazopanib|pazopanib
1511682|NCT00733304|angiogenesis|angiogenesis
1511683|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
1511684|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
1511685|NCT00733278|Postpartum contraception|postpartum contraception
1511686|NCT00733278|Copper IUD|copper iud
1511687|NCT00733265|Renal Impairment|renal impairment
1511688|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
1511689|NCT00733252|small cell lung cancer|small cell lung cancer
1511690|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
1511691|NCT00733252|lung papilloma|lung papilloma
1511692|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
1511693|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
1511694|NCT00733252|malignant mesothelioma|malignant mesothelioma
1511695|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1511696|NCT00733252|lung metastases|lung metastases
1511697|NCT00733239|methadone|methadone
1511698|NCT00733239|opioid dependence|opioid dependence
1511699|NCT00733239|opioid|opioid
1511700|NCT00733226|wheezing|wheezing
1511701|NCT00733226|asthma|asthma
1511702|NCT00733226|childhood|childhood
1511703|NCT00733226|OM-85 BV|om-85 bv
1511704|NCT00733226|Broncho-Vaxom|broncho-vaxom
1511705|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
1511706|NCT00733200|Minor Liver Resection|minor liver resection
1511707|NCT00733200|Major Liver Resection|major liver resection
1511708|NCT00733200|Hilar|hilar
1511709|NCT00733174|IGT|igt
1511710|NCT00733161|passive leg exercise|passive leg exercise
1511711|NCT00733161|congestive heart failure|congestive heart failure
1511712|NCT00733161|endothelium-derived factors|endothelium-derived factors
1511713|NCT00733161|elderly|elderly
1511714|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
1511715|NCT00733135|peripheral vascular disease|peripheral vascular disease
1511716|NCT00733135|atherectomy|atherectomy
1511717|NCT00733135|atherosclerosis|atherosclerosis
1511718|NCT00733135|calcified lesions|calcified lesions
1511719|NCT00733109|CIN2|cin2
1511720|NCT00733109|management|management
1511721|NCT00733096|radiculopathy|radiculopathy
1511722|NCT00733096|sciatica|sciatica
1511723|NCT00733096|low back pain|low back pain
1511724|NCT00733083|tonsillectomy|tonsillectomy
1511725|NCT00733083|paediatric|paediatric
1511726|NCT00733083|pain|pain
1511727|NCT00733083|child|child
1511728|NCT00733083|opiates|opiates
1511729|NCT00733083|pre-emptive|pre-emptive
1511730|NCT00733083|oxycodone|oxycodone
1511731|NCT00733083|morphine|morphine
1511732|NCT00733083|dexamethasone|dexamethasone
1511733|NCT00733070|CTO|cto
1511734|NCT00733070|Chronic Total Occlusion|chronic total occlusion
1511735|NCT00733070|Revascularization|revascularization
1511736|NCT00733057|Minocycline|minocycline
1511737|NCT00733057|Schizophrenia|schizophrenia
1511738|NCT00733057|Negative symptoms|negative symptoms
1511739|NCT00733057|Cognitive|cognitive
1511740|NCT00733044|Objective tinnitus|objective tinnitus
1511741|NCT00733044|Tinnitus|tinnitus
1511742|NCT00733044|RCT|rct
1511743|NCT00733044|Specialised treatment|specialised treatment
1511744|NCT00733044|Usual care|usual care
1511745|NCT00733044|Cost-effectiveness|cost-effectiveness
1511746|NCT00733031|Phase I,|phase i,
1511747|NCT00733031|cancer,|cancer,
1511748|NCT00733031|solid tumors,|solid tumors,
1511749|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
1511750|NCT00733031|dose escalation,|dose escalation,
1511751|NCT00733031|combination treatment,|combination treatment,
1511752|NCT00733031|TRK inhibitor|trk inhibitor
1511753|NCT00733018|Nutrigenomics|nutrigenomics
1511754|NCT00733018|Gene Expression|gene expression
1511755|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
1511756|NCT00733018|Life Style|life style
1511757|NCT00733018|Health Behavior|health behavior
1511758|NCT00732992|Solid tumor|solid tumor
1511759|NCT00732992|malignancy|malignancy
1511760|NCT00732992|sunitinib|sunitinib
1511761|NCT00732992|pemetrexed|pemetrexed
1511762|NCT00732992|phase 1|phase 1
1511763|NCT00732992|neoplasms|neoplasms
1511764|NCT00732979|Elective|elective
1511765|NCT00732979|hepatic|hepatic
1511766|NCT00732979|resection|resection
1511767|NCT00732979|due to any|due to any
1511768|NCT00732979|reason.|reason.
1511769|NCT00732966|cyp2c9|cyp2c9
1511770|NCT00732966|losartan|losartan
1511771|NCT00732966|pharmacogenetics|pharmacogenetics
1511772|NCT00732966|pharmacokinetics|pharmacokinetics
1511773|NCT00732966|pharmacodynamics|pharmacodynamics
1511774|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
1511775|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
1511776|NCT00732953|stent implantation|stent implantation
1511777|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
1511778|NCT00732953|angiographic follow-up|angiographic follow-up
1511779|NCT00732953|clinical follow-up|clinical follow-up
1511780|NCT00732940|SLE|sle
1511781|NCT00732940|Lupus|lupus
1511782|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
1511783|NCT00732940|Antibodies|antibodies
1511784|NCT00732940|Autoimmune Diseases|autoimmune diseases
1511785|NCT00732940|Belimumab|belimumab
1511786|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
1511787|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
1511788|NCT00732914|Sunitinib|sunitinib
1511789|NCT00732914|Sorafenib|sorafenib
1511790|NCT00732914|Sequential|sequential
1511791|NCT00732901|substance abuse|substance abuse
1511792|NCT00732901|cocaine|cocaine
1511793|NCT00732901|impulsivity|impulsivity
1511794|NCT00732901|serotonin|serotonin
1511795|NCT00732901|Remeron|remeron
1511796|NCT00732901|Mirtzapine|mirtzapine
1511797|NCT00732901|Lexapro|lexapro
1511798|NCT00732901|Escatilopram|escatilopram
1511799|NCT00732888|Pharmacokinetics|pharmacokinetics
1511800|NCT00732888|Healthy volunteers|healthy volunteers
1511801|NCT00732888|No condition|no condition
1511802|NCT00732888|Pharmacokinetics study|pharmacokinetics study
1511803|NCT00732862|Type 2 diabetes|type 2 diabetes
1511804|NCT00732862|intensive therapy|intensive therapy
1511805|NCT00732849|immunonutrition|immunonutrition
1511806|NCT00732849|surgical patients|surgical patients
1511807|NCT00732849|postoperative period|postoperative period
1511808|NCT00732836|Liver Cancer|liver cancer
1511809|NCT00732836|Solid Cancer|solid cancer
1511810|NCT00732836|Abraxane|abraxane
1511811|NCT00732836|nab paclitaxel|nab paclitaxel
1511812|NCT00732836|HAI abraxane|hai abraxane
1511813|NCT00732836|HAI|hai
1511814|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
1511815|NCT00732836|hepatic metastases|hepatic metastases
1511816|NCT00732797|Dizziness|dizziness
1511817|NCT00732797|Self-management|self-management
1511818|NCT00732797|booklet-based|booklet-based
1511819|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
1511820|NCT00732784|Pharmacokinetics|pharmacokinetics
1511821|NCT00732784|Healthy volunteers|healthy volunteers
1511822|NCT00732784|No condition|no condition
1511823|NCT00732784|Pharmacokinetics study|pharmacokinetics study
1511824|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
1511825|NCT00732771|hypokalemia|hypokalemia
1511826|NCT00732771|hypertension|hypertension
1511827|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
1511828|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
1511829|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
1511830|NCT00732758|Child|child
1511831|NCT00732758|Adolescent|adolescent
1511832|NCT00732758|African American|african american
1511833|NCT00732758|Caucasian|caucasian
1511834|NCT00732758|Definition|definition
1511835|NCT00732758|Preadolescent|preadolescent
1511836|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1511837|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
1511838|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1511839|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
1511840|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
1511841|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
1511842|NCT00732732|diarrhea|diarrhea
1511843|NCT00732732|Plantain|plantain
1511844|NCT00732732|Green banana|green banana
1511845|NCT00732732|Infants|infants
1511846|NCT00732732|Children|children
1511847|NCT00732706|FNB|fnb
1511848|NCT00732706|Femoral Nerve|femoral nerve
1511849|NCT00732706|Sartorius Twitch|sartorius twitch
1511850|NCT00732706|Quadriceps Twitch|quadriceps twitch
1511851|NCT00732706|Analgesia|analgesia
1511852|NCT00732706|Anesthesia|anesthesia
1511853|NCT00732693|Premature ovarian failure|premature ovarian failure
1511854|NCT00732693|Sex hormone replacement|sex hormone replacement
1511855|NCT00732693|HRT|hrt
1511856|NCT00732693|Blood pressure|blood pressure
1511857|NCT00732693|Bone mineral density|bone mineral density
1511858|NCT00732693|Bone metabolism|bone metabolism
1511859|NCT00732693|Uterine function|uterine function
1511860|NCT00732680|Empty nose syndrome|empty nose syndrome
1511861|NCT00732680|Over resection of turbinate|over resection of turbinate
1511862|NCT00732680|Atrophic rhinitis|atrophic rhinitis
1511863|NCT00732654|Food Allergy|food allergy
1511864|NCT00732654|Oral Immunotherapy|oral immunotherapy
1511865|NCT00732654|Immunoglobulin E|immunoglobulin e
1511866|NCT00732615|Hypoparathyroidism|hypoparathyroidism
1511867|NCT00732602|Glucagon|glucagon
1511868|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
1511869|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
1511870|NCT00732589|suprascapular nerve block|suprascapular nerve block
1511871|NCT00732589|shoulder pain|shoulder pain
1511872|NCT00732589|hemiplegia|hemiplegia
1511873|NCT00732576|Cardiovascular|cardiovascular
1511874|NCT00732576|Calcification|calcification
1511875|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1511876|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1511877|NCT00732550|cholelithiasis|cholelithiasis
1511878|NCT00732550|cholecystitis|cholecystitis
1511879|NCT00732537|Hypoxia|hypoxia
1511880|NCT00732537|Respiratory failure|respiratory failure
1511881|NCT00732537|Infant, term|infant, term
1511882|NCT00732537|Nitric oxide|nitric oxide
1511883|NCT00732524|Hyperglycemia|hyperglycemia
1511884|NCT00732524|Glucose toxicity|glucose toxicity
1511885|NCT00732524|Glargine|glargine
1511886|NCT00732524|Glipizide|glipizide
1511887|NCT00732511|Endothelial dysfunction|endothelial dysfunction
1511888|NCT00732511|Blood vessel stiffness|blood vessel stiffness
1511889|NCT00732511|Nitric oxide|nitric oxide
1511890|NCT00732511|Oxidative stress|oxidative stress
1511891|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1511892|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1511893|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1511894|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1511895|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1511896|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1511897|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1511898|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1511899|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1511900|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1511901|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1511902|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1511903|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1511904|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1511905|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1511906|NCT00732485|Burn injury|burn injury
1511907|NCT00732485|Fenofibrate|fenofibrate
1511908|NCT00732485|Insulin resistance|insulin resistance
1511909|NCT00732485|Mitochondrial function|mitochondrial function
1511910|NCT00732485|Fat oxidation|fat oxidation
1511911|NCT00732485|PPAR|ppar
1511912|NCT00732485|Protein|protein
1511913|NCT00732485|Glucose|glucose
1511914|NCT00732485|Wound|wound
1511915|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1511916|NCT00732472|Magnesium stearate|magnesium stearate
1511917|NCT00732472|GSK573719|gsk573719
1511918|NCT00732459|myocardial protection|myocardial protection
1511919|NCT00732459|cardiac surgery|cardiac surgery
1511920|NCT00732459|heart valve replacement|heart valve replacement
1511921|NCT00732446|moxifloxacin|moxifloxacin
1511922|NCT00732446|dexamethasone|dexamethasone
1511923|NCT00732446|ocular inflammation|ocular inflammation
1511924|NCT00732446|ocular infection|ocular infection
1511925|NCT00732420|pazopanib|pazopanib
1511926|NCT00732420|Phase I|phase i
1511927|NCT00732420|topotecan|topotecan
1511928|NCT00732420|Advanced Solid Tumors|advanced solid tumors
1511929|NCT00732407|aliskiren|aliskiren
1511930|NCT00732407|arteial stiffness|arteial stiffness
1511931|NCT00732407|platelet function|platelet function
1511932|NCT00732407|diabetes mellitus|diabetes mellitus
1511933|NCT00732355|syphilis|syphilis
1511934|NCT00732342|Alcohol Abuse|alcohol abuse
1511935|NCT00732342|Contingency Management|contingency management
1511936|NCT00732342|Treatment Duration|treatment duration
1511937|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1511938|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1512027|NCT00732043|pomegranate|pomegranate
1511939|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1511940|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
1511941|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1511942|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1511943|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1511944|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1511945|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1511946|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1511947|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1511948|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1511949|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1511950|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1511951|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1511952|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1511953|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1511954|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
1511955|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1511956|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1511957|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1511958|NCT00732290|Healthy volunteer|healthy volunteer
1511959|NCT00732290|Pharmacokinetic|pharmacokinetic
1511960|NCT00732290|pharmacodynamic|pharmacodynamic
1511961|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
1511962|NCT00732277|sepsis|sepsis
1511963|NCT00732277|septicaemia|septicaemia
1511964|NCT00732277|septicemia|septicemia
1511965|NCT00732277|paediatric|paediatric
1511966|NCT00732277|pediatric|pediatric
1511967|NCT00732277|children|children
1511968|NCT00732251|Bipolar Disorder|bipolar disorder
1511969|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
1511970|NCT00732251|Mania|mania
1511971|NCT00732251|Mixed mania|mixed mania
1511972|NCT00732251|Allopurinol|allopurinol
1511973|NCT00732238|Spinal Cord Injury|spinal cord injury
1511974|NCT00732238|Urinary Tract Infection|urinary tract infection
1511975|NCT00732238|Catheter Dependent|catheter dependent
1511976|NCT00732225|DisCoVisc OVD|discovisc ovd
1511977|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
1511978|NCT00732212|UGI Bleeding|ugi bleeding
1511979|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
1511980|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
1511981|NCT00732212|Endoscopy|endoscopy
1511982|NCT00732212|Randomized Controlled Trial|randomized controlled trial
1511983|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
1511984|NCT00732212|Variceal hemorrhage|variceal hemorrhage
1511985|NCT00732199|apneic threshold|apneic threshold
1511986|NCT00732199|central apnea|central apnea
1511987|NCT00732199|intermittent hypoxia|intermittent hypoxia
1511988|NCT00732199|aging|aging
1511989|NCT00732199|ventilation|ventilation
1511990|NCT00732199|chemoresponsiveness|chemoresponsiveness
1511991|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
1511992|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
1511993|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
1511994|NCT00732160|Glucose|glucose
1511995|NCT00732160|Insulin|insulin
1511996|NCT00732147|triglycerides|triglycerides
1511997|NCT00732147|endogenous|endogenous
1511998|NCT00732147|glucose|glucose
1511999|NCT00732147|production|production
1512000|NCT00732121|Type 2 Diabetes|type 2 diabetes
1512001|NCT00732108|migraine|migraine
1512002|NCT00732108|headache|headache
1512003|NCT00732108|dizziness|dizziness
1512004|NCT00732108|vertigo|vertigo
1512005|NCT00732108|topiramate|topiramate
1512006|NCT00732108|Topamax|topamax
1512007|NCT00732095|Self-change|self-change
1512008|NCT00732095|Natural recovery|natural recovery
1512009|NCT00732095|Alcohol Drinking|alcohol drinking
1512010|NCT00732095|Mechanisms of Change|mechanisms of change
1512011|NCT00732095|Advertisements|advertisements
1512140|NCT00731458|Stratus;|stratus;
1512012|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
1512013|NCT00732069|hemodialysis|hemodialysis
1512014|NCT00732069|oxidative stress|oxidative stress
1512015|NCT00732069|inflammation|inflammation
1512016|NCT00732069|kallikrein-kinin|kallikrein-kinin
1512017|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
1512018|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
1512019|NCT00732069|RAAS|raas
1512020|NCT00732069|fibrinolysis|fibrinolysis
1512021|NCT00732069|endothelial dysfunction|endothelial dysfunction
1512022|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
1512023|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
1512024|NCT00732043|prostate cancer|prostate cancer
1512025|NCT00732043|prostate-specific antigen|prostate-specific antigen
1512026|NCT00732043|PSA|psa
1512028|NCT00732030|Toric IOL|toric iol
1512029|NCT00732017|Sprain|sprain
1512030|NCT00732017|Electric stimulation|electric stimulation
1512031|NCT00732017|Physical trauma|physical trauma
1512032|NCT00732017|Inflammation|inflammation
1512033|NCT00731991|Muscle|muscle
1512034|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
1512035|NCT00731978|Intraoperative Care|intraoperative care
1512036|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
1512037|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
1512038|NCT00731965|Serology|serology
1512039|NCT00731965|Lymphocytes|lymphocytes
1512040|NCT00731952|surgically resectable|surgically resectable
1512041|NCT00731939|Erectile Dysfunction|erectile dysfunction
1512042|NCT00731939|Penile implant|penile implant
1512043|NCT00731939|Titan|titan
1512044|NCT00731913|Surgical wounds|surgical wounds
1512045|NCT00731913|Sutures|sutures
1512046|NCT00731900|pharmacogenetic|pharmacogenetic
1512047|NCT00731900|study|study
1512048|NCT00731900|Topirmate|topirmate
1512049|NCT00731900|induced|induced
1512050|NCT00731887|Burn injury|burn injury
1512051|NCT00731887|Burn recovery|burn recovery
1512052|NCT00731874|Kidney transplantation|kidney transplantation
1512053|NCT00731874|Immunosuppression|immunosuppression
1512054|NCT00731874|Minimization|minimization
1512055|NCT00731874|Tacrolimus|tacrolimus
1512056|NCT00731874|Prograf|prograf
1512057|NCT00731874|Thymoglobulin|thymoglobulin
1512058|NCT00731848|prostate cancer|prostate cancer
1512059|NCT00731848|prostate-specific antigens|prostate-specific antigens
1512060|NCT00731848|PSA|psa
1512061|NCT00731835|Vascular|vascular
1512062|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1512063|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
1512064|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1512065|NCT00731822|GW685698/GW642444|gw685698/gw642444
1512066|NCT00731809|Crohn's disease|crohn's disease
1512067|NCT00731796|Stroke|stroke
1512068|NCT00731796|Retrochiasmatic|retrochiasmatic
1512069|NCT00731796|Vision|vision
1512070|NCT00731796|VFD|vfd
1512071|NCT00731783|Abscesses|abscesses
1512072|NCT00731783|Furunculosis|furunculosis
1512073|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
1512074|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
1512075|NCT00731783|MRSA|mrsa
1512076|NCT00731770|COPD|copd
1512077|NCT00731770|sleep|sleep
1512078|NCT00731770|daytime somnolence|daytime somnolence
1512079|NCT00731718|Head Lice|head lice
1512080|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
1512081|NCT00731679|IBS|ibs
1512082|NCT00731679|Abdominal pain|abdominal pain
1512083|NCT00731679|Bloating|bloating
1512084|NCT00731679|Diarrhea|diarrhea
1512085|NCT00731679|Rifaximin|rifaximin
1512086|NCT00731666|penile length|penile length
1512087|NCT00731666|IPP|ipp
1512088|NCT00731666|Erectile dysfunction|erectile dysfunction
1512089|NCT00731653|depression|depression
1512090|NCT00731653|combination|combination
1512091|NCT00731640|AcrySof|acrysof
1512092|NCT00731640|ReSTOR|restor
1512093|NCT00731640|Multifocal|multifocal
1512094|NCT00731640|Intraocular Lens|intraocular lens
1512095|NCT00731627|intracranial aneurysm|intracranial aneurysm
1512096|NCT00731614|cognitive therapy|cognitive therapy
1512097|NCT00731614|mirror training|mirror training
1512098|NCT00731614|nondirective therapy|nondirective therapy
1512099|NCT00731614|veterans|veterans
1512100|NCT00731614|amputees|amputees
1512101|NCT00731601|shock|shock
1512102|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
1512103|NCT00731601|rebleeding|rebleeding
1512104|NCT00731575|asthma|asthma
1512105|NCT00731575|child|child
1512106|NCT00731575|pathogenesis|pathogenesis
1512107|NCT00731575|rhinovirus|rhinovirus
1512108|NCT00731575|prednisolone|prednisolone
1512109|NCT00731575|Prevention|prevention
1512110|NCT00731575|pediatric|pediatric
1512111|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
1512112|NCT00731549|Aripiprazole|aripiprazole
1512113|NCT00731549|IM Depot|im depot
1512114|NCT00731549|Schizophrenia|schizophrenia
1512115|NCT00731549|Intramuscular|intramuscular
1512116|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
1512117|NCT00731536|Remicade|remicade
1512118|NCT00731536|Infliximab|infliximab
1512119|NCT00731536|Dutch national database of pathology|dutch national database of pathology
1512120|NCT00731536|PALGA|palga
1512121|NCT00731536|Autoimmune disease|autoimmune disease
1512122|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1512123|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
1512124|NCT00731510|Acute mountain sickness|acute mountain sickness
1512125|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
1512126|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
1512127|NCT00731510|Expedition,|expedition,
1512128|NCT00731510|Hydration,|hydration,
1512129|NCT00731510|Hypoxia|hypoxia
1512130|NCT00731510|Performance|performance
1512131|NCT00731497|SODIS|sodis
1512132|NCT00731497|Drinking Water|drinking water
1512133|NCT00731497|Disinfection|disinfection
1512134|NCT00731497|Intervention Trial|intervention trial
1512135|NCT00731484|Dry Eye Disease|dry eye disease
1512136|NCT00731484|Tear Osmolarity|tear osmolarity
1512137|NCT00731484|Tear Osmolality|tear osmolality
1512138|NCT00731458|OCT;|oct;
1512139|NCT00731458|Cirrus;|cirrus;
1512141|NCT00731458|macular thickness|macular thickness
1512142|NCT00731445|Z-208|z-208
1512143|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
1512144|NCT00731419|biliary|biliary
1512145|NCT00731419|obstruction|obstruction
1512146|NCT00731419|malignant|malignant
1512147|NCT00731419|stent|stent
1512148|NCT00731419|palliation|palliation
1512149|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
1512150|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
1512151|NCT00731393|Influenza|influenza
1512152|NCT00731380|Abraxane|abraxane
1512153|NCT00731380|Head and Neck Cancer|head and neck cancer
1512154|NCT00731380|Determine|determine
1512155|NCT00731380|Maximum|maximum
1512156|NCT00731380|Tolerated dose|tolerated dose
1512157|NCT00731380|ABI-007|abi-007
1512158|NCT00731380|Combination|combination
1512159|NCT00731380|Cisplatin|cisplatin
1512160|NCT00731380|5-Fluorouracil|5-fluorouracil
1512161|NCT00731380|Patients|patients
1512162|NCT00731354|lipoplasty|lipoplasty
1512163|NCT00731354|liposuction|liposuction
1512164|NCT00731354|VASER|vaser
1512165|NCT00731354|body contouring|body contouring
1512166|NCT00731354|body sculpting|body sculpting
1512167|NCT00731354|Any patient|any patient
1512168|NCT00731354|expressing|expressing
1512169|NCT00731354|interest|interest
1512170|NCT00731354|in elective surgery|in elective surgery
1512171|NCT00731341|Uterine fibroids|uterine fibroids
1512172|NCT00731341|Leiomyoma|leiomyoma
1512173|NCT00731341|Menorrhagia|menorrhagia
1512174|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
1512175|NCT00731341|Minimally invasive|minimally invasive
1512176|NCT00731328|refractory anemia|refractory anemia
1512177|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1567610|NCT00508703|Endometrial Cancer|endometrial cancer
1512178|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1512179|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1512180|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1512181|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1512182|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1512183|NCT00731328|aplastic anemia|aplastic anemia
1512184|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1512185|NCT00731315|UTI|uti
1512186|NCT00731315|Kiosk|kiosk
1512187|NCT00731315|Computer Assisted Care|computer assisted care
1512188|NCT00731315|cystitis|cystitis
1512189|NCT00731289|Osteoarthritis|osteoarthritis
1512190|NCT00731289|Knee|knee
1512191|NCT00731289|Hyaluronan|hyaluronan
1512192|NCT00731289|Gait Analysis|gait analysis
1512193|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1512194|NCT00731263|Cancer|cancer
1512195|NCT00731263|Advance solid tumours|advance solid tumours
1512196|NCT00731263|Dose Escalation|dose escalation
1512197|NCT00731263|Preliminary efficacy|preliminary efficacy
1512198|NCT00731263|AZD8055|azd8055
1512199|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
1512200|NCT00731263|Oral administration|oral administration
1512201|NCT00731250|Capsaicin challenge|capsaicin challenge
1512202|NCT00731237|Drug Eluting Stent|drug eluting stent
1512203|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
1512204|NCT00731237|Everolimus|everolimus
1512205|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
1512206|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
1512207|NCT00731211|Metastatic|metastatic
1512208|NCT00731211|Pazopanib|pazopanib
1512209|NCT00731211|Previously-treated|previously-treated
1512210|NCT00731198|ERCP|ercp
1512211|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
1512212|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
1512213|NCT00731185|functional|functional
1512214|NCT00731185|endoscopic|endoscopic
1512215|NCT00731185|sinus|sinus
1512216|NCT00731185|surgery|surgery
1512217|NCT00731172|crohns disease|crohns disease
1512218|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
1512219|NCT00731146|Regional Anesthesia|regional anesthesia
1512220|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
1512221|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
1512408|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
1512222|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
1512223|NCT00731133|disulfiram|disulfiram
1512224|NCT00731133|methamphetamine dependence|methamphetamine dependence
1512225|NCT00731133|open label|open label
1512226|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
1512227|NCT00731120|Mood Disorder|mood disorder
1512228|NCT00731120|Affective Disorder|affective disorder
1512229|NCT00731120|Anxiety Disorder|anxiety disorder
1512230|NCT00731120|Drug Therapy|drug therapy
1512231|NCT00731107|Veress Needle|veress needle
1512232|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
1512233|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
1512234|NCT00731094|overweight|overweight
1512235|NCT00731094|sedentary lifestyle|sedentary lifestyle
1512236|NCT00731094|exercise|exercise
1512237|NCT00731094|primary health care|primary health care
1512238|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
1512239|NCT00731068|Achilles tendon|achilles tendon
1512240|NCT00731042|Skin health|skin health
1512241|NCT00731029|Influenza|influenza
1512242|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
1512243|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
1512244|NCT00731003|serotonin|serotonin
1512245|NCT00731003|gut permeability|gut permeability
1512246|NCT00731003|visceral sensitivity|visceral sensitivity
1512247|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
1512248|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
1512249|NCT00730964|Surveillance|surveillance
1512250|NCT00730964|Optison|optison
1512251|NCT00730964|Perflutren|perflutren
1512252|NCT00730964|Echocardiography|echocardiography
1512253|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
1512254|NCT00730938|fibrin|fibrin
1512255|NCT00730938|endophthalmitis|endophthalmitis
1512256|NCT00730938|cataract extraction|cataract extraction
1512257|NCT00730938|Lens|lens
1512258|NCT00730938|implantation,|implantation,
1512259|NCT00730938|intraocular|intraocular
1512260|NCT00730886|Uterine Fibroids|uterine fibroids
1512261|NCT00730886|Unexplained Infertility|unexplained infertility
1512262|NCT00730886|MRgFUS|mrgfus
1512263|NCT00730886|ExAblate|exablate
1512264|NCT00730886|Focused Ultrasound|focused ultrasound
1512265|NCT00730886|Myomectomy|myomectomy
1512266|NCT00730860|radiofrequency ablation|radiofrequency ablation
1512267|NCT00730860|Cancer of Liver|cancer of liver
1512268|NCT00730860|postoperative|postoperative
1672547|NCT00098293|HIV|hiv
1512269|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
1512270|NCT00730860|prospective|prospective
1512271|NCT00730847|Cervarix|cervarix
1512272|NCT00730847|Filipinos|filipinos
1512273|NCT00730847|Safety and reactogenicity|safety and reactogenicity
1512274|NCT00730847|Human papillomavirus|human papillomavirus
1512275|NCT00730834|tinnitus|tinnitus
1512276|NCT00730834|ringing in the ears|ringing in the ears
1512277|NCT00730834|buzzing|buzzing
1512278|NCT00730834|static|static
1512279|NCT00730834|hyperacusis|hyperacusis
1512280|NCT00730834|loudness discomfort|loudness discomfort
1512281|NCT00730834|Clinically|clinically
1512282|NCT00730834|significant|significant
1512283|NCT00730834|discomfort|discomfort
1512284|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
1512285|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
1512286|NCT00730769|Valganciclovir|valganciclovir
1512287|NCT00730769|Ganciclovir|ganciclovir
1512288|NCT00730769|Pharmacokinetics|pharmacokinetics
1512289|NCT00730769|Solid organ transplantation|solid organ transplantation
1512290|NCT00730769|Transplant|transplant
1512291|NCT00730756|Adolescents|adolescents
1512292|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
1512293|NCT00730756|Adults|adults
1512294|NCT00730756|GW685698|gw685698
1512295|NCT00730756|Air Pollution|air pollution
1512296|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
1512297|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
1512299|NCT00730704|Gardasil|gardasil
1512300|NCT00730704|Post partum|post partum
1512301|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
1512302|NCT00730691|Mood Disorder|mood disorder
1512303|NCT00730691|Affective Disorder|affective disorder
1512304|NCT00730691|Anxiety Disorder|anxiety disorder
1512305|NCT00730691|Drug Therapy|drug therapy
1512306|NCT00730678|Metabolism|metabolism
1512307|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
1512308|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
1512309|NCT00730652|Medarex Inc.|medarex inc.
1512310|NCT00730626|Probiotics|probiotics
1512311|NCT00730626|Immunity|immunity
1512312|NCT00730626|Immune response|immune response
1512313|NCT00730626|Intestinal microflora|intestinal microflora
1512314|NCT00730626|Blood lipids|blood lipids
1512315|NCT00730626|Phagocytosis activity|phagocytosis activity
1512409|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
1512316|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1512317|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
1512318|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1512319|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1512320|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
1512321|NCT00730613|adult ependymoma|adult ependymoma
1512322|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1512323|NCT00730613|adult subependymoma|adult subependymoma
1513195|NCT00727480|fingertips|fingertips
1512324|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1512325|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
1512326|NCT00730613|adult brain stem glioma|adult brain stem glioma
1512327|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
1512328|NCT00730613|adult glioblastoma|adult glioblastoma
1512329|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
1512330|NCT00730613|adult gliosarcoma|adult gliosarcoma
1512331|NCT00730613|adult mixed glioma|adult mixed glioma
1512332|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1512333|NCT00730600|Thai Traditional massage|thai traditional massage
1512334|NCT00730600|Bone Formation|bone formation
1512335|NCT00730600|Bone Resorption|bone resorption
1512336|NCT00730587|Nutrition|nutrition
1512337|NCT00730587|Body Fat|body fat
1512338|NCT00730587|Infant|infant
1512339|NCT00730587|Healthy Babies|healthy babies
1512340|NCT00730561|nerve conduction velocity|nerve conduction velocity
1512341|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1512342|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
1512343|NCT00730522|Methamphetamine|methamphetamine
1512344|NCT00730522|Dependency|dependency
1512345|NCT00730522|Addiction|addiction
1512346|NCT00730522|vigabatrin|vigabatrin
1512347|NCT00730509|cystic fibrosis|cystic fibrosis
1512348|NCT00730509|folate|folate
1512349|NCT00730509|vitamin B12|vitamin b12
1512350|NCT00730496|Embryo culture supernatant|embryo culture supernatant
1512351|NCT00730496|injection|injection
1512352|NCT00730496|embryo transfer|embryo transfer
1512353|NCT00730496|embryo implantation rate|embryo implantation rate
1512354|NCT00730483|liver metastases|liver metastases
1512355|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1512356|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1512357|NCT00730483|islet cell carcinoma|islet cell carcinoma
1512358|NCT00730483|gastrinoma|gastrinoma
1512359|NCT00730483|insulinoma|insulinoma
1512360|NCT00730483|glucagonoma|glucagonoma
1512361|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1512362|NCT00730483|somatostatinoma|somatostatinoma
1512363|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
1512365|NCT00730470|Heregulin|heregulin
1512366|NCT00730470|erb B3|erb b3
1512367|NCT00730470|Solid Tumors|solid tumors
1512368|NCT00730470|Phase I Clinical Study|phase i clinical study
1512369|NCT00730457|influenza|influenza
1512370|NCT00730457|recombinant|recombinant
1512371|NCT00730457|hemagglutinin|hemagglutinin
1512372|NCT00730457|vaccine|vaccine
1512373|NCT00730444|Neuroblastoma|neuroblastoma
1512374|NCT00730444|Nuclear medicine|nuclear medicine
1512375|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
1512376|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
1512377|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
1512378|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1512379|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
1512380|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
1512381|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
1512382|NCT00730405|onychomycosis|onychomycosis
1512383|NCT00730405|nail fungus|nail fungus
1512384|NCT00730405|Toenail fungus|toenail fungus
1512385|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
1512386|NCT00730366|Malaria|malaria
1512387|NCT00730366|Pregnancy|pregnancy
1512388|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
1512389|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
1512390|NCT00730314|unrelated|unrelated
1512391|NCT00730314|BMT|bmt
1512392|NCT00730314|HSCT|hsct
1512393|NCT00730314|bone marrow transplantation|bone marrow transplantation
1512394|NCT00730314|sickle cell disease|sickle cell disease
1512395|NCT00730314|thalassemia|thalassemia
1512396|NCT00730314|CGD|cgd
1512397|NCT00730314|HLH|hlh
1512398|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
1512399|NCT00730314|Hurler|hurler
1512400|NCT00730314|leukodystrophy|leukodystrophy
1512401|NCT00730314|LAD I|lad i
1512402|NCT00730314|Genetic diseases|genetic diseases
1512403|NCT00730314|Red blood cell defects|red blood cell defects
1512404|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
1512405|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
1512406|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
1512407|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
1512410|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
1512411|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
1512412|NCT00730314|Osteopetrosis|osteopetrosis
1512413|NCT00730314|congenital neutropenia|congenital neutropenia
1512414|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
1512415|NCT00730314|Platelets defects|platelets defects
1512514|NCT00729859|Insulin sensitivity|insulin sensitivity
1512416|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
1512417|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
1512418|NCT00730314|Hurler disease|hurler disease
1512419|NCT00730314|leukodystrophies|leukodystrophies
1512420|NCT00730314|Niemann-Pick disease|niemann-pick disease
1512421|NCT00730314|Fucosidosis|fucosidosis
1512422|NCT00730314|Stem cell defects|stem cell defects
1512423|NCT00730314|reticular agenesis|reticular agenesis
1512424|NCT00730301|Emphysema|emphysema
1512425|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1512426|NCT00730301|Lung volume reduction|lung volume reduction
1512427|NCT00730301|Lung function|lung function
1512428|NCT00730288|Dengue|dengue
1512429|NCT00730288|Dengue fever|dengue fever
1512430|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
1512431|NCT00730288|Dengue virus|dengue virus
1512432|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
1512433|NCT00730262|Phase II|phase ii
1512434|NCT00730262|Brain Cancer|brain cancer
1512435|NCT00730249|ADHD|adhd
1512436|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1512437|NCT00730249|adult|adult
1512438|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
1512439|NCT00730249|Medikinet retard|medikinet retard
1512440|NCT00730249|controlled clinical trial|controlled clinical trial
1512441|NCT00730249|safety|safety
1512442|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
1512443|NCT00730249|treatment|treatment
1512444|NCT00730249|central nervous system stimulants|central nervous system stimulants
1512445|NCT00730249|therapeutic uses|therapeutic uses
1512446|NCT00730223|Nevirapine|nevirapine
1512447|NCT00730223|Efavirenz|efavirenz
1512448|NCT00730223|pharmacokinetics|pharmacokinetics
1512449|NCT00730223|healthy|healthy
1512450|NCT00730223|CYP2B6|cyp2b6
1512451|NCT00730223|HIV/AIDS|hiv/aids
1512452|NCT00730210|Hypoparathyroidism|hypoparathyroidism
1512453|NCT00730210|HypoPTH|hypopth
1512454|NCT00730210|PTH|pth
1512455|NCT00730184|acid-base|acid-base
1512456|NCT00730184|potassium|potassium
1512457|NCT00730184|acidosis|acidosis
1512458|NCT00730184|osteoporosis|osteoporosis
1512459|NCT00730184|sarcopenia|sarcopenia
1512460|NCT00730184|calcium absorption|calcium absorption
1512461|NCT00730184|dietary protein|dietary protein
1512462|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
1512463|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
1512464|NCT00730119|GE Monitor|ge monitor
1512465|NCT00730119|Temperature|temperature
1512466|NCT00730119|SpO2|spo2
1512467|NCT00730119|Respiration, ECG|respiration, ecg
1512468|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
1512469|NCT00730106|Alarm symptoms|alarm symptoms
1512470|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
1512471|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
1512472|NCT00730093|Pregnancy|pregnancy
1512473|NCT00730080|phenylketonuria|phenylketonuria
1512474|NCT00730080|sapropterin|sapropterin
1512475|NCT00730080|Kuvan|kuvan
1512476|NCT00730080|cognition|cognition
1512477|NCT00730080|executive abilities|executive abilities
1512478|NCT00730080|brain|brain
1512479|NCT00730067|COPD|copd
1512480|NCT00730067|Pulmonary hypertension|pulmonary hypertension
1512481|NCT00730067|Sildenafil|sildenafil
1512482|NCT00730067|NT-pro BNP|nt-pro bnp
1512483|NCT00730067|apelin|apelin
1512484|NCT00730054|Remifentanil|remifentanil
1512485|NCT00730054|clonidine|clonidine
1512486|NCT00730054|acute pain|acute pain
1512487|NCT00730054|respiration|respiration
1512488|NCT00730054|sedation|sedation
1512489|NCT00730054|cognitive function|cognitive function
1512490|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
1512491|NCT00730041|continuous positive air pressure|continuous positive air pressure
1512492|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
1512493|NCT00730002|Lupus|lupus
1512494|NCT00729989|Meconium Aspiration|meconium aspiration
1512495|NCT00729989|Respiratory Distress|respiratory distress
1512496|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
1512497|NCT00729976|Ibuprofen|ibuprofen
1512498|NCT00729976|Suppository|suppository
1512499|NCT00729976|febrile children|febrile children
1512500|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
1512501|NCT00729924|Raltegravir|raltegravir
1512502|NCT00729924|CSF|csf
1512503|NCT00729924|ABCB1 SNP|abcb1 snp
1512504|NCT00729924|HIV/AIDS|hiv/aids
1512505|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
1512506|NCT00729885|Vertigo|vertigo
1512507|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
1512508|NCT00729885|BPPV|bppv
1512509|NCT00729885|Positional Vertigo|positional vertigo
1512510|NCT00729872|AG011|ag011
1512511|NCT00729872|Ulcerative Colitis|ulcerative colitis
1512512|NCT00729872|human Interleukin-10|human interleukin-10
1512513|NCT00729859|HDL|hdl
1512718|NCT00729040|pedometer|pedometer
1512515|NCT00729859|testosterone|testosterone
1512516|NCT00729859|estradiol|estradiol
1512517|NCT00729859|cholesterol|cholesterol
1512518|NCT00729846|choroidal neovascularization|choroidal neovascularization
1512519|NCT00729846|macular degeneration|macular degeneration
1512520|NCT00729846|macular edema|macular edema
1512521|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
1512522|NCT00729846|vegf|vegf
1512523|NCT00729846|verteporfin PDT|verteporfin pdt
1512524|NCT00729820|PERSONALITY|personality
1512525|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
1512526|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
1512527|NCT00729807|recurrent melanoma|recurrent melanoma
1512528|NCT00729794|Vasopressin|vasopressin
1512529|NCT00729794|Epinephrine|epinephrine
1512530|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
1512531|NCT00729794|Heart Arrest|heart arrest
1512532|NCT00729781|nasal obstruction|nasal obstruction
1512533|NCT00729781|airway resistance|airway resistance
1512534|NCT00729781|soft tissue collapse|soft tissue collapse
1512535|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
1512536|NCT00729768|Renal transplant|renal transplant
1512537|NCT00729768|Raptiva|raptiva
1512538|NCT00729755|Creatine|creatine
1512539|NCT00729755|Augmentation|augmentation
1512540|NCT00729755|Major Depressive Disorder|major depressive disorder
1512541|NCT00729755|Efficacy|efficacy
1512542|NCT00729755|Brain Energy Metabolism|brain energy metabolism
1512543|NCT00729729|Comparative|comparative
1512544|NCT00729729|bioavailability|bioavailability
1512545|NCT00729729|of PCA|of pca
1512546|NCT00729729|formulations|formulations
1512547|NCT00729716|Microfracture|microfracture
1512548|NCT00729716|Cartilage repair|cartilage repair
1512549|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
1512551|NCT00729703|Minimized|minimized
1512552|NCT00729703|ventricular|ventricular
1512553|NCT00729703|pacing|pacing
1512554|NCT00729703|indication|indication
1512555|NCT00729703|Clinical outcome|clinical outcome
1512556|NCT00729703|Inappropriate shock|inappropriate shock
1512557|NCT00729690|Pregabalin|pregabalin
1512558|NCT00729690|CSF|csf
1512559|NCT00729690|Neurotransmitter|neurotransmitter
1512560|NCT00729677|nausea and vomiting|nausea and vomiting
1512561|NCT00729677|colon cancer|colon cancer
1512562|NCT00729677|rectal cancer|rectal cancer
1512563|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
1512564|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
1512565|NCT00729638|RAD001|rad001
1512566|NCT00729638|lenalidomide|lenalidomide
1512567|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
1512568|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1512569|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1512570|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1512571|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
1512572|NCT00729573|Microbicide|microbicide
1512573|NCT00729573|HIV Seronegativity|hiv seronegativity
1512574|NCT00729573|Bone Mineral Density|bone mineral density
1512575|NCT00729560|PCOS|pcos
1512576|NCT00729547|Depression|depression
1512577|NCT00729547|Biofeedback|biofeedback
1512578|NCT00729547|Psychophysiology|psychophysiology
1512579|NCT00729534|Perception|perception
1512580|NCT00729534|Focus Group|focus group
1512581|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
1512582|NCT00729521|Fall injury hospitalization|fall injury hospitalization
1512583|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
1512584|NCT00729521|Fall injury death|fall injury death
1512585|NCT00729508|Cat allergy|cat allergy
1512586|NCT00729508|Immunotherapy|immunotherapy
1512587|NCT00729508|Cat-PAD|cat-pad
1512588|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
1512589|NCT00729495|Phase I,|phase i,
1512590|NCT00729495|Healthy|healthy
1512591|NCT00729495|Volunteer|volunteer
1512592|NCT00729495|Study|study
1512593|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
1512594|NCT00729482|second-line treatment|second-line treatment
1512595|NCT00729482|advanced gastric cancer|advanced gastric cancer
1512596|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
1512597|NCT00729469|Menopausal symptoms|menopausal symptoms
1512598|NCT00729469|Vaginal atrophy|vaginal atrophy
1512599|NCT00729469|Urogenital atrophy|urogenital atrophy
1512600|NCT00729456|Diabetes|diabetes
1512601|NCT00729456|Education|education
1512602|NCT00729456|Ulcer|ulcer
1512603|NCT00729456|Foot|foot
1512604|NCT00729456|Behaviour|behaviour
1512605|NCT00729443|Single dose|single dose
1512606|NCT00729443|Phase 1|phase 1
1512607|NCT00729443|Safety of AZD3241|safety of azd3241
1512608|NCT00729443|tolerability of AZD3241|tolerability of azd3241
1512609|NCT00729430|Heart Attack|heart attack
1512610|NCT00729430|Sudden Cardiac Death|sudden cardiac death
1512611|NCT00729430|Peri-infarct Zone|peri-infarct zone
1512612|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
1512613|NCT00729430|Biological Markers|biological markers
1512614|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
1512615|NCT00729430|Cardiac Arrest|cardiac arrest
1512616|NCT00729417|incontinence|incontinence
1512617|NCT00729417|obstetric risk factors|obstetric risk factors
1512618|NCT00729417|women|women
1512619|NCT00729417|of age 18|of age 18
1512620|NCT00729417|above|above
1512621|NCT00729404|Female Contraception|female contraception
1512622|NCT00729404|Ovulation Inhibition|ovulation inhibition
1512624|NCT00729391|Sexual Risk|sexual risk
1512625|NCT00729391|Substance Abuse|substance abuse
1512626|NCT00729391|Victimization|victimization
1512627|NCT00729391|Violence|violence
1512628|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
1512629|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
1512630|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
1512631|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
1512632|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
1512633|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
1512634|NCT00729339|Mosapride|mosapride
1512635|NCT00729339|Lansoprazole|lansoprazole
1512636|NCT00729326|diabetes|diabetes
1512637|NCT00729326|exenatide|exenatide
1512638|NCT00729326|sitagliptin|sitagliptin
1512639|NCT00729326|Amylin|amylin
1512640|NCT00729326|Lilly|lilly
1512641|NCT00729326|metformin|metformin
1512642|NCT00729326|thiazolidinedione|thiazolidinedione
1512643|NCT00729313|Treatment|treatment
1512644|NCT00729300|cocaine|cocaine
1512645|NCT00729300|disulfiram|disulfiram
1512646|NCT00729300|antabuse|antabuse
1512647|NCT00729300|addiction|addiction
1512648|NCT00729300|stimulant|stimulant
1512649|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
1512650|NCT00729287|stage I bladder cancer|stage i bladder cancer
1512651|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1512652|NCT00729261|mechanical ventilation|mechanical ventilation
1512653|NCT00729261|extubation|extubation
1512654|NCT00729261|outcomes|outcomes
1512655|NCT00729261|brain injury|brain injury
1512656|NCT00729248|Transplants|transplants
1512657|NCT00729248|Kidney Transplantation|kidney transplantation
1512658|NCT00729248|Immunosuppression|immunosuppression
1512660|NCT00729248|Graft Rejection|graft rejection
1512661|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
1512662|NCT00729235|Incidence|incidence
1512663|NCT00729235|of slow VTs|of slow vts
1512664|NCT00729235|in CRT-D patients|in crt-d patients
1512665|NCT00729235|Clinical|clinical
1512666|NCT00729235|relevance|relevance
1512667|NCT00729235|treatment|treatment
1512668|NCT00729235|VTs|vts
1512669|NCT00729235|during|during
1512670|NCT00729235|2-years|2-years
1512671|NCT00729235|follow-up|follow-up
1512672|NCT00729196|Obesity|obesity
1512673|NCT00729196|Type 2 Diabetes|type 2 diabetes
1512674|NCT00729196|Glycemic Load|glycemic load
1512675|NCT00729196|Weight Loss|weight loss
1512676|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
1512677|NCT00729170|Milk|milk
1512678|NCT00729170|Calcium|calcium
1512679|NCT00729170|Weight loss|weight loss
1512680|NCT00729170|Bone density|bone density
1512681|NCT00729170|Appetite|appetite
1512682|NCT00729144|fecal incontinence|fecal incontinence
1512683|NCT00729144|bowel incontinence|bowel incontinence
1512684|NCT00729144|pelvic floor disorder|pelvic floor disorder
1512685|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
1512686|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
1512687|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
1512688|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
1512689|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
1512690|NCT00729092|PET SCAN|pet scan
1512691|NCT00729092|PAIN LEVELS|pain levels
1512692|NCT00729079|Diabetes Prevention|diabetes prevention
1512693|NCT00729079|Pre-Diabetes|pre-diabetes
1512694|NCT00729079|Exercise|exercise
1512695|NCT00729079|Fat Intake|fat intake
1512696|NCT00729079|Fasting blood sugar|fasting blood sugar
1512697|NCT00729079|tobacco cessation|tobacco cessation
1512698|NCT00729053|renal|renal
1512699|NCT00729053|cell|cell
1512700|NCT00729053|renal carcinoma|renal carcinoma
1512701|NCT00729053|metastatic|metastatic
1512702|NCT00729053|recurrent|recurrent
1512703|NCT00729053|treatment naive|treatment naive
1512704|NCT00729040|heart|heart
1512705|NCT00729040|weight|weight
1512706|NCT00729040|Overweight|overweight
1512707|NCT00729040|bmi|bmi
1512708|NCT00729040|diabetes|diabetes
1512709|NCT00729040|type 2|type 2
1512710|NCT00729040|diabetic|diabetic
1512711|NCT00729040|walk|walk
1512712|NCT00729040|walk*|walk*
1512713|NCT00729040|diab*|diab*
1512714|NCT00729040|obese|obese
1512715|NCT00729040|exercise|exercise
1512716|NCT00729040|activity|activity
1512717|NCT00729040|coronary|coronary
1512719|NCT00729027|hypercholesterolemia|hypercholesterolemia
1512720|NCT00729014|herbal nephropathy|herbal nephropathy
1512721|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
1512722|NCT00729014|nephrotoxicity|nephrotoxicity
1512723|NCT00729014|renal disease|renal disease
1512724|NCT00729014|adverse drug reaction|adverse drug reaction
1512725|NCT00729014|Chinese herbal medicine|chinese herbal medicine
1512726|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
1512727|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
1512728|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
1512729|NCT00728975|constipation|constipation
1512730|NCT00728975|cancer|cancer
1512731|NCT00728975|palliative care|palliative care
1512732|NCT00728975|terminal|terminal
1512733|NCT00728975|bowel|bowel
1512734|NCT00728962|dental implants|dental implants
1512735|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
1512736|NCT00728962|multicenter|multicenter
1512737|NCT00728962|observational|observational
1512738|NCT00728962|clinical study|clinical study
1512739|NCT00728962|partial edentulism|partial edentulism
1512740|NCT00728962|single stage|single stage
1512741|NCT00728962|immediate occlusal loading|immediate occlusal loading
1512742|NCT00728962|crestal bone level|crestal bone level
1512743|NCT00728962|short fixed bridge|short fixed bridge
1512744|NCT00728949|breast cancer|breast cancer
1512745|NCT00728949|Postmenopausal|postmenopausal
1512746|NCT00728949|Hormones|hormones
1512747|NCT00728949|Antiestrogen|antiestrogen
1512748|NCT00728936|Hepatitis C|hepatitis c
1512749|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
1512750|NCT00728936|HCV|hcv
1512751|NCT00728923|OCD|ocd
1512752|NCT00728910|Low HDL cholesterol|low hdl cholesterol
1512753|NCT00728910|High triglycerides|high triglycerides
1512754|NCT00728910|niacin|niacin
1512755|NCT00728910|fibrate|fibrate
1512756|NCT00728897|Healthy volunteer|healthy volunteer
1512757|NCT00728897|relative bioavailability.|relative bioavailability.
1512758|NCT00728884|dental implants|dental implants
1512759|NCT00728884|Certain Prevail|certain prevail
1512760|NCT00728884|multicenter|multicenter
1512761|NCT00728884|clinical study|clinical study
1512762|NCT00728884|partial edentulism|partial edentulism
1512763|NCT00728884|total edentulism|total edentulism
1512764|NCT00728884|platform switching|platform switching
1512765|NCT00728884|single stage|single stage
1512766|NCT00728884|early loading|early loading
1512767|NCT00728884|crestal bone level|crestal bone level
1512768|NCT00728884|single tooth replacements|single tooth replacements
1512769|NCT00728884|short or long fixed bridges|short or long fixed bridges
1512770|NCT00728884|overdenture|overdenture
1512771|NCT00728884|fixed denture|fixed denture
1512772|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
1512773|NCT00728858|Hypertension|hypertension
1512774|NCT00728858|SNP|snp
1512775|NCT00728858|Nifedipine|nifedipine
1512776|NCT00728858|Barnidipine|barnidipine
1512777|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
1512778|NCT00728845|large cell lung cancer|large cell lung cancer
1512779|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1512780|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1512781|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1512782|NCT00728832|extended release epidural morphine|extended release epidural morphine
1512783|NCT00728832|morphine|morphine
1512784|NCT00728832|thoracic epidural|thoracic epidural
1512785|NCT00728832|pharmacokinetics|pharmacokinetics
1512786|NCT00728832|pharmacodynamics|pharmacodynamics
1512787|NCT00728832|postoperative pain|postoperative pain
1512788|NCT00728832|upper abdominal surgery|upper abdominal surgery
1512789|NCT00728819|Inpatients|inpatients
1512790|NCT00728819|Requiring|requiring
1512791|NCT00728819|DL PICC|dl picc
1512792|NCT00728819|Access|access
1512793|NCT00728819|Medications|medications
1512794|NCT00728819|Blood|blood
1512795|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
1512796|NCT00728806|Ultrafiltration failure|ultrafiltration failure
1512797|NCT00728806|Biomarker|biomarker
1512798|NCT00728806|Proteomics|proteomics
1512799|NCT00728793|Advanced Solid Tumors|advanced solid tumors
1512800|NCT00728793|EGFR|egfr
1512801|NCT00728793|HDAC|hdac
1512802|NCT00728793|Her2|her2
1512803|NCT00728793|Open-Label|open-label
1512804|NCT00728793|Dose-Escalation|dose-escalation
1512805|NCT00728780|Adverse events|adverse events
1512806|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
1512807|NCT00728767|Heavy drinking|heavy drinking
1512808|NCT00728767|Brief intervention|brief intervention
1512809|NCT00728767|Alcohol prevention|alcohol prevention
1512810|NCT00728767|Randomized trial|randomized trial
1512990|NCT00728208|GSK372475|gsk372475
1512811|NCT00728767|Motivational interviewing|motivational interviewing
1512812|NCT00728767|Intervention Studies|intervention studies
1512813|NCT00728767|prevention & control|prevention & control
1512814|NCT00728754|dental implants|dental implants
1512815|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
1512816|NCT00728754|Lateralized|lateralized
1512817|NCT00728754|non-lateralized|non-lateralized
1512818|NCT00728754|Osseotite Certain|osseotite certain
1512819|NCT00728754|multicenter|multicenter
1512820|NCT00728754|randomized|randomized
1512821|NCT00728754|clinical study|clinical study
1512822|NCT00728754|partial edentulism|partial edentulism
1512823|NCT00728754|single stage|single stage
1512824|NCT00728754|early loading|early loading
1512825|NCT00728754|crestal bone level|crestal bone level
1512826|NCT00728754|short fixed bridge|short fixed bridge
1512827|NCT00728741|Neural Networks|neural networks
1512828|NCT00728741|Cortical Activation|cortical activation
1512829|NCT00728741|Strategy|strategy
1512830|NCT00728741|fMRI|fmri
1512831|NCT00728741|Healthy Volunteer|healthy volunteer
1512832|NCT00728741|HV|hv
1512833|NCT00728728|pregnenolone|pregnenolone
1512834|NCT00728728|schizophrenia|schizophrenia
1512835|NCT00728728|cognitive|cognitive
1512836|NCT00728728|positive symptom|positive symptom
1512837|NCT00728728|negative symptom|negative symptom
1512838|NCT00728728|placebo control|placebo control
1512839|NCT00728715|Budesonide|budesonide
1512840|NCT00728715|Formoterol|formoterol
1512841|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
1512842|NCT00728689|Orthopoxviral|orthopoxviral
1512843|NCT00728689|Smallpox|smallpox
1512844|NCT00728689|Monkey pox|monkey pox
1512845|NCT00728676|PKU,|pku,
1512846|NCT00728676|Phe,|phe,
1512847|NCT00728676|PAH,|pah,
1512848|NCT00728676|Kuvan,|kuvan,
1512849|NCT00728676|Trp,|trp,
1512850|NCT00728676|Tyr|tyr
1512851|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1512852|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
1512853|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
1512854|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
1512855|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
1512856|NCT00728650|primary liver cancer|primary liver cancer
1512857|NCT00728637|Prevention|prevention
1512858|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
1512859|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1512860|NCT00728598|Angiogenesis|angiogenesis
1512861|NCT00728598|Vitreous levels|vitreous levels
1512862|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
1512863|NCT00728598|Fractalkine|fractalkine
1512864|NCT00728598|Growth factor|growth factor
1512865|NCT00728585|mucositis|mucositis
1512866|NCT00728585|graft versus host disease|graft versus host disease
1512867|NCT00728585|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1512868|NCT00728585|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1512869|NCT00728585|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1512870|NCT00728585|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1512871|NCT00728585|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1512872|NCT00728585|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1512873|NCT00728585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1512874|NCT00728585|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1512875|NCT00728585|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1512876|NCT00728585|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1512877|NCT00728585|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1512996|NCT00728182|Coiling|coiling
1512878|NCT00728585|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1512879|NCT00728585|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1512880|NCT00728585|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1512881|NCT00728585|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1512882|NCT00728585|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1512883|NCT00728585|disseminated neuroblastoma|disseminated neuroblastoma
1512884|NCT00728585|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1512885|NCT00728585|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1512886|NCT00728585|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1512887|NCT00728585|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1512888|NCT00728585|recurrent neuroblastoma|recurrent neuroblastoma
1512889|NCT00728585|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1512890|NCT00728585|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1512891|NCT00728585|stage I multiple myeloma|stage i multiple myeloma
1512892|NCT00728585|stage II multiple myeloma|stage ii multiple myeloma
1512893|NCT00728585|stage III multiple myeloma|stage iii multiple myeloma
1512894|NCT00728585|refractory multiple myeloma|refractory multiple myeloma
1512895|NCT00728585|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1512896|NCT00728585|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1512897|NCT00728585|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1512898|NCT00728585|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1512899|NCT00728585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1513194|NCT00727480|vascularity|vascularity
1512900|NCT00728585|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1512901|NCT00728585|stage IIIA breast cancer|stage iiia breast cancer
1512902|NCT00728585|stage IIIB breast cancer|stage iiib breast cancer
1512903|NCT00728585|stage IIIC breast cancer|stage iiic breast cancer
1512904|NCT00728585|stage IV breast cancer|stage iv breast cancer
1512905|NCT00728585|recurrent breast cancer|recurrent breast cancer
1512906|NCT00728559|laparoscopy|laparoscopy
1512907|NCT00728559|preemptive|preemptive
1512908|NCT00728559|postoperative|postoperative
1512910|NCT00728559|trocar|trocar
1512911|NCT00728559|site|site
1512912|NCT00728546|tuberculosis|tuberculosis
1512913|NCT00728546|isoniazid|isoniazid
1512914|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
1512915|NCT00728546|genotyping|genotyping
1512916|NCT00728546|hepatotoxicity|hepatotoxicity
1512917|NCT00728546|pharmacogenetics|pharmacogenetics
1512918|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
1512919|NCT00728520|Leukemia|leukemia
1512920|NCT00728520|Azacitidine|azacitidine
1512921|NCT00728520|Untreated|untreated
1512922|NCT00728520|Elderly|elderly
1512923|NCT00728507|Tuberculosis|tuberculosis
1512924|NCT00728507|Moxifloxacin|moxifloxacin
1512925|NCT00728507|Rifapentine|rifapentine
1512926|NCT00728468|Phase 1|phase 1
1512927|NCT00728468|PF-00299804|pf-00299804
1512928|NCT00728468|Dextromethorphan|dextromethorphan
1512929|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
1512930|NCT00728468|Cancer Patients|cancer patients
1512931|NCT00728442|Clinical practice guidelines|clinical practice guidelines
1512932|NCT00728442|Guideline adherence|guideline adherence
1512933|NCT00728442|Clinical decision support systems|clinical decision support systems
1512934|NCT00728442|Randomized controlled trial|randomized controlled trial
1512935|NCT00728442|Intervention study|intervention study
1512936|NCT00728429|cardiac toxicity|cardiac toxicity
1512937|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1512938|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1512939|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
1512940|NCT00728377|gestational diabetes|gestational diabetes
1512941|NCT00728377|physical activity|physical activity
1512942|NCT00728377|behavior change|behavior change
1512943|NCT00728377|glucose tolerance|glucose tolerance
1512944|NCT00728377|pregnancy|pregnancy
1512945|NCT00728364|Anderson Fabry disease|anderson fabry disease
1512946|NCT00728364|chronic kidney disease|chronic kidney disease
1512947|NCT00728364|prevalence|prevalence
1512948|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
1512949|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
1512950|NCT00728338|dietary supplement|dietary supplement
1512951|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
1512952|NCT00728338|cardiovascular disease|cardiovascular disease
1512953|NCT00728325|PTSD|ptsd
1512954|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
1512955|NCT00728325|Supported Employment|supported employment
1512956|NCT00728312|Methamphetamine|methamphetamine
1512957|NCT00728312|Therapeutics|therapeutics
1512958|NCT00728312|Psychopharmacology|psychopharmacology
1512959|NCT00728312|Amphetamine|amphetamine
1512960|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
1512961|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1512962|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
1512963|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
1512964|NCT00728273|Efficacy|efficacy
1512965|NCT00728273|Vietnam|vietnam
1512966|NCT00728273|school children|school children
1512967|NCT00728273|anemia|anemia
1512968|NCT00728273|fortification|fortification
1512969|NCT00728273|micronutrient|micronutrient
1512970|NCT00728260|Meningitis|meningitis
1512971|NCT00728260|Meningococcal disease|meningococcal disease
1512972|NCT00728260|Menactra vaccine|menactra vaccine
1512973|NCT00728247|Cervical Spine|cervical spine
1512974|NCT00728247|Kinematics|kinematics
1512975|NCT00728247|Manipulation|manipulation
1512976|NCT00728247|Biomechanics|biomechanics
1512977|NCT00728234|aEEG|aeeg
1512978|NCT00728234|preterm infants|preterm infants
1512979|NCT00728234|predictive value|predictive value
1512980|NCT00728234|outcome|outcome
1512981|NCT00728221|Ginseng|ginseng
1512982|NCT00728221|Korean Red Ginseng|korean red ginseng
1512983|NCT00728221|Ginsenoside|ginsenoside
1512984|NCT00728221|Flow Mediated Dilation|flow mediated dilation
1512985|NCT00728221|Endothelial Function|endothelial function
1512986|NCT00728221|Hypertension|hypertension
1512987|NCT00728208|Young|young
1512988|NCT00728208|Elderly|elderly
1512989|NCT00728208|Randomised|randomised
1512991|NCT00728195|Schizophrenia|schizophrenia
1512992|NCT00728195|Central Nervous System|central nervous system
1512993|NCT00728195|JNJ-37822681|jnj-37822681
1512994|NCT00728182|Stroke|stroke
1512995|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
1512997|NCT00728182|Endovascular repair|endovascular repair
1512998|NCT00728182|Brain aneurysm|brain aneurysm
1512999|NCT00728182|NA-1|na-1
1513000|NCT00728169|Asthma|asthma
1513001|NCT00728169|Focus Group|focus group
1513002|NCT00728169|Community Based Participatory Research|community based participatory research
1513003|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1513004|NCT00728156|Coronary artery disease|coronary artery disease
1513005|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
1513006|NCT00728156|Aspirin|aspirin
1513007|NCT00728156|Clopidogrel|clopidogrel
1513008|NCT00728156|Badimon Chamber|badimon chamber
1513009|NCT00728130|carcinoma|carcinoma
1513010|NCT00728130|upper|upper
1513011|NCT00728130|aerodigestive|aerodigestive
1513012|NCT00728130|tract|tract
1513013|NCT00728130|submandibular|submandibular
1513014|NCT00728130|gland|gland
1513015|NCT00728117|indomethacin|indomethacin
1513016|NCT00728117|ibuprofen|ibuprofen
1513017|NCT00728117|preterm infant|preterm infant
1513018|NCT00728104|Learn|learn
1513019|NCT00728104|L-Carnitine|l-carnitine
1513020|NCT00728104|Co-enzyme Q10|co-enzyme q10
1513021|NCT00728104|Effective|effective
1513022|NCT00728104|These supplements|these supplements
1513023|NCT00728104|Compared|compared
1513024|NCT00728104|Standard|standard
1513025|NCT00728091|aquaretic|aquaretic
1513026|NCT00728091|SIADH|siadh
1513027|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
1513028|NCT00728078|liver cancer|liver cancer
1513029|NCT00728078|radiofrequency ablation|radiofrequency ablation
1513030|NCT00728078|thalidomide|thalidomide
1513031|NCT00728052|Tolerability|tolerability
1513032|NCT00728052|dose escalation|dose escalation
1513033|NCT00728052|GSK598809|gsk598809
1513034|NCT00728052|Pharmacodynamics|pharmacodynamics
1513035|NCT00728052|Safety|safety
1513036|NCT00728052|single|single
1513037|NCT00728052|placebo|placebo
1513038|NCT00728052|Smokers|smokers
1513039|NCT00728052|Pharmacokinetics|pharmacokinetics
1513040|NCT00728039|Youth|youth
1513041|NCT00728039|Consensus|consensus
1513042|NCT00728039|Criteria|criteria
1513043|NCT00728039|CVS|cvs
1513044|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
1513045|NCT00728026|Heart rate variability,|heart rate variability,
1513046|NCT00728026|Deep Breathing Test,|deep breathing test,
1513047|NCT00728026|Valsalva maneuver,|valsalva maneuver,
1513048|NCT00728026|Table test,|table test,
1513049|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
1513050|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
1513051|NCT00728026|Vital signs,|vital signs,
1513052|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
1513053|NCT00728026|composite autonomic score|composite autonomic score
1513054|NCT00728013|Acute coronary syndrome|acute coronary syndrome
1513055|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
1513056|NCT00728013|statins|statins
1513057|NCT00728000|Pancreatic Cancer|pancreatic cancer
1513058|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
1513059|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
1513060|NCT00727987|CNTO148|cnto148
1513061|NCT00727987|Golimumab|golimumab
1513062|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
1513063|NCT00727974|Mitochondrial scan|mitochondrial scan
1513064|NCT00727974|Family trios|family trios
1513065|NCT00727948|Breast cancer|breast cancer
1513066|NCT00727948|Angiogenesis|angiogenesis
1513067|NCT00727948|Aspirin|aspirin
1513068|NCT00727948|Tamoxifen|tamoxifen
1513069|NCT00727935|Women|women
1513070|NCT00727935|parturients|parturients
1513071|NCT00727935|with|with
1513072|NCT00727935|realization|realization
1513073|NCT00727935|episiotomy|episiotomy
1513074|NCT00727922|Neuropathy|neuropathy
1513075|NCT00727922|Oxaliplatin|oxaliplatin
1513076|NCT00727922|Mangafodipir|mangafodipir
1513077|NCT00727909|Hearing loss|hearing loss
1513078|NCT00727909|Hearing Aids|hearing aids
1513079|NCT00727909|Speech Perception|speech perception
1513080|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
1513081|NCT00727896|Life style modification,|life style modification,
1513082|NCT00727896|Type 2 diabetes,|type 2 diabetes,
1513083|NCT00727896|SMS,|sms,
1513084|NCT00727896|Patient adherence|patient adherence
1513085|NCT00727883|Breast Cancer|breast cancer
1513086|NCT00727883|Adjuvant TAM|adjuvant tam
1513087|NCT00727883|post-menopausal|post-menopausal
1513088|NCT00727883|women|women
1513089|NCT00727870|Shave Biopsy management|shave biopsy management
1513090|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
1513091|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
1513092|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
1513093|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
1513094|NCT00727857|Type II Diabetes|type ii diabetes
1513095|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1513096|NCT00727857|Dyslipidemia|dyslipidemia
1513097|NCT00727857|Drug Therapy|drug therapy
1513098|NCT00727844|XDR-TB|xdr-tb
1513099|NCT00727844|Linezolid|linezolid
1513100|NCT00727844|Drug Resistance|drug resistance
1513101|NCT00727844|Computed Tomography|computed tomography
1513102|NCT00727844|Pharmacokinetics|pharmacokinetics
1513103|NCT00727844|Tuberculosis|tuberculosis
1513104|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
1513105|NCT00727844|MDR-TB|mdr-tb
1513106|NCT00727831|neurotoxicity|neurotoxicity
1513107|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1513108|NCT00727831|mucositis|mucositis
1513109|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1513110|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1513111|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1513112|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1513113|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1513114|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1513115|NCT00727792|participants|participants
1513116|NCT00727792|scheduled|scheduled
1513117|NCT00727792|clinically|clinically
1513118|NCT00727792|ordered|ordered
1513119|NCT00727792|MRI|mri
1513120|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
1513121|NCT00727766|Clofarabine|clofarabine
1513122|NCT00727766|Clolar|clolar
1513123|NCT00727766|AML|aml
1513124|NCT00727766|Consolidation|consolidation
1513125|NCT00727753|Macular Degeneration|macular degeneration
1513126|NCT00727753|Age-Related Maculopathies|age-related maculopathies
1567709|NCT00508443|Sarcoma|sarcoma
1513127|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1513128|NCT00727740|Pancreatitis|pancreatitis
1513129|NCT00727740|Indomethacin|indomethacin
1513130|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
1513131|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
1513132|NCT00727727|Morbus Parkinson|morbus parkinson
1513133|NCT00727727|Tolerability|tolerability
1513134|NCT00727727|Efficacy|efficacy
1513135|NCT00727727|Post Marketing Surveillance|post marketing surveillance
1513136|NCT00727714|Cement dust exposure|cement dust exposure
1513137|NCT00727714|Cross-shift study|cross-shift study
1513138|NCT00727714|Lung function indices|lung function indices
1513139|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
1513140|NCT00727714|Serum inflammatory markers|serum inflammatory markers
1513141|NCT00727701|varicose ulcer|varicose ulcer
1513142|NCT00727701|veteran|veteran
1513143|NCT00727701|recurrence|recurrence
1513144|NCT00727701|aftercare|aftercare
1513145|NCT00727675|chronic pain|chronic pain
1513146|NCT00727675|opioid dependence|opioid dependence
1513147|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1513148|NCT00727662|Breast Cancer|breast cancer
1513149|NCT00727662|Fatigue|fatigue
1513150|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
1513151|NCT00727662|Physical functioning|physical functioning
1513152|NCT00727662|Quality of life|quality of life
1513153|NCT00727649|fecal incontinence|fecal incontinence
1513154|NCT00727649|adults|adults
1513155|NCT00727649|diarrhea|diarrhea
1513156|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1513157|NCT00727636|immunogenicity|immunogenicity
1513158|NCT00727636|safety|safety
1513159|NCT00727636|HPV|hpv
1513160|NCT00727636|Gardasil|gardasil
1513161|NCT00727636|vaccine|vaccine
1513162|NCT00727623|acute coronary syndrome|acute coronary syndrome
1513163|NCT00727623|myocardial infarction|myocardial infarction
1513164|NCT00727623|predictors of mortality|predictors of mortality
1513165|NCT00727623|reperfusion therapy|reperfusion therapy
1513166|NCT00727610|Adverse drug event|adverse drug event
1513167|NCT00727610|harm|harm
1513168|NCT00727610|patient safety|patient safety
1513169|NCT00727610|clinical decision support|clinical decision support
1513170|NCT00727610|Adverse drug related event|adverse drug related event
1513171|NCT00727584|spinal cord compression|spinal cord compression
1513172|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1513173|NCT00727571|Anemia|anemia
1513174|NCT00727571|Chronic Kidney Disease|chronic kidney disease
1513175|NCT00727571|Quality of Life|quality of life
1513176|NCT00727571|CKD|ckd
1513177|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
1513178|NCT00727558|refractive error|refractive error
1513179|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1513180|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
1513181|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
1513182|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
1513183|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
1513184|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
1513185|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
1513186|NCT00727519|Hemodialysis|hemodialysis
1513187|NCT00727519|Nephrology|nephrology
1513188|NCT00727519|Pomegranate Juice|pomegranate juice
1513189|NCT00727519|Israel|israel
1513190|NCT00727493|osteoporosis,|osteoporosis,
1513191|NCT00727493|bisphosphonate|bisphosphonate
1513192|NCT00727493|therapy|therapy
1513193|NCT00727493|dental implant|dental implant
1513196|NCT00727467|auditory cueing device|auditory cueing device
1513197|NCT00727467|Parkinson's disease|parkinson's disease
1513198|NCT00727467|freezing|freezing
1513199|NCT00727467|gait|gait
1513200|NCT00727467|mobility|mobility
1513201|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
1513202|NCT00727454|CPAP|cpap
1513203|NCT00727454|Heart remodeling|heart remodeling
1513204|NCT00727454|Cardiovascular disease|cardiovascular disease
1513205|NCT00727454|MRI|mri
1513206|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1513207|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
1513208|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
1513209|NCT00727428|FluLaval® TF|flulaval® tf
1513210|NCT00727428|Safety|safety
1513211|NCT00727428|Immunogenicity|immunogenicity
1513212|NCT00727428|Influenza|influenza
1513213|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
1513214|NCT00727415|Lenalidomide|lenalidomide
1513215|NCT00727415|Fludarabine|fludarabine
1513216|NCT00727389|Prevention|prevention
1513217|NCT00727389|Quality of Health Care|quality of health care
1513218|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
1513219|NCT00727376|esophageal|esophageal
1513220|NCT00727376|stenting|stenting
1513221|NCT00727363|probiotics|probiotics
1513222|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
1513223|NCT00727363|preterm infants|preterm infants
1513224|NCT00727363|nosocomial infection|nosocomial infection
1513225|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
1513226|NCT00727350|NSCLC|nsclc
1513227|NCT00727350|Novalis|novalis
1513228|NCT00727350|Stereotactic|stereotactic
1513229|NCT00727350|SBRT|sbrt
1513230|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
1513231|NCT00727337|auditory perception|auditory perception
1513232|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
1513233|NCT00727324|Ulcerative Colitis|ulcerative colitis
1513234|NCT00727324|UC|uc
1513235|NCT00727324|moderate|moderate
1513236|NCT00727324|severe|severe
1513237|NCT00727324|LPS|lps
1513238|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
1513239|NCT00727324|AP|ap
1513240|NCT00727324|BIAP|biap
1513241|NCT00727324|Mucositis|mucositis
1513242|NCT00727285|Cystic Fibrosis|cystic fibrosis
1513243|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
1513244|NCT00727285|gene expression|gene expression
1513245|NCT00727285|biomarker|biomarker
1513246|NCT00727285|inflammation|inflammation
1513247|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
1513248|NCT00727272|Bioavailability|bioavailability
1513249|NCT00727246|Traumatic Brain Injury|traumatic brain injury
1513250|NCT00727246|FMRI|fmri
1513251|NCT00727246|Memory|memory
1513252|NCT00727246|Cognition|cognition
1513253|NCT00727246|Neuropsychology|neuropsychology
1513254|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
1513255|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
1513256|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
1513257|NCT00727233|Kinase Inhibitor|kinase inhibitor
1513258|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
1513259|NCT00727233|NF1|nf1
1513260|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
1513261|NCT00727220|type 1 diabetes|type 1 diabetes
1513262|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
1513263|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1513264|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1513265|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1513266|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1513267|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1513268|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1513269|NCT00727181|aortic valve|aortic valve
1513270|NCT00727181|heart valve|heart valve
1513271|NCT00727181|tissue valve|tissue valve
1513272|NCT00727181|bioprosthesis|bioprosthesis
1513273|NCT00727181|valve disorder|valve disorder
1513274|NCT00727181|valve disease|valve disease
1513275|NCT00727181|cardiac surgery|cardiac surgery
1513276|NCT00727181|aortic valve stenosis|aortic valve stenosis
1513277|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
1513278|NCT00727168|prevalence study|prevalence study
1513279|NCT00727168|glaucoma|glaucoma
1513280|NCT00727142|NPH|nph
1513281|NCT00727142|Hydrocephalus|hydrocephalus
1513282|NCT00727142|Shunt|shunt
1513283|NCT00727129|vasomotor symptoms|vasomotor symptoms
1513284|NCT00727129|estrogen|estrogen
1513285|NCT00727129|estradiol|estradiol
1513286|NCT00727129|hot flashes|hot flashes
1513287|NCT00727103|Varenicline|varenicline
1513288|NCT00727103|Smoking cessation|smoking cessation
1513289|NCT00727103|Schizophrenia|schizophrenia
1513290|NCT00727103|Schizoaffective disorder|schizoaffective disorder
1513291|NCT00727103|Alcohol dependence|alcohol dependence
1513292|NCT00727103|Nicotine dependence|nicotine dependence
1513293|NCT00727064|Healthy Subjects|healthy subjects
1513294|NCT00727051|invasive coronary angiography|invasive coronary angiography
1513295|NCT00727051|multidetector coronary CTA|multidetector coronary cta
1513296|NCT00727051|coronary artery disease|coronary artery disease
1513297|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
1513298|NCT00727038|glaucoma|glaucoma
1513299|NCT00727038|neovascular glaucoma|neovascular glaucoma
1513300|NCT00727038|new onset glaucoma|new onset glaucoma
1513301|NCT00727038|retinal ischemia|retinal ischemia
1513302|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
1513303|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1513304|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
1513305|NCT00727038|carotid stenosis|carotid stenosis
1513306|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
1513307|NCT00727038|neovascular|neovascular
1513308|NCT00727025|skin closure devices|skin closure devices
1513309|NCT00727025|linear scars|linear scars
1513310|NCT00727012|mitral valve|mitral valve
1513311|NCT00727012|heart valve|heart valve
1513312|NCT00727012|valve repair|valve repair
1513313|NCT00727012|valve disorder|valve disorder
1513314|NCT00727012|valve disease|valve disease
1513315|NCT00727012|cardiac surgery|cardiac surgery
1513316|NCT00726999|Gabapentin|gabapentin
1513317|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
1513318|NCT00726999|Narcotic Use|narcotic use
1513319|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1513320|NCT00726973|Macular edema|macular edema
1513321|NCT00726960|Heroin abuse|heroin abuse
1513322|NCT00726960|Opioids|opioids
1513323|NCT00726960|Opiates|opiates
1513324|NCT00726960|Substance abuse|substance abuse
1513325|NCT00726960|Addiction|addiction
1513326|NCT00726934|Neutropenic Diet|neutropenic diet
1513327|NCT00726934|Food Safety Guidelines|food safety guidelines
1513328|NCT00726934|child|child
1513329|NCT00726934|cancer|cancer
1513330|NCT00726908|Obesity|obesity
1513331|NCT00726908|diet|diet
1513332|NCT00726908|carbohydrate|carbohydrate
1513333|NCT00726908|insulin|insulin
1513334|NCT00726895|Bioavailability|bioavailability
1513335|NCT00726882|HCV Infection|hcv infection
1513336|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
1513337|NCT00726843|Headache|headache
1513338|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
1513339|NCT00726843|Pediatric|pediatric
1513340|NCT00726843|Yoga|yoga
1513341|NCT00726830|pain|pain
1513342|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1513343|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1513344|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
1513345|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1513346|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1513347|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1513348|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1513349|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1513350|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1513351|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1513352|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1513353|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1513354|NCT00726830|mast cell leukemia|mast cell leukemia
1513355|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1513356|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1513357|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
1513358|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1513359|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1513360|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1513361|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1513362|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
1513363|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1513458|NCT00726791|chronic pain|chronic pain
1513364|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1513365|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1513366|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1513367|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1513368|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1513369|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1513716|NCT00725738|Stem|stem
1513370|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1513371|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1513372|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
1513373|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1513374|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1513514|NCT00726687|Cancer|cancer
1513375|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1513376|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1513377|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1513378|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1513379|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1513380|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1513381|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1513382|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1513383|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1513384|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1513385|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1513386|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1513387|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1513388|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1513389|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1513390|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1673935|NCT00093379|XRT|xrt
1513391|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1513392|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1513393|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1513394|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1513395|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1513396|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1513397|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1513398|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1513399|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1513400|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1513401|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1513402|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1513403|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1513404|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1513405|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1513406|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1513407|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1513408|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1513409|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1513410|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1513411|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1513412|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1513413|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1513414|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1513415|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1513416|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1513417|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1513418|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1513419|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1513420|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1513421|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1513422|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1513423|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1513424|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1513425|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1513426|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1513427|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1513428|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1513429|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1513430|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1513431|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1513606|NCT00726167|mechanically ventilated|mechanically ventilated
1513432|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1513433|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1513434|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1513435|NCT00726830|intraocular lymphoma|intraocular lymphoma
1513436|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1513437|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1513515|NCT00726687|Indibulin|indibulin
1513438|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1513439|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1513440|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1513441|NCT00726830|primary myelofibrosis|primary myelofibrosis
1513442|NCT00726830|essential thrombocythemia|essential thrombocythemia
1513443|NCT00726830|polycythemia vera|polycythemia vera
1513444|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
1513445|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1513446|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1513447|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
1513448|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
1513449|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
1513450|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
1513451|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1513452|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1513453|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1567710|NCT00508443|Spinal Cancer|spinal cancer
1513454|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1513455|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1513456|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
1513457|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
1513459|NCT00726791|pain disorder|pain disorder
1513460|NCT00726778|race/ethnicity|race/ethnicity
1513461|NCT00726778|insulin senistivity|insulin senistivity
1513462|NCT00726778|genetic admixture|genetic admixture
1513463|NCT00726778|type 2 diabetes|type 2 diabetes
1513464|NCT00726778|obesity|obesity
1513465|NCT00726778|body composition|body composition
1513466|NCT00726778|Insulin dynamics|insulin dynamics
1513467|NCT00726778|Racial/ethnic differences|racial/ethnic differences
1513468|NCT00726752|solid tumor|solid tumor
1513469|NCT00726752|Axitinib|axitinib
1513470|NCT00726752|Pharmacokinetics|pharmacokinetics
1513471|NCT00726752|Phase 1|phase 1
1513472|NCT00726739|recurrent melanoma|recurrent melanoma
1513473|NCT00726713|Metanx|metanx
1513474|NCT00726713|diabetes|diabetes
1513475|NCT00726713|neuropathy|neuropathy
1513476|NCT00726713|folic acid|folic acid
1513477|NCT00726713|folate|folate
1513478|NCT00726713|L-methylfolate|l-methylfolate
1513479|NCT00726713|vitamin B6|vitamin b6
1513480|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
1513481|NCT00726713|vitamin B12|vitamin b12
1513482|NCT00726713|methylcobalamin|methylcobalamin
1513483|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1513484|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1513485|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1513486|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1513487|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1513488|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1513489|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1513490|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1513491|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1513492|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1513493|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1513494|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1513495|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1513496|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1513497|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1513498|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1513499|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1513500|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1513501|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1513502|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1513503|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1513504|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1513505|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1513506|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1513507|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1513508|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1513509|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1513510|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1513511|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1513512|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1513513|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1513516|NCT00726687|Capecitabine|capecitabine
1513517|NCT00726687|Xeloda|xeloda
1513518|NCT00726674|Diabetes HbA1C|diabetes hba1c
1513519|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
1513520|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
1513521|NCT00726661|Avastin|avastin
1513522|NCT00726648|CDP323|cdp323
1513523|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
1513524|NCT00726648|Blood biomarkers|blood biomarkers
1513525|NCT00726622|rectal cancer|rectal cancer
1513526|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1513527|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
1513528|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
1513529|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
1513530|NCT00726583|Cancer|cancer
1513531|NCT00726583|Solid Tumors|solid tumors
1513532|NCT00726583|Carcinoma|carcinoma
1513533|NCT00726583|PI-3K|pi-3k
1513534|NCT00726583|PI3 kinase|pi3 kinase
1513535|NCT00726583|PI3K|pi3k
1513536|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
1513537|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
1513538|NCT00726570|Perioperative Care|perioperative care
1513539|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
1513540|NCT00726544|thrombocytopenia|thrombocytopenia
1513541|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
1513542|NCT00726544|von Willebrand Factor|von willebrand factor
1513543|NCT00726544|ADAMTS13|adamts13
1513544|NCT00726531|Falls prevention|falls prevention
1513545|NCT00726531|Exercise promotion|exercise promotion
1513546|NCT00726531|Older people|older people
1513547|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
1513549|NCT00726466|CNV|cnv
1513550|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
1513551|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
1513552|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
1513553|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
1513554|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
1513555|NCT00726453|STENT THROMBOSIS|stent thrombosis
1513556|NCT00726453|RESTENOTIC LESION|restenotic lesion
1513557|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
1513558|NCT00726440|Type 1 Diabetes|type 1 diabetes
1513559|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
1513560|NCT00726440|HbA1c|hba1c
1513561|NCT00726440|Navigator®|navigator®
1513562|NCT00726427|pharmacokinetics|pharmacokinetics
1513563|NCT00726427|pharmacodynamics|pharmacodynamics
1513564|NCT00726427|AZD1656|azd1656
1513565|NCT00726427|safety|safety
1513566|NCT00726427|tolerability|tolerability
1513567|NCT00726427|Healthy Volunteers|healthy volunteers
1513568|NCT00726414|Bioavailability|bioavailability
1513569|NCT00726401|Allergies|allergies
1513570|NCT00726401|Nasal|nasal
1513571|NCT00726401|Congestion|congestion
1513572|NCT00726401|Sneezing|sneezing
1513573|NCT00726401|Pruritus|pruritus
1513574|NCT00726401|Teary|teary
1513575|NCT00726401|Eyes|eyes
1513576|NCT00726388|safety|safety
1513577|NCT00726388|diclofenac|diclofenac
1513578|NCT00726388|pain, postoperative|pain, postoperative
1513579|NCT00726375|(GVHD)|(gvhd)
1513580|NCT00726362|Statin|statin
1513581|NCT00726362|LDL-C|ldl-c
1513582|NCT00726336|healthy volunteer|healthy volunteer
1513583|NCT00726336|pharmacokinetics|pharmacokinetics
1513584|NCT00726336|GSK1349572|gsk1349572
1513585|NCT00726336|integrase|integrase
1513586|NCT00726323|c-Met|c-met
1513587|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
1513588|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
1513589|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
1513590|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
1513591|NCT00726310|Spondylolisthesis|spondylolisthesis
1513592|NCT00726310|Instability|instability
1513593|NCT00726284|HNP|hnp
1513594|NCT00726271|obesity|obesity
1513595|NCT00726271|appetite set point|appetite set point
1513596|NCT00726219|Major|major
1513597|NCT00726219|knee|knee
1513598|NCT00726219|surgery|surgery
1513599|NCT00726180|Breast cancer|breast cancer
1513600|NCT00726180|Women|women
1513601|NCT00726180|w/Her2|w/her2
1513602|NCT00726180|positive|positive
1513603|NCT00726180|ERnegative|ernegative
1513604|NCT00726180|not metastasized|not metastasized
1513605|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
1513607|NCT00726167|procalcitonin|procalcitonin
1513608|NCT00726167|pneumonia scores|pneumonia scores
1513609|NCT00726154|Bipolar Disorder|bipolar disorder
1513610|NCT00726154|Circadian Rhythm|circadian rhythm
1513611|NCT00726154|Moderators|moderators
1513612|NCT00726154|Lithium|lithium
1513613|NCT00726154|Quetiapine|quetiapine
1513614|NCT00726141|Brief Intervention|brief intervention
1513615|NCT00726141|Smoking Cessation|smoking cessation
1514187|NCT00723918|methadone|methadone
1513616|NCT00726141|Motivational Interviewing|motivational interviewing
1513617|NCT00726141|Expert System|expert system
1513618|NCT00726141|Readiness to Change|readiness to change
1513619|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
1513620|NCT00726141|Adolescents|adolescents
1513621|NCT00726128|DDD|ddd
1513622|NCT00726102|Zinc nutrition|zinc nutrition
1513623|NCT00726102|Growth|growth
1513624|NCT00726102|Development|development
1513625|NCT00726102|China|china
1513626|NCT00726102|Infants|infants
1513627|NCT00726102|Toddlers|toddlers
1513628|NCT00726076|Epilepsy|epilepsy
1513629|NCT00726076|Medication|medication
1513630|NCT00726076|Stress|stress
1513631|NCT00726076|Sleep|sleep
1513632|NCT00726076|Lifestyle Management|lifestyle management
1513633|NCT00726063|dental implants|dental implants
1513634|NCT00726063|Nanotite implant|nanotite implant
1513635|NCT00726063|Osseotite implants|osseotite implants
1513636|NCT00726063|multicenter|multicenter
1513637|NCT00726063|randomized|randomized
1513638|NCT00726063|clinical study|clinical study
1513639|NCT00726063|partial edentulism|partial edentulism
1513640|NCT00726063|prosthesis|prosthesis
1513641|NCT00726050|Theta Burst Stimulation|theta burst stimulation
1513642|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
1513643|NCT00726050|Somatosensory Cortex|somatosensory cortex
1513644|NCT00726050|Tactile Discrimination|tactile discrimination
1513645|NCT00726050|Healthy Volunteer|healthy volunteer
1513646|NCT00726050|HV|hv
1513647|NCT00726037|Denileukin diftitox|denileukin diftitox
1513648|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1513649|NCT00726037|Ontak|ontak
1513650|NCT00726037|Regulatory T-cell|regulatory t-cell
1513651|NCT00726011|due|due
1513652|NCT00726011|cancer treatment|cancer treatment
1513653|NCT00725998|Cochlear Implantation.|cochlear implantation.
1513654|NCT00725998|Cochlear nerve.|cochlear nerve.
1513655|NCT00725998|Child.|child.
1513656|NCT00725998|study|study
1513657|NCT00725998|ECAP|ecap
1513658|NCT00725998|During|during
1513659|NCT00725998|First year|first year
1513660|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
1513661|NCT00725985|Early MS|early ms
1513662|NCT00725985|Multiple Sclerosis|multiple sclerosis
1513663|NCT00725972|Improve|improve
1513664|NCT00725972|Patient care|patient care
1513665|NCT00725972|Applying|applying
1513666|NCT00725972|Systematic|systematic
1513667|NCT00725972|Fashion|fashion
1513668|NCT00725972|Proven|proven
1513669|NCT00725972|Resuscitation|resuscitation
1513670|NCT00725972|Algorithms|algorithms
1513671|NCT00725972|High risk|high risk
1513672|NCT00725972|Surgical|surgical
1513673|NCT00725959|HIV Prevention|hiv prevention
1513674|NCT00725959|Social Networking|social networking
1513675|NCT00725959|Technology Based Intervention|technology based intervention
1513676|NCT00725920|PTSD,|ptsd,
1513677|NCT00725920|posttraumatic|posttraumatic
1513678|NCT00725920|stress|stress
1513679|NCT00725920|disorder,|disorder,
1513680|NCT00725920|randomization,|randomization,
1513681|NCT00725920|placebo,|placebo,
1513682|NCT00725920|controlled|controlled
1513683|NCT00725907|PRP|prp
1513684|NCT00725907|ATFL|atfl
1513685|NCT00725881|PAD|pad
1513686|NCT00725881|Peripheral arterial disease|peripheral arterial disease
1513687|NCT00725881|Peripheral artery disease|peripheral artery disease
1513688|NCT00725881|Intermittent claudication|intermittent claudication
1513689|NCT00725881|IC|ic
1513690|NCT00725881|atherosclerosis|atherosclerosis
1513691|NCT00725881|leg pain|leg pain
1513692|NCT00725881|walking pain|walking pain
1513693|NCT00725868|Major adverse|major adverse
1513694|NCT00725855|Schizophrenia|schizophrenia
1513695|NCT00725855|P50 Sensory Gating|p50 sensory gating
1513696|NCT00725855|Mismatched Negativity|mismatched negativity
1513697|NCT00725829|coagulation|coagulation
1513698|NCT00725829|cholesterol|cholesterol
1513699|NCT00725829|acute ischemia|acute ischemia
1513700|NCT00725829|fibrin clot|fibrin clot
1513701|NCT00725803|Hepatitis C|hepatitis c
1513702|NCT00725803|HCV|hcv
1513703|NCT00725803|Fibrosis|fibrosis
1513704|NCT00725803|Apoptosis|apoptosis
1513705|NCT00725803|GS-9450|gs-9450
1513706|NCT00725790|Erectile Dysfunction|erectile dysfunction
1513707|NCT00725790|Spinal Cord Injury|spinal cord injury
1513708|NCT00725764|VEGFR2|vegfr2
1513709|NCT00725764|XL880|xl880
1513710|NCT00725764|foretinib|foretinib
1513711|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
1513712|NCT00725764|MET|met
1513713|NCT00725764|GSK1363089|gsk1363089
1513714|NCT00725738|Myocardial|myocardial
1513715|NCT00725738|Infarction,|infarction,
1513717|NCT00725738|Cell|cell
1513718|NCT00725738|Therapy|therapy
1513719|NCT00725712|c-Met|c-met
1513720|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
1513721|NCT00725712|adenocarcinoma|adenocarcinoma
1513722|NCT00725712|Gastric cancer|gastric cancer
1513723|NCT00725712|GSK1363089|gsk1363089
1513724|NCT00725712|XL880|xl880
1513725|NCT00725712|MET inhibitor|met inhibitor
1514383|NCT00722943|postnatal|postnatal
1513726|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
1513727|NCT00725673|COPD|copd
1513728|NCT00725673|Osteoporosis|osteoporosis
1513729|NCT00725673|BMD|bmd
1513730|NCT00725673|DEXA-scan|dexa-scan
1513731|NCT00725660|pre eclampsia|pre eclampsia
1513732|NCT00725660|doppler|doppler
1513733|NCT00725660|uterine|uterine
1513734|NCT00725660|arteries|arteries
1513735|NCT00725660|angiogenic|angiogenic
1513736|NCT00725660|factors|factors
1513737|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
1513738|NCT00725647|echocardiography|echocardiography
1513739|NCT00725647|diagnosis|diagnosis
1513740|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
1513741|NCT00725647|preterm infant|preterm infant
1513742|NCT00725634|Neoplasms,|neoplasms,
1513743|NCT00725634|Lymphoma,|lymphoma,
1513744|NCT00725634|Multiple Myeloma,|multiple myeloma,
1513745|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
1513746|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
1513747|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
1513748|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
1513749|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
1513750|NCT00725634|Vascular Diseases|vascular diseases
1513751|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
1513752|NCT00725634|Paraproteinemias|paraproteinemias
1513753|NCT00725634|Blood Protein Disorders|blood protein disorders
1513754|NCT00725634|Hematologic Diseases|hematologic diseases
1513755|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
1513756|NCT00725634|Erlotinib|erlotinib
1513757|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
1513758|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
1513759|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1513760|NCT00725634|Pharmacologic Actions|pharmacologic actions
1513761|NCT00725608|Suboxone|suboxone
1513762|NCT00725608|Subutex|subutex
1513763|NCT00725608|Buprenorphine|buprenorphine
1513764|NCT00725608|Naloxone|naloxone
1513765|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
1513766|NCT00725595|heart failure|heart failure
1513767|NCT00725595|sleep apnea|sleep apnea
1513768|NCT00725595|ventilator|ventilator
1513769|NCT00725569|Caesarian Section|caesarian section
1513770|NCT00725569|Homeopathy|homeopathy
1513771|NCT00725569|Pain|pain
1513772|NCT00725569|Analgesia|analgesia
1513773|NCT00725556|Autism|autism
1513774|NCT00725556|Asperger Syndrome|asperger syndrome
1513775|NCT00725530|Lens deposits|lens deposits
1513776|NCT00725530|Soft contact lens wearers|soft contact lens wearers
1513777|NCT00725517|Icodextrin|icodextrin
1513778|NCT00725517|ultrafiltration|ultrafiltration
1513779|NCT00725517|creatinine clearance|creatinine clearance
1513780|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
1513781|NCT00725491|Reproductive|reproductive
1513782|NCT00725491|techniques|techniques
1513783|NCT00725491|assisted|assisted
1513784|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
1513785|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
1513786|NCT00725478|Morbus Parkinson|morbus parkinson
1513787|NCT00725478|Tolerability|tolerability
1513788|NCT00725478|Efficacy|efficacy
1513789|NCT00725478|Post Marketing Surveillance|post marketing surveillance
1513790|NCT00725465|laparoscopy|laparoscopy
1513791|NCT00725465|CO2 colonoscopy|co2 colonoscopy
1513792|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
1513793|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
1513794|NCT00725465|to evaluate simultaneous CO2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional CO2 insufflation|to evaluate simultaneous co2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional co2 insufflation
1513795|NCT00725426|healthy subjects|healthy subjects
1513796|NCT00725400|Colorectal Cancer|colorectal cancer
1513797|NCT00725400|Erbitux|erbitux
1513798|NCT00725400|Cetuximab|cetuximab
1513799|NCT00725400|Surgery|surgery
1513800|NCT00725400|Radiation|radiation
1513801|NCT00725348|Psoriasis|psoriasis
1513802|NCT00725335|ischemia|ischemia
1513803|NCT00725335|liver cancer|liver cancer
1513804|NCT00725335|radical excision|radical excision
1513805|NCT00725335|prognosis|prognosis
1513806|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1513807|NCT00725309|COPD|copd
1513808|NCT00725309|Elastin|elastin
1513809|NCT00725309|ELN|eln
1513810|NCT00725283|Leukemia|leukemia
1513811|NCT00725283|ASCI|asci
1513812|NCT00725283|Complete remission|complete remission
1513813|NCT00725283|Immunotherapy|immunotherapy
1513814|NCT00725283|adult|adult
1513815|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
1513816|NCT00725283|Tumor antigen|tumor antigen
1513817|NCT00725283|WT1|wt1
1513818|NCT00725244|Radiation Injuries|radiation injuries
1513819|NCT00725244|Telangiectasis|telangiectasis
1513820|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
1513821|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
1513822|NCT00725231|T cell lymphoma|t cell lymphoma
1513823|NCT00725218|NSAIDs|nsaids
1513824|NCT00725218|Postoperative pain|postoperative pain
1513825|NCT00725218|Analgesia|analgesia
1513826|NCT00725218|Abortion|abortion
1513827|NCT00725192|PTSD|ptsd
1513828|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
1513829|NCT00725192|Physical Assault|physical assault
1513830|NCT00725192|Physical Abuse|physical abuse
1513831|NCT00725192|Sexual Assault|sexual assault
1513832|NCT00725192|Sexual Abuse|sexual abuse
1513833|NCT00725192|Interpersonal Assault|interpersonal assault
1513834|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
1513835|NCT00725192|Sleep Impairment|sleep impairment
1513836|NCT00725192|Insomnia|insomnia
1513837|NCT00725192|Hypnosis|hypnosis
1513838|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
1513839|NCT00725179|n-acetylcysteine|n-acetylcysteine
1513840|NCT00725179|liver toxicity|liver toxicity
1513841|NCT00725166|Aging|aging
1513842|NCT00725166|Biopsy|biopsy
1513843|NCT00725166|Skeletal muscle|skeletal muscle
1513844|NCT00725166|Molecular biology|molecular biology
1513845|NCT00725166|Genetic markers|genetic markers
1513846|NCT00725166|Gene expression regulation|gene expression regulation
1513847|NCT00725166|Young and old men|young and old men
1513848|NCT00725166|Healthy volunteers|healthy volunteers
1513849|NCT00725153|Contact lens deposits|contact lens deposits
1513850|NCT00725153|Soft contact lenses|soft contact lenses
1513851|NCT00725153|Myopia|myopia
1513852|NCT00725140|Migraine|migraine
1513853|NCT00725140|Early intervention|early intervention
1513854|NCT00725140|Primary Care|primary care
1513855|NCT00725140|Almotriptan|almotriptan
1513856|NCT00725127|Aspirin|aspirin
1513857|NCT00725127|Chronotherapy|chronotherapy
1513858|NCT00725127|Primary prevention|primary prevention
1513859|NCT00725127|Impaired fasting glucose|impaired fasting glucose
1513860|NCT00725127|Type 2 diabetes|type 2 diabetes
1513861|NCT00725127|Total mortality|total mortality
1513862|NCT00725127|Myocardial infarction|myocardial infarction
1513863|NCT00725127|Stroke|stroke
1513864|NCT00725127|Angina pectoris|angina pectoris
1513865|NCT00725127|Chronic kidney disease|chronic kidney disease
1513866|NCT00725114|due|due
1513867|NCT00725114|cancer|cancer
1513868|NCT00725114|treatment|treatment
1513869|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
1513870|NCT00725088|Exercise Training|exercise training
1513871|NCT00725088|Rehabilitation|rehabilitation
1513872|NCT00725075|Negative symptoms|negative symptoms
1513873|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
1513874|NCT00725075|Add-on treatment|add-on treatment
1513875|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
1513876|NCT00725062|graft versus host disease|graft versus host disease
1513877|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1513878|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1513879|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1513880|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1513881|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1513882|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1513883|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1513884|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1513885|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1513886|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1513887|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1513888|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1513889|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1513890|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
1513891|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
1513892|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
1513893|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
1513894|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1513895|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1513896|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1513897|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1513898|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1513899|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1513900|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1514175|NCT00723944|randomized|randomized
1513901|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1513902|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1513903|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1513904|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1513905|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1513906|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1514384|NCT00722943|weight gain|weight gain
1513907|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1513908|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1513909|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1513910|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1513911|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1513912|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1513913|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1513914|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1513915|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1513916|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1567711|NCT00508430|ASP8825|asp8825
1513917|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1513918|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1513919|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1513920|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1513921|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1513922|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1513923|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1513924|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1513925|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1513926|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1513927|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1513928|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1513929|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1513930|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1513931|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1513932|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1513933|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1513934|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1513935|NCT00725049|dental implants|dental implants
1513936|NCT00725049|Nanotite Certain implant|nanotite certain implant
1513937|NCT00725049|Osseotite|osseotite
1513938|NCT00725049|multicenter|multicenter
1513939|NCT00725049|randomized|randomized
1513940|NCT00725049|clinical study|clinical study
1513941|NCT00725049|partial edentulism|partial edentulism
1513942|NCT00725049|crestal bone level|crestal bone level
1513943|NCT00725049|short fixed bridge|short fixed bridge
1513944|NCT00725049|cost analysis|cost analysis
1513945|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
1513946|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
1513947|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
1513948|NCT00724997|intranasally application|intranasally application
1513949|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
1513950|NCT00724984|PCI-24781|pci-24781
1513951|NCT00724984|Lymphoma|lymphoma
1513952|NCT00724984|Hodgkin Disease|hodgkin disease
1513953|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1513954|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1513955|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
1513956|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
1513957|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1513958|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
1513959|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
1513960|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
1513961|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1513962|NCT00724971|NHL|nhl
1513963|NCT00724919|ESBL|esbl
1513964|NCT00724906|Essential Tremor|essential tremor
1513965|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
1513966|NCT00724906|Parkinson Disease|parkinson disease
1513967|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
1513968|NCT00724906|Diagnosis|diagnosis
1513969|NCT00724906|Subjects|subjects
1513970|NCT00724906|Upper|upper
1513971|NCT00724906|Extremity|extremity
1513972|NCT00724906|Tremor|tremor
1513973|NCT00724906|Less|less
1513974|NCT00724906|Than 2 years|than 2 years
1513975|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
1513976|NCT00724880|clopidogrel|clopidogrel
1513977|NCT00724880|post-operative bleeding|post-operative bleeding
1513978|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
1513979|NCT00724867|Belimumab|belimumab
1513980|NCT00724867|SLE|sle
1513981|NCT00724867|Antibodies|antibodies
1513982|NCT00724867|Lupus|lupus
1513983|NCT00724867|Autoimmune Diseases|autoimmune diseases
1513984|NCT00724828|Bacterial otitis media|bacterial otitis media
1513985|NCT00724828|pneumoniae|pneumoniae
1513986|NCT00724828|sepsis|sepsis
1513987|NCT00724828|bacteremia|bacteremia
1513988|NCT00724828|meningitis|meningitis
1513989|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
1513990|NCT00724802|babies with canavan disease|babies with canavan disease
1513991|NCT00724789|Neonatal outcome|neonatal outcome
1513992|NCT00724789|Congenital malformations|congenital malformations
1513993|NCT00724789|In-Vitro fertilization|in-vitro fertilization
1513994|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
1513995|NCT00724789|Follow-up|follow-up
1513996|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
1513997|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
1513998|NCT00724724|Stroke|stroke
1513999|NCT00724724|Transient Ischemic Attack|transient ischemic attack
1514000|NCT00724711|HIV|hiv
1514001|NCT00724711|HIV 1|hiv 1
1514002|NCT00724685|Ropivacaine|ropivacaine
1514003|NCT00724685|elastomeric pump|elastomeric pump
1514004|NCT00724685|patient controlled analgesia|patient controlled analgesia
1514005|NCT00724685|morphine consumption|morphine consumption
1514006|NCT00724659|Arthrogram|arthrogram
1514007|NCT00724659|Contrast|contrast
1514008|NCT00724659|Joint|joint
1514009|NCT00724659|Ultrasound|ultrasound
1514010|NCT00724646|parents|parents
1514011|NCT00724646|medically fragile|medically fragile
1514012|NCT00724646|death|death
1514013|NCT00724646|end-of-life care|end-of-life care
1514014|NCT00724646|surveys|surveys
1514015|NCT00724633|dialysate|dialysate
1514016|NCT00724633|sodium|sodium
1514017|NCT00724633|hemodialysis|hemodialysis
1514018|NCT00724633|blood pressure|blood pressure
1514019|NCT00724633|thirst|thirst
1514020|NCT00724633|intradialytic symptoms|intradialytic symptoms
1514021|NCT00724633|interdialytic weight gain|interdialytic weight gain
1514022|NCT00724633|extracellular fluid balance|extracellular fluid balance
1514023|NCT00724633|mechanisms|mechanisms
1514024|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
1514025|NCT00724607|Screening|screening
1514026|NCT00724607|neuroimaging|neuroimaging
1514027|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
1514028|NCT00724594|chorioamnionitis|chorioamnionitis
1514029|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
1514030|NCT00724594|neonatal white matter injury|neonatal white matter injury
1514031|NCT00724594|N-acetylcysteine|n-acetylcysteine
1514032|NCT00724594|NAC|nac
1514033|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
1514034|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
1514035|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
1514036|NCT00724555|stroke|stroke
1514037|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
1514038|NCT00724555|tPA|tpa
1514039|NCT00724529|Crohn's Disease|crohn's disease
1514040|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
1514041|NCT00724516|Mammogram|mammogram
1514042|NCT00724516|Biopsy|biopsy
1514043|NCT00724516|Needle|needle
1514044|NCT00724516|Wire|wire
1514045|NCT00724516|Localization|localization
1514046|NCT00724516|Compression|compression
1514047|NCT00724516|Paddle|paddle
1514048|NCT00724503|colon cancer|colon cancer
1514049|NCT00724503|Colorectal carcinoma|colorectal carcinoma
1514050|NCT00724503|liver metastases|liver metastases
1514051|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
1514052|NCT00724503|yttrium-90|yttrium-90
1514053|NCT00724503|FOLFOX|folfox
1514054|NCT00724503|bevacizumab|bevacizumab
1514055|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
1514056|NCT00724490|Deep Brain Stimulation|deep brain stimulation
1514057|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
1514058|NCT00724490|Nucleus Accumbens|nucleus accumbens
1514059|NCT00724438|Contraception|contraception
1514060|NCT00724438|Implanon|implanon
1514061|NCT00724438|Obesity|obesity
1514062|NCT00724438|Blood spots|blood spots
1514063|NCT00724438|Implant|implant
1514064|NCT00724438|Pharmacokinetics|pharmacokinetics
1514065|NCT00724412|Dry Eye|dry eye
1514066|NCT00724412|Corneal Staining|corneal staining
1514067|NCT00724360|relapsed/refractory|relapsed/refractory
1514068|NCT00724360|HER2|her2
1514069|NCT00724360|positive|positive
1514070|NCT00724360|B-ALL|b-all
1514071|NCT00724360|trastuzumab|trastuzumab
1514072|NCT00724347|Auditory Perception|auditory perception
1514073|NCT00724347|Hearing Loss|hearing loss
1514074|NCT00724347|Presbycusis|presbycusis
1514075|NCT00724347|Perceptual Learning|perceptual learning
1514076|NCT00724347|Hearing Prosthesis|hearing prosthesis
1514077|NCT00724347|Speech Discrimination|speech discrimination
1514078|NCT00724347|Delayed Treatment|delayed treatment
1514079|NCT00724334|myelofibrosis|myelofibrosis
1514080|NCT00724321|iloprost|iloprost
1514081|NCT00724321|hypoxic|hypoxic
1514082|NCT00724321|pulmonary|pulmonary
1514083|NCT00724321|vasoconstriction|vasoconstriction
1514084|NCT00724321|altitude|altitude
1514085|NCT00724308|Smoking|smoking
1514086|NCT00724308|Smoking Cessation|smoking cessation
1514087|NCT00724308|Tobacco|tobacco
1514088|NCT00724308|Mental Health|mental health
1514089|NCT00724282|sleep|sleep
1514090|NCT00724282|eszopiclone|eszopiclone
1514385|NCT00722943|DMT|dmt
1514091|NCT00724282|insulin secretion|insulin secretion
1514092|NCT00724282|insulin action|insulin action
1514093|NCT00724282|glucose tolerance|glucose tolerance
1514094|NCT00724269|Contact lens wear|contact lens wear
1514095|NCT00724269|multi-purpose solution|multi-purpose solution
1514096|NCT00724269|corneal staining|corneal staining
1514097|NCT00724256|Pyelonephritis.|pyelonephritis.
1514098|NCT00724256|Urinary Tract Infections.|urinary tract infections.
1514099|NCT00724256|Children.|children.
1514100|NCT00724256|Randomised controlled trial.|randomised controlled trial.
1514101|NCT00724256|Therapy.|therapy.
1514102|NCT00724256|Ceftibuten.|ceftibuten.
1514103|NCT00724204|probiotics|probiotics
1514104|NCT00724204|safety|safety
1514105|NCT00724204|fecal microbiota|fecal microbiota
1514106|NCT00724204|infections|infections
1514107|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
1514108|NCT00724165|physical activity|physical activity
1514109|NCT00724165|Latinas|latinas
1514110|NCT00724152|coping skills|coping skills
1514111|NCT00724152|psychology|psychology
1514112|NCT00724152|audiology|audiology
1514113|NCT00724152|veterans|veterans
1514114|NCT00724152|tinnitus|tinnitus
1514115|NCT00724152|adult|adult
1514116|NCT00724152|intervention studies|intervention studies
1514117|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
1514118|NCT00724152|noise|noise
1514119|NCT00724152|auditory perception|auditory perception
1514120|NCT00724126|Diarrhea|diarrhea
1514121|NCT00724126|Rifaximin|rifaximin
1514122|NCT00724126|IBS|ibs
1514123|NCT00724126|Abdominal pain|abdominal pain
1514124|NCT00724126|Bloating|bloating
1514125|NCT00724113|Shoulder capsulitis|shoulder capsulitis
1514126|NCT00724113|ARTHRO distension|arthro distension
1514127|NCT00724113|Mobilisation|mobilisation
1514128|NCT00724113|Randomised clinical trial|randomised clinical trial
1514129|NCT00724100|Malignancy|malignancy
1514130|NCT00724100|Solid tumor|solid tumor
1514131|NCT00724100|Tubulin inhibitor|tubulin inhibitor
1514132|NCT00724087|short sleep duration|short sleep duration
1514133|NCT00724087|energy expenditure|energy expenditure
1514134|NCT00724087|insulin secretion|insulin secretion
1514135|NCT00724087|insulin action|insulin action
1514136|NCT00724087|lipid turnover|lipid turnover
1514137|NCT00724087|free fatty acids|free fatty acids
1514138|NCT00724074|Arthritis of the knee|arthritis of the knee
1514139|NCT00724074|Knee replacement|knee replacement
1514140|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
1514141|NCT00724074|Arthroplasty, knee|arthroplasty, knee
1514142|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1514143|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1514144|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1514145|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1514146|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1514147|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1514148|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1514149|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1514150|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1514151|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1514152|NCT00724048|Huntington Disease|huntington disease
1514153|NCT00724035|Anesthesia|anesthesia
1514154|NCT00724035|Upper extremity|upper extremity
1514155|NCT00724035|Nerve block|nerve block
1514156|NCT00724035|Ultrasound|ultrasound
1514157|NCT00724035|Brachial plexus|brachial plexus
1514158|NCT00724022|Kidney transplant status|kidney transplant status
1514159|NCT00724022|Steroid free|steroid free
1514160|NCT00724022|Reduced|reduced
1514161|NCT00724022|Calcineurin|calcineurin
1514162|NCT00724022|Inhibitor|inhibitor
1514163|NCT00724022|Immunosuppression|immunosuppression
1514164|NCT00723970|Major Depressive Disorder|major depressive disorder
1514165|NCT00723970|Insomnia|insomnia
1514166|NCT00723970|Hot Flashes|hot flashes
1514167|NCT00723970|Menopause|menopause
1514168|NCT00723970|Quetiapine|quetiapine
1514169|NCT00723944|dental implants|dental implants
1514170|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
1514171|NCT00723944|Lateralized|lateralized
1514172|NCT00723944|non-lateralized|non-lateralized
1514173|NCT00723944|Osseotite Certain|osseotite certain
1514174|NCT00723944|multicenter|multicenter
1514176|NCT00723944|clinical study|clinical study
1514177|NCT00723944|partial edentulism|partial edentulism
1514178|NCT00723944|single stage|single stage
1514179|NCT00723944|early loading|early loading
1514180|NCT00723944|crestal bone level|crestal bone level
1514181|NCT00723944|short fixed bridge|short fixed bridge
1514182|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
1514183|NCT00723918|HIV|hiv
1514184|NCT00723918|AIDS|aids
1514185|NCT00723918|cannabinoid|cannabinoid
1514186|NCT00723918|Cannabis|cannabis
1514188|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
1514189|NCT00723918|polyneuropathy|polyneuropathy
1514190|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
1514191|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
1514192|NCT00723853|Obesity|obesity
1514193|NCT00723853|Type 2 diabetes|type 2 diabetes
1514194|NCT00723853|African American children|african american children
1514195|NCT00723853|African American youth|african american youth
1514196|NCT00723853|Community based|community based
1514197|NCT00723853|Family oriented|family oriented
1567712|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
1514198|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
1514199|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
1514200|NCT00723814|normal|normal
1514201|NCT00723801|Marfan syndrome|marfan syndrome
1514202|NCT00723801|Losartan|losartan
1514203|NCT00723801|Atenolol|atenolol
1514204|NCT00723801|Diastolic Function|diastolic function
1514205|NCT00723801|Aortic Stiffness|aortic stiffness
1514206|NCT00723788|Appendicitis|appendicitis
1514207|NCT00723788|Children|children
1514208|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
1514209|NCT00723775|KALETRA|kaletra
1514210|NCT00723775|GSK706769|gsk706769
1514212|NCT00723775|healthy volunteers|healthy volunteers
1514213|NCT00723762|Valproic acid|valproic acid
1514214|NCT00723762|Urea cycle|urea cycle
1514215|NCT00723762|Ornithine|ornithine
1514216|NCT00723762|Valproate|valproate
1514217|NCT00723762|Side effect|side effect
1514218|NCT00723749|Suboxone|suboxone
1514219|NCT00723749|Subutex|subutex
1514220|NCT00723749|Buprenorphine|buprenorphine
1514221|NCT00723749|Naloxone|naloxone
1514222|NCT00723697|Subutex|subutex
1514223|NCT00723684|ADHD|adhd
1514224|NCT00723684|Children|children
1514225|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
1514226|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
1514227|NCT00723619|asthma|asthma
1514228|NCT00723619|spirometry|spirometry
1514229|NCT00723619|FENO|feno
1514230|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
1514231|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
1514232|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
1514233|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
1514234|NCT00723593|Gastrointestinal|gastrointestinal
1514235|NCT00723593|Apoptotic Assay|apoptotic assay
1514236|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
1514237|NCT00723593|Mucosal Biopsy|mucosal biopsy
1514238|NCT00723593|Graft Versus Host Disease|graft versus host disease
1514239|NCT00723593|GVHD|gvhd
1514240|NCT00723580|Kabuki Syndrome|kabuki syndrome
1514241|NCT00723580|Actigraphy|actigraphy
1514242|NCT00723580|Treatment Response Measurement|treatment response measurement
1514243|NCT00723567|Spectrin Gene|spectrin gene
1514244|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
1514245|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
1514246|NCT00723567|Genetics|genetics
1514247|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
1514248|NCT00723554|inhaled therapy|inhaled therapy
1514249|NCT00723554|power disc-15|power disc-15
1514250|NCT00723528|Psoriasis|psoriasis
1514251|NCT00723528|Ustekinumab|ustekinumab
1514252|NCT00723528|CNTO 1275|cnto 1275
1514253|NCT00723515|White spot lesion|white spot lesion
1514254|NCT00723515|Tooth remineralization|tooth remineralization
1514255|NCT00723515|Fluoride varnishes|fluoride varnishes
1514256|NCT00723502|Helicobacter pylori|helicobacter pylori
1514257|NCT00723502|Eradication|eradication
1514258|NCT00723502|Dyspepsia|dyspepsia
1514259|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
1514260|NCT00723489|Scarification Method|scarification method
1514261|NCT00723489|Atopic Dermatitis|atopic dermatitis
1514262|NCT00723489|IgG antibodies|igg antibodies
1514263|NCT00723476|Quality of Life|quality of life
1514264|NCT00723476|Adolescent|adolescent
1514265|NCT00723476|Advance Care Planning|advance care planning
1514266|NCT00723476|Palliative Care|palliative care
1514267|NCT00723476|End-of-Life Care|end-of-life care
1514268|NCT00723476|HIV/AIDS|hiv/aids
1514269|NCT00723476|Psychological Adjustment|psychological adjustment
1514270|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
1514271|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
1514272|NCT00723424|AZD5672|azd5672
1514273|NCT00723424|digoxin|digoxin
1514274|NCT00723411|Diabetes|diabetes
1514275|NCT00723411|Juvenile Diabetes|juvenile diabetes
1514276|NCT00723411|Diabetes type 1|diabetes type 1
1514277|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
1514278|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
1514279|NCT00723411|Type 1 diabetes|type 1 diabetes
1514280|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
1514281|NCT00723411|Diamyd|diamyd
1514282|NCT00723411|rhGAD65|rhgad65
1514283|NCT00723411|GAD|gad
1514284|NCT00723411|GAD-alum|gad-alum
1514285|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
1514286|NCT00723398|antiestrogens|antiestrogens
1514287|NCT00723398|breast cancer prevention|breast cancer prevention
1514288|NCT00723398|breast density|breast density
1514289|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
1514290|NCT00723385|cholesterol|cholesterol
1514291|NCT00723385|LDL-cholesterol|ldl-cholesterol
1514292|NCT00723385|cholecalciferol|cholecalciferol
1514293|NCT00723385|lipids|lipids
1514294|NCT00723385|C-reactive protein|c-reactive protein
1514295|NCT00723359|Multiple Myeloma|multiple myeloma
1514296|NCT00723359|Refractory|refractory
1514297|NCT00723359|Relapsed|relapsed
1514298|NCT00723346|Relapse|relapse
1514299|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
1514300|NCT00723333|Bone Marrow Transplant|bone marrow transplant
1514301|NCT00723333|Myelofibrosis|myelofibrosis
1514302|NCT00723333|Stem Cell Transplant|stem cell transplant
1514303|NCT00723333|Allogenic Transplant|allogenic transplant
1514304|NCT00723320|Atherosclerosis|atherosclerosis
1514305|NCT00723320|Atorvastatin|atorvastatin
1514306|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
1514307|NCT00723320|CIMT|cimt
1514308|NCT00723320|ABI|abi
1514309|NCT00723320|PWV|pwv
1514310|NCT00723307|No diabetes mellitus|no diabetes mellitus
1514311|NCT00723307|Elevated waist circumference|elevated waist circumference
1514312|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1514313|NCT00723294|male breast cancer|male breast cancer
1514314|NCT00723294|stage IA breast cancer|stage ia breast cancer
1514315|NCT00723294|stage IB breast cancer|stage ib breast cancer
1514316|NCT00723294|stage II breast cancer|stage ii breast cancer
1514317|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
1514318|NCT00723281|CT angiography|ct angiography
1514319|NCT00723281|conventional angiography|conventional angiography
1514320|NCT00723281|intravascular ultrasound|intravascular ultrasound
1514321|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
1514322|NCT00723268|Oral ulcers|oral ulcers
1514323|NCT00723216|Prevention|prevention
1514324|NCT00723216|venous thromboembolism|venous thromboembolism
1514325|NCT00723216|curative surgery|curative surgery
1514326|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1514327|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1514328|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1514329|NCT00723190|CLONICEL|clonicel
1514330|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1514331|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
1514332|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
1514333|NCT00723164|Sevoflurane induction|sevoflurane induction
1514334|NCT00723164|Premedication|premedication
1514335|NCT00723164|laryngeal mask airway|laryngeal mask airway
1514336|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
1514337|NCT00723125|Breast Cancer|breast cancer
1514338|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
1514339|NCT00723112|Erythropoiesis|erythropoiesis
1514340|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
1514341|NCT00723112|Erythroid Progenitors|erythroid progenitors
1514342|NCT00723112|Dyserythropoiesis|dyserythropoiesis
1514343|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
1514344|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
1514345|NCT00723047|Patients|patients
1514346|NCT00723047|CD complicated|cd complicated
1514347|NCT00723047|least|least
1514348|NCT00723047|One perianal fistula|one perianal fistula
1514349|NCT00723047|Draining|draining
1514350|NCT00723047|2 months duration|2 months duration
1514351|NCT00723021|Bronchodilator|bronchodilator
1514352|NCT00723008|anxiety|anxiety
1514353|NCT00723008|insomnia|insomnia
1514354|NCT00723008|pain|pain
1514355|NCT00723008|Alpha Stim|alpha stim
1514356|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
1514357|NCT00722995|Morbid obesity|morbid obesity
1514358|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
1514359|NCT00722995|Gastric bypass|gastric bypass
1514360|NCT00722995|Complications|complications
1514361|NCT00722995|Efficacity|efficacity
1514362|NCT00722995|Safety|safety
1514363|NCT00722995|Compare|compare
1514364|NCT00722982|coxarthrosis|coxarthrosis
1514365|NCT00722982|hip|hip
1514366|NCT00722982|RSA|rsa
1514367|NCT00722982|DXA|dxa
1514368|NCT00722982|C-stem AMT|c-stem amt
1514369|NCT00722982|Marathon|marathon
1514370|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
1514371|NCT00722969|erlotinib|erlotinib
1514372|NCT00722969|sorafenib|sorafenib
1514373|NCT00722956|atorvastatin|atorvastatin
1514374|NCT00722956|AZD5672|azd5672
1514375|NCT00722943|infant|infant
1514376|NCT00722943|premature|premature
1514377|NCT00722943|message|message
1514378|NCT00722943|therapy|therapy
1514379|NCT00722943|NICU|nicu
1514380|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
1514381|NCT00722943|cortisol level|cortisol level
1514382|NCT00722943|stress|stress
1514386|NCT00722943|Development Message Therapy|development message therapy
1514387|NCT00722943|growth|growth
1514388|NCT00722930|Follicular Lymphoma|follicular lymphoma
1514389|NCT00722930|High-risk FLIPI|high-risk flipi
1514390|NCT00722930|R-CHOP|r-chop
1514391|NCT00722930|GOTEL|gotel
1514392|NCT00722930|Partial|partial
1514393|NCT00722930|Complete|complete
1514394|NCT00722930|Response|response
1514395|NCT00722930|Induction|induction
1514396|NCT00722930|Chemotherapy|chemotherapy
1514397|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
1514398|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
1514399|NCT00722917|Type II Diabetes|type ii diabetes
1675065|NCT00090662|HV|hv
1514400|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1514401|NCT00722917|Dyslipidemia|dyslipidemia
1514402|NCT00722917|Drug Therapy|drug therapy
1514403|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
1514404|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
1514405|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
1514406|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
1514407|NCT00722904|Healthy volunteers|healthy volunteers
1514408|NCT00722891|Eye Diseases|eye diseases
1514409|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1514410|NCT00722865|Avastin|avastin
1514411|NCT00722865|bevacizumab|bevacizumab
1514412|NCT00722865|ABVD|abvd
1514413|NCT00722865|angiogenesis|angiogenesis
1514414|NCT00722865|antiangiogenic|antiangiogenic
1514415|NCT00722865|Hodgkin|hodgkin
1514416|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
1514417|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
1514418|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
1514419|NCT00722800|YAZ|yaz
1514420|NCT00722800|oral contraceptive|oral contraceptive
1514421|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
1514422|NCT00722774|Vaccine|vaccine
1514423|NCT00722774|Influenza|influenza
1514424|NCT00722761|YAZ|yaz
1514425|NCT00722761|oral contraceptive|oral contraceptive
1514426|NCT00722761|Acne vulgaris|acne vulgaris
1514427|NCT00722748|Genebank|genebank
1514428|NCT00722748|Gene registry|gene registry
1514429|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
1514430|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
1514431|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
1514432|NCT00722735|Proof-of-Concept|proof-of-concept
1514433|NCT00722709|Pain|pain
1514434|NCT00722709|Fatigue|fatigue
1514435|NCT00722709|Colon|colon
1514436|NCT00722709|Surgery|surgery
1514437|NCT00722709|ERAS|eras
1514438|NCT00722709|Fastrack|fastrack
1514439|NCT00722709|Local anaesthetic|local anaesthetic
1514440|NCT00722709|Peritoneum|peritoneum
1514441|NCT00722709|Metabolic|metabolic
1514442|NCT00722709|Endocrine|endocrine
1514443|NCT00722709|Post surgical metabolic response|post surgical metabolic response
1514444|NCT00722709|Complications|complications
1514445|NCT00722709|Time to passage of flatus|time to passage of flatus
1514446|NCT00722709|Time to passage of stool|time to passage of stool
1514447|NCT00722709|Time to discharge from facility|time to discharge from facility
1514448|NCT00722709|Re-admission rate|re-admission rate
1514449|NCT00722696|Metabolism|metabolism
1514450|NCT00722696|Muscles|muscles
1514451|NCT00722696|Exercise|exercise
1514452|NCT00722670|risk reduction|risk reduction
1514453|NCT00722670|prevention|prevention
1514454|NCT00722670|HIV prevention|hiv prevention
1514455|NCT00722657|asthma|asthma
1514456|NCT00722657|epidemiology|epidemiology
1514457|NCT00722644|HIV|hiv
1514458|NCT00722644|Medication Adherence|medication adherence
1514459|NCT00722644|Stress Management|stress management
1514460|NCT00722644|CD4/Viral Loads|cd4/viral loads
1514461|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
1514462|NCT00722618|Infertility|infertility
1514463|NCT00722605|lung|lung
1514464|NCT00722605|esophageal|esophageal
1514465|NCT00722605|cone beam ct scan|cone beam ct scan
1514466|NCT00722592|cancer|cancer
1514467|NCT00722592|ovarian|ovarian
1514468|NCT00722592|platinum-resistant|platinum-resistant
1514469|NCT00722592|Phase II|phase ii
1514470|NCT00722592|EC145|ec145
1514471|NCT00722592|EC20|ec20
1514472|NCT00722579|Coronary Artery Disease|coronary artery disease
1514473|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
1514474|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
1514475|NCT00722553|Bladder Cancer|bladder cancer
1514476|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
1514477|NCT00722553|Bladder|bladder
1514478|NCT00722553|Carcinoma|carcinoma
1514479|NCT00722553|Urinary|urinary
1514480|NCT00722553|Metastatic|metastatic
1514481|NCT00722553|Relapsed|relapsed
1514482|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
1514483|NCT00722527|Polycythemia|polycythemia
1514484|NCT00722527|Molecular Biology|molecular biology
1514485|NCT00722527|Genetics|genetics
1514486|NCT00722527|Erythropoiesis|erythropoiesis
1514487|NCT00722527|EPOR mutation|epor mutation
1514488|NCT00722527|Thrombocytosis|thrombocytosis
1514489|NCT00722527|Hypoxia|hypoxia
1514490|NCT00722475|recurrent miscarriage|recurrent miscarriage
1514491|NCT00722475|immunology|immunology
1514492|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
1514493|NCT00722475|miscarriage|miscarriage
1514494|NCT00722462|Infertility|infertility
1514495|NCT00722462|IVF|ivf
1514496|NCT00722462|Acupuncture|acupuncture
1514497|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
1514498|NCT00722423|Hepatitis C|hepatitis c
1514499|NCT00722423|integrated care|integrated care
1514500|NCT00722423|alpha interferon|alpha interferon
1514501|NCT00722423|mental health|mental health
1514502|NCT00722410|Carbapenem|carbapenem
1514503|NCT00722410|resistant|resistant
1514504|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
1514505|NCT00722410|Carpapenemases|carpapenemases
1514506|NCT00722410|Probiotics|probiotics
1514507|NCT00722410|VSL3|vsl3
1514508|NCT00722397|genetics, pediatrics|genetics, pediatrics
1514509|NCT00722384|AMD|amd
1514510|NCT00722384|Macular Degeneration|macular degeneration
1514511|NCT00722384|Opko Health|opko health
1514512|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
1514513|NCT00722384|bevasiranib|bevasiranib
1514514|NCT00722384|Cand5|cand5
1514515|NCT00722384|Age-Related|age-related
1514516|NCT00722345|Obesity|obesity
1514517|NCT00722345|Physical activity|physical activity
1514518|NCT00722345|Adolescents|adolescents
1514519|NCT00722345|Exercise counseling intervention|exercise counseling intervention
1514520|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
1514521|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
1514522|NCT00722332|Liver Transplant|liver transplant
1514523|NCT00722319|oral anticoagulation|oral anticoagulation
1514524|NCT00722319|warfarin|warfarin
1514525|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
1514526|NCT00722319|stent|stent
1514527|NCT00722319|antiplatelet agents|antiplatelet agents
1514528|NCT00722306|non-restorative|non-restorative
1514529|NCT00722306|sleep|sleep
1514530|NCT00722293|Solid tumors|solid tumors
1514531|NCT00722293|Cancer|cancer
1514532|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
1514533|NCT00722293|doxorubicin|doxorubicin
1514534|NCT00722293|epirubicin|epirubicin
1514535|NCT00722293|anti-angiogenesis|anti-angiogenesis
1514536|NCT00722293|pharmacodynamics|pharmacodynamics
1514537|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
1514538|NCT00722293|pharmacokinetics|pharmacokinetics
1514539|NCT00722293|Soft Tissue|soft tissue
1514540|NCT00722293|Sarcoma|sarcoma
1514541|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
1514542|NCT00722267|severe COPD|severe copd
1514543|NCT00722267|COPD symptoms|copd symptoms
1514544|NCT00722267|variability of symptoms|variability of symptoms
1514545|NCT00722267|patient's perception|patient's perception
1514546|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
1514547|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
1514548|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
1514549|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
1514550|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1514551|NCT00722254|Flolan|flolan
1514552|NCT00722254|Clonality|clonality
1514553|NCT00722254|CD34+ cells|cd34+ cells
1514554|NCT00722254|Hematologic abnormalities|hematologic abnormalities
1514555|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
1514556|NCT00722241|Interstitial Fluid|interstitial fluid
1514557|NCT00722241|Diabetes Mellitus|diabetes mellitus
1514558|NCT00722215|Endothelin antagonist|endothelin antagonist
1514559|NCT00722215|Chronic kidney disease|chronic kidney disease
1514560|NCT00722215|Proteinuria|proteinuria
1514561|NCT00722215|Cardiovascular disease|cardiovascular disease
1514562|NCT00722215|Blood pressure|blood pressure
1514563|NCT00722215|Arterial stiffness|arterial stiffness
1514564|NCT00722215|Endothelial function|endothelial function
1514565|NCT00722189|Mycoses|mycoses
1514566|NCT00722176|Schizophrenia|schizophrenia
1514567|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
1514568|NCT00722163|Psychosis|psychosis
1514569|NCT00722150|Artesunate|artesunate
1514570|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
1514571|NCT00722150|Cambodia|cambodia
1514572|NCT00722124|tobacco use|tobacco use
1514573|NCT00722124|cigarettes|cigarettes
1514574|NCT00722124|smokers|smokers
1514575|NCT00722111|tongue|tongue
1514576|NCT00722111|pressure|pressure
1514577|NCT00722098|Melanoma|melanoma
1514578|NCT00722098|Dendritic Cell|dendritic cell
1514579|NCT00722098|Vaccine|vaccine
1514580|NCT00722098|Immunotherapy|immunotherapy
1514581|NCT00722098|Cyclophosphamide|cyclophosphamide
1514582|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
1514583|NCT00722085|Cerclage|cerclage
1514584|NCT00722085|Ultrasound|ultrasound
1514585|NCT00722085|Preterm Delivery|preterm delivery
1514586|NCT00722085|Neonatal|neonatal
1514587|NCT00722072|male breast cancer|male breast cancer
1514588|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
1514589|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
1514590|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
1514591|NCT00722072|stage IV breast cancer|stage iv breast cancer
1514592|NCT00722072|recurrent breast cancer|recurrent breast cancer
1514593|NCT00722046|Alzheimer's disease|alzheimer's disease
1514594|NCT00722046|antibody|antibody
1514595|NCT00722046|amyloid|amyloid
1514596|NCT00722033|preterm|preterm
1514597|NCT00722033|aEEG|aeeg
1514598|NCT00722033|apneas|apneas
1514599|NCT00722033|surfactant|surfactant
1567713|NCT00508430|Pain|pain
1514600|NCT00722033|indomethacin|indomethacin
1514601|NCT00722033|aminophyline|aminophyline
1514602|NCT00722020|Asthma|asthma
1514603|NCT00722020|Bronchial Disease|bronchial disease
1514604|NCT00722020|Status Asthmaticus|status asthmaticus
1514605|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
1514606|NCT00722020|the Vest|the vest
1514607|NCT00722020|HFCWO|hfcwo
1514608|NCT00722007|hip resurfacing|hip resurfacing
1514609|NCT00722007|osteoarthritis|osteoarthritis
1514610|NCT00722007|avascular necrosis|avascular necrosis
1514611|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
1514612|NCT00721994|hip resurfacing|hip resurfacing
1514613|NCT00721994|osteoarthritis|osteoarthritis
1514614|NCT00721994|avascular necrosis|avascular necrosis
1514615|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
1514616|NCT00721981|patient preference|patient preference
1514617|NCT00721981|oncology|oncology
1514618|NCT00721981|chemotherapy|chemotherapy
1514619|NCT00721981|NSCLC|nsclc
1514620|NCT00721968|Open angle|open angle
1514621|NCT00721968|Glaucoma|glaucoma
1514622|NCT00721968|Cataract|cataract
1514623|NCT00721968|Surgery|surgery
1514624|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
1514625|NCT00721955|agitation,|agitation,
1514626|NCT00721955|acute,|acute,
1514627|NCT00721955|treatment|treatment
1514628|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
1514629|NCT00721890|chemoprevention|chemoprevention
1514630|NCT00721890|green tea|green tea
1514631|NCT00721890|relapse free-survival|relapse free-survival
1514632|NCT00721890|proteases|proteases
1514633|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1514634|NCT00721864|PIG-A Mutation|pig-a mutation
1514635|NCT00721864|Prion Protein|prion protein
1514636|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
1514637|NCT00721864|Clonal disorder|clonal disorder
1514638|NCT00721838|adolescent obesity|adolescent obesity
1514639|NCT00721838|eating behavior|eating behavior
1514640|NCT00721838|dietary intake|dietary intake
1514641|NCT00721825|Stroke|stroke
1514642|NCT00721825|Cerebral infarct|cerebral infarct
1514643|NCT00721825|Rehabilitation|rehabilitation
1514644|NCT00721825|Double blind Randomized|double blind randomized
1514645|NCT00721825|Placebo controlled|placebo controlled
1514646|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
1514647|NCT00721825|Neuroaid|neuroaid
1514648|NCT00721812|pharmacokinetics|pharmacokinetics
1514649|NCT00721812|Phase 1|phase 1
1514650|NCT00721812|first time in humans|first time in humans
1514651|NCT00721812|IBD|ibd
1514652|NCT00721812|safety|safety
1514653|NCT00721812|human volunteers|human volunteers
1514654|NCT00721799|Positron-Emission Tomography|positron-emission tomography
1514655|NCT00721799|radiation therapy|radiation therapy
1514656|NCT00721799|cisplatin|cisplatin
1514657|NCT00721799|chemotherapy|chemotherapy
1514658|NCT00721799|FLT|flt
1514659|NCT00721786|Smoking cessation|smoking cessation
1514660|NCT00721786|Cigarette smoking|cigarette smoking
1514661|NCT00721786|Tobacco smoking|tobacco smoking
1514662|NCT00721786|Internet interventions|internet interventions
1514663|NCT00721786|Spanish-speaking|spanish-speaking
1514664|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
1514665|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
1514666|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
1514667|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
1514668|NCT00721773|Residual Renal Function|residual renal function
1514669|NCT00721760|Hip fractures|hip fractures
1514670|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
1514671|NCT00721760|Randomized Controlled Trial|randomized controlled trial
1514672|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
1514673|NCT00721734|Myeloma|myeloma
1514674|NCT00721734|Renal Insufficiency|renal insufficiency
1514675|NCT00721734|Proteasome|proteasome
1514676|NCT00721734|Hematological|hematological
1514677|NCT00721734|carfilzomib|carfilzomib
1514678|NCT00721734|PR-171|pr-171
1514679|NCT00721721|Dietary Sodium|dietary sodium
1514680|NCT00721721|Dietary Potassium|dietary potassium
1514681|NCT00721721|Genes|genes
1514682|NCT00721721|Genomics|genomics
1514683|NCT00721708|histidine dipeptides|histidine dipeptides
1514684|NCT00721708|carnosine|carnosine
1514685|NCT00721708|anserine|anserine
1514686|NCT00721695|Cataract|cataract
1514687|NCT00721695|Cataract Extraction|cataract extraction
1514688|NCT00721695|Lens Implantation|lens implantation
1514689|NCT00721695|Phacoemulsification|phacoemulsification
1514690|NCT00721682|Pediatry|pediatry
1514691|NCT00721682|Ill-treatment|ill-treatment
1514692|NCT00721682|Pain|pain
1514693|NCT00721682|maltreated children|maltreated children
1514694|NCT00721669|solid tumor|solid tumor
1514695|NCT00721656|Dry eye syndromes|dry eye syndromes
1514696|NCT00721656|Corneal diseases|corneal diseases
1514697|NCT00721656|Conjunctival Diseases|conjunctival diseases
1514698|NCT00721643|Angelica keiskei|angelica keiskei
1514699|NCT00721643|absorption kinetics|absorption kinetics
1514700|NCT00721643|quercetin|quercetin
1675412|NCT00090103|BPH|bph
1514701|NCT00721630|CAPECITABINE|capecitabine
1514702|NCT00721630|LAPATINIB|lapatinib
1514703|NCT00721604|shock|shock
1514704|NCT00721604|fluid responsiveness|fluid responsiveness
1514705|NCT00721604|volume expansion|volume expansion
1514706|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
1514707|NCT00721591|Habitual abortion|habitual abortion
1514708|NCT00721591|Fetal demise|fetal demise
1514709|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
1514710|NCT00721591|Inherited thrombophilia|inherited thrombophilia
1514711|NCT00721578|Observational study|observational study
1514712|NCT00721578|Effectiveness|effectiveness
1514713|NCT00721578|Safety|safety
1514714|NCT00721578|Tolerability|tolerability
1514715|NCT00721578|Systemic Fungal Infection|systemic fungal infection
1514716|NCT00721565|Breast Cancer|breast cancer
1514717|NCT00721565|Exercise|exercise
1514718|NCT00721565|Social Cognitive Theory|social cognitive theory
1514719|NCT00721565|Adherence|adherence
1514720|NCT00721565|Symptoms|symptoms
1514721|NCT00721565|Body Composition|body composition
1514722|NCT00721552|beta-cell function|beta-cell function
1514723|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
1514724|NCT00721552|glucocorticoid|glucocorticoid
1514725|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
1514726|NCT00721552|sitagliptin|sitagliptin
1514727|NCT00721552|diabetes mellitus|diabetes mellitus
1514728|NCT00721552|steroid diabetes|steroid diabetes
1514729|NCT00721552|insulin resistance|insulin resistance
1514730|NCT00721552|insulin sensitivity|insulin sensitivity
1514731|NCT00721526|alcohol dependence|alcohol dependence
1514732|NCT00721526|alcoholism|alcoholism
1514733|NCT00721526|anxiety disorder|anxiety disorder
1514734|NCT00721526|pharmacotherapy|pharmacotherapy
1514735|NCT00721526|disulfiram|disulfiram
1514736|NCT00721526|lorazepam|lorazepam
1514737|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1514738|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1514739|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1514740|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1514741|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1514742|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1514743|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1514744|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1514745|NCT00721487|C. albicans|c. albicans
1514746|NCT00721487|fluconazole|fluconazole
1514747|NCT00721461|Assess|assess
1514748|NCT00721461|Tolerability|tolerability
1514749|NCT00721461|MedPulser DDS device|medpulser dds device
1514750|NCT00721448|Pharmacokinetics|pharmacokinetics
1514751|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
1514752|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
1514753|NCT00721396|Meningococcal disease,|meningococcal disease,
1514754|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
1514755|NCT00721396|Prevention,|prevention,
1514756|NCT00721396|Vaccination,|vaccination,
1514757|NCT00721396|Infants|infants
1514758|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
1514759|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
1514760|NCT00721370|breast cancer|breast cancer
1514761|NCT00721370|near infrared imaging|near infrared imaging
1514762|NCT00721357|muscles|muscles
1514763|NCT00721357|work|work
1514764|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
1514765|NCT00721357|control groups|control groups
1514766|NCT00721344|Healthy males and females|healthy males and females
1514767|NCT00721331|CombinatoRx|combinatorx
1514768|NCT00721331|Atopic|atopic
1514769|NCT00721331|Dermatitis|dermatitis
1514770|NCT00721331|Topical|topical
1514771|NCT00721331|CRx-197|crx-197
1514772|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
1514773|NCT00721318|chronic widespread pain|chronic widespread pain
1514774|NCT00721318|fibromyalgia|fibromyalgia
1514775|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
1514776|NCT00721318|Estonia|estonia
1514777|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
1514778|NCT00721305|Lovastatin|lovastatin
1514779|NCT00721305|Adaptive Immunity|adaptive immunity
1514780|NCT00721305|Cellular cholesterol|cellular cholesterol
1514781|NCT00721305|Rho GTPases|rho gtpases
1515283|NCT00719719|Mast Cell|mast cell
1514782|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
1514783|NCT00721253|ReSTOR|restor
1514784|NCT00721240|responder|responder
1514785|NCT00721240|leucotriene antagonist|leucotriene antagonist
1514786|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
1514787|NCT00721214|5-azacytidine|5-azacytidine
1514788|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1514789|NCT00721201|subclinical Cushing's|subclinical cushing's
1514790|NCT00721175|biliary stent|biliary stent
1514791|NCT00721175|plastic stent|plastic stent
1514792|NCT00721175|metallic stent|metallic stent
1514793|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
1514794|NCT00721162|Ovarian Cancer,|ovarian cancer,
1514795|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
1514796|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
1514797|NCT00721149|Atrial Fibrillation|atrial fibrillation
1514798|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1514799|NCT00721149|Ablation|ablation
1514800|NCT00721149|Non-randomized|non-randomized
1514801|NCT00721136|bleeding|bleeding
1514802|NCT00721136|anticoagulation|anticoagulation
1514803|NCT00721136|pacemaker|pacemaker
1514804|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1514805|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
1514806|NCT00721110|pain control|pain control
1514807|NCT00721110|nausea|nausea
1514808|NCT00721110|surgery recovery|surgery recovery
1514809|NCT00721097|Severe asthma|severe asthma
1514810|NCT00721097|exacerbation|exacerbation
1514811|NCT00721097|predictive factors|predictive factors
1514812|NCT00721097|Severe|severe
1514813|NCT00721084|short sleep duration|short sleep duration
1514814|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
1514815|NCT00721084|body fat|body fat
1514816|NCT00721084|visceral adiposity|visceral adiposity
1514817|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
1514818|NCT00721084|energy metabolism|energy metabolism
1514819|NCT00721071|Pediatrics|pediatrics
1514820|NCT00721071|Cystic Fibrosis|cystic fibrosis
1514821|NCT00721071|Hypertonic Saline|hypertonic saline
1514822|NCT00721071|Induced Sputum|induced sputum
1514823|NCT00721071|Expectorated Sputum|expectorated sputum
1514824|NCT00721058|Eligible|eligible
1514825|NCT00721058|Operable|operable
1514826|NCT00721058|Disease|disease
1514827|NCT00721058|Conserving|conserving
1514828|NCT00721058|Therapy|therapy
1514829|NCT00721058|Visible mass on mammography|visible mass on mammography
1514830|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
1514831|NCT00721058|Histologically|histologically
1514832|NCT00721058|Proven|proven
1514833|NCT00721045|Heart Failure|heart failure
1514834|NCT00721045|Congestive Heart Failure|congestive heart failure
1514835|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
1514836|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
1514837|NCT00721032|Ablation|ablation
1514838|NCT00721032|Cardiomyopathy|cardiomyopathy
1514839|NCT00721032|Electrophysiology study|electrophysiology study
1514840|NCT00721019|short sleep duration|short sleep duration
1514841|NCT00721019|glucose clamp technique|glucose clamp technique
1514842|NCT00721019|insulin secretion|insulin secretion
1514843|NCT00721019|insulin action|insulin action
1514844|NCT00721019|lipid turnover|lipid turnover
1514845|NCT00721019|free fatty acids|free fatty acids
1514846|NCT00721006|peripheral artery disease|peripheral artery disease
1514847|NCT00721006|peripheral vascular disease|peripheral vascular disease
1514848|NCT00721006|PAD|pad
1514849|NCT00721006|PVD|pvd
1514850|NCT00720993|Colorectal cancer screening|colorectal cancer screening
1514851|NCT00720993|Gene expression|gene expression
1514852|NCT00720993|RTPCR|rtpcr
1514853|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
1514854|NCT00720967|Renal dysfunction|renal dysfunction
1514855|NCT00720967|Hemodialysis|hemodialysis
1514856|NCT00720967|Modified ultrafiltration|modified ultrafiltration
1514857|NCT00720967|Open heart surgery|open heart surgery
1514858|NCT00720954|Thoracoscopy|thoracoscopy
1514859|NCT00720954|Pleural needle biopsy|pleural needle biopsy
1514860|NCT00720954|Malignant pleural diseases|malignant pleural diseases
1514861|NCT00720954|Mesothelioma|mesothelioma
1514862|NCT00720954|Diagnosis|diagnosis
1514863|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
1514942|NCT00720811|Artemesinin|artemesinin
1514943|NCT00720811|based|based
1514944|NCT00720811|Combination|combination
1514864|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
1514865|NCT00720941|SUTENT|sutent
1514866|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
1514867|NCT00720941|Pazopanib|pazopanib
1514868|NCT00720941|Sunitinib|sunitinib
1514869|NCT00720941|GW786034|gw786034
1514870|NCT00720941|Renal cell carcinoma|renal cell carcinoma
1514871|NCT00720928|Behcet's disease|behcet's disease
1514872|NCT00720928|posterior uveitis|posterior uveitis
1514873|NCT00720928|flucinolone acetonide|flucinolone acetonide
1514874|NCT00720928|RETISERT|retisert
1515284|NCT00719719|Tryptase|tryptase
1514875|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
1514876|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
1514877|NCT00720915|anticoagulant therapy|anticoagulant therapy
1514878|NCT00720889|short sleep duration|short sleep duration
1514879|NCT00720889|glucose clamp technique|glucose clamp technique
1514880|NCT00720889|insulin secretion|insulin secretion
1514881|NCT00720889|insulin action|insulin action
1514882|NCT00720889|lipid turnover|lipid turnover
1675621|NCT00089999|ErbB2|erbb2
1514883|NCT00720889|free fatty acids|free fatty acids
1514884|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1514885|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1514886|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1514887|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1514888|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1514889|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1514890|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1514891|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1514892|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1514893|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1514894|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1514895|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1514896|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1514897|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1514898|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1514899|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1514900|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1514901|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1514902|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1514903|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1514904|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1514905|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1514906|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1514907|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1514908|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1514909|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1514910|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1514911|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1514912|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1514913|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1514914|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1514915|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1514916|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1514917|NCT00720850|MDS|mds
1514918|NCT00720850|AML|aml
1514919|NCT00720850|Lenalidomide|lenalidomide
1514920|NCT00720850|monosomy 5|monosomy 5
1514921|NCT00720850|monosomy del5q|monosomy del5q
1514922|NCT00720837|Brain Tumor|brain tumor
1514923|NCT00720837|Brain Cancer|brain cancer
1514924|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
1514925|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
1514926|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
1514927|NCT00720837|MRTI|mrti
1514928|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
1514929|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
1514930|NCT00720837|LITT|litt
1514931|NCT00720824|Immunizations|immunizations
1514932|NCT00720824|Children|children
1514933|NCT00720824|Injections|injections
1514934|NCT00720824|aged 4-6 Years|aged 4-6 years
1514935|NCT00720824|Hypnosis|hypnosis
1514936|NCT00720811|Malaria ACT|malaria act
1514937|NCT00720811|Rapid|rapid
1514938|NCT00720811|Diagnosis|diagnosis
1514939|NCT00720811|Community|community
1514940|NCT00720811|health|health
1514941|NCT00720811|worker|worker
1514945|NCT00720811|Therapy|therapy
1514946|NCT00720811|Anti Malarial|anti malarial
1514947|NCT00720811|Treatment|treatment
1514948|NCT00720811|antibiotics|antibiotics
1514949|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
1514950|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1514951|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
1514952|NCT00720785|Tumor Cytotoxicity|tumor cytotoxicity
1514953|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1514954|NCT00720785|Multiple Myeloma|multiple myeloma
1514955|NCT00720785|Lung Cancer|lung cancer
1514956|NCT00720785|Prostate Cancer|prostate cancer
1514965|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1514966|NCT00720785|CLL|cll
1514967|NCT00720772|coronary calcification|coronary calcification
1514968|NCT00720772|vascular calcification|vascular calcification
1514969|NCT00720772|sodium thiosulfate|sodium thiosulfate
1514970|NCT00720759|stroke|stroke
1514971|NCT00720759|hemiparesis|hemiparesis
1514972|NCT00720759|randomized controlled trial|randomized controlled trial
1514973|NCT00720759|d-cycloserine|d-cycloserine
1514974|NCT00720759|distributed practice|distributed practice
1514975|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
1514976|NCT00720733|HIV|hiv
1514977|NCT00720733|Mood|mood
1514978|NCT00720733|Emotion|emotion
1514979|NCT00720733|Coping|coping
1514980|NCT00720733|Aids|aids
1514981|NCT00720733|Affect|affect
1514982|NCT00720733|Adults|adults
1514983|NCT00720733|Diagnosed|diagnosed
1514984|NCT00720707|Coronally advanced flap|coronally advanced flap
1514985|NCT00720707|gingival recession|gingival recession
1514986|NCT00720707|enamel matrix protein|enamel matrix protein
1514987|NCT00720707|acellular dermal matrix|acellular dermal matrix
1514988|NCT00720707|root coverage|root coverage
1514989|NCT00720668|hepatitis B|hepatitis b
1514990|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
1514991|NCT00720668|radiofrequency ablation|radiofrequency ablation
1514992|NCT00720668|reactivation|reactivation
1514993|NCT00720655|coronary heart disease|coronary heart disease
1514994|NCT00720629|graft versus host disease|graft versus host disease
1514995|NCT00720629|GVHD|gvhd
1514996|NCT00720629|allogeneic transplant|allogeneic transplant
1514997|NCT00720629|GVHD prevention|gvhd prevention
1514998|NCT00720629|unrelated donors|unrelated donors
1514999|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
1515000|NCT00720629|hematological malignancies|hematological malignancies
1515001|NCT00720629|Leukemia|leukemia
1515002|NCT00720629|Lymphoma|lymphoma
1515003|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
1515004|NCT00720629|Myelofibrosis|myelofibrosis
1515005|NCT00720629|Aplastic Anemia|aplastic anemia
1515006|NCT00720629|Multiple Myeloma|multiple myeloma
1515007|NCT00720616|Growth hormone|growth hormone
1515008|NCT00720616|Metabolic syndrome|metabolic syndrome
1515009|NCT00720616|Insulin sensitivity|insulin sensitivity
1515010|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
1515011|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
1515012|NCT00720577|PAD|pad
1515013|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
1515014|NCT00720577|RNA Expression|rna expression
1515015|NCT00720577|Lipid Biomarkers|lipid biomarkers
1515016|NCT00720564|adult glioblastoma|adult glioblastoma
1515017|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1515018|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1515019|NCT00720564|adult gliosarcoma|adult gliosarcoma
1515020|NCT00720564|adult mixed glioma|adult mixed glioma
1515021|NCT00720551|STISIM|stisim
1515022|NCT00720551|Alcohol|alcohol
1515023|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
1515024|NCT00720538|Crohn disease.|crohn disease.
1515025|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
1515026|NCT00720538|Randomised controlled trial.|randomised controlled trial.
1515027|NCT00720538|Therapy.|therapy.
1515028|NCT00720538|Thalidomide.|thalidomide.
1515029|NCT00720538|Children.|children.
1515030|NCT00720525|arterial stiffness|arterial stiffness
1515031|NCT00720525|arterial wave reflections|arterial wave reflections
1515032|NCT00720525|diastolic heart failure|diastolic heart failure
1515033|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
1515034|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1515035|NCT00720512|recurrent colon cancer|recurrent colon cancer
1515036|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
1515037|NCT00720512|stage IV colon cancer|stage iv colon cancer
1515038|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
1515039|NCT00720512|stage III rectal cancer|stage iii rectal cancer
1515040|NCT00720512|stage III colon cancer|stage iii colon cancer
1515041|NCT00720473|Bipolar depression|bipolar depression
1515042|NCT00720473|Elderly|elderly
1515043|NCT00720473|Lamotrigine|lamotrigine
1515044|NCT00720473|Brain energy metabolism|brain energy metabolism
1515052|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1515053|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1515054|NCT00720421|Phase I|phase i
1515055|NCT00720421|pharmacodynamic study|pharmacodynamic study
1515056|NCT00720408|Immunosuppressant|immunosuppressant
1515057|NCT00720408|Graft loss|graft loss
1515058|NCT00720408|Combination drug therapy|combination drug therapy
1515059|NCT00720408|Randomized controlled trial|randomized controlled trial
1515060|NCT00720408|Open level method|open level method
1515061|NCT00720395|Psychiatry|psychiatry
1515062|NCT00720395|Pregnancy|pregnancy
1515063|NCT00720369|Bipolar depression|bipolar depression
1515064|NCT00720369|elderly|elderly
1515065|NCT00720369|Coenzyme Q10|coenzyme q10
1515066|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1515067|NCT00720356|adult glioblastoma|adult glioblastoma
1515068|NCT00720356|adult gliosarcoma|adult gliosarcoma
1515069|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
1515070|NCT00720330|Pain assessment|pain assessment
1515071|NCT00720330|Outcomes|outcomes
1515072|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
1515073|NCT00720317|Sickle Cell Trait|sickle cell trait
1515074|NCT00720317|Vision Loss|vision loss
1515075|NCT00720317|Eye disease|eye disease
1515076|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1515077|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1515078|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1515079|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1515080|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1515081|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1515082|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1515083|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1515084|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1515085|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1515086|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1515087|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1515088|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1515089|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1515090|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1515091|NCT00720291|Metronidazole|metronidazole
1515092|NCT00720291|BV|bv
1515093|NCT00720291|Pregnancy|pregnancy
1515094|NCT00720265|Organ Transplantation|organ transplantation
1515095|NCT00720265|Tacrolimus|tacrolimus
1515096|NCT00720265|Prograf|prograf
1515097|NCT00720265|FK506MR|fk506mr
1515098|NCT00720226|COPD|copd
1515099|NCT00720226|emphysema|emphysema
1515100|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
1515101|NCT00720200|Communication|communication
1515102|NCT00720200|Intensive Care Units|intensive care units
1515103|NCT00720200|Palliative Care|palliative care
1515104|NCT00720200|End-of-Life Issues|end-of-life issues
1515105|NCT00720200|Talking with Your Doctor|talking with your doctor
1515106|NCT00720200|Coping with Chronic Illness|coping with chronic illness
1515107|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
1515108|NCT00720148|Solid tumors|solid tumors
1515109|NCT00720122|Bone density|bone density
1515110|NCT00720122|Bone turnover markers|bone turnover markers
1515111|NCT00720122|rhIGF-1|rhigf-1
1515112|NCT00720122|Bone structure|bone structure
1515113|NCT00720122|Anorexia nervosa|anorexia nervosa
1515114|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
1515115|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
1515116|NCT00720096|Genomic Microarray|genomic microarray
1515117|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1515118|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1515119|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1515120|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1515121|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1515122|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1515123|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1515124|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1515125|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1515126|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1515127|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1515128|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1515129|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1515130|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1515285|NCT00719719|Bone Marrow|bone marrow
1515131|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1515132|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1515133|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1515134|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1515135|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1515136|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1515137|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1515138|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1515139|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1567714|NCT00508417|Malaria Incidence|malaria incidence
1515140|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1515141|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1515142|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1515143|NCT00720070|tongue cancer|tongue cancer
1515144|NCT00720057|Dental Pain|dental pain
1515145|NCT00720057|Analgesia|analgesia
1515146|NCT00720031|Melanoma,|melanoma,
1515147|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
1515148|NCT00720031|immunotherapy|immunotherapy
1515149|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
1515150|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
1515151|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
1515152|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
1515153|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
1515154|NCT00720005|Cataract|cataract
1515155|NCT00720005|cataract extraction|cataract extraction
1515156|NCT00720005|intraocular lens|intraocular lens
1515157|NCT00720005|age related|age related
1515158|NCT00719992|Exercise tolerance test|exercise tolerance test
1515159|NCT00719992|HS-CRP|hs-crp
1515160|NCT00719992|Coronary angiography|coronary angiography
1515161|NCT00719992|Patients|patients
1515162|NCT00719979|Major Depressive Disorder|major depressive disorder
1515163|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
1515164|NCT00719979|Technology Assisted|technology assisted
1515165|NCT00719979|Internet|internet
1515166|NCT00719979|Primary Care|primary care
1515167|NCT00719966|stage IA breast cancer|stage ia breast cancer
1515168|NCT00719966|stage IB breast cancer|stage ib breast cancer
1515169|NCT00719966|stage II breast cancer|stage ii breast cancer
1515170|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
1515171|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
1515172|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
1515173|NCT00719966|stage IV breast cancer|stage iv breast cancer
1515174|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1515175|NCT00719953|Cognitex|cognitex
1515176|NCT00719953|subjects|subjects
1515177|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
1515178|NCT00719927|Social Support|social support
1515179|NCT00719914|eptifibatide|eptifibatide
1515180|NCT00719914|Integrilin|integrilin
1515181|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1515182|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
1515183|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
1515184|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1515185|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
1515186|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1515187|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1515188|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1515189|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1515190|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1515191|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1515192|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1515193|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1515194|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1515195|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1515196|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1515197|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1515198|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1515199|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1515200|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1515201|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1515202|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1515203|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1515204|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1515205|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
1515206|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1515207|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1515208|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1515209|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
1515210|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1515211|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1515212|NCT00719849|refractory anemia|refractory anemia
1515213|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
1515214|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1515215|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1515216|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1515217|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1515218|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1515219|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1515220|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1515221|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1515222|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1515223|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1515224|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1515225|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1515226|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1515227|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1515228|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
1515229|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
1515230|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1515231|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1515232|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1515233|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1515234|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1515235|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1515236|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1515237|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1515238|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1515239|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1515240|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1515241|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1515242|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1515243|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1515244|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1515245|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1515246|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1515247|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1515248|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1515249|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1515250|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1515251|NCT00719849|essential thrombocythemia|essential thrombocythemia
1515252|NCT00719849|polycythemia vera|polycythemia vera
1515253|NCT00719836|SB1518|sb1518
1515254|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
1515255|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
1515256|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
1515257|NCT00719810|complicated|complicated
1515258|NCT00719810|skin|skin
1515259|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
1515260|NCT00719797|stage IV colon cancer|stage iv colon cancer
1515261|NCT00719797|stage III rectal cancer|stage iii rectal cancer
1515262|NCT00719797|stage III colon cancer|stage iii colon cancer
1515263|NCT00719784|Respiratory|respiratory
1515264|NCT00719784|Pulmonary|pulmonary
1515265|NCT00719784|Thoracic|thoracic
1515266|NCT00719784|Chest|chest
1515267|NCT00719784|Lung|lung
1515268|NCT00719771|Osteoarthritis|osteoarthritis
1515269|NCT00719771|Glenohumeral joint|glenohumeral joint
1515270|NCT00719771|Glenoid|glenoid
1515271|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
1515272|NCT00719758|TRK-100STP,|trk-100stp,
1515273|NCT00719758|beraprost sodium,|beraprost sodium,
1515274|NCT00719758|Careload LA|careload la
1515275|NCT00719758|AST-120|ast-120
1515276|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
1515277|NCT00719758|Drug-drug interaction|drug-drug interaction
1515278|NCT00719745|Organ transplantation|organ transplantation
1515279|NCT00719745|Tacrolimus|tacrolimus
1515280|NCT00719745|Prograf|prograf
1515281|NCT00719745|MR4|mr4
1515282|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
1515286|NCT00719719|Hives|hives
1515287|NCT00719719|Adult|adult
1515288|NCT00719719|Anaphylaxis|anaphylaxis
1515289|NCT00719706|Bipolar disorder|bipolar disorder
1515290|NCT00719706|Bipolar depression|bipolar depression
1515291|NCT00719706|Natural substances|natural substances
1515292|NCT00719706|Depression|depression
1515293|NCT00719693|Food effect, phase I|food effect, phase i
1515294|NCT00719693|adverse events|adverse events
1515295|NCT00719680|CVID|cvid
1515296|NCT00719680|XLA|xla
1515297|NCT00719667|OPCAB|opcab
1515298|NCT00719667|coronary|coronary
1515299|NCT00719667|bypass|bypass
1515300|NCT00719667|grafting|grafting
1515301|NCT00719667|off pump|off pump
1515302|NCT00719654|Preeclampsia|preeclampsia
1515303|NCT00719654|Proteome|proteome
1515304|NCT00719654|Pregnancy|pregnancy
1515305|NCT00719641|Colonoscopy|colonoscopy
1515306|NCT00719641|Looping|looping
1515307|NCT00719641|Prevent Looping|prevent looping
1515308|NCT00719641|Colon Cancer Screening|colon cancer screening
1515309|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
1515310|NCT00719628|Postoperative|postoperative
1515311|NCT00719628|Cognitive|cognitive
1515312|NCT00719628|Dysfunction|dysfunction
1515313|NCT00719615|Thyroid Cancer|thyroid cancer
1515314|NCT00719615|Thyroid Nodules|thyroid nodules
1515315|NCT00719615|Vitamin D|vitamin d
1515316|NCT00719602|Coinfection|coinfection
1515317|NCT00719589|Voiding Dysfunction|voiding dysfunction
1515318|NCT00719589|Interstim|interstim
1515319|NCT00719576|Cartilage legions|cartilage legions
1515320|NCT00719576|symptomatic focal cartilage defects|symptomatic focal cartilage defects
1515321|NCT00719576|microfracture|microfracture
1515322|NCT00719576|MACI|maci
1515323|NCT00719576|autologous chondrocyte|autologous chondrocyte
1515324|NCT00719563|fatigue|fatigue
1515325|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1515326|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1515327|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
1515328|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1515329|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1515330|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1515331|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1515332|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1515333|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1515334|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1515335|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1515336|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1515337|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1515338|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1515339|NCT00719563|mast cell leukemia|mast cell leukemia
1515340|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1515341|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
1515342|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1515343|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1515344|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1515345|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1515346|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
1515347|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1515348|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1515349|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1515350|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1515351|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1515352|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1515353|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1515354|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1515355|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1515356|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1515357|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1515358|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1515359|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1515360|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1515361|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1515362|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1515363|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1515364|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1515365|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1515501|NCT00719433|arm therapy|arm therapy
1515366|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1515367|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1515368|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1515369|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1515370|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1515371|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1515372|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1515373|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1515374|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1515375|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1515376|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1515377|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1515378|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1515379|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1515380|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
1515381|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1515382|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1515383|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1515384|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1515385|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1515386|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1515387|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1515388|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1515389|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1515390|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1515391|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1515392|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1515393|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1515394|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1515395|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1515396|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1515397|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1515398|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1515399|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1515400|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1515401|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1515402|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1515403|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1515404|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1515405|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1515406|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1515407|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1515408|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1515409|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1515410|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1515411|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1515412|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1515413|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1515414|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1515415|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1515416|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1515417|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1515418|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1515419|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1515420|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1515421|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1515422|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1515423|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1515424|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1515425|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1515426|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1515427|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1515428|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1515429|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1515430|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1515431|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1567715|NCT00508417|Anemia|anemia
1515432|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1515433|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1515434|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1515435|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1515436|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1515437|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1515438|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1515439|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1515440|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1515441|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1515442|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1515443|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1515444|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1515445|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1515446|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1515447|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1515448|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1515449|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1515450|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1515451|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1515452|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1515453|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1515454|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1515455|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1515456|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1515457|NCT00719563|intraocular lymphoma|intraocular lymphoma
1515458|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1515459|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1515460|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1515461|NCT00719563|primary myelofibrosis|primary myelofibrosis
1515462|NCT00719563|essential thrombocythemia|essential thrombocythemia
1515463|NCT00719563|polycythemia vera|polycythemia vera
1515464|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
1515465|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1515466|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1515467|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
1515468|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
1515469|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
1515470|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
1515471|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
1515472|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1515473|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1515474|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1515475|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1515476|NCT00719550|Locally Advanced|locally advanced
1515477|NCT00719550|Metastatic|metastatic
1515478|NCT00719537|preeclampsia|preeclampsia
1515479|NCT00719537|progesterone|progesterone
1515480|NCT00719537|aspirin|aspirin
1515481|NCT00719537|prevent|prevent
1515482|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
1515483|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
1515484|NCT00719537|risk|risk
1515485|NCT00719524|Neoplasms|neoplasms
1515486|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
1515487|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
1515488|NCT00719511|Allergic|allergic
1515489|NCT00719498|Epo-alpha|epo-alpha
1515490|NCT00719498|Cardiac arrest|cardiac arrest
1515491|NCT00719498|Mild hypothermia|mild hypothermia
1515492|NCT00719485|lumbar decompression|lumbar decompression
1515493|NCT00719472|Follicular NHL|follicular nhl
1515495|NCT00719472|Large B-Cell NHL|large b-cell nhl
1515496|NCT00719446|Acute Lung Injury|acute lung injury
1515497|NCT00719433|stroke|stroke
1515498|NCT00719433|chronic|chronic
1515499|NCT00719433|rehabilitation|rehabilitation
1515500|NCT00719433|robot therapy|robot therapy
1515502|NCT00719420|Randomized clinical trial|randomized clinical trial
1515503|NCT00719420|Helicobacter pylori|helicobacter pylori
1515504|NCT00719420|clarithromycin|clarithromycin
1515505|NCT00719420|metronidazole|metronidazole
1515506|NCT00719420|amoxicillin|amoxicillin
1515507|NCT00719420|proton pump inhibitor|proton pump inhibitor
1515508|NCT00719420|Colombia|colombia
1515509|NCT00719407|birth asphyxia|birth asphyxia
1515510|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
1515511|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1515512|NCT00719407|neuroprotection|neuroprotection
1515513|NCT00719407|neonate|neonate
1515514|NCT00719394|alzheimer Disease|alzheimer disease
1515515|NCT00719368|Groin hernia|groin hernia
1515516|NCT00719368|pain|pain
1515517|NCT00719368|chronic|chronic
1515518|NCT00719368|quantitative sensory testing|quantitative sensory testing
1515519|NCT00719368|Persistent postoperative pain|persistent postoperative pain
1515520|NCT00719342|Retinal vessel diameter|retinal vessel diameter
1515521|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
1515522|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
1515523|NCT00719342|Ocular Physiology|ocular physiology
1515524|NCT00719342|Regional Blood Flow|regional blood flow
1515525|NCT00719329|chlorhexidine|chlorhexidine
1515526|NCT00719329|umbilical cord|umbilical cord
1515527|NCT00719316|Renin inhibitor|renin inhibitor
1515528|NCT00719316|Patients|patients
1515529|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
1515530|NCT00719316|Chronic Kidney Disease|chronic kidney disease
1515531|NCT00719316|Hypertension|hypertension
1515532|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
1515533|NCT00719290|Phacoemulsification|phacoemulsification
1515534|NCT00719290|Goniosynechialysis|goniosynechialysis
1515535|NCT00719290|Outflow facility|outflow facility
1515536|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
1515537|NCT00719277|syncope|syncope
1515539|NCT00719277|implantable ECG monitor|implantable ecg monitor
1515540|NCT00719277|ILR|ilr
1515541|NCT00719264|Renal cell carcinoma|renal cell carcinoma
1515542|NCT00719264|Adults|adults
1515543|NCT00719264|Bevacizumab|bevacizumab
1515544|NCT00719264|RAD001|rad001
1515545|NCT00719264|Everolimus|everolimus
1515546|NCT00719264|Interferon|interferon
1515547|NCT00719264|Clear|clear
1515548|NCT00719264|Roferon|roferon
1515549|NCT00719264|Avastin|avastin
1515550|NCT00719264|Nephrectomy|nephrectomy
1515551|NCT00719264|newly diagnosed|newly diagnosed
1515552|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
1515553|NCT00719251|Electric stimulation|electric stimulation
1515554|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
1515555|NCT00719199|Colorectal cancer|colorectal cancer
1515556|NCT00719199|metastatic cancer|metastatic cancer
1515557|NCT00719199|prior therapy|prior therapy
1515558|NCT00719199|1b|1b
1515559|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
1515560|NCT00719186|Infertility|infertility
1515561|NCT00719186|Pregnancy|pregnancy
1515562|NCT00719186|Women|women
1515563|NCT00719173|nausea and vomiting|nausea and vomiting
1515564|NCT00719173|breast cancer|breast cancer
1515565|NCT00719160|Gastric acid|gastric acid
1515566|NCT00719160|Dietary protein|dietary protein
1515567|NCT00719160|Calcium|calcium
1515568|NCT00719160|Intestinal absorption|intestinal absorption
1515569|NCT00719160|Calcium sensing receptor|calcium sensing receptor
1515570|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
1515571|NCT00719095|prescription opioid|prescription opioid
1515572|NCT00719095|opioid detoxification|opioid detoxification
1515573|NCT00719095|buprenorphine|buprenorphine
1515574|NCT00719095|naltrexone|naltrexone
1515575|NCT00719095|community reinforcement approach|community reinforcement approach
1515576|NCT00719095|prescription opioid abuse|prescription opioid abuse
1515577|NCT00719082|Human Stability|human stability
1515578|NCT00719082|Geriatric|geriatric
1515579|NCT00719082|Posturography|posturography
1515580|NCT00719069|healthy subjects who smoke|healthy subjects who smoke
1515581|NCT00719069|healthy subjects|healthy subjects
1515582|NCT00719056|teicoplanin|teicoplanin
1515583|NCT00719056|prophylaxis|prophylaxis
1515584|NCT00719056|arthroplasty|arthroplasty
1515585|NCT00719056|surgical site infections|surgical site infections
1515586|NCT00719043|Influenza|influenza
1515587|NCT00719043|H5N1|h5n1
1515588|NCT00719043|Avian|avian
1515589|NCT00719043|Vaccines|vaccines
1515590|NCT00719043|Safety|safety
1515591|NCT00719043|Immunogenicity|immunogenicity
1515592|NCT00719043|Pandemic|pandemic
1515593|NCT00719043|Human|human
1515594|NCT00719017|Brachytherapy|brachytherapy
1515595|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
1515596|NCT00719017|Quality of life|quality of life
1515597|NCT00719017|Recurrence|recurrence
1515598|NCT00719017|Treatment|treatment
1515599|NCT00719017|Vaginectomy|vaginectomy
1515600|NCT00719004|Anatomy|anatomy
1515601|NCT00719004|Foot|foot
1515602|NCT00719004|Sonography|sonography
1515603|NCT00719004|Medical|medical
1515604|NCT00718991|CLI|cli
1515605|NCT00718991|excimer laser|excimer laser
1515606|NCT00718991|debulking|debulking
1515607|NCT00718978|bioengineered|bioengineered
1515608|NCT00718978|ski|ski
1515609|NCT00718978|keratinocytes|keratinocytes
1515610|NCT00718978|fibroblasts|fibroblasts
1515611|NCT00718978|skin|skin
1515612|NCT00718978|culture|culture
1515613|NCT00718978|autologous|autologous
1515614|NCT00718978|CSS|css
1515615|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
1515616|NCT00718978|burns|burns
1515617|NCT00718978|ulcers|ulcers
1515618|NCT00718978|giant nevi|giant nevi
1515619|NCT00718978|cicatricial outcomes|cicatricial outcomes
1515620|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
1515621|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
1515622|NCT00718939|Diastolic Heart Failure|diastolic heart failure
1515623|NCT00718939|Cardiac dysfunction|cardiac dysfunction
1515624|NCT00718939|Heart Failure|heart failure
1515625|NCT00718926|dry eye|dry eye
1515626|NCT00718926|Thiol redox|thiol redox
1515627|NCT00718926|Oxidative stress|oxidative stress
1515628|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
1515629|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
1515630|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
1515631|NCT00718913|Capecitabine|capecitabine
1515632|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
1515633|NCT00718861|Osteoporosis|osteoporosis
1515634|NCT00718861|zoledronic acid|zoledronic acid
1515635|NCT00718861|post-menopausal|post-menopausal
1515636|NCT00718848|hemodialysis|hemodialysis
1515637|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
1515638|NCT00718848|left ventricular systolic function|left ventricular systolic function
1515639|NCT00718835|smoking cessation|smoking cessation
1515640|NCT00718835|behavioral treatment|behavioral treatment
1515641|NCT00718835|contingency management|contingency management
1515642|NCT00718835|opioid maintenance|opioid maintenance
1515643|NCT00718835|methadone|methadone
1515644|NCT00718835|buprenorphine|buprenorphine
1515645|NCT00718822|clinical outcome|clinical outcome
1515646|NCT00718822|ICSI cycles|icsi cycles
1515647|NCT00718822|low oxygen|low oxygen
1515648|NCT00718822|poor responders|poor responders
1515649|NCT00718822|pregnancy rate|pregnancy rate
1515650|NCT00718822|prospective randomized study|prospective randomized study
1515651|NCT00718796|cardiovascular disease|cardiovascular disease
1515652|NCT00718796|naturopathic medicine|naturopathic medicine
1515653|NCT00718796|natural health products|natural health products
1515654|NCT00718796|lifestyle intervention|lifestyle intervention
1515655|NCT00718796|dietary advice|dietary advice
1515656|NCT00718796|coronary heart disease|coronary heart disease
1515657|NCT00718770|Not respond|not respond
1515658|NCT00718770|Radioactive iodine|radioactive iodine
1515659|NCT00718770|Therapy|therapy
1515660|NCT00718770|Shows signs|shows signs
1515661|NCT00718770|Aggressive behavior|aggressive behavior
1515662|NCT00718744|Allergen-extract|allergen-extract
1515663|NCT00718744|Standardization|standardization
1515664|NCT00718731|Alzheimer Disease|alzheimer disease
1515665|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
1515666|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
1515667|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
1515668|NCT00718718|CNTO 136|cnto 136
1515669|NCT00718718|Interleukin-6|interleukin-6
1515670|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
1515671|NCT00718718|Methotrexate|methotrexate
1515672|NCT00718718|Placebo|placebo
1515673|NCT00718705|Prematurity|prematurity
1515674|NCT00718705|Ureaplasma spp|ureaplasma spp
1515675|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
1515676|NCT00718705|Amniotic fluid|amniotic fluid
1515677|NCT00718705|Josamycine|josamycine
1515678|NCT00718692|Idiopathic|idiopathic
1515679|NCT00718692|ITP|itp
1515680|NCT00718666|Safety|safety
1515681|NCT00718666|Vaccines, conjugate|vaccines, conjugate
1515682|NCT00718666|Immunogenicity|immunogenicity
1515683|NCT00718666|Meningococcal vaccine|meningococcal vaccine
1515684|NCT00718666|Booster vaccination|booster vaccination
1515685|NCT00718666|Primary vaccination|primary vaccination
1515686|NCT00718666|Neisseria meningitides|neisseria meningitides
1515687|NCT00718666|Toddlers|toddlers
1515688|NCT00718666|Humans|humans
1515689|NCT00718666|Meningococcal disease|meningococcal disease
1515690|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
1515691|NCT00718640|Multiple Myeloma|multiple myeloma
1515692|NCT00718640|Velcade|velcade
1515693|NCT00718640|Bortezomib|bortezomib
1515694|NCT00718640|Dexamethasone|dexamethasone
1515695|NCT00718627|Urea cycle Disorders|urea cycle disorders
1515696|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
1515697|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
1515698|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
1515699|NCT00718627|Citrullinemia|citrullinemia
1515700|NCT00718627|newborns|newborns
1515701|NCT00718627|infants|infants
1515702|NCT00718627|liver cell transplantation|liver cell transplantation
1515703|NCT00718627|liver cell infusion|liver cell infusion
1515704|NCT00718614|Choroidal blood flow|choroidal blood flow
1515907|NCT00717782|pain|pain
1515705|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
1515706|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
1515707|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
1515708|NCT00718601|Myeloma|myeloma
1515709|NCT00718601|Multiple Myeloma|multiple myeloma
1515710|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
1515711|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
1515712|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1515713|NCT00718588|RA|ra
1515714|NCT00718575|Liver Disease|liver disease
1515715|NCT00718575|Transplantation|transplantation
1515716|NCT00718562|nilotinib|nilotinib
1515717|NCT00718562|AMN107|amn107
1515718|NCT00718562|Sunitinib|sunitinib
1515719|NCT00718562|Sunitinib malate|sunitinib malate
1515720|NCT00718562|Imatinib|imatinib
1515721|NCT00718562|Imatinib mesylate|imatinib mesylate
1515722|NCT00718562|Tyrosine|tyrosine
1515723|NCT00718536|Atazanavir|atazanavir
1515724|NCT00718536|Raltegravir|raltegravir
1515725|NCT00718536|once-daily|once-daily
1515726|NCT00718536|pharmacokinetics|pharmacokinetics
1515727|NCT00718536|HIV|hiv
1515728|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515729|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
1515730|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
1515731|NCT00718497|Motor Neuron Disease|motor neuron disease
1515732|NCT00718497|Autonomic Nervous System|autonomic nervous system
1515733|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
1515734|NCT00718497|Movement Disorders|movement disorders
1515735|NCT00718484|Sarcoma|sarcoma
1515736|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
1515737|NCT00718484|Doxorubicin|doxorubicin
1515738|NCT00718484|anthracyclin|anthracyclin
1515739|NCT00718484|Palifosfamide|palifosfamide
1515740|NCT00718484|IFOS|ifos
1515741|NCT00718471|STEMI|stemi
1515742|NCT00718471|Primary PCI|primary pci
1515743|NCT00718471|Anticoagulation|anticoagulation
1515744|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515745|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
1515746|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
1515747|NCT00718458|Motor Neuron Disease|motor neuron disease
1515748|NCT00718458|Autonomic Nervous System|autonomic nervous system
1515749|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
1515750|NCT00718458|Movement Disorders|movement disorders
1515751|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515752|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
1515753|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
1515754|NCT00718445|Motor Neuron Disease|motor neuron disease
1515755|NCT00718445|Autonomic Nervous System|autonomic nervous system
1515756|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
1515757|NCT00718445|Movement Disorders|movement disorders
1515758|NCT00718432|Frailty|frailty
1515759|NCT00718432|Osteoporosis|osteoporosis
1515760|NCT00718432|Depression|depression
1515761|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1515762|NCT00718419|Multiple Myeloma|multiple myeloma
1515763|NCT00718406|Acute coronary syndrome|acute coronary syndrome
1515764|NCT00718406|Chest pain|chest pain
1515765|NCT00718406|Betablockers|betablockers
1515766|NCT00718406|Morphine|morphine
1515767|NCT00718406|Prehospital phase|prehospital phase
1515768|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515769|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
1515770|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
1515771|NCT00718393|Motor Neuron Disease|motor neuron disease
1515772|NCT00718393|Autonomic Nervous System|autonomic nervous system
1515773|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
1515774|NCT00718393|Movement Disorders|movement disorders
1515775|NCT00718354|Bleeding events|bleeding events
1515776|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
1515777|NCT00718328|Intracerebral|intracerebral
1515778|NCT00718328|Hemorrhage|hemorrhage
1515779|NCT00718328|Edema|edema
1515780|NCT00718328|Statins|statins
1515781|NCT00718302|Ankle Fractures|ankle fractures
1515782|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
1515783|NCT00718302|Antiglide Plating|antiglide plating
1515784|NCT00718302|Lateral Plating|lateral plating
1515785|NCT00718289|Citric acid|citric acid
1515786|NCT00718289|citrate|citrate
1515787|NCT00718289|acetic acid|acetic acid
1515788|NCT00718289|acetate|acetate
1515789|NCT00718289|haemodialysis|haemodialysis
1515790|NCT00718289|calcium|calcium
1515791|NCT00718289|hypotension|hypotension
1515792|NCT00718289|haemodynamics|haemodynamics
1515793|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
1515794|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
1515795|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
1515796|NCT00718250|Cancer vaccines|cancer vaccines
1515797|NCT00718250|Immunotherapy|immunotherapy
1515798|NCT00718237|Gastroenteritis|gastroenteritis
1515799|NCT00718237|Rotavirus|rotavirus
1515800|NCT00718224|Knee surgery|knee surgery
1515801|NCT00718224|VTE prevention|vte prevention
1515802|NCT00718198|Inpatient|inpatient
1515803|NCT00718198|Computer Physician Order Entry|computer physician order entry
1515804|NCT00718198|Diabetes Mellitus|diabetes mellitus
1515805|NCT00718185|Sildenafil|sildenafil
1515806|NCT00718185|Pediatrics|pediatrics
1515807|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
1515808|NCT00718172|Gene Expression|gene expression
1515809|NCT00718172|Peginterferon|peginterferon
1515810|NCT00718172|Hepatitis C|hepatitis c
1515811|NCT00718172|Liver Biopsy|liver biopsy
1515812|NCT00718172|HCV|hcv
1515813|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
1515814|NCT00718159|Myeloid Leukemia|myeloid leukemia
1515815|NCT00718159|Relapsed|relapsed
1515816|NCT00718159|Refractory|refractory
1515817|NCT00718146|Influenza|influenza
1515818|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
1515819|NCT00718146|Orthomyxoviruses|orthomyxoviruses
1515820|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
1515821|NCT00718133|Asthma|asthma
1515822|NCT00718133|Allergy|allergy
1515823|NCT00718133|Respiratory|respiratory
1515824|NCT00718133|Pollution|pollution
1515825|NCT00718133|Children|children
1515826|NCT00718133|Air pollution|air pollution
1515827|NCT00718120|Fluviral|fluviral
1515828|NCT00718120|Influenza|influenza
1515829|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515830|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
1515831|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
1515832|NCT00718107|Motor Neuron Disease|motor neuron disease
1515833|NCT00718107|Autonomic Nervous System|autonomic nervous system
1515834|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
1515835|NCT00718107|Movement Disorders|movement disorders
1515836|NCT00718107|Quality of Life|quality of life
1515837|NCT00718094|Ulcerative colitis|ulcerative colitis
1515838|NCT00718094|EGCG|egcg
1515839|NCT00718094|Green tea polyphenols|green tea polyphenols
1515840|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
1515841|NCT00718094|Colitis|colitis
1515843|NCT00718094|Green tea|green tea
1515844|NCT00718068|Potassium chloride|potassium chloride
1515845|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
1515846|NCT00718068|Hypokalemia|hypokalemia
1515847|NCT00718068|Critical Care|critical care
1515848|NCT00718068|Adult|adult
1515849|NCT00718068|Randomized Controlled Trial|randomized controlled trial
1515850|NCT00718055|MRI|mri
1515851|NCT00718055|liverspecific|liverspecific
1515852|NCT00718055|contrast|contrast
1515853|NCT00718055|colorectal|colorectal
1515854|NCT00718055|metastases|metastases
1515855|NCT00718042|healthy donors|healthy donors
1515856|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
1515857|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
1515858|NCT00718029|Raltegravir|raltegravir
1515859|NCT00718029|Drug Concentrations|drug concentrations
1515860|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515861|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
1515862|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
1515863|NCT00718016|Motor Neuron Disease|motor neuron disease
1515864|NCT00718016|Autonomic Nervous System|autonomic nervous system
1515865|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
1515866|NCT00718016|Movement Disorders|movement disorders
1515867|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1515868|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
1515869|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
1515870|NCT00718003|Motor Neuron Disease|motor neuron disease
1515871|NCT00718003|Autonomic Nervous System|autonomic nervous system
1515872|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
1515873|NCT00718003|Movement Disorders|movement disorders
1515874|NCT00717990|Colorectal cancer|colorectal cancer
1515875|NCT00717990|Bevacizumab|bevacizumab
1515876|NCT00717990|XELIRI|xeliri
1515877|NCT00717951|advanced breast cancer|advanced breast cancer
1515878|NCT00717951|docetaxol|docetaxol
1515879|NCT00717951|capecitabine|capecitabine
1515880|NCT00717951|cisplatin|cisplatin
1515881|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1515882|NCT00717925|NHL|nhl
1515883|NCT00717912|BLOOD GLUCOSE|blood glucose
1515884|NCT00717912|glycemic index|glycemic index
1515885|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
1515886|NCT00717899|Asthma|asthma
1515887|NCT00717899|Allergy|allergy
1515888|NCT00717899|Respiratory|respiratory
1515889|NCT00717899|Pollution|pollution
1515890|NCT00717899|Children|children
1515891|NCT00717899|Air pollution|air pollution
1515892|NCT00717886|Breast|breast
1515893|NCT00717886|Lymph Nodes|lymph nodes
1515894|NCT00717873|Mucus Clearance|mucus clearance
1515895|NCT00717873|Secretion Clearance|secretion clearance
1515896|NCT00717873|HFCWO|hfcwo
1515897|NCT00717808|Tranilast|tranilast
1515898|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
1515899|NCT00717808|Pharmacokinetics|pharmacokinetics
1515900|NCT00717808|Methotrexate|methotrexate
1515901|NCT00717795|Survivor|survivor
1515902|NCT00717795|Physical Activity|physical activity
1515903|NCT00717795|NED|ned
1515904|NCT00717795|08-067|08-067
1515905|NCT00717782|botulinum toxin|botulinum toxin
1515906|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
1515908|NCT00717769|Atopic Dermatitis|atopic dermatitis
1515909|NCT00717756|liver cancer, second line|liver cancer, second line
1515910|NCT00717743|RCC|rcc
1515911|NCT00717743|patients|patients
1515912|NCT00717743|scheduled|scheduled
1515913|NCT00717743|nephrectomy|nephrectomy
1515914|NCT00717730|Nutrition|nutrition
1515915|NCT00717730|Children|children
1515916|NCT00717730|Folate|folate
1515917|NCT00717730|Vitamin B12|vitamin b12
1515918|NCT00717730|India|india
1515919|NCT00717730|Homocysteine|homocysteine
1515920|NCT00717730|Methyl Malonic Acid|methyl malonic acid
1515921|NCT00717717|Cancer Survivor|cancer survivor
1515922|NCT00717717|Physical Activity|physical activity
1515923|NCT00717717|Health Behavior|health behavior
1515924|NCT00717717|Psychosocial Well-being|psychosocial well-being
1515925|NCT00717717|Coaching|coaching
1515926|NCT00717717|Long Term|long term
1515927|NCT00717717|Consequences|consequences
1515928|NCT00717717|Chemotherapy|chemotherapy
1515929|NCT00717717|Motivation|motivation
1515930|NCT00717704|Malignant solid tumor|malignant solid tumor
1515931|NCT00717704|Phase 1|phase 1
1515932|NCT00717704|Dose escalation|dose escalation
1515933|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
1515934|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
1515935|NCT00717691|Hallux Limitus|hallux limitus
1515936|NCT00717691|Dynamic Splinting|dynamic splinting
1515937|NCT00717691|Dynasplint|dynasplint
1515938|NCT00717678|Immunosuppressant|immunosuppressant
1515939|NCT00717678|Combination drug therapy|combination drug therapy
1515940|NCT00717678|Graft loss|graft loss
1515941|NCT00717678|Randomized controlled trial|randomized controlled trial
1515942|NCT00717678|Open level method|open level method
1515943|NCT00717665|Hypertension|hypertension
1515944|NCT00717665|Telemanagement|telemanagement
1515945|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
1515946|NCT00717665|Self care|self care
1515947|NCT00717639|diagnostic accuracy|diagnostic accuracy
1515948|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
1515949|NCT00717639|steady state|steady state
1515950|NCT00717639|digital subtraction angiography|digital subtraction angiography
1515951|NCT00717639|peripheral arteries|peripheral arteries
1515952|NCT00717626|Hemophilia|hemophilia
1515953|NCT00717626|Prophylaxis|prophylaxis
1515954|NCT00717626|Youth|youth
1515955|NCT00717626|Young Adults|young adults
1515956|NCT00717626|Feasibility|feasibility
1515957|NCT00717600|bacteriuria|bacteriuria
1515958|NCT00717600|urinary tract infection|urinary tract infection
1515959|NCT00717600|probiotics|probiotics
1515960|NCT00717600|lactobacillus|lactobacillus
1515961|NCT00717600|vagina|vagina
1515962|NCT00717600|bladder|bladder
1515963|NCT00717600|neurogenic bladder|neurogenic bladder
1515964|NCT00717600|spina bifida|spina bifida
1515965|NCT00717600|myelomeningocele|myelomeningocele
1515966|NCT00717600|neuropathic bladder|neuropathic bladder
1515967|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
1515968|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
1515969|NCT00717574|depth of sedation|depth of sedation
1515970|NCT00717574|nitrous oxide|nitrous oxide
1515971|NCT00717574|general anesthesia|general anesthesia
1515972|NCT00717574|anesthesia indices|anesthesia indices
1515973|NCT00717561|CAP|cap
1515974|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
1515975|NCT00717548|Somatic Complaints|somatic complaints
1515976|NCT00717535|health status unknown|health status unknown
1515977|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
1515978|NCT00717522|CC-4047|cc-4047
1515979|NCT00717522|Pomalidomide|pomalidomide
1515980|NCT00717509|schizophrenia|schizophrenia
1515981|NCT00717509|metabolic side effect|metabolic side effect
1515982|NCT00717509|clozapine|clozapine
1515983|NCT00717509|genetic polymorphism|genetic polymorphism
1515984|NCT00717496|Breastfeeding|breastfeeding
1515985|NCT00717496|Telephone Support|telephone support
1515986|NCT00717496|Latino|latino
1515987|NCT00717470|Kidney|kidney
1515988|NCT00717470|Prograf|prograf
1515989|NCT00717470|Transplant|transplant
1515990|NCT00717470|Advagraf|advagraf
1515991|NCT00717470|Immunosuppression|immunosuppression
1515992|NCT00717470|FK506|fk506
1515993|NCT00717444|Substance Abuse|substance abuse
1515994|NCT00717444|HIV|hiv
1515995|NCT00717444|Contingency Management|contingency management
1515996|NCT00717444|Physical Activity|physical activity
1515997|NCT00717431|Deep Brain Stimulation|deep brain stimulation
1515998|NCT00717431|Seizures|seizures
1515999|NCT00717431|Epilepsy|epilepsy
1516000|NCT00717392|ADHD|adhd
1516001|NCT00717392|ASD|asd
1516002|NCT00717379|Organ Transplantation|organ transplantation
1516003|NCT00717379|Tacrolimus|tacrolimus
1516004|NCT00717379|Prograf|prograf
1516005|NCT00717379|Kidney|kidney
1516006|NCT00717379|Immunosuppression|immunosuppression
1516007|NCT00717340|tivozanib|tivozanib
1516008|NCT00717340|AV-951|av-951
1516009|NCT00717327|MRL|mrl
1516010|NCT00717327|Adolescents|adolescents
1516011|NCT00717327|Health Literacy|health literacy
1516376|NCT00716053|COPD|copd
1516379|NCT00716053|BLVR|blvr
1516012|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
1516013|NCT00717288|diabetes|diabetes
1516014|NCT00717288|hyperglycemia|hyperglycemia
1516015|NCT00717288|open heart surgery|open heart surgery
1516016|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
1516017|NCT00717288|detemir|detemir
1516018|NCT00717288|insulin infusion|insulin infusion
1516019|NCT00717288|intravenous insulin|intravenous insulin
1516020|NCT00717275|Brain Metastases|brain metastases
1516021|NCT00717275|Temozolomide|temozolomide
1516023|NCT00717275|TMZ|tmz
1516024|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
1516025|NCT00717275|SRS|srs
1516026|NCT00717236|Certolizumab pegol|certolizumab pegol
1516027|NCT00717236|Cimzia|cimzia
1516028|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
1516029|NCT00717236|Joint Disease|joint disease
1516030|NCT00717236|Chronic Arthritis|chronic arthritis
1516031|NCT00717223|Diabetes|diabetes
1516032|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
1516033|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
1516034|NCT00717223|Literacy|literacy
1516035|NCT00717223|Glycemic control|glycemic control
1516036|NCT00717210|1p/19q loss|1p/19q loss
1516037|NCT00717210|MGMT|mgmt
1516038|NCT00717210|prognostic factors|prognostic factors
1516039|NCT00717210|PCV|pcv
1516040|NCT00717210|temozolomide|temozolomide
1516041|NCT00717197|HGG|hgg
1516042|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
1516043|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1516044|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
1516045|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
1516046|NCT00717197|GBM|gbm
1516047|NCT00717197|Xeloda|xeloda
1516048|NCT00717197|capecitabine|capecitabine
1516049|NCT00717171|electrical stimulation|electrical stimulation
1516050|NCT00717171|pain|pain
1516051|NCT00717171|medication|medication
1516052|NCT00717171|edema|edema
1516053|NCT00717171|interferential|interferential
1516054|NCT00717171|neuromuscular|neuromuscular
1516055|NCT00717171|high voltage pulsed current|high voltage pulsed current
1516056|NCT00717171|knee|knee
1516057|NCT00717158|Health Behavior|health behavior
1516058|NCT00717158|Lifestyle|lifestyle
1516059|NCT00717158|health care costs|health care costs
1516060|NCT00717158|quality of life|quality of life
1516061|NCT00717145|bioequivalence|bioequivalence
1516062|NCT00717132|weight|weight
1516063|NCT00717132|cost effectiveness|cost effectiveness
1516064|NCT00717132|obesity|obesity
1516065|NCT00717132|family based behavioral treatment|family based behavioral treatment
1516066|NCT00717119|GI|gi
1516067|NCT00717119|NSAID|nsaid
1516068|NCT00717119|Complications|complications
1516069|NCT00717119|Treated|treated
1516070|NCT00717119|Patients|patients
1516071|NCT00717106|ILR|ilr
1516072|NCT00717106|ECG monitoring|ecg monitoring
1516073|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
1516074|NCT00717106|syncope|syncope
1516075|NCT00717106|presyncope|presyncope
1516076|NCT00717106|fainting|fainting
1516077|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
1516078|NCT00717080|Cataract|cataract
1516079|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
1516080|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
1516081|NCT00717041|Depression|depression
1516082|NCT00717041|Anxiety|anxiety
1516083|NCT00717041|Cognitive Impairment|cognitive impairment
1516084|NCT00717041|Emergency medicine|emergency medicine
1516085|NCT00717041|prehospital care|prehospital care
1516086|NCT00717028|Cerebral palsy|cerebral palsy
1516087|NCT00717028|Dysphagia|dysphagia
1516088|NCT00717028|Deglutition|deglutition
1516089|NCT00717028|Endoscopy|endoscopy
1516090|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
1516091|NCT00716989|Cutaneous immune system|cutaneous immune system
1516092|NCT00716989|innate immunity|innate immunity
1516093|NCT00716989|tuberculin skin tests|tuberculin skin tests
1516094|NCT00716989|intradermal vaccination|intradermal vaccination
1516095|NCT00716989|pathophysiology|pathophysiology
1516096|NCT00716989|Healthy subjects|healthy subjects
1516097|NCT00716989|Immunosuppressed patients|immunosuppressed patients
1516098|NCT00716976|ototoxicity|ototoxicity
1516099|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1516100|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1516101|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1516102|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1516103|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1516104|NCT00716976|childhood teratoma|childhood teratoma
1516105|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
1516106|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
1516107|NCT00716976|regional neuroblastoma|regional neuroblastoma
1516108|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
1516109|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1516378|NCT00716053|LVRS|lvrs
1516380|NCT00716053|Aeris|aeris
1516110|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
1516111|NCT00716976|localized osteosarcoma|localized osteosarcoma
1516112|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
1516113|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
1516114|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
1516115|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
1516116|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
1516117|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
1516118|NCT00716963|late allergic response|late allergic response
1516119|NCT00716963|fluticasone propionate|fluticasone propionate
1516120|NCT00716937|pilonidal sinus|pilonidal sinus
1516121|NCT00716937|karydakis|karydakis
1516122|NCT00716937|laying open|laying open
1516123|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
1516124|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1516125|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1516126|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1516127|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1516128|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1516129|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1516130|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1516131|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1516132|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
1516133|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1516134|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1516135|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1516136|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1516137|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1516138|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1516139|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1516140|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1516141|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1516142|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1516143|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1516144|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1516145|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1516146|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1516147|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1516148|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1516149|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1516150|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1516151|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1516152|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1516153|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1516154|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1516155|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1516156|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1516157|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1516158|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1516159|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1516160|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1516161|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1516162|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1516163|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1516164|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1516165|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1516166|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1516167|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1516168|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1516169|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1516170|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1516171|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1516172|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1516173|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1516174|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1516175|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1516176|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1516377|NCT00716053|lung volume reduction|lung volume reduction
1516177|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1516178|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1516179|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1516180|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1516181|NCT00716911|primary myelofibrosis|primary myelofibrosis
1516182|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
1516183|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
1516184|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
1516185|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1516186|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1516187|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1516188|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1516189|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
1516190|NCT00716898|Condition|condition
1516191|NCT00716898|Cancer|cancer
1516192|NCT00716898|Patients|patients
1516193|NCT00716898|Thrombosis|thrombosis
1516194|NCT00716898|Unstable|unstable
1516195|NCT00716898|Angina|angina
1516196|NCT00716898|Pectoris|pectoris
1516197|NCT00716885|Heart failure|heart failure
1516198|NCT00716885|Oxidative stress|oxidative stress
1516199|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
1516200|NCT00716885|White blood cells|white blood cells
1516201|NCT00716872|cancer|cancer
1516202|NCT00716872|sleep|sleep
1516203|NCT00716872|insomnia|insomnia
1516204|NCT00716872|Internet|internet
1516205|NCT00716872|SHUTi|shuti
1516206|NCT00716833|pain|pain
1516207|NCT00716833|coxibe|coxibe
1516208|NCT00716833|preemptive|preemptive
1516209|NCT00716833|abdominothoracic|abdominothoracic
1516210|NCT00716833|sensibilisation|sensibilisation
1516211|NCT00716833|Analgesia|analgesia
1516212|NCT00716807|BMS|bms
1516213|NCT00716807|TMD|tmd
1516214|NCT00716794|Prostate cancer|prostate cancer
1516215|NCT00716794|HE3235|he3235
1516216|NCT00716794|Apoptone|apoptone
1516217|NCT00716781|Group B streptococcus|group b streptococcus
1516218|NCT00716781|Sepsis|sepsis
1516219|NCT00716781|Infants|infants
1516220|NCT00716781|Diagnosis|diagnosis
1516221|NCT00716781|Physical examination|physical examination
1516222|NCT00716781|Laboratory tests|laboratory tests
1516223|NCT00716768|Laparoscopic|laparoscopic
1516224|NCT00716768|Inguinal Hernia|inguinal hernia
1516225|NCT00716768|Infants|infants
1516226|NCT00716755|Positron emission tomography|positron emission tomography
1516227|NCT00716755|antipsychotics|antipsychotics
1516228|NCT00716755|risperidone|risperidone
1516229|NCT00716755|olanzapine|olanzapine
1516230|NCT00716755|Dopamine|dopamine
1516231|NCT00716755|D2 receptor|d2 receptor
1516232|NCT00716755|elderly|elderly
1516233|NCT00716755|schizophrenia|schizophrenia
1516234|NCT00716755|schizoaffective disorder|schizoaffective disorder
1516235|NCT00716755|schizophreniform disorder|schizophreniform disorder
1516236|NCT00716755|delusional disorder|delusional disorder
1516237|NCT00716755|psychotic disorder NOS|psychotic disorder nos
1516238|NCT00716729|Questionnaire|questionnaire
1516239|NCT00716729|Hip|hip
1516240|NCT00716729|Groin|groin
1516241|NCT00716729|Disability|disability
1516242|NCT00716729|Strength|strength
1516243|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
1516244|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
1516245|NCT00716703|Appendicitis|appendicitis
1516246|NCT00716703|Computed tomography|computed tomography
1516247|NCT00716703|pediatric|pediatric
1516248|NCT00716703|child|child
1516249|NCT00716703|sensitivity|sensitivity
1516250|NCT00716703|specificity|specificity
1516251|NCT00716703|contrast administration route|contrast administration route
1516252|NCT00716703|time factors|time factors
1516253|NCT00716690|Stem cell transplantation|stem cell transplantation
1516254|NCT00716690|GVHD|gvhd
1516255|NCT00716677|difficult asthma|difficult asthma
1516256|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
1516257|NCT00716664|cystic fibrosis|cystic fibrosis
1516258|NCT00716664|musculoskeletal|musculoskeletal
1516259|NCT00716664|exercise capacity|exercise capacity
1516260|NCT00716664|posture|posture
1516261|NCT00716664|lung function|lung function
1516262|NCT00716664|physical functioning|physical functioning
1516263|NCT00716612|Coenzyme Q 10|coenzyme q 10
1516264|NCT00716612|Statin|statin
1516265|NCT00716612|Myalgia|myalgia
1516266|NCT00716599|malaria|malaria
1516267|NCT00716599|diagnosis|diagnosis
1516268|NCT00716599|rapid diagnostic test|rapid diagnostic test
1516269|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
1516270|NCT00716599|fever case management|fever case management
1516271|NCT00716599|training|training
1516272|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
1516273|NCT00716573|Cardiac transplantation|cardiac transplantation
1516274|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
1516275|NCT00716573|Everolimus|everolimus
1516276|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
1516277|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
1516278|NCT00716482|breast|breast
1516279|NCT00716482|lesion|lesion
1516280|NCT00716482|ultrasound|ultrasound
1516281|NCT00716482|BI-RADS|bi-rads
1516282|NCT00716482|malignancy|malignancy
1516283|NCT00716482|women|women
1516284|NCT00716469|Neurofibroma|neurofibroma
1516285|NCT00716469|Plexiform|plexiform
1516286|NCT00716469|NF1|nf1
1516287|NCT00716469|Photo dynamic therapy|photo dynamic therapy
1516288|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
1516289|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
1516290|NCT00716456|Lung|lung
1516291|NCT00716456|Adenocarcinoma|adenocarcinoma
1516292|NCT00716456|Lung cancer|lung cancer
1516293|NCT00716443|Nasolabial folds|nasolabial folds
1516294|NCT00716443|wrinkles|wrinkles
1516295|NCT00716443|topical anesthetic|topical anesthetic
1516296|NCT00716430|acute coronary syndromes|acute coronary syndromes
1516297|NCT00716430|quality improvement|quality improvement
1516298|NCT00716404|FlowMedica|flowmedica
1516299|NCT00716404|Benephit|benephit
1516300|NCT00716404|TRT|trt
1516301|NCT00716404|Patients|patients
1516302|NCT00716404|Components|components
1516303|NCT00716404|Benephit Infusion System|benephit infusion system
1516304|NCT00716404|Planned|planned
1516305|NCT00716404|To be used|to be used
1516306|NCT00716391|Head and Neck Cancer|head and neck cancer
1516307|NCT00716378|Simulated Driving|simulated driving
1516308|NCT00716378|Risky Driving Behavior|risky driving behavior
1516309|NCT00716378|Social Influences|social influences
1516310|NCT00716365|angiography|angiography
1516311|NCT00716365|hemostasis|hemostasis
1516312|NCT00716365|femoral artery|femoral artery
1516313|NCT00716365|duplex|duplex
1516314|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
1516315|NCT00716352|educational intervention|educational intervention
1516316|NCT00716352|evidence based practice|evidence based practice
1516317|NCT00716352|guidelines|guidelines
1516318|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
1516319|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
1516320|NCT00716326|Chronic pain|chronic pain
1516321|NCT00716326|Neuropathic pain|neuropathic pain
1516322|NCT00716326|Short-term efficacy|short-term efficacy
1516323|NCT00716326|Long-term efficacy|long-term efficacy
1516325|NCT00716300|CVD|cvd
1516326|NCT00716300|HDL kinetics|hdl kinetics
1516327|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
1516328|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
1516329|NCT00716261|Parkinson's disease|parkinson's disease
1516330|NCT00716261|Audio feedback|audio feedback
1516331|NCT00716261|postural control|postural control
1516332|NCT00716235|ADHD|adhd
1516333|NCT00716235|ASD|asd
1516334|NCT00716235|PDD|pdd
1516335|NCT00716235|DCD|dcd
1516336|NCT00716235|Executive Functions|executive functions
1516337|NCT00716196|thin prep|thin prep
1516338|NCT00716196|EUS|eus
1516339|NCT00716183|mastitis|mastitis
1516340|NCT00716183|Staphylococcus|staphylococcus
1516341|NCT00716183|Streptococcus|streptococcus
1516342|NCT00716183|lactation|lactation
1516343|NCT00716183|breastfeeding|breastfeeding
1516344|NCT00716170|Diabetes Mellitus|diabetes mellitus
1516345|NCT00716170|Glucagon|glucagon
1516346|NCT00716170|Insulin|insulin
1516347|NCT00716170|Incretin hormones|incretin hormones
1516348|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
1516349|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
1516350|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
1516351|NCT00716144|Psoriasis|psoriasis
1516352|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1516353|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
1516354|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
1516355|NCT00716131|Motor Neuron Disease|motor neuron disease
1516356|NCT00716131|Autonomic Nervous System|autonomic nervous system
1516357|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
1516358|NCT00716131|Movement Disorders|movement disorders
1516359|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
1516360|NCT00716118|Slow-Freeze|slow-freeze
1516361|NCT00716118|Egg Freezing|egg freezing
1516362|NCT00716118|Meiotic Spindle|meiotic spindle
1516363|NCT00716118|Mitochondria|mitochondria
1516364|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
1516365|NCT00716105|Infant formula|infant formula
1516366|NCT00716105|Protein metabolism|protein metabolism
1516367|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
1516368|NCT00716079|Stroke|stroke
1516369|NCT00716079|antihypertensive drugs|antihypertensive drugs
1516370|NCT00716079|blood pressure|blood pressure
1516371|NCT00716079|disability|disability
1516372|NCT00716079|clinical trial|clinical trial
1516373|NCT00716079|outcomes|outcomes
1516374|NCT00716053|emphysema|emphysema
1516375|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1516381|NCT00716040|AIDS treatment|aids treatment
1516382|NCT00716040|HAART adherence|haart adherence
1516383|NCT00716040|intervention|intervention
1516384|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
1516385|NCT00716014|siRNA|sirna
1516386|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
1516387|NCT00715988|Methadone|methadone
1516388|NCT00715988|analgesia|analgesia
1516389|NCT00715988|newborns|newborns
1516390|NCT00715988|QT prolongation|qt prolongation
1516391|NCT00715988|Young Infants|young infants
1516392|NCT00715975|clobetasol|clobetasol
1516393|NCT00715975|halobetasol|halobetasol
1516394|NCT00715975|psoriasis|psoriasis
1516395|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
1516396|NCT00715962|Hospitalization|hospitalization
1516397|NCT00715962|Aged|aged
1516398|NCT00715949|traumatic brain injury|traumatic brain injury
1516399|NCT00715949|pediatric|pediatric
1516400|NCT00715949|neurocognitive|neurocognitive
1516401|NCT00715949|concussion|concussion
1516402|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
1516403|NCT00715936|Psychosocial stimulation|psychosocial stimulation
1516404|NCT00715936|Care for child development|care for child development
1516405|NCT00715923|informed consent document|informed consent document
1516406|NCT00715923|ethics|ethics
1516407|NCT00715910|Meningococcal vaccine|meningococcal vaccine
1516408|NCT00715910|Booster vaccination|booster vaccination
1516409|NCT00715910|Immunogenicity|immunogenicity
1516410|NCT00715910|Meningococcal disease|meningococcal disease
1516411|NCT00715910|Safety|safety
1516412|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
1516413|NCT00715884|Atherosclerosis|atherosclerosis
1516414|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
1516415|NCT00715871|smoking|smoking
1516416|NCT00715871|smoke cessation|smoke cessation
1516417|NCT00715871|stop smoking|stop smoking
1516418|NCT00715871|quit smoking|quit smoking
1516419|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
1516420|NCT00715871|Smoke Break|smoke break
1516421|NCT00715871|liquid cigarette|liquid cigarette
1516422|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
1516423|NCT00715858|Alzheimer's disease|alzheimer's disease
1516424|NCT00715858|dementia|dementia
1516425|NCT00715858|inflammation|inflammation
1516426|NCT00715858|cytokine|cytokine
1516427|NCT00715858|biomarker|biomarker
1516428|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
1516429|NCT00715858|serum|serum
1516430|NCT00715858|doxycycline|doxycycline
1516431|NCT00715858|rifampin|rifampin
1516432|NCT00715845|cardiovascular disease|cardiovascular disease
1516433|NCT00715845|embolism|embolism
1516434|NCT00715845|microemboli|microemboli
1516435|NCT00715845|cognitive decline|cognitive decline
1516436|NCT00715845|mitral valve repair|mitral valve repair
1516437|NCT00715845|cerebral microemboli|cerebral microemboli
1516438|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
1516439|NCT00715845|CABG|cabg
1516440|NCT00715845|transcranial doppler|transcranial doppler
1516441|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
1516442|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
1516443|NCT00715845|carbon dioxide|carbon dioxide
1516444|NCT00715832|Breast cancer|breast cancer
1516445|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
1516446|NCT00715832|OFA/iLRP|ofa/ilrp
1516447|NCT00715832|Patients|patients
1516448|NCT00715832|Line|line
1516449|NCT00715832|Chemotherapy|chemotherapy
1516450|NCT00715832|Setting|setting
1516451|NCT00715832|Four different lines|four different lines
1516452|NCT00715806|claustrophobia|claustrophobia
1516453|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
1516455|NCT00715806|anxiety|anxiety
1516456|NCT00715806|open design|open design
1516457|NCT00715806|severely anxious patients|severely anxious patients
1516458|NCT00715793|Decitabine|decitabine
1516459|NCT00715793|Temozolomide|temozolomide
1516460|NCT00715793|Metastatic|metastatic
1516461|NCT00715793|Melanoma|melanoma
1516462|NCT00715793|Non-resectable|non-resectable
1516463|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
1516464|NCT00715793|stage IV melanoma|stage iv melanoma
1516465|NCT00715793|TMZ|tmz
1516466|NCT00715793|DTIC|dtic
1516467|NCT00715793|promoter methylation|promoter methylation
1516468|NCT00715793|skin cancer|skin cancer
1516469|NCT00715793|chemotherapy|chemotherapy
1516470|NCT00715767|BLS training|bls training
1516471|NCT00715767|CPR|cpr
1516472|NCT00715767|post graduate education|post graduate education
1516473|NCT00715767|resource-limited settings|resource-limited settings
1516474|NCT00715767|medical education|medical education
1516475|NCT00715767|CPR retention|cpr retention
1516476|NCT00715767|cultural barriers|cultural barriers
1516477|NCT00715741|atelectasis|atelectasis
1516478|NCT00715741|oxygen|oxygen
1516479|NCT00715741|saturation|saturation
1516480|NCT00715728|Plastic surgery|plastic surgery
1516481|NCT00715728|Warming|warming
1516482|NCT00715728|Core temperature|core temperature
1516483|NCT00715728|Bair Hugger|bair hugger
1516484|NCT00715728|Hot Dog heating system|hot dog heating system
1677382|NCT00088296|Placebo|placebo
1516485|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
1516486|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
1516487|NCT00715702|AZD5672|azd5672
1516488|NCT00715676|Osteoporosis|osteoporosis
1516489|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
1516490|NCT00715676|Vitamin D|vitamin d
1516491|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
1516492|NCT00715676|Bone Regeneration|bone regeneration
1516493|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
1516494|NCT00715650|Compensation and Redress|compensation and redress
1516495|NCT00715650|disability evaluation|disability evaluation
1516496|NCT00715637|AML|aml
1516497|NCT00715637|Leukemia|leukemia
1516498|NCT00715637|MDS|mds
1516499|NCT00715637|Amonafide|amonafide
1516500|NCT00715637|Cytarabine|cytarabine
1516501|NCT00715637|Daunorubicin|daunorubicin
1516502|NCT00715637|Lymphatic disorders|lymphatic disorders
1516503|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
1516504|NCT00715611|pemetrexed|pemetrexed
1516505|NCT00715611|cisplatin|cisplatin
1516506|NCT00715611|IMRT|imrt
1516507|NCT00715611|PLEURA|pleura
1516508|NCT00715611|Malignant|malignant
1516509|NCT00715611|08-053|08-053
1516510|NCT00715598|Pain Assessment|pain assessment
1516511|NCT00715598|Measurement|measurement
1516512|NCT00715585|diabetes|diabetes
1516513|NCT00715585|education|education
1516514|NCT00715585|health literacy|health literacy
1516515|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
1516516|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
1516517|NCT00715559|neurotrophic|neurotrophic
1516518|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
1516519|NCT00715559|antidepressant|antidepressant
1516520|NCT00715559|cysteamine|cysteamine
1516521|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
1516522|NCT00715546|Lipodystrophy|lipodystrophy
1516523|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
1516524|NCT00715533|stroke|stroke
1516525|NCT00715533|TIA|tia
1516526|NCT00715533|MRI|mri
1516527|NCT00715533|imaging|imaging
1516528|NCT00715533|acute|acute
1516529|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1516530|NCT00715520|Rehabilitation|rehabilitation
1516531|NCT00715520|Stroke|stroke
1516532|NCT00715520|Plasticity|plasticity
1516533|NCT00715507|decision making|decision making
1516534|NCT00715507|graphic display|graphic display
1516535|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
1516536|NCT00715481|Type 2 diabetes|type 2 diabetes
1516537|NCT00715481|Cardiovascular disease|cardiovascular disease
1516538|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
1516539|NCT00715481|Glomerular filtration rate|glomerular filtration rate
1516540|NCT00715481|Albuminuria|albuminuria
1516541|NCT00715455|CAD|cad
1516542|NCT00715455|PCI|pci
1516543|NCT00715455|ANTICOAGULANT|anticoagulant
1516544|NCT00715442|Kidney|kidney
1516545|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
1516546|NCT00715442|RCC|rcc
1516547|NCT00715442|Sutent|sutent
1516548|NCT00715442|Sunitinib malate|sunitinib malate
1516549|NCT00715442|Clear cell|clear cell
1516550|NCT00715442|SU011248|su011248
1516551|NCT00715442|Nephrectomy|nephrectomy
1516552|NCT00715442|Surgical removal of kidney|surgical removal of kidney
1516553|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
1516554|NCT00715429|leg cramps|leg cramps
1516555|NCT00715429|vitamin D deficiency|vitamin d deficiency
1516556|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
1516557|NCT00715416|Intermittent Claudication|intermittent claudication
1516558|NCT00715416|Angioplasty|angioplasty
1516559|NCT00715390|Children|children
1516560|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
1516561|NCT00715390|General Anesthesia|general anesthesia
1516562|NCT00715377|benztropine|benztropine
1516563|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
1516564|NCT00715377|antipsychotics|antipsychotics
1516565|NCT00715377|elderly population|elderly population
1516566|NCT00715377|side-effects|side-effects
1516567|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
1516568|NCT00715338|elective surgery|elective surgery
1516569|NCT00715338|mechanical ventilation|mechanical ventilation
1516570|NCT00715338|Isofurans|isofurans
1516571|NCT00715338|thrombomodulin|thrombomodulin
1516572|NCT00715338|requiring|requiring
1516573|NCT00715338|mechanical|mechanical
1516574|NCT00715338|ventilation|ventilation
1516575|NCT00715325|colonoscopy|colonoscopy
1516576|NCT00715325|disposable|disposable
1516577|NCT00715325|single use|single use
1516578|NCT00715312|Inflammation|inflammation
1516579|NCT00715312|LDL|ldl
1516580|NCT00715312|Oleic acid|oleic acid
1516581|NCT00715312|Palmitic acid|palmitic acid
1516582|NCT00715312|trans fatty acid|trans fatty acid
1516583|NCT00715312|C-reactive protein|c-reactive protein
1516584|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
1677546|NCT00005805|fatigue|fatigue
1516585|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1516586|NCT00715286|randomized study|randomized study
1516587|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
1516588|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
1516589|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
1516590|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
1516591|NCT00715247|Hematological Malignancies|hematological malignancies
1516592|NCT00715247|Polycythemia Vera|polycythemia vera
1516593|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
1516594|NCT00715247|Myelofibrosis|myelofibrosis
1516595|NCT00715247|Genetics|genetics
1516596|NCT00715247|Chronic Leukemia|chronic leukemia
1516597|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
1516598|NCT00715234|adolescent vaccines|adolescent vaccines
1516599|NCT00715234|Tdap|tdap
1516600|NCT00715234|Meningococcal|meningococcal
1516601|NCT00715234|HPV|hpv
1516602|NCT00715234|Reminder cards|reminder cards
1516603|NCT00715234|Recall messages|recall messages
1516604|NCT00715234|vaccine|vaccine
1516605|NCT00715234|conjugate|conjugate
1516606|NCT00715221|Diabetes|diabetes
1516607|NCT00715195|Cognitive behavioral|cognitive behavioral
1516608|NCT00715195|Long-term study|long-term study
1516609|NCT00715195|Education|education
1516610|NCT00715182|Renal Cell Cancer|renal cell cancer
1516611|NCT00715156|allergy, peach, birch|allergy, peach, birch
1516612|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
1516613|NCT00715156|OAS|oas
1516614|NCT00715156|LTP|ltp
1516615|NCT00715156|systemic reactions|systemic reactions
1516616|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
1516617|NCT00715143|hip|hip
1516618|NCT00715143|replacement|replacement
1516619|NCT00715143|ceramic|ceramic
1516620|NCT00715143|orthopaedic|orthopaedic
1516621|NCT00715143|joint|joint
1516622|NCT00715143|degenerative|degenerative
1516623|NCT00715143|non-inflammatory|non-inflammatory
1516624|NCT00715143|osteoarthritis|osteoarthritis
1516625|NCT00715143|avascular necrosis|avascular necrosis
1516626|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
1516627|NCT00715143|traumatic arthritis|traumatic arthritis
1516628|NCT00715130|Energy|energy
1516629|NCT00715130|Obesity|obesity
1516630|NCT00715130|Energy Balance|energy balance
1516631|NCT00715130|Physical Activity|physical activity
1516632|NCT00715130|Dietary Intake|dietary intake
1516633|NCT00715130|Overweight|overweight
1516634|NCT00715130|Sedentary|sedentary
1516635|NCT00715130|Worksite|worksite
1516636|NCT00715130|Body Mass Index|body mass index
1516637|NCT00715130|Weight Maintenance|weight maintenance
1516638|NCT00715117|children|children
1516639|NCT00715117|pediatric|pediatric
1516640|NCT00715117|Crohn's Disease|crohn's disease
1516641|NCT00715117|naltrexone|naltrexone
1516642|NCT00715117|LDN|ldn
1516643|NCT00715117|IBD|ibd
1516644|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
1516645|NCT00715091|NSAIDS|nsaids
1516646|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
1516647|NCT00715091|SpA|spa
1516648|NCT00715091|Spondyloarthritis|spondyloarthritis
1516649|NCT00715091|radiographic changes|radiographic changes
1516650|NCT00715078|prostate cancer|prostate cancer
1516651|NCT00715078|prostate|prostate
1516652|NCT00715078|immune therapy|immune therapy
1516653|NCT00715078|immunotherapy|immunotherapy
1516654|NCT00715078|vaccine|vaccine
1516655|NCT00715078|dendritic cells|dendritic cells
1516656|NCT00715078|antigen-presenting cells|antigen-presenting cells
1516657|NCT00715078|antigen presenting cells|antigen presenting cells
1516658|NCT00715078|cancer vaccine|cancer vaccine
1516659|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
1516660|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
1516661|NCT00715065|syncope|syncope
1516662|NCT00715065|faint|faint
1516663|NCT00715065|blood|blood
1516664|NCT00715065|blood injury phobia|blood injury phobia
1516665|NCT00715065|phobia|phobia
1516666|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
1516667|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
1516668|NCT00715039|onset of efficacy|onset of efficacy
1516669|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
1516670|NCT00715039|Methods|methods
1516671|NCT00715026|Arthritis|arthritis
1516672|NCT00715026|Total Hip|total hip
1516673|NCT00715026|Ceramic|ceramic
1516674|NCT00715026|Hip Replacement|hip replacement
1516675|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
1516676|NCT00715026|Joint Disease|joint disease
1516677|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
1516678|NCT00715000|Preterm babies hydration|preterm babies hydration
1516679|NCT00715000|Oral rehydration solution|oral rehydration solution
1516680|NCT00715000|Continuous gastric drip|continuous gastric drip
1516681|NCT00715000|Fluid therapy|fluid therapy
1516682|NCT00715000|Premature babies comfort|premature babies comfort
1516683|NCT00715000|Infant care|infant care
1567716|NCT00508417|Clinical Malaria|clinical malaria
1516684|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
1516685|NCT00714987|ARDS|ards
1516686|NCT00714987|Mechanical ventilation|mechanical ventilation
1516687|NCT00714987|PEEP with low level|peep with low level
1516688|NCT00714987|PEEP with high level|peep with high level
1516689|NCT00714987|EVLW|evlw
1516690|NCT00714987|Picco® system|picco® system
1516691|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
1516692|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
1516693|NCT00714974|Bispectral analysis|bispectral analysis
1516694|NCT00714948|Bladder|bladder
1516695|NCT00714948|Urinary|urinary
1516696|NCT00714948|SORAFENIB|sorafenib
1516697|NCT00714948|CISPLATIN|cisplatin
1516698|NCT00714948|GEMCITABINE|gemcitabine
1516699|NCT00714935|Risk Factors|risk factors
1516700|NCT00714935|Risk Reduction Behavior|risk reduction behavior
1516701|NCT00714935|Counseling|counseling
1516702|NCT00714909|Breast cancer|breast cancer
1516703|NCT00714909|Catheter related thrombosis|catheter related thrombosis
1516704|NCT00714909|Diagnosis|diagnosis
1516705|NCT00714909|Echography doppler|echography doppler
1516706|NCT00714909|Risk factors|risk factors
1516707|NCT00714896|smoking cessation|smoking cessation
1516708|NCT00714896|nicotine dependence|nicotine dependence
1516709|NCT00714896|stage-based intervention|stage-based intervention
1516710|NCT00714896|nicotine replacement medications|nicotine replacement medications
1516711|NCT00714896|counseling|counseling
1516712|NCT00714896|substance abuse treatment|substance abuse treatment
1516713|NCT00714883|drug-eluting stents|drug-eluting stents
1516714|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1516716|NCT00714870|Quality of life|quality of life
1516717|NCT00714857|ICU patients|icu patients
1516718|NCT00714857|Dexmedetomidine|dexmedetomidine
1516719|NCT00714857|Sedation|sedation
1516720|NCT00714857|Judged|judged
1516721|NCT00714857|Attending|attending
1516722|NCT00714857|Physician|physician
1516723|NCT00714844|insulin therapy|insulin therapy
1516724|NCT00714844|insulin detemir|insulin detemir
1516725|NCT00714844|waist circumference|waist circumference
1516726|NCT00714831|Physical activity promotion|physical activity promotion
1516727|NCT00714831|Primary health care|primary health care
1516728|NCT00714831|Adherence|adherence
1516729|NCT00714818|Schizophrenia|schizophrenia
1516730|NCT00714818|Bipolar Disorder|bipolar disorder
1516731|NCT00714818|Schizoaffective disorder|schizoaffective disorder
1516732|NCT00714818|Genetic Counseling|genetic counseling
1516733|NCT00714818|Risk perception|risk perception
1516734|NCT00714818|Stigma|stigma
1516735|NCT00714818|Control|control
1516736|NCT00714818|Knowledge|knowledge
1516737|NCT00714818|family members|family members
1516738|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
1516739|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
1516740|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
1516741|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1516742|NCT00714805|Gastric Motility|gastric motility
1516743|NCT00714805|Autonomic Nervous System|autonomic nervous system
1516744|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
1516745|NCT00714805|Movement Disorders|movement disorders
1516746|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
1516747|NCT00714779|Major depressive Disorder|major depressive disorder
1516748|NCT00714779|fluoxetine|fluoxetine
1516749|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
1516750|NCT00714779|PET|pet
1516751|NCT00714753|stage I prostate cancer|stage i prostate cancer
1516752|NCT00714753|stage II prostate cancer|stage ii prostate cancer
1516753|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1516754|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
1516755|NCT00714727|migraine|migraine
1516756|NCT00714727|headache|headache
1516757|NCT00714727|acupuncture|acupuncture
1516758|NCT00714714|acne|acne
1516759|NCT00714714|irritation|irritation
1516760|NCT00714714|objective sensory methods|objective sensory methods
1516761|NCT00714688|Adult|adult
1516762|NCT00714688|ADHD|adhd
1516763|NCT00714688|Concerta|concerta
1516764|NCT00714675|citrulline|citrulline
1516765|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
1516766|NCT00714675|aged|aged
1516767|NCT00714675|protein biosynthesis|protein biosynthesis
1516768|NCT00714675|amino acid|amino acid
1516769|NCT00714662|high flux hemodialysis|high flux hemodialysis
1516770|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
1516771|NCT00714649|and/or radiotherapy|and/or radiotherapy
1516772|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1516773|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
1516774|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
1516775|NCT00714636|Motor Neuron Disease|motor neuron disease
1516776|NCT00714636|Autonomic Nervous System|autonomic nervous system
1516777|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
1516778|NCT00714636|Movement Disorders|movement disorders
1516779|NCT00714623|Coronary Artery Disease|coronary artery disease
1516780|NCT00714623|Coronary Restenosis|coronary restenosis
1516781|NCT00714623|Coronary Thrombosis|coronary thrombosis
1516782|NCT00714623|Drug-Eluting Stents|drug-eluting stents
1516783|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1516784|NCT00714610|Serum metal ion concentration|serum metal ion concentration
1516785|NCT00714597|Venous thrombosis|venous thrombosis
1516786|NCT00714597|Primary prevention|primary prevention
1516787|NCT00714584|Infusions, Intravenous|infusions, intravenous
1516788|NCT00714584|Safety|safety
1516789|NCT00714584|Pharmacokinetics|pharmacokinetics
1516790|NCT00714584|Naltrexone|naltrexone
1516791|NCT00714584|Administration, Oral|administration, oral
1516792|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
1516793|NCT00714571|explicit memory training|explicit memory training
1516794|NCT00714571|mild cognitive impairment|mild cognitive impairment
1516795|NCT00714571|Alzheimer's disease|alzheimer's disease
1516796|NCT00714571|traumatic brain injury|traumatic brain injury
1516797|NCT00714571|veterans|veterans
1516798|NCT00714558|Pharmacokinetics|pharmacokinetics
1516799|NCT00714558|Administration, Oral|administration, oral
1516800|NCT00714558|Naltrexone|naltrexone
1516801|NCT00714558|Biological Availability|biological availability
1516802|NCT00714558|Infusions, Intravenous|infusions, intravenous
1516803|NCT00714558|Fentanyl|fentanyl
1516804|NCT00714558|Safety|safety
1516805|NCT00714558|Naloxone|naloxone
1516806|NCT00714545|Coronary Artery Disease|coronary artery disease
1516807|NCT00714545|Coronary Restenosis|coronary restenosis
1516808|NCT00714545|Brachytherapy|brachytherapy
1516809|NCT00714532|smoking cessation|smoking cessation
1516810|NCT00714532|Asian American|asian american
1516811|NCT00714532|Chinese American|chinese american
1516812|NCT00714532|smoking reduction|smoking reduction
1516813|NCT00714532|stage-based intervention|stage-based intervention
1516814|NCT00714532|expert system|expert system
1516815|NCT00714532|nicotine replacement|nicotine replacement
1516816|NCT00714532|counseling|counseling
1516817|NCT00714519|Xenaderm|xenaderm
1516818|NCT00714519|partial|partial
1516819|NCT00714519|thickness|thickness
1516820|NCT00714519|wounds|wounds
1516821|NCT00714519|Nursing Homes|nursing homes
1516822|NCT00714506|obesity|obesity
1516823|NCT00714506|physical activity|physical activity
1516824|NCT00714506|older adults|older adults
1516825|NCT00714506|functional disability|functional disability
1516826|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
1516827|NCT00714493|remicade|remicade
1516828|NCT00714493|infliximab|infliximab
1516829|NCT00714493|Centocor|centocor
1516830|NCT00714493|etanercept|etanercept
1516831|NCT00714493|enbrel|enbrel
1516832|NCT00714493|adalimumab|adalimumab
1516833|NCT00714493|humira|humira
1516834|NCT00714493|restart|restart
1516835|NCT00714493|swollen joints|swollen joints
1516836|NCT00714493|tender joints.|tender joints.
1516837|NCT00714480|Thymoglobulin|thymoglobulin
1516838|NCT00714480|Renal Transplant|renal transplant
1516839|NCT00714480|Kidney Transplant|kidney transplant
1516840|NCT00714480|Immunosuppression|immunosuppression
1516841|NCT00714480|Induction therapy|induction therapy
1516842|NCT00714467|smoking cessation|smoking cessation
1516843|NCT00714467|Asian|asian
1516844|NCT00714467|Chinese American|chinese american
1516845|NCT00714467|family support|family support
1516846|NCT00714467|social support|social support
1516847|NCT00714467|stage-based intervention|stage-based intervention
1516848|NCT00714441|Diabetes Type 2|diabetes type 2
1516849|NCT00714441|Distress|distress
1516850|NCT00714441|Problem Solving Therapy|problem solving therapy
1516851|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
1516852|NCT00714428|Traumatic Brain Injury|traumatic brain injury
1516853|NCT00714428|Quality of Life|quality of life
1516854|NCT00714402|UTI|uti
1516855|NCT00714389|Urogynecology|urogynecology
1516856|NCT00714376|Prostate cancer|prostate cancer
1516857|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
1516858|NCT00714376|Radical prostatectomy|radical prostatectomy
1516859|NCT00714376|Early rising PSA|early rising psa
1516860|NCT00714376|Taxotere|taxotere
1516861|NCT00714376|Docetaxel|docetaxel
1516862|NCT00714350|Information Display|information display
1516863|NCT00714350|situational awareness|situational awareness
1516864|NCT00714350|Create intuitive visualization|create intuitive visualization
1516865|NCT00714337|Formulation|formulation
1516866|NCT00714337|pharmacokinetics|pharmacokinetics
1516867|NCT00714324|Nutrition|nutrition
1516868|NCT00714324|Screening|screening
1516869|NCT00714311|borderline personality disorder|borderline personality disorder
1516870|NCT00714311|randomized controlled trial|randomized controlled trial
1516871|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
1516872|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
1516873|NCT00714298|biological markers|biological markers
1516874|NCT00714298|emergency service hospital|emergency service hospital
1516875|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
1516876|NCT00714298|ischemia modified albumin|ischemia modified albumin
1516877|NCT00714285|Primary study|primary study
1516878|NCT00714285|immunogenicity|immunogenicity
1516879|NCT00714285|safety|safety
1516880|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
1516881|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
1516882|NCT00714259|allogeneic|allogeneic
1516883|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
1516884|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
1516885|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
1516886|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
1516887|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1516888|NCT00714220|Gastric Motility|gastric motility
1516889|NCT00714220|Autonomic Nervous System|autonomic nervous system
1516890|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
1516891|NCT00714220|Movement Disorders|movement disorders
1516892|NCT00714220|Substrate Utilization|substrate utilization
1516893|NCT00714207|adolescents|adolescents
1516894|NCT00714207|smoking|smoking
1516895|NCT00714207|smoking cessation|smoking cessation
1516896|NCT00714207|tobacco use|tobacco use
1516897|NCT00714194|sedation|sedation
1516898|NCT00714194|delirium|delirium
1516899|NCT00714194|sleep|sleep
1516900|NCT00714194|sedation withdrawal|sedation withdrawal
1516901|NCT00714194|ICU patients|icu patients
1516902|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1516903|NCT00714168|Weight Loss|weight loss
1516904|NCT00714168|Weight Control|weight control
1516905|NCT00714155|Colpocleisis|colpocleisis
1516906|NCT00714142|Renal blood flow|renal blood flow
1516907|NCT00714142|PET imaging|pet imaging
1516908|NCT00714129|Steatosis|steatosis
1516909|NCT00714129|Diabetes|diabetes
1516910|NCT00714116|safety|safety
1516911|NCT00714116|pharmacokinetics|pharmacokinetics
1516912|NCT00714103|Leukemia|leukemia
1516913|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1516914|NCT00714103|CLL|cll
1516915|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
1516916|NCT00714103|purine analogues|purine analogues
1516917|NCT00714103|Cancer|cancer
1516918|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
1516919|NCT00714090|Major depressive disorders|major depressive disorders
1516920|NCT00714090|Depression|depression
1516921|NCT00714090|Venlafaxine|venlafaxine
1516922|NCT00714077|rectal cancer|rectal cancer
1516923|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
1516924|NCT00714077|adjuvant therapy|adjuvant therapy
1516925|NCT00714077|phase III study|phase iii study
1516926|NCT00714038|Quality development project|quality development project
1516927|NCT00714038|primary care nurses|primary care nurses
1516928|NCT00714038|asthma|asthma
1516929|NCT00714038|patient compliance|patient compliance
1516930|NCT00714038|follow-up|follow-up
1516931|NCT00714025|RAD001|rad001
1516932|NCT00714025|TCC|tcc
1516933|NCT00714025|Palliative treatment|palliative treatment
1516934|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
1516935|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
1516936|NCT00714012|Display development|display development
1516937|NCT00714012|Intuitive display use|intuitive display use
1516938|NCT00714012|visualizations are intuitive|visualizations are intuitive
1516939|NCT00713999|Sexually transmitted infections|sexually transmitted infections
1516940|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
1516941|NCT00713999|Schistosoma haematobium|schistosoma haematobium
1516942|NCT00713999|Reproductive health|reproductive health
1516943|NCT00713999|Pelvic examination|pelvic examination
1516944|NCT00713999|Ultrasonography|ultrasonography
1516945|NCT00713999|Questionnaire|questionnaire
1516946|NCT00713999|Madagascar|madagascar
1516947|NCT00713986|Pain|pain
1516948|NCT00713986|Newborn Infant|newborn infant
1516949|NCT00713986|Analgesia|analgesia
1516950|NCT00713960|Quality development project|quality development project
1516951|NCT00713960|primary care nurses|primary care nurses
1516952|NCT00713960|cardiovascular disease|cardiovascular disease
1516953|NCT00713960|secondary prevention|secondary prevention
1516954|NCT00713960|follow-up|follow-up
1516955|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
1516956|NCT00713947|Helicobacter pylori|helicobacter pylori
1516957|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
1516958|NCT00713934|Cirrhosis|cirrhosis
1516959|NCT00713921|Female|female
1516960|NCT00713921|Diabetics|diabetics
1516961|NCT00713921|Stroke|stroke
1516962|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
1516963|NCT00713895|smoking cessation|smoking cessation
1516964|NCT00713895|randomized trial|randomized trial
1516965|NCT00713895|Asian|asian
1516966|NCT00713895|Chinese American|chinese american
1516967|NCT00713895|stages of change|stages of change
1516968|NCT00713882|Survivors|survivors
1516969|NCT00713882|Quality of Life|quality of life
1516970|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
1516971|NCT00713869|Slow freeze|slow freeze
1516972|NCT00713843|Neck Pain|neck pain
1516973|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
1516974|NCT00713843|Physiotherapy|physiotherapy
1516975|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
1516976|NCT00713817|Pain|pain
1516977|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
1516978|NCT00713804|Schizophrenia|schizophrenia
1516979|NCT00713804|Bipolar Disorder|bipolar disorder
1516980|NCT00713804|Schizoaffective disorder|schizoaffective disorder
1516981|NCT00713804|Genetic Counseling|genetic counseling
1516982|NCT00713804|Risk perception|risk perception
1516983|NCT00713804|Stigma|stigma
1516984|NCT00713804|Control|control
1516985|NCT00713804|Knowledge|knowledge
1516986|NCT00713791|Healthy Volunteers|healthy volunteers
1516987|NCT00713791|ZD4054|zd4054
1516988|NCT00713778|Ovarian Cysts|ovarian cysts
1516989|NCT00713778|Electrocoagulation|electrocoagulation
1516990|NCT00713778|Ovarian Function Tests|ovarian function tests
1516991|NCT00713778|Laparoscopy|laparoscopy
1516992|NCT00713765|Healthy volunteers|healthy volunteers
1516993|NCT00713752|HIV-negative|hiv-negative
1516994|NCT00713739|kidney stones|kidney stones
1516995|NCT00713739|ureteral stones|ureteral stones
1516996|NCT00713739|medical expulsion therapy|medical expulsion therapy
1516997|NCT00713726|Pain|pain
1516998|NCT00713726|Analgesia|analgesia
1516999|NCT00713726|Newborn Infant|newborn infant
1517000|NCT00713726|Opioids|opioids
1517001|NCT00713726|Side-effects|side-effects
1517002|NCT00713726|Intensive care|intensive care
1517003|NCT00713726|Postoperative|postoperative
1517004|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1517005|NCT00713713|Tidal volume|tidal volume
1517006|NCT00713713|cardiac output|cardiac output
1517007|NCT00713713|Respiration, Artificial|respiration, artificial
1517008|NCT00713713|Protective ventilation|protective ventilation
1517009|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
1517010|NCT00713700|PDA|pda
1517011|NCT00713687|photodynamic therapy|photodynamic therapy
1517012|NCT00713687|PDT|pdt
1517013|NCT00713687|gemcitabine|gemcitabine
1517014|NCT00713687|oxaliplatin|oxaliplatin
1517015|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
1517016|NCT00713674|Methicillin resistance|methicillin resistance
1517017|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
1517018|NCT00713661|Colorectal Resection|colorectal resection
1517019|NCT00713661|Tachosil|tachosil
1517020|NCT00713635|Congenital Heart Disease|congenital heart disease
1517021|NCT00713622|Partial|partial
1517022|NCT00713622|onset|onset
1517023|NCT00713622|seizures|seizures
1517024|NCT00713609|Acne|acne
1517025|NCT00713609|Acne Vulgaris|acne vulgaris
1517026|NCT00713609|Pimples|pimples
1517027|NCT00713596|Nasal Surgery|nasal surgery
1517028|NCT00713596|Septorhinoplasty|septorhinoplasty
1517029|NCT00713596|fibrin glue|fibrin glue
1517030|NCT00713596|fibrinogen|fibrinogen
1517031|NCT00713596|Swelling|swelling
1517032|NCT00713596|fibrin|fibrin
1517033|NCT00713596|tisseel|tisseel
1517034|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
1517035|NCT00713570|intellectual functioning|intellectual functioning
1517036|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
1517037|NCT00713570|cognitive abilities|cognitive abilities
1517038|NCT00713570|COMT|comt
1517039|NCT00713570|BDNF|bdnf
1517040|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
1517041|NCT00713570|Chinese|chinese
1517042|NCT00713570|Taiwan|taiwan
1517043|NCT00713570|Healthy subjects|healthy subjects
1517044|NCT00713557|coronary angioplasty|coronary angioplasty
1517045|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
1517046|NCT00713544|RA|ra
1517047|NCT00713544|AZD5672|azd5672
1517048|NCT00713531|HIV-negative|hiv-negative
1517049|NCT00713531|male and female clients|male and female clients
1517050|NCT00713531|ages 18-50 years|ages 18-50 years
1517051|NCT00713531|seeking HIV counseling|seeking hiv counseling
1517052|NCT00713531|testing at TRCARC|testing at trcarc
1517053|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
1517054|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1517055|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1517056|NCT00713505|cancer survivor|cancer survivor
1517057|NCT00713505|cognitive/functional effects|cognitive/functional effects
1517058|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1517059|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1517060|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
1517061|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
1517188|NCT00712998|reactive oxygen species|reactive oxygen species
1517062|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
1517063|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
1517064|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1517065|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1517170|NCT00713063|exercise|exercise
1517074|NCT00713479|Chantix|chantix
1517075|NCT00713479|stimulant|stimulant
1517076|NCT00713479|crystal meth|crystal meth
1517077|NCT00713466|CLIPP cases|clipp cases
1517078|NCT00713466|Pediatric clerkship|pediatric clerkship
1517079|NCT00713466|Standardizing|standardizing
1517080|NCT00713466|Students' exposure|students' exposure
1517081|NCT00713466|Essential|essential
1517082|NCT00713466|Enhancing|enhancing
1517083|NCT00713466|Experience|experience
1517084|NCT00713453|Pompe disease|pompe disease
1517085|NCT00713453|muscle|muscle
1517086|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
1517087|NCT00713440|Incretin Effect|incretin effect
1517088|NCT00713440|Steroids|steroids
1517089|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
1517090|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
1517091|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
1517092|NCT00713440|Insulin|insulin
1517093|NCT00713440|C-peptide|c-peptide
1517094|NCT00713440|Glucagon|glucagon
1517095|NCT00713427|Biliary|biliary
1517096|NCT00713427|Strictures|strictures
1517097|NCT00713427|Malignant|malignant
1517098|NCT00713427|Neoplasm|neoplasm
1517099|NCT00713427|Palliation|palliation
1517100|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
1517101|NCT00713414|Dystonia|dystonia
1517102|NCT00713414|Basal Ganglia|basal ganglia
1517103|NCT00713414|PET Imaging|pet imaging
1517104|NCT00713414|fMRI|fmri
1517105|NCT00713414|Voice Disorder|voice disorder
1517106|NCT00713414|Healthy Volunteer|healthy volunteer
1517108|NCT00713375|Autonomic Nervous System|autonomic nervous system
1517109|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1517110|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
1517111|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
1517112|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
1517113|NCT00713349|White|white
1517114|NCT00713349|Petrolatum|petrolatum
1517115|NCT00713349|Xenaderm|xenaderm
1517116|NCT00713349|Vehicle|vehicle
1517117|NCT00713349|Partial thickness wounds|partial thickness wounds
1517118|NCT00713349|Healing|healing
1517119|NCT00713349|Cryo-surgery|cryo-surgery
1517120|NCT00713336|ZD4054|zd4054
1517121|NCT00713336|Healthy Volunteers|healthy volunteers
1517122|NCT00713336|QT interval|qt interval
1517123|NCT00713323|Pain|pain
1517124|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
1517125|NCT00713297|medication errors|medication errors
1517126|NCT00713297|computerized physician order entry|computerized physician order entry
1517127|NCT00713297|pharmaceutical care|pharmaceutical care
1517128|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
1517129|NCT00713297|reengineering|reengineering
1517130|NCT00713284|Kidney transplantation|kidney transplantation
1517131|NCT00713284|Sirolimus|sirolimus
1517132|NCT00713284|Immunosuppression|immunosuppression
1517133|NCT00713284|Tacrolimus|tacrolimus
1517134|NCT00713271|Healthy male|healthy male
1517135|NCT00713271|tolerability|tolerability
1517136|NCT00713271|safety|safety
1517137|NCT00713271|inhalation|inhalation
1517138|NCT00713258|Postmenopausal women|postmenopausal women
1517139|NCT00713258|Back pain|back pain
1517140|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
1517141|NCT00713245|Pompe disease|pompe disease
1517142|NCT00713245|late onset|late onset
1517143|NCT00713232|naming test|naming test
1517144|NCT00713219|IMRT|imrt
1517145|NCT00713219|cetuximab|cetuximab
1517146|NCT00713219|docetaxel|docetaxel
1517147|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
1517148|NCT00713193|Idiopathic TTP|idiopathic ttp
1517149|NCT00713193|Treatment|treatment
1517150|NCT00713193|Exacerbation|exacerbation
1517151|NCT00713193|Relapse|relapse
1517152|NCT00713193|Plasma Exchange|plasma exchange
1517153|NCT00713167|Grape Seed Extract|grape seed extract
1517154|NCT00713167|Hyperlipidemia|hyperlipidemia
1517155|NCT00713154|Radiotherapy|radiotherapy
1517156|NCT00713154|induced|induced
1517157|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
1517158|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
1517159|NCT00713102|in-flight emergency|in-flight emergency
1517160|NCT00713089|Eczema|eczema
1517161|NCT00713089|Asthma|asthma
1517162|NCT00713089|Allergic rhinitis|allergic rhinitis
1517163|NCT00713089|Singapore|singapore
1517164|NCT00713089|Indonesia|indonesia
1517165|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
1517166|NCT00713076|multi-purpose solution|multi-purpose solution
1517167|NCT00713076|contact lens wearers|contact lens wearers
1517168|NCT00713076|Contact lense wearers|contact lense wearers
1517169|NCT00713063|smoking cessation|smoking cessation
1517171|NCT00713063|physical activity|physical activity
1517172|NCT00713063|health education|health education
1517173|NCT00713050|stroke|stroke
1517174|NCT00713050|aphasia|aphasia
1517175|NCT00713050|imitation|imitation
1517176|NCT00713050|mirror neuron|mirror neuron
1517177|NCT00713037|fluoromisonidazole|fluoromisonidazole
1517178|NCT00713037|PET scan|pet scan
1517179|NCT00713037|Hypoxia-PET|hypoxia-pet
1517180|NCT00713037|IMPT|impt
1517181|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
1517182|NCT00713011|Adalat XL|adalat xl
1517183|NCT00713011|Diltiazem|diltiazem
1517184|NCT00713011|Tiazac XC|tiazac xc
1517185|NCT00713011|Proteinuria|proteinuria
1517186|NCT00712998|radiation injuries|radiation injuries
1517187|NCT00712998|free radicals|free radicals
1517189|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
1517190|NCT00712998|free radical production|free radical production
1517191|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
1517192|NCT00712985|Breast cancer|breast cancer
1517193|NCT00712985|aromatase inhibitors|aromatase inhibitors
1517194|NCT00712972|knee injection|knee injection
1517195|NCT00712972|parapatellar|parapatellar
1517196|NCT00712959|Pertussis|pertussis
1517197|NCT00712959|Tetanus|tetanus
1517198|NCT00712959|Diphtheria|diphtheria
1517199|NCT00712959|Acellular pertussis|acellular pertussis
1517200|NCT00712959|ADACEL®,|adacel®,
1517201|NCT00712959|Tdap vaccine|tdap vaccine
1517202|NCT00712933|SLE|sle
1517203|NCT00712933|Belimumab|belimumab
1517204|NCT00712933|Antibodies|antibodies
1517205|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
1517206|NCT00712933|Lupus|lupus
1517207|NCT00712933|Autoimmune Diseases|autoimmune diseases
1517208|NCT00712907|vitamin C|vitamin c
1517209|NCT00712907|retinal blood flow|retinal blood flow
1517210|NCT00712907|intraocular pressure|intraocular pressure
1517211|NCT00712907|retinal vessel diameter|retinal vessel diameter
1517212|NCT00712894|Acute myocardial infarction|acute myocardial infarction
1517213|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
1517214|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
1517215|NCT00712894|Vasodilator agents|vasodilator agents
1517216|NCT00712855|Liver Cancer|liver cancer
1517217|NCT00712842|Diabetes|diabetes
1517218|NCT00712842|ocular blood flow|ocular blood flow
1517219|NCT00712829|Prostate cancer|prostate cancer
1517220|NCT00712829|Imaging|imaging
1517221|NCT00712816|osteoarthritis|osteoarthritis
1517222|NCT00712816|total knee arthroplasty|total knee arthroplasty
1517223|NCT00712816|cryotherapy|cryotherapy
1517224|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
1517225|NCT00712777|Brimonidine|brimonidine
1517226|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
1517227|NCT00712777|Intraocular Pressure|intraocular pressure
1517228|NCT00712764|Adenosine|adenosine
1517229|NCT00712764|Choroidal blood flow|choroidal blood flow
1517230|NCT00712764|Suction cup|suction cup
1517231|NCT00712751|Rectum|rectum
1517232|NCT00712751|Quality of Life|quality of life
1517233|NCT00712751|Sexual Health|sexual health
1517234|NCT00712751|08-073|08-073
1517235|NCT00712738|Nifedipine|nifedipine
1517236|NCT00712738|Thalassemia|thalassemia
1517237|NCT00712738|Hemochromatosis|hemochromatosis
1517238|NCT00712738|Iron Overload|iron overload
1517239|NCT00712738|Iron Excretion|iron excretion
1517240|NCT00712712|bone metastases|bone metastases
1517241|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1517242|NCT00712712|pain|pain
1517243|NCT00712699|Preschool|preschool
1517244|NCT00712699|Children|children
1517245|NCT00712699|ADHD|adhd
1517246|NCT00712699|Medication|medication
1517247|NCT00712699|Controlled Study|controlled study
1517248|NCT00712699|Placebo|placebo
1517249|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
1517250|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
1517251|NCT00712660|prevention|prevention
1517252|NCT00712660|relapse|relapse
1517253|NCT00712660|schizophrenia|schizophrenia
1517254|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
1517255|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
1517256|NCT00712621|breast cancer|breast cancer
1517257|NCT00712621|breast cancer related to depression|breast cancer related to depression
1517258|NCT00712621|Condition|condition
1517259|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
1517260|NCT00712608|Term|term
1517261|NCT00712608|Infant|infant
1517262|NCT00712608|Formula|formula
1517263|NCT00712595|Uterine fibroids|uterine fibroids
1517264|NCT00712595|mifepristone|mifepristone
1517265|NCT00712595|antiprogestins|antiprogestins
1517266|NCT00712582|Non-Hodgkin|non-hodgkin
1517267|NCT00712582|Lymphoma|lymphoma
1517268|NCT00712582|Rituximab|rituximab
1517269|NCT00712582|Cyclophosphamide|cyclophosphamide
1517270|NCT00712582|Doxorubicin|doxorubicin
1517271|NCT00712582|Vincristine|vincristine
1517272|NCT00712582|ifosfamide|ifosfamide
1517273|NCT00712582|etoposide|etoposide
1517274|NCT00712582|carboplatin|carboplatin
1517275|NCT00712582|stem cell transplant|stem cell transplant
1517276|NCT00712582|08-026|08-026
1517277|NCT00712569|Communication|communication
1517278|NCT00712569|Internet|internet
1517279|NCT00712569|Physician|physician
1517280|NCT00712569|Patient|patient
1517281|NCT00712569|08-079|08-079
1517282|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1517283|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1517284|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1517285|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1517286|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1517287|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1517288|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1517289|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1517290|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1517291|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1517292|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1517293|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1517294|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1517295|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1517296|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1517297|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1517298|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1517299|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1517300|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1517301|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1517302|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1517303|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1517304|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1517305|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1517306|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1517307|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1517308|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1517309|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1517310|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1517311|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1517312|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1517313|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1517314|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1517315|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1517316|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1517317|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1517318|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1517319|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1517320|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1517321|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1517322|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1517323|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1517324|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1517325|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
1517326|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
1517327|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
1517328|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
1517329|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
1517330|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
1517331|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
1517332|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
1517333|NCT00712543|constipation|constipation
1517334|NCT00712543|laxative|laxative
1517335|NCT00712543|lactulose|lactulose
1517336|NCT00712543|Kristalose®|kristalose®
1517337|NCT00712530|HIV|hiv
1517338|NCT00712530|Vaccine|vaccine
1517339|NCT00712530|Immune Therapy|immune therapy
1517340|NCT00712530|DermaVir|dermavir
1517341|NCT00712517|postoperative pain|postoperative pain
1517342|NCT00712517|Piritramid|piritramid
1517343|NCT00712517|propofol|propofol
1517344|NCT00712517|sevoflurane|sevoflurane
1517345|NCT00712517|varicose vein|varicose vein
1517346|NCT00712517|Anesthesia|anesthesia
1517442|NCT00712166|inhaled antibiotic|inhaled antibiotic
1517443|NCT00712166|aztreonam lysine|aztreonam lysine
1517347|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
1517348|NCT00712491|wet AMD|wet amd
1517349|NCT00712491|CNV|cnv
1517350|NCT00712465|Atrial fibrillation|atrial fibrillation
1517351|NCT00712465|interaction|interaction
1517352|NCT00712465|pharmacokinetic|pharmacokinetic
1517353|NCT00712452|fertility|fertility
1517354|NCT00712452|chemotherapy|chemotherapy
1517355|NCT00712439|DPN,|dpn,
1517356|NCT00712439|Diabetic|diabetic
1517357|NCT00712439|Peripheral|peripheral
1517358|NCT00712439|Neuropathy|neuropathy
1517359|NCT00712439|Painful|painful
1517360|NCT00712426|Huntington's disease|huntington's disease
1517361|NCT00712426|Creatine|creatine
1517362|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
1517363|NCT00712426|Total Functional Capacity|total functional capacity
1517364|NCT00712426|UHDRS|uhdrs
1517365|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
1517366|NCT00712413|Quadruple therapy|quadruple therapy
1517367|NCT00712413|Safety|safety
1517368|NCT00712413|Efficacy|efficacy
1517369|NCT00712413|Tolerability|tolerability
1517370|NCT00712413|BID dosing|bid dosing
1517371|NCT00712400|Latanoprost|latanoprost
1517372|NCT00712400|Choroidal Blood Flow|choroidal blood flow
1517373|NCT00712400|Intraocular Pressure|intraocular pressure
1517374|NCT00712374|Malaria|malaria
1517375|NCT00712374|All causes mortality|all causes mortality
1517376|NCT00712374|Cost effectiveness|cost effectiveness
1517377|NCT00712361|Invasive|invasive
1517378|NCT00712361|Non-Invasive|non-invasive
1517379|NCT00712361|Peripheral blood parameters|peripheral blood parameters
1517380|NCT00712361|Finger mounted device|finger mounted device
1517381|NCT00712361|Blood tissue|blood tissue
1517382|NCT00712361|Tissue color distribution|tissue color distribution
1517383|NCT00712361|Accuracy|accuracy
1517384|NCT00712361|Tissue pigmentation|tissue pigmentation
1517385|NCT00712361|pH|ph
1517386|NCT00712361|Hemoglobin|hemoglobin
1517387|NCT00712361|Hematocrit|hematocrit
1517388|NCT00712361|SpO2|spo2
1517389|NCT00712361|Blood pressure|blood pressure
1517390|NCT00712361|Pulse|pulse
1517391|NCT00712361|CO2|co2
1517392|NCT00712348|Gaucher disease|gaucher disease
1517393|NCT00712348|imiglucerase|imiglucerase
1517394|NCT00712348|glucocerebrosidase|glucocerebrosidase
1517395|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
1517396|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
1517397|NCT00712335|asthmatics|asthmatics
1517398|NCT00712335|smokers|smokers
1517399|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
1517400|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
1517401|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
1517402|NCT00712309|atherosclerotic|atherosclerotic
1517403|NCT00712309|lesions|lesions
1517404|NCT00712296|Asthma|asthma
1517405|NCT00712296|alternative medicine|alternative medicine
1517406|NCT00712296|complementary medicine|complementary medicine
1517407|NCT00712296|herbal therapy|herbal therapy
1517408|NCT00712283|fitness to drive|fitness to drive
1517409|NCT00712283|operate machines|operate machines
1517410|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
1517411|NCT00712270|Schizophrenia|schizophrenia
1517412|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
1517413|NCT00712270|Risperidone|risperidone
1517414|NCT00712270|Aripiprazole|aripiprazole
1517415|NCT00712270|Fallypride|fallypride
1517416|NCT00712270|Positron emission tomography|positron emission tomography
1517417|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
1517418|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
1517419|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
1517420|NCT00712244|Discovisc|discovisc
1517421|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
1517422|NCT00712231|pseudophakic|pseudophakic
1517423|NCT00712231|anterior chamber depth|anterior chamber depth
1517424|NCT00712231|Pentacam|pentacam
1517425|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
1517426|NCT00712205|Asthma|asthma
1517427|NCT00712205|Vitamin D|vitamin d
1517428|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
1517429|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
1517430|NCT00712192|saphenous vein|saphenous vein
1517431|NCT00712192|endothelial cells|endothelial cells
1517432|NCT00712192|eNOS|enos
1517433|NCT00712192|ET-1|et-1
1517434|NCT00712179|Stroke|stroke
1517435|NCT00712179|walking|walking
1517436|NCT00712179|Treadmill|treadmill
1517437|NCT00712179|body weight support system|body weight support system
1517438|NCT00712166|cystic fibrosis|cystic fibrosis
1517439|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
1517440|NCT00712166|lung infection|lung infection
1517441|NCT00712166|CFQ-R|cfq-r
1517444|NCT00712153|multislice computed tomography|multislice computed tomography
1517445|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
1517446|NCT00712153|Patients|patients
1517447|NCT00712153|underwent|underwent
1517448|NCT00712153|surgeries|surgeries
1517449|NCT00712140|stage IA breast cancer|stage ia breast cancer
1517450|NCT00712140|stage IB breast cancer|stage ib breast cancer
1517451|NCT00712140|stage II breast cancer|stage ii breast cancer
1517452|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
1517453|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
1517454|NCT00712127|Body Fat|body fat
1517455|NCT00712127|Exercise|exercise
1517456|NCT00712127|Metabolic syndrome|metabolic syndrome
1517458|NCT00712127|Nutrition|nutrition
1517459|NCT00712127|Physical Activity|physical activity
1517460|NCT00712127|Weight Loss|weight loss
1517461|NCT00712114|phase I|phase i
1517462|NCT00712114|safety|safety
1517463|NCT00712114|tolerance|tolerance
1517464|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
1517465|NCT00712114|pharmacokinetics|pharmacokinetics
1517466|NCT00712114|methotrexate|methotrexate
1517467|NCT00712114|anti-inflammatory|anti-inflammatory
1517468|NCT00712101|infarction|infarction
1517469|NCT00712101|intervention|intervention
1517470|NCT00712101|stent|stent
1517471|NCT00712101|abciximab|abciximab
1517472|NCT00712101|platelets|platelets
1517474|NCT00712088|Unsafe Sex|unsafe sex
1517475|NCT00712088|High Risk Sex|high risk sex
1517476|NCT00712088|HIV Prevention|hiv prevention
1517477|NCT00712088|African-American|african-american
1517478|NCT00712088|gay|gay
1517479|NCT00712088|bisexual|bisexual
1517480|NCT00712088|intervention trial|intervention trial
1517481|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
1517482|NCT00712075|Social Skills Training|social skills training
1517483|NCT00712075|Experience Sampling Method|experience sampling method
1517484|NCT00712075|Computer-assisted therapy|computer-assisted therapy
1517485|NCT00712075|schizophrenia|schizophrenia
1517486|NCT00712062|PCNSL|pcnsl
1517487|NCT00712062|Pemetrexed|pemetrexed
1517488|NCT00712062|Alimta|alimta
1517489|NCT00712062|Recurrent|recurrent
1517490|NCT00712062|Progressive|progressive
1517491|NCT00712049|intima-media-thickness|intima-media-thickness
1517492|NCT00712049|dyslipidemia|dyslipidemia
1517493|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
1517494|NCT00712049|peripheral artery disease|peripheral artery disease
1517495|NCT00712049|major cardiovascular events|major cardiovascular events
1517496|NCT00712036|Heroin dependence|heroin dependence
1517497|NCT00712036|Interim Methadone Treatment|interim methadone treatment
1517498|NCT00712036|Counseling|counseling
1517499|NCT00712023|Hypothermia|hypothermia
1517500|NCT00712023|Vascular surgery|vascular surgery
1517501|NCT00712023|Forced-air warming mattress|forced-air warming mattress
1517502|NCT00712023|Circulating-water mattress|circulating-water mattress
1517503|NCT00712010|Glucose|glucose
1517504|NCT00712010|Insulin|insulin
1517505|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
1517506|NCT00711984|renal artery stenosis|renal artery stenosis
1517507|NCT00711984|stent|stent
1517508|NCT00711984|comparison of treatments|comparison of treatments
1517509|NCT00711984|progression|progression
1517510|NCT00711984|atherosclerosis|atherosclerosis
1517511|NCT00711984|peripheral artery disease|peripheral artery disease
1517512|NCT00711984|major cardiovascular events|major cardiovascular events
1517513|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
1517514|NCT00711945|Crohn's disease|crohn's disease
1517515|NCT00711945|Relapse|relapse
1517516|NCT00711945|outcomes|outcomes
1517517|NCT00711945|growth|growth
1517518|NCT00711932|Ovarian Cancer|ovarian cancer
1517519|NCT00711932|TRA-8|tra-8
1517520|NCT00711932|Monoclonal Antibody|monoclonal antibody
1517521|NCT00711932|Tissue Slice Technology|tissue slice technology
1517522|NCT00711906|Malaria|malaria
1517523|NCT00711906|Pregnancy|pregnancy
1517524|NCT00711906|HIV|hiv
1517525|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
1517526|NCT00711906|Safety|safety
1517527|NCT00711906|Efficacy|efficacy
1517528|NCT00711880|Pain|pain
1517529|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
1517530|NCT00711854|Staphylococcal infection|staphylococcal infection
1517531|NCT00711841|HELLP syndrome|hellp syndrome
1517532|NCT00711841|dexamethasone|dexamethasone
1517533|NCT00711841|postpartum period|postpartum period
1517534|NCT00711841|class I HELLP syndrome|class i hellp syndrome
1517535|NCT00711815|Women of the state of Alabama|women of the state of alabama
1517536|NCT00711815|CIN 1|cin 1
1517537|NCT00711815|negative biopsy|negative biopsy
1517538|NCT00711815|normal colposcopy|normal colposcopy
1517539|NCT00711815|HPV|hpv
1517540|NCT00711802|Complicated|complicated
1517541|NCT00711802|Skin|skin
1517542|NCT00711802|Structure|structure
1517543|NCT00711789|Acute renal failure|acute renal failure
1517544|NCT00711789|Septic shock|septic shock
1517545|NCT00711789|angiotensin II|angiotensin ii
1517546|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
1517547|NCT00711789|cystatin C|cystatin c
1517548|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
1517549|NCT00711776|Volunteer|volunteer
1517550|NCT00711776|Japanese|japanese
1517551|NCT00711776|Male|male
1517552|NCT00711776|Bioequivalence|bioequivalence
1517553|NCT00711763|Preterm Infant|preterm infant
1517554|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
1517555|NCT00711763|TPN cycling|tpn cycling
1517556|NCT00711763|Hypercalcuria|hypercalcuria
1517557|NCT00711750|underwent|underwent
1517558|NCT00711750|specific|specific
1517559|NCT00711750|creation|creation
1517560|NCT00711750|hospital|hospital
1517561|NCT00711750|November 2003|november 2003
1517562|NCT00711750|October 2005|october 2005
1517563|NCT00711737|metabolic parameters|metabolic parameters
1517564|NCT00711737|escitalopram|escitalopram
1517565|NCT00711737|metabolic syndrome|metabolic syndrome
1517566|NCT00711737|antidepressant|antidepressant
1517567|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1517568|NCT00711724|Adolescent|adolescent
1517569|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
1517570|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
1517571|NCT00711711|Treatment outcome|treatment outcome
1517572|NCT00711685|Topical vancomycin|topical vancomycin
1517573|NCT00711685|mediastinitis|mediastinitis
1517574|NCT00711685|coronary|coronary
1517575|NCT00711685|artery|artery
1517576|NCT00711685|bypass|bypass
1517577|NCT00711685|graft|graft
1517578|NCT00711685|Patients|patients
1517579|NCT00711672|Personal Communication|personal communication
1517580|NCT00711672|Doctor Patient Relations|doctor patient relations
1517581|NCT00711672|Narrative Medicine|narrative medicine
1517582|NCT00711659|Physical exam|physical exam
1517583|NCT00711659|Pediatric clerkship|pediatric clerkship
1517584|NCT00711659|Medical students|medical students
1517585|NCT00711646|Spasticity|spasticity
1517586|NCT00711646|Multiple Sclerosis|multiple sclerosis
1517587|NCT00711633|Premature birth,|premature birth,
1517588|NCT00711633|infant,|infant,
1517589|NCT00711633|infant formula,|infant formula,
1517590|NCT00711633|bacterial colonization,|bacterial colonization,
1517591|NCT00711633|Bifidobacterium,|bifidobacterium,
1517592|NCT00711633|calprotectin|calprotectin
1517593|NCT00711620|sepsis|sepsis
1517594|NCT00711620|Immunotherapy|immunotherapy
1517595|NCT00711620|Thymosin|thymosin
1517596|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
1517597|NCT00711607|combined oral contraceptive|combined oral contraceptive
1517598|NCT00711607|nomegestrol acetate|nomegestrol acetate
1517599|NCT00711607|estradiol|estradiol
1517600|NCT00711607|NOMAC|nomac
1517601|NCT00711607|E2|e2
1517602|NCT00711607|NOMAC-E2|nomac-e2
1517603|NCT00711607|pharmacokinetics|pharmacokinetics
1517604|NCT00711581|Cholecystectomy|cholecystectomy
1517605|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
1517606|NCT00711581|Laparoscopy|laparoscopy
1517607|NCT00711568|depression|depression
1517608|NCT00711568|magnetic stimulation|magnetic stimulation
1517609|NCT00711555|nausea|nausea
1517610|NCT00711555|vomiting|vomiting
1517611|NCT00711555|multiple days|multiple days
1517612|NCT00711555|chemotherapy|chemotherapy
1517613|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
1517614|NCT00711555|quality of life|quality of life
1517615|NCT00711555|therapy|therapy
1517616|NCT00711555|corticosteroids|corticosteroids
1517617|NCT00711555|aprepitant|aprepitant
1517618|NCT00711555|rescue therapy|rescue therapy
1517619|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
1517620|NCT00711542|NSTEMI|nstemi
1517621|NCT00711542|coronary flow reserve|coronary flow reserve
1517622|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
1517623|NCT00711529|hot flashes|hot flashes
1517624|NCT00711529|breast cancer|breast cancer
1517625|NCT00711529|Hypnotherapy|hypnotherapy
1517626|NCT00711529|Quality of Life|quality of life
1517627|NCT00711529|Gabapentin|gabapentin
1517628|NCT00711503|endogenous insulin production|endogenous insulin production
1517629|NCT00711503|C-peptide level|c-peptide level
1517630|NCT00711503|insulin requirement|insulin requirement
1517631|NCT00711490|Diabetic Macular Edema|diabetic macular edema
1517632|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
1517633|NCT00711490|Rapamycin|rapamycin
1517634|NCT00711490|Sirolimus|sirolimus
1517635|NCT00711490|Diabetes|diabetes
1517636|NCT00711477|obesity|obesity
1517637|NCT00711477|overweight|overweight
1517638|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
1517639|NCT00711477|naltrexone|naltrexone
1517640|NCT00711477|bupropion|bupropion
1517641|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
1517642|NCT00711451|systemic vascular resistance|systemic vascular resistance
1517643|NCT00711451|pregnancy|pregnancy
1517644|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
1517645|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
1517742|NCT00711048|pain|pain
1517646|NCT00711451|continuous wave Doppler|continuous wave doppler
1517647|NCT00711438|Breathlessness|breathlessness
1517648|NCT00711438|Dyspnoea|dyspnoea
1517649|NCT00711438|Dyspnea|dyspnea
1517650|NCT00711438|Palliative care|palliative care
1517651|NCT00711438|RCT|rct
1517652|NCT00711438|Randomised controlled trial|randomised controlled trial
1517653|NCT00711438|COPD|copd
1517654|NCT00711438|Chronic respiratory disease|chronic respiratory disease
1517655|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
1517656|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1517657|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
1517658|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
1517659|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
1517660|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
1517661|NCT00711399|Respiratory sounds|respiratory sounds
1517662|NCT00711399|Wheeze|wheeze
1517663|NCT00711399|Cough|cough
1517664|NCT00711386|pharmacokinetics|pharmacokinetics
1517665|NCT00711386|CCR5|ccr5
1517666|NCT00711386|Healthy volunteers|healthy volunteers
1517667|NCT00711386|GSK706769|gsk706769
1517668|NCT00711373|VCA|vca
1517669|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
1517670|NCT00711373|amputation|amputation
1517671|NCT00711373|Hand|hand
1517672|NCT00711360|heart failure|heart failure
1517673|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1517674|NCT00711360|intrathoracic impedance|intrathoracic impedance
1517675|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
1517676|NCT00711360|home monitoring|home monitoring
1517677|NCT00711347|Discovisc|discovisc
1517678|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
1517679|NCT00711321|Alzheimer|alzheimer
1517680|NCT00711321|Morbus Alzheimer|morbus alzheimer
1517681|NCT00711321|Vaccine|vaccine
1517682|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
1517683|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
1517684|NCT00711308|pulmonary embolism|pulmonary embolism
1517685|NCT00711308|low molecular weight heparin|low molecular weight heparin
1517686|NCT00711308|vitamin K antagonist|vitamin k antagonist
1517687|NCT00711308|Longterm|longterm
1517688|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
1517689|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
1517690|NCT00711256|Sunscreen|sunscreen
1517691|NCT00711256|Application|application
1517692|NCT00711256|Vitamin D|vitamin d
1517693|NCT00711256|Sun protection factor|sun protection factor
1517694|NCT00711256|Clothing|clothing
1517695|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1517696|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1517697|NCT00711243|stage III gastric cancer|stage iii gastric cancer
1517698|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
1517699|NCT00711230|HIV|hiv
1517700|NCT00711230|Vaccine|vaccine
1517701|NCT00711230|Immune Therapy|immune therapy
1517702|NCT00711230|DermaVir|dermavir
1517703|NCT00711204|Severe|severe
1517704|NCT00711204|Alzheimer's Disease|alzheimer's disease
1517705|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
1517706|NCT00711165|Asthma|asthma
1517707|NCT00711165|Nitric Oxide|nitric oxide
1517708|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
1517709|NCT00711165|Methacholine Challenge|methacholine challenge
1517710|NCT00711152|diabetes|diabetes
1517711|NCT00711152|protocol-driven structured care|protocol-driven structured care
1517712|NCT00711152|web-based|web-based
1517713|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
1517714|NCT00711139|Alzheimer|alzheimer
1517715|NCT00711139|Morbus Alzheimer|morbus alzheimer
1517716|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
1517717|NCT00711139|Vaccine|vaccine
1517718|NCT00711139|AD|ad
1517719|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
1517720|NCT00711126|intravenous,|intravenous,
1517721|NCT00711126|tolerability|tolerability
1517722|NCT00711126|pharmacokinetics,|pharmacokinetics,
1517723|NCT00711126|oral,|oral,
1517724|NCT00711126|pharmacodynamics,|pharmacodynamics,
1517725|NCT00711126|safety,|safety,
1517726|NCT00711126|GW642444,|gw642444,
1517727|NCT00711126|inhaled,|inhaled,
1517728|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
1517729|NCT00711100|Substitution for cigarettes|substitution for cigarettes
1517730|NCT00711100|Oral tobacco products|oral tobacco products
1517731|NCT00711087|Spinal Cord Injury|spinal cord injury
1517732|NCT00711087|Bladder|bladder
1517733|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
1517734|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
1517735|NCT00711074|pharmacokinetics|pharmacokinetics
1517736|NCT00711074|mass balance|mass balance
1517737|NCT00711074|radiolabel|radiolabel
1517738|NCT00711074|AZD5672|azd5672
1517739|NCT00711048|GERD|gerd
1517740|NCT00711048|healthy volunteer|healthy volunteer
1517741|NCT00711048|esophagus|esophagus
1517743|NCT00711035|CMV|cmv
1517744|NCT00711035|Adenovirus|adenovirus
1517745|NCT00711035|EBV|ebv
1517746|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
1517747|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
1567168|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1517748|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
1517843|NCT00710645|Spasticity|spasticity
1517749|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
1517750|NCT00710996|AcrySof IQ IOL|acrysof iq iol
1517751|NCT00710983|Mortality|mortality
1517752|NCT00710983|Morbidity|morbidity
1517753|NCT00710983|Growth|growth
1517754|NCT00710983|Immunology|immunology
1517755|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
1517756|NCT00710970|Previous Chemotherapy|previous chemotherapy
1517757|NCT00710970|Tamoxifen|tamoxifen
1517758|NCT00710970|Anti-tumor activity|anti-tumor activity
1517759|NCT00710957|Vitamin D|vitamin d
1517760|NCT00710957|Physical Function|physical function
1517761|NCT00710957|Falls|falls
1517762|NCT00710957|Aging|aging
1517763|NCT00710957|CHS|chs
1517764|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
1517765|NCT00710931|Bilateral Cataract|bilateral cataract
1517766|NCT00710931|IOL|iol
1517767|NCT00710931|ReSTOR|restor
1517768|NCT00710931|Aspheric|aspheric
1517769|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
1517770|NCT00710905|Bilateral cataract|bilateral cataract
1517771|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
1517772|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
1517773|NCT00710892|Stage III|stage iii
1517774|NCT00710892|Stage IV|stage iv
1517775|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
1517776|NCT00710892|AML after first relapse|aml after first relapse
1517777|NCT00710892|primary refractory disease|primary refractory disease
1517778|NCT00710892|CML|cml
1517779|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
1517780|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
1517781|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
1517782|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
1517783|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
1517784|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
1517785|NCT00710879|Efficacy|efficacy
1517786|NCT00710866|Influenza Vaccines|influenza vaccines
1517787|NCT00710866|Infant|infant
1517788|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1517789|NCT00710853|Geriatric|geriatric
1517790|NCT00710853|Qi gong|qi gong
1517791|NCT00710853|Yoga|yoga
1517792|NCT00710853|Tai chi|tai chi
1517793|NCT00710853|Geriatric Assessment|geriatric assessment
1517794|NCT00710840|Knee Replacement|knee replacement
1517795|NCT00710840|Knee OA|knee oa
1517796|NCT00710840|OA|oa
1517797|NCT00710827|NEBIDO,|nebido,
1517798|NCT00710827|Hypogonadism,|hypogonadism,
1517799|NCT00710827|Symptomatic late onset,|symptomatic late onset,
1517800|NCT00710827|Testosterone deficiency|testosterone deficiency
1517801|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1517802|NCT00710814|Leptin|leptin
1517803|NCT00710814|Bariatric surgery|bariatric surgery
1517804|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
1517805|NCT00710801|Hepatitis C Virus|hepatitis c virus
1517806|NCT00710801|HCV|hcv
1517807|NCT00710801|Liver Transplant|liver transplant
1517808|NCT00710801|Cyclosporine|cyclosporine
1517809|NCT00710801|Tacrolimus|tacrolimus
1517810|NCT00710801|Myfortic|myfortic
1517811|NCT00710788|QT interval|qt interval
1517812|NCT00710788|QT dispersion|qt dispersion
1517813|NCT00710788|arrhythmias|arrhythmias
1517814|NCT00710788|death|death
1517815|NCT00710788|TC score|tc score
1517816|NCT00710775|Aortic valve stenosis|aortic valve stenosis
1517817|NCT00710775|Heart surgery|heart surgery
1517818|NCT00710775|Endovascular techniques|endovascular techniques
1517819|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
1517820|NCT00710697|Bladder Cancer|bladder cancer
1517821|NCT00710697|Breast Cancer|breast cancer
1517822|NCT00710697|Colorectal Cancer|colorectal cancer
1517823|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
1517824|NCT00710697|Head and Neck Cancer|head and neck cancer
1517825|NCT00710697|Lung Cancer|lung cancer
1517826|NCT00710697|Ovarian Cancer|ovarian cancer
1517827|NCT00710697|Pancreatic Cancer|pancreatic cancer
1517828|NCT00710697|Prostrate Cancer|prostrate cancer
1517829|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
1517830|NCT00710671|HIV positive|hiv positive
1517831|NCT00710671|YMSM|ymsm
1517832|NCT00710671|risk factors|risk factors
1517833|NCT00710671|coping|coping
1517834|NCT00710671|identity development|identity development
1517835|NCT00710671|psychosocial needs|psychosocial needs
1517836|NCT00710658|Internet support|internet support
1517837|NCT00710658|Tailored information|tailored information
1517838|NCT00710658|Self-management|self-management
1517839|NCT00710658|Quality of life|quality of life
1517840|NCT00710658|Online messaging|online messaging
1517841|NCT00710658|Online discussion groups|online discussion groups
1517842|NCT00710645|Multiple Sclerosis|multiple sclerosis
1517844|NCT00710632|cachexia|cachexia
1517845|NCT00710632|lung cancer|lung cancer
1517846|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
1517847|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1517848|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1517849|NCT00710606|contraceptive ring|contraceptive ring
1517850|NCT00710606|obesity|obesity
1517851|NCT00710606|pharmacokinetics|pharmacokinetics
1517852|NCT00710606|pharmacodynamics|pharmacodynamics
1517853|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
1517854|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
1517855|NCT00710593|Human papillomavirus|human papillomavirus
1517856|NCT00710593|HPV vaccine|hpv vaccine
1517857|NCT00710567|Heart Failure|heart failure
1517858|NCT00710567|LVAS|lvas
1517859|NCT00710567|LVAD|lvad
1517860|NCT00710567|Rotary Pump|rotary pump
1517861|NCT00710554|Pain|pain
1517862|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
1517863|NCT00710554|Allodynia|allodynia
1517864|NCT00710541|non invasive ventilation|non invasive ventilation
1517865|NCT00710541|COPD|copd
1517866|NCT00710541|hypercapnia|hypercapnia
1517867|NCT00710541|GOLD stage IV|gold stage iv
1517868|NCT00710528|CLL|cll
1517869|NCT00710528|NHL|nhl
1517870|NCT00710528|AML|aml
1517871|NCT00710528|MM|mm
1517872|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
1517873|NCT00710515|Melanoma|melanoma
1517874|NCT00710515|Phase I|phase i
1517875|NCT00710515|AZD6244|azd6244
1517876|NCT00710502|Transvaginal|transvaginal
1517877|NCT00710502|NOTES|notes
1517878|NCT00710502|Cholecystectomy|cholecystectomy
1517879|NCT00710502|Laparoscopic|laparoscopic
1517880|NCT00710489|Acne|acne
1517881|NCT00710489|Actinic Keratosis|actinic keratosis
1517882|NCT00710489|Dysplastic Nevi|dysplastic nevi
1517883|NCT00710489|Eczema|eczema
1517884|NCT00710489|Psoriasis|psoriasis
1517885|NCT00710489|Vitiligo|vitiligo
1517886|NCT00710489|Skin Cancer|skin cancer
1517887|NCT00710489|Rosacea|rosacea
1517888|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
1517889|NCT00710489|Atopic Dermatosis|atopic dermatosis
1517890|NCT00710463|COPD|copd
1517891|NCT00710463|non invasive ventilation|non invasive ventilation
1517892|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
1517893|NCT00710450|IL13|il13
1517894|NCT00710450|leukotriene|leukotriene
1517895|NCT00710450|histamine|histamine
1517896|NCT00710450|IL4|il4
1517897|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
1517898|NCT00710437|Dexmedetomidine|dexmedetomidine
1517899|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
1517900|NCT00710437|Electroencephalogram|electroencephalogram
1517901|NCT00710424|Pain|pain
1517902|NCT00710424|diabetic neuropathy|diabetic neuropathy
1517903|NCT00710411|humans|humans
1517904|NCT00710411|patients|patients
1517905|NCT00710411|polytrauma|polytrauma
1517906|NCT00710411|complement|complement
1517907|NCT00710411|inflammation|inflammation
1517908|NCT00710411|inflammatory response|inflammatory response
1517909|NCT00710411|biomarkers|biomarkers
1517910|NCT00710411|cytokines|cytokines
1517911|NCT00710411|cell surface markers|cell surface markers
1517912|NCT00710411|apoptosis|apoptosis
1517913|NCT00710411|NF-kappaB|nf-kappab
1517914|NCT00710411|functional polymorphisms|functional polymorphisms
1517915|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
1517916|NCT00710411|severity of injury|severity of injury
1517917|NCT00710411|ISS|iss
1517918|NCT00710411|infections|infections
1517919|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1517920|NCT00710411|SIRS|sirs
1517921|NCT00710411|sepsis|sepsis
1517922|NCT00710411|severe sepsis|severe sepsis
1517923|NCT00710411|shock|shock
1517924|NCT00710411|organ dysfunctions|organ dysfunctions
1517925|NCT00710411|SOFA|sofa
1517926|NCT00710411|severity of disease|severity of disease
1517927|NCT00710411|APACHEII|apacheii
1517928|NCT00710411|SAPSII|sapsii
1517929|NCT00710411|SPAPS3|spaps3
1517930|NCT00710411|length of stay|length of stay
1517931|NCT00710411|wound healing|wound healing
1517932|NCT00710411|outcome|outcome
1517933|NCT00710411|mortality|mortality
1517934|NCT00710398|Dairy Products|dairy products
1517935|NCT00710398|Dietary Protein|dietary protein
1517936|NCT00710398|Body Composition|body composition
1517937|NCT00710398|Fat mass loss|fat mass loss
1517938|NCT00710398|Lean mass gain|lean mass gain
1517939|NCT00710398|Pre-menopausal Women|pre-menopausal women
1517940|NCT00710359|Cobalamin deficiency|cobalamin deficiency
1517941|NCT00710359|Infant|infant
1517942|NCT00710359|Nutrition|nutrition
1517943|NCT00710359|Cobalamin supplementation|cobalamin supplementation
1517944|NCT00710359|Feeding problems|feeding problems
1517945|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
1517946|NCT00710346|Leiomyoma|leiomyoma
1678918|NCT00086541|HCV|hcv
1517947|NCT00710346|Uterus|uterus
1517948|NCT00710346|Fibroids|fibroids
1517949|NCT00710346|Surgical|surgical
1517950|NCT00710320|Children core temperature,|children core temperature,
1517951|NCT00710320|Pediatric surgery,|pediatric surgery,
1517952|NCT00710320|Anesthesia induction|anesthesia induction
1517953|NCT00710294|Refractory Hypertension|refractory hypertension
1517954|NCT00710294|High Blood Pressure|high blood pressure
1517955|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
1517956|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
1517957|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
1517958|NCT00710281|Aneurysm|aneurysm
1517959|NCT00710281|Brain Aneurysm|brain aneurysm
1517960|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
1517961|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
1517962|NCT00710281|Hemodynamic Stress|hemodynamic stress
1517963|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
1517964|NCT00710268|Bevacizumab|bevacizumab
1517965|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1517966|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
1517967|NCT00710268|PARP inhibitor|parp inhibitor
1517968|NCT00710255|Asthma|asthma
1517969|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
1517970|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
1517971|NCT00710255|leukotrienes|leukotrienes
1517972|NCT00710255|adenosine|adenosine
1517973|NCT00710255|exhaled breath condensate|exhaled breath condensate
1517974|NCT00710242|prolonged labor|prolonged labor
1517975|NCT00710229|age related macular degeneration|age related macular degeneration
1517976|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
1517977|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
1517978|NCT00710216|Viral kinetics|viral kinetics
1517979|NCT00710216|Viral dynamics|viral dynamics
1517980|NCT00710216|Telbivudine|telbivudine
1517981|NCT00710216|Lamivudine|lamivudine
1517982|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
1517983|NCT00710203|seborrheic keratoses|seborrheic keratoses
1517984|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
1517985|NCT00710190|Refractory Hypertension|refractory hypertension
1517986|NCT00710190|High Blood Pressure|high blood pressure
1517987|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
1517988|NCT00710177|PPHN|pphn
1517989|NCT00710177|PTGS1|ptgs1
1517990|NCT00710177|NSAID|nsaid
1517991|NCT00710151|neurotoxicity|neurotoxicity
1517992|NCT00710151|cognition in survivors|cognition in survivors
1517993|NCT00710151|diagnostic imaging|diagnostic imaging
1517994|NCT00710138|Cobalamin deficiency|cobalamin deficiency
1517995|NCT00710138|Infant|infant
1517996|NCT00710138|Nutrition|nutrition
1517997|NCT00710138|Cobalamin supplementation|cobalamin supplementation
1517998|NCT00710138|Neurodevelopment|neurodevelopment
1517999|NCT00710138|Neurological symptoms|neurological symptoms
1518000|NCT00710112|CLD|cld
1518001|NCT00710112|VLBW infants|vlbw infants
1518002|NCT00710112|Toll like Receptors|toll like receptors
1518003|NCT00710112|Biomarkers|biomarkers
1518004|NCT00710099|iontophoresis|iontophoresis
1518005|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
1518006|NCT00710099|sildenafil|sildenafil
1518007|NCT00710099|Healthy volunteers|healthy volunteers
1518008|NCT00710086|Remifentanil|remifentanil
1518009|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
1518010|NCT00710086|Intravenous analgesia|intravenous analgesia
1518011|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
1518012|NCT00710073|Neuromodulation|neuromodulation
1518013|NCT00710060|HIV|hiv
1518014|NCT00710060|Popular Opinion Leader|popular opinion leader
1518015|NCT00710060|POL|pol
1518016|NCT00710060|Behavioral Intervention|behavioral intervention
1518017|NCT00710060|STD|std
1518018|NCT00710060|STI|sti
1518019|NCT00710060|Community|community
1518020|NCT00710060|Prevention|prevention
1518021|NCT00710060|International|international
1518022|NCT00710060|Global|global
1518023|NCT00710047|ZD4054|zd4054
1518024|NCT00710047|Zibotentan|zibotentan
1518025|NCT00710047|Healthy Volunteers|healthy volunteers
1518026|NCT00710034|Oral Tobacco Products|oral tobacco products
1518027|NCT00710034|Snus|snus
1518028|NCT00710034|Smoking Substitution|smoking substitution
1518029|NCT00710034|Harm Reduction|harm reduction
1518030|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
1518031|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
1518032|NCT00710021|SLE|sle
1518033|NCT00710021|Vitamin D3|vitamin d3
1518034|NCT00710021|Vitamin D deficiency|vitamin d deficiency
1518035|NCT00710021|IFN alpha expression|ifn alpha expression
1518036|NCT00710008|type 2 diabetes,|type 2 diabetes,
1518037|NCT00710008|exercise training,|exercise training,
1518038|NCT00710008|ATP-synthesis,|atp-synthesis,
1518039|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
1518040|NCT00710008|hepatocellular lipids|hepatocellular lipids
1518041|NCT00710008|first degree relatives of|first degree relatives of
1518042|NCT00710008|patients|patients
1518043|NCT00709982|Norgestimate|norgestimate
1678951|NCT00086567|Blood|blood
1518044|NCT00709982|Contraceptives, Oral|contraceptives, oral
1518045|NCT00709982|Ortho-Cyclen|ortho-cyclen
1518046|NCT00709982|Folic Acid|folic acid
1518047|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
1518048|NCT00709969|Malaria|malaria
1518049|NCT00709969|co-artemether|co-artemether
1518050|NCT00709969|auditory|auditory
1518051|NCT00709969|Plasmodium falciparum|plasmodium falciparum
1518052|NCT00709969|marsh fever|marsh fever
1518053|NCT00709969|remittent fever|remittent fever
1518054|NCT00709969|artemether|artemether
1518055|NCT00709969|artemisinins|artemisinins
1518056|NCT00709969|lumefantrine|lumefantrine
1518057|NCT00709969|child|child
1518058|NCT00709969|infant|infant
1518059|NCT00709969|Africa|africa
1518060|NCT00709956|Ventavis|ventavis
1518061|NCT00709956|iloprost|iloprost
1518062|NCT00709956|inhaled treatment|inhaled treatment
1518063|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
1518064|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
1518065|NCT00709904|primary prevention|primary prevention
1518066|NCT00709904|orthopedic surgery|orthopedic surgery
1518067|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
1518068|NCT00709865|renal insufficiency|renal insufficiency
1518069|NCT00709865|diuretic|diuretic
1518070|NCT00709865|congestive heart failure|congestive heart failure
1518071|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
1518072|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
1518073|NCT00709852|CNS Imaging|cns imaging
1518074|NCT00709839|glucocorticoid|glucocorticoid
1518075|NCT00709839|hydrocortisone|hydrocortisone
1518076|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
1518077|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
1518078|NCT00709813|Symptom management|symptom management
1518079|NCT00709813|Cancer|cancer
1518080|NCT00709813|Patient-centered care|patient-centered care
1518081|NCT00709800|Pandemic Influenza|pandemic influenza
1518082|NCT00709800|Avian Influenza|avian influenza
1518083|NCT00709800|DNA Vaccines|dna vaccines
1518084|NCT00709800|Antibody|antibody
1518085|NCT00709800|T Cells|t cells
1518086|NCT00709800|HA/NP/M2|ha/np/m2
1518087|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
1518088|NCT00709761|Erbb2|erbb2
1518089|NCT00709761|ABRAXANE|abraxane
1518090|NCT00709761|MBC|mbc
1518091|NCT00709761|first or second line therapy|first or second line therapy
1518092|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
1518093|NCT00709761|TYKERB|tykerb
1518094|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1518095|NCT00709748|TENS|tens
1518096|NCT00709748|Empi|empi
1518097|NCT00709748|Electrotherapy|electrotherapy
1518098|NCT00709748|Back pain|back pain
1518099|NCT00709748|Lower back pain|lower back pain
1518100|NCT00709748|Chronic lower back pain|chronic lower back pain
1518101|NCT00709735|stress disorders|stress disorders
1518102|NCT00709735|post-traumatic|post-traumatic
1518103|NCT00709735|memory|memory
1518104|NCT00709735|propranolol|propranolol
1518105|NCT00709735|psychophysiology|psychophysiology
1518106|NCT00709722|Lupus nephritis|lupus nephritis
1518107|NCT00709722|Deoxyspergualin|deoxyspergualin
1518108|NCT00709722|Immunosuppression|immunosuppression
1518109|NCT00709709|stenosis|stenosis
1518110|NCT00709709|coronaropathy|coronaropathy
1518111|NCT00709709|stent|stent
1518112|NCT00709709|bypass surgery|bypass surgery
1518113|NCT00709709|suspect|suspect
1518114|NCT00709709|known|known
1518115|NCT00709696|Tobacco|tobacco
1518116|NCT00709696|nicotine|nicotine
1518117|NCT00709696|smoking|smoking
1518118|NCT00709696|varenicline|varenicline
1518119|NCT00709696|human laboratory study|human laboratory study
1518120|NCT00709696|stress tolerance|stress tolerance
1518121|NCT00709696|startle response|startle response
1518122|NCT00709696|cognitive assessment|cognitive assessment
1518123|NCT00709696|progressive ratio|progressive ratio
1518124|NCT00709670|MSCT|msct
1518125|NCT00709670|Echocardiography|echocardiography
1518126|NCT00709670|Coronarography|coronarography
1518127|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
1518128|NCT00709670|normal ECG|normal ecg
1518129|NCT00709670|normal troponin|normal troponin
1518130|NCT00709670|Acute|acute
1518131|NCT00709657|Age-related macular degeneration|age-related macular degeneration
1518132|NCT00709657|anti-VEGF|anti-vegf
1518133|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
1518134|NCT00709644|Contraceptives, Oral|contraceptives, oral
1518135|NCT00709644|Norgestimate|norgestimate
1518136|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
1518137|NCT00709644|Folic Acid|folic acid
1518138|NCT00709644|Female Contraception|female contraception
1518139|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
1518140|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
1518141|NCT00709631|Biopsy|biopsy
1518142|NCT00709631|Leg ulcer|leg ulcer
1518143|NCT00709631|Chronic wound|chronic wound
1518144|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
1518145|NCT00709631|Basal cell carcinoma|basal cell carcinoma
1518146|NCT00709618|Erbb2|erbb2
1518147|NCT00709618|MBC|mbc
1518148|NCT00709618|First or Second line therapy|first or second line therapy
1518149|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
1518150|NCT00709618|Vinorelbine|vinorelbine
1518151|NCT00709618|Tykerb|tykerb
1518152|NCT00709605|HIV Negative|hiv negative
1518153|NCT00709605|Healthy|healthy
1518154|NCT00709605|Immunity|immunity
1518155|NCT00709605|Preventive|preventive
1518156|NCT00709605|Virus|virus
1518157|NCT00709605|Healthy Volunteer|healthy volunteer
1518158|NCT00709605|HV|hv
1518159|NCT00709592|total body irradiation|total body irradiation
1518160|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
1518161|NCT00709592|thymoglobulin|thymoglobulin
1518162|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
1518163|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
1518164|NCT00709579|Corticotherapy|corticotherapy
1518165|NCT00709566|Hip|hip
1518166|NCT00709566|osteoarthritis|osteoarthritis
1518167|NCT00709566|exercise|exercise
1518168|NCT00709566|manual therapy|manual therapy
1518169|NCT00709553|ZD4054|zd4054
1518170|NCT00709553|Healthy Volunteers|healthy volunteers
1518171|NCT00709527|AMD|amd
1518172|NCT00709514|Oneness|oneness
1518173|NCT00709514|DCB-WH1|dcb-wh1
1518174|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
1518175|NCT00709514|chronic|chronic
1518176|NCT00709514|diabetic|diabetic
1518177|NCT00709514|foot ulcers|foot ulcers
1518178|NCT00709514|topical ointment|topical ointment
1518179|NCT00709501|weight loss|weight loss
1518180|NCT00709501|obesity|obesity
1518181|NCT00709501|overweight|overweight
1518182|NCT00709488|Litx™ BPH System|litx™ bph system
1518183|NCT00709488|LS11|ls11
1518184|NCT00709488|Talaporfin sodium|talaporfin sodium
1518185|NCT00709462|Breast cancer|breast cancer
1518186|NCT00709462|Colorectal cancer|colorectal cancer
1518187|NCT00709462|Pancreatic cancer|pancreatic cancer
1518188|NCT00709462|Bladder cancer|bladder cancer
1518189|NCT00709462|Ovarian cancer|ovarian cancer
1518190|NCT00709462|Metastatic cancer|metastatic cancer
1518191|NCT00709462|Locally advanced cancer|locally advanced cancer
1518192|NCT00709462|Cancer Vaccine|cancer vaccine
1518193|NCT00709462|Vaccine|vaccine
1518194|NCT00709449|Age-related macular degeneration|age-related macular degeneration
1518195|NCT00709449|Glaucoma|glaucoma
1518196|NCT00709436|orthopedic|orthopedic
1518197|NCT00709436|ketamine|ketamine
1518198|NCT00709436|pain|pain
1518199|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
1518200|NCT00709397|HIV-1|hiv-1
1518201|NCT00709397|drug resistance|drug resistance
1518202|NCT00709397|raltegravir|raltegravir
1518203|NCT00709397|integrase inhibitor|integrase inhibitor
1518204|NCT00709371|obesity|obesity
1518205|NCT00709371|zonisamide|zonisamide
1518206|NCT00709371|bupropion|bupropion
1518207|NCT00709358|bacteria|bacteria
1518208|NCT00709358|fungi|fungi
1518209|NCT00709358|real time PCR|real time pcr
1518210|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
1518211|NCT00709358|microbial DNA|microbial dna
1518212|NCT00709358|microbial diagnosis|microbial diagnosis
1518213|NCT00709345|Antipsychotic Medications|antipsychotic medications
1518214|NCT00709345|Behavioral Interventions|behavioral interventions
1518215|NCT00709332|Norgestimate|norgestimate
1518216|NCT00709332|Folic Acid|folic acid
1518217|NCT00709332|Ortho-Cyclen|ortho-cyclen
1518218|NCT00709332|Female contraception|female contraception
1518219|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
1518220|NCT00709332|Drug Interactions|drug interactions
1518221|NCT00709332|Pharmacokinetics|pharmacokinetics
1518222|NCT00709332|Contraceptives, Oral|contraceptives, oral
1518223|NCT00709319|Diabetic retinopathy|diabetic retinopathy
1518224|NCT00709319|Diabetic macular edema|diabetic macular edema
1518225|NCT00709319|dme|dme
1518226|NCT00709319|vitrectomy|vitrectomy
1518227|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
1518228|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
1518229|NCT00709293|ATG|atg
1518230|NCT00709293|Induction Therapy|induction therapy
1518231|NCT00709280|Cystic Fibrosis|cystic fibrosis
1518232|NCT00709280|hypertonic saline|hypertonic saline
1518233|NCT00709280|inhaled saline|inhaled saline
1518234|NCT00709267|Folic Acid|folic acid
1518235|NCT00709267|Chemistry, Analytical|chemistry, analytical
1518236|NCT00709267|Administration, Oral|administration, oral
1518237|NCT00709267|Infusions, Intravenous|infusions, intravenous
1518238|NCT00709267|Biological Availability|biological availability
1518239|NCT00709267|Safety|safety
1518240|NCT00709254|AeroLEF|aerolef
1518241|NCT00709254|fentanyl|fentanyl
1518242|NCT00709254|pharmacokinetics|pharmacokinetics
1518243|NCT00709254|liposome|liposome
1518837|NCT00706732|Influenza|influenza
1518244|NCT00709254|encapsulated|encapsulated
1518245|NCT00709241|Heart failure|heart failure
1518246|NCT00709241|Psychosocial factors|psychosocial factors
1518247|NCT00709241|Depression|depression
1518248|NCT00709241|Patient compliance|patient compliance
1518249|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
1518250|NCT00709215|ALL|all
1518251|NCT00709215|AML|aml
1518252|NCT00709215|blastic CML|blastic cml
1518253|NCT00709189|Pharmacokinetics|pharmacokinetics
1518254|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
1518255|NCT00709189|Drug Interactions|drug interactions
1518256|NCT00709189|Norgestimate|norgestimate
1518257|NCT00709189|Contraceptives, Oral|contraceptives, oral
1518258|NCT00709189|Ortho-Cyclen|ortho-cyclen
1518259|NCT00709189|Folic Acid|folic acid
1518260|NCT00709176|Quality of Life|quality of life
1518261|NCT00709176|Randomized Clinical Trial|randomized clinical trial
1518262|NCT00709176|Advanced Cancer|advanced cancer
1518263|NCT00709176|Breast Cancer|breast cancer
1518264|NCT00709176|Colorectal Cancer|colorectal cancer
1518265|NCT00709176|Lung Cancer|lung cancer
1518266|NCT00709176|Prostate Cancer|prostate cancer
1518267|NCT00709176|Family caregiver|family caregiver
1518268|NCT00709176|cancer survivorship|cancer survivorship
1518269|NCT00709176|coping|coping
1518270|NCT00709176|communication|communication
1518271|NCT00709176|uncertainty|uncertainty
1518272|NCT00709176|support|support
1518273|NCT00709176|depression|depression
1518274|NCT00709176|self-efficacy|self-efficacy
1518275|NCT00709176|benefits of illness|benefits of illness
1518276|NCT00709176|Caregivers|caregivers
1518277|NCT00709163|Pediatric|pediatric
1518278|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
1518279|NCT00709163|Nesiritide|nesiritide
1518280|NCT00709150|Major Depression|major depression
1518281|NCT00709150|Diabetes|diabetes
1518282|NCT00709150|Hispanics|hispanics
1518283|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
1518284|NCT00709137|resistant hypertensions|resistant hypertensions
1518285|NCT00709137|spironolactone|spironolactone
1518286|NCT00709137|amiloride|amiloride
1518287|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1518288|NCT00709124|Respiration, Artificial|respiration, artificial
1518289|NCT00709124|Critical Illness|critical illness
1518290|NCT00709124|Intensive Care Units|intensive care units
1518291|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
1518292|NCT00709124|Muscle Weakness|muscle weakness
1518293|NCT00709124|Paresis|paresis
1518294|NCT00709124|Mechanically|mechanically
1518295|NCT00709124|Ventilated|ventilated
1518296|NCT00709124|Patients|patients
1518297|NCT00709124|Admitted|admitted
1518298|NCT00709124|Medical|medical
1518299|NCT00709111|CCR5 antagonist|ccr5 antagonist
1518300|NCT00709111|CD4 T-cell count|cd4 t-cell count
1518301|NCT00709111|immune activation|immune activation
1518302|NCT00709111|treatment experienced|treatment experienced
1518303|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
1518304|NCT00709098|inhaled treatment|inhaled treatment
1518305|NCT00709098|inhalation solution|inhalation solution
1518306|NCT00709098|iloprost|iloprost
1518307|NCT00709098|Ventavis|ventavis
1518308|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
1518309|NCT00709072|stuttering|stuttering
1518310|NCT00709072|relapse|relapse
1518311|NCT00709072|Lidcombe Program|lidcombe program
1518312|NCT00709072|Preschool children|preschool children
1518313|NCT00709059|hepatitis C|hepatitis c
1518314|NCT00709046|Endoscopic treatment|endoscopic treatment
1518315|NCT00709046|Peptic ulcer|peptic ulcer
1518316|NCT00709046|Bleeding|bleeding
1518317|NCT00709046|Thermocoagulation|thermocoagulation
1518318|NCT00709046|Proton pump inhibitors|proton pump inhibitors
1518319|NCT00709033|refractory|refractory
1518320|NCT00709033|relapsed|relapsed
1518321|NCT00709033|low|low
1518322|NCT00709033|intermediate-grade|intermediate-grade
1518323|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1518324|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1518325|NCT00709020|cancer survivor|cancer survivor
1518326|NCT00709020|breast cancer|breast cancer
1518327|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
1518328|NCT00708968|randomized clinical trial|randomized clinical trial
1518329|NCT00708968|coping|coping
1518330|NCT00708968|quality of life|quality of life
1518331|NCT00708968|family|family
1518332|NCT00708968|family caregiver|family caregiver
1518333|NCT00708968|cancer survivorship|cancer survivorship
1518334|NCT00708968|communication|communication
1518335|NCT00708968|uncertainty|uncertainty
1518336|NCT00708968|support|support
1518337|NCT00708968|family education|family education
1518338|NCT00708968|Caregivers|caregivers
1518339|NCT00708955|Evaluation and Treatment|evaluation and treatment
1518340|NCT00708955|Eye Diseases|eye diseases
1518341|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1518342|NCT00708929|Age-related macular degeneration|age-related macular degeneration
1518343|NCT00708929|Complement factor H|complement factor h
1518344|NCT00708929|Choroidal blood flow|choroidal blood flow
1518345|NCT00708916|Cutaneous lupus|cutaneous lupus
1518346|NCT00708916|Intervention|intervention
1518347|NCT00708916|Discoid lupus|discoid lupus
1518348|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
1518349|NCT00708903|Thorough QTc study|thorough qtc study
1518350|NCT00708890|Substance use disorders|substance use disorders
1518351|NCT00708890|Self-help groups|self-help groups
1518352|NCT00708890|Twelve Step groups|twelve step groups
1518353|NCT00708877|cancer|cancer
1518354|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
1518355|NCT00708851|psoriasis|psoriasis
1518356|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
1518357|NCT00708812|Endostar|endostar
1518358|NCT00708812|Paclitaxel|paclitaxel
1518359|NCT00708812|Carboplatin|carboplatin
1518360|NCT00708760|web based learning|web based learning
1518361|NCT00708760|moderate sedation|moderate sedation
1518362|NCT00708747|Immunoglobulins|immunoglobulins
1518363|NCT00708747|inhibitor proteins|inhibitor proteins
1518364|NCT00708747|human albumin|human albumin
1518365|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1518366|NCT00708747|interleukins|interleukins
1518367|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
1518368|NCT00708734|exercise|exercise
1518369|NCT00708721|hypomethylating therapy|hypomethylating therapy
1518370|NCT00708721|CML|cml
1518371|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
1518372|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
1518373|NCT00708695|nurse|nurse
1518374|NCT00708695|home visits|home visits
1518375|NCT00708695|pregnancy|pregnancy
1518376|NCT00708695|welfare|welfare
1518377|NCT00708695|child development|child development
1518378|NCT00708695|Child Rearing|child rearing
1518379|NCT00708695|Reproductive Behavior|reproductive behavior
1518380|NCT00708695|Risk Reduction Behavior|risk reduction behavior
1518381|NCT00708656|IBD|ibd
1518382|NCT00708656|Colitis|colitis
1518383|NCT00708656|UC|uc
1518384|NCT00708630|yellow fever vaccine|yellow fever vaccine
1518385|NCT00708630|patient information|patient information
1518386|NCT00708630|symptom reports|symptom reports
1518387|NCT00708630|patient satisfaction|patient satisfaction
1518388|NCT00708617|Liver fibrosis|liver fibrosis
1518389|NCT00708617|Alcoholic liver disease|alcoholic liver disease
1518390|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
1518391|NCT00708617|Transient elastography|transient elastography
1518392|NCT00708617|Fibrotest|fibrotest
1518393|NCT00708604|Diabetes Mellitus|diabetes mellitus
1518394|NCT00708604|Kidney Transplantation|kidney transplantation
1518395|NCT00708604|Islet Transplantation|islet transplantation
1518396|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
1518397|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
1518398|NCT00708552|Alzheimer's disease|alzheimer's disease
1518399|NCT00708552|Cognition|cognition
1518400|NCT00708552|SB-742457|sb-742457
1518401|NCT00708526|hypercapnia|hypercapnia
1518402|NCT00708526|hyperpnoea|hyperpnoea
1518403|NCT00708526|accelerated recovery|accelerated recovery
1518404|NCT00708513|Cell Saver|cell saver
1518405|NCT00708513|Liver Tumors|liver tumors
1518406|NCT00708513|Liver Cancer|liver cancer
1518407|NCT00708513|Surgical Oncology|surgical oncology
1518408|NCT00708513|Whipple|whipple
1518409|NCT00708513|Blood Transfusion|blood transfusion
1518410|NCT00708513|Blood salvage|blood salvage
1518411|NCT00708513|cancer surgery|cancer surgery
1518412|NCT00708513|blood loss|blood loss
1518413|NCT00708500|Treatment failure|treatment failure
1518414|NCT00708487|in vitro fertilization|in vitro fertilization
1518415|NCT00708487|oxygen concentration|oxygen concentration
1518416|NCT00708487|blastocyst|blastocyst
1518417|NCT00708487|live birth|live birth
1518418|NCT00708487|embryo|embryo
1518419|NCT00708474|Bone graft|bone graft
1518420|NCT00708474|Bone void filler|bone void filler
1518421|NCT00708474|Bone plug|bone plug
1518422|NCT00708474|OsseoFit™|osseofit™
1518423|NCT00708474|knee|knee
1518424|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
1518425|NCT00708461|obesity|obesity
1518426|NCT00708461|obesity prevention|obesity prevention
1518427|NCT00708461|worksite|worksite
1518428|NCT00708461|environment|environment
1518429|NCT00708461|intervention|intervention
1518430|NCT00708448|NSCLC|nsclc
1518431|NCT00708435|Anticoagulant reversal|anticoagulant reversal
1518432|NCT00708435|Prothrombin|prothrombin
1518433|NCT00708435|Complex|complex
1518434|NCT00708435|Concentrate|concentrate
1518435|NCT00708435|Coagulopathy|coagulopathy
1518436|NCT00708435|induced by|induced by
1518437|NCT00708435|coumarin|coumarin
1518438|NCT00708435|derivatives|derivatives
1518439|NCT00708435|Kcentra|kcentra
1518440|NCT00708422|Ocular surface health|ocular surface health
1518441|NCT00708422|OSDI|osdi
1518442|NCT00708422|TFBUT|tfbut
1518443|NCT00708422|Glaucoma|glaucoma
1518444|NCT00708422|Ocular hypertension|ocular hypertension
1518445|NCT00708422|Corneal staining|corneal staining
1518446|NCT00708409|Ross operation|ross operation
1518447|NCT00708409|autograft procedure|autograft procedure
1518448|NCT00708409|pulmonary homograft|pulmonary homograft
1518449|NCT00708409|root replacement technique|root replacement technique
1518450|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
1518451|NCT00708396|Patients|patients
1518452|NCT00708396|suffer|suffer
1518453|NCT00708396|from|from
1518751|NCT00707187|scleroderma|scleroderma
1518454|NCT00708383|embryo development|embryo development
1518455|NCT00708383|embryo quality|embryo quality
1518456|NCT00708383|implantation|implantation
1518457|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
1518458|NCT00708383|multiple pregnancy|multiple pregnancy
1518459|NCT00708370|Interventional|interventional
1518460|NCT00708370|Non-drug|non-drug
1518461|NCT00708370|Disease Management Program|disease management program
1518462|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
1518463|NCT00708370|Dyslipidemias|dyslipidemias
1518464|NCT00708370|Primary Care Centers|primary care centers
1518465|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
1518466|NCT00708357|ocular blood flow|ocular blood flow
1518467|NCT00708331|Cataract|cataract
1518468|NCT00708331|Extraction|extraction
1518469|NCT00708331|Intraocular Lens|intraocular lens
1518470|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
1518471|NCT00708318|AeroLEF|aerolef
1518472|NCT00708318|fentanyl|fentanyl
1518473|NCT00708318|pharmacokinetic|pharmacokinetic
1518474|NCT00708318|liposome|liposome
1518475|NCT00708318|encapsulated|encapsulated
1518476|NCT00708305|toothpaste|toothpaste
1518477|NCT00708305|plaque fluid|plaque fluid
1518478|NCT00708305|fluoride|fluoride
1518479|NCT00708292|AUY922|auy922
1518480|NCT00708292|Multiple Myeloma|multiple myeloma
1518481|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
1518482|NCT00708292|Phase I/II|phase i/ii
1518483|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
1518484|NCT00708266|Obesity|obesity
1518485|NCT00708266|Diabetes|diabetes
1518486|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
1518487|NCT00708266|Cytokines|cytokines
1518488|NCT00708266|Inflammation|inflammation
1518489|NCT00708266|Subcutaneous fat|subcutaneous fat
1518490|NCT00708266|Adipose tissue|adipose tissue
1518491|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
1518492|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
1518493|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
1518494|NCT00708253|insertion depth|insertion depth
1518495|NCT00708227|Asthma|asthma
1518496|NCT00708227|Pharmacogenetics|pharmacogenetics
1518497|NCT00708227|Salmeterol|salmeterol
1518498|NCT00708227|African American|african american
1518499|NCT00708227|White|white
1518500|NCT00708201|ileus|ileus
1518501|NCT00708201|POI|poi
1518502|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
1518503|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
1518504|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
1518505|NCT00708175|Type II Diabetes|type ii diabetes
1518506|NCT00708175|Diabetes Mellitus|diabetes mellitus
1518507|NCT00708175|Lipoatrophic|lipoatrophic
1518508|NCT00708175|Postmenopausal|postmenopausal
1518509|NCT00708162|HIV|hiv
1518510|NCT00708162|HIV I|hiv i
1518511|NCT00708162|Treatment Experienced|treatment experienced
1518512|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
1518513|NCT00708136|Falls|falls
1518514|NCT00708136|elderly|elderly
1518515|NCT00708136|Balance|balance
1518516|NCT00708136|speed of stepping|speed of stepping
1518517|NCT00708136|Stability|stability
1518518|NCT00708136|ELDERLY FALLERS|elderly fallers
1518519|NCT00708123|remineralization|remineralization
1518520|NCT00708123|enamel|enamel
1518521|NCT00708123|fluoride|fluoride
1518522|NCT00708123|caries|caries
1518523|NCT00708123|in situ|in situ
1518524|NCT00708110|dose-ranging study|dose-ranging study
1518525|NCT00708110|phase IIa|phase iia
1518526|NCT00708110|integrase inhibitor|integrase inhibitor
1518527|NCT00708110|HIV-1 infection|hiv-1 infection
1518528|NCT00708097|fluoride|fluoride
1518529|NCT00708097|in situ|in situ
1518530|NCT00708097|remineralization|remineralization
1518531|NCT00708097|enamel|enamel
1518532|NCT00708097|caries|caries
1518533|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
1518534|NCT00708084|Monoclonal antibody|monoclonal antibody
1518535|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
1518536|NCT00708058|Congestive Heart Failure|congestive heart failure
1518537|NCT00708058|Emergency Department|emergency department
1518538|NCT00708045|Breast Cancer|breast cancer
1518539|NCT00708019|cancer pain|cancer pain
1518540|NCT00708019|bone metastasis|bone metastasis
1518541|NCT00708019|psychoeducational intervention|psychoeducational intervention
1518542|NCT00708019|nurse coaching|nurse coaching
1518543|NCT00708019|patient education|patient education
1518544|NCT00708019|breast cancer|breast cancer
1518545|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
1518546|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
1518547|NCT00707993|Type II Diabetes|type ii diabetes
1518548|NCT00707993|Diabetes Mellitus|diabetes mellitus
1518549|NCT00707993|Lipoatrophic|lipoatrophic
1518550|NCT00707993|Dyslipidemia|dyslipidemia
1518551|NCT00707993|Drug Therapy|drug therapy
1518552|NCT00707980|Major Depressive Disorder|major depressive disorder
1518553|NCT00707980|Depression|depression
1518554|NCT00707980|Melancholia|melancholia
1518555|NCT00707980|Mood Disorder|mood disorder
1518556|NCT00707980|Dysthymic Disorder|dysthymic disorder
1518557|NCT00707980|Drug Therapy|drug therapy
1518558|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
1518559|NCT00707954|Diabetes|diabetes
1518560|NCT00707954|TA-7284|ta-7284
1518561|NCT00707941|Influenza like illness|influenza like illness
1518562|NCT00707941|Pneumonia|pneumonia
1518563|NCT00707941|Bronchiolitis|bronchiolitis
1518564|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
1518565|NCT00707941|Otitis media|otitis media
1518566|NCT00707941|Viral shedding|viral shedding
1518567|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
1518568|NCT00707941|Viral culture|viral culture
1518569|NCT00707941|PCR|pcr
1518570|NCT00707928|retained placenta|retained placenta
1518571|NCT00707915|aged|aged
1518572|NCT00707915|benzodiazepines|benzodiazepines
1518573|NCT00707915|hypnotics|hypnotics
1518574|NCT00707915|cognition|cognition
1518575|NCT00707915|posture|posture
1518576|NCT00707902|Sore throats,|sore throats,
1518577|NCT00707902|Pharyngitis|pharyngitis
1518578|NCT00707902|Acute|acute
1518579|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
1518580|NCT00707863|Escitalopram|escitalopram
1518581|NCT00707863|Lexapro|lexapro
1518582|NCT00707863|fMRI|fmri
1518583|NCT00707863|pictures|pictures
1518584|NCT00707850|Hepatitis C|hepatitis c
1518585|NCT00707850|Thalassemia|thalassemia
1518586|NCT00707850|Pegasys|pegasys
1518587|NCT00707850|Ribavirin|ribavirin
1518588|NCT00707824|pruritus|pruritus
1518589|NCT00707824|epidural morphine|epidural morphine
1518590|NCT00707811|Dyspnea|dyspnea
1518591|NCT00707811|Shortness of Breath|shortness of breath
1518592|NCT00707811|Trouble Breathing|trouble breathing
1518593|NCT00707811|ST2|st2
1518594|NCT00707811|IL-33|il-33
1518595|NCT00707798|Young adults|young adults
1518596|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
1518597|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
1518598|NCT00707785|vitamin A|vitamin a
1518599|NCT00707785|Treatment|treatment
1518600|NCT00707785|neonates|neonates
1518601|NCT00707785|newborn|newborn
1518602|NCT00707785|sepsis|sepsis
1518603|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
1518604|NCT00707785|meningitis|meningitis
1518605|NCT00707785|pneumonia|pneumonia
1518606|NCT00707772|Hepatitis C|hepatitis c
1518607|NCT00707772|Hemophilia|hemophilia
1518608|NCT00707772|Pegasys|pegasys
1518609|NCT00707772|Ribavirin|ribavirin
1518610|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
1518611|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
1518612|NCT00707746|statin intolerant|statin intolerant
1518613|NCT00707746|hypercholesterolemia|hypercholesterolemia
1518614|NCT00707707|breast cancer|breast cancer
1518615|NCT00707707|triple negative|triple negative
1518616|NCT00707707|metastatic|metastatic
1518617|NCT00707694|95 years of age and older|95 years of age and older
1518618|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
1518619|NCT00707668|Diabetes|diabetes
1518620|NCT00707668|metabolic syndrome|metabolic syndrome
1518621|NCT00707668|dyslipidemia|dyslipidemia
1518622|NCT00707668|osteoporosis|osteoporosis
1518623|NCT00707642|West Nile Virus|west nile virus
1518624|NCT00707642|West Nile Vaccine|west nile vaccine
1518625|NCT00707642|West Nile virus disease|west nile virus disease
1518626|NCT00707642|Hawaii Biotech|hawaii biotech
1518627|NCT00707629|type 1 diabetes|type 1 diabetes
1518628|NCT00707629|neurocognitive measures|neurocognitive measures
1518629|NCT00707629|behavioral measures|behavioral measures
1518630|NCT00707603|Insulin resistance|insulin resistance
1518631|NCT00707603|Liver fat|liver fat
1518632|NCT00707603|Muscle fat|muscle fat
1518633|NCT00707603|Abdominal fat|abdominal fat
1518634|NCT00707603|Cytokines|cytokines
1518635|NCT00707577|Worksite Wellness|worksite wellness
1518636|NCT00707577|Weight loss and maintenance|weight loss and maintenance
1518637|NCT00707577|Physical Activity|physical activity
1518638|NCT00707577|Health and Fitness interventions|health and fitness interventions
1518639|NCT00707577|Healthy eating|healthy eating
1518640|NCT00707577|Weight loss|weight loss
1518641|NCT00707577|Maintenance programs|maintenance programs
1518642|NCT00707564|hemostasis|hemostasis
1518643|NCT00707564|tooth extractions|tooth extractions
1518644|NCT00707551|AZD1305|azd1305
1518645|NCT00707551|Verapamil|verapamil
1518646|NCT00707551|Ketoconazole|ketoconazole
1518647|NCT00707551|pharmacokinetics|pharmacokinetics
1518648|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
1518838|NCT00706732|Flu|flu
1567717|NCT00508378|Ovarian Cancer|ovarian cancer
1518649|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
1518650|NCT00707473|Carcinoma of Paranasal Sinuses|carcinoma of paranasal sinuses
1518651|NCT00707473|Paranasal Sinuses|paranasal sinuses
1518652|NCT00707473|Nasal Sinuses|nasal sinuses
1518653|NCT00707473|Nasal Cavity|nasal cavity
1518654|NCT00707473|Squamous Cell Carcinoma|squamous cell carcinoma
1518655|NCT00707473|Undifferentiated Carcinoma|undifferentiated carcinoma
1518656|NCT00707473|Poorly Differentiated Carcinoma|poorly differentiated carcinoma
1518657|NCT00707473|Docetaxel|docetaxel
1518658|NCT00707473|5-Fluorouracil|5-fluorouracil
1518659|NCT00707473|Cisplatin|cisplatin
1518660|NCT00707473|Platinol®|platinol®
1518661|NCT00707473|Platinol®-AQ|platinol®-aq
1518662|NCT00707460|Diabetes|diabetes
1518663|NCT00707460|Cardiovascular|cardiovascular
1518664|NCT00707460|Obesity|obesity
1518665|NCT00707460|First.Nation|first.nation
1518666|NCT00707460|Aboriginal (Health)|aboriginal (health)
1518667|NCT00707460|Dietary|dietary
1518668|NCT00707460|Intervention|intervention
1518669|NCT00707460|Nutrition|nutrition
1518670|NCT00707460|Traditional (Diet)|traditional (diet)
1518671|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
1518672|NCT00707460|(High) protein|(high) protein
1518673|NCT00707460|(High) fibre (er)|(high) fibre (er)
1518674|NCT00707460|(Low) carbohydrate|(low) carbohydrate
1518675|NCT00707447|diabetes-prevention|diabetes-prevention
1518676|NCT00707447|lifestyle modification|lifestyle modification
1518677|NCT00707447|behavior therapy|behavior therapy
1518678|NCT00707447|self-management|self-management
1518679|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
1518680|NCT00707434|Medtronic Guardian|medtronic guardian
1518681|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
1518682|NCT00707434|Glucose Monitoring|glucose monitoring
1518683|NCT00707434|Critically Ill|critically ill
1518684|NCT00707434|ICU|icu
1518685|NCT00707434|Intensive Care Unit|intensive care unit
1518686|NCT00707434|Glycemic Excursions|glycemic excursions
1518687|NCT00707434|Glucose Control|glucose control
1518688|NCT00707434|Glucose Testing|glucose testing
1518689|NCT00707434|Hyperglycemia|hyperglycemia
1518690|NCT00707434|Hypoglycemia|hypoglycemia
1518691|NCT00707434|Insulin Infusion|insulin infusion
1518692|NCT00707382|Pharmacogenetics|pharmacogenetics
1518693|NCT00707382|Compliance|compliance
1518694|NCT00707382|Antipsychotic drugs|antipsychotic drugs
1518695|NCT00707382|Schizophrenia|schizophrenia
1518696|NCT00707369|Periodontitis|periodontitis
1518697|NCT00707369|Mechanical Debridement|mechanical debridement
1518698|NCT00707369|Antibiotics|antibiotics
1518699|NCT00707369|Attachment loss|attachment loss
1518700|NCT00707369|Randomized controlled trial|randomized controlled trial
1518701|NCT00707356|Prostatic disease|prostatic disease
1518702|NCT00707356|genital neoplasm, male|genital neoplasm, male
1518703|NCT00707356|Urogenital neoplasm|urogenital neoplasm
1518704|NCT00707356|Genital disease|genital disease
1518705|NCT00707356|male|male
1518706|NCT00707356|Male urogenital disease|male urogenital disease
1518707|NCT00707356|Neoplasms|neoplasms
1518708|NCT00707356|Neoplasm by site|neoplasm by site
1518709|NCT00707356|prostatic neoplasm|prostatic neoplasm
1518710|NCT00707356|Carcinoma|carcinoma
1518711|NCT00707330|oxidative stress|oxidative stress
1518712|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
1518713|NCT00707330|8-oxodG|8-oxodg
1518714|NCT00707330|clarithromycin|clarithromycin
1518715|NCT00707330|malondialdehyde|malondialdehyde
1518716|NCT00707330|mda|mda
1518717|NCT00707330|vitamine C|vitamine c
1518718|NCT00707330|ascorbic acid|ascorbic acid
1518719|NCT00707317|M. tuberculosis|m. tuberculosis
1518720|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
1518721|NCT00707317|Quantiferon assay|quantiferon assay
1518722|NCT00707317|ELISPOT assay|elispot assay
1518723|NCT00707317|tuberculin skin test|tuberculin skin test
1518724|NCT00707317|immunocompromised patients|immunocompromised patients
1518725|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
1518726|NCT00707304|Talactoferrin|talactoferrin
1518727|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
1518728|NCT00707304|Immunomodulatory agent|immunomodulatory agent
1518729|NCT00707291|contact lens|contact lens
1518730|NCT00707291|normal|normal
1518731|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
1518732|NCT00707252|Erlotinib|erlotinib
1518733|NCT00707252|Polyphenon E|polyphenon e
1518734|NCT00707252|Tarceva|tarceva
1518735|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
1518736|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
1518737|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
1518738|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
1518739|NCT00707226|Choroidal blood flow|choroidal blood flow
1518740|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
1518741|NCT00707226|Intraocular Pressure|intraocular pressure
1518742|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
1518743|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
1518744|NCT00707200|lactic acidosis|lactic acidosis
1518745|NCT00707200|hyperparasitemia|hyperparasitemia
1679662|NCT00085917|Pegasys|pegasys
1518746|NCT00707200|respiratory distress|respiratory distress
1518747|NCT00707200|hypoxia|hypoxia
1518748|NCT00707200|death|death
1518749|NCT00707200|transfusion|transfusion
1518750|NCT00707187|systemic sclerosis|systemic sclerosis
1518752|NCT00707187|raynaud phenomenon|raynaud phenomenon
1518753|NCT00707174|Lentigo Maligna|lentigo maligna
1518754|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
1518755|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
1518756|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1518757|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1518758|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1518759|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1518760|NCT00707070|psoriasis|psoriasis
1518761|NCT00707070|acitretin|acitretin
1518762|NCT00707070|efalizumab|efalizumab
1518763|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
1518764|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
1518765|NCT00707005|bacterial flora|bacterial flora
1518766|NCT00707005|fluoroquinolone|fluoroquinolone
1518767|NCT00707005|LASIK|lasik
1518768|NCT00707005|refractive surgery|refractive surgery
1518769|NCT00706992|MART-1 Peptide|mart-1 peptide
1518770|NCT00706992|Melanoma|melanoma
1518771|NCT00706992|Adjuvant Therapy|adjuvant therapy
1518772|NCT00706992|Gene Therapy|gene therapy
1518773|NCT00706992|T Cell Persistence|t cell persistence
1518774|NCT00706979|smoking|smoking
1518775|NCT00706979|smoking cessation|smoking cessation
1518776|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
1518777|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1518778|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
1518779|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
1518780|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
1518781|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1518782|NCT00706953|VELCADE|velcade
1518783|NCT00706953|DOXIL|doxil
1518784|NCT00706953|relapsed|relapsed
1518785|NCT00706953|Multiple Myeloma|multiple myeloma
1518786|NCT00706940|dry eye|dry eye
1518787|NCT00706940|Optical coherence tomography|optical coherence tomography
1518788|NCT00706927|xalacom|xalacom
1518789|NCT00706927|combigan|combigan
1518790|NCT00706927|ocular blood flow|ocular blood flow
1518791|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
1518792|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
1518793|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1518794|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1518795|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1518796|NCT00706914|COPD|copd
1518797|NCT00706914|COAD|coad
1518798|NCT00706901|MI|mi
1518799|NCT00706901|IHMD|ihmd
1518800|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
1518801|NCT00706875|GTD survivors|gtd survivors
1518802|NCT00706875|questionnaires|questionnaires
1518803|NCT00706875|GTD|gtd
1518928|NCT00706290|depression|depression
1518804|NCT00706862|Non small cell lung cancer|non small cell lung cancer
1518805|NCT00706862|Talactoferrin|talactoferrin
1518806|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
1518807|NCT00706862|DCRA|dcra
1518808|NCT00706862|Immunomodulatory agent|immunomodulatory agent
1518809|NCT00706862|Lactoferrin|lactoferrin
1518810|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
1518811|NCT00706836|anxiety|anxiety
1518812|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
1518813|NCT00706836|fMRI|fmri
1518814|NCT00706836|pregabalin|pregabalin
1518815|NCT00706836|Lyrica|lyrica
1518816|NCT00706823|Endotracheal Intubation|endotracheal intubation
1518817|NCT00706823|Supraglottic Airway|supraglottic airway
1518818|NCT00706810|Cancer|cancer
1518819|NCT00706810|Brain cancer|brain cancer
1518820|NCT00706810|Meningioma|meningioma
1518821|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
1518822|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
1518823|NCT00706771|sodium bicarbonate|sodium bicarbonate
1518824|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
1518825|NCT00706771|renal impairment|renal impairment
1518826|NCT00706771|renal failure|renal failure
1518827|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1518828|NCT00706771|defined|defined
1518829|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
1518830|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
1518831|NCT00706758|Patient education|patient education
1518832|NCT00706745|atherosclerosis|atherosclerosis
1518833|NCT00706745|dietary supplements|dietary supplements
1518834|NCT00706745|randomised controlled trial|randomised controlled trial
1518835|NCT00706745|arterial stiffness|arterial stiffness
1518836|NCT00706745|linoleic acid|linoleic acid
1518839|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
1518840|NCT00706732|Alphavirus|alphavirus
1518841|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
1518842|NCT00706719|Secondary hypogonadism|secondary hypogonadism
1518843|NCT00706719|Semen volume|semen volume
1518844|NCT00706719|Sperm count|sperm count
1518845|NCT00706719|Sperm motility|sperm motility
1518846|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
1518847|NCT00706693|hypoglycemia|hypoglycemia
1518848|NCT00706693|treatment|treatment
1518849|NCT00706693|glucose|glucose
1518850|NCT00706693|sucrose|sucrose
1518851|NCT00706693|fructose|fructose
1518852|NCT00706654|Aripiprazole|aripiprazole
1518853|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
1518854|NCT00706654|Schizophrenia|schizophrenia
1518855|NCT00706615|stage IV breast cancer|stage iv breast cancer
1518856|NCT00706615|recurrent breast cancer|recurrent breast cancer
1518857|NCT00706602|COPD|copd
1518858|NCT00706602|prognosis|prognosis
1518859|NCT00706602|prediction rule|prediction rule
1518860|NCT00706602|health-related quality of life|health-related quality of life
1518861|NCT00706602|risk factors|risk factors
1518862|NCT00706602|derivation|derivation
1518863|NCT00706602|validation|validation
1518864|NCT00706602|exacerbation|exacerbation
1518865|NCT00706602|mortality|mortality
1518866|NCT00706602|primary care|primary care
1518867|NCT00706602|treatment|treatment
1518868|NCT00706602|decision making|decision making
1518869|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
1518870|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
1518871|NCT00706589|Tourette's disorder|tourette's disorder
1518872|NCT00706589|Aripiprazole|aripiprazole
1518873|NCT00706589|Abilify|abilify
1518874|NCT00706589|Children|children
1518875|NCT00706589|Adolescent|adolescent
1518876|NCT00706576|Hepatocellular cancer|hepatocellular cancer
1518877|NCT00706576|HCC|hcc
1518878|NCT00706576|Opioid growth factor|opioid growth factor
1518879|NCT00706576|OGF|ogf
1518880|NCT00706576|Cirrhosis|cirrhosis
1518881|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
1518882|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
1518883|NCT00706511|OSA|osa
1518884|NCT00706511|Diabetes|diabetes
1518885|NCT00706511|Metabolism|metabolism
1518886|NCT00706511|Gender|gender
1518887|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
1518888|NCT00706485|dural brachytherapy|dural brachytherapy
1518889|NCT00706446|Asthma|asthma
1518890|NCT00706446|Pharmacogenetics|pharmacogenetics
1518891|NCT00706446|Beta agonists|beta agonists
1518892|NCT00706446|salmeterol|salmeterol
1518893|NCT00706446|formoterol|formoterol
1518894|NCT00706446|tiotropium|tiotropium
1518895|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
1518896|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
1518897|NCT00706433|Photodynamic Therapy|photodynamic therapy
1518898|NCT00706420|Diabetes Mellitus|diabetes mellitus
1518899|NCT00706420|Islet Transplantation Alone|islet transplantation alone
1518900|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
1518901|NCT00706394|Powerlink|powerlink
1518902|NCT00706394|34mm|34mm
1518903|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1518904|NCT00706394|EVAR|evar
1518905|NCT00706381|Deiodinase|deiodinase
1518906|NCT00706381|Bile Acids|bile acids
1518907|NCT00706381|Cholecystokinin|cholecystokinin
1518908|NCT00706381|Thyroid Hormones|thyroid hormones
1518909|NCT00706381|Energy Expenditure|energy expenditure
1518910|NCT00706381|Health Volunteer|health volunteer
1518911|NCT00706381|HV|hv
1518912|NCT00706368|Sexually transmitted infections|sexually transmitted infections
1518913|NCT00706368|Acceptability|acceptability
1518914|NCT00706368|Adolescent vaginitis|adolescent vaginitis
1518915|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
1518916|NCT00706329|Minimally invasive surgery|minimally invasive surgery
1518917|NCT00706329|Umbilical hernia|umbilical hernia
1518918|NCT00706329|Infant|infant
1518919|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
1518920|NCT00706316|Epstein Barr Virus|epstein barr virus
1518921|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
1518922|NCT00706316|Recurrent|recurrent
1518923|NCT00706316|Metastatic|metastatic
1518924|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
1518925|NCT00706303|COPD|copd
1518926|NCT00706303|self management|self management
1518927|NCT00706290|anxiety|anxiety
1518929|NCT00706290|quality of life|quality of life
1518930|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1518931|NCT00706290|advanced cancer|advanced cancer
1518932|NCT00706290|metastatic cancer|metastatic cancer
1518933|NCT00706290|stage IV cancer|stage iv cancer
1518934|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
1518935|NCT00706277|forced vital capacity|forced vital capacity
1518936|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
1518937|NCT00706264|Short cervix|short cervix
1518938|NCT00706264|preterm birth|preterm birth
1518939|NCT00706264|arabin pessary|arabin pessary
1518940|NCT00706238|metastatic,|metastatic,
1518941|NCT00706238|Melanoma,|melanoma,
1518942|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
1518943|NCT00706238|ASCI|asci
1518944|NCT00706238|MAGE-A3|mage-a3
1518945|NCT00706238|tumor antigen,|tumor antigen,
1518946|NCT00706199|bone marrow|bone marrow
1518947|NCT00706199|antigen expression|antigen expression
1518948|NCT00706199|volunteers|volunteers
1518949|NCT00706186|Mild Alzheimer's|mild alzheimer's
1518950|NCT00706186|Disease|disease
1518951|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
1518952|NCT00706173|PTSD|ptsd
1518953|NCT00706173|Cortisol|cortisol
1518954|NCT00706173|hydrocortisone|hydrocortisone
1518955|NCT00706173|pharmacological treatment|pharmacological treatment
1518956|NCT00706160|Epilepsy|epilepsy
1518957|NCT00706160|Language|language
1518958|NCT00706160|fMRI|fmri
1518959|NCT00706160|Magnetoencephalogram|magnetoencephalogram
1518960|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
1518961|NCT00706160|Partial Epilepsy|partial epilepsy
1518962|NCT00706160|Healthy Volunteer|healthy volunteer
1518963|NCT00706160|HV|hv
1518964|NCT00706147|Hereditary ALS|hereditary als
1518965|NCT00706147|Hereditary neurological disease|hereditary neurological disease
1518966|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
1518967|NCT00706147|Motor Neuron Disease|motor neuron disease
1518968|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1518969|NCT00706147|Familial ALS|familial als
1518970|NCT00706147|Neuromuscular disease|neuromuscular disease
1518971|NCT00706147|SOD1 mutation|sod1 mutation
1518972|NCT00706147|Superoxide dismutase|superoxide dismutase
1518973|NCT00706147|SOD1 positive ALS|sod1 positive als
1518974|NCT00706147|inherited ALS|inherited als
1518975|NCT00706134|Hypertension|hypertension
1518976|NCT00706134|≥ 65 years|≥ 65 years
1518977|NCT00706134|aliskiren|aliskiren
1518978|NCT00706134|placebo|placebo
1518979|NCT00706134|light meal|light meal
1518980|NCT00706121|colon cancer|colon cancer
1518981|NCT00706121|rectal cancer|rectal cancer
1518982|NCT00706121|adenomatous polyp|adenomatous polyp
1518983|NCT00706095|Cancer|cancer
1518984|NCT00706095|advanced solid tumors|advanced solid tumors
1518985|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
1518986|NCT00706069|Vinorelbine oral|vinorelbine oral
1518987|NCT00706069|Capecitabine|capecitabine
1518988|NCT00706043|Low back pain|low back pain
1518989|NCT00706030|Metastatic breast cancer|metastatic breast cancer
1518990|NCT00706030|HKI-272|hki-272
1518991|NCT00706030|Neratinib|neratinib
1518992|NCT00706030|Nerlynx|nerlynx
1518993|NCT00706030|PB-272|pb-272
1518994|NCT00706004|constipation|constipation
1518995|NCT00706004|cystic fibrosis|cystic fibrosis
1518996|NCT00706004|lubiprostone|lubiprostone
1518997|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
1518998|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
1518999|NCT00705965|Coronary artery disease|coronary artery disease
1519000|NCT00705965|depression|depression
1519001|NCT00705965|psychotherapy|psychotherapy
1519002|NCT00705965|randomized controlled trial|randomized controlled trial
1519003|NCT00705952|No diabetes medications|no diabetes medications
1519004|NCT00705952|New onset|new onset
1519005|NCT00705939|Gaucher Disease|gaucher disease
1519006|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
1519007|NCT00705926|Acute Infection|acute infection
1519008|NCT00705926|HIV|hiv
1519009|NCT00705926|HAART|haart
1519010|NCT00705926|Treatment Naive|treatment naive
1519011|NCT00705913|aortic valve|aortic valve
1519012|NCT00705913|heart valve|heart valve
1519013|NCT00705913|valve replacement|valve replacement
1519014|NCT00705913|valve disease|valve disease
1519015|NCT00705900|psoriasis|psoriasis
1519016|NCT00705887|Ultraviolet Rays|ultraviolet rays
1519017|NCT00705887|Motivation|motivation
1519018|NCT00705887|Health Education|health education
1519019|NCT00705887|Randomized Controlled Trial|randomized controlled trial
1519020|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1519021|NCT00705874|cancer|cancer
1519022|NCT00705874|advanced cancer|advanced cancer
1519023|NCT00705874|solid tumors|solid tumors
1519024|NCT00705874|lymphoma|lymphoma
1519025|NCT00705874|CGC-11047|cgc-11047
1519026|NCT00705861|Erectile dysfunction|erectile dysfunction
1519027|NCT00705861|Diabetes Mellitus|diabetes mellitus
1519028|NCT00705861|SK3530|sk3530
1519029|NCT00705848|trachea|trachea
1519030|NCT00705848|malacia|malacia
1519031|NCT00705848|stenosis|stenosis
1519032|NCT00705835|Prostate|prostate
1519033|NCT00705835|ALHYDROGEL|alhydrogel
1519034|NCT00705835|RS-PSMA|rs-psma
1519035|NCT00705809|Epidemiology|epidemiology
1519036|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
1519037|NCT00705796|Hypogonadism|hypogonadism
1519038|NCT00705796|Spermatogenesis|spermatogenesis
1519039|NCT00705796|Quality of Life|quality of life
1519040|NCT00705783|Aripiprazole|aripiprazole
1519041|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
1519042|NCT00705783|Schizophrenia|schizophrenia
1519043|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
1519044|NCT00705770|Intraocular Pressure|intraocular pressure
1519045|NCT00705770|Anecortave Acetate|anecortave acetate
1519046|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
1519047|NCT00705757|Lumigan|lumigan
1519048|NCT00705757|Travatan|travatan
1519049|NCT00705757|Xalatan|xalatan
1519050|NCT00705757|latanoprost|latanoprost
1519051|NCT00705757|bimatoprost|bimatoprost
1519052|NCT00705757|travoprost|travoprost
1519053|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
1519054|NCT00705731|Colorectal cancer screening|colorectal cancer screening
1519055|NCT00705731|Colonoscopy|colonoscopy
1519178|NCT00704990|Pediatrics|pediatrics
1519056|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
1519057|NCT00705731|Cost-effectiveness|cost-effectiveness
1519058|NCT00705718|Endurant Stent Graft System|endurant stent graft system
1519059|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1519060|NCT00705718|Endovascular Treatment|endovascular treatment
1519061|NCT00705705|High-Risk Behavior|high-risk behavior
1519062|NCT00705705|Men Who Have Sex With Men|men who have sex with men
1519063|NCT00705705|HIV Seronegativity|hiv seronegativity
1519064|NCT00705692|Tetanus|tetanus
1519065|NCT00705692|Vaccines|vaccines
1519066|NCT00705692|Renal Dialysis|renal dialysis
1519067|NCT00705692|Levamisole|levamisole
1519068|NCT00705679|Microbicide|microbicide
1519069|NCT00705679|HIV Seronegativity|hiv seronegativity
1519070|NCT00705653|cancer|cancer
1519071|NCT00705653|advanced cancer|advanced cancer
1519072|NCT00705653|solid tumors|solid tumors
1519073|NCT00705653|CGC-11047|cgc-11047
1519074|NCT00705653|PG-11047|pg-11047
1519075|NCT00705640|stage II melanoma|stage ii melanoma
1519076|NCT00705640|stage III melanoma|stage iii melanoma
1519077|NCT00705640|stage IV melanoma|stage iv melanoma
1519078|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1519079|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1519080|NCT00705640|conjunctival melanoma|conjunctival melanoma
1519081|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
1519082|NCT00705640|iris melanoma|iris melanoma
1519083|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
1519084|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
1519085|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1519086|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1519087|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
1519088|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
1519089|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
1519090|NCT00705575|Essential Hypertension|essential hypertension
1519091|NCT00705575|Stage II|stage ii
1519092|NCT00705549|Advanced|advanced
1519093|NCT00705549|NSCLC|nsclc
1519094|NCT00705549|ERCC1|ercc1
1519095|NCT00705549|RRM1|rrm1
1519096|NCT00705549|BCRA1|bcra1
1519097|NCT00705549|Alimta|alimta
1519098|NCT00705549|Gemcitabine|gemcitabine
1519099|NCT00705536|rHuPH20|rhuph20
1519100|NCT00705536|Hyaluronidase|hyaluronidase
1519101|NCT00705536|Insulin|insulin
1519102|NCT00705523|alcohol|alcohol
1519103|NCT00705523|treatment|treatment
1519104|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
1519105|NCT00705523|pharmacotherapy|pharmacotherapy
1519106|NCT00705523|outpatient|outpatient
1519107|NCT00705510|Cyclosporine|cyclosporine
1519108|NCT00705510|Unstable tear film|unstable tear film
1519109|NCT00705510|Meibomian gland|meibomian gland
1519110|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
1519111|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
1519112|NCT00705497|RFA|rfa
1519113|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
1519114|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
1519115|NCT00705445|Malnutrition|malnutrition
1519116|NCT00705445|Diarrhea|diarrhea
1519117|NCT00705445|Pneumonia|pneumonia
1519118|NCT00705445|Growth|growth
1519119|NCT00705445|Zinc Supplements|zinc supplements
1519120|NCT00705445|Microbiome|microbiome
1519121|NCT00705419|Treatment Experienced|treatment experienced
1519122|NCT00705354|Sinusitis|sinusitis
1519123|NCT00705354|Chronic Sinusitis|chronic sinusitis
1519124|NCT00705354|Nasal Surgery|nasal surgery
1519125|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
1519126|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
1519127|NCT00705341|Normal Controls|normal controls
1519128|NCT00705328|low-income families|low-income families
1519129|NCT00705328|children|children
1519130|NCT00705328|recreation|recreation
1519131|NCT00705328|family healthy lifestyle|family healthy lifestyle
1519132|NCT00705328|linkages to community resources|linkages to community resources
1519133|NCT00705328|Families with low incomes|families with low incomes
1519134|NCT00705328|working poor|working poor
1519135|NCT00705328|welfare recipients|welfare recipients
1519331|NCT00704054|CNS Tumor|cns tumor
1519136|NCT00705315|breast cancer|breast cancer
1519137|NCT00705315|chemotherapy|chemotherapy
1519138|NCT00705315|biological therapy|biological therapy
1519139|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1519140|NCT00705302|Outpatient|outpatient
1519141|NCT00705302|Patient education|patient education
1519142|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
1519143|NCT00705302|Self-management|self-management
1519144|NCT00705250|Bendamustine HCL|bendamustine hcl
1519145|NCT00705237|sinusitis|sinusitis
1519146|NCT00705185|Major Depressive Disorder|major depressive disorder
1519147|NCT00705185|Blood Test|blood test
1519148|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
1519149|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
1519150|NCT00705146|Thumb splints|thumb splints
1519151|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
1519152|NCT00705146|Grip and pinch strength|grip and pinch strength
1519153|NCT00705133|pulmonary hypertension|pulmonary hypertension
1519154|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
1519155|NCT00705133|interstitial lung disease|interstitial lung disease
1519156|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
1519157|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
1519158|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
1519159|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
1519160|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
1519161|NCT00705094|cardiac function|cardiac function
1519162|NCT00705094|VO2peak|vo2peak
1519163|NCT00705094|Chemotherapy|chemotherapy
1519164|NCT00705055|Anthropometry|anthropometry
1519165|NCT00705055|face recognition|face recognition
1519166|NCT00705055|genetic disease|genetic disease
1519167|NCT00705055|newborn infant|newborn infant
1519168|NCT00705016|Randomized treatment|randomized treatment
1519169|NCT00705016|open-label|open-label
1519170|NCT00705016|controlled|controlled
1519171|NCT00705016|recurrent|recurrent
1519172|NCT00705016|metastatic|metastatic
1519173|NCT00705016|SCCHN|scchn
1519174|NCT00705016|suitable|suitable
1519175|NCT00705016|for local therapy|for local therapy
1519176|NCT00705003|depression|depression
1519177|NCT00704990|Attention Deficit Disorder|attention deficit disorder
1519179|NCT00704990|Attention|attention
1519180|NCT00704990|Impulsivity|impulsivity
1519181|NCT00704990|Complementary Therapies|complementary therapies
1519182|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
1519183|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
1519184|NCT00704938|recurrent melanoma|recurrent melanoma
1519185|NCT00704938|stage IV melanoma|stage iv melanoma
1519186|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1519187|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
1519188|NCT00704925|3,4 DAP|3,4 dap
1519189|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
1519190|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
1519191|NCT00704886|dementia|dementia
1519192|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
1519193|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
1519194|NCT00704847|tolerability|tolerability
1519195|NCT00704834|Multiple Sclerosis|multiple sclerosis
1519196|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1519197|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
1519198|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
1519199|NCT00704834|Normal Controls|normal controls
1519200|NCT00704834|Blood Draw|blood draw
1519201|NCT00704821|Cancer|cancer
1519202|NCT00704821|PTC299|ptc299
1519203|NCT00704821|VEGF|vegf
1519204|NCT00704821|Angiogenesis|angiogenesis
1519205|NCT00704821|Post-transcriptional control|post-transcriptional control
1519206|NCT00704821|Docetaxel|docetaxel
1519207|NCT00704743|Colles fracture treatment|colles fracture treatment
1519208|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
1519209|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
1519211|NCT00704743|Emergency Department|emergency department
1519212|NCT00704743|cast|cast
1519213|NCT00704743|splint|splint
1519214|NCT00704743|treatment|treatment
1519215|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
1519216|NCT00704730|MTC|mtc
1519217|NCT00704704|high risk MDS|high risk mds
1519218|NCT00704704|IPSS|ipss
1519219|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
1519220|NCT00704704|Thalidomide|thalidomide
1519221|NCT00704704|response rate|response rate
1519222|NCT00704704|cytogenetic response|cytogenetic response
1519223|NCT00704704|QOL questionaries|qol questionaries
1519224|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
1519225|NCT00704678|Chronic Kidney Disease|chronic kidney disease
1519226|NCT00704678|hemodialysis|hemodialysis
1519227|NCT00704678|hyperphosphatemia|hyperphosphatemia
1519228|NCT00704678|Asian|asian
1519229|NCT00704678|patients|patients
1519230|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
1519231|NCT00704665|Skin score|skin score
1519232|NCT00704639|Head and Neck|head and neck
1519233|NCT00704639|Cetuximab|cetuximab
1519234|NCT00704639|Carboplatin|carboplatin
1519235|NCT00704639|Radiotherapy|radiotherapy
1519236|NCT00704626|Multiple Sclerosis|multiple sclerosis
1519237|NCT00704626|Autoimmune disease|autoimmune disease
1519238|NCT00704626|Inflammatory disease|inflammatory disease
1519239|NCT00704626|Myasthenia Gravis|myasthenia gravis
1519240|NCT00704626|Transverse Myelitis|transverse myelitis
1519241|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
1519242|NCT00704600|nelfinavir|nelfinavir
1519243|NCT00704600|radiosensitivity|radiosensitivity
1519244|NCT00704600|chemoradiation|chemoradiation
1519245|NCT00704587|cancer occurence|cancer occurence
1519246|NCT00704587|cancer recurrence|cancer recurrence
1519247|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
1519248|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
1519249|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
1519250|NCT00704561|Optical Coherence Tomography|optical coherence tomography
1519251|NCT00704561|Thrombus|thrombus
1519252|NCT00704509|Schizophrenia|schizophrenia
1519253|NCT00704509|Antipsychotic|antipsychotic
1519254|NCT00704509|Bifeprunox|bifeprunox
1519255|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
1519256|NCT00704483|Chronic Kidney Disease|chronic kidney disease
1519257|NCT00704483|hemodialysis|hemodialysis
1519258|NCT00704483|hyperphosphatemia|hyperphosphatemia
1519259|NCT00704483|hemodiafiltration|hemodiafiltration
1519260|NCT00704470|Patient Simulation|patient simulation
1519261|NCT00704470|Education, Medical, Continuing|education, medical, continuing
1519262|NCT00704470|Education, Medical, Graduate|education, medical, graduate
1519263|NCT00704470|Stress|stress
1519264|NCT00704457|Interstitial Cystitis|interstitial cystitis
1519265|NCT00704457|IC|ic
1519266|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
1519267|NCT00704431|SB-480848|sb-480848
1519268|NCT00704431|darapladib|darapladib
1519269|NCT00704431|tolerability|tolerability
1519270|NCT00704418|Cataract extraction|cataract extraction
1519271|NCT00704418|intraocular lens implantation|intraocular lens implantation
1519272|NCT00704405|hepatitis C|hepatitis c
1519273|NCT00704392|Solid tumors|solid tumors
1519274|NCT00704392|NSCLC|nsclc
1519275|NCT00704379|traumatic brain injury|traumatic brain injury
1519276|NCT00704379|TBI|tbi
1519277|NCT00704379|mood disorders|mood disorders
1519278|NCT00704379|anxiety disorders|anxiety disorders
1519279|NCT00704379|community reintegration|community reintegration
1519280|NCT00704379|executive function|executive function
1519281|NCT00704379|sertraline|sertraline
1519282|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
1519283|NCT00704366|Advanced carcinoma|advanced carcinoma
1519284|NCT00704327|Cognitive Functions|cognitive functions
1519285|NCT00704327|Brain Ischemia|brain ischemia
1519286|NCT00704327|Cerebral Atrophy|cerebral atrophy
1519287|NCT00704327|Dementia|dementia
1519288|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
1519289|NCT00704327|Memory impairment|memory impairment
1519290|NCT00704314|Insulin resistance|insulin resistance
1519291|NCT00704314|Statins|statins
1519292|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
1519293|NCT00704301|Delirium|delirium
1519294|NCT00704301|Confusion|confusion
1519295|NCT00704288|GBM|gbm
1519296|NCT00704288|Malignant gliomas|malignant gliomas
1519297|NCT00704275|dry eye|dry eye
1519298|NCT00704249|HIV infection|hiv infection
1519299|NCT00704249|nevirapine|nevirapine
1519300|NCT00704249|Treatment Experienced|treatment experienced
1519301|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
1519302|NCT00704210|Low Back Pain|low back pain
1519303|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
1519304|NCT00704158|CR011-vcMMAE|cr011-vcmmae
1519305|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
1519306|NCT00704158|metastatic breast cancer|metastatic breast cancer
1519307|NCT00704158|breast cancer|breast cancer
1519308|NCT00704158|CuraGen|curagen
1519309|NCT00704145|Drug Eluting Stents|drug eluting stents
1519310|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
1519311|NCT00704145|Optical Coherence Tomography|optical coherence tomography
1519312|NCT00704119|Rhudex|rhudex
1519313|NCT00704119|pharmacokinetic study|pharmacokinetic study
1519314|NCT00704106|Hepatitis B|hepatitis b
1519315|NCT00704106|HBV|hbv
1519316|NCT00704106|Treatment|treatment
1519317|NCT00704093|pacing|pacing
1519318|NCT00704093|perfusion|perfusion
1519319|NCT00704093|oxidative metabolism|oxidative metabolism
1519320|NCT00704093|efficiency|efficiency
1519321|NCT00704080|GBM|gbm
1519322|NCT00704080|Anaplastic glioma|anaplastic glioma
1519323|NCT00704067|vocational rehabilitation|vocational rehabilitation
1519324|NCT00704067|supported employment|supported employment
1519325|NCT00704067|cognitive training|cognitive training
1519326|NCT00704067|cognitive remediation|cognitive remediation
1519327|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
1519328|NCT00704067|veterans|veterans
1519329|NCT00704054|Pediatric|pediatric
1519330|NCT00704054|Solid Tumor|solid tumor
1519332|NCT00704054|Lymphoma|lymphoma
1519333|NCT00704015|Smoking cessation|smoking cessation
1519334|NCT00704015|Acute injury|acute injury
1519335|NCT00704015|Musculoskeletal|musculoskeletal
1519433|NCT00703534|GERD|gerd
1519336|NCT00704015|Postoperative complications|postoperative complications
1519337|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
1519338|NCT00704002|displacement|displacement
1519339|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
1519340|NCT00704002|conservative treatment|conservative treatment
1519341|NCT00703989|hyperglycemia|hyperglycemia
1519342|NCT00703989|diabetic complications|diabetic complications
1519343|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
1519344|NCT00703989|hexosamine pathway|hexosamine pathway
1519345|NCT00703989|prostacyclin synthase|prostacyclin synthase
1519346|NCT00703989|reactive oxygen species|reactive oxygen species
1519347|NCT00703976|head and neck cancers|head and neck cancers
1519348|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
1519349|NCT00703950|Sucking patterns|sucking patterns
1519350|NCT00703950|preterm infants|preterm infants
1519351|NCT00703950|breastfeeding|breastfeeding
1519352|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
1519354|NCT00703898|nevirapine|nevirapine
1519355|NCT00703898|durability|durability
1519356|NCT00703898|AIDS|aids
1519357|NCT00703898|Treatment Naïve|treatment naïve
1519358|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
1519359|NCT00703885|fMRI|fmri
1519360|NCT00703885|alprazolam|alprazolam
1519361|NCT00703885|anxiety disorders|anxiety disorders
1519362|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
1519363|NCT00703872|Naive|naive
1519364|NCT00703872|Nonresponders|nonresponders
1519365|NCT00703872|Interferon|interferon
1519366|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
1519367|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
1519368|NCT00703859|PK profile of DCA|pk profile of dca
1519369|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
1519370|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
1519371|NCT00703846|Phase 4|phase 4
1519372|NCT00703846|Seborrheic|seborrheic
1519373|NCT00703846|Ketoconazole|ketoconazole
1519374|NCT00703846|Dermatitis|dermatitis
1519375|NCT00703794|ev3 Neurovascular|ev3 neurovascular
1519376|NCT00703794|aneurysms|aneurysms
1519377|NCT00703794|cerebrovascular|cerebrovascular
1519378|NCT00703794|endovascular|endovascular
1519379|NCT00703794|neurovascular therapies|neurovascular therapies
1519380|NCT00703794|RACER|racer
1519381|NCT00703794|AXIUM|axium
1519382|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
1519383|NCT00703794|ev3|ev3
1519384|NCT00703794|MTI|mti
1519385|NCT00703794|Micro Therapeutics|micro therapeutics
1519386|NCT00703794|FX detachable coil system|fx detachable coil system
1519387|NCT00703794|K060747|k060747
1519388|NCT00703794|brain diseases|brain diseases
1519389|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
1519390|NCT00703768|Quality of Life|quality of life
1519391|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
1519392|NCT00703768|Goserelin|goserelin
1519393|NCT00703755|Diabetes|diabetes
1519394|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
1519395|NCT00703755|Metabolic Syndrome|metabolic syndrome
1519396|NCT00703716|mini-invasive|mini-invasive
1519397|NCT00703716|dynamic screw-plate|dynamic screw-plate
1519398|NCT00703716|Surfix|surfix
1519399|NCT00703716|Lock-screw|lock-screw
1519400|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
1519401|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
1519402|NCT00703677|corticobasal degeneration|corticobasal degeneration
1519403|NCT00703677|PSP|psp
1519404|NCT00703677|CBD|cbd
1519405|NCT00703677|lithium|lithium
1519406|NCT00703677|tau|tau
1519407|NCT00703651|Influenza|influenza
1519408|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
1519409|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
1519410|NCT00703651|Intradermal injection|intradermal injection
1519411|NCT00703651|Adults.|adults.
1519412|NCT00703612|Diabetes Mellitus|diabetes mellitus
1519413|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
1519414|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
1519415|NCT00703612|Autologous|autologous
1519416|NCT00703612|Hyperglycemia|hyperglycemia
1519417|NCT00703599|Diabetes Mellitus|diabetes mellitus
1519418|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
1519419|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
1519420|NCT00703599|Autologous|autologous
1519421|NCT00703599|Insulin-dependence|insulin-dependence
1519422|NCT00703586|Maraviroc|maraviroc
1519423|NCT00703586|Treatment Experienced|treatment experienced
1519424|NCT00703573|Atopic Dermatitis|atopic dermatitis
1519425|NCT00703560|HCV|hcv
1519426|NCT00703560|Genotype 1|genotype 1
1519427|NCT00703560|HIV co-infection|hiv co-infection
1519428|NCT00703560|viral kinetics|viral kinetics
1519429|NCT00703560|HCV quasi-species|hcv quasi-species
1519430|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
1519431|NCT00703560|HIV Infections|hiv infections
1519432|NCT00703547|Depression|depression
1519434|NCT00703534|Acid Reflux|acid reflux
1519435|NCT00703534|Heartburn|heartburn
1519436|NCT00703534|Regurgitation|regurgitation
1519437|NCT00703534|non-acid reflux|non-acid reflux
1519438|NCT00703534|PRO measures|pro measures
1519439|NCT00703521|rabies vaccination|rabies vaccination
1519440|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
1519441|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
1519442|NCT00703521|Antibody response|antibody response
1519443|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
1519444|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
1519445|NCT00703508|PCOS|pcos
1519446|NCT00703495|traumatic|traumatic
1519447|NCT00703495|brain injury|brain injury
1519448|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
1519449|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
1519450|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
1519451|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
1519452|NCT00703482|Diabetes|diabetes
1519453|NCT00703469|Hep C|hep c
1519454|NCT00703456|Functional ankle instability|functional ankle instability
1519455|NCT00703456|Balance training|balance training
1519456|NCT00703443|Genetics|genetics
1519457|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
1519458|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1519459|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
1519460|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
1519461|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
1519462|NCT00703443|Heart Failure|heart failure
1519463|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
1519464|NCT00703417|osteoporosis|osteoporosis
1519465|NCT00703417|diabetes|diabetes
1519466|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
1519467|NCT00703404|HIV|hiv
1519468|NCT00703404|Virologic Response|virologic response
1519469|NCT00703404|Treatment Naïve|treatment naïve
1519470|NCT00703391|Chronic|chronic
1519471|NCT00703391|obstructive|obstructive
1519472|NCT00703391|pulmonary|pulmonary
1519473|NCT00703391|lung|lung
1519474|NCT00703391|respiratory disease|respiratory disease
1519475|NCT00703391|tolerability|tolerability
1519476|NCT00703391|placebo-controlled|placebo-controlled
1519477|NCT00703391|pharmacokinetics|pharmacokinetics
1519478|NCT00703391|COPD|copd
1519479|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1519480|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
1519481|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
1519482|NCT00703352|Mustard.|mustard.
1519483|NCT00703352|Senning.|senning.
1519484|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
1519485|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
1519486|NCT00703339|exercise, aerobic|exercise, aerobic
1519487|NCT00703326|Metastatic breast cancer|metastatic breast cancer
1519488|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
1519489|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
1519490|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
1519491|NCT00703274|ischemic stroke|ischemic stroke
1519492|NCT00703274|stroke|stroke
1519493|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
1519494|NCT00703274|cerebrovascular accident|cerebrovascular accident
1519495|NCT00703274|CVA|cva
1519496|NCT00703274|community health services|community health services
1519497|NCT00703274|community health workers|community health workers
1519498|NCT00703274|navigators|navigators
1519499|NCT00703274|health education|health education
1519500|NCT00703274|barriers to care|barriers to care
1519501|NCT00703274|healthcare access|healthcare access
1519502|NCT00703274|healthcare disparities|healthcare disparities
1519503|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1519504|NCT00703248|complementary therapies|complementary therapies
1519505|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
1519506|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
1519507|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
1519508|NCT00703209|diabetes|diabetes
1519509|NCT00703209|burning feet|burning feet
1519510|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
1519511|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
1519512|NCT00703209|Neuropathy|neuropathy
1519513|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
1519514|NCT00703196|cervical cancer|cervical cancer
1519515|NCT00703196|human papilloma virus infection|human papilloma virus infection
1519516|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1519517|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1519518|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1519519|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1519520|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1519521|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1519522|NCT00703144|Pharmacokinetics|pharmacokinetics
1519523|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
1519524|NCT00703144|Septic patients|septic patients
1519525|NCT00703144|oliguric renal failure|oliguric renal failure
1519526|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
1519527|NCT00703131|fistula|fistula
1519528|NCT00703131|anal fistula|anal fistula
1519529|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
1519530|NCT00703118|Telaprevir|telaprevir
1519531|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
1519532|NCT00703118|Ribavirin|ribavirin
1519533|NCT00703105|ovarian cancer|ovarian cancer
1519534|NCT00703105|Tregs|tregs
1519535|NCT00703105|vaccine|vaccine
1519536|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
1519537|NCT00703079|Acromegaly|acromegaly
1519538|NCT00703079|GH|gh
1519539|NCT00703079|IGF-I|igf-i
1519540|NCT00703079|Octreotide-LAR|octreotide-lar
1519541|NCT00703079|Lanreotide|lanreotide
1519542|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
1519543|NCT00703066|Malaria|malaria
1519544|NCT00703066|Vaccine|vaccine
1519545|NCT00703066|GMZ2|gmz2
1519546|NCT00703066|Safety|safety
1519547|NCT00703066|African|african
1519548|NCT00703066|immunogenicity|immunogenicity
1519549|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
1519550|NCT00703040|Care engagement|care engagement
1519551|NCT00703040|Linkage to care|linkage to care
1519552|NCT00703040|HIV Infections|hiv infections
1519553|NCT00703027|diabetes mellitus|diabetes mellitus
1519554|NCT00703027|care decision|care decision
1519555|NCT00703027|data mining|data mining
1519556|NCT00703014|Neonatal outcome|neonatal outcome
1519557|NCT00703014|Congenital malformations|congenital malformations
1519558|NCT00703014|In-Vitro fertilization|in-vitro fertilization
1519559|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
1519560|NCT00703014|Follow-up|follow-up
1519561|NCT00702988|Neonatal outcome|neonatal outcome
1519562|NCT00702988|Congenital malformations|congenital malformations
1519563|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
1519564|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
1519565|NCT00702988|Follow-up|follow-up
1519566|NCT00702975|phase II|phase ii
1519567|NCT00702975|NSCLC|nsclc
1519568|NCT00702975|bevacizumab|bevacizumab
1519569|NCT00702975|erlotinib|erlotinib
1519570|NCT00702975|metastatic NSCLC|metastatic nsclc
1519571|NCT00702962|lung cancer|lung cancer
1519572|NCT00702962|small cell lung cancer|small cell lung cancer
1519573|NCT00702949|breast cancer|breast cancer
1519574|NCT00702949|hot flashes|hot flashes
1519575|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
1519576|NCT00702923|Rising PSA|rising psa
1519577|NCT00702923|Casodex|casodex
1519578|NCT00702923|Tremelimumab|tremelimumab
1519579|NCT00702910|Asthma patients|asthma patients
1519580|NCT00702910|Magnesium stearate|magnesium stearate
1519581|NCT00702910|Tolerability|tolerability
1519582|NCT00702910|Safety|safety
1519583|NCT00702910|Lactose|lactose
1519584|NCT00702910|GW642444M|gw642444m
1519585|NCT00702910|Pharmacodynamics|pharmacodynamics
1519586|NCT00702910|Efficacy|efficacy
1519587|NCT00702910|Pharmacokinetics|pharmacokinetics
1519588|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
1519589|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
1519590|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
1519591|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
1519592|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
1519593|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
1519594|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
1519595|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
1519596|NCT00702858|Breast Cancer|breast cancer
1519597|NCT00702858|Joint Pain|joint pain
1519598|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
1519599|NCT00702845|In vitro fertilization|in vitro fertilization
1519600|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
1519601|NCT00702845|Hormones|hormones
1519602|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
1519603|NCT00702845|Pharmacological Actions|pharmacological actions
1519604|NCT00702845|Randomized|randomized
1519605|NCT00702845|Multi-center|multi-center
1519606|NCT00702845|Multi-national|multi-national
1519607|NCT00702845|Double-blind|double-blind
1519608|NCT00702845|Active-controlled|active-controlled
1519609|NCT00702845|Equivalence|equivalence
1519610|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
1519611|NCT00702832|acute vestibular injury|acute vestibular injury
1519612|NCT00702832|Dizziness|dizziness
1519613|NCT00702832|Nausea|nausea
1519614|NCT00702832|Nystagmus|nystagmus
1519615|NCT00702832|Daily life activities|daily life activities
1519616|NCT00702832|Balance|balance
1519617|NCT00702832|physiotherapy|physiotherapy
1519618|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
1519619|NCT00702819|Safety|safety
1519620|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
1519621|NCT00702806|Hormones|hormones
1519622|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
1519623|NCT00702806|Pharmacological Actions|pharmacological actions
1519624|NCT00702806|Randomized|randomized
1519625|NCT00702806|Multi-center|multi-center
1519626|NCT00702806|Multi-national|multi-national
1519627|NCT00702793|Smoking cessation|smoking cessation
1519628|NCT00702793|schizophrenia|schizophrenia
1519629|NCT00702793|schizoaffective|schizoaffective
1519630|NCT00702793|psychosis|psychosis
1519631|NCT00702793|varenicline|varenicline
1519632|NCT00702793|champix|champix
1519633|NCT00702793|chantix|chantix
1519634|NCT00702793|nicotine dependence|nicotine dependence
1519635|NCT00702780|Alzheimer's disease|alzheimer's disease
1519636|NCT00702780|escitalopram|escitalopram
1519637|NCT00702780|MRI|mri
1519638|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
1519639|NCT00702741|Knee|knee
1519640|NCT00702741|Meniscus|meniscus
1519641|NCT00702741|Meniscectomy|meniscectomy
1519642|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
1519643|NCT00702741|MSCs|mscs
1519644|NCT00702741|Adult Human Stem Cells|adult human stem cells
1519645|NCT00702741|Osiris|osiris
1519646|NCT00702741|Chondrogen|chondrogen
1519647|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
1519648|NCT00702728|Furosemide|furosemide
1519649|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
1519650|NCT00702728|Saline hydration|saline hydration
1519651|NCT00702702|Uterine fibroids|uterine fibroids
1519652|NCT00702702|Anemia|anemia
1519653|NCT00702689|Skin Sclerosis|skin sclerosis
1519654|NCT00702689|Graft Versus Host Disease|graft versus host disease
1519655|NCT00702676|Healthy Volunteers|healthy volunteers
1519656|NCT00702663|Hepatitis B|hepatitis b
1519657|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
1519658|NCT00702663|booster effect|booster effect
1519659|NCT00702663|Taiwan|taiwan
1519660|NCT00702663|young adults|young adults
1519661|NCT00702637|Traumatic Brain Injury|traumatic brain injury
1519662|NCT00702637|Fatigue|fatigue
1519663|NCT00702637|Modafinil|modafinil
1519664|NCT00702637|Somnolence|somnolence
1519665|NCT00702624|Neonatal outcome|neonatal outcome
1519666|NCT00702624|Congenital malformations|congenital malformations
1519667|NCT00702624|In-Vitro fertilization|in-vitro fertilization
1519668|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
1519669|NCT00702624|Follow-up|follow-up
1519670|NCT00702611|Ulcerative Colitis|ulcerative colitis
1519671|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
1519672|NCT00702611|Steroid dependent|steroid dependent
1519673|NCT00702611|Adacolumn|adacolumn
1519674|NCT00702611|Apheresis|apheresis
1519675|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
1519676|NCT00702611|GMA apheresis|gma apheresis
1519677|NCT00702611|Granulocytapheresis|granulocytapheresis
1519678|NCT00702598|Depression|depression
1519679|NCT00702598|occupational function|occupational function
1519680|NCT00702598|rating scales|rating scales
1519682|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
1519683|NCT00702598|CBT|cbt
1519684|NCT00702598|escitalopram|escitalopram
1519685|NCT00702598|antidepressants|antidepressants
1519686|NCT00702585|Ovulation Induction|ovulation induction
1519687|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
1519688|NCT00702585|Hormones|hormones
1519689|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
1519690|NCT00702585|Pharmacological Actions|pharmacological actions
1519691|NCT00702585|Randomized|randomized
1519692|NCT00702585|Multi-center|multi-center
1519693|NCT00702585|Multi-national|multi-national
1519694|NCT00702572|Phase I|phase i
1519695|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1519696|NCT00702546|In-vitro fertilization|in-vitro fertilization
1519697|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
1519698|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
1519699|NCT00702546|Follow-up|follow-up
1519700|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
1519701|NCT00702533|Gastric Analysis|gastric analysis
1519702|NCT00702533|Gastric pH|gastric ph
1519703|NCT00702533|SmartPill|smartpill
1519704|NCT00702533|ph Monitoring|ph monitoring
1519705|NCT00702533|Gastric Secretion|gastric secretion
1519706|NCT00702533|Gastric Acid Output|gastric acid output
1519707|NCT00702533|Healthy Volunteer|healthy volunteer
1519708|NCT00702533|HV|hv
1519709|NCT00702520|Neonatal outcome|neonatal outcome
1519710|NCT00702520|Congenital malformations|congenital malformations
1519711|NCT00702520|In-Vitro fertilization|in-vitro fertilization
1519712|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
1519713|NCT00702520|Follow-up|follow-up
1519804|NCT00702156|Heart Failure|heart failure
1519714|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
1519715|NCT00702494|placental growth factor|placental growth factor
1519716|NCT00702494|monoclonal antibody|monoclonal antibody
1519718|NCT00702494|solid tumors|solid tumors
1520002|NCT00701311|Pelvic pain|pelvic pain
1519719|NCT00702494|Patients with solid tumors|patients with solid tumors
1519720|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
1519721|NCT00702481|Chemoradiation|chemoradiation
1519722|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
1519723|NCT00702468|Spasticity|spasticity
1519724|NCT00702468|Multiple Sclerosis|multiple sclerosis
1519725|NCT00702455|Weight loss maintenance.|weight loss maintenance.
1519726|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
1519727|NCT00702442|Nausea, Vomiting|nausea, vomiting
1519728|NCT00702442|Vomiting episodes|vomiting episodes
1519729|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
1519730|NCT00702416|Anesthesia, Regional|anesthesia, regional
1519731|NCT00702416|Ultrasound|ultrasound
1519732|NCT00702416|Postoperative Pain|postoperative pain
1519733|NCT00702416|Brachial Plexus|brachial plexus
1519734|NCT00702364|Attention|attention
1519735|NCT00702364|Traumatic Brain INjury|traumatic brain injury
1519736|NCT00702364|Atomoxetine|atomoxetine
1519737|NCT00702364|Strattera|strattera
1519738|NCT00702351|Infertility|infertility
1519739|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
1519740|NCT00702351|Drug therapy|drug therapy
1519741|NCT00702351|Hormones|hormones
1519742|NCT00702351|GnRH agonist|gnrh agonist
1519743|NCT00702351|RecFSH|recfsh
1519744|NCT00702351|Corifollitropin alfa|corifollitropin alfa
1519745|NCT00702351|Open-label|open-label
1519746|NCT00702338|Neonatal outcome|neonatal outcome
1519747|NCT00702338|Congenital malformations|congenital malformations
1519748|NCT00702338|Ovulation Induction|ovulation induction
1519749|NCT00702338|Follow-up|follow-up
1519750|NCT00702325|Asthma|asthma
1519751|NCT00702312|Blood pressure|blood pressure
1519752|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1519753|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1519754|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
1519755|NCT00702299|fallopian tube cancer|fallopian tube cancer
1519756|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
1519757|NCT00702286|biofilm formation|biofilm formation
1519758|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
1519759|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
1519760|NCT00702286|tract obstruction|tract obstruction
1519761|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
1519762|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
1519763|NCT00702273|In-vitro fertilization|in-vitro fertilization
1519764|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
1519765|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
1519766|NCT00702273|Follow-up|follow-up
1519767|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
1519768|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1519769|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
1519770|NCT00702247|Overall survival|overall survival
1519771|NCT00702247|Event free survival|event free survival
1519772|NCT00702247|Disease response|disease response
1519773|NCT00702234|Neonatal outcome|neonatal outcome
1519774|NCT00702234|Congenital malformations|congenital malformations
1519775|NCT00702234|In-Vitro fertilization|in-vitro fertilization
1519776|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
1519777|NCT00702234|Follow-up|follow-up
1519778|NCT00702221|high blood pressure|high blood pressure
1519779|NCT00702221|vaccines|vaccines
1519780|NCT00702208|cervical cytology|cervical cytology
1519781|NCT00702208|Pap smear|pap smear
1519782|NCT00702208|self-sampling|self-sampling
1519783|NCT00702208|abnormal|abnormal
1519784|NCT00702208|normal|normal
1519785|NCT00702195|Neonatal outcome|neonatal outcome
1519786|NCT00702195|Congenital malformations|congenital malformations
1519787|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
1519788|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
1519789|NCT00702195|Follow-up|follow-up
1519790|NCT00702195|Ovulation Induction|ovulation induction
1519791|NCT00702195|Neonates|neonates
1519792|NCT00702182|Lung Cancer|lung cancer
1519793|NCT00702182|Vinorelbine|vinorelbine
1519794|NCT00702182|Erlotinib|erlotinib
1519795|NCT00702182|Phase 1|phase 1
1519796|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
1519797|NCT00702169|lung disease|lung disease
1519798|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
1519799|NCT00702169|lung barotrauma|lung barotrauma
1519800|NCT00702169|mechanical ventilation|mechanical ventilation
1519801|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
1519802|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
1519803|NCT00702169|one lung intubation|one lung intubation
1519805|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1519806|NCT00702156|Beta-blockers|beta-blockers
1519807|NCT00702156|Pulmonary Function|pulmonary function
1519808|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
1519809|NCT00702104|prostate cancer|prostate cancer
1519811|NCT00702078|home-based treatment|home-based treatment
1519812|NCT00702078|early intervention|early intervention
1519813|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
1519814|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
1519815|NCT00702052|Lymphoma|lymphoma
1519816|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
1519817|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
1519818|NCT00702052|Refractory Lymphoma|refractory lymphoma
1519819|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
1519820|NCT00702052|PILLAR-1|pillar-1
1519821|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
1519822|NCT00702026|Hypersensitivity|hypersensitivity
1519823|NCT00702026|Probiotics|probiotics
1519824|NCT00702026|Multispecies|multispecies
1519825|NCT00702013|P-glycoprotein|p-glycoprotein
1519826|NCT00702013|lymphocyte|lymphocyte
1519827|NCT00702013|HIV|hiv
1519828|NCT00702013|children|children
1519829|NCT00702013|ontogenesis|ontogenesis
1519830|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
1519831|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
1519832|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
1519833|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
1519834|NCT00702000|ICU acquired paresis|icu acquired paresis
1519835|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
1519836|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
1519837|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
1519838|NCT00701961|Malaria|malaria
1519839|NCT00701961|Pregnancy|pregnancy
1519840|NCT00701961|Pharmacokinetics|pharmacokinetics
1519841|NCT00701961|Sub-Saharan Africa|sub-saharan africa
1519842|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
1519843|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
1519844|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
1519845|NCT00701948|Inflammatory markers|inflammatory markers
1519846|NCT00701948|multiplex dosage|multiplex dosage
1519847|NCT00701935|diabetes mellitus|diabetes mellitus
1519848|NCT00701935|Amylin|amylin
1519849|NCT00701935|Lilly|lilly
1519850|NCT00701922|lung transplantation|lung transplantation
1519851|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
1519852|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
1519853|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
1519854|NCT00701922|Herpesviridae|herpesviridae
1519855|NCT00701909|wound care|wound care
1519856|NCT00701909|procedural pain intensity|procedural pain intensity
1519857|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
1519858|NCT00701909|wound care pain intensity|wound care pain intensity
1519859|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
1519860|NCT00701909|Wound care pain quality|wound care pain quality
1519861|NCT00701909|Level of drowsiness|level of drowsiness
1519862|NCT00701909|level of nausea|level of nausea
1519863|NCT00701909|Level of vomiting|level of vomiting
1519864|NCT00701909|Level of hallucinations|level of hallucinations
1519865|NCT00701909|Level of dysphoria|level of dysphoria
1519866|NCT00701896|HIV|hiv
1519867|NCT00701896|Positive|positive
1519868|NCT00701896|Smokers|smokers
1519869|NCT00701896|Varenicline|varenicline
1519870|NCT00701883|Cholesterol|cholesterol
1519871|NCT00701883|Hyperlipidemia|hyperlipidemia
1519872|NCT00701883|HDL|hdl
1519873|NCT00701883|LDL|ldl
1519874|NCT00701883|Triglycerides|triglycerides
1519875|NCT00701883|Dyslipidemia|dyslipidemia
1519876|NCT00701870|NSCLC|nsclc
1519877|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
1519878|NCT00701870|CIN|cin
1519879|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
1519880|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
1519881|NCT00701844|Aplastic Anemia|aplastic anemia
1519882|NCT00701844|Lymphatic Diseases|lymphatic diseases
1519883|NCT00701844|Leukemia|leukemia
1519884|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
1519885|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
1519886|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
1519887|NCT00701844|Anemia|anemia
1519888|NCT00701844|Quality of Life|quality of life
1519889|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
1519890|NCT00701844|Lymphoma|lymphoma
1519891|NCT00701844|Multiple Myeloma|multiple myeloma
1519892|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
1519893|NCT00701805|Hemodialysis|hemodialysis
1519894|NCT00701805|paricalcitol|paricalcitol
1519895|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
1519896|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1519897|NCT00701779|Dutasteride|dutasteride
1519898|NCT00701779|Tamsulosin|tamsulosin
1519899|NCT00701753|Pharmacogenetic|pharmacogenetic
1519900|NCT00701753|DNA|dna
1519901|NCT00701753|RNA|rna
1519902|NCT00701753|Antipsychotic|antipsychotic
1519903|NCT00701753|Olanzapine|olanzapine
1519904|NCT00701753|Risperidone|risperidone
1519905|NCT00701753|Quetiapine|quetiapine
1519906|NCT00701753|Personalized medicine|personalized medicine
1519907|NCT00701740|photoaging|photoaging
1519908|NCT00701740|isotretinoin|isotretinoin
1519909|NCT00701740|profilometry|profilometry
1519910|NCT00701740|digital analysis|digital analysis
1519911|NCT00701727|metabolic diseases|metabolic diseases
1519912|NCT00701727|metabolic disorder|metabolic disorder
1519913|NCT00701727|dyslipidemias|dyslipidemias
1519914|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
1519915|NCT00701714|Treatment|treatment
1519916|NCT00701714|associated|associated
1519917|NCT00701714|with CRI|with cri
1519918|NCT00701688|Mucositis, Oral|mucositis, oral
1519919|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1519920|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
1519921|NCT00701688|Pharmacokinetics|pharmacokinetics
1519922|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
1519923|NCT00701675|sertraline|sertraline
1519924|NCT00701675|pharmacotherapy|pharmacotherapy
1519925|NCT00701675|geriatric|geriatric
1519926|NCT00701649|mild essential hypertension|mild essential hypertension
1519927|NCT00701649|moderate essential hypertension|moderate essential hypertension
1519928|NCT00701636|Daptomycin|daptomycin
1519929|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
1519930|NCT00701636|Pharmacokinetics|pharmacokinetics
1519931|NCT00701636|Surgical Wound Infection|surgical wound infection
1519932|NCT00701636|Staphylococcus aureus|staphylococcus aureus
1519933|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
1519934|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
1519935|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
1519936|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
1519937|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
1519938|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
1519939|NCT00701584|Phytoestrogens|phytoestrogens
1519940|NCT00701584|Isoflavones|isoflavones
1519941|NCT00701584|Lignans|lignans
1519942|NCT00701584|Breast cancer survival|breast cancer survival
1519943|NCT00701584|breast cancer recurrence|breast cancer recurrence
1519944|NCT00701571|Virtual Reality|virtual reality
1519945|NCT00701571|Oncology|oncology
1519946|NCT00701571|Lumbar puncture|lumbar puncture
1519947|NCT00701545|von Willebrand disease|von willebrand disease
1519948|NCT00701545|VWD, Humate-P®|vwd, humate-p®
1519949|NCT00701545|Infusion volume reduced|infusion volume reduced
1519950|NCT00701545|ivr|ivr
1519951|NCT00701532|Cocaine|cocaine
1519952|NCT00701532|Substance abuse|substance abuse
1519953|NCT00701532|Addiction|addiction
1519954|NCT00701532|Dependence|dependence
1519955|NCT00701532|Modafinil|modafinil
1519956|NCT00701532|Brain imaging|brain imaging
1519957|NCT00701519|CHF,|chf,
1519958|NCT00701519|Sleep apnea,|sleep apnea,
1519959|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
1519960|NCT00701519|Heart failure|heart failure
1519961|NCT00701506|Knee|knee
1519962|NCT00701506|Osteoarthritis|osteoarthritis
1519963|NCT00701506|Treatment|treatment
1519964|NCT00701506|Electrostimulation|electrostimulation
1519965|NCT00701493|Topiramate|topiramate
1519966|NCT00701493|Topiramate oral liquid|topiramate oral liquid
1519967|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
1519968|NCT00701493|topiramate capsules|topiramate capsules
1519969|NCT00701480|acne|acne
1519970|NCT00701480|skin cleanser|skin cleanser
1519971|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
1519972|NCT00701480|Roselle|roselle
1519973|NCT00701480|safety|safety
1519974|NCT00701480|efficacy|efficacy
1519975|NCT00701467|ICD|icd
1519976|NCT00701467|ICD implanted patients|icd implanted patients
1519977|NCT00701454|Thai-muslim|thai-muslim
1519978|NCT00701454|Thai-HALAL|thai-halal
1519979|NCT00701454|Diabetes|diabetes
1519980|NCT00701454|Hypertension|hypertension
1519981|NCT00701454|Hyperlipidemia|hyperlipidemia
1519982|NCT00701454|Metabolic syndrome|metabolic syndrome
1519983|NCT00701441|sleep apnea,|sleep apnea,
1519984|NCT00701441|oxidative stress|oxidative stress
1519985|NCT00701428|Hypertension|hypertension
1519986|NCT00701428|Sleep Apnea|sleep apnea
1519987|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
1519988|NCT00701428|CPAP|cpap
1519989|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
1519990|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
1519991|NCT00701402|dyslipidemic patients|dyslipidemic patients
1519992|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
1519993|NCT00701376|Hepatic disease|hepatic disease
1519994|NCT00701376|Hepatic function|hepatic function
1519995|NCT00701350|Pregnancy|pregnancy
1519996|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
1519997|NCT00701350|Preterm Birth|preterm birth
1519998|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
1519999|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
1520000|NCT00701337|menopausal women|menopausal women
1520001|NCT00701311|Prostatitis|prostatitis
1520003|NCT00701285|heart failure|heart failure
1520004|NCT00701285|pitavastatin|pitavastatin
1520005|NCT00701285|pravastatin|pravastatin
1520006|NCT00701285|statin|statin
1520007|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
1520008|NCT00701259|Treatment of|treatment of
1520009|NCT00701259|over 14 days|over 14 days
1520010|NCT00701246|Anemia|anemia
1520011|NCT00701246|Iron deficiency anemia|iron deficiency anemia
1520012|NCT00701246|Infants|infants
1520013|NCT00701246|Children|children
1520014|NCT00701246|Clinical trials|clinical trials
1520015|NCT00701246|Ferrous sulfate|ferrous sulfate
1520016|NCT00701246|Folic acid|folic acid
1520017|NCT00701246|Daycare centers|daycare centers
1520018|NCT00701246|Anaemia in children|anaemia in children
1520019|NCT00701246|born at term|born at term
1520020|NCT00701246|non-twins|non-twins
1520021|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
1520022|NCT00701246|growth|growth
1520023|NCT00701220|Cardiovascular Disease|cardiovascular disease
1520024|NCT00701220|Cardiomyopathy|cardiomyopathy
1520025|NCT00701220|Heart Disease|heart disease
1520026|NCT00701220|Myocardial Disease|myocardial disease
1520027|NCT00701220|Myocardial Ischemia|myocardial ischemia
1520028|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
1520029|NCT00701194|placement instability|placement instability
1520030|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
1520031|NCT00701194|school readiness|school readiness
1520032|NCT00701194|developmental delays|developmental delays
1520033|NCT00701194|cortisol|cortisol
1520034|NCT00701194|executive functioning|executive functioning
1520035|NCT00701194|therapeutic foster care|therapeutic foster care
1520036|NCT00701194|prevention|prevention
1520037|NCT00701194|early intervention|early intervention
1520038|NCT00701181|Phase II|phase ii
1520039|NCT00701181|Prospective|prospective
1520040|NCT00701181|Randomized|randomized
1520041|NCT00701181|Diabetic Macular Edema|diabetic macular edema
1520042|NCT00701181|PF-04523655|pf-04523655
1520043|NCT00701181|Laser|laser
1520044|NCT00701129|Glycogenesis 2|glycogenesis 2
1520045|NCT00701129|Acid|acid
1520046|NCT00701129|Maltase|maltase
1520047|NCT00701129|Deficiency|deficiency
1520048|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1520049|NCT00701090|Non Insulin Dependent|non insulin dependent
1520050|NCT00701077|Brugada syndrome|brugada syndrome
1520051|NCT00701077|Electrophysiological study|electrophysiological study
1520052|NCT00701077|Ion channel blockade|ion channel blockade
1520053|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
1520054|NCT00701064|phototherapy|phototherapy
1520055|NCT00701064|anxiety|anxiety
1520056|NCT00701064|depression|depression
1520057|NCT00701064|sleep|sleep
1520058|NCT00701064|negative ion generator|negative ion generator
1520059|NCT00701038|Sleep apnea,|sleep apnea,
1520060|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
1520061|NCT00701038|heart failure,|heart failure,
1520062|NCT00701038|CHF|chf
1520063|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
1520064|NCT00701012|low or high ligation|low or high ligation
1520065|NCT00700986|Electroretinography|electroretinography
1520066|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
1520067|NCT00700986|Anti-TNF|anti-tnf
1520068|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
1520069|NCT00700973|anger|anger
1520070|NCT00700973|psychotherapy, brief|psychotherapy, brief
1520071|NCT00700973|diagnosis, dual|diagnosis, dual
1520072|NCT00700947|Heart Disease|heart disease
1520073|NCT00700947|Mitral Regurgitation|mitral regurgitation
1520074|NCT00700947|Heart Valve Disease|heart valve disease
1520075|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
1520076|NCT00700947|Heart Surgery|heart surgery
1520077|NCT00700947|Heart Valve Surgery|heart valve surgery
1520078|NCT00700934|FEV1|fev1
1520079|NCT00700934|mortality|mortality
1520080|NCT00700934|Quality of life|quality of life
1520081|NCT00700908|type 2 diabetes|type 2 diabetes
1520082|NCT00700908|telephone intervention|telephone intervention
1520083|NCT00700908|automated|automated
1520084|NCT00700882|stage IV melanoma|stage iv melanoma
1520085|NCT00700882|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
1520086|NCT00700882|mucosal melanoma|mucosal melanoma
1520087|NCT00700882|recurrent melanoma|recurrent melanoma
1520088|NCT00700882|stage IIIA melanoma|stage iiia melanoma
1520089|NCT00700882|stage IIIB melanoma|stage iiib melanoma
1520090|NCT00700882|stage IIIC melanoma|stage iiic melanoma
1520091|NCT00700869|Altered level of consciousness|altered level of consciousness
1520092|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
1520093|NCT00700869|Respiration|respiration
1520094|NCT00700869|Artificial Respiration|artificial respiration
1520095|NCT00700869|Physiology|physiology
1520096|NCT00700856|diabetes|diabetes
1520097|NCT00700856|cardiovascular disease|cardiovascular disease
1520098|NCT00700856|pioglitazone|pioglitazone
1520099|NCT00700856|sulphonylurea|sulphonylurea
1520497|NCT00699127|anxiety|anxiety
1520100|NCT00700856|metformin monotherapy|metformin monotherapy
1520101|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
1520102|NCT00700843|bariatric surgery|bariatric surgery
1520103|NCT00700843|long term follow up|long term follow up
1520104|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
1520105|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
1520106|NCT00700843|obesity|obesity
1520107|NCT00700804|Calcium retention|calcium retention
1520108|NCT00700804|dietary protein|dietary protein
1520109|NCT00700804|dietary calcium|dietary calcium
1520110|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
1520111|NCT00700778|breast cancer|breast cancer
1520112|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
1520113|NCT00700739|Cervical|cervical
1520114|NCT00700739|Disc|disc
1520115|NCT00700739|Arthroplasty|arthroplasty
1520116|NCT00700739|Spinal|spinal
1520117|NCT00700726|blood test|blood test
1520118|NCT00700726|asthma|asthma
1520119|NCT00700726|skin test|skin test
1520120|NCT00700713|Meningitis|meningitis
1520121|NCT00700713|Meningococcemia|meningococcemia
1520122|NCT00700713|Neisseria meningitidis|neisseria meningitidis
1520123|NCT00700713|Menactra®|menactra®
1520124|NCT00700700|Congestive Heart Failure|congestive heart failure
1520125|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1520126|NCT00700700|Dyspnea|dyspnea
1520127|NCT00700700|Exercise Tolerance|exercise tolerance
1520128|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
1520129|NCT00700674|EEG entropy|eeg entropy
1520130|NCT00700674|Elderly|elderly
1520131|NCT00700674|Decreases|decreases
1520132|NCT00700674|POCD|pocd
1520133|NCT00700674|Use of EEG entropy|use of eeg entropy
1520134|NCT00700674|Geriatric|geriatric
1520135|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
1520136|NCT00700609|Depression|depression
1520137|NCT00700609|Family Therapy|family therapy
1520138|NCT00700609|Adolescents|adolescents
1520139|NCT00700596|Salvia|salvia
1520140|NCT00700596|SA|sa
1520141|NCT00700596|Salvinorin|salvinorin
1520142|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
1520143|NCT00700583|nocturia|nocturia
1520144|NCT00700583|bladder|bladder
1520145|NCT00700583|urination disorders|urination disorders
1520146|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
1520147|NCT00700583|terazosin|terazosin
1520148|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
1520149|NCT00700557|probiotics|probiotics
1520150|NCT00700557|treatment|treatment
1520151|NCT00700544|AML|aml
1520152|NCT00700544|elderly patients|elderly patients
1520153|NCT00700544|Treatment outcome|treatment outcome
1520154|NCT00700531|Hemodialysis|hemodialysis
1520155|NCT00700531|Multiple myeloma|multiple myeloma
1520156|NCT00700531|Cast nephropathy|cast nephropathy
1520157|NCT00700531|Kidney failure|kidney failure
1520158|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
1520159|NCT00700518|Raynaud's Disease|raynaud's disease
1520160|NCT00700518|RP|rp
1520161|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1520162|NCT00700505|BPH|bph
1520163|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1520164|NCT00700505|Urinary Retention|urinary retention
1520165|NCT00700505|Shy Bladder|shy bladder
1520166|NCT00700505|Urinary Hesitancy|urinary hesitancy
1520167|NCT00700505|Bashful Bladder|bashful bladder
1520168|NCT00700505|Paruresis|paruresis
1520169|NCT00700492|subfertility|subfertility
1520170|NCT00700492|pregnancy rate|pregnancy rate
1520171|NCT00700492|miscarriage|miscarriage
1520172|NCT00700479|vascular endothelium|vascular endothelium
1520173|NCT00700479|nitric oxide|nitric oxide
1520174|NCT00700479|aldosterone|aldosterone
1520175|NCT00700479|vascular biology|vascular biology
1520176|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
1520177|NCT00700466|autonomic nervous system;|autonomic nervous system;
1520178|NCT00700466|perioperative care;|perioperative care;
1520179|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
1520180|NCT00700466|Autonomic regulation|autonomic regulation
1520181|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
1520182|NCT00700466|outcome|outcome
1520183|NCT00700440|Radiotherapy|radiotherapy
1520184|NCT00700440|chemotherapy|chemotherapy
1520185|NCT00700440|Drug Targeting|drug targeting
1520186|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
1520187|NCT00700440|Safety.|safety.
1520188|NCT00700440|efficacy|efficacy
1520189|NCT00700427|ADHD|adhd
1520190|NCT00700427|Adult|adult
1520191|NCT00700427|long term|long term
1520192|NCT00700427|maintenance of response|maintenance of response
1520193|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1520194|NCT00700388|Chronic bronchitis|chronic bronchitis
1520195|NCT00700388|COPD|copd
1520196|NCT00700388|Bronchiectasis|bronchiectasis
1520197|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
1520198|NCT00700362|Complications|complications
1520199|NCT00700362|Hyperglycemia|hyperglycemia
1520200|NCT00700362|Insulin infusion|insulin infusion
1520201|NCT00700349|depression|depression
1520202|NCT00700349|stress|stress
1520203|NCT00700349|microcredit|microcredit
1520204|NCT00700349|poverty|poverty
1520205|NCT00700349|South Africa|south africa
1520206|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
1520207|NCT00700336|solid tumors|solid tumors
1520208|NCT00700323|ADHD|adhd
1520209|NCT00700323|ADHD diagnosed children|adhd diagnosed children
1520210|NCT00700310|Partial onset seizures|partial onset seizures
1520211|NCT00700310|E2007|e2007
1520212|NCT00700310|perampanel|perampanel
1520213|NCT00700310|refractory partial seizures|refractory partial seizures
1520214|NCT00700310|adjunctive therapy|adjunctive therapy
1520215|NCT00700310|seizure frequency|seizure frequency
1520216|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
1520217|NCT00700310|safety|safety
1520218|NCT00700310|concomitant AED(s)|concomitant aed(s)
1520219|NCT00700297|Oral aphthosis|oral aphthosis
1520220|NCT00700297|Genital aphthosis|genital aphthosis
1520221|NCT00700297|Psuedofolliculitis|psuedofolliculitis
1520222|NCT00700297|Erythem nodusom|erythem nodusom
1520223|NCT00700297|Joint manifestations|joint manifestations
1520224|NCT00700297|Colchicine|colchicine
1520225|NCT00700284|HIV-I|hiv-i
1520226|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
1520227|NCT00700284|HIV Seronegativity|hiv seronegativity
1520228|NCT00700271|Hypertension|hypertension
1520229|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1520230|NCT00700245|Obese|obese
1520231|NCT00700245|Adults|adults
1520232|NCT00700232|genetics|genetics
1520233|NCT00700232|gene expression|gene expression
1520234|NCT00700232|MDR3|mdr3
1520235|NCT00700232|estrogens|estrogens
1520236|NCT00700232|cholestasis|cholestasis
1520237|NCT00700232|pregnancy|pregnancy
1520238|NCT00700232|controls|controls
1520239|NCT00700219|Preterm Labor|preterm labor
1520240|NCT00700219|Preterm Birth|preterm birth
1520241|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
1520242|NCT00700219|Pregnancy|pregnancy
1520243|NCT00700219|Women|women
1520244|NCT00700206|Hematology|hematology
1520245|NCT00700206|MDS|mds
1520246|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
1520247|NCT00700206|Low Risk MDS|low risk mds
1520248|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
1520249|NCT00700206|Int-1 risk MDS|int-1 risk mds
1520250|NCT00700206|Telintra|telintra
1520251|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
1520252|NCT00700206|ezatiostat|ezatiostat
1520253|NCT00700206|TLK199|tlk199
1520254|NCT00700206|Glutathione|glutathione
1520255|NCT00700206|Glutathione analog|glutathione analog
1520256|NCT00700206|Glutathione Transferase|glutathione transferase
1520257|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
1520258|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
1520259|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
1520260|NCT00700206|Apoptosis|apoptosis
1520261|NCT00700206|Differentiation|differentiation
1520262|NCT00700206|Enzyme inhibitor|enzyme inhibitor
1520263|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
1520264|NCT00700167|98-098|98-098
1520265|NCT00700154|Vascular Surgery|vascular surgery
1520266|NCT00700154|Complications|complications
1520267|NCT00700154|Hyperglycemia|hyperglycemia
1520268|NCT00700154|Insulin infusion|insulin infusion
1520269|NCT00700154|Diabetic ulcers|diabetic ulcers
1520270|NCT00700154|Infection|infection
1520271|NCT00700141|Tachosil|tachosil
1520272|NCT00700141|thyroid|thyroid
1520273|NCT00700141|parathyroid|parathyroid
1520274|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
1520275|NCT00700141|hemorrhage|hemorrhage
1520276|NCT00700141|thyroid surgery|thyroid surgery
1520277|NCT00700128|headaches|headaches
1520278|NCT00700128|migraines|migraines
1520279|NCT00700128|breakthrough bleeding|breakthrough bleeding
1520280|NCT00700128|breakthrough spotting|breakthrough spotting
1520281|NCT00700128|menstrually associated migraines|menstrually associated migraines
1520282|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
1520283|NCT00700115|HAART|haart
1520284|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
1520285|NCT00700115|raltegravir|raltegravir
1520286|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
1520287|NCT00700115|Treatment Experienced|treatment experienced
1520288|NCT00700089|Attempted suicide|attempted suicide
1520289|NCT00700089|Assertive intervention|assertive intervention
1520290|NCT00700089|Prevention|prevention
1520291|NCT00700089|Treatment|treatment
1520292|NCT00700076|ORG 25935|org 25935
1520293|NCT00700076|Ketamine|ketamine
1520294|NCT00700076|healthy subjects|healthy subjects
1520295|NCT00700063|Peplin|peplin
1520296|NCT00700063|Actinic keratosis|actinic keratosis
1520297|NCT00700063|PEP005|pep005
1520298|NCT00700050|Cystic Fibrosis|cystic fibrosis
1520299|NCT00700050|Sex hormones|sex hormones
1520300|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
1520301|NCT00700050|Paediatrics|paediatrics
1520498|NCT00699127|parents|parents
1520302|NCT00700024|Body composition|body composition
1520303|NCT00700024|Physical activity|physical activity
1520304|NCT00700024|Metabolic syndrome|metabolic syndrome
1520305|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
1520306|NCT00699998|ACS|acs
1520307|NCT00699985|Psychological Symptoms|psychological symptoms
1520308|NCT00699985|Behcet's Disease|behcet's disease
1520309|NCT00699972|E2007|e2007
1520310|NCT00699972|perampanel|perampanel
1520311|NCT00699972|refractory partial seizures|refractory partial seizures
1520312|NCT00699972|adjunctive therapy|adjunctive therapy
1520313|NCT00699972|seizure frequency|seizure frequency
1520314|NCT00699972|partial onset seizures|partial onset seizures
1520315|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
1520316|NCT00699972|safety|safety
1520317|NCT00699972|concomitant AED(s)|concomitant aed(s)
1520318|NCT00699959|Coronary patients|coronary patients
1520319|NCT00699959|heart failure|heart failure
1520320|NCT00699959|dyslipidemia|dyslipidemia
1520321|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
1520322|NCT00699933|acute pancreatitis|acute pancreatitis
1520323|NCT00699933|interventional therapy|interventional therapy
1520324|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
1520325|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
1520326|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
1520327|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
1520328|NCT00699907|Ovarian epithelial cancer|ovarian epithelial cancer
1520329|NCT00699907|High risk|high risk
1520330|NCT00699907|Biomarkers|biomarkers
1520331|NCT00699894|PONV|ponv
1520332|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
1520333|NCT00699894|aprepitant|aprepitant
1520334|NCT00699894|ondansetron|ondansetron
1520335|NCT00699894|orthognathic surgery|orthognathic surgery
1520336|NCT00699881|Time to Progression|time to progression
1520337|NCT00699881|Toxicity|toxicity
1520338|NCT00699881|Overall survival|overall survival
1520339|NCT00699881|Response rate|response rate
1520340|NCT00699881|Quality of live|quality of live
1520341|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
1520342|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
1520343|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
1520344|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
1520345|NCT00699842|MDS|mds
1520346|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
1520347|NCT00699842|Non-deletion 5q|non-deletion 5q
1520348|NCT00699842|Lenalidomide|lenalidomide
1520349|NCT00699790|Diabetes|diabetes
1520350|NCT00699790|NOS|nos
1520351|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
1520352|NCT00699764|Herpes simplex|herpes simplex
1520353|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1520354|NCT00699751|Bone Metastases|bone metastases
1520355|NCT00699751|Radium-223|radium-223
1520356|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
1520357|NCT00699725|Compliance|compliance
1520358|NCT00699725|gastroprotector therapy|gastroprotector therapy
1520359|NCT00699725|NSAID|nsaid
1520360|NCT00699725|risk factors|risk factors
1520361|NCT00699712|ADHF|adhf
1520362|NCT00699712|AHF|ahf
1520363|NCT00699712|HF|hf
1520364|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1520365|NCT00699686|Diabetes|diabetes
1520366|NCT00699686|Insulin|insulin
1520367|NCT00699686|Endothelium|endothelium
1520368|NCT00699686|Cardiovascular disease|cardiovascular disease
1520369|NCT00699686|Stem cells|stem cells
1520370|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
1520371|NCT00699673|EuroScore|euroscore
1520372|NCT00699673|Cardiac surgery|cardiac surgery
1520373|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
1520374|NCT00699673|Coronary artery disease|coronary artery disease
1520375|NCT00699673|Valvular disease|valvular disease
1520376|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
1520377|NCT00699660|Disability Examination|disability examination
1520378|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
1520379|NCT00699660|Quality of Care|quality of care
1520380|NCT00699634|Neuropathic|neuropathic
1520381|NCT00699634|Pain|pain
1520382|NCT00699634|Phantom|phantom
1520383|NCT00699634|Limb|limb
1520384|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
1520385|NCT00699621|Hematoma enlargement|hematoma enlargement
1520386|NCT00699621|Antiplatelet agent|antiplatelet agent
1520387|NCT00699621|Platelet transfusion|platelet transfusion
1520388|NCT00699621|Outcome|outcome
1520389|NCT00699608|Zopiclone|zopiclone
1520390|NCT00699608|Hypnotic|hypnotic
1520391|NCT00699608|Residual effects|residual effects
1520392|NCT00699608|Eszopiclone|eszopiclone
1520393|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
1520394|NCT00699582|refractory partial seizures|refractory partial seizures
1520395|NCT00699582|adjunctive therapy|adjunctive therapy
1520396|NCT00699582|seizure frequency|seizure frequency
1520397|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
1520398|NCT00699582|partial onset seizures|partial onset seizures
1520399|NCT00699582|safety|safety
1520400|NCT00699582|concomitant AED(s)|concomitant aed(s)
1520401|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
1520402|NCT00699569|mucositis|mucositis
1520403|NCT00699556|alcohol|alcohol
1520404|NCT00699556|nicotine|nicotine
1520405|NCT00699556|smoking cessation|smoking cessation
1520406|NCT00699556|smoking cessation medications|smoking cessation medications
1520407|NCT00699530|Prolactin|prolactin
1520408|NCT00699530|Insulin resistance|insulin resistance
1520409|NCT00699530|Glucose tolerance|glucose tolerance
1520410|NCT00699530|Body Composition|body composition
1520411|NCT00699530|Substrate metabolism|substrate metabolism
1520412|NCT00699517|tubulin modulator|tubulin modulator
1520413|NCT00699517|endothelium|endothelium
1520414|NCT00699517|combretastatin|combretastatin
1520415|NCT00699517|cisplatin|cisplatin
1520417|NCT00699504|QT|qt
1520418|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
1520419|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
1520420|NCT00699478|post total gastrectomy|post total gastrectomy
1520421|NCT00699478|stomach cancer|stomach cancer
1520422|NCT00699465|Thromboprophylaxis|thromboprophylaxis
1520423|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
1520424|NCT00699465|Enoxaparin|enoxaparin
1520425|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
1520426|NCT00699452|aortic stenosis|aortic stenosis
1520427|NCT00699452|valve|valve
1520428|NCT00699452|candesartan|candesartan
1520429|NCT00699439|Medical Informatics|medical informatics
1520430|NCT00699439|Asthma|asthma
1520431|NCT00699439|Emergency Service, Hospital|emergency service, hospital
1520432|NCT00699439|Bayesian Method|bayesian method
1520433|NCT00699387|Chagas disease|chagas disease
1520434|NCT00699387|Pediatrics|pediatrics
1520435|NCT00699387|benznidazole|benznidazole
1520436|NCT00699387|population pharmacokinetics|population pharmacokinetics
1520437|NCT00699387|neglected diseases|neglected diseases
1520438|NCT00699387|parasitology|parasitology
1520439|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
1520440|NCT00699374|sunitinib|sunitinib
1520441|NCT00699374|phase 3|phase 3
1520442|NCT00699374|randomized|randomized
1520443|NCT00699374|hepatocellular|hepatocellular
1520444|NCT00699374|liver|liver
1520445|NCT00699361|Pantoprazole|pantoprazole
1520446|NCT00699361|congestive heart failure|congestive heart failure
1520447|NCT00699335|pain|pain
1520448|NCT00699335|fentanyl|fentanyl
1520449|NCT00699335|transdermal patch|transdermal patch
1520450|NCT00699322|glucose variability|glucose variability
1520451|NCT00699322|oxidative stress|oxidative stress
1520452|NCT00699322|sitagliptin|sitagliptin
1520453|NCT00699322|glimepiride|glimepiride
1520454|NCT00699309|Total Hip Replacement|total hip replacement
1520455|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
1520456|NCT00699309|Minimally Invasive|minimally invasive
1520457|NCT00699309|Microplasty|microplasty
1520458|NCT00699309|Hip Arthritis|hip arthritis
1520459|NCT00699296|LBH589|lbh589
1520460|NCT00699296|HDAC inhibitor|hdac inhibitor
1520461|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
1520462|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
1520463|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
1520464|NCT00699283|Partial Onset Seizures|partial onset seizures
1520465|NCT00699283|Adults and Adolescents|adults and adolescents
1520466|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
1520467|NCT00699270|Total Shoulder Replacement|total shoulder replacement
1520468|NCT00699270|Shoulder Arthritis|shoulder arthritis
1520469|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
1520470|NCT00699257|Partial Knee Replacement|partial knee replacement
1520471|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
1520472|NCT00699257|Oxford Knee|oxford knee
1520473|NCT00699244|forearm|forearm
1520474|NCT00699244|hand|hand
1520475|NCT00699244|elbow|elbow
1520476|NCT00699244|wrist|wrist
1520477|NCT00699244|brachial plexus|brachial plexus
1520478|NCT00699244|infraclavicular block|infraclavicular block
1520479|NCT00699231|Hepatitis B|hepatitis b
1520480|NCT00699231|Engerix™-B|engerix™-b
1520481|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520482|NCT00699231|Adjuvant|adjuvant
1520483|NCT00699218|Bipolar|bipolar
1520484|NCT00699218|Depression|depression
1520485|NCT00699218|TMS|tms
1520486|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1520487|NCT00699218|treatment|treatment
1520488|NCT00699218|Efficacy|efficacy
1520489|NCT00699218|Safety|safety
1520490|NCT00699192|Blood pressure|blood pressure
1520491|NCT00699192|hypertension|hypertension
1520492|NCT00699192|elderly|elderly
1520493|NCT00699166|IBS|ibs
1520494|NCT00699166|Diarrhea|diarrhea
1520495|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
1520496|NCT00699166|IBS-D|ibs-d
1520499|NCT00699127|NICU|nicu
1520500|NCT00699127|prematurity|prematurity
1520501|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
1520502|NCT00699114|Pain|pain
1520503|NCT00699114|Analgesics|analgesics
1520504|NCT00699114|Molar|molar
1520505|NCT00699114|Third|third
1520506|NCT00699114|Acetaminophen|acetaminophen
1520507|NCT00699114|Paracetamol|paracetamol
1520508|NCT00699114|Ibuprofen|ibuprofen
1520509|NCT00699114|Codeine|codeine
1520510|NCT00699114|Placebo|placebo
1520511|NCT00699101|Breast Cancer|breast cancer
1520512|NCT00699101|Conture®|conture®
1520513|NCT00699101|Brachytherapy|brachytherapy
1520514|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
1520515|NCT00699088|Total Hip Replacement|total hip replacement
1520516|NCT00699088|Minimally Invasive|minimally invasive
1520517|NCT00699088|Microplasty|microplasty
1520518|NCT00699062|antileukotriene|antileukotriene
1520519|NCT00699062|small airway|small airway
1520520|NCT00699062|airway remodeling|airway remodeling
1520521|NCT00699062|HRCT|hrct
1520522|NCT00699049|Alpha blocker|alpha blocker
1520523|NCT00699049|Tamsulosin|tamsulosin
1520524|NCT00699049|Solifenacin|solifenacin
1520525|NCT00699049|Overactive Bladder|overactive bladder
1520526|NCT00699049|Urgency incontinence|urgency incontinence
1520527|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
1520528|NCT00699036|fatty liver|fatty liver
1520529|NCT00699036|insulin resistance|insulin resistance
1520530|NCT00699023|postprandial lipemia|postprandial lipemia
1520531|NCT00699023|type 2 diabetes|type 2 diabetes
1520532|NCT00699023|ezetimibe|ezetimibe
1520533|NCT00699023|hypercholesterolemia|hypercholesterolemia
1520534|NCT00699010|Abuse Liability|abuse liability
1520535|NCT00699010|Abuse Prevention|abuse prevention
1520536|NCT00699010|Abuse Resistance|abuse resistance
1520537|NCT00699010|Abuse Deterrence|abuse deterrence
1520539|NCT00698997|autism spectrum disorder|autism spectrum disorder
1520540|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
1520541|NCT00698997|PDD NOS|pdd nos
1520542|NCT00698997|early steps study|early steps study
1520543|NCT00698997|early start denver model|early start denver model
1520544|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
1520545|NCT00698997|toddler treatment|toddler treatment
1520546|NCT00698997|Sally Rogers|sally rogers
1520547|NCT00698997|University of California, Davis|university of california, davis
1520548|NCT00698997|University of Michigan|university of michigan
1520549|NCT00698997|MIND Institute|mind institute
1520550|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
1520551|NCT00698958|Respiratory insufficiency|respiratory insufficiency
1520552|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
1520553|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
1520554|NCT00698932|HBA1c|hba1c
1520555|NCT00698932|Incretins|incretins
1520556|NCT00698919|Bacterial DNA|bacterial dna
1520557|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
1520558|NCT00698919|Infection|infection
1520559|NCT00698919|Intensive Care Unit|intensive care unit
1520560|NCT00698906|Hepatitis B|hepatitis b
1520561|NCT00698906|HBV-MPL|hbv-mpl
1520562|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
1520563|NCT00698893|Herpes simplex|herpes simplex
1520564|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
1520565|NCT00698880|Portal vein embolization|portal vein embolization
1520566|NCT00698880|Hepatic vein embolization|hepatic vein embolization
1520567|NCT00698880|Liver regeneration|liver regeneration
1520568|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
1520569|NCT00698867|Total Elbow Replacement|total elbow replacement
1520570|NCT00698867|Osteoarthritis|osteoarthritis
1520571|NCT00698867|Elbow arthritis|elbow arthritis
1520572|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
1520573|NCT00698854|Total Knee Replacement|total knee replacement
1520574|NCT00698854|Knee Arthritis|knee arthritis
1520575|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
1520576|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
1520577|NCT00698750|Fractured Humeral Head|fractured humeral head
1520578|NCT00698750|Traumatic Arthritis|traumatic arthritis
1520579|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
1520580|NCT00698750|Shoulder Replacement|shoulder replacement
1520581|NCT00698750|Shoulder Arthritis|shoulder arthritis
1520582|NCT00698737|Opioid|opioid
1520583|NCT00698737|Cocaine|cocaine
1520584|NCT00698711|Prostate cancer|prostate cancer
1520585|NCT00698711|MUC-2-KLH|muc-2-klh
1520586|NCT00698711|QS 21|qs 21
1520587|NCT00698698|tear proteins|tear proteins
1520588|NCT00698698|diabetic retinopathy|diabetic retinopathy
1520589|NCT00698698|HPLC|hplc
1520590|NCT00698698|Mass spectroscopy|mass spectroscopy
1520591|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1520592|NCT00698685|Preparative Regimen|preparative regimen
1520593|NCT00698685|Pentostatin|pentostatin
1520594|NCT00698685|Alemtuzumab|alemtuzumab
1520595|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
1520596|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
1520597|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
1520598|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
1520599|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
1520600|NCT00698685|Multiple Myeloma|multiple myeloma
1520601|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
1520602|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
1520603|NCT00698672|RSA|rsa
1520604|NCT00698646|Systolic blood pressure|systolic blood pressure
1520605|NCT00698646|Diastolic blood pressure|diastolic blood pressure
1520606|NCT00698646|Valsartan|valsartan
1520607|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
1520608|NCT00698633|Hip arthroplasty|hip arthroplasty
1520609|NCT00698607|Everolimus|everolimus
1520610|NCT00698607|Sirolimus|sirolimus
1520611|NCT00698607|drug eluting stent|drug eluting stent
1520612|NCT00698607|Clopidogrel|clopidogrel
1520613|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
1520614|NCT00698581|Partial Onset Seizures|partial onset seizures
1520615|NCT00698581|Adults and Adolescents|adults and adolescents
1520616|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
1520617|NCT00698555|Hepatitis B|hepatitis b
1520618|NCT00698555|HBV-MPL|hbv-mpl
1520619|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520620|NCT00698542|PSST|psst
1520621|NCT00698542|sepsis|sepsis
1520622|NCT00698542|Neuro Care Unit|neuro care unit
1520623|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
1520624|NCT00698542|SSC|ssc
1520625|NCT00698529|Technology Transfer|technology transfer
1520626|NCT00698529|HIV Seronegativity|hiv seronegativity
1520627|NCT00698516|Bevacizumab|bevacizumab
1520628|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
1520629|NCT00698516|Topotecan|topotecan
1520630|NCT00698503|Metal on Metal|metal on metal
1520631|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
1520632|NCT00698503|Total Hip Replacement|total hip replacement
1520633|NCT00698490|Herpes simplex|herpes simplex
1520634|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
1520635|NCT00698464|Pasireotide|pasireotide
1520636|NCT00698464|PK profile,|pk profile,
1520637|NCT00698464|Single dose|single dose
1520638|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
1520639|NCT00698464|Safety|safety
1520640|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
1520641|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
1520642|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
1520643|NCT00698451|Ovarian cancer|ovarian cancer
1520644|NCT00698451|fallopian tube cancer|fallopian tube cancer
1520645|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
1520646|NCT00698451|DOXIL|doxil
1520647|NCT00698451|carboplatin|carboplatin
1520648|NCT00698451|bevacizumab|bevacizumab
1520649|NCT00698438|At least 18 years of age|at least 18 years of age
1520650|NCT00698438|Open-angle glaucoma|open-angle glaucoma
1520651|NCT00698425|Iontophoresis|iontophoresis
1520652|NCT00698425|Ophthalmology|ophthalmology
1520653|NCT00698412|Knee osteoarthritis|knee osteoarthritis
1520654|NCT00698412|Daily cane use|daily cane use
1520655|NCT00698412|Pain|pain
1520656|NCT00698412|Function|function
1520657|NCT00698412|Quality of life|quality of life
1520658|NCT00698412|Energy consumption during the gait|energy consumption during the gait
1520659|NCT00698399|liver|liver
1520660|NCT00698399|transplant|transplant
1520661|NCT00698399|TMAO|tmao
1520662|NCT00698399|NGAL|ngal
1520663|NCT00698399|cystatin-C|cystatin-c
1520664|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
1520665|NCT00698399|Liver Transplant|liver transplant
1520666|NCT00698399|LTx|ltx
1520667|NCT00698399|allantion|allantion
1520668|NCT00698386|Micronutrient Zinc|micronutrient zinc
1520669|NCT00698386|Category I PTB|category i ptb
1520670|NCT00698386|RNTCP|rntcp
1520671|NCT00698386|DOTS|dots
1520672|NCT00698386|Sputum smear conversion|sputum smear conversion
1520673|NCT00698386|Reduced relapse|reduced relapse
1520674|NCT00698386|Immunopathogenesis|immunopathogenesis
1520675|NCT00698386|Category-I|category-i
1520676|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
1520677|NCT00698373|Positron emission tomography,|positron emission tomography,
1520678|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
1520679|NCT00698373|Lung cancer,|lung cancer,
1520680|NCT00698360|chronic kidney disease|chronic kidney disease
1520681|NCT00698360|melatonin|melatonin
1520682|NCT00698360|erythropoietin|erythropoietin
1520683|NCT00698360|circadian rhythm|circadian rhythm
1520684|NCT00698347|Total Knee Replacement|total knee replacement
1520685|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
1520686|NCT00698347|Hip Arthritis|hip arthritis
1520687|NCT00698334|HIV infection|hiv infection
1520688|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1520689|NCT00698334|Tuberculosis|tuberculosis
1520690|NCT00698321|HIV/STD Prevention|hiv/std prevention
1520691|NCT00698321|HIV Seronegativity|hiv seronegativity
1520692|NCT00698295|schizophrenia|schizophrenia
1520693|NCT00698295|atypical antipsychotics|atypical antipsychotics
1520694|NCT00698295|EEG|eeg
1520695|NCT00698243|OSI-027|osi-027
1520696|NCT00698243|Solid tumor|solid tumor
1520697|NCT00698243|Lymphoma|lymphoma
1520698|NCT00698204|Mucositis|mucositis
1520699|NCT00698204|Head and Neck Cancer|head and neck cancer
1520700|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
1520701|NCT00698204|Stomatitis|stomatitis
1520702|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
1520703|NCT00698191|Lupus Nephritis|lupus nephritis
1520704|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
1520705|NCT00698191|Transplantation|transplantation
1520706|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
1520707|NCT00698178|Waist circumference|waist circumference
1520708|NCT00698178|Body mass index|body mass index
1520709|NCT00698178|Obesity|obesity
1520710|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
1520711|NCT00698152|Total Hip Replacement|total hip replacement
1520712|NCT00698152|Hip Arthritis|hip arthritis
1520713|NCT00698152|Polyethylene|polyethylene
1520714|NCT00698139|heart failure|heart failure
1520715|NCT00698139|chronotropic incompetence|chronotropic incompetence
1520716|NCT00698113|anxiety|anxiety
1520717|NCT00698113|depression|depression
1520718|NCT00698113|stress|stress
1520719|NCT00698113|cancer symptoms|cancer symptoms
1520720|NCT00698113|pediatric cancer|pediatric cancer
1520721|NCT00698113|massage|massage
1520722|NCT00698113|parent delivered massage|parent delivered massage
1520723|NCT00698100|DNA|dna
1520724|NCT00698100|HU & MOUSE|hu & mouse
1520725|NCT00698100|TYROSINASE|tyrosinase
1520726|NCT00698087|Hepatitis B|hepatitis b
1520727|NCT00698087|Engerix™-B|engerix™-b
1520728|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
1520729|NCT00698061|Hepatitis B|hepatitis b
1520730|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
1520731|NCT00698048|Sepsis|sepsis
1520732|NCT00698048|Septic Shock|septic shock
1520733|NCT00698048|Vasopressin|vasopressin
1520734|NCT00698048|Copeptin|copeptin
1520735|NCT00698048|Paediatrics|paediatrics
1520736|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
1520737|NCT00698035|ESTRING|estring
1520738|NCT00698022|healthy|healthy
1520739|NCT00698022|weight gain|weight gain
1520740|NCT00698022|anti-psychotic|anti-psychotic
1520741|NCT00698022|risperidone|risperidone
1520742|NCT00698022|mifepristone|mifepristone
1520743|NCT00698022|mitigation|mitigation
1520744|NCT00698022|weight loss|weight loss
1520745|NCT00698009|Neuroblastoma|neuroblastoma
1520746|NCT00698009|Natural Killer Cell|natural killer cell
1520747|NCT00698009|NK Cell Infusion|nk cell infusion
1520748|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
1520749|NCT00698009|Fludarabine|fludarabine
1520750|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
1520751|NCT00698009|Fludara|fludara
1520752|NCT00698009|Cyclophosphamide|cyclophosphamide
1520753|NCT00698009|Cytoxan|cytoxan
1520754|NCT00698009|Neosar|neosar
1520755|NCT00698009|Interleukin-2|interleukin-2
1520756|NCT00698009|IL-2|il-2
1520757|NCT00698009|Proleukin|proleukin
1520758|NCT00698009|Mesna|mesna
1520759|NCT00698009|Mesnex|mesnex
1520760|NCT00698009|Infusion of NK cells|infusion of nk cells
1520761|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
1520762|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
1520763|NCT00698009|Pediatric NK|pediatric nk
1520764|NCT00698009|Pediatric|pediatric
1520765|NCT00697983|Osteoporosis|osteoporosis
1520766|NCT00697983|ATP|atp
1520767|NCT00697983|Purinergic receptors|purinergic receptors
1520768|NCT00697983|Bone mineral density|bone mineral density
1520769|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
1520770|NCT00697970|Hepatitis B|hepatitis b
1520771|NCT00697970|Engerix™-B|engerix™-b
1520772|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
1520773|NCT00697970|Adjuvant|adjuvant
1520774|NCT00697957|acceleration|acceleration
1520775|NCT00697957|bone density|bone density
1520776|NCT00697957|cardiovascular diseases|cardiovascular diseases
1520777|NCT00697957|exercise|exercise
1520778|NCT00697957|female|female
1520779|NCT00697957|fragility fractures|fragility fractures
1520780|NCT00697957|impact intensity|impact intensity
1520781|NCT00697957|intervention studies|intervention studies
1520782|NCT00697957|osteoporosis|osteoporosis
1520783|NCT00697957|premenopause|premenopause
1520784|NCT00697944|FUNGAL INFECTION|fungal infection
1520785|NCT00697944|SEPSIS|sepsis
1520786|NCT00697944|INTENSIVE CARE|intensive care
1520787|NCT00697944|AMBISOME|ambisome
1520788|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
1521081|NCT00696683|scorpion|scorpion
1520789|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
1520790|NCT00697931|Hepatitis B|hepatitis b
1520791|NCT00697931|Engerix™-B|engerix™-b
1520792|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
1520793|NCT00697931|Adjuvant|adjuvant
1520794|NCT00697918|Partial onset seizure|partial onset seizure
1520795|NCT00697918|Adjunctive therapy|adjunctive therapy
1520796|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1520797|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
1520798|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
1520799|NCT00697892|Drug Interactions|drug interactions
1520800|NCT00697879|tumour|tumour
1520801|NCT00697879|Solid tumour|solid tumour
1520802|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
1520803|NCT00697879|dose escalation|dose escalation
1520804|NCT00697879|cancer|cancer
1520805|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
1520806|NCT00697866|Hepatitis B|hepatitis b
1520807|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520808|NCT00697853|Hepatitis B|hepatitis b
1520809|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
1520810|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520811|NCT00697840|Hepatitis B|hepatitis b
1520812|NCT00697840|Engerix™-B|engerix™-b
1520813|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520814|NCT00697840|Adjuvant|adjuvant
1520815|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1520816|NCT00697814|Prolactinoma|prolactinoma
1520817|NCT00697788|pediatric|pediatric
1520818|NCT00697788|burn|burn
1520819|NCT00697788|sedation|sedation
1520820|NCT00697775|Hepatitis B|hepatitis b
1520821|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520822|NCT00697775|Adjuvant|adjuvant
1520823|NCT00697762|Partial onset seizure|partial onset seizure
1520824|NCT00697762|Adjunctive therapy|adjunctive therapy
1520825|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520826|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
1520827|NCT00697749|Hepatitis B|hepatitis b
1520828|NCT00697736|Systemic Scleroderma|systemic scleroderma
1520829|NCT00697736|Echocardiography|echocardiography
1520830|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
1520831|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
1520832|NCT00697723|transit-time flowmetry|transit-time flowmetry
1520833|NCT00697710|Atopic Dermatitis|atopic dermatitis
1520834|NCT00697697|asthmatic children|asthmatic children
1520835|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
1520836|NCT00697684|Clofarabine|clofarabine
1520837|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
1520838|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
1520839|NCT00697671|NK cell infusion|nk cell infusion
1520840|NCT00697671|Immunotherapy|immunotherapy
1520841|NCT00697671|hematologic malignancy|hematologic malignancy
1520842|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
1520843|NCT00697671|haploidentical donor|haploidentical donor
1520844|NCT00697658|Paliperidone ER|paliperidone er
1520845|NCT00697658|Schizophrenia|schizophrenia
1520846|NCT00697645|Stroke,|stroke,
1520847|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
1520848|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
1520849|NCT00697645|rehabilitation|rehabilitation
1520850|NCT00697632|MET|met
1520851|NCT00697632|AXL|axl
1520852|NCT00697632|VEGFR|vegfr
1520853|NCT00697632|NSCLC|nsclc
1520854|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
1520855|NCT00697632|Tumor|tumor
1520856|NCT00697632|Safety|safety
1520857|NCT00697632|Phase 1|phase 1
1520858|NCT00697632|Solid tumor|solid tumor
1520859|NCT00697606|Seprafilm®|seprafilm®
1520860|NCT00697606|cesarean|cesarean
1520861|NCT00697606|adhesions|adhesions
1520862|NCT00697606|primary|primary
1520863|NCT00697606|repeat|repeat
1520864|NCT00697593|Efalizumab|efalizumab
1520865|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
1520866|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
1520867|NCT00697580|Obesity|obesity
1520868|NCT00697580|Type 2 Diabetes|type 2 diabetes
1520869|NCT00697580|Cardiovascular risk|cardiovascular risk
1520870|NCT00697580|Cancer|cancer
1520871|NCT00697580|Latino|latino
1520872|NCT00697580|Adolescents|adolescents
1520873|NCT00697580|Strength Training|strength training
1520874|NCT00697580|Circuit Training|circuit training
1520875|NCT00697580|Nutrition|nutrition
1520876|NCT00697567|Herpes simplex|herpes simplex
1520877|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
1520878|NCT00697554|Hepatitis B|hepatitis b
1520879|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
1520880|NCT00697541|erythematous rosacea|erythematous rosacea
1520881|NCT00697541|facial gel|facial gel
1520882|NCT00697541|brimonidine|brimonidine
1520883|NCT00697541|ophthalmic solution|ophthalmic solution
1520884|NCT00697528|Graves|graves
1520885|NCT00697528|Color Doppler Imaging|color doppler imaging
1520886|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
1520887|NCT00697528|Orbital Venous Flow|orbital venous flow
1520888|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
1520889|NCT00697489|Urinary incontinence|urinary incontinence
1520890|NCT00697489|Mesh|mesh
1520891|NCT00697476|second line chemotherapy|second line chemotherapy
1520892|NCT00697463|Teriparatide|teriparatide
1520893|NCT00697463|Forteo|forteo
1520894|NCT00697463|Osteopenia|osteopenia
1520895|NCT00697463|Osteoporosis|osteoporosis
1520896|NCT00697463|Fracture|fracture
1520897|NCT00697463|Low Bone Density|low bone density
1520898|NCT00697463|Premenopausal women|premenopausal women
1520899|NCT00697411|Aicardi syndrome|aicardi syndrome
1520900|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
1520901|NCT00697411|X-linked disorders|x-linked disorders
1520902|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1520903|NCT00697372|Drug-Eluting Stents|drug-eluting stents
1520904|NCT00697359|Atrial fibrillation|atrial fibrillation
1520905|NCT00697359|Monitoring|monitoring
1520906|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
1520907|NCT00697359|Implantable loop recorder|implantable loop recorder
1520908|NCT00697346|Drug therapy|drug therapy
1520909|NCT00697333|NSCLC|nsclc
1520910|NCT00697333|FDG-PET|fdg-pet
1520911|NCT00697333|Radiotherapy|radiotherapy
1520912|NCT00697333|planning|planning
1520913|NCT00697333|target volumes|target volumes
1520914|NCT00697307|bioequivalence|bioequivalence
1520915|NCT00697307|contraception|contraception
1520916|NCT00697307|contraceptive patch|contraceptive patch
1520917|NCT00697307|ORTHO EVRA|ortho evra
1520918|NCT00697307|norelgestromin|norelgestromin
1520919|NCT00697307|NGMN|ngmn
1520920|NCT00697307|ethinyl estradiol|ethinyl estradiol
1520921|NCT00697307|EE|ee
1520922|NCT00697294|Vitamin D deficiency|vitamin d deficiency
1520923|NCT00697294|Infants|infants
1520924|NCT00697294|Breast feeding|breast feeding
1520925|NCT00697281|allergic rhinitis|allergic rhinitis
1520926|NCT00697281|human|human
1520927|NCT00697281|clinical trial|clinical trial
1520928|NCT00697281|efficacy|efficacy
1520929|NCT00697281|safety|safety
1520930|NCT00697281|challenge test|challenge test
1520931|NCT00697268|Depression|depression
1520932|NCT00697268|Depression Treatment|depression treatment
1520933|NCT00697268|Unipolar Depression|unipolar depression
1520934|NCT00697268|Citalopram|citalopram
1520935|NCT00697268|Serotonin|serotonin
1520936|NCT00697268|Major Depression|major depression
1520937|NCT00697268|Healthy Volunteer|healthy volunteer
1520938|NCT00697268|HV|hv
1520939|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
1520940|NCT00697255|Hormones|hormones
1520941|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
1520942|NCT00697255|Pharmacological Actions|pharmacological actions
1520943|NCT00697255|Monofollicular growth|monofollicular growth
1520944|NCT00697255|Randomized|randomized
1520945|NCT00697255|Open-label|open-label
1520946|NCT00697255|Active-controlled|active-controlled
1520947|NCT00697242|Hepatitis B|hepatitis b
1520948|NCT00697242|Engerix™-B|engerix™-b
1520949|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
1520950|NCT00697229|Hepatitis B|hepatitis b
1520951|NCT00697229|Engerix™-B|engerix™-b
1520952|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520953|NCT00697216|Hepatitis B|hepatitis b
1520954|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520955|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
1520956|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
1520957|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
1520958|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
1520959|NCT00697177|Exercise|exercise
1520960|NCT00697164|Malaria|malaria
1520961|NCT00697164|Treatment|treatment
1520962|NCT00697164|Adjunctive|adjunctive
1520963|NCT00697164|Erythropoietin|erythropoietin
1520964|NCT00697164|Survival|survival
1520965|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
1520966|NCT00697151|ischemic stroke|ischemic stroke
1520967|NCT00697151|patent foramen ovale|patent foramen ovale
1520968|NCT00697151|warfarin|warfarin
1520969|NCT00697151|aspirin|aspirin
1520970|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
1520971|NCT00697138|Cocaine|cocaine
1520972|NCT00697138|Dependence|dependence
1520973|NCT00697138|Pharmacotherapies|pharmacotherapies
1520974|NCT00697125|Hepatitis B|hepatitis b
1520975|NCT00697125|Engerix™-B|engerix™-b
1520976|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
1520977|NCT00697099|VTE prevention|vte prevention
1520978|NCT00697099|Total Hip Replacement|total hip replacement
1520979|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
1520980|NCT00697086|Heart disease|heart disease
1520981|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
1520982|NCT00697073|Idebenone|idebenone
1520983|NCT00697073|ICARS|icars
1520984|NCT00697060|Metastatic|metastatic
1520985|NCT00697060|Previously treated|previously treated
1520986|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
1520987|NCT00697047|Mass Screening|mass screening
1520988|NCT00697047|Population Surveillance|population surveillance
1520989|NCT00697047|Randomized controlled trial|randomized controlled trial
1520990|NCT00697047|Occult Blood|occult blood
1520991|NCT00697047|Colonoscopy|colonoscopy
1520992|NCT00697047|Sigmoidoscopy|sigmoidoscopy
1520993|NCT00697047|Health Behavior|health behavior
1520994|NCT00697047|Colorectal Screening|colorectal screening
1520995|NCT00697021|Thromboelastography|thromboelastography
1520996|NCT00697021|Aspirin|aspirin
1520997|NCT00697021|Clopidogrel|clopidogrel
1520998|NCT00697021|Plavix|plavix
1520999|NCT00697021|Resistance|resistance
1521000|NCT00697021|Platelet|platelet
1521001|NCT00697021|Coronary Stenting|coronary stenting
1521002|NCT00697021|Bare Metal Stent|bare metal stent
1521003|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
1521004|NCT00697021|Overreactivity|overreactivity
1521005|NCT00697021|Primary Coronary Intervention|primary coronary intervention
1521006|NCT00697008|GERD|gerd
1521007|NCT00697008|CLINICAL GUIDELINE|clinical guideline
1521008|NCT00697008|Symptoms|symptoms
1521009|NCT00697008|clinical outcome|clinical outcome
1521010|NCT00696982|Arterial stiffness|arterial stiffness
1521011|NCT00696982|Augmentation index|augmentation index
1521012|NCT00696982|diabetes mellitus|diabetes mellitus
1521013|NCT00696956|local drug delivery|local drug delivery
1521014|NCT00696956|balloon angioplasty|balloon angioplasty
1521015|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
1521016|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
1521017|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
1521018|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
1521019|NCT00696943|cell death|cell death
1521020|NCT00696943|PET imaging|pet imaging
1521021|NCT00696943|brain metastases|brain metastases
1521022|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
1521023|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
1521024|NCT00696917|Hepatitis B|hepatitis b
1521025|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
1521026|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
1521152|NCT00696345|colorectal cancer|colorectal cancer
1521027|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
1521028|NCT00696878|Infertility|infertility
1521029|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
1521030|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
1521031|NCT00696878|Pharmacological Actions|pharmacological actions
1521032|NCT00696878|Multi-center|multi-center
1521034|NCT00696865|Tolerability|tolerability
1521035|NCT00696865|Phase I|phase i
1521036|NCT00696852|Mindfulness|mindfulness
1521037|NCT00696852|Meditation|meditation
1521038|NCT00696852|Yoga|yoga
1521039|NCT00696852|Inflammatory Markers|inflammatory markers
1521040|NCT00696839|Behavior Therapy|behavior therapy
1521041|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
1521042|NCT00696839|Relaxation|relaxation
1521043|NCT00696839|Clinical Nursing Research|clinical nursing research
1521044|NCT00696839|Complementary Therapies|complementary therapies
1521045|NCT00696813|Registry|registry
1521046|NCT00696813|Healthcare Utilization|healthcare utilization
1521047|NCT00696813|Outcome|outcome
1521048|NCT00696813|Safety|safety
1521049|NCT00696813|Efficacy|efficacy
1521050|NCT00696813|Cost-effectiveness|cost-effectiveness
1521051|NCT00696813|Paliperidone ER|paliperidone er
1521052|NCT00696813|Invega®|invega®
1521053|NCT00696813|Oral antipsychotics|oral antipsychotics
1521054|NCT00696800|Infertility|infertility
1521055|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
1521056|NCT00696800|Hormones|hormones
1521057|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
1521058|NCT00696800|Pharmacological actions|pharmacological actions
1521059|NCT00696800|Randomized|randomized
1521060|NCT00696800|Multi-center|multi-center
1521061|NCT00696800|Multi-national|multi-national
1521062|NCT00696800|Double-blind|double-blind
1521063|NCT00696800|Active-controlled|active-controlled
1521064|NCT00696800|Non-inferiority|non-inferiority
1521065|NCT00696761|LUTS|luts
1521066|NCT00696761|BPH|bph
1521067|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
1521068|NCT00696761|bladder contractility|bladder contractility
1521069|NCT00696748|metabolic syndrome|metabolic syndrome
1521070|NCT00696748|hypogonadism|hypogonadism
1521071|NCT00696748|testosterone undecanoate|testosterone undecanoate
1521072|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
1521073|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
1521074|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1521075|NCT00696696|metastatic|metastatic
1521076|NCT00696696|EGRF inhibitor|egrf inhibitor
1521077|NCT00696696|targeted therapy|targeted therapy
1521078|NCT00696696|combined cancer therapy|combined cancer therapy
1521079|NCT00696696|kinase inhibitor|kinase inhibitor
1521080|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
1521082|NCT00696683|sting|sting
1521083|NCT00696683|envenomation|envenomation
1521084|NCT00696683|antivenom|antivenom
1521085|NCT00696631|Heart disease|heart disease
1521086|NCT00696631|morbidity|morbidity
1521474|NCT00695097|Rituximab|rituximab
1521087|NCT00696618|HIV prevention|hiv prevention
1521088|NCT00696618|MSM|msm
1521089|NCT00696618|Enema|enema
1521090|NCT00696618|HIV Seronegativity|hiv seronegativity
1521091|NCT00696605|Hypoosmolality|hypoosmolality
1521092|NCT00696605|Hyperosmolality|hyperosmolality
1521093|NCT00696605|Copeptin|copeptin
1521094|NCT00696605|Vasopressin|vasopressin
1521095|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
1521096|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
1521097|NCT00696592|Bevacizumab|bevacizumab
1521098|NCT00696592|Photodynamic Therapy|photodynamic therapy
1521099|NCT00696579|BCG|bcg
1521100|NCT00696579|Gemcitabine|gemcitabine
1521101|NCT00696579|Intravesical|intravesical
1521102|NCT00696579|Therapy|therapy
1521103|NCT00696579|Superficial|superficial
1521104|NCT00696579|Transitional|transitional
1521105|NCT00696579|Cell carcinoma|cell carcinoma
1521106|NCT00696566|Thrombosis|thrombosis
1521107|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
1521108|NCT00696566|Blood platelets|blood platelets
1521109|NCT00696566|P2 receptor|p2 receptor
1521110|NCT00696566|Cytochrome P450|cytochrome p450
1521111|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
1521112|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
1521113|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
1521114|NCT00696514|fracture|fracture
1521115|NCT00696514|cognition|cognition
1521116|NCT00696501|Neuromuscular mapping|neuromuscular mapping
1521117|NCT00696501|Spinal surgery|spinal surgery
1521118|NCT00696501|Neurodiagnostics|neurodiagnostics
1521119|NCT00696501|Segmental root innervation|segmental root innervation
1521120|NCT00696501|Dermatomal innervation|dermatomal innervation
1521121|NCT00696501|Myotomal innervation|myotomal innervation
1521122|NCT00696501|Nerve roots|nerve roots
1521123|NCT00696501|Sensory|sensory
1521124|NCT00696501|Signs and Symptoms|signs and symptoms
1521125|NCT00696462|forced-air warming|forced-air warming
1521126|NCT00696462|Bair Hugger|bair hugger
1521127|NCT00696462|cesarean section|cesarean section
1521128|NCT00696462|postoperative infection|postoperative infection
1521129|NCT00696462|surgical site infections|surgical site infections
1521130|NCT00696436|Essential Hypertension|essential hypertension
1521131|NCT00696436|Cardiovascular Disease|cardiovascular disease
1521132|NCT00696436|High Blood Pressure|high blood pressure
1521133|NCT00696436|Drug Therapy|drug therapy
1521134|NCT00696423|Infanrix/Hib|infanrix/hib
1521135|NCT00696423|Chinese children|chinese children
1521136|NCT00696410|Heart Failure|heart failure
1521137|NCT00696410|Cardiomyopathy|cardiomyopathy
1521138|NCT00696410|Remodeling|remodeling
1521139|NCT00696410|Antioxidant|antioxidant
1521140|NCT00696410|Zinc|zinc
1521141|NCT00696410|Copper|copper
1521142|NCT00696384|Essential Hypertension|essential hypertension
1521143|NCT00696384|Cardiovascular Disease|cardiovascular disease
1521144|NCT00696384|High Blood Pressure|high blood pressure
1521145|NCT00696384|Drug Therapy|drug therapy
1521146|NCT00696371|Neuroinflammation|neuroinflammation
1521147|NCT00696371|PBR28|pbr28
1521148|NCT00696371|PET Imaging|pet imaging
1521149|NCT00696371|Health Volunteer|health volunteer
1521150|NCT00696371|HV|hv
1521151|NCT00696358|Vitiligo|vitiligo
1521153|NCT00696345|screening|screening
1521154|NCT00696345|biomarker|biomarker
1521155|NCT00696345|plasma|plasma
1521156|NCT00696345|blood|blood
1521157|NCT00696332|ALS|als
1521158|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
1521159|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
1521160|NCT00696306|Stroke|stroke
1521161|NCT00696306|MRI|mri
1521162|NCT00696306|DTI|dti
1521163|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
1521164|NCT00696306|SWI|swi
1521165|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
1521166|NCT00696306|Outcome|outcome
1521167|NCT00696306|Axonal Injury|axonal injury
1521168|NCT00696280|nausea|nausea
1521169|NCT00696280|vomiting|vomiting
1521170|NCT00696280|Carboplatin|carboplatin
1521171|NCT00696280|cancer|cancer
1567277|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1521172|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
1521173|NCT00696241|Essential Hypertension|essential hypertension
1521174|NCT00696241|Cardiovascular Disease|cardiovascular disease
1521175|NCT00696241|High Blood Pressure|high blood pressure
1521176|NCT00696241|Drug Therapy|drug therapy
1521177|NCT00696215|Parkinson's disease|parkinson's disease
1521178|NCT00696215|rasagiline|rasagiline
1521179|NCT00696215|cognition|cognition
1521180|NCT00696215|MAO-B|mao-b
1521181|NCT00696202|Mirena|mirena
1521182|NCT00696202|Levonorgestrel|levonorgestrel
1521183|NCT00696202|Intrauterine device|intrauterine device
1521184|NCT00696202|Efficacy|efficacy
1521185|NCT00696202|Tolerability|tolerability
1521186|NCT00696202|First year of use|first year of use
1521187|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
1521188|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
1521189|NCT00696189|Nitrous oxide|nitrous oxide
1521190|NCT00696176|STAT 3 DECOY|stat 3 decoy
1521191|NCT00696150|ultrasound|ultrasound
1521192|NCT00696150|hip|hip
1521193|NCT00696150|pain|pain
1521194|NCT00696124|lower leg ischemia|lower leg ischemia
1521195|NCT00696124|peripheral artery disease|peripheral artery disease
1521196|NCT00696111|PCOS|pcos
1521197|NCT00696111|OSA|osa
1521198|NCT00696111|Metabolism|metabolism
1521199|NCT00696111|Diabetes|diabetes
1521200|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
1521201|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
1521202|NCT00696085|brief intervention|brief intervention
1521203|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
1521204|NCT00696059|Computed tomography|computed tomography
1521205|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
1521206|NCT00696059|Radiography|radiography
1521207|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
1521208|NCT00696046|CORD BLOOD CELLS|cord blood cells
1521209|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
1521210|NCT00696046|ENGRAFTMENT|engraftment
1521211|NCT00696046|transplants|transplants
1521212|NCT00696033|Benzodiazepines|benzodiazepines
1521213|NCT00696033|Lorazepam|lorazepam
1521214|NCT00696033|Diazepam|diazepam
1521215|NCT00696033|Memory|memory
1521216|NCT00696033|Perceptual priming|perceptual priming
1521217|NCT00696033|Functional brain imaging|functional brain imaging
1521218|NCT00696033|FMRI|fmri
1521219|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
1521220|NCT00696007|Nephroureterectomy|nephroureterectomy
1521221|NCT00696007|Chemotherapy|chemotherapy
1521222|NCT00696007|Gemcitabine|gemcitabine
1521223|NCT00696007|Cisplatin|cisplatin
1521224|NCT00695981|Rotator cuff|rotator cuff
1521225|NCT00695981|Arthroscopic surgery|arthroscopic surgery
1521226|NCT00695981|Open surgery|open surgery
1521227|NCT00695981|Physiotherapy|physiotherapy
1521228|NCT00695981|Physical therapy|physical therapy
1521229|NCT00695981|Effectiveness|effectiveness
1521230|NCT00695981|RCT|rct
1521231|NCT00695981|cost-effectiveness|cost-effectiveness
1521232|NCT00695955|Essential Hypertension|essential hypertension
1521233|NCT00695955|Cardiovascular Disease|cardiovascular disease
1521234|NCT00695955|High Blood Pressure|high blood pressure
1521235|NCT00695955|Drug Therapy|drug therapy
1521236|NCT00695942|preeclampsia|preeclampsia
1521237|NCT00695942|eclampsia|eclampsia
1521238|NCT00695942|retroplacental hematoma|retroplacental hematoma
1521239|NCT00695942|vascular IUGR|vascular iugr
1521240|NCT00695942|IUFD|iufd
1521241|NCT00695942|VTE|vte
1521242|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
1521243|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
1521244|NCT00695903|Staph Aureus|staph aureus
1521245|NCT00695903|Bacteremia|bacteremia
1521246|NCT00695903|MRSA|mrsa
1521247|NCT00695903|Infective Endocarditis|infective endocarditis
1521248|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
1521249|NCT00695903|SABIE|sabie
1521250|NCT00695903|SAIE|saie
1521251|NCT00695903|RIE|rie
1521252|NCT00695890|Pupillometry|pupillometry
1521253|NCT00695890|Sevoflorane|sevoflorane
1521254|NCT00695890|Propofol|propofol
1521255|NCT00695877|HIV Seronegativity|hiv seronegativity
1521256|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
1521257|NCT00695851|PCK3145|pck3145
1521258|NCT00695851|Prostate|prostate
1521259|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
1521260|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
1521261|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
1521262|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
1521263|NCT00695812|Broader autism phenotype|broader autism phenotype
1521264|NCT00695812|Siblings|siblings
1521265|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
1521266|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
1521267|NCT00695799|Propofol|propofol
1521268|NCT00695799|Anesthesia care provider|anesthesia care provider
1521269|NCT00695799|Pollution|pollution
1521270|NCT00695799|Operating room|operating room
1521271|NCT00695799|Environment|environment
1521272|NCT00695786|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1521273|NCT00695786|Lymphoma|lymphoma
1521274|NCT00695786|Lenalidomide|lenalidomide
1521275|NCT00695786|Revlimid|revlimid
1521276|NCT00695786|Rituximab|rituximab
1521277|NCT00695786|Rituxan|rituxan
1521278|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
1521279|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
1521280|NCT00695773|Prostatectomy|prostatectomy
1521281|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
1521282|NCT00695747|Glaucoma|glaucoma
1521283|NCT00695747|Cataracts|cataracts
1521284|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
1521285|NCT00695747|Trabeculectomy|trabeculectomy
1521286|NCT00695734|hemodialysis|hemodialysis
1522158|NCT00692354|Tumour|tumour
1521287|NCT00695734|end stage renal failure|end stage renal failure
1521288|NCT00695734|tuberculosis|tuberculosis
1521289|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
1521290|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
1521291|NCT00695708|schizophrenia|schizophrenia
1521292|NCT00695708|neuroplasticity|neuroplasticity
1521293|NCT00695708|sensory gating|sensory gating
1521294|NCT00695708|cognitive impairment|cognitive impairment
1521295|NCT00695708|MEG|meg
1521296|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
1521297|NCT00695695|Parents|parents
1521298|NCT00695695|Down Syndrome|down syndrome
1521299|NCT00695695|Hope|hope
1521300|NCT00695695|Uncertainty|uncertainty
1521301|NCT00695695|Adaptation|adaptation
1521302|NCT00695695|DS|ds
1521303|NCT00695695|Survey|survey
1521304|NCT00695682|Remicade|remicade
1521305|NCT00695682|Infliximab|infliximab
1521306|NCT00695682|CSME|csme
1521307|NCT00695682|BDR|bdr
1521308|NCT00695682|CNV|cnv
1521309|NCT00695682|AMD|amd
1521310|NCT00695669|H5N1|h5n1
1521311|NCT00695669|immunogenicity|immunogenicity
1521312|NCT00695669|influenza|influenza
1521313|NCT00695669|Avian|avian
1521314|NCT00695669|pandemic|pandemic
1521315|NCT00695669|vaccines|vaccines
1521316|NCT00695669|human|human
1521317|NCT00695669|safety|safety
1521318|NCT00695656|Hypertension|hypertension
1521319|NCT00695656|general practitioner consultation|general practitioner consultation
1521320|NCT00695656|Patients with hypertension|patients with hypertension
1521321|NCT00695630|conscious sedation|conscious sedation
1521322|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
1521323|NCT00695630|behavior/drug effects|behavior/drug effects
1521324|NCT00695617|MARS treatment|mars treatment
1521325|NCT00695617|Citrate anticoagulation|citrate anticoagulation
1521326|NCT00695604|Acute asthma|acute asthma
1521327|NCT00695604|fluticasone|fluticasone
1521328|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
1521329|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
1521330|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
1521331|NCT00695552|Major depression, exercise|major depression, exercise
1521332|NCT00695539|Rosuvastatin|rosuvastatin
1521333|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
1521334|NCT00695526|cranberry|cranberry
1521335|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
1521336|NCT00695526|type 2 diabetes|type 2 diabetes
1521337|NCT00695513|Food supplement|food supplement
1521338|NCT00695513|Haemodialysis|haemodialysis
1521339|NCT00695500|Varenicline|varenicline
1521340|NCT00695500|Alcohol|alcohol
1521341|NCT00695500|Alcohol Use|alcohol use
1521342|NCT00695487|Anesthesia|anesthesia
1521343|NCT00695487|THC|thc
1521344|NCT00695487|Postoperative Nausea|postoperative nausea
1521345|NCT00695474|Hypovitaminosis D|hypovitaminosis d
1521346|NCT00695474|Type 2 diabetes|type 2 diabetes
1521347|NCT00695474|Glycemic control|glycemic control
1521348|NCT00695474|Inflammation|inflammation
1521349|NCT00695474|Blood pressure|blood pressure
1521350|NCT00695461|Colorectal surgery|colorectal surgery
1521351|NCT00695461|Probiotics|probiotics
1521352|NCT00695461|Lactobacillus|lactobacillus
1521353|NCT00695461|Bacterial translocation|bacterial translocation
1521354|NCT00695461|Postoperative complications|postoperative complications
1521355|NCT00695461|Inflammatory reaction|inflammatory reaction
1521356|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
1521357|NCT00695448|solid tumors|solid tumors
1521358|NCT00695435|normal volunteers|normal volunteers
1521359|NCT00695435|anti-infective|anti-infective
1521360|NCT00695435|tobramycin|tobramycin
1521361|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1521362|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1521363|NCT00695422|human papilloma virus infection|human papilloma virus infection
1521364|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1521365|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1521366|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1567718|NCT00508378|Quality of Life|quality of life
1521367|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1521368|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1521369|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1521370|NCT00695422|AIDS-related malignancies|aids-related malignancies
1521371|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1521372|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1521373|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1521374|NCT00695422|multicentric Castleman disease|multicentric castleman disease
1521375|NCT00695422|HIV Infections|hiv infections
1521376|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1521377|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1521763|NCT00693849|MDD|mdd
1521378|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1521379|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1521380|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1521381|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1521382|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1521383|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1521384|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1521385|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1521386|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1521387|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1521388|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1521389|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1521390|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1521391|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1521392|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1521393|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1521395|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
1521396|NCT00695396|Anemia|anemia
1521397|NCT00695396|Epoetin alfa|epoetin alfa
1521398|NCT00695396|EPO|epo
1521399|NCT00695383|Exercise therapy|exercise therapy
1521400|NCT00695383|Physiotherapy|physiotherapy
1521401|NCT00695383|Critical illness|critical illness
1521402|NCT00695383|Intensive care|intensive care
1521403|NCT00695383|Muscle weakness|muscle weakness
1521404|NCT00695383|Mechanical ventilation|mechanical ventilation
1521405|NCT00695370|Children|children
1521406|NCT00695370|cancer|cancer
1521407|NCT00695370|Bone marrow transplantation|bone marrow transplantation
1521408|NCT00695370|Mobilization|mobilization
1521409|NCT00695370|G-CSF|g-csf
1521410|NCT00695370|Children with solid malignancies|children with solid malignancies
1521411|NCT00695357|Asthma treatment|asthma treatment
1521412|NCT00695357|GINA 2006|gina 2006
1521413|NCT00695357|patient perception|patient perception
1521414|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
1521415|NCT00695331|Labor Augmentation|labor augmentation
1521416|NCT00695331|Misoprostol|misoprostol
1521417|NCT00695331|Oxytocin|oxytocin
1521418|NCT00695318|AMD|amd
1521419|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
1521420|NCT00695318|Geographic Atrophy|geographic atrophy
1521421|NCT00695318|GA|ga
1521422|NCT00695305|rilapladib,|rilapladib,
1521423|NCT00695305|Lp-PLA2,|lp-pla2,
1521424|NCT00695305|atherosclerosis|atherosclerosis
1521425|NCT00695305|SB-659032,|sb-659032,
1521426|NCT00695305|FDG-PET,|fdg-pet,
1521427|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
1521428|NCT00695292|Extensive Stage|extensive stage
1521429|NCT00695292|irinotecan|irinotecan
1521430|NCT00695292|carboplatin|carboplatin
1521431|NCT00695292|sunitinib|sunitinib
1521432|NCT00695279|Gene therapy|gene therapy
1521433|NCT00695253|AAA|aaa
1521434|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
1521435|NCT00695240|Analgesia|analgesia
1521436|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
1521437|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
1521438|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
1521439|NCT00695214|Propofol|propofol
1521440|NCT00695214|Sleep Endoscopy|sleep endoscopy
1521441|NCT00695201|DEXAMETHASONE|dexamethasone
1521442|NCT00695201|FLOXURIDINE|floxuridine
1521443|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1521444|NCT00695201|OXALIPLATIN|oxaliplatin
1521445|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
1521446|NCT00695188|MTX polyglutamates|mtx polyglutamates
1521447|NCT00695188|clinical outcome|clinical outcome
1521448|NCT00695175|Hypertension|hypertension
1521449|NCT00695175|Private cardiology consultation|private cardiology consultation
1521450|NCT00695175|Patients with hypertension|patients with hypertension
1521451|NCT00695162|noise|noise
1521452|NCT00695162|speech intelligibility|speech intelligibility
1521453|NCT00695162|cognition|cognition
1521454|NCT00695149|Spinal cord Injury|spinal cord injury
1521455|NCT00695149|Central nervous system|central nervous system
1521456|NCT00695149|Regeneration|regeneration
1521457|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
1521458|NCT00695149|Transplantation|transplantation
1521460|NCT00695136|Cognitive Disorder|cognitive disorder
1521461|NCT00695136|Sleep|sleep
1521462|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
1521463|NCT00695136|ASD|asd
1521464|NCT00695123|Bone Marrow Transplant|bone marrow transplant
1521465|NCT00695123|Sickle Cell Disease|sickle cell disease
1521466|NCT00695123|G-CSF|g-csf
1521467|NCT00695123|Apheresis|apheresis
1521468|NCT00695123|SD|sd
1521469|NCT00695123|Healthy Volunteer|healthy volunteer
1521470|NCT00695123|HV|hv
1521471|NCT00695110|testosterone|testosterone
1521472|NCT00695110|male hypogonadism|male hypogonadism
1521473|NCT00695110|low testosterone|low testosterone
1521475|NCT00695097|Renal Transplant Rejection|renal transplant rejection
1521477|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
1521478|NCT00695084|multiple sclerosis|multiple sclerosis
1521479|NCT00695071|Healthy Volunteers|healthy volunteers
1521480|NCT00695058|Stress incontinence|stress incontinence
1521481|NCT00695058|urge incontinence|urge incontinence
1521482|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
1521483|NCT00695058|vibration|vibration
1521484|NCT00695058|nerve stimulation|nerve stimulation
1521485|NCT00695045|Pain, Postoperative|pain, postoperative
1521486|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1521487|NCT00695045|Morphine|morphine
1521488|NCT00695045|Injections, Intrathecal|injections, intrathecal
1521489|NCT00695032|renal toxicity|renal toxicity
1521490|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1521491|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1521492|NCT00695019|Prevention of Relapse|prevention of relapse
1521493|NCT00695019|HCV genotype 1b|hcv genotype 1b
1521494|NCT00695019|Recurrence|recurrence
1521495|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
1521496|NCT00694993|first time in human|first time in human
1521497|NCT00694993|Allergic rhinitis,|allergic rhinitis,
1521498|NCT00694980|UC|uc
1521499|NCT00694980|Ulcerative Colitis|ulcerative colitis
1521500|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
1521501|NCT00694954|Iron deficiency anemia|iron deficiency anemia
1521502|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
1521503|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
1521504|NCT00694941|ONO-2506PO|ono-2506po
1521505|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1521506|NCT00694941|ALS|als
1521507|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
1521508|NCT00694902|Healthy Volunteers|healthy volunteers
1521509|NCT00694889|Psychosis|psychosis
1521510|NCT00694889|First Episode|first episode
1521511|NCT00694889|Schizophrenia|schizophrenia
1521512|NCT00694889|Cognitive Remediation|cognitive remediation
1521513|NCT00694876|Health Literacy|health literacy
1521514|NCT00694876|Patient Nonadherence|patient nonadherence
1521515|NCT00694876|Patient Noncompliance|patient noncompliance
1521516|NCT00694876|Follow Up|follow up
1521517|NCT00694876|India|india
1521518|NCT00694876|Glaucoma|glaucoma
1521519|NCT00694863|high risk for ESRD|high risk for esrd
1521520|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
1521521|NCT00694863|membranous nephropathy|membranous nephropathy
1521522|NCT00694863|ACTH|acth
1521523|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
1521524|NCT00694837|glioblastoma|glioblastoma
1521525|NCT00694837|nelfinavir|nelfinavir
1521526|NCT00694837|functional imaging|functional imaging
1521527|NCT00694837|AKT pathway|akt pathway
1521528|NCT00694824|Coronary artery calcification|coronary artery calcification
1521529|NCT00694824|calcium score|calcium score
1521530|NCT00694824|(TGF) b1,|(tgf) b1,
1521531|NCT00694824|fetuin A|fetuin a
1521532|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
1521533|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
1521534|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
1521535|NCT00694824|hemodialysis patients|hemodialysis patients
1521536|NCT00694811|Obesity|obesity
1521537|NCT00694811|Weight loss|weight loss
1521538|NCT00694811|Diet|diet
1521539|NCT00694811|Very-low-energy diet|very-low-energy diet
1521540|NCT00694811|Predictive factors|predictive factors
1521541|NCT00694811|Re-feeding|re-feeding
1521542|NCT00694798|STCC|stcc
1521543|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
1521544|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
1521545|NCT00694772|OSA|osa
1521546|NCT00694772|Apnea hypopnea index|apnea hypopnea index
1521547|NCT00694772|AHI|ahi
1521548|NCT00694772|Coblation|coblation
1521549|NCT00694772|Electrocautery|electrocautery
1521550|NCT00694772|Tonsillectomy|tonsillectomy
1521551|NCT00694772|Tonsillotomy|tonsillotomy
1521552|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
1521553|NCT00694759|insulin|insulin
1521554|NCT00694759|PCOS|pcos
1521555|NCT00694759|cortisol regulation|cortisol regulation
1521556|NCT00694759|regulation|regulation
1521557|NCT00694746|ALT|alt
1521558|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
1521559|NCT00694746|Adolescents|adolescents
1521560|NCT00694746|Overweight|overweight
1521561|NCT00694746|Treatment|treatment
1521562|NCT00694733|Obesity|obesity
1521563|NCT00694733|Menopausal Syndrome|menopausal syndrome
1521564|NCT00694733|Cortisol|cortisol
1521565|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
1521566|NCT00694694|Malaria|malaria
1521567|NCT00694694|Africa|africa
1521568|NCT00694694|Child|child
1521569|NCT00694681|Telephonic care management|telephonic care management
1521570|NCT00694668|Deliberate Self-Harm|deliberate self-harm
1521571|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
1521572|NCT00694668|Suicidal Behaviour|suicidal behaviour
1521573|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
1521574|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
1521575|NCT00694655|Yellow Fever|yellow fever
1521576|NCT00694655|Vaccine|vaccine
1521577|NCT00694655|Immunity|immunity
1521578|NCT00694655|yellow fever vaccine|yellow fever vaccine
1521579|NCT00694655|CD8 T cell responses|cd8 t cell responses
1521580|NCT00694642|Refractory angina|refractory angina
1521581|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
1521582|NCT00694629|treatment|treatment
1521583|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
1521584|NCT00694616|Metabolic syndrome|metabolic syndrome
1521585|NCT00694616|Insulin resistance|insulin resistance
1521586|NCT00694616|Hypertension|hypertension
1521587|NCT00694616|Dyslipidemia|dyslipidemia
1521588|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
1521589|NCT00694603|cetuximab|cetuximab
1521590|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1521591|NCT00694590|AMD3100|amd3100
1521592|NCT00694590|Rituximab|rituximab
1521593|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1521594|NCT00694590|CLL|cll
1521595|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1521596|NCT00694590|SLL|sll
1521597|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
1521598|NCT00694577|early invasive breast cancer|early invasive breast cancer
1521599|NCT00694577|radiation|radiation
1521600|NCT00694577|PBI|pbi
1521601|NCT00694564|abdominal pain|abdominal pain
1521602|NCT00694564|children|children
1521603|NCT00694551|vaccine|vaccine
1521604|NCT00694551|PSMA|psma
1521605|NCT00694551|TARP|tarp
1521606|NCT00694551|immunology|immunology
1521607|NCT00694551|PSA|psa
1521608|NCT00694538|Interferential laser therapy|interferential laser therapy
1521609|NCT00694525|21OHD|21ohd
1521610|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
1521611|NCT00694525|CAH|cah
1521612|NCT00694499|Morbidity|morbidity
1521613|NCT00694499|Mortality|mortality
1521614|NCT00694486|otitis|otitis
1521615|NCT00694486|Eustachian tube function|eustachian tube function
1521616|NCT00694486|Normal middle ear status|normal middle ear status
1521617|NCT00694473|hyperglycemia|hyperglycemia
1521618|NCT00694473|hypoglycemia|hypoglycemia
1521619|NCT00694473|insulin|insulin
1521620|NCT00694473|critical illness|critical illness
1521621|NCT00694473|intensive insulin therapy|intensive insulin therapy
1521622|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
1521623|NCT00694473|CGM|cgm
1521624|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
1521625|NCT00694473|intensive care unit|intensive care unit
1521626|NCT00694473|Blood glucose|blood glucose
1521627|NCT00694460|rabies vaccination|rabies vaccination
1521628|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
1521629|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
1521630|NCT00694434|Cryopreservation|cryopreservation
1521631|NCT00694434|Frozen embryo transfer|frozen embryo transfer
1521632|NCT00694434|Graduated Embryo Score|graduated embryo score
1521633|NCT00694421|otitis|otitis
1521634|NCT00694421|Eustachian tube|eustachian tube
1521635|NCT00694421|virus|virus
1521636|NCT00694421|Middle ear disease|middle ear disease
1521637|NCT00694408|End stage liver disease|end stage liver disease
1521638|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
1521639|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
1521640|NCT00694395|Qualitative study|qualitative study
1521641|NCT00694395|stroke|stroke
1521642|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
1521643|NCT00694395|acute ischemic stroke|acute ischemic stroke
1521644|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
1521645|NCT00694382|chemotherapy|chemotherapy
1521646|NCT00694369|Postoperative Dental Pain|postoperative dental pain
1521647|NCT00694343|Cesarean section|cesarean section
1521648|NCT00694343|spinal anesthesia|spinal anesthesia
1521649|NCT00694343|hypotension|hypotension
1521651|NCT00694330|GM-K562|gm-k562
1521652|NCT00694330|malignant glioma|malignant glioma
1521653|NCT00694304|Major Depressive Disorder|major depressive disorder
1521654|NCT00694304|Long-term|long-term
1521655|NCT00694304|Safety|safety
1521656|NCT00694304|Open-label|open-label
1521657|NCT00694291|Rising PSA|rising psa
1521658|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
1521659|NCT00694265|Median Nerve|median nerve
1521660|NCT00694265|Ultrasonography|ultrasonography
1521661|NCT00694265|Prospective cohort study|prospective cohort study
1521662|NCT00694252|Breast cancer|breast cancer
1521663|NCT00694252|Tykerb|tykerb
1521664|NCT00694252|CTCs|ctcs
1521665|NCT00694239|hypertension|hypertension
1521666|NCT00694239|compliance|compliance
1521667|NCT00694226|Adolescent|adolescent
1521668|NCT00694226|Substance use|substance use
1521669|NCT00694226|Brief intervention|brief intervention
1521670|NCT00694226|Child psychiatry|child psychiatry
1521671|NCT00694213|Pandemic Influenza|pandemic influenza
1521672|NCT00694213|Avian Influenza|avian influenza
1521673|NCT00694213|DNA Vaccines|dna vaccines
1521674|NCT00694213|Antibody|antibody
1521675|NCT00694213|T Cells|t cells
1521676|NCT00694213|HA/NP/M2|ha/np/m2
1521677|NCT00694213|Biojector|biojector
1521678|NCT00694200|breast cancer|breast cancer
1521679|NCT00694200|chemotherapy|chemotherapy
1521680|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
1521681|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
1521682|NCT00694174|newborn infant|newborn infant
1521683|NCT00694174|acute procedural pain|acute procedural pain
1521684|NCT00694174|skin blood flow changes|skin blood flow changes
1521685|NCT00694174|sucrose analgesia|sucrose analgesia
1521686|NCT00694174|laser doppler imager|laser doppler imager
1521687|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
1521688|NCT00694161|Transthyretin|transthyretin
1521689|NCT00694161|TTR|ttr
1521690|NCT00694161|ATTR|attr
1521691|NCT00694161|TTR amyloidosis|ttr amyloidosis
1521692|NCT00694161|cardiomyopathy|cardiomyopathy
1521693|NCT00694161|V122I|v122i
1521694|NCT00694161|wild-type TTR|wild-type ttr
1521695|NCT00694161|SSA|ssa
1521696|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
1521697|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
1521698|NCT00694135|Iontophoresis|iontophoresis
1521699|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
1521700|NCT00694135|Ophthalmology|ophthalmology
1521701|NCT00694122|glucose|glucose
1521702|NCT00694122|cortisol|cortisol
1521703|NCT00694122|growth hormone|growth hormone
1521704|NCT00694122|glucagon|glucagon
1521705|NCT00694122|insulin|insulin
1521706|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
1521707|NCT00694109|FH|fh
1521708|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1521709|NCT00694109|HeFH|hefh
1521710|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1521711|NCT00694109|HoFH|hofh
1521712|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1521713|NCT00694057|Metformin|metformin
1521714|NCT00694057|HbA1c|hba1c
1521715|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
1521716|NCT00694031|Mortality|mortality
1521717|NCT00694031|Convective therapies|convective therapies
1521718|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
1521719|NCT00694031|Dialysis Adequacy|dialysis adequacy
1521720|NCT00694031|Age 18 or older|age 18 or older
1521721|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
1521722|NCT00694018|randomized trial|randomized trial
1521723|NCT00694018|walking|walking
1521724|NCT00694005|stent|stent
1521725|NCT00694005|bifurcation|bifurcation
1521726|NCT00694005|balloon angioplasty|balloon angioplasty
1521727|NCT00693966|HPV, Vaccine|hpv, vaccine
1521728|NCT00693953|Evoked Potentials|evoked potentials
1521729|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
1521730|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
1521731|NCT00693953|Electroencephalography|electroencephalography
1521732|NCT00693953|Brain Mapping|brain mapping
1521733|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
1521734|NCT00693940|PAD|pad
1521735|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
1521736|NCT00693927|Allogeneic|allogeneic
1521737|NCT00693927|Nonmyeloablative|nonmyeloablative
1521738|NCT00693927|CD8-depletion|cd8-depletion
1521739|NCT00693927|PBSC|pbsc
1521740|NCT00693927|GVHD|gvhd
1521741|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
1521742|NCT00693914|Brain Tumor|brain tumor
1521743|NCT00693914|Cognitive Late Effects|cognitive late effects
1521744|NCT00693914|Radiation Therapy|radiation therapy
1521745|NCT00693914|Working Memory|working memory
1521746|NCT00693888|dementia|dementia
1521747|NCT00693888|system of care|system of care
1682794|NCT00082615|HV|hv
1521748|NCT00693888|level of care|level of care
1521749|NCT00693888|interventional study|interventional study
1521750|NCT00693888|evaluation|evaluation
1521751|NCT00693888|dementia diagnostic|dementia diagnostic
1521752|NCT00693888|Evaluation of the care study|evaluation of the care study
1521753|NCT00693875|incidence|incidence
1521754|NCT00693875|awareness|awareness
1521755|NCT00693875|general anesthesia|general anesthesia
1521756|NCT00693875|relevant factor|relevant factor
1521757|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
1521758|NCT00693875|the relevant factors|the relevant factors
1521759|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
1521760|NCT00693849|depression|depression
1521761|NCT00693849|CNS|cns
1521762|NCT00693849|iSPOT|ispot
1521764|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1521765|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1521766|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1522159|NCT00692354|Tumor|tumor
1521767|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1521768|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1521769|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1521770|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1521771|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
1521772|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
1521773|NCT00693823|atherosclerosis|atherosclerosis
1521774|NCT00693823|stent|stent
1521775|NCT00693823|angioplasty|angioplasty
1521776|NCT00693823|covered stent|covered stent
1521777|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
1521778|NCT00693797|collagen|collagen
1521779|NCT00693797|aortic stenosis|aortic stenosis
1521780|NCT00693784|Intervertebral Disk|intervertebral disk
1521781|NCT00693784|chronic low back pain|chronic low back pain
1521782|NCT00693784|internal disc disruption|internal disc disruption
1521783|NCT00693784|degenerative disc disease|degenerative disc disease
1521785|NCT00693758|coronary reactivity|coronary reactivity
1521786|NCT00693758|coronary physiology|coronary physiology
1521787|NCT00693745|Acutely|acutely
1521788|NCT00693719|recurrent breast cancer|recurrent breast cancer
1521789|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
1521790|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
1521791|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
1521792|NCT00693719|stage IV breast cancer|stage iv breast cancer
1521793|NCT00693706|cell culture|cell culture
1521794|NCT00693706|Safety|safety
1521795|NCT00693706|Influenza|influenza
1521796|NCT00693706|Humans|humans
1521797|NCT00693706|Adults|adults
1521798|NCT00693706|Immunogenicity|immunogenicity
1521799|NCT00693706|Influenza vaccine|influenza vaccine
1521800|NCT00693706|Vaccine|vaccine
1521801|NCT00693680|depression|depression
1521802|NCT00693680|antidepressant treatment|antidepressant treatment
1521803|NCT00693680|zinc|zinc
1521804|NCT00693680|placebo|placebo
1521805|NCT00693667|osteoporosis|osteoporosis
1521806|NCT00693667|postmenopausal women|postmenopausal women
1521807|NCT00693667|botanical drug|botanical drug
1521808|NCT00693654|Uremic Pruritis|uremic pruritis
1521809|NCT00693641|Jellyfish|jellyfish
1521810|NCT00693641|Cyanea sp|cyanea sp
1521811|NCT00693641|Safe Sea|safe sea
1521812|NCT00693641|Prevention|prevention
1521813|NCT00693641|treatment|treatment
1521814|NCT00693641|Pain relief|pain relief
1521815|NCT00693641|Prevention of pain|prevention of pain
1521816|NCT00693628|volume|volume
1521817|NCT00693628|healing|healing
1521818|NCT00693628|shrinker|shrinker
1521819|NCT00693628|transtibial amputation|transtibial amputation
1521820|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
1521821|NCT00693615|HPV, Vaccine|hpv, vaccine
1521822|NCT00693589|endothelial function|endothelial function
1521823|NCT00693589|flow mediated dilatation|flow mediated dilatation
1521824|NCT00693589|rosuvastatin|rosuvastatin
1521825|NCT00693589|folic acid|folic acid
1521826|NCT00693589|B vitamins|b vitamins
1521827|NCT00693576|renal transplant|renal transplant
1521828|NCT00693576|panel reactive antibody|panel reactive antibody
1521829|NCT00693576|sensitization|sensitization
1521830|NCT00693576|simvastatin|simvastatin
1521831|NCT00693576|immunological|immunological
1521832|NCT00693563|Spinal Cord Injury|spinal cord injury
1521833|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
1521834|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
1521835|NCT00693524|liver allograft transplantation|liver allograft transplantation
1521836|NCT00693524|sequential therapy|sequential therapy
1521837|NCT00693524|tacrolimus|tacrolimus
1521838|NCT00693511|obesity|obesity
1521839|NCT00693511|adolescents|adolescents
1521840|NCT00693511|adiposity|adiposity
1521841|NCT00693511|insulin sensitivity|insulin sensitivity
1521842|NCT00693511|type 2 diabetes|type 2 diabetes
1521843|NCT00693511|Latino|latino
1521844|NCT00693511|circuit training|circuit training
1521845|NCT00693511|physical activity|physical activity
1521846|NCT00693511|motivational interviewing|motivational interviewing
1521847|NCT00693498|pediatrics|pediatrics
1521848|NCT00693498|congenital heart disease|congenital heart disease
1521849|NCT00693472|Antipsychotic Agents|antipsychotic agents
1521850|NCT00693459|Hemorrhoids|hemorrhoids
1521851|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
1521852|NCT00693446|tacrolimus|tacrolimus
1521853|NCT00693446|sirolimus|sirolimus
1521854|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
1521855|NCT00693381|Transplantation|transplantation
1521856|NCT00693381|Graft Rejection|graft rejection
1521857|NCT00693381|Renal Transplantation|renal transplantation
1521858|NCT00693355|gut health|gut health
1521859|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
1521860|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
1521861|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
1521862|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
1522160|NCT00692354|Oral|oral
1521863|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
1521864|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
1521865|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1521866|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1521867|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1521868|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1521869|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
1521870|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
1521871|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
1521872|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
1521873|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
1521874|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
1521875|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1521876|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1521877|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1521878|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1521879|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1521880|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1521881|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1521882|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1521883|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1521884|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1521885|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1521886|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1521887|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1521888|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1521889|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
1521890|NCT00693329|Kidney|kidney
1521891|NCT00693329|NGAL|ngal
1521892|NCT00693316|Healthy volunteer study|healthy volunteer study
1521893|NCT00693303|single subject|single subject
1521894|NCT00693303|quantitative|quantitative
1521895|NCT00693290|Colonoscopy|colonoscopy
1521896|NCT00693290|Colorectal screening|colorectal screening
1521897|NCT00693290|Colon preparation|colon preparation
1521898|NCT00693277|none - entry made in error|none - entry made in error
1521899|NCT00693264|Human Volunteers|human volunteers
1521900|NCT00693264|Hoodia|hoodia
1521901|NCT00693264|Safety|safety
1521902|NCT00693251|stent|stent
1521903|NCT00693251|bifurcation|bifurcation
1521904|NCT00693251|coronary artery stenosis|coronary artery stenosis
1521905|NCT00693251|balloon angioplasty|balloon angioplasty
1521906|NCT00693238|Prostate Cancer|prostate cancer
1521907|NCT00693238|Proton Radiation|proton radiation
1521908|NCT00693225|Erosive Esophagitis|erosive esophagitis
1521909|NCT00693225|Reflux Esophagitis|reflux esophagitis
1521910|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
1521911|NCT00693225|GERD|gerd
1521912|NCT00693225|proton pump inhibitor|proton pump inhibitor
1521913|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
1521914|NCT00693212|ADHD|adhd
1521915|NCT00693212|Adult|adult
1521916|NCT00693212|crossover|crossover
1521917|NCT00693212|randomized|randomized
1521918|NCT00693212|Long-term|long-term
1521919|NCT00693212|Open-label|open-label
1521920|NCT00693212|methylphenidate|methylphenidate
1521921|NCT00693212|Social adjustment|social adjustment
1521922|NCT00693199|Amlodipine|amlodipine
1521923|NCT00693199|Terazosin|terazosin
1521924|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1521925|NCT00693199|Essential hypertension|essential hypertension
1521926|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
1521927|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
1521928|NCT00693173|anal|anal
1521929|NCT00693173|cancer|cancer
1521930|NCT00693173|rectal|rectal
1521931|NCT00693173|IMRT|imrt
1521932|NCT00693173|genital|genital
1521933|NCT00693173|sparing|sparing
1521934|NCT00693173|drop|drop
1521935|NCT00693173|technique|technique
1521936|NCT00693160|healthy volunteers|healthy volunteers
1521937|NCT00693160|analgesia|analgesia
1521938|NCT00693160|pain|pain
1521939|NCT00693160|Healthy subjects|healthy subjects
1521940|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
1521941|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
1521942|NCT00693121|Traumatic Brain Injury|traumatic brain injury
1521943|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
1521944|NCT00693121|Delirium|delirium
1521945|NCT00693121|Amantadine|amantadine
1521946|NCT00693121|Clinical trial|clinical trial
1521947|NCT00693108|Poor|poor
1521948|NCT00693108|Response|response
1521949|NCT00693108|Ovarian|ovarian
1521950|NCT00693108|Stimulation|stimulation
1521951|NCT00693108|IVF|ivf
1521952|NCT00693108|Patients|patients
1521953|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
1521954|NCT00693095|Newly-diagnosed|newly-diagnosed
1521955|NCT00693095|CMV positive|cmv positive
1521956|NCT00693082|PCOS|pcos
1521957|NCT00693082|flaxseed|flaxseed
1521958|NCT00693069|angioplasty|angioplasty
1521959|NCT00693069|clopidogrel|clopidogrel
1521960|NCT00693069|coronary artery disease|coronary artery disease
1521961|NCT00693069|platelets|platelets
1521962|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
1521963|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
1521964|NCT00693056|ED|ed
1521965|NCT00693043|Pain control|pain control
1521966|NCT00693030|Coronary Artery Disease|coronary artery disease
1521967|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
1521968|NCT00693030|Drug-Eluting stents|drug-eluting stents
1521969|NCT00693030|Optical Coherence Tomography|optical coherence tomography
1521970|NCT00693030|Thrombosis|thrombosis
1521971|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
1521972|NCT00692991|Microvascular Obstruction|microvascular obstruction
1521973|NCT00692991|Cardiac MRI|cardiac mri
1521974|NCT00692991|Alcohol Ablation|alcohol ablation
1521975|NCT00692991|Diagnostic PCI|diagnostic pci
1521976|NCT00692978|Monodisperse aerosols|monodisperse aerosols
1521977|NCT00692978|Healthy Volunteers|healthy volunteers
1521978|NCT00692978|Asthmatics|asthmatics
1521979|NCT00692978|Pharmacokinetics|pharmacokinetics
1521980|NCT00692978|Randomized|randomized
1521981|NCT00692965|HIV|hiv
1521982|NCT00692965|Sleep Quality|sleep quality
1521983|NCT00692965|Sleep apnea|sleep apnea
1521984|NCT00692965|Berlin Questionnaire|berlin questionnaire
1521985|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
1521986|NCT00692952|contraceptive efficacy|contraceptive efficacy
1521987|NCT00692939|Stem cell transplantation|stem cell transplantation
1521988|NCT00692939|Crohn's Disease|crohn's disease
1521989|NCT00692926|ALDHbr|aldhbr
1521990|NCT00692926|Umbilical Cord Blood|umbilical cord blood
1521991|NCT00692926|Transplantation|transplantation
1521992|NCT00692926|Hematological malignancy|hematological malignancy
1521993|NCT00692926|MDS|mds
1521994|NCT00692926|severe aplastic anemia|severe aplastic anemia
1521995|NCT00692926|inborn error of metabolism|inborn error of metabolism
1521996|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
1521997|NCT00692926|Hurler's Disease|hurler's disease
1521998|NCT00692926|Tay Sach's|tay sach's
1521999|NCT00692926|PMD|pmd
1522000|NCT00692926|Hunter's Syndrome|hunter's syndrome
1522001|NCT00692926|Krabbe|krabbe
1522002|NCT00692926|MLD|mld
1522003|NCT00692926|ALD|ald
1522004|NCT00692926|ALL|all
1522005|NCT00692926|AML|aml
1522006|NCT00692887|AMD|amd
1522007|NCT00692874|Quality of Life|quality of life
1522008|NCT00692861|Celiac Disease|celiac disease
1522009|NCT00692861|Ataxia|ataxia
1522010|NCT00692861|Adults|adults
1522011|NCT00692861|Health Volunteer|health volunteer
1522013|NCT00692848|Procalcitonin|procalcitonin
1522014|NCT00692848|Antibiotic|antibiotic
1522015|NCT00692848|Fever without source|fever without source
1522016|NCT00692848|Fever without focus|fever without focus
1522017|NCT00692848|bacteremia|bacteremia
1522018|NCT00692848|Urinary tract infection|urinary tract infection
1522019|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
1522020|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
1522021|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
1522022|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
1522023|NCT00692822|Quinolone Resistance|quinolone resistance
1522024|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
1522025|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
1522026|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
1522027|NCT00692809|Tuberculosis|tuberculosis
1522028|NCT00692809|Natural Killer T Cells|natural killer t cells
1522029|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
1522030|NCT00692809|Regulatory T cells|regulatory t cells
1522031|NCT00692809|Interferon-gamma|interferon-gamma
1522032|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
1522033|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
1522034|NCT00692796|Dyspnea|dyspnea
1522035|NCT00692796|Quality of life|quality of life
1522036|NCT00692783|candida|candida
1522037|NCT00692783|dubliniensis|dubliniensis
1522038|NCT00692783|candidiasis|candidiasis
1522039|NCT00692783|HIV|hiv
1522040|NCT00692783|AIDS|aids
1522041|NCT00692783|azole resistance.|azole resistance.
1522042|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
1522043|NCT00692770|Sorafenib|sorafenib
1522044|NCT00692770|Adjuvant|adjuvant
1522045|NCT00692770|Surgical resection|surgical resection
1522046|NCT00692770|Ablation|ablation
1522047|NCT00692770|Nexavar|nexavar
1522048|NCT00692770|Adjuvant therapy|adjuvant therapy
1522049|NCT00692770|Liver cancer|liver cancer
1522050|NCT00692770|HCC|hcc
1522051|NCT00692770|STORM|storm
1522052|NCT00692757|Hypochlorous Acid|hypochlorous acid
1522053|NCT00692757|Colony forming units|colony forming units
1522054|NCT00692757|surgical site infection|surgical site infection
1522055|NCT00692757|nosocomial infection|nosocomial infection
1522056|NCT00692757|bacterial bioburden|bacterial bioburden
1522057|NCT00692757|wound healing|wound healing
1522058|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
1522059|NCT00692744|Cerebral aneurysm|cerebral aneurysm
1522060|NCT00692744|Elderly|elderly
1522061|NCT00692731|green tea,|green tea,
1522062|NCT00692731|polyphenols,|polyphenols,
1522063|NCT00692731|weight loss,|weight loss,
1522064|NCT00692731|body fat|body fat
1522065|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
1522066|NCT00692705|amyloid deposits|amyloid deposits
1522067|NCT00692705|Positron Emission Tomography|positron emission tomography
1522068|NCT00692705|phase I|phase i
1522069|NCT00692653|Localized prostate cancer|localized prostate cancer
1522070|NCT00692653|Treatment decision making|treatment decision making
1522071|NCT00692653|Tailored decision aid|tailored decision aid
1522072|NCT00692640|Cancer|cancer
1522073|NCT00692640|Solid Tumors|solid tumors
1522074|NCT00692640|NSCLC|nsclc
1522075|NCT00692627|Falciparum|falciparum
1522076|NCT00692627|malaria|malaria
1522077|NCT00692627|volume|volume
1522078|NCT00692627|haemodynamics|haemodynamics
1522079|NCT00692601|Acute Exercise protocol|acute exercise protocol
1522080|NCT00692601|Crossover design|crossover design
1522081|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
1522082|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
1522083|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
1522084|NCT00692601|Capsiate Natura|capsiate natura
1522085|NCT00692601|Young|young
1522086|NCT00692601|Male|male
1522087|NCT00692588|Alzheimer's Disease|alzheimer's disease
1522088|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
1522089|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1522090|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
1522091|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
1522092|NCT00692588|Doxycycline|doxycycline
1522093|NCT00692588|Rifampicin|rifampicin
1522094|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
1522095|NCT00692575|Caregivers|caregivers
1522096|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
1522097|NCT00692562|Kidney Transplantation|kidney transplantation
1522098|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1522099|NCT00692562|alemtuzumab|alemtuzumab
1522100|NCT00692549|ultrasound|ultrasound
1522101|NCT00692549|iv access|iv access
1522102|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
1522103|NCT00692536|Obesity|obesity
1522104|NCT00692536|Postmenopausal|postmenopausal
1522105|NCT00692536|Diet intervention|diet intervention
1522106|NCT00692523|Stroke|stroke
1522107|NCT00692523|rehabilitation|rehabilitation
1522108|NCT00692523|Nintendo Wii|nintendo wii
1522109|NCT00692510|AZD3480|azd3480
1522110|NCT00692510|Cocktail|cocktail
1522111|NCT00692510|caffeine|caffeine
1522112|NCT00692510|bupropion|bupropion
1522113|NCT00692510|omeprazole|omeprazole
1522114|NCT00692510|midazolam|midazolam
1522115|NCT00692510|rosiglitazone|rosiglitazone
1522116|NCT00692510|metabolism|metabolism
1522117|NCT00692510|Drug Drug Interaction|drug drug interaction
1522118|NCT00692497|One-Stop|one-stop
1522119|NCT00692497|Public Health Research|public health research
1522120|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
1522121|NCT00692497|Evaluation Studies|evaluation studies
1522122|NCT00692497|Referral|referral
1522123|NCT00692497|Surgery, Outpatient|surgery, outpatient
1522124|NCT00692497|Surgery, Day|surgery, day
1522125|NCT00692497|Telemedicine|telemedicine
1522126|NCT00692484|Antimicrobial|antimicrobial
1522127|NCT00692484|Antisepsis|antisepsis
1522128|NCT00692484|Topical antisepsis|topical antisepsis
1522129|NCT00692471|Sleep|sleep
1522130|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
1522131|NCT00692471|POTS|pots
1522132|NCT00692445|depression|depression
1522133|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
1522135|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
1522136|NCT00692432|CPB|cpb
1522137|NCT00692432|inflammation|inflammation
1522138|NCT00692432|inflammatory marker|inflammatory marker
1522139|NCT00692432|myocardial depression|myocardial depression
1522140|NCT00692432|myocardial depressant factor|myocardial depressant factor
1522141|NCT00692419|pain|pain
1522142|NCT00692419|sexual dysfunction|sexual dysfunction
1522143|NCT00692419|depression|depression
1522144|NCT00692419|symptoms|symptoms
1522145|NCT00692380|gated IMRT|gated imrt
1522146|NCT00692367|Body fat|body fat
1522147|NCT00692367|Exercise|exercise
1522148|NCT00692367|Fatty acids|fatty acids
1522149|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
1522150|NCT00692367|Insulin resistance|insulin resistance
1522151|NCT00692367|Insulin Sensitivity|insulin sensitivity
1522152|NCT00692367|Metabolic syndrome|metabolic syndrome
1522153|NCT00692367|Obesity|obesity
1522154|NCT00692367|Physical activity|physical activity
1522155|NCT00692367|Weight Loss|weight loss
1522156|NCT00692354|Advanced|advanced
1522157|NCT00692354|Solid|solid
1522161|NCT00692341|hepatic impairment|hepatic impairment
1522162|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
1522163|NCT00692315|glutathione|glutathione
1522164|NCT00692315|methionine|methionine
1522165|NCT00692315|folinic acid|folinic acid
1522166|NCT00692315|redox|redox
1522167|NCT00692315|oxidative stress|oxidative stress
1522168|NCT00692315|behavior|behavior
1522169|NCT00692302|Suicide Attempts|suicide attempts
1522170|NCT00692302|Adolescents|adolescents
1522171|NCT00692302|Suicidal|suicidal
1522172|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
1522173|NCT00692289|Quality of Life|quality of life
1522174|NCT00692263|Healthy subjects|healthy subjects
1522175|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
1522176|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
1522177|NCT00692237|Endothelial dysfunction|endothelial dysfunction
1522178|NCT00692237|Sildenafil|sildenafil
1522179|NCT00692224|neonatal jaundice|neonatal jaundice
1522180|NCT00692224|zinc|zinc
1522181|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
1522182|NCT00692224|enterohepatic circulation|enterohepatic circulation
1522183|NCT00692224|bilirubin|bilirubin
1522184|NCT00692211|screening|screening
1522185|NCT00692198|COPD|copd
1522186|NCT00692185|Anorexia Nervosa|anorexia nervosa
1522187|NCT00692172|psoriasis|psoriasis
1522188|NCT00692172|alefacept|alefacept
1522189|NCT00692172|intramuscular|intramuscular
1522190|NCT00692159|TRC102|trc102
1522191|NCT00692159|Methoxyamine HCL|methoxyamine hcl
1522192|NCT00692159|Pemetrexed|pemetrexed
1522193|NCT00692159|Alimta|alimta
1522194|NCT00692159|Tracon|tracon
1522195|NCT00692159|Phase 1|phase 1
1522196|NCT00692159|Cancer|cancer
1522197|NCT00692159|BER|ber
1522198|NCT00692159|Base Excision Repair|base excision repair
1522199|NCT00692159|Small Molecule|small molecule
1522200|NCT00692159|Anti-folate|anti-folate
1522201|NCT00692159|Solid Tumor|solid tumor
1522202|NCT00692159|Neoplastic Processes|neoplastic processes
1522203|NCT00692159|Pathologic Processes|pathologic processes
1522204|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
1522205|NCT00692146|Proof of Mechanism|proof of mechanism
1522206|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
1522207|NCT00692133|schizophrenia|schizophrenia
1522208|NCT00692133|bipolar disorder|bipolar disorder
1522209|NCT00692133|antipsychotic treatment|antipsychotic treatment
1522210|NCT00692133|patients´preferences|patients´preferences
1522211|NCT00692107|Radiotherapy|radiotherapy
1522212|NCT00692107|Dose|dose
1522213|NCT00692094|melatonin|melatonin
1522214|NCT00692094|circadian rhythms|circadian rhythms
1522215|NCT00692094|sleep|sleep
1522216|NCT00692081|adolescents|adolescents
1522217|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
1522218|NCT00692081|social competence training|social competence training
1522219|NCT00692081|vocational training|vocational training
1522220|NCT00692081|group intervention|group intervention
1522221|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
1522222|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
1522223|NCT00692068|residual renal function|residual renal function
1522224|NCT00692068|oxidative stress|oxidative stress
1522225|NCT00692068|carbonyl stress|carbonyl stress
1522226|NCT00692068|peritoneal dialysis|peritoneal dialysis
1522227|NCT00692042|Safety|safety
1522228|NCT00692042|tolerability|tolerability
1522229|NCT00692029|Normal|normal
1522230|NCT00692029|Healthy Volunteers|healthy volunteers
1522231|NCT00692016|Naproxen Sodium|naproxen sodium
1522232|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
1522233|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
1683245|NCT00004246|RT|rt
1522234|NCT00691977|Radiation Therapy|radiation therapy
1522235|NCT00691938|LBH589|lbh589
1522236|NCT00691938|Decitabine|decitabine
1522237|NCT00691938|panobinostat|panobinostat
1522238|NCT00691938|histone deacetylase|histone deacetylase
1522239|NCT00691938|methylation|methylation
1522240|NCT00691938|hypomethylation|hypomethylation
1522241|NCT00691925|refractive surgery|refractive surgery
1522242|NCT00691886|sedation|sedation
1522243|NCT00691873|Allergic|allergic
1522244|NCT00691873|Asthma|asthma
1522245|NCT00691873|Immunotherapy|immunotherapy
1522246|NCT00691860|Parastomal hernias|parastomal hernias
1522247|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
1522248|NCT00691860|Paracolostomy hernias|paracolostomy hernias
1522249|NCT00691860|Peristomal hernias|peristomal hernias
1522250|NCT00691847|Refractive surgery|refractive surgery
1522251|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
1522252|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
1522253|NCT00691821|Bandages|bandages
1522345|NCT00691496|gay|gay
1522254|NCT00691821|Community Health Services|community health services
1522255|NCT00691795|Analgesia|analgesia
1522256|NCT00691795|Epidural|epidural
1522257|NCT00691795|Pregnancy|pregnancy
1522258|NCT00691795|Labor|labor
1522259|NCT00691795|Clonidine|clonidine
1522260|NCT00691795|Fentanyl|fentanyl
1522261|NCT00691795|Bupivacaine|bupivacaine
1522262|NCT00691795|Childbirth|childbirth
1522263|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
1522264|NCT00691769|alopecia|alopecia
1522265|NCT00691769|lupus|lupus
1522266|NCT00691756|renal failure|renal failure
1522267|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
1522268|NCT00691756|cold crystalloid|cold crystalloid
1522269|NCT00691756|cold blood|cold blood
1522270|NCT00691756|renal perfusion|renal perfusion
1522271|NCT00691743|Upper GI Symptoms|upper gi symptoms
1522273|NCT00691743|NSAIDs|nsaids
1522274|NCT00691717|Anecortave acetate|anecortave acetate
1522275|NCT00691717|Open-angle glaucoma|open-angle glaucoma
1522276|NCT00691717|IOP|iop
1522277|NCT00691717|OHT|oht
1522278|NCT00691704|Multiple Myeloma|multiple myeloma
1522279|NCT00691691|Liver malignancy|liver malignancy
1522280|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1522281|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
1522282|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
1522283|NCT00691678|breast cancer|breast cancer
1522284|NCT00691678|aromatase inhibitor|aromatase inhibitor
1522285|NCT00691678|supportive care|supportive care
1522286|NCT00691665|Rhinitis|rhinitis
1522287|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1522288|NCT00691665|allergies|allergies
1522289|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1522290|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1522291|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1522292|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1522293|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1522294|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1522295|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1522296|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1522297|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1522298|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1522299|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1522300|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1522301|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1522302|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1522303|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1522304|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1522305|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1522306|NCT00691639|Open-angle glaucoma|open-angle glaucoma
1522307|NCT00691639|IOP|iop
1522308|NCT00691626|posttraumatic stress|posttraumatic stress
1522309|NCT00691626|nightmares|nightmares
1522310|NCT00691626|sleep|sleep
1522311|NCT00691626|psychotherapy|psychotherapy
1522312|NCT00691626|imagery rehearsal|imagery rehearsal
1522313|NCT00691626|insomnia|insomnia
1522314|NCT00691626|behavioral treatment|behavioral treatment
1522315|NCT00691626|veterans|veterans
1522316|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
1522317|NCT00691626|Operation Enduring Freedom|operation enduring freedom
1522318|NCT00691613|Apoptosis|apoptosis
1522319|NCT00691613|Annexin|annexin
1522320|NCT00691613|Hypoxia|hypoxia
1522321|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
1522322|NCT00691600|abscess|abscess
1567278|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1522323|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
1522324|NCT00691587|mechanical ventilation|mechanical ventilation
1522325|NCT00691587|mechanically ventilated|mechanically ventilated
1522326|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
1522327|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
1522328|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
1522329|NCT00691574|melatonin|melatonin
1522330|NCT00691574|circadian rhythm|circadian rhythm
1522331|NCT00691574|sleep|sleep
1522332|NCT00691561|HIV Prevention|hiv prevention
1522333|NCT00691561|African American|african american
1522334|NCT00691561|Black|black
1522335|NCT00691561|gay|gay
1522336|NCT00691561|Men who have sex men|men who have sex men
1522337|NCT00691561|HIV Seronegativity|hiv seronegativity
1522338|NCT00691548|Stage IV cancer|stage iv cancer
1522339|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
1522340|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
1522341|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
1522342|NCT00691509|breast cancer|breast cancer
1522343|NCT00691496|HIV Prevention|hiv prevention
1522344|NCT00691496|African-American|african-american
1522346|NCT00691496|bisexual|bisexual
1522347|NCT00691496|intervention trial|intervention trial
1522348|NCT00691496|HIV Seronegativity|hiv seronegativity
1522349|NCT00691483|smoking cessation|smoking cessation
1522350|NCT00691483|smoking treatment|smoking treatment
1522592|NCT00690781|spread|spread
1522351|NCT00691483|patient self-selected quit date|patient self-selected quit date
1522352|NCT00691470|Anticoagulation|anticoagulation
1522353|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
1522354|NCT00691470|Coumadin|coumadin
1522355|NCT00691470|Warfarin|warfarin
1522356|NCT00691470|Atrial fibrillation|atrial fibrillation
1522357|NCT00691470|Prosthetic heart valve|prosthetic heart valve
1522358|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
1522359|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
1522360|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
1522361|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
1522362|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
1522363|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
1522364|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
1522365|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
1522366|NCT00691457|Contact lens|contact lens
1522367|NCT00691457|solution|solution
1522368|NCT00691457|confocal microscope|confocal microscope
1522369|NCT00691444|melatonin|melatonin
1522370|NCT00691444|circadian rhythms|circadian rhythms
1522372|NCT00691418|perinatal|perinatal
1522373|NCT00691418|premature|premature
1522374|NCT00691418|pregnancy|pregnancy
1522375|NCT00691418|gestation|gestation
1522376|NCT00691405|Arformoterol|arformoterol
1522377|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
1522378|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
1522379|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
1522380|NCT00691392|MDR TB|mdr tb
1522381|NCT00691392|XDR TB|xdr tb
1522382|NCT00691392|MDR|mdr
1522383|NCT00691392|XDR|xdr
1522384|NCT00691379|Breast cancer|breast cancer
1522385|NCT00691379|Triple negative|triple negative
1522386|NCT00691379|Chemotherapy|chemotherapy
1522387|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
1522388|NCT00691353|Bipolar Disorder|bipolar disorder
1522389|NCT00691353|antipsychotics|antipsychotics
1522390|NCT00691353|social functioning|social functioning
1522391|NCT00691353|mood stabilizers|mood stabilizers
1522392|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
1522393|NCT00691353|atypical antipsychotics|atypical antipsychotics
1522394|NCT00691353|monotherapy|monotherapy
1522395|NCT00691353|cotherapy|cotherapy
1522396|NCT00691340|POAG|poag
1522397|NCT00691340|Alzheimer's disease|alzheimer's disease
1522398|NCT00691340|cellular proteome|cellular proteome
1522399|NCT00691340|human leucocytes|human leucocytes
1522400|NCT00691340|vasospasm|vasospasm
1522401|NCT00691340|Healthy subjects|healthy subjects
1522402|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
1522403|NCT00691314|Stroke|stroke
1522404|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
1522405|NCT00691314|Stents|stents
1522406|NCT00691314|Stenosis|stenosis
1522407|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1522408|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
1522409|NCT00691301|stage III cervical cancer|stage iii cervical cancer
1683420|NCT00003646|cancer|cancer
1522410|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
1522411|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
1522412|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
1522413|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
1522414|NCT00691288|HIV|hiv
1522415|NCT00691288|pediatric|pediatric
1522416|NCT00691288|HAART|haart
1522417|NCT00691275|dehydration|dehydration
1522418|NCT00691275|acute gastroenteritis|acute gastroenteritis
1522419|NCT00691275|ondansetron|ondansetron
1522420|NCT00691275|rehydration|rehydration
1522421|NCT00691262|Atopic dermatitis|atopic dermatitis
1522422|NCT00691262|Prograf|prograf
1522423|NCT00691262|Tacrolimus|tacrolimus
1522424|NCT00691262|FK506|fk506
1522425|NCT00691262|Tacrolimus ointment|tacrolimus ointment
1522426|NCT00691249|Diabetes|diabetes
1522427|NCT00691249|Diet|diet
1522428|NCT00691249|Fiber|fiber
1522429|NCT00691236|osteosarcoma|osteosarcoma
1522430|NCT00691236|zoledronic acid|zoledronic acid
1522431|NCT00691236|bisphosphonates|bisphosphonates
1522432|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
1522433|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
1522434|NCT00691223|Goltz syndrome|goltz syndrome
1522435|NCT00691223|X linked disorders|x linked disorders
1522436|NCT00691223|PORCN|porcn
1522437|NCT00691223|Wnt signaling|wnt signaling
1522438|NCT00691210|Hodgkin's Disease|hodgkin's disease
1522593|NCT00690781|pulse|pulse
1522439|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1522440|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
1522441|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
1522442|NCT00691171|GERD|gerd
1522443|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
1522444|NCT00691171|peptic ulcer|peptic ulcer
1522445|NCT00691171|Diagnosed GERD|diagnosed gerd
1522446|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
1522447|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
1522448|NCT00691171|Risk for ulcer|risk for ulcer
1522449|NCT00691145|Atopic dermatitis|atopic dermatitis
1522450|NCT00691145|Tacrolimus ointment|tacrolimus ointment
1522451|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
1522452|NCT00691132|small cell lung cancer|small cell lung cancer
1522453|NCT00691132|tobacco use disorder|tobacco use disorder
1522454|NCT00691119|breast cancer|breast cancer
1522455|NCT00691119|radiation|radiation
1522456|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
1522457|NCT00691119|relaxation|relaxation
1522458|NCT00691119|visualization|visualization
1522459|NCT00691119|RVT|rvt
1522460|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
1522461|NCT00691119|CAM|cam
1522462|NCT00691119|alternative medicine|alternative medicine
1522463|NCT00691093|observational|observational
1522464|NCT00691080|Melatonin|melatonin
1522465|NCT00691080|Sleep|sleep
1522466|NCT00691080|Autism|autism
1522467|NCT00691080|ASD|asd
1522468|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
1522469|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
1522470|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
1522471|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
1522472|NCT00691041|HIV Prevention|hiv prevention
1522473|NCT00691041|Men who have sex with men|men who have sex with men
1522474|NCT00691041|African American|african american
1522475|NCT00691041|Unprotected sex|unprotected sex
1522476|NCT00691041|HIV Seronegativity|hiv seronegativity
1522477|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
1522478|NCT00691028|RA|ra
1522479|NCT00691028|Infliximab|infliximab
1522480|NCT00691028|TA-650|ta-650
1522481|NCT00691028|Remicade|remicade
1522482|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1522483|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1522484|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1522485|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1522486|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1522487|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1522488|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1522489|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1522490|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1522491|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1522492|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1522493|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1522494|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1522495|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1522496|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1522497|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1522498|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1522499|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1522500|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1522501|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1522502|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1522503|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1522504|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1522505|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1522506|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1522507|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1522508|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1522509|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1522510|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1522511|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1522512|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1522588|NCT00690781|body composition|body composition
1522513|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1522514|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1522515|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1522516|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1522517|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1522518|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1522519|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1522520|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1522521|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1522522|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1522523|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1522524|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1522525|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1522526|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1522527|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1522528|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1522529|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1522530|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1522531|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1522532|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1522533|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1522534|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1522535|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1522536|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1522537|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1522538|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1522539|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1522540|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1522541|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
1522542|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
1522543|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
1522544|NCT00691015|primary myelofibrosis|primary myelofibrosis
1522545|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1522546|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1522547|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1522548|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1522549|NCT00690989|Headache|headache
1522550|NCT00690989|Adherence|adherence
1522551|NCT00690989|Followup|followup
1522552|NCT00690976|HIV Seronegativity|hiv seronegativity
1522553|NCT00690976|HIV risk behavior|hiv risk behavior
1522554|NCT00690976|Unprotected sex|unprotected sex
1522555|NCT00690976|men who have sex with men|men who have sex with men
1522557|NCT00690976|Latino|latino
1522558|NCT00690976|Unsafe Sex|unsafe sex
1522559|NCT00690963|Radiotherapy|radiotherapy
1522560|NCT00690963|Intensity-Modulated|intensity-modulated
1522561|NCT00690963|Dose Fractionation|dose fractionation
1522562|NCT00690950|BPH|bph
1567279|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
1522563|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
1522564|NCT00690924|lung cancer|lung cancer
1522565|NCT00690924|tobacco use disorder|tobacco use disorder
1522566|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
1522567|NCT00690885|chronic cough|chronic cough
1522568|NCT00690885|COPD|copd
1522569|NCT00690885|IPF|ipf
1522570|NCT00690885|interferon alpha|interferon alpha
1522571|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1522572|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1522573|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1522574|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1522575|NCT00690859|Bipolar disorders|bipolar disorders
1522576|NCT00690859|Predictors of recurrence|predictors of recurrence
1522577|NCT00690820|Cystic Fibrosis|cystic fibrosis
1522578|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
1522579|NCT00690807|eczema|eczema
1522580|NCT00690781|casein|casein
1522581|NCT00690781|milk soluble proteins|milk soluble proteins
1522582|NCT00690781|protein feeding pattern|protein feeding pattern
1522583|NCT00690781|overweight|overweight
1522584|NCT00690781|obesity|obesity
1522585|NCT00690781|energy restriction|energy restriction
1522586|NCT00690781|protein metabolism|protein metabolism
1522587|NCT00690781|lean body mass|lean body mass
1522589|NCT00690781|nitrogen balance|nitrogen balance
1522590|NCT00690781|protein synthesis|protein synthesis
1522591|NCT00690781|proteolysis|proteolysis
1522594|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
1522595|NCT00690768|Retinal detachment|retinal detachment
1522596|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
1522597|NCT00690768|Bevacizumab|bevacizumab
1522598|NCT00690768|preoperative|preoperative
1522599|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
1522600|NCT00690755|Diabetic|diabetic
1522601|NCT00690716|Nasal CO2|nasal co2
1522602|NCT00690716|Phase II|phase ii
1522603|NCT00690716|Adaptive|adaptive
1522604|NCT00690716|Randomized|randomized
1522605|NCT00690716|Double-Blind|double-blind
1522606|NCT00690716|Placebo-Controlled|placebo-controlled
1522607|NCT00690716|Multiple-Dose|multiple-dose
1522608|NCT00690716|Multi-center|multi-center
1522609|NCT00690716|Safety|safety
1522610|NCT00690716|Efficacy|efficacy
1522611|NCT00690716|Mild Headache|mild headache
1522612|NCT00690716|Migraineur|migraineur
1522613|NCT00690703|non small cell lung cancer|non small cell lung cancer
1522614|NCT00690703|pulmonary metastases|pulmonary metastases
1522615|NCT00690703|radiofrequency ablation|radiofrequency ablation
1522616|NCT00690690|HIV Seronegativity|hiv seronegativity
1522617|NCT00690690|HIV risk behavior|hiv risk behavior
1522618|NCT00690690|Unprotected sex|unprotected sex
1522619|NCT00690690|men who have sex with men|men who have sex with men
1522620|NCT00690690|gay|gay
1522621|NCT00690690|Latino|latino
1522622|NCT00690690|unsafe sex|unsafe sex
1522623|NCT00690690|high risk sex|high risk sex
1522624|NCT00690677|LBH589|lbh589
1522625|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
1522626|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
1522627|NCT00690664|Hair characteristics|hair characteristics
1522628|NCT00690651|ankle|ankle
1522629|NCT00690651|fracture|fracture
1522630|NCT00690651|mobilisation|mobilisation
1522631|NCT00690651|bed rest|bed rest
1522632|NCT00690651|internal fixation|internal fixation
1522633|NCT00690638|dutogliptin|dutogliptin
1522634|NCT00690638|PHX1149|phx1149
1522635|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
1522636|NCT00690625|Myofacial pain|myofacial pain
1522637|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
1522638|NCT00690612|pediatric|pediatric
1522639|NCT00690612|renal disease|renal disease
1522640|NCT00690612|high blood pressure|high blood pressure
1522641|NCT00690599|Patient satisfaction|patient satisfaction
1522642|NCT00690599|Dentist-Patient relations|dentist-patient relations
1522643|NCT00690599|Answering services|answering services
1522644|NCT00690586|Nephrotic syndrome|nephrotic syndrome
1522645|NCT00690586|Underfill and overfill theory|underfill and overfill theory
1522646|NCT00690586|Steroid resistance|steroid resistance
1522647|NCT00690586|Urine proteomics|urine proteomics
1522648|NCT00690586|AVP|avp
1522649|NCT00690586|ANP|anp
1522650|NCT00690586|Angiotensin II|angiotensin ii
1522651|NCT00690586|Renin and Aldosterone|renin and aldosterone
1522652|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
1522653|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1522654|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1522655|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1522656|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1522657|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1522658|NCT00690547|Functionality|functionality
1522659|NCT00690547|Deliberately|deliberately
1522660|NCT00690547|Activated|activated
1522661|NCT00690547|Quadriceps|quadriceps
1522662|NCT00690547|Femoris|femoris
1522663|NCT00690547|During|during
1522664|NCT00690547|After|after
1522665|NCT00690547|Active|active
1522666|NCT00690547|Extension|extension
1522667|NCT00690534|sarcopenia|sarcopenia
1522668|NCT00690534|aging|aging
1522669|NCT00690534|muscle metabolism|muscle metabolism
1522670|NCT00690521|congestive heart failure|congestive heart failure
1522671|NCT00690521|diuretics|diuretics
1522672|NCT00690521|combination|combination
1522673|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
1522674|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
1522675|NCT00690508|Validate|validate
1522676|NCT00690508|use|use
1522677|NCT00690508|SSTTP|ssttp
1522678|NCT00690508|corrrect|corrrect
1522679|NCT00690508|placement|placement
1522680|NCT00690495|Anesthesia|anesthesia
1522681|NCT00690495|Induction|induction
1522682|NCT00690495|Pain|pain
1522683|NCT00690482|COPD|copd
1522684|NCT00690456|Randomized Controlled Trial|randomized controlled trial
1522685|NCT00690456|Metformin|metformin
1522686|NCT00690443|Hyperlipidemia|hyperlipidemia
1522687|NCT00690430|Carcinoid|carcinoid
1522688|NCT00690430|neuroendocrine|neuroendocrine
1522689|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
1522690|NCT00690430|somatostatin analogue|somatostatin analogue
1522691|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
1522692|NCT00690404|formulation|formulation
1522693|NCT00690404|pharmacokinetic|pharmacokinetic
1522888|NCT00689806|Asthma|asthma
1522694|NCT00690404|crossover formulation|crossover formulation
1522695|NCT00690404|food effect|food effect
1522696|NCT00690404|oral solution|oral solution
1522697|NCT00690404|healthy volunteers|healthy volunteers
1522698|NCT00690391|surgery|surgery
1522699|NCT00690391|prognostic|prognostic
1522700|NCT00690391|palliation|palliation
1522701|NCT00690365|Switching|switching
1522702|NCT00690365|Quetiapine|quetiapine
1522703|NCT00690365|schizophrenia|schizophrenia
1522704|NCT00690365|unsuccessfully treated|unsuccessfully treated
1522705|NCT00690365|antipsychotics|antipsychotics
1522706|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
1522707|NCT00690352|SSAS|ssas
1522708|NCT00690352|substance use disorder|substance use disorder
1522709|NCT00690352|felony drug offender|felony drug offender
1522710|NCT00690352|probation|probation
1522711|NCT00690352|parole|parole
1522712|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
1522713|NCT00690352|CBT|cbt
1522714|NCT00690326|physical activity|physical activity
1522715|NCT00690326|Diabetes mellitus|diabetes mellitus
1522716|NCT00690326|Behavioral change communication|behavioral change communication
1522717|NCT00690326|Household physical activity|household physical activity
1522718|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
1522719|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1522720|NCT00690300|pancreatic cancer|pancreatic cancer
1522721|NCT00690300|pancreas carcinoma|pancreas carcinoma
1522722|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
1522723|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
1522724|NCT00690300|second line|second line
1522725|NCT00690300|palliative|palliative
1522726|NCT00690300|Oxaliplatin|oxaliplatin
1522727|NCT00690300|Docetaxel|docetaxel
1522728|NCT00690300|Taxotere|taxotere
1522729|NCT00690300|Eloxatin|eloxatin
1522730|NCT00690300|Cancer of pancreas|cancer of pancreas
1522731|NCT00690300|Pancreas cancer|pancreas cancer
1522732|NCT00690287|Type 2 diabetes|type 2 diabetes
1522733|NCT00690274|schizophrenia|schizophrenia
1522734|NCT00690274|cognitive deficients|cognitive deficients
1522735|NCT00690274|cognitive enhancing|cognitive enhancing
1522736|NCT00690274|antipsychotics|antipsychotics
1522737|NCT00690261|tumor associated macrophage|tumor associated macrophage
1522738|NCT00690261|lung cancer|lung cancer
1522739|NCT00690261|outcome|outcome
1522740|NCT00690248|Acute mania|acute mania
1522741|NCT00690248|Bipolar disorder|bipolar disorder
1522742|NCT00690248|depressive symptoms|depressive symptoms
1522743|NCT00690248|mixed mania|mixed mania
1522744|NCT00690235|Schizophrenia|schizophrenia
1522745|NCT00690235|Schizoaffective|schizoaffective
1522746|NCT00690235|Olanzapine|olanzapine
1522747|NCT00690235|Zyprexa|zyprexa
1522748|NCT00690235|Clozapine|clozapine
1522749|NCT00690235|Clozaril|clozaril
1522750|NCT00690235|Pramlintide|pramlintide
1522751|NCT00690235|Diabetes|diabetes
1522752|NCT00690235|Weight Gain|weight gain
1522753|NCT00690235|Obesity|obesity
1522754|NCT00690235|Metabolic Syndrome|metabolic syndrome
1522755|NCT00690222|cataract surgery|cataract surgery
1522756|NCT00690222|phacoemulsification|phacoemulsification
1522757|NCT00690222|pupil|pupil
1522758|NCT00690222|dilation|dilation
1522759|NCT00690222|mydriasis|mydriasis
1522760|NCT00690222|intracameral|intracameral
1522761|NCT00690222|topical|topical
1522762|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
1522763|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
1522764|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
1522765|NCT00690209|stem cell therapy|stem cell therapy
1522766|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
1522767|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
1522768|NCT00690209|residual viability|residual viability
1522769|NCT00690183|physical activity|physical activity
1522770|NCT00690183|stem cells|stem cells
1522771|NCT00690183|lifestyle|lifestyle
1522772|NCT00690170|ketamine|ketamine
1522773|NCT00690170|nicotine|nicotine
1522774|NCT00690170|schizophrenia|schizophrenia
1522775|NCT00690170|cognitive deficits|cognitive deficits
1522776|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
1522777|NCT00690170|Mismatch Negativity|mismatch negativity
1522778|NCT00690170|P50 gating|p50 gating
1522779|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
1522780|NCT00690144|simulation|simulation
1522781|NCT00690144|medical education|medical education
1522782|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
1522783|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
1522784|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1522785|NCT00690118|survival time|survival time
1522884|NCT00689832|Child|child
1522786|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
1522787|NCT00690118|quality of life|quality of life
1522788|NCT00690118|non-invasive ventilation|non-invasive ventilation
1522789|NCT00690118|clinical tolerability|clinical tolerability
1522790|NCT00690118|survival|survival
1522791|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
1522792|NCT00690105|Dermatologic Agents|dermatologic agents
1522793|NCT00690105|Topical Drug Administration|topical drug administration
1522794|NCT00690105|Tacrolimus|tacrolimus
1522795|NCT00690105|Calcineurin|calcineurin
1522796|NCT00690105|Corticosteroid|corticosteroid
1522797|NCT00690105|Fluticasone propionate|fluticasone propionate
1522798|NCT00690105|Face|face
1522799|NCT00690092|Coccidioidin|coccidioidin
1522800|NCT00690092|Coccidioidin SD|coccidioidin sd
1522801|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
1522802|NCT00690092|Coccidioidomycosis|coccidioidomycosis
1522803|NCT00690092|Valley Fever|valley fever
1522804|NCT00690092|Coccidioides immitis|coccidioides immitis
1522805|NCT00690079|MAD|mad
1522806|NCT00690079|Multiple ascending dose|multiple ascending dose
1522807|NCT00690079|Chronic pain|chronic pain
1522808|NCT00690079|pain|pain
1522809|NCT00690066|T1DM|t1dm
1522810|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1522811|NCT00690066|Type 1 Diabetes|type 1 diabetes
1522812|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1522813|NCT00690066|Juvenile Diabetes|juvenile diabetes
1522814|NCT00690066|Adult Human Stem Cells|adult human stem cells
1522815|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
1522816|NCT00690066|MSCs|mscs
1522817|NCT00690066|Insulin|insulin
1522818|NCT00690066|Osiris|osiris
1522819|NCT00690066|Prochymal|prochymal
1522820|NCT00690053|Toxicity|toxicity
1522821|NCT00690053|PET|pet
1522822|NCT00690053|HX-4|hx-4
1522823|NCT00690053|cancer|cancer
1522824|NCT00690040|Induction of labor|induction of labor
1522825|NCT00690040|Ripening|ripening
1522826|NCT00690040|Single balloon catheter|single balloon catheter
1522827|NCT00690040|Double balloon catheter|double balloon catheter
1522828|NCT00690014|OAT|oat
1522829|NCT00690014|GFR|gfr
1522830|NCT00690014|renal function|renal function
1522831|NCT00690014|PAH|pah
1522832|NCT00690001|HIV-1 infection|hiv-1 infection
1522833|NCT00690001|Treatment Experienced|treatment experienced
1522834|NCT00689988|Down syndrome|down syndrome
1522835|NCT00689988|communication AIDS for disabled|communication aids for disabled
1522836|NCT00689988|language development disorders|language development disorders
1522837|NCT00689988|vocabulary|vocabulary
1522838|NCT00689988|gestures|gestures
1522839|NCT00689988|language tests|language tests
1522840|NCT00689988|child|child
1522841|NCT00689975|stage IA breast cancer|stage ia breast cancer
1522842|NCT00689975|stage IB breast cancer|stage ib breast cancer
1522843|NCT00689975|stage II breast cancer|stage ii breast cancer
1522844|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
1522845|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
1522846|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
1522847|NCT00689962|Lisfranc|lisfranc
1522848|NCT00689962|fracture|fracture
1522849|NCT00689962|dislocation|dislocation
1522850|NCT00689962|bioabsorbable|bioabsorbable
1522851|NCT00689949|folic acid|folic acid
1522852|NCT00689949|folate|folate
1522853|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
1522854|NCT00689949|formiminoglutamate|formiminoglutamate
1522855|NCT00689949|homocysteine|homocysteine
1522856|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
1522857|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1522858|NCT00689936|Lenalidomide|lenalidomide
1522859|NCT00689936|Revlimid|revlimid
1522860|NCT00689936|phase III|phase iii
1522861|NCT00689910|pharmacokinetics|pharmacokinetics
1522862|NCT00689910|pregnancy|pregnancy
1522863|NCT00689910|Raltegravir|raltegravir
1522864|NCT00689910|HIV|hiv
1522865|NCT00689910|antiretroviral|antiretroviral
1522866|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
1522867|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
1522868|NCT00689897|Deqi|deqi
1522869|NCT00689897|acupuncture|acupuncture
1522870|NCT00689897|psychology|psychology
1522871|NCT00689858|Healthy volunteers|healthy volunteers
1522872|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1522873|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1522874|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1522875|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1522876|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1522877|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
1522878|NCT00689832|Dermatologic Agents|dermatologic agents
1522879|NCT00689832|Topical Drug Administration|topical drug administration
1522880|NCT00689832|Tacrolimus|tacrolimus
1522881|NCT00689832|Calcineurin|calcineurin
1522882|NCT00689832|Corticosteroid|corticosteroid
1522883|NCT00689832|Fluticasone propionate|fluticasone propionate
1522885|NCT00689819|Hypertension|hypertension
1522886|NCT00689819|High blood pressure|high blood pressure
1522887|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
1522889|NCT00689793|Fatigue|fatigue
1522890|NCT00689793|Blood donation|blood donation
1522891|NCT00689793|Iron deficiency|iron deficiency
1522892|NCT00689793|Ferrous sulphate|ferrous sulphate
1522893|NCT00689793|Donation|donation
1522894|NCT00689793|Donors|donors
1522895|NCT00689793|Iron|iron
1522896|NCT00689793|Ferritin|ferritin
1522897|NCT00689793|Hemoglobin|hemoglobin
1522898|NCT00689793|Anemia|anemia
1522899|NCT00689793|Anaemia|anaemia
1522900|NCT00689793|Haemoglobin|haemoglobin
1522901|NCT00689793|Don|don
1522902|NCT00689793|Women blood donors|women blood donors
1522903|NCT00689780|Pain|pain
1522904|NCT00689780|safety|safety
1522905|NCT00689780|chronic low back pain|chronic low back pain
1522906|NCT00689767|drug eluting stent|drug eluting stent
1522907|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1522908|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
1522909|NCT00689754|endoscopy|endoscopy
1522910|NCT00689741|HPV|hpv
1522911|NCT00689741|vaccine|vaccine
1522912|NCT00689715|Cystic tumor|cystic tumor
1522913|NCT00689715|Pancreas|pancreas
1522914|NCT00689715|EUS|eus
1522915|NCT00689702|cetuximab|cetuximab
1522916|NCT00689702|capecitabine|capecitabine
1522917|NCT00689702|radiotherapy|radiotherapy
1522918|NCT00689702|rectal cancer|rectal cancer
1522919|NCT00689676|expressive language|expressive language
1522920|NCT00689676|cognition|cognition
1522921|NCT00689676|early development|early development
1522922|NCT00689676|very low birt weight|very low birt weight
1522923|NCT00689676|prematurity|prematurity
1522924|NCT00689663|cholecystectomy|cholecystectomy
1522925|NCT00689637|AZD3480|azd3480
1522926|NCT00689637|Warfarin|warfarin
1522927|NCT00689637|Drug interaction|drug interaction
1522928|NCT00689624|Colorectal Cancer|colorectal cancer
1522929|NCT00689624|Cetuximab|cetuximab
1522930|NCT00689624|FOLFOXIRI|folfoxiri
1522931|NCT00689611|Acute coronary syndrome|acute coronary syndrome
1522932|NCT00689611|Myocardial infarction|myocardial infarction
1522933|NCT00689611|Smoking cessation|smoking cessation
1522934|NCT00689611|Zyban|zyban
1522935|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
1522936|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
1522937|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
1522938|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
1522939|NCT00689585|RSD|rsd
1522940|NCT00689585|Chronic Pain|chronic pain
1522941|NCT00689585|Ethosuximide|ethosuximide
1522942|NCT00689585|Zarontin|zarontin
1522943|NCT00689585|Anticonvulsant|anticonvulsant
1522944|NCT00689572|cocaine dependence|cocaine dependence
1522945|NCT00689572|cocaine abuse|cocaine abuse
1522946|NCT00689572|cocaine|cocaine
1522947|NCT00689572|crack|crack
1522948|NCT00689559|Alzheimer's disease|alzheimer's disease
1522949|NCT00689559|AZD3480|azd3480
1522950|NCT00689559|Aripiprazole|aripiprazole
1522951|NCT00689533|VEPTR|veptr
1522952|NCT00689533|TIS|tis
1522953|NCT00689533|scoliosis|scoliosis
1522954|NCT00689533|juvenile|juvenile
1522955|NCT00689520|Venous thromboembolism|venous thromboembolism
1522956|NCT00689520|low molecular weight heparin|low molecular weight heparin
1522957|NCT00689520|Vitamin K antagonist|vitamin k antagonist
1522958|NCT00689520|Longterm|longterm
1522959|NCT00689507|Multiple Myeloma|multiple myeloma
1522960|NCT00689507|Relapsed|relapsed
1522961|NCT00689507|Refractory|refractory
1522962|NCT00689507|Bortezomib|bortezomib
1522963|NCT00689507|Velcade|velcade
1522964|NCT00689494|Nanopaz device|nanopaz device
1522965|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
1522966|NCT00689494|Delivery progesterone|delivery progesterone
1522967|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
1522968|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
1522969|NCT00689481|psoriasis|psoriasis
1522970|NCT00689468|Otitis media|otitis media
1522971|NCT00689468|Echinacea|echinacea
1522972|NCT00689468|Osteopathic Medicine|osteopathic medicine
1522973|NCT00689455|Metabolic Syndrome|metabolic syndrome
1522974|NCT00689455|Lipids|lipids
1522975|NCT00689455|Waist Circumference|waist circumference
1522976|NCT00689429|Pilon Fractures|pilon fractures
1522977|NCT00689416|imaging biomarkers|imaging biomarkers
1522978|NCT00689416|MRI|mri
1522979|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
1522980|NCT00689416|Crestor|crestor
1522981|NCT00689403|AZD1305|azd1305
1522982|NCT00689403|pharmacokinetics|pharmacokinetics
1522983|NCT00689403|Properties of different ER formulations|properties of different er formulations
1522984|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
1522985|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
1522986|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
1522987|NCT00689377|Atherosclerosis|atherosclerosis
1522988|NCT00689377|Primary CVD prevention|primary cvd prevention
1523195|NCT00688792|Asthma|asthma
1522989|NCT00689364|Cohort Study|cohort study
1522990|NCT00689364|Colorectal Cancer|colorectal cancer
1522991|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
1523494|NCT00687700|B2-agonist,|b2-agonist,
1522992|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
1522993|NCT00689351|Prevention|prevention
1522994|NCT00689351|against|against
1522995|NCT00689351|pneumococcal|pneumococcal
1522996|NCT00689351|disease|disease
1522997|NCT00689351|Vaccine|vaccine
1522998|NCT00689338|Candida|candida
1522999|NCT00689338|Candidemia|candidemia
1523000|NCT00689338|Systemic Candidiasis|systemic candidiasis
1523002|NCT00689338|Intensive Care Unit|intensive care unit
1523003|NCT00689338|Critical Care Unit|critical care unit
1523004|NCT00689338|Anidulafungin|anidulafungin
1523005|NCT00689338|Ecalta|ecalta
1523006|NCT00689338|Eraxis|eraxis
1523007|NCT00689338|Fluconazole|fluconazole
1523008|NCT00689338|Voriconazole|voriconazole
1523009|NCT00689325|Schizophrenia|schizophrenia
1523010|NCT00689325|remission|remission
1523011|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
1523012|NCT00689325|Quality of Life|quality of life
1523013|NCT00689312|Gastroenteritis|gastroenteritis
1523014|NCT00689312|Pediatrics|pediatrics
1523015|NCT00689312|Rehydration therapy|rehydration therapy
1523016|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
1523017|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
1523018|NCT00689299|Immunotherapy|immunotherapy
1523019|NCT00689299|Allergic rhinitis|allergic rhinitis
1523020|NCT00689299|Cat|cat
1523021|NCT00689299|Perennial allergy|perennial allergy
1523022|NCT00689299|Non-seasonal allergy|non-seasonal allergy
1523023|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
1523024|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
1523025|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
1523026|NCT00689247|AZD1305|azd1305
1523027|NCT00689247|ADME|adme
1523028|NCT00689247|pharmacokinetic|pharmacokinetic
1523029|NCT00689247|Absorption|absorption
1523030|NCT00689247|distribution|distribution
1523031|NCT00689247|metabolism|metabolism
1523032|NCT00689247|excretion|excretion
1523033|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
1523034|NCT00689221|Cilengitide|cilengitide
1523035|NCT00689221|Temozolomide|temozolomide
1523036|NCT00689221|Radiotherapy|radiotherapy
1523037|NCT00689208|Clamp|clamp
1523038|NCT00689195|Curcumin|curcumin
1523039|NCT00689195|Ashwagandha|ashwagandha
1523040|NCT00689195|osteosarcoma|osteosarcoma
1523041|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
1523042|NCT00689195|response|response
1523043|NCT00689182|iron reduction|iron reduction
1523044|NCT00689182|iron overload|iron overload
1523045|NCT00689182|phlebotomy|phlebotomy
1523046|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1523047|NCT00689169|Lymphoma|lymphoma
1523048|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
1523049|NCT00689169|B-Cell lymphoma|b-cell lymphoma
1523050|NCT00689169|Aggressive lymphoma|aggressive lymphoma
1523051|NCT00689156|Epirubicin|epirubicin
1523052|NCT00689156|docetaxel|docetaxel
1523053|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
1523054|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
1523055|NCT00689130|Analgesia|analgesia
1523056|NCT00689130|Bispectral Index|bispectral index
1523057|NCT00689130|BIS Variability|bis variability
1684171|NCT00003398|anemia|anemia
1523058|NCT00689130|Electroencephalography|electroencephalography
1523059|NCT00689130|Electromyography|electromyography
1523060|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
1523061|NCT00689130|Movement|movement
1523062|NCT00689130|Pain, Postoperative|pain, postoperative
1523063|NCT00689130|Somatic Events|somatic events
1523064|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
1523065|NCT00689117|Acne Vulgaris|acne vulgaris
1523066|NCT00689117|Acne|acne
1523067|NCT00689104|Micturition|micturition
1523068|NCT00689104|Urinary incontinence|urinary incontinence
1523069|NCT00689104|Urinary urge incontinence|urinary urge incontinence
1523070|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
1523071|NCT00689104|Urgency|urgency
1523072|NCT00689104|YM178|ym178
1523073|NCT00689104|Frequency|frequency
1523074|NCT00689091|Awareness|awareness
1523075|NCT00689091|BIS Monitor|bis monitor
1523076|NCT00689091|electronic alerts|electronic alerts
1523077|NCT00689091|minimum|minimum
1523078|NCT00689091|alveolar|alveolar
1523079|NCT00689091|concentration|concentration
1523080|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
1523081|NCT00689065|siRNA|sirna
1523082|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
1523083|NCT00689065|Cyclodextrin|cyclodextrin
1523084|NCT00689065|Cancer|cancer
1523085|NCT00689065|Neoplasms|neoplasms
1523086|NCT00689065|Solid Tumor|solid tumor
1523087|NCT00689065|Ovarian Cancer|ovarian cancer
1523088|NCT00689065|Lung Cancer|lung cancer
1523089|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
1523090|NCT00689065|Pancreatic Cancer|pancreatic cancer
1523091|NCT00689065|Breast Cancer|breast cancer
1523092|NCT00689065|Colon Cancer|colon cancer
1523093|NCT00689065|Endometrial Cancer|endometrial cancer
1523094|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
1523095|NCT00689065|Melanoma|melanoma
1523096|NCT00689065|Prostate Cancer|prostate cancer
1523097|NCT00689065|Skin Cancer|skin cancer
1523098|NCT00689065|Thyroid Cancer|thyroid cancer
1523099|NCT00689065|Solid Malignancies|solid malignancies
1523100|NCT00689039|AZD1305|azd1305
1523101|NCT00689039|safety|safety
1523102|NCT00689039|pharmacokinetics|pharmacokinetics
1523103|NCT00689039|multiple ascending doses|multiple ascending doses
1523104|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
1523105|NCT00689026|Colonoscopy|colonoscopy
1523106|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1523107|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1523108|NCT00689026|Cleansing|cleansing
1523109|NCT00689026|Preparation|preparation
1523111|NCT00689026|Quality|quality
1523112|NCT00689013|Herpes Zoster|herpes zoster
1523113|NCT00689013|Prevention & control|prevention & control
1523114|NCT00689013|Pharmacists|pharmacists
1523115|NCT00689013|Pharmacy|pharmacy
1523116|NCT00689013|Pharmacies|pharmacies
1523117|NCT00689013|Aged|aged
1523118|NCT00689013|Immunization|immunization
1523119|NCT00689013|Vaccination|vaccination
1523120|NCT00689000|Leukemia|leukemia
1523121|NCT00689000|AML|aml
1523122|NCT00689000|MDS|mds
1523123|NCT00689000|MM|mm
1523124|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
1523125|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
1523126|NCT00689000|Multiple Myeloma|multiple myeloma
1523127|NCT00689000|Cancer|cancer
1523128|NCT00689000|Hematological malignancies|hematological malignancies
1523129|NCT00689000|Elderly|elderly
1523130|NCT00689000|Refractory|refractory
1523131|NCT00689000|Blood|blood
1523132|NCT00688974|type 2 diabetes|type 2 diabetes
1523133|NCT00688974|obesity|obesity
1523134|NCT00688974|gastric bypass|gastric bypass
1523135|NCT00688974|adjustable gastric banding|adjustable gastric banding
1523136|NCT00688974|BMI > 35.|bmi > 35.
1523137|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
1523138|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
1523139|NCT00688961|aspirin|aspirin
1523140|NCT00688961|platelet aggregation|platelet aggregation
1523141|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
1523142|NCT00688948|pilot clinical trial|pilot clinical trial
1523143|NCT00688935|melatonin|melatonin
1523144|NCT00688935|circadian rhythms|circadian rhythms
1523145|NCT00688935|sleep|sleep
1523146|NCT00688935|sleep disorders|sleep disorders
1523147|NCT00688909|breast cancer|breast cancer
1523148|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
1523149|NCT00688909|letrozole|letrozole
1523150|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
1523151|NCT00688883|Fludarabine|fludarabine
1523152|NCT00688883|Purine analog|purine analog
1523153|NCT00688883|Indolent lymphoma|indolent lymphoma
1523154|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
1523155|NCT00688844|PKU|pku
1523156|NCT00688844|Phenylketonuria|phenylketonuria
1523157|NCT00688844|BH4|bh4
1523158|NCT00688844|Kuvan|kuvan
1523159|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
1523160|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
1523161|NCT00688844|Nutrition|nutrition
1523162|NCT00688844|PHE|phe
1523163|NCT00688844|Phenylalanine|phenylalanine
1523164|NCT00688844|PAH|pah
1523165|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
1523166|NCT00688844|Neurotransmitters|neurotransmitters
1523167|NCT00688844|Serotonin|serotonin
1523168|NCT00688844|Catecholamines|catecholamines
1523169|NCT00688844|Diet|diet
1523170|NCT00688844|Body Fat|body fat
1523171|NCT00688844|Bone Density|bone density
1523172|NCT00688831|AZD1305|azd1305
1523173|NCT00688831|SAD|sad
1523174|NCT00688831|safety|safety
1523175|NCT00688831|pharmcokinetics|pharmcokinetics
1523176|NCT00688831|Safety and tolerability|safety and tolerability
1523177|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
1523178|NCT00688818|Quetiapine|quetiapine
1523179|NCT00688818|Randomized|randomized
1523180|NCT00688818|Placebo-controlled|placebo-controlled
1523181|NCT00688818|Double-blind|double-blind
1523182|NCT00688818|Major depressive disorder|major depressive disorder
1523183|NCT00688818|Dysthymic disorder|dysthymic disorder
1523184|NCT00688818|Anxiety disorders|anxiety disorders
1523185|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
1523186|NCT00688818|Social anxiety disorder|social anxiety disorder
1523187|NCT00688818|Panic disorder|panic disorder
1523188|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
1523189|NCT00688805|Propanolol|propanolol
1523190|NCT00688805|Substance Abuse|substance abuse
1523191|NCT00688805|Craving|craving
1523192|NCT00688805|Imagery|imagery
1523193|NCT00688805|Drug Cues|drug cues
1523194|NCT00688805|Cocaine|cocaine
1523196|NCT00688792|Children|children
1523197|NCT00688792|Adherence|adherence
1523198|NCT00688792|Maternal factors|maternal factors
1523199|NCT00688779|Healthy male|healthy male
1523200|NCT00688779|allergic rhinitis|allergic rhinitis
1523201|NCT00688779|tolerability|tolerability
1523202|NCT00688779|safety|safety
1523203|NCT00688779|intranasally|intranasally
1523204|NCT00688779|Healthy subjects|healthy subjects
1523205|NCT00688766|GIST|gist
1523206|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
1523207|NCT00688753|renal cell carcinoma|renal cell carcinoma
1523208|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
1523209|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
1523210|NCT00688753|adults|adults
1523211|NCT00688753|everolimus|everolimus
1523212|NCT00688740|adjuvant treatment|adjuvant treatment
1523213|NCT00688727|non epileptic seizures|non epileptic seizures
1523214|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
1523215|NCT00688727|dissociative disorders|dissociative disorders
1523216|NCT00688727|Seizure disorders|seizure disorders
1523217|NCT00688727|randomised controlled trial|randomised controlled trial
1523218|NCT00688714|Antiplatelet|antiplatelet
1523219|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
1523220|NCT00688688|Frequency|frequency
1523221|NCT00688688|Overactive Bladder|overactive bladder
1523222|NCT00688688|Urgency|urgency
1523223|NCT00688688|Urinary urge incontinence|urinary urge incontinence
1523224|NCT00688688|Urinary incontinence|urinary incontinence
1523225|NCT00688688|Micturition|micturition
1523226|NCT00688675|GERD|gerd
1523227|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
1523228|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
1523229|NCT00688662|Pancreatitis|pancreatitis
1523230|NCT00688662|Sphincterotomy|sphincterotomy
1523231|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
1523232|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
1523233|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
1523234|NCT00688623|adults|adults
1523235|NCT00688623|everolimus|everolimus
1523236|NCT00688610|primary care|primary care
1523237|NCT00688610|procalcitonin|procalcitonin
1523238|NCT00688610|antibiotic prescription|antibiotic prescription
1523239|NCT00688597|Pompe Disease|pompe disease
1523240|NCT00688584|problem drinking|problem drinking
1523241|NCT00688584|randomized control trial|randomized control trial
1523242|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
1523243|NCT00688571|Pulmonary Valve|pulmonary valve
1523244|NCT00688571|Congenital Heart Disease|congenital heart disease
1523245|NCT00688545|Celecoxib|celecoxib
1523246|NCT00688545|COX-2|cox-2
1523247|NCT00688545|NSAIDs|nsaids
1523248|NCT00688545|observational study|observational study
1523249|NCT00688545|noninterventional study|noninterventional study
1523250|NCT00688545|cohort study|cohort study
1523251|NCT00688545|registry|registry
1523252|NCT00688545|epidemiologic study|epidemiologic study
1523253|NCT00688545|pediatrics|pediatrics
1523254|NCT00688545|rheumatology|rheumatology
1523255|NCT00688545|phase iv study|phase iv study
1523256|NCT00688532|Prostate cancer|prostate cancer
1523257|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
1523258|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
1523259|NCT00688519|Psoriasis|psoriasis
1523260|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
1523261|NCT00688506|Neuromodulation|neuromodulation
1523262|NCT00688506|Brain effects|brain effects
1523263|NCT00688506|Neuroimaging|neuroimaging
1523264|NCT00688493|QT|qt
1523265|NCT00688493|Healthy volunteers|healthy volunteers
1523266|NCT00688480|CKD|ckd
1523267|NCT00688480|LVH|lvh
1523268|NCT00688480|Echo LVH|echo lvh
1523269|NCT00688480|Chronic Stage 3|chronic stage 3
1523270|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
1523271|NCT00688454|Hyperlipidemia|hyperlipidemia
1523272|NCT00688454|Rosuvastatin|rosuvastatin
1523273|NCT00688454|Efficacy|efficacy
1523274|NCT00688454|tolerability|tolerability
1523275|NCT00688454|CRESTOR therapy|crestor therapy
1523276|NCT00688441|Randomized|randomized
1523277|NCT00688441|Double-Blind|double-blind
1523278|NCT00688441|Multi-Center|multi-center
1523279|NCT00688441|Placebo-Controlled|placebo-controlled
1523280|NCT00688441|Phase II|phase ii
1523281|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
1523282|NCT00688441|Carbon Dioxide|carbon dioxide
1523283|NCT00688441|Efficacy|efficacy
1523284|NCT00688441|Safety|safety
1523285|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
1523286|NCT00688441|RQLQ|rqlq
1523287|NCT00688428|esomeprazole|esomeprazole
1523288|NCT00688428|upper gi symptoms|upper gi symptoms
1523289|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
1523290|NCT00688402|Reflux Inhibitor|reflux inhibitor
1523291|NCT00688402|GERD|gerd
1523292|NCT00688402|formulations|formulations
1523293|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
1523294|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
1523295|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
1523296|NCT00688376|Attention|attention
1523297|NCT00688376|cancer|cancer
1523592|NCT00687154|Laser|laser
1523298|NCT00688376|chemotherapy|chemotherapy
1523299|NCT00688376|donepezil|donepezil
1523300|NCT00688376|acetylcholinesterase|acetylcholinesterase
1523301|NCT00688376|inhibitor|inhibitor
1523302|NCT00688363|Diabetes control|diabetes control
1523303|NCT00688363|glycated haemoglobin|glycated haemoglobin
1523304|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
1523305|NCT00688363|type 2-diabetes|type 2-diabetes
1523306|NCT00688363|conventional insulin therapy|conventional insulin therapy
1523307|NCT00688350|Hypertension|hypertension
1523308|NCT00688350|Aging|aging
1523309|NCT00688350|Medication adherence|medication adherence
1523310|NCT00688350|Medication compliance|medication compliance
1523311|NCT00688337|Breast cancer|breast cancer
1523312|NCT00688337|lymph nodes|lymph nodes
1523313|NCT00688337|gene-expression|gene-expression
1523314|NCT00688337|oncotype|oncotype
1523315|NCT00688337|Age over 18|age over 18
1523316|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
1523317|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
1523318|NCT00688324|schizophrenia|schizophrenia
1523319|NCT00688324|schizoaffective disorder|schizoaffective disorder
1523320|NCT00688324|glutamate|glutamate
1523321|NCT00688324|NMDA receptor|nmda receptor
1523322|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1523323|NCT00688324|acamprosate|acamprosate
1523325|NCT00688311|synbiotic|synbiotic
1523326|NCT00688311|probiotic|probiotic
1523327|NCT00688311|immune activation|immune activation
1523328|NCT00688311|blood CD4 count|blood cd4 count
1523329|NCT00688311|bacterial translocation|bacterial translocation
1523330|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
1523331|NCT00688285|chronic kidney disease|chronic kidney disease
1523332|NCT00688285|clinical alerts|clinical alerts
1523333|NCT00688285|late referral|late referral
1523334|NCT00688285|electronic medical record|electronic medical record
1523335|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
1523336|NCT00688272|Safety|safety
1523337|NCT00688272|Photoirritant|photoirritant
1523338|NCT00688272|Photosensitivity|photosensitivity
1523339|NCT00688272|Placebo control|placebo control
1523340|NCT00688272|Ciprofloxacin|ciprofloxacin
1523341|NCT00688272|Eltrombopag|eltrombopag
1523342|NCT00688259|clinical trials|clinical trials
1523343|NCT00688259|psychotherapy|psychotherapy
1523344|NCT00688246|osteoporosis|osteoporosis
1523345|NCT00688246|breast cancer|breast cancer
1523346|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
1523347|NCT00688220|Arthritis|arthritis
1523348|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
1523349|NCT00688220|Epicondylitis|epicondylitis
1523350|NCT00688207|PPAR agonist,|ppar agonist,
1523351|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
1523352|NCT00688207|BRL-049653.|brl-049653.
1523353|NCT00688207|Alzheimer's disease,|alzheimer's disease,
1523354|NCT00688194|stage IV breast cancer|stage iv breast cancer
1523355|NCT00688194|recurrent breast cancer|recurrent breast cancer
1523356|NCT00688168|Multiple Myeloma|multiple myeloma
1523357|NCT00688168|Phone Call|phone call
1523358|NCT00688168|Treatment Naive|treatment naive
1523359|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
1523360|NCT00688168|Questionnaire|questionnaire
1523361|NCT00688168|Survey|survey
1523362|NCT00688168|Interactive Voice Response|interactive voice response
1523363|NCT00688168|Symptom Production|symptom production
1523364|NCT00688168|Pain|pain
1523365|NCT00688168|IVR|ivr
1523366|NCT00688168|MM|mm
1523367|NCT00688129|school readiness|school readiness
1523368|NCT00688129|foster care|foster care
1523369|NCT00688129|maltreatment|maltreatment
1523370|NCT00688129|literacy|literacy
1523371|NCT00688129|social emotional skills|social emotional skills
1523372|NCT00688129|self regulation|self regulation
1523373|NCT00688129|caregiver involvement|caregiver involvement
1523374|NCT00688116|metastatic cancer|metastatic cancer
1523375|NCT00688116|solid tumor|solid tumor
1523376|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
1523377|NCT00688116|STA-9090|sta-9090
1523378|NCT00688116|ganetespib|ganetespib
1523379|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
1523380|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
1523381|NCT00688077|Calcitonin|calcitonin
1523382|NCT00688064|Acne|acne
1523383|NCT00688051|Cystic Fibrosis|cystic fibrosis
1523384|NCT00688051|Adherence to treatment|adherence to treatment
1523385|NCT00688038|Advanced Cancer|advanced cancer
1523386|NCT00688038|Bone Metastases|bone metastases
1523387|NCT00688038|Laser Ablation|laser ablation
1523388|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
1523389|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
1523390|NCT00688038|MRTI|mrti
1523391|NCT00688038|LITT|litt
1523392|NCT00688012|antisense|antisense
1523393|NCT00688012|microRna antagonist|microrna antagonist
1523394|NCT00688012|anti-miR-122|anti-mir-122
1523395|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
1523396|NCT00688012|Hepatitis C|hepatitis c
1523397|NCT00687999|Chronic hepatitis C|chronic hepatitis c
1523398|NCT00687999|diabetes|diabetes
1523399|NCT00687999|Insulin resistance|insulin resistance
1523400|NCT00687999|combination therapy|combination therapy
1523401|NCT00687986|surgery|surgery
1523402|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
1523403|NCT00687986|tumor control|tumor control
1523404|NCT00687986|quality of life|quality of life
1523405|NCT00687960|Diabetes|diabetes
1523406|NCT00687960|Diet|diet
1523407|NCT00687960|Fiber|fiber
1523408|NCT00687960|Age|age
1523409|NCT00687947|FHM|fhm
1523410|NCT00687947|MA|ma
1523411|NCT00687947|healthy controls|healthy controls
1523412|NCT00687947|CGRP|cgrp
1523413|NCT00687934|metastatic cancer|metastatic cancer
1523414|NCT00687934|solid tumor|solid tumor
1523415|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
1523416|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
1523417|NCT00687934|standard therapy exists|standard therapy exists
1523418|NCT00687934|STA-9090|sta-9090
1523419|NCT00687934|ganetespib|ganetespib
1523420|NCT00687921|Knee trauma|knee trauma
1523421|NCT00687921|MRI|mri
1523422|NCT00687921|arthroscopy|arthroscopy
1523423|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
1523424|NCT00687908|Acne|acne
1523425|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
1523426|NCT00687882|Venous Thromboembolism|venous thromboembolism
1523427|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
1523428|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
1523429|NCT00687882|Duration of Therapy|duration of therapy
1523430|NCT00687882|Children|children
1523431|NCT00687869|stroke|stroke
1523432|NCT00687869|rehabilitation|rehabilitation
1523433|NCT00687869|patient care management|patient care management
1523434|NCT00687869|patient participation|patient participation
1523435|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
1523436|NCT00687843|Gastric Cancer|gastric cancer
1523437|NCT00687843|TS-1|ts-1
1523438|NCT00687843|PSK|psk
1523439|NCT00687843|Relapse-free survival|relapse-free survival
1523440|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
1523441|NCT00687830|Morning|morning
1523442|NCT00687830|Evening|evening
1523443|NCT00687830|Bowel Preparation|bowel preparation
1523444|NCT00687830|Efficacy|efficacy
1523445|NCT00687830|Satisfaction|satisfaction
1523446|NCT00687817|NSCLC|nsclc
1523447|NCT00687804|DME|dme
1523448|NCT00687804|Diabetic|diabetic
1523449|NCT00687804|macula|macula
1523450|NCT00687804|edema|edema
1523451|NCT00687804|ranibizumab|ranibizumab
1523452|NCT00687804|RESTORE|restore
1523453|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
1523454|NCT00687791|ologen|ologen
1523455|NCT00687791|oculusgen|oculusgen
1523456|NCT00687791|collagen matrix|collagen matrix
1523457|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
1523458|NCT00687791|Aeon Astron|aeon astron
1523459|NCT00687791|trabeculectomy|trabeculectomy
1523460|NCT00687791|tissue engineering|tissue engineering
1523461|NCT00687791|mitomycin-C|mitomycin-c
1523462|NCT00687778|C11-Acetate|c11-acetate
1523463|NCT00687778|FDG|fdg
1523464|NCT00687778|sarcoma|sarcoma
1523465|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
1523466|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
1523467|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
1523468|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
1523469|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
1523470|NCT00687778|GIST|gist
1523471|NCT00687778|uterine malignancies|uterine malignancies
1523472|NCT00687778|mucin-producing cancer|mucin-producing cancer
1523473|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
1523474|NCT00687778|HCC|hcc
1523475|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
1523476|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
1523477|NCT00687752|fetal deglutition|fetal deglutition
1523478|NCT00687752|larynx|larynx
1523479|NCT00687752|fetal CNS pathology|fetal cns pathology
1523480|NCT00687752|sonography|sonography
1523481|NCT00687752|hydramnios|hydramnios
1523482|NCT00687739|hormone therapy|hormone therapy
1523483|NCT00687739|obesity|obesity
1523484|NCT00687739|postmenopause|postmenopause
1523485|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
1523486|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
1523487|NCT00687739|metabolic syndrome|metabolic syndrome
1523488|NCT00687739|women's health|women's health
1523489|NCT00687726|osteoarthritis|osteoarthritis
1523490|NCT00687726|knee|knee
1523491|NCT00687726|exercise|exercise
1523492|NCT00687726|balance|balance
1523493|NCT00687700|propranolol|propranolol
1523495|NCT00687700|B-antagonist,|b-antagonist,
1523496|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
1523497|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
1523498|NCT00687661|Chronic Kidney Failure|chronic kidney failure
1523499|NCT00687661|Vascular Calcification|vascular calcification
1523500|NCT00687661|Bisphosphonates|bisphosphonates
1523501|NCT00687648|stage IV breast cancer|stage iv breast cancer
1523502|NCT00687648|recurrent breast cancer|recurrent breast cancer
1523503|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
1523504|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1523505|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1523506|NCT00687622|MEK inhibitor|mek inhibitor
1523507|NCT00687622|solid tumors|solid tumors
1523508|NCT00687622|First Time in Human|first time in human
1523509|NCT00687622|GSK1120212|gsk1120212
1523510|NCT00687622|Oncology|oncology
1523511|NCT00687622|melanoma|melanoma
1523512|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
1523513|NCT00687609|Marihuana Abuse|marihuana abuse
1523514|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
1523515|NCT00687583|pediatrics|pediatrics
1523516|NCT00687583|anesthesia|anesthesia
1523517|NCT00687583|head movements|head movements
1523518|NCT00687583|endotracheal tube|endotracheal tube
1523519|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
1523520|NCT00687570|Bowel purity degree|bowel purity degree
1523521|NCT00687570|Bowel preparation|bowel preparation
1523522|NCT00687570|Rectal cancer|rectal cancer
1523523|NCT00687570|Nutritional status|nutritional status
1523524|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
1523525|NCT00687570|Complications|complications
1523526|NCT00687570|Physiological status|physiological status
1523528|NCT00687492|hypercholesterolemia|hypercholesterolemia
1523529|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
1523530|NCT00687492|survey|survey
1523531|NCT00687479|insulin sensitivity|insulin sensitivity
1523532|NCT00687479|insulin secretion|insulin secretion
1523533|NCT00687479|infant outcome|infant outcome
1523534|NCT00687466|Cystic Fibrosis|cystic fibrosis
1523535|NCT00687466|Glucose Intolerance|glucose intolerance
1523536|NCT00687453|Glargine|glargine
1523537|NCT00687453|Type 2 diabetes|type 2 diabetes
1523538|NCT00687453|Basal insulin|basal insulin
1523539|NCT00687414|gene expression|gene expression
1523540|NCT00687414|gene sequencing|gene sequencing
1523541|NCT00687414|gene encoding|gene encoding
1523542|NCT00687414|MPD|mpd
1523543|NCT00687414|MDS|mds
1523544|NCT00687414|AML|aml
1523545|NCT00687414|mDia|mdia
1523546|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
1523547|NCT00687388|Alpha Blockers|alpha blockers
1523548|NCT00687388|Treatment Outcome|treatment outcome
1523549|NCT00687375|Inguinal|inguinal
1523550|NCT00687375|Groin hernia|groin hernia
1523551|NCT00687375|TAPP|tapp
1523552|NCT00687375|TEP|tep
1523553|NCT00687375|Comparing|comparing
1523554|NCT00687375|Two|two
1523555|NCT00687375|Techniques|techniques
1523556|NCT00687349|End-of-Life issues|end-of-life issues
1523557|NCT00687349|Talking with your doctor|talking with your doctor
1523558|NCT00687349|Coping with chronic illness|coping with chronic illness
1523559|NCT00687336|Helicobacter pylori|helicobacter pylori
1523560|NCT00687336|Treatment|treatment
1523561|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
1523562|NCT00687310|Asthma education|asthma education
1523563|NCT00687310|satisfaction adherence|satisfaction adherence
1523564|NCT00687310|Quality of Life|quality of life
1523565|NCT00687310|PIKO meter cluster|piko meter cluster
1523566|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
1523567|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
1523568|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
1523569|NCT00687297|Vandetanib|vandetanib
1523570|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
1523571|NCT00687258|Anemia|anemia
1523572|NCT00687258|Oxidative Stress|oxidative stress
1523573|NCT00687258|Erythropoietin|erythropoietin
1523574|NCT00687258|dialyser membrane|dialyser membrane
1523575|NCT00687258|Vitamin E|vitamin e
1523576|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
1523577|NCT00687258|Erythropoietin resistance|erythropoietin resistance
1523578|NCT00687258|hemodialysis|hemodialysis
1523579|NCT00687245|children|children
1523580|NCT00687245|reflux|reflux
1523581|NCT00687245|GERD|gerd
1523582|NCT00687245|pediatric|pediatric
1523583|NCT00687232|Phase I|phase i
1523584|NCT00687232|Japan|japan
1523585|NCT00687232|Japanese|japanese
1523586|NCT00687232|inhalation|inhalation
1523587|NCT00687219|hepatitis C|hepatitis c
1523588|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
1523589|NCT00687180|Prednisolone dosage|prednisolone dosage
1523590|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
1523591|NCT00687154|DME|dme
1523593|NCT00687154|macular edema|macular edema
1523594|NCT00687154|retinopathy|retinopathy
1523595|NCT00687154|scatter photocoagulation|scatter photocoagulation
1523596|NCT00687141|Safety|safety
1523597|NCT00687141|tolerability|tolerability
1523598|NCT00687141|AZD0328|azd0328
1523599|NCT00687128|Insulin resistance|insulin resistance
1523600|NCT00687128|Metabolic syndrome|metabolic syndrome
1523601|NCT00687128|Aerobic exercise|aerobic exercise
1523602|NCT00687128|Exercise behavior|exercise behavior
1523603|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
1523604|NCT00687115|Respiratory Chamber|respiratory chamber
1523605|NCT00687115|Obesity|obesity
1523606|NCT00687115|Weight Loss|weight loss
1523607|NCT00687115|Overfeeding|overfeeding
1523608|NCT00687102|breast cancer|breast cancer
1523609|NCT00687102|Tamoxifen|tamoxifen
1523610|NCT00687102|Raloxifene|raloxifene
1523611|NCT00687102|hormone therapy|hormone therapy
1523612|NCT00687089|Opiates|opiates
1523613|NCT00687089|Subutex|subutex
1523614|NCT00687089|Buprenorphine|buprenorphine
1523615|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
1523616|NCT00687076|Endovascular Intervention|endovascular intervention
1523617|NCT00687076|MRI|mri
1523618|NCT00687076|Ultrasound|ultrasound
1523619|NCT00687076|Cholesterol Medications|cholesterol medications
1523620|NCT00687076|High Cholesterol|high cholesterol
1523621|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
1523622|NCT00687076|Claudication|claudication
1523623|NCT00687076|Leg Pain|leg pain
1523624|NCT00687076|Niaspan|niaspan
1523625|NCT00687076|Extended Release Niacin|extended release niacin
1523626|NCT00687076|Zetia|zetia
1523627|NCT00687076|Ezetimibe|ezetimibe
1523628|NCT00687076|Simvastatin|simvastatin
1523629|NCT00687076|Zocor|zocor
1523630|NCT00687076|Atorvastatin|atorvastatin
1523631|NCT00687076|Lipitor|lipitor
1523632|NCT00687050|end-stage renal disease|end-stage renal disease
1523633|NCT00687050|chronic kidney disease|chronic kidney disease
1523634|NCT00687037|oral hygiene|oral hygiene
1523635|NCT00687024|Epilepsy|epilepsy
1523636|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
1523637|NCT00687024|Magnetoencephalography|magnetoencephalography
1523638|NCT00687011|Antiemetic|antiemetic
1523639|NCT00686998|Schizophrenia|schizophrenia
1523640|NCT00686985|Docetaxel|docetaxel
1523641|NCT00686985|Carboplatin|carboplatin
1523642|NCT00686985|chemotherapy|chemotherapy
1523643|NCT00686985|relapse SCLC|relapse sclc
1523644|NCT00686972|Bariatric Surgery|bariatric surgery
1523645|NCT00686972|Glucose Regulation|glucose regulation
1523646|NCT00686972|Cardiac Function|cardiac function
1523647|NCT00686972|Body Composition|body composition
1523648|NCT00686946|Severe mental illness|severe mental illness
1523649|NCT00686946|Antipsychotic medications|antipsychotic medications
1523650|NCT00686946|Pregnancy|pregnancy
1523651|NCT00686946|Evidence-based guidelines|evidence-based guidelines
1523652|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
1523653|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1523654|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
1523655|NCT00686881|hepatitis C|hepatitis c
1523656|NCT00686868|GSK1841157;|gsk1841157;
1523657|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
1523658|NCT00686868|B-cell depletion|b-cell depletion
1523659|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
1523660|NCT00686855|tacrolimus|tacrolimus
1523661|NCT00686855|dexamethasone|dexamethasone
1523662|NCT00686855|oral rinse|oral rinse
1523663|NCT00686842|HIV infection|hiv infection
1523664|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1523665|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1523666|NCT00686842|Treatment Experienced|treatment experienced
1523667|NCT00686829|HIV|hiv
1523668|NCT00686829|Treatment Experienced|treatment experienced
1523669|NCT00686816|pre-diabetic|pre-diabetic
1523670|NCT00686816|obese|obese
1523671|NCT00686803|hypertension|hypertension
1523672|NCT00686803|controlled hypertension|controlled hypertension
1523673|NCT00686803|hypertensives|hypertensives
1523674|NCT00686790|Hepatitis D|hepatitis d
1523675|NCT00686790|Hepatitis B|hepatitis b
1523676|NCT00686777|hepatitis C|hepatitis c
1523677|NCT00686764|trans-femoral amputation|trans-femoral amputation
1523678|NCT00686738|osteosarcoma|osteosarcoma
1523679|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
1523680|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
1523681|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
1523682|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1523683|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
1523684|NCT00686712|Glargine|glargine
1523685|NCT00686712|Type 2 diabetes|type 2 diabetes
1523686|NCT00686712|Basal insulin|basal insulin
1523687|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
1523688|NCT00686699|Antipsychotic Agents|antipsychotic agents
1523689|NCT00686673|DECISION AIDS|decision aids
1523690|NCT00686660|copd|copd
1523691|NCT00686660|rehabilitation|rehabilitation
1523692|NCT00686660|quality of life|quality of life
1523693|NCT00686660|inflammation|inflammation
1523694|NCT00686647|Coronary Angioplasty|coronary angioplasty
1523695|NCT00686647|Coronary Stents|coronary stents
1523696|NCT00686647|Scoring Balloons|scoring balloons
1523697|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
1523698|NCT00686634|sitagliptin|sitagliptin
1523699|NCT00686634|type 2 diabetes|type 2 diabetes
1523700|NCT00686634|combination therapy|combination therapy
1523701|NCT00686608|Obesity|obesity
1523702|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1523703|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1523704|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1523705|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1523706|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1523707|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1523708|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1523709|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1523710|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1523711|NCT00686556|ALL|all
1523712|NCT00686556|MDS|mds
1523713|NCT00686543|Antifungal Agents|antifungal agents
1523714|NCT00686543|Anti-Infective Agents|anti-infective agents
1523715|NCT00686530|Fetal Death|fetal death
1523716|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
1523717|NCT00686530|Autopsy|autopsy
1523718|NCT00686530|Telencephalon|telencephalon
1523719|NCT00686530|Pyramidal Tracts|pyramidal tracts
1523720|NCT00686504|Pain|pain
1523721|NCT00686504|PET|pet
1523722|NCT00686504|Phase 1|phase 1
1523723|NCT00686504|Analgesia|analgesia
1523724|NCT00686504|Positron Emission Tomography|positron emission tomography
1523725|NCT00686504|mGlu5 receptor|mglu5 receptor
1523726|NCT00686504|Dose finding|dose finding
1523727|NCT00686504|Analgesia/Pain|analgesia/pain
1523728|NCT00686491|Asthma|asthma
1523729|NCT00686491|Environment|environment
1523730|NCT00686491|Type of sport|type of sport
1523731|NCT00686491|Cardiovascular disease|cardiovascular disease
1523732|NCT00686491|Athletes|athletes
1523733|NCT00686478|burn|burn
1523734|NCT00686478|hypertrophic scar|hypertrophic scar
1523735|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
1523736|NCT00686465|recurrent cancer|recurrent cancer
1523737|NCT00686465|PET/CT|pet/ct
1523738|NCT00686465|FDG|fdg
1523739|NCT00686465|planned management|planned management
1523740|NCT00686465|actual treatment|actual treatment
1523741|NCT00686452|Asthma|asthma
1523742|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
1523743|NCT00686452|Swimmers|swimmers
1523744|NCT00686452|Airway inflammation|airway inflammation
1523745|NCT00686452|Airway remodelling|airway remodelling
1523746|NCT00686439|osteoarthritis|osteoarthritis
1523747|NCT00686439|adalimumab|adalimumab
1523748|NCT00686439|mri|mri
1523749|NCT00686426|Obesity|obesity
1523750|NCT00686426|Weight gain|weight gain
1523751|NCT00686426|regain|regain
1523752|NCT00686426|dairy|dairy
1523753|NCT00686426|calcium|calcium
1523754|NCT00686413|PET|pet
1523755|NCT00686413|AZD3480|azd3480
1523756|NCT00686413|PET examination|pet examination
1523757|NCT00686400|schizophrenia|schizophrenia
1523758|NCT00686400|first-episode|first-episode
1523759|NCT00686400|infection|infection
1523760|NCT00686400|Toxoplasma gondii|toxoplasma gondii
1523761|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
1523762|NCT00686387|Tissue Bank|tissue bank
1523763|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
1523764|NCT00686387|NAT2|nat2
1523765|NCT00686387|EGFR|egfr
1523766|NCT00686387|MGMT|mgmt
1523767|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
1523768|NCT00686374|Crohn's Disease|crohn's disease
1523769|NCT00686374|adalimumab|adalimumab
1523770|NCT00686361|Cystic Fibrosis|cystic fibrosis
1523771|NCT00686361|choline nutrition|choline nutrition
1523772|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
1523773|NCT00686361|CF and oxidative stress|cf and oxidative stress
1523774|NCT00686348|acromegaly|acromegaly
1523775|NCT00686335|asthma|asthma
1523776|NCT00686335|nocturnal asthma|nocturnal asthma
1523777|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
1523778|NCT00686335|signs and symptoms|signs and symptoms
1523779|NCT00686335|lung function|lung function
1523780|NCT00686335|prednisone|prednisone
1523781|NCT00686322|chemotherapy|chemotherapy
1523782|NCT00686322|radiotherapy|radiotherapy
1523783|NCT00686322|lung cancer|lung cancer
1523784|NCT00686309|exhaled NO|exhaled no
1523785|NCT00686309|off line|off line
1523786|NCT00686309|on line|on line
1523787|NCT00686309|comparison|comparison
1523788|NCT00686309|Bland altman method|bland altman method
1523789|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
1523790|NCT00686283|Adolescents|adolescents
1523791|NCT00686283|Diabetes|diabetes
1523792|NCT00686283|Exercise|exercise
1523793|NCT00686270|HIV-1 infection|hiv-1 infection
1523794|NCT00686270|NRTI resistance|nrti resistance
1523795|NCT00686270|M184V mutation|m184v mutation
1523796|NCT00686270|reverse transcriptase|reverse transcriptase
1523797|NCT00686270|apricitabine|apricitabine
1523798|NCT00686270|drug resistance|drug resistance
1523799|NCT00686270|safety and tolerability|safety and tolerability
1523800|NCT00686270|therapy failure|therapy failure
1523801|NCT00686270|Treatment Experienced|treatment experienced
1523802|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
1523803|NCT00686257|noninvasive ventilation|noninvasive ventilation
1523804|NCT00686257|oronasal face mask|oronasal face mask
1523805|NCT00686257|total face mask|total face mask
1523806|NCT00686244|metabolic syndrome|metabolic syndrome
1523807|NCT00686244|physical activity|physical activity
1523808|NCT00686244|overweight|overweight
1523809|NCT00686244|malnutrition|malnutrition
1523810|NCT00686244|prevention|prevention
1523811|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
1523812|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
1523813|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1523814|NCT00686205|healthy donors|healthy donors
1523815|NCT00686205|HIV positives|hiv positives
1523816|NCT00686192|Obesity|obesity
1523817|NCT00686192|Calcium carbonate|calcium carbonate
1523818|NCT00686192|Dietary Supplements|dietary supplements
1523819|NCT00686192|Lipolysis|lipolysis
1523820|NCT00686179|TQT|tqt
1523821|NCT00686179|ECG|ecg
1523822|NCT00686179|QT|qt
1523823|NCT00686179|QTc|qtc
1523824|NCT00686179|AZD3480|azd3480
1523825|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
1523826|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1523827|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
1523828|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
1523829|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
1523830|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
1523831|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
1523832|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
1523833|NCT00686140|Schizophrenia|schizophrenia
1523834|NCT00686140|clinical trial|clinical trial
1523835|NCT00686140|risperidone|risperidone
1523836|NCT00686140|immune|immune
1523837|NCT00686140|celecoxib|celecoxib
1523838|NCT00686127|breast cancer|breast cancer
1523839|NCT00686127|neuropathic pain|neuropathic pain
1523840|NCT00686127|topical lidocaine|topical lidocaine
1523841|NCT00686127|postmastectomy pain|postmastectomy pain
1523842|NCT00686127|breast symptoms|breast symptoms
1523843|NCT00686127|breast pain|breast pain
1523844|NCT00686114|Esophageal cancer|esophageal cancer
1523845|NCT00686114|chemoradiation|chemoradiation
1523846|NCT00686114|radiosensitivity|radiosensitivity
1523847|NCT00686114|EGFR inhibition|egfr inhibition
1523848|NCT00686101|Perception of risk|perception of risk
1523849|NCT00686101|Smoking risks|smoking risks
1523850|NCT00686101|Smoking consequences|smoking consequences
1523851|NCT00686101|Quitting smoking|quitting smoking
1523976|NCT00685568|colon cancer|colon cancer
1523852|NCT00686101|Motivation to quit smoking|motivation to quit smoking
1523853|NCT00686101|Schizophrenia|schizophrenia
1523854|NCT00686088|prostate cancer|prostate cancer
1523855|NCT00686088|locally recurrent|locally recurrent
1523856|NCT00686088|PRX302|prx302
1523857|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1523858|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
1523859|NCT00686075|MEDI-534|medi-534
1523860|NCT00686062|Prenatal testing|prenatal testing
1523861|NCT00686062|Amniocentesis|amniocentesis
1523862|NCT00686062|Decision making|decision making
1523863|NCT00686062|Down syndrome|down syndrome
1523864|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
1523865|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
1523866|NCT00686049|Adherence|adherence
1523867|NCT00686049|Treatment readiness|treatment readiness
1523868|NCT00686049|HIV|hiv
1523869|NCT00686036|prostate cancer|prostate cancer
1523870|NCT00686036|hormone treatment|hormone treatment
1523871|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
1523872|NCT00686023|DHS|dhs
1523873|NCT00686023|IMN|imn
1523874|NCT00686010|CETP Inhibitor|cetp inhibitor
1523875|NCT00686010|HDL-C|hdl-c
1523876|NCT00686010|LDL-C|ldl-c
1523877|NCT00686010|Apolipoprotein|apolipoprotein
1523878|NCT00685997|Malignant lymphoma|malignant lymphoma
1523879|NCT00685997|Hodgkin's disease|hodgkin's disease
1523880|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1523881|NCT00685997|Imaging|imaging
1523882|NCT00685997|Whole-Body MRI|whole-body mri
1523883|NCT00685997|CT|ct
1523884|NCT00685997|Radiation|radiation
1523885|NCT00685984|Type 2 diabetes|type 2 diabetes
1523886|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
1523887|NCT00685984|endothelial function|endothelial function
1523888|NCT00685971|Cystic Fibrosis|cystic fibrosis
1523889|NCT00685971|Vitamin D deficiency|vitamin d deficiency
1523890|NCT00685958|Blood thinner|blood thinner
1523891|NCT00685958|enoxaparin|enoxaparin
1523892|NCT00685958|hip fracture surgery|hip fracture surgery
1523893|NCT00685958|bleeding|bleeding
1523894|NCT00685958|thromboembolism|thromboembolism
1523895|NCT00685945|Bradykinin|bradykinin
1523896|NCT00685945|Obesity|obesity
1523897|NCT00685945|Nitric Oxide Donor|nitric oxide donor
1523898|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
1523899|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
1523900|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
1523901|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
1523902|NCT00685945|Fibrinolysis|fibrinolysis
1523903|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
1523904|NCT00685932|Postpartum pain|postpartum pain
1523905|NCT00685932|Post-cesarean pain|post-cesarean pain
1523906|NCT00685932|Surgical retractor|surgical retractor
1523907|NCT00685932|Elastic retractor|elastic retractor
1523908|NCT00685919|Dopamine|dopamine
1523909|NCT00685919|Natriuresis|natriuresis
1523910|NCT00685919|Catecholamines|catecholamines
1523911|NCT00685906|oral contraceptive|oral contraceptive
1523912|NCT00685906|birth control|birth control
1523913|NCT00685906|Healthy volunteers|healthy volunteers
1523914|NCT00685893|End-of-life issues|end-of-life issues
1523915|NCT00685893|Talking with your doctor|talking with your doctor
1523916|NCT00685893|Coping with chronic illness|coping with chronic illness
1523917|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
1523918|NCT00685880|prolotherapy|prolotherapy
1523919|NCT00685880|intra articular steroid|intra articular steroid
1523920|NCT00685880|hand therapy|hand therapy
1523921|NCT00685867|Staphylococcus aureus|staphylococcus aureus
1523922|NCT00685867|Resistance|resistance
1523923|NCT00685867|Prevention|prevention
1523924|NCT00685854|Macular Telangiectasia|macular telangiectasia
1523925|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1523926|NCT00685854|Ranibizumab|ranibizumab
1523927|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1523928|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1523929|NCT00685815|IV Iron|iv iron
1523930|NCT00685815|Restless Legs Syndrome|restless legs syndrome
1523931|NCT00685815|RLS|rls
1523932|NCT00685815|Iron|iron
1523933|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
1523934|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
1523935|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
1523936|NCT00685763|Pancreatic cancer|pancreatic cancer
1523937|NCT00685763|Unresectable|unresectable
1523938|NCT00685763|Proton radiation|proton radiation
1523939|NCT00685763|Chemotherapy|chemotherapy
1523940|NCT00685750|tumor antigen|tumor antigen
1523941|NCT00685750|biomarkers|biomarkers
1523942|NCT00685737|Hyperlipidemia|hyperlipidemia
1523943|NCT00685724|pathological gambling|pathological gambling
1523944|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
1523945|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
1523946|NCT00685711|Cat allergy|cat allergy
1523947|NCT00685711|Immunotherapy|immunotherapy
1523948|NCT00685711|Cat-PAD|cat-pad
1523949|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
1523950|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
1523951|NCT00685672|labor analgesia|labor analgesia
1523952|NCT00685672|fentanyl|fentanyl
1523953|NCT00685672|epinephrine|epinephrine
1523954|NCT00685659|cocaine dependence|cocaine dependence
1523955|NCT00685659|treatment|treatment
1523956|NCT00685659|continuing care|continuing care
1523957|NCT00685659|outcomes|outcomes
1523958|NCT00685659|incentives|incentives
1523959|NCT00685659|adaptive|adaptive
1523960|NCT00685646|bone metastases|bone metastases
1523961|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
1523962|NCT00685633|stage I prostate cancer|stage i prostate cancer
1523963|NCT00685633|stage II prostate cancer|stage ii prostate cancer
1523964|NCT00685633|stage III prostate cancer|stage iii prostate cancer
1523965|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
1523966|NCT00685607|Pilot Study|pilot study
1523967|NCT00685607|Outcome Measures|outcome measures
1523968|NCT00685594|diabetes|diabetes
1523969|NCT00685594|vitamin D|vitamin d
1523970|NCT00685594|cholecalciferol|cholecalciferol
1523971|NCT00685594|glucose tolerance|glucose tolerance
1523972|NCT00685581|TFA|tfa
1523973|NCT00685581|SFA|sfa
1523974|NCT00685581|Clinical trial|clinical trial
1523975|NCT00685581|fat milk|fat milk
1523977|NCT00685568|rectal cancer|rectal cancer
1523978|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
1523979|NCT00685555|Screen time|screen time
1523980|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
1523981|NCT00685555|Physical Activity|physical activity
1523982|NCT00685555|Obesity|obesity
1523983|NCT00685555|Overweight|overweight
1523984|NCT00685542|diacerein|diacerein
1523985|NCT00685542|osteoarthritis|osteoarthritis
1523986|NCT00685542|hand|hand
1523987|NCT00685529|COPD|copd
1523988|NCT00685529|Arformoterol|arformoterol
1523989|NCT00685529|formoterol|formoterol
1523990|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1523991|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
1523992|NCT00685516|stage I prostate cancer|stage i prostate cancer
1523993|NCT00685516|stage II prostate cancer|stage ii prostate cancer
1523994|NCT00685516|stage III prostate cancer|stage iii prostate cancer
1523995|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
1523996|NCT00685503|Macular Telangiectasia|macular telangiectasia
1523997|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1523998|NCT00685503|Ranibizumab|ranibizumab
1523999|NCT00685503|Neovascularization|neovascularization
1524000|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
1524001|NCT00685490|internal limiting membrane|internal limiting membrane
1524002|NCT00685490|macular edema|macular edema
1524003|NCT00685490|vitrectomy|vitrectomy
1524004|NCT00685477|CCK infusion|cck infusion
1524005|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
1524006|NCT00685477|Normal volunteers|normal volunteers
1524007|NCT00685464|Abciximab|abciximab
1524008|NCT00685464|Reo-Pro|reo-pro
1524009|NCT00685464|Intracoronary|intracoronary
1524010|NCT00685464|PCI|pci
1524011|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
1524012|NCT00685451|addiction|addiction
1524013|NCT00685451|PTSD|ptsd
1524014|NCT00685438|Environmental Medicine|environmental medicine
1524015|NCT00685438|Altitude|altitude
1524016|NCT00685438|Ultraviolet Rays|ultraviolet rays
1524017|NCT00685438|Antioxidants|antioxidants
1524018|NCT00685438|Oxidative Stress|oxidative stress
1524019|NCT00685438|Erythema|erythema
1524020|NCT00685425|Asthma|asthma
1524021|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
1524022|NCT00685412|CIN 2 or 3|cin 2 or 3
1524023|NCT00685412|cervical cancer|cervical cancer
1524024|NCT00685399|Uveitis|uveitis
1524025|NCT00685399|eye|eye
1524026|NCT00685399|IL-17|il-17
1524027|NCT00685399|IL-17A|il-17a
1524028|NCT00685399|IL17|il17
1524029|NCT00685399|AIN457|ain457
1524030|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
1524031|NCT00685399|Behcet's|behcet's
1524032|NCT00685399|Behcet|behcet
1524033|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
1524034|NCT00685399|Multifocal choroiditis|multifocal choroiditis
1524035|NCT00685399|Birdshot|birdshot
1524036|NCT00685399|HLA-B27|hla-b27
1524037|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
1524038|NCT00685399|Retinal vasculitis|retinal vasculitis
1524039|NCT00685399|Sarcoidosis|sarcoidosis
1524040|NCT00685399|Intermediate uveitis|intermediate uveitis
1524041|NCT00685399|Panuveitis|panuveitis
1524042|NCT00685399|Posterior uveitis|posterior uveitis
1524043|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
1524044|NCT00685386|carbon dioxide|carbon dioxide
1524045|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
1567719|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
1524046|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
1524047|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
1524048|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
1524049|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
1524050|NCT00685373|children,|children,
1524051|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
1524052|NCT00685373|CIAS-1 gene,|cias-1 gene,
1524054|NCT00685373|ACZ885,|acz885,
1524055|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
1524056|NCT00685373|antibody,|antibody,
1524057|NCT00685373|autosomal dominant,|autosomal dominant,
1524058|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
1524059|NCT00685360|Tuberculosis|tuberculosis
1524060|NCT00685360|Pulmonary|pulmonary
1524061|NCT00685360|Multidrug resistant|multidrug resistant
1524062|NCT00685360|Antitubercular Agents|antitubercular agents
1524063|NCT00685360|OPC 67683|opc 67683
1524064|NCT00685347|Asthma|asthma
1524065|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
1524066|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
1524067|NCT00685334|Anorexia Nervosa|anorexia nervosa
1524068|NCT00685321|schizophrenia|schizophrenia
1524069|NCT00685321|TMS|tms
1524070|NCT00685321|brain stimulation|brain stimulation
1524071|NCT00685321|negative symptoms|negative symptoms
1524072|NCT00685321|clinical improvement|clinical improvement
1524073|NCT00685321|cognitive improvement|cognitive improvement
1524352|NCT00684008|infection|infection
1524074|NCT00685308|Atherosclerosis|atherosclerosis
1524075|NCT00685308|Intracranial artery|intracranial artery
1524076|NCT00685308|Angioplasty|angioplasty
1524078|NCT00685295|Emergency Department|emergency department
1524079|NCT00685295|acute|acute
1524080|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1524081|NCT00685269|OSAS|osas
1524082|NCT00685256|breast cancer|breast cancer
1524083|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
1524084|NCT00685243|Fraxel|fraxel
1524085|NCT00685243|Pulsed dye laser|pulsed dye laser
1524086|NCT00685243|Surgical scars|surgical scars
1524087|NCT00685230|scorpion sting|scorpion sting
1524088|NCT00685230|envenomation|envenomation
1524089|NCT00685230|alacramyn|alacramyn
1524090|NCT00685191|Raltegravir|raltegravir
1524091|NCT00685191|HIV|hiv
1524092|NCT00685191|dynamics|dynamics
1524093|NCT00685191|viral load|viral load
1524094|NCT00685191|Treatment Experienced|treatment experienced
1524095|NCT00685178|addiction|addiction
1524096|NCT00685178|drug dependence|drug dependence
1524097|NCT00685178|stimulant|stimulant
1524098|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
1524099|NCT00685126|RAD|rad
1524216|NCT00684658|Adolescence|adolescence
1524100|NCT00685126|Reactive Airways Disease|reactive airways disease
1524101|NCT00685126|Levalbuterol|levalbuterol
1524102|NCT00685126|Racemic albuterol|racemic albuterol
1524103|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
1524104|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
1524105|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
1524106|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
1524107|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
1524108|NCT00685074|Motivational Interview|motivational interview
1524109|NCT00685074|Computer based intervention|computer based intervention
1524110|NCT00685074|Substance abuse|substance abuse
1524111|NCT00685074|post-partum|post-partum
1524112|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
1524113|NCT00685048|Gambling|gambling
1524114|NCT00685048|Brief Therapies|brief therapies
1524115|NCT00685048|Substance Abuse|substance abuse
1524116|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
1524117|NCT00685022|Asthma|asthma
1524118|NCT00685022|Racemic albuterol|racemic albuterol
1524119|NCT00685009|Cognition|cognition
1524120|NCT00685009|Memory|memory
1524121|NCT00685009|Hormone Therapy|hormone therapy
1524122|NCT00684983|IGF-1R|igf-1r
1524123|NCT00684983|IMC-A12|imc-a12
1524124|NCT00684970|CRPC|crpc
1524125|NCT00684970|HRPC|hrpc
1524126|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
1524127|NCT00684931|Attention|attention
1524128|NCT00684931|Deficit|deficit
1524129|NCT00684931|Disorder|disorder
1524130|NCT00684931|Hyperactivity|hyperactivity
1524131|NCT00684931|cerebellum|cerebellum
1524132|NCT00684931|alteration|alteration
1524133|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
1524134|NCT00684918|AML, obatoclax|aml, obatoclax
1524135|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1524136|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
1524137|NCT00684905|stage I prostate cancer|stage i prostate cancer
1524138|NCT00684905|stage II prostate cancer|stage ii prostate cancer
1524139|NCT00684905|stage III prostate cancer|stage iii prostate cancer
1524140|NCT00684892|Emphysema|emphysema
1524141|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
1524142|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1524143|NCT00684879|Health Belief Model|health belief model
1524144|NCT00684879|Illness Perceptions|illness perceptions
1524145|NCT00684879|Screening|screening
1524146|NCT00684879|HHT|hht
1524147|NCT00684866|Asthma|asthma
1524148|NCT00684866|Levalbuterol|levalbuterol
1524149|NCT00684866|Racemic Albuterol|racemic albuterol
1524150|NCT00684853|AMD|amd
1524151|NCT00684853|PDT|pdt
1524152|NCT00684853|Avastin|avastin
1524153|NCT00684853|Bevacizumab|bevacizumab
1524154|NCT00684853|Full fluence|full fluence
1524155|NCT00684853|exudative|exudative
1524156|NCT00684853|CNV|cnv
1524157|NCT00684853|Drusen|drusen
1524158|NCT00684853|ARMD|armd
1524159|NCT00684853|Vetaporfin|vetaporfin
1524160|NCT00684853|efficacy|efficacy
1524161|NCT00684853|treatment|treatment
1524162|NCT00684840|Behavioral Economics|behavioral economics
1524163|NCT00684840|Drug self administration|drug self administration
1524164|NCT00684840|Opioid|opioid
1524165|NCT00684827|Asthma|asthma
1524166|NCT00684827|Racemic albuterol|racemic albuterol
1524167|NCT00684814|equivalency|equivalency
1524168|NCT00684814|Therapeutic equivalency|therapeutic equivalency
1524169|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1524170|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
1524261|NCT00684398|Stress and Coping Model|stress and coping model
1524171|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1524172|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1524173|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1524174|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1524175|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
1524176|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
1524177|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
1524178|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1524179|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1524180|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1524181|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1524182|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1524183|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1524184|NCT00684801|recurrent colon cancer|recurrent colon cancer
1524185|NCT00684801|stage III colon cancer|stage iii colon cancer
1524186|NCT00684801|stage IV colon cancer|stage iv colon cancer
1524187|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
1524188|NCT00684801|stage III rectal cancer|stage iii rectal cancer
1524189|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
1524190|NCT00684788|opiate dependence|opiate dependence
1524191|NCT00684788|naltrexone|naltrexone
1524192|NCT00684788|reinforcement|reinforcement
1524193|NCT00684788|behavior therapy|behavior therapy
1524194|NCT00684788|cocaine dependence|cocaine dependence
1524195|NCT00684788|risk reduction behavior|risk reduction behavior
1524196|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
1524197|NCT00684749|Breast augmentation|breast augmentation
1524198|NCT00684749|Breast implant choice|breast implant choice
1524199|NCT00684749|Reoperation rates|reoperation rates
1524200|NCT00684736|septic shock|septic shock
1524201|NCT00684736|shock|shock
1524202|NCT00684736|serotonin|serotonin
1524203|NCT00684736|kynurenine|kynurenine
1524204|NCT00684736|tryptophan|tryptophan
1524205|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
1524206|NCT00684710|Alzheimer Disease|alzheimer disease
1524207|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
1524208|NCT00684684|Bronchoscopy|bronchoscopy
1524209|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
1524210|NCT00684671|Immune memory|immune memory
1524211|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
1524212|NCT00684671|> 41 years old|> 41 years old
1524213|NCT00684658|Type 1 Diabetes|type 1 diabetes
1524214|NCT00684658|Children and Teenagers|children and teenagers
1524215|NCT00684658|Coping with Chronic Illness|coping with chronic illness
1524217|NCT00684658|Internet psychosocial program|internet psychosocial program
1524218|NCT00684658|Coping Skills Training|coping skills training
1524219|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
1524220|NCT00684632|Pain, cancer|pain, cancer
1524221|NCT00684606|Induction of Labor|induction of labor
1524222|NCT00684606|Low Bishop Score|low bishop score
1524223|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
1524224|NCT00684606|IV Oxytocin|iv oxytocin
1524225|NCT00684580|St. Jude Alumni|st. jude alumni
1524226|NCT00684580|St. Jude Life Participants|st. jude life participants
1524227|NCT00684554|Heroin Dependence|heroin dependence
1524228|NCT00684554|Opioid Dependence|opioid dependence
1524229|NCT00684554|Primary Care|primary care
1524230|NCT00684554|Buprenorphine|buprenorphine
1524231|NCT00684541|Social Anxiety|social anxiety
1524232|NCT00684541|Information Processing|information processing
1524233|NCT00684541|Interpretation|interpretation
1524234|NCT00684528|DM 2|dm 2
1524235|NCT00684528|Metformin|metformin
1524236|NCT00684528|Januvia|januvia
1524237|NCT00684528|Community setting|community setting
1524238|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
1524239|NCT00684502|Safety|safety
1524240|NCT00684502|tolerability|tolerability
1524241|NCT00684502|AZD2066|azd2066
1524242|NCT00684502|Pain conditions|pain conditions
1524243|NCT00684489|hypertension|hypertension
1524244|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
1524245|NCT00684463|Antiemetic|antiemetic
1524246|NCT00684450|titration of protamine|titration of protamine
1524247|NCT00684450|exact dose|exact dose
1524248|NCT00684450|protamine|protamine
1524249|NCT00684450|neutralize heparin|neutralize heparin
1524250|NCT00684437|Health Literacy|health literacy
1524251|NCT00684437|Smoking Risk|smoking risk
1524252|NCT00684437|Focus Group|focus group
1524253|NCT00684437|Questionnaire|questionnaire
1524254|NCT00684437|Survey|survey
1524255|NCT00684411|T NHL|t nhl
1524256|NCT00684411|Gleevec|gleevec
1524257|NCT00684411|imatinib mesylate|imatinib mesylate
1524258|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
1524259|NCT00684398|Quality of Life|quality of life
1524260|NCT00684398|Adaptation|adaptation
1524262|NCT00684398|NF1|nf1
1524263|NCT00684398|Survey|survey
1524264|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
1524265|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
1524266|NCT00684346|airway inflammation|airway inflammation
1524267|NCT00684346|cystic fibrosis|cystic fibrosis
1524268|NCT00684346|pediatric|pediatric
1524269|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
1524270|NCT00684333|painless Injections|painless injections
1524271|NCT00684333|Subcutaneous Injections|subcutaneous injections
1524272|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
1524273|NCT00684320|Social Anxiety Disorder|social anxiety disorder
1524274|NCT00684320|Information Processing|information processing
1524275|NCT00684320|Attention Bias|attention bias
1524276|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
1524277|NCT00684307|Risk Factors For Stroke|risk factors for stroke
1524278|NCT00684294|cancer|cancer
1524279|NCT00684294|oncology|oncology
1524280|NCT00684294|solid tumor|solid tumor
1524281|NCT00684268|silibinin|silibinin
1524282|NCT00684268|chronic hepatitis C|chronic hepatitis c
1524283|NCT00684268|peginterferon|peginterferon
1524284|NCT00684268|ribavirin|ribavirin
1524285|NCT00684268|nonresponders|nonresponders
1524286|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
1524287|NCT00684268|safety|safety
1524288|NCT00684255|Autoimmune Disease|autoimmune disease
1524289|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
1524290|NCT00684242|Advanced Cancer|advanced cancer
1524291|NCT00684242|Refractory Cancer Pain|refractory cancer pain
1524292|NCT00684242|Lenalidomide|lenalidomide
1524293|NCT00684242|Revlimid|revlimid
1524294|NCT00684242|CC-5103|cc-5103
1524295|NCT00684229|Anesthesia; regional|anesthesia; regional
1524296|NCT00684229|Cancer recurrence|cancer recurrence
1524297|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
1524298|NCT00684229|Analgesia; opioid|analgesia; opioid
1524299|NCT00684216|metastatic|metastatic
1524300|NCT00684216|ER positive|er positive
1524301|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
1524302|NCT00684190|Reflux Inhibitor|reflux inhibitor
1524303|NCT00684190|GERD|gerd
1524304|NCT00684190|PPI Interaction|ppi interaction
1524305|NCT00684177|infection|infection
1524306|NCT00684177|retapamulin|retapamulin
1524307|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
1524308|NCT00684177|placebo|placebo
1524309|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
1524310|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
1524311|NCT00684164|Neurological injury|neurological injury
1524312|NCT00684151|Lipid-lowering|lipid-lowering
1524313|NCT00684138|cataract|cataract
1524314|NCT00684138|cataract surgery|cataract surgery
1524315|NCT00684138|IOL|iol
1524316|NCT00684138|intraocular lens|intraocular lens
1524317|NCT00684138|ReSTOR|restor
1524318|NCT00684138|Replacement of cataract|replacement of cataract
1524319|NCT00684125|late cardiac tamponade|late cardiac tamponade
1524320|NCT00684112|pediatrics|pediatrics
1524321|NCT00684112|Scoliosis|scoliosis
1524322|NCT00684112|Gabapentin|gabapentin
1524323|NCT00684099|NSCLC|nsclc
1524324|NCT00684099|Pemetrexed|pemetrexed
1524325|NCT00684099|Docetaxel|docetaxel
1524326|NCT00684073|Suboxone|suboxone
1524327|NCT00684073|Subutex|subutex
1524328|NCT00684073|Buprenorphine|buprenorphine
1524329|NCT00684073|Naloxone|naloxone
1524330|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
1524331|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
1524332|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
1524333|NCT00684060|Left Ventricular Mass|left ventricular mass
1524334|NCT00684060|Infarct Size|infarct size
1524335|NCT00684060|End Systolic Volume|end systolic volume
1524336|NCT00684060|End Diastolic Volume|end diastolic volume
1524337|NCT00684047|Fibrin Sealant|fibrin sealant
1524338|NCT00684047|Hemostasis|hemostasis
1524339|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
1524464|NCT00683566|parkinson|parkinson
1524340|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
1524341|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
1524342|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
1524343|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
1524344|NCT00684021|Left Ventricular Mass|left ventricular mass
1524345|NCT00684021|Infarct Size|infarct size
1524346|NCT00684021|End Systolic Volume|end systolic volume
1524347|NCT00684021|End Diastolic Volume|end diastolic volume
1524348|NCT00684008|interleukin-7|interleukin-7
1524349|NCT00684008|immune based therapies|immune based therapies
1524350|NCT00684008|graft vs host disease|graft vs host disease
1524351|NCT00684008|immune reconstitution|immune reconstitution
1524353|NCT00684008|lymphopenia|lymphopenia
1524354|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
1524355|NCT00684008|bone marrow transplantation|bone marrow transplantation
1524356|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
1524357|NCT00684008|immunosuppression|immunosuppression
1524358|NCT00683995|Pain, Cancer|pain, cancer
1524359|NCT00683982|nitazoxanide|nitazoxanide
1524360|NCT00683982|Probiotics|probiotics
1524361|NCT00683982|Diarrhea|diarrhea
1524362|NCT00683982|Rotavirus|rotavirus
1524363|NCT00683982|Children|children
1524364|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
1524365|NCT00683943|Lithium|lithium
1524366|NCT00683917|Uterine fibroids|uterine fibroids
1524367|NCT00683917|Fibroids|fibroids
1524368|NCT00683891|FOCUS|focus
1524369|NCT00683891|Weight gain|weight gain
1524370|NCT00683891|Sialorrhea|sialorrhea
1524371|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
1524372|NCT00683891|FazaClo|fazaclo
1524373|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
1524374|NCT00683891|clozapine|clozapine
1524375|NCT00683891|Hypersalivation|hypersalivation
1524376|NCT00683865|Antibiotic treatment|antibiotic treatment
1524377|NCT00683865|Pelvic infection|pelvic infection
1524378|NCT00683865|Interventional study|interventional study
1524379|NCT00683865|Female|female
1524380|NCT00683852|Depression|depression
1524381|NCT00683839|Tobacco|tobacco
1524382|NCT00683839|Smoking|smoking
1524383|NCT00683839|Smokeless|smokeless
1524384|NCT00683839|Cessation|cessation
1524385|NCT00683839|Public health clinic|public health clinic
1524386|NCT00683839|Dental patients|dental patients
1524387|NCT00683839|5 As|5 as
1524389|NCT00683839|Tobacco Quit Line|tobacco quit line
1524390|NCT00683839|Smokeless tobacco|smokeless tobacco
1524391|NCT00683826|Leucine|leucine
1524392|NCT00683826|Weight Loss|weight loss
1524393|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
1524394|NCT00683813|telehealth|telehealth
1524395|NCT00683813|Internet|internet
1524396|NCT00683800|Menopause|menopause
1524397|NCT00683800|Hot Flush|hot flush
1524398|NCT00683800|Hot Flash|hot flash
1524399|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
1524400|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
1524401|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
1524402|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1524403|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
1524404|NCT00683761|Phase 2|phase 2
1524405|NCT00683761|Phase 1|phase 1
1524406|NCT00683761|Multi-center|multi-center
1524407|NCT00683761|Open label|open label
1524408|NCT00683761|Multiple dose|multiple dose
1524409|NCT00683761|Brain Cancer|brain cancer
1524410|NCT00683761|Brain Tumor|brain tumor
1524412|NCT00683761|glioma|glioma
1524413|NCT00683761|glioblastoma|glioblastoma
1524414|NCT00683761|astrocytoma|astrocytoma
1524415|NCT00683761|oligodendroglioma|oligodendroglioma
1524416|NCT00683761|131I-TM601|131i-tm601
1524417|NCT00683761|TM601|tm601
1524418|NCT00683748|Transplantation|transplantation
1524419|NCT00683748|Immunological monitoring|immunological monitoring
1524420|NCT00683748|Immunological risk|immunological risk
1524421|NCT00683748|T cell reactivity|t cell reactivity
1524422|NCT00683748|Cellular immunity|cellular immunity
1524423|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
1524424|NCT00683722|COPD|copd
1524425|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
1524426|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
1524427|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1524428|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1524429|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1524430|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
1524431|NCT00683722|Chronic Bronchitis|chronic bronchitis
1524432|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
1524433|NCT00683722|MSCs|mscs
1524434|NCT00683722|Adult Human Stem Cells|adult human stem cells
1524435|NCT00683722|Osiris|osiris
1524436|NCT00683722|Prochymal|prochymal
1524437|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
1524438|NCT00683709|Clozapine|clozapine
1524439|NCT00683709|Metabolic Side Effects|metabolic side effects
1524440|NCT00683709|Diet & Exercise|diet & exercise
1524442|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1524443|NCT00683696|Heart Failure|heart failure
1524444|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
1524445|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
1524446|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
1524447|NCT00683696|Echocardiography|echocardiography
1524448|NCT00683696|Normal QRS|normal qrs
1524449|NCT00683696|Heart Disease|heart disease
1524450|NCT00683696|EchoCRT|echocrt
1524451|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
1524452|NCT00683644|tinnitus, zinc|tinnitus, zinc
1524453|NCT00683631|liver cancer|liver cancer
1524454|NCT00683631|liver tumor|liver tumor
1524455|NCT00683631|HCC|hcc
1524456|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
1524457|NCT00683631|hepatoma|hepatoma
1524458|NCT00683618|HMG-CoA|hmg-coa
1524459|NCT00683618|LDL-C|ldl-c
1524460|NCT00683618|CHD|chd
1524461|NCT00683579|HAART|haart
1524462|NCT00683579|DHHS guidelines|dhhs guidelines
1524463|NCT00683579|Treatment Naive|treatment naive
1524465|NCT00683553|Acute Renal Failure|acute renal failure
1524466|NCT00683553|Acute Kidney Injury|acute kidney injury
1524467|NCT00683540|implementation|implementation
1524468|NCT00683540|evaluation|evaluation
1524469|NCT00683540|research methodology|research methodology
1524470|NCT00683540|intervention|intervention
1524471|NCT00683527|Iron supplementation|iron supplementation
1524472|NCT00683527|Timing|timing
1524473|NCT00683527|Serum ferritin|serum ferritin
1524474|NCT00683527|Very low birth weight infants|very low birth weight infants
1524475|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
1524476|NCT00683501|ocular hypertension|ocular hypertension
1524477|NCT00683501|elevated IOP|elevated iop
1524478|NCT00683501|glaucoma|glaucoma
1524479|NCT00683501|neuroprotection|neuroprotection
1524480|NCT00683488|Substance Abuse|substance abuse
1524481|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
1524482|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
1524483|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
1524484|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
1524485|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
1524486|NCT00683488|Individual behavior therapy|individual behavior therapy
1524487|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
1524488|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
1524489|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
1524490|NCT00683488|Complementary Therapies|complementary therapies
1524491|NCT00683475|Prostate Cancer|prostate cancer
1524492|NCT00683449|Asthma|asthma
1524493|NCT00683449|Dose-Escalation|dose-escalation
1524494|NCT00683449|Controlled|controlled
1524495|NCT00683449|MN-221|mn-221
1524496|NCT00683436|insomnia|insomnia
1524497|NCT00683397|assess|assess
1524498|NCT00683397|prevalence|prevalence
1524499|NCT00683397|thrombophilia|thrombophilia
1524500|NCT00683397|common|common
1524501|NCT00683397|VTE|vte
1524502|NCT00683397|risk factors|risk factors
1524503|NCT00683397|patients|patients
1524504|NCT00683384|Arthritis|arthritis
1524505|NCT00683384|psoriatic|psoriatic
1524506|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
1524507|NCT00683371|Sinus Disease|sinus disease
1524508|NCT00683371|Allergy|allergy
1524509|NCT00683371|Maxillary Sinus|maxillary sinus
1524510|NCT00683371|Microarray|microarray
1524511|NCT00683358|cancer|cancer
1524512|NCT00683358|pancreas|pancreas
1524513|NCT00683358|advanced|advanced
1524514|NCT00683358|peptide|peptide
1524515|NCT00683358|vaccination|vaccination
1524516|NCT00683358|VEGFR1|vegfr1
1524517|NCT00683358|HLA|hla
1524518|NCT00683358|gemcitabine|gemcitabine
1524519|NCT00683358|IFA|ifa
1524520|NCT00683358|Cancer of Pancreas|cancer of pancreas
1524521|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
1524522|NCT00683358|Pancreas Cancer|pancreas cancer
1524523|NCT00683332|Observational study|observational study
1524524|NCT00683332|Tigecycline|tigecycline
1524525|NCT00683332|infection|infection
1524526|NCT00683332|skin|skin
1524527|NCT00683332|abdominal|abdominal
1524528|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1524529|NCT00683319|cognitive/functional effects|cognitive/functional effects
1524530|NCT00683319|ototoxicity|ototoxicity
1524531|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1524532|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1524533|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
1524534|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
1524535|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
1524536|NCT00683280|Contingency Management|contingency management
1524537|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
1524538|NCT00683280|varenicline|varenicline
1524539|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
1524540|NCT00683254|nasal obstruction|nasal obstruction
1524541|NCT00683254|nasal stent|nasal stent
1524542|NCT00683241|Vaccine|vaccine
1524543|NCT00683241|Ovarian|ovarian
1524544|NCT00683241|Peritoneal|peritoneal
1524545|NCT00683228|Second hand Smoke|second hand smoke
1524546|NCT00683202|Assisted reproduction|assisted reproduction
1524547|NCT00683202|Ovarian response|ovarian response
1524548|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
1524549|NCT00683202|Doppler ultrasonography|doppler ultrasonography
1524550|NCT00683202|Implantation rate|implantation rate
1524640|NCT00682929|cannabis|cannabis
1524551|NCT00683202|Pregnancy rate|pregnancy rate
1524552|NCT00683202|Live birth rate|live birth rate
1524554|NCT00683176|Diabetic Macular Edema|diabetic macular edema
1524555|NCT00683176|OCT|oct
1524556|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
1524557|NCT00683163|Bone marker formation|bone marker formation
1524558|NCT00683163|Postmenopausal|postmenopausal
1524559|NCT00683163|Trabecular spine BMD|trabecular spine bmd
1524560|NCT00683150|Endothelial Function|endothelial function
1524561|NCT00683150|Abdominal Surgery|abdominal surgery
1524562|NCT00683150|Thoracic Surgery|thoracic surgery
1524563|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
1524564|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
1524565|NCT00683150|DTM|dtm
1524566|NCT00683124|Marfan Syndrome|marfan syndrome
1524567|NCT00683124|Losartan|losartan
1524568|NCT00683124|Nebivolol|nebivolol
1524569|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
1524570|NCT00683124|Aortic Root Dilation|aortic root dilation
1524571|NCT00683111|acute coronary syndrome|acute coronary syndrome
1524572|NCT00683111|acute myocardial infarction|acute myocardial infarction
1524573|NCT00683111|aspirin|aspirin
1524574|NCT00683111|clopidogrel|clopidogrel
1524575|NCT00683111|heparin|heparin
1524576|NCT00683111|thrombolytic|thrombolytic
1524577|NCT00683111|famotidine|famotidine
1524578|NCT00683111|esomeprazole|esomeprazole
1524579|NCT00683098|recurrent hernia|recurrent hernia
1524580|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
1524581|NCT00683098|inguinal pain|inguinal pain
1524582|NCT00683098|questionnaire|questionnaire
1524583|NCT00683085|cancer|cancer
1524584|NCT00683085|pancreas|pancreas
1524585|NCT00683085|advanced|advanced
1524586|NCT00683085|peptide|peptide
1524587|NCT00683085|vaccination|vaccination
1524588|NCT00683085|VEGFR1|vegfr1
1524589|NCT00683085|HLA|hla
1524590|NCT00683085|gemcitabine|gemcitabine
1524591|NCT00683085|IFA|ifa
1524592|NCT00683085|Cancer of Pancreas|cancer of pancreas
1524593|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
1524594|NCT00683085|Pancreas Cancer|pancreas cancer
1524595|NCT00683072|Ventilator|ventilator
1524596|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
1524597|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
1524598|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
1524599|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
1524600|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
1524601|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
1524602|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
1524603|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
1524604|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
1524605|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
1524606|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
1524607|NCT00683033|Contingency Management|contingency management
1524608|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
1524609|NCT00683033|Substance Abusers|substance abusers
1524610|NCT00683020|Chronic Diseases|chronic diseases
1524611|NCT00683020|Diabetes|diabetes
1524612|NCT00683020|Vulnerable population|vulnerable population
1524613|NCT00683020|Urban populations|urban populations
1524614|NCT00683020|Disease Management|disease management
1524615|NCT00683020|Health Information Technology|health information technology
1524616|NCT00683020|Safety|safety
1524617|NCT00683020|Health Literacy|health literacy
1524618|NCT00683020|Level of English Proficiency|level of english proficiency
1524619|NCT00683007|TE echo|te echo
1524620|NCT00683007|hemodilution|hemodilution
1524621|NCT00683007|hypertonic|hypertonic
1524622|NCT00683007|saline|saline
1524623|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
1524624|NCT00682994|Advanced Cancer|advanced cancer
1524625|NCT00682994|Family Member|family member
1524626|NCT00682994|Palliative Care|palliative care
1524627|NCT00682994|Decision Making|decision making
1524628|NCT00682994|Information Disclosure|information disclosure
1524629|NCT00682994|Interview|interview
1524630|NCT00682994|Survey|survey
1524631|NCT00682994|Questionnaire|questionnaire
1524632|NCT00682981|ES-SCLC|es-sclc
1524633|NCT00682981|Obatoclax|obatoclax
1524634|NCT00682968|patient non-adherence|patient non-adherence
1524635|NCT00682968|antihypertensive agents|antihypertensive agents
1524636|NCT00682968|hypertension|hypertension
1524637|NCT00682955|Diarrhea|diarrhea
1524638|NCT00682955|Zinc Sulphate|zinc sulphate
1524639|NCT00682955|Efficacy|efficacy
1524641|NCT00682929|marijuana|marijuana
1524642|NCT00682929|Multiple Sclerosis|multiple sclerosis
1524643|NCT00682929|spasticity|spasticity
1524644|NCT00682916|Obesity|obesity
1524645|NCT00682916|Diabetes|diabetes
1524646|NCT00682916|Soluble Fiber|soluble fiber
1524647|NCT00682916|Overweight|overweight
1524648|NCT00682903|glucose|glucose
1524649|NCT00682903|diabetes|diabetes
1524650|NCT00682903|glycemia|glycemia
1524651|NCT00682877|gastroparesis|gastroparesis
1524652|NCT00682877|Digestive|digestive
1524653|NCT00682877|Gastrointestinal|gastrointestinal
1524654|NCT00682877|Stomach|stomach
1524655|NCT00682877|Motility|motility
1524656|NCT00682877|Non-Invasive|non-invasive
1524657|NCT00682877|Capsule|capsule
1524658|NCT00682877|GI|gi
1524659|NCT00682877|Device|device
1524660|NCT00682877|Digestive System Diseases|digestive system diseases
1524661|NCT00682838|Treatment compliance|treatment compliance
1524662|NCT00682838|Self-management|self-management
1524663|NCT00682838|Telemedicine|telemedicine
1524664|NCT00682825|Anesthesia|anesthesia
1524665|NCT00682825|Awareness|awareness
1524666|NCT00682825|Bispectral|bispectral
1524667|NCT00682825|BIS|bis
1524668|NCT00682825|Recall|recall
1524669|NCT00682799|RC|rc
1524670|NCT00682799|RIC|ric
1524671|NCT00682799|MDS|mds
1524672|NCT00682799|SCT|sct
1524673|NCT00682786|rectal|rectal
1524674|NCT00682786|rectum|rectum
1524675|NCT00682786|cancer|cancer
1524676|NCT00682786|carcinoma|carcinoma
1524677|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
1524678|NCT00682760|Blepharospasm|blepharospasm
1524679|NCT00682747|xerostomia|xerostomia
1524680|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
1524681|NCT00682747|radiotherapy|radiotherapy
1524682|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
1524683|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
1524684|NCT00682708|malnutrition|malnutrition
1524685|NCT00682708|ready to use food|ready to use food
1524686|NCT00682708|Niger|niger
1524687|NCT00682695|stroke|stroke
1524688|NCT00682695|brain attack|brain attack
1524689|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
1524690|NCT00682695|risk factors|risk factors
1524691|NCT00682682|Pain distraction|pain distraction
1524692|NCT00682682|Analgesic interventions|analgesic interventions
1524693|NCT00682682|Burn patients|burn patients
1524694|NCT00682669|Asthma|asthma
1524695|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
1524696|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
1524697|NCT00682669|Spirometry|spirometry
1524698|NCT00682669|Quality of life|quality of life
1524699|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
1524700|NCT00682656|azithromycin|azithromycin
1524701|NCT00682656|N- methyl glucamine|n- methyl glucamine
1524702|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
1524703|NCT00682643|fluticasone furoate|fluticasone furoate
1524704|NCT00682643|ocular safety|ocular safety
1524705|NCT00682630|Malaria|malaria
1524706|NCT00682630|anti-malarial|anti-malarial
1524707|NCT00682630|pyronaridine|pyronaridine
1524708|NCT00682630|ACT|act
1524709|NCT00682617|hip|hip
1524710|NCT00682617|osteoarthritis|osteoarthritis
1524711|NCT00682617|exercise|exercise
1524712|NCT00682617|disability|disability
1524713|NCT00682617|physical function|physical function
1524714|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
1524715|NCT00682591|hepatitis C|hepatitis c
1524716|NCT00682591|drug substitution|drug substitution
1524717|NCT00682591|neurocognitive|neurocognitive
1524718|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
1524719|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
1524720|NCT00682578|falciparum malaria|falciparum malaria
1524721|NCT00682578|vivax malaria|vivax malaria
1524722|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1524723|NCT00682539|diabetic retinopathy|diabetic retinopathy
1524724|NCT00682539|macular edema|macular edema
1524725|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
1524726|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
1524727|NCT00682513|dystonia|dystonia
1524728|NCT00682513|parkinsonism|parkinsonism
1524729|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
1524731|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
1524732|NCT00682513|AHC|ahc
1524733|NCT00682500|Pneumonia|pneumonia
1524734|NCT00682500|Aspiration|aspiration
1524735|NCT00682500|Drowning|drowning
1524736|NCT00682500|inhalation|inhalation
1524737|NCT00682487|Myocardial infarction|myocardial infarction
1524738|NCT00682487|Stress|stress
1524739|NCT00682487|Hair Cortisol|hair cortisol
1524740|NCT00682474|Cigarette smoking|cigarette smoking
1524741|NCT00682474|Nicotine dependence|nicotine dependence
1524742|NCT00682474|Adolescents|adolescents
1524743|NCT00682474|Youth|youth
1524744|NCT00682474|School health|school health
1524745|NCT00682474|Randomized controlled trial|randomized controlled trial
1524746|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
1524747|NCT00682448|Olanzapine|olanzapine
1524748|NCT00682448|Zyprexa|zyprexa
1524749|NCT00682448|Weight Gain|weight gain
1524750|NCT00682448|Antipsychotics|antipsychotics
1524751|NCT00682448|Metformin|metformin
1524752|NCT00682448|Glucophage|glucophage
1524753|NCT00682448|Bipolar Disorder|bipolar disorder
1524754|NCT00682448|Schizophrenia|schizophrenia
1524755|NCT00682448|Depression|depression
1524756|NCT00682448|Diabetes|diabetes
1524757|NCT00682448|Side effects|side effects
1524758|NCT00682448|Metabolic complications|metabolic complications
1524759|NCT00682448|Prevention|prevention
1524760|NCT00682448|Treatment|treatment
1524761|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
1524762|NCT00682435|Nonedlerly patients with acute moderate to severe pain|nonedlerly patients with acute moderate to severe pain
1524763|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
1524764|NCT00682383|Advanced NSCLC|advanced nsclc
1524765|NCT00682383|Lung Cancer|lung cancer
1524766|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
1524767|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
1524768|NCT00682318|Fish oil|fish oil
1524769|NCT00682318|red wine|red wine
1524770|NCT00682318|alcohol|alcohol
1524771|NCT00682318|oxidative stress|oxidative stress
1524772|NCT00682318|Healthy volunteers|healthy volunteers
1524773|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1524774|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
1524775|NCT00682292|Renal transplantation|renal transplantation
1524776|NCT00682292|Immunisation|immunisation
1524777|NCT00682292|Acute rejection|acute rejection
1524778|NCT00682292|Induction therapy|induction therapy
1524779|NCT00682292|Thymoglobulin|thymoglobulin
1524780|NCT00682292|Daclizumab|daclizumab
1524781|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
1524782|NCT00682279|lapatinib|lapatinib
1524783|NCT00682279|GW572016|gw572016
1524784|NCT00682279|topotecan|topotecan
1524785|NCT00682279|oral topotecan|oral topotecan
1524786|NCT00682279|SK&F-104864|sk&f-104864
1524787|NCT00682279|EGFR|egfr
1524788|NCT00682279|ErbB1|erbb1
1524789|NCT00682279|HER-2/neu|her-2/neu
1524790|NCT00682279|ErbB2|erbb2
1524791|NCT00682279|BCRP|bcrp
1524792|NCT00682266|Adolescent|adolescent
1524793|NCT00682266|Overweight|overweight
1524794|NCT00682266|Exercise|exercise
1524795|NCT00682266|multidisciplinary approach|multidisciplinary approach
1524796|NCT00682266|Oxygen uptake|oxygen uptake
1524797|NCT00682266|Flow mediated dilatation|flow mediated dilatation
1524798|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
1524799|NCT00682253|SPECT/CT|spect/ct
1524800|NCT00682253|MRI|mri
1524801|NCT00682253|Breast neoplasms|breast neoplasms
1524802|NCT00682240|retinal morphology|retinal morphology
1524803|NCT00682240|laser treatment|laser treatment
1524804|NCT00682240|pascal laser|pascal laser
1524805|NCT00682240|HD-OCT|hd-oct
1567720|NCT00508378|Interview|interview
1524806|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
1524807|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
1524808|NCT00682201|Pregnancy|pregnancy
1524809|NCT00682201|Blood pressure|blood pressure
1524810|NCT00682201|Cardiac output|cardiac output
1524811|NCT00682188|Overweight|overweight
1524812|NCT00682188|Obesity|obesity
1524813|NCT00682188|Adolescents|adolescents
1524814|NCT00682188|Youth|youth
1524815|NCT00682188|School health|school health
1524816|NCT00682188|Randomized controlled trial|randomized controlled trial
1524817|NCT00682188|Intervention study|intervention study
1524818|NCT00682175|Congestive Heart Failure|congestive heart failure
1524819|NCT00682162|acupuncture|acupuncture
1524820|NCT00682162|randomised controlled trial|randomised controlled trial
1524821|NCT00682162|placebo|placebo
1524822|NCT00682162|sham laser|sham laser
1524823|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
1524824|NCT00682149|Oxidative stress|oxidative stress
1524825|NCT00682149|malondialdehyde|malondialdehyde
1524826|NCT00682149|glutathione|glutathione
1524827|NCT00682149|diabetes|diabetes
1524828|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
1524829|NCT00682149|diet rich in vegetables|diet rich in vegetables
1524830|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
1524831|NCT00682136|postoperative analgesia|postoperative analgesia
1524832|NCT00682136|abdominal surgery|abdominal surgery
1524833|NCT00682136|ropivacaine|ropivacaine
1524834|NCT00682136|local anaesthesia|local anaesthesia
1524835|NCT00682136|tap block|tap block
1524836|NCT00682136|pain management|pain management
1524837|NCT00682123|19-norandrostenedione|19-norandrostenedione
1524838|NCT00682123|steroids|steroids
1524839|NCT00682123|drugs in sport|drugs in sport
1524840|NCT00682123|World Anti-Doping Agency|world anti-doping agency
1524841|NCT00682110|End-stage liver disease|end-stage liver disease
1524842|NCT00682110|Hemodynamic measurements|hemodynamic measurements
1524843|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
1524844|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
1524845|NCT00682110|Cardiac output|cardiac output
1524846|NCT00682084|Cushing's syndrome|cushing's syndrome
1524847|NCT00682084|Glucose tolerance|glucose tolerance
1525454|NCT00679770|Fungal Nail|fungal nail
1524848|NCT00682084|Insulin sensitivity|insulin sensitivity
1524849|NCT00682084|Substrate metabolism|substrate metabolism
1524850|NCT00682084|Body composition|body composition
1524851|NCT00682071|Ultrasound-guided|ultrasound-guided
1524852|NCT00682071|embryo transfer|embryo transfer
1524853|NCT00682071|in-vitro fertilization|in-vitro fertilization
1524854|NCT00682058|body composition|body composition
1524855|NCT00682058|weight loss|weight loss
1524857|NCT00682058|fat distribution|fat distribution
1524858|NCT00682058|fat free mass|fat free mass
1524859|NCT00682058|organ|organ
1524860|NCT00682058|resting energy expenditure|resting energy expenditure
1524861|NCT00682045|tuberculosis|tuberculosis
1524862|NCT00682045|transplantation|transplantation
1524863|NCT00682032|NSCLC|nsclc
1524864|NCT00682019|Erectile Dysfunction|erectile dysfunction
1524865|NCT00682019|Vardenafil|vardenafil
1524866|NCT00682006|Omphalitis|omphalitis
1524867|NCT00682006|4% Chlorhexidine|4% chlorhexidine
1524868|NCT00682006|Newborns|newborns
1524869|NCT00681993|cosmetic|cosmetic
1524870|NCT00681993|effect|effect
1524871|NCT00681993|breast|breast
1524872|NCT00681993|irradiation|irradiation
1524873|NCT00681993|concurrent|concurrent
1524874|NCT00681993|chemotherapy|chemotherapy
1524875|NCT00681993|potential acute|potential acute
1524876|NCT00681993|late skin|late skin
1524877|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
1524878|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
1524879|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
1524880|NCT00681967|Gefitinib|gefitinib
1524881|NCT00681967|IRESSA|iressa
1524882|NCT00681967|EGFR Inhibitor|egfr inhibitor
1524883|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
1524884|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
1524885|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
1524886|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
1524887|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
1524888|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
1524889|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
1524890|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
1524891|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
1524892|NCT00681954|TRALI|trali
1524893|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
1524894|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
1524895|NCT00681928|stage I breast cancer|stage i breast cancer
1524896|NCT00681928|stage II breast cancer|stage ii breast cancer
1524897|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
1524898|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
1524899|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
1524900|NCT00681915|Phase I|phase i
1524901|NCT00681915|Pharmacokinetics|pharmacokinetics
1524902|NCT00681902|Pediatric|pediatric
1524903|NCT00681902|Pain|pain
1524904|NCT00681902|Needle|needle
1524905|NCT00681902|Emergency|emergency
1524906|NCT00681902|Phlebotomy|phlebotomy
1524907|NCT00681902|Intravenous|intravenous
1524908|NCT00681902|Lidocaine|lidocaine
1524909|NCT00681902|Local|local
1524910|NCT00681902|Anesthesia|anesthesia
1524911|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
1524912|NCT00681876|Second line|second line
1524913|NCT00681876|Irinotecan|irinotecan
1524914|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
1524915|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
1524916|NCT00681850|Diabetes|diabetes
1524917|NCT00681850|Benchmarking|benchmarking
1524918|NCT00681850|quality of patient care|quality of patient care
1524919|NCT00681850|Diabetic Population|diabetic population
1524920|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
1524921|NCT00681837|prevalence|prevalence
1524922|NCT00681837|childhood|childhood
1524923|NCT00681837|France|france
1524924|NCT00681811|Metazyme|metazyme
1524925|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
1524926|NCT00681798|pancreatic cancer|pancreatic cancer
1524927|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1524928|NCT00681798|pancreas cancer|pancreas cancer
1524929|NCT00681798|dose escalation study|dose escalation study
1524930|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
1524931|NCT00681798|Zactima|zactima
1524932|NCT00681798|Vandetanib|vandetanib
1524933|NCT00681798|ZD6474|zd6474
1524934|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
1524935|NCT00681772|Erectile Dysfunction|erectile dysfunction
1524936|NCT00681772|Vardenafil|vardenafil
1524937|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
1524938|NCT00681759|Cardiovascular disease|cardiovascular disease
1524939|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
1524940|NCT00681746|Anxiety|anxiety
1524941|NCT00681746|GABA receptors|gaba receptors
1524942|NCT00681746|Positron Emission Tomography|positron emission tomography
1524943|NCT00681746|PET|pet
1524944|NCT00681746|phase I|phase i
1524945|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
1524946|NCT00681720|Anxiety|anxiety
1524947|NCT00681720|GABA receptors|gaba receptors
1524948|NCT00681720|Positron Emission Tomography|positron emission tomography
1524949|NCT00681720|PET|pet
1524950|NCT00681720|phase I|phase i
1524951|NCT00681707|Hypertension|hypertension
1524952|NCT00681707|Post stroke|post stroke
1524953|NCT00681707|JNC7|jnc7
1524954|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
1524955|NCT00681707|survey|survey
1524956|NCT00681694|brachytherapy|brachytherapy
1524957|NCT00681694|radioactive seed implants|radioactive seed implants
1524958|NCT00681681|stroke|stroke
1524959|NCT00681681|vascular marker|vascular marker
1524960|NCT00681681|stroke risk|stroke risk
1524961|NCT00681681|risk factors|risk factors
1524962|NCT00681681|sex differences|sex differences
1524963|NCT00681668|Postpartum Depression|postpartum depression
1524964|NCT00681668|Quetiapine|quetiapine
1524965|NCT00681668|Psychotic Symptoms|psychotic symptoms
1524966|NCT00681642|Corneal epithelial wound|corneal epithelial wound
1524967|NCT00681642|Human autoserum|human autoserum
1524968|NCT00681642|Cord blood|cord blood
1524969|NCT00681629|Schizophrenia|schizophrenia
1524970|NCT00681629|Integrated Care|integrated care
1524971|NCT00681629|Quetiapine|quetiapine
1524972|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
1524973|NCT00681616|Tibia|tibia
1524974|NCT00681616|Trauma|trauma
1524975|NCT00681616|Blood circulation|blood circulation
1524976|NCT00681616|Nerve compression syndromes|nerve compression syndromes
1524977|NCT00681603|corneal neovascularization|corneal neovascularization
1524978|NCT00681603|lipid keratopathy|lipid keratopathy
1524979|NCT00681603|penetrating keratopathy|penetrating keratopathy
1524980|NCT00681603|bevacizumab|bevacizumab
1524981|NCT00681603|Avastin|avastin
1524982|NCT00681603|subconjunctival injection|subconjunctival injection
1524983|NCT00681590|vitamin D|vitamin d
1524984|NCT00681590|deficiency|deficiency
1524985|NCT00681590|elderly|elderly
1524986|NCT00681577|Peptide Vaccine|peptide vaccine
1524987|NCT00681577|URLC10|urlc10
1524988|NCT00681577|KOC1|koc1
1524989|NCT00681577|VEGFR1|vegfr1
1524990|NCT00681577|VEGFR2|vegfr2
1524991|NCT00681564|Periodontitis|periodontitis
1524992|NCT00681564|Oral health|oral health
1524993|NCT00681564|Cardiovascular disease|cardiovascular disease
1524994|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
1524995|NCT00681551|Magnevist|magnevist
1524996|NCT00681551|Brain metastasis|brain metastasis
1524997|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
1524998|NCT00681538|Spasticity|spasticity
1524999|NCT00681538|Multiple Sclerosis|multiple sclerosis
1525000|NCT00681512|NSCLC|nsclc
1525001|NCT00681512|lung cancer|lung cancer
1525002|NCT00681512|non small cell lung cancer|non small cell lung cancer
1525003|NCT00681512|lung carcinoma|lung carcinoma
1525004|NCT00681499|Quality of Life|quality of life
1525005|NCT00681499|Liver Neoplasms|liver neoplasms
1525006|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
1525007|NCT00681486|Ghrelin|ghrelin
1525008|NCT00681486|Nutrition|nutrition
1525009|NCT00681486|Cancer patients|cancer patients
1525010|NCT00681486|Survival|survival
1525011|NCT00681473|proton radiation therapy|proton radiation therapy
1525012|NCT00681473|photon radiation therapy|photon radiation therapy
1525013|NCT00681460|gestational diabetes|gestational diabetes
1525014|NCT00681460|birth weight|birth weight
1525015|NCT00681460|fetal growth|fetal growth
1525016|NCT00681460|insulin resistance|insulin resistance
1525017|NCT00681460|oxidative stress|oxidative stress
1525018|NCT00681460|inflammatory reaction|inflammatory reaction
1525019|NCT00681460|Fetal Development|fetal development
1525020|NCT00681447|lumbar disc herniation|lumbar disc herniation
1525021|NCT00681447|discogenic pain|discogenic pain
1525022|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
1525023|NCT00681447|injections|injections
1525024|NCT00681434|stroke|stroke
1525025|NCT00681434|upper extremity|upper extremity
1525026|NCT00681434|hemiparesis|hemiparesis
1525027|NCT00681421|Peptide Vaccine|peptide vaccine
1525028|NCT00681421|URLC10|urlc10
1525029|NCT00681421|VEGFR1|vegfr1
1525030|NCT00681421|VEGFR2|vegfr2
1525031|NCT00681408|Steatohepatitis|steatohepatitis
1525032|NCT00681408|NASH|nash
1525033|NCT00681408|NAFLD|nafld
1525034|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
1525035|NCT00681408|Exercise conditioning|exercise conditioning
1525036|NCT00681382|Asthma|asthma
1525037|NCT00681382|use of asthma medication|use of asthma medication
1525038|NCT00681382|asthma control|asthma control
1525141|NCT00680979|Overweight|overweight
1525039|NCT00681382|telephone survey|telephone survey
1525040|NCT00681382|patient's perception|patient's perception
1525041|NCT00681369|breast cancer|breast cancer
1525042|NCT00681369|fulvestrant|fulvestrant
1525043|NCT00681369|longitudinal study|longitudinal study
1525044|NCT00681369|France|france
1525045|NCT00681356|TKA|tka
1525046|NCT00681356|Total knee arthroplasty|total knee arthroplasty
1525047|NCT00681356|Total knee replacement|total knee replacement
1525048|NCT00681356|Knee surgery|knee surgery
1525049|NCT00681343|Randomized|randomized
1525050|NCT00681343|study|study
1525051|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
1525052|NCT00681343|induction therapy|induction therapy
1525053|NCT00681343|recipients|recipients
1525054|NCT00681330|Peptide Vaccine|peptide vaccine
1525055|NCT00681330|URLC10|urlc10
1525056|NCT00681330|TTK|ttk
1525057|NCT00681330|KOC1|koc1
1525058|NCT00681317|Phase I|phase i
1525059|NCT00681317|Pharmacokinetics|pharmacokinetics
1525060|NCT00681304|Resected Breast Cancer|resected breast cancer
1525061|NCT00681304|Breast Cancer|breast cancer
1525062|NCT00681291|surgical mesh|surgical mesh
1525063|NCT00681291|inguinal hernia repair|inguinal hernia repair
1525064|NCT00681291|chronic groin pain|chronic groin pain
1525065|NCT00681278|Hypertension|hypertension
1525066|NCT00681278|Type II DM|type ii dm
1525067|NCT00681278|JNC7|jnc7
1525068|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
1525069|NCT00681278|survey|survey
1525070|NCT00681265|ocular lubricants|ocular lubricants
1525071|NCT00681252|Peptide Vaccine|peptide vaccine
1525072|NCT00681252|URLC10|urlc10
1525073|NCT00681252|VEGFR1|vegfr1
1525074|NCT00681252|VEGFR2|vegfr2
1525075|NCT00681239|childhood|childhood
1525076|NCT00681239|epilepsy|epilepsy
1525077|NCT00681239|intractable|intractable
1525078|NCT00681239|seizures|seizures
1525079|NCT00681239|Atkins|atkins
1525080|NCT00681239|ketogenic|ketogenic
1525081|NCT00681226|peripheral arterial disease|peripheral arterial disease
1525082|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1525083|NCT00681226|exercise|exercise
1525084|NCT00681200|Blood Pressure Reduction|blood pressure reduction
1525085|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
1525086|NCT00681200|Meditation|meditation
1525087|NCT00681200|Transcendental Meditation|transcendental meditation
1525088|NCT00681200|Stress Reduction|stress reduction
1525089|NCT00681200|Stress Management|stress management
1525090|NCT00681174|Care, Postoperative|care, postoperative
1525091|NCT00681174|Analgesia|analgesia
1525092|NCT00681174|Analgesics, Opioid|analgesics, opioid
1525093|NCT00681174|Morphine|morphine
1525094|NCT00681174|Remifentanil|remifentanil
1525095|NCT00681174|Oxycodone|oxycodone
1525096|NCT00681174|Anesthesia, Regional|anesthesia, regional
1525097|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
1525098|NCT00681174|Preanesthetic Medication|preanesthetic medication
1525099|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
1525100|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
1525101|NCT00681161|OSA|osa
1525102|NCT00681161|diabetes|diabetes
1525103|NCT00681161|pre-diabetic condition|pre-diabetic condition
1525104|NCT00681161|obesity|obesity
1525105|NCT00681161|blood glucose|blood glucose
1525106|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
1525107|NCT00681161|CPAP|cpap
1525108|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
1525109|NCT00681148|Prostate cancer|prostate cancer
1525110|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
1525111|NCT00681148|Radioactive seed implantation|radioactive seed implantation
1525112|NCT00681135|orthodontics|orthodontics
1525113|NCT00681135|toothbrush|toothbrush
1525114|NCT00681135|interdental brush|interdental brush
1525115|NCT00681135|oral hygiene|oral hygiene
1525116|NCT00681122|Breast Cancer|breast cancer
1525117|NCT00681122|hormone therapy|hormone therapy
1525118|NCT00681122|aromatase inhibitor|aromatase inhibitor
1525119|NCT00681096|Low back pain in nurses|low back pain in nurses
1525120|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
1525121|NCT00681083|Humidification|humidification
1525122|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
1525123|NCT00681070|laceration|laceration
1525124|NCT00681070|wound management|wound management
1525125|NCT00681070|absorbable sutures|absorbable sutures
1525126|NCT00681070|cosmetic outcomes|cosmetic outcomes
1525127|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
1525128|NCT00681044|light chain deposition disease|light chain deposition disease
1525129|NCT00681018|premature|premature
1525130|NCT00681018|infants|infants
1525131|NCT00681005|PPI test|ppi test
1525132|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
1525133|NCT00681005|CYP2C19|cyp2c19
1525134|NCT00681005|rabeprazole|rabeprazole
1525135|NCT00681005|pantoprazole|pantoprazole
1525136|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
1525137|NCT00680979|Prevention|prevention
1525138|NCT00680979|Obesity|obesity
1525139|NCT00680979|Binge Eating|binge eating
1525140|NCT00680979|Adolescents|adolescents
1525142|NCT00680979|Weight Gain|weight gain
1525143|NCT00680966|Treatment efficacy|treatment efficacy
1525144|NCT00680966|Family therapy|family therapy
1525145|NCT00680966|Teens|teens
1525146|NCT00680966|Substance abuse|substance abuse
1525147|NCT00680966|Substance dependence|substance dependence
1525148|NCT00680940|NSCLC|nsclc
1525149|NCT00680927|Atrial Fibrillation|atrial fibrillation
1525150|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
1525151|NCT00680927|Loop recorder|loop recorder
1525152|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
1525153|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1525154|NCT00680901|unresectable|unresectable
1525155|NCT00680901|HER2|her2
1525156|NCT00680901|TYVERB|tyverb
1525157|NCT00680901|ErbB2|erbb2
1525158|NCT00680901|TYKERB|tykerb
1525159|NCT00680901|capecitabine|capecitabine
1525160|NCT00680901|CapeOx|capeox
1525161|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
1525162|NCT00680901|GE junction|ge junction
1525163|NCT00680901|metastatic|metastatic
1525164|NCT00680901|lapatinib|lapatinib
1525165|NCT00680901|oxaliplatin|oxaliplatin
1525166|NCT00680888|Psychosis|psychosis
1525167|NCT00680888|adolescents|adolescents
1525168|NCT00680888|adherence|adherence
1525169|NCT00680888|quetiapine|quetiapine
1525170|NCT00680875|School Based Services|school based services
1525171|NCT00680875|Prevention|prevention
1525172|NCT00680875|Children|children
1525173|NCT00680862|HIV|hiv
1525174|NCT00680862|screening|screening
1525175|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1525176|NCT00680849|Coronary Disease|coronary disease
1525177|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
1525178|NCT00680836|Diarrhea|diarrhea
1525179|NCT00680836|Gulf War|gulf war
1525180|NCT00680836|Veterans|veterans
1525181|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
1525182|NCT00680823|Headache|headache
1525183|NCT00680823|Migraine|migraine
1525184|NCT00680823|Ropivacaine|ropivacaine
1525185|NCT00680797|Aging|aging
1525186|NCT00680797|Hormones|hormones
1525187|NCT00680797|Insulin resistance|insulin resistance
1525188|NCT00680784|sprain|sprain
1525189|NCT00680784|ankle|ankle
1525190|NCT00680784|pain|pain
1525191|NCT00680771|Primary Insomnia|primary insomnia
1525192|NCT00680771|Insomnia|insomnia
1525193|NCT00680771|Good Sleepers|good sleepers
1525194|NCT00680771|Hep B|hep b
1525195|NCT00680771|Vaccine|vaccine
1525196|NCT00680758|male breast cancer|male breast cancer
1525197|NCT00680758|stage IV breast cancer|stage iv breast cancer
1525198|NCT00680745|Dapagliflozin|dapagliflozin
1525199|NCT00680745|efficacy|efficacy
1525200|NCT00680745|safety|safety
1525201|NCT00680745|sulphonylurea|sulphonylurea
1525202|NCT00680745|Type 2 diabetes|type 2 diabetes
1525203|NCT00680732|Malaria|malaria
1525204|NCT00680732|Pregnancy|pregnancy
1525205|NCT00680732|Prevention|prevention
1525206|NCT00680732|Chloroquine|chloroquine
1525207|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
1525208|NCT00680732|Maternal anaemia|maternal anaemia
1525209|NCT00680732|Birth weight|birth weight
1525210|NCT00680732|Foetal anaemia|foetal anaemia
1525211|NCT00680719|substance abuse|substance abuse
1525212|NCT00680719|HIV risk|hiv risk
1525213|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
1525214|NCT00680719|HIV Seronegativity|hiv seronegativity
1525215|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
1525216|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
1525217|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
1525218|NCT00680667|stage I breast cancer|stage i breast cancer
1525219|NCT00680667|stage II breast cancer|stage ii breast cancer
1525220|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
1525221|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
1525222|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
1525223|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1525224|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1525225|NCT00680654|Pulmonary hypertension|pulmonary hypertension
1525226|NCT00680641|COPD|copd
1525227|NCT00680641|Emphysema|emphysema
1525228|NCT00680641|Simvastatin|simvastatin
1525229|NCT00680628|Pulmonary Embolism|pulmonary embolism
1525230|NCT00680628|Tenecteplase|tenecteplase
1525231|NCT00680628|Enoxaparin|enoxaparin
1525232|NCT00680628|Thrombosis|thrombosis
1525233|NCT00680628|Fibrinolytics|fibrinolytics
1525234|NCT00680615|Smokeless tobacco|smokeless tobacco
1525235|NCT00680602|behavior therapy|behavior therapy
1525236|NCT00680602|group therapy|group therapy
1525237|NCT00680602|psychopharmacology|psychopharmacology
1525238|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
1525239|NCT00680576|adolescent substance abuse|adolescent substance abuse
1525240|NCT00680550|Atrial Fibrillation|atrial fibrillation
1525241|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
1525242|NCT00680550|Loop recorder|loop recorder
1525243|NCT00680537|physical therapy program|physical therapy program
1525244|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
1525245|NCT00680511|methamphetamine abuse|methamphetamine abuse
1525246|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
1525247|NCT00680498|Ranibizumab|ranibizumab
1525248|NCT00680498|Lucentis|lucentis
1525455|NCT00679757|Sleep apnea|sleep apnea
1525249|NCT00680498|Photodynamic Therapy|photodynamic therapy
1525250|NCT00680498|Verteporfin|verteporfin
1525251|NCT00680498|Visudyne|visudyne
1525252|NCT00680485|GSK580416|gsk580416
1525253|NCT00680485|ketoconazole interaction|ketoconazole interaction
1525254|NCT00680485|pleuromutilin|pleuromutilin
1525255|NCT00680485|oral dose|oral dose
1525256|NCT00680472|Shoulder pain|shoulder pain
1525257|NCT00680472|Pain|pain
1525258|NCT00680472|Ketoprofen|ketoprofen
1525259|NCT00680472|Topical Patch|topical patch
1525260|NCT00680459|central line infection|central line infection
1525261|NCT00680459|70% ethanol|70% ethanol
1525262|NCT00680459|Sepsis|sepsis
1525263|NCT00680446|Primary Immune Deficiency|primary immune deficiency
1525264|NCT00680446|Subcutaneous|subcutaneous
1525265|NCT00680446|Immunoglobulin G|immunoglobulin g
1525266|NCT00680420|pancreas cancer|pancreas cancer
1525267|NCT00680420|pancreas cyst|pancreas cyst
1525268|NCT00680420|DNA microarray|dna microarray
1525269|NCT00680407|NASH|nash
1525270|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1525271|NCT00680394|abortion|abortion
1525272|NCT00680394|medical abortion|medical abortion
1525273|NCT00680394|mifepristone|mifepristone
1525274|NCT00680394|misoprostol|misoprostol
1525275|NCT00680381|adolescent substance abuse|adolescent substance abuse
1525276|NCT00680368|Feasibility|feasibility
1525277|NCT00680368|Supervision|supervision
1525278|NCT00680368|Assessing|assessing
1525279|NCT00680355|golden rice carotenoids|golden rice carotenoids
1525280|NCT00680355|healthy volunteers|healthy volunteers
1525281|NCT00680355|retinol equivalence|retinol equivalence
1525282|NCT00680342|hepatitis C|hepatitis c
1525283|NCT00680329|Adherence|adherence
1525284|NCT00680329|Compliance|compliance
1525285|NCT00680329|Glaucoma|glaucoma
1525286|NCT00680329|Ocular Hypertension|ocular hypertension
1525287|NCT00680316|Pulmozyme|pulmozyme
1525289|NCT00680303|Early Stuttering|early stuttering
1525290|NCT00680303|Lidcombe Program|lidcombe program
1525291|NCT00680303|Stuttering Treatment|stuttering treatment
1525292|NCT00680303|Efficiency|efficiency
1525293|NCT00680303|Efficacy|efficacy
1525294|NCT00680303|Service Delivery|service delivery
1525295|NCT00680303|Models of intervention|models of intervention
1525296|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
1525297|NCT00680277|spirulina|spirulina
1525298|NCT00680277|carotenoids|carotenoids
1525299|NCT00680264|Treatment Outcomes|treatment outcomes
1525300|NCT00680264|Scoliosis|scoliosis
1525301|NCT00680264|Cerebral Palsy|cerebral palsy
1525302|NCT00680238|Pregnancy|pregnancy
1525303|NCT00680238|implantation|implantation
1525304|NCT00680238|miscarriage|miscarriage
1525305|NCT00680238|sHLA-G|shla-g
1525306|NCT00680225|Choroidal melanoma|choroidal melanoma
1525307|NCT00680225|Lucentis|lucentis
1525308|NCT00680225|TTT-ICG|ttt-icg
1525309|NCT00680212|dietary beta-carotene|dietary beta-carotene
1525310|NCT00680212|vitamin A status|vitamin a status
1525311|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
1525312|NCT00680199|Insomnia|insomnia
1525313|NCT00680199|Primary Insomnia|primary insomnia
1525314|NCT00680199|Good Sleepers|good sleepers
1525316|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
1525317|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
1525318|NCT00680173|Sustained virological response|sustained virological response
1525319|NCT00680173|Peginterferon|peginterferon
1525320|NCT00680173|Ribavirin|ribavirin
1525321|NCT00680160|Onychomycosis|onychomycosis
1525322|NCT00680160|Fungal Nail|fungal nail
1525323|NCT00680147|HPV|hpv
1525324|NCT00680147|Gardasil|gardasil
1525325|NCT00680147|African-American|african-american
1525326|NCT00680147|adolescent|adolescent
1525327|NCT00680147|health behavior|health behavior
1525328|NCT00680147|sexually transmitted infections|sexually transmitted infections
1525329|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
1525330|NCT00680134|Onychomycosis|onychomycosis
1525331|NCT00680134|Fungal Nail|fungal nail
1525332|NCT00680121|Alcoholism|alcoholism
1525333|NCT00680121|Benfotiamine|benfotiamine
1525334|NCT00680121|Thiamine|thiamine
1525335|NCT00680095|Onychomycosis|onychomycosis
1525336|NCT00680095|Fungal Nail|fungal nail
1525337|NCT00680082|statins|statins
1525338|NCT00680082|rosuvastatin|rosuvastatin
1525339|NCT00680082|cross sectional study|cross sectional study
1525340|NCT00680082|France|france
1525341|NCT00680082|CV risk factors|cv risk factors
1525342|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
1525343|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1525344|NCT00680056|Tiotropium|tiotropium
1525345|NCT00680056|Formoterol|formoterol
1525346|NCT00680056|Bronchodilator Agents|bronchodilator agents
1525347|NCT00680056|Exercise Tolerance|exercise tolerance
1525348|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
1525349|NCT00680056|COPD|copd
1525350|NCT00680043|anemia|anemia
1525854|NCT00678145|Diabetes|diabetes
1525351|NCT00680043|chronic kidney disease|chronic kidney disease
1525352|NCT00680043|CKD|ckd
1525353|NCT00680043|chronic renal failure|chronic renal failure
1525354|NCT00680043|CRF|crf
1525355|NCT00680043|erythropoietin|erythropoietin
1525356|NCT00680043|EPO|epo
1525357|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1525358|NCT00680043|ESA|esa
1525359|NCT00680043|Hematide™|hematide™
1525360|NCT00680043|hemoglobin|hemoglobin
1525361|NCT00680043|Hb|hb
1525362|NCT00680043|Hgb|hgb
1525363|NCT00680043|Omontys|omontys
1525364|NCT00680043|peginesatide|peginesatide
1525365|NCT00680043|red blood cell|red blood cell
1525366|NCT00680043|red blood cell production|red blood cell production
1525367|NCT00680030|impedance|impedance
1525368|NCT00680030|manometry|manometry
1525369|NCT00680030|motility disorders|motility disorders
1525370|NCT00680030|ineffective motility|ineffective motility
1525371|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
1525372|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
1525373|NCT00680017|Dyslipidemia|dyslipidemia
1525374|NCT00680017|Kidney Disease|kidney disease
1525375|NCT00680004|Dynamic CTA|dynamic cta
1525376|NCT00680004|follow-up|follow-up
1525377|NCT00680004|EVAR|evar
1525378|NCT00679991|arteriovenous fistula|arteriovenous fistula
1525379|NCT00679991|AVF|avf
1525380|NCT00679991|hemodialysis|hemodialysis
1525381|NCT00679991|vascular access|vascular access
1525382|NCT00679991|PRT 201|prt 201
1525383|NCT00679991|dose escalation|dose escalation
1525384|NCT00679991|dialysis|dialysis
1525385|NCT00679991|fistula|fistula
1525386|NCT00679991|access|access
1525387|NCT00679991|vonapanitase|vonapanitase
1525388|NCT00679991|kidney|kidney
1525389|NCT00679991|renal|renal
1525390|NCT00679978|osteoporosis|osteoporosis
1525391|NCT00679978|glucocorticoid|glucocorticoid
1525392|NCT00679978|bone mineral density|bone mineral density
1525393|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
1525394|NCT00679965|Onychomycosis|onychomycosis
1525395|NCT00679965|Fungal Nail|fungal nail
1525396|NCT00679952|Pancreatic fistula|pancreatic fistula
1525397|NCT00679952|Pancreatic duct stent|pancreatic duct stent
1525398|NCT00679952|Closed suction drainage|closed suction drainage
1525399|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
1525400|NCT00679939|bone|bone
1525401|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
1525402|NCT00679939|bone biomarkers|bone biomarkers
1525403|NCT00679939|dual-energy|dual-energy
1525404|NCT00679939|bone mineral density|bone mineral density
1525405|NCT00679926|HIV|hiv
1525406|NCT00679926|AIDS|aids
1525407|NCT00679926|HIV/AIDS|hiv/aids
1525408|NCT00679926|Treatment Naive|treatment naive
1525409|NCT00679913|Pancreatic cancer|pancreatic cancer
1525410|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
1525411|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
1525412|NCT00679900|Primary Insomnia|primary insomnia
1525413|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
1525414|NCT00679887|chiropractic|chiropractic
1525415|NCT00679887|myofascial trigger points|myofascial trigger points
1525416|NCT00679887|ischemic compression|ischemic compression
1525417|NCT00679887|shoulder pain|shoulder pain
1525418|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
1525419|NCT00679874|Cardiotoxicity|cardiotoxicity
1525420|NCT00679874|Anthracyclines|anthracyclines
1525421|NCT00679874|Trastuzumab|trastuzumab
1525422|NCT00679874|Breast cancer|breast cancer
1525423|NCT00679874|Toxicity|toxicity
1525424|NCT00679861|primary medical care|primary medical care
1525425|NCT00679861|computer expert system|computer expert system
1525426|NCT00679861|motivational interviewing|motivational interviewing
1525427|NCT00679861|health behavior change counselling|health behavior change counselling
1525428|NCT00679861|stages of change|stages of change
1525429|NCT00679848|Weight Loss|weight loss
1525430|NCT00679848|Transoral Suturing|transoral suturing
1525431|NCT00679848|Experimental|experimental
1525432|NCT00679822|OSA|osa
1525433|NCT00679822|sleep apnea|sleep apnea
1525434|NCT00679822|heart failure|heart failure
1525435|NCT00679822|CHF|chf
1525436|NCT00679822|heart clinic|heart clinic
1525437|NCT00679822|clinic|clinic
1525438|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
1525439|NCT00679809|Resident|resident
1525440|NCT00679809|Safety|safety
1525441|NCT00679809|Fatigue|fatigue
1525442|NCT00679809|Continuity|continuity
1525443|NCT00679809|ICU|icu
1525444|NCT00679796|varicella|varicella
1525445|NCT00679796|case-control|case-control
1525446|NCT00679783|Breast cancer|breast cancer
1525447|NCT00679783|Ovarian cancer|ovarian cancer
1525448|NCT00679783|BRCA|brca
1525449|NCT00679783|Triple negative|triple negative
1525550|NCT00679341|TDM-1|tdm-1
1525450|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1525451|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
1525452|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
1525453|NCT00679770|Onychomycosis|onychomycosis
1525456|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
1525457|NCT00679757|Wound healing|wound healing
1525458|NCT00679757|Non-healing wounds|non-healing wounds
1525459|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
1525460|NCT00679744|Sandhoff disease.|sandhoff disease.
1525461|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
1525462|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
1525463|NCT00679744|Hexosaminidase|hexosaminidase
1525464|NCT00679744|Phase I clinical trial.|phase i clinical trial.
1525465|NCT00679731|Psoriasis|psoriasis
1525466|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
1525467|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
1525468|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
1525469|NCT00679679|Treatment|treatment
1525470|NCT00679679|Metformin|metformin
1525471|NCT00679666|keratoconus|keratoconus
1525472|NCT00679666|ectasia|ectasia
1525473|NCT00679666|cross-linking|cross-linking
1525474|NCT00679666|riboflavin|riboflavin
1525475|NCT00679666|UVA light|uva light
1525476|NCT00679666|cornea|cornea
1525477|NCT00679640|candesartan|candesartan
1525478|NCT00679640|heart failure|heart failure
1525479|NCT00679640|cohort study|cohort study
1525480|NCT00679640|France|france
1525481|NCT00679627|Alzheimer's Disease|alzheimer's disease
1525482|NCT00679627|Galantamine|galantamine
1525483|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
1525484|NCT00679627|Memory loss|memory loss
1525485|NCT00679614|Tramacet|tramacet
1525486|NCT00679614|naloxone|naloxone
1525487|NCT00679614|morphine|morphine
1525488|NCT00679614|analgesia|analgesia
1525489|NCT00679614|elderly|elderly
1525490|NCT00679614|elderly patients|elderly patients
1525491|NCT00679601|Onychomycosis|onychomycosis
1525492|NCT00679601|Fungal Nail|fungal nail
1525493|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
1525494|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
1525495|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
1525496|NCT00679588|Abdominal surgery|abdominal surgery
1525497|NCT00679575|statins|statins
1525498|NCT00679575|myocardial infarction|myocardial infarction
1525499|NCT00679575|case-referent study|case-referent study
1525500|NCT00679575|France|france
1525501|NCT00679549|Heart Failure|heart failure
1525502|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
1525504|NCT00679549|CHF|chf
1525505|NCT00679549|Sleep apnea|sleep apnea
1525506|NCT00679549|CHD|chd
1525507|NCT00679536|Reduced Toxicity|reduced toxicity
1525508|NCT00679536|Toxicity|toxicity
1525509|NCT00679536|Event Free Survival|event free survival
1525510|NCT00679536|Graft vs Host Disease|graft vs host disease
1525511|NCT00679523|Onychomycosis|onychomycosis
1525512|NCT00679523|Fungal Nail|fungal nail
1525513|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
1525514|NCT00679510|Rosuvastatin|rosuvastatin
1525515|NCT00679510|Cardiovascular|cardiovascular
1525516|NCT00679510|Intima media thickness|intima media thickness
1525517|NCT00679497|Low risk HIV infection|low risk hiv infection
1525518|NCT00679497|HIV Seronegativity|hiv seronegativity
1525519|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
1525520|NCT00679471|pre-term infants|pre-term infants
1525521|NCT00679471|full-term infants|full-term infants
1525522|NCT00679471|MRI|mri
1525523|NCT00679471|brain structure development|brain structure development
1525524|NCT00679471|pre term|pre term
1525525|NCT00679471|full term|full term
1525526|NCT00679458|analgesia|analgesia
1525527|NCT00679458|pain|pain
1525528|NCT00679458|buprenorphine|buprenorphine
1525529|NCT00679458|opioid|opioid
1525530|NCT00679458|naloxone|naloxone
1525531|NCT00679445|Macular|macular
1525532|NCT00679445|Degeneration|degeneration
1525533|NCT00679445|AMD|amd
1525534|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
1525535|NCT00679432|Ulcerative colitis|ulcerative colitis
1525536|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
1525537|NCT00679393|Calcaneus|calcaneus
1525538|NCT00679393|Intra-articular fracture|intra-articular fracture
1525539|NCT00679393|open reduction internal fixation|open reduction internal fixation
1525540|NCT00679393|primary subtalar fusion|primary subtalar fusion
1525541|NCT00679380|Ulcerative colitis|ulcerative colitis
1525542|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
1525543|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
1525544|NCT00679341|HER2|her2
1525545|NCT00679341|Herceptin|herceptin
1525546|NCT00679341|Taxotere|taxotere
1525547|NCT00679341|MBC|mbc
1525548|NCT00679341|Breast cancer|breast cancer
1525549|NCT00679341|TDM1|tdm1
1525551|NCT00679341|HER2-positive|her2-positive
1525553|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
1525554|NCT00679341|HER2+ breast cancer|her2+ breast cancer
1525555|NCT00679341|Armed Herceptin|armed herceptin
1525556|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
1525557|NCT00679341|Trastuzumab DM1|trastuzumab dm1
1525558|NCT00679315|female voiding dysfunction|female voiding dysfunction
1525559|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
1525560|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
1525561|NCT00679302|skin abscess|skin abscess
1525562|NCT00679302|CA-MRSA|ca-mrsa
1525563|NCT00679289|KW2871|kw2871
1525564|NCT00679289|Ecromeximab|ecromeximab
1525565|NCT00679289|Anti-ganglioside|anti-ganglioside
1525566|NCT00679289|Antibody|antibody
1525567|NCT00679289|Interferon alpha|interferon alpha
1525568|NCT00679289|Metastatic melanoma|metastatic melanoma
1525569|NCT00679276|vaginal prolapse|vaginal prolapse
1525570|NCT00679263|asthma|asthma
1525571|NCT00679263|randomized|randomized
1525572|NCT00679263|placebo controlled|placebo controlled
1525573|NCT00679263|dose escalation|dose escalation
1525574|NCT00679263|safety|safety
1525575|NCT00679263|efficacy|efficacy
1525576|NCT00679263|single blind|single blind
1525577|NCT00679263|MN-221|mn-221
1525578|NCT00679250|allergic rhinitis|allergic rhinitis
1525579|NCT00679250|levocetirizine|levocetirizine
1525580|NCT00679250|nasal provocation testing|nasal provocation testing
1525581|NCT00679250|nasal allergen challenge|nasal allergen challenge
1525582|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
1525583|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
1525584|NCT00679224|observational safety|observational safety
1525585|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
1525586|NCT00679211|HER2|her2
1525587|NCT00679211|MBC|mbc
1525588|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
1525589|NCT00679198|osteoporosis|osteoporosis
1525590|NCT00679198|fracture|fracture
1525591|NCT00679198|communication|communication
1525592|NCT00679198|prescription medication|prescription medication
1525593|NCT00679185|fatigue|fatigue
1525594|NCT00679185|stage I breast cancer|stage i breast cancer
1525595|NCT00679185|stage II breast cancer|stage ii breast cancer
1525596|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
1525597|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
1525598|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
1525599|NCT00679185|lymphedema|lymphedema
1525600|NCT00679133|c-Met|c-met
1525601|NCT00679133|VEGFR|vegfr
1525602|NCT00679133|Ron|ron
1525603|NCT00679133|Cancer|cancer
1525604|NCT00679133|Tumor|tumor
1525605|NCT00679133|Safety|safety
1525606|NCT00679133|Phase 1|phase 1
1525607|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
1525608|NCT00679120|RSA|rsa
1525609|NCT00679120|Bone-remodelling|bone-remodelling
1525610|NCT00679107|Degenerative Disc Disease|degenerative disc disease
1525611|NCT00679068|respiratory mechanics|respiratory mechanics
1525612|NCT00679068|bosentan|bosentan
1525613|NCT00679068|exercise capacity|exercise capacity
1525614|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
1525615|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1525616|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
1525617|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
1525618|NCT00679003|Crohn's disease|crohn's disease
1525619|NCT00679003|Ulcerative colitis|ulcerative colitis
1525620|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
1525621|NCT00679003|Illness behavior|illness behavior
1525622|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
1525623|NCT00678990|Islets of Langerhans|islets of langerhans
1525624|NCT00678990|islets|islets
1525625|NCT00678990|heparin|heparin
1525626|NCT00678977|pharmacokinetics|pharmacokinetics
1525627|NCT00678977|cisplatin|cisplatin
1525628|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
1525629|NCT00678977|Solid tumors|solid tumors
1525630|NCT00678977|anti-angiogenesis|anti-angiogenesis
1525631|NCT00678977|gemcitabine|gemcitabine
1525632|NCT00678964|NSCLC|nsclc
1525633|NCT00678964|Elderly patients|elderly patients
1525634|NCT00678938|smoking reduction|smoking reduction
1525635|NCT00678938|smoking cessation|smoking cessation
1525636|NCT00678938|stages of change|stages of change
1525637|NCT00678938|expert system interventions|expert system interventions
1525638|NCT00678912|mechanical ventilation|mechanical ventilation
1525639|NCT00678912|automated weaning|automated weaning
1525640|NCT00678912|children|children
1525641|NCT00678899|High frequency severe to profound|high frequency severe to profound
1525642|NCT00678886|Type 1 diabetes|type 1 diabetes
1525643|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
1525644|NCT00678886|T1DM|t1dm
1525645|NCT00678886|Type l diabetes|type l diabetes
1525646|NCT00678886|juvenile diabetes|juvenile diabetes
1525647|NCT00678873|Single Incision|single incision
1525648|NCT00678873|Single Access|single access
1525649|NCT00678873|Surgery|surgery
1525650|NCT00678873|Cholecystectomy|cholecystectomy
1525651|NCT00678860|Questionnaire|questionnaire
1525652|NCT00678860|Computer Assisted Interface|computer assisted interface
1525653|NCT00678860|Quality of Life|quality of life
1525654|NCT00678860|Dry Eye|dry eye
1525655|NCT00678860|Ocular Surface Disease|ocular surface disease
1525656|NCT00678860|Healthy Volunteer|healthy volunteer
1525657|NCT00678860|HV|hv
1525658|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
1525659|NCT00678847|chronic venous ulcers|chronic venous ulcers
1525660|NCT00678847|microcurrent|microcurrent
1525661|NCT00678847|chronic wounds|chronic wounds
1525662|NCT00678847|complete healing|complete healing
1525663|NCT00678821|Exercise|exercise
1525664|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
1525665|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
1525666|NCT00678821|Interstitial Lung Disease|interstitial lung disease
1525667|NCT00678795|Detrusor overactivity|detrusor overactivity
1525668|NCT00678795|Multiple Sclerosis|multiple sclerosis
1525669|NCT00678782|knee|knee
1525670|NCT00678782|synovitis|synovitis
1525671|NCT00678782|arthritis|arthritis
1525672|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
1525673|NCT00678782|psoriatic arthritis|psoriatic arthritis
1525674|NCT00678782|spondyloarthropathies|spondyloarthropathies
1525675|NCT00678782|intraarticular|intraarticular
1525676|NCT00678782|etanercept|etanercept
1525677|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
1525678|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
1525679|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
1525680|NCT00678756|local PASI, Nizoral|local pasi, nizoral
1525681|NCT00678743|cholesterol|cholesterol
1525682|NCT00678743|dyslipidemia|dyslipidemia
1525683|NCT00678743|omega 3|omega 3
1525684|NCT00678730|THC|thc
1525685|NCT00678730|COMT gene polymorphism|comt gene polymorphism
1525686|NCT00678730|schizophrenia|schizophrenia
1525687|NCT00678730|cannabis use|cannabis use
1525688|NCT00678717|abdominal|abdominal
1525689|NCT00678717|Pelvic|pelvic
1525690|NCT00678717|Pain|pain
1525691|NCT00678717|SCS|scs
1525692|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
1525693|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
1525694|NCT00678704|Vardenafil|vardenafil
1525695|NCT00678704|PDE5 inhibitor|pde5 inhibitor
1525696|NCT00678704|Erectile Dysfunction|erectile dysfunction
1525697|NCT00678704|Diabetes Mellitus|diabetes mellitus
1525698|NCT00678704|Sexual Dysfunction|sexual dysfunction
1525699|NCT00678691|fibromyalgia|fibromyalgia
1525700|NCT00678691|fatigue|fatigue
1525701|NCT00678678|Physiotherapy|physiotherapy
1525702|NCT00678678|Breathing exercises|breathing exercises
1525703|NCT00678678|Bariatric Surgery|bariatric surgery
1525704|NCT00678678|Laparoscopy|laparoscopy
1525705|NCT00678665|ecg|ecg
1525706|NCT00678665|TSA2000|tsa2000
1525707|NCT00678665|Heart rate variability|heart rate variability
1525708|NCT00678665|wavelets|wavelets
1525709|NCT00678652|Meningococcal vaccine|meningococcal vaccine
1525710|NCT00678652|Neisseria meningitidis|neisseria meningitidis
1525711|NCT00678639|ACS|acs
1525712|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
1525713|NCT00678639|Chest pain|chest pain
1525714|NCT00678639|Cardiac MRI|cardiac mri
1525715|NCT00678639|CMR|cmr
1525716|NCT00678639|Risk Stratification|risk stratification
1525717|NCT00678639|Emergency Department|emergency department
1525967|NCT00677716|brain cancer|brain cancer
1525718|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
1525719|NCT00678613|probiotics|probiotics
1525720|NCT00678613|cirrhosis|cirrhosis
1525721|NCT00678613|prophylaxis|prophylaxis
1525722|NCT00678613|cirrhotic|cirrhotic
1525723|NCT00678613|patients|patients
1525724|NCT00678613|with|with
1525725|NCT00678613|ascites|ascites
1525726|NCT00678613|using|using
1525727|NCT00678600|Informatics|informatics
1525728|NCT00678600|Alerts|alerts
1525729|NCT00678600|Toxicity|toxicity
1525730|NCT00678600|Virologic failure|virologic failure
1525731|NCT00678600|Suboptimal follow up|suboptimal follow up
1525732|NCT00678587|elective invasive procedure.|elective invasive procedure.
1525733|NCT00678587|platelet transfusion|platelet transfusion
1525734|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
1525735|NCT00678587|platelets|platelets
1525736|NCT00678587|thrombopoietin|thrombopoietin
1525737|NCT00678574|hormones|hormones
1525738|NCT00678574|menses|menses
1525739|NCT00678574|PMS|pms
1525740|NCT00678574|PMDD|pmdd
1525741|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
1525742|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
1525743|NCT00678535|Cetuximab|cetuximab
1525744|NCT00678535|Capecitabine|capecitabine
1525745|NCT00678535|Xeloda|xeloda
1525746|NCT00678535|Cisplatin|cisplatin
1525747|NCT00678535|Progression-free survival|progression-free survival
1525748|NCT00678522|Atorvastatin|atorvastatin
1525749|NCT00678522|Renal function|renal function
1525750|NCT00678522|Hemodynamics|hemodynamics
1525751|NCT00678522|Diabetes type II|diabetes type ii
1525752|NCT00678522|sodium excretion|sodium excretion
1525753|NCT00678509|HLA-A*2402|hla-a*2402
1525754|NCT00678509|Peptide Vaccine|peptide vaccine
1525756|NCT00678496|CBT-software|cbt-software
1525757|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
1525758|NCT00678496|CCBT|ccbt
1525759|NCT00678496|Cognitive Therapy|cognitive therapy
1525760|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
1525761|NCT00678496|Depression|depression
1525762|NCT00678496|Multiple Sclerosis|multiple sclerosis
1525763|NCT00678483|Cholesterol|cholesterol
1525764|NCT00678483|HDL|hdl
1525765|NCT00678483|triglycerides|triglycerides
1525766|NCT00678483|insulin|insulin
1525767|NCT00678483|blood glucose|blood glucose
1525768|NCT00678457|alcohol dependence|alcohol dependence
1525769|NCT00678457|alcohol abuse|alcohol abuse
1525770|NCT00678457|drinking|drinking
1525771|NCT00678457|alcohol|alcohol
1525772|NCT00678444|Anxiety|anxiety
1525773|NCT00678444|Satisfaction|satisfaction
1525774|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
1525775|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
1525776|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
1525777|NCT00678431|Alzheimer's Disease|alzheimer's disease
1525778|NCT00678431|Dementia|dementia
1525779|NCT00678431|Nutritional Supplement|nutritional supplement
1525780|NCT00678431|Resveratrol|resveratrol
1525781|NCT00678418|Addiction|addiction
1525782|NCT00678418|Opiate dependence|opiate dependence
1525783|NCT00678418|Inpatient detoxification|inpatient detoxification
1525784|NCT00678418|opioid dependence|opioid dependence
1525785|NCT00678418|heroin dependence|heroin dependence
1525786|NCT00678405|Breathlessness|breathlessness
1525787|NCT00678405|Dyspnoea|dyspnoea
1525788|NCT00678405|Dyspnea|dyspnea
1525789|NCT00678405|Palliative care|palliative care
1525790|NCT00678405|RCT|rct
1525791|NCT00678405|Randomised controlled trial|randomised controlled trial
1525792|NCT00678405|Lung cancer|lung cancer
1525793|NCT00678405|COPD|copd
1525794|NCT00678405|Heart failure|heart failure
1525795|NCT00678405|Chronic respiratory disease|chronic respiratory disease
1525796|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
1525797|NCT00678379|Tonsillectomy|tonsillectomy
1525798|NCT00678379|Postoperative Pain|postoperative pain
1525799|NCT00678379|Clonidine|clonidine
1525800|NCT00678379|Anesthetics, Local|anesthetics, local
1525801|NCT00678366|laparoscopy|laparoscopy
1525802|NCT00678366|carbon dioxide|carbon dioxide
1525803|NCT00678366|oxygen|oxygen
1525804|NCT00678366|pain|pain
1525805|NCT00678366|inflammation|inflammation
1525806|NCT00678353|Degenerative disc disease|degenerative disc disease
1525807|NCT00678340|Randomized Controlled Trial|randomized controlled trial
1525808|NCT00678340|Single-Blind Study|single-blind study
1525809|NCT00678340|Catheter Ablation|catheter ablation
1525810|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1525811|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1525812|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1525813|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1525814|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1525815|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1525816|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1525817|NCT00678314|Anesthetics|anesthetics
1525818|NCT00678314|Local|local
1525819|NCT00678314|ropivacaine|ropivacaine
1525820|NCT00678314|Surgery|surgery
1525821|NCT00678314|Hand|hand
1525822|NCT00678314|carpel tunnel|carpel tunnel
1525823|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
1525824|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1525825|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
1525826|NCT00678288|Renal Cell Cancer|renal cell cancer
1525827|NCT00678288|Interferon|interferon
1525828|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1525829|NCT00678262|pain|pain
1525830|NCT00678262|ECG|ecg
1525831|NCT00678262|Heart rate variability|heart rate variability
1525832|NCT00678262|wavelets|wavelets
1525833|NCT00678249|Hemodialysis|hemodialysis
1525834|NCT00678249|Vascular Prosthesis|vascular prosthesis
1525835|NCT00678249|stenoses|stenoses
1525836|NCT00678249|grafts|grafts
1525837|NCT00678236|RSA|rsa
1525838|NCT00678236|Gonarthritis|gonarthritis
1525839|NCT00678236|Bone Cement|bone cement
1525968|NCT00677716|Cotara|cotara
1525969|NCT00677716|radioactive isotope|radioactive isotope
1525840|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
1525841|NCT00678197|Quality of care|quality of care
1525842|NCT00678197|Access to care|access to care
1525843|NCT00678197|Health Outcomes|health outcomes
1525844|NCT00678184|Atorvastatin|atorvastatin
1525845|NCT00678184|healthy|healthy
1525846|NCT00678184|sodium excretion|sodium excretion
1525847|NCT00678184|hemodynamics|hemodynamics
1525848|NCT00678184|tubular function|tubular function
1525849|NCT00678171|Degenerative Disc Disease|degenerative disc disease
1525850|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
1525851|NCT00678158|Bone|bone
1525852|NCT00678158|Lymph Nodes|lymph nodes
1525853|NCT00678158|Soft Tissue|soft tissue
1525855|NCT00678145|Hypoglycemia|hypoglycemia
1525856|NCT00678145|HAAF|haaf
1525857|NCT00678145|Counterregulation|counterregulation
1525858|NCT00678132|PARP Inhibitor|parp inhibitor
1525859|NCT00678132|Combination Study|combination study
1525860|NCT00678132|Chemotherapy|chemotherapy
1525861|NCT00678132|Advanced Cancer|advanced cancer
1525862|NCT00678132|Neoplasms|neoplasms
1525863|NCT00678132|Cancer|cancer
1525864|NCT00678132|Solid Tumor|solid tumor
1525865|NCT00678119|Kidney cancer|kidney cancer
1525866|NCT00678119|Renal cancer|renal cancer
1525867|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
1525868|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
1525869|NCT00678093|Low back pain|low back pain
1525870|NCT00678093|Manual therapy|manual therapy
1525871|NCT00678093|Mulligan snag|mulligan snag
1525872|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
1525873|NCT00678080|Pregnancy|pregnancy
1525874|NCT00678080|Metformin|metformin
1525875|NCT00678080|Insulin|insulin
1525876|NCT00678080|Pregnant women|pregnant women
1525877|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
1525878|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
1525879|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
1525880|NCT00678067|Blood lipid profile|blood lipid profile
1525881|NCT00678041|urinary catheterization|urinary catheterization
1525882|NCT00678041|urinary tract infection|urinary tract infection
1525883|NCT00678041|urinary incontinence|urinary incontinence
1525884|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
1525885|NCT00678041|antibiotics|antibiotics
1525886|NCT00678028|MBL, UTI|mbl, uti
1525887|NCT00678015|NDGA|ndga
1525888|NCT00678015|Prostate Cancer|prostate cancer
1525889|NCT00678002|solid organ transplant|solid organ transplant
1525890|NCT00677989|perforated appendicitis|perforated appendicitis
1525891|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
1525892|NCT00677989|open appendectomy|open appendectomy
1525893|NCT00677989|cytokines|cytokines
1525894|NCT00677989|free radicals|free radicals
1525895|NCT00677989|oxidized proteins|oxidized proteins
1525896|NCT00677976|fMRI|fmri
1525897|NCT00677976|IBS|ibs
1525898|NCT00677976|Brain Activation|brain activation
1525899|NCT00677963|carotid|carotid
1525900|NCT00677963|atherosclerosis|atherosclerosis
1525901|NCT00677963|arteriosclerosis|arteriosclerosis
1525902|NCT00677963|plaque|plaque
1525903|NCT00677963|neovascularization|neovascularization
1525904|NCT00677963|carotid endarterectomy|carotid endarterectomy
1525905|NCT00677950|Degenerative Disc Disease|degenerative disc disease
1525906|NCT00677937|diabetes mellitus|diabetes mellitus
1525907|NCT00677937|prevention|prevention
1525908|NCT00677937|education|education
1525909|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
1525910|NCT00677937|multi-ethnic|multi-ethnic
1525911|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
1525912|NCT00677924|Colorectal Tumors|colorectal tumors
1525913|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
1525914|NCT00677911|Chronic pain|chronic pain
1525915|NCT00677911|Interleukin-6|interleukin-6
1525916|NCT00677911|pain catastrophizing|pain catastrophizing
1525917|NCT00677911|cytokines|cytokines
1525918|NCT00677911|cortisol|cortisol
1525919|NCT00677898|Patient-Centered Care|patient-centered care
1525920|NCT00677898|Adverse effects|adverse effects
1525921|NCT00677898|Antipsychotics|antipsychotics
1525922|NCT00677885|Alzheimer Disease|alzheimer disease
1525923|NCT00677885|Parkinson's Disease|parkinson's disease
1525924|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
1525925|NCT00677885|PET Imaging|pet imaging
1525927|NCT00677885|Parkinson Disease|parkinson disease
1525928|NCT00677885|PD|pd
1525929|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
1525930|NCT00677859|Leukemia|leukemia
1525931|NCT00677859|Graft vs. Host Disease|graft vs. host disease
1525932|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1525933|NCT00677859|Bone Marrow Transplant|bone marrow transplant
1525934|NCT00677859|Myelodysplasia|myelodysplasia
1525935|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
1525936|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
1525937|NCT00677833|drug treatment|drug treatment
1525938|NCT00677833|clinical trial|clinical trial
1525939|NCT00677820|Influenza|influenza
1525940|NCT00677820|FluMist|flumist
1525941|NCT00677820|vaccine|vaccine
1525942|NCT00677820|prevention|prevention
1525943|NCT00677820|trivalent|trivalent
1525944|NCT00677807|COPD|copd
1525945|NCT00677807|adults|adults
1525946|NCT00677807|β2-agonist|β2-agonist
1525947|NCT00677807|indacaterol|indacaterol
1525948|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
1525949|NCT00677794|Small Bowel|small bowel
1525950|NCT00677768|Biomarkers|biomarkers
1525951|NCT00677768|Plasma|plasma
1525952|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
1525953|NCT00677768|DNA|dna
1525954|NCT00677768|Serum|serum
1525955|NCT00677755|Medical abortion|medical abortion
1525956|NCT00677755|emergency contraception|emergency contraception
1525957|NCT00677755|mifepristone|mifepristone
1525958|NCT00677742|oral contraception|oral contraception
1525959|NCT00677742|hormonal contraception|hormonal contraception
1525960|NCT00677742|contraceptive behavior|contraceptive behavior
1525961|NCT00677742|patient compliance|patient compliance
1525962|NCT00677729|bronchiolitis|bronchiolitis
1525963|NCT00677729|hypertonic saline|hypertonic saline
1525964|NCT00677729|infants|infants
1525965|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
1525966|NCT00677716|GBM|gbm
1525970|NCT00677716|monoclonal antibody|monoclonal antibody
1525971|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
1525972|NCT00677703|birth control pills|birth control pills
1525973|NCT00677703|contraception|contraception
1525974|NCT00677703|continuation|continuation
1525975|NCT00677703|text messaging|text messaging
1525976|NCT00677703|contraceptive continuation|contraceptive continuation
1525977|NCT00677703|contraceptive knowledge|contraceptive knowledge
1525978|NCT00677690|COPD|copd
1525979|NCT00677677|Lung transplant|lung transplant
1525980|NCT00677677|Liver transplant|liver transplant
1525981|NCT00677677|Kidney transplant|kidney transplant
1525982|NCT00677677|Pancreas transplant|pancreas transplant
1525983|NCT00677677|HPV|hpv
1525984|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
1525985|NCT00677664|diabetic retinopathy|diabetic retinopathy
1525986|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
1525987|NCT00677664|copaxone|copaxone
1525988|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
1525989|NCT00677664|retinal function|retinal function
1525990|NCT00677651|adipose|adipose
1525991|NCT00677651|lean|lean
1525992|NCT00677651|obese|obese
1525993|NCT00677651|overweight|overweight
1525994|NCT00677651|healthy|healthy
1525995|NCT00677625|Liver|liver
1525996|NCT00677625|Transplant|transplant
1525997|NCT00677612|HLA-A*0201|hla-a*0201
1525998|NCT00677612|Peptide Vaccine|peptide vaccine
1525999|NCT00677612|VEGFR1|vegfr1
1526000|NCT00677612|VEGFR2|vegfr2
1526001|NCT00677599|Cardiovascular disease|cardiovascular disease
1526002|NCT00677599|type 2 diabetes|type 2 diabetes
1526003|NCT00677599|flavonoids|flavonoids
1526004|NCT00677599|cocoa|cocoa
1526005|NCT00677599|soy|soy
1526006|NCT00677599|epicatechin|epicatechin
1526007|NCT00677599|postmenopausal|postmenopausal
1526008|NCT00677599|carotid intima media thickness|carotid intima media thickness
1526009|NCT00677599|plaque volume|plaque volume
1526010|NCT00677586|colorectal neoplasms|colorectal neoplasms
1526011|NCT00677586|liver metastasis|liver metastasis
1526012|NCT00677586|surgery|surgery
1526013|NCT00677573|ART|art
1526014|NCT00677573|poor responder|poor responder
1526015|NCT00677573|GnRH antagonist|gnrh antagonist
1526016|NCT00677573|Gonadotropins|gonadotropins
1526017|NCT00677560|resistance|resistance
1526018|NCT00677560|reactance|reactance
1526019|NCT00677560|inflammation|inflammation
1526020|NCT00677547|Kidney|kidney
1526021|NCT00677547|Influenza vaccine|influenza vaccine
1526023|NCT00677534|Endstage renal disease|endstage renal disease
1526024|NCT00677534|Vitamin D|vitamin d
1526025|NCT00677534|Monocyte function|monocyte function
1526026|NCT00677508|Constipation|constipation
1526027|NCT00677508|Fecal incontinence|fecal incontinence
1526028|NCT00677508|Quality of life|quality of life
1526029|NCT00677508|Health related quality of life|health related quality of life
1526030|NCT00677495|Gluten-free diet|gluten-free diet
1526031|NCT00677495|Celiac Disease|celiac disease
1526032|NCT00677495|Genetic predisposition|genetic predisposition
1526033|NCT00677495|Phage display library|phage display library
1526034|NCT00677495|Autoimmune diseases|autoimmune diseases
1526035|NCT00677482|liver transplant|liver transplant
1526036|NCT00677482|lung transplant|lung transplant
1526037|NCT00677482|kidney transplant|kidney transplant
1526038|NCT00677482|heart transplant|heart transplant
1526039|NCT00677482|CMV microRNA|cmv microrna
1526040|NCT00677469|Hyperthyroidism|hyperthyroidism
1526041|NCT00677469|Cholestyramine|cholestyramine
1526042|NCT00677456|Gastric Cancer|gastric cancer
1526043|NCT00677456|total gastrectomy|total gastrectomy
1526044|NCT00677456|reconstruction|reconstruction
1526045|NCT00677456|life quality|life quality
1526046|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
1526047|NCT00677443|S-1|s-1
1526048|NCT00677443|Capecitabine|capecitabine
1526049|NCT00677443|Oxaliplatin|oxaliplatin
1526050|NCT00677443|non-inferiority study|non-inferiority study
1526051|NCT00677430|Breast Cancer|breast cancer
1526261|NCT00676624|vitrectomy|vitrectomy
1526052|NCT00677430|Breast Reconstruction|breast reconstruction
1526053|NCT00677430|Digital Imaging|digital imaging
1526054|NCT00677430|Questionnaire|questionnaire
1526055|NCT00677430|Survey|survey
1526056|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
1526057|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
1526058|NCT00677391|Obesity|obesity
1526059|NCT00677378|TRPV1|trpv1
1526060|NCT00677378|Nerve growth factor|nerve growth factor
1526061|NCT00677378|Capsaicin|capsaicin
1526062|NCT00677378|TrkA|trka
1526063|NCT00677378|Retrosternal pain|retrosternal pain
1526064|NCT00677378|Epigastric pain|epigastric pain
1526065|NCT00677378|Esophagitis|esophagitis
1526066|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
1526067|NCT00677352|Panic Disorder|panic disorder
1526068|NCT00677339|Tuberculosis|tuberculosis
1526069|NCT00677339|Adjunctive therapy|adjunctive therapy
1526070|NCT00677339|L-arginine|l-arginine
1526071|NCT00677339|Nitric oxide|nitric oxide
1526072|NCT00677339|Vitamin D|vitamin d
1526073|NCT00677326|HLA-A*0201|hla-a*0201
1526074|NCT00677326|Peptide Vaccine|peptide vaccine
1526075|NCT00677326|VEGFR1|vegfr1
1526076|NCT00677326|VEGFR2|vegfr2
1526077|NCT00677313|metreleptin|metreleptin
1526078|NCT00677313|leptin|leptin
1526079|NCT00677313|Amylin|amylin
1526080|NCT00677313|diabetes mellitus|diabetes mellitus
1526081|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
1526082|NCT00677313|lipodystrophy|lipodystrophy
1526083|NCT00677300|HIV|hiv
1526084|NCT00677300|Treatment Naive|treatment naive
1526085|NCT00677287|HLA-A*2402|hla-a*2402
1526086|NCT00677287|Peptide Vaccine|peptide vaccine
1526087|NCT00677287|RNF43|rnf43
1526088|NCT00677287|TOMM34|tomm34
1526089|NCT00677287|VEGFR1|vegfr1
1526090|NCT00677287|VEGFR2|vegfr2
1526091|NCT00677274|Epidural analgesia|epidural analgesia
1526092|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
1526093|NCT00677261|Knee|knee
1526094|NCT00677261|Arthroplasty|arthroplasty
1526095|NCT00677261|Sciatic|sciatic
1526096|NCT00677261|Nerve|nerve
1526097|NCT00677261|Block|block
1526098|NCT00677261|Regional|regional
1526099|NCT00677261|Anesthesia|anesthesia
1526100|NCT00677261|Infiltration|infiltration
1526101|NCT00677261|Local Anesthetic|local anesthetic
1526102|NCT00677261|Analgesia|analgesia
1526103|NCT00677248|Eprotirome|eprotirome
1526104|NCT00677248|KB2115|kb2115
1526105|NCT00677248|dyslipidemia|dyslipidemia
1526106|NCT00677248|hypercholesterolemia|hypercholesterolemia
1526107|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
1526108|NCT00677235|Hemodialysis|hemodialysis
1526109|NCT00677235|Vascular Prosthesis|vascular prosthesis
1526110|NCT00677235|Stenosis|stenosis
1526111|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
1526112|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
1526113|NCT00677209|house dust mite|house dust mite
1526114|NCT00677209|asthma|asthma
1526115|NCT00677209|autovaccine|autovaccine
1526116|NCT00677209|allergy|allergy
1526117|NCT00677196|PNL|pnl
1526118|NCT00677196|Lithoclast|lithoclast
1526119|NCT00677196|Stonebreaker|stonebreaker
1526120|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
1526121|NCT00677183|NASH|nash
1526122|NCT00677183|Biomarker|biomarker
1526123|NCT00677157|Fatigue|fatigue
1526124|NCT00677157|Fibromyalgia|fibromyalgia
1526125|NCT00677157|Pain|pain
1526126|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
1526127|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
1526128|NCT00677157|CPRS|cprs
1526129|NCT00677157|RSD|rsd
1526130|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
1526131|NCT00677144|S-1|s-1
1526132|NCT00677144|Capecitabine|capecitabine
1526133|NCT00677144|Oxaliplatin|oxaliplatin
1526134|NCT00677131|pediatrics|pediatrics
1526135|NCT00677131|antibiotics|antibiotics
1526136|NCT00677131|patient education|patient education
1526137|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1526138|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1526139|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
1526140|NCT00677118|Clinical trial|clinical trial
1526141|NCT00677105|Lymphoma|lymphoma
1526142|NCT00677105|Neoplasms|neoplasms
1526143|NCT00677105|Solid Tumors|solid tumors
1526144|NCT00677105|Advanced Cancer|advanced cancer
1526145|NCT00677092|Treatment|treatment
1526146|NCT00677092|Chronic kidney disease|chronic kidney disease
1526147|NCT00677092|Fibrosing disorders|fibrosing disorders
1526148|NCT00677092|Imatinib mesylate|imatinib mesylate
1526149|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
1526150|NCT00677079|BRCA-1|brca-1
1526151|NCT00677079|BRCA-2|brca-2
1526152|NCT00677066|bronchiolitis|bronchiolitis
1526153|NCT00677066|oxygen|oxygen
1526154|NCT00677066|children|children
1526155|NCT00677053|Unstable Angina|unstable angina
1526156|NCT00677053|Myocardial Infarction|myocardial infarction
1526157|NCT00677053|Thrombolysis|thrombolysis
1526262|NCT00676624|infection|infection
1526158|NCT00677053|Anticoagulant|anticoagulant
1526159|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
1526160|NCT00677027|Beta-glucan|beta-glucan
1526161|NCT00677027|immune system|immune system
1526162|NCT00677027|Healthy subjects|healthy subjects
1526163|NCT00677014|Heart Failure|heart failure
1526164|NCT00677014|HF|hf
1526165|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1526166|NCT00677014|CRT|crt
1526167|NCT00677014|Optimization|optimization
1526168|NCT00677014|SmartDelay|smartdelay
1526169|NCT00677014|Echocardiography|echocardiography
1526170|NCT00677014|AV Delay|av delay
1526171|NCT00677001|Solid tumors|solid tumors
1526172|NCT00677001|solid malignancies|solid malignancies
1526173|NCT00677001|neoplasms|neoplasms
1526174|NCT00677001|refractory solid tumors|refractory solid tumors
1526175|NCT00677001|advanced solid tumors|advanced solid tumors
1526176|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
1526177|NCT00676988|Infliximab|infliximab
1526178|NCT00676975|Irritable Bowel disease|irritable bowel disease
1526179|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
1526180|NCT00676962|Implementation|implementation
1526181|NCT00676962|facilitation|facilitation
1526182|NCT00676962|psychotherapy|psychotherapy
1526183|NCT00676962|training|training
1526184|NCT00676949|epitope peptide|epitope peptide
1526185|NCT00676949|cyclophosphamide|cyclophosphamide
1526186|NCT00676949|interleukin-2|interleukin-2
1526187|NCT00676936|Cancer|cancer
1526188|NCT00676936|pain|pain
1526189|NCT00676936|corticosteroids|corticosteroids
1526190|NCT00676936|palliative|palliative
1526191|NCT00676936|supportive care|supportive care
1526192|NCT00676936|Cancer patients with pain|cancer patients with pain
1526193|NCT00676910|Advanced Cancer|advanced cancer
1526194|NCT00676910|Malignancies|malignancies
1526195|NCT00676910|Neoplasms|neoplasms
1526196|NCT00676910|Incurable Solid Cancers|incurable solid cancers
1526197|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
1526198|NCT00676884|atopic eczema|atopic eczema
1526199|NCT00676884|atopic dermatitis|atopic dermatitis
1526200|NCT00676884|allergy|allergy
1526201|NCT00676858|Embolism|embolism
1526202|NCT00676858|Argon|argon
1526203|NCT00676845|Arterial stiffness|arterial stiffness
1526204|NCT00676845|Vascular protection|vascular protection
1526205|NCT00676832|colitis|colitis
1526206|NCT00676832|ulcerative|ulcerative
1526207|NCT00676832|moderate|moderate
1526208|NCT00676832|severe|severe
1526209|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
1526210|NCT00676806|full ablation conditioning|full ablation conditioning
1526211|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
1526212|NCT00676793|breast cancer|breast cancer
1526213|NCT00676793|EGCG|egcg
1526214|NCT00676793|Polyphenon E|polyphenon e
1526215|NCT00676793|c-Met|c-met
1526216|NCT00676793|VEGF|vegf
1526217|NCT00676793|HGF|hgf
1526218|NCT00676780|EGCG|egcg
1526219|NCT00676780|polyphenols|polyphenols
1526220|NCT00676780|biomarkers|biomarkers
1526221|NCT00676780|prostate specific antigen|prostate specific antigen
1526222|NCT00676767|Aging|aging
1526223|NCT00676767|Diabetes|diabetes
1526224|NCT00676767|Diet|diet
1526225|NCT00676767|Fiber|fiber
1526226|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
1526227|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
1526228|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
1526229|NCT00676728|JNJ 26481585|jnj 26481585
1526230|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
1526231|NCT00676728|Advanced Leukemia|advanced leukemia
1526232|NCT00676728|Refractory Leukemia|refractory leukemia
1526233|NCT00676702|Pancrelipase|pancrelipase
1526234|NCT00676702|PANCREASE MT|pancrease mt
1526235|NCT00676702|Cross-Over Studies|cross-over studies
1526236|NCT00676702|Duodenum|duodenum
1526237|NCT00676702|Intestine, Small|intestine, small
1526238|NCT00676702|Lipase|lipase
1526239|NCT00676702|Amylases|amylases
1526240|NCT00676702|Peptide Hydrolases|peptide hydrolases
1526241|NCT00676702|Intubation|intubation
1526242|NCT00676702|Safety|safety
1526243|NCT00676702|Capsules|capsules
1526244|NCT00676689|Pulmonic|pulmonic
1526245|NCT00676689|Regurgitation|regurgitation
1526246|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
1526247|NCT00676689|Stenosis|stenosis
1526248|NCT00676689|Congenital Heart Defect|congenital heart defect
1526249|NCT00676676|Depression|depression
1526250|NCT00676676|Major Depressive Disorder|major depressive disorder
1526251|NCT00676663|Breast Neoplasms|breast neoplasms
1526252|NCT00676663|Breast Tumor|breast tumor
1526253|NCT00676663|Mammary Neoplasms|mammary neoplasms
1526254|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
1526255|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
1526256|NCT00676637|Adherence|adherence
1526257|NCT00676637|Compliance|compliance
1526258|NCT00676637|Glaucoma|glaucoma
1526259|NCT00676637|Ocular Hypertension|ocular hypertension
1526260|NCT00676624|uveitis|uveitis
1526263|NCT00676624|severe|severe
1526264|NCT00676611|Acetabular Fractures|acetabular fractures
1526265|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
1526266|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
1526267|NCT00676572|severe asthma|severe asthma
1526268|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
1526269|NCT00676559|Diabetic|diabetic
1526270|NCT00676559|Macular|macular
1526271|NCT00676559|Edema|edema
1526272|NCT00676559|DME|dme
1526273|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
1526274|NCT00676533|Cipro|cipro
1526275|NCT00676533|Urinary Tract Infection|urinary tract infection
1526276|NCT00676520|Angioplasty|angioplasty
1526277|NCT00676520|Coronary Restenosis|coronary restenosis
1526278|NCT00676520|Coronary Artery Disease|coronary artery disease
1526279|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
1526280|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
1526281|NCT00676520|Total Artery Occlusion|total artery occlusion
1526282|NCT00676520|Stents|stents
1526283|NCT00676520|Stent Thrombosis|stent thrombosis
1526284|NCT00676520|Total Coronary Occlusion|total coronary occlusion
1526285|NCT00676520|Vascular Disease|vascular disease
1526286|NCT00676520|Myocardial Ischemia|myocardial ischemia
1526287|NCT00676507|Gene therapy|gene therapy
1526288|NCT00676507|Flow cytometry|flow cytometry
1526289|NCT00676507|Immunoenzyme technique|immunoenzyme technique
1526290|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
1526291|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
1526292|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
1526293|NCT00676481|Patient Education|patient education
1526294|NCT00676481|Emergency Medicine|emergency medicine
1526295|NCT00676481|HIV Prevention|hiv prevention
1526296|NCT00676481|HIV Seronegativity|hiv seronegativity
1526297|NCT00676468|Asthma|asthma
1526298|NCT00676468|Inflammation|inflammation
1526299|NCT00676468|Airway|airway
1526300|NCT00676468|Fish Oil|fish oil
1526301|NCT00676468|Singulair|singulair
1526302|NCT00676455|CT Software|ct software
1526303|NCT00676455|MeVis™|mevis™
1526304|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
1526305|NCT00676416|General anesthesia|general anesthesia
1526306|NCT00676416|Propofol|propofol
1526307|NCT00676416|Immunity|immunity
1526308|NCT00676416|Alveolar Macrophages|alveolar macrophages
1526309|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
1526310|NCT00676390|Heart Failure|heart failure
1526311|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
1526312|NCT00676364|pediatric patients|pediatric patients
1526313|NCT00676364|pain|pain
1526314|NCT00676364|anxiety|anxiety
1526315|NCT00676364|topical anesthetic|topical anesthetic
1526316|NCT00676364|randomized control trial|randomized control trial
1526317|NCT00676338|Amylin|amylin
1526318|NCT00676338|Lilly|lilly
1526319|NCT00676338|exenatide once weekly|exenatide once weekly
1526320|NCT00676338|Byetta|byetta
1526321|NCT00676338|Januvia|januvia
1526322|NCT00676338|sitagliptin|sitagliptin
1526323|NCT00676338|thiazolidinedione|thiazolidinedione
1526324|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
1526325|NCT00676325|traditional treatment|traditional treatment
1526326|NCT00676325|mesh, graft|mesh, graft
1526327|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
1526328|NCT00676325|colporrhaphy|colporrhaphy
1526329|NCT00676312|Osteoporosis|osteoporosis
1526330|NCT00676312|parathyroid hormone|parathyroid hormone
1526331|NCT00676312|pharmacodynamic|pharmacodynamic
1526332|NCT00676312|pharmacokinetic|pharmacokinetic
1526333|NCT00676299|Advanced Solid Cancers|advanced solid cancers
1526334|NCT00676299|Refractory Solid Cancers|refractory solid cancers
1526335|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
1526336|NCT00676299|Phase 1 Study|phase 1 study
1526337|NCT00676299|Oral Chemotherapy|oral chemotherapy
1526338|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
1526339|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
1526340|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
1526341|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
1526342|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
1526343|NCT00676260|Type II Diabetes|type ii diabetes
1526344|NCT00676260|Diabetes Mellitus|diabetes mellitus
1526345|NCT00676260|Lipoatrophic|lipoatrophic
1526346|NCT00676260|Dyslipidemia|dyslipidemia
1526347|NCT00676260|Drug Therapy|drug therapy
1526348|NCT00676247|Ultrasonography|ultrasonography
1526349|NCT00676247|Doppler|doppler
1526350|NCT00676247|Hemodynamics|hemodynamics
1526351|NCT00676247|Neurobehavioral development|neurobehavioral development
1526352|NCT00676234|erythropoietin|erythropoietin
1526353|NCT00676221|Renal transplant recipient|renal transplant recipient
1526354|NCT00676221|Immunosuppression|immunosuppression
1526355|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
1526356|NCT00676221|Quality of life|quality of life
1526357|NCT00676221|Cellcept|cellcept
1526358|NCT00676221|Myfortic|myfortic
1526557|NCT00675441|Prednisone|prednisone
1526359|NCT00676221|Kidney transplant patients.|kidney transplant patients.
1526360|NCT00676208|Shared Medical Appointments|shared medical appointments
1526361|NCT00676208|Diabetes|diabetes
1526362|NCT00676208|Education|education
1526363|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
1526364|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
1526365|NCT00676169|EPIC|epic
1526366|NCT00676156|multiple sclerosis|multiple sclerosis
1526367|NCT00676156|lipoic acid|lipoic acid
1526368|NCT00676156|LA|la
1526369|NCT00676156|pharmacokinetics|pharmacokinetics
1526370|NCT00676156|immunological effects|immunological effects
1526371|NCT00676143|antibody|antibody
1526372|NCT00676143|immunotherapy|immunotherapy
1526373|NCT00676130|Cellulitis|cellulitis
1526374|NCT00676130|Bactrim|bactrim
1526375|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
1526376|NCT00676130|MRSA|mrsa
1526377|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1526378|NCT00676117|male|male
1526379|NCT00676117|Japan|japan
1526380|NCT00676117|Japanese|japanese
1526381|NCT00676117|Healthy volunteers|healthy volunteers
1526382|NCT00676104|Traumatic Brain Injury|traumatic brain injury
1526383|NCT00676104|Trauma|trauma
1526384|NCT00676104|Hypothermia|hypothermia
1526385|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1526386|NCT00676065|Contraception|contraception
1526387|NCT00676065|Thromboembolism|thromboembolism
1526388|NCT00676065|Breast Cancer|breast cancer
1526389|NCT00676052|COPD|copd
1526390|NCT00676052|Multicenter|multicenter
1526391|NCT00676052|GSK233705B|gsk233705b
1526392|NCT00676052|double-blind|double-blind
1526393|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1526394|NCT00676052|randomized|randomized
1526395|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
1526396|NCT00676039|Human Experimentation|human experimentation
1526397|NCT00676039|Bioequivalence|bioequivalence
1526398|NCT00676039|Brand name|brand name
1526399|NCT00676039|Generic|generic
1526400|NCT00676039|Antidepressant|antidepressant
1526401|NCT00676039|Healthy volunteers|healthy volunteers
1526402|NCT00676026|menses|menses
1526403|NCT00676026|women|women
1526404|NCT00676026|healthy controls|healthy controls
1526405|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
1526406|NCT00676013|Burns|burns
1526407|NCT00676013|Skin grafting|skin grafting
1526408|NCT00676013|AlloDerm|alloderm
1526409|NCT00676013|Integra|integra
1526410|NCT00676013|Homograft|homograft
1526411|NCT00676013|Autograft|autograft
1526412|NCT00676013|Burn Scar|burn scar
1526413|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
1526414|NCT00675974|Burn|burn
1526415|NCT00675974|Scar|scar
1526416|NCT00675974|Pressure garments|pressure garments
1526417|NCT00675974|Wound healing|wound healing
1526418|NCT00675974|Burn Injury|burn injury
1526419|NCT00675961|Tomsk|tomsk
1526420|NCT00675961|TB-Alcohol|tb-alcohol
1526421|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
1526422|NCT00675961|Brief counseling intervention|brief counseling intervention
1526423|NCT00675961|Naltrexone|naltrexone
1526424|NCT00675948|Palliative Care|palliative care
1526425|NCT00675948|Pain|pain
1526426|NCT00675948|Cancer|cancer
1526427|NCT00675935|Patient falls|patient falls
1526428|NCT00675935|fall risk|fall risk
1526429|NCT00675935|fall prevention|fall prevention
1526430|NCT00675922|Burn|burn
1526431|NCT00675922|Wounds|wounds
1526432|NCT00675922|Wound infection|wound infection
1526433|NCT00675922|Topical antimicrobials|topical antimicrobials
1526434|NCT00675922|Cerium|cerium
1526435|NCT00675922|Dakins|dakins
1526436|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
1526437|NCT00675922|Silver Nitrate|silver nitrate
1526438|NCT00675909|Sedation|sedation
1526439|NCT00675909|Anxiety|anxiety
1526440|NCT00675909|Minor procedures|minor procedures
1526441|NCT00675909|Emergency Department|emergency department
1526442|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
1526443|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1526444|NCT00675870|Cancer|cancer
1526445|NCT00675870|Leukemia|leukemia
1526446|NCT00675870|APL|apl
1526447|NCT00675870|ATRA|atra
1526448|NCT00675870|Tretinoid|tretinoid
1526449|NCT00675870|Vesanoid|vesanoid
1526450|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
1526451|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
1526452|NCT00675870|Arsenic Trioxide|arsenic trioxide
1526453|NCT00675870|Trisenox|trisenox
1526454|NCT00675870|Retinoid|retinoid
1526455|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
1526456|NCT00675857|Type II diabetes|type ii diabetes
1526457|NCT00675857|Metabolic syndrome|metabolic syndrome
1526458|NCT00675844|Extension study|extension study
1526459|NCT00675844|HIV-1 infection|hiv-1 infection
1526460|NCT00675844|Treatment Naive|treatment naive
1526461|NCT00675831|CD25+|cd25+
1526462|NCT00675831|Tregs|tregs
1526463|NCT00675831|DLI|dli
1526464|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
1526465|NCT00675818|acute kidney injury|acute kidney injury
1526466|NCT00675818|renal replacement therapy|renal replacement therapy
1526467|NCT00675818|critical care unit|critical care unit
1526468|NCT00675818|hemodialysis|hemodialysis
1526469|NCT00675818|hemofiltration|hemofiltration
1526470|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
1526471|NCT00675805|IVIG|ivig
1526472|NCT00675805|adverse reactions|adverse reactions
1526473|NCT00675779|endometriosis|endometriosis
1526474|NCT00675779|atorvastatin|atorvastatin
1526475|NCT00675779|oral|oral
1526476|NCT00675779|contraception|contraception
1526477|NCT00675779|pain|pain
1526478|NCT00675779|relief|relief
1526479|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
1526480|NCT00675753|Genes|genes
1526481|NCT00675753|Ethnology|ethnology
1526482|NCT00675753|Cytokines|cytokines
1526483|NCT00675753|prematurity|prematurity
1526484|NCT00675727|Melanoma|melanoma
1526485|NCT00675727|Mycobacterium w|mycobacterium w
1526486|NCT00675714|anabolic agents|anabolic agents
1526487|NCT00675714|exercise|exercise
1526488|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
1526489|NCT00675688|Menopause|menopause
1526490|NCT00675675|Tourette Syndrome|tourette syndrome
1526491|NCT00675675|Chronic Tic Disorder|chronic tic disorder
1526493|NCT00675675|Behavior Therapy|behavior therapy
1526494|NCT00675675|Habit Reversal Training|habit reversal training
1526495|NCT00675675|Child|child
1526496|NCT00675675|Adolescent|adolescent
1526497|NCT00675675|Neuroimaging|neuroimaging
1526498|NCT00675662|Obesity|obesity
1526499|NCT00675662|overweight|overweight
1526500|NCT00675662|BMI|bmi
1526501|NCT00675662|ifestyle|ifestyle
1526502|NCT00675662|diet|diet
1526503|NCT00675662|nutrition|nutrition
1526504|NCT00675662|physical activity|physical activity
1526505|NCT00675662|pre-school|pre-school
1526506|NCT00675662|toddlers|toddlers
1526507|NCT00675662|children|children
1526508|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
1526509|NCT00675649|Injections|injections
1526510|NCT00675649|Severe, persistent asthma|severe, persistent asthma
1526511|NCT00675636|colon cancer|colon cancer
1526512|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
1526513|NCT00675636|rectal cancer|rectal cancer
1526514|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
1526515|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
1526516|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
1526517|NCT00675610|communication|communication
1526518|NCT00675610|HIV/AIDS|hiv/aids
1526519|NCT00675610|Treatment Experienced|treatment experienced
1526520|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
1526521|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
1526522|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
1526523|NCT00675597|07-178|07-178
1687591|NCT00080093|Condom|condom
1526524|NCT00675558|Obesity|obesity
1526525|NCT00675558|morbid obesity|morbid obesity
1526526|NCT00675558|bariatric surgery|bariatric surgery
1526527|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
1526528|NCT00675519|problem drinkers|problem drinkers
1526529|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
1526530|NCT00675506|Growth Hormone Pulse|growth hormone pulse
1526531|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
1526532|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
1526533|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
1526534|NCT00675467|Pediatric Cancer|pediatric cancer
1526535|NCT00675467|Focus Group|focus group
1526536|NCT00675467|Pediatric cancer patients|pediatric cancer patients
1526537|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
1526538|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
1526539|NCT00675454|COPD|copd
1526540|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
1526541|NCT00675454|Lung Transplant|lung transplant
1526542|NCT00675454|Quality of Life|quality of life
1526543|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
1526544|NCT00675441|cGVHD|cgvhd
1526545|NCT00675441|GVHD|gvhd
1526546|NCT00675441|Lenalidomide|lenalidomide
1526547|NCT00675441|Revlimid|revlimid
1526548|NCT00675441|CC-5013|cc-5013
1526549|NCT00675441|Stem Cell Transplant|stem cell transplant
1526550|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1526551|NCT00675441|Allogeneic HSCT|allogeneic hsct
1526552|NCT00675441|HSCT|hsct
1526553|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
1526554|NCT00675441|Steroids|steroids
1526555|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
1526556|NCT00675441|Corticosteroids|corticosteroids
1526558|NCT00675441|Medrol|medrol
1526559|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1526560|NCT00675415|Hypoxemia|hypoxemia
1526561|NCT00675415|Capnography|capnography
1526562|NCT00675415|Apnea|apnea
1526563|NCT00675415|Sedation|sedation
1526564|NCT00675415|ERCP|ercp
1526566|NCT00675389|HIV|hiv
1526567|NCT00675389|AIDS|aids
1526568|NCT00675389|Community Health Workers|community health workers
1526569|NCT00675389|Mobile Phones|mobile phones
1526570|NCT00675389|Adherence|adherence
1526571|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
1526572|NCT00675376|COPD|copd
1526573|NCT00675376|Lung Transplant|lung transplant
1526574|NCT00675376|Quality of Life|quality of life
1526575|NCT00675376|End Stage Lung Disease|end stage lung disease
1526576|NCT00675363|ICU|icu
1526577|NCT00675363|Sedation strategies|sedation strategies
1526578|NCT00675363|Daily sedative interruption|daily sedative interruption
1526579|NCT00675363|Sedation protocols|sedation protocols
1526580|NCT00675363|Mechanical Ventilation|mechanical ventilation
1526581|NCT00675363|Sedation|sedation
1526582|NCT00675350|Omacetaxine|omacetaxine
1526583|NCT00675350|Homoharringtonine|homoharringtonine
1526584|NCT00675350|HHT|hht
1526585|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
1526586|NCT00675337|iron stores|iron stores
1526587|NCT00675337|anemia|anemia
1526588|NCT00675337|iron deficiency|iron deficiency
1526589|NCT00675337|infancy|infancy
1526590|NCT00675337|placental transfusion|placental transfusion
1526591|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
1526592|NCT00675337|anemia in infancy|anemia in infancy
1526593|NCT00675337|placement of neonate|placement of neonate
1526594|NCT00675324|Colonoscopy|colonoscopy
1526595|NCT00675324|Bowel preparation|bowel preparation
1526596|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
1526597|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
1526598|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
1526599|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
1526600|NCT00675311|Remote monitoring|remote monitoring
1526601|NCT00675311|Type 1 Diabetes|type 1 diabetes
1526602|NCT00675311|Type 2 diabetes|type 2 diabetes
1526603|NCT00675298|Prostatitis|prostatitis
1526604|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
1526605|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
1526606|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
1526607|NCT00675298|Painful bladder syndrome|painful bladder syndrome
1526608|NCT00675298|Urgency|urgency
1526609|NCT00675298|Frequency|frequency
1526610|NCT00675285|airway inflammation|airway inflammation
1526611|NCT00675285|childhood asthma|childhood asthma
1526612|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
1526613|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
1526614|NCT00675285|lung function|lung function
1526615|NCT00675272|brain death|brain death
1526616|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
1526617|NCT00675272|traumatic brain injury|traumatic brain injury
1526618|NCT00675272|brain injury|brain injury
1526619|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
1526620|NCT00675272|organ donation|organ donation
1526621|NCT00675259|stage II breast cancer|stage ii breast cancer
1526622|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
1526623|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
1526624|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
1526625|NCT00675246|corticoid therapy|corticoid therapy
1526626|NCT00675246|fetal lung maturation|fetal lung maturation
1526627|NCT00675246|late preterm|late preterm
1526628|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
1526629|NCT00675246|neonatal death|neonatal death
1526630|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1526631|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1526632|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1526633|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1526634|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1526635|NCT00675207|glaucoma|glaucoma
1526636|NCT00675207|ocular hypertension|ocular hypertension
1526637|NCT00675207|adjunctive treatment|adjunctive treatment
1526638|NCT00675207|prostaglandin|prostaglandin
1526639|NCT00675207|prostaglandin analog|prostaglandin analog
1526640|NCT00675207|brimonidine|brimonidine
1526641|NCT00675207|dorzolamide|dorzolamide
1526642|NCT00675207|brinzolamide|brinzolamide
1526643|NCT00675207|alpha agonist|alpha agonist
1526644|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
1526645|NCT00675207|intraocular pressure|intraocular pressure
1526646|NCT00675194|cisplatin|cisplatin
1526647|NCT00675194|capecitabine|capecitabine
1526648|NCT00675194|gastric|gastric
1526649|NCT00675194|irinotecan|irinotecan
1526650|NCT00675194|metastatic|metastatic
1526651|NCT00675194|chemotherapy|chemotherapy
1526652|NCT00675181|melatonin|melatonin
1526934|NCT00674154|Vitamin D|vitamin d
1526653|NCT00675181|skin blood flow|skin blood flow
1526654|NCT00675181|choroidal blood flow|choroidal blood flow
1526655|NCT00675181|vasospastic subjects|vasospastic subjects
1526656|NCT00675181|normal subjects|normal subjects
1526657|NCT00675168|Lung Cancer|lung cancer
1526658|NCT00675168|PET/CT|pet/ct
1526659|NCT00675168|Diagnosis|diagnosis
1526660|NCT00675155|Apoplexy|apoplexy
1526661|NCT00675155|Cerebral Stroke|cerebral stroke
1526662|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
1526663|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1526664|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
1526665|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
1526666|NCT00675142|Infertility|infertility
1526667|NCT00675142|Intra-uterine insemination|intra-uterine insemination
1526668|NCT00675142|ovarian stimulation|ovarian stimulation
1526669|NCT00675116|safety,|safety,
1526670|NCT00675116|healthy volunteers,|healthy volunteers,
1526671|NCT00675116|GW823296,|gw823296,
1526672|NCT00675116|pharmacokinetics|pharmacokinetics
1526673|NCT00675103|Gout|gout
1526674|NCT00675103|Gouty Arthritis|gouty arthritis
1526675|NCT00675103|Anti-Gout preparations|anti-gout preparations
1526676|NCT00675090|Alzheimers Disease|alzheimers disease
1526677|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
1526678|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
1526679|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
1526680|NCT00675077|Huntington Chorea|huntington chorea
1526681|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
1526682|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
1526683|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
1526684|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
1526685|NCT00675064|pharmacokinetics,|pharmacokinetics,
1526686|NCT00675064|safety|safety
1526687|NCT00675064|single ascending dose,|single ascending dose,
1526688|NCT00675064|Healthy volunteers,|healthy volunteers,
1526689|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
1526690|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
1526691|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
1526692|NCT00675012|NGR-hTNF|ngr-htnf
1526693|NCT00675012|Capecitabine|capecitabine
1526694|NCT00675012|Oxaliplatin|oxaliplatin
1526695|NCT00675012|Colon cancer|colon cancer
1526696|NCT00674999|Burn|burn
1526697|NCT00674999|Partial thickness burn|partial thickness burn
1526698|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
1526699|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
1526700|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
1526701|NCT00674960|Pick Disease|pick disease
1526702|NCT00674960|Pick's Disease|pick's disease
1526703|NCT00674960|Picks Disease of Brain|picks disease of brain
1526704|NCT00674947|Relapsed|relapsed
1526705|NCT00674947|Refractory|refractory
1526706|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
1526707|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
1526708|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
1526709|NCT00674921|Opportunistic Infections|opportunistic infections
1526710|NCT00674921|AIDS|aids
1526711|NCT00674921|HIV|hiv
1526712|NCT00674921|Treatment Experienced|treatment experienced
1526713|NCT00674908|Vaccine|vaccine
1526714|NCT00674908|Prevention|prevention
1526715|NCT00674908|Diphtheria|diphtheria
1526716|NCT00674908|Tetanus|tetanus
1526717|NCT00674908|Pertussis|pertussis
1526718|NCT00674908|Hepatitis B|hepatitis b
1526719|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
1526720|NCT00674908|Vaccine interchangeability|vaccine interchangeability
1526721|NCT00674908|Single vs mixed sequence|single vs mixed sequence
1526722|NCT00674908|Healthy infants|healthy infants
1526723|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
1526724|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
1526725|NCT00674895|Paralysis Agitans|paralysis agitans
1526726|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
1526727|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
1526728|NCT00674895|Primary Parkinsonism|primary parkinsonism
1526729|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1526730|NCT00674882|Follow-up studies|follow-up studies
1526731|NCT00674882|Outcomes research|outcomes research
1526732|NCT00674882|Data collection|data collection
1526733|NCT00674869|sealant|sealant
1526734|NCT00674869|pit|pit
1526735|NCT00674869|child|child
1526736|NCT00674869|over|over
1526737|NCT00674869|6 years old|6 years old
1526738|NCT00674869|least|least
1526739|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
1526740|NCT00674843|MYOPATHIES|myopathies
1526741|NCT00674843|Distal Myopathies|distal myopathies
1526742|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
1526743|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
1526744|NCT00674817|salbutamol,|salbutamol,
1526745|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1526746|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
1526747|NCT00674817|COPD|copd
1526748|NCT00674817|ipratropium bromide,|ipratropium bromide,
1526749|NCT00674817|Asthma|asthma
1526750|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
1526751|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
1526752|NCT00674804|Cancer Diagnosis|cancer diagnosis
1526753|NCT00674804|Recurrence of Cancer|recurrence of cancer
1526754|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
1526755|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
1526756|NCT00674791|breast cancer|breast cancer
1526757|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
1526758|NCT00674791|metastatic breast cancer|metastatic breast cancer
1526759|NCT00674791|immunotherapy|immunotherapy
1526760|NCT00674791|antigen|antigen
1526761|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
1526762|NCT00674778|Radial|radial
1526763|NCT00674778|Femoral|femoral
1526764|NCT00674778|artery|artery
1526765|NCT00674778|Invasive cardiology safety|invasive cardiology safety
1526766|NCT00674739|external genital warts|external genital warts
1526767|NCT00674739|perianal warts|perianal warts
1526768|NCT00674739|condylomata acuminata|condylomata acuminata
1526769|NCT00674739|venereal warts|venereal warts
1526770|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
1526771|NCT00674726|appendicitis|appendicitis
1526772|NCT00674726|gastroenteritis|gastroenteritis
1526773|NCT00674726|temperature|temperature
1526774|NCT00674726|fever|fever
1526775|NCT00674726|acute abdomen|acute abdomen
1526776|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
1526777|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
1526778|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
1526779|NCT00674700|House dust mites allergy|house dust mites allergy
1526780|NCT00674674|topotecan|topotecan
1526781|NCT00674674|pharmacokinetics|pharmacokinetics
1526782|NCT00674674|neoplastic|neoplastic
1526783|NCT00674674|meningitis|meningitis
1526784|NCT00674661|ectasia|ectasia
1526785|NCT00674661|cross-linking|cross-linking
1526786|NCT00674661|crosslinking|crosslinking
1526787|NCT00674661|cornea|cornea
1526788|NCT00674661|riboflavin|riboflavin
1526789|NCT00674661|UVA|uva
1526790|NCT00674648|Multiple Diseases|multiple diseases
1526791|NCT00674648|Hematopoietic System|hematopoietic system
1526792|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
1526793|NCT00674635|adaptive study,|adaptive study,
1526794|NCT00674635|DAS28,|das28,
1526795|NCT00674635|monoclonal antibody|monoclonal antibody
1526796|NCT00674635|GSK315234A;|gsk315234a;
1526797|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
1526798|NCT00674622|Lateral epicondylitis|lateral epicondylitis
1526799|NCT00674622|Tennis elbow|tennis elbow
1526800|NCT00674622|Prolotherapy|prolotherapy
1526801|NCT00674609|Palliative Care|palliative care
1526802|NCT00674609|Pain|pain
1526803|NCT00674609|Cancer|cancer
1526804|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
1526805|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
1526806|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
1526807|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
1526808|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
1526809|NCT00674596|of PTX3 levels.|of ptx3 levels.
1526810|NCT00674583|Conjugate vaccine|conjugate vaccine
1526811|NCT00674583|Meningococcal disease|meningococcal disease
1526812|NCT00674583|Immunogenicity|immunogenicity
1526813|NCT00674583|Meningococcal vaccine|meningococcal vaccine
1526814|NCT00674583|Safety|safety
1526815|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
1526816|NCT00674570|Hydrocortisone|hydrocortisone
1526817|NCT00674570|Cycloserine|cycloserine
1526818|NCT00674570|Extinction, Psychological|extinction, psychological
1526819|NCT00674570|PTSD|ptsd
1526820|NCT00674570|San Francisco|san francisco
1526821|NCT00674557|recurrent breast cancer|recurrent breast cancer
1526822|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
1526823|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
1526824|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
1526825|NCT00674557|stage IV breast cancer|stage iv breast cancer
1526826|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
1526827|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1526828|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1526829|NCT00674544|childhood|childhood
1526830|NCT00674544|children|children
1526831|NCT00674544|obesity|obesity
1527037|NCT00673699|gastroscopy|gastroscopy
1526832|NCT00674544|physical activity|physical activity
1526833|NCT00674544|nutrition|nutrition
1526835|NCT00674544|family|family
1526836|NCT00674531|Arteriosclerosis|arteriosclerosis
1526837|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
1526838|NCT00674531|Enterovirus|enterovirus
1526839|NCT00674531|Artery resection|artery resection
1526840|NCT00674518|Health Promotion|health promotion
1526841|NCT00674518|Health Behavior Change|health behavior change
1526842|NCT00674518|Physical Activity|physical activity
1526843|NCT00674518|Dietary Change|dietary change
1526844|NCT00674518|Weight Loss|weight loss
1526845|NCT00674518|Obesity|obesity
1526846|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
1526847|NCT00674479|Cancer|cancer
1526848|NCT00674479|Blood|blood
1526849|NCT00674479|Bone marrow|bone marrow
1526850|NCT00674479|Lymph nodes|lymph nodes
1526851|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
1526852|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
1526854|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
1526856|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
1526857|NCT00674479|MDS|mds
1526858|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
1526859|NCT00674479|CML|cml
1526860|NCT00674479|INCB018424|incb018424
1526861|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
1526862|NCT00674453|Osteoporosis|osteoporosis
1526863|NCT00674453|lasofoxifene|lasofoxifene
1526864|NCT00674453|bone density|bone density
1526865|NCT00674453|bone markers|bone markers
1526866|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
1526867|NCT00674440|Hyperinsulinism|hyperinsulinism
1526868|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
1526869|NCT00674440|CHI|chi
1526870|NCT00674440|PHHI|phhi
1526871|NCT00674440|F-DOPA|f-dopa
1526872|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
1526873|NCT00674427|AML|aml
1526874|NCT00674427|ALL|all
1526875|NCT00674427|MDS|mds
1526876|NCT00674427|CLL|cll
1526877|NCT00674427|Multiple Myeloma|multiple myeloma
1526878|NCT00674414|stage IA breast cancer|stage ia breast cancer
1526879|NCT00674414|stage IB breast cancer|stage ib breast cancer
1526880|NCT00674414|stage II breast cancer|stage ii breast cancer
1526881|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
1526882|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
1526883|NCT00674388|Children|children
1526884|NCT00674388|Anesthesia|anesthesia
1526885|NCT00674388|Surgery|surgery
1526886|NCT00674388|Complication|complication
1526887|NCT00674375|Chest Pain|chest pain
1526888|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
1526889|NCT00674375|Patient Safety|patient safety
1526890|NCT00674375|Misdiagnosis|misdiagnosis
1526891|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
1526892|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
1526893|NCT00674362|Certolizumab pegol|certolizumab pegol
1526894|NCT00674336|Norovirus|norovirus
1526895|NCT00674336|Gastroenteritis|gastroenteritis
1526896|NCT00674336|Clinical Trial|clinical trial
1526897|NCT00674336|Stomach flu|stomach flu
1526898|NCT00674336|Oysters|oysters
1526899|NCT00674336|Shellfish|shellfish
1526900|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
1526901|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1526902|NCT00674323|PCV|pcv
1526903|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
1526904|NCT00674323|vision|vision
1526905|NCT00674323|polyps|polyps
1526906|NCT00674323|indocyanine green angiography|indocyanine green angiography
1526907|NCT00674323|verteporfin|verteporfin
1526908|NCT00674323|ranibizumab|ranibizumab
1526909|NCT00674323|photodynamic therapy|photodynamic therapy
1526910|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
1526911|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1526912|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
1526913|NCT00674271|Toll-Like Receptors|toll-like receptors
1526914|NCT00674271|Atherosclerosis|atherosclerosis
1526915|NCT00674271|Carotid Arteries|carotid arteries
1526916|NCT00674271|Diabetes Complications|diabetes complications
1526917|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
1526918|NCT00674258|HLA-A*2402|hla-a*2402
1526919|NCT00674258|Peptide Vaccine|peptide vaccine
1526920|NCT00674258|URLC10|urlc10
1526921|NCT00674258|TTK|ttk
1526922|NCT00674258|KOC1|koc1
1526923|NCT00674245|heartburn|heartburn
1526924|NCT00674245|acid reflux|acid reflux
1526925|NCT00674245|GERD|gerd
1526926|NCT00674245|spectrum analysis|spectrum analysis
1526927|NCT00674245|electroencephalogram|electroencephalogram
1526928|NCT00674245|esophagitis|esophagitis
1526929|NCT00674245|peptic|peptic
1526930|NCT00674232|incomplete abortion|incomplete abortion
1526931|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
1526932|NCT00674219|GAD|gad
1526933|NCT00674206|Metastatic breast cancer|metastatic breast cancer
1526935|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
1526936|NCT00674154|hypercalcemia|hypercalcemia
1526937|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
1526938|NCT00674128|pacemaker|pacemaker
1526939|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
1526940|NCT00674128|ICD|icd
1526941|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
1526942|NCT00674128|cyanoacrylate|cyanoacrylate
1526943|NCT00674128|suture|suture
1526944|NCT00674128|Dermabond|dermabond
1526945|NCT00674128|Vicryl|vicryl
1526946|NCT00674102|Vascular disrupting agent|vascular disrupting agent
1526947|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
1526948|NCT00674089|IMR|imr
1526949|NCT00674089|Newborn Mortality|newborn mortality
1526950|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
1526951|NCT00674089|Premature Mortality|premature mortality
1526952|NCT00674089|Mortality|mortality
1526953|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
1526954|NCT00674063|Alefacept|alefacept
1526955|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
1526956|NCT00674037|recruitment|recruitment
1526957|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
1526958|NCT00674024|Pazopanib|pazopanib
1526959|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1526960|NCT00674024|Advanced Cancer|advanced cancer
1526961|NCT00674024|Pharmacokinetics|pharmacokinetics
1526962|NCT00674024|Cancer|cancer
1526963|NCT00674024|Solid Tumor|solid tumor
1526964|NCT00674024|Lymphoma|lymphoma
1526965|NCT00674011|hypertension|hypertension
1526966|NCT00674011|bevacizumab|bevacizumab
1526967|NCT00674011|metastatic breast cancer|metastatic breast cancer
1526968|NCT00673998|Isokinetic|isokinetic
1526969|NCT00673998|Fatigue|fatigue
1526970|NCT00673998|Strength|strength
1526971|NCT00673998|Older|older
1526972|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
1526973|NCT00673972|Functional dyspepsia|functional dyspepsia
1526974|NCT00673972|Gastric emptying|gastric emptying
1526975|NCT00673972|Helicobacter pylori|helicobacter pylori
1526976|NCT00673972|Lansoprazole|lansoprazole
1526977|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
1526978|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
1526979|NCT00673959|Dry eye|dry eye
1526980|NCT00673959|artificial tears|artificial tears
1526981|NCT00673946|bronchiolitis|bronchiolitis
1526982|NCT00673946|hospitalization|hospitalization
1526983|NCT00673946|oximetry|oximetry
1526984|NCT00673946|pediatrics|pediatrics
1526985|NCT00673920|RA|ra
1526986|NCT00673907|Wood smoke|wood smoke
1526987|NCT00673907|Health effects|health effects
1526988|NCT00673907|Human|human
1526989|NCT00673907|Airway inflammation|airway inflammation
1526990|NCT00673907|Cardiovascular effects|cardiovascular effects
1526991|NCT00673855|Dry eye|dry eye
1526992|NCT00673855|Artificial tear|artificial tear
1526993|NCT00673842|Noninvasive assessment|noninvasive assessment
1526994|NCT00673842|Holter|holter
1526995|NCT00673829|Breast Cancer|breast cancer
1526996|NCT00673829|T cells|t cells
1526997|NCT00673829|Gene Transfer|gene transfer
1526998|NCT00673816|Von Hippel Lindau|von hippel lindau
1526999|NCT00673816|Sunitinib Malate|sunitinib malate
1527000|NCT00673816|Sutent|sutent
1527001|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
1527003|NCT00673803|posterior capsule opacification|posterior capsule opacification
1527004|NCT00673803|micro incision|micro incision
1527005|NCT00673803|sharp optic edge|sharp optic edge
1527006|NCT00673790|nebivolol|nebivolol
1527007|NCT00673790|BYSTOLIC ™|bystolic ™
1527008|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
1527009|NCT00673790|lisinopril|lisinopril
1527010|NCT00673790|Prinivil (TM)|prinivil (tm)
1527011|NCT00673790|Zestril (TM)|zestril (tm)
1527012|NCT00673790|losartan|losartan
1527013|NCT00673790|Cozaar (TM)|cozaar (tm)
1527014|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
1527015|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
1527016|NCT00673790|hypertension|hypertension
1527017|NCT00673777|HLA-A*0201|hla-a*0201
1527018|NCT00673777|Peptide Vaccine|peptide vaccine
1527019|NCT00673777|URLC10|urlc10
1527020|NCT00673777|VEGFR1|vegfr1
1527021|NCT00673777|VEGFR2|vegfr2
1527022|NCT00673751|mesenteric blood flow|mesenteric blood flow
1527023|NCT00673751|GLP-2|glp-2
1527024|NCT00673751|short bowel syndrome|short bowel syndrome
1527025|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
1527026|NCT00673738|Lung|lung
1527027|NCT00673738|Thoracic|thoracic
1527028|NCT00673738|Immunotherapy|immunotherapy
1527029|NCT00673738|Radiotherapy|radiotherapy
1527030|NCT00673738|LA - NSCLC|la - nsclc
1527031|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
1527032|NCT00673725|Atopic Dermatitis|atopic dermatitis
1527033|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1527034|NCT00673712|Pneumonia|pneumonia
1527035|NCT00673712|Surgical Site Infection|surgical site infection
1527036|NCT00673699|NBI|nbi
1527038|NCT00673699|biopsy|biopsy
1527039|NCT00673699|intestinal metaplasia|intestinal metaplasia
1527040|NCT00673686|Oral contraceptive|oral contraceptive
1527041|NCT00673686|Ovulation|ovulation
1527042|NCT00673686|Missing pills|missing pills
1527043|NCT00673686|Intake compliance|intake compliance
1527044|NCT00673686|Cycle control|cycle control
1527045|NCT00673660|Statins|statins
1527046|NCT00673660|Compliance|compliance
1527047|NCT00673660|Dyslipidemia|dyslipidemia
1527048|NCT00673647|cannabis|cannabis
1527049|NCT00673647|dependence|dependence
1527050|NCT00673647|marijuana|marijuana
1527051|NCT00673647|CBT|cbt
1527154|NCT00673283|radiography|radiography
1527052|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
1527053|NCT00673634|preoxygenation|preoxygenation
1527054|NCT00673634|method|method
1527055|NCT00673634|efficiency|efficiency
1527056|NCT00673634|obesity|obesity
1527057|NCT00673634|BiPAP|bipap
1527058|NCT00673634|FeO2|feo2
1527059|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
1527060|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
1527061|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
1527062|NCT00673608|Transfusional iron overload,|transfusional iron overload,
1527063|NCT00673608|cardiac iron load|cardiac iron load
1527064|NCT00673595|smoking|smoking
1527065|NCT00673595|varenicline|varenicline
1527066|NCT00673595|flow-mediated dilation|flow-mediated dilation
1527067|NCT00673595|blood pressure|blood pressure
1527068|NCT00673595|baroreflex|baroreflex
1527069|NCT00673582|Statins|statins
1527070|NCT00673582|Intima Media Thickness|intima media thickness
1527071|NCT00673582|Plaque Area|plaque area
1527072|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1527073|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1527074|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1527075|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1527076|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
1527077|NCT00673556|Alefacept|alefacept
1527078|NCT00673543|Corticosteroids|corticosteroids
1527079|NCT00673543|Pregnancy|pregnancy
1527080|NCT00673543|Glucose control|glucose control
1527081|NCT00673530|Hospital malnutrition|hospital malnutrition
1527082|NCT00673530|Nutritional Status|nutritional status
1527083|NCT00673530|Nutrition Assessment|nutrition assessment
1527084|NCT00673530|Enteral Nutrition|enteral nutrition
1527085|NCT00673530|Parenteral Nutrition|parenteral nutrition
1527086|NCT00673530|Severity of illness index|severity of illness index
1527087|NCT00673530|cost analysis|cost analysis
1527088|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
1527089|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
1527090|NCT00673517|High frequency oscillation|high frequency oscillation
1527091|NCT00673517|Lung protective ventilation|lung protective ventilation
1527092|NCT00673517|Biomarkers|biomarkers
1527093|NCT00673517|Biotrauma|biotrauma
1527094|NCT00673504|cancer|cancer
1527095|NCT00673504|pancreatic cancer|pancreatic cancer
1527096|NCT00673504|gemcitabine|gemcitabine
1527097|NCT00673504|sunitinib|sunitinib
1527098|NCT00673504|Phase 2|phase 2
1527099|NCT00673491|Critical Pathways|critical pathways
1527100|NCT00673491|Stroke|stroke
1527101|NCT00673491|Randomized Controlled Trial|randomized controlled trial
1527102|NCT00673491|Effectiveness|effectiveness
1527103|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1527104|NCT00673439|thrombocytopenia|thrombocytopenia
1527105|NCT00673439|HIT|hit
1527106|NCT00673439|thrombosis|thrombosis
1527107|NCT00673439|blood clot|blood clot
1527108|NCT00673439|blood thinner|blood thinner
1527109|NCT00673439|anticoagulant|anticoagulant
1527110|NCT00673439|heparin|heparin
1527111|NCT00673439|warfarin|warfarin
1527112|NCT00673439|fondaparinux|fondaparinux
1527113|NCT00673439|Arixtra|arixtra
1527114|NCT00673426|enoxaparin|enoxaparin
1527115|NCT00673426|chronic renal disease|chronic renal disease
1527116|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
1527117|NCT00673413|Perception|perception
1527118|NCT00673413|Emotions|emotions
1527119|NCT00673413|Adaptation|adaptation
1527120|NCT00673413|Estomia|estomia
1527121|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
1527122|NCT00673400|ODS|ods
1527123|NCT00673400|Rectocele|rectocele
1527124|NCT00673400|Intussusception|intussusception
1527125|NCT00673400|STARR|starr
1527126|NCT00673387|overweight|overweight
1527127|NCT00673387|obesity|obesity
1527128|NCT00673387|pramlintide|pramlintide
1527129|NCT00673387|metreleptin|metreleptin
1527130|NCT00673387|Amylin|amylin
1527131|NCT00673374|emergency|emergency
1527132|NCT00673374|acute|acute
1527133|NCT00673374|nontraumatic|nontraumatic
1527134|NCT00673374|abdominal pain|abdominal pain
1527135|NCT00673374|tenderness|tenderness
1527136|NCT00673374|CT scan|ct scan
1527137|NCT00673374|radiation|radiation
1527138|NCT00673374|diagnosis|diagnosis
1527139|NCT00673348|Mycoses|mycoses
1527140|NCT00673348|Voriconazole|voriconazole
1527141|NCT00673335|breast cancer|breast cancer
1527142|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
1527143|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
1527144|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
1527145|NCT00673322|Colorectal Cancer|colorectal cancer
1527146|NCT00673322|T cells|t cells
1527147|NCT00673322|Gene Transfer|gene transfer
1527148|NCT00673309|burns|burns
1527149|NCT00673296|Bevacizumab|bevacizumab
1527150|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
1527151|NCT00673296|Intravitreal gas|intravitreal gas
1527152|NCT00673283|lung cancer|lung cancer
1527153|NCT00673283|nodules|nodules
1527155|NCT00673283|CT|ct
1527156|NCT00673283|Stereoscopy|stereoscopy
1527157|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1527158|NCT00673244|Renal Replacement Therapy|renal replacement therapy
1527159|NCT00673244|Dialysis|dialysis
1527160|NCT00673231|Dapagliflozin|dapagliflozin
1527161|NCT00673231|efficacy|efficacy
1527162|NCT00673231|safety|safety
1527163|NCT00673231|add on to insulin|add on to insulin
1527164|NCT00673231|Oral AntiDiabetic|oral antidiabetic
1527165|NCT00673231|Type 2 diabetes|type 2 diabetes
1527166|NCT00673218|IL13|il13
1527167|NCT00673218|Cytokines|cytokines
1527168|NCT00673218|Basophil stimulation|basophil stimulation
1527169|NCT00673205|androgen antagonists|androgen antagonists
1527170|NCT00673205|prostate neoplasms|prostate neoplasms
1527171|NCT00673179|Doxorubicin|doxorubicin
1527172|NCT00673179|AD|ad
1527173|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1527174|NCT00673179|Cisplatin|cisplatin
1527175|NCT00673179|Paraplatin®|paraplatin®
1527176|NCT00673179|Methotrexate|methotrexate
1527177|NCT00673179|Ifosfamide|ifosfamide
1527178|NCT00673179|Osteosarcoma|osteosarcoma
1527179|NCT00673179|Sargramostim|sargramostim
1527180|NCT00673179|Leukine™|leukine™
1527181|NCT00673179|Leucovorin|leucovorin
1527182|NCT00673179|Gemcitabine|gemcitabine
1527183|NCT00673179|Gemzar|gemzar
1527184|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1527185|NCT00673179|GM-CSF|gm-csf
1527186|NCT00673179|Questionnaire|questionnaire
1527187|NCT00673179|Survey|survey
1527188|NCT00673166|Staff motivation|staff motivation
1527189|NCT00673166|Hospital mortality|hospital mortality
1527190|NCT00673166|Perception of quality of care|perception of quality of care
1527191|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
1527192|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
1527193|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
1527194|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
1527195|NCT00673140|Gehrig's Disease|gehrig's disease
1527196|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
1527197|NCT00673140|Lou Gehrig Disease|lou gehrig disease
1527198|NCT00673127|hormone refractory|hormone refractory
1527200|NCT00673127|ketoconazole|ketoconazole
1527201|NCT00673127|dutasteride|dutasteride
1527202|NCT00673127|hydrocortisone|hydrocortisone
1527203|NCT00673114|Haplo/cord|haplo/cord
1527204|NCT00673114|hematologic malignancy|hematologic malignancy
1527205|NCT00673114|MDS|mds
1527206|NCT00673114|Aplastic Anemia|aplastic anemia
1527207|NCT00673114|AML|aml
1527208|NCT00673114|ALL|all
1527209|NCT00673114|CML|cml
1527210|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
1527211|NCT00673101|FibroScan|fibroscan
1527212|NCT00673101|transient elastography|transient elastography
1527213|NCT00673101|elastometry|elastometry
1527214|NCT00673101|methotrexate|methotrexate
1527215|NCT00673101|non invasive blood markers|non invasive blood markers
1527216|NCT00673101|FibroTest|fibrotest
1527217|NCT00673101|treatment|treatment
1527218|NCT00673075|carvedilol|carvedilol
1527219|NCT00673075|Coreg (TM)|coreg (tm)
1527220|NCT00673075|hypertension|hypertension
1527221|NCT00673075|blood pressure|blood pressure
1527222|NCT00673075|coronary artery disease|coronary artery disease
1527223|NCT00673075|Nebivolol|nebivolol
1527224|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
1527225|NCT00673049|IGR-1R|igr-1r
1527226|NCT00673049|Non small cell lung cancer|non small cell lung cancer
1527227|NCT00673049|CP-751|cp-751
1527228|NCT00673049|871|871
1527229|NCT00673049|Figitumumab|figitumumab
1527230|NCT00673036|Coronary syndrome|coronary syndrome
1527231|NCT00673036|Myocardial infarction|myocardial infarction
1527232|NCT00673036|French registry|french registry
1527233|NCT00673010|124-IODINE|124-iodine
1527234|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
1527235|NCT00673010|Thyroid|thyroid
1527236|NCT00673010|Parathyroid|parathyroid
1527237|NCT00672997|Glaucoma|glaucoma
1527238|NCT00672997|Hypertension|hypertension
1527239|NCT00672984|QT/QTc|qt/qtc
1527240|NCT00672958|Major Depressive Disorder|major depressive disorder
1527241|NCT00672958|Depression|depression
1527242|NCT00672958|Drug Therapy|drug therapy
1527243|NCT00672958|Major Depressive Episode|major depressive episode
1527244|NCT00672932|raltegravir|raltegravir
1527245|NCT00672932|central nervous system (CNS)|central nervous system (cns)
1527246|NCT00672932|HIV-1|hiv-1
1527247|NCT00672932|AIDS|aids
1527248|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
1527249|NCT00672932|immunoactivation|immunoactivation
1527250|NCT00672932|antiretroviral therapy|antiretroviral therapy
1527251|NCT00672932|suppression|suppression
1527252|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
1527253|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
1527254|NCT00672919|Type II Diabetes|type ii diabetes
1527255|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1527256|NCT00672919|Dyslipidemia|dyslipidemia
1527257|NCT00672919|Drug Therapy|drug therapy
1527258|NCT00672906|anorexia nervosa|anorexia nervosa
1527259|NCT00672906|group parent training|group parent training
1527260|NCT00672906|caregiver burden|caregiver burden
1527261|NCT00672906|eating disorders|eating disorders
1527262|NCT00672906|treatment|treatment
1527263|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
1527264|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
1527265|NCT00672854|parenteral nutrition|parenteral nutrition
1527266|NCT00672854|lipid emulsion|lipid emulsion
1527267|NCT00672854|nosocomial infection|nosocomial infection
1527268|NCT00672854|mortality|mortality
1527269|NCT00672854|endothelial function|endothelial function
1527270|NCT00672854|inflammatory markers|inflammatory markers
1527271|NCT00672854|oxidative stress|oxidative stress
1527272|NCT00672854|immune function|immune function
1527273|NCT00672854|autonomic nervous system|autonomic nervous system
1527274|NCT00672854|insulin sensitivity|insulin sensitivity
1527275|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
1527276|NCT00672841|candidemia|candidemia
1527277|NCT00672841|invasive candidiasis|invasive candidiasis
1527278|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
1527279|NCT00672841|surveillance|surveillance
1527280|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
1527281|NCT00672828|colon cancer|colon cancer
1527282|NCT00672828|rectal cancer|rectal cancer
1527283|NCT00672815|coordinated school health|coordinated school health
1527284|NCT00672815|school health policy evaluation|school health policy evaluation
1527285|NCT00672815|physical activity|physical activity
1527286|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1527287|NCT00672802|COPD|copd
1527288|NCT00672802|Insomnia|insomnia
1527289|NCT00672802|Drug Therapy|drug therapy
1527290|NCT00672789|Sickle cell anemia|sickle cell anemia
1527291|NCT00672789|Children|children
1527292|NCT00672789|Hydroxyurea|hydroxyurea
1527293|NCT00672789|Treatment Adherence|treatment adherence
1527294|NCT00672776|hippocampus|hippocampus
1527295|NCT00672776|paroxetine|paroxetine
1527296|NCT00672776|stress|stress
1527297|NCT00672776|PTSD|ptsd
1527298|NCT00672763|Crohn's Disease|crohn's disease
1527299|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
1527300|NCT00672763|Vitamin D|vitamin d
1527301|NCT00672763|Randomised|randomised
1527302|NCT00672763|Placebo|placebo
1527303|NCT00672750|laparoscopic|laparoscopic
1527304|NCT00672750|myomectomy|myomectomy
1527305|NCT00672750|menorrhagia|menorrhagia
1527306|NCT00672750|pelvic pain|pelvic pain
1527307|NCT00672724|Insomnia|insomnia
1527308|NCT00672724|Sleep Disorder|sleep disorder
1527309|NCT00672724|Drug Therapy|drug therapy
1527310|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
1527311|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
1527312|NCT00672711|Genetic susceptibility|genetic susceptibility
1527313|NCT00672711|COMT|comt
1527314|NCT00672698|SURGICAL RISK|surgical risk
1527315|NCT00672698|ELDERLY|elderly
1527316|NCT00672698|MAJOR SURGERY|major surgery
1527317|NCT00672698|P-POSSUM|p-possum
1527318|NCT00672698|SAPS II|saps ii
1527319|NCT00672685|Cognitive decline|cognitive decline
1527320|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
1527321|NCT00672685|nutrition|nutrition
1527322|NCT00672685|physical exercise|physical exercise
1527323|NCT00672685|cognitive training|cognitive training
1527324|NCT00672685|social activities|social activities
1527325|NCT00672685|frailty|frailty
1527326|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
1527327|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
1527328|NCT00672646|Analgesic effect|analgesic effect
1527329|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
1527330|NCT00672633|Triglycerides|triglycerides
1527331|NCT00672633|Lovaza|lovaza
1527332|NCT00672633|Trial|trial
1527333|NCT00672620|Major Depressive Disorder|major depressive disorder
1527334|NCT00672620|Depression|depression
1527335|NCT00672620|Drug Therapy|drug therapy
1527336|NCT00672620|Major Depressive Episode|major depressive episode
1527337|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
1527338|NCT00672581|Hepatic Impairment|hepatic impairment
1527339|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
1527340|NCT00672555|pilonidal sinus|pilonidal sinus
1527341|NCT00672555|recurrence|recurrence
1527342|NCT00672555|Limberg flap|limberg flap
1527343|NCT00672542|melanoma|melanoma
1527344|NCT00672542|dendritic cell|dendritic cell
1527345|NCT00672542|immunoproteasome|immunoproteasome
1527346|NCT00672542|vaccine|vaccine
1527347|NCT00672529|Childhood Asthma|childhood asthma
1527348|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
1527349|NCT00672529|Alternative Medicine|alternative medicine
1527350|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
1527351|NCT00672516|hemorrhage|hemorrhage
1527352|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
1527353|NCT00672516|blood component transfusion|blood component transfusion
1527354|NCT00672516|hemostasis, surgical|hemostasis, surgical
1527355|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
1527356|NCT00672503|urinary tract infections|urinary tract infections
1527357|NCT00672503|foley-catheter related infections|foley-catheter related infections
1527358|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
1527359|NCT00672490|Acute Mania|acute mania
1527360|NCT00672490|Bipolar Disorder|bipolar disorder
1527361|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
1527362|NCT00672490|Lithium|lithium
1527363|NCT00672477|opioid-induced constipation|opioid-induced constipation
1527364|NCT00672464|Schizophrenia|schizophrenia
1527365|NCT00672464|Schizoaffective|schizoaffective
1527366|NCT00672464|Cardiovascular|cardiovascular
1527367|NCT00672464|Olanzapine|olanzapine
1527368|NCT00672464|Metformin|metformin
1527369|NCT00672464|Simvastatin|simvastatin
1527370|NCT00672451|diabetic kidney disease|diabetic kidney disease
1527371|NCT00672451|albuminuria|albuminuria
1527372|NCT00672412|Treatment Experienced|treatment experienced
1527373|NCT00672399|Amylin|amylin
1527374|NCT00672399|Eli Lilly|eli lilly
1527375|NCT00672399|exenatide|exenatide
1527376|NCT00672399|moxifloxacin|moxifloxacin
1527377|NCT00672386|Diabetes|diabetes
1527378|NCT00672386|Type 2 Diabetes|type 2 diabetes
1527379|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
1527380|NCT00672386|Metabolic Syndrome|metabolic syndrome
1527381|NCT00672386|HbA1c|hba1c
1527382|NCT00672386|Body Weight|body weight
1527383|NCT00672386|Metformin|metformin
1527384|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
1527385|NCT00672373|Schizophrenia|schizophrenia
1527386|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
1527387|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
1527388|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
1527389|NCT00672334|Cardiac surgery|cardiac surgery
1527390|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
1527391|NCT00672334|Oxidative stress|oxidative stress
1527392|NCT00672334|Acute renal dysfunction|acute renal dysfunction
1527393|NCT00672334|Sodium bicarbonate|sodium bicarbonate
1527394|NCT00672321|recurrent melanoma|recurrent melanoma
1527395|NCT00672321|stage IB melanoma|stage ib melanoma
1527396|NCT00672321|stage II melanoma|stage ii melanoma
1527397|NCT00672321|stage IIIA melanoma|stage iiia melanoma
1527398|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
1527399|NCT00672295|Ovarian Cancer|ovarian cancer
1527400|NCT00672295|Peritoneal Cancer|peritoneal cancer
1527401|NCT00672295|Tubal Cancer|tubal cancer
1527402|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
1527403|NCT00672295|Dasatinib|dasatinib
1527404|NCT00672295|Sprycel|sprycel
1527405|NCT00672295|Paclitaxel|paclitaxel
1527406|NCT00672295|Taxol|taxol
1527407|NCT00672295|Carboplatin|carboplatin
1527408|NCT00672295|Paraplatin|paraplatin
1527409|NCT00672282|androgen antagonists|androgen antagonists
1527410|NCT00672282|prostate neoplasms|prostate neoplasms
1527411|NCT00672269|carcinoid|carcinoid
1527412|NCT00672269|family members|family members
1527413|NCT00672269|familial|familial
1527414|NCT00672269|tumors|tumors
1527415|NCT00672269|cancer|cancer
1527416|NCT00672256|Smoking|smoking
1527417|NCT00672256|fMRI|fmri
1527418|NCT00672243|GBM|gbm
1527419|NCT00672243|Brain tumor|brain tumor
1527420|NCT00672243|Erlotinib|erlotinib
1527421|NCT00672243|Sirolimus|sirolimus
1527422|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
1527423|NCT00672243|Glioblastoma|glioblastoma
1527424|NCT00672243|Gliosarcoma3|gliosarcoma3
1527425|NCT00672243|Tarceva|tarceva
1527426|NCT00672243|Rapamune|rapamune
1527427|NCT00672230|Lactation|lactation
1527428|NCT00672230|Breast milk|breast milk
1527429|NCT00672230|Lutein|lutein
1527430|NCT00672230|Lutein supplement|lutein supplement
1527431|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
1527432|NCT00672204|Islet transplant|islet transplant
1527433|NCT00672204|Diabetes Mellitus|diabetes mellitus
1527434|NCT00672204|Hypoglycemia|hypoglycemia
1527435|NCT00672191|HIV|hiv
1527436|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
1527437|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
1527438|NCT00672191|HIV-1|hiv-1
1527439|NCT00672191|ART|art
1527440|NCT00672191|antiretroviral therapy|antiretroviral therapy
1527441|NCT00672191|HAART|haart
1527442|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
1527443|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
1527444|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
1527445|NCT00672191|Treatment Experienced|treatment experienced
1527446|NCT00672178|RCC|rcc
1527447|NCT00672178|metastatic|metastatic
1527448|NCT00672178|sorafenib|sorafenib
1527449|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
1527450|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
1527451|NCT00672165|02-017|02-017
1527452|NCT00672152|Autologous transplantation|autologous transplantation
1527549|NCT00671801|Irinotecan|irinotecan
1527453|NCT00672152|Allogeneic transplantation|allogeneic transplantation
1527454|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
1527455|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
1527456|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
1527457|NCT00672100|post-operative pain|post-operative pain
1527458|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
1527459|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
1527460|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
1527461|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
1527462|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
1527463|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
1527464|NCT00672074|Postoperative Ileus|postoperative ileus
1527465|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
1527466|NCT00672061|Insomnia|insomnia
1527467|NCT00672061|Drug Therapy|drug therapy
1527468|NCT00672048|glaucoma|glaucoma
1527469|NCT00672048|optometrists|optometrists
1527470|NCT00672035|LT|lt
1527471|NCT00672035|Healthy Adults|healthy adults
1527472|NCT00672035|Dose Ranging|dose ranging
1527473|NCT00672035|Patch|patch
1527474|NCT00672035|Vaccine|vaccine
1527475|NCT00672009|prostate cancer|prostate cancer
1527476|NCT00672009|radical prostatectomy|radical prostatectomy
1527477|NCT00672009|ixabepilone|ixabepilone
1527478|NCT00671970|Glioblastoma|glioblastoma
1527479|NCT00671970|Gliosarcoma|gliosarcoma
1527480|NCT00671970|Recurrent MG|recurrent mg
1527481|NCT00671970|Malignant glioma|malignant glioma
1527482|NCT00671970|Glioma|glioma
1527483|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1527484|NCT00671970|GBM|gbm
1527485|NCT00671970|Brain tumor|brain tumor
1527486|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
1527487|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1527488|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1527489|NCT00671970|Bevacizumab|bevacizumab
1527490|NCT00671970|Avastin|avastin
1527491|NCT00671970|Erlotinib|erlotinib
1527492|NCT00671970|Tarceva|tarceva
1527493|NCT00671957|Obesity|obesity
1527494|NCT00671957|Bariatric|bariatric
1527495|NCT00671957|Surgery|surgery
1527496|NCT00671957|Activity|activity
1527497|NCT00671944|protein|protein
1527498|NCT00671944|calcium|calcium
1527499|NCT00671944|parathyroid hormone|parathyroid hormone
1527500|NCT00671944|bone markers|bone markers
1527501|NCT00671944|calcium kinetics|calcium kinetics
1527502|NCT00671944|absorption|absorption
1527503|NCT00671931|dexmedetomidine|dexmedetomidine
1527504|NCT00671931|neuromonitoring|neuromonitoring
1527505|NCT00671931|spine procedures|spine procedures
1527506|NCT00671931|safe dose|safe dose
1527507|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
1527508|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
1527509|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
1527510|NCT00671918|breast cancer|breast cancer
1527511|NCT00671918|lymph nodes|lymph nodes
1527512|NCT00671918|melanoma|melanoma
1527513|NCT00671918|surgery|surgery
1527514|NCT00671905|atrial fibrillation|atrial fibrillation
1527515|NCT00671905|PV isolation|pv isolation
1527516|NCT00671905|ablation|ablation
1527517|NCT00671905|ganglionic plexi|ganglionic plexi
1527518|NCT00671905|parasympathetic denervation|parasympathetic denervation
1527519|NCT00671892|LPS endotoxin|lps endotoxin
1527520|NCT00671892|asthma|asthma
1527521|NCT00671866|OP|op
1527522|NCT00671866|Pesticides|pesticides
1527523|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
1527524|NCT00671866|Occupational Health|occupational health
1527525|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
1527526|NCT00671853|Bipolar Disorder|bipolar disorder
1527527|NCT00671853|Anxiety|anxiety
1527528|NCT00671853|Anxiety Disorders|anxiety disorders
1527529|NCT00671853|Substance Use Disorders|substance use disorders
1527530|NCT00671827|Gynecologic Cancer|gynecologic cancer
1527531|NCT00671827|Cervical Cancer|cervical cancer
1527532|NCT00671827|Endometrial Cancer|endometrial cancer
1527533|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
1527534|NCT00671827|Ovarian Cancer|ovarian cancer
1527535|NCT00671827|Uterine Cancer|uterine cancer
1527536|NCT00671827|Vaginal Cancer|vaginal cancer
1527537|NCT00671827|Vulvar Cancer|vulvar cancer
1527538|NCT00671827|Questionnaire|questionnaire
1527539|NCT00671827|Survey|survey
1527540|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
1527541|NCT00671814|antibiotic|antibiotic
1527542|NCT00671801|Malignant Gliomas|malignant gliomas
1527543|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
1527544|NCT00671801|Gliosarcoma|gliosarcoma
1527545|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
1527546|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
1527547|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
1527548|NCT00671801|Camptosar|camptosar
1527550|NCT00671801|CPT-11|cpt-11
1527551|NCT00671801|Lenalidomide|lenalidomide
1527552|NCT00671801|Revlimid|revlimid
1527553|NCT00671801|CC-5013|cc-5013
1527554|NCT00671775|Bariatric Surgery|bariatric surgery
1527555|NCT00671775|Obesity|obesity
1527556|NCT00671775|Cognitive Function|cognitive function
1527557|NCT00671736|cystic fibrosis|cystic fibrosis
1527558|NCT00671736|Moli1901|moli1901
1527559|NCT00671736|Lancovutide|lancovutide
1527560|NCT00671736|2622U90|2622u90
1527561|NCT00671736|duramycin|duramycin
1527562|NCT00671736|lung|lung
1527563|NCT00671723|Atelectasis|atelectasis
1527564|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
1527565|NCT00671697|MDS|mds
1527566|NCT00671697|hypomethylating agent|hypomethylating agent
1527567|NCT00671697|oxidative stress|oxidative stress
1527568|NCT00671684|Hirschsprung's disease|hirschsprung's disease
1527569|NCT00671684|Constipation|constipation
1527570|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
1527571|NCT00671684|Diagnosis|diagnosis
1527572|NCT00671684|Colonoscopy|colonoscopy
1527573|NCT00671658|Lymphoma|lymphoma
1527574|NCT00671658|HYPER-CVAD|hyper-cvad
1527575|NCT00671658|Leukemia|leukemia
1527576|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1527577|NCT00671658|ALL|all
1527578|NCT00671658|Remission Duration|remission duration
1527579|NCT00671658|Chemotherapy|chemotherapy
1527580|NCT00671658|Asparaginase|asparaginase
1527581|NCT00671658|Cyclophosphamide|cyclophosphamide
1527582|NCT00671658|Cytarabine|cytarabine
1527583|NCT00671658|Dexamethasone|dexamethasone
1527584|NCT00671658|Doxorubicin|doxorubicin
1527585|NCT00671658|Leukine|leukine
1527586|NCT00671658|Methotrexate|methotrexate
1527587|NCT00671658|Rituximab|rituximab
1527588|NCT00671658|Vincristine|vincristine
1527589|NCT00671645|pilot study|pilot study
1527590|NCT00671645|rectal|rectal
1527591|NCT00671645|carcinoma|carcinoma
1527592|NCT00671645|phase II|phase ii
1527593|NCT00671645|preoperative|preoperative
1527594|NCT00671645|RadioChemo|radiochemo
1527595|NCT00671645|molecular|molecular
1527596|NCT00671645|target|target
1527597|NCT00671645|therapy|therapy
1527598|NCT00671645|T3|t3
1527599|NCT00671645|ABCSG|abcsg
1527600|NCT00671645|TAKO|tako
1527602|NCT00671645|08|08
1527603|NCT00671632|Addiction|addiction
1527604|NCT00671619|opthalmology|opthalmology
1527605|NCT00671619|antibody fragment|antibody fragment
1527606|NCT00671619|TNF alpha|tnf alpha
1527607|NCT00671606|Endometrial Cancer|endometrial cancer
1527608|NCT00671606|Lymphatic Mapping|lymphatic mapping
1527609|NCT00671606|Sentinel Node Identification|sentinel node identification
1527610|NCT00671606|Lymph Node|lymph node
1527611|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
1527612|NCT00671606|Total hysterectomy|total hysterectomy
1527613|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
1527614|NCT00671606|Lymph node staging|lymph node staging
1527615|NCT00671606|Laparotomy|laparotomy
1527616|NCT00671606|Laparoscopy|laparoscopy
1527617|NCT00671593|Allergy|allergy
1527618|NCT00671593|Asthma|asthma
1527619|NCT00671593|healthy|healthy
1527620|NCT00671593|Normal|normal
1527621|NCT00671580|Skin Infections|skin infections
1527622|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
1527623|NCT00671567|Sleep Disorder|sleep disorder
1527624|NCT00671567|Insomnia|insomnia
1527625|NCT00671554|Melanoma|melanoma
1527626|NCT00671554|Dendritic cells|dendritic cells
1527627|NCT00671554|Cell therapy|cell therapy
1527628|NCT00671554|BCG vaccine|bcg vaccine
1527629|NCT00671528|Impetiginous|impetiginous
1527630|NCT00671515|Depressive Disorder, Major|depressive disorder, major
1527631|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
1527632|NCT00671515|pioglitazone|pioglitazone
1527633|NCT00671489|Patients|patients
1527634|NCT00671489|high-energy|high-energy
1527635|NCT00671489|admitted|admitted
1527636|NCT00671489|intensive care unit|intensive care unit
1527637|NCT00671489|motor vehicle accident|motor vehicle accident
1527638|NCT00671489|falling from height|falling from height
1527639|NCT00671489|other accident|other accident
1527640|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1527641|NCT00671463|Pancreas surgery|pancreas surgery
1527642|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1527919|NCT00670514|follow-up|follow-up
1527643|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
1527644|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
1527645|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1527646|NCT00671424|Interaction,|interaction,
1527647|NCT00671424|Diabetes,|diabetes,
1527648|NCT00671424|healthy male subjects|healthy male subjects
1527649|NCT00671424|GSK189075,|gsk189075,
1527650|NCT00671424|Diuretics,|diuretics,
1527651|NCT00671411|Ultrasound|ultrasound
1527652|NCT00671411|07-165|07-165
1527653|NCT00671398|Insomnia|insomnia
1527654|NCT00671398|Sleep Disorder|sleep disorder
1527655|NCT00671398|Drug Therapy|drug therapy
1527656|NCT00671385|screening|screening
1527657|NCT00671385|compositional analysis|compositional analysis
1527658|NCT00671385|metabolism|metabolism
1527659|NCT00671385|breast|breast
1527660|NCT00671385|breast cyst|breast cyst
1527661|NCT00671385|breast infection|breast infection
1527662|NCT00671385|breast inflammation|breast inflammation
1527663|NCT00671385|lipoma|lipoma
1527664|NCT00671385|benign growth|benign growth
1527665|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
1527666|NCT00671372|CRC|crc
1527667|NCT00671372|Metastatic CRC|metastatic crc
1527668|NCT00671372|APO2L/TRAIL|apo2l/trail
1527669|NCT00671359|Food effects|food effects
1527670|NCT00671346|Cancer|cancer
1527671|NCT00671346|Coronary artery disease|coronary artery disease
1527672|NCT00671346|Myocardial infarction|myocardial infarction
1527673|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
1527674|NCT00671346|Homocysteine|homocysteine
1527675|NCT00671346|Vitamin B Complex|vitamin b complex
1527676|NCT00671346|Folic acid|folic acid
1527677|NCT00671346|Vitamin B12|vitamin b12
1527678|NCT00671346|Vitamin B6|vitamin b6
1527679|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
1527680|NCT00671346|Osteoporotic fractures|osteoporotic fractures
1527681|NCT00671346|Diabetes|diabetes
1527682|NCT00671333|Randomized|randomized
1527683|NCT00671333|Prospective|prospective
1527684|NCT00671333|Procedure / Surgery|procedure / surgery
1527685|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
1527686|NCT00671307|Gelsolin|gelsolin
1527687|NCT00671307|Trauma|trauma
1527688|NCT00671307|Pneumonia|pneumonia
1527689|NCT00671307|Peritonitis|peritonitis
1527690|NCT00671307|Burn|burn
1527691|NCT00671307|Infection|infection
1527692|NCT00671307|Sepsis|sepsis
1527693|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1527694|NCT00671294|Insomnia|insomnia
1527695|NCT00671281|FESS|fess
1527696|NCT00671281|Tranexamic acid|tranexamic acid
1527697|NCT00671281|Hemostasis|hemostasis
1527698|NCT00671281|Visualization|visualization
1527699|NCT00671268|Grass pollen allergy|grass pollen allergy
1527700|NCT00671268|specific immunotherapy|specific immunotherapy
1527701|NCT00671255|Chronic Insomnia|chronic insomnia
1527702|NCT00671255|Drug Therapy|drug therapy
1527704|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
1527705|NCT00671242|Positron emission tomography,|positron emission tomography,
1527706|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
1527707|NCT00671242|Lung cancer,|lung cancer,
1527708|NCT00671242|Angiogenesis|angiogenesis
1527709|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
1527710|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
1527711|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
1527712|NCT00671229|Healthy|healthy
1527713|NCT00671229|Asthma|asthma
1527714|NCT00671229|Nitric Oxide|nitric oxide
1527715|NCT00671216|safety|safety
1527716|NCT00671216|pharmacodynamics|pharmacodynamics
1527717|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
1527718|NCT00671216|tolerability|tolerability
1527719|NCT00671216|healthy subjects|healthy subjects
1527720|NCT00671216|GS642444|gs642444
1527721|NCT00671216|GSK233705|gsk233705
1527722|NCT00671216|Anticholinergic|anticholinergic
1527723|NCT00671216|ß2 agonist|ß2 agonist
1527724|NCT00671216|pharmacokinetics|pharmacokinetics
1527725|NCT00671203|Tissue oximetry|tissue oximetry
1527726|NCT00671203|Ischemia|ischemia
1527727|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
1527728|NCT00671203|Aortic Stent|aortic stent
1527729|NCT00671203|Vascular Stent|vascular stent
1527730|NCT00671203|Aortic graft|aortic graft
1527731|NCT00671203|Vascular graft|vascular graft
1527732|NCT00671190|Sleep Disorder|sleep disorder
1527733|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
1527734|NCT00671190|Drug Therapy|drug therapy
1527735|NCT00671177|colonoscopy|colonoscopy
1527736|NCT00671177|diagnostic techniques|diagnostic techniques
1527737|NCT00671177|digestive system|digestive system
1527738|NCT00671177|endoscopy|endoscopy
1527739|NCT00671177|gastrointestinal|gastrointestinal
1527740|NCT00671151|COPD exacerbation|copd exacerbation
1527741|NCT00671151|histone|histone
1527742|NCT00671151|steroid resistance|steroid resistance
1527743|NCT00671151|inflammation|inflammation
1527744|NCT00671151|theophylline|theophylline
1527745|NCT00671138|Celiac disease|celiac disease
1527746|NCT00671138|Parasitic infections|parasitic infections
1527747|NCT00671138|necator americanus|necator americanus
1527748|NCT00671138|Immunity|immunity
1527749|NCT00671125|Sleep Disorder|sleep disorder
1527750|NCT00671125|Insomnia|insomnia
1527751|NCT00671125|Drug Therapy|drug therapy
1527752|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1527753|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1527754|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1528215|NCT00669097|TKI258|tki258
1527755|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1527756|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1527757|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1527758|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1527759|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1527760|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1527761|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1527762|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
1527763|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1527764|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1527765|NCT00671112|hairy cell leukemia|hairy cell leukemia
1527766|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
1527767|NCT00671112|transformed lymphoma|transformed lymphoma
1527768|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
1527769|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
1527770|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
1527771|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1527772|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
1527773|NCT00671112|PTCL-NOS|ptcl-nos
1527774|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
1527775|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
1527776|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
1527777|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
1527778|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
1527779|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1527780|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
1527781|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
1527782|NCT00671099|Patients|patients
1527783|NCT00671099|with high-energy|with high-energy
1527784|NCT00671099|admitted|admitted
1688895|NCT00078806|SOJRA|sojra
1527785|NCT00671099|intensive care unit|intensive care unit
1527786|NCT00671099|motor vehicle accident|motor vehicle accident
1527787|NCT00671099|falling from height|falling from height
1527788|NCT00671099|other accident|other accident
1527789|NCT00671086|Chronic Insomnia|chronic insomnia
1527790|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
1527791|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
1527792|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
1527793|NCT00671086|Transient Insomnia|transient insomnia
1527794|NCT00671086|Drug Therapy|drug therapy
1527795|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
1527796|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
1527797|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
1527798|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1527799|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1527800|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1527801|NCT00671073|COPD|copd
1527802|NCT00671073|COAD|coad
1527803|NCT00671060|intrauterine fetal death|intrauterine fetal death
1527804|NCT00671060|misoprostol|misoprostol
1527805|NCT00671047|Autoimmune Diseases|autoimmune diseases
1527806|NCT00671047|Lupus|lupus
1527807|NCT00671021|platelet aggregation|platelet aggregation
1527808|NCT00671021|aspirin|aspirin
1527809|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
1527810|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
1527811|NCT00670982|HER2 positive|her2 positive
1527812|NCT00670982|bevacizumab|bevacizumab
1527813|NCT00670982|vinorelbine|vinorelbine
1527814|NCT00670982|trastuzumab|trastuzumab
1527815|NCT00670969|Obesity|obesity
1527816|NCT00670956|prenatal steroids|prenatal steroids
1527817|NCT00670956|hydrops|hydrops
1527818|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
1527819|NCT00670956|prenatal intervention|prenatal intervention
1527820|NCT00670956|betamethasone|betamethasone
1527821|NCT00670956|prenatal diagnosis|prenatal diagnosis
1527822|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
1527823|NCT00670943|Platelet aggregation|platelet aggregation
1527824|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
1527826|NCT00670917|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1527827|NCT00670904|Smoking cessation|smoking cessation
1527828|NCT00670904|Pharmacist-delivered|pharmacist-delivered
1527829|NCT00670865|Hospitalization|hospitalization
1527830|NCT00670865|Continuity of care|continuity of care
1527831|NCT00670865|Discharge summary|discharge summary
1527832|NCT00670865|Quality improvement|quality improvement
1527833|NCT00670865|Medical records systems|medical records systems
1527834|NCT00670865|Hospital information systems|hospital information systems
1527835|NCT00670852|Glenoid component|glenoid component
1527836|NCT00670852|radiolucent lines|radiolucent lines
1527837|NCT00670852|Glenoid loosening|glenoid loosening
1527838|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
1527839|NCT00670852|autologous bone graft|autologous bone graft
1527840|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
1527841|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
1527842|NCT00670839|HIV infection|hiv infection
1527843|NCT00670826|Patient warming|patient warming
1527844|NCT00670813|Depression|depression
1527845|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
1527846|NCT00670813|Modafinil|modafinil
1527847|NCT00670813|polysomnography sleep|polysomnography sleep
1527848|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
1527849|NCT00670800|Insulin resistance|insulin resistance
1527850|NCT00670800|Metformin|metformin
1527851|NCT00670800|Brain function|brain function
1527852|NCT00670787|Hypertension|hypertension
1527853|NCT00670787|combination pill|combination pill
1527854|NCT00670787|compliance|compliance
1527855|NCT00670774|Kidney|kidney
1527856|NCT00670774|Transplant|transplant
1527857|NCT00670774|donor|donor
1527858|NCT00670761|misoprostol|misoprostol
1527859|NCT00670761|incomplete abortion|incomplete abortion
1527860|NCT00670761|sublingual|sublingual
1527861|NCT00670761|postabortion care|postabortion care
1527862|NCT00670761|MVA|mva
1527863|NCT00670748|Metastatic Cancer|metastatic cancer
1527864|NCT00670748|Gene Therapy|gene therapy
1527865|NCT00670748|Immunotherapy|immunotherapy
1527866|NCT00670748|Tumor Regression|tumor regression
1527867|NCT00670748|Metastatic Melanoma|metastatic melanoma
1527868|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1527869|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
1527870|NCT00670709|encephalography|encephalography
1527871|NCT00670709|quantitative|quantitative
1527872|NCT00670709|biomarkers|biomarkers
1527873|NCT00670696|Topical anesthesia|topical anesthesia
1527874|NCT00670696|Rapydan|rapydan
1527875|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
1527876|NCT00670657|candidemia|candidemia
1527877|NCT00670657|invasive candidiasis|invasive candidiasis
1527878|NCT00670657|Ambisome|ambisome
1527879|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
1527880|NCT00670644|male breast cancer|male breast cancer
1527881|NCT00670644|recurrent breast cancer|recurrent breast cancer
1527882|NCT00670644|stage I breast cancer|stage i breast cancer
1527883|NCT00670644|stage II breast cancer|stage ii breast cancer
1527884|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
1527885|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
1527886|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
1527887|NCT00670644|stage IV breast cancer|stage iv breast cancer
1527888|NCT00670631|Multiple Myeloma|multiple myeloma
1527889|NCT00670631|myeloma|myeloma
1527890|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1527891|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1527892|NCT00670592|HCD122|hcd122
1527893|NCT00670592|CD40|cd40
1527894|NCT00670592|NHL|nhl
1527895|NCT00670592|HL|hl
1527896|NCT00670579|TIVAD|tivad
1527897|NCT00670579|complications|complications
1527898|NCT00670579|nursing|nursing
1527899|NCT00670579|cystic fibrosis|cystic fibrosis
1527900|NCT00670579|implanted|implanted
1527901|NCT00670553|Prostate,|prostate,
1527902|NCT00670553|Head & Neck,|head & neck,
1527903|NCT00670553|Esophageal|esophageal
1527904|NCT00670540|pulmonary embolism|pulmonary embolism
1527905|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
1527906|NCT00670540|recurrence|recurrence
1527907|NCT00670527|Prostate cancer|prostate cancer
1527908|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
1527909|NCT00670527|FCH|fch
1527910|NCT00670527|lymph node metastasis|lymph node metastasis
1527911|NCT00670527|staging|staging
1527912|NCT00670527|sensitivity|sensitivity
1527913|NCT00670527|specificity|specificity
1527914|NCT00670527|PROPET|propet
1527915|NCT00670514|RCT|rct
1527916|NCT00670514|tobacco|tobacco
1527917|NCT00670514|treatment intensity|treatment intensity
1527918|NCT00670514|dentistry|dentistry
1527920|NCT00670514|Smoking cessation|smoking cessation
1527921|NCT00670514|Cost effectiveness|cost effectiveness
1527922|NCT00670475|osteoarthritis|osteoarthritis
1527923|NCT00670475|Knee|knee
1527924|NCT00670475|virgin olive oil|virgin olive oil
1527925|NCT00670475|piroxicam|piroxicam
1527926|NCT00670475|Topical|topical
1527927|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
1527928|NCT00670449|FTY720|fty720
1527929|NCT00670449|multiple sclerosis|multiple sclerosis
1527930|NCT00670449|MS|ms
1527931|NCT00670423|Tacrolimus|tacrolimus
1527932|NCT00670423|Sirolimus|sirolimus
1527933|NCT00670423|Bortezomib|bortezomib
1527934|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
1527935|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
1527936|NCT00670410|Neuroblastoma|neuroblastoma
1527937|NCT00670410|Autologous Transplant|autologous transplant
1527938|NCT00670410|Allogeneic Transplant|allogeneic transplant
1527939|NCT00670410|Immunotherapy|immunotherapy
1527940|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1527941|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1527942|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1527943|NCT00670384|SLIT|slit
1527944|NCT00670384|Immunotherapy|immunotherapy
1527945|NCT00670384|Short ragweed|short ragweed
1527946|NCT00670384|SAR|sar
1527947|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
1527948|NCT00670371|Caregiver burden|caregiver burden
1527949|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1527950|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1527951|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1527952|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1527953|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1527954|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1527955|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1527956|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1527957|NCT00670345|tranexamic acid|tranexamic acid
1527958|NCT00670345|prostatectomy|prostatectomy
1527959|NCT00670345|surgery|surgery
1527960|NCT00670332|coronary artery disease|coronary artery disease
1527961|NCT00670332|echocardiography|echocardiography
1527962|NCT00670332|cardiac imaging|cardiac imaging
1527963|NCT00670332|heart disease|heart disease
1527964|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
1527965|NCT00670332|prognosis|prognosis
1689094|NCT00078663|ICU|icu
1527966|NCT00670306|Cetrorelix|cetrorelix
1527967|NCT00670306|BPH|bph
1527968|NCT00670293|Anorexia Nervosa|anorexia nervosa
1527969|NCT00670293|PET Imaging|pet imaging
1527970|NCT00670293|Dopamine|dopamine
1527971|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
1527972|NCT00670280|Infant Morbidity|infant morbidity
1527973|NCT00670280|Low Birth Weight|low birth weight
1527974|NCT00670280|Low Income Populations|low income populations
1527975|NCT00670280|MCH Research|mch research
1527976|NCT00670280|Respiratory Illnesses|respiratory illnesses
1527977|NCT00670280|Substance Exposed Infants|substance exposed infants
1527978|NCT00670280|Counseling|counseling
1527979|NCT00670267|Asthma|asthma
1527980|NCT00670267|hyperresponsiveness|hyperresponsiveness
1527981|NCT00670254|Sepsis|sepsis
1527982|NCT00670254|Septic|septic
1527983|NCT00670254|Shock|shock
1527984|NCT00670254|Glucocorticoids|glucocorticoids
1527985|NCT00670254|Hydrocortisone|hydrocortisone
1527986|NCT00670215|Prevention of infectious complications|prevention of infectious complications
1527987|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
1527988|NCT00670215|TRNBP|trnbp
1527989|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
1527990|NCT00670163|Men Who Have Sex With Men|men who have sex with men
1527991|NCT00670111|Heart failure|heart failure
1527992|NCT00670111|exercise capacity|exercise capacity
1527993|NCT00670111|ejection fraction|ejection fraction
1527994|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
1527995|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
1527996|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
1527997|NCT00670046|stage I prostate cancer|stage i prostate cancer
1527998|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
1527999|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
1528000|NCT00670046|stage III prostate cancer|stage iii prostate cancer
1528001|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
1528002|NCT00670033|IOP|iop
1528003|NCT00670033|Open-angle glaucoma|open-angle glaucoma
1528004|NCT00670033|Ocular Hypertension|ocular hypertension
1528005|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
1528006|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
1528101|NCT00669604|HIV infected children|hiv infected children
1528007|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
1528008|NCT00670007|Emphysema|emphysema
1528009|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
1528011|NCT00669994|Urinary Tract Infection|urinary tract infection
1528012|NCT00669981|PTSD|ptsd
1528013|NCT00669981|Relationship Distress|relationship distress
1528014|NCT00669981|Couple Therapy|couple therapy
1528015|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
1528016|NCT00669968|Cardiac PET|cardiac pet
1528017|NCT00669968|Rubidium|rubidium
1528018|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
1528019|NCT00669968|Coronary Flow Reserve|coronary flow reserve
1528020|NCT00669968|Adenosine stress test|adenosine stress test
1528021|NCT00669955|H. Pylori|h. pylori
1528022|NCT00669955|Quadruple therapy|quadruple therapy
1528023|NCT00669955|Eradication rate|eradication rate
1528024|NCT00669955|Multinational trial|multinational trial
1528025|NCT00669955|Resistance to antibiotics|resistance to antibiotics
1528026|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
1528027|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
1528028|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
1528029|NCT00669916|Plaque psoriasis|plaque psoriasis
1528030|NCT00669890|AML|aml
1528031|NCT00669890|JMML|jmml
1528032|NCT00669890|MDS|mds
1528033|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
1528034|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
1528035|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
1528036|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
1528037|NCT00669877|Leukemia|leukemia
1528038|NCT00669877|Hyper-CVAD|hyper-cvad
1528039|NCT00669877|Rituximab|rituximab
1528040|NCT00669877|Methotrexate|methotrexate
1528041|NCT00669877|Cytarabine|cytarabine
1528042|NCT00669851|coronary artery disease|coronary artery disease
1528043|NCT00669851|echocardiography|echocardiography
1528044|NCT00669851|cardiac imaging|cardiac imaging
1528045|NCT00669851|heart disease|heart disease
1528046|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
1528047|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
1528048|NCT00669851|myocardial perfusion|myocardial perfusion
1528049|NCT00669838|Anesthesia, Local|anesthesia, local
1528050|NCT00669838|Lidocaine|lidocaine
1528051|NCT00669838|Dental care|dental care
1528052|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
1528053|NCT00669838|Anxiety|anxiety
1528054|NCT00669825|Celiac Disease|celiac disease
1528055|NCT00669812|small intestine lymphoma|small intestine lymphoma
1528056|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1528057|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1528058|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1528059|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1528060|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
1528061|NCT00669760|cystic fibrosis|cystic fibrosis
1528062|NCT00669760|Staphylococcus aureus|staphylococcus aureus
1528063|NCT00669760|persistent colonization-infection|persistent colonization-infection
1528064|NCT00669760|clinical status|clinical status
1528065|NCT00669760|lung function|lung function
1528066|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
1528067|NCT00669747|DCIS|dcis
1528068|NCT00669747|Breast Cancer|breast cancer
1528069|NCT00669747|Carboplatin|carboplatin
1528070|NCT00669747|Intraductal|intraductal
1528071|NCT00669721|osteoprotegerin|osteoprotegerin
1528072|NCT00669721|RANKL|rankl
1528073|NCT00669721|heparin|heparin
1528074|NCT00669721|hemodialysis|hemodialysis
1528075|NCT00669721|anticoagulation|anticoagulation
1528076|NCT00669721|vascular calcification|vascular calcification
1528077|NCT00669708|dry skin|dry skin
1528078|NCT00669708|cooling|cooling
1528079|NCT00669708|itch|itch
1528080|NCT00669695|statins|statins
1528081|NCT00669695|cardiovascular risk|cardiovascular risk
1528082|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
1528083|NCT00669643|Leprosy|leprosy
1528084|NCT00669643|Communicable Diseases|communicable diseases
1528085|NCT00669643|Skin Diseases|skin diseases
1528086|NCT00669643|Multidrug Therapy|multidrug therapy
1528087|NCT00669643|MDT|mdt
1528088|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
1528089|NCT00669643|U-MDT|u-mdt
1528090|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
1528091|NCT00669630|Vulnerable population|vulnerable population
1528092|NCT00669630|High-risk population|high-risk population
1528093|NCT00669630|African-Americans|african-americans
1528094|NCT00669630|Health Disparities|health disparities
1528095|NCT00669630|Clinical Trial|clinical trial
1528096|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1528097|NCT00669617|COPD|copd
1528098|NCT00669617|indacaterol|indacaterol
1528099|NCT00669617|adults|adults
1528100|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
1528102|NCT00669591|breast cancer|breast cancer
1528103|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
1528104|NCT00669591|bavituximab|bavituximab
1528105|NCT00669591|monoclonal antibody|monoclonal antibody
1528106|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
1528107|NCT00669578|polycythemia vera|polycythemia vera
1528108|NCT00669578|essential thrombocythemia|essential thrombocythemia
1528109|NCT00669578|primary myelofibrosis|primary myelofibrosis
1528110|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
1528111|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
1528112|NCT00669539|Refractive error|refractive error
1528113|NCT00669526|anxiety|anxiety
1528114|NCT00669526|depression|depression
1528115|NCT00669526|Major Depressive Disorder|major depressive disorder
1528116|NCT00669526|child|child
1528117|NCT00669526|adolescent|adolescent
1528118|NCT00669526|CBT|cbt
1528119|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1528120|NCT00669526|primary care|primary care
1528121|NCT00669513|partial sleep deprivation|partial sleep deprivation
1528122|NCT00669513|endothelial dysfunction|endothelial dysfunction
1528123|NCT00669513|sympathetic activity|sympathetic activity
1528124|NCT00669513|inflammation|inflammation
1528125|NCT00669500|dietary intake|dietary intake
1528126|NCT00669500|genetic predisposition|genetic predisposition
1528127|NCT00669500|body composition|body composition
1528128|NCT00669487|HIV/AIDS patients|hiv/aids patients
1528129|NCT00669461|Constipation|constipation
1528130|NCT00669461|Parkinson's Disease|parkinson's disease
1528131|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
1528132|NCT00669448|MCS|mcs
1528133|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
1528134|NCT00669448|MBCT|mbct
1528135|NCT00669448|Behavioural intervention|behavioural intervention
1528136|NCT00669448|Stress|stress
1528137|NCT00669448|Illness perceptions|illness perceptions
1528138|NCT00669448|Pilot trial|pilot trial
1528139|NCT00669435|Essential hypertension|essential hypertension
1528140|NCT00669435|Liver steatosis|liver steatosis
1528141|NCT00669422|Ovarian Cancer|ovarian cancer
1528142|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
1528143|NCT00669422|Peritoneal Cancer|peritoneal cancer
1528144|NCT00669422|Uterine Neoplasms|uterine neoplasms
1528145|NCT00669422|Vulvar Cancer|vulvar cancer
1528146|NCT00669422|Endometrial Cancer|endometrial cancer
1528147|NCT00669422|Cervical Cancer|cervical cancer
1528148|NCT00669422|Assay|assay
1528149|NCT00669422|Chemotherapy|chemotherapy
1528150|NCT00669422|Recurrent|recurrent
1528151|NCT00669422|Refractory|refractory
1528152|NCT00669422|Persistent|persistent
1528153|NCT00669422|Chemoresponse|chemoresponse
1689290|NCT00078546|EBV|ebv
1528154|NCT00669422|Sensitivity|sensitivity
1528155|NCT00669422|Precision Therapeutics|precision therapeutics
1528156|NCT00669422|ChemoFx|chemofx
1528157|NCT00669409|monoclonal antibody|monoclonal antibody
1528158|NCT00669396|contraception|contraception
1528159|NCT00669396|emergency contraception|emergency contraception
1528160|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
1528161|NCT00669383|premature delivery|premature delivery
1528162|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
1528163|NCT00669370|advanced gastric cancer|advanced gastric cancer
1528164|NCT00669370|adenocarcinoma|adenocarcinoma
1528165|NCT00669357|End stage heart disease|end stage heart disease
1528166|NCT00669344|cognition|cognition
1528167|NCT00669344|stroke|stroke
1528168|NCT00669344|VCI|vci
1528169|NCT00669344|VCIND|vcind
1528170|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
1528171|NCT00669331|randomized clinical trial|randomized clinical trial
1528172|NCT00669331|mannitol|mannitol
1528173|NCT00669331|mucoactive|mucoactive
1528174|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1528175|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1528176|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1528177|NCT00669305|Genetics|genetics
1528178|NCT00669305|Blood cells|blood cells
1528179|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
1528180|NCT00669305|Bone marrow|bone marrow
1528181|NCT00669305|CD34 cells|cd34 cells
1528182|NCT00669292|esophageal cancer|esophageal cancer
1528183|NCT00669292|peptide|peptide
1528184|NCT00669292|URLC10|urlc10
1528185|NCT00669292|TTK|ttk
1528186|NCT00669292|CpG7909|cpg7909
1528187|NCT00669214|Raptiva|raptiva
1528188|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
1528189|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
1528190|NCT00669214|Scalp|scalp
1528191|NCT00669201|cartilage|cartilage
1528192|NCT00669201|osteoarthritis|osteoarthritis
1528193|NCT00669201|T2 mapping|t2 mapping
1528194|NCT00669201|MRI|mri
1528195|NCT00669201|Wrist|wrist
1528196|NCT00669188|Patient Provider Interaction|patient provider interaction
1528197|NCT00669188|Physician Training|physician training
1528198|NCT00669188|Patient Provider Training|patient provider training
1528199|NCT00669175|Naloxone|naloxone
1528200|NCT00669175|Neonate|neonate
1528201|NCT00669175|Pain|pain
1528202|NCT00669149|ptca|ptca
1528203|NCT00669149|antiaggregant therapy|antiaggregant therapy
1528204|NCT00669149|anticoagulant therapy|anticoagulant therapy
1528324|NCT00668434|Leg Pain|leg pain
1528205|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
1528206|NCT00669136|AFP Immunization|afp immunization
1528207|NCT00669123|Chondroitin sulphate|chondroitin sulphate
1528208|NCT00669123|Knee osteoarthritis|knee osteoarthritis
1528209|NCT00669123|Psoriasis|psoriasis
1528211|NCT00669110|Depression|depression
1528212|NCT00669110|Pediatrics|pediatrics
1528213|NCT00669110|Major Depressive Disorder|major depressive disorder
1528214|NCT00669097|ADME|adme
1528216|NCT00669097|RTKs inhibitor|rtks inhibitor
1528217|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
1528218|NCT00669097|VEGFER inhibitor|vegfer inhibitor
1528219|NCT00669084|Innate Immunity|innate immunity
1528220|NCT00669084|Malaria|malaria
1528221|NCT00669084|Plasmodium|plasmodium
1528222|NCT00669084|Hemoglobinopathy|hemoglobinopathy
1528223|NCT00669084|G6PD Deficiency|g6pd deficiency
1528224|NCT00669058|hygiene|hygiene
1528225|NCT00669045|TNKase|tnkase
1528226|NCT00669045|AMI|ami
1528227|NCT00669006|neuropathic pain|neuropathic pain
1528228|NCT00669006|database|database
1528229|NCT00669006|prospective|prospective
1528230|NCT00669006|national|national
1528231|NCT00668980|Down syndrome|down syndrome
1528232|NCT00668980|symbolic representation|symbolic representation
1528233|NCT00668980|gestures|gestures
1528234|NCT00668980|expressive language development|expressive language development
1528235|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
1528236|NCT00668967|Hypertension|hypertension
1528237|NCT00668954|Diabetes|diabetes
1528238|NCT00668954|Pomegranate|pomegranate
1528239|NCT00668954|Biomarkers|biomarkers
1528240|NCT00668954|Antioxidant|antioxidant
1528241|NCT00668941|Bone Density|bone density
1528242|NCT00668941|Bone Turnover|bone turnover
1528243|NCT00668941|Histomorphometry|histomorphometry
1528244|NCT00668902|CYP2C19|cyp2c19
1528245|NCT00668902|Pantoprazole|pantoprazole
1528246|NCT00668902|Genotype|genotype
1528247|NCT00668902|Pharmacokinetics|pharmacokinetics
1528248|NCT00668902|Metabolism|metabolism
1528249|NCT00668889|Hygiene|hygiene
1528250|NCT00668876|immunonutrition|immunonutrition
1528251|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
1528252|NCT00668876|Th1|th1
1528253|NCT00668876|Th2|th2
1528254|NCT00668876|Th17|th17
1528255|NCT00668837|Paliperidone|paliperidone
1528256|NCT00668837|schizophrenia|schizophrenia
1528257|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
1528258|NCT00668811|thyroid cancer|thyroid cancer
1528259|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
1528260|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
1528261|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
1528262|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
1528263|NCT00668811|Histologically confirmed|histologically confirmed
1528264|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
1528265|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
1528266|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
1528267|NCT00668785|Ranibizumab|ranibizumab
1528268|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1528269|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
1528270|NCT00668785|Safety and Efficacy|safety and efficacy
1528271|NCT00668785|Intravitreal Injection|intravitreal injection
1528272|NCT00668759|atrial fibrillation|atrial fibrillation
1528273|NCT00668759|atrial fib|atrial fib
1528274|NCT00668759|AF|af
1528275|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
1528276|NCT00668733|Actinic keratoses|actinic keratoses
1528277|NCT00668733|Dermatologic disease|dermatologic disease
1528278|NCT00668720|tinnitus|tinnitus
1528279|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
1528280|NCT00668707|melatonin|melatonin
1528281|NCT00668707|natural health product (NHP)|natural health product (nhp)
1528282|NCT00668707|lung cancer|lung cancer
1528283|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
1528284|NCT00668707|randomized clinical trial|randomized clinical trial
1528285|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
1528286|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
1528287|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1528288|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
1528289|NCT00668629|Hygiene|hygiene
1528290|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
1528291|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
1528292|NCT00668603|Hot flush|hot flush
1528293|NCT00668603|Vascular function|vascular function
1528294|NCT00668603|Cardiac function|cardiac function
1528295|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
1528296|NCT00668590|Diabetes|diabetes
1528297|NCT00668577|Hygiene|hygiene
1528298|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
1528299|NCT00668564|Sphingolipidoses|sphingolipidoses
1528300|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
1528301|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
1528302|NCT00668564|Wolman syndrome|wolman syndrome
1528303|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
1528304|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
1528305|NCT00668551|Parkinson disease|parkinson disease
1528306|NCT00668551|Telemedicine|telemedicine
1528307|NCT00668538|Miconazole|miconazole
1528308|NCT00668538|CYP1A2|cyp1a2
1528309|NCT00668538|CYP3A4|cyp3a4
1528310|NCT00668538|Women|women
1528311|NCT00668538|Healthy Subjects|healthy subjects
1528312|NCT00668525|Depression|depression
1528313|NCT00668525|Major Depressive Disorder|major depressive disorder
1528314|NCT00668525|Escitalopram|escitalopram
1528315|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
1528316|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
1528317|NCT00668486|Hygiene|hygiene
1528318|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
1528319|NCT00668460|hygiene|hygiene
1528320|NCT00668447|bone density|bone density
1528321|NCT00668447|bone loss|bone loss
1528322|NCT00668447|postmenopausal|postmenopausal
1528323|NCT00668434|Back Pain|back pain
1528325|NCT00668421|Myelofibrosis|myelofibrosis
1528326|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
1528327|NCT00668421|Polycythemia Vera|polycythemia vera
1528328|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
1528329|NCT00668421|Lestaurtinib|lestaurtinib
1528330|NCT00668408|OTLT|otlt
1528331|NCT00668408|COPD|copd
1528332|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
1528333|NCT00668408|CHF|chf
1528334|NCT00668395|CYP2B6|cyp2b6
1528335|NCT00668395|Efavirenz|efavirenz
1528336|NCT00668395|Pharmacokinetics|pharmacokinetics
1528337|NCT00668395|Pharmacogenetics|pharmacogenetics
1528338|NCT00668395|Drug-Interactions|drug-interactions
1528339|NCT00668382|Cancerous solid tumors|cancerous solid tumors
1528340|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
1528341|NCT00668369|Liver Transplantation|liver transplantation
1528342|NCT00668369|Tolerance|tolerance
1528343|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
1528344|NCT00668369|Immune responses|immune responses
1528345|NCT00668369|Allograft tolerance|allograft tolerance
1528346|NCT00668369|Immunosuppression weaning|immunosuppression weaning
1528347|NCT00668369|Immunosuppression minimization|immunosuppression minimization
1528348|NCT00668356|HIV disease in children|hiv disease in children
1528349|NCT00668356|HIV|hiv
1528350|NCT00668356|children|children
1528351|NCT00668356|didanosine|didanosine
1528352|NCT00668356|bioequivalence|bioequivalence
1528353|NCT00668356|pharmacokinetics|pharmacokinetics
1528354|NCT00668356|treatment experienced|treatment experienced
1528355|NCT00668343|edss attack|edss attack
1528356|NCT00668330|Bone mineral density|bone mineral density
1528357|NCT00668330|ibandronate|ibandronate
1528358|NCT00668330|alfacalcidol|alfacalcidol
1528359|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
1528360|NCT00668304|Sinusitis|sinusitis
1528361|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
1528362|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
1528363|NCT00668291|PRKAR1A|prkar1a
1528364|NCT00668278|Supraglottic airway|supraglottic airway
1528365|NCT00668278|I-gel|i-gel
1528366|NCT00668278|Laryngeal mask|laryngeal mask
1528367|NCT00668278|Controlled ventilation|controlled ventilation
1528368|NCT00668278|Peak airway pressure|peak airway pressure
1528369|NCT00668278|Seal pressure|seal pressure
1528370|NCT00668278|Anaesthesia|anaesthesia
1528371|NCT00668278|Surgery|surgery
1528372|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
1528373|NCT00668265|Opiate Dependence|opiate dependence
1528374|NCT00668265|Methadone-Maintenance|methadone-maintenance
1528375|NCT00668265|Drug Addiction Treatment|drug addiction treatment
1528376|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
1528377|NCT00668252|estrogen|estrogen
1528378|NCT00668252|menopause|menopause
1528379|NCT00668252|cardiovascular risk|cardiovascular risk
1528380|NCT00668239|diffuse macular oedema|diffuse macular oedema
1528381|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
1528382|NCT00668239|laser therapy|laser therapy
1528383|NCT00668226|Hygiene|hygiene
1528384|NCT00668213|Macular Degeneration|macular degeneration
1528385|NCT00668200|Paget's|paget's
1528386|NCT00668200|hypocalcemia|hypocalcemia
1528387|NCT00668200|zoledronic acid|zoledronic acid
1528388|NCT00668200|serum calcium|serum calcium
1528389|NCT00668187|Tay-Sachs disease|tay-sachs disease
1528390|NCT00668187|Sandhoff disease|sandhoff disease
1528391|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
1528392|NCT00668187|LOTS|lots
1528393|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
1528394|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
1528395|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
1528396|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
1528397|NCT00668187|prospective|prospective
1528398|NCT00668187|natural history|natural history
1528399|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
1528400|NCT00668187|gangliosidoses|gangliosidoses
1528401|NCT00668187|β-galactosidase|β-galactosidase
1528402|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
1528403|NCT00668187|hexosaminidase|hexosaminidase
1528404|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
1528405|NCT00668187|Tay-Sachs|tay-sachs
1528406|NCT00668187|Sandhoff|sandhoff
1528407|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
1528408|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
1528409|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
1528410|NCT00668187|juvenile Sandhoff|juvenile sandhoff
1528411|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
1528412|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
1528413|NCT00668148|Sarcoma|sarcoma
1528414|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
1528415|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
1528416|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
1528417|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
1528418|NCT00668148|synovial sarcoma|synovial sarcoma
1528419|NCT00668135|Erectile Dysfunction|erectile dysfunction
1528420|NCT00668135|Vardenafil|vardenafil
1528421|NCT00668109|Erectile Dysfunction|erectile dysfunction
1528422|NCT00668109|Diabetes mellitus|diabetes mellitus
1528423|NCT00668109|Hypertension|hypertension
1528424|NCT00668109|Hyperlipidemia|hyperlipidemia
1528425|NCT00668109|Vardenafil|vardenafil
1528426|NCT00668096|Erectile Dysfunction|erectile dysfunction
1528427|NCT00668096|PDE5 inhibitors|pde5 inhibitors
1528428|NCT00668083|second line|second line
1528429|NCT00668083|Prostate Cancer|prostate cancer
1528430|NCT00668083|bicalutamide|bicalutamide
1528431|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
1528432|NCT00668070|NASH|nash
1528433|NCT00668070|Chronic liver disease|chronic liver disease
1528434|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
1528435|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
1528436|NCT00668044|Ciprofloxacin|ciprofloxacin
1528437|NCT00668044|Burned patients|burned patients
1689540|NCT00078377|Nuvigil|nuvigil
1528438|NCT00668031|Transfusion requirements|transfusion requirements
1528439|NCT00668031|Hip replacement surgery|hip replacement surgery
1528440|NCT00668031|Prevention of blood loss|prevention of blood loss
1528441|NCT00668031|Bloodloss|bloodloss
1528442|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
1528443|NCT00668018|Vardenafil|vardenafil
1528444|NCT00668005|Erectile Dysfunction|erectile dysfunction
1528445|NCT00668005|Arterial hypertension|arterial hypertension
1528446|NCT00668005|Vardenafil|vardenafil
1528447|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
1528448|NCT00667979|Erectile Dysfunction|erectile dysfunction
1528449|NCT00667979|Vardenafil|vardenafil
1528450|NCT00667966|Spinal cord injury|spinal cord injury
1528451|NCT00667966|Urodynamic|urodynamic
1528452|NCT00667966|Erectile dysfunction|erectile dysfunction
1528453|NCT00667966|Vardenafil|vardenafil
1528454|NCT00667953|Temzolomide|temzolomide
1528455|NCT00667953|Gleevec|gleevec
1528456|NCT00667953|Melanoma|melanoma
1528457|NCT00667953|Advanced melanoma|advanced melanoma
1528458|NCT00667953|Phase II|phase ii
1528459|NCT00667940|Medical education|medical education
1528460|NCT00667940|faculty development|faculty development
1528461|NCT00667940|rater training|rater training
1528462|NCT00667940|clinical competence|clinical competence
1528463|NCT00667940|assessment|assessment
1528464|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
1528465|NCT00667927|gene marking|gene marking
1528466|NCT00667914|Hip-unit|hip-unit
1528467|NCT00667914|Geriatric care|geriatric care
1528468|NCT00667914|Mobility|mobility
1528469|NCT00667914|Site of residence|site of residence
1528470|NCT00667901|stage III melanoma|stage iii melanoma
1528471|NCT00667901|stage IV melanoma|stage iv melanoma
1528472|NCT00667888|Prostate Cancer|prostate cancer
1528473|NCT00667888|Radiation|radiation
1528474|NCT00667888|Radiotherapy|radiotherapy
1528475|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1528476|NCT00667888|IMRT|imrt
1528477|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
1528478|NCT00667888|HIMRT|himrt
1528479|NCT00667875|Alcohol Dependence|alcohol dependence
1528480|NCT00667875|Alcoholism|alcoholism
1528481|NCT00667875|Naltrexone|naltrexone
1528482|NCT00667875|Aripiprazole|aripiprazole
1528483|NCT00667875|Substance Abuse|substance abuse
1528484|NCT00667862|Prostate|prostate
1528485|NCT00667862|Cancer|cancer
1528486|NCT00667862|Adenocarcinoma|adenocarcinoma
1528487|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
1528488|NCT00667862|metastatic|metastatic
1528489|NCT00667862|male|male
1528490|NCT00667862|HRPC|hrpc
1528491|NCT00667862|DACi|daci
1528492|NCT00667849|Tibia|tibia
1528493|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
1528494|NCT00667836|NF1|nf1
1528495|NCT00667836|Spinal Anomalies|spinal anomalies
1528496|NCT00667823|SERAPHIN|seraphin
1528497|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1528498|NCT00667823|ACT-064992|act-064992
1528499|NCT00667810|antibody|antibody
1528500|NCT00667810|immunotherapy|immunotherapy
1528501|NCT00667797|Asthma|asthma
1528502|NCT00667797|COPD|copd
1528599|NCT00667524|Dysphagia|dysphagia
1528503|NCT00667797|chronic emphysema|chronic emphysema
1528504|NCT00667797|chronic bronchitis|chronic bronchitis
1528505|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
1528506|NCT00667784|emotional sequelae|emotional sequelae
1528507|NCT00667784|physical sequelae|physical sequelae
1528508|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
1528509|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
1528510|NCT00667784|Questionnaire|questionnaire
1528511|NCT00667784|Survey|survey
1528512|NCT00667784|Sibling Donor|sibling donor
1528513|NCT00667784|Stem Cell Transplant|stem cell transplant
1528514|NCT00667784|Well-Being|well-being
1528515|NCT00667771|Alcohol|alcohol
1528516|NCT00667771|Naltrexone|naltrexone
1528517|NCT00667771|fMRI|fmri
1528518|NCT00667771|Alcoholism|alcoholism
1528519|NCT00667771|Alcoholics|alcoholics
1528520|NCT00667771|Alcohol Dependence|alcohol dependence
1528521|NCT00667745|Lithium|lithium
1528522|NCT00667745|Symptoms|symptoms
1528523|NCT00667745|Medication Changes|medication changes
1528524|NCT00667732|diabetes|diabetes
1528525|NCT00667732|insulin|insulin
1528526|NCT00667732|byetta|byetta
1528527|NCT00667732|glucose|glucose
1528528|NCT00667732|blood sugar|blood sugar
1528529|NCT00667732|metformin|metformin
1528530|NCT00667732|A1c|a1c
1528531|NCT00667719|essential hypertension|essential hypertension
1528532|NCT00667719|high blood pressure|high blood pressure
1528533|NCT00667693|intubation|intubation
1528534|NCT00667693|obese|obese
1528535|NCT00667680|tDCS, major depression|tdcs, major depression
1528536|NCT00667667|whole body vibration|whole body vibration
1528537|NCT00667667|exercise|exercise
1528538|NCT00667667|postmenopausal|postmenopausal
1528539|NCT00667667|BMD|bmd
1528540|NCT00667667|bone|bone
1528541|NCT00667667|elderly females|elderly females
1528542|NCT00667667|Caucasian race|caucasian race
1528543|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
1528544|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1528545|NCT00667641|recurrent breast cancer|recurrent breast cancer
1528546|NCT00667641|stage IV breast cancer|stage iv breast cancer
1528547|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
1528548|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
1528549|NCT00667641|recurrent colon cancer|recurrent colon cancer
1528550|NCT00667641|stage IV colon cancer|stage iv colon cancer
1528551|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
1528552|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
1528553|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1528554|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1528555|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1528556|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1528557|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1528558|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1528559|NCT00667641|recurrent melanoma|recurrent melanoma
1528560|NCT00667641|stage IV melanoma|stage iv melanoma
1528561|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1528562|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
1528563|NCT00667615|vorinostat|vorinostat
1528564|NCT00667615|rituximab|rituximab
1528565|NCT00667615|cyclophosphamide|cyclophosphamide
1528566|NCT00667615|etoposide|etoposide
1528567|NCT00667615|prednisone|prednisone
1528568|NCT00667615|Quality of life|quality of life
1528569|NCT00667615|08-045|08-045
1528570|NCT00667602|Meningococcal|meningococcal
1528571|NCT00667602|ACWY|acwy
1528572|NCT00667602|Conjugate Vaccine|conjugate vaccine
1528573|NCT00667602|Meningitis|meningitis
1528574|NCT00667602|Toddlers|toddlers
1528575|NCT00667602|Infants|infants
1528576|NCT00667602|Concomitant Vaccination|concomitant vaccination
1528577|NCT00667589|sorafenib|sorafenib
1528578|NCT00667589|rash|rash
1528579|NCT00667589|hand foot skin reaction|hand foot skin reaction
1528580|NCT00667576|chronic kidney disease|chronic kidney disease
1528581|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
1528582|NCT00667576|hemodialysis|hemodialysis
1528583|NCT00667576|paricalcitol|paricalcitol
1528584|NCT00667576|maxacalcitol|maxacalcitol
1528585|NCT00667563|human papilloma virus infection|human papilloma virus infection
1528586|NCT00667563|cervical cancer|cervical cancer
1528587|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1528688|NCT00667212|explosive|explosive
1528588|NCT00667563|HIV infection|hiv infection
1528589|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
1528590|NCT00667550|Colorectal disorders|colorectal disorders
1528591|NCT00667550|Urinary incontinence|urinary incontinence
1528592|NCT00667550|Fecal incontinence|fecal incontinence
1528593|NCT00667550|Voiding dysfunction|voiding dysfunction
1528594|NCT00667550|Urgency frequency|urgency frequency
1528595|NCT00667550|Sexual dysfunction|sexual dysfunction
1528596|NCT00667550|Colorectal malignancies|colorectal malignancies
1528597|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
1528598|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
1528600|NCT00667524|Esophageal bougienage|esophageal bougienage
1528601|NCT00667524|Esophageal Dilation|esophageal dilation
1528602|NCT00667511|ESRD|esrd
1528603|NCT00667511|End Stage Renal Disease|end stage renal disease
1528604|NCT00667511|Daily Hemodialysis|daily hemodialysis
1528605|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
1528606|NCT00667511|Hemodialysis|hemodialysis
1528607|NCT00667511|Kidney Failure|kidney failure
1528608|NCT00667511|Kidney Disease|kidney disease
1528609|NCT00667498|Pediatric Obesity|pediatric obesity
1528610|NCT00667498|Insulin Resistance|insulin resistance
1528611|NCT00667498|Hyperinsulinemia|hyperinsulinemia
1528612|NCT00667498|Metformin|metformin
1528613|NCT00667498|Glucose Tolerance|glucose tolerance
1528614|NCT00667498|Microalbuminuria|microalbuminuria
1528615|NCT00667498|Adolescents|adolescents
1528616|NCT00667498|Visceral Fat|visceral fat
1528617|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
1528618|NCT00667459|Cervical Disc|cervical disc
1528619|NCT00667446|GnRH analog|gnrh analog
1528620|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
1528621|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
1528622|NCT00667446|Suppression of LH|suppression of lh
1528623|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
1528624|NCT00667446|CPP|cpp
1528625|NCT00667446|Leuprolide acetate|leuprolide acetate
1528626|NCT00667446|Central Precocious Puberty|central precocious puberty
1528627|NCT00667446|Depot formulation|depot formulation
1528628|NCT00667446|Lupron|lupron
1528629|NCT00667446|Tanner staging|tanner staging
1528630|NCT00667446|Pediatrics|pediatrics
1528631|NCT00667433|HIV|hiv
1528632|NCT00667433|African American|african american
1528633|NCT00667433|treatment naïve|treatment naïve
1528634|NCT00667420|gastric|gastric
1528635|NCT00667420|esophageal|esophageal
1528636|NCT00667420|panitumumab|panitumumab
1528637|NCT00667407|Asthma|asthma
1528638|NCT00667394|Brain Tumor|brain tumor
1528639|NCT00667394|Chemotherapy|chemotherapy
1528640|NCT00667394|Radiation|radiation
1528641|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
1528642|NCT00667394|Glioblastoma|glioblastoma
1528643|NCT00667394|Glioma|glioma
1528644|NCT00667381|Ultrasound guidance|ultrasound guidance
1528645|NCT00667381|Vascular access|vascular access
1528646|NCT00667381|Vascular complications|vascular complications
1528647|NCT00667368|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children
1528648|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
1528649|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1528650|NCT00667329|Lymphoma|lymphoma
1528651|NCT00667329|2CdA|2cda
1528652|NCT00667329|Cladribine|cladribine
1528653|NCT00667329|Leustatin|leustatin
1528654|NCT00667329|Cyclophosphamide|cyclophosphamide
1528655|NCT00667329|Cytoxan|cytoxan
1528656|NCT00667329|Neosar|neosar
1528657|NCT00667329|Rituxan|rituxan
1528658|NCT00667329|Rituximab|rituximab
1528659|NCT00667316|low back pain|low back pain
1528660|NCT00667316|workers|workers
1528661|NCT00667316|disability|disability
1528662|NCT00667316|sick leave|sick leave
1528663|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
1528664|NCT00667290|functional ability|functional ability
1528665|NCT00667290|gait|gait
1528666|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
1528667|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
1528668|NCT00667277|Myelofibrosis|myelofibrosis
1528669|NCT00667277|Idiopathic|idiopathic
1528670|NCT00667277|Bevacizumab|bevacizumab
1528671|NCT00667277|Avastin|avastin
1528672|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
1528673|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
1528674|NCT00667277|JAK2|jak2
1528675|NCT00667264|pain|pain
1528676|NCT00667264|phantom limb|phantom limb
1528677|NCT00667264|stump pain|stump pain
1528678|NCT00667264|catheter|catheter
1528679|NCT00667264|nerve block|nerve block
1528680|NCT00667264|peripheral nerve block|peripheral nerve block
1528681|NCT00667264|ucsd|ucsd
1528682|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
1528683|NCT00667251|recurrent breast cancer|recurrent breast cancer
1528684|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
1528685|NCT00667251|stage IV breast cancer|stage iv breast cancer
1528686|NCT00667212|anger|anger
1528687|NCT00667212|intermittent|intermittent
1528689|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1528690|NCT00667199|Bone Metastases|bone metastases
1528691|NCT00667199|Radium-223|radium-223
1528692|NCT00667199|Palliation of bone pain|palliation of bone pain
1528693|NCT00667186|HIV|hiv
1528694|NCT00667186|Prevention|prevention
1528695|NCT00667186|Public Health|public health
1528696|NCT00667186|Screening|screening
1528697|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
1528698|NCT00667160|Protopic|protopic
1528699|NCT00667160|Pediatric|pediatric
1528700|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
1528794|NCT00666809|Tinnitus|tinnitus
1528701|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1528702|NCT00667121|breast cancer|breast cancer
1528703|NCT00667121|hot flashes|hot flashes
1528704|NCT00667121|depression|depression
1528705|NCT00667095|OAB|oab
1528706|NCT00667095|Over Active Bladder|over active bladder
1528707|NCT00667095|overactive bladder|overactive bladder
1528708|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
1528709|NCT00667095|Urinary Incontinence|urinary incontinence
1528710|NCT00667095|Botox|botox
1528711|NCT00667095|DMSO|dmso
1528712|NCT00667095|bladder instillation|bladder instillation
1528713|NCT00667095|instillation|instillation
1528714|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
1528715|NCT00667095|urge incontinence|urge incontinence
1528716|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
1528717|NCT00667082|Pancreatic Cancer|pancreatic cancer
1528718|NCT00667082|Melanoma|melanoma
1528719|NCT00667082|Lymphoma|lymphoma
1528720|NCT00667082|Multiple Myeloma|multiple myeloma
1528721|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1528722|NCT00667069|stage III prostate cancer|stage iii prostate cancer
1528723|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
1528724|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
1528725|NCT00667056|Protopic|protopic
1528726|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
1528727|NCT00667043|cardiac arrest|cardiac arrest
1528728|NCT00667043|sedation|sedation
1528729|NCT00667043|remifentanil|remifentanil
1528730|NCT00667043|propofol|propofol
1528731|NCT00667043|fentanyl|fentanyl
1528732|NCT00667043|midazolam|midazolam
1528733|NCT00667030|Inflammation|inflammation
1528734|NCT00667030|Aging|aging
1528735|NCT00667030|Metabolism|metabolism
1528736|NCT00667030|Exercise|exercise
1528737|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1528738|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1528739|NCT00666991|ovarian cancer|ovarian cancer
1528740|NCT00666991|Mullerian tumors|mullerian tumors
1528741|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
1528742|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
1528743|NCT00666991|GI tract tumor|gi tract tumor
1528744|NCT00666991|pancreatic cancer|pancreatic cancer
1528745|NCT00666991|colon cancer|colon cancer
1528746|NCT00666978|bladder cancer|bladder cancer
1528747|NCT00666978|cervical cancer|cervical cancer
1528748|NCT00666978|esophageal cancer|esophageal cancer
1528749|NCT00666978|gastric cancer|gastric cancer
1528750|NCT00666978|renal cell carcinoma|renal cell carcinoma
1528751|NCT00666978|adult primary liver cancer|adult primary liver cancer
1528752|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
1528753|NCT00666978|small cell lung cancer|small cell lung cancer
1528754|NCT00666978|pancreatic cancer|pancreatic cancer
1528755|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
1528756|NCT00666978|laryngeal cancer|laryngeal cancer
1528757|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
1528758|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
1528759|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
1528760|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1528761|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
1528762|NCT00666978|tobacco use disorder|tobacco use disorder
1528763|NCT00666965|SPM 962|spm 962
1528764|NCT00666965|rotigotine|rotigotine
1528765|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
1528766|NCT00666965|RLS|rls
1528767|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
1528768|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
1528769|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
1528770|NCT00666926|Phase 1|phase 1
1528771|NCT00666926|Pharmacodynamics|pharmacodynamics
1528772|NCT00666926|FDG-PET|fdg-pet
1528773|NCT00666913|breast cancer in situ|breast cancer in situ
1528774|NCT00666913|stage I breast cancer|stage i breast cancer
1528775|NCT00666913|stage II breast cancer|stage ii breast cancer
1528776|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
1528777|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
1528778|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
1528779|NCT00666913|hot flashes|hot flashes
1528780|NCT00666887|Multiple Sclerosis|multiple sclerosis
1528781|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
1528782|NCT00666887|Minocycline|minocycline
1528783|NCT00666887|Placebo|placebo
1529375|NCT00664859|LCP-AtorFen|lcp-atorfen
1528784|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
1528785|NCT00666848|Metabolic syndrome|metabolic syndrome
1528786|NCT00666848|Hypertension|hypertension
1528787|NCT00666848|Sitagliptin|sitagliptin
1528788|NCT00666848|Enalapril|enalapril
1528789|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
1528790|NCT00666822|stage I breast cancer|stage i breast cancer
1528791|NCT00666822|stage II breast cancer|stage ii breast cancer
1528792|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
1528793|NCT00666809|Vardenafil,|vardenafil,
1528795|NCT00666757|Severe Depressive Episode|severe depressive episode
1528796|NCT00666744|exercise|exercise
1528797|NCT00666744|frequency|frequency
1528798|NCT00666744|duration|duration
1528799|NCT00666731|male breast cancer|male breast cancer
1528800|NCT00666731|breast cancer|breast cancer
1528801|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1528802|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1528803|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
1528804|NCT00666705|maraviroc|maraviroc
1528805|NCT00666705|raltegravir|raltegravir
1528806|NCT00666705|drug interaction study|drug interaction study
1528807|NCT00666705|healthy volunteers|healthy volunteers
1528808|NCT00666692|cancer|cancer
1528809|NCT00666692|carcinoma|carcinoma
1528810|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
1528811|NCT00666692|anti-angiogenesis|anti-angiogenesis
1528812|NCT00666666|prostate Cancer|prostate cancer
1528813|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1528814|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
1528815|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
1528816|NCT00666653|Parkinson's disease|parkinson's disease
1528817|NCT00666653|Dopamine Agonist|dopamine agonist
1528818|NCT00666653|Levodopa|levodopa
1528819|NCT00666653|Pharmacokinetics|pharmacokinetics
1528820|NCT00666653|Dyskinesia|dyskinesia
1528821|NCT00666640|Osteoporosis|osteoporosis
1528822|NCT00666640|Fracture|fracture
1528823|NCT00666640|DXA|dxa
1528824|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1528825|NCT00666640|Computed tomography|computed tomography
1528826|NCT00666640|3D DXA|3d dxa
1528827|NCT00666627|Osteoporosis|osteoporosis
1528828|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
1690005|NCT00078104|Pain|pain
1528829|NCT00666627|Bisphosphonates|bisphosphonates
1528830|NCT00666627|Alendronate|alendronate
1528831|NCT00666627|Ibandronate|ibandronate
1528832|NCT00666627|Risedronate|risedronate
1528833|NCT00666614|Sleep|sleep
1528834|NCT00666614|Fatigue|fatigue
1528835|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
1528836|NCT00666601|Microdialysis|microdialysis
1528837|NCT00666601|Antibiotic|antibiotic
1528838|NCT00666601|Healthy subjects|healthy subjects
1528839|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
1528840|NCT00666549|Myelofibrosis|myelofibrosis
1528841|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
1528842|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
1528843|NCT00666549|Polycythemia Vera|polycythemia vera
1528844|NCT00666536|Hypertension|hypertension
1528845|NCT00666536|adults|adults
1528846|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
1528847|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
1528848|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
1528849|NCT00666510|nitric oxide|nitric oxide
1528850|NCT00666510|bronchospasm|bronchospasm
1528851|NCT00666510|anesthesia|anesthesia
1528852|NCT00666510|induced sputum|induced sputum
1528853|NCT00666510|asthma|asthma
1528854|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
1528855|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
1528856|NCT00666497|Azacitidine|azacitidine
1528857|NCT00666497|Vidaza|vidaza
1528858|NCT00666497|MGCD0103|mgcd0103
1528859|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
1528860|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
1528861|NCT00666497|Epigenetic Therapy|epigenetic therapy
1528862|NCT00666484|neurotoxicity|neurotoxicity
1528863|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1528864|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1528865|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1528866|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1528867|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1528868|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1528869|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1528870|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1528871|NCT00666471|epistaxis|epistaxis
1528872|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
1528873|NCT00666458|Type 2 diabetes|type 2 diabetes
1528874|NCT00666458|metformin|metformin
1528875|NCT00666445|Alzheimer's Disease|alzheimer's disease
1528876|NCT00666445|Diagnosis|diagnosis
1529667|NCT00663572|Newborn|newborn
1528877|NCT00666445|Neuronal function|neuronal function
1528878|NCT00666445|Cognitive Impairment|cognitive impairment
1528879|NCT00666445|Magnetoencephalography|magnetoencephalography
1528880|NCT00666432|schizophrenia|schizophrenia
1528881|NCT00666432|bipolar|bipolar
1528882|NCT00666432|eye movements|eye movements
1528883|NCT00666432|phenotype|phenotype
1528884|NCT00666432|biochemical|biochemical
1528885|NCT00666432|relatives|relatives
1528886|NCT00666419|nonspecific low back pain|nonspecific low back pain
1528887|NCT00666419|schoolchildren|schoolchildren
1528888|NCT00666419|prevalence|prevalence
1528889|NCT00666393|IONSYS™|ionsys™
1528890|NCT00666393|Pain, Postoperative|pain, postoperative
1528891|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
1528892|NCT00666393|Opioids|opioids
1528893|NCT00666393|Pediatrics|pediatrics
1528894|NCT00666380|Malaria|malaria
1528895|NCT00666380|Vaccine|vaccine
1528896|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
1528897|NCT00666380|Phase 1|phase 1
1528898|NCT00666367|COPD|copd
1528899|NCT00666354|Nail Psoriasis|nail psoriasis
1528900|NCT00666354|Psoriasis|psoriasis
1528901|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
1528902|NCT00666354|Methotrexate|methotrexate
1528903|NCT00666328|Hypertension|hypertension
1528904|NCT00666328|Hemorrhage|hemorrhage
1528905|NCT00666328|Intracranial Pressure|intracranial pressure
1528906|NCT00666328|Antihypertensive Agent|antihypertensive agent
1528907|NCT00666328|Calcium Channel Blocker|calcium channel blocker
1528908|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
1528909|NCT00666302|Atopic Dermatitis|atopic dermatitis
1528910|NCT00666302|Protopic|protopic
1528911|NCT00666302|Elidel|elidel
1528912|NCT00666289|polycythemia vera|polycythemia vera
1528913|NCT00666289|essential thrombocythemia|essential thrombocythemia
1528914|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
1528915|NCT00666289|family clusters|family clusters
1528916|NCT00666250|blood pressure|blood pressure
1528917|NCT00666250|dyslipidemia|dyslipidemia
1528918|NCT00666250|hyperglycemia|hyperglycemia
1528919|NCT00666237|Glaucoma|glaucoma
1528920|NCT00666237|Tube shunt surgery|tube shunt surgery
1528921|NCT00666237|Trabeculectomy|trabeculectomy
1528922|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
1528923|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
1528924|NCT00666224|Multiple Sclerosis|multiple sclerosis
1528925|NCT00666211|pain|pain
1528926|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1528927|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1528928|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
1528929|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1528930|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1528931|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1528932|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1528933|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1528934|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1528935|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1529134|NCT00665886|Bacterial Colonization|bacterial colonization
1528936|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1528937|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1528938|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1528939|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1528940|NCT00666211|mast cell leukemia|mast cell leukemia
1528941|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1528942|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1528943|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
1528944|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1528945|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1528946|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1528947|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1528948|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
1528949|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1528950|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1528951|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1528952|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1528953|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1528954|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1528955|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1529668|NCT00663572|nutrition|nutrition
1528956|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1528957|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1528958|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1528959|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1528960|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1528961|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1528962|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1529097|NCT00666107|Gardasil|gardasil
1528963|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1528964|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1528965|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1528966|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1528967|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1528968|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1528969|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1528970|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1528971|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1528972|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1528973|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1528974|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1528975|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1528976|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1528977|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1528978|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1528979|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1528980|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1528981|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1528982|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1528983|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1528984|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1528985|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1528986|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1528987|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1528988|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1528989|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1528990|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1528991|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1528992|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1528993|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1528994|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1528995|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1528996|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1528997|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1528998|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1528999|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1529000|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1529001|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1529002|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1529003|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1529004|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1529005|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1529006|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1529007|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1529008|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1529009|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1529010|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1529011|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1529012|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1529013|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1529014|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1529015|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1529669|NCT00663572|genetic|genetic
1529016|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1529017|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1529018|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1529019|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1529020|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1529021|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1529022|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1529023|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1529024|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1529025|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1529135|NCT00665886|Dwell time|dwell time
1529026|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1529027|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1529028|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1529029|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1529030|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1529031|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1529032|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1529033|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1529034|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1529035|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1529036|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1529037|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1529038|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1529039|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1529040|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1529041|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1529042|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1529043|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1529044|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1529045|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1529046|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1529047|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1529048|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1529049|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1529050|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1529051|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1529052|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1529053|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1529054|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1529055|NCT00666211|intraocular lymphoma|intraocular lymphoma
1529056|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1529057|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1529058|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1529059|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1529060|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1529061|NCT00666211|primary myelofibrosis|primary myelofibrosis
1529062|NCT00666211|essential thrombocythemia|essential thrombocythemia
1529063|NCT00666211|polycythemia vera|polycythemia vera
1529064|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
1529065|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1529066|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1529067|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
1529068|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
1529069|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
1529070|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
1529071|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
1529072|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1529073|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1529074|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1529075|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1529076|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1529077|NCT00666185|Micafungin|micafungin
1529078|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
1529079|NCT00666185|Fluconazole|fluconazole
1529080|NCT00666172|Women's Health|women's health
1529082|NCT00666172|Metabolic Syndrome|metabolic syndrome
1529083|NCT00666172|Arterial Function|arterial function
1529084|NCT00666172|Lipoproteins|lipoproteins
1529085|NCT00666172|Overweight|overweight
1529086|NCT00666159|Atopic Dermatitis|atopic dermatitis
1529087|NCT00666159|Protopic|protopic
1529088|NCT00666159|Pediatric|pediatric
1529089|NCT00666146|Schizophrenia|schizophrenia
1529090|NCT00666146|Genetics|genetics
1529091|NCT00666146|Eyetracking|eyetracking
1529092|NCT00666133|Preeclampsia|preeclampsia
1529093|NCT00666133|Eclampsia|eclampsia
1529094|NCT00666133|Magnesium Sulfate|magnesium sulfate
1529095|NCT00666107|HPV|hpv
1529096|NCT00666107|HIV|hiv
1529098|NCT00666107|Vaccine|vaccine
1529099|NCT00666094|Type 2-diabetes|type 2-diabetes
1529100|NCT00666094|exercise therapy|exercise therapy
1529101|NCT00666094|RCT|rct
1529102|NCT00666094|Norway|norway
1529103|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
1529104|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
1529105|NCT00666055|Sex|sex
1529106|NCT00666055|Aging|aging
1529107|NCT00666055|Antiretroviral|antiretroviral
1529108|NCT00666055|Pharmacokinetics|pharmacokinetics
1529109|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
1529110|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
1529111|NCT00666029|metabolic syndrome|metabolic syndrome
1529112|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
1529113|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
1529114|NCT00666003|Hemodynamics|hemodynamics
1529115|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
1529116|NCT00665977|Nasal Congestion|nasal congestion
1529117|NCT00665977|Sinus congestion|sinus congestion
1529118|NCT00665964|osteoarthritis|osteoarthritis
1529119|NCT00665964|knee|knee
1529120|NCT00665964|total knee arthroplasty|total knee arthroplasty
1529121|NCT00665964|gonarthrrsis|gonarthrrsis
1529122|NCT00665964|polyethylene|polyethylene
1529123|NCT00665964|posterior stabilized|posterior stabilized
1529124|NCT00665951|pediatric|pediatric
1529125|NCT00665951|pharmacokinetics|pharmacokinetics
1529126|NCT00665951|HIV infection|hiv infection
1529127|NCT00665938|Physical development|physical development
1529128|NCT00665899|breast cancer|breast cancer
1529129|NCT00665899|couples|couples
1529130|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
1529131|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
1529132|NCT00665886|Peripheral venous catheter|peripheral venous catheter
1529133|NCT00665886|Catheter-related complication|catheter-related complication
1529136|NCT00665886|Closed system|closed system
1529137|NCT00665886|Costs|costs
1529138|NCT00665886|Polyurethane|polyurethane
1529139|NCT00665886|Teflon|teflon
1529140|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
1529141|NCT00665873|Infections|infections
1529142|NCT00665873|Chemotherapy|chemotherapy
1529143|NCT00665873|Valuated infections TIVAD|valuated infections tivad
1529144|NCT00665860|Osteoporosis|osteoporosis
1529145|NCT00665860|Soy isoflavones|soy isoflavones
1529146|NCT00665860|Postmenopausal women|postmenopausal women
1529147|NCT00665860|Safety|safety
1529148|NCT00665860|Efficacy|efficacy
1529149|NCT00665860|Effective dosage|effective dosage
1529150|NCT00665847|HIV-1|hiv-1
1529151|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
1529152|NCT00665847|TMC125-C213|tmc125-c213
1529153|NCT00665821|nonspecific low back pain|nonspecific low back pain
1529154|NCT00665821|disability|disability
1529155|NCT00665821|sick leave|sick leave
1529156|NCT00665821|catastrophizing|catastrophizing
1529157|NCT00665821|workers|workers
1529158|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
1529159|NCT00665795|multidetector computed tomography|multidetector computed tomography
1529160|NCT00665795|color doppler|color doppler
1529161|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
1529162|NCT00665795|Grave´s Disease|grave´s disease
1529163|NCT00665795|morphometric analysis|morphometric analysis
1529164|NCT00665782|anxiety disorder|anxiety disorder
1529165|NCT00665782|depression|depression
1529166|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1529167|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1529168|NCT00665782|breast cancer in situ|breast cancer in situ
1529169|NCT00665782|stage I breast cancer|stage i breast cancer
1529170|NCT00665782|stage II breast cancer|stage ii breast cancer
1529171|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
1529172|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
1529173|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
1529174|NCT00665769|hypercapnia|hypercapnia
1529175|NCT00665769|normocapnia|normocapnia
1529176|NCT00665769|chronic lung disease|chronic lung disease
1529177|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
1529178|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
1529179|NCT00665769|hypotension|hypotension
1529180|NCT00665769|cerebral autoregulation|cerebral autoregulation
1529181|NCT00665769|heart rate variability|heart rate variability
1529182|NCT00665769|autonomic nervous system|autonomic nervous system
1529183|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
1529184|NCT00665756|Glaucoma|glaucoma
1529185|NCT00665756|Drainage implant|drainage implant
1529186|NCT00665756|Ahmed valve|ahmed valve
1529187|NCT00665756|Second trabeculectomy|second trabeculectomy
1529188|NCT00665717|interaction|interaction
1529189|NCT00665717|statins|statins
1529190|NCT00665717|pharmacokinetics|pharmacokinetics
1529191|NCT00665704|Smoking Cessation|smoking cessation
1529192|NCT00665704|Internet|internet
1529193|NCT00665704|Intervention Studies|intervention studies
1529194|NCT00665704|Health Services Accessibility|health services accessibility
1529195|NCT00665691|All Malignancies|all malignancies
1529196|NCT00665652|Neuropathy|neuropathy
1529197|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
1529198|NCT00665652|MGUS|mgus
1529199|NCT00665639|Micafungin|micafungin
1529200|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
1529201|NCT00665639|caspofungin|caspofungin
1529202|NCT00665613|warfarin use|warfarin use
1529203|NCT00665600|COPD|copd
1529204|NCT00665600|Chronic Bronchitis|chronic bronchitis
1529205|NCT00665600|Chronic Emphysema|chronic emphysema
1529206|NCT00665587|Atrial fibrillation|atrial fibrillation
1529207|NCT00665587|Maze procedure|maze procedure
1529208|NCT00665587|Mid-term results|mid-term results
1529209|NCT00665587|Long-term results|long-term results
1529210|NCT00665587|Surgical ablation|surgical ablation
1529211|NCT00665561|Maraviroc|maraviroc
1529212|NCT00665561|HIV-1|hiv-1
1529213|NCT00665561|Safety|safety
1529214|NCT00665561|Non-interventional|non-interventional
1529215|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
1529216|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
1529217|NCT00665548|x rays|x rays
1529218|NCT00665535|Pressure ulcers|pressure ulcers
1529219|NCT00665535|Nursing facilities|nursing facilities
1529220|NCT00665535|Elderly|elderly
1529221|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
1529222|NCT00665522|Pain|pain
1529223|NCT00665522|Postoperative Analgesia|postoperative analgesia
1529224|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
1529225|NCT00665509|Influenza|influenza
1529226|NCT00665509|Vaccine|vaccine
1529227|NCT00665509|CHMP criteria|chmp criteria
1529228|NCT00665496|Erectile Dysfunction|erectile dysfunction
1529229|NCT00665496|Vardenafil|vardenafil
1529230|NCT00665496|Onset of action|onset of action
1529231|NCT00665470|Malignant Melanoma|malignant melanoma
1529232|NCT00665470|HLA-A2|hla-a2
1529233|NCT00665470|Immunotherapy|immunotherapy
1529234|NCT00665470|Clinical Response|clinical response
1529235|NCT00665470|Skin Cancer|skin cancer
1529236|NCT00665457|stage II breast cancer|stage ii breast cancer
1529237|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
1529238|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
1529239|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
1529240|NCT00665444|bipolar disorder|bipolar disorder
1529241|NCT00665444|sedation|sedation
1529242|NCT00665444|overweight|overweight
1529243|NCT00665444|Abilify|abilify
1529244|NCT00665444|medication|medication
1529245|NCT00665418|Anesthesia|anesthesia
1529246|NCT00665418|children|children
1529247|NCT00665418|Larynx|larynx
1529248|NCT00665405|Delivery, obstetric|delivery, obstetric
1529249|NCT00665405|Atelectasis|atelectasis
1529250|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1529251|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1529252|NCT00665392|tongue cancer|tongue cancer
1529253|NCT00665379|leg lymphedema|leg lymphedema
1529254|NCT00665379|volume measurement|volume measurement
1529255|NCT00665379|compression therapy|compression therapy
1529256|NCT00665379|interface pressure|interface pressure
1529257|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
1529258|NCT00665379|volume change|volume change
1529259|NCT00665353|HIV|hiv
1529260|NCT00665353|HCV|hcv
1529261|NCT00665340|Erectile Dysfunction|erectile dysfunction
1529262|NCT00665340|Vardenafil|vardenafil
1529263|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
1529264|NCT00665327|Pneumonia,|pneumonia,
1529265|NCT00665327|CAP|cap
1529266|NCT00665314|Mobilisation stem cells|mobilisation stem cells
1529267|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
1529268|NCT00665314|Lymphoma|lymphoma
1529269|NCT00665314|Multiple Myeloma|multiple myeloma
1529270|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
1529271|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
1529272|NCT00665288|cardiac arrest|cardiac arrest
1529273|NCT00665288|heart arrest|heart arrest
1529274|NCT00665288|CPR|cpr
1529275|NCT00665288|resuscitation|resuscitation
1529276|NCT00665288|bystander CPR|bystander cpr
1529277|NCT00665275|complementary|complementary
1529278|NCT00665275|alternative|alternative
1529279|NCT00665275|medicine|medicine
1529280|NCT00665262|analgesia|analgesia
1529281|NCT00665262|hip arthroplasty|hip arthroplasty
1529282|NCT00665262|knee arthroplasty|knee arthroplasty
1529283|NCT00665249|problem drinking|problem drinking
1529284|NCT00665249|heavy drinking|heavy drinking
1529285|NCT00665249|Alcohol|alcohol
1529286|NCT00665249|moderation|moderation
1529287|NCT00665249|motivational interviewing|motivational interviewing
1529288|NCT00665236|Migraine|migraine
1529289|NCT00665223|Huntington's Disease|huntington's disease
1529290|NCT00665210|hip arthritis|hip arthritis
1529291|NCT00665210|implant sizing|implant sizing
1529292|NCT00665197|Esophageal cancer|esophageal cancer
1529293|NCT00665197|Brachytherapy|brachytherapy
1529294|NCT00665197|Radiotherapy|radiotherapy
1529295|NCT00665197|Palliation|palliation
1529296|NCT00665197|Dysphagia|dysphagia
1529297|NCT00665184|Hypokinesia|hypokinesia
1529298|NCT00665184|Gait|gait
1529299|NCT00665184|Quality of life|quality of life
1529300|NCT00665184|Dopamine replacement|dopamine replacement
1529301|NCT00665184|Resistance training|resistance training
1529302|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
1529303|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
1529304|NCT00665171|Whole genome analysis|whole genome analysis
1529305|NCT00665171|Multigenerational family study|multigenerational family study
1529306|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
1529307|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1529308|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1529309|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
1529310|NCT00665145|Stem Cells|stem cells
1529311|NCT00665132|wrist|wrist
1529312|NCT00665132|hand|hand
1529313|NCT00665132|pain|pain
1529314|NCT00665132|failed CTR|failed ctr
1529315|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
1529316|NCT00665132|CTS|cts
1529317|NCT00665132|CTR|ctr
1529318|NCT00665132|carpel tunnel release|carpel tunnel release
1529319|NCT00665132|Peripheral nerve|peripheral nerve
1529320|NCT00665132|Median nerve|median nerve
1529321|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
1529322|NCT00665119|Respiration, Artificial|respiration, artificial
1529323|NCT00665119|Remifentanil|remifentanil
1529324|NCT00665119|Respiratory Mechanics|respiratory mechanics
1529325|NCT00665119|Work of Breathing|work of breathing
1529326|NCT00665106|Diabetic macular edema|diabetic macular edema
1529327|NCT00665106|Diabetes|diabetes
1529328|NCT00665106|Diabetic retinopathy|diabetic retinopathy
1529329|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
1529330|NCT00665067|Myelofibrosis|myelofibrosis
1529331|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
1529332|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
1529333|NCT00665067|Polycythemia Vera|polycythemia vera
1529334|NCT00665067|Biomarkers|biomarkers
1529335|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
1529336|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
1529337|NCT00665054|Vardenafil|vardenafil
1529338|NCT00665054|Erectile dysfunction|erectile dysfunction
1529339|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
1529340|NCT00665028|Anesthesia|anesthesia
1529341|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
1529342|NCT00665028|ST monitoring|st monitoring
1529343|NCT00665015|pleural effusion|pleural effusion
1529344|NCT00665015|coronary artery bypass|coronary artery bypass
1529345|NCT00665015|heart valve replacement|heart valve replacement
1529346|NCT00665002|Myeloid|myeloid
1529347|NCT00665002|Monocytic|monocytic
1529348|NCT00665002|Hematopoietic|hematopoietic
1529349|NCT00665002|Neoplasms|neoplasms
1529350|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
1529351|NCT00665002|AML|aml
1529352|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
1529353|NCT00665002|MDS|mds
1529354|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
1529355|NCT00664976|bipolar depression|bipolar depression
1529356|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
1529357|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
1529358|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
1529359|NCT00664963|Drug eluting stent|drug eluting stent
1529360|NCT00664963|Restenosis|restenosis
1529361|NCT00664963|Below the knee|below the knee
1529362|NCT00664963|Intervention|intervention
1529363|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
1529364|NCT00664950|interTAN IM Nail|intertan im nail
1529365|NCT00664950|sliding hip screw|sliding hip screw
1529366|NCT00664924|ICU|icu
1529367|NCT00664898|anti-CD40|anti-cd40
1529368|NCT00664898|Myeloma|myeloma
1529369|NCT00664885|non-psychiatric|non-psychiatric
1529370|NCT00664885|clinics|clinics
1529371|NCT00664872|case manager|case manager
1529372|NCT00664872|suicide|suicide
1529373|NCT00664872|attempt|attempt
1529374|NCT00664872|effectiveness|effectiveness
1529376|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
1529377|NCT00664859|Triglycerides|triglycerides
1529378|NCT00664859|HDL cholesterol|hdl cholesterol
1529379|NCT00664859|LDL cholesterol|ldl cholesterol
1529380|NCT00664859|Atorvastatin|atorvastatin
1529381|NCT00664859|Fenofibrate|fenofibrate
1529382|NCT00664846|Stroke|stroke
1529383|NCT00664846|Prevention Therapy|prevention therapy
1529384|NCT00664833|Erectile dysfunction|erectile dysfunction
1529385|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
1529386|NCT00664833|Patient education|patient education
1529387|NCT00664833|Impotence|impotence
1529388|NCT00664833|Vardenafil|vardenafil
1529389|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
1529390|NCT00664820|probiotics|probiotics
1529391|NCT00664820|Lactobacillus|lactobacillus
1529392|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
1529393|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
1529394|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
1529395|NCT00664781|stage IV breast cancer|stage iv breast cancer
1529396|NCT00664781|recurrent breast cancer|recurrent breast cancer
1529397|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1529398|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1529399|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1529400|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
1529401|NCT00664781|ovarian sarcoma|ovarian sarcoma
1529402|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
1529403|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
1529404|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1529405|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1529406|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1529407|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1529408|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1529409|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1529410|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
1529411|NCT00664768|hypoallergenicity|hypoallergenicity
1529412|NCT00664768|Cow Milk Allergy|cow milk allergy
1529413|NCT00664768|DBPCFC|dbpcfc
1529414|NCT00664768|Stool microflora|stool microflora
1529415|NCT00664768|Stool characteristics|stool characteristics
1529416|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
1529417|NCT00664755|Cue Reactivity|cue reactivity
1529418|NCT00664755|Smoking Cessation|smoking cessation
1529419|NCT00664755|Impulsivity|impulsivity
1529420|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
1529421|NCT00664729|Abdominal|abdominal
1529422|NCT00664729|obesity|obesity
1529423|NCT00664729|exercise|exercise
1529424|NCT00664729|intensity|intensity
1529425|NCT00664729|weight loss|weight loss
1529426|NCT00664729|women|women
1529427|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
1529428|NCT00664716|RA|ra
1529429|NCT00664716|DMARD inadequate response|dmard inadequate response
1529430|NCT00664716|Methotrexate|methotrexate
1529431|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
1529432|NCT00664703|Dopamine|dopamine
1529433|NCT00664703|Methylphenidate|methylphenidate
1529434|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
1529435|NCT00664703|Neurologic Manifestations|neurologic manifestations
1529436|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
1529437|NCT00664703|Hyperkinesis|hyperkinesis
1529438|NCT00664703|Dyskinesias|dyskinesias
1529439|NCT00664690|shoulder surgery|shoulder surgery
1529440|NCT00664690|analgesia|analgesia
1529441|NCT00664677|Adult|adult
1529442|NCT00664677|Leukemia|leukemia
1529443|NCT00664677|Terameprocol|terameprocol
1529444|NCT00664677|Survivin|survivin
1529445|NCT00664677|AML|aml
1529446|NCT00664677|ALL|all
1529447|NCT00664677|ATL|atl
1529448|NCT00664677|CML|cml
1529449|NCT00664677|CLL|cll
1529450|NCT00664677|CMML|cmml
1529451|NCT00664677|MDS|mds
1529452|NCT00664664|insomnia|insomnia
1529453|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
1529454|NCT00664664|sleep quality|sleep quality
1529455|NCT00664664|non-restorative sleep|non-restorative sleep
1529456|NCT00664664|multiple awakenings|multiple awakenings
1529457|NCT00664651|joint contracture|joint contracture
1529458|NCT00664651|total knee arthroplasty|total knee arthroplasty
1529459|NCT00664612|Cervical Spine|cervical spine
1529460|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
1529461|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
1529462|NCT00664586|Phase 1|phase 1
1529463|NCT00664586|Infusion|infusion
1529464|NCT00664586|Refractory Solid Tumors|refractory solid tumors
1529465|NCT00664586|Lymphoma|lymphoma
1529466|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
1529467|NCT00664586|Tumor Response|tumor response
1529468|NCT00664586|Tumor Markers|tumor markers
1529469|NCT00664586|Pharmacokinetics|pharmacokinetics
1529470|NCT00664573|Safety|safety
1529471|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
1529472|NCT00664573|Baminercept alfa|baminercept alfa
1529473|NCT00664573|Methotrexate|methotrexate
1529474|NCT00664573|BG9924|bg9924
1529475|NCT00664573|Efficacy|efficacy
1529476|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
1529477|NCT00664508|Arthroplasty|arthroplasty
1529478|NCT00664508|Hip Replacement|hip replacement
1529479|NCT00664508|motion analysis|motion analysis
1529480|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
1529481|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
1529482|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
1529578|NCT00663962|Pregabalin|pregabalin
1529483|NCT00664456|stage I prostate cancer|stage i prostate cancer
1529484|NCT00664443|cardiac arrest|cardiac arrest
1529486|NCT00664443|resuscitation|resuscitation
1529487|NCT00664443|bystander CPR|bystander cpr
1529488|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
1529489|NCT00664430|Dialysis|dialysis
1529490|NCT00664430|Calcitriol Resistant|calcitriol resistant
1529491|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1529492|NCT00664417|Influenza|influenza
1529493|NCT00664417|A/H5N1|a/h5n1
1529494|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
1529495|NCT00664417|Influenza Pandemics|influenza pandemics
1529496|NCT00664404|Smoking|smoking
1529497|NCT00664404|Smoking Cessation|smoking cessation
1529498|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
1529499|NCT00664404|Nicotine Dependence|nicotine dependence
1529500|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
1529501|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
1529502|NCT00664404|MRI|mri
1529503|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
1529504|NCT00664365|Premature ejaculation.|premature ejaculation.
1529505|NCT00664365|FTIH,|ftih,
1529506|NCT00664365|GSK958108,|gsk958108,
1529507|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
1529508|NCT00664352|Double blind|double blind
1529509|NCT00664352|Placebo controlled|placebo controlled
1529510|NCT00664352|wound healing|wound healing
1529511|NCT00664339|Heart failure,|heart failure,
1529512|NCT00664339|infection,|infection,
1529513|NCT00664339|immune system,|immune system,
1529514|NCT00664339|atherosclerosis|atherosclerosis
1529515|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
1529516|NCT00664313|Linezolid|linezolid
1529517|NCT00664313|Zyvox|zyvox
1529518|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
1529519|NCT00664313|Optic Neuropathy|optic neuropathy
1529520|NCT00664313|Anemia|anemia
1529521|NCT00664313|Thrombocytopenia|thrombocytopenia
1529522|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
1529523|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
1529524|NCT00664300|Frequency levels|frequency levels
1529525|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
1529526|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
1529527|NCT00664261|tobacco use disorder|tobacco use disorder
1529528|NCT00664235|Pressure Ulcers|pressure ulcers
1529529|NCT00664235|Tissue Injury|tissue injury
1529530|NCT00664222|heart failure|heart failure
1529531|NCT00664222|insulin resistance|insulin resistance
1529532|NCT00664222|inflammatory cytokine|inflammatory cytokine
1529533|NCT00664222|spironolactone|spironolactone
1529534|NCT00664222|furosemide|furosemide
1529535|NCT00664209|Parkinson's disease|parkinson's disease
1529536|NCT00664209|levodopa|levodopa
1529537|NCT00664209|Helicobacter pylori|helicobacter pylori
1529538|NCT00664196|Prostate Cancer|prostate cancer
1529539|NCT00664196|T cells|t cells
1529540|NCT00664196|Gene Transfer|gene transfer
1529541|NCT00664183|diabetic retinopathy|diabetic retinopathy
1529542|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1529543|NCT00664157|L-Dopa|l-dopa
1529544|NCT00664157|Deep Brain stimulation|deep brain stimulation
1529545|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
1529546|NCT00664157|Frequency levels|frequency levels
1529547|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
1529548|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
1529549|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1529550|NCT00664131|ALL survivors|all survivors
1529551|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
1529552|NCT00664131|ALL neurologic disability|all neurologic disability
1529553|NCT00664131|ALL late effects|all late effects
1529554|NCT00664118|Doula|doula
1529555|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
1529556|NCT00664118|Neuraxial analgesia|neuraxial analgesia
1529557|NCT00664118|Labor analgesia|labor analgesia
1529558|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1529559|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1529560|NCT00664092|Substance Abuse|substance abuse
1529561|NCT00664092|Ex-Offenders|ex-offenders
1529562|NCT00664092|Substance Abuse Recovery|substance abuse recovery
1529563|NCT00664079|Thyroid Deficiency|thyroid deficiency
1529564|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
1529565|NCT00664053|bone mineral density|bone mineral density
1529566|NCT00664053|bone turnover markers|bone turnover markers
1529567|NCT00664053|strength|strength
1529568|NCT00664053|balance|balance
1529569|NCT00664014|hyponatremia|hyponatremia
1529570|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
1529571|NCT00663988|face transplantation|face transplantation
1529572|NCT00663975|cystic fibrosis|cystic fibrosis
1529573|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
1529574|NCT00663975|pancreatic enzymes|pancreatic enzymes
1529575|NCT00663975|pediatrics|pediatrics
1529576|NCT00663962|Thoracotomy|thoracotomy
1529577|NCT00663962|Post-surgical|post-surgical
1529579|NCT00663949|diabetes|diabetes
1529580|NCT00663949|proteinuria|proteinuria
1529581|NCT00663949|pentoxifylline|pentoxifylline
1529582|NCT00663936|Alzheimer's Disease|alzheimer's disease
1529583|NCT00663936|Alzheimer's|alzheimer's
1529584|NCT00663923|Excimer Laser|excimer laser
1529585|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
1529586|NCT00663923|astigmatism|astigmatism
1529587|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1529588|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1529589|NCT00663910|recurrent skin cancer|recurrent skin cancer
1529590|NCT00663897|functional dyspepsia|functional dyspepsia
1529591|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
1529592|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
1529593|NCT00663897|proton pump inhibitor|proton pump inhibitor
1529594|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
1529595|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
1529596|NCT00663884|mitiglinide|mitiglinide
1529597|NCT00663871|Fish Oil|fish oil
1529598|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
1529599|NCT00663871|Affect|affect
1529600|NCT00663871|Depression|depression
1529601|NCT00663871|Anger|anger
1529602|NCT00663871|Nutrition|nutrition
1529603|NCT00663871|Impulsivity|impulsivity
1529604|NCT00663871|Aggression|aggression
1529605|NCT00663871|Cognition|cognition
1529606|NCT00663871|Behavior|behavior
1529607|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
1529608|NCT00663845|Dyslipidemia|dyslipidemia
1529609|NCT00663845|Vardenafil|vardenafil
1529610|NCT00663832|Male|male
1529611|NCT00663832|Prostate|prostate
1529612|NCT00663832|Cancer|cancer
1529613|NCT00663832|HRPC|hrpc
1529614|NCT00663832|DACi|daci
1529615|NCT00663819|Low anterior colon resection|low anterior colon resection
1529616|NCT00663819|Proctectomy|proctectomy
1529617|NCT00663819|Proctocolectomy|proctocolectomy
1529618|NCT00663819|Anastomosis|anastomosis
1529619|NCT00663819|Rectal Cancer|rectal cancer
1529620|NCT00663819|Ileostomy|ileostomy
1529621|NCT00663806|UTI|uti
1529622|NCT00663793|Male Contraception|male contraception
1529623|NCT00663793|Hypogonadism|hypogonadism
1529624|NCT00663793|Testosterone|testosterone
1529625|NCT00663780|pharmacogenomics|pharmacogenomics
1529626|NCT00663780|polymorphisms|polymorphisms
1529627|NCT00663780|wound healing|wound healing
1529628|NCT00663754|Body Image|body image
1529629|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
1529630|NCT00663741|Sorafenib|sorafenib
1529631|NCT00663741|S-1|s-1
1529632|NCT00663741|Gastric|gastric
1529633|NCT00663741|Cisplatin|cisplatin
1529634|NCT00663741|CDDP|cddp
1529635|NCT00663728|Erectile Dysfunction|erectile dysfunction
1529636|NCT00663728|Vardenafil|vardenafil
1529637|NCT00663715|Sciatic Nerve|sciatic nerve
1529638|NCT00663715|Peripheral Nerve Block|peripheral nerve block
1529639|NCT00663715|Lower extremity surgery|lower extremity surgery
1529640|NCT00663715|Local Anesthesia|local anesthesia
1529641|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
1529642|NCT00663689|erlotinib|erlotinib
1529643|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
1529644|NCT00663650|BCC|bcc
1529645|NCT00663650|Periocular BCC|periocular bcc
1529646|NCT00663650|Frozen Section Control|frozen section control
1529647|NCT00663650|Permanent Section Control|permanent section control
1529648|NCT00663650|Recurrence Rates|recurrence rates
1529649|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
1529650|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
1529651|NCT00663637|work of breathing|work of breathing
1529652|NCT00663637|airway resistance|airway resistance
1529653|NCT00663637|secretions|secretions
1529654|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
1529655|NCT00663637|biofilms|biofilms
1529656|NCT00663637|endotracheal tube|endotracheal tube
1529657|NCT00663611|Immune Function|immune function
1529658|NCT00663611|Metabolism|metabolism
1529659|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
1529660|NCT00663598|Erectile Dysfunction|erectile dysfunction
1529661|NCT00663598|Vardenafil|vardenafil
1529662|NCT00663585|Migraine|migraine
1529663|NCT00663585|Headache|headache
1529664|NCT00663585|Vipassana|vipassana
1529665|NCT00663585|Meditation|meditation
1529666|NCT00663585|Intensive|intensive
1529670|NCT00663572|feeding behaviour|feeding behaviour
1529671|NCT00663572|psychomotor development|psychomotor development
1529672|NCT00663572|long-term effects|long-term effects
1529673|NCT00663572|nutritional imprinting.|nutritional imprinting.
1529674|NCT00663559|renal|renal
1529675|NCT00663559|Sunitinib|sunitinib
1529676|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
1529677|NCT00663546|Malaria|malaria
1529678|NCT00663546|Plasmodium|plasmodium
1529679|NCT00663546|Hemoglobin E|hemoglobin e
1529680|NCT00663546|Alpha-thalssemia|alpha-thalssemia
1529681|NCT00663546|G6PD Deficiency|g6pd deficiency
1529682|NCT00663533|Vasectomy|vasectomy
1529683|NCT00663533|Contraception|contraception
1529684|NCT00663520|Cardiac disease|cardiac disease
1529685|NCT00663520|vascular dysfunction|vascular dysfunction
1529686|NCT00663520|women|women
1529687|NCT00663520|chest pain|chest pain
1529688|NCT00663520|echocardiography|echocardiography
1529689|NCT00663507|Sickle Cell Disease|sickle cell disease
1529690|NCT00663507|Immunosuppression|immunosuppression
1529691|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
1529692|NCT00663507|Transplantation Immunology|transplantation immunology
1529693|NCT00663494|heart failure|heart failure
1529694|NCT00663494|MMP|mmp
1529695|NCT00663494|coronary sinus|coronary sinus
1529696|NCT00663481|CoFactor|cofactor
1529697|NCT00663481|ANX-510|anx-510
1529698|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
1529699|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
1529700|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
1529701|NCT00663455|kidney transplant recipients|kidney transplant recipients
1529702|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
1529703|NCT00663442|ADHD|adhd
1529704|NCT00663442|side effects|side effects
1529705|NCT00663442|sleep|sleep
1529706|NCT00663442|dopamine|dopamine
1529707|NCT00663442|pharmacogenetics|pharmacogenetics
1529708|NCT00663403|daptomycin|daptomycin
1529709|NCT00663403|pharmacokinetics|pharmacokinetics
1529710|NCT00663403|renal replacement therapy|renal replacement therapy
1529711|NCT00663403|critical illness|critical illness
1529712|NCT00663403|intensive care units|intensive care units
1529713|NCT00663377|Heart Failure|heart failure
1529714|NCT00663377|Insulin Resistance|insulin resistance
1529715|NCT00663377|Losartan|losartan
1529716|NCT00663377|ACE inhibitor|ace inhibitor
1529717|NCT00663377|Inflammatory cytokine|inflammatory cytokine
1529718|NCT00663364|dry skin|dry skin
1529719|NCT00663351|Arthritis|arthritis
1529720|NCT00663351|Osteoarthritis|osteoarthritis
1529721|NCT00663351|Traumatic Arthritis|traumatic arthritis
1529722|NCT00663351|Degenerative Joint Disease|degenerative joint disease
1529723|NCT00663351|Avascular Necrosis|avascular necrosis
1529724|NCT00663338|Stroke|stroke
1529725|NCT00663338|Hemispatial neglect|hemispatial neglect
1529726|NCT00663338|Unilateral neglect|unilateral neglect
1529727|NCT00663338|Spatial neglect|spatial neglect
1529728|NCT00663338|Motor|motor
1529729|NCT00663338|Weakness|weakness
1529730|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1529731|NCT00663312|Deep Brain stimulation|deep brain stimulation
1529732|NCT00663312|Hepatic glucose production|hepatic glucose production
1529733|NCT00663312|Insulin|insulin
1529734|NCT00663312|Weight gain|weight gain
1529735|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
1529736|NCT00663299|Intracranial aneurysm|intracranial aneurysm
1529737|NCT00663247|Diverticular disease|diverticular disease
1529738|NCT00663247|Inflammation|inflammation
1529739|NCT00663247|Mesalazine|mesalazine
1529740|NCT00663234|Treatment Experienced|treatment experienced
1529741|NCT00663221|Osteoporosis prevention|osteoporosis prevention
1529742|NCT00663195|heart failure|heart failure
1529743|NCT00663195|fibrosis|fibrosis
1529744|NCT00663195|MMP|mmp
1529745|NCT00663195|spironolactone|spironolactone
1529746|NCT00663195|furosemide|furosemide
1529747|NCT00663182|Entecavir|entecavir
1529748|NCT00663182|cirrhosis|cirrhosis
1529749|NCT00663182|anti-viral|anti-viral
1529750|NCT00663182|therapy|therapy
1529751|NCT00663169|Arthritis Gouty|arthritis gouty
1529752|NCT00663169|ACZ885|acz885
1529753|NCT00663169|IL1B protein|il1b protein
1529754|NCT00663169|Pain|pain
1529755|NCT00663156|lipoaugmentation|lipoaugmentation
1529756|NCT00663156|breast augmentation|breast augmentation
1529757|NCT00663156|fat grafting|fat grafting
1529758|NCT00663156|liposuction|liposuction
1529759|NCT00663156|lipoinfiltration|lipoinfiltration
1529760|NCT00663156|Spear|spear
1529761|NCT00663156|breast implants|breast implants
1529762|NCT00663156|ASERF|aserf
1529763|NCT00663156|Lipivage|lipivage
1529764|NCT00663156|Baker|baker
1529765|NCT00663156|harvest|harvest
1529766|NCT00663156|autologous|autologous
1529767|NCT00663156|Georgetown|georgetown
1529768|NCT00663143|investigate|investigate
1529769|NCT00663143|TZD exposure|tzd exposure
1529770|NCT00663143|in vitro|in vitro
1529771|NCT00663143|alters|alters
1529772|NCT00663143|bone|bone
1529773|NCT00663143|formation|formation
1529774|NCT00663143|differentiation|differentiation
1529775|NCT00663143|capacity|capacity
1529776|NCT00663143|bone marrow|bone marrow
1529777|NCT00663143|stromal cells|stromal cells
1529778|NCT00663130|Erectile Dysfunction|erectile dysfunction
1529779|NCT00663130|Vardenafil|vardenafil
1529780|NCT00663117|naltrexone|naltrexone
1529781|NCT00663117|LDN|ldn
1529782|NCT00663117|IBD|ibd
1529783|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
1529784|NCT00663104|early menopause|early menopause
1529785|NCT00663104|exercise|exercise
1529786|NCT00663104|phytoestrogen|phytoestrogen
1529787|NCT00663104|bone|bone
1530204|NCT00661947|lactate|lactate
1529788|NCT00663104|CHD-risk factors|chd-risk factors
1529789|NCT00663091|WPP-201|wpp-201
1529790|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
1529791|NCT00663078|expert patient programme|expert patient programme
1529792|NCT00663078|deprived population|deprived population
1529793|NCT00663078|women|women
1529794|NCT00663065|Healthy subjects over 65|healthy subjects over 65
1529795|NCT00663065|healthy subjects|healthy subjects
1529796|NCT00663052|Enbrel|enbrel
1529797|NCT00663052|Psoriasis|psoriasis
1529798|NCT00663052|Topical Psoriasis|topical psoriasis
1529799|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
1529800|NCT00663052|Active Psoriasis|active psoriasis
1529801|NCT00663039|Schizophrenia|schizophrenia
1529802|NCT00663039|Eye movements|eye movements
1529803|NCT00663039|phenotype|phenotype
1529804|NCT00663039|biochemical|biochemical
1529805|NCT00663039|relatives|relatives
1529806|NCT00663026|antibody|antibody
1529807|NCT00663026|immunotherapy|immunotherapy
1529808|NCT00663013|burn|burn
1529809|NCT00663013|pain|pain
1529810|NCT00663013|anxiety|anxiety
1529811|NCT00663000|acromegaly|acromegaly
1529812|NCT00663000|diabetes|diabetes
1529813|NCT00663000|insulin resistance|insulin resistance
1529814|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
1529815|NCT00662987|tonsillectomy|tonsillectomy
1529816|NCT00662987|antibiotics|antibiotics
1529817|NCT00662961|Plastic Surgery|plastic surgery
1529818|NCT00662948|Folicular Lymphoma|folicular lymphoma
1529819|NCT00662948|Consolidation|consolidation
1529820|NCT00662948|Maintenance|maintenance
1529821|NCT00662935|deep brain stimulation|deep brain stimulation
1529822|NCT00662935|cluster headache|cluster headache
1529823|NCT00662935|hypothalamus|hypothalamus
1529824|NCT00662922|critical illness|critical illness
1529825|NCT00662922|hypoglycemia|hypoglycemia
1529826|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
1529827|NCT00662922|intensive insulin therapy|intensive insulin therapy
1529828|NCT00662909|Frequency|frequency
1529829|NCT00662909|YM178|ym178
1529830|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
1529831|NCT00662909|Micturition|micturition
1529832|NCT00662909|Urgency|urgency
1529833|NCT00662909|Urinary urge incontinence|urinary urge incontinence
1529834|NCT00662909|Urinary incontinence|urinary incontinence
1529835|NCT00662883|ketamine|ketamine
1529836|NCT00662883|corticosteroid|corticosteroid
1529837|NCT00662883|intranasal|intranasal
1529838|NCT00662883|phase I|phase i
1529839|NCT00662883|Healthy volunteers|healthy volunteers
1529840|NCT00662870|DAPTACEL|daptacel
1529841|NCT00662870|Diphtheria|diphtheria
1529842|NCT00662870|Tetanus|tetanus
1529843|NCT00662870|Whooping Cough|whooping cough
1529844|NCT00662870|Polio|polio
1529845|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
1529846|NCT00662870|Pertussis|pertussis
1529847|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
1529848|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
1529849|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
1529850|NCT00662805|pharmacovigilance|pharmacovigilance
1529851|NCT00662805|COPD|copd
1529852|NCT00662779|asthma|asthma
1529853|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
1529854|NCT00662779|prevention|prevention
1529855|NCT00662779|EIB|eib
1529856|NCT00662779|children|children
1529857|NCT00662766|Black currant|black currant
1529858|NCT00662766|Berry seed|berry seed
1529859|NCT00662766|Press residue|press residue
1529860|NCT00662766|Tocopherol|tocopherol
1529861|NCT00662766|Fatty acids|fatty acids
1529862|NCT00662766|Fiber|fiber
1529863|NCT00662766|Total phenols|total phenols
1529864|NCT00662766|TEAC|teac
1529865|NCT00662766|Comet assay|comet assay
1529866|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
1529867|NCT00662753|hypertension|hypertension
1529868|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
1529869|NCT00662753|nurse telephone follow up|nurse telephone follow up
1529870|NCT00662753|medically underserved populations|medically underserved populations
1529871|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
1529872|NCT00662727|Myocardial Ischemia|myocardial ischemia
1529873|NCT00662727|Refractory Angina|refractory angina
1529874|NCT00662701|Atrial Fibrillation|atrial fibrillation
1529875|NCT00662688|thromboembolism|thromboembolism
1529876|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1529877|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1529878|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
1529879|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
1529880|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
1529881|NCT00662675|Steatorrhea|steatorrhea
1529882|NCT00662675|Malabsorption syndromes|malabsorption syndromes
1529883|NCT00662675|Cystic fibrosis|cystic fibrosis
1529884|NCT00662675|Pediatrics|pediatrics
1529885|NCT00662675|Adult|adult
1529886|NCT00662675|Pancrelipase|pancrelipase
1529887|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
1529888|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
1529889|NCT00662662|Head and Neck Cancer|head and neck cancer
1529890|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
1529891|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1529892|NCT00662662|SCCHN|scchn
1529893|NCT00662662|HPV-16|hpv-16
1529894|NCT00662662|Questionnaire|questionnaire
1529895|NCT00662662|Sexual Behavior|sexual behavior
1529896|NCT00662662|Survey|survey
1529897|NCT00662649|Multiple sclerosis.|multiple sclerosis.
1529898|NCT00662649|Relapse-remitting|relapse-remitting
1529899|NCT00662649|Fingolimod|fingolimod
1529900|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
1529901|NCT00662623|Sleep Apnea|sleep apnea
1529902|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
1529903|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
1529904|NCT00662597|VDA|vda
1529905|NCT00662597|ASA404|asa404
1529906|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
1529907|NCT00662597|NSCLC|nsclc
1529908|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
1529909|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1529910|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
1529911|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
1529912|NCT00662571|acamprosate|acamprosate
1529913|NCT00662571|differentiate|differentiate
1529914|NCT00662571|pharmacogenomic|pharmacogenomic
1529915|NCT00662571|effective individualized treatment|effective individualized treatment
1529916|NCT00662571|alcohol dependent|alcohol dependent
1529917|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
1529918|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
1529919|NCT00662571|decreasing craving|decreasing craving
1529920|NCT00662571|abstinence maintenance|abstinence maintenance
1529921|NCT00662558|Chronic low back pain|chronic low back pain
1529922|NCT00662545|HIV|hiv
1529923|NCT00662545|Hepatitis B|hepatitis b
1529924|NCT00662545|treatment experienced|treatment experienced
1529925|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
1529926|NCT00662493|knee pain|knee pain
1529927|NCT00662493|exercise|exercise
1529928|NCT00662493|rehabilitation|rehabilitation
1529929|NCT00662480|population|population
1529930|NCT00662480|screening|screening
1529931|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
1529932|NCT00662480|peripheral arterial disease|peripheral arterial disease
1529933|NCT00662480|hypertension|hypertension
1529934|NCT00662480|Prevention|prevention
1529935|NCT00662467|Myocardial Infarction|myocardial infarction
1529936|NCT00662467|Hemorrhage|hemorrhage
1529937|NCT00662467|Thromboembolism|thromboembolism
1529938|NCT00662467|Clopidogrel|clopidogrel
1529939|NCT00662467|Aspirin|aspirin
1529940|NCT00662467|Warfarin|warfarin
1529941|NCT00662454|contraceptive|contraceptive
1529942|NCT00662454|efficacy|efficacy
1529943|NCT00662454|body weight|body weight
1529944|NCT00662441|Erectile Dysfunction|erectile dysfunction
1529945|NCT00662441|Vardenafil|vardenafil
1529946|NCT00662428|cost-benefit analysis|cost-benefit analysis
1529947|NCT00662428|practice guideline|practice guideline
1529948|NCT00662428|inpatients|inpatients
1529949|NCT00662415|phantom limb pain|phantom limb pain
1529950|NCT00662415|fMRI|fmri
1529951|NCT00662415|mirror therapy|mirror therapy
1529952|NCT00662402|K Grant|k grant
1529953|NCT00662402|Career Advancement|career advancement
1529954|NCT00662402|Award|award
1529955|NCT00662402|Consultation|consultation
1529956|NCT00662402|Application|application
1529957|NCT00662402|K|k
1529958|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
1529959|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
1529960|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
1529961|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
1529962|NCT00662363|constipation|constipation
1529963|NCT00662363|opioid|opioid
1529964|NCT00662363|rehabilitation|rehabilitation
1529965|NCT00662363|post-operative|post-operative
1529966|NCT00662363|orthopedic|orthopedic
1529967|NCT00662350|BPH|bph
1529968|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
1529969|NCT00662298|severe asthma|severe asthma
1529970|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
1529971|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
1529972|NCT00662285|iron status|iron status
1529973|NCT00662285|blood donors|blood donors
1529974|NCT00662272|Flu|flu
1529975|NCT00662272|Influenza vaccine|influenza vaccine
1529976|NCT00662272|Adjuvant|adjuvant
1529977|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
1529978|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
1529979|NCT00662259|Anxiety disorders|anxiety disorders
1529980|NCT00662259|Generalized anxiety|generalized anxiety
1529981|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1529982|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1530205|NCT00661947|glucose|glucose
1530397|NCT00660959|Euvolemic|euvolemic
1529983|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1529984|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1529985|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1529986|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1529987|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1529988|NCT00662233|ovarian sarcoma|ovarian sarcoma
1529989|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
1529990|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
1529991|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1529992|NCT00662220|chronic|chronic
1529993|NCT00662220|hepatitis C|hepatitis c
1529994|NCT00662220|ribavirin|ribavirin
1529995|NCT00662220|SVR|svr
1529996|NCT00662220|genotype one|genotype one
1529997|NCT00662220|genotype four|genotype four
1529998|NCT00662207|electric stimulation|electric stimulation
1529999|NCT00662207|urethral obstruction|urethral obstruction
1530000|NCT00662207|urodynamics|urodynamics
1530001|NCT00662207|urology|urology
1530002|NCT00662194|HIV|hiv
1530003|NCT00662194|HBV|hbv
1530004|NCT00662194|HCV|hcv
1530005|NCT00662194|co-infection|co-infection
1530006|NCT00662194|innate immunity|innate immunity
1530007|NCT00662181|growth hormone|growth hormone
1530008|NCT00662181|quality of life|quality of life
1530009|NCT00662181|fat redistribution|fat redistribution
1530010|NCT00662181|sugar metabolism|sugar metabolism
1530011|NCT00662181|fat metabolism|fat metabolism
1530012|NCT00662181|cytokines|cytokines
1530013|NCT00662168|carcinoid|carcinoid
1530014|NCT00662168|familial|familial
1530015|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
1530016|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
1530017|NCT00662155|Primary Insomnia|primary insomnia
1530018|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
1530019|NCT00662155|Insomnia|insomnia
1530020|NCT00662155|Sleep|sleep
1530021|NCT00662155|Zolpidem|zolpidem
1530022|NCT00662155|Ambien|ambien
1530023|NCT00662155|CBT|cbt
1530024|NCT00662155|CBT-I|cbt-i
1530025|NCT00662142|DHA|dha
1530026|NCT00662142|fMRI|fmri
1530027|NCT00662129|stage IV breast cancer|stage iv breast cancer
1530028|NCT00662129|male breast cancer|male breast cancer
1530029|NCT00662129|recurrent breast cancer|recurrent breast cancer
1530030|NCT00662116|diastolic heart failure|diastolic heart failure
1530031|NCT00662103|fatigue|fatigue
1530032|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1530033|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1530034|NCT00662103|cancer survivor|cancer survivor
1530035|NCT00662103|stage IA breast cancer|stage ia breast cancer
1530036|NCT00662103|stage IB breast cancer|stage ib breast cancer
1530037|NCT00662103|stage II breast cancer|stage ii breast cancer
1530038|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
1530039|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
1530040|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
1530041|NCT00662103|breast cancer in situ|breast cancer in situ
1530042|NCT00662090|MDS|mds
1530043|NCT00662090|JMML|jmml
1530044|NCT00662090|EWOG-MDS|ewog-mds
1530045|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
1530046|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
1530047|NCT00662077|osteoporosis|osteoporosis
1530048|NCT00662077|bifosfonates|bifosfonates
1530049|NCT00662077|ibandronate|ibandronate
1530050|NCT00662064|Lower urinary tract|lower urinary tract
1530051|NCT00662064|Physiology|physiology
1530052|NCT00662064|Pathology|pathology
1530053|NCT00662064|Immunohistochemistry|immunohistochemistry
1530054|NCT00662064|Urinary bladder|urinary bladder
1530055|NCT00662051|Asthma|asthma
1530056|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
1530057|NCT00662051|Asthma Control Test|asthma control test
1530058|NCT00662038|idiopathic|idiopathic
1530059|NCT00662038|pulmonary|pulmonary
1530060|NCT00662038|fibrosis|fibrosis
1530061|NCT00662012|Leishmaniasis|leishmaniasis
1530062|NCT00662012|Sodium stibogluconate|sodium stibogluconate
1530063|NCT00662012|Pentostam|pentostam
1530064|NCT00662012|sand fly|sand fly
1530191|NCT00661973|asthma|asthma
1530678|NCT00659841|Ciclesonide|ciclesonide
1530065|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1530066|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1530067|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
1530068|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1530069|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
1530070|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
1530071|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
1530072|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
1530073|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
1530074|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1530075|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1530076|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1530077|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1530078|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1530079|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1530080|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1530081|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1530082|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1530083|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1530084|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1530085|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1530086|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1530087|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1530088|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1530089|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1530090|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1530091|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1530092|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1530093|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1530094|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1530095|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1530096|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1530097|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1530098|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1530099|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1530100|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1530101|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1530102|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1530103|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1530104|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1530105|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1530106|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1530107|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1530108|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1530109|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1530110|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1530111|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1530112|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1530113|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1530114|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1530115|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1530116|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1530117|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1530118|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1530119|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1530120|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1530121|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1530122|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1530123|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1530124|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1530125|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1530126|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1530127|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1530128|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1530129|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1530130|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1530131|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1530132|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1530133|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1530134|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1530135|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1530136|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1530137|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1530138|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1530139|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1530140|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1530141|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1530142|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1530143|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1530144|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1530145|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1530146|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1530147|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1530148|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1530149|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1530150|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1530151|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1530152|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1530153|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1530154|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1530155|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1530156|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1530157|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1530158|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1530159|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1530160|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1530161|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1530162|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1530163|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1530164|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1530165|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1530166|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1530167|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1530168|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1530169|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1530170|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1530171|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1530172|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1530173|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1530174|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1530175|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1530176|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1530177|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1530178|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1530179|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1530180|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1530181|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1530182|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
1530183|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1530184|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
1530186|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1530187|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
1530188|NCT00661999|mast cell leukemia|mast cell leukemia
1530189|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1530190|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
1530192|NCT00661973|airway smooth muscle|airway smooth muscle
1530193|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
1530194|NCT00661960|HIV Positive|hiv positive
1530195|NCT00661960|AIDS|aids
1530196|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
1530197|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
1530198|NCT00661960|Immune Reconstitution|immune reconstitution
1530199|NCT00661960|treatment experienced|treatment experienced
1530200|NCT00661947|fructose|fructose
1530201|NCT00661947|sucrose|sucrose
1530202|NCT00661947|high fructose corn syrup|high fructose corn syrup
1530203|NCT00661947|serum uric acid|serum uric acid
1530206|NCT00661947|triglycerides|triglycerides
1530207|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
1530333|NCT00661310|management|management
1530208|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
1530209|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1530210|NCT00661921|AMG 108|amg 108
1530211|NCT00661921|HbA1C|hba1c
1530212|NCT00661921|glucose|glucose
1530213|NCT00661921|metformin|metformin
1530214|NCT00661921|sulfonylurea|sulfonylurea
1530215|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
1530216|NCT00661921|biologic|biologic
1530217|NCT00661921|subcutaneous injection|subcutaneous injection
1530218|NCT00661895|African American|african american
1530219|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1530220|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
1530221|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
1530222|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
1530223|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
1530224|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
1530225|NCT00661843|insomnia|insomnia
1530226|NCT00661843|geriatric|geriatric
1530227|NCT00661843|yoga|yoga
1530228|NCT00661843|sleep|sleep
1530229|NCT00661843|electrocardiogram|electrocardiogram
1530230|NCT00661830|advanced|advanced
1530231|NCT00661830|metastatic|metastatic
1530232|NCT00661830|biliary|biliary
1530233|NCT00661830|tract|tract
1530234|NCT00661817|Exercise|exercise
1530235|NCT00661817|Physical Fitness|physical fitness
1530236|NCT00661817|Patient Compliance|patient compliance
1530237|NCT00661817|Health Behavior|health behavior
1530238|NCT00661791|preterm infants|preterm infants
1530239|NCT00661791|massage|massage
1530240|NCT00661791|physical activity|physical activity
1530241|NCT00661791|weight gain|weight gain
1530242|NCT00661791|length of hospital stay|length of hospital stay
1530243|NCT00661791|NICU|nicu
1530244|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
1530245|NCT00661739|palliative|palliative
1530246|NCT00661739|Breast cancer|breast cancer
1530247|NCT00661739|metastatic|metastatic
1530248|NCT00661739|Bendamustine|bendamustine
1530249|NCT00661739|phase I|phase i
1530250|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
1530251|NCT00661713|Meningococcal disease|meningococcal disease
1530252|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
1530253|NCT00661713|prevention|prevention
1530254|NCT00661713|vaccination|vaccination
1530255|NCT00661713|adolescents|adolescents
1530256|NCT00661700|Erectile Dysfunction|erectile dysfunction
1530257|NCT00661700|Quality of Life|quality of life
1530258|NCT00661674|Palonosetron|palonosetron
1530259|NCT00661674|Hydroxyzine|hydroxyzine
1530260|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
1530261|NCT00661661|Long term open label study in Japan|long term open label study in japan
1530262|NCT00661661|CP-690|cp-690
1530264|NCT00661661|tofacitinib|tofacitinib
1530265|NCT00661648|surgery|surgery
1530266|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
1530267|NCT00661609|Anti-mitotic|anti-mitotic
1530268|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
1530269|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
1530270|NCT00661609|Urothelial Cancer|urothelial cancer
1530271|NCT00661609|Bladder Cancer|bladder cancer
1530272|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
1530273|NCT00661609|Urethra Cancer|urethra cancer
1530274|NCT00661609|Ureter Cancer|ureter cancer
1530275|NCT00661609|Recurrent|recurrent
1530276|NCT00661609|Advanced|advanced
1530277|NCT00661609|Stage IV|stage iv
1530278|NCT00661596|Erectile Dysfunction|erectile dysfunction
1530279|NCT00661596|Vardenafil|vardenafil
1530280|NCT00661583|trabeculectomy|trabeculectomy
1530281|NCT00661583|glaucoma|glaucoma
1530282|NCT00661583|ranibizumab|ranibizumab
1530283|NCT00661570|laryngectomy|laryngectomy
1530284|NCT00661570|larynx cancer|larynx cancer
1530285|NCT00661557|Booster vaccination|booster vaccination
1530286|NCT00661557|Meningococcal vaccine|meningococcal vaccine
1530287|NCT00661557|Meningococcal disease|meningococcal disease
1530288|NCT00661557|Safety|safety
1530482|NCT00660660|Gastric|gastric
1530289|NCT00661557|immunogenicity|immunogenicity
1530290|NCT00661544|Multiple Myeloma|multiple myeloma
1530291|NCT00661544|Ascorbic Acid|ascorbic acid
1530292|NCT00661544|Vitamin C|vitamin c
1530293|NCT00661544|Arsenic Trioxide|arsenic trioxide
1530294|NCT00661544|Trisenox|trisenox
1530295|NCT00661544|Melphalan|melphalan
1530296|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
1530297|NCT00661544|Stem Cell Transplantation|stem cell transplantation
1530298|NCT00661531|Breast cancer|breast cancer
1530299|NCT00661531|Metastatic breast cancer|metastatic breast cancer
1530300|NCT00661531|ER positive breast cancer|er positive breast cancer
1530301|NCT00661531|Hormonal therapy|hormonal therapy
1530396|NCT00660972|Viral Load|viral load
1530302|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
1530303|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
1530304|NCT00661466|Post operative pain|post operative pain
1530305|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
1530306|NCT00661453|SMA|sma
1530307|NCT00661453|Valproic Acid|valproic acid
1530308|NCT00661427|Head and Neck cancer|head and neck cancer
1530309|NCT00661427|Cetuximab|cetuximab
1530310|NCT00661414|Cancer|cancer
1530311|NCT00661414|Solid tumors|solid tumors
1530312|NCT00661401|gammaglobulin|gammaglobulin
1530313|NCT00661401|subcutaneous infusion|subcutaneous infusion
1530314|NCT00661401|specific antibodies|specific antibodies
1530315|NCT00661401|primary antibody deficiency|primary antibody deficiency
1530316|NCT00661375|BAY 43-9006|bay 43-9006
1530317|NCT00661375|Phase II|phase ii
1530318|NCT00661375|Renal cell carcinoma|renal cell carcinoma
1530319|NCT00661375|Response rate|response rate
1530320|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
1530321|NCT00661362|HbA1c|hba1c
1530322|NCT00661362|Incretins|incretins
1530323|NCT00661349|Kaletra|kaletra
1530324|NCT00661349|Nevirapina|nevirapina
1530325|NCT00661349|HCV chronic infection|hcv chronic infection
1530326|NCT00661349|Fibroscan|fibroscan
1530327|NCT00661349|hepatic fibrosis|hepatic fibrosis
1530328|NCT00661349|treatment experienced|treatment experienced
1530329|NCT00661336|stage III melanoma|stage iii melanoma
1530330|NCT00661336|recurrent melanoma|recurrent melanoma
1530331|NCT00661310|re-admissions|re-admissions
1530332|NCT00661310|medicines|medicines
1530334|NCT00661310|patients|patients
1530335|NCT00661310|80 years and older|80 years and older
1530336|NCT00661310|acute|acute
1530337|NCT00661310|admissions|admissions
1530338|NCT00661310|hospital|hospital
1530339|NCT00661297|Erectile Dysfunction|erectile dysfunction
1530340|NCT00661297|Vardenafil|vardenafil
1530341|NCT00661271|mindfulness|mindfulness
1530342|NCT00661271|meditation|meditation
1530343|NCT00661271|urban youth|urban youth
1530344|NCT00661271|stress reduction|stress reduction
1530345|NCT00661271|adolescent|adolescent
1530346|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
1530347|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
1530348|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
1530349|NCT00661258|treatment experienced|treatment experienced
1530350|NCT00661232|Myocardial Viability|myocardial viability
1530351|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
1530352|NCT00661232|Functional Recovery|functional recovery
1530353|NCT00661206|Clopidogrel|clopidogrel
1530354|NCT00661206|Drug-eluting stent|drug-eluting stent
1530355|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1530356|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1530357|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1530358|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
1530359|NCT00661193|large cell lung cancer|large cell lung cancer
1530360|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
1530361|NCT00661141|acetaldehyde|acetaldehyde
1530362|NCT00661141|ethanol|ethanol
1530363|NCT00661141|ALDH2|aldh2
1530364|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
1530365|NCT00661115|Erectile dysfunction|erectile dysfunction
1530366|NCT00661115|Sexual Dysfunction|sexual dysfunction
1530367|NCT00661089|stroke|stroke
1530368|NCT00661089|shoulder pain|shoulder pain
1530369|NCT00661089|spasticity|spasticity
1530370|NCT00661063|neuropathic pain|neuropathic pain
1530371|NCT00661063|ketamine|ketamine
1530372|NCT00661063|clonidine|clonidine
1530373|NCT00661063|association|association
1530374|NCT00661024|thyroid surgery|thyroid surgery
1530375|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
1530376|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
1530377|NCT00661024|predictive values|predictive values
1530378|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
1530379|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
1530380|NCT00661011|Cisplatin|cisplatin
1530381|NCT00661011|Vinorelbine|vinorelbine
1530382|NCT00661011|Radiotherapy|radiotherapy
1530383|NCT00661011|Chemotherapy|chemotherapy
1530384|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
1530385|NCT00661011|Surgery|surgery
1530386|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
1530387|NCT00660998|Erectile dysfunction|erectile dysfunction
1530388|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
1530389|NCT00660998|Vardenafil|vardenafil
1530390|NCT00660985|Acne vulgaris|acne vulgaris
1530391|NCT00660985|Differin|differin
1530392|NCT00660985|Adapalene|adapalene
1530393|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
1530394|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
1530395|NCT00660972|Treatment Naive|treatment naive
1530398|NCT00660959|Hyponatremia|hyponatremia
1530399|NCT00660959|Serum Sodium|serum sodium
1530400|NCT00660959|Fluid Overload|fluid overload
1530401|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
1530402|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
1530403|NCT00660946|chronic anticoagulation|chronic anticoagulation
1530404|NCT00660946|warfarin|warfarin
1530405|NCT00660946|hemodialysis|hemodialysis
1530406|NCT00660946|INR|inr
1530407|NCT00660946|Point of Care|point of care
1530408|NCT00660933|postpartum anemia|postpartum anemia
1530409|NCT00660933|intravenous iron|intravenous iron
1530410|NCT00660907|Dapagliflozin|dapagliflozin
1530411|NCT00660907|efficacy|efficacy
1530412|NCT00660907|safety|safety
1530413|NCT00660907|metformin|metformin
1530414|NCT00660907|Type 2 diabetes|type 2 diabetes
1530415|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
1530416|NCT00660894|stage III colon cancer|stage iii colon cancer
1530417|NCT00660881|Lupus|lupus
1530418|NCT00660881|Monoclonal antibody|monoclonal antibody
1530419|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
1530420|NCT00660868|smell|smell
1530421|NCT00660868|olfaction|olfaction
1530422|NCT00660868|olfactory sensitivity|olfactory sensitivity
1530423|NCT00660868|smell loss|smell loss
1530424|NCT00660868|chemoreception|chemoreception
1530425|NCT00660855|laparoscopy|laparoscopy
1530426|NCT00660842|quality of life|quality of life
1530427|NCT00660842|weekly therapy|weekly therapy
1530428|NCT00660842|neurotoxicity|neurotoxicity
1530429|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1530430|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1530431|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1530432|NCT00660803|Advanced Breast Cancer|advanced breast cancer
1530433|NCT00660803|Hormone Therapy|hormone therapy
1530434|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
1530435|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
1530436|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
1530437|NCT00660777|speech therapy|speech therapy
1530438|NCT00660764|cholesterol|cholesterol
1530439|NCT00660764|coronary heart disease|coronary heart disease
1530440|NCT00660764|rosuvastatin|rosuvastatin
1530441|NCT00660764|LDL-C goal|ldl-c goal
1530442|NCT00660764|hypercholesterolemia|hypercholesterolemia
1530443|NCT00660764|secondary prevention|secondary prevention
1530444|NCT00660764|primary prevention|primary prevention
1530445|NCT00660764|CVA|cva
1530446|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
1530447|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1530448|NCT00660738|walking|walking
1530449|NCT00660738|exercise test|exercise test
1530450|NCT00660738|quality of life|quality of life
1530451|NCT00660738|dyspnea|dyspnea
1530452|NCT00660738|desaturation|desaturation
1530453|NCT00660725|Gemcitabine|gemcitabine
1530454|NCT00660725|Oxaliplatin|oxaliplatin
1530455|NCT00660725|Vandetanib|vandetanib
1530456|NCT00660725|Phase I|phase i
1530457|NCT00660712|Bipolar disorder|bipolar disorder
1530458|NCT00660712|patient characteristics|patient characteristics
1530459|NCT00660712|treatment characteristics|treatment characteristics
1530460|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
1530461|NCT00660699|Gallbladder|gallbladder
1530462|NCT00660699|Pancreatic|pancreatic
1530463|NCT00660699|Ampullary|ampullary
1530464|NCT00660699|Cancer|cancer
1530465|NCT00660686|randomized clinical trial|randomized clinical trial
1530466|NCT00660686|elderly|elderly
1530467|NCT00660686|cancer survivor|cancer survivor
1530468|NCT00660686|bone health|bone health
1530469|NCT00660686|body composition|body composition
1530470|NCT00660686|signs and symptoms|signs and symptoms
1530471|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
1530472|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
1530473|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
1530474|NCT00660673|Levodopa|levodopa
1530475|NCT00660673|Carbidopa|carbidopa
1530476|NCT00660673|Parkinson's Disease|parkinson's disease
1530477|NCT00660673|Dyskinesia|dyskinesia
1530478|NCT00660660|GERD|gerd
1530479|NCT00660660|Esophageal Reflux|esophageal reflux
1530480|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
1530481|NCT00660660|Regurgitation|regurgitation
1530483|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
1530484|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
1530485|NCT00660634|Intermittent Claudication|intermittent claudication
1530486|NCT00660634|Endovascular treatment|endovascular treatment
1530487|NCT00660634|Flow-mediated dilation|flow-mediated dilation
1530488|NCT00660621|High Grade|high grade
1530489|NCT00660621|Malignant|malignant
1530490|NCT00660621|GBM|gbm
1530491|NCT00660608|Transfusion regulation|transfusion regulation
1530492|NCT00660595|Schizophrenia|schizophrenia
1530493|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
1530494|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
1530495|NCT00660595|Pilot study|pilot study
1530693|NCT00659698|surgical|surgical
1530496|NCT00660595|Quetiapine Prolong|quetiapine prolong
1530497|NCT00660595|Risperidone|risperidone
1530498|NCT00660582|Erbitux|erbitux
1530499|NCT00660582|Colorectal cancer|colorectal cancer
1530500|NCT00660582|Oxaliplatin|oxaliplatin
1530501|NCT00660582|Flox|flox
1530502|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
1530503|NCT00660582|K-RAS|k-ras
1530504|NCT00660569|asthma treatment|asthma treatment
1530505|NCT00660569|utilization|utilization
1530506|NCT00660569|real life practice|real life practice
1530507|NCT00660530|stage 5|stage 5
1530508|NCT00660530|chronic|chronic
1530509|NCT00660530|hemodialysis|hemodialysis
1530510|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
1530511|NCT00660491|flow mediated dilatation|flow mediated dilatation
1530512|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
1530513|NCT00660491|blood lipid|blood lipid
1530514|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
1530515|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
1530516|NCT00660465|Healthy subjects|healthy subjects
1530517|NCT00660452|Allergy|allergy
1530518|NCT00660452|SLIT|slit
1530519|NCT00660452|Asthma|asthma
1530520|NCT00660452|House Dust Mites|house dust mites
1530521|NCT00660439|PTSD|ptsd
1530522|NCT00660426|cancer|cancer
1530523|NCT00660426|gastrointestinal|gastrointestinal
1530524|NCT00660426|tumor|tumor
1530525|NCT00660413|Acceleromyography|acceleromyography
1530526|NCT00660413|Mechanomyography|mechanomyography
1530527|NCT00660413|Neuromuscular block|neuromuscular block
1530528|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
1530529|NCT00660413|Dose-response|dose-response
1530530|NCT00660413|Potency|potency
1530531|NCT00660413|Rocuronium|rocuronium
1530532|NCT00660400|Myeloid|myeloid
1530533|NCT00660400|Monocytic|monocytic
1530534|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
1530535|NCT00660387|Carbidopa|carbidopa
1530536|NCT00660387|levodopa|levodopa
1530537|NCT00660387|dyskinesia|dyskinesia
1530538|NCT00660387|Duodopa|duodopa
1530539|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1530540|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
1530541|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
1530542|NCT00660387|DUOPA|duopa
1530543|NCT00660361|HIV|hiv
1530544|NCT00660361|HBV|hbv
1530545|NCT00660361|co-infection|co-infection
1530546|NCT00660361|drug resistance|drug resistance
1530547|NCT00660361|tenofovir|tenofovir
1530548|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
1530549|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
1530550|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
1530551|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
1530552|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1530553|NCT00660348|pain|pain
1530554|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
1530555|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
1530556|NCT00660322|Asthma|asthma
1530557|NCT00660322|Telemedicine|telemedicine
1530558|NCT00660322|Randomized controlled trial|randomized controlled trial
1530559|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
1530560|NCT00660309|renal disease|renal disease
1530561|NCT00660309|hypertension|hypertension
1530562|NCT00660309|renal blood flow|renal blood flow
1530563|NCT00660309|retinal blood flow|retinal blood flow
1530564|NCT00660309|aliskiren|aliskiren
1530565|NCT00660309|irbesartan|irbesartan
1530566|NCT00660309|captopril|captopril
1530567|NCT00660296|CO2|co2
1530568|NCT00660296|pain|pain
1530569|NCT00660296|colonoscopy|colonoscopy
1530570|NCT00660296|cancer|cancer
1530571|NCT00660296|screening|screening
1530572|NCT00660283|GBM|gbm
1530573|NCT00660283|Newly|newly
1530574|NCT00660283|diagnosed|diagnosed
1530575|NCT00660283|malignant|malignant
1530576|NCT00660283|high grade|high grade
1530577|NCT00660270|Chemotherapy|chemotherapy
1530578|NCT00660270|Radiation|radiation
1530579|NCT00660244|Arimidex|arimidex
1530580|NCT00660244|Post menopausal|post menopausal
1530581|NCT00660244|arthralgia|arthralgia
1530582|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1530583|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
1530584|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1530585|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1530586|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1530587|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1530588|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
1530589|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1530590|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1530591|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1530694|NCT00659698|site|site
1530592|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
1530594|NCT00660205|PE|pe
1530595|NCT00660205|D-dimer|d-dimer
1530596|NCT00660205|cancer|cancer
1530597|NCT00660205|VTE|vte
1530598|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
1530599|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
1530600|NCT00660166|Natural killer cells|natural killer cells
1530601|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
1530602|NCT00660166|immunotherapy|immunotherapy
1530603|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
1530604|NCT00660153|tivozanib|tivozanib
1530605|NCT00660153|AV-951|av-951
1530606|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
1530607|NCT00660140|Gallbladder|gallbladder
1530608|NCT00660140|Cancer|cancer
1530609|NCT00660114|Cough variant asthma|cough variant asthma
1530610|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
1530611|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
1530612|NCT00660101|ovarian cancer|ovarian cancer
1530613|NCT00660101|vaccine|vaccine
1530614|NCT00660101|immunotherapy|immunotherapy
1530615|NCT00660101|autologous|autologous
1530616|NCT00660075|Diabetes mellitus|diabetes mellitus
1530617|NCT00660075|Postprandial|postprandial
1530618|NCT00660075|Hyperlipidemia|hyperlipidemia
1530619|NCT00660075|Atherosclerosis|atherosclerosis
1530620|NCT00660062|Major depression|major depression
1530621|NCT00660062|relapse prevention|relapse prevention
1530622|NCT00660062|ECT|ect
1530623|NCT00660062|escitalopram|escitalopram
1530624|NCT00660062|nortriptyline|nortriptyline
1530625|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
1530626|NCT00660036|Refractory|refractory
1530627|NCT00660036|Relapsed|relapsed
1530628|NCT00660036|Second line|second line
1530629|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
1530630|NCT00660036|Mitoxantrone|mitoxantrone
1530631|NCT00660036|Etoposide|etoposide
1530632|NCT00660036|Phase I|phase i
1530633|NCT00660036|Phase II|phase ii
1530634|NCT00660010|CPP|cpp
1530635|NCT00660010|central precocious puberty|central precocious puberty
1530636|NCT00660010|pediatrics|pediatrics
1530637|NCT00660010|suppression of LH|suppression of lh
1530638|NCT00660010|Lupron|lupron
1530639|NCT00660010|leuprolide acetate|leuprolide acetate
1530640|NCT00660010|depot formulation|depot formulation
1530641|NCT00660010|GnRHa|gnrha
1530642|NCT00660010|GnRH agonist|gnrh agonist
1530643|NCT00660010|GNRH analog|gnrh analog
1530644|NCT00660010|LH|lh
1530645|NCT00660010|Tanner staging|tanner staging
1530646|NCT00659997|Ascariasis|ascariasis
1530647|NCT00659997|Trichuriasis|trichuriasis
1530648|NCT00659997|Drug resistance|drug resistance
1530649|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
1530650|NCT00659971|oral candidiasis|oral candidiasis
1530651|NCT00659958|zonisamide|zonisamide
1530652|NCT00659958|partial onset seizures|partial onset seizures
1530653|NCT00659958|effectiveness|effectiveness
1530654|NCT00659958|tolerability|tolerability
1530655|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
1530656|NCT00659932|diabetes|diabetes
1530657|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
1530658|NCT00659906|randomized clinical trial|randomized clinical trial
1530659|NCT00659906|cancer survivor|cancer survivor
1530660|NCT00659906|bone health|bone health
1530661|NCT00659906|body composition|body composition
1530662|NCT00659906|signs and symptoms|signs and symptoms
1530663|NCT00659893|Peplin|peplin
1530664|NCT00659893|PEP005|pep005
1530665|NCT00659893|Actinic Keratosis|actinic keratosis
1530666|NCT00659880|Meniscus transplant|meniscus transplant
1530667|NCT00659880|Meniscal allograft|meniscal allograft
1530668|NCT00659880|MAT|mat
1530669|NCT00659880|Knee|knee
1530670|NCT00659867|Ulcerative Colitis|ulcerative colitis
1530671|NCT00659867|Endomicroscopy|endomicroscopy
1530672|NCT00659867|Chromoendoscopy|chromoendoscopy
1530673|NCT00659867|Confocal colonoscope|confocal colonoscope
1530674|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
1530675|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1530676|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
1530677|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1530679|NCT00659841|Hay Fever|hay fever
1530680|NCT00659841|SAR|sar
1530681|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
1530682|NCT00659828|Obesity|obesity
1530683|NCT00659828|Metabolic Syndrome|metabolic syndrome
1530684|NCT00659828|Diabetes|diabetes
1530685|NCT00659776|ferumoxytol|ferumoxytol
1530686|NCT00659763|IBS|ibs
1530687|NCT00659763|Diagnosis|diagnosis
1530688|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
1530689|NCT00659750|Ciclesonide|ciclesonide
1530690|NCT00659750|PAR|par
1530691|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
1530692|NCT00659724|Dialyzer|dialyzer
1530695|NCT00659698|infection|infection
1530696|NCT00659685|Bioequivalence|bioequivalence
1530697|NCT00659685|Ondansetron ODT|ondansetron odt
1530698|NCT00659685|Fasting|fasting
1530699|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
1530700|NCT00659672|hypertension|hypertension
1530701|NCT00659672|prehypertension|prehypertension
1530702|NCT00659672|high blood pressure|high blood pressure
1530703|NCT00659672|blood pressure|blood pressure
1530704|NCT00659672|heart disease|heart disease
1530705|NCT00659646|Diabetes|diabetes
1530706|NCT00659646|ulcers|ulcers
1530707|NCT00659646|ulcerations|ulcerations
1530708|NCT00659646|infection|infection
1530709|NCT00659633|lidocaine|lidocaine
1530710|NCT00659633|allodynia|allodynia
1530711|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
1530712|NCT00659633|pain|pain
1530713|NCT00659620|Kidney Transplant|kidney transplant
1530714|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
1530715|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
1530716|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
1530717|NCT00659594|Ciclesonide|ciclesonide
1530718|NCT00659594|Hay Fever|hay fever
1530719|NCT00659594|SAR|sar
1530720|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1530721|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
1530722|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
1530723|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
1530724|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1530725|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
1530726|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1530727|NCT00659568|recurrent breast cancer|recurrent breast cancer
1530728|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
1530729|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
1530730|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
1530731|NCT00659568|stage IV breast cancer|stage iv breast cancer
1530732|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
1530733|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1530734|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1530735|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1530736|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1530737|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1530738|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1530739|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1530740|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1530741|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1530742|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1530743|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1530744|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1530745|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1530746|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1530747|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1530748|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1530749|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1530750|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1530751|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1530752|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1530753|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1530754|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1530755|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1530756|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1530757|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1530758|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1530759|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1530760|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1530946|NCT00658905|BSSL|bssl
1530761|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1530762|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1530763|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1530764|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1530765|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1530766|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1530767|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1530768|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1530769|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1530770|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1530771|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1530772|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1567721|NCT00508378|Questionnaire|questionnaire
1530773|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1530774|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1530775|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1530776|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1530777|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1530778|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1530779|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1530780|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1530781|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1530782|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1530783|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1530784|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1530785|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1530786|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1530787|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1530788|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1530789|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
1530790|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
1530791|NCT00659555|drug interaction,|drug interaction,
1530792|NCT00659555|pharmacokinetics,|pharmacokinetics,
1530793|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
1530794|NCT00659555|pazopanib,|pazopanib,
1530795|NCT00659555|angiogenesis,|angiogenesis,
1530796|NCT00659555|ketoconazole|ketoconazole
1530797|NCT00659542|inguinal hernia|inguinal hernia
1530798|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
1530799|NCT00659542|mesh fixation|mesh fixation
1530800|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
1530801|NCT00659529|cystic fibrosis|cystic fibrosis
1530802|NCT00659529|inflammation|inflammation
1530803|NCT00659529|pH|ph
1530804|NCT00659529|EBC|ebc
1530805|NCT00659529|sputum biomarkers|sputum biomarkers
1531058|NCT00658307|randomized|randomized
1530806|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
1530807|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1530808|NCT00659503|Ciclesonide|ciclesonide
1530809|NCT00659503|Hay Fever|hay fever
1530810|NCT00659503|SAR|sar
1530811|NCT00659490|Analgesic effect|analgesic effect
1530812|NCT00659490|Molar extraction|molar extraction
1530813|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
1530814|NCT00659464|Syncope|syncope
1530815|NCT00659464|Tilt Table Testing|tilt table testing
1530816|NCT00659451|Hypertension|hypertension
1530817|NCT00659451|Diabetes mellitus|diabetes mellitus
1530818|NCT00659451|Heart|heart
1530819|NCT00659425|Moxetumomab pasudotox|moxetumomab pasudotox
1530820|NCT00659412|Psoriatic arthritis|psoriatic arthritis
1530821|NCT00659412|psoriasis|psoriasis
1530822|NCT00659412|Alefacept|alefacept
1530823|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
1530824|NCT00659386|Heart failure|heart failure
1530825|NCT00659386|Parvovirus B19|parvovirus b19
1530826|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
1530827|NCT00659373|cognitive/functional effects|cognitive/functional effects
1530828|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1530829|NCT00659373|fatigue|fatigue
1530830|NCT00659373|sleep disorders|sleep disorders
1530831|NCT00659373|stage IA breast cancer|stage ia breast cancer
1530832|NCT00659373|stage IB breast cancer|stage ib breast cancer
1530833|NCT00659373|stage II breast cancer|stage ii breast cancer
1530834|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
1530835|NCT00659334|Combidex|combidex
1530836|NCT00659334|Diagnostic imaging|diagnostic imaging
1530837|NCT00659308|pain|pain
1530838|NCT00659308|bullous keratopathy|bullous keratopathy
1530839|NCT00659308|amniotic membrane|amniotic membrane
1530840|NCT00659308|anterior stromal puncture|anterior stromal puncture
1530841|NCT00659269|Vitamin B-12|vitamin b-12
1530842|NCT00659269|Vitamin B-6|vitamin b-6
1530843|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
1530844|NCT00659269|Taxanes|taxanes
1530845|NCT00659269|Vinca alkaloid|vinca alkaloid
1530846|NCT00659269|Heavy metals|heavy metals
1530847|NCT00659269|Neuropathy|neuropathy
1530848|NCT00659269|Nerve pain|nerve pain
1530849|NCT00659256|Hepatitis C Virus|hepatitis c virus
1530850|NCT00659256|Atherosclerosis|atherosclerosis
1530851|NCT00659256|Intima-Media Thickness|intima-media thickness
1530852|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
1530853|NCT00659256|Hepatitis C|hepatitis c
1530854|NCT00659243|Replacement therapy|replacement therapy
1530855|NCT00659243|Pasteurized breast milk|pasteurized breast milk
1530856|NCT00659243|Preterm infants|preterm infants
1530857|NCT00659243|BSSL|bssl
1530858|NCT00659230|PTSD|ptsd
1530859|NCT00659230|Veterans|veterans
1530860|NCT00659230|Nepicastat|nepicastat
1530861|NCT00659230|OIF/OEF|oif/oef
1530862|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
1530863|NCT00659217|lupus Nephritis|lupus nephritis
1530864|NCT00659191|Healthy volunteer,|healthy volunteer,
1530865|NCT00659191|HIV infected subjects|hiv infected subjects
1530866|NCT00659178|Doxil,|doxil,
1530867|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
1530868|NCT00659178|ovarian cancer|ovarian cancer
1530869|NCT00659178|IL-18,|il-18,
1530870|NCT00659178|combination study,|combination study,
1530871|NCT00659178|immunotherapy,|immunotherapy,
1530872|NCT00659178|cytokine,|cytokine,
1530873|NCT00659165|diabetes|diabetes
1530874|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
1530875|NCT00659165|diabetes mellitus|diabetes mellitus
1530876|NCT00659165|detemir|detemir
1530877|NCT00659165|levemir|levemir
1530878|NCT00659165|glargine|glargine
1530879|NCT00659165|lantus|lantus
1530880|NCT00659165|insulin|insulin
1530881|NCT00659165|appetite|appetite
1530882|NCT00659165|satiety|satiety
1530883|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
1530884|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
1530885|NCT00659165|PYY|pyy
1530886|NCT00659165|ghrelin|ghrelin
1530887|NCT00659165|leptin|leptin
1530888|NCT00659152|ALI/ARDS|ali/ards
1530889|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
1530890|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
1530891|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
1530892|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
1530893|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
1530894|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
1530895|NCT00659087|Total Knee|total knee
1530896|NCT00659087|Range of Motion|range of motion
1530897|NCT00659087|Pain|pain
1530898|NCT00659074|bioequivalence|bioequivalence
1530899|NCT00659074|Ondansetron ODT|ondansetron odt
1530900|NCT00659074|Fasting|fasting
1530901|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
1530902|NCT00659061|micronutrients|micronutrients
1530903|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
1530904|NCT00659048|Ciclesonide|ciclesonide
1530905|NCT00659048|PAR|par
1530906|NCT00659035|driving|driving
1530907|NCT00659035|opioids|opioids
1530908|NCT00659035|impairment|impairment
1530909|NCT00659035|ability|ability
1530910|NCT00659035|patients|patients
1530911|NCT00659035|receiving|receiving
1530912|NCT00659035|oral morphine|oral morphine
1530913|NCT00659035|severe|severe
1530914|NCT00659022|colorectal cancer|colorectal cancer
1530915|NCT00659022|liver metastases|liver metastases
1530916|NCT00659022|angiogenesis|angiogenesis
1530917|NCT00659022|metabolism|metabolism
1530918|NCT00659009|environmental|environmental
1530919|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
1530920|NCT00659009|sleep|sleep
1530921|NCT00659009|respiratory-disturbance|respiratory-disturbance
1530922|NCT00659009|neurobehavioral performance|neurobehavioral performance
1530923|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
1530924|NCT00658970|Open label|open label
1530925|NCT00658970|Dose escalation|dose escalation
1530926|NCT00658957|Diabetes|diabetes
1530927|NCT00658957|Foot Ulcer|foot ulcer
1530928|NCT00658944|Stress urinary incontinence|stress urinary incontinence
1530929|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
1530930|NCT00658944|surgery|surgery
1530931|NCT00658944|trans obturator tape|trans obturator tape
1530932|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
1530933|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
1530934|NCT00658944|outcome|outcome
1530935|NCT00658931|Depression|depression
1530936|NCT00658931|Bereavement|bereavement
1530937|NCT00658931|Pilot Projects|pilot projects
1530938|NCT00658931|Antidepressant Drugs|antidepressant drugs
1530939|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
1530940|NCT00658918|Ciclesonide|ciclesonide
1530941|NCT00658918|Hay Fever|hay fever
1530942|NCT00658918|PAR|par
1530943|NCT00658905|Preterm infants|preterm infants
1530944|NCT00658905|Replacement therapy|replacement therapy
1530945|NCT00658905|Infant formula|infant formula
1530947|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
1530948|NCT00658892|recurrent melanoma|recurrent melanoma
1530949|NCT00658892|stage IV melanoma|stage iv melanoma
1530950|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
1530951|NCT00658853|COPD|copd
1530952|NCT00658853|training|training
1530953|NCT00658853|VO2peak|vo2peak
1530954|NCT00658853|performance|performance
1530955|NCT00658853|ventilation|ventilation
1530956|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
1530957|NCT00658853|one leg training by cycling|one leg training by cycling
1531152|NCT00657943|media|media
1530958|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
1530959|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
1530960|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
1567722|NCT00508378|Caregivers|caregivers
1530961|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
1530962|NCT00658827|Psoriasis|psoriasis
1530963|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
1530964|NCT00658775|GERD|gerd
1530965|NCT00658775|erosive GERD|erosive gerd
1530966|NCT00658775|erosive esophagitis|erosive esophagitis
1530967|NCT00658749|AIR645|air645
1530968|NCT00658749|Altair Therapeutics|altair therapeutics
1530969|NCT00658749|IL4|il4
1530970|NCT00658749|IL13|il13
1530971|NCT00658749|IL-4|il-4
1530972|NCT00658749|IL-13|il-13
1530973|NCT00658710|hemiplegia|hemiplegia
1530974|NCT00658710|stroke|stroke
1530975|NCT00658710|TRIDENT|trident
1530976|NCT00658697|Rising PSA|rising psa
1530977|NCT00658697|androgen deprivation|androgen deprivation
1530978|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
1530979|NCT00658697|docetaxel|docetaxel
1530980|NCT00658697|lupron|lupron
1530981|NCT00658697|zoladex|zoladex
1530982|NCT00658697|bicalutamide|bicalutamide
1530983|NCT00658658|Epidermal Growth Factor|epidermal growth factor
1530984|NCT00658658|Pediatric|pediatric
1530985|NCT00658658|Solid Tumors|solid tumors
1530986|NCT00658658|Panitumumab|panitumumab
1530987|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
1530988|NCT00658645|Schizophrenia|schizophrenia
1530989|NCT00658645|Antipsychotic|antipsychotic
1530990|NCT00658645|Bifeprunox|bifeprunox
1530991|NCT00658632|GERD|gerd
1530992|NCT00658632|erosive GERD|erosive gerd
1530993|NCT00658632|erosive esophagitis|erosive esophagitis
1530994|NCT00658606|plaque psoriasis|plaque psoriasis
1530995|NCT00658606|alefacept|alefacept
1530996|NCT00658606|Amevive|amevive
1530997|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
1530998|NCT00658606|phototherapy|phototherapy
1530999|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1531000|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1531001|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1531002|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1531003|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
1531004|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
1531005|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
1531006|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1531007|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
1531008|NCT00658580|Chemotherapy|chemotherapy
1531009|NCT00658580|Phase III randomised study|phase iii randomised study
1531010|NCT00658528|GERD|gerd
1531011|NCT00658528|erosive GERD|erosive gerd
1531012|NCT00658528|erosive esophagitis|erosive esophagitis
1531013|NCT00658476|Adolescent Depression|adolescent depression
1531014|NCT00658476|Depression|depression
1531015|NCT00658476|Teenage Depression|teenage depression
1531016|NCT00658476|Los Angeles|los angeles
1531017|NCT00658463|Diabetes|diabetes
1531018|NCT00658463|Triglycerides|triglycerides
1531019|NCT00658463|HDL-cholesterol|hdl-cholesterol
1531020|NCT00658463|kinetic|kinetic
1531021|NCT00658463|rosuvastatin|rosuvastatin
1531022|NCT00658450|Malaria, Cerebral|malaria, cerebral
1531023|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
1531024|NCT00658411|AML|aml
1531025|NCT00658411|ALL|all
1531026|NCT00658411|MDS|mds
1531027|NCT00658411|iron overload|iron overload
1531028|NCT00658411|deferoxamine|deferoxamine
1531029|NCT00658398|Alcohol|alcohol
1531030|NCT00658398|dependency|dependency
1531031|NCT00658385|GCSF|gcsf
1531032|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
1531033|NCT00658359|Immunosuppression|immunosuppression
1531034|NCT00658359|JAK inhibitor|jak inhibitor
1531035|NCT00658359|kidney transplantation|kidney transplantation
1531036|NCT00658346|HIV-1 group O|hiv-1 group o
1531037|NCT00658346|HIV-1 group M|hiv-1 group m
1531038|NCT00658346|Cameroon|cameroon
1531039|NCT00658346|HIV-1 infection|hiv-1 infection
1531040|NCT00658346|treatment naïve|treatment naïve
1531041|NCT00658333|Renal Transplantation|renal transplantation
1531042|NCT00658333|Immunosuppression|immunosuppression
1531043|NCT00658333|Renal transplant recipients|renal transplant recipients
1531044|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
1531045|NCT00658320|Renal transplantation|renal transplantation
1531046|NCT00658320|everolimus|everolimus
1531047|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
1531048|NCT00658320|cyclosporine|cyclosporine
1531049|NCT00658320|corticosteroid|corticosteroid
1531050|NCT00658320|basiliximab|basiliximab
1531051|NCT00658320|Banff diagnosis|banff diagnosis
1531052|NCT00658320|Acute rejection|acute rejection
1531053|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
1531054|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
1531153|NCT00657943|thickness|thickness
1531055|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1531056|NCT00658307|double-blind|double-blind
1531057|NCT00658307|sham-controlled|sham-controlled
1531059|NCT00658281|Breast Cancer|breast cancer
1567723|NCT00508365|lisinopril|lisinopril
1531060|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
1531061|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
1531062|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
1531063|NCT00658281|Lymph Nodes|lymph nodes
1531064|NCT00658281|CBCT|cbct
1531065|NCT00658281|OBI KV|obi kv
1531066|NCT00658268|Surgical procedures operative|surgical procedures operative
1531067|NCT00658268|Prosthesis implantation|prosthesis implantation
1531068|NCT00658268|Arthroplasty replacement|arthroplasty replacement
1531069|NCT00658255|stable asthma|stable asthma
1531070|NCT00658255|adults|adults
1531071|NCT00658255|formoterol|formoterol
1531072|NCT00658255|Symbicort|symbicort
1531073|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
1531074|NCT00658255|bronchodilation|bronchodilation
1531075|NCT00658242|craniofacial|craniofacial
1531076|NCT00658242|maxillofacial|maxillofacial
1531077|NCT00658242|osteotomy|osteotomy
1531078|NCT00658242|craniectomy|craniectomy
1531079|NCT00658242|craniotomy|craniotomy
1531080|NCT00658229|Exercise|exercise
1531081|NCT00658229|Prostatic|prostatic
1531082|NCT00658229|Neoplasm|neoplasm
1531083|NCT00658229|Androgen|androgen
1531084|NCT00658229|Deprivation|deprivation
1531085|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
1531086|NCT00658216|Very elderly population|very elderly population
1531087|NCT00658216|Heart failure|heart failure
1531088|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
1531089|NCT00658216|Observational prospective study|observational prospective study
1531090|NCT00658216|Older|older
1531091|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
1531092|NCT00658203|CRT-P|crt-p
1531093|NCT00658203|PEA|pea
1531094|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
1531095|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
1531096|NCT00658203|Sinus rhythm|sinus rhythm
1531097|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
1531098|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
1531099|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
1531100|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
1531101|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
1531102|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
1531103|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
1531104|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
1531105|NCT00658177|Erectile dysfunction|erectile dysfunction
1531106|NCT00658177|Vardenafil|vardenafil
1531107|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
1531108|NCT00658151|focus|focus
1531109|NCT00658151|study|study
1531110|NCT00658151|evaluate|evaluate
1531111|NCT00658151|sonographic|sonographic
1531112|NCT00658151|findings|findings
1531113|NCT00658151|colon|colon
1531114|NCT00658151|patients|patients
1531115|NCT00658151|developed|developed
1531116|NCT00658086|ALN-RSV01|aln-rsv01
1531117|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
1531118|NCT00658073|Kidney transplant|kidney transplant
1531119|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
1531120|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
1531121|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
1531122|NCT00658047|Phase II|phase ii
1531123|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
1531124|NCT00658034|Cancer|cancer
1531125|NCT00658034|Fatigue|fatigue
1531126|NCT00658034|Acupuncture|acupuncture
1531127|NCT00658021|diabetes|diabetes
1531128|NCT00658021|adolescents|adolescents
1531129|NCT00658021|exenatide|exenatide
1531130|NCT00658021|Astra Zeneca|astra zeneca
1531131|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
1531132|NCT00657995|pancreatogenic|pancreatogenic
1531133|NCT00657995|diabetes|diabetes
1531134|NCT00657995|artificial|artificial
1531135|NCT00657995|pancreas|pancreas
1531136|NCT00657969|Polymorphism, genetic|polymorphism, genetic
1531137|NCT00657969|Risk factors|risk factors
1531138|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
1531139|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
1531140|NCT00657969|Genetic predisposition|genetic predisposition
1531141|NCT00657969|Outcome|outcome
1531142|NCT00657969|Therapy|therapy
1531143|NCT00657956|osteoarthritis|osteoarthritis
1531144|NCT00657956|arthroplasty|arthroplasty
1531145|NCT00657956|knee joint|knee joint
1531146|NCT00657956|radiography|radiography
1531147|NCT00657956|surgery|surgery
1531148|NCT00657956|Bone Density|bone density
1531149|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
1531150|NCT00657943|carotid|carotid
1531151|NCT00657943|intima|intima
1531154|NCT00657943|insulin|insulin
1531155|NCT00657943|metformin|metformin
1531156|NCT00657917|leishmaniasis|leishmaniasis
1531157|NCT00657917|cutaneous|cutaneous
1531158|NCT00657917|Old World|old world
1531159|NCT00657917|Leishmania major|leishmania major
1531160|NCT00657917|Treatment|treatment
1531161|NCT00657904|androgen antagonists|androgen antagonists
1531162|NCT00657904|prostate neoplasms|prostate neoplasms
1531163|NCT00657891|Allergic Asthma|allergic asthma
1531164|NCT00657891|Anti IgE|anti ige
1531165|NCT00657891|Xolair|xolair
1531166|NCT00657891|Basophil|basophil
1531167|NCT00657891|IL-13|il-13
1531168|NCT00657891|IL-4|il-4
1531169|NCT00657891|Histamine|histamine
1531170|NCT00657878|platinum free interval|platinum free interval
1531171|NCT00657878|chemotherapy|chemotherapy
1531172|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
1531173|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
1531174|NCT00657839|Vardenafil|vardenafil
1531175|NCT00657839|Genital Disease|genital disease
1531176|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
1531177|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
1531178|NCT00657813|Alzheimer|alzheimer
1531179|NCT00657813|SPECT|spect
1531180|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
1531181|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
1531182|NCT00657787|Veterans|veterans
1531183|NCT00657787|Health Services|health services
1531184|NCT00657774|Asthma|asthma
1531185|NCT00657774|Mild to Moderate|mild to moderate
1531186|NCT00657748|Leukodystrophy|leukodystrophy
1531187|NCT00657748|Canavan disease,|canavan disease,
1531188|NCT00657748|Aspartoacylase,|aspartoacylase,
1531189|NCT00657748|Lithium,|lithium,
1531190|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
1531191|NCT00657735|bipolar|bipolar
1531192|NCT00657735|depression|depression
1531193|NCT00657735|prefrontal|prefrontal
1531194|NCT00657735|cortex|cortex
1531195|NCT00657735|antidepressant|antidepressant
1531196|NCT00657735|response|response
1531197|NCT00657722|Pulmonary hypertension|pulmonary hypertension
1531198|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
1531199|NCT00657722|Operability|operability
1531200|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
1531201|NCT00657722|Operative mortality rate|operative mortality rate
1531202|NCT00657722|Technical failure|technical failure
1531203|NCT00657722|Pulmonary angiography|pulmonary angiography
1531204|NCT00657722|Computed tomography|computed tomography
1531205|NCT00657709|infant|infant
1531206|NCT00657709|Meningococcal disease|meningococcal disease
1531207|NCT00657709|prevention|prevention
1531208|NCT00657709|vaccination|vaccination
1531209|NCT00657696|primary health care|primary health care
1531210|NCT00657696|organizations|organizations
1531211|NCT00657696|learning|learning
1531212|NCT00657696|quality of health care|quality of health care
1531214|NCT00657683|GBS prevention|gbs prevention
1531215|NCT00657670|refractive error|refractive error
1531216|NCT00657670|spectacles|spectacles
1531217|NCT00657670|ready made spectacles|ready made spectacles
1531218|NCT00657670|vision|vision
1531219|NCT00657670|cost effectiveness|cost effectiveness
1531220|NCT00657657|Hepatitis|hepatitis
1531221|NCT00657657|vaccine|vaccine
1531222|NCT00657644|Erectile Dysfunction|erectile dysfunction
1531223|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
1531224|NCT00657631|Delusions|delusions
1531225|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
1531226|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
1531227|NCT00657605|Obesity|obesity
1531228|NCT00657605|Metabolic syndrome|metabolic syndrome
1531229|NCT00657605|Diabetes|diabetes
1531230|NCT00657566|intraabdominal|intraabdominal
1531231|NCT00657566|peritonitis|peritonitis
1531232|NCT00657566|sepsis|sepsis
1531233|NCT00657566|duration|duration
1531234|NCT00657566|antibiotics|antibiotics
1531235|NCT00657540|black widow spider|black widow spider
1531236|NCT00657540|antivenom|antivenom
1531237|NCT00657540|latrodectism|latrodectism
1531238|NCT00657527|Crestor|crestor
1531239|NCT00657527|Rosuvastatin|rosuvastatin
1531240|NCT00657527|Cholesterol|cholesterol
1531241|NCT00657527|Coronary artery disease|coronary artery disease
1531242|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
1531243|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
1531244|NCT00657514|peripheral arterial disease|peripheral arterial disease
1531245|NCT00657514|chronic angina|chronic angina
1531246|NCT00657514|exercise tolerance|exercise tolerance
1531247|NCT00657501|testosterone|testosterone
1531248|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
1531249|NCT00657501|menopause|menopause
1531250|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
1531251|NCT00657475|Heparin low dose|heparin low dose
1531252|NCT00657475|Inflammation|inflammation
1531253|NCT00657475|Blood loss|blood loss
1531254|NCT00657462|Medical Informatics Applications|medical informatics applications
1531255|NCT00657462|Software|software
1531256|NCT00657462|Utilization|utilization
1531257|NCT00657449|sprains and strains|sprains and strains
1531258|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
1531259|NCT00657436|Myocardial Infarction|myocardial infarction
1531260|NCT00657436|Coronary Artery Disease|coronary artery disease
1531261|NCT00657423|Lung Neoplasms|lung neoplasms
1531262|NCT00657423|Endostatins|endostatins
1531263|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
1531264|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
1531265|NCT00657423|Survival Rate|survival rate
1531266|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1531267|NCT00657397|Methadone|methadone
1531268|NCT00657397|Substance Dependence|substance dependence
1531269|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
1531270|NCT00657371|Colorectal Cancer|colorectal cancer
1531271|NCT00657371|Colonoscopy|colonoscopy
1531272|NCT00657371|Third Eye Retroscope|third eye retroscope
1531273|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
1531274|NCT00657371|Polypectomy|polypectomy
1531275|NCT00657358|lidocaine|lidocaine
1531276|NCT00657358|allodynia|allodynia
1531277|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
1531278|NCT00657358|pain|pain
1531279|NCT00657345|trastuzumab|trastuzumab
1531280|NCT00657345|breast cancer|breast cancer
1531281|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
1531282|NCT00657306|Cirrhosis|cirrhosis
1531283|NCT00657306|Ascites|ascites
1531284|NCT00657306|Adrenal insufficiency|adrenal insufficiency
1531285|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
1531286|NCT00657306|Portal hypertension|portal hypertension
1531287|NCT00657293|COPD|copd
1531288|NCT00657293|arm training|arm training
1531289|NCT00657293|dyspnoea|dyspnoea
1531290|NCT00657293|quality of life|quality of life
1531291|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
1531292|NCT00657267|temodar|temodar
1531293|NCT00657267|temozolomide|temozolomide
1531294|NCT00657254|Extension|extension
1531295|NCT00657254|Sorafenib|sorafenib
1531296|NCT00657254|Survival|survival
1531297|NCT00657241|cardiac work|cardiac work
1531298|NCT00657241|coreg cr|coreg cr
1531299|NCT00657241|valsartan|valsartan
1531300|NCT00657241|tonometry|tonometry
1531301|NCT00657228|Anaphylaxis|anaphylaxis
1531302|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
1531304|NCT00657202|neurofibroma|neurofibroma
1531305|NCT00657202|ranibizumab|ranibizumab
1531306|NCT00657202|Lucentis|lucentis
1531307|NCT00657189|Sifalimumab|sifalimumab
1531308|NCT00657189|MEDI-545|medi-545
1531309|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
1531310|NCT00657163|Stroke recovery|stroke recovery
1531311|NCT00657163|Pharmacological modulation|pharmacological modulation
1531312|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
1531313|NCT00657163|Fluoxetine|fluoxetine
1531314|NCT00657163|Brain plasticity|brain plasticity
1531315|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
1531316|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
1531317|NCT00657137|HER2/neu positive|her2/neu positive
1531318|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
1531319|NCT00657124|AEN|aen
1531320|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
1531321|NCT00657098|Side effects|side effects
1531322|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
1531323|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
1531324|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
1531325|NCT00657085|Laser hair removal|laser hair removal
1531326|NCT00657072|scapholunate instability|scapholunate instability
1531327|NCT00657072|neural networks|neural networks
1531328|NCT00657072|scaphoid|scaphoid
1531329|NCT00657072|lunate|lunate
1531330|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
1531331|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
1531332|NCT00657059|IgA nephropathy|iga nephropathy
1531333|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
1531334|NCT00657033|Erectile Dysfunction|erectile dysfunction
1531335|NCT00657020|nicotine|nicotine
1531336|NCT00657020|therapy|therapy
1531337|NCT00657020|fMRI/EEG|fmri/eeg
1531338|NCT00657020|replacement|replacement
1531339|NCT00657007|lupus|lupus
1531340|NCT00657007|SLE|sle
1531341|NCT00656994|Sleep Disorder|sleep disorder
1531342|NCT00656994|Insomnia|insomnia
1531343|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
1531344|NCT00656981|Acne|acne
1531345|NCT00656968|peptic ulcer disease|peptic ulcer disease
1531346|NCT00656968|gastric cancer|gastric cancer
1531347|NCT00656968|therapeutics|therapeutics
1531348|NCT00656955|Kidney Cancer|kidney cancer
1531349|NCT00656955|Renal Cell Cancer|renal cell cancer
1531350|NCT00656955|Heterogeneity|heterogeneity
1531351|NCT00656955|Molecular Epidemiology|molecular epidemiology
1531352|NCT00656955|Survival|survival
1567724|NCT00508365|carvedilol|carvedilol
1531353|NCT00656955|Occupational Exposure|occupational exposure
1531354|NCT00656955|Renal Cancer|renal cancer
1531355|NCT00656955|Survival Study|survival study
1531356|NCT00656942|Pain|pain
1531357|NCT00656929|Vitamin D|vitamin d
1531358|NCT00656929|Viral URI|viral uri
1531359|NCT00656929|Influenza|influenza
1531360|NCT00656929|Colds|colds
1531361|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
1531362|NCT00656916|Bronchiolitis|bronchiolitis
1531363|NCT00656916|Fluticasone Propionate|fluticasone propionate
1531364|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
1531365|NCT00656916|Lung Condition|lung condition
1531366|NCT00656916|PTCB|ptcb
1531367|NCT00656903|Lucentis|lucentis
1531368|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
1531369|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
1531370|NCT00656903|Macular Degeneration|macular degeneration
1531371|NCT00656903|Ranibizumab|ranibizumab
1531372|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
1531373|NCT00656903|AMD|amd
1531374|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
1531375|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
1531376|NCT00656864|Diabetes|diabetes
1531377|NCT00656864|pioglitazone|pioglitazone
1531378|NCT00656864|GIP|gip
1531379|NCT00656851|HIV/AIDS|hiv/aids
1531380|NCT00656851|Heart disease|heart disease
1531381|NCT00656851|Diabetes|diabetes
1531382|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
1531383|NCT00656851|Dyslipidemia|dyslipidemia
1531384|NCT00656851|Visceral adiposity|visceral adiposity
1531385|NCT00656851|treatment experienced|treatment experienced
1531386|NCT00656838|colon|colon
1531387|NCT00656838|rectal|rectal
1531388|NCT00656838|cancer|cancer
1531389|NCT00656838|screening|screening
1531390|NCT00656825|P144|p144
1531391|NCT00656825|TGF-β1|tgf-β1
1531392|NCT00656825|Healthy volunteers|healthy volunteers
1531393|NCT00656825|Cutaneous tolerability|cutaneous tolerability
1531394|NCT00656825|Skin fibrosis|skin fibrosis
1531395|NCT00656825|systemic scleroderma|systemic scleroderma
1531396|NCT00656825|systemic sclerosis|systemic sclerosis
1531397|NCT00656825|Safety|safety
1531398|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
1531399|NCT00656812|Rituximab|rituximab
1531400|NCT00656812|2CdA|2cda
1531401|NCT00656812|chemotherapy|chemotherapy
1531402|NCT00656812|immunotherapy|immunotherapy
1531403|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
1531404|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
1531405|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
1531406|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1531407|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
1531408|NCT00656747|chronic bronchitis|chronic bronchitis
1531409|NCT00656747|bronchitis|bronchitis
1531410|NCT00656747|chest infection|chest infection
1531411|NCT00656747|smoking|smoking
1531412|NCT00656747|lung disease|lung disease
1531413|NCT00656747|lung|lung
1531414|NCT00656747|lungs|lungs
1531415|NCT00656734|Medarex Inc.|medarex inc.
1531416|NCT00656721|bronchiectasis|bronchiectasis
1531417|NCT00656721|physiotherapy|physiotherapy
1531418|NCT00656721|flutter valve|flutter valve
1531419|NCT00656721|impulse oscillation technique|impulse oscillation technique
1531420|NCT00656708|Burns|burns
1531421|NCT00656708|Wounds|wounds
1531422|NCT00656708|Healthcare associated infections|healthcare associated infections
1531423|NCT00656708|MRSA|mrsa
1531424|NCT00656708|VRE|vre
1531425|NCT00656695|Iminoral|iminoral
1531426|NCT00656695|Neoral|neoral
1531427|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
1531428|NCT00656682|Prevention & Control|prevention & control
1531429|NCT00656682|Hyperglycemia|hyperglycemia
1531430|NCT00656682|Obesity|obesity
1531431|NCT00656682|Diabetes Mellitus|diabetes mellitus
1531432|NCT00656682|Cost Benefit Analysis|cost benefit analysis
1531433|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
1531434|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
1531435|NCT00656656|pemphigus|pemphigus
1531436|NCT00656656|rituximab|rituximab
1531437|NCT00656656|immunoadsorption|immunoadsorption
1531532|NCT00656318|menses|menses
1531438|NCT00656656|dexamethasone|dexamethasone
1531439|NCT00656656|treatment|treatment
1531440|NCT00656656|management|management
1531441|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
1531442|NCT00656617|(AML)|(aml)
1531443|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
1531444|NCT00656617|(MDS)|(mds)
1531445|NCT00656617|Leukemia|leukemia
1531446|NCT00656617|Idarubicin|idarubicin
1531447|NCT00656617|Cytarabine|cytarabine
1531448|NCT00656617|Vorinostat|vorinostat
1531449|NCT00656617|Ara-C|ara-c
1531450|NCT00656604|recurrent breast cancer|recurrent breast cancer
1531451|NCT00656604|stage I breast cancer|stage i breast cancer
1693067|NCT00072605|Healthy|healthy
1531452|NCT00656604|stage II breast cancer|stage ii breast cancer
1531453|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
1531454|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
1531455|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
1531456|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
1531457|NCT00656578|Foot|foot
1531458|NCT00656578|Bunion|bunion
1531459|NCT00656578|Bunionectomy|bunionectomy
1531460|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
1531461|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
1531462|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
1531463|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
1531464|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
1531465|NCT00656513|laryngeal cancer|laryngeal cancer
1531466|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
1531467|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
1531468|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1531469|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
1531470|NCT00656513|salivary gland cancer|salivary gland cancer
1531471|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1531472|NCT00656513|xerostomia|xerostomia
1531473|NCT00656513|tongue cancer|tongue cancer
1531474|NCT00656500|surgical patients|surgical patients
1531475|NCT00656500|cigarette smoking|cigarette smoking
1531476|NCT00656500|postoperative complications|postoperative complications
1531477|NCT00656500|telephone counseling|telephone counseling
1531478|NCT00656500|quitlines|quitlines
1531479|NCT00656487|Cannabis Dependence|cannabis dependence
1531480|NCT00656487|Marijuana Dependence|marijuana dependence
1531481|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
1531482|NCT00656487|Rimonabant|rimonabant
1531483|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
1531484|NCT00656487|Neuropsychology|neuropsychology
1531485|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1531486|NCT00656487|Endocannabinoids|endocannabinoids
1531487|NCT00656487|Cortisol|cortisol
1531488|NCT00656474|burn wounds|burn wounds
1531489|NCT00656474|wound healing|wound healing
1531490|NCT00656461|Advanced cancer|advanced cancer
1531491|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
1531492|NCT00656448|AML|aml
1531493|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
1531494|NCT00656448|MDS|mds
1531495|NCT00656448|Leukemia|leukemia
1531496|NCT00656448|Procrit|procrit
1531497|NCT00656448|Epoetin Alfa|epoetin alfa
1531498|NCT00656448|Epogen|epogen
1531499|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1531500|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
1531501|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
1531502|NCT00656435|long acting gas|long acting gas
1531503|NCT00656422|insulin therapy|insulin therapy
1531504|NCT00656422|hepatic fat|hepatic fat
1531505|NCT00656422|type 2 diabetes|type 2 diabetes
1531506|NCT00656422|body composition|body composition
1531507|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
1531508|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
1531509|NCT00656422|Obesity|obesity
1531510|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
1531511|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
1531512|NCT00656409|Prevenar,|prevenar,
1531513|NCT00656409|Immunogenicity ,|immunogenicity ,
1531514|NCT00656409|Vaccine|vaccine
1531515|NCT00656396|Blood loss|blood loss
1531516|NCT00656396|Point of care monitoring|point of care monitoring
1531517|NCT00656396|FFP|ffp
1531518|NCT00656396|Major surgery|major surgery
1531519|NCT00656396|Prothrombin Time|prothrombin time
1531520|NCT00656396|Blood coagulation tests|blood coagulation tests
1531521|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
1531522|NCT00656370|Hylenex|hylenex
1531523|NCT00656370|subcutaneous infusion|subcutaneous infusion
1531524|NCT00656370|hyaluronidase|hyaluronidase
1531525|NCT00656370|rHuPH20|rhuph20
1531526|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
1531527|NCT00656344|PTSD|ptsd
1531528|NCT00656344|Substance Abuse|substance abuse
1531529|NCT00656344|WTC attacks|wtc attacks
1531530|NCT00656344|Iraq War|iraq war
1531531|NCT00656318|women|women
1531533|NCT00656318|oral contraceptives|oral contraceptives
1531534|NCT00656318|Healthy menstruating females|healthy menstruating females
1531535|NCT00656305|Bone Cancer|bone cancer
1531536|NCT00656305|Pain Palliation|pain palliation
1531537|NCT00656305|Metastasis|metastasis
1531538|NCT00656305|Multiple Myeloma|multiple myeloma
1531539|NCT00656305|Breast Cancer|breast cancer
1531540|NCT00656305|Lung Cancer|lung cancer
1531541|NCT00656305|Prostate Cancer|prostate cancer
1531542|NCT00656305|cancer related Pain|cancer related pain
1531543|NCT00656305|Tumors|tumors
1531641|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
1531544|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
1531545|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
1531546|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1531547|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
1531548|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
1531549|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
1531550|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
1531551|NCT00656279|chronic kidney disease|chronic kidney disease
1531552|NCT00656279|predialysis|predialysis
1531553|NCT00656279|hyperphosphatemia|hyperphosphatemia
1531554|NCT00656279|dietary intervention|dietary intervention
1531555|NCT00656279|intensive dietary education|intensive dietary education
1531556|NCT00656279|low phosphorus diet|low phosphorus diet
1531557|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
1531558|NCT00656214|Lichen Planus|lichen planus
1531559|NCT00656201|Infertility|infertility
1531560|NCT00656201|In vitro fertilization|in vitro fertilization
1531561|NCT00656201|Embryo transfer|embryo transfer
1531563|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
1531564|NCT00656201|Progesterone support|progesterone support
1531565|NCT00656188|Erectile Dysfunction|erectile dysfunction
1531566|NCT00656188|Vardenafil|vardenafil
1531567|NCT00656175|lipodystrophy|lipodystrophy
1531568|NCT00656175|fat|fat
1531569|NCT00656175|visceral fat|visceral fat
1531570|NCT00656175|HIV|hiv
1531571|NCT00656175|women|women
1531572|NCT00656175|raltegravir|raltegravir
1531573|NCT00656175|ART|art
1531574|NCT00656175|anti HIV therapy|anti hiv therapy
1531575|NCT00656175|NNRTI|nnrti
1531576|NCT00656175|Protease inhibitor|protease inhibitor
1531577|NCT00656175|integrase inhibitor|integrase inhibitor
1531578|NCT00656175|treatment experienced|treatment experienced
1531579|NCT00656149|telerehabilitation|telerehabilitation
1531580|NCT00656149|functional electrical stimulation|functional electrical stimulation
1531581|NCT00656149|spinal cord injury|spinal cord injury
1531582|NCT00656149|hand function rehabilitation|hand function rehabilitation
1531583|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
1531584|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1531585|NCT00656123|stage IV colon cancer|stage iv colon cancer
1531586|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
1531587|NCT00656123|liver metastases|liver metastases
1531588|NCT00656110|Restless legs syndrome|restless legs syndrome
1531589|NCT00656110|Morton's neuroma|morton's neuroma
1531590|NCT00656110|Randomized controlled trial|randomized controlled trial
1531591|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
1531592|NCT00656071|ARDS|ards
1531593|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
1531594|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
1531595|NCT00656071|respiratory distress|respiratory distress
1531596|NCT00656058|Leukotriene|leukotriene
1531597|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
1531598|NCT00656058|Montelukast|montelukast
1531599|NCT00656058|Stem Cell Transplant|stem cell transplant
1531600|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
1531601|NCT00656045|Obesity|obesity
1531602|NCT00656045|Physical Activity|physical activity
1531603|NCT00656045|Weight Loss|weight loss
1531604|NCT00656045|Exercise|exercise
1531605|NCT00656045|Dietary Intake|dietary intake
1531606|NCT00656045|Energy|energy
1531607|NCT00656045|Behavioral|behavioral
1531608|NCT00656045|Healthy Eating|healthy eating
1531609|NCT00656032|insulin resistance|insulin resistance
1531610|NCT00656032|end stage renal disease|end stage renal disease
1531611|NCT00656006|Hepatitis C|hepatitis c
1531612|NCT00656006|Chronic|chronic
1531613|NCT00656006|Genotype 2 or 3|genotype 2 or 3
1531614|NCT00656006|Treatment naive|treatment naive
1531615|NCT00655993|COPD|copd
1531616|NCT00655993|Inflammation|inflammation
1531617|NCT00655993|CRP levels|crp levels
1531618|NCT00655993|simvastatin|simvastatin
1531619|NCT00655954|COPD|copd
1531620|NCT00655954|asthma|asthma
1531621|NCT00655954|smokers|smokers
1531622|NCT00655954|healthy volunteers|healthy volunteers
1531623|NCT00655954|bronchiectasis|bronchiectasis
1531624|NCT00655954|cystic fibrosis|cystic fibrosis
1531625|NCT00655941|Osteoarthritis|osteoarthritis
1531626|NCT00655941|Obesity|obesity
1531627|NCT00655941|Weight loss|weight loss
1531628|NCT00655941|Dietary instruction|dietary instruction
1531629|NCT00655941|Exercise|exercise
1531630|NCT00655941|Attention|attention
1531631|NCT00655928|Acute lung injury|acute lung injury
1531632|NCT00655928|Lung resection|lung resection
1531633|NCT00655902|Trans fat|trans fat
1531634|NCT00655902|Obesity|obesity
1531635|NCT00655902|Insulin sensitivity|insulin sensitivity
1531636|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
1531637|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
1531638|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
1531639|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
1693302|NCT00071292|MBSR|mbsr
1531640|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
1531642|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1531643|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
1531644|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
1531645|NCT00655863|Type II Diabetes|type ii diabetes
1531646|NCT00655863|Diabetes Mellitus|diabetes mellitus
1531647|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
1531648|NCT00655863|Drug Therapy|drug therapy
1531649|NCT00655850|Lung Cancer|lung cancer
1531650|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
1531651|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
1531652|NCT00655837|Antigens, CD40|antigens, cd40
1531653|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
1531654|NCT00655837|Combined Modality Therapy|combined modality therapy
1531655|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1531656|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1531657|NCT00655837|Hematologic Diseases|hematologic diseases
1531658|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
1531659|NCT00655837|Lymphatic Diseases|lymphatic diseases
1531660|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
1531661|NCT00655837|Lymphoma|lymphoma
1531662|NCT00655811|Healthy volunteers|healthy volunteers
1531663|NCT00655785|Epitope peptide|epitope peptide
1531664|NCT00655785|CTL|ctl
1531665|NCT00655785|Pancreatic cancer|pancreatic cancer
1531666|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
1531667|NCT00655785|VEGFR2|vegfr2
1531668|NCT00655772|chlorine|chlorine
1531669|NCT00655772|dioxide|dioxide
1531670|NCT00655772|mouthwash|mouthwash
1531671|NCT00655772|organoleptic|organoleptic
1531672|NCT00655772|measurements|measurements
1531673|NCT00655772|volatile|volatile
1531674|NCT00655772|sulfur|sulfur
1531675|NCT00655772|compounds|compounds
1531676|NCT00655746|Healthy Subjects|healthy subjects
1531677|NCT00655720|infant formula|infant formula
1531678|NCT00655707|Adult stem cell therapy|adult stem cell therapy
1531679|NCT00655694|COPD|copd
1531680|NCT00655694|smokers|smokers
1531681|NCT00655694|healthy volunteers|healthy volunteers
1531682|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
1531683|NCT00655681|pediatric osteopenia|pediatric osteopenia
1531684|NCT00655681|pamidronate|pamidronate
1531685|NCT00655681|post operative osteopenia|post operative osteopenia
1531686|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
1531687|NCT00655629|Erectile Dysfunction|erectile dysfunction
1531688|NCT00655603|GLP-1|glp-1
1531689|NCT00655603|Glucagon secretion|glucagon secretion
1531690|NCT00655603|Glucose turn-over|glucose turn-over
1531691|NCT00655590|Erectile Dysfunction|erectile dysfunction
1531692|NCT00655590|Sildenafil|sildenafil
1531693|NCT00655590|Vardenafil|vardenafil
1531694|NCT00655590|Spermatogenesis|spermatogenesis
1531695|NCT00655590|Sperm concentration|sperm concentration
1531696|NCT00655590|Sperm count|sperm count
1531697|NCT00655590|Morphology|morphology
1531698|NCT00655590|Motility|motility
1531699|NCT00655590|Reproductive hormonal|reproductive hormonal
1531700|NCT00655577|Aging|aging
1531701|NCT00655577|Osteoporosis|osteoporosis
1531702|NCT00655577|Exercise|exercise
1531703|NCT00655577|Population based|population based
1531704|NCT00655577|Randomized trial|randomized trial
1531705|NCT00655577|Falls|falls
1531706|NCT00655577|Fractures|fractures
1531707|NCT00655551|epilepsy|epilepsy
1531708|NCT00655551|seizures|seizures
1531709|NCT00655551|Lacosamide|lacosamide
1531710|NCT00655551|Vimpat|vimpat
1531711|NCT00655551|intravenous|intravenous
1531712|NCT00655525|inflammation|inflammation
1531713|NCT00655525|end stage renal disease|end stage renal disease
1531714|NCT00655512|pimecrolimus|pimecrolimus
1531715|NCT00655512|hydrocortison|hydrocortison
1531716|NCT00655512|betamethasone|betamethasone
1531717|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
1531718|NCT00655512|Optical Coherence Tomography|optical coherence tomography
1531719|NCT00655512|skin healthy probands|skin healthy probands
1531720|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
1531721|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1531722|NCT00655499|stage IV colon cancer|stage iv colon cancer
1531723|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
1531724|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
1531725|NCT00655499|recurrent colon cancer|recurrent colon cancer
1531726|NCT00655486|Epilepsy|epilepsy
1531727|NCT00655486|seizures|seizures
1531728|NCT00655486|antiepileptic|antiepileptic
1531729|NCT00655486|Lacosamide|lacosamide
1531730|NCT00655486|Vimpat|vimpat
1531731|NCT00655486|safety|safety
1531732|NCT00655486|adjunctive|adjunctive
1531733|NCT00655460|Glucose|glucose
1531734|NCT00655460|Insulin|insulin
1531735|NCT00655460|computer|computer
1531736|NCT00655460|critical care|critical care
1531737|NCT00655447|oophorectomy|oophorectomy
1531738|NCT00655447|ovarian conservation|ovarian conservation
1531739|NCT00655447|stroke|stroke
1531740|NCT00655447|breast cancer|breast cancer
1531741|NCT00655447|ovarian cancer|ovarian cancer
1531742|NCT00655447|other cancer|other cancer
1531743|NCT00655447|hip fracture|hip fracture
1531744|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
1531745|NCT00655434|HSV 2|hsv 2
1531746|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
1531747|NCT00655421|screening|screening
1531748|NCT00655421|oral precancers|oral precancers
1531749|NCT00655421|tobacco users|tobacco users
1531750|NCT00655421|VELScope|velscope
1531751|NCT00655421|Visual Inspection|visual inspection
1531752|NCT00655421|Toluidine Blue|toluidine blue
1531753|NCT00655408|Infants|infants
1531754|NCT00655408|Prevalence|prevalence
1531755|NCT00655408|Iron|iron
1531756|NCT00655408|Deficiency|deficiency
1531757|NCT00655408|Treatment|treatment
1531758|NCT00655395|Leukemia|leukemia
1531759|NCT00655395|MDS|mds
1531760|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
1531761|NCT00655382|dynamic mri|dynamic mri
1531762|NCT00655382|STARR procedure|starr procedure
1531763|NCT00655382|STARR|starr
1531764|NCT00655382|ODS|ods
1531765|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
1531766|NCT00655382|outlet obstruction|outlet obstruction
1531767|NCT00655382|obstructed defecation|obstructed defecation
1531768|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
1531769|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
1531770|NCT00655343|GvHD|gvhd
1531771|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
1531772|NCT00655343|Matched unrelated donor|matched unrelated donor
1531773|NCT00655343|ATG|atg
1531774|NCT00655343|SCT|sct
1531775|NCT00655343|BMT|bmt
1531776|NCT00655343|polyclonal antibody|polyclonal antibody
1531777|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
1531778|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
1531779|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
1531780|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
1531781|NCT00655330|Nephropathy|nephropathy
1531782|NCT00655330|valsartan|valsartan
1531783|NCT00655330|probucol|probucol
1531784|NCT00655330|Proteinuria|proteinuria
1531785|NCT00655317|acupuncture|acupuncture
1531786|NCT00655317|colon surgery|colon surgery
1531787|NCT00655317|post operative ileus|post operative ileus
1531788|NCT00655317|post ileus|post ileus
1531789|NCT00655317|ileus|ileus
1531790|NCT00655317|colectomy|colectomy
1531791|NCT00655317|colorectal pathology|colorectal pathology
1531792|NCT00655291|pain|pain
1531793|NCT00655278|Movement Disorder|movement disorder
1531794|NCT00655252|Expanded access|expanded access
1531795|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
1531796|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
1531797|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
1531798|NCT00655239|Prodrome|prodrome
1531799|NCT00655239|Psychosis|psychosis
1531800|NCT00655239|Schizophrenia|schizophrenia
1531801|NCT00655239|Cognitive Remediation|cognitive remediation
1531802|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
1531803|NCT00655226|Interferon-alpha|interferon-alpha
1531804|NCT00655226|Communicable Diseases|communicable diseases
1531805|NCT00655226|Liver Diseases|liver diseases
1531806|NCT00655226|Depression|depression
1531807|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
1531808|NCT00655226|Interferons|interferons
1531809|NCT00655226|Ribavirin|ribavirin
1531810|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
1531811|NCT00655226|Infection|infection
1531812|NCT00655226|Hepatitis|hepatitis
1531813|NCT00655226|Mood Disorders|mood disorders
1531814|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
1531815|NCT00655226|Hepatitis C|hepatitis c
1531816|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
1531817|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
1531818|NCT00655226|Depressive Disorder, Major|depressive disorder, major
1531819|NCT00655226|Depressive Disorder|depressive disorder
1531820|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
1531821|NCT00655174|autism|autism
1531822|NCT00655174|fluvoxamine|fluvoxamine
1531823|NCT00655174|sertraline|sertraline
1531824|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
1531825|NCT00655174|paediatrics|paediatrics
1531826|NCT00655161|NSCLC|nsclc
1531827|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
1531828|NCT00655148|DTaP-IPV|dtap-ipv
1531829|NCT00655148|Clinical Trial|clinical trial
1531830|NCT00655148|Safety|safety
1531831|NCT00655148|Immunogenicity|immunogenicity
1531832|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
1531833|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1531834|NCT00655096|Screening Protocol|screening protocol
1531835|NCT00655096|Eye Diseases|eye diseases
1693530|NCT00070733|Libido|libido
1531836|NCT00655083|Infantile colic|infantile colic
1531837|NCT00655083|Abdominal Cramps|abdominal cramps
1531838|NCT00655083|Colicky Pain|colicky pain
1531839|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
1531840|NCT00655070|Hibernating Myocardium|hibernating myocardium
1531841|NCT00655070|Blood Flow|blood flow
1531842|NCT00655070|Ultrasound|ultrasound
1531843|NCT00655070|PET imaging|pet imaging
1531844|NCT00655057|Dopamine Transporter|dopamine transporter
1531845|NCT00655057|Biomarker|biomarker
1531846|NCT00655057|SPECT Brain Imaging|spect brain imaging
1531847|NCT00655057|Antidepressant Therapy|antidepressant therapy
1531848|NCT00655031|Punicaceae|punicaceae
1531849|NCT00655031|Pomegranate|pomegranate
1531850|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
1531851|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1531852|NCT00655018|Liver histology|liver histology
1531853|NCT00655018|Insulin Resistance|insulin resistance
1531854|NCT00655018|Weight loss|weight loss
1531855|NCT00655018|Alpha-tocopherol|alpha-tocopherol
1531856|NCT00655018|ascorbic acid|ascorbic acid
1531857|NCT00655005|head and neck cancer|head and neck cancer
1531858|NCT00654966|Urotensin II|urotensin ii
1531859|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
1531860|NCT00654966|Iontophoresis|iontophoresis
1531861|NCT00654966|Healthy volunteers|healthy volunteers
1531862|NCT00654953|cocaine dependence|cocaine dependence
1531863|NCT00654953|depressive symptoms|depressive symptoms
1531865|NCT00654953|sertraline|sertraline
1531866|NCT00654953|gabapentin|gabapentin
1531867|NCT00654927|multiple sclerosis|multiple sclerosis
1531868|NCT00654927|MS|ms
1531869|NCT00654927|walking|walking
1531870|NCT00654927|leg strength|leg strength
1531871|NCT00654927|demyelination|demyelination
1531872|NCT00654914|Sexual Dysfunction|sexual dysfunction
1531873|NCT00654901|Diphtheria|diphtheria
1531874|NCT00654901|Tetanus|tetanus
1531875|NCT00654901|Pertussis|pertussis
1531876|NCT00654901|Hepatitis B|hepatitis b
1531877|NCT00654901|Poliomyelitis|poliomyelitis
1531878|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
1531879|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
1531880|NCT00654888|cataract extraction|cataract extraction
1531881|NCT00654888|surgery|surgery
1531882|NCT00654888|corneal disease|corneal disease
1531883|NCT00654875|Essential Hypertension|essential hypertension
1531884|NCT00654849|Electrosurgery|electrosurgery
1531885|NCT00654849|Gyrus Pk|gyrus pk
1531886|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
1531887|NCT00654849|Blood Loss, Surgical|blood loss, surgical
1531888|NCT00654849|Length of stay|length of stay
1531889|NCT00654849|Overall cost|overall cost
1531890|NCT00654836|recurrent breast cancer|recurrent breast cancer
1531891|NCT00654836|stage III breast cancer|stage iii breast cancer
1531892|NCT00654836|stage IV breast cancer|stage iv breast cancer
1531893|NCT00654810|functional ability|functional ability
1531894|NCT00654810|gait|gait
1531895|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
1531896|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
1531897|NCT00654797|Glucose|glucose
1531898|NCT00654797|Insulin|insulin
1531899|NCT00654797|computer|computer
1531900|NCT00654797|critical care|critical care
1531901|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1531902|NCT00654784|DMD|dmd
1531903|NCT00654784|Duchenne|duchenne
1531904|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
1531905|NCT00654771|clean catch urine|clean catch urine
1531906|NCT00654771|catheterized urine|catheterized urine
1531907|NCT00654758|cancer|cancer
1531908|NCT00654758|carcinoma|carcinoma
1531909|NCT00654758|chemotherapy|chemotherapy
1531910|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
1531911|NCT00654758|anti-angiogenesis|anti-angiogenesis
1531912|NCT00654745|blood pressure reduction|blood pressure reduction
1531913|NCT00654732|Hodgkin Lymphoma|hodgkin lymphoma
1531914|NCT00654732|Lymphoma|lymphoma
1531915|NCT00654732|Adriamycin|adriamycin
1531916|NCT00654732|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1531917|NCT00654732|Adriamycin PFS®|adriamycin pfs®
1531918|NCT00654732|Adriamycin RDF™|adriamycin rdf™
1531919|NCT00654732|Rituxan|rituxan
1531920|NCT00654732|Rituximab|rituximab
1531921|NCT00654732|Bleomycin|bleomycin
1531922|NCT00654732|Bleomycin sulfate|bleomycin sulfate
1531923|NCT00654732|Blenoxane®|blenoxane®
1531924|NCT00654732|BLM|blm
1531925|NCT00654732|Vinblastine|vinblastine
1531926|NCT00654732|Velban|velban
1531927|NCT00654732|Dacarbazine|dacarbazine
1531928|NCT00654732|DTIC|dtic
1531929|NCT00654732|DTIC-Dome®|dtic-dome®
1531930|NCT00654732|R-ABVD|r-abvd
1531931|NCT00654732|ABVD|abvd
1531932|NCT00654719|Heart failure|heart failure
1531933|NCT00654719|cachexia|cachexia
1531934|NCT00654706|Schizophrenia|schizophrenia
1531935|NCT00654706|Cognition|cognition
1531936|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
1531938|NCT00654693|Nihon Kohden|nihon kohden
1531939|NCT00654693|mobile monitoring|mobile monitoring
1531940|NCT00654693|monitoring|monitoring
1531941|NCT00654693|nihon|nihon
1531942|NCT00654693|kohden|kohden
1531943|NCT00654693|monitoring device|monitoring device
1531944|NCT00654693|remote monitoring|remote monitoring
1531945|NCT00654693|wireless|wireless
1531946|NCT00654680|Erectile Dysfunction|erectile dysfunction
1532336|NCT00653471|obesity|obesity
1531947|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
1531948|NCT00654680|Vardenafil|vardenafil
1531949|NCT00654667|Resveratrol|resveratrol
1531950|NCT00654667|Insulin Resistance|insulin resistance
1531951|NCT00654667|Metabolic Syndrome|metabolic syndrome
1531952|NCT00654667|Sirtuin 1|sirtuin 1
1531953|NCT00654667|IGF-1|igf-1
1531954|NCT00654667|Satiety|satiety
1531955|NCT00654667|Leptin|leptin
1531956|NCT00654667|Adiponectin|adiponectin
1531957|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
1531958|NCT00654641|Wound Infection|wound infection
1531959|NCT00654641|Obesity|obesity
1531960|NCT00654641|Cesarean Delivery|cesarean delivery
1531961|NCT00654641|Wound Closure|wound closure
1531962|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
1531963|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
1531964|NCT00654615|randomized controlled trial|randomized controlled trial
1531965|NCT00654615|surgical fixation|surgical fixation
1531966|NCT00654615|volar plate|volar plate
1531967|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
1531968|NCT00654602|cholesterol|cholesterol
1531969|NCT00654602|low density lipoproteins|low density lipoproteins
1531970|NCT00654602|dyslipidaemia|dyslipidaemia
1531971|NCT00654602|Rosuvastatin|rosuvastatin
1531972|NCT00654602|Crestor|crestor
1531973|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1531974|NCT00654589|HCT|hct
1531975|NCT00654589|iron overload|iron overload
1531976|NCT00654589|chelators|chelators
1531977|NCT00654589|ICL670|icl670
1531978|NCT00654589|deferasirox|deferasirox
1531979|NCT00654589|serum ferritin|serum ferritin
1531980|NCT00654589|LIC|lic
1531981|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
1531982|NCT00654589|blood transfusions|blood transfusions
1531983|NCT00654589|adults|adults
1531984|NCT00654589|iron chelation|iron chelation
1531985|NCT00654589|3-6 months|3-6 months
1531986|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1531987|NCT00654576|schizophrenia|schizophrenia
1531988|NCT00654576|antipsychotic|antipsychotic
1531989|NCT00654576|outcome|outcome
1531990|NCT00654576|psychosocial intervention|psychosocial intervention
1531991|NCT00654563|Memory Disorders|memory disorders
1531992|NCT00654563|Memory loss|memory loss
1531993|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
1531994|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
1531995|NCT00654550|Re-epithelialization|re-epithelialization
1531996|NCT00654550|Nexagon|nexagon
1531997|NCT00654550|PRK|prk
1531998|NCT00654550|Coda|coda
1531999|NCT00654537|Cholesterol|cholesterol
1532000|NCT00654537|hypercholesterolemia|hypercholesterolemia
1532001|NCT00654537|low density lipoproteins|low density lipoproteins
1532002|NCT00654524|Endometriosis|endometriosis
1532003|NCT00654524|Recurrence|recurrence
1532004|NCT00654524|Pregnancy Rate|pregnancy rate
1532005|NCT00654524|Laparoscopy|laparoscopy
1532006|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
1532007|NCT00654511|Dexmedetomidine,|dexmedetomidine,
1532008|NCT00654511|fentanyl,|fentanyl,
1532009|NCT00654511|tonsillectomy|tonsillectomy
1532010|NCT00654511|and adenoidectomy,|and adenoidectomy,
1532011|NCT00654485|Cholesterol|cholesterol
1532012|NCT00654485|hypercholesterolemia|hypercholesterolemia
1532013|NCT00654485|low density lipoproteins|low density lipoproteins
1532014|NCT00654485|metabolic syndrome|metabolic syndrome
1532015|NCT00654485|Rosuvastatin|rosuvastatin
1532016|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
1532017|NCT00654446|Cholesterol|cholesterol
1532018|NCT00654446|low density lipoproteins|low density lipoproteins
1532019|NCT00654446|dyslipidaemia|dyslipidaemia
1532020|NCT00654446|Rosuvastatin|rosuvastatin
1532021|NCT00654446|Crestor|crestor
1532022|NCT00654446|Simvastatin|simvastatin
1532023|NCT00654446|Zocor|zocor
1532024|NCT00654446|Renal|renal
1532025|NCT00654446|kidney|kidney
1532026|NCT00654433|Hurler Syndrome|hurler syndrome
1532027|NCT00654433|MPS I|mps i
1532028|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
1532029|NCT00654433|Hunter Syndrome|hunter syndrome
1532030|NCT00654433|MPS II|mps ii
1532031|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
1532032|NCT00654433|MPS III|mps iii
1532033|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
1532034|NCT00654433|MPS VI|mps vi
1532035|NCT00654433|Krabbe Disease|krabbe disease
1532036|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
1532037|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1532039|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
1532040|NCT00654433|ALD|ald
1532041|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
1532042|NCT00654433|AMN|amn
1532043|NCT00654433|Sandhoff Disease|sandhoff disease
1532044|NCT00654433|Tay Sachs Disease|tay sachs disease
1532045|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
1532046|NCT00654433|PMD|pmd
1532047|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
1532048|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
1532049|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
1532050|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
1532051|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
1532052|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
1532053|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
1532054|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1532055|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
1532056|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
1532057|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
1532058|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1532059|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
1532060|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
1532061|NCT00654433|I Cell disease|i cell disease
1532062|NCT00654433|Fucosidosis|fucosidosis
1532063|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
1532064|NCT00654433|Canavan Disease|canavan disease
1532065|NCT00654407|Cholesterol|cholesterol
1532066|NCT00654407|hypercholesterolemia|hypercholesterolemia
1532067|NCT00654407|Coronary Heart disease|coronary heart disease
1532068|NCT00654407|low density lipoproteins|low density lipoproteins
1532069|NCT00654407|Rosuvastatin|rosuvastatin
1532070|NCT00654407|Atorvastatin|atorvastatin
1532071|NCT00654407|simvastatin|simvastatin
1532072|NCT00654394|Cholesterol|cholesterol
1532073|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
1532074|NCT00654394|Hypercholesterolemia|hypercholesterolemia
1532075|NCT00654394|Rosuvastatin|rosuvastatin
1532076|NCT00654394|Crestor|crestor
1532077|NCT00654368|Amgen|amgen
1532078|NCT00654355|atopic dermatitis|atopic dermatitis
1532079|NCT00654355|eczema|eczema
1532080|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
1532081|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
1532082|NCT00654316|TB|tb
1532083|NCT00654316|Tuberculosis|tuberculosis
1532084|NCT00654316|MVA85A|mva85a
1532085|NCT00654316|Vaccine|vaccine
1532086|NCT00654316|BCG|bcg
1532087|NCT00654303|Cholesterol|cholesterol
1532088|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
1532089|NCT00654303|Statins|statins
1532090|NCT00654290|Atrial fibrillation|atrial fibrillation
1532091|NCT00654290|coronary bypass|coronary bypass
1532092|NCT00654290|Amiodarone|amiodarone
1532093|NCT00654290|Propranolol|propranolol
1532094|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
1532095|NCT00654277|bioequivalence|bioequivalence
1532096|NCT00654277|Ondansetron ODT|ondansetron odt
1532097|NCT00654277|Fasting|fasting
1532098|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
1532099|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
1532100|NCT00654251|Machado-Joseph disease|machado-joseph disease
1532101|NCT00654251|Gait monitoring|gait monitoring
1532102|NCT00654251|Functional vision assessment|functional vision assessment
1532103|NCT00654238|Thyroid Cancer|thyroid cancer
1532104|NCT00654238|Anaplastic|anaplastic
1532105|NCT00654238|Medullary|medullary
1532106|NCT00654238|sorafenib|sorafenib
1532107|NCT00654225|Cholesterol|cholesterol
1532108|NCT00654225|low density lipoproteins|low density lipoproteins
1532109|NCT00654225|dyslipidaemia|dyslipidaemia
1532110|NCT00654225|Rosuvastatin|rosuvastatin
1532111|NCT00654225|Crestor|crestor
1532112|NCT00654225|Atorvastatin|atorvastatin
1532113|NCT00654225|Lipitor|lipitor
1532114|NCT00654225|South Asian|south asian
1532115|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
1532116|NCT00654199|CABG|cabg
1532117|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
1532118|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
1532119|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
1532120|NCT00654186|Chemo naive|chemo naive
1532121|NCT00654173|Cholesterol|cholesterol
1532122|NCT00654173|low density lipoproteins|low density lipoproteins
1532123|NCT00654173|dyslipidaemia|dyslipidaemia
1532124|NCT00654173|Rosuvastatin|rosuvastatin
1532125|NCT00654173|Crestor|crestor
1532126|NCT00654173|Atorvastatin|atorvastatin
1532127|NCT00654173|Lipitor|lipitor
1532128|NCT00654173|Zocor|zocor
1532129|NCT00654173|simvastatin|simvastatin
1532130|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
1532131|NCT00654160|stage IV anal cancer|stage iv anal cancer
1532132|NCT00654160|recurrent anal cancer|recurrent anal cancer
1532133|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
1532134|NCT00654160|stage III colon cancer|stage iii colon cancer
1532135|NCT00654160|stage IV colon cancer|stage iv colon cancer
1532136|NCT00654160|recurrent colon cancer|recurrent colon cancer
1532137|NCT00654160|stage III rectal cancer|stage iii rectal cancer
1532138|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
1532139|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
1532140|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
1532141|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
1532142|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
1532143|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1532144|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1532338|NCT00653471|capnography|capnography
1532145|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
1532146|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
1532147|NCT00654160|stage III gastric cancer|stage iii gastric cancer
1532148|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
1532149|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
1532150|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1532151|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1532152|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1532153|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1532154|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
1532155|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1532156|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1532157|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
1532158|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
1532159|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
1532160|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
1532161|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
1532162|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
1532163|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1532164|NCT00654160|small intestine lymphoma|small intestine lymphoma
1532165|NCT00654147|HIV|hiv
1532166|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
1532167|NCT00654147|Integrase inhibitor|integrase inhibitor
1532168|NCT00654147|HIV/AIDS|hiv/aids
1532169|NCT00654147|treatment naïve|treatment naïve
1532170|NCT00654121|prevention|prevention
1532171|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
1532172|NCT00654069|Pain|pain
1532173|NCT00654056|Type 2 diabetes|type 2 diabetes
1532174|NCT00654056|Severe insulin resistance|severe insulin resistance
1532175|NCT00654043|Bioequivalence|bioequivalence
1532176|NCT00654043|Torsemide Tablets|torsemide tablets
1532177|NCT00654043|fed|fed
1532178|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
1532179|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
1532180|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
1532181|NCT00654030|Lung Cancer|lung cancer
1532182|NCT00654004|trifunctional|trifunctional
1532183|NCT00654004|protein|protein
1532184|NCT00654004|deficiency|deficiency
1532185|NCT00654004|TFP|tfp
1532186|NCT00654004|weight|weight
1532187|NCT00654004|regulation|regulation
1532188|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
1532189|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
1532190|NCT00653991|Risky Sexual Behavior|risky sexual behavior
1532191|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
1532192|NCT00653991|HIV Seronegativity|hiv seronegativity
1532193|NCT00653978|ERCP|ercp
1532194|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
1532195|NCT00653978|hilar stricture|hilar stricture
1532196|NCT00653965|Cholesterol|cholesterol
1532197|NCT00653965|low density lipoproteins|low density lipoproteins
1532198|NCT00653965|dyslipidaemia|dyslipidaemia
1532199|NCT00653965|Rosuvastatin|rosuvastatin
1532200|NCT00653965|Crestor|crestor
1532201|NCT00653965|Atorvastatin|atorvastatin
1532202|NCT00653965|Lipitor|lipitor
1532203|NCT00653965|Hispanic|hispanic
1532204|NCT00653952|Paclitaxel HCl|paclitaxel hcl
1532205|NCT00653952|CAELYX|caelyx
1532206|NCT00653952|DOXIL|doxil
1532207|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
1532208|NCT00653952|Doxorubicin HCl|doxorubicin hcl
1532209|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
1532210|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
1532211|NCT00653939|neoplasms, lung|neoplasms, lung
1532212|NCT00653939|lung cancer|lung cancer
1532213|NCT00653939|tumors|tumors
1532214|NCT00653939|NSCLC|nsclc
1532215|NCT00653926|Postoperative pain|postoperative pain
1532216|NCT00653926|Local infiltration analgesia|local infiltration analgesia
1532217|NCT00653926|Knee arthroplasty|knee arthroplasty
1532218|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
1532219|NCT00653900|Verify now|verify now
1532220|NCT00653900|platelet function|platelet function
1532221|NCT00653900|platelet function testing|platelet function testing
1532222|NCT00653900|bleeding risk|bleeding risk
1532223|NCT00653900|periprocedural bleeding|periprocedural bleeding
1532224|NCT00653900|clopidogrel|clopidogrel
1532225|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
1567280|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1532226|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
1532227|NCT00653900|or higher transfusions.|or higher transfusions.
1532228|NCT00653887|Biofeedback|biofeedback
1532229|NCT00653887|anal sphincter|anal sphincter
1532230|NCT00653887|cortical excitability|cortical excitability
1532231|NCT00653887|magnetic stimulation|magnetic stimulation
1532232|NCT00653887|incontinence|incontinence
1532233|NCT00653887|constipation|constipation
1532234|NCT00653874|jaundice|jaundice
1532235|NCT00653874|neonates|neonates
1532236|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
1532237|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
1532238|NCT00653861|Aesthetic correction|aesthetic correction
1532239|NCT00653848|Adjuvant treatment, high risk, radical radiotherapy|adjuvant treatment, high risk, radical radiotherapy
1532241|NCT00653822|alefacept|alefacept
1532242|NCT00653822|pharmacokinetics|pharmacokinetics
1532243|NCT00653822|Japanese|japanese
1532244|NCT00653783|Parkinson disease|parkinson disease
1532245|NCT00653783|Multiple System Atrophy|multiple system atrophy
1532246|NCT00653783|MSA|msa
1532247|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
1532248|NCT00653783|PSP|psp
1532249|NCT00653783|observational|observational
1532250|NCT00653783|biomarker|biomarker
1532251|NCT00653757|stage I prostate cancer|stage i prostate cancer
1532252|NCT00653757|stage II prostate cancer|stage ii prostate cancer
1532253|NCT00653757|stage III prostate cancer|stage iii prostate cancer
1532254|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
1532255|NCT00653744|Cholesterol|cholesterol
1532256|NCT00653744|low density lipoproteins|low density lipoproteins
1532257|NCT00653744|dyslipidaemia|dyslipidaemia
1532258|NCT00653744|Rosuvastatin|rosuvastatin
1532259|NCT00653744|Crestor|crestor
1532260|NCT00653744|Atorvastatin|atorvastatin
1532261|NCT00653744|Lipitor|lipitor
1532262|NCT00653744|African American|african american
1532263|NCT00653731|dementia|dementia
1532264|NCT00653731|snoezelen|snoezelen
1532265|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
1532266|NCT00653731|10-minutes activation|10-minutes activation
1532267|NCT00653731|apathy|apathy
1532268|NCT00653718|Pain|pain
1532269|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
1532270|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
1532271|NCT00653705|Probiotics|probiotics
1532272|NCT00653705|Children|children
1532273|NCT00653705|Child Care Center|child care center
1532274|NCT00653705|Nutrition|nutrition
1532275|NCT00653705|Health promotion|health promotion
1532276|NCT00653692|Substance abuse|substance abuse
1532277|NCT00653692|fetal development|fetal development
1532278|NCT00653692|vagal tone|vagal tone
1532279|NCT00653679|exercise|exercise
1532280|NCT00653679|muscle protein signalling|muscle protein signalling
1532281|NCT00653679|protein synthesis|protein synthesis
1532282|NCT00653666|CPT1A|cpt1a
1532283|NCT00653666|steatosis|steatosis
1532284|NCT00653666|deficiency|deficiency
1532285|NCT00653666|metabolic|metabolic
1532286|NCT00653666|response|response
1532287|NCT00653666|fasting|fasting
1532288|NCT00653653|pharmacogenetics|pharmacogenetics
1532289|NCT00653653|pharmacoeconomics|pharmacoeconomics
1532290|NCT00653653|adverse events|adverse events
1532291|NCT00653653|drug metabolism|drug metabolism
1532292|NCT00653640|rehabilitation|rehabilitation
1532293|NCT00653640|head injury|head injury
1532294|NCT00653640|3 months post injury|3 months post injury
1532295|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
1532296|NCT00653640|very slow walking speed|very slow walking speed
1532297|NCT00653640|able to follow two step commands|able to follow two step commands
1532298|NCT00653614|Oral contraception|oral contraception
1532299|NCT00653601|GPI|gpi
1532300|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
1532301|NCT00653601|Aggrastat|aggrastat
1532302|NCT00653601|Tirofiban|tirofiban
1532303|NCT00653601|Verify now|verify now
1532304|NCT00653601|platelet function testing|platelet function testing
1532305|NCT00653601|bridge therapy|bridge therapy
1532306|NCT00653588|Cholesterol|cholesterol
1532307|NCT00653588|low density lipoproteins|low density lipoproteins
1532308|NCT00653588|Hypercholesterolemia|hypercholesterolemia
1532309|NCT00653588|Coronary Heart Disease|coronary heart disease
1532310|NCT00653588|Rosuvastatin|rosuvastatin
1532311|NCT00653588|Crestor|crestor
1532312|NCT00653588|Atorvastatin|atorvastatin
1532313|NCT00653588|Lipitor|lipitor
1532314|NCT00653575|Sexual Behavior|sexual behavior
1532315|NCT00653575|HIV|hiv
1532316|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
1532317|NCT00653562|polysomnography|polysomnography
1532318|NCT00653562|zolpidem|zolpidem
1532319|NCT00653562|Sleep disorders|sleep disorders
1532320|NCT00653562|adolescent|adolescent
1532321|NCT00653549|Bioequivalence|bioequivalence
1532322|NCT00653549|Torsemide Tablets|torsemide tablets
1532323|NCT00653549|fasting|fasting
1532324|NCT00653536|stroke|stroke
1532325|NCT00653536|neuroflo|neuroflo
1532326|NCT00653536|device|device
1532327|NCT00653536|failure to recanalize|failure to recanalize
1532328|NCT00653510|Type 2 diabetes|type 2 diabetes
1532329|NCT00653510|Dysregulation|dysregulation
1532330|NCT00653510|Metabolism|metabolism
1532331|NCT00653510|Cardiac output|cardiac output
1532332|NCT00653497|Osteoarthritis|osteoarthritis
1532333|NCT00653484|colon cancer|colon cancer
1532334|NCT00653484|rectal cancer|rectal cancer
1532335|NCT00653484|obesity|obesity
1532339|NCT00653471|general anesthesia|general anesthesia
1532340|NCT00653458|bioequivalence|bioequivalence
1532341|NCT00653458|Ondansetron ODT|ondansetron odt
1532342|NCT00653458|fed|fed
1532343|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
1532344|NCT00653445|Low density lipoproteins|low density lipoproteins
1532345|NCT00653445|Hypercholesterolemia|hypercholesterolemia
1532346|NCT00653445|Coronary Heart Disease|coronary heart disease
1532347|NCT00653445|Rosuvastatin|rosuvastatin
1532348|NCT00653445|Crestor|crestor
1532349|NCT00653445|Ezetimibe|ezetimibe
1532350|NCT00653432|Treatment|treatment
1532351|NCT00653432|Osteoarthritis|osteoarthritis
1532352|NCT00653419|bioequivalence|bioequivalence
1532353|NCT00653419|buspirone HCl|buspirone hcl
1532354|NCT00653419|fasting|fasting
1532355|NCT00653406|Schizophrenia|schizophrenia
1532356|NCT00653406|Risperidone|risperidone
1532357|NCT00653406|Intramuscular injection|intramuscular injection
1532358|NCT00653406|Pharmacokinetics|pharmacokinetics
1532359|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
1532360|NCT00653380|bioequivalence|bioequivalence
1532361|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
1532362|NCT00653380|fasting|fasting
1532363|NCT00653367|Thoracotomy|thoracotomy
1532364|NCT00653367|Nerve section|nerve section
1532365|NCT00653367|QST|qst
1532366|NCT00653367|Quantitative Sensory Test|quantitative sensory test
1532367|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
1532368|NCT00653367|Chest|chest
1532369|NCT00653367|Wall|wall
1532370|NCT00653367|Surgical|surgical
1532371|NCT00653367|Incision|incision
1532372|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
1532373|NCT00653354|hallux valgus|hallux valgus
1532374|NCT00653341|insulin naive|insulin naive
1532375|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1532376|NCT00653328|fallopian tube cancer|fallopian tube cancer
1532377|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
1532378|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
1532379|NCT00653263|methamphetamine|methamphetamine
1532380|NCT00653263|drug abuse|drug abuse
1532381|NCT00653263|withdrawal|withdrawal
1532382|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1532383|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1532384|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1532385|NCT00653224|levocetirizine|levocetirizine
1532386|NCT00653224|Xyzal|xyzal
1532387|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1532388|NCT00653224|total symptom score|total symptom score
1532389|NCT00653224|quality of life|quality of life
1532390|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
1532391|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
1532392|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
1532393|NCT00653185|Type II Diabetes|type ii diabetes
1532394|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1532395|NCT00653185|Dyslipidemia|dyslipidemia
1532396|NCT00653185|Hyperglycemia|hyperglycemia
1532397|NCT00653172|CAP|cap
1532398|NCT00653172|community acquired pneumonia|community acquired pneumonia
1532399|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
1532400|NCT00653146|cervical cancer|cervical cancer
1532401|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1532402|NCT00653146|human papilloma virus infection|human papilloma virus infection
1532403|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1532404|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1532405|NCT00653133|ultrasonography|ultrasonography
1532406|NCT00653133|peripheral nerve block|peripheral nerve block
1532407|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
1532408|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
1532409|NCT00653107|Palliation|palliation
1532410|NCT00653107|Cancer oesophagus|cancer oesophagus
1532411|NCT00653107|Stent|stent
1532412|NCT00653107|Brachytherapy|brachytherapy
1532413|NCT00653107|Randomized|randomized
1532414|NCT00653094|crohn|crohn
1532415|NCT00653094|fistula|fistula
1532416|NCT00653094|surgery|surgery
1532417|NCT00653094|fibrin glue|fibrin glue
1532418|NCT00653094|seton drainage|seton drainage
1532419|NCT00653081|Shoulder pain|shoulder pain
1532420|NCT00653081|Supervised Exercises|supervised exercises
1532421|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
1532422|NCT00653055|Bioequivalence|bioequivalence
1532423|NCT00653055|Cabergoline|cabergoline
1532424|NCT00653055|Fasting|fasting
1532425|NCT00653042|Myocardial Ischemia|myocardial ischemia
1532426|NCT00653042|kidney failure|kidney failure
1532427|NCT00653042|CABG|cabg
1532428|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
1532429|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1532430|NCT00653042|heart surgery|heart surgery
1532431|NCT00653042|nesiritide|nesiritide
1532432|NCT00653042|Coronary Heart Disease|coronary heart disease
1532433|NCT00653029|Post concussion syndrome|post concussion syndrome
1532434|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
1532435|NCT00653029|Effort|effort
1532436|NCT00653029|fmri|fmri
1532437|NCT00653016|Contraception|contraception
1532438|NCT00653016|norelgestromin|norelgestromin
1532439|NCT00653016|ethinyl estradiol|ethinyl estradiol
1532440|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
1532441|NCT00653016|EVRA|evra
1532442|NCT00653016|ORTHO EVRA|ortho evra
1532443|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
1532444|NCT00652977|sphincter tears|sphincter tears
1532445|NCT00652977|Ritgen maneuver|ritgen maneuver
1532446|NCT00652977|perineal tears|perineal tears
1532447|NCT00652977|prevention|prevention
1532448|NCT00652977|delivery|delivery
1532449|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
1532450|NCT00652938|Co-administration|co-administration
1532451|NCT00652938|HPV vaccine|hpv vaccine
1532452|NCT00652938|Cervical cancer|cervical cancer
1532453|NCT00652925|arthritis|arthritis
1532454|NCT00652925|juvenile|juvenile
1532455|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
1532456|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1532457|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1532458|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1532459|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1532460|NCT00652899|fallopian tube cancer|fallopian tube cancer
1532461|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
1532462|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
1532463|NCT00652873|Bioequivalence|bioequivalence
1532464|NCT00652873|Cabergoline|cabergoline
1532465|NCT00652873|Fed|fed
1532466|NCT00652860|lung metastases|lung metastases
1532467|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1532468|NCT00652834|Renal transplant recipients|renal transplant recipients
1532469|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
1532470|NCT00652834|Mycophenolic acid|mycophenolic acid
1532471|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
1532472|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
1532473|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
1532474|NCT00652808|knee, OA patients|knee, oa patients
1532475|NCT00652795|bioequivalence|bioequivalence
1532476|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
1532477|NCT00652795|fasting|fasting
1532478|NCT00652769|Lung|lung
1532479|NCT00652769|Cancer|cancer
1532480|NCT00652769|Staging|staging
1532481|NCT00652769|Endobronchial|endobronchial
1532482|NCT00652769|Ultrasound|ultrasound
1532483|NCT00652769|Endoscopic|endoscopic
1532484|NCT00652756|Respiration, Artificial|respiration, artificial
1532485|NCT00652756|Transportation of Patients|transportation of patients
1532486|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
1532487|NCT00652756|Tracheostomy|tracheostomy
1532488|NCT00652743|immunogenicity|immunogenicity
1532489|NCT00652743|safety|safety
1532490|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
1532491|NCT00652730|bioequivalence|bioequivalence
1532492|NCT00652730|buspirone HCl|buspirone hcl
1532493|NCT00652730|fed|fed
1532494|NCT00652704|Bioequivalence|bioequivalence
1532495|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
1532496|NCT00652704|Fed|fed
1532497|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
1532498|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
1532499|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1532500|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1532501|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1532502|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1532503|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1532504|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1532505|NCT00652678|Breast cancer|breast cancer
1532506|NCT00652678|Radiation effects|radiation effects
1532507|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
1532508|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
1532509|NCT00652652|Heart Failure|heart failure
1532510|NCT00652652|Chronic Heart Failure|chronic heart failure
1532511|NCT00652652|Dyspnea|dyspnea
1532512|NCT00652652|nesiritide|nesiritide
1532513|NCT00652652|Natrecor|natrecor
1532514|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
1532515|NCT00652626|MDS|mds
1532516|NCT00652626|AML|aml
1532517|NCT00652626|Solid Tumors|solid tumors
1532518|NCT00652626|Azacitidine|azacitidine
1532519|NCT00652626|PK|pk
1532520|NCT00652626|Pharmacokinetics|pharmacokinetics
1532521|NCT00652626|Renal Impairment|renal impairment
1532522|NCT00652626|Multiple Myeloma|multiple myeloma
1532523|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1532524|NCT00652626|Hodgkin's Disease|hodgkin's disease
1532525|NCT00652613|3DCRT|3dcrt
1532526|NCT00652613|IMRT|imrt
1532527|NCT00652613|HNSCC|hnscc
1532528|NCT00652613|Quality of life|quality of life
1532529|NCT00652613|Major salivary gland sparing|major salivary gland sparing
1532530|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
1532531|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
1532532|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
1532533|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
1532534|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
1532535|NCT00652587|hepatectomy|hepatectomy
1532536|NCT00652587|chemoembolization|chemoembolization
1532537|NCT00652587|randomized controlled trial|randomized controlled trial
1532538|NCT00652587|prognosis|prognosis
1532539|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1532540|NCT00652574|Dasatinib|dasatinib
1532541|NCT00652574|BMS-354825|bms-354825
1532542|NCT00652574|Sprycel|sprycel
1532543|NCT00652574|MPM|mpm
1532544|NCT00652548|Clavicle|clavicle
1532545|NCT00652548|Fracture|fracture
1532546|NCT00652548|Ultrasound|ultrasound
1532547|NCT00652548|Radiation|radiation
1532548|NCT00652522|AF ablation|af ablation
1532549|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
1532550|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
1532551|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
1532552|NCT00652522|persistent AF|persistent af
1532553|NCT00652470|infants|infants
1532554|NCT00652470|Hydrocephalus|hydrocephalus
1532555|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
1532556|NCT00652470|Ventriculostomy|ventriculostomy
1532557|NCT00652470|neurosurgery|neurosurgery
1532558|NCT00652418|Magnevist|magnevist
1532559|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
1532560|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
1532561|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
1532562|NCT00652405|cephalic phase reflex|cephalic phase reflex
1532563|NCT00652405|gene expression|gene expression
1532564|NCT00652405|inflammation|inflammation
1532565|NCT00652405|adiponectin|adiponectin
1532566|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
1532567|NCT00652392|asthma|asthma
1532568|NCT00652392|adolescents|adolescents
1532569|NCT00652392|adults|adults
1532570|NCT00652392|Symbicort|symbicort
1532571|NCT00652392|budesonide/formoterol|budesonide/formoterol
1532572|NCT00652392|budesonide|budesonide
1532573|NCT00652379|Acromegaly|acromegaly
1532574|NCT00652379|Insulin sensitivity|insulin sensitivity
1532575|NCT00652379|Glucose tolerance|glucose tolerance
1532576|NCT00652379|Body composition|body composition
1532577|NCT00652379|Growth Hormone|growth hormone
1532578|NCT00652353|Clinical decision rule|clinical decision rule
1532579|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
1532580|NCT00652353|Ottawa Foot Rule|ottawa foot rule
1532581|NCT00652353|Ankle|ankle
1532582|NCT00652353|Trauma|trauma
1532583|NCT00652353|Education|education
1532584|NCT00652353|Foot Trauma|foot trauma
1532585|NCT00652314|Hemostatic products|hemostatic products
1532586|NCT00652314|Surgical hemostasis|surgical hemostasis
1532587|NCT00652314|Thrombi-gel|thrombi-gel
1532588|NCT00652314|Gelatin Sponge|gelatin sponge
1532589|NCT00652314|Time to hemostasis|time to hemostasis
1532590|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
1532591|NCT00652275|Malaria|malaria
1532592|NCT00652275|vaccine|vaccine
1532593|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
1532594|NCT00652275|Mali|mali
1532595|NCT00652275|Children|children
1532596|NCT00652262|Vardenafil|vardenafil
1532597|NCT00652262|PDE5 inhibitor|pde5 inhibitor
1532598|NCT00652262|Erectile dysfunction|erectile dysfunction
1532599|NCT00652262|Spinal cord injury|spinal cord injury
1532600|NCT00652249|Hydrocephalus|hydrocephalus
1532601|NCT00652249|shunt dysfunction|shunt dysfunction
1532602|NCT00652249|shunt flow|shunt flow
1532603|NCT00652236|Low back pain|low back pain
1532604|NCT00652236|Economics|economics
1532605|NCT00652236|Cost-effectiveness|cost-effectiveness
1532606|NCT00652210|Bladder cancer|bladder cancer
1532607|NCT00652210|prostate cancer|prostate cancer
1532608|NCT00652210|multiphoton microscopy|multiphoton microscopy
1532609|NCT00652197|Hydrocephalus|hydrocephalus
1532610|NCT00652197|shunt dysfunction|shunt dysfunction
1532611|NCT00652197|shunt flow|shunt flow
1532612|NCT00652184|antiviral|antiviral
1532613|NCT00652184|herpes zoster|herpes zoster
1532614|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
1532615|NCT00652184|varicella zoster virus|varicella zoster virus
1532616|NCT00652184|shingles|shingles
1532617|NCT00652171|Treatment|treatment
1532618|NCT00652171|Augmentation|augmentation
1532619|NCT00652171|Resistant depression|resistant depression
1532620|NCT00652171|Lamotrigine|lamotrigine
1532621|NCT00652145|ulcerative colitis|ulcerative colitis
1532622|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
1532623|NCT00652132|ototoxicity|ototoxicity
1532624|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
1532625|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
1532730|NCT00651755|Aprepitant|aprepitant
1532626|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
1532627|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
1532628|NCT00652119|Ovarian Cancer|ovarian cancer
1532629|NCT00652119|Peritoneal Cancer|peritoneal cancer
1532630|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
1532631|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
1532632|NCT00652119|Paclitaxel|paclitaxel
1532633|NCT00652119|Taxol|taxol
1532634|NCT00652119|Carboplatin|carboplatin
1532635|NCT00652119|Paraplatin®|paraplatin®
1532636|NCT00652119|Avastin|avastin
1532637|NCT00652119|Bevacizumab|bevacizumab
1532638|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1532639|NCT00652119|rhuMAb-VEGF|rhumab-vegf
1532640|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
1532641|NCT00652041|Multiple Myeloma|multiple myeloma
1532642|NCT00652041|Relapsed|relapsed
1532643|NCT00652041|Refractary|refractary
1532644|NCT00652028|Pharmacokinetics|pharmacokinetics
1532645|NCT00652028|Pharmacodynamics|pharmacodynamics
1532646|NCT00652028|Escalating dose|escalating dose
1532647|NCT00652028|Dexmedotimidine|dexmedotimidine
1532648|NCT00652028|Intubated|intubated
1532649|NCT00652028|Mechanically ventilated|mechanically ventilated
1532650|NCT00652028|Pediatrics|pediatrics
1532651|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
1532652|NCT00652015|CD39|cd39
1532653|NCT00652015|CD73|cd73
1532655|NCT00652002|Asthma|asthma
1532656|NCT00652002|Symbicort|symbicort
1532657|NCT00652002|budesonide/formoterol|budesonide/formoterol
1532658|NCT00652002|budesonide|budesonide
1532659|NCT00652002|formoterol|formoterol
1532660|NCT00651989|optical coherence tomography|optical coherence tomography
1532661|NCT00651989|spectral domain|spectral domain
1532662|NCT00651989|time domain|time domain
1532663|NCT00651976|stage IA breast cancer|stage ia breast cancer
1532664|NCT00651976|stage IB breast cancer|stage ib breast cancer
1532665|NCT00651976|stage II breast cancer|stage ii breast cancer
1532666|NCT00651976|stage III breast cancer|stage iii breast cancer
1532667|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
1532668|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1532669|NCT00651950|Hydrocephalus|hydrocephalus
1532670|NCT00651950|shunt dysfunction|shunt dysfunction
1532671|NCT00651950|shunt flow|shunt flow
1532672|NCT00651937|Multiple Myeloma|multiple myeloma
1532673|NCT00651937|Primary Amyloidosis|primary amyloidosis
1532674|NCT00651937|Cytokine Modulation|cytokine modulation
1532675|NCT00651937|Melphalan|melphalan
1532676|NCT00651937|Alkeran|alkeran
1532677|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
1532678|NCT00651937|Stem Cell Infusion|stem cell infusion
1532679|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
1532680|NCT00651937|ASCT|asct
1532681|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
1532682|NCT00651937|G-CSF|g-csf
1532683|NCT00651937|Apheresis|apheresis
1532684|NCT00651924|chronic pain|chronic pain
1532685|NCT00651924|IVR|ivr
1532686|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
1532687|NCT00651898|abdominal surgery|abdominal surgery
1532688|NCT00651898|hypothermia|hypothermia
1532689|NCT00651898|circulating water mattress|circulating water mattress
1532690|NCT00651885|UT-15C|ut-15c
1532691|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
1532692|NCT00651885|Treprostinil|treprostinil
1532693|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
1532694|NCT00651872|Functional Impairment|functional impairment
1532695|NCT00651872|Veterans|veterans
1532696|NCT00651872|Military Personnel|military personnel
1532697|NCT00651846|Contraception|contraception
1532698|NCT00651846|Hemostasis|hemostasis
1532699|NCT00651846|Blood Coagulation|blood coagulation
1532700|NCT00651820|wound healing|wound healing
1532701|NCT00651820|scarring|scarring
1532702|NCT00651820|collagenase|collagenase
1532703|NCT00651820|Santyl|santyl
1532704|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
1532705|NCT00651794|Patient Care Team|patient care team
1532706|NCT00651794|Medical Errors|medical errors
1532707|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
1532708|NCT00651781|Relapsed|relapsed
1532709|NCT00651781|Refractory|refractory
1532710|NCT00651768|asthma|asthma
1532711|NCT00651768|adults|adults
1532712|NCT00651768|adolescents|adolescents
1532713|NCT00651768|safety|safety
1532714|NCT00651768|Symbicort|symbicort
1532715|NCT00651768|budesonide/formoterol|budesonide/formoterol
1532716|NCT00651768|budesonide|budesonide
1532717|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1532718|NCT00651755|Lymphoma|lymphoma
1532719|NCT00651755|Nausea|nausea
1532720|NCT00651755|Cyclophosphamide|cyclophosphamide
1532721|NCT00651755|Cytoxan|cytoxan
1532722|NCT00651755|Neosar|neosar
1532723|NCT00651755|Doxorubicin|doxorubicin
1532724|NCT00651755|AD|ad
1532725|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1532726|NCT00651755|Vincristine|vincristine
1532727|NCT00651755|Prednisone|prednisone
1532728|NCT00651755|Rituximab|rituximab
1532729|NCT00651755|Rituxan|rituxan
1532731|NCT00651755|Emend|emend
1532732|NCT00651755|L754030|l754030
1532733|NCT00651755|MK869|mk869
1532734|NCT00651755|Drug Metabolism|drug metabolism
1532735|NCT00651755|CHOP|chop
1532736|NCT00651755|R-CHOP|r-chop
1532737|NCT00651755|NHL|nhl
1532738|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1532739|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1532740|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1532741|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1532742|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1532743|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1532744|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1532745|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1532746|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1532747|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1532748|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1532749|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1532750|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1532751|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1532752|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1532753|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1532754|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1532755|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1532756|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1532757|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1532758|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1532759|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1532760|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1532761|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1532762|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1532763|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1532764|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1532765|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1532766|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1532767|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1532768|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1532769|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1532770|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1532771|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1532772|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1532773|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1532774|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1532775|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1532776|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1532777|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1532778|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1532779|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1532780|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1532781|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1532782|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1532783|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1532784|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1532785|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1532786|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1532787|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1532788|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1532789|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1532790|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1532791|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1532792|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1532793|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1532794|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1532795|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1532796|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1532797|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1532798|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1532799|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1532800|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1532801|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1532802|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1532803|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1532804|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1532805|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1532806|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1532807|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1532808|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1532809|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
1532810|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1532811|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1532812|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1532813|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1532814|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1532815|NCT00651716|primary myelofibrosis|primary myelofibrosis
1532816|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1532817|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1532818|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
1532819|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1532820|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1532821|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1532822|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
1532823|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1532824|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1532825|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1532826|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1532827|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
1532828|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
1532829|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
1532830|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1532831|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1532832|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1532833|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1532834|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
1532835|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
1532836|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
1532837|NCT00651716|stage IV breast cancer|stage iv breast cancer
1532838|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
1532839|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
1532840|NCT00651677|rectal cancer|rectal cancer
1532841|NCT00651677|short term outcomes|short term outcomes
1532842|NCT00651677|straight laparoscopy|straight laparoscopy
1532844|NCT00651651|Symbicort|symbicort
1532845|NCT00651651|budesonide/formoterol|budesonide/formoterol
1532846|NCT00651651|budesonide|budesonide
1532847|NCT00651651|formoterol|formoterol
1532848|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
1532849|NCT00651625|arthrocentesis|arthrocentesis
1532850|NCT00651625|injections|injections
1532851|NCT00651625|anesthesia|anesthesia
1532852|NCT00651625|biopsy|biopsy
1532853|NCT00651625|aspiration|aspiration
1532854|NCT00651625|syringe|syringe
1532855|NCT00651625|safety|safety
1532856|NCT00651625|pain|pain
1532857|NCT00651599|Vasomotor symptoms|vasomotor symptoms
1532858|NCT00651599|Vasomotor System|vasomotor system
1532859|NCT00651573|Surgery|surgery
1532860|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
1532861|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
1532862|NCT00651573|Valve procedure|valve procedure
1532863|NCT00651573|Hematocrit level|hematocrit level
1532864|NCT00651573|Outcomes|outcomes
1532865|NCT00651547|Asthma|asthma
1532866|NCT00651547|Symbicort|symbicort
1532867|NCT00651547|budesonide/formoterol|budesonide/formoterol
1532868|NCT00651547|budesonide|budesonide
1532869|NCT00651547|formoterol|formoterol
1532870|NCT00651547|children|children
1532871|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
1532872|NCT00651521|Angiographic CAD|angiographic cad
1532873|NCT00651521|Chronic kidney disease|chronic kidney disease
1532874|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
1532875|NCT00651521|Body mass index|body mass index
1532876|NCT00651521|Cardiovascular mortality|cardiovascular mortality
1532877|NCT00651521|Coronary angiography|coronary angiography
1532878|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
1532879|NCT00651495|Decision aids|decision aids
1532880|NCT00651495|Seniors|seniors
1532881|NCT00651495|Chronic disease management|chronic disease management
1532882|NCT00651495|Advance directives|advance directives
1532883|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
1532884|NCT00651469|Acne|acne
1532885|NCT00651443|galiximab|galiximab
1532886|NCT00651443|Untreated NHL|untreated nhl
1532887|NCT00651443|antibody|antibody
1532888|NCT00651443|open-label|open-label
1532889|NCT00651430|Balance|balance
1532890|NCT00651430|Voluntary stepping|voluntary stepping
1532891|NCT00651430|function|function
1532892|NCT00651430|disability|disability
1532893|NCT00651430|fear of falls|fear of falls
1532894|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
1532895|NCT00651417|Organic germanium|organic germanium
1532896|NCT00651417|fatigue|fatigue
1532897|NCT00651417|radiation therapy|radiation therapy
1532898|NCT00651417|breast cancer|breast cancer
1532899|NCT00651417|prostate cancer|prostate cancer
1532900|NCT00651365|Advanced solid tumors|advanced solid tumors
1532901|NCT00651365|Refractory solid tumor|refractory solid tumor
1532902|NCT00651365|Antineoplastic protocol|antineoplastic protocol
1532903|NCT00651365|Drug therapy|drug therapy
1532904|NCT00651365|Pharmacokinetics|pharmacokinetics
1532905|NCT00651365|Met inhibitor|met inhibitor
1532906|NCT00651352|NRT|nrt
1532907|NCT00651352|Bioequivalence|bioequivalence
1532908|NCT00651352|Nicotine|nicotine
1532909|NCT00651339|Cerebral Palsy|cerebral palsy
1532910|NCT00651339|Balance|balance
1532911|NCT00651339|Gait|gait
1532912|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1532913|NCT00651326|stage I prostate cancer|stage i prostate cancer
1532914|NCT00651326|stage II prostate cancer|stage ii prostate cancer
1532915|NCT00651326|stage III prostate cancer|stage iii prostate cancer
1532916|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
1532917|NCT00651313|Dysmenorrhea|dysmenorrhea
1532918|NCT00651313|Periods|periods
1532919|NCT00651313|Menstrual|menstrual
1532920|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
1532921|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
1532922|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1532923|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1532924|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1532925|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1532926|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1532927|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1532928|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1532929|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1532930|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1532931|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1532932|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1532933|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1532934|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1532935|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1532936|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1532937|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1532938|NCT00651248|Saliva|saliva
1532939|NCT00651248|Oral health|oral health
1532940|NCT00651248|Aged|aged
1532941|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
1532942|NCT00651209|Telbivudine|telbivudine
1532943|NCT00651209|Tenofovir|tenofovir
1532944|NCT00651209|Roadmap Concept|roadmap concept
1532945|NCT00651196|Type 1 diabetes|type 1 diabetes
1532946|NCT00651196|bone|bone
1694759|NCT00068068|Litx™|litx™
1532947|NCT00651170|Median block nerve|median block nerve
1532948|NCT00651170|Ultrasound|ultrasound
1532949|NCT00651131|post-surgical|post-surgical
1532950|NCT00651131|wound infection|wound infection
1532951|NCT00651131|superficial|superficial
1532952|NCT00651131|deep|deep
1532953|NCT00651131|surgical|surgical
1532954|NCT00651105|Diabetes|diabetes
1532955|NCT00651105|Hyperglycemia|hyperglycemia
1532956|NCT00651105|Healthy|healthy
1532957|NCT00651105|Vildagliptin|vildagliptin
1532958|NCT00651105|Adults|adults
1532959|NCT00651092|turbinectomy|turbinectomy
1532960|NCT00651079|GSK1247303,|gsk1247303,
1532961|NCT00651079|Integrase,|integrase,
1532962|NCT00651079|First Time in Human|first time in human
1532963|NCT00651066|HIV|hiv
1532964|NCT00651066|Tuberculosis|tuberculosis
1532965|NCT00651066|Rifabutin|rifabutin
1532966|NCT00651066|Pharmacokinetics|pharmacokinetics
1532967|NCT00651066|Vietnam|vietnam
1532968|NCT00651040|Polymyositis|polymyositis
1532969|NCT00651040|Dermatomyositis|dermatomyositis
1532970|NCT00651040|Glucocorticoids|glucocorticoids
1532971|NCT00651040|Methotrexate|methotrexate
1532972|NCT00651001|fructose|fructose
1532973|NCT00651001|leptin|leptin
1532974|NCT00651001|metabolic syndrome|metabolic syndrome
1532975|NCT00651001|blood pressure|blood pressure
1532976|NCT00651001|inflammation|inflammation
1532977|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
1532978|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
1532979|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
1532980|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
1532981|NCT00650988|Barrett's Esophagus|barrett's esophagus
1532982|NCT00650988|Cryospray ablation|cryospray ablation
1532983|NCT00650988|High Grade Dysplasia|high grade dysplasia
1532984|NCT00650988|Early Esophageal Cancers|early esophageal cancers
1532985|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
1532986|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
1532987|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
1532988|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
1532989|NCT00650975|STEMI|stemi
1532990|NCT00650975|Laser|laser
1532991|NCT00650975|Thrombus|thrombus
1532992|NCT00650975|Thrombectomy|thrombectomy
1532993|NCT00650962|CPR|cpr
1532994|NCT00650962|Preshock CPR|preshock cpr
1532995|NCT00650962|OHCA|ohca
1532996|NCT00650962|EMS|ems
1532997|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
1532998|NCT00650949|Glioma|glioma
1532999|NCT00650949|Phase Ib/II|phase ib/ii
1533000|NCT00650949|CYT997|cyt997
1533001|NCT00650936|Atrial|atrial
1533002|NCT00650936|Septal|septal
1533003|NCT00650936|Defect|defect
1533004|NCT00650910|lapatinib|lapatinib
1533005|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
1533006|NCT00650910|digoxin|digoxin
1533007|NCT00650897|Efficacy|efficacy
1533008|NCT00650897|Antidepressant|antidepressant
1533009|NCT00650897|Escitalopram|escitalopram
1533010|NCT00650897|Major Depression|major depression
1533011|NCT00650897|Diabetes Mellitus|diabetes mellitus
1533012|NCT00650897|Self Care|self care
1533013|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
1533014|NCT00650871|sleep,|sleep,
1533015|NCT00650871|polysomnography.|polysomnography.
1533016|NCT00650871|GW679769,|gw679769,
1533017|NCT00650871|primary insomnia,|primary insomnia,
1533018|NCT00650871|cognitive function,|cognitive function,
1533019|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
1533020|NCT00650858|rt-PA|rt-pa
1533021|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
1533022|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
1533023|NCT00650806|Obesity|obesity
1533024|NCT00650806|Overweight|overweight
1533025|NCT00650806|Weight loss|weight loss
1533026|NCT00650806|Anti-Obesity Agents|anti-obesity agents
1533027|NCT00650806|Human|human
1533028|NCT00650793|Schizophrenia|schizophrenia
1533029|NCT00650793|paliperidone|paliperidone
1533030|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
1533031|NCT00650754|DHEA|dhea
1533032|NCT00650754|Pregnancy|pregnancy
1533033|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
1533034|NCT00650741|FMD|fmd
1533035|NCT00650728|radiofrequency ablation|radiofrequency ablation
1533036|NCT00650715|Fibromyalgia|fibromyalgia
1533037|NCT00650715|Whole-Body vibration|whole-body vibration
1533038|NCT00650715|Exercise|exercise
1533039|NCT00650715|IGF-1|igf-1
1533040|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
1533041|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
1533042|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
1533043|NCT00650585|smoking|smoking
1533044|NCT00650585|alcohol|alcohol
1533045|NCT00650585|prevention|prevention
1533046|NCT00650585|prevention & control|prevention & control
1533047|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
1533048|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
1533049|NCT00650572|EGFR|egfr
1533050|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
1533051|NCT00650559|COPD|copd
1533052|NCT00650559|Emphysema|emphysema
1533053|NCT00650559|thorax enlargement|thorax enlargement
1533054|NCT00650559|LVRS|lvrs
1533055|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1533056|NCT00650546|NASH|nash
1533057|NCT00650507|children|children
1533058|NCT00650507|cardiac surgery|cardiac surgery
1533059|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
1533060|NCT00650507|SHAM|sham
1533061|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
1533062|NCT00650468|Renal Transplantation|renal transplantation
1533063|NCT00650468|Prograf|prograf
1533064|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
1533065|NCT00650260|intraoperative warming|intraoperative warming
1533066|NCT00650260|anesthesia|anesthesia
1533067|NCT00650260|hypothermia|hypothermia
1533068|NCT00650260|body temperature|body temperature
1533069|NCT00650182|patch|patch
1533070|NCT00650182|fentanyl|fentanyl
1533071|NCT00650182|chronic pain|chronic pain
1533072|NCT00650143|Stem cell|stem cell
1533073|NCT00650143|Myocardial infarction|myocardial infarction
1533074|NCT00650143|G-CSF|g-csf
1533075|NCT00650143|CD26-inhibition|cd26-inhibition
1533076|NCT00650130|driving under the influence|driving under the influence
1533077|NCT00650130|psychoactive substances|psychoactive substances
1533078|NCT00650130|oral fluid|oral fluid
1533079|NCT00650130|whole blood|whole blood
1533080|NCT00650130|plasma|plasma
1533081|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
1533082|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
1533083|NCT00650104|ropinirole IR|ropinirole ir
1533084|NCT00650104|efficacy|efficacy
1533085|NCT00650104|safety|safety
1533086|NCT00650104|open-label|open-label
1533087|NCT00650104|long term safety; REQUIP|long term safety; requip
1533088|NCT00650104|ropinirole XL|ropinirole xl
1533089|NCT00650104|ropinirole CR|ropinirole cr
1533090|NCT00650104|Parkinson's disease|parkinson's disease
1533091|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1533092|NCT00650091|Prednisone|prednisone
1533093|NCT00650091|Azathioprine|azathioprine
1533094|NCT00650091|NAC|nac
1533095|NCT00650091|N-acetylcysteine|n-acetylcysteine
1533096|NCT00650078|Signs and Symptoms|signs and symptoms
1533097|NCT00650078|Autoimmune Diseases|autoimmune diseases
1533098|NCT00650078|Joint Diseases|joint diseases
1533099|NCT00650078|Arthritis|arthritis
1533100|NCT00650078|Connective Tissue Diseases|connective tissue diseases
1533101|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
1533102|NCT00650078|Rheumatic Diseases|rheumatic diseases
1533103|NCT00650078|Predniso(lo)ne|predniso(lo)ne
1533104|NCT00650039|Post surgical pain|post surgical pain
1533105|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1533106|NCT00650039|Arthroscopy|arthroscopy
1533107|NCT00650039|Perioperative pain|perioperative pain
1533108|NCT00649961|Premature Birth|premature birth
1533109|NCT00649961|Brain injury|brain injury
1533110|NCT00649961|Neuroprotection|neuroprotection
1533111|NCT00649961|Melatonin|melatonin
1533112|NCT00649961|Pharmacokinetics|pharmacokinetics
1533113|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
1533114|NCT00649909|Diabetes Mellitus|diabetes mellitus
1533115|NCT00649909|Type II|type ii
1533116|NCT00649909|Aspirin|aspirin
1533117|NCT00649909|Resistance|resistance
1533118|NCT00649883|Influenza|influenza
1533119|NCT00649883|vaccine|vaccine
1533120|NCT00649883|children|children
1533121|NCT00649792|multiple sclerosis|multiple sclerosis
1533122|NCT00649792|MS|ms
1533123|NCT00649792|walking|walking
1533124|NCT00649792|leg strength|leg strength
1533125|NCT00649792|demyelination|demyelination
1533126|NCT00649766|tailored health messages|tailored health messages
1533127|NCT00649766|glaucoma|glaucoma
1533128|NCT00649766|diabetic retinopathy|diabetic retinopathy
1533129|NCT00649766|dilated fundus exams|dilated fundus exams
1533130|NCT00649766|health behavior|health behavior
1533131|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
1533132|NCT00649753|algometer|algometer
1533133|NCT00649753|Chiropractic|chiropractic
1533134|NCT00649753|Manual Therapy|manual therapy
1533135|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
1533137|NCT00649701|Internet|internet
1533138|NCT00649701|MSM|msm
1533139|NCT00649701|Condom Use|condom use
1533140|NCT00649701|Disclosure|disclosure
1533141|NCT00649610|acute low back pain|acute low back pain
1533142|NCT00649584|Antigens, CD30|antigens, cd30
1533143|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
1533144|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
1533145|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
1533146|NCT00649584|Combined Modality Therapy|combined modality therapy
1533147|NCT00649584|Drug Therapy|drug therapy
1533148|NCT00649584|Immunotherapy|immunotherapy
1533149|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1533150|NCT00649584|Disease, Hodgkin|disease, hodgkin
1533151|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1533152|NCT00649584|Hematologic Diseases|hematologic diseases
1533153|NCT00649584|Lymphoma|lymphoma
1533154|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
1533155|NCT00649337|mammography|mammography
1533156|NCT00649337|ultrasound|ultrasound
1533157|NCT00649337|breast cancer|breast cancer
1533158|NCT00649337|screening|screening
1533159|NCT00649298|Randomized Controlled Trial|randomized controlled trial
1533160|NCT00649298|Clinical Trial|clinical trial
1533161|NCT00649298|Controlled Clinical Trial|controlled clinical trial
1533162|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
1533163|NCT00649298|Multicenter Study|multicenter study
1533164|NCT00649298|End Stage Kidney Disease|end stage kidney disease
1533165|NCT00649298|Hemodialysis|hemodialysis
1533166|NCT00649298|Renal Dialysis|renal dialysis
1533167|NCT00649298|Renal Replacement Therapy|renal replacement therapy
1533168|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
1533169|NCT00649298|Extended dialysis|extended dialysis
1533170|NCT00649298|Quality of Life|quality of life
1533171|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
1533172|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
1533173|NCT00649298|Blood Pressure|blood pressure
1533174|NCT00649298|Hypertension|hypertension
1533175|NCT00649298|Anemia|anemia
1533176|NCT00649298|Hematinics|hematinics
1533177|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
1533178|NCT00649298|Cost-utility Analysis|cost-utility analysis
1533179|NCT00649298|Economic Evaluation|economic evaluation
1533180|NCT00649298|Health Care Utilisation|health care utilisation
1533181|NCT00649298|Health Care Costs|health care costs
1533182|NCT00649298|Health Expenditures|health expenditures
1533183|NCT00649298|Hospitalization|hospitalization
1533184|NCT00649298|Cost Analysis|cost analysis
1533185|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
1533186|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
1533187|NCT00649298|Myocardial Infarction|myocardial infarction
1533188|NCT00649298|Stroke|stroke
1533189|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
1533190|NCT00649298|Mortality|mortality
1533191|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
1533192|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
1533193|NCT00649298|Thrombosis|thrombosis
1533194|NCT00649298|Infection|infection
1533195|NCT00649246|genetics|genetics
1533196|NCT00649246|type 1 diabetes|type 1 diabetes
1533197|NCT00649246|biomarkers|biomarkers
1533198|NCT00649246|autoimmunity|autoimmunity
1533199|NCT00649207|WBRT|wbrt
1533200|NCT00649207|Brain Metastases|brain metastases
1533201|NCT00649207|Radiation|radiation
1533202|NCT00649207|ABT-888|abt-888
1533203|NCT00649207|PARP|parp
1533204|NCT00649142|Groin hernia|groin hernia
1533205|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
1533206|NCT00649142|open mesh repair|open mesh repair
1533207|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
1533208|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
1533209|NCT00649025|Asthma|asthma
1533210|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
1533211|NCT00648999|Kaletra|kaletra
1533212|NCT00648986|brittle nails|brittle nails
1533213|NCT00648986|Tazarotene|tazarotene
1533214|NCT00648986|Tazorac|tazorac
1533215|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
1533216|NCT00648908|multiple sclerosis|multiple sclerosis
1533217|NCT00648908|MS|ms
1533218|NCT00648908|walking|walking
1533219|NCT00648908|leg strength|leg strength
1533220|NCT00648908|demyelination|demyelination
1533221|NCT00648895|Hypertension|hypertension
1533222|NCT00648895|Blood pressure|blood pressure
1533223|NCT00648895|Nebivolol|nebivolol
1533224|NCT00648895|Bystolic (TM)|bystolic (tm)
1533225|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
1533226|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
1533227|NCT00648817|HIV-1|hiv-1
1533228|NCT00648817|tenofovir DF|tenofovir df
1533229|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1533230|NCT00648739|Leukemia|leukemia
1533231|NCT00648739|Multiple Myeloma|multiple myeloma
1533232|NCT00648739|CD200|cd200
1533233|NCT00648739|Anti-CD200|anti-cd200
1533234|NCT00648687|prematurity|prematurity
1533235|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
1533236|NCT00648687|pain|pain
1533237|NCT00648687|very low birth weight infants|very low birth weight infants
1533238|NCT00648635|Rectal Cancer|rectal cancer
1533239|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
1533240|NCT00648635|Quality of Life|quality of life
1533241|NCT00648635|QOL|qol
1533242|NCT00648635|Questionnaire|questionnaire
1533243|NCT00648635|Survey|survey
1533244|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
1533245|NCT00648479|Fracture Fixation|fracture fixation
1533528|NCT00646698|Tracers|tracers
1533246|NCT00648453|Fontain II-III stage|fontain ii-iii stage
1533247|NCT00648375|Propanolol|propanolol
1533248|NCT00648375|Beta Blockers|beta blockers
1533249|NCT00648375|Reconsolidation|reconsolidation
1533250|NCT00648375|Cognitive Therapy|cognitive therapy
1533251|NCT00648375|PTSD|ptsd
1533252|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
1533253|NCT00648284|Type 2 diabetes|type 2 diabetes
1533254|NCT00648284|CV risk|cv risk
1533255|NCT00648284|rosiglitazone|rosiglitazone
1533256|NCT00648284|AVANDIA|avandia
1533257|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
1533258|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
1533259|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1533260|NCT00648245|COPD|copd
1533261|NCT00648245|Chronic bronchitis|chronic bronchitis
1533262|NCT00648232|HIV|hiv
1533263|NCT00648232|AIDS|aids
1533264|NCT00648232|Prevention|prevention
1533265|NCT00648232|VCT|vct
1533266|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
1533267|NCT00648206|driving under the influence|driving under the influence
1533268|NCT00648206|psychoactive substances|psychoactive substances
1533269|NCT00648206|blood samples|blood samples
1533270|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
1533271|NCT00648167|ESRD|esrd
1533272|NCT00648167|end-stage renal disease|end-stage renal disease
1533273|NCT00648167|end stage renal disease|end stage renal disease
1533274|NCT00648167|hemodialysis|hemodialysis
1533275|NCT00648167|dialysis|dialysis
1533276|NCT00648167|kidney failure|kidney failure
1533277|NCT00648167|renal failure|renal failure
1533278|NCT00648167|kidney|kidney
1533279|NCT00648167|renal|renal
1533280|NCT00648167|phosphate binder|phosphate binder
1533281|NCT00648167|phosphorus|phosphorus
1533282|NCT00648115|Veterans|veterans
1533283|NCT00648115|Substance-Related Disorders|substance-related disorders
1533284|NCT00648115|Mental Health|mental health
1533285|NCT00648102|Breast cancer|breast cancer
1533286|NCT00648102|Colorectal cancer|colorectal cancer
1533287|NCT00648102|Pancreatic cancer|pancreatic cancer
1533288|NCT00648102|Bladder cancer|bladder cancer
1533289|NCT00648102|Ovarian cancer|ovarian cancer
1533290|NCT00648102|Metastatic cancer|metastatic cancer
1533291|NCT00648102|Locally advanced cancer|locally advanced cancer
1533292|NCT00648102|Cancer Vaccine|cancer vaccine
1533293|NCT00648102|Vaccine|vaccine
1533294|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
1533295|NCT00648037|RITUXIMAB|rituximab
1533296|NCT00648037|Lymphoma|lymphoma
1533297|NCT00647998|Surgical complications|surgical complications
1533298|NCT00647998|Spinal ischemia|spinal ischemia
1533299|NCT00647998|Stroke|stroke
1533300|NCT00647998|Neuroprotection|neuroprotection
1533301|NCT00647946|lipodystrophy|lipodystrophy
1533302|NCT00647933|Females|females
1533303|NCT00647933|Corifollitropin alfa|corifollitropin alfa
1533304|NCT00647933|Antibodies|antibodies
1533305|NCT00647933|Pharmacokinetics|pharmacokinetics
1533306|NCT00647933|Pharmacodynamics|pharmacodynamics
1533307|NCT00647868|pharmacokinetics|pharmacokinetics
1533308|NCT00647868|testosterone|testosterone
1533309|NCT00647868|hypogonadism|hypogonadism
1533310|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
1533311|NCT00647790|PET imaging|pet imaging
1533312|NCT00647790|invasive breast cancer|invasive breast cancer
1533313|NCT00647725|Epidural analgesia|epidural analgesia
1533314|NCT00647725|Latent analgesia|latent analgesia
1533315|NCT00647725|Active analgesia|active analgesia
1533316|NCT00647725|Labor delivery|labor delivery
1533317|NCT00647699|keratoconus|keratoconus
1533318|NCT00647699|cross-linking|cross-linking
1533319|NCT00647699|riboflavin|riboflavin
1533320|NCT00647699|UVA light|uva light
1533321|NCT00647699|cornea|cornea
1533322|NCT00647595|Obesity|obesity
1533323|NCT00647595|Physical activity|physical activity
1533324|NCT00647595|Pregnancy|pregnancy
1533325|NCT00647595|Diabetes mellitus|diabetes mellitus
1533326|NCT00647582|stage I breast cancer|stage i breast cancer
1533327|NCT00647582|stage II breast cancer|stage ii breast cancer
1533328|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
1533329|NCT00647569|mesh repair|mesh repair
1533330|NCT00647569|salvage surgery|salvage surgery
1533331|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
1533332|NCT00647530|stage I colon cancer|stage i colon cancer
1533333|NCT00647530|stage II colon cancer|stage ii colon cancer
1533334|NCT00647530|stage III colon cancer|stage iii colon cancer
1533335|NCT00647504|stent thrombosis|stent thrombosis
1533336|NCT00647504|stent restenosis|stent restenosis
1533337|NCT00647504|intravascular ultrasound|intravascular ultrasound
1533338|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
1533339|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
1567725|NCT00508365|hypertension|hypertension
1533340|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
1533341|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
1533342|NCT00647478|Alzheimer's disease|alzheimer's disease
1533343|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
1533344|NCT00647478|Normal cognitive function|normal cognitive function
1533345|NCT00647478|Observational cross sectional study|observational cross sectional study
1533346|NCT00647465|Influenza vaccine|influenza vaccine
1533347|NCT00647465|interferon|interferon
1533348|NCT00647465|adjuvant|adjuvant
1533349|NCT00647465|the elderly|the elderly
1533350|NCT00647452|Lipid metabolism|lipid metabolism
1533351|NCT00647452|VLDL|vldl
1533352|NCT00647452|Exercise|exercise
1533353|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
1533354|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
1533355|NCT00647439|Immune Mediated|immune mediated
1533356|NCT00647439|Gene Expression Patterns|gene expression patterns
1533357|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
1533358|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
1533359|NCT00647439|AMD|amd
1533360|NCT00647439|Uveitis|uveitis
1533361|NCT00647426|Stage IIIB/IV|stage iiib/iv
1533362|NCT00647413|smoking|smoking
1533363|NCT00647413|passive smoking|passive smoking
1533364|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
1533365|NCT00647413|home smoking ban|home smoking ban
1533366|NCT00647413|urinary cotinine|urinary cotinine
1533367|NCT00647400|Psoriasis|psoriasis
1533368|NCT00647387|muscular|muscular
1533369|NCT00647387|ventricular|ventricular
1533370|NCT00647387|septal|septal
1533371|NCT00647387|defects|defects
1533372|NCT00647387|VSD|vsd
1533373|NCT00647361|respiratory insufficiency|respiratory insufficiency
1533374|NCT00647361|respiration|respiration
1533375|NCT00647361|ventilators|ventilators
1533376|NCT00647361|diaphragm|diaphragm
1533377|NCT00647361|electromyography|electromyography
1533378|NCT00647361|mechanical ventilation|mechanical ventilation
1533379|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1533380|NCT00647348|Simvastatin|simvastatin
1533381|NCT00647348|MRI|mri
1533382|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
1533383|NCT00647296|ALS|als
1533384|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1533385|NCT00647296|Lou Gehrig|lou gehrig
1533386|NCT00647296|Lou Gehrig's|lou gehrig's
1533387|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
1533388|NCT00647296|Motor Neuron Disease|motor neuron disease
1533389|NCT00647296|Nervous System Diseases|nervous system diseases
1533390|NCT00647296|KNS-760704|kns-760704
1533391|NCT00647283|Liver Transplantation|liver transplantation
1533392|NCT00647283|Tolerance|tolerance
1533393|NCT00647283|Allograft tolerance|allograft tolerance
1533394|NCT00647283|Immunosuppression minimization|immunosuppression minimization
1533395|NCT00647283|Immunosuppression weaning|immunosuppression weaning
1533396|NCT00647283|Immunological tolerance|immunological tolerance
1533397|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
1533398|NCT00647244|Tenofovir|tenofovir
1533399|NCT00647244|Abacavir|abacavir
1533400|NCT00647244|Antiretroviral therapy|antiretroviral therapy
1533401|NCT00647244|HIV|hiv
1533402|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
1533403|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
1533404|NCT00647218|stage II breast cancer|stage ii breast cancer
1533405|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
1533406|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
1533407|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
1533408|NCT00647205|Interferon, gamma|interferon, gamma
1533409|NCT00647205|HIV Infections|hiv infections
1533410|NCT00647205|Tuberculosis|tuberculosis
1533411|NCT00647192|atrial fibrillation|atrial fibrillation
1533412|NCT00647192|electrical cardioversion|electrical cardioversion
1533413|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
1533414|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
1533415|NCT00647192|eplerenone|eplerenone
1533416|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
1533417|NCT00647179|Acromegaly|acromegaly
1533418|NCT00647179|Growth Hormone|growth hormone
1533419|NCT00647179|Insulin resistance|insulin resistance
1533420|NCT00647179|Glucose tolerance|glucose tolerance
1533421|NCT00647179|Body Composition|body composition
1533422|NCT00647179|Substrate metabolism|substrate metabolism
1533423|NCT00647166|Vasculitis|vasculitis
1533424|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
1533425|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
1533426|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
1533427|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
1533428|NCT00647166|Azathioprine|azathioprine
1567727|NCT00508352|cancer|cancer
1533429|NCT00647153|stage I colon cancer|stage i colon cancer
1533430|NCT00647153|stage II colon cancer|stage ii colon cancer
1533431|NCT00647153|stage III colon cancer|stage iii colon cancer
1533432|NCT00647153|stage IV colon cancer|stage iv colon cancer
1533433|NCT00647153|stage I rectal cancer|stage i rectal cancer
1533434|NCT00647153|stage II rectal cancer|stage ii rectal cancer
1533435|NCT00647153|stage III rectal cancer|stage iii rectal cancer
1533436|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
1533437|NCT00647140|Thyroid neoplasm|thyroid neoplasm
1533438|NCT00647140|Thyroid carcinoma|thyroid carcinoma
1533439|NCT00647140|Medullary carcinoma|medullary carcinoma
1533440|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
1533441|NCT00647140|18F-L DOPA|18f-l dopa
1533442|NCT00647140|Calcitonin|calcitonin
1533443|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
1533444|NCT00647140|Cervical ultrasonography|cervical ultrasonography
1533445|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
1533446|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
1533447|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
1533448|NCT00647140|Post-PET surgery|post-pet surgery
1533449|NCT00647140|Post-PET biopsy|post-pet biopsy
1533450|NCT00647140|Post-PET histology|post-pet histology
1533451|NCT00647127|Buprenorphine|buprenorphine
1533452|NCT00647127|Fentanyl|fentanyl
1533453|NCT00647127|Analgesic effect|analgesic effect
1533454|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
1533455|NCT00647127|Experimental pain|experimental pain
1533456|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
1533457|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
1533458|NCT00647088|Genetic|genetic
1533459|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
1533460|NCT00647075|Breast cancer|breast cancer
1533461|NCT00647075|undergoing|undergoing
1533462|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
1533463|NCT00647075|symptomatic therapy|symptomatic therapy
1533464|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
1533465|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
1533466|NCT00646984|Lipodystrophy|lipodystrophy
1533467|NCT00646984|Treatment interruption|treatment interruption
1533468|NCT00646984|HIV|hiv
1533469|NCT00646971|Isoprostane|isoprostane
1533470|NCT00646971|Alkane|alkane
1533471|NCT00646971|Exhaled condensate|exhaled condensate
1533472|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
1533473|NCT00646971|Polysomnography|polysomnography
1533474|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
1533475|NCT00646971|Hypoxia|hypoxia
1533476|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
1533477|NCT00646906|acetaminophen|acetaminophen
1533478|NCT00646906|low dose aspirin|low dose aspirin
1533479|NCT00646906|cyclooxygenase|cyclooxygenase
1533480|NCT00646906|prostaglandin|prostaglandin
1533481|NCT00646906|drug interaction|drug interaction
1533482|NCT00646906|platelet inhibition|platelet inhibition
1533483|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
1533484|NCT00646906|oxidant stress|oxidant stress
1533485|NCT00646906|smoking|smoking
1533486|NCT00646893|aneuploidy|aneuploidy
1533487|NCT00646893|miscarriage|miscarriage
1533488|NCT00646893|pregnancy loss|pregnancy loss
1533489|NCT00646893|PGD|pgd
1533490|NCT00646893|PGS|pgs
1533491|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
1533492|NCT00646893|chromosome abnormalities|chromosome abnormalities
1533493|NCT00646893|IVF|ivf
1533494|NCT00646893|ART|art
1533495|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
1533496|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
1533497|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
1533498|NCT00646854|MabCampath|mabcampath
1533499|NCT00646854|Campath|campath
1533500|NCT00646854|CHOP-14|chop-14
1533501|NCT00646854|CD52 expression|cd52 expression
1533502|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
1533503|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
1533504|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
1533505|NCT00646828|Aldosterone|aldosterone
1533506|NCT00646828|Cardiovascular disease|cardiovascular disease
1533507|NCT00646815|insulin sensitivity|insulin sensitivity
1533508|NCT00646815|substrate metabolism|substrate metabolism
1533509|NCT00646815|fatty liver|fatty liver
1533510|NCT00646815|intramyocellular lipids|intramyocellular lipids
1533511|NCT00646815|growth hormone deficiency|growth hormone deficiency
1533512|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
1533513|NCT00646750|Z-BEAM|z-beam
1533514|NCT00646750|Autologous|autologous
1533515|NCT00646750|Lymphoma|lymphoma
1533516|NCT00646750|GELTAMO|geltamo
1533517|NCT00646737|Kidney transplantation|kidney transplantation
1533518|NCT00646737|conversion|conversion
1533519|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
1533520|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
1533521|NCT00646737|tacrolimus|tacrolimus
1533522|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
1533523|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
1533524|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1533525|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
1533526|NCT00646698|Obesity|obesity
1533527|NCT00646698|Body composition|body composition
1533529|NCT00646698|Tissue biopsies|tissue biopsies
1533530|NCT00646672|ECMO|ecmo
1533531|NCT00646672|Cerebral Perfusion|cerebral perfusion
1533532|NCT00646672|Carotid Artery|carotid artery
1533533|NCT00646672|Aneurysm|aneurysm
1533534|NCT00646672|Cerebral Circulation|cerebral circulation
1533535|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
1533536|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1533537|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1533538|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1533539|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1533540|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1533541|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1533542|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1533543|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1533544|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1533545|NCT00646646|Sedation|sedation
1533546|NCT00646646|Eye Movements|eye movements
1533547|NCT00646633|Cancer|cancer
1533548|NCT00646633|Acupuncture|acupuncture
1533549|NCT00646620|asthma|asthma
1533550|NCT00646620|bronchodilatation|bronchodilatation
1533551|NCT00646620|Symbicort|symbicort
1533552|NCT00646620|budesonide/formoterol|budesonide/formoterol
1533553|NCT00646620|Advair Diskus|advair diskus
1533554|NCT00646620|Ventolin|ventolin
1533555|NCT00646607|colorectal neoplasm|colorectal neoplasm
1533556|NCT00646607|high risk|high risk
1533557|NCT00646607|stage II/III|stage ii/iii
1533558|NCT00646594|Asthma|asthma
1533559|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
1533560|NCT00646594|Symbicort|symbicort
1533561|NCT00646594|budesonide/formoterol|budesonide/formoterol
1533562|NCT00646594|Advair|advair
1533563|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
1533564|NCT00646581|Schizophrenia|schizophrenia
1533565|NCT00646581|Memory|memory
1533566|NCT00646581|Concentration|concentration
1533567|NCT00646581|Insulin|insulin
1533569|NCT00646568|ovarian reserve|ovarian reserve
1533570|NCT00646568|androgens|androgens
1533571|NCT00646568|thecal cells|thecal cells
1533572|NCT00646568|Fertility Agents, Female|fertility agents, female
1533573|NCT00646555|Tissue Samples|tissue samples
1533574|NCT00646555|VEGF Receptors|vegf receptors
1533575|NCT00646555|VEGF|vegf
1533576|NCT00646555|Microvessel Density|microvessel density
1533577|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
1533578|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
1533580|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
1533581|NCT00646529|asthma|asthma
1533582|NCT00646529|children|children
1533583|NCT00646529|Symbicort|symbicort
1533584|NCT00646529|budesonide/formoterol|budesonide/formoterol
1533585|NCT00646529|Pulmicort|pulmicort
1533586|NCT00646529|budesonide|budesonide
1533587|NCT00646516|Asthma|asthma
1533588|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
1533589|NCT00646516|Symbicort|symbicort
1533590|NCT00646516|budesonide/formoterol|budesonide/formoterol
1533591|NCT00646516|budesonide|budesonide
1533592|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
1533593|NCT00646503|Telbivudine|telbivudine
1533594|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
1533595|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
1533596|NCT00646464|CPT|cpt
1533597|NCT00646464|ADHD|adhd
1533598|NCT00646451|Essential tremor|essential tremor
1533599|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
1533600|NCT00646438|Diabetes|diabetes
1533601|NCT00646438|CABG|cabg
1533602|NCT00646425|Non-infectious uveitis|non-infectious uveitis
1533603|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
1533604|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
1533605|NCT00646412|Abdominal Surgery|abdominal surgery
1533606|NCT00646412|Laparotomy, median|laparotomy, median
1533607|NCT00646399|Staphylococcal|staphylococcal
1533608|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
1533609|NCT00646399|Monoclonal antibodies|monoclonal antibodies
1533610|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
1533611|NCT00646399|Prophylaxis|prophylaxis
1533612|NCT00646373|Cardiac surgery|cardiac surgery
1533613|NCT00646373|Pump prime|pump prime
1533614|NCT00646373|Blood transfusions|blood transfusions
1533615|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
1533616|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
1533617|NCT00646347|stroke|stroke
1533618|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
1533619|NCT00646347|treatment|treatment
1533620|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
1533621|NCT00646347|neuro hand orthosis|neuro hand orthosis
1533622|NCT00646347|self practice program|self practice program
1533623|NCT00646347|subacute|subacute
1533624|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
1533625|NCT00646334|Incisional Hernia|incisional hernia
1533626|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
1533627|NCT00646321|asthma|asthma
1533628|NCT00646321|children|children
1533629|NCT00646321|adolescents|adolescents
1533630|NCT00646321|Symbicort|symbicort
1533631|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
1533632|NCT00646321|budesonide|budesonide
1533633|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
1534014|NCT00644566|screening|screening
1533635|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
1533636|NCT00646256|schizoaffective|schizoaffective
1533637|NCT00646256|schizotypal|schizotypal
1533638|NCT00646243|Heart failure|heart failure
1533639|NCT00646243|echocardiography|echocardiography
1533640|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
1533641|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
1533642|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
1533643|NCT00646217|SELF Care Talk|self care talk
1533644|NCT00646217|stroke|stroke
1533645|NCT00646217|caregivers|caregivers
1533646|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
1533647|NCT00646204|Parkinson's disease|parkinson's disease
1533648|NCT00646204|non-motor symptoms|non-motor symptoms
1533649|NCT00646165|Leukemia, CLL|leukemia, cll
1533650|NCT00646152|Antiviral|antiviral
1533651|NCT00646152|Influenza|influenza
1533652|NCT00646152|Interferon|interferon
1533653|NCT00646152|Prophylaxis|prophylaxis
1533654|NCT00646152|SARS|sars
1533655|NCT00646152|Healthy Volunteer|healthy volunteer
1533656|NCT00646152|HV|hv
1533657|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1533658|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1533659|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1533660|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1533661|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1533662|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1533663|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1533664|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1533665|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1533666|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1533667|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1533668|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1533669|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1533670|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1533671|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1533672|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1533673|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1533674|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1533675|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1533676|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1533677|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1533678|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1533679|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1533680|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1533681|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1533682|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1533683|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1533684|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1533685|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1533686|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1533687|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1567728|NCT00508352|locoregional|locoregional
1533688|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1533689|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1533690|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1533691|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1533692|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1533693|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1533881|NCT00645385|Tumors|tumors
1533699|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1533700|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1533701|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1533702|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1533703|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1533704|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1533705|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1533706|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1533707|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1533708|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1533709|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1533710|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1533711|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1533712|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1533713|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1533714|NCT00646139|intraocular lymphoma|intraocular lymphoma
1533715|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1533716|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1533717|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1533718|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1533719|NCT00646139|small intestine lymphoma|small intestine lymphoma
1533720|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
1533721|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1533722|NCT00646100|prospective control study|prospective control study
1533723|NCT00646100|best support care|best support care
1533724|NCT00646100|survival|survival
1533725|NCT00646074|Caregiver|caregiver
1533726|NCT00646074|Alzheimer's disease|alzheimer's disease
1533727|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
1533728|NCT00646061|renal colic|renal colic
1533729|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1533730|NCT00646048|AAA|aaa
1533731|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
1533732|NCT00646048|Stent-Graft|stent-graft
1533740|NCT00646009|asthma|asthma
1533741|NCT00646009|adults|adults
1533742|NCT00646009|Symbicort|symbicort
1533743|NCT00646009|budesonide/formoterol|budesonide/formoterol
1533744|NCT00646009|Advair Diskus|advair diskus
1533745|NCT00646009|Ventolin|ventolin
1533746|NCT00645996|Probiotics|probiotics
1533747|NCT00645996|vaccines|vaccines
1533748|NCT00645996|Measles|measles
1533749|NCT00645996|Mumps|mumps
1533750|NCT00645996|Rubella|rubella
1533751|NCT00645983|Chamomile|chamomile
1533752|NCT00645983|Anxiety|anxiety
1533753|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
1533754|NCT00645970|chronic pain|chronic pain
1533755|NCT00645970|combat injuries|combat injuries
1533756|NCT00645970|pain assessment|pain assessment
1533757|NCT00645970|multiple traumas|multiple traumas
1533758|NCT00645970|rehabilitation|rehabilitation
1533759|NCT00645957|drainage|drainage
1533760|NCT00645957|irrigation|irrigation
1533761|NCT00645931|Bone Marrow|bone marrow
1533762|NCT00645931|Bone Marrow Transplant|bone marrow transplant
1533763|NCT00645931|Pediatric|pediatric
1533764|NCT00645931|Psychological Impact|psychological impact
1533765|NCT00645931|Psychology|psychology
1533766|NCT00645918|Platelets|platelets
1533767|NCT00645918|Platelet Function Tests|platelet function tests
1533768|NCT00645918|Clopidogrel|clopidogrel
1533769|NCT00645918|Drug Eluting Stents|drug eluting stents
1533770|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
1533771|NCT00645918|Myocardial Ischemia|myocardial ischemia
1533772|NCT00645918|Stent Thrombosis|stent thrombosis
1533773|NCT00645918|Heart Diseases|heart diseases
1533774|NCT00645918|Coronary Disease|coronary disease
1533775|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
1533776|NCT00645879|Propionic Acidemia|propionic acidemia
1533777|NCT00645879|hyperammonemia|hyperammonemia
1533778|NCT00645879|hypotonia|hypotonia
1533779|NCT00645879|glutamine|glutamine
1533780|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
1533781|NCT00645879|citrate|citrate
1567729|NCT00508352|IMRT|imrt
1533782|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
1533783|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
1533784|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
1533785|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
1533786|NCT00645840|IL1 beta|il1 beta
1533787|NCT00645840|Anakinra|anakinra
1533788|NCT00645827|Insulin|insulin
1533789|NCT00645827|Blood Glucose|blood glucose
1533790|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
1533791|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
1533792|NCT00645801|Amitiza|amitiza
1533793|NCT00645801|GoLYTELY|golytely
1533794|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
1533795|NCT00645801|Preparation Solution|preparation solution
1533796|NCT00645801|Colonoscopy Solution|colonoscopy solution
1533797|NCT00645788|Ciprofloxacin|ciprofloxacin
1533798|NCT00645788|cystic fibrosis|cystic fibrosis
1533799|NCT00645788|sweat test|sweat test
1533800|NCT00645788|pulmonary function test|pulmonary function test
1533801|NCT00645775|Weight loss|weight loss
1533802|NCT00645775|Antiobesity|antiobesity
1533803|NCT00645775|Metabolic syndrome|metabolic syndrome
1533804|NCT00645775|Leptin|leptin
1533805|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
1533806|NCT00645762|Chronic sinusitis|chronic sinusitis
1533807|NCT00645762|Maxillary sinus|maxillary sinus
1533808|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
1533809|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
1533810|NCT00645762|Balloon dilation|balloon dilation
1533811|NCT00645762|Endoscopic visualization|endoscopic visualization
1533812|NCT00645762|Local anesthesia|local anesthesia
1533813|NCT00645762|Canine fossa|canine fossa
1533814|NCT00645762|Less invasive|less invasive
1533815|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
1533816|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
1533817|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
1533818|NCT00645697|tuberculosis|tuberculosis
1533819|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
1533820|NCT00645697|histoplasmosis|histoplasmosis
1533821|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
1533822|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
1533823|NCT00645684|Multicentre|multicentre
1533824|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
1533825|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
1533826|NCT00645684|Laparotomy|laparotomy
1533827|NCT00645645|Holoprosencephaly|holoprosencephaly
1533828|NCT00645645|Agenesis of Corpus|agenesis of corpus
1533829|NCT00645645|Callosum|callosum
1533830|NCT00645645|Genetic Tests|genetic tests
1533831|NCT00645632|localized osteosarcoma|localized osteosarcoma
1533832|NCT00645619|Pneumonia,viral|pneumonia,viral
1533833|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
1533834|NCT00645619|TREM-1 protein,human|trem-1 protein,human
1533835|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1533836|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
1533837|NCT00645606|Elderly patients|elderly patients
1533838|NCT00645593|Bladder Cancer|bladder cancer
1533839|NCT00645567|Biomechanics|biomechanics
1533840|NCT00645567|Ergonomics|ergonomics
1533841|NCT00645567|Spinal Cord Injury|spinal cord injury
1533842|NCT00645567|Pain|pain
1533843|NCT00645567|Shoulder|shoulder
1533844|NCT00645554|Galantamine oral solution|galantamine oral solution
1533845|NCT00645554|Galantamine tablet|galantamine tablet
1533846|NCT00645554|Bioequivalence|bioequivalence
1533847|NCT00645541|Breast Cancer|breast cancer
1533848|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
1533849|NCT00645541|Lymph Nodes|lymph nodes
1533850|NCT00645541|Lymphazurin|lymphazurin
1533851|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
1533852|NCT00645528|insulin|insulin
1533853|NCT00645528|teaching|teaching
1533854|NCT00645502|Schizophrenia|schizophrenia
1533855|NCT00645502|Risperidone|risperidone
1533856|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
1533857|NCT00645502|Bioequivalence|bioequivalence
1533858|NCT00645489|heart failure intervention|heart failure intervention
1533859|NCT00645450|Stress|stress
1533860|NCT00645450|Posttraumatic|posttraumatic
1533861|NCT00645450|PTSD|ptsd
1533862|NCT00645450|Propranolol|propranolol
1533863|NCT00645450|Treatment|treatment
1533864|NCT00645437|renal diseases|renal diseases
1533865|NCT00645437|levofloxacin|levofloxacin
1533866|NCT00645411|Influenza|influenza
1533868|NCT00645411|Cell Culture-Derived|cell culture-derived
1533869|NCT00645411|Egg-Derived|egg-derived
1533870|NCT00645411|Healthy Children|healthy children
1533871|NCT00645411|Healthy Adolescents|healthy adolescents
1533872|NCT00645411|Safety|safety
1533873|NCT00645411|Immunogenicity|immunogenicity
1533874|NCT00645411|Trivalent|trivalent
1533875|NCT00645411|Inactivated|inactivated
1533876|NCT00645411|Vaccination|vaccination
1533878|NCT00645385|AA|aa
1533879|NCT00645385|AO|ao
1533880|NCT00645385|Brain|brain
1533882|NCT00645385|Malignant|malignant
1533883|NCT00645385|Glioblastoma|glioblastoma
1533884|NCT00645385|Multiforme|multiforme
1533885|NCT00645385|Carmustine|carmustine
1533886|NCT00645385|implant|implant
1533887|NCT00645385|BCNU|bcnu
1533888|NCT00645385|Gliadel|gliadel
1533889|NCT00645385|Wafers|wafers
1533890|NCT00645385|MRS|mrs
1533891|NCT00645385|Spectroscopy|spectroscopy
1533892|NCT00645359|dMRI|dmri
1533893|NCT00645359|diffusion MRI|diffusion mri
1533894|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1533895|NCT00645359|DLBCL|dlbcl
1533896|NCT00645346|GBS|gbs
1533897|NCT00645333|breast cancer|breast cancer
1533898|NCT00645333|Phase I clinical trial|phase i clinical trial
1533899|NCT00645333|cancer stem cells|cancer stem cells
1533900|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
1533901|NCT00645333|Notch inhibitors|notch inhibitors
1533902|NCT00645307|paliperidone|paliperidone
1533903|NCT00645307|Schizophrenia|schizophrenia
1533904|NCT00645294|Hepatitis B|hepatitis b
1533905|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
1533906|NCT00645294|Children|children
1533907|NCT00645294|Adolescents|adolescents
1533908|NCT00645294|Pharmacokinetics|pharmacokinetics
1533909|NCT00645190|Alzheimer Disease|alzheimer disease
1533910|NCT00645190|galantamine|galantamine
1533911|NCT00645177|Breast Cancer|breast cancer
1533912|NCT00645164|wound healing|wound healing
1533913|NCT00645164|photoallergenicity|photoallergenicity
1533914|NCT00645164|Healthy subjects|healthy subjects
1533915|NCT00645138|breast carcinoma|breast carcinoma
1533916|NCT00645138|breast cancer|breast cancer
1533917|NCT00645138|paravertebral block|paravertebral block
1533918|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
1533919|NCT00645138|ultrasound|ultrasound
1533920|NCT00645125|pediatric taste test|pediatric taste test
1533921|NCT00645125|antibiotic taste test|antibiotic taste test
1533922|NCT00645125|cefdinir|cefdinir
1533923|NCT00645125|amoxicillin|amoxicillin
1533924|NCT00645099|Paliperidone ER|paliperidone er
1533925|NCT00645099|Olanzapine|olanzapine
1533926|NCT00645099|Schizophrenia|schizophrenia
1533927|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
1533928|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1533929|NCT00645047|PTSD|ptsd
1533930|NCT00645047|Telemedicine|telemedicine
1533931|NCT00645047|Patient-Centered Care|patient-centered care
1533932|NCT00645047|Professional Patient Relationship|professional patient relationship
1533933|NCT00645047|Psychotherapy|psychotherapy
1533934|NCT00645047|Cognitive Therapy|cognitive therapy
1533935|NCT00645008|Stressors|stressors
1533936|NCT00645008|Patient Satisfaction|patient satisfaction
1533937|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
1533938|NCT00645008|Coronary bypass patient|coronary bypass patient
1533939|NCT00644995|Depression|depression
1533940|NCT00644995|Smoking|smoking
1533941|NCT00644995|Physical Activity|physical activity
1533942|NCT00644930|ARDS,|ards,
1533943|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
1533944|NCT00644930|intubation,|intubation,
1533945|NCT00644930|mortality,|mortality,
1533946|NCT00644930|intensive care|intensive care
1533947|NCT00644917|wound healing|wound healing
1533948|NCT00644917|phototoxicity|phototoxicity
1533949|NCT00644917|Healthy Subjects|healthy subjects
1533950|NCT00644904|Multiple Sclerosis|multiple sclerosis
1533951|NCT00644904|Vitamin D|vitamin d
1533952|NCT00644904|Safety|safety
1533953|NCT00644891|Pediatric taste test|pediatric taste test
1533954|NCT00644891|Antibiotic taste test|antibiotic taste test
1533955|NCT00644891|cefdinir|cefdinir
1533956|NCT00644891|amoxicillin|amoxicillin
1533957|NCT00644878|leukemia|leukemia
1533958|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
1533959|NCT00644878|chronic phase|chronic phase
1533960|NCT00644878|molecular response|molecular response
1533961|NCT00644878|nilotinib|nilotinib
1533962|NCT00644878|ENABL|enabl
1533963|NCT00644852|Schizophrenia|schizophrenia
1533964|NCT00644852|Schizoaffective disorder|schizoaffective disorder
1533965|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
1533966|NCT00644826|randomized controlled trial|randomized controlled trial
1533967|NCT00644826|public health|public health
1533968|NCT00644826|Preventive Health Services|preventive health services
1533969|NCT00644787|Pain|pain
1533970|NCT00644787|Cancer|cancer
1533971|NCT00644787|Fentanyl|fentanyl
1533972|NCT00644787|JNS020QD|jns020qd
1533973|NCT00644787|JNS005|jns005
1533974|NCT00644774|pediatric taste test|pediatric taste test
1533975|NCT00644774|antibiotic taste test|antibiotic taste test
1533976|NCT00644774|cefdinir|cefdinir
1533977|NCT00644774|azithromycin|azithromycin
1533978|NCT00644761|Hepatitis B|hepatitis b
1533979|NCT00644761|Post-Liver Transplantation|post-liver transplantation
1533980|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
1533981|NCT00644761|Tacrolimus|tacrolimus
1533982|NCT00644761|Cyclosporine|cyclosporine
1533983|NCT00644735|Erosive Esophagitis|erosive esophagitis
1533985|NCT00644735|Esomeprazole|esomeprazole
1533986|NCT00644735|Lansoprazole|lansoprazole
1533987|NCT00644735|Heartburn|heartburn
1533988|NCT00644722|Intubation|intubation
1533989|NCT00644722|Out-of-hospital|out-of-hospital
1533990|NCT00644722|Laryngoscope|laryngoscope
1533991|NCT00644722|Blades|blades
1533992|NCT00644722|Emergency|emergency
1533993|NCT00644696|Neuroblastoma|neuroblastoma
1533994|NCT00644696|Irinotecan|irinotecan
1533995|NCT00644696|Bortezomib|bortezomib
1533996|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
1533997|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
1533998|NCT00644644|NTX|ntx
1533999|NCT00644644|Nihon Kohden|nihon kohden
1534000|NCT00644644|mobile monitoring|mobile monitoring
1534001|NCT00644618|pancreatic cancer|pancreatic cancer
1534002|NCT00644618|locally advanced|locally advanced
1534003|NCT00644592|Healthy Volunteers|healthy volunteers
1534004|NCT00644579|wart|wart
1534005|NCT00644579|cutaneous|cutaneous
1534006|NCT00644579|transplant|transplant
1534007|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
1534008|NCT00644566|ADHD|adhd
1534009|NCT00644566|Primary Care|primary care
1534010|NCT00644566|Pediatrics|pediatrics
1534011|NCT00644566|Health services|health services
1534012|NCT00644566|shared care|shared care
1534013|NCT00644566|care manager|care manager
1534015|NCT00644540|Influenza|influenza
1534016|NCT00644540|vaccines|vaccines
1534017|NCT00644540|children|children
1534018|NCT00644527|depression|depression
1534019|NCT00644527|music|music
1534020|NCT00644527|sound|sound
1534021|NCT00644527|randomized controlled trial|randomized controlled trial
1534022|NCT00644514|LPS endotoxin|lps endotoxin
1534023|NCT00644514|Asthma|asthma
1534024|NCT00644501|type 1 diabetes|type 1 diabetes
1534025|NCT00644501|beta cells|beta cells
1534026|NCT00644501|immunomodulation|immunomodulation
1534027|NCT00644501|immunointervention|immunointervention
1534028|NCT00644475|Hypertension|hypertension
1534029|NCT00644475|Insulin sensitivity|insulin sensitivity
1534030|NCT00644475|Fibrinolysis|fibrinolysis
1534031|NCT00644462|wheeze detection|wheeze detection
1534032|NCT00644436|tetrix cream|tetrix cream
1534033|NCT00644436|substantivity|substantivity
1534034|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
1534035|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
1534036|NCT00644423|PTSD|ptsd
1534037|NCT00644423|Cognition|cognition
1534038|NCT00644423|Fish Oil|fish oil
1534039|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
1534040|NCT00644410|heart failure|heart failure
1534041|NCT00644410|stem cell|stem cell
1534042|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
1534043|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
1534044|NCT00644397|distal femur fracture|distal femur fracture
1534045|NCT00644397|locked plates|locked plates
1534046|NCT00644397|functional outcomes|functional outcomes
1534047|NCT00644397|cost management|cost management
1534048|NCT00644397|femur head|femur head
1534049|NCT00644397|femur neck|femur neck
1534050|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1534051|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1534052|NCT00644371|Allogeneic|allogeneic
1534053|NCT00644371|Lymphoma|lymphoma
1534054|NCT00644371|GELTAMO|geltamo
1534055|NCT00644371|Z-RIC|z-ric
1534056|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
1534057|NCT00644345|reproducibility|reproducibility
1534058|NCT00644319|malignant pleural effusion|malignant pleural effusion
1534059|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
1534060|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
1534061|NCT00644267|hypertension|hypertension
1534062|NCT00644267|cardiovascular risk|cardiovascular risk
1534063|NCT00644267|risk score|risk score
1534064|NCT00644254|Prognosis|prognosis
1534065|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
1534066|NCT00644241|stem cell therapy|stem cell therapy
1534067|NCT00644241|T2DM|t2dm
1534068|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
1534069|NCT00644215|injected bleb|injected bleb
1534070|NCT00644215|mitomycin drop|mitomycin drop
1534071|NCT00644215|5-Fu injection|5-fu injection
1534072|NCT00644215|early bleb failure|early bleb failure
1534073|NCT00644202|weight control|weight control
1534074|NCT00644189|clofarabine|clofarabine
1534075|NCT00644189|Clolar|clolar
1534076|NCT00644189|lymphoma|lymphoma
1534077|NCT00644189|NHL|nhl
1534078|NCT00644189|oral chemotherapy|oral chemotherapy
1534079|NCT00644163|HIV|hiv
1534080|NCT00644163|STI|sti
1534081|NCT00644163|Risk Reduction|risk reduction
1534082|NCT00644163|Couples|couples
1534083|NCT00644163|African American|african american
1534084|NCT00644163|HIV Seronegativity|hiv seronegativity
1534085|NCT00644150|Risk Reduction Counseling|risk reduction counseling
1534086|NCT00644150|Anhui, China|anhui, china
1534087|NCT00644150|HIV|hiv
1534088|NCT00644150|STI|sti
1534089|NCT00644137|smoking sensations|smoking sensations
1534090|NCT00644137|no cravings|no cravings
1534091|NCT00644137|desire to smoke|desire to smoke
1534092|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1534093|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
1534094|NCT00644124|CHOP protocol|chop protocol
1534095|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
1534096|NCT00644111|Postoperative analgesia|postoperative analgesia
1534097|NCT00644111|Epidural|epidural
1534098|NCT00644111|Lumbar|lumbar
1534099|NCT00644085|IVF and ICSI|ivf and icsi
1534100|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
1534101|NCT00644072|Her2|her2
1534102|NCT00644072|Neoplasms|neoplasms
1534103|NCT00644072|Advanced Cancer|advanced cancer
1534104|NCT00644072|Cancer|cancer
1534105|NCT00644072|Solid Tumor|solid tumor
1534106|NCT00644072|Lymphoma|lymphoma
1534107|NCT00644059|Influenza|influenza
1534108|NCT00644059|vaccine|vaccine
1534109|NCT00644059|children|children
1534110|NCT00644046|Chronic Kidney Disease|chronic kidney disease
1534111|NCT00644046|Prevention|prevention
1534112|NCT00644046|Cardiovascular disease|cardiovascular disease
1534113|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
1534114|NCT00644020|recurrence|recurrence
1534115|NCT00644007|Erectile dysfunction|erectile dysfunction
1534116|NCT00644007|Hypertension|hypertension
1534117|NCT00644007|SK3530|sk3530
1534118|NCT00643994|Prostate Cancer|prostate cancer
1534119|NCT00643994|CyberKnife|cyberknife
1534120|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
1534121|NCT00643994|Radiotherapy|radiotherapy
1534122|NCT00643994|Radiation|radiation
1534123|NCT00643994|Prostate Tumor|prostate tumor
1534124|NCT00643994|Prostate Surgery|prostate surgery
1534125|NCT00643968|HIV virological control|hiv virological control
1534126|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
1534127|NCT00643968|Treatment Experienced|treatment experienced
1534128|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
1534129|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
1534130|NCT00643929|ocular safety|ocular safety
1534131|NCT00643929|HCV|hcv
1534132|NCT00643929|SB-497115-GR|sb-497115-gr
1534133|NCT00643929|CIT|cit
1534134|NCT00643929|ITP|itp
1534135|NCT00643929|cataract|cataract
1534136|NCT00643929|eltrombopag olamine|eltrombopag olamine
1534137|NCT00643929|lens opacity|lens opacity
1534138|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
1534139|NCT00643903|Side Effects|side effects
1534140|NCT00643903|Adherence|adherence
1534141|NCT00643903|Coping|coping
1534142|NCT00643903|HIV|hiv
1534143|NCT00643903|AIDS|aids
1534144|NCT00643903|Complementary Therapies|complementary therapies
1534145|NCT00643890|Keywords:|keywords:
1534146|NCT00643890|Parkinson's disease|parkinson's disease
1534147|NCT00643890|Gene transfer|gene transfer
1534148|NCT00643890|Gene therapy|gene therapy
1534149|NCT00643890|Subthalamic nucleus|subthalamic nucleus
1534150|NCT00643890|Adeno-associated virus|adeno-associated virus
1534151|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
1534152|NCT00643890|Ganglion Cysts|ganglion cysts
1534153|NCT00643890|Movement Disorders|movement disorders
1534154|NCT00643890|Parkinson Disease|parkinson disease
1534155|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
1534156|NCT00643890|Central Nervous System Diseases|central nervous system diseases
1534157|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
1534158|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
1534159|NCT00643890|Brain Diseases|brain diseases
1534160|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
1534161|NCT00643890|Nervous System Diseases|nervous system diseases
1534162|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
1534163|NCT00643877|Regional|regional
1534164|NCT00643877|Liver|liver
1534165|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
1534166|NCT00643864|mirror training|mirror training
1534167|NCT00643864|stroke|stroke
1534168|NCT00643864|hemiparesis|hemiparesis
1534169|NCT00643864|rehabilitation|rehabilitation
1534170|NCT00643825|Temozolomide|temozolomide
1534171|NCT00643825|Phase II|phase ii
1534172|NCT00643825|Chemotherapy|chemotherapy
1534173|NCT00643825|Glioblastoma|glioblastoma
1534174|NCT00643825|Progression-free Survival|progression-free survival
1534175|NCT00643812|Firearm storage|firearm storage
1534176|NCT00643812|Suicide|suicide
1534177|NCT00643812|Unintentional injury|unintentional injury
1534178|NCT00643812|Alaska Native|alaska native
1534179|NCT00643812|Suicide Attempt|suicide attempt
1534180|NCT00643773|Elderly|elderly
1534181|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
1534182|NCT00643760|Neuropathic Pain|neuropathic pain
1534183|NCT00643747|retinal dystrophy|retinal dystrophy
1534184|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
1534185|NCT00643747|RPE65|rpe65
1534186|NCT00643747|gene therapy|gene therapy
1567730|NCT00508352|tomotherapy|tomotherapy
1534187|NCT00643721|Young healthy athletes|young healthy athletes
1534188|NCT00643708|anovulation|anovulation
1534189|NCT00643708|laser|laser
1534190|NCT00643708|ovarian interstitial|ovarian interstitial
1534191|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
1534192|NCT00643708|ultrasound-guided|ultrasound-guided
1534193|NCT00643695|hepatitis C|hepatitis c
1534194|NCT00643695|depression|depression
1534195|NCT00643695|exercise|exercise
1534196|NCT00643682|colonoscopy|colonoscopy
1534197|NCT00643682|bowel preparation|bowel preparation
1534198|NCT00643682|patient education|patient education
1534199|NCT00643682|polyp detection|polyp detection
1534200|NCT00643656|Liver biopsy|liver biopsy
1534201|NCT00643643|HIV|hiv
1534202|NCT00643643|Treatment Naïve|treatment naïve
1534203|NCT00643630|Tetrix crea|tetrix crea
1534204|NCT00643630|skin barrier|skin barrier
1534205|NCT00643630|antigen reaction|antigen reaction
1534206|NCT00643630|prevention|prevention
1534207|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
1534208|NCT00643617|Prostate Cancer|prostate cancer
1534209|NCT00643617|CyberKnife|cyberknife
1534210|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
1534211|NCT00643617|Radiosurgery|radiosurgery
1534212|NCT00643617|Prostate Tumor|prostate tumor
1534213|NCT00643617|Prostate Surgery|prostate surgery
1534308|NCT00643123|Allopurinol|allopurinol
1534214|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
1534215|NCT00643604|treatment satisfaction|treatment satisfaction
1534216|NCT00643604|rapid switch|rapid switch
1534217|NCT00643604|remodulin|remodulin
1534218|NCT00643604|Quality of life|quality of life
1534219|NCT00643591|high grade glioma|high grade glioma
1534220|NCT00643591|FDG-PET-CT|fdg-pet-ct
1534221|NCT00643591|blood proteins|blood proteins
1534222|NCT00643591|prognosis|prognosis
1534223|NCT00643578|formoterol|formoterol
1534224|NCT00643578|methacholine challenge|methacholine challenge
1534225|NCT00643552|Muscle Strength|muscle strength
1534226|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
1534227|NCT00643526|Psoriatic arthritis|psoriatic arthritis
1534228|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
1534229|NCT00643526|Psoriasis|psoriasis
1534230|NCT00643526|Autoinjector|autoinjector
1534231|NCT00643513|QUALITY OF LIFE|quality of life
1534232|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
1534233|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
1534234|NCT00643513|FASLODEX|faslodex
1534235|NCT00643500|Levetiracetam|levetiracetam
1534236|NCT00643500|Keppra|keppra
1534237|NCT00643487|Knee physiology|knee physiology
1534238|NCT00643487|Anterior compartment knee|anterior compartment knee
1534239|NCT00643487|Infrapatellar plica|infrapatellar plica
1534240|NCT00643487|Ligamentum mucosum|ligamentum mucosum
1534241|NCT00643487|Enthesis organ|enthesis organ
1534242|NCT00643487|Fat pad of the knee|fat pad of the knee
1534243|NCT00643487|Patellofemoral kinematics|patellofemoral kinematics
1534244|NCT00643435|self-efficacy|self-efficacy
1534245|NCT00643435|chronic illness|chronic illness
1534246|NCT00643435|health behavior|health behavior
1534247|NCT00643435|education, medical, residency|education, medical, residency
1534248|NCT00643422|normal eyes|normal eyes
1534249|NCT00643396|small cell lung cancer|small cell lung cancer
1534250|NCT00643396|radiotherapy|radiotherapy
1534251|NCT00643370|lung cancer|lung cancer
1534252|NCT00643370|tumor motion|tumor motion
1534253|NCT00643357|children with burns|children with burns
1534254|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
1534255|NCT00643344|obesity|obesity
1534256|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
1534257|NCT00643344|diet and exercise|diet and exercise
1534258|NCT00643344|mindful eating|mindful eating
1534259|NCT00643344|stress|stress
1534260|NCT00643331|Osteoporosis|osteoporosis
1534261|NCT00643331|Exercise|exercise
1534262|NCT00643331|Low bone density|low bone density
1534263|NCT00643331|Falls|falls
1534264|NCT00643318|lung cancer|lung cancer
1534265|NCT00643318|lung tumor|lung tumor
1534266|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
1534267|NCT00643318|NSCLC|nsclc
1534268|NCT00643318|CyberKnife|cyberknife
1534269|NCT00643318|radiosurgery|radiosurgery
1534270|NCT00643318|lung surgery|lung surgery
1534272|NCT00643305|Motivational Interviewing|motivational interviewing
1534273|NCT00643305|Skills|skills
1534274|NCT00643305|Prevention|prevention
1534275|NCT00643305|Mental illness|mental illness
1534276|NCT00643305|Risk reduction|risk reduction
1534277|NCT00643305|HIV/AIDS|hiv/aids
1534278|NCT00643305|HIV Seronegativity|hiv seronegativity
1534279|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
1534280|NCT00643279|Intracardiac pressures|intracardiac pressures
1534281|NCT00643266|recollection training|recollection training
1534282|NCT00643266|aging|aging
1534283|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
1534284|NCT00643266|fMRI|fmri
1534285|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
1534286|NCT00643253|breastfeeding promotion|breastfeeding promotion
1534287|NCT00643253|health promotion|health promotion
1534288|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1534289|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1534290|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1534291|NCT00643214|Tetrix Cream|tetrix cream
1534292|NCT00643214|Antigen reaction|antigen reaction
1534293|NCT00643214|effect on healing|effect on healing
1534294|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
1534295|NCT00643188|Atrial fibrillation|atrial fibrillation
1534296|NCT00643188|Ablation|ablation
1534297|NCT00643188|Heart failure|heart failure
1534298|NCT00643188|Home Monitoring|home monitoring
1534299|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
1534300|NCT00643162|Depression|depression
1534301|NCT00643162|Massage|massage
1534302|NCT00643162|Lexapro|lexapro
1534303|NCT00643162|Alternative Therapy|alternative therapy
1534304|NCT00643162|Anti-depressant|anti-depressant
1534305|NCT00643123|Bipolar Disorder|bipolar disorder
1534306|NCT00643123|Mania|mania
1534307|NCT00643123|Mixed mania|mixed mania
1534309|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
1534310|NCT00643110|Hypoglycemia|hypoglycemia
1534311|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
1534312|NCT00643097|adult gliosarcoma|adult gliosarcoma
1534313|NCT00643097|adult glioblastoma|adult glioblastoma
1534314|NCT00643084|Colorectal|colorectal
1534315|NCT00643084|Bowel preparation|bowel preparation
1534316|NCT00643084|Laparoscopic surgery|laparoscopic surgery
1534317|NCT00643071|Ulcerative colitis|ulcerative colitis
1534318|NCT00643071|Tacrolimus|tacrolimus
1534319|NCT00643071|FK506|fk506
1534320|NCT00643071|Treatment outcome|treatment outcome
1534321|NCT00643058|LPS endotoxin|lps endotoxin
1534322|NCT00643045|Parkinson Disease|parkinson disease
1534323|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
1534324|NCT00643019|Secondary Prevention|secondary prevention
1534325|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
1534326|NCT00643006|Fibromyalgia|fibromyalgia
1534327|NCT00643006|Physical activity|physical activity
1534328|NCT00643006|Function|function
1534329|NCT00643006|Pain|pain
1534330|NCT00643006|Exercise|exercise
1534331|NCT00643006|Inflammation|inflammation
1534332|NCT00642980|Pregnancy|pregnancy
1534333|NCT00642980|Preterm delivery|preterm delivery
1534334|NCT00642980|Bacterial vaginosis|bacterial vaginosis
1534335|NCT00642980|Randomized Clinical Trial|randomized clinical trial
1534336|NCT00642980|Clindamycin|clindamycin
1534337|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
1534338|NCT00642928|Parkinson's disease|parkinson's disease
1534339|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1534340|NCT00642902|Atacicept|atacicept
1534341|NCT00642889|Parkinson's disease|parkinson's disease
1534342|NCT00642863|iron deficiency|iron deficiency
1534343|NCT00642863|iron deficiency anemia|iron deficiency anemia
1534344|NCT00642863|infant|infant
1534345|NCT00642863|development|development
1534346|NCT00642863|behavior|behavior
1534347|NCT00642837|Health-Related Quality of Life|health-related quality of life
1534348|NCT00642837|KEQ-5D|keq-5d
1534349|NCT00642837|Sleep disturbance|sleep disturbance
1534350|NCT00642837|Sleep quality|sleep quality
1534351|NCT00642837|SF-1|sf-1
1534352|NCT00642837|Pain intensity|pain intensity
1534353|NCT00642837|Pain relief|pain relief
1534354|NCT00642837|Tramadol|tramadol
1534355|NCT00642837|Acetaminophen|acetaminophen
1534356|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
1534357|NCT00642811|heart attack|heart attack
1534358|NCT00642811|stable angina|stable angina
1534359|NCT00642785|herpes|herpes
1534360|NCT00642785|HSV|hsv
1534361|NCT00642785|zoster|zoster
1534362|NCT00642785|HZV|hzv
1534363|NCT00642785|shingles|shingles
1534364|NCT00642772|Osteoarthritis|osteoarthritis
1534365|NCT00642772|Veterans|veterans
1534366|NCT00642772|Physical Therapy|physical therapy
1534367|NCT00642772|Health Services Research|health services research
1534368|NCT00642759|NSCLC|nsclc
1534369|NCT00642759|Abraxane|abraxane
1534370|NCT00642759|Carboplatin|carboplatin
1534371|NCT00642759|Bevacizumab|bevacizumab
1534372|NCT00642759|Avastin|avastin
1534373|NCT00642746|Colon|colon
1534374|NCT00642746|Cancer|cancer
1534375|NCT00642746|Metastatic|metastatic
1534376|NCT00642746|Colorectal|colorectal
1534377|NCT00642707|HIV|hiv
1534378|NCT00642707|Treatment Naïve|treatment naïve
1534379|NCT00642694|MDD|mdd
1534380|NCT00642694|Major Depressive Disorder|major depressive disorder
1534381|NCT00642694|Depression|depression
1534382|NCT00642694|Initial Insomnia|initial insomnia
1534383|NCT00642694|sleep|sleep
1534384|NCT00642694|difficulty sleeping|difficulty sleeping
1534385|NCT00642694|down|down
1534386|NCT00642694|sad|sad
1534387|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
1534388|NCT00642655|IVIG|ivig
1534389|NCT00642655|Rituximab|rituximab
1534390|NCT00642655|Highly Sensitized|highly sensitized
1534391|NCT00642655|Kidney Transplantation|kidney transplantation
1534392|NCT00642642|Acne|acne
1534393|NCT00642590|Fertility|fertility
1534394|NCT00642590|Pregnancy|pregnancy
1534395|NCT00642590|Conception|conception
1534396|NCT00642590|Infertility|infertility
1534397|NCT00642590|Behavioral|behavioral
1534398|NCT00642590|Lifestyle|lifestyle
1534399|NCT00642590|Nutrition|nutrition
1534400|NCT00642564|Epilepsy|epilepsy
1534401|NCT00642564|Headache|headache
1534402|NCT00642564|Migraine|migraine
1534403|NCT00642551|vitamin K2|vitamin k2
1534404|NCT00642551|menaquinone-7|menaquinone-7
1534405|NCT00642551|bone health|bone health
1534406|NCT00642551|vascular health|vascular health
1534407|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
1534408|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
1534409|NCT00642525|esophageal resection|esophageal resection
1534410|NCT00642525|diagnostic safety|diagnostic safety
1534411|NCT00642512|CINV|cinv
1534412|NCT00642512|chemotherapy|chemotherapy
1534413|NCT00642512|nausea|nausea
1534414|NCT00642512|vomiting|vomiting
1534415|NCT00642512|retching|retching
1534416|NCT00642499|HIV|hiv
1534417|NCT00642499|AIDS|aids
1534418|NCT00642499|nausea|nausea
1534419|NCT00642499|vomiting|vomiting
1534420|NCT00642499|HAART|haart
1534421|NCT00642499|Treatment Experienced|treatment experienced
1534422|NCT00642499|HIV Infections|hiv infections
1534423|NCT00642486|treatment|treatment
1534424|NCT00642486|positive airway pressure|positive airway pressure
1534425|NCT00642486|compliance|compliance
1534426|NCT00642486|cost effectiveness|cost effectiveness
1534427|NCT00642486|clinical trial|clinical trial
1534428|NCT00642447|noninvasive ventilation|noninvasive ventilation
1534429|NCT00642447|helium|helium
1534430|NCT00642447|oxygen|oxygen
1534431|NCT00642447|sulfur mustard|sulfur mustard
1534432|NCT00642447|chronic bronchitis|chronic bronchitis
1534433|NCT00642447|bronchiolitis|bronchiolitis
1534434|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
1534435|NCT00642421|Acromegaly|acromegaly
1534436|NCT00642395|Multiple Myeloma|multiple myeloma
1534437|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
1534438|NCT00642395|High Dose Melphalan|high dose melphalan
1534439|NCT00642395|Bortezomib|bortezomib
1534440|NCT00642382|Osteoarthritis|osteoarthritis
1534441|NCT00642382|Hyaluronic Acid|hyaluronic acid
1534442|NCT00642369|Polysomnograph|polysomnograph
1534443|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1534444|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
1534445|NCT00642356|non-motor symptoms|non-motor symptoms
1534446|NCT00642356|motor-symptoms|motor-symptoms
1534447|NCT00642343|Balance|balance
1534448|NCT00642343|Severe, Profound deafness|severe, profound deafness
1534449|NCT00642343|Children|children
1534450|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
1534451|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
1534452|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
1534453|NCT00642330|patent|patent
1534454|NCT00642330|ductus|ductus
1534455|NCT00642330|arteriosus|arteriosus
1534456|NCT00642330|ibuprofen|ibuprofen
1534457|NCT00642330|premature|premature
1534458|NCT00642330|infant|infant
1534459|NCT00642317|Healthy Control|healthy control
1534460|NCT00642317|Tobacco Use|tobacco use
1534461|NCT00642317|Tobacco Initiation|tobacco initiation
1534462|NCT00642317|Smoking|smoking
1534463|NCT00642317|Questionnaire|questionnaire
1534464|NCT00642317|Survey|survey
1534465|NCT00642291|Emtricitabine|emtricitabine
1534466|NCT00642291|Pediatric|pediatric
1534467|NCT00642291|HIV-1|hiv-1
1534468|NCT00642291|Treatment of HIV-1|treatment of hiv-1
1534469|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
1534470|NCT00642278|Metformin|metformin
1534471|NCT00642278|Hemoglobin A1c|hemoglobin a1c
1534472|NCT00642252|remineraliation|remineraliation
1534473|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
1534474|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
1534475|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
1534476|NCT00642226|BRVO|brvo
1534477|NCT00642226|Macular Edema|macular edema
1534478|NCT00642226|Triamcinolone|triamcinolone
1534479|NCT00642226|Vitrectomy|vitrectomy
1534480|NCT00642213|stroke|stroke
1534481|NCT00642213|ischemic|ischemic
1534482|NCT00642213|TIA|tia
1534483|NCT00642213|hemorrhage|hemorrhage
1534484|NCT00642213|incidence|incidence
1534485|NCT00642213|case-fatality|case-fatality
1534486|NCT00642213|risk factors|risk factors
1534487|NCT00642213|genetic|genetic
1534488|NCT00642187|Asthma|asthma
1534489|NCT00642187|Pulmicort|pulmicort
1534490|NCT00642187|Turbuhaler|turbuhaler
1534491|NCT00642187|Budesonide|budesonide
1534492|NCT00642187|Flexhaler|flexhaler
1534493|NCT00642161|Asthma|asthma
1534494|NCT00642161|Pulmicort|pulmicort
1534495|NCT00642161|Children|children
1534496|NCT00642161|Paediatrics|paediatrics
1534497|NCT00642161|budesonide|budesonide
1534498|NCT00642161|Flexhaler|flexhaler
1534499|NCT00642148|GW856553|gw856553
1534500|NCT00642148|p38 MAPK|p38 mapk
1534501|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1534502|NCT00642135|premature|premature
1534503|NCT00642135|neonates|neonates
1534504|NCT00642135|infants|infants
1534505|NCT00642135|children|children
1534506|NCT00642135|Mydriasert®|mydriasert®
1534507|NCT00642135|mydriasis|mydriasis
1534508|NCT00642135|fundus|fundus
1534509|NCT00642135|Tropicamide|tropicamide
1534510|NCT00642135|Phenylephrine|phenylephrine
1534511|NCT00642135|clinical trial|clinical trial
1534512|NCT00642135|Infant|infant
1534513|NCT00642135|premature newborns|premature newborns
1534514|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
1534515|NCT00642122|Asthma|asthma
1534516|NCT00642122|Pulmicort|pulmicort
1534517|NCT00642122|budesonide|budesonide
1534518|NCT00642122|respules|respules
1534519|NCT00642122|turbuhaler|turbuhaler
1534520|NCT00642096|High blood pressure|high blood pressure
1534812|NCT00641173|cortisol|cortisol
1534521|NCT00642096|hypertension|hypertension
1534522|NCT00642096|(TOPROL-XL)|(toprol-xl)
1534523|NCT00642096|metoprolol succinate|metoprolol succinate
1534524|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
1534525|NCT00642083|outflow stenosis|outflow stenosis
1534526|NCT00642083|stentgraft|stentgraft
1534527|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
1534528|NCT00642057|chorea|chorea
1534529|NCT00642057|dyskinesia|dyskinesia
1534530|NCT00642057|hyperkinetic|hyperkinetic
1534531|NCT00642044|Keratoconus|keratoconus
1534532|NCT00642031|Hematologic Malignancies|hematologic malignancies
1534533|NCT00642031|Leukemia|leukemia
1534534|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1534535|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1534536|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1534537|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1534538|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
1534539|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
1534540|NCT00642031|Triciribine|triciribine
1534541|NCT00642031|TCN-PM|tcn-pm
1534542|NCT00642031|VD-0002|vd-0002
1534543|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1534544|NCT00642005|Humidification|humidification
1534545|NCT00642005|Laparoscopy|laparoscopy
1534546|NCT00642005|Colon|colon
1534547|NCT00642005|Hemicolectomy|hemicolectomy
1534548|NCT00642005|Warming|warming
1534549|NCT00641992|amebic liver abscess|amebic liver abscess
1534550|NCT00641992|failure|failure
1534551|NCT00641992|prognosis|prognosis
1534552|NCT00641979|Allergic rhinitis|allergic rhinitis
1534553|NCT00641979|Nasal symptoms|nasal symptoms
1534554|NCT00641979|Congestion|congestion
1534555|NCT00641979|Rhinorrhea|rhinorrhea
1534556|NCT00641979|Sneeze|sneeze
1534557|NCT00641979|budesonide|budesonide
1534558|NCT00641979|Rhinocort AQUA|rhinocort aqua
1534559|NCT00641953|Foot Pain|foot pain
1534560|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
1534561|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
1534562|NCT00641940|Prevention|prevention
1534563|NCT00641940|Girls|girls
1534564|NCT00641940|Resilience|resilience
1534565|NCT00641927|bipolar disorder|bipolar disorder
1534566|NCT00641927|bipolar type II disorder|bipolar type ii disorder
1534567|NCT00641927|antidepressant|antidepressant
1534568|NCT00641927|mood stabilizer|mood stabilizer
1534569|NCT00641927|venlafaxine|venlafaxine
1534570|NCT00641927|lithium carbonate|lithium carbonate
1534571|NCT00641914|Asthma|asthma
1534572|NCT00641914|Pulmicort|pulmicort
1534573|NCT00641914|budesonide|budesonide
1534574|NCT00641901|gingivitis|gingivitis
1534575|NCT00641901|pregnancy|pregnancy
1534576|NCT00641901|pre-term birth|pre-term birth
1534577|NCT00641888|Cardiovascular risk|cardiovascular risk
1534578|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
1534579|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
1534580|NCT00641875|arterial stiffness|arterial stiffness
1534581|NCT00641875|artery|artery
1534582|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
1534583|NCT00641875|pulse wave analysis|pulse wave analysis
1534584|NCT00641875|augmentation index|augmentation index
1534585|NCT00641875|end stage renal disease|end stage renal disease
1534586|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
1534587|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
1534588|NCT00641875|cardiovascular|cardiovascular
1534589|NCT00641875|hemodialysis|hemodialysis
1534590|NCT00641862|Pregnancy|pregnancy
1534591|NCT00641862|Maternal Nutritional Status|maternal nutritional status
1534592|NCT00641862|Vitamin B12|vitamin b12
1534593|NCT00641849|BMI|bmi
1534594|NCT00641849|Physical Activity|physical activity
1534595|NCT00641849|Food|food
1534596|NCT00641849|Nutrition|nutrition
1534597|NCT00641849|Dietary behaviors|dietary behaviors
1534598|NCT00641849|Diet|diet
1534599|NCT00641849|Adult|adult
1534600|NCT00641849|Adults|adults
1534601|NCT00641849|Fat|fat
1534602|NCT00641849|Fats|fats
1534603|NCT00641849|Self monitoring|self monitoring
1534604|NCT00641849|Automated feedback|automated feedback
1534605|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
1534606|NCT00641810|Caffeine|caffeine
1534607|NCT00641810|Snoring|snoring
1534608|NCT00641810|Sleep|sleep
1534970|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
1534609|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
1534610|NCT00641797|Vertigo|vertigo
1534611|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
1534612|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
1534613|NCT00641758|Coronary Artery Disease|coronary artery disease
1534614|NCT00641758|endothelial dysfunction|endothelial dysfunction
1534615|NCT00641758|Nitric oxide|nitric oxide
1534616|NCT00641745|Lurasidone|lurasidone
1534617|NCT00641745|Schizophrenia|schizophrenia
1534618|NCT00641745|Latuda|latuda
1534619|NCT00641732|venous thromboembolism|venous thromboembolism
1534620|NCT00641732|oral anticoagulant|oral anticoagulant
1534621|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
1534622|NCT00641732|total knee replacement|total knee replacement
1534623|NCT00641732|drug therapy|drug therapy
1534624|NCT00641693|Allergic rhinitis|allergic rhinitis
1534625|NCT00641693|Paediatric|paediatric
1534626|NCT00641693|Nasal symptoms|nasal symptoms
1534627|NCT00641693|Congestion|congestion
1534628|NCT00641693|Rhinorrhea|rhinorrhea
1534629|NCT00641693|Sneeze|sneeze
1534630|NCT00641693|budesonide|budesonide
1534631|NCT00641693|Rhinocort AQUA|rhinocort aqua
1534632|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
1534633|NCT00641680|Nasal symptoms|nasal symptoms
1534634|NCT00641680|Congestion|congestion
1534635|NCT00641680|Rhinorrhea|rhinorrhea
1534636|NCT00641680|Sneeze|sneeze
1534637|NCT00641680|budesonide|budesonide
1534638|NCT00641680|Rhinocort AQUA|rhinocort aqua
1534639|NCT00641680|Fluticasone propionate|fluticasone propionate
1534640|NCT00641680|Flonase|flonase
1534641|NCT00641667|Pain|pain
1534642|NCT00641667|Cancer|cancer
1534643|NCT00641667|Fentanyl|fentanyl
1534644|NCT00641667|JNS020QD|jns020qd
1534645|NCT00641654|Chronic hepatitis C|chronic hepatitis c
1534646|NCT00641654|genotype 2 or 3|genotype 2 or 3
1534647|NCT00641654|relapse|relapse
1534648|NCT00641654|pegylated interferon|pegylated interferon
1534649|NCT00641654|ribavirin|ribavirin
1534650|NCT00641641|Viral compartments|viral compartments
1534651|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
1534652|NCT00641641|viral species|viral species
1534653|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
1534654|NCT00641628|NAC conservation|nac conservation
1534655|NCT00641602|Erosive Esophagitis|erosive esophagitis
1534656|NCT00641602|Nexium|nexium
1534657|NCT00641602|Heartburn|heartburn
1534658|NCT00641589|Chronic Kidney Disease|chronic kidney disease
1534659|NCT00641589|anemia|anemia
1534660|NCT00641589|epoetin alfa|epoetin alfa
1534661|NCT00641576|Endosseous implants|endosseous implants
1534662|NCT00641563|dexmedetomidine|dexmedetomidine
1534663|NCT00641563|midazolam|midazolam
1534664|NCT00641563|remifentanil|remifentanil
1534665|NCT00641563|Electroencephalography|electroencephalography
1534666|NCT00641563|Event related potentials|event related potentials
1534667|NCT00641563|BIS|bis
1534668|NCT00641563|Bispectral Index|bispectral index
1534669|NCT00641563|Response Entropy|response entropy
1534670|NCT00641563|State Entropy|state entropy
1534671|NCT00641550|physical exercise|physical exercise
1534672|NCT00641550|maternal complications|maternal complications
1534673|NCT00641550|preterm labor|preterm labor
1534674|NCT00641550|birthweight|birthweight
1534675|NCT00641550|Apgar scores|apgar scores
1534676|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1534677|NCT00641524|liver fibrosis|liver fibrosis
1534678|NCT00641524|metabolic syndrome|metabolic syndrome
1534679|NCT00641524|iron overload|iron overload
1534680|NCT00641524|phlebotomy|phlebotomy
1534681|NCT00641511|PTSD|ptsd
1534682|NCT00641498|suicide|suicide
1534683|NCT00641498|parasuicide|parasuicide
1534684|NCT00641498|prevention|prevention
1534685|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
1534686|NCT00641472|Asthma|asthma
1534687|NCT00641472|Pulmicort|pulmicort
1534688|NCT00641472|Children|children
1534689|NCT00641472|paediatrics|paediatrics
1534690|NCT00641472|budesonide|budesonide
1534691|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
1534692|NCT00641459|BPSD|bpsd
1534693|NCT00641459|NPI|npi
1534694|NCT00641459|CGI|cgi
1534695|NCT00641459|MMSE|mmse
1534696|NCT00641446|Children|children
1534697|NCT00641446|Asthma|asthma
1534698|NCT00641446|Varivax|varivax
1534699|NCT00641446|varicella|varicella
1534700|NCT00641446|Pulmicort|pulmicort
1534701|NCT00641446|budesonide|budesonide
1534702|NCT00641433|chemocautery|chemocautery
1534703|NCT00641420|Acne scarring|acne scarring
1534704|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
1534705|NCT00641407|Bedtime insulins|bedtime insulins
1534706|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
1534707|NCT00641407|Glycemic control|glycemic control
1534708|NCT00641407|HbA1c|hba1c
1534709|NCT00641394|cortisol|cortisol
1534710|NCT00641394|hydrocortisone|hydrocortisone
1534711|NCT00641394|psychotherapy|psychotherapy
1534712|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
1534713|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1534714|NCT00641394|depression|depression
1534715|NCT00641394|anxiety|anxiety
1534716|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1534717|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1534718|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1534719|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1534720|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1534721|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1534722|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1534723|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1534724|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1534725|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1534726|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1534727|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1534728|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1534729|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1534730|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1534731|NCT00641381|Burkitt lymphoma|burkitt lymphoma
1534732|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1534733|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1534734|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1534735|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1534736|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1534737|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1534738|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1534739|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1534740|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1534741|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1534742|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1534743|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1534744|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1534745|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1534746|NCT00641381|HIV Infections|hiv infections
1534747|NCT00641381|Treatment Experienced|treatment experienced
1534748|NCT00641368|Adolescent|adolescent
1534749|NCT00641368|Child|child
1534750|NCT00641368|Computer|computer
1534751|NCT00641368|Depression|depression
1534752|NCT00641368|Resilience|resilience
1534753|NCT00641342|Parastomal hernia|parastomal hernia
1534754|NCT00641342|Onlay mesh|onlay mesh
1534755|NCT00641342|Sublay mesh|sublay mesh
1534756|NCT00641342|Pain|pain
1534757|NCT00641342|Health questionnaire|health questionnaire
1534758|NCT00641329|ADHD|adhd
1534759|NCT00641329|ADD|add
1534760|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1534761|NCT00641329|Attention Deficit|attention deficit
1534762|NCT00641329|Clonidine|clonidine
1534763|NCT00641329|CLONICEL|clonicel
1534764|NCT00641329|Addrenex|addrenex
1534765|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
1534766|NCT00641316|Platelet-rich plasma|platelet-rich plasma
1534767|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
1534768|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
1534769|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
1534770|NCT00641303|pain|pain
1534771|NCT00641303|fatigue|fatigue
1534772|NCT00641303|hot flashes|hot flashes
1534773|NCT00641303|sleep disorders|sleep disorders
1534774|NCT00641303|depression|depression
1534775|NCT00641303|anxiety disorder|anxiety disorder
1534776|NCT00641303|stage I breast cancer|stage i breast cancer
1534777|NCT00641303|stage II breast cancer|stage ii breast cancer
1534778|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
1534779|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
1534780|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
1534781|NCT00641290|CABG|cabg
1534782|NCT00641290|Valve surgery|valve surgery
1534783|NCT00641277|endosseous dental implants|endosseous dental implants
1534784|NCT00641277|dental aesthetics|dental aesthetics
1534785|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
1534786|NCT00641264|Omeprazole|omeprazole
1534787|NCT00641264|Losec|losec
1534788|NCT00641264|Quality of Life|quality of life
1534789|NCT00641264|Laryngitis|laryngitis
1534790|NCT00641251|T2 Diabetes|t2 diabetes
1534791|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
1534792|NCT00641238|NSCLC|nsclc
1534793|NCT00641238|lung cancer|lung cancer
1534794|NCT00641225|Ascending Single Dose|ascending single dose
1534795|NCT00641225|Safety|safety
1534796|NCT00641225|Pharmacokinetics|pharmacokinetics
1534797|NCT00641225|Open-label|open-label
1534798|NCT00641212|Allergic rhinitis|allergic rhinitis
1534799|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
1534800|NCT00641212|Paediatric|paediatric
1534801|NCT00641212|Growth|growth
1534802|NCT00641212|budesonide|budesonide
1534803|NCT00641212|Rhinocort AQUA|rhinocort aqua
1534804|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
1534805|NCT00641199|Probiotic|probiotic
1534806|NCT00641199|Quality of life|quality of life
1534807|NCT00641199|Antibiotics|antibiotics
1534808|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
1534809|NCT00641186|Parkinson disease|parkinson disease
1534810|NCT00641186|sleep disturbance|sleep disturbance
1534811|NCT00641173|PTSD|ptsd
1534813|NCT00641173|hippocampus|hippocampus
1534814|NCT00641173|memory|memory
1534815|NCT00641160|vinorelbine|vinorelbine
1534816|NCT00641160|metronomic dosing|metronomic dosing
1534817|NCT00641160|oral administration|oral administration
1534818|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
1534819|NCT00641160|pharmacokinetics|pharmacokinetics
1534820|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
1534821|NCT00641134|Old age|old age
1534822|NCT00641134|Home physical training|home physical training
1534823|NCT00641108|SPECT Brain Imaging|spect brain imaging
1534824|NCT00641108|Cognitive Therapy|cognitive therapy
1534825|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
1534826|NCT00641108|Predictive Biomarker|predictive biomarker
1534827|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1534828|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1534829|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1534830|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1534831|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1534832|NCT00641069|Cardiac arrest|cardiac arrest
1534833|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1534834|NCT00641056|diabetes|diabetes
1534835|NCT00641056|exenatide|exenatide
1534836|NCT00641056|exenatide once weekly|exenatide once weekly
1534837|NCT00641056|metformin|metformin
1534838|NCT00641056|sulfonylurea|sulfonylurea
1534839|NCT00641056|insulin glargine|insulin glargine
1534840|NCT00641056|Amylin|amylin
1534841|NCT00641056|Lilly|lilly
1534842|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1534843|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1534844|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1534845|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1534846|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1534847|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1534848|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1534849|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1534850|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1534851|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1534852|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1534853|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1534854|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1534855|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1534856|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1534857|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1534858|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1534859|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1534860|NCT00640991|Clinical Trial|clinical trial
1534861|NCT00640991|Insulin|insulin
1534862|NCT00640978|Pancreatic Cancer|pancreatic cancer
1534863|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
1534864|NCT00640978|Unresectable|unresectable
1534865|NCT00640978|Metastatic|metastatic
1534866|NCT00640978|RAD001|rad001
1534867|NCT00640978|Everolimus|everolimus
1534868|NCT00640978|Erlotinib|erlotinib
1534869|NCT00640978|OSI-774|osi-774
1534870|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
1534871|NCT00640978|Tarceva|tarceva
1534872|NCT00640952|Parkinson's disease|parkinson's disease
1534873|NCT00640952|impulse control behaviors|impulse control behaviors
1534874|NCT00640952|dopa-dysregulation|dopa-dysregulation
1534875|NCT00640939|Tendonitis|tendonitis
1534876|NCT00640939|Bursitis|bursitis
1534877|NCT00640913|Defunctioning stoma|defunctioning stoma
1534878|NCT00640913|Low anterior resection|low anterior resection
1534879|NCT00640913|TME surgery|tme surgery
1534880|NCT00640913|Early stoma reversal|early stoma reversal
1534881|NCT00640900|overweight|overweight
1534882|NCT00640900|obesity|obesity
1534883|NCT00640900|weight loss|weight loss
1534884|NCT00640900|commercial weight loss program|commercial weight loss program
1534886|NCT00640887|Tuberculosis|tuberculosis
1534887|NCT00640887|Rifabutin|rifabutin
1534888|NCT00640887|Pharmacokinetics|pharmacokinetics
1534889|NCT00640887|South Africa|south africa
1534890|NCT00640874|Prophylaxis|prophylaxis
1534891|NCT00640874|pandemic influenza|pandemic influenza
1534892|NCT00640874|influenza A|influenza a
1534893|NCT00640874|H5N1 virus|h5n1 virus
1534894|NCT00640861|stage II breast cancer|stage ii breast cancer
1534895|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
1534896|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
1534897|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
1534898|NCT00640861|stage IA breast cancer|stage ia breast cancer
1534899|NCT00640861|stage IB breast cancer|stage ib breast cancer
1534900|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
1534901|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
1534902|NCT00640835|Opioid dependence|opioid dependence
1534903|NCT00640809|Bowel Disease|bowel disease
1534904|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
1534905|NCT00640796|NK cell expansion|nk cell expansion
1534906|NCT00640796|CliniMACS device|clinimacs device
1534907|NCT00640796|Immunotherapy|immunotherapy
1534908|NCT00640783|Metabolic syndrome|metabolic syndrome
1534909|NCT00640783|Mediterranean diet|mediterranean diet
1534910|NCT00640783|Inflammatory markers|inflammatory markers
1534911|NCT00640783|Endothelial function|endothelial function
1534912|NCT00640757|Methionine|methionine
1534913|NCT00640757|Metabolic syndrome|metabolic syndrome
1534914|NCT00640757|Glucose Metabolism|glucose metabolism
1534915|NCT00640757|Amino acid|amino acid
1534916|NCT00640757|Insulin clamp|insulin clamp
1534917|NCT00640744|Atherogenesis|atherogenesis
1534918|NCT00640744|Atheroma|atheroma
1534919|NCT00640744|Arteriosclerosis|arteriosclerosis
1534920|NCT00640731|DVT|dvt
1534921|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
1534922|NCT00640731|Venous Thrombosis|venous thrombosis
1534923|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
1534924|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
1534925|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1534926|NCT00640692|GIST|gist
1534927|NCT00640692|Sunitinib|sunitinib
1534928|NCT00640692|Imatinib|imatinib
1534929|NCT00640679|Clopidogrel|clopidogrel
1534930|NCT00640679|Drug-eluting Stent|drug-eluting stent
1534931|NCT00640666|Breast cancer|breast cancer
1534932|NCT00640666|Exercise|exercise
1534933|NCT00640666|Biomarkers|biomarkers
1534934|NCT00640653|Sexual Behavior|sexual behavior
1534935|NCT00640653|Abstinence|abstinence
1534936|NCT00640653|Intervention Studies|intervention studies
1534937|NCT00640653|HIV|hiv
1534938|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
1534939|NCT00640653|Theory of Planned Behavior|theory of planned behavior
1534940|NCT00640653|HIV Seronegativity|hiv seronegativity
1534941|NCT00640640|IOP|iop
1534942|NCT00640640|OPA|opa
1534943|NCT00640640|AMD|amd
1534944|NCT00640640|bevacizumab|bevacizumab
1534945|NCT00640640|ranibizumab|ranibizumab
1534946|NCT00640640|choroidal blood flow|choroidal blood flow
1534947|NCT00640640|DCT|dct
1534948|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
1534949|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
1534950|NCT00640614|Dermatitis, Contact|dermatitis, contact
1534951|NCT00640601|Seroquel|seroquel
1534952|NCT00640601|schizophrenia|schizophrenia
1534953|NCT00640601|Extended Release|extended release
1534954|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
1534955|NCT00640588|Viral kinetics|viral kinetics
1534956|NCT00640588|Telbivudine|telbivudine
1534957|NCT00640588|Adefovir|adefovir
1534958|NCT00640588|Compliance|compliance
1534959|NCT00640562|Schizophrenia|schizophrenia
1534960|NCT00640562|Depression|depression
1534961|NCT00640562|Quetiapine|quetiapine
1534962|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
1534963|NCT00640497|acute GVHD|acute gvhd
1534964|NCT00640497|immunotoxin|immunotoxin
1534965|NCT00640497|anti-CD3|anti-cd3
1534966|NCT00640497|anti-CD7|anti-cd7
1534967|NCT00640497|Ricin A|ricin a
1534968|NCT00640471|recurrent colon cancer|recurrent colon cancer
1534969|NCT00640471|stage IV colon cancer|stage iv colon cancer
1534971|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
1534972|NCT00640445|Clinical Trial|clinical trial
1534973|NCT00640445|Combat Disorders|combat disorders
1534974|NCT00640445|PTSD|ptsd
1534975|NCT00640445|Internet-Based Intervention|internet-based intervention
1534976|NCT00640445|Mental Health Services|mental health services
1534977|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
1534978|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
1534979|NCT00640380|cervical|cervical
1534980|NCT00640380|paravertebral|paravertebral
1534981|NCT00640380|block|block
1534982|NCT00640367|Acute ischemic stroke|acute ischemic stroke
1534983|NCT00640367|thrombolysis|thrombolysis
1534984|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
1534985|NCT00640354|Automated External Defibrillator|automated external defibrillator
1534986|NCT00640354|Resuscitation|resuscitation
1534987|NCT00640354|Pediatric|pediatric
1534988|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
1534989|NCT00640328|ofatumumab|ofatumumab
1534990|NCT00640328|multiple sclerosis|multiple sclerosis
1534991|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1534992|NCT00640315|COPD|copd
1534993|NCT00640315|Pulmonary hypertension|pulmonary hypertension
1534994|NCT00640302|Index cases|index cases
1534995|NCT00640302|pandemic influenza|pandemic influenza
1534996|NCT00640302|influenza A|influenza a
1534997|NCT00640302|H5N1 virus|h5n1 virus
1534998|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
1534999|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
1535000|NCT00640289|Hemophilia|hemophilia
1535001|NCT00640289|Fibrogammin P|fibrogammin p
1535002|NCT00640276|pitavastatin|pitavastatin
1535003|NCT00640276|metabolic syndrome|metabolic syndrome
1535004|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
1535005|NCT00640276|hypercholesterolemia|hypercholesterolemia
1535006|NCT00640263|HIV-1|hiv-1
1535007|NCT00640263|Breastfeeding|breastfeeding
1535008|NCT00640263|Prevention|prevention
1535009|NCT00640263|lamivudine|lamivudine
1535010|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
1535011|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
1535012|NCT00640237|Vitamine D State|vitamine d state
1535013|NCT00640211|Prophylaxis|prophylaxis
1535014|NCT00640211|pandemic influenza|pandemic influenza
1535015|NCT00640211|influenza A|influenza a
1535016|NCT00640211|H5N1 virus|h5n1 virus
1535017|NCT00640198|Aphasia|aphasia
1535018|NCT00640198|Memantine|memantine
1535019|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
1535020|NCT00640198|Event-related potentials|event-related potentials
1535021|NCT00640159|Parkinson's disease|parkinson's disease
1535022|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
1535023|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
1535024|NCT00640133|Deep Brain Stimulation|deep brain stimulation
1535025|NCT00640133|Treatment Refractory|treatment refractory
1535026|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
1535027|NCT00640133|Neurosurgery|neurosurgery
1535028|NCT00640133|Neuroimaging|neuroimaging
1535029|NCT00640120|wheeze detection|wheeze detection
1535030|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
1535031|NCT00640094|Melatonin|melatonin
1535032|NCT00640094|Acute myocardial infarction|acute myocardial infarction
1535033|NCT00640094|Primary angioplasty|primary angioplasty
1535034|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
1535035|NCT00640081|stage IV colon cancer|stage iv colon cancer
1535036|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1535037|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
1535038|NCT00640081|stage III colon cancer|stage iii colon cancer
1535039|NCT00640081|stage III rectal cancer|stage iii rectal cancer
1535040|NCT00640081|recurrent colon cancer|recurrent colon cancer
1535041|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
1535042|NCT00640068|coronary artery disease|coronary artery disease
1535043|NCT00640068|chest pain|chest pain
1535044|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
1535045|NCT00640068|stress test|stress test
1535046|NCT00640068|Coronary Angiography|coronary angiography
1535047|NCT00640055|verbal autopsy|verbal autopsy
1535048|NCT00640055|stillbirth|stillbirth
1535049|NCT00640055|neonatal death|neonatal death
1535050|NCT00640042|pain|pain
1535051|NCT00640042|opioid|opioid
1535052|NCT00640042|abuse|abuse
1535053|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
1535054|NCT00640029|Arthroplasty|arthroplasty
1535055|NCT00640029|Arthrodesis|arthrodesis
1535056|NCT00640029|Prosthesis|prosthesis
1535057|NCT00640029|Disc replacement|disc replacement
1535058|NCT00640029|Spine|spine
1535059|NCT00640029|Lumbar|lumbar
1535060|NCT00640029|Cervical|cervical
1535061|NCT00640029|Intervertebral disk|intervertebral disk
1535062|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
1535063|NCT00640029|Degenerative pathology|degenerative pathology
1535065|NCT00640016|CAT-354|cat-354
1535066|NCT00640016|Tralokinumab|tralokinumab
1535067|NCT00640003|AT|at
1535068|NCT00640003|Ataxia|ataxia
1535069|NCT00640003|Telangiectasia|telangiectasia
1535070|NCT00639990|Intraabdominal pressure|intraabdominal pressure
1535071|NCT00639977|Intraocular Pressure|intraocular pressure
1535072|NCT00639977|Acupuncture|acupuncture
1535073|NCT00639977|Healthy Volunteers|healthy volunteers
1535074|NCT00639964|diabetes|diabetes
1535075|NCT00639964|pregnancy|pregnancy
1535076|NCT00639964|macrosomia|macrosomia
1535077|NCT00639964|lipidics markers|lipidics markers
1535078|NCT00639964|nutritional factors|nutritional factors
1535079|NCT00639964|placenta|placenta
1535080|NCT00639964|umbilical blood cord|umbilical blood cord
1535081|NCT00639951|Snake Bite|snake bite
1535082|NCT00639951|Antivenin Treatment|antivenin treatment
1535083|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
1535084|NCT00639938|HIV Seronegativity|hiv seronegativity
1535085|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
1535086|NCT00639899|Varicocele|varicocele
1535087|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
1535088|NCT00639860|extraction|extraction
1535089|NCT00639860|implant|implant
1535090|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
1535091|NCT00639847|Asthma management|asthma management
1535092|NCT00639847|cost|cost
1535093|NCT00639847|disease management|disease management
1535094|NCT00639847|respiratory care|respiratory care
1535096|NCT00639847|health care utilization|health care utilization
1535097|NCT00639847|health related quality of life|health related quality of life
1535098|NCT00639834|rheumatoid|rheumatoid
1535099|NCT00639834|arthritis|arthritis
1535100|NCT00639834|RA|ra
1535101|NCT00639834|joint inflammation|joint inflammation
1535102|NCT00639834|autoimmune|autoimmune
1535103|NCT00639834|Medarex|medarex
1535104|NCT00639834|Rheumatology|rheumatology
1535105|NCT00639821|Gene expression microarray|gene expression microarray
1535106|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
1535107|NCT00639821|Infliximab|infliximab
1535108|NCT00639808|delayed gastric emptying|delayed gastric emptying
1535109|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
1535110|NCT00639808|diabetes mellitus|diabetes mellitus
1535111|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
1535112|NCT00639795|Cytokines|cytokines
1535113|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
1535114|NCT00639795|Pain|pain
1535115|NCT00639782|thromboembolism|thromboembolism
1535116|NCT00639782|mechanical heart valves|mechanical heart valves
1535117|NCT00639782|randomized|randomized
1535118|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1535119|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1535120|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1535121|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1535122|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1535123|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1535124|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1535125|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1535126|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1535127|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1535128|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1535129|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1535130|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1535131|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1535132|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1535133|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1535134|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1535135|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1535136|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1535137|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
1535138|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1535139|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
1535140|NCT00639756|Uric acid|uric acid
1535141|NCT00639756|Fructose|fructose
1535142|NCT00639756|Hypertension|hypertension
1535143|NCT00639756|Insulin|insulin
1535144|NCT00639756|Glucose|glucose
1535145|NCT00639756|HOMA|homa
1535146|NCT00639743|Pulmonary embolism|pulmonary embolism
1535147|NCT00639743|Heparin|heparin
1535148|NCT00639743|Thrombolytic therapy|thrombolytic therapy
1535149|NCT00639743|Bleeding|bleeding
1535150|NCT00639730|Epilepsy|epilepsy
1535151|NCT00639717|GVHD|gvhd
1535152|NCT00639704|MRI|mri
1535153|NCT00639704|SPECT|spect
1535154|NCT00639704|Cardiac function|cardiac function
1535155|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
1535156|NCT00639678|healthy volunteers|healthy volunteers
1535157|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
1535158|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
1535159|NCT00639652|3D-histology|3d-histology
1535160|NCT00639652|Micrographic surgery|micrographic surgery
1535161|NCT00639652|Mohs surgery|mohs surgery
1535162|NCT00639652|Shave excision|shave excision
1535163|NCT00639652|Recurrence|recurrence
1535164|NCT00639652|Esthetic outcome|esthetic outcome
1535165|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
1535166|NCT00639639|adult gliosarcoma|adult gliosarcoma
1535167|NCT00639587|Cetirizine|cetirizine
1535168|NCT00639587|Zyrtec|zyrtec
1535169|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
1535170|NCT00639561|digestive system|digestive system
1535171|NCT00639561|Diet|diet
1535172|NCT00639548|Deep Sedation|deep sedation
1535173|NCT00639548|EEG|eeg
1535174|NCT00639548|Event-Related Potentials|event-related potentials
1535175|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
1535176|NCT00639548|BIS-Index|bis-index
1535177|NCT00639548|Entropy|entropy
1535178|NCT00639548|ICU|icu
1535179|NCT00639535|Radiology|radiology
1535180|NCT00639535|MRI|mri
1535181|NCT00639535|Positron emission tomography|positron emission tomography
1535182|NCT00639535|Breast Abnormalities|breast abnormalities
1535183|NCT00639535|Dense Breast Tissue|dense breast tissue
1535184|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
1535185|NCT00639522|Maximum tolerated dose|maximum tolerated dose
1535186|NCT00639522|Pharmacokinetics|pharmacokinetics
1535187|NCT00639522|Gastric carcinoma|gastric carcinoma
1535188|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1535189|NCT00639470|Patient Education Handout|patient education handout
1535190|NCT00639470|Parents|parents
1535191|NCT00639470|Patient Education|patient education
1535192|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
1535193|NCT00639457|glucose metabolism|glucose metabolism
1535194|NCT00639457|inflammation|inflammation
1535195|NCT00639457|adipose tissue distribution|adipose tissue distribution
1535196|NCT00639457|cardiac function|cardiac function
1535197|NCT00639457|vascular function|vascular function
1535198|NCT00639457|mass spectrometry|mass spectrometry
1535199|NCT00639457|Treatment Experienced|treatment experienced
1535200|NCT00639431|phantom limb pain|phantom limb pain
1535201|NCT00639431|limb amputation|limb amputation
1535202|NCT00639431|Amputation|amputation
1535203|NCT00639431|Phantom Limb|phantom limb
1535204|NCT00639431|Pain|pain
1535205|NCT00639405|Parathyroid|parathyroid
1535206|NCT00639405|MRI|mri
1535207|NCT00639405|SPECT|spect
1535208|NCT00639392|Sickle cell disease|sickle cell disease
1535209|NCT00639379|toric contact lenses|toric contact lenses
1535210|NCT00639379|vision|vision
1535211|NCT00639379|comfort|comfort
1535212|NCT00639379|toric fit characteristics|toric fit characteristics
1535213|NCT00639379|slit lamp findings|slit lamp findings
1535214|NCT00639366|recurrent breast cancer|recurrent breast cancer
1535215|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
1535216|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
1535217|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
1535218|NCT00639366|stage IV breast cancer|stage iv breast cancer
1535219|NCT00639327|Stomach Neoplasms|stomach neoplasms
1535220|NCT00639327|Second line chemotherapy|second line chemotherapy
1535221|NCT00639327|Refractory to S-1|refractory to s-1
1535222|NCT00639327|irinotecan|irinotecan
1535223|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
1535224|NCT00639327|Phase III study|phase iii study
1535225|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
1535226|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
1535227|NCT00639314|randomized controlled trial|randomized controlled trial
1535228|NCT00639314|delayed gastric empty|delayed gastric empty
1535229|NCT00639314|quality of life|quality of life
1535230|NCT00639301|Survivor|survivor
1535231|NCT00639301|Quality of Life|quality of life
1535232|NCT00639301|Eye|eye
1535233|NCT00639288|Alcohol Dependence|alcohol dependence
1535234|NCT00639288|PTSD|ptsd
1535235|NCT00639288|CPT-C|cpt-c
1535236|NCT00639262|Sorafenib|sorafenib
1535237|NCT00639262|Radiation Therapy|radiation therapy
1535238|NCT00639262|Radiotherapy|radiotherapy
1535239|NCT00639262|Temozolomide|temozolomide
1535240|NCT00639262|Brain Metastases|brain metastases
1697312|NCT00063180|HV|hv
1535241|NCT00639262|Brain Tumors|brain tumors
1535242|NCT00639236|COPD|copd
1535243|NCT00639236|Hypertonic saline|hypertonic saline
1535244|NCT00639236|Quality of life|quality of life
1535245|NCT00639236|Dyspnoea.|dyspnoea.
1535246|NCT00639223|Statin related myalgia|statin related myalgia
1535247|NCT00639223|Hyperlipidemia|hyperlipidemia
1535248|NCT00639223|Red yeast rice|red yeast rice
1535249|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
1535250|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
1535251|NCT00639210|breast cancer|breast cancer
1535252|NCT00639210|exercise|exercise
1535253|NCT00639210|osteoporosis|osteoporosis
1535254|NCT00639210|fracture|fracture
1535255|NCT00639210|quality of life|quality of life
1535256|NCT00639197|Tunneling|tunneling
1535257|NCT00639197|Short term|short term
1535258|NCT00639197|central venous catheters|central venous catheters
1535259|NCT00639197|Ultrasound Guided|ultrasound guided
1535260|NCT00639197|Internal jugular|internal jugular
1535261|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
1535262|NCT00639184|asphyxia|asphyxia
1535263|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
1535264|NCT00639184|home counseling|home counseling
1535265|NCT00639171|breast|breast
1535266|NCT00639171|diagnostic radiology|diagnostic radiology
1535267|NCT00639171|suspicious breast tumors|suspicious breast tumors
1535268|NCT00639171|MRI|mri
1535269|NCT00639145|HIV|hiv
1535270|NCT00639145|Pregnancy|pregnancy
1535271|NCT00639145|Antiretrovirals|antiretrovirals
1535272|NCT00639145|HIV Seronegativity|hiv seronegativity
1535273|NCT00639145|Treatment Experienced|treatment experienced
1535274|NCT00639132|Natural History|natural history
1535275|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
1535276|NCT00639132|Disease Progression|disease progression
1535277|NCT00639106|Breast expander|breast expander
1535278|NCT00639106|Breast reconstruction|breast reconstruction
1535279|NCT00639106|implants|implants
1535280|NCT00639106|08-024|08-024
1535281|NCT00639093|cigarette smoking|cigarette smoking
1535282|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
1535283|NCT00639093|virtual reality|virtual reality
1535284|NCT00639080|Type 2 diabetes|type 2 diabetes
1535285|NCT00639080|Dyslipidemia|dyslipidemia
1535286|NCT00639067|Cancer of Lung|cancer of lung
1535287|NCT00639067|Cancer of the Lung|cancer of the lung
1535288|NCT00639067|Lung Cancer|lung cancer
1535289|NCT00639067|Neoplasms, Lung|neoplasms, lung
1535290|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
1535291|NCT00639067|Pulmonary Cancer|pulmonary cancer
1535292|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
1535293|NCT00639054|classification|classification
1535294|NCT00639054|diagnosis|diagnosis
1535295|NCT00639054|genetics|genetics
1535296|NCT00639054|mortality|mortality
1535297|NCT00639054|pathology|pathology
1535298|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
1535299|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
1535300|NCT00639041|human|human
1535301|NCT00639041|TAG|tag
1535302|NCT00639028|ankle|ankle
1535303|NCT00639028|diagnosis|diagnosis
1535304|NCT00639028|sprain|sprain
1535305|NCT00639028|care|care
1535306|NCT00639028|injury|injury
1535307|NCT00639028|stress radiography|stress radiography
1535308|NCT00639028|ultrasonography|ultrasonography
1535309|NCT00639015|Sepsis|sepsis
1535310|NCT00639015|Septic Shock|septic shock
1535311|NCT00639015|phenylephrine|phenylephrine
1535312|NCT00639015|norepinephrine|norepinephrine
1535313|NCT00639015|catecholamine|catecholamine
1535314|NCT00638989|Asthma|asthma
1535315|NCT00638989|CAT-354|cat-354
1535316|NCT00638989|Tralokinumab|tralokinumab
1535317|NCT00638989|Healthy|healthy
1535318|NCT00638976|Eptifibatide|eptifibatide
1535319|NCT00638976|IV eptifibatide|iv eptifibatide
1535320|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
1535321|NCT00638976|DES stent|des stent
1535322|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
1535323|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
1535324|NCT00638950|disease activity|disease activity
1535325|NCT00638950|inflammation|inflammation
1535326|NCT00638950|oxidative stress|oxidative stress
1535327|NCT00638950|immune system|immune system
1535328|NCT00638924|healthy sedentary women|healthy sedentary women
1535329|NCT00638885|PTSD|ptsd
1535330|NCT00638885|hippocampus|hippocampus
1535331|NCT00638885|twins|twins
1535332|NCT00638872|diabetes|diabetes
1535333|NCT00638872|foot ulcer|foot ulcer
1535334|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
1535335|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
1535337|NCT00638859|children|children
1535338|NCT00638859|Child|child
1535339|NCT00638846|toric contact lenses|toric contact lenses
1535340|NCT00638846|vision|vision
1535341|NCT00638846|comfort|comfort
1535342|NCT00638846|toric fit characteristics|toric fit characteristics
1535343|NCT00638846|slit lamp findings|slit lamp findings
1535344|NCT00638833|Multiple Sclerosis|multiple sclerosis
1535345|NCT00638820|osteopetrosis|osteopetrosis
1535346|NCT00638794|Myocardial Infarction|myocardial infarction
1535347|NCT00638794|Myocardial Ischemia|myocardial ischemia
1535348|NCT00638781|Acute ischemic stroke|acute ischemic stroke
1535349|NCT00638768|physical therapy|physical therapy
1535350|NCT00638768|rehabilitation|rehabilitation
1535352|NCT00638768|osteoporosis|osteoporosis
1535353|NCT00638768|vertebral fracture|vertebral fracture
1535354|NCT00638755|Allergic Rhinitis|allergic rhinitis
1535355|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
1535356|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
1535357|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
1535358|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
1535359|NCT00638729|bispectral index|bispectral index
1535360|NCT00638729|sedation|sedation
1535361|NCT00638729|stress hormones|stress hormones
1535362|NCT00638729|cognitive function|cognitive function
1535363|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
1535364|NCT00638703|hyperoxaluria|hyperoxaluria
1535365|NCT00638703|PH|ph
1535366|NCT00638703|oxalate|oxalate
1535367|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
1535368|NCT00638690|CRPC|crpc
1535369|NCT00638690|Abiraterone Acetate|abiraterone acetate
1535370|NCT00638690|CB7630|cb7630
1535371|NCT00638677|Oral microbiology|oral microbiology
1535372|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
1535373|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
1535374|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
1535375|NCT00638664|the great vessels|the great vessels
1535376|NCT00638664|coronary vasculature|coronary vasculature
1535377|NCT00638664|cardiac|cardiac
1535378|NCT00638664|great vessels|great vessels
1535379|NCT00638651|Tattoos|tattoos
1535380|NCT00638651|Black/blue tattoos|black/blue tattoos
1535381|NCT00638638|Myocardial infarction|myocardial infarction
1535382|NCT00638638|Angioplasty|angioplasty
1535383|NCT00638638|Coronary stenting|coronary stenting
1535384|NCT00638638|Abciximab|abciximab
1535385|NCT00638638|Myocardial reperfusion|myocardial reperfusion
1535386|NCT00638638|Microcirculation|microcirculation
1535387|NCT00638638|EKG|ekg
1535388|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
1535389|NCT00638625|Needle biopsy|needle biopsy
1535390|NCT00638625|CT Scan|ct scan
1535391|NCT00638625|Lung Tumor|lung tumor
1535392|NCT00638625|Lung Mass|lung mass
1535393|NCT00638612|Immunotherapy|immunotherapy
1535394|NCT00638612|Gene Therapy|gene therapy
1535395|NCT00638612|Cytotoxicity|cytotoxicity
1535396|NCT00638612|Tumor vaccine|tumor vaccine
1535397|NCT00638612|Radiation|radiation
1535398|NCT00638612|Surgery|surgery
1535399|NCT00638612|Chemoradiation|chemoradiation
1535400|NCT00638599|Intubation, intratracheal|intubation, intratracheal
1535401|NCT00638599|Homeostasis|homeostasis
1535402|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
1535403|NCT00638599|Breast Neoplasms|breast neoplasms
1535404|NCT00638560|PGC-1alpha|pgc-1alpha
1535405|NCT00638560|PPARgamma|ppargamma
1535406|NCT00638560|oxidative stress|oxidative stress
1535407|NCT00638560|training intervention|training intervention
1535408|NCT00638547|Hurler Syndrome|hurler syndrome
1535409|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
1535410|NCT00638547|Iduronidase deficiency|iduronidase deficiency
1535411|NCT00638534|Acute Otitis Media|acute otitis media
1535412|NCT00638534|AOM|aom
1535413|NCT00638534|children|children
1535414|NCT00638534|Child|child
1535415|NCT00638521|lipids|lipids
1535416|NCT00638521|proteins|proteins
1535417|NCT00638521|membrane|membrane
1535418|NCT00638521|lipid raft|lipid raft
1535419|NCT00638482|Dent's disease|dent's disease
1535420|NCT00638482|Nephrolithiasis|nephrolithiasis
1535421|NCT00638482|clinical trial|clinical trial
1535422|NCT00638482|thiazides|thiazides
1535423|NCT00638469|Psoriasis|psoriasis
1535424|NCT00638469|Biologic|biologic
1535425|NCT00638469|adalimumab|adalimumab
1535426|NCT00638469|narrowband UVB|narrowband uvb
1535427|NCT00638469|phototherapy|phototherapy
1535428|NCT00638469|half-side comparison|half-side comparison
1535429|NCT00638456|Eosinophils|eosinophils
1535430|NCT00638456|Esophagitis|esophagitis
1535431|NCT00638456|Microscopy|microscopy
1535432|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
1535433|NCT00638430|myopia|myopia
1535434|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
1535435|NCT00638404|Preoperative somatic questions|preoperative somatic questions
1535436|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
1535437|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
1535438|NCT00638391|Primary early MCa|primary early mca
1535439|NCT00638391|Arimidex|arimidex
1535440|NCT00638378|Prostate Cancer|prostate cancer
1535441|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
1535442|NCT00638352|Core Biopsy|core biopsy
1535443|NCT00638352|Needle Biopsy|needle biopsy
1535444|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
1535445|NCT00638339|Respiration, artificial|respiration, artificial
1535446|NCT00638339|respiratory insufficiency|respiratory insufficiency
1535447|NCT00638339|noninvasive ventilation|noninvasive ventilation
1535448|NCT00638339|sleep deprivation|sleep deprivation
1535449|NCT00638339|intensive care units|intensive care units
1535543|NCT00637910|Advanced NSCLC|advanced nsclc
1535544|NCT00637910|EGFR|egfr
1535450|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
1535451|NCT00638313|GLP-1|glp-1
1535452|NCT00638300|hemodialysis|hemodialysis
1535453|NCT00638300|iron|iron
1535454|NCT00638300|inflammation|inflammation
1535455|NCT00638300|atomic absorption|atomic absorption
1535456|NCT00638300|dialysate|dialysate
1535457|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
1535458|NCT00638300|large pore dialysate|large pore dialysate
1535459|NCT00638300|bicarbonate|bicarbonate
1535460|NCT00638300|calcium|calcium
1535461|NCT00638300|citrate|citrate
1535462|NCT00638300|ligand|ligand
1535463|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
1535464|NCT00638287|deficiency|deficiency
1535465|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
1535466|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
1535467|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
1535468|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
1535469|NCT00638261|Psoriasis|psoriasis
1535470|NCT00638261|Biologic|biologic
1535471|NCT00638261|Adalimumab|adalimumab
1535472|NCT00638261|Narrow-band UVB|narrow-band uvb
1535473|NCT00638261|phototherapy|phototherapy
1535474|NCT00638261|half-side comparison|half-side comparison
1535475|NCT00638248|Acute ischemic stroke|acute ischemic stroke
1535476|NCT00638235|Pelvic floor repair|pelvic floor repair
1535477|NCT00638235|prolapse|prolapse
1535478|NCT00638235|mesh|mesh
1535479|NCT00638222|Carvedilol|carvedilol
1535480|NCT00638222|Heart Disease|heart disease
1535481|NCT00638222|Vascular Disease|vascular disease
1535482|NCT00638222|Kidney|kidney
1535483|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
1535484|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
1535485|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
1535486|NCT00638170|Urinary Tract Infections|urinary tract infections
1535487|NCT00638170|Cranberry|cranberry
1535488|NCT00638170|Prevention|prevention
1535489|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
1535490|NCT00638157|Staph Aureus|staph aureus
1535491|NCT00638157|endocarditis|endocarditis
1535492|NCT00638157|bacteremia|bacteremia
1535493|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1535494|NCT00638144|Hepatitis C|hepatitis c
1535495|NCT00638144|liver transplantation|liver transplantation
1535496|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
1535497|NCT00638144|monoclonal antibodies|monoclonal antibodies
1535498|NCT00638092|hypothyroxinemia|hypothyroxinemia
1535499|NCT00638092|preterm infants|preterm infants
1535500|NCT00638092|iodine|iodine
1535501|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
1535502|NCT00638092|Iodine supplementation|iodine supplementation
1535503|NCT00638092|Randomised controlled trial|randomised controlled trial
1535504|NCT00638079|Pharmacokinetics|pharmacokinetics
1535505|NCT00638079|Food Effect|food effect
1535506|NCT00638079|Bioavailability|bioavailability
1535507|NCT00638079|Megace ES|megace es
1535508|NCT00638066|vaginismus|vaginismus
1535509|NCT00638066|botulinum toxin A|botulinum toxin a
1535510|NCT00638066|dyspareunia|dyspareunia
1535511|NCT00638066|unconsummated marriage|unconsummated marriage
1535512|NCT00638040|hypoxia|hypoxia
1535513|NCT00638040|lactate|lactate
1535515|NCT00638040|tumor microenvironments|tumor microenvironments
1535516|NCT00638040|survival|survival
1535517|NCT00638027|multiple sclerosis|multiple sclerosis
1535518|NCT00638014|Sternal wound closure|sternal wound closure
1535519|NCT00638014|cardiac surgery|cardiac surgery
1535520|NCT00638014|sternal nonunion|sternal nonunion
1535521|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
1535522|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
1535523|NCT00637988|Barrett's Esophagus|barrett's esophagus
1535524|NCT00637988|Nexium|nexium
1535525|NCT00637975|neuropathic pain|neuropathic pain
1535526|NCT00637975|oxycodone|oxycodone
1535527|NCT00637975|pregabalin|pregabalin
1535528|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
1535529|NCT00637962|HIV|hiv
1535530|NCT00637962|AIDS|aids
1535531|NCT00637962|Vaccine|vaccine
1535532|NCT00637962|intravaginal|intravaginal
1535533|NCT00637962|mucosal|mucosal
1535534|NCT00637962|HIV Seronegativity|hiv seronegativity
1535535|NCT00637949|Osteoarthritis|osteoarthritis
1535536|NCT00637949|lumiracoxib|lumiracoxib
1535537|NCT00637949|rofecoxib|rofecoxib
1535538|NCT00637949|Cox-2|cox-2
1535539|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
1535540|NCT00637936|perioperative oxygen|perioperative oxygen
1535541|NCT00637936|respiratory complications|respiratory complications
1535542|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
1535545|NCT00637910|EGFR copy number|egfr copy number
1535546|NCT00637910|Kras mutations|kras mutations
1535547|NCT00637910|EGRF mutations|egrf mutations
1535548|NCT00637910|Docetaxel|docetaxel
1535549|NCT00637910|Erlotinib|erlotinib
1535550|NCT00637910|Polymorphisms|polymorphisms
1535551|NCT00637897|recurrent breast cancer|recurrent breast cancer
1535552|NCT00637897|stage IV breast cancer|stage iv breast cancer
1535553|NCT00637871|Casodex|casodex
1535554|NCT00637871|bicalutamide|bicalutamide
1535555|NCT00637871|Tamoxifen|tamoxifen
1535556|NCT00637871|Gynaecomastia|gynaecomastia
1535557|NCT00637871|Prostate Cancer|prostate cancer
1535558|NCT00637845|Nexium|nexium
1535559|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
1535560|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1535561|NCT00637845|Heartburn|heartburn
1535562|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1535563|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1535564|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1535565|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1535566|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1535567|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1535568|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1535569|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1535717|NCT00637572|HIV wasting|hiv wasting
1535570|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1535571|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1535572|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1535573|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1535574|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1535575|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1535576|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1535577|NCT00637806|Megestrol acetate|megestrol acetate
1535578|NCT00637806|Anorexia|anorexia
1535579|NCT00637806|Cachexia|cachexia
1535580|NCT00637806|Cancer|cancer
1535581|NCT00637806|Unintended weight loss|unintended weight loss
1535582|NCT00637806|Body weight|body weight
1535583|NCT00637806|Appetite|appetite
1535584|NCT00637806|Megace ES|megace es
1535585|NCT00637793|Xerostomia|xerostomia
1535586|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
1535587|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
1535588|NCT00637780|azulfidine entabs|azulfidine entabs
1535589|NCT00637780|Pharmacokinetics|pharmacokinetics
1535590|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
1535591|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
1535592|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
1535593|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
1535594|NCT00637754|ICD|icd
1535595|NCT00637754|Sports|sports
1535596|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
1535597|NCT00637741|Intermittent claudication|intermittent claudication
1535598|NCT00637741|Critical Limb Ischemia|critical limb ischemia
1535599|NCT00637741|TASC|tasc
1535600|NCT00637728|Megestrol acetate|megestrol acetate
1535601|NCT00637728|Anorexia|anorexia
1535602|NCT00637728|Cachexia|cachexia
1535603|NCT00637728|Lung cancer|lung cancer
1535604|NCT00637728|Pancreatic cancer|pancreatic cancer
1535605|NCT00637728|Unintended weight loss|unintended weight loss
1535606|NCT00637728|Body weight|body weight
1535607|NCT00637728|Appetite|appetite
1535608|NCT00637728|Megace ES|megace es
1535609|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
1535610|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1535611|NCT00637689|Biomarkers|biomarkers
1535612|NCT00637689|Response criteria|response criteria
1535613|NCT00637689|Surrogate endpoints|surrogate endpoints
1535614|NCT00637689|Natural history|natural history
1535615|NCT00637676|malignant pleural effusion|malignant pleural effusion
1535616|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
1535617|NCT00637676|talc pleurodesis|talc pleurodesis
1535618|NCT00637663|Chronic hepatitis B|chronic hepatitis b
1535619|NCT00637663|Lamivudine|lamivudine
1535620|NCT00637663|Entecavir|entecavir
1535621|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
1567731|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
1535622|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1535623|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1535624|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1535625|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1535626|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1535627|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1535628|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1535629|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1535886|NCT00636922|RAD001|rad001
1535630|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1535631|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1535632|NCT00637637|stage IV anal cancer|stage iv anal cancer
1535633|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1535634|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
1535635|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
1535636|NCT00637637|stage IV breast cancer|stage iv breast cancer
1535637|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1535638|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1535639|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1535640|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
1535641|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1535642|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1535643|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1535644|NCT00637637|stage IV colon cancer|stage iv colon cancer
1535645|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1535646|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
1535647|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1535718|NCT00637572|Emaciation|emaciation
1535648|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1535649|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
1535650|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1535651|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1535652|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1535653|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1535654|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1535655|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
1535656|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1535657|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1535658|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1535659|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1535660|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1535661|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1535662|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1535663|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1535664|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1535665|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1535666|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1535667|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1535668|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
1535669|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1535670|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1535671|NCT00637637|stage IV penile cancer|stage iv penile cancer
1535672|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
1535673|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
1535674|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
1535675|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
1535676|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1535677|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1535678|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1535679|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1535798|NCT00637195|HPV|hpv
1535680|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1535681|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1535682|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1535683|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1535684|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1535685|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1535686|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
1535687|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
1535688|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
1535689|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
1535690|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
1535691|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
1535692|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1535693|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
1535694|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
1535695|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1535696|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1535697|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1535698|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
1535699|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1535700|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1535701|NCT00637637|tongue cancer|tongue cancer
1535702|NCT00637624|Acetylcysteine|acetylcysteine
1535703|NCT00637624|Cisplatin|cisplatin
1535704|NCT00637624|Neuropathy|neuropathy
1535705|NCT00637624|Antioxidants|antioxidants
1535706|NCT00637598|Diagnostic Imaging|diagnostic imaging
1535707|NCT00637598|Mammography|mammography
1535708|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
1535709|NCT00637572|Weight loss|weight loss
1535710|NCT00637572|Cachexia|cachexia
1535711|NCT00637572|Anorexia|anorexia
1535712|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
1535713|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
1535714|NCT00637572|Nanocrystal technology|nanocrystal technology
1535715|NCT00637572|Body weight changes|body weight changes
1535716|NCT00637572|AIDS wasting|aids wasting
1535719|NCT00637572|Megace ES|megace es
1535720|NCT00637572|Megace|megace
1535721|NCT00637572|Treatment Experienced|treatment experienced
1535722|NCT00637559|Nexium|nexium
1535723|NCT00637559|Barrett's esophagus|barrett's esophagus
1535724|NCT00637546|Treatment|treatment
1535725|NCT00637546|Efficacy|efficacy
1535726|NCT00637546|Diabetes|diabetes
1535727|NCT00637546|Gait|gait
1535728|NCT00637546|Balance|balance
1535729|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
1535730|NCT00637520|Insulin Resistance|insulin resistance
1535731|NCT00637520|Lipid Metabolism|lipid metabolism
1535732|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
1535733|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
1535734|NCT00637507|Respiration, Artificial|respiration, artificial
1535735|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
1535736|NCT00637507|Adult|adult
1535737|NCT00637494|psychotic depression|psychotic depression
1535738|NCT00637494|major depression with psychotic features|major depression with psychotic features
1535739|NCT00637494|psychosis|psychosis
1535740|NCT00637416|horseness|horseness
1535741|NCT00637403|renal impairment|renal impairment
1535742|NCT00637403|end stage renal disease|end stage renal disease
1535743|NCT00637403|megestrol acetate|megestrol acetate
1535744|NCT00637403|pharmacokinetics|pharmacokinetics
1535745|NCT00637403|hemodialysis|hemodialysis
1535746|NCT00637403|renal dialysis|renal dialysis
1535747|NCT00637403|kidney failure, chronic|kidney failure, chronic
1535748|NCT00637403|renal insufficiency|renal insufficiency
1535749|NCT00637403|Megace ES|megace es
1535750|NCT00637377|Eye diseases|eye diseases
1535751|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
1535752|NCT00637377|Eyes and Vision|eyes and vision
1535753|NCT00637377|Seniors|seniors
1535754|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
1535755|NCT00637377|Retinal Disease|retinal disease
1535756|NCT00637364|pain|pain
1535757|NCT00637364|pancreas|pancreas
1535758|NCT00637364|pancreatic cancer|pancreatic cancer
1535759|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
1535760|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
1535761|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
1535762|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
1535763|NCT00637299|COPD|copd
1535764|NCT00637286|Zolmitriptan|zolmitriptan
1535765|NCT00637286|ZOMIG|zomig
1535766|NCT00637286|migraine|migraine
1535767|NCT00637286|headache response|headache response
1535768|NCT00637286|headache|headache
1535769|NCT00637286|headache pain|headache pain
1535770|NCT00637286|MIDAS|midas
1535771|NCT00637286|HCPC|hcpc
1535772|NCT00637273|diabetes|diabetes
1535773|NCT00637273|exenatide once weekly|exenatide once weekly
1535774|NCT00637273|Byetta|byetta
1535775|NCT00637273|sitagliptin|sitagliptin
1535776|NCT00637273|Januvia|januvia
1535777|NCT00637273|thiazolidinedione|thiazolidinedione
1535778|NCT00637273|Amylin|amylin
1535779|NCT00637273|Lilly|lilly
1535780|NCT00637273|Pioglitazone|pioglitazone
1535781|NCT00637260|motorcortex stimulation|motorcortex stimulation
1535782|NCT00637260|Parkinson's disease|parkinson's disease
1535783|NCT00637260|neuromodulation|neuromodulation
1535784|NCT00637247|pancreatic cancer|pancreatic cancer
1535785|NCT00637247|metastatic|metastatic
1535786|NCT00637247|chemotherapy naive|chemotherapy naive
1535787|NCT00637221|Safety|safety
1535788|NCT00637221|Tolerability|tolerability
1535789|NCT00637208|prostate cancer|prostate cancer
1535790|NCT00637208|venography|venography
1535791|NCT00637208|male patients|male patients
1535792|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
1535793|NCT00637208|PSA level <14|psa level <14
1535794|NCT00637208|presence of varicocele|presence of varicocele
1535795|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1535796|NCT00637195|Hepatitis B|hepatitis b
1535797|NCT00637195|Cervical cancer|cervical cancer
1535799|NCT00637195|Papillomavirus|papillomavirus
1535800|NCT00637182|Gynecomastia|gynecomastia
1535801|NCT00637182|Anastrazole|anastrazole
1535802|NCT00637182|Arimidex|arimidex
1535803|NCT00637182|Pubertal|pubertal
1535804|NCT00637182|males|males
1535805|NCT00637182|boys|boys
1535806|NCT00637169|oxygen therapy|oxygen therapy
1535807|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
1535808|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
1535809|NCT00637143|Renal transplant|renal transplant
1535810|NCT00637143|Cyclosporine|cyclosporine
1535811|NCT00637143|Tacrolimus|tacrolimus
1535812|NCT00637143|Intervention|intervention
1535813|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
1535814|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
1535815|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
1535816|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1535817|NCT00637104|stents|stents
1535818|NCT00637104|restenosis|restenosis
1535819|NCT00637104|biocompatible materials|biocompatible materials
1535820|NCT00637104|ceramics|ceramics
1535821|NCT00637078|hypertension|hypertension
1535822|NCT00637078|hypercholesterolemia|hypercholesterolemia
1535823|NCT00637078|family physicians|family physicians
1535824|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
1535825|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
1535826|NCT00637065|Pulmonary hypertension|pulmonary hypertension
1535827|NCT00637065|Interstitial lung disease|interstitial lung disease
1535828|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1535829|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
1535830|NCT00637065|Bosentan|bosentan
1535831|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
1535832|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
1535833|NCT00637052|preleukemia|preleukemia
1535834|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
1535835|NCT00637039|Advanced cancer|advanced cancer
1535836|NCT00637039|Solid tumour|solid tumour
1535837|NCT00637039|Solid malignancies|solid malignancies
1535838|NCT00637039|Neoplasms|neoplasms
1535839|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
1535840|NCT00637013|Subacromial impingement|subacromial impingement
1535841|NCT00637013|Shoulder|shoulder
1535843|NCT00637013|Effectiveness|effectiveness
1535844|NCT00637013|Cost-effectiveness|cost-effectiveness
1535845|NCT00637000|Opioid dependence|opioid dependence
1535846|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
1535847|NCT00636987|aortic valve|aortic valve
1535848|NCT00636987|mitral valve|mitral valve
1535849|NCT00636987|heart valve|heart valve
1535850|NCT00636987|tissue valve|tissue valve
1535851|NCT00636987|bioprosthesis|bioprosthesis
1535852|NCT00636987|valve disorder|valve disorder
1535853|NCT00636987|valve disease|valve disease
1535854|NCT00636987|cardiac surgery|cardiac surgery
1535855|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
1535856|NCT00636987|aortic valve stenosis|aortic valve stenosis
1535857|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
1535858|NCT00636987|mitral valve stenosis|mitral valve stenosis
1535859|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
1535860|NCT00636974|Leg Surgery.|leg surgery.
1535861|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
1535862|NCT00636948|Rectal cancer surgery|rectal cancer surgery
1535863|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
1535864|NCT00636948|Defunctioning stoma|defunctioning stoma
1535865|NCT00636948|TME surgery|tme surgery
1535866|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
1535867|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
1535868|NCT00636935|HIV|hiv
1535869|NCT00636935|Pneumonia|pneumonia
1535870|NCT00636935|Pulmonary Function Testing|pulmonary function testing
1535871|NCT00636935|Antibiotics|antibiotics
1535872|NCT00636935|Prednisone|prednisone
1535873|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
1535874|NCT00636935|CD4|cd4
1535875|NCT00636935|CD8|cd8
1535876|NCT00636935|Viral Load|viral load
1535877|NCT00636935|Bactrim|bactrim
1535878|NCT00636935|Pentamidine|pentamidine
1535879|NCT00636935|Atovaquone|atovaquone
1535880|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
1535881|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
1535882|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
1535883|NCT00636922|Elderly|elderly
1535884|NCT00636922|Unfit|unfit
1535885|NCT00636922|Everolimus|everolimus
1535887|NCT00636909|AML|aml
1535888|NCT00636909|ALL|all
1535889|NCT00636909|CML|cml
1535890|NCT00636909|CLL|cll
1535891|NCT00636909|MDS|mds
1535892|NCT00636909|NHL|nhl
1535893|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
1535894|NCT00636909|APLASTIC ANEMIA|aplastic anemia
1535895|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
1535896|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
1535897|NCT00636909|ALLOGENEIC|allogeneic
1535898|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
1535899|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
1535900|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
1535901|NCT00636909|FLUDARABINE|fludarabine
1535902|NCT00636909|CYCLOSPORINE|cyclosporine
1535903|NCT00636909|METHOTREXATE|methotrexate
1535904|NCT00636909|G-CSF|g-csf
1535905|NCT00636909|GVHD|gvhd
1535906|NCT00636909|ENGRAFTMENT|engraftment
1535907|NCT00636909|CHIMERISM|chimerism
1535908|NCT00636896|weight gain|weight gain
1535909|NCT00636896|olanzapine|olanzapine
1535910|NCT00636896|atypical antipsychotic|atypical antipsychotic
1535911|NCT00636883|Pancreatic cancer|pancreatic cancer
1535912|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
1535913|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
1535914|NCT00636831|Prophylactic|prophylactic
1535915|NCT00636831|Antibiotic|antibiotic
1535916|NCT00636831|Infection|infection
1535917|NCT00636831|Primary case|primary case
1535918|NCT00636805|Aloxi|aloxi
1535919|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
1535920|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
1535921|NCT00636766|cardiovascular events|cardiovascular events
1536047|NCT00636129|stress management|stress management
1535922|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
1535923|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
1535924|NCT00636727|arthrocentesis|arthrocentesis
1535925|NCT00636727|arthroscopy|arthroscopy
1535926|NCT00636727|arthroplasty|arthroplasty
1535927|NCT00636714|intensive insulin therapy|intensive insulin therapy
1535928|NCT00636714|glucose control|glucose control
1535929|NCT00636714|nurse directed|nurse directed
1535930|NCT00636714|nomogram directed|nomogram directed
1535931|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
1535932|NCT00636701|rehabilitation|rehabilitation
1535933|NCT00636688|Obesity|obesity
1535934|NCT00636688|Lifestyle changes|lifestyle changes
1535935|NCT00636675|Accidental falls|accidental falls
1535936|NCT00636649|Eating disorder|eating disorder
1535937|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
1535938|NCT00636623|Pilates Exercises|pilates exercises
1535939|NCT00636623|Connective Tissue Massage|connective tissue massage
1535940|NCT00636610|Hedgehog|hedgehog
1535941|NCT00636610|CRC|crc
1535942|NCT00636610|Colorectal Cancer|colorectal cancer
1535943|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
1535944|NCT00636584|sodium nitroprusside|sodium nitroprusside
1535945|NCT00636584|thyroid hormones|thyroid hormones
1535946|NCT00636584|thoracic surgery|thoracic surgery
1535947|NCT00636571|Exercise|exercise
1535948|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
1535949|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
1535950|NCT00636558|coxsackie virus|coxsackie virus
1535951|NCT00636558|melanoma|melanoma
1535952|NCT00636558|breast cancer|breast cancer
1535953|NCT00636558|prostate cancer|prostate cancer
1535954|NCT00636545|Genasense|genasense
1535955|NCT00636545|oblimersen|oblimersen
1535956|NCT00636545|antisense|antisense
1535957|NCT00636545|Bcl-2 antisense|bcl-2 antisense
1535958|NCT00636545|Solid Tumors|solid tumors
1535959|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
1535960|NCT00636506|Erectile dysfunction|erectile dysfunction
1535961|NCT00636506|Impotence|impotence
1535962|NCT00636493|retinal vein occlusion|retinal vein occlusion
1535963|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
1535964|NCT00636493|steroid|steroid
1535965|NCT00636493|macular edema|macular edema
1535966|NCT00636480|Antimicrobial|antimicrobial
1535967|NCT00636480|Antisepsis|antisepsis
1535968|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
1535969|NCT00636467|Detection|detection
1535970|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
1535971|NCT00636454|OA|oa
1535972|NCT00636454|Pain|pain
1535973|NCT00636454|Cognitive Therapy|cognitive therapy
1535974|NCT00636454|Behavior Therapy|behavior therapy
1535975|NCT00636454|Knee OA|knee oa
1535976|NCT00636454|Hip OA|hip oa
1535977|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
1535978|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
1535979|NCT00636441|Genomic|genomic
1535980|NCT00636441|Genomic Predictor|genomic predictor
1535981|NCT00636441|Genomic Expression Profiles|genomic expression profiles
1535982|NCT00636441|Randomized|randomized
1535983|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
1535984|NCT00636441|HER2 negative|her2 negative
1535985|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
1535986|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
1535987|NCT00636428|endoscopy|endoscopy
1535988|NCT00636428|Midazolam|midazolam
1535989|NCT00636428|pediatric|pediatric
1535990|NCT00636428|sedation|sedation
1535991|NCT00636428|comfort|comfort
1535992|NCT00636415|Analgesia|analgesia
1535993|NCT00636415|Morphine|morphine
1535994|NCT00636415|Bupivacaine|bupivacaine
1535995|NCT00636415|Osteoarthritis|osteoarthritis
1535996|NCT00636415|Knee|knee
1535997|NCT00636402|Vessel Sealing System|vessel sealing system
1535998|NCT00636402|Cold Knife|cold knife
1535999|NCT00636402|Tonsillectomy|tonsillectomy
1536000|NCT00636402|Pain|pain
1536001|NCT00636402|Postoperative|postoperative
1536002|NCT00636389|Hemodialysis|hemodialysis
1536003|NCT00636389|Dialysis, Renal|dialysis, renal
1536004|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
1536005|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
1536006|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
1536007|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
1536008|NCT00636376|secondary brain damage|secondary brain damage
1536009|NCT00636350|pepper carotenoids|pepper carotenoids
1536010|NCT00636350|xanthophylls|xanthophylls
1536011|NCT00636350|healthy volunteers|healthy volunteers
1536012|NCT00636337|Pediatric|pediatric
1536013|NCT00636337|Brain Tumor|brain tumor
1536014|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1536015|NCT00636337|Inattention|inattention
1536016|NCT00636337|Childhood cancer survivors|childhood cancer survivors
1536017|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
1536018|NCT00636324|Preterm infants|preterm infants
1536019|NCT00636324|Extubation failure|extubation failure
1536020|NCT00636324|Pneumothorax|pneumothorax
1536021|NCT00636324|Lung injury|lung injury
1536022|NCT00636324|Airway pressure|airway pressure
1536023|NCT00636311|Hodgkin disease|hodgkin disease
1536024|NCT00636311|Salvage therapy|salvage therapy
1536025|NCT00636311|Bortezomib|bortezomib
1536026|NCT00636311|Transplantation|transplantation
1536027|NCT00636298|esophageal carcinoma|esophageal carcinoma
1536028|NCT00636298|cancer of the esophagus|cancer of the esophagus
1536029|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
1536030|NCT00636285|A110|a110
1536031|NCT00636285|Safety|safety
1536032|NCT00636272|ICD|icd
1536033|NCT00636272|CRT-D|crt-d
1536034|NCT00636259|Prostate cancer|prostate cancer
1536035|NCT00636259|Casodex|casodex
1536036|NCT00636233|anencephaly|anencephaly
1536037|NCT00636233|acrania|acrania
1536038|NCT00636220|HIV-1 Infections|hiv-1 infections
1536039|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1536040|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1536041|NCT00636155|EL625|el625
1536042|NCT00636155|cenersen|cenersen
1536043|NCT00636129|relaxation|relaxation
1536044|NCT00636129|relaxation response|relaxation response
1536045|NCT00636129|meditation|meditation
1536046|NCT00636129|nitric oxide|nitric oxide
1536048|NCT00636129|stress|stress
1536049|NCT00636129|Relaxation Techniques|relaxation techniques
1536050|NCT00636116|snake bite|snake bite
1536051|NCT00636116|antivenin treatment|antivenin treatment
1536052|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
1536053|NCT00636103|Asthma|asthma
1536054|NCT00636103|Paediatric|paediatric
1536055|NCT00636077|Hemodialysis|hemodialysis
1536056|NCT00636077|Dialysis, Renal|dialysis, renal
1536057|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
1536058|NCT00636051|evidence based practice implementation|evidence based practice implementation
1536059|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
1536060|NCT00636038|beta-carotene|beta-carotene
1536061|NCT00636038|yellow maize|yellow maize
1536062|NCT00636038|vitamin A|vitamin a
1536063|NCT00636012|acupuncture|acupuncture
1536064|NCT00636012|Acupuncture points|acupuncture points
1536065|NCT00635986|Analgesia|analgesia
1536066|NCT00635986|Fentanyl|fentanyl
1536067|NCT00635986|Orthopedic|orthopedic
1536068|NCT00635986|Mechanism of action|mechanism of action
1536069|NCT00635986|Surgery|surgery
1536070|NCT00635973|Iressa|iressa
1536071|NCT00635973|Gefitinib|gefitinib
1536072|NCT00635973|Cancer|cancer
1536073|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
1536074|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1536075|NCT00635960|ALS|als
1536076|NCT00635960|Growth Hormone|growth hormone
1536077|NCT00635960|IGF-I|igf-i
1536078|NCT00635947|Amniotic fluid index|amniotic fluid index
1536079|NCT00635947|maternal hydration|maternal hydration
1536080|NCT00635947|isotonic solution|isotonic solution
1536081|NCT00635947|Amniotic Fluid|amniotic fluid
1536082|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
1536083|NCT00635921|Borderline Personality Disorder|borderline personality disorder
1536084|NCT00635921|ziprasidone|ziprasidone
1536085|NCT00635895|Fibromyalgia|fibromyalgia
1536086|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
1536087|NCT00635895|Connective Tissue Massage|connective tissue massage
1536088|NCT00635895|Pain|pain
1536089|NCT00635895|Health Related Quality of Life|health related quality of life
1536090|NCT00635895|Randomized Controlled Trial|randomized controlled trial
1536091|NCT00635882|mometasone|mometasone
1536092|NCT00635882|formoterol|formoterol
1536093|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
1536094|NCT00635869|evidence based practice implementation|evidence based practice implementation
1536095|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
1536096|NCT00635869|nurse physician collaboration|nurse physician collaboration
1536097|NCT00635856|Iressa|iressa
1536098|NCT00635856|Gefitinib|gefitinib
1536099|NCT00635856|Prostate Cancer|prostate cancer
1536100|NCT00635856|PSA|psa
1536101|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
1536102|NCT00635817|CPP|cpp
1536103|NCT00635817|central precocious puberty|central precocious puberty
1536104|NCT00635817|pediatrics|pediatrics
1536105|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
1536106|NCT00635817|Lupron|lupron
1536107|NCT00635817|leuprolide acetate|leuprolide acetate
1536108|NCT00635817|depot formulation|depot formulation
1536109|NCT00635817|GnRHa|gnrha
1536110|NCT00635817|GnRH agonist|gnrh agonist
1536111|NCT00635817|GnRH analog|gnrh analog
1536112|NCT00635817|luteinizing hormone|luteinizing hormone
1536113|NCT00635791|Malignant Solid Tumour|malignant solid tumour
1536218|NCT00635427|VPRIV|vpriv
1536114|NCT00635791|Renal cell carcinoma|renal cell carcinoma
1536115|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
1536116|NCT00635765|Acromegaly|acromegaly
1536117|NCT00635752|TF-CBT|tf-cbt
1536118|NCT00635752|Effectiveness study|effectiveness study
1536119|NCT00635752|Trauma|trauma
1536120|NCT00635752|Therapy|therapy
1536121|NCT00635739|Whey protein|whey protein
1536122|NCT00635739|Resistance exercise|resistance exercise
1536123|NCT00635739|Physical activity|physical activity
1536124|NCT00635739|Mobility disability|mobility disability
1536125|NCT00635739|Physical function|physical function
1536126|NCT00635739|Muscle mass|muscle mass
1536127|NCT00635739|Muscle strength|muscle strength
1536128|NCT00635739|Older Adults|older adults
1536129|NCT00635739|Mobility-Limited|mobility-limited
1536130|NCT00635726|Bladder Cancer|bladder cancer
1536131|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
1536132|NCT00635700|psychosis|psychosis
1536133|NCT00635700|schizophrenia|schizophrenia
1536134|NCT00635700|prodrome|prodrome
1536135|NCT00635700|ziprasidone|ziprasidone
1536136|NCT00635700|placebo|placebo
1536137|NCT00635687|variceal bleeding|variceal bleeding
1536138|NCT00635687|transient elastography|transient elastography
1536139|NCT00635674|sleep apnea|sleep apnea
1536140|NCT00635674|risk factors|risk factors
1536141|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
1536142|NCT00635674|insulin resistance|insulin resistance
1536143|NCT00635674|metabolic syndrome|metabolic syndrome
1536144|NCT00635674|compliance|compliance
1536145|NCT00635661|function|function
1536146|NCT00635661|disability|disability
1536147|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1536148|NCT00635635|Anxiety,|anxiety,
1536149|NCT00635635|Depression,|depression,
1536150|NCT00635635|Guided Imagery|guided imagery
1536151|NCT00635635|Military Sexual Trauma|military sexual trauma
1536152|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
1536153|NCT00635622|BV|bv
1536154|NCT00635622|UCSF|ucsf
1536155|NCT00635622|SFGH|sfgh
1536156|NCT00635596|MT110|mt110
1536157|NCT00635596|solid tumors|solid tumors
1536158|NCT00635596|phase I|phase i
1536159|NCT00635596|BiTE|bite
1536160|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
1536161|NCT00635583|Bone|bone
1536162|NCT00635583|Dairy Intervention|dairy intervention
1536163|NCT00635583|Girls|girls
1536164|NCT00635583|Boys|boys
1536165|NCT00635583|Calcium|calcium
1536166|NCT00635583|Bone Mineralization|bone mineralization
1536167|NCT00635583|Peak Bone Mass|peak bone mass
1536168|NCT00635583|Bone and Bones|bone and bones
1536169|NCT00635583|Female|female
1536170|NCT00635583|Male|male
1536171|NCT00635583|Adolescent|adolescent
1536172|NCT00635583|Healthy|healthy
1536297|NCT00635141|Hypertonic Saline|hypertonic saline
1536173|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
1536174|NCT00635557|Recurrent|recurrent
1536175|NCT00635557|Relapsed|relapsed
1536176|NCT00635557|Glioblastoma|glioblastoma
1536177|NCT00635557|Multiforme|multiforme
1536178|NCT00635544|Adolescence|adolescence
1536179|NCT00635544|Overweight|overweight
1536180|NCT00635544|Dietary Fiber|dietary fiber
1536181|NCT00635544|Glycemic Index|glycemic index
1536182|NCT00635544|Healthy lifestyle|healthy lifestyle
1536183|NCT00635518|Health Plan Implementation|health plan implementation
1536184|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
1536185|NCT00635518|Breast Feeding|breast feeding
1536186|NCT00635518|Overweight|overweight
1536188|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
1536189|NCT00635518|Public Health|public health
1536190|NCT00635505|Asthma|asthma
1536191|NCT00635505|albuterol|albuterol
1536192|NCT00635505|HFA|hfa
1536193|NCT00635492|diabetes|diabetes
1536194|NCT00635492|insulin|insulin
1536195|NCT00635492|exenatide|exenatide
1536196|NCT00635492|Byetta|byetta
1536197|NCT00635492|Amylin|amylin
1536198|NCT00635492|Lilly|lilly
1536199|NCT00635479|Fractures|fractures
1536200|NCT00635479|Pelvic bones|pelvic bones
1536201|NCT00635479|Acetabulum|acetabulum
1536202|NCT00635479|Hip bones|hip bones
1536203|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
1536204|NCT00635453|Breast Feeding|breast feeding
1536205|NCT00635453|Child|child
1536206|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
1536207|NCT00635453|Public Health|public health
1536208|NCT00635453|Morbidity|morbidity
1536209|NCT00635453|Health Plan Implementation|health plan implementation
1536210|NCT00635440|skeletal muscle|skeletal muscle
1536211|NCT00635440|ubiquitin|ubiquitin
1536212|NCT00635440|proteasome|proteasome
1536213|NCT00635440|IGF-1|igf-1
1536214|NCT00635440|MGF|mgf
1536215|NCT00635440|protein catabolism|protein catabolism
1536216|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
1536217|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
1536219|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
1536220|NCT00635427|Gaucher disease|gaucher disease
1536221|NCT00635427|glucocerebrosidase|glucocerebrosidase
1536222|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
1536223|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
1536224|NCT00635427|glucosylceramidase|glucosylceramidase
1536225|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1536226|NCT00635427|gene activation|gene activation
1536227|NCT00635427|human|human
1536228|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
1536229|NCT00635362|Contraception|contraception
1536230|NCT00635362|Contraceptive Devices|contraceptive devices
1536231|NCT00635362|Intrauterine Devices|intrauterine devices
1536232|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
1536233|NCT00635362|Postpartum Period|postpartum period
1536234|NCT00635349|WOMAC|womac
1536235|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
1536236|NCT00635349|Pain intensity|pain intensity
1536237|NCT00635349|Tramadol|tramadol
1536238|NCT00635349|Acetaminophen|acetaminophen
1536239|NCT00635349|Meloxicam|meloxicam
1536240|NCT00635349|Aceclofenac|aceclofenac
1536241|NCT00635336|Epitope peptide|epitope peptide
1536242|NCT00635336|CTL|ctl
1536243|NCT00635336|Advanced bladder cancer|advanced bladder cancer
1536244|NCT00635336|Vaccination|vaccination
1536245|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
1536246|NCT00635310|Chronic hepatitis C|chronic hepatitis c
1536247|NCT00635310|Chronic hepatitis B|chronic hepatitis b
1536248|NCT00635310|Liver biopsy|liver biopsy
1536249|NCT00635310|Hemodialysis|hemodialysis
1536250|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
1536251|NCT00635297|osteoporosis|osteoporosis
1536252|NCT00635297|vertebroplasty|vertebroplasty
1536253|NCT00635297|prophylactic|prophylactic
1536254|NCT00635297|vertebrae|vertebrae
1536255|NCT00635297|fracture|fracture
1536256|NCT00635271|Asthma|asthma
1536257|NCT00635271|Biomarker|biomarker
1536258|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
1536259|NCT00635271|Cytokine|cytokine
1536260|NCT00635271|Healthy Volunteer|healthy volunteer
1536261|NCT00635271|HV|hv
1536262|NCT00635258|GnRH antagonist|gnrh antagonist
1536263|NCT00635258|oocyte donation|oocyte donation
1536264|NCT00635258|pregnancy|pregnancy
1536265|NCT00635258|implantation|implantation
1536266|NCT00635245|stage IA breast cancer|stage ia breast cancer
1536267|NCT00635245|stage IB breast cancer|stage ib breast cancer
1536268|NCT00635245|stage II breast cancer|stage ii breast cancer
1536269|NCT00635232|Hypertension|hypertension
1536270|NCT00635232|High Blood Pressure|high blood pressure
1536271|NCT00635219|Major depressive disorder|major depressive disorder
1536272|NCT00635219|Placebo-controlled|placebo-controlled
1536273|NCT00635219|Active reference|active reference
1536274|NCT00635219|Multicenter study|multicenter study
1536275|NCT00635219|Randomised study|randomised study
1536276|NCT00635219|Acute treatment|acute treatment
1536277|NCT00635206|OSA|osa
1536278|NCT00635193|Ovarian neoplasms|ovarian neoplasms
1536279|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
1536280|NCT00635193|Angiogenesis|angiogenesis
1536281|NCT00635193|Volociximab|volociximab
1536282|NCT00635193|Ovarian cancer|ovarian cancer
1536283|NCT00635193|Antibody|antibody
1536284|NCT00635193|Monoclonals|monoclonals
1536285|NCT00635180|Isometric exercise|isometric exercise
1536286|NCT00635180|intraocular pressure|intraocular pressure
1536287|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
1536288|NCT00635167|Prostate cancer|prostate cancer
1536289|NCT00635167|prostatic vascularity|prostatic vascularity
1536290|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
1536291|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
1536292|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
1536293|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
1536294|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
1536295|NCT00635141|Cystic Fibrosis|cystic fibrosis
1536296|NCT00635141|Lung Clearance Index|lung clearance index
1536298|NCT00635141|Pediatrics|pediatrics
1536299|NCT00635128|Diphtheria|diphtheria
1536300|NCT00635128|vaccine|vaccine
1536301|NCT00635128|DTP|dtp
1536302|NCT00635128|Poliomyelitis|poliomyelitis
1536303|NCT00635128|Pertussis|pertussis
1536304|NCT00635128|Booster|booster
1536305|NCT00635128|Tetanus|tetanus
1536306|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
1536307|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
1536308|NCT00635089|Cinquil|cinquil
1536309|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
1536310|NCT00635050|Breast cancer|breast cancer
1536311|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
1536312|NCT00635037|Acupuncture|acupuncture
1536313|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
1536314|NCT00635037|Muscle relaxants, central|muscle relaxants, central
1536315|NCT00635037|Quality of life.|quality of life.
1536316|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
1536317|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
1536318|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
1536319|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
1536320|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
1536321|NCT00635011|comorbidity|comorbidity
1536322|NCT00635011|Quality of Life|quality of life
1536323|NCT00635011|Body Weight Changes|body weight changes
1536324|NCT00634998|Vitamin C|vitamin c
1536325|NCT00634998|Ascorbic Acid|ascorbic acid
1536326|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
1536327|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
1536328|NCT00634972|Premature Infants|premature infants
1536329|NCT00634972|ACULAR|acular
1536330|NCT00634972|Refresh Tears|refresh tears
1536331|NCT00634959|HIV Infections|hiv infections
1536332|NCT00634959|Treatment Naïve|treatment naïve
1536333|NCT00634946|Chemonucleolysis|chemonucleolysis
1536334|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
1536335|NCT00634946|Hernia|hernia
1536336|NCT00634933|active|active
1536337|NCT00634933|rheumatoid|rheumatoid
1536338|NCT00634933|arthritis|arthritis
1536339|NCT00634933|anti CD20|anti cd20
1536340|NCT00634920|De novo renal transplantation|de novo renal transplantation
1536341|NCT00634907|Genotyping|genotyping
1536342|NCT00634907|Warfarin dosing|warfarin dosing
1536343|NCT00634907|arthroplasty|arthroplasty
1536344|NCT00634894|Ovarian Cancer|ovarian cancer
1536345|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
1536346|NCT00634894|Peritoneal Cancer|peritoneal cancer
1536347|NCT00634894|Femara|femara
1536348|NCT00634894|Letrozole|letrozole
1536349|NCT00634894|Placebo|placebo
1536350|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1536351|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1536352|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1536353|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1536354|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1536355|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
1536356|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
1536357|NCT00634855|Endothelial dysfunction|endothelial dysfunction
1536358|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
1536359|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
1536360|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
1536361|NCT00634777|chemoradiation|chemoradiation
1698545|NCT00061048|ATL|atl
1536362|NCT00634764|Maternal weight gain|maternal weight gain
1536363|NCT00634764|Neonatal birth weight|neonatal birth weight
1536364|NCT00634764|Weight gain attitude|weight gain attitude
1536365|NCT00634764|Pregnancy|pregnancy
1536366|NCT00634764|Body fat|body fat
1536367|NCT00634764|Maternal Behavior|maternal behavior
1536368|NCT00634764|Birth outcomes|birth outcomes
1536369|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
1536370|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
1536371|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1536372|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
1536373|NCT00634712|Congestive Heart Failure|congestive heart failure
1536374|NCT00634712|Atacand|atacand
1536375|NCT00634712|Candesartan|candesartan
1536376|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
1536377|NCT00634686|immune response|immune response
1536378|NCT00634673|Serum Fatty Acids|serum fatty acids
1536379|NCT00634673|FABP2 Gene|fabp2 gene
1536380|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
1536381|NCT00634647|Chemotherapy|chemotherapy
1536382|NCT00634647|Pharmacokinetics|pharmacokinetics
1536383|NCT00634647|Gene Polymorphisms|gene polymorphisms
1536384|NCT00634647|Prostate Cancer|prostate cancer
1536385|NCT00634634|breast cancer|breast cancer
1536386|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
1536387|NCT00634621|Bladder|bladder
1536388|NCT00634621|Cancer|cancer
1536389|NCT00634621|Cystoscopy|cystoscopy
1536390|NCT00634621|Hexaminolevulinate|hexaminolevulinate
1536391|NCT00634621|Hexvix|hexvix
1536392|NCT00634595|clinical trial|clinical trial
1536393|NCT00634595|randomized|randomized
1536394|NCT00634595|Endostatin|endostatin
1536395|NCT00634595|gene therapy|gene therapy
1536396|NCT00634595|head and neck cancer|head and neck cancer
1536397|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
1536398|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1536399|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
1536400|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
1536401|NCT00634582|bone metastases|bone metastases
1536402|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
1536403|NCT00634556|Tourette Syndrome|tourette syndrome
1536404|NCT00634556|fMRI|fmri
1536405|NCT00634556|levodopa|levodopa
1536406|NCT00634556|working memory|working memory
1536407|NCT00634556|dopamine|dopamine
1536408|NCT00634543|Diabetic neuropathy|diabetic neuropathy
1536409|NCT00634543|Ultracet|ultracet
1536410|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
1536411|NCT00634543|Acetaminophen|acetaminophen
1536412|NCT00634543|Gabapentin|gabapentin
1536413|NCT00634530|Pregnancy|pregnancy
1536414|NCT00634530|Prenatal Care|prenatal care
1536415|NCT00634530|Weight|weight
1536416|NCT00634530|Nutritional Status|nutritional status
1536417|NCT00634504|high dose methotrexate|high dose methotrexate
1536418|NCT00634504|Voraxaze|voraxaze
1536419|NCT00634504|leucovorin|leucovorin
1536420|NCT00634504|delayed elimination|delayed elimination
1536421|NCT00634504|methotrexate toxicity|methotrexate toxicity
1536422|NCT00634504|rescue|rescue
1536423|NCT00634504|renal insufficiency|renal insufficiency
1536424|NCT00634478|essential tremor|essential tremor
1536425|NCT00634478|deep brain stimulation|deep brain stimulation
1536426|NCT00634452|Hodgkin's|hodgkin's
1536427|NCT00634452|Cancer|cancer
1536428|NCT00634452|bi-measurable disease|bi-measurable disease
1536429|NCT00634452|Lymphoma|lymphoma
1536430|NCT00634439|cerebrovascular accident|cerebrovascular accident
1536431|NCT00634439|stroke|stroke
1536432|NCT00634439|transient ischemic attack|transient ischemic attack
1536433|NCT00634439|TIA|tia
1536434|NCT00634439|CVA|cva
1536435|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1536436|NCT00634439|ADHD|adhd
1536437|NCT00634426|Spine|spine
1536438|NCT00634426|Neoplasm metastasis|neoplasm metastasis
1536439|NCT00634426|Treatment, surgical|treatment, surgical
1536440|NCT00634426|Treatment, nonoperative|treatment, nonoperative
1536441|NCT00634426|Quality of life|quality of life
1536442|NCT00634413|COPD|copd
1536443|NCT00634400|Congestive Heart Failure|congestive heart failure
1536444|NCT00634400|Atacand|atacand
1536445|NCT00634400|Candesartan|candesartan
1536446|NCT00634374|Rx medibottle|rx medibottle
1536447|NCT00634374|Oral syringe|oral syringe
1536448|NCT00634374|Liquid medication|liquid medication
1536449|NCT00634374|Bitter-tasting|bitter-tasting
1536450|NCT00634374|Infants|infants
1536451|NCT00634322|osteosarcoma|osteosarcoma
1536452|NCT00634322|high dose methotrexate|high dose methotrexate
1536453|NCT00634322|leucovorin|leucovorin
1536454|NCT00634309|Congestive Heart Failure|congestive heart failure
1536455|NCT00634309|Atacand|atacand
1536456|NCT00634309|Candesartan|candesartan
1536457|NCT00634296|Heart failure|heart failure
1536458|NCT00634296|Systolic dysfunction|systolic dysfunction
1536459|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
1536460|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
1536461|NCT00634257|Advanced Cancer|advanced cancer
1536462|NCT00634257|Solid Tumors|solid tumors
1536463|NCT00634257|Spirituality|spirituality
1536464|NCT00634257|Religiosity|religiosity
1536465|NCT00634257|Symptom Distress|symptom distress
1536466|NCT00634257|Quality of Life|quality of life
1536467|NCT00634257|Caregivers|caregivers
1536468|NCT00634257|Questionnaire|questionnaire
1536469|NCT00634257|Survey|survey
1536470|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
1536471|NCT00634231|Malignant glioma|malignant glioma
1536472|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
1536473|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
1537457|NCT00630500|Memantine|memantine
1536474|NCT00634231|Recurrent ependymoma|recurrent ependymoma
1536475|NCT00634231|Gene therapy|gene therapy
1536476|NCT00634231|Immunotherapy|immunotherapy
1536477|NCT00634218|nicotine|nicotine
1536478|NCT00634218|smoking|smoking
1536479|NCT00634218|smoking cessation|smoking cessation
1536480|NCT00634205|Mesothelioma|mesothelioma
1536481|NCT00634205|Valproate|valproate
1536482|NCT00634205|Doxorubicin|doxorubicin
1536483|NCT00634205|Chemotherapy|chemotherapy
1536484|NCT00634205|Phase II|phase ii
1536485|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
1536486|NCT00634179|Lymphoma|lymphoma
1536487|NCT00634166|thermal injuries|thermal injuries
1536488|NCT00634166|burns|burns
1536489|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
1536490|NCT00634140|gallbladder|gallbladder
1536491|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
1536492|NCT00634114|Reflux Esophagitis|reflux esophagitis
1536493|NCT00634075|Severe sepsis|severe sepsis
1536494|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
1536496|NCT00634062|Affective Lability|affective lability
1536497|NCT00634062|Borderline Personality Disorder|borderline personality disorder
1536498|NCT00634062|Pharmacotherapy|pharmacotherapy
1536499|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
1536500|NCT00634049|BAL8557|bal8557
1536501|NCT00634049|Isavuconazole|isavuconazole
1536502|NCT00634049|Aspergillosis|aspergillosis
1536503|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
1536504|NCT00634049|ASP9766|asp9766
1536505|NCT00634036|Asthma|asthma
1536506|NCT00634036|obesity|obesity
1536507|NCT00634036|exacerbation|exacerbation
1536508|NCT00634036|asthmatics|asthmatics
1536509|NCT00634036|fat|fat
1536510|NCT00634036|overweight|overweight
1536511|NCT00634036|adipose tissue|adipose tissue
1536512|NCT00634036|leptin|leptin
1536513|NCT00634036|adiponectin|adiponectin
1536514|NCT00634036|pioglitazone|pioglitazone
1536515|NCT00634036|Actos|actos
1536516|NCT00634036|wheezing|wheezing
1536517|NCT00634036|Pittsburgh|pittsburgh
1536518|NCT00634036|Pennsylvania|pennsylvania
1536519|NCT00634036|pulmonary|pulmonary
1536520|NCT00634036|lung|lung
1536521|NCT00634010|Advanced Cancer|advanced cancer
1536522|NCT00634010|Solid Tumors|solid tumors
1536523|NCT00634010|Cancer Pain|cancer pain
1536524|NCT00634010|Opioid Pain Killer|opioid pain killer
1536525|NCT00634010|Morphine|morphine
1536526|NCT00634010|Methadone|methadone
1536527|NCT00633997|Diabetes mellitus|diabetes mellitus
1536528|NCT00633997|type 2 diabetes|type 2 diabetes
1536529|NCT00633997|vildagliptin|vildagliptin
1536530|NCT00633997|pharmacokinetics|pharmacokinetics
1536531|NCT00633984|Social Anxiety Disorder|social anxiety disorder
1536532|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
1536533|NCT00633984|D-cycloserine|d-cycloserine
1536534|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
1536535|NCT00633971|Thrombosis|thrombosis
1536536|NCT00633971|Deep vein thrombosis|deep vein thrombosis
1536537|NCT00633971|Venous thrombosis|venous thrombosis
1536538|NCT00633971|Edema|edema
1536539|NCT00633971|stasis ulcers|stasis ulcers
1536540|NCT00633958|18F-FLT|18f-flt
1536541|NCT00633958|FLT|flt
1536542|NCT00633958|PET|pet
1536543|NCT00633958|CNS tumors|cns tumors
1536544|NCT00633958|Newly|newly
1536545|NCT00633958|diagnosed|diagnosed
1536546|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
1536547|NCT00633945|CLE|cle
1536548|NCT00633945|lenalidomide|lenalidomide
1536549|NCT00633945|revlimid|revlimid
1536550|NCT00633945|thalidomide derivative|thalidomide derivative
1536551|NCT00633945|drug|drug
1536552|NCT00633945|lupus|lupus
1536553|NCT00633932|Reflux Esophagitis|reflux esophagitis
1536554|NCT00633919|House dust mites|house dust mites
1536555|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
1536556|NCT00633919|Allergy|allergy
1536557|NCT00633919|Allergic asthma|allergic asthma
1536558|NCT00633906|HIV|hiv
1536559|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
1536560|NCT00633906|Adolescents|adolescents
1536561|NCT00633906|Prevention|prevention
1536562|NCT00633906|HIV Seronegativity|hiv seronegativity
1536563|NCT00633880|NOH|noh
1536564|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
1536565|NCT00633880|Orthostatic hypotension|orthostatic hypotension
1536566|NCT00633880|PAF|paf
1536567|NCT00633880|Pure Autonomic Failure|pure autonomic failure
1536568|NCT00633880|MSA|msa
1536569|NCT00633880|Multiple System Atrophy|multiple system atrophy
1536570|NCT00633880|Neuropathy|neuropathy
1536571|NCT00633880|Autonomic Failure|autonomic failure
1536572|NCT00633880|Parkinson|parkinson
1536573|NCT00633880|Dopamine Deficiency|dopamine deficiency
1536574|NCT00633880|Dopamine|dopamine
1536575|NCT00633880|Droxidopa|droxidopa
1536576|NCT00633867|Tracheal intubation|tracheal intubation
1536577|NCT00633867|Laryngoscopy|laryngoscopy
1536578|NCT00633867|videolaryngoscope|videolaryngoscope
1536579|NCT00633867|McGrath|mcgrath
1536580|NCT00633867|success|success
1536581|NCT00633867|time|time
1536582|NCT00633854|annular array ultrasound|annular array ultrasound
1536583|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
1536584|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
1536585|NCT00633841|Alzheimer|alzheimer
1536586|NCT00633841|Morbus Alzheimer|morbus alzheimer
1536587|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
1536588|NCT00633841|Vaccine|vaccine
1536589|NCT00633841|AD|ad
1536590|NCT00633841|Aβ immunotherapy|aβ immunotherapy
1536591|NCT00633828|Bone Density|bone density
1536592|NCT00633828|Bone mass|bone mass
1536593|NCT00633828|Bone mineral density|bone mineral density
1536594|NCT00633828|Bone structure|bone structure
1536595|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
1536596|NCT00633828|Fat Mass|fat mass
1536597|NCT00633828|Adiposity|adiposity
1536598|NCT00633815|Supine|supine
1536599|NCT00633815|Upright|upright
1536600|NCT00633802|Risperidone|risperidone
1536601|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
1536602|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1536603|NCT00633776|COPD|copd
1536604|NCT00633776|Chronic bronchitis|chronic bronchitis
1536605|NCT00633776|Emphysema|emphysema
1536606|NCT00633776|Perforomist|perforomist
1536607|NCT00633776|Foradil|foradil
1536608|NCT00633776|CT|ct
1536609|NCT00633776|lung function|lung function
1536610|NCT00633763|Diagnostic|diagnostic
1536611|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
1536612|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
1536613|NCT00633750|stage I breast cancer|stage i breast cancer
1536614|NCT00633750|stage II breast cancer|stage ii breast cancer
1536615|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
1536616|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
1536617|NCT00633737|Psychology|psychology
1536618|NCT00633737|Laparoscopy|laparoscopy
1536619|NCT00633737|Cholecystectomy|cholecystectomy
1536620|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
1536621|NCT00633737|Wound healing|wound healing
1536622|NCT00633737|Preparation for surgery|preparation for surgery
1536623|NCT00633737|Stress reduction|stress reduction
1536624|NCT00633737|Stress|stress
1536625|NCT00633737|Relaxation|relaxation
1536626|NCT00633711|OSAS|osas
1536627|NCT00633711|blood pressure|blood pressure
1536628|NCT00633711|sympathetic nervous system|sympathetic nervous system
1536629|NCT00633711|treatment|treatment
1536630|NCT00633711|CPAP|cpap
1536631|NCT00633698|lipoprotein(a)|lipoprotein(a)
1536632|NCT00633698|niacin|niacin
1536633|NCT00633698|placebo|placebo
1536634|NCT00633698|intervention|intervention
1536635|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
1536636|NCT00633685|Fluoxetine|fluoxetine
1536637|NCT00633685|Factors predicting response|factors predicting response
1536638|NCT00633685|Resilience|resilience
1536639|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
1536640|NCT00633672|NSAID|nsaid
1536641|NCT00633672|Nexium|nexium
1536642|NCT00633672|esomeprazole|esomeprazole
1536643|NCT00633672|Gastric Ulcers|gastric ulcers
1536644|NCT00633659|Hemospan|hemospan
1536645|NCT00633659|Oxygen carriers|oxygen carriers
1536646|NCT00633659|Blood substitutes|blood substitutes
1536647|NCT00633659|Ischemia|ischemia
1536648|NCT00633659|Tissue oxygenation|tissue oxygenation
1536649|NCT00633646|nitrogen balance|nitrogen balance
1536650|NCT00633646|malnutrition|malnutrition
1536651|NCT00633646|chronic kidney disease|chronic kidney disease
1536652|NCT00633646|diet|diet
1536653|NCT00633646|glomerular filtration rate|glomerular filtration rate
1536654|NCT00633633|Heart Failure|heart failure
1536655|NCT00633633|Lifestyle Intervention|lifestyle intervention
1536656|NCT00633633|Exercise|exercise
1536657|NCT00633633|Diet|diet
1536658|NCT00633620|colonoscopy|colonoscopy
1536659|NCT00633620|narrow band imaging|narrow band imaging
1536660|NCT00633620|adenoma|adenoma
1536661|NCT00633620|diagnosis|diagnosis
1536662|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
1536663|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
1536664|NCT00633594|Rituximab|rituximab
1536665|NCT00633594|Lenalidomide|lenalidomide
1536666|NCT00633594|Bortezomib|bortezomib
1536667|NCT00633594|Phase 1/2|phase 1/2
1536668|NCT00633581|fatigue|fatigue
1536669|NCT00633581|ascorbic acid|ascorbic acid
1536670|NCT00633581|oxidative stress|oxidative stress
1536671|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
1536672|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
1536673|NCT00633568|Cisplatin|cisplatin
1536674|NCT00633568|Docetaxel|docetaxel
1536675|NCT00633568|Radiotherapy|radiotherapy
1536676|NCT00633568|Chemotherapy|chemotherapy
1536677|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
1536678|NCT00633542|thalidomide|thalidomide
1536679|NCT00633542|maintenance|maintenance
1536680|NCT00633542|interferon|interferon
1536681|NCT00633542|dexamethasone|dexamethasone
1536682|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1536683|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
1536684|NCT00633529|Phase 1b|phase 1b
1536685|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
1536686|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
1536687|NCT00633529|Prior chemotherapy|prior chemotherapy
1536688|NCT00633516|moles|moles
1536689|NCT00633516|melanoma|melanoma
1536690|NCT00633503|free tissue transfer|free tissue transfer
1536691|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
1536692|NCT00633503|complications|complications
1536693|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
1536694|NCT00633503|observation|observation
1536695|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
1536696|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
1536697|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
1536698|NCT00633490|Toxicity|toxicity
1536699|NCT00633490|Efficacy|efficacy
1536700|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1536701|NCT00633477|Septic Shock|septic shock
1536702|NCT00633477|Septicemia|septicemia
1536703|NCT00633477|Drug Therapy|drug therapy
1536704|NCT00633451|shoulder pain|shoulder pain
1536705|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
1536706|NCT00633451|manual therapy|manual therapy
1536707|NCT00633451|rehabilitation|rehabilitation
1537293|NCT00631020|Tobacco|tobacco
1536708|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
1536709|NCT00633412|NSAID|nsaid
1536710|NCT00633412|Nexium|nexium
1536711|NCT00633412|esomeprazole|esomeprazole
1536712|NCT00633412|Gastric Ulcers|gastric ulcers
1536713|NCT00633399|Major Depressive Disorder|major depressive disorder
1536714|NCT00633399|Major Depression|major depression
1536715|NCT00633399|Depression|depression
1536716|NCT00633399|Geodon|geodon
1536717|NCT00633399|Ziprasidone|ziprasidone
1536718|NCT00633399|SSRI Augmentation|ssri augmentation
1536719|NCT00633399|Treatment Resistant Depression|treatment resistant depression
1536720|NCT00633386|Knee Surgery|knee surgery
1536721|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
1536722|NCT00633373|lung|lung
1536723|NCT00633373|transplant|transplant
1536724|NCT00633373|transplant rejection|transplant rejection
1536725|NCT00633373|Cyclosporine|cyclosporine
1536726|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
1536727|NCT00633373|aerosol|aerosol
1536728|NCT00633360|Women|women
1536729|NCT00633360|PMS|pms
1536730|NCT00633360|Depression|depression
1536731|NCT00633347|oocyte donation|oocyte donation
1536732|NCT00633347|endometrial preparation|endometrial preparation
1536733|NCT00633334|Cancer|cancer
1536734|NCT00633334|GI|gi
1536735|NCT00633334|Tumor|tumor
1536736|NCT00633334|Gastrointestinal|gastrointestinal
1536737|NCT00633334|high risk|high risk
1536738|NCT00633321|smoking cessation|smoking cessation
1536739|NCT00633321|quit smoking|quit smoking
1536740|NCT00633321|smoking vaccine|smoking vaccine
1536741|NCT00633321|nicotine vaccine|nicotine vaccine
1536742|NCT00633321|TA-NIC|ta-nic
1536743|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
1536744|NCT00633308|hemodialysis|hemodialysis
1536745|NCT00633295|GIST|gist
1536746|NCT00633295|TKI|tki
1536747|NCT00633295|IMATINIB|imatinib
1536748|NCT00633295|NILOTINIB|nilotinib
1536749|NCT00633295|AMN107|amn107
1536750|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
1536751|NCT00633282|Pioglitazone|pioglitazone
1536752|NCT00633282|Berberine|berberine
1536753|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
1536754|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1536755|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
1536756|NCT00633230|hepatitis C virus|hepatitis c virus
1536757|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
1536758|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
1536759|NCT00633217|DISKUS|diskus
1536760|NCT00633217|Salmeterol|salmeterol
1536761|NCT00633217|Fluticasone Propionate|fluticasone propionate
1536762|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1536763|NCT00633217|Hydroflouroalkane|hydroflouroalkane
1536764|NCT00633217|COPD|copd
1536765|NCT00633217|HFA MDI|hfa mdi
1536766|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
1536767|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
1536768|NCT00633191|Cystic fibrosis|cystic fibrosis
1536769|NCT00633191|Prevention|prevention
1536770|NCT00633191|Infection|infection
1536771|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
1536772|NCT00633191|Gargle|gargle
1536773|NCT00633178|Prenatal Depression|prenatal depression
1536774|NCT00633178|Postpartum Depression|postpartum depression
1536775|NCT00633178|Fetal Development|fetal development
1536776|NCT00633178|Interpersonal Therapy|interpersonal therapy
1536777|NCT00633165|sarcoma|sarcoma
1536778|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
1536779|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
1536780|NCT00633152|linezolid|linezolid
1536781|NCT00633152|ceftaroline|ceftaroline
1536782|NCT00633152|clinical response|clinical response
1536783|NCT00633152|microbiological response|microbiological response
1536784|NCT00633152|Cellulitis|cellulitis
1536785|NCT00633152|Abscess|abscess
1536786|NCT00633152|Wound infection|wound infection
1536787|NCT00633152|Deeper soft tissue|deeper soft tissue
1536788|NCT00633152|Significant surgical intervention|significant surgical intervention
1536789|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
1536790|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
1536791|NCT00633152|bacterial infection|bacterial infection
1536792|NCT00633152|cephalosporin|cephalosporin
1536793|NCT00633152|broad-spectrum activity|broad-spectrum activity
1536794|NCT00633139|Metazym|metazym
1536795|NCT00633139|Late infantile|late infantile
1536796|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
1536797|NCT00633139|Long-term safety|long-term safety
1536798|NCT00633126|PK|pk
1536799|NCT00633126|Pharmacokinetics|pharmacokinetics
1536800|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
1536801|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
1536802|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
1536803|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
1536804|NCT00633074|Influenza|influenza
1536805|NCT00633061|Childhood Cancer|childhood cancer
1536806|NCT00633061|Central Venous Catheter|central venous catheter
1536807|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
1536808|NCT00633061|Catheter-related Infection|catheter-related infection
1536809|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
1536810|NCT00633048|ascending single-dose study|ascending single-dose study
1536811|NCT00633048|healthy subjects|healthy subjects
1536812|NCT00633035|ulcer|ulcer
1536813|NCT00633035|esomeprazole|esomeprazole
1536814|NCT00633035|famotidine|famotidine
1536815|NCT00633035|Neurosurgery|neurosurgery
1536816|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
1536817|NCT00633009|Leishmaniasis|leishmaniasis
1536818|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
1536819|NCT00633009|Skin Test|skin test
1536820|NCT00633009|Conversion|conversion
1536821|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
1536822|NCT00632996|shoulder pain|shoulder pain
1536823|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
1536824|NCT00632996|manual therapy|manual therapy
1536825|NCT00632996|rehabilitation|rehabilitation
1536826|NCT00632970|Raltegravir|raltegravir
1536827|NCT00632970|Lopinavir|lopinavir
1536828|NCT00632918|Image quality|image quality
1536829|NCT00632918|Dual-source CT|dual-source ct
1536830|NCT00632918|Coronary angiography|coronary angiography
1536831|NCT00632918|Heart rate|heart rate
1536832|NCT00632905|Prostate Cancer|prostate cancer
1536833|NCT00632905|Prostatic adenoma|prostatic adenoma
1536834|NCT00632905|Prostatic neoplasm|prostatic neoplasm
1536835|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
1536836|NCT00632892|urine norepinephrine|urine norepinephrine
1536837|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
1536838|NCT00632866|auto-immune diseases|auto-immune diseases
1536839|NCT00632866|hydroxychloroquine|hydroxychloroquine
1536840|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
1536841|NCT00632866|inflammatory arthritides|inflammatory arthritides
1536842|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
1536843|NCT00632866|dryness|dryness
1536844|NCT00632866|joint diseases|joint diseases
1536845|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
1536846|NCT00632814|Kogenate,|kogenate,
1536847|NCT00632814|Children,|children,
1536848|NCT00632814|Factor VIII,|factor viii,
1536849|NCT00632814|Hemophilia A,|hemophilia a,
1536850|NCT00632814|Prophylactic|prophylactic
1536851|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
1536852|NCT00632801|chewing gum|chewing gum
1536853|NCT00632801|ileus|ileus
1536854|NCT00632801|post-operative care|post-operative care
1536855|NCT00632801|colectomy|colectomy
1536856|NCT00632788|myocardial infarction|myocardial infarction
1536857|NCT00632788|catheterization|catheterization
1536858|NCT00632788|angioplasty|angioplasty
1536859|NCT00632788|door-to-balloon time|door-to-balloon time
1536860|NCT00632775|pediatrics|pediatrics
1536861|NCT00632775|Hyponatremia|hyponatremia
1536862|NCT00632775|Sodium Chloride|sodium chloride
1536863|NCT00632775|maintenance fluids|maintenance fluids
1536864|NCT00632762|Amantadine benefit|amantadine benefit
1536865|NCT00632762|Dyskinesia|dyskinesia
1536866|NCT00632762|Parkinson's disease|parkinson's disease
1536867|NCT00632736|ropinirole XL|ropinirole xl
1536868|NCT00632736|REQUIP|requip
1536869|NCT00632736|Parkinson's disease|parkinson's disease
1536870|NCT00632736|long term safety|long term safety
1536871|NCT00632736|efficacy|efficacy
1536872|NCT00632736|safety|safety
1536873|NCT00632736|ropinirole CR|ropinirole cr
1537653|NCT00629746|Thyroid|thyroid
1536874|NCT00632736|ropinirole IR|ropinirole ir
1536875|NCT00632736|open-label|open-label
1536876|NCT00632723|oestrogen receptor|oestrogen receptor
1536877|NCT00632723|ER negative tumours|er negative tumours
1536878|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
1536879|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
1536880|NCT00632710|hands|hands
1536881|NCT00632710|randomized controlled|randomized controlled
1536882|NCT00632710|low level laser|low level laser
1536883|NCT00632697|endometriosis|endometriosis
1536884|NCT00632697|immunomodulation|immunomodulation
1536885|NCT00632697|infertility|infertility
1536886|NCT00632697|laparoscopic surgery|laparoscopic surgery
1536887|NCT00632697|pentoxifylline|pentoxifylline
1536888|NCT00632684|Family Caregiving|family caregiving
1536889|NCT00632684|Dementia|dementia
1536890|NCT00632671|Obesity cohort|obesity cohort
1536891|NCT00632658|cGVHD|cgvhd
1536892|NCT00632645|Huntington|huntington
1536893|NCT00632645|Neuroleptic|neuroleptic
1536894|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
1536895|NCT00632645|Independence Scale|independence scale
1536896|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
1536897|NCT00632632|World Trade Center Victims|world trade center victims
1536898|NCT00632632|Iraq War Veterans|iraq war veterans
1536899|NCT00632632|PTSD|ptsd
1536900|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
1536901|NCT00632619|ADHD|adhd
1536902|NCT00632606|pregnant women|pregnant women
1537294|NCT00631020|Adolescent|adolescent
1536903|NCT00632593|Early Complications of both techniques|early complications of both techniques
1536904|NCT00632593|Fistula rate|fistula rate
1536905|NCT00632593|Dehiscence rate|dehiscence rate
1536906|NCT00632593|reoperation rate and cause|reoperation rate and cause
1536907|NCT00632580|Pain, Postoperative|pain, postoperative
1536908|NCT00632567|Anal incontinence|anal incontinence
1536909|NCT00632567|First delivery was traumatic|first delivery was traumatic
1536910|NCT00632567|No anal incontinence|no anal incontinence
1536911|NCT00632528|MEOPA|meopa
1536912|NCT00632528|spasticity|spasticity
1536913|NCT00632528|multilevel surgery|multilevel surgery
1536914|NCT00632528|cerebral palsy|cerebral palsy
1536915|NCT00632528|children|children
1536916|NCT00632515|Colorectal Cancer|colorectal cancer
1536917|NCT00632515|CRC|crc
1536918|NCT00632515|Familial CRC|familial crc
1536919|NCT00632515|Cancer Screening|cancer screening
1536920|NCT00632515|Questionnaire|questionnaire
1536921|NCT00632515|First Degree Relatives|first degree relatives
1536922|NCT00632515|FDRs|fdrs
1536923|NCT00632515|Risk Communication|risk communication
1536924|NCT00632489|Refractory Malignancy|refractory malignancy
1536925|NCT00632489|Breast Cancer|breast cancer
1536926|NCT00632489|LBH589|lbh589
1536927|NCT00632489|Capecitabine|capecitabine
1536928|NCT00632489|Lapatinib|lapatinib
1536929|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
1536930|NCT00632476|Vitamin C|vitamin c
1536931|NCT00632476|Newborn Lung Function|newborn lung function
1536932|NCT00632476|Ascorbic Acid|ascorbic acid
1536933|NCT00632463|Transplant|transplant
1536934|NCT00632463|Immunosuppression|immunosuppression
1536935|NCT00632437|Brain Tumor|brain tumor
1536936|NCT00632437|Craniotomy Surgery|craniotomy surgery
1536937|NCT00632437|Brain Function|brain function
1536938|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
1536939|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
1536940|NCT00632437|Cortical Mapping|cortical mapping
1536941|NCT00632437|Somatosensory Cortex|somatosensory cortex
1536942|NCT00632437|Cerebral blood flow|cerebral blood flow
1536943|NCT00632437|CBF|cbf
1536944|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
1536945|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
1536946|NCT00632398|massage|massage
1536947|NCT00632398|oncology massage|oncology massage
1536948|NCT00632398|palliative care|palliative care
1536949|NCT00632398|supportive care|supportive care
1536950|NCT00632398|integrative oncology|integrative oncology
1536951|NCT00632398|informal caregiving|informal caregiving
1536952|NCT00632398|spouse caregiving|spouse caregiving
1536953|NCT00632398|family caregiving|family caregiving
1536954|NCT00632398|caregiver education|caregiver education
1536955|NCT00632398|psychosocial oncology|psychosocial oncology
1536956|NCT00632398|caregiver stress|caregiver stress
1536957|NCT00632398|coping with cancer|coping with cancer
1536958|NCT00632398|quality of life|quality of life
1536959|NCT00632398|end of life care|end of life care
1536960|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1536961|NCT00632359|CLL|cll
1536962|NCT00632359|Lenalidomide|lenalidomide
1536963|NCT00632359|Revlimid|revlimid
1536964|NCT00632346|childhood abuse|childhood abuse
1536965|NCT00632346|overweight|overweight
1536966|NCT00632346|obesity|obesity
1536967|NCT00632346|BMI as a young adult|bmi as a young adult
1536968|NCT00632346|childhood physical abuse|childhood physical abuse
1536969|NCT00632346|childhood emotional abuse|childhood emotional abuse
1536970|NCT00632346|childhood sexual abuse|childhood sexual abuse
1536971|NCT00632346|childhood physical neglect|childhood physical neglect
1537654|NCT00629746|RLN|rln
1536972|NCT00632346|childhood emotional neglect|childhood emotional neglect
1536973|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
1536974|NCT00632346|parental marital discord|parental marital discord
1536975|NCT00632346|household members with substance abuse|household members with substance abuse
1536976|NCT00632346|household members with mental illness|household members with mental illness
1536977|NCT00632346|household members with criminal behavior|household members with criminal behavior
1536978|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
1536979|NCT00632333|Epitope peptide|epitope peptide
1536980|NCT00632333|Vaccination|vaccination
1536981|NCT00632333|Chemoradiation|chemoradiation
1536982|NCT00632333|Esophageal cancer|esophageal cancer
1536983|NCT00632320|Ventilator, mechanical|ventilator, mechanical
1536984|NCT00632320|Ventilator weaning|ventilator weaning
1536985|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
1536986|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
1536987|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
1536988|NCT00632320|COPD|copd
1536989|NCT00632307|lung tumor|lung tumor
1536990|NCT00632307|pleural tumor|pleural tumor
1536991|NCT00632307|interstitial lung disease|interstitial lung disease
1536992|NCT00632307|airway infection|airway infection
1536993|NCT00632307|COPD|copd
1536994|NCT00632307|sleep apnea|sleep apnea
1536995|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
1536996|NCT00632307|breath analysis|breath analysis
1536997|NCT00632294|Bone Cancer|bone cancer
1536998|NCT00632294|Allograft Retrieval|allograft retrieval
1536999|NCT00632294|Allograft Bone|allograft bone
1537000|NCT00632294|Bone Mineral Density|bone mineral density
1537001|NCT00632268|mTOR inhibitor|mtor inhibitor
1537002|NCT00632268|RAD001|rad001
1537003|NCT00632268|everolimus|everolimus
1537004|NCT00632268|chemotherapy|chemotherapy
1537005|NCT00632268|cisplatin|cisplatin
1537006|NCT00632268|high-dose 5-FU|high-dose 5-fu
1537007|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
1537008|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
1537009|NCT00632255|Newly diagnosed|newly diagnosed
1537010|NCT00632255|Late side effects|late side effects
1537011|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
1537012|NCT00632190|cervical cancer|cervical cancer
1537013|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1537014|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1537015|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1537016|NCT00632138|sexual dysfunction|sexual dysfunction
1537017|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1537018|NCT00632138|prostate cancer|prostate cancer
1537019|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
1537020|NCT00632138|urinary incontinence|urinary incontinence
1537021|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
1537022|NCT00632112|large volume nebulizer|large volume nebulizer
1537023|NCT00632099|cocaine|cocaine
1537024|NCT00632099|treatment|treatment
1537025|NCT00632099|progesterone|progesterone
1537026|NCT00632086|PK|pk
1537027|NCT00632073|HIV Infections|hiv infections
1537028|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1537029|NCT00632073|treatment experienced|treatment experienced
1537030|NCT00632060|Low Back Pain|low back pain
1537031|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
1537032|NCT00632047|breast cancer|breast cancer
1537033|NCT00632047|cervical cancer|cervical cancer
1537034|NCT00632034|fracture|fracture
1537035|NCT00632034|tibia|tibia
1537036|NCT00632034|stem cell|stem cell
1537037|NCT00632021|Low Health Literacy|low health literacy
1537038|NCT00632021|Medication Errors|medication errors
1537039|NCT00632021|Cardiovascular Disease|cardiovascular disease
1537040|NCT00632021|Pharmacist|pharmacist
1537041|NCT00632021|Care Transition|care transition
1537042|NCT00631995|Neisseria meningitidis|neisseria meningitidis
1537043|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
1537044|NCT00631969|Erectile Dysfunction|erectile dysfunction
1537045|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
1537046|NCT00631904|Pacemaker|pacemaker
1537047|NCT00631878|Staphylococcal|staphylococcal
1537048|NCT00631878|Monoclonal antibodies|monoclonal antibodies
1537049|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
1537050|NCT00631878|Prophylaxis|prophylaxis
1537051|NCT00631865|melanocytes|melanocytes
1537052|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
1537053|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
1537054|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
1537055|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
1537056|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
1537057|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
1537058|NCT00631826|Shoulder|shoulder
1537059|NCT00631826|Injuries|injuries
1537060|NCT00631826|Flexiblity|flexiblity
1537061|NCT00631826|Rotational resistance|rotational resistance
1537062|NCT00631800|Staphylococcal|staphylococcal
1537063|NCT00631800|Monoclonal antibodies|monoclonal antibodies
1537064|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
1537065|NCT00631800|Prophylaxis|prophylaxis
1537066|NCT00631787|Nitric Oxide|nitric oxide
1537067|NCT00631787|Hemolysis|hemolysis
1537068|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
1537069|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
1537070|NCT00631787|Organ Dysfuntion|organ dysfuntion
1537071|NCT00631787|Healthy Volunteer|healthy volunteer
1537073|NCT00631774|type 2 diabetes|type 2 diabetes
1537074|NCT00631774|meal replacement|meal replacement
1537075|NCT00631774|postprandial response|postprandial response
1537076|NCT00631774|Glucerna SR|glucerna sr
1537077|NCT00631761|urethrocystoscopy|urethrocystoscopy
1537078|NCT00631761|cystoscopy|cystoscopy
1537079|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
1537080|NCT00631748|cocaine|cocaine
1537081|NCT00631748|quetiapine fumarate|quetiapine fumarate
1537082|NCT00631748|dependence|dependence
1537083|NCT00631748|abuse|abuse
1537084|NCT00631748|addiction|addiction
1537085|NCT00631748|treatment|treatment
1537086|NCT00631735|cancer|cancer
1537087|NCT00631735|qualitative|qualitative
1537088|NCT00631722|PANSS|panss
1537089|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
1537090|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
1537091|NCT00631657|placebo controlled|placebo controlled
1537092|NCT00631657|randomized|randomized
1537093|NCT00631657|double blind|double blind
1537094|NCT00631644|Adolescents|adolescents
1537095|NCT00631644|Eating Behavior|eating behavior
1537096|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
1537097|NCT00631644|Disordered Eating|disordered eating
1537098|NCT00631644|Food Intake|food intake
1537099|NCT00631644|Macronutrient Composition|macronutrient composition
1537100|NCT00631644|Obesity|obesity
1537101|NCT00631644|Adolescent|adolescent
1537102|NCT00631644|Healthy Volunteer|healthy volunteer
1537103|NCT00631644|HV|hv
1537104|NCT00631631|Drug Therapy|drug therapy
1537105|NCT00631605|eating disorders|eating disorders
1537106|NCT00631605|ghrelin|ghrelin
1537107|NCT00631605|leptin|leptin
1537108|NCT00631605|BIA|bia
1537109|NCT00631592|GSK1349572,|gsk1349572,
1537110|NCT00631592|healthy volunteers,|healthy volunteers,
1537111|NCT00631592|repeat dose,|repeat dose,
1537112|NCT00631592|relative bioavailability|relative bioavailability
1537113|NCT00631592|Healthy subjects|healthy subjects
1537114|NCT00631566|HIV|hiv
1537115|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1537116|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
1537117|NCT00631540|renal artery stenosis|renal artery stenosis
1537118|NCT00631540|hypertension|hypertension
1537119|NCT00631540|renovascular|renovascular
1537120|NCT00631540|renal artery blockage|renal artery blockage
1537121|NCT00631540|renal artery disease|renal artery disease
1537122|NCT00631540|renal arteries|renal arteries
1537123|NCT00631540|angioplasty renal artery|angioplasty renal artery
1537124|NCT00631540|renal artery stent|renal artery stent
1537125|NCT00631540|renal artery doppler|renal artery doppler
1537126|NCT00631540|renovascular hypertension|renovascular hypertension
1537127|NCT00631540|kidney stenosis|kidney stenosis
1537128|NCT00631540|renal artery|renal artery
1537129|NCT00631540|stent|stent
1537130|NCT00631540|stenting|stenting
1537131|NCT00631540|kidney disease|kidney disease
1537132|NCT00631540|renal failure|renal failure
1537133|NCT00631540|atherosclerosis|atherosclerosis
1537134|NCT00631540|arterial hypertension|arterial hypertension
1537135|NCT00631540|stenosis|stenosis
1537136|NCT00631527|Prostate Cancer|prostate cancer
1537137|NCT00631527|Radiation Therapy|radiation therapy
1537139|NCT00631527|Radiotherapy|radiotherapy
1537140|NCT00631527|Hormone Ablation|hormone ablation
1537141|NCT00631527|Sunitinib Malate|sunitinib malate
1537142|NCT00631527|Leuprolide|leuprolide
1537143|NCT00631527|Lupron|lupron
1537144|NCT00631527|Zoladex|zoladex
1537145|NCT00631527|Goserelin|goserelin
1537146|NCT00631527|Casodex|casodex
1537147|NCT00631527|Bicalutamide|bicalutamide
1537148|NCT00631527|SU011248|su011248
1537149|NCT00631527|Sutent|sutent
1537150|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
1537151|NCT00631514|antihypertensive drugs|antihypertensive drugs
1537152|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1537153|NCT00631514|interaction|interaction
1537154|NCT00631514|family practice|family practice
1537155|NCT00631514|arterial blood pressure|arterial blood pressure
1537156|NCT00631501|tendinopathy|tendinopathy
1537157|NCT00631501|tennis elbow|tennis elbow
1537158|NCT00631501|lateral epicondylitis|lateral epicondylitis
1537159|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
1537160|NCT00631501|MMP-inhibitor|mmp-inhibitor
1537161|NCT00631475|Actelion|actelion
1537162|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1537163|NCT00631475|bosentan|bosentan
1537164|NCT00631475|Tracleer|tracleer
1537165|NCT00631475|Interstitial Lung Disease|interstitial lung disease
1537166|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
1537167|NCT00631462|primary myelofibrosis|primary myelofibrosis
1537168|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
1537169|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
1537170|NCT00631449|HIV|hiv
1537171|NCT00631449|Treatment intensification|treatment intensification
1537172|NCT00631449|Low level viremia|low level viremia
1537173|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
1537174|NCT00631449|treatment experienced|treatment experienced
1537175|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
1537176|NCT00631436|Electroencephalography|electroencephalography
1537177|NCT00631436|Blast Injury|blast injury
1537178|NCT00631436|Traumatic Brain Injury|traumatic brain injury
1537179|NCT00631410|Phase 1|phase 1
1537180|NCT00631410|CRC|crc
1537181|NCT00631410|SU011248|su011248
1537182|NCT00631410|Sunitinib|sunitinib
1537183|NCT00631410|FOLFOX|folfox
1537184|NCT00631410|Colorectal cancer|colorectal cancer
1537185|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
1537186|NCT00631397|weakening of the bones|weakening of the bones
1537187|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
1537188|NCT00631384|HIV|hiv
1537189|NCT00631384|HIV seronegativity|hiv seronegativity
1537190|NCT00631371|temsirolimus|temsirolimus
1537295|NCT00631020|Dependence|dependence
1537191|NCT00631371|renal cell carcinoma|renal cell carcinoma
1537192|NCT00631371|kidney cancer|kidney cancer
1537193|NCT00631371|urogenital cancer|urogenital cancer
1537194|NCT00631358|Ocular inflammation|ocular inflammation
1537195|NCT00631345|prediabetes|prediabetes
1537196|NCT00631345|overweight|overweight
1537197|NCT00631345|obesity|obesity
1537198|NCT00631345|metabolic syndrome|metabolic syndrome
1537199|NCT00631345|community health worker|community health worker
1537200|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
1537201|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
1537202|NCT00631319|OA|oa
1537203|NCT00631319|Chronic Pain|chronic pain
1537204|NCT00631319|Osteoarthritis|osteoarthritis
1537205|NCT00631319|OA Pain|oa pain
1537206|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
1537207|NCT00631319|Pain|pain
1537208|NCT00631319|Hip Pain|hip pain
1537209|NCT00631319|Knee Pain|knee pain
1537210|NCT00631319|Joint Pain|joint pain
1537211|NCT00631293|Healthy volunteers|healthy volunteers
1537212|NCT00631280|Decision Aid|decision aid
1537213|NCT00631280|Informed Choice|informed choice
1537214|NCT00631280|Adherence|adherence
1537215|NCT00631267|reduction|reduction
1537216|NCT00631267|satisfaction|satisfaction
1537217|NCT00631267|visual-analog scale|visual-analog scale
1537218|NCT00631267|complications|complications
1537219|NCT00631267|functional outcome|functional outcome
1537220|NCT00631267|radiological outcome|radiological outcome
1537221|NCT00631241|Cervical Cancer|cervical cancer
1537222|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
1537223|NCT00631241|Sentinel Nodes|sentinel nodes
1537224|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
1537225|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
1537226|NCT00631241|SPECT/CT|spect/ct
1537227|NCT00631228|drug eluting stents|drug eluting stents
1537228|NCT00631228|stents|stents
1537229|NCT00631228|Angioplasty|angioplasty
1537230|NCT00631228|coronary artery disease|coronary artery disease
1537231|NCT00631228|total coronary occlusion|total coronary occlusion
1537232|NCT00631228|coronary artery restenosis|coronary artery restenosis
1537233|NCT00631228|stent thrombosis|stent thrombosis
1537234|NCT00631228|vascular disease|vascular disease
1537235|NCT00631228|myocardial ischemia|myocardial ischemia
1537236|NCT00631228|coronary artery stenosis|coronary artery stenosis
1537237|NCT00631215|Hyperbaric|hyperbaric
1537238|NCT00631215|Oxygen|oxygen
1537239|NCT00631215|autism|autism
1537240|NCT00631202|FRDA|frda
1537241|NCT00631202|Erythropoietin|erythropoietin
1537242|NCT00631202|Epoetin alfa|epoetin alfa
1537243|NCT00631189|dyslipidemia|dyslipidemia
1537244|NCT00631176|oral intubation|oral intubation
1537245|NCT00631176|just in time|just in time
1537246|NCT00631176|simulation education|simulation education
1537247|NCT00631176|high fidelity training|high fidelity training
1537248|NCT00631176|intubation training|intubation training
1537249|NCT00631176|intubation success|intubation success
1537250|NCT00631163|Iron Overload,|iron overload,
1537251|NCT00631163|Chelation,|chelation,
1537252|NCT00631163|MDS,|mds,
1537253|NCT00631163|Chronic Anemia,|chronic anemia,
1537254|NCT00631163|Deferasirox,|deferasirox,
1537255|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
1537256|NCT00631150|Levetiracetam|levetiracetam
1537257|NCT00631150|Keppra|keppra
1537258|NCT00631137|musculoskeletal complications|musculoskeletal complications
1537259|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1537361|NCT00630747|enlarged adenoids|enlarged adenoids
1537260|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1537261|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
1537262|NCT00631137|adult glioblastoma|adult glioblastoma
1537263|NCT00631137|adult gliosarcoma|adult gliosarcoma
1537264|NCT00631124|Contraception|contraception
1537265|NCT00631111|dental pain|dental pain
1537266|NCT00631111|analgesic|analgesic
1537267|NCT00631111|NSAID|nsaid
1537268|NCT00631111|ibuprofen|ibuprofen
1537269|NCT00631111|aspirin|aspirin
1537270|NCT00631098|Resuscitation|resuscitation
1537271|NCT00631098|venous cannulation|venous cannulation
1537272|NCT00631098|external jugular vein|external jugular vein
1537273|NCT00631098|cubital vein|cubital vein
1537274|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
1537275|NCT00631072|iNKT|inkt
1537276|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
1537277|NCT00631059|Hitachi|hitachi
1537278|NCT00631059|Leukemia|leukemia
1537279|NCT00631059|Relapse|relapse
1537280|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
1537281|NCT00631046|n-3 LCPUFA|n-3 lcpufa
1537282|NCT00631046|Fish oil|fish oil
1537283|NCT00631046|essential fatty acids|essential fatty acids
1537284|NCT00631046|infant growth|infant growth
1537285|NCT00631046|obesity|obesity
1537286|NCT00631046|Intestinal microbiota|intestinal microbiota
1537287|NCT00631033|obesity|obesity
1537288|NCT00631033|hyperinsulinism|hyperinsulinism
1537289|NCT00631033|diazoxide|diazoxide
1537290|NCT00631033|metformin|metformin
1537291|NCT00631020|Youth|youth
1537292|NCT00631020|Smoking|smoking
1537296|NCT00631020|Teen smoking|teen smoking
1537297|NCT00631020|Smoking and youth|smoking and youth
1537298|NCT00631020|Youth and tobacco|youth and tobacco
1537299|NCT00631007|Type 2 diabetes|type 2 diabetes
1537300|NCT00631007|diabetes|diabetes
1537301|NCT00631007|diabetes mellitus|diabetes mellitus
1537302|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
1537303|NCT00631007|non-TZD|non-tzd
1537304|NCT00631007|thiazolidinedione|thiazolidinedione
1537305|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
1537306|NCT00631007|SPPARM|spparm
1537307|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
1537308|NCT00631007|PPAR gamma|ppar gamma
1537309|NCT00631007|insulin sensitizer|insulin sensitizer
1537310|NCT00631007|glucose control|glucose control
1537311|NCT00631007|endocrinopathy|endocrinopathy
1537312|NCT00631007|hypoglycemic agent|hypoglycemic agent
1537313|NCT00631007|sulfonylurea|sulfonylurea
1537314|NCT00631007|metformin|metformin
1537315|NCT00631007|pioglitazone|pioglitazone
1537316|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
1537317|NCT00630994|primary myelofibrosis|primary myelofibrosis
1537318|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
1537319|NCT00630994|essential thrombocythemia|essential thrombocythemia
1537320|NCT00630994|polycythemia vera|polycythemia vera
1537321|NCT00630981|dissociative disorders|dissociative disorders
1537322|NCT00630968|Levetiracetam|levetiracetam
1537323|NCT00630968|Keppra|keppra
1537324|NCT00630955|Alcohol Drinking|alcohol drinking
1537325|NCT00630955|Memantine|memantine
1537326|NCT00630942|PSC|psc
1537327|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
1537328|NCT00630916|Aortic valve|aortic valve
1537329|NCT00630916|Aortic disease|aortic disease
1537330|NCT00630916|Aortic incompetence|aortic incompetence
1537331|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
1537332|NCT00630890|External Beam Radiation|external beam radiation
1537333|NCT00630890|Cyberknife|cyberknife
1537334|NCT00630890|Capecitabine|capecitabine
1567732|NCT00508339|Limb Sparing Surgery|limb sparing surgery
1537335|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
1537336|NCT00630838|Hirschsprung disease|hirschsprung disease
1537337|NCT00630838|enterocolitis|enterocolitis
1537338|NCT00630838|probiotics|probiotics
1537339|NCT00630812|cystic fibrosis|cystic fibrosis
1537340|NCT00630812|mannitol|mannitol
1537341|NCT00630812|mucoactive|mucoactive
1537342|NCT00630799|prostate|prostate
1537343|NCT00630799|cancer|cancer
1537344|NCT00630773|CPR|cpr
1537345|NCT00630773|compression sensor|compression sensor
1537346|NCT00630773|chest compression adjuncts|chest compression adjuncts
1537347|NCT00630747|Hunter syndrome|hunter syndrome
1537348|NCT00630747|hunters syndrome|hunters syndrome
1537349|NCT00630747|hunter's syndrome|hunter's syndrome
1537350|NCT00630747|hunter disease|hunter disease
1537351|NCT00630747|hunters disease|hunters disease
1537352|NCT00630747|hunter's disease|hunter's disease
1537353|NCT00630747|MPS II|mps ii
1537354|NCT00630747|MPSII|mpsii
1537355|NCT00630747|MPS2|mps2
1537356|NCT00630747|MPS 2|mps 2
1537357|NCT00630747|mucopolysaccharides|mucopolysaccharides
1537358|NCT00630747|lysosomal storage disease|lysosomal storage disease
1537359|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
1537360|NCT00630747|chronic ear infection|chronic ear infection
1537362|NCT00630747|mps symptoms|mps symptoms
1537363|NCT00630747|mps diagnosis|mps diagnosis
1537364|NCT00630747|mps ii therapy|mps ii therapy
1537365|NCT00630747|MPS II treatment|mps ii treatment
1537366|NCT00630747|ert treatment|ert treatment
1537367|NCT00630747|elaprase|elaprase
1537368|NCT00630747|idursulfase|idursulfase
1537369|NCT00630747|iduronate sulfatase|iduronate sulfatase
1537370|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
1537371|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
1537372|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
1537373|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
1537374|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
1537375|NCT00630747|hunter's disease treatment|hunter's disease treatment
1537376|NCT00630747|mps society|mps society
1537377|NCT00630734|HIV|hiv
1537378|NCT00630734|Pravastatin|pravastatin
1537379|NCT00630734|Darunavir|darunavir
1537380|NCT00630734|Ritonavir|ritonavir
1537381|NCT00630734|Genetic|genetic
1537382|NCT00630708|Renal insufficiency|renal insufficiency
1537383|NCT00630708|Benazepril|benazepril
1537384|NCT00630708|Losartan|losartan
1537385|NCT00630708|combination treatment|combination treatment
1537386|NCT00630708|Safety|safety
1537387|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
1537388|NCT00630682|Methamphetamine|methamphetamine
1537389|NCT00630682|Drug Abuse|drug abuse
1537390|NCT00630682|Drug Treatment|drug treatment
1537391|NCT00630682|Addiction|addiction
1537392|NCT00630682|Meth|meth
1537393|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
1537394|NCT00630669|Internal hemorrhoids|internal hemorrhoids
1537395|NCT00630669|Rubber band ligation|rubber band ligation
1537396|NCT00630669|Bipolar coagulation|bipolar coagulation
1537397|NCT00630656|sepsis|sepsis
1537398|NCT00630656|talactoferrin|talactoferrin
1537399|NCT00630656|lactoferrin|lactoferrin
1537400|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
1537401|NCT00630630|Levetiracetam|levetiracetam
1537402|NCT00630630|Keppra|keppra
1537403|NCT00630617|Obesity|obesity
1537404|NCT00630617|Prevention|prevention
1537405|NCT00630617|Childhood|childhood
1537406|NCT00630617|Children|children
1537407|NCT00630617|Primary care-giver|primary care-giver
1537408|NCT00630604|ultrasonography|ultrasonography
1537409|NCT00630604|knee|knee
1537410|NCT00630604|early degeneration|early degeneration
1537411|NCT00630604|cartilage|cartilage
1537412|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
1537413|NCT00630591|DAMES|dames
1537414|NCT00630591|Breast Cancer|breast cancer
1537415|NCT00630591|Weight Loss|weight loss
1537416|NCT00630591|Home-based weight loss|home-based weight loss
1537417|NCT00630591|Quality of Life|quality of life
1537418|NCT00630591|Diet|diet
1537419|NCT00630591|Exercise|exercise
1537420|NCT00630591|Daughter|daughter
1537421|NCT00630591|Mother|mother
1537422|NCT00630591|Cancer Prevention|cancer prevention
1537423|NCT00630591|Prevention|prevention
1537424|NCT00630578|PTSD|ptsd
1537425|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
1537426|NCT00630578|Physical Assault|physical assault
1537427|NCT00630578|Physical Abuse|physical abuse
1537428|NCT00630578|Sexual Assault|sexual assault
1537429|NCT00630578|Sexual Abuse|sexual abuse
1537430|NCT00630578|Interpersonal Assault|interpersonal assault
1537431|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
1537432|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1537433|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1537434|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1567281|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
1537435|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1537436|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1537437|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1537438|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1537439|NCT00630552|AMG 479|amg 479
1537440|NCT00630552|Gemcitabine|gemcitabine
1537441|NCT00630552|TR-2|tr-2
1537442|NCT00630552|IGF-1R|igf-1r
1537443|NCT00630552|AMG 655|amg 655
1537444|NCT00630552|Pancreatic cancer|pancreatic cancer
1537445|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
1537446|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1537447|NCT00630539|Menopausal symptoms|menopausal symptoms
1537448|NCT00630539|Urogenital atrophy|urogenital atrophy
1537449|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
1537450|NCT00630539|Vaginal atrophy|vaginal atrophy
1537451|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
1537452|NCT00630513|antibiotics|antibiotics
1537453|NCT00630513|localized peritonitis|localized peritonitis
1537454|NCT00630513|ertapenem|ertapenem
1537455|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
1537456|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
1537458|NCT00630500|Placebo-controlled|placebo-controlled
1537459|NCT00630500|Parallel group|parallel group
1537460|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
1537461|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
1537462|NCT00630435|Premarin®|premarin®
1537463|NCT00630422|Rett Syndrome|rett syndrome
1537464|NCT00630422|Selfcare|selfcare
1537465|NCT00630422|Mobility limitation|mobility limitation
1537466|NCT00630422|Interpersonal relations|interpersonal relations
1537467|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
1537468|NCT00630409|Renal cell carcinoma|renal cell carcinoma
1537469|NCT00630409|Kidney Cancer|kidney cancer
1537470|NCT00630409|Gemcitabine|gemcitabine
1537471|NCT00630409|Doxil|doxil
1537472|NCT00630409|Chemotherapy|chemotherapy
1537473|NCT00630396|stroke|stroke
1537474|NCT00630396|ischemic|ischemic
1537475|NCT00630396|neuroprotection|neuroprotection
1537476|NCT00630396|minocycline|minocycline
1537477|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
1537478|NCT00630396|biomarkers|biomarkers
1537479|NCT00630396|pharmacokinetics|pharmacokinetics
1537480|NCT00630396|antiapoptotic|antiapoptotic
1537481|NCT00630396|anti-inflammatory|anti-inflammatory
1537482|NCT00630396|treatment|treatment
1537483|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
1537484|NCT00630396|thrombolysis|thrombolysis
1537485|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
1537486|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
1537487|NCT00630396|cerebrovascular accident|cerebrovascular accident
1537488|NCT00630396|cerebral stroke|cerebral stroke
1537489|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
1537490|NCT00630383|Parasite|parasite
1537491|NCT00630383|Necator|necator
1537492|NCT00630383|immune regulation|immune regulation
1537493|NCT00630383|regulatory T cells|regulatory t cells
1537494|NCT00630383|foxp3|foxp3
1537495|NCT00630383|cytokines|cytokines
1537496|NCT00630383|multiple sclerosis|multiple sclerosis
1537497|NCT00630383|hygiene hypothesis|hygiene hypothesis
1537498|NCT00630357|Levetiracetam|levetiracetam
1537499|NCT00630357|Keppra|keppra
1537500|NCT00630344|RAD001|rad001
1537501|NCT00630344|bicalutamide|bicalutamide
1537502|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
1537503|NCT00630331|Influenza|influenza
1537505|NCT00630331|Cell Culture-Derived|cell culture-derived
1537506|NCT00630331|Egg-Derived|egg-derived
1537507|NCT00630331|Healthy Adults|healthy adults
1537508|NCT00630331|Efficacy|efficacy
1537509|NCT00630331|Safety|safety
1537510|NCT00630331|Immunogenicity|immunogenicity
1537511|NCT00630331|Trivalent|trivalent
1537512|NCT00630331|Inactivated|inactivated
1537513|NCT00630331|Influenza-Like Illness|influenza-like illness
1537514|NCT00630331|Vaccination|vaccination
1537515|NCT00630318|MR scanning|mr scanning
1537516|NCT00630305|toric|toric
1537517|NCT00630305|endothelial bleb|endothelial bleb
1537518|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
1537519|NCT00630279|chronic pancreatitis|chronic pancreatitis
1537520|NCT00630266|Heart failure|heart failure
1537521|NCT00630266|left ventricular dilation|left ventricular dilation
1537522|NCT00630266|mitral valve repair|mitral valve repair
1537523|NCT00630266|mitral valve replacement|mitral valve replacement
1537524|NCT00630253|Fanconi anemia|fanconi anemia
1537525|NCT00630240|epirubicin|epirubicin
1537526|NCT00630240|mitomycin C|mitomycin c
1537527|NCT00630240|cisplatin|cisplatin
1537528|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
1537529|NCT00630227|emphysema|emphysema
1537530|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1537531|NCT00630227|lung volume reduction|lung volume reduction
1537532|NCT00630214|Total thyroidectomy|total thyroidectomy
1537533|NCT00630214|CND|cnd
1537534|NCT00630214|hypocalcemia|hypocalcemia
1537535|NCT00630214|calcium|calcium
1537536|NCT00630214|vitamin D|vitamin d
1537537|NCT00630201|opioid dependence|opioid dependence
1537538|NCT00630201|opioid addiction|opioid addiction
1537539|NCT00630201|buprenorphine|buprenorphine
1537540|NCT00630201|methadone|methadone
1537541|NCT00630201|heroin|heroin
1537542|NCT00630201|implant|implant
1537543|NCT00630201|opioid withdrawal|opioid withdrawal
1537544|NCT00630201|opioid pain medication|opioid pain medication
1537545|NCT00630201|suboxone|suboxone
1537546|NCT00630188|prostate cancer screening|prostate cancer screening
1537547|NCT00630188|shared decision making|shared decision making
1537548|NCT00630188|prostate-specific antigen|prostate-specific antigen
1537549|NCT00630188|decision making|decision making
1537550|NCT00630188|physician-patient relations|physician-patient relations
1537551|NCT00630175|Insomnia|insomnia
1537552|NCT00630162|protozoa|protozoa
1537553|NCT00630162|Amoeba|amoeba
1537554|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
1537555|NCT00630149|Pemetrexed|pemetrexed
1537556|NCT00630110|Non Small Cell Lung|non small cell lung
1537557|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
1537558|NCT00630084|chronic hepatitis C|chronic hepatitis c
1537559|NCT00630084|sustained virological response|sustained virological response
1537560|NCT00630084|peginterferon|peginterferon
1537561|NCT00630084|ribavirin|ribavirin
1537562|NCT00630084|neoplasms|neoplasms
1537563|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
1537564|NCT00630071|Procalcitonin|procalcitonin
1537565|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
1537566|NCT00630058|Protease Inhibitor|protease inhibitor
1537567|NCT00630058|Telaprevir|telaprevir
1537568|NCT00630032|stage II breast cancer|stage ii breast cancer
1537569|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
1537570|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
1537571|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
1537572|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
1537573|NCT00629993|cervical cancer screening|cervical cancer screening
1537574|NCT00629993|medically underserved women|medically underserved women
1537575|NCT00629993|HPV vaccine|hpv vaccine
1537576|NCT00629967|chronic hepatitis C|chronic hepatitis c
1537577|NCT00629967|genotype 1|genotype 1
1537578|NCT00629967|rapid virological response|rapid virological response
1537579|NCT00629967|sustained virological response|sustained virological response
1537580|NCT00629967|peginterferon|peginterferon
1537581|NCT00629967|ribavirin|ribavirin
1537582|NCT00629967|treatment duration|treatment duration
1537583|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
1537584|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
1537585|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
1537586|NCT00629915|Moyamoya|moyamoya
1537587|NCT00629915|stroke|stroke
1537588|NCT00629902|Heart valve prosthesis|heart valve prosthesis
1537589|NCT00629889|seizure|seizure
1537590|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1537591|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
1537592|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1537593|NCT00629889|adult glioblastoma|adult glioblastoma
1537594|NCT00629889|adult gliosarcoma|adult gliosarcoma
1537595|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
1537596|NCT00629889|adult brain stem glioma|adult brain stem glioma
1537597|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
1537598|NCT00629889|adult medulloblastoma|adult medulloblastoma
1537599|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1537600|NCT00629889|adult ependymoma|adult ependymoma
1537601|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
1537602|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
1537603|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1537604|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
1537605|NCT00629889|adult pineoblastoma|adult pineoblastoma
1537606|NCT00629889|adult pineocytoma|adult pineocytoma
1537607|NCT00629889|adult mixed glioma|adult mixed glioma
1537608|NCT00629889|adult papillary meningioma|adult papillary meningioma
1537609|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
1537610|NCT00629889|adult grade II meningioma|adult grade ii meningioma
1537611|NCT00629876|Chemotherapy|chemotherapy
1537612|NCT00629876|Drug Therapy|drug therapy
1537613|NCT00629863|stage I gastric cancer|stage i gastric cancer
1537614|NCT00629863|stage II gastric cancer|stage ii gastric cancer
1537615|NCT00629863|stage III gastric cancer|stage iii gastric cancer
1537616|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
1537617|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
1537618|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
1537619|NCT00629850|spinal cord injury|spinal cord injury
1537620|NCT00629850|respiratory muscle training|respiratory muscle training
1537621|NCT00629850|sleep quality|sleep quality
1537622|NCT00629837|FVIII|fviii
1537623|NCT00629837|Long acting|long acting
1537624|NCT00629837|pk|pk
1537625|NCT00629824|chronic hepatitis C|chronic hepatitis c
1537626|NCT00629824|sustained virological response|sustained virological response
1537627|NCT00629824|rapid virological response|rapid virological response
1537628|NCT00629824|peginterferon|peginterferon
1537629|NCT00629824|ribavirin|ribavirin
1537630|NCT00629824|old age|old age
1537631|NCT00629811|Cicatrix|cicatrix
1537632|NCT00629811|Scar|scar
1537633|NCT00629811|TGFβ3|tgfβ3
1537634|NCT00629811|Avotermin|avotermin
1537635|NCT00629811|Juvista|juvista
1537636|NCT00629811|RN1001|rn1001
1537637|NCT00629798|Busulfan|busulfan
1537638|NCT00629798|Melphalan|melphalan
1537639|NCT00629798|Fludarabine|fludarabine
1537640|NCT00629798|08-008|08-008
1537641|NCT00629785|asthma|asthma
1537642|NCT00629785|pulmonary function tests|pulmonary function tests
1537643|NCT00629785|obesity|obesity
1537644|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
1537645|NCT00629772|Infliximab|infliximab
1537646|NCT00629759|Jennerex|jennerex
1537647|NCT00629759|unresectable liver tumors|unresectable liver tumors
1537648|NCT00629759|primary liver cancer|primary liver cancer
1537649|NCT00629759|metastatic liver cancer|metastatic liver cancer
1537650|NCT00629759|oncolytic virus|oncolytic virus
1537651|NCT00629759|vaccinia virus|vaccinia virus
1537652|NCT00629759|Pexa-Vec|pexa-vec
1537656|NCT00629733|pharmacokinetics|pharmacokinetics
1537657|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
1537658|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
1537659|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
1537660|NCT00629707|DKA|dka
1537661|NCT00629707|cerebral edema|cerebral edema
1537662|NCT00629707|brain edema|brain edema
1537663|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
1537664|NCT00629655|fMRI|fmri
1537665|NCT00629655|spinal cord|spinal cord
1537666|NCT00629655|human|human
1537667|NCT00629655|health|health
1537668|NCT00629655|cerebral infarction|cerebral infarction
1537669|NCT00629655|healthy|healthy
1537670|NCT00629642|Neurogenic bladder|neurogenic bladder
1537671|NCT00629642|Vesicare|vesicare
1537672|NCT00629629|Health Plan Implementation|health plan implementation
1537673|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
1537674|NCT00629629|Breastfeeding|breastfeeding
1537675|NCT00629629|Complementary feeding|complementary feeding
1537676|NCT00629629|Morbidity|morbidity
1537677|NCT00629629|Anemia|anemia
1537678|NCT00629629|Public policy|public policy
1537679|NCT00629616|stage II breast cancer|stage ii breast cancer
1537680|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
1537681|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
1537682|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
1537683|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
1537684|NCT00629603|chronic liver disease|chronic liver disease
1537685|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
1537686|NCT00629577|cervical cancer|cervical cancer
1537687|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1537688|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1537689|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1537690|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
1537691|NCT00629551|Major Depressive Disorder|major depressive disorder
1537692|NCT00629551|Depression|depression
1537693|NCT00629551|Major Depressive Episode|major depressive episode
1537694|NCT00629551|Antidepressant|antidepressant
1537695|NCT00629538|congestive heart failure|congestive heart failure
1537696|NCT00629538|thoracentesis|thoracentesis
1537697|NCT00629538|transudative pleural effusions|transudative pleural effusions
1537698|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
1537699|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
1537700|NCT00629499|Her2-positive|her2-positive
1537701|NCT00629499|nab paclitaxel|nab paclitaxel
1537702|NCT00629499|cyclophosphamide|cyclophosphamide
1537703|NCT00629499|trastuzumab|trastuzumab
1537704|NCT00629486|cytokine gene|cytokine gene
1537705|NCT00629486|hepatitis B|hepatitis b
1537706|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
1537707|NCT00629486|chronic liver disease|chronic liver disease
1537708|NCT00629473|multiple myeloma|multiple myeloma
1537709|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
1537710|NCT00629473|lymphomas|lymphomas
1537711|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
1537712|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
1537713|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
1537714|NCT00629460|Pulmonary Nodules|pulmonary nodules
1537715|NCT00629447|Primary Brain Tumor|primary brain tumor
1537716|NCT00629447|Venous Thromboembolism|venous thromboembolism
1537718|NCT00629434|Diabetes Education|diabetes education
1537719|NCT00629434|Telemedicine|telemedicine
1537720|NCT00629395|pediatric|pediatric
1537721|NCT00629395|brain tumor|brain tumor
1537722|NCT00629395|survivors|survivors
1537723|NCT00629382|abdominal sepsis|abdominal sepsis
1537724|NCT00629382|abdominal surgery|abdominal surgery
1537725|NCT00629382|septic shock|septic shock
1537726|NCT00629382|polymyxin B|polymyxin b
1537727|NCT00629382|hemoperfusion|hemoperfusion
1537728|NCT00629382|Endotoxins|endotoxins
1537729|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
1537730|NCT00629343|Mesothelioma|mesothelioma
1537731|NCT00629343|Azacitidine|azacitidine
1537732|NCT00629343|Temozolomide|temozolomide
1537733|NCT00629343|Temodar|temodar
1537734|NCT00629330|prostate cancer|prostate cancer
1537735|NCT00629330|prostate cancer screening|prostate cancer screening
1537736|NCT00629330|prostate specific antigen|prostate specific antigen
1537737|NCT00629330|African American males|african american males
1537738|NCT00629317|Skin Aging|skin aging
1537739|NCT00629317|Rejuvenation|rejuvenation
1537740|NCT00629317|Photodynamic Therapy|photodynamic therapy
1537741|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
1537742|NCT00629304|type 1 diabetes|type 1 diabetes
1537743|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
1537744|NCT00629304|HbA1c|hba1c
1537745|NCT00629291|iron overload|iron overload
1537746|NCT00629291|Thalassemia|thalassemia
1537747|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
1537748|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
1537749|NCT00629278|stage IA breast cancer|stage ia breast cancer
1537750|NCT00629278|stage IB breast cancer|stage ib breast cancer
1537751|NCT00629278|stage II breast cancer|stage ii breast cancer
1537752|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
1537753|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
1537754|NCT00629265|Dysphagia|dysphagia
1537755|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
1537756|NCT00629265|Head & Neck Cancer|head & neck cancer
1537757|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
1537758|NCT00629252|Schizophrenia|schizophrenia
1537759|NCT00629252|PPI|ppi
1537760|NCT00629252|P50|p50
1537761|NCT00629252|CANTAB|cantab
1537762|NCT00629252|sensory gating|sensory gating
1537763|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
1537764|NCT00629239|COPD|copd
1537765|NCT00629239|tolerability|tolerability
1537766|NCT00629239|inhalation|inhalation
1537767|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1537768|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1537769|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1537770|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1537771|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1537772|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1537773|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1537774|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1537775|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1537776|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1537901|NCT00628784|Ablation|ablation
1537777|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1537778|NCT00629213|prevention,|prevention,
1537779|NCT00629213|type 2 diabetes,|type 2 diabetes,
1537780|NCT00629213|metabolic syndrome,|metabolic syndrome,
1537781|NCT00629213|acarbose treatment|acarbose treatment
1537782|NCT00629200|Advanced Malignancies|advanced malignancies
1537783|NCT00629200|Solid Tumors|solid tumors
1537784|NCT00629200|Melanoma|melanoma
1537785|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
1537786|NCT00629200|Phase I Studies|phase i studies
1537787|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
1537788|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
1537789|NCT00629200|Intron A|intron a
1537791|NCT00629187|Lung Neoplasm|lung neoplasm
1537792|NCT00629187|Breast Neoplasm|breast neoplasm
1537793|NCT00629187|Melanoma|melanoma
1537794|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
1537795|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
1537796|NCT00629187|Neoplasm Second Primary|neoplasm second primary
1537797|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1537798|NCT00629174|Cognitive function|cognitive function
1537799|NCT00629174|Elderly|elderly
1537800|NCT00629174|Exercise|exercise
1537801|NCT00629174|Mental activity|mental activity
1537802|NCT00629148|metastasis|metastasis
1537803|NCT00629148|chemotherapy|chemotherapy
1537804|NCT00629148|breast cancer|breast cancer
1537805|NCT00629148|Vinorelbine|vinorelbine
1537806|NCT00629148|Capecitabine|capecitabine
1537807|NCT00629148|sequential chemotherapy|sequential chemotherapy
1537808|NCT00629148|TTF|ttf
1537809|NCT00629135|abscess|abscess
1537810|NCT00629135|intraabdominal abscess|intraabdominal abscess
1537811|NCT00629135|Moxifloxacine|moxifloxacine
1537812|NCT00629135|Moxifloxacin|moxifloxacin
1537813|NCT00629135|Metronidazole|metronidazole
1537814|NCT00629135|Tazobactam|tazobactam
1537815|NCT00629135|Piperacilline|piperacilline
1537816|NCT00629135|Piperacillin|piperacillin
1537817|NCT00629135|Tazobac|tazobac
1537818|NCT00629122|Kidney Transplantation|kidney transplantation
1537819|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
1537820|NCT00629122|Pharmacokinetics|pharmacokinetics
1537821|NCT00629122|Sublingual administration|sublingual administration
1537822|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
1537823|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
1537824|NCT00629096|Marrow stem cells|marrow stem cells
1537825|NCT00629096|Myocardial regeneration|myocardial regeneration
1537826|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
1537827|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
1537828|NCT00629083|SUI|sui
1537829|NCT00629083|Bulkamid|bulkamid
1537830|NCT00629083|Urinary Incontinence|urinary incontinence
1537831|NCT00629070|cerebral palsy|cerebral palsy
1537832|NCT00629070|muscle strength|muscle strength
1537833|NCT00629070|muscle architecture|muscle architecture
1537834|NCT00629070|ultrasound|ultrasound
1537835|NCT00629070|rehabilitation|rehabilitation
1537836|NCT00629070|rectus femoris|rectus femoris
1537837|NCT00629070|quadriceps muscle|quadriceps muscle
1537838|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
1537839|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
1537840|NCT00629031|Paromomycin|paromomycin
1537841|NCT00629018|Stem Cells|stem cells
1537842|NCT00629018|Heart Failure|heart failure
1537843|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
1537844|NCT00629005|rehabilitation|rehabilitation
1537845|NCT00629005|upper extremity|upper extremity
1537846|NCT00629005|motor skills|motor skills
1537847|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
1537848|NCT00628966|Heart Attack|heart attack
1537850|NCT00628966|Risk Stratification|risk stratification
1537851|NCT00628966|Arrhythmia|arrhythmia
1537852|NCT00628953|Asthma|asthma
1537853|NCT00628953|Acid Reflux|acid reflux
1537854|NCT00628953|Nexium|nexium
1537855|NCT00628953|Esomeprazole|esomeprazole
1537856|NCT00628914|Major Depressive Disorder|major depressive disorder
1537857|NCT00628914|Insomnia|insomnia
1537858|NCT00628914|Escitalopram|escitalopram
1537859|NCT00628914|Lexapro|lexapro
1537860|NCT00628914|Eszopiclone|eszopiclone
1537861|NCT00628914|Lunesta|lunesta
1537862|NCT00628914|Cordance|cordance
1537863|NCT00628901|Leiomyoma|leiomyoma
1537864|NCT00628901|Uterine Fibroids|uterine fibroids
1537865|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
1537866|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
1537867|NCT00628901|Uterine Neoplasms|uterine neoplasms
1537868|NCT00628901|Menorrhagia|menorrhagia
1537869|NCT00628888|Unipolar Depression|unipolar depression
1537870|NCT00628888|Anxiety|anxiety
1537871|NCT00628888|Adolescent|adolescent
1537872|NCT00628888|Emotion|emotion
1537873|NCT00628888|Cognitive Behavioral|cognitive behavioral
1537874|NCT00628875|mechanical ventilation|mechanical ventilation
1537875|NCT00628875|thoracic impedence|thoracic impedence
1537876|NCT00628875|defibrillator pads|defibrillator pads
1537877|NCT00628875|ventilation detection|ventilation detection
1537878|NCT00628875|pediatric ventilation|pediatric ventilation
1537879|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1537880|NCT00628862|COPD|copd
1537881|NCT00628849|Mandible|mandible
1537882|NCT00628849|fracture|fracture
1537883|NCT00628849|Champy|champy
1537884|NCT00628849|AO technique|ao technique
1537885|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
1537886|NCT00628836|Shoulder subluxation|shoulder subluxation
1537887|NCT00628823|Celiac Disease|celiac disease
1537888|NCT00628823|Endomysial antibodies|endomysial antibodies
1537889|NCT00628823|Mild enteropathy|mild enteropathy
1537890|NCT00628823|Treatment|treatment
1537891|NCT00628823|Gluten-free diet|gluten-free diet
1537892|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
1537893|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1537894|NCT00628810|stage IV colon cancer|stage iv colon cancer
1537895|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
1537896|NCT00628810|recurrent colon cancer|recurrent colon cancer
1537897|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
1537898|NCT00628797|systemic sclerosis|systemic sclerosis
1537899|NCT00628797|skin fibrosis|skin fibrosis
1537900|NCT00628784|Dysplasia|dysplasia
1537902|NCT00628784|Squamous dysplasia|squamous dysplasia
1537903|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
1537904|NCT00628784|Cryotherapy|cryotherapy
1537905|NCT00628771|HIV Prevention|hiv prevention
1537906|NCT00628771|Teen Pregnancy|teen pregnancy
1537907|NCT00628771|Translational Research|translational research
1537908|NCT00628771|Group Care|group care
1537909|NCT00628771|Prenatal Care|prenatal care
1537910|NCT00628771|STD Prevention|std prevention
1537911|NCT00628771|Gonorrhea|gonorrhea
1537912|NCT00628771|Chlamydia|chlamydia
1537913|NCT00628771|Adolescent Health|adolescent health
1537914|NCT00628771|Community Health Centers|community health centers
1537915|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
1537916|NCT00628771|HIV seronegativity|hiv seronegativity
1537917|NCT00628758|Symbicort|symbicort
1537918|NCT00628758|Turbuhaler|turbuhaler
1537919|NCT00628758|Persistent Asthma|persistent asthma
1537920|NCT00628745|TRANSTHYRETIN|transthyretin
1537921|NCT00628745|AMYLOIDOSIS|amyloidosis
1537922|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
1537923|NCT00628732|Cyclophosphamide|cyclophosphamide
1537924|NCT00628732|Topotecan|topotecan
1537925|NCT00628732|Phase II|phase ii
1537926|NCT00628732|Children|children
1537927|NCT00628732|Relapsed solid tumors|relapsed solid tumors
1537928|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
1537929|NCT00628719|India|india
1537930|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
1537931|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
1537932|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
1537933|NCT00628706|memory|memory
1537934|NCT00628706|reward|reward
1537935|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
1537936|NCT00628706|endocannabinoids|endocannabinoids
1537938|NCT00628680|Renal Disease|renal disease
1537939|NCT00628680|Kidney Failure|kidney failure
1537940|NCT00628680|End Stage Renal Disease|end stage renal disease
1537941|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
1537942|NCT00628667|CPL|cpl
1537943|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
1537944|NCT00628667|Esomeprazole|esomeprazole
1537945|NCT00628667|Nexium|nexium
1537946|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
1537947|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
1537948|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
1537949|NCT00628628|TLS|tls
1537950|NCT00628628|hyperuricemia|hyperuricemia
1537951|NCT00628628|Leukemia|leukemia
1537952|NCT00628628|Lymphoma|lymphoma
1537953|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
1537954|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
1537955|NCT00628628|CML|cml
1537956|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
1537957|NCT00628628|LDH|ldh
1537958|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
1537959|NCT00628628|Rasburicase|rasburicase
1537960|NCT00628628|Elitek™|elitek™
1537961|NCT00628615|Urodynamics|urodynamics
1537962|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
1537963|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
1537964|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
1537965|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
1537966|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
1537967|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
1537968|NCT00628576|lower extremities|lower extremities
1537969|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
1537970|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
1537971|NCT00628576|Heparins|heparins
1537972|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
1537973|NCT00628576|Tinzaparin|tinzaparin
1537974|NCT00628550|cardiac arrest|cardiac arrest
1537975|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
1537976|NCT00628550|vasopressin|vasopressin
1537977|NCT00628550|epinephrine|epinephrine
1537978|NCT00628550|pediatrics|pediatrics
1537979|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
1537980|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
1537981|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
1537982|NCT00628498|VOD|vod
1537983|NCT00628485|swallowing function|swallowing function
1537984|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
1537985|NCT00628472|botulinum toxin a|botulinum toxin a
1537986|NCT00628472|botox|botox
1537987|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
1537988|NCT00628472|injections|injections
1537989|NCT00628459|iron|iron
1537990|NCT00628459|multiple micronutrient|multiple micronutrient
1537991|NCT00628459|malaria|malaria
1537992|NCT00628459|anemia|anemia
1537993|NCT00628459|preschool children|preschool children
1537994|NCT00628446|spinal cord injury|spinal cord injury
1537995|NCT00628446|Coronary artery calcium|coronary artery calcium
1537996|NCT00628446|Dyslipidemia|dyslipidemia
1537997|NCT00628433|phase I/II|phase i/ii
1537998|NCT00628433|ulcerative colitis|ulcerative colitis
1537999|NCT00628433|safety|safety
1538000|NCT00628433|tolerance|tolerance
1538001|NCT00628433|pharmacokinetics|pharmacokinetics
1538002|NCT00628420|Schizophrenia|schizophrenia
1538003|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
1538004|NCT00628420|clozapine|clozapine
1538005|NCT00628420|psychosis|psychosis
1538006|NCT00628420|randomized|randomized
1538007|NCT00628420|placebo studies|placebo studies
1538008|NCT00628407|leaning|leaning
1538009|NCT00628407|CPR|cpr
1538010|NCT00628407|sternal pressure|sternal pressure
1538011|NCT00628407|incomplete release|incomplete release
1538012|NCT00628407|chest compressions|chest compressions
1538013|NCT00628407|pediatric|pediatric
1538014|NCT00628394|Cognition|cognition
1538015|NCT00628394|schizophrenia|schizophrenia
1538016|NCT00628394|Atomoxetine|atomoxetine
1538017|NCT00628394|Strattera|strattera
1538018|NCT00628394|cognitive remediation|cognitive remediation
1538019|NCT00628381|sepsis|sepsis
1538020|NCT00628381|microcirculation|microcirculation
1538021|NCT00628381|nitric oxide|nitric oxide
1538022|NCT00628381|citrulline|citrulline
1538023|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1538024|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1538025|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1538026|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
1538027|NCT00628368|stage I rectal cancer|stage i rectal cancer
1538028|NCT00628368|stage II rectal cancer|stage ii rectal cancer
1538029|NCT00628368|stage III rectal cancer|stage iii rectal cancer
1538030|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
1538031|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
1538032|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
1538033|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
1538034|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
1538035|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
1538036|NCT00628355|lidocaine|lidocaine
1538037|NCT00628355|ischemic compression|ischemic compression
1538038|NCT00628355|chronic pelvic pain|chronic pelvic pain
1538039|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
1538040|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1538041|NCT00628342|GERD|gerd
1538042|NCT00628342|Esomeprazole|esomeprazole
1538043|NCT00628342|Heartburn|heartburn
1538044|NCT00628342|Nexium|nexium
1538045|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
1538046|NCT00628316|tinnitus|tinnitus
1538047|NCT00628316|caffeine|caffeine
1538048|NCT00628303|Good health|good health
1538049|NCT00628277|Obesity|obesity
1538050|NCT00628277|coronary heart disease|coronary heart disease
1538051|NCT00628277|coronary risk factors|coronary risk factors
1538052|NCT00628277|weight loss|weight loss
1538053|NCT00628277|exercise|exercise
1538054|NCT00628264|cardiac surgery|cardiac surgery
1538055|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
1538056|NCT00628264|valve surgery|valve surgery
1538057|NCT00628264|acute kidney injury|acute kidney injury
1538058|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
1538059|NCT00628251|BRCA1 protein|brca1 protein
1538060|NCT00628251|BRCA2 protein|brca2 protein
1538061|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1538062|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
1538063|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1538064|NCT00628238|CLL|cll
1538065|NCT00628238|CLL Research Consortium|cll research consortium
1538066|NCT00628238|CRC|crc
1538067|NCT00628238|Revlimid|revlimid
1538068|NCT00628238|lenalidomide|lenalidomide
1538069|NCT00628238|Rituximab|rituximab
1538070|NCT00628238|Rituxan|rituxan
1538071|NCT00628238|First-line|first-line
1538072|NCT00628238|therapy|therapy
1538073|NCT00628238|untreated|untreated
1538074|NCT00628238|Frontline|frontline
1538075|NCT00628225|Smoking cessation|smoking cessation
1538076|NCT00628212|insulin resistance|insulin resistance
1538077|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
1538078|NCT00628186|stent|stent
1538079|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
1538080|NCT00628186|hospital stay|hospital stay
1538081|NCT00628186|complication|complication
1538082|NCT00628186|pancreatic fistula|pancreatic fistula
1538083|NCT00628160|Septic shock|septic shock
1538084|NCT00628160|Cirrhosis|cirrhosis
1538085|NCT00628160|Survival|survival
1538086|NCT00628147|colonic neoplasms|colonic neoplasms
1538087|NCT00628147|colonoscopy|colonoscopy
1538088|NCT00628147|narrow band imaging|narrow band imaging
1538089|NCT00628147|diagnostic techniques|diagnostic techniques
1538090|NCT00628134|cystic fibrosis|cystic fibrosis
1538091|NCT00628134|surfactant|surfactant
1538092|NCT00628134|aerosol|aerosol
1538093|NCT00628134|inhaled drug|inhaled drug
1538094|NCT00628134|inhaled antibiotic|inhaled antibiotic
1538095|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
1538096|NCT00628108|Xyzal|xyzal
1538097|NCT00628108|Levocetirizine|levocetirizine
1538098|NCT00628108|Allergy|allergy
1538099|NCT00628108|Children|children
1538100|NCT00628108|Seasonal Allergies|seasonal allergies
1538101|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
1538102|NCT00628082|Cardiac Energetics|cardiac energetics
1538103|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
1538104|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
1538105|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
1538106|NCT00628069|Orthopedics|orthopedics
1538107|NCT00628069|bone fixation|bone fixation
1538108|NCT00628056|Perhexiline|perhexiline
1538109|NCT00628056|diabetes|diabetes
1538110|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
1538111|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
1538112|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1538114|NCT00628043|patients|patients
1538115|NCT00628043|with|with
1538116|NCT00628043|chemotherapy|chemotherapy
1538117|NCT00628043|induced|induced
1538118|NCT00628043|anemia|anemia
1538119|NCT00628030|Behavioral intervention|behavioral intervention
1538120|NCT00628030|Obesity prevention|obesity prevention
1538121|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
1538122|NCT00628017|Alzheimer's disease|alzheimer's disease
1538123|NCT00628017|mild cognitive impairment|mild cognitive impairment
1538124|NCT00628017|fish oil|fish oil
1538125|NCT00628017|cognition|cognition
1538126|NCT00627978|breast|breast
1538127|NCT00627965|Sildenafil citrate|sildenafil citrate
1538128|NCT00627965|Prevention|prevention
1538129|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
1538130|NCT00627965|Acute Mountain Sickness|acute mountain sickness
1538131|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
1538132|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
1538133|NCT00627952|hypertension|hypertension
1538301|NCT00627250|Amantadine|amantadine
1538134|NCT00627952|intraglomerular pressure|intraglomerular pressure
1538135|NCT00627926|Genotype 1|genotype 1
1538136|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
1538137|NCT00627900|drug-eluting stents|drug-eluting stents
1538138|NCT00627887|Depressive Disorder, Major|depressive disorder, major
1538139|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
1538140|NCT00627887|Lithium Carbonate|lithium carbonate
1538141|NCT00627887|venlafaxine|venlafaxine
1538142|NCT00627848|Alzheimer's disease|alzheimer's disease
1538143|NCT00627848|fmri|fmri
1538144|NCT00627848|face recognition|face recognition
1538145|NCT00627848|rivastigmine|rivastigmine
1538146|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
1538147|NCT00627835|head and neck|head and neck
1538148|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
1538149|NCT00627822|Medical students|medical students
1538150|NCT00627822|Medical education|medical education
1538151|NCT00627822|Private hospital|private hospital
1538152|NCT00627822|Patient satisfaction|patient satisfaction
1538153|NCT00627822|Questionnaires|questionnaires
1538154|NCT00627809|coronary microcirculation|coronary microcirculation
1538155|NCT00627809|acut myocardial infarction|acut myocardial infarction
1538156|NCT00627809|infarct size|infarct size
1538157|NCT00627809|streptokinase|streptokinase
1538158|NCT00627809|reperfusion|reperfusion
1538160|NCT00627796|IGF-I|igf-i
1538161|NCT00627796|tumor|tumor
1538162|NCT00627796|lanreotide|lanreotide
1538163|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
1538164|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
1538165|NCT00627770|Treatment outcome|treatment outcome
1538166|NCT00627757|metabolic syndrome|metabolic syndrome
1538167|NCT00627757|weight gain|weight gain
1538168|NCT00627757|antipsychotic drugs|antipsychotic drugs
1538169|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
1538170|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
1538171|NCT00627731|Asthma Patients|asthma patients
1538172|NCT00627718|Age-related macular degeneration|age-related macular degeneration
1538173|NCT00627718|HRT|hrt
1538174|NCT00627718|Macular edema|macular edema
1538175|NCT00627718|Screening for disease|screening for disease
1538176|NCT00627692|Constipation in elderly patients|constipation in elderly patients
1538177|NCT00627679|Pediatric asthma|pediatric asthma
1538178|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1538179|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1538180|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1538181|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1538182|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1538183|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1538184|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
1538185|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1538186|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
1538187|NCT00627666|mast cell leukemia|mast cell leukemia
1538188|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1538189|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1538190|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1538191|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1538192|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1538193|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1538194|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1538195|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1538196|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1538197|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1538198|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1538199|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1538200|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1538201|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1538202|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1538203|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1538204|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1538205|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
1538206|NCT00627653|PPAR|ppar
1538207|NCT00627653|PET study|pet study
1538208|NCT00627653|heart metabolism|heart metabolism
1538209|NCT00627614|stage I breast cancer|stage i breast cancer
1538210|NCT00627614|stage II breast cancer|stage ii breast cancer
1538211|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
1538212|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
1538213|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
1538214|NCT00627614|stage IV breast cancer|stage iv breast cancer
1538215|NCT00627588|ProSavin|prosavin
1538216|NCT00627588|Parkinson's Disease|parkinson's disease
1538217|NCT00627588|Gene Therapy|gene therapy
1538218|NCT00627575|drug interaction|drug interaction
1538219|NCT00627575|pharmacokinetics|pharmacokinetics
1538220|NCT00627575|healthy volunteers|healthy volunteers
1538221|NCT00627562|robotic|robotic
1538222|NCT00627562|robot assisted|robot assisted
1538223|NCT00627562|minimally invasive|minimally invasive
1538224|NCT00627562|tumors of head and neck|tumors of head and neck
1538225|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
1538226|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
1538227|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
1538228|NCT00627510|Antidepressant|antidepressant
1538229|NCT00627510|Antipsychotic|antipsychotic
1538230|NCT00627510|Treatment adherence|treatment adherence
1538231|NCT00627510|Compliance|compliance
1538232|NCT00627510|Metabolism|metabolism
1538233|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
1538234|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
1538235|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
1538236|NCT00627484|Insulin resistance|insulin resistance
1538237|NCT00627484|Insulin sensitivity|insulin sensitivity
1538238|NCT00627484|bariatric surgery|bariatric surgery
1538239|NCT00627484|diabetes|diabetes
1538240|NCT00627484|calorie restriction|calorie restriction
1538241|NCT00627484|body composition|body composition
1538242|NCT00627458|Hexavalent vaccine|hexavalent vaccine
1538243|NCT00627458|Booster|booster
1538244|NCT00627432|stage III bladder cancer|stage iii bladder cancer
1538245|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
1538246|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1538247|NCT00627406|GnRH antagonist|gnrh antagonist
1538248|NCT00627406|GnRH agonist|gnrh agonist
1538250|NCT00627406|OHSS|ohss
1538251|NCT00627406|In vitro fertilization|in vitro fertilization
1538252|NCT00627406|ovulation induction|ovulation induction
1538253|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
1538254|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
1538255|NCT00627380|HIV|hiv
1538256|NCT00627380|AIDS|aids
1538257|NCT00627380|insulin resistance|insulin resistance
1538258|NCT00627380|diabetes|diabetes
1538259|NCT00627380|dyslipidemia|dyslipidemia
1538260|NCT00627380|visceral adiposity|visceral adiposity
1538261|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
1538262|NCT00627380|cardiovascular disease|cardiovascular disease
1538263|NCT00627380|hypertension|hypertension
1538264|NCT00627380|endothelial function|endothelial function
1538265|NCT00627380|quality of life|quality of life
1538266|NCT00627380|Complementary Therapies|complementary therapies
1538267|NCT00627367|Acute Pain, Emergency Department, ED, Hydromorphone, Dilaudid Protocolized Nonprotocolized Usual Care|acute pain, emergency department, ed, hydromorphone, dilaudid protocolized nonprotocolized usual care
1538268|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
1538269|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
1538270|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1538271|NCT00627341|Exposure Therapy|exposure therapy
1538272|NCT00627341|Relapse Prevention|relapse prevention
1538273|NCT00627341|Anorexia Nervosa|anorexia nervosa
1538274|NCT00627328|Physiologic Pacing|physiologic pacing
1538275|NCT00627328|Dual Chamber Pacing|dual chamber pacing
1538276|NCT00627328|Atrioventricular Block|atrioventricular block
1538277|NCT00627328|Bradycardia|bradycardia
1538278|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
1538279|NCT00627315|Obesity|obesity
1538280|NCT00627315|Insulin Resistance|insulin resistance
1538281|NCT00627315|Bariatric Surgery|bariatric surgery
1538282|NCT00627315|Gastric Banding|gastric banding
1538283|NCT00627315|Gastric Bypass|gastric bypass
1538284|NCT00627302|Quality of Vision|quality of vision
1538285|NCT00627289|Chronic pain|chronic pain
1538286|NCT00627289|groin hernia|groin hernia
1538287|NCT00627289|neuropathic pain|neuropathic pain
1538288|NCT00627289|chronic postoperative pain|chronic postoperative pain
1538289|NCT00627289|Postherniotomy pain|postherniotomy pain
1538290|NCT00627289|Neuroplastic changes|neuroplastic changes
1538291|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1538292|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
1538294|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
1538295|NCT00627263|Arrhythmia|arrhythmia
1538296|NCT00627263|Stress|stress
1538297|NCT00627263|Anger|anger
1538298|NCT00627250|Irritability|irritability
1538299|NCT00627250|Aggression|aggression
1538300|NCT00627250|Brain Injury|brain injury
1538302|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
1538303|NCT00627237|Brain Injuries|brain injuries
1538304|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
1538305|NCT00627237|Executive Functioning|executive functioning
1538306|NCT00627211|quality assessment|quality assessment
1538307|NCT00627211|pain reduction|pain reduction
1538308|NCT00627211|gastroscopy|gastroscopy
1538309|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
1538310|NCT00627211|Patient satisfaction|patient satisfaction
1538311|NCT00627185|Tobacco control|tobacco control
1538312|NCT00627185|Tobacco cessation|tobacco cessation
1538313|NCT00627185|Tobacco use|tobacco use
1538314|NCT00627172|Coronary artery disease|coronary artery disease
1538315|NCT00627172|MDCT|mdct
1538316|NCT00627172|Positron emission tomography|positron emission tomography
1538317|NCT00627172|Ultrasound|ultrasound
1538318|NCT00627159|community-based|community-based
1538319|NCT00627159|culturally-sensitive|culturally-sensitive
1538320|NCT00627159|high risk assessment|high risk assessment
1538321|NCT00627159|education classes|education classes
1538322|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
1538323|NCT00627159|Indo-Asian population|indo-asian population
1538324|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
1538325|NCT00627146|ChAgly CD3|chagly cd3
1538326|NCT00627133|Alcohol seizure|alcohol seizure
1538327|NCT00627120|healthy volunteers|healthy volunteers
1538328|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
1538329|NCT00627068|cardiovascular|cardiovascular
1538330|NCT00627068|vasodilation|vasodilation
1538331|NCT00627068|endothelium|endothelium
1538332|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
1538333|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
1538334|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
1538335|NCT00627055|Kaletra monotherapy|kaletra monotherapy
1538336|NCT00627055|Thailand|thailand
1538337|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
1538338|NCT00627055|treatment experienced|treatment experienced
1538339|NCT00627042|Liver disease|liver disease
1538340|NCT00627042|Neoplasms|neoplasms
1538341|NCT00627042|Liver neoplasms|liver neoplasms
1538342|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1538343|NCT00627029|Care coordination|care coordination
1538344|NCT00627029|Disease management|disease management
1538345|NCT00627029|Medicare|medicare
1538346|NCT00627029|Fee-for-service|fee-for-service
1538347|NCT00627029|Random assignment|random assignment
1538348|NCT00627029|Elderly|elderly
1538349|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
1538350|NCT00627016|GERD|gerd
1538351|NCT00627016|heartburn|heartburn
1538352|NCT00627016|sleep disturbance|sleep disturbance
1538353|NCT00627016|nocturnal Reflux|nocturnal reflux
1538354|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1538355|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1538356|NCT00626977|Analgesia|analgesia
1538357|NCT00626977|Obstetrical|obstetrical
1538358|NCT00626977|Anesthesia|anesthesia
1538359|NCT00626977|Epidural|epidural
1538360|NCT00626977|Newborn|newborn
1538361|NCT00626977|Anesthetics, local|anesthetics, local
1538362|NCT00626977|Clonidine|clonidine
1538363|NCT00626977|Pregnant women|pregnant women
1538364|NCT00626977|Infant, newborn|infant, newborn
1538365|NCT00626964|Arterial stiffness|arterial stiffness
1538366|NCT00626964|PulseWave velocity|pulsewave velocity
1538367|NCT00626964|Body composition|body composition
1538368|NCT00626964|Bioimpedance|bioimpedance
1538369|NCT00626964|Morbid Obesity|morbid obesity
1538370|NCT00626964|APO A|apo a
1538371|NCT00626964|APO B|apo b
1538372|NCT00626964|Framingham risk score|framingham risk score
1538373|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
1538374|NCT00626964|Lifestyle Intervention|lifestyle intervention
1538375|NCT00626964|Bariatric Surgery|bariatric surgery
1538376|NCT00626964|Low Energy Diet|low energy diet
1538377|NCT00626951|LMA Supreme|lma supreme
1538378|NCT00626951|LMA ProSeal|lma proseal
1538379|NCT00626951|Laryngeal mask airway|laryngeal mask airway
1538380|NCT00626951|Ventilation|ventilation
1538381|NCT00626938|sarcoidosis|sarcoidosis
1538382|NCT00626938|protein profile|protein profile
1538383|NCT00626938|CYP-450|cyp-450
1538384|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
1538385|NCT00626938|HLA|hla
1538386|NCT00626925|Randomized Trial|randomized trial
1538387|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
1538388|NCT00626925|Topiramate Treatment|topiramate treatment
1538389|NCT00626912|large aneurysm|large aneurysm
1538390|NCT00626912|recurrence|recurrence
1538391|NCT00626912|hydrocoil|hydrocoil
1538392|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
1538393|NCT00626886|Herniorrhaphy|herniorrhaphy
1538394|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
1538395|NCT00626886|Postoperative pain|postoperative pain
1538396|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
1538397|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
1538398|NCT00626860|melanoma|melanoma
1538399|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
1538400|NCT00626847|Nuclear Genetics|nuclear genetics
1538401|NCT00626847|Mitochondrial DNA|mitochondrial dna
1538402|NCT00626847|POAG|poag
1538403|NCT00626834|cocaine addiction|cocaine addiction
1538404|NCT00626834|vigabatrin|vigabatrin
1538405|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
1538406|NCT00626834|cocaine|cocaine
1538407|NCT00626834|cocaine related disorders|cocaine related disorders
1538408|NCT00626834|behavior addictive|behavior addictive
1538409|NCT00626834|mental disorders|mental disorders
1538410|NCT00626834|therapeutic uses|therapeutic uses
1538411|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
1538412|NCT00626834|disorder of environmental origin|disorder of environmental origin
1538413|NCT00626834|central nervous system stimulants|central nervous system stimulants
1538414|NCT00626834|central nervous system agents|central nervous system agents
1538415|NCT00626834|pharmacological actions|pharmacological actions
1538416|NCT00626834|substance related disorders|substance related disorders
1538417|NCT00626821|Stoma|stoma
1538418|NCT00626821|Ostomy|ostomy
1538419|NCT00626782|glaucoma|glaucoma
1538420|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
1538421|NCT00626782|ranibizumab|ranibizumab
1538422|NCT00626782|mitomycin C|mitomycin c
1538423|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
1538424|NCT00626769|Genistein|genistein
1538425|NCT00626769|Bone mineral density|bone mineral density
1538426|NCT00626769|digital mammography|digital mammography
1538427|NCT00626769|safety|safety
1538428|NCT00626756|fluid|fluid
1538429|NCT00626756|Lidco technology|lidco technology
1538430|NCT00626756|guided therapy|guided therapy
1538809|NCT00625404|women|women
1538431|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
1538432|NCT00626730|adult grade II meningioma|adult grade ii meningioma
1538433|NCT00626730|adult grade III meningioma|adult grade iii meningioma
1538434|NCT00626717|Keratoconus|keratoconus
1538435|NCT00626717|Cross linking|cross linking
1538436|NCT00626717|Riboflavin|riboflavin
1538437|NCT00626704|Sarcoma|sarcoma
1538438|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
1538439|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
1538440|NCT00626704|AMG 655|amg 655
1538441|NCT00626704|STS|sts
1538442|NCT00626704|Doxorubicin|doxorubicin
1538443|NCT00626704|Death receptor|death receptor
1538444|NCT00626704|TRAIL receptor|trail receptor
1538445|NCT00626704|Apoptosis|apoptosis
1538446|NCT00626691|antioxidant|antioxidant
1538447|NCT00626691|walnut|walnut
1538448|NCT00626691|nutritional status|nutritional status
1538449|NCT00626691|Antioxidant capacity|antioxidant capacity
1538450|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
1538451|NCT00626678|Azathioprine|azathioprine
1538452|NCT00626678|Prednisone|prednisone
1538453|NCT00626665|Raynaud disease|raynaud disease
1538454|NCT00626665|Scleroderma|scleroderma
1538455|NCT00626639|palifermin|palifermin
1538456|NCT00626639|Clinical Trial|clinical trial
1538457|NCT00626639|Oncology|oncology
1538458|NCT00626639|Head & Neck|head & neck
1538459|NCT00626626|leukemia|leukemia
1538460|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
1538461|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
1538462|NCT00626626|lymphoma|lymphoma
1538463|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
1538464|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
1538465|NCT00626600|Observational|observational
1538466|NCT00626600|Infusion|infusion
1538467|NCT00626600|Severe cancer pain|severe cancer pain
1538468|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
1538469|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
1538470|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
1538471|NCT00626587|Probe location|probe location
1538472|NCT00626587|Diagnostic yield|diagnostic yield
1538473|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
1538474|NCT00626574|Epoetin alfa|epoetin alfa
1538475|NCT00626574|aneurysm|aneurysm
1538476|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
1538477|NCT00626561|Cervical Cancer|cervical cancer
1538478|NCT00626561|Uterine Cancer|uterine cancer
1538479|NCT00626561|Bevacizumab|bevacizumab
1538480|NCT00626561|Avastin|avastin
1538481|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1538482|NCT00626561|rhuMAb-VEGF|rhumab-vegf
1538483|NCT00626561|Paclitaxel|paclitaxel
1538484|NCT00626561|Taxol|taxol
1538485|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
1538486|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
1538487|NCT00626548|Endothelin A|endothelin a
1538488|NCT00626548|Endothelin A antagonist|endothelin a antagonist
1538489|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
1538490|NCT00626535|Nexium|nexium
1538491|NCT00626535|Esomeprazole|esomeprazole
1538492|NCT00626522|Bronchitis|bronchitis
1538494|NCT00626522|Emphysema|emphysema
1538495|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
1538496|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
1538497|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
1538498|NCT00626483|adult gliosarcoma|adult gliosarcoma
1538499|NCT00626470|Trochanter|trochanter
1538500|NCT00626470|Femur|femur
1538501|NCT00626470|Fracture|fracture
1538502|NCT00626431|Lupron Depot|lupron depot
1538503|NCT00626431|prostate cancer|prostate cancer
1538504|NCT00626431|leuprolide acetate|leuprolide acetate
1538505|NCT00626405|stage IV melanoma|stage iv melanoma
1538506|NCT00626379|Coronary Heart Disease|coronary heart disease
1538507|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
1538508|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
1538509|NCT00626379|Mortality|mortality
1538510|NCT00626366|Nasal Spray|nasal spray
1538511|NCT00626366|Nasal Drop|nasal drop
1538512|NCT00626366|Intranasal Medication|intranasal medication
1538513|NCT00626353|Stroke|stroke
1538514|NCT00626353|rehabilitation|rehabilitation
1538515|NCT00626353|motor recovery|motor recovery
1538516|NCT00626353|cognition|cognition
1538517|NCT00626353|quality of life|quality of life
1538518|NCT00626340|menopause|menopause
1538519|NCT00626340|women|women
1538520|NCT00626340|major depressive disorder|major depressive disorder
1538521|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1538522|NCT00626327|vaccine|vaccine
1538523|NCT00626327|toddlers|toddlers
1538524|NCT00626327|healthy|healthy
1538525|NCT00626327|meningitis|meningitis
1538526|NCT00626327|meningococcal|meningococcal
1538527|NCT00626327|measles|measles
1538528|NCT00626327|mumps|mumps
1538529|NCT00626327|rubella|rubella
1538530|NCT00626327|varicella|varicella
1538806|NCT00625404|HIV Prevention|hiv prevention
1538531|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
1538532|NCT00626301|efficacy|efficacy
1538533|NCT00626301|safety|safety
1538534|NCT00626301|pharmacokinetics|pharmacokinetics
1538535|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
1538536|NCT00626301|Thai children|thai children
1538537|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
1538538|NCT00626301|treatment experienced|treatment experienced
1538539|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
1538540|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
1538541|NCT00626275|arthritis|arthritis
1538542|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
1538543|NCT00626262|Nexium|nexium
1538544|NCT00626262|Esomeprazole|esomeprazole
1538545|NCT00626262|Administration methods.|administration methods.
1538546|NCT00626249|Nephropathy|nephropathy
1538547|NCT00626249|Kidney Disease|kidney disease
1538548|NCT00626249|Diabetic|diabetic
1538549|NCT00626249|Renal|renal
1538550|NCT00626249|Diabetics|diabetics
1538551|NCT00626236|ADHD and conduct problems|adhd and conduct problems
1538552|NCT00626223|ESRD patients|esrd patients
1538553|NCT00626223|C-reactive protein|c-reactive protein
1538554|NCT00626223|homocysteine|homocysteine
1538555|NCT00626223|5-MTHF|5-mthf
1538556|NCT00626223|survival|survival
1538557|NCT00626223|Hemodialysis patients|hemodialysis patients
1538558|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1538559|NCT00626210|Sleep|sleep
1538560|NCT00626210|Fatigue|fatigue
1538561|NCT00626210|Memory|memory
1538562|NCT00626197|SLE|sle
1538563|NCT00626197|Lupus|lupus
1538564|NCT00626197|BELONG|belong
1538565|NCT00626184|Celiac Disease|celiac disease
1538566|NCT00626171|smoking|smoking
1538567|NCT00626171|asthma|asthma
1538568|NCT00626171|sputum|sputum
1538569|NCT00626158|pancreatic cancer|pancreatic cancer
1538570|NCT00626158|biliary cancer|biliary cancer
1538571|NCT00626158|gemcitabine|gemcitabine
1538572|NCT00626158|capecitabine|capecitabine
1538573|NCT00626145|BMMNC|bmmnc
1538574|NCT00626145|STEMI|stemi
1538575|NCT00626145|stem cell|stem cell
1538576|NCT00626145|intracoronary delivery|intracoronary delivery
1538577|NCT00626132|Blood pressure|blood pressure
1538578|NCT00626132|Herbs|herbs
1538579|NCT00626132|Food|food
1538580|NCT00626119|breast cancer|breast cancer
1538581|NCT00626106|postmenopausal|postmenopausal
1538582|NCT00626106|hormone receptor positive|hormone receptor positive
1538583|NCT00626106|locally advanced|locally advanced
1538584|NCT00626106|metastatic|metastatic
1538585|NCT00626080|Insulin|insulin
1538586|NCT00626080|Detemir|detemir
1538587|NCT00626080|Brain|brain
1538588|NCT00626080|Glucose metabolism|glucose metabolism
1538589|NCT00626067|Travatan Dosing Aid|travatan dosing aid
1538590|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
1538591|NCT00626054|Colonoscopy|colonoscopy
1538592|NCT00626054|PEG Solution|peg solution
1538593|NCT00626041|Community pharmacies|community pharmacies
1538594|NCT00626041|Primary care networks|primary care networks
1538595|NCT00626041|Global risk assessment|global risk assessment
1538596|NCT00626041|Blood pressure screening|blood pressure screening
1538597|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
1538598|NCT00626028|Nitric Oxide|nitric oxide
1538599|NCT00626028|INOmax®|inomax®
1538600|NCT00626028|Acute Lung Injury|acute lung injury
1538601|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
1538602|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
1538603|NCT00626028|Congenital Heart Disease|congenital heart disease
1538604|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
1538605|NCT00626028|vasoreactivity|vasoreactivity
1538606|NCT00626015|adult glioblastoma|adult glioblastoma
1538607|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
1538608|NCT00626015|adult gliosarcoma|adult gliosarcoma
1538609|NCT00626015|adult high grade glioma|adult high grade glioma
1538610|NCT00626002|Open label|open label
1538611|NCT00625989|asthma|asthma
1538612|NCT00625989|atopy|atopy
1538613|NCT00625989|allergen challenge|allergen challenge
1538614|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
1538615|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
1538616|NCT00625976|Graded exposure in vivo|graded exposure in vivo
1538617|NCT00625976|Physiotherapy|physiotherapy
1538618|NCT00625976|Pain-related fear|pain-related fear
1538619|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
1538620|NCT00625963|ILD;|ild;
1538621|NCT00625963|CT Imaging;|ct imaging;
1538622|NCT00625963|Echocardiogram;|echocardiogram;
1538623|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
1538624|NCT00625963|Pulmonary Function Tests|pulmonary function tests
1538625|NCT00625950|Hyperprolactinemia|hyperprolactinemia
1538626|NCT00625950|Endometriosis|endometriosis
1538627|NCT00625950|laparoscopy|laparoscopy
1538628|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
1538742|NCT00625625|stage I rectal cancer|stage i rectal cancer
1538807|NCT00625404|Oral PrEP|oral prep
1538629|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1538630|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1538631|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1538632|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1538633|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1538634|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1538635|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1538636|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1538637|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1538638|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1538639|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1538640|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1538641|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1538642|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1538643|NCT00625937|tongue cancer|tongue cancer
1538644|NCT00625924|Plastic surgery|plastic surgery
1538645|NCT00625924|reconstruction|reconstruction
1538646|NCT00625911|thoracotomy|thoracotomy
1538647|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
1538648|NCT00625911|ketamine|ketamine
1538649|NCT00625911|pain|pain
1538650|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
1538651|NCT00625898|invasive breast cancer|invasive breast cancer
1538652|NCT00625898|bevacizumab|bevacizumab
1538653|NCT00625898|NSABP|nsabp
1538654|NCT00625898|Roche|roche
1538655|NCT00625898|CIRG|cirg
1538656|NCT00625898|trastuzumab|trastuzumab
1538657|NCT00625898|cyclophosphamide|cyclophosphamide
1538658|NCT00625898|docetaxel|docetaxel
1538659|NCT00625898|carboplatin|carboplatin
1538660|NCT00625898|5-fluorouracil|5-fluorouracil
1538661|NCT00625898|epirubicin|epirubicin
1538662|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
1538663|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
1538664|NCT00625885|Knee injuries/surgery|knee injuries/surgery
1538665|NCT00625885|Outcomes research|outcomes research
1538666|NCT00625885|Prospective Studies|prospective studies
1538667|NCT00625859|pharmacodynamics|pharmacodynamics
1538668|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
1538669|NCT00625859|pharmacokinetics,|pharmacokinetics,
1538670|NCT00625820|Kidney Disease|kidney disease
1538671|NCT00625820|Albuminuria|albuminuria
1538672|NCT00625820|Glomerular filtration rate|glomerular filtration rate
1538673|NCT00625807|Stress|stress
1538674|NCT00625807|meditation|meditation
1538675|NCT00625807|stress reduction|stress reduction
1538676|NCT00625807|fMRI|fmri
1538677|NCT00625807|behavioral|behavioral
1538678|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
1538679|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
1538680|NCT00625781|Pregnancy|pregnancy
1538681|NCT00625781|Fetal macrosomia|fetal macrosomia
1538682|NCT00625781|Treatment|treatment
1538683|NCT00625781|Perinatal morbidity|perinatal morbidity
1538684|NCT00625768|Antibody|antibody
1538685|NCT00625768|safety|safety
1538686|NCT00625768|tolerability|tolerability
1538687|NCT00625768|efficacy|efficacy
1538688|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1538689|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
1538690|NCT00625755|renal cell carcinoma|renal cell carcinoma
1538691|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
1538692|NCT00625742|Advanced Cancer|advanced cancer
1538693|NCT00625742|Cancer Cachexia|cancer cachexia
1538694|NCT00625742|Cachexia|cachexia
1538695|NCT00625742|Melatonin|melatonin
1538696|NCT00625742|Juven|juven
1538697|NCT00625742|Exercise Training|exercise training
1538698|NCT00625742|Weight Loss|weight loss
1538699|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1538700|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1538701|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1538702|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1538703|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1538704|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1538705|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1538706|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1538707|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1538708|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1538709|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1538808|NCT00625404|Truvada|truvada
1538710|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1538711|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1538712|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1538713|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1538714|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1538715|NCT00625703|Pharmacokinetic|pharmacokinetic
1538716|NCT00625690|lung cancer|lung cancer
1538717|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
1538718|NCT00625677|reduced dose|reduced dose
1538719|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
1538720|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1538721|NCT00625664|Cancer|cancer
1538722|NCT00625664|Neoplasms|neoplasms
1538723|NCT00625664|Bladder|bladder
1538724|NCT00625664|Urothelial Tract|urothelial tract
1538725|NCT00625651|Colon Cancer|colon cancer
1538726|NCT00625651|Colorectal Cancer|colorectal cancer
1538727|NCT00625651|Rectal Cancer|rectal cancer
1538728|NCT00625651|AMG 655|amg 655
1538729|NCT00625651|Bevacizumab|bevacizumab
1538730|NCT00625651|Modified FOLFOX6|modified folfox6
1538731|NCT00625651|mFOLFOX6|mfolfox6
1538732|NCT00625651|FOLFOX|folfox
1538733|NCT00625638|Advanced Cancer|advanced cancer
1538734|NCT00625638|Caregiver|caregiver
1538735|NCT00625638|Interactive Voice Response|interactive voice response
1538736|NCT00625638|Symptom Control|symptom control
1538737|NCT00625638|IVR System|ivr system
1538738|NCT00625638|Questionnaire|questionnaire
1538739|NCT00625625|stage I colon cancer|stage i colon cancer
1538740|NCT00625625|stage II colon cancer|stage ii colon cancer
1538741|NCT00625625|stage III colon cancer|stage iii colon cancer
1538743|NCT00625625|stage II rectal cancer|stage ii rectal cancer
1538744|NCT00625625|stage III rectal cancer|stage iii rectal cancer
1538745|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1538746|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
1538747|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
1538748|NCT00625573|Colon Cancer|colon cancer
1538749|NCT00625573|Abraxis Oncology|abraxis oncology
1538750|NCT00625573|Abraxane|abraxane
1538751|NCT00625573|Phase II|phase ii
1538752|NCT00625573|Colorectal|colorectal
1538753|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
1538754|NCT00625573|CCOP|ccop
1538755|NCT00625560|Chronic hepatitis B|chronic hepatitis b
1538756|NCT00625560|Lamivudine|lamivudine
1538757|NCT00625560|Entecavir|entecavir
1538758|NCT00625534|Hernia|hernia
1538759|NCT00625534|Laparoscopy|laparoscopy
1538760|NCT00625534|Pain|pain
1538761|NCT00625534|Sexual|sexual
1538762|NCT00625534|Quality|quality
1538763|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
1538764|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
1538765|NCT00625495|Nexium|nexium
1538766|NCT00625495|Esomeprazole|esomeprazole
1538767|NCT00625495|Administration methods.|administration methods.
1538768|NCT00625482|BCG vaccine|bcg vaccine
1538769|NCT00625482|Oral polio vaccine|oral polio vaccine
1538770|NCT00625482|Vitamin A supplementation|vitamin a supplementation
1538771|NCT00625482|Low-birth-weigth|low-birth-weigth
1538772|NCT00625482|Sex-differential|sex-differential
1538773|NCT00625482|Prevention|prevention
1539150|NCT00623974|Rocaltrol|rocaltrol
1538774|NCT00625482|Immunological parameters|immunological parameters
1538775|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
1538776|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1538777|NCT00625469|bosentan|bosentan
1538778|NCT00625456|phase I|phase i
1538779|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
1538780|NCT00625456|oncolytic virus|oncolytic virus
1538781|NCT00625456|vaccinia virus|vaccinia virus
1538782|NCT00625456|melanoma|melanoma
1538783|NCT00625456|lung cancer|lung cancer
1538784|NCT00625456|renal cell carcinoma|renal cell carcinoma
1538785|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1538786|NCT00625456|Pexa-Vec|pexa-vec
1538787|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1538788|NCT00625443|ITP|itp
1538789|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
1538790|NCT00625430|Prostate Cancer|prostate cancer
1538791|NCT00625430|Gene Therapy|gene therapy
1538792|NCT00625430|Fludarabine|fludarabine
1538793|NCT00625430|Adenovirus|adenovirus
1538794|NCT00625430|phase I|phase i
1538795|NCT00625417|male breast cancer|male breast cancer
1538796|NCT00625417|stage IA breast cancer|stage ia breast cancer
1538797|NCT00625417|stage IB breast cancer|stage ib breast cancer
1538798|NCT00625417|stage II breast cancer|stage ii breast cancer
1538799|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
1538800|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
1538801|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
1538802|NCT00625417|stage IV breast cancer|stage iv breast cancer
1538803|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
1538804|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
1538805|NCT00625404|HIV|hiv
1538810|NCT00625404|Tenofovir|tenofovir
1538811|NCT00625404|TDF|tdf
1538812|NCT00625404|FTC|ftc
1538813|NCT00625404|emtricitabine|emtricitabine
1538814|NCT00625404|hepatitis|hepatitis
1538815|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
1538816|NCT00625404|HIV Seronegativity|hiv seronegativity
1538817|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
1538818|NCT00625378|Cancer|cancer
1538819|NCT00625378|Sorafenib|sorafenib
1538820|NCT00625378|Extension program|extension program
1538821|NCT00625365|DEFINITY|definity
1538822|NCT00625365|Safety|safety
1538823|NCT00625365|Survelliance|survelliance
1538824|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1538825|NCT00625352|Aged|aged
1538826|NCT00625352|Gemcitabine|gemcitabine
1538827|NCT00625352|UFT|uft
1538828|NCT00625339|Chronic hepatitis B|chronic hepatitis b
1538829|NCT00625339|Lamivudine|lamivudine
1538830|NCT00625339|Entecavir|entecavir
1538831|NCT00625326|psoriasis|psoriasis
1538832|NCT00625313|Cataract|cataract
1538833|NCT00625313|aphakia|aphakia
1538834|NCT00625313|intraocular lens|intraocular lens
1538835|NCT00625313|IOL|iol
1538836|NCT00625313|Optical correction of aphakia|optical correction of aphakia
1538837|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
1538838|NCT00625300|Parkinson's Disease|parkinson's disease
1538839|NCT00625274|Nexium|nexium
1538840|NCT00625274|esomeprazole|esomeprazole
1538841|NCT00625274|lansoprazole|lansoprazole
1538842|NCT00625274|pantoprazole|pantoprazole
1538843|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
1538844|NCT00625261|Language delay|language delay
1538845|NCT00625261|Speech and language disorders|speech and language disorders
1538846|NCT00625261|Early language intervention|early language intervention
1538847|NCT00625261|Parent-based language intervention|parent-based language intervention
1538848|NCT00625235|Obesity|obesity
1538849|NCT00625235|Weight loss|weight loss
1538850|NCT00625235|Weight maintenance|weight maintenance
1538851|NCT00625235|VLED|vled
1538852|NCT00625222|Electroencephalography|electroencephalography
1538853|NCT00625222|Seizure frequency|seizure frequency
1538854|NCT00625222|Seizure severity|seizure severity
1538855|NCT00625209|septic shock|septic shock
1538856|NCT00625209|coagulation|coagulation
1538857|NCT00625209|immunomodulation|immunomodulation
1538858|NCT00625209|survival|survival
1538859|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
1538860|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1538861|NCT00625183|stage II rectal cancer|stage ii rectal cancer
1538862|NCT00625183|stage III rectal cancer|stage iii rectal cancer
1538863|NCT00625170|Antipsychotics|antipsychotics
1538864|NCT00625170|Olanzapine|olanzapine
1538865|NCT00625170|Haloperidol|haloperidol
1538866|NCT00625170|Insulin resistance|insulin resistance
1538867|NCT00625170|Dyslipidemia|dyslipidemia
1538868|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
1538869|NCT00625131|Tobacco Use Disorder|tobacco use disorder
1538870|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
1538871|NCT00625118|reactogenicity|reactogenicity
1538872|NCT00625118|local reactions|local reactions
1538873|NCT00625118|systemic symptoms|systemic symptoms
1538874|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
1538875|NCT00625079|pulmonary hypertension|pulmonary hypertension
1538876|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
1538877|NCT00625079|interstitial lung disease|interstitial lung disease
1538878|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1538879|NCT00625066|precancerous condition|precancerous condition
1538880|NCT00625066|colon cancer|colon cancer
1538881|NCT00625066|rectal cancer|rectal cancer
1538882|NCT00625053|Neuroticism|neuroticism
1538883|NCT00625053|Hernia, ventral|hernia, ventral
1538884|NCT00625053|Laparoscopy|laparoscopy
1538885|NCT00625053|Quality of life|quality of life
1538886|NCT00625040|Incretin effect|incretin effect
1538887|NCT00625040|Gastric banding|gastric banding
1538888|NCT00625040|Glucagon|glucagon
1538889|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
1538890|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
1538891|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
1538892|NCT00625040|Insulin|insulin
1538893|NCT00625040|C-peptide|c-peptide
1538894|NCT00625027|Emergency Department Visit|emergency department visit
1538895|NCT00625027|Telehealth Ontario|telehealth ontario
1538896|NCT00625027|Triage Levels|triage levels
1538897|NCT00625014|Insulin resistance|insulin resistance
1538898|NCT00625014|Dyslipidemia|dyslipidemia
1538899|NCT00625014|Haloperidol|haloperidol
1538900|NCT00625001|Turner Syndrome|turner syndrome
1538901|NCT00625001|bone mineral density|bone mineral density
1538902|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
1538903|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1538904|NCT00624988|Spinal cord injury|spinal cord injury
1538905|NCT00624988|vibration therapy|vibration therapy
1538906|NCT00624988|bone density|bone density
1538907|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1538908|NCT00624962|neuroblastoma|neuroblastoma
1538909|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
1538910|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
1538911|NCT00624962|childhood ependymoma|childhood ependymoma
1538912|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
1538913|NCT00624962|childhood meningioma|childhood meningioma
1538914|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1538915|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1538916|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1538917|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
1538918|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
1538919|NCT00624962|childhood brain tumor|childhood brain tumor
1538920|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
1538921|NCT00624949|Turner syndrome|turner syndrome
1538922|NCT00624949|aortic dimensions|aortic dimensions
1538923|NCT00624949|blood pressure|blood pressure
1538924|NCT00624949|aortic dilatation|aortic dilatation
1538925|NCT00624949|aortic rupture|aortic rupture
1538926|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1538927|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1538928|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1538929|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1538930|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1538931|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1538932|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1538933|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
1538934|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1538935|NCT00624923|Coronary Artery Disease|coronary artery disease
1538936|NCT00624923|Inflammation|inflammation
1538937|NCT00624923|Overweight|overweight
1538938|NCT00624923|Metabolic Syndrome|metabolic syndrome
1538939|NCT00624923|Salsalate|salsalate
1538940|NCT00624910|Post Operative Pain|post operative pain
1538941|NCT00624910|Hysterectomy|hysterectomy
1538942|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
1538943|NCT00624871|Interleukin 1-beta|interleukin 1-beta
1538944|NCT00624871|Interleukin 6|interleukin 6
1538945|NCT00624871|Vitamin C|vitamin c
1538946|NCT00624871|HIE|hie
1538947|NCT00624871|neonates|neonates
1538948|NCT00624858|Depression|depression
1538949|NCT00624858|depressed|depressed
1538950|NCT00624858|overweight|overweight
1538951|NCT00624858|obese|obese
1538952|NCT00624845|Meniscectomy|meniscectomy
1538953|NCT00624832|Asthma|asthma
1538954|NCT00624832|allergen challenge|allergen challenge
1538955|NCT00624832|bronchoprovocation|bronchoprovocation
1538956|NCT00624832|Methacholine challenge|methacholine challenge
1538957|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
1538958|NCT00624832|Nitric Oxide|nitric oxide
1538959|NCT00624832|skin prick test|skin prick test
1538960|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
1538961|NCT00624819|Haemophilus influenzae|haemophilus influenzae
1538962|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1538963|NCT00624819|Antibody persistence|antibody persistence
1538964|NCT00624806|Pressure ulcer|pressure ulcer
1538965|NCT00624806|Telemedicine|telemedicine
1538966|NCT00624793|Nausea|nausea
1538967|NCT00624793|Vomiting|vomiting
1538968|NCT00624793|Retching|retching
1538969|NCT00624793|HIV/AIDS|hiv/aids
1538970|NCT00624793|Symptom Management|symptom management
1538971|NCT00624793|Complementary Therapies|complementary therapies
1538972|NCT00624767|insulin|insulin
1538973|NCT00624767|insulin aspart|insulin aspart
1538974|NCT00624767|Type 2 Diabetes|type 2 diabetes
1538975|NCT00624767|diabetes mellitus|diabetes mellitus
1538976|NCT00624754|Obstructive airway disease|obstructive airway disease
1538977|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
1538978|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1538979|NCT00624754|bone marrow transplantation|bone marrow transplantation
1538980|NCT00624754|inhaled treatment|inhaled treatment
1538981|NCT00624754|Budesonide Formoterol|budesonide formoterol
1538982|NCT00624741|Parkinson's disease|parkinson's disease
1538983|NCT00624741|Antiparkinsonian|antiparkinsonian
1538984|NCT00624741|Compassionate use|compassionate use
1538985|NCT00624728|Positron-Emission Tomography|positron-emission tomography
1538986|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
1538987|NCT00624728|18F-FLT|18f-flt
1538988|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
1538989|NCT00624728|Astrocytoma|astrocytoma
1538990|NCT00624728|Glioblastoma|glioblastoma
1538991|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
1538992|NCT00624689|Body composition|body composition
1538993|NCT00624689|Glucose tolerance|glucose tolerance
1538994|NCT00624689|Intima-media thickness|intima-media thickness
1538995|NCT00624689|Visual acuity|visual acuity
1538996|NCT00624689|Neurological development|neurological development
1538997|NCT00624676|Acne|acne
1538998|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
1538999|NCT00624676|benzoyl peroxide|benzoyl peroxide
1539000|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
1539001|NCT00624650|Acute Lung Injury|acute lung injury
1539002|NCT00624650|Extravascular Lung Water|extravascular lung water
1539003|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1539004|NCT00624637|aromatherapy|aromatherapy
1539005|NCT00624637|massage|massage
1539006|NCT00624637|comfort|comfort
1539007|NCT00624637|postoperative|postoperative
1539008|NCT00624637|infants|infants
1539009|NCT00624637|craniofacial surgery|craniofacial surgery
1539010|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1539011|NCT00624624|bariatric surgery|bariatric surgery
1539012|NCT00624624|serum androgen levels|serum androgen levels
1539013|NCT00624624|bone density|bone density
1539014|NCT00624611|CPB|cpb
1539015|NCT00624611|red blood cell washing|red blood cell washing
1539016|NCT00624585|MDS|mds
1539017|NCT00624585|MDS/MPD|mds/mpd
1539018|NCT00624585|MDS/AML|mds/aml
1539019|NCT00624585|CMML|cmml
1539020|NCT00624585|Excess Marrow Blasts|excess marrow blasts
1539021|NCT00624572|primary teeth|primary teeth
1539022|NCT00624572|chlorexidine|chlorexidine
1539023|NCT00624572|root canal therapy|root canal therapy
1539024|NCT00624572|Pulpectomy|pulpectomy
1539025|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
1539026|NCT00624546|GERD|gerd
1539027|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
1539028|NCT00624546|antireflux surgery|antireflux surgery
1539029|NCT00624546|Barrett's|barrett's
1539030|NCT00624546|Esophagus|esophagus
1539031|NCT00624546|Esophagitis|esophagitis
1539032|NCT00624533|Low back Pain|low back pain
1539033|NCT00624533|Physical Therapy Modalities|physical therapy modalities
1539034|NCT00624533|Exercise Movement Techniques|exercise movement techniques
1539035|NCT00624533|Primary Health Care|primary health care
1539036|NCT00624520|Stress, Psychological|stress, psychological
1539037|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
1539038|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
1539039|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
1539040|NCT00624520|Cognitive Therapy|cognitive therapy
1539041|NCT00624520|Anger|anger
1539042|NCT00624494|venous oxygen saturation|venous oxygen saturation
1539043|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
1539044|NCT00624481|osteoporosis|osteoporosis
1539045|NCT00624481|osteopenia|osteopenia
1539046|NCT00624481|bone mineral density|bone mineral density
1539047|NCT00624481|teriparatide|teriparatide
1539048|NCT00624468|atacicept|atacicept
1539049|NCT00624468|neuritis|neuritis
1539050|NCT00624455|Gabapentin|gabapentin
1539051|NCT00624455|tonsillectomy|tonsillectomy
1539052|NCT00624455|post-operative pain|post-operative pain
1539627|NCT00622180|Vitiligo|vitiligo
1539053|NCT00624455|morphine requirements|morphine requirements
1539054|NCT00624455|randomized double blind|randomized double blind
1539055|NCT00624455|adenotonsillectomy|adenotonsillectomy
1539056|NCT00624429|Asthma|asthma
1539057|NCT00624429|Children|children
1539058|NCT00624416|Obesity therapy|obesity therapy
1539059|NCT00624416|fat|fat
1539060|NCT00624416|drug mechanism|drug mechanism
1539061|NCT00624416|adipose tissue|adipose tissue
1539062|NCT00624416|cellular pharmacology|cellular pharmacology
1539063|NCT00624403|Anesthesia|anesthesia
1539064|NCT00624403|Laryngeal mask airway|laryngeal mask airway
1539065|NCT00624351|Lupus|lupus
1539066|NCT00624351|Monoclonal antibody|monoclonal antibody
1539067|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
1539068|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
1539069|NCT00624338|Placebo|placebo
1539070|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
1539071|NCT00624312|Procrit|procrit
1539072|NCT00624312|Erythropoietin|erythropoietin
1539073|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
1539074|NCT00624299|botox|botox
1539075|NCT00624299|limb reconstructions|limb reconstructions
1539076|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
1539077|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1539078|NCT00624286|COPD|copd
1539079|NCT00624286|indacaterol|indacaterol
1539080|NCT00624273|digital ulcers,|digital ulcers,
1539081|NCT00624273|systemic sclerosis,|systemic sclerosis,
1539082|NCT00624273|sildenafil,|sildenafil,
1539083|NCT00624273|vasoactive therapies|vasoactive therapies
1539084|NCT00624260|Colorectal cancer|colorectal cancer
1539085|NCT00624260|Recurrence|recurrence
1539086|NCT00624260|Positron Emission Tomography|positron emission tomography
1539087|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
1539191|NCT00623857|Calcium|calcium
1539192|NCT00623857|Malaria|malaria
1539088|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
1539089|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
1539090|NCT00624247|routine HIV testing|routine hiv testing
1539091|NCT00624247|jails|jails
1539092|NCT00624247|criminal justice system|criminal justice system
1539093|NCT00624247|substance abuse|substance abuse
1539094|NCT00624247|mental illness|mental illness
1539095|NCT00624247|HIV|hiv
1539096|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
1539097|NCT00624234|reading disabilities|reading disabilities
1539098|NCT00624234|NF-1|nf-1
1539099|NCT00624234|learning disabilities|learning disabilities
1539100|NCT00624234|tutoring intervention|tutoring intervention
1539101|NCT00624208|Randomized|randomized
1539102|NCT00624208|double-blind|double-blind
1539103|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
1539104|NCT00624195|HIV Dementia|hiv dementia
1539105|NCT00624195|HAART|haart
1539106|NCT00624195|Cognitive Impairment|cognitive impairment
1539107|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
1539108|NCT00624195|Viral Load|viral load
1539109|NCT00624195|CNS Drug Penetration|cns drug penetration
1539110|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
1539111|NCT00624169|Mortality|mortality
1539112|NCT00624156|Breast Cancer|breast cancer
1539113|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
1539114|NCT00624130|Contraception,|contraception,
1539115|NCT00624130|Cycle control,|cycle control,
1539116|NCT00624130|Bleeding pattern|bleeding pattern
1539117|NCT00624117|shoulder joint|shoulder joint
1539118|NCT00624117|recovery of function|recovery of function
1539119|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
1539120|NCT00624117|rehabilitation|rehabilitation
1539121|NCT00624104|VLDL|vldl
1539122|NCT00624104|Kinetics|kinetics
1539123|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
1539124|NCT00624104|Obesity|obesity
1539125|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
1539126|NCT00624078|faboterapics|faboterapics
1539127|NCT00624078|treatment|treatment
1539128|NCT00624078|scorpion sting|scorpion sting
1539129|NCT00624078|envenomation|envenomation
1539130|NCT00624065|target blood pressure|target blood pressure
1539131|NCT00624065|hypertension|hypertension
1539132|NCT00624065|COREG CR|coreg cr
1539133|NCT00624065|carvedilol CR|carvedilol cr
1539134|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
1539135|NCT00624065|lisinopril|lisinopril
1539136|NCT00624039|presbyopia|presbyopia
1539137|NCT00624013|Diabetes|diabetes
1539138|NCT00624013|Depression|depression
1539139|NCT00624013|diabetes outcomes|diabetes outcomes
1539140|NCT00624013|quality of life|quality of life
1539141|NCT00624000|Ischemic Stroke|ischemic stroke
1539142|NCT00623987|Residual vein thrombosis|residual vein thrombosis
1539143|NCT00623987|Optimal duration|optimal duration
1539144|NCT00623987|Oral anticoagulants|oral anticoagulants
1539145|NCT00623974|Hypocalcemia|hypocalcemia
1539146|NCT00623974|Teriparatide|teriparatide
1539147|NCT00623974|Forteo|forteo
1539148|NCT00623974|Calcium|calcium
1539149|NCT00623974|Calcitriol|calcitriol
1539151|NCT00623961|Neuropathic Pain|neuropathic pain
1539152|NCT00623948|Pressure ulcers|pressure ulcers
1539153|NCT00623948|Electrical Stimulation|electrical stimulation
1539154|NCT00623948|Spinal Cord Injury|spinal cord injury
1539155|NCT00623935|AML|aml
1539156|NCT00623922|Patient education|patient education
1539157|NCT00623922|Nurse consultation|nurse consultation
1539158|NCT00623922|Arthritis|arthritis
1539159|NCT00623922|Wellbeing|wellbeing
1539160|NCT00623922|Coping|coping
1539161|NCT00623922|Health related quality of life|health related quality of life
1539162|NCT00623909|Laser Therapy|laser therapy
1539163|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
1539164|NCT00623909|AvicennaTM laser|avicennatm laser
1539165|NCT00623896|Nehb|nehb
1539166|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
1539167|NCT00623896|STEMI|stemi
1539168|NCT00623896|ECG|ecg
1539169|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
1539170|NCT00623857|Micronutrients|micronutrients
1539171|NCT00623857|Zinc|zinc
1539172|NCT00623857|Vitamins|vitamins
1539173|NCT00623857|Trace elements|trace elements
1539174|NCT00623857|Minerals|minerals
1539175|NCT00623857|Vitamin A|vitamin a
1539176|NCT00623857|Vitamin B1|vitamin b1
1539177|NCT00623857|Vitamin B2|vitamin b2
1539178|NCT00623857|Niacin|niacin
1539179|NCT00623857|Vitamin B6|vitamin b6
1539180|NCT00623857|Folic acid|folic acid
1539181|NCT00623857|Vitamin B12|vitamin b12
1539182|NCT00623857|Vitamin C|vitamin c
1539183|NCT00623857|Vitamin D|vitamin d
1539184|NCT00623857|Vitamin E|vitamin e
1539185|NCT00623857|Vitamin K|vitamin k
1539186|NCT00623857|Iron|iron
1539187|NCT00623857|Iodine|iodine
1539188|NCT00623857|Copper|copper
1539189|NCT00623857|Selenium|selenium
1539190|NCT00623857|Magnesium|magnesium
1539193|NCT00623857|Immunity|immunity
1539194|NCT00623857|Anthropometry|anthropometry
1539195|NCT00623844|Prevention|prevention
1539196|NCT00623844|Physical activity|physical activity
1539197|NCT00623844|Obesity|obesity
1539198|NCT00623844|Motor skills|motor skills
1539199|NCT00623844|Kindergarten|kindergarten
1539200|NCT00623831|MBV|mbv
1539201|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
1539202|NCT00623831|NY-ESO-1|ny-eso-1
1539203|NCT00623818|Mirror Therapy|mirror therapy
1539204|NCT00623818|Phantom Limb Pain|phantom limb pain
1539205|NCT00623818|Amputee|amputee
1539206|NCT00623818|Healthy Volunteer|healthy volunteer
1539207|NCT00623818|HV|hv
1539208|NCT00623792|Morbid obesity|morbid obesity
1539209|NCT00623792|Diet therapy|diet therapy
1539210|NCT00623792|Bariatric Surgery|bariatric surgery
1539211|NCT00623792|Gastric bypass|gastric bypass
1539212|NCT00623792|Behavior therapy|behavior therapy
1539213|NCT00623792|Randomized controlled trial|randomized controlled trial
1539214|NCT00623792|Weight loss|weight loss
1539215|NCT00623753|Vaccine|vaccine
1539216|NCT00623753|Prevention|prevention
1539217|NCT00623753|HIV|hiv
1539218|NCT00623753|AIDS|aids
1539219|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
1539220|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
1539221|NCT00623740|Hydrocortisone|hydrocortisone
1539222|NCT00623740|Very low birth weight|very low birth weight
1539223|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1539224|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
1539225|NCT00623727|Hemophilia A|hemophilia a
1539226|NCT00623727|FVIII disease|fviii disease
1539227|NCT00623727|rFVIII|rfviii
1539228|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
1539229|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
1539230|NCT00623688|Metered Dose Inhalers|metered dose inhalers
1539231|NCT00623688|Nebulizers|nebulizers
1539232|NCT00623688|Randomized Controlled Trial|randomized controlled trial
1539233|NCT00623675|zeolites|zeolites
1539234|NCT00623675|nutraceuticals|nutraceuticals
1539235|NCT00623675|natural supplements|natural supplements
1539236|NCT00623675|Healthy volunteers|healthy volunteers
1539237|NCT00623662|Glucose infusion|glucose infusion
1539238|NCT00623662|Liver function|liver function
1539239|NCT00623662|Liver resection|liver resection
1539240|NCT00623662|Albumin synthesis|albumin synthesis
1539241|NCT00623662|Stable isotopes|stable isotopes
1539242|NCT00623636|Migraine|migraine
1539243|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
1539244|NCT00623610|pancreatic beta cell|pancreatic beta cell
1539245|NCT00623610|transplantation|transplantation
1539246|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
1539247|NCT00623584|corneal transplantation|corneal transplantation
1539248|NCT00623584|corneal grafting|corneal grafting
1539249|NCT00623584|corneal grafts|corneal grafts
1539250|NCT00623584|culture media|culture media
1539251|NCT00623584|corneal culturing|corneal culturing
1539252|NCT00623584|in vitro culturing|in vitro culturing
1539253|NCT00623571|frail elderly|frail elderly
1539254|NCT00623571|hospital at home|hospital at home
1539255|NCT00623571|heart failure|heart failure
1539256|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
1539257|NCT00623558|head and neck neoplasm|head and neck neoplasm
1539258|NCT00623558|cetuximab|cetuximab
1539259|NCT00623558|docetaxel|docetaxel
1539260|NCT00623558|cisplatin|cisplatin
1539261|NCT00623558|radiotherapy|radiotherapy
1539262|NCT00623545|Exenatide|exenatide
1539263|NCT00623545|Byetta|byetta
1539264|NCT00623545|weight loss|weight loss
1539265|NCT00623545|energy expenditure|energy expenditure
1539266|NCT00623545|normal volunteers|normal volunteers
1539267|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
1539268|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
1539269|NCT00623506|TBI|tbi
1539270|NCT00623506|Pregnenolone|pregnenolone
1539271|NCT00623506|Cognition|cognition
1539272|NCT00623493|Screening|screening
1539273|NCT00623493|Suicide|suicide
1539274|NCT00623493|Emergency Department|emergency department
1539275|NCT00623493|Children and Adolescents|children and adolescents
1539276|NCT00623493|Suicide Risk|suicide risk
1539277|NCT00623480|Hemophilia A|hemophilia a
1539278|NCT00623467|Central Nervous System Imaging|central nervous system imaging
1539279|NCT00623467|Diagnostic Imaging|diagnostic imaging
1539280|NCT00623454|anxiety|anxiety
1539281|NCT00623454|panic disorder|panic disorder
1539282|NCT00623454|chest pain|chest pain
1539283|NCT00623454|palpitations|palpitations
1539284|NCT00623441|Coronary Artery Disease|coronary artery disease
1539285|NCT00623441|Drug-eluting stent|drug-eluting stent
1539286|NCT00623402|Metastatic melanoma|metastatic melanoma
1539287|NCT00623402|Pegylated interferon|pegylated interferon
1539288|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
1539289|NCT00623402|Sorafenib|sorafenib
1539290|NCT00623402|PegIntron|pegintron
1539291|NCT00623402|Therapeutic Uses|therapeutic uses
1539292|NCT00623402|melanoma (skin)|melanoma (skin)
1539293|NCT00623389|Neurologic disorders|neurologic disorders
1539294|NCT00623389|Rare disease|rare disease
1539295|NCT00623389|Spinal cord injuries|spinal cord injuries
1539296|NCT00623389|Stroke|stroke
1539297|NCT00623389|Paraplegia|paraplegia
1539298|NCT00623389|Tetraplegia|tetraplegia
1539299|NCT00623363|Parkinson's Disease|parkinson's disease
1539300|NCT00623363|motor complications|motor complications
1539301|NCT00623363|dyskinesia|dyskinesia
1539302|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
1539303|NCT00623350|Telemedicine|telemedicine
1539304|NCT00623350|Stroke, Acute|stroke, acute
1539305|NCT00623350|Rural|rural
1539306|NCT00623350|Thrombolysis|thrombolysis
1539307|NCT00623350|Consultation|consultation
1539308|NCT00623337|care seeking|care seeking
1539309|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
1539310|NCT00623337|newborn care practices|newborn care practices
1539311|NCT00623337|low birth weight babies|low birth weight babies
1539312|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
1539313|NCT00623298|depression|depression
1539314|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
1539315|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
1539316|NCT00623285|Pain.|pain.
1539317|NCT00623285|Postoperative.|postoperative.
1539318|NCT00623285|CABG.|cabg.
1539319|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
1539320|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
1539321|NCT00623246|OSA|osa
1539322|NCT00623246|Adherence|adherence
1539323|NCT00623246|CPAP|cpap
1539324|NCT00623246|Cognition|cognition
1539325|NCT00623233|Breast Neoplasm|breast neoplasm
1539326|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
1539327|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
1539328|NCT00623181|Influenza|influenza
1539329|NCT00623181|Influenza virus|influenza virus
1539330|NCT00623168|Ribavirin|ribavirin
1539331|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
1539332|NCT00623155|malaria|malaria
1539333|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
1539334|NCT00623155|season|season
1539335|NCT00623155|children|children
1539336|NCT00623142|Myocardial protection|myocardial protection
1539337|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
1539338|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
1539339|NCT00623142|Preconditioning|preconditioning
1539340|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
1539341|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
1539342|NCT00623129|laryngeal cancer|laryngeal cancer
1539343|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
1539344|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
1539345|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1539346|NCT00623129|salivary gland cancer|salivary gland cancer
1539347|NCT00623129|xerostomia|xerostomia
1539348|NCT00623129|radiation toxicity|radiation toxicity
1539349|NCT00623116|Kallmann Syndrome|kallmann syndrome
1539350|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1539523|NCT00622674|recurrent colon cancer|recurrent colon cancer
1539351|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
1539352|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
1539353|NCT00623103|rivastigmine|rivastigmine
1539354|NCT00623090|prostate cancer screening education|prostate cancer screening education
1539355|NCT00623090|behavioral oncology|behavioral oncology
1539356|NCT00623090|randomized trial|randomized trial
1539357|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1539358|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1539359|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
1539360|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
1539361|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
1539362|NCT00623077|adult primary liver cancer|adult primary liver cancer
1539363|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1539364|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1539365|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1539366|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1539367|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1539368|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1539369|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1539370|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1539371|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
1539372|NCT00623077|stage V Wilms tumor|stage v wilms tumor
1539373|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1539374|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
1539375|NCT00623077|childhood mixed glioma|childhood mixed glioma
1539376|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1539377|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1539378|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
1539379|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1539380|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1539381|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1539382|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1539383|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1539384|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1539385|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1539386|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1539387|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1539388|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1539389|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1539390|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1539391|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1539392|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1539393|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
1539394|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
1539395|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
1539396|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
1539397|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1539398|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
1539399|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1539400|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1539401|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1539402|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1539403|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
1539404|NCT00623064|stage III bladder cancer|stage iii bladder cancer
1539405|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1539406|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1539407|NCT00623051|male circumcision|male circumcision
1539409|NCT00623051|sexual behavior|sexual behavior
1539410|NCT00623051|HIV prevention|hiv prevention
1539411|NCT00623051|HIV Seronegativity|hiv seronegativity
1539412|NCT00623038|Apgar score|apgar score
1539413|NCT00623038|neonatal assessment|neonatal assessment
1539414|NCT00623038|preterm infants|preterm infants
1539415|NCT00623038|resuscitation|resuscitation
1539416|NCT00623025|HIV|hiv
1539417|NCT00623025|Steatorrhea|steatorrhea
1539418|NCT00622999|Malnutrition|malnutrition
1539419|NCT00622999|Colon cancer|colon cancer
1539420|NCT00622999|Colon surgery|colon surgery
1539421|NCT00622999|Outcome|outcome
1539422|NCT00622999|Complication rate|complication rate
1539423|NCT00622973|Prostate cancer|prostate cancer
1539424|NCT00622973|Bladder cancer|bladder cancer
1539425|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
1539426|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
1539427|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
1539428|NCT00622973|Imaging influence on surgery|imaging influence on surgery
1539429|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
1539430|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
1539431|NCT00622960|obesity|obesity
1539432|NCT00622960|type 2 diabetes|type 2 diabetes
1539433|NCT00622960|weight loss|weight loss
1539434|NCT00622960|monounsaturated fat|monounsaturated fat
1539435|NCT00622960|diet|diet
1539436|NCT00622947|Depression|depression
1539437|NCT00622947|antidepressant effect|antidepressant effect
1539438|NCT00622947|rTMS|rtms
1539439|NCT00622947|sham|sham
1539440|NCT00622947|cognition|cognition
1539441|NCT00622947|saliva cortisol|saliva cortisol
1539442|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
1539443|NCT00622934|multiple trauma|multiple trauma
1539444|NCT00622921|PTSD|ptsd
1539445|NCT00622921|alcohol dependence|alcohol dependence
1539446|NCT00622895|scleroderma|scleroderma
1539447|NCT00622895|systemic sclerosis|systemic sclerosis
1539448|NCT00622882|Staphylococcus aureus|staphylococcus aureus
1539449|NCT00622882|Bacteremia|bacteremia
1539450|NCT00622882|Outcome|outcome
1539451|NCT00622882|Mortality|mortality
1539452|NCT00622882|Recurrence|recurrence
1539453|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
1539454|NCT00622869|Liver transplantation|liver transplantation
1539455|NCT00622869|everolimus|everolimus
1539456|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
1539457|NCT00622869|tacrolimus|tacrolimus
1539458|NCT00622869|renal function|renal function
1539459|NCT00622869|MDRD formula|mdrd formula
1539460|NCT00622869|progression of fibrosis|progression of fibrosis
1539461|NCT00622856|diabetes|diabetes
1539462|NCT00622856|adolescents|adolescents
1539463|NCT00622856|psychological therapy|psychological therapy
1539464|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1539465|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
1539466|NCT00622843|PPV|ppv
1539467|NCT00622843|PCV|pcv
1539468|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
1539469|NCT00622843|Prevnar|prevnar
1539470|NCT00622843|Pneumovax|pneumovax
1539471|NCT00622843|HIV|hiv
1539472|NCT00622830|darapladib,|darapladib,
1539473|NCT00622830|SB480848,|sb480848,
1539474|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
1539475|NCT00622817|Epinephrine|epinephrine
1539476|NCT00622817|Nasal decongestant|nasal decongestant
1539477|NCT00622817|RSV|rsv
1539478|NCT00622817|xylometazoline|xylometazoline
1539479|NCT00622817|Bronchiolitis|bronchiolitis
1539480|NCT00622804|Stomach cancer|stomach cancer
1539481|NCT00622804|Gastrectomy|gastrectomy
1539482|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
1539483|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
1539484|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
1539485|NCT00622791|coronary artery disease|coronary artery disease
1539486|NCT00622791|propofol|propofol
1539487|NCT00622791|pharmacokinetics|pharmacokinetics
1539488|NCT00622791|pharmacodynamics|pharmacodynamics
1539489|NCT00622778|intracranial bleeding|intracranial bleeding
1539490|NCT00622778|computed tomography scan|computed tomography scan
1539491|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
1539492|NCT00622752|Smoking cessation|smoking cessation
1539493|NCT00622752|Craving|craving
1539494|NCT00622752|Smokers|smokers
1539495|NCT00622739|Bipolar Disorder|bipolar disorder
1539496|NCT00622739|Children|children
1539497|NCT00622739|Adolescents|adolescents
1539498|NCT00622739|Treatment|treatment
1539499|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1539500|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
1539501|NCT00622726|Premature infants|premature infants
1539502|NCT00622726|Bevacizumab|bevacizumab
1539503|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
1539504|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
1539505|NCT00622726|Stage 3 ROP|stage 3 rop
1539506|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
1539507|NCT00622713|Alzheimer's disease|alzheimer's disease
1539508|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
1539509|NCT00622713|rivastigmine|rivastigmine
1539510|NCT00622700|MS|ms
1539511|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
1539512|NCT00622700|CIS|cis
1539513|NCT00622700|CDMS|cdms
1539514|NCT00622700|relapses|relapses
1539515|NCT00622687|iloprost|iloprost
1539516|NCT00622687|systemic sclerosis|systemic sclerosis
1539517|NCT00622687|digital ulcers|digital ulcers
1539518|NCT00622687|observational study|observational study
1539519|NCT00622687|randomized|randomized
1539520|NCT00622674|recurrent breast cancer|recurrent breast cancer
1539521|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1539522|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
1539524|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
1539525|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
1539526|NCT00622674|recurrent sarcoma|recurrent sarcoma
1539527|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
1539528|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
1539529|NCT00622661|Glycemic response|glycemic response
1539530|NCT00622661|Glycemic index|glycemic index
1539531|NCT00622661|Obesity|obesity
1539532|NCT00622661|Carbohydrates|carbohydrates
1539533|NCT00622661|Insulin|insulin
1539534|NCT00622661|Blood glucose|blood glucose
1539535|NCT00622648|Medical prevention therapy|medical prevention therapy
1539536|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1539537|NCT00622635|COPD|copd
1539538|NCT00622635|indacaterol|indacaterol
1539539|NCT00622609|first time in human,|first time in human,
1539540|NCT00622609|MAG|mag
1539541|NCT00622609|monoclonal antibody,|monoclonal antibody,
1539542|NCT00622609|healthy subjects,|healthy subjects,
1539543|NCT00622609|GSK249320,|gsk249320,
1539544|NCT00622596|opiate dependence|opiate dependence
1539545|NCT00622596|buprenorphine|buprenorphine
1539546|NCT00622583|Herniorrhaphy|herniorrhaphy
1539547|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
1539548|NCT00622544|Microalbuminuria|microalbuminuria
1539549|NCT00622544|Proteinuria|proteinuria
1539550|NCT00622531|heart failure|heart failure
1539551|NCT00622531|BNP|bnp
1539552|NCT00622531|natriuretic peptide|natriuretic peptide
1539553|NCT00622518|otitis media|otitis media
1539554|NCT00622518|children|children
1539555|NCT00622505|Multiple myeloma|multiple myeloma
1539556|NCT00622505|zoledronic acid|zoledronic acid
1539557|NCT00622505|skeletal complications|skeletal complications
1539558|NCT00622505|bone|bone
1539559|NCT00622492|VV-ECMO|vv-ecmo
1539560|NCT00622492|VA-ECMO|va-ecmo
1539561|NCT00622492|PPHN|pphn
1539562|NCT00622492|organ circulation|organ circulation
1539563|NCT00622479|Sorafenib|sorafenib
1539564|NCT00622479|Hypophosphatemia|hypophosphatemia
1539565|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
1539566|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
1539567|NCT00622466|stage IV breast cancer|stage iv breast cancer
1539568|NCT00622466|male breast cancer|male breast cancer
1539569|NCT00622466|recurrent breast cancer|recurrent breast cancer
1539570|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
1539571|NCT00622440|HSIL|hsil
1539572|NCT00622440|HGAIN|hgain
1539573|NCT00622440|AIN|ain
1539574|NCT00622440|neoplasia|neoplasia
1539575|NCT00622440|dysplasia|dysplasia
1539576|NCT00622440|TCM|tcm
1539577|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
1539578|NCT00622401|stage IV breast cancer|stage iv breast cancer
1539579|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
1539580|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
1539581|NCT00622401|IL-12|il-12
1539582|NCT00622375|Pharmacokinetic study|pharmacokinetic study
1539583|NCT00622375|Healthy subjects|healthy subjects
1539584|NCT00622362|Immunotherapy|immunotherapy
1539585|NCT00622362|Allergy|allergy
1539586|NCT00622362|Allergoid|allergoid
1539587|NCT00622362|Depigmented|depigmented
1539588|NCT00622362|Polymerized|polymerized
1539589|NCT00622362|Allergen-extract|allergen-extract
1539590|NCT00622362|mites|mites
1539591|NCT00622362|Asthma|asthma
1539592|NCT00622349|Randomised phase III|randomised phase iii
1539593|NCT00622349|Chemotherapy|chemotherapy
1539594|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
1539595|NCT00622336|Multiple Myeloma|multiple myeloma
1539596|NCT00622336|Revlimid|revlimid
1539597|NCT00622323|diabetes|diabetes
1539598|NCT00622323|exenatide|exenatide
1539599|NCT00622323|metformin|metformin
1539600|NCT00622323|sulfonylurea|sulfonylurea
1539601|NCT00622323|Byetta|byetta
1539602|NCT00622323|Amylin|amylin
1539603|NCT00622323|Lilly|lilly
1539604|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1539605|NCT00622271|Adolescents and Families|adolescents and families
1539606|NCT00622271|Group Therapy Intervention|group therapy intervention
1539607|NCT00622258|everolimus|everolimus
1539608|NCT00622258|mTOR inhibitor|mtor inhibitor
1539609|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1539610|NCT00622245|Depression|depression
1539611|NCT00622245|Bipolar disorder|bipolar disorder
1539612|NCT00622245|Placebo-controlled|placebo-controlled
1539613|NCT00622245|Double-blind|double-blind
1539614|NCT00622245|Multicenter|multicenter
1539615|NCT00622245|Clinical study|clinical study
1539616|NCT00622245|Mania|mania
1539617|NCT00622232|HIV-1|hiv-1
1539618|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
1539619|NCT00622219|Alcohol abuse|alcohol abuse
1539620|NCT00622219|Drug abuse|drug abuse
1539621|NCT00622206|Pharmacokinetics|pharmacokinetics
1539622|NCT00622206|ritonavir|ritonavir
1539623|NCT00622206|saquinavir|saquinavir
1539624|NCT00622206|safety and toxicity|safety and toxicity
1539625|NCT00622206|treatment experienced|treatment experienced
1539626|NCT00622193|NSCLC|nsclc
1539628|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
1539629|NCT00622180|Excilite|excilite
1539630|NCT00622167|Plaque characteristics|plaque characteristics
1539631|NCT00622167|DSCT|dsct
1539632|NCT00622167|IVUS|ivus
1539633|NCT00622141|bioequivalence|bioequivalence
1539634|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
1539635|NCT00622141|saftey|saftey
1539636|NCT00622141|pharmacokinetics|pharmacokinetics
1539637|NCT00622128|Behavioral Research|behavioral research
1539638|NCT00622128|Dementia|dementia
1539639|NCT00622128|Aggression|aggression
1539640|NCT00622102|warfarin|warfarin
1539641|NCT00622102|adherence|adherence
1539642|NCT00622102|Mechanical heart valves|mechanical heart valves
1539643|NCT00622089|diabetes|diabetes
1539644|NCT00622089|type 2 diabetes|type 2 diabetes
1539645|NCT00622089|cholesterol|cholesterol
1539646|NCT00622076|postoperative|postoperative
1539647|NCT00622076|Catheterization|catheterization
1539648|NCT00622076|colporrhaphy|colporrhaphy
1539649|NCT00622076|cystocele|cystocele
1539650|NCT00622076|cystitis|cystitis
1539651|NCT00622063|cancer, solid tumor|cancer, solid tumor
1539652|NCT00622024|Arrhythmia|arrhythmia
1539653|NCT00622024|Depression|depression
1539654|NCT00622024|Coronary Artery Disease|coronary artery disease
1539655|NCT00621998|Risperidone|risperidone
1539656|NCT00621998|Olanzapine|olanzapine
1539657|NCT00621998|Tardive dyskinesia|tardive dyskinesia
1539658|NCT00621972|acute renal failure|acute renal failure
1539659|NCT00621972|arteriovenous fistula|arteriovenous fistula
1539660|NCT00621972|KIM-1|kim-1
1539661|NCT00621972|chronic kidney disease|chronic kidney disease
1539662|NCT00621959|levocetirizine|levocetirizine
1539663|NCT00621959|Xyzal|xyzal
1539664|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1539665|NCT00621959|total symptom score|total symptom score
1539666|NCT00621959|quality of life|quality of life
1539667|NCT00621946|Asthma|asthma
1539668|NCT00621946|Depression|depression
1539669|NCT00621946|Escitalopram|escitalopram
1539670|NCT00621907|randomized|randomized
1539671|NCT00621907|analgesic|analgesic
1539672|NCT00621907|caesarean scars|caesarean scars
1539673|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
1539674|NCT00621907|infiltration|infiltration
1539675|NCT00621907|levobupivacaïne|levobupivacaïne
1539676|NCT00621907|Chirocaïne|chirocaïne
1539677|NCT00621907|caesarian|caesarian
1539678|NCT00621907|unique administration|unique administration
1539679|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
1539680|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
1539681|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
1539682|NCT00621894|ITP|itp
1539683|NCT00621881|hepatic impairment|hepatic impairment
1539684|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1539685|NCT00621868|ASP1941|asp1941
1539686|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
1539687|NCT00621842|Aged|aged
1539688|NCT00621842|lamotrigine|lamotrigine
1539689|NCT00621816|nitroprusside|nitroprusside
1539690|NCT00621816|intensive care unit|intensive care unit
1539691|NCT00621816|hypertension|hypertension
1539692|NCT00621816|blood pressure reduction|blood pressure reduction
1539693|NCT00621803|Probiotic|probiotic
1539694|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
1539695|NCT00621803|Gastric colonization|gastric colonization
1539696|NCT00621803|Respiratory tract colonization|respiratory tract colonization
1539697|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
1539698|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
1539699|NCT00621790|fenoldopam|fenoldopam
1539700|NCT00621790|acute renal failure|acute renal failure
1539701|NCT00621790|renal replacement therapy|renal replacement therapy
1539702|NCT00621790|mortality|mortality
1539703|NCT00621790|cardiac surgery|cardiac surgery
1539704|NCT00621790|cardiac anesthesia|cardiac anesthesia
1539705|NCT00621790|intensive care unit|intensive care unit
1539706|NCT00621777|schizophrenia|schizophrenia
1539707|NCT00621777|bipolar disorder|bipolar disorder
1539708|NCT00621777|varenicline|varenicline
1539709|NCT00621777|smoking cessation|smoking cessation
1539710|NCT00621777|relapse prevention|relapse prevention
1539711|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
1539712|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
1539713|NCT00621764|Hepatitis A|hepatitis a
1539714|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
1539715|NCT00621751|Brain Injury|brain injury
1539716|NCT00621751|Irritability|irritability
1539717|NCT00621751|Aggression|aggression
1539718|NCT00621738|mental stress|mental stress
1539844|NCT00621309|drug interactions|drug interactions
1539719|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
1539720|NCT00621738|platelet adhesion|platelet adhesion
1539721|NCT00621725|Advanced cancer|advanced cancer
1539722|NCT00621725|metastatic|metastatic
1539723|NCT00621725|hepatic impairment|hepatic impairment
1539724|NCT00621712|Renal Dialysis|renal dialysis
1539725|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
1539726|NCT00621712|Dialysis, Renal|dialysis, renal
1539727|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
1539728|NCT00621699|pharmacokinetics|pharmacokinetics
1539729|NCT00621699|drug interactions|drug interactions
1539730|NCT00621699|ezetimibe|ezetimibe
1539731|NCT00621699|tacrolimus|tacrolimus
1539732|NCT00621699|human experimentation|human experimentation
1539733|NCT00621686|adult glioblastoma|adult glioblastoma
1539734|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
1539735|NCT00621686|adult gliosarcoma|adult gliosarcoma
1539736|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
1539737|NCT00621673|Hemophilia A,|hemophilia a,
1539738|NCT00621673|Inhibitor formation,|inhibitor formation,
1539739|NCT00621673|rFVIII|rfviii
1539740|NCT00621660|Acupuncture therapy|acupuncture therapy
1539741|NCT00621660|Cancer|cancer
1539742|NCT00621660|Emesis|emesis
1539743|NCT00621660|Expectations|expectations
1539744|NCT00621660|Placebo|placebo
1539745|NCT00621647|Seroquel|seroquel
1539746|NCT00621647|dementia|dementia
1539747|NCT00621647|agitation symptoms|agitation symptoms
1539748|NCT00621647|Alzheimer's disease|alzheimer's disease
1539749|NCT00621647|vascular dementia|vascular dementia
1539750|NCT00621647|quetiapine fumarate|quetiapine fumarate
1539751|NCT00621634|Tardive dyskinesia|tardive dyskinesia
1539752|NCT00621634|Schizophrenia|schizophrenia
1539753|NCT00621634|Essential fatty acids|essential fatty acids
1539754|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
1539755|NCT00621621|AVNRT|avnrt
1539756|NCT00621608|Chronic ulcers|chronic ulcers
1539757|NCT00621608|Diabetes|diabetes
1539758|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
1539759|NCT00621595|School Breakfast|school breakfast
1539760|NCT00621595|Diet|diet
1539761|NCT00621595|Nutrition|nutrition
1539762|NCT00621595|Brain Function|brain function
1539763|NCT00621595|Cognition|cognition
1539764|NCT00621595|USDA|usda
1539765|NCT00621595|Healthy Children|healthy children
1539766|NCT00621569|Blood Pressure|blood pressure
1539767|NCT00621569|Dash Diet|dash diet
1539768|NCT00621543|Intrauterine Device|intrauterine device
1539769|NCT00621543|Induced Abortion|induced abortion
1539770|NCT00621543|Medical Abortion|medical abortion
1539771|NCT00621530|Total hip arthroplasty|total hip arthroplasty
1539772|NCT00621530|Total hip replacement|total hip replacement
1539773|NCT00621530|Pain, postoperative|pain, postoperative
1539774|NCT00621530|Ketorolac|ketorolac
1539775|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
1539776|NCT00621517|Restless Legs Syndrome|restless legs syndrome
1539777|NCT00621517|Bupropion|bupropion
1539778|NCT00621504|ceftaroline|ceftaroline
1539779|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
1539780|NCT00621504|CAP|cap
1539781|NCT00621504|IV (intravenous)|iv (intravenous)
1539782|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
1539783|NCT00621504|Haemophilus influenzae|haemophilus influenzae
1539784|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
1539785|NCT00621504|Chlamydophila spp|chlamydophila spp
1539786|NCT00621504|Legionella spp|legionella spp
1539787|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
1539788|NCT00621504|antimicrobial resistance|antimicrobial resistance
1539789|NCT00621504|pneumococci|pneumococci
1539790|NCT00621504|Ceftriaxone|ceftriaxone
1539791|NCT00621504|bacteria|bacteria
1539792|NCT00621504|ß-lactam|ß-lactam
1539793|NCT00621504|beta-lactam|beta-lactam
1539794|NCT00621504|antibiotic|antibiotic
1539795|NCT00621491|cardiac pacing|cardiac pacing
1539796|NCT00621491|pacing complication|pacing complication
1539797|NCT00621491|venous thrombosis|venous thrombosis
1539798|NCT00621491|warfarin|warfarin
1539799|NCT00621491|anticoagulation|anticoagulation
1539800|NCT00621491|randomized trial|randomized trial
1539801|NCT00621465|Psychosis|psychosis
1539802|NCT00621465|Homelessness|homelessness
1539803|NCT00621465|Case Management|case management
1539804|NCT00621465|Severe Mental Illness|severe mental illness
1539805|NCT00621439|ocular melanoma|ocular melanoma
1539806|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
1539807|NCT00621426|dialysis|dialysis
1539808|NCT00621426|end stage renal disease|end stage renal disease
1539809|NCT00621426|sudden cardiac death|sudden cardiac death
1539810|NCT00621426|T-wave alternans|t-wave alternans
1539811|NCT00621426|Cardiac electrical instability|cardiac electrical instability
1539812|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
1539813|NCT00621426|Ventricular repolarization|ventricular repolarization
1539814|NCT00621413|prostate|prostate
1539815|NCT00621413|cancer|cancer
1539816|NCT00621413|intermediate risk|intermediate risk
1539817|NCT00621413|high risk|high risk
1539818|NCT00621413|brachytherapy|brachytherapy
1539819|NCT00621413|Cesium-131|cesium-131
1539820|NCT00621413|seed brachytherapy|seed brachytherapy
1539821|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
1539822|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
1539823|NCT00621387|reactive arthritis|reactive arthritis
1539824|NCT00621387|antibiotics|antibiotics
1539825|NCT00621374|Pain Management|pain management
1539826|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
1539827|NCT00621374|Hypnosis|hypnosis
1539828|NCT00621361|Lung Cancer|lung cancer
1539829|NCT00621361|AZD2171|azd2171
1539830|NCT00621361|cediranib|cediranib
1539831|NCT00621361|RECENTIN|recentin
1539832|NCT00621361|etoposide|etoposide
1539833|NCT00621361|cisplatin|cisplatin
1539834|NCT00621348|maintenance fluids|maintenance fluids
1539835|NCT00621348|hyponatremia|hyponatremia
1539836|NCT00621348|vasopressin|vasopressin
1539837|NCT00621348|children|children
1539838|NCT00621335|Open angle glaucoma|open angle glaucoma
1539839|NCT00621335|Ocular hypertension|ocular hypertension
1539840|NCT00621335|Parallel comparison|parallel comparison
1539841|NCT00621335|Combigan|combigan
1539842|NCT00621335|Cosopt|cosopt
1539843|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
1539845|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
1539846|NCT00621309|Pregnane X-receptor|pregnane x-receptor
1539847|NCT00621309|induction|induction
1539848|NCT00621309|drug metabolism|drug metabolism
1539849|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
1539850|NCT00621296|Protease Inhibitor|protease inhibitor
1539851|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
1539852|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
1539854|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
1539855|NCT00621257|Crohn's Disease|crohn's disease
1539856|NCT00621257|Ulcerative Colitis|ulcerative colitis
1539857|NCT00621257|Vitamin D|vitamin d
1539858|NCT00621244|HDAC inhibitor|hdac inhibitor
1539859|NCT00621244|Oral|oral
1539860|NCT00621244|LBH589|lbh589
1539861|NCT00621244|Lymphoma|lymphoma
1539862|NCT00621244|Leukemia|leukemia
1539863|NCT00621244|Multiple myeloma|multiple myeloma
1540858|NCT00617604|alefacept|alefacept
1539864|NCT00621231|Protein Function|protein function
1539865|NCT00621231|normal versus high protein intake|normal versus high protein intake
1539866|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
1539867|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
1539868|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
1539869|NCT00621192|meropenem|meropenem
1539870|NCT00621192|infants|infants
1539871|NCT00621192|intra-abdominal infection|intra-abdominal infection
1539872|NCT00621192|pharmacokinetics|pharmacokinetics
1539873|NCT00621192|safety|safety
1539874|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
1539875|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
1539876|NCT00621166|Pharmacokinetics|pharmacokinetics
1539877|NCT00621166|Pregnancy|pregnancy
1539878|NCT00621166|Antiviral activity|antiviral activity
1539879|NCT00621166|Safety|safety
1539880|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
1539881|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
1539882|NCT00621153|severe hypertension|severe hypertension
1539883|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
1539884|NCT00621114|Dialysis, Renal|dialysis, renal
1539885|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
1539886|NCT00621114|Hemodialysis|hemodialysis
1539887|NCT00621101|pharmacokinetics|pharmacokinetics
1539888|NCT00621101|drug interactions|drug interactions
1539889|NCT00621101|ezetimibe|ezetimibe
1539890|NCT00621101|sirolimus|sirolimus
1539891|NCT00621101|human experimentation|human experimentation
1539892|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
1539893|NCT00621062|varicose|varicose
1539894|NCT00621062|vein|vein
1539895|NCT00621062|ligation|ligation
1539896|NCT00621062|laser|laser
1539897|NCT00621062|foam|foam
1539898|NCT00621062|sclerotherapy|sclerotherapy
1539899|NCT00621062|radiofrequency|radiofrequency
1539900|NCT00621062|duplex|duplex
1539901|NCT00621062|sf36|sf36
1539902|NCT00621062|Aberdeen|aberdeen
1539903|NCT00621062|VCSS|vcss
1539904|NCT00621062|quality|quality
1539905|NCT00621062|recurrence|recurrence
1539906|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
1539907|NCT00621049|Resected|resected
1539908|NCT00621049|Carboplatin|carboplatin
1539909|NCT00621049|Docetaxel|docetaxel
1539910|NCT00621049|Bevacizumab|bevacizumab
1539911|NCT00621049|Erlotinib|erlotinib
1539912|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1539913|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1539914|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1539915|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1539916|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1539917|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1539918|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1539919|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1539920|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1539921|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1539922|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1539923|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1539924|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1539925|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1539926|NCT00621036|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1539927|NCT00621036|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1539928|NCT00621036|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1539929|NCT00621036|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1539930|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1539931|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1539932|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1539933|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1539934|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1539935|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1539936|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1539937|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1539938|NCT00621036|intraocular lymphoma|intraocular lymphoma
1539939|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1539940|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1539941|NCT00621036|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1539942|NCT00621036|small intestine lymphoma|small intestine lymphoma
1539943|NCT00621036|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1539944|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
1539946|NCT00620997|cornea|cornea
1539947|NCT00620997|analgesia|analgesia
1539948|NCT00620997|topical|topical
1539949|NCT00620997|anesthetic|anesthetic
1539950|NCT00620984|Staphylococcus aureus|staphylococcus aureus
1539951|NCT00620984|Breastfeeding|breastfeeding
1539952|NCT00620984|Lactational Mastitis|lactational mastitis
1539953|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
1539954|NCT00620984|staphylococcal infections|staphylococcal infections
1539955|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
1539956|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
1539957|NCT00620971|Cisplatin|cisplatin
1539958|NCT00620971|VInorelbine|vinorelbine
1539959|NCT00620971|Docetaxel|docetaxel
1539960|NCT00620971|Gemcitabine|gemcitabine
1539961|NCT00620971|Bevacizumab|bevacizumab
1539962|NCT00620958|Mediation|mediation
1539963|NCT00620958|Outcome|outcome
1539964|NCT00620958|CBT|cbt
1539965|NCT00620958|Child Anxiety Intervention|child anxiety intervention
1539966|NCT00620945|Congenital heart surgery|congenital heart surgery
1539967|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
1539968|NCT00620945|Phenoxybenzamine|phenoxybenzamine
1539969|NCT00620906|manipulation|manipulation
1539970|NCT00620906|manual therapy|manual therapy
1539971|NCT00620906|Sacroiliac joint|sacroiliac joint
1539972|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
1539973|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
1539974|NCT00620893|refractive regression|refractive regression
1539975|NCT00620841|Tacrolimus|tacrolimus
1539976|NCT00620841|Renal Transplantation|renal transplantation
1539977|NCT00620841|genetic polymorphisms|genetic polymorphisms
1539978|NCT00620841|Drug drug interactions|drug drug interactions
1539979|NCT00620815|avian flu|avian flu
1539980|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
1539981|NCT00620815|influenza vaccine|influenza vaccine
1539982|NCT00620815|prepandemic vaccine|prepandemic vaccine
1539983|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
1539984|NCT00620815|tetravalent vaccine|tetravalent vaccine
1539985|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
1539986|NCT00620802|Platelet function testing|platelet function testing
1539987|NCT00620802|Healthy volunteers|healthy volunteers
1539988|NCT00620789|Insomnia|insomnia
1539989|NCT00620789|Depression|depression
1539990|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
1539991|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
1539992|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
1539993|NCT00620776|Combined treatment|combined treatment
1539994|NCT00620763|Meat protein|meat protein
1539995|NCT00620763|acid load|acid load
1539996|NCT00620763|calcium retention|calcium retention
1539997|NCT00620763|postmenopausal women|postmenopausal women
1539998|NCT00620750|Alcohol dependence|alcohol dependence
1539999|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1540000|NCT00620711|HIE|hie
1540001|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
1540002|NCT00620711|Cooling|cooling
1540003|NCT00620711|hypothermia|hypothermia
1540004|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1540005|NCT00620698|motor neuron disease|motor neuron disease
1540006|NCT00620698|outcome measure|outcome measure
1540007|NCT00620698|biomarker|biomarker
1540008|NCT00620698|impedance|impedance
1540009|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
1540010|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
1540011|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
1540012|NCT00620672|n-3 status and gestation|n-3 status and gestation
1540013|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
1540014|NCT00620646|clopidogrel|clopidogrel
1540015|NCT00620646|platelets|platelets
1540016|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
1540017|NCT00620633|Bone Marrow|bone marrow
1540018|NCT00620620|Healthy adult volunteers|healthy adult volunteers
1540019|NCT00620607|gastric|gastric
1540020|NCT00620594|Neoplasms|neoplasms
1540021|NCT00620594|breast neoplasms|breast neoplasms
1540022|NCT00620594|breast diseases|breast diseases
1540023|NCT00620594|solid tumors|solid tumors
1540024|NCT00620594|BEZ235|bez235
1540025|NCT00620594|breast cancer|breast cancer
1540026|NCT00620594|PI3K Inhibitor|pi3k inhibitor
1540027|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
1540028|NCT00620594|kinase|kinase
1540029|NCT00620594|advanced|advanced
1540030|NCT00620568|Safety|safety
1540031|NCT00620568|Tolerability|tolerability
1540032|NCT00620568|Schizophrenia|schizophrenia
1540033|NCT00620542|Coronary artery disease|coronary artery disease
1540034|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
1540035|NCT00620529|cardiovascular risk|cardiovascular risk
1540036|NCT00620529|metabolism|metabolism
1540037|NCT00620529|blood pressure|blood pressure
1540038|NCT00620529|liver fat|liver fat
1540039|NCT00620529|heart rate variability|heart rate variability
1540040|NCT00620503|PK|pk
1540041|NCT00620503|Pharmacokinetics|pharmacokinetics
1540042|NCT00620490|Epidural analgesia|epidural analgesia
1540043|NCT00620490|Contraindications|contraindications
1540044|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
1540045|NCT00620490|ropivacaine|ropivacaine
1540046|NCT00620490|Visual analogical scale|visual analogical scale
1540047|NCT00620490|Morphine|morphine
1540048|NCT00620490|Side effects|side effects
1540049|NCT00620490|Pain and thoracotomy|pain and thoracotomy
1540050|NCT00620451|Treatment|treatment
1540051|NCT00620451|Active|active
1540052|NCT00620451|Celiac|celiac
1540053|NCT00620451|Remission|remission
1540054|NCT00620451|Induction|induction
1540055|NCT00620438|Lumefantrine|lumefantrine
1540056|NCT00620438|Efavirenz|efavirenz
1540057|NCT00620438|Nevirapine|nevirapine
1540058|NCT00620438|Rifampicin|rifampicin
1540059|NCT00620438|HIV|hiv
1540060|NCT00620425|sumatriptan|sumatriptan
1540061|NCT00620425|Intraject|intraject
1540062|NCT00620425|Local Site Reactions|local site reactions
1540063|NCT00620412|influenza|influenza
1540064|NCT00620412|vaccines|vaccines
1540065|NCT00620412|probiotics|probiotics
1540066|NCT00620412|LGG|lgg
1540067|NCT00620399|lumbar fusion|lumbar fusion
1540068|NCT00620386|Intubating conditions|intubating conditions
1540069|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
1540070|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
1540071|NCT00620386|neuromuscular blockade|neuromuscular blockade
1540072|NCT00620373|Dense breast tissue|dense breast tissue
1540073|NCT00620373|Breast Cancer Screening|breast cancer screening
1540074|NCT00620373|Molecular Breast Imaging|molecular breast imaging
1540075|NCT00620373|Breast Cancer|breast cancer
1540076|NCT00620373|Breast|breast
1540077|NCT00620360|dietary fructose|dietary fructose
1540078|NCT00620360|plasma lipids|plasma lipids
1540079|NCT00620360|healthy humans|healthy humans
1540080|NCT00620360|gender differences|gender differences
1540081|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
1540435|NCT00619281|Morbidity|morbidity
1540082|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
1540083|NCT00620347|ED (extensive disease)|ed (extensive disease)
1540084|NCT00620347|RR (response rate)|rr (response rate)
1540085|NCT00620334|ASTHMA|asthma
1540086|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
1540087|NCT00620295|recurrent breast cancer|recurrent breast cancer
1540088|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
1540089|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1540090|NCT00620295|recurrent colon cancer|recurrent colon cancer
1540091|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
1540092|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
1540093|NCT00620295|ovarian cancer|ovarian cancer
1540094|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
1540095|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
1540096|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
1540097|NCT00620269|NSCLC|nsclc
1540098|NCT00620269|EGFR mutation|egfr mutation
1540099|NCT00620269|Erlotinib|erlotinib
1540100|NCT00620269|IP chemotherapy|ip chemotherapy
1540101|NCT00620269|CCRT|ccrt
1540102|NCT00620256|Glaucoma|glaucoma
1540103|NCT00620256|Hypertension|hypertension
1540104|NCT00620243|Ovarian cancer|ovarian cancer
1540105|NCT00620243|PET|pet
1540106|NCT00620243|CT|ct
1540107|NCT00620243|04-064|04-064
1540108|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
1540109|NCT00620217|heart ischemia|heart ischemia
1540110|NCT00620217|coronary artery disease|coronary artery disease
1540111|NCT00620217|plasmid|plasmid
1540112|NCT00620217|VEGF|vegf
1540113|NCT00620217|FGF|fgf
1540114|NCT00620217|percutaneous|percutaneous
1540115|NCT00620217|gene therapy|gene therapy
1540116|NCT00620217|SPECT|spect
1540117|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
1540118|NCT00620204|atorvastatin|atorvastatin
1540119|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
1540120|NCT00620204|endothelial dysfunction|endothelial dysfunction
1540121|NCT00620191|metformin|metformin
1540122|NCT00620191|mild cognitive impairment|mild cognitive impairment
1540123|NCT00620191|alzheimer's disease|alzheimer's disease
1540124|NCT00620191|overweight|overweight
1540125|NCT00620191|insulin|insulin
1540126|NCT00620178|candesartan|candesartan
1540127|NCT00620178|losartan|losartan
1540128|NCT00620178|blood pressure|blood pressure
1540129|NCT00620178|cardiovascular disease|cardiovascular disease
1540130|NCT00620178|health care consumption|health care consumption
1540131|NCT00620165|tremor|tremor
1540132|NCT00620165|writing|writing
1540133|NCT00620165|feeding|feeding
1540134|NCT00620165|pouring|pouring
1540135|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1540136|NCT00620139|chemoradiotherapy|chemoradiotherapy
1540137|NCT00620139|molecular effects|molecular effects
1540138|NCT00620139|05-016|05-016
1540139|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
1540140|NCT00620126|Ulcerative colitis|ulcerative colitis
1540141|NCT00620126|Telemedicine|telemedicine
1541269|NCT00616018|drug safety|drug safety
1540142|NCT00620126|Telemanagement|telemanagement
1540143|NCT00620126|Chronic disease|chronic disease
1540144|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
1540145|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
1540146|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
1540147|NCT00620087|Molecular Breast Imaging|molecular breast imaging
1540148|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
1540149|NCT00620048|heart|heart
1540150|NCT00620048|stem Cells|stem cells
1540151|NCT00620048|low EF|low ef
1540152|NCT00620048|heart attack|heart attack
1540153|NCT00620048|cardiomyopathy|cardiomyopathy
1540154|NCT00620048|congestive heart failure|congestive heart failure
1540155|NCT00620048|cardiovascular disease|cardiovascular disease
1540156|NCT00620048|Heart Failure|heart failure
1540157|NCT00620048|Low Ejection Fraction|low ejection fraction
1540158|NCT00620022|indacaterol|indacaterol
1540159|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1540160|NCT00620022|exercise endurance|exercise endurance
1540161|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
1540162|NCT00620022|COPD|copd
1540163|NCT00620009|Empathy|empathy
1540164|NCT00620009|Feedback|feedback
1540165|NCT00620009|Psychotherapy|psychotherapy
1540166|NCT00619996|Prostate Cancer|prostate cancer
1540167|NCT00619996|Sorafenib|sorafenib
1540168|NCT00619996|Nexavar|nexavar
1540169|NCT00619996|Docetaxel|docetaxel
1540170|NCT00619996|Pisa|pisa
1540171|NCT00619996|Ricci|ricci
1540172|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
1540173|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
1540174|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
1540175|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
1540176|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
1540177|NCT00619983|Low back pain, chronic|low back pain, chronic
1540178|NCT00619944|HIV|hiv
1540179|NCT00619944|lumefantrine|lumefantrine
1540180|NCT00619944|lopinavir|lopinavir
1540181|NCT00619944|Africa|africa
1540182|NCT00619944|Antimalarials|antimalarials
1540183|NCT00619944|treatment naïve|treatment naïve
1540184|NCT00619931|Healthy adult volunteers|healthy adult volunteers
1540185|NCT00619918|bronchiolitis|bronchiolitis
1540186|NCT00619918|hypertonic saline|hypertonic saline
1540187|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
1540188|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
1540189|NCT00619905|ACZ885|acz885
1540190|NCT00619892|SSRI Resistant|ssri resistant
1540191|NCT00619892|Seroquel SR|seroquel sr
1540192|NCT00619892|Seroquel XR|seroquel xr
1540193|NCT00619892|Panic Disorder|panic disorder
1540194|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
1540195|NCT00619892|Quetiapine SR|quetiapine sr
1540196|NCT00619892|Quetiapine XR|quetiapine xr
1540197|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
1540198|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
1540199|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
1540200|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
1540201|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
1540202|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
1540203|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
1540204|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
1540205|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
1540206|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
1540207|NCT00619879|Busulfan|busulfan
1540208|NCT00619879|Total Body Irradiation|total body irradiation
1540209|NCT00619879|VP-16|vp-16
1540210|NCT00619879|Etoposide|etoposide
1540211|NCT00619879|Cyclophosphamide|cyclophosphamide
1540212|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
1540213|NCT00619866|bone mineral density|bone mineral density
1540214|NCT00619866|NBI-56418|nbi-56418
1540215|NCT00619866|estradiol|estradiol
1540216|NCT00619866|Endometriosis|endometriosis
1540217|NCT00619866|Pelvic Pain|pelvic pain
1540218|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
1540219|NCT00619840|ADHD|adhd
1540220|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1540221|NCT00619840|adult|adult
1540222|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
1540223|NCT00619840|Medikinet retard|medikinet retard
1540224|NCT00619840|long-term observation|long-term observation
1540225|NCT00619840|controlled clinical trial|controlled clinical trial
1540226|NCT00619840|safety|safety
1540227|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
1540228|NCT00619840|treatment|treatment
1540229|NCT00619840|central nervous system stimulants|central nervous system stimulants
1540230|NCT00619840|therapeutic uses|therapeutic uses
1540231|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
1540232|NCT00619827|Rhinitis|rhinitis
1540233|NCT00619827|Conjunctivitis|conjunctivitis
1540234|NCT00619827|Allergen challenge|allergen challenge
1540235|NCT00619827|Allergen exposition chamber|allergen exposition chamber
1540236|NCT00619827|Grass pollen tablet|grass pollen tablet
1540237|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1540238|NCT00619814|Colon polyps|colon polyps
1540239|NCT00619814|Fecal occult blood test|fecal occult blood test
1540240|NCT00619814|Double contrast barium enema|double contrast barium enema
1540241|NCT00619814|Colonoscopy|colonoscopy
1540242|NCT00619801|Xyzal|xyzal
1540243|NCT00619801|Levocetirizine|levocetirizine
1540244|NCT00619801|Allergy|allergy
1540245|NCT00619801|Children|children
1540246|NCT00619801|Seasonal Allergies|seasonal allergies
1540247|NCT00619775|Carotid Artery Disease|carotid artery disease
1540248|NCT00619775|Embolic Protection|embolic protection
1540249|NCT00619762|Breast reconstruction|breast reconstruction
1540250|NCT00619736|Healthy|healthy
1540251|NCT00619710|skin infections|skin infections
1540252|NCT00619710|MERREM|merrem
1540253|NCT00619710|PRIMAXIN IV|primaxin iv
1540254|NCT00619710|complex abscess|complex abscess
1540255|NCT00619710|perirectal abscess|perirectal abscess
1540256|NCT00619710|wound infections|wound infections
1540257|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
1540258|NCT00619710|cellulitis|cellulitis
1540259|NCT00619710|Meropenem|meropenem
1540260|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
1540261|NCT00619671|Rituxan|rituxan
1540262|NCT00619671|Rituximab|rituximab
1540263|NCT00619671|Myasthenia Gravis|myasthenia gravis
1540265|NCT00619658|telephone follow-up|telephone follow-up
1540266|NCT00619658|medical abortion|medical abortion
1540267|NCT00619658|induced abortion|induced abortion
1540268|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1540269|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1540270|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
1540271|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1540272|NCT00619645|refractory anemia|refractory anemia
1540273|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1540274|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1540275|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1540276|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1540277|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1540278|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1540279|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1540280|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1540281|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1540282|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1540283|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1540284|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1540285|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
1540286|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1540367|NCT00619502|Hepatitis B|hepatitis b
1540287|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1540288|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1540289|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1540290|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1540291|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1540292|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1540293|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1540294|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1540295|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1540296|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1540297|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1540298|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1540299|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1540300|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1540301|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1540302|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1540303|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1540304|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1540305|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1540306|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1540307|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1540308|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1540309|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1540310|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1540311|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1540312|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1540313|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1540314|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1540315|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1540316|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1540317|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1540318|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1540319|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1540320|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1540321|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1540322|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
1540323|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
1540324|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
1540325|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1540326|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1540329|NCT00619619|Adolescent|adolescent
1540330|NCT00619619|Pharmacokinetic|pharmacokinetic
1540331|NCT00619619|Outpatient|outpatient
1540332|NCT00619619|Pediatrics|pediatrics
1540333|NCT00619619|Depressive Disorder|depressive disorder
1540334|NCT00619619|Major|major
1540335|NCT00619606|prevention of hypoxia|prevention of hypoxia
1540336|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
1540337|NCT00619593|Heart failure|heart failure
1540338|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
1540339|NCT00619593|Sudden cardiac death|sudden cardiac death
1540340|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
1540341|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1540342|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
1540343|NCT00619580|E coli|e coli
1540344|NCT00619567|Cognition|cognition
1540345|NCT00619567|Rehabilitation|rehabilitation
1540346|NCT00619567|Cognitive Stimulation|cognitive stimulation
1540347|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
1540348|NCT00619567|AIDS|aids
1540349|NCT00619554|Healthy volunteers|healthy volunteers
1540351|NCT00619541|Sorafenib|sorafenib
1540352|NCT00619541|Pisa|pisa
1540353|NCT00619541|Ricci|ricci
1540354|NCT00619541|5-FU|5-fu
1540355|NCT00619541|5FU|5fu
1540356|NCT00619541|5 FU|5 fu
1540357|NCT00619541|Advanced HCC|advanced hcc
1540358|NCT00619528|Transplants|transplants
1540359|NCT00619528|Kidney Transplantation|kidney transplantation
1540360|NCT00619528|Immunosuppression|immunosuppression
1540361|NCT00619528|HLA Antigens|hla antigens
1540362|NCT00619528|Stem Cells|stem cells
1540363|NCT00619528|Bone Marrow|bone marrow
1540364|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1540365|NCT00619515|stage I prostate cancer|stage i prostate cancer
1540366|NCT00619515|stage II prostate cancer|stage ii prostate cancer
1540369|NCT00619502|Diphtheria|diphtheria
1540370|NCT00619502|Pertussis|pertussis
1540371|NCT00619502|H.influenzae type b|h.influenzae type b
1540372|NCT00619476|Neuropathic Pain|neuropathic pain
1540373|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
1540374|NCT00619476|PHN|phn
1540375|NCT00619463|Traumatic Brain Injury|traumatic brain injury
1540376|NCT00619463|Exercise|exercise
1540377|NCT00619463|Cognition|cognition
1540378|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
1540379|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
1540380|NCT00619450|atrial fibrillation|atrial fibrillation
1540381|NCT00619450|cardiac pacing|cardiac pacing
1540382|NCT00619450|CAT scanner|cat scanner
1540383|NCT00619437|schizophrenia|schizophrenia
1540384|NCT00619437|genetics|genetics
1540385|NCT00619437|family|family
1540386|NCT00619437|multiplex|multiplex
1540387|NCT00619437|haplotypes|haplotypes
1540388|NCT00619424|erlotinib|erlotinib
1540389|NCT00619424|pharmacokinetics|pharmacokinetics
1540390|NCT00619424|Solid tumors|solid tumors
1540391|NCT00619424|pemetrexed|pemetrexed
1540392|NCT00619424|anti-angiogenesis|anti-angiogenesis
1540393|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
1540394|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
1540395|NCT00619411|Major Depression|major depression
1540396|NCT00619411|Dysthymic Disorder|dysthymic disorder
1540397|NCT00619411|Adjustment Disorder|adjustment disorder
1540398|NCT00619411|With Depressed Mood|with depressed mood
1540399|NCT00619411|Depressive|depressive
1540400|NCT00619411|Disorder Not|disorder not
1540401|NCT00619411|Otherwise|otherwise
1540402|NCT00619411|Specified|specified
1540403|NCT00619411|Adolescent|adolescent
1540404|NCT00619411|Psychotherapy|psychotherapy
1540405|NCT00619398|FK506|fk506
1540406|NCT00619398|tacrolimus|tacrolimus
1540407|NCT00619398|prograf|prograf
1540408|NCT00619398|Liver transplantation|liver transplantation
1540409|NCT00619385|Pharmacokinetics|pharmacokinetics
1540410|NCT00619372|OKT3|okt3
1540411|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
1540412|NCT00619372|oral tolerance|oral tolerance
1540413|NCT00619372|anti-CD3|anti-cd3
1540414|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
1540415|NCT00619346|Safety|safety
1540416|NCT00619346|Tolerability|tolerability
1540417|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
1540418|NCT00619320|HIV primary prevention|hiv primary prevention
1540419|NCT00619320|Health promotion|health promotion
1540420|NCT00619320|Health behavior|health behavior
1540421|NCT00619320|Risk reduction behavior|risk reduction behavior
1540422|NCT00619320|Sexual behavior|sexual behavior
1540423|NCT00619320|Safe sex|safe sex
1540424|NCT00619320|Women's health|women's health
1540425|NCT00619320|Minority health|minority health
1540426|NCT00619320|Pregnant Women|pregnant women
1540427|NCT00619320|HIV seronegativity|hiv seronegativity
1540428|NCT00619294|Coronary Vasospasm|coronary vasospasm
1540429|NCT00619294|Endothelium, Vascular|endothelium, vascular
1540430|NCT00619294|Vasodilation|vasodilation
1540431|NCT00619294|Hyperemia|hyperemia
1540432|NCT00619281|Cardiac surgery|cardiac surgery
1540433|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
1540434|NCT00619281|Mortality|mortality
1540436|NCT00619268|Temsirolimus|temsirolimus
1540437|NCT00619268|Bevacizumab|bevacizumab
1540438|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1540439|NCT00619268|Non-progression|non-progression
1540440|NCT00619255|Adolescents|adolescents
1540441|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
1540442|NCT00619255|Substance Abuse|substance abuse
1540443|NCT00619255|Posttraumatic Stress|posttraumatic stress
1540444|NCT00619255|Family Centered Care|family centered care
1540445|NCT00619255|Trauma Systems|trauma systems
1540446|NCT00619242|Esophageal cancer|esophageal cancer
1540447|NCT00619229|Alprostadil|alprostadil
1540448|NCT00619229|prostaglandin E1|prostaglandin e1
1540449|NCT00619229|Prostavasin®|prostavasin®
1540450|NCT00619229|macular degeneration|macular degeneration
1540451|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
1540452|NCT00619203|Bacterial meningitis|bacterial meningitis
1540453|NCT00619203|glycerol|glycerol
1540454|NCT00619203|high dose paracetamol|high dose paracetamol
1540455|NCT00619203|children|children
1540456|NCT00619190|open label|open label
1540457|NCT00619190|aripiprazole|aripiprazole
1540458|NCT00619190|children|children
1540459|NCT00619190|adolescents|adolescents
1540460|NCT00619190|autism spectrum disorders|autism spectrum disorders
1540461|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1540462|NCT00619164|Coronary Stenosis|coronary stenosis
1540463|NCT00619164|Coronary Thrombosis|coronary thrombosis
1540464|NCT00619151|aortic valve|aortic valve
1540465|NCT00619151|heart valve|heart valve
1540466|NCT00619151|valve replacement|valve replacement
1540467|NCT00619151|Valve disease|valve disease
1540468|NCT00619138|Cognitive therapy|cognitive therapy
1540469|NCT00619138|Stepped care|stepped care
1540470|NCT00619138|Self-help|self-help
1540471|NCT00619138|Internet|internet
1540473|NCT00619112|adult glioblastoma|adult glioblastoma
1540474|NCT00619112|adult gliosarcoma|adult gliosarcoma
1540475|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1540476|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1540477|NCT00619112|adult mixed glioma|adult mixed glioma
1540478|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
1540479|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
1540480|NCT00619099|Decitabine|decitabine
1540481|NCT00619099|Dacogen|dacogen
1540482|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
1540483|NCT00619086|thyroidectomy|thyroidectomy
1540484|NCT00619086|dexamethasone|dexamethasone
1540485|NCT00619086|steroid|steroid
1540486|NCT00619086|nausea|nausea
1540487|NCT00619073|blood platelets|blood platelets
1540488|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
1540489|NCT00619073|antiplatelet drugs|antiplatelet drugs
1540490|NCT00619073|clopidogrel|clopidogrel
1540491|NCT00619060|skin cancer|skin cancer
1540492|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
1540493|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1540494|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1540495|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1540496|NCT00619008|obesity|obesity
1540497|NCT00619008|low carbohydrate diet|low carbohydrate diet
1540498|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
1540499|NCT00619008|weight regulation hormones|weight regulation hormones
1540500|NCT00619008|hunger|hunger
1540501|NCT00619008|satiety|satiety
1540502|NCT00619008|energy expenditure|energy expenditure
1540503|NCT00619008|body composition|body composition
1540504|NCT00619008|weight loss|weight loss
1540505|NCT00618982|Kidney cancer,|kidney cancer,
1540506|NCT00618982|Sorafenib,|sorafenib,
1540507|NCT00618982|Dose escalation,|dose escalation,
1540508|NCT00618982|No previous treatment|no previous treatment
1540509|NCT00618969|Haploidentical|haploidentical
1540510|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1540511|NCT00618969|leukemia|leukemia
1540512|NCT00618969|myeloma|myeloma
1540513|NCT00618969|Hodgkin's disease|hodgkin's disease
1540514|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1540515|NCT00618956|NSRI|nsri
1540516|NCT00618956|milnacipran|milnacipran
1540517|NCT00618956|fibromyalgia|fibromyalgia
1540518|NCT00618956|blood pressure|blood pressure
1540519|NCT00618956|hypertension|hypertension
1540520|NCT00618917|NSCLC|nsclc
1540521|NCT00618917|lung cancer|lung cancer
1540522|NCT00618917|chemotherapy|chemotherapy
1540523|NCT00618917|radiation therapy|radiation therapy
1540524|NCT00618917|radiation toxicity|radiation toxicity
1540525|NCT00618904|Probiotics|probiotics
1540526|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
1540527|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
1540528|NCT00618865|Major Depressive Disorder|major depressive disorder
1540529|NCT00618865|Pregnancy|pregnancy
1540530|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
1540531|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
1540532|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
1540533|NCT00618852|Pediatrics|pediatrics
1540534|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
1540535|NCT00618852|Furosemide|furosemide
1540536|NCT00618852|Fluid Overload|fluid overload
1540537|NCT00618839|Complex skin defects|complex skin defects
1540538|NCT00618839|Burns|burns
1540539|NCT00618839|Wound infection|wound infection
1540540|NCT00618839|Skin trauma|skin trauma
1540541|NCT00618826|Breast cancer|breast cancer
1540542|NCT00618800|Falls|falls
1540543|NCT00618800|Elderly|elderly
1540544|NCT00618800|Injury|injury
1540545|NCT00618800|Medication|medication
1540546|NCT00618800|Pharmacy|pharmacy
1540547|NCT00618800|Pharmacist|pharmacist
1540548|NCT00618761|glucose clamp|glucose clamp
1540549|NCT00618761|beta-cell|beta-cell
1540550|NCT00618748|Bipolar|bipolar
1540551|NCT00618709|Healthy volunteers|healthy volunteers
1540552|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1540553|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1540554|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1540555|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1540556|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1540557|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1540558|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1540559|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1540560|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1540561|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1540562|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1540563|NCT00618683|AVNRT|avnrt
1540564|NCT00618683|Atrioventricular|atrioventricular
1540565|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
1540566|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
1540567|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
1540568|NCT00618670|aging|aging
1540569|NCT00618670|gait|gait
1540570|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
1540571|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
1540572|NCT00618670|muscle function|muscle function
1540573|NCT00618670|muscle strength|muscle strength
1540574|NCT00618670|quality of life|quality of life
1540575|NCT00618657|pre-operative|pre-operative
1540576|NCT00618657|neo-adjuvant|neo-adjuvant
1540577|NCT00618657|triple negative|triple negative
1540578|NCT00618657|HER2 positive|her2 positive
1540579|NCT00618657|hormone receptor positive|hormone receptor positive
1540580|NCT00618657|breast|breast
1540581|NCT00618657|Carboplatin|carboplatin
1540582|NCT00618657|Nab-paclitaxel|nab-paclitaxel
1540583|NCT00618657|Trastuzumab|trastuzumab
1540584|NCT00618657|Bevacizumab|bevacizumab
1540585|NCT00618657|Inflammatory|inflammatory
1540586|NCT00618631|Smoking|smoking
1540587|NCT00618631|Nicotine|nicotine
1540588|NCT00618631|Endogenous Opioids|endogenous opioids
1540589|NCT00618631|PET Study|pet study
1540590|NCT00618631|Carfentanil|carfentanil
1540591|NCT00618605|HIV Seronegativity|hiv seronegativity
1540592|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
1540593|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
1540594|NCT00618592|cardiac surgery|cardiac surgery
1540595|NCT00618592|spine surgery|spine surgery
1540596|NCT00618592|insulin resistance|insulin resistance
1540597|NCT00618592|insulin sensitivity|insulin sensitivity
1540598|NCT00618592|short insulin tolerance test|short insulin tolerance test
1540599|NCT00618592|HOMA|homa
1540600|NCT00618592|outcomes|outcomes
1540601|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
1540602|NCT00618566|Women with physical Disabilities|women with physical disabilities
1540603|NCT00618566|Secondary Conditions|secondary conditions
1540604|NCT00618566|Depression|depression
1540605|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
1540606|NCT00618566|Consumer Control|consumer control
1540607|NCT00618553|Lung Cancer|lung cancer
1540608|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
1540609|NCT00618553|Questionnaire|questionnaire
1540610|NCT00618553|Survey|survey
1540611|NCT00618553|Lung Function|lung function
1703234|NCT00047060|CTCL|ctcl
1540612|NCT00618553|Quality of Life|quality of life
1540613|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1540614|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1540615|NCT00618527|multiple sclerosis|multiple sclerosis
1540616|NCT00618514|Varicose Veins|varicose veins
1540617|NCT00618514|Laser Ablation|laser ablation
1540618|NCT00618514|Laser Wire Fibers|laser wire fibers
1540619|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1540620|NCT00618488|Probiotics|probiotics
1540621|NCT00618488|BB12|bb12
1540622|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
1540623|NCT00618475|Depression|depression
1540624|NCT00618475|End Stage Renal Disease|end stage renal disease
1540625|NCT00618475|Kidney Disease|kidney disease
1540626|NCT00618475|Mental Health|mental health
1540627|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
1540628|NCT00618462|Pathological Gambling|pathological gambling
1540629|NCT00618449|Trachoma|trachoma
1540630|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
1540631|NCT00618436|Seizures|seizures
1540632|NCT00618436|Traumatic Brain Injury|traumatic brain injury
1540633|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1540634|NCT00618423|Neuropathic pain|neuropathic pain
1540635|NCT00618423|Chronic pain|chronic pain
1540636|NCT00618423|Acute postoperative pain|acute postoperative pain
1540637|NCT00618423|Ketamine|ketamine
1540638|NCT00618423|Back surgery|back surgery
1540639|NCT00618423|Anesthesia|anesthesia
1540640|NCT00618423|Perioperative|perioperative
1540641|NCT00618397|ketamine|ketamine
1540642|NCT00618397|pharmacokinetics|pharmacokinetics
1540643|NCT00618397|sedation|sedation
1540644|NCT00618397|critical care|critical care
1540645|NCT00618397|opioid tolerance|opioid tolerance
1540646|NCT00618397|NMDA Antagonist|nmda antagonist
1540647|NCT00618384|TACE|tace
1540648|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
1540649|NCT00618371|Intensification|intensification
1540650|NCT00618371|HIV viremia|hiv viremia
1540651|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
1540652|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
1540653|NCT00618293|intraoperative bleeding|intraoperative bleeding
1540654|NCT00618293|aortic-valve replacement|aortic-valve replacement
1540655|NCT00618293|aortic stenosis|aortic stenosis
1540656|NCT00618293|Von Willebrand|von willebrand
1540657|NCT00618293|HEAMATE|heamate
1540658|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
1540659|NCT00618241|interactions|interactions
1540660|NCT00618241|neuropathic pain|neuropathic pain
1540661|NCT00618241|pharmacokinetics|pharmacokinetics
1540662|NCT00618215|cluster-randomised trial|cluster-randomised trial
1540663|NCT00618215|routine oral examination|routine oral examination
1540664|NCT00618215|implementation research|implementation research
1540665|NCT00618215|practice based research|practice based research
1540666|NCT00618215|CPG|cpg
1540667|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
1540668|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
1540669|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
1540670|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1540671|NCT00618176|adverse effects|adverse effects
1540672|NCT00618176|Treatment Outcome|treatment outcome
1540673|NCT00618176|Drug Resistance, Viral|drug resistance, viral
1540674|NCT00618176|treatment naïve|treatment naïve
1540675|NCT00618163|Anti-inflammatory|anti-inflammatory
1540676|NCT00618150|GERD|gerd
1540677|NCT00618150|Dyspepsia|dyspepsia
1540678|NCT00618150|Education|education
1540679|NCT00618150|Information|information
1540680|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1540681|NCT00618137|Gene expression profiling|gene expression profiling
1540682|NCT00618137|Inert dusts|inert dusts
1540683|NCT00618137|Natural course|natural course
1540684|NCT00618137|Prospective assessment|prospective assessment
1540685|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
1540686|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
1540687|NCT00618098|anticoagulant reversal|anticoagulant reversal
1540688|NCT00618098|urgent surgery|urgent surgery
1540689|NCT00618098|invasive procedures|invasive procedures
1540690|NCT00618098|vitamin K|vitamin k
1540691|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
1540692|NCT00618072|hyperinsulinemia|hyperinsulinemia
1540693|NCT00618072|insulin resistance|insulin resistance
1540694|NCT00618072|perimenopause|perimenopause
1540695|NCT00618072|obesity|obesity
1540696|NCT00618072|overweight|overweight
1540697|NCT00618072|women|women
1540698|NCT00618033|Hemodialysis|hemodialysis
1540699|NCT00618033|ESRD|esrd
1540700|NCT00618020|CTO|cto
1540701|NCT00618020|Chronic Total Occlusion|chronic total occlusion
1540702|NCT00618020|Revascularization|revascularization
1540703|NCT00617994|psoriasis|psoriasis
1540704|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
1540705|NCT00617981|liver cancer|liver cancer
1540706|NCT00617942|Breast Cancer|breast cancer
1540707|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
1540708|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1540709|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
1540710|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
1540711|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
1540712|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1540713|NCT00617929|primary myelofibrosis|primary myelofibrosis
1540714|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1540715|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1540716|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1540717|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
1540718|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1540719|NCT00617929|Burkitt lymphoma|burkitt lymphoma
1540720|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
1540721|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
1540722|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
1540723|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
1540724|NCT00617929|breast cancer|breast cancer
1540725|NCT00617929|follicular lymphoma|follicular lymphoma
1540726|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
1540727|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
1540728|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
1540729|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1540730|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1540731|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1540732|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1540733|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1540734|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1540735|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
1540736|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
1540737|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1540738|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1540739|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1540740|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1540741|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
1540742|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
1540743|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
1540744|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1540745|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1540746|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1540747|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1540748|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1540749|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1540750|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1540751|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1540752|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1540753|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1540754|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1540755|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1540756|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1540757|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1540758|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1540759|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1540760|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1540761|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
1540762|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
1540763|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
1540764|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1540765|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1540766|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1540767|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1540768|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1540769|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1540770|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1540771|NCT00617929|stage IV breast cancer|stage iv breast cancer
1540772|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1540773|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1540774|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1540775|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1540776|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1540777|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1540778|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1540779|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1540780|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1540781|NCT00617916|hyperspectral imaging|hyperspectral imaging
1540782|NCT00617916|tissue oxygenation|tissue oxygenation
1540783|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
1540784|NCT00617916|wound healing|wound healing
1540785|NCT00617916|prevention|prevention
1540787|NCT00617903|papulopustular|papulopustular
1540788|NCT00617903|azelaic acid|azelaic acid
1540789|NCT00617903|foam|foam
1540790|NCT00617890|anti-IGF-1R|anti-igf-1r
1540791|NCT00617851|Influenza|influenza
1540792|NCT00617851|adults|adults
1540793|NCT00617851|different lots|different lots
1540794|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
1540795|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
1540796|NCT00617838|Celiac disease|celiac disease
1540797|NCT00617838|genetic risk|genetic risk
1540798|NCT00617838|gluten introduction|gluten introduction
1540799|NCT00617838|predicting antibodies|predicting antibodies
1540800|NCT00617825|chronic venous disorders|chronic venous disorders
1540801|NCT00617825|cryotherapy|cryotherapy
1540802|NCT00617825|skin microcirculation|skin microcirculation
1540803|NCT00617825|skin temperature|skin temperature
1540804|NCT00617812|Vaccine|vaccine
1540805|NCT00617812|Prevention|prevention
1540806|NCT00617812|Diphtheria|diphtheria
1540807|NCT00617812|Tetanus|tetanus
1540808|NCT00617812|Pertussis|pertussis
1540809|NCT00617812|Hepatitis B|hepatitis b
1540810|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
1540811|NCT00617812|Healthy infants|healthy infants
1540812|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
1540813|NCT00617799|stage IV melanoma|stage iv melanoma
1540814|NCT00617786|urinary urgency|urinary urgency
1540815|NCT00617786|urinary frequency|urinary frequency
1540816|NCT00617786|urge incontinence|urge incontinence
1540817|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
1540818|NCT00617786|urgency|urgency
1540819|NCT00617786|frequency|frequency
1540820|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1540821|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1540822|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
1540823|NCT00617747|Zolmitriptan|zolmitriptan
1540824|NCT00617747|ZOMIG|zomig
1540825|NCT00617747|migraine|migraine
1540826|NCT00617747|headache response|headache response
1540827|NCT00617747|headache|headache
1540828|NCT00617747|headache pain|headache pain
1540829|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
1540830|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
1540831|NCT00617734|Cetuximab|cetuximab
1540832|NCT00617734|Erbitux|erbitux
1540833|NCT00617734|IMC-A12|imc-a12
1540834|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
1540835|NCT00617721|Scott syndrome,|scott syndrome,
1540836|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
1540837|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
1540838|NCT00617695|Zolmitriptan|zolmitriptan
1540839|NCT00617695|ZOMIG|zomig
1540840|NCT00617695|migraine|migraine
1540841|NCT00617695|headache response|headache response
1540842|NCT00617695|headache|headache
1540843|NCT00617695|headache pain|headache pain
1540844|NCT00617682|Maternal immunization|maternal immunization
1540845|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1540846|NCT00617682|Otitis media|otitis media
1540847|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
1540848|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
1540849|NCT00617669|Endothelin A|endothelin a
1540850|NCT00617669|Endothelin A antagonist|endothelin a antagonist
1540851|NCT00617656|LUNG CANCER|lung cancer
1540852|NCT00617643|Nevirapine|nevirapine
1540853|NCT00617643|Rifampicin|rifampicin
1540854|NCT00617643|Pharmacokinetics|pharmacokinetics
1540855|NCT00617617|isoflavones|isoflavones
1540857|NCT00617604|kidney transplant|kidney transplant
1540859|NCT00617591|Lenalidomide|lenalidomide
1540860|NCT00617591|Revlimid|revlimid
1540861|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1540862|NCT00617591|Doxil|doxil
1540863|NCT00617591|Dexamethasone|dexamethasone
1540864|NCT00617591|Decadron|decadron
1540865|NCT00617578|Antitachy pacing|antitachy pacing
1540866|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1540867|NCT00617552|postoperative ileus|postoperative ileus
1540868|NCT00617552|POI|poi
1540869|NCT00617552|major open abdominal surgery|major open abdominal surgery
1540870|NCT00617539|recurrent breast cancer|recurrent breast cancer
1540871|NCT00617539|stage IV breast cancer|stage iv breast cancer
1540872|NCT00617539|male breast cancer|male breast cancer
1540873|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
1540874|NCT00617526|HIV|hiv
1540875|NCT00617526|treatment naïve|treatment naïve
1540876|NCT00617500|climacteric|climacteric
1540877|NCT00617500|complementary therapy|complementary therapy
1540878|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
1540879|NCT00617474|erythropoietin|erythropoietin
1540880|NCT00617474|kidney allograft survival|kidney allograft survival
1540881|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
1540882|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
1540883|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
1540884|NCT00617461|Neuropathic pain|neuropathic pain
1540885|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
1540886|NCT00617448|Ligasure|ligasure
1540887|NCT00617448|randomized controlled trial|randomized controlled trial
1540888|NCT00617448|Postoperative pain|postoperative pain
1540889|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
1540890|NCT00617448|Local Anesthesia|local anesthesia
1540891|NCT00617448|Safety procedure long term|safety procedure long term
1540892|NCT00617448|Day Surgery|day surgery
1540893|NCT00617435|Trans fatty acid|trans fatty acid
1540894|NCT00617435|Insulin resistance|insulin resistance
1540895|NCT00617435|Skeletal muscle|skeletal muscle
1540896|NCT00617435|Adipose tissue|adipose tissue
1540897|NCT00617409|SCLC|sclc
1540898|NCT00617409|vaccine|vaccine
1540899|NCT00617409|immunize|immunize
1540900|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
1540901|NCT00617396|Seroquel|seroquel
1540902|NCT00617396|Abdominal Pain|abdominal pain
1540903|NCT00617383|demyelinating disease|demyelinating disease
1540904|NCT00617383|multiple sclerosis|multiple sclerosis
1540905|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
1540907|NCT00617383|non-concordant|non-concordant
1540908|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
1540909|NCT00617383|brain MRI|brain mri
1540910|NCT00617383|proteomics|proteomics
1540911|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
1540912|NCT00617370|EPIRUBICIN|epirubicin
1540913|NCT00617370|PEGFILGRASTIM|pegfilgrastim
1540914|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
1540915|NCT00617357|incisional hernia|incisional hernia
1540916|NCT00617357|abdominal hernia repair|abdominal hernia repair
1540917|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
1540918|NCT00617344|Dengue fever|dengue fever
1540919|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
1540920|NCT00617344|Dengue virus|dengue virus
1540921|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
1540922|NCT00617318|Pomegranate|pomegranate
1540923|NCT00617318|Influenza|influenza
1540924|NCT00617318|Common Cold|common cold
1540925|NCT00617318|Cough|cough
1540926|NCT00617318|Severity|severity
1540927|NCT00617318|Efficacy|efficacy
1540928|NCT00617305|ambrisentan|ambrisentan
1540929|NCT00617305|PAH|pah
1540930|NCT00617305|combination therapy|combination therapy
1540931|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
1540932|NCT00617305|cardiovascular|cardiovascular
1540933|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
1540934|NCT00617305|ERA|era
1540935|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
1540936|NCT00617292|21OHD|21ohd
1540937|NCT00617292|CAH|cah
1540938|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
1540939|NCT00617240|antipsychotic|antipsychotic
1540940|NCT00617240|metformin|metformin
1540941|NCT00617240|children|children
1540942|NCT00617240|adolescents|adolescents
1540943|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
1540944|NCT00617214|Schizophrenia|schizophrenia
1540945|NCT00617214|Integrated care program|integrated care program
1540946|NCT00617214|Seroquel|seroquel
1540947|NCT00617201|cocaine|cocaine
1540948|NCT00617201|dependence|dependence
1540949|NCT00617201|stimulants|stimulants
1540950|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1540951|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
1540952|NCT00617175|therapies reduction|therapies reduction
1540953|NCT00617175|Shocks|shocks
1540954|NCT00617175|Quality of Life|quality of life
1540955|NCT00617149|exercise,|exercise,
1541765|NCT00613535|Coblation|coblation
1540956|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
1540957|NCT00617136|Surgery|surgery
1540958|NCT00617136|Anesthesia|anesthesia
1540959|NCT00617136|Hypothermia|hypothermia
1540960|NCT00617136|Temperature|temperature
1540961|NCT00617136|Perioperative|perioperative
1540962|NCT00617136|Temperature Management|temperature management
1540963|NCT00617110|diesel exhaust particles|diesel exhaust particles
1540964|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
1540965|NCT00617110|flu vaccine|flu vaccine
1540966|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
1540967|NCT00617084|Drug Eluting Stents|drug eluting stents
1540968|NCT00617084|Interventional Cardiology|interventional cardiology
1540969|NCT00617071|colon cancer|colon cancer
1540970|NCT00617071|rectal cancer|rectal cancer
1540971|NCT00617058|antipsychotic|antipsychotic
1540972|NCT00617058|metformin|metformin
1540973|NCT00617058|children|children
1540974|NCT00617058|adolescents|adolescents
1540975|NCT00617045|Post Partum Depression|post partum depression
1540976|NCT00617006|Anesthesia Workspace|anesthesia workspace
1540977|NCT00617006|Hospital Acquired Infections|hospital acquired infections
1540978|NCT00617006|Hand Hygiene|hand hygiene
1540979|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
1540980|NCT00617006|Bacterial Contamination|bacterial contamination
1540981|NCT00616980|PAD|pad
1540982|NCT00616980|PVD|pvd
1540983|NCT00616980|CLI|cli
1540984|NCT00616980|Stem Cells|stem cells
1540985|NCT00616967|stage II breast cancer|stage ii breast cancer
1540986|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
1540987|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
1540988|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
1540989|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
1540990|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
1540991|NCT00616954|mismatched|mismatched
1540992|NCT00616954|Stem cell transplatation|stem cell transplatation
1540993|NCT00616954|Bone marrow transplantation|bone marrow transplantation
1540994|NCT00616954|T cell depletion|t cell depletion
1540995|NCT00616954|engraftment|engraftment
1540996|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
1540997|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
1540998|NCT00616941|Ovarian Cancer|ovarian cancer
1540999|NCT00616941|Cancer Vaccine|cancer vaccine
1541000|NCT00616928|vaccines|vaccines
1541001|NCT00616928|immunogenicity|immunogenicity
1541002|NCT00616928|human|human
1541003|NCT00616928|safety|safety
1541004|NCT00616928|influenza|influenza
1541005|NCT00616915|Wellbutrin SR|wellbutrin sr
1541006|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
1541007|NCT00616876|lactulose|lactulose
1541008|NCT00616876|prebiotic|prebiotic
1541009|NCT00616876|premature infant|premature infant
1541010|NCT00616876|enteral feeding|enteral feeding
1541011|NCT00616876|stools|stools
1541012|NCT00616876|lactobacillus|lactobacillus
1541013|NCT00616876|nutrition|nutrition
1541014|NCT00616876|growth|growth
1541015|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
1541016|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
1541017|NCT00616850|Femoral Block Catheter|femoral block catheter
1541018|NCT00616837|Remote consultation/*methods|remote consultation/*methods
1541019|NCT00616837|Orthopaedics methods|orthopaedics methods
1541020|NCT00616837|Telemedicine|telemedicine
1541021|NCT00616837|Follow-up study|follow-up study
1541022|NCT00616837|Ambulatory care|ambulatory care
1541023|NCT00616824|Acellular dermal matrix|acellular dermal matrix
1541024|NCT00616824|breast reconstruction|breast reconstruction
1541025|NCT00616824|tissue expander|tissue expander
1541026|NCT00616824|postoperative pain|postoperative pain
1541027|NCT00616824|complication|complication
1541028|NCT00616824|pain|pain
1541029|NCT00616824|patient satisfaction|patient satisfaction
1541030|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
1541031|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1541032|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1541033|NCT00616759|Depression|depression
1541034|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
1541035|NCT00616746|Alcohol, nicotine|alcohol, nicotine
1541036|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
1541037|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
1541038|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
1541039|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
1541040|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
1541041|NCT00616707|Inflammation|inflammation
1541042|NCT00616707|Oxidative Stress|oxidative stress
1541043|NCT00616707|Microalbuminuria|microalbuminuria
1541044|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
1541045|NCT00616655|Anxiety|anxiety
1541046|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
1541047|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1541048|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
1541049|NCT00616616|appendectomy|appendectomy
1541050|NCT00616616|cholecystectomy|cholecystectomy
1541051|NCT00616616|gastric banding|gastric banding
1541052|NCT00616616|adrenalectomy|adrenalectomy
1541053|NCT00616616|Gastric lap-band placement|gastric lap-band placement
1541054|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
1541055|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
1541056|NCT00616603|Dexamethasone.|dexamethasone.
1541057|NCT00616590|sleep disorders|sleep disorders
1541058|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1541059|NCT00616590|fatigue|fatigue
1541060|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1541061|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1541062|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1541063|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1541064|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1541065|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1541066|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1541067|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1541068|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1541069|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1541070|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1541071|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1541072|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1541073|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1541074|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1541075|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1541076|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1541077|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1541078|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1541079|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1541080|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1541081|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1541082|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1541083|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1541084|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1541085|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1541086|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1541087|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1541088|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1541089|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1541090|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1541091|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1541092|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1541093|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1541094|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1541095|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1541096|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1541097|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1541098|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1541099|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1541100|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1541101|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1541102|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1541103|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1541104|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1541105|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1541106|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1541107|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1541270|NCT00616018|non drinkers|non drinkers
1541108|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1541109|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1541110|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1541111|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1541112|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1541113|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1541114|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1541115|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1541116|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1541117|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1541118|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1541119|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1541120|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1541121|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1541122|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1541123|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1541124|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1541125|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1541126|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1541127|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1541128|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1541129|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1541130|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1541131|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1541132|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1541133|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1541134|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1541135|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1541136|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1541137|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1541138|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1541139|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1541140|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1541141|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1541142|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
1541143|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
1541144|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
1541145|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
1541146|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
1541147|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
1541148|NCT00616564|GM-CSF|gm-csf
1541149|NCT00616564|Interleukin|interleukin
1541150|NCT00616564|IL-2|il-2
1541151|NCT00616564|Sargrostim|sargrostim
1541152|NCT00616551|Acromegaly|acromegaly
1541153|NCT00616538|Atopic|atopic
1541154|NCT00616538|Dermatitis|dermatitis
1541155|NCT00616538|eczema|eczema
1541156|NCT00616538|skin barrier|skin barrier
1541157|NCT00616538|ceramide|ceramide
1541158|NCT00616538|topical|topical
1541159|NCT00616538|inflamation|inflamation
1541160|NCT00616538|steroid|steroid
1541161|NCT00616538|SCORAD|scorad
1541162|NCT00616538|glucocorticoids|glucocorticoids
1541163|NCT00616538|EpiCeram|epiceram
1541164|NCT00616538|Cutivate|cutivate
1541165|NCT00616538|fluticasone|fluticasone
1541166|NCT00616512|Water|water
1541167|NCT00616512|oral care|oral care
1541168|NCT00616512|oral hygiene|oral hygiene
1541169|NCT00616512|dysphagia|dysphagia
1541170|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
1541171|NCT00616512|thickened liquids|thickened liquids
1541872|NCT00613132|RAD0001|rad0001
1541172|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1541173|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
1541174|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1541175|NCT00616499|large cell lung cancer|large cell lung cancer
1541176|NCT00616460|safety|safety
1541177|NCT00616460|efficacy|efficacy
1541178|NCT00616421|vaccine|vaccine
1541179|NCT00616421|children|children
1541180|NCT00616421|healthy|healthy
1541181|NCT00616421|meningitis|meningitis
1541182|NCT00616421|meningococcal|meningococcal
1541183|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
1541184|NCT00616421|Menveo|menveo
1541185|NCT00616408|GH|gh
1541186|NCT00616408|IGF-I|igf-i
1541187|NCT00616408|GH-secreting tumors|gh-secreting tumors
1541188|NCT00616408|Octreotide|octreotide
1541189|NCT00616395|Infant Nutrition|infant nutrition
1541190|NCT00616395|Soy Phytochemicals|soy phytochemicals
1541191|NCT00616395|Infant Body Composition|infant body composition
1541192|NCT00616395|Brain Function|brain function
1541193|NCT00616395|Cognition and Development|cognition and development
1541194|NCT00616395|Healthy Infants|healthy infants
1541195|NCT00616382|PDA|pda
1541196|NCT00616382|indomethacin|indomethacin
1541197|NCT00616382|pentoxifylline|pentoxifylline
1541198|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
1541199|NCT00616369|pulmonary hypertension|pulmonary hypertension
1541200|NCT00616369|hypertension|hypertension
1541201|NCT00616369|cardiomyopathy|cardiomyopathy
1541202|NCT00616369|arrhythmias|arrhythmias
1541203|NCT00616356|Yellow Fever|yellow fever
1541204|NCT00616343|ET|et
1541205|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
1541206|NCT00616304|severe falciparum malaria|severe falciparum malaria
1541207|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
1541208|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
1541209|NCT00616278|Growth Failure AND|growth failure and
1541210|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
1541211|NCT00616278|End Stage Renal Disease|end stage renal disease
1541212|NCT00616265|Sleep apnea|sleep apnea
1541213|NCT00616265|Refractory Hypertension|refractory hypertension
1541214|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
1541215|NCT00616265|CPAP|cpap
1541216|NCT00616252|Antiretroviral|antiretroviral
1541217|NCT00616252|Pharmacokinetics|pharmacokinetics
1541218|NCT00616252|Pregnancy|pregnancy
1541219|NCT00616239|Melasma|melasma
1541220|NCT00616239|Dark spots on the face|dark spots on the face
1541221|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1541222|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
1541223|NCT00616174|Cesarean delivery|cesarean delivery
1541224|NCT00616174|Active Warming|active warming
1541225|NCT00616174|Neonatal Temperature|neonatal temperature
1541226|NCT00616161|Acute Heart Failure|acute heart failure
1541227|NCT00616161|Inotropes|inotropes
1541228|NCT00616161|Lusitropic agents|lusitropic agents
1541229|NCT00616161|Istaroxime|istaroxime
1541231|NCT00616148|Epilepsy|epilepsy
1541232|NCT00616148|Seizures|seizures
1541233|NCT00616135|Breast|breast
1541234|NCT00616135|Stem Cell|stem cell
1541235|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
1541236|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
1541237|NCT00616135|ADRC|adrc
1541238|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
1541239|NCT00616135|Breast Reconstruction|breast reconstruction
1541240|NCT00616135|Cancer|cancer
1541241|NCT00616135|Carcinoma|carcinoma
1541242|NCT00616135|Autologous fat transplantation|autologous fat transplantation
1541243|NCT00616135|Autologous fat|autologous fat
1541244|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
1541245|NCT00616135|Functional breast deformity|functional breast deformity
1541246|NCT00616135|Lumpectomy|lumpectomy
1541247|NCT00616135|Segmental mastectomy|segmental mastectomy
1541248|NCT00616135|Quadrantectomy|quadrantectomy
1541249|NCT00616135|breast conservation therapy|breast conservation therapy
1541250|NCT00616122|recurrent breast cancer|recurrent breast cancer
1541251|NCT00616122|stage IV breast cancer|stage iv breast cancer
1541252|NCT00616122|male breast cancer|male breast cancer
1541253|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
1541254|NCT00616083|Breast Feeding|breast feeding
1541255|NCT00616083|Body Composition|body composition
1541256|NCT00616083|Body Fat|body fat
1541257|NCT00616083|Infant|infant
1541258|NCT00616083|Diet|diet
1541259|NCT00616083|Healthy Infants|healthy infants
1541260|NCT00616057|fructans supplementation|fructans supplementation
1541261|NCT00616044|Spinal Anesthesia|spinal anesthesia
1541262|NCT00616044|Epidural Anesthesia|epidural anesthesia
1541263|NCT00616044|Orthopedic procedures|orthopedic procedures
1541264|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1541265|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1541266|NCT00616018|acetaminophen|acetaminophen
1541267|NCT00616018|protein adducts|protein adducts
1541268|NCT00616018|hepatic function|hepatic function
1541271|NCT00616005|Glioblastoma|glioblastoma
1541272|NCT00616005|GBM|gbm
1541273|NCT00616005|Brain tumor|brain tumor
1541274|NCT00616005|Temodar|temodar
1541275|NCT00616005|Temozolomide|temozolomide
1541276|NCT00616005|Irinotecan|irinotecan
1541277|NCT00616005|CPT-11|cpt-11
1541278|NCT00616005|Camptosar|camptosar
1541279|NCT00616005|Malignant glioma|malignant glioma
1541280|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
1541281|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
1541282|NCT00615979|trauma|trauma
1541283|NCT00615979|portable ultrasound|portable ultrasound
1541284|NCT00615979|telemedicine|telemedicine
1541285|NCT00615979|Department of Defense|department of defense
1541286|NCT00615966|kidney transplantation|kidney transplantation
1541287|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
1541288|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
1541289|NCT00615940|HER2negative|her2negative
1541290|NCT00615927|Glioblastoma|glioblastoma
1541291|NCT00615927|Gliosarcoma|gliosarcoma
1541292|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1541293|NCT00615927|GBM|gbm
1541294|NCT00615927|Imatinib Mesylate|imatinib mesylate
1541295|NCT00615927|Gleevec|gleevec
1541296|NCT00615927|Hydroxyurea|hydroxyurea
1541297|NCT00615927|Droxia|droxia
1541298|NCT00615927|Hydrea|hydrea
1541299|NCT00615927|Hydroxycarbamide|hydroxycarbamide
1541300|NCT00615927|Imatinib|imatinib
1541301|NCT00615927|Brain tumor|brain tumor
1541302|NCT00615927|Malignant brain tumor|malignant brain tumor
1541303|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1541304|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
1541305|NCT00615901|cyclophosphamide|cyclophosphamide
1541306|NCT00615901|methotrexate|methotrexate
1541307|NCT00615901|fluorouracil|fluorouracil
1541308|NCT00615901|PEG-filgrastim|peg-filgrastim
1541309|NCT00615888|elective open repair|elective open repair
1541310|NCT00615888|complications|complications
1541311|NCT00615888|morbidity and mortality|morbidity and mortality
1541312|NCT00615888|fast track patient management|fast track patient management
1541313|NCT00615875|naproxen|naproxen
1541314|NCT00615875|acute pain|acute pain
1541315|NCT00615875|postoperative pain|postoperative pain
1541316|NCT00615875|thoracic surgery|thoracic surgery
1541317|NCT00615875|head and neck surgery|head and neck surgery
1541318|NCT00615875|opiate sparing|opiate sparing
1541319|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
1541320|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
1541321|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1541322|NCT00615810|LDL|ldl
1541323|NCT00615810|HDL|hdl
1541324|NCT00615810|triglycerides|triglycerides
1541325|NCT00615810|non HDL cholesterol|non hdl cholesterol
1541326|NCT00615810|cholesterol|cholesterol
1541327|NCT00615810|HIV 1|hiv 1
1541328|NCT00615810|Metabolic parameters|metabolic parameters
1541329|NCT00615810|treatment experienced|treatment experienced
1541330|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
1541332|NCT00615784|Bexarotene|bexarotene
1541333|NCT00615758|Erlotinib|erlotinib
1541334|NCT00615758|Biological therapy|biological therapy
1541335|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
1541336|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
1541337|NCT00615745|treatment experienced|treatment experienced
1541338|NCT00615732|qigong|qigong
1541339|NCT00615732|traditional chinese medicine|traditional chinese medicine
1541340|NCT00615732|exercise therapy|exercise therapy
1541341|NCT00615732|neck pain|neck pain
1541342|NCT00615719|Chest Pain|chest pain
1541343|NCT00615719|Coronary Angiography|coronary angiography
1541344|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
1541345|NCT00615719|Computed Tomography|computed tomography
1541346|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
1541347|NCT00615693|Uveitis|uveitis
1541348|NCT00615693|Macular Edema|macular edema
1541349|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
1541350|NCT00615667|Tacrolimus|tacrolimus
1541351|NCT00615654|Hydrotherapy,|hydrotherapy,
1541352|NCT00615654|RCT,|rct,
1541353|NCT00615641|Children|children
1541354|NCT00615641|Nutrition|nutrition
1541355|NCT00615641|Body Fat|body fat
1541356|NCT00615641|Physical Activity|physical activity
1541357|NCT00615641|Diet|diet
1541358|NCT00615641|Childhood Obesity|childhood obesity
1541359|NCT00615641|Healthy Children|healthy children
1541360|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
1541361|NCT00615615|Levetiracetam|levetiracetam
1541362|NCT00615615|Keppra|keppra
1541363|NCT00615602|Early breast cancer|early breast cancer
1541364|NCT00615602|Axillary node positive|axillary node positive
1541365|NCT00615602|HER2 overexpression|her2 overexpression
1541366|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
1541367|NCT00615602|Dose dense|dose dense
1541368|NCT00615602|Docetaxel|docetaxel
1541369|NCT00615602|Trastuzumab|trastuzumab
1541370|NCT00615602|FEC|fec
1541462|NCT00615160|Metastatic melanoma|metastatic melanoma
1541371|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
1541372|NCT00615589|high risk|high risk
1541373|NCT00615589|relapse|relapse
1541374|NCT00615589|persistent|persistent
1541375|NCT00615576|Smoker,|smoker,
1541376|NCT00615576|Male,|male,
1541377|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
1541378|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
1541379|NCT00615576|Healthy Volunteer,|healthy volunteer,
1704067|NCT00040885|fatigue|fatigue
1541380|NCT00615550|Preterm|preterm
1541381|NCT00615550|Cervix|cervix
1541382|NCT00615537|Thyroid Nodule|thyroid nodule
1541383|NCT00615537|Thyroid Cancer|thyroid cancer
1541384|NCT00615537|Laser Ablation|laser ablation
1541385|NCT00615537|LITT|litt
1541386|NCT00615537|Nodular Goiter|nodular goiter
1541387|NCT00615537|Thyroid Mass|thyroid mass
1541388|NCT00615524|Breast cancer|breast cancer
1541389|NCT00615524|Advanced|advanced
1541390|NCT00615524|Metastatic|metastatic
1541391|NCT00615524|Pazopanib|pazopanib
1541392|NCT00615524|GW786034|gw786034
1541393|NCT00615524|Exemestane|exemestane
1541394|NCT00615524|Efficacy|efficacy
1541395|NCT00615524|Tolerability|tolerability
1541396|NCT00615524|Health-Related Quality of Life|health-related quality of life
1541397|NCT00615511|schizophrenia|schizophrenia
1541398|NCT00615511|schizoaffective disorder|schizoaffective disorder
1541399|NCT00615511|negative symptoms|negative symptoms
1541400|NCT00615511|cognition|cognition
1541401|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
1541402|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
1541403|NCT00615472|Parkinson's Disease|parkinson's disease
1541404|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
1541405|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
1541406|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
1541407|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
1541408|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
1541409|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
1541410|NCT00615433|Schizophrenia|schizophrenia
1541411|NCT00615433|Latuda|latuda
1541412|NCT00615433|Lurasidone|lurasidone
1541413|NCT00615420|Mucositis|mucositis
1541414|NCT00615420|Radiation|radiation
1541415|NCT00615420|Honey|honey
1541416|NCT00615407|Asthma, alcohol|asthma, alcohol
1541417|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
1541418|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
1541419|NCT00615381|Craniotomy|craniotomy
1541420|NCT00615381|Insulin|insulin
1541421|NCT00615381|Neuropsychology|neuropsychology
1541422|NCT00615368|Type 1 diabetes|type 1 diabetes
1541423|NCT00615368|Hypoglycaemia|hypoglycaemia
1541424|NCT00615368|Cognitive function|cognitive function
1541425|NCT00615368|Erythropoietin|erythropoietin
1541426|NCT00615355|vitiligo|vitiligo
1541427|NCT00615355|narrow-band UVB|narrow-band uvb
1541428|NCT00615355|ReCell|recell
1541429|NCT00615355|transplantation|transplantation
1541430|NCT00615355|laser|laser
1541431|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
1541432|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
1541433|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
1541434|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
1541435|NCT00615277|Young adults|young adults
1541436|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
1541437|NCT00615277|Cognitive function|cognitive function
1541438|NCT00615277|Mood|mood
1541439|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
1541440|NCT00615251|In vitro fertilization|in vitro fertilization
1541441|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
1541442|NCT00615225|brain death|brain death
1541443|NCT00615225|inflammation|inflammation
1541444|NCT00615225|endotoxin|endotoxin
1541445|NCT00615225|transplantation|transplantation
1541446|NCT00615225|graft|graft
1541447|NCT00615225|apoptosis|apoptosis
1541448|NCT00615225|Systemic inflammatory response|systemic inflammatory response
1541449|NCT00615225|Apoptosis activation|apoptosis activation
1541450|NCT00615225|Graft outcome|graft outcome
1541451|NCT00615212|Healthy Subjects,|healthy subjects,
1541452|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
1541453|NCT00615212|Repeat Dose|repeat dose
1541454|NCT00615212|GSK376501,|gsk376501,
1541455|NCT00615186|Neuradiab|neuradiab
1541456|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
1541457|NCT00615186|Anti-tenascin|anti-tenascin
1541458|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
1541459|NCT00615186|Survival|survival
1541460|NCT00615173|Tacrolimus|tacrolimus
1541461|NCT00615173|lupus nephritis|lupus nephritis
1541763|NCT00613535|Crepitus|crepitus
1541463|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
1541464|NCT00615147|Any cancer|any cancer
1541465|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
1541466|NCT00615134|treatment experienced|treatment experienced
1541467|NCT00615121|Smoking|smoking
1541468|NCT00615121|Hypertension|hypertension
1541469|NCT00615121|Diabetes|diabetes
1541470|NCT00615121|Cardiovascular disease|cardiovascular disease
1541471|NCT00615121|Renal Failure|renal failure
1541472|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
1541474|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
1541475|NCT00615017|Sepsis|sepsis
1541476|NCT00615017|septic shock|septic shock
1541477|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1541478|NCT00615004|Acromegaly|acromegaly
1541479|NCT00615004|GH|gh
1541480|NCT00615004|IGF-I|igf-i
1541481|NCT00615004|Octreotide-LAR|octreotide-lar
1541482|NCT00615004|Lanreotide|lanreotide
1541483|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
1541484|NCT00614991|Healthy Subjects|healthy subjects
1541485|NCT00614991|Pharmacokinetics study|pharmacokinetics study
1541486|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
1541487|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
1541488|NCT00614965|Cancer|cancer
1541489|NCT00614965|NSCLC|nsclc
1541490|NCT00614965|second-line chemotherapy|second-line chemotherapy
1541491|NCT00614965|irinotecan|irinotecan
1541492|NCT00614965|pemetrexed|pemetrexed
1541493|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
1541494|NCT00614939|HbA1c|hba1c
1541495|NCT00614939|incretins|incretins
1541496|NCT00614939|Renal Impairment|renal impairment
1541497|NCT00614926|Fatigue|fatigue
1541498|NCT00614926|low energy|low energy
1541499|NCT00614926|ALS|als
1541500|NCT00614926|treatment|treatment
1541501|NCT00614913|Proton|proton
1541502|NCT00614913|Radiotherapy|radiotherapy
1541503|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
1541504|NCT00614913|Liver Cancer|liver cancer
1541505|NCT00614900|COPD|copd
1541506|NCT00614900|pulmonary hypertension|pulmonary hypertension
1541507|NCT00614900|NT-proBNP|nt-probnp
1541508|NCT00614900|6 minutes walk test|6 minutes walk test
1541509|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
1541510|NCT00614887|Pituitary gland|pituitary gland
1541511|NCT00614887|Adrenal gland|adrenal gland
1541512|NCT00614874|Asthma|asthma
1541513|NCT00614874|Avandia|avandia
1541514|NCT00614861|Non-cancer pain|non-cancer pain
1541515|NCT00614861|Pain|pain
1541516|NCT00614848|restenosis|restenosis
1541517|NCT00614835|Gemcitabine|gemcitabine
1541518|NCT00614835|Docetaxel|docetaxel
1541519|NCT00614835|uterine sarcoma|uterine sarcoma
1541520|NCT00614809|gefitinib|gefitinib
1541521|NCT00614809|brain metastasis|brain metastasis
1541522|NCT00614796|COPD|copd
1541523|NCT00614796|Lifestyle|lifestyle
1541524|NCT00614796|Pedometer|pedometer
1541525|NCT00614783|Screening|screening
1541526|NCT00614770|colonoscopy|colonoscopy
1541527|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
1541528|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
1541529|NCT00614744|Hypothermia|hypothermia
1541530|NCT00614744|Neonatal depression|neonatal depression
1541531|NCT00614744|Perinatal asphyxia|perinatal asphyxia
1541532|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
1541533|NCT00614731|KLH|klh
1541534|NCT00614731|atopic dermatitis|atopic dermatitis
1541535|NCT00614731|IgG antibodies|igg antibodies
1541536|NCT00614731|scarification|scarification
1541537|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1541538|NCT00614718|lead failure|lead failure
1541539|NCT00614718|pace/sense lead|pace/sense lead
1541540|NCT00614718|ICD complication|icd complication
1541541|NCT00614718|inappropriate therapy|inappropriate therapy
1541542|NCT00614718|Defibrillators|defibrillators
1541543|NCT00614679|biofilm|biofilm
1541544|NCT00614679|catheter lock solution|catheter lock solution
1541545|NCT00614679|catheter salvage|catheter salvage
1541546|NCT00614666|coccidioidomycosis|coccidioidomycosis
1541547|NCT00614666|Valley Fever|valley fever
1541548|NCT00614666|nikkomycin Z|nikkomycin z
1541549|NCT00614653|Pancreatic Cancer|pancreatic cancer
1541550|NCT00614653|Bevacizumab|bevacizumab
1541551|NCT00614653|Avastin™|avastin™
1541552|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1541553|NCT00614653|rhuMAb-VEGF|rhumab-vegf
1541554|NCT00614653|Erlotinib|erlotinib
1541555|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
1541556|NCT00614653|Tarceva|tarceva
1541557|NCT00614653|OSI-774|osi-774
1541558|NCT00614653|Capecitabine|capecitabine
1541559|NCT00614653|Xeloda|xeloda
1541560|NCT00614640|HAART|haart
1541561|NCT00614640|Therapeutic vaccine|therapeutic vaccine
1541562|NCT00614614|Meningococcal disease|meningococcal disease
1541563|NCT00614614|Toddlers|toddlers
1541564|NCT00614614|Neisseria meningitidis|neisseria meningitidis
1541565|NCT00614614|Meningococcal vaccines|meningococcal vaccines
1541566|NCT00614614|Immunogenicity|immunogenicity
1541567|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
1541568|NCT00614614|Safety|safety
1541569|NCT00614614|Vaccines, conjugate|vaccines, conjugate
1541570|NCT00614614|Booster vaccination|booster vaccination
1541571|NCT00614601|pancreatic cancer|pancreatic cancer
1541572|NCT00614601|vaccine therapy|vaccine therapy
1541573|NCT00614588|temperature|temperature
1541574|NCT00614588|monitor|monitor
1541575|NCT00614588|surgery|surgery
1541576|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
1541577|NCT00614549|Levetiracetam|levetiracetam
1541578|NCT00614549|Keppra|keppra
1541579|NCT00614549|Epilepsy|epilepsy
1541580|NCT00614549|Efficacy|efficacy
1541581|NCT00614549|Safety|safety
1541582|NCT00614536|Reflux Symptom Index|reflux symptom index
1541583|NCT00614536|Reflux Finding Score|reflux finding score
1541584|NCT00614536|Rabeprazole|rabeprazole
1541585|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
1541586|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
1541587|NCT00614523|MDS|mds
1541588|NCT00614523|Low Risk MDS|low risk mds
1541589|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
1541590|NCT00614523|Thrombocytopenia|thrombocytopenia
1541591|NCT00614484|Proton|proton
1541592|NCT00614484|Radiation|radiation
1541593|NCT00614458|latent HIV|latent hiv
1541594|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
1541595|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
1541596|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
1541597|NCT00614458|HIV replication|hiv replication
1541598|NCT00614458|treatment experienced|treatment experienced
1541599|NCT00614445|Nausea|nausea
1541600|NCT00614445|Vomiting|vomiting
1541601|NCT00614445|Pregnancy|pregnancy
1541602|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
1541603|NCT00614445|Pregnancy complications|pregnancy complications
1541604|NCT00614432|anticoagulation|anticoagulation
1541605|NCT00614432|surgical abortion|surgical abortion
1541606|NCT00614419|Hernioplasty|hernioplasty
1541607|NCT00614419|polypropylene|polypropylene
1541608|NCT00614419|extracellular matrix|extracellular matrix
1541609|NCT00614419|xenograft|xenograft
1541610|NCT00614406|Celebrex|celebrex
1541611|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
1541612|NCT00614406|ovulation|ovulation
1541613|NCT00614406|menstrual cycles|menstrual cycles
1541614|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
1541615|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
1541616|NCT00614341|diabetes mellitus|diabetes mellitus
1541617|NCT00614341|neuropathy|neuropathy
1541618|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
1541619|NCT00614341|pulsed electric fild|pulsed electric fild
1541620|NCT00614328|Alcohol|alcohol
1541621|NCT00614328|Alcohol Abuse|alcohol abuse
1541622|NCT00614328|Alcohol Drinking|alcohol drinking
1541623|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
1541624|NCT00614289|Hand Eczema|hand eczema
1541625|NCT00614276|Sexual Dysfunction|sexual dysfunction
1541626|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
1541627|NCT00614276|Female Cancer Survivors|female cancer survivors
1541628|NCT00614276|Tendrils|tendrils
1541629|NCT00614276|Website program|website program
1541630|NCT00614276|Self-help tool|self-help tool
1541631|NCT00614276|Sexual counseling|sexual counseling
1541632|NCT00614276|Questionnaires|questionnaires
1541633|NCT00614263|Colonoscopy|colonoscopy
1541634|NCT00614263|Sedation levels|sedation levels
1541635|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
1541636|NCT00614211|Cervix|cervix
1541637|NCT00614211|Cervical|cervical
1541638|NCT00614211|Cancer|cancer
1541639|NCT00614211|Carcinoma|carcinoma
1541640|NCT00614211|Radical hysterectomy|radical hysterectomy
1541641|NCT00614211|Hysterectomy|hysterectomy
1541642|NCT00614211|Laparoscopy|laparoscopy
1541643|NCT00614211|Laparoscopic|laparoscopic
1541644|NCT00614211|Robotic|robotic
1541645|NCT00614211|Squamous Cell|squamous cell
1541646|NCT00614211|Adenosquamous|adenosquamous
1541647|NCT00614211|Adenocarcinoma|adenocarcinoma
1541648|NCT00614211|Lymphatic Mapping|lymphatic mapping
1541649|NCT00614211|IOLM|iolm
1541650|NCT00614211|SPECT|spect
1541651|NCT00614211|Sentinel Node|sentinel node
1541652|NCT00614211|Uterine cervix|uterine cervix
1541653|NCT00614198|autism|autism
1541654|NCT00614198|autism spectrum disorder|autism spectrum disorder
1541655|NCT00614198|diet|diet
1541656|NCT00614198|gluten|gluten
1541657|NCT00614198|casein|casein
1541658|NCT00614198|intervention|intervention
1541659|NCT00614198|peptide|peptide
1541660|NCT00614198|randomised|randomised
1541661|NCT00614198|controlled|controlled
1541662|NCT00614198|adaptive design|adaptive design
1541663|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
1541664|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
1541665|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
1541764|NCT00613535|Stability|stability
1541666|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
1541667|NCT00614172|Proton|proton
1541668|NCT00614172|Radiation|radiation
1541669|NCT00614172|Breast cancer|breast cancer
1541670|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
1541671|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
1541672|NCT00614133|protein metabolism|protein metabolism
1541673|NCT00614133|surgery|surgery
1541674|NCT00614133|parenteral nutrition|parenteral nutrition
1541675|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
1541676|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
1541677|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
1541678|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
1541679|NCT00614081|Renal transplant recipients|renal transplant recipients
1541680|NCT00614068|Treatment|treatment
1541681|NCT00614068|PTSD|ptsd
1541682|NCT00614042|CLL|cll
1541683|NCT00614042|NHL|nhl
1541684|NCT00614042|TRU-016|tru-016
1541685|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1541686|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1541687|NCT00614029|sumatriptan|sumatriptan
1541688|NCT00614029|Injections|injections
1541689|NCT00614029|Subcutaneous|subcutaneous
1541690|NCT00614016|healthy volunteers|healthy volunteers
1541691|NCT00614003|decisional conflict;|decisional conflict;
1541692|NCT00614003|decision quality;|decision quality;
1541693|NCT00614003|place of end of life care;|place of end of life care;
1541694|NCT00614003|provider education|provider education
1541695|NCT00613977|fetal lung maturity|fetal lung maturity
1541696|NCT00613977|lamellar body count|lamellar body count
1541697|NCT00613964|Natriuretic Peptides|natriuretic peptides
1541698|NCT00613964|Heart Failure|heart failure
1541699|NCT00613964|Renal Failure|renal failure
1541700|NCT00613938|Acute pain|acute pain
1541701|NCT00613938|bunionectomy|bunionectomy
1541702|NCT00613938|tapentadol|tapentadol
1541703|NCT00613925|endometrial biopsy|endometrial biopsy
1541704|NCT00613925|pain management|pain management
1541705|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
1541706|NCT00613899|home care|home care
1541707|NCT00613899|home rehabilitation|home rehabilitation
1541708|NCT00613899|telemedicine|telemedicine
1541709|NCT00613899|ALS|als
1541710|NCT00613886|NPH|nph
1541711|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
1541712|NCT00613873|colonoscopy|colonoscopy
1541713|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
1541714|NCT00613847|PET Scan|pet scan
1541715|NCT00613847|Invasive Solid Tumors|invasive solid tumors
1541716|NCT00613834|Essure sterilization|essure sterilization
1541717|NCT00613834|pain management|pain management
1541718|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
1541719|NCT00613821|surgical abortion|surgical abortion
1541720|NCT00613821|pain management|pain management
1541722|NCT00613808|leg|leg
1541723|NCT00613808|ulcer|ulcer
1541724|NCT00613795|pneumonia|pneumonia
1541725|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
1541726|NCT00613795|probiotics|probiotics
1541727|NCT00613795|Lactobacillus GG|lactobacillus gg
1541728|NCT00613769|Surgical site infections|surgical site infections
1541729|NCT00613717|iron deficiency anemia|iron deficiency anemia
1541730|NCT00613717|iron deficiency|iron deficiency
1541731|NCT00613717|infant|infant
1541732|NCT00613717|development|development
1541733|NCT00613717|behavior|behavior
1541734|NCT00613691|Refractory|refractory
1541735|NCT00613691|Progressive|progressive
1541736|NCT00613678|pain|pain
1541737|NCT00613678|activities of daily living|activities of daily living
1541738|NCT00613678|symptoms|symptoms
1541739|NCT00613678|self-management|self-management
1541740|NCT00613652|solid tumors|solid tumors
1541741|NCT00613652|solid malignancies|solid malignancies
1541742|NCT00613626|Extensive Stage|extensive stage
1541743|NCT00613626|Untreated|untreated
1541744|NCT00613600|Safety|safety
1541745|NCT00613600|Efficacy|efficacy
1541746|NCT00613600|Glucomannan|glucomannan
1541747|NCT00613600|Dietary fiber|dietary fiber
1541748|NCT00613600|Weight loss|weight loss
1541749|NCT00613587|Interleukin 13|interleukin 13
1541750|NCT00613587|Interleukin 4|interleukin 4
1541751|NCT00613587|Leukotrienes|leukotrienes
1541752|NCT00613587|Basophil Histamine Release|basophil histamine release
1541753|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
1541754|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
1541755|NCT00613548|Moderate|moderate
1541756|NCT00613548|Mitral|mitral
1541757|NCT00613548|Regurgitation|regurgitation
1541758|NCT00613548|CABG|cabg
1541759|NCT00613535|Partial Meniscectomy|partial meniscectomy
1541760|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
1541761|NCT00613535|MR Imaging|mr imaging
1541762|NCT00613535|Mechanical Debridement|mechanical debridement
1541766|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
1541767|NCT00613535|Debridement|debridement
1541768|NCT00613535|Recurrent Knee Pain|recurrent knee pain
1541769|NCT00613535|meniscectomy|meniscectomy
1541770|NCT00613535|meniscus|meniscus
1541771|NCT00613535|cartilage lesion|cartilage lesion
1541772|NCT00613535|articular cartilage lesion|articular cartilage lesion
1541773|NCT00613535|articular cartilage|articular cartilage
1541774|NCT00613535|knee|knee
1541775|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
1541776|NCT00613509|Melanoma, Cancer|melanoma, cancer
1541777|NCT00613496|Atrial Fibrillation|atrial fibrillation
1541778|NCT00613496|irbesartan|irbesartan
1541779|NCT00613496|AT-II-antagonist|at-ii-antagonist
1541780|NCT00613496|Adhesion Molecules|adhesion molecules
1541781|NCT00613496|oxidative stress markers|oxidative stress markers
1541782|NCT00613496|hsCRP|hscrp
1541783|NCT00613496|ICAM|icam
1541784|NCT00613496|VCAM|vcam
1541785|NCT00613496|MCP-1|mcp-1
1541786|NCT00613496|vWF|vwf
1541787|NCT00613496|TGFβ1|tgfβ1
1541788|NCT00613496|TNF-α|tnf-α
1541789|NCT00613496|Interleukin-6|interleukin-6
1541790|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
1541791|NCT00613470|Depression|depression
1541792|NCT00613470|Antidepressants|antidepressants
1541793|NCT00613444|Acne|acne
1541794|NCT00613444|laser|laser
1541795|NCT00613431|pharmacodynamics|pharmacodynamics
1541796|NCT00613405|substance-related disorders|substance-related disorders
1541797|NCT00613392|antioxidant|antioxidant
1541798|NCT00613392|oxidant stress|oxidant stress
1541799|NCT00613392|trauma|trauma
1541800|NCT00613392|free radical|free radical
1541801|NCT00613379|HIV|hiv
1541802|NCT00613379|treatment naïve|treatment naïve
1541803|NCT00613366|intrauterine device|intrauterine device
1541804|NCT00613366|cervical dilation|cervical dilation
1541805|NCT00613366|nulliparous women|nulliparous women
1541806|NCT00613366|pain management|pain management
1541807|NCT00613353|Female|female
1541808|NCT00613340|Cervical pain|cervical pain
1541809|NCT00613340|Zygapophysial joint|zygapophysial joint
1541810|NCT00613340|Specificity|specificity
1541811|NCT00613327|Overactive bladder|overactive bladder
1541812|NCT00613327|Oxybutynin chloride|oxybutynin chloride
1541813|NCT00613327|OROS|oros
1541814|NCT00613288|acute|acute
1541815|NCT00613288|testosterone|testosterone
1541816|NCT00613288|experimental|experimental
1541817|NCT00613288|hypogonadism|hypogonadism
1541818|NCT00613288|lipolysis|lipolysis
1541819|NCT00613288|insulin sensitivity|insulin sensitivity
1541820|NCT00613288|protein|protein
1541821|NCT00613288|metabolism|metabolism
1541822|NCT00613288|Experimental hypogonadism|experimental hypogonadism
1541823|NCT00613288|Testosterone substitution|testosterone substitution
1541824|NCT00613275|PNRP|pnrp
1541825|NCT00613275|Navigation|navigation
1541826|NCT00613275|Navigator|navigator
1541827|NCT00613275|Activation|activation
1541828|NCT00613275|Disparities|disparities
1541829|NCT00613275|Primary Care|primary care
1541830|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
1541831|NCT00613262|Narrow Band Imaging|narrow band imaging
1541832|NCT00613249|HIV-1 Infection|hiv-1 infection
1541833|NCT00613249|HIV Seronegativity|hiv seronegativity
1541834|NCT00613223|Malignant Gliomas|malignant gliomas
1541835|NCT00613223|Etopophos|etopophos
1541836|NCT00613223|Toposar|toposar
1541837|NCT00613223|VePesid|vepesid
1541838|NCT00613223|Etoposide|etoposide
1541839|NCT00613223|Vandetanib|vandetanib
1541840|NCT00613223|Zactima|zactima
1541841|NCT00613223|ZD6474|zd6474
1541842|NCT00613223|VP-16|vp-16
1541843|NCT00613223|Brain Tumor|brain tumor
1541844|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
1541845|NCT00613223|Gliosarcoma|gliosarcoma
1541846|NCT00613223|Glioblastoma|glioblastoma
1541847|NCT00613223|Glioma|glioma
1541848|NCT00613223|Malignant Glioma|malignant glioma
1541849|NCT00613223|GBM|gbm
1541850|NCT00613210|preterm delivery|preterm delivery
1541851|NCT00613210|shory cervix|shory cervix
1541852|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
1541853|NCT00613210|uterine artery doppler|uterine artery doppler
1541854|NCT00613210|singeltone|singeltone
1541855|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
1541856|NCT00613210|without rupter of membranes|without rupter of membranes
1542091|NCT00612638|CPT-11|cpt-11
1541857|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
1541858|NCT00613197|Crohn's Disease|crohn's disease
1541859|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
1541860|NCT00613184|Bronchiolitis|bronchiolitis
1541861|NCT00613184|Pediatric|pediatric
1541862|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
1541863|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
1541864|NCT00613145|Refractory Malignancy|refractory malignancy
1541865|NCT00613145|Phase I|phase i
1541866|NCT00613145|Sorafenib|sorafenib
1541867|NCT00613145|Capecitabine|capecitabine
1541868|NCT00613132|Glioblastoma|glioblastoma
1541869|NCT00613132|Gliosarcoma|gliosarcoma
1541870|NCT00613132|GBM|gbm
1541871|NCT00613132|Brain tumor|brain tumor
1541873|NCT00613132|Hydroxyurea|hydroxyurea
1541874|NCT00613132|Gleevec|gleevec
1541875|NCT00613132|Imatinib|imatinib
1541876|NCT00613132|Droxia|droxia
1541877|NCT00613132|Everolimus|everolimus
1541878|NCT00613132|Hydrea|hydrea
1541879|NCT00613132|Hydroxycarbamide|hydroxycarbamide
1541880|NCT00613132|Recurrent GBM|recurrent gbm
1541881|NCT00613132|Imatinib mesylate|imatinib mesylate
1541882|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
1541883|NCT00613119|Inflammation|inflammation
1541884|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
1541885|NCT00613119|Dementia|dementia
1541886|NCT00613119|PBR28|pbr28
1541887|NCT00613119|PET Imaging|pet imaging
1541888|NCT00613093|Temodar|temodar
1541889|NCT00613093|Temozolomide|temozolomide
1541890|NCT00613093|O6-BG|o6-bg
1541891|NCT00613093|O6-Benzylguanine|o6-benzylguanine
1541892|NCT00613093|NSC 637037|nsc 637037
1541893|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
1541894|NCT00613093|Brain tumor|brain tumor
1541895|NCT00613093|CNS tumor|cns tumor
1541896|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
1541897|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
1541898|NCT00613093|Glioma|glioma
1541899|NCT00613080|stage III rectal cancer|stage iii rectal cancer
1541900|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1541901|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
1541902|NCT00613067|N100|n100
1541903|NCT00613067|Central serotonergic activity|central serotonergic activity
1541904|NCT00613054|GBM|gbm
1541905|NCT00613054|Brain tumor|brain tumor
1541906|NCT00613054|Zactima|zactima
1541907|NCT00613054|Gleevec|gleevec
1541908|NCT00613054|Hydroxyurea|hydroxyurea
1541909|NCT00613054|Glioblastoma|glioblastoma
1541910|NCT00613054|Gliosarcoma|gliosarcoma
1541911|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
1541912|NCT00613054|ZD6474|zd6474
1541913|NCT00613054|Malignant glioma|malignant glioma
1541914|NCT00613054|Imatinib|imatinib
1541915|NCT00613054|Droxia|droxia
1541916|NCT00613054|Hydrea|hydrea
1541917|NCT00613054|Hydroxycarbamide|hydroxycarbamide
1541918|NCT00613054|Vandetanib|vandetanib
1541919|NCT00613028|Glioblastoma|glioblastoma
1541920|NCT00613028|Gliosarcoma|gliosarcoma
1541921|NCT00613028|GBM|gbm
1541922|NCT00613028|Bevacizumab|bevacizumab
1541923|NCT00613028|Avastin|avastin
1541924|NCT00613028|Etoposide|etoposide
1541925|NCT00613028|Brain tumor|brain tumor
1541926|NCT00613028|Irinotecan|irinotecan
1541927|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
1541928|NCT00613028|Temodar|temodar
1541929|NCT00613028|Temozolomide|temozolomide
1541930|NCT00613028|Etopophos|etopophos
1541931|NCT00613028|Toposar|toposar
1541932|NCT00613028|VePesid|vepesid
1541933|NCT00613028|VP-16|vp-16
1541934|NCT00613028|Camptosar|camptosar
1541935|NCT00613015|Cocaine Addiction|cocaine addiction
1541936|NCT00613015|Cocaine Dependence|cocaine dependence
1541937|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
1541938|NCT00613002|testosterone|testosterone
1541939|NCT00613002|menopause|menopause
1541940|NCT00612989|Glioblastoma|glioblastoma
1541941|NCT00612989|Gliosarcoma|gliosarcoma
1541942|NCT00612989|GBM|gbm
1541943|NCT00612989|Temodar|temodar
1541944|NCT00612989|Temozolomide|temozolomide
1541945|NCT00612989|O6-BG|o6-bg
1541946|NCT00612989|O6-Benzylguanine|o6-benzylguanine
1541947|NCT00612989|Recurrent GBM|recurrent gbm
1541948|NCT00612989|Progressive GBM|progressive gbm
1541949|NCT00612989|Brain tumor|brain tumor
1541950|NCT00612989|Malignant glioma|malignant glioma
1541951|NCT00612989|Neulasta|neulasta
1541952|NCT00612989|Pegfilgrastim|pegfilgrastim
1541953|NCT00612976|treatment of COPD|treatment of copd
1541954|NCT00612976|documentation of relevant data|documentation of relevant data
1541955|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
1541956|NCT00612963|Candidiasis, Oral|candidiasis, oral
1541957|NCT00612963|Thrush|thrush
1541958|NCT00612963|Candidiasis|candidiasis
1541959|NCT00612937|Group B Streptococci|group b streptococci
1541960|NCT00612937|Respiratory Disease|respiratory disease
1541961|NCT00612937|Beta Lactam|beta lactam
1541962|NCT00612937|Newborn|newborn
1541963|NCT00612937|Respiratory Distress|respiratory distress
1541964|NCT00612898|HIV infection|hiv infection
1541965|NCT00612898|Drug resistance|drug resistance
1541966|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
1541967|NCT00612898|Nucleoside analogue|nucleoside analogue
1541968|NCT00612898|treatment experienced|treatment experienced
1541969|NCT00612859|Levetiracetam|levetiracetam
1541970|NCT00612859|Keppra|keppra
1541971|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
1541972|NCT00612846|Choledocholithiasis|choledocholithiasis
1541973|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
1541974|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
1541975|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
1541976|NCT00612833|Vasectomy|vasectomy
1541977|NCT00612833|Male contraception|male contraception
1542488|NCT00611325|Bortezomib|bortezomib
1541978|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
1541979|NCT00612833|Semen analysis|semen analysis
1541980|NCT00612833|Surgical techniques|surgical techniques
1541981|NCT00612833|Fascial interposition|fascial interposition
1541982|NCT00612833|Cautery|cautery
1541983|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
1542558|NCT00610974|walking|walking
1541984|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
1541985|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
1541986|NCT00612807|Older Adults|older adults
1541987|NCT00612794|exenatide|exenatide
1541988|NCT00612794|Byetta|byetta
1541989|NCT00612794|diabetes|diabetes
1541990|NCT00612794|Amylin|amylin
1541991|NCT00612794|Lilly|lilly
1541992|NCT00612781|intraocular lens|intraocular lens
1541993|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
1541994|NCT00612781|contrast acuity|contrast acuity
1541995|NCT00612781|color vision|color vision
1541996|NCT00612768|Bioequivalence|bioequivalence
1541997|NCT00612768|Thimerosal|thimerosal
1541998|NCT00612768|Fragrance Mix|fragrance mix
1541999|NCT00612768|PVP formulation|pvp formulation
1542000|NCT00612768|Contact dermatitis|contact dermatitis
1542001|NCT00612755|chronic hepatitis C|chronic hepatitis c
1542002|NCT00612755|co-infection|co-infection
1542003|NCT00612755|extend treatment|extend treatment
1542004|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
1542005|NCT00612742|Cardiovascular event|cardiovascular event
1542006|NCT00612742|Breast Cancer|breast cancer
1542007|NCT00612742|Testosterone|testosterone
1542008|NCT00612742|Menopause|menopause
1542009|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1542010|NCT00612729|intraocular lens|intraocular lens
1542011|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
1542012|NCT00612729|contrast acuity|contrast acuity
1542013|NCT00612729|color vision|color vision
1542014|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
1542015|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
1542016|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
1542017|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
1542018|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1542019|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1542020|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1542021|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1542022|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1542023|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1542024|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1542025|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1542026|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1542027|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1542028|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1542029|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1542030|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1542031|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1542032|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1542033|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1542034|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1542035|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1542036|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1542037|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1542038|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1542039|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1542040|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1542041|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1542042|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1542043|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1542044|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1542045|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1542046|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1542047|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1542048|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1542049|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1542050|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1542051|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1542052|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1542053|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1542054|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1542055|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1542056|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1542057|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1542058|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1542059|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1542060|NCT00612716|Burkitt lymphoma|burkitt lymphoma
1542061|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1542062|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1542063|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1542064|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1542065|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1542066|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
1542067|NCT00612703|Tumor|tumor
1542068|NCT00612690|Children|children
1542069|NCT00612690|School-Based Mental Health Services|school-based mental health services
1542070|NCT00612690|Urban Poverty|urban poverty
1542071|NCT00612677|recurrent|recurrent
1542072|NCT00612677|non-small cell|non-small cell
1542073|NCT00612651|GBM|gbm
1542074|NCT00612651|Malignant glioma|malignant glioma
1542075|NCT00612651|Brain tumor|brain tumor
1542076|NCT00612651|Temodar|temodar
1542077|NCT00612651|Temozolomide|temozolomide
1542078|NCT00612651|SCH 66336|sch 66336
1542079|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
1542080|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
1542081|NCT00612651|Gliosarcoma|gliosarcoma
1542082|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
1542083|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1542084|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1542085|NCT00612638|Temodar|temodar
1542086|NCT00612638|Temozolomide|temozolomide
1542087|NCT00612638|O6-Benzylguanine|o6-benzylguanine
1542088|NCT00612638|O6-BG|o6-bg
1542089|NCT00612638|NSC 637037|nsc 637037
1542090|NCT00612638|Irinotecan|irinotecan
1542092|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
1542093|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
1542094|NCT00612638|Malignant glioma|malignant glioma
1542095|NCT00612560|breast neoplasms|breast neoplasms
1542096|NCT00612560|phytoestrogens|phytoestrogens
1542097|NCT00612560|tumor characteristics|tumor characteristics
1542098|NCT00612560|proliferation|proliferation
1542099|NCT00612560|apoptosis|apoptosis
1542100|NCT00612560|estrogen receptor|estrogen receptor
1542101|NCT00612560|HER2|her2
1542102|NCT00612547|Protozoan Infections|protozoan infections
1542103|NCT00612547|Communicable Diseases|communicable diseases
1542104|NCT00612547|Malaria Infection|malaria infection
1542105|NCT00612547|Malaria, falciparum|malaria, falciparum
1542106|NCT00612547|Malaria, vivax|malaria, vivax
1542107|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
1542108|NCT00612521|Coronary artery disease|coronary artery disease
1542109|NCT00612521|Coronary artery stenting|coronary artery stenting
1542110|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
1542111|NCT00612521|Adenosine|adenosine
1542112|NCT00612508|contraception|contraception
1542113|NCT00612508|NuvaRing|nuvaring
1542114|NCT00612508|Desogen|desogen
1542115|NCT00612508|vaginal biopsy|vaginal biopsy
1542116|NCT00612482|Substance abuse|substance abuse
1542117|NCT00612469|dental caries|dental caries
1542118|NCT00612469|vancomycin|vancomycin
1542119|NCT00612469|chlorhexidine|chlorhexidine
1542120|NCT00612469|sodium fluoride|sodium fluoride
1542121|NCT00612469|mutans streptococci|mutans streptococci
1542122|NCT00612456|angiogenesis|angiogenesis
1542123|NCT00612456|pazopanib,|pazopanib,
1542124|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
1542125|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
1542126|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
1542127|NCT00612443|breast cancer|breast cancer
1542128|NCT00612430|Glioblastoma|glioblastoma
1542129|NCT00612430|Gliosarcoma|gliosarcoma
1542130|NCT00612430|GBM|gbm
1542131|NCT00612430|MG|mg
1542132|NCT00612430|Brain tumor|brain tumor
1542133|NCT00612430|Bevacizumab|bevacizumab
1542134|NCT00612430|Avastin|avastin
1542135|NCT00612430|Etoposide|etoposide
1542136|NCT00612430|VP-16|vp-16
1542137|NCT00612430|Etopophos|etopophos
1542138|NCT00612430|Toposar|toposar
1542139|NCT00612430|VePesid|vepesid
1542140|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
1542141|NCT00612430|Recurrent GBM|recurrent gbm
1542142|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
1542143|NCT00612430|Malignant glioma|malignant glioma
1542144|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
1542145|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
1542146|NCT00612404|endoscopy|endoscopy
1542147|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
1542148|NCT00612391|humerus fracture|humerus fracture
1542149|NCT00612378|Glabellar Furrowing|glabellar furrowing
1542150|NCT00612365|Body Composition|body composition
1542151|NCT00612365|Abdomen|abdomen
1542152|NCT00612365|Atherosclerosis|atherosclerosis
1542153|NCT00612339|Glioma|glioma
1542154|NCT00612339|Temozolomide|temozolomide
1542155|NCT00612339|Temodar|temodar
1542156|NCT00612339|Avastin|avastin
1542157|NCT00612339|Bevacizumab|bevacizumab
1542158|NCT00612339|GBM|gbm
1542159|NCT00612339|Gliosarcoma|gliosarcoma
1542160|NCT00612339|Multifocal GBM|multifocal gbm
1542161|NCT00612339|Brain tumor|brain tumor
1542162|NCT00612339|Unresectable GBM|unresectable gbm
1542163|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
1542164|NCT00612313|Major Depressive Disorder|major depressive disorder
1542165|NCT00612313|MDD|mdd
1542166|NCT00612313|Children|children
1542167|NCT00612313|Adolescents|adolescents
1542168|NCT00612313|Antidepressant|antidepressant
1542169|NCT00612313|CBT|cbt
1542170|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
1542171|NCT00612300|Gait training|gait training
1542172|NCT00612300|Lokomat|lokomat
1542173|NCT00612300|Physical therapy|physical therapy
1542174|NCT00612287|Pain|pain
1542175|NCT00612287|Chronic pain|chronic pain
1542176|NCT00612287|Buprenorphine|buprenorphine
1542177|NCT00612287|Drug addiction|drug addiction
1542178|NCT00612274|allogeneic|allogeneic
1542179|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
1542180|NCT00612248|Osteoarthritis|osteoarthritis
1542181|NCT00612248|Thumb|thumb
1542182|NCT00612248|Splint|splint
1542183|NCT00612248|Pain|pain
1542184|NCT00612248|Function|function
1542185|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
1542186|NCT00612235|epilepsy|epilepsy
1542187|NCT00612235|lamotrigine|lamotrigine
1542188|NCT00612235|levetiracetam|levetiracetam
1542189|NCT00612235|carbamazepine|carbamazepine
1542190|NCT00612235|phenytoin|phenytoin
1542191|NCT00612235|lamictal|lamictal
1542192|NCT00612235|keppra|keppra
1542193|NCT00612235|tegretol|tegretol
1542194|NCT00612235|carbatrol|carbatrol
1542195|NCT00612235|dilantin|dilantin
1542196|NCT00612222|Immunotherapy|immunotherapy
1542197|NCT00612222|Metastatic Melanoma|metastatic melanoma
1542198|NCT00612222|Vaccination|vaccination
1542199|NCT00612222|Tumor Regression|tumor regression
1542200|NCT00612222|Skin Cancer|skin cancer
1542201|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
1542202|NCT00612196|Safety and tolerability|safety and tolerability
1542203|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1542204|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
1542205|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
1542206|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
1542207|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
1542208|NCT00612157|CPAP Compliance|cpap compliance
1542209|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
1542210|NCT00612144|Type 2 DM|type 2 dm
1542211|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
1542212|NCT00612118|Allergic rhinitis,|allergic rhinitis,
1542213|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
1542214|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
1542215|NCT00612092|Coronary CT angiography|coronary ct angiography
1542216|NCT00612092|Radiation dose estimates|radiation dose estimates
1542217|NCT00612079|Sertindole|sertindole
1542218|NCT00612079|sensory gating|sensory gating
1542220|NCT00612079|P50 suppression|p50 suppression
1542221|NCT00612079|CANTAB|cantab
1542222|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
1542223|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
1542224|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
1542225|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1542226|NCT00612053|cardiovascular disease|cardiovascular disease
1542227|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
1542228|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
1542229|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
1542230|NCT00612053|unprotected left main disease|unprotected left main disease
1542231|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
1542232|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
1542233|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
1542234|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
1542235|NCT00612014|delayed gastric emptying|delayed gastric emptying
1542236|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
1705023|NCT00029029|pain|pain
1542237|NCT00612014|diabetes mellitus|diabetes mellitus
1542238|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1542239|NCT00612001|adult glioblastoma|adult glioblastoma
1542240|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
1542241|NCT00612001|adult gliosarcoma|adult gliosarcoma
1542242|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1542243|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
1542244|NCT00612001|adult mixed glioma|adult mixed glioma
1542245|NCT00611988|Walking therapy|walking therapy
1542246|NCT00611988|Diabetes mellitus|diabetes mellitus
1542247|NCT00611988|Peripheral arterial disease|peripheral arterial disease
1542248|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
1542249|NCT00611975|Healthy Volunteers|healthy volunteers
1542250|NCT00611975|Antidepressant Side Effects|antidepressant side effects
1542251|NCT00611975|Fluoxetine|fluoxetine
1542252|NCT00611975|Bupropion|bupropion
1542253|NCT00611975|Prolactin|prolactin
1542254|NCT00611975|Testosterone|testosterone
1542255|NCT00611975|Estradiol|estradiol
1542256|NCT00611975|Progesterone|progesterone
1542257|NCT00611975|Sexual Function|sexual function
1542258|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
1542259|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
1542260|NCT00611949|Geranium oil|geranium oil
1542261|NCT00611949|Neuropathy|neuropathy
1542262|NCT00611949|Shingles|shingles
1542263|NCT00611949|Herpes zoster|herpes zoster
1542264|NCT00611936|Atomoxetine|atomoxetine
1542265|NCT00611936|Stress|stress
1542266|NCT00611936|d-amphetamine|d-amphetamine
1542267|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
1542268|NCT00611923|PMDD|pmdd
1542269|NCT00611923|PMS|pms
1542270|NCT00611897|NMDA|nmda
1542271|NCT00611897|glutamate|glutamate
1542272|NCT00611897|N-acetylcysteine|n-acetylcysteine
1542273|NCT00611897|P3|p3
1542274|NCT00611858|5-FU|5-fu
1542275|NCT00611858|cetuximab|cetuximab
1542276|NCT00611858|radiation|radiation
1542277|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1542278|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
1542279|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
1542280|NCT00611832|behavior problems|behavior problems
1542281|NCT00611832|children|children
1542282|NCT00611832|prevention|prevention
1542283|NCT00611832|television|television
1542284|NCT00611832|media|media
1542285|NCT00611832|parenting|parenting
1542286|NCT00611819|hepatitis|hepatitis
1542287|NCT00611819|co-infection|co-infection
1542288|NCT00611806|Cognition|cognition
1542289|NCT00611806|Folic Acid|folic acid
1542290|NCT00611806|B12|b12
1542291|NCT00611793|Refractory Malignancy|refractory malignancy
1542292|NCT00611793|Advanced Malignancies|advanced malignancies
1542293|NCT00611793|PTK787/ZK222584|ptk787/zk222584
1542294|NCT00611793|Bevacizumab|bevacizumab
1542295|NCT00611780|Coronary CT angiography|coronary ct angiography
1542296|NCT00611780|Radiation dose estimates|radiation dose estimates
1542297|NCT00611767|Thiopental|thiopental
1542299|NCT00611767|Family History|family history
1542300|NCT00611767|Vulnerability|vulnerability
1542301|NCT00611767|GABA|gaba
1542302|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
1542303|NCT00611728|Glioblastoma|glioblastoma
1542304|NCT00611728|CPT 11|cpt 11
1542305|NCT00611728|Sutent|sutent
1542306|NCT00611728|Sunitinib|sunitinib
1542307|NCT00611728|Sunitinib malate|sunitinib malate
1542308|NCT00611728|Malignant Glioma|malignant glioma
1542309|NCT00611728|GBM|gbm
1542310|NCT00611728|Irinotecan|irinotecan
1542311|NCT00611728|Camptosar|camptosar
1542312|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
1542313|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1542314|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1542315|NCT00611728|SU011248|su011248
1542316|NCT00611728|Brain tumor|brain tumor
1542317|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
1542318|NCT00611715|recurrent breast cancer|recurrent breast cancer
1542319|NCT00611715|stage IV breast cancer|stage iv breast cancer
1542320|NCT00611702|ELISPOT|elispot
1542321|NCT00611702|RT-PCR|rt-pcr
1542322|NCT00611702|Luminex|luminex
1542323|NCT00611702|Genomics|genomics
1542324|NCT00611689|Refractory Malignancy|refractory malignancy
1542325|NCT00611689|Solid Tumors|solid tumors
1542326|NCT00611689|PTK787|ptk787
1542327|NCT00611689|ZK222584|zk222584
1542328|NCT00611676|osteoarthritis pain|osteoarthritis pain
1542329|NCT00611676|activity limitation|activity limitation
1542330|NCT00611676|antidepressant|antidepressant
1542331|NCT00611676|depression|depression
1542332|NCT00611676|single-blind|single-blind
1542333|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
1542334|NCT00611663|SLE|sle
1542335|NCT00611663|Vaccination|vaccination
1542336|NCT00611663|Immunosuppression|immunosuppression
1542337|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
1542338|NCT00611663|Stable SLE|stable sle
1542339|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
1542340|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
1542341|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
1542342|NCT00611650|tobacco use disorder|tobacco use disorder
1542343|NCT00611637|Immunotherapy|immunotherapy
1542344|NCT00611624|MammoSite|mammosite
1542345|NCT00611624|brachytherapy|brachytherapy
1542346|NCT00611572|GABA|gaba
1542347|NCT00611572|glutamate|glutamate
1542348|NCT00611572|NMDA|nmda
1542349|NCT00611572|P300|p300
1542350|NCT00611572|MMN|mmn
1542351|NCT00611559|Infanrix hexa|infanrix hexa
1542352|NCT00611559|combined vaccine|combined vaccine
1542353|NCT00611546|preterm|preterm
1542354|NCT00611546|parenteral nutrition|parenteral nutrition
1542355|NCT00611546|TPN|tpn
1542356|NCT00611546|lipid emulsions|lipid emulsions
1542357|NCT00611546|photo-protection|photo-protection
1542358|NCT00611546|oxidative stress|oxidative stress
1542359|NCT00611533|Menopause|menopause
1542360|NCT00611533|Cognition|cognition
1542361|NCT00611520|treatment of COPD|treatment of copd
1542362|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
1542363|NCT00611494|Drug tolerance|drug tolerance
1542364|NCT00611494|Quality of Life|quality of life
1542365|NCT00611429|Treatment|treatment
1542366|NCT00611429|Adherence|adherence
1542367|NCT00611429|Intervention|intervention
1542368|NCT00611429|Quality of Life|quality of life
1542369|NCT00611416|catechins|catechins
1542370|NCT00611416|caffeine|caffeine
1542371|NCT00611416|energy expenditure|energy expenditure
1542372|NCT00611416|fat oxidation|fat oxidation
1542373|NCT00611416|appetite|appetite
1542374|NCT00611403|LASIK|lasik
1542375|NCT00611390|Viral laryngitis;|viral laryngitis;
1542376|NCT00611390|Viral tracheitis;|viral tracheitis;
1542377|NCT00611390|Herbal medicine;|herbal medicine;
1542378|NCT00611390|Traditional medicine;|traditional medicine;
1542379|NCT00611390|Aromatic essential oils;|aromatic essential oils;
1542380|NCT00611377|delirium|delirium
1542381|NCT00611377|mechanical ventilation|mechanical ventilation
1542382|NCT00611377|age|age
1542383|NCT00611377|severity score|severity score
1542384|NCT00611364|Physical therapy|physical therapy
1542385|NCT00611364|hypertension|hypertension
1542386|NCT00611364|aged|aged
1542387|NCT00611364|exercise|exercise
1542388|NCT00611364|Physical exercise|physical exercise
1542389|NCT00611364|Physical activity|physical activity
1542390|NCT00611351|graft versus host disease|graft versus host disease
1542391|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1542392|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1542544|NCT00611078|04-088|04-088
1542393|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1542394|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1542395|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1542396|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1542397|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1542398|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1542399|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1542400|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1542401|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1542402|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1542403|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
1542404|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
1542405|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1542406|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1542407|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1542408|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1542409|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
1542410|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1542411|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1542412|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1542413|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1542414|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1542415|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1542416|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1542417|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1542418|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1542419|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1542420|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1542489|NCT00611325|Velcade|velcade
1542421|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1542422|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1542423|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1542424|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1542425|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1542426|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1542427|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1542428|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1542429|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1542430|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1542431|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1542432|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1542433|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1542434|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1542435|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1542436|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1542437|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1542438|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1542439|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1542440|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1542441|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1542442|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1542443|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1542444|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1542445|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1542446|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1542447|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1542448|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1542449|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1542450|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1542451|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1542452|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1542453|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1542454|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1542455|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1542456|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1542457|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1542458|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1542459|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1542460|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1542461|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1542462|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1542463|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1542464|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1542465|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1542466|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1542467|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1542468|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1542469|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1542470|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1542471|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1542472|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1542473|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1542474|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
1542475|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
1542476|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
1542477|NCT00611338|Complementary Therapies|complementary therapies
1542478|NCT00611325|Glioblastoma|glioblastoma
1542479|NCT00611325|Gliosarcoma|gliosarcoma
1542480|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
1542481|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
1542483|NCT00611325|Recurrent GBM|recurrent gbm
1542484|NCT00611325|Malignant glioma|malignant glioma
1542485|NCT00611325|Brain tumor|brain tumor
1542486|NCT00611325|Avastin|avastin
1705327|NCT00027586|PTK|ptk
1542487|NCT00611325|Bevacizumab|bevacizumab
1542490|NCT00611312|Alzheimer's disease|alzheimer's disease
1542491|NCT00611312|Cognitive training|cognitive training
1542492|NCT00611299|Probiotics|probiotics
1542493|NCT00611299|Immune response|immune response
1542494|NCT00611299|Blood lipids|blood lipids
1542495|NCT00611299|Intestinal microflora|intestinal microflora
1542496|NCT00611299|Tolerance|tolerance
1542497|NCT00611286|Drug-eluting stent|drug-eluting stent
1542498|NCT00611286|clopidogrel|clopidogrel
1542499|NCT00611286|bare metal stent|bare metal stent
1542500|NCT00611286|landmark analysis|landmark analysis
1542501|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
1542502|NCT00611273|Glabellar Furrowing|glabellar furrowing
1542503|NCT00611260|Meditation|meditation
1542504|NCT00611260|Congestive Heart Failure|congestive heart failure
1542505|NCT00611260|ICD|icd
1542506|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1542507|NCT00611221|massage|massage
1542508|NCT00611221|labour|labour
1542509|NCT00611195|Anesthesia|anesthesia
1542510|NCT00611195|Children|children
1542511|NCT00611195|Larynx|larynx
1542512|NCT00611182|dyspnea|dyspnea
1542513|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
1542514|NCT00611182|interstitial lung disease|interstitial lung disease
1542515|NCT00611182|shortness of breath|shortness of breath
1542516|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1542517|NCT00611169|tirofiban|tirofiban
1542518|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
1542519|NCT00611169|Myocardial Infarction|myocardial infarction
1542520|NCT00611156|Thermogenesis|thermogenesis
1542521|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
1542522|NCT00611156|energy expenditure|energy expenditure
1542523|NCT00611156|fat oxidation|fat oxidation
1542524|NCT00611156|bioactive ingredients|bioactive ingredients
1542525|NCT00611156|spices|spices
1542526|NCT00611156|ginger|ginger
1542527|NCT00611156|horseradish|horseradish
1542528|NCT00611156|black pepper|black pepper
1542529|NCT00611156|mustard|mustard
1542530|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
1542531|NCT00611143|Atorvastatin|atorvastatin
1542532|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
1542533|NCT00611130|Cocaine|cocaine
1542534|NCT00611130|Addiction|addiction
1542535|NCT00611130|Dependence|dependence
1542536|NCT00611130|Treatment|treatment
1542537|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
1542538|NCT00611117|activity|activity
1542539|NCT00611117|exercise|exercise
1542540|NCT00611104|breast cancer|breast cancer
1542541|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
1542542|NCT00611078|environment|environment
1542543|NCT00611078|pollutants|pollutants
1542545|NCT00611052|Depressive Disorder|depressive disorder
1542546|NCT00611052|Depressive Disorder, Major|depressive disorder, major
1542547|NCT00611052|Mental Health|mental health
1542548|NCT00611052|Prevention|prevention
1542549|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
1542550|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
1542551|NCT00611039|dose reduction|dose reduction
1542552|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
1542553|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
1542554|NCT00611000|colon cancer|colon cancer
1542555|NCT00611000|rectal cancer|rectal cancer
1542556|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
1542557|NCT00610974|Spinal cord injury|spinal cord injury
1542559|NCT00610974|gait training|gait training
1542560|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
1542561|NCT00610974|rehabilitation|rehabilitation
1542562|NCT00610961|BK Polyomavirus|bk polyomavirus
1542563|NCT00610961|Transplantation, Kidney|transplantation, kidney
1542564|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
1542565|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1542566|NCT00610935|Influenza|influenza
1542567|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
1542568|NCT00610922|Performance of motor skills|performance of motor skills
1542570|NCT00610870|Myocardial infarct size|myocardial infarct size
1542571|NCT00610870|Atorvastatin|atorvastatin
1542572|NCT00610870|SPECT|spect
1542573|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1542574|NCT00610844|lung cancer|lung cancer
1542575|NCT00610844|lung metastasis|lung metastasis
1542576|NCT00610844|radiofrequency ablation|radiofrequency ablation
1542578|NCT00610805|lupus|lupus
1542579|NCT00610805|cardiovascular|cardiovascular
1542580|NCT00610805|IMT|imt
1542581|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
1542582|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
1542583|NCT00610779|Herbal medicine;|herbal medicine;
1542584|NCT00610779|Traditional medicine;|traditional medicine;
1542585|NCT00610779|Aromatic essential oils;|aromatic essential oils;
1542586|NCT00610766|coronary CT angiography|coronary ct angiography
1542587|NCT00610766|radiation dose estimates|radiation dose estimates
1542588|NCT00610753|Anorexia nervosa|anorexia nervosa
1542589|NCT00610753|Adolescents|adolescents
1542590|NCT00610753|Family therapy|family therapy
1542591|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
1542592|NCT00610740|cervical cancer|cervical cancer
1542593|NCT00610740|endometrial carcinoma|endometrial carcinoma
1542594|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
1542595|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1542596|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1542597|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
1542598|NCT00610714|Cancer|cancer
1542599|NCT00610714|Tumour|tumour
1542600|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
1542601|NCT00610714|Ovarian Cancer|ovarian cancer
1542602|NCT00610675|Fifty two weeks|fifty two weeks
1542603|NCT00610675|Open label|open label
1542604|NCT00610675|extension|extension
1542605|NCT00610662|cervical cancer|cervical cancer
1542606|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1542607|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1542608|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1542609|NCT00610649|randomized|randomized
1542610|NCT00610649|placebo controlled|placebo controlled
1542611|NCT00610649|maximum tolerated dose|maximum tolerated dose
1542612|NCT00610636|FOLFOX-4|folfox-4
1542613|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1542614|NCT00610636|colorectal cancer|colorectal cancer
1542615|NCT00610636|liver metastasis|liver metastasis
1542616|NCT00610636|resectability|resectability
1542617|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
1542618|NCT00610623|Pneumonia|pneumonia
1542619|NCT00610623|Ventilator-Associated|ventilator-associated
1542620|NCT00610623|Quorum Sensing|quorum sensing
1542621|NCT00610610|Fibromyalgia|fibromyalgia
1542622|NCT00610610|Paroxetine|paroxetine
1542623|NCT00610597|liver|liver
1542624|NCT00610597|alcohol|alcohol
1542625|NCT00610597|lymphocyte|lymphocyte
1542626|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
1542627|NCT00610584|acupuncture|acupuncture
1542628|NCT00610584|RCT|rct
1542629|NCT00610584|CAM|cam
1542630|NCT00610571|Temodar|temodar
1542631|NCT00610571|Temozolomide|temozolomide
1542632|NCT00610571|Topotecan|topotecan
1542633|NCT00610571|Hycamtin|hycamtin
1542634|NCT00610571|Malignant Gliomas|malignant gliomas
1542635|NCT00610571|Brain tumor|brain tumor
1542636|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
1542637|NCT00610571|AA|aa
1542638|NCT00610571|GBM|gbm
1542639|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
1542640|NCT00610571|Gliosarcoma|gliosarcoma
1542641|NCT00610545|ATORVASTATIN|atorvastatin
1542642|NCT00610545|VASCULAR SURGERY|vascular surgery
1542643|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
1542644|NCT00610532|pharmacoresistance|pharmacoresistance
1542645|NCT00610532|healthy volunteers|healthy volunteers
1542646|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
1542647|NCT00610519|Herbal medicine;|herbal medicine;
1542648|NCT00610519|Traditional medicine;|traditional medicine;
1542649|NCT00610519|Aromatic essential oils;|aromatic essential oils;
1542650|NCT00610506|Atypical Depression|atypical depression
1542651|NCT00610493|Advanced Cancer|advanced cancer
1542652|NCT00610493|Bevacizumab|bevacizumab
1542653|NCT00610493|Temsirolimus|temsirolimus
1542654|NCT00610493|Avastin|avastin
1542655|NCT00610493|Torisel|torisel
1542656|NCT00610493|CCI-779|cci-779
1542657|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1542658|NCT00610493|rhuMAb-VEGF|rhumab-vegf
1542659|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
1542660|NCT00610493|DCE|dce
1542661|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
1542662|NCT00610493|MRI|mri
1542663|NCT00610480|Dry Eyes|dry eyes
1542664|NCT00610480|Tear Film Stability|tear film stability
1542665|NCT00610454|Levetiracetam|levetiracetam
1542666|NCT00610454|Keppra|keppra
1542667|NCT00610441|randomized|randomized
1542668|NCT00610441|double blind|double blind
1542669|NCT00610441|placebo controlled|placebo controlled
1542670|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
1542671|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
1542672|NCT00610376|Handwashing|handwashing
1542673|NCT00610376|Randomized controlled trial|randomized controlled trial
1542674|NCT00610376|Cluster randomization|cluster randomization
1542675|NCT00610376|Community intervention trial|community intervention trial
1542676|NCT00610376|Disease prevention|disease prevention
1542677|NCT00610376|Pediatric communicable disease|pediatric communicable disease
1542678|NCT00610376|Preschool|preschool
1542679|NCT00610376|Illness absenteeism|illness absenteeism
1542680|NCT00610350|Levosimendan|levosimendan
1542681|NCT00610350|pre-conditioning|pre-conditioning
1542682|NCT00610350|cardiac surgery|cardiac surgery
1542683|NCT00610350|myocardial function|myocardial function
1542684|NCT00610350|contractility|contractility
1705447|NCT00026247|pain|pain
1542685|NCT00610350|heart|heart
1542686|NCT00610350|ischaemia|ischaemia
1542687|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
1542688|NCT00610324|oral decontamination|oral decontamination
1542689|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
1542690|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
1542691|NCT00610324|critical illness|critical illness
1542692|NCT00610324|mechanical ventilation|mechanical ventilation
1542693|NCT00610324|tracheal intubation|tracheal intubation
1542694|NCT00610324|prophylaxis|prophylaxis
1542695|NCT00610311|Metastatic Melanoma|metastatic melanoma
1542696|NCT00610311|Immunotherapy|immunotherapy
1542697|NCT00610311|Vaccination|vaccination
1542698|NCT00610311|Tumor Regression|tumor regression
1542699|NCT00610311|Skin Cancer|skin cancer
1542700|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
1542701|NCT00610272|single bone metastasis|single bone metastasis
1542702|NCT00610272|multiple bone metastasis|multiple bone metastasis
1542703|NCT00610272|pain relief|pain relief
1542704|NCT00610272|radiotherapy|radiotherapy
1542705|NCT00610259|Depressive disorder|depressive disorder
1542706|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
1542707|NCT00610259|Behavior therapy|behavior therapy
1542708|NCT00610246|Thorax|thorax
1542709|NCT00610246|Abdomen|abdomen
1542710|NCT00610246|Pelvis|pelvis
1542711|NCT00610246|Lesion|lesion
1542712|NCT00610246|Cancer|cancer
1542713|NCT00610246|Radiation|radiation
1542714|NCT00610246|Chemotherapy|chemotherapy
1542715|NCT00610246|Phase 1|phase 1
1542716|NCT00610246|Advanced Cancer|advanced cancer
1542717|NCT00610246|Sorafenib|sorafenib
1542718|NCT00610246|Nexavar|nexavar
1542719|NCT00610246|BAY43-9006|bay43-9006
1542720|NCT00610233|deep brain stimulation|deep brain stimulation
1542721|NCT00610233|urodynamics|urodynamics
1542722|NCT00610220|pediatrics|pediatrics
1542723|NCT00610220|wrist fractures|wrist fractures
1542724|NCT00610220|casting|casting
1542725|NCT00610220|wrist splint|wrist splint
1542726|NCT00610207|Anal fistula|anal fistula
1542727|NCT00610207|fistula in ano|fistula in ano
1542728|NCT00610207|anorectal fistula|anorectal fistula
1542729|NCT00610207|Crohn's Disease|crohn's disease
1542730|NCT00610181|Breast Cancer|breast cancer
1542731|NCT00610181|Breast Carcinoma|breast carcinoma
1542732|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
1542733|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
1542734|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
1542735|NCT00610181|MRI|mri
1542736|NCT00610168|dTpa vaccine|dtpa vaccine
1542737|NCT00610168|pertussis|pertussis
1542738|NCT00610168|Tdap|tdap
1542739|NCT00610168|Boostrix|boostrix
1542740|NCT00610168|booster|booster
1542741|NCT00610168|tetanus|tetanus
1542742|NCT00610168|diphtheria|diphtheria
1542743|NCT00610142|atopic dermatitis|atopic dermatitis
1542744|NCT00610142|pimecrolimus|pimecrolimus
1542745|NCT00610142|hydrocortison|hydrocortison
1542746|NCT00610142|Optical Coherence Tomography|optical coherence tomography
1542748|NCT00610090|UNITE|unite
1542749|NCT00610090|AAA|aaa
1542750|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1542751|NCT00610090|Stent|stent
1542752|NCT00610090|Graft|graft
1542753|NCT00610077|Letrozole|letrozole
1542754|NCT00610077|Clomiphene citrate|clomiphene citrate
1542755|NCT00610077|Anovulatory infertility|anovulatory infertility
1542756|NCT00610077|Ovulation induction|ovulation induction
1542757|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
1542758|NCT00610064|Sacral neuromodulation|sacral neuromodulation
1542759|NCT00610064|Brain effects|brain effects
1542760|NCT00610064|Neuroimaging|neuroimaging
1542761|NCT00610064|Neuromodulation|neuromodulation
1542762|NCT00610051|severe heart failure|severe heart failure
1542763|NCT00610051|transplants|transplants
1542764|NCT00610038|neonatal|neonatal
1542765|NCT00610038|diabetes mellitus|diabetes mellitus
1542766|NCT00610038|mutation|mutation
1542767|NCT00610038|KIR6.2|kir6.2
1542768|NCT00610038|SUR1|sur1
1542769|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
1542770|NCT00610025|NOTES|notes
1542771|NCT00610025|transgastric endoscopy|transgastric endoscopy
1542772|NCT00610025|obesity surgery|obesity surgery
1542773|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
1542774|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1542775|NCT00610012|MRCC|mrcc
1542776|NCT00610012|Therapy-reality|therapy-reality
1542777|NCT00610012|Observation|observation
1542778|NCT00610012|Registry|registry
1542779|NCT00610012|RCC|rcc
1542780|NCT00610012|ARCC|arcc
1542781|NCT00610012|Germany|germany
1542782|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1542783|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
1542784|NCT00610012|Renal Cell Cancer|renal cell cancer
1542785|NCT00610012|Sorafenib|sorafenib
1542786|NCT00610012|Sunitinib|sunitinib
1542787|NCT00610012|Interferon|interferon
1542788|NCT00610012|Interleukin|interleukin
1542789|NCT00610012|Temsirolimus|temsirolimus
1542790|NCT00610012|Pazopanib|pazopanib
1542791|NCT00610012|Cytokines|cytokines
1542793|NCT00609999|Glioblastoma|glioblastoma
1542794|NCT00609999|Gliosarcoma|gliosarcoma
1542795|NCT00609999|GBM|gbm
1542796|NCT00609999|Recurrent MG|recurrent mg
1542797|NCT00609999|Erlotinib|erlotinib
1542798|NCT00609999|Dasatinib|dasatinib
1542799|NCT00609999|Brain tumor|brain tumor
1542800|NCT00609999|Malignant glioma|malignant glioma
1542801|NCT00609999|Tarceva|tarceva
1542802|NCT00609999|Sprycel|sprycel
1542803|NCT00609986|Kidney|kidney
1542804|NCT00609986|Transplantation|transplantation
1542805|NCT00609986|Diabetes|diabetes
1542806|NCT00609986|Hyperglycemia|hyperglycemia
1542807|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
1542808|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
1542809|NCT00609934|renal cell carcinoma|renal cell carcinoma
1542810|NCT00609934|kidney cancer|kidney cancer
1542811|NCT00609934|bone metastases|bone metastases
1542812|NCT00609934|RCC|rcc
1542813|NCT00609934|bone pain|bone pain
1542814|NCT00609934|palliative radiotherapy|palliative radiotherapy
1542815|NCT00609934|sorafenib|sorafenib
1542816|NCT00609934|radiation|radiation
1542817|NCT00609934|renal cell|renal cell
1542818|NCT00609882|Nasal CPAP|nasal cpap
1542819|NCT00609882|High flow nasal cannula|high flow nasal cannula
1542820|NCT00609882|Neonate|neonate
1542821|NCT00609843|Bladder cancer|bladder cancer
1542822|NCT00609843|Radiotherapy|radiotherapy
1542823|NCT00609843|Tumour delineation|tumour delineation
1542824|NCT00609843|Markers|markers
1542825|NCT00609830|Glucocorticoids|glucocorticoids
1542826|NCT00609830|Osteoporosis|osteoporosis
1542827|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
1542828|NCT00609830|Prevention|prevention
1542829|NCT00609830|GIOP|giop
1542830|NCT00609830|Patient Education|patient education
1542831|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
1542832|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
1542833|NCT00609817|GCS 100|gcs 100
1542834|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
1542835|NCT00609804|Advanced|advanced
1542836|NCT00609804|Erlotinib|erlotinib
1542837|NCT00609804|Sorafenib|sorafenib
1542838|NCT00609804|Progressing on erlotinib|progressing on erlotinib
1542839|NCT00609791|recurrent breast cancer|recurrent breast cancer
1542840|NCT00609791|stage IV breast cancer|stage iv breast cancer
1542841|NCT00609791|male breast cancer|male breast cancer
1542842|NCT00609778|CPR|cpr
1542843|NCT00609778|Mechanical|mechanical
1542844|NCT00609778|Manual|manual
1542845|NCT00609778|Survival|survival
1542846|NCT00609778|ROSC|rosc
1542847|NCT00609765|advanced|advanced
1542848|NCT00609765|unresectable|unresectable
1542849|NCT00609765|metastatic|metastatic
1542850|NCT00609765|endocrine|endocrine
1542851|NCT00609765|tumors|tumors
1542852|NCT00609752|Crohn Disease|crohn disease
1542853|NCT00609752|Children|children
1542854|NCT00609752|Bone Density|bone density
1542855|NCT00609752|Prednisolone|prednisolone
1542856|NCT00609752|Liquid Diet Therapy|liquid diet therapy
1542857|NCT00609752|Quality of Life|quality of life
1542858|NCT00609752|Metabolic Bone Disease|metabolic bone disease
1542859|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1542860|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
1542861|NCT00609726|Pancreatitis|pancreatitis
1542862|NCT00609726|EUS|eus
1542863|NCT00609713|Child|child
1542864|NCT00609713|Obesity|obesity
1542865|NCT00609700|burn injury|burn injury
1542866|NCT00609700|volume replacement|volume replacement
1542867|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
1542868|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
1542869|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
1542870|NCT00609687|sarcoidosis|sarcoidosis
1542871|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
1542872|NCT00609687|vitreous biopsy|vitreous biopsy
1542873|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
1542874|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
1542875|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
1542876|NCT00609648|Dental Anxiety|dental anxiety
1542877|NCT00609648|Dental Phobia|dental phobia
1542878|NCT00609648|Odontophobia|odontophobia
1542879|NCT00609635|Respiratory|respiratory
1542880|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
1542881|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
1542882|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
1542883|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
1542884|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
1542885|NCT00609609|Stem cell graft|stem cell graft
1542886|NCT00609609|Graft Versus Host Disease|graft versus host disease
1542887|NCT00609609|GVHD|gvhd
1542888|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
1542889|NCT00609609|ECP|ecp
1542890|NCT00609609|Photopheresis|photopheresis
1542891|NCT00609609|Methylprednisolone|methylprednisolone
1542892|NCT00609609|Medrol|medrol
1542893|NCT00609609|Depo-Medrol|depo-medrol
1542894|NCT00609609|Solu-Medrol|solu-medrol
1542895|NCT00609596|dutasteride|dutasteride
1542896|NCT00609596|tamsulosin|tamsulosin
1542897|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
1542898|NCT00609570|hypertension|hypertension
1542899|NCT00609570|supplement|supplement
1542900|NCT00609570|HRV|hrv
1542901|NCT00609557|osteoarthritis pain|osteoarthritis pain
1542902|NCT00609557|activity limitation|activity limitation
1542903|NCT00609557|antidepressant|antidepressant
1542904|NCT00609557|depression|depression
1542905|NCT00609557|single-blind|single-blind
1542906|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
1542907|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
1542908|NCT00609531|restricted interests|restricted interests
1542909|NCT00609531|Aspergers|aspergers
1542910|NCT00609531|Autism|autism
1542911|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
1542912|NCT00609505|genetic counseling|genetic counseling
1542913|NCT00609505|breast cancer|breast cancer
1542914|NCT00609505|ovarian cancer|ovarian cancer
1542915|NCT00609505|telemedicine|telemedicine
1542916|NCT00609505|Cancer genetic counseling|cancer genetic counseling
1542917|NCT00609479|Distal radius fracture|distal radius fracture
1542918|NCT00609479|Colle´s fracture|colle´s fracture
1542919|NCT00609479|Internal fixation|internal fixation
1542920|NCT00609479|External fixation|external fixation
1542921|NCT00609479|DASH|dash
1542922|NCT00609479|PRWE|prwe
1542923|NCT00609466|Opioid|opioid
1542924|NCT00609466|Central acting analgesic|central acting analgesic
1542925|NCT00609466|CG5503 IR|cg5503 ir
1542926|NCT00609466|Postoperative pain|postoperative pain
1542927|NCT00609466|Bunionectomy|bunionectomy
1542928|NCT00609466|Morphine|morphine
1542929|NCT00609466|Placebo|placebo
1542930|NCT00609453|Control participants|control participants
1542931|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
1542932|NCT00609427|cognitive training|cognitive training
1542933|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
1542934|NCT00609414|Burns|burns
1542935|NCT00609414|Albumin|albumin
1542936|NCT00609414|Fluid Resuscitation|fluid resuscitation
1542937|NCT00609401|Sorafenib|sorafenib
1542939|NCT00609401|Metastatic disease|metastatic disease
1542940|NCT00609375|Sepsis|sepsis
1542941|NCT00609375|Bacteremia|bacteremia
1542942|NCT00609375|Intravenous infusions|intravenous infusions
1542943|NCT00609375|cefepime|cefepime
1542944|NCT00609362|BMD|bmd
1542945|NCT00609362|Rosiglitazone|rosiglitazone
1542946|NCT00609362|Bone marrow fat|bone marrow fat
1543661|NCT00606632|Kidney|kidney
1542947|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
1542948|NCT00609323|Pain|pain
1542949|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
1542950|NCT00609310|clinical trial|clinical trial
1542951|NCT00609310|flavonoid treatment|flavonoid treatment
1542952|NCT00609310|neoplasia recurrence|neoplasia recurrence
1542953|NCT00609310|colorectal cancer|colorectal cancer
1542954|NCT00609310|polypectomy|polypectomy
1542955|NCT00609310|adenoma in Colon|adenoma in colon
1542956|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
1542957|NCT00609310|postpolypectomy patients|postpolypectomy patients
1542958|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1542959|NCT00609297|pain|pain
1542960|NCT00609284|Stage III|stage iii
1542961|NCT00609284|Stage IV|stage iv
1542962|NCT00609284|locally advanced|locally advanced
1542963|NCT00609245|epilepsy|epilepsy
1542964|NCT00609245|photosensitive|photosensitive
1542965|NCT00609245|valproic acid|valproic acid
1542966|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1542967|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1542968|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1542969|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1542970|NCT00609180|Acute Lung Injury|acute lung injury
1542971|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1542972|NCT00609180|Feeding|feeding
1542973|NCT00609180|Critical Care|critical care
1542974|NCT00609180|Ventilator|ventilator
1542975|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
1542976|NCT00609180|Antioxidant|antioxidant
1542977|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
1542978|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
1542979|NCT00609154|Type 2 diabetes|type 2 diabetes
1542980|NCT00609154|Insulin|insulin
1542981|NCT00609154|biosynthesis|biosynthesis
1542982|NCT00609154|Non diabetic control|non diabetic control
1542983|NCT00609128|tears|tears
1542984|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
1542985|NCT00609128|olopatadine|olopatadine
1542986|NCT00609128|impression cytology|impression cytology
1542987|NCT00609115|Sub-acute care|sub-acute care
1542988|NCT00609115|Robotics|robotics
1542989|NCT00609102|Type 2 diabetes|type 2 diabetes
1542990|NCT00609089|Family|family
1542991|NCT00609089|treatment|treatment
1542992|NCT00609089|reinforcement|reinforcement
1542993|NCT00609089|substance|substance
1542994|NCT00609089|trial|trial
1542995|NCT00609089|drug|drug
1542996|NCT00609089|abuse|abuse
1542997|NCT00609089|HIV|hiv
1542998|NCT00609089|risk|risk
1542999|NCT00609063|Statins|statins
1543000|NCT00609063|Myalgia|myalgia
1543001|NCT00609063|Muscle Cramp|muscle cramp
1543002|NCT00609050|cystic fibrosis|cystic fibrosis
1543003|NCT00609050|exercise|exercise
1543004|NCT00609050|perceived exertion|perceived exertion
1543005|NCT00609050|aerobic fitness|aerobic fitness
1543006|NCT00609050|lung function|lung function
1543007|NCT00609050|health related quality of life|health related quality of life
1543008|NCT00609050|self-regulated exercise|self-regulated exercise
1543009|NCT00609037|Gastric Bypass|gastric bypass
1543010|NCT00609037|Body contouring|body contouring
1543011|NCT00609037|Excessive weight loss|excessive weight loss
1543012|NCT00609011|Melanoma|melanoma
1543013|NCT00609011|Metastatic|metastatic
1543014|NCT00608998|Chronic renal failure|chronic renal failure
1543015|NCT00608998|Vasculopathy|vasculopathy
1543016|NCT00608998|Cardiovascular risk|cardiovascular risk
1543017|NCT00608998|Chronic renal failure patients|chronic renal failure patients
1543018|NCT00608985|sleeplessness|sleeplessness
1543019|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
1543020|NCT00608985|almorexant|almorexant
1543021|NCT00608985|insomnia|insomnia
1543022|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
1543023|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
1543024|NCT00608972|breast cancer|breast cancer
1543025|NCT00608959|Skin colonization|skin colonization
1543026|NCT00608959|Catheter colonization|catheter colonization
1543027|NCT00608959|Catheter site infection|catheter site infection
1543028|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
1543029|NCT00608946|cognitive status over time|cognitive status over time
1543030|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
1543031|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543032|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1543033|NCT00608920|SPECT|spect
1543034|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
1543035|NCT00608894|Chronic active hepatitis|chronic active hepatitis
1543036|NCT00608881|Huntington's disease|huntington's disease
1543037|NCT00608881|Huntington disease|huntington disease
1543038|NCT00608881|HD|hd
1543039|NCT00608881|coenzyme Q10|coenzyme q10
1543040|NCT00608881|CoQ|coq
1543041|NCT00608868|Carcinoma|carcinoma
1543042|NCT00608868|Non Small Cell Lung|non small cell lung
1543043|NCT00608868|EGFR mutation|egfr mutation
1543044|NCT00608868|Gefitinib|gefitinib
1543045|NCT00608855|bone metastases|bone metastases
1543046|NCT00608855|pain|pain
1543047|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543048|NCT00608816|epinephrine|epinephrine
1543049|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
1543050|NCT00608777|Localized mild breakthrough|localized mild breakthrough
1543051|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1543052|NCT00608764|COPD|copd
1543053|NCT00608764|Emphysema|emphysema
1543054|NCT00608764|Chronic Bronchitis|chronic bronchitis
1543055|NCT00608764|Genetics|genetics
1543056|NCT00608764|Association Studies|association studies
1543057|NCT00608764|Computed Tomography|computed tomography
1543058|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
1543059|NCT00608738|neutropenia|neutropenia
1543060|NCT00608738|infection|infection
1543061|NCT00608738|radiation toxicity|radiation toxicity
1543062|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1543063|NCT00608738|malnutrition|malnutrition
1543064|NCT00608738|musculoskeletal complications|musculoskeletal complications
1543065|NCT00608738|thrombocytopenia|thrombocytopenia
1543066|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543067|NCT00608725|heart rate|heart rate
1543068|NCT00608725|blood pressure|blood pressure
1543069|NCT00608725|blood volume|blood volume
1543070|NCT00608725|sympathetic nervous system|sympathetic nervous system
1543071|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
1543072|NCT00608725|orthostatic intolerance|orthostatic intolerance
1543073|NCT00608725|POTS|pots
1543074|NCT00608712|bariatric surgery|bariatric surgery
1543075|NCT00608712|ulcer prevention|ulcer prevention
1543076|NCT00608699|Flushing|flushing
1543077|NCT00608699|GSK256073A,|gsk256073a,
1543078|NCT00608699|Dose Escalation,|dose escalation,
1543079|NCT00608699|Immediate Release Niacin,|immediate release niacin,
1543080|NCT00608686|NIAAA|niaaa
1543081|NCT00608686|Alcohol|alcohol
1543082|NCT00608686|Neurosteroids|neurosteroids
1543083|NCT00608686|Intoxication|intoxication
1543084|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
1543085|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
1543086|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
1543712|NCT00606359|Influenza|influenza
1543087|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
1543088|NCT00608660|Acupuncture|acupuncture
1543089|NCT00608660|RCT|rct
1543090|NCT00608634|actinic keratosis|actinic keratosis
1543091|NCT00608621|physostigmine|physostigmine
1543092|NCT00608621|postoperative analgesia|postoperative analgesia
1543093|NCT00608621|pain|pain
1543094|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
1543095|NCT00608621|Opioid consumption|opioid consumption
1543096|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
1543097|NCT00608621|Hemodynamics|hemodynamics
1543098|NCT00608621|Mobilisation|mobilisation
1543099|NCT00608621|Side effects|side effects
1543100|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1543101|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
1543102|NCT00608595|stage I rectal cancer|stage i rectal cancer
1543103|NCT00608595|stage II rectal cancer|stage ii rectal cancer
1543104|NCT00608595|stage III rectal cancer|stage iii rectal cancer
1543105|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
1543106|NCT00608582|TMS|tms
1543107|NCT00608582|Treat Naming|treat naming
1543108|NCT00608582|Aphasia|aphasia
1543109|NCT00608582|Chronic Stroke|chronic stroke
1543110|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
1543111|NCT00608569|Drug Therapy, Combination|drug therapy, combination
1543112|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
1543113|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
1543114|NCT00608569|Viral Load|viral load
1543115|NCT00608569|Virologic Failure|virologic failure
1543116|NCT00608556|Heterotaxy|heterotaxy
1543117|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1543118|NCT00608556|Congenital Heart Disease|congenital heart disease
1543119|NCT00608556|Genetic Study|genetic study
1543120|NCT00608556|Situs Inversus|situs inversus
1543121|NCT00608543|cognitive function|cognitive function
1543122|NCT00608543|psychosocial function|psychosocial function
1543123|NCT00608543|augmentation|augmentation
1543124|NCT00608543|treatment refractory depression|treatment refractory depression
1543125|NCT00608530|pain|pain
1543126|NCT00608530|chronic pain|chronic pain
1543127|NCT00608530|chronic back pain|chronic back pain
1543128|NCT00608530|randomized clinical trial|randomized clinical trial
1543129|NCT00608517|graft versus host disease|graft versus host disease
1543130|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1543131|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1543132|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1543764|NCT00606034|Omnipod|omnipod
1543133|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1543134|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1543135|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1543136|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1543137|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1543138|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1543139|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1543140|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1543141|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1543142|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1543143|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1543144|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1543145|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1543146|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1543147|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1543148|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1543149|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1543150|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1543151|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1543152|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1543153|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
1543154|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1567834|NCT00508040|Interferon alpha 2a|interferon alpha 2a
1543155|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1543156|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1543157|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1543158|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1543159|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1543160|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1543161|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1543162|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1543163|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1543164|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
1543165|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
1543166|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
1543167|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1543168|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1543169|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1543170|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1543171|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1543172|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1543173|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1543174|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1543175|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1543176|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1543177|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1543178|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1543179|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1543180|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
1543181|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1543182|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1543183|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1543184|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1543185|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1543186|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1543187|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1543188|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1543189|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1543190|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1543191|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1543192|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1543193|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1543194|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1543195|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1543196|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
1543197|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
1543198|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1543199|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1543200|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1543201|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1543202|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1543203|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1543204|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1543205|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1543206|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1543207|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1543208|NCT00608504|Behavioral Economics|behavioral economics
1543209|NCT00608504|Drug self administration|drug self administration
1543210|NCT00608504|Opioid|opioid
1543211|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
1543212|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
1543213|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
1543214|NCT00608491|Persistent Congestion|persistent congestion
1543215|NCT00608491|Ultra Filtration|ultra filtration
1543216|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
1543217|NCT00608465|Obesity|obesity
1543218|NCT00608465|PAI-1|pai-1
1543219|NCT00608452|Lung|lung
1543220|NCT00608452|Ovarian|ovarian
1543221|NCT00608452|Breast|breast
1543222|NCT00608452|Hodgkin's|hodgkin's
1543223|NCT00608439|CAST|cast
1543224|NCT00608439|Centella asiatica|centella asiatica
1543225|NCT00608439|Diabetes|diabetes
1543226|NCT00608439|Diabetic neuropathy|diabetic neuropathy
1543227|NCT00608426|African Americans|african americans
1543228|NCT00608426|telephone counseling|telephone counseling
1543229|NCT00608426|community health planning|community health planning
1543919|NCT00605098|HIV|hiv
1543230|NCT00608426|ethnic groups|ethnic groups
1543231|NCT00608400|CLA|cla
1543232|NCT00608400|PTH|pth
1543233|NCT00608400|nutritional supplement|nutritional supplement
1543234|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
1543235|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1543236|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1543237|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1543238|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1543239|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1543240|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1543241|NCT00608348|exercise|exercise
1543242|NCT00608348|hypoglycemia|hypoglycemia
1543243|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
1543244|NCT00608335|Antifungal|antifungal
1543245|NCT00608335|Echinocandin|echinocandin
1543246|NCT00608335|Candidiasis|candidiasis
1543247|NCT00608335|Micafungin|micafungin
1543248|NCT00608322|Sepsis|sepsis
1543249|NCT00608322|Severe sepsis|severe sepsis
1543250|NCT00608322|Septic shock|septic shock
1543251|NCT00608283|Kidney transplant|kidney transplant
1543252|NCT00608283|Live donor transplant|live donor transplant
1543253|NCT00608244|Tacrolimus|tacrolimus
1543254|NCT00608244|Pharmacokinetics|pharmacokinetics
1543255|NCT00608244|Liver Transplantation|liver transplantation
1543256|NCT00608218|Asthma|asthma
1543257|NCT00608218|ciclesonide|ciclesonide
1543258|NCT00608218|inhaled steroids|inhaled steroids
1543259|NCT00608218|Alvesco|alvesco
1543260|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1543261|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1543262|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1543263|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1543264|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1543265|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1543266|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1543267|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1543268|NCT00608192|HIV|hiv
1543269|NCT00608192|viral hepatitis|viral hepatitis
1543270|NCT00608192|methadone maintenance|methadone maintenance
1543271|NCT00608192|case management|case management
1543272|NCT00608192|costs|costs
1543273|NCT00608192|vaccination|vaccination
1543274|NCT00608192|risk reduction education|risk reduction education
1543275|NCT00608179|epinephrine|epinephrine
1543276|NCT00608179|glucose clamp|glucose clamp
1543277|NCT00608153|essential hypertension|essential hypertension
1543279|NCT00608153|compliance|compliance
1543280|NCT00608153|candesartan|candesartan
1543281|NCT00608140|Advanced Heart Failure|advanced heart failure
1543282|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
1543283|NCT00608140|Mitral Regurgitation|mitral regurgitation
1543284|NCT00608140|Mitral Valve Replacement|mitral valve replacement
1543285|NCT00608140|Congestive Heart Failure|congestive heart failure
1543286|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
1543287|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
1543288|NCT00608140|Annular Ring|annular ring
1543289|NCT00608101|hypoglycemia|hypoglycemia
1543290|NCT00608101|exercise|exercise
1543291|NCT00608101|corticosteroids|corticosteroids
1543292|NCT00608088|Breast feeding|breast feeding
1543293|NCT00608088|breastfeeding|breastfeeding
1543294|NCT00608088|randomized clinical trial|randomized clinical trial
1543295|NCT00608088|poverty|poverty
1543296|NCT00608062|endothelial function|endothelial function
1543297|NCT00608062|women|women
1543298|NCT00608062|female|female
1543299|NCT00608062|estrogen deficiency|estrogen deficiency
1543300|NCT00608062|sex hormones|sex hormones
1543301|NCT00608062|adiposity|adiposity
1543302|NCT00608062|oxidative stress|oxidative stress
1543303|NCT00608062|antioxidants|antioxidants
1543304|NCT00608049|Blood Pressure|blood pressure
1543305|NCT00608049|Diabetes|diabetes
1543306|NCT00608049|Nutrition|nutrition
1543307|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
1543308|NCT00608049|Lipoproteins|lipoproteins
1543309|NCT00608049|Insulin Resistance|insulin resistance
1543310|NCT00608036|Adolescents|adolescents
1543311|NCT00608036|Neighborhood|neighborhood
1543312|NCT00608036|Walkability|walkability
1543313|NCT00608036|Physical Activity|physical activity
1543314|NCT00608036|Quality of Life|quality of life
1543315|NCT00608036|Ecological Analysis|ecological analysis
1543316|NCT00608036|Dietary Patterns|dietary patterns
1543317|NCT00608036|Weight Status|weight status
1543318|NCT00608036|Neighborhood Environment|neighborhood environment
1543319|NCT00608036|Food Environment|food environment
1543320|NCT00608036|Recreation Environment|recreation environment
1543321|NCT00608023|HIV|hiv
1543322|NCT00608023|Lipodystrophy|lipodystrophy
1543323|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
1543324|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
1543325|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
1543326|NCT00608023|Treatment experienced|treatment experienced
1543327|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
1543328|NCT00607997|Leukemia|leukemia
1543329|NCT00607997|Myeloid|myeloid
1543330|NCT00607997|Elderly|elderly
1543331|NCT00607997|Hematologic|hematologic
1543332|NCT00607997|Blood|blood
1543333|NCT00607997|Cancer|cancer
1543334|NCT00607997|Malignancy|malignancy
1543335|NCT00607997|SNS-595|sns-595
1543336|NCT00607997|Sunesis|sunesis
1543337|NCT00607997|Hematologic Diseases|hematologic diseases
1543338|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
1543339|NCT00607997|Older|older
1543340|NCT00607997|voreloxin|voreloxin
1543341|NCT00607997|reveal-1|reveal-1
1543342|NCT00607984|thiotepa|thiotepa
1543343|NCT00607984|melphalan|melphalan
1543344|NCT00607984|brain tumor|brain tumor
1543345|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
1543346|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
1543347|NCT00607958|Tipranavir|tipranavir
1543348|NCT00607958|ritonavir|ritonavir
1543349|NCT00607958|dose reduction|dose reduction
1543350|NCT00607958|inhibitory quotient|inhibitory quotient
1543351|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
1543352|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
1543353|NCT00607945|weight loss|weight loss
1543354|NCT00607945|rosiglitazone|rosiglitazone
1543355|NCT00607945|glucose control|glucose control
1543356|NCT00607945|insulin sensitivity|insulin sensitivity
1543357|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
1543358|NCT00607906|safety|safety
1543359|NCT00607906|pharmacodynamics|pharmacodynamics
1543360|NCT00607906|diabetes|diabetes
1543361|NCT00607906|pharmacokinetics|pharmacokinetics
1543362|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
1543363|NCT00607880|vascular access device complications|vascular access device complications
1543364|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543365|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
1543366|NCT00607867|Diet|diet
1543367|NCT00607867|Glycohemoglobin|glycohemoglobin
1543368|NCT00607867|Lipids|lipids
1543369|NCT00607867|Kidney Function|kidney function
1543370|NCT00607867|Glycemic Index|glycemic index
1543371|NCT00607867|Dietary Protein|dietary protein
1543372|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
1543373|NCT00607854|Zevalin|zevalin
1543374|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
1543375|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
1543376|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1543377|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
1543378|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1543379|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1543380|NCT00607815|PTSD|ptsd
1543381|NCT00607815|OEF/OIF|oef/oif
1543382|NCT00607815|Combat|combat
1543383|NCT00607815|Treatment|treatment
1543385|NCT00607815|PCT|pct
1543386|NCT00607815|Cognitive|cognitive
1543387|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543388|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1543389|NCT00607776|dry, eyes|dry, eyes
1543390|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
1543391|NCT00607763|Antifungal|antifungal
1543392|NCT00607763|Echinocandin|echinocandin
1543393|NCT00607763|Candidiasis|candidiasis
1543394|NCT00607763|Micafungin|micafungin
1543395|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
1543396|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1543397|NCT00607685|Trabeculectomy|trabeculectomy
1543398|NCT00607685|Wound healing|wound healing
1543399|NCT00607685|5 Fluorouracil|5 fluorouracil
1543400|NCT00607685|Hyaluronic acid|hyaluronic acid
1543401|NCT00607685|post-operative scarring|post-operative scarring
1543402|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
1543403|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
1543404|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
1543405|NCT00607672|Fibrinolysis|fibrinolysis
1543406|NCT00607672|Inflammation|inflammation
1543407|NCT00607659|Chlamydia|chlamydia
1543408|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
1543409|NCT00607659|Adolescent Health|adolescent health
1543410|NCT00607659|Female Health|female health
1567938|NCT00507728|Bupropion|bupropion
1543411|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
1543412|NCT00607659|Infertility|infertility
1543413|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
1543414|NCT00607646|hypoglycemia|hypoglycemia
1543415|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
1543416|NCT00607633|essential hypertension|essential hypertension
1543920|NCT00605098|Pregnancy|pregnancy
1543418|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
1543419|NCT00607633|candesartan|candesartan
1543420|NCT00607620|Alcohol Abuse|alcohol abuse
1543421|NCT00607620|Alcohol Dependence|alcohol dependence
1543422|NCT00607620|Alcohol Use Disorder|alcohol use disorder
1543423|NCT00607620|Screening|screening
1543424|NCT00607620|Brief Intervention|brief intervention
1543425|NCT00607620|Motivational Interviewing|motivational interviewing
1543426|NCT00607607|ovarian cancer|ovarian cancer
1543427|NCT00607607|endometrial cancer|endometrial cancer
1543428|NCT00607581|amyloidosis|amyloidosis
1543429|NCT00607581|lenalidomide|lenalidomide
1543430|NCT00607581|cyclophosphamide|cyclophosphamide
1543431|NCT00607581|dexamethasone|dexamethasone
1543432|NCT00607568|physical stress|physical stress
1543433|NCT00607568|psychological stress|psychological stress
1543434|NCT00607555|Infant, premature|infant, premature
1543435|NCT00607555|Infant, very low birth weight|infant, very low birth weight
1543436|NCT00607555|Apnea|apnea
1543437|NCT00607555|Feeding methods|feeding methods
1543438|NCT00607555|Diaphragm|diaphragm
1543439|NCT00607542|spasticity|spasticity
1543440|NCT00607542|cerebral palsy|cerebral palsy
1543441|NCT00607542|baclofen|baclofen
1543442|NCT00607542|pharmacokinetics|pharmacokinetics
1543443|NCT00607542|pharmacodynamics|pharmacodynamics
1543444|NCT00607542|dosing|dosing
1543445|NCT00607542|safety|safety
1543446|NCT00607542|efficacy|efficacy
1543447|NCT00607529|Multiple Diseases|multiple diseases
1543448|NCT00607516|fracture|fracture
1543449|NCT00607516|arthroplasty|arthroplasty
1543450|NCT00607516|wear|wear
1543451|NCT00607516|osteoporosis|osteoporosis
1543452|NCT00607516|bone|bone
1543453|NCT00607490|Vulvodynia|vulvodynia
1543454|NCT00607490|Vulvar pain|vulvar pain
1543455|NCT00607490|Dyspareunia|dyspareunia
1543456|NCT00607490|Sexual dysfunction|sexual dysfunction
1543457|NCT00607490|Vestibulitis|vestibulitis
1543458|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
1543459|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
1543460|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
1543461|NCT00607425|screening|screening
1543462|NCT00607425|saliva|saliva
1543463|NCT00607425|gene expression|gene expression
1543464|NCT00607425|healthy control subject|healthy control subject
1543465|NCT00607412|PTSD|ptsd
1543466|NCT00607412|substance use disorders|substance use disorders
1543467|NCT00607412|psychotherapy|psychotherapy
1543468|NCT00607399|Solid tumor|solid tumor
1543469|NCT00607399|Advanced Cancer|advanced cancer
1543470|NCT00607399|MET Inhibitor|met inhibitor
1543471|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
1543472|NCT00607386|Hunter syndrome|hunter syndrome
1543473|NCT00607386|hunters syndrome|hunters syndrome
1543474|NCT00607386|hunter's syndrome|hunter's syndrome
1543475|NCT00607386|hunter disease|hunter disease
1543476|NCT00607386|hunters disease|hunters disease
1543477|NCT00607386|hunter's disease|hunter's disease
1543479|NCT00607386|MPSII|mpsii
1543480|NCT00607386|MPS2|mps2
1543481|NCT00607386|MPS 2|mps 2
1543482|NCT00607386|mucopolysaccharides|mucopolysaccharides
1543483|NCT00607386|lysosomal storage disease|lysosomal storage disease
1543484|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
1543485|NCT00607386|chronic ear infection|chronic ear infection
1543486|NCT00607386|enlarged adenoids|enlarged adenoids
1543487|NCT00607386|mps symptoms|mps symptoms
1543488|NCT00607386|mps diagnosis|mps diagnosis
1543489|NCT00607386|mps ii therapy|mps ii therapy
1543490|NCT00607386|MPS II treatment|mps ii treatment
1543491|NCT00607386|ert treatment|ert treatment
1543492|NCT00607386|elaprase|elaprase
1543493|NCT00607386|idursulfase|idursulfase
1543494|NCT00607386|iduronate sulfatase|iduronate sulfatase
1543495|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
1543496|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
1543497|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
1543498|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
1543499|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
1543500|NCT00607386|hunter's disease treatment|hunter's disease treatment
1543501|NCT00607386|mps society|mps society
1543502|NCT00607373|Apolipoprotein B|apolipoprotein b
1543503|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1543504|NCT00607373|LDL-receptor gene|ldl-receptor gene
1543505|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
1543506|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
1543507|NCT00607347|Hypertension|hypertension
1543508|NCT00607347|Adverse metabolic effects|adverse metabolic effects
1543509|NCT00607347|Beta blockers|beta blockers
1543510|NCT00607347|Dyslipidemia|dyslipidemia
1543511|NCT00607347|Atenolol|atenolol
1543512|NCT00607347|New onset diabetes|new onset diabetes
1543513|NCT00607347|Pharmacokinetic study|pharmacokinetic study
1543514|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
1543515|NCT00607334|Child Language|child language
1543516|NCT00607334|Language Therapy|language therapy
1543517|NCT00607334|Vocabulary|vocabulary
1543518|NCT00607321|restenosis|restenosis
1543519|NCT00607321|Coronary Disease|coronary disease
1543520|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
1543521|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
1543522|NCT00607295|chemotherapy|chemotherapy
1543523|NCT00607295|hormonal therapy|hormonal therapy
1543524|NCT00607295|urogenital atrophy|urogenital atrophy
1543525|NCT00607269|Drug Abuse|drug abuse
1543526|NCT00607269|Contingency management|contingency management
1543527|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
1543528|NCT00607269|Homosexuality|homosexuality
1543529|NCT00607269|Homeless Persons|homeless persons
1543530|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
1543531|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
1543532|NCT00607230|immune modulation|immune modulation
1543533|NCT00607230|cure|cure
1543534|NCT00607230|autoimmunity|autoimmunity
1543535|NCT00607217|Coronary artery diseases|coronary artery diseases
1543536|NCT00607217|Myocardial infarction|myocardial infarction
1543537|NCT00607217|Stable angina|stable angina
1543538|NCT00607217|Influenza|influenza
1543539|NCT00607217|Vaccine|vaccine
1543540|NCT00607204|Basic Research|basic research
1543541|NCT00607204|Individual Sleep Duration|individual sleep duration
1543542|NCT00607204|Melatonin|melatonin
1543543|NCT00607204|Electroencephalogram|electroencephalogram
1543544|NCT00607204|Alertness|alertness
1543545|NCT00607204|Mood|mood
1543546|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
1543547|NCT00607178|Influenza|influenza
1543548|NCT00607178|Vaccine|vaccine
1543549|NCT00607126|impaired ambulation|impaired ambulation
1543550|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
1543551|NCT00607113|Avastin|avastin
1543552|NCT00607113|Bevacizumab|bevacizumab
1543553|NCT00607113|RAD001|rad001
1543554|NCT00607113|Everolimus|everolimus
1543555|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
1543556|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
1543557|NCT00607100|Band Atrophy|band atrophy
1543558|NCT00607061|Glutathione|glutathione
1543559|NCT00607061|Cysteine|cysteine
1543560|NCT00607061|Synthesis rate|synthesis rate
1543561|NCT00607061|Newborns|newborns
1543562|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
1543563|NCT00607022|dental implant|dental implant
1543564|NCT00607022|early loading|early loading
1543565|NCT00607022|traditional loading|traditional loading
1543566|NCT00607022|anterior|anterior
1543567|NCT00607022|implant stability|implant stability
1543568|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
1543569|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
1543570|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
1543571|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
1543572|NCT00606996|Drug Abuse|drug abuse
1543573|NCT00606996|Drug Dependence|drug dependence
1543574|NCT00606996|Alcohol Abuse|alcohol abuse
1543575|NCT00606996|Alcohol Dependence|alcohol dependence
1543576|NCT00606996|Major Depressive Disorder|major depressive disorder
1543577|NCT00606996|Dysthymic Disorder|dysthymic disorder
1543578|NCT00606996|Prisoners|prisoners
1543579|NCT00606996|Women|women
1543580|NCT00606970|Chemotherapy|chemotherapy
1543581|NCT00606970|Breast Cancer|breast cancer
1543582|NCT00606970|Colon Cancer|colon cancer
1543583|NCT00606970|Lung Cancer|lung cancer
1543584|NCT00606957|Obesity|obesity
1543585|NCT00606957|Metabolism|metabolism
1543586|NCT00606944|enhanced recovery program|enhanced recovery program
1543587|NCT00606931|biopsy|biopsy
1543589|NCT00606931|image-guidance|image-guidance
1543590|NCT00606931|breast cancer|breast cancer
1543593|NCT00606918|Strength testing|strength testing
1543594|NCT00606918|Disease progression|disease progression
1543595|NCT00606918|ALS|als
1543596|NCT00606918|Healthy Adults|healthy adults
1543597|NCT00606905|Recurrent miscarriage|recurrent miscarriage
1543598|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
1543599|NCT00606905|Habitual abortion|habitual abortion
1543600|NCT00606905|IVIG|ivig
1543601|NCT00606905|Randomized Controlled Trial|randomized controlled trial
1543602|NCT00606892|therapeutic effects|therapeutic effects
1543603|NCT00606879|Solid tumor|solid tumor
1543604|NCT00606879|Advanced Cancer|advanced cancer
1543605|NCT00606879|MET inhibitor|met inhibitor
1543606|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
1543607|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
1543608|NCT00606853|Substance abuse|substance abuse
1543609|NCT00606853|Contingency Management|contingency management
1543610|NCT00606840|overweight|overweight
1543611|NCT00606840|prevention of weight gain|prevention of weight gain
1543612|NCT00606840|young adults|young adults
1543613|NCT00606840|self-regulation|self-regulation
1543614|NCT00606840|daily weighing|daily weighing
1543615|NCT00606840|weight gain prevention|weight gain prevention
1543616|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
1543617|NCT00606827|Contrast media|contrast media
1543618|NCT00606827|Angiography|angiography
1543619|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
1543620|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
1543621|NCT00606801|cognitive enhancers|cognitive enhancers
1543622|NCT00606801|Nootropic Agents|nootropic agents
1543623|NCT00606788|randomized clinical trials|randomized clinical trials
1543624|NCT00606788|intensive care|intensive care
1543625|NCT00606788|mechanical ventilation|mechanical ventilation
1543626|NCT00606788|ventilator weaning|ventilator weaning
1543627|NCT00606788|clinical protocols|clinical protocols
1543628|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
1543629|NCT00606788|humans|humans
1543630|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
1543631|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1543632|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1543633|NCT00606775|Cardiomyopathies|cardiomyopathies
1543634|NCT00606775|Troponin I|troponin i
1543635|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
1543636|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
1543637|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
1543638|NCT00606736|sex hormone level|sex hormone level
1543639|NCT00606736|menstrual cycle|menstrual cycle
1543640|NCT00606736|Gonadal Hormones|gonadal hormones
1543641|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
1543642|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
1543643|NCT00606697|Primary Insomnia Adults|primary insomnia adults
1543644|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1543645|NCT00606684|COPD|copd
1543646|NCT00606684|GW642444|gw642444
1543647|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
1543648|NCT00606658|Insomnia|insomnia
1543649|NCT00606658|Ayurveda|ayurveda
1543650|NCT00606658|Shirodhara|shirodhara
1543651|NCT00606658|Quality of Life|quality of life
1543652|NCT00606632|Renal Mass|renal mass
1543653|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
1543654|NCT00606632|Cancer of Kidney|cancer of kidney
1543655|NCT00606632|Kidney Cancer|kidney cancer
1543656|NCT00606632|Neoplasms|neoplasms
1543657|NCT00606632|cG250|cg250
1543658|NCT00606632|antibody, monoclonal|antibody, monoclonal
1543659|NCT00606632|Iodine 124|iodine 124
1543660|NCT00606632|Positron-Emission Tomography|positron-emission tomography
1543662|NCT00606632|Renal Cancer|renal cancer
1543663|NCT00606632|Renal Neoplasms|renal neoplasms
1543664|NCT00606619|Gastrectomy|gastrectomy
1543665|NCT00606619|Oral feeding|oral feeding
1543666|NCT00606619|Nutrition|nutrition
1543667|NCT00606619|Gastric cancer|gastric cancer
1543668|NCT00606593|insomnia|insomnia
1543669|NCT00606593|elderly|elderly
1543670|NCT00606593|sleeplessness|sleeplessness
1543671|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
1543672|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
1543673|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
1543674|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
1543675|NCT00606554|Ventilator Weaning|ventilator weaning
1543676|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
1543677|NCT00606541|Social Anxiety Disorder|social anxiety disorder
1543678|NCT00606541|Quetiapine XR|quetiapine xr
1543679|NCT00606541|Prevention|prevention
1543680|NCT00606541|tolerability|tolerability
1543681|NCT00606528|Antiviral therapy|antiviral therapy
1543682|NCT00606515|Pharmacokinetics|pharmacokinetics
1543683|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
1543684|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
1543685|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
1543686|NCT00606502|NSCLC|nsclc
1543687|NCT00606502|Lung Cancer|lung cancer
1543688|NCT00606502|Pralatrexate|pralatrexate
1543689|NCT00606502|Erlotinib|erlotinib
1543690|NCT00606502|Tarceva|tarceva
1543691|NCT00606502|PDX|pdx
1543692|NCT00606502|Smoking|smoking
1543693|NCT00606502|Smoker|smoker
1543694|NCT00606450|plaque psoriasis|plaque psoriasis
1543695|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
1543696|NCT00606437|Stem Cell Transplantation|stem cell transplantation
1543697|NCT00606424|head and neck cancer|head and neck cancer
1543698|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
1543699|NCT00606411|Topiramate|topiramate
1543700|NCT00606411|Parasomnia|parasomnia
1543701|NCT00606398|colorectal metastases|colorectal metastases
1543702|NCT00606385|Recurrence|recurrence
1543703|NCT00606385|Survival|survival
1543704|NCT00606385|Immunology|immunology
1543705|NCT00606385|Laparoscopy|laparoscopy
1543706|NCT00606372|Off-pump|off-pump
1543707|NCT00606372|OPCAB|opcab
1543708|NCT00606372|EuroSCORE|euroscore
1543709|NCT00606372|high-risk patients|high-risk patients
1543710|NCT00606372|Quality of life|quality of life
1543711|NCT00606372|Validity of EuroSCORE|validity of euroscore
1543713|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
1543714|NCT00606359|Renal Transplant|renal transplant
1543715|NCT00606346|Crohn's Disease|crohn's disease
1543716|NCT00606346|Ulcerative Colitis|ulcerative colitis
1543717|NCT00606346|Indeterminate Colitis|indeterminate colitis
1543718|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
1543719|NCT00606346|Immunomodulators|immunomodulators
1543720|NCT00606346|infliximab|infliximab
1543721|NCT00606346|TNF-alpha|tnf-alpha
1543722|NCT00606333|Coronary artery disease|coronary artery disease
1543723|NCT00606333|drug-eluting stents|drug-eluting stents
1543724|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
1543725|NCT00606294|Head|head
1543726|NCT00606294|Neck|neck
1543727|NCT00606294|04-070|04-070
1543728|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
1543729|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1543730|NCT00606268|HSCT|hsct
1543731|NCT00606268|Micafungin|micafungin
1543732|NCT00606255|blood pressure|blood pressure
1543733|NCT00606255|compliance|compliance
1543734|NCT00606255|treatment|treatment
1543735|NCT00606216|MRI|mri
1543736|NCT00606164|Alzheimer's Disease|alzheimer's disease
1543737|NCT00606164|bryostatin 1|bryostatin 1
1543738|NCT00606164|bryostatin|bryostatin
1543739|NCT00606164|safety|safety
1543740|NCT00606164|efficacy|efficacy
1543741|NCT00606164|pharmacokinetics|pharmacokinetics
1543742|NCT00606164|pharmacodynamics|pharmacodynamics
1543743|NCT00606164|protein kinase C|protein kinase c
1543744|NCT00606151|drug eluding stents|drug eluding stents
1543745|NCT00606151|perioperative bridging|perioperative bridging
1543746|NCT00606151|Stents|stents
1543747|NCT00606125|Chemotherapy|chemotherapy
1543748|NCT00606125|Solid Tumors|solid tumors
1543749|NCT00606125|Sorafenib|sorafenib
1543750|NCT00606125|Carboplatin|carboplatin
1543751|NCT00606125|Paclitaxel|paclitaxel
1543752|NCT00606099|Adults|adults
1543753|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
1543754|NCT00606099|telbivudin|telbivudin
1543755|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
1543756|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
1543757|NCT00606060|Hemophilia,|hemophilia,
1543758|NCT00606060|Continuous Infusion|continuous infusion
1543759|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
1543760|NCT00606034|Type 2 diabetes|type 2 diabetes
1543761|NCT00606034|Insulin Resistance|insulin resistance
1543762|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
1543763|NCT00606034|U-500 Insulin|u-500 insulin
1543765|NCT00606008|Sutent|sutent
1543766|NCT00605995|Schizophrenia|schizophrenia
1543767|NCT00605995|Randomized trial|randomized trial
1543768|NCT00605995|Statin|statin
1543769|NCT00605995|Placebo|placebo
1543771|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
1543772|NCT00605956|head lice|head lice
1543773|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
1543774|NCT00605943|Retinal Disease|retinal disease
1543775|NCT00605943|Bevacizumab|bevacizumab
1543776|NCT00605943|Ranibizumab|ranibizumab
1543777|NCT00605943|Retinal Eye Disease|retinal eye disease
1543778|NCT00605943|Macular Degeneration|macular degeneration
1543779|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
1543780|NCT00605930|PSP|psp
1543781|NCT00605930|Nutriceutical|nutriceutical
1543782|NCT00605930|Pyruvate|pyruvate
1543783|NCT00605930|Creatine|creatine
1543784|NCT00605930|Niacinamide|niacinamide
1543785|NCT00605904|Chemical Stressor|chemical stressor
1543786|NCT00605904|Alcoholism|alcoholism
1543787|NCT00605904|Yohimbine|yohimbine
1543788|NCT00605904|Acamprosate|acamprosate
1543789|NCT00605904|Craving|craving
1543790|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
1543791|NCT00605878|Bacteria|bacteria
1543792|NCT00605878|Filaggrin|filaggrin
1543793|NCT00605878|Skin|skin
1543794|NCT00605878|Microbiome|microbiome
1543795|NCT00605878|Atopic Dermatitis|atopic dermatitis
1543796|NCT00605878|Eczema|eczema
1543797|NCT00605878|Health Volunteer|health volunteer
1543798|NCT00605878|HG|hg
1543799|NCT00605852|Allergic rhinitis|allergic rhinitis
1543800|NCT00605852|first time in human|first time in human
1543801|NCT00605839|mobile technology|mobile technology
1543802|NCT00605839|cell phones|cell phones
1543803|NCT00605839|type 1 diabetes|type 1 diabetes
1543804|NCT00605800|Liver resection|liver resection
1543805|NCT00605774|catecholamines|catecholamines
1543806|NCT00605774|diabetes|diabetes
1543807|NCT00605774|exercise|exercise
1543808|NCT00605761|Cystic Fibrosis|cystic fibrosis
1543809|NCT00605761|Lung function|lung function
1567939|NCT00507728|Wellbutrin|wellbutrin
1543810|NCT00605761|Anti-Inflammatory|anti-inflammatory
1543811|NCT00605748|catheter ablation|catheter ablation
1543812|NCT00605748|atrial fibrillation|atrial fibrillation
1543813|NCT00605748|pulmonary vein|pulmonary vein
1543814|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1543815|NCT00605696|Acute Lung Injury|acute lung injury
1543816|NCT00605657|ALPS|alps
1544227|NCT00603746|GW685698X|gw685698x
1543817|NCT00605657|Valproic Acid|valproic acid
1543818|NCT00605657|Lymphadenopathy|lymphadenopathy
1543819|NCT00605657|Splenomegaly|splenomegaly
1543820|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
1543821|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
1543822|NCT00605631|Pacing|pacing
1543823|NCT00605605|endothelial function|endothelial function
1543824|NCT00605605|atherosclerosis|atherosclerosis
1543825|NCT00605605|smoking|smoking
1543826|NCT00605605|inflammation|inflammation
1543827|NCT00605605|antioxidant|antioxidant
1543828|NCT00605592|Type 1 Diabetes|type 1 diabetes
1543829|NCT00605592|Kidney Transplant|kidney transplant
1543830|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
1543831|NCT00605592|Islet Transplant|islet transplant
1543832|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
1543833|NCT00605592|University of Virginia|university of virginia
1543834|NCT00605592|Islet Transplantation|islet transplantation
1543835|NCT00605592|Kidney Transplantation|kidney transplantation
1543836|NCT00605566|Neuroendocrine|neuroendocrine
1543837|NCT00605566|sorafenib|sorafenib
1543838|NCT00605566|cyclophosphamide|cyclophosphamide
1543839|NCT00605566|pharmacodynamic|pharmacodynamic
1543840|NCT00605540|COPD|copd
1543841|NCT00605540|Survival|survival
1543842|NCT00605540|Exacerbation|exacerbation
1543843|NCT00605540|Disease markers|disease markers
1543844|NCT00605527|Acute Lung Injury|acute lung injury
1543845|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1543846|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
1543847|NCT00605514|Healthy|healthy
1543848|NCT00605514|Immunity|immunity
1543849|NCT00605514|T-Cells|t-cells
1543850|NCT00605514|Filovirus|filovirus
1543851|NCT00605514|Healthy Volunteer|healthy volunteer
1543852|NCT00605514|HV|hv
1543853|NCT00605488|Pet Scan|pet scan
1543854|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1543855|NCT00605475|Canakinumab|canakinumab
1543856|NCT00605475|ACZ885|acz885
1543857|NCT00605475|IL-1B antagonist|il-1b antagonist
1543858|NCT00605475|metformin|metformin
1543859|NCT00605475|glycemic control|glycemic control
1543860|NCT00605475|insulin sensitivity|insulin sensitivity
1543861|NCT00605449|GSK376501|gsk376501
1543862|NCT00605449|Simvastatin|simvastatin
1543863|NCT00605449|Healthy Subjects|healthy subjects
1543864|NCT00605449|Repeat Dose|repeat dose
1543865|NCT00605449|Drug Interaction|drug interaction
1543866|NCT00605449|Randomized|randomized
1543867|NCT00605449|Pharmacokinetics|pharmacokinetics
1543868|NCT00605436|overweight|overweight
1543869|NCT00605436|sedentary|sedentary
1543870|NCT00605436|metabolic syndrome|metabolic syndrome
1543871|NCT00605423|AMD|amd
1543872|NCT00605423|Almera|almera
1543873|NCT00605423|Steroid|steroid
1543874|NCT00605423|Macular|macular
1543875|NCT00605423|ARMD|armd
1543876|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
1543877|NCT00605410|Antimuscarinic|antimuscarinic
1543878|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
1543879|NCT00605371|Healthy volunteers|healthy volunteers
1543880|NCT00605371|Bioequivalence|bioequivalence
1543881|NCT00605371|Food Effects|food effects
1543882|NCT00605358|geriatric depression|geriatric depression
1543883|NCT00605319|BPH|bph
1543884|NCT00605319|BOO|boo
1543885|NCT00605306|Asthma|asthma
1543886|NCT00605306|spirometry|spirometry
1543887|NCT00605306|lung function|lung function
1543888|NCT00605306|serum cortisol|serum cortisol
1543889|NCT00605306|serum potassium|serum potassium
1543890|NCT00605306|plasma glucose|plasma glucose
1543891|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
1543892|NCT00605267|Breast Cancer|breast cancer
1543893|NCT00605267|Breast Neoplasms|breast neoplasms
1543894|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
1543895|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
1543896|NCT00605254|P-Glycoprotein|p-glycoprotein
1543897|NCT00605254|Positron Emission Tomography|positron emission tomography
1543898|NCT00605254|Blood Brain Barrier|blood brain barrier
1543899|NCT00605254|Quantitative Imaging|quantitative imaging
1543900|NCT00605254|Multi-Drug Transporter|multi-drug transporter
1543901|NCT00605254|Healthy Volunteer|healthy volunteer
1543902|NCT00605254|HV|hv
1543903|NCT00605241|pharmacodynamics,|pharmacodynamics,
1543904|NCT00605241|pharmacokinetics,|pharmacokinetics,
1543905|NCT00605241|tolerability,|tolerability,
1543906|NCT00605241|Safety,|safety,
1543907|NCT00605241|single dose,|single dose,
1543908|NCT00605241|placebo,|placebo,
1543909|NCT00605241|Nicotine reward|nicotine reward
1543910|NCT00605241|GSK598809|gsk598809
1543911|NCT00605176|Actinic keratosis|actinic keratosis
1543912|NCT00605176|Skin disease|skin disease
1543913|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
1543914|NCT00605150|Unresectable HCC|unresectable hcc
1543915|NCT00605124|osteoarthritis|osteoarthritis
1543916|NCT00605124|knee|knee
1543917|NCT00605124|total knee arthroplasty|total knee arthroplasty
1543918|NCT00605124|exercise|exercise
1543921|NCT00605098|Vertical disease transmission|vertical disease transmission
1543922|NCT00605098|Pharmacokinetics|pharmacokinetics
1543923|NCT00605098|HIV seronegativity|hiv seronegativity
1543924|NCT00605072|cognitive disorders|cognitive disorders
1543925|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
1543926|NCT00605059|Alzheimer|alzheimer
1543927|NCT00605059|SPECT|spect
1543928|NCT00605046|Alzheimer|alzheimer
1543929|NCT00605046|SPECT|spect
1543930|NCT00605007|COPD|copd
1543931|NCT00605007|Diabetes|diabetes
1543932|NCT00605007|Respiratory Disorders|respiratory disorders
1543933|NCT00604994|Lymphoedema|lymphoedema
1543934|NCT00604994|Gynaecology|gynaecology
1543935|NCT00604994|Oncology|oncology
1543936|NCT00604994|Malignant|malignant
1543937|NCT00604994|Benign|benign
1543938|NCT00604994|Incidence|incidence
1543939|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
1543940|NCT00604955|kala-azar|kala-azar
1543941|NCT00604955|Bihar, India|bihar, india
1543942|NCT00604942|Oesophagus|oesophagus
1543943|NCT00604942|Dysphagia|dysphagia
1543944|NCT00604942|Impedance|impedance
1543945|NCT00604942|High Resolution Manometry|high resolution manometry
1543946|NCT00604942|Peristalsis|peristalsis
1543947|NCT00604942|Contractile Pressure|contractile pressure
1543948|NCT00604942|Coordination of contraction|coordination of contraction
1543949|NCT00604942|Bolus transport|bolus transport
1543950|NCT00604929|muscle protein synthesis|muscle protein synthesis
1543951|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
1543952|NCT00604929|nutrition|nutrition
1543953|NCT00604916|oral hygiene|oral hygiene
1543954|NCT00604890|Double-Blind|double-blind
1543955|NCT00604890|Placebo|placebo
1543956|NCT00604890|Topical|topical
1543957|NCT00604890|Treatment|treatment
1543958|NCT00604890|Dose-Ranging|dose-ranging
1543959|NCT00604890|sBCC|sbcc
1543960|NCT00604877|exercise|exercise
1543961|NCT00604877|glucose metabolism|glucose metabolism
1543962|NCT00604877|insulin sensitivity|insulin sensitivity
1543963|NCT00604877|Vascular Function|vascular function
1543964|NCT00604864|deep endometriosis|deep endometriosis
1543965|NCT00604864|pelvic pain|pelvic pain
1543966|NCT00604864|infliximab|infliximab
1543967|NCT00604864|anti TNFa|anti tnfa
1543968|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
1543969|NCT00604838|urinary incontinence|urinary incontinence
1543970|NCT00604838|pregnancy|pregnancy
1543971|NCT00604838|home test|home test
1543972|NCT00604838|vaginal wetness|vaginal wetness
1543973|NCT00604825|menopause|menopause
1543974|NCT00604825|hormone therapy|hormone therapy
1543975|NCT00604825|hot flashes|hot flashes
1543976|NCT00604825|vasomotor symptoms|vasomotor symptoms
1543977|NCT00604786|Basophils|basophils
1543978|NCT00604786|Mast Cells|mast cells
1543980|NCT00604786|IgE receptors|ige receptors
1543981|NCT00604786|omalizumab|omalizumab
1543982|NCT00604773|delirium|delirium
1543983|NCT00604773|critical care|critical care
1543984|NCT00604773|risk factors|risk factors
1543985|NCT00604773|prediction|prediction
1543986|NCT00604747|motor learning|motor learning
1543987|NCT00604747|hemiplegia|hemiplegia
1543988|NCT00604747|stroke|stroke
1543989|NCT00604747|practice|practice
1543990|NCT00604747|physiotherapy|physiotherapy
1543991|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1543992|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
1543993|NCT00604695|No Reflow|no reflow
1543994|NCT00604682|psoriasis|psoriasis
1543995|NCT00604669|Diabetes|diabetes
1543996|NCT00604669|Nutrition/Dietics|nutrition/dietics
1543997|NCT00604669|clinical outcomes|clinical outcomes
1543998|NCT00604669|total parenteral nutrition|total parenteral nutrition
1543999|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
1544000|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
1544001|NCT00604643|Endovascular Stent Graft|endovascular stent graft
1544002|NCT00604643|Endograft|endograft
1544003|NCT00604630|stroke|stroke
1544004|NCT00604630|EPO|epo
1544005|NCT00604630|erythropoietin|erythropoietin
1544006|NCT00604630|ischemia|ischemia
1544007|NCT00604630|hypoxia|hypoxia
1544008|NCT00604630|antiapoptosis|antiapoptosis
1544009|NCT00604630|neuroprotection|neuroprotection
1544010|NCT00604630|rtPA|rtpa
1544011|NCT00604630|thrombolysis|thrombolysis
1544012|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
1544013|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
1544014|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
1544015|NCT00604617|Tuberculin Test|tuberculin test
1544016|NCT00604617|South Africa|south africa
1544017|NCT00604591|Dementia Treatment|dementia treatment
1544018|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
1544019|NCT00604591|Dopamine|dopamine
1544020|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
1544021|NCT00604578|Pioglitazone|pioglitazone
1544022|NCT00604578|Asthma|asthma
1544023|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
1544024|NCT00604578|Airflow Obstruction|airflow obstruction
1544025|NCT00604578|Airway Inflammation|airway inflammation
1544026|NCT00604565|Hemodialysis|hemodialysis
1544027|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
1544028|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
1544029|NCT00604552|Endovascular Stent Graft|endovascular stent graft
1544030|NCT00604552|Endograft|endograft
1544031|NCT00604539|Chondroitin sulphate|chondroitin sulphate
1544032|NCT00604539|Synovitis|synovitis
1544033|NCT00604539|Knee osteoarthritis|knee osteoarthritis
1544034|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
1544035|NCT00604526|recurrent|recurrent
1544036|NCT00604487|induction|induction
1544037|NCT00604487|cervix|cervix
1544038|NCT00604487|balloon|balloon
1544039|NCT00604487|Bishop|bishop
1544040|NCT00604474|Deafness|deafness
1544041|NCT00604474|Hearing Loss|hearing loss
1544042|NCT00604474|Cochlear Implants|cochlear implants
1544043|NCT00604474|Advanced Bionics|advanced bionics
1544044|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
1544045|NCT00604461|Carboplatin|carboplatin
1544046|NCT00604461|Bevacizumab|bevacizumab
1544047|NCT00604461|Avastin|avastin
1544048|NCT00604461|Pemetrexed|pemetrexed
1544049|NCT00604461|Alimta|alimta
1544050|NCT00604448|pulses|pulses
1544051|NCT00604448|beans|beans
1544052|NCT00604448|obesity|obesity
1544053|NCT00604448|overweight|overweight
1544054|NCT00604448|metabolic syndrome|metabolic syndrome
1544055|NCT00604435|breast cancer|breast cancer
1544056|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1544057|NCT00604435|docetaxel|docetaxel
1544058|NCT00604435|epirubicin|epirubicin
1544059|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
1544060|NCT00604435|chemotherapy|chemotherapy
1544061|NCT00604435|endostatin|endostatin
1544062|NCT00604422|Colonic disease|colonic disease
1544063|NCT00604422|Ulcerative colitis|ulcerative colitis
1544064|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
1544065|NCT00604357|CNI free|cni free
1544066|NCT00604357|mTOR inhibition|mtor inhibition
1544067|NCT00604357|induction|induction
1544068|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
1544069|NCT00604357|renal function|renal function
1544070|NCT00604357|liver transplantation|liver transplantation
1544071|NCT00604331|Pyruvic Acid|pyruvic acid
1544072|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
1544073|NCT00604331|Catecholamines|catecholamines
1544074|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
1544075|NCT00604331|Cardiac Output|cardiac output
1544076|NCT00604331|Cardiac Index|cardiac index
1544077|NCT00604331|Cardiac Function|cardiac function
1544078|NCT00604318|quality of life|quality of life
1544079|NCT00604292|Colonic Diseases|colonic diseases
1544080|NCT00604279|Schizophrenia|schizophrenia
1544081|NCT00604279|Paliperidone|paliperidone
1544082|NCT00604279|Paliperidone palmitate|paliperidone palmitate
1544083|NCT00604279|Risperidone|risperidone
1544084|NCT00604279|Risperidone long acting injection|risperidone long acting injection
1544085|NCT00604279|R092670|r092670
1544086|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
1544087|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
1544088|NCT00604240|NICU|nicu
1544089|NCT00604240|caregivers|caregivers
1544090|NCT00604240|discharge instructions|discharge instructions
1544091|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
1544092|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
1544093|NCT00604227|pulmonary function testing|pulmonary function testing
1544094|NCT00604227|hypoxia|hypoxia
1544095|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
1544096|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
1544097|NCT00604214|Sepsis|sepsis
1544098|NCT00604214|Septic shock|septic shock
1544099|NCT00604201|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
1544100|NCT00604201|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
1544101|NCT00604201|Stem Cell Transplant|stem cell transplant
1544102|NCT00604201|Haploidentical Stem Cells|haploidentical stem cells
1544103|NCT00604201|Umbilical Cord Blood|umbilical cord blood
1544104|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
1544105|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
1544106|NCT00604201|MDS|mds
1544107|NCT00604175|HIV|hiv
1544108|NCT00604175|HPV 6|hpv 6
1544109|NCT00604175|HPV 11|hpv 11
1544110|NCT00604175|HPV 16|hpv 16
1544111|NCT00604175|HPV 18|hpv 18
1544112|NCT00604175|Vaccine|vaccine
1544113|NCT00604162|Suspected colonic disease|suspected colonic disease
1544114|NCT00604162|Known colonic disease|known colonic disease
1544115|NCT00604136|melanoma|melanoma
1544116|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
1544117|NCT00604136|interleukin-2|interleukin-2
1544118|NCT00604123|JNJ-17166864|jnj-17166864
1544119|NCT00604123|allergic rhinitis|allergic rhinitis
1544120|NCT00604123|pharmacokinetics|pharmacokinetics
1544121|NCT00604123|biomarkers|biomarkers
1544122|NCT00604123|rhinitis symptoms|rhinitis symptoms
1544123|NCT00604123|mountain cedar pollen|mountain cedar pollen
1544124|NCT00604110|Biventricular pacing|biventricular pacing
1544125|NCT00604110|resynchronisation therapy|resynchronisation therapy
1544126|NCT00604110|cardiac surgery|cardiac surgery
1544127|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
1544128|NCT00604097|youth suicide|youth suicide
1544129|NCT00604097|family therapy|family therapy
1544130|NCT00604097|primary care|primary care
1544131|NCT00604097|intervention|intervention
1544132|NCT00604084|Scabies|scabies
1544133|NCT00604084|Ivermectin|ivermectin
1544134|NCT00604084|Lindane|lindane
1544135|NCT00604084|Mass Eradication|mass eradication
1544136|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
1544137|NCT00604058|Poliomyelitis|poliomyelitis
1544138|NCT00604058|intradermal|intradermal
1544139|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
1544140|NCT00604045|cognitive bias|cognitive bias
1544141|NCT00604045|attention|attention
1544142|NCT00604045|combat|combat
1544143|NCT00604045|neuroimaging|neuroimaging
1544144|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
1544145|NCT00604019|sepsis|sepsis
1544146|NCT00604019|septic shock|septic shock
1544147|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
1544148|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
1544149|NCT00603967|Breast Cancer|breast cancer
1544150|NCT00603967|Postmenopausal|postmenopausal
1544151|NCT00603967|Aromatase|aromatase
1544152|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
1544153|NCT00603954|Hematological malignancies.|hematological malignancies.
1544154|NCT00603954|GVHD.|gvhd.
1544155|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
1544156|NCT00603941|Neoplasm|neoplasm
1544157|NCT00603941|Tumor|tumor
1544158|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
1544159|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
1544160|NCT00603928|attitude|attitude
1544161|NCT00603928|attitude of health personnel|attitude of health personnel
1544162|NCT00603928|ethics|ethics
1544163|NCT00603928|bioethics|bioethics
1544164|NCT00603928|biomedical ethics|biomedical ethics
1544165|NCT00603928|patient care|patient care
1544166|NCT00603928|physicians|physicians
1544167|NCT00603928|placebo effect|placebo effect
1544168|NCT00603928|placebos|placebos
1544169|NCT00603928|questionnaires|questionnaires
1544170|NCT00603928|therapy|therapy
1544171|NCT00603928|general practice|general practice
1544172|NCT00603915|gemcitabine|gemcitabine
1544173|NCT00603915|carboplatin|carboplatin
1544174|NCT00603915|cisplatin|cisplatin
1544175|NCT00603915|erlotinib|erlotinib
1544176|NCT00603915|tarceva|tarceva
1544177|NCT00603915|nasopharyngeal|nasopharyngeal
1544178|NCT00603902|Obesity|obesity
1544179|NCT00603902|Weight loss|weight loss
1544180|NCT00603902|lorcaserin|lorcaserin
1544181|NCT00603902|APD356|apd356
1544182|NCT00603902|BLOSSOM|blossom
1544183|NCT00603902|Hypertension|hypertension
1544184|NCT00603902|Dyslipidemia|dyslipidemia
1544185|NCT00603902|Sleep apnea|sleep apnea
1544186|NCT00603902|glucose tolerance|glucose tolerance
1544187|NCT00603902|cardiovascular disease|cardiovascular disease
1544188|NCT00603902|Arena|arena
1544189|NCT00603889|Hookworm|hookworm
1544190|NCT00603889|Allergy|allergy
1544191|NCT00603889|Vaccine|vaccine
1544192|NCT00603889|Skin test|skin test
1544193|NCT00603863|pancreatic cancer|pancreatic cancer
1544194|NCT00603863|hPAM4|hpam4
1544195|NCT00603863|MUC1 antibody|muc1 antibody
1544196|NCT00603863|cancer of the pancreas|cancer of the pancreas
1544197|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
1544198|NCT00603837|Hypothermia|hypothermia
1544199|NCT00603837|Prevention|prevention
1544200|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
1544201|NCT00603837|Polyethylene Wrap|polyethylene wrap
1544202|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
1544203|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
1544204|NCT00603824|fondaparinux|fondaparinux
1544205|NCT00603811|Influenza vaccines|influenza vaccines
1544206|NCT00603811|M2e|m2e
1544207|NCT00603798|Actinic keratosis|actinic keratosis
1544208|NCT00603798|Dermatologic disease|dermatologic disease
1544209|NCT00603785|Chronic sinusitis|chronic sinusitis
1544210|NCT00603785|Xolair|xolair
1544211|NCT00603785|Nasal Discharge|nasal discharge
1544212|NCT00603785|Nasal Obstruction|nasal obstruction
1544213|NCT00603785|Facial Pain|facial pain
1544214|NCT00603785|Hyposmia|hyposmia
1544215|NCT00603772|Tretinoin|tretinoin
1544216|NCT00603772|exposure to UV light|exposure to uv light
1544217|NCT00603772|phototoxicity|phototoxicity
1544218|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
1544219|NCT00603759|COX2 inhibitor|cox2 inhibitor
1544220|NCT00603759|head and neck cancer|head and neck cancer
1544221|NCT00603759|chemoradiation|chemoradiation
1544222|NCT00603746|Adolescents|adolescents
1544223|NCT00603746|Adults|adults
1544224|NCT00603746|Asthma|asthma
1544225|NCT00603746|Pharmacokinetics|pharmacokinetics
1544226|NCT00603746|Pharmacogenetics|pharmacogenetics
1544228|NCT00603733|Ulcerative Colitis|ulcerative colitis
1544229|NCT00603733|5-Aminosalicylate|5-aminosalicylate
1544230|NCT00603720|PET|pet
1544231|NCT00603720|Heart metabolism|heart metabolism
1544232|NCT00603720|Nitric oxide|nitric oxide
1544233|NCT00603720|Myocardial remodeling|myocardial remodeling
1544234|NCT00603707|capsule|capsule
1544235|NCT00603707|constipation|constipation
1544236|NCT00603707|whole gut transit|whole gut transit
1544237|NCT00603707|colonic transit|colonic transit
1544238|NCT00603707|gastric emptying|gastric emptying
1544239|NCT00603707|small bowel transit|small bowel transit
1544240|NCT00603694|Hippocampus|hippocampus
1544241|NCT00603694|Memory|memory
1544242|NCT00603694|Radiation|radiation
1544243|NCT00603681|constipation|constipation
1544244|NCT00603681|aged|aged
1544245|NCT00603681|polyethylene glycol|polyethylene glycol
1544246|NCT00603668|CLL|cll
1544247|NCT00603655|Diet|diet
1544248|NCT00603655|glycemic load|glycemic load
1544249|NCT00603655|overweight|overweight
1544250|NCT00603655|obesity|obesity
1544251|NCT00603655|hyperlipidemia|hyperlipidemia
1544252|NCT00603642|AMG 531|amg 531
1544253|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1544254|NCT00603642|ITP|itp
1544255|NCT00603642|Thrombocytopenia|thrombocytopenia
1544256|NCT00603642|Japan|japan
1544257|NCT00603642|Placebo controlled|placebo controlled
1544258|NCT00603642|Phase 3|phase 3
1544259|NCT00603629|Acute Asthma|acute asthma
1544260|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
1544261|NCT00603616|Crohn disease|crohn disease
1544262|NCT00603616|Crohn's disease|crohn's disease
1544263|NCT00603616|Rifaximin|rifaximin
1544264|NCT00603603|C-section|c-section
1544265|NCT00603603|Surg Wound Infect|surg wound infect
1544266|NCT00603590|Cardiovascular disease|cardiovascular disease
1544267|NCT00603590|primary prevention|primary prevention
1544268|NCT00603590|Polypill|polypill
1544269|NCT00603590|efficacy|efficacy
1544270|NCT00603590|safety|safety
1544271|NCT00603590|ADR|adr
1544272|NCT00603590|Diabetes|diabetes
1544273|NCT00603590|Adherence|adherence
1544274|NCT00603590|Compliance|compliance
1544275|NCT00603564|CPAP|cpap
1544276|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
1544277|NCT00603564|acute respiratory failure|acute respiratory failure
1544278|NCT00603564|hypoxemia|hypoxemia
1544279|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
1544280|NCT00603551|Osteoporosis|osteoporosis
1544281|NCT00603551|Cancer|cancer
1544282|NCT00603551|Chemotherapy|chemotherapy
1544283|NCT00603551|Bone Density|bone density
1544284|NCT00603551|DXA Scan|dxa scan
1544285|NCT00603551|Heel Scan|heel scan
1544286|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
1544287|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
1544288|NCT00603499|Diabetes|diabetes
1544289|NCT00603499|Hypertension|hypertension
1544290|NCT00603499|Hypomagnesemia|hypomagnesemia
1544291|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
1544292|NCT00603486|GE Dinamap|ge dinamap
1544293|NCT00603486|SuperSTAT|superstat
1544294|NCT00603460|Ovarian Cancer|ovarian cancer
1544295|NCT00603460|Peritoneal Cancer|peritoneal cancer
1544296|NCT00603434|Methamphetamine|methamphetamine
1544297|NCT00603421|borderline personality disorder|borderline personality disorder
1544298|NCT00603421|suicide|suicide
1544299|NCT00603421|suicidality|suicidality
1544300|NCT00603421|suicide attempt|suicide attempt
1544301|NCT00603421|suicidal behavior|suicidal behavior
1544302|NCT00603421|self-injurious behavior|self-injurious behavior
1544303|NCT00603421|self-harm behavior|self-harm behavior
1544304|NCT00603421|suicide prevention center|suicide prevention center
1544305|NCT00603421|telephone intervention|telephone intervention
1544306|NCT00603408|Breast Cancer|breast cancer
1544307|NCT00603408|Locally Advanced|locally advanced
1544308|NCT00603408|Neoadjuvant|neoadjuvant
1544309|NCT00603382|Adults|adults
1544310|NCT00603382|Pharmacokinetics|pharmacokinetics
1544311|NCT00603382|Pharmacogenetics|pharmacogenetics
1544312|NCT00603382|Asthma|asthma
1544313|NCT00603382|Adolescents|adolescents
1544314|NCT00603382|GW685698X|gw685698x
1544315|NCT00603369|HIV prevention|hiv prevention
1544316|NCT00603369|HIV seronegativity|hiv seronegativity
1544317|NCT00603356|GIST|gist
1544318|NCT00603356|Ovarian Cancer|ovarian cancer
1544319|NCT00603356|Mesothelioma|mesothelioma
1544320|NCT00603356|Renal|renal
1544321|NCT00603356|Colorectal Cancer|colorectal cancer
1544322|NCT00603356|Sarcoma|sarcoma
1544323|NCT00603356|NSCLC|nsclc
1544324|NCT00603356|Cancer|cancer
1544325|NCT00603343|antimuscarinics|antimuscarinics
1544326|NCT00603343|children|children
1544327|NCT00603343|overactive bladder|overactive bladder
1544328|NCT00603343|propiverine|propiverine
1544329|NCT00603343|urinary incontinence|urinary incontinence
1544330|NCT00603343|urotherapy|urotherapy
1544331|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
1544332|NCT00603330|Graft-versus-host disease|graft-versus-host disease
1544333|NCT00603330|Poor graft function|poor graft function
1544334|NCT00603330|Chimerism|chimerism
1544335|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
1544336|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
1544337|NCT00603317|Warfarin|warfarin
1544338|NCT00603317|Drug interaction|drug interaction
1544339|NCT00603317|Pharmacogenetics|pharmacogenetics
1544340|NCT00603317|Amoxicillin|amoxicillin
1544341|NCT00603317|Clavulanic acid|clavulanic acid
1544342|NCT00603304|Serenoa repens|serenoa repens
1544343|NCT00603304|Urological symptoms|urological symptoms
1544344|NCT00603304|hyperplasia|hyperplasia
1544346|NCT00603291|obesity|obesity
1544347|NCT00603291|weight loss|weight loss
1544348|NCT00603291|lorcaserin|lorcaserin
1544349|NCT00603291|APD356|apd356
1544350|NCT00603291|BLOOM-DM|bloom-dm
1544351|NCT00603291|hypertension|hypertension
1544352|NCT00603291|dyslipidemia|dyslipidemia
1544353|NCT00603291|sleep apnea|sleep apnea
1544354|NCT00603291|glucose tolerance|glucose tolerance
1544355|NCT00603291|cardiovascular disease|cardiovascular disease
1544356|NCT00603291|Arena|arena
1544357|NCT00603278|Adolescents|adolescents
1544358|NCT00603278|Adults|adults
1544359|NCT00603278|Pharmacokinetics|pharmacokinetics
1544360|NCT00603278|Asthma|asthma
1544361|NCT00603278|GW685698X|gw685698x
1544362|NCT00603278|Pharmacogenetics|pharmacogenetics
1544363|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1544364|NCT00603265|Neuropathic Pain|neuropathic pain
1544365|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
1544366|NCT00603252|risk factors|risk factors
1544367|NCT00603239|diabetes|diabetes
1544368|NCT00603239|exenatide|exenatide
1544369|NCT00603239|metformin|metformin
1544370|NCT00603239|thiazolidinedione|thiazolidinedione
1544371|NCT00603239|Byetta|byetta
1544372|NCT00603239|Amylin|amylin
1544373|NCT00603239|Lilly|lilly
1544374|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
1544375|NCT00603226|Coronary angiography|coronary angiography
1544376|NCT00603226|Acute coronary syndrome|acute coronary syndrome
1544377|NCT00603226|Chest pain|chest pain
1544378|NCT00603226|Unstable angina|unstable angina
1544379|NCT00603213|Congestive Heart Failure|congestive heart failure
1544380|NCT00603213|Impedance|impedance
1544381|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
1544382|NCT00603200|Quality of Life|quality of life
1544383|NCT00603187|Male Contraception|male contraception
1544384|NCT00603187|Acyline|acyline
1544386|NCT00603174|mechanical ventilation|mechanical ventilation
1544387|NCT00603174|infants|infants
1544388|NCT00603174|pediatric intensive care|pediatric intensive care
1544389|NCT00603174|infant|infant
1544390|NCT00603148|Genetic Polymorphism|genetic polymorphism
1544391|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
1544392|NCT00603148|Phenotype|phenotype
1544393|NCT00603122|altitude illness|altitude illness
1544394|NCT00603122|hypoxia|hypoxia
1544395|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
1544396|NCT00603083|Hip Arthroplasty|hip arthroplasty
1544397|NCT00603083|Treatment Outcome|treatment outcome
1544398|NCT00603083|Local Anesthesia|local anesthesia
1544399|NCT00603070|Medication Errors|medication errors
1544400|NCT00603070|Adverse Drug Events|adverse drug events
1544401|NCT00603070|Patient Safety|patient safety
1544402|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
1544403|NCT00603070|Medication Reconciliation|medication reconciliation
1544404|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
1544405|NCT00603018|eating disorders|eating disorders
1544406|NCT00603018|anorexia nervosa|anorexia nervosa
1544407|NCT00603018|anorexia|anorexia
1544409|NCT00603018|brain imaging|brain imaging
1544410|NCT00603018|serotonin|serotonin
1544411|NCT00603018|fMRI|fmri
1544412|NCT00603018|Prozac|prozac
1544413|NCT00603018|fluoxetine|fluoxetine
1544414|NCT00603005|Glaucoma|glaucoma
1544415|NCT00603005|Adherence|adherence
1544416|NCT00602992|3T MRI|3t mri
1544417|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
1544418|NCT00602979|endotracheal intubation|endotracheal intubation
1544419|NCT00602979|intubation|intubation
1544420|NCT00602979|laryngoscopy|laryngoscopy
1544421|NCT00602979|laryngoscope|laryngoscope
1544422|NCT00602979|surgery|surgery
1544423|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
1544424|NCT00602966|slow freeze|slow freeze
1544425|NCT00602966|vitrification|vitrification
1544426|NCT00602940|PCOS|pcos
1544427|NCT00602940|ovulation|ovulation
1544428|NCT00602940|hormones|hormones
1544429|NCT00602940|women|women
1544430|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
1544431|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
1544432|NCT00602914|Intradermal|intradermal
1544433|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
1544434|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1544435|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1544436|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1544437|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1544438|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1544439|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1544440|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1544441|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1544442|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1544443|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1544444|NCT00602758|AIDS|aids
1544445|NCT00602758|Adherence|adherence
1544446|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
1544447|NCT00602758|HIV|hiv
1544448|NCT00602745|pancreatic cancer|pancreatic cancer
1544449|NCT00602732|Partner Abuse|partner abuse
1544450|NCT00602732|Preventive Intervention|preventive intervention
1544451|NCT00602732|Postpartum Depression|postpartum depression
1544452|NCT00602732|Postpartum PTSD|postpartum ptsd
1544453|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
1544454|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
1544455|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
1544456|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
1544457|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
1544458|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1544459|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
1544460|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
1544461|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
1544462|NCT00602693|B-cell lymphoma|b-cell lymphoma
1544463|NCT00602693|follicular lymphoma|follicular lymphoma
1544464|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
1544465|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1544466|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
1544467|NCT00602693|multiple myeloma|multiple myeloma
1544468|NCT00602680|Alzheimer|alzheimer
1544469|NCT00602680|cognitive|cognitive
1544470|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1544471|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1544472|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1544473|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1544474|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
1544475|NCT00602667|childhood high grade glioma|childhood high grade glioma
1544476|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1544477|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1544478|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1544479|NCT00602628|breast cancer in situ|breast cancer in situ
1544480|NCT00602628|stage I breast cancer|stage i breast cancer
1544481|NCT00602628|stage II breast cancer|stage ii breast cancer
1544482|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
1544483|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
1544484|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
1544485|NCT00602589|open-label|open-label
1544486|NCT00602589|randomized|randomized
1544487|NCT00602589|crossover|crossover
1544488|NCT00602589|bioequivalence|bioequivalence
1544489|NCT00602576|recurrent melanoma|recurrent melanoma
1544490|NCT00602576|stage III melanoma|stage iii melanoma
1544491|NCT00602576|stage IV melanoma|stage iv melanoma
1544492|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
1544493|NCT00602563|Information Processing|information processing
1544494|NCT00602550|HIV|hiv
1544495|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
1544496|NCT00602537|Hypomania|hypomania
1544497|NCT00602537|Antidepressant|antidepressant
1544498|NCT00602537|Mood Stabilizer|mood stabilizer
1544499|NCT00602537|Venlafaxine|venlafaxine
1544500|NCT00602537|Lithium Carbonate|lithium carbonate
1544501|NCT00602537|Major Depressive Episode|major depressive episode
1544502|NCT00602537|Hypomanic Episodes|hypomanic episodes
1544503|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
1544504|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
1544505|NCT00602511|Multiple myeloma|multiple myeloma
1544506|NCT00602511|Relapsing|relapsing
1544507|NCT00602511|Refractory|refractory
1544508|NCT00602511|Thalidomide|thalidomide
1544509|NCT00602511|Bortezomib|bortezomib
1544510|NCT00602511|Randomized clinical trial|randomized clinical trial
1544511|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
1544512|NCT00602446|iron overload|iron overload
1544513|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
1544514|NCT00602420|pain|pain
1544515|NCT00602420|musculoskeletal complications|musculoskeletal complications
1544516|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1544517|NCT00602368|cervical cancer|cervical cancer
1544518|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1544519|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1544520|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1544521|NCT00602355|Postpartum|postpartum
1544522|NCT00602355|Depression|depression
1544523|NCT00602355|Medication Therapy|medication therapy
1544524|NCT00602355|Zoloft|zoloft
1544525|NCT00602355|Sertraline|sertraline
1544526|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
1544527|NCT00602329|recurrent colon cancer|recurrent colon cancer
1544528|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
1544529|NCT00602329|stage III colon cancer|stage iii colon cancer
1544530|NCT00602329|stage III rectal cancer|stage iii rectal cancer
1544531|NCT00602329|stage IV colon cancer|stage iv colon cancer
1544532|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
1544533|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
1544534|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1544535|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1544536|NCT00602316|stage IA breast cancer|stage ia breast cancer
1544537|NCT00602316|stage IB breast cancer|stage ib breast cancer
1544538|NCT00602316|stage II breast cancer|stage ii breast cancer
1544539|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
1544540|NCT00602290|Major Depression|major depression
1544541|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
1544542|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
1544543|NCT00602290|Elderly|elderly
1544544|NCT00602290|Geriatric|geriatric
1544545|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
1544546|NCT00602290|Quality of Life|quality of life
1544547|NCT00602290|Disability|disability
1544548|NCT00602290|Comorbidity|comorbidity
1544549|NCT00602290|Medical Burden|medical burden
1544550|NCT00602290|Safety|safety
1544551|NCT00602290|Candidate Genes|candidate genes
1544552|NCT00602264|Anorexia nervosa|anorexia nervosa
1544553|NCT00602264|Adipokines|adipokines
1544554|NCT00602264|Ghrelin|ghrelin
1544555|NCT00602264|Fat mass|fat mass
1544556|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
1544557|NCT00602199|stage IV melanoma|stage iv melanoma
1544558|NCT00602186|female voiding dysfunction|female voiding dysfunction
1544559|NCT00602186|Tamsolusin|tamsolusin
1544560|NCT00602186|prazosin|prazosin
1544561|NCT00602160|Food allergy|food allergy
1544562|NCT00602160|Chinese Herbs|chinese herbs
1544563|NCT00602160|Investigational new drug|investigational new drug
1544564|NCT00602160|Herbs|herbs
1544565|NCT00602160|Therapeutic medicine|therapeutic medicine
1544566|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
1544567|NCT00602147|mucositis|mucositis
1544568|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
1544569|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
1544570|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
1544571|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
1544572|NCT00602108|stage I breast cancer|stage i breast cancer
1544573|NCT00602108|stage II breast cancer|stage ii breast cancer
1544574|NCT00602095|Labor induction|labor induction
1544575|NCT00602095|cervical ripening|cervical ripening
1544576|NCT00602095|misoprostol|misoprostol
1544577|NCT00602095|dinoprostone|dinoprostone
1544578|NCT00602095|balloon catheter|balloon catheter
1544579|NCT00602095|prostaglandin|prostaglandin
1544580|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
1544581|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
1544582|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
1544583|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
1544584|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
1544585|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
1544586|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
1544587|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
1544588|NCT00602082|gastrinoma|gastrinoma
1544589|NCT00602082|insulinoma|insulinoma
1544590|NCT00602082|glucagonoma|glucagonoma
1544591|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1544592|NCT00602082|somatostatinoma|somatostatinoma
1544593|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1544594|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1544595|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1544596|NCT00602082|islet cell carcinoma|islet cell carcinoma
1544597|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1544598|NCT00602069|PTSD|ptsd
1544599|NCT00602069|Intimate Partner Violence|intimate partner violence
1544600|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
1544601|NCT00602069|Empowerment|empowerment
1544602|NCT00602056|Immunization dropout|immunization dropout
1544603|NCT00602056|Immunization card|immunization card
1544604|NCT00602056|Center based education|center based education
1544605|NCT00602030|lung cancer|lung cancer
1544606|NCT00602030|NSCLC|nsclc
1544607|NCT00602030|lung neoplasms|lung neoplasms
1544608|NCT00602030|respiratory|respiratory
1544609|NCT00602004|Arteriovenous fistula|arteriovenous fistula
1544610|NCT00602004|hypertrophy|hypertrophy
1544611|NCT00602004|losartan|losartan
1544612|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1544613|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1544614|NCT00601978|Parkinson's disease|parkinson's disease
1544615|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
1544616|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
1544617|NCT00601978|non-motor symptoms|non-motor symptoms
1544618|NCT00601978|event-related potential|event-related potential
1544619|NCT00601978|ERP|erp
1544620|NCT00601978|EEG|eeg
1544621|NCT00601978|electroencephalogram|electroencephalogram
1544622|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
1544623|NCT00601952|cognitive bias|cognitive bias
1544624|NCT00601952|attention|attention
1544625|NCT00601952|combat|combat
1544626|NCT00601939|Abused|abused
1544627|NCT00601939|Female|female
1544628|NCT00601939|African American|african american
1544629|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
1544630|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
1544631|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
1544632|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
1544633|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
1544634|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1544635|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1544636|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1544637|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1544638|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1544639|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1544640|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1544641|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1544642|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1544643|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1544644|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1544645|NCT00601887|Anti-inflammatory|anti-inflammatory
1544646|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1544647|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1544648|NCT00601848|malignant pleural effusion|malignant pleural effusion
1544649|NCT00601835|Diphtheria|diphtheria
1544650|NCT00601835|Tetanus|tetanus
1544651|NCT00601809|Gastrointestinal|gastrointestinal
1544652|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
1544653|NCT00601809|Oral water soluble contrast|oral water soluble contrast
1544654|NCT00601809|Non-operative Conservative Management|non-operative conservative management
1544655|NCT00601809|Operative rate|operative rate
1544656|NCT00601809|Hospital stay|hospital stay
1544657|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
1544658|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1544659|NCT00601757|Preventive Intervention|preventive intervention
1544660|NCT00601757|Postpartum Depression|postpartum depression
1544661|NCT00601757|Women on Public Assistance|women on public assistance
1544662|NCT00601744|Orbital Exenteration|orbital exenteration
1544663|NCT00601744|Eye Cancer|eye cancer
1544664|NCT00601744|Social-Psychological Aspects|social-psychological aspects
1544665|NCT00601744|Quality of Life|quality of life
1544666|NCT00601744|Questionnaire|questionnaire
1544667|NCT00601744|Facial Appearance|facial appearance
1544668|NCT00601744|Survey|survey
1544669|NCT00601744|Interview|interview
1544670|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
1544671|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1544672|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1544673|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
1544674|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
1544675|NCT00601705|stage III gastric cancer|stage iii gastric cancer
1544676|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
1544677|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
1544678|NCT00601705|stage II gastric cancer|stage ii gastric cancer
1544679|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1544680|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1544681|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
1544682|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
1544683|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
1544684|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
1544685|NCT00601653|Binge Eating Disorder|binge eating disorder
1544687|NCT00601653|Nutrition|nutrition
1544688|NCT00601653|Energy Density|energy density
1544689|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
1544690|NCT00601653|CBT|cbt
1544691|NCT00601640|skin cancer|skin cancer
1544692|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1544693|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
1544694|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
1544695|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1544696|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
1544697|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1544698|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1544699|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1544700|NCT00601562|HIV|hiv
1544701|NCT00601549|Rectal cancer|rectal cancer
1544702|NCT00601549|CCRT|ccrt
1544703|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
1544704|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
1544705|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
1544706|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
1544707|NCT00601510|stage III gastric cancer|stage iii gastric cancer
1544708|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
1544709|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
1544710|NCT00601471|ankle sprain|ankle sprain
1544711|NCT00601471|ankle injuries|ankle injuries
1544712|NCT00601471|sprains and strains|sprains and strains
1544713|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
1544714|NCT00601445|Changes in sleep with aging|changes in sleep with aging
1544715|NCT00601432|open-label|open-label
1544716|NCT00601432|randomized|randomized
1544717|NCT00601432|crossover|crossover
1544718|NCT00601432|food effect|food effect
1544719|NCT00601406|male breast cancer|male breast cancer
1544720|NCT00601406|stage IA breast cancer|stage ia breast cancer
1544721|NCT00601406|stage IB breast cancer|stage ib breast cancer
1544722|NCT00601406|stage II breast cancer|stage ii breast cancer
1544723|NCT00601406|stage I prostate cancer|stage i prostate cancer
1544724|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
1544725|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
1544726|NCT00601406|stage III prostate cancer|stage iii prostate cancer
1544727|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
1544728|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
1544729|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
1544730|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
1544731|NCT00601406|stage III cervical cancer|stage iii cervical cancer
1544732|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
1544733|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
1544734|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
1544735|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
1544736|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
1544737|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
1544738|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
1544739|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
1544740|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
1544741|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
1544742|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
1544743|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
1544744|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
1544745|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
1544746|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1544747|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1544748|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1544749|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
1544750|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
1544751|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
1544752|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1544753|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1544754|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1544755|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
1544756|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
1544757|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
1544758|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1544759|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1544760|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1544761|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1544762|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1544763|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1544764|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1544765|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1544766|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
1544767|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
1544768|NCT00601406|ovarian sarcoma|ovarian sarcoma
1544769|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
1544770|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
1544771|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
1544772|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
1544773|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
1544774|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
1544775|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1544776|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1544777|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1544778|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1544779|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1544780|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
1544781|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
1544782|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
1544783|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
1544784|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
1544785|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
1544786|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1544787|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1544788|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1544789|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1544790|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
1544791|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
1544792|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
1544793|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
1544794|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
1544795|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
1544796|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
1544797|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
1544798|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
1544799|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
1544800|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
1544801|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
1544802|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
1544803|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
1544804|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
1544805|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
1544806|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
1544807|NCT00601354|Binge Eating|binge eating
1544808|NCT00601354|Orlistat|orlistat
1544809|NCT00601354|Alli|alli
1544810|NCT00601354|Guided Self-Help|guided self-help
1544811|NCT00601341|arthralgia|arthralgia
1544812|NCT00601341|joint pain|joint pain
1544813|NCT00601341|knee injuries|knee injuries
1544814|NCT00601341|knee joint|knee joint
1544815|NCT00601341|low back pain|low back pain
1544816|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
1544817|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
1544818|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1544819|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
1544820|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
1544821|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
1544822|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
1544823|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
1544824|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
1544825|NCT00601276|pedophilia|pedophilia
1544826|NCT00601276|antiandrogens|antiandrogens
1544827|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
1544828|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
1544829|NCT00601263|Asthma|asthma
1544830|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
1544831|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
1544832|NCT00601237|HIV Prevention|hiv prevention
1544833|NCT00601237|Mobile Phone|mobile phone
1544834|NCT00601237|Technology-Based Intervention|technology-based intervention
1544835|NCT00601237|HIV|hiv
1544836|NCT00601237|HIV Seronegativity|hiv seronegativity
1544837|NCT00601224|Social Cognition|social cognition
1544838|NCT00601224|Group Therapy|group therapy
1544839|NCT00601224|Psychosocial Intervention|psychosocial intervention
1544840|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
1544841|NCT00601198|Colon and rectum|colon and rectum
1544842|NCT00601185|06-009|06-009
1544843|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
1544844|NCT00601185|shave-biopsy|shave-biopsy
1544845|NCT00601172|vomiting|vomiting
1544846|NCT00601172|colorectal cancer|colorectal cancer
1544847|NCT00601172|nausea|nausea
1544848|NCT00601172|oxaliplatin|oxaliplatin
1544849|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
1544850|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
1544851|NCT00601159|cisplatin|cisplatin
1544852|NCT00601159|chemotherapy|chemotherapy
1544853|NCT00601146|Hodgkin's disease|hodgkin's disease
1544854|NCT00601146|CT scan|ct scan
1544855|NCT00601133|Solid Tumors|solid tumors
1544856|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
1544857|NCT00601133|Postural Instability|postural instability
1544858|NCT00601133|Balance|balance
1544859|NCT00601133|Function|function
1544860|NCT00601133|Walking|walking
1544861|NCT00601133|Questionnaire|questionnaire
1544862|NCT00601133|Survey|survey
1544863|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
1544864|NCT00601120|RF ablation|rf ablation
1544865|NCT00601107|psoriasis|psoriasis
1544866|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
1544867|NCT00601107|plaque psoriasis|plaque psoriasis
1544868|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
1544869|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1544870|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1544871|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1544872|NCT00601081|Very low birth weight infants|very low birth weight infants
1544873|NCT00601081|HMF|hmf
1544874|NCT00601081|immune system function|immune system function
1544875|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
1544876|NCT00601055|COPD|copd
1544877|NCT00601055|Geriatric Depression|geriatric depression
1544878|NCT00601055|Problem-Solving Therapy|problem-solving therapy
1544879|NCT00601055|Treatment Adherence|treatment adherence
1544880|NCT00601042|smoking reduction|smoking reduction
1544881|NCT00601042|smoking cessation|smoking cessation
1544882|NCT00601042|randomized trial|randomized trial
1544883|NCT00601042|Swedish snus|swedish snus
1544884|NCT00601042|smokeless tobacco|smokeless tobacco
1544885|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
1544886|NCT00601016|Infantile hemangioma|infantile hemangioma
1544887|NCT00601016|Hemangioma|hemangioma
1544888|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
1544889|NCT00601016|benign tumors of infancy|benign tumors of infancy
1544890|NCT00601016|Congenital hemangioma|congenital hemangioma
1544891|NCT00601016|Capillary|capillary
1544892|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
1544893|NCT00600990|PONV|ponv
1544894|NCT00600977|ALL|all
1544895|NCT00600977|Chemotherapy|chemotherapy
1544896|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
1544897|NCT00600977|elderly ALL|elderly all
1544898|NCT00600964|CLL|cll
1544899|NCT00600964|obatoclax|obatoclax
1544900|NCT00600938|iron overload|iron overload
1545975|NCT00596375|Analgesia|analgesia
1544901|NCT00600938|cardiac iron|cardiac iron
1544902|NCT00600938|haemosiderosis|haemosiderosis
1544903|NCT00600938|myocardial T2*|myocardial t2*
1544904|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
1544905|NCT00600938|LVEF|lvef
1544906|NCT00600938|cardiac dysfunction|cardiac dysfunction
1544907|NCT00600938|thalassaemia|thalassaemia
1544908|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
1544909|NCT00600938|DBA|dba
1544910|NCT00600938|sideroblastic anemia|sideroblastic anemia
1544911|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
1544912|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
1544913|NCT00600938|liver MRI|liver mri
1544914|NCT00600938|deferasirox|deferasirox
1544915|NCT00600938|deferoxamine|deferoxamine
1544916|NCT00600938|ICL670|icl670
1544917|NCT00600938|DFO|dfo
1544918|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
1544919|NCT00600925|Colorectal surgery|colorectal surgery
1544920|NCT00600912|lipid emulsion|lipid emulsion
1544921|NCT00600912|fish oil|fish oil
1544922|NCT00600912|parenteral nutrition|parenteral nutrition
1544923|NCT00600912|leucotriene LTB5|leucotriene ltb5
1544924|NCT00600912|hepatic function|hepatic function
1544925|NCT00600899|Postoperative pain treatment|postoperative pain treatment
1544926|NCT00600886|Acromegaly,|acromegaly,
1544927|NCT00600886|adult,|adult,
1544928|NCT00600886|growth hormone,|growth hormone,
1544929|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
1544930|NCT00600886|somatostatin analogue|somatostatin analogue
1544931|NCT00600873|neuroprotection|neuroprotection
1544932|NCT00600873|oxidative stress|oxidative stress
1544933|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
1544934|NCT00600860|Newly diagnosed|newly diagnosed
1544935|NCT00600847|urticaria|urticaria
1544936|NCT00600847|cold urticaria|cold urticaria
1544937|NCT00600847|acquired cold urticaria|acquired cold urticaria
1567940|NCT00507728|Wellbutrin SR|wellbutrin sr
1544938|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
1544939|NCT00600795|NPH|nph
1544940|NCT00600795|TGF-beta|tgf-beta
1544941|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
1544942|NCT00600769|MAC|mac
1544943|NCT00600769|NTM|ntm
1544944|NCT00600756|schizophrenia|schizophrenia
1544945|NCT00600756|SWNK|swnk
1544946|NCT00600743|Eating|eating
1544947|NCT00600743|Food Intake|food intake
1544948|NCT00600743|Appetite|appetite
1544949|NCT00600730|fMRi|fmri
1544950|NCT00600730|hypoglycemia|hypoglycemia
1544951|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
1544952|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
1544953|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
1544954|NCT00600717|Functional Mapping|functional mapping
1544955|NCT00600717|Epilepsy|epilepsy
1544956|NCT00600717|Migraine|migraine
1544957|NCT00600717|HFOs|hfos
1544958|NCT00600717|ripples|ripples
1544959|NCT00600717|fast ripples|fast ripples
1544960|NCT00600717|high-gamma|high-gamma
1544961|NCT00600704|Allogenic Blood Use|allogenic blood use
1544962|NCT00600704|Total Blood Loss|total blood loss
1544963|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
1544964|NCT00600691|Finasteride|finasteride
1544965|NCT00600691|hematuria|hematuria
1544966|NCT00600691|hematospermia|hematospermia
1544967|NCT00600691|prostate biopsy|prostate biopsy
1544968|NCT00600678|food for special medical purposes|food for special medical purposes
1544969|NCT00600665|Sickle Cell Anemia|sickle cell anemia
1544970|NCT00600665|Sickle Cell Disease|sickle cell disease
1544971|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
1544972|NCT00600652|flow cytometry|flow cytometry
1544973|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
1544974|NCT00600652|prediction|prediction
1544975|NCT00600639|old patients|old patients
1544976|NCT00600639|NIV|niv
1544977|NCT00600639|Intubation|intubation
1544978|NCT00600639|COPD|copd
1544979|NCT00600613|Radiation Therapy|radiation therapy
1544980|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1544981|NCT00600587|Genes, erbB-1|genes, erbb-1
1544982|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1544983|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
1544984|NCT00600574|fibromyalgia|fibromyalgia
1544985|NCT00600574|physical therapies|physical therapies
1544986|NCT00600574|stretching|stretching
1544987|NCT00600574|Ai Chi|ai chi
1544988|NCT00600561|meditation|meditation
1544989|NCT00600561|mindfulness|mindfulness
1544990|NCT00600561|HIV|hiv
1544991|NCT00600561|CD4|cd4
1544992|NCT00600561|Complementary Therapies|complementary therapies
1544993|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
1544994|NCT00600548|Miltefosine|miltefosine
1544995|NCT00600548|Meglumine antimoniate|meglumine antimoniate
1544996|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
1544997|NCT00600535|Prostate neoplasms|prostate neoplasms
1544998|NCT00600535|Abiraterone acetate|abiraterone acetate
1544999|NCT00600535|CB7630|cb7630
1545000|NCT00600535|Prostate cancer|prostate cancer
1545001|NCT00600535|Pharmacokinetics|pharmacokinetics
1545090|NCT00600067|Glycemic Control|glycemic control
1545002|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
1545003|NCT00600522|hepatectomy|hepatectomy
1545004|NCT00600522|colorectal liver metastases|colorectal liver metastases
1545005|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
1545006|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
1545007|NCT00600509|Levetiracetam|levetiracetam
1545008|NCT00600509|Keppra|keppra
1545009|NCT00600496|ARRY-142886|arry-142886
1545010|NCT00600496|AZD6244|azd6244
1545011|NCT00600496|Cancer|cancer
1545012|NCT00600496|Colon Cancer|colon cancer
1545013|NCT00600496|Breast Cancer|breast cancer
1545014|NCT00600496|Lung Cancer|lung cancer
1545015|NCT00600496|Melanoma|melanoma
1545016|NCT00600496|Kidney Cancer|kidney cancer
1545017|NCT00600483|obesity|obesity
1545018|NCT00600483|diabetes|diabetes
1545019|NCT00600470|Behavior Problems|behavior problems
1545020|NCT00600470|Behavior Disorders|behavior disorders
1545021|NCT00600457|healing time|healing time
1545022|NCT00600457|pain|pain
1545023|NCT00600457|infection|infection
1545024|NCT00600444|permanent venous access|permanent venous access
1545025|NCT00600444|chemotherapy|chemotherapy
1545026|NCT00600444|parenteral nutrition|parenteral nutrition
1545027|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
1545028|NCT00600444|benign diseases|benign diseases
1545029|NCT00600444|malignant diseases|malignant diseases
1545030|NCT00600431|nevus count|nevus count
1545031|NCT00600431|children|children
1545032|NCT00600431|chemotherapy|chemotherapy
1545033|NCT00600418|PTSD|ptsd
1545034|NCT00600418|DYADIC TREATMENT|dyadic treatment
1545035|NCT00600418|WAR AND TERROR|war and terror
1545036|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
1545037|NCT00600405|Nephrolithiasis|nephrolithiasis
1545038|NCT00600405|Ureteral Calculi|ureteral calculi
1545039|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
1545040|NCT00600353|nausea|nausea
1545041|NCT00600353|cancer|cancer
1545042|NCT00600353|CINV|cinv
1545043|NCT00600327|Stroke|stroke
1545044|NCT00600327|thrombosis|thrombosis
1545045|NCT00600327|thromboembolic|thromboembolic
1545046|NCT00600327|Transient Ischemic Attack|transient ischemic attack
1545048|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
1545049|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
1545050|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
1545051|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
1545052|NCT00600301|Macula|macula
1545053|NCT00600301|Edema|edema
1545054|NCT00600275|BGT226|bgt226
1545055|NCT00600275|Solid tumors|solid tumors
1545056|NCT00600275|Breast cancer|breast cancer
1545057|NCT00600275|Cowden Syndrome|cowden syndrome
1545058|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
1545059|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
1545060|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
1545061|NCT00600262|severe nonproliferative|severe nonproliferative
1545062|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1545063|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
1545064|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
1545065|NCT00600249|Breast cancer.|breast cancer.
1545066|NCT00600249|Triple negative.|triple negative.
1545067|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
1545068|NCT00600249|Targeted therapy.|targeted therapy.
1545069|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
1545070|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
1545071|NCT00600184|Stroke|stroke
1545072|NCT00600184|Rehabilitation|rehabilitation
1545073|NCT00600184|Robotics|robotics
1545074|NCT00600171|dose ranging|dose ranging
1545075|NCT00600171|placebo|placebo
1545076|NCT00600171|asthma|asthma
1545077|NCT00600171|safety|safety
1545078|NCT00600171|efficacy|efficacy
1545079|NCT00600171|pharmacokinetics|pharmacokinetics
1545080|NCT00600158|colectomy|colectomy
1545081|NCT00600145|Human volunteers|human volunteers
1545082|NCT00600145|amphetamine dependence|amphetamine dependence
1545083|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
1545084|NCT00600093|Amantadine|amantadine
1545085|NCT00600067|Diabetes|diabetes
1545086|NCT00600067|Type 2 Diabetes|type 2 diabetes
1545087|NCT00600067|Diabetes Mellitus|diabetes mellitus
1545088|NCT00600067|Metabolic Diseases|metabolic diseases
1545089|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
1545091|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
1545092|NCT00600054|Common Terminology Criteria|common terminology criteria
1545093|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
1545094|NCT00600054|Human antihuman antibody|human antihuman antibody
1545095|NCT00600054|pharmacokinetics|pharmacokinetics
1545096|NCT00600054|monoclonal antibody|monoclonal antibody
1545097|NCT00600054|Informed Consent Form|informed consent form
1545098|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
1545099|NCT00600041|pantoprazole|pantoprazole
1545100|NCT00600041|Cardiac Output|cardiac output
1545101|NCT00600041|Echocardiography|echocardiography
1545102|NCT00600041|adverse effects|adverse effects
1545103|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
1545104|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
1545105|NCT00600015|Advanced|advanced
1545106|NCT00600015|Sorafenib|sorafenib
1545107|NCT00600015|Erlotinib|erlotinib
1545108|NCT00600015|Double-blind|double-blind
1545109|NCT00600015|Placebo-controlled|placebo-controlled
1545110|NCT00600002|GM-CSF|gm-csf
1545111|NCT00600002|Leukine|leukine
1545112|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1545113|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
1545114|NCT00599989|stage I breast cancer|stage i breast cancer
1545115|NCT00599989|stage II breast cancer|stage ii breast cancer
1545116|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
1545117|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1545118|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
1545119|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1545120|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1545121|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1545122|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1545123|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1545124|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1545125|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
1545126|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
1545127|NCT00599989|breast cancer in situ|breast cancer in situ
1545128|NCT00599950|Mitomycin C|mitomycin c
1545129|NCT00599950|Corneal epithelium|corneal epithelium
1545130|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
1545131|NCT00599950|Confocal microscope|confocal microscope
1545133|NCT00599924|advanced solid tumors,|advanced solid tumors,
1545134|NCT00599924|colorectal cancer,|colorectal cancer,
1545227|NCT00599521|Adapalene|adapalene
1545135|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
1545136|NCT00599924|FOLFOX|folfox
1545137|NCT00599911|Drug therapy|drug therapy
1545138|NCT00599911|Depressive disorder|depressive disorder
1545139|NCT00599911|Antidepressive agents|antidepressive agents
1545140|NCT00599911|Depressive symptoms|depressive symptoms
1545141|NCT00599911|Affective disorders|affective disorders
1545142|NCT00599911|Randomized controlled trial|randomized controlled trial
1545143|NCT00599911|Placebo-controlled|placebo-controlled
1545144|NCT00599911|Double-blind|double-blind
1545145|NCT00599911|Active reference|active reference
1545146|NCT00599911|Multicenter study|multicenter study
1545147|NCT00599898|Preterm labor|preterm labor
1545148|NCT00599898|Atosiban|atosiban
1545149|NCT00599898|Nifedipine|nifedipine
1545150|NCT00599872|Allergy|allergy
1545151|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
1545152|NCT00599872|Allergic Rhinitis|allergic rhinitis
1545153|NCT00599859|lactase|lactase
1545154|NCT00599859|lactose|lactose
1545155|NCT00599859|microflora|microflora
1545156|NCT00599846|age-related macular degeneration|age-related macular degeneration
1545157|NCT00599846|geographic atrophy|geographic atrophy
1545158|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1545159|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
1545160|NCT00599820|Angioid Streaks|angioid streaks
1545161|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
1545162|NCT00599820|Bevacizumab|bevacizumab
1545163|NCT00599794|Sepsis|sepsis
1545164|NCT00599794|Intravascular volume|intravascular volume
1545165|NCT00599794|Ultrasound|ultrasound
1545166|NCT00599794|Noninvasive measurement|noninvasive measurement
1545167|NCT00599781|adenosine deaminase|adenosine deaminase
1545168|NCT00599781|SCID|scid
1545169|NCT00599781|gene therapy|gene therapy
1545170|NCT00599781|retroviral vector|retroviral vector
1545171|NCT00599742|Balance disorder|balance disorder
1545172|NCT00599742|Vestibular disorder|vestibular disorder
1545173|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
1545174|NCT00599742|Separation anxiety disorder|separation anxiety disorder
1545175|NCT00599742|Children|children
1545176|NCT00599742|Balance training|balance training
1545177|NCT00599716|dry eye syndrome|dry eye syndrome
1545178|NCT00599716|dry eye disease|dry eye disease
1545179|NCT00599716|Vismed|vismed
1545180|NCT00599716|dry eye|dry eye
1545181|NCT00599716|sodium hyaluronate|sodium hyaluronate
1545182|NCT00599716|hyaluronic acid|hyaluronic acid
1545183|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
1545184|NCT00599690|Corneal thickness|corneal thickness
1545185|NCT00599690|Confocal microscope|confocal microscope
1545186|NCT00599677|acupuncture|acupuncture
1545187|NCT00599677|meridian|meridian
1545188|NCT00599677|acupoint|acupoint
1545189|NCT00599664|Urinary Calculi|urinary calculi
1545190|NCT00599664|Urinary Stones|urinary stones
1545191|NCT00599664|Urinary Tract Stones|urinary tract stones
1545193|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
1545194|NCT00599651|Newborn RDS|newborn rds
1545195|NCT00599625|Crohn's Disease|crohn's disease
1545196|NCT00599612|GW856553,|gw856553,
1545197|NCT00599612|radiolabel|radiolabel
1545198|NCT00599612|ADME,|adme,
1545199|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
1545200|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
1545201|NCT00599599|Complementary Therapies|complementary therapies
1545202|NCT00599586|migraine|migraine
1545203|NCT00599586|acupuncture|acupuncture
1545204|NCT00599586|efficacy|efficacy
1545205|NCT00599586|safety|safety
1545206|NCT00599586|meridian|meridian
1545207|NCT00599586|acupoint|acupoint
1545208|NCT00599573|HIV|hiv
1545209|NCT00599573|cocaine dependence|cocaine dependence
1545210|NCT00599573|cocaine abuse|cocaine abuse
1545211|NCT00599573|cocaine addiction|cocaine addiction
1545212|NCT00599573|cocaine users|cocaine users
1545213|NCT00599573|cocaine-related disorders|cocaine-related disorders
1545214|NCT00599573|HIV Infection|hiv infection
1545215|NCT00599560|Meniere's disease|meniere's disease
1545216|NCT00599560|stress|stress
1545217|NCT00599560|vasopressin|vasopressin
1545218|NCT00599560|endolymphatic sac|endolymphatic sac
1545219|NCT00599560|V2 receptor|v2 receptor
1545220|NCT00599560|cyclic AMP|cyclic amp
1567282|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1545221|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
1545222|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
1545223|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
1545224|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
1545225|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1545226|NCT00599521|Acne Vulgaris|acne vulgaris
1545228|NCT00599508|memory|memory
1545229|NCT00599508|aging|aging
1545230|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1545231|NCT00599495|Multiple Myeloma|multiple myeloma
1545232|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
1545233|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
1545234|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
1545235|NCT00599482|THALASSEMIA|thalassemia
1545236|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
1545237|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
1545238|NCT00599469|SENILE PLAQUES|senile plaques
1545239|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
1545240|NCT00599469|NEUROPIL THREADS|neuropil threads
1545241|NCT00599456|Hot flashes|hot flashes
1545242|NCT00599456|Menopause|menopause
1545243|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
1545244|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
1545245|NCT00599443|Safety|safety
1545246|NCT00599443|Reactogenicity|reactogenicity
1545247|NCT00599430|Probiotic|probiotic
1545248|NCT00599430|Lactobacillus|lactobacillus
1545249|NCT00599430|NCFM|ncfm
1545250|NCT00599430|Bifidobacterium|bifidobacterium
1545251|NCT00599430|Healthy children|healthy children
1545252|NCT00599404|Pharmacokinetics study|pharmacokinetics study
1545253|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
1545254|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
1545255|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
1545256|NCT00599365|adherence|adherence
1545257|NCT00599365|pharmacist intervention|pharmacist intervention
1545258|NCT00599365|persistence|persistence
1545259|NCT00599365|renal clinic|renal clinic
1545260|NCT00599365|pill count|pill count
1545261|NCT00599352|Hypovitaminosis|hypovitaminosis
1545262|NCT00599352|Chronic liver disease|chronic liver disease
1545263|NCT00599339|Rotigotine|rotigotine
1545264|NCT00599339|Neupro|neupro
1545265|NCT00599326|Exjade PCT Study|exjade pct study
1545266|NCT00599326|PCT Study|pct study
1545267|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
1545268|NCT00599287|ICU delirium|icu delirium
1545269|NCT00599287|Hypoactive delirium|hypoactive delirium
1545270|NCT00599287|Haloperidol|haloperidol
1545271|NCT00599287|Methylphenidate|methylphenidate
1545272|NCT00599287|Rivastigmine|rivastigmine
1545273|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
1545276|NCT00599274|Avonex|avonex
1545277|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
1545278|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
1545279|NCT00599235|Hypertension|hypertension
1545280|NCT00599235|Exercise capacity|exercise capacity
1545281|NCT00599235|PDE5 inhibitors|pde5 inhibitors
1545283|NCT00599222|macular degeneration|macular degeneration
1545284|NCT00599222|anti-VEGF|anti-vegf
1545285|NCT00599222|laser treatment|laser treatment
1545286|NCT00599196|Rotigotine|rotigotine
1545287|NCT00599196|Neupro®|neupro®
1545288|NCT00599183|Cervical spine herniation|cervical spine herniation
1545289|NCT00599183|MRI cervical spine|mri cervical spine
1545290|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
1545291|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
1545292|NCT00599144|Cholecystectomy|cholecystectomy
1545293|NCT00599131|Cancer of Larynx|cancer of larynx
1545296|NCT00599092|pituitary tumor|pituitary tumor
1545297|NCT00599092|recurrence|recurrence
1545298|NCT00599079|MAC|mac
1545299|NCT00599066|M-Entropy|m-entropy
1545300|NCT00599053|Ureaplasma|ureaplasma
1545301|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1545302|NCT00599053|very low birthweight|very low birthweight
1545303|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
1545304|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
1545305|NCT00599001|healthy volunteer|healthy volunteer
1545306|NCT00599001|research subjects|research subjects
1545307|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
1545308|NCT00599001|phase 1|phase 1
1545309|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
1545310|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
1545311|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
1545312|NCT00598962|MAC|mac
1545313|NCT00598949|Pituitary|pituitary
1545314|NCT00598949|Adenoma|adenoma
1545315|NCT00598949|Tumor|tumor
1545316|NCT00598949|Acromegaly|acromegaly
1545317|NCT00598949|Prolactinoma|prolactinoma
1545318|NCT00598949|Cushing's|cushing's
1545319|NCT00598936|Hypoxia|hypoxia
1545320|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
1545321|NCT00598923|tbi|tbi
1545322|NCT00598923|traumatic brain injury|traumatic brain injury
1545323|NCT00598923|epilepsy|epilepsy
1545324|NCT00598910|HIV infection|hiv infection
1545325|NCT00598897|MAC|mac
1545326|NCT00598884|Clinical Protocols|clinical protocols
1545327|NCT00598884|Behavioral Research|behavioral research
1545328|NCT00598884|Prevention|prevention
1545329|NCT00598871|Thymosin beta 4|thymosin beta 4
1545330|NCT00598871|Corneal wound healing|corneal wound healing
1545331|NCT00598871|Vitrectomy|vitrectomy
1545332|NCT00598871|Diabetes|diabetes
1545333|NCT00598858|prostate cancer|prostate cancer
1545334|NCT00598858|Prostatectomy|prostatectomy
1545335|NCT00598845|Endometrial cancer|endometrial cancer
1545336|NCT00598845|Molecular markers|molecular markers
1545337|NCT00598845|Lymph node metastasis|lymph node metastasis
1545338|NCT00598845|Prospective study|prospective study
1545339|NCT00598845|Prognosis|prognosis
1545340|NCT00598845|Cancer of Endometrium|cancer of endometrium
1545341|NCT00598845|Tumor Markers, Biological|tumor markers, biological
1545342|NCT00598832|Acne Vulgaris|acne vulgaris
1545343|NCT00598832|Adapalene|adapalene
1545344|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
1545345|NCT00598819|Oxygen Monitoring|oxygen monitoring
1545346|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
1545347|NCT00598780|Levocetirizine|levocetirizine
1545348|NCT00598780|Xyzal|xyzal
1545349|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
1545350|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
1545351|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
1545352|NCT00598767|Aortic valve stenosis|aortic valve stenosis
1545353|NCT00598767|3D echocardiogram|3d echocardiogram
1545354|NCT00598767|3D computed tomography|3d computed tomography
1545355|NCT00598754|Aortic valve stenosis|aortic valve stenosis
1545356|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
1545357|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
1545358|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
1545359|NCT00598741|Bone|bone
1545360|NCT00598741|Sarcoma|sarcoma
1545361|NCT00598741|04-083|04-083
1545362|NCT00598728|Survivors|survivors
1545363|NCT00598728|Quality of Life|quality of life
1545364|NCT00598715|In-stent restenosis|in-stent restenosis
1545365|NCT00598715|In-DES-restenosis|in-des-restenosis
1545366|NCT00598715|paclitaxel|paclitaxel
1545367|NCT00598715|sirolimus|sirolimus
1545368|NCT00598689|LASIK|lasik
1545369|NCT00598689|Ocular Lubricants|ocular lubricants
1545370|NCT00598689|Corneal Epithelium|corneal epithelium
1545371|NCT00598689|Wound Healing|wound healing
1545372|NCT00598663|Type 1 diabetes|type 1 diabetes
1545373|NCT00598650|Lewy Body Disease|lewy body disease
1545374|NCT00598650|Dementia|dementia
1545375|NCT00598650|Clinical Trial|clinical trial
1545376|NCT00598650|Phase II|phase ii
1545378|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
1545379|NCT00598637|drug eluting stent|drug eluting stent
1545380|NCT00598637|left main disease|left main disease
1545381|NCT00598611|urticaria|urticaria
1545382|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
1545383|NCT00598598|Aortic valve stenosis|aortic valve stenosis
1545384|NCT00598598|3D echocardiogram|3d echocardiogram
1545385|NCT00598572|Deferoxamine|deferoxamine
1545386|NCT00598572|Safety|safety
1545387|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
1545388|NCT00598559|Acute pain|acute pain
1545389|NCT00598559|Fever|fever
1545390|NCT00598559|IV Acetaminophen|iv acetaminophen
1545391|NCT00598559|Analgesic|analgesic
1545392|NCT00598546|Stomach|stomach
1545393|NCT00598546|Gastric|gastric
1545394|NCT00598546|Stomach Tumor|stomach tumor
1545395|NCT00598546|Stomach Cancer|stomach cancer
1545396|NCT00598507|ZK-EPO|zk-epo
1545397|NCT00598507|ZK219477|zk219477
1545398|NCT00598507|EpothiloneZK|epothilonezk
1545399|NCT00598494|effect of bedrest|effect of bedrest
1545400|NCT00598494|cardiac atrophy|cardiac atrophy
1545401|NCT00598481|SCID|scid
1545402|NCT00598481|gene therapy|gene therapy
1545403|NCT00598481|Adenosine deaminase|adenosine deaminase
1545404|NCT00598481|retroviral vector|retroviral vector
1545405|NCT00598455|angiomyolipomata|angiomyolipomata
1545406|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
1545407|NCT00598442|anemia|anemia
1545408|NCT00598442|chronic kidney disease|chronic kidney disease
1545409|NCT00598442|CKD|ckd
1545410|NCT00598442|chronic renal failure|chronic renal failure
1545411|NCT00598442|CRF|crf
1545412|NCT00598442|erythropoietin|erythropoietin
1545413|NCT00598442|EPO|epo
1567941|NCT00507728|Zyban|zyban
1545414|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1545415|NCT00598442|ESA|esa
1545416|NCT00598442|Hematide™|hematide™
1545417|NCT00598442|hemoglobin|hemoglobin
1545418|NCT00598442|Hb|hb
1545419|NCT00598442|Hgb|hgb
1545420|NCT00598442|Omontys|omontys
1545421|NCT00598442|peginesatide|peginesatide
1545422|NCT00598442|red blood cell|red blood cell
1545423|NCT00598442|red blood cell production|red blood cell production
1545424|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
1545425|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
1545426|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
1545427|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
1545428|NCT00598429|Mechanical ventilation|mechanical ventilation
1545429|NCT00598429|Meconium, aspiration|meconium, aspiration
1545430|NCT00598416|Hepatitis C|hepatitis c
1545431|NCT00598416|Substance Abuse|substance abuse
1545432|NCT00598416|Psychoeducation|psychoeducation
1545433|NCT00598416|Psychiatric functioning|psychiatric functioning
1545434|NCT00598416|Physical Functioning|physical functioning
1545435|NCT00598416|Quality of Life|quality of life
1545436|NCT00598416|NIAAA|niaaa
1545437|NCT00598416|Alcohol|alcohol
1545438|NCT00598403|Cystitis|cystitis
1545439|NCT00598390|Cannabinoid|cannabinoid
1545440|NCT00598390|CB1 Receptor|cb1 receptor
1545441|NCT00598390|Brain Imaging|brain imaging
1545442|NCT00598390|PET Imaging|pet imaging
1545443|NCT00598390|[11C]MePPEP|[11c]meppep
1545444|NCT00598390|Healthy Volunteer|healthy volunteer
1545445|NCT00598390|HV|hv
1545446|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1545447|NCT00598377|Adrenal functions|adrenal functions
1545448|NCT00598377|Renal volume|renal volume
1545449|NCT00598377|Glomerular filtration rate|glomerular filtration rate
1545450|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
1545451|NCT00598364|thyroid|thyroid
1545452|NCT00598364|nodule|nodule
1545453|NCT00598364|genetic|genetic
1545454|NCT00598364|mutation|mutation
1545455|NCT00598364|malignancy|malignancy
1545456|NCT00598351|Meningioma|meningioma
1545457|NCT00598351|Ependymoma|ependymoma
1545458|NCT00598351|Schwannoma|schwannoma
1545459|NCT00598351|Acoustic Neuroma|acoustic neuroma
1545460|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
1545461|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
1545462|NCT00598351|NF2|nf2
1545463|NCT00598325|Nicotine|nicotine
1545464|NCT00598325|Vaccine|vaccine
1545465|NCT00598325|Immunogenicity|immunogenicity
1545466|NCT00598325|Tobacco|tobacco
1545467|NCT00598325|Habits|habits
1545468|NCT00598299|corneal epithelium|corneal epithelium
1545469|NCT00598286|CB1 Receptor|cb1 receptor
1545471|NCT00598286|Cannabinoid|cannabinoid
1545472|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
1545473|NCT00598286|Brain Imaging|brain imaging
1545474|NCT00598286|Healthy Volunteer|healthy volunteer
1545475|NCT00598286|HV|hv
1545476|NCT00598273|anemia|anemia
1545477|NCT00598273|chronic kidney disease|chronic kidney disease
1545478|NCT00598273|CKD|ckd
1545479|NCT00598273|chronic renal failure|chronic renal failure
1545480|NCT00598273|CRF|crf
1545481|NCT00598273|erythropoietin|erythropoietin
1545482|NCT00598273|EPO|epo
1545483|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1545484|NCT00598273|ESA|esa
1545485|NCT00598273|Hematide™|hematide™
1545486|NCT00598273|hemoglobin|hemoglobin
1545487|NCT00598273|Hb|hb
1545488|NCT00598273|Hgb|hgb
1545489|NCT00598273|Omontys|omontys
1545490|NCT00598273|peginesatide|peginesatide
1545491|NCT00598273|red blood cell|red blood cell
1545492|NCT00598273|red blood cell production|red blood cell production
1545493|NCT00598260|active management|active management
1545494|NCT00598260|induction of labor|induction of labor
1545495|NCT00598260|cesarean delivery|cesarean delivery
1545496|NCT00598260|Cesarean|cesarean
1545497|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
1545498|NCT00598208|In-vitro fertilization|in-vitro fertilization
1545499|NCT00598195|Ketamine|ketamine
1545500|NCT00598195|Phamacokinetics|phamacokinetics
1545501|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
1545502|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
1545503|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1545504|NCT00598182|OROS methylphenidate|oros methylphenidate
1545505|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1545506|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1545507|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1545508|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1545509|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1545510|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1545511|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1545512|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1545513|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
1545514|NCT00598130|Excision of a kidney|excision of a kidney
1545515|NCT00598117|Esophageal|esophageal
1545516|NCT00598117|CancerEsophagus|canceresophagus
1545517|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
1545518|NCT00598091|Solid Tumors|solid tumors
1545519|NCT00598091|Phase I|phase i
1545520|NCT00598091|Expanded Cohort|expanded cohort
1545521|NCT00598091|Pancreatic Cancer|pancreatic cancer
1545522|NCT00598091|Dasatinib|dasatinib
1545523|NCT00598091|Gemcitabine|gemcitabine
1545524|NCT00598065|lung|lung
1545525|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
1545526|NCT00598026|Tele medicine|tele medicine
1545527|NCT00598026|ICD follow-up|icd follow-up
1545528|NCT00598026|Cost / benefit study|cost / benefit study
1545529|NCT00598013|Kidney Transplantation|kidney transplantation
1545530|NCT00598013|Thiazolidinediones|thiazolidinediones
1545531|NCT00598013|Insulin Resistance|insulin resistance
1545532|NCT00598013|Atherosclerosis|atherosclerosis
1545533|NCT00598000|Lung cancer|lung cancer
1545534|NCT00598000|Quality of Life|quality of life
1545535|NCT00598000|VATS|vats
1545536|NCT00598000|thoracotomy|thoracotomy
1545537|NCT00598000|05-006|05-006
1545538|NCT00597987|BRCA1|brca1
1545539|NCT00597974|carotid artery stenosis|carotid artery stenosis
1545540|NCT00597974|Neuropsychological tests|neuropsychological tests
1545541|NCT00597974|Stroke|stroke
1545542|NCT00597974|Transient ischemia|transient ischemia
1545543|NCT00597974|Stenting|stenting
1545544|NCT00597961|Lung|lung
1545545|NCT00597961|skin|skin
1545546|NCT00597961|melanoma|melanoma
1545547|NCT00597948|mental retardation|mental retardation
1545548|NCT00597948|downs syndrome|downs syndrome
1545549|NCT00597948|autism|autism
1545550|NCT00597948|autism spectrum disorder|autism spectrum disorder
1545551|NCT00597948|cerebral palsy|cerebral palsy
1545552|NCT00597948|developmental disability|developmental disability
1545553|NCT00597948|developmental disabilities|developmental disabilities
1545554|NCT00597948|intellectual disability|intellectual disability
1545555|NCT00597948|intellectual disabilities|intellectual disabilities
1545556|NCT00597948|health promotion|health promotion
1545557|NCT00597948|disease prevention|disease prevention
1545558|NCT00597948|physical health|physical health
1545559|NCT00597948|emotional health|emotional health
1545560|NCT00597948|behavioral health|behavioral health
1545561|NCT00597948|mental health|mental health
1545562|NCT00597948|spiritual health|spiritual health
1545563|NCT00597948|prevention|prevention
1545564|NCT00597935|prolapse|prolapse
1545565|NCT00597935|urinary incontinence|urinary incontinence
1545566|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
1545567|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
1545568|NCT00597935|behavioral therapy|behavioral therapy
1545569|NCT00597935|pelvic muscle training|pelvic muscle training
1545570|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
1545571|NCT00597922|Heart Attack|heart attack
1545572|NCT00597922|Gender Differences|gender differences
1545573|NCT00597922|Risk Factors|risk factors
1545574|NCT00597922|Quality of Care|quality of care
1545575|NCT00597909|Ammonul®|ammonul®
1545576|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
1545577|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
1545578|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
1545579|NCT00597883|carotid endarterectomy|carotid endarterectomy
1545580|NCT00597883|Neuropsychological tests|neuropsychological tests
1545581|NCT00597883|Stroke|stroke
1545582|NCT00597883|Transient ischemia|transient ischemia
1545583|NCT00597870|TAA|taa
1545584|NCT00597844|type I thyroplasty|type i thyroplasty
1545585|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
1545586|NCT00597831|depression|depression
1545587|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
1545588|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
1545589|NCT00597831|intracranial pressure|intracranial pressure
1545590|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1545591|NCT00597792|Plicator|plicator
1545592|NCT00597792|Full-thickness Plication|full-thickness plication
1545593|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
1545594|NCT00597766|CVA|cva
1545595|NCT00597766|Hemiplegia|hemiplegia
1545596|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
1545597|NCT00597766|Subacromial steroid injection|subacromial steroid injection
1545598|NCT00597753|anemia|anemia
1545599|NCT00597753|chronic kidney disease|chronic kidney disease
1545600|NCT00597753|CKD|ckd
1545601|NCT00597753|chronic renal failure|chronic renal failure
1545602|NCT00597753|CRF|crf
1545603|NCT00597753|dialysis|dialysis
1545604|NCT00597753|erythropoietin|erythropoietin
1545605|NCT00597753|EPO|epo
1545606|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1545607|NCT00597753|ESA|esa
1545608|NCT00597753|Hematide™|hematide™
1545609|NCT00597753|hemodialysis|hemodialysis
1545610|NCT00597753|hemoglobin|hemoglobin
1545611|NCT00597753|Hb|hb
1545612|NCT00597753|Hgb|hgb
1545613|NCT00597753|Omontys|omontys
1545614|NCT00597753|peginesatide|peginesatide
1545615|NCT00597753|red blood cell|red blood cell
1545616|NCT00597753|red blood cell production|red blood cell production
1545617|NCT00597727|Peanut Allergy|peanut allergy
1545618|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
1545619|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
1545620|NCT00597701|Alcohol withdrawal|alcohol withdrawal
1545621|NCT00597701|Delirium tremors|delirium tremors
1545622|NCT00597675|Peanut allergy|peanut allergy
1545623|NCT00597636|smokers|smokers
1545624|NCT00597623|Osteoarthritis|osteoarthritis
1545625|NCT00597623|Hand|hand
1545626|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
1545627|NCT00597623|Biological Therapy|biological therapy
1545628|NCT00597610|Rectum|rectum
1545629|NCT00597610|Rectal|rectal
1546240|NCT00595049|artery|artery
1545630|NCT00597597|Metastatic breast cancer|metastatic breast cancer
1545631|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
1545632|NCT00597597|HER2/neu negative|her2/neu negative
1545633|NCT00597597|EGFR positive|egfr positive
1545634|NCT00597584|anemia|anemia
1545635|NCT00597584|chronic kidney disease|chronic kidney disease
1545636|NCT00597584|CKD|ckd
1545637|NCT00597584|chronic renal failure|chronic renal failure
1545638|NCT00597584|CRF|crf
1545639|NCT00597584|dialysis|dialysis
1545640|NCT00597584|erythropoietin|erythropoietin
1545641|NCT00597584|EPO|epo
1545642|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1545643|NCT00597584|ESA|esa
1545644|NCT00597584|Hematide™|hematide™
1545645|NCT00597584|hemodialysis|hemodialysis
1545646|NCT00597584|hemoglobin|hemoglobin
1545647|NCT00597584|Hb|hb
1545648|NCT00597584|Hgb|hgb
1545649|NCT00597584|Omontys|omontys
1545650|NCT00597584|peginesatide|peginesatide
1545651|NCT00597584|red blood cell|red blood cell
1545652|NCT00597584|red blood cell production|red blood cell production
1545653|NCT00597558|Egg allergy|egg allergy
1545654|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
1545655|NCT00597545|Neuropsychological tests|neuropsychological tests
1545656|NCT00597545|Stroke|stroke
1545657|NCT00597545|Transient ischemia|transient ischemia
1545658|NCT00597545|Hypoperfusion|hypoperfusion
1545659|NCT00597545|Ischemia|ischemia
1545660|NCT00597532|Breast Cancer|breast cancer
1545661|NCT00597532|Soy|soy
1545662|NCT00597532|Milk|milk
1545663|NCT00597532|Supplementation|supplementation
1545664|NCT00597532|02-062|02-062
1545665|NCT00597519|Cancer|cancer
1545666|NCT00597519|Leukemia|leukemia
1545667|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
1545668|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1545669|NCT00597519|Total Body Irradiation|total body irradiation
1545670|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
1545671|NCT00597519|06-014|06-014
1545672|NCT00597506|colorectal|colorectal
1545673|NCT00597506|refractory|refractory
1545674|NCT00597506|adenocarcinoma|adenocarcinoma
1545675|NCT00597506|bevacizumab|bevacizumab
1545676|NCT00597506|everolimus|everolimus
1545677|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1545678|NCT00597493|GBM|gbm
1545679|NCT00597493|Glioblastoma|glioblastoma
1545680|NCT00597493|Sorafenib|sorafenib
1545681|NCT00597493|Temozolomide|temozolomide
1545682|NCT00597493|Brain Tumor|brain tumor
1545683|NCT00597493|Recurrent GBM|recurrent gbm
1545684|NCT00597493|Temodar|temodar
1545685|NCT00597493|Gliosarcoma|gliosarcoma
1545686|NCT00597493|Glioma|glioma
1545687|NCT00597493|Nexavar|nexavar
1545688|NCT00597480|Growth hormone|growth hormone
1545689|NCT00597480|Child|child
1545690|NCT00597480|insulin resistance|insulin resistance
1545691|NCT00597480|metabolic syndrome X|metabolic syndrome x
1545692|NCT00597480|children born small for gestational age|children born small for gestational age
1545693|NCT00597467|myopia|myopia
1545694|NCT00597467|hyperopia|hyperopia
1545695|NCT00597467|extended wear|extended wear
1545696|NCT00597467|ametropia|ametropia
1545697|NCT00597454|Breast|breast
1545698|NCT00597441|unrelated|unrelated
1545699|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
1545700|NCT00597441|thymus transplantation|thymus transplantation
1545701|NCT00597415|Osteoarthritis|osteoarthritis
1545702|NCT00597415|Knee pain|knee pain
1545703|NCT00597402|Avastin|avastin
1545704|NCT00597402|Bevacizumab|bevacizumab
1545705|NCT00597402|Temozolomide|temozolomide
1545706|NCT00597402|Temodar|temodar
1545707|NCT00597402|Irinotecan|irinotecan
1545708|NCT00597402|Camptosar|camptosar
1545709|NCT00597402|GBM|gbm
1545710|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
1545711|NCT00597402|Gliosarcoma|gliosarcoma
1545712|NCT00597402|Brain tumor|brain tumor
1545713|NCT00597402|Glioma|glioma
1545714|NCT00597402|New GBM|new gbm
1545715|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
1545716|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
1545717|NCT00597389|propranolol|propranolol
1545718|NCT00597389|inderol|inderol
1545719|NCT00597389|child|child
1545720|NCT00597389|trauma|trauma
1545721|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
1545722|NCT00597376|memory loss|memory loss
1545723|NCT00597363|vascular access site|vascular access site
1545724|NCT00597363|arterial puncture|arterial puncture
1545725|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
1545726|NCT00597350|Fenugreek|fenugreek
1545727|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
1545728|NCT00597350|Diabetes mellitus|diabetes mellitus
1545729|NCT00597350|Blood sugar|blood sugar
1545730|NCT00597350|Insulin|insulin
1545731|NCT00597350|Glucose|glucose
1545732|NCT00597337|bullying|bullying
1545733|NCT00597337|victimisation|victimisation
1545734|NCT00597337|aggressive behavior|aggressive behavior
1545735|NCT00597324|Allen's test|allen's test
1545736|NCT00597324|lactate|lactate
1545737|NCT00597324|safety|safety
1545738|NCT00597324|radial intervention|radial intervention
1545739|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
1545740|NCT00597311|rectal cancer|rectal cancer
1545741|NCT00597311|radiotherapy|radiotherapy
1545742|NCT00597311|radiochemotherapy|radiochemotherapy
1545743|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
1545744|NCT00597298|cardiac surgery|cardiac surgery
1545745|NCT00597298|respiratory muscle training|respiratory muscle training
1545746|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
1545747|NCT00597285|Magnetic Resonance|magnetic resonance
1545748|NCT00597285|Epilepsy|epilepsy
1545749|NCT00597285|HHV-6B|hhv-6b
1545750|NCT00597285|Healthy Volunteer|healthy volunteer
1545751|NCT00597285|HV|hv
1545752|NCT00597272|melanoma|melanoma
1545753|NCT00597272|resected local|resected local
1545754|NCT00597272|systemic metastasis|systemic metastasis
1545755|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
1545756|NCT00597246|Brain|brain
1545757|NCT00597246|CNS|cns
1545758|NCT00597246|Central Nervous System|central nervous system
1545759|NCT00597207|CPR|cpr
1545760|NCT00597207|mechanical|mechanical
1545761|NCT00597207|manual|manual
1545762|NCT00597207|outcome|outcome
1545763|NCT00597207|survival|survival
1545764|NCT00597207|quality|quality
1545765|NCT00597194|inguinal hernia|inguinal hernia
1545766|NCT00597194|laparoscopic repair|laparoscopic repair
1545767|NCT00597194|open repair|open repair
1545768|NCT00597194|randomized|randomized
1545769|NCT00597181|Inflammatory response|inflammatory response
1545770|NCT00597168|Schizophrenia|schizophrenia
1545771|NCT00597168|atypical antipsychotic|atypical antipsychotic
1545772|NCT00597168|quality of life|quality of life
1545773|NCT00597168|ambulatory setting|ambulatory setting
1545774|NCT00597142|renal stent|renal stent
1545775|NCT00597142|stent|stent
1545776|NCT00597142|atherosclerosis|atherosclerosis
1545777|NCT00597142|aortorenal ostium|aortorenal ostium
1545778|NCT00597142|renal|renal
1545779|NCT00597142|renal artery|renal artery
1545780|NCT00597142|PTRA|ptra
1545781|NCT00597129|pancreatic cancer|pancreatic cancer
1545782|NCT00597129|cancer of the pancreas|cancer of the pancreas
1545783|NCT00597129|pancreas cancer|pancreas cancer
1545784|NCT00597116|Mesothelioma|mesothelioma
1545785|NCT00597116|inoperable|inoperable
1545786|NCT00597116|relapsed|relapsed
1545787|NCT00597103|Hemodialysis|hemodialysis
1545788|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
1545789|NCT00597103|Sleep Apnea|sleep apnea
1545790|NCT00597103|Restless Leg Syndrome|restless leg syndrome
1545791|NCT00597103|Cognitive Function|cognitive function
1545792|NCT00597090|Infections|infections
1545793|NCT00597090|lymphoma|lymphoma
1545794|NCT00597064|asthma|asthma
1545795|NCT00597064|asthma control questionnaire|asthma control questionnaire
1545796|NCT00597064|oral corticosteroid|oral corticosteroid
1545797|NCT00597064|air trapping|air trapping
1545798|NCT00597064|AQLQ|aqlq
1545799|NCT00597064|control|control
1545800|NCT00597064|quality of life|quality of life
1545801|NCT00597038|Dasatinib|dasatinib
1545802|NCT00597038|Dacarbazine|dacarbazine
1545803|NCT00597025|Malnutrition|malnutrition
1545804|NCT00597025|Hypoalbuminemia|hypoalbuminemia
1545805|NCT00597025|Dietary Supplements|dietary supplements
1545806|NCT00597025|Hemodialysis|hemodialysis
1545807|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
1545808|NCT00597012|Meniscal Tear|meniscal tear
1545809|NCT00597012|Osteoarthritis|osteoarthritis
1545810|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
1545811|NCT00597012|Physical Therapy|physical therapy
1545812|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1545813|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1545814|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1545815|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
1545816|NCT00596999|Beta Thalassemia|beta thalassemia
1545817|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
1545818|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
1545819|NCT00596986|Depression|depression
1545820|NCT00596986|Duloxetine|duloxetine
1545821|NCT00596986|Psychotherapy|psychotherapy
1545822|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
1545823|NCT00596960|Alcohol Abuse|alcohol abuse
1545824|NCT00596960|Alcohol Dependence|alcohol dependence
1545825|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
1545826|NCT00596960|Drug Dependence|drug dependence
1545827|NCT00596960|Hepatitis C|hepatitis c
1545828|NCT00596960|Motivation|motivation
1545829|NCT00596947|kidney transplantation|kidney transplantation
1545830|NCT00596947|tacrolimus|tacrolimus
1545831|NCT00596947|Prograf|prograf
1545832|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
1545833|NCT00596947|CellCept|cellcept
1545834|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
1545835|NCT00596947|prednisone withdrawal|prednisone withdrawal
1545836|NCT00596947|prednisone maintenance|prednisone maintenance
1545837|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
1545838|NCT00596947|Thymoglobulin|thymoglobulin
1545839|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1545840|NCT00596934|Insulin resistance|insulin resistance
1545841|NCT00596934|Obesity|obesity
1545842|NCT00596934|Leptin therapy|leptin therapy
1545843|NCT00596934|NASH|nash
1545844|NCT00596921|Ultrasonography|ultrasonography
1545845|NCT00596921|Central Venous Pressure|central venous pressure
1545846|NCT00596921|Noninvasive monitoring|noninvasive monitoring
1545847|NCT00596921|Shock|shock
1545848|NCT00596921|Resuscitation|resuscitation
1545849|NCT00596908|Essential Tremor|essential tremor
1545850|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
1545851|NCT00596908|Parkinson Disease|parkinson disease
1545852|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
1545853|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
1545854|NCT00596882|smoking cessation|smoking cessation
1545855|NCT00596882|nicotine dependence|nicotine dependence
1545856|NCT00596882|message prime|message prime
1545857|NCT00596882|recruitment|recruitment
1545858|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
1545859|NCT00596856|Referral behavior|referral behavior
1545860|NCT00596856|Oral health risk assessment|oral health risk assessment
1545861|NCT00596856|Guideline development and dissemination|guideline development and dissemination
1545862|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
1545863|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
1545864|NCT00596830|CP-751|cp-751
1545865|NCT00596830|871|871
1545866|NCT00596817|Relapse prevention|relapse prevention
1545867|NCT00596817|Antidepressants|antidepressants
1545868|NCT00596817|Placebo-controlled|placebo-controlled
1545869|NCT00596817|Double-blind|double-blind
1545870|NCT00596817|Multicentre study|multicentre study
1545871|NCT00596804|NHL|nhl
1545872|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1545873|NCT00596804|follicular lymphoma|follicular lymphoma
1545874|NCT00596804|B-cell lymphoma|b-cell lymphoma
1545875|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
1545876|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
1545877|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
1545878|NCT00596804|MALT|malt
1545879|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
1545880|NCT00596804|High-Grade|high-grade
1545881|NCT00596804|Intermediate-Grade|intermediate-grade
1545882|NCT00596804|Low-Grade|low-grade
1545883|NCT00596804|Mixed|mixed
1545884|NCT00596778|Physical therapy specialty|physical therapy specialty
1545885|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
1545886|NCT00596778|Anesthesia recovery period|anesthesia recovery period
1545887|NCT00596778|Spirometry|spirometry
1545888|NCT00596765|Brain Injury|brain injury
1545889|NCT00596765|Neuropsychology|neuropsychology
1545890|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
1545891|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
1545892|NCT00596752|Alprostadil|alprostadil
1545893|NCT00596752|Prostavasin|prostavasin
1545894|NCT00596752|PAOD|paod
1545895|NCT00596752|Fontaine Stage IV|fontaine stage iv
1545896|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
1545897|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
1545898|NCT00596713|general population|general population
1545899|NCT00596700|Capsule endoscopy|capsule endoscopy
1545900|NCT00596700|Crohn's disease|crohn's disease
1545901|NCT00596700|IBD|ibd
1545902|NCT00596700|Activity score|activity score
1545903|NCT00596700|Small bowel|small bowel
1545904|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
1545905|NCT00596700|Recruiting|recruiting
1545906|NCT00596687|diabetes|diabetes
1545907|NCT00596687|post-op complications|post-op complications
1545908|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
1545909|NCT00596674|Women|women
1545910|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
1545911|NCT00596674|Health Behaviors|health behaviors
1545912|NCT00596674|Quality of Life|quality of life
1545913|NCT00596661|coronary stent|coronary stent
1545914|NCT00596648|Lung Cancer|lung cancer
1545915|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1545916|NCT00596648|NSCLC|nsclc
1545917|NCT00596635|UTI|uti
1545918|NCT00596635|elderly|elderly
1545919|NCT00596635|prevention|prevention
1545920|NCT00596635|cranberry|cranberry
1545921|NCT00596635|E.Coli|e.coli
1545922|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
1545923|NCT00596622|Bipolar|bipolar
1545924|NCT00596622|Mania|mania
1545925|NCT00596622|Depression|depression
1545926|NCT00596622|Lithium|lithium
1545927|NCT00596622|fMRI|fmri
1545928|NCT00596622|Pictures|pictures
1545929|NCT00596622|Brain Scan|brain scan
1545930|NCT00596609|Injections, intrathecal|injections, intrathecal
1545931|NCT00596609|Transcranial|transcranial
1545932|NCT00596609|Spinal Fusion|spinal fusion
1546733|NCT00592618|ESRD|esrd
1545933|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
1545934|NCT00596596|Constipation|constipation
1545935|NCT00596596|prucalopride|prucalopride
1545936|NCT00596570|Atrial fibrillation|atrial fibrillation
1545937|NCT00596570|Oral Anticoagulation|oral anticoagulation
1545938|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
1545939|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
1545940|NCT00596544|sexual dysfunction|sexual dysfunction
1545941|NCT00596531|Tinnitus|tinnitus
1545942|NCT00596531|acamprosate|acamprosate
1545943|NCT00596531|clinical trial|clinical trial
1545944|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1545945|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
1545946|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
1545947|NCT00596505|silicone oil|silicone oil
1545948|NCT00596479|CAD|cad
1545949|NCT00596479|G-CSF|g-csf
1545950|NCT00596479|Collaterals|collaterals
1545951|NCT00596479|CFI|cfi
1545952|NCT00596479|perfusion|perfusion
1545953|NCT00596466|open-label|open-label
1545954|NCT00596466|extension study|extension study
1545955|NCT00596466|pregabalin|pregabalin
1545956|NCT00596466|partial epilepsy|partial epilepsy
1545957|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
1545958|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
1545959|NCT00596440|smoking|smoking
1545960|NCT00596440|teachable moment|teachable moment
1545961|NCT00596440|cancer|cancer
1545962|NCT00596427|type two diabetes|type two diabetes
1545963|NCT00596427|gluconeogenesis|gluconeogenesis
1545964|NCT00596427|glucose|glucose
1545965|NCT00596427|lipid synthesis|lipid synthesis
1545966|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
1545967|NCT00596427|colesevelam HCl|colesevelam hcl
1545968|NCT00596414|liver|liver
1545969|NCT00596414|biopsy|biopsy
1545970|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
1545971|NCT00596375|Lidocaine|lidocaine
1545972|NCT00596375|Infant|infant
1545973|NCT00596375|Urinary Catheterization|urinary catheterization
1545974|NCT00596375|Emergency Medicine|emergency medicine
1545980|NCT00596349|Quality of Life|quality of life
1545981|NCT00596349|Survivorship|survivorship
1545982|NCT00596323|antenna|antenna
1545983|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
1545984|NCT00596323|electromagnetic|electromagnetic
1545985|NCT00596310|Lung cancer|lung cancer
1545986|NCT00596310|screening|screening
1545987|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
1545988|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
1545989|NCT00596297|Bevacizumab|bevacizumab
1545990|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
1545991|NCT00596297|preoperative|preoperative
1545992|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
1545993|NCT00596284|Alzheimer's Disease|alzheimer's disease
1545994|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1545995|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
1545996|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
1545997|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1545998|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
1545999|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
1546000|NCT00596219|HEAD|head
1546001|NCT00596219|NECK|neck
1546002|NCT00596219|SQUAMOUS|squamous
1546003|NCT00596219|CARCINOMA|carcinoma
1546004|NCT00596193|Hyperalgesia|hyperalgesia
1546005|NCT00596193|nociceptors|nociceptors
1546006|NCT00596193|Neurons|neurons
1546007|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
1546008|NCT00596180|brain injury|brain injury
1546009|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
1546010|NCT00596167|pharmacokinetics|pharmacokinetics
1546011|NCT00596167|levofloxacin|levofloxacin
1546012|NCT00596167|gentamicin|gentamicin
1546013|NCT00596167|vancomycin|vancomycin
1546014|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
1546015|NCT00596141|Surgery, Oral|surgery, oral
1546016|NCT00596128|Blood glucose|blood glucose
1546017|NCT00596128|Clinical pathways|clinical pathways
1546018|NCT00596076|Low back pain|low back pain
1546019|NCT00596063|pharmacokinetics|pharmacokinetics
1546020|NCT00596063|pharmacodynamics|pharmacodynamics
1546021|NCT00596063|recombinant human insulin|recombinant human insulin
1546022|NCT00596063|healthy volunteers|healthy volunteers
1546023|NCT00596050|procedural sedation|procedural sedation
1546024|NCT00596050|fracture reduction|fracture reduction
1546025|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
1546026|NCT00596050|etomidate|etomidate
1546027|NCT00596050|ketamine|ketamine
1546028|NCT00596050|analgesia|analgesia
1546029|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
1546034|NCT00595998|AMD, HMP, PHP|amd, hmp, php
1546035|NCT00595985|Time to Progression|time to progression
1546036|NCT00595985|Toxicity|toxicity
1546037|NCT00595985|Overall survival|overall survival
1546038|NCT00595985|Response rate|response rate
1546039|NCT00595985|Quality of live|quality of live
1546040|NCT00595985|Toxicities|toxicities
1546041|NCT00595972|Time to Progression|time to progression
1546042|NCT00595972|Overall survival|overall survival
1546043|NCT00595972|Response rate|response rate
1546044|NCT00595972|Quality of Live|quality of live
1546045|NCT00595972|Toxicities|toxicities
1546046|NCT00595933|Head and Neck cancer|head and neck cancer
1546047|NCT00595933|Radiation therapy|radiation therapy
1546048|NCT00595933|Dry mouth remedies|dry mouth remedies
1546049|NCT00595933|Dry Mouth|dry mouth
1546050|NCT00595933|Xerostomia|xerostomia
1546051|NCT00595920|Tovaxin|tovaxin
1546052|NCT00595920|Autologous|autologous
1546053|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
1546054|NCT00595907|tuberculosis|tuberculosis
1546055|NCT00595907|interferon gamma release assays|interferon gamma release assays
1546056|NCT00595907|treatment|treatment
1546057|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
1546058|NCT00595894|African Americans|african americans
1546059|NCT00595894|osteopenia|osteopenia
1546060|NCT00595894|osteoporosis|osteoporosis
1546061|NCT00595894|bone mineral density|bone mineral density
1546062|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
1546063|NCT00595881|Abscess|abscess
1546064|NCT00595881|Cellulitis|cellulitis
1546065|NCT00595881|Soft tissue infection|soft tissue infection
1546066|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
1546067|NCT00595868|Nicotine|nicotine
1546068|NCT00595868|Smoking|smoking
1546069|NCT00595868|Smoking Cessation|smoking cessation
1546070|NCT00595855|glaucoma|glaucoma
1546071|NCT00595855|surgery|surgery
1546072|NCT00595855|non penetrating procedures|non penetrating procedures
1546073|NCT00595855|cataract|cataract
1546074|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
1546075|NCT00595829|Polycythemia Vera|polycythemia vera
1546076|NCT00595829|PV|pv
1546077|NCT00595816|low back pain|low back pain
1546078|NCT00595816|physical fitness|physical fitness
1546079|NCT00595816|injury|injury
1546080|NCT00595816|prevention|prevention
1546081|NCT00595816|conscripts|conscripts
1546082|NCT00595777|Institutional change|institutional change
1546083|NCT00595777|Improved pain management|improved pain management
1546084|NCT00595764|Buprenorphine|buprenorphine
1546085|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
1546086|NCT00595764|Counseling|counseling
1546087|NCT00595764|Primary care|primary care
1546088|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
1546089|NCT00595738|Congestive heart failure|congestive heart failure
1546090|NCT00595738|Cardiac biomarkers|cardiac biomarkers
1546091|NCT00595738|Hemodynamics|hemodynamics
1546092|NCT00595738|Tailored therapy|tailored therapy
1546093|NCT00595725|Cervix|cervix
1546094|NCT00595725|Endometrium|endometrium
1546095|NCT00595725|Cervical Carcinoma|cervical carcinoma
1546096|NCT00595725|Lymphatic Mapping|lymphatic mapping
1546097|NCT00595712|Genovarum|genovarum
1546098|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
1546099|NCT00595712|allograft|allograft
1546100|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
1546101|NCT00595673|Perfusion|perfusion
1546102|NCT00595673|Echocardiograpy|echocardiograpy
1546103|NCT00595673|SPECT|spect
1546104|NCT00595673|angiography|angiography
1546105|NCT00595673|Chest pain|chest pain
1546106|NCT00595660|Palpable Breast Mass|palpable breast mass
1546107|NCT00595660|FNA|fna
1546108|NCT00595660|Cytology|cytology
1546109|NCT00595660|Fine needle aspiration|fine needle aspiration
1546110|NCT00595660|Specimen Adequacy|specimen adequacy
1546111|NCT00595634|Hip|hip
1546112|NCT00595634|Fracture|fracture
1546113|NCT00595634|Intertrochanteric|intertrochanteric
1546114|NCT00595634|intramedullary|intramedullary
1546115|NCT00595608|aftercare|aftercare
1546116|NCT00595608|nasal septum|nasal septum
1546117|NCT00595608|turbinates|turbinates
1546118|NCT00595595|Dental Pulp|dental pulp
1546119|NCT00595595|Regenerative Medicine|regenerative medicine
1546120|NCT00595595|Odontoblasts|odontoblasts
1546121|NCT00595595|Stem Cells|stem cells
1567942|NCT00507728|Varenicline|varenicline
1546122|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
1546123|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
1546124|NCT00595569|flexible insulin therapy|flexible insulin therapy
1546125|NCT00595569|diabetes education|diabetes education
1546126|NCT00595569|diabetes|diabetes
1546128|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
1546129|NCT00595556|Zonisamide|zonisamide
1546130|NCT00595556|Pharmacotherapy|pharmacotherapy
1546131|NCT00595556|Alcohol dependence|alcohol dependence
1546132|NCT00595556|anticonvulsant|anticonvulsant
1546133|NCT00595530|ketamine|ketamine
1546134|NCT00595530|vasoocclusive pain|vasoocclusive pain
1546135|NCT00595517|gastrointestinal|gastrointestinal
1546136|NCT00595517|GI|gi
1546137|NCT00595517|NSAID|nsaid
1546138|NCT00595517|Japan|japan
1546139|NCT00595517|Japanese|japanese
1547031|NCT00591487|plastic|plastic
1546140|NCT00595517|Gastric ulcer|gastric ulcer
1546141|NCT00595517|duodenal ulcer|duodenal ulcer
1546142|NCT00595504|schizophrenia|schizophrenia
1546143|NCT00595504|metabolism|metabolism
1546144|NCT00595504|antipsychotics|antipsychotics
1546145|NCT00595504|diabetes|diabetes
1546146|NCT00595504|rozerem|rozerem
1546147|NCT00595491|Asthma|asthma
1546148|NCT00595491|Inflammation|inflammation
1546149|NCT00595491|Allergic|allergic
1546150|NCT00595491|Airway|airway
1546151|NCT00595491|Challenge|challenge
1546152|NCT00595491|Chemokines|chemokines
1546153|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
1546154|NCT00595439|Electromyogram|electromyogram
1546155|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1546156|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
1546157|NCT00595439|Focal Hand Dystonia|focal hand dystonia
1546158|NCT00595439|Focal Dystonia|focal dystonia
1546159|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
1546160|NCT00595439|CRPS|crps
1546161|NCT00595426|Knee Arthroplasty|knee arthroplasty
1546162|NCT00595426|Factor Xa|factor xa
1546163|NCT00595426|VTE|vte
1546164|NCT00595426|Thrombosis|thrombosis
1546165|NCT00595426|Anticoagulants|anticoagulants
1546166|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
1546167|NCT00595413|Atacicept|atacicept
1546168|NCT00595413|Adalimumab|adalimumab
1546169|NCT00595413|Humira®|humira®
1546170|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
1546171|NCT00595361|asthma|asthma
1546172|NCT00595361|exercise induced asthma|exercise induced asthma
1546173|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
1546174|NCT00595361|long acting beta agonist|long acting beta agonist
1546175|NCT00595361|salmeterol|salmeterol
1546176|NCT00595361|exercise challenge|exercise challenge
1546177|NCT00595361|bronchoprotection|bronchoprotection
1546178|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
1546179|NCT00595361|pharmacogenetics|pharmacogenetics
1546180|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
1546181|NCT00595335|Rituximab|rituximab
1546182|NCT00595335|Proptosis|proptosis
1546183|NCT00595322|Bevacizumab|bevacizumab
1546184|NCT00595322|Radiation Treatment|radiation treatment
1546185|NCT00595322|Brain Cancer|brain cancer
1546186|NCT00595296|BreastCancer|breastcancer
1546187|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
1546188|NCT00595296|Metastasis|metastasis
1546189|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
1546190|NCT00595283|Preschool Depression|preschool depression
1546191|NCT00595283|Emotion Development|emotion development
1546192|NCT00595283|Parent Child Interaction|parent child interaction
1546193|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
1546194|NCT00595244|Perfusion|perfusion
1546195|NCT00595244|Echocardiograpy|echocardiograpy
1546196|NCT00595244|SPECT|spect
1546197|NCT00595244|angiography|angiography
1546198|NCT00595244|Chest pain|chest pain
1546199|NCT00595231|GAD|gad
1546200|NCT00595218|Patient Preferences|patient preferences
1546201|NCT00595218|Patient Satisfaction|patient satisfaction
1546202|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
1546203|NCT00595205|vaccination|vaccination
1546204|NCT00595205|intussusception|intussusception
1546205|NCT00595205|Rotavirus|rotavirus
1546206|NCT00595205|vaccine|vaccine
1546207|NCT00595179|Infrared|infrared
1546208|NCT00595179|Imaging Techniques|imaging techniques
1546209|NCT00595179|Kidney Reperfusion|kidney reperfusion
1546210|NCT00595179|Pneumoperitoneum|pneumoperitoneum
1546211|NCT00595179|Nephrectomy|nephrectomy
1546212|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
1546213|NCT00595140|Acromegaly,|acromegaly,
1546214|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
1546215|NCT00595140|somatostatin analogue,|somatostatin analogue,
1546216|NCT00595140|combined medical treatment,|combined medical treatment,
1546217|NCT00595140|acute effect,|acute effect,
1546218|NCT00595140|endogenous GH|endogenous gh
1546219|NCT00595127|Fanconi|fanconi
1546220|NCT00595127|Anemia|anemia
1546221|NCT00595127|Stem Cell|stem cell
1546222|NCT00595127|Transplant|transplant
1546223|NCT00595114|COPD|copd
1546224|NCT00595114|Airway|airway
1546225|NCT00595114|Inflammation|inflammation
1546226|NCT00595114|Infection|infection
1546227|NCT00595114|Lipid Mediators|lipid mediators
1546228|NCT00595114|Oxidative Stress|oxidative stress
1546229|NCT00595088|Bladder Cancer|bladder cancer
1546230|NCT00595088|Refractory|refractory
1546231|NCT00595075|sleep|sleep
1546232|NCT00595075|performance|performance
1546233|NCT00595075|night shift|night shift
1546234|NCT00595075|Ramelteon|ramelteon
1546235|NCT00595075|Healthy Individuals|healthy individuals
1546236|NCT00595062|Breast|breast
1546237|NCT00595062|Cancer|cancer
1546238|NCT00595049|pulmonary|pulmonary
1546239|NCT00595049|arterial|arterial
1546241|NCT00595049|hypertension|hypertension
1546242|NCT00595049|systemic|systemic
1546243|NCT00595049|sclerosis|sclerosis
1546244|NCT00595049|scleroderma|scleroderma
1546245|NCT00595049|remodelling|remodelling
1546246|NCT00595049|bosentan|bosentan
1546247|NCT00595049|tracleer|tracleer
1546248|NCT00595049|intravascular|intravascular
1546249|NCT00595023|Sentinel lymph node|sentinel lymph node
1546250|NCT00595023|Metastasis|metastasis
1546251|NCT00595010|Child Maltreatment|child maltreatment
1546252|NCT00595010|Child Neglect|child neglect
1546253|NCT00595010|Child Physical Abuse|child physical abuse
1546254|NCT00595010|Evidence-Based Practice|evidence-based practice
1546255|NCT00594997|Lyme disease|lyme disease
1546256|NCT00594997|educational intervention for children|educational intervention for children
1546257|NCT00594997|tick borne illness|tick borne illness
1546258|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
1546259|NCT00594997|Self-efficacy|self-efficacy
1546260|NCT00594997|tick prevention|tick prevention
1546261|NCT00594997|tick avoidance|tick avoidance
1546262|NCT00594997|health behavior modification|health behavior modification
1546263|NCT00594971|Health Services Research|health services research
1546264|NCT00594971|Family practice|family practice
1546265|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
1546266|NCT00594919|acute kidney injury|acute kidney injury
1546267|NCT00594919|ngal|ngal
1546268|NCT00594919|cardiac surgery|cardiac surgery
1546269|NCT00594906|Fracture Healing|fracture healing
1546270|NCT00594906|Teriparatide|teriparatide
1546271|NCT00594906|Forteo|forteo
1546272|NCT00594906|Pelvic Fractures|pelvic fractures
1546274|NCT00594893|Arthroplasty|arthroplasty
1546475|NCT00593944|monoclonal|monoclonal
1546275|NCT00594893|Minimally Invasive|minimally invasive
1546276|NCT00594880|HIV|hiv
1546277|NCT00594880|HIV-1|hiv-1
1546278|NCT00594880|Pegasys|pegasys
1546279|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
1546280|NCT00594880|Viral Suppression|viral suppression
1546281|NCT00594880|ART cessation|art cessation
1546282|NCT00594880|Immune function|immune function
1546283|NCT00594880|Innate Immunity|innate immunity
1546284|NCT00594880|Toxicity|toxicity
1546285|NCT00594880|Immune-based therapy|immune-based therapy
1546286|NCT00594880|Treatment interruption|treatment interruption
1546287|NCT00594867|Healthy|healthy
1546288|NCT00594867|Volunteer|volunteer
1546289|NCT00594854|NSAID|nsaid
1546290|NCT00594854|Gastric Ulcer|gastric ulcer
1546291|NCT00594854|High risk|high risk
1546292|NCT00594854|Arthrotec|arthrotec
1546293|NCT00594854|Vimovo|vimovo
1546294|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
1546295|NCT00594841|Shoulder dislocation|shoulder dislocation
1546296|NCT00594841|AC dislocation|ac dislocation
1546297|NCT00594828|Patient self-testing|patient self-testing
1546298|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
1546299|NCT00594828|Expert Systems|expert systems
1546300|NCT00594828|Point-of-Care Systems|point-of-care systems
1546301|NCT00594828|International Normalized Ratio|international normalized ratio
1546302|NCT00594815|Lymphoma|lymphoma
1546303|NCT00594815|Central Nervous System|central nervous system
1546304|NCT00594802|ALLERGIC REACTION|allergic reaction
1546305|NCT00594789|Osteoporosis|osteoporosis
1546306|NCT00594789|Fractures|fractures
1546307|NCT00594789|Bone densitometry|bone densitometry
1546308|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1546309|NCT00594776|Cone Beam CT|cone beam ct
1546310|NCT00594776|CBCT|cbct
1546311|NCT00594776|Bone Tumors|bone tumors
1546312|NCT00594776|Autographs|autographs
1546313|NCT00594776|Allographs|allographs
1546314|NCT00594763|Turner syndrome|turner syndrome
1546315|NCT00594763|Thromboembolic disease|thromboembolic disease
1546316|NCT00594737|PET|pet
1546317|NCT00594737|frontotemporal dementia|frontotemporal dementia
1546318|NCT00594737|memantine|memantine
1546319|NCT00594737|Pick's disease|pick's disease
1546320|NCT00594724|Tongue|tongue
1546321|NCT00594724|Carcinoma|carcinoma
1546322|NCT00594724|Cancer|cancer
1546323|NCT00594724|02-093|02-093
1546324|NCT00594711|Psychotherapy|psychotherapy
1546325|NCT00594711|depression|depression
1546326|NCT00594698|Perfusion|perfusion
1546327|NCT00594698|Echocardiography|echocardiography
1546328|NCT00594698|Cardiac angiography|cardiac angiography
1546329|NCT00594698|SPECT|spect
1546330|NCT00594685|Heparin|heparin
1546331|NCT00594685|Thromboembolism|thromboembolism
1546332|NCT00594685|Thrombosis|thrombosis
1546333|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1546334|NCT00594672|Cataracts|cataracts
1546335|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
1546336|NCT00594672|AMD|amd
1546337|NCT00594672|Cataract|cataract
1546338|NCT00594659|Marijuana|marijuana
1546339|NCT00594659|Treatment|treatment
1546340|NCT00594659|Behavioral|behavioral
1546341|NCT00594659|Computer|computer
1546342|NCT00594659|Internet|internet
1546343|NCT00594646|HIV Prevention|hiv prevention
1546344|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
1546345|NCT00594646|HIV seronegativity|hiv seronegativity
1546346|NCT00594633|Cognitive dysfunction|cognitive dysfunction
1546347|NCT00594607|clotting|clotting
1546348|NCT00594607|hemodialysis|hemodialysis
1546349|NCT00594607|anticoagulation|anticoagulation
1546350|NCT00594607|bleeding risk|bleeding risk
1546351|NCT00594594|spinal cord injury|spinal cord injury
1546352|NCT00594594|urinary tract infection|urinary tract infection
1546353|NCT00594594|probiotics|probiotics
1546354|NCT00594594|Lactobacilli|lactobacilli
1546355|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
1546356|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
1546357|NCT00594555|AML|aml
1546358|NCT00594555|CML,Blast Crisis|cml,blast crisis
1546359|NCT00594542|lidocaine|lidocaine
1546360|NCT00594542|local anesthesia|local anesthesia
1546361|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
1546362|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1546363|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
1546364|NCT00594516|Low Back Pain|low back pain
1546365|NCT00594516|Dose Equivalence|dose equivalence
1546366|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
1546367|NCT00594516|Tapentadol-IR|tapentadol-ir
1546368|NCT00594516|Tapentadol-ER|tapentadol-er
1546369|NCT00594503|traumatic brain injury|traumatic brain injury
1546370|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
1546371|NCT00594477|IMRT|imrt
1546372|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
1546373|NCT00594464|Rotigotine|rotigotine
1546374|NCT00594464|NEUPRO®|neupro®
1546375|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
1546376|NCT00594464|perioperative use|perioperative use
1546377|NCT00594464|anaesthesia,|anaesthesia,
1546378|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
1546379|NCT00594451|cigarette smoking|cigarette smoking
1546380|NCT00594451|gene-environmental interactions|gene-environmental interactions
1546381|NCT00594451|autoimmunity|autoimmunity
1546382|NCT00594451|disease severity|disease severity
1546383|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
1546384|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
1546385|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
1546386|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
1546387|NCT00594412|Hepatic Steatosis|hepatic steatosis
1546388|NCT00594412|Liver Fat|liver fat
1546389|NCT00594412|Liver Biopsy|liver biopsy
1546390|NCT00594412|Liver|liver
1546391|NCT00594412|Hepatitis|hepatitis
1546392|NCT00594412|Fatty Liver|fatty liver
1546393|NCT00594399|Aging|aging
1546394|NCT00594399|Exercise|exercise
1546395|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
1546396|NCT00594399|Obesity|obesity
1546397|NCT00594399|Functional Status|functional status
1546398|NCT00594399|Disability|disability
1546399|NCT00594399|Health Services Research|health services research
1546400|NCT00594399|Randomized Controlled Trial|randomized controlled trial
1546401|NCT00594399|Diabetes|diabetes
1546402|NCT00594399|Adaptive Randomization Design|adaptive randomization design
1546403|NCT00594386|Rotigotine|rotigotine
1546404|NCT00594386|Neupro|neupro
1546405|NCT00594373|Microbicide|microbicide
1546406|NCT00594373|HIV Seronegativity|hiv seronegativity
1546407|NCT00594360|Exercise Prescription|exercise prescription
1546408|NCT00594360|Self-efficacy|self-efficacy
1546409|NCT00594360|Decisional Balance|decisional balance
1546410|NCT00594360|Readiness to Change|readiness to change
1546411|NCT00594360|Physical Activity|physical activity
1546412|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
1546413|NCT00594334|osteopenia|osteopenia
1546414|NCT00594334|periodontitis|periodontitis
1546415|NCT00594321|spinal fractures|spinal fractures
1546416|NCT00594269|Antidepressants|antidepressants
1546417|NCT00594269|Antipsychotics|antipsychotics
1546418|NCT00594269|Dementia|dementia
1546419|NCT00594269|Discontinuation study|discontinuation study
1546420|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
1546421|NCT00594256|Schizophrenia|schizophrenia
1546422|NCT00594256|Sleep Architecture|sleep architecture
1546423|NCT00594256|Sodium Oxybate|sodium oxybate
1546424|NCT00594256|Insomnia|insomnia
1546425|NCT00594256|Cognition|cognition
1546426|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
1546427|NCT00594230|Refractory|refractory
1546428|NCT00594230|LBH589|lbh589
1546429|NCT00594217|PCOS|pcos
1546430|NCT00594191|Statins|statins
1546431|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1546432|NCT00594191|Cirrhosis|cirrhosis
1546433|NCT00594191|Portal hypertension|portal hypertension
1546434|NCT00594191|Variceal bleeding|variceal bleeding
1546435|NCT00594178|spinal cord injury|spinal cord injury
1546436|NCT00594165|Rotigotine|rotigotine
1546437|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
1546438|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
1546439|NCT00594139|urge predominant incontinence|urge predominant incontinence
1546440|NCT00594126|Myeloma|myeloma
1546441|NCT00594126|Multiple Myeloma|multiple myeloma
1546442|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
1546443|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
1546444|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1546445|NCT00594100|carotid artery stenosis|carotid artery stenosis
1546446|NCT00594100|embolic protection device|embolic protection device
1546447|NCT00594100|GORE Neuro Protection System|gore neuro protection system
1546448|NCT00594100|GORE Flow Reversal System|gore flow reversal system
1546449|NCT00594100|reverse flow|reverse flow
1546450|NCT00594100|proximal occlusion device|proximal occlusion device
1546451|NCT00594100|GNPS|gnps
1546452|NCT00594100|Parodi|parodi
1546453|NCT00594100|EMPiRE|empire
1546454|NCT00594100|distal embolization|distal embolization
1546455|NCT00594100|minimizing risks of CAS|minimizing risks of cas
1546456|NCT00594100|PAES|paes
1546457|NCT00594048|high blood pressure|high blood pressure
1546458|NCT00594035|Spinal procedure|spinal procedure
1546459|NCT00594035|Dura incision|dura incision
1546460|NCT00594022|Electric Stimulation|electric stimulation
1546461|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
1546462|NCT00594022|Transient Insomnia|transient insomnia
1546463|NCT00594022|Insomnia|insomnia
1546464|NCT00593970|influenza|influenza
1546465|NCT00593970|vaccine|vaccine
1546466|NCT00593970|pregnancy|pregnancy
1546467|NCT00593957|Rett Syndrome|rett syndrome
1546468|NCT00593957|Dextromethorphan|dextromethorphan
1546470|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1546471|NCT00593944|B cell|b cell
1546472|NCT00593944|leukemia|leukemia
1546473|NCT00593944|lymphocyte|lymphocyte
1546474|NCT00593944|antibody|antibody
1546476|NCT00593944|cancer|cancer
1546477|NCT00593944|blood|blood
1546478|NCT00593931|Brain functional MRI|brain functional mri
1546479|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
1546480|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1546481|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
1546482|NCT00593905|Pharmacogenomics|pharmacogenomics
1546483|NCT00593905|DNA Testing|dna testing
1546484|NCT00593905|sitaxsentan|sitaxsentan
1546485|NCT00593905|bosentan|bosentan
1546486|NCT00593905|ambrisentan|ambrisentan
1546487|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
1546488|NCT00593905|Letairis|letairis
1546489|NCT00593905|Tracleer|tracleer
1546490|NCT00593905|Thelin|thelin
1546491|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
1546492|NCT00593905|Pulmonary Artery|pulmonary artery
1546493|NCT00593892|Cytokine Levels|cytokine levels
1546494|NCT00593892|Traumatic Injury|traumatic injury
1546495|NCT00593892|Multisystem Organ Failure|multisystem organ failure
1546496|NCT00593879|MDD|mdd
1546497|NCT00593879|Depression|depression
1546498|NCT00593879|Mecamylamine|mecamylamine
1546499|NCT00593879|Add-on Therapy|add-on therapy
1546500|NCT00593879|Major Depressive Disorder|major depressive disorder
1546501|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
1546502|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
1546503|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
1546504|NCT00593801|transfusion need|transfusion need
1546505|NCT00593801|erythropoietin|erythropoietin
1546506|NCT00593801|trace elements|trace elements
1546507|NCT00593801|antioxidant enzymes|antioxidant enzymes
1546508|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
1546509|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
1546510|NCT00593788|GIN test|gin test
1546511|NCT00593788|gap detection|gap detection
1546512|NCT00593788|temporal resolution|temporal resolution
1546513|NCT00593788|auditory perception|auditory perception
1546514|NCT00593788|psychoacoustics|psychoacoustics
1546515|NCT00593775|implantation rate|implantation rate
1546516|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
1546517|NCT00593762|Aspirin|aspirin
1546518|NCT00593762|Clopidogrel|clopidogrel
1546519|NCT00593762|Resistance|resistance
1546520|NCT00593762|Catheter interventional procedure|catheter interventional procedure
1546521|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
1546522|NCT00593749|obesity prevention|obesity prevention
1546523|NCT00593749|corner stores|corner stores
1546524|NCT00593749|schools|schools
1546525|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
1546526|NCT00593723|IMRT|imrt
1546527|NCT00593710|Randomized|randomized
1546528|NCT00593710|double-blind superiority trial|double-blind superiority trial
1546529|NCT00593697|breast cancer|breast cancer
1546530|NCT00593697|adjuvant therapy|adjuvant therapy
1546531|NCT00593697|trastuzumab|trastuzumab
1546532|NCT00593697|chemotherapy|chemotherapy
1546533|NCT00593684|neonate|neonate
1546534|NCT00593684|central lines|central lines
1546535|NCT00593684|very low birth weight|very low birth weight
1546536|NCT00593684|silver alginate|silver alginate
1546630|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
1547032|NCT00591487|surgery|surgery
1546537|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
1546538|NCT00593658|hypoxemia|hypoxemia
1546539|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
1546540|NCT00593658|cirrhosis|cirrhosis
1546541|NCT00593645|Conditioning regimens|conditioning regimens
1546542|NCT00593645|Stem Cell Transplantation|stem cell transplantation
1546543|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1546544|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1546545|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
1546546|NCT00593645|Clofarabine|clofarabine
1546547|NCT00593645|Cytarabine|cytarabine
1546548|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
1546549|NCT00593632|low HDL|low hdl
1546550|NCT00593619|Intravenous Iron|intravenous iron
1546551|NCT00593619|Safety|safety
1546552|NCT00593619|Perioperative|perioperative
1546553|NCT00593619|Iron deficiency|iron deficiency
1546554|NCT00593619|Non hemodialysis population|non hemodialysis population
1546555|NCT00593619|Perioperative blood conservation|perioperative blood conservation
1546556|NCT00593606|Rotigotine|rotigotine
1546557|NCT00593606|NEUPRO|neupro
1546558|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
1546559|NCT00593606|safety and tolerability|safety and tolerability
1546560|NCT00593606|Parkinson disease|parkinson disease
1546561|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
1546562|NCT00593593|Dutasteride|dutasteride
1546563|NCT00593593|pharmacovigilance|pharmacovigilance
1546564|NCT00593580|Ovarian cancer|ovarian cancer
1546565|NCT00593580|bone mineral density|bone mineral density
1546566|NCT00593580|bisphosphonates|bisphosphonates
1546567|NCT00593580|chemotherapy|chemotherapy
1546568|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
1546569|NCT00593541|MRI|mri
1546570|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
1546571|NCT00593528|cirrhotic HTP|cirrhotic htp
1546572|NCT00593502|influenza|influenza
1546573|NCT00593502|children|children
1546574|NCT00593502|acute otitis media|acute otitis media
1546575|NCT00593502|oseltamivir|oseltamivir
1546576|NCT00593489|Insulin|insulin
1546577|NCT00593489|Diabetes Mellitus|diabetes mellitus
1546578|NCT00593489|Practice Behaviour|practice behaviour
1546579|NCT00593489|Preceptor|preceptor
1546580|NCT00593489|Pharmacy|pharmacy
1546581|NCT00593476|Type 2 Diabetes|type 2 diabetes
1546582|NCT00593476|Glycemic Control|glycemic control
1546583|NCT00593476|Diabetes Support and Education|diabetes support and education
1546584|NCT00593476|Portion Control|portion control
1546585|NCT00593476|Prepackaged meals|prepackaged meals
1546586|NCT00593463|opioid dependence|opioid dependence
1546587|NCT00593463|methadone|methadone
1546588|NCT00593463|opioid|opioid
1546589|NCT00593450|bevacizumab|bevacizumab
1546590|NCT00593450|ranibizumab|ranibizumab
1546591|NCT00593450|choroidal neovascularization|choroidal neovascularization
1546592|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
1546593|NCT00593411|MD Analyze|md analyze
1546594|NCT00593411|Central Nervous System|central nervous system
1546595|NCT00593411|Spine Disease|spine disease
1546596|NCT00593411|Peripheral Nerve|peripheral nerve
1546598|NCT00593398|pregnant women|pregnant women
1546599|NCT00593398|infants|infants
1546600|NCT00593398|Cameroon|cameroon
1546601|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
1546602|NCT00593372|Alzheimer's Disease|alzheimer's disease
1546603|NCT00593372|Memory|memory
1546604|NCT00593372|Treatment|treatment
1546605|NCT00593359|Spinal surgery|spinal surgery
1546606|NCT00593359|Prone spinal surgery|prone spinal surgery
1546607|NCT00593333|Femur Fracture|femur fracture
1546608|NCT00593333|Intramedullary Nailing|intramedullary nailing
1546609|NCT00593333|Trochanteric Nailing|trochanteric nailing
1546610|NCT00593333|Piriformis Starting Portal|piriformis starting portal
1567943|NCT00507728|Chantix|chantix
1546611|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
1546612|NCT00593320|SRS|srs
1546613|NCT00593307|glycemic response|glycemic response
1546614|NCT00593307|hunger|hunger
1546615|NCT00593294|PCOS|pcos
1546616|NCT00593294|oral contraceptives|oral contraceptives
1546617|NCT00593294|physical exercise|physical exercise
1546618|NCT00593294|CVR|cvr
1546619|NCT00593281|Hyaluronidase|hyaluronidase
1546620|NCT00593281|Hylenex|hylenex
1546621|NCT00593281|subcutaneous|subcutaneous
1546622|NCT00593281|morphine|morphine
1546623|NCT00593281|absorption|absorption
1546624|NCT00593281|bioavailability|bioavailability
1546625|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
1546626|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
1546627|NCT00593242|autologous cord blood cells|autologous cord blood cells
1546628|NCT00593242|newborn infants|newborn infants
1546629|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
1546631|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
1546632|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
1546633|NCT00593216|vertigo|vertigo
1546634|NCT00593216|vestibular|vestibular
1546635|NCT00593177|Plaque psoriasis|plaque psoriasis
1546636|NCT00593177|Psoriasis|psoriasis
1546637|NCT00593164|Hypothermia, Induced|hypothermia, induced
1546638|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
1546639|NCT00593164|Resuscitation|resuscitation
1546640|NCT00593164|Coma|coma
1546641|NCT00593151|Antimetabolites|antimetabolites
1546642|NCT00593151|Virus Diseases|virus diseases
1546643|NCT00593151|Anti-Infective Agents|anti-infective agents
1546644|NCT00593151|RNA Virus Infections|rna virus infections
1546645|NCT00593151|Digestive System Diseases|digestive system diseases
1546646|NCT00593151|Flaviviridae Infections|flaviviridae infections
1546647|NCT00593151|Antineoplastic Agents|antineoplastic agents
1546648|NCT00593151|Therapeutic Uses|therapeutic uses
1546649|NCT00593151|Antiviral Agents|antiviral agents
1546650|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
1546651|NCT00593151|Pharmacologic Actions|pharmacologic actions
1546652|NCT00593138|Focalin XR|focalin xr
1546653|NCT00593138|Adult|adult
1546654|NCT00593138|PET scan|pet scan
1546655|NCT00593125|cocaine|cocaine
1546656|NCT00593125|opioids|opioids
1546657|NCT00593125|heroin|heroin
1546658|NCT00593125|levetiracetam|levetiracetam
1546659|NCT00593112|HMRS Scanning|hmrs scanning
1546660|NCT00593112|ADHD|adhd
1546661|NCT00593112|Child|child
1546662|NCT00593112|Adolescent|adolescent
1546663|NCT00593112|HMRS Scans|hmrs scans
1546664|NCT00593099|Bipolar Disorder|bipolar disorder
1546665|NCT00593099|Nicotine Dependence|nicotine dependence
1546666|NCT00593099|Smoking Cessation|smoking cessation
1546667|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
1546668|NCT00593086|wound care|wound care
1546669|NCT00593060|Temsirolimus|temsirolimus
1546670|NCT00593060|cetuximab|cetuximab
1546671|NCT00593060|metastatic disease|metastatic disease
1546672|NCT00593047|hypercholesterolemia|hypercholesterolemia
1546673|NCT00593034|Alcohol abuse|alcohol abuse
1546674|NCT00593034|Drug abuse|drug abuse
1546675|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
1546676|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
1546677|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
1546678|NCT00593021|Capsule Endoscopy|capsule endoscopy
1546679|NCT00593021|CT Enterography|ct enterography
1546680|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
1546681|NCT00592943|Adults|adults
1546682|NCT00592943|Healthy Volunteers|healthy volunteers
1546683|NCT00592943|Nuvigil|nuvigil
1546684|NCT00592943|Armodafinil|armodafinil
1546685|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
1546686|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
1546687|NCT00592917|osteoporosis|osteoporosis
1546688|NCT00592917|fractures|fractures
1546689|NCT00592917|risk of fracture|risk of fracture
1546690|NCT00592917|vitamin-D|vitamin-d
1546691|NCT00592917|calcium|calcium
1546692|NCT00592917|falls|falls
1546693|NCT00592917|bone mineral density|bone mineral density
1546694|NCT00592917|bone metabolism|bone metabolism
1546695|NCT00592904|Neuralgia|neuralgia
1546696|NCT00592904|neuropathy|neuropathy
1546697|NCT00592891|brain injury|brain injury
1546698|NCT00592891|brain disorders|brain disorders
1546699|NCT00592852|bipolar disorder|bipolar disorder
1546700|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
1546701|NCT00592852|Prozac|prozac
1546702|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
1546703|NCT00592826|PHP|php
1546704|NCT00592826|HMP|hmp
1546705|NCT00592826|HPHP|hphp
1546706|NCT00592826|AMD|amd
1546707|NCT00592826|CNV|cnv
1546708|NCT00592813|rehabilitation|rehabilitation
1546709|NCT00592813|function|function
1546710|NCT00592800|statistics|statistics
1546711|NCT00592800|probability|probability
1546712|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
1546713|NCT00592774|PHN)|phn)
1546714|NCT00592761|Deglutition Disorders|deglutition disorders
1546715|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
1546716|NCT00592761|SEMG|semg
1546717|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
1546718|NCT00592696|Adolescent depression|adolescent depression
1546719|NCT00592696|Adolescent smoking|adolescent smoking
1546720|NCT00592683|bipolar disorder|bipolar disorder
1546721|NCT00592683|fish oil|fish oil
1546722|NCT00592683|aripiprazole|aripiprazole
1546723|NCT00592683|children|children
1546724|NCT00592657|retrospective chart review|retrospective chart review
1546725|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
1546726|NCT00592644|ectasia|ectasia
1546727|NCT00592644|vascular lesions|vascular lesions
1546728|NCT00592644|vocal cords|vocal cords
1546729|NCT00592644|voice|voice
1546730|NCT00592644|pulsed dye laser|pulsed dye laser
1546731|NCT00592631|asthma|asthma
1546732|NCT00592631|sleep apnea|sleep apnea
1546734|NCT00592618|Hemodialysis|hemodialysis
1546735|NCT00592618|Sleep Apnea|sleep apnea
1546736|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
1546737|NCT00592592|proton radiation therapy|proton radiation therapy
1546738|NCT00592566|Severe leptospirosis|severe leptospirosis
1546739|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
1546740|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
1546741|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
1546742|NCT00592553|Nonsense mutation|nonsense mutation
1546743|NCT00592553|Premature stop codon|premature stop codon
1546744|NCT00592553|DMD/BMD|dmd/bmd
1546745|NCT00592553|PTC124|ptc124
1546746|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
1546747|NCT00592501|proton radiation|proton radiation
1546748|NCT00592501|photon radiation|photon radiation
1546749|NCT00592501|5-FU|5-fu
1546750|NCT00592501|cisplatin|cisplatin
1546751|NCT00592488|Septic shock|septic shock
1546752|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
1546753|NCT00592475|conivaptan|conivaptan
1546754|NCT00592475|Liver Cirrhosis|liver cirrhosis
1546755|NCT00592475|Hypertension, Portal|hypertension, portal
1546756|NCT00592462|Breast Cancer|breast cancer
1546757|NCT00592462|Whole Body MRI|whole body mri
1546758|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
1546759|NCT00592462|Metastases|metastases
1546760|NCT00592449|Insomnia|insomnia
1546761|NCT00592449|Knee pain|knee pain
1546762|NCT00592449|Osteoarthritis|osteoarthritis
1546763|NCT00592449|Arthritis|arthritis
1546764|NCT00592449|Sleep|sleep
1546765|NCT00592436|ADHD|adhd
1546766|NCT00592436|pediatric|pediatric
1546767|NCT00592436|children|children
1546768|NCT00592423|Lateral neck rotation|lateral neck rotation
1546769|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
1546770|NCT00592397|Dietary Intervention|dietary intervention
1546771|NCT00592397|Nutrigenomics|nutrigenomics
1546772|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
1546773|NCT00592397|Gene Expression|gene expression
1546774|NCT00592397|Gene Expression Profiling|gene expression profiling
1546775|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
1546776|NCT00592397|Biological Markers|biological markers
1546777|NCT00592397|Food|food
1546778|NCT00592397|Obesity|obesity
1546779|NCT00592397|Blood|blood
1546780|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
1546781|NCT00592384|spinal cord injuries|spinal cord injuries
1546782|NCT00592384|major depressive disorder|major depressive disorder
1546783|NCT00592384|dysthymia|dysthymia
1546784|NCT00592384|antidepressant agents|antidepressant agents
1546785|NCT00592384|pain|pain
1546786|NCT00592384|quality of life|quality of life
1546787|NCT00592384|muscle spasticity|muscle spasticity
1546788|NCT00592384|community participation|community participation
1546789|NCT00592384|anxiety|anxiety
1546790|NCT00592358|bipolar disorder|bipolar disorder
1546791|NCT00592358|children|children
1546792|NCT00592358|adolescents|adolescents
1546793|NCT00592358|Invega|invega
1546794|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
1546795|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
1546796|NCT00592345|proton radiation therapy|proton radiation therapy
1546797|NCT00592345|photon radiation therapy|photon radiation therapy
1546798|NCT00592345|radiation applicator plaque|radiation applicator plaque
1546799|NCT00592319|Papilloma|papilloma
1546800|NCT00592319|pulsed dye laser|pulsed dye laser
1546801|NCT00592319|Celebrex|celebrex
1546802|NCT00592319|voice|voice
1546804|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
1546805|NCT00592306|reperfusion lung injury|reperfusion lung injury
1546806|NCT00592306|primary graft dysfunction|primary graft dysfunction
1546807|NCT00592306|lung transplantation|lung transplantation
1546808|NCT00592293|proton beam radiation|proton beam radiation
1546809|NCT00592280|Pancreas transplantation|pancreas transplantation
1546810|NCT00592280|graft pancreatitis|graft pancreatitis
1546811|NCT00592280|Two-layer method|two-layer method
1546812|NCT00592280|organ preservation|organ preservation
1546813|NCT00592267|pediatric|pediatric
1546814|NCT00592267|bipolar disorder|bipolar disorder
1546815|NCT00592254|ADHD|adhd
1546816|NCT00592254|Adults|adults
1546817|NCT00592241|Insulin Pump|insulin pump
1546818|NCT00592228|intermediate lesion|intermediate lesion
1546819|NCT00592228|drug-eluting stent|drug-eluting stent
1546820|NCT00592228|fractional flow reserve|fractional flow reserve
1546821|NCT00592215|Second trimester labor induction|second trimester labor induction
1546822|NCT00592202|Morbid obesity|morbid obesity
1546823|NCT00592202|Adolescents|adolescents
1546824|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
1546825|NCT00592202|Adjustable gastric band|adjustable gastric band
1546826|NCT00592202|Treatment|treatment
1546827|NCT00592189|Burns|burns
1546828|NCT00592189|Wound healing|wound healing
1546829|NCT00592189|Amnion|amnion
1546830|NCT00592163|Cancer|cancer
1546831|NCT00592163|Arsenic|arsenic
1546832|NCT00592150|Essential Hypertension|essential hypertension
1546833|NCT00592137|calcium carbonate|calcium carbonate
1546834|NCT00592137|obesity|obesity
1546835|NCT00592137|dairy|dairy
1546836|NCT00592137|energy expenditure|energy expenditure
1546837|NCT00592124|Microbicide|microbicide
1546838|NCT00592124|HIV Seronegativity|hiv seronegativity
1546839|NCT00592111|Pediatric|pediatric
1546840|NCT00592111|Hodgkin's Disease|hodgkin's disease
1546841|NCT00592111|96-016|96-016
1546842|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
1546843|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
1546844|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
1546845|NCT00592085|Tobacco Use|tobacco use
1546846|NCT00592085|Smoking|smoking
1546847|NCT00592085|Alcohol Use|alcohol use
1546848|NCT00592085|Smoking Cessation|smoking cessation
1546849|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1546850|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
1546851|NCT00592072|Hypoglycemia|hypoglycemia
1546852|NCT00592046|Phase I|phase i
1546853|NCT00592046|Hematologic Cancers|hematologic cancers
1546854|NCT00592046|Blood Cancers|blood cancers
1546855|NCT00592046|Leukemia|leukemia
1546856|NCT00592046|multiple myeloma|multiple myeloma
1546857|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
1546858|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
1546859|NCT00592033|COPD oxygen|copd oxygen
1546860|NCT00592033|COPD rehabilitation|copd rehabilitation
1546861|NCT00592033|exercise|exercise
1546862|NCT00592020|kidney|kidney
1546863|NCT00592020|transplantation|transplantation
1546864|NCT00592020|minimal invasive|minimal invasive
1546865|NCT00592020|short transverse|short transverse
1546866|NCT00592020|hockey stick|hockey stick
1546867|NCT00592020|incision|incision
1546868|NCT00592020|quality of life|quality of life
1546869|NCT00592020|planned kidney transplantation|planned kidney transplantation
1546870|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
1546871|NCT00592007|Stage IIIB|stage iiib
1546872|NCT00592007|Stage IV|stage iv
1546873|NCT00592007|Stable on Erlotinib|stable on erlotinib
1546874|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
1546875|NCT00591994|tinnitus|tinnitus
1546876|NCT00591994|piribedil|piribedil
1546877|NCT00591994|acoustic otoemissions|acoustic otoemissions
1546878|NCT00591994|ECoG|ecog
1546879|NCT00591981|Geriatric|geriatric
1546880|NCT00591981|Thoracic|thoracic
1546881|NCT00591981|neoplasm|neoplasm
1546882|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
1546883|NCT00591968|ultrasound|ultrasound
1546884|NCT00591968|telediagnosis|telediagnosis
1546885|NCT00591968|teleultrasound|teleultrasound
1546886|NCT00591968|telesonography|telesonography
1546887|NCT00591968|teleultrasonography|teleultrasonography
1546888|NCT00591968|teleradiology|teleradiology
1546889|NCT00591968|telemedicine|telemedicine
1546890|NCT00591968|dominican republic|dominican republic
1546891|NCT00591968|puntacana|puntacana
1546892|NCT00591968|veron|veron
1546893|NCT00591968|store-and-forward|store-and-forward
1546894|NCT00591968|asynchronous|asynchronous
1546895|NCT00591955|geriatric|geriatric
1546896|NCT00591955|sepsis|sepsis
1546897|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
1546898|NCT00591942|dental cement|dental cement
1546899|NCT00591942|ceramic crowns|ceramic crowns
1546900|NCT00591942|three-unit bridges|three-unit bridges
1546901|NCT00591942|sensitivity|sensitivity
1546902|NCT00591916|burn|burn
1546903|NCT00591916|donor site|donor site
1546904|NCT00591916|grafting|grafting
1546905|NCT00591916|scar|scar
1546906|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
1546907|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
1546908|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
1546909|NCT00591903|Tissue Sample|tissue sample
1546910|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
1546911|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
1546912|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
1546913|NCT00591877|AC: acupuncture|ac: acupuncture
1546914|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
1546915|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
1546916|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
1546917|NCT00591877|Acupuncture|acupuncture
1546918|NCT00591877|Yoga|yoga
1546919|NCT00591864|Benign breast disease|benign breast disease
1546920|NCT00591864|Breast|breast
1546921|NCT00591864|MRI|mri
1546922|NCT00591864|Mammography|mammography
1546923|NCT00591864|Ultrasound|ultrasound
1546924|NCT00591864|Molecular Breast Imaging|molecular breast imaging
1546925|NCT00591864|Breast Cancer|breast cancer
1546926|NCT00591851|breast cancer|breast cancer
1546927|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
1546928|NCT00591851|cardiac safety|cardiac safety
1546929|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
1546930|NCT00591838|SBRT|sbrt
1546931|NCT00591773|Blood pressure|blood pressure
1546932|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
1546933|NCT00591760|Heart Failure|heart failure
1546934|NCT00591760|Growth Hormone|growth hormone
1546935|NCT00591760|Anabolism|anabolism
1546936|NCT00591760|Anabolic Deficiency|anabolic deficiency
1546937|NCT00591760|Hormone replacement|hormone replacement
1546938|NCT00591747|randomized clinical trial|randomized clinical trial
1546939|NCT00591747|elderly|elderly
1546940|NCT00591747|cancer survivor|cancer survivor
1546941|NCT00591747|bone health|bone health
1546942|NCT00591747|body composition|body composition
1546943|NCT00591747|signs and symptoms|signs and symptoms
1546944|NCT00591734|Metastatic Melanoma|metastatic melanoma
1546945|NCT00591734|Everolimus|everolimus
1546946|NCT00591734|RAD001|rad001
1546947|NCT00591734|Bevacizumab|bevacizumab
1546948|NCT00591721|energy conservation education|energy conservation education
1546949|NCT00591721|occupational therapy intervention|occupational therapy intervention
1546950|NCT00591721|fatigue management|fatigue management
1546951|NCT00591721|psychoeducation|psychoeducation
1546952|NCT00591708|calcium|calcium
1546953|NCT00591708|bone|bone
1546954|NCT00591708|bone density|bone density
1546955|NCT00591708|adolescence|adolescence
1546956|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
1546957|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
1546958|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
1546959|NCT00591669|Crohn's disease|crohn's disease
1546960|NCT00591643|Adrenal tumors|adrenal tumors
1546961|NCT00591643|Adrenal malignancies|adrenal malignancies
1546962|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
1546963|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
1546964|NCT00591643|Imaging|imaging
1546965|NCT00591643|Scanning|scanning
1546966|NCT00591643|tumor localization|tumor localization
1546967|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
1546968|NCT00591630|Lymphoma|lymphoma
1546969|NCT00591630|Zevalin|zevalin
1546970|NCT00591630|Ibritumomab|ibritumomab
1546971|NCT00591630|IDEC-Y2B8|idec-y2b8
1546972|NCT00591630|Carmustine|carmustine
1546973|NCT00591630|BCNU|bcnu
1546974|NCT00591630|BiCNU|bicnu
1546975|NCT00591630|Etoposide|etoposide
1546976|NCT00591630|VePesid|vepesid
1546977|NCT00591630|Cytarabine|cytarabine
1546978|NCT00591630|Ara-C|ara-c
1546979|NCT00591630|Cytosar|cytosar
1546980|NCT00591630|DepoCyt|depocyt
1546981|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1546982|NCT00591630|Melphalan|melphalan
1546983|NCT00591630|Rituximab|rituximab
1546984|NCT00591630|Rituxan|rituxan
1546985|NCT00591630|BEAM|beam
1546986|NCT00591617|Opioids|opioids
1546987|NCT00591617|drug dependence|drug dependence
1546988|NCT00591617|drug abuse|drug abuse
1546989|NCT00591617|treatment|treatment
1546990|NCT00591604|burn|burn
1546991|NCT00591604|vitamin D|vitamin d
1546992|NCT00591604|nutrition|nutrition
1546993|NCT00591604|burn recovery|burn recovery
1546994|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1546995|NCT00591591|sleep disordered breathing|sleep disordered breathing
1546996|NCT00591591|polysomnography (psg)|polysomnography (psg)
1546997|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
1546998|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
1546999|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
1547000|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
1547001|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
1547002|NCT00591578|Blood pressure|blood pressure
1547003|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
1547004|NCT00591565|Anxiety|anxiety
1547005|NCT00591565|SSRI|ssri
1547006|NCT00591565|SNRI|snri
1547007|NCT00591565|Acamprosate|acamprosate
1547008|NCT00591552|Lung cancer|lung cancer
1547009|NCT00591552|Lymph node dissection|lymph node dissection
1547010|NCT00591539|Carotid Artery Disease|carotid artery disease
1547011|NCT00591539|Intima-Media Thickening|intima-media thickening
1547012|NCT00591539|Carotid Ultrasound|carotid ultrasound
1547013|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
1547014|NCT00591539|Cancer Survivors|cancer survivors
1547015|NCT00591539|Head or Neck Cancer|head or neck cancer
1547016|NCT00591539|Radiation Therapy|radiation therapy
1547018|NCT00591513|burns|burns
1547019|NCT00591513|burn scars|burn scars
1547020|NCT00591513|congenital giant nevi|congenital giant nevi
1547021|NCT00591500|Melanoma|melanoma
1547022|NCT00591500|Skin cancer|skin cancer
1547023|NCT00591500|Genetic Susceptibility|genetic susceptibility
1547024|NCT00591500|polymorphisms|polymorphisms
1547025|NCT00591487|suction|suction
1547026|NCT00591487|assisted|assisted
1547027|NCT00591487|lipectomy|lipectomy
1547028|NCT00591487|liposuction|liposuction
1547029|NCT00591487|contour|contour
1547030|NCT00591487|cosmetic|cosmetic
1547033|NCT00591487|Klein|klein
1547034|NCT00591487|tumescent|tumescent
1547035|NCT00591487|technique|technique
1547036|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
1547038|NCT00591474|Probiotics|probiotics
1547039|NCT00591474|colonization|colonization
1547040|NCT00591474|gut health|gut health
1547041|NCT00591461|Barrett's Esophagus|barrett's esophagus
1547042|NCT00591461|Upper Endoscopy|upper endoscopy
1547043|NCT00591461|Esophageal biopsies|esophageal biopsies
1547044|NCT00591461|Accuracy|accuracy
1547045|NCT00591461|Interobserver Agreement|interobserver agreement
1547046|NCT00591448|Thermal injury|thermal injury
1547047|NCT00591435|Anesthesia|anesthesia
1547048|NCT00591435|Surgery|surgery
1547049|NCT00591435|Education|education
1547050|NCT00591435|Economics|economics
1547051|NCT00591422|Arsenic|arsenic
1547052|NCT00591422|Cancer|cancer
1547053|NCT00591383|Cancer|cancer
1547054|NCT00591383|Indibulin|indibulin
1547055|NCT00591383|Erlotinib|erlotinib
1547056|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
1547057|NCT00591370|III or IV melanoma|iii or iv melanoma
1547058|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
1547059|NCT00591357|Clostridium difficile|clostridium difficile
1547060|NCT00591357|loperamide|loperamide
1547061|NCT00591344|Parkinson's disease|parkinson's disease
1547062|NCT00591344|exercise|exercise
1547063|NCT00591331|Head Lice|head lice
1547064|NCT00591318|Ceftriaxone|ceftriaxone
1547065|NCT00591318|Psychosis|psychosis
1547066|NCT00591318|Schizophrenia|schizophrenia
1547067|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
1547068|NCT00591305|papilloma|papilloma
1547069|NCT00591305|PDL|pdl
1547070|NCT00591305|diindolylmethane|diindolylmethane
1547071|NCT00591305|recurrence|recurrence
1547072|NCT00591292|cancer|cancer
1547073|NCT00591292|tumor|tumor
1547074|NCT00591292|solid tumor|solid tumor
1547075|NCT00591292|advanced tumor|advanced tumor
1547076|NCT00591279|large bowel cancer|large bowel cancer
1547077|NCT00591279|polyps|polyps
1547078|NCT00591279|colorectal cancer|colorectal cancer
1547079|NCT00591266|Blood pressure|blood pressure
1547080|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
1547081|NCT00591266|Drug Therapy|drug therapy
1547082|NCT00591253|Blood pressure|blood pressure
1547083|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
1547084|NCT00591253|Drug Therapy|drug therapy
1547085|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
1547086|NCT00591240|Biosensing techniques|biosensing techniques
1547087|NCT00591240|Microchip analytical procedures|microchip analytical procedures
1547088|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
1547089|NCT00591214|Protease Inhibitor|protease inhibitor
1547090|NCT00591201|Spondylarthritis|spondylarthritis
1547091|NCT00591201|TNF|tnf
1547092|NCT00591201|Infliximab|infliximab
1547093|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
1547094|NCT00591201|Juvenile SpA|juvenile spa
1547095|NCT00591201|Juvenile arthritis|juvenile arthritis
1547096|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
1547097|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
1547098|NCT00591149|cancer|cancer
1547099|NCT00591149|head and neck cancer|head and neck cancer
1547100|NCT00591149|squamous cell cancer|squamous cell cancer
1547101|NCT00591123|Unresectable|unresectable
1547102|NCT00591123|Metastatic|metastatic
1547103|NCT00591123|Esophagus|esophagus
1547104|NCT00591123|Gastric Cardia|gastric cardia
1547105|NCT00591097|urine|urine
1547106|NCT00591097|pediatric|pediatric
1547107|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
1547108|NCT00591084|randomized trial|randomized trial
1547109|NCT00591084|ischemic stroke|ischemic stroke
1547110|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
1547111|NCT00591071|hyperglycemia|hyperglycemia
1547112|NCT00591071|insulin treatment|insulin treatment
1547113|NCT00591071|intensive care|intensive care
1547114|NCT00591071|hypoglycemia|hypoglycemia
1547115|NCT00591071|mechanical ventilation|mechanical ventilation
1547116|NCT00591071|critically ill patients|critically ill patients
1547117|NCT00591058|recurrent glioma|recurrent glioma
1547118|NCT00591058|Phase I|phase i
1547119|NCT00591058|Multi-Center|multi-center
1547120|NCT00591058|Open label|open label
1547121|NCT00591058|Brain Cancer|brain cancer
1547122|NCT00591058|Brain tumor|brain tumor
1547124|NCT00591058|Glioma|glioma
1547125|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
1547126|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
1547127|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1547128|NCT00591045|efficacy|efficacy
1547129|NCT00591045|safety|safety
1547130|NCT00591045|chemotherapy|chemotherapy
1547131|NCT00591032|Critical illness|critical illness
1547132|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
1547133|NCT00591032|Intensive care|intensive care
1547134|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
1547135|NCT00591032|Low-T3 syndrome|low-t3 syndrome
1547136|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
1547137|NCT00591006|Phenytoin|phenytoin
1547138|NCT00591006|Dilantin|dilantin
1547139|NCT00591006|Corticosteroid|corticosteroid
1547140|NCT00591006|Neuroprotection|neuroprotection
1547141|NCT00591006|Mania|mania
1547142|NCT00591006|Cognition|cognition
1547143|NCT00591006|Mood|mood
1547144|NCT00591006|Memory|memory
1547145|NCT00591006|Hydrocortisone|hydrocortisone
1547146|NCT00591006|Healthy Controls|healthy controls
1547147|NCT00591006|MRI|mri
1547148|NCT00591006|hippocampal activation|hippocampal activation
1547149|NCT00590993|MRSI|mrsi
1547150|NCT00590993|MRI|mri
1547151|NCT00590993|Prostate Cancer|prostate cancer
1547152|NCT00590980|Stroke|stroke
1547153|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
1547154|NCT00590980|Brain|brain
1547155|NCT00590980|Blood Flow|blood flow
1547156|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
1547157|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
1547158|NCT00590954|Malignant Gliomas|malignant gliomas
1547159|NCT00590954|CNS|cns
1547160|NCT00590954|Brain Cancer|brain cancer
1547161|NCT00590954|Cancer|cancer
1547162|NCT00590954|Perifosine|perifosine
1547163|NCT00590941|Lymphoma|lymphoma
1547164|NCT00590941|Rituximab|rituximab
1547165|NCT00590941|CHOP|chop
1547166|NCT00590915|ALL|all
1547167|NCT00590902|non small cell lung cancer|non small cell lung cancer
1547470|NCT00589667|PEMETREXED|pemetrexed
1547168|NCT00590889|artificial heart valve|artificial heart valve
1547169|NCT00590889|mitral heart valve|mitral heart valve
1547170|NCT00590889|aortic heart valve|aortic heart valve
1547171|NCT00590889|endocarditis|endocarditis
1547172|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
1547173|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
1547174|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1547175|NCT00590876|Hypoglycemia|hypoglycemia
1547176|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
1547177|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
1547178|NCT00590837|AML|aml
1547179|NCT00590837|Chemotherapy|chemotherapy
1547180|NCT00590837|older|older
1547181|NCT00590837|De novo AML|de novo aml
1547182|NCT00590824|Melanoma|melanoma
1547183|NCT00590824|hu14.18-IL2|hu14.18-il2
1547184|NCT00590811|adolescents|adolescents
1547185|NCT00590811|young adults|young adults
1547186|NCT00590811|dysmenorrhea|dysmenorrhea
1547187|NCT00590811|pelvic pain|pelvic pain
1547188|NCT00590798|Cardiac Catheterization|cardiac catheterization
1547189|NCT00590798|Walk|walk
1547190|NCT00590798|Heart Catheterization|heart catheterization
1547191|NCT00590798|Coronary Disease|coronary disease
1547192|NCT00590798|Heart Disease|heart disease
1547193|NCT00590798|Coronary Artery Disease|coronary artery disease
1547194|NCT00590785|High Risk|high risk
1547195|NCT00590785|Breast Cancer|breast cancer
1547196|NCT00590785|Positive Nodes|positive nodes
1547197|NCT00590785|Cyclophosphamide|cyclophosphamide
1547198|NCT00590785|Doxorubicin|doxorubicin
1547199|NCT00590785|96-041|96-041
1547200|NCT00590772|sleep|sleep
1547201|NCT00590772|somnolence|somnolence
1547202|NCT00590772|allergies|allergies
1547203|NCT00590772|rhinitis|rhinitis
1547204|NCT00590772|fatigue|fatigue
1547205|NCT00590720|Asthma|asthma
1547206|NCT00590720|Bronchitis|bronchitis
1547207|NCT00590707|Hip fractures|hip fractures
1547208|NCT00590707|Femoral neck fractures|femoral neck fractures
1547209|NCT00590707|Trochanteric fractures|trochanteric fractures
1547210|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
1547211|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
1547212|NCT00590707|Delirium|delirium
1547213|NCT00590707|Confusion|confusion
1547214|NCT00590694|ranibizumab|ranibizumab
1547215|NCT00590694|Lucentis|lucentis
1547216|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
1547217|NCT00590694|Macular Degeneration|macular degeneration
1547218|NCT00590694|PrONTO|pronto
1547219|NCT00590668|atrial fibrillation|atrial fibrillation
1547220|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
1547221|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
1547222|NCT00590655|maintenance therapy|maintenance therapy
1547223|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
1547224|NCT00590642|OCD|ocd
1547225|NCT00590642|treatment-resistant|treatment-resistant
1547226|NCT00590642|SSRI|ssri
1547227|NCT00590629|Women with and without CAD|women with and without cad
1547228|NCT00590616|Aortic atheroma|aortic atheroma
1547229|NCT00590603|Multiple myeloma|multiple myeloma
1547230|NCT00590577|Schizophrenia|schizophrenia
1547231|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
1547232|NCT00590564|Hepatitis C|hepatitis c
1547233|NCT00590564|Sho-saiko-to|sho-saiko-to
1547234|NCT00590564|SST|sst
1547235|NCT00590564|Interferon Therapy|interferon therapy
1547236|NCT00590551|Skin Breakdown|skin breakdown
1547237|NCT00590551|Skin Damage|skin damage
1547238|NCT00590551|Skin Integrity|skin integrity
1547239|NCT00590551|Pressure|pressure
1547240|NCT00590551|Slings|slings
1547241|NCT00590525|hsCRP|hscrp
1547242|NCT00590512|dietary salt|dietary salt
1547243|NCT00590512|sodium|sodium
1547244|NCT00590512|blood vessels|blood vessels
1547245|NCT00590512|vascular function|vascular function
1547246|NCT00590512|endothelial function|endothelial function
1547247|NCT00590512|heart disease risk|heart disease risk
1547248|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
1547249|NCT00590499|agitation|agitation
1547250|NCT00590499|craniotomy|craniotomy
1547251|NCT00590499|incidence|incidence
1547252|NCT00590499|risk factor|risk factor
1547253|NCT00590499|outcome|outcome
1547254|NCT00590473|Interstitial Cystitis|interstitial cystitis
1547255|NCT00590473|IC|ic
1547256|NCT00590473|Neuromodulation|neuromodulation
1547257|NCT00590473|Interstim Therapy|interstim therapy
1547258|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1547259|NCT00590460|Fanconi Anemia|fanconi anemia
1547260|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
1547261|NCT00590460|fludarabine|fludarabine
1547262|NCT00590460|campath|campath
1547263|NCT00590460|anti-CD45|anti-cd45
1547264|NCT00590447|1st-line therapy|1st-line therapy
1547265|NCT00590447|single agent rituximab|single agent rituximab
1547266|NCT00590447|CHOP|chop
1547267|NCT00590447|risk stratification|risk stratification
1547268|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
1547269|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
1547270|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
1547271|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
1547272|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
1547273|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
1547274|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
1547275|NCT00590434|screening|screening
1547276|NCT00590434|colonoscopy|colonoscopy
1547277|NCT00590408|coenzyme Q10|coenzyme q10
1547279|NCT00590408|myalgia|myalgia
1547280|NCT00590395|Cholecystitis|cholecystitis
1547281|NCT00590395|FDG PET/CT|fdg pet/ct
1547282|NCT00590395|HIDA scan|hida scan
1547283|NCT00590356|Device closure|device closure
1547284|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
1547285|NCT00590291|Coronary Artery Disease|coronary artery disease
1547286|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
1547287|NCT00590291|Myocardial Infarction|myocardial infarction
1547288|NCT00590291|CAD|cad
1547289|NCT00590291|MI|mi
1547290|NCT00590291|Heart Attack|heart attack
1547291|NCT00590291|AVM|avm
1547292|NCT00590291|genetic|genetic
1547293|NCT00590291|familial|familial
1547294|NCT00590278|Tomudex|tomudex
1547295|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
1547296|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
1547297|NCT00590265|bipolar type II disorder|bipolar type ii disorder
1547298|NCT00590265|depression|depression
1547299|NCT00590265|remission|remission
1547300|NCT00590265|light-therapy|light-therapy
1547301|NCT00590265|efficacy|efficacy
1547302|NCT00590265|safety|safety
1547303|NCT00590252|Magnetic Resonance|magnetic resonance
1547304|NCT00590252|Imaging|imaging
1547305|NCT00590252|Spectroscopy|spectroscopy
1547306|NCT00590239|Barrett's Esophagus|barrett's esophagus
1547307|NCT00590239|Neoplasia|neoplasia
1547308|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
1547309|NCT00590239|High resolution endoscopy|high resolution endoscopy
1547310|NCT00590239|Chromoendoscopy|chromoendoscopy
1547311|NCT00590226|type 2 diabetes|type 2 diabetes
1547312|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
1547313|NCT00590226|SQ insulin|sq insulin
1547314|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
1547315|NCT00590213|Casodex|casodex
1547316|NCT00590213|Prostate Cancer|prostate cancer
1547317|NCT00590200|CAD|cad
1547318|NCT00590200|Cardiovascular Disease|cardiovascular disease
1547319|NCT00590200|CVD|cvd
1547320|NCT00590200|MI|mi
1547321|NCT00590200|Myocardial Infarction|myocardial infarction
1547322|NCT00590200|Heart Attack|heart attack
1547323|NCT00590200|CABG|cabg
1547324|NCT00590200|Revascularization|revascularization
1547325|NCT00590200|genetic|genetic
1547326|NCT00590174|stent|stent
1547327|NCT00590174|antiplatelet therapy|antiplatelet therapy
1547328|NCT00590161|Fatty Liver|fatty liver
1547329|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
1547330|NCT00590161|NAFLD|nafld
1547331|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
1547332|NCT00590161|NASH|nash
1547333|NCT00590161|pentoxifylline|pentoxifylline
1547334|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
1547335|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
1547336|NCT00590122|Parkinson's disease|parkinson's disease
1547337|NCT00590122|"time to on"|"time to on"
1547338|NCT00590122|delayed on|delayed on
1547339|NCT00590109|Breast Cancer|breast cancer
1547340|NCT00590109|Jewish|jewish
1547341|NCT00590109|BRCA1|brca1
1547342|NCT00590109|BRCA2|brca2
1547343|NCT00590109|97-029|97-029
1547344|NCT00590096|Neuroblastoma|neuroblastoma
1547345|NCT00590096|Pheochromocytoma|pheochromocytoma
1547346|NCT00590096|MIBG|mibg
1547347|NCT00590083|stem cell transplantation|stem cell transplantation
1547348|NCT00590083|adenovirus|adenovirus
1547349|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
1547350|NCT00590083|prophylaxis|prophylaxis
1547351|NCT00590070|myocardial infarction|myocardial infarction
1547352|NCT00590070|no reflow|no reflow
1547353|NCT00590070|primary PCI|primary pci
1547354|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
1547355|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
1547356|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
1547357|NCT00590044|insulin therapy|insulin therapy
1547358|NCT00590044|DKA|dka
1547359|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
1547360|NCT00590031|Cisplatin|cisplatin
1547361|NCT00590031|Irinotecan|irinotecan
1547362|NCT00590031|Radiation Therapy|radiation therapy
1547363|NCT00590031|02-045|02-045
1547364|NCT00590018|Congenital heart disease.|congenital heart disease.
1547365|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
1547366|NCT00590018|Corticosteroids.|corticosteroids.
1547367|NCT00590018|Hydrocortisone.|hydrocortisone.
1547368|NCT00590018|Blood pressure.|blood pressure.
1547369|NCT00590018|Inotropes.|inotropes.
1547370|NCT00590005|severe asthma|severe asthma
1547371|NCT00590005|poorly controlled asthma|poorly controlled asthma
1547372|NCT00589979|Osteoarthritis|osteoarthritis
1547373|NCT00589979|Knee|knee
1547374|NCT00589979|Lidoderm|lidoderm
1547375|NCT00589979|Lidocaine|lidocaine
1547376|NCT00589979|Topical patch|topical patch
1547377|NCT00589979|Adjunct therapy|adjunct therapy
1547378|NCT00589966|prostate cancer treatment|prostate cancer treatment
1547379|NCT00589966|treatment side-effects|treatment side-effects
1547380|NCT00589966|early diagnosis|early diagnosis
1547381|NCT00589966|African American Men|african american men
1547382|NCT00589966|coping skills training|coping skills training
1547383|NCT00589966|quality of life|quality of life
1547384|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
1547385|NCT00589953|Extreme Prematurity|extreme prematurity
1547386|NCT00589953|Erythropoietin|erythropoietin
1547387|NCT00589953|Perinatal Brain Injury|perinatal brain injury
1547388|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
1547389|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
1547390|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
1547391|NCT00589953|Randomized Clinical Trial|randomized clinical trial
1547392|NCT00589927|stents|stents
1547393|NCT00589927|cilostazol|cilostazol
1547394|NCT00589914|Schizophrenia|schizophrenia
1547395|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
1547396|NCT00589901|metastatic breast cancer|metastatic breast cancer
1547397|NCT00589901|capecitabine|capecitabine
1547398|NCT00589901|synergistic effect|synergistic effect
1547399|NCT00589901|chemotherapy|chemotherapy
1547400|NCT00589888|hypertension|hypertension
1547401|NCT00589888|metabolic syndrome|metabolic syndrome
1547402|NCT00589888|vascular reactivity|vascular reactivity
1547403|NCT00589888|Elevated blood pressure|elevated blood pressure
1547404|NCT00589888|lipid toxicity|lipid toxicity
1547405|NCT00589875|Immunotherapy|immunotherapy
1547406|NCT00589875|Cytotoxicity|cytotoxicity
1547407|NCT00589875|Tumor vaccine|tumor vaccine
1547408|NCT00589862|Drug Eluting Stents|drug eluting stents
1547409|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
1547410|NCT00589862|Aspirin Resistance|aspirin resistance
1547411|NCT00589849|Myocardial Infarction|myocardial infarction
1547412|NCT00589849|Arrhythmia|arrhythmia
1547413|NCT00589849|T-wave alternans|t-wave alternans
1547414|NCT00589836|HCM|hcm
1547415|NCT00589836|HOCM|hocm
1547416|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1547417|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
1547418|NCT00589836|myocardial torsion|myocardial torsion
1547419|NCT00589823|Pain|pain
1547420|NCT00589823|Cancer|cancer
1547421|NCT00589823|Breakthrough|breakthrough
1547422|NCT00589810|ISR|isr
1547423|NCT00589810|in-stent restenosis|in-stent restenosis
1547424|NCT00589810|restenosis|restenosis
1547425|NCT00589810|BMS|bms
1547426|NCT00589810|bare metal stent|bare metal stent
1547427|NCT00589810|revascularization|revascularization
1547428|NCT00589810|genetic|genetic
1547429|NCT00589810|cardiac catheterization|cardiac catheterization
1547430|NCT00589797|Degenerative|degenerative
1547431|NCT00589797|Disc|disc
1547432|NCT00589784|Sunitinib|sunitinib
1547433|NCT00589784|Brain Cancer|brain cancer
1547434|NCT00589784|CNS Cancer|cns cancer
1547435|NCT00589784|meningioma|meningioma
1547436|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
1547437|NCT00589784|hemangioblastoma|hemangioblastoma
1547438|NCT00589784|malignant meningioma|malignant meningioma
1547439|NCT00589784|neurofibromatosis|neurofibromatosis
1547819|NCT00588796|metabolism|metabolism
1547440|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
1547441|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
1547442|NCT00589784|07-135|07-135
1547443|NCT00589771|IBS|ibs
1547444|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
1547445|NCT00589771|probiotics|probiotics
1547446|NCT00589771|cytokine|cytokine
1547447|NCT00589771|histology|histology
1547448|NCT00589771|Efficacy|efficacy
1547449|NCT00589758|Right Ventricle|right ventricle
1547450|NCT00589758|Echocardiogram|echocardiogram
1547451|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
1547452|NCT00589745|Diagnosis|diagnosis
1547453|NCT00589732|stents|stents
1547454|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
1547455|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
1547456|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
1547457|NCT00589706|anti-body treatment|anti-body treatment
1547458|NCT00589706|survival|survival
1547459|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1547460|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
1547461|NCT00589693|Doripenem|doripenem
1547462|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
1547463|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
1547464|NCT00589680|Diabetic Acidosis|diabetic acidosis
1547465|NCT00589680|Diabetic Ketosis|diabetic ketosis
1547466|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
1547467|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
1547468|NCT00589667|Head and Neck Cancer|head and neck cancer
1547469|NCT00589667|GEMCITABINE|gemcitabine
1547471|NCT00589667|ALTIMA|altima
1547472|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
1547473|NCT00589667|carcinoma|carcinoma
1547475|NCT00589667|larynx|larynx
1547476|NCT00589667|paranasal sinus|paranasal sinus
1547477|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
1547478|NCT00589654|amenorrhea|amenorrhea
1547479|NCT00589654|menstrual cycle|menstrual cycle
1547480|NCT00589654|Breast cancer|breast cancer
1547481|NCT00589654|questionnaire|questionnaire
1547482|NCT00589654|97-127|97-127
1547483|NCT00589641|adolescents|adolescents
1547484|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
1547485|NCT00589641|depression|depression
1547486|NCT00589641|substance abuse|substance abuse
1547487|NCT00589628|Childhood|childhood
1547488|NCT00589628|Uveitis|uveitis
1547489|NCT00589615|vitamin D|vitamin d
1547490|NCT00589615|bone density|bone density
1547491|NCT00589602|Adult leukemia|adult leukemia
1547492|NCT00589602|lymphoma|lymphoma
1547493|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
1547494|NCT00589602|plasma cell disorders|plasma cell disorders
1547495|NCT00589589|burns|burns
1547496|NCT00589589|hypoglycemia|hypoglycemia
1547497|NCT00589589|hyperglycemia|hyperglycemia
1547498|NCT00589589|glucose monitoring|glucose monitoring
1547499|NCT00589563|graft versus host disease|graft versus host disease
1547500|NCT00589563|infection|infection
1547501|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
1547502|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
1547503|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
1547504|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
1547505|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1547506|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1547507|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1547508|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1547509|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1547510|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1547511|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1567944|NCT00507728|Placebo|placebo
1547512|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1547513|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1547514|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1547515|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1547516|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1547517|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1547518|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1547519|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1547520|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1547521|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1547522|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1547523|NCT00589563|Burkitt lymphoma|burkitt lymphoma
1547524|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1547525|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1547526|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1547527|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1547528|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1547529|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1547530|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1547531|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1547532|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1547533|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1547534|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1547535|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1547536|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1547537|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1547538|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1547539|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1547540|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1547541|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1547542|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1547543|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1547544|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1547545|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1547546|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1547547|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1547548|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1547549|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1547550|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1547551|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1547552|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1547553|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1547554|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1547555|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1547556|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1547557|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1547558|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1547559|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1547560|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1547561|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1547562|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1547563|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1547564|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1547565|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
1547566|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
1547567|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1547568|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1547569|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1547570|NCT00589563|small intestine lymphoma|small intestine lymphoma
1547571|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1547572|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1547573|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1547574|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1547575|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1547576|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1547577|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1547578|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1547579|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1547580|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1547581|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1547582|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1547583|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1547584|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1547648|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
1547585|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1547586|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1547587|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1547588|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1547589|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1547590|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1547591|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1547592|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1547593|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1547594|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1547595|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1547596|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1547597|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1547598|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1547599|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1547600|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1547601|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1547602|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1547603|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1547604|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1547851|NCT00588640|Pain|pain
1547605|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1547606|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1547607|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1547608|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1547609|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1547610|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1547611|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1547612|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1547613|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1547614|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1547615|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1547616|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1547617|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1547618|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1547619|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1547620|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1547621|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1547622|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1547623|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1547624|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1547625|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1547626|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1547627|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1547628|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1547629|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1547630|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1547631|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1547632|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1547633|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
1547634|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
1547635|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
1547636|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1547637|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1547638|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1547639|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1547640|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1547641|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1547642|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1547643|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1547644|NCT00589563|primary myelofibrosis|primary myelofibrosis
1547645|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
1547646|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1547647|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
1547731|NCT00589277|Tobacco|tobacco
1547649|NCT00589537|testicular seminoma|testicular seminoma
1547650|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1547651|NCT00589524|blocked arteries|blocked arteries
1547652|NCT00589524|narrowing arteries|narrowing arteries
1547653|NCT00589524|IVUS|ivus
1547654|NCT00589524|CT|ct
1547655|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
1547656|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
1547657|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
1547658|NCT00589459|acute coronary syndrome|acute coronary syndrome
1547659|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
1547660|NCT00589446|Embryoscopy|embryoscopy
1547661|NCT00589446|recurrent miscarriage|recurrent miscarriage
1547662|NCT00589446|missed abortion|missed abortion
1547663|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
1547664|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
1547665|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1547666|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
1547667|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
1547668|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
1547669|NCT00589394|normal response|normal response
1547670|NCT00589394|immunodeficiency|immunodeficiency
1547671|NCT00589394|Healthy patients|healthy patients
1547672|NCT00589394|Healthy Volunteers|healthy volunteers
1547673|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1547674|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1547675|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1547676|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1547677|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1547678|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1547679|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1547680|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1547681|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1547682|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
1547683|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1547684|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1547685|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1547686|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1547687|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1547688|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1547689|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1547690|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1547691|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1547692|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1547693|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1547694|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1547695|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1547696|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1547697|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1547698|NCT00589368|Brain Infarction|brain infarction
1547699|NCT00589368|pathology|pathology
1547700|NCT00589368|physiopathology|physiopathology
1547701|NCT00589368|psychology|psychology
1547702|NCT00589368|rehabilitation|rehabilitation
1547703|NCT00589368|Fingers|fingers
1547704|NCT00589368|Grasp|grasp
1547705|NCT00589368|Functional Laterality|functional laterality
1547706|NCT00589368|Hand|hand
1547707|NCT00589368|Strength|strength
1547708|NCT00589368|Neuronal Plasticity|neuronal plasticity
1547709|NCT00589368|Psychomotor Performance|psychomotor performance
1547710|NCT00589368|Biomechanis|biomechanis
1547711|NCT00589368|Touch|touch
1547712|NCT00589368|Weight-Bearing|weight-bearing
1547713|NCT00589355|c-reactive protein|c-reactive protein
1547714|NCT00589355|endothelial dysfunction|endothelial dysfunction
1547715|NCT00589355|glucose intolerance|glucose intolerance
1547716|NCT00589329|Preterm birth|preterm birth
1547717|NCT00589329|antibiotics|antibiotics
1547718|NCT00589329|preterm labor|preterm labor
1547719|NCT00589329|respiratory distress|respiratory distress
1547720|NCT00589329|pergnancy|pergnancy
1547721|NCT00589303|Atrial Fibrillation|atrial fibrillation
1547722|NCT00589303|Heart Failure|heart failure
1547723|NCT00589303|AV Node ablation|av node ablation
1547724|NCT00589303|Cardiac pacemaker|cardiac pacemaker
1547725|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
1547726|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
1547727|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
1547728|NCT00589290|Thymic Carcinoma|thymic carcinoma
1547729|NCT00589290|Thymoma|thymoma
1547730|NCT00589277|Smoking|smoking
1547732|NCT00589277|Message Framing|message framing
1547733|NCT00589264|zinc|zinc
1547734|NCT00589264|iron|iron
1547735|NCT00589264|child development|child development
1547736|NCT00589264|visual attention|visual attention
1547737|NCT00589264|Peru|peru
1547738|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
1547739|NCT00589238|stage II breast cancer|stage ii breast cancer
1547740|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
1547741|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
1547742|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
1547744|NCT00589225|PH type I|ph type i
1547745|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
1547746|NCT00589225|Hyperoxaluria|hyperoxaluria
1547747|NCT00589225|Primary Oxalosis|primary oxalosis
1547748|NCT00589225|PH type II|ph type ii
1547749|NCT00589225|PH type III|ph type iii
1547750|NCT00589225|Genetic testing for PH|genetic testing for ph
1547751|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
1547752|NCT00589225|Hereditary study for PH|hereditary study for ph
1547753|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
1547754|NCT00589212|GliaSite|gliasite
1547755|NCT00589212|Brain metastases|brain metastases
1547756|NCT00589212|1-3 METS|1-3 mets
1547757|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1547758|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1547852|NCT00588640|HEENT cancer|heent cancer
1547853|NCT00588627|Chronic cough|chronic cough
1547759|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1547760|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1547761|NCT00589173|Preventive Care|preventive care
1547762|NCT00589173|Health information technology|health information technology
1547763|NCT00589173|Personal health record|personal health record
1547764|NCT00589121|radiation fibrosis|radiation fibrosis
1547765|NCT00589121|radiation toxicity|radiation toxicity
1547766|NCT00589121|lymphedema|lymphedema
1547767|NCT00589121|musculoskeletal complications|musculoskeletal complications
1547768|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1547769|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1547770|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1547771|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1547772|NCT00589108|knee arthroplasty|knee arthroplasty
1547773|NCT00589082|AML|aml
1547774|NCT00589082|elderly|elderly
1547775|NCT00589082|DaunoXome|daunoxome
1547776|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1547904|NCT00588445|Gefitnib|gefitnib
1547777|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1547778|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1547779|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1547780|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
1547781|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1547782|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1547783|NCT00588978|c-reactive protein|c-reactive protein
1547784|NCT00588978|obesity|obesity
1547785|NCT00588978|women's cardiovascular health|women's cardiovascular health
1547786|NCT00588965|QT interval|qt interval
1547787|NCT00588965|beta-blocker|beta-blocker
1547788|NCT00588965|exercise|exercise
1547789|NCT00588965|electrocardiogram|electrocardiogram
1547790|NCT00588965|repolarizaton|repolarizaton
1547792|NCT00588939|heartburn|heartburn
1547793|NCT00588926|Deep Brain Stimulation|deep brain stimulation
1547794|NCT00588926|Movement Disorders|movement disorders
1547795|NCT00588926|Remifentanil|remifentanil
1547796|NCT00588926|Sedation|sedation
1547797|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
1547798|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
1547799|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
1547800|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1547801|NCT00588913|lung metastases|lung metastases
1547802|NCT00588900|stage IV colon cancer|stage iv colon cancer
1547803|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
1547804|NCT00588900|recurrent colon cancer|recurrent colon cancer
1547805|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
1547806|NCT00588874|male osteoporosis|male osteoporosis
1547807|NCT00588874|male osteopenia|male osteopenia
1547808|NCT00588874|calciotropic hormones|calciotropic hormones
1547809|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
1547810|NCT00588848|OSA|osa
1547811|NCT00588848|Postoperative|postoperative
1547812|NCT00588848|CPAP|cpap
1547813|NCT00588835|pharmacokinetics|pharmacokinetics
1547814|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
1547815|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1547816|NCT00588796|fibrinogen|fibrinogen
1547817|NCT00588796|burns|burns
1547818|NCT00588796|trauma|trauma
1547820|NCT00588757|IVC filters|ivc filters
1547821|NCT00588757|Trauma|trauma
1547822|NCT00588757|Dwell time|dwell time
1547823|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
1547824|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
1547825|NCT00588718|Proteomics in blood|proteomics in blood
1547826|NCT00588718|Genomics in blood|genomics in blood
1547827|NCT00588718|Multi-center|multi-center
1547828|NCT00588705|Daughters|daughters
1547829|NCT00588705|Communication|communication
1547830|NCT00588705|genetic risk|genetic risk
1547831|NCT00588705|Genetic Counseling|genetic counseling
1547832|NCT00588692|Heart Failure|heart failure
1547833|NCT00588692|Afterload Reduction|afterload reduction
1547834|NCT00588692|Sphygmocor|sphygmocor
1547835|NCT00588679|Prostate Cancer|prostate cancer
1547836|NCT00588679|Cancer|cancer
1547837|NCT00588679|MRI|mri
1547838|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
1547839|NCT00588679|06-035|06-035
1547840|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
1547841|NCT00588666|urinary bladder|urinary bladder
1547842|NCT00588666|Cancer|cancer
1547843|NCT00588666|ureter|ureter
1547844|NCT00588666|renal pelvis|renal pelvis
1547845|NCT00588666|chemotherapy|chemotherapy
1547846|NCT00588653|Crohn's disease|crohn's disease
1547847|NCT00588653|capsule endoscopy|capsule endoscopy
1547848|NCT00588653|computed tomography enterography|computed tomography enterography
1547849|NCT00588653|colonoscopy|colonoscopy
1547850|NCT00588653|small bowel follow-through|small bowel follow-through
1547854|NCT00588627|Post nasal drip|post nasal drip
1547855|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
1547856|NCT00588588|Intensive Care|intensive care
1547857|NCT00588588|Antibiotics|antibiotics
1547858|NCT00588588|Mortality|mortality
1547859|NCT00588588|Length of stay|length of stay
1547860|NCT00588575|Barrett's Esophagus|barrett's esophagus
1547861|NCT00588562|PH|ph
1547862|NCT00588562|PH1|ph1
1547863|NCT00588562|PH2|ph2
1547864|NCT00588562|PH3|ph3
1547865|NCT00588562|PHI|phi
1547866|NCT00588562|PHII|phii
1547867|NCT00588562|PHIII|phiii
1547868|NCT00588562|PH NonI-NonII|ph noni-nonii
1547869|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
1547870|NCT00588562|Primary Oxalosis|primary oxalosis
1547871|NCT00588562|Hyperoxaluria|hyperoxaluria
1547872|NCT00588562|Oxalate|oxalate
1547873|NCT00588562|Cystinuria|cystinuria
1547874|NCT00588562|Cystine|cystine
1547875|NCT00588562|APRT|aprt
1547876|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
1547877|NCT00588562|Dent disease|dent disease
1547878|NCT00588562|Dent|dent
1547879|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
1547880|NCT00588536|LCH|lch
1547881|NCT00588536|6-Thioguanine|6-thioguanine
1547882|NCT00588536|6-TG|6-tg
1547883|NCT00588536|Methotrexate|methotrexate
1547884|NCT00588536|MTX|mtx
1547885|NCT00588536|94-132|94-132
1547886|NCT00588523|Brain|brain
1547887|NCT00588523|CNS|cns
1547888|NCT00588523|TEMOZOLOMIDE|temozolomide
1547889|NCT00588523|Busulfan|busulfan
1547890|NCT00588523|Thiotepa|thiotepa
1547891|NCT00588510|Sarcoma|sarcoma
1547892|NCT00588510|Bone|bone
1547893|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
1547894|NCT00588484|Carotid artery|carotid artery
1547895|NCT00588484|Common carotid artery|common carotid artery
1547896|NCT00588484|Measurement|measurement
1547897|NCT00588484|Ultrasound|ultrasound
1547898|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
1547899|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
1547900|NCT00588458|MELD score|meld score
1547901|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
1547902|NCT00588445|Lung Cancer|lung cancer
1547903|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
1547905|NCT00588445|Cancer|cancer
1547906|NCT00588445|NSCLC|nsclc
1547907|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
1547908|NCT00588445|smoker|smoker
1547909|NCT00588432|Stroke|stroke
1547910|NCT00588432|Immobilization|immobilization
1547911|NCT00588432|Myofacial Pain|myofacial pain
1547912|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
1547913|NCT00588419|Breast Cancer|breast cancer
1547914|NCT00588419|Cancer|cancer
1547915|NCT00588419|Breast Sensation|breast sensation
1547916|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
1547917|NCT00588406|acute, emergency department|acute, emergency department
1547918|NCT00588380|GLP-1|glp-1
1547919|NCT00588380|Insulin Secretion|insulin secretion
1547920|NCT00588367|Inflammation|inflammation
1547921|NCT00588367|Pancreas|pancreas
1547922|NCT00588367|Chronic pancreatitis|chronic pancreatitis
1547923|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
1547924|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
1547925|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
1547926|NCT00588354|herniated disk|herniated disk
1547927|NCT00588354|radiculopathy|radiculopathy
1547928|NCT00588354|clonidine|clonidine
1547929|NCT00588354|epidural|epidural
1547930|NCT00588354|steroid|steroid
1547931|NCT00588354|corticosteroid|corticosteroid
1547932|NCT00588354|nucleus pulposus|nucleus pulposus
1547933|NCT00588354|transforaminal|transforaminal
1547934|NCT00588341|Melanoma|melanoma
1547935|NCT00588341|Skin Cancer|skin cancer
1547936|NCT00588341|Cancer|cancer
1547937|NCT00588341|Temozolamide|temozolamide
1547939|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
1547940|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
1547941|NCT00588289|Pediatric Cancers|pediatric cancers
1547942|NCT00588289|Oncology|oncology
1547943|NCT00588276|measurable disease|measurable disease
1547944|NCT00588276|locally advanced disease|locally advanced disease
1547945|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
1547946|NCT00588263|Cancer|cancer
1547947|NCT00588263|00-087|00-087
1547948|NCT00588237|ovary|ovary
1547949|NCT00588237|BEVACIZUMAB|bevacizumab
1547950|NCT00588237|CISPLATIN|cisplatin
1547951|NCT00588237|TAXOL|taxol
1547952|NCT00588224|stomach|stomach
1547953|NCT00588224|accommodation|accommodation
1547954|NCT00588224|volume|volume
1547955|NCT00588224|SPECT|spect
1547956|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
1547957|NCT00588224|healthy volunteers|healthy volunteers
1547958|NCT00588211|Cancer related-Risks|cancer related-risks
1547959|NCT00588211|Risk Perception|risk perception
1547960|NCT00588211|Survey|survey
1547961|NCT00588211|Focus Group|focus group
1547962|NCT00588211|Smoking cessation|smoking cessation
1547963|NCT00588211|tobacco|tobacco
1547964|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
1547965|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
1547966|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
1547967|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
1547968|NCT00588185|Pet Imaging|pet imaging
1547969|NCT00588185|Pet scan|pet scan
1547970|NCT00588185|00-095|00-095
1547971|NCT00588172|Metformin|metformin
1547972|NCT00588172|Type 2 diabetes|type 2 diabetes
1547973|NCT00588172|Oct1|oct1
1547974|NCT00588159|Preoperative gabapentin|preoperative gabapentin
1547975|NCT00588159|Acute pain|acute pain
1547976|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
1547977|NCT00588159|Epidural analgesia|epidural analgesia
1547978|NCT00588146|anemia|anemia
1547979|NCT00588146|HHT|hht
1547980|NCT00588146|Liver disease|liver disease
1547981|NCT00588146|Hypoxemia|hypoxemia
1547982|NCT00588146|Iron deficiency anemia|iron deficiency anemia
1547983|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
1547984|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
1547985|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
1547986|NCT00588120|Hyperoxaluria|hyperoxaluria
1547987|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
1547988|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
1547989|NCT00588120|Oxaluric|oxaluric
1547990|NCT00588120|High Oxalate|high oxalate
1547991|NCT00588120|Oxalate|oxalate
1547992|NCT00588120|C13|c13
1547993|NCT00588120|Oxalate Diet|oxalate diet
1547994|NCT00588107|Cancer|cancer
1547995|NCT00588107|Smoker|smoker
1547996|NCT00588107|Web based intervention|web based intervention
1547997|NCT00588107|Partnership for Health|partnership for health
1547998|NCT00588107|Cancer Survivors|cancer survivors
1547999|NCT00588094|Lymphoma|lymphoma
1548000|NCT00588094|ASCT|asct
1548001|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
1548002|NCT00588094|Cancer|cancer
1548003|NCT00588094|Second line therapy|second line therapy
1548004|NCT00588094|ICE|ice
1548005|NCT00588094|Stem cell transplant|stem cell transplant
1548006|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
1548007|NCT00588068|Adrenal Gland|adrenal gland
1548008|NCT00588068|No stage requirement|no stage requirement
1548009|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1548010|NCT00588042|Coronary Artery Disease|coronary artery disease
1548011|NCT00588042|Coronary Occlusion|coronary occlusion
1548012|NCT00588029|Family members|family members
1548013|NCT00588016|Itraconazole|itraconazole
1548014|NCT00588003|Breast|breast
1548015|NCT00588003|ANASTROZOLE|anastrozole
1548016|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
1548017|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
1548018|NCT00587964|Cancer|cancer
1548019|NCT00587964|Brain Metastasis|brain metastasis
1548020|NCT00587964|Radiosurgery|radiosurgery
1548021|NCT00587964|Bladder cancer|bladder cancer
1548022|NCT00587964|Breast cancer|breast cancer
1548023|NCT00587964|Cervical cancer|cervical cancer
1548024|NCT00587964|Colon cancer|colon cancer
1548025|NCT00587964|HEENT cancer|heent cancer
1548026|NCT00587964|Lung cancer|lung cancer
1548027|NCT00587964|Melanoma|melanoma
1548028|NCT00587964|Pancreatic cancer|pancreatic cancer
1548029|NCT00587964|Prostate cancer|prostate cancer
1548030|NCT00587964|Rectal cancer|rectal cancer
1548031|NCT00587964|Sarcoma|sarcoma
1548032|NCT00587964|Testicular cancer|testicular cancer
1548033|NCT00587964|Radiation|radiation
1548034|NCT00587951|Clinical decision-making|clinical decision-making
1548035|NCT00587951|Ictal SPECT|ictal spect
1548036|NCT00587951|Epilepsy surgery|epilepsy surgery
1548037|NCT00587938|congestive heart failure|congestive heart failure
1548038|NCT00587938|Brain naturietic peptide|brain naturietic peptide
1548039|NCT00587938|hospital utilization cost|hospital utilization cost
1548040|NCT00587925|osteoporosis|osteoporosis
1548041|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
1548042|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
1548043|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1548044|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
1548045|NCT00587912|Cancer|cancer
1548046|NCT00587912|AIDS|aids
1548047|NCT00587899|Atrial Fibrillation|atrial fibrillation
1548048|NCT00587899|AF|af
1548049|NCT00587899|A fib|a fib
1548050|NCT00587899|cardiac ablation|cardiac ablation
1548051|NCT00587899|modified maze procedure|modified maze procedure
1548052|NCT00587886|Cancer|cancer
1548053|NCT00587886|Endometrial cancer|endometrial cancer
1548054|NCT00587886|Ovarian cancer|ovarian cancer
1548055|NCT00587886|Corpus Uteri|corpus uteri
1548056|NCT00587886|Endometrium|endometrium
1548057|NCT00587873|Relapsed|relapsed
1548058|NCT00587873|Hodgkin's Disease|hodgkin's disease
1548059|NCT00587873|Methotrexate|methotrexate
1548060|NCT00587873|6-Thioguanine|6-thioguanine
1548061|NCT00587873|94-030|94-030
1548062|NCT00587847|leukemia|leukemia
1548063|NCT00587821|Breast Cancer|breast cancer
1548064|NCT00587821|Breast biopsy|breast biopsy
1548065|NCT00587808|Heart Failure|heart failure
1548066|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
1548067|NCT00587808|Stroke Volume|stroke volume
1548068|NCT00587769|Smoking|smoking
1548069|NCT00587769|Smoking cessation|smoking cessation
1548070|NCT00587769|Bupropion|bupropion
1548071|NCT00587769|Varenicline|varenicline
1548072|NCT00587769|Tobacco use disorder|tobacco use disorder
1548073|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
1548074|NCT00587756|colorectal liver metastases|colorectal liver metastases
1548075|NCT00587756|hepatectomy|hepatectomy
1548076|NCT00587756|portal vein embolization|portal vein embolization
1548077|NCT00587756|Liver|liver
1548078|NCT00587730|heart disease|heart disease
1548079|NCT00587730|cardiac disease|cardiac disease
1548080|NCT00587730|chest pain|chest pain
1548081|NCT00587730|myocardial infarction|myocardial infarction
1548082|NCT00587730|heart attack|heart attack
1548083|NCT00587691|Tovaxin|tovaxin
1548085|NCT00587691|Autologous|autologous
1548086|NCT00587678|PAD|pad
1548087|NCT00587665|Pain|pain
1548088|NCT00587652|Barrett Esophagus|barrett esophagus
1548089|NCT00587652|Methylene blue|methylene blue
1548090|NCT00587652|Chromoendoscopy|chromoendoscopy
1548091|NCT00587639|Adolescent|adolescent
1548092|NCT00587639|Depression|depression
1548093|NCT00587639|rTMS|rtms
1548094|NCT00587626|neck pain|neck pain
1548095|NCT00587626|shoulder pain|shoulder pain
1548096|NCT00587626|cervical pain|cervical pain
1548097|NCT00587626|chronic|chronic
1548098|NCT00587626|recurrent|recurrent
1548099|NCT00587600|Barrett's Esophagus|barrett's esophagus
1548100|NCT00587600|High Grade Dysplasia|high grade dysplasia
1548101|NCT00587600|Photodynamic Therapy|photodynamic therapy
1548102|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
1548103|NCT00587561|schizophrenia|schizophrenia
1548104|NCT00587561|social cognition|social cognition
1548105|NCT00587561|cognition|cognition
1548106|NCT00587561|treatment|treatment
1548107|NCT00587561|outcome|outcome
1548108|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
1548109|NCT00587535|hemochromatosis|hemochromatosis
1548110|NCT00587535|liver cirrhosis|liver cirrhosis
1548111|NCT00587535|liver diseases|liver diseases
1548112|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1548113|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
1548114|NCT00587522|Plicator|plicator
1548115|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
1548116|NCT00587496|HSV DNA|hsv dna
1548117|NCT00587496|volunteers|volunteers
1548118|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
1548119|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
1548120|NCT00587483|ventricular fibrillation|ventricular fibrillation
1548121|NCT00587483|amiodarone|amiodarone
1548122|NCT00587483|lidocaine|lidocaine
1548123|NCT00587483|cardiac surgery|cardiac surgery
1548124|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
1548125|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1548126|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
1548127|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1548128|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
1548129|NCT00587444|heparin management|heparin management
1548130|NCT00587431|Prostate|prostate
1548131|NCT00587431|Cancer|cancer
1548132|NCT00587431|Docetaxel|docetaxel
1548133|NCT00587431|03-076|03-076
1548134|NCT00587405|Watermelon Stomach|watermelon stomach
1548135|NCT00587405|Cryotherapy|cryotherapy
1548136|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
1548137|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1548138|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
1548139|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
1548140|NCT00587392|Plicator|plicator
1548141|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
1548142|NCT00587353|tobacco use cessation|tobacco use cessation
1548143|NCT00587353|radiation oncology|radiation oncology
1548144|NCT00587353|smoking|smoking
1548145|NCT00587314|Photodynamic Therapy|photodynamic therapy
1548146|NCT00587314|Barrett's Esophagus|barrett's esophagus
1548147|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
1548148|NCT00587301|Child Obesity|child obesity
1548149|NCT00587288|Cinquil™|cinquil™
1548150|NCT00587288|Reslizumab|reslizumab
1548151|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1548152|NCT00587275|GERD|gerd
1548153|NCT00587262|Cochlear|cochlear
1548154|NCT00587262|Hearing|hearing
1548155|NCT00587262|High frequency hearing loss|high frequency hearing loss
1548156|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
1548157|NCT00587236|Autofluorescence|autofluorescence
1548158|NCT00587236|Narrow Band|narrow band
1548159|NCT00587236|High definition white light|high definition white light
1548160|NCT00587210|Crohn Disease|crohn disease
1548161|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
1548162|NCT00587197|esophageal varices|esophageal varices
1548163|NCT00587197|portal hypertension|portal hypertension
1548164|NCT00587197|gastric varices|gastric varices
1548165|NCT00587197|cost effectiveness|cost effectiveness
1548166|NCT00587184|Barrett's Esophagus|barrett's esophagus
1548167|NCT00587184|Confocal Microscopy|confocal microscopy
1548168|NCT00587171|Amblyopia|amblyopia
1548169|NCT00587171|Vision Therapy|vision therapy
1548170|NCT00587171|Patching|patching
1548171|NCT00587158|Paricalcitol|paricalcitol
1548172|NCT00587158|Parathyroid Hormone|parathyroid hormone
1548173|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
1548174|NCT00587158|Chronic Kidney Disease|chronic kidney disease
1548175|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
1548176|NCT00587158|Vitamin D Receptor|vitamin d receptor
1548177|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
1548178|NCT00587158|Zemplar®|zemplar®
1548179|NCT00587145|Stomach Neoplasms|stomach neoplasms
1548180|NCT00587145|Secondary|secondary
1548181|NCT00587145|Combination chemotherapy|combination chemotherapy
1548182|NCT00587145|S-1|s-1
1548183|NCT00587145|Docetaxel|docetaxel
1548184|NCT00587145|oxaliplatin|oxaliplatin
1548185|NCT00587132|Diabetes mellitus|diabetes mellitus
1548186|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
1548187|NCT00587119|Urso|urso
1548188|NCT00587119|Budesonide|budesonide
1548189|NCT00587119|PBC|pbc
1548190|NCT00587119|overlap AIH|overlap aih
1548191|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
1548192|NCT00587093|Newly diagnosed|newly diagnosed
1548193|NCT00587093|CA 125|ca 125
1548194|NCT00587093|CT scan|ct scan
1548195|NCT00587093|01-048|01-048
1548196|NCT00587067|FUDR|fudr
1548197|NCT00587067|FLOXORUIDINE|floxoruidine
1548198|NCT00587067|DEXAMETHASONE|dexamethasone
1548199|NCT00587067|Hepatic|hepatic
1548200|NCT00587067|Cancer|cancer
1548201|NCT00587067|02-120|02-120
1548202|NCT00587054|leukemia|leukemia
1548203|NCT00587054|non-Hodgkins|non-hodgkins
1548204|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
1548205|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
1548206|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
1548207|NCT00587054|cytoreductive regimen|cytoreductive regimen
1548208|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
1548209|NCT00587041|Synbiotic|synbiotic
1548210|NCT00587041|Urine Oxalate|urine oxalate
1548211|NCT00587041|Probiotic|probiotic
1548212|NCT00587041|Kidney Stone|kidney stone
1548213|NCT00587041|Gastric Bypass|gastric bypass
1548214|NCT00587041|Crohn's|crohn's
1548215|NCT00587041|Stone|stone
1548216|NCT00587041|Hyperoxaluria|hyperoxaluria
1548217|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
1548218|NCT00587028|Colonography|colonography
1548219|NCT00587028|Colonoscopy|colonoscopy
1548220|NCT00587028|Virtual|virtual
1548221|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
1548222|NCT00587028|Large intestine|large intestine
1548223|NCT00587028|colon|colon
1548224|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
1548225|NCT00587002|Women|women
1548226|NCT00586989|Barrett's Esophagus|barrett's esophagus
1548227|NCT00586989|Esophageal Cancer|esophageal cancer
1548228|NCT00586989|High Grade Dysplasia|high grade dysplasia
1548229|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
1548230|NCT00586963|Erosive Esophagitis|erosive esophagitis
1548231|NCT00586963|Reflux Esophagitis|reflux esophagitis
1548232|NCT00586963|GERD|gerd
1548233|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
1548234|NCT00586950|High risk patients|high risk patients
1548235|NCT00586950|End-stage renal failure|end-stage renal failure
1548236|NCT00586950|Cardiovascular events|cardiovascular events
1548237|NCT00586950|prognosis|prognosis
1548238|NCT00586937|Lung Cancer Survivors|lung cancer survivors
1548239|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1548240|NCT00586911|NASH|nash
1548241|NCT00586911|Betaine|betaine
1548242|NCT00586898|Prostate|prostate
1548243|NCT00586898|Cancer|cancer
1548244|NCT00586898|Hormones|hormones
1548245|NCT00586898|01-085|01-085
1548246|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
1548247|NCT00586898|ESTROGENS|estrogens
1548248|NCT00586898|LUPRON|lupron
1548249|NCT00586898|TESTOSTERONE|testosterone
1548250|NCT00586898|ZOLADEX|zoladex
1548251|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1548252|NCT00586885|NASH|nash
1548253|NCT00586885|L-Alanine|l-alanine
1548254|NCT00586872|Barrett's Esophagus|barrett's esophagus
1548255|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
1548256|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
1548257|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1548258|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
1548259|NCT00586859|Plicator|plicator
1548260|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
1548261|NCT00586846|Cisplatin|cisplatin
1548262|NCT00586846|Doxorubicin|doxorubicin
1548565|NCT00585286|scarring|scarring
1548263|NCT00586846|Methotrexate|methotrexate
1548264|NCT00586846|Osteosarcoma|osteosarcoma
1548265|NCT00586846|03-074|03-074
1548266|NCT00586833|Heart Failure|heart failure
1548267|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
1548268|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
1548269|NCT00586833|Edema, Cardiac|edema, cardiac
1548270|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
1548271|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
1548272|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
1548273|NCT00586807|Ulcerative colitis|ulcerative colitis
1548274|NCT00586807|pediatrics|pediatrics
1548275|NCT00586807|UC|uc
1548276|NCT00586807|protein metabolism|protein metabolism
1548277|NCT00586807|energy expenditure|energy expenditure
1548278|NCT00586794|Hypertension|hypertension
1548279|NCT00586794|Eisenmenger|eisenmenger
1548280|NCT00586781|ankle replacement|ankle replacement
1548281|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
1548282|NCT00586781|degenerative ankle disease|degenerative ankle disease
1548283|NCT00586755|Intensive Induction|intensive induction
1548284|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
1548285|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
1548286|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
1548287|NCT00586742|SLAP lesions|slap lesions
1548288|NCT00586742|labral repair|labral repair
1548289|NCT00586742|bicepstenodesis|bicepstenodesis
1548290|NCT00586742|conservative treatment|conservative treatment
1548291|NCT00586729|Burn|burn
1548292|NCT00586729|Burn wound management|burn wound management
1548293|NCT00586729|Burn graft|burn graft
1548294|NCT00586703|Stem cell transplant|stem cell transplant
1548295|NCT00586703|mismatched donor|mismatched donor
1548296|NCT00586703|NK infusion|nk infusion
1548297|NCT00586690|Stem cell transplant|stem cell transplant
1548298|NCT00586690|matched donor|matched donor
1548299|NCT00586690|NK infusion|nk infusion
1548300|NCT00586677|child abuse|child abuse
1548301|NCT00586677|child neglect|child neglect
1548302|NCT00586677|PCIT|pcit
1548303|NCT00586677|Lutzker|lutzker
1548304|NCT00586677|attachment|attachment
1548305|NCT00586677|parenting|parenting
1548306|NCT00586638|cognition|cognition
1548307|NCT00586638|cognition disorders|cognition disorders
1548308|NCT00586638|executive function|executive function
1548309|NCT00586638|cognitive control|cognitive control
1548310|NCT00586638|attentional control|attentional control
1548311|NCT00586638|biomedical enhancement|biomedical enhancement
1548312|NCT00586638|cognitive enhancement|cognitive enhancement
1548313|NCT00586638|computerized|computerized
1548314|NCT00586638|computer-based|computer-based
1548315|NCT00586638|video game|video game
1548316|NCT00586612|Conjugate vaccine|conjugate vaccine
1548317|NCT00586612|Persistence|persistence
1548318|NCT00586612|Hib vaccine|hib vaccine
1548319|NCT00586612|Combination vaccine|combination vaccine
1548320|NCT00586612|Meningococcal vaccine|meningococcal vaccine
1548321|NCT00586612|Safety|safety
1548322|NCT00586612|Preterm/full-term infants|preterm/full-term infants
1548323|NCT00586612|Immunogenicity|immunogenicity
1548325|NCT00586599|CD|cd
1548326|NCT00586599|UC|uc
1548327|NCT00586599|Crohn's Disease|crohn's disease
1548328|NCT00586599|Ulcerative Colitis|ulcerative colitis
1548329|NCT00586599|Pediatric|pediatric
1548330|NCT00586599|inflammatory markers|inflammatory markers
1548331|NCT00586573|ADHD|adhd
1548332|NCT00586573|Namenda|namenda
1548333|NCT00586560|solid tumors|solid tumors
1548334|NCT00586547|Haploidentical|haploidentical
1548335|NCT00586547|Stem Cell Transplant|stem cell transplant
1548336|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
1548337|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
1548338|NCT00586521|Coagulation Disorders|coagulation disorders
1548339|NCT00586495|Sorafenib|sorafenib
1548340|NCT00586495|Nexavar|nexavar
1548341|NCT00586495|Metastatic RCC|metastatic rcc
1548342|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
1548343|NCT00586495|Unresectable RCC|unresectable rcc
1548344|NCT00586482|cigarettes, surgery|cigarettes, surgery
1548345|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
1548346|NCT00586469|Influenza|influenza
1548347|NCT00586443|solid tumors|solid tumors
1548348|NCT00586443|avastin|avastin
1548349|NCT00586443|Phase I|phase i
1548350|NCT00586443|Phase 1|phase 1
1548351|NCT00586443|combination therapy|combination therapy
1548352|NCT00586443|bevacizumab|bevacizumab
1548353|NCT00586443|RAD001|rad001
1548354|NCT00586443|everolimus|everolimus
1548355|NCT00586443|pantitumumab|pantitumumab
1548356|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
1548357|NCT00586430|Alzheimer's disease|alzheimer's disease
1548358|NCT00586430|somnolence|somnolence
1548359|NCT00586430|Early detection|early detection
1548360|NCT00586417|angiogenesis|angiogenesis
1548361|NCT00586417|tumor angiogenesis|tumor angiogenesis
1548362|NCT00586417|biomarkers|biomarkers
1548363|NCT00586417|healthy volunteers|healthy volunteers
1548364|NCT00586404|Barrett's Esophagus|barrett's esophagus
1548566|NCT00585286|laser|laser
1548365|NCT00586404|Esophageal neoplasms|esophageal neoplasms
1548366|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
1548367|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
1548368|NCT00586391|B cell Lymphoma|b cell lymphoma
1548369|NCT00586391|Cancer|cancer
1548370|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1548371|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
1548372|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1548373|NCT00586365|complex elbow trauma|complex elbow trauma
1548374|NCT00586365|prevention|prevention
1548375|NCT00586365|complication|complication
1548376|NCT00586365|naproxen|naproxen
1548377|NCT00586365|NSAIDS|nsaids
1548378|NCT00586352|Pediatric|pediatric
1548379|NCT00586352|Crohn's disease|crohn's disease
1548380|NCT00586352|Ulcerative colitis|ulcerative colitis
1548381|NCT00586339|HPV|hpv
1548382|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1548383|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1548384|NCT00586339|Cervical cancer|cervical cancer
1548385|NCT00586339|Papillomavirus|papillomavirus
1548386|NCT00586326|MammoSite|mammosite
1548387|NCT00586326|DCIS|dcis
1548388|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
1548389|NCT00586300|Knee pain|knee pain
1548390|NCT00586287|Phenprocoumon|phenprocoumon
1548391|NCT00586287|Dosing algorithm|dosing algorithm
1548392|NCT00586287|loading dose|loading dose
1548393|NCT00586274|Stem Cell Transplant|stem cell transplant
1548394|NCT00586274|Anemia|anemia
1548395|NCT00586274|Fanconi|fanconi
1548396|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
1548397|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
1548398|NCT00586261|Proteinuria|proteinuria
1548399|NCT00586261|Albuminuria|albuminuria
1548400|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
1548401|NCT00586235|Fusion|fusion
1548402|NCT00586235|Ultrasound|ultrasound
1548403|NCT00586235|Computed tomography|computed tomography
1548404|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
1548405|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
1548406|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
1548408|NCT00586209|sickle cell disease|sickle cell disease
1548409|NCT00586209|sickle cell anemia|sickle cell anemia
1548410|NCT00586209|L-glutamine|l-glutamine
1548411|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
1548412|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
1548413|NCT00586196|Delirium|delirium
1548414|NCT00586196|Postoperative confusion|postoperative confusion
1548415|NCT00586196|Hip fracture|hip fracture
1548416|NCT00586196|Long bone fracture|long bone fracture
1548417|NCT00586183|Ventricular Remodeling|ventricular remodeling
1548418|NCT00586170|nonunion|nonunion
1548419|NCT00586170|fracture|fracture
1548420|NCT00586157|ADHD|adhd
1548421|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1548422|NCT00586157|Daytrana|daytrana
1548423|NCT00586157|MTS Patch|mts patch
1548424|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
1548425|NCT00586131|end-stage renal disease|end-stage renal disease
1548426|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
1548427|NCT00586131|metabolic acidosis|metabolic acidosis
1548428|NCT00586131|nitrogen balances|nitrogen balances
1548429|NCT00586118|Sedation|sedation
1548430|NCT00586118|Volatile anaesthetic|volatile anaesthetic
1548431|NCT00586118|Sevoflurane|sevoflurane
1548432|NCT00586118|Propofol|propofol
1548433|NCT00586118|Recovery|recovery
1548434|NCT00586105|Sorafenib|sorafenib
1548435|NCT00586105|Nexavar|nexavar
1548436|NCT00586105|Metastatic RCC|metastatic rcc
1548437|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
1548438|NCT00586105|Unresectable RCC|unresectable rcc
1548439|NCT00586092|Phase I|phase i
1548440|NCT00586092|Phase 1|phase 1
1548441|NCT00586092|avastin|avastin
1548442|NCT00586092|bevacizumab|bevacizumab
1548443|NCT00586092|ABT-510|abt-510
1548444|NCT00586092|solid tumors|solid tumors
1548445|NCT00586092|angiogenesis|angiogenesis
1548446|NCT00586066|Bipolar disorder|bipolar disorder
1548447|NCT00586066|Cognitive dysfunction|cognitive dysfunction
1548448|NCT00586066|Memantine|memantine
1548449|NCT00586066|NMDA antagonist|nmda antagonist
1548450|NCT00586053|Colonic Polyps|colonic polyps
1548451|NCT00586053|Colon|colon
1548452|NCT00586053|Large Intestine|large intestine
1548453|NCT00586053|Cecum|cecum
1548454|NCT00586053|Sigmoid|sigmoid
1548455|NCT00586053|Rectum|rectum
1548456|NCT00586053|Colonoscopy|colonoscopy
1548457|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
1548458|NCT00586053|CT Colonography|ct colonography
1548459|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
1548460|NCT00586053|Colonography|colonography
1548461|NCT00586040|skin cancer|skin cancer
1548462|NCT00586040|skin excision|skin excision
1548463|NCT00586040|laser|laser
1548464|NCT00586040|superficial sutures|superficial sutures
1548465|NCT00586040|wound healing|wound healing
1548466|NCT00586027|cardiac surgery|cardiac surgery
1548467|NCT00586027|low cardiac output|low cardiac output
1548468|NCT00586027|natriuretic peptide B|natriuretic peptide b
1548469|NCT00586027|mortality|mortality
1548470|NCT00586027|morbidity|morbidity
1548471|NCT00586014|Multiple myeloma|multiple myeloma
1548472|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
1548473|NCT00586001|Anxiety|anxiety
1548474|NCT00586001|Emotional Disorders|emotional disorders
1548475|NCT00586001|Unified|unified
1548476|NCT00586001|Depression|depression
1548477|NCT00585962|proton beam radiation|proton beam radiation
1548478|NCT00585910|ADHD|adhd
1548479|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1548480|NCT00585910|Strattera|strattera
1548481|NCT00585910|Concerta|concerta
1548482|NCT00585910|Atomoxetine|atomoxetine
1548483|NCT00585910|OROS Methylphenidate|oros methylphenidate
1548484|NCT00585897|Diabetes|diabetes
1548485|NCT00585897|Obesity|obesity
1548486|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
1548487|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
1548488|NCT00585845|Cancer|cancer
1548489|NCT00585845|Ovarian cancer|ovarian cancer
1548490|NCT00585845|Pancreatic cancer|pancreatic cancer
1548491|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
1548492|NCT00585845|Mesothelioma|mesothelioma
1548493|NCT00585845|Mesothelin|mesothelin
1548494|NCT00585845|Immunotherapy|immunotherapy
1548495|NCT00585832|hypertension|hypertension
1548496|NCT00585832|pre-hypertension|pre-hypertension
1548497|NCT00585832|adolescents|adolescents
1548498|NCT00585832|diet|diet
1548499|NCT00585832|vascular function|vascular function
1548500|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
1548501|NCT00585793|HIV/AIDS|hiv/aids
1548502|NCT00585767|Hydronephrosis|hydronephrosis
1548503|NCT00585715|Cellulite|cellulite
1548504|NCT00585715|Nd:YAG Laser|nd:yag laser
1548505|NCT00585702|Bipolar Disorder|bipolar disorder
1548506|NCT00585702|Pregnancy|pregnancy
1548507|NCT00585702|Infant Development|infant development
1548508|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
1548509|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
1548510|NCT00585650|etanercept|etanercept
1548511|NCT00585650|Enbrel|enbrel
1548512|NCT00585637|Vitamin D|vitamin d
1548513|NCT00585637|Blacks|blacks
1548514|NCT00585637|cancer|cancer
1548515|NCT00585637|hypertension|hypertension
1548516|NCT00585624|Esophagectomy|esophagectomy
1548517|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
1548518|NCT00585624|Whipple|whipple
1548519|NCT00585611|Heart Failure, Congestive|heart failure, congestive
1548520|NCT00585585|Depression|depression
1548521|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
1548522|NCT00585572|Normal Tissues/Brains|normal tissues/brains
1548523|NCT00585572|Alzheimer|alzheimer
1548524|NCT00585572|Motor Neuron Disease|motor neuron disease
1548525|NCT00585572|Dementia|dementia
1548526|NCT00585572|Healthy Control Volunteers|healthy control volunteers
1548527|NCT00585572|Populations At Risk|populations at risk
1548528|NCT00585572|MCI|mci
1548529|NCT00585559|Lipid|lipid
1548530|NCT00585559|Peroxidation|peroxidation
1548531|NCT00585559|N-Acetylcysteine|n-acetylcysteine
1548532|NCT00585559|Acetaminophen|acetaminophen
1548533|NCT00585559|Vasospasm|vasospasm
1548534|NCT00585546|heart failure|heart failure
1548535|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
1548536|NCT00585546|heart assist device|heart assist device
1548537|NCT00585546|clenbuterol|clenbuterol
1548839|NCT00583895|dermatitis|dermatitis
1548538|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
1548539|NCT00585546|heart transplantation|heart transplantation
1548540|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
1548541|NCT00585507|Fulvestrant|fulvestrant
1548542|NCT00585481|Epidemiological Study|epidemiological study
1548543|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
1548544|NCT00585481|Preterm Brazilian children|preterm brazilian children
1548545|NCT00585455|vascular endothelium|vascular endothelium
1548546|NCT00585455|nitric oxide|nitric oxide
1548547|NCT00585455|depression|depression
1548548|NCT00585455|heart failure|heart failure
1548549|NCT00585455|vascular biology|vascular biology
1548550|NCT00585416|Prostate Cancer|prostate cancer
1548551|NCT00585416|Hormone Refractory|hormone refractory
1548552|NCT00585416|Metastatic|metastatic
1548553|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
1548554|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
1548555|NCT00585364|cytokine expression|cytokine expression
1548556|NCT00585338|facial telangiectasia,|facial telangiectasia,
1548557|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
1548558|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
1548559|NCT00585312|FAP|fap
1548560|NCT00585299|steatosis|steatosis
1548561|NCT00585299|fatty liver|fatty liver
1548562|NCT00585299|insulin sensitivity|insulin sensitivity
1548563|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
1548564|NCT00585286|acne vulgaris|acne vulgaris
1548567|NCT00585260|asthma|asthma
1548568|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
1548569|NCT00585260|mannitol|mannitol
1548570|NCT00585260|methacholine|methacholine
1548571|NCT00585247|birthmarks|birthmarks
1548572|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1548573|NCT00585221|Imatinib|imatinib
1548574|NCT00585221|Peginterferon α-2b|peginterferon α-2b
1548575|NCT00585221|Immunotherapy|immunotherapy
1548576|NCT00585221|Targeted therapy|targeted therapy
1548577|NCT00585208|insomnia|insomnia
1548578|NCT00585208|sleep disturbance|sleep disturbance
1548579|NCT00585208|bipolar disorder|bipolar disorder
1548580|NCT00585195|Crizotinib|crizotinib
1548581|NCT00585195|dose-finding|dose-finding
1548582|NCT00585195|drug-drug interaction|drug-drug interaction
1548583|NCT00585195|ALK rearrangements|alk rearrangements
1548584|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
1548585|NCT00585195|c-Met dependent tumors|c-met dependent tumors
1548586|NCT00585195|ROS1 rearrangements|ros1 rearrangements
1548587|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
1548588|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
1548589|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
1548590|NCT00585182|Obesity|obesity
1548591|NCT00585182|venous thrombosis|venous thrombosis
1548592|NCT00585182|Anticoagulants|anticoagulants
1548593|NCT00585169|Pathological Gambling|pathological gambling
1548594|NCT00585169|Compulsive Gambling|compulsive gambling
1548595|NCT00585169|Gambling Addiction|gambling addiction
1548596|NCT00585169|Gambling|gambling
1548597|NCT00585169|Treatment|treatment
1548598|NCT00585169|Memantine|memantine
1548599|NCT00585169|Pharmacology|pharmacology
1548600|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
1548601|NCT00585143|Dyslipidemia|dyslipidemia
1548602|NCT00585078|capecitabine|capecitabine
1548603|NCT00585078|oxaliplatin|oxaliplatin
1548604|NCT00585052|Ovarian Cancer|ovarian cancer
1548605|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
1548606|NCT00585052|Lovastatin|lovastatin
1548607|NCT00585052|Paclitaxel|paclitaxel
1548608|NCT00585039|child|child
1548609|NCT00585039|emergency department|emergency department
1548610|NCT00585026|Refractive error|refractive error
1548611|NCT00585026|Asthenopia|asthenopia
1548612|NCT00585026|Presbyopia|presbyopia
1548613|NCT00585026|Eyeglasses|eyeglasses
1548614|NCT00585026|Productivity|productivity
1548615|NCT00585026|Visual comfort|visual comfort
1548616|NCT00585026|Ergonomics|ergonomics
1548617|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
1548618|NCT00585013|Anti-inflammatory|anti-inflammatory
1548619|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
1548620|NCT00584974|Depression|depression
1548621|NCT00584974|Mental Disorders|mental disorders
1548622|NCT00584974|Mood Disorders|mood disorders
1548623|NCT00584974|Depressive Disorder, Major|depressive disorder, major
1548624|NCT00584974|Dysthymic Disorder|dysthymic disorder
1548625|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
1548626|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
1548627|NCT00584935|Pemphigoid|pemphigoid
1548628|NCT00584935|Blistering Diseases|blistering diseases
1548629|NCT00584935|Blindness|blindness
1548630|NCT00584935|Autoimmune|autoimmune
1548631|NCT00584935|Rituximab|rituximab
1548632|NCT00584922|Esophageal injury|esophageal injury
1548633|NCT00584922|Catheter Ablation|catheter ablation
1548634|NCT00584922|Atrial Fibrillation|atrial fibrillation
1548635|NCT00584896|heart disease|heart disease
1548636|NCT00584896|coronary artery disease|coronary artery disease
1548637|NCT00584896|echocardiogram|echocardiogram
1548638|NCT00584896|ultrasound|ultrasound
1548639|NCT00584896|angiogram|angiogram
1548640|NCT00584896|SPECT|spect
1548641|NCT00584896|chest pain|chest pain
1548642|NCT00584896|perfusion|perfusion
1548643|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
1548644|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
1548645|NCT00584831|astigmatism|astigmatism
1548646|NCT00584831|visual acuity|visual acuity
1548647|NCT00584831|orientation|orientation
1548648|NCT00584831|contact lenses|contact lenses
1548649|NCT00584818|coronary artery disease|coronary artery disease
1548650|NCT00584818|chest pain|chest pain
1548651|NCT00584818|healthy volunteers|healthy volunteers
1548652|NCT00584818|SPECT|spect
1548653|NCT00584818|angiogram|angiogram
1548654|NCT00584818|ultrasound|ultrasound
1548655|NCT00584818|echocardiogram|echocardiogram
1548656|NCT00584818|perfusion|perfusion
1548657|NCT00584805|EEE|eee
1548658|NCT00584792|Prostate Cancer|prostate cancer
1548659|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
1548660|NCT00584753|Breast cancer|breast cancer
1548661|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
1548662|NCT00584727|astigmatism|astigmatism
1548663|NCT00584727|visual acuity|visual acuity
1548664|NCT00584727|fit|fit
1548665|NCT00584727|comfort|comfort
1548666|NCT00584727|satisfaction|satisfaction
1548667|NCT00584727|contact lens|contact lens
1548668|NCT00584714|ultrasound|ultrasound
1548669|NCT00584714|perfusion|perfusion
1548670|NCT00584714|SPECT|spect
1548671|NCT00584714|coronary artery disease|coronary artery disease
1548672|NCT00584714|chest pain|chest pain
1548673|NCT00584714|low probability|low probability
1548674|NCT00584714|angiography|angiography
1548675|NCT00584714|clinical outcomes|clinical outcomes
1548676|NCT00584688|anorexia|anorexia
1548677|NCT00584688|nervosa|nervosa
1548678|NCT00584688|eating|eating
1548679|NCT00584688|disorder|disorder
1548680|NCT00584688|study|study
1548681|NCT00584688|research|research
1548682|NCT00584688|clinical|clinical
1548683|NCT00584688|trial|trial
1548684|NCT00584688|psychiatry|psychiatry
1548685|NCT00584688|psychiatric|psychiatric
1548686|NCT00584675|GERD|gerd
1548687|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
1548688|NCT00584662|Rhinitis|rhinitis
1548689|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
1548690|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
1548691|NCT00584649|Sinus Tachycardia|sinus tachycardia
1548692|NCT00584649|Palpitations|palpitations
1548693|NCT00584649|Fast Heart rate|fast heart rate
1548694|NCT00584636|child|child
1548695|NCT00584636|emergency department|emergency department
1548696|NCT00584623|dysphagia|dysphagia
1548697|NCT00584623|videofluoroscopy|videofluoroscopy
1548698|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
1548699|NCT00584610|Women's health|women's health
1548700|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
1548701|NCT00584597|Head and neck cancer|head and neck cancer
1548702|NCT00584597|TRAUMEEL|traumeel
1548703|NCT00584597|Mucositis|mucositis
1548704|NCT00584597|Radiation|radiation
1548705|NCT00584597|Oral cancer|oral cancer
1548706|NCT00584597|Inflammation of the mouth|inflammation of the mouth
1548707|NCT00584597|Homeopathic Medication|homeopathic medication
1548708|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
1548709|NCT00584558|Arrhythmia|arrhythmia
1548710|NCT00584558|Catheter Ablation|catheter ablation
1548711|NCT00584545|pharyngeal manometry|pharyngeal manometry
1548712|NCT00584545|videofluoroscopy|videofluoroscopy
1548713|NCT00584532|Localized|localized
1548714|NCT00584532|Prostate|prostate
1548715|NCT00584532|Cancer|cancer
1548716|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
1548717|NCT00584506|orbital fractures|orbital fractures
1548718|NCT00584467|GEM|gem
1548719|NCT00584467|Arteriosclerosis|arteriosclerosis
1548720|NCT00584467|biomarkers|biomarkers
1548721|NCT00584467|Atherosclerosis|atherosclerosis
1548722|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
1548723|NCT00584428|Breast Cancer|breast cancer
1548724|NCT00584428|Cancer Treatment|cancer treatment
1548725|NCT00584428|Breast Cancer Treatment|breast cancer treatment
1548726|NCT00584415|Catheter Ablation|catheter ablation
1548727|NCT00584415|Atrial Fibrillation|atrial fibrillation
1548728|NCT00584402|liver cancer|liver cancer
1548729|NCT00584389|Obesity|obesity
1548730|NCT00584389|Energy expenditure|energy expenditure
1548731|NCT00584389|Fatty acid|fatty acid
1548732|NCT00584389|Triglyceride|triglyceride
1548733|NCT00584376|Essential tremor|essential tremor
1548734|NCT00584376|tremor|tremor
1548735|NCT00584376|pregabalin|pregabalin
1548736|NCT00584376|lyrica|lyrica
1548737|NCT00584350|coronary angiogram|coronary angiogram
1548738|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
1548739|NCT00584337|tomography|tomography
1548740|NCT00584337|coronary artery disease|coronary artery disease
1548741|NCT00584337|Stress Test|stress test
1548742|NCT00584337|Coronary CT Angiography|coronary ct angiography
1548743|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
1548744|NCT00584337|Non invasive testing|non invasive testing
1548745|NCT00584324|elective surgery|elective surgery
1548746|NCT00584324|general anesthesia|general anesthesia
1548747|NCT00584324|implicit memory|implicit memory
1548748|NCT00584298|Barostat|barostat
1548749|NCT00584298|distention|distention
1548750|NCT00584298|IBS|ibs
1548751|NCT00584298|irritable|irritable
1548752|NCT00584298|bowel|bowel
1548753|NCT00584298|syndrome|syndrome
1548754|NCT00584298|colorectal|colorectal
1548755|NCT00584298|sensation|sensation
1548756|NCT00584298|modulation|modulation
1548757|NCT00584298|reproducibility|reproducibility
1548758|NCT00584272|cleft palate|cleft palate
1548759|NCT00584272|suture materials|suture materials
1548760|NCT00584259|GERD|gerd
1548761|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
1548762|NCT00584246|Restless legs syndrome|restless legs syndrome
1548763|NCT00584246|RLS|rls
1548764|NCT00584246|Pregabalin|pregabalin
1548765|NCT00584246|Lyrica|lyrica
1548766|NCT00584233|breast cancer|breast cancer
1548767|NCT00584220|Astigmatism|astigmatism
1548768|NCT00584220|vision|vision
1548769|NCT00584220|comfort|comfort
1548770|NCT00584220|satisfaction|satisfaction
1548771|NCT00584220|contact lenses|contact lenses
1548772|NCT00584207|uterine fibroids|uterine fibroids
1548773|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
1548774|NCT00584168|UPPP|uppp
1548775|NCT00584168|Dexamethasone|dexamethasone
1548776|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
1548777|NCT00584168|Pain Management|pain management
1548778|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
1548779|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
1548780|NCT00584155|Lactated Ringer's|lactated ringer's
1548781|NCT00584155|Ear Cancer|ear cancer
1548782|NCT00584155|Hearing loss|hearing loss
1548783|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
1548784|NCT00584142|breast cancer|breast cancer
1548785|NCT00584142|survivors|survivors
1548786|NCT00584129|Cancer|cancer
1548787|NCT00584129|Dysphagia|dysphagia
1548788|NCT00584129|Radiation|radiation
1548918|NCT00583622|Gemcitabine|gemcitabine
1548789|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
1548790|NCT00584116|Aortic Valve Replacement|aortic valve replacement
1548791|NCT00584116|AVR|avr
1548792|NCT00584103|transradial amputation|transradial amputation
1548793|NCT00584103|prosthesis|prosthesis
1548794|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
1548795|NCT00584103|inexpensive|inexpensive
1548796|NCT00584103|custom prosthesis|custom prosthesis
1548797|NCT00584103|adult transradial amputation|adult transradial amputation
1548798|NCT00584090|urinary incontinence|urinary incontinence
1548799|NCT00584090|parkinson's disease|parkinson's disease
1548800|NCT00584090|vesicare|vesicare
1548801|NCT00584090|solifenacin succinate|solifenacin succinate
1548802|NCT00584064|patent|patent
1548803|NCT00584064|foramen|foramen
1548805|NCT00584064|PFO|pfo
1548806|NCT00584051|Control group|control group
1548807|NCT00584038|contraceptive compliance|contraceptive compliance
1548808|NCT00584038|educational intervention|educational intervention
1548809|NCT00584038|oral contraception|oral contraception
1548810|NCT00584025|Parkinson's disease|parkinson's disease
1548811|NCT00584025|dyskinesia|dyskinesia
1548812|NCT00584025|levetiracetam|levetiracetam
1548813|NCT00584025|keppra|keppra
1548814|NCT00584012|Any cancer|any cancer
1548815|NCT00584012|Breast cancer|breast cancer
1548816|NCT00584012|Lovastatin|lovastatin
1548817|NCT00584012|Docetaxel|docetaxel
1548818|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
1548819|NCT00583986|top mounted|top mounted
1548820|NCT00583986|actuation indicator|actuation indicator
1548821|NCT00583986|Asthma|asthma
1548822|NCT00583986|COPD|copd
1548823|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1548824|NCT00583960|swallowing problems|swallowing problems
1548825|NCT00583960|tracheal stenosis|tracheal stenosis
1548826|NCT00583947|Asthma|asthma
1548827|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
1548828|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
1548829|NCT00583921|Atrial Fibrillation|atrial fibrillation
1548830|NCT00583921|ICD|icd
1548831|NCT00583921|BiV ICD|biv icd
1548832|NCT00583921|CHF|chf
1548833|NCT00583921|Congestive Heart Failure|congestive heart failure
1548834|NCT00583921|AF|af
1548835|NCT00583908|astigmatism|astigmatism
1548836|NCT00583908|orientation|orientation
1548837|NCT00583908|visual acuity|visual acuity
1548838|NCT00583908|contact lenses|contact lenses
1548840|NCT00583895|atopic|atopic
1548841|NCT00583895|ImCOOH|imcooh
1548842|NCT00583895|safety|safety
1548843|NCT00583895|tolerability|tolerability
1548844|NCT00583895|efficacy|efficacy
1548845|NCT00583895|pharmacokinetics|pharmacokinetics
1548846|NCT00583882|Central Venous Catheter|central venous catheter
1548847|NCT00583882|Guidewire|guidewire
1548848|NCT00583882|Burn|burn
1548849|NCT00583869|Post-operative Pain|post-operative pain
1548850|NCT00583869|Fracture Patients|fracture patients
1548851|NCT00583869|Pregabalin|pregabalin
1548852|NCT00583869|LYRICA|lyrica
1548853|NCT00583856|computer aided design|computer aided design
1548854|NCT00583856|maxillofacial fracture|maxillofacial fracture
1548855|NCT00583856|orbital design|orbital design
1548856|NCT00583843|Lumpectomy|lumpectomy
1548857|NCT00583843|Ultrasonography|ultrasonography
1548858|NCT00583843|Radiotherapy|radiotherapy
1548859|NCT00583830|Lung Cancer|lung cancer
1548860|NCT00583804|Spinal Cord Injury|spinal cord injury
1548861|NCT00583804|Tetraplegia|tetraplegia
1548862|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
1548863|NCT00583804|Neuroprosthesis|neuroprosthesis
1548864|NCT00583791|muscular|muscular
1548865|NCT00583791|ventricular|ventricular
1548866|NCT00583791|septal|septal
1548867|NCT00583791|defects|defects
1548868|NCT00583791|VSD|vsd
1548869|NCT00583778|Asthma|asthma
1548870|NCT00583778|Bronchodilators|bronchodilators
1548871|NCT00583778|Levalbuterol|levalbuterol
1548872|NCT00583778|Ipratropium|ipratropium
1548873|NCT00583765|Kidney Failure, Acute|kidney failure, acute
1548874|NCT00583765|Hemodialysis|hemodialysis
1548875|NCT00583765|Hemofiltration|hemofiltration
1548876|NCT00583765|Anticoagulation|anticoagulation
1548877|NCT00583765|Citrate|citrate
1548878|NCT00583752|prostate cancer|prostate cancer
1548879|NCT00583752|vaccine|vaccine
1548880|NCT00583752|immunotherapy|immunotherapy
1548881|NCT00583739|Fatigue|fatigue
1548882|NCT00583739|Yoga|yoga
1548883|NCT00583739|Anxiety|anxiety
1548884|NCT00583739|Quality of Life|quality of life
1548885|NCT00583726|chemotherapy|chemotherapy
1548886|NCT00583726|exercise|exercise
1548887|NCT00583726|diet|diet
1548888|NCT00583726|fruit|fruit
1548889|NCT00583726|vegetables|vegetables
1548890|NCT00583726|low-fat|low-fat
1548891|NCT00583700|Breast Neoplasms|breast neoplasms
1548892|NCT00583700|Radiotherapy|radiotherapy
1548893|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
1548894|NCT00583687|Changing vascular tone|changing vascular tone
1548895|NCT00583687|Tissue Oxymetry|tissue oxymetry
1548896|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
1548897|NCT00583674|Gastric Cancer|gastric cancer
1548898|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
1548899|NCT00583674|AMG 386|amg 386
1548900|NCT00583674|Cisplatin|cisplatin
1548901|NCT00583674|Capecitabine|capecitabine
1548902|NCT00583661|Ventricular Assist Device|ventricular assist device
1548903|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
1548904|NCT00583648|urinary tract infections|urinary tract infections
1548905|NCT00583648|urine|urine
1548906|NCT00583648|urinalysis|urinalysis
1548907|NCT00583648|urine protocols|urine protocols
1548908|NCT00583648|urinalysis protocols|urinalysis protocols
1548909|NCT00583648|nursing protocols|nursing protocols
1548910|NCT00583648|Emergency Department|emergency department
1548911|NCT00583635|Preeclampsia|preeclampsia
1548912|NCT00583635|Prevention|prevention
1548913|NCT00583635|Food Supplement|food supplement
1548914|NCT00583622|Ovarian Cancer|ovarian cancer
1548915|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
1548916|NCT00583622|Bevacizumab|bevacizumab
1548917|NCT00583622|Carboplatin|carboplatin
1548919|NCT00583622|Docetaxel|docetaxel
1548920|NCT00583622|Melphalan|melphalan
1548921|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
1548922|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
1548924|NCT00583544|Healthy|healthy
1548925|NCT00583544|Healthy Volunteers|healthy volunteers
1548926|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
1548927|NCT00583531|Pouchitis|pouchitis
1548928|NCT00583531|Ulcerative Colitis|ulcerative colitis
1548929|NCT00583505|membranous|membranous
1548930|NCT00583505|ventricular|ventricular
1548931|NCT00583505|septal|septal
1548932|NCT00583505|defects|defects
1548934|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
1548935|NCT00583492|Prostate Cancer|prostate cancer
1548936|NCT00583492|Adenocarinomas|adenocarinomas
1548937|NCT00583492|Tumors of the Prostate|tumors of the prostate
1548938|NCT00583492|Gene Therapy|gene therapy
1548939|NCT00583492|IMRT|imrt
1548940|NCT00583466|submucosal cushion|submucosal cushion
1548941|NCT00583466|polypectomy|polypectomy
1548942|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
1548943|NCT00583453|Tonsillectomy|tonsillectomy
1548944|NCT00583453|Analgesia|analgesia
1548945|NCT00583453|Pain measurement|pain measurement
1548946|NCT00583453|Celecoxib|celecoxib
1548947|NCT00583440|12-step|12-step
1548948|NCT00583440|mutual help|mutual help
1548949|NCT00583440|dual diagnosis|dual diagnosis
1548950|NCT00583440|serious mental illness|serious mental illness
1548951|NCT00583401|PFO|pfo
1548952|NCT00583401|stroke|stroke
1548953|NCT00583388|cardiology|cardiology
1548954|NCT00583388|preventive medicine|preventive medicine
1548955|NCT00583388|cardiovascular physiology|cardiovascular physiology
1548956|NCT00583388|healthy subjects|healthy subjects
1548957|NCT00583375|arthritis|arthritis
1548958|NCT00583375|ankle pain|ankle pain
1548959|NCT00583375|foot pain|foot pain
1548960|NCT00583375|hindfoot fracture|hindfoot fracture
1548961|NCT00583375|ankle fracture|ankle fracture
1548962|NCT00583362|SLE|sle
1548963|NCT00583362|Lupus|lupus
1548964|NCT00583349|Bladder Cancer|bladder cancer
1548965|NCT00583349|Chemotherapy|chemotherapy
1548966|NCT00583349|Bladder Neoplasms|bladder neoplasms
1548967|NCT00583310|Prehypertension|prehypertension
1548968|NCT00583297|Arrhythmia|arrhythmia
1548969|NCT00583297|Heart Failure|heart failure
1548970|NCT00583297|T-wave Alternans|t-wave alternans
1548971|NCT00583297|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
1548972|NCT00583297|Biological Markers|biological markers
1548973|NCT00583297|Molecular Genetics|molecular genetics
1548974|NCT00583297|Corus CAD|corus cad
1548975|NCT00583297|ASGES|asges
1548976|NCT00583297|Age/Sex/Gene Expression Score|age/sex/gene expression score
1548977|NCT00583297|Gene Expression|gene expression
1548978|NCT00583297|GES|ges
1548979|NCT00583297|CVD|cvd
1548980|NCT00583297|Precision Medicine|precision medicine
1548981|NCT00583297|Sudden Cardiac Death|sudden cardiac death
1548982|NCT00583297|Electrophysiology Study|electrophysiology study
1548983|NCT00583297|Cardiovascular Disease|cardiovascular disease
1548984|NCT00583297|ICD|icd
1548985|NCT00583297|EPS|eps
1548986|NCT00583297|SCD|scd
1548987|NCT00583297|TWA|twa
1548988|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
1548989|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
1548990|NCT00583284|ventricular tachycardia|ventricular tachycardia
1548991|NCT00583245|Osteoarthritis|osteoarthritis
1548992|NCT00583245|Gait training|gait training
1548993|NCT00583245|Knee pain|knee pain
1548994|NCT00583245|Rehabilitation|rehabilitation
1548995|NCT00583245|Physical Therapy|physical therapy
1548996|NCT00583232|Pediatric|pediatric
1548997|NCT00583232|Crohn's disease|crohn's disease
1548998|NCT00583232|protein metabolism|protein metabolism
1548999|NCT00583232|energy metabolism|energy metabolism
1549000|NCT00583206|sepsis|sepsis
1549001|NCT00583206|atrophy|atrophy
1549002|NCT00583206|muscle|muscle
1549003|NCT00583206|weakness|weakness
1549004|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
1549005|NCT00583193|Duloxetine|duloxetine
1549006|NCT00583193|Antidepressants|antidepressants
1549007|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
1549008|NCT00583180|hypoesthesia|hypoesthesia
1549009|NCT00583167|HIV|hiv
1549010|NCT00583167|AIDS|aids
1549011|NCT00583167|CNS|cns
1549012|NCT00583167|brain|brain
1549013|NCT00583167|affects|affects
1549014|NCT00583154|constipation|constipation
1549015|NCT00583154|laxative|laxative
1549016|NCT00583128|IBS|ibs
1549017|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
1549018|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
1549019|NCT00583102|AML|aml
1549020|NCT00583102|Lovastatin|lovastatin
1549021|NCT00583102|Cytarabine|cytarabine
1549022|NCT00583076|Pouchitis|pouchitis
1549023|NCT00583076|Active Pouchitis|active pouchitis
1549024|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
1549025|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
1549026|NCT00583037|Sleep quality|sleep quality
1549027|NCT00583037|Adult|adult
1549028|NCT00583037|Critical Care|critical care
1549029|NCT00583024|prostate cancer|prostate cancer
1549030|NCT00583024|vaccine|vaccine
1549031|NCT00583024|immunotherapy|immunotherapy
1549032|NCT00583011|Amniocentesis|amniocentesis
1549033|NCT00583011|Genetic amniocentesis|genetic amniocentesis
1549034|NCT00583011|Fetal lung maturity|fetal lung maturity
1549035|NCT00583011|Pain control|pain control
1549036|NCT00583011|Pregnancy|pregnancy
1549037|NCT00583011|High risk pregnancy|high risk pregnancy
1549038|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
1549039|NCT00582998|Calcaneus Fracture|calcaneus fracture
1549040|NCT00582998|Pilon Fracture|pilon fracture
1549041|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
1549042|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
1549043|NCT00582985|Tracon|tracon
1549044|NCT00582985|CD105|cd105
1549045|NCT00582985|Anti CD105|anti cd105
1549046|NCT00582985|TRC105|trc105
1549047|NCT00582985|Phase 1|phase 1
1549048|NCT00582985|Cancer|cancer
1549049|NCT00582985|Monoclonal antibody|monoclonal antibody
1549050|NCT00582985|Solid Tumor|solid tumor
1549051|NCT00582972|Calcium Absorption|calcium absorption
1549052|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
1549053|NCT00582972|Omeprazole|omeprazole
1549054|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
1549055|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
1549056|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
1549057|NCT00582959|radiology imaging|radiology imaging
1549058|NCT00582959|malignancy|malignancy
1549059|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
1549060|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
1549061|NCT00582933|Cancer|cancer
1549062|NCT00582933|Donors|donors
1549063|NCT00582933|Leukemia|leukemia
1549064|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
1549065|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1549066|NCT00582933|Lymphoma|lymphoma
1549067|NCT00582933|AML|aml
1549068|NCT00582933|ALL|all
1549069|NCT00582933|CML|cml
1549070|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
1549071|NCT00582933|Bone marrow transplant|bone marrow transplant
1549072|NCT00582920|osseous lesions|osseous lesions
1549073|NCT00582920|breast cancer|breast cancer
1549074|NCT00582920|metastatic breast cancer|metastatic breast cancer
1549075|NCT00582907|FMF|fmf
1549076|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
1549077|NCT00582907|Periodic fever syndromes|periodic fever syndromes
1549078|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
1549079|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
1549080|NCT00582907|colchicine|colchicine
1549081|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
1549082|NCT00582894|Hematologic diseases|hematologic diseases
1549083|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
1549084|NCT00582881|MCTD|mctd
1549085|NCT00582881|SLE|sle
1549086|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
1549087|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
1549088|NCT00582868|Cleaved-tau protein|cleaved-tau protein
1549089|NCT00582868|Brain oxygen tension level|brain oxygen tension level
1549090|NCT00582855|AQW051|aqw051
1549091|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
1549092|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
1549093|NCT00582842|Early Stage|early stage
1549094|NCT00582842|Localized|localized
1549095|NCT00582829|Colorectal|colorectal
1549096|NCT00582829|Cancer|cancer
1549097|NCT00582829|Screening|screening
1549098|NCT00582829|Intervention|intervention
1549099|NCT00582829|Family|family
1549100|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
1549101|NCT00582803|breast cancer|breast cancer
1549102|NCT00582803|germline mutation|germline mutation
1549103|NCT00582803|BRCA1|brca1
1549104|NCT00582803|BRCA2|brca2
1549105|NCT00582803|family history|family history
1549106|NCT00582803|genetic testing|genetic testing
1549107|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
1549108|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
1549109|NCT00582790|Renal Cell Cancer|renal cell cancer
1549110|NCT00582790|Metastatic|metastatic
1549111|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
1549112|NCT00582777|chronic renal disease|chronic renal disease
1549113|NCT00582777|hypertensive renal disease|hypertensive renal disease
1549114|NCT00582777|African Americans|african americans
1549115|NCT00582777|ABPM|abpm
1549116|NCT00582764|Breast Lesion|breast lesion
1549117|NCT00582764|Lesion|lesion
1549118|NCT00582764|Breast|breast
1549119|NCT00582764|Cancer|cancer
1549120|NCT00582764|05-091|05-091
1549121|NCT00582751|Volumetric Analysis|volumetric analysis
1549122|NCT00582751|Multiple Diseases|multiple diseases
1549123|NCT00582738|Fibrosis progression|fibrosis progression
1549124|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
1549125|NCT00582738|viral infection|viral infection
1549126|NCT00582738|liver transplant recipients|liver transplant recipients
1549127|NCT00582738|everolimus|everolimus
1549128|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
1549129|NCT00582725|DLBCL, Elderly|dlbcl, elderly
1549130|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
1549131|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
1549132|NCT00582712|lithium|lithium
1549133|NCT00582699|Pancreatic Cancer|pancreatic cancer
1549134|NCT00582699|Pancreatic|pancreatic
1549135|NCT00582686|Calcaneus Fractures|calcaneus fractures
1549136|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
1549137|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
1549138|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
1549139|NCT00582634|non small cell lung cancer|non small cell lung cancer
1549140|NCT00582634|adjuvant|adjuvant
1549141|NCT00582634|cisplatin|cisplatin
1549142|NCT00582634|docetaxel|docetaxel
1549143|NCT00582621|Genetic Studies|genetic studies
1549144|NCT00582621|00-069|00-069
1549145|NCT00582621|blood|blood
1549146|NCT00582621|saliva|saliva
1549147|NCT00582621|buccal cell|buccal cell
1549148|NCT00582582|Metastatic|metastatic
1549149|NCT00582582|Hormone Refractory|hormone refractory
1549150|NCT00582582|Prostate Cancer|prostate cancer
1549151|NCT00582569|Breast lesion|breast lesion
1549152|NCT00582569|Spectroscopy|spectroscopy
1549153|NCT00582569|MRI|mri
1549154|NCT00582556|bone mineral density|bone mineral density
1549155|NCT00582543|Prostate Cancer|prostate cancer
1549156|NCT00582543|Prostate|prostate
1549157|NCT00582530|Prostate Cancer|prostate cancer
1549158|NCT00582530|Early Prostate Cancer|early prostate cancer
1549159|NCT00582530|Radical Prostatectomy|radical prostatectomy
1549160|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
1549161|NCT00582517|Knee Dislocation|knee dislocation
1549162|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
1549163|NCT00582517|External Brace|external brace
1549164|NCT00582504|Encephalitis,VEE|encephalitis,vee
1549165|NCT00582491|Modafinil|modafinil
1549166|NCT00582491|Sleep|sleep
1549167|NCT00582491|Cognition|cognition
1549168|NCT00582491|Cocaine Dependence|cocaine dependence
1549169|NCT00582478|Breast cancer|breast cancer
1549170|NCT00582478|Quality of Life|quality of life
1549171|NCT00582452|HNPCC|hnpcc
1549172|NCT00582452|prophylactic colectomy|prophylactic colectomy
1549173|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
1549174|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
1549175|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
1549176|NCT00582439|Bone Graft|bone graft
1549177|NCT00582426|Colorectal cancer|colorectal cancer
1549178|NCT00582426|diarrhea|diarrhea
1549179|NCT00582426|drug therapy|drug therapy
1549180|NCT00582426|octreotide|octreotide
1549181|NCT00582426|fluorouracil|fluorouracil
1549182|NCT00582426|irinotecan|irinotecan
1549183|NCT00582426|capecitabine|capecitabine
1549184|NCT00582426|prevention|prevention
1549185|NCT00582413|Head and Neck Cancer|head and neck cancer
1549186|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
1549187|NCT00582374|Periodontal Disease|periodontal disease
1549188|NCT00582374|Preterm Birth|preterm birth
1549189|NCT00582374|Low Birth Weight|low birth weight
1549190|NCT00582374|Pregnancy|pregnancy
1549191|NCT00582361|Open Fractures|open fractures
1549192|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
1549193|NCT00582361|Irrigation and Debridement|irrigation and debridement
1549194|NCT00582348|Lung Cancer|lung cancer
1549195|NCT00582348|Survivor|survivor
1549196|NCT00582348|Lung|lung
1549197|NCT00582335|Colorectal cancer|colorectal cancer
1549198|NCT00582335|Genetic testing|genetic testing
1549199|NCT00582335|Genetic mutations|genetic mutations
1549200|NCT00582322|Breast Cancer|breast cancer
1549201|NCT00582322|Ovarian Cancer|ovarian cancer
1549202|NCT00582322|Family History|family history
1549203|NCT00582322|Genetic Studies|genetic studies
1549204|NCT00582309|Glycemic Control|glycemic control
1549205|NCT00582309|Intravenous Infusion|intravenous infusion
1549206|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
1549207|NCT00582309|Infusion|infusion
1549208|NCT00582309|Critically Ill|critically ill
1549209|NCT00582296|Lynch syndrome|lynch syndrome
1549210|NCT00582296|04-144|04-144
1549211|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
1549212|NCT00582270|follicular|follicular
1549213|NCT00582270|non-follicular|non-follicular
1549214|NCT00582270|infectious disease|infectious disease
1549215|NCT00582257|Gastric Cancer|gastric cancer
1549216|NCT00582257|Stomach Cancer|stomach cancer
1549218|NCT00582244|Menopausal symptoms|menopausal symptoms
1549219|NCT00582244|Quality of Life|quality of life
1549220|NCT00582244|Breast cancer|breast cancer
1549221|NCT00582244|Multicenter trial|multicenter trial
1549222|NCT00582231|Penile injection therapy|penile injection therapy
1549223|NCT00582231|Erectile dysfunction|erectile dysfunction
1549224|NCT00582231|Radical pelvic surgery|radical pelvic surgery
1549225|NCT00582231|Penile Injection Anxiety|penile injection anxiety
1549226|NCT00582218|HIV/AIDS|hiv/aids
1549227|NCT00582218|Access to care|access to care
1549228|NCT00582205|Ovarian Cancer|ovarian cancer
1549229|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
1549230|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
1549231|NCT00582205|Uterine Cancer|uterine cancer
1549232|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
1549233|NCT00582205|IP Chemotherapy|ip chemotherapy
1549234|NCT00582205|Gynecologic Cancer|gynecologic cancer
1549235|NCT00582205|Women's Cancer|women's cancer
1549236|NCT00582205|Cisplatin|cisplatin
1549237|NCT00582205|Paclitaxel|paclitaxel
1549238|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
1549239|NCT00582192|Phase I trial|phase i trial
1549240|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
1549241|NCT00582179|Draining Hematoma|draining hematoma
1549242|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
1549243|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
1549244|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
1549245|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma|zevalin, high tumor burden indolent non-hodgkin's lymphoma
1549246|NCT00582140|Prostate|prostate
1549247|NCT00582140|Cancer|cancer
1549248|NCT00582140|Stage D0|stage d0
1549249|NCT00582140|Non-Metastatic|non-metastatic
1549250|NCT00582140|Rising PSA|rising psa
1549251|NCT00582127|senile|senile
1549252|NCT00582127|dementia|dementia
1549253|NCT00582114|Hemodialysis|hemodialysis
1549254|NCT00582114|Hypertension|hypertension
1549255|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
1549256|NCT00582101|HIV|hiv
1549257|NCT00582101|prevention|prevention
1549258|NCT00582101|families|families
1549259|NCT00582101|Latinos|latinos
1549260|NCT00582101|communication|communication
1549261|NCT00582101|sexuality|sexuality
1549262|NCT00582101|monitoring|monitoring
1549263|NCT00582101|health promotion|health promotion
1549264|NCT00582101|HIV Prevention|hiv prevention
1549265|NCT00582101|HIV Seronegativity|hiv seronegativity
1549266|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
1549267|NCT00582075|Cancer|cancer
1549268|NCT00582075|Brain metastases|brain metastases
1549269|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
1549270|NCT00582075|Temodar|temodar
1549271|NCT00582075|Temozolomide|temozolomide
1549272|NCT00582062|Gastric Cancer|gastric cancer
1549273|NCT00582062|Pancreatic cancer|pancreatic cancer
1549274|NCT00582049|Retinoblastoma|retinoblastoma
1549275|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
1549276|NCT00582049|Paternal exposures|paternal exposures
1549277|NCT00582036|Hyperglycemia|hyperglycemia
1549278|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1549279|NCT00582036|Bone marrow transplant|bone marrow transplant
1549280|NCT00582036|High blood sugar|high blood sugar
1549281|NCT00582023|HIV|hiv
1549282|NCT00582023|coping|coping
1549283|NCT00582023|emotion|emotion
1549284|NCT00582023|affect|affect
1549285|NCT00582023|HIV infection|hiv infection
1549286|NCT00582023|Complimentary therapies|complimentary therapies
1549287|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
1549288|NCT00582010|nitric oxide|nitric oxide
1549289|NCT00582010|inflammation|inflammation
1549290|NCT00582010|cell-death|cell-death
1549291|NCT00582010|Liver-function post transplantation|liver-function post transplantation
1549292|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
1549293|NCT00581984|breast cancer|breast cancer
1549294|NCT00581984|breast reconstruction|breast reconstruction
1549295|NCT00581984|silicone implants|silicone implants
1549296|NCT00581971|Radiosensitization|radiosensitization
1549297|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
1549298|NCT00581971|Celecoxib|celecoxib
1549299|NCT00581971|Head and Neck Cancer|head and neck cancer
1549300|NCT00581971|Chemoradiation|chemoradiation
1549301|NCT00581958|total body irradiation|total body irradiation
1549302|NCT00581958|Cancer|cancer
1549303|NCT00581958|Hematopoietic System|hematopoietic system
1549304|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
1549305|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
1549306|NCT00581906|Head and Neck Cancer|head and neck cancer
1549307|NCT00581906|Head Cancer|head cancer
1549308|NCT00581906|Neck Cancer|neck cancer
1549309|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
1549310|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1549311|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
1549312|NCT00581906|06-007|06-007
1549313|NCT00581893|epilepsy|epilepsy
1549314|NCT00581893|cognitive impairment|cognitive impairment
1549315|NCT00581893|driving simulation|driving simulation
1549316|NCT00581893|cross-over study|cross-over study
1549317|NCT00581880|end stage|end stage
1549318|NCT00581880|Terminally Ill|terminally ill
1549319|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
1549320|NCT00581841|Healthy adult normals|healthy adult normals
1549321|NCT00581828|Calcium Absorption|calcium absorption
1549322|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
1549323|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
1549324|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
1549325|NCT00581828|Hypovitaminosis D|hypovitaminosis d
1549326|NCT00581828|Vitamin D|vitamin d
1549327|NCT00581828|Bone Mineral Density|bone mineral density
1549328|NCT00581828|Physical Function|physical function
1549329|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1549330|NCT00581802|Treatment Naive|treatment naive
1549331|NCT00581802|Latent HIV Infections|latent hiv infections
1549332|NCT00581789|non small cell lung cancer|non small cell lung cancer
1549333|NCT00581789|sunitinib|sunitinib
1549334|NCT00581789|erlotinib|erlotinib
1549335|NCT00581789|phase 1|phase 1
1549336|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
1549337|NCT00581750|Biopsy|biopsy
1549338|NCT00581750|Breast|breast
1549339|NCT00581750|01-135|01-135
1549340|NCT00581724|breast cancer|breast cancer
1549341|NCT00581724|Colorectal cancer|colorectal cancer
1549342|NCT00581724|Prostate cancer|prostate cancer
1549343|NCT00581724|Head and Neck cancer|head and neck cancer
1549344|NCT00581724|Lung cancer|lung cancer
1549345|NCT00581724|cancer survivors|cancer survivors
1549346|NCT00581724|07-068|07-068
1549347|NCT00581724|quality of life|quality of life
1549348|NCT00581724|Pain in cancer survivors|pain in cancer survivors
1549349|NCT00581711|Electronic Health Record|electronic health record
1549350|NCT00581711|Clinical Decision Support|clinical decision support
1549351|NCT00581711|Otitis Media|otitis media
1549352|NCT00581698|Melanoma|melanoma
1549353|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
1549354|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
1549355|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
1549356|NCT00581685|Chronic pain|chronic pain
1549357|NCT00581685|Preemptive analgesia|preemptive analgesia
1549358|NCT00581685|Pregabalin|pregabalin
1549359|NCT00581685|Celecoxib|celecoxib
1549360|NCT00581685|Hip Arthroplasty|hip arthroplasty
1549361|NCT00581685|Osteoarthritis|osteoarthritis
1549362|NCT00581672|Anxiety|anxiety
1549363|NCT00581672|Black men|black men
1549364|NCT00581672|Prostate Cancer|prostate cancer
1549365|NCT00581672|07-125|07-125
1549366|NCT00581633|saline|saline
1549367|NCT00581633|sodium|sodium
1549368|NCT00581633|kidney|kidney
1549369|NCT00581633|tachycardia|tachycardia
1549370|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
1549371|NCT00581607|Sarcoidosis|sarcoidosis
1549569|NCT00580697|Frequency|frequency
1549372|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
1549373|NCT00581594|Posterior wall defects|posterior wall defects
1549374|NCT00581594|Graft-augmented repair|graft-augmented repair
1549375|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
1549376|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
1549377|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
1549378|NCT00581581|head cooling|head cooling
1549379|NCT00581581|neonatal asphyxia|neonatal asphyxia
1549380|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
1549381|NCT00581555|Psoriasis|psoriasis
1549382|NCT00581529|breast|breast
1549383|NCT00581516|Prostate Cancer|prostate cancer
1549384|NCT00581516|PCA3|pca3
1549385|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
1549386|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
1549387|NCT00581490|Premature pubarche|premature pubarche
1549388|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
1549389|NCT00581490|Metabolic syndrome|metabolic syndrome
1549390|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
1549391|NCT00581477|blood pressure|blood pressure
1549392|NCT00581477|congenital|congenital
1549393|NCT00581477|orthostasis|orthostasis
1549394|NCT00581477|catecholamines|catecholamines
1549395|NCT00581464|Smoking cessation|smoking cessation
1549396|NCT00581464|Tobacco dependence|tobacco dependence
1549397|NCT00581464|Mindfulness|mindfulness
1549398|NCT00581464|fMRI|fmri
1549399|NCT00581464|Craving|craving
1549400|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
1549401|NCT00581425|BCC|bcc
1549402|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
1549403|NCT00581425|Intron-A|intron-a
1549404|NCT00581425|Aldara|aldara
1549405|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
1549406|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
1549407|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
1549408|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
1549409|NCT00581399|Open heart surgery|open heart surgery
1549410|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
1549411|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1549412|NCT00581399|Chest Tube|chest tube
1549413|NCT00581399|Valve Replacement|valve replacement
1549414|NCT00581399|Valve Repair|valve repair
1549415|NCT00581386|Endotracheal Intubation|endotracheal intubation
1549416|NCT00581386|Supraglottic Airway|supraglottic airway
1549417|NCT00581373|water|water
1549418|NCT00581373|orthostatic hypotension|orthostatic hypotension
1549419|NCT00581373|blood pressure|blood pressure
1549420|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
1549421|NCT00581360|bortezomib|bortezomib
1549422|NCT00581360|doxorubicin|doxorubicin
1549423|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
1549424|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
1549425|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
1549426|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
1549427|NCT00581321|water|water
1549428|NCT00581321|blood pressure|blood pressure
1549429|NCT00581321|vascular resistance|vascular resistance
1549430|NCT00581321|cardiac transplantation|cardiac transplantation
1549431|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
1549432|NCT00581295|internal bleeding|internal bleeding
1549433|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
1549434|NCT00581282|Cocaine abstinence|cocaine abstinence
1549435|NCT00581282|PET scan|pet scan
1549436|NCT00581256|left sided|left sided
1549437|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
1549438|NCT00581230|Endotracheal Intubation|endotracheal intubation
1549439|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
1549440|NCT00581217|Burn injury|burn injury
1549441|NCT00581217|Skin graft|skin graft
1549442|NCT00581217|Donor site dressing|donor site dressing
1549443|NCT00581217|Outcomes|outcomes
1549444|NCT00581217|Infection rate|infection rate
1549445|NCT00581217|Healing time|healing time
1549446|NCT00581217|Cosmetic Result|cosmetic result
1549447|NCT00581217|Pain|pain
1549448|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
1549449|NCT00581204|trauma situations|trauma situations
1549450|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
1549452|NCT00581191|Healthy|healthy
1549453|NCT00581178|Ureteral Stent|ureteral stent
1549454|NCT00581178|Kidney Stones|kidney stones
1549455|NCT00581152|TBX3|tbx3
1549456|NCT00581126|BENEFIX|benefix
1549457|NCT00581126|Hemophilia B|hemophilia b
1549458|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
1549459|NCT00581113|neural stem cell|neural stem cell
1549460|NCT00581113|brain metastases|brain metastases
1549461|NCT00581113|radiosurgery|radiosurgery
1549462|NCT00581100|Nail Psoriasis|nail psoriasis
1549463|NCT00581100|Plaque Psoriasis|plaque psoriasis
1549464|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
1549465|NCT00581087|DHEA|dhea
1549466|NCT00581087|six-minute walk test|six-minute walk test
1549467|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
1549468|NCT00581074|obesity|obesity
1549469|NCT00581074|diet|diet
1549470|NCT00581074|weight loss|weight loss
1549471|NCT00581074|metabolic syndrome|metabolic syndrome
1549472|NCT00581061|Incontinence|incontinence
1549473|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
1549474|NCT00581048|Asthma|asthma
1549475|NCT00581048|Allergy|allergy
1549476|NCT00581048|Atopy|atopy
1549477|NCT00581048|Vitamin E|vitamin e
1549478|NCT00581048|GSTP1|gstp1
1549479|NCT00581048|Oxidative stress|oxidative stress
1549480|NCT00581035|Meningococcal disease|meningococcal disease
1549481|NCT00581035|pneumococcal disease|pneumococcal disease
1549482|NCT00581035|meningitis|meningitis
1549483|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
1549484|NCT00581022|sleep|sleep
1549485|NCT00581022|insomnia|insomnia
1549486|NCT00581009|Sleep deprivation|sleep deprivation
1549487|NCT00581009|antidepressant|antidepressant
1549488|NCT00581009|depression|depression
1549489|NCT00581009|chronobiological|chronobiological
1549490|NCT00580996|water|water
1549491|NCT00580996|orthostatic hypotension|orthostatic hypotension
1549492|NCT00580996|blood pressure|blood pressure
1549493|NCT00580983|Head and Neck cancer|head and neck cancer
1549494|NCT00580970|prostate cancer|prostate cancer
1549495|NCT00580970|radiation therapy|radiation therapy
1549496|NCT00580970|lovastatin|lovastatin
1549497|NCT00580970|rectal injury|rectal injury
1549498|NCT00580957|Obesity|obesity
1549499|NCT00580957|Hypertension|hypertension
1549500|NCT00580957|Autonomic Nervous System|autonomic nervous system
1549501|NCT00580944|Port wine stain|port wine stain
1549502|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
1549503|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
1549504|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
1549505|NCT00580918|fMRI|fmri
1549506|NCT00580905|Adenosine|adenosine
1549507|NCT00580905|Cytokines|cytokines
1549508|NCT00580905|Inflammation|inflammation
1549509|NCT00580905|VEGF|vegf
1549510|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
1549511|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
1549512|NCT00580879|Sphincter tear|sphincter tear
1549513|NCT00580866|Elbow|elbow
1549514|NCT00580866|Upper Extremity Fractures|upper extremity fractures
1549515|NCT00580866|Distal Humerus|distal humerus
1549516|NCT00580866|Elbow Injuries|elbow injuries
1549517|NCT00580866|Dislocations|dislocations
1549518|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
1549519|NCT00580853|smoking lapse behavior|smoking lapse behavior
1549520|NCT00580853|smoking cessation|smoking cessation
1549521|NCT00580853|varenicline|varenicline
1549522|NCT00580853|bupropion|bupropion
1549523|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
1549524|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
1549525|NCT00580840|Joint Disease|joint disease
1549526|NCT00580840|Arthritis|arthritis
1549527|NCT00580840|Certolizumab pegol|certolizumab pegol
1549528|NCT00580840|Cimzia|cimzia
1549529|NCT00580814|Brookhaven|brookhaven
1549530|NCT00580814|ADHD|adhd
1549531|NCT00580814|Dopamine|dopamine
1549532|NCT00580814|methylphenidate|methylphenidate
1549534|NCT00580801|Hepatitis C|hepatitis c
1549535|NCT00580801|Telaprevir|telaprevir
1549536|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
1549537|NCT00580801|Pegasys|pegasys
1549538|NCT00580801|Ribavirin|ribavirin
1549539|NCT00580801|Copegus|copegus
1549540|NCT00580788|Endocrine System Diseases|endocrine system diseases
1549541|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
1549542|NCT00580788|Hormones|hormones
1549543|NCT00580788|Malignancy|malignancy
1549544|NCT00580788|Postmenopausal Women|postmenopausal women
1549545|NCT00580788|Bone metabolism|bone metabolism
1549546|NCT00580775|Menopause|menopause
1549547|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
1549548|NCT00580775|Sudden Cardiac Death|sudden cardiac death
1549549|NCT00580749|Pancreatitis|pancreatitis
1549550|NCT00580749|enteral feeding|enteral feeding
1549551|NCT00580749|distal jejunal feeding|distal jejunal feeding
1549552|NCT00580749|naso gastric feeding|naso gastric feeding
1549553|NCT00580749|pancreatic rest|pancreatic rest
1549554|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
1549555|NCT00580723|acne|acne
1549556|NCT00580723|rosacea|rosacea
1549557|NCT00580723|acne rosacea|acne rosacea
1549558|NCT00580723|papulopustular rosacea|papulopustular rosacea
1549559|NCT00580723|erythema|erythema
1549560|NCT00580723|telangiectasia|telangiectasia
1549561|NCT00580723|flushing|flushing
1549562|NCT00580710|type 1 diabetes|type 1 diabetes
1549563|NCT00580710|hypoglycemia|hypoglycemia
1549564|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
1549565|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
1549566|NCT00580697|Gynecologic malignancy|gynecologic malignancy
1549567|NCT00580697|Urinary incontinence|urinary incontinence
1549568|NCT00580697|Fecal incontinence|fecal incontinence
1549570|NCT00580697|Voiding dysfunction|voiding dysfunction
1549571|NCT00580697|Sexual dysfunction|sexual dysfunction
1549572|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
1549573|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
1549574|NCT00580658|Dystonia|dystonia
1549575|NCT00580645|alcohol|alcohol
1549576|NCT00580645|smoking cessation|smoking cessation
1549577|NCT00580645|varenicline|varenicline
1549578|NCT00580645|bupropion|bupropion
1549579|NCT00580645|smoking cessation medications|smoking cessation medications
1549580|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
1549581|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
1549582|NCT00580619|Autonomic nervous system|autonomic nervous system
1549583|NCT00580606|Food Allergy|food allergy
1549584|NCT00580606|Peanut Allergy|peanut allergy
1549585|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
1549586|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1549587|NCT00580593|ALS|als
1549588|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
1549589|NCT00580593|NIPPV|nippv
1549590|NCT00580593|forced vital capacity|forced vital capacity
1549591|NCT00580593|FVC|fvc
1549592|NCT00580567|Impulsivity|impulsivity
1549593|NCT00580567|Gambling|gambling
1549594|NCT00580567|Pathological Gamblers|pathological gamblers
1549595|NCT00580567|Problem Gamblers|problem gamblers
1549596|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
1549597|NCT00580567|Risk-taking|risk-taking
1549598|NCT00580567|Inhibition|inhibition
1549599|NCT00580567|Gambling Severity|gambling severity
1549600|NCT00580515|Cancer|cancer
1549601|NCT00580515|Randomized Controlled Trial|randomized controlled trial
1549602|NCT00580515|Family Therapy intervention|family therapy intervention
1549603|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
1549604|NCT00580489|helicopter|helicopter
1549605|NCT00580489|aeromedical|aeromedical
1549606|NCT00580489|pain relief|pain relief
1549607|NCT00580489|analgesia|analgesia
1549608|NCT00580489|fentanyl|fentanyl
1549609|NCT00580489|morphine|morphine
1549610|NCT00580489|adverse events|adverse events
1549611|NCT00580476|Breast Cancer|breast cancer
1549612|NCT00580476|Prostate Cancer|prostate cancer
1549613|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
1549614|NCT00580463|tissue collection|tissue collection
1549615|NCT00580385|BONE|bone
1549616|NCT00580359|Stomach Neoplasms|stomach neoplasms
1549617|NCT00580359|Secondary|secondary
1549618|NCT00580359|Combination chemotherapy|combination chemotherapy
1549619|NCT00580359|S-1|s-1
1549620|NCT00580359|Capecitabine|capecitabine
1549621|NCT00580346|Aspiration pneumonia|aspiration pneumonia
1549622|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
1549623|NCT00580346|Vocal cord closure|vocal cord closure
1549624|NCT00580346|Modified barium swallow|modified barium swallow
1549625|NCT00580333|ER negative|er negative
1549626|NCT00580333|PR negative|pr negative
1549627|NCT00580333|HER2 negative|her2 negative
1549628|NCT00580320|melanoma|melanoma
1549629|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
1549630|NCT00580320|APUD tumor|apud tumor
1549631|NCT00580320|dacarbazine|dacarbazine
1549632|NCT00580320|bortezomib|bortezomib
1549633|NCT00580320|velcade|velcade
1549634|NCT00580307|Headache|headache
1549635|NCT00580307|Rhinogenic|rhinogenic
1549636|NCT00580307|Nose|nose
1549637|NCT00580307|Nasal septum|nasal septum
1549638|NCT00580307|Deviated septum|deviated septum
1549639|NCT00580307|Surgery|surgery
1549640|NCT00580307|Septoplasty|septoplasty
1549641|NCT00580307|Turbinoplasty|turbinoplasty
1549642|NCT00580307|Contact point|contact point
1549643|NCT00580307|HIT-6|hit-6
1549644|NCT00580294|Sciatica|sciatica
1549749|NCT00579917|Bone Marrow|bone marrow
1549645|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
1549646|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
1549647|NCT00580294|Low Back Pain|low back pain
1549648|NCT00580294|Neck Pain|neck pain
1549649|NCT00580294|Headache|headache
1549650|NCT00580294|Back Pain|back pain
1549651|NCT00580294|Arthritis|arthritis
1549652|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
1549653|NCT00580294|Chronic Pain|chronic pain
1549654|NCT00580294|Contractures|contractures
1549655|NCT00580294|Diabetes|diabetes
1549656|NCT00580294|Fibromyalgia|fibromyalgia
1549657|NCT00580294|Foot Pain|foot pain
1549658|NCT00580294|Fracture|fracture
1549659|NCT00580294|Hip|hip
1549660|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
1549661|NCT00580294|Migraine|migraine
1549662|NCT00580294|Neuropathic Pain|neuropathic pain
1549663|NCT00580294|Osteoarthritis|osteoarthritis
1549664|NCT00580294|Osteoporosis|osteoporosis
1549665|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
1549666|NCT00580294|Scoliosis|scoliosis
1549667|NCT00580294|Nerve pain|nerve pain
1549668|NCT00580294|Opana|opana
1549669|NCT00580294|Opioid|opioid
1549670|NCT00580294|Opioid Rotation|opioid rotation
1549671|NCT00580294|Oxymorphone|oxymorphone
1549672|NCT00580294|Morphine|morphine
1549673|NCT00580294|neuropathic|neuropathic
1549674|NCT00580294|oxycodone|oxycodone
1549675|NCT00580281|Gastric cancer|gastric cancer
1549676|NCT00580281|Leukemia|leukemia
1549677|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1549678|NCT00580281|Imatinib|imatinib
1549679|NCT00580281|Gleevec|gleevec
1549680|NCT00580255|CHF|chf
1549681|NCT00580255|CRT|crt
1549682|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
1549683|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
1549684|NCT00580255|BioZ|bioz
1549685|NCT00580255|Optivol|optivol
1549686|NCT00580242|Myelodysplasia|myelodysplasia
1549687|NCT00580229|Rituxan|rituxan
1549688|NCT00580229|Rituximab|rituximab
1549689|NCT00580216|stroke|stroke
1549690|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
1549691|NCT00580203|HEENT cancers|heent cancers
1549692|NCT00580203|larynx|larynx
1549693|NCT00580203|thyroid|thyroid
1549694|NCT00580203|sarcoma|sarcoma
1549695|NCT00580203|specimen analysis|specimen analysis
1549696|NCT00580177|Inguinal hernia|inguinal hernia
1549697|NCT00580177|Randomized controlled trial|randomized controlled trial
1549698|NCT00580177|Surgery|surgery
1549699|NCT00580177|Complications|complications
1549700|NCT00580177|Surgical mesh|surgical mesh
1549701|NCT00580151|Pain not controled by morphine|pain not controled by morphine
1549702|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
1549703|NCT00580138|Deglutition Disorders|deglutition disorders
1549704|NCT00580138|Evaluation|evaluation
1549705|NCT00580138|Real-time internet|real-time internet
1549706|NCT00580112|Breast Neoplasms|breast neoplasms
1549707|NCT00580112|Trabectedin|trabectedin
1549708|NCT00580112|Yondelis|yondelis
1549709|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
1549710|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
1549711|NCT00580086|Breast cancer|breast cancer
1549712|NCT00580086|MR spectroscopy|mr spectroscopy
1549713|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1549714|NCT00580060|AJCC|ajcc
1549715|NCT00580060|stage|stage
1549716|NCT00580060|IIB|iib
1549717|NCT00580060|IIC|iic
1549718|NCT00580060|III|iii
1549719|NCT00580060|IV|iv
1549720|NCT00580060|Melanoma|melanoma
1549721|NCT00580060|HLA-A2+|hla-a2+
1549722|NCT00580060|Vaccine|vaccine
1549723|NCT00580047|bone density|bone density
1549724|NCT00580047|osteopenia|osteopenia
1549725|NCT00580047|transplant|transplant
1549726|NCT00580047|zoledronic acid|zoledronic acid
1549727|NCT00580047|alendronate|alendronate
1549728|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
1549729|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
1549730|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
1549731|NCT00580021|Breast Cancer|breast cancer
1549732|NCT00580021|Pancreatic Cancer|pancreatic cancer
1549733|NCT00580008|tomography|tomography
1549734|NCT00580008|coronary artery disease|coronary artery disease
1549735|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
1549736|NCT00580008|vein graft|vein graft
1549737|NCT00579982|Mood disorder|mood disorder
1549738|NCT00579943|very low birth weight infant|very low birth weight infant
1549739|NCT00579943|cerebral autoregulation|cerebral autoregulation
1549740|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
1549741|NCT00579943|carbon dioxide|carbon dioxide
1549742|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
1549743|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
1549744|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
1549745|NCT00579930|Bone|bone
1549746|NCT00579930|Soft Tissue|soft tissue
1549747|NCT00579917|Survivor|survivor
1549748|NCT00579917|Behavioral Intervention|behavioral intervention
1549750|NCT00579917|Stem Cell Transplantation|stem cell transplantation
1549751|NCT00579904|PCOS|pcos
1549752|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
1549753|NCT00579904|insulin resistance|insulin resistance
1549754|NCT00579904|fish oil|fish oil
1549755|NCT00579904|walnut-oil|walnut-oil
1549756|NCT00579904|walnuts|walnuts
1549757|NCT00579904|almonds|almonds
1549758|NCT00579904|monounsaturated fats|monounsaturated fats
1549759|NCT00579904|polyunsaturated fats|polyunsaturated fats
1549760|NCT00579904|MUFA|mufa
1549761|NCT00579904|PUFA|pufa
1549762|NCT00579891|colorectal cancer|colorectal cancer
1549763|NCT00579891|tissue collection|tissue collection
1549764|NCT00579865|Quality of Life|quality of life
1549765|NCT00579852|Lung|lung
1549766|NCT00579839|PreTerm Birth|preterm birth
1549767|NCT00579839|PreTerm Neonate|preterm neonate
1549768|NCT00579839|High risk pregnancy|high risk pregnancy
1549769|NCT00579839|Preterm Baby|preterm baby
1549770|NCT00579839|Premature Baby|premature baby
1549771|NCT00579839|Cord Clamping|cord clamping
1549772|NCT00579839|Milking the cord|milking the cord
1549773|NCT00579813|obesity|obesity
1549774|NCT00579813|inflammation|inflammation
1549775|NCT00579813|diabetes|diabetes
1549776|NCT00579800|Vibrant-DE|vibrant-de
1549777|NCT00579800|IDEAL|ideal
1549778|NCT00579800|MRI|mri
1549779|NCT00579800|Breast|breast
1549780|NCT00579800|07-091|07-091
1549781|NCT00579787|cervical cancer|cervical cancer
1549782|NCT00579787|quality of life assessment|quality of life assessment
1549783|NCT00579787|behavioral|behavioral
1549784|NCT00579774|Aging|aging
1549785|NCT00579774|oxidative stress|oxidative stress
1549786|NCT00579774|glycoxidative stress|glycoxidative stress
1549787|NCT00579774|glycation|glycation
1549788|NCT00579774|inflammation|inflammation
1549789|NCT00579774|nutrition|nutrition
1549790|NCT00579774|low AGE intake|low age intake
1549791|NCT00579774|dietary AGEs|dietary ages
1549792|NCT00579761|Endocarditis|endocarditis
1549793|NCT00579761|neurological deficit|neurological deficit
1549794|NCT00579748|OCT imaging|oct imaging
1549795|NCT00579748|Barrett's esophagus|barrett's esophagus
1549796|NCT00579735|Breast cancer|breast cancer
1549797|NCT00579709|Thymus Transplantation|thymus transplantation
1549798|NCT00579709|DiGeorge Anomaly|digeorge anomaly
1549799|NCT00579709|DiGeorge Syndrome|digeorge syndrome
1549800|NCT00579709|Athymia|athymia
1549801|NCT00579709|Low T cell numbers|low t cell numbers
1549802|NCT00579709|Immunoreconstitution|immunoreconstitution
1549803|NCT00579709|Immunodeficiency|immunodeficiency
1549804|NCT00579709|Complete DiGeorge|complete digeorge
1549805|NCT00579709|Typical DiGeorge|typical digeorge
1549806|NCT00579709|Atypical DiGeorge|atypical digeorge
1549807|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
1549808|NCT00579696|Multiple Diseases|multiple diseases
1549809|NCT00579696|Queens|queens
1549810|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
1549811|NCT00579683|NSCLC|nsclc
1549812|NCT00579683|metastatic disease|metastatic disease
1549813|NCT00579683|resistent disease|resistent disease
1549814|NCT00579683|RNA analysis|rna analysis
1549815|NCT00579683|04-103|04-103
1549816|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
1549817|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
1549818|NCT00579631|survivors|survivors
1549819|NCT00579631|adolescent|adolescent
1549820|NCT00579631|pediatric|pediatric
1549821|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
1549822|NCT00579618|aged 60 years or older|aged 60 years or older
1549823|NCT00579605|Breastfeeding|breastfeeding
1549824|NCT00579605|Self-efficacy|self-efficacy
1549825|NCT00579605|Motivational Interviewing|motivational interviewing
1549826|NCT00579579|Bowel function|bowel function
1549827|NCT00579579|Bladder function|bladder function
1549828|NCT00579579|Sexual function|sexual function
1549829|NCT00579579|Quality of life|quality of life
1549830|NCT00579566|Biochemical Determinants|biochemical determinants
1549831|NCT00579566|Molecular Determinants|molecular determinants
1549832|NCT00579553|Pre Term|pre term
1549833|NCT00579553|Pre Term Birth|pre term birth
1549834|NCT00579553|Premature Birth|premature birth
1549835|NCT00579553|Premature baby|premature baby
1549836|NCT00579553|High risk pregnancy|high risk pregnancy
1549837|NCT00579553|Progesterone|progesterone
1549838|NCT00579553|IM Progesterone|im progesterone
1549839|NCT00579553|Vaginal Progesterone|vaginal progesterone
1549840|NCT00579527|DiGeorge Anomaly|digeorge anomaly
1549841|NCT00579527|Thymus Transplantation|thymus transplantation
1549842|NCT00579527|DiGeorge Syndrome|digeorge syndrome
1549843|NCT00579527|Athymia|athymia
1549844|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
1549845|NCT00579527|Hypocalcemia|hypocalcemia
1549846|NCT00579527|Hypoparathyroidism|hypoparathyroidism
1549847|NCT00579527|Low T cell numbers|low t cell numbers
1549848|NCT00579527|Immunoreconstitution|immunoreconstitution
1549849|NCT00579527|Immunodeficiency|immunodeficiency
1549850|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
1549851|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
1549852|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
1549853|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
1549854|NCT00579501|Myxoid|myxoid
1549855|NCT00579501|Liposarcoma|liposarcoma
1549856|NCT00579501|Trabectedin|trabectedin
1549857|NCT00579501|Dexamethasone|dexamethasone
1549858|NCT00579475|mifepristone|mifepristone
1549859|NCT00579475|leiomyomas|leiomyomas
1549860|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
1549861|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
1549862|NCT00579449|child abuse|child abuse
1549863|NCT00579449|child neglect|child neglect
1549864|NCT00579436|inflammation|inflammation
1549865|NCT00579436|obesity|obesity
1549866|NCT00579436|diabetes|diabetes
1549867|NCT00579423|prostate|prostate
1549868|NCT00579423|cancer|cancer
1549869|NCT00579423|vaccine|vaccine
1549870|NCT00579410|gastric acid|gastric acid
1549871|NCT00579410|esophageal reflux|esophageal reflux
1549872|NCT00579410|peptic ulcer|peptic ulcer
1549873|NCT00579410|heartburn|heartburn
1549874|NCT00579397|Markers of Inflammation|markers of inflammation
1549875|NCT00579397|acute graft versus host disease|acute graft versus host disease
1549876|NCT00579397|predicting aGVHD|predicting agvhd
1549877|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
1549878|NCT00579384|Reflex epilepsy|reflex epilepsy
1549879|NCT00579384|Epilepsy|epilepsy
1549880|NCT00579384|JNJ-26489112|jnj-26489112
1549881|NCT00579371|islet transplantation|islet transplantation
1549882|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
1549883|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
1549884|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
1549885|NCT00579358|Congenital heart defects|congenital heart defects
1549886|NCT00579332|PSA|psa
1549887|NCT00579332|biochemical failure|biochemical failure
1549888|NCT00579319|breast cancer|breast cancer
1549889|NCT00579306|hypertension|hypertension
1549890|NCT00579306|stroke|stroke
1549891|NCT00579306|cerebrovascular accident|cerebrovascular accident
1549892|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
1549893|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
1549894|NCT00579280|Randomized|randomized
1549895|NCT00579280|Double-Blind|double-blind
1549896|NCT00579280|Placebo-Controlled|placebo-controlled
1549897|NCT00579280|Quetiapine|quetiapine
1549898|NCT00579280|DivalproexSodiumER|divalproexsodiumer
1549899|NCT00579280|Bipolar|bipolar
1549900|NCT00579280|Anxiety|anxiety
1549901|NCT00579280|Panic|panic
1549902|NCT00579280|GAD|gad
1549903|NCT00579267|MINI-KID|mini-kid
1549904|NCT00579267|structured diagnostic interview|structured diagnostic interview
1549905|NCT00579267|reliability and validity|reliability and validity
1549906|NCT00579267|K-SADS|k-sads
1549907|NCT00579267|Sheehan Disability Scale|sheehan disability scale
1549908|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
1549909|NCT00579228|Diabetes|diabetes
1549910|NCT00579228|Vascular risk|vascular risk
1549911|NCT00579228|Inflammation|inflammation
1549912|NCT00579215|Cancer|cancer
1549913|NCT00579215|Enhanced Care|enhanced care
1549914|NCT00579215|Decision-Making|decision-making
1549915|NCT00579215|Advance Lung Cancer|advance lung cancer
1549916|NCT00579215|Questionaires|questionaires
1549917|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
1549918|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
1549919|NCT00579202|Dialyzer|dialyzer
1549920|NCT00579189|ear tubes|ear tubes
1549921|NCT00579189|ear drainage|ear drainage
1549922|NCT00579189|ear infection|ear infection
1549923|NCT00579189|ear drops|ear drops
1549924|NCT00579163|Blood|blood
1549925|NCT00579163|Salvia|salvia
1549926|NCT00579163|Tissue|tissue
1549927|NCT00579150|Birth Defects|birth defects
1549928|NCT00579150|High Risk Pregnancy|high risk pregnancy
1549929|NCT00579150|Type 2 Diabetes|type 2 diabetes
1549930|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
1549931|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
1549932|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
1549933|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
1549934|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
1549935|NCT00579137|Fludarabine|fludarabine
1549936|NCT00579137|monoclonal antibodies|monoclonal antibodies
1549937|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
1549938|NCT00579124|T cell Depletion|t cell depletion
1549939|NCT00579124|Unrelated|unrelated
1549940|NCT00579124|Related|related
1549941|NCT00579124|Donor|donor
1549942|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
1549943|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
1549944|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1549945|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1549946|NCT00579111|Multiple Myeloma|multiple myeloma
1549947|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
1550144|NCT00578240|90-040|90-040
1549948|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
1549949|NCT00579111|Hematologic Diseases|hematologic diseases
1549950|NCT00579111|Fludarabine|fludarabine
1549951|NCT00579111|Busulfan|busulfan
1549952|NCT00579111|Campath|campath
1549953|NCT00579111|Alemtuzumab|alemtuzumab
1549954|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
1549955|NCT00579098|Atrial Fibrillation|atrial fibrillation
1549956|NCT00579098|Arrhythmia|arrhythmia
1549957|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
1549958|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
1549959|NCT00579098|Inflammation|inflammation
1549960|NCT00579098|Endothelial dysfunction|endothelial dysfunction
1549961|NCT00579072|Prostate|prostate
1549962|NCT00579072|cognitive effects|cognitive effects
1549963|NCT00579072|06-084|06-084
1549964|NCT00579046|Anemia|anemia
1549965|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1549966|NCT00579046|Erythropoietin|erythropoietin
1549967|NCT00579046|6-minute walk test|6-minute walk test
1549968|NCT00579033|somatosensory|somatosensory
1549969|NCT00579033|cortex|cortex
1549970|NCT00579033|neuroimaging|neuroimaging
1549971|NCT00579033|tactile|tactile
1549972|NCT00579033|cortical plasticity|cortical plasticity
1549973|NCT00579033|dystonia|dystonia
1549974|NCT00579020|cornea|cornea
1549975|NCT00579020|inflammation|inflammation
1549976|NCT00579020|blepharitis|blepharitis
1549977|NCT00579020|lid infection|lid infection
1549978|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
1549979|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
1549980|NCT00578994|Unicompartmental Knee|unicompartmental knee
1549981|NCT00578994|Partial Knee|partial knee
1549982|NCT00578994|Knee arthroplasty|knee arthroplasty
1549983|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
1549984|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
1549985|NCT00578981|Bone Loss|bone loss
1549986|NCT00578981|Low Bone Density|low bone density
1549987|NCT00578968|COPD|copd
1549988|NCT00578968|Tiotropium|tiotropium
1549989|NCT00578968|Spiriva|spiriva
1549990|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
1549991|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
1549992|NCT00578929|allergic rhinitis|allergic rhinitis
1549993|NCT00578929|allergies|allergies
1549994|NCT00578929|seasonal allergies|seasonal allergies
1549995|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
1549996|NCT00578903|Severe|severe
1549997|NCT00578890|diabetic foot|diabetic foot
1549998|NCT00578890|osteomyelitis|osteomyelitis
1549999|NCT00578877|Contraception|contraception
1550000|NCT00578877|SILCS Diaphragm|silcs diaphragm
1550001|NCT00578877|Contraceptive Gel|contraceptive gel
1550002|NCT00578864|Neuroblastoma|neuroblastoma
1550003|NCT00578864|Etoposide|etoposide
1550004|NCT00578864|Cisplatin|cisplatin
1550005|NCT00578864|Adriamycin|adriamycin
1550006|NCT00578864|Cyclophosphamide|cyclophosphamide
1550007|NCT00578864|Cytoxan|cytoxan
1550008|NCT00578851|Hip Arthroplasty|hip arthroplasty
1550009|NCT00578851|Hip Arthritis|hip arthritis
1550010|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
1550011|NCT00578799|ulcerative colitis|ulcerative colitis
1550012|NCT00578773|ear tubes|ear tubes
1550013|NCT00578773|ear infection|ear infection
1550014|NCT00578773|ear drops|ear drops
1550015|NCT00578773|ear tube surgery|ear tube surgery
1550016|NCT00578773|acute otitis media|acute otitis media
1550017|NCT00578760|hearing loss|hearing loss
1550018|NCT00578760|ototoxicity|ototoxicity
1550019|NCT00578760|cisplatin|cisplatin
1550020|NCT00578747|Breast Cancer|breast cancer
1550021|NCT00578747|Breast Neoplasms|breast neoplasms
1550022|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
1550023|NCT00578747|Mastectomy|mastectomy
1550025|NCT00578721|Colorectal cancer|colorectal cancer
1550026|NCT00578721|aspirin|aspirin
1550027|NCT00578708|membranous|membranous
1550028|NCT00578708|ventricular|ventricular
1550029|NCT00578708|septal|septal
1550030|NCT00578708|defect|defect
1550031|NCT00578708|VSD|vsd
1550032|NCT00578695|Hyponatremia|hyponatremia
1550033|NCT00578695|Serum Sodium|serum sodium
1550034|NCT00578695|Fluid Overload|fluid overload
1550035|NCT00578695|Heart Failure|heart failure
1550036|NCT00578695|Acute Heart Failure|acute heart failure
1550037|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
1550038|NCT00578669|Smoking Cessation|smoking cessation
1550039|NCT00578669|Tobacco Use Cessation|tobacco use cessation
1550040|NCT00578669|Antidepressants|antidepressants
1550041|NCT00578656|Food Allergy|food allergy
1550042|NCT00578656|Milk Allergy|milk allergy
1550043|NCT00578643|Stem Cell Transplant|stem cell transplant
1550044|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
1550045|NCT00578643|Fludarabine|fludarabine
1550046|NCT00578643|Busulfan|busulfan
1550047|NCT00578643|Cyclophosphamide|cyclophosphamide
1550048|NCT00578630|pediatric tumors|pediatric tumors
1550049|NCT00578630|genetic test development|genetic test development
1550143|NCT00578240|Clinical Metastases|clinical metastases
1550050|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
1550051|NCT00578617|Atrial fibrillation|atrial fibrillation
1550052|NCT00578617|Left Atrial Ablation|left atrial ablation
1550053|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
1550054|NCT00578617|Catheter Ablation|catheter ablation
1550055|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
1550056|NCT00578591|Graft Versus Host Disease|graft versus host disease
1550057|NCT00578591|GVHD|gvhd
1550058|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
1550059|NCT00578591|AHT|aht
1550060|NCT00578591|posttransplant|posttransplant
1550061|NCT00578591|Rituximab|rituximab
1550062|NCT00578578|Omega3 fatty acids|omega3 fatty acids
1550063|NCT00578578|hsCRP|hscrp
1550064|NCT00578578|CAD|cad
1550065|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
1550066|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
1550067|NCT00578565|Rheumatology|rheumatology
1550068|NCT00578565|Rituximab|rituximab
1550069|NCT00578552|tobacco|tobacco
1550070|NCT00578552|smoking|smoking
1550071|NCT00578552|gabapentin|gabapentin
1550072|NCT00578552|abstinence|abstinence
1550073|NCT00578539|Stem Cell Transplantation|stem cell transplantation
1550074|NCT00578526|urothelial cancer|urothelial cancer
1550075|NCT00578526|targeted therapy|targeted therapy
1550076|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
1550077|NCT00578526|SU011248|su011248
1550078|NCT00578526|clinical trial|clinical trial
1550079|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
1550080|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
1550081|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
1550082|NCT00578474|Acute otitis media|acute otitis media
1550083|NCT00578474|Tympanostomy tubes|tympanostomy tubes
1550084|NCT00578461|Stem Cell Transplant|stem cell transplant
1550085|NCT00578461|myeloproliferative disease|myeloproliferative disease
1550086|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
1550087|NCT00578461|Leukemia|leukemia
1550088|NCT00578461|Cancer|cancer
1550089|NCT00578461|Lymphoma|lymphoma
1550090|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
1550091|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
1550092|NCT00578435|ERYTHROPOIESIS|erythropoiesis
1550093|NCT00578435|Genetic Disorders|genetic disorders
1550094|NCT00578435|Sickle Cell Anemia|sickle cell anemia
1550095|NCT00578435|Thalassemia|thalassemia
1550096|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
1550097|NCT00578422|PAD|pad
1550098|NCT00578422|Peripheral Artery Disease|peripheral artery disease
1550099|NCT00578422|IVUS|ivus
1550100|NCT00578422|Plaque|plaque
1550101|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
1550102|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
1550103|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
1550104|NCT00578383|Depression|depression
1550105|NCT00578383|Major depression|major depression
1550106|NCT00578383|Bipolar Disorder|bipolar disorder
1550107|NCT00578383|Bipolar depression|bipolar depression
1550108|NCT00578383|LFMS|lfms
1550109|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
1550110|NCT00578383|mood disorders|mood disorders
1550111|NCT00578383|affective disorders|affective disorders
1550112|NCT00578370|Ciclosporin|ciclosporin
1550113|NCT00578370|Plaque type psoriasis|plaque type psoriasis
1550114|NCT00578370|Psoriasis plaque test|psoriasis plaque test
1550115|NCT00578370|Sonography|sonography
1550116|NCT00578370|Cyclosporin|cyclosporin
1550117|NCT00578370|Psoriasis|psoriasis
1550118|NCT00578357|problem gambling|problem gambling
1550119|NCT00578357|personalized feedback|personalized feedback
1550120|NCT00578357|gambling addiction|gambling addiction
1550121|NCT00578344|Sickle Cell Disease|sickle cell disease
1550122|NCT00578344|SCD|scd
1550123|NCT00578344|Hemoglobin SS|hemoglobin ss
1550124|NCT00578344|Hemoglobin SC|hemoglobin sc
1550125|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
1550126|NCT00578344|HLA genotype|hla genotype
1550127|NCT00578344|Severe anemia|severe anemia
1550128|NCT00578344|Transfusion therapy|transfusion therapy
1550129|NCT00578331|rhinitis|rhinitis
1550130|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
1550131|NCT00578331|allergic rhinitis|allergic rhinitis
1550132|NCT00578292|transfusion-dependent|transfusion-dependent
1550133|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
1550134|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
1550135|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
1550136|NCT00578292|iron chelating agents|iron chelating agents
1550137|NCT00578292|severe|severe
1550138|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
1550139|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
1550140|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
1550141|NCT00578240|benign|benign
1550142|NCT00578240|Rising PSA|rising psa
1550145|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
1550146|NCT00578227|cervical cancer|cervical cancer
1550147|NCT00578227|HPV vaccine,|hpv vaccine,
1550148|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
1550149|NCT00578214|skin cancer|skin cancer
1550150|NCT00578214|anxiety|anxiety
1550151|NCT00578214|basal cell carcinoma|basal cell carcinoma
1550152|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
1550153|NCT00578214|midazolam|midazolam
1550154|NCT00578214|versed|versed
1550155|NCT00578201|Esophageal neoplasms|esophageal neoplasms
1550156|NCT00578201|Cetuximab|cetuximab
1550157|NCT00578201|Oxaliplatin|oxaliplatin
1550158|NCT00578201|Fluorouracil|fluorouracil
1550159|NCT00578201|radiotherapy|radiotherapy
1550160|NCT00578188|Adolescent Health|adolescent health
1550161|NCT00578188|Sexually transmitted infection|sexually transmitted infection
1550162|NCT00578188|Women's Health|women's health
1550163|NCT00578175|Vaccines|vaccines
1550164|NCT00578175|Rubella|rubella
1550165|NCT00578175|Varicella Vaccine|varicella vaccine
1550166|NCT00578175|Children|children
1550167|NCT00578175|Humans|humans
1550168|NCT00578175|Mumps|mumps
1550169|NCT00578175|Immunogenicity|immunogenicity
1550170|NCT00578175|Safety|safety
1550171|NCT00578175|Measles|measles
1550172|NCT00578175|Combined Vaccine|combined vaccine
1550173|NCT00578162|Cancer|cancer
1550174|NCT00578162|Survivors|survivors
1550175|NCT00578149|chemoradiotherapy|chemoradiotherapy
1550176|NCT00578149|Lung cancer|lung cancer
1550177|NCT00578136|Rectus Sheath|rectus sheath
1550178|NCT00578136|Local infiltration|local infiltration
1550179|NCT00578136|Pain Control|pain control
1550180|NCT00578123|Prostate|prostate
1550181|NCT00578123|Cancer|cancer
1550182|NCT00578123|Quality of Life|quality of life
1550183|NCT00578123|Questionaires|questionaires
1550184|NCT00578123|04-094|04-094
1550185|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
1550186|NCT00578071|esophageal cancer|esophageal cancer
1550187|NCT00578032|head|head
1550188|NCT00578032|neck|neck
1550189|NCT00578032|cancer|cancer
1550190|NCT00578032|reconstruction|reconstruction
1550191|NCT00578032|quality of life|quality of life
1550192|NCT00578032|07-150|07-150
1550193|NCT00578019|Comparative|comparative
1550194|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
1550195|NCT00578019|Intramedullary nailing|intramedullary nailing
1550196|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
1550197|NCT00578006|toxicity related symptoms|toxicity related symptoms
1550198|NCT00578006|04-020|04-020
1550199|NCT00577993|Lymphoma|lymphoma
1550200|NCT00577993|Follicular Lymphoma|follicular lymphoma
1550201|NCT00577993|Indolent Lymphoma|indolent lymphoma
1550202|NCT00577993|Fludarabine|fludarabine
1550203|NCT00577993|Novantrone|novantrone
1550204|NCT00577993|Mitoxantrone|mitoxantrone
1550205|NCT00577993|Decadron|decadron
1550206|NCT00577993|Dexamethasone|dexamethasone
1550207|NCT00577993|Rituximab|rituximab
1550208|NCT00577993|Anti-CD20|anti-cd20
1550209|NCT00577993|IDEC-C2B8|idec-c2b8
1550210|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
1550211|NCT00577993|Interferon|interferon
1550212|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
1550214|NCT00577993|Doxorubicin|doxorubicin
1550215|NCT00577993|Vincristine|vincristine
1550216|NCT00577993|Bleomycin|bleomycin
1550217|NCT00577993|Cyclophosphamide|cyclophosphamide
1550218|NCT00577993|Etoposide|etoposide
1550219|NCT00577993|Cisplatin|cisplatin
1550220|NCT00577993|Ara-C|ara-c
1550221|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
1550222|NCT00577993|Procarbazine|procarbazine
1550223|NCT00577993|Prednisone|prednisone
1550224|NCT00577993|FND|fnd
1550225|NCT00577980|Prostate Cancer|prostate cancer
1550226|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
1550227|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
1550228|NCT00577980|Testosterone|testosterone
1550229|NCT00577980|CRPC|crpc
1550230|NCT00577980|TRT|trt
1550231|NCT00577967|Uremic pruritis|uremic pruritis
1550232|NCT00577954|Coma|coma
1550233|NCT00577954|TBI|tbi
1550234|NCT00577954|Stroke|stroke
1550235|NCT00577954|SAH|sah
1550236|NCT00577954|Cerebral Anoxia|cerebral anoxia
1550237|NCT00577954|Multimodal MRI|multimodal mri
1550238|NCT00577915|Breast cancer|breast cancer
1550239|NCT00577915|MRI spectroscopy|mri spectroscopy
1550240|NCT00577915|Diagnostic radiology|diagnostic radiology
1550241|NCT00577902|head and neck cancer|head and neck cancer
1550242|NCT00577824|diabetes|diabetes
1550243|NCT00577824|exenatide|exenatide
1550244|NCT00577824|LY2148568|ly2148568
1550245|NCT00577824|Byetta|byetta
1550246|NCT00577824|Lilly|lilly
1550247|NCT00577824|Amylin|amylin
1550248|NCT00577811|Special Need Plans|special need plans
1550249|NCT00577811|Fee for Services|fee for services
1550250|NCT00577811|Access to Care|access to care
1550251|NCT00577811|Medicaid|medicaid
1550252|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1550564|NCT00576732|Children|children
1550253|NCT00577798|cardiac toxicity|cardiac toxicity
1550254|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1550255|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1550256|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1550257|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1550258|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1550259|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1550260|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1550261|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1550262|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1550263|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1550264|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1550265|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1550266|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1550267|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1550268|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1550269|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1550490|NCT00577135|Cardio Renal Failure|cardio renal failure
1550270|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1550271|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1550272|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1550273|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1550274|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1550275|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1550276|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1550277|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1550278|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1550279|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1550280|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1550281|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1550282|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1550283|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1550284|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1550285|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1550286|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1550287|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1550288|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1550289|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1550290|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1550291|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1550292|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1550293|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1550294|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1550295|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1550296|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1550297|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1550298|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1550299|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1550300|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1550301|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1550302|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1550303|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1550304|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1550305|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1550306|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1550307|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1550308|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1550309|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1550310|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1550311|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1550312|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1550313|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1550314|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1550315|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1550316|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1550317|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1550318|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1550319|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1550320|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1550321|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1550322|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1550323|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1550324|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1550325|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1550326|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1550327|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1550328|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1550329|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1550330|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1550331|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1550332|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1550333|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1550334|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1550335|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1550336|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1550337|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1550338|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1550339|NCT00577785|cystectomy|cystectomy
1550340|NCT00577772|SmartPill Capsule|smartpill capsule
1550341|NCT00577772|Digestive System Diseases|digestive system diseases
1550342|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
1550343|NCT00577772|Gastrointestinal Device|gastrointestinal device
1550344|NCT00577772|Oro-cecal|oro-cecal
1550345|NCT00577759|Quality assurance, health care|quality assurance, health care
1550346|NCT00577759|primary health care|primary health care
1550347|NCT00577759|community health services|community health services
1550348|NCT00577759|referral and consultation|referral and consultation
1550349|NCT00577759|exercise|exercise
1550351|NCT00577759|tobacco|tobacco
1550352|NCT00577746|Non Small Cell Lung|non small cell lung
1550353|NCT00577733|Pulmonary function test|pulmonary function test
1550354|NCT00577733|Methacholine challenge|methacholine challenge
1550355|NCT00577733|Breathing variability|breathing variability
1550356|NCT00577733|Polygraphy|polygraphy
1550357|NCT00577707|Lung Cancer|lung cancer
1550358|NCT00577707|Erlotinib|erlotinib
1550359|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
1550360|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1550362|NCT00577681|Lipoproteins|lipoproteins
1550363|NCT00577681|Inflammatory Markers|inflammatory markers
1550364|NCT00577681|Coagulation Markers|coagulation markers
1550365|NCT00577681|Treatment Experienced|treatment experienced
1550366|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
1550367|NCT00577642|aminobisphosphonates|aminobisphosphonates
1550368|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
1550369|NCT00577629|NHL|nhl
1550370|NCT00577629|Bexxar|bexxar
1550371|NCT00577629|high dose chemotherapy|high dose chemotherapy
1550372|NCT00577616|Endovascular repair|endovascular repair
1550373|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
1550374|NCT00577616|Mortality at 30 days|mortality at 30 days
1550375|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
1550376|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
1550377|NCT00577590|Diabetes|diabetes
1550378|NCT00577590|PET|pet
1550379|NCT00577590|Heart Metabolism|heart metabolism
1550380|NCT00577590|Lovaza|lovaza
1550381|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
1550382|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
1550383|NCT00577525|HERPES VIRUS|herpes virus
1550384|NCT00577525|ADENOVIRUS|adenovirus
1550385|NCT00577499|cystic fibrosis|cystic fibrosis
1550386|NCT00577499|constipation|constipation
1550387|NCT00577499|lubiprostone|lubiprostone
1550388|NCT00577499|nutrition|nutrition
1550389|NCT00577499|pulmonary function|pulmonary function
1550390|NCT00577447|autism|autism
1550391|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
1550392|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
1550393|NCT00577434|Procedural sedation|procedural sedation
1550394|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
1550395|NCT00577408|Opiate Dependence|opiate dependence
1550396|NCT00577408|Heroin Dependence|heroin dependence
1550397|NCT00577408|Naltrexone|naltrexone
1550941|NCT00574639|Alprazolam|alprazolam
1550399|NCT00577382|malignant melanoma|malignant melanoma
1550400|NCT00577369|arterial line|arterial line
1550401|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
1550402|NCT00577304|Raynaud's|raynaud's
1550403|NCT00577304|Nitroglycerin|nitroglycerin
1550404|NCT00577304|Scleroderma|scleroderma
1550405|NCT00577278|graft versus host disease|graft versus host disease
1550406|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1550407|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1550408|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1550409|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1550410|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1550411|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1550412|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1550413|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1550414|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1550415|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1550416|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1550417|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1550418|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1550419|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1550420|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1550421|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1550422|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1550423|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1550424|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1550425|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1550426|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1550427|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1550428|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1550429|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1550430|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1550431|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1550432|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1550433|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1550434|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1550435|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1550436|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1550437|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1550438|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1550439|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1550440|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1550441|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1550442|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1550443|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1550444|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1550445|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1550446|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1550447|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1550448|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1550449|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1550450|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1550451|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1550452|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1550453|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1550454|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1550455|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1550456|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1550457|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1550458|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1550459|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1550460|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1550461|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1550462|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1550463|NCT00577265|Asthma Control|asthma control
1550464|NCT00577252|Cystic fibrosis|cystic fibrosis
1550465|NCT00577252|Adolescents|adolescents
1550466|NCT00577252|Coping Compliance|coping compliance
1550467|NCT00577252|Adjustment|adjustment
1550468|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
1550469|NCT00577213|Diagnosis|diagnosis
1550470|NCT00577213|Hemangiomas|hemangiomas
1550471|NCT00577213|Vascular Malformations|vascular malformations
1550472|NCT00577213|Venular Malformations|venular malformations
1550473|NCT00577213|Venous Malformations|venous malformations
1550474|NCT00577213|Lymphatic Malformations|lymphatic malformations
1550475|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
1550476|NCT00577174|Children|children
1550477|NCT00577174|Obesity|obesity
1550478|NCT00577174|Insulin resistance|insulin resistance
1550479|NCT00577174|Diabetes|diabetes
1550480|NCT00577174|Mitochondrial Function|mitochondrial function
1550481|NCT00577161|pixantrone|pixantrone
1550482|NCT00577161|NHL|nhl
1550483|NCT00577161|rituximab|rituximab
1550484|NCT00577161|fludarabine|fludarabine
1550485|NCT00577148|NASH|nash
1550486|NCT00577148|chronic liver disease|chronic liver disease
1550487|NCT00577135|Loop Diuretics|loop diuretics
1550488|NCT00577135|Furosemide|furosemide
1550489|NCT00577135|Fluid Overload|fluid overload
1550966|NCT00574574|anthocyanin|anthocyanin
1550491|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
1550492|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
1550493|NCT00577096|multiple myeloma|multiple myeloma
1550494|NCT00577096|polysomnography|polysomnography
1550495|NCT00577096|quality of life|quality of life
1550496|NCT00577096|exercise|exercise
1550497|NCT00577083|miss rates|miss rates
1550498|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1550499|NCT00577057|Stage III - IVB|stage iii - ivb
1550500|NCT00577044|NAFLD|nafld
1550501|NCT00577005|GABAergic|gabaergic
1550502|NCT00577005|levetiracetam|levetiracetam
1550503|NCT00576992|Barrett's Esophagus|barrett's esophagus
1550504|NCT00576992|Demographics|demographics
1550505|NCT00576992|Questionnaire|questionnaire
1550506|NCT00576992|Heartburn|heartburn
1550507|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1550508|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1550509|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
1550510|NCT00576927|Sleep hygiene|sleep hygiene
1550511|NCT00576927|Sleep latency|sleep latency
1550512|NCT00576927|Elderly sleep|elderly sleep
1550513|NCT00576927|Nursing Home sleep|nursing home sleep
1550514|NCT00576914|adjuvant therapy|adjuvant therapy
1550515|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
1550516|NCT00576914|vinorelbine|vinorelbine
1550517|NCT00576914|cisplatin|cisplatin
1568047|NCT00507325|Sample Collection|sample collection
1550518|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
1550519|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
1550520|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
1550521|NCT00576888|Thrombocytopenia|thrombocytopenia
1550522|NCT00576888|Hemangiomas|hemangiomas
1550523|NCT00576888|Hemangiomatosis|hemangiomatosis
1550524|NCT00576888|Lymphatic malformation|lymphatic malformation
1550525|NCT00576888|Kasabach-Merritt|kasabach-merritt
1550526|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
1550527|NCT00576888|Angiomatosis|angiomatosis
1550528|NCT00576875|Depression|depression
1550530|NCT00576875|Neuroimaging|neuroimaging
1550531|NCT00576875|Postmortem|postmortem
1550532|NCT00576875|Knockout mouse|knockout mouse
1550533|NCT00576836|Thymus Transplantation|thymus transplantation
1550534|NCT00576836|DiGeorge Syndrome|digeorge syndrome
1550535|NCT00576836|DiGeorge Anomaly|digeorge anomaly
1550536|NCT00576836|Athymia|athymia
1550537|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
1550538|NCT00576836|Hypocalcemia|hypocalcemia
1550539|NCT00576836|Hypoparathyroidism|hypoparathyroidism
1550540|NCT00576836|Low T cell numbers|low t cell numbers
1550541|NCT00576836|Immunoreconstitution|immunoreconstitution
1550542|NCT00576836|Immunodeficiency|immunodeficiency
1550543|NCT00576836|Complete DiGeorge|complete digeorge
1550544|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
1550545|NCT00576836|Typical DiGeorge|typical digeorge
1550546|NCT00576823|child|child
1550547|NCT00576823|bladder|bladder
1550548|NCT00576823|neuropathic|neuropathic
1550549|NCT00576823|alpha blockers|alpha blockers
1550550|NCT00576797|vaginal|vaginal
1550551|NCT00576797|bacteria|bacteria
1550552|NCT00576797|microflora|microflora
1550553|NCT00576797|bacterial DNA|bacterial dna
1550554|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
1550555|NCT00576784|type 2 diabetes|type 2 diabetes
1550556|NCT00576784|insulin treatment|insulin treatment
1550557|NCT00576784|ß-cell function|ß-cell function
1550558|NCT00576745|Sutures|sutures
1550559|NCT00576732|Irritability|irritability
1550560|NCT00576732|Risperidone|risperidone
1550561|NCT00576732|Antipsychotic agent|antipsychotic agent
1550562|NCT00576732|Autism|autism
1550563|NCT00576732|Adolescents|adolescents
1550565|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
1550566|NCT00576693|ischemic stroke|ischemic stroke
1550567|NCT00576693|intracranial stenting|intracranial stenting
1550568|NCT00576693|vascular risk factor management|vascular risk factor management
1550569|NCT00576680|RAD001|rad001
1550570|NCT00576680|temozolomide|temozolomide
1550571|NCT00576667|NASH|nash
1550572|NCT00576667|chronic liver disease|chronic liver disease
1550573|NCT00576615|healthy volunteers|healthy volunteers
1550574|NCT00576615|amnesic effects|amnesic effects
1550575|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
1550576|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
1550577|NCT00576563|rectal cancer|rectal cancer
1550578|NCT00576563|blood proteins|blood proteins
1550579|NCT00576563|irradiation|irradiation
1550580|NCT00576563|FDG-PET-CT|fdg-pet-ct
1550581|NCT00576550|Hand eczema|hand eczema
1550582|NCT00576550|Prevention|prevention
1551436|NCT00572598|paclitaxel|paclitaxel
1550583|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
1550584|NCT00576524|Hypotension during dialysis|hypotension during dialysis
1550585|NCT00576524|End Stage Renal Disease|end stage renal disease
1550586|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
1550587|NCT00576524|Low Blood Pressure|low blood pressure
1550588|NCT00576511|Constipation|constipation
1550589|NCT00576511|Prucalopride|prucalopride
1550590|NCT00576511|Colonic Transit Time|colonic transit time
1550591|NCT00576498|GERD|gerd
1550592|NCT00576498|NBI|nbi
1550593|NCT00576498|AFI|afi
1550594|NCT00576498|IM|im
1550595|NCT00576498|SSBE|ssbe
1550596|NCT00576498|LSBE|lsbe
1550597|NCT00576498|LGD|lgd
1550598|NCT00576498|HGD|hgd
1550599|NCT00576485|Cataract|cataract
1550600|NCT00576485|Intraocular lens|intraocular lens
1550601|NCT00576485|Spherical aberration|spherical aberration
1550602|NCT00576485|Contrast sensitivity|contrast sensitivity
1550603|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
1550604|NCT00576407|Thymus Transplantation|thymus transplantation
1550605|NCT00576407|DiGeorge Syndrome|digeorge syndrome
1550606|NCT00576407|Athymia|athymia
1550607|NCT00576407|Low T cell numbers|low t cell numbers
1550608|NCT00576407|Immunoreconstitution|immunoreconstitution
1550609|NCT00576407|Primary immunodeficiency|primary immunodeficiency
1550610|NCT00576407|DiGeorge Anomaly|digeorge anomaly
1550611|NCT00576407|Complete DiGeorge|complete digeorge
1550612|NCT00576407|Typical DiGeorge|typical digeorge
1550613|NCT00576394|Glucose, Insulin|glucose, insulin
1550614|NCT00576381|Precedex|precedex
1550615|NCT00576381|Open Heart Surgery|open heart surgery
1550616|NCT00576381|Dexmedetomidine|dexmedetomidine
1550617|NCT00576381|Sedation|sedation
1550618|NCT00576355|Adolescent|adolescent
1550619|NCT00576355|Psychopathology|psychopathology
1550620|NCT00576355|Interpersonal Therapy|interpersonal therapy
1550621|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
1550622|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
1550623|NCT00576316|Asthma|asthma
1550624|NCT00576264|open abdominal surgery|open abdominal surgery
1550625|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
1550626|NCT00576264|peritoneal stem cells|peritoneal stem cells
1550627|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
1550628|NCT00576251|Ocular inflammation|ocular inflammation
1550629|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
1550630|NCT00576238|Atopic eczema|atopic eczema
1550631|NCT00576238|Topical corticosteroid|topical corticosteroid
1550632|NCT00576225|NSCLC|nsclc
1550633|NCT00576225|women|women
1550634|NCT00576225|CT-2103|ct-2103
1550635|NCT00576225|paclitaxel|paclitaxel
1550636|NCT00576225|carboplatin|carboplatin
1550637|NCT00576212|termination fetal anomaly|termination fetal anomaly
1550638|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
1550639|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
1550640|NCT00576173|Cancer pain|cancer pain
1550641|NCT00576173|Breakthrough pain|breakthrough pain
1550642|NCT00576173|acetaminophen|acetaminophen
1550643|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
1550644|NCT00576173|Ultracet|ultracet
1550645|NCT00576160|medication adherence|medication adherence
1550646|NCT00576147|TBI|tbi
1550647|NCT00576147|NIRS|nirs
1550648|NCT00576147|Hematoma|hematoma
1550649|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
1550650|NCT00576082|Lyme borreliosis|lyme borreliosis
1550651|NCT00576082|Erythema migrans|erythema migrans
1550652|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
1550653|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
1550654|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
1550655|NCT00576082|Borrelia afzelii|borrelia afzelii
1550656|NCT00576082|Borrelia garinii|borrelia garinii
1550657|NCT00576069|asthma|asthma
1550658|NCT00576069|lung function|lung function
1550659|NCT00576069|inflammation|inflammation
1550660|NCT00576056|Hepatocellular|hepatocellular
1550661|NCT00576056|Carcinoma|carcinoma
1550662|NCT00576056|TACE|tace
1550663|NCT00576056|Sorafenib|sorafenib
1550664|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
1550665|NCT00576056|Nexavar|nexavar
1550666|NCT00576056|Unresectable|unresectable
1550667|NCT00576043|training|training
1550668|NCT00576043|Patient satisfaction|patient satisfaction
1550669|NCT00576043|endoscopy|endoscopy
1550670|NCT00576043|simulator|simulator
1550671|NCT00576043|Safety|safety
1550672|NCT00576017|Cancer pain treatment|cancer pain treatment
1550673|NCT00576017|Fentanyl TTS|fentanyl tts
1550674|NCT00576017|Dihydrocodeine|dihydrocodeine
1550675|NCT00576017|Tramadol|tramadol
1550676|NCT00576017|Cancer pain|cancer pain
1550677|NCT00576017|Durogesic|durogesic
1550678|NCT00576017|Ultram|ultram
1550679|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
1550680|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
1550681|NCT00575978|breast cancer|breast cancer
1550682|NCT00575965|simvastatin|simvastatin
1550683|NCT00575939|HIV|hiv
1550684|NCT00575939|IMT|imt
1550685|NCT00575939|coronary|coronary
1550686|NCT00575939|Treatment Naive|treatment naive
1550687|NCT00575926|Randomized controlled trial|randomized controlled trial
1550688|NCT00575926|Lingzhi|lingzhi
1550689|NCT00575926|Immune functions|immune functions
1550690|NCT00575926|Quality of life|quality of life
1550691|NCT00575926|Survival|survival
1550692|NCT00575900|Adolescent obesity,|adolescent obesity,
1550693|NCT00575900|low carbohydrate diets|low carbohydrate diets
1550694|NCT00575900|metabolic risk factors|metabolic risk factors
1550695|NCT00575900|BMI|bmi
1550696|NCT00575887|Temozolomide|temozolomide
1550697|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
1550698|NCT00575887|Chemotherapy|chemotherapy
1550699|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
1550700|NCT00575874|pioglitazone HCl|pioglitazone hcl
1550701|NCT00575874|thiazolidinedione|thiazolidinedione
1550702|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
1550703|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
1550704|NCT00575861|asthma|asthma
1568148|NCT00506922|Leukemia|leukemia
1550705|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
1550706|NCT00575861|lung function|lung function
1550707|NCT00575848|Schizophrenia|schizophrenia
1550708|NCT00575848|Glycine|glycine
1550709|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
1550710|NCT00575835|vitamin D|vitamin d
1550711|NCT00575835|seasonal variation|seasonal variation
1550712|NCT00575835|PTH|pth
1550713|NCT00575835|bone markers|bone markers
1550714|NCT00575822|GERD|gerd
1550715|NCT00575822|Sham|sham
1550716|NCT00575822|Randomized Controlled Study|randomized controlled study
1550717|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
1550718|NCT00575822|Plicator|plicator
1550719|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
1550720|NCT00575796|pediatrics|pediatrics
1550721|NCT00575796|Low Grade Glioma|low grade glioma
1550722|NCT00575796|Vinblastine|vinblastine
1550723|NCT00575783|type 1 diabetes|type 1 diabetes
1550724|NCT00575783|hypoglycemia|hypoglycemia
1550725|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
1550726|NCT00575757|Steatosis|steatosis
1550727|NCT00575757|NASH|nash
1550728|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1550729|NCT00575744|Axillary Node Dissection|axillary node dissection
1550730|NCT00575744|Intraoperative Injection|intraoperative injection
1550731|NCT00575744|Lumpectomy|lumpectomy
1550732|NCT00575744|Mastectomy|mastectomy
1550733|NCT00575718|Quitting tobacco|quitting tobacco
1550734|NCT00575718|tobacco use|tobacco use
1550735|NCT00575679|Automobile driving|automobile driving
1550736|NCT00575679|Driving under the influence|driving under the influence
1550737|NCT00575679|Interview, psychological|interview, psychological
1550738|NCT00575679|Brief intervention|brief intervention
1550739|NCT00575679|Brief motivational interview|brief motivational interview
1550740|NCT00575666|cognition, psychopathology|cognition, psychopathology
1550741|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
1550742|NCT00575653|Meningococcal vaccines|meningococcal vaccines
1550743|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
1550744|NCT00575653|Vaccination|vaccination
1550745|NCT00575653|Vaccines|vaccines
1550746|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
1550747|NCT00575627|Hepatitis C|hepatitis c
1550748|NCT00575627|persistently normal ALT|persistently normal alt
1550749|NCT00575627|pNNALT|pnnalt
1550750|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
1550751|NCT00575627|Pegylated Interferon|pegylated interferon
1550752|NCT00575627|Combined therapy|combined therapy
1550753|NCT00575614|Constipation|constipation
1550754|NCT00575614|Prucalopride|prucalopride
1550755|NCT00575614|Ano-rectal physiology|ano-rectal physiology
1550756|NCT00575614|Oro-caecal transit time|oro-caecal transit time
1550757|NCT00575614|QOL|qol
1550758|NCT00575601|pco|pco
1550759|NCT00575601|simvastatin|simvastatin
1550760|NCT00575601|ivf|ivf
1550761|NCT00575601|embryo transfer|embryo transfer
1550762|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
1550763|NCT00575588|HbA1c|hba1c
1550764|NCT00575588|incretins|incretins
1550765|NCT00575575|Suicidal ideation|suicidal ideation
1550766|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
1550767|NCT00575536|spasticity|spasticity
1550768|NCT00575536|rhizotomy|rhizotomy
1550769|NCT00575536|surgery|surgery
1550770|NCT00575523|atropine|atropine
1550771|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
1550772|NCT00575523|hepatoma|hepatoma
1550773|NCT00575523|bradycardia|bradycardia
1550774|NCT00575523|arrhythmia|arrhythmia
1550775|NCT00575510|unified theory of behavior|unified theory of behavior
1550776|NCT00575510|Pap test|pap test
1550777|NCT00575510|cervical dysplasia|cervical dysplasia
1550778|NCT00575510|women's health|women's health
1550779|NCT00575497|Hemodialysis|hemodialysis
1550780|NCT00575497|Adequacy|adequacy
1550781|NCT00575497|Frequency|frequency
1550782|NCT00575484|Congestive Heart Failure|congestive heart failure
1550783|NCT00575484|Renal Insufficiency|renal insufficiency
1550784|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
1550785|NCT00575484|Diuretic Resistance|diuretic resistance
1550786|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
1550787|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
1550788|NCT00575471|thiazolidinedione|thiazolidinedione
1550789|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
1550790|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
1550791|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
1550792|NCT00575432|renal function|renal function
1550793|NCT00575432|renal transplant|renal transplant
1550794|NCT00575432|urinary calculi|urinary calculi
1550795|NCT00575432|healthy controls|healthy controls
1550796|NCT00575432|kidney|kidney
1550797|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
1550798|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1550799|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1550800|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1550801|NCT00575354|Sevoflurane|sevoflurane
1550802|NCT00575354|Isoflurane|isoflurane
1550803|NCT00575354|Breast tumor|breast tumor
1550804|NCT00575354|Anesthesia|anesthesia
1550805|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
1550806|NCT00575341|DHEA|dhea
1550807|NCT00575341|Pubes|pubes
1550808|NCT00575328|Sexual Dysfunction|sexual dysfunction
1550809|NCT00575328|Bipolar Disorder|bipolar disorder
1550810|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
1550811|NCT00575315|HIV|hiv
1550812|NCT00575315|Histology|histology
1550813|NCT00575302|IVF|ivf
1550814|NCT00575302|poor responder|poor responder
1550815|NCT00575302|recFSH|recfsh
1550816|NCT00575302|Fertilization in Vitro|fertilization in vitro
1550817|NCT00575302|Poor responders|poor responders
1550818|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
1550819|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
1550820|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
1550821|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
1550822|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
1550823|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
1550824|NCT00575250|Life Style//|life style//
1550825|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
1550826|NCT00575237|Shoulder pain|shoulder pain
1550827|NCT00575237|PDNV|pdnv
1550828|NCT00575237|Anesthesia|anesthesia
1550829|NCT00575237|Residual CO2|residual co2
1550830|NCT00575237|Postoperative Pain|postoperative pain
1550831|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
1550832|NCT00575224|Hepatitis C|hepatitis c
1550833|NCT00575224|Genotype 6|genotype 6
1550834|NCT00575224|Novel genoytpe|novel genoytpe
1550835|NCT00575224|HCV|hcv
1550836|NCT00575224|Treatment|treatment
1550837|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
1550838|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
1550839|NCT00575211|LVEF < 40%|lvef < 40%
1550840|NCT00575198|Chest tubes|chest tubes
1550841|NCT00575198|Trauma|trauma
1550842|NCT00575185|Mono|mono
1550843|NCT00575185|Mononucleosis|mononucleosis
1550844|NCT00575185|Epstein-Barr virus|epstein-barr virus
1550845|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
1550846|NCT00575172|cardiovascular disease|cardiovascular disease
1550847|NCT00575172|macrovascular event|macrovascular event
1550848|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
1550849|NCT00575159|pharmacodynamics|pharmacodynamics
1550850|NCT00575159|Adult male and females,|adult male and females,
1550851|NCT00575146|glioblastoma|glioblastoma
1550852|NCT00575146|ketogenic diet|ketogenic diet
1550853|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
1550854|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
1550855|NCT00575042|PBC|pbc
1550856|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
1550857|NCT00575042|Fenofibrate|fenofibrate
1550858|NCT00575042|Triglide|triglide
1550859|NCT00575029|megestrol acetate|megestrol acetate
1550860|NCT00575029|adrenal insufficiency|adrenal insufficiency
1550861|NCT00575029|adrenal suppression|adrenal suppression
1550862|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
1550863|NCT00574990|Safety Management|safety management
1550864|NCT00574990|Management, Medication Therapy|management, medication therapy
1550865|NCT00574990|Cooperative Behavior|cooperative behavior
1550866|NCT00574990|Drug Therapy Management|drug therapy management
1550867|NCT00574990|Physician Nurse Relationships|physician nurse relationships
1550868|NCT00574990|Side Effects|side effects
1550869|NCT00574990|Hospital Information Systems|hospital information systems
1550870|NCT00574990|Documentation|documentation
1550871|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
1550872|NCT00574977|vaccinia|vaccinia
1550873|NCT00574977|virus|virus
1550874|NCT00574977|tumor|tumor
1550875|NCT00574977|melanoma|melanoma
1550876|NCT00574977|breast cancer|breast cancer
1550877|NCT00574977|squamous cell cancer|squamous cell cancer
1550878|NCT00574977|colorectal|colorectal
1550879|NCT00574977|liver|liver
1550880|NCT00574977|pancreatic|pancreatic
1550881|NCT00574977|adenocarcinoma|adenocarcinoma
1550882|NCT00574951|fallopian tube cancer|fallopian tube cancer
1550883|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1550884|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1550885|NCT00574925|H. pylori|h. pylori
1550886|NCT00574912|Type 2 diabetes|type 2 diabetes
1550887|NCT00574912|Insulin Glargine|insulin glargine
1550888|NCT00574912|Endogenous Glucose Production|endogenous glucose production
1550889|NCT00574899|Prostate|prostate
1550890|NCT00574873|Bosutinib|bosutinib
1550891|NCT00574873|imatinib|imatinib
1550892|NCT00574873|CML|cml
1550893|NCT00574860|Oral Mucositis|oral mucositis
1550894|NCT00574860|Chemoradiation therapy|chemoradiation therapy
1550895|NCT00574860|Head and neck cancer|head and neck cancer
1550896|NCT00574847|ischemic heart disease|ischemic heart disease
1550897|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
1550898|NCT00574847|escitalopram|escitalopram
1550899|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
1550900|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
1550901|NCT00574808|Primary care|primary care
1550902|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
1550903|NCT00574808|Chronic Disease Management|chronic disease management
1550904|NCT00574808|Chronic Disease Prevention|chronic disease prevention
1550905|NCT00574808|Chronic Care Model|chronic care model
1550906|NCT00574808|Outreach Facilitation|outreach facilitation
1550907|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
1550908|NCT00574782|rosuvastatin|rosuvastatin
1550909|NCT00574782|LDL-C goal|ldl-c goal
1550910|NCT00574782|hypercholesterolemia|hypercholesterolemia
1550911|NCT00574769|RAD001|rad001
1550912|NCT00574769|mTOR inhibition|mtor inhibition
1550913|NCT00574769|docetaxel|docetaxel
1550914|NCT00574769|bevacizumab|bevacizumab
1550915|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1550916|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
1550917|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
1550918|NCT00574769|prostate cancer|prostate cancer
1550919|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
1550920|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
1550921|NCT00574717|hyperopia|hyperopia
1550922|NCT00574717|ocular refraction|ocular refraction
1550923|NCT00574717|infant|infant
1550924|NCT00574717|vision|vision
1550925|NCT00574691|Closure Device|closure device
1550926|NCT00574691|Angiography|angiography
1550927|NCT00574691|Angioplasty|angioplasty
1550928|NCT00574691|Hemostasis|hemostasis
1550929|NCT00574691|Heart Catheterization|heart catheterization
1550930|NCT00574691|Coronary Angiography|coronary angiography
1550931|NCT00574678|Screening tool for cancer|screening tool for cancer
1550932|NCT00574665|Type 2 Diabetes|type 2 diabetes
1550933|NCT00574665|Endothelial Function|endothelial function
1550934|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
1550935|NCT00574652|HCV+|hcv+
1550936|NCT00574652|cryoglobulinemia|cryoglobulinemia
1550937|NCT00574652|Vasculitis|vasculitis
1550938|NCT00574652|IL-2 treatment|il-2 treatment
1550939|NCT00574652|safety and efficacy|safety and efficacy
1550940|NCT00574639|Type 1 Diabetes|type 1 diabetes
1550942|NCT00574639|Exercise|exercise
1550943|NCT00574626|NHL|nhl
1550944|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
1550945|NCT00574626|BMT|bmt
1550946|NCT00574626|Bone Marrow Transplant|bone marrow transplant
1550947|NCT00574626|PBSCT|pbsct
1550948|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1550949|NCT00574626|PSCT|psct
1550950|NCT00574613|Skin fibrosis|skin fibrosis
1550951|NCT00574613|systemic scleroderma|systemic scleroderma
1550952|NCT00574613|systemic sclerosis|systemic sclerosis
1550953|NCT00574613|P144|p144
1550954|NCT00574613|orphan drug|orphan drug
1550955|NCT00574613|soluble collagen|soluble collagen
1550956|NCT00574613|durometer|durometer
1550957|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
1550958|NCT00574600|HIV Seronegativity|hiv seronegativity
1550959|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
1550960|NCT00574587|Vorinostat|vorinostat
1550961|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1550962|NCT00574574|cardiovascular disease|cardiovascular disease
1550963|NCT00574574|CVD|cvd
1550964|NCT00574574|skin health|skin health
1550965|NCT00574574|postmenopausal women|postmenopausal women
1550967|NCT00574574|inflammation|inflammation
1550968|NCT00574561|CT angiography (CTA)|ct angiography (cta)
1550969|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
1550970|NCT00574561|heart disease|heart disease
1550971|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
1550972|NCT00574535|Reproductive Hormones|reproductive hormones
1550973|NCT00574522|HIV|hiv
1550974|NCT00574522|AIDS|aids
1550975|NCT00574522|Radiation|radiation
1550976|NCT00574522|Far infrared|far infrared
1550977|NCT00574522|Treatment|treatment
1550978|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1550979|NCT00574522|Complimentary therapies|complimentary therapies
1550980|NCT00574509|NHL|nhl
1550981|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
1550982|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
1550983|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
1550984|NCT00574509|AHSCT|ahsct
1550985|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1550986|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1550987|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1550988|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1550989|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1550990|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1550991|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1550992|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1550993|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1550994|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1550995|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1550996|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1550997|NCT00574483|Renal cell carcinoma|renal cell carcinoma
1550998|NCT00574457|Atherosclerosis|atherosclerosis
1550999|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
1551000|NCT00574457|Carotid Ultrasound|carotid ultrasound
1551001|NCT00574457|Handheld ultrasound|handheld ultrasound
1551002|NCT00574457|Office Practice|office practice
1551003|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
1551004|NCT00574457|Carotid Plaque|carotid plaque
1551005|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
1551006|NCT00574431|Critical care|critical care
1551007|NCT00574431|Intensive care unit|intensive care unit
1551008|NCT00574431|Early enteral nutrition|early enteral nutrition
1551009|NCT00574431|Nutritional management protocol|nutritional management protocol
1551010|NCT00574418|Fibroid Tumor|fibroid tumor
1551011|NCT00574418|Fibroid Uterus|fibroid uterus
1551012|NCT00574418|Fibroids, Uterine|fibroids, uterine
1551013|NCT00574418|Fibromyoma|fibromyoma
1551014|NCT00574418|Uterine Neoplasms|uterine neoplasms
1551015|NCT00574405|Insulin pump|insulin pump
1551016|NCT00574405|Beta cell|beta cell
1551017|NCT00574392|skin disorders|skin disorders
1551018|NCT00574379|Allergic Rhinitis|allergic rhinitis
1551019|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
1551020|NCT00574379|Pollen Allergy|pollen allergy
1551021|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
1551022|NCT00574366|recurrent breast cancer|recurrent breast cancer
1551023|NCT00574366|stage IV breast cancer|stage iv breast cancer
1551024|NCT00574366|male breast cancer|male breast cancer
1551025|NCT00574353|colorectal cancer|colorectal cancer
1551026|NCT00574353|07-151|07-151
1551027|NCT00574340|Type 2 Diabetes|type 2 diabetes
1551028|NCT00574340|Endothelial Function|endothelial function
1551029|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
1551030|NCT00574340|Hypoglycemia|hypoglycemia
1551031|NCT00574327|Role|role
1551032|NCT00574327|Registry|registry
1551033|NCT00574327|Barrett's Esophagus|barrett's esophagus
1551034|NCT00574314|women|women
1551035|NCT00574314|Registry|registry
1551036|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
1551037|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
1551038|NCT00574301|Breast Conservation Therapy|breast conservation therapy
1551039|NCT00574301|Mastectomy|mastectomy
1551040|NCT00574301|MRI|mri
1551041|NCT00574288|Multiple Myeloma|multiple myeloma
1551042|NCT00574288|Daratumumab|daratumumab
1551043|NCT00574288|Safety|safety
1551044|NCT00574288|HuMax-CD38|humax-cd38
1551045|NCT00574288|Dose-escalation|dose-escalation
1551046|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
1551047|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
1551048|NCT00574275|gemcitabine|gemcitabine
1551049|NCT00574262|acute ischemic stroke|acute ischemic stroke
1551050|NCT00574262|clinical pathway|clinical pathway
1551051|NCT00574262|quality of care|quality of care
1551052|NCT00574262|secondary prevention|secondary prevention
1551053|NCT00574249|Psoriasis|psoriasis
1551054|NCT00574249|Moderate Psoriasis|moderate psoriasis
1551055|NCT00574249|Severe Psoriasis|severe psoriasis
1551056|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
1551057|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
1551058|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
1551059|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
1551060|NCT00574210|Therapeutic Uses|therapeutic uses
1551061|NCT00574210|Antihistamine Drug|antihistamine drug
1551062|NCT00574210|Ragweed Pollen|ragweed pollen
1551063|NCT00574197|Heart Transplant|heart transplant
1551064|NCT00574197|gastrointestinal|gastrointestinal
1551065|NCT00574197|Cellcept|cellcept
1551066|NCT00574197|Myfortic|myfortic
1551067|NCT00574197|GI|gi
1551068|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
1551069|NCT00574184|ED|ed
1551070|NCT00574184|Erectile Dysfunction|erectile dysfunction
1551071|NCT00574158|ozone|ozone
1551072|NCT00574158|inflammatory airway disease|inflammatory airway disease
1551073|NCT00574158|polymorphisms|polymorphisms
1551074|NCT00574145|fatigue|fatigue
1551075|NCT00574145|depression|depression
1551076|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1551077|NCT00574145|stage I breast cancer|stage i breast cancer
1551078|NCT00574145|stage II breast cancer|stage ii breast cancer
1551079|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
1551080|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
1551081|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
1551082|NCT00574145|recurrent breast cancer|recurrent breast cancer
1551083|NCT00574119|heart failure|heart failure
1551084|NCT00574119|positron emission tomography|positron emission tomography
1551085|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
1551086|NCT00574119|myocardial energetics|myocardial energetics
1551087|NCT00574119|myocardial perfusion|myocardial perfusion
1551088|NCT00574106|Cancer|cancer
1551089|NCT00574106|Tumors|tumors
1551090|NCT00574093|combination therapy|combination therapy
1551091|NCT00574093|Lucentis|lucentis
1551092|NCT00574093|Visudyne|visudyne
1551093|NCT00574054|Familial Dementia|familial dementia
1551094|NCT00574054|Semantic Dementia|semantic dementia
1551095|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
1551096|NCT00574041|Multiple Sclerosis|multiple sclerosis
1551097|NCT00574041|Avonex|avonex
1551098|NCT00574041|side effects|side effects
1551099|NCT00574041|flu like symptoms|flu like symptoms
1551100|NCT00574028|IBD Study|ibd study
1551101|NCT00574015|toothache|toothache
1551102|NCT00574015|regional anesthesia|regional anesthesia
1551103|NCT00574015|emergency department|emergency department
1551104|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1551105|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1551106|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1551107|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1551108|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1551109|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1551110|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1551111|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1551112|NCT00573976|SCIM|scim
1551113|NCT00573976|SCIM III|scim iii
1551114|NCT00573976|Multi-Center|multi-center
1551115|NCT00573976|United States|united states
1551116|NCT00573963|Cesarean section|cesarean section
1551117|NCT00573950|cilostazol|cilostazol
1551118|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
1551119|NCT00573950|Metabolic Syndrome|metabolic syndrome
1551120|NCT00573950|adipocytokines|adipocytokines
1551121|NCT00573950|arterial stiffness|arterial stiffness
1551122|NCT00573950|Pulse wave velocity|pulse wave velocity
1551123|NCT00573937|Neoplasms|neoplasms
1551124|NCT00573937|Pain|pain
1551125|NCT00573937|Methadone|methadone
1551126|NCT00573937|Morphine|morphine
1551127|NCT00573911|Barrett's esophagus|barrett's esophagus
1551128|NCT00573911|GERD|gerd
1551129|NCT00573898|daptomycin|daptomycin
1551130|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
1551131|NCT00573885|small cell lung cancer|small cell lung cancer
1551132|NCT00573885|tobacco use disorder|tobacco use disorder
1551133|NCT00573872|Radiosurgery|radiosurgery
1551134|NCT00573872|Phase II|phase ii
1551135|NCT00573872|Cancer|cancer
1551136|NCT00573872|Spinal|spinal
1551137|NCT00573872|AVM|avm
1551138|NCT00573859|Smoking|smoking
1551139|NCT00573859|ADHD|adhd
1551140|NCT00573859|Stimulant medication|stimulant medication
1551141|NCT00573846|IBD|ibd
1551142|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1551143|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
1551144|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
1551145|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
1551146|NCT00573820|Cancer of Prostate|cancer of prostate
1551147|NCT00573820|Cancer of the Prostate|cancer of the prostate
1551148|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
1552405|NCT00568815|Toxicity|toxicity
1551149|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
1551150|NCT00573820|Prostate Cancer|prostate cancer
1551151|NCT00573820|Prostate Neoplasms|prostate neoplasms
1551152|NCT00573820|Prostatic Cancer|prostatic cancer
1551153|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
1551154|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
1551155|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
1551156|NCT00573807|Lower back pain|lower back pain
1551157|NCT00573794|Ulcerative Colitis|ulcerative colitis
1551158|NCT00573781|Systems biology|systems biology
1551159|NCT00573781|Nutrigenomics|nutrigenomics
1551160|NCT00573781|Metabolomics|metabolomics
1551161|NCT00573781|Gene expression|gene expression
1551162|NCT00573781|Fat tissue|fat tissue
1551163|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
1551164|NCT00573781|Gene clusters|gene clusters
1551165|NCT00573781|Gene expression profiles|gene expression profiles
1551166|NCT00573781|Personal diets|personal diets
1551167|NCT00573781|Metabolic syndrome|metabolic syndrome
1551168|NCT00573781|Type 2 Diabetes|type 2 diabetes
1551169|NCT00573781|Atherosclerosis|atherosclerosis
1551170|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
1551171|NCT00573755|stage IV breast cancer|stage iv breast cancer
1551172|NCT00573755|recurrent breast cancer|recurrent breast cancer
1551173|NCT00573742|hypertension|hypertension
1568149|NCT00506922|Lymphoma|lymphoma
1551174|NCT00573729|vascular malformation|vascular malformation
1551175|NCT00573716|bone mineral content|bone mineral content
1551176|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
1551177|NCT00573716|risperidone monotherapy|risperidone monotherapy
1551178|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
1551179|NCT00573703|Stress incontinence|stress incontinence
1551180|NCT00573703|Surgery|surgery
1551181|NCT00573703|TOT|tot
1551182|NCT00573703|Treatment|treatment
1551183|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
1551184|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1551185|NCT00573664|Cesarean section|cesarean section
1551186|NCT00573664|Gabapentin|gabapentin
1551187|NCT00573651|JIA|jia
1551188|NCT00573651|SEA syndrome|sea syndrome
1551189|NCT00573651|AS|as
1551190|NCT00573651|psoriatic arthritis|psoriatic arthritis
1551191|NCT00573651|HPV vaccine|hpv vaccine
1551192|NCT00573638|glaucoma|glaucoma
1551193|NCT00573638|compliance|compliance
1551194|NCT00573638|eye drops|eye drops
1551195|NCT00573638|deliver aid|deliver aid
1551196|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
1551197|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
1551198|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
1551199|NCT00573612|Fibromyalgia|fibromyalgia
1551200|NCT00573612|Fibromyalgia patients|fibromyalgia patients
1551201|NCT00573599|Migraine|migraine
1551202|NCT00573599|Emergency|emergency
1551203|NCT00573599|imitrex|imitrex
1551204|NCT00573599|prochlorperazine|prochlorperazine
1551205|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
1551206|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
1551207|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
1551208|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
1551209|NCT00573573|HYPOCALCEMIA|hypocalcemia
1551210|NCT00573560|Heart failure|heart failure
1551211|NCT00573560|percutaneous|percutaneous
1551212|NCT00573560|interventional cardiology|interventional cardiology
1551213|NCT00573560|apical remodeling|apical remodeling
1551214|NCT00573560|LV dilatation|lv dilatation
1551215|NCT00573560|akinesis|akinesis
1551216|NCT00573560|dyskinesis|dyskinesis
1551217|NCT00573547|depression|depression
1551218|NCT00573547|chronic renal failures|chronic renal failures
1551219|NCT00573547|end stage renal disease|end stage renal disease
1551220|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1551221|NCT00573534|ADHD|adhd
1551222|NCT00573534|ADD|add
1551223|NCT00573534|Prevention|prevention
1551224|NCT00573534|Substance use|substance use
1551225|NCT00573534|Adolescent|adolescent
1551226|NCT00573521|ESBL positive cultures|esbl positive cultures
1551227|NCT00573508|Overactive Bladder|overactive bladder
1551228|NCT00573495|Advanced breast cancer|advanced breast cancer
1551229|NCT00573482|weight gain prevention|weight gain prevention
1551230|NCT00573482|obesity|obesity
1551231|NCT00573482|overweight|overweight
1551232|NCT00573482|food environment|food environment
1551233|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
1551234|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
1551235|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
1551236|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
1551237|NCT00573469|gastrointestinal|gastrointestinal
1551238|NCT00573469|GI|gi
1551239|NCT00573469|Crohn's disease|crohn's disease
1551240|NCT00573469|Japan|japan
1551241|NCT00573469|Japanese|japanese
1551242|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
1551243|NCT00573456|Type 2 Diabetes|type 2 diabetes
1551244|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
1551245|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
1551246|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
1551247|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
1551248|NCT00573430|hypertension|hypertension
1551249|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
1551250|NCT00573417|Schizophrenia|schizophrenia
1551251|NCT00573417|Clozapine|clozapine
1551252|NCT00573417|Cognition|cognition
1551253|NCT00573417|Metabolic Syndrome|metabolic syndrome
1551254|NCT00573417|Negative Symptoms|negative symptoms
1551255|NCT00573417|Wakefulness|wakefulness
1551256|NCT00573417|Fatigue|fatigue
1551257|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1551259|NCT00573365|dermatitis|dermatitis
1551260|NCT00573365|skin|skin
1551261|NCT00573365|radiation|radiation
1551262|NCT00573365|light|light
1551263|NCT00573365|LED photomodulation|led photomodulation
1551264|NCT00573365|Gentlewaves|gentlewaves
1551265|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
1551266|NCT00573352|Osteoarthrosis|osteoarthrosis
1551267|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
1551268|NCT00573339|Cardiac|cardiac
1551269|NCT00573339|MRI|mri
1551270|NCT00573339|normal controls|normal controls
1551271|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
1551272|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
1551273|NCT00573313|SAMe|same
1551274|NCT00573300|Schizophrenia|schizophrenia
1551275|NCT00573300|Immune System|immune system
1551276|NCT00573300|Kynurenate|kynurenate
1551277|NCT00573300|tryptophan metabolism|tryptophan metabolism
1551278|NCT00573300|NMDA receptor|nmda receptor
1551279|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
1551280|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
1551281|NCT00573274|Cesarean section|cesarean section
1551282|NCT00573274|Cardiac Output|cardiac output
1551283|NCT00573274|Physioflow|physioflow
1551284|NCT00573274|Cardiography, Impedance|cardiography, impedance
1551285|NCT00573261|Diabetic neuropathy|diabetic neuropathy
1551286|NCT00573261|Pregabalin|pregabalin
1551287|NCT00573261|Lyrica|lyrica
1551288|NCT00573248|Nicotine|nicotine
1551289|NCT00573248|ADHD|adhd
1551290|NCT00573248|Gender|gender
1551291|NCT00573235|isolates|isolates
1551292|NCT00573235|infection|infection
1551293|NCT00573235|E coli isolates|e coli isolates
1551294|NCT00573222|Asthma|asthma
1551295|NCT00573209|Impotence|impotence
1551296|NCT00573209|Male Impotence|male impotence
1551297|NCT00573209|Male Sexual Impotence|male sexual impotence
1551298|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
1551299|NCT00573196|Depression, Bipolar|depression, bipolar
1551300|NCT00573196|Mania|mania
1551301|NCT00573196|Manic Disorder|manic disorder
1551302|NCT00573196|Manic State|manic state
1551303|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
1551304|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
1551305|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
1551306|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
1551307|NCT00573170|Migraine, acute|migraine, acute
1551308|NCT00573170|Migraine|migraine
1551309|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
1551310|NCT00573170|Naproxen sodium|naproxen sodium
1551311|NCT00573170|Sumatriptan succinate|sumatriptan succinate
1551312|NCT00573170|TREXIMET®|treximet®
1551313|NCT00573157|nephritis|nephritis
1551314|NCT00573157|atacicept|atacicept
1551315|NCT00573131|Esophageal cancer|esophageal cancer
1551316|NCT00573131|Localized esophageal cancer|localized esophageal cancer
1551317|NCT00573131|Operable esophageal cancer|operable esophageal cancer
1551318|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
1551319|NCT00573131|Esophagectomy|esophagectomy
1551320|NCT00573131|Phase 2|phase 2
1551321|NCT00573131|Paclitaxel|paclitaxel
1551322|NCT00573131|Tumor|tumor
1551323|NCT00573131|Local|local
1551324|NCT00573131|Chemotherapy|chemotherapy
1551325|NCT00573131|radiation therapy|radiation therapy
1551326|NCT00573131|surgery|surgery
1551327|NCT00573131|OncoGel|oncogel
1551328|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1551329|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
1551330|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
1551331|NCT00573092|Genomics|genomics
1551332|NCT00573092|Genome-Wide Association Study|genome-wide association study
1551333|NCT00573079|Kidney|kidney
1551334|NCT00573079|Infants|infants
1551335|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
1551336|NCT00573066|Dexmedetomidine|dexmedetomidine
1551337|NCT00573053|hypercapneic response|hypercapneic response
1551338|NCT00573053|hyperoxic response|hyperoxic response
1551339|NCT00573053|breathing pattern|breathing pattern
1551340|NCT00573053|periodic breathing|periodic breathing
1551341|NCT00573053|sighs|sighs
1551342|NCT00573040|Radiotherapy|radiotherapy
1551343|NCT00573040|NSCLC|nsclc
1551344|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1551345|NCT00573027|microvascular dysfunction|microvascular dysfunction
1551346|NCT00573027|Microvascular|microvascular
1551347|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
1551348|NCT00573001|naive|naive
1551349|NCT00573001|HIV-1|hiv-1
1551350|NCT00573001|simplified treatment|simplified treatment
1551351|NCT00573001|Treatment Experienced|treatment experienced
1551352|NCT00572988|symptom management|symptom management
1551353|NCT00572988|function status|function status
1551354|NCT00572988|physical activity|physical activity
1551355|NCT00572988|health care utilization|health care utilization
1551356|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
1551357|NCT00572949|heart disease|heart disease
1551358|NCT00572949|chest pain|chest pain
1551359|NCT00572949|coronary artery disease|coronary artery disease
1551360|NCT00572949|atherosclerosis|atherosclerosis
1551361|NCT00572936|Glaucoma|glaucoma
1551362|NCT00572936|Ocular Hypertension|ocular hypertension
1551363|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
1551364|NCT00572923|radiotherapy|radiotherapy
1551365|NCT00572923|LD-SCLC|ld-sclc
1551366|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
1551367|NCT00572897|Myelofibrosis|myelofibrosis
1551368|NCT00572897|Myeloproliferative disease|myeloproliferative disease
1551369|NCT00572897|Stem Cell Transplant|stem cell transplant
1551370|NCT00572897|Allogeneic Transplant|allogeneic transplant
1551371|NCT00572897|Conditioning Regimen|conditioning regimen
1551372|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
1551373|NCT00572897|Fludarabine|fludarabine
1551374|NCT00572897|Melphalan|melphalan
1551376|NCT00572884|permethrin|permethrin
1551377|NCT00572884|pyrethroid|pyrethroid
1551378|NCT00572884|pharmacokinetics|pharmacokinetics
1551379|NCT00572884|metabolism|metabolism
1551380|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
1551381|NCT00572884|human exposure|human exposure
1551382|NCT00572858|Hypo E|hypo e
1551383|NCT00572845|Basal Energy Expenditure|basal energy expenditure
1551384|NCT00572845|Spasticity|spasticity
1551385|NCT00572845|Modified Ashworth Scale|modified ashworth scale
1551386|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
1551387|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
1551388|NCT00572819|Hysteroscopy|hysteroscopy
1551389|NCT00572819|Misoprostol|misoprostol
1551390|NCT00572819|Postmenopausal women|postmenopausal women
1551391|NCT00572819|Cervical ripening|cervical ripening
1551392|NCT00572819|Dilatation|dilatation
1551393|NCT00572819|Sequential trial|sequential trial
1551394|NCT00572819|Estradiol|estradiol
1551395|NCT00572780|Crohn's Disease|crohn's disease
1551396|NCT00572780|CT Enteroclysis|ct enteroclysis
1551397|NCT00572767|randomised-controlled trial|randomised-controlled trial
1551398|NCT00572767|ischemic stroke|ischemic stroke
1551399|NCT00572767|motor recovery|motor recovery
1551400|NCT00572767|amphetamine|amphetamine
1551401|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
1551402|NCT00572741|Autism|autism
1551403|NCT00572741|vitamin B 12|vitamin b 12
1551404|NCT00572741|glutathione|glutathione
1551405|NCT00572715|kidney|kidney
1551406|NCT00572715|neonates|neonates
1551407|NCT00572702|Biocompatible Materials|biocompatible materials
1551408|NCT00572702|Female|female
1551409|NCT00572702|Humans|humans
1551410|NCT00572702|Pelvic Floor|pelvic floor
1551411|NCT00572702|Polypropylenes|polypropylenes
1551412|NCT00572702|Prostheses and Implants|prostheses and implants
1551413|NCT00572702|Surgical Mesh|surgical mesh
1551414|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
1551415|NCT00572689|Exenatide|exenatide
1551416|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
1551417|NCT00572689|Pharmacodynamics|pharmacodynamics
1551418|NCT00572689|Pharmacokinetics|pharmacokinetics
1551419|NCT00572663|Proteinuria|proteinuria
1551420|NCT00572663|Antioxidant|antioxidant
1551421|NCT00572663|N-acetylcysteine|n-acetylcysteine
1551422|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
1551423|NCT00572624|Heart Metabolism|heart metabolism
1551424|NCT00572624|Obesity|obesity
1551425|NCT00572624|Weight loss|weight loss
1551426|NCT00572624|Gastric bypass surgery|gastric bypass surgery
1551427|NCT00572624|Diet and exercise|diet and exercise
1551428|NCT00572611|Mass Balance|mass balance
1551429|NCT00572611|Metabolism|metabolism
1551430|NCT00572611|Absorption|absorption
1551431|NCT00572611|Excretion|excretion
1551432|NCT00572611|Pharmacokinetics|pharmacokinetics
1551433|NCT00572598|PET|pet
1551434|NCT00572598|multidrug resistance|multidrug resistance
1551435|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
1551437|NCT00572598|breast cancer|breast cancer
1551438|NCT00572598|dosimetry|dosimetry
1551439|NCT00572598|imaging feasibility|imaging feasibility
1551440|NCT00572585|Ulcerative colitis|ulcerative colitis
1551441|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
1551442|NCT00572585|AEB071|aeb071
1551443|NCT00572585|Modified Baron score|modified baron score
1551444|NCT00572585|Partial Mayo score|partial mayo score
1551445|NCT00572533|End-Stage Renal Disease|end-stage renal disease
1551446|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
1551447|NCT00572520|Depressive Disorder|depressive disorder
1551448|NCT00572520|Weight Loss|weight loss
1551449|NCT00572520|Behavioral Treatment|behavioral treatment
1551450|NCT00572520|Behavior Therapy|behavior therapy
1551451|NCT00572520|Randomized Clinical Trial|randomized clinical trial
1551452|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
1551453|NCT00572507|Safety and Efficacy|safety and efficacy
1551454|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
1551455|NCT00572507|Laparotomy|laparotomy
1551456|NCT00572494|Tibial arteries|tibial arteries
1551457|NCT00572494|Absorbable implants|absorbable implants
1551458|NCT00572494|Stents|stents
1551459|NCT00572494|Limb salvage|limb salvage
1551460|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
1551461|NCT00572481|Axillary Node Dissection|axillary node dissection
1551462|NCT00572481|Prevention of lymphedema|prevention of lymphedema
1551463|NCT00572481|Prevention of neuroma|prevention of neuroma
1551464|NCT00572481|Prevention of seroma|prevention of seroma
1551465|NCT00572468|cancer|cancer
1551466|NCT00572468|pre-operative surgery|pre-operative surgery
1551467|NCT00572468|prostate|prostate
1551468|NCT00572468|prostatectomy|prostatectomy
1551469|NCT00572468|radiation|radiation
1551470|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
1551471|NCT00572455|Ocular Hypertension|ocular hypertension
1551472|NCT00572442|Non-invasive heart scan|non-invasive heart scan
1551473|NCT00572442|MCG|mcg
1551474|NCT00572442|Cardiac Risk Factors|cardiac risk factors
1551475|NCT00572442|healthy volunteers|healthy volunteers
1551476|NCT00572429|HIV/AIDS|hiv/aids
1551477|NCT00572429|HAART|haart
1551478|NCT00572429|high cholesterol|high cholesterol
1551479|NCT00572429|exercise|exercise
1551480|NCT00572429|L-carnitine|l-carnitine
1551481|NCT00572429|Complimentary therapies|complimentary therapies
1551482|NCT00572416|fatigue|fatigue
1551483|NCT00572416|activity-rest|activity-rest
1551484|NCT00572416|sleep-wake|sleep-wake
1551485|NCT00572416|psychological distress|psychological distress
1551486|NCT00572416|symptom management|symptom management
1551487|NCT00572403|microalbuminuria|microalbuminuria
1551488|NCT00572403|risk factors|risk factors
1551489|NCT00572377|Sexual|sexual
1551490|NCT00572377|Arousal|arousal
1551491|NCT00572377|Female|female
1551492|NCT00572364|Cancer|cancer
1551493|NCT00572364|Advanced solid malignancies|advanced solid malignancies
1551494|NCT00572351|Wine|wine
1551495|NCT00572325|radiotherapy|radiotherapy
1551496|NCT00572325|NSCLC|nsclc
1551497|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1551498|NCT00572312|Proteinuria,|proteinuria,
1551499|NCT00572312|atorvastatin|atorvastatin
1551500|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
1551501|NCT00572286|heart transplant|heart transplant
1551502|NCT00572286|advanced heart failure|advanced heart failure
1551503|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
1551504|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
1551505|NCT00572286|echocardiogram|echocardiogram
1551506|NCT00572260|MRSA|mrsa
1551507|NCT00572260|Increased risk for infection|increased risk for infection
1551508|NCT00572234|Methamphetamine|methamphetamine
1551509|NCT00572234|Bupropion SR|bupropion sr
1551510|NCT00572221|CQI|cqi
1551511|NCT00572221|QA|qa
1551512|NCT00572221|Best Practice|best practice
1551513|NCT00572221|Quality Improvement|quality improvement
1551514|NCT00572221|Nursing Facilities|nursing facilities
1551515|NCT00572221|Nursing Homes|nursing homes
1551516|NCT00572221|Care|care
1551517|NCT00572195|Epilepsy|epilepsy
1551518|NCT00572195|Responsive neurostimulation|responsive neurostimulation
1551519|NCT00572195|RNS System|rns system
1551520|NCT00572195|NeuroPace|neuropace
1551521|NCT00572195|Brain stimulation|brain stimulation
1551522|NCT00572195|Seizures|seizures
1551523|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1551524|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1551525|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1551526|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1551527|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1551528|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
1551529|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
1551530|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
1551531|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1551532|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
1551533|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1551534|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1551535|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1551536|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1551537|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1551538|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1551539|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1551540|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
1551541|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
1551542|NCT00572156|growth|growth
1551543|NCT00572156|ISS|iss
1551544|NCT00572156|Constitutional growth delay|constitutional growth delay
1551545|NCT00572156|Primary IGFD|primary igfd
1551546|NCT00572156|Primary IGF Deficiency|primary igf deficiency
1551547|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
1551548|NCT00572143|Continuity of Patient Care*|continuity of patient care*
1551549|NCT00572143|Follow-Up Studies|follow-up studies
1551550|NCT00572143|Quality of Life|quality of life
1551551|NCT00572143|Patient Satisfaction|patient satisfaction
1551552|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
1551553|NCT00572130|Cyclin G1 gene|cyclin g1 gene
1551554|NCT00572130|Osteosarcoma|osteosarcoma
1551555|NCT00572117|Bipolar Disorder|bipolar disorder
1551556|NCT00572117|Manic Disorder|manic disorder
1551557|NCT00572117|Alcoholism|alcoholism
1551558|NCT00572117|Alcohol Abuse|alcohol abuse
1551559|NCT00572117|Alcohol Dependence|alcohol dependence
1551560|NCT00572117|Clinical Trial|clinical trial
1551561|NCT00572117|Evaluation Trial|evaluation trial
1551562|NCT00572117|Intervention Trial|intervention trial
1551563|NCT00572117|Validation Studies|validation studies
1551564|NCT00572091|Heart Failure|heart failure
1551565|NCT00572091|Mitral Regurgitation|mitral regurgitation
1551566|NCT00572078|solid tumor|solid tumor
1551567|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
1551569|NCT00572039|Vision Function|vision function
1551570|NCT00572039|Problem Solving Treatment|problem solving treatment
1551571|NCT00572039|PST|pst
1551572|NCT00572026|Attention deficit|attention deficit
1551573|NCT00572026|Hyperactivity|hyperactivity
1551574|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1551575|NCT00571987|Breast cancer|breast cancer
1551576|NCT00571987|Lumpectomy|lumpectomy
1551577|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
1551578|NCT00571987|Negative margins|negative margins
1551579|NCT00571987|Breast Conserving Surgery|breast conserving surgery
1551580|NCT00571961|HIV|hiv
1551581|NCT00571961|Pharmacokinetics|pharmacokinetics
1551582|NCT00571961|Buprenorphine|buprenorphine
1551583|NCT00571961|Kaletra|kaletra
1551584|NCT00571961|HIV Seronegativity|hiv seronegativity
1551585|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
1551586|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
1551587|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
1551588|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
1551589|NCT00571909|Chronic Kidney Pain|chronic kidney pain
1551590|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
1551591|NCT00571909|Kidney Cyst|kidney cyst
1551592|NCT00571909|VSPL|vspl
1551593|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
1551594|NCT00571896|constipation|constipation
1551595|NCT00571896|SennaS|sennas
1551596|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1551597|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1551598|NCT00571883|tongue cancer|tongue cancer
1551599|NCT00571844|High Blood Pressure|high blood pressure
1551600|NCT00571844|Exercise|exercise
1551601|NCT00571844|Diet|diet
1551602|NCT00571844|Biomarkers|biomarkers
1551603|NCT00571831|macula edema|macula edema
1551604|NCT00571831|intraocular lens|intraocular lens
1551605|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
1551606|NCT00571818|euglycemic|euglycemic
1551607|NCT00571818|transplant|transplant
1551608|NCT00571818|pancreas|pancreas
1551609|NCT00571818|hyperglycemic|hyperglycemic
1551610|NCT00571818|kidney|kidney
1551611|NCT00571805|cigarette|cigarette
1551612|NCT00571805|craving|craving
1551613|NCT00571805|reward|reward
1551614|NCT00571792|COPD|copd
1551615|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
1551616|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
1551617|NCT00571792|symptoms of COPD|symptoms of copd
1551618|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
1551619|NCT00571766|chronic Hypertension|chronic hypertension
1551620|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
1551621|NCT00571753|NAT2 genotyping|nat2 genotyping
1551622|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
1551623|NCT00571740|stage IV colon cancer|stage iv colon cancer
1551624|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
1551625|NCT00571740|recurrent colon cancer|recurrent colon cancer
1551626|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
1551627|NCT00571727|growth|growth
1551628|NCT00571727|insulin like growth factor|insulin like growth factor
1551629|NCT00571727|Larons syndrome|larons syndrome
1551630|NCT00571714|Chronic hepatitis C|chronic hepatitis c
1551631|NCT00571714|Pilot Comparison|pilot comparison
1551632|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
1551633|NCT00571714|Ribavirin|ribavirin
1551634|NCT00571714|Betaine|betaine
1551635|NCT00571714|Genotype 1|genotype 1
1551636|NCT00571714|Treatment naive|treatment naive
1551638|NCT00571701|RRP|rrp
1551639|NCT00571688|Bipolar Disorder|bipolar disorder
1551640|NCT00571688|Depression, Bipolar|depression, bipolar
1551641|NCT00571688|Mania|mania
1551642|NCT00571675|Prostate Cancer|prostate cancer
1551643|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1551644|NCT00571675|HRPC|hrpc
1551645|NCT00571675|Docetaxel|docetaxel
1551646|NCT00571675|Taxotere|taxotere
1551647|NCT00571675|Prednisone|prednisone
1551648|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
1551649|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
1551650|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
1551651|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
1551652|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
1551653|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
1551654|NCT00571649|Medical illness|medical illness
1551655|NCT00571636|Opioids infusion|opioids infusion
1551656|NCT00571636|mechanical ventilation|mechanical ventilation
1551657|NCT00571623|Brain Injury|brain injury
1551658|NCT00571623|Intracranial hypertension|intracranial hypertension
1551659|NCT00571623|Human subjects|human subjects
1551660|NCT00571623|Nursing care|nursing care
1551661|NCT00571610|Heart Failure|heart failure
1551662|NCT00571610|Mitral Regurgitation|mitral regurgitation
1551663|NCT00571597|surgery|surgery
1551664|NCT00571597|ablation|ablation
1551665|NCT00571597|radiofrequency|radiofrequency
1551666|NCT00571597|minimaze|minimaze
1551667|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
1551668|NCT00571571|Identity difussion|identity difussion
1551669|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
1551670|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
1551671|NCT00571571|Identity|identity
1551672|NCT00571571|Identity crisis|identity crisis
1551673|NCT00571571|Identity pathology|identity pathology
1551674|NCT00571545|Traumatic brain injury|traumatic brain injury
1551675|NCT00571545|Depression|depression
1551676|NCT00571545|Exercise|exercise
1551677|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1551678|NCT00571506|Vascular Diseases|vascular diseases
1551679|NCT00571506|Thiazolidinediones|thiazolidinediones
1551680|NCT00571506|Platelet Aggregation|platelet aggregation
1551681|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
1551682|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
1551683|NCT00571493|BEAM|beam
1551684|NCT00571493|Velcade|velcade
1551685|NCT00571480|auricular acupuncture|auricular acupuncture
1551686|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
1551687|NCT00571480|acupuncture|acupuncture
1551688|NCT00571467|Autoimmune Diseases|autoimmune diseases
1551689|NCT00571467|Bleeding Disorders|bleeding disorders
1551690|NCT00571467|Blood and Blood Disorders|blood and blood disorders
1551691|NCT00571454|depression|depression
1551692|NCT00571454|primary care|primary care
1551693|NCT00571454|Latino|latino
1551694|NCT00571454|telephone|telephone
1551695|NCT00571454|care management|care management
1551696|NCT00571441|stroke|stroke
1551697|NCT00571441|Brain injury|brain injury
1551698|NCT00571441|nursing|nursing
1551699|NCT00571441|Critical care|critical care
1551700|NCT00571428|COPD|copd
1551701|NCT00571428|Chronic Bronchitis|chronic bronchitis
1551702|NCT00571428|Emphysema|emphysema
1551703|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
1551704|NCT00571402|Family Treatment|family treatment
1551705|NCT00571402|Pharmacotherapy|pharmacotherapy
1551706|NCT00571389|Stage IV|stage iv
1551707|NCT00571389|Advanced Stage III|advanced stage iii
1551708|NCT00571376|Quality of health care|quality of health care
1551709|NCT00571376|Health care costs|health care costs
1551710|NCT00571350|Cystocele|cystocele
1551711|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
1551712|NCT00571350|urinary incontinence|urinary incontinence
1551713|NCT00571337|Stop infliximab.|stop infliximab.
1551714|NCT00571324|hyperinsulinism|hyperinsulinism
1551715|NCT00571324|hypoglycemia|hypoglycemia
1551716|NCT00571324|KATP channel|katp channel
1551717|NCT00571324|Kir6.2|kir6.2
1551718|NCT00571311|Assent|assent
1551719|NCT00571311|Adolescent|adolescent
1551720|NCT00571311|Informed Consent|informed consent
1551721|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
1551722|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
1551723|NCT00571298|Mesothelioma|mesothelioma
1551724|NCT00571298|cisplatin|cisplatin
1551725|NCT00571298|gemcitabine|gemcitabine
1551726|NCT00571298|amifostine|amifostine
1551727|NCT00571298|sodium thiosulfate|sodium thiosulfate
1551728|NCT00571285|Parkinson's disease|parkinson's disease
1551729|NCT00571285|Nutrition|nutrition
1551730|NCT00571285|Vitamin supplement|vitamin supplement
1551731|NCT00571285|Motor function|motor function
1551732|NCT00571285|Non-motor function|non-motor function
1551733|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
1551734|NCT00571272|Cholestasis|cholestasis
1551735|NCT00571272|Childhood Diseases|childhood diseases
1551736|NCT00571272|Genetic Diseases|genetic diseases
1551737|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
1551738|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
1551739|NCT00571259|Sodium citrate|sodium citrate
1551740|NCT00571259|Gentamicin|gentamicin
1551741|NCT00571259|Prophylaxis|prophylaxis
1551742|NCT00571259|Hemodialysis|hemodialysis
1551743|NCT00571259|Central venous catheter|central venous catheter
1551744|NCT00571246|treatment|treatment
1551745|NCT00571246|Lamotrigine|lamotrigine
1551746|NCT00571246|Topiramate|topiramate
1551747|NCT00571246|alcohol dependence|alcohol dependence
1551748|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
1551749|NCT00571233|Single Ventricle|single ventricle
1551750|NCT00571233|Congenital Heart Disease|congenital heart disease
1551751|NCT00571233|Children|children
1551752|NCT00571233|Fontan|fontan
1551753|NCT00571233|Tricuspid Atresia|tricuspid atresia
1551754|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1551755|NCT00571233|Heart Failure|heart failure
1551756|NCT00571233|Biomarkers|biomarkers
1551757|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
1551758|NCT00571233|unbalanced AV canal|unbalanced av canal
1551759|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
1551760|NCT00571220|gastric bypass|gastric bypass
1551761|NCT00571220|diabetes|diabetes
1551762|NCT00571220|obesity|obesity
1551763|NCT00571220|diet-induced weight loss|diet-induced weight loss
1551764|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
1551765|NCT00571220|incretin effect|incretin effect
1551766|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
1551767|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
1551768|NCT00571207|checklist|checklist
1551769|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
1551770|NCT00571181|Algorithms|algorithms
1551771|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
1551772|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
1551773|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
1551774|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
1551775|NCT00571181|Feasibility Studies|feasibility studies
1551776|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
1551777|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
1551778|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
1551779|NCT00571181|Prospective Studies|prospective studies
1551780|NCT00571181|Software|software
1551781|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
1551782|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
1551783|NCT00571168|high dose chemotherapy|high dose chemotherapy
1551784|NCT00571142|edema|edema
1551785|NCT00571142|retinal thickness|retinal thickness
1551786|NCT00571142|diabetic retinopathy|diabetic retinopathy
1551787|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
1553370|NCT00564265|GIST|gist
1551788|NCT00571116|Metastatic Melanoma|metastatic melanoma
1551789|NCT00571116|Disulfiram|disulfiram
1551790|NCT00571116|Arsenic Trioxide|arsenic trioxide
1551791|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
1551792|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
1551793|NCT00571090|Thyroid nodule|thyroid nodule
1551794|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
1551795|NCT00571077|Thyroid neoplasms|thyroid neoplasms
1551796|NCT00571077|thyroid nodules|thyroid nodules
1551797|NCT00571077|electrical impedance scanning|electrical impedance scanning
1551798|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
1551799|NCT00571038|Hypertension|hypertension
1551800|NCT00571038|Self-help groups|self-help groups
1551801|NCT00571038|Community health networks|community health networks
1551802|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
1551803|NCT00571038|Patient participation|patient participation
1551804|NCT00571038|Randomized clinical trial|randomized clinical trial
1551805|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
1551806|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
1551807|NCT00571025|family genetics|family genetics
1551808|NCT00571025|genetic counseling|genetic counseling
1551809|NCT00571025|genetic marker|genetic marker
1551810|NCT00571025|genetic polymorphism|genetic polymorphism
1551811|NCT00571025|genetic susceptibility|genetic susceptibility
1551812|NCT00571012|glaucoma|glaucoma
1551813|NCT00571012|outflow facility|outflow facility
1551814|NCT00571012|Healthy eye function|healthy eye function
1551815|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1551816|NCT00570999|Palifermin|palifermin
1551817|NCT00570999|Kepivance|kepivance
1551818|NCT00570999|Prevenar|prevenar
1551819|NCT00570999|Placebo|placebo
1551820|NCT00570986|Plaque Psoriasis|plaque psoriasis
1551821|NCT00570973|Variceal Bleeding|variceal bleeding
1551822|NCT00570973|Cirrhosis|cirrhosis
1551823|NCT00570973|Encephalopathy|encephalopathy
1551824|NCT00570973|Endoscopic band ligation|endoscopic band ligation
1551825|NCT00570973|TIPS|tips
1551826|NCT00570960|Peritonitis|peritonitis
1551827|NCT00570947|CPR Anytime|cpr anytime
1551828|NCT00570921|Breast cancer|breast cancer
1551829|NCT00570921|Fulvestrant|fulvestrant
1551830|NCT00570921|Everolimus|everolimus
1551831|NCT00570908|brain metastasis|brain metastasis
1551832|NCT00570908|breast cancer|breast cancer
1551833|NCT00570908|metastatic breast cancer|metastatic breast cancer
1551834|NCT00570895|Iron|iron
1551835|NCT00570895|Absorption|absorption
1551836|NCT00570895|Ascorbic Acid|ascorbic acid
1551837|NCT00570895|Ferrous Fumarate|ferrous fumarate
1551838|NCT00570882|Renal cell carcinoma|renal cell carcinoma
1551839|NCT00570882|Sunitinib|sunitinib
1551840|NCT00570882|phase II study|phase ii study
1551841|NCT00570882|Randomized study|randomized study
1551842|NCT00570869|Infant CPR|infant cpr
1551843|NCT00570856|Folic Acid|folic acid
1551844|NCT00570856|Homocysteine|homocysteine
1551845|NCT00570856|intima-media thickness|intima-media thickness
1551846|NCT00570817|Methotrexate|methotrexate
1551847|NCT00570817|Nephrotoxicity|nephrotoxicity
1551848|NCT00570817|Hydration|hydration
1551849|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1551850|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1551851|NCT00570817|Medulloblastoma|medulloblastoma
1551852|NCT00570817|Ependymoma|ependymoma
1551853|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
1551854|NCT00570804|Smoking Cessation|smoking cessation
1551855|NCT00570804|Puerto Rico Quitline|puerto rico quitline
1551856|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
1551857|NCT00570804|Oral Cancer|oral cancer
1551858|NCT00570804|Risk Reduction|risk reduction
1551859|NCT00570804|Tobacco Use|tobacco use
1551860|NCT00570804|Alcohol Use|alcohol use
1551861|NCT00570804|MAPS|maps
1551862|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
1551863|NCT00570804|Telephone Interview|telephone interview
1551864|NCT00570804|Counseling|counseling
1551865|NCT00570791|Cornea|cornea
1551866|NCT00570791|Tonometers|tonometers
1551867|NCT00570791|Goldmann applanation|goldmann applanation
1551868|NCT00570791|Tonopen|tonopen
1551869|NCT00570791|Shiotz|shiotz
1551870|NCT00570791|Pneumatonometer|pneumatonometer
1551871|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
1551872|NCT00570739|Colesevelam|colesevelam
1551873|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1551874|NCT00570739|Pre-diabetes|pre-diabetes
1551875|NCT00570739|Metformin|metformin
1551876|NCT00570700|prostate|prostate
1551877|NCT00570687|Inhaled Insulin|inhaled insulin
1551878|NCT00570674|SSCHN|sschn
1551879|NCT00570674|Abraxane|abraxane
1551880|NCT00570674|IMRT|imrt
1551881|NCT00570648|Corneal transplantation|corneal transplantation
1551882|NCT00570635|GIST|gist
1551883|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
1551884|NCT00570622|Cirrhosis|cirrhosis
1551885|NCT00570622|oxidative stress|oxidative stress
1551886|NCT00570622|pioglitazone|pioglitazone
1551887|NCT00570609|CPR|cpr
1551888|NCT00570583|Depression|depression
1551889|NCT00570583|Cognitive impairment|cognitive impairment
1551890|NCT00570583|Dementia|dementia
1551891|NCT00570583|Neuroimaging|neuroimaging
1551892|NCT00570583|Genetics|genetics
1551893|NCT00570570|stroke|stroke
1551894|NCT00570570|hemiplegia|hemiplegia
1551895|NCT00570570|gait|gait
1551896|NCT00570570|Strengthening|strengthening
1551897|NCT00570570|Physiotherapy|physiotherapy
1551898|NCT00570557|Skill Maintenance|skill maintenance
1551899|NCT00570557|Skill Decay|skill decay
1551900|NCT00570557|Screening|screening
1551901|NCT00570544|copd|copd
1551902|NCT00570544|emphysema|emphysema
1551903|NCT00570544|tiotropium|tiotropium
1551904|NCT00570544|lung function|lung function
1551905|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
1551906|NCT00570518|driving under the influence|driving under the influence
1551907|NCT00570518|psychoactive substances|psychoactive substances
1551908|NCT00570518|roadside surveys|roadside surveys
1551909|NCT00570518|hospital surveys|hospital surveys
1551910|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
1551911|NCT00570492|allergic rhinitis|allergic rhinitis
1551912|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
1551913|NCT00570492|growth|growth
1551914|NCT00570479|Retisert|retisert
1551915|NCT00570479|Uveitis|uveitis
1551916|NCT00570479|glaucoma|glaucoma
1551917|NCT00570466|Type 2 Diabetes|type 2 diabetes
1551918|NCT00570466|Prevention|prevention
1551919|NCT00570466|Children|children
1551920|NCT00570466|Diet|diet
1551921|NCT00570466|Physical Activity|physical activity
1551922|NCT00570440|AE adverse event|ae adverse event
1551923|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1551924|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1551925|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
1551926|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1551927|NCT00570440|DCF data collection forms|dcf data collection forms
1551928|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
1551929|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1551930|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1551931|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1551932|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
1551933|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
1551934|NCT00570440|IRB Institutional Review Board|irb institutional review board
1551935|NCT00570440|IU international units|iu international units
1551936|NCT00570440|mg milligram(s)|mg milligram(s)
1551937|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1551938|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
1551939|NCT00570440|SAE serious adverse event|sae serious adverse event
1551940|NCT00570440|µg microgram|µg microgram
1551941|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
1551942|NCT00570440|WB Western Blot|wb western blot
1551943|NCT00570427|psychotherapy|psychotherapy
1551944|NCT00570427|behavior therapy|behavior therapy
1551945|NCT00570427|counseling|counseling
1551946|NCT00570427|aging|aging
1551947|NCT00570427|medically underserved population|medically underserved population
1551948|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
1551949|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1551950|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1551951|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1551952|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1551953|NCT00570388|Neurocognitive|neurocognitive
1551954|NCT00570388|Alcohol Dependence|alcohol dependence
1551955|NCT00570388|Prometa|prometa
1551956|NCT00570388|Prometa Protocol|prometa protocol
1551957|NCT00570388|Starosta|starosta
1551958|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
1551959|NCT00570362|Normal tension glaucoma|normal tension glaucoma
1551960|NCT00570362|Glutathione|glutathione
1551961|NCT00570362|Antioxidant|antioxidant
1551962|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
1551963|NCT00570349|Cystic Fibrosis|cystic fibrosis
1551964|NCT00570336|HCV|hcv
1551965|NCT00570336|HCV treatment failure|hcv treatment failure
1551966|NCT00570336|Elevated aminotransferases|elevated aminotransferases
1551967|NCT00570323|Breast Cancer|breast cancer
1551968|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
1551969|NCT00570297|Pediatric|pediatric
1551970|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
1551971|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
1551972|NCT00570284|Cancer|cancer
1551973|NCT00570284|solid tumor|solid tumor
1551974|NCT00570284|food effect|food effect
1551975|NCT00570284|HDAC inhibitor|hdac inhibitor
1551976|NCT00570284|oral|oral
1551977|NCT00570284|LBH589|lbh589
1551978|NCT00570271|placebo effect|placebo effect
1551979|NCT00570271|blood pressure|blood pressure
1551980|NCT00570271|autonomic nervous system|autonomic nervous system
1551981|NCT00570271|prestige|prestige
1551982|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
1551983|NCT00570245|Lung transplantation|lung transplantation
1551984|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
1551985|NCT00570206|Probation|probation
1551986|NCT00570206|Motivational|motivational
1551987|NCT00570180|newly diagnosed|newly diagnosed
1551988|NCT00570167|Osteoarthritis|osteoarthritis
1551989|NCT00570167|Hip|hip
1551990|NCT00570167|Artroplasty|artroplasty
1551991|NCT00570167|Resurfacing|resurfacing
1551992|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
1551993|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
1551994|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1551995|NCT00570154|Diabetes|diabetes
1551996|NCT00570154|Monocyte|monocyte
1551997|NCT00570154|Macrophages|macrophages
1551998|NCT00570154|Proteome|proteome
1551999|NCT00570154|Type 2 Diabetes|type 2 diabetes
1552406|NCT00568789|Insomnia|insomnia
1552000|NCT00570154|Insulin Resistance|insulin resistance
1552001|NCT00570154|Insulin Sensitivity|insulin sensitivity
1552002|NCT00570154|Pre-Diabetes|pre-diabetes
1552003|NCT00570154|Healthy Volunteer|healthy volunteer
1552004|NCT00570154|HV|hv
1552005|NCT00570128|Down Syndrome|down syndrome
1552006|NCT00570128|trisomy 21|trisomy 21
1552007|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
1552008|NCT00570102|dietary manipulation|dietary manipulation
1552009|NCT00570102|infants|infants
1552010|NCT00570102|feasibility|feasibility
1552011|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
1552012|NCT00570089|Ranolazine|ranolazine
1552013|NCT00570089|Myocardial ischemia|myocardial ischemia
1552014|NCT00570089|Double blinded|double blinded
1552015|NCT00570089|Placebo controlled|placebo controlled
1552016|NCT00570063|Schizophrenia|schizophrenia
1552017|NCT00570063|acute exacerbation|acute exacerbation
1552018|NCT00570063|and PF-02545920|and pf-02545920
1552019|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
1552020|NCT00570037|Influenza|influenza
1552021|NCT00570037|Vaccine|vaccine
1552022|NCT00570037|Children|children
1552023|NCT00570024|Acupuncture|acupuncture
1552024|NCT00570024|Coronary Artery Disease|coronary artery disease
1552025|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1552026|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1552027|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1552028|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1552029|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1552030|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1552031|NCT00569985|Treatment Experienced|treatment experienced
1552032|NCT00569959|fasting lipid measures|fasting lipid measures
1552033|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
1552034|NCT00569959|clinical decision-making|clinical decision-making
1552035|NCT00569959|LDL-Cholesterol|ldl-cholesterol
1552036|NCT00569946|AG-013736|ag-013736
1552037|NCT00569946|RCC|rcc
1552038|NCT00569946|Phase 2|phase 2
1552039|NCT00569933|Hip Surgery|hip surgery
1552040|NCT00569933|Perioperative|perioperative
1552041|NCT00569933|suggestions/imagery|suggestions/imagery
1552042|NCT00569907|type 2 diabetes|type 2 diabetes
1552043|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
1552044|NCT00569907|exenatide|exenatide
1552045|NCT00569907|exenatide use|exenatide use
1552046|NCT00569881|Epithelium|epithelium
1552047|NCT00569881|Wound Healing|wound healing
1552048|NCT00569881|PRK|prk
1552049|NCT00569868|PLASMACYTOMA|plasmacytoma
1552050|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
1552051|NCT00569829|anxiety disorders|anxiety disorders
1552052|NCT00569829|school-based intervention|school-based intervention
1552053|NCT00569829|randomized, controlled trial|randomized, controlled trial
1552054|NCT00569816|myocardial protection|myocardial protection
1552055|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
1552056|NCT00569816|volatile anesthetics|volatile anesthetics
1552057|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
1552058|NCT00569790|S-1|s-1
1552059|NCT00569790|Irinotecan|irinotecan
1552060|NCT00569790|Bevacizumab|bevacizumab
1552061|NCT00569764|schizophrenia|schizophrenia
1552062|NCT00569764|metabolic syndrome|metabolic syndrome
1552063|NCT00569764|aripiprazole|aripiprazole
1552064|NCT00569751|de novo|de novo
1552065|NCT00569751|coronary|coronary
1552066|NCT00569751|coronary artery disease|coronary artery disease
1552067|NCT00569751|coronary disease|coronary disease
1552068|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
1552069|NCT00569738|somatostatin analog|somatostatin analog
1552070|NCT00569738|Gallium 68|gallium 68
1552071|NCT00569738|PET|pet
1552072|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
1552073|NCT00569712|precancerous condition|precancerous condition
1552074|NCT00569699|S-1|s-1
1552075|NCT00569699|Bevacizumab|bevacizumab
1552076|NCT00569686|PAD|pad
1552077|NCT00569686|peripheral artery disease|peripheral artery disease
1552078|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1552079|NCT00569673|fallopian tube cancer|fallopian tube cancer
1552080|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1552081|NCT00569660|Myelofibrosis|myelofibrosis
1552083|NCT00569660|Leukemia|leukemia
1552084|NCT00569660|Azacitidine|azacitidine
1552085|NCT00569660|Vidaza|vidaza
1552086|NCT00569647|preoperative anxiety|preoperative anxiety
1552087|NCT00569647|burn reconstruction|burn reconstruction
1552088|NCT00569634|Venous blood gas|venous blood gas
1552089|NCT00569634|Arterial blood gas|arterial blood gas
1552090|NCT00569634|pH|ph
1552091|NCT00569634|pCO2|pco2
1552092|NCT00569634|Bicarbonate|bicarbonate
1552093|NCT00569608|Parental stress|parental stress
1552094|NCT00569608|Early discharge|early discharge
1552095|NCT00569608|Anxiety|anxiety
1552096|NCT00569608|Depression|depression
1552407|NCT00568789|Aged|aged
1552097|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
1552098|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
1552099|NCT00569582|Cushing's Disease|cushing's disease
1552100|NCT00569582|Cushing's Syndrome|cushing's syndrome
1552101|NCT00569582|Cushings|cushings
1552102|NCT00569582|Pituitary|pituitary
1552103|NCT00569582|ACTH|acth
1552104|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
1552105|NCT00569582|Ectopic|ectopic
1552106|NCT00569582|Adrenal adenoma|adrenal adenoma
1552107|NCT00569582|Adrenal carcinoma|adrenal carcinoma
1552108|NCT00569582|Adrenal autonomy|adrenal autonomy
1552109|NCT00569582|Cortisol|cortisol
1552110|NCT00569582|Hypercortisolemia|hypercortisolemia
1552111|NCT00569582|Cushingoid|cushingoid
1552112|NCT00569582|Moon facies|moon facies
1552113|NCT00569582|Dorsocervical fat|dorsocervical fat
1552114|NCT00569582|Plethora|plethora
1552115|NCT00569582|Hirsutism|hirsutism
1552116|NCT00569582|Violaceous striae|violaceous striae
1552117|NCT00569582|Hormone|hormone
1552118|NCT00569582|Contraceptive|contraceptive
1552119|NCT00569582|Endocrine|endocrine
1552120|NCT00569582|Cushing Syndrome|cushing syndrome
1552121|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
1552122|NCT00569556|Diabetes Mellitus|diabetes mellitus
1552123|NCT00569556|Chronic Care Model|chronic care model
1552124|NCT00569556|Case Management|case management
1552125|NCT00569543|breast cancer in situ|breast cancer in situ
1552126|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1552127|NCT00569543|stage I breast cancer|stage i breast cancer
1552128|NCT00569543|stage II breast cancer|stage ii breast cancer
1552129|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
1552130|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
1552131|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
1552132|NCT00569543|stage IV breast cancer|stage iv breast cancer
1552133|NCT00569530|nitric oxide|nitric oxide
1552134|NCT00569530|surfactant|surfactant
1552135|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1552136|NCT00569530|prematurity|prematurity
1552137|NCT00569530|neonates|neonates
1552138|NCT00569530|iNO|ino
1552139|NCT00569530|Infasurf|infasurf
1552140|NCT00569530|lung function|lung function
1552141|NCT00569530|ventilated infants|ventilated infants
1552142|NCT00569517|obesity|obesity
1552143|NCT00569517|CBT|cbt
1552144|NCT00569517|Atypical antipsychotics|atypical antipsychotics
1552145|NCT00569517|metabolic syndrome|metabolic syndrome
1552146|NCT00569504|schizophrenia|schizophrenia
1552147|NCT00569504|antipsychotics|antipsychotics
1552148|NCT00569504|metabolic syndrome|metabolic syndrome
1552149|NCT00569504|prevalence|prevalence
1552150|NCT00569478|ICD|icd
1552151|NCT00569478|Rehabilitation|rehabilitation
1552152|NCT00569465|nitric oxide|nitric oxide
1552153|NCT00569465|oxidative stress|oxidative stress
1552154|NCT00569465|diabetes|diabetes
1552155|NCT00569465|hypertension|hypertension
1552156|NCT00569465|endothelial dysfunction|endothelial dysfunction
1552157|NCT00569439|Labor|labor
1552158|NCT00569439|Carbohydrate|carbohydrate
1552159|NCT00569439|Dystocia|dystocia
1552160|NCT00569413|Sex|sex
1552161|NCT00569413|brain imaging|brain imaging
1552162|NCT00569413|dopamine|dopamine
1552163|NCT00569413|sexual disorder|sexual disorder
1552164|NCT00569387|pancreatic cancer|pancreatic cancer
1552165|NCT00569387|vaccine|vaccine
1552166|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
1552167|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
1552168|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
1552169|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
1552170|NCT00569322|ICU|icu
1552171|NCT00569322|Admission|admission
1552172|NCT00569322|BG|bg
1552173|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1552382|NCT00568958|heavy episodic drinking|heavy episodic drinking
1552174|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1552175|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1552176|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1552177|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1552178|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1552179|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1552180|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1552181|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1552182|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1552183|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1552184|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1552185|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1552186|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1552187|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1552408|NCT00568789|Postural Balance|postural balance
1552188|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1552189|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1552190|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1552191|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1552192|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1552193|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1552194|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1552195|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1552196|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1552197|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1552198|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1552199|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1552200|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1552201|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
1552202|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
1552203|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
1552204|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
1552205|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1552206|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1552207|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1552208|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1552209|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1552210|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1552211|NCT00569309|small intestine lymphoma|small intestine lymphoma
1552212|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1552213|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1552214|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1552215|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1552216|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1552217|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1552218|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1552219|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1552220|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1552221|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1552222|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1552223|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1552224|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1552225|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1552226|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1552227|NCT00569283|primary myelofibrosis|primary myelofibrosis
1552228|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1552229|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1552230|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1552231|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1552232|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
1552233|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1552234|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1552235|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1552236|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1552237|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1552238|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1552239|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1552240|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1552241|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1552242|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1552243|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1552244|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1552245|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1552246|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1552247|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1552248|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1552810|NCT00566787|afib|afib
1552249|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1552250|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1552251|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1552252|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1552253|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1552254|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1552255|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1552256|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1552257|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1552258|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1552259|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1552260|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1552261|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1552262|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1552263|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1552264|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1552265|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1552266|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1552267|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1552268|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1552269|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1552270|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1552271|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1552272|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1552273|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1552274|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1552275|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1552276|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1552277|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1552278|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1552279|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1552280|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1552281|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1552282|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1552283|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1552284|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1552285|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1552286|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
1552287|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1552288|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1552289|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1552290|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1552291|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1552292|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1552293|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1552294|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1552295|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1552296|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1552297|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1552298|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
1552299|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
1552300|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1552301|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1552302|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1552303|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
1552304|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
1552305|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1552306|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1552307|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1552308|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1552309|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1552310|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1552311|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1552312|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1552409|NCT00568789|Drug Therapy|drug therapy
1552313|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1552314|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1552315|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
1552316|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
1552317|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
1552318|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
1552319|NCT00569283|stage IV breast cancer|stage iv breast cancer
1552320|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1552321|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1552322|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1552323|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1552324|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1552325|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1552326|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1552327|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1552328|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1552329|NCT00569257|LHRH receptor|lhrh receptor
1552330|NCT00569257|receptor positive tumors|receptor positive tumors
1552331|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1552332|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
1552333|NCT00569244|Menstrual Pain|menstrual pain
1552334|NCT00569244|Oral Contraception|oral contraception
1552335|NCT00569231|Warts|warts
1552336|NCT00569231|Candida|candida
1552337|NCT00569231|HPV|hpv
1552338|NCT00569231|Injections, Intralesional|injections, intralesional
1552339|NCT00569231|Immune System|immune system
1552340|NCT00569192|asthmatic children|asthmatic children
1552341|NCT00569179|Myeloid Malignancies|myeloid malignancies
1552342|NCT00569179|Bone Marrow Transplant|bone marrow transplant
1552343|NCT00569179|AML|aml
1552344|NCT00569179|ALL|all
1552345|NCT00569179|MDS|mds
1552346|NCT00569179|CML|cml
1552347|NCT00569166|fatigue|fatigue
1552348|NCT00569166|sleep disorders|sleep disorders
1552349|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1552350|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1552351|NCT00569166|breast cancer|breast cancer
1552352|NCT00569166|hot flashes|hot flashes
1552353|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
1552354|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
1552355|NCT00569088|Chinese Medicine|chinese medicine
1552356|NCT00569088|pathogenesis|pathogenesis
1552357|NCT00569088|YURE|yure
1552358|NCT00569075|Apoptic biomarkers|apoptic biomarkers
1552359|NCT00569075|Early detection periodontitis|early detection periodontitis
1552360|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
1552361|NCT00569075|Healthy subjects|healthy subjects
1552362|NCT00569062|Psychomotor retardation|psychomotor retardation
1552363|NCT00569062|cytokines|cytokines
1552364|NCT00569062|GW856553|gw856553
1552365|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1552366|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
1552367|NCT00569023|Beta Carotene|beta carotene
1552368|NCT00569023|visual functions|visual functions
1552369|NCT00569023|Fundus albipunctatus|fundus albipunctatus
1552370|NCT00569023|Night Blindness|night blindness
1552371|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
1552372|NCT00569010|AML|aml
1552373|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
1552374|NCT00569010|MDS|mds
1552375|NCT00569010|Leukemia|leukemia
1552376|NCT00568997|Atopic dermatitis eczema pediatric pimecrolimus malignancy|atopic dermatitis eczema pediatric pimecrolimus malignancy
1552377|NCT00568971|DCF|dcf
1552378|NCT00568971|Advanced gastric cancer|advanced gastric cancer
1552379|NCT00568971|Phase II study|phase ii study
1552380|NCT00568971|Efficacy|efficacy
1552381|NCT00568971|Toxicity|toxicity
1552383|NCT00568958|young adults|young adults
1552384|NCT00568958|naltrexone|naltrexone
1552385|NCT00568958|BASICS counseling|basics counseling
1552386|NCT00568958|alcohol-related consequences|alcohol-related consequences
1552387|NCT00568958|double-blind trial|double-blind trial
1552388|NCT00568958|randomized clinical trial|randomized clinical trial
1552389|NCT00568945|Atrial Fibrillation|atrial fibrillation
1552390|NCT00568945|Capadenoson|capadenoson
1552391|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
1552392|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
1552393|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
1552394|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
1552395|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
1552396|NCT00568841|erlotinib|erlotinib
1552397|NCT00568841|FDG-PET|fdg-pet
1552398|NCT00568841|FLT-PET|flt-pet
1552399|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
1552400|NCT00568828|Macular Pigment|macular pigment
1552401|NCT00568815|DLBCL|dlbcl
1552402|NCT00568815|Rituximab|rituximab
1552403|NCT00568815|ESHAP|eshap
1552404|NCT00568815|Efficacy|efficacy
1552410|NCT00568763|stage IV melanoma|stage iv melanoma
1552411|NCT00568763|recurrent melanoma|recurrent melanoma
1552412|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1552413|NCT00568737|Severe Sepsis|severe sepsis
1552414|NCT00568724|Hydronephrosis|hydronephrosis
1552415|NCT00568724|Ureteral obstruction|ureteral obstruction
1552416|NCT00568711|Doxycycline,|doxycycline,
1552417|NCT00568711|Rifampin|rifampin
1552418|NCT00568711|Scrub typhus.|scrub typhus.
1552419|NCT00568672|Major Depression|major depression
1552420|NCT00568672|Olanzapine|olanzapine
1552421|NCT00568672|add-on therapy|add-on therapy
1552422|NCT00568672|antidepressant|antidepressant
1552423|NCT00568672|atypical antipsychotic|atypical antipsychotic
1552424|NCT00568659|Gas exchange|gas exchange
1552425|NCT00568659|Respiratory mechanics|respiratory mechanics
1552426|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
1552427|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
1552428|NCT00568607|Response Rate|response rate
1552429|NCT00568607|TTP|ttp
1552430|NCT00568607|OS|os
1552431|NCT00568607|Toxicities|toxicities
1552432|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
1552433|NCT00568594|Atherosclerosis,|atherosclerosis,
1552434|NCT00568594|HDL,|hdl,
1552435|NCT00568594|Inflammation,|inflammation,
1552436|NCT00568568|Growth Hormone|growth hormone
1552437|NCT00568568|GH signaling|gh signaling
1552438|NCT00568568|Insulin resistance|insulin resistance
1552439|NCT00568568|Insulin Signaling|insulin signaling
1552440|NCT00568542|cardiomyopathy|cardiomyopathy
1552441|NCT00568542|ischemia|ischemia
1552442|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
1552443|NCT00568542|remodeling|remodeling
1552444|NCT00568529|Advanced gastric cancer|advanced gastric cancer
1552445|NCT00568529|Response rate|response rate
1552446|NCT00568529|Side effects|side effects
1552447|NCT00568529|time to progression|time to progression
1552448|NCT00568529|overall survival|overall survival
1552449|NCT00568516|ASP3550|asp3550
1552450|NCT00568516|Degarelix|degarelix
1552451|NCT00568516|Prostate cancer|prostate cancer
1552452|NCT00568516|Prostatic neoplasms|prostatic neoplasms
1552453|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
1552454|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
1552455|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
1552456|NCT00568464|Response rate|response rate
1552457|NCT00568464|TTP|ttp
1552458|NCT00568464|OS|os
1552459|NCT00568464|Toxicity|toxicity
1552460|NCT00568451|stage IV melanoma|stage iv melanoma
1552461|NCT00568451|recurrent melanoma|recurrent melanoma
1552462|NCT00568412|atopic dermatitis|atopic dermatitis
1552463|NCT00568399|Coronary|coronary
1552464|NCT00568399|Calcification|calcification
1552465|NCT00568399|Dialysis|dialysis
1552466|NCT00568399|Thiosulfate|thiosulfate
1552467|NCT00568399|Cardiovascular|cardiovascular
1552468|NCT00568386|Dry eye|dry eye
1552469|NCT00568373|Gastroparesis|gastroparesis
1552470|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
1552471|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
1552472|NCT00568334|chickenpox|chickenpox
1552473|NCT00568334|varicella|varicella
1552474|NCT00568334|two-dose schedule|two-dose schedule
1552475|NCT00568334|second year of life|second year of life
1552476|NCT00568321|monoclonal antibody|monoclonal antibody
1552477|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
1552478|NCT00568308|PI-88|pi-88
1552479|NCT00568308|Phase III|phase iii
1552480|NCT00568308|Adjuvant Therapy|adjuvant therapy
1552481|NCT00568308|Hepatoma|hepatoma
1552482|NCT00568308|Liver Cancer|liver cancer
1552483|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
1552484|NCT00568256|Ulcerative Colitis|ulcerative colitis
1552485|NCT00568256|IBD Flare-Up|ibd flare-up
1552486|NCT00568256|Stress|stress
1552487|NCT00568243|Visuomotor Integration|visuomotor integration
1552488|NCT00568243|Visual Attention|visual attention
1552489|NCT00568243|Healthy Volunteer|healthy volunteer
1552490|NCT00568243|HV|hv
1552491|NCT00568230|heart failure|heart failure
1552492|NCT00568230|mitral regurgitation|mitral regurgitation
1552493|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
1552494|NCT00568191|Age-related macular degeneration|age-related macular degeneration
1552495|NCT00568191|choroidal neovascularization|choroidal neovascularization
1552496|NCT00568191|Stratus OCT|stratus oct
1552497|NCT00568191|Cirrus OCT|cirrus oct
1552498|NCT00568165|Heart failure, congestive|heart failure, congestive
1552499|NCT00568165|Echocardiography|echocardiography
1552500|NCT00568165|Patient care team|patient care team
1552501|NCT00568152|Apples|apples
1552502|NCT00568152|Dietary intervention|dietary intervention
1552503|NCT00568152|Procyanidins|procyanidins
1552504|NCT00568139|adrenal cancer|adrenal cancer
1552505|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
1552506|NCT00568139|adverse events|adverse events
1552507|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
1552508|NCT00568126|Depression|depression
1552509|NCT00568126|Sexual Dysfunction|sexual dysfunction
1552510|NCT00568113|preterm labour|preterm labour
1552511|NCT00568113|n acetyl cysteine|n acetyl cysteine
1552512|NCT00568113|bacterial vaginosis|bacterial vaginosis
1552513|NCT00568100|gas exchange|gas exchange
1552514|NCT00568100|pressure support ventilation|pressure support ventilation
1552515|NCT00568100|respiratory mechanics|respiratory mechanics
1552516|NCT00568100|COPD|copd
1552517|NCT00568100|NAVA|nava
1552518|NCT00568087|N-acetylcysteine|n-acetylcysteine
1552519|NCT00568087|Alcoholism|alcoholism
1552520|NCT00568087|Treatment|treatment
1552521|NCT00568061|INOT44|inot44
1552522|NCT00568061|NOMI|nomi
1552523|NCT00568048|stage IV melanoma|stage iv melanoma
1552524|NCT00568048|recurrent melanoma|recurrent melanoma
1552525|NCT00568035|diabetic|diabetic
1552526|NCT00568035|peripheral|peripheral
1552527|NCT00568035|neuropathy|neuropathy
1552528|NCT00568009|Congestive Heart Failure|congestive heart failure
1552529|NCT00568009|Impaired Renal Function|impaired renal function
1552530|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
1552531|NCT00567970|liver metastases|liver metastases
1552532|NCT00567957|pre-eclampsia|pre-eclampsia
1552533|NCT00567957|remifentanil|remifentanil
1552534|NCT00567957|anesthesia, general|anesthesia, general
1552535|NCT00567957|analgesics, opioid|analgesics, opioid
1552536|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
1552537|NCT00567957|Cesarean section|cesarean section
1552538|NCT00567957|newborn|newborn
1552539|NCT00567957|maternal haemodynamic|maternal haemodynamic
1552540|NCT00567944|Physical Therapy Modalities|physical therapy modalities
1552541|NCT00567944|Electric Stimulation|electric stimulation
1552542|NCT00567944|Postural Balance|postural balance
1552543|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
1552544|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
1552545|NCT00567918|FK506|fk506
1552546|NCT00567918|Tacrolimus|tacrolimus
1552547|NCT00567905|Type 2 Diabetes|type 2 diabetes
1552548|NCT00567905|Green tea extract|green tea extract
1552549|NCT00567905|overweight|overweight
1552550|NCT00567892|tinnitus|tinnitus
1552551|NCT00567892|subjective tinnitus|subjective tinnitus
1552552|NCT00567892|therapy|therapy
1552553|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1552554|NCT00567892|clinical trial|clinical trial
1552555|NCT00567879|Breast Cancer|breast cancer
1552556|NCT00567879|HER2 positive|her2 positive
1552557|NCT00567879|adult-female|adult-female
1552558|NCT00567879|LBH589|lbh589
1552559|NCT00567879|HDAC inhibitor|hdac inhibitor
1552560|NCT00567879|panobinostat|panobinostat
1552561|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
1552562|NCT00567853|mitral valve disease|mitral valve disease
1552563|NCT00567853|mitral valve repair|mitral valve repair
1552564|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
1552565|NCT00567853|heart valve|heart valve
1552566|NCT00567853|valve disease|valve disease
1552567|NCT00567853|cardiac surgery|cardiac surgery
1552568|NCT00567840|Early Bactericidal Activity|early bactericidal activity
1552569|NCT00567840|EBA|eba
1552570|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
1552571|NCT00567840|PA-824|pa-824
1552572|NCT00567840|Pretomanid|pretomanid
1552573|NCT00567840|CL-007|cl-007
1552574|NCT00567827|Pneumonia|pneumonia
1552575|NCT00567814|Cocaine|cocaine
1552576|NCT00567814|Dependence|dependence
1552577|NCT00567814|Addiction|addiction
1552578|NCT00567814|Cortisol|cortisol
1552579|NCT00567814|GABA|gaba
1552580|NCT00567801|Lower Extremity|lower extremity
1552581|NCT00567801|Ischemia|ischemia
1552582|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
1552583|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
1552584|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
1552585|NCT00567762|FK506|fk506
1552586|NCT00567762|Tacrolimus|tacrolimus
1552587|NCT00567749|HIV-1 Infections|hiv-1 infections
1552588|NCT00567736|low back pain|low back pain
1552589|NCT00567736|complementary therapies|complementary therapies
1552590|NCT00567697|ranibizumab|ranibizumab
1552591|NCT00567697|CRVO|crvo
1552592|NCT00567697|macular edema|macular edema
1552593|NCT00567697|sham|sham
1552594|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
1552595|NCT00567684|Urothelial Cancer|urothelial cancer
1552596|NCT00567684|Bladder Cancer|bladder cancer
1552597|NCT00567684|Computed Tomography Urography|computed tomography urography
1552598|NCT00567684|CTU|ctu
1552599|NCT00567684|Intravenous Urography|intravenous urography
1552600|NCT00567684|IVU|ivu
1552601|NCT00567684|TCC|tcc
1552602|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
1552603|NCT00567671|keratoconus|keratoconus
1552604|NCT00567671|ectasia|ectasia
1716041|NCT00047944|Emotion|emotion
1552605|NCT00567671|cross-linking|cross-linking
1552606|NCT00567671|riboflavin|riboflavin
1552607|NCT00567671|UVA light|uva light
1552608|NCT00567671|cornea|cornea
1552609|NCT00567632|Pneumococci|pneumococci
1552610|NCT00567632|Antibody|antibody
1552611|NCT00567632|Standard laboratory values|standard laboratory values
1552612|NCT00567619|GERD|gerd
1552613|NCT00567619|NIS|nis
1552614|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
1552615|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
1552616|NCT00567580|stage III prostate cancer|stage iii prostate cancer
1552617|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1552618|NCT00567554|breast cancer|breast cancer
1552619|NCT00567554|primary systemic therapy|primary systemic therapy
1552620|NCT00567554|pCR Rates|pcr rates
1552621|NCT00567554|Bevacizumab|bevacizumab
1552622|NCT00567554|Trastuzumab|trastuzumab
1552623|NCT00567554|Lapatinib|lapatinib
1552624|NCT00567554|Everolimus|everolimus
1552625|NCT00567541|shoulder|shoulder
1552626|NCT00567541|pain|pain
1552627|NCT00567541|stroke|stroke
1552628|NCT00567541|subluxation|subluxation
1552629|NCT00567528|Soft tissue injuries|soft tissue injuries
1552630|NCT00567528|Topical ibuprofen|topical ibuprofen
1552631|NCT00567528|Adolescent athletes|adolescent athletes
1552632|NCT00567489|ESRD|esrd
1552633|NCT00567489|Diabetes|diabetes
1552634|NCT00567489|CAPD|capd
1552635|NCT00567489|APD|apd
1552636|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
1552637|NCT00567463|Asthma|asthma
1552638|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
1552639|NCT00567463|Methacholine|methacholine
1552640|NCT00567463|Induced sputum|induced sputum
1552641|NCT00567463|bronchial biopsies|bronchial biopsies
1552642|NCT00567450|sciatic block|sciatic block
1552643|NCT00567450|ropivacaine|ropivacaine
1552644|NCT00567450|mepivacaine|mepivacaine
1552645|NCT00567450|locoregional anesthesia|locoregional anesthesia
1552646|NCT00567437|aortic stenosis|aortic stenosis
1552647|NCT00567437|prognosis|prognosis
1552648|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
1552649|NCT00567424|epilepsy|epilepsy
1552650|NCT00567424|refractory|refractory
1552651|NCT00567424|seizure|seizure
1552652|NCT00567424|drug interactions|drug interactions
1552653|NCT00567424|pharmacokinetics|pharmacokinetics
1552654|NCT00567411|Glaucoma|glaucoma
1552656|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
1552657|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
1552658|NCT00567411|intraocular pressure|intraocular pressure
1552659|NCT00567398|ESRD|esrd
1552660|NCT00567398|Diabetes|diabetes
1552661|NCT00567398|CAPD|capd
1552662|NCT00567398|APD|apd
1552663|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
1552664|NCT00567372|sub-tenon|sub-tenon
1552665|NCT00567372|Bevacizumab|bevacizumab
1552666|NCT00567359|NSCLC|nsclc
1552667|NCT00567359|erlotinib|erlotinib
1552668|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
1552669|NCT00567359|EGFR|egfr
1552670|NCT00567346|randomised|randomised
1552671|NCT00567346|double-blind|double-blind
1552672|NCT00567346|placebo-controlled|placebo-controlled
1552673|NCT00567346|efficacy and safety|efficacy and safety
1552674|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
1552675|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1552676|NCT00567346|Allergy|allergy
1552677|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
1552678|NCT00567346|Immunotherapy|immunotherapy
1552679|NCT00567346|Grass pollen extract|grass pollen extract
1552680|NCT00567320|varenicline|varenicline
1552681|NCT00567294|Osteoporosis|osteoporosis
1552682|NCT00567294|Medication adherence|medication adherence
1552683|NCT00567294|Telephonic education|telephonic education
1552684|NCT00567294|Motivational interviewing|motivational interviewing
1552685|NCT00567281|Schizoaffective disorder|schizoaffective disorder
1552686|NCT00567281|Auditory Hallucinations|auditory hallucinations
1552687|NCT00567281|Voices|voices
1552688|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1552689|NCT00567281|rTMS|rtms
1552690|NCT00567281|Wernicke's Area|wernicke's area
1552691|NCT00567281|Middle Temporal Cortex|middle temporal cortex
1552692|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
1552693|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
1552694|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
1552695|NCT00567255|Obesity|obesity
1552696|NCT00567242|aphasia|aphasia
1552697|NCT00567242|therapies, investigational|therapies, investigational
1552698|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
1552699|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
1552700|NCT00567242|language|language
1552701|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
1552702|NCT00567190|Herceptin|herceptin
1552703|NCT00567190|Breast cancer|breast cancer
1552704|NCT00567190|MBC|mbc
1552705|NCT00567190|Taxotere|taxotere
1552706|NCT00567190|HER2|her2
1552707|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
1552708|NCT00567190|HER2 + breast cancer|her2 + breast cancer
1552709|NCT00567190|HER2-positive|her2-positive
1552710|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
1552711|NCT00567164|Oral Contraception|oral contraception
1552712|NCT00567164|Birth Control pill|birth control pill
1552809|NCT00566787|Atrial Fibrillation|atrial fibrillation
1552713|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
1552714|NCT00567164|Contraceptive efficacy|contraceptive efficacy
1552715|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
1552716|NCT00567125|laparoscopy|laparoscopy
1552717|NCT00567125|cytokines|cytokines
1552718|NCT00567125|VEGF-A|vegf-a
1552719|NCT00567125|endostatin|endostatin
1552720|NCT00567099|Psychiatry|psychiatry
1552721|NCT00567099|Antipsychotic|antipsychotic
1552722|NCT00567099|Psychopharmacology|psychopharmacology
1552723|NCT00567099|Clinical Trial|clinical trial
1552724|NCT00567099|Open Label|open label
1552725|NCT00567099|Schizophrenia|schizophrenia
1552726|NCT00567099|Sensory Gating|sensory gating
1552727|NCT00567099|Attention|attention
1552728|NCT00567099|Memory|memory
1552729|NCT00567086|Migraine|migraine
1552730|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
1552731|NCT00567073|GSD-II|gsd-ii
1552732|NCT00567073|Pompe Disease|pompe disease
1552733|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
1552734|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1552735|NCT00567073|Glycogenosis II|glycogenosis ii
1552736|NCT00567060|Piracetam|piracetam
1552737|NCT00567060|Nootropil|nootropil
1552738|NCT00567034|Zyprexa|zyprexa
1552739|NCT00567034|naltrexone|naltrexone
1552740|NCT00567034|schizophrenia|schizophrenia
1552741|NCT00567034|Metabolic Syndrome|metabolic syndrome
1552742|NCT00567034|pain|pain
1552743|NCT00567021|reflux|reflux
1552744|NCT00567021|NSAR treatment|nsar treatment
1552745|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
1552746|NCT00567008|cocaine|cocaine
1552747|NCT00567008|crack cocaine|crack cocaine
1552748|NCT00567008|cocaine-related disorders|cocaine-related disorders
1552749|NCT00567008|substance-related disorders|substance-related disorders
1552750|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
1552751|NCT00566995|Kidney Tumors|kidney tumors
1552752|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
1552753|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
1552754|NCT00566995|EGFR Inhibitor|egfr inhibitor
1552755|NCT00566995|VHL|vhl
1552756|NCT00566995|Von Hippel Lindau|von hippel lindau
1552757|NCT00566995|Kidney Tumor|kidney tumor
1552758|NCT00566982|Urogenital atrophy|urogenital atrophy
1552759|NCT00566982|Menopausal symptoms|menopausal symptoms
1552760|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
1552761|NCT00566982|Vaginal atrophy|vaginal atrophy
1552762|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
1552763|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
1552764|NCT00566956|Hydrosalpinx|hydrosalpinx
1552765|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
1552766|NCT00566917|Vagina|vagina
1552767|NCT00566917|Prolapse|prolapse
1552768|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
1552769|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
1552770|NCT00566904|Pain after Shingles|pain after shingles
1552771|NCT00566904|Shingles|shingles
1552772|NCT00566904|PHN|phn
1552773|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
1552774|NCT00566891|pci|pci
1552775|NCT00566891|tirofiban|tirofiban
1552776|NCT00566891|side effects|side effects
1552777|NCT00566878|Glycogen Storage Disease|glycogen storage disease
1552778|NCT00566878|GSD-II|gsd-ii
1552779|NCT00566878|Pompe Disease|pompe disease
1552780|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
1552781|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1552782|NCT00566878|Glycogenosis II|glycogenosis ii
1552783|NCT00566852|cognitive/functional effects|cognitive/functional effects
1552784|NCT00566852|neurotoxicity|neurotoxicity
1552785|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
1552973|NCT00566189|Omentum|omentum
1552786|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1552787|NCT00566839|COPD|copd
1552788|NCT00566839|LVRS|lvrs
1552789|NCT00566839|Awake surgery|awake surgery
1552790|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
1552791|NCT00566839|One-lung ventilation|one-lung ventilation
1552792|NCT00566839|Emphysema|emphysema
1552793|NCT00566839|VATS|vats
1552794|NCT00566839|Lung surgery|lung surgery
1552795|NCT00566826|Physical Function|physical function
1552796|NCT00566826|Total Knee Replacement|total knee replacement
1552797|NCT00566826|Physical Activity|physical activity
1552798|NCT00566826|Behavioral Support|behavioral support
1552799|NCT00566826|Arthroplasty|arthroplasty
1552800|NCT00566826|Function|function
1552801|NCT00566826|Self-Care|self-care
1552802|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1552803|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
1552804|NCT00566813|Exenatide|exenatide
1552805|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
1552806|NCT00566800|esophageal cancer|esophageal cancer
1552807|NCT00566800|Barrett esophagus|barrett esophagus
1552808|NCT00566787|AF|af
1552811|NCT00566787|racing heart|racing heart
1552812|NCT00566787|cabg|cabg
1552813|NCT00566787|valve|valve
1552814|NCT00566787|ablation|ablation
1552815|NCT00566787|bipolar|bipolar
1552816|NCT00566787|radiofrequency|radiofrequency
1552817|NCT00566787|rf|rf
1552818|NCT00566774|myocardial infarction|myocardial infarction
1552819|NCT00566774|secondary prevention|secondary prevention
1552820|NCT00566774|health insurance|health insurance
1552821|NCT00566774|cost-sharing|cost-sharing
1552822|NCT00566761|Macular edema|macular edema
1552823|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
1552824|NCT00566761|bevacizumab|bevacizumab
1552825|NCT00566761|triamcinolone|triamcinolone
1552826|NCT00566709|transfusion|transfusion
1552827|NCT00566709|NIRS|nirs
1552828|NCT00566709|cerebral oxygenation|cerebral oxygenation
1552829|NCT00566709|red blood cell|red blood cell
1552830|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
1552831|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
1552832|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
1552833|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
1552834|NCT00566696|Bone marrow transplant|bone marrow transplant
1552835|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
1552836|NCT00566696|T cell depletion methodology|t cell depletion methodology
1552837|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
1552838|NCT00566696|Campath-1H intravenous|campath-1h intravenous
1552839|NCT00566683|Propofol|propofol
1552840|NCT00566683|colonoscopy|colonoscopy
1552841|NCT00566683|sedation|sedation
1552842|NCT00566683|pain|pain
1552843|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
1552844|NCT00566670|Hemodialysis|hemodialysis
1552845|NCT00566657|Critical Limb Ischemia|critical limb ischemia
1552846|NCT00566657|Peripheral Artery Disease|peripheral artery disease
1552847|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
1552848|NCT00566644|endometrial cancer|endometrial cancer
1552849|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
1552850|NCT00566631|Schizophrenia|schizophrenia
1552851|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
1552852|NCT00566631|Invega|invega
1552853|NCT00566618|Breast Cancer|breast cancer
1552854|NCT00566618|Bone Metastases|bone metastases
1552855|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
1552856|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
1552857|NCT00566618|Dasatinib|dasatinib
1552858|NCT00566618|Zometa|zometa
1552859|NCT00566618|Zoledronic Acid|zoledronic acid
1552860|NCT00566618|Zoledronate|zoledronate
1552861|NCT00566618|BMS-345825|bms-345825
1552862|NCT00566618|Sprycel®|sprycel®
1552863|NCT00566579|Human papillomavirus|human papillomavirus
1552864|NCT00566579|Clearance|clearance
1552865|NCT00566579|Cryotherapy|cryotherapy
1552866|NCT00566566|adipocytokines|adipocytokines
1552867|NCT00566566|inflammatory markers|inflammatory markers
1552868|NCT00566566|cardiovascular disease|cardiovascular disease
1552869|NCT00566566|diabetes mellitus|diabetes mellitus
1552870|NCT00566566|Leptin|leptin
1552871|NCT00566553|Grape Seed Extract|grape seed extract
1552872|NCT00566553|Breast Cancer|breast cancer
1552873|NCT00566553|Estrogen Levels|estrogen levels
1552874|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
1552875|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1552876|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1552877|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1552878|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1553171|NCT00565344|Medicaid|medicaid
1552879|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1552880|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1552881|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1552882|NCT00566514|fibromyalgia|fibromyalgia
1552883|NCT00566514|ribose|ribose
1552884|NCT00566514|d-ribose|d-ribose
1552885|NCT00566514|dextrose|dextrose
1552886|NCT00566501|Moderate-to-severe|moderate-to-severe
1552887|NCT00566501|Alzheimer's|alzheimer's
1552888|NCT00566501|Disease|disease
1552889|NCT00566488|Thymus Transplantation|thymus transplantation
1552890|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
1552891|NCT00566488|DiGeorge Syndrome|digeorge syndrome
1552892|NCT00566488|Hypoparathyroidism|hypoparathyroidism
1552893|NCT00566488|Athymia|athymia
1552894|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1552895|NCT00566449|ADHD|adhd
1552896|NCT00566449|JNJ-31001074|jnj-31001074
1552897|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
1552898|NCT00566436|Superficial Femoral Artery|superficial femoral artery
1552899|NCT00566436|Remote Endarterectomy|remote endarterectomy
1553292|NCT00564655|pediatrics|pediatrics
1552900|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
1552901|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
1552902|NCT00566436|Vascular Patency|vascular patency
1552904|NCT00566423|Biomarkers|biomarkers
1552905|NCT00566423|MIF|mif
1552906|NCT00566423|BNP|bnp
1552907|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
1552908|NCT00566410|DCA|dca
1552909|NCT00566410|Phase I|phase i
1552910|NCT00566410|Dose Escalation|dose escalation
1552911|NCT00566410|Solid Tumours|solid tumours
1552912|NCT00566410|Dichloroacetate|dichloroacetate
1552913|NCT00566410|Pharmacokinetic|pharmacokinetic
1552914|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
1552915|NCT00566384|Loss of libido|loss of libido
1552916|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
1552917|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1552918|NCT00566371|insomnia|insomnia
1552919|NCT00566371|atomoxetine|atomoxetine
1552920|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
1552921|NCT00566358|duodenal exclusion|duodenal exclusion
1552922|NCT00566358|bariatric surgery|bariatric surgery
1552923|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
1552924|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1552925|NCT00566358|insulin|insulin
1552926|NCT00566358|glucagon|glucagon
1552927|NCT00566358|ghrelin|ghrelin
1552928|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
1552929|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1552930|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
1552931|NCT00566332|Fludarabine|fludarabine
1552932|NCT00566332|Chlorambucil|chlorambucil
1552933|NCT00566319|Exercise|exercise
1552934|NCT00566306|Clostridium difficile|clostridium difficile
1552935|NCT00566306|disinfectant|disinfectant
1552936|NCT00566280|MBI|mbi
1552937|NCT00566280|Mammogram|mammogram
1552938|NCT00566280|Breast Cancer|breast cancer
1552939|NCT00566280|Breast Ultrasound|breast ultrasound
1552940|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
1552941|NCT00566280|Molecular Breast Imaging|molecular breast imaging
1552942|NCT00566254|Epilepsy|epilepsy
1552943|NCT00566254|paediatric|paediatric
1552944|NCT00566254|partial onset seizures|partial onset seizures
1552945|NCT00566241|Body weight|body weight
1552946|NCT00566241|Body composition|body composition
1552947|NCT00566241|Pulmonary function|pulmonary function
1552948|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
1552949|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1552950|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1552951|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1552952|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1552953|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
1552954|NCT00566215|Insulin resistance|insulin resistance
1552955|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
1552956|NCT00566215|Omentum|omentum
1552957|NCT00566215|duodenal exclusion|duodenal exclusion
1552958|NCT00566215|bariatric surgery|bariatric surgery
1552959|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
1552960|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1552961|NCT00566215|insulin|insulin
1552962|NCT00566215|glucagon|glucagon
1552963|NCT00566215|ghrelin|ghrelin
1552964|NCT00566215|adiponectin|adiponectin
1552965|NCT00566215|Cytokines|cytokines
1552966|NCT00566202|Major Depressive Disorder|major depressive disorder
1552967|NCT00566202|Depression|depression
1552968|NCT00566202|JNJ-18038683|jnj-18038683
1552969|NCT00566202|Escitalopram|escitalopram
1552970|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
1552971|NCT00566189|Insulin resistance|insulin resistance
1552972|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
1552974|NCT00566189|duodenal exclusion|duodenal exclusion
1552975|NCT00566189|bariatric surgery|bariatric surgery
1552976|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
1552977|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1552978|NCT00566189|insulin|insulin
1552979|NCT00566189|glucagon|glucagon
1552980|NCT00566189|ghrelin|ghrelin
1716574|NCT00044304|HES|hes
1552981|NCT00566189|adiponectin|adiponectin
1552982|NCT00566189|Cytokines|cytokines
1552983|NCT00566176|Atrial Fibrillation|atrial fibrillation
1552984|NCT00566176|AF|af
1552985|NCT00566176|AFIB|afib
1552986|NCT00566176|racing heart|racing heart
1552987|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
1552988|NCT00566176|pvi|pvi
1552989|NCT00566176|mini maze|mini maze
1552990|NCT00566176|maze|maze
1552991|NCT00566150|Keppra|keppra
1552992|NCT00566150|Levetiracetam|levetiracetam
1552993|NCT00566150|Anticonvulsant|anticonvulsant
1552994|NCT00566150|Depression|depression
1552995|NCT00566150|Bipolar Disorder|bipolar disorder
1552996|NCT00566150|Affective Disorders|affective disorders
1552997|NCT00566150|Mood Disorders|mood disorders
1552998|NCT00566150|Double Blind|double blind
1552999|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
1553000|NCT00566137|Scleroderma|scleroderma
1553001|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
1553002|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
1553003|NCT00566111|Ceftriaxone|ceftriaxone
1553004|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
1553005|NCT00566111|Glutamatergic System|glutamatergic system
1553006|NCT00566111|Double-Blind|double-blind
1553007|NCT00566111|Mood Disorders|mood disorders
1553008|NCT00566111|Bipolar Disorder|bipolar disorder
1553009|NCT00566111|Depression|depression
1553010|NCT00566111|Affective Disorders|affective disorders
1553011|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
1553012|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
1553013|NCT00566085|MBI|mbi
1553014|NCT00566085|Breast Cancer|breast cancer
1553015|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
1553016|NCT00566085|Molecular Breast Imaging|molecular breast imaging
1553017|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
1553018|NCT00566059|therapeutic advice|therapeutic advice
1553019|NCT00566033|AUDIT|audit
1553020|NCT00566033|Chronic kidney disease|chronic kidney disease
1553021|NCT00566033|Clinical trial|clinical trial
1553022|NCT00566033|Creatinine|creatinine
1553023|NCT00566033|Multiple intervents|multiple intervents
1553024|NCT00566033|Nephrology guidelines.|nephrology guidelines.
1553025|NCT00566020|Open-label extension|open-label extension
1553026|NCT00566020|Tolerability|tolerability
1553027|NCT00566020|Lamotrigine|lamotrigine
1553028|NCT00566020|Safety|safety
1553029|NCT00566020|Bipolar I disorder|bipolar i disorder
1553030|NCT00566007|disc herniation|disc herniation
1553031|NCT00566007|lumbar|lumbar
1553032|NCT00566007|ozone therapy|ozone therapy
1553033|NCT00565994|hemodialysis|hemodialysis
1553034|NCT00565994|Vascular access|vascular access
1553035|NCT00565994|arteriovenous fistula|arteriovenous fistula
1553036|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
1553037|NCT00565994|arteriovenous grafts|arteriovenous grafts
1553038|NCT00565981|B-CLL|b-cll
1553039|NCT00565981|refractory|refractory
1553040|NCT00565981|molecular profiling|molecular profiling
1553041|NCT00565981|alemtuzumab|alemtuzumab
1553042|NCT00565981|fludarabinephosphate|fludarabinephosphate
1553043|NCT00565968|stage IIIB melanoma|stage iiib melanoma
1553044|NCT00565968|stage IIIC melanoma|stage iiic melanoma
1553045|NCT00565968|recurrent melanoma|recurrent melanoma
1553046|NCT00565955|Montelukast|montelukast
1553047|NCT00565955|Acute Asthma|acute asthma
1553048|NCT00565942|Integrative medicine|integrative medicine
1553049|NCT00565942|Primary care|primary care
1553050|NCT00565942|Swedish massage therapy|swedish massage therapy
1553051|NCT00565942|Manual therapy|manual therapy
1553052|NCT00565942|Naprapathy|naprapathy
1553053|NCT00565942|Shiatsu|shiatsu
1553054|NCT00565942|Acupuncture/TCM|acupuncture/tcm
1553055|NCT00565942|Qigong|qigong
1553056|NCT00565942|Pragmatic RCT|pragmatic rct
1553057|NCT00565942|Health services research|health services research
1553058|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
1553059|NCT00565916|Post-Menopausal|post-menopausal
1553060|NCT00565916|PET|pet
1553061|NCT00565916|Estrogen|estrogen
1553062|NCT00565916|Progesterone|progesterone
1553063|NCT00565916|Heart Metabolism|heart metabolism
1553064|NCT00565916|Cardiovascular Disease|cardiovascular disease
1553065|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
1553066|NCT00565903|PPB|ppb
1553067|NCT00565903|cystic nephroma|cystic nephroma
1553068|NCT00565903|DICER1|dicer1
1553069|NCT00565903|miRNA|mirna
1553070|NCT00565890|very low birth weight infant|very low birth weight infant
1553071|NCT00565890|hypothyroxinemia|hypothyroxinemia
1553072|NCT00565890|outcomes|outcomes
1553073|NCT00565877|Catheter|catheter
1553074|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
1553075|NCT00565877|ultrasound|ultrasound
1553076|NCT00565877|malposition|malposition
1553077|NCT00565864|Hypothyroidism|hypothyroidism
1553078|NCT00565864|Cognition|cognition
1553079|NCT00565864|Metabolism|metabolism
1553080|NCT00565838|Randomized study|randomized study
1553081|NCT00565838|surgical treatment|surgical treatment
1553082|NCT00565838|autologous fascial sling|autologous fascial sling
1553083|NCT00565838|TVT|tvt
1553084|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
1553085|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
1553086|NCT00565799|DM|dm
1553087|NCT00565760|Acute|acute
1553088|NCT00565760|Pain|pain
1553089|NCT00565747|GM-CSF|gm-csf
1553090|NCT00565747|infertility|infertility
1553091|NCT00565721|Static PET imaging|static pet imaging
1553092|NCT00565721|Dynamic PET imaging|dynamic pet imaging
1553093|NCT00565721|Angiogenesis|angiogenesis
1553094|NCT00565721|αvβ3 integrins|αvβ3 integrins
1553095|NCT00565721|oncology imaging|oncology imaging
1553096|NCT00565708|stage II colon cancer|stage ii colon cancer
1553927|NCT00561899|efficacy|efficacy
1553097|NCT00565708|stage III colon cancer|stage iii colon cancer
1553098|NCT00565708|stage II rectal cancer|stage ii rectal cancer
1553099|NCT00565708|stage III rectal cancer|stage iii rectal cancer
1553100|NCT00565695|Visual Outcomes|visual outcomes
1553101|NCT00565695|Patient Satisfaction|patient satisfaction
1553102|NCT00565695|Cataract Extraction|cataract extraction
1553103|NCT00565669|Treatment|treatment
1553104|NCT00565669|Dry Eye|dry eye
1553105|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
1553106|NCT00565643|Adhesion|adhesion
1553107|NCT00565643|Seprafilm|seprafilm
1553108|NCT00565643|Cesarean section|cesarean section
1553109|NCT00565617|depression|depression
1553110|NCT00565617|epidural|epidural
1553111|NCT00565617|cortical stimulation|cortical stimulation
1553112|NCT00565617|brain stimulation|brain stimulation
1553113|NCT00565617|treatment-resistant|treatment-resistant
1553114|NCT00565617|deep brain stimulation|deep brain stimulation
1553115|NCT00565617|TMS|tms
1553116|NCT00565617|DBS|dbs
1553117|NCT00565617|ECS|ecs
1553118|NCT00565604|Perforator Veins|perforator veins
1553119|NCT00565604|Incompetent Veins|incompetent veins
1553120|NCT00565604|Varicose Veins|varicose veins
1553121|NCT00565591|asthma|asthma
1553122|NCT00565591|inhaler device|inhaler device
1553123|NCT00565591|albuterol sulfate|albuterol sulfate
1553124|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
1553125|NCT00565552|silicone gel|silicone gel
1553126|NCT00565552|cicatrix|cicatrix
1553127|NCT00565552|wound healing|wound healing
1553128|NCT00565552|scar|scar
1553129|NCT00565552|keloid|keloid
1553130|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
1553131|NCT00565539|interferon lambda|interferon lambda
1553132|NCT00565539|interleukin 29|interleukin 29
1553133|NCT00565539|hepatitis C|hepatitis c
1553134|NCT00565539|virus|virus
1553135|NCT00565539|infection|infection
1553136|NCT00565539|liver|liver
1553137|NCT00565526|Autonomic Nervous System|autonomic nervous system
1553138|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
1553139|NCT00565526|Pathogenesis|pathogenesis
1553140|NCT00565526|Cholinergic|cholinergic
1553141|NCT00565526|Parasympathetic|parasympathetic
1553142|NCT00565526|Sjogren Syndrome|sjogren syndrome
1553143|NCT00565487|Radiotherapy|radiotherapy
1553144|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
1553145|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
1553146|NCT00565474|Renal transplantation|renal transplantation
1553147|NCT00565474|fluvastatin|fluvastatin
1553148|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1553149|NCT00565435|Chiari I Malformation|chiari i malformation
1553150|NCT00565422|Internet addiction|internet addiction
1553151|NCT00565422|Problematic internet use|problematic internet use
1553152|NCT00565422|Escitalopram|escitalopram
1553153|NCT00565422|Lexapro|lexapro
1553154|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
1553155|NCT00565383|Pregnancy|pregnancy
1553156|NCT00565383|37 Weeks Gestation|37 weeks gestation
1553157|NCT00565383|Breech Presentation|breech presentation
1553158|NCT00565383|Version Procedure|version procedure
1553159|NCT00565383|Pain Control|pain control
1553160|NCT00565383|Neuraxial analgesia|neuraxial analgesia
1553161|NCT00565370|Gastric cancer|gastric cancer
1553162|NCT00565370|capecitabine|capecitabine
1553163|NCT00565370|cisplatin|cisplatin
1553164|NCT00565370|sorafenib|sorafenib
1553165|NCT00565370|phase I|phase i
1553166|NCT00565370|phase II|phase ii
1553167|NCT00565357|Postnatal Growth|postnatal growth
1553168|NCT00565357|Postnatal Development|postnatal development
1553169|NCT00565357|Noise|noise
1553170|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
1553172|NCT00565344|Disenrollment|disenrollment
1553173|NCT00565318|Benfotiamine|benfotiamine
1553174|NCT00565318|Diabetes|diabetes
1553175|NCT00565318|Nephropathy|nephropathy
1553176|NCT00565305|Healing Touch|healing touch
1553177|NCT00565305|NK cytotoxicity|nk cytotoxicity
1553178|NCT00565305|cytokines|cytokines
1553179|NCT00565305|fatigue|fatigue
1553180|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
1553181|NCT00565253|pulmonary embolism|pulmonary embolism
1553182|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
1553183|NCT00565240|ovarian synchronization|ovarian synchronization
1553184|NCT00565240|folliculogenesis|folliculogenesis
1553185|NCT00565214|vitamin supplements|vitamin supplements
1553186|NCT00565214|healthy smokers|healthy smokers
1553187|NCT00565214|epithelial lung tissue|epithelial lung tissue
1553188|NCT00565214|bronchoscopy|bronchoscopy
1553189|NCT00565214|antioxidant levels|antioxidant levels
1553190|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
1553191|NCT00565175|Treatment resistant|treatment resistant
1553192|NCT00565175|Chronic|chronic
1553193|NCT00565136|Device study|device study
1553194|NCT00565136|Pelvic floor weakness|pelvic floor weakness
1553195|NCT00565136|Fecal incontinence|fecal incontinence
1553196|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
1553197|NCT00565097|Polycystic Liver Disease|polycystic liver disease
1553198|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1553199|NCT00565097|Liver cyst|liver cyst
1553200|NCT00565097|Lanreotide|lanreotide
1553201|NCT00565071|Cost-effectiveness|cost-effectiveness
1553202|NCT00565071|Diagnosis|diagnosis
1553203|NCT00565071|Treatment|treatment
1553204|NCT00565071|Malaria|malaria
1553205|NCT00565045|hand|hand
1553206|NCT00565045|stroke|stroke
1553207|NCT00565045|hemiplegia|hemiplegia
1553208|NCT00565045|electrical stimulation|electrical stimulation
1553209|NCT00565045|recovery|recovery
1553210|NCT00565032|postpartum depression|postpartum depression
1553211|NCT00565032|thyroxine|thyroxine
1553212|NCT00565032|thyroid antibodies|thyroid antibodies
1553213|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
1553214|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
1553215|NCT00564980|Randomized|randomized
1553216|NCT00564980|Prospective|prospective
1553217|NCT00564980|Procedure / Surgery|procedure / surgery
1553218|NCT00564954|ADHD|adhd
1553219|NCT00564954|children|children
1553220|NCT00564954|laboratory classroom|laboratory classroom
1553221|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1553222|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
1553223|NCT00564941|beta-Thalassemia|beta-thalassemia
1553224|NCT00564941|Iron Overload|iron overload
1553225|NCT00564941|Iron Chelating Agents|iron chelating agents
1553226|NCT00564941|deferasirox|deferasirox
1553227|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
1553228|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
1553229|NCT00564928|HRPC|hrpc
1553230|NCT00564928|CRPC|crpc
1553231|NCT00564915|Epilepsy|epilepsy
1553232|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
1553233|NCT00564902|Skin Carotenoids|skin carotenoids
1553234|NCT00564902|Lipofuscin|lipofuscin
1553235|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
1553236|NCT00564902|Visual Field Progression|visual field progression
1553237|NCT00564902|Contrast Sensitivity|contrast sensitivity
1553238|NCT00564902|Color Vision|color vision
1553239|NCT00564902|Cognitive Function|cognitive function
1553240|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
1553241|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
1553242|NCT00564876|carcinoma|carcinoma
1553243|NCT00564876|dasatinib|dasatinib
1553244|NCT00564876|neoadjuvant|neoadjuvant
1553245|NCT00564876|adjuvant|adjuvant
1553246|NCT00564876|resection|resection
1553247|NCT00564876|genomic signature|genomic signature
1553248|NCT00564876|predictor|predictor
1553249|NCT00564876|microarray|microarray
1553250|NCT00564863|Diarrhea|diarrhea
1553251|NCT00564863|ETEC|etec
1553252|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
1553253|NCT00564837|Reconstruction|reconstruction
1553254|NCT00564837|Rehabilitation|rehabilitation
1553255|NCT00564837|Home-based|home-based
1553256|NCT00564824|coronary disease|coronary disease
1553257|NCT00564824|atherosclerosis|atherosclerosis
1553258|NCT00564824|endothelial function|endothelial function
1553259|NCT00564824|caffeine|caffeine
1553260|NCT00564824|cerebrovascular disease|cerebrovascular disease
1553261|NCT00564824|prevention|prevention
1553262|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
1553263|NCT00564811|Hepatitis C|hepatitis c
1553264|NCT00564811|Nutritional status|nutritional status
1553265|NCT00564811|Liver Function Tests|liver function tests
1553266|NCT00564811|Antiviral Agents|antiviral agents
1553267|NCT00564798|protocoladolescents|protocoladolescents
1553268|NCT00564798|children|children
1553269|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
1553270|NCT00564798|weight loss/management|weight loss/management
1553271|NCT00564798|program evaluation|program evaluation
1553272|NCT00564772|raltegravir|raltegravir
1553273|NCT00564772|lopinavir|lopinavir
1553274|NCT00564772|ritonavir|ritonavir
1553275|NCT00564772|pharmacokinetics|pharmacokinetics
1553277|NCT00564746|SB-681323,|sb-681323,
1553278|NCT00564746|ADME,|adme,
1553279|NCT00564746|radiolabel|radiolabel
1553280|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
1553281|NCT00564694|recurrent colon cancer|recurrent colon cancer
1553282|NCT00564694|stage I colon cancer|stage i colon cancer
1553283|NCT00564694|stage II colon cancer|stage ii colon cancer
1553284|NCT00564694|stage III colon cancer|stage iii colon cancer
1553285|NCT00564694|stage IV colon cancer|stage iv colon cancer
1553286|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1553287|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
1553288|NCT00564694|stage I rectal cancer|stage i rectal cancer
1553289|NCT00564694|stage II rectal cancer|stage ii rectal cancer
1553290|NCT00564694|stage III rectal cancer|stage iii rectal cancer
1553291|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
1553293|NCT00564655|Gastric Tube Insertion|gastric tube insertion
1553294|NCT00564655|Anesthesia|anesthesia
1553295|NCT00564655|Regional Anesthetic|regional anesthetic
1553296|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
1553297|NCT00564616|cardiac arrest|cardiac arrest
1553298|NCT00564616|video cell phone|video cell phone
1553299|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
1553300|NCT00564603|Glucocorticoid|glucocorticoid
1553301|NCT00564603|Opioids|opioids
1553302|NCT00564603|Balanced analgesia|balanced analgesia
1553303|NCT00564577|Diarrhea ETEC|diarrhea etec
1553304|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
1553305|NCT00564564|pharmacological treatment|pharmacological treatment
1553306|NCT00564564|quetiapine|quetiapine
1553307|NCT00564564|clomipramine|clomipramine
1553308|NCT00564564|SSRI|ssri
1553309|NCT00564551|Prediabetes|prediabetes
1553310|NCT00564551|Type 2 diabetes|type 2 diabetes
1553311|NCT00564551|Metabolic syndrome|metabolic syndrome
1553312|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
1553313|NCT00564551|Weight loss|weight loss
1553314|NCT00564551|Milk products|milk products
1553315|NCT00564551|Calcium|calcium
1553316|NCT00564538|liver transplant|liver transplant
1553317|NCT00564525|children|children
1553318|NCT00564525|abdominal pain|abdominal pain
1553319|NCT00564525|amitriptyline|amitriptyline
1553320|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1553321|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1553322|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1553323|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1553324|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1553325|NCT00564499|COPD|copd
1553326|NCT00564499|Symbicort|symbicort
1553327|NCT00564499|General Practitioners|general practitioners
1553328|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
1553329|NCT00564473|internal medicine|internal medicine
1553330|NCT00564473|herbal medicine|herbal medicine
1553331|NCT00564473|prevalence|prevalence
1553332|NCT00564473|attitudes|attitudes
1553333|NCT00564473|herb-drug interaction|herb-drug interaction
1553334|NCT00564434|delirium|delirium
1553335|NCT00564434|pathophysiology|pathophysiology
1553336|NCT00564434|risk factors|risk factors
1553337|NCT00564434|pain|pain
1553338|NCT00564434|dementia|dementia
1553339|NCT00564382|Acute coronary syndrome|acute coronary syndrome
1553340|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1553341|NCT00564382|Contrast agents|contrast agents
1553342|NCT00564382|Gadolinium|gadolinium
1553343|NCT00564369|HIV testing|hiv testing
1553344|NCT00564369|HIV Seronegativity|hiv seronegativity
1553345|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
1553346|NCT00564343|Balance|balance
1553347|NCT00564343|Water based training|water based training
1553348|NCT00564343|Physical functioning|physical functioning
1553349|NCT00564343|stepping behavior|stepping behavior
1553350|NCT00564330|dental erosion|dental erosion
1553352|NCT00564330|proton pump inhibitor|proton pump inhibitor
1553353|NCT00564317|PTSD|ptsd
1553354|NCT00564317|Depression|depression
1553355|NCT00564317|Suicidality|suicidality
1553356|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
1553357|NCT00564317|KIDNET|kidnet
1553358|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
1553359|NCT00564317|Meditation|meditation
1553360|NCT00564317|Relaxation|relaxation
1553361|NCT00564317|War|war
1553362|NCT00564304|Nasal Potential Difference|nasal potential difference
1553363|NCT00564291|OCT|oct
1553364|NCT00564278|Hispanic Americans|hispanic americans
1553365|NCT00564278|Major Depressive Disorder|major depressive disorder
1553366|NCT00564278|Antidepressant Therapy|antidepressant therapy
1553367|NCT00564278|Motivational Interviewing|motivational interviewing
1553368|NCT00564278|Treatment Retention|treatment retention
1553369|NCT00564278|Treatment Adherence|treatment adherence
1553371|NCT00564226|urge urinary incontinence|urge urinary incontinence
1553372|NCT00564213|Myopia|myopia
1553373|NCT00564213|Mitomycin|mitomycin
1553374|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
1553375|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
1553376|NCT00564174|lupus anticoagulant|lupus anticoagulant
1553377|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
1553378|NCT00564174|thrombophilia|thrombophilia
1553379|NCT00564174|low molecular weight heparin|low molecular weight heparin
1553380|NCT00564174|aspirin|aspirin
1553381|NCT00564174|randomized clinical trial|randomized clinical trial
1553382|NCT00564148|antiVEGF therapy|antivegf therapy
1553383|NCT00564135|hysterectomy|hysterectomy
1553384|NCT00564135|laparoscopy|laparoscopy
1553385|NCT00564135|urinary retention|urinary retention
1553386|NCT00564135|urinary tract infection|urinary tract infection
1553387|NCT00564135|catheterization|catheterization
1553388|NCT00564122|Murmur|murmur
1553389|NCT00564122|Artificial-Intelligence|artificial-intelligence
1553390|NCT00564122|Stethoscope|stethoscope
1553391|NCT00564122|Congenital Heart Disease|congenital heart disease
1553392|NCT00564122|Structural Heart Disease|structural heart disease
1553393|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
1553394|NCT00564070|Depression|depression
1553395|NCT00564070|Diabetes|diabetes
1553396|NCT00564070|Adherence|adherence
1553397|NCT00564057|HIV|hiv
1553398|NCT00564057|blood pressure|blood pressure
1553399|NCT00564057|left ventricle|left ventricle
1553400|NCT00564057|metabolic profile|metabolic profile
1553401|NCT00564057|treatment experienced|treatment experienced
1553402|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
1553403|NCT00564044|mesh extrusion|mesh extrusion
1553404|NCT00564044|mid-urethral sling|mid-urethral sling
1553405|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
1553406|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
1553407|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
1553408|NCT00564005|stroke rehabilitation|stroke rehabilitation
1553409|NCT00564005|cortical reorganization|cortical reorganization
1553410|NCT00564005|kinematic analysis|kinematic analysis
1553411|NCT00563979|age related macular degeneration|age related macular degeneration
1553412|NCT00563979|supplementation|supplementation
1553413|NCT00563979|macular pigment|macular pigment
1553414|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
1553415|NCT00563953|Breast|breast
1553416|NCT00563953|Cancer|cancer
1553417|NCT00563953|Anthracyclines|anthracyclines
1553418|NCT00563953|Cardiopathy|cardiopathy
1553419|NCT00563940|diabetic macular edema|diabetic macular edema
1553420|NCT00563940|OCT|oct
1553421|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1553422|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
1553423|NCT00563914|Malaria|malaria
1553424|NCT00563901|CHD|chd
1553425|NCT00563901|Combined CHD|combined chd
1553426|NCT00563901|Stroke|stroke
1553427|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
1553428|NCT00563901|Pharmacogenetics|pharmacogenetics
1553429|NCT00563901|End-Stage Renal Disease|end-stage renal disease
1553430|NCT00563901|Heart Failure|heart failure
1553431|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
1553432|NCT00563901|Angina|angina
1553433|NCT00563901|Coronary Revascularizations|coronary revascularizations
1553434|NCT00563901|CHD Mortality|chd mortality
1553435|NCT00563901|Lisinopril|lisinopril
1553436|NCT00563901|Chlorthalidone|chlorthalidone
1553437|NCT00563901|Amlodipine|amlodipine
1553438|NCT00563901|Doxazosin|doxazosin
1553439|NCT00563888|PTSD|ptsd
1553440|NCT00563888|torture survivors|torture survivors
1553441|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
1553442|NCT00563888|trauma-related memory processes|trauma-related memory processes
1553443|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
1553444|NCT00563875|Platelets|platelets
1553445|NCT00563875|Platelet aggregation|platelet aggregation
1553446|NCT00563875|Drug resistance|drug resistance
1553447|NCT00563875|Aspirin|aspirin
1553448|NCT00563875|Diabetes mellitus|diabetes mellitus
1553449|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1553450|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
1553451|NCT00563836|ovarian cancer|ovarian cancer
1553452|NCT00563836|catumaxomab|catumaxomab
1553453|NCT00563836|phase II|phase ii
1553454|NCT00563836|intraoperative|intraoperative
1553455|NCT00563836|adjuvant|adjuvant
1553456|NCT00563836|trifunctional antibody|trifunctional antibody
1553457|NCT00563823|stage IV melanoma|stage iv melanoma
1553458|NCT00563823|recurrent melanoma|recurrent melanoma
1553459|NCT00563810|Adult|adult
1553460|NCT00563810|Aged|aged
1553461|NCT00563797|treatment|treatment
1553462|NCT00563797|alcohol dependence|alcohol dependence
1553463|NCT00563797|depression|depression
1553464|NCT00563797|mecamylamine|mecamylamine
1553465|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
1553466|NCT00563784|Lung Cancer|lung cancer
1553467|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
1553468|NCT00563784|Adenocarcinoma|adenocarcinoma
1553469|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
1553470|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
1553471|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
1553472|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
1553473|NCT00563784|Erlotinib|erlotinib
1553474|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
1553475|NCT00563784|OSI-774|osi-774
1553476|NCT00563784|Tarceva|tarceva
1553477|NCT00563784|Carboplatin|carboplatin
1553478|NCT00563784|Paraplatin|paraplatin
1553479|NCT00563784|Paclitaxel|paclitaxel
1553480|NCT00563784|Taxol|taxol
1553481|NCT00563784|NSCLC|nsclc
1553482|NCT00563758|Chronic constipation|chronic constipation
1553483|NCT00563745|COPD|copd
1553484|NCT00563745|ALS|als
1553485|NCT00563745|Telemedicine|telemedicine
1553486|NCT00563745|mechanical ventilation|mechanical ventilation
1553487|NCT00563745|Integrated care|integrated care
1553488|NCT00563745|strict follow up|strict follow up
1553489|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
1553490|NCT00563745|telemedicine programme|telemedicine programme
1553491|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
1553492|NCT00563745|frail patients|frail patients
1553493|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
1553494|NCT00563693|heart failure|heart failure
1553495|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
1553496|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
1553497|NCT00563680|AMG 479|amg 479
1553498|NCT00563680|IGF-1R|igf-1r
1553499|NCT00563680|Insulin-like growth factor|insulin-like growth factor
1553500|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
1553501|NCT00563680|Ewing's|ewing's
1553502|NCT00563680|Sarcoma|sarcoma
1553503|NCT00563667|Pterygium|pterygium
1553504|NCT00563667|Cataract|cataract
1553505|NCT00563667|Astigmatism|astigmatism
1553506|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1553507|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
1553508|NCT00563641|NCPAP|ncpap
1553509|NCT00563641|Very early surfactant|very early surfactant
1553510|NCT00563628|Pattern Scan Laser.|pattern scan laser.
1553511|NCT00563628|Photocoagulation.|photocoagulation.
1553512|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
1553513|NCT00563628|Laser treatment|laser treatment
1553514|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
1553515|NCT00563602|Portal hypertension|portal hypertension
1553516|NCT00563602|Prevention of rebleeding|prevention of rebleeding
1553517|NCT00563602|Complications of cirrhosis|complications of cirrhosis
1553518|NCT00563602|Portal hemodynamic|portal hemodynamic
1553519|NCT00563602|Prazosine|prazosine
1553520|NCT00563602|Nadolol|nadolol
1553521|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
1553522|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
1553523|NCT00563576|Depo-Provera|depo-provera
1553524|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
1553525|NCT00563576|Metrorrhagia|metrorrhagia
1553526|NCT00563576|Irregular Bleeding|irregular bleeding
1553527|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
1553528|NCT00563537|neurology|neurology
1553529|NCT00563537|sclerosis|sclerosis
1553530|NCT00563537|imaging|imaging
1553531|NCT00563537|tomography|tomography
1553532|NCT00563511|smoking cessation|smoking cessation
1553533|NCT00563498|Veno-occlusive disease|veno-occlusive disease
1553534|NCT00563498|Mucositis|mucositis
1553535|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1553536|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
1553537|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
1553538|NCT00563459|Epilepsy, seizures|epilepsy, seizures
1553539|NCT00563459|partial onset seizures|partial onset seizures
1553540|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
1553541|NCT00563459|carisbamate|carisbamate
1553542|NCT00563459|topiramate|topiramate
1553543|NCT00563459|levetiracetam|levetiracetam
1553544|NCT00563446|Anemia|anemia
1553545|NCT00563446|End-stage renal failure|end-stage renal failure
1553546|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
1553547|NCT00563433|diabetic|diabetic
1553548|NCT00563433|diabetes mellitus|diabetes mellitus
1553549|NCT00563433|foot|foot
1553550|NCT00563433|ulcers|ulcers
1553551|NCT00563433|Floxin|floxin
1553552|NCT00563433|oral antibiotic|oral antibiotic
1553553|NCT00563433|topical cream|topical cream
1553554|NCT00563420|Lung cancer|lung cancer
1553555|NCT00563407|skin toxicity prediction|skin toxicity prediction
1553556|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
1553557|NCT00563394|diabetic|diabetic
1553558|NCT00563394|diabetes mellitus|diabetes mellitus
1553559|NCT00563394|foot|foot
1553560|NCT00563394|ulcers|ulcers
1553561|NCT00563394|Floxin|floxin
1553562|NCT00563394|oral antibiotic|oral antibiotic
1553563|NCT00563394|topical cream|topical cream
1553564|NCT00563355|chronic kidney disease|chronic kidney disease
1553565|NCT00563355|cardiovascular disease|cardiovascular disease
1553566|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
1553567|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
1553568|NCT00563316|colorectal cancer|colorectal cancer
1553569|NCT00563316|chemotherapy|chemotherapy
1553570|NCT00563316|cancer|cancer
1553571|NCT00563316|metastatic|metastatic
1553572|NCT00563316|irinotecan|irinotecan
1553573|NCT00563316|EGFr|egfr
1553574|NCT00563316|epidermal growth factor|epidermal growth factor
1553575|NCT00563277|Pterygium|pterygium
1553576|NCT00563277|Cataract|cataract
1553577|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
1553578|NCT00563264|obesity|obesity
1553579|NCT00563264|parenting|parenting
1553580|NCT00563264|postpartum period|postpartum period
1553581|NCT00563264|family research|family research
1553582|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
1553583|NCT00563238|Extubation|extubation
1553584|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
1553585|NCT00563212|Fibrosis|fibrosis
1553586|NCT00563212|Interferons|interferons
1553587|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
1553588|NCT00563212|Pathologic Processes|pathologic processes
1553589|NCT00563212|Lung Diseases|lung diseases
1553590|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
1553591|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1553592|NCT00563212|Aerosols|aerosols
1553593|NCT00563199|smoking cessation|smoking cessation
1553594|NCT00563199|smoking behaviors|smoking behaviors
1553595|NCT00563186|infection control|infection control
1553596|NCT00563186|nosocomial infection|nosocomial infection
1553597|NCT00563186|hospital design|hospital design
1553598|NCT00563186|physical plant design|physical plant design
1553599|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
1553600|NCT00563160|lung cancer|lung cancer
1553601|NCT00563147|tivozanib|tivozanib
1553602|NCT00563147|AV-951|av-951
1553603|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
1553604|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
1553606|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1553607|NCT00563121|VEGF|vegf
1553608|NCT00563121|Vitreous|vitreous
1553609|NCT00563121|Subretinal Fluid|subretinal fluid
1553610|NCT00563121|ELISA|elisa
1553611|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
1553612|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
1553613|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
1553614|NCT00563082|SLE|sle
1553615|NCT00563082|Genetics|genetics
1553616|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
1553617|NCT00563056|Formoterol|formoterol
1553618|NCT00563056|Fluticasone|fluticasone
1553619|NCT00563056|Asthma|asthma
1553620|NCT00563043|Pattern Scan Laser.|pattern scan laser.
1553621|NCT00563043|Photocoagulation.|photocoagulation.
1553622|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
1553623|NCT00563043|Laser treatment.|laser treatment.
1553624|NCT00563043|Electroretinogram.|electroretinogram.
1553625|NCT00563043|a wave.|a wave.
1553626|NCT00563043|b wave.|b wave.
1553627|NCT00563043|Implicit time.|implicit time.
1553628|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
1553629|NCT00563030|Neutrophils|neutrophils
1553630|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1553631|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
1553632|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
1553633|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
1553634|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
1553635|NCT00563017|Schizo-affective disorders|schizo-affective disorders
1553636|NCT00563004|Diabetes mellitus|diabetes mellitus
1553637|NCT00563004|Herbal treatment|herbal treatment
1553638|NCT00563004|Food supplement|food supplement
1553639|NCT00562991|exhaled NO|exhaled no
1553640|NCT00562991|asthma|asthma
1553641|NCT00562991|child|child
1553642|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1553643|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1553644|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1553645|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1553646|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1568150|NCT00506922|Methotrexate|methotrexate
1553647|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1553648|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1553649|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1553650|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1553651|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1553652|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1553653|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1553654|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1553655|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1553656|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1553657|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1553658|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1553659|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1553660|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1553661|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1553662|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1553663|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1554024|NCT00561522|Recurrence|recurrence
1553664|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1553665|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1553666|NCT00562952|Natriuretic peptide|natriuretic peptide
1553667|NCT00562952|Prognosis|prognosis
1553668|NCT00562952|Diabetes|diabetes
1553669|NCT00562952|Heart failure|heart failure
1553670|NCT00562952|Heart disease|heart disease
1553671|NCT00562939|Antibody Formation|antibody formation
1553672|NCT00562939|Antibody Affinity|antibody affinity
1553673|NCT00562939|Immunity|immunity
1553674|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
1553675|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
1553676|NCT00562926|Schizophrenia|schizophrenia
1553677|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
1553678|NCT00562913|Cancer|cancer
1553679|NCT00562913|Sorafenib|sorafenib
1553680|NCT00562913|Cyclophosphamide|cyclophosphamide
1553681|NCT00562913|Doxorubicin|doxorubicin
1553682|NCT00562887|Crohn's Disease|crohn's disease
1553683|NCT00562874|HIV|hiv
1553684|NCT00562874|AIDS|aids
1553685|NCT00562874|WOMEN|women
1553686|NCT00562874|KENYA|kenya
1553687|NCT00562874|NUTRITION|nutrition
1553688|NCT00562874|HIV/AIDS|hiv/aids
1553689|NCT00562874|treatment naive|treatment naive
1553690|NCT00562861|Bipolar Disorder|bipolar disorder
1553691|NCT00562861|Bipolar Depression|bipolar depression
1553692|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
1553693|NCT00562861|Clinical Pharmacology|clinical pharmacology
1553694|NCT00562848|gastric emptying|gastric emptying
1553695|NCT00562848|pharmacokinetic|pharmacokinetic
1553696|NCT00562848|tolerability|tolerability
1553697|NCT00562848|safety|safety
1553698|NCT00562848|GSK962040|gsk962040
1553699|NCT00562848|gut motility|gut motility
1553700|NCT00562848|First Time in Human|first time in human
1553701|NCT00562835|ARDS|ards
1553702|NCT00562835|Adult|adult
1553703|NCT00562835|Methylprednisolone|methylprednisolone
1553704|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
1553705|NCT00562796|Cardiovascular Disease|cardiovascular disease
1553706|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
1553707|NCT00562796|Insulin Resistance|insulin resistance
1553708|NCT00562783|HBV|hbv
1553709|NCT00562783|HCV|hcv
1553710|NCT00562783|Liver cirrhosis|liver cirrhosis
1553711|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1553712|NCT00562770|CLL|cll
1553713|NCT00562770|Leukemia|leukemia
1553714|NCT00562757|Wedensky modulation|wedensky modulation
1553715|NCT00562757|Risk stratification|risk stratification
1553716|NCT00562757|Electrophysiology|electrophysiology
1553717|NCT00562757|Noninvasive|noninvasive
1553718|NCT00562757|Ischemic heart disease|ischemic heart disease
1553719|NCT00562757|ICD guidelines|icd guidelines
1553720|NCT00562757|Myocardial infarction|myocardial infarction
1553721|NCT00562718|stage II breast cancer|stage ii breast cancer
1553722|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
1553723|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
1553724|NCT00562718|male breast cancer|male breast cancer
1553725|NCT00562718|recurrent breast cancer|recurrent breast cancer
1553726|NCT00562705|growth hormone|growth hormone
1553727|NCT00562705|eating regulation|eating regulation
1553728|NCT00562705|nutritional intervention|nutritional intervention
1553729|NCT00562705|short stature|short stature
1553730|NCT00562705|ISS|iss
1553731|NCT00562705|SGA|sga
1553732|NCT00562705|IGHD|ighd
1553733|NCT00562705|MPHD|mphd
1553734|NCT00562692|Heart failure|heart failure
1553735|NCT00562692|OAD|oad
1553736|NCT00562692|BNP|bnp
1553737|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
1553738|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
1553739|NCT00562666|cell therapy|cell therapy
1553740|NCT00562666|T lymphocytes|t lymphocytes
1553741|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
1553742|NCT00562653|profile autoantibodies|profile autoantibodies
1553743|NCT00562653|clinical symptoms|clinical symptoms
1553744|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1553745|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1553746|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1553747|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1553748|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1553749|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1553750|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1553751|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1553752|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1553753|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1553754|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1553755|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1553756|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1553757|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1553758|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1553759|NCT00562640|06-155|06-155
1553760|NCT00562627|osteoarthritis|osteoarthritis
1553761|NCT00562627|knee arthroplasty|knee arthroplasty
1553762|NCT00562627|local infiltration analgesia|local infiltration analgesia
1553763|NCT00562627|TKA|tka
1553764|NCT00562627|epidural analgesia|epidural analgesia
1553765|NCT00562627|operation|operation
1553766|NCT00562627|surgery|surgery
1553767|NCT00562601|Leukapheresis|leukapheresis
1553768|NCT00562601|Plasmapheresis|plasmapheresis
1553769|NCT00562601|Lymphocytes|lymphocytes
1553770|NCT00562601|Neutrophils|neutrophils
1553771|NCT00562536|Umbilical cord clamping|umbilical cord clamping
1553772|NCT00562536|Preterm infants|preterm infants
1553773|NCT00562536|Randomized controlled trial|randomized controlled trial
1553774|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
1553775|NCT00562523|Cancer|cancer
1553776|NCT00562523|Docetaxel|docetaxel
1553777|NCT00562523|Sorafenib|sorafenib
1553778|NCT00562510|HIV-1 infection|hiv-1 infection
1553779|NCT00562510|raltegravir|raltegravir
1553780|NCT00562510|immune discordance|immune discordance
1553781|NCT00562510|treatment experienced|treatment experienced
1553782|NCT00562497|Acute GVHD|acute gvhd
1553783|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
1553784|NCT00562471|adhesions|adhesions
1553785|NCT00562471|gynecologic surgery|gynecologic surgery
1553786|NCT00562471|laparoscopy|laparoscopy
1553787|NCT00562471|laparotomy|laparotomy
1553788|NCT00562471|polyethylene glycol|polyethylene glycol
1553789|NCT00562471|hydrogel|hydrogel
1553790|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
1553791|NCT00562458|Advanced breast cancer|advanced breast cancer
1553792|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
1553793|NCT00562445|Adrenal insufficiency|adrenal insufficiency
1553794|NCT00562445|GI bleeding|gi bleeding
1553795|NCT00562445|Portal hypertension|portal hypertension
1553796|NCT00562445|Acute pancreatitis|acute pancreatitis
1553797|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
1553798|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
1553799|NCT00562432|atrial fibrillation|atrial fibrillation
1553800|NCT00562432|CABG|cabg
1553801|NCT00562432|ganglionated plexi|ganglionated plexi
1553802|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
1553803|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1553804|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1553805|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1553806|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1553807|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1553808|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1553809|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1553810|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1553811|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1553812|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1553813|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1568151|NCT00506922|Tacrolimus|tacrolimus
1553814|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1553815|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1553816|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1553817|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1553818|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1553819|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1553820|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1553821|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1553822|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1553823|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1553824|NCT00562380|small intestine lymphoma|small intestine lymphoma
1553825|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1553826|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1553827|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1553828|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1553829|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1553830|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
1553831|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
1553832|NCT00562341|obesity|obesity
1553833|NCT00562341|psa|psa
1553834|NCT00562341|prostate cancer|prostate cancer
1553835|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1553926|NCT00561899|tolerability|tolerability
1553836|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1553837|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1553838|NCT00562302|lung biopsy|lung biopsy
1553840|NCT00562289|Patent Foramen Ovale|patent foramen ovale
1553841|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
1553842|NCT00562289|Antiplatelet therapy|antiplatelet therapy
1553843|NCT00562289|Oral anticoagulants|oral anticoagulants
1553844|NCT00562289|Transcatheter closure|transcatheter closure
1553845|NCT00562289|Migraine|migraine
1553846|NCT00562276|IUD|iud
1553847|NCT00562276|insertion timing|insertion timing
1553848|NCT00562263|overweight|overweight
1553849|NCT00562263|obesity|obesity
1553850|NCT00562263|adolescent|adolescent
1553851|NCT00562263|insulin resistance|insulin resistance
1553852|NCT00562263|treatment|treatment
1553853|NCT00562237|immunogenicity|immunogenicity
1553854|NCT00562237|safety|safety
1553855|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
1553856|NCT00562224|PCI-24781|pci-24781
1553857|NCT00562224|Neoplasms by site|neoplasms by site
1553858|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
1553859|NCT00562224|Hodgkin disease|hodgkin disease
1553860|NCT00562224|Multiple myeloma|multiple myeloma
1553861|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
1553862|NCT00562211|children|children
1553863|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1553864|NCT00562185|ovarian sarcoma|ovarian sarcoma
1553865|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1553866|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
1553867|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
1553868|NCT00562159|rhinitis|rhinitis
1553869|NCT00562159|conjunctivitis|conjunctivitis
1553870|NCT00562159|allergy|allergy
1553871|NCT00562159|allergen|allergen
1553872|NCT00562159|immunotherapy|immunotherapy
1553873|NCT00562146|nutrition|nutrition
1553874|NCT00562146|enteral access|enteral access
1553875|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
1553876|NCT00562094|Pantoprazole|pantoprazole
1553877|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
1553878|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
1553879|NCT00562094|sleep disorders|sleep disorders
1553880|NCT00562081|asthma|asthma
1553881|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
1553882|NCT00562081|metabolites|metabolites
1553883|NCT00562081|asthma education|asthma education
1553884|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1553885|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1553886|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1553887|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1553888|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1553889|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1553890|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1553891|NCT00562068|small intestine lymphoma|small intestine lymphoma
1553892|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1553893|NCT00562042|pulmonary embolism|pulmonary embolism
1553894|NCT00562042|risk stratification|risk stratification
1553895|NCT00562042|prognosis|prognosis
1553896|NCT00562042|troponin|troponin
1553897|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
1553898|NCT00562042|echocardiogram|echocardiogram
1553899|NCT00562029|Diabetes Mellitus|diabetes mellitus
1553900|NCT00562029|Surgery|surgery
1553901|NCT00562029|Duodenal Bypass|duodenal bypass
1553902|NCT00562029|Resolution|resolution
1553903|NCT00562029|Surgical Procedures|surgical procedures
1553904|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
1553998|NCT00561652|Veterans|veterans
1553905|NCT00562003|Ovarian cancer study|ovarian cancer study
1553906|NCT00561990|pancreatic cancer|pancreatic cancer
1553907|NCT00561977|Nutrition|nutrition
1553908|NCT00561977|Dietary Quality|dietary quality
1553909|NCT00561977|Weight loss|weight loss
1553910|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
1553911|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
1553912|NCT00561938|tolerance|tolerance
1553913|NCT00561938|intravenous fluorescein|intravenous fluorescein
1553914|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
1553915|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
1553916|NCT00561912|Renal Cell Cancer|renal cell cancer
1553917|NCT00561912|Clear Cell|clear cell
1553918|NCT00561912|Kidney|kidney
1553919|NCT00561912|Decitabine|decitabine
1553920|NCT00561912|Dacogen|dacogen
1553921|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
1553922|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
1553923|NCT00561912|Intron A®|intron a®
1553925|NCT00561899|safety|safety
1553928|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
1553929|NCT00561899|children|children
1553930|NCT00561886|COPD|copd
1553931|NCT00561886|lung function|lung function
1553932|NCT00561886|dysnpea|dysnpea
1553933|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
1553934|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
1553935|NCT00561860|Telemedicine|telemedicine
1553936|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
1553937|NCT00561834|ranibizumab|ranibizumab
1553938|NCT00561834|naion|naion
1553939|NCT00561821|elderly|elderly
1553940|NCT00561821|randomized|randomized
1553941|NCT00561821|placebo controlled|placebo controlled
1553942|NCT00561808|PCO/PCOD|pco/pcod
1553943|NCT00561808|IVM|ivm
1553944|NCT00561808|Immature Oocytes|immature oocytes
1553945|NCT00561795|AGO|ago
1553946|NCT00561795|Advanced,|advanced,
1553947|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
1553948|NCT00561795|Genetics|genetics
1553949|NCT00561795|GW786034,|gw786034,
1553950|NCT00561795|Pazopanib,|pazopanib,
1553951|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
1553952|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
1553953|NCT00561782|SCI Pain|sci pain
1553954|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
1553955|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
1553956|NCT00561782|MRS|mrs
1553957|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
1553958|NCT00561769|poor responder|poor responder
1553959|NCT00561769|growth hormone|growth hormone
1553960|NCT00561769|luteal|luteal
1553961|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1553962|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1553963|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1553964|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1553965|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1553966|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1553967|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1553968|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1553969|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1553970|NCT00561743|Multiple myeloma|multiple myeloma
1553971|NCT00561743|response rate|response rate
1553972|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
1553973|NCT00561743|safety|safety
1553974|NCT00561743|tolerability|tolerability
1553975|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
1553976|NCT00561730|Pantoprazole|pantoprazole
1553977|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
1553978|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
1553979|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1553980|NCT00561717|Ragweed|ragweed
1553981|NCT00561717|Pollen|pollen
1553982|NCT00561717|Allergy|allergy
1553983|NCT00561704|obese female|obese female
1553984|NCT00561704|Type 2 Diabetes|type 2 diabetes
1568152|NCT00506922|Pentostatin|pentostatin
1553985|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
1553986|NCT00561704|Glucose Metabolism|glucose metabolism
1553987|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1553988|NCT00561704|Adiponectin|adiponectin
1553989|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
1553990|NCT00561678|Postoperative Confusion|postoperative confusion
1553991|NCT00561678|Postoperative Delirium|postoperative delirium
1553992|NCT00561678|PD|pd
1553993|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
1553994|NCT00561678|POCD|pocd
1553995|NCT00561652|Low back pain|low back pain
1553996|NCT00561652|Chiropractic|chiropractic
1553997|NCT00561652|Exercise|exercise
1553999|NCT00561639|sepsis|sepsis
1554000|NCT00561639|immunosuppressed|immunosuppressed
1554001|NCT00561639|multiplex PCR|multiplex pcr
1554002|NCT00561639|diagnosis|diagnosis
1554003|NCT00561639|therapeutic|therapeutic
1554004|NCT00561613|Diaphragm|diaphragm
1554005|NCT00561613|postcoital test|postcoital test
1554006|NCT00561613|SILCS|silcs
1554007|NCT00561613|nonoxynol-9|nonoxynol-9
1554008|NCT00561600|Hip arthroplasty|hip arthroplasty
1554009|NCT00561600|Acetabular cup replacement|acetabular cup replacement
1554010|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
1554011|NCT00561587|novel antipsychotic|novel antipsychotic
1554012|NCT00561587|quetiapine|quetiapine
1554013|NCT00561587|depression|depression
1554014|NCT00561587|psychopathology|psychopathology
1554015|NCT00561574|elderly|elderly
1554016|NCT00561574|randomized|randomized
1554017|NCT00561574|double blind|double blind
1554018|NCT00561561|Schizophrenia|schizophrenia
1554019|NCT00561561|Prepulse Inhibition|prepulse inhibition
1554020|NCT00561561|Acoustic Startle|acoustic startle
1554021|NCT00561535|IBS|ibs
1554022|NCT00561535|Diarrhea|diarrhea
1554023|NCT00561535|Rome III|rome iii
1554025|NCT00561522|Metastasis|metastasis
1554026|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
1554027|NCT00561522|Radical Hepatic Resection|radical hepatic resection
1554028|NCT00561522|Drug Prevention|drug prevention
1554029|NCT00561522|Capecitabine|capecitabine
1554030|NCT00561522|Surgery|surgery
1554031|NCT00561496|HIV prevention|hiv prevention
1554032|NCT00561496|Microbicides|microbicides
1554033|NCT00561496|Pharmacokinetics|pharmacokinetics
1554034|NCT00561496|vaginal biopsies|vaginal biopsies
1554035|NCT00561483|Acute heart failure|acute heart failure
1554036|NCT00561483|cystatin C|cystatin c
1554037|NCT00561483|renal failure|renal failure
1554038|NCT00561483|biomarker|biomarker
1554039|NCT00561470|colorectal cancer|colorectal cancer
1554040|NCT00561470|metastatic|metastatic
1554041|NCT00561470|anti-angiogenic|anti-angiogenic
1554042|NCT00561470|irinotecan|irinotecan
1554043|NCT00561470|5-FU|5-fu
1554044|NCT00561470|FOLFIRI|folfiri
1554045|NCT00561457|Iliac|iliac
1554046|NCT00561457|Artery|artery
1554047|NCT00561457|Occlusive|occlusive
1554048|NCT00561457|Stenosis|stenosis
1554049|NCT00561444|Prostate Cancer|prostate cancer
1554050|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
1554051|NCT00561444|Robotic prostatectomy|robotic prostatectomy
1554052|NCT00561444|Photon external beam radiation|photon external beam radiation
1554053|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
1554054|NCT00561444|Proton radiation|proton radiation
1554055|NCT00561444|Radioisotopic implant|radioisotopic implant
1554056|NCT00561444|Cryotherapy|cryotherapy
1554057|NCT00561444|Quality of Life|quality of life
1554058|NCT00561444|Questionnaire|questionnaire
1554059|NCT00561444|Survey|survey
1554060|NCT00561444|QOL|qol
1554061|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
1554062|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1554063|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1554064|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1554065|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1554066|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1554067|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1554068|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1554069|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1554070|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1554071|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1554072|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1554073|NCT00561418|small intestine lymphoma|small intestine lymphoma
1554074|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1554075|NCT00561405|Stroke|stroke
1554076|NCT00561405|Walking|walking
1554077|NCT00561405|Motor learning|motor learning
1554078|NCT00561405|Skill acquisition|skill acquisition
1554079|NCT00561392|Alzheimer's Disease|alzheimer's disease
1554080|NCT00561392|Rivastigmine|rivastigmine
1554081|NCT00561392|Patch|patch
1554082|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1554083|NCT00561379|not previously treated|not previously treated
1554084|NCT00561366|ALS|als
1554085|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
1554086|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
1554087|NCT00561353|Tibotec|tibotec
1554088|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
1554089|NCT00561353|TMC435350-C201|tmc435350-c201
1554090|NCT00561353|TMC435|tmc435
1554091|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
1554092|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
1554093|NCT00561340|ADHD|adhd
1554094|NCT00561340|Growth|growth
1554095|NCT00561340|Atomoxetine|atomoxetine
1554096|NCT00561340|Pediasure|pediasure
1554097|NCT00561327|hypertension|hypertension
1554098|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
1554099|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
1554100|NCT00561314|sexual dysfunction|sexual dysfunction
1554101|NCT00561314|urinary incontinence|urinary incontinence
1554102|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1554103|NCT00561314|stage I prostate cancer|stage i prostate cancer
1554104|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
1554105|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
1554106|NCT00561288|Acetaminophen|acetaminophen
1554107|NCT00561288|Social Psychology|social psychology
1554108|NCT00561288|Affect|affect
1554109|NCT00561288|Interpersonal Rejection|interpersonal rejection
1554110|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1554111|NCT00561262|stage I prostate cancer|stage i prostate cancer
1554112|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
1554113|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
1554114|NCT00561262|stage III prostate cancer|stage iii prostate cancer
1554115|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1554116|NCT00561223|pulmonary hypertension|pulmonary hypertension
1554117|NCT00561210|infections|infections
1554118|NCT00561184|H5N1 Pandemic|h5n1 pandemic
1554119|NCT00561145|Anorexia of ageing|anorexia of ageing
1554120|NCT00561145|Anorexia of aging|anorexia of aging
1554121|NCT00561145|Energy balance|energy balance
1554122|NCT00561145|Elderly|elderly
1554123|NCT00561132|vanadium|vanadium
1554124|NCT00561132|insulin sensitivity|insulin sensitivity
1554125|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
1554126|NCT00561132|triglycerides|triglycerides
1554127|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
1554128|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
1554129|NCT00561119|gemcitabine|gemcitabine
1554130|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
1554131|NCT00561106|Bell´s palsy|bell´s palsy
1554132|NCT00561106|prednisone|prednisone
1554133|NCT00561106|valacyclovir|valacyclovir
1554134|NCT00561093|Hypoalbuminemia|hypoalbuminemia
1554135|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
1554136|NCT00561093|Inflammation|inflammation
1554137|NCT00561093|Oxidative stress|oxidative stress
1554138|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
1554139|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
1554140|NCT00561067|Spinal cord injury|spinal cord injury
1554141|NCT00561067|spinal shock|spinal shock
1554142|NCT00561067|erythropoietin|erythropoietin
1554143|NCT00561054|Coimbra|coimbra
1554144|NCT00561054|NSCLC|nsclc
1554145|NCT00561054|CETUXIMAB|cetuximab
1554146|NCT00561041|alcohol|alcohol
1554147|NCT00561041|alcohol use disorder|alcohol use disorder
1554148|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
1554149|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
1554150|NCT00561041|individual aftercare therapy|individual aftercare therapy
1554151|NCT00561028|Atherosclerosis|atherosclerosis
1554152|NCT00561028|Coronary artery disease|coronary artery disease
1554153|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
1554154|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
1554155|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
1554156|NCT00561015|Genotype 2|genotype 2
1554157|NCT00561015|Genotype 3|genotype 3
1554158|NCT00561015|Telaprevir|telaprevir
1554159|NCT00561002|Influenza Vaccine|influenza vaccine
1554160|NCT00561002|Influenza Virus|influenza virus
1554161|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
1554162|NCT00561002|Fluzone®|fluzone®
1554163|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
1554165|NCT00560989|Beryllium|beryllium
1554166|NCT00560989|Genetic|genetic
1554167|NCT00560989|Environmental|environmental
1554168|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
1554169|NCT00560976|hemodialysis|hemodialysis
1554170|NCT00560976|iron|iron
1554171|NCT00560976|inflammation|inflammation
1554172|NCT00560976|Oxidative Stress|oxidative stress
1554173|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
1554174|NCT00560963|gemcitabine|gemcitabine
1554175|NCT00560963|everolimus|everolimus
1554176|NCT00560937|Schizophrenia|schizophrenia
1554177|NCT00560937|Pregnenolone|pregnenolone
1554178|NCT00560937|Cognition|cognition
1554179|NCT00560937|Negative Symptoms|negative symptoms
1554180|NCT00560911|oral anticoagulation|oral anticoagulation
1554181|NCT00560911|self-management|self-management
1554182|NCT00560911|elderly patients|elderly patients
1554183|NCT00560911|randomised controlled trial|randomised controlled trial
1554184|NCT00560898|staining|staining
1554185|NCT00560898|epithelial barrier function|epithelial barrier function
1554186|NCT00560885|atrial fibrillation|atrial fibrillation
1554187|NCT00560885|af|af
1554188|NCT00560885|ablation|ablation
1554189|NCT00560885|arrhythmia|arrhythmia
1554190|NCT00560885|racing heart|racing heart
1554191|NCT00560885|afib|afib
1554192|NCT00560885|surgical ablation|surgical ablation
1554193|NCT00560872|atrial flutter|atrial flutter
1554194|NCT00560872|ablation|ablation
1554195|NCT00560872|navigation|navigation
1554196|NCT00560859|Sleep disordered breathing|sleep disordered breathing
1554197|NCT00560859|Sleep apnea|sleep apnea
1554198|NCT00560859|Tonsillectomy|tonsillectomy
1554199|NCT00560859|Adenoidectomy|adenoidectomy
1554200|NCT00560859|Snoring|snoring
1554201|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
1554202|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1554203|NCT00560846|Gastric cancer|gastric cancer
1554204|NCT00560846|Esophageal cancer|esophageal cancer
1554205|NCT00560846|Surgical complications|surgical complications
1554206|NCT00560846|Immunonutrition|immunonutrition
1554207|NCT00560820|β-thalassemia|β-thalassemia
1554208|NCT00560820|transfusional iron overload|transfusional iron overload
1554209|NCT00560820|renal function|renal function
1554210|NCT00560820|renal biomarkers|renal biomarkers
1554211|NCT00560820|deferasirox|deferasirox
1554212|NCT00560807|WAD II|wad ii
1554213|NCT00560807|WAD III|wad iii
1554214|NCT00560807|mobilization|mobilization
1554215|NCT00560807|dosage|dosage
1554306|NCT00560313|prevention|prevention
1554307|NCT00560313|vaccination|vaccination
1554216|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
1554217|NCT00560807|neck pain|neck pain
1554218|NCT00560794|Minimal Residual Disease|minimal residual disease
1554219|NCT00560794|adult ALL|adult all
1554220|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
1554221|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
1554222|NCT00560794|Blinatumomab|blinatumomab
1554223|NCT00560794|MT103|mt103
1554224|NCT00560781|PTSD|ptsd
1554225|NCT00560781|Pregnenolone|pregnenolone
1554226|NCT00560781|Cognition|cognition
1554227|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
1554228|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
1554229|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
1554230|NCT00560729|elderly people|elderly people
1554231|NCT00560690|Hepatitis C|hepatitis c
1554232|NCT00560690|metformin|metformin
1554233|NCT00560690|Insulin Resistance|insulin resistance
1554234|NCT00560677|Schizophrenia|schizophrenia
1554235|NCT00560677|PTSD|ptsd
1554236|NCT00560677|Cognition|cognition
1554237|NCT00560664|knee|knee
1554238|NCT00560664|chondral defect|chondral defect
1554239|NCT00560664|osteochondral defect|osteochondral defect
1554240|NCT00560651|keratoconus|keratoconus
1554241|NCT00560651|cornea|cornea
1554242|NCT00560651|cross linking|cross linking
1554243|NCT00560651|UV-light|uv-light
1554244|NCT00560651|riboflavin|riboflavin
1554245|NCT00560612|PTSD|ptsd
1554246|NCT00560612|Paroxetine|paroxetine
1554247|NCT00560612|Subthreshold|subthreshold
1554248|NCT00560599|MRSA|mrsa
1554249|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1554250|NCT00560599|Staphylococcus aureus|staphylococcus aureus
1554251|NCT00560599|Skin Infections|skin infections
1554252|NCT00560599|Body Decolonization|body decolonization
1554253|NCT00560599|Environmental Decolonization|environmental decolonization
1554254|NCT00560586|sleep fragmentation|sleep fragmentation
1554255|NCT00560586|apnea|apnea
1554256|NCT00560586|hypoxia|hypoxia
1554257|NCT00560560|Refractory Colorectal|refractory colorectal
1554258|NCT00560560|Single arm|single arm
1554259|NCT00560560|Phase 2|phase 2
1554260|NCT00560534|Magnetic resonance|magnetic resonance
1554261|NCT00560534|whole body|whole body
1554262|NCT00560534|angiography|angiography
1554263|NCT00560534|venous compression|venous compression
1554264|NCT00560534|MRI|mri
1554265|NCT00560521|CPAP|cpap
1554266|NCT00560521|Tuberculosis|tuberculosis
1554267|NCT00560521|Pleural effusion|pleural effusion
1554268|NCT00560521|Physiotherapy|physiotherapy
1568153|NCT00506909|oxytocin|oxytocin
1718369|NCT00035308|SLE|sle
1554269|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1554270|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1554271|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1554272|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1554273|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
1554274|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1554275|NCT00560495|large cell lung cancer|large cell lung cancer
1554276|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
1554277|NCT00560482|prostate|prostate
1554278|NCT00560482|cancer|cancer
1554279|NCT00560482|prostatic cancer|prostatic cancer
1554280|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
1554281|NCT00560469|Adipokines|adipokines
1554282|NCT00560469|Inflammation|inflammation
1554283|NCT00560469|Metabolic syndrome|metabolic syndrome
1554381|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
1554284|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
1554285|NCT00560443|bone fracture|bone fracture
1554286|NCT00560443|ketorolac|ketorolac
1554287|NCT00560443|tramadol|tramadol
1554288|NCT00560378|Tacrolimus|tacrolimus
1554289|NCT00560378|Administration, topical|administration, topical
1554290|NCT00560378|Drug safety|drug safety
1554291|NCT00560378|Adults|adults
1554292|NCT00560378|Children|children
1554293|NCT00560365|stage I colon cancer|stage i colon cancer
1554294|NCT00560365|stage II colon cancer|stage ii colon cancer
1554295|NCT00560365|stage III colon cancer|stage iii colon cancer
1554296|NCT00560365|stage I rectal cancer|stage i rectal cancer
1554297|NCT00560365|stage II rectal cancer|stage ii rectal cancer
1554298|NCT00560365|stage III rectal cancer|stage iii rectal cancer
1554299|NCT00560339|Congestive Heart Failure|congestive heart failure
1554300|NCT00560339|Implantable Defibrillators|implantable defibrillators
1554301|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
1554302|NCT00560326|Paediatric patients|paediatric patients
1554303|NCT00560326|Tacrolimus|tacrolimus
1554304|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
1554305|NCT00560313|Meningococcal disease|meningococcal disease
1554308|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1554309|NCT00560287|Non-invasive ventilation|non-invasive ventilation
1554310|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
1554311|NCT00560261|Sickle cell disease;|sickle cell disease;
1554312|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
1554313|NCT00560261|Children|children
1554314|NCT00560248|Chest Pain|chest pain
1554315|NCT00560248|STEMI|stemi
1554316|NCT00560248|UA/NSTEMI|ua/nstemi
1554317|NCT00560248|ACS|acs
1554318|NCT00560248|Emergency Department|emergency department
1554319|NCT00560222|randomized controlled trial|randomized controlled trial
1554320|NCT00560222|lactoferrin|lactoferrin
1554321|NCT00560222|children|children
1554322|NCT00560222|diarrhea|diarrhea
1554323|NCT00560222|malnutrition|malnutrition
1554324|NCT00560222|growth|growth
1554325|NCT00560209|ONO-1101|ono-1101
1554326|NCT00560209|Coronary Artery Disease|coronary artery disease
1554327|NCT00560209|Multi-slice CT|multi-slice ct
1554328|NCT00560196|Neuropathic pain|neuropathic pain
1554329|NCT00560196|Chronic pain|chronic pain
1554330|NCT00560196|Depression|depression
1554331|NCT00560196|Anxiety|anxiety
1554332|NCT00560183|Acute|acute
1554333|NCT00560183|Bunionectomy|bunionectomy
1554334|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
1554335|NCT00560170|endothelial function|endothelial function
1554336|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
1554337|NCT00560157|ICU patients|icu patients
1554338|NCT00560118|recurrent melanoma|recurrent melanoma
1554339|NCT00560118|stage IV melanoma|stage iv melanoma
1554340|NCT00560105|COPD|copd
1554341|NCT00560092|Magnesium|magnesium
1554342|NCT00560092|Pain|pain
1554343|NCT00560092|Morphine|morphine
1554344|NCT00560092|Intrathecal|intrathecal
1554345|NCT00560092|NMDA|nmda
1554346|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
1554347|NCT00560066|influenza|influenza
1554348|NCT00560066|vaccine|vaccine
1554349|NCT00560053|Multiple Myeloma|multiple myeloma
1554350|NCT00560053|Alternating chemotherapy|alternating chemotherapy
1554351|NCT00560053|Transplantation|transplantation
1554352|NCT00560040|Troponin|troponin
1554353|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
1554354|NCT00560040|Exercise|exercise
1554355|NCT00560040|Echocardiography|echocardiography
1554356|NCT00560027|postpartum depression|postpartum depression
1554357|NCT00560027|intimate partner violence|intimate partner violence
1554358|NCT00560001|frail elderly|frail elderly
1554359|NCT00560001|medication errors|medication errors
1554360|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
1554361|NCT00560001|guideline adherence|guideline adherence
1554362|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
1554363|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
1554364|NCT00559988|Home Monitoring|home monitoring
1554365|NCT00559988|Oral Anticoagulation|oral anticoagulation
1554366|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
1554367|NCT00559962|LDL|ldl
1554368|NCT00559962|hepatic fat|hepatic fat
1554369|NCT00559897|bone metastases|bone metastases
1554370|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1554371|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1554372|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1554373|NCT00559884|pharmacokinetics,|pharmacokinetics,
1554374|NCT00559884|healthy male and females,|healthy male and females,
1554375|NCT00559884|pharmacodynamics|pharmacodynamics
1554376|NCT00559871|dyskinesia|dyskinesia
1554377|NCT00559871|movement disorders|movement disorders
1554378|NCT00559871|basal ganglia diseases|basal ganglia diseases
1554379|NCT00559871|JP-1730|jp-1730
1554380|NCT00559871|Parkinson|parkinson
1554382|NCT00559871|fluctuations|fluctuations
1554383|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1554384|NCT00559858|breast cancer|breast cancer
1554385|NCT00559858|male breast cancer|male breast cancer
1554386|NCT00559858|colon cancer|colon cancer
1554387|NCT00559858|rectal cancer|rectal cancer
1554388|NCT00559832|acute mountain sickness|acute mountain sickness
1554389|NCT00559832|intermittent hypoxia|intermittent hypoxia
1554390|NCT00559832|acclimatization|acclimatization
1554391|NCT00559819|Alcohol|alcohol
1554392|NCT00559819|Driving|driving
1554393|NCT00559819|Impairment|impairment
1554394|NCT00559806|immobilisation|immobilisation
1554395|NCT00559806|aging|aging
1554396|NCT00559806|resistance training|resistance training
1554397|NCT00559806|atrophy|atrophy
1554398|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
1554399|NCT00559780|Resistance training|resistance training
1554400|NCT00559780|Aging|aging
1554401|NCT00559780|hip-surgery|hip-surgery
1554402|NCT00559767|Kidney Function|kidney function
1554403|NCT00559767|Genes|genes
1554404|NCT00559767|Association Analysis|association analysis
1554509|NCT00559286|perfusion|perfusion
1554405|NCT00559767|Polymorphisms|polymorphisms
1554406|NCT00559767|Diabetes|diabetes
1554407|NCT00559741|stage IV colon cancer|stage iv colon cancer
1554408|NCT00559741|recurrent colon cancer|recurrent colon cancer
1554409|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
1554410|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
1554411|NCT00559715|bevacizumab|bevacizumab
1554412|NCT00559715|ranibizumab|ranibizumab
1554413|NCT00559715|macular degeneration|macular degeneration
1554414|NCT00559715|age-related|age-related
1554415|NCT00559715|neovascular|neovascular
1554416|NCT00559715|intravitreal injection|intravitreal injection
1554417|NCT00559715|vision loss|vision loss
1554418|NCT00559715|outpatient setting|outpatient setting
1554419|NCT00559702|natalizumab|natalizumab
1554420|NCT00559702|multiple sclerosis|multiple sclerosis
1554421|NCT00559702|Tysabri ®|tysabri ®
1554422|NCT00559689|asthma patients|asthma patients
1554423|NCT00559689|well-controlled|well-controlled
1554424|NCT00559676|recurrent colon cancer|recurrent colon cancer
1554425|NCT00559676|stage IV colon cancer|stage iv colon cancer
1554426|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
1554427|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
1554428|NCT00559663|Flavonoid|flavonoid
1554429|NCT00559663|hsCRP|hscrp
1554430|NCT00559663|HDL|hdl
1554431|NCT00559663|LDL|ldl
1554432|NCT00559663|platelet reactivity|platelet reactivity
1554433|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
1554434|NCT00559650|Double blind study,|double blind study,
1554435|NCT00559650|BAY58-2667|bay58-2667
1554436|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
1554437|NCT00559624|safety|safety
1554438|NCT00559624|tolerability|tolerability
1554439|NCT00559624|dose-escalation|dose-escalation
1554440|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
1554441|NCT00559611|Lung Cancer|lung cancer
1554442|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
1554443|NCT00559611|Fine Needle Aspiration|fine needle aspiration
1554444|NCT00559611|Mediastinoscopy|mediastinoscopy
1554445|NCT00559611|EBUS-FNA|ebus-fna
1554446|NCT00559611|EBUS|ebus
1554447|NCT00559611|Needle Biopsy|needle biopsy
1554448|NCT00559611|NSCLC|nsclc
1554449|NCT00559598|pancreatic cancer|pancreatic cancer
1554450|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
1554451|NCT00559572|Exercise|exercise
1554452|NCT00559572|Group Counseling|group counseling
1554453|NCT00559572|Obesity|obesity
1554454|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
1554455|NCT00559520|Patients|patients
1554456|NCT00559520|Suffering|suffering
1554457|NCT00559520|Undernutrition|undernutrition
1554458|NCT00559520|Requiring|requiring
1554459|NCT00559520|Vascular|vascular
1554460|NCT00559520|Surgery|surgery
1554461|NCT00559494|complete spinal cord injury|complete spinal cord injury
1554462|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
1554463|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
1554464|NCT00559494|traumatic|traumatic
1554465|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
1554466|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
1554467|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
1554468|NCT00559442|right ventricular function|right ventricular function
1554469|NCT00559442|hypoxia|hypoxia
1554470|NCT00559429|Prostate Cancer|prostate cancer
1554471|NCT00559416|HIV/AIDS|hiv/aids
1554472|NCT00559416|HLA-B*57|hla-b*57
1554473|NCT00559416|Cell Transfer|cell transfer
1554474|NCT00559416|HIV|hiv
1554475|NCT00559416|treatment experienced|treatment experienced
1554476|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
1554477|NCT00559403|South Africa|south africa
1554478|NCT00559403|Intervention Studies|intervention studies
1554479|NCT00559403|Sexual Behavior|sexual behavior
1554480|NCT00559403|Adolescents|adolescents
1554481|NCT00559403|STD|std
1554482|NCT00559403|HIV Seronegativity|hiv seronegativity
1554483|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
1554484|NCT00559390|Metabolic Syndrome|metabolic syndrome
1554485|NCT00559390|PCOS|pcos
1554486|NCT00559390|children|children
1554487|NCT00559390|girls|girls
1554488|NCT00559390|daughters|daughters
1554489|NCT00559390|sisters|sisters
1554490|NCT00559390|irregular periods|irregular periods
1554491|NCT00559351|esophagectomy|esophagectomy
1554492|NCT00559351|chemotherapy|chemotherapy
1554493|NCT00559351|chemoradiotherapy|chemoradiotherapy
1554494|NCT00559351|combined modality therapy|combined modality therapy
1554495|NCT00559338|CHF|chf
1554496|NCT00559338|Heart Failure|heart failure
1554497|NCT00559338|Dyspnea|dyspnea
1554498|NCT00559338|Cardiomyopathy|cardiomyopathy
1554499|NCT00559312|mild COPD|mild copd
1554500|NCT00559312|dyspnea|dyspnea
1554501|NCT00559312|exercise|exercise
1554502|NCT00559312|combination therapy|combination therapy
1554503|NCT00559299|163090|163090
1554504|NCT00559299|placebo-controlled|placebo-controlled
1554505|NCT00559299|MDD|mdd
1554506|NCT00559299|Depression|depression
1554507|NCT00559299|Tolerability|tolerability
1554508|NCT00559299|MDE|mde
1554510|NCT00559286|microcirculation|microcirculation
1554511|NCT00559286|RBC function|rbc function
1554512|NCT00559286|NO metabolism|no metabolism
1554513|NCT00559286|AT receptor blocker|at receptor blocker
1554514|NCT00559234|Optic Nerve|optic nerve
1554515|NCT00559234|Retina|retina
1554516|NCT00559234|Cornea|cornea
1554517|NCT00559234|Lens|lens
1554518|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
1554519|NCT00559234|Inherited Eye Disease|inherited eye disease
1554520|NCT00559234|Genetic Eye Disease|genetic eye disease
1554521|NCT00559221|AML|aml
1554522|NCT00559208|Children and Youth|children and youth
1554523|NCT00559208|Families|families
1554524|NCT00559208|Differential Response|differential response
1554525|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1554526|NCT00559195|anemia|anemia
1554527|NCT00559195|fatigue|fatigue
1554528|NCT00559169|epilepsy|epilepsy
1554529|NCT00559169|seizures|seizures
1554530|NCT00559169|menstrual cycle|menstrual cycle
1554531|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1554532|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1554533|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1554534|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1554535|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1554536|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1554537|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1554538|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1554539|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1554540|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1554541|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1554542|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1554543|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1554544|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1554545|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1567283|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
1554546|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1554547|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1554548|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1554549|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1554550|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1554551|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
1554552|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1554553|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
1554554|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
1554555|NCT00559143|AV conduction disturbances|av conduction disturbances
1554556|NCT00559143|LV function|lv function
1554557|NCT00559143|Biventricular Pacing|biventricular pacing
1554558|NCT00559143|Conductance Catheters|conductance catheters
1554559|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1554560|NCT00559130|Acute Lung Injury|acute lung injury
1554561|NCT00559130|Sepsis|sepsis
1554562|NCT00559130|Hemoperfusion|hemoperfusion
1554660|NCT00558727|Tumor|tumor
1554563|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1554564|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1554565|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1554566|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1554567|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1554568|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1554569|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1554570|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1554571|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1554572|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1554573|NCT00559091|AML|aml
1554574|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
1554575|NCT00559091|leukemia|leukemia
1554576|NCT00559091|relapsed|relapsed
1554577|NCT00559091|refractory|refractory
1554578|NCT00559091|M4|m4
1554579|NCT00559091|M5|m5
1554580|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
1554581|NCT00559078|Psychosexual Development|psychosexual development
1554582|NCT00559078|Sexual Development|sexual development
1554583|NCT00559078|Intersex|intersex
1554584|NCT00559078|Qualitative|qualitative
1554585|NCT00559078|CAH|cah
1554586|NCT00559078|Interview|interview
1554587|NCT00559078|Disorder of Sex Development|disorder of sex development
1554588|NCT00559078|Telephone|telephone
1554589|NCT00559078|Quality of Life|quality of life
1554590|NCT00559078|Mental Health|mental health
1554591|NCT00559078|Counseling|counseling
1554592|NCT00559065|Case-Cohort Study|case-cohort study
1554593|NCT00559065|Leukemia|leukemia
1554594|NCT00559065|Lymphoma|lymphoma
1554595|NCT00559065|Benzene|benzene
1554596|NCT00559065|Blood Disorders|blood disorders
1554597|NCT00559065|Solvent Exposure|solvent exposure
1554598|NCT00559065|Cancer Risk|cancer risk
1554599|NCT00559052|Enzymes|enzymes
1554600|NCT00559052|VIOKASE|viokase
1554601|NCT00559052|Bioavailability|bioavailability
1554602|NCT00559039|breast cancer|breast cancer
1554603|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1554604|NCT00559013|Staple line reinforcement|staple line reinforcement
1554605|NCT00559013|Staple line buttress|staple line buttress
1554606|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
1554607|NCT00559000|PTSD|ptsd
1554608|NCT00559000|Children|children
1554609|NCT00559000|trauma-focused Treatment|trauma-focused treatment
1554610|NCT00559000|KIDNET|kidnet
1554611|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
1554612|NCT00558987|Discipline|discipline
1554613|NCT00558987|Parenting|parenting
1554614|NCT00558987|Primary Care|primary care
1554615|NCT00558987|Videos|videos
1554616|NCT00558961|CLL|cll
1554617|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1554618|NCT00558961|leukemia|leukemia
1554619|NCT00558961|gleevec|gleevec
1554620|NCT00558961|chlorambucil|chlorambucil
1554621|NCT00558948|Bone Marrow Transplant|bone marrow transplant
1554622|NCT00558948|Bone Mineral Density|bone mineral density
1554623|NCT00558948|Survivors|survivors
1554624|NCT00558948|Muscle Strength|muscle strength
1554625|NCT00558922|Lung|lung
1554626|NCT00558922|Non small cell|non small cell
1554627|NCT00558922|antisense|antisense
1554628|NCT00558922|oligonucleotide|oligonucleotide
1554629|NCT00558922|paclitaxel|paclitaxel
1554630|NCT00558922|carboplatin|carboplatin
1554631|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
1554632|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
1554633|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
1718882|NCT00033774|HV|hv
1554634|NCT00558870|Solid Tumors|solid tumors
1554635|NCT00558870|Morphine|morphine
1554636|NCT00558870|Methadone|methadone
1554637|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
1554638|NCT00558870|Pain|pain
1554639|NCT00558844|Cystic Fibrosis|cystic fibrosis
1554640|NCT00558844|Respiratory Infections|respiratory infections
1554641|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1554642|NCT00558844|CFTR|cftr
1554643|NCT00558831|Acne|acne
1554644|NCT00558779|Coronary artery bypass|coronary artery bypass
1554645|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
1554646|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
1554647|NCT00558766|Behavior|behavior
1554648|NCT00558766|Gambling|gambling
1554649|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
1554650|NCT00558766|Dopamine|dopamine
1554651|NCT00558766|Parkinson Disease|parkinson disease
1554652|NCT00558766|PD|pd
1554653|NCT00558740|Dietary protein|dietary protein
1554654|NCT00558740|Fructose|fructose
1554655|NCT00558740|VLDL-triglycerides|vldl-triglycerides
1554656|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
1554657|NCT00558740|Lipid oxidation|lipid oxidation
1554658|NCT00558727|Advanced Solid Tumors|advanced solid tumors
1554659|NCT00558727|Solid Tumors|solid tumors
1554661|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1554662|NCT00558727|Chemotherapy|chemotherapy
1554663|NCT00558727|Benzoquinone|benzoquinone
1554664|NCT00558701|burns|burns
1554665|NCT00558701|donor site|donor site
1554666|NCT00558701|healing|healing
1554667|NCT00558701|microcurrent|microcurrent
1554668|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1554669|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
1554670|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1554671|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
1554672|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1554673|NCT00558675|Multiple Myeloma|multiple myeloma
1554674|NCT00558675|Immunotherapy|immunotherapy
1554675|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
1554676|NCT00558662|compression therapy|compression therapy
1554677|NCT00558662|venous leg ulcer|venous leg ulcer
1554678|NCT00558662|sub bandage pressure|sub bandage pressure
1554679|NCT00558636|NSCLC|nsclc
1554680|NCT00558623|lead, blood|lead, blood
1554681|NCT00558623|pregnancy|pregnancy
1554682|NCT00558623|calcium|calcium
1554683|NCT00558623|randomized trial|randomized trial
1554684|NCT00558623|dietary supplementation|dietary supplementation
1554685|NCT00558623|bone resorption|bone resorption
1554686|NCT00558597|Proteomics|proteomics
1554687|NCT00558597|Lung Transplantation|lung transplantation
1554688|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
1554689|NCT00558584|immunoadsorption|immunoadsorption
1554690|NCT00558584|immunoglobulin G|immunoglobulin g
1554691|NCT00558558|Solid Tumors|solid tumors
1554692|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
1554693|NCT00558558|Weight Loss|weight loss
1554694|NCT00558558|Haelan|haelan
1554695|NCT00558558|Fermented Soy Product|fermented soy product
1554696|NCT00558558|Nutrition|nutrition
1554697|NCT00558558|Cachexia|cachexia
1554698|NCT00558545|Breast|breast
1554699|NCT00558545|paclitaxel|paclitaxel
1554700|NCT00558545|antisense|antisense
1554701|NCT00558545|oligonucleotide|oligonucleotide
1554702|NCT00558532|Morbid obesity|morbid obesity
1554703|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
1554704|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1554705|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1554706|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1554707|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
1554708|NCT00558506|activity|activity
1554709|NCT00558506|treatment|treatment
1554710|NCT00558506|clinical trial|clinical trial
1554711|NCT00558454|Iron supplements|iron supplements
1554712|NCT00558454|Infant|infant
1554713|NCT00558454|Low birth weight|low birth weight
1554714|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
1554715|NCT00558454|Safety|safety
1554716|NCT00558376|Colonoscopy|colonoscopy
1554717|NCT00558363|Prostate Cancer|prostate cancer
1554718|NCT00558363|AVODART|avodart
1554719|NCT00558363|PSA|psa
1554720|NCT00558363|dutasteride|dutasteride
1554721|NCT00558363|PSADT|psadt
1554722|NCT00558363|Prostate specific antigen|prostate specific antigen
1554723|NCT00558363|radical therapy|radical therapy
1554724|NCT00558363|doubling time|doubling time
1554725|NCT00558350|lobectomy|lobectomy
1554726|NCT00558350|inflammatory reaction|inflammatory reaction
1554727|NCT00558350|intrapulmonary|intrapulmonary
1554728|NCT00558350|intrapleural|intrapleural
1554729|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
1554730|NCT00558324|LASIK|lasik
1554731|NCT00558324|Confocal microscopy|confocal microscopy
1554732|NCT00558324|Flap|flap
1554733|NCT00558311|Aneurysmal|aneurysmal
1554734|NCT00558311|Subarachnoid|subarachnoid
1554735|NCT00558311|Hemorrhage|hemorrhage
1554736|NCT00558311|vasospasm|vasospasm
1554737|NCT00558311|clazosentan|clazosentan
1554738|NCT00558311|PIVLAZ|pivlaz
1554739|NCT00558311|Actelion|actelion
1554740|NCT00558311|surgical clipping|surgical clipping
1554741|NCT00558298|schizophrenia|schizophrenia
1554742|NCT00558298|schizoaffective disorder|schizoaffective disorder
1554743|NCT00558298|risperidone|risperidone
1554744|NCT00558298|intramuscular injection|intramuscular injection
1554745|NCT00558298|long-acting injectable|long-acting injectable
1554746|NCT00558285|COPD|copd
1554747|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1554748|NCT00558285|Indacaterol|indacaterol
1554749|NCT00558285|QVA149|qva149
1554750|NCT00558272|breast cancer|breast cancer
1554751|NCT00558272|prostate cancer|prostate cancer
1554752|NCT00558272|metastatic bone disease|metastatic bone disease
1554753|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
1554754|NCT00558246|Breast Lift|breast lift
1554755|NCT00558246|Breast Reduction|breast reduction
1554756|NCT00558246|Breast Reconstruction|breast reconstruction
1554757|NCT00558246|Plastic Surgery|plastic surgery
1554758|NCT00558246|Skin Closure|skin closure
1554759|NCT00558246|Wound Healing|wound healing
1554760|NCT00558246|Dermabond|dermabond
1554761|NCT00558233|Colorectal cancer|colorectal cancer
1554762|NCT00558233|Screening|screening
1554763|NCT00558233|Health literacy|health literacy
1554764|NCT00558233|Patient education|patient education
1554765|NCT00558233|Computer assisted instruction|computer assisted instruction
1554766|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
1554767|NCT00558220|Immunotherapy, passive|immunotherapy, passive
1554768|NCT00558220|Remission induction|remission induction
1554769|NCT00558220|Autologous transplantation|autologous transplantation
1554770|NCT00558207|Pancreatic cancer|pancreatic cancer
1554771|NCT00558207|pancreas cancer|pancreas cancer
1554772|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
1554773|NCT00558194|Weight loss|weight loss
1554774|NCT00558181|B CLL|b cll
1554775|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
1554776|NCT00558181|Methylprednisolone|methylprednisolone
1554777|NCT00558181|Rituximab|rituximab
1554778|NCT00558168|Anastrazole|anastrazole
1554779|NCT00558168|safety|safety
1554780|NCT00558168|early breast cancer|early breast cancer
1554781|NCT00558155|immunonutrition|immunonutrition
1554782|NCT00558155|enteral nutrition|enteral nutrition
1554783|NCT00558155|parenteral nutrition|parenteral nutrition
1554784|NCT00558155|surgery|surgery
1554785|NCT00558142|contrast nephropathy|contrast nephropathy
1554886|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
1554786|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
1554787|NCT00558142|chronic kidney disease|chronic kidney disease
1554788|NCT00558142|acetylcysteine|acetylcysteine
1554789|NCT00558142|clinical study|clinical study
1554790|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
1554791|NCT00558129|X-STOP® IPD|x-stop® ipd
1554792|NCT00558129|Interspinous process decompression|interspinous process decompression
1554793|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
1554794|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
1554795|NCT00558116|Dynamic Splinting|dynamic splinting
1554796|NCT00558116|Nerve Conduction Studies|nerve conduction studies
1554797|NCT00558116|Splinting|splinting
1554798|NCT00558116|Levine Katz Survey|levine katz survey
1554799|NCT00558103|GW572016|gw572016
1554800|NCT00558103|Breast Cancer|breast cancer
1554802|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
1554803|NCT00558103|Pazopanib|pazopanib
1554804|NCT00558103|ErbB2|erbb2
1554805|NCT00558103|Cutaneous Disease|cutaneous disease
1554806|NCT00558103|Tykerb|tykerb
1554807|NCT00558103|Inflammatory|inflammatory
1554808|NCT00558103|Skin|skin
1554809|NCT00558103|Her2|her2
1554810|NCT00558103|Lapatinib|lapatinib
1554811|NCT00558103|GW786034|gw786034
1554812|NCT00558090|pain|pain
1554813|NCT00558090|Intensive Care Unit|intensive care unit
1554814|NCT00558090|morphine|morphine
1554815|NCT00558090|pKpD|pkpd
1554816|NCT00558090|numerical rating scale|numerical rating scale
1554817|NCT00558090|critically ill patients|critically ill patients
1554818|NCT00558077|Anovulation|anovulation
1554819|NCT00558077|Clomiphene citrate|clomiphene citrate
1554820|NCT00558077|Fertility|fertility
1554821|NCT00558077|Metformin|metformin
1554822|NCT00558077|Ovulation induction|ovulation induction
1554823|NCT00558077|PCOS|pcos
1554824|NCT00558077|Sterility|sterility
1554825|NCT00558077|Treatment|treatment
1554826|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
1554827|NCT00558051|Colorectal Cancer|colorectal cancer
1554828|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
1554829|NCT00558051|Colorectal Tumors|colorectal tumors
1554830|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
1554831|NCT00558038|Hepatic|hepatic
1554832|NCT00558038|Encephalopathy|encephalopathy
1554833|NCT00558038|Liver|liver
1554834|NCT00558038|Liver Disease|liver disease
1554835|NCT00558038|Liver Failure|liver failure
1554836|NCT00558038|Lactulose|lactulose
1554837|NCT00558038|AST-120|ast-120
1554838|NCT00558012|Osteoporosis|osteoporosis
1554839|NCT00558012|Bone loss|bone loss
1554840|NCT00558012|Frail Geriatric Women|frail geriatric women
1554841|NCT00558012|Nursing Home Patients|nursing home patients
1554842|NCT00558012|Fragility Fractures|fragility fractures
1554843|NCT00557999|Cardiology|cardiology
1554844|NCT00557999|Mechanical ventilation|mechanical ventilation
1554845|NCT00557999|Intensive care|intensive care
1554846|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
1554847|NCT00557986|2-Surgery|2-surgery
1554848|NCT00557986|3-Survival|3-survival
1554849|NCT00557947|Abdominoplasty|abdominoplasty
1554850|NCT00557947|Body Lift|body lift
1554851|NCT00557947|Plastic Surgery|plastic surgery
1554852|NCT00557947|Skin Closure|skin closure
1554853|NCT00557947|Wound Healing|wound healing
1554854|NCT00557947|Dermabond|dermabond
1554855|NCT00557934|tetralogy of Fallot|tetralogy of fallot
1554856|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
1554857|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
1554858|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
1554859|NCT00557934|pressure-volume loops|pressure-volume loops
1554860|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
1554861|NCT00557921|ACS|acs
1554862|NCT00557921|CAD|cad
1554863|NCT00557921|MI|mi
1554864|NCT00557921|PCI|pci
1554865|NCT00557921|PTCA|ptca
1554866|NCT00557921|NSTEMI|nstemi
1554867|NCT00557921|STEMI|stemi
1554868|NCT00557921|acute coronary syndrome|acute coronary syndrome
1554869|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
1554870|NCT00557921|coronary artery stent placement|coronary artery stent placement
1554871|NCT00557921|coronary thrombosis|coronary thrombosis
1554872|NCT00557921|myocardial infarction|myocardial infarction
1554873|NCT00557921|myocardial ischemia|myocardial ischemia
1554874|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
1554875|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1554876|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
1554877|NCT00557921|duodenal obstruction|duodenal obstruction
1554878|NCT00557921|duodenal ulcer|duodenal ulcer
1554879|NCT00557921|dyspepsia|dyspepsia
1554880|NCT00557921|esophagitis, peptic|esophagitis, peptic
1554881|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
1554882|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
1554883|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
1554884|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
1554885|NCT00557921|peptic ulcer|peptic ulcer
1554887|NCT00557908|Von Willebrand Disease|von willebrand disease
1554888|NCT00557908|VWD|vwd
1554889|NCT00557908|prophylaxis|prophylaxis
1554890|NCT00557895|Asthma|asthma
1554891|NCT00557895|Hypersensitivity|hypersensitivity
1554892|NCT00557895|Peanut Allergy|peanut allergy
1554893|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
1554894|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
1554895|NCT00557882|prolapse|prolapse
1554896|NCT00557882|uterus|uterus
1554897|NCT00557882|mesh|mesh
1554898|NCT00557882|bladder|bladder
1554899|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
1554900|NCT00557843|Bupivacaine|bupivacaine
1554901|NCT00557843|Colon|colon
1554902|NCT00557843|Surgery|surgery
1554903|NCT00557843|Oxygenation|oxygenation
1554904|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
1554905|NCT00557830|Kidney Cancer|kidney cancer
1554906|NCT00557817|HCT|hct
1554907|NCT00557817|autologous|autologous
1554908|NCT00557817|erythropoiesis|erythropoiesis
1554909|NCT00557817|iron saccharate|iron saccharate
1554910|NCT00557817|erythropoietin|erythropoietin
1554911|NCT00557817|darbepoetin alpha|darbepoetin alpha
1554912|NCT00557804|Congestive Heart Failure|congestive heart failure
1554913|NCT00557791|AMD|amd
1554914|NCT00557791|ARMD|armd
1554915|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
1554916|NCT00557791|Bevasiranib|bevasiranib
1554917|NCT00557791|siRNA|sirna
1554918|NCT00557778|prevention|prevention
1554919|NCT00557778|dyslipidemia|dyslipidemia
1554920|NCT00557765|Tuberculosis|tuberculosis
1554921|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
1554922|NCT00557765|Interferon gamma release assay|interferon gamma release assay
1554923|NCT00557765|Contact tracing|contact tracing
1554924|NCT00557739|CRx-191|crx-191
1554925|NCT00557739|Plaque|plaque
1554926|NCT00557739|Psoriasis|psoriasis
1554927|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
1554928|NCT00557739|mometasone furoate|mometasone furoate
1554929|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
1554930|NCT00557726|Inflammation|inflammation
1554931|NCT00557726|Infection|infection
1554932|NCT00557726|Fever|fever
1554933|NCT00557700|Mild to moderate asthma|mild to moderate asthma
1554934|NCT00557687|IVF|ivf
1554935|NCT00557687|ovarian reserve|ovarian reserve
1554936|NCT00557687|poor response|poor response
1554937|NCT00557661|Heart failure|heart failure
1554938|NCT00557661|CD-NP|cd-np
1554939|NCT00557648|Anxiety|anxiety
1554940|NCT00557648|Children|children
1554941|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1554942|NCT00557648|School-Based Interventions|school-based interventions
1554943|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
1554944|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
1554945|NCT00557622|CAPS|caps
1554946|NCT00557622|fMRI|fmri
1554947|NCT00557622|Paroxetine|paroxetine
1554948|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
1554949|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
1554950|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
1554951|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
1554952|NCT00557596|Pancreatic|pancreatic
1554953|NCT00557596|antisense|antisense
1554954|NCT00557596|oligonucleotide|oligonucleotide
1554955|NCT00557596|gemcitabine|gemcitabine
1554956|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
1554957|NCT00557570|Antiretroviral|antiretroviral
1554958|NCT00557570|Opportunistic Infection|opportunistic infection
1554959|NCT00557570|treatment experienced|treatment experienced
1554960|NCT00557570|treatment naive|treatment naive
1554961|NCT00557557|Colorectal|colorectal
1554962|NCT00557557|liver|liver
1554963|NCT00557557|cancer|cancer
1554964|NCT00557557|metastases|metastases
1554965|NCT00557544|migraine|migraine
1554966|NCT00557544|metoclopramide|metoclopramide
1554967|NCT00557544|ketoprofen|ketoprofen
1554968|NCT00557544|child|child
1554969|NCT00557492|pancreas|pancreas
1554970|NCT00557492|pancreatic|pancreatic
1554971|NCT00557492|cancer|cancer
1554972|NCT00557492|resectable|resectable
1554973|NCT00557466|QMF|qmf
1554974|NCT00557466|indacaterol|indacaterol
1554975|NCT00557466|TWISTHALER® device|twisthaler® device
1554976|NCT00557440|Asthma|asthma
1554977|NCT00557440|QMF|qmf
1554978|NCT00557440|Indacaterol|indacaterol
1554979|NCT00557440|Mometasone|mometasone
1554980|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
1554981|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
1554982|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
1554983|NCT00557414|prognosis|prognosis
1554984|NCT00557388|muscle loss|muscle loss
1554985|NCT00557388|aging|aging
1554986|NCT00557388|protein|protein
1554987|NCT00557388|amino acids|amino acids
1554988|NCT00557388|exercise|exercise
1556254|NCT00552071|Acromegaly|acromegaly
1554989|NCT00557388|protein synthesis|protein synthesis
1554990|NCT00557375|Brain Tumors|brain tumors
1554992|NCT00557362|Keratitis|keratitis
1554993|NCT00557362|Eye Infection, Fungal|eye infection, fungal
1554994|NCT00557362|Fungal Eye Infection|fungal eye infection
1554995|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
1554996|NCT00557362|Fungal Keratitis|fungal keratitis
1554997|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
1554998|NCT00557362|Voriconazole|voriconazole
1554999|NCT00557362|Natamycin|natamycin
1555000|NCT00557349|gastric bypass surgery|gastric bypass surgery
1555001|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
1555002|NCT00557349|Complication, Postoperative|complication, postoperative
1555003|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
1555004|NCT00557297|asthma|asthma
1555005|NCT00557297|SMART|smart
1555006|NCT00557297|inhaled|inhaled
1555007|NCT00557297|glucocorticosteroid|glucocorticosteroid
1555008|NCT00557297|reliever|reliever
1555009|NCT00557297|maintenance|maintenance
1555010|NCT00557297|single inhaler|single inhaler
1555011|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
1555012|NCT00557245|HIV infection|hiv infection
1555013|NCT00557245|HIV uninfected partners|hiv uninfected partners
1555014|NCT00557245|Double Blind|double blind
1555015|NCT00557245|Placebo|placebo
1555016|NCT00557245|Seroconversion|seroconversion
1555017|NCT00557245|TDF|tdf
1555018|NCT00557245|FTC TDF|ftc tdf
1555019|NCT00557245|Safety|safety
1555020|NCT00557245|HIV Seronegativity|hiv seronegativity
1555021|NCT00557232|bevacizumab|bevacizumab
1555022|NCT00557232|rubeosis iridis|rubeosis iridis
1555023|NCT00557232|glaucoma|glaucoma
1555024|NCT00557219|cardiac surgery|cardiac surgery
1555025|NCT00557219|fenoldopam|fenoldopam
1555026|NCT00557219|ketanserin|ketanserin
1555027|NCT00557219|renal replacement therapy|renal replacement therapy
1555028|NCT00557206|Recurrent Disease|recurrent disease
1555029|NCT00557206|Metastatic Disease|metastatic disease
1555030|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
1555031|NCT00557206|Multicenter|multicenter
1555032|NCT00557206|Phase II|phase ii
1555033|NCT00557180|Steroid Resistance|steroid resistance
1555034|NCT00557180|Inflammation|inflammation
1555035|NCT00557154|Pediatrics|pediatrics
1555036|NCT00557154|Venous access|venous access
1555037|NCT00557154|Emergency|emergency
1555038|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
1555039|NCT00557128|COREG CR,|coreg cr,
1555040|NCT00557128|lisinopril,|lisinopril,
1555041|NCT00557128|hypertension,|hypertension,
1555042|NCT00557128|dose proportionality,|dose proportionality,
1555043|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
1555044|NCT00557115|Quality of life|quality of life
1555045|NCT00557115|Quadriceps|quadriceps
1555046|NCT00557115|Muscle|muscle
1555047|NCT00557115|Exacerbation|exacerbation
1555048|NCT00557102|liver metastases|liver metastases
1555049|NCT00557102|lung metastases|lung metastases
1555050|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
1555051|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
1555052|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1555053|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
1555054|NCT00557102|recurrent colon cancer|recurrent colon cancer
1555055|NCT00557102|stage IV colon cancer|stage iv colon cancer
1555056|NCT00557089|Pediatrics|pediatrics
1555057|NCT00557089|Cystic Fibrosis|cystic fibrosis
1555058|NCT00557089|Lung Clearance Index|lung clearance index
1555059|NCT00557089|rhDNAse|rhdnase
1555060|NCT00557076|Randomized Clinical Trial|randomized clinical trial
1555061|NCT00557076|Auditory Stimulation|auditory stimulation
1555062|NCT00557050|Hamstring|hamstring
1555063|NCT00557050|Muscle|muscle
1555064|NCT00557050|Injury|injury
1555065|NCT00557050|Prevention|prevention
1555066|NCT00557050|Muscles|muscles
1555067|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
1555068|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
1555069|NCT00557024|liver cancer|liver cancer
1555070|NCT00557024|radiofrequency ablation|radiofrequency ablation
1555071|NCT00557024|radiotherapy|radiotherapy
1555072|NCT00557024|adjuvant therapy|adjuvant therapy
1555073|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
1555074|NCT00556959|ADHD|adhd
1555075|NCT00556959|Clonidine|clonidine
1555076|NCT00556959|Attention Deficit|attention deficit
1555077|NCT00556959|Hyperactivity|hyperactivity
1555078|NCT00556959|CLONICEL|clonicel
1555079|NCT00556959|Addrenex|addrenex
1555080|NCT00556946|Vascular Malformation|vascular malformation
1555081|NCT00556933|Induction|induction
1555082|NCT00556933|rATG|ratg
1555083|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
1555084|NCT00556920|Coreg CR|coreg cr
1555085|NCT00556907|DCIS|dcis
1555189|NCT00556413|recurrent colon cancer|recurrent colon cancer
1555086|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
1555087|NCT00556868|High school students|high school students
1555088|NCT00556868|Boarding school|boarding school
1555089|NCT00556868|Breakfast|breakfast
1555091|NCT00556868|Memory|memory
1555092|NCT00556868|Attention|attention
1555093|NCT00556868|Mood|mood
1555094|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
1555095|NCT00556855|research study|research study
1555096|NCT00556855|E-do|e-do
1555097|NCT00556855|HK-03|hk-03
1555098|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
1555099|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
1555100|NCT00556816|COPD|copd
1555101|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
1555102|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
1555103|NCT00556803|liver cancer|liver cancer
1555104|NCT00556803|radiofrequency ablation|radiofrequency ablation
1555105|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1555106|NCT00556803|adjuvant therapy|adjuvant therapy
1555107|NCT00556777|stage I breast cancer|stage i breast cancer
1555108|NCT00556764|ANAM|anam
1555109|NCT00556764|Parkinson's|parkinson's
1555110|NCT00556751|Electrocardiogram|electrocardiogram
1555111|NCT00556751|Electrocardiography|electrocardiography
1555112|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
1555113|NCT00556751|Cholesterol|cholesterol
1555114|NCT00556751|Blood Pressure|blood pressure
1555115|NCT00556751|Diabetes|diabetes
1555116|NCT00556738|HFPV|hfpv
1555117|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
1555118|NCT00556699|NHL|nhl
1555119|NCT00556699|Rituxan|rituxan
1555120|NCT00556699|anti-CD40|anti-cd40
1555121|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
1555122|NCT00556660|Alzheimer|alzheimer
1555123|NCT00556660|SPECT|spect
1555124|NCT00556647|fast-track diagnosis|fast-track diagnosis
1555125|NCT00556647|PET-CT|pet-ct
1555126|NCT00556647|endoscopic techniques|endoscopic techniques
1555127|NCT00556647|lung cancer|lung cancer
1555128|NCT00556634|HIV|hiv
1555129|NCT00556634|efavirenz|efavirenz
1555130|NCT00556634|central nervous system|central nervous system
1555131|NCT00556634|adverse effects|adverse effects
1555132|NCT00556621|stage II bladder cancer|stage ii bladder cancer
1555133|NCT00556621|stage III bladder cancer|stage iii bladder cancer
1555134|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1555135|NCT00556595|atrial fibrillation|atrial fibrillation
1555136|NCT00556595|paroxysmal|paroxysmal
1555137|NCT00556595|symptomatic|symptomatic
1555138|NCT00556595|drug-refractory|drug-refractory
1555139|NCT00556569|Physical activity|physical activity
1555140|NCT00556569|Obesity|obesity
1555141|NCT00556543|Rib Fracture|rib fracture
1555142|NCT00556543|Rib Fracture Repair|rib fracture repair
1555143|NCT00556543|Rib Fracture ORIF|rib fracture orif
1555144|NCT00556543|Flail Chest|flail chest
1555145|NCT00556543|Implant|implant
1555146|NCT00556543|Prosthesis|prosthesis
1555147|NCT00556543|Rib fracture non-union|rib fracture non-union
1555148|NCT00556543|Chest wall deformity|chest wall deformity
1555149|NCT00556530|Congenital Heart Defects|congenital heart defects
1555150|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1555151|NCT00556530|Copy Number Variations|copy number variations
1555152|NCT00556530|Whole Genome Association Study|whole genome association study
1555153|NCT00556517|Hamstring|hamstring
1555154|NCT00556517|Strain|strain
1555155|NCT00556517|Rehabilitation|rehabilitation
1555156|NCT00556517|muscles|muscles
1555157|NCT00556504|add-on treatment|add-on treatment
1555158|NCT00556504|botanical drug|botanical drug
1555159|NCT00556504|HCV genotype 1|hcv genotype 1
1555160|NCT00556504|TCM-700C|tcm-700c
1555161|NCT00556504|genotype I|genotype i
1555162|NCT00556491|renal|renal
1555163|NCT00556491|kidney|kidney
1555164|NCT00556491|injury|injury
1555165|NCT00556491|acute|acute
1555166|NCT00556491|bypass|bypass
1555167|NCT00556491|cardiac|cardiac
1555168|NCT00556491|minocycline|minocycline
1555169|NCT00556491|prevention|prevention
1555170|NCT00556491|Acute Kidney Failure|acute kidney failure
1555171|NCT00556478|Premature Ejaculation|premature ejaculation
1555172|NCT00556478|Lidocaine|lidocaine
1555173|NCT00556478|Prilocaine|prilocaine
1555174|NCT00556478|EMLA® cream|emla® cream
1555175|NCT00556478|topical anesthetics|topical anesthetics
1555176|NCT00556465|diabetic nephropathy|diabetic nephropathy
1555177|NCT00556465|proteinuria|proteinuria
1555178|NCT00556465|antioxidant|antioxidant
1555179|NCT00556439|Vasculitis|vasculitis
1555180|NCT00556439|Arteritis|arteritis
1555181|NCT00556439|Takayasu's|takayasu's
1555182|NCT00556439|Temporal Arteritis|temporal arteritis
1555183|NCT00556439|Abatacept|abatacept
1555184|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
1555185|NCT00556426|IVC Filter|ivc filter
1555186|NCT00556426|Pulmonary Embolism|pulmonary embolism
1555187|NCT00556413|stage IV colon cancer|stage iv colon cancer
1555188|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
1555190|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
1555191|NCT00556400|Uterine Bleeding|uterine bleeding
1555192|NCT00556400|Thrombocytopenia|thrombocytopenia
1555193|NCT00556400|Aplastic Anemia|aplastic anemia
1555194|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
1555195|NCT00556400|Menorrhagia|menorrhagia
1555196|NCT00556387|traumatic brain injury|traumatic brain injury
1555197|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
1555198|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
1555199|NCT00556374|estrogen receptor positive|estrogen receptor positive
1555200|NCT00556374|progesterone receptor positive|progesterone receptor positive
1555201|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
1555202|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
1555203|NCT00556374|postmenopausal woman|postmenopausal woman
1555204|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
1555205|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1555206|NCT00556348|bevacizumab|bevacizumab
1555208|NCT00556348|Complications|complications
1555209|NCT00556348|Visual acuity|visual acuity
1555210|NCT00556348|OCt|oct
1555211|NCT00556348|Age Macular Degeneration|age macular degeneration
1555212|NCT00556335|manual aspiration|manual aspiration
1555213|NCT00556335|conventional|conventional
1555214|NCT00556335|length of stay|length of stay
1555215|NCT00556283|outlet obstruction|outlet obstruction
1555216|NCT00556283|rectocele|rectocele
1555217|NCT00556270|pain|pain
1555218|NCT00556270|fentanyl|fentanyl
1555219|NCT00556270|transdermal patch|transdermal patch
1555220|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
1555221|NCT00556231|NIRS|nirs
1555222|NCT00556231|cardiac output|cardiac output
1555223|NCT00556231|anaerobic threshold|anaerobic threshold
1555224|NCT00556231|exercise stress|exercise stress
1555225|NCT00556231|congenital heart defect|congenital heart defect
1555226|NCT00556218|Breast Cancer|breast cancer
1555227|NCT00556218|Tibetan Meditation|tibetan meditation
1555228|NCT00556218|Quality of Life|quality of life
1555229|NCT00556218|Cognitive Function|cognitive function
1555230|NCT00556218|QOL|qol
1555231|NCT00556205|mRCC|mrcc
1555232|NCT00556205|sunitinib|sunitinib
1555233|NCT00556205|bevacizumab|bevacizumab
1555234|NCT00556192|SLE|sle
1555235|NCT00556192|Rituximab|rituximab
1555236|NCT00556192|Methylprednisolone|methylprednisolone
1555237|NCT00556192|Cyclophosphamide|cyclophosphamide
1555238|NCT00556166|Enterra therapy|enterra therapy
1555239|NCT00556166|Gastric Simulation System|gastric simulation system
1555240|NCT00556153|brain tumors, children|brain tumors, children
1555241|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
1555242|NCT00556127|Rituximab|rituximab
1555243|NCT00556127|ASCT|asct
1555244|NCT00556114|eye exam|eye exam
1555245|NCT00556114|Retina|retina
1555246|NCT00556101|Magnetic resonance|magnetic resonance
1555247|NCT00556101|whole body|whole body
1555248|NCT00556101|angiography|angiography
1555249|NCT00556101|questionnaire|questionnaire
1555250|NCT00556088|LBH589|lbh589
1555251|NCT00556088|Phase I|phase i
1555252|NCT00556088|Solid Tumors|solid tumors
1555253|NCT00556088|Paclitaxel|paclitaxel
1555254|NCT00556088|Carboplatin|carboplatin
1555255|NCT00556088|Bevacizumab|bevacizumab
1555256|NCT00556088|Dose escalation|dose escalation
1555257|NCT00556075|Endometriosis|endometriosis
1555258|NCT00556075|Pelvic pain|pelvic pain
1555259|NCT00556075|Oral progesterone blocker|oral progesterone blocker
1555260|NCT00556049|mRCC|mrcc
1555261|NCT00556049|sunitinib|sunitinib
1555262|NCT00556049|gemcitabine|gemcitabine
1555263|NCT00556036|healthy|healthy
1555264|NCT00556036|overweight|overweight
1555265|NCT00556036|obese|obese
1555266|NCT00556036|anorexia nervosa|anorexia nervosa
1555267|NCT00556036|weight|weight
1555268|NCT00556036|cortisol|cortisol
1555269|NCT00556036|hormone|hormone
1555270|NCT00556036|bone density|bone density
1555271|NCT00556036|bone|bone
1555272|NCT00556036|osteopenia|osteopenia
1555273|NCT00556036|osteoporosis|osteoporosis
1555274|NCT00556036|amenorrhea|amenorrhea
1555275|NCT00556036|menses|menses
1555276|NCT00556036|irregular|irregular
1555277|NCT00556036|stress|stress
1555278|NCT00556036|depression|depression
1555279|NCT00556036|exercise|exercise
1555280|NCT00556036|diet|diet
1555281|NCT00556023|interventional|interventional
1555282|NCT00556023|dose-finding|dose-finding
1555283|NCT00555997|Major Depressive Disorder|major depressive disorder
1555284|NCT00555997|Major Depression|major depression
1555285|NCT00555997|Depression|depression
1555286|NCT00555997|Geodon|geodon
1555287|NCT00555997|Ziprasidone|ziprasidone
1555288|NCT00555984|Intracranial tumors|intracranial tumors
1555289|NCT00555984|Inflammatory markers|inflammatory markers
1555290|NCT00555984|Craniotomy|craniotomy
1555291|NCT00555984|Postoperative complications|postoperative complications
1555292|NCT00555958|Obesity|obesity
1555293|NCT00555958|Bariatric surgery|bariatric surgery
1555294|NCT00555958|Excess weight loss|excess weight loss
1555295|NCT00555958|Vagus nerve|vagus nerve
1555296|NCT00555958|Vagal blocking|vagal blocking
1555297|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
1555298|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
1555299|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
1555300|NCT00555945|Sliding hip screw|sliding hip screw
1555301|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
1555302|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
1555303|NCT00555932|Pediatrics|pediatrics
1555304|NCT00555932|Cranial Ultrasound|cranial ultrasound
1555305|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
1555306|NCT00555919|Metastatic breast cancer|metastatic breast cancer
1555308|NCT00555919|Stage IV breast cancer|stage iv breast cancer
1555309|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
1555310|NCT00555893|randomized|randomized
1555311|NCT00555893|blinded|blinded
1555312|NCT00555893|controlled|controlled
1555313|NCT00555893|efficacy|efficacy
1555314|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
1555315|NCT00555867|compliance|compliance
1555316|NCT00555867|Postmenopausal women|postmenopausal women
1555317|NCT00555854|Motivational interviewing,|motivational interviewing,
1555318|NCT00555854|Multidisciplinary|multidisciplinary
1555319|NCT00555854|Life style changes|life style changes
1555320|NCT00555854|Prevention|prevention
1555321|NCT00555854|Compliance|compliance
1555322|NCT00555854|Self Care|self care
1555323|NCT00555854|Behaviour|behaviour
1555324|NCT00555841|breast cancer|breast cancer
1555325|NCT00555828|Myocardial Infarction|myocardial infarction
1555326|NCT00555828|Myocardial infarct|myocardial infarct
1555327|NCT00555828|Infarction|infarction
1555328|NCT00555802|Low Back Pain|low back pain
1555329|NCT00555802|Motor Control Exercise|motor control exercise
1555330|NCT00555802|General exercise|general exercise
1555331|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
1555332|NCT00555802|Transversus abdominis|transversus abdominis
1555333|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
1555334|NCT00555789|kidney transplantation|kidney transplantation
1555335|NCT00555789|rejection|rejection
1555336|NCT00555789|AEB071|aeb071
1555337|NCT00555789|tacrolimus|tacrolimus
1555338|NCT00555789|mycophenolic acid|mycophenolic acid
1555339|NCT00555789|immunosuppression|immunosuppression
1555340|NCT00555776|tinnitus|tinnitus
1555341|NCT00555776|gabapentin|gabapentin
1555342|NCT00555763|Intraocular pressure|intraocular pressure
1555343|NCT00555763|Goldmann tonometry|goldmann tonometry
1555344|NCT00555763|applanation tonometry|applanation tonometry
1555345|NCT00555763|Tonometry, Ocular|tonometry, ocular
1555346|NCT00555750|sleep|sleep
1555347|NCT00555750|metabolism|metabolism
1555348|NCT00555750|insulin|insulin
1555349|NCT00555750|glucose|glucose
1555350|NCT00555750|actigraphy|actigraphy
1555351|NCT00555750|diary|diary
1555352|NCT00555750|volumetry|volumetry
1555353|NCT00555750|GABA|gaba
1555354|NCT00555737|Celiac Disease|celiac disease
1555355|NCT00555737|Capsule Endoscopy|capsule endoscopy
1555356|NCT00555737|small Bowel Disease|small bowel disease
1555357|NCT00555724|Relapsed|relapsed
1555358|NCT00555724|refractory|refractory
1555359|NCT00555724|solid tumor|solid tumor
1555360|NCT00555711|Brain tumor|brain tumor
1555362|NCT00555698|Depression|depression
1555363|NCT00555685|Heart Failure|heart failure
1555364|NCT00555685|Renal failure|renal failure
1555365|NCT00555685|Hyponatremia|hyponatremia
1555366|NCT00555659|Degeneration|degeneration
1555367|NCT00555659|Spondylosis|spondylosis
1555368|NCT00555659|Spondylolisthesis|spondylolisthesis
1555369|NCT00555659|Stenosis|stenosis
1555370|NCT00555633|Photoprotection|photoprotection
1555371|NCT00555633|Sunscreen|sunscreen
1555372|NCT00555633|After-sun-lotion|after-sun-lotion
1555373|NCT00555633|DNA repair enzymes|dna repair enzymes
1555374|NCT00555633|liposomes|liposomes
1555375|NCT00555633|skin cancer|skin cancer
1555376|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
1555377|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
1555378|NCT00555607|asthma|asthma
1555379|NCT00555607|COPD|copd
1555380|NCT00555607|severe|severe
1555381|NCT00555607|controlled|controlled
1555382|NCT00555607|mild|mild
1555383|NCT00555607|biomarker|biomarker
1555384|NCT00555607|exacerbation|exacerbation
1555385|NCT00555594|corneal neovascularization|corneal neovascularization
1555386|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
1555387|NCT00555594|Immunologic rejection|immunologic rejection
1555388|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
1555389|NCT00555581|Systemic Sclerosis|systemic sclerosis
1555390|NCT00555568|mental health|mental health
1555391|NCT00555568|group processes|group processes
1555392|NCT00555555|Factor VIII deficiency|factor viii deficiency
1555393|NCT00555555|Von Willebrand disease|von willebrand disease
1555394|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
1555395|NCT00555555|Bleeding disorders|bleeding disorders
1555396|NCT00555555|Blood disorders|blood disorders
1555397|NCT00555542|B-cell|b-cell
1555398|NCT00555542|rituximab|rituximab
1555399|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
1555400|NCT00555529|COPD|copd
1555401|NCT00555529|exhaled breath condensate|exhaled breath condensate
1555402|NCT00555529|applanation tonometry|applanation tonometry
1555403|NCT00555529|induced sputum|induced sputum
1555404|NCT00555529|smokers|smokers
1555405|NCT00555529|healthy control|healthy control
1555406|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
1555407|NCT00555503|prospective study|prospective study
1555408|NCT00555503|registry|registry
1555409|NCT00555503|quality of life|quality of life
1555410|NCT00555503|mastectomy|mastectomy
1555411|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
1555412|NCT00555503|BrCa1|brca1
1555413|NCT00555503|BrCa2|brca2
1555414|NCT00555503|breast cancer prevention|breast cancer prevention
1555416|NCT00555490|Diabetes|diabetes
1555417|NCT00555490|Nephropathy|nephropathy
1555418|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
1555419|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
1555420|NCT00555451|phase I|phase i
1555421|NCT00555451|safety|safety
1555422|NCT00555451|tolerance|tolerance
1555423|NCT00555451|insulin resistance|insulin resistance
1555424|NCT00555451|obese|obese
1555425|NCT00555451|pharmacokinetics|pharmacokinetics
1555426|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
1555427|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
1555428|NCT00555438|renal impairment|renal impairment
1555429|NCT00555438|Arixtra|arixtra
1555430|NCT00555438|anti-Xa activity|anti-xa activity
1555431|NCT00555425|Buprenorphine|buprenorphine
1555432|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
1555433|NCT00555425|Counseling|counseling
1555434|NCT00555425|Primary care|primary care
1555435|NCT00555412|pharmacokinetic|pharmacokinetic
1555436|NCT00555412|multidose|multidose
1555437|NCT00555412|Staccato Loxapine|staccato loxapine
1555438|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
1555439|NCT00555399|Anaplastic Glioma|anaplastic glioma
1555440|NCT00555399|Vorinostat|vorinostat
1555441|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
1555442|NCT00555399|SAHA|saha
1555443|NCT00555399|MSK-390|msk-390
1555444|NCT00555399|Zolinza|zolinza
1555445|NCT00555399|Isotretinoin|isotretinoin
1555446|NCT00555399|Accutane|accutane
1555447|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
1555448|NCT00555399|Carboplatin|carboplatin
1555449|NCT00555399|Paraplatin|paraplatin
1555450|NCT00555399|CBT|cbt
1555451|NCT00555399|Temozolomide|temozolomide
1555452|NCT00555399|Temodar|temodar
1555453|NCT00555386|Selenium|selenium
1555454|NCT00555386|Soy|soy
1555455|NCT00555386|Breast Cancer Risk|breast cancer risk
1555456|NCT00555373|Pediatric|pediatric
1555457|NCT00555373|Renal|renal
1555458|NCT00555373|Transplant|transplant
1555459|NCT00555360|Health Information Technology|health information technology
1555460|NCT00555360|Patient Care Management|patient care management
1555461|NCT00555360|Self Care|self care
1555462|NCT00555360|Quality of Life|quality of life
1555463|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
1555464|NCT00555347|Sarcoidosis|sarcoidosis
1555465|NCT00555347|Fatigue|fatigue
1555466|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
1555467|NCT00555334|liver cancer|liver cancer
1555468|NCT00555334|radiofrequency ablation|radiofrequency ablation
1555469|NCT00555334|lamivudine|lamivudine
1555470|NCT00555308|urolithiasis|urolithiasis
1555471|NCT00555308|ultrasound|ultrasound
1555472|NCT00555308|hydronephrosis|hydronephrosis
1555473|NCT00555282|central venous catheter|central venous catheter
1555475|NCT00555282|coated catheter|coated catheter
1555476|NCT00555282|bacteriaemia|bacteriaemia
1555477|NCT00555282|bloodstream infection|bloodstream infection
1555478|NCT00555269|Macular pucker|macular pucker
1555479|NCT00555269|Macular hole|macular hole
1555480|NCT00555269|Membrane Blue|membrane blue
1555481|NCT00555269|Infracyanine Green|infracyanine green
1555482|NCT00555269|Peripheral Visual Field|peripheral visual field
1555483|NCT00555256|NSCLC|nsclc
1555484|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
1555485|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1555486|NCT00555230|Crestor|crestor
1555487|NCT00555230|Rosuvastatin|rosuvastatin
1555488|NCT00555217|kidney disease|kidney disease
1555489|NCT00555217|nephropathy|nephropathy
1555490|NCT00555217|type 2 diabetes|type 2 diabetes
1555491|NCT00555217|hyperkalemia|hyperkalemia
1555492|NCT00555217|acute kidney injury|acute kidney injury
1555493|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
1555494|NCT00555191|fructose|fructose
1555495|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
1555496|NCT00555191|malabsorption|malabsorption
1555497|NCT00555191|Glut5 transporter gene|glut5 transporter gene
1555498|NCT00555178|Polymorphic light eruption|polymorphic light eruption
1555499|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
1555500|NCT00555178|Seasonal fluctuation|seasonal fluctuation
1555501|NCT00555178|UV radiation|uv radiation
1555502|NCT00555178|Phototherapy|phototherapy
1555503|NCT00555165|Macular Degeneration|macular degeneration
1555504|NCT00555165|Visual Impairment|visual impairment
1555505|NCT00555165|Quality of Life|quality of life
1555506|NCT00555165|Implantable Telescope|implantable telescope
1555507|NCT00555139|anxiety,|anxiety,
1555508|NCT00555139|depression,|depression,
1555509|NCT00555139|fMRI|fmri
1555510|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
1555511|NCT00555126|Polytrauma|polytrauma
1555512|NCT00555126|Hypothermia|hypothermia
1555513|NCT00555126|Wound Infection|wound infection
1555514|NCT00555126|Blood Loss|blood loss
1555515|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
1555516|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
1555517|NCT00555113|Visual acuity|visual acuity
1555518|NCT00555113|Choroidal neovascularization|choroidal neovascularization
1555519|NCT00555113|angioid streaks|angioid streaks
1555520|NCT00555087|Erectile dysfunction|erectile dysfunction
1555521|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
1555522|NCT00555061|SID|sid
1555523|NCT00555061|impetigo|impetigo
1555524|NCT00555061|pharmacokinetics|pharmacokinetics
1555525|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
1555526|NCT00555061|Skin abnormalities|skin abnormalities
1555527|NCT00555061|Dermatoses|dermatoses
1555528|NCT00555061|pediatric|pediatric
1555529|NCT00555061|infection|infection
1555530|NCT00555061|SITL|sitl
1555531|NCT00555048|graft versus host disease|graft versus host disease
1555532|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1555533|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1555534|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1555535|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1555536|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1555537|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1555538|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1555539|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1555540|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1555541|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1555542|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1555543|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1555544|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1555545|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1555546|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1555547|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1555548|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1555549|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1555550|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1555551|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1555552|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1555553|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1555554|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1555555|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1555556|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1555557|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1555558|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1555559|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1555560|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1555561|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1555562|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1555563|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1555564|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1555565|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1555566|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1555567|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1555568|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1555569|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
1555570|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1555571|NCT00555035|GSK1349572,|gsk1349572,
1555572|NCT00555035|healthy volunteers|healthy volunteers
1555573|NCT00555022|Anticholinergic,|anticholinergic,
1555574|NCT00555022|FTIH,|ftih,
1555575|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
1555576|NCT00555022|Plethysmography|plethysmography
1555577|NCT00555022|COPD,|copd,
1555578|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
1555579|NCT00554996|urinary tract infection|urinary tract infection
1555580|NCT00554996|urinary catheter|urinary catheter
1555581|NCT00554996|Escherichia coli|escherichia coli
1555582|NCT00554996|biofilm|biofilm
1555583|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
1555584|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
1555585|NCT00554970|Adult Asthmatics|adult asthmatics
1555586|NCT00554944|Fluid Management|fluid management
1555587|NCT00554944|surgery|surgery
1555588|NCT00554944|Obesity|obesity
1555589|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1555590|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
1555591|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
1555592|NCT00554918|bone metastases|bone metastases
1555593|NCT00554905|ablation|ablation
1555594|NCT00554905|catheter|catheter
1555595|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1555596|NCT00554905|therapy|therapy
1555597|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1555598|NCT00554905|Humans|humans
1555599|NCT00554905|Liver Neoplasms|liver neoplasms
1555600|NCT00554892|Rectal cancer|rectal cancer
1555601|NCT00554892|Sphincter preservation|sphincter preservation
1555602|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
1555603|NCT00554892|Post operative morbidity|post operative morbidity
1555604|NCT00554892|Anastomotic leakage|anastomotic leakage
1555605|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
1555606|NCT00554827|Lymphoma|lymphoma
1555607|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1555608|NCT00554827|T-cell Lymphoma|t-cell lymphoma
1555609|NCT00554827|Mycosis fungoides|mycosis fungoides
1555610|NCT00554827|Sézary syndrome|sézary syndrome
1555611|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
1555612|NCT00554814|Iron deficiency|iron deficiency
1555613|NCT00554814|Ferritin|ferritin
1555614|NCT00554814|Encapsulated iron|encapsulated iron
1555615|NCT00554814|Infant formula|infant formula
1555616|NCT00554801|Central Auditory Processing|central auditory processing
1555617|NCT00554801|Traumatic Brain Injury|traumatic brain injury
1555618|NCT00554801|Hearing Loss|hearing loss
1555619|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
1555620|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1555621|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1555622|NCT00554762|mechanical pain,|mechanical pain,
1555623|NCT00554762|heat pain,|heat pain,
1555625|NCT00554762|efficacy|efficacy
1555626|NCT00554762|dose response,|dose response,
1555627|NCT00554762|GW842166,|gw842166,
1555628|NCT00554762|Single,|single,
1555629|NCT00554762|pharmacodynamics,|pharmacodynamics,
1555630|NCT00554762|repeat dose,|repeat dose,
1555631|NCT00554749|Selective mutism|selective mutism
1555632|NCT00554749|Children|children
1555633|NCT00554749|Treatment|treatment
1555634|NCT00554736|Pollen Allergy|pollen allergy
1555635|NCT00554736|Allergy|allergy
1555636|NCT00554723|Stroke|stroke
1555637|NCT00554723|Cerebral infarct|cerebral infarct
1555638|NCT00554723|Recovery|recovery
1555639|NCT00554723|Double blind|double blind
1555640|NCT00554723|Randomized|randomized
1555641|NCT00554723|Placebo|placebo
1555642|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
1555643|NCT00554723|Neuroaid|neuroaid
1555644|NCT00554710|Crohn's disease|crohn's disease
1555645|NCT00554710|immunomodulators|immunomodulators
1555646|NCT00554710|biologicals|biologicals
1555647|NCT00554697|tissue oxygenation|tissue oxygenation
1555648|NCT00554697|perioperative|perioperative
1555649|NCT00554697|outcome|outcome
1555650|NCT00554684|Outcome|outcome
1555651|NCT00554684|Elderly|elderly
1555652|NCT00554684|ICU|icu
1555653|NCT00554684|Quality of Life|quality of life
1555654|NCT00554671|Diabetes Mellitus|diabetes mellitus
1555655|NCT00554671|Clinical pharmacists|clinical pharmacists
1555656|NCT00554671|guideline adherence|guideline adherence
1555657|NCT00554671|group medical visits|group medical visits
1555658|NCT00554671|behavioral modification|behavioral modification
1555659|NCT00554671|pharmacotherapy|pharmacotherapy
1555660|NCT00554645|obesity|obesity
1555661|NCT00554645|children|children
1555662|NCT00554645|psychological intervention|psychological intervention
1555663|NCT00554632|Contraceptive|contraceptive
1555664|NCT00554632|Venous thrombosis|venous thrombosis
1555665|NCT00554632|Coagulation parameter|coagulation parameter
1555666|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1555667|NCT00554619|Ambrisentan|ambrisentan
1555668|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
1555669|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
1555670|NCT00554606|ACZ885|acz885
1555671|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
1555672|NCT00554580|outcome measure|outcome measure
1555673|NCT00554580|clinical trial|clinical trial
1555674|NCT00554567|HIV/AIDS|hiv/aids
1555675|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
1555676|NCT00554567|Rural India|rural india
1555677|NCT00554567|HIV Care|hiv care
1555678|NCT00554567|Health Services Research|health services research
1555679|NCT00554528|Cervical|cervical
1555680|NCT00554528|disc|disc
1555681|NCT00554528|prosthesis|prosthesis
1555682|NCT00554528|adjacent|adjacent
1555683|NCT00554528|disease|disease
1555684|NCT00554528|randomized|randomized
1555685|NCT00554528|prospective|prospective
1555686|NCT00554528|study|study
1555687|NCT00554515|Kidney|kidney
1555688|NCT00554515|Renal Cell|renal cell
1555689|NCT00554515|Metastatic|metastatic
1555690|NCT00554515|interleukin-2|interleukin-2
1555691|NCT00554515|select|select
1555692|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1555693|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1555694|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1555695|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1555696|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1555697|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1555698|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
1555699|NCT00554476|Treatment|treatment
1555700|NCT00554476|Corticosteroid|corticosteroid
1555701|NCT00554476|Elbow Cast|elbow cast
1555702|NCT00554476|Icing|icing
1555703|NCT00554476|NSAIDs|nsaids
1555704|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
1555705|NCT00554437|Accidental Falls|accidental falls
1555707|NCT00554437|Age 65 and older|age 65 and older
1555708|NCT00554437|noninstitualized populations|noninstitualized populations
1555709|NCT00554424|oocyte retrieval|oocyte retrieval
1555710|NCT00554424|pain relief|pain relief
1555711|NCT00554424|Local anaesthetic|local anaesthetic
1555712|NCT00554411|Travatan Z|travatan z
1555713|NCT00554411|glaucoma|glaucoma
1555714|NCT00554411|tear film break up time|tear film break up time
1555715|NCT00554398|Raltegravir|raltegravir
1555716|NCT00554398|MK-0518|mk-0518
1555717|NCT00554398|Treatment intensification|treatment intensification
1555718|NCT00554398|HIV-1 latency|hiv-1 latency
1555719|NCT00554398|HIV eradication|hiv eradication
1555720|NCT00554398|treatment experienced|treatment experienced
1555721|NCT00554372|Jennerex|jennerex
1555722|NCT00554372|HCC|hcc
1555723|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
1555724|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
1555725|NCT00554372|liver cancer|liver cancer
1555726|NCT00554372|Phase 2|phase 2
1555727|NCT00554372|oncolytic virus|oncolytic virus
1555728|NCT00554372|Pexa-Vec|pexa-vec
1555729|NCT00554359|Acute Kidney Injury|acute kidney injury
1555730|NCT00554359|Acute Renal Failure|acute renal failure
1555731|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
1555732|NCT00554320|vulvodynia|vulvodynia
1555733|NCT00554320|painful bladder syndrome|painful bladder syndrome
1555734|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
1555735|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
1555736|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
1555737|NCT00554307|indomethacin|indomethacin
1555738|NCT00554307|neoprofen|neoprofen
1555739|NCT00554307|blood flow|blood flow
1555740|NCT00554294|children|children
1555741|NCT00554294|primary prevention|primary prevention
1555742|NCT00554294|environmental change|environmental change
1555743|NCT00554294|behavioural change|behavioural change
1555744|NCT00554294|school setting|school setting
1555745|NCT00554294|changing of drinking habits|changing of drinking habits
1555846|NCT00553761|Electrophysiological tests|electrophysiological tests
1555746|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
1555747|NCT00554281|Type 1 diabetes|type 1 diabetes
1555748|NCT00554281|Hypoglycemia|hypoglycemia
1555749|NCT00554281|Glucose sensor|glucose sensor
1555750|NCT00554268|Advanced Cancers|advanced cancers
1555751|NCT00554268|Solid Tumors|solid tumors
1555752|NCT00554268|PBI-05204|pbi-05204
1555753|NCT00554255|Pharmacodynamics|pharmacodynamics
1555754|NCT00554255|Japanese|japanese
1555755|NCT00554255|safety|safety
1555756|NCT00554255|Pharmacokinetics|pharmacokinetics
1555757|NCT00554242|endothelium|endothelium
1555758|NCT00554242|antioxidants|antioxidants
1555759|NCT00554242|flavonoids|flavonoids
1555760|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
1555761|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
1555762|NCT00554229|Endothelin A|endothelin a
1555763|NCT00554229|Endothelin A antagonist|endothelin a antagonist
1555764|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
1555765|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
1555766|NCT00554177|sexual|sexual
1555767|NCT00554177|combat|combat
1555768|NCT00554177|PTSD|ptsd
1555769|NCT00554177|Clinical trial|clinical trial
1555770|NCT00554177|Trauma|trauma
1555771|NCT00554177|PTSD treatment|ptsd treatment
1555772|NCT00554177|PTSD medication|ptsd medication
1555773|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
1555774|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
1555775|NCT00554164|Positron emission tomography|positron emission tomography
1555776|NCT00554164|Chemotherapy|chemotherapy
1555777|NCT00554138|rosuvastatin|rosuvastatin
1555778|NCT00554138|dipyridamole|dipyridamole
1555779|NCT00554138|caffeine|caffeine
1555780|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
1555781|NCT00554112|Exercise Training|exercise training
1555782|NCT00554112|Glucose Intolerance|glucose intolerance
1555783|NCT00554112|Human Aging|human aging
1555784|NCT00554112|Insulin Secretion|insulin secretion
1555785|NCT00554073|Magnetic resonance|magnetic resonance
1555786|NCT00554073|whole body|whole body
1555787|NCT00554073|angiography|angiography
1555788|NCT00554073|vasovist|vasovist
1555789|NCT00554073|gadofosveset|gadofosveset
1555790|NCT00554073|blood pool agent|blood pool agent
1555791|NCT00554073|3T|3t
1555792|NCT00554073|1.5T|1.5t
1555793|NCT00554073|Field strength|field strength
1555794|NCT00554047|Dementia|dementia
1555795|NCT00554047|Caregivers|caregivers
1555796|NCT00554047|Costs and cost analysis|costs and cost analysis
1555797|NCT00554047|Multicenter study|multicenter study
1555798|NCT00554047|Randomized controlled trial|randomized controlled trial
1555799|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
1555800|NCT00554047|Quality of life|quality of life
1555801|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
1555802|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
1555803|NCT00554021|Central venous catheter|central venous catheter
1555804|NCT00554021|nosocomial infection|nosocomial infection
1555805|NCT00554008|Appendicitis|appendicitis
1555806|NCT00554008|laparoscopy|laparoscopy
1555807|NCT00554008|randomized trial|randomized trial
1555808|NCT00554008|children|children
1555809|NCT00554008|pediatric|pediatric
1555810|NCT00553982|Replacement|replacement
1555811|NCT00553982|Knee|knee
1555812|NCT00553982|Patella|patella
1555813|NCT00553982|Arthroplasty|arthroplasty
1555814|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
1555815|NCT00553943|lymphoma|lymphoma
1555816|NCT00553943|cerebral lymphoma|cerebral lymphoma
1555817|NCT00553943|central nervous system|central nervous system
1555818|NCT00553943|cytarabine|cytarabine
1555819|NCT00553943|rituximab|rituximab
1555820|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
1555821|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
1555822|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
1555823|NCT00553917|Pregnancy|pregnancy
1555824|NCT00553917|Depression|depression
1555825|NCT00553917|Antidepressants|antidepressants
1555826|NCT00553852|Very Severe Obesity|very severe obesity
1555827|NCT00553852|Body Composition|body composition
1555828|NCT00553852|GH deficiency|gh deficiency
1555829|NCT00553852|IGF-I|igf-i
1555830|NCT00553852|LASGB|lasgb
1555831|NCT00553852|GH therapy|gh therapy
1555832|NCT00553839|anesthesia|anesthesia
1555833|NCT00553839|children|children
1555834|NCT00553839|ketamine|ketamine
1555835|NCT00553839|pharmacokinetics|pharmacokinetics
1555836|NCT00553813|Unresectable|unresectable
1555837|NCT00553813|Gemcitabine|gemcitabine
1555838|NCT00553813|Taxane|taxane
1555839|NCT00553813|TPI 287|tpi 287
1555840|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
1555841|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
1555842|NCT00553761|Band atrophy|band atrophy
1555843|NCT00553761|Pattern electroretinogram|pattern electroretinogram
1555844|NCT00553761|Chiasmal compression|chiasmal compression
1555845|NCT00553761|Neural loss|neural loss
1555847|NCT00553735|Dry Eye|dry eye
1555848|NCT00553735|Graft versus Host Disease|graft versus host disease
1555849|NCT00553735|GVHD|gvhd
1555850|NCT00553722|hypertension|hypertension
1555851|NCT00553722|dialysis|dialysis
1555852|NCT00553722|hyperaldosteronism|hyperaldosteronism
1555853|NCT00553709|nausea|nausea
1555854|NCT00553709|vomiting|vomiting
1555855|NCT00553709|retching|retching
1555856|NCT00553709|emesis|emesis
1555857|NCT00553709|surgery|surgery
1555858|NCT00553709|anesthesia|anesthesia
1555859|NCT00553696|chemotherapy|chemotherapy
1555860|NCT00553696|combination|combination
1555861|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
1555862|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1555863|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
1555864|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1555865|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1555866|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
1555867|NCT00553683|recurrent colon cancer|recurrent colon cancer
1555868|NCT00553683|recurrent breast cancer|recurrent breast cancer
1555869|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
1555870|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1555871|NCT00553683|recurrent melanoma|recurrent melanoma
1555872|NCT00553683|stage IV breast cancer|stage iv breast cancer
1555873|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
1555874|NCT00553683|stage IV colon cancer|stage iv colon cancer
1555875|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1555876|NCT00553683|stage IV melanoma|stage iv melanoma
1555877|NCT00553683|liver metastases|liver metastases
1555878|NCT00553670|coronary artery|coronary artery
1555879|NCT00553670|bifurcation|bifurcation
1555880|NCT00553670|stent|stent
1555881|NCT00553670|intravascular ultrasound|intravascular ultrasound
1555882|NCT00553670|fractional flow reserve|fractional flow reserve
1555883|NCT00553657|Experimental Medicine|experimental medicine
1555884|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
1555885|NCT00553631|Gaucher disease|gaucher disease
1555886|NCT00553631|glucocerebrosidase|glucocerebrosidase
1555887|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
1555888|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
1555889|NCT00553631|glucosylceramidase|glucosylceramidase
1555890|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1555891|NCT00553631|gene activation|gene activation
1555893|NCT00553618|Interleukin 2|interleukin 2
1555894|NCT00553618|Proleukin|proleukin
1555895|NCT00553618|DTIC|dtic
1555896|NCT00553618|Dacarbazine|dacarbazine
1555897|NCT00553618|metastatic melanoma|metastatic melanoma
1555898|NCT00553618|adjuvant|adjuvant
1555899|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
1555900|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
1555901|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
1555902|NCT00553566|stage I bladder cancer|stage i bladder cancer
1555903|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1555904|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
1555905|NCT00553553|Adult|adult
1555906|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
1555907|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
1555908|NCT00553540|backache|backache
1555909|NCT00553540|low backpain|low backpain
1555910|NCT00553540|sciatica|sciatica
1555911|NCT00553514|Infertility|infertility
1555912|NCT00553514|Oligo-anovulation|oligo-anovulation
1555913|NCT00553514|GONAL-f®|gonal-f®
1555914|NCT00553514|AS900672-Enriched|as900672-enriched
1555915|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
1555916|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1555917|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1555918|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1555919|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1555920|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1555921|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1555922|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1555923|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1555924|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1555925|NCT00553488|diabetes|diabetes
1555926|NCT00553488|insulin|insulin
1555927|NCT00553488|subcutaneous|subcutaneous
1555928|NCT00553488|intra-dermal|intra-dermal
1555929|NCT00553488|blood glucose|blood glucose
1555930|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1555931|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1555932|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
1555933|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1555934|NCT00553462|large cell lung cancer|large cell lung cancer
1555935|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
1555936|NCT00553449|nocturnal heartburn|nocturnal heartburn
1555937|NCT00553449|day-time heartburn|day-time heartburn
1555938|NCT00553449|rabeprazole|rabeprazole
1555939|NCT00553449|GERD|gerd
1555940|NCT00553436|colon|colon
1555941|NCT00553436|rectum|rectum
1555942|NCT00553436|polyp|polyp
1555943|NCT00553436|EMR|emr
1555944|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
1555945|NCT00553410|stage IA breast cancer|stage ia breast cancer
1555946|NCT00553410|stage IB breast cancer|stage ib breast cancer
1555947|NCT00553410|stage II breast cancer|stage ii breast cancer
1555948|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
1555949|NCT00553397|Living donor lung transplant|living donor lung transplant
1555950|NCT00553397|End stage lung disease|end stage lung disease
1555951|NCT00553384|smell|smell
1555952|NCT00553384|olfaction|olfaction
1555953|NCT00553384|androstadienone|androstadienone
1555954|NCT00553384|women|women
1555955|NCT00553384|pheromones|pheromones
1555956|NCT00553384|Healthy Volunteers|healthy volunteers
1555957|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
1555958|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1555959|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1555960|NCT00553358|Lapatinib|lapatinib
1555962|NCT00553358|Early Breast Cancer|early breast cancer
1555963|NCT00553358|Neoadjuvant|neoadjuvant
1555964|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1555965|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
1555966|NCT00553345|stage I bladder cancer|stage i bladder cancer
1555967|NCT00553319|ADHD|adhd
1555968|NCT00553319|Cocaine|cocaine
1555969|NCT00553319|Treatment|treatment
1555970|NCT00553293|infertility|infertility
1555971|NCT00553293|in vitro fertilization|in vitro fertilization
1555972|NCT00553293|LH supplementation|lh supplementation
1555973|NCT00553293|Benefits|benefits
1555974|NCT00553241|TIA|tia
1555975|NCT00553241|prognosis|prognosis
1555976|NCT00553241|evaluation|evaluation
1555977|NCT00553241|management|management
1555978|NCT00553228|maternal immunization|maternal immunization
1555979|NCT00553228|whooping cough|whooping cough
1555980|NCT00553228|pertussis|pertussis
1555981|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1555982|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
1555983|NCT00553215|stage I bladder cancer|stage i bladder cancer
1555984|NCT00553215|stage II bladder cancer|stage ii bladder cancer
1555985|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1555986|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1555987|NCT00553189|PARP Inhibitor|parp inhibitor
1555988|NCT00553189|Advanced Cancer|advanced cancer
1555989|NCT00553189|Combination Therapy|combination therapy
1555990|NCT00553189|Early Trial|early trial
1555991|NCT00553189|DNA Damage Repair|dna damage repair
1555992|NCT00553189|Topotecan|topotecan
1555993|NCT00553189|Cancer|cancer
1555994|NCT00553189|Solid Tumor|solid tumor
1555995|NCT00553189|Lymphoma|lymphoma
1555996|NCT00553176|Infliximab|infliximab
1555997|NCT00553176|Immune disorder|immune disorder
1555998|NCT00553176|Remicade|remicade
1555999|NCT00553176|Registry|registry
1556000|NCT00553176|Crohn's Disease|crohn's disease
1556001|NCT00553163|Hypnotherapy|hypnotherapy
1556002|NCT00553163|Prevention of relapse|prevention of relapse
1556003|NCT00553163|ulcerative colitis|ulcerative colitis
1556004|NCT00553150|adult gliosarcoma|adult gliosarcoma
1556005|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
1556006|NCT00553150|adult glioblastoma|adult glioblastoma
1556007|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1556008|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
1556009|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1556010|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1556011|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
1556012|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
1556013|NCT00553124|stage I bladder cancer|stage i bladder cancer
1556014|NCT00553124|stage II bladder cancer|stage ii bladder cancer
1556015|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1556016|NCT00553111|syphilis|syphilis
1556017|NCT00553111|video education|video education
1556018|NCT00553111|knowledge|knowledge
1556019|NCT00553111|black|black
1556020|NCT00553111|hispanic|hispanic
1556021|NCT00553085|anxiety disorders|anxiety disorders
1556022|NCT00553085|children|children
1556023|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
1556024|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
1556025|NCT00553085|temperament|temperament
1556026|NCT00553072|Asphyxia|asphyxia
1556027|NCT00553072|perinatal|perinatal
1556028|NCT00553072|magnesium sulphate|magnesium sulphate
1556029|NCT00553059|nausea and vomiting|nausea and vomiting
1558630|NCT00541749|SLE|sle
1556030|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
1556031|NCT00553059|Palonosetron|palonosetron
1556032|NCT00553059|Dexamethasone|dexamethasone
1556033|NCT00553046|ethics|ethics
1556034|NCT00553046|COPD|copd
1556035|NCT00553046|end of life|end of life
1556036|NCT00553046|mechanical ventilation|mechanical ventilation
1556037|NCT00553046|CRF home ventilated patients|crf home ventilated patients
1556038|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
1556039|NCT00553007|Periodontal disease|periodontal disease
1556040|NCT00553007|Metabolic Syndrome|metabolic syndrome
1556041|NCT00552994|Drug eluting stent|drug eluting stent
1556042|NCT00552994|Diabetics|diabetics
1556043|NCT00552994|Intravascular ultrasound|intravascular ultrasound
1556044|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
1556045|NCT00552981|common cold|common cold
1556046|NCT00552981|Finnish sauna|finnish sauna
1556048|NCT00552968|trauma|trauma
1556049|NCT00552968|pain|pain
1556050|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
1556051|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
1556052|NCT00552955|Chyle|chyle
1556053|NCT00552955|Ascites|ascites
1556054|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
1556055|NCT00552955|LAM|lam
1556056|NCT00552942|obesity|obesity
1556057|NCT00552942|diabetes|diabetes
1556058|NCT00552942|cytokines|cytokines
1556059|NCT00552890|obesity|obesity
1556060|NCT00552890|atkins|atkins
1556061|NCT00552890|weight reduction|weight reduction
1556062|NCT00552890|kidney function|kidney function
1556063|NCT00552877|PCI|pci
1556064|NCT00552877|Drug-eluting stent|drug-eluting stent
1556065|NCT00552851|acromegaly|acromegaly
1556066|NCT00552851|heart failure|heart failure
1556067|NCT00552851|hypertrophy|hypertrophy
1556068|NCT00552851|cardiomegaly|cardiomegaly
1556069|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
1556070|NCT00552838|Antimicrobial utilization|antimicrobial utilization
1556071|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1556072|NCT00552825|long-term lung function|long-term lung function
1556073|NCT00552812|Aortic Coarctation|aortic coarctation
1556074|NCT00552812|Heart Defects, Congenital|heart defects, congenital
1556075|NCT00552812|Stents|stents
1556076|NCT00552812|Heart Catheterization|heart catheterization
1556077|NCT00552799|cellulitis|cellulitis
1556078|NCT00552799|lymphoedema|lymphoedema
1556079|NCT00552799|penicillin|penicillin
1556080|NCT00552799|clinical trial|clinical trial
1556081|NCT00552786|noise|noise
1556082|NCT00552786|hearing loss|hearing loss
1556083|NCT00552786|temporary threshold shift|temporary threshold shift
1556084|NCT00552773|SINUSITIS|sinusitis
1556085|NCT00552773|CYCLAMEN|cyclamen
1556086|NCT00552747|fenofibrate|fenofibrate
1556087|NCT00552747|coronary heart disease|coronary heart disease
1556088|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
1556089|NCT00552734|Type 1 diabetes|type 1 diabetes
1556090|NCT00552734|Improved glycemic control|improved glycemic control
1556091|NCT00552734|Glucose excursions|glucose excursions
1556092|NCT00552734|Target range glucose levels|target range glucose levels
1556093|NCT00552734|Insulin guidance software|insulin guidance software
1556094|NCT00552734|Advisor|advisor
1556095|NCT00552721|Motor control|motor control
1556096|NCT00552721|Spasticity|spasticity
1556097|NCT00552708|COREG CR|coreg cr
1556098|NCT00552695|intravenous catheter|intravenous catheter
1556099|NCT00552695|emergency department|emergency department
1556100|NCT00552695|pain|pain
1556101|NCT00552682|HIV|hiv
1556102|NCT00552682|fibromialgy|fibromialgy
1556103|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
1556104|NCT00552682|duloxetine|duloxetine
1556105|NCT00552682|pain|pain
1556106|NCT00552682|treatment experienced|treatment experienced
1556107|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
1556108|NCT00552669|Drug Eluting Stents|drug eluting stents
1556109|NCT00552669|Stents Bare Metal|stents bare metal
1556110|NCT00552669|Stent Thrombosis|stent thrombosis
1556111|NCT00552669|Coronary revascularization|coronary revascularization
1556112|NCT00552669|Survival|survival
1556113|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1556114|NCT00552656|Drug-eluting stents|drug-eluting stents
1556115|NCT00552656|Treatment Outcome|treatment outcome
1556116|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
1556117|NCT00552643|Chronic wounds|chronic wounds
1556118|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
1556119|NCT00552643|Ulcers|ulcers
1556120|NCT00552643|Exposed bones|exposed bones
1556121|NCT00552643|Exposed Tendons|exposed tendons
1556122|NCT00552643|Granulation tissue|granulation tissue
1556123|NCT00552643|Polyheal 1|polyheal 1
1556124|NCT00552643|Wound care|wound care
1556125|NCT00552643|Wound healing|wound healing
1556126|NCT00552643|Diabetic wounds healing|diabetic wounds healing
1556127|NCT00552643|Post trauma|post trauma
1556128|NCT00552643|Post surgery complication|post surgery complication
1556227|NCT00552344|Clinical remission|clinical remission
1556228|NCT00552292|metabolic syndrome|metabolic syndrome
1556129|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
1556130|NCT00552630|lead poisoning|lead poisoning
1556131|NCT00552630|chelation|chelation
1556132|NCT00552604|multiple sclerosis|multiple sclerosis
1556133|NCT00552604|muscle stiffness|muscle stiffness
1556134|NCT00552604|spasticity|spasticity
1556135|NCT00552604|pain|pain
1556136|NCT00552604|treatment|treatment
1556137|NCT00552604|cannabinoids|cannabinoids
1556138|NCT00552591|family risk|family risk
1556139|NCT00552591|behavior modification|behavior modification
1556140|NCT00552591|lifestyle change|lifestyle change
1556141|NCT00552591|prevention of CHD|prevention of chd
1556142|NCT00552591|health care costs|health care costs
1556143|NCT00552578|drug dependence|drug dependence
1556144|NCT00552578|substance abuse|substance abuse
1556145|NCT00552578|substance use disorders|substance use disorders
1556146|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
1556147|NCT00552578|neuralgia|neuralgia
1556148|NCT00552578|back pain|back pain
1556253|NCT00552084|Fish Oil|fish oil
1556149|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
1556150|NCT00552552|cancer-related fatigue|cancer-related fatigue
1556151|NCT00552552|self-management|self-management
1556152|NCT00552552|patient education|patient education
1556153|NCT00552552|cancer survivors|cancer survivors
1556154|NCT00552552|chronic disease|chronic disease
1556155|NCT00552539|syphilis|syphilis
1556156|NCT00552539|educational video|educational video
1556157|NCT00552539|knowledge|knowledge
1556158|NCT00552539|black|black
1556159|NCT00552539|Hispanic|hispanic
1556160|NCT00552526|Epilepsy|epilepsy
1556161|NCT00552526|Children|children
1556162|NCT00552526|Mental retardation|mental retardation
1556163|NCT00552526|Ketogenic diet|ketogenic diet
1556164|NCT00552526|Diet|diet
1556165|NCT00552513|timing|timing
1556166|NCT00552513|intervention|intervention
1556167|NCT00552513|early|early
1556168|NCT00552513|delayed|delayed
1556169|NCT00552513|acute coronary syndromes|acute coronary syndromes
1556170|NCT00552513|PCI|pci
1556171|NCT00552513|angiography|angiography
1556172|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
1556173|NCT00552513|unstable angina|unstable angina
1556174|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
1556175|NCT00552487|Hashimoto disease|hashimoto disease
1556176|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
1556177|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
1556178|NCT00552474|Parkinson disease|parkinson disease
1556179|NCT00552474|Movement disorders|movement disorders
1556180|NCT00552474|Deep Brain Stimulation|deep brain stimulation
1556181|NCT00552474|Libra|libra
1556182|NCT00552474|l-dopa|l-dopa
1556183|NCT00552474|levodopa|levodopa
1556184|NCT00552474|neuromodulation|neuromodulation
1556185|NCT00552474|neurostimulation|neurostimulation
1556186|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
1556187|NCT00552474|STN|stn
1556188|NCT00552474|Subthalamic nucleus|subthalamic nucleus
1556189|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
1556190|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
1556191|NCT00552461|Rituximab|rituximab
1556192|NCT00552461|Idiopathic|idiopathic
1556193|NCT00552461|Symptomatic|symptomatic
1556194|NCT00552461|GM-CSF Antibody|gm-csf antibody
1556195|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
1556196|NCT00552422|gastroparesis|gastroparesis
1556197|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
1556198|NCT00552409|Diabetes mellitus|diabetes mellitus
1556199|NCT00552409|Type 2 diabetes|type 2 diabetes
1556200|NCT00552409|Chronic kidney disease|chronic kidney disease
1556201|NCT00552409|Diabetic kidney disease|diabetic kidney disease
1556202|NCT00552409|Microalbuminuria|microalbuminuria
1556203|NCT00552409|Albuminuria|albuminuria
1556204|NCT00552409|Vitamin D|vitamin d
1556205|NCT00552409|Cholecalciferol|cholecalciferol
1556206|NCT00552409|Kidney|kidney
1556207|NCT00552409|Renal|renal
1556208|NCT00552409|Cardiovascular|cardiovascular
1556209|NCT00552409|Clinical trial|clinical trial
1556210|NCT00552409|Placebo|placebo
1556211|NCT00552396|multiple myeloma|multiple myeloma
1556212|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
1556213|NCT00552383|Preterm Infant|preterm infant
1556214|NCT00552383|Behaviour|behaviour
1556215|NCT00552383|Developmental Care|developmental care
1556216|NCT00552383|NIDCAP|nidcap
1556217|NCT00552383|Family Centred Care|family centred care
1556218|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
1556219|NCT00552344|CDP 870|cdp 870
1556220|NCT00552344|Certolizumab Pegol|certolizumab pegol
1556221|NCT00552344|CIMZIA|cimzia
1556222|NCT00552344|Crohn's Disease|crohn's disease
1556223|NCT00552344|Crohn Disease|crohn disease
1556224|NCT00552344|CD Induction|cd induction
1556225|NCT00552344|Induction|induction
1556226|NCT00552344|Clinical response|clinical response
1556229|NCT00552292|hypertension|hypertension
1556230|NCT00552292|obesity|obesity
1556231|NCT00552292|dyslipidemia|dyslipidemia
1556232|NCT00552292|hyperglycemia|hyperglycemia
1556233|NCT00552292|cardiovascular complications|cardiovascular complications
1556234|NCT00552279|HPV|hpv
1556235|NCT00552279|cervical cancer|cervical cancer
1556236|NCT00552279|papillomavirus|papillomavirus
1556237|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1556238|NCT00552266|Methylphenidate|methylphenidate
1556239|NCT00552266|Trichotillomania|trichotillomania
1556240|NCT00552266|Attention deficit|attention deficit
1556241|NCT00552214|Nucleic acid test|nucleic acid test
1556242|NCT00552214|HIV-1|hiv-1
1556243|NCT00552214|hepatitis|hepatitis
1556244|NCT00552214|HBV|hbv
1556245|NCT00552214|HCV|hcv
1556246|NCT00552214|TMA|tma
1556247|NCT00552214|HIV Seronegativity|hiv seronegativity
1556248|NCT00552201|kidney transplantation|kidney transplantation
1556249|NCT00552201|Tacrolimus|tacrolimus
1556250|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
1556251|NCT00552201|genotype|genotype
1556252|NCT00552188|Atherosclerosis|atherosclerosis
1556255|NCT00552071|Octreotide LAR|octreotide lar
1556256|NCT00552071|Ultrasound guidance|ultrasound guidance
1556257|NCT00552058|CDP 870|cdp 870
1556258|NCT00552058|Certolizumab Pegol|certolizumab pegol
1556259|NCT00552058|CIMZIA ®|cimzia ®
1556260|NCT00552058|Crohn's disease|crohn's disease
1556261|NCT00552058|Induction|induction
1556262|NCT00552058|Clinical remission|clinical remission
1556263|NCT00552058|Clinical response|clinical response
1556264|NCT00552045|epilepsy|epilepsy
1556265|NCT00552045|localization-related epilepsy|localization-related epilepsy
1556266|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
1556267|NCT00552045|infantile spasms|infantile spasms
1556268|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1556269|NCT00552045|polymicrogyria|polymicrogyria
1556270|NCT00552045|periventricular heterotopias|periventricular heterotopias
1556271|NCT00552045|malformations of cortical development|malformations of cortical development
1556272|NCT00552045|phenome|phenome
1556273|NCT00552045|genome|genome
1556274|NCT00552045|genotype|genotype
1556275|NCT00552045|phenotype|phenotype
1556276|NCT00552006|PTSD|ptsd
1556277|NCT00552006|Treatment|treatment
1556278|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
1556279|NCT00552006|Combat|combat
1556280|NCT00552006|Child Soldiers|child soldiers
1556281|NCT00552006|Dissemination|dissemination
1556282|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
1556283|NCT00552006|Africa|africa
1556284|NCT00551993|laparoscopy|laparoscopy
1556285|NCT00551993|robot|robot
1556286|NCT00551993|vaginal prolapse|vaginal prolapse
1556287|NCT00551993|sacrocolpopexy|sacrocolpopexy
1556288|NCT00551993|sacral colpopexy|sacral colpopexy
1556289|NCT00551980|Headache|headache
1556290|NCT00551980|Cervical Pain|cervical pain
1556291|NCT00551980|Cognitive treatment|cognitive treatment
1556292|NCT00551980|Relaxation|relaxation
1556293|NCT00551980|Exercise|exercise
1556294|NCT00551967|clinical outcomes|clinical outcomes
1556295|NCT00551967|radiographic outcomes|radiographic outcomes
1556296|NCT00551967|total hip arthroplasty|total hip arthroplasty
1556297|NCT00551967|survivorship|survivorship
1556298|NCT00551928|Multiple Myeloma|multiple myeloma
1556299|NCT00551928|Lenalidomide|lenalidomide
1556300|NCT00551928|High dose Melphalan|high dose melphalan
1556301|NCT00551928|Mobilization|mobilization
1556302|NCT00551928|CD34|cd34
1556303|NCT00551902|Glaucoma|glaucoma
1556304|NCT00551902|trabeculectomy|trabeculectomy
1556305|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
1556306|NCT00551902|anterior chamber infusion|anterior chamber infusion
1556307|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1556308|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
1556309|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
1556310|NCT00551850|solid tumors|solid tumors
1556311|NCT00551850|advanced cancer|advanced cancer
1556312|NCT00551837|Lung Transplantation|lung transplantation
1556313|NCT00551837|Kidney Transplnatation|kidney transplnatation
1556314|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
1556315|NCT00551837|Influenza|influenza
1556316|NCT00551824|esophageal stricture|esophageal stricture
1556317|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
1556318|NCT00551811|ozone challenge|ozone challenge
1556319|NCT00551811|single dose,|single dose,
1556320|NCT00551798|Hodgkin's Disease|hodgkin's disease
1556321|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
1556322|NCT00551798|Chemoresistance|chemoresistance
1556323|NCT00551798|MIBI|mibi
1556324|NCT00551798|PGP|pgp
1556325|NCT00551798|MRP1|mrp1
1556326|NCT00551798|Tumor response|tumor response
1556327|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
1556328|NCT00551785|Menopause|menopause
1556329|NCT00551785|Androgen|androgen
1556330|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
1556677|NCT00550277|Refractory|refractory
1556331|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1556332|NCT00551759|chemoradiotherapy|chemoradiotherapy
1556333|NCT00551759|oxaliplatin|oxaliplatin
1556334|NCT00551759|cetuximab|cetuximab
1556335|NCT00551759|docetaxel|docetaxel
1556336|NCT00551746|purple grape juice|purple grape juice
1556337|NCT00551746|antioxidants|antioxidants
1556338|NCT00551746|platelet aggregation|platelet aggregation
1556339|NCT00551746|anti-thrombotic|anti-thrombotic
1556340|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1556341|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1556342|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1556343|NCT00551720|HIV|hiv
1556344|NCT00551720|HIV positive|hiv positive
1556345|NCT00551720|AIDS|aids
1556346|NCT00551720|smoking cessation|smoking cessation
1556347|NCT00551720|smoking|smoking
1556348|NCT00551720|smoking counseling|smoking counseling
1556349|NCT00551707|CombinatoRx|combinatorx
1556350|NCT00551707|CRx-102|crx-102
1556351|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
1556352|NCT00551707|Prednisolone|prednisolone
1556518|NCT00551031|Elderly|elderly
1556353|NCT00551707|Dipyridamole|dipyridamole
1556354|NCT00551707|ACR20|acr20
1556355|NCT00551694|GSK256073A|gsk256073a
1556356|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
1556357|NCT00551681|epicardial lead|epicardial lead
1556358|NCT00551681|coronary sinus|coronary sinus
1556359|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
1556360|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
1556361|NCT00551655|Tenofovir|tenofovir
1556362|NCT00551655|Treatment Experienced|treatment experienced
1556363|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
1556364|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
1556365|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
1556366|NCT00551603|anemia correction|anemia correction
1556367|NCT00551603|hemoglobin stability|hemoglobin stability
1556368|NCT00551590|diabetes mellitus|diabetes mellitus
1556369|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
1556370|NCT00551590|sitagliptin|sitagliptin
1556371|NCT00551590|exendin(9-39)|exendin(9-39)
1556372|NCT00551590|GLP-1|glp-1
1556373|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
1556374|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
1556375|NCT00551577|Docetaxel,|docetaxel,
1556376|NCT00551577|Neoplasm, Residual|neoplasm, residual
1556377|NCT00551564|total body water|total body water
1556378|NCT00551564|T2DM,|t2dm,
1556379|NCT00551564|Healthy Obese,|healthy obese,
1556380|NCT00551564|Insulin Resistance,|insulin resistance,
1556381|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
1556382|NCT00551564|Glucose Disposal,|glucose disposal,
1556383|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
1556384|NCT00551551|Pelvic floor|pelvic floor
1556385|NCT00551551|Kegel exercises|kegel exercises
1556386|NCT00551551|Quality of Life|quality of life
1556387|NCT00551551|Pelvic Pain|pelvic pain
1556388|NCT00551538|Diabetes|diabetes
1556389|NCT00551538|Diabetic|diabetic
1556390|NCT00551538|Insulin|insulin
1556391|NCT00551538|Glargine|glargine
1556392|NCT00551538|Lispro|lispro
1556393|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
1556394|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
1556395|NCT00551525|stage III prostate cancer|stage iii prostate cancer
1556396|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
1556397|NCT00551512|cancer|cancer
1556398|NCT00551512|solid tumors|solid tumors
1556399|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
1556400|NCT00551486|Pyrosequencing|pyrosequencing
1556401|NCT00551486|BRAFV600E mutation|brafv600e mutation
1556402|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
1556403|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
1556404|NCT00551473|pharmacodynamics,|pharmacodynamics,
1556405|NCT00551473|tolerance|tolerance
1556406|NCT00551473|H2 antagonist,|h2 antagonist,
1556407|NCT00551473|AH23844,|ah23844,
1556408|NCT00551473|lavoltidine,|lavoltidine,
1556409|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
1556410|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1556411|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1556412|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1556413|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1556414|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1556415|NCT00551395|glaucoma|glaucoma
1556416|NCT00551395|laser|laser
1556417|NCT00551395|trabeculoplasty|trabeculoplasty
1556418|NCT00551382|Montelukast|montelukast
1556419|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
1556420|NCT00551382|leukotriene|leukotriene
1556421|NCT00551382|Children|children
1556422|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1556423|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1556678|NCT00550277|LBH589|lbh589
1556424|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
1556425|NCT00551369|large cell lung cancer|large cell lung cancer
1556426|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
1556427|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1556428|NCT00551356|Diabetes|diabetes
1556429|NCT00551356|Diabetic|diabetic
1556430|NCT00551356|Insulin|insulin
1556431|NCT00551356|Humalog|humalog
1556432|NCT00551356|Lantus|lantus
1556433|NCT00551356|Glargine|glargine
1556434|NCT00551356|Lispro|lispro
1556435|NCT00551330|Treatment Experienced|treatment experienced
1556436|NCT00551317|SB480848,|sb480848,
1556437|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
1556438|NCT00551317|darapladib,|darapladib,
1556439|NCT00551278|sentinel lymph node|sentinel lymph node
1556440|NCT00551278|metastasis|metastasis
1556441|NCT00551278|molecular pathology|molecular pathology
1556442|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1556443|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1556444|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1556445|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1556446|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1556447|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1556448|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1556449|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1556450|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1556451|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1556452|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1556453|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1568154|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
1556454|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1556455|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1556456|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1556457|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1556458|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1556459|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1556460|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1556461|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1556462|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1556463|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1556464|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1556465|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1556466|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1556467|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1556468|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1556469|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1556470|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1556471|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1556472|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1556473|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1556474|NCT00551226|TB|tb
1556475|NCT00551226|Patients with tuberculosis|patients with tuberculosis
1556476|NCT00551213|anti-IGF-1R|anti-igf-1r
1556477|NCT00551200|Buphenyl|buphenyl
1556478|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
1556479|NCT00551200|Urea Cycle Disorder|urea cycle disorder
1556480|NCT00551200|UCD|ucd
1556481|NCT00551161|Alzheimer disease|alzheimer disease
1556482|NCT00551161|memantine|memantine
1556483|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
1556484|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1556485|NCT00551161|N-acetylaspartate|n-acetylaspartate
1556486|NCT00551161|inositol|inositol
1556487|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
1556488|NCT00551161|tau proteins|tau proteins
1556489|NCT00551161|amyloid beta-protein|amyloid beta-protein
1556490|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
1556491|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1556492|NCT00551122|testicular seminoma|testicular seminoma
1556493|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1556494|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1556495|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1556496|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1556497|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1556498|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1556499|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1556500|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1556501|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1556502|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1556503|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1556504|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1556505|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1556506|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1556507|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1556508|NCT00551096|Advanced Solid Tumors|advanced solid tumors
1556509|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
1556510|NCT00551044|prostatic neoplasms|prostatic neoplasms
1556511|NCT00551044|bicalutamide|bicalutamide
1556512|NCT00551044|quality of life|quality of life
1556513|NCT00551044|osteoporosis|osteoporosis
1556514|NCT00551031|Influenza|influenza
1556515|NCT00551031|Orthomyxoviruses|orthomyxoviruses
1556516|NCT00551031|Myxovirus Infection|myxovirus infection
1556517|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1556519|NCT00551018|Treatment Naive|treatment naive
1556520|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1556521|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1556522|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1556523|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
1556524|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
1556525|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
1556526|NCT00550979|heart disease risk|heart disease risk
1556527|NCT00550966|Fibromyalgia|fibromyalgia
1556528|NCT00550966|Quality of life|quality of life
1556529|NCT00550966|Primary Care|primary care
1556530|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
1556531|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
1556532|NCT00550940|epilepsy|epilepsy
1556533|NCT00550940|attention|attention
1556534|NCT00550940|emotion|emotion
1556535|NCT00550940|behavior problems|behavior problems
1556536|NCT00550940|child|child
1556537|NCT00550940|adolescent|adolescent
1556538|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1556539|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
1556540|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1556541|NCT00550888|uterus|uterus
1556542|NCT00550888|abdominal delivery|abdominal delivery
1556543|NCT00550888|suture techniques|suture techniques
1556544|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
1556545|NCT00550875|Immunotherapy|immunotherapy
1556546|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
1556547|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1556666|NCT00550342|B cell|b cell
1556548|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1556549|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
1556550|NCT00550810|Sutent|sutent
1556551|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
1556552|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
1556553|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1556554|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1556555|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1556556|NCT00550784|fallopian tube cancer|fallopian tube cancer
1556557|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
1556558|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
1556559|NCT00550732|Triazoles|triazoles
1556560|NCT00550706|Prescription point prevalence|prescription point prevalence
1556561|NCT00550706|Drug utilization|drug utilization
1556562|NCT00550706|Define Daily Dose|define daily dose
1556563|NCT00550693|bloodstream infections|bloodstream infections
1556564|NCT00550693|hemodialysis catheter|hemodialysis catheter
1556565|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
1556566|NCT00550667|adult|adult
1556567|NCT00550667|diagnostic validity|diagnostic validity
1556568|NCT00550667|neuropsychological functions|neuropsychological functions
1556569|NCT00550667|social functioning|social functioning
1556570|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1556571|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1556572|NCT00550654|recurrent melanoma|recurrent melanoma
1556573|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
1556574|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
1556575|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
1556576|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1556577|NCT00550654|stage IV melanoma|stage iv melanoma
1556578|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
1556579|NCT00550654|ovarian sarcoma|ovarian sarcoma
1556580|NCT00550654|chondrosarcoma|chondrosarcoma
1556581|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
1556582|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
1556583|NCT00550654|lung metastases|lung metastases
1556584|NCT00550654|liver metastases|liver metastases
1556585|NCT00550654|bone metastases|bone metastases
1556586|NCT00550641|fibromyalgia|fibromyalgia
1556587|NCT00550641|pool-based exercise|pool-based exercise
1556588|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
1556589|NCT00550628|colon cancer|colon cancer
1556590|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1556591|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
1556592|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
1556593|NCT00550615|Dasatinib|dasatinib
1556594|NCT00550602|Tracheomalacia|tracheomalacia
1556595|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
1556596|NCT00550602|Airway Stabilization|airway stabilization
1556597|NCT00550602|Bronchoscopy|bronchoscopy
1556598|NCT00550602|Stent Placement|stent placement
1556599|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
1556600|NCT00550602|COPD|copd
1556601|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1556602|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
1556603|NCT00550576|Digoxin Antibodies|digoxin antibodies
1556604|NCT00550576|Bipolar Disorder|bipolar disorder
1556605|NCT00550563|recurrent colon cancer|recurrent colon cancer
1556606|NCT00550563|stage I colon cancer|stage i colon cancer
1556607|NCT00550563|stage II colon cancer|stage ii colon cancer
1556608|NCT00550563|stage III colon cancer|stage iii colon cancer
1556609|NCT00550563|stage IV colon cancer|stage iv colon cancer
1556610|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
1556611|NCT00550563|stage I rectal cancer|stage i rectal cancer
1556612|NCT00550563|stage II rectal cancer|stage ii rectal cancer
1556613|NCT00550563|stage III rectal cancer|stage iii rectal cancer
1556614|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
1556615|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
1556616|NCT00550550|rhinitis|rhinitis
1556617|NCT00550550|conjunctivitis|conjunctivitis
1556619|NCT00550550|allergen|allergen
1556620|NCT00550550|immunotherapy|immunotherapy
1556621|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1556622|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1556623|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1556624|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
1556625|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1556626|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1556627|NCT00550537|large cell lung cancer|large cell lung cancer
1556628|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
1556629|NCT00550524|Knee osteoarthritis|knee osteoarthritis
1556630|NCT00550511|Abdominal pain|abdominal pain
1556631|NCT00550511|ultrasound|ultrasound
1556632|NCT00550511|surgery|surgery
1556633|NCT00550511|emergency department|emergency department
1556634|NCT00550511|diagnostic accuracy|diagnostic accuracy
1556635|NCT00550498|Retinal Vasculitis|retinal vasculitis
1556636|NCT00550498|Retinal Edema|retinal edema
1556637|NCT00550498|Behcet's Disease|behcet's disease
1556638|NCT00550472|probiotics|probiotics
1556639|NCT00550472|atopic dermatitis|atopic dermatitis
1556640|NCT00550472|immune system|immune system
1556641|NCT00550472|human|human
1556642|NCT00550472|Lactobacillus|lactobacillus
1556643|NCT00550472|Bifidobacterium|bifidobacterium
1556644|NCT00550472|healthy subjects|healthy subjects
1556645|NCT00550459|Hyponatremia|hyponatremia
1556646|NCT00550459|Cognitive|cognitive
1556647|NCT00550459|Neurological Function|neurological function
1556648|NCT00550459|Elderly|elderly
1556649|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
1556650|NCT00550420|open-label extension|open-label extension
1556651|NCT00550420|tolerability|tolerability
1556652|NCT00550420|Alzheimer's disease|alzheimer's disease
1556653|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
1556654|NCT00550420|safety|safety
1556655|NCT00550420|cognition|cognition
1556656|NCT00550420|BRL-049653|brl-049653
1556657|NCT00550407|Lamotrigine|lamotrigine
1556658|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
1556659|NCT00550407|Bipolar I disorder|bipolar i disorder
1556660|NCT00550394|Adolescents|adolescents
1556661|NCT00550381|healthy subjects|healthy subjects
1556662|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
1556663|NCT00550342|FSGS|fsgs
1556664|NCT00550342|Proteinuria|proteinuria
1556665|NCT00550342|rituximab|rituximab
1556667|NCT00550342|autoimmune|autoimmune
1556668|NCT00550342|CD20|cd20
1556669|NCT00550342|treatment|treatment
1556670|NCT00550342|children|children
1556671|NCT00550290|vulvectomy|vulvectomy
1556672|NCT00550290|wound infection|wound infection
1556673|NCT00550290|wound complication|wound complication
1556674|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
1556675|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
1556676|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
1556679|NCT00550264|Hospital Readmission|hospital readmission
1556680|NCT00550264|Continuity of Care|continuity of care
1556681|NCT00550264|Quality of Health Care|quality of health care
1556682|NCT00550251|Nausea|nausea
1556683|NCT00550251|Vomiting|vomiting
1556684|NCT00550251|Emesis|emesis
1556685|NCT00550251|Palliative|palliative
1556686|NCT00550251|Terminal|terminal
1556687|NCT00550251|Cancer|cancer
1556688|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
1556689|NCT00550225|succinate|succinate
1556690|NCT00550225|anti-muscarinic|anti-muscarinic
1556691|NCT00550225|b-agonist|b-agonist
1556692|NCT00550212|healthy subjects|healthy subjects
1556693|NCT00550199|Solid Tumors|solid tumors
1556694|NCT00550199|Phase I|phase i
1556695|NCT00550199|LBH589|lbh589
1556696|NCT00550199|Gemcitabine|gemcitabine
1556697|NCT00550186|spinal anesthesia|spinal anesthesia
1556698|NCT00550186|preload|preload
1556699|NCT00550186|diuresis|diuresis
1556700|NCT00550186|bladder retention|bladder retention
1556701|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
1556702|NCT00550134|Breast Cancer|breast cancer
1556703|NCT00550134|Quality of life|quality of life
1556704|NCT00550108|pancreatic cyst|pancreatic cyst
1556705|NCT00550108|ethanol injection|ethanol injection
1556706|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
1556707|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
1556708|NCT00550095|Valsartan|valsartan
1556709|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
1556710|NCT00550082|Anticoagulation|anticoagulation
1556711|NCT00550082|High-Risk|high-risk
1556712|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
1556713|NCT00550082|Pulmonary Embolism|pulmonary embolism
1556715|NCT00550069|late preterm infants|late preterm infants
1556716|NCT00550069|near term infants|near term infants
1556717|NCT00550069|outcome|outcome
1556718|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
1556719|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
1556720|NCT00550030|Psoriasis|psoriasis
1556721|NCT00550030|UVB radiation|uvb radiation
1556722|NCT00550030|Biologics|biologics
1556723|NCT00550030|Etanercept|etanercept
1556724|NCT00550030|PASI|pasi
1556725|NCT00550004|Unresectable|unresectable
1556726|NCT00550004|locally advanced|locally advanced
1556727|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
1556728|NCT00550004|Stage III|stage iii
1556729|NCT00550004|Stage IV|stage iv
1556730|NCT00549991|High Blood Pressure|high blood pressure
1556731|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
1556732|NCT00549939|child|child
1556733|NCT00549939|bladder|bladder
1556734|NCT00549939|neuropathic|neuropathic
1556735|NCT00549939|alpha blockers|alpha blockers
1556736|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
1556737|NCT00549900|HPV vaccine,|hpv vaccine,
1556738|NCT00549900|Cervical cancer|cervical cancer
1556739|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
1556740|NCT00549874|insulin resistance|insulin resistance
1556741|NCT00549874|type 2 diabetes|type 2 diabetes
1556742|NCT00549874|myocardial perfusion|myocardial perfusion
1556743|NCT00549874|nitrosative stress|nitrosative stress
1556744|NCT00549874|thiazolidinediones|thiazolidinediones
1556745|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1556746|NCT00549861|Contrast agents|contrast agents
1556747|NCT00549861|Gadobutrol|gadobutrol
1556748|NCT00549861|Fibrosis|fibrosis
1556749|NCT00549861|Prognosis|prognosis
1556750|NCT00549861|Magnetic Resonance|magnetic resonance
1556751|NCT00549861|Gadolinium|gadolinium
1556752|NCT00549848|Leukemia|leukemia
1556753|NCT00549835|mucositis pain|mucositis pain
1556754|NCT00549835|cancer|cancer
1556755|NCT00549835|pain|pain
1556756|NCT00549835|acupuncture|acupuncture
1556757|NCT00549835|mucositis|mucositis
1556758|NCT00549835|cancer pain|cancer pain
1556759|NCT00549822|aromatase inhibitor|aromatase inhibitor
1556760|NCT00549822|CA 15-3|ca 15-3
1556761|NCT00549822|Hormone receptor positive|hormone receptor positive
1556762|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
1556763|NCT00549796|coronary artery disease|coronary artery disease
1556764|NCT00549796|angioplasty|angioplasty
1556765|NCT00549796|stent|stent
1556766|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
1556767|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
1556768|NCT00549796|randomized trial|randomized trial
1556769|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
1556770|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
1556771|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
1556772|NCT00549757|cardiovascular disease|cardiovascular disease
1556773|NCT00549757|micro-albuminuria|micro-albuminuria
1556774|NCT00549757|macro-albuminuria|macro-albuminuria
1556775|NCT00549757|RAAS|raas
1556776|NCT00549757|renin inhibitor|renin inhibitor
1556877|NCT00549237|RYGBP|rygbp
1556777|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
1556778|NCT00549744|ASTHMA|asthma
1556779|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
1556780|NCT00549731|autism|autism
1556781|NCT00549731|autistic|autistic
1556782|NCT00549731|language|language
1556783|NCT00549731|development|development
1556784|NCT00549731|developmental|developmental
1556785|NCT00549731|assessment|assessment
1556786|NCT00549718|Schizophrenia|schizophrenia
1556787|NCT00549718|SM-13496|sm-13496
1556788|NCT00549718|Latuda|latuda
1556789|NCT00549718|Lurasidone|lurasidone
1556790|NCT00549705|Anticoagulation|anticoagulation
1556791|NCT00549705|Thrombosis|thrombosis
1556792|NCT00549705|Bleeding|bleeding
1556793|NCT00549705|Clotting|clotting
1556794|NCT00549705|Pulmonary Embolism|pulmonary embolism
1556795|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
1556796|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1556797|NCT00549679|COPD|copd
1556798|NCT00549679|Repeat Dose|repeat dose
1556799|NCT00549679|GSK256066|gsk256066
1556800|NCT00549666|OC DDI|oc ddi
1556801|NCT00549666|lurasidone|lurasidone
1556806|NCT00549653|rosuvastatin|rosuvastatin
1556807|NCT00549640|nicotine dependence|nicotine dependence
1556808|NCT00549640|tobacco dependence|tobacco dependence
1556809|NCT00549614|heart failure|heart failure
1556810|NCT00549601|Alzheimer's|alzheimer's
1556811|NCT00549601|rivastigmine|rivastigmine
1556812|NCT00549601|transdermal|transdermal
1556813|NCT00549601|safety|safety
1556814|NCT00549601|randomized|randomized
1556815|NCT00549601|switch|switch
1556816|NCT00549601|patch|patch
1556817|NCT00549588|Polymorphic light eruption|polymorphic light eruption
1556818|NCT00549588|UV radiation|uv radiation
1556819|NCT00549588|photoprotection|photoprotection
1556820|NCT00549588|sunscreen|sunscreen
1556821|NCT00549588|DNA repair enzymes|dna repair enzymes
1556822|NCT00549588|after-sun-lotion|after-sun-lotion
1556823|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
1556824|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
1556825|NCT00549575|L-Arginine|l-arginine
1556826|NCT00549575|Nitric Oxide Donor|nitric oxide donor
1556827|NCT00549562|Autistic Disorder|autistic disorder
1556828|NCT00549536|calcium supplementation|calcium supplementation
1556829|NCT00549536|intracellular ions|intracellular ions
1556830|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
1556832|NCT00549523|Alternative Medicine|alternative medicine
1556833|NCT00549523|Complementary Medicine|complementary medicine
1556834|NCT00549510|COREG CR,|coreg cr,
1556835|NCT00549510|lisinopril,|lisinopril,
1556836|NCT00549510|hypertension,|hypertension,
1556837|NCT00549510|dose proportionality,|dose proportionality,
1556838|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
1556839|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
1556840|NCT00549484|Thrombocytopenia|thrombocytopenia
1556841|NCT00549484|Thrombopoietin|thrombopoietin
1556842|NCT00549484|Platelet Transfusion|platelet transfusion
1556843|NCT00549484|Platelet Factor 4|platelet factor 4
1556844|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
1556845|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
1556846|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1556847|NCT00549445|COPD|copd
1556848|NCT00549445|Exacerbation|exacerbation
1556849|NCT00549445|Macrolide|macrolide
1556850|NCT00549406|Vision|vision
1556851|NCT00549406|Visual attention|visual attention
1556852|NCT00549406|Postural balance|postural balance
1556853|NCT00549406|Geriatrics|geriatrics
1556854|NCT00549393|intensive care unit|intensive care unit
1556855|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
1556856|NCT00549393|pediatric|pediatric
1556857|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
1556858|NCT00549367|Nutritional status|nutritional status
1556859|NCT00549367|Nutrition counselling|nutrition counselling
1556860|NCT00549367|Nutrition assessment|nutrition assessment
1556861|NCT00549367|HIV|hiv
1556862|NCT00549367|Alternative Medicine|alternative medicine
1556863|NCT00549367|Complementary Medicine|complementary medicine
1556864|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
1556865|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
1556866|NCT00549341|Torticollis|torticollis
1556867|NCT00549341|Cervical Dystonia|cervical dystonia
1556868|NCT00549328|anti-angiogenesis|anti-angiogenesis
1556869|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
1556870|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
1556871|NCT00549263|Safety|safety
1556872|NCT00549263|Pharmacokinetics|pharmacokinetics
1556873|NCT00549263|Bioequivalence|bioequivalence
1556874|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
1556875|NCT00549250|Neonates|neonates
1556876|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
1556878|NCT00549237|Early nutrition|early nutrition
1556879|NCT00549237|Lean body mass|lean body mass
1556880|NCT00549237|Length of stay|length of stay
1556881|NCT00549237|Body Composition|body composition
1556882|NCT00549211|Healthy Subjects,|healthy subjects,
1556883|NCT00549211|Safety,|safety,
1556884|NCT00549211|Tolerability,|tolerability,
1556885|NCT00549211|Pharmacokinetics|pharmacokinetics
1556886|NCT00549198|tenofovir|tenofovir
1556887|NCT00549198|HIV|hiv
1556888|NCT00549198|efavirenz|efavirenz
1556889|NCT00549198|naive|naive
1556890|NCT00549198|lamivudine|lamivudine
1556891|NCT00549198|abacavir|abacavir
1556892|NCT00549198|emtricitabine|emtricitabine
1556893|NCT00549198|renal|renal
1556900|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
1556901|NCT00549159|endometrial ablation|endometrial ablation
1556902|NCT00549146|reversibility|reversibility
1556903|NCT00549146|COPD|copd
1556904|NCT00549146|lung function|lung function
1556905|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
1556906|NCT00549120|Healthy Subjects|healthy subjects
1556907|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
1556908|NCT00549120|propranolol|propranolol
1556909|NCT00549120|beta-blocker|beta-blocker
1556910|NCT00549120|beta-agonist|beta-agonist
1556911|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
1556912|NCT00549107|open heart surgery|open heart surgery
1556913|NCT00549107|infants|infants
1556914|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
1556915|NCT00549081|DHEA|dhea
1556917|NCT00549081|low ovarian response|low ovarian response
1556918|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
1556919|NCT00549042|Back Pain|back pain
1556920|NCT00549042|Chronic Low Back Pain|chronic low back pain
1556921|NCT00549042|Chronic Back Pain|chronic back pain
1556922|NCT00549042|Pain|pain
1556923|NCT00549042|Chronic Pain|chronic pain
1556924|NCT00549029|muscle disorder|muscle disorder
1556925|NCT00549029|statins|statins
1556926|NCT00549029|creatine kinase|creatine kinase
1556927|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
1556928|NCT00548977|spermatogenesis defect|spermatogenesis defect
1556929|NCT00548977|male infertility|male infertility
1556930|NCT00548977|azoospermia|azoospermia
1556931|NCT00548977|oligozoospermia|oligozoospermia
1556932|NCT00548977|Y chromosome markers|y chromosome markers
1556933|NCT00548977|estrogen gene|estrogen gene
1556934|NCT00548964|Ketamine|ketamine
1556935|NCT00548964|glutamate|glutamate
1556936|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
1556937|NCT00548964|treatment resistant|treatment resistant
1556938|NCT00548964|major depressive disorder|major depressive disorder
1556939|NCT00548964|lithium|lithium
1556940|NCT00548951|Dementia|dementia
1556941|NCT00548938|Brain Tumor|brain tumor
1556942|NCT00548938|GBM|gbm
1556943|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
1556944|NCT00548938|Giladel|giladel
1556945|NCT00548938|Temozolomide|temozolomide
1556946|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
1556947|NCT00548912|Hemodialysis|hemodialysis
1556948|NCT00548912|Spironolactone|spironolactone
1556949|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1556950|NCT00548899|Targeted therapy|targeted therapy
1556951|NCT00548886|QT Prolongation|qt prolongation
1556952|NCT00548886|QT Interval|qt interval
1556953|NCT00548886|Epinephrine|epinephrine
1556954|NCT00548886|Stress test|stress test
1556955|NCT00548847|Leukemia|leukemia
1556956|NCT00548834|CDP870|cdp870
1556957|NCT00548834|Certolizumab Pegol|certolizumab pegol
1556958|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1556959|NCT00548795|ARDS|ards
1556960|NCT00548795|Neutrophil|neutrophil
1556961|NCT00548769|PK,|pk,
1556962|NCT00548769|SB-683699,|sb-683699,
1556963|NCT00548769|multiple sclerosis|multiple sclerosis
1556964|NCT00548769|firategrast,|firategrast,
1556965|NCT00548769|surface area,|surface area,
1556966|NCT00548756|Brain Cancer|brain cancer
1556967|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
1556968|NCT00548756|Quality of Life|quality of life
1556969|NCT00548756|QOL|qol
1556970|NCT00548756|Questionnaire|questionnaire
1556971|NCT00548756|Survey|survey
1556972|NCT00548756|WBRT|wbrt
1556973|NCT00548743|Depression|depression
1556974|NCT00548743|Postpartum|postpartum
1556975|NCT00548743|Dyad satisfaction|dyad satisfaction
1556976|NCT00548743|Parenting comfort|parenting comfort
1556977|NCT00548743|Screening|screening
1556978|NCT00548743|Management|management
1556979|NCT00548743|Follow up|follow up
1556980|NCT00548743|Primary care|primary care
1556981|NCT00548743|Practice based research|practice based research
1556982|NCT00548730|Bronchoscopy|bronchoscopy
1556983|NCT00548730|Endoscopy|endoscopy
1556984|NCT00548730|Image Enhancement|image enhancement
1556985|NCT00548730|Autofluorescence|autofluorescence
1556986|NCT00548730|Narrow Band Image|narrow band image
1556987|NCT00548717|GVHD|gvhd
1556988|NCT00548717|Stem cell transplantation|stem cell transplantation
1556989|NCT00548717|Sirolimus|sirolimus
1556990|NCT00548704|Extravasation|extravasation
1556991|NCT00548704|Anthracyclines|anthracyclines
1556992|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
1556993|NCT00548665|Atherosclerosis|atherosclerosis
1556994|NCT00548665|Smoking cessation|smoking cessation
1556995|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
1556996|NCT00548665|Ultrasonography|ultrasonography
1556997|NCT00548665|Health behavior|health behavior
1556998|NCT00548652|apathy|apathy
1556999|NCT00548652|obesity|obesity
1557000|NCT00548652|methylphenidate|methylphenidate
1557001|NCT00548652|MOVE|move
1557002|NCT00548652|medical crisis counselling|medical crisis counselling
1557003|NCT00548626|Pancreatic Cancer|pancreatic cancer
1557004|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
1557005|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
1557006|NCT00548626|Cytopathology|cytopathology
1557007|NCT00548613|Myocardial Infarction|myocardial infarction
1557008|NCT00548613|Heart Attack|heart attack
1557009|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1557010|NCT00548600|Prostate Cancer|prostate cancer
1557011|NCT00548600|Iridium|iridium
1557012|NCT00548600|Implant|implant
1557013|NCT00548600|Radiotherapy|radiotherapy
1557014|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
1557015|NCT00548561|extravasation|extravasation
1557016|NCT00548561|anthracyclines|anthracyclines
1557017|NCT00548548|Avastin|avastin
1557018|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
1557019|NCT00548548|AVAGAST|avagast
1557020|NCT00548522|Type 1 Diabetes|type 1 diabetes
1557021|NCT00548522|Pregnancy|pregnancy
1557022|NCT00548522|Islet Mass|islet mass
1557023|NCT00548522|C-peptide|c-peptide
1557024|NCT00548496|fractured wrist|fractured wrist
1557025|NCT00548496|Distal radial fracture,|distal radial fracture,
1557026|NCT00548483|Endotracheal intubation|endotracheal intubation
1557027|NCT00548483|Laryngeal edema|laryngeal edema
1557028|NCT00548483|Cuff-leak test|cuff-leak test
1557029|NCT00548483|Corticosteroids|corticosteroids
1557030|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
1557031|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
1557032|NCT00548470|schizophrenia|schizophrenia
1557033|NCT00548470|varenicline|varenicline
1557034|NCT00548470|cognition|cognition
1557035|NCT00548470|cigarette smoking|cigarette smoking
1557036|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
1557037|NCT00548444|Tuberculosis|tuberculosis
1557038|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
1557039|NCT00548444|MVA85A|mva85a
1557040|NCT00548444|Deuterium|deuterium
1557041|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
1557042|NCT00548431|6-mercaptopurine|6-mercaptopurine
1557043|NCT00548431|methotrexate|methotrexate
1557044|NCT00548431|asparaginase|asparaginase
1557045|NCT00548405|Multiple Sclerosis|multiple sclerosis
1557046|NCT00548392|breast|breast
1557047|NCT00548392|cancer|cancer
1557048|NCT00548392|ultrasound|ultrasound
1557049|NCT00548392|high risk|high risk
1557050|NCT00548392|marker clip|marker clip
1557051|NCT00548379|vitamin D|vitamin d
1557052|NCT00548379|pneumonia|pneumonia
1557053|NCT00548366|cirrhosis|cirrhosis
1557054|NCT00548366|portal hypertension|portal hypertension
1557055|NCT00548366|ascites|ascites
1557056|NCT00548366|sodium restriction|sodium restriction
1557057|NCT00548327|Genes|genes
1557058|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1557059|NCT00548327|Dopamine|dopamine
1557060|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1557061|NCT00548327|Neuropsychological Testing|neuropsychological testing
1557062|NCT00548327|Schizophrenia|schizophrenia
1557063|NCT00548327|Atomoxetine|atomoxetine
1557064|NCT00548327|Cognitive Study|cognitive study
1557065|NCT00548327|Pharmacogenetics|pharmacogenetics
1557066|NCT00548327|Normal Volunteers|normal volunteers
1557067|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
1557068|NCT00548327|Healthy Volunteer|healthy volunteer
1557069|NCT00548314|Matriderm|matriderm
1557070|NCT00548314|Dermal matrix|dermal matrix
1557071|NCT00548314|VAC therapy|vac therapy
1557072|NCT00548314|Split skin graft|split skin graft
1557073|NCT00548314|Burns|burns
1557074|NCT00548314|Scar quality|scar quality
1557075|NCT00548275|Buprenorphine|buprenorphine
1557076|NCT00548275|Drug counseling|drug counseling
1557077|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
1557078|NCT00548275|HIV Seronegativity|hiv seronegativity
1557079|NCT00548275|HIV risk behaviors|hiv risk behaviors
1557080|NCT00548262|Open-label|open-label
1557081|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
1557082|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
1557083|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
1557084|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
1557085|NCT00548236|exercise intervention|exercise intervention
1557086|NCT00548236|AACT|aact
1557087|NCT00548223|recurrence of stroke|recurrence of stroke
1557088|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
1557089|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
1557090|NCT00548210|Hypertrophy|hypertrophy
1557091|NCT00548210|scarring|scarring
1557092|NCT00548210|scar treatment|scar treatment
1557093|NCT00548210|silicone|silicone
1557094|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
1557095|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
1557096|NCT00548197|tractional retinal detachment|tractional retinal detachment
1557097|NCT00548197|Diabetic retinopathy|diabetic retinopathy
1557098|NCT00548184|primary breast cancers|primary breast cancers
1557099|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
1557100|NCT00548158|diabetes|diabetes
1557101|NCT00548145|Pitavastatin|pitavastatin
1557102|NCT00548145|Statins|statins
1557103|NCT00548145|Donepezil|donepezil
1557104|NCT00548145|Alzheimer's Disease|alzheimer's disease
1557105|NCT00548145|Hypercholesterolemia|hypercholesterolemia
1557106|NCT00548145|ADAS-Jcog|adas-jcog
1557107|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
1557108|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
1557109|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
1557110|NCT00548093|advanced|advanced
1557111|NCT00548093|previously treated|previously treated
1557112|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
1557113|NCT00548054|cholera|cholera
1557114|NCT00548054|vaccine|vaccine
1557115|NCT00548054|Kolkata|kolkata
1557116|NCT00548054|West Bengal|west bengal
1557117|NCT00548054|India|india
1557118|NCT00548054|immunogenicity|immunogenicity
1557119|NCT00548054|safety|safety
1557120|NCT00548054|infants|infants
1557121|NCT00548054|expanded programme on immunization|expanded programme on immunization
1557122|NCT00548041|HIV|hiv
1557123|NCT00548041|Emergency Department|emergency department
1557124|NCT00548041|HIV Seronegativity|hiv seronegativity
1557125|NCT00548002|Staphylococcus aureus|staphylococcus aureus
1557126|NCT00548002|bacteremia|bacteremia
1557127|NCT00548002|endocarditis|endocarditis
1557128|NCT00548002|sepsis|sepsis
1557129|NCT00548002|fluoroquinolone|fluoroquinolone
1557130|NCT00548002|rifampin|rifampin
1557131|NCT00548002|levofloxacin|levofloxacin
1557132|NCT00548002|trovafloxacin|trovafloxacin
1557133|NCT00547989|ASA class I and II|asa class i and ii
1557134|NCT00547976|Inflammation|inflammation
1557135|NCT00547976|Unstable Plaque|unstable plaque
1557136|NCT00547976|Macrophage|macrophage
1557137|NCT00547976|Thrombosis|thrombosis
1557138|NCT00547976|Autoradiography|autoradiography
1557139|NCT00547976|Atherosclerosis|atherosclerosis
1557140|NCT00547976|Vasculitis|vasculitis
1557141|NCT00547963|Alcohol Drinking|alcohol drinking
1557142|NCT00547963|Marijuana Smoking|marijuana smoking
1557143|NCT00547963|Substance Use|substance use
1557144|NCT00547963|Emergency Department (ED)|emergency department (ed)
1557145|NCT00547937|Sleep Apnea|sleep apnea
1557146|NCT00547937|Oxidative Stress|oxidative stress
1557147|NCT00547937|Nitric oxide|nitric oxide
1557148|NCT00547937|Cardiovascular disease|cardiovascular disease
1557149|NCT00547911|Entacapone|entacapone
1557150|NCT00547911|Carbidopa|carbidopa
1557151|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
1557152|NCT00547911|Norepinephrine|norepinephrine
1557153|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
1557154|NCT00547898|HIV|hiv
1557155|NCT00547898|AIDS|aids
1557156|NCT00547898|Diarrhea|diarrhea
1557157|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
1557158|NCT00547885|dihydrocodeine|dihydrocodeine
1557159|NCT00547885|opioids, long acting|opioids, long acting
1557160|NCT00547885|opioids, short acting|opioids, short acting
1557161|NCT00547885|Chronic pain|chronic pain
1557162|NCT00547885|non-malignant pain|non-malignant pain
1557163|NCT00547859|microcirculation|microcirculation
1557164|NCT00547859|cardiac surgery|cardiac surgery
1557165|NCT00547859|metabolism|metabolism
1557166|NCT00547859|capnometry|capnometry
1557167|NCT00547846|Cough|cough
1557168|NCT00547846|Antitussive|antitussive
1557169|NCT00547846|PDC-748|pdc-748
1557170|NCT00547846|PhytoHealth|phytohealth
1557171|NCT00547833|language disorders|language disorders
1557172|NCT00547833|language learning disabilities|language learning disabilities
1557173|NCT00547833|vocabulary|vocabulary
1557174|NCT00547833|reading|reading
1557175|NCT00547820|radiation dose|radiation dose
1557176|NCT00547820|VCUG|vcug
1557177|NCT00547820|pediatric patients|pediatric patients
1557178|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
1557179|NCT00547729|Heart Failure|heart failure
1557180|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
1557181|NCT00547716|Hepatitis C|hepatitis c
1557182|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
1557183|NCT00547716|Omacor|omacor
1557184|NCT00547716|Interferon|interferon
1557185|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
1557186|NCT00547703|Functional dyspepsia|functional dyspepsia
1557187|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
1557188|NCT00547703|Nortriptyline|nortriptyline
1557189|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
1557190|NCT00547677|liver metastases|liver metastases
1557191|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1557192|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
1557193|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
1557194|NCT00547651|Lung Cancer|lung cancer
1557195|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
1557196|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
1557197|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
1557198|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
1557199|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
1557200|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
1557201|NCT00547638|laceration/wound closure|laceration/wound closure
1557202|NCT00547638|topical skin adhesive|topical skin adhesive
1557203|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1557204|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
1557205|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
1557206|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
1557207|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
1557208|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
1557209|NCT00547560|Alzheimer Disease|alzheimer disease
1557210|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1557211|NCT00547534|Bortezomib|bortezomib
1557212|NCT00547534|Bendamustine|bendamustine
1557213|NCT00547534|Rituximab|rituximab
1557214|NCT00547534|Relapsed|relapsed
1557215|NCT00547534|Refractory|refractory
1557216|NCT00547534|Mantle Cell|mantle cell
1557217|NCT00547534|Indolent|indolent
1557218|NCT00547482|Type 2 Diabetes|type 2 diabetes
1557219|NCT00547482|Overweight|overweight
1557220|NCT00547482|Obese|obese
1557221|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
1557222|NCT00547469|IBS-c|ibs-c
1557223|NCT00547469|IBS constipation|ibs constipation
1557224|NCT00547469|women with IBS|women with ibs
1557225|NCT00547469|women with constipation|women with constipation
1557226|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1557227|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1557228|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1557229|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
1557230|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
1557231|NCT00547443|large cell lung cancer|large cell lung cancer
1557232|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1557233|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1557234|NCT00547391|adults|adults
1557235|NCT00547391|children|children
1557236|NCT00547391|tonsillectomy|tonsillectomy
1557237|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
1557238|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
1557239|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1557240|NCT00547339|stage I prostate cancer|stage i prostate cancer
1557241|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
1557242|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
1557243|NCT00547300|Hypertension|hypertension
1557244|NCT00547300|Nebivolol|nebivolol
1557245|NCT00547300|Beta blocker|beta blocker
1557246|NCT00547300|Tolerability|tolerability
1557247|NCT00547261|solid tumor|solid tumor
1557248|NCT00547261|antimitotic|antimitotic
1557249|NCT00547261|tubulin binder|tubulin binder
1557250|NCT00547248|Booster vaccination.|booster vaccination.
1557251|NCT00547248|Immunogenicity|immunogenicity
1557252|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
1557253|NCT00547248|Safety|safety
1557254|NCT00547248|Pneumococcal disease|pneumococcal disease
1557255|NCT00547235|infection|infection
1557256|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
1557257|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1557258|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1557259|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1557260|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1557261|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1557262|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1557263|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1557264|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1557265|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1557266|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1557267|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1557443|NCT00546195|Polysaccharide|polysaccharide
1557268|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1557269|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1557270|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1557271|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1557272|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1557273|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1557274|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1557275|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1557276|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1557277|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1557278|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1557279|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1557280|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1557281|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1557282|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1557283|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1557284|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1557285|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1557286|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1557287|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1557288|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1557289|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1557290|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1557291|NCT00547170|pelvic infection|pelvic infection
1557292|NCT00547170|abortion|abortion
1557293|NCT00547170|doxycycline|doxycycline
1557294|NCT00547157|head and neck|head and neck
1557295|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
1557296|NCT00547157|radiotherapy|radiotherapy
1557297|NCT00547157|chemoradiotherapy|chemoradiotherapy
1557298|NCT00547157|panitumumab|panitumumab
1557299|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
1557300|NCT00547157|EGFr|egfr
1557301|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
1557302|NCT00547157|SCCHN|scchn
1557303|NCT00547157|locally advanced SCCHN|locally advanced scchn
1557304|NCT00547157|HNC|hnc
1557305|NCT00547157|epidermal growth factor|epidermal growth factor
1557306|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
1557307|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
1557308|NCT00547118|Metabolic abnormalities|metabolic abnormalities
1557309|NCT00547118|Safety|safety
1557310|NCT00547118|Satiety|satiety
1557311|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1557312|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1557313|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1557314|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1557315|NCT00547066|ITP|itp
1557316|NCT00547066|hA20|ha20
1557317|NCT00547066|Treatment|treatment
1557318|NCT00547040|calcification|calcification
1557319|NCT00547040|bone lesions|bone lesions
1557320|NCT00547027|diabetes|diabetes
1557321|NCT00547027|physical activity|physical activity
1557322|NCT00547027|print-based intervention|print-based intervention
1557323|NCT00547027|tailored intervention|tailored intervention
1557324|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
1557325|NCT00547001|Menopause|menopause
1557326|NCT00547001|Hot flashes|hot flashes
1557327|NCT00547001|vasomotor symptoms|vasomotor symptoms
1557328|NCT00547001|tapering regimen|tapering regimen
1557329|NCT00547001|hormonal therapy|hormonal therapy
1557330|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
1557331|NCT00546988|primary treatment|primary treatment
1557332|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
1557333|NCT00546988|high-dose therapy|high-dose therapy
1557334|NCT00546988|cytogenetics|cytogenetics
1557335|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
1557336|NCT00546975|nutritional intervention|nutritional intervention
1559180|NCT00539136|PillCam™,|pillcam™,
1557337|NCT00546975|functional status|functional status
1557338|NCT00546975|quality of life|quality of life
1557339|NCT00546949|Decompression, Surgical|decompression, surgical
1557340|NCT00546949|x-stop|x-stop
1557341|NCT00546949|lumbar decompression|lumbar decompression
1557342|NCT00546949|spinal stenosis|spinal stenosis
1557343|NCT00546949|radiculopathy|radiculopathy
1557344|NCT00546936|Histoplasmosis|histoplasmosis
1557345|NCT00546884|End of Life|end of life
1557346|NCT00546884|Advance Directives|advance directives
1557347|NCT00546884|Randomized controlled trial|randomized controlled trial
1557348|NCT00546884|End of life care|end of life care
1557349|NCT00546884|End of life advance care planning|end of life advance care planning
1557350|NCT00546858|Pelvic pain|pelvic pain
1557351|NCT00546858|Vulvar pain|vulvar pain
1557352|NCT00546806|Rehabilitation,|rehabilitation,
1557353|NCT00546806|Treatment outcome,|treatment outcome,
1557354|NCT00546806|Whiplash injuries,|whiplash injuries,
1557355|NCT00546806|Randomized Clinical Trials|randomized clinical trials
1557356|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
1557357|NCT00546780|Multiple Myeloma|multiple myeloma
1557358|NCT00546780|Heat Shock Protein 90|heat shock protein 90
1557359|NCT00546780|Hsp90|hsp90
1557360|NCT00546780|KOS-953|kos-953
1557361|NCT00546780|17-AAG|17-aag
1557362|NCT00546780|bortezomib|bortezomib
1557363|NCT00546780|first relapse|first relapse
1557364|NCT00546780|tanespimycin|tanespimycin
1557365|NCT00546780|TIME-1|time-1
1557366|NCT00546741|Diabetes,NOS|diabetes,nos
1557367|NCT00546689|HIV|hiv
1557368|NCT00546689|aids|aids
1557369|NCT00546689|intestinal parasites|intestinal parasites
1557370|NCT00546689|eosinophils|eosinophils
1557371|NCT00546689|immunoglobulins|immunoglobulins
1557372|NCT00546689|HIV/aids|hiv/aids
1557373|NCT00546689|Treatment Experienced|treatment experienced
1557374|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
1557375|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
1557376|NCT00546611|PEP005|pep005
1557377|NCT00546611|Common Wart(s)|common wart(s)
1557378|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
1557379|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
1557380|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
1557381|NCT00546559|Lipophilic statins|lipophilic statins
1557382|NCT00546559|Insulin resistance|insulin resistance
1557383|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
1557384|NCT00546546|Crohn|crohn
1557385|NCT00546546|immunosuppressants|immunosuppressants
1557386|NCT00546546|natural history|natural history
1557387|NCT00546546|steroids|steroids
1557388|NCT00546520|Asthma|asthma
1557389|NCT00546520|Ciclesonide|ciclesonide
1557390|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
1557391|NCT00546520|Sputum|sputum
1557392|NCT00546520|Nitric oxide|nitric oxide
1557393|NCT00546468|stomach cancer|stomach cancer
1557394|NCT00546468|laparoscopy|laparoscopy
1557395|NCT00546468|gastrectomy|gastrectomy
1557396|NCT00546468|QOL|qol
1557397|NCT00546468|survival|survival
1557398|NCT00546468|clinical study|clinical study
1557399|NCT00546455|Obesity|obesity
1557400|NCT00546455|insulin resistance|insulin resistance
1557401|NCT00546442|insulin resistance|insulin resistance
1557402|NCT00546442|chronic hepatitis C|chronic hepatitis c
1557403|NCT00546442|genotype 1|genotype 1
1557404|NCT00546429|Proximal femoral fracture|proximal femoral fracture
1557405|NCT00546429|Trochanteric fracture|trochanteric fracture
1557406|NCT00546429|Intramedullary nailing|intramedullary nailing
1557407|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
1557408|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1557409|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1557410|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1557411|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1557412|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1557413|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1557414|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1557415|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1557416|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1557417|NCT00546351|Lacosamide|lacosamide
1557418|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
1557419|NCT00546299|COPD|copd
1557420|NCT00546299|exertional hypoxemia|exertional hypoxemia
1557421|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
1557422|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
1557423|NCT00546273|Vaccine|vaccine
1557424|NCT00546260|STEMI|stemi
1557425|NCT00546260|ACS|acs
1557426|NCT00546234|asthma|asthma
1557427|NCT00546234|tiotropium|tiotropium
1557428|NCT00546234|smoking|smoking
1557429|NCT00546234|eNO|eno
1557430|NCT00546234|metabolites|metabolites
1557431|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
1557432|NCT00546221|Depression|depression
1557433|NCT00546221|Mental health|mental health
1557434|NCT00546221|Exercise|exercise
1557435|NCT00546221|Prescribed exercise|prescribed exercise
1557436|NCT00546221|Physical health|physical health
1557437|NCT00546221|Social wellbeing|social wellbeing
1557438|NCT00546208|bladder function|bladder function
1557439|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
1557440|NCT00546208|hydronephrosis|hydronephrosis
1557441|NCT00546195|Cord Blood|cord blood
1557442|NCT00546195|Neutrophils|neutrophils
1558811|NCT00540904|prevention|prevention
1557444|NCT00546195|Gene Expression|gene expression
1557445|NCT00546182|Lipophilic statins|lipophilic statins
1557446|NCT00546182|Insulin resistance|insulin resistance
1557447|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
1557448|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
1557449|NCT00546156|ER positive|er positive
1557450|NCT00546156|PR positive|pr positive
1557451|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
1557452|NCT00546130|ED-SCLC|ed-sclc
1557453|NCT00546130|small cell lung cancer|small cell lung cancer
1557454|NCT00546130|CPT-11|cpt-11
1557455|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
1557456|NCT00546130|CDDP|cddp
1557457|NCT00546130|cisplatin|cisplatin
1557458|NCT00546130|PSK|psk
1557459|NCT00546130|Krestin|krestin
1557460|NCT00546117|otitis media with effusion|otitis media with effusion
1557461|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
1557462|NCT00546117|ear infection|ear infection
1557463|NCT00546117|proton pump inhibitor|proton pump inhibitor
1557464|NCT00546104|Advanced Breast Cancer|advanced breast cancer
1557465|NCT00546104|Breast cancer|breast cancer
1557466|NCT00546104|Dasatinib|dasatinib
1557467|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
1557468|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
1557469|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
1557470|NCT00546091|Imaging|imaging
1557471|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
1557472|NCT00546091|Thermography|thermography
1557473|NCT00546091|Laser Doppler Imaging|laser doppler imaging
1557474|NCT00546091|Vasculature|vasculature
1557475|NCT00546091|Healthy Volunteer|healthy volunteer
1557476|NCT00546091|HV|hv
1557477|NCT00546078|HPV vaccine|hpv vaccine
1557478|NCT00546078|Cervical cancer|cervical cancer
1557479|NCT00546078|Human papillomavirus infection|human papillomavirus infection
1557480|NCT00546065|Barrett's esophagus|barrett's esophagus
1557481|NCT00546065|ablation|ablation
1557482|NCT00546065|esomeprazole|esomeprazole
1557483|NCT00546065|Barrett's cancer|barrett's cancer
1557484|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
1557485|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
1557486|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
1557487|NCT00546039|Prostate cancer|prostate cancer
1557488|NCT00546039|Localized prostatectomy|localized prostatectomy
1557489|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
1557490|NCT00546039|Chemoprevention|chemoprevention
1557491|NCT00546039|Genistein|genistein
1557492|NCT00546039|BONISTEIN™|bonistein™
1557493|NCT00546026|placental function|placental function
1557494|NCT00546026|high-risk pregnancies|high-risk pregnancies
1557495|NCT00546026|psychological distress|psychological distress
1557496|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
1557497|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
1557498|NCT00546013|glaucoma|glaucoma
1557499|NCT00545987|HIV vaccine|hiv vaccine
1557500|NCT00545987|HIV|hiv
1557501|NCT00545987|AIDS|aids
1557502|NCT00545987|prevention|prevention
1557503|NCT00545987|HIV/AIDS|hiv/aids
1557504|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
1557505|NCT00545987|HIV Seronegativity|hiv seronegativity
1557506|NCT00545974|Randomized|randomized
1557507|NCT00545974|Double-Blind|double-blind
1557508|NCT00545974|Placebo-Controlled|placebo-controlled
1557509|NCT00545974|memantine|memantine
1557510|NCT00545974|Namenda|namenda
1557511|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
1557512|NCT00545974|Semantic Dementia|semantic dementia
1557513|NCT00545974|FTD|ftd
1557514|NCT00545974|SD|sd
1557515|NCT00545974|dementia|dementia
1557516|NCT00545974|behavioral decline|behavioral decline
1557517|NCT00545974|cognitive decline|cognitive decline
1557518|NCT00545961|respiratory infection|respiratory infection
1557519|NCT00545961|sinusitis|sinusitis
1557520|NCT00545961|rhinosinusitis|rhinosinusitis
1557521|NCT00545961|children|children
1557522|NCT00545961|middle meatal specimens|middle meatal specimens
1557523|NCT00545961|respiratory track bacteria|respiratory track bacteria
1557524|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
1557525|NCT00545961|pneumococci|pneumococci
1557526|NCT00545961|haemophilus|haemophilus
1557527|NCT00545961|moraxella|moraxella
1557528|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1557529|NCT00545948|NSCLC|nsclc
1559919|NCT00537823|Metastasis|metastasis
1557530|NCT00545948|Non-Squamous|non-squamous
1557531|NCT00545948|Genomics|genomics
1557532|NCT00545948|Guided Therapy|guided therapy
1557533|NCT00545948|Directed Therapy|directed therapy
1557534|NCT00545948|Genomic Expression Profiles|genomic expression profiles
1557535|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
1557536|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1557537|NCT00545922|anxiety|anxiety
1557538|NCT00545922|depression|depression
1557539|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
1557540|NCT00545883|GERD|gerd
1557541|NCT00545883|esophagitis|esophagitis
1557542|NCT00545883|PPI|ppi
1557543|NCT00545857|Type 1 diabetes|type 1 diabetes
1557544|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
1557545|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
1557546|NCT00545857|pioglitazone|pioglitazone
1557547|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
1557548|NCT00545831|Sepsis Prevention|sepsis prevention
1557549|NCT00545831|Central Venous Catheters|central venous catheters
1557550|NCT00545831|Taurolidine|taurolidine
1557551|NCT00545805|Insulin resistance|insulin resistance
1557552|NCT00545805|Metabolic syndrome X|metabolic syndrome x
1557553|NCT00545805|Obesity|obesity
1557554|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
1557555|NCT00545805|Omentum|omentum
1557556|NCT00545805|Bariatric surgery|bariatric surgery
1557557|NCT00545805|Glucose Clamp Technique|glucose clamp technique
1557558|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
1557559|NCT00545805|Adiponectin|adiponectin
1557560|NCT00545805|Cytokines|cytokines
1557561|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
1557562|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
1557563|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
1557564|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
1557565|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
1557566|NCT00545792|Vaginal recurrence|vaginal recurrence
1557567|NCT00545792|Brachytherapy|brachytherapy
1557568|NCT00545792|Radiation Treatment|radiation treatment
1557569|NCT00545792|External Beam Radiation|external beam radiation
1557570|NCT00545792|Avastin|avastin
1557571|NCT00545792|Bevacizumab|bevacizumab
1557572|NCT00545766|Prostate Cancer|prostate cancer
1557573|NCT00545766|Hormone Refractory|hormone refractory
1557574|NCT00545766|Vinflunine|vinflunine
1557575|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
1557576|NCT00545753|Human Head lice|human head lice
1557577|NCT00545727|Diabetes|diabetes
1557578|NCT00545727|Children|children
1557579|NCT00545727|Adolescents|adolescents
1557580|NCT00545727|Diet|diet
1557581|NCT00545727|Glycemic index|glycemic index
1557582|NCT00545701|Influenza|influenza
1557583|NCT00545701|A/H5N1 strain|a/h5n1 strain
1557584|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
1557585|NCT00545701|Influenza Pandemics|influenza pandemics
1557586|NCT00545662|traumatic brain injury|traumatic brain injury
1557587|NCT00545662|cognition|cognition
1557588|NCT00545662|behavioral outcome|behavioral outcome
1557589|NCT00545662|functional outcome|functional outcome
1557590|NCT00545662|treatment|treatment
1557591|NCT00545662|early intervention|early intervention
1557592|NCT00545662|citicoline|citicoline
1557593|NCT00545649|Fibromyalgia|fibromyalgia
1557594|NCT00545649|chronic pain|chronic pain
1557595|NCT00545649|physical|physical
1557596|NCT00545649|exercise|exercise
1557597|NCT00545649|activity|activity
1557598|NCT00545649|education|education
1557599|NCT00545623|HIV/AIDS|hiv/aids
1557600|NCT00545623|Alternative Medicine|alternative medicine
1557601|NCT00545623|Complementary Medicine|complementary medicine
1557602|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
1557603|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
1557604|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1557605|NCT00545558|Coinfection|coinfection
1557606|NCT00545558|Treatment Naive|treatment naive
1557607|NCT00545545|Colorectal|colorectal
1557608|NCT00545545|Carcinoma|carcinoma
1557609|NCT00545545|Recurrent|recurrent
1557610|NCT00545545|Progressive|progressive
1557611|NCT00545545|Cetuximab|cetuximab
1557612|NCT00545545|Irinotecan|irinotecan
1557613|NCT00545545|5-Fluorouracil|5-fluorouracil
1557614|NCT00545519|Multiple Myeloma|multiple myeloma
1557615|NCT00545519|Thymoglobulin|thymoglobulin
1557616|NCT00545506|wound infection|wound infection
1557617|NCT00545506|tissue oxygen tension|tissue oxygen tension
1557618|NCT00545506|local warming|local warming
1557619|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
1557620|NCT00545493|Chronic encephalitis|chronic encephalitis
1557621|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
1557622|NCT00545493|Hemiparesis|hemiparesis
1557623|NCT00545493|Epilepsy|epilepsy
1557624|NCT00545467|Aripiprazole|aripiprazole
1557625|NCT00545467|schizophrenia|schizophrenia
1557626|NCT00545467|antipsychotics|antipsychotics
1557627|NCT00545467|pharmacogenomics|pharmacogenomics
1557628|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
1557629|NCT00545454|Inflammation|inflammation
1557630|NCT00545454|anti-cytokine|anti-cytokine
1557631|NCT00545454|anti-chemokine|anti-chemokine
1557632|NCT00545441|Anal fistula|anal fistula
1557633|NCT00545441|fistula in ano|fistula in ano
1557634|NCT00545441|anorectal fistula|anorectal fistula
1557635|NCT00545428|Nasal acquired diseases|nasal acquired diseases
1557636|NCT00545428|Nasal congenital diseases|nasal congenital diseases
1557637|NCT00545428|Rhinoplasty|rhinoplasty
1557638|NCT00545428|Grafts|grafts
1557639|NCT00545415|fruit|fruit
1557640|NCT00545415|antioxidant|antioxidant
1557641|NCT00545415|Healthy subjects|healthy subjects
1557642|NCT00545350|Prevention|prevention
1557643|NCT00545350|Falls, accidental falls|falls, accidental falls
1557644|NCT00545350|Fractures|fractures
1557645|NCT00545350|Physical injuries|physical injuries
1557646|NCT00545350|Women|women
1557647|NCT00545350|Elderly|elderly
1557648|NCT00545350|Physical exercise|physical exercise
1557649|NCT00545350|Balance exercise|balance exercise
1557650|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
1557651|NCT00545298|Nitric Oxide|nitric oxide
1557652|NCT00545298|Venous Leg Ulcers|venous leg ulcers
1557653|NCT00545285|clinical outcomes|clinical outcomes
1557654|NCT00545285|radiographic outcomes|radiographic outcomes
1557655|NCT00545285|total hip arthroplasty|total hip arthroplasty
1557656|NCT00545285|survivorship|survivorship
1557657|NCT00545272|QMF|qmf
1557658|NCT00545272|indacaterol|indacaterol
1557659|NCT00545272|Twisthaler®|twisthaler®
1557660|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
1557661|NCT00545246|VEGF Trap|vegf trap
1557662|NCT00545194|Prostaglandin E2|prostaglandin e2
1557663|NCT00545194|Intravaginal gel|intravaginal gel
1557664|NCT00545194|Bishop score|bishop score
1557665|NCT00545194|Induction of labor|induction of labor
1557666|NCT00545194|randomized trial|randomized trial
1557667|NCT00545194|Vaginal insert|vaginal insert
1557668|NCT00545181|bacterial vaginosis|bacterial vaginosis
1557669|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
1557670|NCT00545181|recurrence|recurrence
1557671|NCT00545168|head lice|head lice
1557672|NCT00545025|Influenza|influenza
1557673|NCT00545025|Influenza vaccine|influenza vaccine
1557674|NCT00545012|Levetiracetam|levetiracetam
1557675|NCT00545012|Keppra|keppra
1557676|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1557677|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1557678|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1557679|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1557680|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1557681|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1557682|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1557683|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1557684|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1557685|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1557686|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1557687|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1557688|NCT00544986|breast cancer|breast cancer
1557689|NCT00544986|post menopausal women|post menopausal women
1557690|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
1557691|NCT00544960|AT101|at101
1557692|NCT00544960|AT-101|at-101
1557693|NCT00544960|cancer|cancer
1557694|NCT00544960|lung|lung
1557695|NCT00544960|non-small cell|non-small cell
1557696|NCT00544960|docetaxel|docetaxel
1557697|NCT00544960|bcl|bcl
1557698|NCT00544947|Respiratory Depression|respiratory depression
1557699|NCT00544947|Caesarean Section|caesarean section
1557700|NCT00544947|Diamorphine|diamorphine
1557701|NCT00544947|Fentanyl|fentanyl
1557702|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
1557703|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
1557704|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
1557705|NCT00544856|mild cognitive impairment|mild cognitive impairment
1557706|NCT00544830|stage IV prostate cancer|stage iv prostate cancer
1557707|NCT00544830|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1557708|NCT00544830|recurrent prostate cancer|recurrent prostate cancer
1557709|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
1557710|NCT00544817|Temozolomide|temozolomide
1557711|NCT00544817|Sorafenib|sorafenib
1557712|NCT00544817|First-line|first-line
1557713|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
1557714|NCT00544817|Phase II|phase ii
1557715|NCT00544804|recurrent breast cancer|recurrent breast cancer
1557716|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
1557717|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
1557718|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
1557719|NCT00544804|stage IV breast cancer|stage iv breast cancer
1557720|NCT00544804|bone metastases|bone metastases
1557721|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
1557722|NCT00544791|Melatonin|melatonin
1557723|NCT00544791|Antioxidant|antioxidant
1557724|NCT00544791|Memory|memory
1557725|NCT00544791|Alzheimer|alzheimer
1557726|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1557727|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1557728|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1557729|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
1557730|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
1557807|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
1557731|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1557732|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1557733|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
1557734|NCT00544765|Breast cancer|breast cancer
1557735|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
1557736|NCT00544765|pCR rates|pcr rates
1557737|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
1557738|NCT00544739|Coronary Artery Disease|coronary artery disease
1557739|NCT00544739|Premature|premature
1557740|NCT00544739|Female|female
1557741|NCT00544726|Rehabilitation|rehabilitation
1557742|NCT00544700|stage IV colon cancer|stage iv colon cancer
1557743|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
1557744|NCT00544687|Skin|skin
1557745|NCT00544687|Atrophy|atrophy
1557746|NCT00544687|CRX-191|crx-191
1557747|NCT00544687|mometasone furoate|mometasone furoate
1557748|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
1557749|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
1557750|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1557751|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
1557752|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
1557753|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1557754|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1557755|NCT00544622|Stroke treatment|stroke treatment
1557756|NCT00544622|Rehabilitation|rehabilitation
1557757|NCT00544622|Stroke chain|stroke chain
1557758|NCT00544622|Stroke unit|stroke unit
1557759|NCT00544609|Bladder|bladder
1557760|NCT00544609|Sorafenib|sorafenib
1557761|NCT00544609|Radiotherapy|radiotherapy
1557762|NCT00544583|Abdominal wall|abdominal wall
1557763|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1557764|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1557765|NCT00544544|Bipolar|bipolar
1557766|NCT00544544|depression|depression
1557767|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
1557768|NCT00544518|type 2 diabetes|type 2 diabetes
1557769|NCT00544518|Benfluorex|benfluorex
1557770|NCT00544518|Metformin|metformin
1557771|NCT00544518|insulin secretion|insulin secretion
1557772|NCT00544518|glucose control|glucose control
1557773|NCT00544492|arteriovenous fistula|arteriovenous fistula
1557774|NCT00544492|dialysis access|dialysis access
1557775|NCT00544492|pain|pain
1557776|NCT00544492|anxiety|anxiety
1557777|NCT00544492|fistula related complications|fistula related complications
1557778|NCT00544492|aneurysm|aneurysm
1557779|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
1557780|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1557781|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1557782|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1557783|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
1557784|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1557785|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1557786|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1557787|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1557788|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1557789|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1557790|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1557791|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1557792|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1557793|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1557794|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1557795|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1557796|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1557926|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1557797|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1557798|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1557799|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1557800|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1557801|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1557802|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1557803|NCT00544453|SPECT|spect
1557804|NCT00544453|Alzheimer disease|alzheimer disease
1557805|NCT00544440|Prostate neoplasms|prostate neoplasms
1557806|NCT00544440|Prostate cancer|prostate cancer
1559944|NCT00537758|overeating|overeating
1557808|NCT00544440|Abiraterone acetate|abiraterone acetate
1557809|NCT00544440|CB7630|cb7630
1557810|NCT00544440|Prednisone|prednisone
1557811|NCT00544440|Testosterone|testosterone
1557812|NCT00544440|Bone marrow|bone marrow
1557813|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
1557814|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1557815|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1557816|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1557817|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1557818|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1557819|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1557820|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1557821|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1557822|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1557823|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1557824|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1557825|NCT00544401|infertility|infertility
1557826|NCT00544401|in vitro fertilization|in vitro fertilization
1557827|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
1557828|NCT00544401|acupuncture|acupuncture
1557829|NCT00544401|hypnosis|hypnosis
1557830|NCT00544401|hypnopuncture|hypnopuncture
1557831|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1557832|NCT00544388|Xyzal tablet|xyzal tablet
1557833|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1557834|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1557835|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
1557836|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
1557837|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
1557838|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
1557839|NCT00544349|stage IV colon cancer|stage iv colon cancer
1557840|NCT00544349|recurrent colon cancer|recurrent colon cancer
1557841|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
1557842|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
1557843|NCT00544349|liver metastases|liver metastases
1557844|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1557845|NCT00544336|recurrent breast cancer|recurrent breast cancer
1557846|NCT00544336|stage I breast cancer|stage i breast cancer
1557847|NCT00544336|stage II breast cancer|stage ii breast cancer
1557848|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
1557849|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
1557850|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
1557851|NCT00544336|stage IV breast cancer|stage iv breast cancer
1557852|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
1557853|NCT00544336|stage I prostate cancer|stage i prostate cancer
1557854|NCT00544336|stage II prostate cancer|stage ii prostate cancer
1557855|NCT00544336|stage III prostate cancer|stage iii prostate cancer
1557856|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
1557857|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1557858|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
1557859|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1557860|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
1557861|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1557862|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1557863|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1557864|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1557865|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1557866|NCT00544336|recurrent colon cancer|recurrent colon cancer
1557867|NCT00544336|stage I colon cancer|stage i colon cancer
1557868|NCT00544336|stage II colon cancer|stage ii colon cancer
1557869|NCT00544336|stage III colon cancer|stage iii colon cancer
1557870|NCT00544336|stage IV colon cancer|stage iv colon cancer
1557871|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1557872|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1557873|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1557874|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1557875|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1557876|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1557877|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1557878|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1557879|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1557993|NCT00544284|adult subependymoma|adult subependymoma
1557880|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1557881|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1557882|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1557883|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1557884|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1557885|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1557886|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1557887|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1557888|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1557889|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1557890|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1557891|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1557892|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1557893|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1557894|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1557895|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1557896|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1557897|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1557898|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1557899|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1557900|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1557901|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1557902|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1557903|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1557904|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1557905|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1557906|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1557907|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1557908|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1557909|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1557910|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1557911|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1557912|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1557913|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1557914|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1557915|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1557916|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1557917|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1557918|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1557919|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1557920|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1557921|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1557922|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1557923|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1557924|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1557925|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1558222|NCT00543530|HIV|hiv
1557927|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1557928|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1568155|NCT00506896|glucocorticoid|glucocorticoid
1557929|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1557930|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1557931|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1557932|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1557933|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1557994|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
1560045|NCT00537238|Epilepsy|epilepsy
1557934|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1557935|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1557936|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1557937|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1557938|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1557939|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1557940|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1558519|NCT00542230|Erythrocytes|erythrocytes
1557941|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1557942|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1557943|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1557944|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1557945|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1557946|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1557947|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1557948|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1557949|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1557950|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1557951|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1557952|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1557953|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1557954|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1557955|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1557956|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
1557957|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1557958|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1557959|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1557960|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1557961|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1557962|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1557963|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1557964|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
1557965|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
1557966|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
1557967|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
1557968|NCT00544323|alveolar bone|alveolar bone
1557969|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
1557970|NCT00544297|Actinic Keratosis|actinic keratosis
1557971|NCT00544297|Topical|topical
1557972|NCT00544297|Dermatology|dermatology
1557973|NCT00544297|Hand|hand
1557974|NCT00544284|adult glioblastoma|adult glioblastoma
1557975|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1557976|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
1557977|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
1557978|NCT00544284|adult gliosarcoma|adult gliosarcoma
1557979|NCT00544284|adult mixed glioma|adult mixed glioma
1557980|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1557981|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
1557982|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
1557983|NCT00544284|adult brain stem glioma|adult brain stem glioma
1557984|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1557985|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
1557986|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
1557987|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
1557988|NCT00544284|adult medulloblastoma|adult medulloblastoma
1557989|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1557990|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
1557991|NCT00544284|adult ependymoma|adult ependymoma
1557992|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1557995|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
1557996|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1557997|NCT00544284|adult grade I meningioma|adult grade i meningioma
1557998|NCT00544284|adult grade II meningioma|adult grade ii meningioma
1557999|NCT00544284|adult grade III meningioma|adult grade iii meningioma
1558000|NCT00544284|adult papillary meningioma|adult papillary meningioma
1558001|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
1558002|NCT00544284|adult pineoblastoma|adult pineoblastoma
1558003|NCT00544284|adult pineocytoma|adult pineocytoma
1558004|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
1558005|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1558006|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1558007|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1558008|NCT00544271|BOOSTRIX|boostrix
1558009|NCT00544271|INFANRIX|infanrix
1558010|NCT00544258|Pharmacokinetic study|pharmacokinetic study
1558011|NCT00544258|Actinic Keratosis|actinic keratosis
1558012|NCT00544258|Topical|topical
1558013|NCT00544258|Dermatology|dermatology
1558014|NCT00544245|overweight|overweight
1558015|NCT00544245|obesity|obesity
1558016|NCT00544245|accelerometer|accelerometer
1558017|NCT00544245|pedometer|pedometer
1558018|NCT00544245|energy balance|energy balance
1558019|NCT00544245|weight loss|weight loss
1558020|NCT00544245|weight maintenance|weight maintenance
1558021|NCT00544232|Breast Cancer|breast cancer
1558022|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
1558023|NCT00544232|pCR rates|pcr rates
1558024|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1558025|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1558026|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1558027|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1558028|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1558029|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1558030|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1558031|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1558032|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1558033|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
1558034|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
1558035|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
1558036|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1558037|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1558038|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1558039|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
1558040|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
1558041|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
1558042|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
1558043|NCT00544193|stage II gastric cancer|stage ii gastric cancer
1558044|NCT00544193|stage III gastric cancer|stage iii gastric cancer
1558045|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
1558046|NCT00544193|stage I gastric cancer|stage i gastric cancer
1558047|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
1558048|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
1558049|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
1558050|NCT00544167|Breast Cancer|breast cancer
1558051|NCT00544167|Early Stage|early stage
1558052|NCT00544167|High Risk|high risk
1558053|NCT00544167|Node Positive|node positive
1558054|NCT00544167|Doxorubicin|doxorubicin
1558055|NCT00544167|Cyclophosphamide|cyclophosphamide
1558056|NCT00544167|Paclitaxel|paclitaxel
1558057|NCT00544167|Sorafenib|sorafenib
1558058|NCT00544154|CDP870|cdp870
1558059|NCT00544154|Certolizumab pegol|certolizumab pegol
1558060|NCT00544141|Temperature measurement|temperature measurement
1558061|NCT00544128|HIV|hiv
1558062|NCT00544128|initial therapy|initial therapy
1558063|NCT00544128|once daily|once daily
1558064|NCT00544128|randomized trial|randomized trial
1558065|NCT00544128|non inferiority|non inferiority
1558066|NCT00544128|Treatment Naive|treatment naive
1558067|NCT00544115|graft versus host disease|graft versus host disease
1558068|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1558069|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1558070|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1558071|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1558072|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1558073|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1558074|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1558075|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1558076|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
1558808|NCT00540904|contrast|contrast
1558077|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1558078|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1558079|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1558080|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1558081|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1558082|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1558083|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1558084|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1558085|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1558086|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1558087|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1558088|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1558089|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1558090|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1558091|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1558092|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1558093|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1558094|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1558095|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1558096|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1558097|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1558098|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1558099|NCT00544115|essential thrombocythemia|essential thrombocythemia
1558100|NCT00544115|polycythemia vera|polycythemia vera
1558101|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1558102|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1558103|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1558104|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1558105|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1558106|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1558107|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1558108|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1558109|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1558110|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1558111|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1558112|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1558113|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1558114|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1558115|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1558116|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1558117|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1558118|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1558119|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1558120|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1558121|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1558122|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1558123|NCT00544115|Burkitt lymphoma|burkitt lymphoma
1558124|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1558125|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1558126|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1558127|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1568156|NCT00506896|intraarticular injection|intraarticular injection
1558128|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1558326|NCT00542971|AML|aml
1558129|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1558130|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1558131|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1558132|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1558133|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
1558134|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
1558135|NCT00544115|aplastic anemia|aplastic anemia
1558136|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1558137|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1558138|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1558139|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1558140|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1558141|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
1558142|NCT00544102|Insulin Resistance|insulin resistance
1558143|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
1558144|NCT00544102|Atherosclerosis|atherosclerosis
1558145|NCT00544102|Lupus|lupus
1558146|NCT00544102|SLE|sle
1558147|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
1558148|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1558149|NCT00544050|Levetiracetam|levetiracetam
1558150|NCT00544050|Keppra|keppra
1558151|NCT00544024|Mefloquine|mefloquine
1558152|NCT00544011|stage IV colon cancer|stage iv colon cancer
1558153|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
1558154|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
1558155|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1558156|NCT00543998|Sinusitis|sinusitis
1558157|NCT00543985|metabolic syndrome|metabolic syndrome
1558158|NCT00543985|obesity|obesity
1558159|NCT00543985|exercise|exercise
1558160|NCT00543907|breast reconstruction|breast reconstruction
1558161|NCT00543907|DIEP flap|diep flap
1558162|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
1558163|NCT00543881|telemedicine|telemedicine
1558164|NCT00543881|remote patient monitoring|remote patient monitoring
1558165|NCT00543881|chronic heart failure|chronic heart failure
1558166|NCT00543881|mortality|mortality
1558167|NCT00543881|health economics|health economics
1558168|NCT00543855|Lewy Body Disease|lewy body disease
1558169|NCT00543855|Dementia|dementia
1558170|NCT00543855|Clinical Trial|clinical trial
1558171|NCT00543855|Phase II|phase ii
1558172|NCT00543855|E2020|e2020
1558173|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
1558174|NCT00543842|Rectal Cancer|rectal cancer
1558175|NCT00543842|Bevacizumab|bevacizumab
1558176|NCT00543842|Erlotinib|erlotinib
1558177|NCT00543842|Capecitabine|capecitabine
1558178|NCT00543829|breast cancer|breast cancer
1558179|NCT00543829|doxorubicin|doxorubicin
1558180|NCT00543829|docetaxel|docetaxel
1558181|NCT00543829|tamoxifen|tamoxifen
1558182|NCT00543777|Liver Cancer|liver cancer
1558183|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
1558184|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
1558185|NCT00543777|Liver Disease|liver disease
1558186|NCT00543777|Fatty Liver|fatty liver
1558187|NCT00543777|Liver Fibrosis|liver fibrosis
1558188|NCT00543777|Liver Cirrhosis|liver cirrhosis
1558189|NCT00543777|MRE|mre
1558190|NCT00543777|2PD MRI|2pd mri
1558191|NCT00543777|phase correction algorithm|phase correction algorithm
1558192|NCT00543764|Intraoperative Pathway|intraoperative pathway
1558193|NCT00543764|Breast Reconstruction|breast reconstruction
1558194|NCT00543764|DIEP flap|diep flap
1558195|NCT00543725|Antiretroviral|antiretroviral
1558196|NCT00543725|HIV-1|hiv-1
1558197|NCT00543725|AIDS|aids
1558198|NCT00543725|TMC278-C215|tmc278-c215
1558199|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
1558200|NCT00543725|Treatment Naive|treatment naive
1558201|NCT00543712|Sarcoma|sarcoma
1558202|NCT00543712|synovial sarcoma|synovial sarcoma
1558203|NCT00543712|APM4171g|apm4171g
1558204|NCT00543686|Pre-School Asthma|pre-school asthma
1558205|NCT00543686|Responder Profiles|responder profiles
1558206|NCT00543686|Fluticasone|fluticasone
1558207|NCT00543686|Montelukast|montelukast
1558208|NCT00543686|Leukotriene|leukotriene
1558209|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
1558210|NCT00543673|Healthy term infants|healthy term infants
1558211|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
1558212|NCT00543647|Fenofibrate|fenofibrate
1558213|NCT00543647|Glomerular filtration rate|glomerular filtration rate
1558214|NCT00543647|inulin clearance|inulin clearance
1558215|NCT00543647|creatinine|creatinine
1558216|NCT00543647|healthy volunteers|healthy volunteers
1558217|NCT00543647|cross-over|cross-over
1558218|NCT00543608|pneumonia|pneumonia
1568157|NCT00506896|arthritis|arthritis
1558219|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
1558220|NCT00543569|kidney transplant|kidney transplant
1558221|NCT00543569|alefacept|alefacept
1558223|NCT00543530|Treatment Experienced|treatment experienced
1558224|NCT00543504|Advanced Cancer|advanced cancer
1558225|NCT00543504|Bevacizumab|bevacizumab
1558226|NCT00543504|Avastin|avastin
1558227|NCT00543504|Sorafenib|sorafenib
1558228|NCT00543504|BAY 43-9006|bay 43-9006
1558229|NCT00543504|Erlotinib|erlotinib
1558230|NCT00543504|OSI-774|osi-774
1558231|NCT00543504|Tarceva|tarceva
1558232|NCT00543504|Trastuzumab|trastuzumab
1558233|NCT00543504|Herceptin|herceptin
1558234|NCT00543504|Sunitinib|sunitinib
1558235|NCT00543504|SU011248|su011248
1558236|NCT00543504|Sutent|sutent
1558237|NCT00543504|Cetuximab|cetuximab
1558238|NCT00543504|Lapatinib|lapatinib
1558239|NCT00543504|Tykerb|tykerb
1558240|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1558241|NCT00543504|rhuMAb-VEGF|rhumab-vegf
1558242|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
1558243|NCT00543504|GW572016|gw572016
1558244|NCT00543504|Sunitinib Malate|sunitinib malate
1558245|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
1558246|NCT00543478|Diarrhea|diarrhea
1558247|NCT00543478|Probiotics|probiotics
1558248|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
1558249|NCT00543426|Multicenter clinical study|multicenter clinical study
1558250|NCT00543400|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1558251|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
1558252|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
1558253|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
1558254|NCT00543335|Lung Cancer|lung cancer
1558255|NCT00543335|NSCLC|nsclc
1558256|NCT00543335|Radiation Therapy|radiation therapy
1558257|NCT00543335|Sorafenib|sorafenib
1558258|NCT00543335|BAY 43-9006|bay 43-9006
1558259|NCT00543335|Thoracic Radiation|thoracic radiation
1558260|NCT00543309|Fontan Operation|fontan operation
1558261|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
1558262|NCT00543309|Heart Defects, Congenital|heart defects, congenital
1558263|NCT00543309|Milrinone|milrinone
1558520|NCT00542230|Drug Screen|drug screen
1558264|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
1558265|NCT00543296|uveitis|uveitis
1558266|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
1558267|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
1558268|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
1558269|NCT00543270|EVAR|evar
1558270|NCT00543270|AAA|aaa
1558271|NCT00543270|Aneurysm|aneurysm
1558272|NCT00543270|Powerlink|powerlink
1558273|NCT00543244|Chronic hepatitis C|chronic hepatitis c
1558274|NCT00543244|Pegylated interferon|pegylated interferon
1558275|NCT00543244|Ribavirin|ribavirin
1558276|NCT00543244|Virokinetics|virokinetics
1558277|NCT00543231|ECOG|ecog
1558278|NCT00543231|MRT|mrt
1558279|NCT00543231|NCI CTC|nci ctc
1558280|NCT00543231|SAE|sae
1558281|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
1558282|NCT00543192|Endometrial Cancer|endometrial cancer
1558283|NCT00543192|Sexual Function|sexual function
1558284|NCT00543166|Sjögren's syndrome|sjögren's syndrome
1558285|NCT00543166|fatigue|fatigue
1558286|NCT00543166|salivary gland|salivary gland
1558287|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
1558288|NCT00543153|Advanced Cancer|advanced cancer
1558289|NCT00543153|Exceptional Patient|exceptional patient
1558290|NCT00543153|Cancer Care|cancer care
1558291|NCT00543153|Interview|interview
1558292|NCT00543140|Obesity|obesity
1558293|NCT00543140|Morbid Obesity|morbid obesity
1558294|NCT00543114|CLL|cll
1558295|NCT00543114|SLL|sll
1558296|NCT00543114|Revlimid|revlimid
1558297|NCT00543114|lenalidomide|lenalidomide
1558298|NCT00543101|HIV/AIDS|hiv/aids
1558299|NCT00543101|darunavir|darunavir
1558300|NCT00543101|Protease inhibitors|protease inhibitors
1558301|NCT00543101|Dual boosted|dual boosted
1558302|NCT00543101|Treatment experienced|treatment experienced
1558303|NCT00543088|Schizophrenia|schizophrenia
1558304|NCT00543088|Bipolar Disorder|bipolar disorder
1558305|NCT00543088|manic episode|manic episode
1558306|NCT00543088|atypical antipsychotic|atypical antipsychotic
1558307|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
1558308|NCT00543075|Renal Function|renal function
1558309|NCT00543075|Adult|adult
1558310|NCT00543075|Genasense|genasense
1558311|NCT00543075|oblimersen|oblimersen
1558312|NCT00543075|G3139|g3139
1558313|NCT00543075|Genta|genta
1558314|NCT00543075|Pharmacokinetics|pharmacokinetics
1558315|NCT00543049|platinum refractory|platinum refractory
1558316|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
1558317|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
1558318|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
1558319|NCT00543036|Cannabis|cannabis
1558320|NCT00543036|Addiction|addiction
1558321|NCT00543036|Craving|craving
1558322|NCT00543036|TMS|tms
1558323|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
1558324|NCT00542997|SCIG|scig
1558325|NCT00542971|Leukemia|leukemia
1558327|NCT00542971|High-Risk MDS|high-risk mds
1558328|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
1558329|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
1558330|NCT00542971|Idarubicin|idarubicin
1558331|NCT00542971|Ara-C|ara-c
1558332|NCT00542971|Cytarabine|cytarabine
1558333|NCT00542971|Sorafenib|sorafenib
1558334|NCT00542971|BAY43-9006|bay43-9006
1558335|NCT00542958|Cancer|cancer
1558336|NCT00542958|Refractory solid tumor|refractory solid tumor
1558337|NCT00542945|Heart Failure|heart failure
1558338|NCT00542945|ICD|icd
1558339|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
1558340|NCT00542932|COPD|copd
1558341|NCT00542932|Exercise|exercise
1558342|NCT00542932|Home|home
1558343|NCT00542906|healthy volunteers|healthy volunteers
1558344|NCT00542906|Somatosensory stimuli|somatosensory stimuli
1558345|NCT00542906|fMRI|fmri
1558809|NCT00540904|nephropathy|nephropathy
1558346|NCT00542906|second somatosensory area|second somatosensory area
1558347|NCT00542906|insular cortex|insular cortex
1558348|NCT00542906|functional anatomy|functional anatomy
1558349|NCT00542893|bcl-2|bcl-2
1558350|NCT00542893|CFR|cfr
1558351|NCT00542893|DTIC|dtic
1558352|NCT00542893|ECOG|ecog
1558353|NCT00542893|EMEA|emea
1558354|NCT00542893|MedDRA|meddra
1558355|NCT00542893|NCI CTC|nci ctc
1558356|NCT00542893|SAE|sae
1558357|NCT00542880|COPD|copd
1558358|NCT00542880|Symbicort|symbicort
1558359|NCT00542880|Seretide|seretide
1558360|NCT00542867|Hypercholesterolemia|hypercholesterolemia
1558361|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
1558362|NCT00542867|Survey|survey
1558363|NCT00542854|arrhythmia|arrhythmia
1558364|NCT00542854|pacemaker|pacemaker
1558365|NCT00542854|defibrillator|defibrillator
1558366|NCT00542854|electromagnetic interference|electromagnetic interference
1558367|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
1558368|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
1558369|NCT00542815|Chronic Kidney Disease|chronic kidney disease
1558370|NCT00542815|Dialysis|dialysis
1558371|NCT00542815|Hyperphosphatemia|hyperphosphatemia
1558372|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
1558373|NCT00542789|gastrointestinal|gastrointestinal
1558374|NCT00542789|GI|gi
1558375|NCT00542789|NSAID|nsaid
1558376|NCT00542789|Japan|japan
1558377|NCT00542789|Japanese|japanese
1558378|NCT00542789|Gastric ulcer|gastric ulcer
1558379|NCT00542789|duodenal ulcer|duodenal ulcer
1558380|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
1558381|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
1558382|NCT00542776|influenza vaccine|influenza vaccine
1558383|NCT00542776|antibody titers|antibody titers
1558384|NCT00542776|seroprotective titers|seroprotective titers
1558385|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
1558386|NCT00542763|Sjogren's syndrome|sjogren's syndrome
1558387|NCT00542763|Mycophenolate sodium|mycophenolate sodium
1558388|NCT00542750|Cannabis|cannabis
1558389|NCT00542750|Marijuana|marijuana
1558390|NCT00542750|Pharmacotherapy|pharmacotherapy
1558391|NCT00542750|Adolescent|adolescent
1558392|NCT00542737|Acute Lung Injury|acute lung injury
1558393|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1558394|NCT00542737|Acute Respiratory Failure|acute respiratory failure
1558395|NCT00542737|Web-Based Intervention|web-based intervention
1558396|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
1558397|NCT00542724|Insulin|insulin
1558398|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
1558399|NCT00542724|Juvenile diabetes|juvenile diabetes
1558400|NCT00542711|Curcumin|curcumin
1558401|NCT00542711|Bioavilability|bioavilability
1558402|NCT00542711|Healthy subjects|healthy subjects
1558403|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1558404|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
1558405|NCT00542698|Physical Activity|physical activity
1558406|NCT00542672|Mexican American|mexican american
1558407|NCT00542672|Dietary Intake|dietary intake
1558408|NCT00542672|Child-Feeding Practices|child-feeding practices
1558409|NCT00542672|Weight|weight
1558410|NCT00542672|Cultural Values|cultural values
1558411|NCT00542659|Atrial fibrillation|atrial fibrillation
1558412|NCT00542659|Maze procedure|maze procedure
1558413|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
1558414|NCT00542633|Diabetes|diabetes
1558415|NCT00542633|Insulin|insulin
1558416|NCT00542633|NIDDM|niddm
1558417|NCT00542633|Rapid acting|rapid acting
1558418|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1558419|NCT00542607|Xyzal tablets|xyzal tablets
1558420|NCT00542594|breast cancer|breast cancer
1558421|NCT00542594|anastrozole|anastrozole
1558422|NCT00542581|Visual Outcomes|visual outcomes
1558423|NCT00542581|Patient Satisfaction|patient satisfaction
1558424|NCT00542581|Ophthalmology|ophthalmology
1558425|NCT00542581|Cataractous Lens|cataractous lens
1558426|NCT00542542|Breast Cancer|breast cancer
1558427|NCT00542542|Reconstructive Surgery|reconstructive surgery
1558428|NCT00542542|Paravertebral Block|paravertebral block
1558429|NCT00542542|Anesthesia|anesthesia
1558430|NCT00542542|Propofol|propofol
1558431|NCT00542542|Fentanyl|fentanyl
1558432|NCT00542542|Ropivacaine|ropivacaine
1558433|NCT00542542|Midazolam|midazolam
1558434|NCT00542529|Healthy Subjects|healthy subjects
1558435|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
1558436|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
1558437|NCT00542516|Hemodilution|hemodilution
1558438|NCT00542516|Hetastarch|hetastarch
1558439|NCT00542516|Colloids|colloids
1558440|NCT00542503|Cardiac Outcomes|cardiac outcomes
1558441|NCT00542503|MRI|mri
1558442|NCT00542503|Cardiac Stress Testing|cardiac stress testing
1558443|NCT00542490|Endometrial cancer|endometrial cancer
1558444|NCT00542490|Gynecologic Cancer|gynecologic cancer
1558445|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
1558446|NCT00542490|Vaginal radiation|vaginal radiation
1558447|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
1558448|NCT00542451|node-negative breast cancer|node-negative breast cancer
1558449|NCT00542451|HER-2 positive|her-2 positive
1558450|NCT00542438|Cardiovascular Disease|cardiovascular disease
1558451|NCT00542438|Cancer Prevention|cancer prevention
1558452|NCT00542438|Physical Activity|physical activity
1558453|NCT00542438|Body Composition|body composition
1558454|NCT00542438|Environment|environment
1558455|NCT00542438|Exercise|exercise
1558456|NCT00542425|osteoporosis|osteoporosis
1558457|NCT00542425|postmenopausal|postmenopausal
1558458|NCT00542425|bone loss|bone loss
1558459|NCT00542399|levemir|levemir
1558460|NCT00542399|type 1 diabetes|type 1 diabetes
1558461|NCT00542386|Chronic Kidney Disease|chronic kidney disease
1558462|NCT00542386|Dialysis|dialysis
1558463|NCT00542386|Hyperphosphatemia|hyperphosphatemia
1558464|NCT00542386|Dyslipidemia|dyslipidemia
1558465|NCT00542386|Phosphate binder|phosphate binder
1558466|NCT00542373|Oral Cancer|oral cancer
1558467|NCT00542373|Oral Cavity Mucosa|oral cavity mucosa
1558468|NCT00542373|Leukoplakia|leukoplakia
1558469|NCT00542373|Erythroplakia|erythroplakia
1558470|NCT00542373|Fluorescence Imaging|fluorescence imaging
1558471|NCT00542373|Reflectance Imaging|reflectance imaging
1558472|NCT00542373|Multispectral Digital Microscope|multispectral digital microscope
1558473|NCT00542373|Portable Spectroscopy System|portable spectroscopy system
1558474|NCT00542373|Fast Excitation-Emission Matrix|fast excitation-emission matrix
1558475|NCT00542373|PS2|ps2
1558476|NCT00542373|MDM|mdm
1558477|NCT00542373|Fast EEM4|fast eem4
1558478|NCT00542360|Accidental Falls|accidental falls
1558479|NCT00542360|Aged|aged
1558480|NCT00542360|Social Marketing|social marketing
1558481|NCT00542360|Exercise|exercise
1558482|NCT00542360|Accident Prevention|accident prevention
1558483|NCT00542360|Religion|religion
1558484|NCT00542360|Randomized Controlled Trial|randomized controlled trial
1558485|NCT00542347|gastric acid|gastric acid
1558486|NCT00542347|proton pump inhibitors|proton pump inhibitors
1558487|NCT00542347|omeprazole|omeprazole
1558488|NCT00542347|esomeprazole|esomeprazole
1558489|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
1558490|NCT00542334|Type 1 diabetes|type 1 diabetes
1558491|NCT00542334|Children|children
1558492|NCT00542334|Adolescents|adolescents
1558493|NCT00542334|CGMS|cgms
1558494|NCT00542321|lateral rotation|lateral rotation
1558495|NCT00542321|kinetic therapy|kinetic therapy
1558496|NCT00542321|mechanical ventilation|mechanical ventilation
1558497|NCT00542321|pulmonary complications|pulmonary complications
1558498|NCT00542282|lung sounds,|lung sounds,
1558499|NCT00542282|airway obstruction,|airway obstruction,
1558500|NCT00542282|asthma,|asthma,
1558501|NCT00542282|auscultation|auscultation
1558502|NCT00542269|Hypertension|hypertension
1558503|NCT00542269|Metabolic Syndrome|metabolic syndrome
1558504|NCT00542269|Dual combination therapy|dual combination therapy
1558505|NCT00542269|Triple combination therapy|triple combination therapy
1558506|NCT00542269|Aliskiren|aliskiren
1558507|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
1558508|NCT00542256|Apoplexy|apoplexy
1558509|NCT00542256|Cerebral Stroke|cerebral stroke
1558510|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1558511|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
1558512|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
1558513|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1558514|NCT00542256|Stroke|stroke
1558515|NCT00542256|Stroke, Acute|stroke, acute
1558516|NCT00542256|Vascular Accident, Brain|vascular accident, brain
1558517|NCT00542243|enlarged prostate|enlarged prostate
1558518|NCT00542243|finasteride|finasteride
1558521|NCT00542230|Sickle Cell Trait|sickle cell trait
1558522|NCT00542230|Sickle Cell Disease|sickle cell disease
1558523|NCT00542217|Healthy Volunteers|healthy volunteers
1558524|NCT00542204|Diabetes|diabetes
1558525|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1558526|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
1558527|NCT00542204|Internet|internet
1558528|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
1558529|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
1558530|NCT00542204|Care management|care management
1558531|NCT00542204|Disease Management|disease management
1558532|NCT00542204|Diabetes self-management|diabetes self-management
1558533|NCT00542204|Consumer Health Information|consumer health information
1558534|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
1558535|NCT00542204|Computerized Medical Records System|computerized medical records system
1558536|NCT00542204|Automated Medical Records System|automated medical records system
1558537|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
1558538|NCT00542204|Remote patient monitoring|remote patient monitoring
1558539|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
1558540|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1558541|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
1558543|NCT00542152|Ulcerative colitis|ulcerative colitis
1558544|NCT00542152|refractory to steroids|refractory to steroids
1558545|NCT00542139|Osteoarthritis|osteoarthritis
1558546|NCT00542139|Knee arthroplasty|knee arthroplasty
1558547|NCT00542139|Steroid injection|steroid injection
1558548|NCT00542139|Rehabilitation|rehabilitation
1558549|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
1558550|NCT00542113|Parental|parental
1558551|NCT00542113|Parents|parents
1558552|NCT00542113|Prevention|prevention
1558553|NCT00542113|Energy balance|energy balance
1558554|NCT00542113|Glucose regulation|glucose regulation
1558555|NCT00542113|Healthy lifestyles|healthy lifestyles
1558556|NCT00542113|Healthy families|healthy families
1558557|NCT00542113|Active living|active living
1558558|NCT00542074|Bacterial vaginosis|bacterial vaginosis
1558559|NCT00542074|recurrence|recurrence
1558560|NCT00542074|male factor|male factor
1558561|NCT00542061|COPD|copd
1558562|NCT00542061|Asthma|asthma
1558563|NCT00542061|Lung function|lung function
1558564|NCT00542061|Monitoring|monitoring
1558565|NCT00542061|Primary Care|primary care
1558566|NCT00542048|Hepatic metastases|hepatic metastases
1558567|NCT00542048|Angiogenesis|angiogenesis
1558568|NCT00542048|EndoTAG-1|endotag-1
1558569|NCT00542048|Pharmacokinetics|pharmacokinetics
1558570|NCT00542048|Pharmacodynamics|pharmacodynamics
1558571|NCT00542048|Metastases of the liver|metastases of the liver
1558572|NCT00542035|Analgesia|analgesia
1558573|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
1558574|NCT00541983|Diabetes|diabetes
1558575|NCT00541983|Type 2|type 2
1558576|NCT00541983|Mellitus|mellitus
1558577|NCT00541970|viral infections|viral infections
1558578|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1558579|NCT00541970|safety|safety
1558580|NCT00541970|vaccine|vaccine
1558581|NCT00541970|immunogenicity|immunogenicity
1558582|NCT00541970|cervical cancer|cervical cancer
1558583|NCT00541957|Major depression|major depression
1558584|NCT00541957|Primary care|primary care
1558585|NCT00541944|hyponatremia|hyponatremia
1558586|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
1558587|NCT00541944|classification of hyponatremia|classification of hyponatremia
1558588|NCT00541918|sevoflurane,|sevoflurane,
1558589|NCT00541918|propofol,|propofol,
1558590|NCT00541918|heart surgery,|heart surgery,
1558591|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
1558592|NCT00541918|memory disorders,|memory disorders,
1558593|NCT00541892|Cell Culture Techniques|cell culture techniques
1558594|NCT00541879|Childhood|childhood
1558595|NCT00541879|Prevention|prevention
1558596|NCT00541879|Energy balance|energy balance
1558597|NCT00541879|Glucose regulation|glucose regulation
1558598|NCT00541879|Healthy lifestyle|healthy lifestyle
1558599|NCT00541879|Healthy eating|healthy eating
1558600|NCT00541879|Active living|active living
1558601|NCT00541866|Leukemia|leukemia
1558602|NCT00541866|Acute Myeloid|acute myeloid
1558603|NCT00541866|Relapsed|relapsed
1558604|NCT00541866|Refractory|refractory
1558605|NCT00541866|Cancer|cancer
1558607|NCT00541866|Cytarabine|cytarabine
1558608|NCT00541866|SNS-595|sns-595
1558609|NCT00541866|Phase 1|phase 1
1558610|NCT00541866|Voreloxin|voreloxin
1558611|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
1558612|NCT00541853|Hypertension|hypertension
1558613|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
1558614|NCT00541853|Calcium Channel Blocker|calcium channel blocker
1558615|NCT00541853|Kidney Volume|kidney volume
1558616|NCT00541840|Sarcoma|sarcoma
1558617|NCT00541840|Sorafenib|sorafenib
1558618|NCT00541840|GEIS|geis
1558619|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
1558620|NCT00541814|Renal Transplantation|renal transplantation
1558621|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
1558622|NCT00541814|Cyclosporine|cyclosporine
1558623|NCT00541814|Withdrawal|withdrawal
1558624|NCT00541814|Minimisation|minimisation
1558625|NCT00541762|Neurotensin|neurotensin
1558626|NCT00541762|Human|human
1558627|NCT00541762|Physiology of neurotensin|physiology of neurotensin
1558628|NCT00541762|fat perfusion|fat perfusion
1558629|NCT00541762|healthy subjects|healthy subjects
1558631|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
1558632|NCT00541710|menopause|menopause
1558633|NCT00541710|genistein|genistein
1558634|NCT00541710|pre-diabetes|pre-diabetes
1558635|NCT00541671|Narcotics|narcotics
1558636|NCT00541671|Nausea|nausea
1558637|NCT00541619|hypertension|hypertension
1558638|NCT00541619|sympathetic activity|sympathetic activity
1558639|NCT00541619|early renal damage|early renal damage
1558640|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1558641|NCT00541606|Pharmaceutical Care|pharmaceutical care
1558642|NCT00541606|Collaborative Practice|collaborative practice
1558643|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
1558644|NCT00541593|NOTES|notes
1558645|NCT00541567|Wheight management in T2D|wheight management in t2d
1558646|NCT00541515|Type 1 diabetes|type 1 diabetes
1558647|NCT00541515|Artificial pancreas|artificial pancreas
1558648|NCT00541515|Insulin Pump|insulin pump
1558649|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
1558650|NCT00541489|Osteoarthritis|osteoarthritis
1558651|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
1558652|NCT00541463|HIV|hiv
1558653|NCT00541463|Treatment Experienced|treatment experienced
1558654|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
1558655|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
1558656|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
1558657|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
1558658|NCT00541424|Lymphoma|lymphoma
1558659|NCT00541424|CT Colonography|ct colonography
1558660|NCT00541424|PET Scan|pet scan
1558661|NCT00541424|PET/CT Scan|pet/ct scan
1558662|NCT00541424|Gas Insufflation|gas insufflation
1558663|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
1558664|NCT00541398|Schizophrenia|schizophrenia
1558665|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
1558666|NCT00541385|malaria|malaria
1558667|NCT00541385|pediatric|pediatric
1558668|NCT00541385|Africa|africa
1558669|NCT00541385|Phillipines|phillipines
1558670|NCT00541385|Coartem|coartem
1558671|NCT00541385|Artesunate|artesunate
1558672|NCT00541385|lumefantrine|lumefantrine
1558673|NCT00541385|Arthemeter|arthemeter
1558674|NCT00541385|pyronaridine|pyronaridine
1558675|NCT00541385|Pyramax|pyramax
1558676|NCT00541346|Autism|autism
1558677|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
1558678|NCT00541346|ADHD|adhd
1558679|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
1558680|NCT00541333|Dry AMD|dry amd
1558681|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
1558682|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
1558683|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
1558684|NCT00541294|Tuberculosis|tuberculosis
1558685|NCT00541294|HIV|hiv
1558686|NCT00541294|Diagnostics|diagnostics
1558687|NCT00541294|Pediatrics|pediatrics
1558688|NCT00541281|prostate cancer|prostate cancer
1558689|NCT00541281|hormone resistant|hormone resistant
1558690|NCT00541281|metastatic|metastatic
1558691|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
1558692|NCT00541281|randomized study|randomized study
1558693|NCT00541268|Heart Failure|heart failure
1558694|NCT00541268|ICD|icd
1558695|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
1558696|NCT00541255|Bronchial Asthma|bronchial asthma
1558697|NCT00541255|Food Allergy|food allergy
1558698|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
1558699|NCT00541216|congenital myasthenia|congenital myasthenia
1558700|NCT00541216|ephedrine|ephedrine
1558701|NCT00541203|tomography|tomography
1558702|NCT00541203|coronary artery disease|coronary artery disease
1558703|NCT00541203|Stress Test|stress test
1558704|NCT00541203|Coronary Angiography|coronary angiography
1558705|NCT00541190|cystic fibrosis|cystic fibrosis
1558706|NCT00541190|mucociliary clearance|mucociliary clearance
1558707|NCT00541190|outcome measures|outcome measures
1558708|NCT00541177|prevention myopia|prevention myopia
1558709|NCT00541164|CMT|cmt
1558710|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
1558711|NCT00541164|CoQ10|coq10
1558712|NCT00541164|Coenzyme Q10|coenzyme q10
1558713|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
1558714|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
1558715|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
1558716|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1558717|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
1558718|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
1558719|NCT00541138|adult gliosarcoma|adult gliosarcoma
1558720|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1558721|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1560022|NCT00537368|Phase 1|phase 1
1558722|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1558723|NCT00541138|adult brain stem glioma|adult brain stem glioma
1558724|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
1558725|NCT00541138|adult ependymoma|adult ependymoma
1558726|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1558727|NCT00541138|adult subependymoma|adult subependymoma
1558728|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1558729|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
1558730|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1558731|NCT00541138|adult mixed glioma|adult mixed glioma
1558732|NCT00541125|recurrent colon cancer|recurrent colon cancer
1558733|NCT00541125|stage IV colon cancer|stage iv colon cancer
1558734|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
1558735|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
1558810|NCT00540904|bicarbonate|bicarbonate
1558736|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
1558737|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1558738|NCT00541112|stage III rectal cancer|stage iii rectal cancer
1558739|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
1558740|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1558741|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1558742|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1558743|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1558744|NCT00541086|stage IA breast cancer|stage ia breast cancer
1558745|NCT00541086|stage IB breast cancer|stage ib breast cancer
1558746|NCT00541086|stage II breast cancer|stage ii breast cancer
1558747|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
1558748|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
1558749|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
1558750|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1558751|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1558752|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
1558753|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1558754|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
1558755|NCT00541047|sexual dysfunction|sexual dysfunction
1558756|NCT00541047|urinary complications|urinary complications
1558757|NCT00541047|gastrointestinal complications|gastrointestinal complications
1558758|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1558759|NCT00541047|stage I prostate cancer|stage i prostate cancer
1558760|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
1558761|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
1558762|NCT00541047|stage III prostate cancer|stage iii prostate cancer
1558763|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1558764|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1558765|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1558766|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1558767|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1558768|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1558769|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1558770|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1558771|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1558772|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
1558773|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
1558774|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1558775|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
1558776|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
1558777|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
1558778|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
1558779|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
1558780|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1558781|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1558782|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1558783|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1558784|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1558785|NCT00540969|bone metastases|bone metastases
1558786|NCT00540969|pain|pain
1558787|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1558788|NCT00540969|stage IV melanoma|stage iv melanoma
1558789|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
1558790|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1558791|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1558792|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1558793|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1558794|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1560023|NCT00537368|solid tumor|solid tumor
1558795|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1558796|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1558797|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1558798|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1558799|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1558800|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1558801|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1558802|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1558803|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1558804|NCT00540943|cetuximab|cetuximab
1558805|NCT00540943|irinotecan,|irinotecan,
1558806|NCT00540943|pazopanib,|pazopanib,
1558807|NCT00540943|Colorectal cancer,|colorectal cancer,
1558812|NCT00540878|Formulation Drug Study|formulation drug study
1558813|NCT00540865|Homebound Persons|homebound persons
1558814|NCT00540865|Case Management|case management
1558815|NCT00540865|Problem Solving Therapy|problem solving therapy
1558816|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
1558817|NCT00540813|bifurcation stenosis|bifurcation stenosis
1558818|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
1558819|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
1558820|NCT00540800|chemotherapy|chemotherapy
1558821|NCT00540800|first-line|first-line
1558822|NCT00540800|metastatic breast cancer|metastatic breast cancer
1558823|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
1558824|NCT00540774|oral cancer|oral cancer
1558825|NCT00540774|oral mucositis|oral mucositis
1558826|NCT00540774|oral stomatitis|oral stomatitis
1558827|NCT00540774|Dry mouth|dry mouth
1558828|NCT00540774|Gingivitis|gingivitis
1558829|NCT00540761|Coronary Artery Disease|coronary artery disease
1558830|NCT00540761|Atherosclerosis|atherosclerosis
1558831|NCT00540748|first trimester abortion|first trimester abortion
1558832|NCT00540748|oxytocin|oxytocin
1558833|NCT00540696|Anemia|anemia
1558834|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
1558835|NCT00540696|darbepoetin alfa|darbepoetin alfa
1558836|NCT00540696|chemotherapy|chemotherapy
1558837|NCT00540670|Coronary artery disease|coronary artery disease
1558838|NCT00540644|Multiple Myeloma|multiple myeloma
1558839|NCT00540644|Revlimid|revlimid
1558840|NCT00540631|House Dust Mite Allergen|house dust mite allergen
1558841|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
1558842|NCT00540605|Microbicide|microbicide
1558843|NCT00540605|Pregnancy|pregnancy
1558844|NCT00540605|HIV Seronegativity|hiv seronegativity
1558845|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
1558846|NCT00540592|Influenza infection|influenza infection
1558847|NCT00540592|Fluarix|fluarix
1558848|NCT00540579|Pancreas|pancreas
1558849|NCT00540579|Untreated|untreated
1558850|NCT00540579|Advanced|advanced
1558851|NCT00540579|Gemcitabine|gemcitabine
1558852|NCT00540579|CC-4047|cc-4047
1558853|NCT00540553|SARM,|sarm,
1558854|NCT00540553|FTIH,|ftih,
1558855|NCT00540553|pharmacokinetics|pharmacokinetics
1558856|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
1558857|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1558858|NCT00540501|zanamivir,|zanamivir,
1558859|NCT00540501|influenza virus,|influenza virus,
1558860|NCT00540501|healthy volunteer,|healthy volunteer,
1558861|NCT00540501|PK, drug interaction,|pk, drug interaction,
1558862|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
1558863|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1558864|NCT00540475|Interstitial Lung Disease|interstitial lung disease
1558865|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
1558866|NCT00540462|Gastric bypass|gastric bypass
1558867|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
1558868|NCT00540462|Sugar control|sugar control
1558869|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
1558870|NCT00540449|TMC278-C209|tmc278-c209
1558871|NCT00540449|Antiretroviral|antiretroviral
1558872|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1558873|NCT00540449|HIV-1|hiv-1
1558874|NCT00540449|AIDS|aids
1558875|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
1558876|NCT00540449|Treatment Naive|treatment naive
1558877|NCT00540436|Ambrisentan|ambrisentan
1558878|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1558879|NCT00540436|6MWD|6mwd
1558880|NCT00540423|thrombopoietin,|thrombopoietin,
1558881|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
1558882|NCT00540423|eltrombopag,|eltrombopag,
1558883|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
1558884|NCT00540423|blood platelet,|blood platelet,
1558885|NCT00540423|splenectomy|splenectomy
1558886|NCT00540384|Anemia|anemia
1558887|NCT00540384|Solid tumors|solid tumors
1558888|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
1558889|NCT00540384|NESP|nesp
1558890|NCT00540371|Port Wine Stain|port wine stain
1558891|NCT00540358|Triple negative breast cancer|triple negative breast cancer
1558892|NCT00540345|chronic hepatitis C|chronic hepatitis c
1558893|NCT00540345|genotype 2|genotype 2
1558894|NCT00540345|rapid virological response|rapid virological response
1558895|NCT00540345|sustained virological response|sustained virological response
1558896|NCT00540345|peginterferon|peginterferon
1558897|NCT00540345|ribavirin|ribavirin
1558898|NCT00540345|treatment duration|treatment duration
1558899|NCT00540332|Oncology|oncology
1558901|NCT00540332|HNC|hnc
1558902|NCT00540332|head and neck|head and neck
1558903|NCT00540332|oral mucositis|oral mucositis
1558904|NCT00540332|OM|om
1558905|NCT00540332|proteinurea|proteinurea
1558906|NCT00540332|palifermin|palifermin
1558907|NCT00540332|clinical trial|clinical trial
1558908|NCT00540319|Risky behaviors|risky behaviors
1558909|NCT00540319|Prenatal care|prenatal care
1558910|NCT00540319|Substance use|substance use
1558911|NCT00540319|Domestic violence|domestic violence
1558912|NCT00540306|breast tissue|breast tissue
1558913|NCT00540280|NSCLC|nsclc
1558914|NCT00540267|Schizophrenia|schizophrenia
1558915|NCT00540267|Alcohol Abuse|alcohol abuse
1558916|NCT00540267|Bone Density|bone density
1558917|NCT00540254|Chronic Fatigue|chronic fatigue
1558918|NCT00540254|Insomnia|insomnia
1558919|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
1558920|NCT00540228|Influenza|influenza
1558921|NCT00540228|Influenza Vaccine|influenza vaccine
1558922|NCT00540202|Effectiveness|effectiveness
1558923|NCT00540202|Oral quinine|oral quinine
1558924|NCT00540202|Coartem|coartem
1558925|NCT00540202|Uncomplicated malaria|uncomplicated malaria
1558926|NCT00540202|Children|children
1558927|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
1558928|NCT00540176|Dichloroacetate|dichloroacetate
1558929|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
1558930|NCT00540176|Glioma|glioma
1558931|NCT00540150|Immunotherapy|immunotherapy
1558932|NCT00540150|Mite|mite
1558933|NCT00540150|Asthma|asthma
1558934|NCT00540150|bronchial provocation|bronchial provocation
1558935|NCT00540150|SIT|sit
1558936|NCT00540150|specific immunotherapy|specific immunotherapy
1558937|NCT00540137|Antiretroviral therapy|antiretroviral therapy
1558938|NCT00540137|Neurocognitive function|neurocognitive function
1558939|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
1558940|NCT00540137|HIV disease|hiv disease
1558941|NCT00540137|Treatment Naive|treatment naive
1558942|NCT00540111|Soluble fiber|soluble fiber
1558943|NCT00540111|HIV/aids|hiv/aids
1558944|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
1558945|NCT00540111|Cytokines|cytokines
1558946|NCT00540111|Alternative Medicine|alternative medicine
1558947|NCT00540111|Complementary Medicine|complementary medicine
1558948|NCT00540098|panic disorder|panic disorder
1558949|NCT00540098|pharmacotherapy|pharmacotherapy
1558950|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
1558951|NCT00540098|SSRI|ssri
1558952|NCT00540098|paroxetine|paroxetine
1558953|NCT00540098|exercise|exercise
1558954|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
1558955|NCT00540059|Prostate carcinoma|prostate carcinoma
1558956|NCT00540059|LHRH|lhrh
1558957|NCT00540059|Zoladex|zoladex
1558958|NCT00540046|IUD|iud
1558959|NCT00540046|Second trimester termination|second trimester termination
1558960|NCT00540046|Contraception|contraception
1558961|NCT00540033|probiotics|probiotics
1558962|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
1558963|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
1558964|NCT00540020|Brain Injuries|brain injuries
1558965|NCT00540020|Cognition|cognition
1558966|NCT00540020|Randomized Trials|randomized trials
1558967|NCT00540020|Rehabilitation|rehabilitation
1558968|NCT00540020|Treatment Outcome|treatment outcome
1558969|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
1558970|NCT00540007|Lenalidomide|lenalidomide
1558971|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
1558972|NCT00540007|Thalidomide|thalidomide
1558973|NCT00539994|Altabax|altabax
1558974|NCT00539994|SB-275833|sb-275833
1558975|NCT00539994|retapamulin|retapamulin
1558976|NCT00539994|nasal colonization|nasal colonization
1558977|NCT00539994|PK|pk
1558978|NCT00539994|tolerability|tolerability
1558979|NCT00539994|safety|safety
1558980|NCT00539994|efficacy|efficacy
1558981|NCT00539981|Influenza|influenza
1558982|NCT00539955|intimate partner violence|intimate partner violence
1558983|NCT00539955|alcohol use|alcohol use
1558984|NCT00539955|substance use|substance use
1558985|NCT00539942|Randomized Clinical Trials|randomized clinical trials
1558986|NCT00539942|Randomized Controlled Trial|randomized controlled trial
1558987|NCT00539942|Venous thrombosis|venous thrombosis
1558988|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
1558989|NCT00539942|Doppler Ultrasound|doppler ultrasound
1558990|NCT00539942|Postoperative complications|postoperative complications
1558991|NCT00539903|Activity Level|activity level
1558992|NCT00539877|Gstric cancer|gstric cancer
1558993|NCT00539877|Pritoneal seeding|pritoneal seeding
1558994|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
1558995|NCT00539877|Irinotecan|irinotecan
1558996|NCT00539864|Influenza|influenza
1558997|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
1558998|NCT00539851|Diabetes Mellitus|diabetes mellitus
1558999|NCT00539838|SLE|sle
1559000|NCT00539825|Anticholinergic,|anticholinergic,
1559001|NCT00539825|Plethysmography|plethysmography
1559002|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
1559003|NCT00539825|COPD,|copd,
1559004|NCT00539825|FTIH,|ftih,
1559005|NCT00539812|Intimate partner violence|intimate partner violence
1559006|NCT00539812|alcohol use|alcohol use
1559007|NCT00539812|substance use|substance use
1559008|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
1559009|NCT00539799|lupus nephritis|lupus nephritis
1559010|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
1559011|NCT00539760|domain antibody|domain antibody
1559012|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
1559013|NCT00539747|Presymptomatic|presymptomatic
1559014|NCT00539747|Huntington Disease|huntington disease
1559015|NCT00539747|Meaning Making|meaning making
1559016|NCT00539747|Genetic Testing|genetic testing
1559017|NCT00539747|HD|hd
1559018|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1559019|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
1559020|NCT00539734|ranibizumab|ranibizumab
1559021|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
1559022|NCT00539734|electrophysiology|electrophysiology
1559023|NCT00539734|electroretinography|electroretinography
1559024|NCT00539721|Nausea|nausea
1559025|NCT00539721|Vomiting|vomiting
1559026|NCT00539708|Non-invasive ventilation|non-invasive ventilation
1559027|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
1559028|NCT00539708|Mechanical ventilation|mechanical ventilation
1559029|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
1559030|NCT00539695|Stem Cell transplant|stem cell transplant
1559031|NCT00539695|Graft verus host disease|graft verus host disease
1559032|NCT00539695|IL-2|il-2
1559033|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1559034|NCT00539695|ALL|all
1559035|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
1559036|NCT00539695|AML|aml
1559037|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
1559038|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
1559039|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
1559040|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
1559041|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
1559042|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
1559043|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
1559044|NCT00539656|Ex vivo expansion|ex vivo expansion
1559045|NCT00539656|Alternative donor|alternative donor
1559046|NCT00539643|Liver Cancer|liver cancer
1559047|NCT00539643|Hepatoma|hepatoma
1559048|NCT00539643|07-099|07-099
1559049|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
1559050|NCT00539617|erlotinib|erlotinib
1559051|NCT00539617|folfox|folfox
1559052|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
1559053|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
1559054|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
1559055|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
1559056|NCT00539565|biliary atresia|biliary atresia
1559057|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
1559058|NCT00539565|corticosteroids|corticosteroids
1559059|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
1559060|NCT00539513|OCD|ocd
1559061|NCT00539513|glutamate|glutamate
1559062|NCT00539513|N-Acetylcysteine|n-acetylcysteine
1559063|NCT00539513|augmentation|augmentation
1559064|NCT00539500|Neuroblastoma|neuroblastoma
1559065|NCT00539500|ClinicMACS|clinicmacs
1559066|NCT00539500|CliniMACS|clinimacs
1559067|NCT00539500|Stem Cell Transplantation|stem cell transplantation
1559068|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
1559069|NCT00539500|Pediatric|pediatric
1559070|NCT00539500|Solid Tumors|solid tumors
1559071|NCT00539500|Carboplatin|carboplatin
1559072|NCT00539500|Paraplatin|paraplatin
1559073|NCT00539500|Etoposide|etoposide
1559074|NCT00539500|VePesid|vepesid
1559075|NCT00539500|Melphalan|melphalan
1559076|NCT00539500|Alkeran|alkeran
1559077|NCT00539500|CD133+ Cells|cd133+ cells
1559078|NCT00539474|ROLL trial|roll trial
1559079|NCT00539474|Minimally invasive surgery|minimally invasive surgery
1559080|NCT00539474|Non palpable breast cancer|non palpable breast cancer
1559081|NCT00539435|Diabetes Mellitus|diabetes mellitus
1559082|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
1559083|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
1559084|NCT00539435|Cardiac Disease|cardiac disease
1559085|NCT00539422|breast cancer|breast cancer
1559086|NCT00539422|cytochrome 450|cytochrome 450
1559087|NCT00539422|CYP2D6*4|cyp2d6*4
1559088|NCT00539422|Ferritin|ferritin
1559089|NCT00539422|oxidative stress|oxidative stress
1559090|NCT00539422|cancer|cancer
1559091|NCT00539422|cancer breast|cancer breast
1559092|NCT00539409|Diabetes Mellitus|diabetes mellitus
1559093|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
1559094|NCT00539409|Diabetic Quality of Life|diabetic quality of life
1559095|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
1559096|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
1559097|NCT00539383|Lung cancer|lung cancer
1559098|NCT00539383|Breast cancer|breast cancer
1559099|NCT00539383|Melanoma|melanoma
1559100|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
1559101|NCT00539383|Brain metastases|brain metastases
1559102|NCT00539370|Scleritis|scleritis
1560524|NCT00535392|Infusion|infusion
1559103|NCT00539370|Intermediate Uveitis|intermediate uveitis
1559104|NCT00539370|Posterior Uveitis|posterior uveitis
1559105|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
1559106|NCT00539370|Data Analysis|data analysis
1559107|NCT00539370|Data Collection|data collection
1559108|NCT00539370|Sample Analysis|sample analysis
1559109|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
1559110|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
1559111|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
1559112|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1559113|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
1559114|NCT00539331|NSCLC|nsclc
1559115|NCT00539331|AZD2171|azd2171
1559116|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
1559117|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1559118|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
1559119|NCT00539305|hormone replacement therapy|hormone replacement therapy
1559120|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
1559121|NCT00539305|testosterone supplementation|testosterone supplementation
1559122|NCT00539292|pediatrics|pediatrics
1559123|NCT00539292|gastroschisis|gastroschisis
1559124|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
1559125|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
1559126|NCT00539279|Combat Disorders|combat disorders
1559127|NCT00539279|Elderly|elderly
1559128|NCT00539279|Geriatrics|geriatrics
1559129|NCT00539279|Implosive therapy|implosive therapy
1559130|NCT00539279|Neuropsychological Test|neuropsychological test
1559131|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
1559132|NCT00539279|Psychotherapy|psychotherapy
1559133|NCT00539279|Randomized Controlled Trial|randomized controlled trial
1559134|NCT00539279|Relaxation techniques|relaxation techniques
1559135|NCT00539266|Claudication|claudication
1559136|NCT00539266|Critical limb ischemia|critical limb ischemia
1559137|NCT00539266|Cell therapy|cell therapy
1559138|NCT00539266|Bone marrow|bone marrow
1559139|NCT00539253|liver cancer|liver cancer
1559140|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
1559141|NCT00539240|acid reflux|acid reflux
1559142|NCT00539240|acid regurgitation|acid regurgitation
1559143|NCT00539240|esophagitis|esophagitis
1559144|NCT00539240|GERD|gerd
1559145|NCT00539240|heartburn|heartburn
1559146|NCT00539240|pain|pain
1559147|NCT00539240|peptic|peptic
1559148|NCT00539227|Breast Cancer|breast cancer
1559149|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
1559150|NCT00539227|Mastectomy|mastectomy
1559151|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
1559152|NCT00539227|Immediate reconstruction|immediate reconstruction
1559153|NCT00539227|Reconstructive surgery|reconstructive surgery
1559154|NCT00539227|Questionnaire|questionnaire
1559155|NCT00539227|Survey|survey
1559156|NCT00539227|NAC|nac
1559157|NCT00539201|GSK706769,|gsk706769,
1559158|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
1559159|NCT00539201|HIV|hiv
1559160|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
1559161|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
1559162|NCT00539188|glutamate|glutamate
1559163|NCT00539188|N-Acetylcysteine|n-acetylcysteine
1559164|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
1559165|NCT00539175|diabetes mellitus|diabetes mellitus
1559166|NCT00539175|neuropathy|neuropathy
1559167|NCT00539175|diabetic neuropathy|diabetic neuropathy
1559168|NCT00539162|Ovarian Cancer|ovarian cancer
1559169|NCT00539162|CA 125 Algorithm|ca 125 algorithm
1559170|NCT00539162|Cancer Detection|cancer detection
1559171|NCT00539162|Questionnaire|questionnaire
1559172|NCT00539162|Survey|survey
1559173|NCT00539149|Acute otitis media|acute otitis media
1559174|NCT00539149|Otitis media with effusion|otitis media with effusion
1559175|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
1559176|NCT00539136|GSK561679,|gsk561679,
1559177|NCT00539136|Pharmacokinetic,|pharmacokinetic,
1559178|NCT00539136|healthy volunteers,|healthy volunteers,
1559179|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
1559181|NCT00539136|acoustic vest|acoustic vest
1559182|NCT00539123|buprenorphine|buprenorphine
1559183|NCT00539123|drug counseling|drug counseling
1559184|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
1559185|NCT00539097|pediatrics|pediatrics
1559186|NCT00539084|microneedles|microneedles
1559187|NCT00539084|microneedle|microneedle
1559188|NCT00539084|intradermal|intradermal
1559189|NCT00539071|schizophrenia|schizophrenia
1559190|NCT00539071|schizoaffective disorder|schizoaffective disorder
1559191|NCT00539071|long acting injectable|long acting injectable
1559192|NCT00539071|treatment resistant|treatment resistant
1559193|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
1559194|NCT00539032|N. meningitidis|n. meningitidis
1559195|NCT00539032|Meningitis|meningitis
1559196|NCT00539032|Meningococcemia|meningococcemia
1559197|NCT00539019|nutrition assessment|nutrition assessment
1559198|NCT00539019|pediatric|pediatric
1559199|NCT00539006|fluticasone propionate|fluticasone propionate
1559200|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
1559201|NCT00539006|fluticasone furoate|fluticasone furoate
1559202|NCT00539006|experience|experience
1559203|NCT00539006|GW685698X|gw685698x
1559204|NCT00539006|preference|preference
1559205|NCT00538980|Polycythemia Vera|polycythemia vera
1559206|NCT00538980|PV|pv
1559207|NCT00538980|P Vera|p vera
1559208|NCT00538967|Collagenases|collagenases
1559209|NCT00538967|MMP|mmp
1559210|NCT00538967|Cathepsins|cathepsins
1559211|NCT00538967|Doxycycline|doxycycline
1559212|NCT00538967|Aneurysm|aneurysm
1559213|NCT00538954|Perioperative|perioperative
1559214|NCT00538954|recovery|recovery
1559215|NCT00538954|nutrition|nutrition
1559216|NCT00538954|enhanced|enhanced
1559217|NCT00538954|laxative|laxative
1559218|NCT00538941|chocolate,|chocolate,
1559219|NCT00538941|heart failure,|heart failure,
1559220|NCT00538941|endothelial function,|endothelial function,
1559221|NCT00538941|platelet adhesion,|platelet adhesion,
1559222|NCT00538941|oxidative stress,|oxidative stress,
1559223|NCT00538941|baroreceptor function,|baroreceptor function,
1559224|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
1559225|NCT00538928|extracorporeal lung support|extracorporeal lung support
1559226|NCT00538928|hypoxia|hypoxia
1559227|NCT00538928|hypercapnia|hypercapnia
1559228|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1559229|NCT00538915|immunodeficiency|immunodeficiency
1559230|NCT00538915|humoral immunity|humoral immunity
1559231|NCT00538915|antibody deficiency|antibody deficiency
1559232|NCT00538915|PID|pid
1559233|NCT00538915|PIDD|pidd
1559234|NCT00538902|Humira, methotrexate|humira, methotrexate
1559235|NCT00538889|Adult|adult
1559236|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1559237|NCT00538850|pain|pain
1559238|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1559239|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1559240|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1559241|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1559242|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1559243|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1559244|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1559245|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1559246|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1559247|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1559248|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1559249|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1559250|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1567284|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1559251|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1559252|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1559253|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1559254|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1559255|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1559256|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1559257|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1559258|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1559259|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1559260|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1559261|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1559262|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1559263|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1559264|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1559265|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1559266|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1559267|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1559268|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1559269|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1559270|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1559271|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1559272|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1559273|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1559274|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1559275|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1559276|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1559277|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1559278|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1559279|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1559280|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1559281|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1559282|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1559283|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1559284|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1559285|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1559286|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1559287|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1559288|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1559289|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1559290|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1559291|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1559292|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1559293|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1559294|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1559295|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1559296|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1559297|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1559298|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1559299|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
1559300|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
1559301|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
1559302|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1559303|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1559304|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1559305|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1559306|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1559307|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1559308|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1559309|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1559310|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1559311|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1559312|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1559313|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1559314|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1559315|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1559316|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1559317|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1559318|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1559319|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1559320|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1559321|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1559322|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1559323|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1559324|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1559325|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1559326|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1559327|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1559328|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1559329|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1559330|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1559719|NCT00538850|stage IIB melanoma|stage iib melanoma
1559331|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1559332|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1559333|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1559334|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
1559335|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1559336|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1559337|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1559338|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1559339|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1559340|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1559341|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1559342|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1559343|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1559344|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1559345|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1559346|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1559347|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1559348|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1559349|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1559350|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1559351|NCT00538850|primary myelofibrosis|primary myelofibrosis
1559352|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1559353|NCT00538850|essential thrombocythemia|essential thrombocythemia
1559354|NCT00538850|polycythemia vera|polycythemia vera
1559355|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1559356|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1559357|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1559358|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1559359|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1559360|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1559361|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1559362|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
1559363|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1559364|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1559365|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1559366|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1559367|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1559368|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
1559369|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1559370|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
1559371|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1559372|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
1559373|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1559374|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1559375|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1559376|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1559377|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
1559378|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1559379|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1559380|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
1559381|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1559382|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1559383|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1559384|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1559385|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1559386|NCT00538850|intraocular lymphoma|intraocular lymphoma
1559387|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1559388|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1559389|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1560024|NCT00537368|cancer|cancer
1559390|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1559391|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1559392|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1559393|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1559394|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1559395|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1559396|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1559397|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1559398|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1559399|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1559400|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1559515|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
1559401|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1559402|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1559403|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1559404|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1559405|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1559406|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1559407|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1559408|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1559409|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1559410|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1559411|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1559412|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1559413|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1559414|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1559415|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1559416|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1559417|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1559418|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1559419|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1559420|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1559421|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1559422|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1559423|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1559424|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1559425|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1559426|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1559427|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1559428|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1559429|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1559430|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1559431|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1559432|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1559433|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1559434|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1559435|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1559436|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1559437|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1559438|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1559439|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1559440|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1559441|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1559442|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1559443|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1559575|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
1559444|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1559445|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1559446|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1559447|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1559448|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1559449|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1559450|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1559451|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1559452|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1559453|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1559454|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1559516|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
1559455|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1559456|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1559457|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1559458|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1559459|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1559460|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1559461|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1559462|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1559463|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1559464|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1559465|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1559466|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1559467|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1559468|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1559469|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1559470|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1559471|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1559472|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1559473|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1568256|NCT00506480|endometrial implantation|endometrial implantation
1559474|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1559475|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1559476|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
1559477|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1559478|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1559479|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1559480|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1559481|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1559482|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1559483|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1559484|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
1559485|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
1559486|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
1559487|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
1559488|NCT00538850|adult grade I meningioma|adult grade i meningioma
1559489|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
1559490|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
1559491|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1559492|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
1559493|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1559494|NCT00538850|adult pineocytoma|adult pineocytoma
1559495|NCT00538850|adult ependymoma|adult ependymoma
1559496|NCT00538850|adult subependymoma|adult subependymoma
1559497|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
1560025|NCT00537355|ragweed|ragweed
1559498|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1559499|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
1559500|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1559501|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1559502|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1559503|NCT00538850|adult medulloblastoma|adult medulloblastoma
1559504|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1559505|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
1559506|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1559507|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
1559508|NCT00538850|adult glioblastoma|adult glioblastoma
1559509|NCT00538850|adult gliosarcoma|adult gliosarcoma
1559510|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
1559511|NCT00538850|adult grade III meningioma|adult grade iii meningioma
1559512|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1559513|NCT00538850|adult pineoblastoma|adult pineoblastoma
1559514|NCT00538850|adult mixed glioma|adult mixed glioma
1559592|NCT00538850|insulinoma|insulinoma
1559517|NCT00538850|adult papillary meningioma|adult papillary meningioma
1559518|NCT00538850|adult brain stem glioma|adult brain stem glioma
1559519|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
1559520|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
1559521|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
1559522|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
1559523|NCT00538850|stage III cervical cancer|stage iii cervical cancer
1559524|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
1559525|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
1559526|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
1559527|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1559528|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
1559529|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
1559530|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
1559531|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1559532|NCT00538850|fallopian tube cancer|fallopian tube cancer
1559533|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1559534|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1559535|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1559536|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1559537|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1559538|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1559539|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1559540|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1559541|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1559542|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1559543|NCT00538850|ovarian sarcoma|ovarian sarcoma
1559544|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
1559545|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
1559546|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
1559547|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
1559548|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
1559549|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
1559550|NCT00538850|recurrent colon cancer|recurrent colon cancer
1559551|NCT00538850|stage I colon cancer|stage i colon cancer
1559552|NCT00538850|stage II colon cancer|stage ii colon cancer
1559553|NCT00538850|stage III colon cancer|stage iii colon cancer
1559554|NCT00538850|stage IV colon cancer|stage iv colon cancer
1559555|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
1559556|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
1559557|NCT00538850|stage I bladder cancer|stage i bladder cancer
1559558|NCT00538850|stage II bladder cancer|stage ii bladder cancer
1559559|NCT00538850|stage III bladder cancer|stage iii bladder cancer
1559560|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
1559561|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
1559562|NCT00538850|stage I gastric cancer|stage i gastric cancer
1559563|NCT00538850|stage II gastric cancer|stage ii gastric cancer
1559564|NCT00538850|stage III gastric cancer|stage iii gastric cancer
1559565|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
1559566|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
1559567|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
1559568|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1559569|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1559570|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
1559571|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1559572|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1559573|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
1559574|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
1560500|NCT00535483|algorithm|algorithm
1559576|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
1559577|NCT00538850|distal urethral cancer|distal urethral cancer
1559578|NCT00538850|proximal urethral cancer|proximal urethral cancer
1559579|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
1559580|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1559581|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
1559582|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
1559583|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
1559584|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1559585|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1559586|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
1559587|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1559588|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1559589|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1559590|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1559591|NCT00538850|gastrinoma|gastrinoma
1559593|NCT00538850|WDHA syndrome|wdha syndrome
1559594|NCT00538850|glucagonoma|glucagonoma
1559595|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1559596|NCT00538850|somatostatinoma|somatostatinoma
1559597|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1559598|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
1559599|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1559600|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1559601|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1559602|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
1559603|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
1559604|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1559605|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1559606|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1559607|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1559608|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
1559609|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
1559610|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
1559611|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
1559612|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
1559613|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
1559614|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1559615|NCT00538850|small intestine lymphoma|small intestine lymphoma
1559616|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1559617|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1559618|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1559619|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1559620|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1559621|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1725907|NCT00000886|Mannose|mannose
1559622|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1559623|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1559624|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
1559625|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
1559626|NCT00538850|liver metastases|liver metastases
1559627|NCT00538850|lung metastases|lung metastases
1559628|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1559629|NCT00538850|lung papilloma|lung papilloma
1559630|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
1559631|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1559632|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1559633|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
1559634|NCT00538850|stage II breast cancer|stage ii breast cancer
1559635|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
1559636|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
1559637|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
1559638|NCT00538850|stage IV breast cancer|stage iv breast cancer
1559639|NCT00538850|recurrent breast cancer|recurrent breast cancer
1559640|NCT00538850|male breast cancer|male breast cancer
1559641|NCT00538850|breast cancer in situ|breast cancer in situ
1559642|NCT00538850|localized osteosarcoma|localized osteosarcoma
1559643|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
1559644|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
1559645|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1559646|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1559647|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1559648|NCT00538850|chondrosarcoma|chondrosarcoma
1559649|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
1559650|NCT00538850|desmoid tumor|desmoid tumor
1559651|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1559652|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1559653|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1559654|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1559655|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1559656|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1559657|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
1559658|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
1559659|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1559660|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
1559661|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1559662|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1559663|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1559664|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1559665|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
1559666|NCT00538850|stage I penile cancer|stage i penile cancer
1559667|NCT00538850|stage II penile cancer|stage ii penile cancer
1559668|NCT00538850|stage III penile cancer|stage iii penile cancer
1559669|NCT00538850|stage IV penile cancer|stage iv penile cancer
1559670|NCT00538850|recurrent penile cancer|recurrent penile cancer
1559671|NCT00538850|stage I prostate cancer|stage i prostate cancer
1559672|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
1559673|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
1559674|NCT00538850|stage III prostate cancer|stage iii prostate cancer
1559675|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
1559676|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
1559677|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
1559678|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
1559679|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
1559680|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
1559681|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
1559682|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
1559683|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
1559684|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
1559685|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
1559686|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
1559687|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
1559688|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
1559689|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
1559690|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
1559691|NCT00538850|stage I anal cancer|stage i anal cancer
1559692|NCT00538850|stage II anal cancer|stage ii anal cancer
1559693|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
1559694|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
1559695|NCT00538850|stage IV anal cancer|stage iv anal cancer
1559696|NCT00538850|recurrent anal cancer|recurrent anal cancer
1559697|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
1559698|NCT00538850|stage I rectal cancer|stage i rectal cancer
1559699|NCT00538850|stage II rectal cancer|stage ii rectal cancer
1559700|NCT00538850|stage III rectal cancer|stage iii rectal cancer
1559701|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
1559702|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
1559703|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
1559704|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
1559705|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
1559706|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
1559707|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
1559708|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
1559709|NCT00538850|stage I thymoma|stage i thymoma
1559710|NCT00538850|stage II thymoma|stage ii thymoma
1559711|NCT00538850|stage III thymoma|stage iii thymoma
1559712|NCT00538850|stage IVA thymoma|stage iva thymoma
1559713|NCT00538850|stage IVB thymoma|stage ivb thymoma
1559714|NCT00538850|recurrent melanoma|recurrent melanoma
1559715|NCT00538850|stage 0 melanoma|stage 0 melanoma
1559716|NCT00538850|stage IA melanoma|stage ia melanoma
1559717|NCT00538850|stage IB melanoma|stage ib melanoma
1559718|NCT00538850|stage IIA melanoma|stage iia melanoma
1559720|NCT00538850|stage IIC melanoma|stage iic melanoma
1559721|NCT00538850|stage IIIA melanoma|stage iiia melanoma
1559722|NCT00538850|stage IIIB melanoma|stage iiib melanoma
1559723|NCT00538850|stage IIIC melanoma|stage iiic melanoma
1559724|NCT00538850|stage IV melanoma|stage iv melanoma
1559725|NCT00538824|myeloma|myeloma
1559726|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
1559727|NCT00538798|Pharmacokinetics|pharmacokinetics
1559728|NCT00538798|Binding Potential|binding potential
1559729|NCT00538798|Glutamate|glutamate
1559730|NCT00538798|Positron Emission Tomography|positron emission tomography
1559731|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
1559732|NCT00538798|Healthy Volunteer|healthy volunteer
1559733|NCT00538798|HV|hv
1559832|NCT00538356|Home Monitoring|home monitoring
1559833|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
1559734|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
1559735|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1559736|NCT00538772|Biomarkers|biomarkers
1559737|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
1559738|NCT00538759|Aortic valve stenosis|aortic valve stenosis
1559739|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
1559740|NCT00538759|Aortic valve restenosis|aortic valve restenosis
1559741|NCT00538733|myeloma|myeloma
1559742|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1559743|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
1559744|NCT00538720|PHPT|phpt
1559745|NCT00538720|Parathyroid glands|parathyroid glands
1559746|NCT00538720|Vitamin D deficiency|vitamin d deficiency
1559747|NCT00538720|Vitamin D|vitamin d
1559748|NCT00538720|Ergocalciferol|ergocalciferol
1559749|NCT00538707|mental stress|mental stress
1559750|NCT00538707|platelet adhesion|platelet adhesion
1559751|NCT00538707|platelet function|platelet function
1559752|NCT00538707|catecholamines|catecholamines
1559854|NCT00538161|cardiac surgery|cardiac surgery
1559943|NCT00537758|dietary restriction|dietary restriction
1559753|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
1559754|NCT00538668|Prostate|prostate
1559755|NCT00538668|Prostate Cancer|prostate cancer
1559756|NCT00538668|Prostate Ca|prostate ca
1559757|NCT00538655|amphetamine|amphetamine
1559758|NCT00538655|methamphetamine|methamphetamine
1559759|NCT00538655|addition|addition
1559760|NCT00538655|treatment study|treatment study
1559761|NCT00538655|drug use|drug use
1559762|NCT00538655|modafinil|modafinil
1559763|NCT00538642|schizophrenia|schizophrenia
1559764|NCT00538642|antipsychotics|antipsychotics
1559765|NCT00538642|diabetes|diabetes
1559766|NCT00538642|bipolar disorder|bipolar disorder
1559767|NCT00538616|Brain Injury|brain injury
1559768|NCT00538590|ologen|ologen
1559769|NCT00538590|collagen matrix|collagen matrix
1559770|NCT00538590|glaucoma|glaucoma
1559771|NCT00538590|trabeculectomy|trabeculectomy
1559772|NCT00538590|Mitomycin-C|mitomycin-c
1559773|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
1559774|NCT00538564|prolonged, painful erection|prolonged, painful erection
1559775|NCT00538564|priapism|priapism
1559776|NCT00538564|sickle cell anemia|sickle cell anemia
1559777|NCT00538551|HD|hd
1559778|NCT00538551|NHL|nhl
1559779|NCT00538538|Macular Degeneration|macular degeneration
1559780|NCT00538538|AMD|amd
1559781|NCT00538538|Hemorrhage|hemorrhage
1559782|NCT00538538|Wet AMD|wet amd
1559783|NCT00538512|Influenza|influenza
1559784|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
1559785|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
1559786|NCT00538512|Vaccine Efficacy|vaccine efficacy
1559787|NCT00538499|pain|pain
1559788|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
1559789|NCT00538486|Hypertension|hypertension
1559790|NCT00538486|Abdominal obesity|abdominal obesity
1559791|NCT00538486|Treatment|treatment
1559792|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
1559793|NCT00538473|Influenza Infection|influenza infection
1559794|NCT00538473|Fluarix|fluarix
1559795|NCT00538460|tomography|tomography
1559796|NCT00538460|coronary artery disease|coronary artery disease
1559797|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
1559798|NCT00538447|CML|cml
1559799|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
1559800|NCT00538434|GERD|gerd
1559801|NCT00538434|EE|ee
1559802|NCT00538434|Reslizumab|reslizumab
1559803|NCT00538434|IL-5|il-5
1559804|NCT00538434|Interleukin-5|interleukin-5
1559805|NCT00538434|Cinquil|cinquil
1559806|NCT00538421|propofol|propofol
1559807|NCT00538421|Anaesthesia|anaesthesia
1559808|NCT00538421|Sevoflurane|sevoflurane
1559809|NCT00538421|Abdominal|abdominal
1559810|NCT00538421|Aortic|aortic
1559811|NCT00538421|Aneurysm|aneurysm
1559812|NCT00538408|Magnetic resonance|magnetic resonance
1559813|NCT00538408|whole body|whole body
1559814|NCT00538408|angiography|angiography
1559815|NCT00538408|vasovist|vasovist
1559816|NCT00538408|gadofosveset|gadofosveset
1559817|NCT00538408|dotarem|dotarem
1559818|NCT00538408|blood pool agent|blood pool agent
1559819|NCT00538382|Malaria|malaria
1559820|NCT00538382|Pregnancy|pregnancy
1559821|NCT00538382|Artesunate|artesunate
1559822|NCT00538382|Pharmacokinetics|pharmacokinetics
1559823|NCT00538382|Pharmacodynamics|pharmacodynamics
1559824|NCT00538382|Democratic Republic of Congo|democratic republic of congo
1559825|NCT00538369|Nursing|nursing
1559826|NCT00538369|critical care|critical care
1559827|NCT00538369|sedation assessment|sedation assessment
1559828|NCT00538369|Bispectral index|bispectral index
1559829|NCT00538356|Heart failure|heart failure
1559830|NCT00538356|Rehospitalization:|rehospitalization:
1559831|NCT00538356|Packer composite score|packer composite score
1559834|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1559835|NCT00538343|brain metastases|brain metastases
1559836|NCT00538343|breast cancer|breast cancer
1559837|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
1559838|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
1559839|NCT00538317|primary angioplasty,|primary angioplasty,
1559840|NCT00538317|tirofiban|tirofiban
1559841|NCT00538291|recurrent colon cancer|recurrent colon cancer
1559842|NCT00538291|stage IV colon cancer|stage iv colon cancer
1559843|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
1559844|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
1559845|NCT00538278|AML|aml
1559846|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
1559847|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
1559848|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
1559849|NCT00538213|Fluarix|fluarix
1559850|NCT00538213|Influenza infection|influenza infection
1559851|NCT00538200|Nutrition|nutrition
1559852|NCT00538200|COPD|copd
1559853|NCT00538161|Acute lung injury|acute lung injury
1559855|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
1559856|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
1559857|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
1559858|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
1559859|NCT00538135|randomised controlled trial|randomised controlled trial
1559860|NCT00538135|borderline personality disorder|borderline personality disorder
1559861|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
1559862|NCT00538135|treatment as usual|treatment as usual
1559863|NCT00538122|schizophrenia|schizophrenia
1559864|NCT00538122|schizoaffective disorder|schizoaffective disorder
1559865|NCT00538122|bipolar disorder|bipolar disorder
1559866|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
1559867|NCT00538122|safety|safety
1559868|NCT00538122|arrythmias|arrythmias
1559869|NCT00538109|CML in Blast Crisis|cml in blast crisis
1559870|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
1559871|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1559872|NCT00538083|Cocoa|cocoa
1559873|NCT00538083|Overweight adults|overweight adults
1559874|NCT00538083|Endothelial function|endothelial function
1559875|NCT00538083|Blood pressure|blood pressure
1559876|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
1559877|NCT00538083|Dark chocolate|dark chocolate
1559878|NCT00538083|Sugar|sugar
1559879|NCT00538070|Sarcosine|sarcosine
1559880|NCT00538070|Glycine|glycine
1559881|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1559882|NCT00538070|Schizophrenia|schizophrenia
1559883|NCT00538057|Healthy volunteers|healthy volunteers
1559884|NCT00538044|pulmonary hypertension|pulmonary hypertension
1559885|NCT00538044|simvastatin|simvastatin
1559886|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
1559887|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
1559888|NCT00538005|recurrent melanoma|recurrent melanoma
1559889|NCT00538005|stage IV melanoma|stage iv melanoma
1559890|NCT00537992|combined surgery,|combined surgery,
1559891|NCT00537992|cataract surgery,|cataract surgery,
1559892|NCT00537992|vitrectomy,|vitrectomy,
1559893|NCT00537992|blue light-filter iols|blue light-filter iols
1559894|NCT00537979|Dialysis|dialysis
1559895|NCT00537979|Hyperparathyroidism|hyperparathyroidism
1559896|NCT00537979|Zemplar|zemplar
1559897|NCT00537966|Primary HIV Infection|primary hiv infection
1559898|NCT00537953|Leishmaniasis|leishmaniasis
1559899|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
1559900|NCT00537953|Miltefosine|miltefosine
1559901|NCT00537953|Glucantime|glucantime
1559902|NCT00537953|Antimony|antimony
1559903|NCT00537953|Pentavalent antimonials|pentavalent antimonials
1559904|NCT00537953|Combination therapy|combination therapy
1559905|NCT00537927|laparoscopic correction|laparoscopic correction
1559906|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
1559907|NCT00537927|mesh fixation|mesh fixation
1559908|NCT00537927|postoperative pain|postoperative pain
1559909|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
1559910|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
1559911|NCT00537862|Kidney Transplant Patients|kidney transplant patients
1559912|NCT00537862|Immunosuppresion|immunosuppresion
1559913|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
1559914|NCT00537836|Hot flushes|hot flushes
1559915|NCT00537836|Therapy of hot flushes|therapy of hot flushes
1559916|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
1559917|NCT00537836|Hormone replacement therapy|hormone replacement therapy
1559918|NCT00537823|Colorectal Cancer|colorectal cancer
1559920|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
1559921|NCT00537810|Obesity|obesity
1559922|NCT00537810|Binge eating|binge eating
1559923|NCT00537810|Sibutramine|sibutramine
1559924|NCT00537810|Self-help|self-help
1559925|NCT00537810|Primary care|primary care
1559926|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
1559927|NCT00537797|Positron Emission Tomography|positron emission tomography
1559928|NCT00537797|18FDG|18fdg
1559929|NCT00537784|platelets tendon ligament|platelets tendon ligament
1559930|NCT00537771|Early Breast cancer|early breast cancer
1559931|NCT00537771|adjuvant therapy|adjuvant therapy
1559932|NCT00537771|hormone receptor|hormone receptor
1559933|NCT00537771|hormonal therapy|hormonal therapy
1559934|NCT00537771|anastrozole|anastrozole
1559935|NCT00537771|tamoxifen|tamoxifen
1559936|NCT00537758|binge eating disorder|binge eating disorder
1559937|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
1559938|NCT00537758|combination therapy|combination therapy
1559939|NCT00537758|obesity|obesity
1559940|NCT00537758|weight loss|weight loss
1559941|NCT00537758|body weight|body weight
1559942|NCT00537758|clinical trial|clinical trial
1559945|NCT00537758|weight control|weight control
1559946|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
1559947|NCT00537719|healthy|healthy
1559948|NCT00537719|pharmacodynamics|pharmacodynamics
1559949|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
1559950|NCT00537719|pharmacokinetics|pharmacokinetics
1559951|NCT00537719|scintigraphy|scintigraphy
1559952|NCT00537719|radiation|radiation
1559953|NCT00537719|albiglutide|albiglutide
1559954|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
1559955|NCT00537706|Health Status|health status
1559956|NCT00537706|Low-income|low-income
1559957|NCT00537706|Priority-setting|priority-setting
1559958|NCT00537706|Group Discussion|group discussion
1559959|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
1559960|NCT00537693|Sepsis|sepsis
1559961|NCT00537693|Convection|convection
1559962|NCT00537693|Diffusion|diffusion
1559963|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
1559964|NCT00537680|Idebenone|idebenone
1559965|NCT00537680|ICARS|icars
1559966|NCT00537667|IL-1ra|il-1ra
1559967|NCT00537667|PEG sTNF-RI|peg stnf-ri
1559968|NCT00537667|Synovial biopsy|synovial biopsy
1559969|NCT00537667|Inflammation|inflammation
1559970|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
1559971|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
1559972|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
1559973|NCT00537654|AVODART,|avodart,
1559974|NCT00537654|FLOMAX|flomax
1559975|NCT00537641|noninvasive ventilation|noninvasive ventilation
1559976|NCT00537602|cystic fibrosis|cystic fibrosis
1559977|NCT00537602|miglustat|miglustat
1559978|NCT00537602|Zavesca|zavesca
1559979|NCT00537602|Actelion|actelion
1559980|NCT00537602|nasal potential difference|nasal potential difference
1559981|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
1559982|NCT00537589|arthrocentesis|arthrocentesis
1559983|NCT00537589|ultrasound|ultrasound
1559984|NCT00537589|emergency|emergency
1559985|NCT00537550|ALL|all
1559986|NCT00537550|Adult|adult
1559987|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
1559988|NCT00537524|Bird flu|bird flu
1559989|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
1559990|NCT00537524|influenza vaccine|influenza vaccine
1559991|NCT00537524|prepandemic vaccine|prepandemic vaccine
1559992|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
1559993|NCT00537524|toddlers|toddlers
1559994|NCT00537524|children|children
1559995|NCT00537524|adolescents|adolescents
1559996|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
1559997|NCT00537485|SPM 962|spm 962
1559998|NCT00537485|rotigotine|rotigotine
1559999|NCT00537485|Parkinson's disease|parkinson's disease
1560000|NCT00537485|monotherapy|monotherapy
1560001|NCT00537472|Bupivacaine|bupivacaine
1560002|NCT00537472|spinal anesthesia|spinal anesthesia
1560003|NCT00537472|total knee arthroplasty|total knee arthroplasty
1560004|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
1560005|NCT00537446|noninvasive ventilation|noninvasive ventilation
1560006|NCT00537433|Medication errors|medication errors
1560007|NCT00537433|Patient nonadherence|patient nonadherence
1560008|NCT00537433|Literacy|literacy
1560009|NCT00537433|Communication|communication
1560010|NCT00537420|weight loss|weight loss
1560011|NCT00537420|dieting|dieting
1560012|NCT00537407|Hepatitis|hepatitis
1560013|NCT00537407|Hepatitis C|hepatitis c
1560014|NCT00537394|Treatment Experienced|treatment experienced
1560015|NCT00537381|Prostatic neoplasms|prostatic neoplasms
1560016|NCT00537381|CNTO 95|cnto 95
1560017|NCT00537381|Intetumumab|intetumumab
1560018|NCT00537381|Docetaxel|docetaxel
1560019|NCT00537381|Prednisone|prednisone
1560020|NCT00537368|infusion|infusion
1560021|NCT00537368|CNTO 888|cnto 888
1560026|NCT00537355|ragweed allergy|ragweed allergy
1560027|NCT00537355|allergy|allergy
1560028|NCT00537355|allergies|allergies
1560029|NCT00537355|allergic|allergic
1560030|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
1560031|NCT00537355|allergic rhinitis|allergic rhinitis
1560032|NCT00537342|Immunotherapy|immunotherapy
1560033|NCT00537342|Allergoid|allergoid
1560034|NCT00537342|Depigmented|depigmented
1560035|NCT00537342|Polymerized|polymerized
1560036|NCT00537342|Allergen-extract|allergen-extract
1560037|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
1560038|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
1560039|NCT00537264|health-related quality of life|health-related quality of life
1560040|NCT00537264|primary care|primary care
1560041|NCT00537264|computer-assisted instruction|computer-assisted instruction
1560042|NCT00537238|Epilepsies partial|epilepsies partial
1560043|NCT00537238|Partial Seizure Disorder|partial seizure disorder
1560044|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
1560046|NCT00537225|peripheral arterial disease|peripheral arterial disease
1560047|NCT00537225|walking time|walking time
1560048|NCT00537225|lifestyle modification|lifestyle modification
1560049|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
1560050|NCT00537225|exercise|exercise
1560051|NCT00537225|diet|diet
1560052|NCT00537225|claudication|claudication
1560053|NCT00537212|Psoriasis|psoriasis
1560054|NCT00537212|Weight loss|weight loss
1560055|NCT00537212|diet|diet
1560056|NCT00537199|Head And Neck|head and neck
1560057|NCT00537199|Oropharynx|oropharynx
1560058|NCT00537199|Oral Cancer|oral cancer
1560059|NCT00537199|OraTest|oratest
1560060|NCT00537199|OraTest Dye|oratest dye
1560061|NCT00537199|Rinse Staining Procedure|rinse staining procedure
1560062|NCT00537199|Visual Examination|visual examination
1560063|NCT00537186|Congestive heart failure|congestive heart failure
1560064|NCT00537186|Anaemia|anaemia
1560065|NCT00537186|Iron oligosaccharide|iron oligosaccharide
1560066|NCT00537160|Pediatrics|pediatrics
1560067|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
1560068|NCT00537147|West Nile Virus|west nile virus
1560069|NCT00537147|Dengue Virus|dengue virus
1560070|NCT00537134|Aneurysm|aneurysm
1560071|NCT00537134|Brain|brain
1560072|NCT00537134|Unruptured|unruptured
1560073|NCT00537134|observation|observation
1560074|NCT00537134|treatment|treatment
1560075|NCT00537134|Endovascular|endovascular
1560076|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
1560077|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
1560078|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
1560079|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
1560080|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1560081|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1560082|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1560083|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1560084|NCT00537121|stage III gastric cancer|stage iii gastric cancer
1560198|NCT00536783|Open Label|open label
1560085|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
1560086|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
1560087|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1560088|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1560089|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
1560090|NCT00537095|follicular|follicular
1560091|NCT00537095|papillary|papillary
1560092|NCT00537082|FTY720,|fty720,
1560093|NCT00537082|MS|ms
1560094|NCT00537043|hypertension,|hypertension,
1560095|NCT00537043|carvedilol,|carvedilol,
1560096|NCT00537043|repeat-dosing|repeat-dosing
1560097|NCT00537004|primary progressive aphasia|primary progressive aphasia
1560098|NCT00537004|frontotemporal dementia|frontotemporal dementia
1560099|NCT00537004|semantic dementia|semantic dementia
1560100|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
1560101|NCT00537004|progressive aphasia|progressive aphasia
1560102|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
1560103|NCT00536978|Lymphoma|lymphoma
1560104|NCT00536978|Leukemia|leukemia
1560105|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
1560106|NCT00536978|CLL|cll
1560107|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
1560108|NCT00536978|Follicular Lymphoma|follicular lymphoma
1560109|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
1560110|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
1560111|NCT00536978|Splenic Lymphoma|splenic lymphoma
1560112|NCT00536978|MALT|malt
1560113|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
1560114|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
1560115|NCT00536978|ARA-C|ara-c
1560116|NCT00536978|BCNU|bcnu
1560117|NCT00536978|Campath-1H|campath-1h
1560118|NCT00536978|Cytoxan|cytoxan
1560119|NCT00536978|Etoposide|etoposide
1560120|NCT00536978|Fludarabine|fludarabine
1560121|NCT00536978|Melphalan|melphalan
1560122|NCT00536978|Rituximab|rituximab
1560697|NCT00534586|SSEP|ssep
1560123|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1560124|NCT00536978|T-Cell Cell Adback|t-cell cell adback
1560125|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
1560126|NCT00536965|Hyperlipidemia|hyperlipidemia
1560127|NCT00536965|Need-to-treat|need-to-treat
1560128|NCT00536965|NIS|nis
1560129|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
1560130|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1560131|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1560132|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1560133|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1560134|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1560522|NCT00535392|Levetiracetam|levetiracetam
1560135|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1560136|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1560137|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1560138|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1560139|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1560140|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1560141|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1560142|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1560143|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1560144|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1560145|NCT00536926|telemedicine|telemedicine
1560146|NCT00536926|lung transplantation|lung transplantation
1560147|NCT00536926|home spirometry|home spirometry
1560148|NCT00536913|Symbicort pMDI|symbicort pmdi
1560149|NCT00536913|spacer|spacer
1560150|NCT00536913|children|children
1560151|NCT00536900|Substance abuse|substance abuse
1560152|NCT00536900|Behavior therapy|behavior therapy
1560153|NCT00536900|representative payee|representative payee
1560154|NCT00536900|cocaine abuse|cocaine abuse
1560155|NCT00536900|alcohol abuse|alcohol abuse
1560156|NCT00536900|case management|case management
1560157|NCT00536900|dual diagnosis|dual diagnosis
1560158|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1560159|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
1560160|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
1560161|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
1560162|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
1560163|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
1560164|NCT00536861|erlotinib|erlotinib
1560165|NCT00536861|cranial radiotherapy|cranial radiotherapy
1560166|NCT00536848|Probiotics|probiotics
1560167|NCT00536848|HIV|hiv
1560168|NCT00536848|AIDS|aids
1560169|NCT00536848|Diarrhea|diarrhea
1560170|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
1560171|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
1560172|NCT00536848|Immune system|immune system
1560173|NCT00536848|Infectious Diseases|infectious diseases
1560174|NCT00536848|Complementary Therapies|complementary therapies
1560175|NCT00536848|Treatment Naive|treatment naive
1560176|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1560177|NCT00536835|Cancer|cancer
1560178|NCT00536835|First time in human|first time in human
1560179|NCT00536835|PLK1 inhibitor|plk1 inhibitor
1560180|NCT00536835|Advanced Solid Tumor|advanced solid tumor
1560181|NCT00536835|GSK461364|gsk461364
1560182|NCT00536822|rehabilitation|rehabilitation
1560183|NCT00536822|pediatrics|pediatrics
1560184|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
1560185|NCT00536809|oxaliplatin|oxaliplatin
1560186|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
1560187|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
1560188|NCT00536809|capecitabine|capecitabine
1560189|NCT00536809|lapatinib|lapatinib
1560190|NCT00536796|Hyperlipidemia|hyperlipidemia
1560191|NCT00536796|Need-to-treat|need-to-treat
1560192|NCT00536796|NIS|nis
1560193|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
1560194|NCT00536783|Psychiatry|psychiatry
1560195|NCT00536783|Antipsychotic|antipsychotic
1560196|NCT00536783|Psychopharmacology|psychopharmacology
1560197|NCT00536783|Clinical Trial|clinical trial
1560199|NCT00536783|Schizophrenia|schizophrenia
1560200|NCT00536783|Sensory Gating|sensory gating
1560201|NCT00536783|Attention|attention
1560202|NCT00536783|Memory|memory
1560203|NCT00536731|Asthma|asthma
1560204|NCT00536731|Symbicort|symbicort
1560205|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
1560206|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1560207|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1560208|NCT00536705|asthma|asthma
1560209|NCT00536705|child|child
1560210|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
1560211|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
1560212|NCT00536692|macular edema|macular edema
1560213|NCT00536692|DME|dme
1560214|NCT00536692|diabetic|diabetic
1560215|NCT00536692|mecamylamine|mecamylamine
1560216|NCT00536692|Comentis|comentis
1560217|NCT00536679|Relative Bioavailability|relative bioavailability
1560218|NCT00536679|Randomised|randomised
1560219|NCT00536679|GSK163090|gsk163090
1560220|NCT00536679|Food Effect|food effect
1560221|NCT00536666|Chronic kidney disease|chronic kidney disease
1560222|NCT00536666|Aneamia|aneamia
1560223|NCT00536666|Iron oligosaccharide|iron oligosaccharide
1560224|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
1560225|NCT00536653|prostate cancer|prostate cancer
1560226|NCT00536653|bone density|bone density
1560227|NCT00536653|osteoporosis|osteoporosis
1560228|NCT00536653|androgen antagonists|androgen antagonists
1560229|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
1560230|NCT00536627|DNA vaccine|dna vaccine
1560231|NCT00536614|pancreatic cancer|pancreatic cancer
1560232|NCT00536614|metastatic|metastatic
1560233|NCT00536614|EGFR|egfr
1560234|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
1560235|NCT00536575|Multiple Myeloma|multiple myeloma
1560236|NCT00536575|Relapsed|relapsed
1560237|NCT00536575|Refractory|refractory
1560238|NCT00536575|Sorafenib|sorafenib
1560239|NCT00536575|Bortezomib|bortezomib
1560240|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
1560241|NCT00536562|Randomized Controlled Trial|randomized controlled trial
1560242|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
1560243|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
1560244|NCT00536562|Vascular Protection|vascular protection
1560245|NCT00536549|Glucose monitoring system|glucose monitoring system
1560246|NCT00536549|life style intervention|life style intervention
1560247|NCT00536536|Childhood|childhood
1560248|NCT00536536|Obesity|obesity
1560249|NCT00536536|Primary Care|primary care
1560250|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1560251|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
1560252|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
1560253|NCT00536523|fallopian tube cancer|fallopian tube cancer
1560254|NCT00536510|High Cholesterol|high cholesterol
1560255|NCT00536510|Excess lipids|excess lipids
1560256|NCT00536497|GW842166,|gw842166,
1560257|NCT00536497|Healthy volunteers,|healthy volunteers,
1560258|NCT00536497|Inflammatory Pain.|inflammatory pain.
1560259|NCT00536484|Overactive Bladder|overactive bladder
1560260|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
1560261|NCT00536458|Chemotherapy|chemotherapy
1560262|NCT00536458|Radiotherapy|radiotherapy
1560263|NCT00536458|Molecular analyses|molecular analyses
1560264|NCT00536458|primary|primary
1560265|NCT00536445|NAVA|nava
1560266|NCT00536445|Preterm|preterm
1560267|NCT00536445|Case study|case study
1560268|NCT00536406|Geriatric|geriatric
1560269|NCT00536406|Nursing Homes|nursing homes
1560270|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
1560271|NCT00536393|chemotherapy|chemotherapy
1560272|NCT00536393|toxicity|toxicity
1560273|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
1560274|NCT00536367|Heart Failure, Congestive|heart failure, congestive
1560275|NCT00536367|Mortality Prediction Model|mortality prediction model
1560276|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1560277|NCT00536341|untreated|untreated
1560278|NCT00536341|minimally treated|minimally treated
1560279|NCT00536341|fludarabine|fludarabine
1560280|NCT00536341|rituximab|rituximab
1560281|NCT00536341|lenalidomide|lenalidomide
1560282|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
1560283|NCT00536328|predictive value|predictive value
1560284|NCT00536328|treatment success|treatment success
1560285|NCT00536328|patient satisfaction|patient satisfaction
1560286|NCT00536328|proton pump inhibitor|proton pump inhibitor
1560287|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
1560288|NCT00536328|PPU|ppu
1560289|NCT00536315|COPD|copd
1560290|NCT00536302|OA|oa
1560291|NCT00536302|Knee arthritis|knee arthritis
1560292|NCT00536302|Osteoarthritis|osteoarthritis
1560293|NCT00536302|Nutritional supplement|nutritional supplement
1560294|NCT00536302|CAM|cam
1560295|NCT00536302|MRI|mri
1560296|NCT00536289|Blunt needles|blunt needles
1560297|NCT00536289|obstetric lacerations|obstetric lacerations
1560298|NCT00536289|Needlestick injuries|needlestick injuries
1560299|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
1560300|NCT00536276|vitamin D|vitamin d
1560301|NCT00536250|Pre-Diabetes|pre-diabetes
1560302|NCT00536250|Childhood Obesity|childhood obesity
1560303|NCT00536250|Metabolic Syndrome|metabolic syndrome
1560304|NCT00536250|insulin resistance|insulin resistance
1560305|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
1560306|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
1560307|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
1560308|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
1560309|NCT00536224|Health promotion|health promotion
1560310|NCT00536224|Emergency Medical Services|emergency medical services
1560311|NCT00536224|Randomized controlled trial|randomized controlled trial
1560312|NCT00536224|Chest pain observation unit|chest pain observation unit
1560313|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
1560314|NCT00536211|Exercise|exercise
1560315|NCT00536211|Physical Activity|physical activity
1560316|NCT00536211|Metformin|metformin
1560317|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
1560318|NCT00536211|Muscle Biopsy|muscle biopsy
1560319|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
1560320|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
1560321|NCT00536211|Detraining|detraining
1560322|NCT00536211|Inactivity|inactivity
1560323|NCT00536211|Skeletal muscle|skeletal muscle
1560324|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
1560325|NCT00536185|ALOX5|alox5
1560326|NCT00536185|5-lipoxygenase|5-lipoxygenase
1560327|NCT00536185|Heart Disease|heart disease
1560328|NCT00536185|Blacks|blacks
1560329|NCT00536172|Antidepressant|antidepressant
1560330|NCT00536172|Major depression|major depression
1560331|NCT00536172|Prevention|prevention
1560332|NCT00536172|Head and neck cancer|head and neck cancer
1560333|NCT00536159|nurse-community health worker team|nurse-community health worker team
1560334|NCT00536159|perinatal depression|perinatal depression
1560335|NCT00536159|stress|stress
1560336|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
1560337|NCT00536146|Glucocorticoid|glucocorticoid
1560338|NCT00536146|Steroids|steroids
1560339|NCT00536146|Dose-Responsive Curve|dose-responsive curve
1560340|NCT00536146|EC50|ec50
1560341|NCT00536146|Stress Response|stress response
1560342|NCT00536146|Alcoholism|alcoholism
1560343|NCT00536133|zinc|zinc
1560344|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
1560345|NCT00536120|MS|ms
1560346|NCT00536120|Multiple sclerosis|multiple sclerosis
1560347|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1560348|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
1560349|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
1560350|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
1560351|NCT00536094|Youth|youth
1560352|NCT00536094|School|school
1560353|NCT00536094|African American|african american
1560354|NCT00536081|Breast cancer|breast cancer
1560355|NCT00536081|Adjuvant|adjuvant
1560356|NCT00536081|Advanced|advanced
1560357|NCT00536081|Chemotherapy|chemotherapy
1560358|NCT00536081|G-CSF|g-csf
1560359|NCT00536081|Pegfilgrastim|pegfilgrastim
1560360|NCT00536081|Prevention|prevention
1560361|NCT00536081|Febrile neutropenia|febrile neutropenia
1560362|NCT00536068|platelet|platelet
1560363|NCT00536068|aggregation|aggregation
1560364|NCT00536068|aspirin|aspirin
1560365|NCT00536055|breast cancer|breast cancer
1560366|NCT00536055|prostate cancer|prostate cancer
1560367|NCT00536055|dyadic coping|dyadic coping
1560368|NCT00536042|minocycline|minocycline
1560369|NCT00536042|asthma|asthma
1560370|NCT00536042|oral steroids|oral steroids
1560371|NCT00536042|IgE|ige
1560372|NCT00536029|Melanoma|melanoma
1560373|NCT00536029|SIAscope|siascope
1560374|NCT00536029|pigmented skin lesions|pigmented skin lesions
1560375|NCT00536016|AMD|amd
1560376|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1560377|NCT00536003|preterm delivery|preterm delivery
1560378|NCT00536003|preterm labor|preterm labor
1560379|NCT00536003|perinatal morbidity|perinatal morbidity
1560380|NCT00536003|perinatal mortality|perinatal mortality
1560381|NCT00535990|Cholecystectomy|cholecystectomy
1560382|NCT00535990|Appendectomy|appendectomy
1560383|NCT00535990|Esophageal|esophageal
1560384|NCT00535990|Surgical|surgical
1560385|NCT00535990|Procedures|procedures
1560386|NCT00535990|Surgery|surgery
1560387|NCT00535990|Gastric|gastric
1560388|NCT00535990|bypass|bypass
1560389|NCT00535977|Gene expression|gene expression
1560390|NCT00535977|Prostate|prostate
1560391|NCT00535977|Broccoli|broccoli
1560392|NCT00535977|Cancer|cancer
1560393|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
1560394|NCT00535964|Cigarette Smoking|cigarette smoking
1560395|NCT00535964|Tobacco Use|tobacco use
1560396|NCT00535964|Adolescents|adolescents
1560397|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
1560398|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
1560399|NCT00535951|NSCLC|nsclc
1560400|NCT00535951|lung cancer|lung cancer
1560401|NCT00535951|pleural mesothelioma|pleural mesothelioma
1560402|NCT00535951|malignant|malignant
1560403|NCT00535951|advanced stage|advanced stage
1560404|NCT00535951|mesothelioma|mesothelioma
1560405|NCT00535951|phase I|phase i
1560406|NCT00535951|LBH589|lbh589
1560407|NCT00535951|dextromethorphan|dextromethorphan
1560408|NCT00535951|CYP2D6|cyp2d6
1560409|NCT00535951|oral|oral
1560410|NCT00535925|type 2 diabetes|type 2 diabetes
1560411|NCT00535925|nephropathy|nephropathy
1560412|NCT00535925|CV events|cv events
1560413|NCT00535912|CLL|cll
1560414|NCT00535899|Aortic stenosis|aortic stenosis
1560415|NCT00535899|Speckle tracking imaging|speckle tracking imaging
1560416|NCT00535899|Low ejection fraction|low ejection fraction
1560417|NCT00535899|Aortic valve replacement|aortic valve replacement
1560418|NCT00535899|Strain|strain
1560419|NCT00535886|Trans Fatty Acids|trans fatty acids
1560420|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
1560421|NCT00535886|vaccenic acid|vaccenic acid
1560422|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
1560523|NCT00535392|Keppra®|keppra®
1560423|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
1560424|NCT00535886|Beef|beef
1560425|NCT00535873|Leukemia|leukemia
1560426|NCT00535873|CLL|cll
1560427|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1560428|NCT00535873|SLL|sll
1560429|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
1560430|NCT00535873|Untreated CLL|untreated cll
1560431|NCT00535873|Lenalidomide|lenalidomide
1560432|NCT00535873|CC-5013|cc-5013
1560433|NCT00535873|Revlimid|revlimid
1560434|NCT00535873|Oral|oral
1560435|NCT00535860|Osteoporosis|osteoporosis
1560436|NCT00535860|Transdermal|transdermal
1560437|NCT00535860|hPTH(1-34)|hpth(1-34)
1560438|NCT00535847|Genotype 1|genotype 1
1560439|NCT00535834|stage I prostate cancer|stage i prostate cancer
1560440|NCT00535834|stage II prostate cancer|stage ii prostate cancer
1560441|NCT00535834|stage III prostate cancer|stage iii prostate cancer
1560442|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1560443|NCT00535821|Emergency Department|emergency department
1560444|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
1560445|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
1560446|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
1560447|NCT00535769|topical|topical
1560448|NCT00535769|medication adherence|medication adherence
1560449|NCT00535769|adherence|adherence
1560450|NCT00535769|compliance|compliance
1560451|NCT00535769|medication compliance|medication compliance
1560452|NCT00535769|sunscreen|sunscreen
1560453|NCT00535769|reminder|reminder
1560454|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
1560455|NCT00535717|Urethral stricture|urethral stricture
1560456|NCT00535717|Ayurvedic treatment|ayurvedic treatment
1560457|NCT00535717|mutra marg sankoch|mutra marg sankoch
1560458|NCT00535717|uttarbasti|uttarbasti
1560459|NCT00535717|Sesame oil|sesame oil
1560460|NCT00535717|Honey|honey
1560461|NCT00535717|Rock salt|rock salt
1560462|NCT00535678|Mammography|mammography
1560463|NCT00535678|mammogram|mammogram
1560464|NCT00535678|breast|breast
1560465|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
1560466|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
1560467|NCT00535600|Bariatric Surgery|bariatric surgery
1560468|NCT00535600|Insulin Action|insulin action
1560469|NCT00535600|Insulin Secretion|insulin secretion
1560470|NCT00535600|Insulin Resistance|insulin resistance
1560471|NCT00535600|Gut Hormones|gut hormones
1560472|NCT00535600|Obesity|obesity
1560473|NCT00535587|Fibromyalgia|fibromyalgia
1560474|NCT00535587|Exercise|exercise
1560475|NCT00535587|Mestinon|mestinon
1560476|NCT00535574|retinoids|retinoids
1560477|NCT00535574|bexarotene|bexarotene
1560478|NCT00535574|schizophrenia|schizophrenia
1560479|NCT00535574|PANSS|panss
1560480|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
1560481|NCT00535561|iron deficiency anemia|iron deficiency anemia
1560482|NCT00535561|anemia|anemia
1560483|NCT00535561|hypothyroidism|hypothyroidism
1560484|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
1560485|NCT00535548|Chronic wounds|chronic wounds
1560486|NCT00535548|Pressure sores|pressure sores
1560487|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
1560488|NCT00535548|Wound healing|wound healing
1560489|NCT00535535|Elevated triglycerides|elevated triglycerides
1560490|NCT00535535|Diabetes|diabetes
1560491|NCT00535535|Cardiovascular disease|cardiovascular disease
1560492|NCT00535522|Pharmacokinetics|pharmacokinetics
1560493|NCT00535522|pharmacodynamics|pharmacodynamics
1560494|NCT00535522|maximal tolerated dose|maximal tolerated dose
1560495|NCT00535483|blood microdialysis|blood microdialysis
1560496|NCT00535483|glucose monitoring|glucose monitoring
1560497|NCT00535483|glucose control|glucose control
1560498|NCT00535483|automated blood sampling|automated blood sampling
1560499|NCT00535483|online-sensor|online-sensor
1560501|NCT00535483|type 1 diabetes|type 1 diabetes
1560502|NCT00535457|anxiety|anxiety
1560503|NCT00535457|maladaptive behavior|maladaptive behavior
1560504|NCT00535457|anesthesia|anesthesia
1560505|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
1560506|NCT00535444|Hypertension|hypertension
1560507|NCT00535444|parish nurse|parish nurse
1560508|NCT00535431|Asthma|asthma
1560509|NCT00535431|allergy|allergy
1560510|NCT00535431|interleukin-4|interleukin-4
1560511|NCT00535431|interleukin-13|interleukin-13
1560512|NCT00535431|IL-4|il-4
1560513|NCT00535431|IL-13|il-13
1560514|NCT00535418|Breast cancer|breast cancer
1560515|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
1560516|NCT00535418|treatment duration|treatment duration
1560517|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
1560518|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
1560519|NCT00535405|High Cholesterol|high cholesterol
1560520|NCT00535392|Epilepsy|epilepsy
1560521|NCT00535392|Child|child
1560525|NCT00535392|Intravenous|intravenous
1560526|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
1560527|NCT00535379|sunitinib|sunitinib
1560528|NCT00535379|recurrent|recurrent
1560529|NCT00535379|progressive|progressive
1560530|NCT00535353|recurrent colon cancer|recurrent colon cancer
1560531|NCT00535353|stage IV colon cancer|stage iv colon cancer
1560532|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
1560533|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
1560534|NCT00535353|stage III rectal cancer|stage iii rectal cancer
1560535|NCT00535353|stage III colon cancer|stage iii colon cancer
1560536|NCT00535340|Anxiety|anxiety
1560537|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
1560538|NCT00535327|Mammography|mammography
1560539|NCT00535327|mammogram|mammogram
1560540|NCT00535327|breast|breast
1560541|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
1560542|NCT00535314|Melanoma|melanoma
1560543|NCT00535301|cystocele|cystocele
1560544|NCT00535301|uterine prolapse|uterine prolapse
1560545|NCT00535301|urinary incontinence|urinary incontinence
1560546|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
1560547|NCT00535262|Bipolar|bipolar
1560548|NCT00535262|depression|depression
1560549|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
1560550|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
1560551|NCT00535223|Group therapy|group therapy
1560552|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
1560553|NCT00535223|Randomized Controlled Trial|randomized controlled trial
1560554|NCT00535223|Treatment outcome|treatment outcome
1560555|NCT00535223|Veterans|veterans
1560556|NCT00535223|War|war
1560557|NCT00535210|spinal cord injury|spinal cord injury
1560558|NCT00535210|exercise rehabilitation|exercise rehabilitation
1560559|NCT00535210|inpatient|inpatient
1560560|NCT00535210|RCT|rct
1560561|NCT00535210|physical function|physical function
1560562|NCT00535184|Mammography|mammography
1560563|NCT00535184|mammogram|mammogram
1560564|NCT00535184|breast|breast
1560565|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
1560566|NCT00535158|Chronic Kidney disease|chronic kidney disease
1560567|NCT00535158|Dialysis|dialysis
1560568|NCT00535158|Vitamin D|vitamin d
1560569|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
1560570|NCT00535145|antipsychotic|antipsychotic
1560571|NCT00535145|paliperidone ER|paliperidone er
1560572|NCT00535145|liver disease|liver disease
1560573|NCT00535145|Schizophrenia|schizophrenia
1560574|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
1560575|NCT00535145|Invega|invega
1560576|NCT00535132|schizophrenia|schizophrenia
1560577|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
1560578|NCT00535106|Ventricular fibrillation|ventricular fibrillation
1560579|NCT00535106|Cardiac arrest|cardiac arrest
1560580|NCT00535106|Automated external defibrillator|automated external defibrillator
1560581|NCT00535106|AED|aed
1560582|NCT00535106|Waveform based algorithms|waveform based algorithms
1560583|NCT00535106|VF waveform analysis|vf waveform analysis
1560584|NCT00535093|Pharyngitis|pharyngitis
1560585|NCT00535093|Community infections|community infections
1560586|NCT00535093|Rapid Testing|rapid testing
1560587|NCT00535093|Group A Streptococcus|group a streptococcus
1560588|NCT00535080|actinic|actinic
1560589|NCT00535080|keratoses|keratoses
1560590|NCT00535080|superficial|superficial
1560591|NCT00535080|basal|basal
1560592|NCT00535080|carcinomas|carcinomas
1560593|NCT00535080|Bowen's|bowen's
1560594|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
1560595|NCT00535067|Breast Cancer|breast cancer
1560596|NCT00535067|Questionnaire|questionnaire
1560597|NCT00535067|Survey|survey
1560598|NCT00535067|Neuropathic Pain|neuropathic pain
1560599|NCT00535067|Cancer Survivors|cancer survivors
1560600|NCT00535067|Quality of Life|quality of life
1560601|NCT00535067|QOL|qol
1560602|NCT00535054|Dry Eye Syndrome|dry eye syndrome
1560603|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
1560604|NCT00535028|asthma|asthma
1560605|NCT00535028|allergy|allergy
1560606|NCT00535028|interleukin-4|interleukin-4
1560607|NCT00535028|interleukin-13|interleukin-13
1560608|NCT00535028|IL-4|il-4
1560609|NCT00535028|IL-13|il-13
1560610|NCT00535028|atopic|atopic
1560611|NCT00535028|late asthmatic response|late asthmatic response
1560612|NCT00535028|inflammation|inflammation
1560613|NCT00535002|Cocaine Addiction|cocaine addiction
1560614|NCT00535002|Cocaine Dependence|cocaine dependence
1560615|NCT00534989|NHL and HD|nhl and hd
1560616|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
1560617|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
1560618|NCT00534937|Venous stasis ulcer|venous stasis ulcer
1560619|NCT00534937|Compression pump|compression pump
1560620|NCT00534937|Randomized trial|randomized trial
1560621|NCT00534937|Flexitouch compression|flexitouch compression
1560622|NCT00534924|IR injury|ir injury
1560623|NCT00534924|MRI|mri
1560624|NCT00534924|Vitamin C|vitamin c
1560625|NCT00534924|Postconditioning|postconditioning
1560626|NCT00534911|Depression|depression
1560627|NCT00534911|Physical Illness|physical illness
1560628|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
1560629|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
1560630|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
1560631|NCT00534885|Healive|healive
1560632|NCT00534885|safety|safety
1560633|NCT00534885|immunogenicity|immunogenicity
1560634|NCT00534885|immune persistence|immune persistence
1560635|NCT00534872|4 Parallel cohorts|4 parallel cohorts
1560636|NCT00534872|Healthy Female|healthy female
1560637|NCT00534872|Healthy Elderly|healthy elderly
1560638|NCT00534872|Pharmacokinetic|pharmacokinetic
1560639|NCT00534872|Safety and Tolerability|safety and tolerability
1560640|NCT00534846|premenstrual syndrome|premenstrual syndrome
1560641|NCT00534846|mastalgia|mastalgia
1560642|NCT00534846|toremifene|toremifene
1560643|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
1560644|NCT00534833|Diphtheria|diphtheria
1560645|NCT00534833|Tetanus|tetanus
1560646|NCT00534833|Pertussis|pertussis
1560647|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
1560648|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
1560649|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
1560650|NCT00534781|Achilles|achilles
1560651|NCT00534781|Tendinosis|tendinosis
1560652|NCT00534781|Tendinitis|tendinitis
1560653|NCT00534781|Achilles Tendinosis|achilles tendinosis
1560654|NCT00534781|Achilles Tendinitis|achilles tendinitis
1560655|NCT00534781|Coblation|coblation
1560656|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
1560657|NCT00534781|Surgical Debridement|surgical debridement
1560658|NCT00534781|Debridement|debridement
1560659|NCT00534781|Heel Pain|heel pain
1560660|NCT00534781|Achilles Pain|achilles pain
1560661|NCT00534742|Siblings|siblings
1560662|NCT00534729|Organ Preservation|organ preservation
1560663|NCT00534729|Carboplatin|carboplatin
1560664|NCT00534729|Taxol|taxol
1560665|NCT00534729|RT|rt
1560666|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
1560667|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
1560668|NCT00534716|Cannabis|cannabis
1560669|NCT00534716|doping|doping
1560670|NCT00534716|THC|thc
1560671|NCT00534716|GC/MS|gc/ms
1560672|NCT00534716|Pharmacokinetics|pharmacokinetics
1560673|NCT00534716|Volunteers|volunteers
1560674|NCT00534690|Pulmonary disease|pulmonary disease
1560675|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
1560676|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
1560677|NCT00534677|Variceal bleed|variceal bleed
1560678|NCT00534677|Cirrhosis|cirrhosis
1560679|NCT00534677|Vasoactive agents|vasoactive agents
1560680|NCT00534677|Terlipressin|terlipressin
1560681|NCT00534677|Octreotide|octreotide
1560682|NCT00534677|Safety & Efficacy|safety & efficacy
1560683|NCT00534638|HPV vaccine|hpv vaccine
1560684|NCT00534638|Healthy adolescents|healthy adolescents
1560685|NCT00534638|Cervical cancer|cervical cancer
1560686|NCT00534638|Safety|safety
1560687|NCT00534638|Immunogenicity|immunogenicity
1560688|NCT00534638|Cervarix|cervarix
1560689|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
1560690|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
1560691|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
1560692|NCT00534599|anxiety|anxiety
1560693|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
1560694|NCT00534599|anxiety disorder|anxiety disorder
1560695|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
1560696|NCT00534586|Pain|pain
1560698|NCT00534586|CHEPS|cheps
1560699|NCT00534586|Propofol|propofol
1560700|NCT00534586|Sevoflurane|sevoflurane
1560701|NCT00534586|S-Ketamine|s-ketamine
1560702|NCT00534586|Remifentanil|remifentanil
1560703|NCT00534586|Healthy volunteers|healthy volunteers
1560704|NCT00534534|Pancreatitis|pancreatitis
1560705|NCT00534534|acute|acute
1560706|NCT00534534|alcoholic|alcoholic
1560707|NCT00534534|recurrence|recurrence
1560708|NCT00534534|alcoholism|alcoholism
1560709|NCT00534534|treatment|treatment
1560710|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
1560711|NCT00534521|overactive bladder|overactive bladder
1560712|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
1560713|NCT00534508|Skin|skin
1560714|NCT00534508|Pharmacokinetics|pharmacokinetics
1560715|NCT00534508|Tacrolimus|tacrolimus
1560716|NCT00534508|dermatitis, atopic|dermatitis, atopic
1560717|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
1560718|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
1560719|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
1560720|NCT00534482|fitness|fitness
1560721|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1560722|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1560723|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1560724|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1560725|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1560726|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
1560727|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1560728|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1560729|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1560730|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1560731|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1560732|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1560733|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1560734|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1560735|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1560736|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1560737|NCT00534456|exploratory study|exploratory study
1560738|NCT00534456|anemia|anemia
1560739|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
1560740|NCT00534456|biomarkers|biomarkers
1560741|NCT00534456|echocardiography|echocardiography
1560742|NCT00534443|peptic ulcer|peptic ulcer
1560743|NCT00534443|gastritis|gastritis
1560744|NCT00534443|sTREM-1|strem-1
1560745|NCT00534443|cytokines|cytokines
1560746|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
1560747|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
1560748|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1560749|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1560750|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1560751|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1560752|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1560753|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1560754|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1560755|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1560756|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1560757|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1560758|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1560759|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1560760|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
1560761|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1560762|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1560763|NCT00534417|Hormone|hormone
1560764|NCT00534417|Receptor|receptor
1560765|NCT00534417|Positive|positive
1560766|NCT00534417|Metastatic|metastatic
1560767|NCT00534417|Breast|breast
1560768|NCT00534417|Cancer|cancer
1560769|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
1560770|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
1560771|NCT00534404|Nicotine Patches|nicotine patches
1560772|NCT00534404|Telephone Counseling|telephone counseling
1560773|NCT00534404|Smoking Abstinence|smoking abstinence
1560774|NCT00534391|Antibiotics|antibiotics
1560775|NCT00534391|hordeolum|hordeolum
1560776|NCT00534378|Nerve agent|nerve agent
1560777|NCT00534378|Midazolam|midazolam
1560778|NCT00534378|Seizures|seizures
1560779|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
1560780|NCT00534365|stress urinary incontinence|stress urinary incontinence
1560781|NCT00534365|sling procedures|sling procedures
1560782|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
1560784|NCT00534352|AIDS|aids
1560785|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
1560786|NCT00534352|PREZISTA|prezista
1560787|NCT00534352|darunavir|darunavir
1560788|NCT00534352|TMC114|tmc114
1560789|NCT00534352|TMC125|tmc125
1560790|NCT00534352|Protease Inhibitor|protease inhibitor
1560791|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
1560792|NCT00534352|Truvada|truvada
1560793|NCT00534352|Treatment Naive|treatment naive
1560794|NCT00534300|ICD-pacemaker|icd-pacemaker
1560795|NCT00534287|sepsis|sepsis
1560796|NCT00534287|antibiotics|antibiotics
1560797|NCT00534287|carbapenems|carbapenems
1560798|NCT00534287|fluoroquinolones|fluoroquinolones
1560799|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
1560800|NCT00534274|stage II breast cancer|stage ii breast cancer
1560801|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
1560802|NCT00534261|Multiple Sclerosis|multiple sclerosis
1560803|NCT00534261|Avonex|avonex
1560804|NCT00534261|Interferon beta-1a|interferon beta-1a
1560805|NCT00534222|Patients with a manic episode|patients with a manic episode
1560908|NCT00533988|Catheter-related infection|catheter-related infection
1560909|NCT00533988|Insertion site|insertion site
1560806|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
1560807|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1560808|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1560809|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
1560810|NCT00534196|stage I prostate cancer|stage i prostate cancer
1560811|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
1560812|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
1560813|NCT00534196|stage III prostate cancer|stage iii prostate cancer
1560814|NCT00534183|Metabolic syndrome|metabolic syndrome
1560815|NCT00534183|Obesity|obesity
1560816|NCT00534183|Diabetes|diabetes
1560817|NCT00534170|Probiotic|probiotic
1560818|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
1560819|NCT00534170|Nutritional status|nutritional status
1560820|NCT00534157|intracranial pressure|intracranial pressure
1560821|NCT00534157|intraocular pressure|intraocular pressure
1560822|NCT00534157|tonometry|tonometry
1560823|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1560824|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1560825|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1560826|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1560827|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1560828|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1560829|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1560830|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1560831|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1560832|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1560833|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1560834|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1560835|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1560836|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1560837|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
1560838|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
1560839|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
1560840|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
1560841|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1560842|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1560843|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1560844|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1560845|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1560846|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1560847|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1560848|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1560849|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1560850|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1560851|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1560852|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1560853|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1560854|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1560855|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1560856|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1560857|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1560858|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1560859|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1560860|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1560861|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1560862|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1560863|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1560864|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1560865|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1560866|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1560867|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1560868|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1560869|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1560870|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1560871|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1560872|NCT00534105|Pregnancy|pregnancy
1560873|NCT00534105|Gestational diabetes|gestational diabetes
1560874|NCT00534105|Hyperlipidemia|hyperlipidemia
1560875|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
1560876|NCT00534092|X STOP|x stop
1560877|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
1560878|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
1560879|NCT00534053|colon cancer screening|colon cancer screening
1560880|NCT00534053|mail reminders|mail reminders
1560881|NCT00534053|fecal occult blood test|fecal occult blood test
1560882|NCT00534053|compliance|compliance
1560883|NCT00534027|NSCLC|nsclc
1560884|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
1560885|NCT00534027|Paclitaxel|paclitaxel
1560886|NCT00534027|Carboplatin|carboplatin
1560887|NCT00534027|AMG 655|amg 655
1560888|NCT00534001|bladder cancer|bladder cancer
1560889|NCT00534001|cervical cancer|cervical cancer
1560890|NCT00534001|esophageal cancer|esophageal cancer
1560891|NCT00534001|gastric cancer|gastric cancer
1560892|NCT00534001|renal cell carcinoma|renal cell carcinoma
1560893|NCT00534001|adult primary liver cancer|adult primary liver cancer
1560894|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
1560895|NCT00534001|small cell lung cancer|small cell lung cancer
1560896|NCT00534001|pancreatic cancer|pancreatic cancer
1560897|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
1560898|NCT00534001|laryngeal cancer|laryngeal cancer
1560899|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
1560900|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
1560901|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
1560902|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1560903|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
1560904|NCT00534001|tobacco use disorder|tobacco use disorder
1560905|NCT00533988|Central venous catheters|central venous catheters
1560906|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
1560907|NCT00533988|Duration of catheter use|duration of catheter use
1560910|NCT00533988|Parenteral nutrition|parenteral nutrition
1560911|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
1560912|NCT00533975|Colon Cancer screening|colon cancer screening
1560913|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
1560914|NCT00533975|colonoscopy|colonoscopy
1560915|NCT00533975|diagnostic validity|diagnostic validity
1560916|NCT00533962|Glaucoma|glaucoma
1560917|NCT00533962|Anecortave Acetate|anecortave acetate
1560918|NCT00533962|Intraocular pressure|intraocular pressure
1560919|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
1560920|NCT00533949|radiation toxicity|radiation toxicity
1560921|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1560922|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1560923|NCT00533936|stage II breast cancer|stage ii breast cancer
1560924|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
1560925|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
1560926|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
1560927|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
1560928|NCT00533923|mini-transplant|mini-transplant
1560929|NCT00533923|AML|aml
1560930|NCT00533923|ALL|all
1560931|NCT00533923|CML|cml
1560932|NCT00533923|CLL|cll
1560933|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
1560934|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
1560935|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
1560936|NCT00533923|Aplastic anemia|aplastic anemia
1560937|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
1560938|NCT00533923|GM-CSF|gm-csf
1560939|NCT00533923|Cyclosporin|cyclosporin
1560940|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
1560941|NCT00533923|Cyclophosphamide|cyclophosphamide
1560942|NCT00533923|CAMPATH-1H|campath-1h
1560943|NCT00533923|GVHD|gvhd
1560944|NCT00533923|CMV|cmv
1560945|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
1560946|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
1560947|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
1560948|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
1560949|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
1561136|NCT00532844|6R-BH4|6r-bh4
1560950|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1560951|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1560952|NCT00533884|delirium|delirium
1560953|NCT00533884|cognitive/functional effects|cognitive/functional effects
1560954|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
1560955|NCT00533884|laryngeal cancer|laryngeal cancer
1560956|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
1560957|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1560958|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
1560959|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
1560960|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1560961|NCT00533884|salivary gland cancer|salivary gland cancer
1560962|NCT00533884|esophageal cancer|esophageal cancer
1560963|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
1560964|NCT00533884|small cell lung cancer|small cell lung cancer
1560965|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
1560966|NCT00533858|Systolic hypertension|systolic hypertension
1560967|NCT00533832|depression|depression
1560968|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
1560969|NCT00533819|Exercise intervention|exercise intervention
1560970|NCT00533819|Maths Scores|maths scores
1560971|NCT00533819|Blood pressure|blood pressure
1560972|NCT00533819|Female school children|female school children
1560973|NCT00533819|Body mass index|body mass index
1560974|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
1560975|NCT00533806|Active Control|active control
1560976|NCT00533806|Relaxation Therapy|relaxation therapy
1560977|NCT00533806|Young Children|young children
1560978|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
1560979|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
1560980|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
1560981|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
1560982|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
1560983|NCT00533715|Health|health
1560984|NCT00533702|Phase II|phase ii
1560985|NCT00533702|Melanoma|melanoma
1560986|NCT00533702|IMC-1121B|imc-1121b
1560987|NCT00533702|ImClone|imclone
1560988|NCT00533637|Allergic rhinitis|allergic rhinitis
1560989|NCT00533637|Nasal spray|nasal spray
1560990|NCT00533637|Anti-histamine|anti-histamine
1560991|NCT00533637|Tolerability|tolerability
1560992|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
1560993|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
1560994|NCT00533585|Lung Cancer|lung cancer
1560995|NCT00533585|NSCLC|nsclc
1560996|NCT00533585|malignant pleural effusions|malignant pleural effusions
1560997|NCT00533585|Sorafenib|sorafenib
1560998|NCT00533585|Paclitaxel|paclitaxel
1560999|NCT00533585|Taxol|taxol
1561000|NCT00533585|Carboplatin|carboplatin
1561001|NCT00533585|Paraplatin|paraplatin
1561002|NCT00533585|Bevacizumab|bevacizumab
1561003|NCT00533585|Avastin|avastin
1561004|NCT00533585|BAY 43-9006|bay 43-9006
1561005|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1561006|NCT00533585|rhuMAb-VEGF|rhumab-vegf
1561007|NCT00533559|type 2 diabetes|type 2 diabetes
1561008|NCT00533559|free fatty acids|free fatty acids
1561009|NCT00533559|insulin resistance|insulin resistance
1561010|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
1561011|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
1561012|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
1561013|NCT00533533|Phase I/II study|phase i/ii study
1561014|NCT00533533|Advanced gastric cancer|advanced gastric cancer
1561015|NCT00533533|First line treatment|first line treatment
1561016|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
1561017|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
1561018|NCT00533507|Pneumococcal disease|pneumococcal disease
1561019|NCT00533507|Safety|safety
1561020|NCT00533507|Immunogenicity|immunogenicity
1561021|NCT00533507|Primary vaccination|primary vaccination
1561022|NCT00533468|pain|pain
1561023|NCT00533468|lumbar puncture|lumbar puncture
1561024|NCT00533468|neonates|neonates
1561025|NCT00533468|infants|infants
1561026|NCT00533468|emergency department|emergency department
1561027|NCT00533468|topical anesthesia|topical anesthesia
1561028|NCT00533468|LMX4|lmx4
1561029|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
1561030|NCT00533442|Rapamycin|rapamycin
1561031|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
1561032|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
1561033|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
1561034|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
1561035|NCT00533416|Targeted Therapy|targeted therapy
1561036|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
1561037|NCT00533416|MDS|mds
1561038|NCT00533390|efavirenz|efavirenz
1561039|NCT00533390|tuberculosis|tuberculosis
1561040|NCT00533390|AIDS|aids
1561041|NCT00533390|rifampicin|rifampicin
1561042|NCT00533390|efficacy|efficacy
1561043|NCT00533390|safety|safety
1561137|NCT00532844|BH4|bh4
1561044|NCT00533390|Treatment Naive|treatment naive
1561045|NCT00533338|Breast Cancer|breast cancer
1561046|NCT00533338|Cancer Survivors|cancer survivors
1561047|NCT00533338|Weight Gain Prevention|weight gain prevention
1561048|NCT00533338|Diet|diet
1561049|NCT00533338|Exercise|exercise
1561050|NCT00533338|Questionnaire|questionnaire
1561051|NCT00533338|Survey|survey
1561052|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
1561053|NCT00533286|physiotherapy|physiotherapy
1561054|NCT00533286|Tuebingen concept|tuebingen concept
1561055|NCT00533286|benzodiazepines|benzodiazepines
1561056|NCT00533286|muscle relaxants|muscle relaxants
1561057|NCT00533286|disc herniation|disc herniation
1561058|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
1561059|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
1561060|NCT00533247|Pre-emptive Pain|pre-emptive pain
1561061|NCT00533247|Preoperative Pain|preoperative pain
1561062|NCT00533247|Pain Prophylaxis|pain prophylaxis
1561063|NCT00533247|Celebrex|celebrex
1561064|NCT00533247|Celecoxib|celecoxib
1561065|NCT00533234|Elbow fracture|elbow fracture
1561066|NCT00533234|Elbow dislocation|elbow dislocation
1561067|NCT00533234|Radial head fracture|radial head fracture
1561068|NCT00533234|Radial neck fracture|radial neck fracture
1561069|NCT00533221|growth hormone|growth hormone
1561070|NCT00533221|strength|strength
1561071|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
1561072|NCT00533195|UVA1|uva1
1561073|NCT00533195|PUVA|puva
1561074|NCT00533195|atopic dermatitis|atopic dermatitis
1561075|NCT00533182|Influenza Infection|influenza infection
1561076|NCT00533182|Immunocompromised Host|immunocompromised host
1561077|NCT00533182|Resistance Mutations|resistance mutations
1561078|NCT00533182|Prolonged Infection|prolonged infection
1561079|NCT00533169|Neuroblastoma|neuroblastoma
1561080|NCT00533169|ZD6474|zd6474
1561081|NCT00533169|Zactima|zactima
1561082|NCT00533169|Isotretinoin|isotretinoin
1561083|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
1561084|NCT00533169|Accutane|accutane
1561085|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
1561086|NCT00533156|Closure Device|closure device
1561087|NCT00533156|Angiography|angiography
1561088|NCT00533156|Angioplasty|angioplasty
1561089|NCT00533156|Hemostasis|hemostasis
1561090|NCT00533156|Heart Catheterization|heart catheterization
1561091|NCT00533156|Vascular Closure|vascular closure
1561092|NCT00533156|Peripheral Closure|peripheral closure
1561093|NCT00533156|Coronary Angiography|coronary angiography
1561094|NCT00533143|Solid cancer patient|solid cancer patient
1561095|NCT00533143|Non-invasive ventilation|non-invasive ventilation
1561096|NCT00533143|Acute Respiratory Failure|acute respiratory failure
1561097|NCT00533130|AO|ao
1561098|NCT00533130|Pediatric|pediatric
1561099|NCT00533130|Classification|classification
1561100|NCT00533130|Long Bones|long bones
1561101|NCT00533130|fractures|fractures
1561102|NCT00533130|bones|bones
1561103|NCT00533117|suicide|suicide
1561104|NCT00533117|self-mutilation|self-mutilation
1561105|NCT00533117|fluoxetine|fluoxetine
1561106|NCT00533117|placebo|placebo
1561107|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
1561108|NCT00533117|supportive therapy|supportive therapy
1561109|NCT00533104|Limb ischemia|limb ischemia
1561110|NCT00533104|Cell Therapy|cell therapy
1561111|NCT00533078|omega3 fatty acid|omega3 fatty acid
1561112|NCT00533078|parenteral nutrition|parenteral nutrition
1561113|NCT00533078|chemotherapy|chemotherapy
1561114|NCT00533078|infection|infection
1561115|NCT00533078|neutropenia|neutropenia
1561116|NCT00533065|Aging|aging
1561117|NCT00533052|Behavioral weight loss|behavioral weight loss
1561118|NCT00532974|HIV|hiv
1561119|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
1561120|NCT00532974|Vaccines|vaccines
1561121|NCT00532974|HIV Vaccines|hiv vaccines
1561122|NCT00532974|Peptide|peptide
1561123|NCT00532974|Peptide Vaccines|peptide vaccines
1561124|NCT00532974|HIV 1|hiv 1
1561125|NCT00532883|Sickle Cell Disease|sickle cell disease
1561126|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
1561127|NCT00532883|Painful Crises|painful crises
1561128|NCT00532883|Acute Chest Syndrome|acute chest syndrome
1561129|NCT00532870|laparoscopy|laparoscopy
1561130|NCT00532870|ventral hernia|ventral hernia
1561131|NCT00532870|mesh|mesh
1561132|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
1561133|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
1561134|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
1561135|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
1561138|NCT00532844|BH4 deficiency|bh4 deficiency
1561139|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
1561140|NCT00532844|endothelial dysfunction|endothelial dysfunction
1561141|NCT00532844|NO|no
1561142|NCT00532844|Hypertension|hypertension
1727994|NCT00018070|AMD|amd
1561143|NCT00532844|Nitric Oxide|nitric oxide
1561144|NCT00532844|Vitamin C|vitamin c
1561145|NCT00532818|Epigenetic therapy|epigenetic therapy
1561146|NCT00532818|Hydralazine|hydralazine
1561147|NCT00532818|Valproate|valproate
1561148|NCT00532818|Cervical cancer|cervical cancer
1561149|NCT00532818|Randomized|randomized
1561150|NCT00532818|Phase III|phase iii
1561151|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
1561152|NCT00532792|Avian|avian
1561153|NCT00532792|Pandemic|pandemic
1561154|NCT00532792|Influenza|influenza
1561155|NCT00532792|A/H5N1|a/h5n1
1561156|NCT00532779|Obesity|obesity
1561157|NCT00532779|Antiobesity agents|antiobesity agents
1561158|NCT00532779|Antiobesity drugs|antiobesity drugs
1561159|NCT00532779|Overweight drug therapy|overweight drug therapy
1561160|NCT00532779|Obese drug therapy|obese drug therapy
1561161|NCT00532779|Weight loss drug effects|weight loss drug effects
1561162|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
1561163|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
1561164|NCT00532779|Double blind method|double blind method
1561165|NCT00532779|Combination drug therapy|combination drug therapy
1561166|NCT00532779|Delayed action preparations|delayed action preparations
1561167|NCT00532766|Healthy subjects|healthy subjects
1561168|NCT00532753|empowerment|empowerment
1561169|NCT00532753|health|health
1561170|NCT00532753|education|education
1561171|NCT00532740|liver metastases|liver metastases
1561172|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
1561173|NCT00532727|Breast Cancer|breast cancer
1561174|NCT00532727|Triple Negative|triple negative
1561175|NCT00532701|Chronic hepatitis C|chronic hepatitis c
1561176|NCT00532701|Genotype|genotype
1561177|NCT00532701|Interferon|interferon
1561178|NCT00532701|Ribavirin|ribavirin
1561179|NCT00532701|Genotype 2|genotype 2
1561180|NCT00532701|Peginterferon|peginterferon
1561181|NCT00532688|acetylcysteine|acetylcysteine
1561182|NCT00532688|N-acetylcysteine|n-acetylcysteine
1561183|NCT00532688|heart failure|heart failure
1561184|NCT00532688|renal failure|renal failure
1561185|NCT00532675|Myeloma|myeloma
1561186|NCT00532675|Multiple Myeloma|multiple myeloma
1561187|NCT00532675|Lenalidomide|lenalidomide
1561188|NCT00532675|Revlimid|revlimid
1561189|NCT00532675|Dexamethasone|dexamethasone
1561190|NCT00532675|LBH589|lbh589
1561191|NCT00532675|Combination|combination
1561192|NCT00532662|Epidural|epidural
1561193|NCT00532662|Intravenous|intravenous
1561194|NCT00532662|Ketamine|ketamine
1561195|NCT00532662|Analgesia|analgesia
1561196|NCT00532662|Caudal|caudal
1561197|NCT00532662|Pediatric|pediatric
1561198|NCT00532662|Regional|regional
1561199|NCT00532662|Local Anesthetics|local anesthetics
1561200|NCT00532636|Airway|airway
1561201|NCT00532636|Airway obstruction|airway obstruction
1561202|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
1561203|NCT00532636|Respiration artificial|respiration artificial
1561204|NCT00532636|Ventilation|ventilation
1561205|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
1561206|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
1561207|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
1561208|NCT00532610|Diabetes,|diabetes,
1561209|NCT00532610|ECG,|ecg,
1561210|NCT00532610|Healthy Volunteers|healthy volunteers
1561211|NCT00532610|GSK189075,|gsk189075,
1561212|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
1561213|NCT00532597|Hemodialysis|hemodialysis
1561214|NCT00532597|Hemodiafiltration|hemodiafiltration
1561215|NCT00532584|COPD|copd
1561216|NCT00532584|inhaled steroids|inhaled steroids
1561217|NCT00532584|bronchodilator|bronchodilator
1561218|NCT00532584|gene expression|gene expression
1561219|NCT00532584|smoker's lungs|smoker's lungs
1561220|NCT00532571|CoQ10|coq10
1561221|NCT00532571|PSP|psp
1561222|NCT00532571|CBD|cbd
1561223|NCT00532558|Hyperlipidemia|hyperlipidemia
1561224|NCT00532558|Drug Therapy|drug therapy
1561225|NCT00532532|Multiple sclerosis|multiple sclerosis
1561226|NCT00532493|Combat Trauma|combat trauma
1561227|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
1561228|NCT00532493|PTSD|ptsd
1561229|NCT00532493|Sleep Disturbance|sleep disturbance
1561230|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
1561231|NCT00532480|Depression|depression
1561232|NCT00532480|Duloxetine|duloxetine
1561233|NCT00532480|fMRI|fmri
1561234|NCT00532480|pictures|pictures
1561235|NCT00532467|healthy volunteers|healthy volunteers
1561236|NCT00532415|Vitrectomy|vitrectomy
1561237|NCT00532415|Visualization|visualization
1561238|NCT00532402|Monitoring|monitoring
1561239|NCT00532402|Breathing Gas|breathing gas
1561240|NCT00532402|Propofol|propofol
1561241|NCT00532389|Myeloma|myeloma
1562093|NCT00528736|prediction|prediction
1561242|NCT00532389|Multiple Myeloma|multiple myeloma
1561243|NCT00532389|Bortezomib|bortezomib
1728102|NCT00017745|DNA|dna
1561245|NCT00532389|Combination|combination
1561246|NCT00532376|epilepsy|epilepsy
1561247|NCT00532376|depression|depression
1561248|NCT00532376|fMRI|fmri
1561249|NCT00532376|emotion|emotion
1561250|NCT00532350|COPD|copd
1561251|NCT00532350|pharmacokinetics|pharmacokinetics
1561252|NCT00532350|plethysmography|plethysmography
1561253|NCT00532350|cycle ergometry|cycle ergometry
1561254|NCT00532350|exercise testing|exercise testing
1561255|NCT00532350|spirometry|spirometry
1561256|NCT00532337|ONO-5334|ono-5334
1561257|NCT00532337|osteoporosis|osteoporosis
1561258|NCT00532337|osteopenia|osteopenia
1561259|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1561260|NCT00532324|Staphylococcus aureus|staphylococcus aureus
1561261|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
1561262|NCT00532324|Prevention|prevention
1561263|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
1561264|NCT00532324|Pregnant women|pregnant women
1561265|NCT00532311|Hyperlipidemia|hyperlipidemia
1561266|NCT00532311|Drug Therapy|drug therapy
1561267|NCT00532298|Fluarix|fluarix
1561268|NCT00532298|Influenza Infection|influenza infection
1561269|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
1561270|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1561271|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
1561272|NCT00532259|Stem cell transplantation|stem cell transplantation
1561273|NCT00532259|Relapsed|relapsed
1561274|NCT00532259|Refractory|refractory
1561275|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1561276|NCT00532220|osteonecrosis|osteonecrosis
1561277|NCT00532220|bone marrow edema|bone marrow edema
1561278|NCT00532220|ibandronate|ibandronate
1561279|NCT00532220|bisphosphonate|bisphosphonate
1561280|NCT00532220|knee|knee
1561281|NCT00532194|ovarian cancer|ovarian cancer
1561282|NCT00532194|fallopian tube cancer|fallopian tube cancer
1561283|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
1561284|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
1561285|NCT00532194|randomised controlled trial|randomised controlled trial
1561286|NCT00532194|Cediranib|cediranib
1561287|NCT00532194|AZD2171|azd2171
1561288|NCT00532194|efficacy|efficacy
1561289|NCT00532181|Health insurance|health insurance
1561290|NCT00532181|Health utilization rates|health utilization rates
1561291|NCT00532181|Saving Behavior|saving behavior
1561292|NCT00532181|Risk aversion|risk aversion
1561293|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
1561294|NCT00532168|late presenters|late presenters
1561295|NCT00532168|antiretroviral therapy|antiretroviral therapy
1561296|NCT00532168|immune reconstitution|immune reconstitution
1561297|NCT00532168|Treatment Naive|treatment naive
1561298|NCT00532155|lung cancer|lung cancer
1561299|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
1561300|NCT00532155|chemotherapy|chemotherapy
1561301|NCT00532116|Healthy|healthy
1561302|NCT00532116|Elderly|elderly
1561303|NCT00532116|Non Elderly|non elderly
1561304|NCT00532116|Healthy Volunteers|healthy volunteers
1561305|NCT00532103|Suicidal Ideation|suicidal ideation
1561306|NCT00532103|Major Depressive Disorder|major depressive disorder
1561307|NCT00532103|Suicide Risk|suicide risk
1561308|NCT00532103|Antidepressant Medication|antidepressant medication
1561309|NCT00532077|renal,|renal,
1561310|NCT00532077|pharmacology,|pharmacology,
1561311|NCT00532077|Osteoporosis|osteoporosis
1561312|NCT00532064|Advanced Cancers|advanced cancers
1561313|NCT00532064|Cardiotoxicity Detection|cardiotoxicity detection
1561314|NCT00532064|Heart Damage|heart damage
1561315|NCT00532064|Troponin 1 Blood Test|troponin 1 blood test
1561316|NCT00532064|B-type Natriuretic Peptide Blood Test|b-type natriuretic peptide blood test
1561317|NCT00532064|Questionnaire|questionnaire
1561318|NCT00532064|Survey|survey
1561319|NCT00532064|BNP|bnp
1561320|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
1561321|NCT00532038|Osteoarthritis|osteoarthritis
1561322|NCT00532038|Pain|pain
1561323|NCT00532025|Sorafenib|sorafenib
1561324|NCT00532025|NSCLC|nsclc
1561325|NCT00532025|Adjuvant Treatment|adjuvant treatment
1561326|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
1561327|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
1561328|NCT00532012|RhuDex®|rhudex®
1561329|NCT00532012|Meglumine|meglumine
1561330|NCT00532012|Oral Bioavailability|oral bioavailability
1561331|NCT00531999|Raltegravir|raltegravir
1561332|NCT00531999|Euglycaemic clamp|euglycaemic clamp
1561333|NCT00531999|healthy volunteer|healthy volunteer
1561334|NCT00531986|Monotherapy|monotherapy
1561335|NCT00531986|Neuropsychological tests|neuropsychological tests
1561336|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
1561337|NCT00531986|HIV viral load in genital|hiv viral load in genital
1561338|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
1561432|NCT00531518|Supported education|supported education
1561339|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
1561340|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
1561341|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
1561342|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
1561343|NCT00531986|Treatment Experienced|treatment experienced
1561344|NCT00531973|breast cancer|breast cancer
1561345|NCT00531973|echocardiography|echocardiography
1561346|NCT00531973|neoplasia|neoplasia
1561347|NCT00531947|Mental Health|mental health
1561348|NCT00531947|Adolescents|adolescents
1561349|NCT00531947|Major Depressive Disorder|major depressive disorder
1561350|NCT00531947|Depression|depression
1561351|NCT00531947|Adolescent Depression|adolescent depression
1561352|NCT00531947|Pediatric Depression|pediatric depression
1561353|NCT00531921|Heart Diseases|heart diseases
1561354|NCT00531921|Kidney Diseases|kidney diseases
1561355|NCT00531921|Liver Diseases|liver diseases
1561356|NCT00531921|Liver Failure|liver failure
1561357|NCT00531921|Lung Diseases|lung diseases
1561358|NCT00531921|Transplant|transplant
1561359|NCT00531921|Transplantation, Homologous|transplantation, homologous
1561360|NCT00531921|Rejection|rejection
1561361|NCT00531921|Kidney Failure|kidney failure
1561362|NCT00531908|Growth Hormone|growth hormone
1561363|NCT00531908|Epithelial sodium channel|epithelial sodium channel
1561364|NCT00531908|Hypertension|hypertension
1561365|NCT00531908|A Furosemide|a furosemide
1561366|NCT00531908|Nasal Mucosa|nasal mucosa
1561367|NCT00531895|major depression|major depression
1561368|NCT00531895|chronic headache|chronic headache
1561369|NCT00531895|antidepressant|antidepressant
1561370|NCT00531895|duloxetine|duloxetine
1561371|NCT00531882|healthy volunteers|healthy volunteers
1561372|NCT00531882|neutrophil migration|neutrophil migration
1561373|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
1561374|NCT00531882|simvastatin|simvastatin
1561375|NCT00531882|pioglitazone|pioglitazone
1561376|NCT00531869|safewater|safewater
1561377|NCT00531869|randomized|randomized
1561378|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
1561379|NCT00531843|deep vein thrombosis|deep vein thrombosis
1561380|NCT00531843|venous thromboembolism|venous thromboembolism
1561381|NCT00531843|pulmonary embolism|pulmonary embolism
1561382|NCT00531830|children with PDD|children with pdd
1561384|NCT00531791|exacerbation|exacerbation
1561385|NCT00531791|fluticasone|fluticasone
1561386|NCT00531791|salmeterol|salmeterol
1561387|NCT00531791|steroid|steroid
1561388|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
1561389|NCT00531778|early detection|early detection
1561390|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
1561391|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
1561392|NCT00531765|cardiac cath|cardiac cath
1561393|NCT00531765|creatinine|creatinine
1561394|NCT00531765|contrast|contrast
1561395|NCT00531765|nephropathy|nephropathy
1561396|NCT00531739|Surgery|surgery
1561397|NCT00531739|Colectomy|colectomy
1561398|NCT00531739|Proctocolectomy|proctocolectomy
1561399|NCT00531739|Adhesions|adhesions
1561400|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
1561401|NCT00531700|influenza|influenza
1561402|NCT00531700|risk behaviors|risk behaviors
1561403|NCT00531700|immunization|immunization
1561404|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
1561405|NCT00531700|personally controlled health record|personally controlled health record
1561406|NCT00531700|Indivo|indivo
1561407|NCT00531687|relapse|relapse
1561408|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
1561409|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
1561410|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
1561411|NCT00531622|Depression|depression
1561412|NCT00531622|Major Depressive Episode|major depressive episode
1561413|NCT00531622|Antidepressant|antidepressant
1561414|NCT00531596|Elderly|elderly
1561415|NCT00531596|Non Elderly|non elderly
1561416|NCT00531596|Healthy Volunteers|healthy volunteers
1561417|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
1561418|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
1561419|NCT00531557|Darunavir|darunavir
1561420|NCT00531557|Euglycaemic clamp|euglycaemic clamp
1561421|NCT00531557|HIV|hiv
1561422|NCT00531557|Treatment Experienced|treatment experienced
1561423|NCT00531531|pulmonary infection|pulmonary infection
1561424|NCT00531531|transmission|transmission
1561425|NCT00531531|P.Aeruginosa|p.aeruginosa
1561426|NCT00531531|surfaces|surfaces
1561427|NCT00531518|Schizophrenia|schizophrenia
1561428|NCT00531518|Bipolar disorder|bipolar disorder
1561429|NCT00531518|Psychosis|psychosis
1561430|NCT00531518|Prodromal psychosis|prodromal psychosis
1561431|NCT00531518|Family psychoeducation|family psychoeducation
1561433|NCT00531518|Supported employment|supported employment
1561434|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
1561435|NCT00531518|Major depression|major depression
1561436|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
1561437|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
1561438|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
1561439|NCT00531505|Obesity|obesity
1561440|NCT00531492|Maternal and child health|maternal and child health
1561441|NCT00531492|Developing country|developing country
1561442|NCT00531492|Skin to skin care|skin to skin care
1561443|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
1561444|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
1561445|NCT00531466|Spinal cord injury|spinal cord injury
1561446|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
1561447|NCT00531427|Chronic pain,|chronic pain,
1561448|NCT00531427|OA of the knee,|oa of the knee,
1561449|NCT00531427|opioid,|opioid,
1561450|NCT00531427|transdermal|transdermal
1561451|NCT00531414|Asthmatic|asthmatic
1561452|NCT00531414|healthy|healthy
1561453|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
1561454|NCT00531362|Atherosclerosis|atherosclerosis
1561455|NCT00531362|Aspirin|aspirin
1561456|NCT00531362|Resistance,|resistance,
1561457|NCT00531362|Acute coronary syndromes|acute coronary syndromes
1561458|NCT00531349|Endometrial Cancer|endometrial cancer
1561459|NCT00531349|Anesthesia; regional|anesthesia; regional
1561460|NCT00531349|cancer recurrence|cancer recurrence
1561461|NCT00531349|Analgesia; opioid|analgesia; opioid
1561462|NCT00531336|age-related Macular degeneration|age-related macular degeneration
1561463|NCT00531336|Macugen|macugen
1561464|NCT00531336|Avastin|avastin
1561465|NCT00531323|Pharmacokinetic|pharmacokinetic
1561466|NCT00531323|TMC125|tmc125
1561467|NCT00531323|Healthy volunteers|healthy volunteers
1561468|NCT00531323|Efavarinz|efavarinz
1561469|NCT00531310|CML|cml
1561470|NCT00531310|allogeneic SCT|allogeneic sct
1561471|NCT00531310|matched family donor|matched family donor
1561472|NCT00531310|unrelated donor|unrelated donor
1561473|NCT00531310|cord blood donor|cord blood donor
1561474|NCT00531310|persistent disease|persistent disease
1561475|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
1561476|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
1561477|NCT00531284|Ovarian Cancer|ovarian cancer
1561478|NCT00531284|Renal Cancer|renal cancer
1561479|NCT00531284|Other solid tumors|other solid tumors
1561480|NCT00531284|multiple myeloma|multiple myeloma
1561481|NCT00531284|lymphoma|lymphoma
1561482|NCT00531258|Depression|depression
1561483|NCT00531258|TBI|tbi
1561484|NCT00531258|TMS|tms
1561485|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
1561486|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
1561487|NCT00531245|Phase I/II study|phase i/ii study
1561488|NCT00531245|Colorectal cancer|colorectal cancer
1561489|NCT00531245|First line treatment|first line treatment
1561490|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
1561491|NCT00531232|oral clofarabine|oral clofarabine
1561492|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
1561493|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
1561494|NCT00531219|appendicitis|appendicitis
1561495|NCT00531219|cholelithiasis|cholelithiasis
1561496|NCT00531219|gallstones|gallstones
1561497|NCT00531193|Healthy male volunteers|healthy male volunteers
1561498|NCT00531180|Esophageal Cancer|esophageal cancer
1561499|NCT00531180|Lung Cancer|lung cancer
1561500|NCT00531180|Thoracic Malignancies|thoracic malignancies
1561501|NCT00531180|4D CT scans|4d ct scans
1561502|NCT00531180|Lung Function|lung function
1561503|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
1561504|NCT00531167|rescue therapy|rescue therapy
1561505|NCT00531141|age-related macular degeneration|age-related macular degeneration
1561506|NCT00531141|optical coherence tomography|optical coherence tomography
1561507|NCT00531141|retinal thickness|retinal thickness
1561508|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
1561509|NCT00531128|Sitosterol|sitosterol
1561510|NCT00531128|Nutrigenomics|nutrigenomics
1561511|NCT00531128|Gene Expression|gene expression
1561512|NCT00531128|Insulin Resistance|insulin resistance
1561513|NCT00531128|Sitosterolemia|sitosterolemia
1561514|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
1561515|NCT00531115|elderly patients|elderly patients
1561516|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
1561517|NCT00531102|oxygen|oxygen
1561518|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
1561519|NCT00531102|infant, newborn|infant, newborn
1561520|NCT00531102|resuscitation|resuscitation
1561521|NCT00531089|TTP|ttp
1561522|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
1561523|NCT00531089|HUS|hus
1561524|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
1561525|NCT00531089|plasma exchange|plasma exchange
1561526|NCT00531076|bevacizumab|bevacizumab
1561527|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
1561528|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
1561529|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
1561530|NCT00531050|COPD|copd
1561531|NCT00531050|cycle ergometry|cycle ergometry
1561532|NCT00531050|exercise testing|exercise testing
1561533|NCT00531050|spirometry|spirometry
1561534|NCT00531050|cardiovascular|cardiovascular
1561535|NCT00531050|salbutamol|salbutamol
1561536|NCT00531050|indacaterol|indacaterol
1561537|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1561538|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
1561539|NCT00531024|Exudative Neovascular|exudative neovascular
1561540|NCT00531024|AMD|amd
1561541|NCT00531024|Avastin|avastin
1561542|NCT00531024|Systemic|systemic
1561543|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
1561544|NCT00531011|Stents|stents
1561545|NCT00531011|Drug-eluting Stent|drug-eluting stent
1561546|NCT00531011|Angioplasty|angioplasty
1561547|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
1561548|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
1561549|NCT00531011|Stent Thrombosis|stent thrombosis
1561550|NCT00530998|appendicitis|appendicitis
1561551|NCT00530998|cholelithiasis|cholelithiasis
1561552|NCT00530998|Gallstones|gallstones
1561553|NCT00530985|disability|disability
1561554|NCT00530985|substance abuse|substance abuse
1561555|NCT00530985|vocational rehabilitation|vocational rehabilitation
1561556|NCT00530985|case management|case management
1561557|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
1561558|NCT00530972|relapsers|relapsers
1561559|NCT00530907|Advanced Cancer|advanced cancer
1561560|NCT00530907|Valproic Acid|valproic acid
1561561|NCT00530907|Depakene|depakene
1561562|NCT00530907|Bevacizumab|bevacizumab
1561563|NCT00530907|Avastin|avastin
1561564|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1561565|NCT00530907|rhuMAb-VEGF|rhumab-vegf
1561566|NCT00530894|Valvular Heart Disease|valvular heart disease
1561567|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
1561568|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
1561569|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
1561570|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
1561571|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
1561572|NCT00530855|Epilepsy|epilepsy
1561573|NCT00530855|Partial-onset Seizures|partial-onset seizures
1561574|NCT00530855|Lacosamide|lacosamide
1561575|NCT00530855|Monotherapy|monotherapy
1561576|NCT00530855|Vimpat|vimpat
1561577|NCT00530829|diarrhea|diarrhea
1561578|NCT00530829|zinc|zinc
1561579|NCT00530829|oral rehydration therapy|oral rehydration therapy
1561580|NCT00530803|pain|pain
1561581|NCT00530803|venipuncture|venipuncture
1561582|NCT00530803|children|children
1561583|NCT00530790|Restless Legs Syndrome|restless legs syndrome
1561584|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
1561585|NCT00530777|valacyclovir|valacyclovir
1561586|NCT00530777|Randomized Controlled Trials|randomized controlled trials
1561587|NCT00530777|HIV|hiv
1561588|NCT00530777|herpes|herpes
1561589|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
1561590|NCT00530777|HIV Seronegativity|hiv seronegativity
1561591|NCT00530764|Pain|pain
1561592|NCT00530764|Cancer|cancer
1561593|NCT00530764|Palliative|palliative
1561594|NCT00530751|breast cancer|breast cancer
1561595|NCT00530738|HPN|hpn
1561596|NCT00530738|lipid emulsion|lipid emulsion
1561597|NCT00530738|long term|long term
1561598|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
1561599|NCT00530725|occult pneumothorax|occult pneumothorax
1561600|NCT00530725|mechanical ventilation|mechanical ventilation
1561601|NCT00530725|critical care|critical care
1561602|NCT00530725|pneumothorax|pneumothorax
1561603|NCT00530725|thoracostomy|thoracostomy
1561604|NCT00530712|SFA|sfa
1561605|NCT00530712|Popliteal|popliteal
1561606|NCT00530712|Stent|stent
1561607|NCT00530712|EverFlex|everflex
1561608|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
1561609|NCT00530699|Phase 1|phase 1
1561610|NCT00530699|AZD1152|azd1152
1561611|NCT00530686|Diabetes Mellitus|diabetes mellitus
1561612|NCT00530686|Hypoglycemia|hypoglycemia
1561613|NCT00530686|Hyperglycemia|hyperglycemia
1561614|NCT00530686|Type 1 Diabetes|type 1 diabetes
1561615|NCT00530686|Islet cell transplantation|islet cell transplantation
1561616|NCT00530660|Pandemic influenza|pandemic influenza
1568257|NCT00506480|Oocyte Donation|oocyte donation
1728608|NCT00013546|Turners|turners
1561617|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
1561618|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1561619|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1561620|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1561621|NCT00530595|hemodialysis|hemodialysis
1561622|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
1561623|NCT00530569|Breast Cancer|breast cancer
1561624|NCT00530569|Herceptin Therapy|herceptin therapy
1561625|NCT00530543|Robot|robot
1561626|NCT00530543|Gait|gait
1561627|NCT00530543|Stroke|stroke
1561628|NCT00530530|ASP8825|asp8825
1561629|NCT00530530|Restless legs Syndrome|restless legs syndrome
1561630|NCT00530530|XP13512|xp13512
1561631|NCT00530517|migraine|migraine
1561632|NCT00530517|sumatripatan|sumatripatan
1561633|NCT00530504|Carotid Artery Disease|carotid artery disease
1561634|NCT00530504|Embolic Protection|embolic protection
1561635|NCT00530491|lung resection|lung resection
1561636|NCT00530491|reduced pulmonary function|reduced pulmonary function
1561637|NCT00530478|Donepezil|donepezil
1561638|NCT00530478|Stroke|stroke
1561639|NCT00530478|Cognitive function|cognitive function
1561640|NCT00530478|Cognitive neural network|cognitive neural network
1561641|NCT00530452|COX-2|cox-2
1561642|NCT00530452|carbonic anhydrase|carbonic anhydrase
1561643|NCT00530452|osteoarthritis|osteoarthritis
1561644|NCT00530452|anti-inflammatory|anti-inflammatory
1561645|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
1561646|NCT00530426|Heart Failure, Congestive|heart failure, congestive
1561647|NCT00530426|Registry|registry
1561648|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
1561649|NCT00530426|Dyspnea|dyspnea
1561650|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
1561651|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
1561652|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
1561653|NCT00530400|Neurosurgery|neurosurgery
1561654|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
1561655|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
1561656|NCT00530387|Photocontact|photocontact
1561657|NCT00530387|Dermatitis|dermatitis
1561658|NCT00530387|NSAID|nsaid
1561659|NCT00530387|Sunscreen|sunscreen
1561660|NCT00530387|Photopatch|photopatch
1561661|NCT00530374|Pediatrics|pediatrics
1561662|NCT00530374|Malnutrition|malnutrition
1561663|NCT00530374|Iron Deficiency|iron deficiency
1561664|NCT00530374|Sprinkles|sprinkles
1561665|NCT00530374|Oral Iron Supplementation|oral iron supplementation
1561666|NCT00530361|Myocardial Ischemia|myocardial ischemia
1561667|NCT00530361|Kidney failure|kidney failure
1561668|NCT00530361|CABG|cabg
1561669|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
1561670|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1561671|NCT00530361|Heart surgery|heart surgery
1561672|NCT00530361|Nesiritide|nesiritide
1561673|NCT00530361|Coronary Heart Disease|coronary heart disease
1561674|NCT00530348|Multiple Sclerosis|multiple sclerosis
1561675|NCT00530322|Adhesions|adhesions
1561676|NCT00530322|Laparoscopy|laparoscopy
1561677|NCT00530322|Colorectal surgery|colorectal surgery
1561678|NCT00530322|Colorectal disease|colorectal disease
1561679|NCT00530309|GLP-1|glp-1
1561680|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
1561681|NCT00530309|safety|safety
1561682|NCT00530309|GSK716155|gsk716155
1561683|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
1561684|NCT00530309|tolerability|tolerability
1561685|NCT00530309|pharmacokinetics|pharmacokinetics
1561686|NCT00530309|pharmacodynamics|pharmacodynamics
1561687|NCT00530296|Depression|depression
1561688|NCT00530296|End stage renal disease|end stage renal disease
1561689|NCT00530296|Quality of Life|quality of life
1561690|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
1561691|NCT00530283|Squamous|squamous
1561692|NCT00530283|Unknown Primary|unknown primary
1561693|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
1561694|NCT00530270|Sickle Cell Disease|sickle cell disease
1561696|NCT00530270|Acute Chest Syndrome|acute chest syndrome
1561697|NCT00530270|Hgb SS|hgb ss
1561698|NCT00530270|Hgb Sβ0|hgb sβ0
1561699|NCT00530270|Dexamethasone|dexamethasone
1561700|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1561701|NCT00530257|Methylphenidate|methylphenidate
1561702|NCT00530257|Attention|attention
1561703|NCT00530257|Working Memory|working memory
1561704|NCT00530244|cystic fibrosis|cystic fibrosis
1561705|NCT00530244|fatty acids|fatty acids
1561706|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
1561707|NCT00530244|infant formula|infant formula
1561708|NCT00530244|growth|growth
1561709|NCT00530244|pancreatic function|pancreatic function
1561710|NCT00530231|Capsule endoscopy|capsule endoscopy
1561711|NCT00530231|Missing rate|missing rate
1561712|NCT00530205|weight changes|weight changes
1561713|NCT00530205|malnutrition|malnutrition
1561714|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1561715|NCT00530192|Refractory Cancer|refractory cancer
1561716|NCT00530192|Molecular Profile|molecular profile
1561717|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1561718|NCT00530179|Positron Emission Tomography|positron emission tomography
1561719|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
1561720|NCT00530179|Stem Cell Transplantation|stem cell transplantation
1561721|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1561722|NCT00530166|Asthma|asthma
1561723|NCT00530166|persistant asthma|persistant asthma
1561724|NCT00530166|controller medications|controller medications
1561725|NCT00530166|FEV1|fev1
1561726|NCT00530153|Eating|eating
1561727|NCT00530153|Food Habits|food habits
1561728|NCT00530153|Adolescent|adolescent
1561729|NCT00530153|Dental Research|dental research
1561730|NCT00530140|Follicular Lymphoma|follicular lymphoma
1561731|NCT00530140|Idiotype vaccine|idiotype vaccine
1561732|NCT00530127|Friedreich's ataxia|friedreich's ataxia
1561733|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1561734|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1561735|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1561736|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1561737|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1561738|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1561739|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
1561740|NCT00530075|Vasculitis|vasculitis
1561741|NCT00530075|Gusperimus|gusperimus
1561742|NCT00530075|Immunosuppression|immunosuppression
1561743|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
1561744|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1561745|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
1561746|NCT00530049|laryngeal cancer|laryngeal cancer
1561747|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
1561748|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1561749|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
1561750|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
1561751|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1561752|NCT00530049|salivary gland cancer|salivary gland cancer
1561753|NCT00530049|tongue cancer|tongue cancer
1561754|NCT00530049|07-098|07-098
1561755|NCT00530036|Mortality|mortality
1561756|NCT00530036|Patient readmission|patient readmission
1561757|NCT00530036|Institutionalization|institutionalization
1561758|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1561759|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1561760|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
1561761|NCT00529997|Lumbar Spine|lumbar spine
1561762|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
1561763|NCT00529997|Spondylolisthesis|spondylolisthesis
1561764|NCT00529997|Dynamic Stabilization|dynamic stabilization
1561765|NCT00529997|Motion Preserving|motion preserving
1561766|NCT00529997|Arthroplasty|arthroplasty
1561767|NCT00529997|Randomized|randomized
1561768|NCT00529997|Investigational|investigational
1561769|NCT00529997|Back Pain|back pain
1561770|NCT00529997|Leg Pain|leg pain
1561771|NCT00529984|CEA|cea
1561772|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
1561773|NCT00529984|Metastatic malignancies|metastatic malignancies
1561774|NCT00529984|VRP Vaccine|vrp vaccine
1561775|NCT00529984|Alphavirus replicons|alphavirus replicons
1561776|NCT00529984|Molecular therapeutics|molecular therapeutics
1561777|NCT00529984|Stage III colon cancer|stage iii colon cancer
1561778|NCT00529971|Mindfulness|mindfulness
1561779|NCT00529971|HIV|hiv
1561780|NCT00529971|Male|male
1561781|NCT00529971|Living with HIV|living with hiv
1561782|NCT00529971|18-70 years of age|18-70 years of age
1561783|NCT00529971|live within one hour of hospital|live within one hour of hospital
1561784|NCT00529971|fluent in English|fluent in english
1561785|NCT00529971|Complementary Therapies|complementary therapies
1561786|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1561787|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
1561788|NCT00529958|Patellar Tendon|patellar tendon
1561789|NCT00529958|Hamstring Tendon|hamstring tendon
1561790|NCT00529958|Double-Bundle|double-bundle
1561791|NCT00529958|Autograft|autograft
1561792|NCT00529945|PFO|pfo
1561793|NCT00529945|Stroke|stroke
1561794|NCT00529945|Transient Ischemic Attack|transient ischemic attack
1561795|NCT00529945|Migraine|migraine
1561796|NCT00529945|Decompression Illness|decompression illness
1561797|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
1561798|NCT00529932|Celltherapy|celltherapy
1561799|NCT00529932|Bone Marrow|bone marrow
1561800|NCT00529919|Overweight|overweight
1561802|NCT00529919|Weight loss|weight loss
1561803|NCT00529919|Medium chain triglycerides|medium chain triglycerides
1561804|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
1561805|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1561806|NCT00529906|neuropsychological deficits|neuropsychological deficits
1561807|NCT00529906|endophenotype|endophenotype
1561808|NCT00529906|molecular genetics|molecular genetics
1561809|NCT00529906|candidate gene|candidate gene
1561810|NCT00529906|family-based association study|family-based association study
1561811|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
1561812|NCT00529893|neuropsychological functioning|neuropsychological functioning
1561813|NCT00529893|Atomoxetine|atomoxetine
1561814|NCT00529880|AML|aml
1561815|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
1561816|NCT00529867|P. falciparum malaria|p. falciparum malaria
1561817|NCT00529867|children|children
1561818|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
1561819|NCT00529854|Intensive care unit|intensive care unit
1561820|NCT00529854|medical documentation|medical documentation
1561821|NCT00529854|medical billing|medical billing
1561822|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
1561823|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
1561824|NCT00529828|CLA|cla
1561825|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
1561826|NCT00529828|Oleic acid|oleic acid
1561827|NCT00529828|Controlled dietary trial|controlled dietary trial
1561828|NCT00529815|Continuous|continuous
1561829|NCT00529815|blood|blood
1561830|NCT00529815|glucose|glucose
1561831|NCT00529815|monitoring|monitoring
1561832|NCT00529815|diabetes|diabetes
1561833|NCT00529815|type2|type2
1561834|NCT00529802|metastatic|metastatic
1561835|NCT00529802|renal|renal
1561836|NCT00529802|cell|cell
1561837|NCT00529802|carcinoma|carcinoma
1561838|NCT00529802|cancer|cancer
1561839|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
1561840|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
1561841|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
1561842|NCT00529737|Breast Cancer|breast cancer
1561843|NCT00529737|Marker Clip Migration|marker clip migration
1561844|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
1561845|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
1561846|NCT00529737|Breast Biopsy|breast biopsy
1561847|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
1561848|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
1561849|NCT00529711|coronary|coronary
1561850|NCT00529711|artery|artery
1561851|NCT00529711|bypass|bypass
1561852|NCT00529711|grafting|grafting
1561853|NCT00529711|IV|iv
1561854|NCT00529711|cardiac output|cardiac output
1561855|NCT00529698|HIV|hiv
1561856|NCT00529698|Tat protein|tat protein
1561857|NCT00529698|Preventative vaccine|preventative vaccine
1561858|NCT00529698|Healthy volunteers|healthy volunteers
1561859|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
1561860|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
1561861|NCT00529672|endovenous laser therapy|endovenous laser therapy
1561862|NCT00529672|sclerotherapy|sclerotherapy
1561863|NCT00529672|crossectomy and stripping|crossectomy and stripping
1561864|NCT00529672|surgery|surgery
1561865|NCT00529672|treatment|treatment
1561866|NCT00529672|varicose veins|varicose veins
1561867|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
1561868|NCT00529646|Healthy adult volunteers|healthy adult volunteers
1561869|NCT00529633|Inflammation|inflammation
1561870|NCT00529633|albumin|albumin
1561871|NCT00529620|Malaria|malaria
1561872|NCT00529620|IPT|ipt
1561873|NCT00529620|preventive treatment|preventive treatment
1561874|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
1561875|NCT00529594|Laser Photocoagulation|laser photocoagulation
1561876|NCT00529594|Pain relief|pain relief
1561877|NCT00529581|multiple sclerosis|multiple sclerosis
1561878|NCT00529581|cognitive impairment|cognitive impairment
1561879|NCT00529581|cognitive dysfunction|cognitive dysfunction
1562257|NCT00528164|behavior|behavior
1562003|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
1561880|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
1561881|NCT00529568|hepatitis C|hepatitis c
1561882|NCT00529568|ribavirin|ribavirin
1561883|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
1561884|NCT00529568|thrombopoietin|thrombopoietin
1561885|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
1561886|NCT00529568|platelets|platelets
1561887|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
1561888|NCT00529529|asthma|asthma
1561889|NCT00529529|QAB149|qab149
1561890|NCT00529529|indacaterol|indacaterol
1561891|NCT00529516|Fluarix|fluarix
1561892|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
1561893|NCT00529516|Influenza infection|influenza infection
1561894|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
1561895|NCT00529503|Lymphoma|lymphoma
1561896|NCT00529503|Antigens, CD40|antigens, cd40
1561897|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
1561898|NCT00529503|Combined Modality Therapy|combined modality therapy
1561899|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1561900|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1561901|NCT00529503|Hematologic Diseases|hematologic diseases
1561902|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
1561903|NCT00529503|Lymphatic Diseases|lymphatic diseases
1561904|NCT00529490|coronary|coronary
1561905|NCT00529490|artery|artery
1561906|NCT00529490|bypass|bypass
1561907|NCT00529490|grafting|grafting
1561908|NCT00529490|I.V.|i.v.
1561909|NCT00529490|cardiac output|cardiac output
1561910|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1561911|NCT00529464|Cervical Dysplasia|cervical dysplasia
1561912|NCT00529464|Cervical Cancer|cervical cancer
1561913|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
1561914|NCT00529464|Colposcopy|colposcopy
1561915|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
1561916|NCT00529464|LEEP|leep
1561917|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
1561918|NCT00529425|Femoral neck fracture|femoral neck fracture
1561919|NCT00529425|Hip fracture|hip fracture
1561920|NCT00529399|immune tolerance|immune tolerance
1561921|NCT00529399|immunotherapy|immunotherapy
1561922|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
1561923|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
1561924|NCT00529399|Beta-cell function|beta-cell function
1561925|NCT00529399|T-cells|t-cells
1561926|NCT00529399|DPT-1|dpt-1
1561927|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
1561928|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
1561929|NCT00529399|juvenile diabetes|juvenile diabetes
1561931|NCT00529399|diabetes mellitus|diabetes mellitus
1561932|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
1561933|NCT00529399|TrialNet|trialnet
1561934|NCT00529386|prostatitis|prostatitis
1561935|NCT00529386|Botox|botox
1561936|NCT00529360|Acute Leukemia|acute leukemia
1561937|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1561938|NCT00529360|Clofarabine|clofarabine
1561939|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1561940|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
1561941|NCT00529334|Breast Cancer|breast cancer
1561942|NCT00529334|Partial breast irradiation|partial breast irradiation
1561943|NCT00529334|Radiosurgery|radiosurgery
1561944|NCT00529334|CyberKnife|cyberknife
1561945|NCT00529334|Radiotherapy|radiotherapy
1561946|NCT00529334|PBI|pbi
1561947|NCT00529308|Tourette|tourette
1561948|NCT00529308|Tourette's|tourette's
1561949|NCT00529295|misoprostol|misoprostol
1561950|NCT00529295|labor induction|labor induction
1561951|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
1561952|NCT00529282|increased body temperature|increased body temperature
1561953|NCT00529282|cancer chemotherapy|cancer chemotherapy
1561954|NCT00529282|ceftobiprole|ceftobiprole
1561955|NCT00529282|pseudomonas infections|pseudomonas infections
1561956|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
1561957|NCT00529256|Adult smokers|adult smokers
1561958|NCT00529243|Treatment Experience|treatment experience
1561959|NCT00529243|On enfuvirtide|on enfuvirtide
1561960|NCT00529230|Advanced Cancer|advanced cancer
1561961|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
1561962|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
1561963|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
1561964|NCT00529230|Questionnaire|questionnaire
1561965|NCT00529217|Dissociative|dissociative
1561966|NCT00529217|Dissociation|dissociation
1561967|NCT00529217|Depersonalization|depersonalization
1561968|NCT00529217|Depersonalization Disorder|depersonalization disorder
1561969|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1561970|NCT00529217|TMS|tms
1561971|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
1561972|NCT00529217|rTMS|rtms
1561973|NCT00529204|Fatty Liver|fatty liver
1563340|NCT00524368|Ritonavir|ritonavir
1561974|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1561975|NCT00529204|NAFDL|nafdl
1561976|NCT00529204|Diabetes|diabetes
1561977|NCT00529204|ALT|alt
1561978|NCT00529204|exenatide|exenatide
1561979|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
1561980|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
1561981|NCT00529191|Insulin|insulin
1561982|NCT00529191|Pancreas|pancreas
1561983|NCT00529191|Beta Cells|beta cells
1561984|NCT00529165|injection to meal time|injection to meal time
1561985|NCT00529165|human insulin|human insulin
1561986|NCT00529152|Iron Overload|iron overload
1561987|NCT00529139|Extended dialysis|extended dialysis
1561988|NCT00529139|Acute kidney injury|acute kidney injury
1561989|NCT00529139|Intensive care unit|intensive care unit
1561990|NCT00529139|Renal replacement therapy|renal replacement therapy
1561991|NCT00529139|Survival|survival
1561992|NCT00529139|Dialysis|dialysis
1561993|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
1561994|NCT00529126|pain|pain
1561995|NCT00529126|Postoperative|postoperative
1561996|NCT00529126|analgesia|analgesia
1561997|NCT00529113|pancreatic cancer|pancreatic cancer
1561998|NCT00529113|gemcitabine|gemcitabine
1561999|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
1562000|NCT00529074|Epidural Analgesia|epidural analgesia
1562001|NCT00529061|Sickle Cell Disease|sickle cell disease
1562002|NCT00529061|Sickle Cell Anemia|sickle cell anemia
1562004|NCT00529048|Incretin effect|incretin effect
1562005|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
1562006|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
1562007|NCT00529035|Chronic GVHD|chronic gvhd
1562008|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
1562009|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1562010|NCT00529022|Advanced Cancer|advanced cancer
1562011|NCT00529022|Solid Tumors|solid tumors
1562012|NCT00529022|Ovarian Cancer|ovarian cancer
1562013|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
1562014|NCT00529022|Peritoneal Cancer|peritoneal cancer
1562015|NCT00529022|Azacitidine|azacitidine
1562016|NCT00529022|5-Azacitidine|5-azacitidine
1562017|NCT00529022|5-Aza|5-aza
1562018|NCT00529022|Vidaza™|vidaza™
1562019|NCT00529022|5-AZC|5-azc
1562020|NCT00529022|AZA-CR|aza-cr
1562021|NCT00529022|Ladakamycin|ladakamycin
1562022|NCT00529022|NSC-102816|nsc-102816
1562023|NCT00529022|Vidaza|vidaza
1562024|NCT00529022|Valproic Acid|valproic acid
1562025|NCT00529022|Depakene|depakene
1562026|NCT00529022|Carboplatin|carboplatin
1562027|NCT00529022|Paraplatin|paraplatin
1562028|NCT00529009|PK analysis|pk analysis
1562029|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
1562030|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
1562031|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
1562032|NCT00528970|POI|poi
1562033|NCT00528970|Hernia|hernia
1562034|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
1562035|NCT00528970|Post Operative Ileus|post operative ileus
1562036|NCT00528957|Phase 3|phase 3
1562037|NCT00528957|Randomized, Open-Label|randomized, open-label
1562038|NCT00528957|Treatment-Experienced|treatment-experienced
1562039|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1562040|NCT00528957|HIV|hiv
1562041|NCT00528957|Tenofovir DF|tenofovir df
1562042|NCT00528957|Pediatrics|pediatrics
1562043|NCT00528944|alveolar volume|alveolar volume
1562044|NCT00528944|pulmonary function testing|pulmonary function testing
1562045|NCT00528944|emphysema|emphysema
1562046|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
1562047|NCT00528918|diabetes|diabetes
1562048|NCT00528918|hyperglycemia|hyperglycemia
1562049|NCT00528918|insulin|insulin
1562050|NCT00528918|Apidra|apidra
1562051|NCT00528918|Glargine|glargine
1562052|NCT00528905|Schizophrenia|schizophrenia
1562053|NCT00528905|Cognitive Deficits|cognitive deficits
1562054|NCT00528892|Treatment Experienced|treatment experienced
1562055|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1562056|NCT00528879|Diabetes Mellitus|diabetes mellitus
1562057|NCT00528879|Endocrine System Diseases|endocrine system diseases
1562058|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
1562059|NCT00528879|Metabolic Diseases|metabolic diseases
1562060|NCT00528879|Metformin|metformin
1562061|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
1562062|NCT00528879|Pharmacologic Actions|pharmacologic actions
1562063|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
1562064|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1562065|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
1562066|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
1562067|NCT00528866|stage III prostate cancer|stage iii prostate cancer
1562068|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
1562069|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1562070|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
1562071|NCT00528814|Hand Sanitizer|hand sanitizer
1562072|NCT00528814|Respiratory Infection|respiratory infection
1562073|NCT00528801|Sickle Cell Disease|sickle cell disease
1562074|NCT00528801|Sickle Cell Anemia|sickle cell anemia
1562075|NCT00528801|Hemoglobin SS|hemoglobin ss
1562076|NCT00528801|Hemoglobin SB0|hemoglobin sb0
1562077|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
1562078|NCT00528775|large cell lung cancer|large cell lung cancer
1729252|NCT00007241|OA|oa
1562079|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
1562080|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1562081|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1562082|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1562083|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1562084|NCT00528762|Epidemiology|epidemiology
1562085|NCT00528762|Puberty|puberty
1562086|NCT00528762|Body Weight|body weight
1562087|NCT00528762|Body Image|body image
1562088|NCT00528762|Focus Group|focus group
1562089|NCT00528749|Respiratory effort|respiratory effort
1562090|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
1562091|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
1562092|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
1562094|NCT00528736|ductus intervention|ductus intervention
1562095|NCT00528723|beclomethasone|beclomethasone
1562096|NCT00528723|as needed|as needed
1562097|NCT00528723|salbutamol|salbutamol
1562098|NCT00528723|wheezing|wheezing
1562099|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
1562100|NCT00528684|Oncolytics Biotech|oncolytics biotech
1562101|NCT00528684|cancer alternative therapies|cancer alternative therapies
1562102|NCT00528684|malignant glioma|malignant glioma
1562103|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
1562104|NCT00528684|oncolytic virus|oncolytic virus
1562105|NCT00528684|reovirus|reovirus
1562106|NCT00528684|REOLYSIN|reolysin
1562107|NCT00528671|phenprocoumon|phenprocoumon
1562108|NCT00528671|INR self-management|inr self-management
1562109|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
1562110|NCT00528671|bleeding|bleeding
1562111|NCT00528671|thromboembolism|thromboembolism
1562112|NCT00528658|Soft Tissue Injuries|soft tissue injuries
1562113|NCT00528632|Gallstones|gallstones
1562114|NCT00528632|Gallbladder|gallbladder
1562115|NCT00528632|Cholesterolosis|cholesterolosis
1562116|NCT00528632|Serum cholesterol|serum cholesterol
1562117|NCT00528632|triglycerides|triglycerides
1562118|NCT00528632|Body Mass Index|body mass index
1562119|NCT00528619|Solid tumor malignancy|solid tumor malignancy
1562120|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
1562121|NCT00528619|sunitinib|sunitinib
1562122|NCT00528619|pemetrexed|pemetrexed
1562123|NCT00528619|Phase 1|phase 1
1562124|NCT00528619|Mesothelioma|mesothelioma
1562125|NCT00528593|HIV|hiv
1562126|NCT00528593|AIDS|aids
1562127|NCT00528593|neuropathy|neuropathy
1562128|NCT00528593|Procrit|procrit
1562129|NCT00528593|epoetin alfa|epoetin alfa
1562130|NCT00528593|erythropoetin|erythropoetin
1562131|NCT00528593|Treatment Experienced|treatment experienced
1562132|NCT00528580|Sepsis|sepsis
1562133|NCT00528580|Statin|statin
1562134|NCT00528580|Infection|infection
1562135|NCT00528580|Immunomodulatory|immunomodulatory
1562136|NCT00528554|CINV|cinv
1562137|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
1562138|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
1562139|NCT00528528|Genotype 1|genotype 1
1562140|NCT00528528|Telaprevir|telaprevir
1562141|NCT00528528|Treatment-naïve|treatment-naïve
1562142|NCT00528528|VX-950-C208|vx-950-c208
1562143|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
1562144|NCT00528515|anesthesia intravenous|anesthesia intravenous
1562145|NCT00528515|propofol|propofol
1562146|NCT00528515|anesthesia inhalation|anesthesia inhalation
1562147|NCT00528515|desflurane|desflurane
1562148|NCT00528515|heart surgery|heart surgery
1562149|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
1562150|NCT00528515|hemodynamic processes|hemodynamic processes
1562151|NCT00528515|anesthesia|anesthesia
1562152|NCT00528502|Parathyroid Disease|parathyroid disease
1562153|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
1562154|NCT00528502|MIPS|mips
1562155|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
1562156|NCT00528502|Lidocaine|lidocaine
1562157|NCT00528502|Saline|saline
1562158|NCT00528489|HIV Seronegativity|hiv seronegativity
1562159|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
1562160|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
1562161|NCT00528476|pyelonephritis|pyelonephritis
1562162|NCT00528476|cystitis|cystitis
1562163|NCT00528476|risk factor|risk factor
1562164|NCT00528476|children|children
1562165|NCT00528476|urodynamics|urodynamics
1562166|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
1562167|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
1562168|NCT00528463|phantom lomb pain|phantom lomb pain
1562169|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1562258|NCT00528164|body mass index|body mass index
1562170|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1562171|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1562172|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
1562173|NCT00528437|CNS germ cell tumors|cns germ cell tumors
1562174|NCT00528437|Ependymomas|ependymomas
1562175|NCT00528437|AT/RT|at/rt
1562176|NCT00528437|High grade glioma|high grade glioma
1562177|NCT00528437|Other malignant brain tumors|other malignant brain tumors
1562178|NCT00528411|Coronary artery disease|coronary artery disease
1562180|NCT00528411|heart attack|heart attack
1562181|NCT00528411|stable angina|stable angina
1562182|NCT00528411|Stable coronary artery disease|stable coronary artery disease
1562183|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1562184|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1562185|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1562186|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1562187|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1562188|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1562189|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1562190|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1562191|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1562192|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1562193|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1562194|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1562195|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1562196|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1562197|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1562198|NCT00528385|Proteinuria|proteinuria
1562199|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
1562200|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
1562201|NCT00528359|antipsychotic drugs|antipsychotic drugs
1562202|NCT00528359|schizophrenia|schizophrenia
1562203|NCT00528359|β-cell function|β-cell function
1562204|NCT00528359|insulin resistance|insulin resistance
1562205|NCT00528346|chronic pain|chronic pain
1562206|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
1562207|NCT00528346|fMRI|fmri
1562208|NCT00528346|cognitive training|cognitive training
1562209|NCT00528333|Lintuzumab|lintuzumab
1562210|NCT00528333|Antigens, CD33|antigens, cd33
1562211|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
1562212|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1562213|NCT00528333|Hematologic Diseases|hematologic diseases
1562214|NCT00528333|Leukemia|leukemia
1562215|NCT00528320|Congestive Heart Failure|congestive heart failure
1562216|NCT00528320|Heart Failure|heart failure
1562217|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1562218|NCT00528320|ICD|icd
1562219|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
1562220|NCT00528320|Defibrillator|defibrillator
1562221|NCT00528307|myocardial perfusion|myocardial perfusion
1562222|NCT00528307|His ablation|his ablation
1562223|NCT00528307|biventricular pacing|biventricular pacing
1562224|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
1562225|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
1562226|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
1562227|NCT00528281|Pemetrexed,|pemetrexed,
1562228|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
1562229|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
1562230|NCT00528268|SMA|sma
1562231|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
1562232|NCT00528255|cervical ripening|cervical ripening
1562233|NCT00528255|induction of labor|induction of labor
1562234|NCT00528216|Analgesics|analgesics
1562235|NCT00528216|Capsaicin|capsaicin
1562236|NCT00528203|Sickle Cell Disease|sickle cell disease
1562237|NCT00528203|Sickle Cell Anemia|sickle cell anemia
1562238|NCT00528203|DNA|dna
1562239|NCT00528190|Cystic Fibrosis|cystic fibrosis
1562240|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
1562241|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
1562242|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
1562243|NCT00528177|my-opioid receptor|my-opioid receptor
1562244|NCT00528177|oxycodone|oxycodone
1562245|NCT00528177|morphine|morphine
1562246|NCT00528177|postoperative pain|postoperative pain
1562247|NCT00528164|children|children
1562248|NCT00528164|overweight|overweight
1562249|NCT00528164|obesity|obesity
1562250|NCT00528164|family|family
1562251|NCT00528164|intervention|intervention
1562252|NCT00528164|control|control
1562253|NCT00528164|randomized|randomized
1562254|NCT00528164|physical activity|physical activity
1562255|NCT00528164|diet|diet
1562256|NCT00528164|nutrition|nutrition
1562259|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
1562260|NCT00528138|Appendicitis|appendicitis
1562261|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
1562263|NCT00528138|Values of bilirubin|values of bilirubin
1562264|NCT00528138|Values of liver function test|values of liver function test
1562265|NCT00528138|Values of white blood cells|values of white blood cells
1562266|NCT00528138|Values of CRP|values of crp
1562267|NCT00528125|pain prevention|pain prevention
1562268|NCT00528125|neonatal pain|neonatal pain
1562269|NCT00528125|laser acupuncture|laser acupuncture
1562270|NCT00528125|complementary and alternative medicine|complementary and alternative medicine
1562271|NCT00528112|Contraception|contraception
1562272|NCT00528112|Intrauterine|intrauterine
1562273|NCT00528112|IUD|iud
1562274|NCT00528112|IUS|ius
1562275|NCT00528086|Group visits|group visits
1562276|NCT00528073|Rifaximin-EIR|rifaximin-eir
1562277|NCT00528073|Crohn's disease|crohn's disease
1562278|NCT00528073|remission|remission
1562279|NCT00528060|HIV infections|hiv infections
1562280|NCT00528060|atazanavir|atazanavir
1562281|NCT00528060|Pharmacokinetics|pharmacokinetics
1562282|NCT00528060|Treatment Naive|treatment naive
1562283|NCT00528047|Cancer|cancer
1562284|NCT00528047|Solid Tumor|solid tumor
1562285|NCT00528047|Metastatic|metastatic
1562286|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
1562287|NCT00528034|Vaginal Cancer|vaginal cancer
1562288|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
1562289|NCT00528034|Lymphatic Mapping|lymphatic mapping
1562290|NCT00528034|Sentinel Lymph Node|sentinel lymph node
1562291|NCT00528034|Isosulfan Blue|isosulfan blue
1562292|NCT00528034|Lymph|lymph
1562293|NCT00528021|Head Lice|head lice
1562294|NCT00528021|Lice Infestation|lice infestation
1562295|NCT00528021|Pediculosis|pediculosis
1562296|NCT00528021|Pediculosis Capitis|pediculosis capitis
1562297|NCT00528008|infection|infection
1562298|NCT00528008|sepsis|sepsis
1562299|NCT00528008|povidone-iodine|povidone-iodine
1562300|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
1562301|NCT00528008|fever|fever
1562302|NCT00528008|erythema|erythema
1562303|NCT00528008|leukocytosis|leukocytosis
1562304|NCT00528008|drainage|drainage
1562305|NCT00528008|vaginal discharge|vaginal discharge
1562306|NCT00528008|elective cesarean section|elective cesarean section
1562307|NCT00527982|Head and Neck Cancer|head and neck cancer
1562308|NCT00527982|Lung Cancer|lung cancer
1562309|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
1562310|NCT00527982|Celecoxib|celecoxib
1562311|NCT00527982|Celebrex|celebrex
1562312|NCT00527969|American ginseng extract|american ginseng extract
1562313|NCT00527969|Panax quinquefolius|panax quinquefolius
1562314|NCT00527969|Memory enhancement|memory enhancement
1562315|NCT00527969|Cognitive function|cognitive function
1562316|NCT00527969|Working memory|working memory
1562317|NCT00527969|Declarative memory|declarative memory
1562318|NCT00527969|Psychomotor speed|psychomotor speed
1562319|NCT00527969|Executive skills|executive skills
1562320|NCT00527969|Psychosocial adaptation|psychosocial adaptation
1562321|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
1562322|NCT00527930|Breast Neoplasms|breast neoplasms
1562323|NCT00527930|Oxaliplatin|oxaliplatin
1562324|NCT00527930|S1|s1
1562325|NCT00527917|IC/PBS|ic/pbs
1562326|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
1562327|NCT00527904|osteoarthritis|osteoarthritis
1562328|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
1562329|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
1562330|NCT00527904|NSAIDS|nsaids
1562331|NCT00527891|Liver Cancer|liver cancer
1562332|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
1562333|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
1562334|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
1562335|NCT00527878|Ranitidine Therapy|ranitidine therapy
1562336|NCT00527878|Job's Syndrome|job's syndrome
1562337|NCT00527878|Cross-Over Study|cross-over study
1562338|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
1562339|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
1562340|NCT00527878|Job Syndrome|job syndrome
1562341|NCT00527878|Immune Deficiency|immune deficiency
1562342|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
1562343|NCT00527852|Flocked swab|flocked swab
1562344|NCT00527852|Group A streptococcus pharyngitis|group a streptococcus pharyngitis
1562345|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
1562346|NCT00527826|health care utilisation|health care utilisation
1562347|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1562348|NCT00527826|quality of life|quality of life
1562349|NCT00527826|compliance|compliance
1562350|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
1562351|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
1562352|NCT00527813|prone position|prone position
1562353|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
1562354|NCT00527800|Malaria|malaria
1562355|NCT00527800|HIV|hiv
1562657|NCT00526552|cholesterol|cholesterol
1562356|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
1562357|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
1562358|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
1562359|NCT00527800|Acute Infection|acute infection
1562360|NCT00527787|NSAID|nsaid
1562361|NCT00527787|gastric ulcers|gastric ulcers
1562362|NCT00527787|Vimovo|vimovo
1562363|NCT00527787|Naproxen|naproxen
1562364|NCT00527787|Esomeprazole|esomeprazole
1562365|NCT00527774|Hepatitis C|hepatitis c
1562366|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
1562367|NCT00527774|dialysis|dialysis
1562368|NCT00527774|mortality|mortality
1562369|NCT00527774|hospitalization|hospitalization
1562370|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
1562371|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
1562372|NCT00527761|Metastatic Melanoma|metastatic melanoma
1562373|NCT00527761|Temozolomide|temozolomide
1562374|NCT00527761|Temodar|temodar
1562375|NCT00527761|Taxotere|taxotere
1562376|NCT00527761|Cisplatin|cisplatin
1562377|NCT00527761|TTC|ttc
1562378|NCT00527748|Range of Motion|range of motion
1562680|NCT00526435|Arthritis|arthritis
1562379|NCT00527748|Ankle Fractures|ankle fractures
1562380|NCT00527748|Elderly patients|elderly patients
1562381|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
1562382|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
1562383|NCT00527722|Lung Cancer|lung cancer
1562384|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
1562385|NCT00527722|Lung Biopsy|lung biopsy
1562386|NCT00527722|Lung Plug|lung plug
1562387|NCT00527722|Air Leaks|air leaks
1562388|NCT00527683|vigabatrin|vigabatrin
1562390|NCT00527683|addiction|addiction
1562391|NCT00527683|treatment|treatment
1562392|NCT00527683|cocaine dependence|cocaine dependence
1562393|NCT00527670|Genomics|genomics
1562394|NCT00527657|Brain Neoplasms|brain neoplasms
1562395|NCT00527657|Melanoma|melanoma
1562396|NCT00527657|Metastatic Melanoma|metastatic melanoma
1562397|NCT00527657|Brain Metastasis|brain metastasis
1562398|NCT00527657|Temozolomide|temozolomide
1562399|NCT00527657|Temodar|temodar
1562400|NCT00527657|Thalidomide|thalidomide
1562401|NCT00527657|Thalomid|thalomid
1562402|NCT00527657|Lomustine|lomustine
1562403|NCT00527657|CCNU|ccnu
1562404|NCT00527657|CeeNU|ceenu
1562405|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
1562406|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
1562407|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
1562408|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
1562409|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
1562410|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
1562411|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
1562412|NCT00527618|Treatment Naive|treatment naive
1562413|NCT00527605|placebo control|placebo control
1562414|NCT00527605|Chinese|chinese
1562415|NCT00527605|Dutasteride|dutasteride
1562416|NCT00527605|Randomized|randomized
1562417|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1562418|NCT00527605|Double blind|double blind
1562419|NCT00527592|Comfort|comfort
1562420|NCT00527579|Epilepsy|epilepsy
1562421|NCT00527579|Taenia Solium|taenia solium
1562422|NCT00527579|Microglia|microglia
1562423|NCT00527579|Neuroinflammation|neuroinflammation
1562424|NCT00527579|Compartment Model|compartment model
1562425|NCT00527579|Neurocysticercosis|neurocysticercosis
1562426|NCT00527579|Healthy Volunteer|healthy volunteer
1562427|NCT00527579|HV|hv
1562428|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
1562429|NCT00527553|Macular pigment|macular pigment
1562430|NCT00527553|AMD|amd
1562431|NCT00527553|ARM|arm
1562432|NCT00527514|Hypertension|hypertension
1562433|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
1562434|NCT00527514|Calcium Channel Blocker|calcium channel blocker
1562435|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
1562436|NCT00527501|Open-angle glaucoma|open-angle glaucoma
1562437|NCT00527501|ocular hypertension|ocular hypertension
1562438|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
1562439|NCT00527488|BPH|bph
1562440|NCT00527488|PK/PD|pk/pd
1562441|NCT00527488|GnRH antagonist|gnrh antagonist
1562442|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
1562443|NCT00527475|photodynamic therapy|photodynamic therapy
1562444|NCT00527475|neovascularization|neovascularization
1562445|NCT00527462|Asthma GINA 1|asthma gina 1
1562446|NCT00527423|VEGF Trap-Eye|vegf trap-eye
1562447|NCT00527423|Macular Degeneration|macular degeneration
1562448|NCT00527423|AMD|amd
1562449|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1562450|NCT00527397|Diabetes Mellitus|diabetes mellitus
1562451|NCT00527384|Stress|stress
1562452|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
1562453|NCT00527358|violence|violence
1562454|NCT00527345|Asthma|asthma
1562455|NCT00527345|Diesel exhaust|diesel exhaust
1562456|NCT00527332|Hospitalization|hospitalization
1562457|NCT00527332|Postoperative care|postoperative care
1562458|NCT00527332|Quality of Life|quality of life
1562459|NCT00527332|Health economy|health economy
1562460|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
1562461|NCT00527332|Anesthesia, General|anesthesia, general
1562462|NCT00527319|NSCLC|nsclc
1562463|NCT00527319|anorexia|anorexia
1562464|NCT00527319|cachexia|cachexia
1562465|NCT00527319|grip strength|grip strength
1562466|NCT00527319|lean body mass|lean body mass
1562467|NCT00527306|aphthous stomatitis|aphthous stomatitis
1562468|NCT00527306|canker sores|canker sores
1562469|NCT00527306|multivitamins|multivitamins
1562470|NCT00527306|vitamin deficiency|vitamin deficiency
1562471|NCT00527293|stage I breast cancer|stage i breast cancer
1562472|NCT00527293|stage II breast cancer|stage ii breast cancer
1562473|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1562474|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1562475|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1562476|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1562477|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1562478|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
1562479|NCT00527280|Face transplantation|face transplantation
1562480|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
1562481|NCT00527228|Muscular dystrophy|muscular dystrophy
1562482|NCT00527228|therapy|therapy
1562483|NCT00527228|steroids|steroids
1562484|NCT00527228|deflazacort|deflazacort
1562485|NCT00527228|dysferlinopathy|dysferlinopathy
1562486|NCT00527228|LGMD|lgmd
1562487|NCT00527228|MM|mm
1562488|NCT00527189|Arthritis|arthritis
1562489|NCT00527189|Exercise|exercise
1562490|NCT00527189|Balance - Postural Control|balance - postural control
1562491|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
1562492|NCT00527176|Corticosteroid|corticosteroid
1562493|NCT00527176|Pulse therapy|pulse therapy
1562494|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
1562495|NCT00527176|q Space Imaging|q space imaging
1562496|NCT00527163|Echocardiogram|echocardiogram
1562497|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
1562498|NCT00527163|Malaria|malaria
1562499|NCT00527163|Mali|mali
1562500|NCT00527163|Screening|screening
1562501|NCT00527098|Trauma Resuscitation|trauma resuscitation
1562502|NCT00527072|plaque psoriasis|plaque psoriasis
1562503|NCT00527072|psoriasis|psoriasis
1562504|NCT00527072|infliximab|infliximab
1562505|NCT00527072|remicade|remicade
1562506|NCT00527072|etanercept|etanercept
1562507|NCT00527072|enbrel|enbrel
1562508|NCT00527072|psunrise|psunrise
1562509|NCT00527072|C0168Z04|c0168z04
1562510|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
1562511|NCT00527033|YM178|ym178
1562512|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
1562513|NCT00527020|qEEG,|qeeg,
1562514|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
1562515|NCT00527020|ERP|erp
1562516|NCT00527020|GSK1018921,|gsk1018921,
1562517|NCT00527020|FTIH,|ftih,
1562518|NCT00527020|schizophrenia,|schizophrenia,
1562519|NCT00527020|single-dose,|single-dose,
1562520|NCT00527020|healthy volunteers,|healthy volunteers,
1562521|NCT00527020|MMN,|mmn,
1562522|NCT00527007|Vasopressor|vasopressor
1562523|NCT00527007|Epinephrine|epinephrine
1562524|NCT00527007|Norepinephrine|norepinephrine
1562525|NCT00527007|Cooling|cooling
1562526|NCT00527007|Fever|fever
1562527|NCT00527007|ICU|icu
1562528|NCT00526994|intimate partner violence|intimate partner violence
1562529|NCT00526994|domestic violence|domestic violence
1562530|NCT00526994|spouse abuse|spouse abuse
1562531|NCT00526994|screening|screening
1562532|NCT00526955|Manual muscle testing|manual muscle testing
1562533|NCT00526942|ACRD|acrd
1562534|NCT00526942|Visual Memory|visual memory
1562535|NCT00526942|Visual Perception|visual perception
1562536|NCT00526942|Speed|speed
1562537|NCT00526942|Computerized|computerized
1562538|NCT00526942|SAAGE|saage
1562539|NCT00526942|Cognitive Decline|cognitive decline
1562540|NCT00526916|Epilepsy|epilepsy
1562541|NCT00526916|Taenia Solium|taenia solium
1562542|NCT00526916|Microglia|microglia
1562543|NCT00526916|Neuroinflammation|neuroinflammation
1562544|NCT00526916|Compartment Model|compartment model
1562545|NCT00526916|Neurocysticercosis|neurocysticercosis
1562546|NCT00526916|Healthy Volunteer|healthy volunteer
1562547|NCT00526916|HV|hv
1562548|NCT00526903|IBS|ibs
1562549|NCT00526903|abdominal pain|abdominal pain
1562550|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
1562551|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
1562552|NCT00526903|diarrhea|diarrhea
1562553|NCT00526903|constipation|constipation
1562554|NCT00526903|bloating|bloating
1562555|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
1562556|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
1562557|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1562558|NCT00526890|large cell lung cancer|large cell lung cancer
1563341|NCT00524355|GERD|gerd
1562559|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1562560|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1562561|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1562562|NCT00526877|Schizophrenia|schizophrenia
1562563|NCT00526877|Schizoaffective disorders|schizoaffective disorders
1562564|NCT00526877|Risperidone|risperidone
1562565|NCT00526877|Risperdal Consta|risperdal consta
1562566|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
1562567|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
1562568|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
1562569|NCT00526838|Solid Tumor|solid tumor
1562570|NCT00526838|Multiple Myeloma|multiple myeloma
1562571|NCT00526786|Low Grade Dysplasia|low grade dysplasia
1562572|NCT00526786|High Grade Dysplasia|high grade dysplasia
1562573|NCT00526786|Barrett's Esophagus|barrett's esophagus
1562574|NCT00526786|Cryospray ablation|cryospray ablation
1562575|NCT00526786|ICE|ice
1562576|NCT00526786|Cryotherapy|cryotherapy
1562577|NCT00526786|Cryo|cryo
1562578|NCT00526786|CryoSpray|cryospray
1562579|NCT00526773|motivational therapy|motivational therapy
1562679|NCT00526448|tailoring treatment|tailoring treatment
1562580|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
1562581|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
1562582|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
1562583|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
1562584|NCT00526721|Hypercholesterolemia|hypercholesterolemia
1562585|NCT00526721|Crestor|crestor
1562586|NCT00526721|LDL target goal|ldl target goal
1562587|NCT00526721|high risk patients|high risk patients
1562588|NCT00526721|Naturalistic|naturalistic
1562589|NCT00526721|Observational|observational
1562590|NCT00526708|dyslipidemia|dyslipidemia
1562591|NCT00526708|hypertension|hypertension
1562592|NCT00526708|rosuvastatin|rosuvastatin
1562593|NCT00526708|efficacy|efficacy
1562594|NCT00526708|Naturalistic|naturalistic
1562595|NCT00526708|Observational|observational
1562596|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
1562597|NCT00526695|Organ Protection|organ protection
1562598|NCT00526695|Anesthetics|anesthetics
1562599|NCT00526682|Antiobesity|antiobesity
1562600|NCT00526682|Weight loss|weight loss
1562601|NCT00526669|tumor biopsy|tumor biopsy
1562602|NCT00526669|capecitabine|capecitabine
1562603|NCT00526669|first line|first line
1562604|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
1562605|NCT00526669|Gastric cancer|gastric cancer
1562606|NCT00526669|newly diagnosed|newly diagnosed
1562607|NCT00526669|GE junction|ge junction
1562608|NCT00526669|lapatinib|lapatinib
1562609|NCT00526669|metastatic or unresectable|metastatic or unresectable
1562610|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1562611|NCT00526656|stage II bladder cancer|stage ii bladder cancer
1562612|NCT00526656|stage III bladder cancer|stage iii bladder cancer
1562613|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
1562614|NCT00526643|stage IIIB|stage iiib
1562615|NCT00526643|Stage IV|stage iv
1562616|NCT00526643|chemotherapy|chemotherapy
1562617|NCT00526643|monotherapy|monotherapy
1562618|NCT00526643|combination chemotherapy|combination chemotherapy
1562619|NCT00526643|poor performance status|poor performance status
1562620|NCT00526630|freezing|freezing
1562621|NCT00526630|gait|gait
1562622|NCT00526630|festination|festination
1562623|NCT00526630|shuffling|shuffling
1562624|NCT00526630|balance|balance
1562625|NCT00526617|Solid Tumor|solid tumor
1562626|NCT00526617|Melanoma|melanoma
1562627|NCT00526617|Breast cancer|breast cancer
1562628|NCT00526617|Ovarian cancer|ovarian cancer
1562629|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
1562630|NCT00526617|Fallopian tube cancer|fallopian tube cancer
1562631|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
1562632|NCT00526617|HCC|hcc
1562633|NCT00526617|BRCA deficient|brca deficient
1562634|NCT00526617|BRCA mutation|brca mutation
1562635|NCT00526617|Temozolomide|temozolomide
1562636|NCT00526617|Temodar|temodar
1562637|NCT00526617|TMZ|tmz
1562638|NCT00526617|ABT-888|abt-888
1562639|NCT00526617|PARP inhibitor|parp inhibitor
1562640|NCT00526604|return to work|return to work
1562641|NCT00526604|low back pain|low back pain
1562642|NCT00526604|work related rehabilitation|work related rehabilitation
1562643|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1562644|NCT00526591|stage I prostate cancer|stage i prostate cancer
1562645|NCT00526591|stage II prostate cancer|stage ii prostate cancer
1562646|NCT00526591|stage III prostate cancer|stage iii prostate cancer
1562647|NCT00526578|Pancreatic Cancer|pancreatic cancer
1562648|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
1562649|NCT00526578|PACGENE|pacgene
1562650|NCT00526578|Healthy Control|healthy control
1562651|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
1562653|NCT00526578|Questionnaire|questionnaire
1562654|NCT00526552|dyslipidemia|dyslipidemia
1562655|NCT00526552|rosuvastatin|rosuvastatin
1562656|NCT00526552|diabetes|diabetes
1562658|NCT00526552|Naturalistic|naturalistic
1562659|NCT00526552|Observational|observational
1562660|NCT00526539|THR|thr
1562661|NCT00526539|reversed hybrid|reversed hybrid
1562662|NCT00526539|wear|wear
1562663|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
1562664|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1562665|NCT00526500|Anoxic Brain Injury|anoxic brain injury
1562666|NCT00526500|Passive Gait Training|passive gait training
1562667|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
1562668|NCT00526500|Electroencephalogram|electroencephalogram
1562669|NCT00526500|Event Related Potentials|event related potentials
1562670|NCT00526487|Thoracic Dissection|thoracic dissection
1562671|NCT00526487|Dissection|dissection
1562672|NCT00526487|Endovascular|endovascular
1562673|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1562674|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
1562675|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
1562676|NCT00526461|large cell lung cancer|large cell lung cancer
1562677|NCT00526448|high dose of ribavirin|high dose of ribavirin
1562678|NCT00526448|extend treatment duration|extend treatment duration
1562681|NCT00526435|osteoarthritis|osteoarthritis
1562682|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
1562683|NCT00526435|fibromyalgia|fibromyalgia
1562684|NCT00526435|lupus|lupus
1562685|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
1562686|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1562687|NCT00526396|chemotherapy|chemotherapy
1562688|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
1562689|NCT00526383|Major depressive disorder|major depressive disorder
1562690|NCT00526383|Antidepressants|antidepressants
1562691|NCT00526383|Weight gain|weight gain
1562692|NCT00526383|Metabolic syndromes|metabolic syndromes
1562693|NCT00526370|self test|self test
1562694|NCT00526370|PAP smear|pap smear
1562695|NCT00526370|tampon test|tampon test
1562696|NCT00526370|E6/E7|e6/e7
1562697|NCT00526370|mRNA|mrna
1562698|NCT00526370|HPV|hpv
1562699|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
1562700|NCT00526357|asthma|asthma
1562701|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
1562702|NCT00526357|inflammation|inflammation
1562703|NCT00526344|remission of asthma|remission of asthma
1562704|NCT00526331|Perioperative Therapy|perioperative therapy
1562705|NCT00526331|Perioperative Hydration|perioperative hydration
1562706|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
1562707|NCT00526331|Vigileo Monitor|vigileo monitor
1562708|NCT00526331|FloTrac Sensor|flotrac sensor
1562709|NCT00526331|Fluid Volume|fluid volume
1562710|NCT00526331|APCO|apco
1562711|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
1562712|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1562713|NCT00526318|regional neuroblastoma|regional neuroblastoma
1562714|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
1562715|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
1562716|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1562717|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
1562718|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1562719|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1562720|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1562721|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1562722|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1562723|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1562724|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1562725|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1562726|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1562727|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1562728|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1562729|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1562730|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1562731|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1562732|NCT00526279|Hypertension|hypertension
1562733|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
1562734|NCT00526279|COMBAT|combat
1562735|NCT00526279|Compliance|compliance
1562736|NCT00526279|Naturalistic|naturalistic
1562737|NCT00526279|Observational|observational
1562738|NCT00526253|Congestive Heart Failure|congestive heart failure
1562739|NCT00526253|CHF|chf
1562740|NCT00526253|Heart Disease|heart disease
1562741|NCT00526253|Heart Attack|heart attack
1562742|NCT00526253|Stem Cell|stem cell
1562743|NCT00526253|Myoblast|myoblast
1562744|NCT00526253|Bioheart|bioheart
1562745|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
1562938|NCT00525746|Epidemiologic markers|epidemiologic markers
1562746|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
1562747|NCT00526201|Arthritis|arthritis
1562748|NCT00526201|Osteoarthritis|osteoarthritis
1562749|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
1562750|NCT00526201|Fibromyalgia|fibromyalgia
1562751|NCT00526201|Lupus|lupus
1562752|NCT00526188|Primovist|primovist
1562753|NCT00526188|Chinese patients|chinese patients
1562754|NCT00526188|Liver MRI|liver mri
1562755|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1562756|NCT00526175|Minimal Residual Disease|minimal residual disease
1562757|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1562758|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1562759|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1562760|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1562761|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1562762|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1562763|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1562764|NCT00526149|recurrent breast cancer|recurrent breast cancer
1562765|NCT00526149|stage IV breast cancer|stage iv breast cancer
1562766|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1562767|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1562768|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1562769|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1562770|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1562771|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1562772|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
1562773|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
1562774|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1562775|NCT00526149|adult angiosarcoma|adult angiosarcoma
1562776|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1562777|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
1562778|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
1562779|NCT00526149|adult liposarcoma|adult liposarcoma
1562780|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1562781|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
1562782|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
1562783|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1562784|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
1562785|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
1562786|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
1562787|NCT00526149|ovarian sarcoma|ovarian sarcoma
1562788|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
1562789|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
1562790|NCT00526149|recurrent melanoma|recurrent melanoma
1562791|NCT00526149|stage IV melanoma|stage iv melanoma
1562792|NCT00526136|Atrial Fibrillation|atrial fibrillation
1562793|NCT00526123|Dialysis|dialysis
1562794|NCT00526123|Dialysis Catheter|dialysis catheter
1562795|NCT00526123|Kidney Disease|kidney disease
1562796|NCT00526123|Dialysis Clinic|dialysis clinic
1562797|NCT00526123|Chronic Catheter|chronic catheter
1562798|NCT00526123|Catheter|catheter
1562799|NCT00526123|Kidney|kidney
1562800|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
1562801|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
1562802|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
1562803|NCT00526110|Cancer of the Stomach|cancer of the stomach
1562804|NCT00526110|5-Fluorouracil|5-fluorouracil
1562805|NCT00526110|5-FU|5-fu
1562806|NCT00526110|Adrucil|adrucil
1562807|NCT00526110|Efudex|efudex
1562808|NCT00526110|Docetaxel|docetaxel
1562809|NCT00526110|Oxaliplatin|oxaliplatin
1562810|NCT00526110|Eloxatin|eloxatin
1562811|NCT00526110|Taxotere|taxotere
1562812|NCT00526110|Esophagus|esophagus
1562813|NCT00526084|ALL|all
1562814|NCT00526084|Healthy subjects|healthy subjects
1562815|NCT00526071|Fabry Disease|fabry disease
1562816|NCT00526071|Lysosomal Storage Disorder|lysosomal storage disorder
1562817|NCT00526058|Heparin|heparin
1562818|NCT00526058|Extracorporeal|extracorporeal
1562819|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
1562820|NCT00526058|Apheresis|apheresis
1562821|NCT00526058|Device|device
1562822|NCT00526045|AUY922|auy922
1562823|NCT00526045|Solid tumors|solid tumors
1562824|NCT00526045|Breast Cancer|breast cancer
1562825|NCT00526045|Phase I/II|phase i/ii
1562826|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
1562827|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
1562828|NCT00526045|HER2+|her2+
1562830|NCT00526045|HSP90|hsp90
1562831|NCT00526032|Skin Cancer|skin cancer
1562832|NCT00526032|Cancerous skin lesions|cancerous skin lesions
1562833|NCT00526032|Melanoma Detection|melanoma detection
1562834|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
1562835|NCT00526032|OIR Imaging Probe|oir imaging probe
1562836|NCT00526019|remission of asthma|remission of asthma
1562837|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
1562838|NCT00525993|sports|sports
1562839|NCT00525993|ankle|ankle
1562840|NCT00525993|sprain|sprain
1562841|NCT00525993|etoricoxib|etoricoxib
1562842|NCT00525993|antiinflammatory|antiinflammatory
1562843|NCT00525993|treatment outcome|treatment outcome
1562844|NCT00525980|Breast Cancer|breast cancer
1562845|NCT00525980|Cancer Risk|cancer risk
1562846|NCT00525980|CD-ROM|cd-rom
1562847|NCT00525980|Focus Group|focus group
1562848|NCT00525980|Cancer Genetics|cancer genetics
1562849|NCT00525967|Cancer Pain|cancer pain
1562850|NCT00525967|Methadone|methadone
1562851|NCT00525967|Morphine|morphine
1562852|NCT00525967|Acetaminophen|acetaminophen
1562853|NCT00525967|Palliative Care|palliative care
1562854|NCT00525954|Coronary|coronary
1562855|NCT00525954|Artery|artery
1562856|NCT00525954|Artheroschlerosis|artheroschlerosis
1563460|NCT00523939|Lymphoma|lymphoma
1562857|NCT00525954|Phospholipase|phospholipase
1562858|NCT00525954|CAD|cad
1562859|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
1562860|NCT00525928|craving|craving
1562861|NCT00525928|smoking|smoking
1562862|NCT00525928|depression|depression
1562863|NCT00525915|Esophageal Cancer|esophageal cancer
1562864|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
1562865|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
1562866|NCT00525915|Radiation Therapy|radiation therapy
1562867|NCT00525915|5-Fluorouracil|5-fluorouracil
1562868|NCT00525915|5-FU|5-fu
1562869|NCT00525915|Adrucil|adrucil
1562870|NCT00525915|Efudex|efudex
1562871|NCT00525915|Oxaliplatin|oxaliplatin
1562872|NCT00525889|diabetes|diabetes
1562873|NCT00525889|juvenile diabetes|juvenile diabetes
1562874|NCT00525889|type 1 diabetes|type 1 diabetes
1562875|NCT00525889|diabetes mellitus|diabetes mellitus
1562876|NCT00525889|recent onset|recent onset
1562877|NCT00525889|new onset|new onset
1562878|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
1562879|NCT00525876|Lymphoma|lymphoma
1562880|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1562881|NCT00525876|Rituximab|rituximab
1562882|NCT00525876|Cyclophosphamide|cyclophosphamide
1562883|NCT00525876|Neosar|neosar
1562884|NCT00525876|Cytoxan|cytoxan
1562885|NCT00525876|Fludarabine|fludarabine
1562886|NCT00525876|Fludara|fludara
1562887|NCT00525876|Fludarabine phosphate|fludarabine phosphate
1562888|NCT00525876|Rituxan|rituxan
1562889|NCT00525876|Alemtuzumab|alemtuzumab
1562890|NCT00525876|CAMPATH-1H|campath-1h
1562891|NCT00525876|Campath|campath
1562892|NCT00525876|Total Body Irradiation|total body irradiation
1562893|NCT00525876|TBI|tbi
1562894|NCT00525863|schizophrenia|schizophrenia
1562895|NCT00525863|oxygen therapy|oxygen therapy
1562896|NCT00525850|cardiovascular disease|cardiovascular disease
1562897|NCT00525850|weight loss|weight loss
1562898|NCT00525837|varenicline|varenicline
1562899|NCT00525837|depression|depression
1562900|NCT00525837|anhedonia|anhedonia
1562901|NCT00525837|smoking|smoking
1562902|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
1562903|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
1562904|NCT00525824|Atherosclerosis|atherosclerosis
1562905|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
1562906|NCT00525785|Stomach Cancer|stomach cancer
1562907|NCT00525785|Gastric Cancer|gastric cancer
1562908|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
1562909|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
1562910|NCT00525785|Esophageal|esophageal
1562911|NCT00525785|Gastric|gastric
1562912|NCT00525785|5-Fluorouracil|5-fluorouracil
1562913|NCT00525785|5-FU|5-fu
1562914|NCT00525785|Adrucil|adrucil
1562915|NCT00525785|Efudex|efudex
1562916|NCT00525785|Folinic Acid|folinic acid
1562917|NCT00525785|Oxaliplatin|oxaliplatin
1562918|NCT00525785|Eloxatin|eloxatin
1562919|NCT00525785|Chemoradiotherapy|chemoradiotherapy
1562920|NCT00525785|Radiation|radiation
1562921|NCT00525785|Radiotherapy|radiotherapy
1562922|NCT00525785|XRT|xrt
1562923|NCT00525772|asthma|asthma
1562924|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
1562925|NCT00525772|sputum eosinophils|sputum eosinophils
1562926|NCT00525759|Breast cancer|breast cancer
1562927|NCT00525759|Zoledronic acid|zoledronic acid
1562928|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1562929|NCT00525759|Synergy|synergy
1562930|NCT00525759|Apoptosis|apoptosis
1562931|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
1562932|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
1562933|NCT00525746|Leukemia|leukemia
1562934|NCT00525746|MDS|mds
1562935|NCT00525746|AML|aml
1562936|NCT00525746|Malignancy|malignancy
1562937|NCT00525746|Molecular Epidemiology|molecular epidemiology
1562939|NCT00525746|Clinical markers|clinical markers
1562940|NCT00525746|Constitutional genetic markers|constitutional genetic markers
1562941|NCT00525746|Case-comparison study|case-comparison study
1562942|NCT00525733|HIV-1|hiv-1
1562943|NCT00525733|Acute Infection|acute infection
1562944|NCT00525733|Treatment Naive|treatment naive
1562945|NCT00525720|Prostate Cancer|prostate cancer
1562946|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
1562947|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
1562948|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
1562949|NCT00525720|Brachytherapy|brachytherapy
1562950|NCT00525720|Prostate brachytherapy|prostate brachytherapy
1562951|NCT00525720|Prostate implant|prostate implant
1562952|NCT00525720|Prostate|prostate
1562953|NCT00525720|Questionnaire|questionnaire
1562954|NCT00525720|Survey|survey
1562955|NCT00525707|acute heart failure|acute heart failure
1562956|NCT00525707|Actelion|actelion
1562957|NCT00525707|tezosentan|tezosentan
1562958|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
1562959|NCT00525707|New onset of heart failure|new onset of heart failure
1562960|NCT00525681|Obese|obese
1562961|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
1562962|NCT00525681|Pharmacokinetics|pharmacokinetics
1562963|NCT00525681|Interaction|interaction
1562964|NCT00525668|multiple sclerosis|multiple sclerosis
1562965|NCT00525668|inflammation|inflammation
1562966|NCT00525668|neurodegeneration|neurodegeneration
1562967|NCT00525668|neuroprotection|neuroprotection
1562968|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
1562969|NCT00525655|Colorectal Cancer|colorectal cancer
1562970|NCT00525655|Multimedia Intervention|multimedia intervention
1562971|NCT00525655|Questionnaire|questionnaire
1562972|NCT00525655|Survey|survey
1562973|NCT00525655|FAP|fap
1562974|NCT00525642|Breast-adjuvant|breast-adjuvant
1562975|NCT00525642|Breast-chemotherapy|breast-chemotherapy
1562976|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
1562977|NCT00525616|bullous pemphigoid|bullous pemphigoid
1562978|NCT00525616|mabthera|mabthera
1562979|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1562980|NCT00525603|CML|cml
1562981|NCT00525603|Leukemia|leukemia
1562982|NCT00525603|Cyclophosphamide|cyclophosphamide
1562983|NCT00525603|Fludarabine|fludarabine
1562984|NCT00525603|Alemtuzumab|alemtuzumab
1562985|NCT00525603|Rituximab|rituximab
1562986|NCT00525603|CFAR|cfar
1562987|NCT00525590|Gliadel|gliadel
1562988|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
1562989|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1562990|NCT00525564|Exercise|exercise
1562991|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
1562992|NCT00525564|Bronchodilation|bronchodilation
1562993|NCT00525564|Salmeterol|salmeterol
1562994|NCT00525525|Glioblastoma|glioblastoma
1562995|NCT00525525|Gliosarcoma|gliosarcoma
1562996|NCT00525525|Bevacizumab|bevacizumab
1562997|NCT00525525|Avastin|avastin
1562998|NCT00525525|Erlotinib|erlotinib
1562999|NCT00525525|Tarceva|tarceva
1563000|NCT00525525|Temozolomide|temozolomide
1563001|NCT00525525|Temodar|temodar
1563002|NCT00525499|acne|acne
1563003|NCT00525486|Nifedipine|nifedipine
1563004|NCT00525486|Tocolysis|tocolysis
1563005|NCT00525486|Maintenance|maintenance
1563006|NCT00525486|Preterm delivery|preterm delivery
1563007|NCT00525486|extended release nifedipine|extended release nifedipine
1563009|NCT00525460|fertility|fertility
1563010|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
1563011|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
1563012|NCT00525460|fertility sparing|fertility sparing
1563013|NCT00525447|Antigens, CD40|antigens, cd40
1563014|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
1563015|NCT00525447|Combined Modality Therapy|combined modality therapy
1563016|NCT00525447|Multiple Myeloma|multiple myeloma
1563017|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
1563018|NCT00525447|Hematologic Diseases|hematologic diseases
1563019|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
1563020|NCT00525447|Hemostatic Disorders|hemostatic disorders
1563021|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
1563022|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
1563023|NCT00525447|Paraproteinemias|paraproteinemias
1563024|NCT00525447|Vascular Diseases|vascular diseases
1563025|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
1568258|NCT00506480|in vitro fertilization|in vitro fertilization
1563026|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
1563027|NCT00525421|curcuminoids|curcuminoids
1563028|NCT00525421|oral lichen planus|oral lichen planus
1563029|NCT00525421|c reactive protein|c reactive protein
1563030|NCT00525421|interleukin 6|interleukin 6
1563031|NCT00525408|HRPC|hrpc
1563032|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
1563033|NCT00525408|Docetaxel|docetaxel
1563034|NCT00525408|Mycobacterium w|mycobacterium w
1563035|NCT00525395|Phototherapy|phototherapy
1563036|NCT00525395|Vitiligo scoring system|vitiligo scoring system
1563037|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1563038|NCT00525382|Xyzal tablets|xyzal tablets
1563039|NCT00525356|Aorta|aorta
1563040|NCT00525356|Dissection|dissection
1563041|NCT00525356|Thoracic|thoracic
1563042|NCT00525343|Avonex pivotal trial|avonex pivotal trial
1563043|NCT00525343|Avonex|avonex
1563044|NCT00525343|Avonex long term follow-up|avonex long term follow-up
1563045|NCT00525343|Avonex outcomes|avonex outcomes
1563046|NCT00525317|Pregnancy|pregnancy
1563047|NCT00525317|Magnesium|magnesium
1563048|NCT00525317|Leg Pain|leg pain
1563049|NCT00525304|medical co-morbidity|medical co-morbidity
1563050|NCT00525304|diabetes|diabetes
1563051|NCT00525304|heart disease|heart disease
1563052|NCT00525304|respiratory illness|respiratory illness
1563053|NCT00525291|Exercise Therapy|exercise therapy
1563054|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
1563055|NCT00525291|Adult|adult
1563056|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
1563057|NCT00525291|EMG - Biofeedback|emg - biofeedback
1563058|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
1563059|NCT00525291|Augmented biofeedback|augmented biofeedback
1563060|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1563061|NCT00525278|Xyzal tablets|xyzal tablets
1563062|NCT00525265|Vasopressin antagonist|vasopressin antagonist
1563063|NCT00525265|Cardiac Edema|cardiac edema
1563064|NCT00525265|Diuretics|diuretics
1563065|NCT00525252|Liver cirrhosis|liver cirrhosis
1563066|NCT00525252|Alcoholism|alcoholism
1563067|NCT00525252|Craving|craving
1563068|NCT00525239|Lipids|lipids
1563069|NCT00525239|lipoproteins|lipoproteins
1563070|NCT00525239|VLDL|vldl
1563071|NCT00525239|triglycerides|triglycerides
1563072|NCT00525239|apo B100|apo b100
1563074|NCT00525239|apo A1|apo a1
1563075|NCT00525239|endothelial dysfunction|endothelial dysfunction
1563076|NCT00525239|insulin secretion|insulin secretion
1563077|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
1563078|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
1563079|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
1563080|NCT00525239|Treatment Experienced|treatment experienced
1563081|NCT00525226|Psychiatry|psychiatry
1563082|NCT00525226|Psychology|psychology
1563083|NCT00525226|Pregnancy|pregnancy
1563084|NCT00525226|Stress|stress
1563085|NCT00525226|Anxiety|anxiety
1563086|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
1563087|NCT00525200|predictive marker|predictive marker
1563088|NCT00525200|personalized therapy|personalized therapy
1563089|NCT00525200|response assessment|response assessment
1563090|NCT00525200|p53 genotype|p53 genotype
1563091|NCT00525187|onychomycosis|onychomycosis
1563092|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
1563093|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
1563094|NCT00525174|Amblyopia|amblyopia
1563095|NCT00525174|Patching|patching
1563096|NCT00525174|Bangerter filters|bangerter filters
1563097|NCT00525161|breast cancer|breast cancer
1563098|NCT00525161|Sorafenib|sorafenib
1563099|NCT00525161|Nexavar|nexavar
1563100|NCT00525161|Endocrine Therapy|endocrine therapy
1563101|NCT00525122|hyperthyroidism|hyperthyroidism
1563102|NCT00525122|radioactive iodine|radioactive iodine
1563103|NCT00525122|antithyroid drugs|antithyroid drugs
1563104|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
1563105|NCT00525109|Cholesterol|cholesterol
1563106|NCT00525109|Hyperlipidemia|hyperlipidemia
1563107|NCT00525109|Gene array|gene array
1563108|NCT00525083|hyperlipidemia|hyperlipidemia
1563109|NCT00525083|HDL-C|hdl-c
1563110|NCT00525083|low density lipoprotein|low density lipoprotein
1563111|NCT00525057|Bone Cancer|bone cancer
1563112|NCT00525057|Orthopaedic Oncology|orthopaedic oncology
1563113|NCT00525057|Orthopaedics|orthopaedics
1563114|NCT00525057|Myeloma|myeloma
1563115|NCT00525057|Lymphoma|lymphoma
1563116|NCT00525057|Deep Venous Thrombosis|deep venous thrombosis
1563117|NCT00525057|DVT Prophylaxis|dvt prophylaxis
1563118|NCT00525057|Thromboembolic disease|thromboembolic disease
1563119|NCT00525057|Blood clots|blood clots
1563120|NCT00525057|Dalteparin|dalteparin
1563121|NCT00525057|Fragmin|fragmin
1563122|NCT00525057|Surgery|surgery
1563123|NCT00525057|Bone Tumor|bone tumor
1563124|NCT00525057|Tumor of soft tissue|tumor of soft tissue
1563125|NCT00525057|Lower extremity|lower extremity
1563126|NCT00525057|Leg|leg
1563127|NCT00525057|TED hose|ted hose
1563128|NCT00525057|Mechanical compression stocking|mechanical compression stocking
1563129|NCT00525031|Melanoma|melanoma
1563130|NCT00525031|Temozolomide|temozolomide
1563131|NCT00525031|Temodar|temodar
1563132|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
1563133|NCT00525031|PEG-Intron|peg-intron
1563134|NCT00525031|PGI|pgi
1563135|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
1563136|NCT00525031|Surgery|surgery
1563137|NCT00525018|Pain|pain
1563138|NCT00525018|Functional neuroimaging|functional neuroimaging
1563139|NCT00525018|Neuropathy|neuropathy
1563140|NCT00525018|Thermal sensation|thermal sensation
1563141|NCT00525005|Stomach Neoplasm|stomach neoplasm
1563142|NCT00525005|Docetaxel|docetaxel
1563143|NCT00525005|Oxaliplatin|oxaliplatin
1563144|NCT00525005|S-1|s-1
1563145|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1563146|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
1563147|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
1563148|NCT00524992|Lipodystrophy|lipodystrophy
1563149|NCT00524992|Metabolic Syndrome|metabolic syndrome
1563150|NCT00524992|Tubular Injury|tubular injury
1563151|NCT00524992|Renal Biopsy|renal biopsy
1563152|NCT00524992|Proteinuria|proteinuria
1563153|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
1563154|NCT00524992|HAART Toxicity|haart toxicity
1563155|NCT00524992|HIV Positive|hiv positive
1563156|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
1563157|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1563158|NCT00524953|non-T-cell depleted|non-t-cell depleted
1563159|NCT00524953|UV-c|uv-c
1563160|NCT00524953|GVHD|gvhd
1563161|NCT00524940|Influenza|influenza
1563162|NCT00524940|Orthomyxoviruses|orthomyxoviruses
1563163|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1563164|NCT00524927|Incident Pain|incident pain
1563165|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
1563166|NCT00524914|Parkinson's disease|parkinson's disease
1563167|NCT00524914|Pain|pain
1563168|NCT00524914|Nociceptive threshold|nociceptive threshold
1563169|NCT00524914|Functional imaging|functional imaging
1563170|NCT00524914|Cerebral activity|cerebral activity
1563171|NCT00524914|Dopamine agonist.|dopamine agonist.
1563172|NCT00524901|Apoptosis|apoptosis
1563173|NCT00524901|CABG|cabg
1563174|NCT00524901|Coronary Artery Disease|coronary artery disease
1563175|NCT00524901|Three Vessel Disease|three vessel disease
1563176|NCT00524901|Erythropoietin|erythropoietin
1563177|NCT00524901|EPO-receptor signaling|epo-receptor signaling
1563178|NCT00524888|Hand|hand
1563179|NCT00524888|Laceration|laceration
1563180|NCT00524888|bioadhesive|bioadhesive
1563181|NCT00524888|ER|er
1563182|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
1563183|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
1563184|NCT00524875|Bevacizumab|bevacizumab
1563185|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
1563186|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1563187|NCT00524862|Ejection Fraction|ejection fraction
1563188|NCT00524862|QRS duration|qrs duration
1563189|NCT00524849|Breast cancer|breast cancer
1563190|NCT00524849|Bone metastasis|bone metastasis
1563191|NCT00524849|Circulating VEGF|circulating vegf
1563192|NCT00524849|Zoledronic acid|zoledronic acid
1563193|NCT00524849|Angiogenesis|angiogenesis
1563194|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
1563195|NCT00524836|Xyzal tablets|xyzal tablets
1563196|NCT00524823|Prostate Cancer|prostate cancer
1563197|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
1563198|NCT00524823|FACS|facs
1563199|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
1563200|NCT00524797|Myelosuppression,|myelosuppression,
1563201|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
1563202|NCT00524797|leucopenia,|leucopenia,
1563203|NCT00524797|thrombocytopenia,|thrombocytopenia,
1563204|NCT00524797|Profonycia|profonycia
1563205|NCT00524784|GVHD|gvhd
1563206|NCT00524784|HSCT|hsct
1563207|NCT00524784|BMT|bmt
1563208|NCT00524784|APOPTOTIC CELLS|apoptotic cells
1563209|NCT00524771|Contraception|contraception
1563210|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
1563211|NCT00524758|ologen|ologen
1563212|NCT00524758|oculusgen|oculusgen
1563213|NCT00524758|collagen matrix|collagen matrix
1563214|NCT00524758|trabeculectomy|trabeculectomy
1563215|NCT00524758|filtering surgery|filtering surgery
1563216|NCT00524758|mitomycin-C|mitomycin-c
1563217|NCT00524758|MMC|mmc
1563218|NCT00524758|Aeon Astron|aeon astron
1563219|NCT00524745|Gardasil|gardasil
1563220|NCT00524745|Human Papillomavirus|human papillomavirus
1563221|NCT00524745|HPV vaccine|hpv vaccine
1563222|NCT00524745|Cervical cancer|cervical cancer
1563223|NCT00524732|Pertussis|pertussis
1563224|NCT00524732|Tetanus|tetanus
1563225|NCT00524732|Diphtheria|diphtheria
1563226|NCT00524706|S-1|s-1
1563227|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
1563228|NCT00524706|tegafur|tegafur
1563229|NCT00524706|Gimeracil|gimeracil
1563230|NCT00524706|Oteracil Potassium|oteracil potassium
1563231|NCT00524706|Leucovorin|leucovorin
1563232|NCT00524706|Calcium Folinate|calcium folinate
1563233|NCT00524706|Oxaliplatin|oxaliplatin
1563234|NCT00524706|L-OHP|l-ohp
1563235|NCT00524706|colorectal cancer|colorectal cancer
1563236|NCT00524693|Bronchiolitis|bronchiolitis
1563237|NCT00524693|controlled clinical trial|controlled clinical trial
1563238|NCT00524693|pediatrics|pediatrics
1563239|NCT00524693|Infants|infants
1563240|NCT00524693|montelukast|montelukast
1563339|NCT00524368|Darunavir|darunavir
1563241|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
1563242|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1563243|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
1563244|NCT00524680|stage I prostate cancer|stage i prostate cancer
1563245|NCT00524680|stage II prostate cancer|stage ii prostate cancer
1563246|NCT00524680|stage III prostate cancer|stage iii prostate cancer
1563247|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
1563248|NCT00524667|Active CLL|active cll
1563249|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
1563250|NCT00524641|Asthma|asthma
1563251|NCT00524641|Symbicort|symbicort
1563252|NCT00524641|NIS|nis
1563253|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
1563254|NCT00524615|spironolactone|spironolactone
1563255|NCT00524615|aldosterone antagonists|aldosterone antagonists
1563256|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
1563257|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
1563258|NCT00524602|Stereotaxis|stereotaxis
1563259|NCT00524602|Arrythmia|arrythmia
1563260|NCT00524602|Catheter ablation|catheter ablation
1563261|NCT00524602|Heart|heart
1563461|NCT00523939|Leukemia|leukemia
1563262|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
1563263|NCT00524576|Hepatitis B|hepatitis b
1563264|NCT00524576|Persistence|persistence
1563265|NCT00524576|Challenge dose|challenge dose
1563266|NCT00524563|Acinetobacter|acinetobacter
1563267|NCT00524563|bloodstream infection|bloodstream infection
1563268|NCT00524563|Isolate|isolate
1563269|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
1563270|NCT00524550|insulin secretion|insulin secretion
1563271|NCT00524550|insulin sensitivity|insulin sensitivity
1563272|NCT00524550|Beta-cell function|beta-cell function
1563273|NCT00524550|Adiponectin|adiponectin
1563274|NCT00524550|Appetite|appetite
1563275|NCT00524550|Satiety|satiety
1563276|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
1563277|NCT00524550|Endocannabinoids|endocannabinoids
1563278|NCT00524550|Glucose metabolism|glucose metabolism
1563279|NCT00524550|Lipid metabolism|lipid metabolism
1563280|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
1563281|NCT00524550|Appetite regulation|appetite regulation
1563282|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
1563283|NCT00524537|Crohn's Disease|crohn's disease
1563284|NCT00524524|solid tumors|solid tumors
1563285|NCT00524524|biopsy|biopsy
1563286|NCT00524511|cesarean|cesarean
1563287|NCT00524511|wound|wound
1563288|NCT00524511|Dermabond|dermabond
1563289|NCT00524511|superglue|superglue
1563290|NCT00524511|staples|staples
1563291|NCT00524511|wound complications|wound complications
1563292|NCT00524498|OPC-18|opc-18
1563293|NCT00524498|Interferon-alpha|interferon-alpha
1563294|NCT00524498|Fluorouracil|fluorouracil
1563295|NCT00524485|actinic keratosis|actinic keratosis
1563296|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
1563297|NCT00524472|cardiac surgery|cardiac surgery
1563298|NCT00524472|Outcome|outcome
1563299|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
1563300|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
1563301|NCT00524446|Infant|infant
1563302|NCT00524446|Sub-Saharan Africa|sub-saharan africa
1563303|NCT00524446|Complementary feeding|complementary feeding
1563304|NCT00524446|Fortified spread|fortified spread
1563305|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
1563306|NCT00524446|Malnutrition|malnutrition
1563307|NCT00524446|Stunting|stunting
1563308|NCT00524446|Growth|growth
1563309|NCT00524446|Morbidity|morbidity
1563310|NCT00524446|Development|development
1563311|NCT00524446|Haemoglobin|haemoglobin
1563312|NCT00524433|acute heart failure|acute heart failure
1563313|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
1563314|NCT00524433|new onset of heart failure|new onset of heart failure
1563315|NCT00524433|tezosentan|tezosentan
1563316|NCT00524433|Actelion|actelion
1563317|NCT00524420|Pain|pain
1563318|NCT00524420|Fatigue|fatigue
1563319|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
1563320|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
1563321|NCT00524420|Depression|depression
1563322|NCT00524420|Major Depressive Disorder|major depressive disorder
1563323|NCT00524407|Anemia|anemia
1563324|NCT00524407|hemoglobin|hemoglobin
1563325|NCT00524407|chemotherapy|chemotherapy
1563326|NCT00524407|hematologic response|hematologic response
1563327|NCT00524407|subcutaneous injection|subcutaneous injection
1563328|NCT00524407|Epoetin alfa|epoetin alfa
1563329|NCT00524407|FACT-An|fact-an
1563330|NCT00524407|LASA|lasa
1563331|NCT00524407|PROCRIT|procrit
1563332|NCT00524394|VLBW|vlbw
1563333|NCT00524394|sepsis|sepsis
1563334|NCT00524394|diagnosis|diagnosis
1563335|NCT00524394|suspected sepsis|suspected sepsis
1563336|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
1563337|NCT00524368|HIV-1 Infection|hiv-1 infection
1563338|NCT00524368|TMC-114|tmc-114
1563342|NCT00524355|GIS|gis
1563343|NCT00524355|heartburn|heartburn
1563344|NCT00524355|NIS|nis
1563345|NCT00524355|PPI|ppi
1563346|NCT00524342|IL-11|il-11
1563347|NCT00524342|von Willebrand disease|von willebrand disease
1563348|NCT00524342|von Willebrand factor|von willebrand factor
1563349|NCT00524342|VWFmRNA|vwfmrna
1563350|NCT00524342|menorrhagia|menorrhagia
1563351|NCT00524329|upper GI-symptoms|upper gi-symptoms
1563352|NCT00524329|heartburn|heartburn
1563353|NCT00524329|NSAID|nsaid
1563354|NCT00524329|risk|risk
1563355|NCT00524329|PPI|ppi
1563356|NCT00524329|Bloating|bloating
1563357|NCT00524329|Regurgitation|regurgitation
1563358|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1563359|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
1563360|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1563361|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1563362|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
1563363|NCT00524303|ErbB2 Positive|erbb2 positive
1563364|NCT00524303|Lapatinib|lapatinib
1563365|NCT00524303|Invasive Breast Cancer|invasive breast cancer
1563366|NCT00524290|Acinetobacter|acinetobacter
1563367|NCT00524290|infection|infection
1563369|NCT00524277|stage I breast cancer|stage i breast cancer
1563370|NCT00524277|stage II breast cancer|stage ii breast cancer
1563371|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
1563372|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
1563373|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
1563374|NCT00524277|male breast cancer|male breast cancer
1563375|NCT00524251|Patients with reflux complaints|patients with reflux complaints
1563376|NCT00524251|GERD|gerd
1563377|NCT00524251|quality of life|quality of life
1563378|NCT00524251|lifestyle adjustments|lifestyle adjustments
1563379|NCT00524238|hypothyroidism|hypothyroidism
1563380|NCT00524238|glucose turnover|glucose turnover
1563381|NCT00524238|clamp|clamp
1563382|NCT00524238|insulin resistance|insulin resistance
1563383|NCT00524238|lipid turnover|lipid turnover
1563384|NCT00524238|amino acid turnover|amino acid turnover
1563385|NCT00524225|IL-11|il-11
1563386|NCT00524225|von Willebrand disease|von willebrand disease
1563387|NCT00524225|von Willebrand factor|von willebrand factor
1563388|NCT00524225|VWFmRNA|vwfmrna
1563389|NCT00524225|surgery|surgery
1563390|NCT00524199|homocysteine|homocysteine
1563391|NCT00524199|hemodialysis|hemodialysis
1563392|NCT00524199|mesna|mesna
1563393|NCT00524186|stage III gastric cancer|stage iii gastric cancer
1563394|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
1563395|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1563396|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
1563397|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
1563398|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
1563399|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1563400|NCT00524173|Emtricitabine|emtricitabine
1563401|NCT00524173|Tenofovir|tenofovir
1563402|NCT00524173|Antiviral Therapy|antiviral therapy
1563403|NCT00524173|Hepatitis B|hepatitis b
1563404|NCT00524173|HBV|hbv
1563405|NCT00524160|Fentanyl|fentanyl
1563406|NCT00524160|opioid analgesics|opioid analgesics
1563407|NCT00524160|arthritis|arthritis
1563408|NCT00524160|osteoarthritis|osteoarthritis
1563409|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
1563410|NCT00524160|transdermal administration|transdermal administration
1563411|NCT00524147|loculated pleural effusion|loculated pleural effusion
1563412|NCT00524147|pigtail drainage|pigtail drainage
1563413|NCT00524147|pleural effusion|pleural effusion
1563414|NCT00524147|pleural thickening|pleural thickening
1563415|NCT00524147|tuberculosis|tuberculosis
1563416|NCT00524134|Epilepsy|epilepsy
1563417|NCT00524134|Seizure|seizure
1563418|NCT00524134|p-glycoprotein|p-glycoprotein
1563419|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1563420|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1563421|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
1563422|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
1563423|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
1563424|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
1563425|NCT00524108|shunt|shunt
1563426|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
1563427|NCT00524095|prophylaxis|prophylaxis
1563428|NCT00524095|Antibiotic|antibiotic
1563429|NCT00524095|inhaled steroids|inhaled steroids
1563430|NCT00524095|bronchiectasis|bronchiectasis
1563431|NCT00524095|prevalence|prevalence
1563432|NCT00524095|chronic bronchitis|chronic bronchitis
1563433|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
1563434|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
1563435|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1563436|NCT00524056|Essential Tremor|essential tremor
1563437|NCT00524056|Tremor|tremor
1563438|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
1563439|NCT00524043|Schizophrenia|schizophrenia
1563440|NCT00524030|Epilepsy|epilepsy
1563441|NCT00524030|partial seizures|partial seizures
1563442|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
1563443|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
1563444|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
1563445|NCT00524017|laryngeal cancer|laryngeal cancer
1563446|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
1563447|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
1563448|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
1563449|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1563450|NCT00524017|salivary gland cancer|salivary gland cancer
1563451|NCT00524017|precancerous condition|precancerous condition
1563452|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
1563453|NCT00523978|Atrial Fibrillation|atrial fibrillation
1563454|NCT00523965|Kala-azar|kala-azar
1563455|NCT00523965|miltefosine|miltefosine
1563456|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
1563457|NCT00523952|dermatitis, atopic|dermatitis, atopic
1563458|NCT00523952|tacrolimus|tacrolimus
1563459|NCT00523952|adult|adult
1563462|NCT00523939|Leukemic Meningitis|leukemic meningitis
1563463|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
1563464|NCT00523926|Tuberculosis|tuberculosis
1563465|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
1563466|NCT00523913|diabetes;|diabetes;
1563467|NCT00523913|rosiglitazone|rosiglitazone
1563468|NCT00523913|Avandia;|avandia;
1563469|NCT00523900|malnutrition|malnutrition
1563470|NCT00523900|underweight|underweight
1563471|NCT00523900|low body weight|low body weight
1563472|NCT00523900|BMI under 19|bmi under 19
1563473|NCT00523900|under nourished|under nourished
1563474|NCT00523900|malnourished|malnourished
1563475|NCT00523887|Radiation pain|radiation pain
1563476|NCT00523887|Duragesic|duragesic
1563477|NCT00523887|Fentanyl|fentanyl
1563478|NCT00523887|Pain|pain
1563479|NCT00523861|Glucose|glucose
1563480|NCT00523861|Insulin sensitivity|insulin sensitivity
1563481|NCT00523861|Glucose metabolism|glucose metabolism
1563482|NCT00523861|Appetite|appetite
1563483|NCT00523861|Satiety|satiety
1563484|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
1563485|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
1563486|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
1563615|NCT00523458|Therapy|therapy
1563616|NCT00523458|Treatment Naive|treatment naive
1563487|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
1563488|NCT00523809|Breast Cancer|breast cancer
1563489|NCT00523809|Ovarian Cancer|ovarian cancer
1563490|NCT00523809|Stem Cell Transplantation|stem cell transplantation
1563491|NCT00523809|Bevacizumab|bevacizumab
1563492|NCT00523809|Fludarabine|fludarabine
1563493|NCT00523809|Melphalan|melphalan
1563494|NCT00523809|Avastin|avastin
1563495|NCT00523809|Thymoglobulin|thymoglobulin
1563496|NCT00523809|ATG|atg
1563497|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
1563498|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1563499|NCT00523809|AHSCT|ahsct
1563500|NCT00523796|dyslipidemia|dyslipidemia
1563501|NCT00523796|in practice survey|in practice survey
1563502|NCT00523796|Vietnam|vietnam
1563503|NCT00523783|Schizophrenia|schizophrenia
1563504|NCT00523783|Schizoaffective|schizoaffective
1563505|NCT00523783|quetiapine|quetiapine
1563506|NCT00523783|long-term efficacy|long-term efficacy
1563507|NCT00523783|Naturalistic|naturalistic
1563508|NCT00523783|Observational|observational
1563509|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
1563510|NCT00523770|Pneumonia|pneumonia
1563511|NCT00523757|heart failure|heart failure
1563512|NCT00523757|collagen|collagen
1563513|NCT00523757|diastolic function|diastolic function
1563514|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
1563515|NCT00523731|Stem cells|stem cells
1563516|NCT00523731|Rest pain|rest pain
1563517|NCT00523731|claudication|claudication
1568259|NCT00506480|endometrial sampling|endometrial sampling
1563518|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
1563519|NCT00523731|Angiogenesis|angiogenesis
1563520|NCT00523731|no-option cases|no-option cases
1563521|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
1563522|NCT00523718|OCD|ocd
1563523|NCT00523718|glutamate|glutamate
1563524|NCT00523718|riluzole|riluzole
1563525|NCT00523718|augmentation|augmentation
1563526|NCT00523718|treatment|treatment
1563527|NCT00523705|premenstrual syndrome|premenstrual syndrome
1563528|NCT00523705|PMS|pms
1563529|NCT00523705|PMDD|pmdd
1563530|NCT00523705|treatment|treatment
1563531|NCT00523705|SSRI|ssri
1563532|NCT00523692|Early arthritis|early arthritis
1563533|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
1563534|NCT00523692|Rheumatoid factor|rheumatoid factor
1563535|NCT00523692|Anti CCP antibody|anti ccp antibody
1563536|NCT00523692|Remission|remission
1563537|NCT00523692|Anti-TNF therapy|anti-tnf therapy
1563538|NCT00523692|methotrexate|methotrexate
1563539|NCT00523679|Asthma|asthma
1563540|NCT00523679|Symbicort|symbicort
1563541|NCT00523679|SMART|smart
1563542|NCT00523679|inhaler|inhaler
1563543|NCT00523679|compliance|compliance
1563544|NCT00523679|Naturalistic|naturalistic
1563545|NCT00523679|Observational|observational
1563546|NCT00523666|Alzheimer's disease|alzheimer's disease
1563547|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
1563548|NCT00523640|metastatic|metastatic
1563549|NCT00523640|renal cell|renal cell
1563550|NCT00523640|kidney|kidney
1563551|NCT00523640|neoplasm|neoplasm
1563552|NCT00523627|Energy Expenditure|energy expenditure
1563553|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
1563554|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
1563555|NCT00523627|Fasting|fasting
1563556|NCT00523627|Weight Gain|weight gain
1563557|NCT00523614|venous thromboembolism|venous thromboembolism
1563558|NCT00523601|Bipolar depression|bipolar depression
1563559|NCT00523601|quetiapine|quetiapine
1563560|NCT00523601|observational|observational
1563561|NCT00523601|Naturalistic|naturalistic
1563562|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
1563563|NCT00523588|Pulsed dye laser|pulsed dye laser
1563564|NCT00523575|Elderly|elderly
1563565|NCT00523575|Osteoporosis|osteoporosis
1563566|NCT00523575|hip fracture|hip fracture
1563567|NCT00523575|malnutrition|malnutrition
1563568|NCT00523575|nutritional support|nutritional support
1563569|NCT00523562|fructose|fructose
1563570|NCT00523562|dietary lipids|dietary lipids
1563571|NCT00523562|dietary proteins|dietary proteins
1563572|NCT00523562|hepatic steatosis|hepatic steatosis
1563573|NCT00523562|insulin resistance|insulin resistance
1563574|NCT00523562|Healthy humans|healthy humans
1563575|NCT00523562|overweight humans|overweight humans
1563576|NCT00523562|obese humans|obese humans
1563577|NCT00523549|Hypertension|hypertension
1563578|NCT00523549|systolic blood pressure|systolic blood pressure
1563579|NCT00523549|diastolic dysfunction|diastolic dysfunction
1563580|NCT00523549|valsartan|valsartan
1563581|NCT00523549|amlodipine|amlodipine
1563582|NCT00523536|High Blood Pressure|high blood pressure
1563583|NCT00523536|Cardiovascular|cardiovascular
1563584|NCT00523523|Rehabilitation|rehabilitation
1563585|NCT00523523|hemiplegia|hemiplegia
1563586|NCT00523523|stroke|stroke
1563587|NCT00523523|upper extremity|upper extremity
1563588|NCT00523523|motor skills|motor skills
1563589|NCT00523523|therapy|therapy
1563590|NCT00523510|breastmilk|breastmilk
1563591|NCT00523510|perinatal HIV|perinatal hiv
1563592|NCT00523510|infant feeding|infant feeding
1563593|NCT00523510|flash heat|flash heat
1563594|NCT00523510|pasteurization|pasteurization
1563595|NCT00523510|pmtct|pmtct
1563596|NCT00523510|HIV|hiv
1563597|NCT00523510|HIV Seronegativity|hiv seronegativity
1563598|NCT00523510|Treatment Naive|treatment naive
1563599|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
1563600|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
1563601|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
1563602|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
1563603|NCT00523484|Prostate Cancer|prostate cancer
1563604|NCT00523484|Prostate Specific Antigen|prostate specific antigen
1563605|NCT00523484|Naturalistic|naturalistic
1563606|NCT00523484|Observational|observational
1563607|NCT00523471|prostate cancer|prostate cancer
1563608|NCT00523471|gamma H2AX|gamma h2ax
1563609|NCT00523471|radiosensitivity|radiosensitivity
1563610|NCT00523458|Co-infection|co-infection
1563611|NCT00523458|Tuberculosis|tuberculosis
1563612|NCT00523458|HIV|hiv
1563613|NCT00523458|Drug interactions|drug interactions
1563614|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
1563617|NCT00523445|Schizophrenia|schizophrenia
1563618|NCT00523445|Cognition|cognition
1563619|NCT00523445|Varenicline|varenicline
1563620|NCT00523432|ovarian cancer|ovarian cancer
1563621|NCT00523432|cervical cancer|cervical cancer
1563622|NCT00523432|uterine cancer|uterine cancer
1563623|NCT00523432|fallopian tube cancer|fallopian tube cancer
1563624|NCT00523432|endometrial cancer|endometrial cancer
1563625|NCT00523432|vaginal cancer|vaginal cancer
1563626|NCT00523432|peritoneal cancer|peritoneal cancer
1563627|NCT00523432|reproductive cancer|reproductive cancer
1563628|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
1563629|NCT00523406|vision,|vision,
1563630|NCT00523406|macula,|macula,
1563631|NCT00523406|macular degeneration|macular degeneration
1563632|NCT00523406|optical coherence tomography|optical coherence tomography
1563633|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
1563634|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
1563635|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1563636|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
1563637|NCT00523354|TNF-alpha|tnf-alpha
1563638|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
1563639|NCT00523354|Infliximab|infliximab
1563640|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
1563641|NCT00523341|low bone density|low bone density
1563642|NCT00523341|fractures|fractures
1563643|NCT00523341|low bone mass|low bone mass
1563644|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
1563645|NCT00523328|Arthritis|arthritis
1563646|NCT00523328|BG9924|bg9924
1563647|NCT00523328|methotrexate|methotrexate
1563648|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
1563649|NCT00523315|Breast Cancer|breast cancer
1563650|NCT00523315|compliance|compliance
1563651|NCT00523315|Naturalistic|naturalistic
1563652|NCT00523315|Observational|observational
1563653|NCT00523302|Major Depression|major depression
1563654|NCT00523302|Fibromyalgia|fibromyalgia
1563655|NCT00523302|TMS|tms
1563656|NCT00523289|Ropivacaine|ropivacaine
1563657|NCT00523289|Bupivacaine|bupivacaine
1563658|NCT00523289|Upper Extremity|upper extremity
1563659|NCT00523289|Local anesthetic|local anesthetic
1563660|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
1563661|NCT00523250|Glaucoma|glaucoma
1563662|NCT00523224|Stem cells|stem cells
1563663|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
1563664|NCT00523224|Congestive Heart Failure|congestive heart failure
1563665|NCT00523224|Coronary Artery Disease|coronary artery disease
1563666|NCT00523224|Angiogenesis|angiogenesis
1563667|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1563668|NCT00523211|Treatment Experienced|treatment experienced
1563669|NCT00523198|Cortisol|cortisol
1563670|NCT00523185|alcohol withdrawal|alcohol withdrawal
1563671|NCT00523185|lorazepam|lorazepam
1563672|NCT00523185|diazepam|diazepam
1563673|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
1563674|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1563675|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
1563676|NCT00523146|Herbal remedy|herbal remedy
1563677|NCT00523133|alcoholism|alcoholism
1563678|NCT00523133|naltrexone|naltrexone
1563679|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
1563680|NCT00523107|Fatigue|fatigue
1563681|NCT00523107|Standard Palliative Care|standard palliative care
1563682|NCT00523107|PG2|pg2
1563683|NCT00523107|QLQ-C30|qlq-c30
1563684|NCT00523107|Compassionate|compassionate
1563685|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
1563686|NCT00523081|collaborative care|collaborative care
1563687|NCT00523068|overactive bladder|overactive bladder
1563688|NCT00523068|stress urinary incontinence|stress urinary incontinence
1563689|NCT00523068|detrusor overactivity|detrusor overactivity
1563690|NCT00523068|urodynamics|urodynamics
1563691|NCT00523055|Pain|pain
1563692|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
1563693|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
1563694|NCT00523055|Ultrasound|ultrasound
1563695|NCT00523029|Self-management programs|self-management programs
1563696|NCT00523029|Chronic medical illness|chronic medical illness
1563697|NCT00523016|acupuncture|acupuncture
1563698|NCT00523016|electroacupuncture|electroacupuncture
1563699|NCT00523016|sham acupuncture|sham acupuncture
1563700|NCT00523016|spinal cord injury|spinal cord injury
1563701|NCT00523016|neuropathic pain|neuropathic pain
1563702|NCT00523016|burning pain|burning pain
1563703|NCT00523003|weight loss|weight loss
1563704|NCT00523003|obesity|obesity
1563705|NCT00523003|high protein|high protein
1563706|NCT00523003|meal replacement|meal replacement
1563707|NCT00522977|Myocardial strain|myocardial strain
1563708|NCT00522977|Myocardial function|myocardial function
1563709|NCT00522977|Pregnancy|pregnancy
1563710|NCT00522977|Postpartum|postpartum
1563711|NCT00522977|Echocardiography|echocardiography
1563712|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
1563713|NCT00522977|Systolic function|systolic function
1563714|NCT00522977|Diastolic function|diastolic function
1563715|NCT00522964|Chinese-American|chinese-american
1563716|NCT00522964|Children|children
1563717|NCT00522964|Obesity|obesity
1563718|NCT00522964|health behaviors|health behaviors
1563719|NCT00522964|Behavioral intervention|behavioral intervention
1563721|NCT00522951|MRI|mri
1563722|NCT00522951|Brain Metastasis|brain metastasis
1563723|NCT00522951|Gadolinium|gadolinium
1563724|NCT00522951|Imaging|imaging
1563725|NCT00522951|Diagnostic Agent|diagnostic agent
1563726|NCT00522938|Lung|lung
1563727|NCT00522938|Cancer|cancer
1563728|NCT00522938|Non-small|non-small
1563729|NCT00522938|Lung Cancer|lung cancer
1563730|NCT00522938|NSCLC|nsclc
1563731|NCT00522938|erlotinib|erlotinib
1563732|NCT00522938|oral|oral
1563733|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
1563734|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
1563735|NCT00522925|hypertension|hypertension
1563736|NCT00522925|high blood pressure|high blood pressure
1563737|NCT00522912|Trachoma|trachoma
1563738|NCT00522912|Trichiasis|trichiasis
1563739|NCT00522912|Surgery|surgery
1563740|NCT00522912|Epilation|epilation
1563741|NCT00522912|Ethiopia|ethiopia
1563742|NCT00522899|aged|aged
1563743|NCT00522899|exercise|exercise
1563744|NCT00522899|cognitive therapy|cognitive therapy
1563745|NCT00522899|dementia|dementia
1563746|NCT00522899|prevention|prevention
1563747|NCT00522886|cetuximab|cetuximab
1563748|NCT00522886|concurrent|concurrent
1563749|NCT00522886|iso-toxic|iso-toxic
1563750|NCT00522886|NSCLC|nsclc
1563751|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
1563752|NCT00522873|Hot flushes|hot flushes
1563753|NCT00522873|Sweating episodes|sweating episodes
1563754|NCT00522873|Vaginal dryness|vaginal dryness
1563755|NCT00522860|Trichiasis|trichiasis
1563756|NCT00522860|Trachoma|trachoma
1563757|NCT00522860|Surgery|surgery
1563758|NCT00522860|Suture|suture
1563759|NCT00522860|Ethiopia|ethiopia
1563760|NCT00522847|Postmenopausal|postmenopausal
1563761|NCT00522847|non dry eye|non dry eye
1563762|NCT00522834|melanoma|melanoma
1563763|NCT00522834|oncology|oncology
1563764|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
1563765|NCT00522821|IgG subclass deficiency|igg subclass deficiency
1563766|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
1563767|NCT00522821|therapy|therapy
1564406|NCT00520663|Volunteer,|volunteer,
1563768|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1563769|NCT00522821|co-trimoxazole|co-trimoxazole
1563770|NCT00522808|HCV|hcv
1563771|NCT00522808|antiviral|antiviral
1563772|NCT00522808|PK|pk
1563773|NCT00522808|Safety|safety
1563774|NCT00522795|Esophageal Cancer|esophageal cancer
1563775|NCT00522769|binge eating|binge eating
1563776|NCT00522769|adolescent girls|adolescent girls
1563777|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
1563778|NCT00522756|Kidney Failure, Acute|kidney failure, acute
1563779|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
1563780|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
1563781|NCT00522756|Sodium Chloride|sodium chloride
1563782|NCT00522756|Prevention and control|prevention and control
1563783|NCT00522743|SGA|sga
1563784|NCT00522743|GH|gh
1563785|NCT00522743|GnRHa|gnrha
1563786|NCT00522743|IGF-1|igf-1
1563787|NCT00522730|Liver failure|liver failure
1563788|NCT00522730|Liver cirrhosis|liver cirrhosis
1563789|NCT00522730|Parenteral nutrition|parenteral nutrition
1563790|NCT00522730|Enteral nutrition|enteral nutrition
1563791|NCT00522730|Lipids|lipids
1563792|NCT00522730|Safety|safety
1563793|NCT00522730|Drug tolerance|drug tolerance
1563794|NCT00522704|Arteriovenous fistula|arteriovenous fistula
1563795|NCT00522704|Access blood flow|access blood flow
1563796|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
1563797|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
1563798|NCT00522704|Hemodialysis treatment|hemodialysis treatment
1563799|NCT00522691|Fecal incontinence|fecal incontinence
1563800|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
1563801|NCT00522678|Healthy Volunteers|healthy volunteers
1563802|NCT00522652|cancer|cancer
1563803|NCT00522652|advanced cancer|advanced cancer
1563804|NCT00522652|lymphoma|lymphoma
1563805|NCT00522639|lung cancer|lung cancer
1563806|NCT00522639|FDG-PET-CT|fdg-pet-ct
1563807|NCT00522639|blood proteins|blood proteins
1563808|NCT00522639|prognose|prognose
1563809|NCT00522626|Fetus|fetus
1563810|NCT00522626|Drug abuse|drug abuse
1563811|NCT00522626|Fetal development|fetal development
1563812|NCT00522626|Substance abuse|substance abuse
1563813|NCT00522626|Opioids|opioids
1563814|NCT00522626|Methadone|methadone
1563815|NCT00522613|recovery|recovery
1563816|NCT00522613|serious mental illness|serious mental illness
1563817|NCT00522613|bipolar disorder|bipolar disorder
1563818|NCT00522613|schizophrenia|schizophrenia
1563819|NCT00522613|schizoaffective disorder|schizoaffective disorder
1563820|NCT00522600|eyedrops|eyedrops
1563821|NCT00522600|compliance|compliance
1563822|NCT00522600|glaucoma medications|glaucoma medications
1563823|NCT00522600|adherence|adherence
1563824|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
1563825|NCT00522561|Healthy volunteers|healthy volunteers
1563826|NCT00522561|running|running
1563827|NCT00522561|energetic cost|energetic cost
1563828|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
1563829|NCT00522561|contractile components|contractile components
1563830|NCT00522561|elastic components|elastic components
1563831|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
1563832|NCT00522548|African American|african american
1563833|NCT00522548|Kidney Transplant|kidney transplant
1563834|NCT00522535|AAA|aaa
1563835|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
1563836|NCT00522535|Endovascular|endovascular
1563837|NCT00522535|EVAR|evar
1563838|NCT00522535|Aorta|aorta
1563839|NCT00522535|Stent Graft|stent graft
1563840|NCT00522535|Stent|stent
1563841|NCT00522535|Tortuous|tortuous
1563842|NCT00522535|High Angle|high angle
1563843|NCT00522535|Angled Necks|angled necks
1563844|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
1563845|NCT00522496|Craniocerebral trauma|craniocerebral trauma
1563846|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
1564199|NCT00521404|Gemzar|gemzar
1563847|NCT00522496|microdialysis|microdialysis
1563848|NCT00522457|Breast Cancer|breast cancer
1563849|NCT00522457|investigational drug|investigational drug
1563850|NCT00522457|drug therapy|drug therapy
1563851|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
1563852|NCT00522457|Immunotherapy|immunotherapy
1563853|NCT00522457|Metastatic breast cancer|metastatic breast cancer
1563854|NCT00522457|Advanced breast cancer|advanced breast cancer
1563855|NCT00522457|Stage IV breast cancer|stage iv breast cancer
1563856|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
1563857|NCT00522457|Her-2/neu|her-2/neu
1563858|NCT00522457|Trastuzumab refractory|trastuzumab refractory
1563859|NCT00522431|Hypogonadism|hypogonadism
1563860|NCT00522418|Epilepsy|epilepsy
1563861|NCT00522418|VNS Therapy|vns therapy
1563862|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
1563863|NCT00522405|Thalidomide|thalidomide
1563864|NCT00522405|Capecitabine|capecitabine
1563865|NCT00522405|Treatment|treatment
1563866|NCT00522392|Consolidation therapy|consolidation therapy
1563867|NCT00522392|First-line therapy|first-line therapy
1564407|NCT00520663|Metabolism,|metabolism,
1563868|NCT00522392|Proteasome inhibitor|proteasome inhibitor
1563869|NCT00522392|Thalidomide analogue|thalidomide analogue
1563870|NCT00522392|Quality of life|quality of life
1563871|NCT00522379|Parkinson's disease|parkinson's disease
1563872|NCT00522379|rotigotine|rotigotine
1563873|NCT00522379|patch|patch
1563874|NCT00522379|transdermal|transdermal
1563875|NCT00522379|dopamine agonist|dopamine agonist
1563876|NCT00522379|off time|off time
1563877|NCT00522379|Neupro|neupro
1563878|NCT00522353|obesity|obesity
1563879|NCT00522353|weight loss|weight loss
1563880|NCT00522353|satiety hormones|satiety hormones
1563881|NCT00522353|body composition|body composition
1563882|NCT00522353|appetite ratings|appetite ratings
1563883|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
1563884|NCT00522340|ICD|icd
1563885|NCT00522340|Exercise|exercise
1563886|NCT00522340|Cardiac|cardiac
1563887|NCT00522340|Inflammation|inflammation
1563888|NCT00522327|Immigrant|immigrant
1563889|NCT00522327|Interpreting|interpreting
1563890|NCT00522314|Non-invasive ventilation|non-invasive ventilation
1563891|NCT00522314|Airway clearance|airway clearance
1563892|NCT00522314|Bronchiectasis|bronchiectasis
1563893|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1563894|NCT00522301|fallopian tube cancer|fallopian tube cancer
1563895|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1563896|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1563897|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1563898|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1563899|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1563900|NCT00522288|Myopia|myopia
1563901|NCT00522288|Self-Perception|self-perception
1563902|NCT00522288|Contact Lenses|contact lenses
1563903|NCT00522288|Glasses|glasses
1563904|NCT00522288|Randomized|randomized
1563905|NCT00522288|Children|children
1563906|NCT00522288|Self-esteem|self-esteem
1563907|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
1563908|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
1563909|NCT00522275|partial seizures|partial seizures
1563910|NCT00522275|AEDs|aeds
1563911|NCT00522275|antiepileptic drugs|antiepileptic drugs
1563912|NCT00522275|seizures|seizures
1563913|NCT00522262|Breast Neoplasms|breast neoplasms
1563914|NCT00522262|Exercise|exercise
1563915|NCT00522262|Physical activity|physical activity
1563916|NCT00522262|Estrone|estrone
1563917|NCT00522262|Estradiol|estradiol
1563918|NCT00522262|Adiposity|adiposity
1563919|NCT00522262|Breast density|breast density
1563920|NCT00522262|Mammographic density|mammographic density
1563921|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
1563922|NCT00522262|Insulin Resistance|insulin resistance
1563923|NCT00522262|Women|women
1563924|NCT00522262|Postmenopause|postmenopause
1563925|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1563926|NCT00522249|RCC|rcc
1563927|NCT00522249|M3thodist|m3thodist
1563928|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
1563929|NCT00522249|Sunitinib|sunitinib
1563930|NCT00522249|Tarceva|tarceva
1563931|NCT00522249|Peg IFN|peg ifn
1563932|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
1563933|NCT00522223|Cervical Cancer|cervical cancer
1563934|NCT00522223|Cancer Survivors|cancer survivors
1563935|NCT00522223|Cervix Cancer|cervix cancer
1563936|NCT00522223|Sexual Functioning|sexual functioning
1563937|NCT00522223|Quality Of Life|quality of life
1563938|NCT00522223|Questionnaire|questionnaire
1563939|NCT00522223|Radiation Therapy|radiation therapy
1563940|NCT00522223|Radical Hysterectomy|radical hysterectomy
1563941|NCT00522210|type 1 diabetes|type 1 diabetes
1563942|NCT00522210|children|children
1563943|NCT00522210|long acting insulin analogue|long acting insulin analogue
1563944|NCT00522210|hemoglobin A1c|hemoglobin a1c
1563945|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
1563946|NCT00522197|small cell lung cancer|small cell lung cancer
1563947|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
1563948|NCT00522184|intra-articular injection|intra-articular injection
1563949|NCT00522184|acute synovitis|acute synovitis
1563950|NCT00522184|etanercept|etanercept
1563951|NCT00522171|Harmonic|harmonic
1563952|NCT00522171|Massive Weight Loss|massive weight loss
1563953|NCT00522171|Electro Surgery|electro surgery
1563954|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
1563955|NCT00522171|Obesity|obesity
1563956|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1563957|NCT00522132|intravenous artesunate|intravenous artesunate
1563958|NCT00522132|severe malaria|severe malaria
1563959|NCT00522132|Plasmodium falciparum|plasmodium falciparum
1563960|NCT00522132|Africa|africa
1563961|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
1563962|NCT00522119|Essential Hypertension|essential hypertension
1563963|NCT00522119|High Blood Pressure|high blood pressure
1563964|NCT00522106|Behavioral graded activity|behavioral graded activity
1563965|NCT00522106|Hip|hip
1563966|NCT00522106|Knee|knee
1563967|NCT00522106|Physical therapy|physical therapy
1563968|NCT00522106|Exercise therapy|exercise therapy
1563969|NCT00522093|constipation|constipation
1563970|NCT00522067|influenza|influenza
1563971|NCT00522067|influenza vaccine|influenza vaccine
1563972|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
1563973|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
1563974|NCT00522067|surface antigen|surface antigen
1563975|NCT00522054|Exercise|exercise
1563976|NCT00522054|Physical function|physical function
1563977|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
1563978|NCT00522054|Tai Chi|tai chi
1563979|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
1563980|NCT00522028|QoL|qol
1563981|NCT00522028|Osteodensitometry|osteodensitometry
1563982|NCT00522028|Arterial pressure|arterial pressure
1563983|NCT00522028|PTH|pth
1563984|NCT00522015|PSP|psp
1563985|NCT00522015|dementia|dementia
1563986|NCT00522015|neuropsychology|neuropsychology
1563987|NCT00522015|treatment|treatment
1563988|NCT00522002|Connective tissue diseases|connective tissue diseases
1563989|NCT00522002|Blood coagulation disorders|blood coagulation disorders
1563990|NCT00522002|Leg ulcers|leg ulcers
1563991|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
1563992|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
1563993|NCT00522002|Systemic Scleroderma|systemic scleroderma
1563994|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
1563995|NCT00521989|Osteoarthritis|osteoarthritis
1563996|NCT00521989|Knee|knee
1563997|NCT00521989|CRx-102|crx-102
1563998|NCT00521989|prednisolone|prednisolone
1563999|NCT00521989|dipyridamole|dipyridamole
1564000|NCT00521989|CombinatoRx|combinatorx
1564001|NCT00521989|WOMAC|womac
1564002|NCT00521976|Risk assessment|risk assessment
1564003|NCT00521976|Chest pain|chest pain
1564004|NCT00521976|Coronary Artery Disease|coronary artery disease
1564005|NCT00521976|Acute coronary syndromes|acute coronary syndromes
1564006|NCT00521976|Factor XIIa|factor xiia
1564007|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
1564008|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
1564009|NCT00521976|Omega-3|omega-3
1564010|NCT00521963|Intraarticular injection|intraarticular injection
1564011|NCT00521963|Infliximab|infliximab
1564012|NCT00521950|Pharmacogenetics|pharmacogenetics
1564013|NCT00521950|Cost Effectiveness|cost effectiveness
1564014|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
1564015|NCT00521950|Crohn Disease|crohn disease
1564016|NCT00521950|Ulcerative Colitis|ulcerative colitis
1564017|NCT00521950|Randomized Controlled Trials|randomized controlled trials
1564018|NCT00521911|Intervention Studies|intervention studies
1564019|NCT00521911|Randomized Controlled Trials|randomized controlled trials
1564020|NCT00521911|Cognitive Therapy|cognitive therapy
1564021|NCT00521911|Hospitals, General|hospitals, general
1564022|NCT00521911|Prevalence|prevalence
1564023|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
1564024|NCT00521885|Bleeding rates|bleeding rates
1564025|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
1564026|NCT00521872|surgery (STARR operation)|surgery (starr operation)
1564027|NCT00521859|Hematologic Malignancies|hematologic malignancies
1564028|NCT00521859|Leukemia|leukemia
1564029|NCT00521859|Lymphoma|lymphoma
1564030|NCT00521859|Myeloma|myeloma
1564031|NCT00521859|Hodgkin's Disease|hodgkin's disease
1564032|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
1564033|NCT00521859|Cloretazine|cloretazine
1564034|NCT00521859|VNP40101M|vnp40101m
1564035|NCT00521859|Fludarabine|fludarabine
1564036|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
1564037|NCT00521859|Fludara|fludara
1564039|NCT00521859|Antithymocyte|antithymocyte
1564040|NCT00521859|Thymoglobulin|thymoglobulin
1564041|NCT00521833|Kataract|kataract
1564042|NCT00521833|Astigmatism|astigmatism
1564043|NCT00521833|phacoemulsification|phacoemulsification
1564383|NCT00520741|Monotherapy|monotherapy
1564044|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
1564045|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
1564046|NCT00521820|Type II Diabetes|type ii diabetes
1564047|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1564048|NCT00521820|Dyslipidemia|dyslipidemia
1564049|NCT00521820|Drug Therapy|drug therapy
1564050|NCT00521807|Hypnosis,|hypnosis,
1564051|NCT00521807|Chronic widespread pain,|chronic widespread pain,
1564052|NCT00521807|CWP,|cwp,
1564053|NCT00521807|General Practice|general practice
1564054|NCT00521794|Arrhythmia|arrhythmia
1564055|NCT00521794|Muscle Weakness|muscle weakness
1564056|NCT00521794|Periodic Paralysis|periodic paralysis
1564057|NCT00521794|Channelopathy|channelopathy
1564058|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
1564059|NCT00521781|Hormonal Therapy|hormonal therapy
1564060|NCT00521781|Abraxane|abraxane
1564061|NCT00521781|M3thodist|m3thodist
1564062|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
1564063|NCT00521768|Anxiety disorder|anxiety disorder
1564408|NCT00520663|Absorption,|absorption,
1564064|NCT00521768|Comunity base intervention|comunity base intervention
1564065|NCT00521768|Education|education
1564066|NCT00521768|Behavioural treatment|behavioural treatment
1564067|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
1564068|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
1564069|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
1564070|NCT00521742|Type II Diabetes|type ii diabetes
1564071|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1564072|NCT00521742|Dyslipidemia|dyslipidemia
1564073|NCT00521742|Drug Therapy|drug therapy
1564074|NCT00521729|Thyroid|thyroid
1564075|NCT00521729|Thermoregulation|thermoregulation
1564076|NCT00521729|Catecholamines|catecholamines
1564077|NCT00521729|Energy Expenditure|energy expenditure
1564078|NCT00521729|Obesity|obesity
1564079|NCT00521729|Healthy Volunteer|healthy volunteer
1564080|NCT00521729|HV|hv
1564081|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
1564082|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
1564083|NCT00521703|lidocaine|lidocaine
1564084|NCT00521703|propofol|propofol
1564085|NCT00521703|child|child
1564086|NCT00521703|adolescent|adolescent
1564087|NCT00521677|VAP|vap
1564088|NCT00521677|Oral care|oral care
1564089|NCT00521677|Acquired pneumonia|acquired pneumonia
1564090|NCT00521677|Mortality|mortality
1564091|NCT00521677|LOS in ICU|los in icu
1564092|NCT00521677|LOS in hospital|los in hospital
1564093|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
1564094|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
1564095|NCT00521651|Physical Activity|physical activity
1564096|NCT00521651|Cancer Risk|cancer risk
1564097|NCT00521612|sevoflurane|sevoflurane
1564098|NCT00521612|isoflurane|isoflurane
1564099|NCT00521612|anaesthesia|anaesthesia
1564100|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
1564101|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
1564102|NCT00521560|stem cell transplantation|stem cell transplantation
1564103|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
1564104|NCT00521547|Acupuncture|acupuncture
1564105|NCT00521547|Analgesia|analgesia
1564106|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
1564107|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
1564108|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
1564109|NCT00521547|Normal Volunteers|normal volunteers
1564110|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
1564111|NCT00521534|Congestive Heart Failure|congestive heart failure
1564112|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
1564113|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1564115|NCT00521508|kidney|kidney
1564116|NCT00521508|Berger'disease|berger'disease
1564117|NCT00521508|regulatory T cells|regulatory t cells
1564118|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
1564119|NCT00521495|static magnetic field|static magnetic field
1564120|NCT00521495|permanent magnet|permanent magnet
1564121|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
1564122|NCT00521495|median nerve|median nerve
1564123|NCT00521482|recurrent|recurrent
1564124|NCT00521482|after standard therapy|after standard therapy
1564125|NCT00521469|Disequilibrium|disequilibrium
1564126|NCT00521469|Spinal Manipulation|spinal manipulation
1564127|NCT00521469|Postural control|postural control
1564128|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1564129|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1564130|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1564131|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1564132|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1564133|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1564134|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1564135|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1564136|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1564137|NCT00521430|aplastic anemia|aplastic anemia
1564138|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1564139|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1564140|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1564141|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1564142|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1564143|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1564144|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1564145|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1564409|NCT00520624|EIL|eil
1564146|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1564147|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
1564148|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1564149|NCT00521430|refractory anemia|refractory anemia
1564150|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
1564151|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1564152|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1564153|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1564154|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1564155|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1564156|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1564157|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1564158|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1564159|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1564160|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1564161|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1564162|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1564163|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
1564164|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1564165|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1564166|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1564167|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1564168|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1564169|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1564170|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1564171|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1564172|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1564173|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1564174|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1564175|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1564176|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1564177|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
1564178|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
1564179|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
1564180|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1564181|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1564182|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1564183|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1564184|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1564185|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1564186|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1564187|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1564188|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1564189|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1564190|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1564191|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1564192|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1564193|NCT00521417|RCT|rct
1564194|NCT00521404|Pancreatic cancer|pancreatic cancer
1564195|NCT00521404|chemotherapy naive|chemotherapy naive
1564196|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
1564197|NCT00521404|CS1008|cs1008
1564198|NCT00521404|Gemcitabine|gemcitabine
1564200|NCT00521391|smoking cessation|smoking cessation
1564201|NCT00521391|nicotine|nicotine
1564202|NCT00521391|physical activity|physical activity
1564203|NCT00521378|Diabetes|diabetes
1564204|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
1564205|NCT00521365|Bipolar Disorder|bipolar disorder
1564206|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
1564207|NCT00521365|Mania|mania
1564208|NCT00521365|Manic Disorder|manic disorder
1564209|NCT00521365|Manic State|manic state
1564210|NCT00521352|TMS|tms
1564211|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
1564212|NCT00521339|Apremilast,|apremilast,
1564213|NCT00521339|Psoriasis,|psoriasis,
1564214|NCT00521339|PASI-75,|pasi-75,
1564215|NCT00521339|sPGA|spga
1564216|NCT00521326|doppler|doppler
1564217|NCT00521326|coronary stenosis|coronary stenosis
1564218|NCT00521326|non-invasive testing|non-invasive testing
1564219|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
1564410|NCT00520611|Obesity|obesity
1564220|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
1564221|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
1564222|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
1564223|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
1564224|NCT00521300|Acromegaly|acromegaly
1564225|NCT00521287|Immunologic Surveillance|immunologic surveillance
1564226|NCT00521287|Vaccination|vaccination
1564227|NCT00521287|Immunotherapy|immunotherapy
1564228|NCT00521287|Dendritic Cells|dendritic cells
1564229|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
1564230|NCT00521274|HRPC|hrpc
1564231|NCT00521274|MVA 5T4|mva 5t4
1564232|NCT00521274|Trovax®|trovax®
1564233|NCT00521274|Docetaxel|docetaxel
1564234|NCT00521274|M3thodist|m3thodist
1564235|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1564236|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1564237|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1564238|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1564239|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1564240|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1564241|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1564242|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1564243|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1564244|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1564245|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1564246|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1564247|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1564248|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1564249|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1568260|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
1564250|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1564251|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1564252|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1564253|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
1564254|NCT00521248|buprenorphine|buprenorphine
1564255|NCT00521248|neonatal|neonatal
1564256|NCT00521248|opioid withdrawal|opioid withdrawal
1564257|NCT00521235|risk factors|risk factors
1564258|NCT00521235|metabolic syndrome|metabolic syndrome
1564259|NCT00521235|dentists|dentists
1564260|NCT00521235|trainers|trainers
1564261|NCT00521235|Healthy subjects|healthy subjects
1564262|NCT00521235|students|students
1564263|NCT00521235|seniors|seniors
1564264|NCT00521222|asthma|asthma
1564265|NCT00521222|beta agonist|beta agonist
1564266|NCT00521222|bronchodilator|bronchodilator
1564267|NCT00521222|pulmonary|pulmonary
1564268|NCT00521222|genotype|genotype
1564269|NCT00521222|pharmacogenomics|pharmacogenomics
1564270|NCT00521222|corticosteroid|corticosteroid
1564271|NCT00521222|allergy|allergy
1564272|NCT00521222|immunology|immunology
1564273|NCT00521209|Impoverished Population|impoverished population
1564274|NCT00521196|migraine|migraine
1564275|NCT00521196|headache|headache
1564276|NCT00521196|chronic|chronic
1564277|NCT00521196|pain|pain
1564278|NCT00521196|brain|brain
1564279|NCT00521196|neurology|neurology
1564280|NCT00521196|stimulation|stimulation
1564281|NCT00521196|noninvasive|noninvasive
1564282|NCT00521196|transcranial|transcranial
1564283|NCT00521196|direct|direct
1564284|NCT00521196|current|current
1564285|NCT00521196|tDCS|tdcs
1564287|NCT00521196|rTMS|rtms
1564288|NCT00521196|BIDMC|bidmc
1564289|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
1564290|NCT00521170|Levocetirizine|levocetirizine
1564291|NCT00521170|Wheal and flare|wheal and flare
1564292|NCT00521170|Allergic|allergic
1564293|NCT00521157|Substance abuse|substance abuse
1564294|NCT00521157|Opiate dependency|opiate dependency
1564295|NCT00521157|Treatment|treatment
1564296|NCT00521157|Relapse prevention|relapse prevention
1564297|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1564298|NCT00521131|Xyzal tablets|xyzal tablets
1564299|NCT00521105|Type 1 Diabetes|type 1 diabetes
1564300|NCT00521105|Telemedicine|telemedicine
1564301|NCT00521105|Children|children
1564302|NCT00521092|Treatment Experienced|treatment experienced
1564303|NCT00521079|Obesity|obesity
1564304|NCT00521079|Bariatric surgery|bariatric surgery
1564305|NCT00521079|Excess weight loss|excess weight loss
1564306|NCT00521079|Vagus nerve|vagus nerve
1564307|NCT00521079|Vagal blocking|vagal blocking
1564308|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
1564309|NCT00521053|immune|immune
1564310|NCT00521053|vaccine|vaccine
1564311|NCT00521053|systemic|systemic
1564411|NCT00520611|Weight Loss|weight loss
1564312|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
1564313|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
1564314|NCT00521040|Xyzal tablets|xyzal tablets
1564315|NCT00521027|Debridement|debridement
1564316|NCT00521027|hydrosurgery|hydrosurgery
1564317|NCT00521027|Versajet|versajet
1564318|NCT00521027|leg ulcer|leg ulcer
1564319|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1564320|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1564321|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1564322|NCT00521001|stage IV melanoma|stage iv melanoma
1564323|NCT00520988|hypertension|hypertension
1564324|NCT00520988|intervention|intervention
1564325|NCT00520988|disease management|disease management
1564326|NCT00520988|telephone-based|telephone-based
1564327|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
1564328|NCT00520975|Trastuzumab|trastuzumab
1564329|NCT00520975|Bevacizumab|bevacizumab
1564330|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
1564331|NCT00520975|HER2/NEU|her2/neu
1564332|NCT00520962|cardiovascular disease|cardiovascular disease
1564333|NCT00520962|glucose intolerance|glucose intolerance
1564334|NCT00520962|type 2 diabetes|type 2 diabetes
1564335|NCT00520962|endothelial dysfunction|endothelial dysfunction
1564336|NCT00520962|inflammation|inflammation
1564337|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
1564338|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
1564339|NCT00520949|H.pylori|h.pylori
1564340|NCT00520949|Triple therapy failure|triple therapy failure
1564341|NCT00520949|Quadruple therapy|quadruple therapy
1564342|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
1564343|NCT00520910|Skin Aging and Damage|skin aging and damage
1564344|NCT00520897|chronic HIV infection|chronic hiv infection
1564345|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
1564346|NCT00520897|Treatment Experienced|treatment experienced
1732186|NCT00001746|HCM|hcm
1564347|NCT00520884|frailty|frailty
1564348|NCT00520884|ghrelin|ghrelin
1564349|NCT00520884|appetite|appetite
1564350|NCT00520884|weight loss|weight loss
1564351|NCT00520871|Cardiovascular disease|cardiovascular disease
1564352|NCT00520871|Blueberruy|blueberruy
1564353|NCT00520871|Antioxidants|antioxidants
1564354|NCT00520871|Oxidative stress|oxidative stress
1564355|NCT00520871|Inflammation|inflammation
1564356|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1564357|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1564358|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1564359|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1564360|NCT00520832|Primary Insomnia|primary insomnia
1564361|NCT00520832|Microcurrent Therapy|microcurrent therapy
1564362|NCT00520832|Sleep Surveys|sleep surveys
1564363|NCT00520819|Antioxidants|antioxidants
1564364|NCT00520819|Phytochemicals|phytochemicals
1564365|NCT00520819|Oxidative stress|oxidative stress
1564366|NCT00520819|Inflammation|inflammation
1564367|NCT00520819|Endothelial function|endothelial function
1564368|NCT00520806|Heart failure|heart failure
1564369|NCT00520806|Renal dysfunction|renal dysfunction
1564370|NCT00520806|Relaxin|relaxin
1564371|NCT00520806|Vasodilator|vasodilator
1564372|NCT00520780|Chronic Heart Failure|chronic heart failure
1564373|NCT00520780|Iron deficiency|iron deficiency
1564374|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
1564375|NCT00520780|Anaemia|anaemia
1564376|NCT00520780|Heart disease|heart disease
1564377|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
1564378|NCT00520767|light chain deposition disease|light chain deposition disease
1564379|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
1564380|NCT00520741|Epilepsy|epilepsy
1564381|NCT00520741|Partial Onset Seizures|partial onset seizures
1564382|NCT00520741|Lacosamide|lacosamide
1564384|NCT00520741|Vimpat|vimpat
1564385|NCT00520728|Schizophrenia|schizophrenia
1564386|NCT00520728|Psychosis|psychosis
1564387|NCT00520728|Occupational Disengagement|occupational disengagement
1564388|NCT00520728|Occupational Imbalance|occupational imbalance
1564389|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
1564390|NCT00520715|commensal flora|commensal flora
1564391|NCT00520715|carriage|carriage
1564392|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
1564393|NCT00520702|Lung Cancer|lung cancer
1564394|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
1564395|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1564396|NCT00520702|3D CRT|3d crt
1564397|NCT00520702|IMRT|imrt
1564398|NCT00520702|NSCLC|nsclc
1564399|NCT00520702|TRP|trp
1564400|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
1564401|NCT00520663|Distribution,|distribution,
1564402|NCT00520663|SB-649868,|sb-649868,
1564403|NCT00520663|Healthy,|healthy,
1564404|NCT00520663|Excretion,|excretion,
1564405|NCT00520663|Sleep disturbances|sleep disturbances
1564412|NCT00520611|Financial Incentives|financial incentives
1564413|NCT00520611|Lottery|lottery
1564414|NCT00520611|Deposit|deposit
1564415|NCT00520585|atorvastatin|atorvastatin
1564416|NCT00520585|repolarisation|repolarisation
1564417|NCT00520585|cardiomyocytes|cardiomyocytes
1564418|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
1564419|NCT00520546|PET|pet
1564420|NCT00520546|MRI|mri
1564421|NCT00520546|Choline|choline
1564422|NCT00520546|FEC|fec
1564423|NCT00520546|prostate cancer|prostate cancer
1564424|NCT00520533|Clinical trials|clinical trials
1564425|NCT00520533|cG250 mAb|cg250 mab
1564426|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
1564427|NCT00520533|sunitinib|sunitinib
1564428|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
1564429|NCT00520533|Positron-Emission Tomography|positron-emission tomography
1564430|NCT00520533|Pharmacokinetics|pharmacokinetics
1564431|NCT00520533|Pharmacodynamics|pharmacodynamics
1564432|NCT00520520|post resuscitation|post resuscitation
1564433|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
1564434|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
1564435|NCT00520507|Depression|depression
1564436|NCT00520507|Bipolar Disorder|bipolar disorder
1564437|NCT00520507|Major|major
1564438|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
1564439|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
1564440|NCT00520494|CVID|cvid
1564441|NCT00520494|XLA|xla
1564442|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
1564443|NCT00520494|IgG trough level|igg trough level
1564444|NCT00520494|Quality of life|quality of life
1564445|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
1564446|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
1564447|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
1564448|NCT00520468|MDS|mds
1564449|NCT00520468|Erythropoietin|erythropoietin
1564450|NCT00520468|Darbepoetin alfa|darbepoetin alfa
1564451|NCT00520468|Aranesp|aranesp
1564452|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
1564453|NCT00520468|G-CSF|g-csf
1564454|NCT00520468|Filgrastim|filgrastim
1564455|NCT00520468|Neupogen|neupogen
1564456|NCT00520468|Prednisone|prednisone
1564457|NCT00520468|Cyclosporin A|cyclosporin a
1564458|NCT00520468|Sandimmune|sandimmune
1564459|NCT00520468|CYA|cya
1564460|NCT00520468|Cyclosporine|cyclosporine
1564461|NCT00520442|fracture|fracture
1564462|NCT00520429|Depression|depression
1564463|NCT00520429|Anxiety|anxiety
1564464|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1564465|NCT00520429|Heart Failure, Congestive|heart failure, congestive
1564466|NCT00520377|Sinus Lift Surgery|sinus lift surgery
1564467|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
1564468|NCT00520377|Insufficient Bone Height|insufficient bone height
1564469|NCT00520338|celecoxib|celecoxib
1564470|NCT00520338|postoperative pain|postoperative pain
1564471|NCT00520338|thyroidectomy|thyroidectomy
1564472|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
1564473|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
1564474|NCT00520312|PAD|pad
1564475|NCT00520312|Functional Impairment|functional impairment
1564476|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
1564477|NCT00520299|metastatic melanoma|metastatic melanoma
1564478|NCT00520299|ADI|adi
1564479|NCT00520299|ADI-PEG 20|adi-peg 20
1564480|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
1564481|NCT00520299|arginine|arginine
1564482|NCT00520299|enzyme therapy|enzyme therapy
1564483|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
1564484|NCT00520247|enalapril|enalapril
1564485|NCT00520247|folic acid|folic acid
1564486|NCT00520247|hyperglycemia|hyperglycemia
1564487|NCT00520247|hypertension|hypertension
1564488|NCT00520247|fasting plasma glucose|fasting plasma glucose
1564489|NCT00520234|Candida|candida
1564490|NCT00520234|Prophylaxis|prophylaxis
1564491|NCT00520234|High risk adults|high risk adults
1564492|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
1564493|NCT00520221|minocycline|minocycline
1564494|NCT00520221|pleurodesis|pleurodesis
1564495|NCT00520221|aspiration|aspiration
1564496|NCT00520221|pneumothorax|pneumothorax
1564497|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
1564498|NCT00520221|First attack|first attack
1564499|NCT00520221|Successful aspiration|successful aspiration
1564500|NCT00520208|ATRA|atra
1564501|NCT00520208|Trisenox|trisenox
1564502|NCT00520208|Arsenic|arsenic
1564503|NCT00520208|Arsenic Trioxide|arsenic trioxide
1564504|NCT00520208|APL|apl
1564505|NCT00520169|bioavailability|bioavailability
1564506|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
1564507|NCT00520130|Unrelated Donors|unrelated donors
1564508|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
1564509|NCT00520130|Leukemia|leukemia
1564510|NCT00520130|Lymphoma|lymphoma
1564511|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1564512|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
1564513|NCT00520130|Multiple Myeloma|multiple myeloma
1564514|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1564515|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1564516|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
1564517|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
1564518|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
1564519|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
1564520|NCT00520039|Otitis Media|otitis media
1564521|NCT00520039|Effusion|effusion
1564522|NCT00520039|OMM|omm
1564523|NCT00520039|OMT|omt
1564524|NCT00520039|Resolution|resolution
1564525|NCT00520026|suicide|suicide
1564526|NCT00520026|prevention|prevention
1564527|NCT00520026|lithium|lithium
1564528|NCT00520026|suicidality|suicidality
1564529|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1564530|NCT00519987|pharmacokinetics|pharmacokinetics
1564531|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1564532|NCT00519974|stage I breast cancer|stage i breast cancer
1564533|NCT00519974|stage II breast cancer|stage ii breast cancer
1564534|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
1564535|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
1564536|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
1564537|NCT00519974|stage IV breast cancer|stage iv breast cancer
1564538|NCT00519974|recurrent breast cancer|recurrent breast cancer
1564539|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
1564540|NCT00519935|family therapy|family therapy
1564541|NCT00519935|adolescents|adolescents
1568261|NCT00506467|Lung Cancer|lung cancer
1564542|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
1564543|NCT00519883|Anastrozole|anastrozole
1564544|NCT00519883|Exercise|exercise
1564545|NCT00519870|Pulmonary hypertension|pulmonary hypertension
1564546|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
1564547|NCT00519870|Calcium channel blocker|calcium channel blocker
1564548|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1564549|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1564550|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1564551|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1564552|NCT00519818|Hydrocortisone|hydrocortisone
1564553|NCT00519818|Pharmacokinetic|pharmacokinetic
1564554|NCT00519818|Pharmacodynamic|pharmacodynamic
1564555|NCT00519805|thromboembolism|thromboembolism
1564556|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1564557|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
1564558|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1564559|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1564560|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1564561|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1564562|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1564563|NCT00519792|Relapse|relapse
1564564|NCT00519792|HCV|hcv
1564565|NCT00519792|Hepatitis C|hepatitis c
1564566|NCT00519792|Interferon|interferon
1564567|NCT00519792|Ribavirin|ribavirin
1564568|NCT00519779|affect|affect
1564569|NCT00519779|inflammation|inflammation
1564570|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
1564571|NCT00519766|Nicotine Metabolism|nicotine metabolism
1564572|NCT00519766|Pregnancy|pregnancy
1564573|NCT00519753|Glaucoma|glaucoma
1564574|NCT00519740|grass-pollen|grass-pollen
1564575|NCT00519740|allergy|allergy
1564576|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
1564577|NCT00519740|asthma|asthma
1564578|NCT00519727|diabetes|diabetes
1564579|NCT00519701|sickle cell anemia|sickle cell anemia
1564580|NCT00519701|hydroxyurea|hydroxyurea
1564581|NCT00519688|tegafur|tegafur
1564582|NCT00519688|thalidomide|thalidomide
1564583|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
1564584|NCT00519675|Chronic hand eczema|chronic hand eczema
1564585|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
1564586|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
1564587|NCT00519662|Solid|solid
1564588|NCT00519662|Tumors|tumors
1564589|NCT00519662|Advanced|advanced
1564590|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
1564591|NCT00519649|Challenge dose|challenge dose
1564592|NCT00519636|experience|experience
1564593|NCT00519636|GW685698X|gw685698x
1564594|NCT00519636|fluticasone furoate|fluticasone furoate
1564595|NCT00519636|preference|preference
1564596|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
1564597|NCT00519636|fluticasone propionate|fluticasone propionate
1564598|NCT00519623|diabetes|diabetes
1564599|NCT00519623|insulin|insulin
1564600|NCT00519623|blood sugar|blood sugar
1564601|NCT00519623|type 1 diabetes|type 1 diabetes
1564602|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
1564603|NCT00519623|transdermal|transdermal
1564604|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
1564605|NCT00519597|Coronary Artery Disease|coronary artery disease
1564606|NCT00519597|Sleep Apnea|sleep apnea
1564607|NCT00519597|CPAP|cpap
1564608|NCT00519597|Revascularization|revascularization
1564609|NCT00519597|Mortality|mortality
1564610|NCT00519584|Interscalene nerve block|interscalene nerve block
1564611|NCT00519584|Dexamethasone|dexamethasone
1564612|NCT00519584|Ropivacaine|ropivacaine
1564613|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
1564614|NCT00519545|breast|breast
1564615|NCT00519545|cancer|cancer
1564616|NCT00519545|stage|stage
1564618|NCT00519545|four|four
1564619|NCT00519532|Neupro®|neupro®
1564620|NCT00519532|Rotigotine|rotigotine
1564621|NCT00519532|Parkinson's Disease|parkinson's disease
1564622|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
1564623|NCT00519506|Pulmonary Embolism|pulmonary embolism
1564625|NCT00519493|Clozex|clozex
1564626|NCT00519493|Sutures|sutures
1564627|NCT00519480|Tolerability|tolerability
1564628|NCT00519480|GSK189075,|gsk189075,
1564629|NCT00519480|Metformin,|metformin,
1564630|NCT00519480|Safety,|safety,
1564631|NCT00519480|Diabetes,|diabetes,
1564632|NCT00519467|dose-ranging study|dose-ranging study
1564633|NCT00519467|SB-714703|sb-714703
1564634|NCT00519467|artesunate,|artesunate,
1564635|NCT00519467|malaria|malaria
1564636|NCT00519467|CDA,|cda,
1564637|NCT00519467|chlorproguanil,|chlorproguanil,
1564638|NCT00519467|dapsone,|dapsone,
1564639|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
1564640|NCT00519454|Estrogen receptors|estrogen receptors
1564641|NCT00519454|T cells|t cells
1564642|NCT00519454|Hormones|hormones
1564643|NCT00519454|Female adult SLE|female adult sle
1564644|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
1564645|NCT00519428|depression|depression
1564646|NCT00519428|Major Depressive Disorder|major depressive disorder
1564647|NCT00519415|Tongue plate|tongue plate
1564648|NCT00519415|Facemask|facemask
1564649|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
1564650|NCT00519415|orthodontic angle class three|orthodontic angle class three
1564651|NCT00519402|partial tonsillectomy|partial tonsillectomy
1564652|NCT00519402|complete tonsillectomy|complete tonsillectomy
1564653|NCT00519402|tonsillectomy|tonsillectomy
1564654|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
1564655|NCT00519402|apnea|apnea
1564656|NCT00519376|pharmacodynamics,|pharmacodynamics,
1564657|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1564658|NCT00519376|safety,|safety,
1564659|NCT00519376|COPD patients|copd patients
1564660|NCT00519376|pharmacokinetics,|pharmacokinetics,
1564661|NCT00519376|tolerability,|tolerability,
1564662|NCT00519376|GW642444,|gw642444,
1564663|NCT00519363|Lupus|lupus
1564664|NCT00519363|TLR's|tlr's
1564665|NCT00519363|Hyperlipidemia|hyperlipidemia
1564666|NCT00519363|age eighteen to sixty|age eighteen to sixty
1564667|NCT00519363|female with SLE|female with sle
1564668|NCT00519363|SLEDAI, greater than four|sledai, greater than four
1564669|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
1564670|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
1564671|NCT00519337|Atrial Fibrillation|atrial fibrillation
1564672|NCT00519337|cardiac surgery|cardiac surgery
1564673|NCT00519337|ascorbic acid|ascorbic acid
1564674|NCT00519337|vitamin-c|vitamin-c
1564675|NCT00519337|inflammation|inflammation
1564676|NCT00519324|Gastric Cancer|gastric cancer
1564677|NCT00519324|RAD001|rad001
1564678|NCT00519324|mTOR|mtor
1564679|NCT00519311|Intellectual disability|intellectual disability
1564680|NCT00519311|Health promotion|health promotion
1564681|NCT00519311|RCT|rct
1564682|NCT00519298|Alzheimer Disease|alzheimer disease
1564683|NCT00519285|metastatic|metastatic
1564684|NCT00519285|prostate|prostate
1564685|NCT00519285|cancer|cancer
1564686|NCT00519272|Cervical Cancer|cervical cancer
1564687|NCT00519272|Cervix|cervix
1564688|NCT00519272|Precancerous Lesions|precancerous lesions
1564689|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
1564690|NCT00519272|CIS|cis
1564691|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
1564692|NCT00519272|Barriers to Care|barriers to care
1564693|NCT00519272|Harris County|harris county
1564694|NCT00519272|Questionnaire|questionnaire
1564695|NCT00519246|Breast Neoplasms|breast neoplasms
1564696|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
1564697|NCT00519246|Analgesia|analgesia
1564698|NCT00519233|HRPC|hrpc
1564699|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
1564700|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
1564701|NCT00519207|pediatrics|pediatrics
1564702|NCT00519207|pain|pain
1564703|NCT00519207|infants|infants
1564704|NCT00519207|newborn screening|newborn screening
1564705|NCT00519207|venipuncture|venipuncture
1564706|NCT00519207|lidocaine|lidocaine
1564707|NCT00519207|sucrose|sucrose
1564708|NCT00519194|Arrhythmia|arrhythmia
1564709|NCT00519194|Atrial Fibrillation|atrial fibrillation
1564710|NCT00519181|HTLV|htlv
1564711|NCT00519181|HAM/TSP|ham/tsp
1564712|NCT00519181|VALPROIC ACID|valproic acid
1564713|NCT00519181|PROVIRAL LOAD|proviral load
1564714|NCT00519129|Pain|pain
1564715|NCT00519129|Patient satisfaction|patient satisfaction
1564716|NCT00519103|microarray|microarray
1564717|NCT00519103|Inflammtion|inflammtion
1564718|NCT00519103|fibrosis|fibrosis
1564719|NCT00519090|leukemia|leukemia
1564720|NCT00519090|bone marrow|bone marrow
1564721|NCT00519090|leukemia symptoms|leukemia symptoms
1564722|NCT00519090|cml|cml
1564723|NCT00519090|complete blood count|complete blood count
1564724|NCT00519090|lymphocyte|lymphocyte
1564725|NCT00519090|blood cancer|blood cancer
1564726|NCT00519090|leukocytes|leukocytes
1564727|NCT00519090|chronic leukemia|chronic leukemia
1564728|NCT00519090|bone marrow biopsy|bone marrow biopsy
1564729|NCT00519090|leukemia research|leukemia research
1564730|NCT00519090|leukemia cells|leukemia cells
1564731|NCT00519090|bone marrow disease|bone marrow disease
1564732|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
1564733|NCT00519090|blood cancer symptoms|blood cancer symptoms
1564734|NCT00519090|white blood cell diseases|white blood cell diseases
1564735|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
1564736|NCT00519090|leukemia treatment|leukemia treatment
1564737|NCT00519090|leukemia facts|leukemia facts
1564738|NCT00519090|leucemia|leucemia
1564739|NCT00519090|facts about leukemia|facts about leukemia
1564740|NCT00519090|myelogenous leukemia|myelogenous leukemia
1564741|NCT00519090|newly diagnosed CML|newly diagnosed cml
1564742|NCT00519090|suboptimal response|suboptimal response
1564743|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
1564744|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
1564745|NCT00519077|cancer|cancer
1564746|NCT00519077|squamous cell|squamous cell
1564747|NCT00519077|carcinoma|carcinoma
1564748|NCT00519077|head|head
1564749|NCT00519077|neck|neck
1564750|NCT00519064|influenza|influenza
1564751|NCT00519064|influenza vaccine|influenza vaccine
1564752|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
1564753|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
1564754|NCT00519051|depression|depression
1564755|NCT00519051|primary care|primary care
1564756|NCT00519051|pharmacotherapy|pharmacotherapy
1564757|NCT00519038|Critical Pathways|critical pathways
1564758|NCT00519038|Congestive Heart Failure|congestive heart failure
1564759|NCT00519038|Randomized Controlled Trial|randomized controlled trial
1564760|NCT00519038|Effectiveness|effectiveness
1564761|NCT00519025|Linezolid|linezolid
1564762|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
1564763|NCT00519025|Infections|infections
1564764|NCT00519012|early nonresponse|early nonresponse
1564765|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
1564766|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
1564767|NCT00518986|Excessive Sleepiness|excessive sleepiness
1564768|NCT00518960|ProAlgaZyme|proalgazyme
1564769|NCT00518960|Algae|algae
1564770|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
1564771|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
1564772|NCT00518960|Hyperlipidemia|hyperlipidemia
1564773|NCT00518960|Metabolic Syndrome|metabolic syndrome
1564774|NCT00518947|Bipolar Disorder|bipolar disorder
1564775|NCT00518947|Mania|mania
1564776|NCT00518947|Antimanic|antimanic
1564777|NCT00518947|Verapamil|verapamil
1564778|NCT00518947|Lithium|lithium
1564779|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
1564780|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
1564781|NCT00518934|cells|cells
1564782|NCT00518921|adenosin agonist|adenosin agonist
1564783|NCT00518921|chronic stable angina|chronic stable angina
1564784|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
1564785|NCT00518908|Organ protection|organ protection
1564786|NCT00518895|Melanoma|melanoma
1564787|NCT00518895|Advanced Melanoma|advanced melanoma
1564788|NCT00518895|Malignant Melanoma|malignant melanoma
1564789|NCT00518895|Metastatic Melanoma|metastatic melanoma
1564790|NCT00518895|Skin Cancer|skin cancer
1564791|NCT00518895|Genasense|genasense
1564792|NCT00518895|oblimersen|oblimersen
1564793|NCT00518895|antisense|antisense
1564794|NCT00518895|Bcl-2 antisense|bcl-2 antisense
1564795|NCT00518895|G3139|g3139
1564796|NCT00518895|dacarbazine|dacarbazine
1564797|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1564798|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
1564799|NCT00518869|Chemotherapy|chemotherapy
1564800|NCT00518869|Myelosuppression|myelosuppression
1564801|NCT00518869|Quality of Life|quality of life
1564802|NCT00518869|Fatigue|fatigue
1565102|NCT00517387|Depression|depression
1564803|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
1564804|NCT00518856|birth asphyxia|birth asphyxia
1564805|NCT00518856|neonatal sepsis|neonatal sepsis
1564806|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
1564807|NCT00518843|binge eating|binge eating
1564808|NCT00518843|purging|purging
1564809|NCT00518830|postnatal depression|postnatal depression
1564810|NCT00518830|primary care|primary care
1564811|NCT00518830|depressed women|depressed women
1564812|NCT00518817|Dystrophy|dystrophy
1564813|NCT00518817|Cardiomyopathy|cardiomyopathy
1564814|NCT00518791|Integrated health care system|integrated health care system
1564815|NCT00518791|Treatment effectiveness|treatment effectiveness
1564816|NCT00518791|Cost effectiveness|cost effectiveness
1564817|NCT00518791|Program evaluation|program evaluation
1564818|NCT00518778|fusariosis|fusariosis
1564819|NCT00518778|solid organ transplants|solid organ transplants
1564820|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
1564821|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
1564822|NCT00518752|Oral Hygiene|oral hygiene
1564823|NCT00518752|Oral Care|oral care
1564824|NCT00518752|Xerostomia|xerostomia
1564825|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
1564826|NCT00518713|Epilepsy|epilepsy
1564827|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
1564828|NCT00518713|Drop seizures|drop seizures
1564829|NCT00518713|Clobazam|clobazam
1564830|NCT00518674|pain|pain
1564831|NCT00518674|local infiltration analgesia|local infiltration analgesia
1564832|NCT00518661|quinolone resistance|quinolone resistance
1564833|NCT00518661|ESBL|esbl
1564834|NCT00518661|Klebsiella species|klebsiella species
1564835|NCT00518661|Infection|infection
1564836|NCT00518648|Accidental falls|accidental falls
1564837|NCT00518648|Prevention|prevention
1564838|NCT00518648|Treatment effectiveness|treatment effectiveness
1564839|NCT00518635|Growth hormone|growth hormone
1564840|NCT00518635|Insulin sensitivity|insulin sensitivity
1564841|NCT00518635|Polycystic ovary|polycystic ovary
1564842|NCT00518609|Neonatal|neonatal
1564843|NCT00518609|Sepsis|sepsis
1564844|NCT00518609|Global Network|global network
1564845|NCT00518609|Antibiotics|antibiotics
1564846|NCT00518609|India|india
1564847|NCT00518609|International|international
1564848|NCT00518609|Maternal and child health|maternal and child health
1564849|NCT00518596|Neonatal|neonatal
1564850|NCT00518596|Sepsis|sepsis
1564851|NCT00518596|Global Network|global network
1564852|NCT00518596|Probiotics|probiotics
1564853|NCT00518596|India|india
1564854|NCT00518596|International|international
1564855|NCT00518596|Maternal and child health|maternal and child health
1564856|NCT00518583|Breast cancer|breast cancer
1564857|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
1564858|NCT00518570|PMDD|pmdd
1564860|NCT00518570|Levetiracetam|levetiracetam
1564861|NCT00518557|liver cancer|liver cancer
1564862|NCT00518557|interventional radiology|interventional radiology
1564863|NCT00518557|Chemoembolization|chemoembolization
1564864|NCT00518557|Safety|safety
1564865|NCT00518557|Effectiveness|effectiveness
1564866|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
1564867|NCT00518531|osteoporosis|osteoporosis
1564868|NCT00518531|low bone mineral density|low bone mineral density
1564869|NCT00518531|alendronate|alendronate
1564870|NCT00518531|denosumab|denosumab
1564871|NCT00518531|adherence|adherence
1564872|NCT00518531|preference|preference
1564873|NCT00518531|satisfaction|satisfaction
1564874|NCT00518531|postmenopausal|postmenopausal
1564875|NCT00518531|women|women
1564876|NCT00518518|Asthma|asthma
1564877|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
1564878|NCT00518518|Children|children
1564879|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
1564880|NCT00518479|Hypertension|hypertension
1565079|NCT00517582|Bradykinin|bradykinin
1564881|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
1564882|NCT00518466|Obesity|obesity
1564883|NCT00518453|Influenza vaccine|influenza vaccine
1564884|NCT00518440|Liver disease|liver disease
1564885|NCT00518440|Liver injury|liver injury
1564886|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
1564887|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
1564888|NCT00518401|Stem cells|stem cells
1564889|NCT00518401|Stem cell transplantation|stem cell transplantation
1564890|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
1564891|NCT00518388|Epidemiology|epidemiology
1564892|NCT00518388|Cervical Cancer|cervical cancer
1564893|NCT00518388|Human Papillomavirus|human papillomavirus
1564894|NCT00518388|Focus Group|focus group
1564895|NCT00518388|Questionnaire|questionnaire
1564896|NCT00518388|Survey|survey
1564897|NCT00518388|HPV|hpv
1564898|NCT00518362|TW|tw
1564899|NCT00518362|Valsartan|valsartan
1564900|NCT00518362|treatment|treatment
1564901|NCT00518362|diabetic nephropathy|diabetic nephropathy
1564902|NCT00518362|Proteinuria|proteinuria
1564903|NCT00518323|Schizophrenia|schizophrenia
1564904|NCT00518323|Antipsychotic|antipsychotic
1564905|NCT00518310|Interstitial lung disease|interstitial lung disease
1564906|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1564907|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
1564908|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
1564909|NCT00518310|Therapy|therapy
1564910|NCT00518310|Azathioprine|azathioprine
1564911|NCT00518310|Steroids|steroids
1564912|NCT00518310|Glucocorticoids|glucocorticoids
1564913|NCT00518310|Corticosteroids|corticosteroids
1564914|NCT00518310|Prednisone|prednisone
1564915|NCT00518297|Antivirals / HIV|antivirals / hiv
1564916|NCT00518284|Restenosis|restenosis
1564917|NCT00518284|Superficial Femoral Artery|superficial femoral artery
1564918|NCT00518284|Prevention of restenosis|prevention of restenosis
1564919|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
1564920|NCT00518258|Parkinson's Disease|parkinson's disease
1564921|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1564922|NCT00518258|neuropsychological assessment|neuropsychological assessment
1564923|NCT00518245|unstable angina|unstable angina
1564924|NCT00518245|drug therapy|drug therapy
1564925|NCT00518245|myocardial ischemia|myocardial ischemia
1564926|NCT00518245|myocardial infarction|myocardial infarction
1564927|NCT00518245|hemorrhage|hemorrhage
1564928|NCT00518232|Methylphenidate|methylphenidate
1732962|NCT00001512|GM-CSF|gm-csf
1564929|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1564930|NCT00518219|TW|tw
1564931|NCT00518219|Valsartan|valsartan
1564932|NCT00518219|treatment|treatment
1564933|NCT00518219|membranous nephropathy|membranous nephropathy
1564934|NCT00518219|proteinuria|proteinuria
1564935|NCT00518206|Clinical Trial|clinical trial
1564936|NCT00518206|Phase 2|phase 2
1564937|NCT00518206|Cancer Vaccine|cancer vaccine
1564938|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
1564939|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
1564940|NCT00518206|Cyclophosphamide|cyclophosphamide
1564941|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
1564942|NCT00518180|Meningococcal|meningococcal
1564943|NCT00518180|meningitis|meningitis
1564944|NCT00518180|vaccine|vaccine
1564945|NCT00518180|adolescents|adolescents
1564946|NCT00518167|Type 2 diabetes|type 2 diabetes
1564947|NCT00518167|primary prevention|primary prevention
1564948|NCT00518167|diet|diet
1564949|NCT00518167|physical activity|physical activity
1564950|NCT00518167|intervention|intervention
1564951|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
1564952|NCT00518167|lifestyle|lifestyle
1564953|NCT00518167|randomized controlled study|randomized controlled study
1564954|NCT00518154|AIDS|aids
1564955|NCT00518154|Immunological non-responders|immunological non-responders
1564956|NCT00518154|Neuroimmune modulation|neuroimmune modulation
1564957|NCT00518154|Pyridostigmine|pyridostigmine
1564958|NCT00518154|Treatment Experienced|treatment experienced
1564959|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
1564960|NCT00518128|Leptin|leptin
1564961|NCT00518128|Homocysteine|homocysteine
1564962|NCT00518128|C-reactive protein|c-reactive protein
1564963|NCT00518115|GLP-1,|glp-1,
1564964|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
1564965|NCT00518115|pharmacokinetics,|pharmacokinetics,
1564966|NCT00518115|pharmacodynamics,|pharmacodynamics,
1564967|NCT00518115|GSK716155,|gsk716155,
1564968|NCT00518115|metformin,|metformin,
1564969|NCT00518115|exenatide|exenatide
1564970|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1564971|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
1564972|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
1564973|NCT00518102|Cancer|cancer
1564974|NCT00518102|Cancer incidence|cancer incidence
1564975|NCT00518102|Cancer mortality|cancer mortality
1564976|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
1564977|NCT00518050|Health Behaviors|health behaviors
1564978|NCT00518050|Surveillance|surveillance
1564979|NCT00518050|06-128|06-128
1564980|NCT00518024|tinnitus|tinnitus
1564981|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
1564982|NCT00518024|treatment|treatment
1564983|NCT00518024|cortex|cortex
1564984|NCT00517998|Lung volume reduction|lung volume reduction
1564985|NCT00517998|Bronchoscopy|bronchoscopy
1564986|NCT00517998|Emphysema|emphysema
1564987|NCT00517998|COPD|copd
1564988|NCT00517998|NETT|nett
1564989|NCT00517998|Lung disease|lung disease
1564990|NCT00517998|COLD|cold
1564991|NCT00517998|BLVR|blvr
1564992|NCT00517985|perimenopausal depression|perimenopausal depression
1564993|NCT00517985|duloxetine|duloxetine
1564994|NCT00517985|cymbalta|cymbalta
1564995|NCT00517985|major depressive disorder|major depressive disorder
1564996|NCT00517985|women|women
1564997|NCT00517972|perimenopausal depression|perimenopausal depression
1564998|NCT00517972|omacor|omacor
1564999|NCT00517972|major depressive disorder|major depressive disorder
1565000|NCT00517972|women|women
1565001|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
1565002|NCT00517959|conformal radiotherapy|conformal radiotherapy
1565003|NCT00517959|late sequelae|late sequelae
1565004|NCT00517959|cognition|cognition
1565005|NCT00517959|endocrine dysfunction|endocrine dysfunction
1565006|NCT00517946|anti-allergy.|anti-allergy.
1565007|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
1565008|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
1565010|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1565011|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
1565012|NCT00517894|lymphoma|lymphoma
1565013|NCT00517894|aggressive|aggressive
1565014|NCT00517894|chemotherapy|chemotherapy
1565015|NCT00517894|dose-dense|dose-dense
1565016|NCT00517868|bladder|bladder
1565017|NCT00517868|pain|pain
1565018|NCT00517868|urgency|urgency
1565019|NCT00517868|frequency|frequency
1565020|NCT00517842|Parkinson's disease|parkinson's disease
1565021|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
1565022|NCT00517803|micronutrients|micronutrients
1565023|NCT00517803|immunodeficiency|immunodeficiency
1565024|NCT00517803|probiotics|probiotics
1565025|NCT00517803|yogurt|yogurt
1565026|NCT00517803|Healthy|healthy
1565027|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1565028|NCT00517803|Complementary Therapies|complementary therapies
1565029|NCT00517790|Refractory|refractory
1565030|NCT00517790|Metastatic|metastatic
1565031|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
1565032|NCT00517777|metabolic syndrome|metabolic syndrome
1565033|NCT00517777|cardiac remodelling|cardiac remodelling
1565034|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
1565035|NCT00517764|major depressive disorder|major depressive disorder
1565037|NCT00517764|escitalopram|escitalopram
1565038|NCT00517764|open-label|open-label
1565039|NCT00517764|major depression|major depression
1565040|NCT00517764|serotonin transporter|serotonin transporter
1565041|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
1565042|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
1565043|NCT00517751|X-STOP Spacer|x-stop spacer
1565044|NCT00517751|Interspinous process decompression|interspinous process decompression
1565045|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
1565046|NCT00517725|exercise|exercise
1565047|NCT00517725|lung diffusion|lung diffusion
1565048|NCT00517725|hypoxia|hypoxia
1565049|NCT00517725|chemoreceptor|chemoreceptor
1565050|NCT00517725|beta-blockers|beta-blockers
1565051|NCT00517725|heart failure|heart failure
1565052|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
1565053|NCT00517712|Arsenic trioxide|arsenic trioxide
1565054|NCT00517712|Molecular remission|molecular remission
1565055|NCT00517712|Toxicity profile|toxicity profile
1565056|NCT00517712|Maintenance therapy|maintenance therapy
1565057|NCT00517686|Poor risk factor control|poor risk factor control
1565058|NCT00517686|Treatment intensification|treatment intensification
1565059|NCT00517686|Medication adherence|medication adherence
1565060|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
1565061|NCT00517673|Healthy Volunteer|healthy volunteer
1565062|NCT00517660|Healthy subjects|healthy subjects
1565063|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
1565064|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
1565065|NCT00517647|ADHD|adhd
1565066|NCT00517647|atomoxetine|atomoxetine
1565067|NCT00517647|preschool children|preschool children
1565068|NCT00517647|efficacy|efficacy
1565069|NCT00517647|safety|safety
1565070|NCT00517634|asthma|asthma
1565071|NCT00517634|allergen challenge|allergen challenge
1565072|NCT00517634|IL-5|il-5
1565073|NCT00517634|eosinophils|eosinophils
1565074|NCT00517621|Peritoneal cancer|peritoneal cancer
1565075|NCT00517621|Relapse or progression|relapse or progression
1565076|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
1565077|NCT00517582|ACE Inhibitor|ace inhibitor
1565078|NCT00517582|Angioedema|angioedema
1565080|NCT00517582|Swelling|swelling
1565081|NCT00517569|Gene Therapy|gene therapy
1565082|NCT00517569|GX-12|gx-12
1565083|NCT00517569|HIV-1|hiv-1
1565084|NCT00517569|Interleukin|interleukin
1565085|NCT00517569|AIDS|aids
1565086|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
1565087|NCT00517569|Treatment Naive|treatment naive
1565088|NCT00517556|Dysmenorrhea|dysmenorrhea
1565089|NCT00517556|continuous OCP|continuous ocp
1565090|NCT00517543|inflammation|inflammation
1565091|NCT00517517|Pandemic influenza|pandemic influenza
1565092|NCT00517504|methylphenidate|methylphenidate
1565093|NCT00517504|ritalin|ritalin
1565094|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1565095|NCT00517504|developmental disorder|developmental disorder
1565096|NCT00517504|preschool children|preschool children
1565097|NCT00517426|heart failure,|heart failure,
1565098|NCT00517426|exercise|exercise
1565099|NCT00517426|periodic breathing,|periodic breathing,
1565100|NCT00517426|acetazolamide|acetazolamide
1565101|NCT00517400|PTSD|ptsd
1565103|NCT00517387|SSRI|ssri
1565104|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
1565105|NCT00517387|Cognition|cognition
1565106|NCT00517387|Mood|mood
1565107|NCT00517387|Quality of Life|quality of life
1565108|NCT00517348|Adult|adult
1565109|NCT00517335|anorexia nervosa|anorexia nervosa
1565110|NCT00517335|bulimia nervosa|bulimia nervosa
1565111|NCT00517322|left atrial volume|left atrial volume
1565112|NCT00517322|hypertension|hypertension
1565113|NCT00517322|ramipril|ramipril
1565114|NCT00517322|irbesartan|irbesartan
1565115|NCT00517322|diastolic function|diastolic function
1565116|NCT00517283|diabetes|diabetes
1565117|NCT00517283|gastric emptying|gastric emptying
1565118|NCT00517283|exenatide|exenatide
1565119|NCT00517283|Byetta|byetta
1565120|NCT00517283|Amylin|amylin
1565121|NCT00517283|Lilly|lilly
1565122|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
1565123|NCT00517257|Retinal vein occlusion|retinal vein occlusion
1565124|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
1565125|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
1565126|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
1565127|NCT00517257|Visual loss|visual loss
1565128|NCT00517257|Atorvastatin|atorvastatin
1565129|NCT00517257|Statin|statin
1565130|NCT00517257|Neovascularization|neovascularization
1565131|NCT00517257|Thrombosis|thrombosis
1565132|NCT00517244|Children|children
1565133|NCT00517244|Healthy Controls|healthy controls
1565134|NCT00517244|Assessment|assessment
1565135|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
1565136|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
1565137|NCT00517231|Cytokines|cytokines
1565138|NCT00517231|Acute Phase Response|acute phase response
1565139|NCT00517231|Treatment|treatment
1565140|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
1565141|NCT00517205|upper ureteric stone|upper ureteric stone
1565142|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1565143|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
1565144|NCT00517166|tourniquet|tourniquet
1565145|NCT00517166|extremity injury|extremity injury
1565146|NCT00517166|hemostatic device|hemostatic device
1565147|NCT00517153|Zavesca|zavesca
1565148|NCT00517153|miglustat|miglustat
1565149|NCT00517153|Niemann-Pick Type C|niemann-pick type c
1565150|NCT00517153|Actelion|actelion
1565151|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
1565152|NCT00517127|Intraoperative care|intraoperative care
1565153|NCT00517127|Ringer's lactate|ringer's lactate
1565154|NCT00517127|Voluven|voluven
1565155|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
1565156|NCT00517127|Doppler effect|doppler effect
1565157|NCT00517114|Reflux laryngitis|reflux laryngitis
1565158|NCT00517101|spondyloarthropathy|spondyloarthropathy
1565159|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
1565160|NCT00517101|antibodies|antibodies
1565161|NCT00517088|Physical Activity|physical activity
1565162|NCT00517088|Breast Cancer|breast cancer
1565163|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1565164|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1565165|NCT00517075|Schizophrenia|schizophrenia
1565166|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
1565167|NCT00517075|Treatment|treatment
1565168|NCT00517075|Negative Symptoms|negative symptoms
1565169|NCT00517075|Social Dysfunction|social dysfunction
1565170|NCT00517075|TMS|tms
1565171|NCT00517075|rTMS|rtms
1565172|NCT00517062|Growth hormone|growth hormone
1565173|NCT00517062|insulin sensitivity|insulin sensitivity
1565174|NCT00517062|cortisol|cortisol
1565175|NCT00517049|NHL|nhl
1565176|NCT00517049|Rituxan|rituxan
1565177|NCT00517049|Lymphoma|lymphoma
1565178|NCT00517049|CD20-positive|cd20-positive
1565179|NCT00517049|B-Cell|b-cell
1565180|NCT00517049|APM4083g|apm4083g
1565181|NCT00517036|Major Depression|major depression
1565182|NCT00517036|Omega-3|omega-3
1565183|NCT00517036|Major Depressive Disorder|major depressive disorder
1565184|NCT00517023|Implantable Loop Recorder|implantable loop recorder
1565185|NCT00517023|Home monitoring|home monitoring
1565186|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
1565187|NCT00517010|Age-related macular degeneration|age-related macular degeneration
1565188|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
1565189|NCT00517010|Wet macular degeneration|wet macular degeneration
1565190|NCT00517010|Intravitreal injection|intravitreal injection
1565191|NCT00517010|Proton beam irradiation|proton beam irradiation
1565192|NCT00517010|Lucentis|lucentis
1565193|NCT00517010|Ranibizumab|ranibizumab
1565194|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
1565195|NCT00516984|LF/HF ratio|lf/hf ratio
1565196|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
1565197|NCT00516958|diabetic|diabetic
1565199|NCT00516958|infection|infection
1565200|NCT00516958|topical|topical
1565201|NCT00516958|wound|wound
1565202|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
1565203|NCT00516932|Suicidal Event|suicidal event
1565204|NCT00516932|Behavioral Activation|behavioral activation
1565205|NCT00516919|Obesity|obesity
1565206|NCT00516919|Binge Eating|binge eating
1565207|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
1565208|NCT00516919|Orlistat|orlistat
1565209|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
1565210|NCT00516893|natalizumab|natalizumab
1565211|NCT00516893|Tysabri|tysabri
1565212|NCT00516893|Multiple Sclerosis|multiple sclerosis
1565213|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1565214|NCT00516880|chronic kidney disease|chronic kidney disease
1565215|NCT00516880|cardiovascular disease|cardiovascular disease
1565216|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
1565217|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
1565218|NCT00516841|peritoneal cancer|peritoneal cancer
1565219|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
1565220|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
1565221|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1565222|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1565223|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1565224|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1565225|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1565226|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1565227|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1565228|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1565229|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1565230|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1565231|NCT00516802|dacarbazine|dacarbazine
1565232|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
1565233|NCT00516750|stage II bladder cancer|stage ii bladder cancer
1565234|NCT00516750|stage III bladder cancer|stage iii bladder cancer
1565235|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
1565236|NCT00516724|malignant solid tumours|malignant solid tumours
1565237|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1565238|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
1565239|NCT00516698|stage I breast cancer|stage i breast cancer
1565240|NCT00516698|stage II breast cancer|stage ii breast cancer
1565241|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
1565242|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
1565243|NCT00516685|LUNG CANCER|lung cancer
1565244|NCT00516685|NSCLC|nsclc
1565245|NCT00516685|EGF|egf
1565246|NCT00516685|CANCER VACCINE|cancer vaccine
1565247|NCT00516685|IMMUNOTHERAPY|immunotherapy
1565248|NCT00516672|lapatinib,|lapatinib,
1565249|NCT00516672|cancer|cancer
1565250|NCT00516672|pharmacokinetics,|pharmacokinetics,
1565251|NCT00516672|safety,|safety,
1565252|NCT00516672|pazopanib,|pazopanib,
1565253|NCT00516672|Japanese patients,|japanese patients,
1565254|NCT00516659|ETEC|etec
1565255|NCT00516659|Traveler's diarrhea|traveler's diarrhea
1565256|NCT00516659|TCI|tci
1565257|NCT00516659|patch vaccine|patch vaccine
1565258|NCT00516659|diarrhea prevention|diarrhea prevention
1565259|NCT00516659|epidemiology ETEC|epidemiology etec
1565260|NCT00516659|Escherichia coli|escherichia coli
1565261|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
1565262|NCT00516646|Alegebrium|alegebrium
1565263|NCT00516633|Asthma|asthma
1565264|NCT00516633|Adherence|adherence
1565265|NCT00516633|Burden of asthma|burden of asthma
1565266|NCT00516633|Quality of life|quality of life
1565267|NCT00516633|Questionnaires|questionnaires
1565268|NCT00516620|Body Weight|body weight
1565269|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
1565270|NCT00516607|adult mixed glioma|adult mixed glioma
1565271|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1565272|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1565273|NCT00516607|adult glioblastoma|adult glioblastoma
1565274|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
1565275|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
1565276|NCT00516607|adult gliosarcoma|adult gliosarcoma
1565277|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1565278|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
1565279|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
1565280|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1565281|NCT00516581|Treatment Experienced|treatment experienced
1565282|NCT00516581|Treatment Naive|treatment naive
1565283|NCT00516555|Breech Presentation|breech presentation
1565284|NCT00516555|External Cephalic version|external cephalic version
1565285|NCT00516555|Thyroid Function Tests|thyroid function tests
1565286|NCT00516542|stage IV breast cancer|stage iv breast cancer
1565287|NCT00516542|recurrent breast cancer|recurrent breast cancer
1565288|NCT00516542|male breast cancer|male breast cancer
1565289|NCT00516516|muscle cramp|muscle cramp
1565290|NCT00516516|pregnancy|pregnancy
1565291|NCT00516516|carnitine|carnitine
1565292|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
1565293|NCT00516490|GnRH agonist|gnrh agonist
1565294|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
1565295|NCT00516490|luteal phase|luteal phase
1565296|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
1565297|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
1565298|NCT00516477|Gene transfer|gene transfer
1565299|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1565300|NCT00516464|Vitrectomy|vitrectomy
1565301|NCT00516464|Ranibizumab|ranibizumab
1565302|NCT00516438|malignant solid tumours|malignant solid tumours
1565303|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
1565304|NCT00516438|polymerases|polymerases
1565305|NCT00516425|stage IA breast cancer|stage ia breast cancer
1565306|NCT00516425|stage IB breast cancer|stage ib breast cancer
1565307|NCT00516425|stage II breast cancer|stage ii breast cancer
1565308|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
1565309|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1565310|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1565311|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1565312|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1565313|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1565314|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1565315|NCT00516399|Fungal keratitis|fungal keratitis
1565316|NCT00516399|povidone iodine|povidone iodine
1565317|NCT00516399|childhood blindness|childhood blindness
1565318|NCT00516399|povidone-iodine|povidone-iodine
1565319|NCT00516386|Adolescents|adolescents
1565320|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
1565321|NCT00516386|Bone formation markers|bone formation markers
1565322|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
1565323|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
1565324|NCT00516373|BRCA 1 protein|brca 1 protein
1565325|NCT00516373|BRCA 2 protein|brca 2 protein
1565326|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
1565327|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
1565328|NCT00516360|Infant, Newborn|infant, newborn
1565329|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
1565330|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
1565331|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1565332|NCT00516347|esophageal cancer|esophageal cancer
1565333|NCT00516347|Barrett esophagus|barrett esophagus
1565334|NCT00516334|brain|brain
1565335|NCT00516334|electroencephalography|electroencephalography
1565336|NCT00516334|premature infant|premature infant
1565337|NCT00516334|neurodevelopment|neurodevelopment
1565338|NCT00516321|thrombopoietin|thrombopoietin
1565339|NCT00516321|hepatitis C|hepatitis c
1565340|NCT00516321|ribavirin|ribavirin
1565341|NCT00516321|platelets|platelets
1565342|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
1565343|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
1565345|NCT00516308|Critical Limb Ischemia|critical limb ischemia
1565346|NCT00516308|PAD|pad
1565347|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
1565348|NCT00516308|Artherosclerosis|artherosclerosis
1565349|NCT00516308|Leg pain|leg pain
1565350|NCT00516308|Cardiovascular|cardiovascular
1565351|NCT00516308|Atherectomy|atherectomy
1565352|NCT00516308|NightHawk|nighthawk
1565353|NCT00516282|adult glioblastoma|adult glioblastoma
1565354|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
1565355|NCT00516282|adult gliosarcoma|adult gliosarcoma
1565356|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1565357|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1565945|NCT00514046|MTC|mtc
1565358|NCT00516282|adult mixed glioma|adult mixed glioma
1565359|NCT00516269|Breast Cancer|breast cancer
1565360|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
1565361|NCT00516269|GI Cancer|gi cancer
1565362|NCT00516269|Fatigue|fatigue
1565363|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
1565364|NCT00516269|Methylphenidate|methylphenidate
1565365|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
1565366|NCT00516269|Concerta|concerta
1565367|NCT00516269|Ritalin|ritalin
1565368|NCT00516269|Placebo|placebo
1565369|NCT00516256|Prostate Cancer|prostate cancer
1565370|NCT00516256|Quality of Life|quality of life
1565371|NCT00516256|Cancer Information Mentor|cancer information mentor
1565372|NCT00516256|CHESS|chess
1565373|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
1565374|NCT00516256|Social support|social support
1565375|NCT00516256|Skill-building tools|skill-building tools
1565376|NCT00516230|Colonic Neoplasms|colonic neoplasms
1565377|NCT00516230|Lynch syndrome|lynch syndrome
1565378|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1565379|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1565380|NCT00516204|Hyperlipidemia|hyperlipidemia
1565381|NCT00516204|Diabetics|diabetics
1565382|NCT00516204|NIS|nis
1565383|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
1565384|NCT00516191|Multiple Myeloma|multiple myeloma
1565385|NCT00516191|Velcade|velcade
1565386|NCT00516191|Doxil|doxil
1565387|NCT00516191|Melphalan|melphalan
1565388|NCT00516178|Fish oil supplement|fish oil supplement
1565389|NCT00516178|n-3 PUFA|n-3 pufa
1565390|NCT00516178|Cardiac function|cardiac function
1565391|NCT00516178|Membrane incorporation|membrane incorporation
1565392|NCT00516178|Inflammation|inflammation
1565393|NCT00516178|Clinical outcome|clinical outcome
1565394|NCT00516165|liver cancer|liver cancer
1565395|NCT00516165|RAD001|rad001
1565396|NCT00516152|Matched Unrelated Donor|matched unrelated donor
1565397|NCT00516152|Stem Cell Transplantation|stem cell transplantation
1565398|NCT00516152|Busulfan|busulfan
1565399|NCT00516152|fludarabine|fludarabine
1565400|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
1565401|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
1565402|NCT00516126|hemostasis monitoring|hemostasis monitoring
1565403|NCT00516126|perioperative blood loss|perioperative blood loss
1565404|NCT00516113|paroxetine|paroxetine
1565405|NCT00516113|onset of action|onset of action
1565406|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
1565407|NCT00516100|NSCLC|nsclc
1565408|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1565409|NCT00516074|exenatide|exenatide
1565410|NCT00516074|Byetta|byetta
1565411|NCT00516074|type 2 diabetes|type 2 diabetes
1565412|NCT00516074|heart rate|heart rate
1565413|NCT00516074|Amylin|amylin
1565414|NCT00516074|Lilly|lilly
1565415|NCT00516048|exenatide|exenatide
1565416|NCT00516048|Byetta|byetta
1565417|NCT00516048|antibodies|antibodies
1565418|NCT00516048|Amylin|amylin
1565419|NCT00516048|Lilly|lilly
1565420|NCT00516035|Bird Flu|bird flu
1565421|NCT00516009|RADICULAR PAIN|radicular pain
1565422|NCT00516009|DISC HERNIATION|disc herniation
1565423|NCT00516009|DEXAMETHASONE|dexamethasone
1565424|NCT00516009|VAS|vas
1565425|NCT00515996|panic disorder|panic disorder
1565426|NCT00515996|paroxetine|paroxetine
1565427|NCT00515996|genetic polymorphism|genetic polymorphism
1565428|NCT00515996|serotonin|serotonin
1565429|NCT00515983|melanoma|melanoma
1565430|NCT00515983|dendritic cells|dendritic cells
1565431|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
1565432|NCT00515983|therapeutic vaccine|therapeutic vaccine
1565433|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
1565434|NCT00515970|Curettage|curettage
1565435|NCT00515970|Excision|excision
1565436|NCT00515970|Recurrence|recurrence
1565437|NCT00515970|Complication|complication
1565438|NCT00515970|Esthetic outcome|esthetic outcome
1565439|NCT00515944|No condition|no condition
1565440|NCT00515944|healthy volunteers|healthy volunteers
1565441|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1565442|NCT00515931|GIST|gist
1565443|NCT00515931|Sarcoma|sarcoma
1565444|NCT00515931|Radiation therapy|radiation therapy
1565445|NCT00515931|Radiotherapy|radiotherapy
1565446|NCT00515918|Iron deficiency|iron deficiency
1565447|NCT00515918|brain|brain
1565448|NCT00515918|cognition|cognition
1565449|NCT00515918|behavior|behavior
1565450|NCT00515879|Generalized subtype|generalized subtype
1565451|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
1565452|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
1565453|NCT00515866|Advanced Solid Tumours|advanced solid tumours
1565454|NCT00515853|Rectal neoplasms|rectal neoplasms
1565455|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
1565456|NCT00515853|Fecal Incontinence|fecal incontinence
1565457|NCT00515853|Aged|aged
1565458|NCT00515853|Anterior resection|anterior resection
1565459|NCT00515827|Treatment Experienced|treatment experienced
1565460|NCT00515814|Legal blindness|legal blindness
1565461|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
1565462|NCT00515814|Hereditary condition|hereditary condition
1565463|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
1565464|NCT00515814|Retina implant|retina implant
1565465|NCT00515814|Subretinal implant|subretinal implant
1565466|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
1565467|NCT00515801|hypoglycemia|hypoglycemia
1565468|NCT00515801|sulfonylurea|sulfonylurea
1565469|NCT00515801|glucagon|glucagon
1565470|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
1565471|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
1565472|NCT00515788|Temozolomide|temozolomide
1565473|NCT00515788|Temodar|temodar
1565474|NCT00515788|DepoCyt|depocyt
1565475|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
1565476|NCT00515788|Liposomal ara-C|liposomal ara-c
1565477|NCT00515762|persistent alopecia|persistent alopecia
1565478|NCT00515762|docetaxel|docetaxel
1565479|NCT00515762|breast cancer|breast cancer
1565480|NCT00515736|selenium|selenium
1565481|NCT00515736|oxidative stress|oxidative stress
1565482|NCT00515736|glutathione peroxidase|glutathione peroxidase
1565483|NCT00515736|critically ill|critically ill
1565484|NCT00515736|outcome|outcome
1565485|NCT00515736|supplementation|supplementation
1565486|NCT00515723|control|control
1565487|NCT00515723|risperidone|risperidone
1565488|NCT00515723|olanzapine|olanzapine
1565489|NCT00515723|quetiapine|quetiapine
1565490|NCT00515723|ziprasidone|ziprasidone
1565491|NCT00515710|Hemophilia B|hemophilia b
1565492|NCT00515710|Gene Transfer|gene transfer
1565493|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
1565494|NCT00515710|Coagulation Factor IX|coagulation factor ix
1565495|NCT00515710|Long-term Follow-up|long-term follow-up
1565496|NCT00515710|Delayed Adverse Events|delayed adverse events
1565497|NCT00515671|self-management|self-management
1565498|NCT00515671|recovery|recovery
1565499|NCT00515671|severe mental illness|severe mental illness
1565500|NCT00515658|Major depression|major depression
1565501|NCT00515658|Theta-burst rTMS|theta-burst rtms
1565502|NCT00515658|Cortical excitability|cortical excitability
1565503|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
1565504|NCT00515645|Autonomic nervous system|autonomic nervous system
1565505|NCT00515645|Immersion|immersion
1565506|NCT00515645|Heart rate variability|heart rate variability
1565507|NCT00515645|Head-down tilt|head-down tilt
1565508|NCT00515645|Healthy volunteers|healthy volunteers
1565509|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
1565510|NCT00515632|Balaglitazone|balaglitazone
1565511|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
1565512|NCT00515632|HbA1c|hba1c
1565513|NCT00515632|Weight gain|weight gain
1565514|NCT00515632|Oedema|oedema
1565515|NCT00515632|Fasting blood glucose|fasting blood glucose
1565516|NCT00515593|osteoporosis|osteoporosis
1565517|NCT00515593|postmenopausal women|postmenopausal women
1565518|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
1565519|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
1565520|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
1565521|NCT00515580|tongue suture|tongue suture
1565522|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
1565523|NCT00515580|minimally invasive|minimally invasive
1565524|NCT00515567|explanted lungs|explanted lungs
1565525|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
1565526|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
1565527|NCT00515554|PET|pet
1565528|NCT00515554|advances stages|advances stages
1565529|NCT00515554|Rituximab|rituximab
1565530|NCT00515541|Platelet|platelet
1565531|NCT00515541|Cardiovascular|cardiovascular
1565532|NCT00515541|Lipid|lipid
1565533|NCT00515541|Fish Oil|fish oil
1565534|NCT00515541|Omega 3|omega 3
1565535|NCT00515541|DHA|dha
1565536|NCT00515541|EPA|epa
1565537|NCT00515541|Bleeding|bleeding
1565538|NCT00515541|Clotting|clotting
1565539|NCT00515541|platelet function|platelet function
1565540|NCT00515541|Lipid profile|lipid profile
1565541|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
1565542|NCT00515528|metastatic melanoma|metastatic melanoma
1565543|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1565544|NCT00515502|GSK573719,|gsk573719,
1565545|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
1565546|NCT00515489|Schizophrenia|schizophrenia
1565547|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
1565548|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
1565549|NCT00515476|metabolic syndrome|metabolic syndrome
1565550|NCT00515476|HDL-Cholesterol|hdl-cholesterol
1565551|NCT00515476|EPC|epc
1565552|NCT00515476|endothelial function|endothelial function
1565553|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
1565554|NCT00515463|Osteopenia|osteopenia
1565555|NCT00515463|Osteoporosis|osteoporosis
1565556|NCT00515463|AMG 162|amg 162
1565557|NCT00515463|Postmenopausal|postmenopausal
1565558|NCT00515463|Pre-filled syringe|pre-filled syringe
1565559|NCT00515450|Myasthenia Gravis|myasthenia gravis
1565560|NCT00515437|Sialorrhea|sialorrhea
1565561|NCT00515424|Glaucoma|glaucoma
1565562|NCT00515424|Ocular Hypertension|ocular hypertension
1565563|NCT00515424|RKI983|rki983
1565564|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
1565565|NCT00515411|gastroesophageal junction|gastroesophageal junction
1565566|NCT00515411|gastric cancer|gastric cancer
1565567|NCT00515411|adenocarcinoma|adenocarcinoma
1565568|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
1565569|NCT00515411|metastatic gastric|metastatic gastric
1565570|NCT00515385|Randomized|randomized
1565571|NCT00515385|Double-Blind|double-blind
1565572|NCT00515385|Dose-Escalation|dose-escalation
1565573|NCT00515385|Cohort Study|cohort study
1565574|NCT00515372|Ovarian Cancer|ovarian cancer
1565575|NCT00515372|Peritoneal Cancer|peritoneal cancer
1565576|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
1565577|NCT00515372|Depression|depression
1565578|NCT00515372|Telephone Counseling|telephone counseling
1565579|NCT00515372|Quality of Life|quality of life
1565580|NCT00515359|Sedation|sedation
1565581|NCT00515359|MRI|mri
1565582|NCT00515359|pediatric|pediatric
1565583|NCT00515359|propofol|propofol
1565584|NCT00515359|brain|brain
1565585|NCT00515359|spine|spine
1565586|NCT00515359|quality of MRI|quality of mri
1565587|NCT00515359|Continuous propofol dosing|continuous propofol dosing
1565588|NCT00515359|continuous propofol administration|continuous propofol administration
1565589|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
1565590|NCT00515359|intermittent propofol administration|intermittent propofol administration
1565591|NCT00515359|Sedative agent|sedative agent
1565592|NCT00515359|propofol continuous infusions|propofol continuous infusions
1565593|NCT00515359|Recovery time|recovery time
1565594|NCT00515359|Complications of sedation|complications of sedation
1565595|NCT00515359|bolus dosing|bolus dosing
1565596|NCT00515346|CLI|cli
1565597|NCT00515346|Critical Limb Ischemia|critical limb ischemia
1565598|NCT00515333|Alzheimer|alzheimer
1565599|NCT00515333|Dementia|dementia
1565600|NCT00515320|Autism|autism
1565601|NCT00515320|children|children
1565602|NCT00515320|adolescent|adolescent
1565603|NCT00515320|Fluoxetine|fluoxetine
1565604|NCT00515320|Autistic Disorder|autistic disorder
1565605|NCT00515320|Repetitive behavior|repetitive behavior
1565606|NCT00515320|SSRI|ssri
1565607|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
1565608|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
1565609|NCT00515307|Bone marrow|bone marrow
1565610|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
1565611|NCT00515307|Hepatocyte|hepatocyte
1565612|NCT00515294|Caffeine|caffeine
1565613|NCT00515294|Alcohol|alcohol
1565614|NCT00515294|Alcohol Consumption|alcohol consumption
1565615|NCT00515294|Residual Effects|residual effects
1565616|NCT00515294|Family History|family history
1565617|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
1565618|NCT00515294|Driving Simulation|driving simulation
1565619|NCT00515294|Reaction Time|reaction time
1565620|NCT00515281|prematurity|prematurity
1565621|NCT00515281|nitric oxide|nitric oxide
1565622|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1565623|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
1565624|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
1565625|NCT00515281|neurodevelopment|neurodevelopment
1565626|NCT00515268|LPS challenge,|lps challenge,
1565627|NCT00515268|Healthy volunteers|healthy volunteers
1565628|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
1565629|NCT00515255|Neuropharm|neuropharm
1565630|NCT00515255|NPL-2003|npl-2003
1565631|NCT00515242|massage therapy|massage therapy
1565632|NCT00515242|relaxation treatments|relaxation treatments
1565633|NCT00515229|cystic fibrosis|cystic fibrosis
1565634|NCT00515229|ceramide|ceramide
1565635|NCT00515229|amitriptyline|amitriptyline
1565636|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
1565637|NCT00515229|lung function|lung function
1565638|NCT00515216|Phase II|phase ii
1565639|NCT00515216|Gastric cancer|gastric cancer
1565640|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
1565641|NCT00515216|Metastatic|metastatic
1565642|NCT00515216|FOLFOX|folfox
1565643|NCT00515216|Thymidylate synthase|thymidylate synthase
1565644|NCT00515216|Pharmacogenomic|pharmacogenomic
1565645|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
1565646|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
1565647|NCT00515190|Stomach Neoplasms|stomach neoplasms
1565648|NCT00515190|Secondary|secondary
1565649|NCT00515190|Combination chemotherapy|combination chemotherapy
1565650|NCT00515190|S-1|s-1
1565651|NCT00515190|oxaliplatin|oxaliplatin
1565652|NCT00515177|mindfulness|mindfulness
1565653|NCT00515177|meditation|meditation
1565654|NCT00515177|MBSR|mbsr
1565655|NCT00515177|mindfulness meditation|mindfulness meditation
1565656|NCT00515177|sleep|sleep
1565657|NCT00515177|insomnia|insomnia
1565658|NCT00515177|chronic insomnia|chronic insomnia
1565659|NCT00515177|primary insomnia|primary insomnia
1565660|NCT00515177|Minnesota|minnesota
1565661|NCT00515164|lung volume reduction|lung volume reduction
1565662|NCT00515164|emphysema|emphysema
1565663|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1565664|NCT00515151|Bloodstream Infection|bloodstream infection
1565665|NCT00515151|Bacteremia|bacteremia
1565666|NCT00515151|Central Venous Catheter|central venous catheter
1565667|NCT00515151|Alcohol|alcohol
1565668|NCT00515151|Disinfection|disinfection
1565669|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
1565670|NCT00515138|B-Cell NHL|b-cell nhl
1565671|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
1565672|NCT00515138|RICE|rice
1565673|NCT00515125|Quality of life|quality of life
1565674|NCT00515125|Supplement|supplement
1565675|NCT00515125|Care home|care home
1565676|NCT00515125|Elderly|elderly
1565677|NCT00515125|Malnutrition|malnutrition
1565678|NCT00515112|prostate|prostate
1565679|NCT00515112|cancer|cancer
1565777|NCT00514696|Leukemia|leukemia
1565680|NCT00515112|testosterone replacement|testosterone replacement
1565681|NCT00515112|AndroGel|androgel
1565682|NCT00515112|prostatic cancer|prostatic cancer
1565683|NCT00515112|prostatic neoplasms|prostatic neoplasms
1565684|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
1565685|NCT00515099|New-onset T1DM|new-onset t1dm
1565686|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
1565687|NCT00515099|New-onset T1D|new-onset t1d
1565688|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
1565689|NCT00515099|Autoimmune diabetes|autoimmune diabetes
1565690|NCT00515099|Thymoglobulin|thymoglobulin
1565692|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
1734014|NCT00001184|IBD|ibd
1565693|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
1565694|NCT00515073|Endometrial Cancer|endometrial cancer
1565695|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
1565696|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
1565697|NCT00515073|Paclitaxel|paclitaxel
1565698|NCT00515073|Taxol|taxol
1565699|NCT00515060|Advanced Cancer|advanced cancer
1565700|NCT00515060|Therapy-Induced Pain|therapy-induced pain
1565701|NCT00515060|Pain Threshold|pain threshold
1565702|NCT00515060|Sensory Tests|sensory tests
1565703|NCT00515060|Stimuli|stimuli
1565704|NCT00515060|Pain|pain
1565705|NCT00515047|Atopic Dermatitis|atopic dermatitis
1565706|NCT00515047|Eczema|eczema
1565707|NCT00515047|Eczema Herpeticum|eczema herpeticum
1565708|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
1565709|NCT00515047|Herpes Simplex|herpes simplex
1565710|NCT00515047|Vaccinia|vaccinia
1565711|NCT00515034|Doripenem|doripenem
1565712|NCT00515034|Imipenem|imipenem
1565713|NCT00515034|Cilastatin|cilastatin
1565714|NCT00515034|Vancomycin|vancomycin
1565715|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
1565716|NCT00515034|Ileus|ileus
1565717|NCT00515034|Hospitalized|hospitalized
1565718|NCT00515034|Fever|fever
1565719|NCT00515021|Metabolic syndrome|metabolic syndrome
1565720|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
1565721|NCT00515021|Diurnal drug regimen|diurnal drug regimen
1565722|NCT00515021|PAI-1 levels|pai-1 levels
1565723|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
1565724|NCT00514982|Colitis|colitis
1565725|NCT00514982|Medical Therapy|medical therapy
1565726|NCT00514982|Immunopathogenesis|immunopathogenesis
1565727|NCT00514982|Cytokine|cytokine
1565728|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
1565729|NCT00514982|HPS|hps
1565730|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
1565731|NCT00514969|STI571|sti571
1565732|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
1565733|NCT00514930|radiofrequency ablation|radiofrequency ablation
1565734|NCT00514930|liver cancer|liver cancer
1565735|NCT00514930|complications|complications
1565736|NCT00514930|liver tumors|liver tumors
1565737|NCT00514904|safety|safety
1565738|NCT00514904|meningococcal vaccine|meningococcal vaccine
1565739|NCT00514904|immunogenicity|immunogenicity
1565740|NCT00514878|nausea|nausea
1565741|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
1565742|NCT00514878|postoperative pain|postoperative pain
1565743|NCT00514865|ONO-2333Ms|ono-2333ms
1565744|NCT00514865|Major Depressive Disorder|major depressive disorder
1565745|NCT00514839|Prescription drug use disorder|prescription drug use disorder
1565746|NCT00514839|Brief intervention|brief intervention
1565747|NCT00514839|General hospital|general hospital
1565748|NCT00514839|Motivational Interviewing|motivational interviewing
1565749|NCT00514800|Home monitoring|home monitoring
1565750|NCT00514800|Primary care|primary care
1565751|NCT00514800|Hypertension|hypertension
1565752|NCT00514800|TIA|tia
1565753|NCT00514787|Asthma|asthma
1565754|NCT00514787|NIS|nis
1565755|NCT00514774|Huntington chorea|huntington chorea
1565756|NCT00514774|chorea|chorea
1565757|NCT00514774|hereditary|hereditary
1565758|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
1565759|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
1565760|NCT00514774|TUDCA|tudca
1565761|NCT00514774|UDCA|udca
1565762|NCT00514761|colorectal cancer|colorectal cancer
1565763|NCT00514761|AZD6244|azd6244
1565764|NCT00514748|breast reconstruction|breast reconstruction
1565765|NCT00514748|DIEP|diep
1565766|NCT00514748|vessel pedicle|vessel pedicle
1565767|NCT00514735|atrial fibrillation|atrial fibrillation
1565768|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
1565769|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
1565770|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
1565771|NCT00514709|Diphtheria|diphtheria
1565772|NCT00514709|Tetanus|tetanus
1565773|NCT00514709|Pertussis|pertussis
1565774|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
1565775|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
1565776|NCT00514696|Cancer|cancer
1565778|NCT00514696|GCS-100|gcs-100
1565780|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
1565781|NCT00514644|Panorama|panorama
1565782|NCT00514644|Carotid stenoses|carotid stenoses
1565783|NCT00514618|Term Pregnancy|term pregnancy
1565784|NCT00514618|Diabetes|diabetes
1565785|NCT00514618|Cervical Ripening|cervical ripening
1565786|NCT00514618|Induction|induction
1565787|NCT00514618|misoprostol|misoprostol
1565788|NCT00514618|Term Gestational Diabetics|term gestational diabetics
1565789|NCT00514605|HIV 1|hiv 1
1565790|NCT00514605|AIDS|aids
1565791|NCT00514605|Assay|assay
1565792|NCT00514605|Rapid Test|rapid test
1565793|NCT00514605|HIV-1|hiv-1
1565794|NCT00514605|HIV Seronegativity|hiv seronegativity
1565795|NCT00514592|Carotid stenosis|carotid stenosis
1565796|NCT00514592|Carotid endarterectomy|carotid endarterectomy
1565797|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
1565798|NCT00514579|Hematologic Malignancies|hematologic malignancies
1565799|NCT00514579|Leukemia|leukemia
1565800|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
1565801|NCT00514566|Polyamide|polyamide
1565802|NCT00514566|Polydioxanone|polydioxanone
1565803|NCT00514566|Midline|midline
1565804|NCT00514566|Abdominal|abdominal
1565805|NCT00514566|Closure|closure
1565806|NCT00514553|Prenatal Testing|prenatal testing
1565807|NCT00514553|Test Decision-Making|test decision-making
1565808|NCT00514553|Decision-Making Intervention|decision-making intervention
1565809|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
1565810|NCT00514553|Informed Choice|informed choice
1565811|NCT00514553|Decision Making|decision making
1565812|NCT00514553|Counseling|counseling
1565813|NCT00514540|Prostate Cancer|prostate cancer
1565814|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
1565815|NCT00514540|Carboplatin|carboplatin
1565816|NCT00514540|Docetaxel|docetaxel
1565817|NCT00514540|Taxotere|taxotere
1565818|NCT00514540|Paraplatin|paraplatin
1565819|NCT00514514|Everolimus|everolimus
1565820|NCT00514514|mycophenolate|mycophenolate
1565821|NCT00514514|CNI-free|cni-free
1565822|NCT00514514|kidney transplantation|kidney transplantation
1565823|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
1565824|NCT00514488|STI 571|sti 571
1565825|NCT00514488|CML022|cml022
1565826|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
1565827|NCT00514475|Zevalin|zevalin
1565828|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
1565829|NCT00514475|Radioimmunotherapy|radioimmunotherapy
1565830|NCT00514475|High-dose therapy|high-dose therapy
1565831|NCT00514475|First line|first line
1565832|NCT00514436|Asthma|asthma
1565833|NCT00514436|children|children
1565834|NCT00514436|low-income, underserved|low-income, underserved
1565835|NCT00514436|Reduction in hospitalization|reduction in hospitalization
1565836|NCT00514410|Depression|depression
1565837|NCT00514410|Folate|folate
1565838|NCT00514410|Folic acid|folic acid
1565839|NCT00514410|Antidepressants|antidepressants
1565840|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1565841|NCT00514371|Multiple Myeloma|multiple myeloma
1565842|NCT00514371|Heat Shock Protein 90|heat shock protein 90
1565843|NCT00514371|Hsp90|hsp90
1565844|NCT00514371|KOS-953|kos-953
1565845|NCT00514371|17-AAG|17-aag
1565846|NCT00514371|bortezomib|bortezomib
1565847|NCT00514371|relapsed-refractory|relapsed-refractory
1565848|NCT00514371|tanespimycin|tanespimycin
1565849|NCT00514358|Fungal|fungal
1565850|NCT00514358|Infection|infection
1565851|NCT00514358|sepsis|sepsis
1565852|NCT00514358|pharmacokinetics|pharmacokinetics
1565853|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1565854|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1565855|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1565856|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1566033|NCT00513734|intensive care|intensive care
1565857|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1565858|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1565859|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1565860|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1565861|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1565862|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1565863|NCT00514332|colorectal stents|colorectal stents
1565864|NCT00514332|colonic obstruction|colonic obstruction
1565865|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
1565866|NCT00514332|colorectal surgery|colorectal surgery
1565867|NCT00514306|Advanced Cancer|advanced cancer
1565868|NCT00514306|Breast cancer|breast cancer
1565869|NCT00514306|Renal cancer|renal cancer
1565870|NCT00514306|Ovarian Cancer|ovarian cancer
1565871|NCT00514306|Metastatic Cancer|metastatic cancer
1565872|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
1565873|NCT00514306|Colorectal cancer|colorectal cancer
1565874|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1565875|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1565876|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1565877|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
1565878|NCT00514280|Birth Weight|birth weight
1565879|NCT00514280|Gestational Age|gestational age
1565880|NCT00514280|Lead|lead
1565881|NCT00514280|Tobacco Smoke|tobacco smoke
1734219|NCT00001145|KLH|klh
1565882|NCT00514267|Prostate Cancer|prostate cancer
1565883|NCT00514267|HRPC|hrpc
1565884|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1565885|NCT00514267|YM155|ym155
1565886|NCT00514267|Treatment Outcome|treatment outcome
1565887|NCT00514267|Solid Tumors|solid tumors
1565888|NCT00514254|endometrial cancer|endometrial cancer
1565889|NCT00514254|risk factors|risk factors
1565890|NCT00514254|questionnaire|questionnaire
1565891|NCT00514254|07-093|07-093
1565892|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1565893|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1565894|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
1565895|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1565896|NCT00514215|lung metastases|lung metastases
1565897|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1565898|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1565899|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1565900|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1565901|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1565902|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1565903|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
1565904|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
1565905|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1565906|NCT00514202|cocaine|cocaine
1565907|NCT00514202|ADHD|adhd
1565908|NCT00514202|attention|attention
1565909|NCT00514202|hyperactivity|hyperactivity
1565910|NCT00514202|drug|drug
1565911|NCT00514202|dependence|dependence
1565912|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
1565913|NCT00514189|Leukemia|leukemia
1565914|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
1565915|NCT00514189|Vaccine|vaccine
1565916|NCT00514189|AML|aml
1565917|NCT00514189|mRNA|mrna
1565918|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
1565919|NCT00514163|gemcitabine|gemcitabine
1565920|NCT00514163|S-1|s-1
1565921|NCT00514163|phaseⅡstudy|phaseⅱstudy
1565922|NCT00514150|angiography|angiography
1565923|NCT00514150|complications|complications
1565924|NCT00514150|contrast media|contrast media
1565925|NCT00514150|kidney|kidney
1565926|NCT00514150|prevention|prevention
1565927|NCT00514098|Microbicide|microbicide
1565928|NCT00514098|Seroconversion|seroconversion
1565929|NCT00514098|Treatment Experienced|treatment experienced
1565930|NCT00514098|Treatment Naive|treatment naive
1565931|NCT00514085|recurrent melanoma|recurrent melanoma
1565932|NCT00514085|stage IV melanoma|stage iv melanoma
1565933|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
1565934|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
1565935|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
1565936|NCT00514059|Booster immunization|booster immunization
1565937|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
1565938|NCT00514059|Immunity|immunity
1565939|NCT00514059|Safety|safety
1565940|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
1565941|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
1565942|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
1565943|NCT00514046|Pediatric|pediatric
1565944|NCT00514046|Pharmacokinetics|pharmacokinetics
1565946|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
1565947|NCT00514046|MEN|men
1565948|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1565949|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
1565950|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
1565951|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
1565952|NCT00514007|Ovarian cancer|ovarian cancer
1565953|NCT00514007|Renal cancer|renal cancer
1565954|NCT00514007|Advanced Cancer|advanced cancer
1565955|NCT00514007|Metastatic cancer|metastatic cancer
1565956|NCT00514007|Breast cancer|breast cancer
1565957|NCT00514007|Colorectal cancer|colorectal cancer
1565958|NCT00513994|Pharmacokinetics|pharmacokinetics
1565959|NCT00513994|Nitroglycerin|nitroglycerin
1565960|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
1565961|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1565962|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
1566056|NCT00513656|Efficacy|efficacy
1565963|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1565964|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
1565965|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1565966|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1565967|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1565968|NCT00513942|Fetal Movement|fetal movement
1565969|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
1565970|NCT00513942|Fetus|fetus
1565971|NCT00513929|Severe Pneumonia|severe pneumonia
1565972|NCT00513929|Zinc|zinc
1565973|NCT00513929|Associated pathogens|associated pathogens
1565974|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
1565975|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
1565976|NCT00513916|breast cancer|breast cancer
1565977|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
1565978|NCT00513903|Pulmonary Diseases|pulmonary diseases
1565979|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
1565980|NCT00513890|Bronchiolitis|bronchiolitis
1565981|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
1565982|NCT00513890|Clinical score|clinical score
1565983|NCT00513890|Citical care|citical care
1565984|NCT00513890|Infant|infant
1565985|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1565986|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1565987|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1565988|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
1565989|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
1565990|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
1565991|NCT00513864|Opioid Analgesics|opioid analgesics
1565992|NCT00513864|Morphine|morphine
1565993|NCT00513864|Codeine|codeine
1565994|NCT00513864|Sickle Cell Disease|sickle cell disease
1565995|NCT00513851|Advanced Cancer|advanced cancer
1565996|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
1565997|NCT00513851|Small cell lung cancer|small cell lung cancer
1565998|NCT00513851|Uterine cancer|uterine cancer
1565999|NCT00513851|Ovarian cancer|ovarian cancer
1566000|NCT00513851|Renal cancer|renal cancer
1566001|NCT00513851|Head and neck cancer|head and neck cancer
1566002|NCT00513851|Cervical cancer|cervical cancer
1566003|NCT00513851|Metastatic cancer|metastatic cancer
1566004|NCT00513851|Colorectal cancer|colorectal cancer
1566005|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
1566006|NCT00513825|Contrast Nephropathy|contrast nephropathy
1566007|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
1566008|NCT00513825|Prevention|prevention
1566009|NCT00513786|Endometrial Cancer|endometrial cancer
1566010|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
1566011|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
1566012|NCT00513786|Cancer treatment|cancer treatment
1566013|NCT00513786|gyn cancer|gyn cancer
1566014|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
1566015|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
1566016|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
1566017|NCT00513760|Pharmacogenetics|pharmacogenetics
1566018|NCT00513760|Singulair|singulair
1566019|NCT00513760|montelukast|montelukast
1566020|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
1566021|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
1566022|NCT00513760|Intestinal Absorption|intestinal absorption
1566023|NCT00513760|pharmacokinetics|pharmacokinetics
1566024|NCT00513760|absorption|absorption
1566025|NCT00513760|biochemical transport|biochemical transport
1566026|NCT00513760|Membrane Transport Proteins|membrane transport proteins
1566027|NCT00513760|Drug Interactions|drug interactions
1566028|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1566029|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1566030|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1566031|NCT00513734|keratopathy|keratopathy
1566032|NCT00513734|exposure|exposure
1566035|NCT00513734|ulcer|ulcer
1566036|NCT00513734|Corneal|corneal
1566037|NCT00513721|prostate|prostate
1566038|NCT00513721|prostate cancer|prostate cancer
1566039|NCT00513721|surgical margins|surgical margins
1566040|NCT00513721|gleason score|gleason score
1566041|NCT00513721|positive lateral biopsies|positive lateral biopsies
1566042|NCT00513708|Detoxification|detoxification
1566043|NCT00513708|Treatment|treatment
1566044|NCT00513682|Cystic Fibrosis|cystic fibrosis
1566045|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
1566046|NCT00513682|Steatorrhea|steatorrhea
1566047|NCT00513682|Children 7 to 11 years|children 7 to 11 years
1566048|NCT00513682|Pancreatic enzyme|pancreatic enzyme
1566049|NCT00513669|Malaria|malaria
1566050|NCT00513669|Vaccine|vaccine
1566051|NCT00513669|Falciparum|falciparum
1566052|NCT00513669|Trial|trial
1566053|NCT00513669|Phase I|phase i
1566054|NCT00513669|Safety|safety
1566055|NCT00513669|Immunogenicity|immunogenicity
1566057|NCT00513656|chronic|chronic
1566058|NCT00513656|cancer|cancer
1566059|NCT00513656|pain|pain
1566060|NCT00513656|constipation|constipation
1566061|NCT00513656|oxycodone|oxycodone
1566062|NCT00513656|naloxone|naloxone
1566063|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
1566064|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
1566065|NCT00513643|duration of action|duration of action
1566066|NCT00513643|late metabolic activity|late metabolic activity
1566067|NCT00513643|hypoglycaemia|hypoglycaemia
1566068|NCT00513617|Sickle Cell Disease|sickle cell disease
1566069|NCT00513617|Anemia|anemia
1566070|NCT00513617|Nitric Oxide|nitric oxide
1566071|NCT00513617|Vaso Occlusive Events|vaso occlusive events
1566072|NCT00513617|Arginine Supplementation|arginine supplementation
1566073|NCT00513604|Clinical Response|clinical response
1566074|NCT00513604|Immunotherapy|immunotherapy
1566075|NCT00513604|Cancer|cancer
1566076|NCT00513604|Cytokines|cytokines
1566077|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
1566078|NCT00513604|Melanoma|melanoma
1566079|NCT00513604|Skin Cancer|skin cancer
1566080|NCT00513604|Malignant Melanoma|malignant melanoma
1566081|NCT00513591|Pregnancy|pregnancy
1566082|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
1566083|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
1566084|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
1566085|NCT00513591|Scleroderma|scleroderma
1566086|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
1566087|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1566088|NCT00513578|refractory anemia|refractory anemia
1566089|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1566090|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1566091|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1566092|NCT00513565|GSK561679,|gsk561679,
1566093|NCT00513565|single,|single,
1566094|NCT00513565|dose,|dose,
1566095|NCT00513565|lorazepam,|lorazepam,
1566096|NCT00513565|fMRI,|fmri,
1566097|NCT00513565|BOLD,|bold,
1566098|NCT00513565|healthy volunteers|healthy volunteers
1566099|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
1566100|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
1566101|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
1566102|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1566103|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1566104|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1566105|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
1566106|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1566107|NCT00513526|infection|infection
1566108|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
1566109|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1566110|NCT00513513|HIV|hiv
1566111|NCT00513513|AIDS|aids
1566112|NCT00513513|TMC114|tmc114
1566113|NCT00513513|Protease inhibitor|protease inhibitor
1566114|NCT00513513|Darunavir|darunavir
1566115|NCT00513513|Antiretroviral agents|antiretroviral agents
1566116|NCT00513513|Treatment Naive|treatment naive
1566117|NCT00513500|community health care|community health care
1566118|NCT00513500|community health worker|community health worker
1566119|NCT00513500|malaria|malaria
1566120|NCT00513500|pneumonia|pneumonia
1566121|NCT00513500|rapid diagnostic test|rapid diagnostic test
1566122|NCT00513487|Allergic Rhinitis|allergic rhinitis
1566123|NCT00513487|dust mites|dust mites
1566124|NCT00513487|IgE|ige
1566125|NCT00513487|IL-13|il-13
1566126|NCT00513487|nasal|nasal
1566127|NCT00513487|inflammation|inflammation
1566128|NCT00513474|graft versus host disease|graft versus host disease
1566129|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1566130|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1566205|NCT00513357|Weight Loss|weight loss
1566305|NCT00513084|Predictors,|predictors,
1566131|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1566132|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1566133|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1566134|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1566135|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1566136|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1566137|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1566138|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1566139|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1566140|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1566141|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1566142|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1566143|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1566144|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1566145|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1566146|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1566147|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1566148|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1566149|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1566150|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
1566151|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1566152|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1566153|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1566154|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1566155|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1566156|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1566157|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1566158|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1566159|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1566160|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1566161|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1566162|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1566163|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1566164|NCT00513474|primary myelofibrosis|primary myelofibrosis
1566165|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1566166|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1566167|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1566168|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1566292|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
1566169|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1566170|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
1566171|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
1566172|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1566173|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1566174|NCT00513448|Chronic Disabling Condition|chronic disabling condition
1566175|NCT00513448|Comparative Evaluation|comparative evaluation
1566176|NCT00513448|Physical Activity|physical activity
1566177|NCT00513448|Physical Therapy|physical therapy
1566178|NCT00513448|Rehabilitation|rehabilitation
1566179|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
1566180|NCT00513422|Glucosamine|glucosamine
1566181|NCT00513422|Chondroitin|chondroitin
1566182|NCT00513422|Disease progression|disease progression
1566184|NCT00513409|Immunogenicity|immunogenicity
1566185|NCT00513409|Pneumococcal disease|pneumococcal disease
1566186|NCT00513409|Safety|safety
1566187|NCT00513409|Booster vaccination|booster vaccination
1566188|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
1566189|NCT00513396|Randomized control trial|randomized control trial
1566190|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
1566191|NCT00513396|isoniazid|isoniazid
1566192|NCT00513396|standardized regimen|standardized regimen
1566193|NCT00513396|adjuvant therapy|adjuvant therapy
1566194|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
1566195|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
1566196|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
1566197|NCT00513370|Psoriasis|psoriasis
1566198|NCT00513370|adalimumab|adalimumab
1566199|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
1566200|NCT00513357|Lung Cancer|lung cancer
1566201|NCT00513357|Cachexia|cachexia
1566202|NCT00513357|Melatonin|melatonin
1566203|NCT00513357|Placebo|placebo
1566204|NCT00513357|Anorexia|anorexia
1566206|NCT00513344|Endothelial function|endothelial function
1566207|NCT00513344|Arterial stiffness|arterial stiffness
1566208|NCT00513344|Dark chocolate|dark chocolate
1566209|NCT00513344|Milk chocolate|milk chocolate
1566210|NCT00513344|Polyphenols|polyphenols
1566211|NCT00513331|Barrett's Esophagus|barrett's esophagus
1566212|NCT00513331|GERD|gerd
1566213|NCT00513331|Carcinoma|carcinoma
1566214|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
1566215|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
1566216|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
1566217|NCT00513279|Safety,|safety,
1566218|NCT00513279|GSK618334|gsk618334
1566219|NCT00513279|pharmacokinetics,|pharmacokinetics,
1566220|NCT00513279|repeat dose,|repeat dose,
1566221|NCT00513279|tolerability,|tolerability,
1566222|NCT00513279|pharmacodynamics,|pharmacodynamics,
1566223|NCT00513279|placebo,|placebo,
1566425|NCT00512616|Ceftriaxone|ceftriaxone
1566224|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
1566225|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
1566226|NCT00513266|recurrent colon cancer|recurrent colon cancer
1566227|NCT00513266|stage IV colon cancer|stage iv colon cancer
1566228|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
1566229|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1566230|NCT00513266|liver metastases|liver metastases
1566231|NCT00513266|lung metastases|lung metastases
1566232|NCT00513253|lapatinib|lapatinib
1566233|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
1566234|NCT00513240|erythropoetin|erythropoetin
1566235|NCT00513240|neuroprotection|neuroprotection
1566236|NCT00513240|neonate|neonate
1566237|NCT00513240|cardiac|cardiac
1566238|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
1566239|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
1566240|NCT00513240|electroencephalogram|electroencephalogram
1566241|NCT00513214|Diabetes|diabetes
1566242|NCT00513214|Type 2|type 2
1566243|NCT00513214|Mellitus|mellitus
1566244|NCT00513201|lyspro|lyspro
1566245|NCT00513201|regular insulin|regular insulin
1566246|NCT00513201|cirrhotic patients|cirrhotic patients
1566247|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1566248|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1566249|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1566250|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1566251|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1566252|NCT00513175|Allogeneic SCT|allogeneic sct
1566253|NCT00513175|Matched unrelated donors|matched unrelated donors
1566254|NCT00513175|hematologic malignancies|hematologic malignancies
1566255|NCT00513175|renal cell carcinoma|renal cell carcinoma
1566256|NCT00513175|aplastic anemia|aplastic anemia
1566257|NCT00513162|Advanced Cancers|advanced cancers
1566258|NCT00513162|Brain|brain
1566259|NCT00513162|CNS|cns
1566260|NCT00513162|Neural|neural
1566261|NCT00513162|Pediatrics|pediatrics
1566262|NCT00513162|Spinal|spinal
1566263|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
1566264|NCT00513162|Brain Metastases|brain metastases
1566265|NCT00513162|Valproate|valproate
1566266|NCT00513162|Valproic Acid|valproic acid
1566267|NCT00513162|Depakene|depakene
1566268|NCT00513162|Etoposide|etoposide
1566269|NCT00513162|VePesid|vepesid
1566270|NCT00513149|angioplasty|angioplasty
1566271|NCT00513149|clopidogrel|clopidogrel
1566272|NCT00513149|coronary artery disease|coronary artery disease
1566273|NCT00513149|PFA|pfa
1566274|NCT00513136|Fatigue|fatigue
1566275|NCT00513136|Breast Cancer|breast cancer
1566276|NCT00513136|Behavioral Research|behavioral research
1566277|NCT00513136|Quality of Life|quality of life
1566278|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
1566279|NCT00513123|DCF|dcf
1566280|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
1566281|NCT00513123|Digital Colposcopy|digital colposcopy
1566282|NCT00513123|DC|dc
1566283|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1566284|NCT00513123|Cervical Cancer|cervical cancer
1566285|NCT00513123|Cervix|cervix
1566286|NCT00513123|Vagina|vagina
1566287|NCT00513123|Lesions of the cervix|lesions of the cervix
1566288|NCT00513123|Precancerous lesions|precancerous lesions
1566289|NCT00513110|Endotoxin|endotoxin
1566290|NCT00513110|Adenosine|adenosine
1566291|NCT00513110|Caffeine|caffeine
1566293|NCT00513097|Epidemiology|epidemiology
1566294|NCT00513097|Cancer Prevention|cancer prevention
1566295|NCT00513097|Smoking Cessation|smoking cessation
1566296|NCT00513097|Smoking Prevention|smoking prevention
1566297|NCT00513097|Focus Groups|focus groups
1566298|NCT00513084|Behavioral,|behavioral,
1566299|NCT00513084|Self-Determination Theory,|self-determination theory,
1566300|NCT00513084|Motivational Interviewing,|motivational interviewing,
1566301|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
1566302|NCT00513084|Motivation,|motivation,
1566303|NCT00513084|Moderators,|moderators,
1566304|NCT00513084|Mediators,|mediators,
1566306|NCT00513084|Weight|weight
1566307|NCT00513058|metastatic breast cancer|metastatic breast cancer
1566308|NCT00513058|advanced breast cancer|advanced breast cancer
1566309|NCT00513045|Nightmares|nightmares
1566310|NCT00513045|treatment|treatment
1566311|NCT00513045|self-help|self-help
1566312|NCT00513032|propofol|propofol
1566313|NCT00513032|anaesthesia induction|anaesthesia induction
1566314|NCT00513032|parathyroidectomy|parathyroidectomy
1566315|NCT00513032|methylene blue|methylene blue
1566316|NCT00513032|General anesthesia|general anesthesia
1566317|NCT00513019|Neurotic Excoriation|neurotic excoriation
1566318|NCT00513019|Pathologic Skin Picking|pathologic skin picking
1566319|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
1566320|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
1566321|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
1566322|NCT00512980|intermediate stages|intermediate stages
1566323|NCT00512967|oxidative stress|oxidative stress
1566324|NCT00512967|antioxidants|antioxidants
1566325|NCT00512967|inflammation|inflammation
1566326|NCT00512967|quercetin|quercetin
1566327|NCT00512954|airway inflammation|airway inflammation
1566328|NCT00512954|susceptibility to infections|susceptibility to infections
1566329|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
1566330|NCT00512954|infective exacerbations|infective exacerbations
1566331|NCT00512954|asthma|asthma
1566332|NCT00512954|COPD|copd
1566333|NCT00512928|vitamin K2|vitamin k2
1566334|NCT00512928|oral anticoagulation|oral anticoagulation
1566335|NCT00512928|interference|interference
1566336|NCT00512928|level of anticoagulation|level of anticoagulation
1566337|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
1566338|NCT00512915|Farfield Sensing|farfield sensing
1566339|NCT00512915|Pacing lead|pacing lead
1566340|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
1566341|NCT00512915|Bradycardia|bradycardia
1566342|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
1566344|NCT00512889|MART-1|mart-1
1566345|NCT00512889|Melan-A|melan-a
1566346|NCT00512889|artificial APC|artificial apc
1566347|NCT00512889|melanoma|melanoma
1566348|NCT00512889|metastatic melanoma|metastatic melanoma
1566349|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
1566350|NCT00512889|adoptive cell transfer|adoptive cell transfer
1566351|NCT00512889|immunotherapy|immunotherapy
1566352|NCT00512850|Folic acid|folic acid
1566353|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
1566354|NCT00512837|Telemedicine|telemedicine
1566355|NCT00512837|clinical management|clinical management
1566356|NCT00512837|empowerment|empowerment
1566357|NCT00512837|engagement|engagement
1566358|NCT00512837|education|education
1566359|NCT00512824|calcium|calcium
1566360|NCT00512824|probiotics|probiotics
1566361|NCT00512824|diarrhea|diarrhea
1566362|NCT00512824|children|children
1566363|NCT00512824|Indonesia|indonesia
1566364|NCT00512824|Healthy children|healthy children
1566365|NCT00512824|acute diarrhea|acute diarrhea
1566366|NCT00512811|furosemide|furosemide
1566367|NCT00512811|inhalation|inhalation
1566368|NCT00512811|dyspnea|dyspnea
1566369|NCT00512811|spirometry|spirometry
1566370|NCT00512811|mustard gas|mustard gas
1566371|NCT00512811|bronchiolitis|bronchiolitis
1566372|NCT00512811|sulfur mustard|sulfur mustard
1566373|NCT00512798|stage III melanoma|stage iii melanoma
1566374|NCT00512798|stage IV melanoma|stage iv melanoma
1566375|NCT00512798|recurrent melanoma|recurrent melanoma
1566376|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1566377|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
1566378|NCT00512798|melanoma (skin)|melanoma (skin)
1566379|NCT00512785|Imidafenacin|imidafenacin
1566380|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
1566381|NCT00512785|overactive bladder|overactive bladder
1566382|NCT00512785|antimuscarinic|antimuscarinic
1566383|NCT00512772|Time series|time series
1566384|NCT00512772|Implementation|implementation
1566385|NCT00512746|small cell lung cancer|small cell lung cancer
1566386|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
1566387|NCT00512746|precancerous condition|precancerous condition
1566388|NCT00512733|Healthy volunteers|healthy volunteers
1566389|NCT00512720|PAD|pad
1566390|NCT00512720|Peripheral Artery Disease|peripheral artery disease
1566391|NCT00512720|PVD|pvd
1566392|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
1566393|NCT00512720|Leg Blockage|leg blockage
1566394|NCT00512720|Angioplasty|angioplasty
1566395|NCT00512720|Stent|stent
1566396|NCT00512720|Claudication|claudication
1566397|NCT00512707|testosterone|testosterone
1566398|NCT00512707|erectile dysfunction|erectile dysfunction
1566399|NCT00512707|sildenafil|sildenafil
1566400|NCT00512694|Lupus|lupus
1566401|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
1566402|NCT00512694|Cutaneous Lupus|cutaneous lupus
1566403|NCT00512681|Stomach Neoplasms|stomach neoplasms
1566404|NCT00512681|Secondary|secondary
1566405|NCT00512681|Combination chemotherapy|combination chemotherapy
1566406|NCT00512681|S-1|s-1
1566407|NCT00512681|irinotecan|irinotecan
1566408|NCT00512681|oxaliplatin|oxaliplatin
1566409|NCT00512655|Fear of falling|fear of falling
1566410|NCT00512655|Intraindividual variability|intraindividual variability
1566411|NCT00512655|Cognition|cognition
1566412|NCT00512655|Fall prevention|fall prevention
1566413|NCT00512655|Fear|fear
1566414|NCT00512655|Frail elderly|frail elderly
1566415|NCT00512655|Intervention|intervention
1566416|NCT00512642|Non-Small Cell Lung Cancer|non-small cell lung cancer
1566417|NCT00512642|p53|p53
1566418|NCT00512642|Smoking|smoking
1566419|NCT00512642|Carcinogenesis|carcinogenesis
1566420|NCT00512642|Loss of Heterozygosity|loss of heterozygosity
1566421|NCT00512629|PN|pn
1566422|NCT00512629|cholestasis|cholestasis
1566423|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
1566424|NCT00512629|short bowel syndrome|short bowel syndrome
1566426|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
1566427|NCT00512616|Glutamatergic System|glutamatergic system
1566428|NCT00512616|Double-Blind|double-blind
1566429|NCT00512616|Mood Disorders|mood disorders
1566430|NCT00512616|Bipolar Disorder|bipolar disorder
1566431|NCT00512616|Depression|depression
1566432|NCT00512603|cerebro vascular event|cerebro vascular event
1566433|NCT00512590|fibromyalgia|fibromyalgia
1566434|NCT00512590|relaxation|relaxation
1566435|NCT00512590|imagery|imagery
1566436|NCT00512590|pain|pain
1566437|NCT00512590|functional status|functional status
1566438|NCT00512590|self efficacy|self efficacy
1566439|NCT00512590|minority health|minority health
1566440|NCT00512577|sickle cell disease|sickle cell disease
1566441|NCT00512577|pre-operative transfusion|pre-operative transfusion
1566442|NCT00512577|blood transfusion|blood transfusion
1566443|NCT00512564|Sickle Cell Anemia|sickle cell anemia
1566444|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
1566445|NCT00512564|Iron overload|iron overload
1566446|NCT00512564|Non transferrin binding iron|non transferrin binding iron
1566447|NCT00512564|Hepcidin|hepcidin
1566448|NCT00512551|Cervical Cancer|cervical cancer
1566449|NCT00512551|DNA Array Analysis|dna array analysis
1566450|NCT00512551|Gene Expression|gene expression
1566451|NCT00512551|DNA|dna
1566452|NCT00512538|Diabetic foot|diabetic foot
1566453|NCT00512512|transoral|transoral
1566454|NCT00512512|transluminal|transluminal
1566455|NCT00512512|endoscopic|endoscopic
1566456|NCT00512512|laparoscopic|laparoscopic
1566457|NCT00512512|liver|liver
1566458|NCT00512512|biopsy|biopsy
1566459|NCT00512499|Osteoporosis|osteoporosis
1566460|NCT00512499|Fragility fractures|fragility fractures
1566461|NCT00512499|Fracture clinics|fracture clinics
1566462|NCT00512499|Orthopedic surgeons|orthopedic surgeons
1566463|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
1566464|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
1566465|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
1566466|NCT00512460|Solid Tumor|solid tumor
1566467|NCT00512460|Lymphoma|lymphoma
1566468|NCT00512460|Leukemia|leukemia
1566469|NCT00512460|Brain Tumor|brain tumor
1566470|NCT00512460|RTA 744|rta 744
1566471|NCT00512447|Aging|aging
1566472|NCT00512434|tibial|tibial
1566473|NCT00512434|shaft|shaft
1566474|NCT00512434|fracture|fracture
1566475|NCT00512434|open|open
1566476|NCT00512434|bone-marrow|bone-marrow
1566477|NCT00512434|graft|graft
1566478|NCT00512434|injection|injection
1566479|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
1566480|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
1566481|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
1566482|NCT00512395|epidural analgesia|epidural analgesia
1566483|NCT00512395|pain score|pain score
1566484|NCT00512395|postoperative ileus|postoperative ileus
1566485|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
1566486|NCT00512382|Aspiration|aspiration
1566487|NCT00512382|ASHTMA|ashtma
1566488|NCT00512382|COUGH|cough
1566489|NCT00512382|WHEEZE|wheeze
1566490|NCT00512382|PH-IMPEDANCE|ph-impedance
1566491|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
1566492|NCT00512369|Metabolic pathways|metabolic pathways
1566493|NCT00512369|Atherosclerosis|atherosclerosis
1566494|NCT00512369|Monocyte Function|monocyte function
1566495|NCT00512343|Synovial Fluid|synovial fluid
1566496|NCT00512343|Arthritis|arthritis
1566497|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
1566498|NCT00512330|childhood|childhood
1566499|NCT00512330|tuberculosis|tuberculosis
1566500|NCT00512330|diagnostic|diagnostic
1566501|NCT00512330|lipoarabinomannan|lipoarabinomannan
1566502|NCT00512330|ELISA|elisa
1566503|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
1566504|NCT00512317|partial onset epilepsy|partial onset epilepsy
1566505|NCT00512317|adult epilepsy|adult epilepsy
1566506|NCT00512317|partial seizures|partial seizures
1566507|NCT00512317|anticonvulsant|anticonvulsant
1566606|NCT00511966|Rabeprazole|rabeprazole
1566508|NCT00512317|catamenial epilepsy|catamenial epilepsy
1566509|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
1566510|NCT00512291|Advanced Cancer|advanced cancer
1566511|NCT00512291|Hyperactive Delirium|hyperactive delirium
1566512|NCT00512291|Mixed Delirium|mixed delirium
1566513|NCT00512291|Olanzapine|olanzapine
1566514|NCT00512278|Hepatitis|hepatitis
1566515|NCT00512278|HCV|hcv
1566516|NCT00512278|Hepatitis C|hepatitis c
1566517|NCT00512265|n-acetylcysteine|n-acetylcysteine
1566518|NCT00512265|esophagectomy|esophagectomy
1566519|NCT00512265|inflammatory reaction|inflammatory reaction
1566520|NCT00512265|pulmonary morbidity|pulmonary morbidity
1566521|NCT00512252|Plerixafor|plerixafor
1566522|NCT00512252|CXCR4|cxcr4
1566523|NCT00512252|Chemosensitization|chemosensitization
1566524|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
1566525|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
1566526|NCT00512239|Biomarkers|biomarkers
1566527|NCT00512239|Autoantibodies|autoantibodies
1566528|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
1566529|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
1566530|NCT00512226|Sickle Cell Anemia|sickle cell anemia
1566531|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
1566532|NCT00512226|Iron Overload|iron overload
1566534|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
1566535|NCT00512213|major abdominal surgery|major abdominal surgery
1566536|NCT00512213|complication|complication
1566537|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
1566538|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
1566539|NCT00512174|Radical Cystectomy|radical cystectomy
1566540|NCT00512174|Bladder Reconstruction|bladder reconstruction
1566541|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
1566542|NCT00512122|early parenteral nutrition|early parenteral nutrition
1566543|NCT00512122|critical illness|critical illness
1566544|NCT00512122|respiratory failure|respiratory failure
1566545|NCT00512122|kidney failure|kidney failure
1566546|NCT00512122|hepatic failure|hepatic failure
1566547|NCT00512122|muscle strength|muscle strength
1566548|NCT00512122|rehabilitation|rehabilitation
1566549|NCT00512122|overfeeding|overfeeding
1566550|NCT00512122|Reduced Oral Intake|reduced oral intake
1566551|NCT00512109|vascular risk|vascular risk
1566552|NCT00512109|perioperative|perioperative
1566553|NCT00512109|vascular events|vascular events
1566554|NCT00512109|cohort study|cohort study
1566555|NCT00512109|surgery|surgery
1566556|NCT00512096|Genitourinary|genitourinary
1566557|NCT00512096|Penile Cancer|penile cancer
1566558|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1566559|NCT00512096|Extirpative Surgery|extirpative surgery
1566560|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
1566561|NCT00512096|Cisplatin|cisplatin
1566562|NCT00512096|Platinol-AQ|platinol-aq
1566563|NCT00512096|Platinol|platinol
1566564|NCT00512096|CDDP|cddp
1566565|NCT00512096|Ifosfamide|ifosfamide
1566566|NCT00512096|Ifex|ifex
1566567|NCT00512096|Paclitaxel|paclitaxel
1566568|NCT00512096|Taxol|taxol
1566569|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
1566570|NCT00512070|schizophrenia|schizophrenia
1566571|NCT00512070|schizoaffective disorder|schizoaffective disorder
1566572|NCT00512070|bipolar disorder|bipolar disorder
1566573|NCT00512070|olanzapine|olanzapine
1566574|NCT00512070|melatonin|melatonin
1566575|NCT00512070|obesity|obesity
1566576|NCT00512070|metabolic syndrome|metabolic syndrome
1566577|NCT00512057|cardiac syndrome X|cardiac syndrome x
1566578|NCT00512057|endothelial function|endothelial function
1566579|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
1566580|NCT00512031|atherosclerosis|atherosclerosis
1566581|NCT00512031|metabolic pathways|metabolic pathways
1566582|NCT00512031|monocyte adhesion,|monocyte adhesion,
1566583|NCT00512018|Electric Stimulation|electric stimulation
1566584|NCT00512018|Quadriceps Muscle|quadriceps muscle
1566585|NCT00512018|Muscle Strength|muscle strength
1566586|NCT00512018|Neuromuscular Properties|neuromuscular properties
1566587|NCT00512018|Tension-Length Relationship|tension-length relationship
1566588|NCT00512018|Healthy young adults|healthy young adults
1566589|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
1566590|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1566591|NCT00512005|Less invasive repair|less invasive repair
1566592|NCT00512005|Percutaneous MV repair|percutaneous mv repair
1566593|NCT00512005|Mitral Valve Repair|mitral valve repair
1566594|NCT00512005|Heart Failure|heart failure
1566595|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
1566596|NCT00511992|Ovarian Cancer|ovarian cancer
1566597|NCT00511992|Gynecologic Cancer|gynecologic cancer
1566598|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
1566599|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
1566600|NCT00511992|IP chemotherapy|ip chemotherapy
1566601|NCT00511992|Intraperitoneal|intraperitoneal
1566602|NCT00511992|Avastin|avastin
1566603|NCT00511992|Bevacizumab|bevacizumab
1566604|NCT00511979|Healthy Patients|healthy patients
1566605|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
1566607|NCT00511953|Hot flashes|hot flashes
1566608|NCT00511953|Hot flushes|hot flushes
1566609|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
1566610|NCT00511927|heart|heart
1566611|NCT00511927|failure|failure
1566612|NCT00511927|growth|growth
1566613|NCT00511927|hormone|hormone
1566614|NCT00511927|igf|igf
1566615|NCT00511927|dilative|dilative
1566616|NCT00511927|cardiomyopathy|cardiomyopathy
1566617|NCT00511914|Influenza vaccine|influenza vaccine
1566618|NCT00511901|anemia|anemia
1566619|NCT00511901|function|function
1566620|NCT00511901|rehabilitation|rehabilitation
1566621|NCT00511888|chronic heart failure|chronic heart failure
1566622|NCT00511888|hypertension|hypertension
1566623|NCT00511888|beta blockers|beta blockers
1566624|NCT00511875|diabetic retinopathy|diabetic retinopathy
1566625|NCT00511875|diabetes|diabetes
1566626|NCT00511875|diabetic eye studies|diabetic eye studies
1566627|NCT00511875|neovascularization|neovascularization
1566628|NCT00511862|TheraSphere|therasphere
1566629|NCT00511862|radioactive microspheres|radioactive microspheres
1566630|NCT00511862|Yttrium-90|yttrium-90
1566631|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
1566632|NCT00511836|alcoholism|alcoholism
1566633|NCT00511836|addiction|addiction
1566634|NCT00511836|alcohol detoxification|alcohol detoxification
1566635|NCT00511823|drug-drug interaction,|drug-drug interaction,
1566636|NCT00511823|rosiglitazone,|rosiglitazone,
1566637|NCT00511823|safety|safety
1566638|NCT00511823|CYP2C8,|cyp2c8,
1566639|NCT00511823|pharmacokinetics,|pharmacokinetics,
1566640|NCT00511823|CYP3A4,|cyp3a4,
1566641|NCT00511823|granisetron,|granisetron,
1566642|NCT00511823|dolasetron,|dolasetron,
1566643|NCT00511823|CYP2D6,|cyp2d6,
1566644|NCT00511823|casopitant,|casopitant,
1566645|NCT00511810|Sadness|sadness
1566646|NCT00511810|Insomnia|insomnia
1566647|NCT00511810|Loss of appetite|loss of appetite
1566648|NCT00511810|Fatigue|fatigue
1566649|NCT00511810|Trouble thinking|trouble thinking
1566650|NCT00511797|Dysmenorrhea|dysmenorrhea
1566651|NCT00511797|Dysmenorrheal score|dysmenorrheal score
1566652|NCT00511797|Drospirenone|drospirenone
1566653|NCT00511797|DRSP|drsp
1566654|NCT00511797|Ethinylestradiol|ethinylestradiol
1566655|NCT00511784|Contraception|contraception
1566656|NCT00511784|Hormonal contraception|hormonal contraception
1566657|NCT00511784|Oral contraception|oral contraception
1566658|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
1566659|NCT00511784|Transdermal|transdermal
1566660|NCT00511784|Venous thromboembolism|venous thromboembolism
1566661|NCT00511784|Norelgestromin|norelgestromin
1566662|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
1566663|NCT00511758|Cervical Dysplasia|cervical dysplasia
1566664|NCT00511758|Digital Imaging|digital imaging
1566665|NCT00511758|Colposcopy|colposcopy
1566666|NCT00511758|Cervix|cervix
1566667|NCT00511745|Interactions|interactions
1566668|NCT00511745|Adjusted doses|adjusted doses
1566669|NCT00511745|Duodenal Ulcer|duodenal ulcer
1566670|NCT00511745|Gastric Ulcer|gastric ulcer
1566671|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
1566672|NCT00511745|Rabeprazole|rabeprazole
1566673|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
1566674|NCT00511693|fragility fracture|fragility fracture
1566675|NCT00511693|management of osteoporosis|management of osteoporosis
1566676|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
1566677|NCT00511693|small volume hospitals|small volume hospitals
1566678|NCT00511654|depression|depression
1566679|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
1566680|NCT00511641|Ovarian Cancer|ovarian cancer
1566681|NCT00511641|Cancer Screening|cancer screening
1566682|NCT00511641|Quality of Life|quality of life
1566683|NCT00511641|Questionnaire|questionnaire
1566684|NCT00511641|Screening|screening
1566685|NCT00511641|Survey|survey
1566686|NCT00511628|Schizophrenia|schizophrenia
1566687|NCT00511628|Risperidone|risperidone
1566688|NCT00511628|Schizoaffective disorder|schizoaffective disorder
1566689|NCT00511628|Schizophreniform disorder|schizophreniform disorder
1566690|NCT00511628|Weight gain|weight gain
1566691|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1566692|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
1566693|NCT00511615|Cervical Cancer|cervical cancer
1566694|NCT00511615|Colposcopy|colposcopy
1566695|NCT00511615|Molecular Imaging|molecular imaging
1566696|NCT00511615|LEEP|leep
1566697|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
1566698|NCT00511576|Breast Cancer|breast cancer
1566699|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
1566700|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1566701|NCT00511576|Prostate Cancer|prostate cancer
1566702|NCT00511576|Gastric Cancer|gastric cancer
1566703|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
1566704|NCT00511576|HDAC Inhibitor|hdac inhibitor
1566705|NCT00511576|Taxotere|taxotere
1566706|NCT00511576|Docetaxel|docetaxel
1566707|NCT00511563|Cortisol,|cortisol,
1566708|NCT00511563|stress,|stress,
1566709|NCT00511563|response,|response,
1566710|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
1566711|NCT00511563|cytokine.|cytokine.
1566712|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
1566713|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
1566714|NCT00511550|allogeneic transplantation|allogeneic transplantation
1566715|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
1566716|NCT00511537|AML|aml
1566717|NCT00511537|ALL|all
1566718|NCT00511537|CML|cml
1566719|NCT00511537|Lymphoma|lymphoma
1566720|NCT00511537|Myelodysplasia|myelodysplasia
1566721|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
1566722|NCT00511537|Hematopoietic disorders|hematopoietic disorders
1566724|NCT00511524|inflammation,|inflammation,
1566726|NCT00511524|PET|pet
1566727|NCT00511524|analgesia,|analgesia,
1566728|NCT00511511|hypertension|hypertension
1566729|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
1566730|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1566731|NCT00511511|Sunitinib|sunitinib
1566732|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
1566733|NCT00511498|Nightly sildenafil|nightly sildenafil
1566734|NCT00511485|Cancer|cancer
1566735|NCT00511485|Adenocarcinoma|adenocarcinoma
1566736|NCT00511485|Phase II|phase ii
1566737|NCT00511485|Lung|lung
1566738|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
1566739|NCT00511485|NSCLC|nsclc
1566740|NCT00511485|EC145|ec145
1566741|NCT00511485|EC20|ec20
1566742|NCT00511459|Randomized|randomized
1566743|NCT00511459|4-Arm|4-arm
1566744|NCT00511459|Placebo controlled|placebo controlled
1566745|NCT00511459|Phase 2 Trial|phase 2 trial
1566746|NCT00511459|AMG 386|amg 386
1566747|NCT00511459|Paclitaxel|paclitaxel
1566748|NCT00511459|Bevacizumab|bevacizumab
1566749|NCT00511459|First-line Therapy|first-line therapy
1566750|NCT00511459|Her-2 Negative|her-2 negative
1566751|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
1566752|NCT00511446|Stomach neoplasms|stomach neoplasms
1566753|NCT00511446|docetaxel|docetaxel
1566754|NCT00511446|oxaliplatin|oxaliplatin
1566755|NCT00511446|capecitabine|capecitabine
1566756|NCT00511420|cocoa|cocoa
1566757|NCT00511420|cardiovascular disease|cardiovascular disease
1566758|NCT00511420|blood pressure|blood pressure
1566759|NCT00511407|Acute renal failure|acute renal failure
1566760|NCT00511407|Bioartificial kidney|bioartificial kidney
1566761|NCT00511407|Cell therapy|cell therapy
1566762|NCT00511407|Hemofiltration|hemofiltration
1566763|NCT00511407|Septic shock|septic shock
1566764|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
1566765|NCT00511381|Hearing Loss|hearing loss
1566766|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
1566767|NCT00511381|Deafness|deafness
1566768|NCT00511368|HIV|hiv
1566769|NCT00511368|treatment experienced|treatment experienced
1566770|NCT00511368|AIDS|aids
1566771|NCT00511329|growth hormone|growth hormone
1566772|NCT00511329|short stature|short stature
1566773|NCT00511329|growth failure|growth failure
1566774|NCT00511329|chronic illness|chronic illness
1566775|NCT00511303|Philadelphia chromosome|philadelphia chromosome
1566776|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
1566777|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
1566778|NCT00511277|quetiapine|quetiapine
1566779|NCT00511277|schizophrenia|schizophrenia
1566780|NCT00511277|first-episode psychosis|first-episode psychosis
1566781|NCT00511277|depression|depression
1566782|NCT00511277|psychopathology|psychopathology
1566783|NCT00511264|Laparoscopy|laparoscopy
1566784|NCT00511264|Ultrasound|ultrasound
1566785|NCT00511264|Cancer|cancer
1566786|NCT00511264|Biopsy|biopsy
1566787|NCT00511251|IS-SEM|is-sem
1566788|NCT00511238|Onyx|onyx
1566789|NCT00511238|PR171|pr171
1566790|NCT00511238|carfilzomib|carfilzomib
1566791|NCT00511238|multiple myeloma|multiple myeloma
1566792|NCT00511238|relapsed|relapsed
1566793|NCT00511238|refractory|refractory
1566794|NCT00511225|dialysis|dialysis
1566795|NCT00511225|Vitamin D|vitamin d
1566796|NCT00511212|severe peritonitis|severe peritonitis
1566797|NCT00511212|SSI|ssi
1566798|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
1566799|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
1566800|NCT00511186|Sepsis|sepsis
1566801|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
1566802|NCT00511186|inflammation|inflammation
1566803|NCT00511186|infection|infection
1566804|NCT00511186|renal failure|renal failure
1566805|NCT00511173|mechanical valve|mechanical valve
1566806|NCT00511160|myocarditis|myocarditis
1566807|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
1566808|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
1566809|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
1566810|NCT00511147|IVIG|ivig
1566811|NCT00511147|ITP|itp
1566812|NCT00511134|insomnia|insomnia
1566813|NCT00511134|nicotine dependence|nicotine dependence
1566814|NCT00511134|smoking|smoking
1566815|NCT00511134|smoking cessation|smoking cessation
1566816|NCT00511134|zyban|zyban
1566817|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
1566818|NCT00511121|tyrosine kinase|tyrosine kinase
1566819|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1566820|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
1566821|NCT00511095|HBV vaccine|hbv vaccine
1566822|NCT00511095|Hepatitis B|hepatitis b
1566823|NCT00511095|Hepatitis|hepatitis
1566825|NCT00511069|Bortezomib|bortezomib
1566826|NCT00511069|CML033|cml033
1566828|NCT00511056|Adherence|adherence
1566829|NCT00511056|Compliance|compliance
1566830|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
1566831|NCT00511056|ARV|arv
1566832|NCT00511056|ART|art
1566833|NCT00511056|Sexual Risk Behavior|sexual risk behavior
1566834|NCT00511056|Unsafe|unsafe
1566835|NCT00511056|Transmission|transmission
1566836|NCT00511043|PTK787|ptk787
1566837|NCT00511043|DLCL|dlcl
1566838|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
1566839|NCT00511030|Diabetes|diabetes
1566840|NCT00511017|Solid Tumors|solid tumors
1566841|NCT00511017|Doxercalciferol|doxercalciferol
1566842|NCT00511017|Pediatric Cancer|pediatric cancer
1566843|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
1566844|NCT00511017|Calcium|calcium
1566845|NCT00511017|Vitamin D|vitamin d
1566846|NCT00511004|Brugia Malayi|brugia malayi
1566847|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
1566848|NCT00511004|Albendazole|albendazole
1566849|NCT00511004|Diethylcarbamazine|diethylcarbamazine
1566850|NCT00510991|ASTHMA|asthma
1566851|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
1566852|NCT00510978|Ulcerative Colitis|ulcerative colitis
1566853|NCT00510978|Crohn's disease|crohn's disease
1566854|NCT00510978|Probiotics|probiotics
1566855|NCT00510978|Gastrointestinal|gastrointestinal
1566856|NCT00510965|choroidal neovascularization|choroidal neovascularization
1566857|NCT00510965|angioid streaks|angioid streaks
1566858|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
1566859|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
1566860|NCT00510965|therapy|therapy
1566861|NCT00510965|ranibizumab|ranibizumab
1566862|NCT00510965|lucentis|lucentis
1566863|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
1566864|NCT00510952|diabetes|diabetes
1566865|NCT00510952|type 2|type 2
1566866|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
1566867|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
1566868|NCT00510939|expression of NFkB|expression of nfkb
1566869|NCT00510913|Treatment efficacy|treatment efficacy
1566870|NCT00510913|Transplantation rejection|transplantation rejection
1566871|NCT00510913|Kidney transplantation|kidney transplantation
1566872|NCT00510913|Cyclosporine|cyclosporine
1566873|NCT00510913|tacrolimus|tacrolimus
1566874|NCT00510887|follicular lymphoma|follicular lymphoma
1566875|NCT00510887|Velcade|velcade
1566876|NCT00510887|VR-FND|vr-fnd
1566877|NCT00510874|Influenza|influenza
1566878|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
1566879|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
1566880|NCT00510835|septic shock|septic shock
1566881|NCT00510835|resuscitation|resuscitation
1566882|NCT00510835|sepsis|sepsis
1566883|NCT00510835|cost-effectiveness|cost-effectiveness
1566884|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
1566885|NCT00510835|early goal directed therapy|early goal directed therapy
1566886|NCT00510835|emergency medicine|emergency medicine
1566887|NCT00510835|critical care medicine|critical care medicine
1566888|NCT00510822|Cimicoxib|cimicoxib
1566889|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
1566890|NCT00510822|Sertraline|sertraline
1566891|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
1566892|NCT00510796|Colon Cancer|colon cancer
1566893|NCT00510796|Endometrial Cancer|endometrial cancer
1566894|NCT00510796|Cancer Screening|cancer screening
1566895|NCT00510796|Interview|interview
1566896|NCT00510796|HNPCC|hnpcc
1566897|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
1566898|NCT00510783|emergency department|emergency department
1566899|NCT00510783|IV levetiracetam|iv levetiracetam
1566900|NCT00510783|Keppra|keppra
1566901|NCT00510783|seizures|seizures
1566902|NCT00510783|phenytoin|phenytoin
1566903|NCT00510783|Dilantin|dilantin
1566904|NCT00510783|Grand Mal seizure|grand mal seizure
1566905|NCT00510770|CPAP|cpap
1566906|NCT00510770|Post-opreative|post-opreative
1566907|NCT00510770|ARF|arf
1566908|NCT00510770|liver transplant|liver transplant
1566909|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
1566910|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
1566911|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
1566912|NCT00510731|Cardiac Sudden Death|cardiac sudden death
1566913|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
1566914|NCT00510731|Heart Rate Variability|heart rate variability
1566915|NCT00510718|Prostate|prostate
1566916|NCT00510718|Cancer|cancer
1566917|NCT00510718|Hormone|hormone
1566918|NCT00510718|Refractory|refractory
1566919|NCT00510718|Castration|castration
1566920|NCT00510705|adiposity|adiposity
1566921|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
1566922|NCT00510692|EPA|epa
1566923|NCT00510692|EPA 99%|epa 99%
1566924|NCT00510692|Fatty acid|fatty acid
1566925|NCT00510692|omega-3|omega-3
1566926|NCT00510692|apoptosis|apoptosis
1566927|NCT00510692|cell proliferation|cell proliferation
1566928|NCT00510692|colonic mucosa|colonic mucosa
1566929|NCT00510692|polyp|polyp
1566930|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
1566932|NCT00510692|resolvin|resolvin
1566933|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
1566934|NCT00510692|IRA|ira
1566935|NCT00510692|PUFA|pufa
1566936|NCT00510692|Endoscopy|endoscopy
1566937|NCT00510679|Benin|benin
1566938|NCT00510679|child health|child health
1566939|NCT00510679|developing country|developing country
1566940|NCT00510679|health services research|health services research
1566941|NCT00510679|health worker performance|health worker performance
1566942|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
1566943|NCT00510666|Pain, Postoperative|pain, postoperative
1566944|NCT00510666|Analgesics, Opioid|analgesics, opioid
1566945|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
1566946|NCT00510666|Pain Measurement|pain measurement
1566947|NCT00510653|Ovarian Cancer|ovarian cancer
1566948|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
1566949|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
1566950|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
1566951|NCT00510653|Taxane-Resistant|taxane-resistant
1566952|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
1566953|NCT00510653|Imatinib Mesylate|imatinib mesylate
1566954|NCT00510653|Gleevec|gleevec
1566955|NCT00510653|STI571|sti571
1566956|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
1566957|NCT00510640|thyroid carcinoma|thyroid carcinoma
1566958|NCT00510640|Sunitinib|sunitinib
1566959|NCT00510640|RECIST guidelines|recist guidelines
1566960|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
1566961|NCT00510627|Colorectal Cancer|colorectal cancer
1566962|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
1566963|NCT00510627|Chemotherapy|chemotherapy
1566964|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
1566965|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
1566966|NCT00510588|adiposity|adiposity
1566967|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
1566968|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
1566969|NCT00510575|Scoliosis Management|scoliosis management
1566970|NCT00510575|Spinal Fusion|spinal fusion
1566971|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
1566972|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
1566973|NCT00510562|Cranial manipulation|cranial manipulation
1566974|NCT00510562|Visual function|visual function
1566975|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
1566976|NCT00510523|MS|ms
1566977|NCT00510523|Balance|balance
1566978|NCT00510523|Multiple Sclerosis|multiple sclerosis
1566979|NCT00510510|COPD|copd
1566980|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
1566981|NCT00510510|antimuscarinic|antimuscarinic
1566982|NCT00510497|dendritic cell|dendritic cell
1566983|NCT00510497|therapeutic vaccine|therapeutic vaccine
1566984|NCT00510497|HIV-1|hiv-1
1566985|NCT00510497|apoptotic cells|apoptotic cells
1566986|NCT00510497|Phase I/II|phase i/ii
1566987|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
1566988|NCT00510484|Cystic Fibrosis|cystic fibrosis
1566989|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
1566990|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
1566991|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
1566992|NCT00510432|heparin|heparin
1566993|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1566994|NCT00510432|HIT|hit
1566995|NCT00510432|allergy|allergy
1566996|NCT00510432|skin|skin
1566997|NCT00510432|dermatology|dermatology
1566998|NCT00510432|DTH|dth
1566999|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
1567000|NCT00510432|histology|histology
1567001|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
1567002|NCT00510432|Age over 18 years|age over 18 years
1567003|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
1567004|NCT00510419|Migraine|migraine
1567005|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1567006|NCT00510406|Treatment|treatment
1567007|NCT00510406|Solifenacin succinate|solifenacin succinate
1567008|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
1567009|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
1567010|NCT00510393|Critical Limb Ischemia|critical limb ischemia
1567011|NCT00510393|CLI|cli
1567012|NCT00510393|Drug Eluting Stent|drug eluting stent
1567013|NCT00510393|DES|des
1567014|NCT00510393|Bare Metal Stent|bare metal stent
1567015|NCT00510393|BMS|bms
1567016|NCT00510367|Breast Cancer|breast cancer
1567017|NCT00510367|FAC|fac
1567018|NCT00510367|Doxorubicin|doxorubicin
1567019|NCT00510367|Adriamycin|adriamycin
1567020|NCT00510367|Rubex|rubex
1567035|NCT00510341|Residency Training|residency training
1567036|NCT00510341|Skill Assessment|skill assessment
1567037|NCT00510328|whole body vibration|whole body vibration
1567038|NCT00510328|muscle physiology|muscle physiology
1567040|NCT00510315|survivors|survivors
1567041|NCT00510315|women|women
1567042|NCT00510315|leukemia survivors|leukemia survivors
1567043|NCT00510315|cancer or a related illness|cancer or a related illness
1567044|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
1567045|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1567046|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
1567047|NCT00510315|aplastic anemia|aplastic anemia
1567048|NCT00510315|treated with total body irradiation|treated with total body irradiation
1567049|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
1567050|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
1567051|NCT00510302|Melanoma|melanoma
1567052|NCT00510302|Questionnaire|questionnaire
1567053|NCT00510302|Survey|survey
1567054|NCT00510302|First Degree Relative|first degree relative
1567055|NCT00510302|Interview|interview
1567056|NCT00510289|Sorafenib|sorafenib
1567057|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
1567058|NCT00510289|MDS|mds
1567059|NCT00510263|Prednisolone|prednisolone
1567060|NCT00510263|Valacyclovir|valacyclovir
1567061|NCT00510250|Cervix Cancer|cervix cancer
1567062|NCT00510250|Cervical Cancer|cervical cancer
1567063|NCT00510250|Sorafenib|sorafenib
1567064|NCT00510250|Cisplatin|cisplatin
1567065|NCT00510250|Radiation|radiation
1567066|NCT00510250|Radiotherapy|radiotherapy
1567067|NCT00510250|Phase I|phase i
1567068|NCT00510250|Phase II|phase ii
1567069|NCT00510250|Carcinoma|carcinoma
1567070|NCT00510250|Cancer|cancer
1567071|NCT00510250|Cervix|cervix
1567072|NCT00510237|HIV|hiv
1567073|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
1567074|NCT00510198|Heart Disease|heart disease
1567075|NCT00510198|Congestive Heart Failure|congestive heart failure
1567076|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
1567077|NCT00510185|coronary artery disease|coronary artery disease
1567078|NCT00510185|coronary angioplasty|coronary angioplasty
1567079|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
1567080|NCT00510185|elderly|elderly
1567081|NCT00510172|Headache|headache
1567082|NCT00510172|Migraine|migraine
1567083|NCT00510172|Vasodilatation|vasodilatation
1567084|NCT00510159|Schistosoma haematobium|schistosoma haematobium
1567085|NCT00510159|Praziquantel|praziquantel
1567086|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
1567087|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
1567088|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
1567089|NCT00510120|Conduct Disorder|conduct disorder
1567090|NCT00510120|Behavior Problems in Youth|behavior problems in youth
1567091|NCT00510120|Argumentativeness|argumentativeness
1567092|NCT00510120|Children|children
1567093|NCT00510120|Therapy|therapy
1567094|NCT00510120|Attention Deficit Disorder|attention deficit disorder
1567095|NCT00510094|Social Skills|social skills
1567096|NCT00510094|Anger Management|anger management
1567097|NCT00510094|Relational Aggression|relational aggression
1567098|NCT00510068|Phase III|phase iii
1567099|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
1567100|NCT00510068|RAD001|rad001
1567101|NCT00510068|NET|net
1567102|NCT00510068|everolimus|everolimus
1567103|NCT00510068|mTOr|mtor
1567104|NCT00510068|islet cell|islet cell
1093570|NCT02589028|incretin hormone|incretin hormone
1492491|NCT00808665|GPCR|gpcr
1567186|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1567187|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1567188|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1567189|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1567190|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1567191|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1567192|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1567193|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1567194|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1567681|NCT00508482|Acupuncture|acupuncture
1567195|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1567196|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1567197|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1567198|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1567199|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1567200|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1567201|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1567202|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1567203|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1567204|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1567205|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1567206|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1567207|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1567208|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1567209|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1567210|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1567211|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1567212|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1567213|NCT00509691|recurrent breast cancer|recurrent breast cancer
1567214|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1567215|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1567216|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1567217|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1567218|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1567219|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1567220|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1567221|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1567222|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1567223|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1567224|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1567225|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1567226|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1567227|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1567228|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
1567229|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1567230|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1567231|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1567232|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1567233|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1567234|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1567235|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
1567236|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
1567237|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1567238|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1567239|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1567240|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1567241|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
1567242|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
1567243|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1567244|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1567245|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1567246|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1567247|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1567248|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1567249|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1567250|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1567251|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1567252|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1567253|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1567254|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1567255|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1567256|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
1567257|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1567258|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1567259|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
1567260|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
1567261|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
1567262|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1567263|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1567425|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
1567264|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1567265|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1567266|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1567267|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1567268|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1567269|NCT00509691|stage IV breast cancer|stage iv breast cancer
1567270|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1567271|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1567272|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1567273|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1567274|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1567275|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1567276|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1567295|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1567296|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1567297|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1567298|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1567299|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1567300|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1567301|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1567302|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1567303|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1567304|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1567305|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1567306|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1567307|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1567308|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1567309|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1567310|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
1567311|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1567312|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1567313|NCT00509652|Hemochromatosis|hemochromatosis
1567314|NCT00509652|Primary hemochromatosis|primary hemochromatosis
1567315|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
1567316|NCT00509652|Therapy|therapy
1567317|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
1567318|NCT00509652|Phlebotomy|phlebotomy
1567319|NCT00509652|Apheresis|apheresis
1567320|NCT00509652|Efficacy|efficacy
1567321|NCT00509626|fatigue|fatigue
1567322|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1567323|NCT00509626|weight changes|weight changes
1567324|NCT00509626|depression|depression
1567325|NCT00509626|stage I breast cancer|stage i breast cancer
1567326|NCT00509626|stage II breast cancer|stage ii breast cancer
1567327|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
1567328|NCT00509600|JMML|jmml
1567329|NCT00509600|Leukemia|leukemia
1567330|NCT00509600|Etanercept|etanercept
1567331|NCT00509600|Enbrel|enbrel
1567332|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
1567333|NCT00509574|statins|statins
1567334|NCT00509574|hyperlipidemia|hyperlipidemia
1567335|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1567336|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1567337|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
1567338|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
1567339|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
1567340|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
1567341|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
1567342|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
1567343|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
1567344|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
1567345|NCT00509535|SCORAD|scorad
1567346|NCT00509535|pruritus|pruritus
1567347|NCT00509535|microflora|microflora
1567348|NCT00509535|TEWL|tewl
1567349|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
1567350|NCT00509496|Refractory|refractory
1567351|NCT00509496|Gene Therapy|gene therapy
1567352|NCT00509496|HLA-A2 Positive|hla-a2 positive
1567353|NCT00509496|Stage IV Melanoma|stage iv melanoma
1567354|NCT00509496|Melanoma|melanoma
1567355|NCT00509496|Skin Cancer|skin cancer
1567356|NCT00509496|Malignant Melanoma|malignant melanoma
1567357|NCT00509483|multinodular|multinodular
1567358|NCT00509483|goitre|goitre
1567359|NCT00509483|recombinant human TSH|recombinant human tsh
1567360|NCT00509457|NSCLC, vaccination|nsclc, vaccination
1567361|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
1567362|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
1567363|NCT00509431|adult gliosarcoma|adult gliosarcoma
1567364|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1567365|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1567366|NCT00509431|adult mixed glioma|adult mixed glioma
1567367|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
1567368|NCT00509431|adult glioblastoma|adult glioblastoma
1567369|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1567370|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
1567371|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1567372|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
1567384|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
1567385|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
1567386|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
1567387|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
1567388|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
1567389|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
1567390|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
1567391|NCT00509366|genomics|genomics
1567392|NCT00509366|genomics predictor|genomics predictor
1567393|NCT00509366|genomics analysis|genomics analysis
1567394|NCT00509366|squamous|squamous
1567395|NCT00509366|non-squamous|non-squamous
1567396|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
1567397|NCT00509340|antiretroviral|antiretroviral
1567398|NCT00509340|adherence|adherence
1567399|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
1567400|NCT00509327|postoperative ileus|postoperative ileus
1567401|NCT00509327|colorectal surgery|colorectal surgery
1567402|NCT00509327|bisacodyl|bisacodyl
1567403|NCT00509327|laxatives|laxatives
1567404|NCT00509301|brain cancer|brain cancer
1567405|NCT00509301|Cotara|cotara
1567406|NCT00509301|radioactive isotope|radioactive isotope
1567407|NCT00509301|monoclonal antibody|monoclonal antibody
1567408|NCT00509301|radiation distribution|radiation distribution
1567409|NCT00509288|Refractory|refractory
1567410|NCT00509288|Gene Therapy|gene therapy
1567411|NCT00509288|HLA-A2 Positive|hla-a2 positive
1567412|NCT00509288|Stage IV Melanoma|stage iv melanoma
1567413|NCT00509288|Melanoma|melanoma
1567414|NCT00509288|Skin Cancer|skin cancer
1567415|NCT00509288|Malignant Melanoma|malignant melanoma
1567416|NCT00509223|Type 2 diabetes|type 2 diabetes
1567417|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
1567418|NCT00509223|Glycemic control|glycemic control
1567419|NCT00509223|Insulin resistance|insulin resistance
1567420|NCT00509223|Sleep disordered breathing|sleep disordered breathing
1567421|NCT00509210|Liver Disease|liver disease
1567422|NCT00509197|Asthma|asthma
1567423|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
1567424|NCT00509197|sputum eosinophils|sputum eosinophils
1567427|NCT00509171|embolism|embolism
1567428|NCT00509171|femur fracture|femur fracture
1567429|NCT00509171|lavage|lavage
1567430|NCT00509171|TEE|tee
1567431|NCT00509171|reamer|reamer
1567432|NCT00509171|IM nail|im nail
1567433|NCT00509158|safety|safety
1567434|NCT00509158|immunogenicity|immunogenicity
1567435|NCT00509158|efficacy|efficacy
1567436|NCT00509145|Relapsing|relapsing
1567437|NCT00509145|Remitting|remitting
1567438|NCT00509119|apoplexia|apoplexia
1567439|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
1567440|NCT00509106|ceftaroline|ceftaroline
1567441|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
1567442|NCT00509106|CAP|cap
1567443|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
1567444|NCT00509106|Haemophilus influenzae|haemophilus influenzae
1567445|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
1567446|NCT00509106|Chlamydophila spp|chlamydophila spp
1567447|NCT00509106|Legionella ssp|legionella ssp
1567448|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
1567449|NCT00509106|antimicrobial resistance|antimicrobial resistance
1567450|NCT00509106|pneumococci|pneumococci
1567451|NCT00509106|beta-lactam|beta-lactam
1567452|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
1567453|NCT00509106|ceftriaxone|ceftriaxone
1567454|NCT00509106|antibiotic|antibiotic
1567455|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1567456|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1567457|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1567458|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1567459|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1567460|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1567461|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1567462|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1567463|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1567464|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1567465|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1567466|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1567467|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1567468|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
1567469|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1567470|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1567471|NCT00509080|mitral regurgitation|mitral regurgitation
1567482|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
1567483|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
1567484|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
1567485|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1567486|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
1567487|NCT00509028|Asthma|asthma
1567488|NCT00509028|Bronchial|bronchial
1567489|NCT00509015|antimalarials|antimalarials
1567490|NCT00509015|malaria transmission|malaria transmission
1567491|NCT00509015|mass drug administration|mass drug administration
1567492|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
1567493|NCT00509015|primaquine|primaquine
1567494|NCT00509015|gametocytes|gametocytes
1567495|NCT00509015|QT-NASBA|qt-nasba
1567496|NCT00509002|Salivary Gland Cancer|salivary gland cancer
1567497|NCT00509002|Iressa|iressa
1567498|NCT00509002|ZD1839|zd1839
1567499|NCT00508989|Acetylcholine|acetylcholine
1567500|NCT00508989|Forearm Blood Flow|forearm blood flow
1567501|NCT00508989|HDL|hdl
1567502|NCT00508989|L-NMMA|l-nmma
1567503|NCT00508989|Sickle Cell Anemia|sickle cell anemia
1567504|NCT00508989|Sickle Cell Disease|sickle cell disease
1567505|NCT00508976|bupivacaine|bupivacaine
1567506|NCT00508976|marcaine|marcaine
1567507|NCT00508976|lidocaine|lidocaine
1567508|NCT00508976|normal saline|normal saline
1567509|NCT00508976|narcotics|narcotics
1567510|NCT00508976|analog pain scale|analog pain scale
1567511|NCT00508976|postoperative pain|postoperative pain
1567512|NCT00508976|preemptive|preemptive
1567513|NCT00508976|aerosolization|aerosolization
1567514|NCT00508976|streamed|streamed
1567515|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
1567516|NCT00508950|Vaccines|vaccines
1567517|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
1567518|NCT00508950|Adult|adult
1567519|NCT00508937|Diet|diet
1567520|NCT00508937|Protein|protein
1567521|NCT00508937|Glucose|glucose
1567522|NCT00508937|Insulin|insulin
1567523|NCT00508937|Cholesterol|cholesterol
1567524|NCT00508937|Triglycerides|triglycerides
1567525|NCT00508937|LDL subclasses|ldl subclasses
1567526|NCT00508924|Argatroban|argatroban
1567527|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
1567528|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
1567529|NCT00508924|Activated clotting time|activated clotting time
1567530|NCT00508924|PCI|pci
1567531|NCT00508924|ACT|act
1567532|NCT00508911|open-label,|open-label,
1567533|NCT00508911|oral contraceptive,|oral contraceptive,
1567534|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
1567535|NCT00508911|single-sequence,|single-sequence,
1567536|NCT00508911|volunteers|volunteers
1567537|NCT00508911|GW876008,|gw876008,
1567538|NCT00508911|repeat-dose,|repeat-dose,
1567539|NCT00508911|female,|female,
1567540|NCT00508911|pharmacokinetics,|pharmacokinetics,
1567541|NCT00508898|lupus nephritis|lupus nephritis
1567542|NCT00508898|proteinuria|proteinuria
1567543|NCT00508898|chronic kidney diseases|chronic kidney diseases
1567544|NCT00508898|SLE|sle
1567545|NCT00508885|hyperphosphatemia|hyperphosphatemia
1567546|NCT00508885|niacinamide|niacinamide
1567547|NCT00508885|ESRD|esrd
1567548|NCT00508885|peritoneal dialysis|peritoneal dialysis
1567549|NCT00508885|renal osteodystrophy|renal osteodystrophy
1567550|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
1567551|NCT00508872|Oxaliplatin|oxaliplatin
1567552|NCT00508872|Eloxatin|eloxatin
1567553|NCT00508872|Fluorouracil|fluorouracil
1567554|NCT00508872|Leucovorin|leucovorin
1567555|NCT00508872|Bevacizumab|bevacizumab
1567808|NCT00508105|Shoulder|shoulder
1567556|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1567557|NCT00508872|rhuMAb-VEGF|rhumab-vegf
1567558|NCT00508872|Folfox-B|folfox-b
1567559|NCT00508872|5-FU|5-fu
1567560|NCT00508872|Avastin|avastin
1567561|NCT00508859|depression|depression
1567562|NCT00508859|adolescents|adolescents
1567563|NCT00508859|maintenance treatment|maintenance treatment
1567564|NCT00508859|antidepressant|antidepressant
1567565|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
1567566|NCT00508846|Gynecologic Cancers|gynecologic cancers
1567567|NCT00508846|Genetic Counseling|genetic counseling
1567568|NCT00508846|Questionnaire|questionnaire
1567569|NCT00508846|Survey|survey
1567570|NCT00508846|HNPCC|hnpcc
1567571|NCT00508833|Adjuvants|adjuvants
1567572|NCT00508833|HBsAg|hbsag
1567573|NCT00508820|Platelet|platelet
1567574|NCT00508820|AMG 531|amg 531
1567575|NCT00508820|Thrombopoietin|thrombopoietin
1567576|NCT00508820|blood disorder|blood disorder
1567577|NCT00508820|bleeding disorder|bleeding disorder
1567578|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1567579|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1567580|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
1567581|NCT00508820|TPO|tpo
1567582|NCT00508820|thrombopoietic protein|thrombopoietic protein
1567583|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
1567584|NCT00508807|Solid Tumors|solid tumors
1567611|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1567612|NCT00508703|IMRT|imrt
1567613|NCT00508703|Computed Tomography|computed tomography
1567614|NCT00508703|CT|ct
1567615|NCT00508703|CT Scan|ct scan
1567616|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
1567617|NCT00508690|Colorectal Surgery|colorectal surgery
1567618|NCT00508690|Laparoscopy|laparoscopy
1568631|NCT00505232|Hyper-CVAD|hyper-cvad
1567619|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1567620|NCT00508677|Mazindol|mazindol
1567621|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
1567622|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
1567623|NCT00508638|Heart Failure|heart failure
1567624|NCT00508612|Blood Pressure|blood pressure
1567625|NCT00508612|Systolic Blood Pressure|systolic blood pressure
1567626|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
1567627|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1567628|NCT00508612|Relaxation|relaxation
1567629|NCT00508612|Meditation|meditation
1567630|NCT00508612|Coping Skills|coping skills
1567631|NCT00508612|Adolescents|adolescents
1567632|NCT00508599|type 2 diabetes|type 2 diabetes
1567633|NCT00508599|bed rest|bed rest
1567634|NCT00508599|insulin resistance|insulin resistance
1567635|NCT00508599|insulin|insulin
1567636|NCT00508599|glucose|glucose
1567637|NCT00508599|orthostatic response|orthostatic response
1567638|NCT00508586|Breast cancer|breast cancer
1567639|NCT00508586|PTC299|ptc299
1567640|NCT00508586|VEGF|vegf
1567641|NCT00508586|Angiogenesis|angiogenesis
1567642|NCT00508586|Post-transcriptional control|post-transcriptional control
1567643|NCT00508586|Aromatase inhibitors|aromatase inhibitors
1567644|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
1567645|NCT00508573|Lynch Syndrome|lynch syndrome
1567646|NCT00508573|HNPCC|hnpcc
1567647|NCT00508573|Syndrome Registry|syndrome registry
1567648|NCT00508573|Questionnaire|questionnaire
1567649|NCT00508573|Endometrial cancer|endometrial cancer
1567650|NCT00508573|Ovarian cancer|ovarian cancer
1567651|NCT00508560|Contingency management|contingency management
1567652|NCT00508560|Smoking cessation|smoking cessation
1567653|NCT00508560|Psychotic disorders|psychotic disorders
1567654|NCT00508560|Veterans|veterans
1567655|NCT00508547|Methotrexate|methotrexate
1567656|NCT00508547|Acitretin|acitretin
1567657|NCT00508547|Cyclosporine|cyclosporine
1567658|NCT00508547|Systemic PUVA|systemic puva
1567659|NCT00508547|Infliximab|infliximab
1567660|NCT00508547|Adalimumab|adalimumab
1567661|NCT00508547|Alefacept|alefacept
1567662|NCT00508547|Efalizumab|efalizumab
1567663|NCT00508547|Etanercept|etanercept
1567664|NCT00508547|Psoriasis|psoriasis
1567665|NCT00508547|Psoriatic arthritis|psoriatic arthritis
1567666|NCT00508547|Skin disease|skin disease
1567667|NCT00508547|Cosentyx|cosentyx
1567668|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
1567669|NCT00508534|gastric pH|gastric ph
1567670|NCT00508521|cerebrovascular accident|cerebrovascular accident
1567671|NCT00508521|electrical stimulation|electrical stimulation
1567672|NCT00508521|motor learning|motor learning
1567673|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
1567674|NCT00508508|Heart Failure|heart failure
1567675|NCT00508508|Peer Support|peer support
1567676|NCT00508508|Self Management|self management
1567677|NCT00508495|pain, postoperative|pain, postoperative
1567678|NCT00508495|replacement, total hip|replacement, total hip
1567679|NCT00508495|total hip replacement|total hip replacement
1567680|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
1567682|NCT00508482|Functional constipation|functional constipation
1567683|NCT00508469|Intraocular pressure|intraocular pressure
1567684|NCT00508469|Open-angle glaucoma|open-angle glaucoma
1567685|NCT00508469|Ocular hypertension|ocular hypertension
1567686|NCT00508469|Adherence|adherence
1567687|NCT00508469|Compliance|compliance
1567688|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
1567689|NCT00508456|Methionine Restriction|methionine restriction
1567690|NCT00508456|Hominex-2|hominex-2
1567691|NCT00508456|Methionine Restriction Diet|methionine restriction diet
1567692|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
1567693|NCT00508456|Temozolomide|temozolomide
1567694|NCT00508456|Temodar|temodar
1567695|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
1567696|NCT00508443|SSRS|ssrs
1567697|NCT00508443|CT-on-Rails|ct-on-rails
1567698|NCT00508443|Metastatic Spine Disease|metastatic spine disease
1567699|NCT00508443|Spinal Neoplasms|spinal neoplasms
1567700|NCT00508443|Radiation Therapy|radiation therapy
1567701|NCT00508443|Trilogy|trilogy
1567702|NCT00508443|Cancer|cancer
1567703|NCT00508443|Breast Cancer|breast cancer
1567704|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
1567705|NCT00508443|Genitourinary Disease|genitourinary disease
1567706|NCT00508443|Lung Cancer|lung cancer
1567707|NCT00508443|Lymphoma|lymphoma
1567708|NCT00508443|Melanoma|melanoma
1567733|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
1567734|NCT00508339|Radiotherapy|radiotherapy
1567735|NCT00508339|Quality of Life|quality of life
1567736|NCT00508339|Questionnaire|questionnaire
1567738|NCT00508339|TESS|tess
1567739|NCT00508326|Advanced Cancer|advanced cancer
1567740|NCT00508326|Solid Tumor|solid tumor
1567741|NCT00508326|Liver Metastasis|liver metastasis
1567742|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
1567743|NCT00508326|Liver|liver
1567744|NCT00508326|Paclitaxel|paclitaxel
1567745|NCT00508326|Taxol|taxol
1567746|NCT00508313|Lung Cancer|lung cancer
1567747|NCT00508313|Healthy Control|healthy control
1567748|NCT00508313|Thermal Imaging|thermal imaging
1567749|NCT00508313|Thermal Signatures|thermal signatures
1567750|NCT00508313|Radiation Therapy|radiation therapy
1567751|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
1567752|NCT00508300|laparoscopic|laparoscopic
1567753|NCT00508300|colectomy|colectomy
1567754|NCT00508300|Fast Track|fast track
1567755|NCT00508300|epidural|epidural
1567756|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
1567757|NCT00508274|breast cancer|breast cancer
1567758|NCT00508274|lapatinib|lapatinib
1567759|NCT00508274|HER2+ positive|her2+ positive
1567760|NCT00508274|TYVERB|tyverb
1567761|NCT00508274|TYKERB|tykerb
1567762|NCT00508261|Meningococcal vaccine|meningococcal vaccine
1567763|NCT00508261|Immunogenicity|immunogenicity
1567764|NCT00508261|Routine infancy vaccination|routine infancy vaccination
1567765|NCT00508261|Safety|safety
1567766|NCT00508248|omega 3fatty acids|omega 3fatty acids
1567767|NCT00508235|Neurofibromatosis|neurofibromatosis
1567768|NCT00508235|Quality of Friendships|quality of friendships
1567769|NCT00508235|Disease Severity|disease severity
1567770|NCT00508235|Questionnaire|questionnaire
1567771|NCT00508235|NF-1|nf-1
1567772|NCT00508222|HIV|hiv
1567773|NCT00508222|HCV|hcv
1567774|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
1567775|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
1567776|NCT00508222|Treatment Experienced|treatment experienced
1567777|NCT00508209|high-dose melphalan|high-dose melphalan
1567778|NCT00508209|bortezomib|bortezomib
1567779|NCT00508209|response|response
1567780|NCT00508209|toxicity|toxicity
1567781|NCT00508209|relapse|relapse
1567782|NCT00508196|right ventricular pacing|right ventricular pacing
1567783|NCT00508196|endothelial function|endothelial function
1567784|NCT00508196|cardiac output|cardiac output
1567785|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
1567786|NCT00508170|Head and Neck Cancer|head and neck cancer
1567787|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
1567788|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
1567789|NCT00508170|Sexual Behavior|sexual behavior
1567790|NCT00508170|Questionnaire|questionnaire
1567791|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
1567792|NCT00508144|Lung Cancer|lung cancer
1567793|NCT00508144|NSCLC|nsclc
1567794|NCT00508144|Malignant pleural effusion|malignant pleural effusion
1567795|NCT00508144|Pericardial effusion|pericardial effusion
1567796|NCT00508144|Pemetrexed|pemetrexed
1567797|NCT00508144|Alimta|alimta
1567798|NCT00508144|LY231514|ly231514
1567799|NCT00508144|Poor Performance Status|poor performance status
1567800|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
1567801|NCT00508131|Milk fortification|milk fortification
1567802|NCT00508131|Effectivness evaluation|effectivness evaluation
1567803|NCT00508131|Iron deficiency anemia|iron deficiency anemia
1567804|NCT00508131|Stunting|stunting
1567805|NCT00508131|Zinc deficiency|zinc deficiency
1567806|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
1567807|NCT00508105|Osteoarthritis|osteoarthritis
1567809|NCT00508105|tenotomy|tenotomy
1567810|NCT00508105|ostotomy|ostotomy
1567811|NCT00508092|appendicectomy|appendicectomy
1567812|NCT00508092|pain|pain
1567813|NCT00508092|local anaesthetic|local anaesthetic
1567814|NCT00508092|nerve block|nerve block
1567815|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
1567816|NCT00508079|Venous Disease|venous disease
1567817|NCT00508079|Varicose Veins|varicose veins
1567818|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
1567819|NCT00508079|PAD|pad
1567820|NCT00508066|Congenital Scoliosis|congenital scoliosis
1567821|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
1567822|NCT00508066|Spinal Fusion|spinal fusion
1567823|NCT00508066|Post-Operative Pain Management|post-operative pain management
1567824|NCT00508066|Infusion Catheter|infusion catheter
1567825|NCT00508053|wound infection|wound infection
1567826|NCT00508053|incisional hernia|incisional hernia
1567827|NCT00508053|wound dehiscence|wound dehiscence
1567828|NCT00508053|wound healing|wound healing
1567829|NCT00508053|postoperative complications|postoperative complications
1567830|NCT00508053|surgical techniques|surgical techniques
1567831|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
1567832|NCT00508040|Macular edema|macular edema
1567833|NCT00508040|Prednisone|prednisone
1567835|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
1567836|NCT00508040|With Visual acuity loss|with visual acuity loss
1567837|NCT00508027|sickle cell disease|sickle cell disease
1567838|NCT00508027|simvastatin|simvastatin
1567839|NCT00508027|statin drugs|statin drugs
1567840|NCT00508027|nitric oxide donors|nitric oxide donors
1567841|NCT00508027|vascular injury|vascular injury
1567842|NCT00508014|Cardiovascular disease|cardiovascular disease
1567843|NCT00508014|Diabetes|diabetes
1567844|NCT00508014|Quality improvement|quality improvement
1567845|NCT00508014|Peer review|peer review
1567846|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
1567847|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
1567848|NCT00507988|Cognitive Training|cognitive training
1567849|NCT00507988|Complex Problem Solving|complex problem solving
1567850|NCT00507988|Goal Management|goal management
1567851|NCT00507988|Planning|planning
1567852|NCT00507975|Smoking|smoking
1567853|NCT00507975|pregnancy|pregnancy
1567854|NCT00507975|newborn|newborn
1567855|NCT00507975|birth weight|birth weight
1567856|NCT00507975|nicotine patch|nicotine patch
1567857|NCT00507975|birth|birth
1567858|NCT00507962|Advanced Cancer|advanced cancer
1567859|NCT00507962|Dominant Liver Involvement|dominant liver involvement
1567860|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
1567861|NCT00507962|Cisplatin|cisplatin
1567862|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
1567863|NCT00507962|Platinol-AQ|platinol-aq
1567864|NCT00507962|Platinol|platinol
1567865|NCT00507962|CDDP|cddp
1567866|NCT00507962|Doxil|doxil
1567867|NCT00507962|Liposomal|liposomal
1567868|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1567869|NCT00507949|COPD|copd
1567870|NCT00507949|body weight|body weight
1567871|NCT00507949|megestrol acetate|megestrol acetate
1567872|NCT00507949|cytokines|cytokines
1567873|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
1567874|NCT00507936|Painful|painful
1567875|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
1567876|NCT00507936|Neuralgia|neuralgia
1567877|NCT00507936|Diabetic|diabetic
1567878|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
1567879|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
1567880|NCT00507923|Breast Cancer|breast cancer
1567881|NCT00507923|Tibetan Yoga|tibetan yoga
1567882|NCT00507923|Stretching|stretching
1567883|NCT00507923|Yoga|yoga
1567884|NCT00507923|Fatigue|fatigue
1567885|NCT00507923|Sleep|sleep
1567886|NCT00507923|Questionnaire|questionnaire
1567887|NCT00507923|Survey|survey
1567888|NCT00507910|ankle fracture|ankle fracture
1567889|NCT00507910|pes planus|pes planus
1567890|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
1567891|NCT00507884|Kidney Neoplasms|kidney neoplasms
1567892|NCT00507884|Renal Tumors|renal tumors
1567893|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
1567894|NCT00507884|3 Tesla MRI|3 tesla mri
1567895|NCT00507884|MRI|mri
1567896|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
1567897|NCT00507858|Head and Neck Cancer|head and neck cancer
1567898|NCT00507858|Squamous Cell Cancer|squamous cell cancer
1567899|NCT00507858|Alimta|alimta
1567900|NCT00507858|Pemetrexed|pemetrexed
1567901|NCT00507858|Dexamethasone|dexamethasone
1567902|NCT00507858|HNSCC|hnscc
1567903|NCT00507858|Decadron|decadron
1567904|NCT00507832|Prurigo nodularis|prurigo nodularis
1567905|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
1567906|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1567907|NCT00507819|Tricuspid Atresia|tricuspid atresia
1567908|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
1567909|NCT00507806|Microbubbles|microbubbles
1568021|NCT00507455|Treatment|treatment
1567910|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
1567911|NCT00507806|TIBI|tibi
1567912|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
1567913|NCT00507806|modified Rankin Scale|modified rankin scale
1567914|NCT00507806|Recanalization|recanalization
1567915|NCT00507806|Perflutren|perflutren
1567916|NCT00507780|GnRH Antagonist|gnrh antagonist
1567917|NCT00507780|Premature Ovarian Failure|premature ovarian failure
1567918|NCT00507780|Fertility|fertility
1567919|NCT00507780|Chemotherapy|chemotherapy
1567920|NCT00507780|POF|pof
1567921|NCT00507754|Advanced Cancer|advanced cancer
1567922|NCT00507754|Solid Tumors|solid tumors
1567923|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
1567924|NCT00507754|Tuberculin Skin Test|tuberculin skin test
1567925|NCT00507754|Tuberculosis|tuberculosis
1567926|NCT00507754|T-SPOT TB test|t-spot tb test
1567927|NCT00507754|TB|tb
1567928|NCT00507741|Cancer|cancer
1567929|NCT00507741|Ovarian|ovarian
1567930|NCT00507741|Endometrial|endometrial
1567931|NCT00507741|Phase II|phase ii
1567932|NCT00507741|EC145|ec145
1567933|NCT00507741|EC20|ec20
1567934|NCT00507728|Pharmacogenetics|pharmacogenetics
1567935|NCT00507728|Emotional Reactivity|emotional reactivity
1567936|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
1567937|NCT00507728|Smoking|smoking
1567945|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
1567946|NCT00507715|l-dopa levels|l-dopa levels
1567947|NCT00507715|plantago ovata husk|plantago ovata husk
1567948|NCT00507689|Truvada|truvada
1567949|NCT00507689|HBIg|hbig
1567950|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
1567951|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
1567952|NCT00507676|Asthma|asthma
1567953|NCT00507676|Wheezing|wheezing
1567954|NCT00507676|Infant|infant
1567955|NCT00507663|beta blocker|beta blocker
1567956|NCT00507663|functional recovery|functional recovery
1567957|NCT00507650|Pressure ulcers|pressure ulcers
1567958|NCT00507650|Geriatrics|geriatrics
1567959|NCT00507650|Nursing home|nursing home
1567960|NCT00507650|Fluid balance|fluid balance
1567961|NCT00507650|Collagen deposition|collagen deposition
1567962|NCT00507611|breast|breast
1567963|NCT00507611|sentinel lymph node|sentinel lymph node
1567964|NCT00507611|node mapping|node mapping
1567965|NCT00507598|colorectal cancer|colorectal cancer
1567966|NCT00507598|metabolomics|metabolomics
1567967|NCT00507585|Liver Cancer|liver cancer
1567968|NCT00507585|Liver metastases|liver metastases
1567969|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
1567970|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
1567971|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
1567972|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
1567973|NCT00507585|Fluorouracil|fluorouracil
1567974|NCT00507585|5-FU|5-fu
1567975|NCT00507585|Adrucil|adrucil
1567976|NCT00507585|Efudex|efudex
1567977|NCT00507585|5-fluorouracil|5-fluorouracil
1567978|NCT00507585|Avastin|avastin
1567979|NCT00507585|Leucovorin|leucovorin
1567980|NCT00507585|Oxaliplatin|oxaliplatin
1567981|NCT00507585|Bevacizumab|bevacizumab
1567982|NCT00507572|Solid Tumors|solid tumors
1567983|NCT00507572|Pregnancy|pregnancy
1567984|NCT00507572|Data Collection|data collection
1567985|NCT00507546|sleep|sleep
1567986|NCT00507546|melatonin|melatonin
1567987|NCT00507546|spinal cord injury|spinal cord injury
1567988|NCT00507546|insomnia|insomnia
1567989|NCT00507546|tetraplegia|tetraplegia
1567990|NCT00507533|CPAP|cpap
1567991|NCT00507533|Hematologic|hematologic
1567992|NCT00507533|Neutropenic|neutropenic
1567993|NCT00507533|ARF|arf
1567994|NCT00507520|RCT|rct
1567995|NCT00507520|Almonds|almonds
1567996|NCT00507520|Hyperlipidemia|hyperlipidemia
1567997|NCT00507520|Blood Lipids|blood lipids
1567998|NCT00507507|tenofovir|tenofovir
1567999|NCT00507507|monotherapy|monotherapy
1568000|NCT00507507|emtricitabine|emtricitabine
1568001|NCT00507507|combination|combination
1568002|NCT00507507|hepatitis B|hepatitis b
1568003|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
1568004|NCT00507494|kidney transplantation|kidney transplantation
1568005|NCT00507494|filtration fraction|filtration fraction
1568006|NCT00507494|proteinuria|proteinuria
1568007|NCT00507481|Sleep|sleep
1568008|NCT00507481|ICU|icu
1568009|NCT00507481|Delirium|delirium
1568010|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
1568011|NCT00507481|ICU patients|icu patients
1568012|NCT00507468|bone marrow|bone marrow
1568013|NCT00507468|autologous|autologous
1568014|NCT00507468|ejection fraction|ejection fraction
1568015|NCT00507468|left ventricle|left ventricle
1568016|NCT00507468|heart attack|heart attack
1568017|NCT00507468|myocardial infarction|myocardial infarction
1568018|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
1568019|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1568020|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
1568022|NCT00507455|Solifenacin Succinate|solifenacin succinate
1568023|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
1568024|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
1568025|NCT00507442|who have received no prior treatment|who have received no prior treatment
1568026|NCT00507429|thyroid neoplasms|thyroid neoplasms
1568027|NCT00507429|thyroid cancer|thyroid cancer
1568028|NCT00507429|thyroid carcinoma|thyroid carcinoma
1568029|NCT00507390|fish oils|fish oils
1568030|NCT00507377|Esophageal Benign Disease|esophageal benign disease
1568031|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1568032|NCT00507377|Hiatal Hernia|hiatal hernia
1568033|NCT00507377|Antireflux Surgery|antireflux surgery
1568034|NCT00507377|Short Esophagus|short esophagus
1568035|NCT00507351|Breast Cancer|breast cancer
1568036|NCT00507351|Colorectal Cancer|colorectal cancer
1568037|NCT00507351|Lung Cancer|lung cancer
1568038|NCT00507351|Prostate Cancer|prostate cancer
1568039|NCT00507351|Pain Management|pain management
1568040|NCT00507351|Questionnaire|questionnaire
1568041|NCT00507351|Survey|survey
1568042|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
1568043|NCT00507325|Malignant Melanoma|malignant melanoma
1568044|NCT00507325|Blood Sample|blood sample
1568045|NCT00507325|Tumor Sample|tumor sample
1568046|NCT00507325|Long-term storage|long-term storage
1568048|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
1568049|NCT00507299|Child maltreatment|child maltreatment
1568050|NCT00507299|Physician education|physician education
1568051|NCT00507299|Prevention|prevention
1568052|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1568053|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
1568054|NCT00507273|GISTs|gists
1568055|NCT00507273|GIST Registry|gist registry
1568056|NCT00507273|Registry|registry
1568057|NCT00507260|Leukemia|leukemia
1568058|NCT00507260|Lymphoma|lymphoma
1568059|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
1568060|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
1568061|NCT00507260|BMT|bmt
1568062|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
1568063|NCT00507260|Fatigue|fatigue
1568064|NCT00507260|Nutritional Assessment|nutritional assessment
1568065|NCT00507260|Nutritional Intervention|nutritional intervention
1568066|NCT00507260|Malnutrition|malnutrition
1568067|NCT00507247|Catheter-Related Infection|catheter-related infection
1568068|NCT00507247|Bloodstream Infections|bloodstream infections
1568069|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
1568070|NCT00507247|Daptomycin|daptomycin
1568071|NCT00507234|COPD|copd
1568072|NCT00507221|HIV|hiv
1568073|NCT00507221|Helminthiasis|helminthiasis
1568074|NCT00507221|Co-infection|co-infection
1568075|NCT00507221|Treatment Naive|treatment naive
1568076|NCT00507208|trismus|trismus
1568077|NCT00507208|head and neck cancer|head and neck cancer
1568078|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
1568079|NCT00507195|Postoperative delirium|postoperative delirium
1568080|NCT00507195|hypnotics|hypnotics
1568081|NCT00507195|propofol|propofol
1568082|NCT00507195|sevoflurane|sevoflurane
1568083|NCT00507195|desflurane|desflurane
1568084|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
1568085|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
1568086|NCT00507182|Oral Cancer|oral cancer
1568087|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
1568088|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
1568089|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
1568090|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
1568091|NCT00507182|Cancerous lesions|cancerous lesions
1568092|NCT00507182|Mouth|mouth
1568093|NCT00507143|Colorectal neoplasms|colorectal neoplasms
1568094|NCT00507143|Secondary|secondary
1568095|NCT00507143|irinotecan|irinotecan
1568096|NCT00507143|Pharmacokinetics|pharmacokinetics
1568097|NCT00507143|Pharmacodynamics|pharmacodynamics
1568098|NCT00507143|SLCO1B1|slco1b1
1568099|NCT00507143|PXR|pxr
1568100|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
1568101|NCT00507117|Polysomnography|polysomnography
1568102|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
1568103|NCT00507104|traumatic brain injury|traumatic brain injury
1568104|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
1568105|NCT00507104|Hypopituitarism|hypopituitarism
1568106|NCT00507091|ZD6474|zd6474
1568107|NCT00507091|Irinotecan|irinotecan
1568108|NCT00507091|5-Fluorouracil|5-fluorouracil
1568109|NCT00507091|Leucovorin|leucovorin
1568110|NCT00507091|colorectal|colorectal
1568111|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
1568112|NCT00507078|Leptin|leptin
1568113|NCT00507078|Homocysteine|homocysteine
1568114|NCT00507078|C-reactive Protein|c-reactive protein
1568115|NCT00507052|Hemodialysis|hemodialysis
1568116|NCT00507052|Residual Renal Function|residual renal function
1568117|NCT00507039|PD20 FEV1|pd20 fev1
1568118|NCT00507039|grass pollen|grass pollen
1568119|NCT00507039|one-step|one-step
1568120|NCT00507013|vascular closure device|vascular closure device
1568121|NCT00506974|sleep|sleep
1568122|NCT00506974|normal sleepers|normal sleepers
1568123|NCT00506948|Hematological Malignancies|hematological malignancies
1568124|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
1569368|NCT00502827|AIDS|aids
1568125|NCT00506948|Graft Versus Host Disease|graft versus host disease
1568126|NCT00506948|GVHD|gvhd
1568127|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1568128|NCT00506948|AHSCT|ahsct
1568129|NCT00506948|Leukemia|leukemia
1568130|NCT00506948|Lymphoma|lymphoma
1568131|NCT00506948|T-Cells|t-cells
1568132|NCT00506948|Thymoglobulin|thymoglobulin
1568133|NCT00506948|ATG|atg
1568134|NCT00506948|rATG|ratg
1568135|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
1568136|NCT00506948|Rapamune|rapamune
1568137|NCT00506948|Sirolimus|sirolimus
1568138|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
1568139|NCT00506948|Cellcept|cellcept
1568140|NCT00506948|MMF|mmf
1568141|NCT00506935|methamphetamine|methamphetamine
1568142|NCT00506935|GVG|gvg
1568143|NCT00506935|vigabatrin|vigabatrin
1568144|NCT00506935|stimulant|stimulant
1568145|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
1568146|NCT00506922|GVHD Prevention|gvhd prevention
1568147|NCT00506922|Hodgkin's Disease|hodgkin's disease
1568158|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
1568159|NCT00506870|INR self monitoring|inr self monitoring
1568160|NCT00506870|cost benefit evaluation|cost benefit evaluation
1568161|NCT00506857|Hematologic Malignancies|hematologic malignancies
1568162|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
1568163|NCT00506857|Leukemia|leukemia
1568164|NCT00506857|MDS|mds
1568165|NCT00506857|Lymphoma|lymphoma
1568166|NCT00506857|Myeloma|myeloma
1568167|NCT00506857|Fludarabine|fludarabine
1568168|NCT00506857|Fludara|fludara
1568169|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
1568170|NCT00506857|Busulfan|busulfan
1568171|NCT00506857|Busulfex|busulfex
1568172|NCT00506857|Myleran|myleran
1568173|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
1568174|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
1568175|NCT00506857|G-CSF|g-csf
1568176|NCT00506857|Apheresis|apheresis
1568177|NCT00506857|Blood cell infusion|blood cell infusion
1568178|NCT00506844|Rectal neoplasms|rectal neoplasms
1568179|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
1568180|NCT00506844|Cetuximab|cetuximab
1568181|NCT00506844|Irinotecan|irinotecan
1568182|NCT00506844|Capecitabine|capecitabine
1568183|NCT00506844|Radiotherapy|radiotherapy
1568184|NCT00506844|Combination chemotherapy|combination chemotherapy
1568185|NCT00506818|emotional symptoms|emotional symptoms
1568186|NCT00506818|vascular risk-factors|vascular risk-factors
1568187|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
1568188|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
1568189|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
1568190|NCT00506779|Uterine Cancer|uterine cancer
1568191|NCT00506779|UPSC|upsc
1568192|NCT00506779|Taxol|taxol
1568193|NCT00506779|Paclitaxel|paclitaxel
1568194|NCT00506779|Gleevec|gleevec
1568195|NCT00506779|Imatinib Mesylate|imatinib mesylate
1568196|NCT00506779|STI571|sti571
1568197|NCT00506766|Urinary Incontinence|urinary incontinence
1568198|NCT00506766|Self efficacy|self efficacy
1568199|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
1568200|NCT00506766|Bladder training|bladder training
1568201|NCT00506753|substance abuse|substance abuse
1568202|NCT00506714|Osteoarthritis|osteoarthritis
1568203|NCT00506714|Walking Sticks|walking sticks
1568204|NCT00506714|Canes|canes
1568205|NCT00506675|Amblyopia|amblyopia
1568206|NCT00506675|Atropine|atropine
1568207|NCT00506675|Patching|patching
1568208|NCT00506649|protocol|protocol
1568209|NCT00506649|analgesia|analgesia
1568210|NCT00506649|sedation|sedation
1568211|NCT00506649|delirium|delirium
1568212|NCT00506649|coma|coma
1568213|NCT00506623|Rectal neoplasm|rectal neoplasm
1568214|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
1568215|NCT00506623|Radiotherapy|radiotherapy
1568216|NCT00506623|Combination chemotherapy|combination chemotherapy
1568217|NCT00506623|Irinotecan|irinotecan
1568218|NCT00506623|Capecitabine|capecitabine
1568219|NCT00506610|Pain|pain
1568220|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
1568221|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
1568222|NCT00506610|Shingles|shingles
1568223|NCT00506610|Herpes Zoster|herpes zoster
1568224|NCT00506610|Neuropathic Pain|neuropathic pain
1568225|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1568226|NCT00506597|Leukemia|leukemia
1568227|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
1568228|NCT00506597|Erwinase|erwinase
1568229|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
1568230|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
1568231|NCT00506584|Fortification of human breast milk|fortification of human breast milk
1568232|NCT00506571|colorectal neoplasms|colorectal neoplasms
1568233|NCT00506571|secondary|secondary
1568234|NCT00506571|Combination chemotherapy|combination chemotherapy
1568236|NCT00506571|irinotecan|irinotecan
1568237|NCT00506571|oxaliplatin|oxaliplatin
1568238|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
1568239|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
1568240|NCT00506558|spinal fusion|spinal fusion
1568241|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
1568242|NCT00506532|Lung transplantation|lung transplantation
1568243|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
1568244|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
1568245|NCT00506506|N-acetylcysteine|n-acetylcysteine
1568246|NCT00506506|Chronic kidney disease|chronic kidney disease
1568247|NCT00506506|eGFR|egfr
1568248|NCT00506506|Cystatin C|cystatin c
1568249|NCT00506506|proteinuria|proteinuria
1568250|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
1568251|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
1568252|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
1568253|NCT00506493|Surgical Ablation|surgical ablation
1568254|NCT00506480|Embryo Implantation|embryo implantation
1568255|NCT00506480|Endometrium|endometrium
1568844|NCT00504452|ART|art
1568283|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
1568284|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
1568285|NCT00506376|Cervical Cancer|cervical cancer
1568286|NCT00506376|Hysterectomy|hysterectomy
1568287|NCT00506376|Interview|interview
1568288|NCT00506363|scar|scar
1568289|NCT00506363|surgery|surgery
1568290|NCT00506363|lasers|lasers
1568291|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
1568292|NCT00506324|Chemotherapy|chemotherapy
1568293|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
1568294|NCT00506324|Dysphagia|dysphagia
1568295|NCT00506311|Superficial Groin Dissection|superficial groin dissection
1568296|NCT00506311|Melanoma|melanoma
1568297|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
1568298|NCT00506311|Fibrin Sealant|fibrin sealant
1568299|NCT00506311|Tisseel|tisseel
1568300|NCT00506311|Seroma|seroma
1568301|NCT00506298|Diabetes|diabetes
1568302|NCT00506298|CRx-401|crx-401
1568303|NCT00506298|Bezafibrate|bezafibrate
1568304|NCT00506298|Diflunisal|diflunisal
1568305|NCT00506298|Metformin|metformin
1568306|NCT00506298|plasma glucose|plasma glucose
1568307|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1568308|NCT00506285|ADHD|adhd
1568309|NCT00506285|Adult|adult
1568310|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
1568311|NCT00506285|Daytrana|daytrana
1568312|NCT00506272|diabetes mellitus|diabetes mellitus
1568313|NCT00506272|hyperglycemia|hyperglycemia
1568314|NCT00506272|hypoglycemia|hypoglycemia
1568315|NCT00506272|self care|self care
1568316|NCT00506259|Deletion 17p11.2|deletion 17p11.2
1568317|NCT00506259|Melatonin|melatonin
1568318|NCT00506259|Phototherapy|phototherapy
1568319|NCT00506259|Behavioral Phenotype|behavioral phenotype
1568320|NCT00506259|Developmental Delay/MR|developmental delay/mr
1568321|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
1568322|NCT00506259|Sleep Disturbance|sleep disturbance
1568323|NCT00506259|SMS|sms
1568324|NCT00506259|Sleep Disorder|sleep disorder
1568325|NCT00506246|anaesthesia|anaesthesia
1568326|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
1568327|NCT00506233|GVHD|gvhd
1568328|NCT00506233|Questionnaire|questionnaire
1568329|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
1568330|NCT00506207|Combination chemotherapy|combination chemotherapy
1568332|NCT00506207|Irinotecan|irinotecan
1568333|NCT00506207|Oxaliplatin|oxaliplatin
1568334|NCT00506194|type 2 diabetes|type 2 diabetes
1568335|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
1568336|NCT00506194|insulin|insulin
1568337|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
1568338|NCT00506194|ß-cell function|ß-cell function
1568339|NCT00506168|Colorectal neoplasms|colorectal neoplasms
1568340|NCT00506168|Secondary|secondary
1568341|NCT00506168|Drug therapy, combination|drug therapy, combination
1568342|NCT00506168|Irinotecan|irinotecan
1568343|NCT00506168|Capecitabine|capecitabine
1568344|NCT00506155|Bladder Cancer|bladder cancer
1568345|NCT00506155|Urothelial Cancer|urothelial cancer
1568346|NCT00506155|Avastin|avastin
1568347|NCT00506155|Bevacizumab|bevacizumab
1568348|NCT00506155|Cisplatin|cisplatin
1568349|NCT00506155|Doxorubicin|doxorubicin
1568350|NCT00506155|Methotrexate|methotrexate
1568351|NCT00506155|Vinblastine|vinblastine
1568352|NCT00506155|M-VAC|m-vac
1568353|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1568354|NCT00506129|CTCL|ctcl
1568355|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
1568356|NCT00506129|Lymphoma|lymphoma
1568357|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
1568358|NCT00506129|PBPC|pbpc
1568359|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
1568360|NCT00506129|Stem Cell Transplant|stem cell transplant
1568361|NCT00506129|SCT|sct
1568362|NCT00506129|Fludarabine|fludarabine
1568363|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
1568364|NCT00506129|Fludara|fludara
1568365|NCT00506129|Melphalan|melphalan
1568366|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
1568367|NCT00506116|Self-directed pushing|self-directed pushing
1568368|NCT00506116|Antenatal perineal massage|antenatal perineal massage
1568369|NCT00506103|Thyroidectomy|thyroidectomy
1568370|NCT00506103|Central neck dissection|central neck dissection
1568371|NCT00506103|Harmonic scalpel|harmonic scalpel
1568372|NCT00506103|Perioperative complications|perioperative complications
1568374|NCT00506090|surgery|surgery
1568375|NCT00506090|lasers|lasers
1568376|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
1568377|NCT00506077|residual schizophrenia|residual schizophrenia
1568378|NCT00506064|Breast Cancer|breast cancer
1568379|NCT00506064|Sleep|sleep
1568380|NCT00506064|Melatonin|melatonin
1568381|NCT00506064|Placebo|placebo
1568382|NCT00506064|Survey|survey
1568383|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
1568432|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
1568433|NCT00505895|APBSCT|apbsct
1568434|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
1568435|NCT00505895|BMT|bmt
1568436|NCT00505895|Rituxan|rituxan
1568437|NCT00505895|Rituximab|rituximab
1568438|NCT00505895|FM140|fm140
1568439|NCT00505895|FM100|fm100
1568440|NCT00505882|Type 1 diabetes|type 1 diabetes
1568441|NCT00505882|Pramlintide|pramlintide
1568442|NCT00505882|Weight gain|weight gain
1568443|NCT00505882|Intensive insulin therapy|intensive insulin therapy
1568444|NCT00505882|Beta cell|beta cell
1568445|NCT00505869|Pregnant Smokers|pregnant smokers
1568446|NCT00505869|Mood Management Intervention|mood management intervention
1568447|NCT00505869|Health & Wellness Intervention|health & wellness intervention
1568448|NCT00505869|Smoking Cessation|smoking cessation
1568449|NCT00505869|Questionnaire|questionnaire
1568450|NCT00505869|Survey|survey
1568451|NCT00505830|Asperger Syndrom|asperger syndrom
1568452|NCT00505830|Autism Quotient|autism quotient
1568453|NCT00505830|French version|french version
1568454|NCT00505830|screening|screening
1568455|NCT00505830|diagnostic test|diagnostic test
1568456|NCT00505830|accuracy|accuracy
1568457|NCT00505804|dexmedetomidine|dexmedetomidine
1568458|NCT00505804|haloperidol|haloperidol
1568459|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
1568460|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
1568461|NCT00505791|Vasodilator therapy|vasodilator therapy
1568462|NCT00505765|Cognition|cognition
1568463|NCT00505765|Schizophrenia|schizophrenia
1568464|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
1568465|NCT00505739|Endometrial Cancer|endometrial cancer
1568466|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
1568467|NCT00505739|RU-486|ru-486
1568468|NCT00505739|Mifepristone|mifepristone
1568469|NCT00505739|LGESS|lgess
1568470|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1568471|NCT00505726|Cervical Cancer|cervical cancer
1568472|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
1568473|NCT00505726|Colposcopy|colposcopy
1568474|NCT00505713|Sarcoma|sarcoma
1568475|NCT00505713|Rexin-G|rexin-g
1568476|NCT00505713|Gene Therapy|gene therapy
1568477|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
1568478|NCT00505687|Rotigotine|rotigotine
1568479|NCT00505687|Neupro®|neupro®
1568480|NCT00505661|Ovarian Cancer|ovarian cancer
1568481|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
1568482|NCT00505661|Peritoneal Cancer|peritoneal cancer
1568483|NCT00505661|Letrozole|letrozole
1568484|NCT00505661|Femara|femara
1568485|NCT00505648|Hypersensitivity|hypersensitivity
1568486|NCT00505648|Syndrome|syndrome
1568487|NCT00505648|Tegeline|tegeline
1568488|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
1568489|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
1568490|NCT00505635|Melanoma|melanoma
1568491|NCT00505635|Temozolomide|temozolomide
1568492|NCT00505635|Velban|velban
1568493|NCT00505635|Vinblastine|vinblastine
1568494|NCT00505635|Cisplatin|cisplatin
1568495|NCT00505635|Interleukin-2|interleukin-2
1568496|NCT00505635|Intron-A|intron-a
1568497|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
1568498|NCT00505635|Thalidomide|thalidomide
1568499|NCT00505635|Thalomid|thalomid
1568500|NCT00505635|Temodar|temodar
1568501|NCT00505635|Proleukin|proleukin
1568502|NCT00505609|fertility awareness-based method|fertility awareness-based method
1568503|NCT00505609|family planning|family planning
1568504|NCT00505609|Standard Days Method|standard days method
1568708|NCT00504855|Waterproof|waterproof
1568505|NCT00505609|Institute for Reproductive Health|institute for reproductive health
1568506|NCT00505609|Efficacy|efficacy
1568507|NCT00505609|CycleBeads|cyclebeads
1568508|NCT00505596|Prenatal testing|prenatal testing
1568509|NCT00505596|Decisionmaking|decisionmaking
1568510|NCT00505596|Decision aid|decision aid
1568511|NCT00505596|Informed choice|informed choice
1568512|NCT00505570|Migraine|migraine
1568513|NCT00505570|Migraine with aura|migraine with aura
1568514|NCT00505570|Patent foramen ovale|patent foramen ovale
1568515|NCT00505570|PFO|pfo
1568516|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
1568517|NCT00505557|Dual plane|dual plane
1568518|NCT00505557|Endoscope|endoscope
1568519|NCT00505557|Transaxillary incision|transaxillary incision
1568520|NCT00505544|Advanced Cancer|advanced cancer
1568521|NCT00505544|Questionnaire|questionnaire
1568522|NCT00505544|Survey|survey
1568523|NCT00505544|Sleep Disturbance|sleep disturbance
1568524|NCT00505544|Sleep Quality|sleep quality
1568525|NCT00505531|Pain|pain
1568526|NCT00505518|Major Depressive Disorder|major depressive disorder
1568527|NCT00505518|Telepsychiatry|telepsychiatry
1568528|NCT00505518|Chinese American|chinese american
1568529|NCT00505518|Nursing Home|nursing home
1568530|NCT00505505|Neurointensive care|neurointensive care
1568531|NCT00505505|Intensive insulin infusion|intensive insulin infusion
1568532|NCT00505505|Hypoglycemia|hypoglycemia
1569574|NCT00502112|Preleukemia|preleukemia
1568536|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
1568537|NCT00505492|MMMT|mmmt
1568538|NCT00505492|Uterine Neoplasms|uterine neoplasms
1568539|NCT00505492|Radiation Therapy|radiation therapy
1568540|NCT00505492|Paclitaxel|paclitaxel
1568541|NCT00505492|Carboplatin|carboplatin
1568542|NCT00505492|Cisplatin|cisplatin
1568543|NCT00505492|Taxol|taxol
1568544|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
1568545|NCT00505479|pregnancy|pregnancy
1568546|NCT00505479|iodine|iodine
1568547|NCT00505479|deficiency|deficiency
1568548|NCT00505466|Human Genetics|human genetics
1568549|NCT00505466|Genetic Counseling|genetic counseling
1568550|NCT00505466|Genetic Testing|genetic testing
1568551|NCT00505466|p53 Mutation|p53 mutation
1568552|NCT00505466|Genetics|genetics
1568553|NCT00505453|Influenza|influenza
1568554|NCT00505427|PCOS|pcos
1568555|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
1568556|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
1568557|NCT00505427|alpha lipoic acid|alpha lipoic acid
1568558|NCT00505427|insulin resistance|insulin resistance
1568559|NCT00505427|oxidative stress|oxidative stress
1568560|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
1568561|NCT00505414|Analgesic|analgesic
1568562|NCT00505414|Tapentadol Extended Release|tapentadol extended release
1568563|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
1568564|NCT00505414|Pain assessment|pain assessment
1568565|NCT00505414|Placebo|placebo
1568566|NCT00505401|HIV|hiv
1568567|NCT00505401|Tat protein|tat protein
1568568|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1568569|NCT00505388|asthma|asthma
1568570|NCT00505388|bronchial|bronchial
1568571|NCT00505388|Symbicort|symbicort
1568572|NCT00505375|CTLA4-Ig|ctla4-ig
1568573|NCT00505375|Abatacept|abatacept
1568574|NCT00505375|Beta-cell function|beta-cell function
1568575|NCT00505375|T-cells|t-cells
1568576|NCT00505375|DPT-1|dpt-1
1568577|NCT00505375|treatment|treatment
1568578|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
1568579|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
1568580|NCT00505375|juvenile diabetes|juvenile diabetes
1568581|NCT00505375|T1D|t1d
1568582|NCT00505375|diabetes mellitus|diabetes mellitus
1568583|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
1568584|NCT00505375|TrialNet|trialnet
1568585|NCT00505349|neurotrophic factors|neurotrophic factors
1568586|NCT00505349|cognitive status|cognitive status
1568587|NCT00505349|young adults|young adults
1568588|NCT00505349|mature adults|mature adults
1568589|NCT00505349|cognitive training|cognitive training
1568590|NCT00505336|Diastolic heart failure|diastolic heart failure
1568591|NCT00505336|Markers of collagen turnover|markers of collagen turnover
1568592|NCT00505336|Statins|statins
1568593|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
1568594|NCT00505323|Cortex stimulation|cortex stimulation
1568595|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
1568596|NCT00505323|Effectiveness|effectiveness
1568597|NCT00505323|Quality of life improvement|quality of life improvement
1568598|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
1568599|NCT00505310|Kidney Cancer|kidney cancer
1568600|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
1568601|NCT00505310|Emotional Expression|emotional expression
1568602|NCT00505310|Writing|writing
1568603|NCT00505310|Questionnaire|questionnaire
1568604|NCT00505310|Survey|survey
1568605|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
1568606|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1568707|NCT00504855|Pressure ulcer|pressure ulcer
1568607|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
1568608|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
1568609|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
1568610|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
1568611|NCT00505284|Diabetic neuropathy|diabetic neuropathy
1568612|NCT00505271|Breast Cancer|breast cancer
1568613|NCT00505271|Rexin-G|rexin-g
1568614|NCT00505271|Gene Therapy|gene therapy
1568615|NCT00505258|Bacteremia|bacteremia
1568616|NCT00505258|Bloodstream infection|bloodstream infection
1568617|NCT00505258|Staphylococcus aureus|staphylococcus aureus
1568618|NCT00505258|Staphylococcal Infections|staphylococcal infections
1568619|NCT00505258|MRSA|mrsa
1568620|NCT00505258|MSSA|mssa
1568621|NCT00505245|Advanced Cancer|advanced cancer
1568622|NCT00505245|Symptom Distress|symptom distress
1568623|NCT00505245|MDASI|mdasi
1568624|NCT00505245|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
1568625|NCT00505245|Quality of Life|quality of life
1568626|NCT00505245|Questionnaire|questionnaire
1568627|NCT00505245|Interactive voice response telephone system|interactive voice response telephone system
1568628|NCT00505245|IVR|ivr
1568629|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
1568630|NCT00505232|Rituximab|rituximab
1568632|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
1568633|NCT00505232|Zevalin(R)|zevalin(r)
1568634|NCT00505219|Osteonecrosis|osteonecrosis
1568640|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
1568641|NCT00505167|randomized trial|randomized trial
1568642|NCT00505154|Heart failure|heart failure
1568643|NCT00505154|inflammation|inflammation
1568644|NCT00505154|cytokines|cytokines
1568645|NCT00505141|Childhood Brain Cancer|childhood brain cancer
1568646|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
1568647|NCT00505128|Biliary pancreatitis|biliary pancreatitis
1568648|NCT00505128|Bile duct stones|bile duct stones
1568649|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
1568650|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
1568651|NCT00505128|ERCP|ercp
1568652|NCT00505102|Kidney Diseases|kidney diseases
1568653|NCT00505102|Heart Transplantation|heart transplantation
1568654|NCT00505102|Everolimus|everolimus
1568655|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
1568656|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
1568657|NCT00505076|Cognition|cognition
1568658|NCT00505076|Schizophrenia|schizophrenia
1568659|NCT00505063|vaccine|vaccine
1568660|NCT00505063|childhood|childhood
1568661|NCT00505063|cancer|cancer
1568662|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
1568663|NCT00505037|ASP1585|asp1585
1568664|NCT00505037|Renal Dialysis|renal dialysis
1568665|NCT00505037|Chronic Kidney Disease|chronic kidney disease
1568666|NCT00505037|Hyperphosphatemia|hyperphosphatemia
1568667|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
1568668|NCT00505024|Esophageal Cancer|esophageal cancer
1568669|NCT00505024|Lung Cancer|lung cancer
1568670|NCT00505024|Interactive Voice Response System|interactive voice response system
1568671|NCT00505024|IVRS|ivrs
1568672|NCT00505011|susceptibility|susceptibility
1568673|NCT00505011|genes|genes
1568674|NCT00505011|environment|environment
1568675|NCT00505011|ophthalmopathy|ophthalmopathy
1568676|NCT00505011|outcome|outcome
1568677|NCT00504998|Pancreatic cancer|pancreatic cancer
1568678|NCT00504998|Rexin-G|rexin-g
1568679|NCT00504998|Treatment|treatment
1568680|NCT00504985|Advanced Cancer|advanced cancer
1568681|NCT00504985|Hematologic Malignancy|hematologic malignancy
1568682|NCT00504985|Fatigue|fatigue
1568683|NCT00504985|Emergency Center|emergency center
1568684|NCT00504985|Survey|survey
1568685|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
1568686|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
1568687|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1568688|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
1568689|NCT00504933|Rhinitis|rhinitis
1568690|NCT00504933|Allergic|allergic
1568691|NCT00504933|Seasonal|seasonal
1568692|NCT00504933|Hay Fever|hay fever
1568693|NCT00504933|Pollen Allergy|pollen allergy
1568694|NCT00504933|Pollinosis|pollinosis
1568695|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
1568696|NCT00504920|Leukemia|leukemia
1568697|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
1568698|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
1568699|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
1568700|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
1568701|NCT00504920|Questionnaire|questionnaire
1568702|NCT00504907|RSV|rsv
1568703|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
1568704|NCT00504881|Epilepsy|epilepsy
1568705|NCT00504881|Brivaracetam|brivaracetam
1568706|NCT00504881|Partial Onset Seizures|partial onset seizures
1568709|NCT00504855|Gortex|gortex
1568710|NCT00504855|Cast padding|cast padding
1568711|NCT00504855|Pediatric|pediatric
1568712|NCT00504855|Heel|heel
1568713|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
1568714|NCT00504842|Microbubbles|microbubbles
1568715|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
1568716|NCT00504842|TIBI|tibi
1568717|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
1568718|NCT00504842|modified Rankin Scale|modified rankin scale
1568719|NCT00504842|Recanalization|recanalization
1568720|NCT00504842|Perflutren|perflutren
1568721|NCT00504829|LCP-AtorFen|lcp-atorfen
1568722|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
1568723|NCT00504829|Triglycerides|triglycerides
1568724|NCT00504829|HDL cholesterol|hdl cholesterol
1568725|NCT00504829|LDL cholesterol|ldl cholesterol
1568726|NCT00504829|Atorvastatin|atorvastatin
1568727|NCT00504829|Fenofibrate|fenofibrate
1568728|NCT00504816|healthy female,|healthy female,
1568729|NCT00504816|pharmacokinetics,|pharmacokinetics,
1568730|NCT00504816|pharmacodynamics|pharmacodynamics
1568731|NCT00504816|drug interaction,|drug interaction,
1568732|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
1568733|NCT00504790|GSK923295,|gsk923295,
1568734|NCT00504790|First Time in Human,|first time in human,
1568735|NCT00504790|pharmacodynamics|pharmacodynamics
1568736|NCT00504790|cancer,|cancer,
1568737|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
1568738|NCT00504790|Refractory Cancer|refractory cancer
1568739|NCT00504790|CENPE,|cenpe,
1568740|NCT00504790|Phase I,|phase i,
1568741|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
1568742|NCT00504764|Arsenic Trioxide|arsenic trioxide
1568743|NCT00504751|diffuse large b cell|diffuse large b cell
1568744|NCT00504738|lung disease|lung disease
1568745|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1568746|NCT00504738|asthma|asthma
1568747|NCT00504738|smokers|smokers
1568748|NCT00504738|non-smokers|non-smokers
1568749|NCT00504725|Lobectomy|lobectomy
1568750|NCT00504725|VATS|vats
1568751|NCT00504712|Testosterone|testosterone
1568752|NCT00504712|Hypogonadism|hypogonadism
1568753|NCT00504712|Diabetes|diabetes
1568754|NCT00504712|PVD|pvd
1568755|NCT00504712|RCT|rct
1568756|NCT00504699|breast cancer|breast cancer
1568757|NCT00504699|ovarian stimulation|ovarian stimulation
1568758|NCT00504699|aromatase inhibitors|aromatase inhibitors
1568759|NCT00504699|letrozole|letrozole
1568760|NCT00504699|fertility preservation|fertility preservation
1568761|NCT00504699|recurrence|recurrence
1568762|NCT00504660|Anaplastic Glioma|anaplastic glioma
1568763|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
1568764|NCT00504660|Brain Cancer|brain cancer
1568765|NCT00504660|6-Thioguanine|6-thioguanine
1568766|NCT00504660|Capecitabine|capecitabine
1568767|NCT00504660|Celecoxib|celecoxib
1568768|NCT00504660|Temozolomide|temozolomide
1568769|NCT00504660|Xeloda|xeloda
1568770|NCT00504660|Temodar|temodar
1568771|NCT00504660|TMZ|tmz
1568772|NCT00504660|CCNU|ccnu
1568773|NCT00504660|6-TG|6-tg
1568774|NCT00504647|Hypertrophic|hypertrophic
1568775|NCT00504647|Cardiomyopathy|cardiomyopathy
1568776|NCT00504647|Diastolic|diastolic
1568777|NCT00504647|Ventricular|ventricular
1568778|NCT00504647|Interaction|interaction
1568779|NCT00504647|Biventricular|biventricular
1568780|NCT00504647|Pacemaker|pacemaker
1568781|NCT00504634|Multiple Myeloma|multiple myeloma
1568782|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
1568783|NCT00504634|Bortezomib|bortezomib
1568784|NCT00504634|Velcade|velcade
1568785|NCT00504634|PS-341|ps-341
1568786|NCT00504621|personality|personality
1568787|NCT00504621|fatigue|fatigue
1568788|NCT00504621|quality of life|quality of life
1568789|NCT00504621|health care consumption|health care consumption
1568790|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
1568791|NCT00504582|Axillary Node Dissection|axillary node dissection
1568792|NCT00504582|Fibrin Sealant|fibrin sealant
1568793|NCT00504582|Tisseel|tisseel
1568794|NCT00504582|Melanoma|melanoma
1568795|NCT00504582|Seroma|seroma
1568796|NCT00504556|Anti-coagulant|anti-coagulant
1568797|NCT00504556|Non-valvular|non-valvular
1568798|NCT00504556|Venous Thromboembolism|venous thromboembolism
1568799|NCT00504556|Prevention of Blood Clots|prevention of blood clots
1568800|NCT00504556|Atrial Fibrillation|atrial fibrillation
1568801|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1568802|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
1568803|NCT00504517|Outpatient continuity training|outpatient continuity training
1568804|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
1568805|NCT00504517|Evaluation|evaluation
1568806|NCT00504517|New graduation requirements|new graduation requirements
1568807|NCT00504504|Hodgkin's Disease|hodgkin's disease
1568808|NCT00504504|Lymphoma|lymphoma
1568809|NCT00504504|Rituximab|rituximab
1568810|NCT00504504|Rituxan|rituxan
1568811|NCT00504504|Adriamycin|adriamycin
1568812|NCT00504504|Doxorubicin|doxorubicin
1568813|NCT00504504|Rubex|rubex
1568814|NCT00504504|Bleomycin|bleomycin
1568815|NCT00504504|Bleomycin sulfate|bleomycin sulfate
1568816|NCT00504504|Blenoxane|blenoxane
1568817|NCT00504504|BLM|blm
1568818|NCT00504504|Dacarbazine|dacarbazine
1568819|NCT00504504|DTIC|dtic
1568820|NCT00504504|DTIC-Dome|dtic-dome
1568821|NCT00504504|Vincristine|vincristine
1568822|NCT00504504|Vinblastine|vinblastine
1568823|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
1568824|NCT00504504|ABVD|abvd
1568825|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
1568826|NCT00504491|Rituximab-CHOP|rituximab-chop
1568827|NCT00504491|Alemtuzumab|alemtuzumab
1568828|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
1568829|NCT00504478|Inflammation|inflammation
1568830|NCT00504478|carbohydrates|carbohydrates
1568831|NCT00504478|omega-3|omega-3
1568832|NCT00504478|overweight|overweight
1568833|NCT00504478|diet|diet
1568834|NCT00504465|Labor|labor
1568835|NCT00504465|Labor induction|labor induction
1568836|NCT00504465|Cervical ripening|cervical ripening
1568837|NCT00504465|Dinoprostone|dinoprostone
1568838|NCT00504465|Fetal safety|fetal safety
1568839|NCT00504465|Oxytocin|oxytocin
1568840|NCT00504465|Cesarean delivery|cesarean delivery
1568841|NCT00504452|HIV|hiv
1568842|NCT00504452|viral|viral
1568843|NCT00504452|Viral decay acceleration|viral decay acceleration
1568854|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
1568855|NCT00504413|Methadone|methadone
1568856|NCT00504413|Polymorphism, genetic|polymorphism, genetic
1568857|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
1568858|NCT00504400|macular telangiectasia|macular telangiectasia
1568859|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
1568860|NCT00504400|nonproliferative|nonproliferative
1568861|NCT00504400|therapy|therapy
1568862|NCT00504400|intravitreal injection|intravitreal injection
1568863|NCT00504400|ranibizumab|ranibizumab
1568864|NCT00504400|lucentis|lucentis
1568865|NCT00504387|Burning mouth disorder|burning mouth disorder
1568866|NCT00504387|Taste disorder|taste disorder
1568867|NCT00504387|Quantitative sensory testing|quantitative sensory testing
1568868|NCT00504387|Gustatory testing|gustatory testing
1568869|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
1568870|NCT00504387|Oral burning|oral burning
1568871|NCT00504374|Lung Cancer|lung cancer
1568872|NCT00504374|Epidemiology|epidemiology
1568873|NCT00504374|Symptoms|symptoms
1568874|NCT00504374|Gene Polymorphisms|gene polymorphisms
1568875|NCT00504374|Questionnaire|questionnaire
1568876|NCT00504374|Survey|survey
1568877|NCT00504361|Asthma|asthma
1568878|NCT00504361|COPD|copd
1568879|NCT00504361|Interstitial Lung Disease|interstitial lung disease
1568880|NCT00504361|Cystic Fibrosis|cystic fibrosis
1568881|NCT00504361|Lung Cancer|lung cancer
1568882|NCT00504361|smokers|smokers
1568883|NCT00504361|non-smokers|non-smokers
1568884|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
1568885|NCT00504348|Polymyositis|polymyositis
1568886|NCT00504348|Dermatomyositis|dermatomyositis
1568887|NCT00504348|Tacrolimus|tacrolimus
1568888|NCT00504348|Corticosteroids|corticosteroids
1568889|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
1568890|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
1568891|NCT00504335|Radiation Injury|radiation injury
1568892|NCT00504335|BIO 300|bio 300
1568893|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
1568894|NCT00504309|triglycerides|triglycerides
1568895|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
1568896|NCT00504309|omega-3|omega-3
1568897|NCT00504309|n-3|n-3
1568898|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
1568899|NCT00504309|EPA|epa
1568900|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
1568901|NCT00504309|DHA|dha
1568902|NCT00504309|flow mediated dilation|flow mediated dilation
1568903|NCT00504309|fish|fish
1568904|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
1568905|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1568906|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
1568907|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1568908|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1568909|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1568910|NCT00504244|SLE|sle
1568911|NCT00504244|SLEDAI|sledai
1568912|NCT00504244|Azathioprine|azathioprine
1568913|NCT00504244|Myfortic|myfortic
1568914|NCT00504231|influenza|influenza
1568915|NCT00504231|prevention|prevention
1568916|NCT00504231|intradermal|intradermal
1568917|NCT00504231|vaccine|vaccine
1568918|NCT00504231|delivery|delivery
1568919|NCT00504231|elderly|elderly
1568920|NCT00504218|Growth Factor|growth factor
1568921|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
1568922|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
1568923|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
1568924|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
1568925|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
1568926|NCT00504218|Obesity|obesity
1568927|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
1568928|NCT00504218|Thyroid Disorder|thyroid disorder
1568929|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
1568930|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
1568931|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
1568932|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1568933|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1569881|NCT00501176|SEMS|sems
1568934|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1568935|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1568936|NCT00504205|intraocular lymphoma|intraocular lymphoma
1568937|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1568938|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1568939|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1568940|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1568941|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1568942|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1569105|NCT00503854|Symptom Burden|symptom burden
1568943|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1568944|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1568945|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1568946|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1568947|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1568948|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1568949|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1568950|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1568951|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1568952|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1568953|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1568954|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1568955|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1568956|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1568957|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1568958|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1568959|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1568960|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1568961|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1568962|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1568963|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1568964|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1568965|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1568966|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1568967|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1568968|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1568969|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1568970|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1568971|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1568972|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1568973|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1568974|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1568975|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1568976|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1568977|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1568978|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1568979|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1568980|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1568981|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1568982|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1568983|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1568984|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1568985|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1568986|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1569104|NCT00503854|Fatigue|fatigue
1568987|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1568988|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
1569161|NCT00503763|Simvastatin|simvastatin
1568989|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
1568990|NCT00504179|cardiovascular disease|cardiovascular disease
1568991|NCT00504140|Osteosarcoma|osteosarcoma
1568992|NCT00504140|Interferon Alpha|interferon alpha
1568993|NCT00504140|IFN-|ifn-
1568994|NCT00504140|Roferon|roferon
1568995|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
1568996|NCT00504140|Etoposide|etoposide
1568997|NCT00504140|VP-16|vp-16
1568998|NCT00504127|Arthritis|arthritis
1568999|NCT00504127|Degenerative|degenerative
1569000|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
1569001|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
1569002|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
1569003|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
1569004|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
1569005|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
1569006|NCT00504088|CLI|cli
1569007|NCT00504088|Critical Limb Ischemia|critical limb ischemia
1569008|NCT00504088|PAD|pad
1569009|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
1569010|NCT00504088|Artherosclerosis|artherosclerosis
1569011|NCT00504088|Leg Pain|leg pain
1569012|NCT00504088|Cardiovascular|cardiovascular
1569013|NCT00504088|Artherectomy|artherectomy
1569014|NCT00504088|Bypass|bypass
1569015|NCT00504088|Peripheral Bypass|peripheral bypass
1569016|NCT00504088|PROOF|proof
1569277|NCT00503256|Survey|survey
1569017|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1569018|NCT00504075|Bleeding disorders|bleeding disorders
1569019|NCT00504075|Immune System and Disorders|immune system and disorders
1569020|NCT00504062|asthma|asthma
1569021|NCT00504062|bronchial|bronchial
1569022|NCT00504049|Cerebral Palsy|cerebral palsy
1569023|NCT00504049|Electromyography|electromyography
1569024|NCT00504049|Wavelet Analysis|wavelet analysis
1569025|NCT00504036|Obesity|obesity
1569026|NCT00504036|Morbid obesity|morbid obesity
1569027|NCT00504036|Gastric balloon|gastric balloon
1569028|NCT00504036|Gastric by-pass|gastric by-pass
1569029|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
1569030|NCT00504023|Paget disease of the vulva|paget disease of the vulva
1569031|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
1569032|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
1569033|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
1569034|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
1569035|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
1569036|NCT00504023|imiquimod|imiquimod
1569037|NCT00504023|07-029|07-029
1569038|NCT00504010|arnica|arnica
1569039|NCT00504010|muscle soreness|muscle soreness
1569040|NCT00504010|exercise|exercise
1569041|NCT00504010|eccentric|eccentric
1569042|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1569043|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1569044|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1569045|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1569046|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1569047|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1569048|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1569049|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1569050|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1569051|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1569052|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1569053|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1569054|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
1569055|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
1569056|NCT00503984|Pain|pain
1569057|NCT00503971|Vorinostat|vorinostat
1569058|NCT00503971|NSCLC|nsclc
1569059|NCT00503971|EGFR|egfr
1569060|NCT00503971|Erlotinib|erlotinib
1569061|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
1569062|NCT00503958|small cell lung cancer|small cell lung cancer
1569063|NCT00503958|health status unknown|health status unknown
1569064|NCT00503945|sleep apnea|sleep apnea
1569065|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
1569066|NCT00503945|echocardiography|echocardiography
1569067|NCT00503945|Natriuretic peptide|natriuretic peptide
1569068|NCT00503932|Rectal Cancer|rectal cancer
1569069|NCT00503932|Capecitabine|capecitabine
1569070|NCT00503932|Proton Therapy|proton therapy
1569071|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
1569072|NCT00503932|Gastrointestinal|gastrointestinal
1569073|NCT00503932|Proton Radiotherapy|proton radiotherapy
1569074|NCT00503919|Cervix|cervix
1569075|NCT00503919|Cervical dysplasia|cervical dysplasia
1569076|NCT00503919|Cervical neoplasia|cervical neoplasia
1569077|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1569078|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
1569079|NCT00503919|MDC|mdc
1569080|NCT00503919|Acetic acid|acetic acid
1569081|NCT00503919|Colposcopy|colposcopy
1569082|NCT00503919|Spectroscopy|spectroscopy
1569083|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
1569084|NCT00503919|Abnormal Pap Smear|abnormal pap smear
1569085|NCT00503906|stage IV breast cancer|stage iv breast cancer
1569086|NCT00503906|recurrent breast cancer|recurrent breast cancer
1569087|NCT00503893|Wilms' Tumor|wilms' tumor
1569088|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
1569089|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
1569090|NCT00503893|Aniridia|aniridia
1569091|NCT00503893|Questionnaire|questionnaire
1569092|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1569093|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1569094|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1569095|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1569097|NCT00503867|SIR-Spheres|sir-spheres
1569098|NCT00503867|Y-90 Microspheres|y-90 microspheres
1569099|NCT00503867|brachytherapy|brachytherapy
1569100|NCT00503867|SIRT|sirt
1569101|NCT00503867|liver cancer|liver cancer
1569102|NCT00503854|Solid Tumors|solid tumors
1569103|NCT00503854|Febrile Neutropenia|febrile neutropenia
1569109|NCT00503841|recurrent breast cancer|recurrent breast cancer
1569110|NCT00503841|stage II breast cancer|stage ii breast cancer
1569111|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
1569112|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
1569113|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
1569114|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
1569115|NCT00503828|Osteoarthritis|osteoarthritis
1569116|NCT00503828|WOMAC|womac
1569117|NCT00503828|6-minute walk|6-minute walk
1569118|NCT00503815|colonoscopy|colonoscopy
1569119|NCT00503815|bowel preparation|bowel preparation
1569120|NCT00503815|prep|prep
1569121|NCT00503802|Sleep Apnea|sleep apnea
1569122|NCT00503802|Sleep disordered breathing|sleep disordered breathing
1569123|NCT00503802|Nasal Obstruction|nasal obstruction
1569124|NCT00503802|Turbinate|turbinate
1569125|NCT00503802|Radiofrequency|radiofrequency
1569126|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
1569127|NCT00503802|CPAP|cpap
1569128|NCT00503802|Sleep surgery|sleep surgery
1569129|NCT00503789|Healthy infants|healthy infants
1569130|NCT00503776|xerostomia|xerostomia
1569131|NCT00503776|mucositis|mucositis
1569132|NCT00503776|dysphagia|dysphagia
1569133|NCT00503776|radiation toxicity|radiation toxicity
1569134|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1569135|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1569136|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1569137|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1569138|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1569139|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1569140|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1569141|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1569142|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1569143|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1569144|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1569145|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1569146|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1569147|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1569148|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1569149|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1569150|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1569151|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1569152|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1569153|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1569154|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1569155|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1569156|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1569157|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
1569158|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
1569159|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
1569160|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
1569162|NCT00503763|Paraprotein|paraprotein
1569163|NCT00503750|Breast Cancer|breast cancer
1569164|NCT00503737|colorectal cancer screening|colorectal cancer screening
1569165|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
1569166|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1569167|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1569168|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1569169|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1569170|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
1569171|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
1569172|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1569173|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1569174|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
1569175|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1569176|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
1569177|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1569178|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1569179|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1569180|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
1569181|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
1569182|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
1569183|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1569184|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1569185|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
1569186|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
1569187|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
1569188|NCT00503711|ZD6474 PK|zd6474 pk
1569189|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
1569190|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
1569191|NCT00503672|Motor Activity|motor activity
1569192|NCT00503672|Pregnancy|pregnancy
1569193|NCT00503672|Accelerometer|accelerometer
1569194|NCT00503659|PC20 FEV1|pc20 fev1
1569195|NCT00503659|PD20FEV1|pd20fev1
1569196|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
1569197|NCT00503659|bronchial asthma|bronchial asthma
1569198|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1569199|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
1569200|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
1569201|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
1569202|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
1569203|NCT00503646|stage I prostate cancer|stage i prostate cancer
1569204|NCT00503633|sleep disorders|sleep disorders
1569205|NCT00503633|genetics|genetics
1569206|NCT00503620|Cerebral Palsy|cerebral palsy
1569207|NCT00503620|Botulinum Toxin|botulinum toxin
1569208|NCT00503620|Neuromuscular Function|neuromuscular function
1569209|NCT00503607|colonoscopy|colonoscopy
1569210|NCT00503607|bowel preparation|bowel preparation
1569211|NCT00503607|prep|prep
1569212|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
1569213|NCT00503594|Brain lymphoma|brain lymphoma
1569214|NCT00503594|Elderly|elderly
1569215|NCT00503594|Chemotherapy|chemotherapy
1569216|NCT00503594|Methotrexate|methotrexate
1569217|NCT00503594|Temozolomide|temozolomide
1569218|NCT00503594|Procarbazine|procarbazine
1569219|NCT00503594|Vincristine|vincristine
1569220|NCT00503594|Cytarabine|cytarabine
1569221|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1569222|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1569223|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1569224|NCT00503555|Primary Health Care|primary health care
1569225|NCT00503555|Hispanic Americans|hispanic americans
1569226|NCT00503542|Vaginitis|vaginitis
1569227|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
1569228|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
1569229|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
1569230|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
1569231|NCT00503477|Japan|japan
1569232|NCT00503477|Phase I|phase i
1569233|NCT00503477|solid tumor|solid tumor
1569234|NCT00503477|AZD2171|azd2171
1569235|NCT00503464|guideline|guideline
1569236|NCT00503464|adherence|adherence
1569237|NCT00503451|Advanced cancer|advanced cancer
1569238|NCT00503451|solid tumors|solid tumors
1569239|NCT00503451|lymphoma|lymphoma
1569240|NCT00503451|HDAC|hdac
1569241|NCT00503451|LBH589|lbh589
1569242|NCT00503451|adults|adults
1569243|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1569244|NCT00503438|Arthritis|arthritis
1569245|NCT00503438|Osteoarthritis|osteoarthritis
1569246|NCT00503438|Arthroplasty|arthroplasty
1569247|NCT00503412|phase I|phase i
1569248|NCT00503412|AZD2171|azd2171
1569249|NCT00503412|solid tumor|solid tumor
1569250|NCT00503412|metastatic tumor|metastatic tumor
1569251|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
1569252|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
1569253|NCT00503386|acute|acute
1569254|NCT00503386|delayed|delayed
1569255|NCT00503386|emesis|emesis
1569256|NCT00503386|antiemetics|antiemetics
1569257|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
1569258|NCT00503386|granisetron|granisetron
1569259|NCT00503386|palonosetron|palonosetron
1569260|NCT00503360|Ocular Hypertension|ocular hypertension
1569261|NCT00503360|SAD448|sad448
1569262|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
1569263|NCT00503347|Treatment Naive|treatment naive
1569264|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
1569265|NCT00503308|HIV Seronegativity|hiv seronegativity
1569266|NCT00503295|reovirus|reovirus
1569267|NCT00503295|oncolytic virus|oncolytic virus
1569268|NCT00503295|sarcoma|sarcoma
1569269|NCT00503295|REOLYSIN|reolysin
1569270|NCT00503295|Oncolytics Biotech|oncolytics biotech
1569271|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
1569272|NCT00503269|Local anaesthesia|local anaesthesia
1569273|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1569274|NCT00503256|Leukemia|leukemia
1569275|NCT00503256|Lymphoma|lymphoma
1569276|NCT00503256|Questionnaire|questionnaire
1569283|NCT00503217|intrauterine insemination|intrauterine insemination
1569284|NCT00503217|GnRH agonist|gnrh agonist
1569285|NCT00503217|implantation|implantation
1569286|NCT00503204|cancer|cancer
1569287|NCT00503204|tumor|tumor
1569288|NCT00503204|advance solid tumour|advance solid tumour
1569289|NCT00503204|glioblastoma|glioblastoma
1569290|NCT00503204|malignant brain tumour|malignant brain tumour
1569291|NCT00503191|Autism|autism
1569292|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
1569293|NCT00503165|Menitorix|menitorix
1569294|NCT00503165|vaccine|vaccine
1569295|NCT00503126|pediatrics|pediatrics
1569296|NCT00503126|bivalirudin|bivalirudin
1569297|NCT00503100|Pain|pain
1569298|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
1569299|NCT00503087|Injections|injections
1569300|NCT00503087|Vacuum|vacuum
1569301|NCT00503087|Pain|pain
1569302|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
1569303|NCT00503087|PSF|psf
1569304|NCT00503074|Diet, reducing|diet, reducing
1569305|NCT00503074|Television|television
1569306|NCT00503074|Child Behavior|child behavior
1569307|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
1569308|NCT00503061|Symbicort SMART|symbicort smart
1569309|NCT00503061|GPRD|gprd
1569310|NCT00503048|atopy|atopy
1569311|NCT00503048|atopic diseases|atopic diseases
1569312|NCT00503048|children|children
1569313|NCT00503048|orphanages|orphanages
1569314|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
1569315|NCT00503035|Colorectal Tumors|colorectal tumors
1569316|NCT00503035|Molecular Targeting|molecular targeting
1569317|NCT00503035|Celecoxib|celecoxib
1569318|NCT00503035|Celebrex|celebrex
1569319|NCT00503035|SC-58635|sc-58635
1569320|NCT00503035|Apoptosis Induction|apoptosis induction
1569321|NCT00503035|Colon|colon
1569322|NCT00503035|Rectum|rectum
1569323|NCT00503035|colonoscopy|colonoscopy
1569324|NCT00503035|Biopsy|biopsy
1569325|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
1569326|NCT00503022|ACZ885|acz885
1569327|NCT00503009|Rhinovirus|rhinovirus
1569328|NCT00503009|Asthma|asthma
1569329|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
1569330|NCT00502983|Epidemiology|epidemiology
1569331|NCT00502983|Leukemia|leukemia
1569332|NCT00502983|Healthy Control|healthy control
1569333|NCT00502983|Lifestyle Factors|lifestyle factors
1569334|NCT00502983|Genetic Susceptibility|genetic susceptibility
1569335|NCT00502983|Interview|interview
1569336|NCT00502983|AML|aml
1569337|NCT00502970|Chronic HCV|chronic hcv
1569338|NCT00502970|Treatment|treatment
1569339|NCT00502957|biofeedback|biofeedback
1569340|NCT00502957|constipation|constipation
1569341|NCT00502944|HIV|hiv
1569342|NCT00502944|Testing|testing
1569343|NCT00502944|HIV Seronegativity|hiv seronegativity
1569344|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
1569345|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
1569346|NCT00502905|Busulfan|busulfan
1569347|NCT00502905|Busulfex|busulfex
1569348|NCT00502905|Myleran|myleran
1569349|NCT00502905|Fludarabine|fludarabine
1569350|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
1569351|NCT00502905|Fludara|fludara
1569352|NCT00502892|Solid Tumors|solid tumors
1569353|NCT00502892|Topotecan|topotecan
1569354|NCT00502892|Hycamtin|hycamtin
1569355|NCT00502892|Ifosfamide|ifosfamide
1569356|NCT00502892|Ifex|ifex
1569357|NCT00502892|Carboplatin|carboplatin
1569358|NCT00502892|Paraplatin|paraplatin
1569359|NCT00502892|Pediatric|pediatric
1569360|NCT00502892|Children|children
1569361|NCT00502892|Young Adults|young adults
1569362|NCT00502866|breastfeeding|breastfeeding
1569363|NCT00502866|vitamin D supplementation|vitamin d supplementation
1569364|NCT00502866|rickets|rickets
1569365|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
1569366|NCT00502827|HIV positive|hiv positive
1569367|NCT00502827|HIV Positive Smokers|hiv positive smokers
1569369|NCT00502827|Cell Phone Intervention|cell phone intervention
1569370|NCT00502827|CPI|cpi
1569371|NCT00502827|Smoking Cessation|smoking cessation
1569372|NCT00502827|Interview|interview
1569373|NCT00502814|Breast Cancer|breast cancer
1569374|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
1569375|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
1569376|NCT00502814|Mechanical Testing|mechanical testing
1569377|NCT00502814|Skin Ultrasound|skin ultrasound
1569378|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
1569379|NCT00502814|CT Scan|ct scan
1569380|NCT00502801|Pneumonia|pneumonia
1569381|NCT00502801|Lung Infection|lung infection
1569382|NCT00502801|Bacterial Infection|bacterial infection
1569383|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
1569384|NCT00502801|Ventilator Infection|ventilator infection
1569385|NCT00502801|Antibiotic Therapy|antibiotic therapy
1569386|NCT00502775|ragweed|ragweed
1569387|NCT00502775|once daily|once daily
1569388|NCT00502775|fexofenadine|fexofenadine
1569389|NCT00502775|fluticasone furoate|fluticasone furoate
1569390|NCT00502775|allergic rhinitis|allergic rhinitis
1569391|NCT00502762|small-cell lung cancer|small-cell lung cancer
1569397|NCT00502749|Quality of Life|quality of life
1569398|NCT00502749|Questionnaire|questionnaire
1569399|NCT00502749|Survey|survey
1569400|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
1569401|NCT00502723|Surgical Procedures|surgical procedures
1569402|NCT00502723|Laparoscopic|laparoscopic
1569403|NCT00502697|preterm|preterm
1569404|NCT00502697|prematurity|prematurity
1569405|NCT00502697|home visitation|home visitation
1569406|NCT00502697|system of care|system of care
1569407|NCT00502684|breast cancer|breast cancer
1569408|NCT00502684|surgery|surgery
1569409|NCT00502684|immune suppression|immune suppression
1569410|NCT00502684|beta blockers|beta blockers
1569411|NCT00502684|COX2 inhibitors|cox2 inhibitors
1569412|NCT00502658|Overweight|overweight
1569413|NCT00502658|Obese|obese
1569414|NCT00502658|Dietary Supplements|dietary supplements
1569415|NCT00502658|Shakes|shakes
1569416|NCT00502658|Nutrition|nutrition
1569417|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
1569418|NCT00502645|algorithm|algorithm
1569419|NCT00502645|cs-1 decision support system|cs-1 decision support system
1569420|NCT00502645|insulin|insulin
1569421|NCT00502645|hyperglycemia|hyperglycemia
1569422|NCT00502645|tight glycemic control|tight glycemic control
1569423|NCT00502645|intensive care|intensive care
1569424|NCT00502645|adults|adults
1569425|NCT00502632|Pleural empyema|pleural empyema
1569426|NCT00502632|Pleural effusion|pleural effusion
1569427|NCT00502632|Dornase alfa|dornase alfa
1569428|NCT00502632|Urokinase|urokinase
1569429|NCT00502632|Children|children
1569430|NCT00502619|Low back pain|low back pain
1569431|NCT00502619|acupuncture|acupuncture
1569432|NCT00502619|treadmill exercise|treadmill exercise
1569433|NCT00502606|provisional restoration|provisional restoration
1569434|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
1569435|NCT00502606|cement|cement
1569436|NCT00502606|biofilm|biofilm
1569437|NCT00502606|bacteria|bacteria
1569438|NCT00502606|flora|flora
1569439|NCT00502606|plaque|plaque
1569440|NCT00502606|dental|dental
1569441|NCT00502606|prosthesis|prosthesis
1569442|NCT00502593|Influenza|influenza
1569443|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
1569444|NCT00502580|Oral Cancer|oral cancer
1569445|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
1569446|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
1569447|NCT00502580|Interview|interview
1569448|NCT00502580|MDM|mdm
1569449|NCT00502567|advanced solid tumors|advanced solid tumors
1569450|NCT00502567|AZD2171|azd2171
1569451|NCT00502567|Phase I|phase i
1569452|NCT00502554|lung function|lung function
1569453|NCT00502554|FEV1|fev1
1569454|NCT00502528|Infarction|infarction
1569455|NCT00502528|Endothelin|endothelin
1569456|NCT00502528|Perfusion|perfusion
1569457|NCT00502515|Diabetes|diabetes
1569458|NCT00502515|Neuropathy|neuropathy
1569459|NCT00502502|Anal Cancer|anal cancer
1569460|NCT00502502|Colorectal Cancer|colorectal cancer
1569461|NCT00502502|Esophageal Cancer|esophageal cancer
1569462|NCT00502502|Gastric Cancer|gastric cancer
1569463|NCT00502502|Lung Cancer|lung cancer
1569464|NCT00502502|Questionnaire|questionnaire
1569465|NCT00502502|Survey|survey
1569466|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
1569467|NCT00502502|Symptoms|symptoms
1569468|NCT00502502|Cytokines|cytokines
1569469|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
1569470|NCT00502476|MRSA|mrsa
1569471|NCT00502476|VRE|vre
1569472|NCT00502476|BSI|bsi
1569473|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
1569575|NCT00502099|Chronic hepatitis C|chronic hepatitis c
1569474|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
1569475|NCT00502450|Acute mastoiditis|acute mastoiditis
1569476|NCT00502450|Hearing loss|hearing loss
1569477|NCT00502450|Mastoidectomy|mastoidectomy
1569478|NCT00502450|Audiogram|audiogram
1569479|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
1569480|NCT00502424|Hand|hand
1569481|NCT00502424|Splint|splint
1569482|NCT00502424|Occupational Therapy|occupational therapy
1569483|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
1569484|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
1569485|NCT00502411|Radiation Therapy|radiation therapy
1569486|NCT00502411|Extremity and Trunk|extremity and trunk
1569487|NCT00502411|EBRT|ebrt
1569488|NCT00502411|Sarcoma|sarcoma
1569489|NCT00502411|Doxorubicin|doxorubicin
1569490|NCT00502411|AD|ad
1569491|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1569492|NCT00502411|XRT|xrt
1569493|NCT00502411|RT|rt
1569494|NCT00502411|Radiotherapy|radiotherapy
1569495|NCT00502385|Phase I|phase i
1569496|NCT00502385|AML|aml
1569497|NCT00502385|de novo or secondary AML|de novo or secondary aml
1569498|NCT00502385|AZD2171|azd2171
1569499|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
1569500|NCT00502346|Pharmacodynamics|pharmacodynamics
1569501|NCT00502333|back pain|back pain
1569504|NCT00502333|catastrophizing|catastrophizing
1569505|NCT00502333|coping strategies|coping strategies
1569506|NCT00502333|disability|disability
1569507|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
1569508|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
1569509|NCT00502320|Ramelteon|ramelteon
1569510|NCT00502320|Psychiatry|psychiatry
1569511|NCT00502320|Randomized Controlled Trial|randomized controlled trial
1569512|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
1569513|NCT00502320|Circadian Rhythm|circadian rhythm
1569514|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
1569515|NCT00502307|AV-951|av-951
1569516|NCT00502307|tivozanib|tivozanib
1569517|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
1569518|NCT00502281|Gonadotropins|gonadotropins
1569519|NCT00502281|Infertility|infertility
1569520|NCT00502281|Intrauterine insemination|intrauterine insemination
1569521|NCT00502281|PCOS|pcos
1569522|NCT00502281|Timed intercourse|timed intercourse
1569523|NCT00502281|Treatment|treatment
1569524|NCT00502268|Coronary Calcification|coronary calcification
1569525|NCT00502268|Endstage Renal Disease|endstage renal disease
1569526|NCT00502268|Parathyroid hormone|parathyroid hormone
1569527|NCT00502255|Telemonitoring|telemonitoring
1569528|NCT00502255|Cost-effectiveness|cost-effectiveness
1569529|NCT00502255|Heart failure|heart failure
1569530|NCT00502255|Case management|case management
1569531|NCT00502229|Clomiphene citrate|clomiphene citrate
1569532|NCT00502229|Controlled overian stimulation|controlled overian stimulation
1569533|NCT00502229|Infertility|infertility
1569534|NCT00502229|Metformin|metformin
1569535|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
1569536|NCT00502229|Treatment|treatment
1569537|NCT00502216|Tobacco|tobacco
1569538|NCT00502216|Smoking|smoking
1569539|NCT00502216|Weight|weight
1569540|NCT00502216|Naltrexone|naltrexone
1569541|NCT00502216|Varenicline|varenicline
1569542|NCT00502203|Uterine Neoplasms|uterine neoplasms
1569543|NCT00502203|Endometrial Cancer|endometrial cancer
1569544|NCT00502203|Paclitaxel|paclitaxel
1569545|NCT00502203|Taxol|taxol
1569546|NCT00502203|Carboplatin|carboplatin
1569547|NCT00502203|Paraplatin|paraplatin
1569548|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
1569549|NCT00502203|MMMT|mmmt
1569550|NCT00502203|Immunohistochemical markers|immunohistochemical markers
1569551|NCT00502190|pessary|pessary
1569552|NCT00502190|extending pregnancy|extending pregnancy
1569553|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
1569554|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
1569555|NCT00502177|Quality of Life|quality of life
1569556|NCT00502177|Questionnaire|questionnaire
1569557|NCT00502177|Survey|survey
1569558|NCT00502177|CHPP|chpp
1569559|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
1569560|NCT00502138|diabetes|diabetes
1569561|NCT00502138|insulin|insulin
1569562|NCT00502138|pramlintide|pramlintide
1569563|NCT00502138|IDDM|iddm
1569564|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
1569565|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
1569566|NCT00502125|Oral Mucosa Disease|oral mucosa disease
1569567|NCT00502125|Neoplasia Detection|neoplasia detection
1569568|NCT00502112|Lintuzumab|lintuzumab
1569569|NCT00502112|Antigens, CD33|antigens, cd33
1569570|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
1569571|NCT00502112|Combined Modality Therapy|combined modality therapy
1569572|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
1569573|NCT00502112|Hematologic Diseases|hematologic diseases
1570954|NCT00498407|Cancer|cancer
1569576|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
1569577|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
1569578|NCT00502099|early virologic response|early virologic response
1569579|NCT00502099|sustained virologic response|sustained virologic response
1569580|NCT00502086|Chronic hepatitis C|chronic hepatitis c
1569581|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
1569582|NCT00502086|Mortality|mortality
1569583|NCT00502086|Complications|complications
1569584|NCT00502086|Health-related quality of live|health-related quality of live
1569585|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
1569586|NCT00502086|Nutritional supplement|nutritional supplement
1569587|NCT00502060|Phase I|phase i
1569588|NCT00502060|AZD2171|azd2171
1569589|NCT00502060|ZD1839|zd1839
1569590|NCT00502060|solid tumor|solid tumor
1569591|NCT00502047|plantago ovata husk|plantago ovata husk
1569592|NCT00502047|soluble fibre|soluble fibre
1569593|NCT00502047|hypercholesterolemia|hypercholesterolemia
1569594|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
1569595|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
1569596|NCT00502034|Low-dose Interleukin|low-dose interleukin
1569597|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
1569598|NCT00502021|obesity|obesity
1569599|NCT00502021|alpha linolenic acid|alpha linolenic acid
1569600|NCT00502021|flaxseed|flaxseed
1569601|NCT00502021|C-reactive protein|c-reactive protein
1569602|NCT00502021|inflammation|inflammation
1569603|NCT00502008|Diabetes|diabetes
1569605|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
1569606|NCT00502008|Coccinia indica|coccinia indica
1569607|NCT00502008|Blood glucose levels|blood glucose levels
1569608|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
1569609|NCT00501995|Systemic Sclerosis|systemic sclerosis
1569610|NCT00501995|Scleroderma|scleroderma
1569611|NCT00501995|immunoablation|immunoablation
1569612|NCT00501982|surfactant|surfactant
1569613|NCT00501982|RDS|rds
1569614|NCT00501982|nCPAP|ncpap
1569615|NCT00501982|Mechanical Ventilation|mechanical ventilation
1569616|NCT00501982|Premature Infants|premature infants
1569617|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
1569618|NCT00501969|Rotigotine|rotigotine
1569619|NCT00501969|Neupro®|neupro®
1569620|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
1569621|NCT00501956|malnutrition anorexia|malnutrition anorexia
1569622|NCT00501956|parenteral nutrition|parenteral nutrition
1569623|NCT00501930|Dose Escalation;|dose escalation;
1569624|NCT00501930|Supratherapeutic;|supratherapeutic;
1569625|NCT00501930|GSK189075;|gsk189075;
1569626|NCT00501930|Diabetes|diabetes
1569627|NCT00501917|acute myocardial infarction|acute myocardial infarction
1569628|NCT00501904|Anovulation|anovulation
1569629|NCT00501904|Infertility|infertility
1569630|NCT00501904|Metformin|metformin
1569631|NCT00501904|PCOS|pcos
1569632|NCT00501904|Treatment|treatment
1569633|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
1569634|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
1569635|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
1569636|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1569637|NCT00501891|Avastin|avastin
1569638|NCT00501891|Bevacizumab|bevacizumab
1569639|NCT00501891|Temodar|temodar
1569640|NCT00501891|Temozolomide|temozolomide
1569641|NCT00501878|phenylephrine|phenylephrine
1569642|NCT00501878|mydriasis|mydriasis
1569643|NCT00501878|diabetes mellitus|diabetes mellitus
1569644|NCT00501865|healthy volunteers|healthy volunteers
1569645|NCT00501865|food effect,|food effect,
1569646|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
1569647|NCT00501865|GW273225,|gw273225,
1569648|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
1569649|NCT00501839|Anovulation|anovulation
1569650|NCT00501839|Clomiphene citrate|clomiphene citrate
1569651|NCT00501839|Infertility|infertility
1569652|NCT00501839|PCOS|pcos
1569653|NCT00501839|Treatment|treatment
1569654|NCT00501826|Leukemia|leukemia
1569655|NCT00501826|ALL|all
1569656|NCT00501826|T-cell ALL|t-cell all
1569657|NCT00501826|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1569658|NCT00501826|Hyper-CVAD|hyper-cvad
1569659|NCT00501826|Doxorubicin|doxorubicin
1569660|NCT00501826|Cyclophosphamide|cyclophosphamide
1569661|NCT00501826|Cytarabine|cytarabine
1569662|NCT00501826|Dexamethasone|dexamethasone
1569663|NCT00501826|Methotrexate|methotrexate
1569664|NCT00501826|Vincristine|vincristine
1569665|NCT00501826|Nelarabine|nelarabine
1569666|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
1569667|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
1569668|NCT00501813|Hepatectomy|hepatectomy
1569669|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
1569670|NCT00501813|Local regional treatment|local regional treatment
1569671|NCT00501800|Reproductive Health|reproductive health
1569672|NCT00501800|Fertility|fertility
1569673|NCT00501800|Infertility|infertility
1569674|NCT00501800|Genetics|genetics
1569879|NCT00501176|Pancreas|pancreas
1571161|NCT00497562|FIQ|fiq
1569675|NCT00501800|Continental Population Groups|continental population groups
1569676|NCT00501800|Epidemiology|epidemiology
1569677|NCT00501800|Aging|aging
1569678|NCT00501800|Health|health
1569679|NCT00501787|Anovulation|anovulation
1569680|NCT00501787|metformin|metformin
1569681|NCT00501787|PCOS|pcos
1569682|NCT00501787|treatment|treatment
1569683|NCT00501774|Localized vulvodynia|localized vulvodynia
1569684|NCT00501774|Helicobacter pylori|helicobacter pylori
1569685|NCT00501774|peptic disease|peptic disease
1569686|NCT00501774|omeprazole|omeprazole
1569687|NCT00501761|Endometrial Cancer|endometrial cancer
1569688|NCT00501761|Healthy Controls|healthy controls
1569689|NCT00501761|Social Cognitive Theory|social cognitive theory
1569690|NCT00501761|Behavioral Intervention|behavioral intervention
1569691|NCT00501761|Physical Activity|physical activity
1569692|NCT00501761|Exercise Program|exercise program
1569693|NCT00501761|Questionnaire|questionnaire
1569694|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
1569695|NCT00501748|acute transverse myelitis|acute transverse myelitis
1569696|NCT00501735|T-Cell|t-cell
1569697|NCT00501735|Lymphoma|lymphoma
1569698|NCT00501735|Forodesine|forodesine
1569699|NCT00501735|Mycosis Fungoides|mycosis fungoides
1569700|NCT00501722|cirrhotic ascites|cirrhotic ascites
1569701|NCT00501722|hyponatraemia|hyponatraemia
1569702|NCT00501683|metabolite profiling|metabolite profiling
1569703|NCT00501683|excretion,|excretion,
1569704|NCT00501683|radioactivity,|radioactivity,
1569705|NCT00501683|pharmacokinetic,|pharmacokinetic,
1569706|NCT00501683|mass balance,|mass balance,
1569707|NCT00501670|Herpes zoster|herpes zoster
1569708|NCT00501670|PCR|pcr
1569709|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
1569710|NCT00501670|Shingles|shingles
1569711|NCT00501670|GSK Biologicals|gsk biologicals
1569712|NCT00501657|gastric emptying|gastric emptying
1569713|NCT00501657|glycemia|glycemia
1569714|NCT00501657|appetite|appetite
1569715|NCT00501657|incretin hormones|incretin hormones
1569716|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
1569717|NCT00501644|Ovarian Cancer|ovarian cancer
1569718|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
1569719|NCT00501644|Peritoneal Cancer|peritoneal cancer
1569720|NCT00501644|Epithelial Ovarian|epithelial ovarian
1569721|NCT00501644|Peritoneal|peritoneal
1569722|NCT00501644|Fallopian Tube|fallopian tube
1569723|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
1569724|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
1569725|NCT00501644|Carboplatin|carboplatin
1569726|NCT00501644|Paraplatin|paraplatin
1569727|NCT00501644|GM-CSF|gm-csf
1569728|NCT00501644|Sargramostim|sargramostim
1569729|NCT00501644|Interferon Gamma|interferon gamma
1569730|NCT00501644|Quality of Life|quality of life
1569731|NCT00501644|QOL|qol
1569732|NCT00501631|Addiction|addiction
1569733|NCT00501631|Alcoholism|alcoholism
1569734|NCT00501631|Inpatient detoxification|inpatient detoxification
1569735|NCT00501618|Schizophrenia|schizophrenia
1569736|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
1569737|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
1569738|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
1569739|NCT00501618|bio-equivalence|bio-equivalence
1569740|NCT00501618|desmethylclozapine|desmethylclozapine
1569741|NCT00501618|clozapine plasma level|clozapine plasma level
1569742|NCT00501618|equivalence|equivalence
1569743|NCT00501618|fazaclo|fazaclo
1569744|NCT00501618|generic clozapine|generic clozapine
1569745|NCT00501605|Phase I|phase i
1569746|NCT00501605|AZD2171|azd2171
1569747|NCT00501605|advanced solid tumors|advanced solid tumors
1569748|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
1569749|NCT00501592|Metabolic Disorder|metabolic disorder
1569750|NCT00501592|Diabetes|diabetes
1569751|NCT00501592|NAFLD|nafld
1569752|NCT00501566|cirrhotic ascites|cirrhotic ascites
1569753|NCT00501553|Heart Failure,|heart failure,
1569754|NCT00501553|Vitamin D status,|vitamin d status,
1569755|NCT00501553|NT-proBNP|nt-probnp
1569756|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
1569757|NCT00501540|lithium|lithium
1569758|NCT00501527|Allergoid|allergoid
1569759|NCT00501527|Depigmented|depigmented
1569760|NCT00501527|Polymerized|polymerized
1569761|NCT00501527|Allergen-extract|allergen-extract
1569762|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
1569763|NCT00501527|Asthma|asthma
1569764|NCT00501514|chronic heart failure|chronic heart failure
1569765|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
1569766|NCT00501514|oxygen consumption|oxygen consumption
1569767|NCT00501514|growth hormone|growth hormone
1569768|NCT00501501|Rehospitalization|rehospitalization
1569769|NCT00501501|Cesarean|cesarean
1569770|NCT00501501|Vaginal delivery|vaginal delivery
1569771|NCT00501488|pharmacodynamics|pharmacodynamics
1569772|NCT00501488|insulin resistance|insulin resistance
1569773|NCT00501488|therapy|therapy
1569774|NCT00501488|volunteer|volunteer
1569775|NCT00501475|N-acetylcysteine|n-acetylcysteine
1569776|NCT00501475|nephropathy|nephropathy
1569777|NCT00501475|bicarbonate|bicarbonate
1569880|NCT00501176|cancer|cancer
1569778|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1569779|NCT00501462|renal insufficiency|renal insufficiency
1569780|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
1569781|NCT00501449|Questionnaire|questionnaire
1569782|NCT00501449|Psychosocial|psychosocial
1569783|NCT00501449|Surveillance Behaviors|surveillance behaviors
1569784|NCT00501449|MEN Syndromes|men syndromes
1569785|NCT00501423|antiplatelet drug|antiplatelet drug
1569786|NCT00501423|resistance|resistance
1569787|NCT00501423|atherothrombosis|atherothrombosis
1569788|NCT00501410|Colorectal Cancer|colorectal cancer
1569789|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
1569790|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
1569791|NCT00501410|5-FU|5-fu
1569792|NCT00501410|Cetuximab|cetuximab
1569793|NCT00501410|Dasatinib|dasatinib
1569794|NCT00501410|Leucovorin|leucovorin
1569795|NCT00501410|Oxaliplatin|oxaliplatin
1569796|NCT00501410|5-Fluorouracil|5-fluorouracil
1569797|NCT00501410|BMS-354825|bms-354825
1569798|NCT00501410|Eloxatin|eloxatin
1569799|NCT00501410|Sprycel|sprycel
1569800|NCT00501410|C225|c225
1569801|NCT00501410|Erbitux|erbitux
1569802|NCT00501410|IMC-C225|imc-c225
1569803|NCT00501410|Adrucil|adrucil
1569804|NCT00501410|Efudex|efudex
1569805|NCT00501410|Folinic Acid|folinic acid
1569806|NCT00501397|ketoconazole,|ketoconazole,
1569807|NCT00501397|drug interaction,|drug interaction,
1569808|NCT00501397|pharmacokinetics|pharmacokinetics
1569809|NCT00501397|T2DM,|t2dm,
1570622|NCT00499343|Neupogen|neupogen
1569810|NCT00501384|cirrhotic ascites|cirrhotic ascites
1569811|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1569812|NCT00501371|MCS|mcs
1569813|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1569814|NCT00501371|International prostate symptom score|international prostate symptom score
1569815|NCT00501371|Voiding|voiding
1569816|NCT00501371|Alpha-blockers|alpha-blockers
1569817|NCT00501358|SLEEP APNEA|sleep apnea
1569818|NCT00501358|venous thromboembolism|venous thromboembolism
1569819|NCT00501358|COAGULABILITY|coagulability
1569820|NCT00501358|COAGULATION FACTORS|coagulation factors
1569821|NCT00501358|HYPOXIA|hypoxia
1569822|NCT00501345|Thrombocytopenia|thrombocytopenia
1569823|NCT00501345|Platelet Function|platelet function
1569824|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
1569825|NCT00501345|Myocardial Infarction|myocardial infarction
1569826|NCT00501345|Heart Attack|heart attack
1569827|NCT00501345|Aspirin|aspirin
1569828|NCT00501332|neutropenia|neutropenia
1569829|NCT00501332|breast|breast
1569830|NCT00501332|cancer|cancer
1569831|NCT00501332|chemotherapy|chemotherapy
1569832|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
1569833|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
1569834|NCT00501319|Lung Cancer|lung cancer
1569835|NCT00501319|Questionnaire|questionnaire
1569836|NCT00501319|Survey|survey
1569837|NCT00501319|NSCLC|nsclc
1569838|NCT00501319|IVR|ivr
1569839|NCT00501306|Condyloma Accuminata|condyloma accuminata
1569840|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
1569841|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
1569842|NCT00501306|Anal Cancer Screening|anal cancer screening
1569843|NCT00501280|Epidemiology|epidemiology
1569844|NCT00501280|Genetic Susceptibility|genetic susceptibility
1569845|NCT00501280|Migrant Farmworker Children|migrant farmworker children
1569846|NCT00501280|Migrant Education Program|migrant education program
1569847|NCT00501280|Interview|interview
1569848|NCT00501280|Questionnaire|questionnaire
1569849|NCT00501267|solabegron,|solabegron,
1569850|NCT00501267|oxybutynin,|oxybutynin,
1569851|NCT00501267|healthy adults,|healthy adults,
1569852|NCT00501267|drug interaction|drug interaction
1569853|NCT00501254|Slow release ASA|slow release asa
1569854|NCT00501254|Platelet functionalism|platelet functionalism
1569855|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
1569856|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
1569857|NCT00501228|Stem Cell Transplantation|stem cell transplantation
1569858|NCT00501228|Tissue Repair|tissue repair
1569859|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
1569860|NCT00501228|Filgrastim|filgrastim
1569861|NCT00501228|RhG-CSF|rhg-csf
1569862|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
1569863|NCT00501215|PHPT|phpt
1569864|NCT00501215|Parathyroidectomy|parathyroidectomy
1569865|NCT00501215|Polysomnogram|polysomnogram
1569866|NCT00501215|PSG|psg
1569867|NCT00501215|Sleep Quality|sleep quality
1569868|NCT00501215|Interview|interview
1569869|NCT00501202|diabetes mellitus|diabetes mellitus
1569870|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
1569871|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
1569872|NCT00501189|Gardasil|gardasil
1569873|NCT00501189|Human Papilloma Virus|human papilloma virus
1569874|NCT00501189|Papanicolaou Smear|papanicolaou smear
1569875|NCT00501189|ASCUS|ascus
1569876|NCT00501189|LGSIL|lgsil
1569877|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
1571367|NCT00496860|melanoma|melanoma
1569878|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
1569882|NCT00501176|Plastic|plastic
1569883|NCT00501176|stent|stent
1569884|NCT00501176|Whipple|whipple
1569885|NCT00501176|Jaundicie|jaundicie
1569886|NCT00501163|Schizophrenia|schizophrenia
1569887|NCT00501163|Cardiovascular|cardiovascular
1569888|NCT00501163|Risk|risk
1569889|NCT00501150|linezolid|linezolid
1569890|NCT00501150|vancomycin|vancomycin
1569891|NCT00501150|glycopeptides|glycopeptides
1569892|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
1569893|NCT00501150|resistant gram positive infections|resistant gram positive infections
1569895|NCT00501137|HPV vaccine|hpv vaccine
1569896|NCT00501137|Gardasil|gardasil
1569897|NCT00501137|Human Papillomavirus|human papillomavirus
1569898|NCT00501137|vaccine|vaccine
1569899|NCT00501137|2 dose versus 3|2 dose versus 3
1569900|NCT00501111|Dementia|dementia
1569901|NCT00501111|Alzheimer Type|alzheimer type
1569902|NCT00501111|Alzheimer Disease|alzheimer disease
1569903|NCT00501098|Leukemia|leukemia
1569904|NCT00501098|Prophylaxis|prophylaxis
1569905|NCT00501098|Fungal Infections|fungal infections
1569906|NCT00501098|Caspofungin|caspofungin
1569907|NCT00501072|hyperglycemia|hyperglycemia
1569908|NCT00501072|hypoglycemia|hypoglycemia
1569909|NCT00501072|glucose variability|glucose variability
1569910|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
1569911|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
1569912|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
1569913|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
1569914|NCT00501059|Aspirin|aspirin
1569915|NCT00501046|Kidney Diseases|kidney diseases
1569916|NCT00501033|Induction of labor|induction of labor
1569917|NCT00501033|Cesarean|cesarean
1569918|NCT00501033|Endometritis|endometritis
1569919|NCT00501033|Foley|foley
1569920|NCT00501033|Infections|infections
1569921|NCT00501020|Type 2 Diabetes|type 2 diabetes
1569922|NCT00501020|metformin|metformin
1569923|NCT00501020|rosiglitazone|rosiglitazone
1569924|NCT00500994|Conversion Disorder|conversion disorder
1569925|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
1569926|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
1569927|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1569928|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
1569929|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
1569930|NCT00500994|PMD|pmd
1569931|NCT00500994|NES|nes
1569932|NCT00500994|Healthy Volunteer|healthy volunteer
1569933|NCT00500994|HV|hv
1569934|NCT00500981|Fluid responsiveness|fluid responsiveness
1569935|NCT00500968|Pancreas|pancreas
1569936|NCT00500968|Leakage|leakage
1569937|NCT00500968|Fistula|fistula
1569938|NCT00500968|tail|tail
1569939|NCT00500955|microalbuminuria,|microalbuminuria,
1569940|NCT00500955|Type 2 Diabetes|type 2 diabetes
1569941|NCT00500955|rosiglitazone,|rosiglitazone,
1569942|NCT00500942|Interventional Radiology|interventional radiology
1569943|NCT00500942|Pain Quantification|pain quantification
1569944|NCT00500942|Pain Management|pain management
1569945|NCT00500942|Patient Satisfaction|patient satisfaction
1569946|NCT00500942|Questionnaire|questionnaire
1569947|NCT00500942|Survey|survey
1569948|NCT00500929|OHSP|ohsp
1569949|NCT00500929|High risk|high risk
1569950|NCT00500929|Geriatrics|geriatrics
1569951|NCT00500903|Advanced malignancies|advanced malignancies
1569952|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
1569953|NCT00500890|Carboplatin|carboplatin
1569954|NCT00500890|Cyclophosphamide|cyclophosphamide
1569955|NCT00500890|Etoposide|etoposide
1569956|NCT00500890|Vincristine|vincristine
1569957|NCT00500890|Paraplatin|paraplatin
1569958|NCT00500890|Cytoxan|cytoxan
1569959|NCT00500890|Neosar|neosar
1569960|NCT00500877|Smoking cessation|smoking cessation
1569961|NCT00500877|Phone Counseling|phone counseling
1569962|NCT00500864|COPD|copd
1569963|NCT00500864|Magnesium|magnesium
1569964|NCT00500864|Pulmonary function|pulmonary function
1569965|NCT00500864|Exercise Physiology|exercise physiology
1569966|NCT00500851|critical illness|critical illness
1569967|NCT00500851|enteral nutrition|enteral nutrition
1569968|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
1569969|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1569970|NCT00500838|Transthoracic Impedance|transthoracic impedance
1569971|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1569972|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
1569973|NCT00500825|resting energy expenditure|resting energy expenditure
1569974|NCT00500812|biologic drug|biologic drug
1569975|NCT00500812|transport sequence|transport sequence
1569976|NCT00500812|rho|rho
1569977|NCT00500812|spinal cord injury|spinal cord injury
1569978|NCT00500812|paralysis|paralysis
1569979|NCT00500812|paraplegia|paraplegia
1569980|NCT00500812|tetraplegia|tetraplegia
1569981|NCT00500812|quadraplegia|quadraplegia
1569982|NCT00500812|trauma|trauma
1569983|NCT00500812|nervous system|nervous system
1571467|NCT00496561|ECP|ecp
1569984|NCT00500812|fibrin sealant|fibrin sealant
1569985|NCT00500812|neurosurgery|neurosurgery
1569986|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1569987|NCT00500799|Blink Reflex|blink reflex
1569988|NCT00500799|Blepharospasm|blepharospasm
1569989|NCT00500799|Healthy Volunteer|healthy volunteer
1569990|NCT00500799|HV|hv
1569991|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
1569992|NCT00500773|inflammation|inflammation
1569993|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
1569994|NCT00500760|Head and Neck Cancer|head and neck cancer
1569995|NCT00500760|panitumumab|panitumumab
1569996|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
1569997|NCT00500734|Cardiomyopathy|cardiomyopathy
1569998|NCT00500734|Tissue Bank|tissue bank
1569999|NCT00500734|Heart Disease|heart disease
1570000|NCT00500734|Heart Failure|heart failure
1570001|NCT00500734|Congestive Heart Failure|congestive heart failure
1570002|NCT00500721|healthy subjects|healthy subjects
1570003|NCT00500708|Heart failure|heart failure
1570004|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
1570005|NCT00500708|Biological Markers|biological markers
1570006|NCT00500708|Molecular Genetics|molecular genetics
1570007|NCT00500708|Coronary Heart Disease|coronary heart disease
1570008|NCT00500708|Gene Expression|gene expression
1570009|NCT00500708|GES|ges
1570010|NCT00500708|CVD|cvd
1570011|NCT00500708|CHD|chd
1570012|NCT00500708|Precision Medicine|precision medicine
1570013|NCT00500708|Genome-wide association study|genome-wide association study
1570623|NCT00499343|Apheresis|apheresis
1570014|NCT00500708|Cardiovascular Disease|cardiovascular disease
1570015|NCT00500708|CAD|cad
1570016|NCT00500708|GWAS|gwas
1570017|NCT00500708|DISCERN|discern
1570018|NCT00500682|Kidney Diseases|kidney diseases
1570019|NCT00500669|Varicose veins|varicose veins
1570020|NCT00500669|wound infection|wound infection
1570021|NCT00500669|recurrence|recurrence
1570022|NCT00500617|Atherosclerosis|atherosclerosis
1570023|NCT00500617|Biological Markers|biological markers
1570024|NCT00500617|Molecular Genetics|molecular genetics
1570025|NCT00500617|Gene Expression|gene expression
1570026|NCT00500617|GES|ges
1570027|NCT00500617|CAD|cad
1570028|NCT00500617|CVD|cvd
1570029|NCT00500617|CHD|chd
1570030|NCT00500617|Clinical Validity|clinical validity
1570031|NCT00500617|Precision Medicine|precision medicine
1570032|NCT00500617|ASGES|asges
1570033|NCT00500617|CT Angiography|ct angiography
1570034|NCT00500617|Corus CAD|corus cad
1570035|NCT00500617|Coronary angiorgram|coronary angiorgram
1570036|NCT00500617|Age/Sex/Gene expression Score|age/sex/gene expression score
1570037|NCT00500617|Coronary Artery Disease|coronary artery disease
1570038|NCT00500617|Angina Pectoris|angina pectoris
1570039|NCT00500617|Chest Pain|chest pain
1570040|NCT00500617|Cardiovascular Disease|cardiovascular disease
1570041|NCT00500617|Coronary Heart Disease|coronary heart disease
1570042|NCT00500617|CTA|cta
1570043|NCT00500617|PREDICT|predict
1570044|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
1570045|NCT00500591|Endometrial Cancer|endometrial cancer
1570046|NCT00500591|Obesity|obesity
1570047|NCT00500591|Survey|survey
1570048|NCT00500591|Questionnaire|questionnaire
1570049|NCT00500578|Hematological Malignancies|hematological malignancies
1570050|NCT00500578|Respiratory Infection|respiratory infection
1570051|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
1570052|NCT00500578|RSV|rsv
1570053|NCT00500578|Ribavirin|ribavirin
1570054|NCT00500578|Virazole|virazole
1570055|NCT00500565|Breast Cancer|breast cancer
1570056|NCT00500565|On-Q Pain Relief System|on-q pain relief system
1570057|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
1570058|NCT00500565|Breast Reconstruction|breast reconstruction
1570059|NCT00500565|TRAM flap|tram flap
1570060|NCT00500565|Bupivicaine|bupivicaine
1570061|NCT00500565|Pain Management|pain management
1570062|NCT00500552|Perhexiline|perhexiline
1570063|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1570064|NCT00500539|Asthma|asthma
1570065|NCT00500539|omalizumab|omalizumab
1570066|NCT00500539|safety|safety
1570067|NCT00500539|allergic asthma|allergic asthma
1570068|NCT00500539|adolescents|adolescents
1570069|NCT00500526|COPD|copd
1570070|NCT00500526|Pulmonary function|pulmonary function
1570071|NCT00500526|Respiratory muscle|respiratory muscle
1570072|NCT00500526|Dyspnea|dyspnea
1570073|NCT00500526|Quality of life|quality of life
1570074|NCT00500513|Lung Cancer|lung cancer
1570075|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
1570076|NCT00500513|Tumor Motion|tumor motion
1570077|NCT00500513|Pulmonary Function|pulmonary function
1570078|NCT00500513|Fiducial Marker|fiducial marker
1570079|NCT00500487|HIV prevention|hiv prevention
1570080|NCT00500487|HIV seronegativity|hiv seronegativity
1570081|NCT00500474|Meniere's disease|meniere's disease
1570082|NCT00500474|inner ear|inner ear
1570083|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
1570084|NCT00500474|steroids|steroids
1570085|NCT00500474|declined surgery|declined surgery
1571468|NCT00496561|PC20M|pc20m
1570086|NCT00500474|natural course|natural course
1570087|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
1570088|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
1570089|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
1570090|NCT00500461|intravenous infusion,|intravenous infusion,
1570091|NCT00500461|pharmacokinetics|pharmacokinetics
1570092|NCT00500461|healthy subjects,|healthy subjects,
1570093|NCT00500461|safety,|safety,
1570094|NCT00500461|tolerability,|tolerability,
1570095|NCT00500461|Anticholinergic,|anticholinergic,
1570096|NCT00500461|oral dosing,|oral dosing,
1570097|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
1570098|NCT00500435|Cervical Cancer|cervical cancer
1570099|NCT00500435|Laparoscopy|laparoscopy
1570100|NCT00500435|Lymph Node Dissection|lymph node dissection
1570101|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
1570102|NCT00500422|Solid Tumors|solid tumors
1570103|NCT00500422|Doxil|doxil
1570104|NCT00500422|Adriamycin|adriamycin
1570105|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1570106|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
1570107|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1570108|NCT00500422|Gemcitabine|gemcitabine
1570109|NCT00500422|Gemzar|gemzar
1570110|NCT00500422|Bortezomib|bortezomib
1570111|NCT00500422|Velcade|velcade
1570112|NCT00500422|PS341|ps341
1570113|NCT00500422|PS-341|ps-341
1570114|NCT00500422|LDP-341|ldp-341
1570115|NCT00500422|MLN341|mln341
1570116|NCT00500409|rhPTH(1-34)|rhpth(1-34)
1570117|NCT00500409|Osteoporosis|osteoporosis
1570118|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
1570119|NCT00500396|ROP.|rop.
1570120|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
1570121|NCT00500396|VEGF.|vegf.
1570122|NCT00500396|Vitreous.|vitreous.
1570123|NCT00500396|Subretinal Fluid.|subretinal fluid.
1570124|NCT00500396|ELISA.|elisa.
1570125|NCT00500383|Breast Cancer Risk|breast cancer risk
1570126|NCT00500383|BRCA1|brca1
1570127|NCT00500383|BRCA2|brca2
1570128|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
1570129|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1570130|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
1570131|NCT00500370|exenatide|exenatide
1570132|NCT00500370|obesity|obesity
1570133|NCT00500370|diabetes|diabetes
1570134|NCT00500370|Amylin|amylin
1570135|NCT00500370|Lilly|lilly
1570136|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
1570137|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
1570138|NCT00500344|Electroretinography|electroretinography
1570139|NCT00500344|Retinal Function|retinal function
1570140|NCT00500331|Pioglitazone|pioglitazone
1570141|NCT00500331|HbA1c|hba1c
1570142|NCT00500331|Diabetes mellitus|diabetes mellitus
1570143|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
1570144|NCT00500305|indomethacin therapy|indomethacin therapy
1570145|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
1570146|NCT00500292|colorectal|colorectal
1570147|NCT00500292|cancer|cancer
1570148|NCT00500292|zactima|zactima
1570149|NCT00500279|Drug-eluting stent|drug-eluting stent
1570150|NCT00500279|Restenosis|restenosis
1570151|NCT00500279|Celecoxib|celecoxib
1570152|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
1570153|NCT00500253|asthma|asthma
1570154|NCT00500253|children|children
1570155|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
1570156|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1570157|NCT00500240|Leukemia|leukemia
1570158|NCT00500240|Lymphoma|lymphoma
1570159|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
1570160|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
1570161|NCT00500240|Blood Sugar|blood sugar
1570162|NCT00500240|Hyperglycemia|hyperglycemia
1570163|NCT00500240|Insulin Aspart|insulin aspart
1570164|NCT00500240|Insulin Glargine|insulin glargine
1570165|NCT00500240|Hyper-CVAD|hyper-cvad
1570166|NCT00500214|inguinal hernia|inguinal hernia
1570167|NCT00500214|herniorrhaphy|herniorrhaphy
1570168|NCT00500214|mesh repair|mesh repair
1570169|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
1570170|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
1570171|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
1570172|NCT00500201|Healthy Volunteer|healthy volunteer
1570173|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1570174|NCT00500188|GIST|gist
1570175|NCT00500188|Kit expression|kit expression
1570176|NCT00500188|Resectable|resectable
1570177|NCT00500188|Imatinib Mesylate|imatinib mesylate
1570178|NCT00500188|Gleevec|gleevec
1570179|NCT00500188|STI-571|sti-571
1570180|NCT00500188|Imatinib|imatinib
1570181|NCT00500188|NSC-716051|nsc-716051
1570182|NCT00500175|diabetes|diabetes
1570183|NCT00500175|ulceration|ulceration
1570184|NCT00500175|amputation|amputation
1570185|NCT00500175|pressure sores|pressure sores
1570186|NCT00500175|shear friction|shear friction
1570187|NCT00500136|bias|bias
1570188|NCT00500123|alpha-1|alpha-1
1570189|NCT00500123|antitrypsin|antitrypsin
1570191|NCT00500123|genetic testing|genetic testing
1570192|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
1570193|NCT00500123|AATD|aatd
1570194|NCT00500110|Prostate Cancer|prostate cancer
1570195|NCT00500110|Hormonal Ablation|hormonal ablation
1570196|NCT00500110|Docetaxel|docetaxel
1570197|NCT00500110|Imatinib Mesylate|imatinib mesylate
1570198|NCT00500110|STI571|sti571
1570199|NCT00500110|Gleevec|gleevec
1570200|NCT00500110|Taxotere|taxotere
1570201|NCT00500110|Goserelin Acetate|goserelin acetate
1570202|NCT00500110|Zoladex|zoladex
1570203|NCT00500110|Leuprolide|leuprolide
1570204|NCT00500110|Lupron|lupron
1570205|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
1570206|NCT00500084|Pancreatectomy|pancreatectomy
1570207|NCT00500058|Rituximab,|rituximab,
1570208|NCT00500058|oncology|oncology
1570209|NCT00500058|IL-18,|il-18,
1570210|NCT00500058|combination study,|combination study,
1570211|NCT00500058|cytokine,|cytokine,
1570212|NCT00500045|CRVO|crvo
1570213|NCT00500045|HRVO|hrvo
1570214|NCT00500045|BRVO|brvo
1570215|NCT00500032|Adult|adult
1570216|NCT00499980|Breast cancer|breast cancer
1570217|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1570218|NCT00499980|Oximetry|oximetry
1570219|NCT00499967|genital warts|genital warts
1570220|NCT00499967|venereal warts|venereal warts
1570221|NCT00499967|human papilloma virus|human papilloma virus
1570222|NCT00499954|microdialysis|microdialysis
1570223|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
1570224|NCT00499954|glucose sensor|glucose sensor
1570225|NCT00499954|glucose monitoring|glucose monitoring
1570226|NCT00499954|type 1 diabetes|type 1 diabetes
1570227|NCT00499954|Guardian RT|guardian rt
1570228|NCT00499954|Glucoday S|glucoday s
1570229|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
1570230|NCT00499928|SB-751689|sb-751689
1570231|NCT00499928|osteoporosis|osteoporosis
1570232|NCT00499928|metabolism|metabolism
1570233|NCT00499928|excretion|excretion
1570235|NCT00499902|acute ischemic stroke|acute ischemic stroke
1570236|NCT00499902|stroke|stroke
1570237|NCT00499902|alfimeprase|alfimeprase
1570238|NCT00499902|blood clot|blood clot
1570239|NCT00499902|brain|brain
1570240|NCT00499902|thrombus|thrombus
1570241|NCT00499902|thrombolytic|thrombolytic
1570242|NCT00499902|thrombosis|thrombosis
1570243|NCT00499902|plasminogen activator|plasminogen activator
1570244|NCT00499902|arterial flow|arterial flow
1570245|NCT00499902|neurology|neurology
1570246|NCT00499902|intra-arterial|intra-arterial
1570247|NCT00499902|intra-thrombus|intra-thrombus
1570248|NCT00499902|catheter-directed|catheter-directed
1570249|NCT00499902|symptomatic ICH|symptomatic ich
1570250|NCT00499902|ICH|ich
1570251|NCT00499902|AOL|aol
1570252|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
1570253|NCT00499902|recanalization|recanalization
1570254|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1570255|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1570256|NCT00499889|Leukemia|leukemia
1570257|NCT00499889|Imatinib Mesylate|imatinib mesylate
1570258|NCT00499889|Gleevec|gleevec
1570259|NCT00499889|Busulfan|busulfan
1570260|NCT00499889|Busulfex|busulfex
1570261|NCT00499889|Myleran|myleran
1570262|NCT00499889|Fludarabine|fludarabine
1570263|NCT00499889|ATG|atg
1570264|NCT00499889|STI571|sti571
1570265|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
1570266|NCT00499889|Thymoglobulin|thymoglobulin
1570267|NCT00499876|Human immune deficiency virus|human immune deficiency virus
1570268|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
1570269|NCT00499876|malaria|malaria
1570270|NCT00499876|mefloquine|mefloquine
1570271|NCT00499876|prophylaxis|prophylaxis
1570272|NCT00499876|HIV/AIDS|hiv/aids
1570273|NCT00499876|Treatment Naive|treatment naive
1570274|NCT00499850|ZD6474|zd6474
1570275|NCT00499850|FOLFOX|folfox
1570276|NCT00499850|colorectal|colorectal
1570277|NCT00499850|adenocarcinoma|adenocarcinoma
1570278|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1570279|NCT00500266|vaccine|vaccine
1570280|NCT00499824|Diabetes|diabetes
1570281|NCT00499824|Management guidelines|management guidelines
1570282|NCT00499824|Efficacy|efficacy
1570283|NCT00499798|infertility|infertility
1570284|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1570285|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1570286|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
1570287|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
1570288|NCT00499798|adult gliosarcoma|adult gliosarcoma
1570289|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1570290|NCT00499798|adult brain stem glioma|adult brain stem glioma
1570291|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1570292|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
1570293|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
1570294|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
1570295|NCT00499798|adult medulloblastoma|adult medulloblastoma
1570296|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1570297|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
1570298|NCT00499798|adult ependymoma|adult ependymoma
1570299|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1570300|NCT00499798|adult subependymoma|adult subependymoma
1570301|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
1570302|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
1570303|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1570304|NCT00499798|adult papillary meningioma|adult papillary meningioma
1570305|NCT00499798|adult grade I meningioma|adult grade i meningioma
1570306|NCT00499798|adult grade II meningioma|adult grade ii meningioma
1570307|NCT00499798|adult grade III meningioma|adult grade iii meningioma
1570308|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1570309|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
1570310|NCT00499798|adult pineoblastoma|adult pineoblastoma
1570311|NCT00499798|adult pineocytoma|adult pineocytoma
1570312|NCT00499798|adult mixed glioma|adult mixed glioma
1570313|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
1570314|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1570315|NCT00499785|depression|depression
1570316|NCT00499785|cognitive/functional effects|cognitive/functional effects
1570317|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1570318|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1570319|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1570320|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1570321|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1570322|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1570323|NCT00499759|fatigue|fatigue
1570324|NCT00499759|depression|depression
1570325|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1570326|NCT00499759|musculoskeletal complications|musculoskeletal complications
1570327|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
1570328|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1570329|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1570330|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1570331|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1570332|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1570333|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1570334|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1570335|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1570336|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1570337|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1570338|NCT00499746|drug discrimination|drug discrimination
1570339|NCT00499746|opioid pharmacology|opioid pharmacology
1570340|NCT00499746|behavioral pharmacology|behavioral pharmacology
1570341|NCT00499746|human research|human research
1570342|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
1570343|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1570344|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1570345|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1570346|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1570347|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1570348|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1570349|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
1570350|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
1570351|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
1570352|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
1570353|NCT00499733|stage III prostate cancer|stage iii prostate cancer
1570354|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
1570355|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
1570356|NCT00499733|male breast cancer|male breast cancer
1570357|NCT00499733|recurrent breast cancer|recurrent breast cancer
1570358|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
1570359|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
1570360|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
1570361|NCT00499733|stage IV breast cancer|stage iv breast cancer
1570362|NCT00499733|chondrosarcoma|chondrosarcoma
1570363|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
1570364|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
1570365|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1570366|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1570367|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1570368|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1570369|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1570370|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1570371|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1570372|NCT00499733|ovarian sarcoma|ovarian sarcoma
1570373|NCT00499733|stage III uterine sarcoma|stage iii uterine sarcoma
1570374|NCT00499733|stage IV uterine sarcoma|stage iv uterine sarcoma
1570375|NCT00499733|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1570376|NCT00499733|classic Kaposi sarcoma|classic kaposi sarcoma
1570377|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1570378|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1570379|NCT00499733|stage III colon cancer|stage iii colon cancer
1570380|NCT00499733|stage IV colon cancer|stage iv colon cancer
1570381|NCT00499733|recurrent colon cancer|recurrent colon cancer
1570382|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1570383|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1570384|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
1570385|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
1570386|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
1570387|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
1570388|NCT00499733|localized osteosarcoma|localized osteosarcoma
1570389|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
1570390|NCT00499733|stage IV melanoma|stage iv melanoma
1570391|NCT00499733|recurrent melanoma|recurrent melanoma
1570392|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1570393|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1570394|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1570395|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1570396|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1570397|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1570398|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1570399|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1570400|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1570401|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1570402|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1570403|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1570404|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1570405|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1570406|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1570407|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1570408|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1570409|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1570410|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1570411|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1570412|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1570413|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1570414|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1570415|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1570416|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1570417|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1570418|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1570419|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1570420|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1570421|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1570422|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1570423|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1570424|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1570425|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1570426|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1570427|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1570428|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1570429|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1570430|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1570431|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1570432|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1570433|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1570434|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
1570435|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
1570436|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
1570437|NCT00499733|intraocular lymphoma|intraocular lymphoma
1570438|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1570439|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
1570440|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
1570441|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1570442|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
1570443|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1570444|NCT00499733|conjunctival melanoma|conjunctival melanoma
1570445|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
1570446|NCT00499733|stage IIIA melanoma|stage iiia melanoma
1570447|NCT00499733|stage IIIB melanoma|stage iiib melanoma
1570448|NCT00499733|stage IIIC melanoma|stage iiic melanoma
1570449|NCT00499733|tongue cancer|tongue cancer
1570450|NCT00499720|Cystic Fibrosis|cystic fibrosis
1570451|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
1570452|NCT00499720|airway infection|airway infection
1570453|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
1570454|NCT00499707|HbA1c|hba1c
1570455|NCT00499707|Drug-naive|drug-naive
1570456|NCT00499707|type 2 diabetes|type 2 diabetes
1570457|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
1570458|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
1570459|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1570460|NCT00499681|stage I breast cancer|stage i breast cancer
1570461|NCT00499681|stage II breast cancer|stage ii breast cancer
1570462|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
1570463|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
1570464|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1570465|NCT00499668|nausea and vomiting|nausea and vomiting
1570466|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
1570467|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1570468|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1570469|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1570470|NCT00499668|essential thrombocythemia|essential thrombocythemia
1570471|NCT00499668|polycythemia vera|polycythemia vera
1570472|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1570473|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
1570474|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
1570475|NCT00499668|mast cell leukemia|mast cell leukemia
1570476|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
1570477|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1570478|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1570479|NCT00499668|hairy cell leukemia|hairy cell leukemia
1570480|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
1570481|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
1570482|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
1570483|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1570484|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1570485|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1570486|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
1570487|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
1570488|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1570489|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1570490|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1570491|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
1570492|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
1570493|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
1570494|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
1570495|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
1570496|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
1570497|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
1570498|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
1570499|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
1570500|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
1570501|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
1570847|NCT00498836|Cancer|cancer
1570502|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1570503|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1570504|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1570505|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
1570506|NCT00499668|intraocular lymphoma|intraocular lymphoma
1570507|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
1570508|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1570509|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
1570510|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
1570511|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1570512|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1570513|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1570514|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
1570515|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
1570516|NCT00499642|Healthy Subjects|healthy subjects
1570517|NCT00499629|healthy subjects|healthy subjects
1570518|NCT00499616|regional neuroblastoma|regional neuroblastoma
1570519|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
1570520|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
1570521|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1570522|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
1570523|NCT00499603|Breast Cancer|breast cancer
1570524|NCT00499603|ER negative|er negative
1570525|NCT00499603|PR negative|pr negative
1570526|NCT00499603|HER2neu negative|her2neu negative
1570527|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
1570528|NCT00499603|Paclitaxel|paclitaxel
1570529|NCT00499603|Taxol|taxol
1570530|NCT00499603|RAD001|rad001
1570531|NCT00499603|FEC|fec
1570532|NCT00499603|5-Fluorouracil|5-fluorouracil
1570533|NCT00499603|5-FU|5-fu
1570534|NCT00499603|Adrucil|adrucil
1570535|NCT00499603|Efudex|efudex
1570536|NCT00499603|Epirubicin|epirubicin
1570537|NCT00499603|Cyclophosphamide|cyclophosphamide
1570538|NCT00499590|AMD|amd
1570539|NCT00499590|Macular Degeneration|macular degeneration
1570540|NCT00499590|bevasiranib|bevasiranib
1570541|NCT00499590|COBALT study|cobalt study
1570542|NCT00499590|age related macular degeneration|age related macular degeneration
1570543|NCT00499590|wet AMD|wet amd
1570544|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
1570545|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
1570546|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
1570547|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
1570548|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
1570549|NCT00499551|Anterior Uveitis|anterior uveitis
1570550|NCT00499551|Posterior Uveitis|posterior uveitis
1570551|NCT00499551|Intermediate Uveitis|intermediate uveitis
1570552|NCT00499551|Panuveitis|panuveitis
1570553|NCT00499551|Iontophoresis|iontophoresis
1570554|NCT00499551|Dexamethasone|dexamethasone
1570555|NCT00499538|healthy subjects|healthy subjects
1570556|NCT00499525|male breast cancer|male breast cancer
1570557|NCT00499525|recurrent breast cancer|recurrent breast cancer
1570558|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
1570559|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
1570560|NCT00499525|stage IV breast cancer|stage iv breast cancer
1570561|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
1570562|NCT00499512|Ovarian Cancer|ovarian cancer
1570563|NCT00499512|Peritoneal Cancer|peritoneal cancer
1570564|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
1570565|NCT00499512|Spirituality|spirituality
1570566|NCT00499512|Religion|religion
1570567|NCT00499512|Quality of Life|quality of life
1570568|NCT00499512|Questionnaire|questionnaire
1570570|NCT00499499|Cancer|cancer
1570571|NCT00499499|solid tumors|solid tumors
1570572|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
1570573|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
1570574|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
1570575|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1570576|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
1570577|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1570578|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
1570579|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1570580|NCT00499447|large cell lung cancer|large cell lung cancer
1570581|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
1570582|NCT00499434|aids|aids
1570583|NCT00499421|Prostate Cancer|prostate cancer
1570584|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
1570585|NCT00499421|Fiducial Markers|fiducial markers
1570586|NCT00499421|Acculoc System|acculoc system
1570587|NCT00499421|Center Of Mass|center of mass
1570588|NCT00499421|EBRT|ebrt
1570589|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1570590|NCT00499408|stage I prostate cancer|stage i prostate cancer
1570848|NCT00498836|Metastatic|metastatic
1570591|NCT00499408|stage II prostate cancer|stage ii prostate cancer
1570592|NCT00499408|stage III prostate cancer|stage iii prostate cancer
1570593|NCT00499395|stage IV colon cancer|stage iv colon cancer
1570594|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
1570595|NCT00499395|recurrent colon cancer|recurrent colon cancer
1570596|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
1570597|NCT00499395|liver metastases|liver metastases
1570598|NCT00499382|Advanced Cancers|advanced cancers
1570599|NCT00499382|Cardiac Function|cardiac function
1570600|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
1570601|NCT00499382|Positron Emission Tomography|positron emission tomography
1570602|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
1570603|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
1570604|NCT00499382|PET/CT|pet/ct
1570605|NCT00499382|RNV|rnv
1570606|NCT00499356|friction|friction
1570607|NCT00499356|pressure|pressure
1570608|NCT00499356|insole|insole
1570609|NCT00499356|ulcer|ulcer
1570610|NCT00499356|prevention|prevention
1570611|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1570612|NCT00499343|Lymphoma|lymphoma
1570613|NCT00499343|Etoposide|etoposide
1570614|NCT00499343|G-CSF|g-csf
1570615|NCT00499343|GM-CSF|gm-csf
1570616|NCT00499343|Isophosphamide|isophosphamide
1570617|NCT00499343|Rituximab|rituximab
1570618|NCT00499343|Ifosfamide|ifosfamide
1570619|NCT00499343|Sargramostim|sargramostim
1570620|NCT00499343|Leukine|leukine
1570621|NCT00499343|Filgrastim|filgrastim
1570624|NCT00499343|Stem Cell Collection|stem cell collection
1570625|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1570626|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
1570627|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
1570628|NCT00499330|large cell lung cancer|large cell lung cancer
1570629|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1570630|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1570631|NCT00499317|Urgency|urgency
1570632|NCT00499317|Frequency|frequency
1570633|NCT00499317|Pelvic pain|pelvic pain
1570634|NCT00499317|Sexual dysfunction|sexual dysfunction
1570635|NCT00499317|Erectile dysfunction|erectile dysfunction
1570636|NCT00499317|Painful intercourse|painful intercourse
1570637|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
1570638|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
1570639|NCT00499304|Breathing artifacts|breathing artifacts
1570640|NCT00499304|COPD|copd
1570641|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1570642|NCT00499291|recurrent breast cancer|recurrent breast cancer
1570643|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
1570644|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
1570645|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
1570646|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
1570647|NCT00499291|stage III prostate cancer|stage iii prostate cancer
1570648|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
1570649|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1570650|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1570651|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1570652|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1570653|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1570654|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
1570655|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
1570656|NCT00499291|stage III bladder cancer|stage iii bladder cancer
1570657|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
1570658|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
1570659|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
1570660|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
1570661|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1570662|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1570663|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1570664|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1570665|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
1570666|NCT00499291|stage III cervical cancer|stage iii cervical cancer
1570667|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
1570668|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
1570669|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1570670|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
1570671|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1570672|NCT00499291|fallopian tube cancer|fallopian tube cancer
1570673|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1570674|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1570675|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1570676|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1570677|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1570678|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1570679|NCT00499291|ovarian sarcoma|ovarian sarcoma
1570680|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
1570681|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
1570682|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
1570683|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
1570684|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1570685|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1570686|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1570687|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
1570688|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
1570689|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
1570690|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1570691|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1570692|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1570693|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1570694|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1570695|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1570696|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1570697|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1570698|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1570699|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1570700|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1570701|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1570702|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1570703|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1570704|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
1570705|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
1570706|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
1570707|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
1570708|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
1570709|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
1570710|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
1570711|NCT00499291|stage III gastric cancer|stage iii gastric cancer
1570712|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
1570713|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1570714|NCT00499291|adult teratoma|adult teratoma
1570715|NCT00499291|ovarian teratoma|ovarian teratoma
1570716|NCT00499291|testicular teratoma|testicular teratoma
1570717|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1570718|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1570719|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1570720|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1570721|NCT00499278|Osteoarthritis|osteoarthritis
1570722|NCT00499278|joint|joint
1570723|NCT00499278|knee|knee
1570725|NCT00499278|surgery|surgery
1570726|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
1570727|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
1570728|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1570729|NCT00499239|Hematologic Malignancies|hematologic malignancies
1570731|NCT00499239|NHL|nhl
1570732|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1570733|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1570734|NCT00499239|CLL and NHL|cll and nhl
1570735|NCT00499239|Multiple Myeloma|multiple myeloma
1570736|NCT00499239|MM|mm
1570737|NCT00499187|Fanconi|fanconi
1570738|NCT00499187|Kidney|kidney
1570739|NCT00499187|Renal|renal
1570740|NCT00499187|HIV|hiv
1570741|NCT00499187|HIV-1|hiv-1
1570742|NCT00499187|Treatment Experienced|treatment experienced
1570743|NCT00499174|stage II prostate cancer|stage ii prostate cancer
1570744|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1570745|NCT00499161|Individualized care|individualized care
1570746|NCT00499161|Relationship based care|relationship based care
1570747|NCT00499161|Negotiated care|negotiated care
1570748|NCT00499161|Patient focused care|patient focused care
1570749|NCT00499122|stage II breast cancer|stage ii breast cancer
1570750|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
1570751|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
1570752|NCT00499109|RRM1|rrm1
1570753|NCT00499109|ERCC1|ercc1
1570754|NCT00499109|Customized Chemotherapy|customized chemotherapy
1570755|NCT00499096|Chronic Illness|chronic illness
1570756|NCT00499096|Disease management|disease management
1570757|NCT00499096|Health Behaviors|health behaviors
1570758|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
1570759|NCT00499083|stage II breast cancer|stage ii breast cancer
1570760|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
1570761|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
1571570|NCT00496132|CLL|cll
1570762|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
1570763|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1570764|NCT00499070|aplastic anemia|aplastic anemia
1570765|NCT00499070|Fanconi anemia|fanconi anemia
1570766|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
1570767|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
1570768|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
1570769|NCT00499057|early stage breast cancer|early stage breast cancer
1570770|NCT00499044|cognition|cognition
1570771|NCT00499044|attention|attention
1570772|NCT00499044|memory|memory
1570773|NCT00499044|concentration|concentration
1570774|NCT00499044|schizophrenia|schizophrenia
1570775|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
1570776|NCT00499018|Rituximab|rituximab
1570777|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1570778|NCT00498992|dermatologic complications|dermatologic complications
1570779|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1570780|NCT00498979|stage IV melanoma|stage iv melanoma
1570781|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1570782|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
1570783|NCT00498979|adult glioblastoma|adult glioblastoma
1570784|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
1570785|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1570786|NCT00498979|adult brain stem glioma|adult brain stem glioma
1570787|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
1570788|NCT00498979|adult ependymoma|adult ependymoma
1570789|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1570790|NCT00498979|adult subependymoma|adult subependymoma
1570791|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1570792|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
1570793|NCT00498979|mixed gliomas|mixed gliomas
1570794|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
1570795|NCT00498979|recurrent melanoma|recurrent melanoma
1570796|NCT00498979|adult gliosarcoma|adult gliosarcoma
1570797|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1570798|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1570799|NCT00498966|Kidney|kidney
1570800|NCT00498966|perifosine|perifosine
1570801|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
1570802|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1570803|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1570804|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1570805|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1570806|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1570807|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
1570808|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
1570809|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
1570810|NCT00498927|adult glioblastoma|adult glioblastoma
1570811|NCT00498927|adult gliosarcoma|adult gliosarcoma
1570812|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1570813|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
1570814|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1570815|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1570816|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
1570817|NCT00498927|adult ependymoma|adult ependymoma
1570818|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1570819|NCT00498927|adult subependymoma|adult subependymoma
1570820|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1570821|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
1570822|NCT00498927|adult brain stem glioma|adult brain stem glioma
1570823|NCT00498927|adult mixed glioma|adult mixed glioma
1570824|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1570825|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
1570826|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
1570827|NCT00498914|YM155|ym155
1570828|NCT00498914|Treatment outcomes|treatment outcomes
1570829|NCT00498914|Refractory|refractory
1570830|NCT00498901|stage IV breast cancer|stage iv breast cancer
1570831|NCT00498901|recurrent breast cancer|recurrent breast cancer
1570832|NCT00498888|urge urinary incontinence|urge urinary incontinence
1570833|NCT00498888|rehabilitation|rehabilitation
1570834|NCT00498888|anticholinergic|anticholinergic
1570835|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
1570836|NCT00498875|Head and Neck Cancer|head and neck cancer
1570837|NCT00498875|Depression|depression
1570838|NCT00498875|Questionnaire|questionnaire
1570839|NCT00498875|Survey|survey
1570840|NCT00498875|Interview|interview
1570841|NCT00498849|Sleep apnea|sleep apnea
1570842|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
1570843|NCT00498849|Microarray|microarray
1570844|NCT00498849|Polysomnography|polysomnography
1570845|NCT00498836|CP-4055|cp-4055
1570846|NCT00498836|Elacyt|elacyt
1570849|NCT00498836|Malignant melanoma|malignant melanoma
1570850|NCT00498836|Combination treatment|combination treatment
1570851|NCT00498836|Sorafenib|sorafenib
1570852|NCT00498836|Nexavar|nexavar
1570853|NCT00498797|prostate cancer|prostate cancer
1570854|NCT00498797|zactima|zactima
1570855|NCT00498797|vandetanib|vandetanib
1570856|NCT00498797|metastatic|metastatic
1570857|NCT00498784|Intra-uterine contraception|intra-uterine contraception
1570858|NCT00498784|Intrauterine Devices|intrauterine devices
1570859|NCT00498771|Lymphedema|lymphedema
1570860|NCT00498771|Aquatic Exercise|aquatic exercise
1570861|NCT00498771|Breast Cancer|breast cancer
1570862|NCT00498758|Parkinson's disease|parkinson's disease
1570863|NCT00498758|Gait Disturbances|gait disturbances
1570864|NCT00498758|Mobility|mobility
1570865|NCT00498758|Quality of life|quality of life
1570866|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
1570867|NCT00498719|Leukemia|leukemia
1570868|NCT00498719|Lymphoma|lymphoma
1570869|NCT00498719|Brain Tumor|brain tumor
1570870|NCT00498719|Attention Deficit|attention deficit
1570871|NCT00498719|Cognitive Training Program|cognitive training program
1570872|NCT00498719|Central Nervous System|central nervous system
1570874|NCT00498719|CTP|ctp
1570875|NCT00498706|Depressive Disorder, Major|depressive disorder, major
1570876|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
1570877|NCT00498706|Psychotherapy|psychotherapy
1570878|NCT00498706|Telemedicine|telemedicine
1570879|NCT00498706|Primary Care|primary care
1570880|NCT00498680|Erectile Dysfunction|erectile dysfunction
1570881|NCT00498680|Treatment|treatment
1570884|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
1570885|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
1570886|NCT00498641|perceptual learning|perceptual learning
1570887|NCT00498641|occlusion therapy|occlusion therapy
1570888|NCT00498628|Alcoholism|alcoholism
1570889|NCT00498628|Alcohol dependence|alcohol dependence
1570890|NCT00498628|Quetiapine|quetiapine
1570891|NCT00498615|scleroderma|scleroderma
1570892|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
1570893|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
1570894|NCT00498576|hypertension|hypertension
1570895|NCT00498576|kidney transplant|kidney transplant
1570896|NCT00498576|melatonin|melatonin
1570897|NCT00498576|adiponectin|adiponectin
1570898|NCT00498563|high altitude|high altitude
1570899|NCT00498563|sleep|sleep
1570900|NCT00498563|altitude illness|altitude illness
1570901|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
1570902|NCT00498563|psychomotor performance|psychomotor performance
1570903|NCT00498563|mood states|mood states
1570904|NCT00498550|Clozapine|clozapine
1570905|NCT00498550|Schizophrenia|schizophrenia
1570906|NCT00498550|Dual Diagnosis|dual diagnosis
1570907|NCT00498550|Substance Abuse|substance abuse
1570908|NCT00498550|Cannabis Abuse|cannabis abuse
1570909|NCT00498537|spironolactone|spironolactone
1570910|NCT00498537|aldosterone|aldosterone
1570911|NCT00498537|diabetic nephropathy|diabetic nephropathy
1570912|NCT00498537|proteinuria|proteinuria
1570913|NCT00498537|hyperkalemia|hyperkalemia
1570914|NCT00498537|albuminuria|albuminuria
1570915|NCT00498537|renal failure|renal failure
1570916|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1570917|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
1570918|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
1570919|NCT00498524|sibling concordance|sibling concordance
1570920|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
1570921|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
1570922|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
1570923|NCT00498498|severe head injury|severe head injury
1570924|NCT00498498|Endothelin|endothelin
1570926|NCT00498498|Plasma|plasma
1570927|NCT00498498|Cellular Apoptosis|cellular apoptosis
1570928|NCT00498485|chronic|chronic
1570929|NCT00498485|fatigue|fatigue
1570930|NCT00498485|pain|pain
1570931|NCT00498485|sleep|sleep
1570932|NCT00498485|xyrem|xyrem
1570933|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
1570934|NCT00498485|no hypertension|no hypertension
1570935|NCT00498485|no sleep apnea|no sleep apnea
1570936|NCT00498472|BNP|bnp
1570937|NCT00498472|heart failure|heart failure
1570938|NCT00498459|Physical activity|physical activity
1570939|NCT00498459|Randomised trial|randomised trial
1570940|NCT00498459|Prevention|prevention
1570941|NCT00498459|Adolescents|adolescents
1570942|NCT00498459|Obesity|obesity
1570943|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
1570944|NCT00498433|Aliskiren|aliskiren
1570945|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
1570946|NCT00498433|Hypertension|hypertension
1570947|NCT00498433|Abdominal obesity|abdominal obesity
1570948|NCT00498420|HUE-MAN|hue-man
1570949|NCT00498420|Rare disorder|rare disorder
1570950|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
1570951|NCT00498420|Dysostosis|dysostosis
1570952|NCT00498407|CP-4055|cp-4055
1570953|NCT00498407|ELACYT(TM)|elacyt(tm)
1570955|NCT00498407|Colorectal cancer|colorectal cancer
1570956|NCT00498407|CRC|crc
1570957|NCT00498407|Second line therapy|second line therapy
1570958|NCT00498394|Obesity|obesity
1570959|NCT00498394|Weight loss|weight loss
1570960|NCT00498394|Diet fads|diet fads
1570961|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
1570962|NCT00498368|Proteinuria|proteinuria
1570963|NCT00498368|Renal Fibrosis|renal fibrosis
1570964|NCT00498355|uveitis|uveitis
1570965|NCT00498355|cytoid macular edema|cytoid macular edema
1570966|NCT00498355|steroid|steroid
1570967|NCT00498355|Lucentis|lucentis
1570968|NCT00498329|fMRI|fmri
1570969|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
1570970|NCT00498329|Attention|attention
1570971|NCT00498329|Sensorimotor Integration|sensorimotor integration
1570972|NCT00498329|Human Brain|human brain
1570973|NCT00498329|Healthy Volunteer|healthy volunteer
1570974|NCT00498329|HV|hv
1570975|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
1570976|NCT00498316|Leukemia|leukemia
1570977|NCT00498316|Cord Blood Expansion|cord blood expansion
1570978|NCT00498316|Umbilical Cord Blood|umbilical cord blood
1570979|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
1570980|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
1570981|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1570982|NCT00498316|ALL|all
1570983|NCT00498316|AML|aml
1570984|NCT00498316|MDS|mds
1570985|NCT00498303|influenza vaccine|influenza vaccine
1570986|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
1570987|NCT00498290|Colorectal Surgery|colorectal surgery
1570988|NCT00498277|Osteoporosis|osteoporosis
1570989|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
1570990|NCT00498277|Vertebral Fractures|vertebral fractures
1570991|NCT00498277|Quantitative Diffusion|quantitative diffusion
1570992|NCT00498277|Fat Imaging|fat imaging
1570993|NCT00498277|Spine|spine
1570994|NCT00498264|Exercise|exercise
1570995|NCT00498264|Rehabilitation|rehabilitation
1570996|NCT00498264|Strength exercise|strength exercise
1570997|NCT00498264|Aerobic exercise|aerobic exercise
1570998|NCT00498264|Pain|pain
1570999|NCT00498251|lung injury, acute|lung injury, acute
1571000|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
1571001|NCT00498251|lung cancer|lung cancer
1571002|NCT00498251|salbutamol|salbutamol
1571003|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
1571004|NCT00498225|Pancreatic Cancer|pancreatic cancer
1571005|NCT00498212|Heplisav|heplisav
1571006|NCT00498212|Hepatitis B|hepatitis b
1571007|NCT00498212|Hepatitis|hepatitis
1571008|NCT00498212|HBV|hbv
1571009|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
1571010|NCT00498212|kidney disease|kidney disease
1571011|NCT00498212|renal disease|renal disease
1571012|NCT00498212|kidney failure|kidney failure
1571013|NCT00498212|renal failure|renal failure
1571014|NCT00498199|Multiples sclerosis|multiples sclerosis
1571015|NCT00498199|oscillopsia|oscillopsia
1571016|NCT00498199|eye movements|eye movements
1571017|NCT00498199|motion detection|motion detection
1571018|NCT00498199|retinal slip|retinal slip
1571019|NCT00498199|nystagmus|nystagmus
1571020|NCT00498186|Rotigotine|rotigotine
1571021|NCT00498186|Neupro®|neupro®
1571022|NCT00498173|Autistic Disorder|autistic disorder
1571023|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
1571024|NCT00498160|Kidney transplant|kidney transplant
1571025|NCT00498160|Tolerance|tolerance
1571026|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
1571027|NCT00498147|amputation|amputation
1571028|NCT00498147|angina|angina
1571029|NCT00498147|angiography|angiography
1571030|NCT00498147|angioplasty|angioplasty
1571031|NCT00498147|arterial disease|arterial disease
1571032|NCT00498147|artery disease|artery disease
1571033|NCT00498147|bypass|bypass
1571034|NCT00498147|CABG|cabg
1571035|NCT00498147|cad|cad
1571036|NCT00498147|carotid|carotid
1571037|NCT00498147|cerebral accident|cerebral accident
1571038|NCT00498147|CHF|chf
1571039|NCT00498147|CRF|crf
1571040|NCT00498147|CVA|cva
1571041|NCT00498147|endarterectomy|endarterectomy
1571042|NCT00498147|heart attack|heart attack
1571043|NCT00498147|heart failure|heart failure
1571044|NCT00498147|infarct|infarct
1571045|NCT00498147|kidney disease|kidney disease
1571046|NCT00498147|kidney failure|kidney failure
1571047|NCT00498147|laser|laser
1571048|NCT00498147|nephropathy|nephropathy
1571049|NCT00498147|neuropathy|neuropathy
1571050|NCT00498147|pad|pad
1571051|NCT00498147|PCI|pci
1571052|NCT00498147|percutaneous coronary|percutaneous coronary
1571053|NCT00498147|percutaneous transluminal|percutaneous transluminal
1571054|NCT00498147|pvd|pvd
1571055|NCT00498147|renal failure|renal failure
1571056|NCT00498147|retinopathy|retinopathy
1571057|NCT00498147|revascularization|revascularization
1571058|NCT00498147|schemia|schemia
1571059|NCT00498147|stenosis|stenosis
1571060|NCT00498147|stent|stent
1571061|NCT00498147|stroke|stroke
1571062|NCT00498147|transient|transient
1571063|NCT00498147|ulcer|ulcer
1571064|NCT00498147|vascular disease|vascular disease
1571065|NCT00498134|Gastric cancer|gastric cancer
1571066|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
1571067|NCT00498121|Procalcitonin.|procalcitonin.
1571068|NCT00498108|Rotigotine|rotigotine
1571069|NCT00498108|Restless Legs Syndrome|restless legs syndrome
1571070|NCT00498095|Delayed renal graft function|delayed renal graft function
1571071|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
1571072|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
1571073|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
1571074|NCT00498056|HIV Seronegativity|hiv seronegativity
1571075|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
1571076|NCT00498043|Lymphoma|lymphoma
1571077|NCT00498043|PET|pet
1571078|NCT00498043|Chemotherapy|chemotherapy
1571079|NCT00498043|Rituximab|rituximab
1571080|NCT00498030|Insulin Resistance|insulin resistance
1571081|NCT00498030|Stress, Psychological|stress, psychological
1571082|NCT00498017|Infections|infections
1571083|NCT00498004|Quality of Life|quality of life
1571084|NCT00498004|Schizophrenia|schizophrenia
1571085|NCT00498004|Quetiapine|quetiapine
1571086|NCT00498004|Risperidone|risperidone
1571087|NCT00497991|AML|aml
1571088|NCT00497991|phase I/II|phase i/ii
1571089|NCT00497991|AZD1152|azd1152
1571090|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
1571091|NCT00497965|Balance|balance
1571092|NCT00497965|Chiropractic|chiropractic
1571093|NCT00497965|Older Adults|older adults
1571094|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1571095|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
1571096|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1571097|NCT00497939|Currently on alpha blocker|currently on alpha blocker
1571098|NCT00497926|Kidney transplant|kidney transplant
1571099|NCT00497926|Tolerance|tolerance
1571100|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
1571101|NCT00497913|Tennis Elbow|tennis elbow
1571102|NCT00497913|Botulinum Toxin|botulinum toxin
1571103|NCT00497874|depression|depression
1571104|NCT00497874|stage of change|stage of change
1571105|NCT00497874|intervention|intervention
1571106|NCT00497874|randomized clinical trial|randomized clinical trial
1571107|NCT00497874|population-based|population-based
1571108|NCT00497874|expert system|expert system
1571109|NCT00497861|Low back pain|low back pain
1571110|NCT00497861|Chiropractic|chiropractic
1571111|NCT00497861|Spinal manipulation|spinal manipulation
1571112|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
1571113|NCT00497835|motor seizures|motor seizures
1571114|NCT00497835|accelerometer|accelerometer
1571115|NCT00497835|algorithm|algorithm
1571116|NCT00497835|detection|detection
1571117|NCT00497835|alert|alert
1571118|NCT00497822|Dementia|dementia
1571119|NCT00497809|Breast Cancer|breast cancer
1571120|NCT00497809|Neutropenia|neutropenia
1571121|NCT00497809|Chemotherapy|chemotherapy
1571122|NCT00497809|High risk|high risk
1571123|NCT00497796|cytomegalovirus|cytomegalovirus
1571124|NCT00497796|CMV|cmv
1571125|NCT00497796|prophylaxis|prophylaxis
1571126|NCT00497796|liver|liver
1571127|NCT00497796|liver transplant|liver transplant
1571128|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
1571129|NCT00497744|CAPD peritonitis|capd peritonitis
1571130|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
1571131|NCT00497731|Advanced solid tumors|advanced solid tumors
1571132|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
1571133|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
1571134|NCT00497705|Heart Defects, Congenital|heart defects, congenital
1571135|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
1571136|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
1571137|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
1571138|NCT00497705|Congenital Heart Disease|congenital heart disease
1571139|NCT00497705|Heart Defects|heart defects
1571140|NCT00497679|advanced solid tumours|advanced solid tumours
1571141|NCT00497666|Diabetes|diabetes
1571142|NCT00497666|Diabetic nephropathy|diabetic nephropathy
1571143|NCT00497666|renal protection|renal protection
1571144|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
1571145|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
1571146|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
1571147|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
1571148|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
1571149|NCT00497601|Amphotericin B|amphotericin b
1571150|NCT00497601|Fat emulsion|fat emulsion
1571151|NCT00497588|laryngeal cancer|laryngeal cancer
1571152|NCT00497588|RADIOTHERAPY|radiotherapy
1571153|NCT00497588|Voice Quality|voice quality
1571154|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
1571155|NCT00497575|diagnosis|diagnosis
1571156|NCT00497575|L-thyroxine|l-thyroxine
1571157|NCT00497575|newborn screening|newborn screening
1571158|NCT00497562|Fibromyalgia|fibromyalgia
1571159|NCT00497562|growth hormone|growth hormone
1571162|NCT00497549|Esophagectomy|esophagectomy
1571163|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
1571164|NCT00497549|side-to-side stapled|side-to-side stapled
1571165|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1571166|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
1571167|NCT00497523|Asthma|asthma
1571168|NCT00497523|Young Children|young children
1571169|NCT00497523|Corticosteroids|corticosteroids
1571170|NCT00497523|Beclomethasone|beclomethasone
1571171|NCT00497523|Salbutamol|salbutamol
1571172|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
1571173|NCT00497523|Suspension for nebulisation|suspension for nebulisation
1571174|NCT00497510|Balance|balance
1571175|NCT00497510|Chiropractic|chiropractic
1571176|NCT00497510|Older Adults|older adults
1571177|NCT00497497|CRC|crc
1571178|NCT00497497|Colon cancer|colon cancer
1571179|NCT00497497|Avastin|avastin
1571180|NCT00497497|APM4187g|apm4187g
1571181|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
1571182|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
1571183|NCT00497471|Iron supplementation|iron supplementation
1571184|NCT00497471|Tanzania|tanzania
1571185|NCT00497458|breast|breast
1571186|NCT00497458|neoplasms|neoplasms
1571187|NCT00497458|anastrazole|anastrazole
1571188|NCT00497458|testosterone|testosterone
1571189|NCT00497445|Peripheral arterial disease|peripheral arterial disease
1571190|NCT00497445|Exercise therapy|exercise therapy
1571191|NCT00497445|Angioplasty|angioplasty
1571192|NCT00497445|Bypass surgery|bypass surgery
1571193|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
1571194|NCT00497419|STEMI|stemi
1571195|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
1571196|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
1571197|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1571198|NCT00497406|helical tomotherapy|helical tomotherapy
1571199|NCT00497406|reduction of xerostomia|reduction of xerostomia
1571200|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
1571201|NCT00497367|safety|safety
1571202|NCT00497367|feasibility|feasibility
1571203|NCT00497367|bifurcation|bifurcation
1571204|NCT00497367|lesion|lesion
1571205|NCT00497367|de novo|de novo
1571206|NCT00497367|intervention|intervention
1571207|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
1571208|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
1571209|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
1571210|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
1571211|NCT00497315|NSCLC|nsclc
1571212|NCT00497315|Chemoradiation|chemoradiation
1571213|NCT00497315|locally advanced NSCLC|locally advanced nsclc
1571214|NCT00497315|pemetrexed|pemetrexed
1571215|NCT00497315|lung cancer|lung cancer
1571216|NCT00497302|cocaine|cocaine
1571217|NCT00497302|opiate|opiate
1571218|NCT00497302|pregnancy|pregnancy
1571219|NCT00497302|post-partum|post-partum
1571220|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
1571221|NCT00497302|contingency management|contingency management
1571222|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
1571223|NCT00497302|women|women
1571224|NCT00497289|n-3 PUFA|n-3 pufa
1571225|NCT00497289|parenteral nutrition|parenteral nutrition
1571226|NCT00497289|preterm infant|preterm infant
1571227|NCT00497276|Adults|adults
1571228|NCT00497276|Anesthesia recovery period|anesthesia recovery period
1571229|NCT00497276|Comparative study|comparative study
1571230|NCT00497276|Electric stimulation|electric stimulation
1571231|NCT00497276|Humans|humans
1571232|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
1571233|NCT00497276|Patient satisfaction|patient satisfaction
1571234|NCT00497276|Peripheral nerves|peripheral nerves
1571235|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
1571236|NCT00497276|Ultrasonography|ultrasonography
1571237|NCT00497276|Treatment outcome|treatment outcome
1571238|NCT00497276|Nerve blocks/economics|nerve blocks/economics
1571239|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
1571240|NCT00497250|Iressa|iressa
1571241|NCT00497250|radiation therapy|radiation therapy
1571242|NCT00497250|Chinese|chinese
1571243|NCT00497250|NSCLC|nsclc
1571244|NCT00497250|chemotherapy|chemotherapy
1571245|NCT00497237|Asthma|asthma
1571246|NCT00497237|Stepdown|stepdown
1571247|NCT00497237|Beclomethasone|beclomethasone
1571248|NCT00497237|Formoterol|formoterol
1571249|NCT00497237|Corticosteroids|corticosteroids
1571250|NCT00497224|Pancreatic Cancer|pancreatic cancer
1571251|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
1571252|NCT00497224|Pancreas|pancreas
1571253|NCT00497224|Adenocarcinoma|adenocarcinoma
1571254|NCT00497224|Erlotinib|erlotinib
1571255|NCT00497224|Tarceva|tarceva
1571256|NCT00497224|OSI-774|osi-774
1571257|NCT00497224|Phase II|phase ii
1571258|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
1571259|NCT00497198|Type 2 Diabetes|type 2 diabetes
1571260|NCT00497198|anion-exchange resin|anion-exchange resin
1571261|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
1571262|NCT00497185|Somatization Disorder|somatization disorder
1571263|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
1571264|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
1571265|NCT00497185|SF-36|sf-36
1571266|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
1571267|NCT00497146|paricalcitol|paricalcitol
1571268|NCT00497146|Zemplar|zemplar
1571269|NCT00497146|PRIMO|primo
1571270|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
1571271|NCT00497133|glucoseintolerance|glucoseintolerance
1571272|NCT00497120|sleep apnea|sleep apnea
1571273|NCT00497120|snoring|snoring
1571274|NCT00497120|acetazolamide|acetazolamide
1571275|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
1571276|NCT00497120|daytime sleepiness|daytime sleepiness
1571277|NCT00497120|upper airway|upper airway
1571278|NCT00497107|UFT/LV|uft/lv
1571279|NCT00497107|PSK|psk
1571280|NCT00497107|Colorectal cancer|colorectal cancer
1571281|NCT00497107|Adjuvant therapy|adjuvant therapy
1571282|NCT00497094|carotid artery stenting|carotid artery stenting
1571283|NCT00497094|atherosclerosis|atherosclerosis
1571284|NCT00497094|cerebrovascular|cerebrovascular
1571285|NCT00497094|stroke|stroke
1571286|NCT00497081|Methamphetamine|methamphetamine
1571287|NCT00497081|HIV|hiv
1571288|NCT00497081|MSM|msm
1571289|NCT00497081|HIV Seronegativity|hiv seronegativity
1571290|NCT00497068|smoking|smoking
1571292|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
1571293|NCT00497055|Methamphetamine|methamphetamine
1571294|NCT00497055|HIV|hiv
1571295|NCT00497055|MSM|msm
1571296|NCT00497055|HIV Seronegativity|hiv seronegativity
1571297|NCT00497029|dental caries|dental caries
1571298|NCT00497029|early childhood caries|early childhood caries
1571299|NCT00497029|caries prevention|caries prevention
1571300|NCT00497029|infants|infants
1571301|NCT00497016|hypertension|hypertension
1571302|NCT00497016|statin|statin
1571303|NCT00497016|sympathetic|sympathetic
1571304|NCT00497003|Endothelial function|endothelial function
1571305|NCT00497003|Beta blocker|beta blocker
1571306|NCT00497003|Type 2 diabetes|type 2 diabetes
1571307|NCT00497003|Chronic heart failure|chronic heart failure
1571308|NCT00496990|male|male
1571309|NCT00496990|female|female
1571310|NCT00496990|couple|couple
1571311|NCT00496990|cocaine|cocaine
1571312|NCT00496990|opiate|opiate
1571313|NCT00496990|methadone|methadone
1571314|NCT00496990|detoxification|detoxification
1571315|NCT00496990|pregnancy|pregnancy
1571316|NCT00496977|lung cancer|lung cancer
1571317|NCT00496977|CT scan|ct scan
1571318|NCT00496977|screening|screening
1571319|NCT00496964|Botulinum toxin type A|botulinum toxin type a
1571320|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
1571321|NCT00496964|Knee Injuries|knee injuries
1571322|NCT00496964|Exercise Therapy|exercise therapy
1571323|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
1571324|NCT00496951|Methadone|methadone
1571325|NCT00496951|Vagal tone|vagal tone
1571326|NCT00496938|Stents|stents
1571327|NCT00496938|Angioplasty|angioplasty
1571328|NCT00496938|Total coronary occlusions|total coronary occlusions
1571329|NCT00496938|Coronary restenosis|coronary restenosis
1571330|NCT00496938|Stent thrombosis|stent thrombosis
1571331|NCT00496938|Everolimus|everolimus
1571332|NCT00496899|Labor|labor
1571333|NCT00496899|Obstetric|obstetric
1571334|NCT00496899|cervical dilatation|cervical dilatation
1571335|NCT00496886|Pain|pain
1571336|NCT00496886|Nociception|nociception
1571337|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1571338|NCT00496873|NHL|nhl
1571339|NCT00496873|Lymphoma|lymphoma
1571340|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1571341|NCT00496873|SLL|sll
1571342|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1571343|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
1571344|NCT00496873|Follicular lymphoma|follicular lymphoma
1571345|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
1571346|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1571347|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1571348|NCT00496873|CLL|cll
1571349|NCT00496873|Bulky Lymphoma|bulky lymphoma
1571350|NCT00496873|Nipent|nipent
1571351|NCT00496873|Cytoxan|cytoxan
1571352|NCT00496873|Rituxan|rituxan
1571353|NCT00496873|Cyclophosphamide|cyclophosphamide
1571354|NCT00496873|Rituximab|rituximab
1571355|NCT00496873|Pentostatin|pentostatin
1571356|NCT00496860|cancer|cancer
1571357|NCT00496860|p53|p53
1571358|NCT00496860|immunotherapy|immunotherapy
1571359|NCT00496860|targeted|targeted
1571360|NCT00496860|metastatic|metastatic
1571361|NCT00496860|malignancy|malignancy
1571362|NCT00496860|malignancies|malignancies
1571363|NCT00496860|interleukin-2|interleukin-2
1571364|NCT00496860|IL-2|il-2
1571365|NCT00496860|fusion protein|fusion protein
1571366|NCT00496860|antitumor|antitumor
1571368|NCT00496860|renal cancer|renal cancer
1571369|NCT00496860|lung cancer|lung cancer
1571370|NCT00496860|kidney cancer|kidney cancer
1571371|NCT00496860|breast cancer|breast cancer
1571372|NCT00496860|colorectal cancer|colorectal cancer
1571373|NCT00496860|colon cancer|colon cancer
1571374|NCT00496860|renal cell carcinoma|renal cell carcinoma
1571375|NCT00496860|advanced cancer|advanced cancer
1571376|NCT00496860|head and neck cancer|head and neck cancer
1571377|NCT00496860|breast tumors|breast tumors
1571378|NCT00496860|cancer of head and neck|cancer of head and neck
1571379|NCT00496860|esophagus cancer|esophagus cancer
1571380|NCT00496860|lymphoma|lymphoma
1571381|NCT00496860|ovarian cancer|ovarian cancer
1571382|NCT00496860|ovary cancer|ovary cancer
1571383|NCT00496860|bladder cancer|bladder cancer
1571384|NCT00496860|stomach cancer|stomach cancer
1571385|NCT00496860|TCR|tcr
1571386|NCT00496860|T-cell receptor|t-cell receptor
1571387|NCT00496860|P53 gene|p53 gene
1571388|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
1571389|NCT00496847|rhPDGF,|rhpdgf,
1571390|NCT00496847|periodontal disease|periodontal disease
1571391|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
1571392|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
1571393|NCT00496808|Breast Cancer|breast cancer
1571394|NCT00496808|Herceptin|herceptin
1571395|NCT00496808|Trastuzumab|trastuzumab
1571396|NCT00496808|DCIS|dcis
1571397|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
1571398|NCT00496782|Treatment Experienced|treatment experienced
1571399|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1571400|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
1571401|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
1571402|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
1571403|NCT00496730|Metabolic Disorder|metabolic disorder
1571404|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
1571405|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
1571406|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
1571407|NCT00496704|recurrent colon cancer|recurrent colon cancer
1571408|NCT00496704|stage III colon cancer|stage iii colon cancer
1571409|NCT00496704|stage IV colon cancer|stage iv colon cancer
1571410|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1571411|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
1571412|NCT00496704|stage III rectal cancer|stage iii rectal cancer
1571413|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
1571414|NCT00496691|HIV prevention|hiv prevention
1571415|NCT00496691|HIV Seronegativity|hiv seronegativity
1571417|NCT00496678|navigation|navigation
1571418|NCT00496678|navigator|navigator
1571419|NCT00496678|activation|activation
1571420|NCT00496678|disparities|disparities
1571421|NCT00496678|randomized control trial|randomized control trial
1571422|NCT00496678|primary care|primary care
1571423|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
1571424|NCT00496665|Stage IV breast cancer|stage iv breast cancer
1571425|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
1571426|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
1571427|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
1571428|NCT00496652|Antibody|antibody
1571429|NCT00496652|Radiotherapy|radiotherapy
1571430|NCT00496639|hemodialysis|hemodialysis
1571431|NCT00496639|arterio-venous grafts|arterio-venous grafts
1571432|NCT00496639|angioplasty|angioplasty
1571433|NCT00496639|stents|stents
1571434|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
1571435|NCT00496626|HPV infections|hpv infections
1571436|NCT00496613|Breast cancer|breast cancer
1571437|NCT00496613|survivor|survivor
1571438|NCT00496587|Genitourinary|genitourinary
1571439|NCT00496587|Kidney Cancer|kidney cancer
1571440|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
1571441|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
1571443|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
1571444|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
1571445|NCT00496587|Capecitabine|capecitabine
1571446|NCT00496587|Xeloda|xeloda
1571447|NCT00496587|Gemcitabine|gemcitabine
1571448|NCT00496587|Gemzar|gemzar
1571449|NCT00496587|Bevacizumab|bevacizumab
1571450|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1571451|NCT00496587|rhuMAb-VEGF|rhumab-vegf
1571452|NCT00496587|Avastin|avastin
1571453|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1571454|NCT00496587|VEGF|vegf
1571455|NCT00496574|asthma|asthma
1571456|NCT00496574|immunotherapy|immunotherapy
1571457|NCT00496574|efficacy|efficacy
1571458|NCT00496574|children|children
1571459|NCT00496574|symptoms score|symptoms score
1571460|NCT00496574|quality of life|quality of life
1571461|NCT00496574|spirometry|spirometry
1571462|NCT00496574|PC20M|pc20m
1571463|NCT00496561|asthma|asthma
1571464|NCT00496561|immunotherapy|immunotherapy
1571465|NCT00496561|children|children
1571466|NCT00496561|regulatory T cells|regulatory t cells
1571469|NCT00496561|Quality of Life|quality of life
1571470|NCT00496561|Symptoms score|symptoms score
1571471|NCT00496561|Spirometry|spirometry
1571472|NCT00496548|Crohn's Disease|crohn's disease
1571473|NCT00496535|head|head
1571474|NCT00496535|neck|neck
1571475|NCT00496535|cancer|cancer
1571476|NCT00496535|neoplasm|neoplasm
1571477|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
1571478|NCT00496522|Proton Beam Therapy|proton beam therapy
1571479|NCT00496522|Chondrosarcoma|chondrosarcoma
1571480|NCT00496522|CNS|cns
1571481|NCT00496509|ZD6474|zd6474
1571482|NCT00496509|Colorectal Cancer|colorectal cancer
1571483|NCT00496509|Liver Metastases|liver metastases
1571484|NCT00496509|Biomarkers|biomarkers
1571485|NCT00496483|Tacrolimus|tacrolimus
1571486|NCT00496483|Pharmacokinetics|pharmacokinetics
1571487|NCT00496483|Kidney Transplantation|kidney transplantation
1571488|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
1571489|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
1571490|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
1571491|NCT00496457|TRO19622|tro19622
1571492|NCT00496457|Trophos|trophos
1571493|NCT00496444|Advanced Cancers|advanced cancers
1571494|NCT00496444|Azacytidine|azacytidine
1571495|NCT00496444|5-Azacitidine|5-azacitidine
1571496|NCT00496444|5-aza|5-aza
1571497|NCT00496444|Vidaza|vidaza
1571502|NCT00496444|Valproic Acid|valproic acid
1571503|NCT00496444|Depakene|depakene
1571504|NCT00496418|colostomy|colostomy
1571505|NCT00496418|parastomal|parastomal
1571506|NCT00496418|peristomal|peristomal
1571507|NCT00496418|hernia|hernia
1571508|NCT00496418|mesh|mesh
1571509|NCT00496418|surgery|surgery
1571510|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
1571511|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
1571512|NCT00496405|Retinal Thickness|retinal thickness
1571513|NCT00496405|Diabetic Macular Edema|diabetic macular edema
1571514|NCT00496405|Optical Coherent Tomography|optical coherent tomography
1571515|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
1571516|NCT00496379|metastatic breast cancer|metastatic breast cancer
1571517|NCT00496379|invasive breast cancer|invasive breast cancer
1571518|NCT00496379|brain metastases|brain metastases
1571519|NCT00496379|ZK-EPO|zk-epo
1571520|NCT00496353|Neoplasm Malignant|neoplasm malignant
1571521|NCT00496340|Pentostatin|pentostatin
1571522|NCT00496340|Busulfan|busulfan
1571523|NCT00496340|Rituxan|rituxan
1571524|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
1571525|NCT00496301|renal|renal
1571526|NCT00496301|sorafenib|sorafenib
1571527|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
1571528|NCT00496288|BRCA mutation|brca mutation
1571529|NCT00496288|Breast cancer|breast cancer
1571530|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
1571531|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
1571532|NCT00496275|NSCLC|nsclc
1571533|NCT00496275|ZACTIMA|zactima
1571534|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
1571535|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
1571536|NCT00496262|Pharmacokinetics|pharmacokinetics
1571537|NCT00496262|Thrombelastography|thrombelastography
1571538|NCT00496249|Prostate|prostate
1571539|NCT00496249|cancer|cancer
1571540|NCT00496249|brachytherapy|brachytherapy
1571541|NCT00496249|radiation|radiation
1571542|NCT00496249|semen|semen
1571543|NCT00496249|fertility|fertility
1571544|NCT00496236|head|head
1571545|NCT00496236|neck|neck
1571546|NCT00496236|cancer|cancer
1571547|NCT00496236|neoplasm|neoplasm
1571548|NCT00496223|Sunitinib|sunitinib
1571549|NCT00496223|Dacarbazine|dacarbazine
1571550|NCT00496223|Melanoma|melanoma
1571551|NCT00496210|Adaptation|adaptation
1571552|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
1571553|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
1571554|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
1571555|NCT00496210|Caregiver Adaptation|caregiver adaptation
1571556|NCT00496197|candidemia|candidemia
1571557|NCT00496197|invasive candidiasis|invasive candidiasis
1571558|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
1571559|NCT00496184|Nifedipine treatment|nifedipine treatment
1571560|NCT00496184|Vestibulitis|vestibulitis
1571561|NCT00496184|Placebo|placebo
1571656|NCT00495781|dialysis|dialysis
1571657|NCT00495781|erythropoietin|erythropoietin
1571562|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
1571563|NCT00496158|hepatitis b virus|hepatitis b virus
1571564|NCT00496145|diabetes|diabetes
1571565|NCT00496145|self management|self management
1571566|NCT00496145|patient education|patient education
1571567|NCT00496145|telephone reinforcement|telephone reinforcement
1571568|NCT00496145|Spanish Diabetes|spanish diabetes
1571569|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
1571571|NCT00496132|Leukemia|leukemia
1571572|NCT00496132|Lymph|lymph
1571573|NCT00496119|Proton Beam Therapy|proton beam therapy
1571574|NCT00496119|Skull Base Chordoma|skull base chordoma
1571575|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
1571576|NCT00496119|Chordoma|chordoma
1571577|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
1571578|NCT00496067|Fibroids|fibroids
1571579|NCT00496067|Menorrhagia|menorrhagia
1571580|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
1571581|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
1571582|NCT00496028|Solid tumors|solid tumors
1571583|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
1571584|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
1571585|NCT00496015|Meningococcal disease|meningococcal disease
1571586|NCT00496015|Carriage|carriage
1571587|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
1571588|NCT00496015|Safety|safety
1571589|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
1571590|NCT00496015|Fever|fever
1571591|NCT00496015|Pneumococcal disease|pneumococcal disease
1571592|NCT00496015|Immunogenicity|immunogenicity
1571909|NCT00494871|12620|12620
1571593|NCT00496015|Meningococcal vaccine|meningococcal vaccine
1571594|NCT00496015|Booster vaccination|booster vaccination
1571595|NCT00496002|Hepatitis B virus|hepatitis b virus
1571596|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
1571597|NCT00495989|Handicapped individuals|handicapped individuals
1571598|NCT00495976|common cold|common cold
1571600|NCT00495976|influenza|influenza
1571601|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
1571602|NCT00495950|Melanoma|melanoma
1571603|NCT00495950|Lymphedema|lymphedema
1571604|NCT00495950|Limb Swelling|limb swelling
1571605|NCT00495950|Questionnaire|questionnaire
1571606|NCT00495950|Quality of Life|quality of life
1571607|NCT00495950|Physical Function|physical function
1571608|NCT00495950|Survey|survey
1571609|NCT00495885|Sleep problems|sleep problems
1571610|NCT00495885|insomnia|insomnia
1571611|NCT00495885|sleeplessness|sleeplessness
1571612|NCT00495885|primary insomnia|primary insomnia
1571613|NCT00495885|insomnia disorder|insomnia disorder
1571614|NCT00495872|Solid Tumors|solid tumors
1571615|NCT00495872|Advanced Cancer|advanced cancer
1571616|NCT00495872|Dasatinib|dasatinib
1571617|NCT00495872|Erlotinib|erlotinib
1571618|NCT00495872|Lapatinib|lapatinib
1571619|NCT00495872|Lenalidomide|lenalidomide
1571620|NCT00495872|Sorafenib|sorafenib
1571621|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
1571622|NCT00495872|Sunitinib Malate|sunitinib malate
1571623|NCT00495872|Sunitinib|sunitinib
1571624|NCT00495872|Valproic Acid|valproic acid
1571625|NCT00495872|SU011248|su011248
1571626|NCT00495859|Immunonutrition|immunonutrition
1571627|NCT00495859|immune enhancing diets|immune enhancing diets
1571628|NCT00495859|arginine|arginine
1571629|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
1571630|NCT00495859|nucleotides|nucleotides
1571631|NCT00495859|liver transplantation|liver transplantation
1571632|NCT00495859|clinical trial|clinical trial
1571633|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
1571634|NCT00495846|Somatostatin analogues|somatostatin analogues
1571635|NCT00495846|Somatostatin receptors|somatostatin receptors
1571636|NCT00495846|Octreotide|octreotide
1571637|NCT00495846|Lanreotide|lanreotide
1571638|NCT00495846|IGF-I|igf-i
1571639|NCT00495846|IGF-II|igf-ii
1571640|NCT00495833|Hypertension|hypertension
1571641|NCT00495820|Alzheimer's Disease|alzheimer's disease
1571642|NCT00495820|Apathy|apathy
1571643|NCT00495820|Dementia|dementia
1571644|NCT00495820|Methylphenidate|methylphenidate
1571645|NCT00495807|Psychological Tests|psychological tests
1571646|NCT00495807|Pain, Postoperative|pain, postoperative
1571647|NCT00495807|Nurses|nurses
1571648|NCT00495794|diabetes|diabetes
1571649|NCT00495794|hypertension|hypertension
1571650|NCT00495794|adherence|adherence
1571651|NCT00495794|implementation|implementation
1571652|NCT00495794|medications|medications
1571653|NCT00495794|organization of care|organization of care
1571654|NCT00495781|functional iron deficiency|functional iron deficiency
1571655|NCT00495781|renal anemia|renal anemia
1571658|NCT00495781|darbepoetin|darbepoetin
1571659|NCT00495768|Hepatitis C|hepatitis c
1571660|NCT00495768|HCV|hcv
1571661|NCT00495768|Depression|depression
1571662|NCT00495768|Interferons|interferons
1571663|NCT00495768|Ribavirin|ribavirin
1571664|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
1571665|NCT00495729|SB-649868,|sb-649868,
1571666|NCT00495729|Simvastatin|simvastatin
1571667|NCT00495729|Repeated dose,|repeated dose,
1571668|NCT00495703|Cancer survivors|cancer survivors
1571669|NCT00495703|Chemotherapy|chemotherapy
1571670|NCT00495703|Cognitive function|cognitive function
1571671|NCT00495703|Exercise|exercise
1571672|NCT00495703|Physical Activity|physical activity
1571673|NCT00495690|Zinc recipients|zinc recipients
1571674|NCT00495690|Placebo recipients|placebo recipients
1571675|NCT00495677|Treatment Experienced|treatment experienced
1571676|NCT00495677|Treatment Naive|treatment naive
1571677|NCT00495664|titanium|titanium
1571678|NCT00495664|paclitaxel|paclitaxel
1571679|NCT00495664|stent|stent
1571680|NCT00495664|myocardial infarction|myocardial infarction
1571681|NCT00495664|angioplasty|angioplasty
1571682|NCT00495664|PCI|pci
1571683|NCT00495651|HIV|hiv
1571684|NCT00495651|HAART|haart
1571685|NCT00495651|Early Intervention|early intervention
1571686|NCT00495651|Naive patients|naive patients
1571687|NCT00495638|6-Minute Walk|6-minute walk
1571688|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
1571689|NCT00495638|Echocardiogram|echocardiogram
1571690|NCT00495638|Sickle Cell Anemia|sickle cell anemia
1571691|NCT00495638|Pulmonary Function Tests|pulmonary function tests
1571692|NCT00495638|Sickle Cell Disease|sickle cell disease
1571693|NCT00495638|SCD|scd
1571694|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
1571695|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
1571696|NCT00495625|Sunitinib malate|sunitinib malate
1571697|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1571698|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
1571699|NCT00495625|Tyrosine kinases|tyrosine kinases
1571700|NCT00495625|Liver|liver
1571701|NCT00495612|Xolair|xolair
1571702|NCT00495612|Allergic asthma|allergic asthma
1571703|NCT00495612|Cat allergy|cat allergy
1571704|NCT00495599|Obese|obese
1571705|NCT00495599|Adipose Tissue|adipose tissue
1571706|NCT00495599|Visfatin|visfatin
1571707|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
1571708|NCT00495586|COPD|copd
1571709|NCT00495586|Antibiotics|antibiotics
1571710|NCT00495560|induction|induction
1571711|NCT00495560|abortion|abortion
1571712|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
1571713|NCT00495560|misoprostol|misoprostol
1571714|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
1571715|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
1571716|NCT00495521|Crohn's|crohn's
1571717|NCT00495521|Crohn's Disease|crohn's disease
1571718|NCT00495521|Acute Flare|acute flare
1571719|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
1571720|NCT00495521|Children|children
1571721|NCT00495521|Pediatrics|pediatrics
1571722|NCT00495521|Ileo-cecal|ileo-cecal
1571723|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
1571724|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
1571725|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
1571726|NCT00495508|Quinine|quinine
1571727|NCT00495508|Artemether|artemether
1571728|NCT00495508|Lumefantrine|lumefantrine
1571729|NCT00495508|malaria|malaria
1571730|NCT00495508|Uganda|uganda
1571731|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
1571732|NCT00495508|pregnancy|pregnancy
1571733|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
1571734|NCT00495482|Euthanasia|euthanasia
1571735|NCT00495482|Assisted Suicide|assisted suicide
1571736|NCT00495482|Assisted Dying|assisted dying
1571737|NCT00495482|Palliative Care Medicine|palliative care medicine
1571738|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
1571739|NCT00495456|cardiovascular|cardiovascular
1571740|NCT00495456|risk|risk
1571741|NCT00495456|longitudinal|longitudinal
1571742|NCT00495456|prospective|prospective
1571743|NCT00495430|Healthy|healthy
1571744|NCT00495430|Lung sounds|lung sounds
1571745|NCT00495430|Breath sounds|breath sounds
1571746|NCT00495417|Alzheimer|alzheimer
1571747|NCT00495417|Morbus Alzheimer|morbus alzheimer
1571748|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
1571749|NCT00495417|Vaccine|vaccine
1571750|NCT00495417|AD|ad
1571751|NCT00495417|Aβ immunotherapy|aβ immunotherapy
1571752|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
1571753|NCT00495404|opiates|opiates
1571754|NCT00495404|prescriptions|prescriptions
1571755|NCT00495404|addiction|addiction
1571756|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
1571757|NCT00495378|PROCRIT|procrit
1571758|NCT00495378|Epoetin alfa|epoetin alfa
1571759|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
1571760|NCT00495365|Anemia|anemia
1571761|NCT00495365|low blood count|low blood count
1571762|NCT00495365|chronic kidney disease|chronic kidney disease
1571763|NCT00495365|chronic kidney failure|chronic kidney failure
1571764|NCT00495365|darbepoetin alfa|darbepoetin alfa
1571765|NCT00495365|epoetin alfa|epoetin alfa
1571766|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
1571767|NCT00495352|Schizophrenia|schizophrenia
1571768|NCT00495352|NRT|nrt
1571769|NCT00495352|Bupropion|bupropion
1571770|NCT00495352|Stages of change|stages of change
1571771|NCT00495326|drug interactions|drug interactions
1571772|NCT00495326|Treatment Naive|treatment naive
1571773|NCT00495313|Rosacea|rosacea
1571774|NCT00495300|HSC/MUD Transplant|hsc/mud transplant
1571775|NCT00495300|NMDP|nmdp
1571776|NCT00495300|NMDP Data Collection|nmdp data collection
1571777|NCT00495300|NMDP Samples|nmdp samples
1571778|NCT00495300|BMT|bmt
1571779|NCT00495300|Samples|samples
1571780|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
1571781|NCT00495287|Adult patients|adult patients
1571782|NCT00495287|Cytogenetic risk class|cytogenetic risk class
1571783|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
1571784|NCT00495287|Risk-oriented therapy|risk-oriented therapy
1571785|NCT00495274|Bioequivalent|bioequivalent
1571786|NCT00495274|pharmacodynamic|pharmacodynamic
1571787|NCT00495274|Reference formulation|reference formulation
1571788|NCT00495274|5 new formulation|5 new formulation
1571789|NCT00495274|Food effect|food effect
1571790|NCT00495274|Pharmacokinetics|pharmacokinetics
1571791|NCT00495261|Gambling|gambling
1571792|NCT00495261|Mindfulness|mindfulness
1571793|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
1571794|NCT00495248|group intervention|group intervention
1571795|NCT00495248|stroke|stroke
1571796|NCT00495248|senior centres|senior centres
1571797|NCT00495248|health promotion|health promotion
1571798|NCT00495235|Endometrial Cancer|endometrial cancer
1571799|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1571800|NCT00495235|Insulin Resistance|insulin resistance
1571801|NCT00495235|Pre-diabetes|pre-diabetes
1571802|NCT00495235|Harris County|harris county
1571803|NCT00495235|PCOS|pcos
1571804|NCT00495235|Uterus|uterus
1571805|NCT00495235|Questionnaire|questionnaire
1571806|NCT00495235|Body mass index|body mass index
1571807|NCT00495235|BMI|bmi
1571808|NCT00495222|gastrojejunostomy|gastrojejunostomy
1571809|NCT00495222|stoma|stoma
1571810|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
1571811|NCT00495209|Breast Cancer|breast cancer
1571812|NCT00495209|Qigong|qigong
1571813|NCT00495209|Medical Qigong|medical qigong
1571814|NCT00495209|External Qi Therapy|external qi therapy
1571815|NCT00495209|EQT|eqt
1571816|NCT00495183|cocaine dependence|cocaine dependence
1571817|NCT00495183|cocaine use|cocaine use
1571818|NCT00495183|CNS stimulants|cns stimulants
1571819|NCT00495183|caffeine|caffeine
1571820|NCT00495183|biperiden|biperiden
1571821|NCT00495183|placebo|placebo
1571822|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
1571823|NCT00495170|Lung Cancer|lung cancer
1571824|NCT00495170|Proton Radiotherapy|proton radiotherapy
1571825|NCT00495170|Proton Beam|proton beam
1571826|NCT00495170|Paclitaxel|paclitaxel
1571827|NCT00495170|Taxol|taxol
1571828|NCT00495170|Carboplatin|carboplatin
1571829|NCT00495170|Paraplatin|paraplatin
1571830|NCT00495170|NSCLC|nsclc
1571831|NCT00495144|Phase I|phase i
1571832|NCT00495144|Advanced Solid Tumors|advanced solid tumors
1571833|NCT00495144|Hypoxia|hypoxia
1571834|NCT00495144|Prodrug|prodrug
1571835|NCT00495144|Multi-Center|multi-center
1571836|NCT00495144|Open-Label|open-label
1571837|NCT00495144|Dose-Escalation|dose-escalation
1571838|NCT00495131|Chronic hepatitis C|chronic hepatitis c
1571839|NCT00495131|Genotype 1|genotype 1
1571840|NCT00495131|Interferon|interferon
1571841|NCT00495131|Ribavirin|ribavirin
1571842|NCT00495118|schizophrenia|schizophrenia
1571843|NCT00495118|schizoaffective disorder|schizoaffective disorder
1571844|NCT00495118|risperidone|risperidone
1571845|NCT00495118|intramuscular injection|intramuscular injection
1571846|NCT00495118|long-acting injectable|long-acting injectable
1571847|NCT00495092|cocaine dependence|cocaine dependence
1571848|NCT00495092|cocaine use|cocaine use
1571849|NCT00495092|cocaine craving|cocaine craving
1571850|NCT00495079|acute|acute
1571851|NCT00495079|lymphoblastic|lymphoblastic
1571852|NCT00495079|lymphocytic|lymphocytic
1571853|NCT00495079|leukemia|leukemia
1571854|NCT00495079|leukaemia|leukaemia
1571855|NCT00495079|lukemia|lukemia
1571856|NCT00495079|leukimia|leukimia
1571857|NCT00495079|ALL|all
1571858|NCT00495079|Marqibo|marqibo
1571859|NCT00495079|Hana Biosciences|hana biosciences
1571860|NCT00495079|vincristine|vincristine
1571861|NCT00495079|liposomal|liposomal
1571862|NCT00495079|liposome|liposome
1571863|NCT00495079|optisome|optisome
1571864|NCT00495079|hematology|hematology
1571865|NCT00495079|malignancy|malignancy
1571866|NCT00495079|hematological|hematological
1571867|NCT00495079|relapsed|relapsed
1571868|NCT00495079|anti-leukemia|anti-leukemia
1571869|NCT00495079|adult|adult
1571870|NCT00495079|chemotherapy|chemotherapy
1571970|NCT00494663|diabetes|diabetes
1571871|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
1571872|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
1571873|NCT00495040|Lung Cancer|lung cancer
1571874|NCT00495040|Proton Radiotherapy|proton radiotherapy
1571875|NCT00495040|Proton Beam|proton beam
1571876|NCT00495040|NSCLC|nsclc
1571877|NCT00495027|PTSD|ptsd
1571878|NCT00495027|prevention|prevention
1571879|NCT00495027|World Wide Web|world wide web
1571880|NCT00495027|Behavior Therapy|behavior therapy
1571881|NCT00495014|GSK376501,|gsk376501,
1571882|NCT00495014|Single Dose,|single dose,
1571883|NCT00495014|Dose Escalation,|dose escalation,
1571884|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
1571885|NCT00494949|Anesthesia, spinal|anesthesia, spinal
1571886|NCT00494949|Blood substitutes|blood substitutes
1571887|NCT00494949|Oxygen therapeutics|oxygen therapeutics
1571888|NCT00494949|Orthopedic surgery|orthopedic surgery
1571889|NCT00494949|Plasma expanders|plasma expanders
1571890|NCT00494949|Vasoconstriction|vasoconstriction
1571891|NCT00494949|Hemospan|hemospan
1571893|NCT00494936|HCV|hcv
1571894|NCT00494936|Treatment Naive|treatment naive
1571895|NCT00494936|Treatment Experienced|treatment experienced
1571896|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
1571897|NCT00494910|Palliative Care|palliative care
1571898|NCT00494910|Terminally Ill|terminally ill
1571899|NCT00494910|Group Therapy|group therapy
1571900|NCT00494910|07-094|07-094
1571901|NCT00494884|Type 2 diabetes|type 2 diabetes
1571902|NCT00494884|vildagliptin|vildagliptin
1571903|NCT00494884|metformin combination|metformin combination
1571904|NCT00494871|BAY59-7939|bay59-7939
1571905|NCT00494871|Rivaroxaban|rivaroxaban
1571906|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
1571907|NCT00494871|Japanese Patients|japanese patients
1571908|NCT00494871|Phase III|phase iii
1571910|NCT00494858|Bulimia nervosa|bulimia nervosa
1571911|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
1571912|NCT00494858|Personality Disorders|personality disorders
1571913|NCT00494845|Mindfulness|mindfulness
1571914|NCT00494845|Elderly|elderly
1571915|NCT00494845|Chronic Illness|chronic illness
1571916|NCT00494845|Back Pain|back pain
1571917|NCT00494845|Chronic Low Back Pain|chronic low back pain
1571918|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
1571919|NCT00494845|MMSE score of over 23|mmse score of over 23
1571920|NCT00494845|Speaks English|speaks english
1571921|NCT00494832|Dexmedetomidine|dexmedetomidine
1571922|NCT00494832|Evoked potentials|evoked potentials
1571923|NCT00494832|Spine surgery|spine surgery
1571924|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
1571925|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
1571926|NCT00494806|Rocking Chair|rocking chair
1571927|NCT00494806|Abdominal Cancer|abdominal cancer
1571928|NCT00494793|Open abdomen|open abdomen
1571929|NCT00494793|Fascial closure|fascial closure
1571930|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
1571931|NCT00494793|Mesh|mesh
1571932|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
1571933|NCT00494793|Intraabdominal pressure|intraabdominal pressure
1571934|NCT00494793|Incisional hernia|incisional hernia
1571935|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
1571936|NCT00494780|ofatumumab|ofatumumab
1571937|NCT00494767|body composition|body composition
1571938|NCT00494767|obesity|obesity
1571939|NCT00494767|4C model|4c model
1571940|NCT00494767|hunger|hunger
1571941|NCT00494767|weight loss|weight loss
1571942|NCT00494754|autism spectrum disorder|autism spectrum disorder
1571943|NCT00494754|family genetic study|family genetic study
1571944|NCT00494754|gene|gene
1571945|NCT00494754|phenotype|phenotype
1571946|NCT00494754|endophenotype|endophenotype
1571947|NCT00494728|Smoking|smoking
1571948|NCT00494728|Depression|depression
1571949|NCT00494728|Major Depressive Disorder|major depressive disorder
1571950|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
1571951|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
1571952|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
1571953|NCT00494728|Nicotine Patch|nicotine patch
1571954|NCT00494728|CBASP|cbasp
1571955|NCT00494728|MDD|mdd
1571956|NCT00494702|Asphyxia|asphyxia
1571957|NCT00494702|Resuscitation|resuscitation
1571958|NCT00494702|Oxidative stress|oxidative stress
1571959|NCT00494702|Prematurity|prematurity
1571960|NCT00494702|Follow up|follow up
1571961|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
1571962|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
1571963|NCT00494689|cerebral ischemia|cerebral ischemia
1571964|NCT00494689|hydrocephalus|hydrocephalus
1571965|NCT00494689|Barthel's index|barthel's index
1571966|NCT00494676|Hemianopia|hemianopia
1571967|NCT00494676|Mobility|mobility
1571968|NCT00494676|Rehabilitation|rehabilitation
1571969|NCT00494676|Low vision|low vision
1571971|NCT00494663|type 2 diabetes|type 2 diabetes
1571972|NCT00494663|cholesterol|cholesterol
1571973|NCT00494650|PTSD|ptsd
1571974|NCT00494650|Schizophrenia|schizophrenia
1571975|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
1571976|NCT00494650|Bipolar Disorder|bipolar disorder
1571977|NCT00494650|Major Depression|major depression
1571978|NCT00494624|Wheezing|wheezing
1571979|NCT00494624|virus|virus
1571980|NCT00494624|child|child
1571981|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
1571982|NCT00494585|CEP-701|cep-701
1571983|NCT00494585|Leukemia|leukemia
1571984|NCT00494585|Myelofibrosis|myelofibrosis
1571985|NCT00494585|MF|mf
1571986|NCT00494585|JAK2|jak2
1571987|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1571988|NCT00494585|Lestaurtinib|lestaurtinib
1571989|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
1571990|NCT00494585|CIMF|cimf
1571991|NCT00494572|Montelukast|montelukast
1571992|NCT00494572|Albuterol|albuterol
1571993|NCT00494572|Status Asthmaticus|status asthmaticus
1571994|NCT00494572|Asthma|asthma
1571995|NCT00494559|Type 2 Diabetes|type 2 diabetes
1571996|NCT00494559|Pioglitazone|pioglitazone
1571997|NCT00494559|restenosis|restenosis
1571998|NCT00494546|prostate|prostate
1571999|NCT00494546|brachytherapy|brachytherapy
1572000|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
1572001|NCT00494533|prostacyclin analogue|prostacyclin analogue
1572002|NCT00494533|intravenous|intravenous
1572003|NCT00494520|Anomia|anomia
1572004|NCT00494520|Aphasia|aphasia
1572005|NCT00494520|Traumatic Brain Injury|traumatic brain injury
1572006|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
1572007|NCT00494507|periodic paralysis|periodic paralysis
1572008|NCT00494507|dichlorphenamide|dichlorphenamide
1572009|NCT00494494|cystoid macular edema|cystoid macular edema
1572010|NCT00494494|cataract|cataract
1572011|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
1572012|NCT00494494|optical coherence tomography|optical coherence tomography
1572013|NCT00494481|Zactima|zactima
1572014|NCT00494468|Insomnia|insomnia
1572015|NCT00494468|Sleep Disorder|sleep disorder
1572016|NCT00494468|Sleep Deprivation|sleep deprivation
1572017|NCT00494455|critical illness|critical illness
1572018|NCT00494455|hyperglycemia|hyperglycemia
1572019|NCT00494455|intensive insulin therapy|intensive insulin therapy
1572020|NCT00494455|glucose monitoring|glucose monitoring
1572021|NCT00494455|shock|shock
1572022|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
1572023|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1572024|NCT00494442|KU-0059436|ku-0059436
1572025|NCT00494442|AZD2281|azd2281
1572026|NCT00494442|BRCA1 protein|brca1 protein
1572027|NCT00494442|BRCA2 protein|brca2 protein
1572028|NCT00494429|Preterm Neonates|preterm neonates
1572029|NCT00494429|Morphine|morphine
1572030|NCT00494429|Critically ill|critically ill
1572031|NCT00494403|sprain proprioception|sprain proprioception
1572032|NCT00494390|Biometry|biometry
1572033|NCT00494390|corneal opacity|corneal opacity
1572034|NCT00494390|astigmatism|astigmatism
1572035|NCT00494390|refraction|refraction
1572036|NCT00494364|ear disease|ear disease
1572037|NCT00494364|otitis|otitis
1572038|NCT00494364|Eustachian tube|eustachian tube
1572039|NCT00494364|mastoid air cells|mastoid air cells
1572040|NCT00494364|Normal healthy volunteers|normal healthy volunteers
1572041|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
1572042|NCT00494351|Nd:YAG laser|nd:yag laser
1572043|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
1572044|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
1572045|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
1572046|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
1572047|NCT00494312|Type II Diabetes|type ii diabetes
1572048|NCT00494312|Diabetes Mellitus|diabetes mellitus
1572049|NCT00494312|Lipoatrophic|lipoatrophic
1572050|NCT00494312|Dyslipidemia|dyslipidemia
1572051|NCT00494312|Liver|liver
1572052|NCT00494312|Drug Therapy|drug therapy
1572053|NCT00494299|HCC|hcc
1572054|NCT00494299|Cancer|cancer
1572055|NCT00494299|Liver Cancer|liver cancer
1572056|NCT00494299|TACE|tace
1572057|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
1572058|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
1572059|NCT00494286|Treatment Dissemination|treatment dissemination
1572060|NCT00494273|Haitian American Adolescents|haitian american adolescents
1572061|NCT00494273|HIV Prevention|hiv prevention
1572062|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
1572063|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
1572064|NCT00494260|illness behavior|illness behavior
1572065|NCT00494260|social learning|social learning
1572066|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
1572067|NCT00494247|acute coronary syndromes|acute coronary syndromes
1572068|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
1572069|NCT00494247|coronary stent|coronary stent
1572070|NCT00494234|Advanced breast cancer|advanced breast cancer
1572071|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
1572072|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
1572073|NCT00494234|BRCA1 protein|brca1 protein
1572074|NCT00494234|BRCA2 protein|brca2 protein
1572075|NCT00494221|Colorectal cancer|colorectal cancer
1572076|NCT00494221|Recentin|recentin
1572077|NCT00494221|Metastatic Cancer|metastatic cancer
1572078|NCT00494221|FOLFOX|folfox
1572079|NCT00494208|androgens|androgens
1572080|NCT00494208|testosterone|testosterone
1572189|NCT00493883|Therasphere|therasphere
1572081|NCT00494208|testosterone deficiency|testosterone deficiency
1572082|NCT00494208|women|women
1572083|NCT00494208|menopause|menopause
1572084|NCT00494208|surgical Menopause|surgical menopause
1572085|NCT00494208|hysterectomy|hysterectomy
1572086|NCT00494208|oophorectomy|oophorectomy
1572087|NCT00494208|ovariectomy|ovariectomy
1572088|NCT00494208|sexual dysfunction|sexual dysfunction
1572089|NCT00494208|sexual function|sexual function
1572090|NCT00494208|muscle function|muscle function
1572091|NCT00494208|insulin sensitivity|insulin sensitivity
1572092|NCT00494208|body composition|body composition
1572093|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
1572094|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
1572095|NCT00494195|LGMD|lgmd
1572096|NCT00494195|LGMD2D|lgmd2d
1572097|NCT00494195|gene therapy|gene therapy
1572098|NCT00494195|gene transfer|gene transfer
1572099|NCT00494195|muscular dystrophy|muscular dystrophy
1572100|NCT00494195|SGCA|sgca
1572101|NCT00494195|sarcoglycan|sarcoglycan
1572102|NCT00494195|limb girdle|limb girdle
1572103|NCT00494195|adeno-associated virus|adeno-associated virus
1572104|NCT00494195|AAV|aav
1572105|NCT00494195|AAV1|aav1
1572106|NCT00494182|Head and Neck Cancer|head and neck cancer
1572107|NCT00494182|Squamous Cell Carcinoma|squamous cell carcinoma
1572108|NCT00494182|Sorafenib|sorafenib
1572109|NCT00494182|BAY 43-9006|bay 43-9006
1572113|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
1572114|NCT00494169|Kallmann Syndrome|kallmann syndrome
1572115|NCT00494169|Puberty|puberty
1572116|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
1572117|NCT00494169|Hypothalamus|hypothalamus
1572118|NCT00494169|anosmia|anosmia
1572119|NCT00494169|GnRH deficiency|gnrh deficiency
1572120|NCT00494143|Amputee|amputee
1572121|NCT00494143|Economy|economy
1572122|NCT00494143|Efficiency|efficiency
1572123|NCT00494143|Foot|foot
1572124|NCT00494143|Gait|gait
1572125|NCT00494143|Kinematics|kinematics
1572126|NCT00494143|Kinetics|kinetics
1572127|NCT00494143|Prosthesis|prosthesis
1572128|NCT00494104|vitamin D deficiency|vitamin d deficiency
1572129|NCT00494104|breastfed infant|breastfed infant
1572130|NCT00494104|northern latitude|northern latitude
1572131|NCT00494104|infant|infant
1572132|NCT00494104|breastfed|breastfed
1572133|NCT00494104|winter|winter
1572134|NCT00494104|vitamin D status|vitamin d status
1572135|NCT00494078|critical illness|critical illness
1572136|NCT00494078|hyperglycemia|hyperglycemia
1572137|NCT00494078|intensive insulin therapy|intensive insulin therapy
1572138|NCT00494078|glucose monitoring|glucose monitoring
1572139|NCT00494052|Coronary Heart Disease|coronary heart disease
1572140|NCT00494052|Choice Behavior|choice behavior
1572141|NCT00494052|Risk Factors|risk factors
1572142|NCT00494052|Risk Assessment|risk assessment
1572143|NCT00494052|Primary Prevention|primary prevention
1572144|NCT00494052|Decision Making|decision making
1572145|NCT00494052|Decision Aids|decision aids
1572146|NCT00494052|Patient Compliance|patient compliance
1572147|NCT00494039|prostate|prostate
1572148|NCT00494039|cancer|cancer
1572149|NCT00494039|radiation|radiation
1572150|NCT00494039|brachytherapy|brachytherapy
1572151|NCT00494013|diabetes|diabetes
1572152|NCT00494013|type 2|type 2
1572153|NCT00493987|Testosterone|testosterone
1572154|NCT00493987|Androgens|androgens
1572155|NCT00493987|Dihydrotestosterone|dihydrotestosterone
1572156|NCT00493987|5-alpha reductase|5-alpha reductase
1572157|NCT00493987|Body Composition|body composition
1572158|NCT00493987|Muscle|muscle
1572159|NCT00493987|Sexual function|sexual function
1572160|NCT00493987|Men|men
1572161|NCT00493987|Healthy Men|healthy men
1572162|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1572163|NCT00493974|COPD|copd
1572164|NCT00493974|Exacerbation|exacerbation
1572165|NCT00493974|Anti-leukotriene|anti-leukotriene
1572166|NCT00493974|Length of Stay|length of stay
1572167|NCT00493974|LOS|los
1572168|NCT00493961|Kallmann Syndrome|kallmann syndrome
1572169|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
1572170|NCT00493961|GnRH deficiency|gnrh deficiency
1572171|NCT00493935|bedtime snack|bedtime snack
1572172|NCT00493935|hypoglycemia|hypoglycemia
1572173|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
1572174|NCT00493935|glucose monitoring|glucose monitoring
1572175|NCT00493922|Malaria|malaria
1572176|NCT00493922|Diagnosis|diagnosis
1572177|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
1572178|NCT00493922|Microscopy|microscopy
1572179|NCT00493922|Clinical diagnosis|clinical diagnosis
1572180|NCT00493922|Africa|africa
1572181|NCT00493909|thoracotomy|thoracotomy
1572182|NCT00493909|pain therapy|pain therapy
1572183|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
1572184|NCT00493909|intrathecal opioids|intrathecal opioids
1572185|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
1572186|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
1572187|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
1572188|NCT00493896|VTE prophylaxis|vte prophylaxis
1572190|NCT00493883|Yttrium|yttrium
1572191|NCT00493883|liver|liver
1572192|NCT00493883|cancer|cancer
1572193|NCT00493883|radiation|radiation
1572194|NCT00493857|Colorectal cancer|colorectal cancer
1572195|NCT00493857|Monoclonal antibody|monoclonal antibody
1572196|NCT00493857|Anti-EGFR|anti-egfr
1572197|NCT00493844|Chest pain|chest pain
1572198|NCT00493844|Unstable angina|unstable angina
1572199|NCT00493844|NT-proBNP|nt-probnp
1572200|NCT00493844|Exercise test.|exercise test.
1572201|NCT00493831|smoking reduction|smoking reduction
1572202|NCT00493831|inflammation|inflammation
1572203|NCT00493831|harm reduction|harm reduction
1572204|NCT00493831|lipid biomarkers|lipid biomarkers
1572205|NCT00493818|GSK690693,|gsk690693,
1572206|NCT00493818|Solid Tumors,|solid tumors,
1572207|NCT00493818|Lymphoma,|lymphoma,
1572208|NCT00493818|AKT|akt
1572209|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
1572210|NCT00493766|LBH589|lbh589
1572211|NCT00493766|Prostate Cancer|prostate cancer
1572212|NCT00493766|HRPC|hrpc
1572213|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1572214|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
1572215|NCT00493727|Oxidative stress|oxidative stress
1572216|NCT00493727|N-acetylcysteine|n-acetylcysteine
1572217|NCT00493727|NAC|nac
1572223|NCT00493714|Advanced Cancer|advanced cancer
1572224|NCT00493714|Delirium|delirium
1572225|NCT00493714|Restlessness|restlessness
1572226|NCT00493714|Confusion|confusion
1572227|NCT00493714|Caregivers|caregivers
1572228|NCT00493714|Questionnaire|questionnaire
1572229|NCT00493688|Abdominal Cancer|abdominal cancer
1572230|NCT00493688|Pelvic Cancer|pelvic cancer
1572231|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
1572232|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
1572233|NCT00493688|CPET|cpet
1572234|NCT00493675|Cystic duct leakage|cystic duct leakage
1572235|NCT00493636|Breast Cancer|breast cancer
1572236|NCT00493610|Oxidant stress|oxidant stress
1572237|NCT00493610|N-acetylcysteine|n-acetylcysteine
1572238|NCT00493610|Hepatitis C|hepatitis c
1572239|NCT00493610|Liver disease|liver disease
1572240|NCT00493610|Mucomyst|mucomyst
1572241|NCT00493610|Isoprostane|isoprostane
1572242|NCT00493597|Atherosclerosis|atherosclerosis
1572243|NCT00493597|Restenosis|restenosis
1572244|NCT00493597|EPC|epc
1572245|NCT00493597|DC|dc
1572246|NCT00493584|Myocardial Infarction|myocardial infarction
1572247|NCT00493584|Myocardial Ischemia|myocardial ischemia
1572248|NCT00493584|Myocardial Revascularization|myocardial revascularization
1572249|NCT00493584|Telemedicine|telemedicine
1572250|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1572251|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
1572252|NCT00493571|MDS|mds
1572253|NCT00493571|Gimatecan|gimatecan
1572254|NCT00493571|Leukemia|leukemia
1572255|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
1572256|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
1572257|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
1572258|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
1572259|NCT00493545|Multicenter|multicenter
1572260|NCT00493545|Open-Label|open-label
1572261|NCT00493545|Nonrandomized|nonrandomized
1572262|NCT00493545|Safety|safety
1572263|NCT00493519|Cephalic phase|cephalic phase
1572264|NCT00493519|Anorexia nervosa|anorexia nervosa
1572265|NCT00493519|Bulimia nervosa|bulimia nervosa
1572266|NCT00493519|obese binge eaters|obese binge eaters
1572267|NCT00493519|VAS|vas
1572268|NCT00493519|EDI|edi
1572269|NCT00493519|shame-feed procedure|shame-feed procedure
1572270|NCT00493506|ProAlgaZyme|proalgazyme
1572271|NCT00493506|HIV|hiv
1572272|NCT00493506|HAART|haart
1572273|NCT00493506|hsCRP|hscrp
1572274|NCT00493506|Oxidative stress|oxidative stress
1572275|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
1572276|NCT00493506|Algae|algae
1572277|NCT00493506|HAART adverse effects|haart adverse effects
1572278|NCT00493506|HBV|hbv
1572279|NCT00493493|Cymetra|cymetra
1572280|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1572281|NCT00493467|Lymphoma|lymphoma
1572282|NCT00493467|Indolent Lymphomas|indolent lymphomas
1572283|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
1572284|NCT00493467|Zevalin|zevalin
1572285|NCT00493454|Indolent Lymphoma|indolent lymphoma
1572286|NCT00493454|Extranodal Marginal|extranodal marginal
1572287|NCT00493454|Nodal Marginal Zone|nodal marginal zone
1572288|NCT00493454|Splenic Marginal|splenic marginal
1572289|NCT00493454|MALT Type|malt type
1572290|NCT00493454|Zevalin|zevalin
1572291|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
1572292|NCT00493454|Rituximab|rituximab
1572293|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
1572294|NCT00493428|GABAergic Activity|gabaergic activity
1572295|NCT00493428|Baclofen|baclofen
1572296|NCT00493415|microcirculation|microcirculation
1572297|NCT00493415|sepsis|sepsis
1572298|NCT00493415|nitroglycerine|nitroglycerine
1572299|NCT00493415|SDF imaging|sdf imaging
1572300|NCT00493402|Antineoplastic Agents|antineoplastic agents
1572301|NCT00493402|administration & dosage|administration & dosage
1572302|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1572303|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1572304|NCT00493402|Humans|humans
1572305|NCT00493402|Liver Neoplasms|liver neoplasms
1572306|NCT00493402|therapy|therapy
1572307|NCT00493389|ACTH stimulation test|acth stimulation test
1572308|NCT00493389|cortisol|cortisol
1572309|NCT00493389|stress|stress
1572310|NCT00493376|tirapazamine|tirapazamine
1572311|NCT00493376|DNA damage|dna damage
1572312|NCT00493376|comet assay|comet assay
1572313|NCT00493363|falciparum malaria|falciparum malaria
1572314|NCT00493363|artemisinins|artemisinins
1572315|NCT00493363|artesunate|artesunate
1572316|NCT00493363|resistance|resistance
1572317|NCT00493350|Breast Cancer|breast cancer
1572318|NCT00493350|Circulating Tumor Cells|circulating tumor cells
1572319|NCT00493350|Gene Profiling|gene profiling
1572320|NCT00493350|International Stage Stratification Study|international stage stratification study
1572321|NCT00493350|Blood Sample|blood sample
1572322|NCT00493350|ISSS|isss
1572323|NCT00493337|Adherence|adherence
1572324|NCT00493337|Compliance|compliance
1572325|NCT00493337|Statins|statins
1572326|NCT00493337|Intervention|intervention
1572327|NCT00493337|Hypercholesterolemia|hypercholesterolemia
1572328|NCT00493324|psoriasis|psoriasis
1572329|NCT00493324|alefacept|alefacept
1572330|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
1572331|NCT00493324|Immunization|immunization
1572332|NCT00493298|disease progression|disease progression
1572333|NCT00493298|Multiple Sclerosis|multiple sclerosis
1572334|NCT00493298|disease activity|disease activity
1572335|NCT00493298|Tysabri|tysabri
1572336|NCT00493298|natalizumab|natalizumab
1572337|NCT00493298|long-term safety|long-term safety
1572338|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
1572339|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
1572340|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
1572341|NCT00493272|Hemodilution|hemodilution
1572342|NCT00493272|Fibrinogen|fibrinogen
1572343|NCT00493272|Hemostasis|hemostasis
1572345|NCT00493259|Health-Related Quality of Life|health-related quality of life
1572346|NCT00493233|schizophrenia|schizophrenia
1572347|NCT00493233|antipsychotics|antipsychotics
1572348|NCT00493233|polypharmacy|polypharmacy
1572349|NCT00493233|double-blind|double-blind
1572350|NCT00493233|randomized|randomized
1572351|NCT00493220|ceftriaxone|ceftriaxone
1572352|NCT00493220|cephalosporins|cephalosporins
1572353|NCT00493220|pharmacokinetics|pharmacokinetics
1572354|NCT00493220|subcutaneous|subcutaneous
1572355|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1572356|NCT00493220|hyaluronidase|hyaluronidase
1572357|NCT00493220|hyaluronan|hyaluronan
1572358|NCT00493220|rHuPH20|rhuph20
1572359|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
1572360|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
1572361|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
1572362|NCT00493194|Sirolimus|sirolimus
1572363|NCT00493181|oprelvekin|oprelvekin
1572364|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1572365|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1572366|NCT00493181|Leukemia|leukemia
1572367|NCT00493181|CML|cml
1572368|NCT00493181|Thrombocytopenia|thrombocytopenia
1572369|NCT00493181|Imatinib|imatinib
1572370|NCT00493181|IL-11|il-11
1572371|NCT00493181|Interleukin 11|interleukin 11
1572372|NCT00493181|Neumega|neumega
1572373|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
1572374|NCT00493129|SM|sm
1572375|NCT00493129|Mast Cell Leukemia|mast cell leukemia
1572376|NCT00493129|Leukemia|leukemia
1572377|NCT00493129|Denileukin Diftitox|denileukin diftitox
1572378|NCT00493129|Ontak|ontak
1572379|NCT00493116|recovery of efficacy|recovery of efficacy
1572380|NCT00493116|MxA protein|mxa protein
1572381|NCT00493116|neutralizing antibodies|neutralizing antibodies
1572382|NCT00493116|Multiple sclerosis|multiple sclerosis
1572782|NCT00491608|safety|safety
1572383|NCT00493103|thyroglobulin gene|thyroglobulin gene
1572384|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
1572385|NCT00493103|gene mutations|gene mutations
1572386|NCT00493103|fetal goiter|fetal goiter
1572387|NCT00493103|iodine nutrition|iodine nutrition
1572388|NCT00493090|Professional|professional
1572389|NCT00493090|patient partnership|patient partnership
1572390|NCT00493090|patient satisfaction|patient satisfaction
1572391|NCT00493090|professional training|professional training
1572392|NCT00493077|Multiple Sclerosis|multiple sclerosis
1572393|NCT00493077|Neutralizing antibodies|neutralizing antibodies
1572394|NCT00493077|Safety|safety
1572395|NCT00493077|Low immunogenicity|low immunogenicity
1572396|NCT00493077|interferon|interferon
1572397|NCT00493077|interferon-beta-1a|interferon-beta-1a
1572398|NCT00493051|diabetes|diabetes
1572399|NCT00493051|nonhealing|nonhealing
1572400|NCT00493051|ulcers|ulcers
1572401|NCT00493051|neuropathic|neuropathic
1572402|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
1572403|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1572404|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
1572405|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
1572406|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
1572407|NCT00493012|body weight|body weight
1572408|NCT00493012|body compostion|body compostion
1572409|NCT00493012|vitamin D|vitamin d
1572410|NCT00493012|blood pressure|blood pressure
1572411|NCT00492999|recurrent colon cancer|recurrent colon cancer
1572412|NCT00492999|stage IV colon cancer|stage iv colon cancer
1572413|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
1572414|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
1572415|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
1572416|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1572417|NCT00492999|liver metastases|liver metastases
1572418|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
1572419|NCT00492986|Cancer|cancer
1572420|NCT00492973|arthroplasty|arthroplasty
1572421|NCT00492973|replacement|replacement
1572422|NCT00492973|knee|knee
1572423|NCT00492960|larazotide acetate|larazotide acetate
1572424|NCT00492947|Phase I|phase i
1572425|NCT00492947|dendritic cell|dendritic cell
1572426|NCT00492947|vaccine|vaccine
1572427|NCT00492947|intra tumoral|intra tumoral
1572428|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
1572429|NCT00492934|subfertility|subfertility
1572430|NCT00492934|endometrium thickness|endometrium thickness
1572431|NCT00492934|implantation rate|implantation rate
1572432|NCT00492934|embryo cryopreservation|embryo cryopreservation
1572433|NCT00492934|embryo transfer|embryo transfer
1572434|NCT00492921|graft versus host disease|graft versus host disease
1572435|NCT00492908|Coronary Revascularization|coronary revascularization
1572436|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
1572437|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
1572438|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
1572439|NCT00492882|Follicular Arrest|follicular arrest
1572440|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
1572442|NCT00492869|kidney transplantation|kidney transplantation
1572443|NCT00492869|rejection|rejection
1572444|NCT00492869|AEB071|aeb071
1572445|NCT00492869|tacrolimus|tacrolimus
1572446|NCT00492869|mycophenolic|mycophenolic
1572447|NCT00492869|basiliximab|basiliximab
1572448|NCT00492869|immunosuppression|immunosuppression
1572449|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1572450|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1572451|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1572452|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
1572453|NCT00492830|Phase 1|phase 1
1572454|NCT00492830|TRC093|trc093
1572455|NCT00492830|denatured collagen|denatured collagen
1572456|NCT00492830|solid tumor|solid tumor
1572457|NCT00492830|antibody|antibody
1572458|NCT00492830|TRACON|tracon
1572459|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
1572460|NCT00492830|Metastatic solid tumors|metastatic solid tumors
1572461|NCT00492817|Spinal Neoplasms|spinal neoplasms
1572462|NCT00492817|Paraspinal Metastases|paraspinal metastases
1572463|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
1572464|NCT00492817|CT-on-Rails|ct-on-rails
1572465|NCT00492817|Spinal Cord|spinal cord
1572466|NCT00492817|SBRT|sbrt
1572467|NCT00492804|inguinal hernia|inguinal hernia
1572468|NCT00492804|chronic pain|chronic pain
1572469|NCT00492804|neurectomy|neurectomy
1572470|NCT00492804|hypesthesia|hypesthesia
1572471|NCT00492791|crohn's disease|crohn's disease
1572472|NCT00492791|capsule endoscopes|capsule endoscopes
1572473|NCT00492765|Combination therapy|combination therapy
1572474|NCT00492765|Simvastatin|simvastatin
1572475|NCT00492765|Multiple Sclerosis|multiple sclerosis
1572476|NCT00492765|Interferon-beta-1a|interferon-beta-1a
1572477|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
1572478|NCT00492739|Pediatric|pediatric
1572479|NCT00492739|Immunosuppression|immunosuppression
1572480|NCT00492739|Varicella vaccine|varicella vaccine
1572481|NCT00492739|B cell response|b cell response
1572482|NCT00492739|T cell response|t cell response
1572483|NCT00492739|Antibodies|antibodies
1572484|NCT00492739|Varicella|varicella
1572485|NCT00492739|Chickenpox|chickenpox
1572486|NCT00492739|transplantation|transplantation
1572487|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
1572488|NCT00492713|Bioavailability|bioavailability
1572489|NCT00492713|Dark Chocolate|dark chocolate
1572490|NCT00492713|Milk Chocolate|milk chocolate
1572491|NCT00492713|Polyphenols|polyphenols
1572492|NCT00492700|steatosis,|steatosis,
1572493|NCT00492700|fibrosis,|fibrosis,
1572494|NCT00492700|diabetes,|diabetes,
1572495|NCT00492700|obesity|obesity
1572496|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1572497|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
1572498|NCT00492687|adult gliosarcoma|adult gliosarcoma
1572499|NCT00492687|adult glioblastoma|adult glioblastoma
1572500|NCT00492674|TKA|tka
1572501|NCT00492674|Arthroplasty|arthroplasty
1572502|NCT00492674|Knee|knee
1572503|NCT00492674|Osteoarthritis|osteoarthritis
1572504|NCT00492674|Rehabilitation|rehabilitation
1572505|NCT00492661|Tacrolimus|tacrolimus
1572506|NCT00492661|Prograf|prograf
1572507|NCT00492661|PRIDE|pride
1572508|NCT00492648|GSK Biologicals|gsk biologicals
1572509|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
1572510|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
1572511|NCT00492648|Vaccine|vaccine
1572512|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
1572513|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
1572514|NCT00492648|Shingles|shingles
1572515|NCT00492622|Gastroparesis|gastroparesis
1572516|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
1572517|NCT00492622|heartburn|heartburn
1572518|NCT00492609|Surgery|surgery
1572519|NCT00492609|Navigation|navigation
1572520|NCT00492609|ACL|acl
1572521|NCT00492609|IKDC|ikdc
1572522|NCT00492609|comparative study|comparative study
1572523|NCT00492583|probiotic|probiotic
1572524|NCT00492583|health|health
1572525|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
1572526|NCT00492583|BB-12|bb-12
1572527|NCT00492570|Multiple Sclerosis|multiple sclerosis
1572528|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
1572529|NCT00492570|early treatment|early treatment
1572530|NCT00492570|Avonex|avonex
1572531|NCT00492570|interferon beta 1a|interferon beta 1a
1572532|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
1572533|NCT00492557|Pneumococcal Disease|pneumococcal disease
1572534|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
1572535|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1572536|NCT00492544|safety|safety
1572537|NCT00492544|cervical cancer|cervical cancer
1572538|NCT00492544|immunogenicity|immunogenicity
1572539|NCT00492544|vaccine|vaccine
1572540|NCT00492544|viral infections|viral infections
1572541|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
1572542|NCT00492531|Interventional Study|interventional study
1572543|NCT00492531|6-Minute Walk|6-minute walk
1572544|NCT00492531|Sickle Cell Anemia|sickle cell anemia
1572545|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
1572546|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
1572547|NCT00492531|Sickle Cell Disease|sickle cell disease
1572548|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
1572549|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
1572550|NCT00492518|Prophylaxis|prophylaxis
1572551|NCT00492518|Theophylline|theophylline
1572552|NCT00492518|Acetylcysteine|acetylcysteine
1572553|NCT00492518|Coronary angiography|coronary angiography
1572554|NCT00492505|stage IIIA melanoma|stage iiia melanoma
1572555|NCT00492505|stage IIIB melanoma|stage iiib melanoma
1572556|NCT00492505|stage IIIC melanoma|stage iiic melanoma
1572557|NCT00492492|radius,|radius,
1572558|NCT00492492|pinning,|pinning,
1572559|NCT00492492|fixed-angle plate,|fixed-angle plate,
1572560|NCT00492492|quick-DASH,|quick-dash,
1572561|NCT00492492|HERZBERG-score.|herzberg-score.
1572562|NCT00492466|Multiple Sclerosis|multiple sclerosis
1572563|NCT00492466|antibody|antibody
1572564|NCT00492466|Neutralizing antibody|neutralizing antibody
1572565|NCT00492466|Binding antibody|binding antibody
1572566|NCT00492466|MxA protein|mxa protein
1572567|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
1572568|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
1572569|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
1572570|NCT00492440|recurrent melanoma|recurrent melanoma
1572571|NCT00492440|stage IV melanoma|stage iv melanoma
1572572|NCT00492414|Panic disorder (PD)|panic disorder (pd)
1572573|NCT00492388|breakthrough|breakthrough
1572574|NCT00492388|pain|pain
1572575|NCT00492388|cancer|cancer
1572576|NCT00492362|hemodialysis|hemodialysis
1572577|NCT00492362|exercise|exercise
1572578|NCT00492362|physical fitness|physical fitness
1572579|NCT00492362|dialysis adequacy|dialysis adequacy
1572580|NCT00492349|Varenicline|varenicline
1572581|NCT00492349|Neurobiology|neurobiology
1572582|NCT00492349|clinical trial|clinical trial
1572583|NCT00492349|cognitive deficits|cognitive deficits
1572584|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
1572585|NCT00492336|Cognitive impairments|cognitive impairments
1572586|NCT00492336|Negative symptoms|negative symptoms
1572587|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
1572588|NCT00492323|herpes virus|herpes virus
1572589|NCT00492323|rash|rash
1572590|NCT00492323|varicella-zoster virus|varicella-zoster virus
1572591|NCT00492323|shingles.|shingles.
1572592|NCT00492310|Smoking|smoking
1572593|NCT00492310|tobacco|tobacco
1572594|NCT00492310|women|women
1572595|NCT00492310|yoga|yoga
1572596|NCT00492284|Macular Degeneration|macular degeneration
1572597|NCT00492284|AMD|amd
1572598|NCT00492284|CNV|cnv
1572599|NCT00492284|Choroidal neovascularization|choroidal neovascularization
1572600|NCT00492284|Photodynamic therapy|photodynamic therapy
1573002|NCT00490568|BRL-049653|brl-049653
1572601|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
1572602|NCT00492271|Friulimicin B|friulimicin b
1572603|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
1572604|NCT00492271|First in Man|first in man
1572605|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
1572606|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
1572607|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
1572608|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
1572609|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1572610|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
1572611|NCT00492245|PTK|ptk
1572612|NCT00492245|corneal opacity|corneal opacity
1572613|NCT00492245|mitomycin|mitomycin
1572614|NCT00492232|Chronic Insomnia|chronic insomnia
1572615|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
1572616|NCT00492232|Drug Therapy|drug therapy
1572617|NCT00492219|arthroplasty|arthroplasty
1572618|NCT00492219|replacement|replacement
1572619|NCT00492219|knee|knee
1572620|NCT00492219|prosthesis|prosthesis
1572621|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
1572622|NCT00492206|NSCLC|nsclc
1572623|NCT00492206|EGFR Inhibitor|egfr inhibitor
1572624|NCT00492206|Radiation Therapy|radiation therapy
1572826|NCT00491335|Emphysema|emphysema
1572625|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
1572626|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
1572627|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
1572628|NCT00492167|regional neuroblastoma|regional neuroblastoma
1572629|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
1572630|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
1572631|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
1572632|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
1572633|NCT00492141|Lung Involvement|lung involvement
1572634|NCT00492141|Temozolomide|temozolomide
1572636|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
1572637|NCT00492141|Aerosol L9-NC|aerosol l9-nc
1572638|NCT00492141|L9-NC|l9-nc
1572639|NCT00492128|hypertension|hypertension
1572640|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
1572641|NCT00492128|diuretic|diuretic
1572642|NCT00492128|combination therapy|combination therapy
1572643|NCT00492115|sleep|sleep
1572644|NCT00492115|dementia|dementia
1572645|NCT00492115|apnea|apnea
1572646|NCT00492115|memory|memory
1572647|NCT00492115|Parkinson's disease|parkinson's disease
1572648|NCT00492102|pharmacokinetics|pharmacokinetics
1572649|NCT00492102|Montelukast|montelukast
1572650|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1572651|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
1572652|NCT00492076|Specific immunotherapy|specific immunotherapy
1572653|NCT00492076|Mite|mite
1572654|NCT00492076|Asthma|asthma
1572655|NCT00492063|safety|safety
1572656|NCT00492063|immunogenicity|immunogenicity
1572657|NCT00492063|non-inferiority|non-inferiority
1572658|NCT00492063|MDCK|mdck
1572659|NCT00492063|cell culture-derived|cell culture-derived
1572660|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
1572661|NCT00492063|influenza prevention|influenza prevention
1572662|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1572663|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
1572664|NCT00492050|Stem Cell Collection|stem cell collection
1572665|NCT00492050|Bortezomib|bortezomib
1572666|NCT00492050|LDP-341|ldp-341
1572667|NCT00492050|MLN341|mln341
1572668|NCT00492050|PS-341|ps-341
1572669|NCT00492050|Velcade|velcade
1572670|NCT00492050|Rituximab|rituximab
1572671|NCT00492050|Rituxan|rituxan
1572672|NCT00492037|hyponatremia|hyponatremia
1572673|NCT00492037|hypervolemic|hypervolemic
1572674|NCT00492037|euvolemic|euvolemic
1572675|NCT00492037|conivaptan|conivaptan
1572676|NCT00492024|Respiratory Tract Infection|respiratory tract infection
1572677|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
1572678|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
1572679|NCT00492011|Biological Clock Disturbances|biological clock disturbances
1572680|NCT00492011|Jet Lag Syndrome|jet lag syndrome
1572681|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
1572682|NCT00492011|Drug Therapy|drug therapy
1572683|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
1572684|NCT00491985|Influenza Pandemic|influenza pandemic
1572685|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
1572686|NCT00491959|oral mucosa|oral mucosa
1572687|NCT00491959|limbal insufficiency|limbal insufficiency
1572688|NCT00491959|transplantation|transplantation
1572689|NCT00491959|cornea|cornea
1572690|NCT00491959|ocular surface|ocular surface
1572691|NCT00491946|Cancer|cancer
1572692|NCT00491946|Actinomycin|actinomycin
1572693|NCT00491946|Vincristine|vincristine
1572694|NCT00491920|osteoporosis|osteoporosis
1572695|NCT00491920|bone mineral density|bone mineral density
1572696|NCT00491920|vitamin D|vitamin d
1572697|NCT00491907|folic acid|folic acid
1572698|NCT00491907|endothelial function|endothelial function
1572699|NCT00491907|baroreceptor function|baroreceptor function
1572700|NCT00491907|heart failure|heart failure
1572701|NCT00491894|Mental Retardation|mental retardation
1572702|NCT00491894|Neurological Impairment|neurological impairment
1572703|NCT00491894|Cerebral Palsy|cerebral palsy
1572704|NCT00491894|Drooling|drooling
1572705|NCT00491894|Neurological Conditions|neurological conditions
1572706|NCT00491881|blood pressure|blood pressure
1572707|NCT00491881|No added salt diet|no added salt diet
1572708|NCT00491881|urinary sodium|urinary sodium
1572709|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
1572710|NCT00491855|Peritoneal Cancer|peritoneal cancer
1572711|NCT00491855|Bevacizumab|bevacizumab
1572712|NCT00491855|Avastin|avastin
1572713|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
1572714|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1572715|NCT00491855|rhuMAb-VEGF|rhumab-vegf
1572716|NCT00491855|Oxaliplatin|oxaliplatin
1572717|NCT00491855|Eloxatin|eloxatin
1572718|NCT00491855|Paclitaxel|paclitaxel
1572719|NCT00491855|Taxol|taxol
1572720|NCT00491842|Huntington's Disease|huntington's disease
1572721|NCT00491842|Disclosure|disclosure
1572722|NCT00491842|Adaptation|adaptation
1572723|NCT00491842|Communication About Huntington's Disease|communication about huntington's disease
1572724|NCT00491842|Huntington Disease|huntington disease
1572726|NCT00491842|Phone Interview|phone interview
1572728|NCT00491816|cancer|cancer
1572729|NCT00491816|breast cancer|breast cancer
1572730|NCT00491803|COPD|copd
1572731|NCT00491790|montelukast|montelukast
1572732|NCT00491790|Albuterol|albuterol
1572733|NCT00491790|Status Asthmaticus|status asthmaticus
1572734|NCT00491790|Asthma|asthma
1572735|NCT00491777|Noninvasive|noninvasive
1572736|NCT00491777|Hemodynamic|hemodynamic
1572737|NCT00491777|Monitoring|monitoring
1572738|NCT00491777|Critical Care|critical care
1572739|NCT00491777|Swan-Ganz|swan-ganz
1572740|NCT00491751|endothelium|endothelium
1572741|NCT00491751|nitric oxide|nitric oxide
1572742|NCT00491751|statins|statins
1572743|NCT00491751|ascorbic acid|ascorbic acid
1572744|NCT00491738|RCC|rcc
1572745|NCT00491738|Renal cell cancer|renal cell cancer
1572746|NCT00491738|Avastin|avastin
1572747|NCT00491738|Sutent|sutent
1572748|NCT00491712|Glaucoma|glaucoma
1572749|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
1572750|NCT00491712|Drainage implant devices|drainage implant devices
1572751|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
1572752|NCT00491712|Triamcinolone|triamcinolone
1572753|NCT00491699|NSCLC|nsclc
1572754|NCT00491686|Long-term depression|long-term depression
1572755|NCT00491673|Fracture|fracture
1572756|NCT00491673|Femoral neck|femoral neck
1572757|NCT00491673|Arthroplasty|arthroplasty
1572758|NCT00491660|Gravity|gravity
1572759|NCT00491660|Mechanical ventilation|mechanical ventilation
1572760|NCT00491660|Infants|infants
1572761|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
1572762|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
1572763|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
1572764|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
1572765|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
1572766|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
1572767|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1572768|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
1572769|NCT00491634|treosulfan|treosulfan
1572770|NCT00491621|kidney|kidney
1572771|NCT00491621|tumor|tumor
1572772|NCT00491621|Molecular Markers|molecular markers
1572773|NCT00491621|Cytology|cytology
1572774|NCT00491621|Histology|histology
1572775|NCT00491621|Cystic kidney tumor|cystic kidney tumor
1572776|NCT00491608|Phase 3b|phase 3b
1572777|NCT00491608|rThrombin|rthrombin
1572778|NCT00491608|spine surgery|spine surgery
1572779|NCT00491608|vascular surgery|vascular surgery
1572780|NCT00491608|hemostasis|hemostasis
1572781|NCT00491608|immunogenicity|immunogenicity
1572783|NCT00491595|Soy isoflavones|soy isoflavones
1572784|NCT00491595|Genotoxicity|genotoxicity
1572785|NCT00491595|Apoptosis|apoptosis
1572786|NCT00491595|Estrogenic effects|estrogenic effects
1572787|NCT00491569|Schizophrenia|schizophrenia
1572788|NCT00491569|sarcosine|sarcosine
1572789|NCT00491569|D-serine|d-serine
1572790|NCT00491569|NMDA|nmda
1572791|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
1572792|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
1572793|NCT00491556|Treatment Naive|treatment naive
1572794|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1572795|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
1572796|NCT00491491|radioimmunotherapy|radioimmunotherapy
1572797|NCT00491491|zevalin|zevalin
1572798|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
1572799|NCT00491478|Stereotypy|stereotypy
1572800|NCT00491478|Sertraline|sertraline
1572903|NCT00491036|cardiogenic shock|cardiogenic shock
1573498|NCT00488696|Stent-Graft|stent-graft
1572801|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
1572802|NCT00491452|Ischemic MR|ischemic mr
1572803|NCT00491452|Annuloplasty|annuloplasty
1572804|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
1572805|NCT00491439|vitrectomy|vitrectomy
1572806|NCT00491439|corneal transplantation|corneal transplantation
1572807|NCT00491439|Epi-LASIK|epi-lasik
1572808|NCT00491439|wound healing|wound healing
1572809|NCT00491426|Infection|infection
1572810|NCT00491426|Anti-Infective Agents|anti-infective agents
1572811|NCT00491426|Antifungal Agents|antifungal agents
1572812|NCT00491426|Proteomics|proteomics
1572813|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
1572814|NCT00491400|endothelium|endothelium
1572815|NCT00491400|obesity|obesity
1572816|NCT00491400|diabetes mellitus|diabetes mellitus
1572817|NCT00491400|dyslipidemia|dyslipidemia
1572818|NCT00491387|hypertension|hypertension
1572819|NCT00491387|sympathetic nervous system|sympathetic nervous system
1572820|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
1572821|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
1572822|NCT00491348|fMRI|fmri
1572823|NCT00491348|Worry|worry
1572824|NCT00491335|AIDS|aids
1572825|NCT00491335|Lung Cancer|lung cancer
1572828|NCT00491335|HIV Infection|hiv infection
1572829|NCT00491335|Smoking|smoking
1572830|NCT00491322|Vitamin D|vitamin d
1572831|NCT00491322|Vitamin D deficiency|vitamin d deficiency
1572832|NCT00491322|Insulin resistance|insulin resistance
1572833|NCT00491322|Diabetes|diabetes
1572834|NCT00491322|Diabetes mellitus|diabetes mellitus
1572835|NCT00491322|FGF-23|fgf-23
1572836|NCT00491322|FGF23|fgf23
1572837|NCT00491322|Phosphate|phosphate
1572838|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
1572839|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
1572840|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
1572841|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
1572842|NCT00491270|Premature Birth|premature birth
1572843|NCT00491257|Influenza|influenza
1572844|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
1572845|NCT00491257|Orthomyxoviruses|orthomyxoviruses
1572846|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
1572847|NCT00491244|Chronic hepatitis C|chronic hepatitis c
1572848|NCT00491244|Hemodialysis|hemodialysis
1572849|NCT00491244|Interferon|interferon
1572850|NCT00491244|Ribavirin|ribavirin
1572851|NCT00491231|orthostatic hypotension|orthostatic hypotension
1572852|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1572853|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
1572854|NCT00491218|downstream resource utilization|downstream resource utilization
1572855|NCT00491192|Fever|fever
1572856|NCT00491192|Acute cerebral damage|acute cerebral damage
1572857|NCT00491192|Normothermia|normothermia
1572858|NCT00491192|Diclofenac|diclofenac
1572859|NCT00491192|ICU|icu
1572860|NCT00491192|Outcome|outcome
1572861|NCT00491192|Intracranial pressure|intracranial pressure
1572862|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
1572863|NCT00491192|Traumatic brain injury|traumatic brain injury
1572864|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
1572865|NCT00491179|Chronic hepatitis C|chronic hepatitis c
1572866|NCT00491179|hemodialysis|hemodialysis
1572867|NCT00491179|interferon|interferon
1572868|NCT00491179|ribavirin|ribavirin
1572869|NCT00491166|diabetic macular edema|diabetic macular edema
1572870|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
1572871|NCT00491153|asthma|asthma
1572872|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
1572873|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
1572874|NCT00491153|methacholine|methacholine
1572875|NCT00491140|EGFR|egfr
1572876|NCT00491140|KRAS|kras
1572877|NCT00491140|BRAF|braf
1572878|NCT00491140|MET|met
1572879|NCT00491140|IGFR1|igfr1
1572880|NCT00491101|Asthma Control|asthma control
1572881|NCT00491101|Quality of Life|quality of life
1572882|NCT00491101|Children|children
1572883|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
1572884|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
1572885|NCT00491075|Non-Clear Cell|non-clear cell
1572886|NCT00491075|Pemetrexed|pemetrexed
1572887|NCT00491075|Gemcitabine|gemcitabine
1572888|NCT00491075|LY231514|ly231514
1572890|NCT00491075|MTA|mta
1572891|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
1572892|NCT00491075|NSC-698037|nsc-698037
1572893|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1572894|NCT00491075|Gemzar|gemzar
1572895|NCT00491075|RCC|rcc
1572896|NCT00491062|Parkinson's disease|parkinson's disease
1572897|NCT00491062|enteric nervous system|enteric nervous system
1572898|NCT00491049|prophylaxis|prophylaxis
1572899|NCT00491049|intraocular surgery|intraocular surgery
1572900|NCT00491049|endophthalmitis|endophthalmitis
1572901|NCT00491049|antibiotic|antibiotic
1572902|NCT00491036|Acute myocardial infarction|acute myocardial infarction
1572904|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
1572905|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
1572906|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
1572907|NCT00491010|atrial flutter|atrial flutter
1572908|NCT00491010|ablation|ablation
1572909|NCT00491010|voltage targeted|voltage targeted
1572910|NCT00490997|ketamine|ketamine
1572911|NCT00490997|propofol|propofol
1572912|NCT00490997|sedation|sedation
1572913|NCT00490997|pediatric|pediatric
1572914|NCT00490997|emergency department|emergency department
1572915|NCT00490997|fracture|fracture
1572916|NCT00490984|obstructive sleep apena|obstructive sleep apena
1572917|NCT00490984|tongue|tongue
1572918|NCT00490984|surgery|surgery
1572919|NCT00490971|Bipolar Disorder|bipolar disorder
1572920|NCT00490971|Mania|mania
1572921|NCT00490971|Depression|depression
1572922|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
1572923|NCT00490958|heart Failure|heart failure
1572924|NCT00490958|haemodialysis|haemodialysis
1572925|NCT00490958|telmisartan|telmisartan
1572926|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1572927|NCT00490932|Watery diarrhea|watery diarrhea
1573225|NCT00489697|bevacizumab|bevacizumab
1572928|NCT00490932|Bloody diarrhea|bloody diarrhea
1572929|NCT00490919|Chronic pain|chronic pain
1572930|NCT00490919|opioid|opioid
1572931|NCT00490919|transdermal|transdermal
1572932|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
1572933|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
1572934|NCT00490893|counterregulation|counterregulation
1572935|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
1572936|NCT00490893|insulin therapy|insulin therapy
1572937|NCT00490828|Cardiac surgery|cardiac surgery
1572938|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1572939|NCT00490828|health-related quality of life|health-related quality of life
1572940|NCT00490802|Autism|autism
1572941|NCT00490802|Treatment|treatment
1572942|NCT00490802|Oxytocin|oxytocin
1572943|NCT00490802|Adults|adults
1572944|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
1572945|NCT00490789|tuberous sclerosis|tuberous sclerosis
1572946|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
1572947|NCT00490789|sirolimus|sirolimus
1572948|NCT00490789|angiomyolioma|angiomyolioma
1572949|NCT00490789|rapamycin|rapamycin
1572950|NCT00490789|mTOR|mtor
1572951|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1572952|NCT00490776|adults|adults
1572953|NCT00490776|Mycosis Fungoides|mycosis fungoides
1572954|NCT00490776|Sézary Syndrome|sézary syndrome
1572955|NCT00490776|CTCL|ctcl
1572956|NCT00490763|Prostate Cancer|prostate cancer
1572957|NCT00490763|Active Surveillance|active surveillance
1572958|NCT00490763|Prostate Specific Antigen|prostate specific antigen
1572959|NCT00490763|Questionnaire|questionnaire
1572960|NCT00490763|Survey|survey
1572961|NCT00490750|Heller Dor|heller dor
1572962|NCT00490750|Heller Toupet|heller toupet
1572963|NCT00490750|Myotomy|myotomy
1572964|NCT00490737|ESRD|esrd
1572965|NCT00490737|dialysis|dialysis
1572966|NCT00490737|hemodialysis|hemodialysis
1572967|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
1572968|NCT00490724|Heart failure, congestive|heart failure, congestive
1572969|NCT00490724|Nesiritide and|nesiritide and
1572970|NCT00490724|JNS004|jns004
1572971|NCT00490698|Kidney Cancer|kidney cancer
1572972|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
1572973|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
1572974|NCT00490698|Zoledronate|zoledronate
1572975|NCT00490698|Zometa|zometa
1572976|NCT00490698|Atorvastatin|atorvastatin
1572977|NCT00490698|Lipitor|lipitor
1572978|NCT00490698|RCC|rcc
1572979|NCT00490672|Hypertension|hypertension
1572980|NCT00490672|Diabetes Mellitus|diabetes mellitus
1572981|NCT00490672|Hyperlipidaemia|hyperlipidaemia
1572982|NCT00490672|Primary Care|primary care
1572983|NCT00490672|Community Care|community care
1572984|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
1572985|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
1572986|NCT00490633|Influenza|influenza
1572987|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
1572988|NCT00490633|Face Mask|face mask
1572989|NCT00490633|Hand Hygiene|hand hygiene
1572990|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
1572991|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
1572992|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
1572993|NCT00490594|ACL|acl
1572994|NCT00490594|ligament|ligament
1572995|NCT00490594|ACL injury|acl injury
1572996|NCT00490581|Early housing after hospitalization|early housing after hospitalization
1572997|NCT00490568|cognition|cognition
1572998|NCT00490568|Alzheimer's disease|alzheimer's disease
1572999|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
1573000|NCT00490568|safety|safety
1573001|NCT00490568|adjunctive therapy|adjunctive therapy
1573003|NCT00490568|tolerability|tolerability
1573004|NCT00490568|open-label extension|open-label extension
1573005|NCT00490555|Male Contraception|male contraception
1573006|NCT00490555|Testosterone|testosterone
1573007|NCT00490555|Testis|testis
1573008|NCT00490555|Contraception|contraception
1573009|NCT00490555|Prostate|prostate
1573010|NCT00490542|Bipolar Disorder|bipolar disorder
1573011|NCT00490542|Major Depression|major depression
1573012|NCT00490542|Clinical pharmacology|clinical pharmacology
1573013|NCT00490542|Clinical Trial|clinical trial
1573014|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
1573015|NCT00490503|Breast Cancer|breast cancer
1573016|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
1573017|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1573018|NCT00490503|DCE-MRI|dce-mri
1573019|NCT00490503|DW-MRI|dw-mri
1573020|NCT00490503|MRS|mrs
1573021|NCT00490503|MRI|mri
1573022|NCT00490477|acute renal failure|acute renal failure
1573023|NCT00490477|lipopolysaccharide|lipopolysaccharide
1573024|NCT00490477|tubular apoptosis|tubular apoptosis
1573025|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
1573026|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
1573323|NCT00489424|transient|transient
1573027|NCT00490464|Patients with SAH or ICH|patients with sah or ich
1573028|NCT00490438|perineometry|perineometry
1573029|NCT00490438|Modified Oxford Score|modified oxford score
1573030|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
1573031|NCT00490438|urinary incontinence|urinary incontinence
1573032|NCT00490438|vaginal palpation|vaginal palpation
1573033|NCT00490425|probiotics|probiotics
1573034|NCT00490425|LGG|lgg
1573035|NCT00490425|praevention|praevention
1573036|NCT00490425|allergic asthma|allergic asthma
1573037|NCT00490425|children|children
1573038|NCT00490412|Vitamin D|vitamin d
1573039|NCT00490412|Treatment Experienced|treatment experienced
1573040|NCT00490386|Retrospective|retrospective
1573041|NCT00490386|Length of Stay|length of stay
1573042|NCT00490386|Helicobacter pylori|helicobacter pylori
1573043|NCT00490347|VentrAssistTM|ventrassisttm
1573044|NCT00490347|LVAD|lvad
1573045|NCT00490347|End-stage heart failure|end-stage heart failure
1573046|NCT00490347|Cardiomyopathy|cardiomyopathy
1573047|NCT00490334|Carcinomas|carcinomas
1573048|NCT00490334|Squamous Cel|squamous cel
1573049|NCT00490334|Adenocarcinoma|adenocarcinoma
1573050|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1573051|NCT00490321|VentrAssistTM|ventrassisttm
1573052|NCT00490321|LVAD|lvad
1573053|NCT00490321|End-stage heart failure|end-stage heart failure
1573054|NCT00490321|Cardiomyopathy|cardiomyopathy
1573055|NCT00490308|luteal|luteal
1573056|NCT00490308|phase|phase
1573057|NCT00490308|estradiol|estradiol
1573058|NCT00490308|pregnancy|pregnancy
1573059|NCT00490308|rate|rate
1573060|NCT00490295|biomarkers|biomarkers
1573061|NCT00490295|brain ischemia|brain ischemia
1573062|NCT00490295|neonates|neonates
1573063|NCT00490295|cardiac surgery|cardiac surgery
1573064|NCT00490295|congenital heart disease|congenital heart disease
1573065|NCT00490282|Head and Neck Cancer|head and neck cancer
1573066|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
1573067|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
1573068|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1573069|NCT00490282|IMRT|imrt
1573070|NCT00490282|ART|art
1573071|NCT00490269|Marijuana dependence|marijuana dependence
1573072|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
1573073|NCT00490256|Renal Complications|renal complications
1573074|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
1573075|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
1573076|NCT00490256|Modified Perfusion|modified perfusion
1573077|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
1573078|NCT00490256|Pediatrics|pediatrics
1573079|NCT00490256|Cardiac Defects|cardiac defects
1573080|NCT00490256|intestinal ischemia|intestinal ischemia
1573179|NCT00489866|OEF|oef
1573081|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
1573082|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
1573083|NCT00490256|Creatinine|creatinine
1573084|NCT00490256|C-reactive protein levels|c-reactive protein levels
1573085|NCT00490243|Asthma|asthma
1573086|NCT00490243|Children|children
1573087|NCT00490243|Exercise|exercise
1573088|NCT00490243|Pulmonary Function|pulmonary function
1573089|NCT00490243|Budesonide|budesonide
1573090|NCT00490243|Montelukast|montelukast
1573091|NCT00490243|Formoterol|formoterol
1573092|NCT00490230|Paromomycin|paromomycin
1573093|NCT00490230|Gentamicin|gentamicin
1573094|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
1573095|NCT00490217|incidence|incidence
1573096|NCT00490217|Finland|finland
1573097|NCT00490217|etiology|etiology
1573098|NCT00490217|liver cirrhosis|liver cirrhosis
1573099|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
1573100|NCT00490204|Placebo control|placebo control
1573101|NCT00490204|anti-histamine|anti-histamine
1573102|NCT00490204|Cetirizine|cetirizine
1573700|NCT00487929|cpap|cpap
1573103|NCT00490178|Type II diabetes|type ii diabetes
1573104|NCT00490178|dyslipidemia|dyslipidemia
1573105|NCT00490178|metformin|metformin
1573106|NCT00490178|fenofibrate|fenofibrate
1573107|NCT00490178|synordia|synordia
1573108|NCT00490152|HIV|hiv
1573109|NCT00490152|Microbicide Gel|microbicide gel
1573110|NCT00490152|HIV Seronegativity|hiv seronegativity
1573111|NCT00490139|Adjuvant|adjuvant
1573112|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
1573113|NCT00490139|Early stage breast cancer|early stage breast cancer
1573114|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
1573115|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
1573116|NCT00490126|Laparoscopy|laparoscopy
1573117|NCT00490126|Gynecology|gynecology
1573118|NCT00490126|Demographics|demographics
1573119|NCT00490126|Perioperative Care|perioperative care
1573120|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
1573121|NCT00490100|Growth Hormone|growth hormone
1573122|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
1573123|NCT00490100|Bone Age|bone age
1573124|NCT00490100|Growth Failure|growth failure
1573125|NCT00490100|XSCID|xscid
1573126|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
1573127|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
1573128|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
1573129|NCT00490087|Hysteroscopic resection|hysteroscopic resection
1573130|NCT00490087|Conservative treatment|conservative treatment
1573131|NCT00490087|Fertile women|fertile women
1573132|NCT00490074|AIDS Vaccines|aids vaccines
1573133|NCT00490074|Vaccines, DNA|vaccines, dna
1573134|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
1573135|NCT00490074|HIV Seronegativity|hiv seronegativity
1573136|NCT00490048|Ulcerative colits|ulcerative colits
1573137|NCT00490048|lung|lung
1573138|NCT00490048|Induced sputum|induced sputum
1573139|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
1573140|NCT00490035|Epilepsy|epilepsy
1573141|NCT00490035|Brivaracetam|brivaracetam
1573142|NCT00490035|Partial Onset Seizures|partial onset seizures
1573143|NCT00490022|Dihydrotestosterone|dihydrotestosterone
1573144|NCT00490022|Androgen|androgen
1573145|NCT00490022|Prostate|prostate
1573146|NCT00489970|Persistence|persistence
1573147|NCT00489970|immunogenicity|immunogenicity
1573148|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
1573149|NCT00489957|echocardiography|echocardiography
1573150|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1573151|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
1573152|NCT00489944|iris melanoma|iris melanoma
1573153|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
1573154|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
1573155|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
1573156|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
1573157|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
1573158|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
1573159|NCT00489931|Avian Influenza|avian influenza
1573160|NCT00489931|Healthy|healthy
1573161|NCT00489931|Immunity|immunity
1573162|NCT00489931|Preventive|preventive
1573163|NCT00489931|Bird Flu|bird flu
1573164|NCT00489931|Healthy Volunteer|healthy volunteer
1573165|NCT00489931|HV|hv
1573166|NCT00489905|prostate cancer|prostate cancer
1573167|NCT00489905|bone mineral density|bone mineral density
1573168|NCT00489892|traumatic brain injury|traumatic brain injury
1573169|NCT00489892|TBI|tbi
1573170|NCT00489892|working memory|working memory
1573171|NCT00489892|modafinil|modafinil
1573172|NCT00489892|fMRI|fmri
1573173|NCT00489892|MRI|mri
1573174|NCT00489879|Mobile Health Units|mobile health units
1573175|NCT00489879|Chronic Disease|chronic disease
1573176|NCT00489866|PTSD|ptsd
1573177|NCT00489866|Antidepressant|antidepressant
1573178|NCT00489866|Aripiprazole|aripiprazole
1573180|NCT00489866|OIF|oif
1573181|NCT00489853|COPD|copd
1573182|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
1573183|NCT00489827|Coronary Artery Bypass|coronary artery bypass
1573184|NCT00489827|Myocardial Protection|myocardial protection
1573185|NCT00489827|Angina, Unstable|angina, unstable
1573186|NCT00489827|Myocardial Ischemia|myocardial ischemia
1573187|NCT00489827|Myocardial Infarction|myocardial infarction
1573188|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
1573189|NCT00489827|Glutamate|glutamate
1573190|NCT00489814|Prostate Cancer|prostate cancer
1573191|NCT00489814|Prostate Proton Therapy|prostate proton therapy
1573192|NCT00489814|Proton Radiation Therapy|proton radiation therapy
1573193|NCT00489814|Proton Radiotherapy|proton radiotherapy
1573194|NCT00489814|Quality of Life|quality of life
1573195|NCT00489814|QOL|qol
1573196|NCT00489814|Questionnaire|questionnaire
1573197|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
1573198|NCT00489801|Exercise|exercise
1573199|NCT00489801|Heart failure|heart failure
1573200|NCT00489801|Coronary heart disease|coronary heart disease
1573201|NCT00489788|MRI|mri
1573202|NCT00489788|Ventricular Strain|ventricular strain
1573203|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
1573204|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
1573205|NCT00489762|Childhood|childhood
1573206|NCT00489762|Asthma|asthma
1573207|NCT00489762|Heating|heating
1573208|NCT00489762|Insulation|insulation
1573209|NCT00489762|Respiratory symptoms|respiratory symptoms
1573210|NCT00489749|Achilles tendon rupture|achilles tendon rupture
1573211|NCT00489749|Open surgical repair|open surgical repair
1573212|NCT00489749|Early functional mobilization|early functional mobilization
1573213|NCT00489749|Weightbearing|weightbearing
1573214|NCT00489749|Rehabilitation|rehabilitation
1573215|NCT00489736|Atrial Fibrillation|atrial fibrillation
1573216|NCT00489736|sinus rhythm|sinus rhythm
1573217|NCT00489736|amiodarone|amiodarone
1573218|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
1573219|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
1573220|NCT00489723|Pt. without internal stent|pt. without internal stent
1573221|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
1573222|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
1573223|NCT00489697|colorectal cancer|colorectal cancer
1573224|NCT00489697|hepatic metastases|hepatic metastases
1573226|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
1573227|NCT00489697|chemotherapy regimens|chemotherapy regimens
1573228|NCT00489697|tumor vascularity|tumor vascularity
1573229|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
1573230|NCT00489671|pancreatic cancer|pancreatic cancer
1573231|NCT00489671|precancerous condition|precancerous condition
1573232|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
1573233|NCT00489658|sleeping sickness|sleeping sickness
1573234|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
1573235|NCT00489658|combination|combination
1573236|NCT00489658|eflornithine|eflornithine
1573237|NCT00489658|nifurtimox|nifurtimox
1573238|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
1573239|NCT00489645|pramlintide|pramlintide
1573240|NCT00489645|gastric emptying|gastric emptying
1573241|NCT00489645|T1DM|t1dm
1573242|NCT00489645|postprandial|postprandial
1573243|NCT00489632|Leukemia|leukemia
1573244|NCT00489632|Pediatrics|pediatrics
1573245|NCT00489632|Cancer|cancer
1573246|NCT00489632|Coping|coping
1573247|NCT00489632|Caregiver|caregiver
1573248|NCT00489632|Questionnaire|questionnaire
1573249|NCT00489632|Children|children
1573250|NCT00489632|Resiliency|resiliency
1573251|NCT00489632|Adjustment|adjustment
1573252|NCT00489632|Illness-related factors|illness-related factors
1573253|NCT00489619|Infectious diseases|infectious diseases
1573254|NCT00489619|Democratic Republic of Congo|democratic republic of congo
1573255|NCT00489619|Malaria|malaria
1573256|NCT00489619|International|international
1573257|NCT00489619|Maternal and child health|maternal and child health
1573258|NCT00489619|Women's Health|women's health
1573259|NCT00489619|Global Network|global network
1573260|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
1573261|NCT00489606|SK3530|sk3530
1573262|NCT00489606|tamsulosin|tamsulosin
1573263|NCT00489606|hemodynamic interaction|hemodynamic interaction
1573264|NCT00489606|safety|safety
1573265|NCT00489593|Advanced Cancer|advanced cancer
1573266|NCT00489593|Weight Loss|weight loss
1573267|NCT00489593|Cachexia|cachexia
1573268|NCT00489593|Olanzapine|olanzapine
1573269|NCT00489593|Zyprexa|zyprexa
1573270|NCT00489593|Fluoxetine|fluoxetine
1573271|NCT00489593|Symbyax|symbyax
1573272|NCT00489580|stroke|stroke
1573273|NCT00489580|weakness|weakness
1573274|NCT00489580|motor recovery|motor recovery
1573275|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
1573276|NCT00489554|Primary vaccination|primary vaccination
1573277|NCT00489554|Safety|safety
1573278|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
1573279|NCT00489554|Pneumococcal disease|pneumococcal disease
1573280|NCT00489554|Immunogenicity|immunogenicity
1573281|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
1573283|NCT00489528|serostim|serostim
1573284|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
1573285|NCT00489528|Body Composition|body composition
1573286|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1573287|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
1573288|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
1573289|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
1573290|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
1573291|NCT00489515|stage I colon cancer|stage i colon cancer
1573292|NCT00489515|stage II colon cancer|stage ii colon cancer
1573293|NCT00489515|stage III colon cancer|stage iii colon cancer
1573294|NCT00489515|stage IV colon cancer|stage iv colon cancer
1573295|NCT00489515|stage I gastric cancer|stage i gastric cancer
1573296|NCT00489515|stage II gastric cancer|stage ii gastric cancer
1573297|NCT00489515|stage III gastric cancer|stage iii gastric cancer
1573298|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
1573299|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
1573300|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
1573301|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
1573302|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1573303|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1573304|NCT00489489|MS|ms
1573305|NCT00489489|interferon-beta|interferon-beta
1573306|NCT00489489|adjunctive therapy|adjunctive therapy
1573307|NCT00489489|relapses|relapses
1573308|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
1573309|NCT00489463|LNG-IUS|lng-ius
1573310|NCT00489463|TCu 380A|tcu 380a
1573311|NCT00489463|Ultrasonography|ultrasonography
1573312|NCT00489463|Doppler color|doppler color
1573313|NCT00489463|power Doppler|power doppler
1573314|NCT00489463|female|female
1573315|NCT00489463|Volunteers|volunteers
1573316|NCT00489450|SK3530|sk3530
1573317|NCT00489450|alcohol|alcohol
1573318|NCT00489450|pharmacokinetics|pharmacokinetics
1573319|NCT00489450|safety|safety
1573320|NCT00489437|diagnosis|diagnosis
1573321|NCT00489424|zoledronic acid|zoledronic acid
1573322|NCT00489424|post dose symptoms|post dose symptoms
1573324|NCT00489424|acetaminophen|acetaminophen
1573325|NCT00489424|fluvastatin|fluvastatin
1573326|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1573327|NCT00489411|neurotoxicity|neurotoxicity
1573328|NCT00489411|pain|pain
1573329|NCT00489411|peripheral neuropathy|peripheral neuropathy
1573330|NCT00489385|Fibrosis|fibrosis
1573331|NCT00489385|Viral Kinetics|viral kinetics
1573332|NCT00489385|Hepatotoxicity|hepatotoxicity
1573333|NCT00489385|Immunity|immunity
1573334|NCT00489385|HIV Infection|hiv infection
1573335|NCT00489385|Hepatitis C|hepatitis c
1573336|NCT00489385|HCV|hcv
1573337|NCT00489385|Treatment Experienced|treatment experienced
1573338|NCT00489385|Treatment Naive|treatment naive
1573339|NCT00489333|ProAlgaZyme|proalgazyme
1573340|NCT00489333|Metabolic syndrome|metabolic syndrome
1573341|NCT00489333|Inflammation|inflammation
1573342|NCT00489333|Cardiovascular|cardiovascular
1573343|NCT00489333|hsCRP|hscrp
1573344|NCT00489333|Lipids|lipids
1573345|NCT00489333|Algae|algae
1573346|NCT00489320|Coronary disease|coronary disease
1573347|NCT00489320|Arteries|arteries
1573348|NCT00489320|Atherosclerosis|atherosclerosis
1573349|NCT00489320|Arteriosclerosis|arteriosclerosis
1573350|NCT00489307|Advanced Cancer|advanced cancer
1573351|NCT00489307|Solid Tumors|solid tumors
1573352|NCT00489307|Fatigue|fatigue
1573353|NCT00489307|Pain|pain
1573354|NCT00489307|Nausea|nausea
1573355|NCT00489307|Anorexia|anorexia
1573356|NCT00489307|Dexamethasone|dexamethasone
1573357|NCT00489307|Decadron|decadron
1573358|NCT00489307|Placebo|placebo
1573359|NCT00489294|Human growth hormone|human growth hormone
1573360|NCT00489294|idiopathic short stature|idiopathic short stature
1573361|NCT00489294|short stature|short stature
1573362|NCT00489281|sickle cell disease|sickle cell disease
1573363|NCT00489268|Barrett's Esophagus|barrett's esophagus
1573364|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
1573365|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
1573366|NCT00489255|Parkinson's disease|parkinson's disease
1573367|NCT00489255|Anti-emetic|anti-emetic
1573368|NCT00489255|Nausea|nausea
1573369|NCT00489255|Vomiting|vomiting
1573370|NCT00489229|Rosiglitazone|rosiglitazone
1573371|NCT00489229|Ramipril|ramipril
1573372|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
1573373|NCT00489229|Arterial stiffness|arterial stiffness
1573374|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
1573375|NCT00489216|Graft Versus Host Disease|graft versus host disease
1573376|NCT00489216|GVHD|gvhd
1573377|NCT00489216|Efalizumab|efalizumab
1573378|NCT00489216|Raptiva|raptiva
1573379|NCT00489216|Steroid|steroid
1573380|NCT00489216|Refractory|refractory
1573381|NCT00489216|Skin|skin
1573382|NCT00489216|Liver|liver
1573383|NCT00489216|Lineberger|lineberger
1573384|NCT00489216|University of North Carolina|university of north carolina
1573385|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
1573386|NCT00489177|response|response
1573387|NCT00489177|Defibrillators|defibrillators
1573388|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
1573390|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1573391|NCT00489125|recurrent breast cancer|recurrent breast cancer
1573392|NCT00489125|stage I breast cancer|stage i breast cancer
1573393|NCT00489125|stage II breast cancer|stage ii breast cancer
1573394|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
1573395|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
1573396|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
1573397|NCT00489125|stage IV breast cancer|stage iv breast cancer
1573398|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1573497|NCT00488696|Endovascular|endovascular
1573399|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1573400|NCT00489060|Cryoablation|cryoablation
1573401|NCT00489060|Radiation|radiation
1573402|NCT00489060|Prostate Cancer|prostate cancer
1573403|NCT00489034|HIV|hiv
1573404|NCT00489034|adolescent females|adolescent females
1573405|NCT00489034|adherence|adherence
1573406|NCT00489034|clinical care|clinical care
1573407|NCT00489034|risk behaviors|risk behaviors
1573408|NCT00489021|Subacute care|subacute care
1573409|NCT00489021|Activities of Daily Living|activities of daily living
1573410|NCT00489021|Cognition assessment|cognition assessment
1573411|NCT00489021|Mood assessment|mood assessment
1573412|NCT00489021|Incontinence control|incontinence control
1573413|NCT00489008|Lung Cancer|lung cancer
1573414|NCT00489008|Non-Small Cell|non-small cell
1573415|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
1573416|NCT00489008|SBRT|sbrt
1573417|NCT00489008|NSCLC|nsclc
1573418|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1573419|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
1573420|NCT00488969|Morphine|morphine
1573421|NCT00488969|Chronic Pain|chronic pain
1573422|NCT00488969|Spinal Cord Injury|spinal cord injury
1573423|NCT00488969|Neuropathic Pain|neuropathic pain
1573424|NCT00488956|foot|foot
1573425|NCT00488956|ankle|ankle
1573429|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
1573430|NCT00488943|Zenith|zenith
1573431|NCT00488943|Endovascular|endovascular
1573432|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
1573433|NCT00488930|Obesity|obesity
1573434|NCT00488930|Hyperglycemia|hyperglycemia
1573435|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
1573436|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
1573437|NCT00488917|Liver cirrhosis|liver cirrhosis
1573438|NCT00488917|acute liver failure|acute liver failure
1573439|NCT00488917|liver transplantation|liver transplantation
1573440|NCT00488917|sepsis, infection|sepsis, infection
1573441|NCT00488917|endothelium|endothelium
1573442|NCT00488917|lipids|lipids
1573443|NCT00488917|diagnosis|diagnosis
1573444|NCT00488917|prognosis|prognosis
1573445|NCT00488904|infection|infection
1573446|NCT00488904|colorectalcancer|colorectalcancer
1573447|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
1573448|NCT00488904|complications|complications
1573449|NCT00488891|Schizophrenia|schizophrenia
1573450|NCT00488891|Paliperdone ER|paliperdone er
1573451|NCT00488891|Invega|invega
1573452|NCT00488891|Observational|observational
1573453|NCT00488891|Antipsychotic agents|antipsychotic agents
1573454|NCT00488878|Ovarian Cancer|ovarian cancer
1573455|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
1573456|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
1573457|NCT00488878|Low Malignant Potential|low malignant potential
1573458|NCT00488878|Peritoneum Tumors|peritoneum tumors
1573459|NCT00488878|Psammocarcinoma|psammocarcinoma
1573460|NCT00488878|Data Collection|data collection
1573461|NCT00488878|Research Database|research database
1573462|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
1573463|NCT00488839|Spasticity|spasticity
1573464|NCT00488839|Multiple Sclerosis|multiple sclerosis
1573465|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
1573466|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
1573467|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
1573468|NCT00488787|dental|dental
1573469|NCT00488787|surgery|surgery
1573470|NCT00488787|analgesia|analgesia
1573471|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
1573472|NCT00488774|Colitis, ulcerative|colitis, ulcerative
1573473|NCT00488774|Golimumab|golimumab
1573474|NCT00488774|CNTO 148|cnto 148
1573475|NCT00488761|Tigecycline|tigecycline
1573476|NCT00488761|cSSSI|csssi
1573477|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
1573478|NCT00488748|MST|mst
1573479|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
1573480|NCT00488748|ECT|ect
1573481|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
1573482|NCT00488748|Depression|depression
1573483|NCT00488748|Magnetic|magnetic
1573484|NCT00488735|Randomized controlled trial|randomized controlled trial
1573485|NCT00488735|Back pain|back pain
1573486|NCT00488735|Neck pain|neck pain
1573487|NCT00488735|Rehabilitation|rehabilitation
1573488|NCT00488735|Cognitive-behavioral|cognitive-behavioral
1573489|NCT00488735|Primary care|primary care
1573490|NCT00488735|Sick-listing|sick-listing
1573491|NCT00488735|Health-care utilization.|health-care utilization.
1573492|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
1573493|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
1573494|NCT00488709|Multi Drug Resistance|multi drug resistance
1573495|NCT00488696|Aneurysm|aneurysm
1573496|NCT00488696|Aortic Arch|aortic arch
1573499|NCT00488683|Meningococcal disease|meningococcal disease
1573500|NCT00488683|Prevention|prevention
1573501|NCT00488683|Vaccination|vaccination
1573502|NCT00488670|Alzheimer's disease|alzheimer's disease
1573503|NCT00488670|elderly|elderly
1573504|NCT00488670|open-label|open-label
1573505|NCT00488670|escitalopram|escitalopram
1573506|NCT00488657|speech|speech
1573507|NCT00488657|Parkinson's disease|parkinson's disease
1573508|NCT00488657|treatment|treatment
1573509|NCT00488657|speech intelligibility|speech intelligibility
1573510|NCT00488657|speaking rate|speaking rate
1573511|NCT00488644|Hypothyroidism|hypothyroidism
1573512|NCT00488644|Brain Tumor|brain tumor
1573513|NCT00488644|Levothyroxine|levothyroxine
1573514|NCT00488644|Liothyronine|liothyronine
1573515|NCT00488644|Synthroid|synthroid
1573516|NCT00488644|Cytomel|cytomel
1573517|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
1573518|NCT00488631|Golimumab|golimumab
1573519|NCT00488631|CNTO 148|cnto 148
1573520|NCT00488618|Mania|mania
1573521|NCT00488618|Bipolar I Disorder|bipolar i disorder
1573522|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
1573523|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1573524|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1573525|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
1573526|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
1573527|NCT00488592|Proteinase-3|proteinase-3
1573528|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
1573529|NCT00488592|MDS|mds
1573530|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
1573531|NCT00488592|AML|aml
1573532|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
1573533|NCT00488592|CML|cml
1573534|NCT00488579|iron prophylaxis|iron prophylaxis
1573535|NCT00488579|pregnancy|pregnancy
1573536|NCT00488579|birth weight|birth weight
1573537|NCT00488579|prematurity|prematurity
1573538|NCT00488579|perinatal mortality|perinatal mortality
1573539|NCT00488566|bipolar disorder,|bipolar disorder,
1573540|NCT00488566|single doses,|single doses,
1573541|NCT00488566|resting motor threshold|resting motor threshold
1573542|NCT00488566|TMS,|tms,
1573543|NCT00488553|Lymphoma|lymphoma
1573544|NCT00488553|Epidemiology|epidemiology
1573545|NCT00488553|Lifestyle Factors|lifestyle factors
1573546|NCT00488553|Questionnaire|questionnaire
1573547|NCT00488553|Survey|survey
1573548|NCT00488540|newborn|newborn
1573549|NCT00488540|infant|infant
1573550|NCT00488540|pain|pain
1573551|NCT00488540|acetaminophen|acetaminophen
1573552|NCT00488540|paracetamol|paracetamol
1573553|NCT00488540|mode of delivery|mode of delivery
1573554|NCT00488540|vacuum extraction|vacuum extraction
1573555|NCT00488540|forceps extraction|forceps extraction
1573556|NCT00488540|cesarean section|cesarean section
1573557|NCT00488540|EDIN scale|edin scale
1573558|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
1573559|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
1573560|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
1573561|NCT00488514|Long-term Safety|long-term safety
1573562|NCT00488514|Migraine|migraine
1573563|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
1573564|NCT00488514|sumatriptan succinate|sumatriptan succinate
1573565|NCT00488514|naproxen sodium|naproxen sodium
1573566|NCT00488501|intrathoracic impedance|intrathoracic impedance
1573567|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
1573568|NCT00488501|heart failure|heart failure
1573569|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
1573570|NCT00488462|hypovolemic shock|hypovolemic shock
1573571|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
1573675|NCT00488046|Bird Flu|bird flu
1573572|NCT00488462|safe motherhood|safe motherhood
1573573|NCT00488462|maternal mortality|maternal mortality
1573574|NCT00488462|maternal morbidity|maternal morbidity
1573575|NCT00488449|Dose Escalation|dose escalation
1573576|NCT00488449|GSK256073A,|gsk256073a,
1573577|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
1573578|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
1573579|NCT00488436|Cyclosporine|cyclosporine
1573580|NCT00488423|diabetes|diabetes
1573581|NCT00488423|MIDAS|midas
1573582|NCT00488423|gut hormones|gut hormones
1573583|NCT00488423|gastric bypass|gastric bypass
1573584|NCT00488423|lap band|lap band
1573585|NCT00488410|Chronic heart failure|chronic heart failure
1573586|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
1573587|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
1573588|NCT00488410|ventricular asynchrony|ventricular asynchrony
1573589|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
1573590|NCT00488397|Tygacil|tygacil
1573591|NCT00488397|microdilution method|microdilution method
1573592|NCT00488397|Tigecycline|tigecycline
1573593|NCT00488397|In-Vitro|in-vitro
1573594|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
1573701|NCT00487929|oxidative stress|oxidative stress
1573595|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
1573596|NCT00488358|abdominal|abdominal
1573597|NCT00488358|aortic|aortic
1573598|NCT00488358|aneurysm|aneurysm
1573599|NCT00488358|Zenith|zenith
1573600|NCT00488358|blood pressure|blood pressure
1573601|NCT00488345|cIAI|ciai
1573602|NCT00488345|cSSSI|csssi
1573603|NCT00488345|CAP|cap
1573604|NCT00488345|Child|child
1573605|NCT00488332|Head and Neck Cancer|head and neck cancer
1573606|NCT00488332|Oral Mucositis|oral mucositis
1573607|NCT00488332|Optical Coherence Tomography|optical coherence tomography
1573608|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
1573609|NCT00488332|Optical Assessment|optical assessment
1573610|NCT00488319|Schizophrenia|schizophrenia
1573611|NCT00488319|Adolescent|adolescent
1573612|NCT00488319|Paliperidone|paliperidone
1573613|NCT00488319|Antipsychotic agents|antipsychotic agents
1573614|NCT00488319|Antipsychotic drugs|antipsychotic drugs
1573615|NCT00488319|Psychosis.|psychosis.
1573616|NCT00488306|Tigecycline|tigecycline
1573617|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
1573618|NCT00488306|cIAI|ciai
1573619|NCT00488293|Telemedicine|telemedicine
1573620|NCT00488293|Skin diseases|skin diseases
1573621|NCT00488293|Dermatology|dermatology
1573927|NCT00487305|vaccine|vaccine
1573622|NCT00488293|Quality of life|quality of life
1573623|NCT00488293|Economics|economics
1573624|NCT00488280|walking|walking
1573625|NCT00488280|walking recovery|walking recovery
1573626|NCT00488280|physical therapy|physical therapy
1573627|NCT00488280|locomotor training|locomotor training
1573628|NCT00488280|body weight support|body weight support
1573629|NCT00488280|neuroplasticity|neuroplasticity
1573630|NCT00488280|step|step
1573631|NCT00488280|treadmill|treadmill
1573632|NCT00488280|treadmill training|treadmill training
1573633|NCT00488280|locomotion|locomotion
1573634|NCT00488267|Osteoarthritis|osteoarthritis
1573635|NCT00488267|Pain|pain
1573636|NCT00488254|Long QT Syndrome|long qt syndrome
1573637|NCT00488254|Romano Ward|romano ward
1573638|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
1573639|NCT00488241|Eczema|eczema
1573640|NCT00488241|Medical device|medical device
1573641|NCT00488215|constipation|constipation
1573642|NCT00488215|prucalopride|prucalopride
1573643|NCT00488215|MTD|mtd
1573644|NCT00488215|cardiovascular safety|cardiovascular safety
1573645|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
1573646|NCT00488202|Sexual Function|sexual function
1573647|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
1573648|NCT00488176|children|children
1573649|NCT00488176|montelukast|montelukast
1573650|NCT00488176|cetirizine|cetirizine
1573651|NCT00488163|schizophrenia|schizophrenia
1573652|NCT00488163|cognition|cognition
1573653|NCT00488163|atomoxetine|atomoxetine
1573654|NCT00488163|norepinephrine|norepinephrine
1573655|NCT00488163|dopamine|dopamine
1573656|NCT00488137|constipation|constipation
1573657|NCT00488137|prucalopride|prucalopride
1573658|NCT00488137|QOL|qol
1573659|NCT00488137|SCBM|scbm
1573660|NCT00488137|PAC-SYM|pac-sym
1573661|NCT00488124|short stature|short stature
1573662|NCT00488111|Regional anesthesia|regional anesthesia
1573663|NCT00488111|Fluid Therapy|fluid therapy
1573664|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
1573665|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
1573666|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
1573667|NCT00488072|Advanced Cancer|advanced cancer
1573668|NCT00488072|Anorexia|anorexia
1573669|NCT00488072|Weight Loss|weight loss
1573670|NCT00488072|Insomnia|insomnia
1573671|NCT00488072|Appetite|appetite
1573672|NCT00488072|Mirtazapine|mirtazapine
1573673|NCT00488072|Placebo|placebo
1573674|NCT00488059|Treatment Experienced|treatment experienced
1573676|NCT00488033|Coronary Artery Disease|coronary artery disease
1573677|NCT00488033|Diabetes|diabetes
1573678|NCT00488033|CT Angiography|ct angiography
1573679|NCT00488020|rest pain|rest pain
1573680|NCT00488020|ischemic ulcers|ischemic ulcers
1573681|NCT00488007|Alzheimer disease|alzheimer disease
1573682|NCT00488007|Cognitive impairment|cognitive impairment
1573683|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
1573684|NCT00488007|Hearing aids|hearing aids
1573685|NCT00487994|Hypercholesterolemia|hypercholesterolemia
1573686|NCT00487994|Hyperlipidemia|hyperlipidemia
1573687|NCT00487994|Drug Therapy|drug therapy
1573688|NCT00487981|Pain|pain
1573689|NCT00487981|Implantable stimulation device|implantable stimulation device
1573690|NCT00487981|Neuropathy|neuropathy
1573691|NCT00487968|healthy adult volunteers|healthy adult volunteers
1573692|NCT00487968|eltrombopag|eltrombopag
1573693|NCT00487955|gastritis|gastritis
1573694|NCT00487955|helicobacter pylori|helicobacter pylori
1573696|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
1573697|NCT00487929|sleep apnea|sleep apnea
1573698|NCT00487929|morbidity|morbidity
1573699|NCT00487929|cardiovascular|cardiovascular
1573702|NCT00487916|Blood Stage|blood stage
1573703|NCT00487916|Investigational|investigational
1573704|NCT00487916|Vaccine|vaccine
1573705|NCT00487916|Malaria|malaria
1573706|NCT00487916|Healthy Volunteer|healthy volunteer
1573707|NCT00487916|HV|hv
1573708|NCT00487903|Coronary Artery Disease|coronary artery disease
1573709|NCT00487903|Echocardiogram|echocardiogram
1573710|NCT00487903|Contrast|contrast
1573711|NCT00487903|Perfusion|perfusion
1573712|NCT00487903|Ultrasound|ultrasound
1573713|NCT00487903|Normal volunteers|normal volunteers
1573714|NCT00487890|Geriatric|geriatric
1573715|NCT00487890|Abdominal|abdominal
1573716|NCT00487890|Surgery|surgery
1573717|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
1573718|NCT00487890|intrabdominal surgery|intrabdominal surgery
1573719|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
1573720|NCT00487851|Pancreatic|pancreatic
1573721|NCT00487851|cancer|cancer
1573722|NCT00487851|Periampullay|periampullay
1573723|NCT00487851|Neoplasms|neoplasms
1573724|NCT00487851|Biliary|biliary
1573725|NCT00487851|Duodenal|duodenal
1573726|NCT00487851|Jaundice|jaundice
1573727|NCT00487851|obstruction|obstruction
1573728|NCT00487851|pancreas cancer|pancreas cancer
1573729|NCT00487851|Pancreatic cancer|pancreatic cancer
1573730|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
1573731|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
1573732|NCT00487838|Photochemical Changes|photochemical changes
1573733|NCT00487838|Colored Sunglasses|colored sunglasses
1573734|NCT00487838|Pseudophakes|pseudophakes
1573735|NCT00487838|Fundus Camera|fundus camera
1573736|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
1573737|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
1573738|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
1573739|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
1573740|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
1573741|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
1573743|NCT00487838|Age-Related Macular Changes|age-related macular changes
1573744|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
1573745|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
1573746|NCT00487812|Acute myocardial infarction|acute myocardial infarction
1573747|NCT00487812|left ventricular remodelling|left ventricular remodelling
1573748|NCT00487812|SPECT imaging|spect imaging
1573749|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
1573750|NCT00487799|ADHF|adhf
1573751|NCT00487799|Heart Failure|heart failure
1573752|NCT00487786|Antisense|antisense
1573753|NCT00487786|Heat Shock Protein|heat shock protein
1573754|NCT00487773|asthma|asthma
1573755|NCT00487773|children|children
1573756|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
1573757|NCT00487773|bone metabolism|bone metabolism
1573758|NCT00487760|Lung Cancer|lung cancer
1573759|NCT00487760|African-American Families|african-american families
1573760|NCT00487760|Genetic Risk Communication|genetic risk communication
1573761|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
1573762|NCT00487760|Health Disparities|health disparities
1573763|NCT00487760|Smoking Cessation|smoking cessation
1573764|NCT00487734|Metabolic Syndrome|metabolic syndrome
1573765|NCT00487734|Hypogonadism|hypogonadism
1573766|NCT00487734|Insulin Resistance|insulin resistance
1573767|NCT00487721|Prostate cancer|prostate cancer
1573768|NCT00487708|ACZ885|acz885
1573769|NCT00487708|NALP3 mutations|nalp3 mutations
1573770|NCT00487708|Interleukin-1beta|interleukin-1beta
1573771|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
1573772|NCT00487695|Barrett's esophagus|barrett's esophagus
1573773|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
1573774|NCT00487695|Endoscopy|endoscopy
1573775|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
1573776|NCT00487682|herpes zoster|herpes zoster
1573777|NCT00487682|ASP2151|asp2151
1573778|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
1573779|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
1573780|NCT00487669|xyotax|xyotax
1573781|NCT00487669|alimta|alimta
1573782|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
1573783|NCT00487643|Lacritin|lacritin
1573784|NCT00487630|Heterozygous females|heterozygous females
1573785|NCT00487630|Cardiomyopathy|cardiomyopathy
1573786|NCT00487617|Arteriopathy|arteriopathy
1573787|NCT00487617|endothelial function|endothelial function
1573788|NCT00487617|fruit juice|fruit juice
1573789|NCT00487604|Coronary Artery Disease|coronary artery disease
1573790|NCT00487604|Drug Eluting Stent|drug eluting stent
1573791|NCT00487604|Bare Metal Stent|bare metal stent
1573792|NCT00487604|Subacute thrombosis|subacute thrombosis
1573793|NCT00487604|Bleeding|bleeding
1573794|NCT00487604|Economic|economic
1573795|NCT00487591|cholesterol|cholesterol
1573796|NCT00487591|dyslipidemia|dyslipidemia
1573797|NCT00487591|omega 3|omega 3
1573798|NCT00487578|Post traumatic headache|post traumatic headache
1573799|NCT00487578|Head trauma|head trauma
1573800|NCT00487578|Head injury|head injury
1573801|NCT00487578|Headache|headache
1573802|NCT00487578|Naratriptan|naratriptan
1573803|NCT00487565|Total knee replacement|total knee replacement
1573804|NCT00487565|Total knee arthroplasty|total knee arthroplasty
1573805|NCT00487565|Osteoarthritis|osteoarthritis
1573806|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
1573807|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
1573808|NCT00487552|endoscopy|endoscopy
1573809|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
1573810|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
1573811|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
1573812|NCT00487552|gastric malignancy|gastric malignancy
1573813|NCT00487552|duodenal stent|duodenal stent
1573814|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
1573815|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
1573816|NCT00487539|Golimumab|golimumab
1573817|NCT00487539|CNTO 148|cnto 148
1573818|NCT00487526|Bypass|bypass
1573819|NCT00487526|Duodenal jejunal|duodenal jejunal
1573820|NCT00487526|type 2 diabetes|type 2 diabetes
1573821|NCT00487526|non-obese adults|non-obese adults
1573822|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
1573823|NCT00487513|vaccination|vaccination
1573824|NCT00487500|Major Depressive Disorder|major depressive disorder
1573825|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
1573826|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
1573828|NCT00487461|Vasospasm|vasospasm
1573829|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
1573830|NCT00487448|Chemotherapy|chemotherapy
1573831|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
1573832|NCT00487448|Bone marrow transplantation|bone marrow transplantation
1573833|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
1573834|NCT00487435|CG5503|cg5503
1573835|NCT00487435|Tapentadol|tapentadol
1573836|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
1573837|NCT00487435|osteoarthritis|osteoarthritis
1573838|NCT00487435|lower back pain|lower back pain
1573839|NCT00487435|analgesic|analgesic
1573840|NCT00487435|opioid|opioid
1573841|NCT00487422|constipation|constipation
1573842|NCT00487422|prucalopride|prucalopride
1573843|NCT00487422|QOL|qol
1573844|NCT00487422|SCBM|scbm
1573845|NCT00487422|PAC-SYM|pac-sym
1573846|NCT00487409|Ulcerative colitis|ulcerative colitis
1573847|NCT00487409|Crohn's disease|crohn's disease
1573848|NCT00487409|Colorectal polyps|colorectal polyps
1573849|NCT00487409|Colorectal malignancy|colorectal malignancy
1573850|NCT00487409|Endometriosis|endometriosis
1573851|NCT00487409|Diverticulitis|diverticulitis
1573852|NCT00487409|Colonic inertia|colonic inertia
1573853|NCT00487396|capsule endoscopy|capsule endoscopy
1573854|NCT00487396|Crohn's disease|crohn's disease
1573855|NCT00487396|small bowel disease|small bowel disease
1573856|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
1573857|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
1573858|NCT00487383|Cerebellum|cerebellum
1573859|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1573860|NCT00487383|Blepharospasm|blepharospasm
1573861|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
1573862|NCT00487383|Focal Dystonia|focal dystonia
1573863|NCT00487383|Dystonia|dystonia
1573864|NCT00487383|Healthy Volunteer|healthy volunteer
1573865|NCT00487383|HV|hv
1573866|NCT00487370|Acupuncture|acupuncture
1573867|NCT00487370|Gold implantation|gold implantation
1573981|NCT00487084|analgesia|analgesia
1573868|NCT00487370|Osteoarthritis|osteoarthritis
1573869|NCT00487370|Knee osteoarthritis|knee osteoarthritis
1573870|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
1573871|NCT00487370|Intervention|intervention
1573872|NCT00487370|Family practice|family practice
1573873|NCT00487357|Epidemiology|epidemiology
1573874|NCT00487357|Cancer Prevention|cancer prevention
1573875|NCT00487357|Questionnaire|questionnaire
1573876|NCT00487357|MATCh|match
1573877|NCT00487357|Survey|survey
1573878|NCT00487344|medicaid|medicaid
1573879|NCT00487344|insurance|insurance
1573880|NCT00487344|education|education
1573881|NCT00487344|clinical|clinical
1573882|NCT00487344|trial|trial
1573883|NCT00487344|healthcare|healthcare
1573884|NCT00487344|reimburse|reimburse
1573885|NCT00487344|pay|pay
1573886|NCT00487344|free|free
1573887|NCT00487344|assist|assist
1573888|NCT00487344|study|study
1573889|NCT00487344|oklahoma|oklahoma
1573890|NCT00487344|edmond|edmond
1573891|NCT00487344|Oklahoma City|oklahoma city
1573892|NCT00487344|diet|diet
1573893|NCT00487344|nutrition|nutrition
1573894|NCT00487344|weight loss|weight loss
1573895|NCT00487344|body|body
1573896|NCT00487344|fat|fat
1573897|NCT00487344|obese|obese
1573898|NCT00487344|overweight|overweight
1573899|NCT00487344|health|health
1573900|NCT00487344|medical|medical
1573901|NCT00487344|therapy|therapy
1573902|NCT00487344|meal plan|meal plan
1573903|NCT00487344|jenny craig|jenny craig
1573904|NCT00487344|weight watcher|weight watcher
1573905|NCT00487344|LA Weightloss|la weightloss
1573906|NCT00487344|Bryan Attebery|bryan attebery
1573907|NCT00487344|Results|results
1573908|NCT00487344|YMCA|ymca
1573909|NCT00487344|UCO|uco
1573910|NCT00487344|OSU|osu
1573911|NCT00487344|OU|ou
1573912|NCT00487344|clinics|clinics
1573913|NCT00487344|physicians|physicians
1573914|NCT00487344|surgery|surgery
1573915|NCT00487344|pills|pills
1573916|NCT00487344|financial|financial
1573917|NCT00487344|money|money
1573918|NCT00487331|Solid Tumors|solid tumors
1573919|NCT00487331|Acupuncture|acupuncture
1573920|NCT00487331|Uncontrolled Pain|uncontrolled pain
1573921|NCT00487331|Pain|pain
1573922|NCT00487318|fluvastatin|fluvastatin
1573923|NCT00487318|hepatitis C|hepatitis c
1573924|NCT00487318|chronic hepatitis C|chronic hepatitis c
1573925|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
1573926|NCT00487305|GM-CSF|gm-csf
1573933|NCT00487292|bright light pulses|bright light pulses
1573934|NCT00487292|sleep|sleep
1573935|NCT00487279|Coronary|coronary
1573936|NCT00487279|Artery|artery
1573937|NCT00487279|Disease|disease
1573938|NCT00487279|Sudden|sudden
1573939|NCT00487279|Cardiac|cardiac
1573940|NCT00487279|Death|death
1573941|NCT00487279|ICD|icd
1573942|NCT00487266|Acupuncture|acupuncture
1573943|NCT00487266|Torque|torque
1573944|NCT00487266|Force Decay|force decay
1573945|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1573946|NCT00487253|Leishmania Viannia|leishmania viannia
1573947|NCT00487253|Pediatric|pediatric
1573948|NCT00487253|Miltefosine|miltefosine
1573949|NCT00487253|Randomized|randomized
1573950|NCT00487253|Colombia|colombia
1573951|NCT00487240|diabetes|diabetes
1573952|NCT00487240|type 1|type 1
1573953|NCT00487227|caffeine|caffeine
1573954|NCT00487227|coffee|coffee
1573955|NCT00487227|decaffeinated|decaffeinated
1573956|NCT00487227|cognition|cognition
1573957|NCT00487227|mood|mood
1573958|NCT00487227|autonomic|autonomic
1573959|NCT00487201|liver transplantation|liver transplantation
1573960|NCT00487201|biliary strictures|biliary strictures
1573961|NCT00487201|ERCP|ercp
1573962|NCT00487175|Pain|pain
1573963|NCT00487175|sensitization|sensitization
1573964|NCT00487175|analgesia|analgesia
1573965|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
1573966|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
1573967|NCT00487149|Repeatability|repeatability
1573968|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
1573969|NCT00487136|Drug Interaction|drug interaction
1573970|NCT00487136|Pharmacokinetics|pharmacokinetics
1573971|NCT00487136|Pharmacodynamics|pharmacodynamics
1573972|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
1573973|NCT00487110|Pain|pain
1573974|NCT00487110|serotonin|serotonin
1573975|NCT00487110|interaction|interaction
1573976|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
1573977|NCT00487097|intensive care|intensive care
1573978|NCT00487097|critically ill|critically ill
1573979|NCT00487097|fish oil|fish oil
1573980|NCT00487097|pressure sores|pressure sores
1573982|NCT00487084|tubal ligation|tubal ligation
1573983|NCT00487084|chloroprocaine|chloroprocaine
1573984|NCT00487071|Anal fistula|anal fistula
1573985|NCT00487071|High-type|high-type
1573986|NCT00487071|Anal fistula plug|anal fistula plug
1573987|NCT00487071|Efficacy|efficacy
1573988|NCT00487071|Recurrence|recurrence
1573989|NCT00487058|Gimatecan|gimatecan
1573990|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
1573991|NCT00487058|advanced solid tumors|advanced solid tumors
1573992|NCT00487045|Hemorrhoids|hemorrhoids
1573993|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
1573994|NCT00487045|Reduction|reduction
1573995|NCT00487045|Prevention|prevention
1573996|NCT00487045|Stabilizer Device|stabilizer device
1573997|NCT00487045|Pregnant|pregnant
1573998|NCT00487045|Vaginal Birth|vaginal birth
1573999|NCT00487045|Single Birth|single birth
1574000|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
1574001|NCT00487032|allergic rhinitis|allergic rhinitis
1574002|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
1574003|NCT00487032|imidazolines|imidazolines
1574004|NCT00487032|corticosteroid|corticosteroid
1574005|NCT00487019|ampicillin|ampicillin
1574006|NCT00487019|penicillin G|penicillin g
1574007|NCT00487019|gentamicin|gentamicin
1574008|NCT00487019|neonatal sepsis|neonatal sepsis
1574009|NCT00487019|empiric therapy|empiric therapy
1574010|NCT00486993|Diet|diet
1574011|NCT00486993|Exercise|exercise
1574012|NCT00486993|Smoking|smoking
1574013|NCT00486993|Stress|stress
1574014|NCT00486993|Polyphenols|polyphenols
1574015|NCT00486980|influenza|influenza
1574016|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
1574017|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
1574018|NCT00486954|lapatinib|lapatinib
1574019|NCT00486954|paclitaxel|paclitaxel
1574020|NCT00486954|ErbB2|erbb2
1574021|NCT00486954|Gastric cancer|gastric cancer
1574022|NCT00486954|Advanced gastric cancer|advanced gastric cancer
1574023|NCT00486941|Primary Prevention|primary prevention
1574024|NCT00486941|Health Promotion|health promotion
1574025|NCT00486941|Diet|diet
1574026|NCT00486941|Exercise|exercise
1574027|NCT00486941|Risk Factors|risk factors
1574028|NCT00486941|Randomized Controlled Trial|randomized controlled trial
1574029|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
1574030|NCT00486915|Atrial Fibrillation|atrial fibrillation
1574031|NCT00486915|Left Atrial Appendage|left atrial appendage
1574032|NCT00486915|Surgical Ligation|surgical ligation
1574033|NCT00486915|Thromboembolism|thromboembolism
1574034|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
1574035|NCT00486902|Ketamine|ketamine
1574036|NCT00486902|Spinal Anesthesia|spinal anesthesia
1574037|NCT00486902|C-section|c-section
1574038|NCT00486889|Glycogenesis 2|glycogenesis 2
1574039|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
1574040|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
1574041|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
1574042|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
1574043|NCT00486850|RDS|rds
1574044|NCT00486850|Preterm|preterm
1574045|NCT00486850|SIMV|simv
1574046|NCT00486850|NIPPV|nippv
1574047|NCT00486811|Osteoarthritis|osteoarthritis
1574048|NCT00486811|Knee|knee
1574049|NCT00486811|Pain Assessment|pain assessment
1574050|NCT00486811|CG5503 PR|cg5503 pr
1574051|NCT00486811|Centrally acting analgesic|centrally acting analgesic
1574052|NCT00486811|Placebo|placebo
1574053|NCT00486811|Oxycodone|oxycodone
1574054|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
1574055|NCT00486811|Tapentadol|tapentadol
1574056|NCT00486798|acute schizophrenia|acute schizophrenia
1574057|NCT00486798|schizoaffective disorder|schizoaffective disorder
1574058|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
1574059|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
1574177|NCT00486265|AML|aml
1574060|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
1574061|NCT00486746|sleep apnea|sleep apnea
1574062|NCT00486746|lifestyle intervention|lifestyle intervention
1574063|NCT00486746|cardiovascular|cardiovascular
1574064|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
1574065|NCT00486733|soft tissue wounds|soft tissue wounds
1574066|NCT00486707|Ovarian Cancer|ovarian cancer
1574067|NCT00486707|Questionnaire|questionnaire
1574068|NCT00486707|Genetic Testing|genetic testing
1574069|NCT00486707|Survey|survey
1574070|NCT00486694|Malaria, vivax|malaria, vivax
1574071|NCT00486694|Afghanistan|afghanistan
1574072|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1574073|NCT00486694|drug resistance|drug resistance
1574074|NCT00486681|Glucose monitoring|glucose monitoring
1574075|NCT00486681|Diabetes management|diabetes management
1574076|NCT00486681|Information system|information system
1574077|NCT00486681|In-patient glycemic control|in-patient glycemic control
1574078|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
1574079|NCT00486668|invasive breast cancer|invasive breast cancer
1574080|NCT00486668|lapatinib|lapatinib
1574081|NCT00486668|neoadjuvant|neoadjuvant
1574082|NCT00486668|NSABP|nsabp
1574083|NCT00486668|paclitaxel|paclitaxel
1574084|NCT00486668|trastuzumab|trastuzumab
1574085|NCT00486668|doxorubicin|doxorubicin
1574086|NCT00486668|cyclophosphamide|cyclophosphamide
1574087|NCT00486655|Cholecystectomy|cholecystectomy
1574088|NCT00486655|NOTES|notes
1574089|NCT00486655|Transgastric|transgastric
1574090|NCT00486629|Exercise|exercise
1574091|NCT00486629|Diet|diet
1574092|NCT00486629|Pregnancy|pregnancy
1574093|NCT00486629|Obesity|obesity
1574094|NCT00486629|Macrosomia|macrosomia
1574095|NCT00486603|adult glioblastoma|adult glioblastoma
1574096|NCT00486603|adult gliosarcoma|adult gliosarcoma
1574097|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
1574098|NCT00486590|Human milk fortification|human milk fortification
1574099|NCT00486590|Premature neonate|premature neonate
1574100|NCT00486590|Very low birth weight|very low birth weight
1574101|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
1574102|NCT00486564|Treatment|treatment
1574103|NCT00486564|Refractory or Relapsed|refractory or relapsed
1574104|NCT00486551|Anger control training|anger control training
1574105|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
1574106|NCT00486551|Behavior therapy|behavior therapy
1574107|NCT00486551|Tourette Syndrome|tourette syndrome
1574108|NCT00486551|Randomized trial|randomized trial
1574109|NCT00486551|Anger|anger
1574110|NCT00486551|Aggression|aggression
1574111|NCT00486525|fatigue|fatigue
1574112|NCT00486525|depression|depression
1574113|NCT00486525|pain|pain
1574114|NCT00486525|cancer survivor|cancer survivor
1574115|NCT00486525|stage IA breast cancer|stage ia breast cancer
1574116|NCT00486525|stage IB breast cancer|stage ib breast cancer
1574117|NCT00486525|stage II breast cancer|stage ii breast cancer
1574118|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
1574119|NCT00486525|breast cancer in situ|breast cancer in situ
1574120|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
1574121|NCT00486499|radiation|radiation
1574122|NCT00486499|brachytherapy|brachytherapy
1574123|NCT00486499|prostate|prostate
1574124|NCT00486499|cancer|cancer
1574125|NCT00486486|24-hour IOP control|24-hour iop control
1574126|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
1574127|NCT00486460|pancreas|pancreas
1574128|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
1574129|NCT00486460|Inoperatable|inoperatable
1574130|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
1574131|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1574132|NCT00486408|HIV Seronegativity|hiv seronegativity
1574133|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
1574134|NCT00486408|Adenovirus|adenovirus
1574135|NCT00486395|prematurity|prematurity
1574136|NCT00486395|randomized trial|randomized trial
1574137|NCT00486395|RDS|rds
1574138|NCT00486395|surfactant|surfactant
1574139|NCT00486395|CPAP|cpap
1574140|NCT00486395|ventilation|ventilation
1574141|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
1574142|NCT00486382|vaccine|vaccine
1574143|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
1574144|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1574145|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
1574146|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
1574147|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
1574148|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1574149|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1574150|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1574151|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1574152|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
1574153|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
1574154|NCT00486343|Asthma|asthma
1574155|NCT00486343|ICS|ics
1574156|NCT00486343|5-LO Inhibition|5-lo inhibition
1574157|NCT00486343|Leukotrienes|leukotrienes
1574158|NCT00486343|Asthma control|asthma control
1574159|NCT00486343|Asthma exacerbations|asthma exacerbations
1574160|NCT00486330|HIV|hiv
1574161|NCT00486330|Pharmacokinetics|pharmacokinetics
1574162|NCT00486330|Buprenorphine|buprenorphine
1574163|NCT00486330|Tipranavir|tipranavir
1574164|NCT00486330|HIV Seronegativity|hiv seronegativity
1574165|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
1574166|NCT00486304|cachexia|cachexia
1574167|NCT00486304|weight changes|weight changes
1574168|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1574169|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1574170|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1574171|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1574172|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1574173|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
1574174|NCT00486265|Phase I|phase i
1574175|NCT00486265|Phase II|phase ii
1574176|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
1574178|NCT00486265|cancer|cancer
1574179|NCT00486239|Epilepsy|epilepsy
1574180|NCT00486239|memory|memory
1574181|NCT00486239|emotion|emotion
1574182|NCT00486213|dermatologic complications|dermatologic complications
1574183|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1574184|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1574185|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1574186|NCT00486200|ASP2151|asp2151
1574187|NCT00486200|Herpes Genitalis|herpes genitalis
1574188|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
1574189|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
1574190|NCT00486200|Treatment Outcome|treatment outcome
1574191|NCT00486200|Genital Herpes|genital herpes
1574192|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1574193|NCT00486187|Thiazolidinediones|thiazolidinediones
1574194|NCT00486187|Rosiglitazone|rosiglitazone
1574195|NCT00486187|Adipokine|adipokine
1574196|NCT00486187|Inflammation|inflammation
1574197|NCT00486187|Cardiometabolic risk|cardiometabolic risk
1574198|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
1574199|NCT00486174|Sepsis|sepsis
1574200|NCT00486174|Methylene Blue|methylene blue
1574201|NCT00486174|Norepinephrine|norepinephrine
1574202|NCT00486161|Obesity|obesity
1574203|NCT00486161|Ghrelin|ghrelin
1574204|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
1574205|NCT00486161|Growth hormone|growth hormone
1574206|NCT00486161|Insulin|insulin
1574207|NCT00486161|Cycloergometer exercise|cycloergometer exercise
1574208|NCT00486148|Formula|formula
1574209|NCT00486148|Feeding|feeding
1574210|NCT00486148|Healthy|healthy
1574211|NCT00486148|Full|full
1574212|NCT00486148|Term|term
1574213|NCT00486148|Infants|infants
1574214|NCT00486135|Cancer|cancer
1574215|NCT00486135|Solid tumors|solid tumors
1574216|NCT00486135|Lymphoma|lymphoma
1574217|NCT00486109|Diabetes|diabetes
1574218|NCT00486096|cannulation|cannulation
1574219|NCT00486096|infant|infant
1574220|NCT00486096|femoral arterial|femoral arterial
1574221|NCT00486070|cardiac anomaly|cardiac anomaly
1574222|NCT00486070|pulmonary veins|pulmonary veins
1574223|NCT00486070|cyanosis|cyanosis
1574224|NCT00486070|flow reversal|flow reversal
1574225|NCT00486070|TAPAVC|tapavc
1574226|NCT00486057|Daclizumab|daclizumab
1574227|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
1574228|NCT00486057|Heart Transplant|heart transplant
1574229|NCT00486057|Rejection|rejection
1574230|NCT00486044|amyloid protein|amyloid protein
1574231|NCT00486044|apolipoprotein|apolipoprotein
1574232|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
1574233|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
1574234|NCT00486044|inflammation|inflammation
1574235|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
1574236|NCT00486044|prevention & control|prevention & control
1574237|NCT00486031|IBD|ibd
1574238|NCT00486031|UC|uc
1574239|NCT00486031|Ulcerative Colitis|ulcerative colitis
1574240|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
1574241|NCT00486018|Lucentis|lucentis
1574242|NCT00486018|RVO|rvo
1574243|NCT00486018|BRVO|brvo
1574244|NCT00486018|Edema|edema
1574245|NCT00485992|blood stream infection|blood stream infection
1574246|NCT00485992|CICU|cicu
1574247|NCT00485992|pediatric|pediatric
1574248|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
1574249|NCT00485979|Breast Cancer|breast cancer
1574250|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
1574251|NCT00485966|Adult Leukemia|adult leukemia
1574252|NCT00485966|CLL|cll
1574253|NCT00485966|B-CLL|b-cll
1574254|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1574255|NCT00485966|B-cell CLL|b-cell cll
1574256|NCT00485953|Osteoporosis|osteoporosis
1574257|NCT00485953|breast cancer|breast cancer
1574258|NCT00485953|aromatase inhibitors|aromatase inhibitors
1574259|NCT00485953|bone loss|bone loss
1574260|NCT00485953|bone mineral density|bone mineral density
1574261|NCT00485940|constipation|constipation
1574262|NCT00485940|prucalopride|prucalopride
1574263|NCT00485940|QOL|qol
1574264|NCT00485940|SCBM|scbm
1574265|NCT00485940|PAC-SYM|pac-sym
1574266|NCT00485927|Trauma|trauma
1574267|NCT00485927|Stress|stress
1574268|NCT00485927|Simulation|simulation
1574269|NCT00485914|employment|employment
1574270|NCT00485914|work|work
1574271|NCT00485836|CRVO|crvo
1574272|NCT00485836|RVO|rvo
1574273|NCT00485836|Lucentis|lucentis
1574274|NCT00485836|Edema|edema
1574275|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1574276|NCT00485797|Dual tasking|dual tasking
1574277|NCT00485797|Postural Control|postural control
1574278|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
1574279|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
1574280|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
1574281|NCT00485745|surgery|surgery
1574282|NCT00485745|repeat sternotomy|repeat sternotomy
1574283|NCT00485745|pediatrics|pediatrics
1574284|NCT00485732|Cervical neoplasia|cervical neoplasia
1574285|NCT00485732|AS04|as04
1574286|NCT00485732|Randomized|randomized
1574287|NCT00485732|Cervical cancer|cervical cancer
1574288|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
1574289|NCT00485732|Phase IIIb|phase iiib
1574290|NCT00485732|Korea|korea
1574291|NCT00485732|HPV|hpv
1574292|NCT00485732|Double-blind|double-blind
1574293|NCT00485732|Controlled|controlled
1574294|NCT00485719|Cancer|cancer
1574295|NCT00485719|Solid Tumors|solid tumors
1574296|NCT00485706|dialysis|dialysis
1574297|NCT00485706|vascular calcification|vascular calcification
1574298|NCT00485706|bone mineralism|bone mineralism
1574299|NCT00485706|arterial stiffness|arterial stiffness
1574300|NCT00485706|bone metabolism|bone metabolism
1574301|NCT00485706|chronic kidney disease|chronic kidney disease
1574302|NCT00485693|pain|pain
1574303|NCT00485693|postoperative|postoperative
1574304|NCT00485693|total knee arthroplasty|total knee arthroplasty
1574305|NCT00485693|analgesia|analgesia
1574306|NCT00485667|pain|pain
1574307|NCT00485667|postoperative|postoperative
1574308|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
1574309|NCT00485654|Intestinal Malrotation|intestinal malrotation
1574310|NCT00485654|Functional Asplenia|functional asplenia
1574311|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
1574312|NCT00485641|Stroke|stroke
1574313|NCT00485641|SaeboFlex|saeboflex
1574314|NCT00485641|Hand function|hand function
1574315|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
1574316|NCT00485615|fish oil|fish oil
1574317|NCT00485615|Omega 3|omega 3
1574318|NCT00485615|Social Anxiety Disorder|social anxiety disorder
1574319|NCT00485602|malocclusion|malocclusion
1574320|NCT00485602|aligner|aligner
1574321|NCT00485602|crowding|crowding
1574322|NCT00485602|expansion|expansion
1574323|NCT00485602|orthodontic treatment|orthodontic treatment
1574324|NCT00485589|FILM|film
1574325|NCT00485589|RA|ra
1574331|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
1574332|NCT00485563|Progressive|progressive
1574333|NCT00485563|Metastatic|metastatic
1574334|NCT00485563|Experimental|experimental
1574335|NCT00485537|GnRH antagonist|gnrh antagonist
1574336|NCT00485537|GnRH agonist|gnrh agonist
1574337|NCT00485537|ICSI|icsi
1574338|NCT00485537|miscarriage rate|miscarriage rate
1574339|NCT00485537|pregnancy outcome|pregnancy outcome
1574340|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
1574341|NCT00485524|Serum Lactate Levels|serum lactate levels
1574342|NCT00485524|post operative outcomes|post operative outcomes
1574343|NCT00485485|Head and Neck Cancer|head and neck cancer
1574344|NCT00485485|Squamous Cell Cancer|squamous cell cancer
1574345|NCT00485485|Imatinib Mesylate|imatinib mesylate
1574346|NCT00485485|Gleevec|gleevec
1574347|NCT00485485|Imatinib|imatinib
1574348|NCT00485485|STI571|sti571
1574349|NCT00485485|Docetaxel|docetaxel
1574350|NCT00485485|Taxotere|taxotere
1574351|NCT00485472|Osteoarthritis|osteoarthritis
1574352|NCT00485472|lacosamide|lacosamide
1574353|NCT00485472|VIMPAT|vimpat
1574354|NCT00485433|hernia|hernia
1574355|NCT00485433|unilateral|unilateral
1574356|NCT00485433|postoperative|postoperative
1574357|NCT00485433|analgesia|analgesia
1574358|NCT00485420|Internet based disease management program|internet based disease management program
1574360|NCT00485394|age-related macular degeneration|age-related macular degeneration
1574361|NCT00485394|geographic atrophy|geographic atrophy
1574362|NCT00485394|GA|ga
1574363|NCT00485368|marfan syndrome|marfan syndrome
1574364|NCT00485368|aortic root diameter|aortic root diameter
1574365|NCT00485355|hysterectomy|hysterectomy
1574366|NCT00485355|Laparoscopy|laparoscopy
1574367|NCT00485355|robotics|robotics
1574368|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
1574369|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
1574370|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
1574371|NCT00485316|Colorectal carcinoma|colorectal carcinoma
1574372|NCT00485316|Rectal carcinoma|rectal carcinoma
1574373|NCT00485316|Laparoscopy|laparoscopy
1574374|NCT00485316|Laparoscopic surgery|laparoscopic surgery
1574375|NCT00485316|Open surgery|open surgery
1574376|NCT00485316|Randomized trial|randomized trial
1574377|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
1574378|NCT00485303|Prostate cancer|prostate cancer
1574379|NCT00485303|Abiraterone acetate|abiraterone acetate
1574380|NCT00485303|CB7630|cb7630
1574381|NCT00485303|Prednisone|prednisone
1574382|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
1574383|NCT00485277|Breast cancer|breast cancer
1574384|NCT00485277|Vaccine|vaccine
1574385|NCT00485277|Metastatic|metastatic
1574386|NCT00485277|HER-2-positive|her-2-positive
1574387|NCT00485277|Phase I|phase i
1574388|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
1574389|NCT00485251|operation time in minutes|operation time in minutes
1574390|NCT00485251|pain score from 1-10|pain score from 1-10
1574391|NCT00485251|recurrence|recurrence
1574392|NCT00485251|survival|survival
1574393|NCT00485238|glaucoma|glaucoma
1574394|NCT00485212|postoperative pain|postoperative pain
1574395|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
1574396|NCT00485199|vitrectomy|vitrectomy
1574397|NCT00485199|retinal detachment|retinal detachment
1574398|NCT00485199|macular hole|macular hole
1574399|NCT00485199|treatment|treatment
1574400|NCT00485199|multi-center|multi-center
1574401|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
1574402|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
1574403|NCT00485160|Indomethacin|indomethacin
1574404|NCT00485160|Ibuprofen|ibuprofen
1574405|NCT00485160|Renal effects|renal effects
1574406|NCT00485147|Claudication|claudication
1574407|NCT00485147|peripheral arterial disease|peripheral arterial disease
1574408|NCT00485147|Diagnosis|diagnosis
1574409|NCT00485147|Exercise|exercise
1574410|NCT00485147|Walking impairment|walking impairment
1574411|NCT00485147|Disability|disability
1574412|NCT00485121|Ezetimibe|ezetimibe
1574413|NCT00485121|Statin|statin
1574414|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
1574415|NCT00485121|Adipokine|adipokine
1574416|NCT00485121|Adiponectin|adiponectin
1574417|NCT00485121|C-reactive protein|c-reactive protein
1574418|NCT00485121|Coronary artery disease|coronary artery disease
1574419|NCT00485121|Metabolic Syndrome|metabolic syndrome
1574420|NCT00485121|Obesity|obesity
1574421|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
1574422|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
1574423|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
1574424|NCT00485108|intra ocular pressure|intra ocular pressure
1574425|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
1574426|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
1574427|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
1574428|NCT00485082|Cystic Fibrosis|cystic fibrosis
1574429|NCT00485082|Disclosure|disclosure
1574430|NCT00485082|Dating Partner|dating partner
1574431|NCT00485082|Phone Interview|phone interview
1574432|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
1574433|NCT00485069|L-dopa|l-dopa
1574434|NCT00485069|Parkinson's Disease|parkinson's disease
1574435|NCT00485069|Dopamine agonist|dopamine agonist
1574436|NCT00485056|Diabetes|diabetes
1574437|NCT00485056|Tissue doppler imaging|tissue doppler imaging
1574438|NCT00485056|Wave intensity analysis.|wave intensity analysis.
1574439|NCT00485043|T'ai Chi|t'ai chi
1574440|NCT00485043|Osteoarthritis|osteoarthritis
1574441|NCT00485043|Exercise|exercise
1574442|NCT00485043|Older adults|older adults
1574443|NCT00485030|coronary artery disease|coronary artery disease
1574444|NCT00485030|stent|stent
1574445|NCT00485030|angioplasty|angioplasty
1574446|NCT00485017|Obesity|obesity
1574447|NCT00485017|Weight Loss|weight loss
1574448|NCT00485004|Coronary artery disease|coronary artery disease
1574449|NCT00485004|Stent|stent
1574450|NCT00485004|Angioplasty|angioplasty
1574451|NCT00484991|Phenylketonuria|phenylketonuria
1574453|NCT00484991|Phenylketonurias|phenylketonurias
1574454|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
1574455|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
1574456|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
1574457|NCT00484978|Surgery|surgery
1574458|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
1574459|NCT00484978|radiation|radiation
1574460|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
1574461|NCT00484965|Coronary stent|coronary stent
1574462|NCT00484965|Inflammation|inflammation
1574463|NCT00484965|Atherosclerosis|atherosclerosis
1574464|NCT00484965|Immunosuppressive|immunosuppressive
1574465|NCT00484952|rotavirus|rotavirus
1574466|NCT00484952|diarrheal diseases|diarrheal diseases
1574467|NCT00484952|hospitalizations|hospitalizations
1574468|NCT00484952|multicenter|multicenter
1574469|NCT00484952|children|children
1574470|NCT00484952|under five year old|under five year old
1574471|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
1574472|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
1574473|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
1574474|NCT00484926|coronary disease|coronary disease
1574475|NCT00484926|stents|stents
1574476|NCT00484926|antiplatelet drugs|antiplatelet drugs
1574477|NCT00484926|drug-eluting stents|drug-eluting stents
1574478|NCT00484913|healthy subjects|healthy subjects
1574479|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
1574480|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
1574481|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
1574482|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
1574483|NCT00484900|24 hour treatment|24 hour treatment
1574484|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
1574485|NCT00484887|Hernia mesh|hernia mesh
1574486|NCT00484887|Implanted mesh material|implanted mesh material
1574487|NCT00484887|Explanted mesh material|explanted mesh material
1574488|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
1574489|NCT00484874|Radioimmunotherapy|radioimmunotherapy
1574490|NCT00484874|Bexxar|bexxar
1574491|NCT00484874|I-131 Tositumomab|i-131 tositumomab
1574492|NCT00484874|Safety|safety
1574493|NCT00484874|Efficacy|efficacy
1574494|NCT00484874|Nuclear Medicine|nuclear medicine
1574495|NCT00484874|Monoclonal antibody|monoclonal antibody
1574496|NCT00484874|Radiolabeled|radiolabeled
1574497|NCT00484861|Women|women
1574498|NCT00484861|Healthy Volunteers|healthy volunteers
1574499|NCT00484861|Triglyceride|triglyceride
1574500|NCT00484861|Healthy Volunteer|healthy volunteer
1574501|NCT00484861|HV|hv
1574502|NCT00484848|oncology, medical|oncology, medical
1574503|NCT00484848|implantable catheter|implantable catheter
1574504|NCT00484848|vascular access ports|vascular access ports
1574505|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
1574506|NCT00484848|Vortex®|vortex®
1574507|NCT00484848|Celsite®|celsite®
1574508|NCT00484848|Vacutainer®|vacutainer®
1574509|NCT00484848|venous cut-down|venous cut-down
1574510|NCT00484835|Abdominal|abdominal
1574511|NCT00484835|Hysterectomy|hysterectomy
1574512|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
1574513|NCT00484835|Electrosurgery|electrosurgery
1574514|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
1574515|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
1574516|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
1574517|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1574518|NCT00484796|Carotid Surgery|carotid surgery
1574519|NCT00484796|Cerebral Ischemia|cerebral ischemia
1574520|NCT00484796|Cognitive Deficits|cognitive deficits
1574521|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
1574522|NCT00484796|Neuromonitoring|neuromonitoring
1574523|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
1575605|NCT00480675|injection|injection
1574524|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
1574525|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
1574526|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
1574527|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
1574528|NCT00484757|Narcolepsy|narcolepsy
1574529|NCT00484757|Orexines|orexines
1574530|NCT00484757|sleep|sleep
1574531|NCT00484757|cognition|cognition
1574532|NCT00484757|cytokines|cytokines
1574533|NCT00484744|pain|pain
1574534|NCT00484744|orthodontic|orthodontic
1574535|NCT00484744|acetaminophen|acetaminophen
1574536|NCT00484744|ibuprofen|ibuprofen
1574537|NCT00484744|separator|separator
1574538|NCT00484705|Androgens|androgens
1574539|NCT00484705|Menstrual pattern|menstrual pattern
1574540|NCT00484705|Insulin resistance|insulin resistance
1574541|NCT00484705|Adipocytes|adipocytes
1574542|NCT00484705|Obesity|obesity
1574543|NCT00484705|Stress|stress
1574544|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
1574545|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
1574546|NCT00484692|randomized controlled trial|randomized controlled trial
1574547|NCT00484692|smoking cessation|smoking cessation
1574548|NCT00484692|nicotine dependence|nicotine dependence
1574549|NCT00484692|sustained-release bupropion|sustained-release bupropion
1574550|NCT00484692|psychotherapy|psychotherapy
1574551|NCT00484692|psychodynamic model training|psychodynamic model training
1574552|NCT00484666|recurrent|recurrent
1574553|NCT00484666|platinum|platinum
1574554|NCT00484666|resistant|resistant
1574555|NCT00484666|ovarian|ovarian
1574556|NCT00484666|primary|primary
1574557|NCT00484666|peritoneal|peritoneal
1574558|NCT00484666|cancer|cancer
1574559|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
1574560|NCT00484627|Exercise|exercise
1574562|NCT00484627|Creatine|creatine
1574563|NCT00484627|Muscle|muscle
1574564|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
1574565|NCT00484588|VAP|vap
1574566|NCT00484575|Sevoflurane|sevoflurane
1574567|NCT00484575|CABG|cabg
1574568|NCT00484575|cardioprotection|cardioprotection
1574569|NCT00484575|AnaConDa|anaconda
1574570|NCT00484562|oxygen|oxygen
1574571|NCT00484562|COPD|copd
1574572|NCT00484562|exercise|exercise
1574573|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
1574574|NCT00484536|CDP323|cdp323
1574575|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
1574576|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
1574577|NCT00484536|Oral Compound|oral compound
1574578|NCT00484536|MS|ms
1574579|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
1574580|NCT00484510|Ascorbic Acid|ascorbic acid
1574581|NCT00484510|Vitamin C|vitamin c
1574582|NCT00484510|Charcot Marie Tooth|charcot marie tooth
1574583|NCT00484510|CMT|cmt
1574584|NCT00484510|CMT1a|cmt1a
1574585|NCT00484497|Sleep quality|sleep quality
1574586|NCT00484497|food supplement|food supplement
1574587|NCT00484497|randomized controlled trial|randomized controlled trial
1574588|NCT00484497|actigraphy|actigraphy
1574589|NCT00484497|Leeds|leeds
1574590|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
1574591|NCT00484484|Cancer|cancer
1574592|NCT00484484|Refractory pain|refractory pain
1574593|NCT00484484|Uncontrolled pain|uncontrolled pain
1574594|NCT00484484|Ketamine|ketamine
1574595|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
1574596|NCT00484458|Degenerative Disc Disease|degenerative disc disease
1574597|NCT00484458|Total Disc Replacement|total disc replacement
1574598|NCT00484445|Chronic critical illness|chronic critical illness
1574599|NCT00484445|Functional status|functional status
1574600|NCT00484445|Outcomes|outcomes
1574601|NCT00484445|Post-ICU|post-icu
1574602|NCT00484432|NGR-hTNF|ngr-htnf
1574603|NCT00484432|Ovarian cancer|ovarian cancer
1574604|NCT00484432|Doxorubicin|doxorubicin
1574605|NCT00484419|Colesevelam HCl,|colesevelam hcl,
1574606|NCT00484419|rosiglitazone|rosiglitazone
1574607|NCT00484419|sitagliptin|sitagliptin
1574608|NCT00484419|Type 2 diabetes|type 2 diabetes
1574609|NCT00484419|metformin|metformin
1574610|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
1574611|NCT00484406|Atherosclerosis|atherosclerosis
1574612|NCT00484406|Genetic polymorphism|genetic polymorphism
1574613|NCT00484406|Acute coronary syndromes|acute coronary syndromes
1574614|NCT00484380|Valvular surgery|valvular surgery
1574615|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
1574616|NCT00484380|Coronary stenosis|coronary stenosis
1574617|NCT00484380|Coronary revascularisation|coronary revascularisation
1574618|NCT00484367|Alcohol abuse|alcohol abuse
1574619|NCT00484367|Substance abuse|substance abuse
1574620|NCT00484367|Cannabis abuse|cannabis abuse
1574621|NCT00484367|Adolescents|adolescents
1574622|NCT00484367|Group therapy|group therapy
1574623|NCT00484367|Family therapy|family therapy
1574624|NCT00484354|Acute Renal Failure|acute renal failure
1574625|NCT00484354|Cardiac Surgery|cardiac surgery
1574626|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
1574627|NCT00484354|Length of Stay|length of stay
1574628|NCT00484354|Mortality|mortality
1574629|NCT00484341|NGR-hTNF|ngr-htnf
1574630|NCT00484341|Doxorubicin|doxorubicin
1574631|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
1574632|NCT00484328|hepatitis C|hepatitis c
1574633|NCT00484328|Ribavirin|ribavirin
1574634|NCT00484328|Dosage|dosage
1574635|NCT00484328|Pharmacokinetics|pharmacokinetics
1574636|NCT00484315|drug-eluting stent|drug-eluting stent
1574637|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
1574638|NCT00484315|DES|des
1574639|NCT00484302|Marijuana Abuse|marijuana abuse
1574640|NCT00484302|Psychotic Disorders|psychotic disorders
1574641|NCT00484302|Schizophrenia|schizophrenia
1574642|NCT00484276|NGR-hTNF|ngr-htnf
1574643|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
1574644|NCT00484250|Oral Lichen Planus|oral lichen planus
1574645|NCT00484250|Metronidazole|metronidazole
1574646|NCT00484250|Doxycycline|doxycycline
1574647|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
1574648|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
1574649|NCT00484185|Hemophilia B|hemophilia b
1574650|NCT00484185|BeneFIX|benefix
1574651|NCT00484185|Safety|safety
1574652|NCT00484185|Efficacy|efficacy
1574653|NCT00484172|Obesity|obesity
1574654|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
1574655|NCT00484146|Sepsis|sepsis
1574656|NCT00484146|Early Stage|early stage
1574657|NCT00484146|Immune System|immune system
1574658|NCT00484146|Receptors|receptors
1574659|NCT00484146|Cytokines|cytokines
1574660|NCT00484133|sepsis|sepsis
1574661|NCT00484133|severe sepsis|severe sepsis
1574662|NCT00484133|microcirculation|microcirculation
1574663|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
1574664|NCT00484120|Osteoarthritis|osteoarthritis
1574665|NCT00484120|Diclofenac|diclofenac
1574666|NCT00484120|Nano-emulsion|nano-emulsion
1574667|NCT00484094|Rapamune|rapamune
1574668|NCT00484094|Safety|safety
1574669|NCT00484094|Efficacy|efficacy
1574670|NCT00484094|Kidney Transplantation|kidney transplantation
1574671|NCT00484081|TESE|tese
1574672|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
1574673|NCT00484081|MICRODISSECTION|microdissection
1574674|NCT00484081|AZOOSPERMIA|azoospermia
1574675|NCT00484081|ICSI|icsi
1574676|NCT00484068|type 2 diabetes|type 2 diabetes
1574677|NCT00484068|microalbuminuria|microalbuminuria
1574678|NCT00484068|chicken-based diet|chicken-based diet
1574679|NCT00484068|ACE inhibitor|ace inhibitor
1574680|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
1574681|NCT00484042|pancreatitis|pancreatitis
1574682|NCT00484042|polyamine|polyamine
1574683|NCT00484042|cytokine|cytokine
1574684|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
1574685|NCT00484029|TMD|tmd
1574686|NCT00484029|TMJ/TMD|tmj/tmd
1574687|NCT00484029|Pain Management|pain management
1574688|NCT00484029|Pain|pain
1574689|NCT00484029|Headaches|headaches
1574690|NCT00484016|adjuvant|adjuvant
1574691|NCT00484016|chemotherapy|chemotherapy
1574692|NCT00484016|observation|observation
1574693|NCT00484016|resected|resected
1574694|NCT00484016|cancers|cancers
1574695|NCT00484003|Atopic eczema|atopic eczema
1574696|NCT00484003|Pimecrolimus|pimecrolimus
1574697|NCT00484003|Children|children
1574698|NCT00484003|Quality of life|quality of life
1574699|NCT00484003|Safety|safety
1574700|NCT00484003|Atopic dermatitis|atopic dermatitis
1574701|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
1574702|NCT00483964|Schizophrenia|schizophrenia
1574703|NCT00483964|Herbal extracts|herbal extracts
1574704|NCT00483964|Randomized|randomized
1574705|NCT00483964|Controlled|controlled
1574706|NCT00483964|Clinical Trial|clinical trial
1574707|NCT00483951|Myocardial Infarction|myocardial infarction
1574708|NCT00483951|Myocardial Ischemia|myocardial ischemia
1574709|NCT00483951|Atherosclerosis|atherosclerosis
1574710|NCT00483951|Congenital Heart Disease|congenital heart disease
1574711|NCT00483951|Valvular Heart Disease|valvular heart disease
1574712|NCT00483951|Heart Disease|heart disease
1574713|NCT00483951|Cardiovascular Disease|cardiovascular disease
1574714|NCT00483951|Heart Valve Disease|heart valve disease
1574715|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
1574716|NCT00483925|flow mediated dilatation|flow mediated dilatation
1574717|NCT00483925|intima media thickness|intima media thickness
1574718|NCT00483925|insulin resistance|insulin resistance
1574719|NCT00483925|hypopituitarism|hypopituitarism
1574720|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
1574721|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
1574722|NCT00483912|pancreatitis, MARS|pancreatitis, mars
1574794|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
1574723|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
1574724|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
1574725|NCT00483886|constipation|constipation
1574726|NCT00483886|prucalopride|prucalopride
1574727|NCT00483886|QOL|qol
1574728|NCT00483886|SCBM|scbm
1574729|NCT00483886|PAC-SYM|pac-sym
1574730|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
1574731|NCT00483860|Cancer|cancer
1574732|NCT00483860|Solid tumor,|solid tumor,
1574733|NCT00483860|normal renal function|normal renal function
1574734|NCT00483860|renal impairment,|renal impairment,
1574735|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
1574736|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
1574737|NCT00483847|TYSABRI|tysabri
1574738|NCT00483847|natalizumab|natalizumab
1574739|NCT00483847|Multiple Sclerosis|multiple sclerosis
1574740|NCT00483834|Bevacizumab|bevacizumab
1574741|NCT00483834|Avastin|avastin
1574742|NCT00483834|CPT-11|cpt-11
1574743|NCT00483834|Irinotecan|irinotecan
1574744|NCT00483834|Camptothecin-11|camptothecin-11
1574745|NCT00483834|Capecitabine|capecitabine
1574746|NCT00483834|Xeloda|xeloda
1574747|NCT00483834|Metastatic|metastatic
1574748|NCT00483834|Colorectal|colorectal
1574749|NCT00483834|Colon|colon
1574750|NCT00483834|Rectal|rectal
1574751|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1574752|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1574753|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1574754|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1574755|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1574756|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1574757|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1574758|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1575650|NCT00480506|chimerism|chimerism
1574759|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1574760|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1574761|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1574762|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1574763|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1574764|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1574765|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1574766|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1574767|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1574768|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1574769|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1574770|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1574771|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1574772|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1574773|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1574774|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1574775|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1574776|NCT00483782|Brenner tumor|brenner tumor
1574777|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
1574778|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1574779|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1574862|NCT00483574|Rubella|rubella
1574780|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1574781|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1574782|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1574783|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1574784|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1574785|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1574786|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1574787|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1574788|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1574789|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1574907|NCT00483301|Sorafenib|sorafenib
1574790|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1574791|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1574792|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1574793|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
1575606|NCT00480675|fluoroscopy|fluoroscopy
1574795|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
1574796|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
1574797|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
1574798|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
1574799|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1574800|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1574801|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1574802|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1574803|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
1574804|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
1574805|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
1574806|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
1574807|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
1574808|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
1574809|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1574810|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1574811|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1574812|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1574813|NCT00483769|Cystis Fibrosis|cystis fibrosis
1574814|NCT00483769|Glucose intolerance|glucose intolerance
1574815|NCT00483769|Glargine|glargine
1574816|NCT00483769|FEV1%|fev1%
1574817|NCT00483756|Immunosuppression|immunosuppression
1574818|NCT00483756|JAK3 inhibitor|jak3 inhibitor
1574819|NCT00483756|kidney transplantation.|kidney transplantation.
1574820|NCT00483717|Migraine|migraine
1574821|NCT00483717|Ketorolac|ketorolac
1574822|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
1574823|NCT00483691|Intervention|intervention
1574824|NCT00483691|Home Visit|home visit
1574825|NCT00483691|Growth|growth
1574826|NCT00483691|Child Development|child development
1574926|NCT00483223|PgR negative|pgr negative
1574827|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1574828|NCT00483678|sexual dysfunction|sexual dysfunction
1574829|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
1574830|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
1574831|NCT00483678|stage III prostate cancer|stage iii prostate cancer
1574832|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
1574833|NCT00483665|endoleak|endoleak
1574834|NCT00483652|multiple sclerosis|multiple sclerosis
1574835|NCT00483652|MS|ms
1574836|NCT00483652|walking|walking
1574837|NCT00483652|leg strength|leg strength
1574838|NCT00483652|demyelination|demyelination
1574839|NCT00483639|anxiety disorder|anxiety disorder
1574840|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1574841|NCT00483639|head and neck cancer|head and neck cancer
1574842|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
1574843|NCT00483639|small cell lung cancer|small cell lung cancer
1574844|NCT00483626|hemodynamic|hemodynamic
1574845|NCT00483626|pulmonary hypertension|pulmonary hypertension
1574846|NCT00483626|sildenafil|sildenafil
1574847|NCT00483613|Daily stress|daily stress
1574848|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
1574849|NCT00483613|Quality of life|quality of life
1574850|NCT00483613|SLEDAI|sledai
1574851|NCT00483600|Fondaparinux|fondaparinux
1574852|NCT00483600|Pharmacokinetic|pharmacokinetic
1574853|NCT00483587|NSTEMI|nstemi
1574854|NCT00483587|Acute coronary syndrome|acute coronary syndrome
1574855|NCT00483587|Heme arginate|heme arginate
1574856|NCT00483587|HO-1|ho-1
1574857|NCT00483587|Heme oxygenase-1|heme oxygenase-1
1574858|NCT00483574|Menactra® vaccine|menactra® vaccine
1574859|NCT00483574|Meningococcal meningitis|meningococcal meningitis
1574860|NCT00483574|Measles|measles
1574861|NCT00483574|Mumps|mumps
1574863|NCT00483574|Varicella virus|varicella virus
1574864|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
1574865|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1574866|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1574867|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
1574868|NCT00483561|stage III prostate cancer|stage iii prostate cancer
1574869|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
1574870|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
1574871|NCT00483522|Rehabilitation|rehabilitation
1574872|NCT00483522|Directive counseling|directive counseling
1574873|NCT00483522|Brain injuries|brain injuries
1574874|NCT00483509|NGR-hTNF|ngr-htnf
1574875|NCT00483509|SCLC|sclc
1574876|NCT00483483|HIV|hiv
1574877|NCT00483483|Unsafe sex|unsafe sex
1574878|NCT00483483|High-risk sex|high-risk sex
1574879|NCT00483483|Needle sharing|needle sharing
1574880|NCT00483483|STDs|stds
1574881|NCT00483470|Hepatitis A|hepatitis a
1574986|NCT00482924|brown adipose tissue|brown adipose tissue
1574882|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1574883|NCT00483444|Rehabilitation|rehabilitation
1574884|NCT00483444|Brain injuries|brain injuries
1574885|NCT00483444|Directive counseling|directive counseling
1574886|NCT00483431|vitamin K2|vitamin k2
1574887|NCT00483431|dosis-response|dosis-response
1574888|NCT00483431|osteocalcin|osteocalcin
1574889|NCT00483431|matrix-gla protein|matrix-gla protein
1574890|NCT00483418|male|male
1574891|NCT00483418|cancer|cancer
1574892|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
1574893|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1574894|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1574895|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1574896|NCT00483392|insulin|insulin
1574897|NCT00483392|rosiglitazone|rosiglitazone
1574898|NCT00483392|metformin|metformin
1574899|NCT00483392|hiv|hiv
1574900|NCT00483392|protease inhibitors|protease inhibitors
1574901|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1574902|NCT00483327|Well|well
1574903|NCT00483327|Moderately|moderately
1574904|NCT00483327|Differentiated|differentiated
1574905|NCT00483301|Melanoma|melanoma
1574906|NCT00483301|Abraxane|abraxane
1574908|NCT00483301|BAY 43-9006|bay 43-9006
1574909|NCT00483301|Abraxis|abraxis
1574910|NCT00483288|cervical cancer|cervical cancer
1574911|NCT00483275|Accidental Falls|accidental falls
1574912|NCT00483275|Accident Prevention|accident prevention
1574913|NCT00483275|Patient Education|patient education
1574914|NCT00483275|Exercise Training|exercise training
1574915|NCT00483275|Alfacalcidol|alfacalcidol
1574916|NCT00483262|Temsirolimus|temsirolimus
1574917|NCT00483262|Bortezomib|bortezomib
1574918|NCT00483249|Thoracoabdominal|thoracoabdominal
1574919|NCT00483249|Paravisceral|paravisceral
1574920|NCT00483249|Aneurysm|aneurysm
1574921|NCT00483249|Endovascular|endovascular
1574922|NCT00483249|Stent-Graft|stent-graft
1574923|NCT00483249|Aorta|aorta
1574924|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
1574925|NCT00483223|ER negative|er negative
1574927|NCT00483223|HER2 negative|her2 negative
1574928|NCT00483223|cisplatin|cisplatin
1574929|NCT00483223|carboplatinum|carboplatinum
1574930|NCT00483223|platinum|platinum
1574931|NCT00483223|p63|p63
1574932|NCT00483223|p73|p73
1574933|NCT00483197|VentrAssistTM|ventrassisttm
1574934|NCT00483197|LVAD|lvad
1574935|NCT00483197|End-stage heart failure|end-stage heart failure
1574936|NCT00483197|Cardiomyopathy|cardiomyopathy
1574937|NCT00483158|Helicobacter pylori|helicobacter pylori
1574938|NCT00483158|Fluoroquinolones|fluoroquinolones
1574939|NCT00483158|First in Man|first in man
1574940|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
1574941|NCT00483119|IVIg|ivig
1574942|NCT00483119|cyclophosphamide|cyclophosphamide
1574943|NCT00483119|treatment|treatment
1574944|NCT00483119|pemphigus antibodies|pemphigus antibodies
1574945|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1574946|NCT00483106|Genetics|genetics
1574947|NCT00483106|Pharmacogenetics|pharmacogenetics
1574948|NCT00483093|NGR-hTNF|ngr-htnf
1574949|NCT00483093|cisplatin|cisplatin
1574950|NCT00483093|solid tumors|solid tumors
1574951|NCT00483080|NGR-hTNF|ngr-htnf
1574952|NCT00483080|CRC|crc
1574953|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
1574954|NCT00483067|Leukemia|leukemia
1574955|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
1574956|NCT00483067|Cladribine|cladribine
1574957|NCT00483067|Cytarabine|cytarabine
1574958|NCT00483067|Ara-C|ara-c
1574959|NCT00483067|2-CdA|2-cda
1574960|NCT00483067|G-CSF|g-csf
1574961|NCT00483067|HES|hes
1574962|NCT00483054|HIV|hiv
1574963|NCT00483054|tuberculosis|tuberculosis
1574964|NCT00483054|efavirenz|efavirenz
1574965|NCT00483054|nevirapine|nevirapine
1574966|NCT00483054|rifampicin|rifampicin
1574967|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
1574968|NCT00483015|presentation|presentation
1574969|NCT00483015|outcome|outcome
1574970|NCT00483015|response|response
1574971|NCT00483015|never- smokers|never- smokers
1574972|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
1574973|NCT00482963|HIV|hiv
1574974|NCT00482963|Contraception|contraception
1574975|NCT00482963|Antiretroviral agents|antiretroviral agents
1574976|NCT00482963|Pharmacokinetics|pharmacokinetics
1574977|NCT00482937|Safety|safety
1574978|NCT00482937|Heart Failure|heart failure
1574979|NCT00482924|obesity|obesity
1574980|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
1574981|NCT00482924|adipokines|adipokines
1574982|NCT00482924|preatherosclerosis|preatherosclerosis
1574983|NCT00482924|low grade inflammation|low grade inflammation
1574984|NCT00482924|dyslipidemia|dyslipidemia
1574985|NCT00482924|insulin resistance|insulin resistance
1574987|NCT00482924|white adipose tissue|white adipose tissue
1574988|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
1574989|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
1574990|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1574991|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
1574992|NCT00482911|iris melanoma|iris melanoma
1574993|NCT00482911|conjunctival melanoma|conjunctival melanoma
1574994|NCT00482885|Esophagus|esophagus
1574995|NCT00482885|Peristalsis|peristalsis
1574996|NCT00482885|Contractile Pressure|contractile pressure
1574997|NCT00482885|Coordination of contraction|coordination of contraction
1574998|NCT00482885|Bolus transport|bolus transport
1574999|NCT00482885|Esophageal function|esophageal function
1575000|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1575001|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1575002|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1575003|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1575004|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1575005|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1575006|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1575007|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1575008|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1575009|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1575010|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1575011|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1575012|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1575013|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1575151|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
1575014|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1575015|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1575016|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1575017|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1575018|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1575019|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1575020|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1575021|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1575022|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1575023|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1575024|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1575025|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1575026|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1575027|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1575028|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1575029|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1575030|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1575098|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1576000|NCT00479102|Babies|babies
1575031|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1575032|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1575033|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1575034|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1575035|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1575036|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1575037|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1575038|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1575039|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1575040|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1575041|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1575042|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1575043|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1575044|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
1575045|NCT00482846|mucositis|mucositis
1575046|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1575047|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
1575048|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
1575049|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
1575050|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1575051|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1575052|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1575053|NCT00482820|anxiety|anxiety
1575054|NCT00482820|attention-biases|attention-biases
1575055|NCT00482820|children|children
1575056|NCT00482807|stage I prostate cancer|stage i prostate cancer
1575057|NCT00482807|stage II prostate cancer|stage ii prostate cancer
1575058|NCT00482807|stage III prostate cancer|stage iii prostate cancer
1575059|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
1575060|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1575061|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
1575062|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
1575063|NCT00482781|Apnea|apnea
1575064|NCT00482781|Bradycardia|bradycardia
1575065|NCT00482781|Preterm Infant|preterm infant
1575066|NCT00482781|Immunization|immunization
1575067|NCT00482781|DTaP|dtap
1575068|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
1575069|NCT00482755|male breast cancer|male breast cancer
1575070|NCT00482755|stage II breast cancer|stage ii breast cancer
1575071|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
1575072|NCT00482742|Chronic Total Occlusion|chronic total occlusion
1575073|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1575074|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
1575075|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
1575076|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
1575077|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
1575152|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
1575751|NCT00480090|Prostate|prostate
1575078|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1575079|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1575080|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1575081|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1575082|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1575083|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1575084|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1575085|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1575086|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1575087|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1575088|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1575089|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1575090|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1575091|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1575092|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1575093|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1575094|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1575095|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1575096|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1575097|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1575278|NCT00481936|Neoplasms|neoplasms
1575099|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1575100|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1575101|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1575102|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1575103|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1575104|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1575105|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1575106|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1575107|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1575108|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1575109|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1575110|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1575111|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1575112|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1575113|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1575114|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1575115|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1575116|NCT00482716|anemia|anemia
1575117|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
1575118|NCT00482690|Smoking cessation|smoking cessation
1575119|NCT00482690|Biomarkers|biomarkers
1575120|NCT00482690|Aldehydes|aldehydes
1575121|NCT00482690|Exhaled breath|exhaled breath
1575122|NCT00482690|Harm Reduction|harm reduction
1575123|NCT00482690|Cigarette smoking|cigarette smoking
1575124|NCT00482690|cessation|cessation
1575125|NCT00482690|reduction|reduction
1575126|NCT00482677|adult glioblastoma|adult glioblastoma
1575127|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
1575128|NCT00482677|adult gliosarcoma|adult gliosarcoma
1575129|NCT00482586|adult primary liver cancer|adult primary liver cancer
1575130|NCT00482586|liver metastases|liver metastases
1575131|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
1575132|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
1575133|NCT00482573|Cardiotocography/methods|cardiotocography/methods
1575134|NCT00482573|Dental restoration, permanent|dental restoration, permanent
1575135|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
1575136|NCT00482573|Lidocaine|lidocaine
1575137|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
1575138|NCT00482573|Epinephrine|epinephrine
1575139|NCT00482573|Pregnancy|pregnancy
1575140|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
1575141|NCT00482560|Sucrose|sucrose
1575142|NCT00482560|Breastfeeding|breastfeeding
1575143|NCT00482560|Heel lance|heel lance
1575144|NCT00482547|urinary tract infection|urinary tract infection
1575145|NCT00482547|urinary catheter|urinary catheter
1575146|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1575147|NCT00482508|Asthma|asthma
1575148|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
1575149|NCT00482508|omalizumab|omalizumab
1575150|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
1575343|NCT00481754|Hormones|hormones
1575153|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
1575154|NCT00482482|Yoga|yoga
1575155|NCT00482482|Bipolar disorder|bipolar disorder
1575156|NCT00482482|Major depression|major depression
1575157|NCT00482482|Dysthymia|dysthymia
1575158|NCT00482482|Randomized|randomized
1575159|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
1575160|NCT00482469|ischemia|ischemia
1575161|NCT00482469|reperfusion|reperfusion
1575162|NCT00482469|DIEP-flap|diep-flap
1575163|NCT00482469|flap|flap
1575164|NCT00482456|Nitrous oxide|nitrous oxide
1575165|NCT00482456|Homocysteine|homocysteine
1575166|NCT00482456|folate|folate
1575167|NCT00482456|vitamin B12|vitamin b12
1575168|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
1575169|NCT00482430|Residual schizophrenia|residual schizophrenia
1575170|NCT00482391|recurrent breast cancer|recurrent breast cancer
1575171|NCT00482391|stage I breast cancer|stage i breast cancer
1575172|NCT00482391|stage II breast cancer|stage ii breast cancer
1575173|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
1575174|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
1575175|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
1575176|NCT00482391|male breast cancer|male breast cancer
1575177|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
1575178|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
1575179|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
1575180|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
1575181|NCT00482378|pain|pain
1575182|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1575183|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
1575184|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1575791|NCT00479973|cinnamon|cinnamon
1575185|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1575186|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1575187|NCT00482339|bacterial contamination|bacterial contamination
1575188|NCT00482339|platelet concentrates|platelet concentrates
1575189|NCT00482339|blood donation|blood donation
1575190|NCT00482339|looxster|looxster
1575191|NCT00482339|pureprove|pureprove
1575192|NCT00482339|bacterial genomic DNA|bacterial genomic dna
1575193|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
1575194|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
1575195|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
1575196|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1575197|NCT00482313|ADHD|adhd
1575198|NCT00482313|Prison|prison
1575199|NCT00482313|Treatment|treatment
1575200|NCT00482313|Randomized|randomized
1575201|NCT00482313|Double-Blind|double-blind
1575202|NCT00482313|Placebo Control|placebo control
1575203|NCT00482313|Parallel Assignment|parallel assignment
1575204|NCT00482313|Efficacy Study|efficacy study
1575205|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
1575206|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1575207|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
1575208|NCT00482274|stage I prostate cancer|stage i prostate cancer
1575209|NCT00482274|stage II prostate cancer|stage ii prostate cancer
1575210|NCT00482274|stage III prostate cancer|stage iii prostate cancer
1575211|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
1575212|NCT00482261|myeloma|myeloma
1575213|NCT00482261|relapse|relapse
1575214|NCT00482261|refractory|refractory
1575215|NCT00482261|elderly|elderly
1575216|NCT00482261|lenalidomide|lenalidomide
1575217|NCT00482248|Asthma|asthma
1575218|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
1575219|NCT00482248|omalizumab|omalizumab
1575220|NCT00482248|allergic asthma|allergic asthma
1575221|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
1575222|NCT00482222|stage IV colon cancer|stage iv colon cancer
1575223|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1575224|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
1575225|NCT00482222|liver metastases|liver metastases
1575226|NCT00482222|recurrent colon cancer|recurrent colon cancer
1575227|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
1575228|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
1575229|NCT00482183|Bare metal stent|bare metal stent
1575230|NCT00482183|Major adverse cardiac events|major adverse cardiac events
1575231|NCT00482183|Pioglitazone|pioglitazone
1575232|NCT00482183|Restenosis|restenosis
1575233|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
1575234|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
1575235|NCT00482118|Air Pollution|air pollution
1575236|NCT00482118|Tumor Markers|tumor markers
1575237|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
1575238|NCT00482118|Molecular Epidemiology|molecular epidemiology
1575239|NCT00482118|Environmental Epidemiology|environmental epidemiology
1575240|NCT00482118|Lung Cancer|lung cancer
1575241|NCT00482105|melanoma|melanoma
1575242|NCT00482092|Crohn's disease|crohn's disease
1575243|NCT00482092|adult stem cell therapy|adult stem cell therapy
1575244|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
1575245|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
1575246|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
1575247|NCT00482066|ANCA|anca
1575248|NCT00482040|CPAP|cpap
1575249|NCT00482040|Preterm|preterm
1575250|NCT00482040|Prematurity|prematurity
1575251|NCT00482040|Apnea of prematurity|apnea of prematurity
1575252|NCT00482027|HIV vaccine|hiv vaccine
1575253|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
1575254|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
1575255|NCT00482027|Safety|safety
1575256|NCT00482027|Immunogenicity|immunogenicity
1575257|NCT00482027|Biodistribution|biodistribution
1575258|NCT00482027|HIV prevention|hiv prevention
1575259|NCT00482001|Donepezil|donepezil
1575260|NCT00482001|Driving|driving
1575261|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
1575262|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
1575263|NCT00482001|Psychopharmacology|psychopharmacology
1575264|NCT00482001|Aricept|aricept
1575265|NCT00481988|depression|depression
1575266|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
1575267|NCT00481988|direct current stimulation|direct current stimulation
1575268|NCT00481988|tdcs|tdcs
1575269|NCT00481975|binge eating|binge eating
1575270|NCT00481975|eating disorders|eating disorders
1575271|NCT00481975|obesity|obesity
1575272|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
1575273|NCT00481949|pH measurement|ph measurement
1575274|NCT00481949|symptom association|symptom association
1575275|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
1575276|NCT00481949|Functional Heartburn|functional heartburn
1575277|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
1575279|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
1575280|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
1575281|NCT00481923|hypocaloric diet|hypocaloric diet
1575282|NCT00481923|energy intake|energy intake
1575283|NCT00481897|overweight|overweight
1575284|NCT00481897|obesity|obesity
1575285|NCT00481897|type 2 diabetes|type 2 diabetes
1575286|NCT00481897|diabetes|diabetes
1575287|NCT00481897|worksite cost|worksite cost
1575288|NCT00481897|nutrition|nutrition
1575289|NCT00481884|Breast Cancer|breast cancer
1575290|NCT00481884|Radiation Dermatitis|radiation dermatitis
1575291|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
1575292|NCT00481884|Aquaphor|aquaphor
1575293|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
1575294|NCT00481871|Lymphoma|lymphoma
1575295|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
1575296|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1575297|NCT00481871|PTCL|ptcl
1575298|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
1575299|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
1575603|NCT00480688|BCG|bcg
1575300|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1575301|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
1575302|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
1575303|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
1575304|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
1575305|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
1575306|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
1575307|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
1575308|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
1575309|NCT00481871|PDX|pdx
1575310|NCT00481871|Pralatrexate|pralatrexate
1575311|NCT00481871|Gemcitabine|gemcitabine
1575312|NCT00481871|Gemzar|gemzar
1575313|NCT00481871|Vitamin B12|vitamin b12
1575314|NCT00481871|Folic acid|folic acid
1575315|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1575316|NCT00481858|biomarker|biomarker
1575317|NCT00481858|prognosis|prognosis
1575318|NCT00481858|apoptosis|apoptosis
1575319|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
1575320|NCT00481858|stable isotope|stable isotope
1575321|NCT00481858|diagnosis evaluation|diagnosis evaluation
1575322|NCT00481858|outcomes|outcomes
1575323|NCT00481858|CD19|cd19
1575324|NCT00481858|CD5|cd5
1575325|NCT00481819|Kidney Transplantation|kidney transplantation
1575326|NCT00481819|Tacrolimus|tacrolimus
1575327|NCT00481819|Methylprednisolone|methylprednisolone
1575328|NCT00481819|Prednisolone|prednisolone
1575329|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
1575330|NCT00481806|Virchow's Triad|virchow's triad
1575331|NCT00481806|Thrombin|thrombin
1575332|NCT00481806|Graft Failure|graft failure
1575333|NCT00481793|Plutonium|plutonium
1575334|NCT00481793|Ionizing Radiation|ionizing radiation
1575335|NCT00481793|Polymorphism|polymorphism
1575336|NCT00481793|Biological Marker|biological marker
1575337|NCT00481793|Russia|russia
1575338|NCT00481767|Safety|safety
1575339|NCT00481767|Immunogenicity|immunogenicity
1575340|NCT00481767|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
1575341|NCT00481754|Endometrium|endometrium
1575342|NCT00481754|PTEN|pten
1575344|NCT00481754|Carcinogenesis|carcinogenesis
1575345|NCT00481754|Etiology|etiology
1575346|NCT00481754|Tissue Evaluation|tissue evaluation
1575347|NCT00481754|Questionnaire|questionnaire
1575348|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
1575349|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
1575350|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
1575351|NCT00481715|North Carolina|north carolina
1575352|NCT00481689|Cipro|cipro
1575353|NCT00481689|Complicated UTI|complicated uti
1575354|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
1575355|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
1575356|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
1575357|NCT00481624|advanced lung cancer|advanced lung cancer
1575358|NCT00481624|Procrit|procrit
1575359|NCT00481624|Epoetin Alfa|epoetin alfa
1575360|NCT00481624|Ferric Gluconate|ferric gluconate
1575361|NCT00481624|iron supplementation|iron supplementation
1575362|NCT00481611|Industry Hygiene|industry hygiene
1575363|NCT00481611|Molecular Epidemiology|molecular epidemiology
1575364|NCT00481611|Cancer Susceptibility|cancer susceptibility
1575365|NCT00481611|Genotoxicity|genotoxicity
1575366|NCT00481611|Immune Function|immune function
1575367|NCT00481611|Cancer Susceptability|cancer susceptability
1575368|NCT00481585|claudin|claudin
1575369|NCT00481585|electrophysiology|electrophysiology
1575370|NCT00481585|breast|breast
1575371|NCT00481585|screening|screening
1575372|NCT00481572|Sepsis|sepsis
1575373|NCT00481572|Septic Shock|septic shock
1575374|NCT00481572|vasopressin|vasopressin
1575375|NCT00481572|terlipressin|terlipressin
1575376|NCT00481559|Voraxaze|voraxaze
1575377|NCT00481559|glucarpidase|glucarpidase
1575378|NCT00481559|carboxypeptidase|carboxypeptidase
1575379|NCT00481559|cancer|cancer
1575380|NCT00481559|lymphoma|lymphoma
1575381|NCT00481559|leukemia|leukemia
1575382|NCT00481559|osteosarcoma|osteosarcoma
1575383|NCT00481559|methotrexate|methotrexate
1575384|NCT00481559|delayed elimination|delayed elimination
1575385|NCT00481559|renal insufficiency|renal insufficiency
1575386|NCT00481559|toxicity|toxicity
1575387|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
1575388|NCT00481546|LCA|lca
1575389|NCT00481546|RPE65|rpe65
1575390|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
1575391|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
1575392|NCT00481533|Cesarean Delivery|cesarean delivery
1575393|NCT00481533|Uterine Contractility|uterine contractility
1575394|NCT00481507|Probiotic|probiotic
1575395|NCT00481507|Cultured dairy drink|cultured dairy drink
1575396|NCT00481507|Health|health
1575397|NCT00481507|10 day antibiotic|10 day antibiotic
1575398|NCT00481507|Otherwise healthy|otherwise healthy
1575399|NCT00481494|Glaucoma|glaucoma
1575400|NCT00481494|Drug compliance|drug compliance
1575401|NCT00481494|Personality|personality
1575402|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
1575403|NCT00481468|Coronary artery disease|coronary artery disease
1575404|NCT00481468|chest pain|chest pain
1575405|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
1575406|NCT00481455|temozolomide|temozolomide
1575407|NCT00481442|Septic shock|septic shock
1575408|NCT00481442|Sepsis|sepsis
1575409|NCT00481442|Norepinephrine|norepinephrine
1575410|NCT00481442|Phenylephrine|phenylephrine
1575411|NCT00481429|Biomarker|biomarker
1575412|NCT00481429|Glitazone|glitazone
1575413|NCT00481429|Diabetes|diabetes
1575414|NCT00481416|Esophageal Varices|esophageal varices
1575415|NCT00481416|PillCam Eso|pillcam eso
1575416|NCT00481416|Capsule Endoscopy|capsule endoscopy
1575417|NCT00481416|Given Imaging|given imaging
1575418|NCT00481416|Inscope|inscope
1575419|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
1575420|NCT00481390|HIV|hiv
1575421|NCT00481390|HLA-B*5701|hla-b*5701
1575422|NCT00481390|prevalence|prevalence
1575423|NCT00481390|Treatment Experienced|treatment experienced
1575424|NCT00481390|Treatment Naive|treatment naive
1575425|NCT00481377|Ablation|ablation
1575426|NCT00481377|Ventricular tachycardia|ventricular tachycardia
1575427|NCT00481377|coronary artery disease|coronary artery disease
1575428|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
1575429|NCT00481364|hemodialysis|hemodialysis
1575430|NCT00481364|endothelial function|endothelial function
1575431|NCT00481364|coronary artery calcification|coronary artery calcification
1575432|NCT00481364|atherosclerosis|atherosclerosis
1575433|NCT00481364|statin|statin
1575434|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
1575435|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
1575436|NCT00481351|lipid lowering therapy|lipid lowering therapy
1575437|NCT00481338|Cohort|cohort
1575438|NCT00481338|Quality of life|quality of life
1575439|NCT00481338|Health resource use|health resource use
1575440|NCT00481338|Disability|disability
1575441|NCT00481338|Prognosis|prognosis
1575442|NCT00481312|Initial Sedation|initial sedation
1575545|NCT00480935|Neoadjuvant|neoadjuvant
1575443|NCT00481312|Mechanical ventilation|mechanical ventilation
1575444|NCT00481299|Insulin|insulin
1575445|NCT00481299|glucose|glucose
1575446|NCT00481299|lipids|lipids
1575447|NCT00481299|prolactinoma|prolactinoma
1575448|NCT00481299|hyperprolactinemia|hyperprolactinemia
1575449|NCT00481286|Group clinics|group clinics
1575450|NCT00481286|Goal setting|goal setting
1575451|NCT00481286|Diabetes|diabetes
1575452|NCT00481286|Hypertension|hypertension
1575453|NCT00481286|Age 50+|age 50+
1575454|NCT00481273|MDS|mds
1575455|NCT00481260|Hgb C|hgb c
1575456|NCT00481260|Screening|screening
1575457|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
1575458|NCT00481234|Anesthesia, General|anesthesia, general
1575459|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
1575460|NCT00481234|Heart Rate|heart rate
1575461|NCT00481234|Forecasting|forecasting
1575462|NCT00481221|Thalassemia|thalassemia
1575463|NCT00481221|Iron Deficiency|iron deficiency
1575464|NCT00481221|Carrier screening|carrier screening
1575465|NCT00481208|open-angle glaucoma|open-angle glaucoma
1575466|NCT00481208|diurnal fluctuation|diurnal fluctuation
1575467|NCT00481208|intraocular pressure|intraocular pressure
1575468|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
1575469|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
1575470|NCT00481182|PK|pk
1575471|NCT00481182|PD|pd
1575472|NCT00481182|FPV|fpv
1575473|NCT00481182|RTV|rtv
1575474|NCT00481182|APV|apv
1575475|NCT00481182|ritonavir|ritonavir
1575476|NCT00481182|fosamprenavir|fosamprenavir
1575477|NCT00481182|amprenavir|amprenavir
1575478|NCT00481182|methadone|methadone
1575479|NCT00481182|pharmacokinetics|pharmacokinetics
1575480|NCT00481182|pharmacodynamics|pharmacodynamics
1575481|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1575482|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
1575483|NCT00481143|MDS|mds
1575484|NCT00481143|iron overload|iron overload
1575485|NCT00481143|chelation|chelation
1575486|NCT00481143|chelators|chelators
1575487|NCT00481143|ICL670|icl670
1575488|NCT00481143|Deferasirox|deferasirox
1575489|NCT00481143|serum ferritin|serum ferritin
1575490|NCT00481143|LIC|lic
1575491|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
1575492|NCT00481143|Refractory Anemia|refractory anemia
1575493|NCT00481143|RA|ra
1575494|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
1575495|NCT00481143|RARS|rars
1575496|NCT00481143|blood transfusions|blood transfusions
1575497|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
1575498|NCT00481130|Alport Syndrome|alport syndrome
1575499|NCT00481130|x linked|x linked
1575500|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
1575604|NCT00480675|bursitis|bursitis
1575501|NCT00481130|glomerular basement membrane|glomerular basement membrane
1575502|NCT00481130|hereditary nephritis|hereditary nephritis
1575503|NCT00481130|familial benign haematuria|familial benign haematuria
1575504|NCT00481130|type IV collagen|type iv collagen
1575505|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
1575506|NCT00481130|vison loss|vison loss
1575507|NCT00481104|Obesity|obesity
1575508|NCT00481065|Bird flu|bird flu
1575509|NCT00481065|influenza vaccine|influenza vaccine
1575510|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
1575511|NCT00481065|Prepandemic vaccine|prepandemic vaccine
1575512|NCT00481052|Adult|adult
1575513|NCT00481052|CML|cml
1575514|NCT00481052|Philadelphia positive|philadelphia positive
1575515|NCT00481052|Nilotinib|nilotinib
1575516|NCT00481052|early chronic phase|early chronic phase
1575517|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
1575518|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
1575519|NCT00481039|Sickle cell disease|sickle cell disease
1575520|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
1575521|NCT00481039|Population screening|population screening
1575522|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
1575523|NCT00481013|Adult|adult
1575524|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
1575525|NCT00481000|Clinical Psychology|clinical psychology
1575526|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
1575527|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
1575528|NCT00480987|Leukemia|leukemia
1575529|NCT00480987|Oxaliplatin|oxaliplatin
1575530|NCT00480987|Fludarabine|fludarabine
1575531|NCT00480987|Cytarabine|cytarabine
1575532|NCT00480987|AML|aml
1575533|NCT00480987|MDS|mds
1575534|NCT00480974|Sickle cell anemia|sickle cell anemia
1575535|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
1575536|NCT00480974|Hydroxyurea|hydroxyurea
1575537|NCT00480948|infant|infant
1575538|NCT00480948|infant formula|infant formula
1575539|NCT00480948|fatty acids|fatty acids
1575540|NCT00480948|palmitic acid|palmitic acid
1575541|NCT00480948|stool|stool
1575542|NCT00480948|calcium|calcium
1575543|NCT00480935|Localized|localized
1575544|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
1575546|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
1575547|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1575548|NCT00480922|steatohepatitis|steatohepatitis
1575549|NCT00480922|overweight|overweight
1575550|NCT00480922|insulin resistance|insulin resistance
1575551|NCT00480896|Dermatitis, atopic|dermatitis, atopic
1575552|NCT00480896|Tacrolimus|tacrolimus
1575553|NCT00480896|Child|child
1575554|NCT00480896|treatment outcomes|treatment outcomes
1575555|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
1575556|NCT00480870|Alzheimer|alzheimer
1575557|NCT00480870|polysomnography|polysomnography
1575558|NCT00480870|REM sleep|rem sleep
1575559|NCT00480870|donepezil|donepezil
1575560|NCT00480870|sleep apnea|sleep apnea
1575561|NCT00480870|oxygen saturation|oxygen saturation
1575562|NCT00480857|Prostate|prostate
1575563|NCT00480857|Radiation|radiation
1575564|NCT00480844|schizophrenia|schizophrenia
1575565|NCT00480844|Sertindole|sertindole
1575566|NCT00480844|Risperidone|risperidone
1575567|NCT00480844|cognitive impairment|cognitive impairment
1575568|NCT00480831|NSCLC|nsclc
1575569|NCT00480831|Cancer|cancer
1575570|NCT00480831|Avastin|avastin
1575571|NCT00480831|APM4074g|apm4074g
1575572|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
1575573|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
1575574|NCT00480792|HIV Infections|hiv infections
1575575|NCT00480779|Prediabetes|prediabetes
1575576|NCT00480779|Metabolic syndrome|metabolic syndrome
1575577|NCT00480779|Prevention|prevention
1575578|NCT00480779|Lifestyle intervention|lifestyle intervention
1575579|NCT00480766|Glucocorticoid|glucocorticoid
1575580|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
1575581|NCT00480753|Raynaud's Disease|raynaud's disease
1575582|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
1575583|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
1575584|NCT00480740|Dexmedetomidine|dexmedetomidine
1575585|NCT00480740|Congenital heart disease|congenital heart disease
1575586|NCT00480740|pharmacokinetics|pharmacokinetics
1575587|NCT00480740|pharmacodynamics|pharmacodynamics
1575588|NCT00480740|pediatric|pediatric
1575589|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
1575590|NCT00480740|Fontan physiology|fontan physiology
1575591|NCT00480740|Cardiac transplant|cardiac transplant
1575592|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
1575593|NCT00480727|Re-tension|re-tension
1575594|NCT00480727|Pin loosening|pin loosening
1575595|NCT00480714|TB|tb
1575596|NCT00480714|Vaccine|vaccine
1575597|NCT00480714|BCG|bcg
1575598|NCT00480701|Alzheimer|alzheimer
1575599|NCT00480701|Parkinson|parkinson
1575600|NCT00480701|dementia|dementia
1575601|NCT00480701|neurologic|neurologic
1575602|NCT00480688|TB|tb
1575607|NCT00480662|Paget's bone disease|paget's bone disease
1575608|NCT00480649|SERETIDE|seretide
1575609|NCT00480649|asthma|asthma
1575610|NCT00480649|Korean|korean
1575611|NCT00480649|ACT|act
1575612|NCT00480623|Prostate Cancer|prostate cancer
1575613|NCT00480623|Biochemical Failure|biochemical failure
1575614|NCT00480623|Radical Prostatectomy|radical prostatectomy
1575615|NCT00480610|Dermatitis, atopic|dermatitis, atopic
1575616|NCT00480610|Tacrolimus|tacrolimus
1575618|NCT00480610|treatment outcomes|treatment outcomes
1575619|NCT00480597|gemcitabine|gemcitabine
1575620|NCT00480597|vinorelbine|vinorelbine
1575621|NCT00480597|cisplatin|cisplatin
1575622|NCT00480597|capecitabine|capecitabine
1575623|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
1575624|NCT00480584|pancreatic|pancreatic
1575625|NCT00480584|gemcitabine|gemcitabine
1575626|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
1575627|NCT00480584|capecitabine|capecitabine
1575628|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
1575629|NCT00480558|HIV|hiv
1575630|NCT00480558|MVA85A|mva85a
1575631|NCT00480558|TB|tb
1575632|NCT00480558|Tuberculosis|tuberculosis
1575633|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
1575634|NCT00480558|Safety|safety
1575635|NCT00480558|Immunogenicity|immunogenicity
1575636|NCT00480558|Efficacy|efficacy
1575637|NCT00480558|Treatment Naive|treatment naive
1575638|NCT00480545|Women with bleeding disorders|women with bleeding disorders
1575639|NCT00480545|Menstrual cycle|menstrual cycle
1575640|NCT00480545|Women|women
1575641|NCT00480545|Healthy volunteers|healthy volunteers
1575642|NCT00480532|birth control|birth control
1575643|NCT00480532|continuous contraception|continuous contraception
1575644|NCT00480532|break-through bleeding|break-through bleeding
1575645|NCT00480519|meatotomy|meatotomy
1575646|NCT00480519|meatal stenosis|meatal stenosis
1575647|NCT00480519|local anaesthesia|local anaesthesia
1575648|NCT00480519|feasibility|feasibility
1575649|NCT00480519|pain control|pain control
1575651|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
1575653|NCT00480480|Trauma|trauma
1575654|NCT00480480|Grief|grief
1575655|NCT00480480|Depression|depression
1575656|NCT00480480|Adolescent|adolescent
1575657|NCT00480480|War|war
1575658|NCT00480480|Group|group
1575659|NCT00480480|Therapy|therapy
1575660|NCT00480480|Treatment|treatment
1575661|NCT00480480|Intervention|intervention
1575662|NCT00480480|School|school
1575663|NCT00480480|Development|development
1575664|NCT00480454|TB|tb
1575665|NCT00480454|Tuberculosis|tuberculosis
1575666|NCT00480454|Infants|infants
1575667|NCT00480454|EPI|epi
1575668|NCT00480441|Marijuana|marijuana
1575669|NCT00480441|Addiction|addiction
1575670|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
1575671|NCT00480441|Clinical Trial|clinical trial
1575672|NCT00480441|Dronabinol|dronabinol
1575673|NCT00480441|Behavioral Therapy|behavioral therapy
1575674|NCT00480441|Adults|adults
1575675|NCT00480441|Neuroimaging|neuroimaging
1575676|NCT00480441|Neuropsychological Testing|neuropsychological testing
1575677|NCT00480441|Neurocognitive Testing|neurocognitive testing
1575678|NCT00480441|Behavioral Probes|behavioral probes
1575679|NCT00480428|Radioactive Fallout|radioactive fallout
1575680|NCT00480428|Childhood Exposures|childhood exposures
1575681|NCT00480428|External Radiation Dose|external radiation dose
1575682|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
1575683|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
1575684|NCT00480402|preterm birth|preterm birth
1575685|NCT00480402|progesterone|progesterone
1575686|NCT00480402|twins|twins
1575687|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
1575688|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
1575689|NCT00480389|Metastatic|metastatic
1575690|NCT00480389|Sorafenib tosylate|sorafenib tosylate
1575691|NCT00480389|Preoperative treatment|preoperative treatment
1575692|NCT00480376|transrectal biopsy|transrectal biopsy
1575693|NCT00480376|prostate|prostate
1575694|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
1575695|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
1575696|NCT00480363|PETHEMA|pethema
1575697|NCT00480363|Smoldering|smoldering
1575698|NCT00480350|HIV|hiv
1575699|NCT00480350|virological response|virological response
1575700|NCT00480350|CD4|cd4
1575701|NCT00480350|food supplement|food supplement
1575702|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
1575703|NCT00480350|Complementary Therapies|complementary therapies
1575704|NCT00480337|PCOS|pcos
1575705|NCT00480337|Fertility Preservation|fertility preservation
1575706|NCT00480337|Repeated IVF Failure|repeated ivf failure
1575707|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
1575708|NCT00480311|symptomatic|symptomatic
1575709|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
1575710|NCT00480311|disability|disability
1575711|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
1575712|NCT00480311|quality of life|quality of life
1575713|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
1575714|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
1575715|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
1575716|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
1575717|NCT00480272|clinical remission|clinical remission
1575718|NCT00480259|blood urea nitrogen|blood urea nitrogen
1575719|NCT00480259|nitrogen balance|nitrogen balance
1575720|NCT00480259|nutrition|nutrition
1575721|NCT00480259|intensive care|intensive care
1575722|NCT00480246|receptor oocupancy|receptor oocupancy
1575723|NCT00480233|depression|depression
1575724|NCT00480233|screening|screening
1575725|NCT00480233|primary care|primary care
1575726|NCT00480233|validity|validity
1575727|NCT00480233|Hebrew|hebrew
1575728|NCT00480233|Primary care and general medical patients|primary care and general medical patients
1575729|NCT00480220|specific care|specific care
1575730|NCT00480220|assistance plan|assistance plan
1575731|NCT00480220|Alzheimer's disease|alzheimer's disease
1575732|NCT00480181|Neuropathic pain|neuropathic pain
1575733|NCT00480181|Multiple Sclerosis|multiple sclerosis
1575734|NCT00480181|Nabilone|nabilone
1575735|NCT00480181|Gabapentin|gabapentin
1575736|NCT00480168|child|child
1575737|NCT00480168|adolescent|adolescent
1575738|NCT00480168|weight gain|weight gain
1575739|NCT00480168|endocrine disruptors|endocrine disruptors
1575740|NCT00480129|grass allergies,|grass allergies,
1575741|NCT00480129|ragweed allergies,|ragweed allergies,
1575742|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
1575743|NCT00480129|bifidobacterium,|bifidobacterium,
1575744|NCT00480129|functional foods,|functional foods,
1575745|NCT00480129|yogurt,|yogurt,
1575746|NCT00480129|inflammatory cytokines|inflammatory cytokines
1575747|NCT00480116|Consistency|consistency
1575748|NCT00480116|Immunogenicity|immunogenicity
1575749|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
1575750|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
1575752|NCT00480090|Androgen independent|androgen independent
1575753|NCT00480090|Phase II|phase ii
1575754|NCT00480090|Second line|second line
1575755|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
1575756|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
1575757|NCT00480064|AML|aml
1575758|NCT00480064|older patients|older patients
1575759|NCT00480064|lomustine|lomustine
1575760|NCT00480051|Cardiac Failure|cardiac failure
1575761|NCT00480051|Pacemaker|pacemaker
1575762|NCT00480051|Dyssynchrony|dyssynchrony
1575763|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
1575764|NCT00480051|Narrow QRS|narrow qrs
1575765|NCT00480038|symptomatic|symptomatic
1575766|NCT00480038|lumbar disc herniation|lumbar disc herniation
1575767|NCT00480038|disability|disability
1575768|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
1575769|NCT00480038|quality of life|quality of life
1575770|NCT00480025|ASCI|asci
1575771|NCT00480025|Immunotherapeutic|immunotherapeutic
1575772|NCT00480025|MAGRIT|magrit
1575773|NCT00480025|Tumor antigen|tumor antigen
1575774|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
1575775|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
1575776|NCT00480012|healthy subjects|healthy subjects
1575777|NCT00479999|HIV-Negative|hiv-negative
1575778|NCT00479999|Healthy|healthy
1575779|NCT00479999|Immunity|immunity
1575780|NCT00479999|Preventive|preventive
1575781|NCT00479999|Virus|virus
1575782|NCT00479999|Healthy Volunteer|healthy volunteer
1575783|NCT00479999|HV|hv
1575784|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
1575785|NCT00479986|diabetes mellitus|diabetes mellitus
1575786|NCT00479986|monocyte activation|monocyte activation
1575787|NCT00479986|cardiovascular risk|cardiovascular risk
1575788|NCT00479973|diabetes|diabetes
1575789|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
1575790|NCT00479973|type 2 diabetes|type 2 diabetes
1575792|NCT00479973|natural health product|natural health product
1575793|NCT00479973|hypercholesterolemia|hypercholesterolemia
1575794|NCT00479973|dyslipidemia|dyslipidemia
1575795|NCT00479973|elevated cholesterol|elevated cholesterol
1575796|NCT00479960|Asthenozoospermia|asthenozoospermia
1575797|NCT00479960|Azoospermia|azoospermia
1575798|NCT00479960|Oligospermia|oligospermia
1575799|NCT00479960|Omega-3|omega-3
1575800|NCT00479960|Fatty Acids|fatty acids
1575801|NCT00479947|Yeast vaginitis|yeast vaginitis
1575802|NCT00479947|Probiotics|probiotics
1575803|NCT00479947|Lactobacilli|lactobacilli
1575804|NCT00479947|Fluconazole|fluconazole
1575805|NCT00479934|scleroderma|scleroderma
1575806|NCT00479934|imatinib|imatinib
1575807|NCT00479934|PDGFR|pdgfr
1575808|NCT00479934|Rodnan|rodnan
1575809|NCT00479921|Influenza|influenza
1575810|NCT00479921|Vaccine|vaccine
1575811|NCT00479921|CHMP criteria|chmp criteria
1575812|NCT00479908|Blood pressure|blood pressure
1575813|NCT00479908|Angina|angina
1575814|NCT00479908|Sildenafil|sildenafil
1575815|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
1575816|NCT00479908|Organic nitrate|organic nitrate
1575817|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
1575818|NCT00479908|Drug interaction|drug interaction
1575819|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
1575820|NCT00479895|Myocardial Ischemia|myocardial ischemia
1575821|NCT00479895|Balloon Occlusion|balloon occlusion
1575822|NCT00479895|Catheter Lab|catheter lab
1575823|NCT00479856|ErbB1|erbb1
1575824|NCT00479856|ErbB2|erbb2
1575825|NCT00479856|GW572016|gw572016
1575826|NCT00479856|lapatinib|lapatinib
1575827|NCT00479856|Relapsed breast cancer|relapsed breast cancer
1575828|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
1575829|NCT00479856|MBC|mbc
1575830|NCT00479856|EGFR|egfr
1575831|NCT00479856|Her-2/neu|her-2/neu
1575832|NCT00479856|FISH amplification|fish amplification
1575833|NCT00479843|Alzheimer Disease|alzheimer disease
1575834|NCT00479843|Dementia|dementia
1575835|NCT00479843|Elderly|elderly
1575836|NCT00479843|Nutrition|nutrition
1575837|NCT00479843|Malnutrition|malnutrition
1575838|NCT00479843|Weight Loss|weight loss
1575839|NCT00479830|Epidemiology|epidemiology
1575840|NCT00479830|Health Risks|health risks
1575841|NCT00479830|Questionnaire|questionnaire
1575842|NCT00479830|Interview|interview
1575843|NCT00479830|South Asian|south asian
1575844|NCT00479830|Asian Indian|asian indian
1575845|NCT00479830|Bangladeshi|bangladeshi
1575846|NCT00479830|Pakistani|pakistani
1575847|NCT00479830|Sri Lankan|sri lankan
1575848|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
1575849|NCT00479804|indication for CMR|indication for cmr
1575850|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
1575851|NCT00479791|Fatty acids|fatty acids
1575852|NCT00479791|Postprandial response|postprandial response
1575853|NCT00479791|Insulin|insulin
1575854|NCT00479791|Glucose|glucose
1575855|NCT00479791|Triglycerides|triglycerides
1576549|NCT00477165|Barostat|barostat
1575856|NCT00479778|Postmenopause|postmenopause
1575857|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
1575858|NCT00479765|recurrent|recurrent
1575859|NCT00479765|Phase 1|phase 1
1575860|NCT00479765|Phase 2|phase 2
1575861|NCT00479765|Phase I|phase i
1575862|NCT00479765|Phase II|phase ii
1575863|NCT00479765|brain|brain
1575864|NCT00479765|cancer|cancer
1575865|NCT00479765|paclitaxel|paclitaxel
1575866|NCT00479765|intracranial|intracranial
1575867|NCT00479765|tumor|tumor
1575868|NCT00479765|local|local
1575869|NCT00479765|chemotherapy|chemotherapy
1575870|NCT00479765|brain tumor|brain tumor
1575871|NCT00479765|brain cancer|brain cancer
1575872|NCT00479765|glioma|glioma
1575873|NCT00479765|OncoGel|oncogel
1575874|NCT00479739|formoterol/budesonide|formoterol/budesonide
1575875|NCT00479739|exacerbations|exacerbations
1575876|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
1575877|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
1575878|NCT00479739|asthma control|asthma control
1575879|NCT00479713|High Cholesterol|high cholesterol
1575880|NCT00479687|Osteoarthritis|osteoarthritis
1575881|NCT00479687|Shoulder|shoulder
1575883|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
1575884|NCT00479674|Advanced Breast Cancer|advanced breast cancer
1575885|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
1575886|NCT00479674|Triple Negative|triple negative
1575887|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
1575888|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
1575889|NCT00479661|initial sedation|initial sedation
1575890|NCT00479661|mechanical ventilation|mechanical ventilation
1575891|NCT00479635|HRPC|hrpc
1575892|NCT00479635|TPI 287|tpi 287
1575893|NCT00479635|Taxane|taxane
1575894|NCT00479635|MDR|mdr
1575895|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1575896|NCT00479622|Membranous Nephropathy|membranous nephropathy
1575897|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
1575898|NCT00479609|Insulin resistance|insulin resistance
1575899|NCT00479609|Glucose tolerance|glucose tolerance
1575900|NCT00479609|Type 2 diabetes|type 2 diabetes
1575901|NCT00479609|Androgen sensitivity|androgen sensitivity
1575902|NCT00479596|Overactive Bladder|overactive bladder
1575903|NCT00479596|OAB|oab
1575904|NCT00479596|Refractory OAB|refractory oab
1575905|NCT00479596|Botox|botox
1575906|NCT00479596|Bladder|bladder
1575907|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
1575908|NCT00479557|Alzheimer's Disease|alzheimer's disease
1575909|NCT00479557|active immunization|active immunization
1575910|NCT00479531|Restless Legs Syndrome|restless legs syndrome
1575911|NCT00479531|Sequential Compression Device|sequential compression device
1575912|NCT00479531|Sleep Quality|sleep quality
1575913|NCT00479531|Quality of Life|quality of life
1575914|NCT00479518|stroke|stroke
1575915|NCT00479518|transient ischemic attack|transient ischemic attack
1575916|NCT00479518|albuminuria|albuminuria
1575917|NCT00479518|BNP|bnp
1575919|NCT00479492|Obesity, weight loss|obesity, weight loss
1575920|NCT00479479|cobalamin|cobalamin
1575921|NCT00479479|methylmalonic acid|methylmalonic acid
1575922|NCT00479479|homocysteine|homocysteine
1575923|NCT00479479|folate|folate
1575924|NCT00479479|newborns|newborns
1575925|NCT00479479|infants|infants
1575926|NCT00479479|Deficiency Disease|deficiency disease
1575927|NCT00479479|Breastfeeding|breastfeeding
1575928|NCT00479479|Infant|infant
1575929|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
1575930|NCT00479375|screening|screening
1575931|NCT00479375|human papillomavirus|human papillomavirus
1575932|NCT00479362|Pacemaker|pacemaker
1575933|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
1575934|NCT00479362|Hemorrhage|hemorrhage
1575935|NCT00479362|Hematoma|hematoma
1575936|NCT00479362|Thrombosis|thrombosis
1575937|NCT00479362|Embolism|embolism
1575938|NCT00479336|OPC-41061|opc-41061
1575939|NCT00479336|Tolvaptan|tolvaptan
1575940|NCT00479336|ascites|ascites
1575941|NCT00479336|Cirrhosis|cirrhosis
1575942|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
1575943|NCT00479284|Non-invasive ventilation|non-invasive ventilation
1575944|NCT00479284|Polysomnography|polysomnography
1575945|NCT00479284|Average volume assured pressure support|average volume assured pressure support
1575946|NCT00479271|RCT|rct
1575947|NCT00479271|Dementia|dementia
1575948|NCT00479271|community trial|community trial
1575949|NCT00479271|Homebased care|homebased care
1575950|NCT00479271|caregiver burden|caregiver burden
1575951|NCT00479271|Behavioural problems|behavioural problems
1575952|NCT00479271|Dementia in subjects|dementia in subjects
1575953|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
1575954|NCT00479271|Mental health of carers|mental health of carers
1575955|NCT00479245|nonspecific low back pain|nonspecific low back pain
1575956|NCT00479245|disability|disability
1575957|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
1575958|NCT00479245|quality of life|quality of life
1575959|NCT00479232|Leukemia|leukemia
1575960|NCT00479232|Myelocytic|myelocytic
1575961|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
1575962|NCT00479206|artesuante|artesuante
1575963|NCT00479206|falciparum malaria|falciparum malaria
1575964|NCT00479206|Cambodia|cambodia
1575965|NCT00479206|Artemisinin resistance|artemisinin resistance
1575966|NCT00479193|Burns|burns
1575967|NCT00479193|Dressing change|dressing change
1575968|NCT00479180|Hemodialysis access|hemodialysis access
1575969|NCT00479180|Arteriovenous graft|arteriovenous graft
1575970|NCT00479180|Arteriovenous fistula|arteriovenous fistula
1575971|NCT00479180|End stage renal disease|end stage renal disease
1575972|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1575973|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
1575974|NCT00479167|Lymphoma|lymphoma
1575975|NCT00479154|Restless Leg Syndrome|restless leg syndrome
1575976|NCT00479154|Botulinum Toxin|botulinum toxin
1575977|NCT00479154|RLS|rls
1575978|NCT00479141|Treatment Naive|treatment naive
1575979|NCT00479141|Treatment Experienced|treatment experienced
1575980|NCT00479141|Complementary Therapies|complementary therapies
1575981|NCT00479128|Solid Tumor|solid tumor
1575982|NCT00479128|Bladder Cancer|bladder cancer
1575983|NCT00479128|Ureteral Cancer|ureteral cancer
1575984|NCT00479128|Urothelial Cancer|urothelial cancer
1575985|NCT00479128|Urethral Cancer|urethral cancer
1575986|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
1575987|NCT00479128|Bortezomib|bortezomib
1575988|NCT00479128|Gemcitabine|gemcitabine
1575989|NCT00479128|Doxorubicin|doxorubicin
1575990|NCT00479128|Gemzar|gemzar
1575991|NCT00479128|Adriamycin|adriamycin
1575992|NCT00479128|Velcade|velcade
1575993|NCT00479128|LDP-341|ldp-341
1575994|NCT00479128|MLN341|mln341
1575995|NCT00479128|PS-341|ps-341
1576123|NCT00478686|Xeloda|xeloda
1575996|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1575997|NCT00479128|AD|ad
1575998|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1575999|NCT00479102|Iron supplementation|iron supplementation
1576001|NCT00479102|Prevention|prevention
1576002|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
1576003|NCT00479089|Urothelium|urothelium
1576004|NCT00479089|Urothelial Cancer|urothelial cancer
1576005|NCT00479089|Bladder Cancer|bladder cancer
1576006|NCT00479089|Docetaxel|docetaxel
1576007|NCT00479089|Taxotere|taxotere
1576008|NCT00479089|ZD1839|zd1839
1576009|NCT00479089|Gefitinib|gefitinib
1576010|NCT00479089|Iressa|iressa
1576011|NCT00479089|Consolidation Therapy|consolidation therapy
1576012|NCT00479076|antineoplastic agents|antineoplastic agents
1576013|NCT00479076|VEGF Trap|vegf trap
1576014|NCT00479063|MODIC changes|modic changes
1576015|NCT00479063|chronic low back pain|chronic low back pain
1576016|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1576017|NCT00479063|vertebrae|vertebrae
1576018|NCT00479063|intervertebral disc|intervertebral disc
1576019|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
1576121|NCT00478686|Toxicity|toxicity
1576020|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
1576021|NCT00479011|fluid management|fluid management
1576022|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
1576023|NCT00479011|high-risk surgery|high-risk surgery
1576024|NCT00478998|expulsion therapy|expulsion therapy
1576025|NCT00478998|tamsulosin|tamsulosin
1576026|NCT00478998|ureterolithiasis|ureterolithiasis
1576028|NCT00478985|Leukemia|leukemia
1576029|NCT00478985|Adult Chronic|adult chronic
1576030|NCT00478985|Myeloid|myeloid
1576031|NCT00478972|obese|obese
1576032|NCT00478972|diabetes|diabetes
1576033|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
1576034|NCT00478959|Lenalidomide|lenalidomide
1576035|NCT00478959|Revlimid|revlimid
1576036|NCT00478959|Hodgkin's|hodgkin's
1576037|NCT00478959|Hodgkin|hodgkin
1576038|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
1576039|NCT00478959|Hodgkin's Disease|hodgkin's disease
1576040|NCT00478959|Lymphoma|lymphoma
1576041|NCT00478946|colorectal cancer|colorectal cancer
1576042|NCT00478946|picoplatin|picoplatin
1576043|NCT00478946|FOLFOX|folfox
1576044|NCT00478946|FOLPI|folpi
1576045|NCT00478946|chemotherapy|chemotherapy
1576046|NCT00478933|Arrhythmia|arrhythmia
1576047|NCT00478933|Ventricular|ventricular
1576048|NCT00478933|Atrial|atrial
1576049|NCT00478933|Tachycardia|tachycardia
1576050|NCT00478933|Fibrillation|fibrillation
1576051|NCT00478933|Flutter|flutter
1576052|NCT00478933|GNB3|gnb3
1576053|NCT00478933|GNAS|gnas
1576054|NCT00478933|GNAQ|gnaq
1576055|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
1576056|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
1576057|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
1576058|NCT00478894|knee injuries / surgery|knee injuries / surgery
1576059|NCT00478894|outcomes research|outcomes research
1576060|NCT00478894|prospective studies|prospective studies
1576061|NCT00478894|osteoarthritis|osteoarthritis
1576062|NCT00478868|MODIC changes|modic changes
1576063|NCT00478868|chronic low back pain|chronic low back pain
1576064|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1576065|NCT00478868|vertebrae|vertebrae
1576066|NCT00478868|intervertebral disc|intervertebral disc
1576067|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
1576068|NCT00478842|Deep brain stimulation|deep brain stimulation
1576069|NCT00478842|Globus PALLIDUS|globus pallidus
1576070|NCT00478816|Bird flu|bird flu
1576071|NCT00478816|influenza vaccine|influenza vaccine
1576072|NCT00478816|prepandemic vaccine|prepandemic vaccine
1576073|NCT00478803|Standardized surgical procedure|standardized surgical procedure
1576074|NCT00478803|Aortic root aneurysm|aortic root aneurysm
1576075|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
1576076|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
1576077|NCT00478803|Aortic annuloplasty|aortic annuloplasty
1576078|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
1576079|NCT00478803|Sinus of Valsalva|sinus of valsalva
1576080|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
1576081|NCT00478790|Glaucoma|glaucoma
1576082|NCT00478790|Pterygium|pterygium
1576083|NCT00478790|collagen matrix|collagen matrix
1576084|NCT00478790|OculusGen|oculusgen
1576085|NCT00478790|trabeculectomy|trabeculectomy
1576086|NCT00478790|Anti scarring|anti scarring
1576087|NCT00478790|pterygium recurrence|pterygium recurrence
1576088|NCT00478790|tissue engineering|tissue engineering
1576089|NCT00478790|ologen|ologen
1576090|NCT00478790|Aeon Astron|aeon astron
1576091|NCT00478777|CC-5013|cc-5013
1576092|NCT00478777|Revlimid|revlimid
1576093|NCT00478777|Lenalidomide|lenalidomide
1576094|NCT00478777|Celgene|celgene
1576095|NCT00478777|Multiple Myeloma|multiple myeloma
1576096|NCT00478764|intraocular|intraocular
1576097|NCT00478764|triamcinolone|triamcinolone
1576098|NCT00478764|gatifloxicin|gatifloxicin
1576099|NCT00478764|inflammation|inflammation
1576100|NCT00478764|visual acuity|visual acuity
1576101|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
1576102|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
1576103|NCT00478738|b-agonist,|b-agonist,
1576104|NCT00478738|COPD.|copd.
1576105|NCT00478738|pharmacodynamic,|pharmacodynamic,
1576106|NCT00478738|pharmacokinetic,|pharmacokinetic,
1576107|NCT00478738|anti muscarinic,|anti muscarinic,
1576108|NCT00478725|Metastatic Cancer|metastatic cancer
1576109|NCT00478725|Advanced Cancer|advanced cancer
1576110|NCT00478712|Hirschsprung|hirschsprung
1576111|NCT00478699|SCAT|scat
1576112|NCT00478699|BRCA1|brca1
1576113|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
1576114|NCT00478699|ADJUVANT|adjuvant
1576115|NCT00478699|LUNG|lung
1576116|NCT00478699|GECP-SCAT|gecp-scat
1576117|NCT00478686|Breast Cancer|breast cancer
1576118|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
1576119|NCT00478686|DPYD|dpyd
1576120|NCT00478686|DPYD Variants|dpyd variants
1576122|NCT00478686|Capecitabine|capecitabine
1576124|NCT00478673|NexStent|nexstent
1576125|NCT00478673|FilterWire EZ|filterwire ez
1576126|NCT00478673|Boston Scientific|boston scientific
1576127|NCT00478673|Carotid Artery|carotid artery
1576128|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
1576129|NCT00478673|Carotid Revascularization|carotid revascularization
1576130|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
1576131|NCT00478647|Gaucher disease|gaucher disease
1576132|NCT00478647|glucocerebrosidase|glucocerebrosidase
1576133|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
1576134|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
1576135|NCT00478647|glucosylceramidase|glucosylceramidase
1576136|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1576137|NCT00478647|gene activation|gene activation
1576139|NCT00478634|Colorectal Cancer|colorectal cancer
1576140|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
1576141|NCT00478634|Colorectal Tumors|colorectal tumors
1576142|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
1576143|NCT00478621|HPV|hpv
1576144|NCT00478595|obese|obese
1576145|NCT00478595|diabetes|diabetes
1576146|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
1576147|NCT00478582|Anemia|anemia
1576148|NCT00478582|Visual scale|visual scale
1576149|NCT00478582|nephrological patients|nephrological patients
1576150|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
1576151|NCT00478556|CT scan|ct scan
1576152|NCT00478556|oral contrast|oral contrast
1576153|NCT00478543|Loop diuretics|loop diuretics
1576154|NCT00478543|Chronic Kidney Disease|chronic kidney disease
1576155|NCT00478543|Hypertension|hypertension
1576156|NCT00478543|Blood pressure control|blood pressure control
1576157|NCT00478543|Left ventricular mass|left ventricular mass
1576158|NCT00478517|Spinal trauma|spinal trauma
1576159|NCT00478517|erythropoietin|erythropoietin
1576160|NCT00478517|dose escalation study|dose escalation study
1576161|NCT00478504|anovulation|anovulation
1576162|NCT00478504|ovulation induction,|ovulation induction,
1576163|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
1576164|NCT00478504|clomifene citrate|clomifene citrate
1576165|NCT00478504|letrozole|letrozole
1576167|NCT00478478|Ischemic|ischemic
1576168|NCT00478478|Thrombus|thrombus
1576169|NCT00478478|Embolectomy|embolectomy
1576170|NCT00478478|Thrombectomy|thrombectomy
1576171|NCT00478478|Merci|merci
1576172|NCT00478478|Concentric|concentric
1576173|NCT00478478|Embolus|embolus
1576174|NCT00478478|Embolism|embolism
1576175|NCT00478478|Mechanical|mechanical
1576176|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
1576177|NCT00478465|fatigue|fatigue
1576178|NCT00478465|valganciclovir|valganciclovir
1576179|NCT00478465|valcyte|valcyte
1576180|NCT00478465|Epstein-Barr virus|epstein-barr virus
1576181|NCT00478465|EBV|ebv
1576182|NCT00478465|Human herpes virus 6|human herpes virus 6
1576183|NCT00478465|HHV 6|hhv 6
1576184|NCT00478465|herpes viruses|herpes viruses
1576185|NCT00478465|herpes|herpes
1576186|NCT00478439|aging|aging
1576187|NCT00478439|age-related macular degeneration|age-related macular degeneration
1576188|NCT00478439|macular pigment|macular pigment
1576189|NCT00478439|dark adaptation|dark adaptation
1576190|NCT00478400|Recovery|recovery
1576191|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
1576192|NCT00478400|Awareness|awareness
1576193|NCT00478400|Neurologic deficits|neurologic deficits
1576194|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
1576195|NCT00478348|Postoperative Complications|postoperative complications
1576196|NCT00478348|Drainage|drainage
1576197|NCT00478348|Infection|infection
1576198|NCT00478348|Seroma|seroma
1576199|NCT00478348|Hematoma|hematoma
1576200|NCT00478348|Recurrence|recurrence
1576201|NCT00478348|Abdominal Wall|abdominal wall
1576202|NCT00478348|Hernia|hernia
1576203|NCT00478348|Surgical Mesh|surgical mesh
1576204|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
1576205|NCT00478335|polyuria|polyuria
1576206|NCT00478335|urine osmolality|urine osmolality
1576207|NCT00478335|aquaporin-2|aquaporin-2
1576208|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
1576209|NCT00478322|Diabetes;|diabetes;
1576210|NCT00478322|Type II diabetes;|type ii diabetes;
1576211|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
1576212|NCT00478322|Obesity|obesity
1576213|NCT00478309|colon cancer|colon cancer
1576214|NCT00478309|rectal cancer|rectal cancer
1576215|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
1576216|NCT00478296|Pulmonary hypertension|pulmonary hypertension
1576217|NCT00478296|Sildenafil|sildenafil
1576218|NCT00478296|Bosentan|bosentan
1576219|NCT00478296|Trisomy 21|trisomy 21
1576220|NCT00478296|Atrial septal defect|atrial septal defect
1576221|NCT00478283|breast cancer|breast cancer
1576222|NCT00478257|fatigue|fatigue
1576223|NCT00478257|sleep|sleep
1576224|NCT00478257|quality of life|quality of life
1576225|NCT00478257|light|light
1576226|NCT00478257|cancer|cancer
1576615|NCT00476944|Angiomax|angiomax
1576227|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
1576228|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
1576229|NCT00478231|Multicenter|multicenter
1576230|NCT00478231|Open Label|open label
1576231|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
1576232|NCT00478231|Treatment Experienced|treatment experienced
1576233|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
1576234|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
1576235|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
1576236|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
1576237|NCT00478192|hyponatremia|hyponatremia
1576238|NCT00478192|hypervolemic|hypervolemic
1576239|NCT00478192|euvolemic|euvolemic
1576240|NCT00478192|edematous|edematous
1576241|NCT00478192|conivaptan|conivaptan
1576242|NCT00478179|herpes zoster|herpes zoster
1576243|NCT00478179|shingles|shingles
1576244|NCT00478179|PHN|phn
1576245|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
1576246|NCT00478179|neuropathic pain|neuropathic pain
1576247|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
1576248|NCT00478114|Sorafenib|sorafenib
1576249|NCT00478101|Pain|pain
1576250|NCT00478088|Single Level|single level
1576251|NCT00478088|Cervical Disc Disease|cervical disc disease
1576252|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
1576253|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
1576254|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
1576255|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
1576256|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1576257|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1576258|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1576259|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1576260|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
1576261|NCT00478036|glaucoma|glaucoma
1576262|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
1576263|NCT00478036|anterior chamber flare|anterior chamber flare
1576264|NCT00478023|Opioid|opioid
1576265|NCT00478023|Central acting analgesic|central acting analgesic
1576266|NCT00478023|Pain postoperative|pain postoperative
1576267|NCT00478023|Abdomen acute|abdomen acute
1576268|NCT00478023|CG5503 IR|cg5503 ir
1576269|NCT00478023|Morphine|morphine
1576270|NCT00478023|Placebo|placebo
1576271|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1576272|NCT00478010|stage III colon cancer|stage iii colon cancer
1576273|NCT00478010|stage IV colon cancer|stage iv colon cancer
1576274|NCT00478010|stage III rectal cancer|stage iii rectal cancer
1576275|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
1576276|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
1576277|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
1576278|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
1576279|NCT00477997|Growth Hormone|growth hormone
1576280|NCT00477997|Insulin Signaling|insulin signaling
1576281|NCT00477997|GH signaling|gh signaling
1576282|NCT00477984|Alcohol|alcohol
1576283|NCT00477984|Driving|driving
1576284|NCT00477984|Multitasking|multitasking
1576285|NCT00477984|ERP|erp
1576286|NCT00477984|social drinkers|social drinkers
1576287|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
1576288|NCT00477958|cognitive/functional effects|cognitive/functional effects
1576289|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1576290|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1576291|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1576292|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
1576293|NCT00477945|APBSCT|apbsct
1576294|NCT00477945|clofarabine|clofarabine
1576295|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
1576296|NCT00477932|mutations|mutations
1576297|NCT00477932|DNA|dna
1576298|NCT00477932|RNA|rna
1576299|NCT00477919|stage IV melanoma|stage iv melanoma
1576300|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
1576386|NCT00477737|thermodilution|thermodilution
1576301|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1576302|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
1576303|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
1576304|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
1576305|NCT00477919|adult gliosarcoma|adult gliosarcoma
1576306|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1576307|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1576308|NCT00477919|stage IV colon cancer|stage iv colon cancer
1576309|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
1576310|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
1576311|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
1576312|NCT00477919|male breast cancer|male breast cancer
1576313|NCT00477919|stage IV breast cancer|stage iv breast cancer
1576314|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1576315|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1576316|NCT00477919|ovarian sarcoma|ovarian sarcoma
1576317|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
1576319|NCT00477919|anorexia|anorexia
1576320|NCT00477919|cachexia|cachexia
1576321|NCT00477919|pain|pain
1576322|NCT00477919|weight changes|weight changes
1576323|NCT00477919|depression|depression
1576324|NCT00477919|poor performance status|poor performance status
1576325|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
1576326|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1576327|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
1576328|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1576329|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
1576330|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
1576331|NCT00477919|recurrent breast cancer|recurrent breast cancer
1576332|NCT00477919|recurrent colon cancer|recurrent colon cancer
1576333|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
1576334|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
1576335|NCT00477919|recurrent melanoma|recurrent melanoma
1576336|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1576337|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1576338|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1576339|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
1576340|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
1576341|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
1576342|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
1576343|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
1576344|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
1576345|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1576346|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1576347|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1576444|NCT00477477|risk factors|risk factors
1576348|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1576349|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
1576350|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
1576351|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1576352|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
1576353|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
1576354|NCT00477919|adult glioblastoma|adult glioblastoma
1576355|NCT00477906|melanoma|melanoma
1576356|NCT00477906|vaccine|vaccine
1576357|NCT00477906|metastatic|metastatic
1576358|NCT00477906|autologous|autologous
1576359|NCT00477880|gastric cancer|gastric cancer
1576360|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
1576361|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1576362|NCT00477841|esophageal Cancer|esophageal cancer
1576363|NCT00477841|Dysphagia|dysphagia
1576364|NCT00477841|Stent|stent
1576491|NCT00477334|Black population|black population
1576365|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
1576366|NCT00477828|sleep apnea|sleep apnea
1576367|NCT00477828|dementia|dementia
1576368|NCT00477828|excessive sleepiness|excessive sleepiness
1576369|NCT00477828|cognition|cognition
1576370|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
1576371|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
1576372|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
1576373|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
1576374|NCT00477802|Parkinson's disease|parkinson's disease
1576375|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
1576376|NCT00477789|chronic heart failure|chronic heart failure
1576377|NCT00477789|diastolic dysfunction|diastolic dysfunction
1576378|NCT00477789|uric acid|uric acid
1576379|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
1576380|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
1576381|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
1576382|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
1576383|NCT00477737|cardioprotection|cardioprotection
1576384|NCT00477737|sevoflurane|sevoflurane
1576385|NCT00477737|esophageal Doppler|esophageal doppler
1576387|NCT00477737|coronary artery bypass|coronary artery bypass
1576388|NCT00477724|latent|latent
1576389|NCT00477711|Cetuximab|cetuximab
1576390|NCT00477711|cisplatin|cisplatin
1576391|NCT00477711|capecitabine|capecitabine
1576392|NCT00477711|first line treatment|first line treatment
1576393|NCT00477685|Glaucoma|glaucoma
1576394|NCT00477685|Collagen matrix|collagen matrix
1576395|NCT00477685|OculusGen|oculusgen
1576396|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
1576397|NCT00477685|anti scarring|anti scarring
1576398|NCT00477685|tissue engineering|tissue engineering
1576399|NCT00477685|ologen|ologen
1576400|NCT00477685|Aeon Astron|aeon astron
1576401|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
1576402|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
1576403|NCT00477646|colon cancer|colon cancer
1576404|NCT00477646|rectal cancer|rectal cancer
1576405|NCT00477646|breast cancer|breast cancer
1576406|NCT00477646|cervical cancer|cervical cancer
1576407|NCT00477633|Contraception|contraception
1576408|NCT00477620|Myopia|myopia
1576409|NCT00477620|Prevention|prevention
1576410|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
1576411|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1576412|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1576413|NCT00477594|ISIS 301012|isis 301012
1576414|NCT00477594|mipomersen|mipomersen
1576415|NCT00477594|Open Label Extension|open label extension
1576416|NCT00477581|diabetes|diabetes
1576417|NCT00477581|exenatide|exenatide
1576418|NCT00477581|sitagliptin|sitagliptin
1576419|NCT00477581|Amylin|amylin
1576420|NCT00477581|Lilly|lilly
1576421|NCT00477568|Wheelchair users|wheelchair users
1576422|NCT00477568|Back pain|back pain
1576423|NCT00477568|Prevalence|prevalence
1576424|NCT00477568|Risk factors|risk factors
1576425|NCT00477555|aortic valve|aortic valve
1576426|NCT00477555|concomitant procedures|concomitant procedures
1576427|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
1576428|NCT00477555|stented valve|stented valve
1576429|NCT00477542|Clofarabine|clofarabine
1576430|NCT00477542|allogeneic HSCT|allogeneic hsct
1576431|NCT00477542|refractory malignancies|refractory malignancies
1576432|NCT00477503|Central Nervous System Tumors|central nervous system tumors
1576433|NCT00477503|Brain Tumors|brain tumors
1576434|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
1576435|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
1576436|NCT00477503|Human CSF Flow|human csf flow
1576437|NCT00477503|Nuclear Imaging|nuclear imaging
1576438|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
1576439|NCT00477503|In-111 DTPA|in-111 dtpa
1576440|NCT00477477|overweight|overweight
1576441|NCT00477477|metabolic syndrome|metabolic syndrome
1576442|NCT00477477|adolescent|adolescent
1576443|NCT00477477|cardiovascular|cardiovascular
1576445|NCT00477477|hypertension|hypertension
1576446|NCT00477477|dyslipidemia|dyslipidemia
1576447|NCT00477477|inflammation|inflammation
1576448|NCT00477477|coagulopathy|coagulopathy
1576449|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
1576450|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
1576451|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
1576452|NCT00477464|GW572016,|gw572016,
1576453|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
1576454|NCT00477464|HER-2/new,|her-2/new,
1576455|NCT00477464|pharmacokinetics|pharmacokinetics
1576456|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
1576457|NCT00477425|Avastin|avastin
1576458|NCT00477412|Mantle Cell Lymphoma|mantle cell lymphoma
1576459|NCT00477412|Lymphoma|lymphoma
1576460|NCT00477412|Bortezomib|bortezomib
1576461|NCT00477412|LDP-341|ldp-341
1576462|NCT00477412|MLN341|mln341
1576463|NCT00477412|Velcade|velcade
1576464|NCT00477412|Cyclophosphamide|cyclophosphamide
1576465|NCT00477412|Neosar|neosar
1576466|NCT00477412|Cytoxan|cytoxan
1576467|NCT00477412|Doxorubicin|doxorubicin
1576468|NCT00477412|Adriamycin|adriamycin
1576469|NCT00477412|Rubex|rubex
1576470|NCT00477412|Rituximab|rituximab
1576471|NCT00477412|Vincristine|vincristine
1576472|NCT00477412|Methotrexate|methotrexate
1576473|NCT00477412|Cytarabine|cytarabine
1576474|NCT00477412|Cytosar|cytosar
1576475|NCT00477412|DepoCyt|depocyt
1576476|NCT00477412|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1576477|NCT00477412|Mesna|mesna
1576478|NCT00477412|Dexamethasone|dexamethasone
1576479|NCT00477399|Obesity|obesity
1576480|NCT00477399|Weight loss maintenance|weight loss maintenance
1576482|NCT00477399|Life Style|life style
1576483|NCT00477399|Follow Up|follow up
1576484|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
1576485|NCT00477386|platinum resistant|platinum resistant
1576486|NCT00477386|decitabine|decitabine
1576487|NCT00477347|Liver Transplantation|liver transplantation
1576488|NCT00477347|Anesthesia, general|anesthesia, general
1576489|NCT00477347|Closed-loop|closed-loop
1576490|NCT00477334|Recurrent genital herpes|recurrent genital herpes
1576492|NCT00477321|Interleukin 7|interleukin 7
1576493|NCT00477321|Immune Reconstitution|immune reconstitution
1576494|NCT00477321|T Cell Turnover|t cell turnover
1576495|NCT00477321|CD4 Lymphenia|cd4 lymphenia
1576496|NCT00477321|Immune-Based Therapies|immune-based therapies
1576497|NCT00477321|HIV Infection|hiv infection
1576498|NCT00477308|HIV children|hiv children
1576499|NCT00477308|genotypic resistance|genotypic resistance
1576500|NCT00477308|dual NRTIs|dual nrtis
1576501|NCT00477308|Salvage therapy|salvage therapy
1576502|NCT00477308|treatment outcome|treatment outcome
1576503|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
1576504|NCT00477308|Treatment Failure|treatment failure
1576505|NCT00477295|Epilepsy|epilepsy
1576506|NCT00477282|Ovarian|ovarian
1576507|NCT00477282|Cancer|cancer
1576508|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
1576509|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
1576510|NCT00477256|Pediatric Cancer|pediatric cancer
1576511|NCT00477256|Child Adjustment|child adjustment
1576512|NCT00477256|School Reintegration|school reintegration
1576513|NCT00477256|Caregiver|caregiver
1576514|NCT00477256|Questionnaire|questionnaire
1576515|NCT00477256|Quality of Life|quality of life
1576516|NCT00477256|Survey|survey
1576517|NCT00477243|Advanced Cancer|advanced cancer
1576518|NCT00477243|Palliative Care Patients|palliative care patients
1576519|NCT00477243|Spirituality|spirituality
1576520|NCT00477243|Locus of Control|locus of control
1576521|NCT00477243|Questionnaire|questionnaire
1576523|NCT00477230|PAF|paf
1576524|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1576525|NCT00477230|ablation|ablation
1576526|NCT00477230|failed drugs|failed drugs
1576527|NCT00477217|Osteonecrosis|osteonecrosis
1576528|NCT00477217|zoledronic acid|zoledronic acid
1576529|NCT00477217|knee|knee
1576530|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1576531|NCT00477204|dyslipidemia|dyslipidemia
1576532|NCT00477204|adolescents|adolescents
1576533|NCT00477191|psoriasis|psoriasis
1576534|NCT00477191|metabolic syndrome|metabolic syndrome
1576535|NCT00477191|Syndrome X|syndrome x
1576536|NCT00477191|diabetes|diabetes
1576537|NCT00477191|insulin resistance|insulin resistance
1576538|NCT00477191|obesity|obesity
1576539|NCT00477191|hypertension|hypertension
1576540|NCT00477191|hyperlipidemia|hyperlipidemia
1576541|NCT00477191|hypercholesterolemia|hypercholesterolemia
1576542|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
1576543|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
1576544|NCT00477165|Antidepressant|antidepressant
1576545|NCT00477165|IBS|ibs
1576546|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
1576547|NCT00477165|SSRI|ssri
1576548|NCT00477165|Visceral sensitivity|visceral sensitivity
1576550|NCT00477165|Quality of life|quality of life
1576551|NCT00477165|Depression|depression
1576552|NCT00477152|dehydration|dehydration
1576553|NCT00477152|fluid therapy|fluid therapy
1576554|NCT00477152|pediatrics|pediatrics
1576555|NCT00477152|emergency medicine|emergency medicine
1576556|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
1576557|NCT00477152|hyaluronidase|hyaluronidase
1576558|NCT00477152|hypodermoclysis|hypodermoclysis
1576559|NCT00477152|clysis|clysis
1576560|NCT00477152|subcutaneous hydration|subcutaneous hydration
1576561|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
1576562|NCT00477152|hyaluronan|hyaluronan
1576563|NCT00477152|rHuPH20|rhuph20
1576564|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
1576565|NCT00477126|Norvir®|norvir®
1576566|NCT00477126|Thailand|thailand
1576567|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
1576568|NCT00477113|natalizumab|natalizumab
1576570|NCT00477113|Tysabri|tysabri
1576571|NCT00477113|Multiple Sclerosis|multiple sclerosis
1576572|NCT00477113|TYGRIS|tygris
1576573|NCT00477100|Inflammatory Breast Cancer|inflammatory breast cancer
1576574|NCT00477100|Cancer Registry|cancer registry
1576575|NCT00477100|Core Biopsy|core biopsy
1576576|NCT00477100|Skin Biopsy|skin biopsy
1576577|NCT00477100|IBC|ibc
1576578|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1576579|NCT00477074|emphysema|emphysema
1576580|NCT00477074|inflammation|inflammation
1576581|NCT00477074|repair|repair
1576582|NCT00477061|MORPHINE|morphine
1576583|NCT00477061|ANALGESIA|analgesia
1576584|NCT00477061|ACUTE APPENDICITS|acute appendicits
1576585|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
1576586|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
1576587|NCT00477022|Vacuum compression therapy|vacuum compression therapy
1576588|NCT00477022|Stereology|stereology
1576589|NCT00477022|Ulcer Area|ulcer area
1576590|NCT00477022|Vasotrain|vasotrain
1576591|NCT00477022|Random Controlled Trial.|random controlled trial.
1576592|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
1576593|NCT00477009|Snoring|snoring
1576594|NCT00477009|Mandibular advancement|mandibular advancement
1576595|NCT00477009|Activator appliances|activator appliances
1576700|NCT00476684|radiofrequency|radiofrequency
1576596|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
1576597|NCT00477009|Blood pressure|blood pressure
1576598|NCT00477009|Inflammation|inflammation
1576599|NCT00477009|Oxidative stress|oxidative stress
1576600|NCT00477009|Hormones|hormones
1576601|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
1576602|NCT00476996|RA|ra
1576603|NCT00476996|SCRIPT|script
1576604|NCT00476996|anti-CD20|anti-cd20
1576605|NCT00476996|CD20|cd20
1576606|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
1576607|NCT00476970|Colorectal Cancer|colorectal cancer
1576608|NCT00476970|Cancer Screening|cancer screening
1576609|NCT00476970|Patient Navigation|patient navigation
1576610|NCT00476970|Low English Proficiency|low english proficiency
1576611|NCT00476957|Drug Eluting Stents|drug eluting stents
1576612|NCT00476957|Interventional Cardiology|interventional cardiology
1576613|NCT00476944|CAD|cad
1576614|NCT00476944|Coronary Artery Disease|coronary artery disease
1576620|NCT00476931|Diabetic neuropathy|diabetic neuropathy
1576621|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
1576622|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
1576623|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
1576624|NCT00476918|diabetic macular edema|diabetic macular edema
1576625|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
1576626|NCT00476918|intravitreal|intravitreal
1576628|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
1576629|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
1576630|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
1576631|NCT00476905|Pigmented Lesions|pigmented lesions
1576632|NCT00476905|Benign Lesions|benign lesions
1576633|NCT00476905|Skin Cancer|skin cancer
1576634|NCT00476905|Spectral Diagnosis|spectral diagnosis
1576635|NCT00476905|Optical Spectroscopy|optical spectroscopy
1576636|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
1576637|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
1576638|NCT00476892|Prolapse symptoms|prolapse symptoms
1576639|NCT00476892|Urinary symptoms|urinary symptoms
1576640|NCT00476892|Sexual function|sexual function
1576641|NCT00476892|randomised controlled trial|randomised controlled trial
1576642|NCT00476879|Growth hormone|growth hormone
1576643|NCT00476879|Fasting|fasting
1576644|NCT00476879|Signaltransduction|signaltransduction
1576645|NCT00476879|fatty liver|fatty liver
1576646|NCT00476879|insulin sensitivity|insulin sensitivity
1576647|NCT00476879|forearm model|forearm model
1576648|NCT00476879|protein metabolism|protein metabolism
1576649|NCT00476879|respiratory quotient|respiratory quotient
1576650|NCT00476866|Paraplegia|paraplegia
1576651|NCT00476866|tetraplegia|tetraplegia
1576652|NCT00476866|lung compliance|lung compliance
1576653|NCT00476866|work of breathing|work of breathing
1576654|NCT00476866|hyperinflation|hyperinflation
1576655|NCT00476866|rehabilitation|rehabilitation
1576656|NCT00476853|HIV-TB|hiv-tb
1576657|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
1576658|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
1576659|NCT00476853|Treatment Naive|treatment naive
1576660|NCT00476827|Breast Cancer|breast cancer
1576661|NCT00476827|Metastatic|metastatic
1576662|NCT00476827|Brain|brain
1576663|NCT00476827|Anti-angiogenesis|anti-angiogenesis
1576664|NCT00476814|cystic fibrosis,|cystic fibrosis,
1576665|NCT00476814|nasal potential difference,|nasal potential difference,
1576666|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
1576667|NCT00476801|UVA1|uva1
1576668|NCT00476801|scleroderma|scleroderma
1576669|NCT00476801|keloids|keloids
1576670|NCT00476801|light therapy|light therapy
1576671|NCT00476801|morphea|morphea
1576672|NCT00476788|pediatrics|pediatrics
1576673|NCT00476788|CSII|csii
1576674|NCT00476788|diabetes|diabetes
1576675|NCT00476788|C-peptide|c-peptide
1576676|NCT00476788|adverse events|adverse events
1576677|NCT00476775|obesity|obesity
1576678|NCT00476775|prevention|prevention
1576679|NCT00476775|girls|girls
1576680|NCT00476775|Latina/Hispanic|latina/hispanic
1576681|NCT00476775|Dance|dance
1576682|NCT00476775|television|television
1576683|NCT00476775|screen time|screen time
1576684|NCT00476736|COPD|copd
1576685|NCT00476736|Pulmonary function|pulmonary function
1576686|NCT00476736|Air trapping|air trapping
1576687|NCT00476736|Acetyl cystein|acetyl cystein
1576688|NCT00476723|HIV infection|hiv infection
1576689|NCT00476723|Hepatitis coinfection|hepatitis coinfection
1576690|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
1576691|NCT00476710|Bile acid|bile acid
1576692|NCT00476710|Stable isotope|stable isotope
1576693|NCT00476710|Colesevelam HCl|colesevelam hcl
1576694|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
1576695|NCT00476697|UVA1|uva1
1576696|NCT00476697|scleroderma|scleroderma
1576697|NCT00476697|keloids|keloids
1576698|NCT00476697|morphea|morphea
1576699|NCT00476697|light therapy|light therapy
1576701|NCT00476671|neuropsychiatric|neuropsychiatric
1576702|NCT00476671|neurocognitive|neurocognitive
1576703|NCT00476671|psychiatric|psychiatric
1576704|NCT00476671|HIV related dementia|hiv related dementia
1576705|NCT00476671|MCMD|mcmd
1576706|NCT00476671|HIV-1|hiv-1
1576707|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
1576708|NCT00476671|Treatment Experienced|treatment experienced
1576709|NCT00476658|Obesity|obesity
1576710|NCT00476658|macrophage infiltration|macrophage infiltration
1576711|NCT00476658|insulinoresistance|insulinoresistance
1576712|NCT00476658|inflammation|inflammation
1576713|NCT00476632|Epidemiology|epidemiology
1576714|NCT00476632|Questionnaire|questionnaire
1576715|NCT00476632|Controls|controls
1576718|NCT00476619|acute renal failure|acute renal failure
1576719|NCT00476619|Erythropoietin|erythropoietin
1576720|NCT00476619|CT scan|ct scan
1576721|NCT00476606|HIV children|hiv children
1576722|NCT00476606|HAART|haart
1576723|NCT00476606|ARV|arv
1576724|NCT00476606|Second line HAART|second line haart
1576725|NCT00476606|Viral Load|viral load
1576726|NCT00476606|Combination drug|combination drug
1576727|NCT00476606|Treatment Experienced|treatment experienced
1576728|NCT00476606|Treatment Naive|treatment naive
1576729|NCT00476593|Uveitis|uveitis
1576730|NCT00476593|Iritis|iritis
1576731|NCT00476593|Macular Thickness|macular thickness
1576732|NCT00476593|HLA-B27 related|hla-b27 related
1576733|NCT00476593|Macular edema|macular edema
1576734|NCT00476593|Macular thickening|macular thickening
1576735|NCT00476593|OCT|oct
1576736|NCT00476593|mfERG|mferg
1576737|NCT00476593|Eye drops|eye drops
1576738|NCT00476593|Dexamethosone|dexamethosone
1576739|NCT00476593|Diclofenac|diclofenac
1576740|NCT00476593|Retinal aging|retinal aging
1576741|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
1576742|NCT00476580|Epidemiology|epidemiology
1576743|NCT00476580|Cancer Risk|cancer risk
1576744|NCT00476580|US Migrant|us migrant
1576745|NCT00476580|Questionnaire|questionnaire
1576746|NCT00476580|Survey|survey
1576747|NCT00476580|Acculturation|acculturation
1576748|NCT00476580|Health and Cancer Risks|health and cancer risks
1576749|NCT00476580|Health Habits|health habits
1576750|NCT00476567|exercise|exercise
1576751|NCT00476567|pregnancy|pregnancy
1576752|NCT00476567|prevention|prevention
1576753|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
1576755|NCT00476567|complications|complications
1576756|NCT00476567|physiotherapy|physiotherapy
1576757|NCT00476554|CTCL|ctcl
1576758|NCT00476541|AML|aml
1576759|NCT00476541|Children|children
1576760|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
1576761|NCT00476541|Stem cell transplantation|stem cell transplantation
1576762|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
1576763|NCT00476528|Early intervention|early intervention
1576764|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
1576765|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
1576766|NCT00476515|Kidney transplantation|kidney transplantation
1576767|NCT00476515|Donor specific antibodies|donor specific antibodies
1576768|NCT00476515|Positive cross match|positive cross match
1576769|NCT00476502|genetic polymorphism|genetic polymorphism
1576770|NCT00476502|CYP 3A|cyp 3a
1576771|NCT00476502|MDR-1|mdr-1
1576772|NCT00476502|Thai|thai
1576773|NCT00476502|HIV|hiv
1576774|NCT00476502|Treatment Experienced|treatment experienced
1576775|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
1576776|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
1576777|NCT00476489|topical steroids|topical steroids
1576778|NCT00476476|Tarceva|tarceva
1576779|NCT00476476|erlotinib|erlotinib
1576780|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
1576781|NCT00476463|TDF+FTC|tdf+ftc
1576782|NCT00476463|FTC|ftc
1576783|NCT00476463|HIV/HBV|hiv/hbv
1576784|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
1576785|NCT00476463|Treatment Naive|treatment naive
1576786|NCT00476450|Oral Microbial Flora|oral microbial flora
1576787|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
1576788|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1576789|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
1576790|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
1576791|NCT00476424|Treatment Experienced|treatment experienced
1576792|NCT00476411|isolated HBc|isolated hbc
1576793|NCT00476411|HBV vaccine response|hbv vaccine response
1576794|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
1576795|NCT00476398|Capsule endoscopy|capsule endoscopy
1576796|NCT00476398|Wireless imaging|wireless imaging
1576797|NCT00476398|esophagus|esophagus
1576798|NCT00476398|stomach|stomach
1576799|NCT00476372|neuropsychology|neuropsychology
1576800|NCT00476372|cognitive impairment|cognitive impairment
1576801|NCT00476372|motor disorder|motor disorder
1576802|NCT00476372|parkinson's disease|parkinson's disease
1576803|NCT00476359|Lopinavir/r|lopinavir/r
1576804|NCT00476359|Saquinavir|saquinavir
1576805|NCT00476359|Dual boosted PIs|dual boosted pis
1576806|NCT00476359|Pharmacokinetics|pharmacokinetics
1576807|NCT00476359|HIV children|hiv children
1576808|NCT00476359|C min|c min
1576809|NCT00476359|Second line HAART|second line haart
1576810|NCT00476359|ARV|arv
1576811|NCT00476359|VL failure|vl failure
1576812|NCT00476359|Dosage|dosage
1576813|NCT00476359|To evaluate treatment response|to evaluate treatment response
1576814|NCT00476359|Treatment Experienced|treatment experienced
1576815|NCT00476346|physical training|physical training
1576816|NCT00476346|military training|military training
1576817|NCT00476346|bone|bone
1576818|NCT00476346|fracture prevention|fracture prevention
1576819|NCT00476346|young adult|young adult
1576823|NCT00476333|Perturbation|perturbation
1576824|NCT00476333|Footwear|footwear
1576825|NCT00476320|echocardiography|echocardiography
1576826|NCT00476320|myocardial infarction|myocardial infarction
1576827|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
1576828|NCT00476320|revascularization|revascularization
1576829|NCT00476320|viability|viability
1576830|NCT00476307|Flu vaccine|flu vaccine
1576831|NCT00476294|Multiple Myeloma|multiple myeloma
1576832|NCT00476294|Disease-Free Survival|disease-free survival
1576834|NCT00476294|G-CSF|g-csf
1576835|NCT00476294|Autologous Transplantation|autologous transplantation
1576836|NCT00476255|child safety restraint|child safety restraint
1576837|NCT00476255|injury prevention|injury prevention
1576838|NCT00476255|automotive|automotive
1576839|NCT00476242|heroin abuse|heroin abuse
1576840|NCT00476242|opiate abuse|opiate abuse
1576841|NCT00476242|opioid dependence|opioid dependence
1576842|NCT00476242|naltrexone|naltrexone
1576843|NCT00476242|memantine|memantine
1576844|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1576845|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1576846|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
1576847|NCT00476229|Lymphoma|lymphoma
1576848|NCT00476229|Leukemia|leukemia
1576849|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
1576850|NCT00476229|Tacrolimus|tacrolimus
1576851|NCT00476229|Thymoglobulin|thymoglobulin
1576852|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
1576853|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
1576854|NCT00476216|Venous Thromboembolism|venous thromboembolism
1576855|NCT00476216|VTE|vte
1576856|NCT00476216|Arixtra|arixtra
1576857|NCT00476203|Breast Cancer|breast cancer
1576858|NCT00476203|Yoga|yoga
1576859|NCT00476203|Quality of Life|quality of life
1576860|NCT00476203|Obesity|obesity
1576861|NCT00476203|Fatigue|fatigue
1576862|NCT00476203|Weight|weight
1576863|NCT00476190|ALL|all
1576864|NCT00476177|DC|dc
1576865|NCT00476177|DLI|dli
1576866|NCT00476177|graft vs. host disease|graft vs. host disease
1576867|NCT00476177|GVHD|gvhd
1576868|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
1576869|NCT00476164|C4d|c4d
1576870|NCT00476164|Anti-CD20|anti-cd20
1576871|NCT00476164|B cells|b cells
1576872|NCT00476164|Antibody|antibody
1576873|NCT00476151|DPN|dpn
1576874|NCT00476151|Diabetic|diabetic
1576875|NCT00476151|Nerve Pain|nerve pain
1576876|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
1576877|NCT00476138|Glaucoma|glaucoma
1576878|NCT00476138|Optic Nerve|optic nerve
1576879|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
1576880|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
1576881|NCT00476112|Atrial flutter|atrial flutter
1576882|NCT00476112|RSD1235|rsd1235
1576883|NCT00476086|oxaliplatin|oxaliplatin
1576884|NCT00476086|gemcitabine|gemcitabine
1576885|NCT00476086|MMMT|mmmt
1576886|NCT00476060|Cirrhosis|cirrhosis
1576887|NCT00476060|Bone marrow|bone marrow
1576888|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
1576889|NCT00476060|MELD score|meld score
1576890|NCT00476060|Quality of life|quality of life
1576891|NCT00476034|Osteoarthritis|osteoarthritis
1576892|NCT00476034|lumiracoxib|lumiracoxib
1576893|NCT00476034|celecoxib|celecoxib
1576894|NCT00476034|Cox-2|cox-2
1576895|NCT00476034|knee|knee
1576896|NCT00476021|postpartum|postpartum
1576897|NCT00476021|contraception|contraception
1576898|NCT00476021|postplacental IUD|postplacental iud
1576899|NCT00476021|intrauterine devices|intrauterine devices
1576900|NCT00476008|Alzheimer's Disease|alzheimer's disease
1576901|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
1576902|NCT00476008|Driving|driving
1576903|NCT00476008|Driving Impairment|driving impairment
1576904|NCT00475982|Diet|diet
1576905|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
1576906|NCT00475982|Weight Loss|weight loss
1576907|NCT00475956|Cancer|cancer
1576908|NCT00475956|Tumour|tumour
1576909|NCT00475956|Advanced Solid Tumour|advanced solid tumour
1576910|NCT00475956|Lung Cancer|lung cancer
1576911|NCT00475956|Breast Cancer|breast cancer
1576912|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
1576913|NCT00475956|Colon Cancer|colon cancer
1576914|NCT00475956|Gastric Cancer|gastric cancer
1576915|NCT00475956|Choriocarcinoma|choriocarcinoma
1576916|NCT00475956|Liver Cancer|liver cancer
1576917|NCT00475956|Myeloma|myeloma
1576918|NCT00475956|Ovarian Cancer|ovarian cancer
1576919|NCT00475956|Pancreatic Cancer|pancreatic cancer
1576920|NCT00475956|Peritoneal Cancer|peritoneal cancer
1576921|NCT00475943|Swallowing Disorders|swallowing disorders
1576922|NCT00475943|Swallowing|swallowing
1576923|NCT00475943|Videofluoroscopy|videofluoroscopy
1576924|NCT00475943|Dysphagia|dysphagia
1576925|NCT00475943|Epiglottis|epiglottis
1576926|NCT00475943|Healthy Volunteer|healthy volunteer
1576927|NCT00475943|HV|hv
1576928|NCT00475930|MRSA|mrsa
1576929|NCT00475930|Staphylococcus aureus|staphylococcus aureus
1576930|NCT00475917|Advanced malignancies|advanced malignancies
1576932|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
1576933|NCT00475904|PHN|phn
1576934|NCT00475904|Neuropathy|neuropathy
1576935|NCT00475904|Nerve Pain|nerve pain
1576936|NCT00475904|Topical|topical
1576937|NCT00475891|isolate|isolate
1576938|NCT00475891|infection|infection
1576939|NCT00475891|linezolid|linezolid
1576940|NCT00475878|opiate use|opiate use
1576941|NCT00475878|depression|depression
1576942|NCT00475878|buprenorphine|buprenorphine
1576943|NCT00475878|escitalopram|escitalopram
1576944|NCT00475865|MS|ms
1576945|NCT00475865|glatiramer acetate|glatiramer acetate
1576946|NCT00475865|adjunctive therapy|adjunctive therapy
1576947|NCT00475865|relapses|relapses
1576948|NCT00475852|Heart Decompensation|heart decompensation
1576949|NCT00475852|Dyspnea|dyspnea
1576950|NCT00475852|Heart failure|heart failure
1576951|NCT00475852|Nesiritide|nesiritide
1576952|NCT00475852|Decompensated|decompensated
1576953|NCT00475852|ADHF|adhf
1576954|NCT00475839|stress urinary incontinence|stress urinary incontinence
1576955|NCT00475839|sling procedures|sling procedures
1576956|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
1576957|NCT00475839|transobturator|transobturator
1576958|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
1576959|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
1577429|NCT00474240|cholesterol|cholesterol
1576960|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
1576961|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
1576962|NCT00475826|Coronary artery calcification|coronary artery calcification
1576963|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
1576964|NCT00475800|Osteoarthritis|osteoarthritis
1576965|NCT00475800|lumiracoxib|lumiracoxib
1576966|NCT00475800|celecoxib|celecoxib
1576967|NCT00475800|Cox-2|cox-2
1576968|NCT00475800|knee|knee
1576969|NCT00475787|Older Adults|older adults
1576970|NCT00475787|Patient Education|patient education
1576971|NCT00475787|Randomized Controlled Trial|randomized controlled trial
1576972|NCT00475787|Sham procedure|sham procedure
1576973|NCT00475787|Spinal Manipulation|spinal manipulation
1576974|NCT00475787|Veterans|veterans
1576975|NCT00475761|Breast biopsy|breast biopsy
1576976|NCT00475761|Breast imaging|breast imaging
1576977|NCT00475761|Breast Cancer|breast cancer
1576978|NCT00475761|Mammographic Density|mammographic density
1576979|NCT00475761|Breast|breast
1576980|NCT00475748|cervical spine|cervical spine
1576981|NCT00475748|spinal cord|spinal cord
1576982|NCT00475748|trauma|trauma
1576983|NCT00475748|spinal cord injury|spinal cord injury
1576984|NCT00475748|central cord syndrome|central cord syndrome
1576985|NCT00475722|cancer|cancer
1576986|NCT00475722|colon|colon
1576987|NCT00475722|prevention|prevention
1576988|NCT00475722|healthy eating|healthy eating
1576989|NCT00475722|Mediterranean diet|mediterranean diet
1576990|NCT00475722|PGE2|pge2
1576991|NCT00475722|cyclooxygenase|cyclooxygenase
1576992|NCT00475722|lipoxygenase|lipoxygenase
1576993|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
1576994|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
1576995|NCT00475709|aortic valve|aortic valve
1576996|NCT00475709|heart valve|heart valve
1576997|NCT00475709|tissue valve|tissue valve
1576998|NCT00475709|bioprosthesis|bioprosthesis
1576999|NCT00475709|valve disorder|valve disorder
1577000|NCT00475709|valve disease|valve disease
1577001|NCT00475709|cardiac surgery|cardiac surgery
1577002|NCT00475709|aortic valve stenosis|aortic valve stenosis
1577003|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
1577004|NCT00475683|Doxorubicin|doxorubicin
1577005|NCT00475683|Mucositis|mucositis
1577006|NCT00475683|Prevention|prevention
1577007|NCT00475683|Curcumin|curcumin
1577008|NCT00475631|Clubfoot|clubfoot
1577009|NCT00475631|Chart review|chart review
1577010|NCT00475618|Early chilhood caries|early chilhood caries
1577011|NCT00475618|Prevention|prevention
1577012|NCT00475618|Fluoride varnish|fluoride varnish
1577013|NCT00475618|fluoride toothpaste|fluoride toothpaste
1577014|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
1577015|NCT00475618|Professional cleaning|professional cleaning
1577016|NCT00475605|atopic dermatitis|atopic dermatitis
1577017|NCT00475605|child|child
1577018|NCT00475605|tacrolimus ointment|tacrolimus ointment
1577019|NCT00475605|Protopic Ointment|protopic ointment
1577020|NCT00475592|Esophageal Varices|esophageal varices
1577021|NCT00475592|Gastric Varices|gastric varices
1577022|NCT00475592|Capsule Endoscopy|capsule endoscopy
1577023|NCT00475592|Portal Hypertension|portal hypertension
1577024|NCT00475592|Cirrhosis|cirrhosis
1577025|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1577026|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
1577027|NCT00475579|endotracheal tube|endotracheal tube
1577028|NCT00475579|polyurethane cuff|polyurethane cuff
1577029|NCT00475579|polyvinyl cuff|polyvinyl cuff
1577030|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
1577031|NCT00475553|spotting|spotting
1577032|NCT00475553|PMS|pms
1577033|NCT00475553|nuvaring|nuvaring
1577034|NCT00475553|birth control|birth control
1577038|NCT00475553|continuous use|continuous use
1577039|NCT00475540|prolapse|prolapse
1577040|NCT00475540|uterus|uterus
1577041|NCT00475540|pelvic organ|pelvic organ
1577042|NCT00475540|vaginal prolpase|vaginal prolpase
1577043|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
1577044|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
1577045|NCT00475501|anabolic effects|anabolic effects
1577046|NCT00475501|finasteride|finasteride
1577047|NCT00475501|male hypogonadism|male hypogonadism
1577048|NCT00475501|sarcopenia|sarcopenia
1577049|NCT00475501|testosterone|testosterone
1577050|NCT00475488|radial artery|radial artery
1577051|NCT00475488|right internal thoracic artery|right internal thoracic artery
1577052|NCT00475488|saphenous vein|saphenous vein
1577053|NCT00475488|grafts|grafts
1577054|NCT00475488|coronary bypass surgery|coronary bypass surgery
1577055|NCT00475475|Overweight|overweight
1577056|NCT00475475|Obesity|obesity
1577057|NCT00475475|Appetite|appetite
1577058|NCT00475475|Dietary sugars|dietary sugars
1577059|NCT00475475|Fructose|fructose
1577060|NCT00475475|Glucose|glucose
1577061|NCT00475475|Leptin|leptin
1577062|NCT00475475|Insulin|insulin
1577063|NCT00475475|Ghrelin|ghrelin
1577064|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
1577065|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
1577066|NCT00475449|Stent|stent
1577067|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
1577068|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
1577069|NCT00475436|GSK573719,|gsk573719,
1577070|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1577071|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
1577072|NCT00475410|Complex perianal fistula|complex perianal fistula
1577073|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
1577074|NCT00475410|Advanced cell therapy|advanced cell therapy
1577075|NCT00475410|Fibrin glue|fibrin glue
1577076|NCT00475384|Acute Myelogenous Leukemia|acute myelogenous leukemia
1577077|NCT00475384|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1577078|NCT00475384|Myelodysplastic Syndrome|myelodysplastic syndrome
1577079|NCT00475384|Stem Cell Transplant|stem cell transplant
1577080|NCT00475384|Haploidentical Donor|haploidentical donor
1577081|NCT00475384|Leukemia|leukemia
1577082|NCT00475384|Fludarabine|fludarabine
1577083|NCT00475384|Total Body Irradiation|total body irradiation
1577084|NCT00475384|Thiotepa|thiotepa
1577085|NCT00475371|Healthy|healthy
1577086|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
1577087|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
1577088|NCT00475345|Bedtime snacks|bedtime snacks
1577089|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
1577090|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1577091|NCT00475345|CSII|csii
1577092|NCT00475345|Intensive therapy|intensive therapy
1577093|NCT00475319|Dry Eye Syndromes|dry eye syndromes
1577094|NCT00475319|OPC-12759|opc-12759
1577095|NCT00475306|Metoclopramide|metoclopramide
1577096|NCT00475306|Nausea|nausea
1577097|NCT00475306|Akathisia|akathisia
1577098|NCT00475306|Emergency department|emergency department
1577099|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
1577100|NCT00475293|2nd-line Therapy|2nd-line therapy
1577101|NCT00475293|panitumumab|panitumumab
1577102|NCT00475293|irinotecan|irinotecan
1577103|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
1577104|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
1577105|NCT00475280|Older patients|older patients
1577106|NCT00475280|> 60 years old|> 60 years old
1577107|NCT00475280|Ph negative|ph negative
1577108|NCT00475267|aortic valve|aortic valve
1577109|NCT00475267|heart valve|heart valve
1577110|NCT00475267|tissue valve|tissue valve
1577111|NCT00475267|bioprosthesis|bioprosthesis
1577112|NCT00475267|valve disorder|valve disorder
1577113|NCT00475267|valve disease|valve disease
1577114|NCT00475267|cardiac surgery|cardiac surgery
1577115|NCT00475267|aortic valve stenosis|aortic valve stenosis
1577116|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
1577117|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
1577118|NCT00475254|stress|stress
1577119|NCT00475254|sleepiness|sleepiness
1577120|NCT00475254|low vision|low vision
1577121|NCT00475254|mind-body|mind-body
1577122|NCT00475241|Combat Disorders|combat disorders
1577123|NCT00475241|Cortisol|cortisol
1577124|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
1577125|NCT00475241|Psychophysiology|psychophysiology
1577126|NCT00475241|Therapy|therapy
1577127|NCT00475241|Treatment|treatment
1577128|NCT00475241|Veterans|veterans
1577129|NCT00475228|levonorgestrel IUD|levonorgestrel iud
1577130|NCT00475228|IUD|iud
1577131|NCT00475228|dilation and evacuation|dilation and evacuation
1577132|NCT00475228|contraception|contraception
1577133|NCT00475189|birth control|birth control
1577134|NCT00475189|PMS|pms
1577135|NCT00475189|headaches|headaches
1577136|NCT00475189|mood swings|mood swings
1577137|NCT00475189|pelvic pain|pelvic pain
1577138|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
1577139|NCT00475176|Non-Responders|non-responders
1577140|NCT00475176|SAMe|same
1577141|NCT00475176|Natural Killer Cells|natural killer cells
1577142|NCT00475176|Interferon Signaling|interferon signaling
1577143|NCT00475176|Ribavirin|ribavirin
1577144|NCT00475176|Peginterferon|peginterferon
1577145|NCT00475176|Hemolysis|hemolysis
1577146|NCT00475176|STAT|stat
1577147|NCT00475176|Hepatitis C|hepatitis c
1577148|NCT00475163|Obesity|obesity
1577149|NCT00475163|Mentoring|mentoring
1577150|NCT00475163|Fitness|fitness
1577151|NCT00475163|Self-esteem|self-esteem
1577152|NCT00475137|Bipolar II Disorder|bipolar ii disorder
1577153|NCT00475137|depression|depression
1577154|NCT00475137|Lamotrigine|lamotrigine
1577155|NCT00475137|Add On antidepressant|add on antidepressant
1577156|NCT00475137|randomized|randomized
1577157|NCT00475137|single blind|single blind
1577158|NCT00475137|parallel group|parallel group
1577159|NCT00475124|Pacemaker follow-up|pacemaker follow-up
1577160|NCT00475124|Telecardiology|telecardiology
1577161|NCT00475124|Home Monitoring|home monitoring
1577162|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
1577163|NCT00475111|Emotion Regulation|emotion regulation
1577164|NCT00475111|Pain Management|pain management
1577165|NCT00475111|Psychological Adaptation|psychological adaptation
1577166|NCT00475111|Coping Efficacy|coping efficacy
1577167|NCT00475111|Markers of Disease Activity|markers of disease activity
1577168|NCT00475098|Low molecular weight heparin|low molecular weight heparin
1577169|NCT00475098|Lung cancer|lung cancer
1577170|NCT00475098|Non small cell lung cancer|non small cell lung cancer
1577171|NCT00475098|Adjuvant therapy|adjuvant therapy
1577172|NCT00475098|Anticoagulants|anticoagulants
1577173|NCT00475098|Heparin|heparin
1577174|NCT00475085|nausea and vomiting|nausea and vomiting
1577175|NCT00475085|recurrent breast cancer|recurrent breast cancer
1577176|NCT00475085|stage I breast cancer|stage i breast cancer
1577177|NCT00475085|stage II breast cancer|stage ii breast cancer
1577178|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
1577179|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
1577180|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
1577181|NCT00475085|stage IV breast cancer|stage iv breast cancer
1577182|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
1577183|NCT00475085|male breast cancer|male breast cancer
1577184|NCT00475059|kidney transplantation|kidney transplantation
1577185|NCT00475059|Glomerular filtration rate|glomerular filtration rate
1577186|NCT00475059|inulin clearance|inulin clearance
1577187|NCT00475059|MDRD equation|mdrd equation
1577188|NCT00475059|cystatin C|cystatin c
1577189|NCT00475059|cimetidine|cimetidine
1577190|NCT00475046|smoking|smoking
1577191|NCT00475046|post partum|post partum
1577192|NCT00475046|relapse prevention|relapse prevention
1577193|NCT00475046|motivational interviewing|motivational interviewing
1577195|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
1577196|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
1577197|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
1577198|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
1577199|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
1577200|NCT00475020|Myelofibrosis|myelofibrosis
1577201|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
1577202|NCT00475020|Polycythemia Vera|polycythemia vera
1577203|NCT00475020|Busulfan|busulfan
1577204|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
1577205|NCT00475020|ATG|atg
1577206|NCT00475020|Fludarabine|fludarabine
1577207|NCT00475020|Thymoglobulin|thymoglobulin
1577208|NCT00475007|Emphysema|emphysema
1577209|NCT00475007|IBV® Valve|ibv® valve
1577210|NCT00475007|COPD|copd
1577211|NCT00475007|Shortness of Breath|shortness of breath
1577212|NCT00475007|Spiration|spiration
1577213|NCT00474994|chondrosarcoma|chondrosarcoma
1577214|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
1577215|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
1577290|NCT00474877|Splints|splints
1577216|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
1577217|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
1577218|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1577219|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1577220|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
1577221|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
1577222|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1577223|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1577224|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
1577225|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1577226|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1577227|NCT00474994|ovarian sarcoma|ovarian sarcoma
1577228|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
1577229|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
1577230|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
1577231|NCT00474994|desmoid tumor|desmoid tumor
1577232|NCT00474994|adult angiosarcoma|adult angiosarcoma
1577233|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1577234|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
1577235|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
1577236|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
1577237|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
1577238|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1577239|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
1577240|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1577241|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
1577242|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
1577243|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1577244|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
1577245|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
1577246|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
1577430|NCT00474227|obesity|obesity
1577247|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1577248|NCT00474994|adult liposarcoma|adult liposarcoma
1577249|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
1577250|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
1577251|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1577252|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
1577253|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
1577254|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
1577255|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
1577256|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1577257|NCT00474981|neonatal mortality|neonatal mortality
1577258|NCT00474981|infant mortality|infant mortality
1577259|NCT00474981|newborn caring practices|newborn caring practices
1577260|NCT00474942|Hypertension|hypertension
1577261|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
1577262|NCT00474942|Hypokalemia|hypokalemia
1577263|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1577264|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1577265|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
1577266|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
1577267|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
1577268|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1577269|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1577270|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1577271|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1577272|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1577273|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1577274|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1577275|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1577276|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1577277|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1577278|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1577279|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1577280|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1577281|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1577282|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1577283|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1577284|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1577285|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1577286|NCT00474916|Neuropathic pain|neuropathic pain
1577287|NCT00474916|Cancer|cancer
1577288|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
1577289|NCT00474877|Clinical|clinical
1577291|NCT00474877|Rheumatoid|rheumatoid
1577292|NCT00474864|Endothelial Function,|endothelial function,
1577293|NCT00474864|vascular compliance,|vascular compliance,
1577294|NCT00474864|atherosclerosis|atherosclerosis
1577295|NCT00474851|Endometriosis|endometriosis
1577296|NCT00474851|Adolescents|adolescents
1577297|NCT00474851|Bone density|bone density
1577298|NCT00474851|GnRH Agonist|gnrh agonist
1577299|NCT00474851|Add-back therapy|add-back therapy
1577300|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
1577301|NCT00474838|intensive insulin therapy|intensive insulin therapy
1577302|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
1577303|NCT00474747|Severe Aplastic Anemia|severe aplastic anemia
1577304|NCT00474747|Total Body Irradiation|total body irradiation
1577305|NCT00474747|Antithymocyte Globulin|antithymocyte globulin
1577306|NCT00474747|Cyclophosphamide|cyclophosphamide
1577311|NCT00474747|Fludarabine Phosphate|fludarabine phosphate
1577312|NCT00474747|Thymoglobulin|thymoglobulin
1577313|NCT00474747|ATG|atg
1577314|NCT00474747|TBI|tbi
1577315|NCT00474747|Cyclosporine|cyclosporine
1577316|NCT00474747|Tacrolimus|tacrolimus
1577317|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
1577318|NCT00474734|liver transplantation|liver transplantation
1577319|NCT00474734|staging|staging
1577320|NCT00474734|intravascular ultrasound|intravascular ultrasound
1577321|NCT00474721|child|child
1577322|NCT00474721|pain|pain
1577323|NCT00474721|analgesics|analgesics
1577324|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
1577325|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
1577326|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
1577327|NCT00474656|high frequency oscillation|high frequency oscillation
1577328|NCT00474656|lung-protective ventilation|lung-protective ventilation
1577329|NCT00474656|ARDS|ards
1577431|NCT00474227|weight gain|weight gain
1577330|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
1577331|NCT00474630|Obesity|obesity
1577332|NCT00474630|Overweight|overweight
1577333|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1577334|NCT00474604|breast cancer|breast cancer
1577335|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
1577336|NCT00474565|Catheter,|catheter,
1577337|NCT00474565|Aortic root injection,|aortic root injection,
1577338|NCT00474565|low dose contrast injection,|low dose contrast injection,
1577339|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
1577340|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
1577341|NCT00474539|Vaccine|vaccine
1577342|NCT00474526|Meningococcal|meningococcal
1577343|NCT00474526|meningitis|meningitis
1577344|NCT00474526|vaccine|vaccine
1577345|NCT00474526|infants|infants
1577346|NCT00474526|Meningococcal meningitis|meningococcal meningitis
1577347|NCT00474526|Meningococcal disease|meningococcal disease
1577348|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
1577349|NCT00474500|Iron absorption|iron absorption
1577350|NCT00474500|Coca-Cola|coca-cola
1577351|NCT00474487|Meningococcal|meningococcal
1577352|NCT00474487|meningitis|meningitis
1577353|NCT00474487|vaccine|vaccine
1577354|NCT00474487|adolescents|adolescents
1577355|NCT00474487|adults|adults
1577356|NCT00474474|virtual patient|virtual patient
1577357|NCT00474474|therapeutic decision making|therapeutic decision making
1577358|NCT00474461|coronary artery disease|coronary artery disease
1577359|NCT00474461|Heart Attack|heart attack
1577360|NCT00474461|Heart failure|heart failure
1577361|NCT00474461|Cardiac Stem Cells|cardiac stem cells
1577362|NCT00474461|Coronary Artery Bypass|coronary artery bypass
1577363|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
1577364|NCT00474448|Survey|survey
1577365|NCT00474448|Quality of Life|quality of life
1577366|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
1577367|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
1577368|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
1577369|NCT00474435|Tuberculosis|tuberculosis
1577371|NCT00474435|Coinfection|coinfection
1577372|NCT00474435|Pharmacokinetics|pharmacokinetics
1577373|NCT00474435|Emtricitabine|emtricitabine
1577374|NCT00474435|Tenofovir|tenofovir
1577375|NCT00474435|Rifampin|rifampin
1577376|NCT00474435|Efavirenz|efavirenz
1577377|NCT00474435|Treatment Naive|treatment naive
1577378|NCT00474422|breastfeeding|breastfeeding
1577379|NCT00474422|support|support
1577380|NCT00474409|Vertigo|vertigo
1577381|NCT00474409|Posterior circulation infarction|posterior circulation infarction
1577382|NCT00474396|Uric acid|uric acid
1577383|NCT00474396|Dairy|dairy
1577384|NCT00474396|Diet|diet
1577385|NCT00474383|Prostate neoplasms|prostate neoplasms
1577386|NCT00474383|CB7630|cb7630
1577387|NCT00474383|Abiraterone acetate|abiraterone acetate
1577388|NCT00474383|Glucocorticoid|glucocorticoid
1577389|NCT00474383|Prednisone|prednisone
1577390|NCT00474383|Prednisolone|prednisolone
1577391|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1577392|NCT00474357|Bipolar affective disorder|bipolar affective disorder
1577393|NCT00474357|myths|myths
1577394|NCT00474357|preconceived notions|preconceived notions
1577395|NCT00474357|stigma|stigma
1577396|NCT00474357|hope|hope
1577397|NCT00474344|Genetics|genetics
1577398|NCT00474344|Clubfoot|clubfoot
1577399|NCT00474344|DNA|dna
1577400|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
1577401|NCT00474331|DNA sequencing|dna sequencing
1577402|NCT00474331|EXT genes|ext genes
1577403|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
1577404|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
1577405|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
1577406|NCT00474318|Adolescents|adolescents
1577409|NCT00474318|Surgery for Weight Loss|surgery for weight loss
1577410|NCT00474318|Teen-LABS|teen-labs
1577411|NCT00474305|PTSD|ptsd
1577412|NCT00474305|Prolonged Exposure|prolonged exposure
1577413|NCT00474305|Virtual Reality|virtual reality
1577414|NCT00474292|Stroke|stroke
1577415|NCT00474292|Rehabilitation|rehabilitation
1577416|NCT00474292|Plasticity|plasticity
1577417|NCT00474292|fMRI|fmri
1577418|NCT00474292|Reorganization|reorganization
1577419|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
1577420|NCT00474279|Body composition|body composition
1577421|NCT00474279|Functional ability|functional ability
1577422|NCT00474279|Aging|aging
1577423|NCT00474279|Sarcopenia|sarcopenia
1577424|NCT00474266|MMRV vaccine|mmrv vaccine
1577425|NCT00474266|co-administration|co-administration
1577426|NCT00474266|immunogenicity|immunogenicity
1577427|NCT00474266|meningococcal vaccine|meningococcal vaccine
1577428|NCT00474266|conjugate vaccine|conjugate vaccine
1577432|NCT00474227|schizophrenia|schizophrenia
1577433|NCT00474227|schizoaffective disorder|schizoaffective disorder
1577434|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
1577435|NCT00474214|STEMI|stemi
1577436|NCT00474214|Primary PCI|primary pci
1577437|NCT00474214|Length of Stay|length of stay
1577438|NCT00474214|Early Discharge|early discharge
1577439|NCT00474201|Pharmacokinetic|pharmacokinetic
1577440|NCT00474201|HIV|hiv
1577441|NCT00474201|Drug-Drug Interaction|drug-drug interaction
1577442|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
1577443|NCT00474201|Gemfibrozil|gemfibrozil
1577444|NCT00474201|Healthy Volunteer|healthy volunteer
1577445|NCT00474201|HV|hv
1577446|NCT00474188|Celgene|celgene
1577447|NCT00474188|Revlimid|revlimid
1577448|NCT00474188|Lenalidomide|lenalidomide
1577449|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
1577450|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
1577451|NCT00474188|CC-5013|cc-5013
1577452|NCT00474188|Response Rate|response rate
1577453|NCT00474188|Tumor Control Rate|tumor control rate
1577454|NCT00474188|Duration of Response|duration of response
1577455|NCT00474188|Time to Progression|time to progression
1577456|NCT00474188|Progression-free survival and safety|progression-free survival and safety
1577457|NCT00474162|Cesarean section|cesarean section
1577458|NCT00474162|coagulation changes|coagulation changes
1577459|NCT00474123|angina|angina
1577460|NCT00474123|atherosclerosis|atherosclerosis
1577461|NCT00474123|simvastatin|simvastatin
1577462|NCT00474123|ezetimibe|ezetimibe
1577463|NCT00474123|inflammation|inflammation
1577464|NCT00474110|Ketamine|ketamine
1577465|NCT00474110|hydromorphone|hydromorphone
1577466|NCT00474110|pediatric mucositis|pediatric mucositis
1577467|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
1577468|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
1577469|NCT00474097|Diverticulitis|diverticulitis
1577470|NCT00474097|Colonic Polyps|colonic polyps
1577471|NCT00474097|Crohn Disease|crohn disease
1577472|NCT00474084|Stent|stent
1577473|NCT00474084|Hydroxyapatite|hydroxyapatite
1577474|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
1577475|NCT00474084|Angioplasty|angioplasty
1577476|NCT00474071|Remifentanil|remifentanil
1577477|NCT00474071|endotracheal intubation|endotracheal intubation
1577478|NCT00474071|pediatrics|pediatrics
1577479|NCT00474058|rotigotine|rotigotine
1577480|NCT00474058|Neupro®|neupro®
1577481|NCT00474058|Parkinson's Disease|parkinson's disease
1577482|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
1577483|NCT00474032|Botox injection|botox injection
1577484|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
1577485|NCT00474019|pediatrics|pediatrics
1577486|NCT00474019|neonates|neonates
1577487|NCT00473993|Hepatitis C|hepatitis c
1577488|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
1577489|NCT00473993|Methadone|methadone
1577490|NCT00473993|Buprenorphine|buprenorphine
1577492|NCT00473993|Interferon, pegylated|interferon, pegylated
1577493|NCT00473980|MHC|mhc
1577494|NCT00473980|CTLs|ctls
1577495|NCT00473980|Colon carcinoma|colon carcinoma
1577496|NCT00473980|NSAID|nsaid
1577497|NCT00473980|Survival|survival
1577498|NCT00473967|Vaccine|vaccine
1577499|NCT00473967|Hookworm|hookworm
1577500|NCT00473967|Phase 1|phase 1
1577501|NCT00473967|Na-ASP-2|na-asp-2
1577502|NCT00473941|colorectal cancer|colorectal cancer
1577503|NCT00473941|colon cancer|colon cancer
1577504|NCT00473941|rectal cancer|rectal cancer
1577505|NCT00473928|Macular|macular
1577506|NCT00473928|degeration|degeration
1577507|NCT00473928|Complement|complement
1577508|NCT00473876|Chronic Heart Failure|chronic heart failure
1577509|NCT00473876|Insulin Resistance|insulin resistance
1577510|NCT00473876|Metformin|metformin
1577511|NCT00473876|Peak VO2|peak vo2
1577512|NCT00473863|Acute coronary syndrome|acute coronary syndrome
1577513|NCT00473863|Acute myocardial infarction|acute myocardial infarction
1577514|NCT00473863|Unstable angina|unstable angina
1577515|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
1577516|NCT00473863|Coronary Angiography|coronary angiography
1577517|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
1577518|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
1577519|NCT00473850|DNA sequencing|dna sequencing
1577520|NCT00473850|EXT genes|ext genes
1577521|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
1577522|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
1577523|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
1577524|NCT00473837|malaria|malaria
1577525|NCT00473837|anaemia|anaemia
1577526|NCT00473837|chloroquine|chloroquine
1577527|NCT00473837|iron delocalisation|iron delocalisation
1577528|NCT00473837|macrophages|macrophages
1577529|NCT00473824|hepatitis C|hepatitis c
1577530|NCT00473824|liver transplantation|liver transplantation
1577531|NCT00473824|immune globulin|immune globulin
1577532|NCT00473811|Glycemic index|glycemic index
1577533|NCT00473811|carbohydrates|carbohydrates
1577735|NCT00473096|Indigency|indigency
1577534|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
1577535|NCT00473811|randomized clinical trial|randomized clinical trial
1577536|NCT00473798|Patient Satisfaction|patient satisfaction
1577537|NCT00473798|Quality of Life|quality of life
1577538|NCT00473798|Psychological Distress|psychological distress
1577539|NCT00473798|Cervical Cancer|cervical cancer
1577540|NCT00473798|Cervical Cancer Screening|cervical cancer screening
1577541|NCT00473798|Questionnaire|questionnaire
1577542|NCT00473785|Cardiovascular disease|cardiovascular disease
1577543|NCT00473785|Prevention|prevention
1577544|NCT00473785|Lifestyle|lifestyle
1577545|NCT00473772|cobalt chromium stent|cobalt chromium stent
1577546|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1577547|NCT00473772|DEBlue|deblue
1577548|NCT00473772|drug eluting balloon|drug eluting balloon
1577549|NCT00473746|Prostate neoplasms|prostate neoplasms
1577550|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
1577551|NCT00473746|Abiraterone acetate|abiraterone acetate
1577552|NCT00473746|CB7630|cb7630
1577553|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
1577554|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
1577555|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
1577556|NCT00473733|PCR ANALYSIS|pcr analysis
1577557|NCT00473707|Third stage of labor|third stage of labor
1577558|NCT00473668|Hepatitis B|hepatitis b
1577559|NCT00473668|Tetanus|tetanus
1577560|NCT00473668|Diphtheria|diphtheria
1577561|NCT00473668|Pertussis|pertussis
1577562|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
1577563|NCT00473655|Triglycerides|triglycerides
1577564|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
1577565|NCT00473655|statins|statins
1577566|NCT00473655|rosuvastatin|rosuvastatin
1577567|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
1577568|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
1577569|NCT00473642|Ranibizumab|ranibizumab
1577570|NCT00473642|Lucentis|lucentis
1577571|NCT00473642|Verteporfin|verteporfin
1577572|NCT00473642|Visudyne|visudyne
1577573|NCT00473642|Photodynamic therapy|photodynamic therapy
1577574|NCT00473616|Phase I|phase i
1577575|NCT00473616|solid tumors|solid tumors
1577576|NCT00473616|solid malignancies|solid malignancies
1577577|NCT00473616|cancer Eligibility|cancer eligibility
1577578|NCT00473603|androgens|androgens
1577579|NCT00473603|fatty acids|fatty acids
1577580|NCT00473590|Avastin|avastin
1577581|NCT00473590|AMBER|amber
1577582|NCT00473590|Myeloma|myeloma
1577583|NCT00473590|Velcade|velcade
1577584|NCT00473564|Lesions|lesions
1577585|NCT00473564|Biopsy|biopsy
1577586|NCT00473564|Surgery|surgery
1577587|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1577588|NCT00473551|Lymphoma|lymphoma
1577589|NCT00473551|Myeloma|myeloma
1577590|NCT00473551|Leukemia|leukemia
1577591|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
1577592|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
1577593|NCT00473551|Fludarabine|fludarabine
1577594|NCT00473551|Fludara|fludara
1577595|NCT00473551|Rituximab|rituximab
1577596|NCT00473551|Rituxan|rituxan
1577597|NCT00473551|Cyclophosphamide|cyclophosphamide
1577598|NCT00473551|Cytoxan®|cytoxan®
1577599|NCT00473551|Neosar®|neosar®
1577600|NCT00473551|Stem Cell Transplantation|stem cell transplantation
1577601|NCT00473551|T-lymphocytes|t-lymphocytes
1577602|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
1577603|NCT00473551|Graft vs. Host Disease|graft vs. host disease
1577604|NCT00473551|GVHD|gvhd
1577605|NCT00473551|Allogenic Transplant|allogenic transplant
1577606|NCT00473551|Sirolimus|sirolimus
1577607|NCT00473551|Rapamycin|rapamycin
1577608|NCT00473538|Structured exercise training program|structured exercise training program
1577609|NCT00473538|Infertility|infertility
1577610|NCT00473538|Menstrual cycle|menstrual cycle
1577611|NCT00473538|PCOS|pcos
1577612|NCT00473538|Treatment|treatment
1577613|NCT00473512|Abiraterone acetate|abiraterone acetate
1577614|NCT00473512|CB7630|cb7630
1577615|NCT00473512|Prostatic neoplasms|prostatic neoplasms
1577922|NCT00472173|MTA|mta
1577616|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
1577617|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
1577618|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
1577619|NCT00473499|drug eluting balloon|drug eluting balloon
1577620|NCT00473499|drug eluting stent|drug eluting stent
1577621|NCT00473499|stem cells|stem cells
1577622|NCT00473473|homeopathy|homeopathy
1577623|NCT00473473|Traumeel|traumeel
1577624|NCT00473473|mechanical ventilation|mechanical ventilation
1577625|NCT00473473|secretions|secretions
1577626|NCT00473460|Chronic bronchitis|chronic bronchitis
1577627|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1577628|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
1577629|NCT00473460|Prevention therapy|prevention therapy
1577630|NCT00473460|Antibiotics|antibiotics
1577631|NCT00473460|Fluoroquinolone|fluoroquinolone
1577632|NCT00473460|Moxifloxacin|moxifloxacin
1577633|NCT00473460|AECB|aecb
1577634|NCT00473447|Rehabilitation|rehabilitation
1577635|NCT00473447|Children|children
1577636|NCT00473447|Cerebral Palsy|cerebral palsy
1577638|NCT00473447|Paresis|paresis
1577639|NCT00473434|Schizophrenia|schizophrenia
1577640|NCT00473434|Drug Therapy|drug therapy
1577641|NCT00473434|Treatment Outcome|treatment outcome
1577642|NCT00473408|Glioma|glioma
1577643|NCT00473408|DCE-MRI|dce-mri
1577644|NCT00473408|Angiogenesis|angiogenesis
1577645|NCT00473408|Cancer stem cells|cancer stem cells
1577646|NCT00473408|Tumor vasculature|tumor vasculature
1577647|NCT00473382|Lucentis|lucentis
1577648|NCT00473382|DME|dme
1577649|NCT00473382|Diabetes|diabetes
1577650|NCT00473382|Vision loss|vision loss
1577651|NCT00473369|atypical adenoma|atypical adenoma
1577652|NCT00473369|Ki-67|ki-67
1577653|NCT00473369|p53|p53
1577654|NCT00473369|pituitary|pituitary
1577655|NCT00473369|prognosis|prognosis
1577656|NCT00473356|Morbid obesity|morbid obesity
1577657|NCT00473356|Lean body mass|lean body mass
1577658|NCT00473356|amino acid supplement|amino acid supplement
1577659|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
1577660|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
1577661|NCT00473343|PDT with Metvix cream|pdt with metvix cream
1577662|NCT00473343|"High risk BCC"|"high risk bcc"
1577663|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
1577664|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
1577665|NCT00473330|Lucentis|lucentis
1577666|NCT00473330|DME|dme
1577667|NCT00473330|Diabetes|diabetes
1577668|NCT00473330|Vision loss|vision loss
1577669|NCT00473317|sunlight|sunlight
1577670|NCT00473317|UVB|uvb
1577671|NCT00473317|Vitamin D|vitamin d
1577672|NCT00473304|Safety|safety
1577673|NCT00473304|Efficacy|efficacy
1577674|NCT00473304|Adaptation|adaptation
1577675|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
1577676|NCT00473291|pleural effusion|pleural effusion
1577677|NCT00473291|lung sounds|lung sounds
1577678|NCT00473291|acoustic monitoring|acoustic monitoring
1577679|NCT00473278|tear protein|tear protein
1577680|NCT00473252|aspergillus infections|aspergillus infections
1577681|NCT00473252|immunosuppression|immunosuppression
1577682|NCT00473252|kidney transplantation|kidney transplantation
1577683|NCT00473252|hemodialysis|hemodialysis
1577684|NCT00473252|galactomannan test|galactomannan test
1577685|NCT00473252|fine dust|fine dust
1577686|NCT00473252|construction activity|construction activity
1577687|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
1577688|NCT00473239|vitamin D|vitamin d
1577689|NCT00473239|cholecalciferol|cholecalciferol
1577690|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
1577691|NCT00473213|Multiple Sclerosis|multiple sclerosis
1577692|NCT00473213|Interferon|interferon
1577693|NCT00473213|Magnetic Resonance|magnetic resonance
1577694|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
1577695|NCT00473200|homocysteine|homocysteine
1577696|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
1577697|NCT00473200|SAMe|same
1577698|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
1577903|NCT00472303|Cancer related pain|cancer related pain
1577699|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
1577700|NCT00473187|growth disorders|growth disorders
1577701|NCT00473187|anthropometry|anthropometry
1577702|NCT00473187|human growth hormone|human growth hormone
1577703|NCT00473174|Ramipril|ramipril
1577704|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1577705|NCT00473174|Chronotherapy|chronotherapy
1577706|NCT00473174|Circadian|circadian
1577707|NCT00473174|Non-dipper|non-dipper
1577708|NCT00473161|movement disorders|movement disorders
1577709|NCT00473161|childhood|childhood
1577710|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
1577711|NCT00473148|Mechanical ventilation|mechanical ventilation
1577712|NCT00473148|Weaning|weaning
1577713|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
1577714|NCT00473148|Fluid balance|fluid balance
1577715|NCT00473148|Diuretics|diuretics
1577716|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
1577717|NCT00473148|for at least 24 hours|for at least 24 hours
1577718|NCT00473148|Respiratory insufficiency|respiratory insufficiency
1577719|NCT00473135|Dengue Fever|dengue fever
1577720|NCT00473135|Dengue Vaccine|dengue vaccine
1577721|NCT00473135|Dengue Virus|dengue virus
1577722|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1577723|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
1577724|NCT00473122|Breast Cancer|breast cancer
1577725|NCT00473122|Breast Reconstruction|breast reconstruction
1577726|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
1577727|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
1577728|NCT00473122|Mastectomy|mastectomy
1577729|NCT00473122|XRT|xrt
1577730|NCT00473109|Hemodialysis|hemodialysis
1577731|NCT00473109|Heparin|heparin
1577732|NCT00473109|Clotting|clotting
1577733|NCT00473096|Decision making|decision making
1577734|NCT00473096|Patient Education|patient education
1577736|NCT00473096|Minority group|minority group
1577737|NCT00473083|Rash|rash
1577738|NCT00473083|Erlotinib|erlotinib
1577739|NCT00473083|Lung Cancer|lung cancer
1577740|NCT00473057|acute stroke|acute stroke
1577741|NCT00473057|middle cerebral artery|middle cerebral artery
1577869|NCT00472459|Actinic keratosis|actinic keratosis
1577742|NCT00473057|autologous transplantation|autologous transplantation
1577743|NCT00473057|bone marrow cells|bone marrow cells
1577744|NCT00473057|stem cells|stem cells
1577745|NCT00473057|cell therapy|cell therapy
1577746|NCT00473031|bone mass|bone mass
1577747|NCT00473031|calcium absorption|calcium absorption
1577748|NCT00473031|bone quality|bone quality
1577749|NCT00473031|fracture risk|fracture risk
1577750|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
1577751|NCT00473018|HIV Seronegativity|hiv seronegativity
1577752|NCT00472992|Pregnancy|pregnancy
1577753|NCT00472992|TYSABRI|tysabri
1577754|NCT00472940|Cancer|cancer
1577755|NCT00472940|Hypogonadism|hypogonadism
1577756|NCT00472940|testosterone|testosterone
1577757|NCT00472940|cachexia|cachexia
1577758|NCT00472914|Hypertonia|hypertonia
1577759|NCT00472914|Childhood|childhood
1577760|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
1577761|NCT00472901|Afamelanotide|afamelanotide
1577762|NCT00472901|CUV1647|cuv1647
1577763|NCT00472901|photoprotection|photoprotection
1577764|NCT00472901|sun poisoning|sun poisoning
1577765|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
1577766|NCT00472888|cataract surgery|cataract surgery
1577767|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
1577768|NCT00472888|diabetes mellitus|diabetes mellitus
1577769|NCT00472888|hypertension|hypertension
1577770|NCT00472888|pupil|pupil
1577771|NCT00472875|hypoglycaemia|hypoglycaemia
1577772|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
1577773|NCT00472849|OFAR 2|ofar 2
1577774|NCT00472849|Oxaliplatin|oxaliplatin
1577775|NCT00472849|Fludarabine|fludarabine
1577776|NCT00472849|Cytarabine|cytarabine
1577777|NCT00472849|Ara-C|ara-c
1577778|NCT00472849|Rituximab|rituximab
1577779|NCT00472849|Richter's Transformation|richter's transformation
1577780|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
1577781|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
1577782|NCT00472849|Leukemia|leukemia
1577783|NCT00472849|CLL|cll
1577784|NCT00472823|cholecalciferol|cholecalciferol
1577785|NCT00472823|vitamin D deficiency|vitamin d deficiency
1577786|NCT00472823|bone density|bone density
1577787|NCT00472823|dietary calcium|dietary calcium
1577788|NCT00472823|hypercalcemia|hypercalcemia
1577789|NCT00472823|hypercalciuria|hypercalciuria
1577790|NCT00472810|Glaucoma|glaucoma
1577791|NCT00472810|Collagen matrix|collagen matrix
1577792|NCT00472810|ologen|ologen
1577793|NCT00472810|OculusGen|oculusgen
1577794|NCT00472810|Antifibrotic|antifibrotic
1577795|NCT00472810|Trabeculectomy|trabeculectomy
1577796|NCT00472810|anti scarring|anti scarring
1577797|NCT00472810|tissue engineering|tissue engineering
1577798|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
1577799|NCT00472810|Aeon Astron|aeon astron
1577800|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
1577801|NCT00472745|bone mass|bone mass
1577802|NCT00472745|calcium absorption|calcium absorption
1577803|NCT00472745|bone quality|bone quality
1577804|NCT00472745|fracture risk|fracture risk
1577805|NCT00472745|arthritis|arthritis
1577806|NCT00472745|osteoporosis|osteoporosis
1577807|NCT00472732|UCD|ucd
1577808|NCT00472732|OTCD|otcd
1577809|NCT00472732|Ammonia|ammonia
1577810|NCT00472732|Urea Metabolism|urea metabolism
1577811|NCT00472732|Inborn Errors|inborn errors
1577812|NCT00472719|HIV Seronegativity|hiv seronegativity
1577813|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
1577814|NCT00472719|Adenovirus|adenovirus
1577815|NCT00472706|Treatment|treatment
1577816|NCT00472706|Excision|excision
1577817|NCT00472706|Photodynamic therapy|photodynamic therapy
1577818|NCT00472706|Recurrence rate|recurrence rate
1577819|NCT00472706|Cosmetic outcome|cosmetic outcome
1577820|NCT00472693|Breast cancer|breast cancer
1577821|NCT00472693|Metastatic breast cancer|metastatic breast cancer
1577822|NCT00472693|Second-Line Therapy|second-line therapy
1577823|NCT00472693|Triple Negative|triple negative
1577824|NCT00472693|Her-2 negative|her-2 negative
1577825|NCT00472693|Hormone receptor negative|hormone receptor negative
1577826|NCT00472693|Abraxane|abraxane
1577827|NCT00472693|Bevacizumab|bevacizumab
1577828|NCT00472680|bone mass|bone mass
1577829|NCT00472680|calcium absorption|calcium absorption
1577830|NCT00472680|bone quality|bone quality
1577831|NCT00472680|fracture risk|fracture risk
1577832|NCT00472667|Bacterial infections|bacterial infections
1577833|NCT00472667|Procalcitonin|procalcitonin
1577834|NCT00472667|Intensive care unit|intensive care unit
1577835|NCT00472667|Antibiotic therapy|antibiotic therapy
1577836|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
1577837|NCT00472654|bone mass|bone mass
1577838|NCT00472654|calcium absorption|calcium absorption
1577839|NCT00472654|bone quality|bone quality
1577840|NCT00472654|fracture risk|fracture risk
1577841|NCT00472615|Bipolar Disorder|bipolar disorder
1577842|NCT00472615|Menstrual Cycle|menstrual cycle
1577843|NCT00472615|Depression|depression
1577844|NCT00472615|Mania or Hypomania|mania or hypomania
1577845|NCT00472615|Predictor|predictor
1577846|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
1577847|NCT00472576|NMDA Receptor|nmda receptor
1577848|NCT00472576|Depression Treatment|depression treatment
1577849|NCT00472576|Unipolar Depression|unipolar depression
1577850|NCT00472576|Treatment Resistant|treatment resistant
1577851|NCT00472576|Glutamatergic|glutamatergic
1577852|NCT00472576|Depression|depression
1577853|NCT00472576|Major Depression|major depression
1577854|NCT00472563|bicarbonate|bicarbonate
1577855|NCT00472563|nephropathy|nephropathy
1577856|NCT00472563|contrast|contrast
1577857|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
1577858|NCT00472537|Ventral hernia|ventral hernia
1577859|NCT00472537|Incisional hernia|incisional hernia
1577860|NCT00472498|Cardiac Arrest|cardiac arrest
1577861|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
1577862|NCT00472472|restenosis|restenosis
1577863|NCT00472472|peripheral arterial disease|peripheral arterial disease
1577864|NCT00472472|paccocath|paccocath
1577865|NCT00472472|drug-coated balloon|drug-coated balloon
1577866|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
1577867|NCT00472459|Organ transplant recipients|organ transplant recipients
1577868|NCT00472459|Photodynamic therapy|photodynamic therapy
1577871|NCT00472446|Thyroid gland|thyroid gland
1577872|NCT00472446|cervical block|cervical block
1577873|NCT00472446|Pain, Postoperative|pain, postoperative
1577874|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
1577875|NCT00472407|Normal|normal
1577876|NCT00472394|Medical abortion|medical abortion
1577877|NCT00472394|Preferences|preferences
1577878|NCT00472394|Willingness to Pay|willingness to pay
1577879|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
1577880|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
1577881|NCT00472381|Insulin treatment|insulin treatment
1577882|NCT00472381|Insulin|insulin
1577883|NCT00472381|DWI|dwi
1577884|NCT00472381|MRI|mri
1577885|NCT00472368|Advanced cancer|advanced cancer
1577886|NCT00472368|lymphoma|lymphoma
1577887|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
1577888|NCT00472368|adult|adult
1577889|NCT00472355|Parkinson's disease|parkinson's disease
1577890|NCT00472355|PD|pd
1577891|NCT00472355|apomorphine|apomorphine
1577892|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
1577893|NCT00472342|impaired fasting glucose|impaired fasting glucose
1577894|NCT00472342|diabetes|diabetes
1577895|NCT00472342|adipokine|adipokine
1577896|NCT00472342|adiponectin|adiponectin
1577897|NCT00472342|RBP-4|rbp-4
1577898|NCT00472342|adrenomedullin|adrenomedullin
1577899|NCT00472303|Opioid|opioid
1577900|NCT00472303|Central acting analgesic|central acting analgesic
1577901|NCT00472303|CG5503 PR|cg5503 pr
1577902|NCT00472303|Tumor related pain|tumor related pain
1577904|NCT00472303|Morphine|morphine
1577905|NCT00472303|Pain assessment|pain assessment
1577906|NCT00472303|Placebo|placebo
1577907|NCT00472290|Hematology|hematology
1577908|NCT00472290|MDS|mds
1577909|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
1577910|NCT00472290|Thrombocytopenia|thrombocytopenia
1577911|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
1577912|NCT00472251|dutasteride|dutasteride
1577913|NCT00472251|body mass index|body mass index
1577914|NCT00472251|testosterone|testosterone
1577915|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
1577916|NCT00472225|rituximab|rituximab
1577917|NCT00472186|Tonsillectomy|tonsillectomy
1577918|NCT00472186|Pain|pain
1577919|NCT00472173|Apexification|apexification
1577920|NCT00472173|Pulp necrosis|pulp necrosis
1577921|NCT00472173|Calcium hydroxide|calcium hydroxide
1577923|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
1577924|NCT00472160|Preoxygenation|preoxygenation
1577925|NCT00472160|Non Invasive Ventilation|non invasive ventilation
1577926|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
1577927|NCT00472160|Intubation,|intubation,
1577928|NCT00472160|Organ failure|organ failure
1577929|NCT00472134|Hernia|hernia
1577930|NCT00472134|Ventral|ventral
1577931|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
1577932|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
1577933|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
1577934|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
1577935|NCT00472108|PDT with placebo cream|pdt with placebo cream
1577936|NCT00472108|Histological verification|histological verification
1577937|NCT00472095|diabetes|diabetes
1577938|NCT00472095|fotonovela|fotonovela
1577939|NCT00472095|Latino|latino
1577940|NCT00472082|Immunosuppression|immunosuppression
1577941|NCT00472082|Renal Transplantation|renal transplantation
1577942|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
1577943|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
1577944|NCT00472069|myofibers|myofibers
1577945|NCT00472069|satellite cells|satellite cells
1577946|NCT00472069|myotubes|myotubes
1577947|NCT00472069|urethral|urethral
1577948|NCT00472069|Muscle fibres|muscle fibres
1577949|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1577950|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
1577951|NCT00472056|Lymphoma|lymphoma
1577952|NCT00472056|BEAM Chemotherapy|beam chemotherapy
1577953|NCT00472056|Carmustine|carmustine
1577954|NCT00472056|BCNU|bcnu
1577955|NCT00472056|BiCNU|bicnu
1577956|NCT00472056|Etoposide|etoposide
1577957|NCT00472056|VePesid|vepesid
1577958|NCT00472056|Cytarabine|cytarabine
1577959|NCT00472056|Cytosar|cytosar
1577960|NCT00472056|DepoCyt|depocyt
1577961|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1577962|NCT00472056|Ara-C|ara-c
1577963|NCT00472056|Melphalan|melphalan
1577964|NCT00472056|Rituximab|rituximab
1577965|NCT00472056|Rituxan|rituxan
1577966|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
1577967|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
1577968|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
1577969|NCT00472043|Metvix|metvix
1577970|NCT00472043|Histological verification|histological verification
1577971|NCT00472043|PDT with Metvix cream|pdt with metvix cream
1577972|NCT00472043|PDT with Placebo cream|pdt with placebo cream
1577973|NCT00472030|bullous pemphigoid|bullous pemphigoid
1577974|NCT00472030|omalizumab|omalizumab
1577975|NCT00472030|xolair|xolair
1577977|NCT00472030|autoimmunity|autoimmunity
1577978|NCT00472030|skin disease|skin disease
1577979|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1577980|NCT00471991|Oral contraceptive|oral contraceptive
1577981|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
1577982|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
1577983|NCT00471978|small cell lung cancer|small cell lung cancer
1577984|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1577985|NCT00471952|Migraine|migraine
1577986|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
1577987|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
1577988|NCT00471926|Diabetes Care|diabetes care
1577989|NCT00471913|Femur|femur
1577990|NCT00471913|Fracture|fracture
1577991|NCT00471913|Antegrade|antegrade
1577992|NCT00471913|Nailing|nailing
1577993|NCT00471913|Shaft|shaft
1577994|NCT00471913|Abductor|abductor
1577995|NCT00471887|stage III melanoma|stage iii melanoma
1577996|NCT00471887|stage IV melanoma|stage iv melanoma
1577997|NCT00471887|recurrent melanoma|recurrent melanoma
1577998|NCT00471861|Inflammatory Markers|inflammatory markers
1577999|NCT00471861|Migraine|migraine
1578000|NCT00471848|Thymoglobuline|thymoglobuline
1578001|NCT00471848|Rabbit ATG|rabbit atg
1578002|NCT00471848|Ciclosporin|ciclosporin
1578003|NCT00471848|Aplastic Anemia|aplastic anemia
1578004|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1578005|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1578006|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
1578007|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1578008|NCT00471835|large cell lung cancer|large cell lung cancer
1578009|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
1578010|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
1578011|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
1578012|NCT00471783|gingivitis|gingivitis
1578013|NCT00471783|chlorhexidine|chlorhexidine
1578014|NCT00471783|dental floss|dental floss
1578016|NCT00471783|bleeding on probing|bleeding on probing
1578017|NCT00471783|gingival and plaque indices|gingival and plaque indices
1578018|NCT00471757|pnuemonia|pnuemonia
1578019|NCT00471757|influenca|influenca
1578020|NCT00471744|benign epilepsy|benign epilepsy
1578023|NCT00471744|rolandic epilepsy|rolandic epilepsy
1578024|NCT00471744|levetiracetam|levetiracetam
1578025|NCT00471744|sulthiame|sulthiame
1578026|NCT00471731|Ocular Surface Disease|ocular surface disease
1578027|NCT00471731|Imprinting|imprinting
1578028|NCT00471731|Eye Abnormalities|eye abnormalities
1578029|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
1578030|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
1578031|NCT00471731|Turner Syndrome|turner syndrome
1578032|NCT00471731|TS|ts
1578033|NCT00471731|Premature Ovarian Failure|premature ovarian failure
1578034|NCT00471731|POF|pof
1578035|NCT00471731|Healthy Volunteer|healthy volunteer
1578036|NCT00471731|HV|hv
1578037|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1578038|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
1578039|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
1578040|NCT00471705|Miltefosine|miltefosine
1578041|NCT00471705|Leishmaniasis|leishmaniasis
1578042|NCT00471705|Glucantime|glucantime
1578043|NCT00471705|Thermotherapy|thermotherapy
1578044|NCT00471705|Colombia|colombia
1578045|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
1578046|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1578047|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
1578048|NCT00471679|regional neuroblastoma|regional neuroblastoma
1578049|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
1578051|NCT00471666|Filariasis|filariasis
1578052|NCT00471666|Coinfection|coinfection
1578053|NCT00471666|Co-Infection|co-infection
1578054|NCT00471653|thrombocytopenia|thrombocytopenia
1578055|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1578056|NCT00471653|adult brain stem glioma|adult brain stem glioma
1578057|NCT00471653|adult mixed glioma|adult mixed glioma
1578058|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
1578059|NCT00471653|adult gliosarcoma|adult gliosarcoma
1578060|NCT00471653|adult glioblastoma|adult glioblastoma
1578061|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1578062|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
1578063|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1578064|NCT00471640|pneumonia|pneumonia
1578065|NCT00471640|dexamethasone|dexamethasone
1578066|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
1578067|NCT00471614|HIV|hiv
1578068|NCT00471614|AIDS|aids
1578069|NCT00471614|uridine|uridine
1578070|NCT00471614|mitochondria|mitochondria
1578071|NCT00471614|insulin resistance|insulin resistance
1578072|NCT00471614|Treatment Experienced|treatment experienced
1578073|NCT00471601|recurrent breast cancer|recurrent breast cancer
1578074|NCT00471601|stage IA breast cancer|stage ia breast cancer
1578075|NCT00471601|stage IB breast cancer|stage ib breast cancer
1578076|NCT00471601|stage II breast cancer|stage ii breast cancer
1578077|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
1578078|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
1578079|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
1578080|NCT00471601|stage IV breast cancer|stage iv breast cancer
1578081|NCT00471588|Dopamine|dopamine
1578082|NCT00471588|OCD|ocd
1578083|NCT00471588|MRI|mri
1578084|NCT00471588|stimulant users|stimulant users
1578085|NCT00471575|fatty liver|fatty liver
1578086|NCT00471575|pregnancy|pregnancy
1578087|NCT00471575|ultra sound|ultra sound
1578088|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
1578089|NCT00471575|controls-women with normal liver|controls-women with normal liver
1578090|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
1578091|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578092|NCT00471549|Diabetes|diabetes
1578093|NCT00471549|Dyslipidaemia|dyslipidaemia
1578094|NCT00471549|Atherosclerosis|atherosclerosis
1578095|NCT00471549|Osteoprotegerin|osteoprotegerin
1578096|NCT00471549|Adhesion molecules|adhesion molecules
1578097|NCT00471549|Simvastatin|simvastatin
1578098|NCT00471523|Anovulation|anovulation
1578099|NCT00471523|Clomiphene citrate|clomiphene citrate
1578100|NCT00471523|Infertility|infertility
1578101|NCT00471523|Metformin|metformin
1578102|NCT00471523|PCOS|pcos
1578103|NCT00471523|Treatment|treatment
1578104|NCT00471510|androgenetic alopecia|androgenetic alopecia
1578105|NCT00471510|male pattern hair loss|male pattern hair loss
1578106|NCT00471510|male pattern baldness|male pattern baldness
1578107|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
1578108|NCT00471497|leukemia|leukemia
1578109|NCT00471497|bone marrow|bone marrow
1578110|NCT00471497|leukemia symptoms|leukemia symptoms
1578111|NCT00471497|lukemia|lukemia
1578112|NCT00471497|cml|cml
1578113|NCT00471497|complete blood count|complete blood count
1578114|NCT00471497|lymphocyte|lymphocyte
1578115|NCT00471497|blood cancer|blood cancer
1578116|NCT00471497|leukocytes|leukocytes
1578117|NCT00471497|chronic leukemia|chronic leukemia
1578118|NCT00471497|bone marrow biopsy|bone marrow biopsy
1578119|NCT00471497|leukemia research|leukemia research
1578120|NCT00471497|leukemia cells|leukemia cells
1578121|NCT00471497|bone marrow disease|bone marrow disease
1578122|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
1578123|NCT00471497|blood cancer symptoms|blood cancer symptoms
1578124|NCT00471497|white blood cell diseases|white blood cell diseases
1578125|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
1578126|NCT00471497|leukemia treatment|leukemia treatment
1578127|NCT00471497|leukemia facts|leukemia facts
1578128|NCT00471497|leucemia|leucemia
1578129|NCT00471497|facts about leukemia|facts about leukemia
1578130|NCT00471497|myelogenous leukemia|myelogenous leukemia
1578131|NCT00471497|newly diagnosed CML|newly diagnosed cml
1578221|NCT00471250|Healthy Volunteer|healthy volunteer
1578132|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
1578133|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1578134|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1578135|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
1578136|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1578137|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
1578138|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
1578139|NCT00471471|recurrent melanoma|recurrent melanoma
1578140|NCT00471471|stage IV melanoma|stage iv melanoma
1578141|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1578142|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
1578143|NCT00471471|iris melanoma|iris melanoma
1578144|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
1578145|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
1578146|NCT00471471|conjunctival melanoma|conjunctival melanoma
1578147|NCT00471471|stage IIIA melanoma|stage iiia melanoma
1578148|NCT00471471|stage IIIB melanoma|stage iiib melanoma
1578149|NCT00471471|stage IIIC melanoma|stage iiic melanoma
1578150|NCT00471458|Radioiodine|radioiodine
1578151|NCT00471458|Hyperthyroidism|hyperthyroidism
1578152|NCT00471458|Morbidity|morbidity
1578153|NCT00471458|Cardiovascular diseases|cardiovascular diseases
1578154|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578156|NCT00471445|neurotoxicity|neurotoxicity
1578157|NCT00471445|peripheral neuropathy|peripheral neuropathy
1578158|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
1578159|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
1578160|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
1578161|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
1578162|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1578163|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1578164|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
1578165|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
1578166|NCT00471432|recurrent breast cancer|recurrent breast cancer
1578167|NCT00471432|stage IV breast cancer|stage iv breast cancer
1578168|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1578169|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1578170|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578171|NCT00471432|male breast cancer|male breast cancer
1578172|NCT00471393|TMJ|tmj
1578173|NCT00471393|Osteoarthritis|osteoarthritis
1578174|NCT00471393|Degenerative Joint disease|degenerative joint disease
1578175|NCT00471367|Phase I|phase i
1578176|NCT00471367|AZD4877|azd4877
1578177|NCT00471367|Lymphoma|lymphoma
1578178|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
1578179|NCT00471341|arteriosclerosis|arteriosclerosis
1578180|NCT00471341|coronary disease|coronary disease
1578181|NCT00471341|inflammation|inflammation
1578182|NCT00471341|COX-2 inhibition|cox-2 inhibition
1578183|NCT00471341|hypertension|hypertension
1578184|NCT00471328|GIST|gist
1578185|NCT00471328|adults|adults
1578186|NCT00471328|imatinib resistant|imatinib resistant
1578187|NCT00471328|sunitinib resistant|sunitinib resistant
1578188|NCT00471328|AMN107|amn107
1578189|NCT00471328|nilotinib|nilotinib
1578190|NCT00471328|treatment|treatment
1578294|NCT00470821|actigraphy|actigraphy
1578191|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
1578192|NCT00471315|SOD|sod
1578193|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
1578194|NCT00471315|Sphincterotomy|sphincterotomy
1578195|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1578196|NCT00471302|Healthy Volunteers|healthy volunteers
1578197|NCT00471302|Immunological Parameters|immunological parameters
1578198|NCT00471302|Mali|mali
1578199|NCT00471302|B Lymphocyte|b lymphocyte
1578200|NCT00471302|Malaria|malaria
1578201|NCT00471302|Healthy Volunteer|healthy volunteer
1578202|NCT00471289|Critical Limb Ischemia|critical limb ischemia
1578203|NCT00471289|Stents|stents
1578204|NCT00471289|Drug Eluting Stents|drug eluting stents
1578205|NCT00471289|Peripheral arterial disease|peripheral arterial disease
1578206|NCT00471289|PAD|pad
1578209|NCT00471289|Infrapopliteal|infrapopliteal
1578210|NCT00471289|Infragenicular|infragenicular
1578211|NCT00471289|Interventional Radiology|interventional radiology
1578212|NCT00471289|CLI|cli
1578213|NCT00471289|DES|des
1578214|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
1578215|NCT00471250|Bronchoscopy|bronchoscopy
1578216|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
1578217|NCT00471250|Nasal Mucosal Biopsy|nasal mucosal biopsy
1578218|NCT00471250|Research Procedures|research procedures
1578219|NCT00471250|Infection Susceptibility|infection susceptibility
1578220|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
1578223|NCT00471237|bone mineral density,|bone mineral density,
1578224|NCT00471237|Ronacaleret|ronacaleret
1578225|NCT00471237|teriparatide|teriparatide
1578226|NCT00471237|alendronate,|alendronate,
1578227|NCT00471237|Post-menopausal women,|post-menopausal women,
1578228|NCT00471237|osteoporosis,|osteoporosis,
1578229|NCT00471237|SB-751689|sb-751689
1578230|NCT00471185|Male Contraception|male contraception
1578231|NCT00471185|Acyline|acyline
1578232|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
1578233|NCT00471133|melanoma|melanoma
1578234|NCT00471133|DNA vaccine|dna vaccine
1578235|NCT00471133|tyrosinase|tyrosinase
1578236|NCT00471133|electroporation|electroporation
1578237|NCT00471107|Frontal Lobe|frontal lobe
1578238|NCT00471107|Language|language
1578239|NCT00471107|Dementia|dementia
1578240|NCT00471107|Healthy Volunteer|healthy volunteer
1578242|NCT00471094|heartburn|heartburn
1578243|NCT00471094|erosive esophagitis|erosive esophagitis
1578244|NCT00471094|healing|healing
1578245|NCT00471094|population pharmacokinetics|population pharmacokinetics
1578246|NCT00471094|Quality of Life (QoL)|quality of life (qol)
1578247|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
1578248|NCT00471081|Humans;|humans;
1578249|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
1578250|NCT00471081|Safety|safety
1578251|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
1578252|NCT00471081|Toddlers;|toddlers;
1578253|NCT00471081|Immunogenicity;|immunogenicity;
1578254|NCT00471055|osteoarthritis|osteoarthritis
1578255|NCT00471055|knee|knee
1578256|NCT00471055|capsaicin gel|capsaicin gel
1578257|NCT00471055|capsicum|capsicum
1578258|NCT00471042|Heroin Dependence|heroin dependence
1578259|NCT00471042|Opioid Dependence|opioid dependence
1578260|NCT00471042|Primary Care|primary care
1578261|NCT00471042|Buprenorphine|buprenorphine
1578262|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
1578263|NCT00471003|Hypertension|hypertension
1578264|NCT00470990|IHH|ihh
1578265|NCT00470990|Kallmann syndrome|kallmann syndrome
1578266|NCT00470990|hypogonadism|hypogonadism
1578267|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
1578268|NCT00470964|IOP lowering effect|iop lowering effect
1578269|NCT00470964|Adverse effects|adverse effects
1578270|NCT00470964|IOP spikes|iop spikes
1578271|NCT00470951|rectal cancer|rectal cancer
1578272|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
1578273|NCT00470951|open resection|open resection
1578274|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
1578275|NCT00470951|randomized trial|randomized trial
1578276|NCT00470925|Neurological|neurological
1578277|NCT00470925|Dopamine|dopamine
1578278|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
1578279|NCT00470912|photoprotection|photoprotection
1578280|NCT00470912|photoprovocation|photoprovocation
1578281|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
1578282|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
1578283|NCT00470899|Kleihauer-Betke|kleihauer-betke
1578284|NCT00470847|Herceptin|herceptin
1578285|NCT00470847|breast cancer|breast cancer
1578286|NCT00470847|radiation therapy|radiation therapy
1578287|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
1578288|NCT00470847|SRS|srs
1578289|NCT00470847|whole brain radiation|whole brain radiation
1578290|NCT00470847|WBRT|wbrt
1578291|NCT00470834|prostate cancer|prostate cancer
1578292|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
1578293|NCT00470821|melatonin|melatonin
1578295|NCT00470821|sedation|sedation
1578296|NCT00470821|critical patients|critical patients
1578297|NCT00470821|ICU|icu
1578298|NCT00470808|Minors|minors
1578299|NCT00470808|Enrollment in another study|enrollment in another study
1578300|NCT00470808|Males|males
1578301|NCT00470808|HBA1C greater than 7|hba1c greater than 7
1578302|NCT00470808|Drug therapy for DM|drug therapy for dm
1578303|NCT00470795|diabetes|diabetes
1578304|NCT00470795|gastroparesis|gastroparesis
1578305|NCT00470795|acupuncture|acupuncture
1578306|NCT00470795|symptoms|symptoms
1578307|NCT00470795|gastric emptying|gastric emptying
1578308|NCT00470782|colonic neoplasms|colonic neoplasms
1578309|NCT00470782|exercise|exercise
1578310|NCT00470782|body composition|body composition
1578311|NCT00470782|anthropometry|anthropometry
1578312|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
1578313|NCT00470769|Renal scintigraphy|renal scintigraphy
1578314|NCT00470769|Kidney failure|kidney failure
1578315|NCT00470769|GFR|gfr
1578316|NCT00470743|Ibuprofen|ibuprofen
1578317|NCT00470743|Indomethacin|indomethacin
1578318|NCT00470743|Infant, very low birth weight|infant, very low birth weight
1578319|NCT00470743|Prematurity|prematurity
1578320|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
1578321|NCT00470717|late preterm infant|late preterm infant
1578322|NCT00470717|breastfeeding|breastfeeding
1578323|NCT00470717|formula feeding|formula feeding
1578324|NCT00470717|rehospitalization|rehospitalization
1578325|NCT00470717|telephone|telephone
1578326|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
1578327|NCT00470704|Herceptin|herceptin
1578328|NCT00470704|trastuzumab|trastuzumab
1578329|NCT00470678|Age-related|age-related
1578330|NCT00470678|macular|macular
1578331|NCT00470678|degeneration|degeneration
1578332|NCT00470678|AMD|amd
1578333|NCT00470678|Ranibizumab|ranibizumab
1578334|NCT00470678|Anti-VEGF|anti-vegf
1578335|NCT00470678|choroidal|choroidal
1578336|NCT00470678|neovascularization|neovascularization
1578337|NCT00470678|CNV|cnv
1578338|NCT00470678|Asian patients|asian patients
1578339|NCT00470678|Korea|korea
1578340|NCT00470678|Taiwan|taiwan
1578341|NCT00470678|associated|associated
1578342|NCT00470652|pain|pain
1578343|NCT00470652|Pain Measurement|pain measurement
1578344|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
1578345|NCT00470652|Informatics|informatics
1578346|NCT00470639|TMS|tms
1578347|NCT00470639|Treatment|treatment
1578348|NCT00470639|Bipolar|bipolar
1578349|NCT00470639|Efficacy|efficacy
1578350|NCT00470626|Pulmonary Embolism|pulmonary embolism
1578351|NCT00470626|Venous Thromboembolism|venous thromboembolism
1578352|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
1578353|NCT00470626|IVC|ivc
1578354|NCT00470626|PE|pe
1578355|NCT00470613|Neoplasm|neoplasm
1578356|NCT00470587|chest pain|chest pain
1578357|NCT00470587|myocardial infarction|myocardial infarction
1578358|NCT00470587|unstable angina|unstable angina
1578359|NCT00470574|recurrent breast cancer|recurrent breast cancer
1578360|NCT00470574|stage IV breast cancer|stage iv breast cancer
1578361|NCT00470574|male breast cancer|male breast cancer
1578362|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
1578363|NCT00470548|male breast cancer|male breast cancer
1578364|NCT00470548|recurrent breast cancer|recurrent breast cancer
1578365|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
1578366|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
1578367|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
1578368|NCT00470548|stage IV breast cancer|stage iv breast cancer
1578369|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1578370|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1578371|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1578372|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1578373|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578374|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1578375|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
1578376|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
1578377|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
1578378|NCT00470522|methotrexate|methotrexate
1578379|NCT00470522|folic acid|folic acid
1578380|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
1578381|NCT00470522|steroid|steroid
1578383|NCT00470483|Social Anxiety Disorder|social anxiety disorder
1578384|NCT00470483|fRMI|frmi
1578385|NCT00470444|Cardiac Surgery|cardiac surgery
1578386|NCT00470444|Transfusion Medicine|transfusion medicine
1578387|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
1578388|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
1578389|NCT00470418|Alzheimer Disease|alzheimer disease
1578390|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
1578391|NCT00470418|Alzheimer's Disease|alzheimer's disease
1578392|NCT00470418|clinical trial|clinical trial
1578393|NCT00470418|dementia|dementia
1578394|NCT00470418|diabetes|diabetes
1578395|NCT00470418|dietary supplements|dietary supplements
1578396|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
1578397|NCT00470418|Therapeutics|therapeutics
1578398|NCT00470405|adult solid tumor|adult solid tumor
1578399|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578400|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1578401|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1578402|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1578403|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1578404|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1578405|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1578406|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1578407|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1578408|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1578409|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1578410|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1578411|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1578412|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1578840|NCT00469209|Bortezomib|bortezomib
1578413|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1578414|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1578415|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1578416|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1578417|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1578418|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1578419|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1578420|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1578421|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1578422|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1578423|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1578424|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1578425|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1578426|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1578427|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1578428|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1578429|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1578430|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1578431|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1578432|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1578433|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1578434|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1578435|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1578436|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1578437|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1578438|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1578439|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1578440|NCT00470392|Erythema|erythema
1578441|NCT00470392|optimization|optimization
1578442|NCT00470392|Papule|papule
1578443|NCT00470392|Plaque|plaque
1578444|NCT00470392|pretreatment|pretreatment
1578445|NCT00470392|T cells|t cells
1578446|NCT00470392|UVB laser light|uvb laser light
1578447|NCT00470392|psoriasis|psoriasis
1578448|NCT00470392|topical administration|topical administration
1578449|NCT00470379|stage II melanoma|stage ii melanoma
1578450|NCT00470379|stage III melanoma|stage iii melanoma
1578451|NCT00470379|stage IV melanoma|stage iv melanoma
1578452|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1578453|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1578454|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1578455|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1578456|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1578457|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1578458|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
1578459|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1578460|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1578461|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1578462|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1578463|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1578464|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
1578465|NCT00470366|testicular seminoma|testicular seminoma
1578466|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1578467|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1578468|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
1578469|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1578470|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1578471|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
1578472|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
1578473|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1578474|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
1578475|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
1578476|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
1578477|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1578478|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
1578479|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1578480|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1578481|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1578482|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
1578483|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
1578484|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1578485|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1578486|NCT00470366|adult teratoma|adult teratoma
1578487|NCT00470366|testicular immature teratoma|testicular immature teratoma
1578488|NCT00470366|testicular mature teratoma|testicular mature teratoma
1578489|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
1578490|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
1578491|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
1578492|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
1578493|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
1578494|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
1578495|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1578496|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1578497|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1578498|NCT00470353|recurrent colon cancer|recurrent colon cancer
1578499|NCT00470353|stage I colon cancer|stage i colon cancer
1578500|NCT00470353|stage II colon cancer|stage ii colon cancer
1578501|NCT00470353|stage III colon cancer|stage iii colon cancer
1578502|NCT00470340|Recurrence|recurrence
1578503|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
1578504|NCT00470340|Liver|liver
1578505|NCT00470340|Liver Neoplasms|liver neoplasms
1578506|NCT00470340|Liver Cirrhosis|liver cirrhosis
1578507|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1578508|NCT00470340|Iodized Oil|iodized oil
1578509|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
1578510|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
1578511|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
1578512|NCT00470340|Randomized Controlled Trials|randomized controlled trials
1578513|NCT00470340|Multicenter Studies|multicenter studies
1578514|NCT00470340|Cisplatin|cisplatin
1578515|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
1578516|NCT00470340|Injections, Intravenous|injections, intravenous
1578517|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
1578518|NCT00470327|Interstitial lung diseases|interstitial lung diseases
1578519|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1578520|NCT00470327|Sarcoidosis|sarcoidosis
1578521|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
1578522|NCT00470314|Acute liver failure|acute liver failure
1578523|NCT00470314|Ornithine Aspartate|ornithine aspartate
1578524|NCT00470314|Ammonia|ammonia
1578525|NCT00470314|Encephalopathy|encephalopathy
1578526|NCT00470288|cesarean delivery|cesarean delivery
1578527|NCT00470288|bladder flaps|bladder flaps
1578528|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1578529|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
1578530|NCT00470262|fenofibrate|fenofibrate
1578531|NCT00470262|Inflammation|inflammation
1578532|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
1578533|NCT00470262|pioglitazone|pioglitazone
1578534|NCT00470262|Prediabetic State|prediabetic state
1578535|NCT00470262|insulin resistance|insulin resistance
1578536|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
1578537|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
1578538|NCT00470249|stage IV breast cancer|stage iv breast cancer
1578539|NCT00470249|recurrent breast cancer|recurrent breast cancer
1578540|NCT00470249|male breast cancer|male breast cancer
1578541|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
1578542|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
1578543|NCT00470236|Breast conserving therapy|breast conserving therapy
1578544|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
1578545|NCT00470236|Tumour bed boost|tumour bed boost
1578546|NCT00470236|Fractionation schedules|fractionation schedules
1578547|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
1578548|NCT00470223|localized osteosarcoma|localized osteosarcoma
1578549|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
1578550|NCT00470210|Ribavirin|ribavirin
1578551|NCT00470210|non-responders|non-responders
1578552|NCT00470210|HCV co-infected patients|hcv co-infected patients
1578553|NCT00470210|sustained virological response|sustained virological response
1578554|NCT00470210|Treatment Experienced|treatment experienced
1578731|NCT00469612|NeuroVision|neurovision
1578555|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1578556|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1578557|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
1578558|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
1578559|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
1578560|NCT00470158|zinc|zinc
1578561|NCT00470158|iron|iron
1578562|NCT00470158|interaction|interaction
1578563|NCT00470158|diarrhea|diarrhea
1578564|NCT00470158|delivery|delivery
1578565|NCT00470145|unmilled formulation,|unmilled formulation,
1578566|NCT00470145|micronised formulation|micronised formulation
1578567|NCT00470145|relative bioavailability,|relative bioavailability,
1578568|NCT00470132|ventricular shunt|ventricular shunt
1578569|NCT00470119|breast cancer|breast cancer
1578570|NCT00470119|obesity|obesity
1578571|NCT00470119|weight changes|weight changes
1578572|NCT00470106|Cognition|cognition
1578573|NCT00470106|Remediation|remediation
1578574|NCT00470106|Schizophrenia|schizophrenia
1578575|NCT00470106|Social Cognition|social cognition
1578576|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
1578689|NCT00469742|Cardiac Defects|cardiac defects
1578577|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
1578578|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
1578579|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
1578580|NCT00470080|Venepuncture|venepuncture
1578581|NCT00470080|Pain|pain
1578582|NCT00470080|Emla cream|emla cream
1578583|NCT00470080|Oral sucrose solution|oral sucrose solution
1578584|NCT00470080|Premature infant|premature infant
1578585|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
1578586|NCT00470080|included in the study.|included in the study.
1578587|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
1578588|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1578589|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
1578590|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1578591|NCT00470041|Healthy volunteers|healthy volunteers
1578592|NCT00470028|TMS|tms
1578593|NCT00470028|Treatment|treatment
1578594|NCT00470028|Adolescents|adolescents
1578595|NCT00470028|Safety|safety
1578596|NCT00470028|Efficacy|efficacy
1578597|NCT00470015|stage II melanoma|stage ii melanoma
1578598|NCT00470015|stage III melanoma|stage iii melanoma
1578599|NCT00470015|stage IV melanoma|stage iv melanoma
1578600|NCT00470015|recurrent melanoma|recurrent melanoma
1578601|NCT00470002|growth hormone|growth hormone
1578602|NCT00470002|nitric oxide|nitric oxide
1578603|NCT00470002|nitrate|nitrate
1578604|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
1578605|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
1578606|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
1578607|NCT00470002|blood pressure|blood pressure
1578608|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
1578609|NCT00469989|immune system|immune system
1578610|NCT00469989|allergy|allergy
1578611|NCT00469989|hookworm infection|hookworm infection
1578612|NCT00469989|parasite infection|parasite infection
1578613|NCT00469989|asthma|asthma
1578614|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1578615|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1578616|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1578617|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1578618|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1578619|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1578620|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
1578621|NCT00469950|PCI|pci
1578622|NCT00469950|stent|stent
1578623|NCT00469950|training|training
1578624|NCT00469950|endothelial function|endothelial function
1578625|NCT00469950|restenosis|restenosis
1578626|NCT00469950|late luminal loss|late luminal loss
1578627|NCT00469950|heart rate variability|heart rate variability
1578628|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
1578629|NCT00469950|inflammatory markers|inflammatory markers
1578630|NCT00469937|radiation toxicity|radiation toxicity
1578631|NCT00469937|neurotoxicity|neurotoxicity
1578632|NCT00469937|cognitive/functional effects|cognitive/functional effects
1578633|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1578634|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
1578635|NCT00469924|Informatics|informatics
1578636|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
1578637|NCT00469924|Hospital Communication Systems|hospital communication systems
1578638|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
1578639|NCT00469924|Point-of-Care Systems|point-of-care systems
1578640|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
1578641|NCT00469911|Heart|heart
1578642|NCT00469911|Transplant|transplant
1578643|NCT00469911|MRS|mrs
1578644|NCT00469911|MRI|mri
1578645|NCT00469911|Spectroscopy|spectroscopy
1578646|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1578647|NCT00469885|Smoking cessation|smoking cessation
1578648|NCT00469885|cardiovascular disease|cardiovascular disease
1578649|NCT00469885|smoking reduction|smoking reduction
1578650|NCT00469885|nicotine replacement|nicotine replacement
1578651|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1578652|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1578653|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1578841|NCT00469196|mesothelioma|mesothelioma
1578842|NCT00469196|tomotherapy|tomotherapy
1578654|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1578655|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1578656|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1578657|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1578658|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1578659|NCT00469846|Pre-Eclampsia|pre-eclampsia
1578660|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
1578661|NCT00469846|Preterm labor|preterm labor
1578662|NCT00469833|Diabetes|diabetes
1578663|NCT00469833|Glucose Tolerance|glucose tolerance
1578664|NCT00469833|Incretin|incretin
1578665|NCT00469833|Insulin|insulin
1578666|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1578667|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1578668|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1578669|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1578670|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1578671|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1578672|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1578673|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1578674|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
1578675|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1578676|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1578677|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
1578678|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
1578679|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
1578680|NCT00469807|Ghrelin|ghrelin
1578681|NCT00469807|Pregnancy outcome|pregnancy outcome
1578682|NCT00469794|arrhythmias|arrhythmias
1578683|NCT00469794|Athletes|athletes
1578684|NCT00469794|exercise|exercise
1578685|NCT00469768|HIV-1 infection|hiv-1 infection
1578686|NCT00469768|HIV Seronegativity|hiv seronegativity
1578687|NCT00469742|Cardiology|cardiology
1578688|NCT00469742|Pediatrics|pediatrics
1578690|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
1578691|NCT00469742|Aprotinin|aprotinin
1578692|NCT00469742|thrombosis|thrombosis
1578693|NCT00469742|renal dysfunction|renal dysfunction
1578694|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
1578695|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
1578696|NCT00469729|Hematological Malignancies|hematological malignancies
1578697|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
1578698|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
1578699|NCT00469716|Fluid balance|fluid balance
1578700|NCT00469716|respiratory function|respiratory function
1578701|NCT00469716|cardiac function|cardiac function
1578702|NCT00469716|inflammation|inflammation
1578703|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
1578704|NCT00469703|Pancreatitis|pancreatitis
1578705|NCT00469664|Schizophrenia|schizophrenia
1578706|NCT00469664|Schizoaffective|schizoaffective
1578707|NCT00469664|Cognitive Impairment|cognitive impairment
1578708|NCT00469664|Cognition|cognition
1578709|NCT00469664|Memory|memory
1578710|NCT00469664|Attention|attention
1578711|NCT00469664|Concentration|concentration
1578712|NCT00469651|Malaria|malaria
1578713|NCT00469651|vaccine|vaccine
1578714|NCT00469651|MSP3LSP|msp3lsp
1578715|NCT00469651|Safety|safety
1578716|NCT00469651|children|children
1578717|NCT00469651|Tanzania|tanzania
1578718|NCT00469638|atrial fibrillation|atrial fibrillation
1578719|NCT00469638|paroxysmal|paroxysmal
1578720|NCT00469638|persistent|persistent
1578721|NCT00469638|symptomatic|symptomatic
1578722|NCT00469638|ablation|ablation
1578723|NCT00469638|catheter|catheter
1578724|NCT00469638|introducer|introducer
1578725|NCT00469638|Agilis NxT|agilis nxt
1578726|NCT00469638|sinus rhythm|sinus rhythm
1578727|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1578728|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
1578729|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
1578730|NCT00469612|Myopia|myopia
1578732|NCT00469612|Visual acuity|visual acuity
1578733|NCT00469612|Contrast sensitivity|contrast sensitivity
1578734|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
1578735|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
1578736|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
1578737|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
1578738|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
1578739|NCT00469599|Hemodialysis|hemodialysis
1578740|NCT00469560|MDS|mds
1578741|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
1578742|NCT00469560|Deferasirox|deferasirox
1578743|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
1578744|NCT00469547|HIV Seronegativity|hiv seronegativity
1578745|NCT00469534|minimized time to beam|minimized time to beam
1578746|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
1578747|NCT00469534|PET-scan|pet-scan
1578748|NCT00469508|Methamphetamine|methamphetamine
1578749|NCT00469508|Modafinil|modafinil
1578750|NCT00469508|Medication|medication
1578751|NCT00469508|Contingency Management|contingency management
1578752|NCT00469508|Crystal meth|crystal meth
1578753|NCT00469508|Los Angeles|los angeles
1578754|NCT00469508|Addiction|addiction
1578755|NCT00469508|Meth|meth
1578756|NCT00469482|Delirium|delirium
1578757|NCT00469482|Cognitive Impairment|cognitive impairment
1578758|NCT00469482|Sleep|sleep
1578759|NCT00469482|Polysomnography|polysomnography
1578760|NCT00469482|Sedation|sedation
1578761|NCT00469482|Mechanical Ventilation|mechanical ventilation
1578762|NCT00469482|Critical Illness|critical illness
1578763|NCT00469469|Adrenal Cortex|adrenal cortex
1578764|NCT00469469|ACC|acc
1578765|NCT00469456|memantine|memantine
1578766|NCT00469456|Alzheimer's Disease|alzheimer's disease
1578767|NCT00469456|communication|communication
1578768|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
1578769|NCT00469443|Irinotecan|irinotecan
1578770|NCT00469443|Capecitabine|capecitabine
1578771|NCT00469443|Bevacizumab|bevacizumab
1578772|NCT00469430|appendicitis|appendicitis
1578773|NCT00469430|treatment|treatment
1578774|NCT00469430|antibiotics|antibiotics
1578775|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
1578776|NCT00469417|Photodynamic therapy|photodynamic therapy
1578777|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
1578778|NCT00469404|Transdermal patch|transdermal patch
1578779|NCT00469404|Centrally acting analgesic|centrally acting analgesic
1578780|NCT00469404|Plasma level|plasma level
1578781|NCT00469404|Healthy volunteers|healthy volunteers
1578782|NCT00469391|Weight Reduction|weight reduction
1578783|NCT00469378|firategrast|firategrast
1578784|NCT00469378|lymphocytes|lymphocytes
1578785|NCT00469378|leukocytes|leukocytes
1578786|NCT00469378|SB-683699|sb-683699
1578787|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
1578788|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
1578789|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
1578790|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
1578791|NCT00469352|Pharmacogenetics|pharmacogenetics
1578792|NCT00469352|Genetics|genetics
1578793|NCT00469352|Treatment response|treatment response
1578794|NCT00469352|AMD|amd
1578795|NCT00469352|Wet AMD|wet amd
1578796|NCT00469352|Age-related macular degeneration|age-related macular degeneration
1578797|NCT00469339|Diabetes|diabetes
1578798|NCT00469339|Colon Cancer|colon cancer
1578799|NCT00469339|Cardiovascular Disease|cardiovascular disease
1578800|NCT00469326|coronary artery disease|coronary artery disease
1578801|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
1578802|NCT00469326|atorvastatin|atorvastatin
1578803|NCT00469313|copd|copd
1578804|NCT00469313|inspiratory muscle training|inspiratory muscle training
1578805|NCT00469313|IF|if
1578806|NCT00469300|herpes labialis|herpes labialis
1578807|NCT00469300|cold sore|cold sore
1578808|NCT00469300|acyclovir|acyclovir
1578809|NCT00469300|iontophoresis|iontophoresis
1578810|NCT00469300|topical|topical
1578811|NCT00469287|diabetes mellitus|diabetes mellitus
1578812|NCT00469287|blood sugar|blood sugar
1578813|NCT00469287|overweight|overweight
1578814|NCT00469287|obesity|obesity
1578815|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
1578816|NCT00469274|Pertussis|pertussis
1578817|NCT00469274|Healthcare worker|healthcare worker
1578818|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
1578819|NCT00469274|Vaccination|vaccination
1578820|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
1578821|NCT00469274|exposure to pertussis|exposure to pertussis
1578822|NCT00469261|Myocardial infarction|myocardial infarction
1578823|NCT00469261|Ventricular remodeling|ventricular remodeling
1578824|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
1578825|NCT00469261|Doxycycline|doxycycline
1578826|NCT00469248|Myocardial infarction|myocardial infarction
1578827|NCT00469248|Cardiogenic shock|cardiogenic shock
1578828|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
1578829|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
1578830|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
1578831|NCT00469222|small cell lung cancer|small cell lung cancer
1578832|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
1578833|NCT00469209|Multiple Myeloma|multiple myeloma
1578834|NCT00469209|Melphalan|melphalan
1578835|NCT00469209|Trisenox|trisenox
1578836|NCT00469209|Arsenic Trioxide|arsenic trioxide
1578837|NCT00469209|Ascorbic Acid|ascorbic acid
1578838|NCT00469209|Vitamin C|vitamin c
1578839|NCT00469209|Velcade|velcade
1578843|NCT00469170|HIV-1|hiv-1
1578844|NCT00469170|HIV seronegativity|hiv seronegativity
1578845|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
1578846|NCT00469144|Stem Cell Transplantation|stem cell transplantation
1578847|NCT00469144|Leukemia|leukemia
1578848|NCT00469144|Busulfan|busulfan
1578849|NCT00469144|Fludarabine|fludarabine
1578850|NCT00469144|MDS|mds
1578851|NCT00469144|AML|aml
1578852|NCT00469131|liver transplantation,|liver transplantation,
1578853|NCT00469131|HCV recurrence,|hcv recurrence,
1578854|NCT00469131|immunosuppression|immunosuppression
1578855|NCT00469105|Type 2 Diabetes|type 2 diabetes
1578856|NCT00469105|Diabetes Education|diabetes education
1578857|NCT00469105|Health Literacy|health literacy
1578858|NCT00469079|Biomarkers|biomarkers
1578859|NCT00469079|Smoking|smoking
1578860|NCT00469079|Tobacco|tobacco
1578861|NCT00469079|Cessation|cessation
1578862|NCT00469066|small cell lung cancer|small cell lung cancer
1578863|NCT00469066|bladder cancer|bladder cancer
1578864|NCT00469066|conformal radiotherapy|conformal radiotherapy
1578865|NCT00469053|Transdermal patch|transdermal patch
1578866|NCT00469053|multidose|multidose
1578867|NCT00469053|Centrally acting analgesic|centrally acting analgesic
1578868|NCT00469053|Plasma level|plasma level
1578869|NCT00469053|Healthy volunteers|healthy volunteers
1578870|NCT00469040|GW642444,|gw642444,
1578871|NCT00469040|healthy subjects|healthy subjects
1578872|NCT00469040|magnesium stearate,|magnesium stearate,
1578873|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1578874|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
1578875|NCT00469014|AML|aml
1578876|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
1578877|NCT00469014|MDS|mds
1578878|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
1578879|NCT00469014|CML|cml
1578880|NCT00469014|Busulfan|busulfan
1578881|NCT00469014|Busulfex|busulfex
1578882|NCT00469014|Myleran|myleran
1578883|NCT00469014|Fludarabine|fludarabine
1578884|NCT00469014|Fludara|fludara
1578885|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
1578886|NCT00469014|Clofarabine|clofarabine
1578887|NCT00469014|Clofarex|clofarex
1578888|NCT00469014|Clolar|clolar
1578889|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1578890|NCT00469014|ASCT|asct
1578891|NCT00469014|Stem Cell|stem cell
1578892|NCT00469014|Gleevec|gleevec
1578893|NCT00469014|Imatinib Mesylate|imatinib mesylate
1578894|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
1578895|NCT00468949|Health-Related Quality of Life|health-related quality of life
1578896|NCT00468949|Dupuytren's Disease|dupuytren's disease
1578897|NCT00468949|Health Utilities Index|health utilities index
1578898|NCT00468949|Short Form-36;|short form-36;
1578899|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
1578900|NCT00468936|anti-rejection|anti-rejection
1578901|NCT00468936|GI side effects|gi side effects
1578902|NCT00468936|heart transplant patients|heart transplant patients
1578903|NCT00468923|Primary prevention|primary prevention
1578904|NCT00468923|Cholesterol lowering|cholesterol lowering
1578905|NCT00468923|Blood pressure lowering|blood pressure lowering
1578906|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
1578907|NCT00468897|Alzheimers Disease|alzheimers disease
1578908|NCT00468897|healthy volunteers|healthy volunteers
1578909|NCT00468897|bioequivalence|bioequivalence
1578910|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
1578911|NCT00468858|Dengue|dengue
1578912|NCT00468858|Virus|virus
1578913|NCT00468858|Live-attenuated|live-attenuated
1578914|NCT00468858|Vaccine|vaccine
1578915|NCT00468858|Dengue viral infection|dengue viral infection
1578916|NCT00468858|Dengue Vaccine|dengue vaccine
1578917|NCT00468845|pain after hysterectomy|pain after hysterectomy
1578918|NCT00468845|amount of opioids used|amount of opioids used
1578919|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
1578920|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
1578921|NCT00468806|PET scan|pet scan
1578922|NCT00468806|Health Males|health males
1578923|NCT00468793|central venous saturation|central venous saturation
1578924|NCT00468793|bowel surgery|bowel surgery
1578925|NCT00468793|morbidity|morbidity
1578926|NCT00468793|intravenous infusions|intravenous infusions
1578927|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
1578928|NCT00468780|paramedics|paramedics
1578929|NCT00468780|triage nurse|triage nurse
1578930|NCT00468780|triage levels|triage levels
1578931|NCT00468780|inter-rater reliability|inter-rater reliability
1578932|NCT00468780|health services outcomes|health services outcomes
1578933|NCT00468767|Atrial fibrillation|atrial fibrillation
1578934|NCT00468767|RSD1235|rsd1235
1578935|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
1578936|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
1578937|NCT00468741|Breast Cancer|breast cancer
1578938|NCT00468741|Internet|internet
1578939|NCT00468741|Computer|computer
1578940|NCT00468741|Support|support
1578941|NCT00468741|Information|information
1578942|NCT00468741|Education|education
1578943|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
1578944|NCT00468741|CHESS Information Services only|chess information services only
1578945|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
1578946|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
1578947|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
1578948|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
1578949|NCT00468715|stage IV breast cancer|stage iv breast cancer
1578950|NCT00468715|recurrent breast cancer|recurrent breast cancer
1578951|NCT00468715|male breast cancer|male breast cancer
1578952|NCT00468689|SB-751689,|sb-751689,
1578953|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
1578954|NCT00468689|Osteoporosis,|osteoporosis,
1578955|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
1578956|NCT00468689|Oral dose|oral dose
1578957|NCT00468676|major Depressive Disorder|major depressive disorder
1578958|NCT00468676|Diabetes|diabetes
1578959|NCT00468676|Heart Disease|heart disease
1578960|NCT00468663|preeclampsia|preeclampsia
1578961|NCT00468663|preterm delivery|preterm delivery
1578962|NCT00468663|lipid peroxidation|lipid peroxidation
1578963|NCT00468663|inflammation|inflammation
1578964|NCT00468637|heart failure|heart failure
1578965|NCT00468637|cardiovascular high risk|cardiovascular high risk
1578966|NCT00468637|erectile dysfunction|erectile dysfunction
1578967|NCT00468637|cardiovascular disease|cardiovascular disease
1578968|NCT00468624|Growth hormone|growth hormone
1578969|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
1578970|NCT00468624|pegvisomant|pegvisomant
1578971|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1578972|NCT00468611|Multiple Sclerosis|multiple sclerosis
1578973|NCT00468598|troponin|troponin
1578974|NCT00468598|long-term outcome|long-term outcome
1578975|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
1578976|NCT00468585|Breast cancer|breast cancer
1578977|NCT00468585|Metastatic breast cancer|metastatic breast cancer
1578978|NCT00468585|Breast|breast
1578979|NCT00468585|Metastatic|metastatic
1578980|NCT00468572|Emotion|emotion
1578981|NCT00468572|Oxytocin|oxytocin
1578982|NCT00468572|Cortisol|cortisol
1578983|NCT00468559|pediatrics|pediatrics
1578984|NCT00468559|neonates|neonates
1578985|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
1578986|NCT00468520|induction of labor|induction of labor
1578987|NCT00468520|cervical ripening|cervical ripening
1578988|NCT00468520|Foley catheter|foley catheter
1578989|NCT00468520|oxytocin|oxytocin
1578990|NCT00468507|CCK release|cck release
1578991|NCT00468494|non diabetic|non diabetic
1578992|NCT00468494|catabolic energy state|catabolic energy state
1578993|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
1578994|NCT00468481|Folic Acid|folic acid
1578995|NCT00468468|breast cancer|breast cancer
1578996|NCT00468468|Internet|internet
1578997|NCT00468468|computer|computer
1578998|NCT00468468|support|support
1578999|NCT00468468|information|information
1579000|NCT00468468|education|education
1579001|NCT00468455|Colorectal Surgery|colorectal surgery
1579002|NCT00468455|Abdominal Surgery|abdominal surgery
1579003|NCT00468455|Diverticulitis|diverticulitis
1579004|NCT00468455|Colon Cancer|colon cancer
1579005|NCT00468455|Rectal Cancer|rectal cancer
1579006|NCT00468455|Colon Polyp|colon polyp
1579007|NCT00468455|Rectal Polyp|rectal polyp
1579008|NCT00468455|Crohn's Disease|crohn's disease
1579116|NCT00468039|metformin|metformin
1579009|NCT00468442|Insulin dependence|insulin dependence
1579010|NCT00468442|Hypoglycemia|hypoglycemia
1579011|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
1579012|NCT00468429|Glaucoma|glaucoma
1579013|NCT00468429|Bevacizumab|bevacizumab
1579014|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
1579015|NCT00468429|Mitomycin C|mitomycin c
1579016|NCT00468429|Intraocular Pressure|intraocular pressure
1579017|NCT00468403|Insulin dependence|insulin dependence
1579018|NCT00468403|Hypoglycemia|hypoglycemia
1579019|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
1579020|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
1579021|NCT00468351|bevacizumab|bevacizumab
1579022|NCT00468351|diabetes|diabetes
1579023|NCT00468351|intravitreal|intravitreal
1579024|NCT00468351|macular edema|macular edema
1579025|NCT00468351|triamcinolone|triamcinolone
1579027|NCT00468338|general anesthesia|general anesthesia
1579028|NCT00468338|dental rehabilitation|dental rehabilitation
1579029|NCT00468338|mental retardation|mental retardation
1579030|NCT00468325|coronary artery disease|coronary artery disease
1579031|NCT00468325|chest pain|chest pain
1579032|NCT00468325|emergency room|emergency room
1579033|NCT00468299|early|early
1579034|NCT00468299|pregnancy|pregnancy
1579035|NCT00468299|failure|failure
1579036|NCT00468299|mifepristone|mifepristone
1579037|NCT00468299|misoprostol|misoprostol
1579038|NCT00468299|buccal|buccal
1579039|NCT00468299|miscarriage|miscarriage
1579040|NCT00468299|fetal|fetal
1579041|NCT00468299|demise|demise
1579042|NCT00468299|anembryonic|anembryonic
1579043|NCT00468299|progesterone|progesterone
1579044|NCT00468286|Prostate Cancer|prostate cancer
1579045|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
1579046|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
1579047|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
1579048|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
1579049|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
1579050|NCT00468260|Cancer|cancer
1579051|NCT00468260|EPO906|epo906
1579052|NCT00468260|Patupilone|patupilone
1579053|NCT00468247|mean systemic pressure|mean systemic pressure
1579054|NCT00468247|fluid therapy|fluid therapy
1579055|NCT00468247|closed loop control|closed loop control
1579056|NCT00468247|circulation modelling|circulation modelling
1579057|NCT00468234|smoking cessation|smoking cessation
1579058|NCT00468234|harm reduction|harm reduction
1579059|NCT00468234|biomarker|biomarker
1579060|NCT00468234|exhaled breath condensate|exhaled breath condensate
1579061|NCT00468221|Ozone|ozone
1579062|NCT00468221|Healthy Adults|healthy adults
1579063|NCT00468208|Vasculitis|vasculitis
1579064|NCT00468208|Relapse|relapse
1579065|NCT00468208|Wegener's|wegener's
1579066|NCT00468208|Treatment|treatment
1579067|NCT00468195|tomography|tomography
1579068|NCT00468195|coronary artery disease|coronary artery disease
1579069|NCT00468195|obesity|obesity
1579070|NCT00468182|Multiple sclerosis|multiple sclerosis
1579071|NCT00468182|Interferon beta|interferon beta
1579072|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
1579073|NCT00468169|Cetuximab|cetuximab
1579074|NCT00468169|Erbitux|erbitux
1579075|NCT00468169|locally|locally
1579076|NCT00468169|advanced|advanced
1579077|NCT00468169|head|head
1579078|NCT00468169|neck|neck
1579079|NCT00468169|cancer|cancer
1579080|NCT00468169|neoplasms|neoplasms
1579081|NCT00468169|squamous|squamous
1579082|NCT00468169|carcinoma|carcinoma
1579083|NCT00468169|lymphoepithelioma|lymphoepithelioma
1579084|NCT00468156|fruit|fruit
1579085|NCT00468156|vegetables|vegetables
1579086|NCT00468156|prevention|prevention
1579087|NCT00468156|cancer|cancer
1579088|NCT00468156|counseling|counseling
1579089|NCT00468156|cancer risk|cancer risk
1579090|NCT00468130|Aggression|aggression
1579091|NCT00468130|Irritability|irritability
1579092|NCT00468130|Global autism severity|global autism severity
1579093|NCT00468117|Hypoglycemia|hypoglycemia
1579094|NCT00468117|Kidney Transplant|kidney transplant
1579095|NCT00468117|Insulin independence|insulin independence
1579096|NCT00468117|Islet Transplantation|islet transplantation
1579097|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
1579098|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
1579099|NCT00468104|empyema|empyema
1579100|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
1579101|NCT00468091|GLP-1|glp-1
1579102|NCT00468091|exendin(9-39)|exendin(9-39)
1579103|NCT00468091|atropine|atropine
1579104|NCT00468091|human|human
1579105|NCT00468091|motility|motility
1579106|NCT00468078|Parkinson's disease|parkinson's disease
1579107|NCT00468078|Essential tremor|essential tremor
1579108|NCT00468078|F-18 FPCIT|f-18 fpcit
1579109|NCT00468078|PET|pet
1579110|NCT00468065|intravenous|intravenous
1579111|NCT00468065|catheter|catheter
1579112|NCT00468065|IV|iv
1579113|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
1579114|NCT00468052|tonsillectomy|tonsillectomy
1579115|NCT00468052|adenoidectomy|adenoidectomy
1579117|NCT00468039|vildagliptin|vildagliptin
1579118|NCT00468039|initial combination|initial combination
1579119|NCT00468026|BPH|bph
1579120|NCT00468026|Prostate|prostate
1579121|NCT00468026|Stent|stent
1579122|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1579123|NCT00468013|Fibromyalgia|fibromyalgia
1579124|NCT00468013|Irritable Bowel|irritable bowel
1579125|NCT00468013|Chronic Fatigue|chronic fatigue
1579126|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
1579127|NCT00468013|Resilience Building Exercises|resilience building exercises
1579128|NCT00468013|Depression|depression
1579129|NCT00468013|Well-Being|well-being
1579130|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
1579131|NCT00468000|Critical Limb Ischemia|critical limb ischemia
1579132|NCT00468000|Ischemia|ischemia
1579133|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
1579134|NCT00468000|ixmyelocel-T|ixmyelocel-t
1579135|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
1579136|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
1579137|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
1579138|NCT00467961|Leukemia|leukemia
1579139|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1579140|NCT00467961|CLL|cll
1579141|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1579142|NCT00467961|CML|cml
1579143|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
1579144|NCT00467961|AML|aml
1579145|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
1579146|NCT00467961|ALL|all
1579147|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
1579148|NCT00467961|MDS|mds
1579149|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
1579150|NCT00467935|amd|amd
1579151|NCT00467935|disciform|disciform
1579152|NCT00467935|fibrosis|fibrosis
1579153|NCT00467935|Lucentis|lucentis
1579154|NCT00467935|scotoma|scotoma
1579155|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
1579156|NCT00467922|colorectal disease|colorectal disease
1579157|NCT00467922|Crohn's|crohn's
1579158|NCT00467922|diverticulitis|diverticulitis
1579159|NCT00467922|Colorectal resections|colorectal resections
1579160|NCT00467909|micronutrients|micronutrients
1579161|NCT00467909|cognition|cognition
1579162|NCT00467909|DHA|dha
1579163|NCT00467909|healthy children|healthy children
1579164|NCT00467896|PAH|pah
1579165|NCT00467896|iloprost|iloprost
1579166|NCT00467896|Ventavis|ventavis
1579167|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1579168|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
1579169|NCT00467896|Cotherix|cotherix
1579170|NCT00467883|Zygomycosis|zygomycosis
1579171|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
1579172|NCT00467870|investigational|investigational
1579173|NCT00467870|testosterone|testosterone
1579174|NCT00467870|testosterone undecanoate|testosterone undecanoate
1579175|NCT00467870|TU|tu
1579176|NCT00467870|Hypogonadism|hypogonadism
1579177|NCT00467870|primary hypogonadism|primary hypogonadism
1579178|NCT00467870|secondary hypogonadism|secondary hypogonadism
1579179|NCT00467857|cyanoacrylates|cyanoacrylates
1579180|NCT00467857|microbial sealants|microbial sealants
1579181|NCT00467857|skin flora contamination|skin flora contamination
1579182|NCT00467857|surgery|surgery
1579183|NCT00467844|Cachexia|cachexia
1579184|NCT00467844|Muscle Wasting|muscle wasting
1579185|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
1579186|NCT00467844|Colorectal Cancer|colorectal cancer
1579187|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1579188|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
1579189|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
1579190|NCT00467831|Restrictive Lung Disease|restrictive lung disease
1579191|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
1579192|NCT00467831|Albinism|albinism
1579193|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
1579194|NCT00467831|Metabolic Disease|metabolic disease
1579195|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
1579196|NCT00467831|HPS|hps
1579197|NCT00467831|Lung Disease|lung disease
1579198|NCT00467818|Aggression|aggression
1579199|NCT00467818|Irritability|irritability
1579200|NCT00467818|Global severity|global severity
1579201|NCT00467805|Light exposure|light exposure
1579202|NCT00467805|light spectrum|light spectrum
1579203|NCT00467805|reproductive hormones|reproductive hormones
1579204|NCT00467805|women|women
1579205|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
1579206|NCT00467792|mastocytosis|mastocytosis
1579207|NCT00467792|mastocytomas|mastocytomas
1579208|NCT00467766|dementia|dementia
1579209|NCT00467766|Counseling|counseling
1579210|NCT00467753|Irritability|irritability
1579211|NCT00467753|Functional Ability|functional ability
1579212|NCT00467753|Aggression|aggression
1579213|NCT00467753|Mood Instability|mood instability
1579214|NCT00467727|Diagnostic Mammography|diagnostic mammography
1579215|NCT00467727|Breast Imaging|breast imaging
1579216|NCT00467727|Phase Contrast Mammography|phase contrast mammography
1579217|NCT00467727|X-Ray Mammography|x-ray mammography
1579218|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
1579219|NCT00467701|pneumonia|pneumonia
1579220|NCT00467701|Legionnaires disease|legionnaires disease
1579221|NCT00467701|risk factors|risk factors
1579222|NCT00467688|type 1 diabetes|type 1 diabetes
1579223|NCT00467688|glucose excursion|glucose excursion
1579224|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
1579225|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
1579226|NCT00467675|NonDiabetes|nondiabetes
1579227|NCT00467675|CGM|cgm
1579228|NCT00467649|Symlin|symlin
1579229|NCT00467649|Amylin|amylin
1579230|NCT00467649|insulin|insulin
1579231|NCT00467649|Humalog|humalog
1579232|NCT00467649|Novolog|novolog
1579233|NCT00467649|Apidra|apidra
1579234|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1579235|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
1579236|NCT00467636|Insulin|insulin
1579237|NCT00467623|Pregnancy|pregnancy
1579238|NCT00467623|holotranscobalamin|holotranscobalamin
1579239|NCT00467623|cobalamin|cobalamin
1579240|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
1579241|NCT00467623|reference interval|reference interval
1579242|NCT00467610|myelodysplastic|myelodysplastic
1579243|NCT00467610|MDS|mds
1579244|NCT00467610|Panhematin|panhematin
1579245|NCT00467610|Hemin|hemin
1579246|NCT00467597|Dyskinesia|dyskinesia
1579247|NCT00467597|Levodopa|levodopa
1579248|NCT00467597|Movement Disorders|movement disorders
1579249|NCT00467597|Parkinson Disease|parkinson disease
1579250|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
1579251|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
1579252|NCT00467571|platelet|platelet
1579253|NCT00467558|Impulse Control Disorder|impulse control disorder
1579254|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
1579255|NCT00467545|HBeAg-positive|hbeag-positive
1579256|NCT00467545|chronic hepatitis B|chronic hepatitis b
1579257|NCT00467545|telbivudine|telbivudine
1579258|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
1579259|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
1579260|NCT00467454|Pyromania|pyromania
1579261|NCT00467454|Fire Setting|fire setting
1579262|NCT00467454|Compulsive Fire Setting|compulsive fire setting
1579263|NCT00467428|ADHD|adhd
1579264|NCT00467415|Walking|walking
1579265|NCT00467415|Treadmill|treadmill
1579266|NCT00467415|Partial Weightbearing|partial weightbearing
1579267|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
1579268|NCT00467389|Acetylcholine|acetylcholine
1579269|NCT00467389|Acetylcholinesterase|acetylcholinesterase
1579270|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
1579271|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
1579272|NCT00467350|constipation|constipation
1579273|NCT00467350|treatment|treatment
1579274|NCT00467350|fecal impaction|fecal impaction
1579275|NCT00467350|pediatric|pediatric
1579276|NCT00467337|insole|insole
1579277|NCT00467337|osteoarthritis|osteoarthritis
1579278|NCT00467337|pain|pain
1579279|NCT00467337|valgus knee|valgus knee
1579280|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
1579281|NCT00467324|surgery|surgery
1579282|NCT00467324|tongue|tongue
1579283|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
1579284|NCT00467311|Cystatin C|cystatin c
1579285|NCT00467311|Contrast media|contrast media
1579286|NCT00467311|Creatinine|creatinine
1579287|NCT00467311|Cardiac Catheterization|cardiac catheterization
1579288|NCT00467298|Exercise|exercise
1579289|NCT00467298|heart failure|heart failure
1579290|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1579291|NCT00467298|patient education|patient education
1579292|NCT00467298|costs|costs
1579293|NCT00467298|quality of life|quality of life
1579294|NCT00467285|Bone Density|bone density
1579295|NCT00467285|C-telopeptide|c-telopeptide
1579296|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
1579297|NCT00467285|N-telopeptide|n-telopeptide
1579298|NCT00467285|Osteocalcin|osteocalcin
1579299|NCT00467285|Osteoporosis|osteoporosis
1579300|NCT00467285|Thiazolidinediones|thiazolidinediones
1579301|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1579302|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
1579303|NCT00467272|Bloodstream Infection|bloodstream infection
1579304|NCT00467272|Daptomycin|daptomycin
1579305|NCT00467272|Cubicin|cubicin
1579306|NCT00467272|CRBSI|crbsi
1579307|NCT00467259|Natural Menopause|natural menopause
1579308|NCT00467246|Diabetes emergencies|diabetes emergencies
1579309|NCT00467220|Calorie restriction|calorie restriction
1579310|NCT00467220|alternate day fasting|alternate day fasting
1579311|NCT00467220|calorie intake|calorie intake
1579312|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1579883|NCT00464958|Spasticity|spasticity
1579313|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1579314|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1579315|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
1579316|NCT00467181|cardiac surgery|cardiac surgery
1579317|NCT00467181|renal dysfunction|renal dysfunction
1579318|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
1579319|NCT00467168|postprandial|postprandial
1579320|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
1579321|NCT00467168|type 2 diabetes|type 2 diabetes
1579322|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
1579323|NCT00467142|stage IV colon cancer|stage iv colon cancer
1579324|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
1579325|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
1579326|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1579327|NCT00467142|recurrent colon cancer|recurrent colon cancer
1579328|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
1579329|NCT00467129|stage IV colon cancer|stage iv colon cancer
1579330|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
1579331|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
1579332|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1579333|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
1579334|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
1579335|NCT00467103|Adult Aphasia|adult aphasia
1579336|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
1579337|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1579338|NCT00467103|Language Recovery|language recovery
1579339|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
1579340|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
1579341|NCT00467090|Parkinson's Disease|parkinson's disease
1579343|NCT00467090|Genetic|genetic
1579344|NCT00467090|Family Studies|family studies
1579345|NCT00467090|LRRK-2|lrrk-2
1579346|NCT00467090|Parkinson Disease|parkinson disease
1579347|NCT00467090|PD|pd
1579348|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
1579349|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
1579350|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
1579351|NCT00467064|Disease self-management|disease self-management
1579352|NCT00467064|Community programs|community programs
1579353|NCT00467038|affect|affect
1579354|NCT00467038|aggression|aggression
1579355|NCT00467038|anger|anger
1579356|NCT00467038|behavior therapy|behavior therapy
1579357|NCT00467038|borderline personality disorder|borderline personality disorder
1579358|NCT00467038|MRI, functional|mri, functional
1579359|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
1579360|NCT00467025|RCC|rcc
1579361|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
1579362|NCT00466999|misoprostol|misoprostol
1579363|NCT00466999|incomplete abortion|incomplete abortion
1579364|NCT00466999|PAC|pac
1579365|NCT00466986|recurrent|recurrent
1579366|NCT00466986|ovarian|ovarian
1579367|NCT00466986|cancer|cancer
1579368|NCT00466986|platinum sensitive|platinum sensitive
1579369|NCT00466973|Atrial fibrillation|atrial fibrillation
1579370|NCT00466973|ablation device comparison|ablation device comparison
1579371|NCT00466973|ablation in right atria|ablation in right atria
1579372|NCT00466947|Otitis media|otitis media
1579373|NCT00466947|Pneumonia|pneumonia
1579374|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
1579375|NCT00466947|Pneumococcal disease|pneumococcal disease
1579376|NCT00466947|Booster vaccination|booster vaccination
1579377|NCT00466947|Immunogenicity|immunogenicity
1579378|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
1579379|NCT00466947|Safety|safety
1579380|NCT00466947|Efficacy|efficacy
1579381|NCT00466947|Carriage|carriage
1579382|NCT00466934|Cerebral Blood Flow|cerebral blood flow
1579383|NCT00466934|Cerebral Cortex|cerebral cortex
1579384|NCT00466934|Cognition|cognition
1579385|NCT00466934|Optical Imaging|optical imaging
1579386|NCT00466934|Healthy Volunteer|healthy volunteer
1579387|NCT00466934|HV|hv
1579388|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1579389|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1579390|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1579391|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1579392|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1579393|NCT00466895|Leukemia|leukemia
1579394|NCT00466895|Lenalidomide|lenalidomide
1579395|NCT00466882|obese|obese
1579396|NCT00466882|renal failure|renal failure
1579397|NCT00466882|renal transplant candidate|renal transplant candidate
1579398|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
1579399|NCT00466856|neoplastic syndrome|neoplastic syndrome
1579400|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1579401|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1579402|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1580736|NCT00462124|cancer|cancer
1579403|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
1579404|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1579405|NCT00466856|liver metastases|liver metastases
1579406|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
1579407|NCT00466856|gastrinoma|gastrinoma
1579408|NCT00466856|insulinoma|insulinoma
1579409|NCT00466856|WDHA syndrome|wdha syndrome
1579410|NCT00466856|glucagonoma|glucagonoma
1579411|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1579412|NCT00466856|somatostatinoma|somatostatinoma
1579413|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
1579414|NCT00466843|Leukemia|leukemia
1579415|NCT00466843|Autoimmune Disease|autoimmune disease
1579416|NCT00466830|pain|pain
1579417|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1579418|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
1579419|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
1579420|NCT00466830|stage I breast cancer|stage i breast cancer
1579421|NCT00466830|stage II breast cancer|stage ii breast cancer
1579422|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
1579423|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
1579424|NCT00466804|heart transplant recipients|heart transplant recipients
1579425|NCT00466804|organ transplantation|organ transplantation
1579426|NCT00466804|immune biomarkers|immune biomarkers
1579427|NCT00466804|transplant rejection|transplant rejection
1579428|NCT00466765|Fat Grafting|fat grafting
1579429|NCT00466765|Breast Augmentation|breast augmentation
1579430|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
1579431|NCT00466765|Lumpectomy|lumpectomy
1579432|NCT00466765|Mastectomy|mastectomy
1579433|NCT00466765|Micromastia|micromastia
1579434|NCT00466765|Asymmetry|asymmetry
1579435|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
1579436|NCT00466765|Post implant removal filling defect|post implant removal filling defect
1579437|NCT00466765|Post Mastectomy|post mastectomy
1579438|NCT00466765|Autologous Fat Transfer|autologous fat transfer
1579439|NCT00466765|Tubular breasts|tubular breasts
1579440|NCT00466765|Tuberous breasts|tuberous breasts
1579441|NCT00466765|Constricted breasts|constricted breasts
1579442|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1579443|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1579444|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1579445|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1579446|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1579447|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
1579448|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
1579449|NCT00466687|stage IV melanoma|stage iv melanoma
1579450|NCT00466687|recurrent melanoma|recurrent melanoma
1579452|NCT00466674|RICT|rict
1579453|NCT00466674|conditioning|conditioning
1579454|NCT00466674|allograft|allograft
1579455|NCT00466661|Acamprosate|acamprosate
1579456|NCT00466661|Alcoholism|alcoholism
1579457|NCT00466661|Bipolar disorder|bipolar disorder
1579458|NCT00466661|Comorbidity|comorbidity
1579459|NCT00466661|Craving|craving
1579460|NCT00466661|Depression|depression
1579461|NCT00466661|GABA|gaba
1579462|NCT00466661|Glutamate|glutamate
1579463|NCT00466661|Mania|mania
1579464|NCT00466661|Pharmacotherapy|pharmacotherapy
1579465|NCT00466661|Withdrawal|withdrawal
1579466|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
1579467|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
1579468|NCT00466635|Infectious diarrhea|infectious diarrhea
1579469|NCT00466635|C. difficile|c. difficile
1579470|NCT00466635|CDAD|cdad
1579471|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1579472|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
1579473|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
1579474|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
1579475|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
1579476|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
1579477|NCT00466635|Clostridium difficile|clostridium difficile
1579478|NCT00466622|PCOS|pcos
1579479|NCT00466622|pregnancy|pregnancy
1579480|NCT00466622|metformin|metformin
1579481|NCT00466622|blood flow|blood flow
1579482|NCT00466622|Pulsatility index|pulsatility index
1579483|NCT00466609|clomipramine|clomipramine
1579484|NCT00466609|quetiapine|quetiapine
1579485|NCT00466609|fluoxetine|fluoxetine
1579486|NCT00466609|placebo|placebo
1579487|NCT00466609|augmentation|augmentation
1579488|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
1579489|NCT00466596|allergic rhinitis|allergic rhinitis
1579490|NCT00466596|mild asthma|mild asthma
1579491|NCT00466596|dust mite allergy|dust mite allergy
1579492|NCT00466596|gamma tocopherol|gamma tocopherol
1579493|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
1579494|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
1579495|NCT00466544|Chronic tonsillitis|chronic tonsillitis
1579496|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
1579497|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1579498|NCT00466531|06-138|06-138
1579499|NCT00466518|Kidney transplant|kidney transplant
1579500|NCT00466518|type 2 diabetes|type 2 diabetes
1579501|NCT00466518|sitagliptin|sitagliptin
1579502|NCT00466505|recurrent colon cancer|recurrent colon cancer
1579503|NCT00466505|stage IV colon cancer|stage iv colon cancer
1579504|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
1579505|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
1579506|NCT00466492|Drug Administration Schedule|drug administration schedule
1579507|NCT00466492|Intensive Care Units|intensive care units
1579508|NCT00466492|Length of Stay|length of stay
1579509|NCT00466492|Respiration, Artificial|respiration, artificial
1579510|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
1579511|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
1579512|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
1579513|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
1579514|NCT00466479|neuroprotection|neuroprotection
1579515|NCT00466479|alpha one agonists|alpha one agonists
1579516|NCT00466479|glaucoma|glaucoma
1579517|NCT00466479|visual field|visual field
1579612|NCT00466050|IVUS|ivus
1579518|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
1579519|NCT00466466|SCLC|sclc
1579520|NCT00466466|Advanced Lung Cancer|advanced lung cancer
1579521|NCT00466466|RAD|rad
1579522|NCT00466466|RAD001|rad001
1579523|NCT00466466|Chemotherapy|chemotherapy
1579524|NCT00466466|Cisplatin|cisplatin
1579525|NCT00466466|Etoposide|etoposide
1579526|NCT00466375|hemangioma|hemangioma
1579527|NCT00466375|vascular anomaly|vascular anomaly
1579528|NCT00466375|infantile hemangioma|infantile hemangioma
1579529|NCT00466362|Obesity|obesity
1579530|NCT00466362|Diabetes|diabetes
1579531|NCT00466362|Weight|weight
1579532|NCT00466362|Lifestyle|lifestyle
1579533|NCT00466362|Follow up|follow up
1579534|NCT00466349|SMA Type I|sma type i
1579535|NCT00466349|SMA Type II|sma type ii
1579536|NCT00466349|SMA Type III|sma type iii
1579537|NCT00466349|SMN|smn
1579538|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
1579539|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
1579540|NCT00466349|Registry|registry
1579541|NCT00466349|SMA Type IV|sma type iv
1579542|NCT00466336|Chronic hepatitis C|chronic hepatitis c
1579543|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
1579544|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
1579545|NCT00466336|Biochemical indices|biochemical indices
1579546|NCT00466336|Hepatic fibrosis|hepatic fibrosis
1579547|NCT00466336|Cirrhosis|cirrhosis
1579548|NCT00466323|Mental Illness|mental illness
1579549|NCT00466323|Schizophrenia|schizophrenia
1579550|NCT00466323|Education|education
1579551|NCT00466323|Family member treatment|family member treatment
1579552|NCT00466323|Active psychoses|active psychoses
1579553|NCT00466310|Schizophrenia|schizophrenia
1579554|NCT00466310|Metabolomics|metabolomics
1579555|NCT00466297|Interprofessional|interprofessional
1579556|NCT00466297|Collaboration|collaboration
1579557|NCT00466297|Teamwork|teamwork
1579558|NCT00466297|General internal medicine|general internal medicine
1579559|NCT00466297|Cluster randomized|cluster randomized
1579560|NCT00466271|Chronic hepatitis C|chronic hepatitis c
1579561|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
1579562|NCT00466271|Hepatic fibrosis|hepatic fibrosis
1579563|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
1579564|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
1579565|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1579566|NCT00466258|HIV|hiv
1579567|NCT00466258|R-CHOP|r-chop
1579568|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
1579569|NCT00466258|Treatment Experienced|treatment experienced
1579570|NCT00466245|MVA Vaccine|mva vaccine
1579571|NCT00466232|Small Cell|small cell
1579572|NCT00466232|Lung Cancer|lung cancer
1579573|NCT00466232|Treatment|treatment
1579574|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
1579575|NCT00466219|Absence of graft rejection|absence of graft rejection
1579576|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
1579577|NCT00466206|pectus excavatum|pectus excavatum
1579578|NCT00466206|magnetic alteration|magnetic alteration
1579579|NCT00466206|chest wall deformity|chest wall deformity
1579580|NCT00466193|Insomnia|insomnia
1579581|NCT00466180|Once-a-day|once-a-day
1579582|NCT00466180|Adherence|adherence
1579583|NCT00466180|Nevirapine|nevirapine
1579584|NCT00466180|Patient noncompliance|patient noncompliance
1579585|NCT00466180|Administration and dosage|administration and dosage
1579586|NCT00466180|Treatment Experienced|treatment experienced
1579587|NCT00466154|Aspirin resistance|aspirin resistance
1579588|NCT00466154|Platelet activation|platelet activation
1579589|NCT00466154|Hypercholesterolemia|hypercholesterolemia
1579590|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
1579591|NCT00466128|preterm rupture|preterm rupture
1579592|NCT00466128|PPROM|pprom
1579593|NCT00466102|Breast Cancer|breast cancer
1579594|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
1579595|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
1579596|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
1579597|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
1579598|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
1579599|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
1579600|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
1579601|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
1579602|NCT00466076|Drusen|drusen
1579603|NCT00466076|AMD|amd
1579604|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
1579605|NCT00466063|Iron overload|iron overload
1579606|NCT00466063|children|children
1579607|NCT00466063|deferasirox|deferasirox
1579608|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
1579609|NCT00466050|plaque rupture,|plaque rupture,
1579610|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
1579611|NCT00466050|coronary angiography,|coronary angiography,
1579613|NCT00466037|Rheumatoid|rheumatoid
1579614|NCT00466037|rituximab|rituximab
1579615|NCT00466037|influenza|influenza
1579616|NCT00466024|Asthma|asthma
1579617|NCT00466024|persistent|persistent
1579618|NCT00466024|children|children
1579619|NCT00466024|particulates|particulates
1579620|NCT00466024|ETS|ets
1579621|NCT00465998|Ultrasound|ultrasound
1579622|NCT00465998|Induced labor|induced labor
1579623|NCT00465998|Cervical length|cervical length
1579624|NCT00465998|Engagement of fetal head|engagement of fetal head
1579625|NCT00465998|Occiput posterior|occiput posterior
1579626|NCT00465998|Outcome of labor|outcome of labor
1579627|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
1579628|NCT00465985|children|children
1579629|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
1579630|NCT00465985|CIAS-1 gene|cias-1 gene
1579631|NCT00465985|NALP-3|nalp-3
1579632|NCT00465985|ACZ885|acz885
1579633|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
1579634|NCT00465985|antibody|antibody
1579635|NCT00465985|autosomal dominant|autosomal dominant
1579636|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
1579637|NCT00465972|HIV|hiv
1579638|NCT00465972|Insomnia|insomnia
1579639|NCT00465972|Cytokines|cytokines
1579640|NCT00465972|Adherence|adherence
1579641|NCT00465959|COPD|copd
1579642|NCT00465946|Salt supplementation|salt supplementation
1579643|NCT00465946|Vasovagal syncope|vasovagal syncope
1579644|NCT00465946|Orthostatic tolerance|orthostatic tolerance
1579645|NCT00465946|Healthy volunteers|healthy volunteers
1579646|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1579647|NCT00465933|AIDA|aida
1579648|NCT00465920|schizophrenia|schizophrenia
1579649|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
1579650|NCT00465920|early onset psychosis|early onset psychosis
1579651|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
1579652|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
1579653|NCT00465894|overactive bladder|overactive bladder
1579654|NCT00465894|urge leakage|urge leakage
1579655|NCT00465894|nightime urination|nightime urination
1579656|NCT00465894|incontinence|incontinence
1579657|NCT00465894|urinary frequency|urinary frequency
1579658|NCT00465881|Diabetes|diabetes
1579659|NCT00465881|CGM|cgm
1579660|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
1579661|NCT00465868|Coronary Revascularization|coronary revascularization
1579662|NCT00465868|Microvascular Obstruction|microvascular obstruction
1579663|NCT00465868|Cardiac MR|cardiac mr
1579664|NCT00465868|Collagen Turnover|collagen turnover
1579665|NCT00465868|Heart failure, post-mi|heart failure, post-mi
1579666|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
1579667|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
1579668|NCT00465855|Randomized controlled trial|randomized controlled trial
1579669|NCT00465855|Clinical investigation|clinical investigation
1579670|NCT00465842|Hepatitis|hepatitis
1579671|NCT00465842|Liver Cirrhosis|liver cirrhosis
1579672|NCT00465842|HCC|hcc
1579673|NCT00465829|Obesity|obesity
1579674|NCT00465816|non-inferiority|non-inferiority
1579675|NCT00465816|adolescents|adolescents
1579676|NCT00465816|meningococcal vaccine|meningococcal vaccine
1579677|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
1579678|NCT00465790|biomarkers|biomarkers
1579679|NCT00465790|neuroimaging|neuroimaging
1579680|NCT00465790|genetics|genetics
1579681|NCT00465790|PET|pet
1579682|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
1580737|NCT00462124|radiation|radiation
1579683|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
1579684|NCT00465790|Huntington|huntington
1579685|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
1579686|NCT00465777|malaria|malaria
1579687|NCT00465777|mortality|mortality
1579688|NCT00465777|hospital|hospital
1579689|NCT00465777|incentive|incentive
1579690|NCT00465777|personnel|personnel
1579691|NCT00465777|paediatric|paediatric
1579692|NCT00465764|healthy infants|healthy infants
1579693|NCT00465725|Picoplatin|picoplatin
1579694|NCT00465725|tumor|tumor
1579695|NCT00465725|cancer|cancer
1579696|NCT00465725|sarcoma|sarcoma
1579697|NCT00465725|neoplasm|neoplasm
1579698|NCT00465725|advanced|advanced
1579699|NCT00465725|platinum|platinum
1579700|NCT00465725|chemotherapy|chemotherapy
1579701|NCT00465725|Solid Tumor|solid tumor
1579702|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
1579703|NCT00465712|external cephalic version|external cephalic version
1579704|NCT00465712|breech presentation|breech presentation
1579705|NCT00465699|Eczema|eczema
1579706|NCT00465699|Pediatric|pediatric
1579707|NCT00465699|Vitamin B12|vitamin b12
1579708|NCT00465686|handwriting|handwriting
1579709|NCT00465686|child|child
1579710|NCT00465686|primary school|primary school
1579711|NCT00465686|posture|posture
1579712|NCT00465686|assistive device|assistive device
1579713|NCT00465673|breast cancer|breast cancer
1579714|NCT00465673|brain metastatsis|brain metastatsis
1579715|NCT00465673|Lipo-Dox|lipo-dox
1579716|NCT00465660|Osteoarthritis|osteoarthritis
1579717|NCT00465660|Cartilage|cartilage
1579718|NCT00465660|Exercise|exercise
1579719|NCT00465660|Progressive Resistance Training|progressive resistance training
1579720|NCT00465647|Postoperative pain|postoperative pain
1579721|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
1579722|NCT00465647|opioid|opioid
1579723|NCT00465647|pharmacokinetics|pharmacokinetics
1579724|NCT00465647|pharmacodynamics|pharmacodynamics
1579725|NCT00465634|Screening|screening
1579726|NCT00465634|uterine artery Doppler|uterine artery doppler
1579727|NCT00465634|HELLP syndrome|hellp syndrome
1579728|NCT00465634|abruption|abruption
1579729|NCT00465621|Open-angle glaucoma|open-angle glaucoma
1579730|NCT00465621|ocular hypertension|ocular hypertension
1579731|NCT00465608|adults|adults
1579732|NCT00465608|PTSD|ptsd
1579733|NCT00465608|trauma|trauma
1579734|NCT00465608|AZF|azf
1579735|NCT00465608|propranolol|propranolol
1579736|NCT00465608|reconsolidation|reconsolidation
1579737|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
1579738|NCT00465608|chronic form|chronic form
1579739|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
1579740|NCT00465582|carriage|carriage
1579741|NCT00465582|Neisseria meningitidis|neisseria meningitidis
1579742|NCT00465582|risk factors|risk factors
1579743|NCT00465569|Food Allergy|food allergy
1579744|NCT00465569|Oral Immunotherapy|oral immunotherapy
1579745|NCT00465569|Immunoglobulin E|immunoglobulin e
1579746|NCT00465543|Nasal polyposis|nasal polyposis
1579747|NCT00465543|Mint tea|mint tea
1579748|NCT00465543|Double-blind|double-blind
1579749|NCT00465543|Placebo-controlled|placebo-controlled
1579750|NCT00465543|Crossover|crossover
1579751|NCT00465517|Partial onset seizures|partial onset seizures
1579752|NCT00465517|Complex-partial seizures|complex-partial seizures
1579753|NCT00465517|Anticonvulsant|anticonvulsant
1579754|NCT00465517|Partial seizures|partial seizures
1579755|NCT00465517|Catamenial epilepsy|catamenial epilepsy
1579756|NCT00465504|local analgesia|local analgesia
1579757|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
1579758|NCT00465504|iontophoresis|iontophoresis
1579759|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
1579760|NCT00465491|refractory|refractory
1579761|NCT00465491|chemotherapy|chemotherapy
1579762|NCT00465491|progressed|progressed
1579763|NCT00465491|second-line treatment|second-line treatment
1579764|NCT00465491|small cell lung cancer|small cell lung cancer
1579765|NCT00465491|best supportive care|best supportive care
1579766|NCT00465491|picoplatin|picoplatin
1579767|NCT00465478|Diabetes Mellitus|diabetes mellitus
1579768|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
1579769|NCT00465478|Transplantation|transplantation
1579770|NCT00465465|Tuberculosis|tuberculosis
1579771|NCT00465465|TB|tb
1579772|NCT00465465|MVA 85A|mva 85a
1579773|NCT00465465|BCG|bcg
1579774|NCT00465439|femoral artery sheath|femoral artery sheath
1579775|NCT00465439|vasovagal reaction|vasovagal reaction
1579776|NCT00465439|pain|pain
1579777|NCT00465439|perception|perception
1579778|NCT00465426|HIV Infection|hiv infection
1579779|NCT00465426|Cardiovascular Disease|cardiovascular disease
1579780|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
1579781|NCT00465426|Inflammatory Markers|inflammatory markers
1579782|NCT00465426|Treatment Experienced|treatment experienced
1579783|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
1579784|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
1580833|NCT00461682|rectal pain|rectal pain
1579785|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
1579786|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
1579787|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
1579788|NCT00465400|oxidative stress|oxidative stress
1579789|NCT00465400|photodynamic therapy|photodynamic therapy
1579790|NCT00465374|ARDS|ards
1579791|NCT00465374|Pressure/time curve|pressure/time curve
1579792|NCT00465374|Stress Index|stress index
1579793|NCT00465361|Growth and Development|growth and development
1579794|NCT00465361|Child Development|child development
1579795|NCT00465361|Developmental Surveillance|developmental surveillance
1579796|NCT00465361|Medical Education|medical education
1579797|NCT00465361|Internship and Residency|internship and residency
1579798|NCT00465348|normal tension glaucoma|normal tension glaucoma
1579799|NCT00465348|vascular dysregulation|vascular dysregulation
1581459|NCT00459433|SMS|sms
1579800|NCT00465335|computed tomography|computed tomography
1579801|NCT00465335|stress test|stress test
1579802|NCT00465335|equivocal|equivocal
1579803|NCT00465335|catheterization|catheterization
1579804|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
1579805|NCT00465309|CO2 removal|co2 removal
1579806|NCT00465309|protective ventilation|protective ventilation
1579807|NCT00465309|ARDS|ards
1579808|NCT00466388|dry mouth|dry mouth
1579994|NCT00464555|Type 1 diabetes|type 1 diabetes
1579809|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
1579810|NCT00465270|Cryptogenic|cryptogenic
1579811|NCT00465270|Stroke|stroke
1579812|NCT00465270|PFO|pfo
1579813|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
1579814|NCT00465231|Induction of labour|induction of labour
1579815|NCT00465231|Bupivacaine consumption|bupivacaine consumption
1579816|NCT00465231|Prevention|prevention
1579817|NCT00465218|Bioprosthesis|bioprosthesis
1579818|NCT00465218|Thrombosis|thrombosis
1579819|NCT00465218|Cerebral emboli|cerebral emboli
1579820|NCT00465218|Transcranial Doppler|transcranial doppler
1579821|NCT00465218|Platelet function tests|platelet function tests
1579822|NCT00465205|HIV infection|hiv infection
1579823|NCT00465205|HIV Shedding|hiv shedding
1579824|NCT00465205|HSV suppression|hsv suppression
1579825|NCT00465205|Co-infected|co-infected
1579826|NCT00465205|Women|women
1579827|NCT00465205|Reactivation|reactivation
1579828|NCT00465205|Valacyclovir|valacyclovir
1579829|NCT00465205|Treatment Naive|treatment naive
1579830|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
1579831|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
1579832|NCT00465179|Renal Cell Cancer|renal cell cancer
1579833|NCT00465179|Kidney Cancer|kidney cancer
1579834|NCT00465179|Papillary|papillary
1579835|NCT00465179|Chromophobe|chromophobe
1579836|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
1579837|NCT00465179|CDC|cdc
1579838|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
1579839|NCT00465179|RMC|rmc
1579840|NCT00465179|Sunitinib Malate|sunitinib malate
1579841|NCT00465179|Sutent|sutent
1579842|NCT00465179|SU011248|su011248
1579843|NCT00465166|Accidental dural puncture|accidental dural puncture
1579844|NCT00465166|Labour epidural|labour epidural
1579845|NCT00465166|Ultrasound|ultrasound
1579846|NCT00465166|Ligamentum flavum|ligamentum flavum
1579847|NCT00465153|Inflammation|inflammation
1579848|NCT00465153|cytokines|cytokines
1579849|NCT00465153|sarcopenia|sarcopenia
1579850|NCT00465153|strength|strength
1579851|NCT00465153|muscle|muscle
1579852|NCT00465153|aging|aging
1579853|NCT00465153|exercise|exercise
1579854|NCT00465114|Preeclampsia|preeclampsia
1579855|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
1579856|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1579857|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
1579858|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
1579859|NCT00465101|GreenLight|greenlight
1579860|NCT00465101|Laserscope|laserscope
1579861|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
1579862|NCT00465101|enlarged prostate|enlarged prostate
1579863|NCT00465062|Lysosomal Disease|lysosomal disease
1579864|NCT00465062|Lipids|lipids
1579865|NCT00465062|B Lymphocytes|b lymphocytes
1579866|NCT00465062|Brain Damage|brain damage
1579867|NCT00465062|Gaucher Disease|gaucher disease
1579868|NCT00465062|GD|gd
1579869|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
1579870|NCT00465036|fat absorption|fat absorption
1579871|NCT00465036|fibres|fibres
1579872|NCT00465023|proton beam irradiation|proton beam irradiation
1579873|NCT00465023|liver cancer|liver cancer
1579874|NCT00465010|Adolescence|adolescence
1579875|NCT00465010|Sexual health|sexual health
1579876|NCT00465010|Communication|communication
1579877|NCT00465010|Parenting|parenting
1579878|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
1579879|NCT00464984|Weight loss|weight loss
1579880|NCT00464984|Physical fitness|physical fitness
1579881|NCT00464984|Quality of life|quality of life
1579882|NCT00464958|Fatigue|fatigue
1579884|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
1579885|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
1579886|NCT00464958|Fatigue Severity Scale|fatigue severity scale
1579887|NCT00464932|COPD|copd
1579888|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
1579889|NCT00464932|Lung Function|lung function
1579890|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
1579891|NCT00464893|gastric cancer|gastric cancer
1579892|NCT00464893|catumaxomab|catumaxomab
1579893|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1579894|NCT00464893|phase II|phase ii
1579895|NCT00464893|interoperative|interoperative
1579896|NCT00464893|trifunctional antibody|trifunctional antibody
1579897|NCT00464880|Placebo-controlled study|placebo-controlled study
1579898|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
1581717|NCT00458432|Brain|brain
1579899|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
1579900|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
1579901|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
1579902|NCT00464867|Bifidobacterium breve|bifidobacterium breve
1579903|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
1579904|NCT00464867|immunogenicity|immunogenicity
1579996|NCT00464555|T1DM|t1dm
1579997|NCT00464555|Insulin dependence|insulin dependence
1579905|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
1579906|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
1579907|NCT00464854|Glucose control|glucose control
1579908|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
1579909|NCT00464854|Multiple daily injections|multiple daily injections
1579910|NCT00464841|Tsui Test|tsui test
1579911|NCT00464841|Combined Spinal Epidural|combined spinal epidural
1579912|NCT00464841|Labour|labour
1579913|NCT00464828|Central venous cannulation|central venous cannulation
1579914|NCT00464828|Internal jugular vein|internal jugular vein
1579915|NCT00464828|Ultrasound|ultrasound
1579916|NCT00464828|Obstetrics|obstetrics
1579917|NCT00464815|immunogenicity|immunogenicity
1579918|NCT00464815|safety|safety
1579919|NCT00464815|meningococcal vaccine|meningococcal vaccine
1579920|NCT00464802|healthy|healthy
1579921|NCT00464802|safety|safety
1579922|NCT00464789|Postmenopausal|postmenopausal
1579923|NCT00464776|Randomized|randomized
1579924|NCT00464776|double-blind|double-blind
1579925|NCT00464776|cross-over|cross-over
1579926|NCT00464776|4-period|4-period
1579927|NCT00464776|4 treatment|4 treatment
1579928|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
1579929|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
1579930|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
1579931|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
1579932|NCT00464763|Mental Health|mental health
1579933|NCT00464763|Neurological Disease|neurological disease
1579934|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
1579935|NCT00464750|Cardiac output|cardiac output
1579936|NCT00464750|Thermodilution|thermodilution
1579937|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
1579938|NCT00464737|Rotigotine|rotigotine
1579939|NCT00464737|Neupro|neupro
1579940|NCT00464724|Prostate Cancer|prostate cancer
1579941|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
1579942|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
1579943|NCT00464724|AIR-MRSI|air-mrsi
1579944|NCT00464724|PFC-MRSI|pfc-mrsi
1579945|NCT00464724|3 Tesla|3 tesla
1579946|NCT00464724|MRSI|mrsi
1579947|NCT00464724|PFC|pfc
1579948|NCT00464711|depression|depression
1579949|NCT00464711|biology|biology
1579950|NCT00464698|OCD|ocd
1579951|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
1579952|NCT00464698|Obsessions|obsessions
1579953|NCT00464698|Compulsions|compulsions
1579954|NCT00464698|Duloxetine|duloxetine
1579955|NCT00464698|Cymbalta|cymbalta
1579956|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
1579957|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
1579958|NCT00464659|memory deficit|memory deficit
1579959|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
1579960|NCT00464659|Sham CPAP|sham cpap
1579961|NCT00464646|NSABP|nsabp
1579962|NCT00464646|Epirubicin|epirubicin
1579963|NCT00464646|Cyclophosphamide|cyclophosphamide
1579964|NCT00464646|Docetaxel|docetaxel
1579965|NCT00464646|Trastuzumab|trastuzumab
1579966|NCT00464646|Bevacizumab|bevacizumab
1579967|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
1579968|NCT00464646|HER2|her2
1579969|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
1579970|NCT00464646|Adjuvant Therapy|adjuvant therapy
1579971|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
1579972|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
1579973|NCT00464633|CLL|cll
1579974|NCT00464633|PLL|pll
1579975|NCT00464633|flavopiridol|flavopiridol
1579976|NCT00464620|Dasatinib|dasatinib
1579977|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
1579978|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
1579979|NCT00464620|Chondrosarcoma|chondrosarcoma
1579980|NCT00464620|Ewing's|ewing's
1579981|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
1579982|NCT00464620|Chordoma|chordoma
1579983|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
1579984|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
1579985|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
1579986|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
1579987|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
1579988|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
1579989|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
1579990|NCT00464568|hayfever|hayfever
1579991|NCT00464555|Allogeneic Islets|allogeneic islets
1579992|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
1579993|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
1580862|NCT00461617|insulin|insulin
1579998|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
1579999|NCT00464555|Islet transplant|islet transplant
1580000|NCT00464555|Islet transplantation|islet transplantation
1580001|NCT00464555|Islet graft|islet graft
1580002|NCT00464542|herpes simplex virus|herpes simplex virus
1580003|NCT00464529|blood glucose|blood glucose
1580004|NCT00464529|hyperglycemia|hyperglycemia
1580005|NCT00464529|hypoglycemia|hypoglycemia
1580006|NCT00464529|Perioperative care|perioperative care
1580007|NCT00464529|inpatient|inpatient
1580008|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
1580009|NCT00464503|statins|statins
1580010|NCT00464503|proteinuria|proteinuria
1580011|NCT00464503|proteomic analysis|proteomic analysis
1580012|NCT00464503|healthy volunteers|healthy volunteers
1580013|NCT00464490|Weaning|weaning
1580014|NCT00464490|Extuvation|extuvation
1580015|NCT00464490|Dexmedetomidine|dexmedetomidine
1580016|NCT00464477|Autism|autism
1580017|NCT00464477|Autistic disorder|autistic disorder
1580018|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
1580019|NCT00464477|Asperger syndrome|asperger syndrome
1580020|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
1580021|NCT00464477|Rett syndrome|rett syndrome
1580022|NCT00464464|Parkinson's disease|parkinson's disease
1580023|NCT00464464|PD|pd
1580024|NCT00464464|depression|depression
1580025|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
1580026|NCT00464464|social support|social support
1580027|NCT00464425|Electroacupuncture|electroacupuncture
1580028|NCT00464425|Postoperative ileus|postoperative ileus
1580029|NCT00464425|Colorectal surgery|colorectal surgery
1580030|NCT00464425|Laparoscopic surgery|laparoscopic surgery
1580031|NCT00464425|Randomised trial|randomised trial
1580032|NCT00464412|Osteoporosis|osteoporosis
1580033|NCT00464412|Knowledge|knowledge
1580034|NCT00464412|Beliefs|beliefs
1580035|NCT00464412|Education|education
1580036|NCT00464412|Women|women
1580037|NCT00464399|De novo renal transplantation|de novo renal transplantation
1580038|NCT00464399|CNI-free protocol|cni-free protocol
1580039|NCT00464399|adults|adults
1580040|NCT00464399|everolimus|everolimus
1580041|NCT00464399|rejections|rejections
1580042|NCT00464386|Severe burns|severe burns
1580043|NCT00464386|Severe Trauma|severe trauma
1580044|NCT00464386|Closed loop insulin|closed loop insulin
1580045|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
1580046|NCT00464373|Prostatitis|prostatitis
1580047|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
1580048|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
1580049|NCT00464373|Drug therapy|drug therapy
1580050|NCT00464373|Injections, intramuscular|injections, intramuscular
1580051|NCT00464347|AMD|amd
1580052|NCT00464347|wet AMD|wet amd
1580053|NCT00464347|verteporfin PDT|verteporfin pdt
1580054|NCT00464347|Avastin|avastin
1580055|NCT00464347|TAC-PF|tac-pf
1580056|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
1580057|NCT00464308|Heartburn|heartburn
1580058|NCT00464308|Proton pump inhibitor|proton pump inhibitor
1580059|NCT00464308|GORD|gord
1580060|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
1580061|NCT00464295|Phase 2 Trial|phase 2 trial
1580062|NCT00464295|Capecitabine|capecitabine
1580063|NCT00464295|Treatment Efficacy|treatment efficacy
1580064|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
1580065|NCT00464282|Positron emission tomography,|positron emission tomography,
1580066|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
1580067|NCT00464282|Lung cancer,|lung cancer,
1580068|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
1580069|NCT00464282|Ki-67|ki-67
1580070|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
1580071|NCT00464269|Epilepsy|epilepsy
1580072|NCT00464269|Brivaracetam|brivaracetam
1580073|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
1580074|NCT00464256|abstinence|abstinence
1580075|NCT00464243|Sleep problems|sleep problems
1580076|NCT00464243|Insomnia|insomnia
1580077|NCT00464243|Sleeplessness|sleeplessness
1580078|NCT00464243|Polysomnographic|polysomnographic
1580079|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
1580080|NCT00464230|Treatment|treatment
1580081|NCT00464230|Function|function
1580082|NCT00464230|Pain|pain
1580083|NCT00464230|Quality of life|quality of life
1580084|NCT00464230|Complications|complications
1580085|NCT00464230|Reoperations|reoperations
1580086|NCT00464230|Internal Fixation|internal fixation
1580087|NCT00464230|Hemiarthroplasty|hemiarthroplasty
1580088|NCT00464230|Activities of Daily Living|activities of daily living
1580089|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
1580090|NCT00464191|bipolar depression|bipolar depression
1580091|NCT00464191|SSRI|ssri
1580092|NCT00464191|escitalopram|escitalopram
1580093|NCT00464191|bipolar disorder|bipolar disorder
1580094|NCT00464191|antidepressant|antidepressant
1580095|NCT00464191|treatment trial|treatment trial
1580096|NCT00464191|RCT|rct
1580097|NCT00464178|multiple myeloma|multiple myeloma
1580098|NCT00464178|myeloma|myeloma
1580099|NCT00464178|relapsed myeloma|relapsed myeloma
1580100|NCT00464178|refractory myeloma|refractory myeloma
1580101|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
1580102|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
1580103|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
1580104|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
1580105|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
1580106|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
1580107|NCT00464178|Myeloma Proteins|myeloma proteins
1580108|NCT00464178|hnRNP A1|hnrnp a1
1580109|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
1580110|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
1580111|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
1580112|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
1580113|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
1580114|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
1580115|NCT00464178|McPC603 antibody|mcpc603 antibody
1580116|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
1580117|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
1580118|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
1580119|NCT00464178|myeloma cell activator|myeloma cell activator
1580120|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
1580121|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
1580122|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
1580123|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
1580124|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
1580125|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
1580126|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
1580127|NCT00464178|myeloma protein Dob|myeloma protein dob
1580128|NCT00464178|myeloma protein M 467|myeloma protein m 467
1580129|NCT00464178|myeloma protein M467|myeloma protein m467
1580130|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
1580131|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
1580132|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
1580133|NCT00464178|myeloma protein Rou|myeloma protein rou
1580134|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
1580135|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
1580136|NCT00464178|myeloma protein T15|myeloma protein t15
1580137|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
1580138|NCT00464178|myeloma protein W3129|myeloma protein w3129
1580139|NCT00464178|myeloma protein WIE|myeloma protein wie
1580140|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
1580141|NCT00464178|myeloma antigen KMA|myeloma antigen kma
1580142|NCT00464178|MYEOV protein, human|myeov protein, human
1580143|NCT00464178|protein 460|protein 460
1580144|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
1580145|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
1580146|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
1580147|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
1580148|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
1580149|NCT00464165|abstinence|abstinence
1580150|NCT00464139|endometriosis|endometriosis
1580151|NCT00464139|prevalence|prevalence
1580152|NCT00464139|fertility|fertility
1580153|NCT00464139|pain|pain
1580154|NCT00464139|ultrasound|ultrasound
1580155|NCT00464126|crystalloid|crystalloid
1580156|NCT00464126|colloid|colloid
1580157|NCT00464126|pediatric|pediatric
1580158|NCT00464126|cardiac|cardiac
1580159|NCT00464126|resuscitation|resuscitation
1580160|NCT00464126|Postoperative|postoperative
1580161|NCT00464113|Myeloid Leukemia|myeloid leukemia
1580162|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
1580163|NCT00464113|Ph+ ALL|ph+ all
1580164|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
1580165|NCT00464100|congenital heart disease|congenital heart disease
1580166|NCT00464100|NIRS monitoring|nirs monitoring
1580167|NCT00464100|hypoxia|hypoxia
1580168|NCT00464074|fatigue|fatigue
1580169|NCT00464074|Tysabri|tysabri
1580170|NCT00464074|cognition|cognition
1580171|NCT00464061|Sleep problems|sleep problems
1580172|NCT00464061|Insomnia|insomnia
1580173|NCT00464061|Sleeplessness|sleeplessness
1580174|NCT00464061|Primary insomnia|primary insomnia
1580175|NCT00464061|Insomnia disorder|insomnia disorder
1580176|NCT00464035|Obesity|obesity
1580177|NCT00464035|Calcium|calcium
1580178|NCT00464035|Fat absorption|fat absorption
1581718|NCT00458432|Fear|fear
1580179|NCT00464035|Postprandial lipid profile|postprandial lipid profile
1580180|NCT00464035|appetite|appetite
1580181|NCT00464022|pain, endoscopy|pain, endoscopy
1580182|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
1580183|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
1580184|NCT00464009|Prevention|prevention
1580185|NCT00464009|Continuing medical education|continuing medical education
1580186|NCT00464009|Randomized controlled trial|randomized controlled trial
1580187|NCT00463996|Ovarian cancer|ovarian cancer
1580188|NCT00463996|MRI|mri
1580189|NCT00463996|Contrast agent|contrast agent
1580190|NCT00463970|Chronic low back pain|chronic low back pain
1580191|NCT00463970|Brief cognitive intervention|brief cognitive intervention
1580192|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
1580193|NCT00463970|Seal oil|seal oil
1580194|NCT00463957|sildenafil|sildenafil
1580195|NCT00463957|tadalafil|tadalafil
1580196|NCT00463957|phosphodiesterase|phosphodiesterase
1580197|NCT00463957|visual persistence|visual persistence
1580198|NCT00463957|reaction time|reaction time
1580199|NCT00463944|Electronic voting system|electronic voting system
1580200|NCT00463931|Schistosomiasis|schistosomiasis
1580201|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
1580202|NCT00463931|Community-based volunteer|community-based volunteer
1580203|NCT00463931|School based treatment approach|school based treatment approach
1580204|NCT00463905|osteoporosis|osteoporosis
1580205|NCT00463905|vertebral fractures|vertebral fractures
1580206|NCT00463905|randomised controlled trial|randomised controlled trial
1580207|NCT00463905|screening|screening
1580208|NCT00463892|melanoma|melanoma
1580209|NCT00463892|lymph nodes|lymph nodes
1580210|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
1580211|NCT00463892|screening|screening
1580212|NCT00463892|detection|detection
1580213|NCT00463879|Schizophrenia|schizophrenia
1580214|NCT00463879|Cognition|cognition
1580215|NCT00463879|Smoking|smoking
1580216|NCT00463879|Galantamine|galantamine
1580217|NCT00463879|Nicotine|nicotine
1580218|NCT00463879|Cognitive Deficits|cognitive deficits
1580219|NCT00463866|Asthma|asthma
1580220|NCT00463853|Bone Marrow Cells|bone marrow cells
1580221|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
1580222|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
1580223|NCT00463853|Phase I Study|phase i study
1580224|NCT00463853|Stem Cells|stem cells
1580225|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
1580226|NCT00463840|oxaliplatin|oxaliplatin
1580227|NCT00463840|chemoradiation|chemoradiation
1580229|NCT00463827|asthma|asthma
1580230|NCT00463827|smokers|smokers
1580231|NCT00463827|statin|statin
1580232|NCT00463827|atorvastatin|atorvastatin
1580233|NCT00463827|randomised|randomised
1580234|NCT00463827|placebo|placebo
1580235|NCT00463827|cigarette|cigarette
1580236|NCT00463827|blind|blind
1580237|NCT00463827|COPD|copd
1580238|NCT00463814|Advanced Malignancy|advanced malignancy
1580239|NCT00463814|Cancer Eligibility|cancer eligibility
1580240|NCT00463814|Malignancy|malignancy
1580241|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
1580242|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
1580243|NCT00463788|cancer|cancer
1580244|NCT00463788|breast|breast
1580245|NCT00463788|metastatic|metastatic
1580246|NCT00463788|triple negative|triple negative
1580247|NCT00463775|Treatment|treatment
1580248|NCT00463775|Topiramate|topiramate
1580249|NCT00463775|Alcohol Dependence|alcohol dependence
1580250|NCT00463775|Borderline Personality Disorder|borderline personality disorder
1580251|NCT00463749|primary PCI|primary pci
1580252|NCT00463749|nephropathy|nephropathy
1580253|NCT00463749|infarct size|infarct size
1580254|NCT00463749|infarction|infarction
1580255|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
1580256|NCT00463736|short term tocolysis|short term tocolysis
1580257|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
1580258|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
1580259|NCT00463723|graft rejection|graft rejection
1580260|NCT00463723|immunosuppression|immunosuppression
1580261|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
1580262|NCT00463697|GW642444,|gw642444,
1580263|NCT00463697|magnesium stearate,|magnesium stearate,
1580264|NCT00463697|asthmatic patients|asthmatic patients
1580265|NCT00463658|Falls|falls
1580266|NCT00463658|Home Care|home care
1580267|NCT00463658|Aging Population|aging population
1580268|NCT00463658|Clinical Effectiveness|clinical effectiveness
1580269|NCT00463658|Health Economics|health economics
1580270|NCT00463632|schistosomiasis|schistosomiasis
1580271|NCT00463632|anaemia|anaemia
1580272|NCT00463632|pregnancy|pregnancy
1580273|NCT00463593|schistosomiasis|schistosomiasis
1580274|NCT00463593|helminthes|helminthes
1580275|NCT00463593|anaemia|anaemia
1580276|NCT00463580|depression|depression
1580277|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
1580278|NCT00463580|infliximab|infliximab
1581823|NCT00458055|Niacin|niacin
1580279|NCT00463580|treatment resistant depression|treatment resistant depression
1580280|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
1580281|NCT00463580|bipolar I disorder|bipolar i disorder
1580282|NCT00463580|bipolar II disorder|bipolar ii disorder
1580283|NCT00463567|indacaterol|indacaterol
1580284|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
1580285|NCT00463554|Incontinence|incontinence
1580286|NCT00463554|Stress Urinary|stress urinary
1580287|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
1580288|NCT00463541|Urgency|urgency
1580289|NCT00463541|VESIcare®|vesicare®
1580290|NCT00463541|Solifenacin succinate|solifenacin succinate
1580291|NCT00463528|schistosomiasis|schistosomiasis
1580292|NCT00463528|gender perspectives|gender perspectives
1580293|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
1580294|NCT00463515|NSCLC|nsclc
1580295|NCT00463515|Chemoradiation|chemoradiation
1580296|NCT00463515|lung cancer|lung cancer
1580297|NCT00463515|induction chemotherapy|induction chemotherapy
1580298|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
1580299|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
1580300|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
1580301|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
1580302|NCT00463502|in TSH and fT4|in tsh and ft4
1580303|NCT00463489|lifestyle intervention|lifestyle intervention
1580304|NCT00463489|breast|breast
1580305|NCT00463489|cancer|cancer
1580306|NCT00463489|adjuvant|adjuvant
1580307|NCT00463489|letrozole|letrozole
1580308|NCT00463489|weight loss|weight loss
1580309|NCT00463489|BMI|bmi
1580310|NCT00463489|post-menopausal|post-menopausal
1580311|NCT00463489|estrogen receptor positive|estrogen receptor positive
1580312|NCT00463489|progesterone receptor positive|progesterone receptor positive
1580313|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
1580314|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
1580315|NCT00463437|Fever.|fever.
1580316|NCT00463437|Meningococcal disease.|meningococcal disease.
1580317|NCT00463437|Pneumococcal disease.|pneumococcal disease.
1580318|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
1580319|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
1580320|NCT00463437|Immunogenicity.|immunogenicity.
1580321|NCT00463437|Booster vaccination.|booster vaccination.
1580322|NCT00463437|Safety.|safety.
1580323|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
1580324|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
1580325|NCT00463424|Range of Motion, Articular|range of motion, articular
1580326|NCT00463424|Randomized Controlled Trials|randomized controlled trials
1580327|NCT00463424|Swanson|swanson
1580328|NCT00463424|NeuFlex|neuflex
1580329|NCT00463411|osteoporosis|osteoporosis
1580330|NCT00463411|male|male
1580331|NCT00463411|fracture risk|fracture risk
1580332|NCT00463411|genetical epidemiology|genetical epidemiology
1580333|NCT00463398|Endometriosis|endometriosis
1580334|NCT00463398|Fertility Surgery|fertility surgery
1580335|NCT00463398|Quality of Life|quality of life
1580336|NCT00463398|Pain|pain
1580337|NCT00463398|Sexual Function|sexual function
1580338|NCT00463398|Health economics|health economics
1580339|NCT00463398|Recurrence|recurrence
1580340|NCT00463398|Pregnancy|pregnancy
1580341|NCT00463385|Celgene|celgene
1580342|NCT00463385|CC-4047|cc-4047
1580343|NCT00463385|Myelofibrosis|myelofibrosis
1580344|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
1580345|NCT00463385|myeloid metaplasia|myeloid metaplasia
1580346|NCT00463385|JAK2|jak2
1580347|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
1580348|NCT00463385|Prednisone|prednisone
1580349|NCT00463385|Phase II|phase ii
1580350|NCT00463385|pomalidomide|pomalidomide
1580351|NCT00463385|bone marrow histology|bone marrow histology
1580352|NCT00463385|imids|imids
1580353|NCT00463385|MMM|mmm
1580354|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
1580355|NCT00463385|exposure to Thorotrast|exposure to thorotrast
1580356|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
1580357|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
1580834|NCT00461682|IBS|ibs
1580358|NCT00463385|history of polycythemia vera|history of polycythemia vera
1580359|NCT00463359|basal cell carcinoma|basal cell carcinoma
1580360|NCT00463359|curettage|curettage
1580361|NCT00463359|Imiquimod|imiquimod
1580362|NCT00463359|treatment|treatment
1580363|NCT00463346|Treatment|treatment
1580364|NCT00463346|Alcohol Dependence|alcohol dependence
1580365|NCT00463346|Schizophrenia|schizophrenia
1580366|NCT00463333|postoperative delirium|postoperative delirium
1580367|NCT00463333|psychometric testing|psychometric testing
1580368|NCT00463333|EEG|eeg
1580369|NCT00463333|serum markers|serum markers
1580370|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
1580371|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
1580372|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
1580373|NCT00463307|schistosomiasis|schistosomiasis
1580374|NCT00463307|Schistosoma mansoni|schistosoma mansoni
1580375|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
1580377|NCT00463294|On-pump|on-pump
1580378|NCT00463294|Off-pump|off-pump
1580379|NCT00463281|stroke, ischemic|stroke, ischemic
1580380|NCT00463281|computed tomography|computed tomography
1580381|NCT00463281|thrombolysis|thrombolysis
1580382|NCT00463268|osteopenia|osteopenia
1580383|NCT00463268|osteoporosis prevention|osteoporosis prevention
1580384|NCT00463268|alendronate|alendronate
1580385|NCT00463255|Diet|diet
1580386|NCT00463255|elderly|elderly
1580387|NCT00463255|age-related diseases|age-related diseases
1580388|NCT00463255|prevention|prevention
1580389|NCT00463255|cognitive decline|cognitive decline
1580390|NCT00463255|Clinical study|clinical study
1580391|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
1580392|NCT00463229|stroke|stroke
1580393|NCT00463229|rehabilitation|rehabilitation
1580394|NCT00463229|home care services|home care services
1580395|NCT00463229|effectiveness|effectiveness
1580396|NCT00463229|quantitative research|quantitative research
1580397|NCT00463229|interdisciplinary|interdisciplinary
1580398|NCT00463229|cost|cost
1580399|NCT00463229|health services research, integrated|health services research, integrated
1580400|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
1580401|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
1580402|NCT00463203|grade II glioma|grade ii glioma
1580403|NCT00463203|meningeoma|meningeoma
1580404|NCT00463203|ependymoma|ependymoma
1580405|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
1580406|NCT00463190|Probiotics|probiotics
1580407|NCT00463190|Diarrhea|diarrhea
1580408|NCT00463190|Enterocolitis|enterocolitis
1580409|NCT00463177|Pain|pain
1580410|NCT00463177|Chronic pain|chronic pain
1580411|NCT00463177|Pain disorder|pain disorder
1580412|NCT00463177|Functional MRI|functional mri
1580413|NCT00463177|Sensitization|sensitization
1580414|NCT00463164|functional MRI|functional mri
1580415|NCT00463151|Rebamipide|rebamipide
1580416|NCT00463151|Enema|enema
1580417|NCT00463151|Ulcerative Colitis|ulcerative colitis
1580418|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
1580419|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
1580420|NCT00463125|Scleroderma, systemic|scleroderma, systemic
1580421|NCT00463125|therapeutic|therapeutic
1580422|NCT00463125|platelet gel|platelet gel
1580423|NCT00463112|Obesity|obesity
1580424|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
1580425|NCT00463112|weight loss|weight loss
1580426|NCT00463112|Hyperadrogonemia|hyperadrogonemia
1580427|NCT00463112|Sibutramine|sibutramine
1580428|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
1580429|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
1580430|NCT00463099|Knee injuries/surgery|knee injuries/surgery
1580431|NCT00463099|Outcomes research|outcomes research
1580432|NCT00463099|Prospective Studies|prospective studies
1580433|NCT00463086|Tuberculosis|tuberculosis
1580434|NCT00463086|TB|tb
1580435|NCT00463086|Mycobacteria|mycobacteria
1580436|NCT00463086|HIV|hiv
1580437|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
1580438|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
1580439|NCT00463086|HAART|haart
1580440|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
1580441|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
1580442|NCT00463086|INH|inh
1580443|NCT00463086|Opportunistic infections|opportunistic infections
1580444|NCT00463086|HIV-1|hiv-1
1580445|NCT00463086|Treatment Experienced|treatment experienced
1580446|NCT00463086|AIDS|aids
1580447|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
1580448|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
1580449|NCT00463047|Breakthrough pain|breakthrough pain
1580450|NCT00463047|Opioid-tolerant|opioid-tolerant
1580451|NCT00463047|Chronic pain|chronic pain
1580452|NCT00463034|stage IV breast cancer|stage iv breast cancer
1580453|NCT00463034|stage I breast cancer|stage i breast cancer
1580835|NCT00461669|hip|hip
1580454|NCT00463034|stage II breast cancer|stage ii breast cancer
1580455|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
1580456|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
1580457|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
1580458|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
1580459|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
1580460|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1580461|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1580462|NCT00463008|adult glioblastoma|adult glioblastoma
1580463|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
1580464|NCT00463008|adult gliosarcoma|adult gliosarcoma
1580465|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
1580466|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
1580467|NCT00462995|Lung Cancer|lung cancer
1580468|NCT00462995|Erlotinib|erlotinib
1580469|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
1580470|NCT00462982|stage IV melanoma|stage iv melanoma
1580471|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
1580472|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
1580473|NCT00462982|recurrent melanoma|recurrent melanoma
1580474|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
1580475|NCT00462969|Endometrial cancer|endometrial cancer
1580476|NCT00462969|Sonohysterography|sonohysterography
1580477|NCT00462956|lapatinib|lapatinib
1580478|NCT00462956|metastatic breast cancer|metastatic breast cancer
1581066|NCT00460746|PREZISTA|prezista
1580479|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
1580480|NCT00462956|Stage IV breast cancer|stage iv breast cancer
1580482|NCT00462956|ErbB1|erbb1
1580483|NCT00462943|CML|cml
1580484|NCT00462943|HHT|hht
1580485|NCT00462943|Homoharringtonine|homoharringtonine
1580486|NCT00462943|Omacetaxine|omacetaxine
1580487|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
1580488|NCT00462917|family genetics|family genetics
1580489|NCT00462917|genetic counseling|genetic counseling
1580490|NCT00462917|genetic marker|genetic marker
1580491|NCT00462917|genetic polymorphism|genetic polymorphism
1580492|NCT00462917|genetic screening|genetic screening
1580493|NCT00462917|genetic susceptibility|genetic susceptibility
1580494|NCT00462891|breast cancer|breast cancer
1580495|NCT00462878|Febrile neutropenia|febrile neutropenia
1580496|NCT00462865|breast cancer|breast cancer
1580497|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1580498|NCT00462865|adjuvant treatment|adjuvant treatment
1580499|NCT00462865|consolidation therapy|consolidation therapy
1580500|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
1580501|NCT00462852|thromboembolism|thromboembolism
1580502|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
1580503|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
1580504|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1580505|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
1580506|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
1580507|NCT00462839|Estimated Blood Loss|estimated blood loss
1580508|NCT00462839|Obstetrics|obstetrics
1580509|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
1580510|NCT00462813|cervical cancer|cervical cancer
1580511|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1580512|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1580513|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1580514|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
1580515|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1580516|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1580517|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1580518|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1580519|NCT00462774|Myocardial infarction|myocardial infarction
1580520|NCT00462774|Heart failure|heart failure
1580521|NCT00462774|Cell therapy|cell therapy
1580522|NCT00462774|Bone marrow|bone marrow
1580523|NCT00462774|CD133|cd133
1580524|NCT00462774|Bypass surgery|bypass surgery
1580525|NCT00462774|Stem cells|stem cells
1580526|NCT00462761|RTK|rtk
1580527|NCT00462761|kinase|kinase
1580528|NCT00462761|inhibitor|inhibitor
1580529|NCT00462761|tyrosine|tyrosine
1580530|NCT00462761|acute|acute
1580531|NCT00462761|FLT3|flt3
1580532|NCT00462761|AC220|ac220
1580533|NCT00462761|pharmacokinetic|pharmacokinetic
1580534|NCT00462761|pharmacokinetics|pharmacokinetics
1580535|NCT00462761|PK|pk
1580536|NCT00462761|pharmacodynamic|pharmacodynamic
1580537|NCT00462761|pharmacodynamics|pharmacodynamics
1580538|NCT00462761|mutations|mutations
1580539|NCT00462761|PD|pd
1580540|NCT00462761|receptor|receptor
1580541|NCT00462761|class III|class iii
1580542|NCT00462761|relapsed|relapsed
1580543|NCT00462761|refractory|refractory
1580544|NCT00462761|t(8;21)|t(8;21)
1580545|NCT00462761|q22;q22|q22;q22
1580546|NCT00462761|AML1/ETO|aml1/eto
1580547|NCT00462761|t(16;16|t(16;16
1580548|NCT00462761|p13;q22|p13;q22
1580549|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
1580550|NCT00462761|inv(16)|inv(16)
1580551|NCT00462761|p13q22|p13q22
1580552|NCT00462761|11q23|11q23
1580553|NCT00462761|dysplasia|dysplasia
1580554|NCT00462761|myeloid|myeloid
1580555|NCT00462761|myelomonocytic|myelomonocytic
1580556|NCT00462761|monoblastic|monoblastic
1580557|NCT00462761|monocytic|monocytic
1580558|NCT00462761|erythroid|erythroid
1580559|NCT00462761|erythroleukemia|erythroleukemia
1580560|NCT00462761|megakaryoblastic|megakaryoblastic
1580561|NCT00462761|basophilic|basophilic
1580562|NCT00462761|panmyelosis|panmyelosis
1580563|NCT00462761|myelofibrosis|myelofibrosis
1580564|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
1580565|NCT00462722|body composition|body composition
1580566|NCT00462722|bone density|bone density
1580567|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
1580568|NCT00462722|bone metabolism|bone metabolism
1580569|NCT00462722|muscle function|muscle function
1580570|NCT00462722|muscle strength|muscle strength
1580571|NCT00462709|Hereditary angioedema|hereditary angioedema
1580572|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
1580573|NCT00462696|stage II breast cancer|stage ii breast cancer
1580574|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
1580575|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
1580576|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
1580577|NCT00462683|Stroke|stroke
1580578|NCT00462683|Anoxia|anoxia
1580579|NCT00462683|Brain Injury|brain injury
1580580|NCT00462683|Rehabilitation|rehabilitation
1580581|NCT00462683|Osteoporosis|osteoporosis
1580582|NCT00462683|Osteopenia|osteopenia
1580583|NCT00462670|Cardiac edema|cardiac edema
1580584|NCT00462670|OPC-41061|opc-41061
1580585|NCT00462670|Vasopressin antagonist|vasopressin antagonist
1580586|NCT00462657|infection|infection
1580587|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1580588|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1580589|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1580590|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1580591|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1580592|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1580593|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1580594|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1580595|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1580596|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1580597|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1580598|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1580599|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1580600|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1580601|NCT00462657|graft versus host disease|graft versus host disease
1580602|NCT00462644|adrenal insufficiency|adrenal insufficiency
1580603|NCT00462644|etomidate|etomidate
1580604|NCT00462644|rapid sequence induction|rapid sequence induction
1580605|NCT00462631|coronary artery|coronary artery
1580606|NCT00462631|Diabetes|diabetes
1580607|NCT00462618|Insomnia|insomnia
1580608|NCT00462618|Elderly|elderly
1580609|NCT00462618|Affective disorders|affective disorders
1580610|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
1580611|NCT00462592|airway inflammation|airway inflammation
1580612|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
1580613|NCT00462579|positive culture|positive culture
1580614|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
1580615|NCT00462566|Motor cortex stimulation|motor cortex stimulation
1580616|NCT00462566|neuropathic|neuropathic
1580617|NCT00462566|pain|pain
1580618|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
1580619|NCT00462566|deafferentation facial pain|deafferentation facial pain
1580620|NCT00462540|COPD|copd
1580621|NCT00462540|Formoterol|formoterol
1580622|NCT00462540|Ipratropium|ipratropium
1580623|NCT00462540|Crossover|crossover
1580624|NCT00462527|Cystatin C|cystatin c
1580625|NCT00462527|Acute renal failure|acute renal failure
1580626|NCT00462527|Gastroenteritis|gastroenteritis
1580627|NCT00462527|Dehydration|dehydration
1580628|NCT00462501|stage II rectal cancer|stage ii rectal cancer
1580629|NCT00462501|stage III rectal cancer|stage iii rectal cancer
1580630|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1580631|NCT00462475|GH|gh
1580632|NCT00462475|IGF-I|igf-i
1580633|NCT00462475|GH deficiency|gh deficiency
1580634|NCT00462475|Atherosclerosis|atherosclerosis
1580635|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
1580636|NCT00462449|Botulinum Toxin|botulinum toxin
1580637|NCT00462449|Ness H200|ness h200
1580638|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
1580639|NCT00462449|Repetitive Task Practice|repetitive task practice
1580640|NCT00462436|functional foods|functional foods
1580641|NCT00462436|soy|soy
1580642|NCT00462436|nuts|nuts
1580643|NCT00462436|LDL cholesterol|ldl cholesterol
1580644|NCT00462436|fibre|fibre
1580645|NCT00462436|secondary prevention|secondary prevention
1580646|NCT00462436|risk reduction|risk reduction
1580647|NCT00462436|endothelial function|endothelial function
1580648|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
1580649|NCT00462436|inflammation|inflammation
1580650|NCT00462436|glycemic control|glycemic control
1580651|NCT00462436|HOMA|homa
1580652|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
1580653|NCT00462423|First-line therapy|first-line therapy
1580654|NCT00462410|recurrent breast cancer|recurrent breast cancer
1580655|NCT00462410|stage I breast cancer|stage i breast cancer
1580656|NCT00462410|stage II breast cancer|stage ii breast cancer
1580657|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
1580658|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
1580659|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
1580660|NCT00462410|stage IV breast cancer|stage iv breast cancer
1580661|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
1580662|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1580663|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1580664|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
1581067|NCT00460746|darunavir|darunavir
1580665|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
1580666|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
1580667|NCT00462397|stage III cervical cancer|stage iii cervical cancer
1580668|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
1580669|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
1580670|NCT00462371|quality of life|quality of life
1580671|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
1580672|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
1580673|NCT00462371|metabolic control|metabolic control
1580674|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1580675|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1580676|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
1580677|NCT00462306|Pregnancy|pregnancy
1580678|NCT00462306|Berlin Questionnaire|berlin questionnaire
1580679|NCT00462267|Nutrition|nutrition
1580680|NCT00462267|Exercise|exercise
1580681|NCT00462267|Body mass index|body mass index
1580682|NCT00462267|Lifestyle change|lifestyle change
1580684|NCT00462267|Overweight|overweight
1580685|NCT00462267|Adolescents|adolescents
1580686|NCT00462267|Teens|teens
1580687|NCT00462254|Ramelteon|ramelteon
1580688|NCT00462254|Parkinson's disease|parkinson's disease
1580689|NCT00462254|Sleep disturbances|sleep disturbances
1580690|NCT00462241|Chest pain|chest pain
1580691|NCT00462241|Chest wall|chest wall
1580692|NCT00462241|Atypical chest pain|atypical chest pain
1580693|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
1580694|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
1580695|NCT00462241|Physical examination|physical examination
1580696|NCT00462241|Randomized controlled trial|randomized controlled trial
1580697|NCT00462241|Treatment study|treatment study
1580698|NCT00462241|Chiropractor|chiropractor
1580699|NCT00462228|traumatic brain injury|traumatic brain injury
1580700|NCT00462228|memory|memory
1580701|NCT00462228|attention|attention
1580702|NCT00462202|Diabetes|diabetes
1580703|NCT00462202|Microalbuminuria|microalbuminuria
1580704|NCT00462202|Proteinuria|proteinuria
1580705|NCT00462202|Albuminuria|albuminuria
1580706|NCT00462202|KRX-101|krx-101
1580707|NCT00462202|Sulodexide|sulodexide
1580708|NCT00462202|Nephropathy|nephropathy
1580709|NCT00462202|Keryx|keryx
1580710|NCT00462202|Collaborative Study Group|collaborative study group
1580711|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
1580712|NCT00462189|CAT-8015|cat-8015
1580713|NCT00462189|HA22|ha22
1580714|NCT00462189|HCL|hcl
1580715|NCT00462189|Relapse|relapse
1580716|NCT00462189|Refractory|refractory
1580717|NCT00462189|immunotherapy|immunotherapy
1580718|NCT00462189|immunotoxin|immunotoxin
1580719|NCT00462176|colorectal endometriosis|colorectal endometriosis
1580720|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
1580721|NCT00462176|dysmenorroe|dysmenorroe
1580722|NCT00462176|dyspareunia|dyspareunia
1580723|NCT00462176|quality of life|quality of life
1580724|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
1580725|NCT00462150|expressed emotion|expressed emotion
1580726|NCT00462150|randomized controlled trial|randomized controlled trial
1580727|NCT00462150|affect|affect
1580728|NCT00462150|blood sedimentation|blood sedimentation
1580729|NCT00462150|psychophysiology|psychophysiology
1580730|NCT00462150|feasibility studies|feasibility studies
1580731|NCT00462150|intervention studies|intervention studies
1580732|NCT00462150|time management|time management
1580733|NCT00462137|GERD|gerd
1580734|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
1580735|NCT00462124|Prostate|prostate
1580738|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
1580739|NCT00462124|intrarectal balloon|intrarectal balloon
1580740|NCT00462111|indometacin|indometacin
1580741|NCT00462111|reaction time|reaction time
1580742|NCT00462111|postural balance|postural balance
1580743|NCT00462111|obstacle avoidance|obstacle avoidance
1580744|NCT00462111|accidental falls|accidental falls
1580745|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
1580746|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
1580747|NCT00462098|bisphosphonates|bisphosphonates
1580748|NCT00462085|cerebral palsy|cerebral palsy
1580749|NCT00462085|ankle foot orthosis|ankle foot orthosis
1580750|NCT00462085|emg|emg
1580751|NCT00462085|surface electromyography|surface electromyography
1580752|NCT00462085|gait analysis|gait analysis
1580753|NCT00462059|Transition of care|transition of care
1580754|NCT00462059|Continuity of care|continuity of care
1580755|NCT00462046|Berberine|berberine
1580756|NCT00462046|Type 2 diabetes|type 2 diabetes
1580757|NCT00462046|Dyslipidemia|dyslipidemia
1580758|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
1580760|NCT00461994|CHILDREN|children
1580761|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
1580762|NCT00461994|DIET|diet
1580763|NCT00461994|EXERCISE|exercise
1581068|NCT00460746|TMC114|tmc114
1580764|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
1580765|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
1580766|NCT00461981|FluMist|flumist
1580767|NCT00461968|Cholesterol|cholesterol
1580768|NCT00461968|LDL|ldl
1580769|NCT00461968|Ezetimibe|ezetimibe
1580770|NCT00461968|Statin|statin
1580771|NCT00461968|Zetia|zetia
1580772|NCT00461968|Zocor|zocor
1580773|NCT00461968|Simvastin|simvastin
1580774|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
1580775|NCT00461955|first line treatment|first line treatment
1580776|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
1580777|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
1580778|NCT00461942|Health Food;|health food;
1580779|NCT00461942|Green Tea;|green tea;
1580780|NCT00461942|Neuroprotection|neuroprotection
1580781|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
1580782|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
1580783|NCT00461929|chromosome abnormality|chromosome abnormality
1580784|NCT00461929|imatinib|imatinib
1580785|NCT00461929|bone marrow aspiration|bone marrow aspiration
1580786|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
1580787|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
1580788|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
1580789|NCT00461916|long protocol|long protocol
1580790|NCT00461916|ICSI|icsi
1580791|NCT00461903|essential hypertension|essential hypertension
1580792|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
1580793|NCT00461890|Alcohol|alcohol
1580794|NCT00461890|Veterans|veterans
1580795|NCT00461890|Primary Care|primary care
1580796|NCT00461890|Naltrexone|naltrexone
1580797|NCT00461864|fracture|fracture
1580798|NCT00461864|occult|occult
1580799|NCT00461864|hip|hip
1580800|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
1580801|NCT00461838|colorectal endometriosis|colorectal endometriosis
1580802|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
1580803|NCT00461838|dysmenorroe|dysmenorroe
1580804|NCT00461838|dyspareunia|dyspareunia
1580805|NCT00461838|quality of life|quality of life
1580806|NCT00461825|Immunosuppression|immunosuppression
1580807|NCT00461825|Kidney transplantation|kidney transplantation
1580808|NCT00461825|multicenter study|multicenter study
1580809|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
1580810|NCT00461799|Bilirubin.|bilirubin.
1580811|NCT00461799|Phototherapy.|phototherapy.
1580812|NCT00461799|Orlistat.|orlistat.
1580813|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
1580814|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
1580815|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
1580816|NCT00461747|Untreated|untreated
1580817|NCT00461747|Transplant|transplant
1580818|NCT00461747|Younger|younger
1580819|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
1580820|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
1580821|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
1580822|NCT00461734|Heart Block|heart block
1580823|NCT00461734|Pacemaker|pacemaker
1580824|NCT00461734|Atrial Fibrillation|atrial fibrillation
1580825|NCT00461734|Ejection Fraction|ejection fraction
1580826|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
1580827|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
1580828|NCT00461695|Ageing|ageing
1580829|NCT00461695|Vaccine|vaccine
1580830|NCT00461695|Immunity|immunity
1580831|NCT00461682|TRPV1 antagonist|trpv1 antagonist
1580832|NCT00461682|Fecal Urgency|fecal urgency
1580836|NCT00461669|fracture|fracture
1580837|NCT00461669|ultrasound|ultrasound
1580838|NCT00461656|Antiseptic|antiseptic
1580839|NCT00461656|Povidone-Iodine|povidone-iodine
1580840|NCT00461643|Anovulation|anovulation
1580841|NCT00461643|Clomiphene citrate|clomiphene citrate
1580842|NCT00461643|Infertility|infertility
1580843|NCT00461643|Metformin|metformin
1580844|NCT00461643|PCOS|pcos
1580845|NCT00461643|RCT|rct
1580846|NCT00461643|Treatment|treatment
1580847|NCT00461630|coronary heart disease|coronary heart disease
1580848|NCT00461630|cardiovascular disease|cardiovascular disease
1580849|NCT00461630|stroke|stroke
1580850|NCT00461630|peripheral arterial disease|peripheral arterial disease
1580851|NCT00461630|diabetes mellitus|diabetes mellitus
1580852|NCT00461630|cholesterol|cholesterol
1580853|NCT00461630|HDL cholesterol|hdl cholesterol
1580854|NCT00461630|simvastatin|simvastatin
1580855|NCT00461630|ezetimibe|ezetimibe
1580856|NCT00461630|ER niacin|er niacin
1580857|NCT00461630|laropiprant|laropiprant
1580858|NCT00461617|diabetes|diabetes
1580859|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
1580860|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
1580861|NCT00461617|HbA1C|hba1c
1580863|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
1580864|NCT00461604|baclofen|baclofen
1580865|NCT00461604|impedance|impedance
1580866|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
1580867|NCT00461578|P.falciparum|p.falciparum
1580868|NCT00461578|malaria|malaria
1580869|NCT00461578|lapdap+artesunate|lapdap+artesunate
1580870|NCT00461578|safety|safety
1580871|NCT00461578|efficay|efficay
1580872|NCT00461565|Retina|retina
1580873|NCT00461565|PDE-5|pde-5
1580874|NCT00461565|Levitra|levitra
1580875|NCT00461565|Viagra|viagra
1580876|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
1580877|NCT00461552|Lipodystrophy|lipodystrophy
1580878|NCT00461552|HIV|hiv
1580879|NCT00461552|HAART|haart
1580880|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
1580881|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
1580882|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
1580883|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
1580884|NCT00461552|Treatment Experienced|treatment experienced
1580885|NCT00461539|Tobacco Use|tobacco use
1580886|NCT00461539|Alcohol and Drug Use|alcohol and drug use
1580887|NCT00461539|Obesity|obesity
1580888|NCT00461539|Risky Sexual Behavior|risky sexual behavior
1580889|NCT00461526|IBS|ibs
1580890|NCT00461526|d-IBS|d-ibs
1580891|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
1580892|NCT00461513|Heart Failure, Congestive|heart failure, congestive
1580893|NCT00461513|Disease Management|disease management
1580894|NCT00461513|Health Status|health status
1580895|NCT00461513|Quality of Life|quality of life
1580896|NCT00461513|Telemedicine|telemedicine
1580897|NCT00461513|Depression|depression
1580898|NCT00461500|persistent|persistent
1580899|NCT00461500|moderate|moderate
1580900|NCT00461500|asthma|asthma
1580901|NCT00461500|adults|adults
1580902|NCT00461500|Initial|initial
1580903|NCT00461500|Maintenance|maintenance
1580905|NCT00461487|Adolescent Behavior|adolescent behavior
1580906|NCT00461487|Communication|communication
1580907|NCT00461487|Health Behavior|health behavior
1580908|NCT00461487|Risk-Taking|risk-taking
1580909|NCT00461487|Sexual Behavior|sexual behavior
1580910|NCT00461474|Shoulder pain|shoulder pain
1580911|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
1580912|NCT00461474|Exercise|exercise
1580913|NCT00461474|Physical therapy techniques|physical therapy techniques
1580914|NCT00461474|Motor performance|motor performance
1580915|NCT00461448|Potassium supplement|potassium supplement
1580916|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
1580917|NCT00461448|Pain|pain
1580918|NCT00461448|Disease Activity|disease activity
1580919|NCT00461422|IVF|ivf
1580920|NCT00461422|GnRH antagonist|gnrh antagonist
1580921|NCT00461409|Neonatal Seizures|neonatal seizures
1580922|NCT00461409|Treatment|treatment
1580923|NCT00461409|Anticonvulsant|anticonvulsant
1580924|NCT00461409|Levetiracetam|levetiracetam
1580925|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1580926|NCT00461396|First demyelinating event|first demyelinating event
1580927|NCT00461396|MRI features consistent with MS|mri features consistent with ms
1580928|NCT00461370|safety|safety
1580929|NCT00461370|Phase 1|phase 1
1580930|NCT00461370|pharmacokinetics|pharmacokinetics
1580931|NCT00461370|SRX251|srx251
1580932|NCT00461370|Azevan|azevan
1580933|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
1580934|NCT00461357|Old for Old|old for old
1580935|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
1580936|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
1580937|NCT00461344|Breast|breast
1580938|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
1580939|NCT00461331|Glycemic control|glycemic control
1580940|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
1580941|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
1580942|NCT00461318|vocational rehabilitation|vocational rehabilitation
1580943|NCT00461318|psychosis|psychosis
1580944|NCT00461318|cross country comparison|cross country comparison
1580945|NCT00461305|Dysmenorrhea|dysmenorrhea
1580946|NCT00461305|Intracyclic bleeding|intracyclic bleeding
1580947|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
1580948|NCT00461305|Ethinylestradiol|ethinylestradiol
1580949|NCT00461279|attachment|attachment
1580950|NCT00461279|depression|depression
1580951|NCT00461279|IPT|ipt
1580952|NCT00461279|CBT|cbt
1582025|NCT00457223|excision|excision
1580953|NCT00461279|pharmacotherapy|pharmacotherapy
1580954|NCT00461266|Treatment Experienced|treatment experienced
1580955|NCT00461253|breast cancer|breast cancer
1580956|NCT00461240|heart|heart
1580957|NCT00461240|MRS|mrs
1580958|NCT00461240|acromegaly|acromegaly
1580959|NCT00461240|growth hormone|growth hormone
1580960|NCT00461227|Puerto Rican|puerto rican
1580961|NCT00461227|Allergies|allergies
1580962|NCT00461214|laparoscopy|laparoscopy
1580963|NCT00461214|surgery|surgery
1580964|NCT00461214|technical skills|technical skills
1580965|NCT00461214|outcomes|outcomes
1580966|NCT00461214|resident training|resident training
1580967|NCT00461201|Health Services Research|health services research
1580968|NCT00461201|Nurse Practitioners|nurse practitioners
1580969|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1580970|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
1580971|NCT00461201|Patient Satisfaction|patient satisfaction
1580972|NCT00461201|Primary Health Care|primary health care
1580973|NCT00461201|Professional Autonomy|professional autonomy
1580974|NCT00461188|acromegaly|acromegaly
1580975|NCT00461188|gigantism|gigantism
1580976|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
1580977|NCT00461188|Familial acromegaly|familial acromegaly
1580978|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
1580979|NCT00461188|FIPA|fipa
1580980|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
1580981|NCT00461188|PAP|pap
1580982|NCT00461175|Uterine Perforation|uterine perforation
1580983|NCT00461149|Acromegaly|acromegaly
1580984|NCT00461149|GH|gh
1580985|NCT00461149|IGF-I|igf-i
1580986|NCT00461149|Pituitary tumors|pituitary tumors
1580987|NCT00461149|Octreotide|octreotide
1580988|NCT00461136|Time course|time course
1580989|NCT00461136|antiproteinuric|antiproteinuric
1580990|NCT00461136|blood pressure|blood pressure
1580991|NCT00461136|lowering effect|lowering effect
1580992|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
1580993|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
1580994|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
1580995|NCT00461097|Egg Allergy|egg allergy
1580996|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
1580997|NCT00461097|Food Allergy|food allergy
1580998|NCT00461084|Lymphoma|lymphoma
1580999|NCT00461084|Advanced Stage|advanced stage
1581000|NCT00461084|Untreated|untreated
1581001|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
1581002|NCT00461084|Untreated Lymphoma|untreated lymphoma
1581003|NCT00461084|07-038|07-038
1581004|NCT00461071|Bulimia nervosa|bulimia nervosa
1581005|NCT00461071|Guided Self-help|guided self-help
1581006|NCT00461071|Psycho-education|psycho-education
1581007|NCT00461045|multiple myeloma|multiple myeloma
1581008|NCT00461045|proteasome inhibitor|proteasome inhibitor
1581009|NCT00461045|relapsed|relapsed
1581010|NCT00461045|refractory|refractory
1581011|NCT00460993|Aging|aging
1581012|NCT00460993|Sleep|sleep
1581013|NCT00460993|Nursing Home|nursing home
1581014|NCT00460993|Sleep in nursing homes|sleep in nursing homes
1581015|NCT00460980|resident training|resident training
1581016|NCT00460980|laparoscopic skills|laparoscopic skills
1581017|NCT00460980|surgical skills assessment|surgical skills assessment
1581018|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
1581019|NCT00460928|congenital heart block|congenital heart block
1581020|NCT00460928|neonatal lupus|neonatal lupus
1581021|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
1581022|NCT00460928|Sjogren syndrome|sjogren syndrome
1581023|NCT00460928|autoantibodies|autoantibodies
1581024|NCT00460928|SSA/Ro|ssa/ro
1581025|NCT00460928|SSB/La|ssb/la
1581026|NCT00460928|autoimmunity|autoimmunity
1581027|NCT00460928|pregnancy|pregnancy
1581028|NCT00460928|intravenous immune globulin|intravenous immune globulin
1581029|NCT00460928|IVIG|ivig
1581030|NCT00460928|immunoglobulin|immunoglobulin
1581031|NCT00460915|Lacidipine|lacidipine
1581032|NCT00460915|Amlodipine|amlodipine
1581034|NCT00460902|drug resistant depression|drug resistant depression
1581035|NCT00460889|hand assist|hand assist
1581036|NCT00460889|laparoscopy|laparoscopy
1581037|NCT00460889|renal donor|renal donor
1581038|NCT00460889|outcomes|outcomes
1581039|NCT00460876|topotecan|topotecan
1581040|NCT00460876|periocular|periocular
1581041|NCT00460876|chemotherapy|chemotherapy
1581042|NCT00460863|sleep|sleep
1581043|NCT00460863|hemodialysis|hemodialysis
1581044|NCT00460863|daytime sleepiness|daytime sleepiness
1581045|NCT00460863|temperature|temperature
1581046|NCT00460837|colorectal cancer|colorectal cancer
1581047|NCT00460837|bowel preparation regimen|bowel preparation regimen
1581048|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
1581049|NCT00460824|transplant|transplant
1581050|NCT00460824|HLA antibodies matching|hla antibodies matching
1581051|NCT00460824|immunologic mismatching|immunologic mismatching
1581052|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
1581053|NCT00460811|IBS|ibs
1581054|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
1581055|NCT00460811|linaclotide acetate|linaclotide acetate
1581056|NCT00460811|linaclotide|linaclotide
1581057|NCT00460811|MD-1100|md-1100
1581058|NCT00460798|Sunitinib|sunitinib
1581059|NCT00460798|kidney diseases|kidney diseases
1581060|NCT00460798|urogenital neoplasms|urogenital neoplasms
1581061|NCT00460798|kidney cancer|kidney cancer
1581062|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
1581063|NCT00460746|HIV|hiv
1581064|NCT00460746|AIDS|aids
1581065|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
1581069|NCT00460746|TMC125|tmc125
1581070|NCT00460746|Protease Inhibitor|protease inhibitor
1581071|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
1581072|NCT00460746|enfuvirtide|enfuvirtide
1581073|NCT00460746|Treatment Experienced|treatment experienced
1581074|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1581075|NCT00460720|ADHD|adhd
1581076|NCT00460720|Methylphenidate|methylphenidate
1581077|NCT00460720|MPH|mph
1581078|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
1581079|NCT00460707|GW679769|gw679769
1581080|NCT00460707|healthy adult subjects|healthy adult subjects
1581081|NCT00460707|casopitant|casopitant
1581082|NCT00460707|ketoconazole|ketoconazole
1581083|NCT00460694|allogeneic transplant|allogeneic transplant
1581084|NCT00460694|haematological malignancies|haematological malignancies
1581085|NCT00460694|allogeneic CIK cells|allogeneic cik cells
1581086|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
1581087|NCT00460681|Thymopentin|thymopentin
1581088|NCT00460681|Recurrence|recurrence
1581089|NCT00460681|Resection|resection
1581090|NCT00460668|elective thoracotomy|elective thoracotomy
1581091|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
1581092|NCT00460668|quality of life|quality of life
1581093|NCT00460655|Post-Stroke|post-stroke
1581094|NCT00460655|Lower Limb|lower limb
1581095|NCT00460655|botulinum toxin type A|botulinum toxin type a
1581096|NCT00460655|Spasticity|spasticity
1581097|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
1581098|NCT00460642|Egg donation (ED).|egg donation (ed).
1581099|NCT00460642|IVF.|ivf.
1581100|NCT00460642|ART.|art.
1581101|NCT00460642|Implantation.|implantation.
1581102|NCT00460642|GnRH antagonist.|gnrh antagonist.
1581103|NCT00460642|Cetrotide.|cetrotide.
1581104|NCT00460642|Endometrial response.|endometrial response.
1581105|NCT00460642|Infertility treatments:|infertility treatments:
1581106|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
1581107|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
1581108|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
1581109|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
1581110|NCT00460616|Prolactin|prolactin
1581111|NCT00460616|Prolactinomas|prolactinomas
1581112|NCT00460616|Dopamine-Agonists|dopamine-agonists
1581113|NCT00460616|Cabergoline|cabergoline
1581114|NCT00460616|Cardiac valve disease|cardiac valve disease
1581115|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
1581116|NCT00460590|Tuberculosis|tuberculosis
1581117|NCT00460590|TB|tb
1581118|NCT00460590|MVA 85A|mva 85a
1581119|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
1581120|NCT00460564|Spasticity|spasticity
1581121|NCT00460564|Post-Stroke|post-stroke
1581122|NCT00460564|botulinum toxin type A|botulinum toxin type a
1581123|NCT00460564|Upper Limb|upper limb
1581124|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
1581125|NCT00460538|lectranal|lectranal
1581126|NCT00460538|allergy|allergy
1581127|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
1581128|NCT00460512|Schizophrenia|schizophrenia
1581129|NCT00460512|Flexible dosing|flexible dosing
1581130|NCT00460512|Non-acute patients|non-acute patients
1581131|NCT00460512|Antipsychotic|antipsychotic
1581132|NCT00460512|Atypical|atypical
1581133|NCT00460512|INVEGA|invega
1581134|NCT00460499|Diabetes|diabetes
1581135|NCT00460473|Mental Health|mental health
1581136|NCT00460473|Neurological Disease|neurological disease
1581137|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
1581138|NCT00460460|Phase I|phase i
1581139|NCT00460460|cancer|cancer
1581140|NCT00460460|lymphoma|lymphoma
1581141|NCT00460460|leukemia|leukemia
1581142|NCT00460460|myeloma|myeloma
1581143|NCT00460460|AML|aml
1581144|NCT00460460|ALL|all
1581145|NCT00460460|NHL|nhl
1581146|NCT00460460|MM|mm
1581147|NCT00460447|anti-CD33|anti-cd33
1581148|NCT00460447|Immunotoxin|immunotoxin
1581149|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
1581150|NCT00460434|Prolapse|prolapse
1581151|NCT00460434|Urinary incontinence|urinary incontinence
1581152|NCT00460434|TVT|tvt
1581153|NCT00460421|Oral Mucositis|oral mucositis
1581154|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1581155|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
1581156|NCT00460421|Palifermin|palifermin
1581157|NCT00460421|Kepivance|kepivance
1581158|NCT00460408|Macular degeneration|macular degeneration
1581159|NCT00460408|Safety|safety
1581160|NCT00460408|Non-interventional|non-interventional
1581161|NCT00460408|Non-randomized|non-randomized
1581162|NCT00460395|Brain Metastasis|brain metastasis
1581163|NCT00460395|Cerebral Metastases|cerebral metastases
1581164|NCT00460395|Brain Cancer|brain cancer
1581165|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
1581166|NCT00460395|Craniotomy|craniotomy
1581167|NCT00460382|HIV infections|hiv infections
1581168|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
1581169|NCT00460382|etravirine|etravirine
1581170|NCT00460382|darunavir|darunavir
1581171|NCT00460382|MK 0518|mk 0518
1581172|NCT00460382|raltegravir|raltegravir
1581173|NCT00460382|Treatment Experienced|treatment experienced
1581174|NCT00460382|Antiviral drug resistance|antiviral drug resistance
1581175|NCT00460369|uncomplicated malaria|uncomplicated malaria
1581176|NCT00460369|children|children
1581177|NCT00460369|treatment|treatment
1581178|NCT00460369|effectiveness|effectiveness
1581179|NCT00460343|patient non-adherence|patient non-adherence
1581180|NCT00460343|antihypertensive agents|antihypertensive agents
1581181|NCT00460343|community pharmacy services|community pharmacy services
1581182|NCT00460343|professional roles|professional roles
1581183|NCT00460330|diagnosis|diagnosis
1581184|NCT00460330|galactomannan|galactomannan
1581185|NCT00460330|glucan|glucan
1581186|NCT00460330|real-time PCR|real-time pcr
1581187|NCT00460330|invasive fungal infection|invasive fungal infection
1581188|NCT00460330|aspergillosis|aspergillosis
1581189|NCT00460330|Chinese patients|chinese patients
1581190|NCT00460317|lung|lung
1581191|NCT00460317|cancer|cancer
1581192|NCT00460317|chemotherapy|chemotherapy
1581193|NCT00460317|paclitaxel|paclitaxel
1581194|NCT00460317|carboplatin|carboplatin
1581195|NCT00460317|placebo|placebo
1581196|NCT00460317|angiogenesis|angiogenesis
1581197|NCT00460317|VEGF|vegf
1581198|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
1581199|NCT00460304|Type I diabetes|type i diabetes
1581200|NCT00460304|Insulin pump|insulin pump
1581201|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
1581202|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
1581203|NCT00460304|Correction factor|correction factor
1581204|NCT00460304|Pramlintide|pramlintide
1581205|NCT00460291|PAD|pad
1581206|NCT00460291|vein bypass|vein bypass
1581207|NCT00460291|supported varicose veins|supported varicose veins
1581208|NCT00460278|Cancer|cancer
1581209|NCT00460278|Solid Tumors|solid tumors
1581210|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
1581211|NCT00460265|Epidermal Growth Factor|epidermal growth factor
1581212|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1581213|NCT00460265|SCCHN|scchn
1581214|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
1581215|NCT00460265|EGFr|egfr
1581216|NCT00460265|Head and Neck Cancer|head and neck cancer
1581217|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
1581218|NCT00460252|algorithm|algorithm
1581219|NCT00460252|insulin|insulin
1581220|NCT00460252|hyperglycemia|hyperglycemia
1581221|NCT00460252|tight glycemic control|tight glycemic control
1581222|NCT00460252|intensive care|intensive care
1581223|NCT00460252|adults|adults
1581224|NCT00460239|Opioid addiction|opioid addiction
1581225|NCT00460239|Opioid dependence|opioid dependence
1581226|NCT00460239|Buprenorphine|buprenorphine
1581227|NCT00460226|Korean|korean
1581228|NCT00460226|Bipolar I disorder|bipolar i disorder
1581229|NCT00460226|Non-serious rash|non-serious rash
1581230|NCT00460226|Lamotrigine|lamotrigine
1581231|NCT00460213|home blood pressure|home blood pressure
1581232|NCT00460200|depression|depression
1581233|NCT00460200|fatigue|fatigue
1581234|NCT00460200|sleep disorders|sleep disorders
1581235|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1581236|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
1581237|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
1581238|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
1581239|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
1581240|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
1581241|NCT00460161|acupuncture|acupuncture
1581242|NCT00460161|amputation|amputation
1581243|NCT00460161|phantom limb pain|phantom limb pain
1581244|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
1581245|NCT00460148|pharmacokinetic,|pharmacokinetic,
1581246|NCT00460148|formulation,|formulation,
1581247|NCT00460148|food effect,|food effect,
1581248|NCT00460148|SK&F101468,|sk&f101468,
1581249|NCT00460148|PD|pd
1581250|NCT00460135|Resistance|resistance
1581251|NCT00460135|Training|training
1581252|NCT00460135|Obesity|obesity
1581253|NCT00460135|Children|children
1581254|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
1581255|NCT00460122|Transfusion Reactions|transfusion reactions
1581256|NCT00460122|Platelet Donors|platelet donors
1581257|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1582437|NCT00455598|Diabetes|diabetes
1581258|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1581259|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1581260|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1581261|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
1581262|NCT00460083|Atopic Dermatitis|atopic dermatitis
1581263|NCT00460083|eczema|eczema
1581264|NCT00460083|dermatitis|dermatitis
1581265|NCT00460083|skin barrier|skin barrier
1581266|NCT00460083|barrier repair|barrier repair
1581267|NCT00460083|ceramide|ceramide
1581268|NCT00460083|physiologic lipid|physiologic lipid
1581269|NCT00460083|pruritus|pruritus
1581270|NCT00460083|Elidel|elidel
1581271|NCT00460083|Epiceram|epiceram
1581272|NCT00460083|topical steroid|topical steroid
1581273|NCT00460057|osteoporosis|osteoporosis
1581274|NCT00460057|alendronate|alendronate
1581275|NCT00460057|bone marker|bone marker
1581276|NCT00460044|ADMA|adma
1581277|NCT00460044|Preterms|preterms
1581278|NCT00460044|infants|infants
1581279|NCT00460044|mechanical ventilation|mechanical ventilation
1581280|NCT00460044|Preterm infants|preterm infants
1581281|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1581282|NCT00460031|stage III prostate cancer|stage iii prostate cancer
1581283|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
1581284|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
1581285|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
1581286|NCT00460018|Weight Loss|weight loss
1581287|NCT00460018|Physical Activity|physical activity
1581288|NCT00460018|Breastfeeding|breastfeeding
1581289|NCT00460018|Pregnancy|pregnancy
1581290|NCT00460018|Postpartum|postpartum
1581291|NCT00460018|Intervention|intervention
1581292|NCT00460018|Prevention|prevention
1581293|NCT00460005|Migraine|migraine
1581294|NCT00460005|headache|headache
1581295|NCT00460005|observational|observational
1581297|NCT00459992|Weight Gain|weight gain
1581298|NCT00459992|Adult|adult
1581299|NCT00459992|Histamine|histamine
1581300|NCT00459992|Metabolism|metabolism
1581301|NCT00459992|Overweight|overweight
1581302|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1581303|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
1581304|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
1581305|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
1581306|NCT00459940|Growth hormone|growth hormone
1581307|NCT00459940|Lipolysis|lipolysis
1581308|NCT00459940|Insulin resistance|insulin resistance
1581309|NCT00459940|Pioglitazone|pioglitazone
1581310|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
1581311|NCT00459927|Adenotonsillectomy|adenotonsillectomy
1581312|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
1581313|NCT00459927|Floseal|floseal
1581314|NCT00459914|sleep apnea|sleep apnea
1581315|NCT00459914|refractory hypertension|refractory hypertension
1581316|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
1581317|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
1581318|NCT00459888|CLI|cli
1581319|NCT00459888|Critical Limb Ischemia|critical limb ischemia
1581320|NCT00459888|Infrapopliteal|infrapopliteal
1581321|NCT00459888|Cryoplasty|cryoplasty
1581322|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
1581323|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
1581324|NCT00459849|Melanoma|melanoma
1581325|NCT00459849|Brachytherapy|brachytherapy
1581326|NCT00459849|Ultrasonography|ultrasonography
1581327|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1581328|NCT00459823|Cancer|cancer
1581329|NCT00459823|solid tumors|solid tumors
1581330|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1581331|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
1581332|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
1581333|NCT00459797|GlideScope|glidescope
1581334|NCT00459797|cobalt|cobalt
1581335|NCT00459797|single-use|single-use
1581336|NCT00459797|intubation|intubation
1581337|NCT00459797|airway|airway
1581338|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
1581339|NCT00459784|Improvement|improvement
1581340|NCT00459784|Dementia early diagnosis|dementia early diagnosis
1581341|NCT00459784|Dementia management|dementia management
1581342|NCT00459784|Primary care|primary care
1581343|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
1581344|NCT00459771|prevention|prevention
1581345|NCT00459771|trastuzumab|trastuzumab
1581346|NCT00459771|cardiotoxicity|cardiotoxicity
1581347|NCT00459758|hypertension|hypertension
1581348|NCT00459758|Hans|hans
1581349|NCT00459758|Electrical stimulation|electrical stimulation
1581350|NCT00459745|Cardiovascular Disease|cardiovascular disease
1581351|NCT00459745|Fenofibrate|fenofibrate
1581352|NCT00459745|LDL cholesterol|ldl cholesterol
1581353|NCT00459745|HDL cholesterol|hdl cholesterol
1581354|NCT00459745|Hyperlipidemia|hyperlipidemia
1581355|NCT00459745|Pravastatin|pravastatin
1581356|NCT00459745|Triglycerides|triglycerides
1582537|NCT00455117|analgesia|analgesia
1581357|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
1581358|NCT00459719|Liver Transplantation|liver transplantation
1581359|NCT00459719|Tacrolimus|tacrolimus
1581360|NCT00459719|Methylprednisolone|methylprednisolone
1581361|NCT00459719|Prednisolone|prednisolone
1581362|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
1581363|NCT00459693|HIV-Dementia|hiv-dementia
1581364|NCT00459693|Brain|brain
1581365|NCT00459693|PET|pet
1581366|NCT00459693|PBR28|pbr28
1581367|NCT00459693|MCMD|mcmd
1581368|NCT00459693|HIV Positive|hiv positive
1581369|NCT00459693|HIV Dementia|hiv dementia
1581370|NCT00459693|AIDS Related Dementia|aids related dementia
1581371|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
1581372|NCT00459693|Healthy Volunteer|healthy volunteer
1581373|NCT00459693|HV|hv
1581374|NCT00459680|hypertension|hypertension
1581375|NCT00459680|acupuncture|acupuncture
1581376|NCT00459680|laser|laser
1581377|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
1581378|NCT00459667|interferon beta 1b|interferon beta 1b
1581379|NCT00459667|Betaferon|betaferon
1581380|NCT00459667|Betaseron|betaseron
1581381|NCT00459654|HRPC|hrpc
1581382|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
1581383|NCT00459654|Metastatic Cancer|metastatic cancer
1581384|NCT00459641|Osteogenic Gel|osteogenic gel
1581385|NCT00459641|Solitary Bone Cysts|solitary bone cysts
1581386|NCT00459628|early breast cancer|early breast cancer
1581387|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
1581388|NCT00459602|laparoscopic surgery|laparoscopic surgery
1581389|NCT00459589|Cancer|cancer
1581390|NCT00459589|elderly|elderly
1581391|NCT00459589|malnutrition|malnutrition
1581392|NCT00459589|chemotherapy|chemotherapy
1581393|NCT00459589|survival|survival
1581394|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
1581395|NCT00459589|morbidity|morbidity
1581396|NCT00459576|Asthma|asthma
1581397|NCT00459576|Eczema|eczema
1581398|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
1581399|NCT00459576|Infant|infant
1581400|NCT00459563|vitamin D|vitamin d
1581401|NCT00459563|blood pressure|blood pressure
1581402|NCT00459563|hypertension|hypertension
1581403|NCT00459563|Vitamin D insufficient|vitamin d insufficient
1581404|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
1581405|NCT00459550|Alzheimer's Disease|alzheimer's disease
1581406|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
1581407|NCT00459537|Toenail fungus|toenail fungus
1581408|NCT00459537|Onychomycosis|onychomycosis
1581409|NCT00459537|Nail fungus|nail fungus
1581410|NCT00459537|Toenail fungal infection|toenail fungal infection
1581411|NCT00459537|Tinea unguium|tinea unguium
1581412|NCT00459537|Dermatophytes|dermatophytes
1581413|NCT00459537|Foot dermatoses|foot dermatoses
1581414|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
1581415|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
1581416|NCT00459524|Leukemia|leukemia
1581417|NCT00459524|Quality of Life|quality of life
1581418|NCT00459524|Questionnaire|questionnaire
1581419|NCT00459524|Survey|survey
1581420|NCT00459524|Neurocognitive Function|neurocognitive function
1581421|NCT00459524|AML|aml
1581422|NCT00459524|MDS|mds
1581423|NCT00459524|QOL|qol
1581424|NCT00459511|Adrenomedullin|adrenomedullin
1581425|NCT00459511|Glucose|glucose
1581426|NCT00459511|Insulin|insulin
1581427|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
1581428|NCT00459511|Pediatric|pediatric
1581429|NCT00459511|Cortisol|cortisol
1581430|NCT00459511|ACTH|acth
1581431|NCT00459498|NIS|nis
1581432|NCT00459498|thyroid adenoma|thyroid adenoma
1581433|NCT00459498|thyroid cancer|thyroid cancer
1581434|NCT00459498|Iodine uptake|iodine uptake
1581435|NCT00459498|expression|expression
1581436|NCT00459485|Plasm zinc concentration|plasm zinc concentration
1581437|NCT00459485|Zinc supplementation|zinc supplementation
1581438|NCT00459485|Assessment of zinc status|assessment of zinc status
1581439|NCT00459485|Plasma zinc concentration|plasma zinc concentration
1581440|NCT00459472|resident training|resident training
1581441|NCT00459472|laparoscopy|laparoscopy
1581442|NCT00459472|virtual reality|virtual reality
1581443|NCT00459472|surgical education|surgical education
1581444|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
1581445|NCT00459446|Gadolinium Contrast|gadolinium contrast
1581446|NCT00459446|Gadofosveset|gadofosveset
1581447|NCT00459446|Atherosclerosis|atherosclerosis
1581448|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
1581449|NCT00459446|Cardiovascular Disease|cardiovascular disease
1581450|NCT00459446|Blocked Arteries|blocked arteries
1581451|NCT00459446|Peripheral Artery Disease|peripheral artery disease
1581452|NCT00459446|PAD|pad
1581453|NCT00459446|Intermittent Claudication|intermittent claudication
1581454|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
1581455|NCT00459433|Low back pain|low back pain
1581456|NCT00459433|Return to work|return to work
1581457|NCT00459433|Biopsychosocial|biopsychosocial
1581458|NCT00459433|Screening|screening
1581460|NCT00459433|Non specific low back pain|non specific low back pain
1581461|NCT00459420|Parkinson's disease|parkinson's disease
1581462|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
1581463|NCT00459420|Caffeine|caffeine
1581464|NCT00459420|Disease-Modifying|disease-modifying
1581465|NCT00459368|asthma|asthma
1581466|NCT00459368|patient compliance|patient compliance
1581467|NCT00459368|metered dose inhalers|metered dose inhalers
1581468|NCT00459368|corticosteroids|corticosteroids
1581469|NCT00459368|health behaviour|health behaviour
1581470|NCT00459368|prevention & control|prevention & control
1581471|NCT00459355|Alzheimer's disease|alzheimer's disease
1581472|NCT00459355|Dementia|dementia
1581473|NCT00459355|Safety|safety
1581474|NCT00459355|Home Care Services|home care services
1581475|NCT00459329|Depression|depression
1581476|NCT00459329|Epilepsy|epilepsy
1581477|NCT00459329|Problem-Solving Therapy|problem-solving therapy
1581478|NCT00459329|Mental Health|mental health
1581479|NCT00459329|Neurology|neurology
1581480|NCT00459329|Home-based health care|home-based health care
1581481|NCT00459329|Community-based program|community-based program
1581482|NCT00459329|Collaborative care|collaborative care
1581483|NCT00459303|cataract|cataract
1581484|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
1581485|NCT00459303|functional vision|functional vision
1581486|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1581487|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1581488|NCT00459290|fallopian tube cancer|fallopian tube cancer
1581489|NCT00459277|Pain|pain
1581490|NCT00459277|Cancer|cancer
1581491|NCT00459264|Folic Acid|folic acid
1581492|NCT00459264|Prevention|prevention
1581493|NCT00459264|Depression|depression
1581494|NCT00459264|Bipolar Disorder|bipolar disorder
1581495|NCT00459264|Teenagers|teenagers
1581496|NCT00459251|N-acetyltransferase|n-acetyltransferase
1581497|NCT00459251|Pharmacogenetics|pharmacogenetics
1581498|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1581499|NCT00459225|Pediatrics|pediatrics
1581500|NCT00459225|Cardiac Defect|cardiac defect
1581501|NCT00459225|Cardiac Surgery|cardiac surgery
1581502|NCT00459225|Single Ventricle|single ventricle
1581503|NCT00459225|Anemia|anemia
1581504|NCT00459225|blood transfusions|blood transfusions
1581505|NCT00459225|red cell volume|red cell volume
1581506|NCT00459225|red cell distribution|red cell distribution
1581507|NCT00459225|oral iron|oral iron
1581508|NCT00459225|ferrous sulfate|ferrous sulfate
1581509|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
1581510|NCT00459225|Hemoglobin|hemoglobin
1581511|NCT00459225|Iron Deficiency|iron deficiency
1581512|NCT00459186|prostate cancer|prostate cancer
1581513|NCT00459186|RAD001|rad001
1581514|NCT00459186|mTOR inhibition|mtor inhibition
1581515|NCT00459186|docetaxel|docetaxel
1581516|NCT00459173|abstinence|abstinence
1581517|NCT00459173|maintenance|maintenance
1581518|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
1581519|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
1581520|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
1581521|NCT00459160|Penetrating Trauma|penetrating trauma
1581522|NCT00459134|sexual dysfunction|sexual dysfunction
1581523|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
1581524|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1581525|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1581526|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1581527|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1581528|NCT00459082|Dexmedetomine|dexmedetomine
1581529|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
1581530|NCT00459069|tumor vaccine|tumor vaccine
1581532|NCT00459043|SCCHN|scchn
1581533|NCT00459030|colon cancer|colon cancer
1581534|NCT00459030|rectal cancer|rectal cancer
1581535|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
1581536|NCT00459017|Mean blood pressure|mean blood pressure
1581537|NCT00459017|Wrist manometer|wrist manometer
1581538|NCT00459017|Frequent measurement|frequent measurement
1581539|NCT00459004|weight loss|weight loss
1581540|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
1581541|NCT00458991|growth hormone deficiency|growth hormone deficiency
1581542|NCT00458991|short stature|short stature
1581543|NCT00458991|phenotyping|phenotyping
1581544|NCT00458952|MIBG|mibg
1581545|NCT00458952|iobenguane|iobenguane
1581546|NCT00458952|iodine|iodine
1581547|NCT00458952|I 131|i 131
1581548|NCT00458952|radiotherapy|radiotherapy
1581549|NCT00458952|radiopharmaceutical|radiopharmaceutical
1581550|NCT00458952|dosimetry|dosimetry
1581551|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
1581552|NCT00458952|Ultratrace|ultratrace
1581553|NCT00458952|no carrier added|no carrier added
1581554|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
1581555|NCT00458926|ventilation, mechanical|ventilation, mechanical
1581556|NCT00458926|intubation, endotracheal|intubation, endotracheal
1581557|NCT00458926|respiratory insufficiency|respiratory insufficiency
1581558|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
1581559|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1581560|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
1581561|NCT00458887|ototoxicity|ototoxicity
1581562|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1581563|NCT00458874|CV risk factors|cv risk factors
1581564|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
1581565|NCT00458874|lifestyle intervention|lifestyle intervention
1581566|NCT00458874|motivation|motivation
1581567|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
1581568|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1581569|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1581570|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1581571|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1581572|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1581573|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
1581574|NCT00458835|Allergic rhinitis|allergic rhinitis
1581575|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
1581576|NCT00458809|recurrent colon cancer|recurrent colon cancer
1581577|NCT00458809|stage IV colon cancer|stage iv colon cancer
1581578|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
1581579|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
1581580|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
1581581|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1581582|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
1581583|NCT00458796|musculoskeletal complications|musculoskeletal complications
1581584|NCT00458796|pain|pain
1581585|NCT00458796|stage IV breast cancer|stage iv breast cancer
1581586|NCT00458796|male breast cancer|male breast cancer
1581587|NCT00458796|recurrent breast cancer|recurrent breast cancer
1581588|NCT00458796|bone metastases|bone metastases
1581589|NCT00458783|Transfusion|transfusion
1581590|NCT00458783|Cardiac|cardiac
1581591|NCT00458783|Blood storage duration|blood storage duration
1581592|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
1581593|NCT00458757|Amputees|amputees
1581594|NCT00458757|Affordance|affordance
1581595|NCT00458757|Peripersonal space|peripersonal space
1581596|NCT00458757|Pseudo neglect|pseudo neglect
1581597|NCT00458757|Reaching|reaching
1581598|NCT00458757|Spatial|spatial
1581599|NCT00458757|visual|visual
1581600|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1581601|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1581602|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1581603|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1581604|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1581605|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1581606|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1581607|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1581608|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
1581609|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
1581610|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1581611|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
1581612|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
1581613|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
1581614|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1581615|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1581616|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1581617|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1581618|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
1581619|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1581620|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
1581621|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1582109|NCT00456911|prevention|prevention
1581622|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1581623|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
1581624|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
1581625|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
1581626|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
1581627|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1581628|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1581629|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1581630|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1581631|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1581632|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1581633|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1581634|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1581635|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1581636|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1581637|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1581638|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1581639|NCT00458718|abstinence|abstinence
1581640|NCT00458718|nicotine patch|nicotine patch
1581641|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
1581642|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
1581643|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
1581644|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
1581645|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
1581646|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
1581647|NCT00458666|Amniotic fluid|amniotic fluid
1581649|NCT00458666|coagulation|coagulation
1581650|NCT00458666|factor X activation|factor x activation
1581651|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
1581652|NCT00458653|GM-CSF|gm-csf
1581653|NCT00458653|high dose chemotherapy|high dose chemotherapy
1581654|NCT00458627|Plethysmograpy|plethysmograpy
1581655|NCT00458627|preschool|preschool
1581656|NCT00458627|methacholine challenge|methacholine challenge
1581657|NCT00458627|spirometry|spirometry
1581658|NCT00458627|asthma|asthma
1581659|NCT00458614|Cystic Fibrosis|cystic fibrosis
1581660|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
1581661|NCT00458588|breast cancer|breast cancer
1581662|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
1581663|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
1581664|NCT00458575|CNTO 2476|cnto 2476
1581665|NCT00458575|Subretinal|subretinal
1581666|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
1581667|NCT00458575|Light perception (LP)|light perception (lp)
1581668|NCT00458575|Hand motion (HM)|hand motion (hm)
1581669|NCT00458562|cervical cancer|cervical cancer
1581670|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
1581671|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
1581672|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1581673|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1581674|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1581675|NCT00458549|stage I prostate cancer|stage i prostate cancer
1581676|NCT00458549|stage II prostate cancer|stage ii prostate cancer
1581677|NCT00458549|stage III prostate cancer|stage iii prostate cancer
1581678|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
1581679|NCT00458536|GM-CSF|gm-csf
1581680|NCT00458536|vaccine|vaccine
1581681|NCT00458536|debulking nephrectomy|debulking nephrectomy
1581682|NCT00458536|dendritic cells|dendritic cells
1581683|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1581684|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1581685|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1581686|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1581687|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1581688|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1581689|NCT00458510|Pain|pain
1581690|NCT00458510|Cancer|cancer
1581691|NCT00458510|Breakthrough|breakthrough
1581692|NCT00458497|Holofiber|holofiber
1581693|NCT00458497|chronic foot pain|chronic foot pain
1581694|NCT00458497|sleep quality|sleep quality
1581695|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
1581696|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
1581697|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
1581698|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
1581699|NCT00458471|Urinary Catheter|urinary catheter
1581700|NCT00458471|Spinal Cord Injury|spinal cord injury
1581701|NCT00458471|Escherichia Coli|escherichia coli
1581702|NCT00458471|Urinary Tract Infection|urinary tract infection
1581703|NCT00458458|Endometriosis|endometriosis
1581704|NCT00458458|Dysmenorrhea|dysmenorrhea
1581705|NCT00458458|Pelvic Pain|pelvic pain
1581706|NCT00458458|Period Pain|period pain
1581707|NCT00458458|Menstrual Cramps|menstrual cramps
1581708|NCT00458458|Dyspareunia|dyspareunia
1581709|NCT00458458|Norethindrone Acetate|norethindrone acetate
1581710|NCT00458458|Lupron Depot|lupron depot
1581711|NCT00458458|Bone Density|bone density
1581712|NCT00458458|Lipid Profile|lipid profile
1581713|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
1581714|NCT00458432|fMRI|fmri
1581715|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
1581716|NCT00458432|Functional Activity|functional activity
1581719|NCT00458432|Healthy Volunteer|healthy volunteer
1581720|NCT00458432|HV|hv
1581721|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
1581722|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
1581723|NCT00458406|child|child
1581724|NCT00458406|CPAP|cpap
1581725|NCT00458393|HIV|hiv
1581726|NCT00458393|Chemoprophylaxis|chemoprophylaxis
1581727|NCT00458393|Hepatitis|hepatitis
1581728|NCT00458393|Viral human hepatitis|viral human hepatitis
1581729|NCT00458393|HIV Seronegativity|hiv seronegativity
1581730|NCT00458380|Doppler ultrasonography|doppler ultrasonography
1581731|NCT00458380|Embryos|embryos
1581732|NCT00458380|Infertility|infertility
1581733|NCT00458380|IVF|ivf
1581734|NCT00458380|Oocytes|oocytes
1581735|NCT00458380|Tubal factor|tubal factor
1581736|NCT00458380|unexplained infertility|unexplained infertility
1581737|NCT00458367|PASS|pass
1581738|NCT00458367|Safety Assessment|safety assessment
1581739|NCT00458367|Efficacy Assessment|efficacy assessment
1581740|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
1581741|NCT00458354|Spinal Sealant|spinal sealant
1581742|NCT00458354|Spinal Sealant System|spinal sealant system
1581743|NCT00458354|Dural Repair|dural repair
1581744|NCT00458354|Spinal Surgery|spinal surgery
1581745|NCT00458341|Cystic fibrosis|cystic fibrosis
1581746|NCT00458341|Nonsense mutation|nonsense mutation
1581747|NCT00458341|Premature stop codon|premature stop codon
1581748|NCT00458302|HIV|hiv
1581749|NCT00458302|Monotherapy|monotherapy
1581750|NCT00458302|Darunavir|darunavir
1581751|NCT00458302|Protease inhibitor|protease inhibitor
1581752|NCT00458302|Early pre-treated|early pre-treated
1581753|NCT00458302|Undetectable|undetectable
1581754|NCT00458302|Treatment Experienced|treatment experienced
1581755|NCT00458276|Left sided heart disease|left sided heart disease
1581756|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
1581757|NCT00458276|Right ventricular failure|right ventricular failure
1581758|NCT00458276|Cardiac surgery|cardiac surgery
1581759|NCT00458276|heart-lung machine|heart-lung machine
1581760|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
1581761|NCT00458276|tezosentan|tezosentan
1581762|NCT00458276|Actelion|actelion
1581763|NCT00458263|Growth Hormone treatment|growth hormone treatment
1581764|NCT00458263|ISS|iss
1581765|NCT00458263|Biochemical markers|biochemical markers
1581766|NCT00458263|Growth response|growth response
1581767|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1581768|NCT00458250|Haploidentical|haploidentical
1581769|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
1581770|NCT00458250|human, Bone Marrow|human, bone marrow
1581771|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
1581772|NCT00458250|CAMPATH|campath
1581773|NCT00458250|Alemtuzumab|alemtuzumab
1581774|NCT00458250|AML|aml
1581775|NCT00458250|ALL|all
1581776|NCT00458250|10. Eligibility|10. eligibility
1581777|NCT00458237|HER2 positive|her2 positive
1581778|NCT00458237|metastatic breast cancer|metastatic breast cancer
1581779|NCT00458237|RAD001|rad001
1581780|NCT00458237|Herceptin|herceptin
1581781|NCT00458224|overweight|overweight
1581782|NCT00458224|obesity|obesity
1581783|NCT00458224|child|child
1581784|NCT00458211|Schizophrenia|schizophrenia
1581785|NCT00458211|Ziprasidone|ziprasidone
1581786|NCT00458198|Selective Mutism|selective mutism
1581787|NCT00458172|lay theories|lay theories
1581788|NCT00458172|health concepts|health concepts
1581789|NCT00458172|survey|survey
1581790|NCT00458172|internet research|internet research
1581791|NCT00458172|Ideas about health|ideas about health
1581792|NCT00458159|CC-11006|cc-11006
1581793|NCT00458159|RA|ra
1581794|NCT00458159|MDS|mds
1581795|NCT00458159|Celgene|celgene
1581796|NCT00458159|RCMD-RS|rcmd-rs
1581797|NCT00458159|RARS|rars
1581798|NCT00458159|RAEB-1|raeb-1
1581799|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
1581800|NCT00458133|aerobic exercise|aerobic exercise
1581801|NCT00458133|resistance exercise|resistance exercise
1581802|NCT00458133|type 2 diabetes|type 2 diabetes
1581803|NCT00458133|hemoglobin A1C|hemoglobin a1c
1581804|NCT00458133|exercise|exercise
1581805|NCT00458120|Dengue Fever|dengue fever
1581806|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1581807|NCT00458120|Dengue Vaccination|dengue vaccination
1582110|NCT00456911|children|children
1581808|NCT00458107|Pharmacokinetics|pharmacokinetics
1581809|NCT00458107|Pharmacodynamics|pharmacodynamics
1581810|NCT00458094|Exercise|exercise
1581811|NCT00458094|Mental Illness|mental illness
1581812|NCT00458094|Community Psychiatry|community psychiatry
1581813|NCT00458094|Peer Support|peer support
1581814|NCT00458094|Mental Disorders|mental disorders
1581815|NCT00458068|preterm infant|preterm infant
1581816|NCT00458068|iron supplementation|iron supplementation
1581817|NCT00458068|iron deficiency|iron deficiency
1581818|NCT00458068|blood transfusion|blood transfusion
1581819|NCT00458055|Lipid lowering agents|lipid lowering agents
1581820|NCT00458055|Drug treatment|drug treatment
1581821|NCT00458055|Statin|statin
1581822|NCT00458055|Fibrate|fibrate
1581824|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
1581825|NCT00458042|Ventavis|ventavis
1581826|NCT00458042|iloporst|iloporst
1581827|NCT00458042|Remodulin|remodulin
1581828|NCT00458042|treprostinil|treprostinil
1581829|NCT00458042|PAH|pah
1581830|NCT00458042|prostacyclin|prostacyclin
1581831|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
1581832|NCT00458029|obesity|obesity
1581833|NCT00458029|prevention|prevention
1581834|NCT00458029|adolescence|adolescence
1581835|NCT00458029|school based|school based
1581836|NCT00458003|Preeclampsia|preeclampsia
1581837|NCT00458003|Spinal Anesthesia|spinal anesthesia
1581838|NCT00458003|Hypotension|hypotension
1581839|NCT00458003|Cesarean Delivery|cesarean delivery
1581840|NCT00458003|Phenylephrine|phenylephrine
1581841|NCT00458003|Ephedrine|ephedrine
1581842|NCT00457990|Neurocognitive outcome|neurocognitive outcome
1581843|NCT00457990|preterm infant|preterm infant
1581844|NCT00457990|very low birth weight|very low birth weight
1581845|NCT00457990|iron deficiency|iron deficiency
1581846|NCT00457990|iron supplementation|iron supplementation
1581847|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1581848|NCT00457977|COPD|copd
1581849|NCT00457977|Pneumococcal|pneumococcal
1581850|NCT00457977|Vaccine|vaccine
1581851|NCT00457977|Opsonization|opsonization
1581852|NCT00457977|Antibodies|antibodies
1581853|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
1581854|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
1581855|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
1581856|NCT00457964|RAD001|rad001
1581857|NCT00457964|Angiomyolipmas|angiomyolipmas
1581858|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1581859|NCT00457951|COPD|copd
1581860|NCT00457951|Heparin|heparin
1581861|NCT00457951|ODSH|odsh
1581862|NCT00457951|Exacerbations of COPD|exacerbations of copd
1581863|NCT00457938|lipodystrophy|lipodystrophy
1581864|NCT00457925|absorption,|absorption,
1581865|NCT00457925|metabolism,|metabolism,
1581866|NCT00457925|excretion|excretion
1581867|NCT00457925|distribution,|distribution,
1581868|NCT00457899|schizophrenia|schizophrenia
1581869|NCT00457899|schizoaffective disorder|schizoaffective disorder
1581870|NCT00457899|quetiapine|quetiapine
1581871|NCT00457899|seroquel|seroquel
1581872|NCT00457899|titration|titration
1581873|NCT00457873|surgery|surgery
1581875|NCT00457860|PLL|pll
1581876|NCT00457860|SLL|sll
1581877|NCT00457860|Relapse|relapse
1581878|NCT00457860|Refractory|refractory
1581879|NCT00457860|immunotoxin|immunotoxin
1581880|NCT00457860|HA22|ha22
1581881|NCT00457860|CAT-8015|cat-8015
1581882|NCT00457860|immunotherapy|immunotherapy
1581883|NCT00457847|PGD|pgd
1581884|NCT00457834|Heart failure|heart failure
1581885|NCT00457834|Dyssynchrony|dyssynchrony
1581886|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
1581887|NCT00457834|Atrial fibrillation|atrial fibrillation
1581888|NCT00457834|RVOT|rvot
1581889|NCT00457834|RVapex|rvapex
1581890|NCT00457821|G551D mutation|g551d mutation
1581891|NCT00457821|Fibrosis|fibrosis
1581892|NCT00457821|Pancreatic Diseases|pancreatic diseases
1581893|NCT00457821|Digestive System Diseases|digestive system diseases
1581894|NCT00457821|Lung Diseases|lung diseases
1581895|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
1581896|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
1581897|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
1581898|NCT00457821|Pathologic Processes|pathologic processes
1581899|NCT00457808|TSC and LAM|tsc and lam
1581900|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
1581901|NCT00457782|Cancer|cancer
1581902|NCT00457782|Blood disorders|blood disorders
1581903|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
1581904|NCT00457782|Lymphoma|lymphoma
1581905|NCT00457782|Multiple Myeloma|multiple myeloma
1581906|NCT00457769|Aricept|aricept
1581907|NCT00457769|Donepezil|donepezil
1581908|NCT00457769|Memory|memory
1581909|NCT00457769|vascular dementia|vascular dementia
1581910|NCT00457769|stroke|stroke
1581911|NCT00457769|functional tasks|functional tasks
1581912|NCT00457769|self-generation|self-generation
1581913|NCT00457756|LDL cholesterol|ldl cholesterol
1581914|NCT00457756|HDL cholesterol|hdl cholesterol
1581915|NCT00457756|natural supplement|natural supplement
1581916|NCT00457756|guar gum|guar gum
1581917|NCT00457756|phytosterols|phytosterols
1581918|NCT00457756|policosanol|policosanol
1581919|NCT00457756|chrysanthemum|chrysanthemum
1581920|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
1581921|NCT00457730|Multiple Sclerosis|multiple sclerosis
1581922|NCT00457730|Duloxetine|duloxetine
1581923|NCT00457730|Pain|pain
1581924|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
1581925|NCT00457704|MRSA|mrsa
1581926|NCT00457704|Home Care|home care
1581927|NCT00457704|Risk factors|risk factors
1581928|NCT00457704|transmissions|transmissions
1582538|NCT00455117|pain|pain
1581929|NCT00457704|observational study|observational study
1581930|NCT00457691|colorectal neoplasms|colorectal neoplasms
1581931|NCT00457678|Vision loss|vision loss
1581932|NCT00457678|Retina|retina
1581933|NCT00457678|VEG-F|veg-f
1581934|NCT00457678|Fovea|fovea
1581936|NCT00457665|HIV|hiv
1581937|NCT00457665|Lipodystrophy|lipodystrophy
1581938|NCT00457665|Treatment Experienced|treatment experienced
1581939|NCT00457652|Rosuvastatin|rosuvastatin
1581940|NCT00457652|Caffeine|caffeine
1581941|NCT00457652|Ischemia|ischemia
1581942|NCT00457652|Reperfusion|reperfusion
1581943|NCT00457639|lipodystrophy|lipodystrophy
1581944|NCT00457626|Children|children
1581945|NCT00457626|pediatrics|pediatrics
1581946|NCT00457626|High Blood Pressure|high blood pressure
1581947|NCT00457626|Hypertension|hypertension
1581948|NCT00457626|Valsartan|valsartan
1581949|NCT00457613|alkaline phosphatase|alkaline phosphatase
1581950|NCT00457613|sepsis|sepsis
1581951|NCT00457613|kidney function|kidney function
1581952|NCT00457600|information technology|information technology
1581953|NCT00457600|emergency department|emergency department
1581954|NCT00457600|medication error|medication error
1581955|NCT00457600|quality of care|quality of care
1581956|NCT00457600|patient-centered care|patient-centered care
1581957|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
1581958|NCT00457548|Alcohol use|alcohol use
1581959|NCT00457548|Brief Interventions|brief interventions
1581960|NCT00457548|Injuries|injuries
1581961|NCT00457548|Emergency Department Patients|emergency department patients
1581962|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
1581963|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
1581964|NCT00457535|adiponectin|adiponectin
1581965|NCT00457535|mortality|mortality
1581966|NCT00457522|intimate partner violence|intimate partner violence
1581967|NCT00457522|depression|depression
1581968|NCT00457522|PTSD|ptsd
1581969|NCT00457522|fatigue|fatigue
1581970|NCT00457509|Pandemic influenza|pandemic influenza
1581971|NCT00457509|Avian influenza|avian influenza
1581972|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
1581973|NCT00457509|A/H5N1|a/h5n1
1581974|NCT00457496|Behavior Therapy|behavior therapy
1581975|NCT00457496|Relaxation Techniques|relaxation techniques
1581976|NCT00457496|Cognitive Therapy|cognitive therapy
1581977|NCT00457496|Exercise Movement Techniques|exercise movement techniques
1581978|NCT00457483|hypertension|hypertension
1581979|NCT00457483|diuretic|diuretic
1581980|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
1581981|NCT00457483|prediction|prediction
1581982|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
1581983|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
1581984|NCT00457431|resuscitation|resuscitation
1581985|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
1581986|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
1581987|NCT00457405|atherosclerosis|atherosclerosis
1581988|NCT00457405|dipyridamole|dipyridamole
1581989|NCT00457405|annexin A5 targeting|annexin a5 targeting
1581990|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
1581991|NCT00457392|sunitinib|sunitinib
1581992|NCT00457392|erlotinib|erlotinib
1581993|NCT00457392|Phase 3|phase 3
1581994|NCT00457379|Coronary artery disease|coronary artery disease
1581995|NCT00457379|HDL-Cholesterol|hdl-cholesterol
1581996|NCT00457379|Endothelial Function|endothelial function
1581997|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
1581998|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
1581999|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
1582000|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
1582001|NCT00457327|protective ileostomy|protective ileostomy
1582002|NCT00457327|rectal cancer|rectal cancer
1582003|NCT00457327|low anterior resection|low anterior resection
1582004|NCT00457314|single-large scale deletions|single-large scale deletions
1582005|NCT00457314|point mutations in mtDNA|point mutations in mtdna
1582006|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
1582007|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
1582008|NCT00457288|Topical treatment|topical treatment
1582009|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
1582010|NCT00457262|LDL|ldl
1582011|NCT00457262|HDL|hdl
1582012|NCT00457262|postmenopausal women|postmenopausal women
1582013|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
1582014|NCT00457249|Pertussis|pertussis
1582015|NCT00457249|Tetanus|tetanus
1582016|NCT00457249|Diphtheria|diphtheria
1582017|NCT00457249|Tdap|tdap
1582018|NCT00457236|Clopidogrel|clopidogrel
1582019|NCT00457236|Coronary Artery Disease|coronary artery disease
1582020|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
1582021|NCT00457236|Drug Resistance|drug resistance
1582022|NCT00457236|PCI|pci
1582023|NCT00457223|pterygium|pterygium
1582024|NCT00457223|pterygia|pterygia
1582026|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
1582027|NCT00457223|fibrin glue|fibrin glue
1582028|NCT00457223|suture|suture
1582029|NCT00457210|Psychology|psychology
1582030|NCT00457197|bipolar disorder|bipolar disorder
1582031|NCT00457197|alcohol dependence|alcohol dependence
1582032|NCT00457197|mania|mania
1582033|NCT00457197|manic disorder|manic disorder
1582034|NCT00457197|depression|depression
1582035|NCT00457184|Migraine|migraine
1582036|NCT00457184|Thrombosis|thrombosis
1582037|NCT00457184|Thrombophilia|thrombophilia
1582038|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
1582039|NCT00457158|pulmonary embolism|pulmonary embolism
1582040|NCT00457158|inferior vena cava filters|inferior vena cava filters
1582041|NCT00457158|venous thrombosis|venous thrombosis
1582042|NCT00457158|randomized controlled trial|randomized controlled trial
1582043|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
1582044|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
1582045|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
1582046|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1582047|NCT00457145|Macular Telangiectasia|macular telangiectasia
1582048|NCT00457132|Knee|knee
1582049|NCT00457132|Osteoarthritis|osteoarthritis
1582050|NCT00457132|WOMAC|womac
1582051|NCT00457132|ALF|alf
1582052|NCT00457132|Wedging|wedging
1582053|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
1582054|NCT00457119|NSCLC|nsclc
1582055|NCT00457119|Advanced Lung Cancer|advanced lung cancer
1582056|NCT00457119|RAD|rad
1582057|NCT00457119|RAD001|rad001
1582058|NCT00457119|chemotherapy|chemotherapy
1582059|NCT00457119|carboplatin|carboplatin
1582060|NCT00457119|paclitaxel|paclitaxel
1582061|NCT00457119|bevacizumab|bevacizumab
1582062|NCT00457106|panic|panic
1582063|NCT00457093|Type 2 Diabetes|type 2 diabetes
1582064|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
1582065|NCT00457093|basal insulin|basal insulin
1582066|NCT00457080|capnography|capnography
1582067|NCT00457080|safety|safety
1582068|NCT00457080|opioids|opioids
1582069|NCT00457080|respiratory depression|respiratory depression
1582070|NCT00457080|postoperative|postoperative
1582071|NCT00457080|orthopedic|orthopedic
1582072|NCT00457080|OSA|osa
1582073|NCT00457080|apnea|apnea
1582074|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
1582075|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
1582076|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
1582077|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1582078|NCT00457067|Macular Telangiectasia|macular telangiectasia
1582079|NCT00457054|Mood Regulating Circuit|mood regulating circuit
1582080|NCT00457054|Lithium|lithium
1582081|NCT00457054|fMRI|fmri
1582082|NCT00457041|Trust|trust
1582083|NCT00457041|Decision Making|decision making
1582084|NCT00457041|Vulnerability|vulnerability
1582085|NCT00457041|Survey|survey
1582086|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
1582087|NCT00457028|Anxiety|anxiety
1582088|NCT00457028|Treatment efficacy|treatment efficacy
1582089|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
1582090|NCT00456989|Androgen Independent|androgen independent
1582091|NCT00456989|Prostate Cancer|prostate cancer
1582092|NCT00456989|Taxotere|taxotere
1582093|NCT00456989|Doxil|doxil
1582094|NCT00456989|AIPC|aipc
1582095|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
1582096|NCT00456976|Seligiline|seligiline
1582097|NCT00456976|Negative symptoms|negative symptoms
1582098|NCT00456976|Schizopherenia|schizopherenia
1582099|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1582100|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
1582101|NCT00456963|diabetes|diabetes
1582102|NCT00456963|hypertension|hypertension
1582103|NCT00456963|therapeutic strategies|therapeutic strategies
1582104|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
1582105|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
1582106|NCT00456950|vulnerable plaque|vulnerable plaque
1582107|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
1582108|NCT00456911|obesity|obesity
1582111|NCT00456911|adults|adults
1582112|NCT00456911|family|family
1582113|NCT00456911|dietary|dietary
1582114|NCT00456911|coaching|coaching
1582115|NCT00456911|body mass index|body mass index
1582116|NCT00456911|fat mass|fat mass
1582117|NCT00456885|obesity|obesity
1582118|NCT00456885|double blind|double blind
1582119|NCT00456885|placebo controlled|placebo controlled
1582120|NCT00456885|weight loss|weight loss
1582121|NCT00456885|appetite|appetite
1582122|NCT00456885|energy expenditure|energy expenditure
1582123|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
1582124|NCT00456859|chronic kidney disease|chronic kidney disease
1582125|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
1582126|NCT00456859|randomized clinical trial|randomized clinical trial
1582127|NCT00456859|composite endpoint|composite endpoint
1582128|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
1582129|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
1582130|NCT00456833|NSCLC|nsclc
1582446|NCT00455572|ASCI|asci
1582131|NCT00456833|Advanced lung cancer|advanced lung cancer
1582132|NCT00456833|RAD|rad
1582133|NCT00456833|RAD001|rad001
1582134|NCT00456833|erlotinib|erlotinib
1582135|NCT00456820|Mood Regulating Circuit|mood regulating circuit
1582136|NCT00456820|SSRI|ssri
1582137|NCT00456820|fMRI|fmri
1582138|NCT00456807|Human Papillomavirus|human papillomavirus
1582139|NCT00456794|Parkinson's disease|parkinson's disease
1582140|NCT00456794|Levodopa|levodopa
1582141|NCT00456794|End of dose wearing off|end of dose wearing off
1582142|NCT00456794|OFF time|off time
1582143|NCT00456781|rotator cuff|rotator cuff
1582144|NCT00456781|randomized clinical trial|randomized clinical trial
1582145|NCT00456768|Panic Disorder|panic disorder
1582146|NCT00456768|Anxiety|anxiety
1582147|NCT00456768|Treatment efficacy|treatment efficacy
1582148|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
1582149|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
1582150|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
1582151|NCT00456742|Anxiety|anxiety
1582152|NCT00456742|Treatment efficacy|treatment efficacy
1582153|NCT00456729|Iron deficiency|iron deficiency
1582154|NCT00456729|Malabsorption|malabsorption
1582155|NCT00456729|Giardiasis|giardiasis
1582156|NCT00456716|BAC lung cancer|bac lung cancer
1582157|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
1582158|NCT00456703|fluids,|fluids,
1582159|NCT00456703|restriction,|restriction,
1582160|NCT00456703|infection,|infection,
1582161|NCT00456703|bowel surgery,|bowel surgery,
1582162|NCT00456703|open abdominal|open abdominal
1582163|NCT00456690|Thalassemia|thalassemia
1582164|NCT00456690|Nutrition|nutrition
1582165|NCT00456690|Endocrine|endocrine
1582166|NCT00456690|BMI|bmi
1582167|NCT00456677|minocycline|minocycline
1582168|NCT00456677|asthma|asthma
1582169|NCT00456677|oral corticosteroids|oral corticosteroids
1582170|NCT00456664|CMV|cmv
1582171|NCT00456664|IRIS|iris
1582172|NCT00456651|Sleep Apnea|sleep apnea
1582173|NCT00456651|Obesity|obesity
1582174|NCT00456651|Neuropeptides|neuropeptides
1582175|NCT00456651|Hormones|hormones
1582176|NCT00456638|OP-CABG|op-cabg
1582177|NCT00456638|Depodur traditional drug|depodur traditional drug
1582178|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
1582179|NCT00456625|Challenge dose|challenge dose
1582180|NCT00456586|Parkinson's disease|parkinson's disease
1582181|NCT00456586|Levodopa therapy|levodopa therapy
1582182|NCT00456586|End of dose wearing off|end of dose wearing off
1582183|NCT00456586|Off time|off time
1582184|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
1582185|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
1582186|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
1582187|NCT00456547|Coagulation|coagulation
1582188|NCT00456534|Smoking|smoking
1582189|NCT00456521|Obesity|obesity
1582190|NCT00456521|Behavior Modification|behavior modification
1582191|NCT00456469|TB|tb
1582192|NCT00456469|latent|latent
1582193|NCT00456469|infection|infection
1582194|NCT00456469|Ethiopia|ethiopia
1582195|NCT00456443|Thalassemia|thalassemia
1582196|NCT00456443|Sickle cell anemia|sickle cell anemia
1582197|NCT00456443|Splenectomy|splenectomy
1582198|NCT00456443|Infections|infections
1582199|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
1582200|NCT00456417|Neurological|neurological
1582201|NCT00456417|Alzheimers|alzheimers
1582202|NCT00456404|peppermint water|peppermint water
1582203|NCT00456404|nipple crack|nipple crack
1582204|NCT00456404|lactating women|lactating women
1582205|NCT00456391|Brain CT scan|brain ct scan
1582206|NCT00456391|Pediatric emergency room|pediatric emergency room
1582207|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1582208|NCT00456365|Cystic kidney disease|cystic kidney disease
1582209|NCT00456365|High blood pressure|high blood pressure
1582210|NCT00456365|Statin|statin
1582211|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
1582212|NCT00456326|Heparin|heparin
1582708|NCT00454454|memory|memory
1582213|NCT00456326|Unfractionated Heparin|unfractionated heparin
1582214|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
1582215|NCT00456326|Anticoagulation|anticoagulation
1582216|NCT00456326|Thrombocytopenia|thrombocytopenia
1582217|NCT00456326|Thrombosis|thrombosis
1582218|NCT00456326|Venous Thrombosis|venous thrombosis
1582219|NCT00456326|Pulmonary Embolism|pulmonary embolism
1582220|NCT00456313|asthma|asthma
1582221|NCT00456313|fluticasone propionate|fluticasone propionate
1582222|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
1582223|NCT00456313|combination product|combination product
1582224|NCT00456313|innate immune response|innate immune response
1582225|NCT00456313|neutrophil priming|neutrophil priming
1582226|NCT00456300|Type 1 Diabetes|type 1 diabetes
1582227|NCT00456300|Hyperglycemia|hyperglycemia
1582228|NCT00456300|Hypoglycemia|hypoglycemia
1582229|NCT00456287|Sleep Apnea|sleep apnea
1582230|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
1582231|NCT00456287|Platelet function markers|platelet function markers
1582232|NCT00456287|Endothelial dysfunction|endothelial dysfunction
1582233|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
1582234|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
1582235|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
1582236|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
1582237|NCT00456274|Amenorrhea|amenorrhea
1582238|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
1582239|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
1582240|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
1582241|NCT00456248|Liver|liver
1582242|NCT00456248|Pegylated|pegylated
1582243|NCT00456248|Interferon|interferon
1582244|NCT00456248|Ribavirin|ribavirin
1582245|NCT00456248|Combination|combination
1582246|NCT00456248|Nonresponder|nonresponder
1582247|NCT00456248|Relapser|relapser
1582248|NCT00456248|HCV|hcv
1582249|NCT00456248|Infergen|infergen
1582250|NCT00456248|SVR|svr
1582251|NCT00456222|Sleep|sleep
1582252|NCT00456222|Circadian rhythms|circadian rhythms
1582253|NCT00456222|Menstrual cycle|menstrual cycle
1582254|NCT00456209|Lived Experiences|lived experiences
1582255|NCT00456209|Adolescents|adolescents
1582256|NCT00456209|Cancer Treatment|cancer treatment
1582257|NCT00456209|Occupations|occupations
1582258|NCT00456196|COPD|copd
1582259|NCT00456196|Thrombosis|thrombosis
1582260|NCT00456196|Cancer|cancer
1582261|NCT00456196|Renal|renal
1582262|NCT00456196|Elderly|elderly
1582263|NCT00456196|Surgery|surgery
1582264|NCT00456196|Orthopedic Surgery|orthopedic surgery
1582265|NCT00456196|Medically Ill|medically ill
1582266|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
1582267|NCT00456196|Pulmonary Embolism|pulmonary embolism
1582268|NCT00456196|Anticoagulation|anticoagulation
1582269|NCT00456183|Tuberculosis|tuberculosis
1582270|NCT00456183|Latent|latent
1582272|NCT00456183|Vaccine|vaccine
1582273|NCT00456183|MVA 85A|mva 85a
1582274|NCT00456170|Vaginal|vaginal
1582275|NCT00456170|Hysterectomy|hysterectomy
1582276|NCT00456170|Harmonic|harmonic
1582277|NCT00456170|Ligasure|ligasure
1582278|NCT00456170|Sutures|sutures
1582279|NCT00456170|Modern|modern
1582280|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
1582281|NCT00456157|Osteoarthritis|osteoarthritis
1582282|NCT00456157|Osteophytes|osteophytes
1582283|NCT00456157|Knee|knee
1582284|NCT00456157|Intra-articular|intra-articular
1582285|NCT00456157|OP-1|op-1
1582286|NCT00456144|GnRH|gnrh
1582287|NCT00456144|Insulin sensitivity|insulin sensitivity
1582288|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
1582289|NCT00456118|preeclampsia|preeclampsia
1582290|NCT00456118|intervillositis|intervillositis
1582291|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
1582292|NCT00456105|Type 2 diabetes|type 2 diabetes
1582293|NCT00456105|Post-op dysglycemia|post-op dysglycemia
1582294|NCT00456105|Peripheral vascular disease|peripheral vascular disease
1582295|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
1582296|NCT00456092|psoriatic arthritis|psoriatic arthritis
1582297|NCT00456092|ACR|acr
1582298|NCT00456092|PASI|pasi
1582299|NCT00456092|DAS|das
1582300|NCT00456092|pharmacokinetic|pharmacokinetic
1582301|NCT00456092|biopsy|biopsy
1582302|NCT00456066|Acute myocardial infarction|acute myocardial infarction
1582303|NCT00456066|Thromboaspiration|thromboaspiration
1582304|NCT00456066|Infarct size|infarct size
1582305|NCT00456066|Left ventricular remodelling|left ventricular remodelling
1582306|NCT00456053|Renal Anemia|renal anemia
1582307|NCT00456053|Renal Failure|renal failure
1582308|NCT00456053|Kidney Disease|kidney disease
1582309|NCT00456053|Human EPO|human epo
1582310|NCT00456040|amyloidosis|amyloidosis
1582311|NCT00456040|heart failure|heart failure
1582312|NCT00456040|heart transplant|heart transplant
1582313|NCT00456040|stem cell transplant|stem cell transplant
1582314|NCT00456027|Type 2 Diabetes|type 2 diabetes
1582315|NCT00456027|LADA|lada
1582316|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
1582317|NCT00456027|Autoimmunity|autoimmunity
1582318|NCT00456027|HbA1c|hba1c
1582319|NCT00456027|C-peptide|c-peptide
1582320|NCT00456014|Major Depression|major depression
1582321|NCT00456014|Antidepressants|antidepressants
1582322|NCT00456001|heparin|heparin
1582323|NCT00456001|low molecular weight heparin|low molecular weight heparin
1582324|NCT00456001|enoxaparin|enoxaparin
1582325|NCT00456001|anticoagulation|anticoagulation
1582326|NCT00456001|thrombosis|thrombosis
1582327|NCT00456001|venous thrombosis|venous thrombosis
1582328|NCT00456001|thromboembolism|thromboembolism
1582329|NCT00456001|pulmonary embolism|pulmonary embolism
1582330|NCT00456001|medication|medication
1582331|NCT00455988|questionnaire developement|questionnaire developement
1582332|NCT00455988|regularity|regularity
1582333|NCT00455988|lifestyle|lifestyle
1582334|NCT00455988|type 2 diabetes|type 2 diabetes
1582335|NCT00455975|Kidney Cancer|kidney cancer
1582336|NCT00455975|Renal Cancer|renal cancer
1582337|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
1582338|NCT00455962|estrogen|estrogen
1582339|NCT00455962|progesterone|progesterone
1582340|NCT00455962|African-American|african-american
1582341|NCT00455962|Caucasian|caucasian
1582342|NCT00455962|infusion|infusion
1582343|NCT00455962|gonadotropins|gonadotropins
1582344|NCT00455962|healthy|healthy
1582345|NCT00455936|Adenocarcinoma|adenocarcinoma
1582346|NCT00455936|NSCLC|nsclc
1582347|NCT00455936|gemcitabine|gemcitabine
1582348|NCT00455936|Cisplatin|cisplatin
1582349|NCT00455936|Gefitinib|gefitinib
1582350|NCT00455936|Never smoker|never smoker
1582351|NCT00455923|asthma|asthma
1582352|NCT00455923|exacerbation|exacerbation
1582353|NCT00455923|persistent|persistent
1582354|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1582355|NCT00455923|mild|mild
1582356|NCT00455923|GINAII|ginaii
1582357|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
1582358|NCT00455910|MDS|mds
1582359|NCT00455910|Bone marrow diseases|bone marrow diseases
1582360|NCT00455910|Thalidomide|thalidomide
1582361|NCT00455910|Cytopenias|cytopenias
1582362|NCT00455910|Anemia|anemia
1582363|NCT00455897|granulocyte monocyte colony stimulating factor|granulocyte monocyte colony stimulating factor
1582364|NCT00455897|Leukine|leukine
1582365|NCT00455897|Sargramostim|sargramostim
1582366|NCT00455897|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1582367|NCT00455897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1582368|NCT00455871|macular degeneration|macular degeneration
1582369|NCT00455845|Endometriosis|endometriosis
1582370|NCT00455845|Lng IUD|lng iud
1582371|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
1582372|NCT00455832|sperm concentration|sperm concentration
1582373|NCT00455832|sperm motility|sperm motility
1582374|NCT00455832|sperm morphology|sperm morphology
1582375|NCT00455832|peginterferon|peginterferon
1582376|NCT00455832|ribavirin|ribavirin
1582377|NCT00455832|hepatitis C|hepatitis c
1582378|NCT00455819|pulmonary embolism|pulmonary embolism
1582379|NCT00455819|pro-BNP|pro-bnp
1582380|NCT00455819|home treatment|home treatment
1582381|NCT00455806|Helicobacter pylori|helicobacter pylori
1582382|NCT00455806|rescue therapy|rescue therapy
1582383|NCT00455806|eradication therapy|eradication therapy
1582384|NCT00455806|esomeprazole|esomeprazole
1582385|NCT00455806|moxifloxacin|moxifloxacin
1582386|NCT00455806|resistance|resistance
1582387|NCT00455793|HIV|hiv
1582388|NCT00455793|atherosclerosis|atherosclerosis
1582389|NCT00455780|Eating|eating
1582390|NCT00455780|Dieting|dieting
1582391|NCT00455780|Meal replacements|meal replacements
1582392|NCT00455780|Energy Density|energy density
1582393|NCT00455780|Weight Loss Maintenance|weight loss maintenance
1582394|NCT00455767|persistent ARDS|persistent ards
1582395|NCT00455767|alveolar inflammation|alveolar inflammation
1582396|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
1582397|NCT00455767|mechanichal ventilation|mechanichal ventilation
1582398|NCT00455767|P/V curve|p/v curve
1582399|NCT00455767|Static compliance|static compliance
1582400|NCT00455767|elastase activity|elastase activity
1582401|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
1582402|NCT00455741|menopause|menopause
1582403|NCT00455741|estrogen|estrogen
1582404|NCT00455741|progesterone|progesterone
1582405|NCT00455741|hormone replacement|hormone replacement
1582406|NCT00455741|aging|aging
1582408|NCT00455715|Schizophrenia|schizophrenia
1582409|NCT00455715|Cognition|cognition
1582410|NCT00455715|Sildenafil|sildenafil
1582411|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
1582412|NCT00455702|schizophrenia|schizophrenia
1582413|NCT00455702|cognition|cognition
1582414|NCT00455702|d-cycloserine|d-cycloserine
1582415|NCT00455702|memory|memory
1582416|NCT00455689|Lupron|lupron
1582417|NCT00455689|Premenopausal|premenopausal
1582418|NCT00455689|Hot flashes|hot flashes
1582419|NCT00455689|PET|pet
1582420|NCT00455689|MRI|mri
1582421|NCT00455676|Scarf Osteotomy|scarf osteotomy
1582422|NCT00455676|Chevron Osteotomy|chevron osteotomy
1582423|NCT00455676|Comparison|comparison
1582424|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
1582425|NCT00455663|Medication Adherence|medication adherence
1582426|NCT00455650|schizophrenia|schizophrenia
1582427|NCT00455650|cognition|cognition
1582428|NCT00455650|nicotinic receptors|nicotinic receptors
1582429|NCT00455650|mecamylamine|mecamylamine
1582430|NCT00455650|varenicline|varenicline
1582431|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
1582432|NCT00455624|insulin resistance|insulin resistance
1582433|NCT00455611|Heart Failure, Congestive|heart failure, congestive
1582434|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
1582435|NCT00455611|Baroreflex|baroreflex
1582436|NCT00455611|Echocardiography|echocardiography
1582438|NCT00455585|Pharmacokinetics|pharmacokinetics
1582439|NCT00455585|Antiretrovirals|antiretrovirals
1582440|NCT00455585|Uganda|uganda
1582442|NCT00455585|Treatment Experienced|treatment experienced
1582443|NCT00455572|Immunotherapeutic|immunotherapeutic
1582444|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
1582445|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
1582447|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
1582448|NCT00455559|GIST|gist
1582449|NCT00455559|Perifosine|perifosine
1582450|NCT00455559|Gleevec|gleevec
1582451|NCT00455546|Coronary|coronary
1582452|NCT00455546|Artery|artery
1582453|NCT00455546|Atherosclerosis|atherosclerosis
1582454|NCT00455546|Phospholipase|phospholipase
1582455|NCT00455546|CAD|cad
1582456|NCT00455533|Early Breast Cancer|early breast cancer
1582457|NCT00455520|Diabetic neuropathy|diabetic neuropathy
1582458|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
1582459|NCT00455520|Polyneuropathy|polyneuropathy
1582460|NCT00455520|Peripheral neuropathy|peripheral neuropathy
1582461|NCT00455507|Parkinson's disease|parkinson's disease
1582462|NCT00455507|levodopa|levodopa
1582463|NCT00455507|end of dose wearing off|end of dose wearing off
1582464|NCT00455507|OFF time|off time
1582465|NCT00455494|Drug-resistant malaria|drug-resistant malaria
1582466|NCT00455494|Bioavailability|bioavailability
1582467|NCT00455494|Food-effect study|food-effect study
1582468|NCT00455468|Severe pneumonia|severe pneumonia
1582469|NCT00455468|children|children
1582470|NCT00455468|day care management|day care management
1582471|NCT00455468|hospitalized management|hospitalized management
1582472|NCT00455468|Randomized controlled trial|randomized controlled trial
1582473|NCT00455468|Under five children|under five children
1582474|NCT00455429|Atopic Dermatitis|atopic dermatitis
1582475|NCT00455429|JNJ-26113100|jnj-26113100
1582476|NCT00455416|Low grade lymphoma|low grade lymphoma
1582477|NCT00455416|Diet|diet
1582478|NCT00455416|Antioxidants|antioxidants
1582479|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
1582480|NCT00455403|Metabolic Syndrome|metabolic syndrome
1582481|NCT00455403|Atherosclerosis|atherosclerosis
1582482|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
1582483|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
1582484|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
1582485|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
1582486|NCT00455377|Cement dust exposure|cement dust exposure
1582487|NCT00455377|Induced sputum|induced sputum
1582488|NCT00455377|Airway inflammation|airway inflammation
1582489|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
1582490|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
1582491|NCT00455364|Lung transplant|lung transplant
1582492|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
1582493|NCT00455351|Palliative treatment|palliative treatment
1582494|NCT00455351|Max. tolerable dose|max. tolerable dose
1582495|NCT00455338|meal|meal
1582496|NCT00455338|composition|composition
1582497|NCT00455338|postprandial|postprandial
1582498|NCT00455338|PCOS|pcos
1582499|NCT00455338|androgen|androgen
1582500|NCT00455325|Insulin Resistance|insulin resistance
1582501|NCT00455325|Atherosclerosis|atherosclerosis
1582502|NCT00455325|Metabolic Syndrome|metabolic syndrome
1582503|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
1582504|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1582505|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
1582506|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
1582507|NCT00455286|CNS Lymphoma|cns lymphoma
1582508|NCT00455273|Breast Cancer|breast cancer
1582509|NCT00455273|DCE MRI|dce mri
1582510|NCT00455234|Aggression|aggression
1582511|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
1582512|NCT00455221|CML|cml
1582513|NCT00455221|Imatinib|imatinib
1582514|NCT00455221|vaccine|vaccine
1582515|NCT00455221|peptide|peptide
1582516|NCT00455221|gene|gene
1582517|NCT00455221|MRD|mrd
1582518|NCT00455221|DNA|dna
1582519|NCT00455182|Acupuncture|acupuncture
1582520|NCT00455182|Hip Arthroplasty|hip arthroplasty
1582521|NCT00455182|Knee Arthroplasty|knee arthroplasty
1582522|NCT00455182|Pain Management|pain management
1582523|NCT00455169|Influenza|influenza
1582524|NCT00455169|Infant, Premature|infant, premature
1582525|NCT00455169|Immunization|immunization
1582526|NCT00455169|Vaccination|vaccination
1582527|NCT00455156|Contraception|contraception
1582528|NCT00455156|Vaginal Ring|vaginal ring
1582529|NCT00455143|Postoperative delirium|postoperative delirium
1582530|NCT00455143|PD|pd
1582531|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
1582532|NCT00455143|POCD|pocd
1582533|NCT00455130|mannitol|mannitol
1582534|NCT00455130|cystic fibrosis|cystic fibrosis
1582535|NCT00455130|mucolytic|mucolytic
1582536|NCT00455130|mucoactive|mucoactive
1582539|NCT00455117|neurosurgery|neurosurgery
1582540|NCT00455117|NSAIDS|nsaids
1582541|NCT00455117|parecoxib|parecoxib
1582542|NCT00455117|morphine consumption|morphine consumption
1582543|NCT00455104|Fabry Disease|fabry disease
1582544|NCT00455104|National Registry|national registry
1582640|NCT00454662|Hypertension|hypertension
1582545|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
1582546|NCT00455078|Gastric reflux|gastric reflux
1582547|NCT00455078|Lung transplant|lung transplant
1582548|NCT00455078|chronic rejection|chronic rejection
1582549|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
1582550|NCT00455065|whole grain|whole grain
1582551|NCT00455065|metabolic syndrome|metabolic syndrome
1582552|NCT00455065|weight loss|weight loss
1582553|NCT00455052|XMT-1001|xmt-1001
1582554|NCT00455052|cancer|cancer
1582555|NCT00455052|tumor|tumor
1582556|NCT00455052|camptothecin|camptothecin
1582557|NCT00455052|Fleximer|fleximer
1582558|NCT00455052|polymer|polymer
1582559|NCT00455052|Phase 1|phase 1
1582560|NCT00455052|safety|safety
1582561|NCT00455052|pharmacokinetics|pharmacokinetics
1582562|NCT00455052|maximum tolerated dose|maximum tolerated dose
1582563|NCT00455052|NSCLC|nsclc
1582564|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
1582565|NCT00455052|SCLC|sclc
1582566|NCT00455052|small cell lung cancer|small cell lung cancer
1582567|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
1582568|NCT00455013|Kidney transplant|kidney transplant
1582569|NCT00454987|antibody persistence|antibody persistence
1582570|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
1582571|NCT00454987|conjugate vaccine|conjugate vaccine
1582572|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
1582573|NCT00454974|end stage renal failure|end stage renal failure
1582574|NCT00454974|dialysis|dialysis
1582575|NCT00454974|wearable artificial kidney|wearable artificial kidney
1582576|NCT00454961|Malaria|malaria
1582577|NCT00454961|Plasmodium falciparum|plasmodium falciparum
1582578|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
1582579|NCT00454961|effectiveness|effectiveness
1582580|NCT00454948|Obesity prevention|obesity prevention
1582581|NCT00454948|Dietary intake|dietary intake
1582582|NCT00454948|Physical activity|physical activity
1582583|NCT00454948|Mexican American|mexican american
1582584|NCT00454948|Family Characteristics|family characteristics
1582585|NCT00454935|epilepsy|epilepsy
1582586|NCT00454935|glioma|glioma
1582587|NCT00454922|glaucoma|glaucoma
1582588|NCT00454922|patient educator|patient educator
1582589|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
1582590|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
1582591|NCT00454896|Urgency|urgency
1582592|NCT00454896|VESIcare®|vesicare®
1582593|NCT00454896|Solifenacin succinate|solifenacin succinate
1582594|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
1582595|NCT00454870|Alzheimer's Disease|alzheimer's disease
1582596|NCT00454870|Cognition|cognition
1582597|NCT00454870|Cognitive impairment|cognitive impairment
1582598|NCT00454857|Thrombocytopenia|thrombocytopenia
1582599|NCT00454857|Chart Review|chart review
1582600|NCT00454857|Platelet|platelet
1582601|NCT00454857|Retrospective|retrospective
1582602|NCT00454857|Prospective|prospective
1582603|NCT00454857|Non-interventional|non-interventional
1582604|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
1582605|NCT00454857|Quality of Life (QOL)|quality of life (qol)
1582606|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
1582607|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
1582608|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
1582609|NCT00454857|Observational|observational
1582610|NCT00454831|Hypercholesterolemia|hypercholesterolemia
1582611|NCT00454831|LDL-cholesterol|ldl-cholesterol
1582612|NCT00454831|chitosan|chitosan
1582613|NCT00454831|HEP-40|hep-40
1582614|NCT00454805|Advanced Breast Cancer|advanced breast cancer
1582615|NCT00454792|Low back pain|low back pain
1582616|NCT00454792|Modic changes|modic changes
1582617|NCT00454779|SCCHNC|scchnc
1582618|NCT00454779|Metastatic|metastatic
1582619|NCT00454779|Recurrent|recurrent
1582620|NCT00454766|Patient Education|patient education
1582621|NCT00454766|Cervical Dysplasia|cervical dysplasia
1582622|NCT00454766|Questionnaire|questionnaire
1582623|NCT00454753|Myeloid, Chronic|myeloid, chronic
1582624|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
1582625|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
1582626|NCT00454740|Urgency|urgency
1582627|NCT00454740|VESIcare®|vesicare®
1582628|NCT00454740|Solifenacin succinate|solifenacin succinate
1582629|NCT00454701|Psoriasis|psoriasis
1582630|NCT00454701|Alefacept|alefacept
1582631|NCT00454701|Amevive®|amevive®
1583288|NCT00453089|Symptoms|symptoms
1582632|NCT00454701|Drug exposure|drug exposure
1582633|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
1582634|NCT00454688|Asimadoline|asimadoline
1582635|NCT00454675|Smokers|smokers
1582636|NCT00454675|Chronic Bronchitis|chronic bronchitis
1582637|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
1582638|NCT00454675|COPD|copd
1582641|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
1582759|NCT00454259|Human volunteer|human volunteer
1582642|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1582643|NCT00454662|Calcium Channel Blockers|calcium channel blockers
1582644|NCT00454662|Diuretics|diuretics
1582645|NCT00454662|Combination Drug Therapy|combination drug therapy
1582646|NCT00454662|Diabetes|diabetes
1582647|NCT00454649|axitinib|axitinib
1582648|NCT00454649|chemotherapy|chemotherapy
1582649|NCT00454649|anti-angiogenesis|anti-angiogenesis
1582650|NCT00454649|VEGF inhibition|vegf inhibition
1582651|NCT00454623|Adiponectin|adiponectin
1582652|NCT00454623|diabetes|diabetes
1582653|NCT00454623|metabolism|metabolism
1582654|NCT00454623|Adiponectin levels|adiponectin levels
1582655|NCT00454610|Pediatric|pediatric
1582656|NCT00454610|Overweight|overweight
1582657|NCT00454610|Obesity|obesity
1582658|NCT00454610|Intervention|intervention
1582659|NCT00454610|Prevention|prevention
1582660|NCT00454610|Mexican American|mexican american
1582661|NCT00454584|Psoriasis|psoriasis
1582662|NCT00454584|CNTO 1275|cnto 1275
1582663|NCT00454584|Etanercept|etanercept
1582664|NCT00454584|Immune diorder|immune diorder
1582665|NCT00454584|Skin disorder|skin disorder
1582666|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
1582667|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
1582668|NCT00454532|Breast Cancer|breast cancer
1582669|NCT00454532|Bionovo|bionovo
1582670|NCT00454532|BZL101|bzl101
1582671|NCT00454532|Chinese Herbs|chinese herbs
1582672|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
1582673|NCT00454519|cisplatin|cisplatin
1582674|NCT00454519|mitomycin|mitomycin
1582675|NCT00454519|gastric cancer|gastric cancer
1582676|NCT00454519|colorectal cancer|colorectal cancer
1582677|NCT00454493|omacor|omacor
1582678|NCT00454493|fish oil|fish oil
1582679|NCT00454493|omega 3|omega 3
1582680|NCT00454493|fatty acids|fatty acids
1582681|NCT00454493|coronary artery disease|coronary artery disease
1582682|NCT00454493|endothelial function|endothelial function
1582683|NCT00454493|heart rate variability|heart rate variability
1582684|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
1582685|NCT00454493|QT dispersion|qt dispersion
1582686|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1582687|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1582688|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1582689|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1582690|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1582691|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
1582692|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
1582693|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1582694|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1582695|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1582696|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1582697|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1582698|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1582699|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1582700|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1582701|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1582702|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1582703|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1582704|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1582705|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1582706|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1582707|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1582709|NCT00454454|display enhanced testing|display enhanced testing
1582710|NCT00454441|Sleep Quality|sleep quality
1582711|NCT00454441|Menopausal Symptoms|menopausal symptoms
1582712|NCT00454441|Actigraph|actigraph
1582713|NCT00454441|Bionovo|bionovo
1582714|NCT00454441|MF101|mf101
1582715|NCT00454428|Bypass Surgery|bypass surgery
1582716|NCT00454428|Coronary Artery|coronary artery
1582717|NCT00454415|Diet|diet
1582718|NCT00454415|Body Mass Index|body mass index
1582719|NCT00454415|BMI|bmi
1582720|NCT00454389|Macular|macular
1582721|NCT00454389|Degeneration|degeneration
1582722|NCT00454389|AMD|amd
1582723|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
1582724|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1582725|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1582726|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1582727|NCT00454376|gastrinoma|gastrinoma
1582728|NCT00454376|insulinoma|insulinoma
1582729|NCT00454376|WDHA syndrome|wdha syndrome
1582730|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1582731|NCT00454376|somatostatinoma|somatostatinoma
1582732|NCT00454376|glucagonoma|glucagonoma
1582733|NCT00454376|liver metastases|liver metastases
1582734|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
1582735|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
1582736|NCT00454337|HIV-1 infection|hiv-1 infection
1582737|NCT00454337|enfuvirtide|enfuvirtide
1582738|NCT00454337|raltegravir|raltegravir
1582739|NCT00454337|treatment experienced|treatment experienced
1582740|NCT00454324|Lung cancer|lung cancer
1582741|NCT00454324|Small cell lung cancer|small cell lung cancer
1582742|NCT00454324|Abraxane|abraxane
1582743|NCT00454324|Paclitaxel|paclitaxel
1582744|NCT00454324|Carboplatin|carboplatin
1582745|NCT00454324|Phase II|phase ii
1582746|NCT00454324|Randomized|randomized
1582747|NCT00454324|Lineberger|lineberger
1582749|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
1582750|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
1582751|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
1582752|NCT00454298|Arthritis|arthritis
1582753|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
1582754|NCT00454272|febrile|febrile
1582755|NCT00454272|neutropenia|neutropenia
1582756|NCT00454272|cancer|cancer
1582757|NCT00454272|Gram positive infection|gram positive infection
1582758|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
1582760|NCT00454259|Fentanyl|fentanyl
1582761|NCT00454259|Randomized Controlled Trial|randomized controlled trial
1582762|NCT00454259|Pain chronicisation|pain chronicisation
1582763|NCT00454259|Predictive test|predictive test
1582764|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
1582765|NCT00454233|YM543|ym543
1582766|NCT00454233|Treatment|treatment
1582767|NCT00454233|Safety|safety
1582768|NCT00454233|efficacy|efficacy
1582769|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
1582770|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1582771|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1582772|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1582773|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1582774|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
1582775|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
1582776|NCT00454181|human papilloma virus|human papilloma virus
1582777|NCT00454181|warts, oral|warts, oral
1582778|NCT00454181|papillomatosis|papillomatosis
1582779|NCT00454181|treatment experienced|treatment experienced
1582780|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1582781|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1582782|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1582783|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1582784|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1582785|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1582786|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1582787|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1582788|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1582789|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1582790|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1582791|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1582792|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1582793|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1582794|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1582795|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1582796|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1582797|NCT00454155|HSCT|hsct
1582798|NCT00454155|AGVHD|agvhd
1582799|NCT00454155|Myeloablative|myeloablative
1582800|NCT00454155|Allogeneic|allogeneic
1582801|NCT00454155|Hematopoietic|hematopoietic
1582802|NCT00454155|Stem|stem
1582803|NCT00454155|Cell|cell
1582804|NCT00454155|Transplantation|transplantation
1582805|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
1582806|NCT00454116|Colon Cancer|colon cancer
1582807|NCT00454116|Rectal Cancer|rectal cancer
1582808|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
1582809|NCT00454103|adrenal tumor|adrenal tumor
1582810|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
1582811|NCT00454090|Advanced Malignancies|advanced malignancies
1582812|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
1582813|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
1582814|NCT00454064|back pain|back pain
1582815|NCT00454064|low back pain|low back pain
1582816|NCT00454064|biofeedback|biofeedback
1582817|NCT00454064|randomized controlled study|randomized controlled study
1582818|NCT00454064|EMG biofeedback|emg biofeedback
1582819|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
1582820|NCT00454038|cystectomy|cystectomy
1582821|NCT00454038|augmentation|augmentation
1582823|NCT00454038|amputation|amputation
1582824|NCT00454038|implant|implant
1582825|NCT00454025|glaucoma|glaucoma
1582826|NCT00454025|intraocular pressure|intraocular pressure
1582827|NCT00454025|postural changes|postural changes
1582828|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
1582829|NCT00454012|biophysical profile|biophysical profile
1582830|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
1582831|NCT00453999|influenza|influenza
1582832|NCT00453999|flu|flu
1582833|NCT00453986|immunogenicity|immunogenicity
1582834|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
1582835|NCT00453986|co-administration|co-administration
1582836|NCT00453986|meningococcal vaccine|meningococcal vaccine
1582837|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
1582838|NCT00453986|conjugate vaccine|conjugate vaccine
1582839|NCT00453973|anemia|anemia
1582840|NCT00453973|chronic kidney disease|chronic kidney disease
1582841|NCT00453973|CKD|ckd
1582842|NCT00453973|chronic renal failure|chronic renal failure
1582843|NCT00453973|CRF|crf
1582844|NCT00453973|dialysis|dialysis
1582845|NCT00453973|erythropoietin|erythropoietin
1582846|NCT00453973|EPO|epo
1582847|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1582848|NCT00453973|ESA|esa
1582849|NCT00453973|Hematide™|hematide™
1582850|NCT00453973|hemodialysis|hemodialysis
1582851|NCT00453973|hemoglobin|hemoglobin
1582852|NCT00453973|Hb|hb
1582853|NCT00453973|Hgb|hgb
1582854|NCT00453973|Omontys|omontys
1582855|NCT00453973|peginesatide|peginesatide
1582856|NCT00453973|red blood cell|red blood cell
1582857|NCT00453973|red blood cell production|red blood cell production
1582858|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
1582859|NCT00453960|Genistein|genistein
1582860|NCT00453960|Isoflavones|isoflavones
1582861|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
1582862|NCT00453934|Diabetes|diabetes
1582863|NCT00453934|Type 1 Diabetes|type 1 diabetes
1582864|NCT00453934|Type 2 Diabetes|type 2 diabetes
1582865|NCT00453934|Physiologic Insulin|physiologic insulin
1582866|NCT00453934|Basal Insulin|basal insulin
1582867|NCT00453934|Bolus Insulin|bolus insulin
1582868|NCT00453934|Mealtime insulin|mealtime insulin
1582869|NCT00453934|Insulin patch|insulin patch
1582870|NCT00453934|Multiple daily injections|multiple daily injections
1582871|NCT00453921|TBI|tbi
1582872|NCT00453921|Memory|memory
1582873|NCT00453921|Methylphenidate|methylphenidate
1582874|NCT00453921|Ritalin|ritalin
1582875|NCT00453921|Memory and Attention Training|memory and attention training
1582876|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
1582877|NCT00453895|Sunitinib|sunitinib
1582878|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
1582879|NCT00453869|Liver fibrosis|liver fibrosis
1582880|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
1582881|NCT00453869|FibroMeter|fibrometer
1582882|NCT00453869|FibroScan®|fibroscan®
1582883|NCT00453856|Malaria|malaria
1582884|NCT00453856|Sulfadoxine|sulfadoxine
1582885|NCT00453856|Pyrimethamine|pyrimethamine
1582886|NCT00453856|Resistance|resistance
1582887|NCT00453856|Gabon|gabon
1582888|NCT00453843|Stroke|stroke
1582889|NCT00453843|movement therapy|movement therapy
1582890|NCT00453843|robotics|robotics
1582891|NCT00453843|rehabilitation robotics|rehabilitation robotics
1582892|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
1582893|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
1582894|NCT00453817|islet transplantation|islet transplantation
1582895|NCT00453817|imaging|imaging
1582896|NCT00453817|graft monitoring|graft monitoring
1582897|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
1582898|NCT00453804|Alcohol dependence|alcohol dependence
1582899|NCT00453804|Major Mental Illness|major mental illness
1582900|NCT00453804|Injectable naltrexone|injectable naltrexone
1582901|NCT00453791|GW805858|gw805858
1582902|NCT00453791|MDI|mdi
1582903|NCT00453791|asthma|asthma
1582904|NCT00453791|surfactant|surfactant
1582905|NCT00453778|mild asthma|mild asthma
1582906|NCT00453778|FLIXOTIDE|flixotide
1582907|NCT00453778|methacholine|methacholine
1582908|NCT00453778|bronchial challenge|bronchial challenge
1582909|NCT00453778|leukotriene D4|leukotriene d4
1582910|NCT00453765|cough|cough
1582911|NCT00453765|hyperreactivity|hyperreactivity
1582912|NCT00453765|montelukast|montelukast
1582913|NCT00453752|systemic sclerosis|systemic sclerosis
1582914|NCT00453752|pulmonary hypertension|pulmonary hypertension
1582915|NCT00453752|echocardiography|echocardiography
1582916|NCT00453752|N-Terminal proBNP|n-terminal probnp
1582917|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
1582918|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
1582919|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
1582920|NCT00453726|Respiratory insufficiency|respiratory insufficiency
1582921|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1582922|NCT00453713|Interstitial lung disease|interstitial lung disease
1582923|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
1582924|NCT00453713|Health disparities|health disparities
1582925|NCT00453700|chagas|chagas
1582926|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
1582927|NCT00453687|COPD|copd
1582928|NCT00453687|GSK233705,|gsk233705,
1582929|NCT00453687|Magnesium Stearate,|magnesium stearate,
1582930|NCT00453674|Adrenal cancer|adrenal cancer
1582931|NCT00453674|Treatment|treatment
1582932|NCT00453674|Surgery|surgery
1582933|NCT00453674|Mitotane|mitotane
1582934|NCT00453661|Breast Cancer|breast cancer
1582935|NCT00453661|Cervical Cancer|cervical cancer
1582936|NCT00453661|Prostate Cancer|prostate cancer
1582937|NCT00453661|Colorectal Cancer|colorectal cancer
1582938|NCT00453661|Lung Cancer|lung cancer
1582939|NCT00453661|Cancer Prevention|cancer prevention
1582940|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
1582941|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
1582942|NCT00453661|CMS|cms
1582943|NCT00453661|Hispanic American|hispanic american
1582944|NCT00453661|Cancer Screening Assessment|cancer screening assessment
1582945|NCT00453661|Annual Questionnaire|annual questionnaire
1582946|NCT00453661|Patient Navigator|patient navigator
1582947|NCT00453661|Educational Materials|educational materials
1582948|NCT00453648|stable isotopes|stable isotopes
1582949|NCT00453648|vitamin A|vitamin a
1582950|NCT00453648|beta-carotene|beta-carotene
1582951|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
1582952|NCT00453648|iron|iron
1582953|NCT00453648|zinc|zinc
1582954|NCT00453648|absorption|absorption
1582955|NCT00453648|bioavailability|bioavailability
1582956|NCT00453648|vitamin A equivalency|vitamin a equivalency
1582957|NCT00453648|Bangladesh|bangladesh
1582958|NCT00453648|women|women
1582959|NCT00453635|Cancer|cancer
1582960|NCT00453635|Breast cancer|breast cancer
1582961|NCT00453635|First line treatment|first line treatment
1582962|NCT00453635|Docetaxel|docetaxel
1582963|NCT00453635|Carboplatin|carboplatin
1582964|NCT00453635|Herceptin|herceptin
1582965|NCT00453635|Vinorelbine|vinorelbine
1582966|NCT00453622|Heart Failure|heart failure
1582967|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1582968|NCT00453622|Risk stratification|risk stratification
1582969|NCT00453622|Prediction|prediction
1582970|NCT00453622|Proteomics|proteomics
1582971|NCT00453622|Chemokine|chemokine
1582972|NCT00453622|cardiac enzymes|cardiac enzymes
1582973|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
1582974|NCT00453609|Bipolar Disorders|bipolar disorders
1582975|NCT00453609|Schizophrenia|schizophrenia
1582976|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
1582977|NCT00453609|Alcohol Dependence|alcohol dependence
1582978|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
1582979|NCT00453596|infertile women|infertile women
1582980|NCT00453596|thin endometrial thickness|thin endometrial thickness
1582981|NCT00453596|implantation failure|implantation failure
1582982|NCT00453583|Pediatric|pediatric
1582983|NCT00453583|Allergies|allergies
1582984|NCT00453583|Antihistamines|antihistamines
1582985|NCT00453583|Non-interventional|non-interventional
1582986|NCT00453570|Diphteria|diphteria
1582987|NCT00453570|Tetanus|tetanus
1582988|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
1582989|NCT00453570|Poliomyelitis|poliomyelitis
1582990|NCT00453570|Pertussis|pertussis
1582991|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
1582992|NCT00453544|computer assisted instruction|computer assisted instruction
1582993|NCT00453544|decision making|decision making
1583076|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
1582994|NCT00453544|educational resource design /development|educational resource design /development
1582995|NCT00453544|executive function|executive function
1582996|NCT00453531|Forearm Ischemia|forearm ischemia
1582997|NCT00453531|Endothelial Function|endothelial function
1582998|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
1582999|NCT00453531|Venous Plethysmography|venous plethysmography
1583000|NCT00453531|Healthy Volunteer|healthy volunteer
1583001|NCT00453531|HV|hv
1583002|NCT00453518|SVG|svg
1583003|NCT00453518|Saphenous Vein Graft|saphenous vein graft
1583004|NCT00453518|Embolic Protection|embolic protection
1583005|NCT00453518|Distal Protection|distal protection
1583006|NCT00453518|EPD|epd
1583007|NCT00453518|FiberNet|fibernet
1583008|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
1583009|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
1583010|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1583011|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
1583012|NCT00453505|Primary Motor Cortex|primary motor cortex
1583013|NCT00453505|Corticomotor Excitability|corticomotor excitability
1583014|NCT00453505|Healthy Volunteer|healthy volunteer
1583015|NCT00453505|HV|hv
1583016|NCT00453479|muscarinic receptor,|muscarinic receptor,
1583017|NCT00453479|bronchodilators|bronchodilators
1583018|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
1583019|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
1583020|NCT00453453|Congestive heart failure|congestive heart failure
1583021|NCT00453453|observation unit|observation unit
1583022|NCT00453453|nesiritide|nesiritide
1583023|NCT00453440|HIV|hiv
1583024|NCT00453440|HLA-B*5701|hla-b*5701
1583025|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
1583026|NCT00453440|HIV Infection|hiv infection
1583027|NCT00453427|PTL NOS|ptl nos
1583028|NCT00453427|AILD|aild
1583029|NCT00453427|NHL|nhl
1583030|NCT00453427|CHOP|chop
1583031|NCT00453414|PAH|pah
1583032|NCT00453414|Pediatric|pediatric
1583033|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1583034|NCT00453401|cold sore|cold sore
1583035|NCT00453375|Diabetic|diabetic
1583036|NCT00453375|Diabetes|diabetes
1583037|NCT00453375|Type 1 Diabetes|type 1 diabetes
1583038|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1583039|NCT00453375|autoimmune disease|autoimmune disease
1583040|NCT00453362|NSCLC|nsclc
1583041|NCT00453362|Tarceva|tarceva
1583042|NCT00453362|Positron emission technology|positron emission technology
1583043|NCT00453362|PET|pet
1583044|NCT00453362|Computerized tomography|computerized tomography
1583045|NCT00453362|CT|ct
1583046|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
1583047|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1583048|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1583049|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1583050|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1583051|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1583052|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1583053|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1583054|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1583055|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1583056|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1583057|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1583058|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1583059|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1583060|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1583061|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1583062|NCT00453336|oral leukoplakia|oral leukoplakia
1583063|NCT00453323|Esophageal Cancer|esophageal cancer
1583064|NCT00453323|Phase II|phase ii
1583065|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
1583066|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
1583067|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1583068|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1583069|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
1583070|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
1583071|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
1583072|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1583073|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
1583074|NCT00453310|testicular seminoma|testicular seminoma
1583075|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
1583456|NCT00452374|DepoCyt|depocyt
1583077|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1583078|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
1583079|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1583080|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
1583081|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1583082|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1583083|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1583289|NCT00453089|Bionovo|bionovo
1583084|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1583085|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1583086|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1583087|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1583088|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1583089|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1583090|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1583091|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1583092|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1583093|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1583094|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
1583095|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1583096|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1583097|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1583098|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1583099|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1583100|NCT00453310|testicular immature teratoma|testicular immature teratoma
1583101|NCT00453310|testicular mature teratoma|testicular mature teratoma
1583102|NCT00453310|adult teratoma|adult teratoma
1583103|NCT00453297|Bionovo|bionovo
1583104|NCT00453297|MF101|mf101
1583105|NCT00453297|Herbs|herbs
1583197|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
1583305|NCT00453024|Sutures|sutures
1583106|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
1583107|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
1583108|NCT00453258|ocular proteomics|ocular proteomics
1583109|NCT00453258|eye disease|eye disease
1583110|NCT00453258|proteomics|proteomics
1583111|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1583112|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1583113|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1583114|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1583115|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1583116|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
1583117|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1583118|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1583119|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1583120|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1583121|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1583122|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
1583123|NCT00453232|testicular seminoma|testicular seminoma
1583124|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
1583125|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1583126|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1583127|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1583128|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1583129|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1583130|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1583131|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1583132|NCT00453232|adult teratoma|adult teratoma
1583133|NCT00453232|testicular immature teratoma|testicular immature teratoma
1583134|NCT00453232|testicular mature teratoma|testicular mature teratoma
1583135|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1583136|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1583137|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1583138|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1583139|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1583140|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1583141|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1583142|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1583143|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1583144|NCT00453206|primary myelofibrosis|primary myelofibrosis
1583145|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1583209|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1583146|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1583147|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1583148|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1583149|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1583150|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1583380|NCT00452712|fever|fever
1583151|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1583152|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1583153|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1583154|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1583155|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1583156|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1583157|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1583158|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1583159|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1583160|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1583161|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1583162|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
1583163|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1583164|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1583165|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1583166|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1583167|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1583168|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1583169|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1583170|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1583171|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1583172|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1583173|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1583174|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1583175|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1583176|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1583177|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1583178|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
1583179|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1583180|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1583181|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1583182|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1583183|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
1583184|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
1583185|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1583186|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1583187|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1583188|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1583189|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1583190|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1583191|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1583192|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1583193|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1583194|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1583195|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1583196|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1583198|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1583199|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1583200|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1583201|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1583925|NCT00450502|Cytotoxic|cytotoxic
1583202|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1583203|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1583204|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1583205|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1583206|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1583207|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1583208|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1583210|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1583211|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1583212|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1583213|NCT00453206|polycythemia vera|polycythemia vera
1583214|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1583215|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1583216|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1583217|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1583218|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1583219|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1583220|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1583221|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1583222|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1583223|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1583224|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1583225|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1583226|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1583227|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1583228|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1583229|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1583230|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1583231|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1583232|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1583233|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1583234|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1583235|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1583236|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1583237|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1583238|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1583239|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1583240|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1583241|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1583242|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
1583243|NCT00453193|Alemtuzumab|alemtuzumab
1583244|NCT00453193|Pentostatin|pentostatin
1583245|NCT00453193|Campath-1H|campath-1h
1583246|NCT00453193|Deoxycoformycin|deoxycoformycin
1583247|NCT00453193|Lymphoma|lymphoma
1583248|NCT00453193|Leukemia|leukemia
1583249|NCT00453180|Autistic Disorder|autistic disorder
1583250|NCT00453180|Asperger's|asperger's
1583251|NCT00453180|PDD NOS|pdd nos
1583252|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
1583253|NCT00453180|Autism|autism
1583254|NCT00453180|N-acetylcysteine|n-acetylcysteine
1583255|NCT00453180|acetylcysteine|acetylcysteine
1583256|NCT00453180|NAC|nac
1583257|NCT00453180|antioxidant|antioxidant
1583258|NCT00453180|treatment|treatment
1583259|NCT00453180|core symptoms|core symptoms
1583260|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
1583261|NCT00453180|Asperger's Disorder|asperger's disorder
1583262|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
1583263|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
1583264|NCT00453167|Small cell lung cancer|small cell lung cancer
1583265|NCT00453167|second-line therapy|second-line therapy
1583266|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
1583267|NCT00453141|Preterm delivery|preterm delivery
1583268|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
1583269|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
1583270|NCT00453128|associated conditions|associated conditions
1583271|NCT00453115|Non small cell lung cancer|non small cell lung cancer
1583272|NCT00453115|advanced stage IIIB|advanced stage iiib
1583273|NCT00453115|Stage IV|stage iv
1583274|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
1583275|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
1584208|NCT00449345|Quantiferon|quantiferon
1583276|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
1583277|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
1583278|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
1583279|NCT00453102|MZL|mzl
1583280|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
1583281|NCT00453102|Splenic MZL|splenic mzl
1583282|NCT00453102|Nodal MZL|nodal mzl
1583283|NCT00453102|Gastric MZL|gastric mzl
1583284|NCT00453089|Chinese Herbs|chinese herbs
1583285|NCT00453089|Postmenopausal|postmenopausal
1583286|NCT00453089|Vaginal Atrophy|vaginal atrophy
1583287|NCT00453089|Vulvar Atrophy|vulvar atrophy
1583291|NCT00453076|Biliary Obstruction|biliary obstruction
1583292|NCT00453050|stage III melanoma|stage iii melanoma
1583293|NCT00453050|stage IV melanoma|stage iv melanoma
1583294|NCT00453050|skin metastases|skin metastases
1583295|NCT00453037|hypertension|hypertension
1583381|NCT00452699|fluticasone propionate|fluticasone propionate
1583296|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
1583297|NCT00453037|education program|education program
1583298|NCT00453037|life style|life style
1583299|NCT00453024|Advanced glaucoma|advanced glaucoma
1583300|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
1583301|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
1583302|NCT00453024|Pericardial patch graft|pericardial patch graft
1583303|NCT00453024|Tissue glue|tissue glue
1583304|NCT00453024|Scleral flap|scleral flap
1583306|NCT00453011|vitreous loss|vitreous loss
1583307|NCT00453011|intraocular lenses|intraocular lenses
1583308|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
1583309|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
1583310|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
1583311|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
1583312|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
1583313|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
1583314|NCT00452972|Cesarean delivery|cesarean delivery
1583315|NCT00452972|Spinal anesthesia|spinal anesthesia
1583316|NCT00452972|Nausea|nausea
1583317|NCT00452972|Vomiting|vomiting
1583318|NCT00452972|Pain|pain
1583319|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1583320|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
1583321|NCT00452920|stage III cervical cancer|stage iii cervical cancer
1583322|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
1583323|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
1583324|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
1583325|NCT00452868|cognitive/functional effects|cognitive/functional effects
1583326|NCT00452868|neurotoxicity|neurotoxicity
1583327|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1583328|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1583329|NCT00452868|radiation toxicity|radiation toxicity
1583330|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1583331|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
1583332|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
1583333|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
1583334|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
1583335|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
1583336|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1583337|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
1583338|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
1583339|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
1583340|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1583341|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
1583342|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
1583343|NCT00452868|childhood ependymoma|childhood ependymoma
1583344|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
1583345|NCT00452855|Nausea|nausea
1583346|NCT00452855|Vomiting|vomiting
1583347|NCT00452855|Post operative|post operative
1583348|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
1583349|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
1583350|NCT00452816|Chronic Disease|chronic disease
1583351|NCT00452816|Employer Health Costs|employer health costs
1583352|NCT00452816|Health Promotion|health promotion
1583353|NCT00452816|Insurance Benefits|insurance benefits
1583354|NCT00452816|Marketing of Health Services|marketing of health services
1583355|NCT00452816|Mass Screening|mass screening
1583356|NCT00452816|Prevention & Control|prevention & control
1583357|NCT00452816|Tobacco Use Cessation|tobacco use cessation
1583358|NCT00452816|Workplace|workplace
1583359|NCT00452803|Non small cell lung cancer|non small cell lung cancer
1583360|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
1583361|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
1583362|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
1583363|NCT00452764|COPD|copd
1583364|NCT00452764|Healthy|healthy
1583365|NCT00452764|Regulatory T cell|regulatory t cell
1583366|NCT00452764|Heme oxygenase-1|heme oxygenase-1
1583367|NCT00452764|peripheral blood|peripheral blood
1583368|NCT00452751|gastric cancer|gastric cancer
1583369|NCT00452751|laparoscopic surgery|laparoscopic surgery
1583370|NCT00452751|survival|survival
1583371|NCT00452751|preoperative staging|preoperative staging
1583372|NCT00452751|morbidity|morbidity
1583373|NCT00452751|quality of life|quality of life
1583470|NCT00452309|pad|pad
1583374|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
1583375|NCT00452751|cost|cost
1583376|NCT00452738|animal-assisted intervention|animal-assisted intervention
1583377|NCT00452738|pre surgery anxiety|pre surgery anxiety
1583378|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
1583379|NCT00452712|orthostatism|orthostatism
1583382|NCT00452699|long-term study|long-term study
1583383|NCT00452699|Salmeterol|salmeterol
1583384|NCT00452699|FLOVENT 250|flovent 250
1583385|NCT00452699|Asthma|asthma
1583386|NCT00452699|ADVAIR 250|advair 250
1583387|NCT00452686|Chinese DT vaccin|chinese dt vaccin
1583388|NCT00452660|IRON|iron
1583389|NCT00452660|oxidative stress|oxidative stress
1583390|NCT00452660|MDS|mds
1583391|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
1583392|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
1583393|NCT00452634|Irinotecan|irinotecan
1583394|NCT00452634|cisplatin|cisplatin
1583395|NCT00452634|Simvastatin|simvastatin
1583396|NCT00452634|Extensive disease|extensive disease
1583397|NCT00452634|SCLC|sclc
1583398|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
1583399|NCT00452621|TBE|tbe
1583400|NCT00452582|ischemic stroke|ischemic stroke
1583401|NCT00452582|recovery|recovery
1583402|NCT00452582|sildenafil|sildenafil
1583403|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
1583404|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
1583405|NCT00452556|Radiotherapy|radiotherapy
1583406|NCT00452556|Docetaxel|docetaxel
1583407|NCT00452556|Leuprolide Acetate|leuprolide acetate
1583408|NCT00452543|Major depressive disorder|major depressive disorder
1583409|NCT00452543|Alcoholism|alcoholism
1583410|NCT00452543|Alcohol abuse|alcohol abuse
1583411|NCT00452543|Alcohol dependence|alcohol dependence
1583412|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
1583413|NCT00452517|bare metal stents|bare metal stents
1583414|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
1583415|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
1583416|NCT00452517|acute coronary syndrome|acute coronary syndrome
1583541|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
1583417|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
1583418|NCT00452517|major adverse cardiac events|major adverse cardiac events
1583419|NCT00452517|in-stent restenosis|in-stent restenosis
1583420|NCT00452517|target lesion revascularisation|target lesion revascularisation
1583421|NCT00452478|Hyperphosphataemia|hyperphosphataemia
1583422|NCT00452465|Elderly|elderly
1583423|NCT00452465|Nursing care plan|nursing care plan
1583424|NCT00452465|Quality of Life|quality of life
1583425|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
1583426|NCT00452439|Leukemia|leukemia
1583427|NCT00452439|Lymphoma|lymphoma
1583428|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1583429|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1583430|NCT00452439|Actonel|actonel
1583431|NCT00452439|Risedronate|risedronate
1583432|NCT00452439|Bone Loss|bone loss
1583433|NCT00452439|Osteoporosis|osteoporosis
1583434|NCT00452426|Propofol|propofol
1583435|NCT00452426|Diprivan|diprivan
1583436|NCT00452426|Colonoscopy|colonoscopy
1583437|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
1583438|NCT00452426|Conscious Sedation|conscious sedation
1583439|NCT00452387|Prostate Cancer|prostate cancer
1583440|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1583441|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1583442|NCT00452374|CLL|cll
1583443|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
1583444|NCT00452374|PLL|pll
1583445|NCT00452374|Richter's Transformation|richter's transformation
1583446|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
1583447|NCT00452374|Hodgkin's disease|hodgkin's disease
1583448|NCT00452374|Acute leukemia|acute leukemia
1583449|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
1583450|NCT00452374|Oxaliplatin|oxaliplatin
1583451|NCT00452374|Eloxatin|eloxatin
1583452|NCT00452374|Fludarabine|fludarabine
1583453|NCT00452374|Cytarabine|cytarabine
1583454|NCT00452374|Ara-C|ara-c
1583455|NCT00452374|Cytosar|cytosar
1583457|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1583458|NCT00452374|Rituximab|rituximab
1583459|NCT00452374|Rituxan|rituxan
1583460|NCT00452348|FLOVENT|flovent
1583461|NCT00452348|fluticasone|fluticasone
1583462|NCT00452348|12 month|12 month
1583463|NCT00452348|salmeterol|salmeterol
1583464|NCT00452348|asthma|asthma
1583465|NCT00452348|ADVAIR|advair
1583466|NCT00452322|Testosterone|testosterone
1583467|NCT00452322|Hypogonadism|hypogonadism
1583468|NCT00452322|Safety|safety
1583469|NCT00452309|peripheral arterial disease|peripheral arterial disease
1583471|NCT00452309|ankle brachial index|ankle brachial index
1583472|NCT00452309|abi|abi
1583473|NCT00452296|inpatients with COPD|inpatients with copd
1583474|NCT00452296|glucose control|glucose control
1583475|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
1583476|NCT00452244|Gefitinib|gefitinib
1583477|NCT00452244|Simvastatin|simvastatin
1583478|NCT00452244|NSCLC|nsclc
1583479|NCT00452244|Advanced NSCLC|advanced nsclc
1583480|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
1583481|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1583482|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1583483|NCT00452218|PAH|pah
1583484|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
1583485|NCT00452205|bone marrow transplantation|bone marrow transplantation
1583486|NCT00452205|graft versus host disease|graft versus host disease
1583487|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
1583488|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
1583489|NCT00452192|Metabolic syndrome|metabolic syndrome
1583490|NCT00452179|Sleep maintenance|sleep maintenance
1583491|NCT00452179|Insomnia|insomnia
1583492|NCT00452179|Sleep Consolidation|sleep consolidation
1583493|NCT00452179|Sleep|sleep
1583494|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
1583495|NCT00452153|legionellosis|legionellosis
1583496|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
1583497|NCT00452153|PCR|pcr
1583498|NCT00452140|Breast Cancer|breast cancer
1583499|NCT00452140|investigational drug|investigational drug
1583500|NCT00452140|drug therapy|drug therapy
1583501|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
1583502|NCT00452140|Immunotherapy|immunotherapy
1583503|NCT00452140|Metastatic breast cancer|metastatic breast cancer
1583504|NCT00452140|Advanced breast cancer|advanced breast cancer
1583505|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
1583506|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
1583507|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
1583508|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
1583509|NCT00452140|Her-2/neu|her-2/neu
1583510|NCT00452127|NHL|nhl
1583511|NCT00452127|Indolent|indolent
1583512|NCT00452127|Follicular|follicular
1583513|NCT00452114|Bronchiectasis|bronchiectasis
1583514|NCT00452101|Osteoarthritis|osteoarthritis
1583515|NCT00452101|Clinical trial|clinical trial
1583516|NCT00452101|Aquamin F|aquamin f
1583517|NCT00452101|Glucosamine|glucosamine
1583518|NCT00452088|Malaria vaccine|malaria vaccine
1583519|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
1583520|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
1583521|NCT00452088|Burkina Faso children|burkina faso children
1583522|NCT00452075|EGFR expression|egfr expression
1583523|NCT00452075|erlotinib|erlotinib
1583524|NCT00452062|cuff-leak test|cuff-leak test
1583525|NCT00452062|intubation|intubation
1583526|NCT00452062|corticosteroids|corticosteroids
1583527|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
1583528|NCT00452049|parathyroidectomy|parathyroidectomy
1583529|NCT00452049|arterial stiffness|arterial stiffness
1583530|NCT00452049|renal function|renal function
1583531|NCT00452036|risk factors|risk factors
1583532|NCT00452036|plain x ray|plain x ray
1583533|NCT00452036|cranial computed tomography|cranial computed tomography
1583534|NCT00452036|minor head injury|minor head injury
1583535|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
1583536|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
1583537|NCT00452023|Polycythemia Vera|polycythemia vera
1583538|NCT00452023|Pegasys|pegasys
1583539|NCT00452023|IFN-alpha2a|ifn-alpha2a
1583540|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
1583542|NCT00452010|TENS|tens
1583543|NCT00452010|chronic low back pain|chronic low back pain
1583544|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
1583545|NCT00452010|placebo|placebo
1583546|NCT00452010|Roland scale|roland scale
1583547|NCT00451997|AML|aml
1583548|NCT00451997|MDS|mds
1583549|NCT00451997|Gleevec|gleevec
1583550|NCT00451997|Ara-C|ara-c
1583551|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
1583552|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
1583553|NCT00451984|interleukin-2|interleukin-2
1583554|NCT00451984|vaccination|vaccination
1583555|NCT00451984|treatment experienced|treatment experienced
1583556|NCT00451958|Degarelix|degarelix
1584448|NCT00448396|Cancer|cancer
1583557|NCT00451958|prostate cancer|prostate cancer
1583558|NCT00451932|Malononitrilamide|malononitrilamide
1583559|NCT00451932|Immunosuppression|immunosuppression
1583560|NCT00451932|treatment efficacy|treatment efficacy
1583561|NCT00451932|treatment effectiveness|treatment effectiveness
1583562|NCT00451919|MRI|mri
1583563|NCT00451919|Neuropsychology|neuropsychology
1583564|NCT00451893|Inguinal hernia|inguinal hernia
1583565|NCT00451893|polypropylene mesh|polypropylene mesh
1583566|NCT00451893|heavy-weight mesh|heavy-weight mesh
1583567|NCT00451893|light-weight mesh|light-weight mesh
1583568|NCT00451880|Cancer|cancer
1583569|NCT00451880|Solid Tumors|solid tumors
1583571|NCT00451867|interstitial cystitis research|interstitial cystitis research
1583572|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
1583573|NCT00451867|pelvic pain research|pelvic pain research
1583671|NCT00451451|remitting|remitting
1583574|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
1583575|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
1583576|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
1583577|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
1583578|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
1583579|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
1583580|NCT00451854|Drug testing|drug testing
1583581|NCT00451854|Adolescence|adolescence
1583582|NCT00451854|Student athlete|student athlete
1583583|NCT00451854|Substance abuse|substance abuse
1583584|NCT00451854|Alcohol use|alcohol use
1583585|NCT00451854|Drug use|drug use
1583586|NCT00451841|Cough|cough
1583587|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
1583588|NCT00451841|Exhaled breath condensate|exhaled breath condensate
1583589|NCT00451828|Statins|statins
1583590|NCT00451828|Cholesterol|cholesterol
1583591|NCT00451828|Pharmacogenetics|pharmacogenetics
1583592|NCT00451802|Biotechnology|biotechnology
1583593|NCT00451802|Specimen|specimen
1583594|NCT00451802|Health Management Center|health management center
1583595|NCT00451789|Minor head injury|minor head injury
1583596|NCT00451789|iintracranial bleeding|iintracranial bleeding
1583597|NCT00451789|traumatic brain injury|traumatic brain injury
1583598|NCT00451789|Cranial computed tomography|cranial computed tomography
1583599|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
1583600|NCT00451776|cardiac surgery|cardiac surgery
1583601|NCT00451776|adrenal insufficiency|adrenal insufficiency
1583602|NCT00451776|etomidate|etomidate
1583603|NCT00451776|propofol|propofol
1583604|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
1583605|NCT00451763|Fundus oculi|fundus oculi
1583606|NCT00451763|Retinal neovascularization|retinal neovascularization
1583607|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
1583608|NCT00451763|Tomography, optical coherence|tomography, optical coherence
1583609|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
1583610|NCT00451750|phobia|phobia
1583611|NCT00451750|cortisol|cortisol
1583612|NCT00451750|memory|memory
1583613|NCT00451750|treatment|treatment
1583614|NCT00451737|Six-minute walk test|six-minute walk test
1583615|NCT00451737|Neuromuscular system|neuromuscular system
1583616|NCT00451737|Influence factors|influence factors
1583617|NCT00451724|Prospective|prospective
1583618|NCT00451724|Randomized|randomized
1583619|NCT00451724|Double blinded|double blinded
1583620|NCT00451724|Sedation|sedation
1583621|NCT00451724|Ketamine|ketamine
1583622|NCT00451724|Intranasal|intranasal
1583623|NCT00451711|Prophylaxis|prophylaxis
1583624|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
1583625|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
1583626|NCT00451711|Invasive Fungal Infections|invasive fungal infections
1583627|NCT00451698|Erythropoietin|erythropoietin
1583628|NCT00451698|Congenital heart surgery|congenital heart surgery
1583629|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
1583630|NCT00451659|PTSD|ptsd
1583631|NCT00451659|Veterans|veterans
1583632|NCT00451659|Deployed|deployed
1583633|NCT00451620|Type 2 diabetes|type 2 diabetes
1583634|NCT00451620|Hypoglycemia|hypoglycemia
1583635|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
1583636|NCT00451620|Insulin levels|insulin levels
1583637|NCT00451607|premature|premature
1583638|NCT00451607|newborn|newborn
1583639|NCT00451607|heart rate variability|heart rate variability
1583640|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
1583641|NCT00451607|noise|noise
1583642|NCT00451594|ITP|itp
1583643|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
1583644|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
1583645|NCT00451581|Choledocholithiasis|choledocholithiasis
1583646|NCT00451581|Efficacy|efficacy
1583647|NCT00451581|Complication|complication
1583648|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
1583649|NCT00451542|Bipolar Disorder|bipolar disorder
1583650|NCT00451542|Relapse|relapse
1583651|NCT00451542|Retrospective|retrospective
1583652|NCT00451516|Plant, medicine|plant, medicine
1583653|NCT00451516|Psychiatry|psychiatry
1583654|NCT00451516|Major depressive disorder|major depressive disorder
1583655|NCT00451516|Anxiety|anxiety
1583656|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
1583657|NCT00451503|Hearing|hearing
1583658|NCT00451503|Auditory rehabilitation|auditory rehabilitation
1583659|NCT00451503|Middle ear implant|middle ear implant
1583660|NCT00451503|Surgery|surgery
1583661|NCT00451490|agomelatin|agomelatin
1583662|NCT00451490|prozac|prozac
1583663|NCT00451490|heart rate variability|heart rate variability
1583664|NCT00451490|major depression|major depression
1583665|NCT00451490|sleep|sleep
1583666|NCT00451490|depressive symptoms|depressive symptoms
1583667|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
1583668|NCT00451451|relapsing|relapsing
1583669|NCT00451451|multiple sclerosis|multiple sclerosis
1583672|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
1583673|NCT00451438|electromyography|electromyography
1583674|NCT00451438|gluteus medius|gluteus medius
1583675|NCT00451438|tensor fascia lata|tensor fascia lata
1583676|NCT00451425|pregnancy|pregnancy
1583677|NCT00451425|weight gain|weight gain
1583678|NCT00451425|obesity|obesity
1583679|NCT00451425|macrosomia|macrosomia
1583680|NCT00451412|Venous thromboembolism|venous thromboembolism
1583681|NCT00451412|Medical patients|medical patients
1583682|NCT00451412|Heparin|heparin
1583683|NCT00451412|Low molecular weight heparin|low molecular weight heparin
1583684|NCT00451412|Deep vein thrombosis|deep vein thrombosis
1583685|NCT00451412|Certoparin|certoparin
1583686|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
1583687|NCT00451399|Weight gain|weight gain
1583688|NCT00451399|antipsychotic|antipsychotic
1583689|NCT00451399|lifestyle interventions|lifestyle interventions
1583690|NCT00451399|metformin|metformin
1583691|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
1583692|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
1583693|NCT00451360|Diacerein|diacerein
1583694|NCT00451360|Hip osteoarthritis|hip osteoarthritis
1583695|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
1583696|NCT00451360|Double blind study|double blind study
1583697|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
1583698|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
1583699|NCT00451321|type 1 diabetes|type 1 diabetes
1583700|NCT00451321|diabetes mellitus|diabetes mellitus
1583701|NCT00451321|diabetes|diabetes
1583702|NCT00451308|Induction of labor|induction of labor
1583703|NCT00451308|vaginal delivery|vaginal delivery
1583704|NCT00451308|cesarean section|cesarean section
1583705|NCT00451308|foley balloon cathether|foley balloon cathether
1583706|NCT00451308|method of labor induction|method of labor induction
1583707|NCT00451308|perinatal outcomes|perinatal outcomes
1583708|NCT00451295|Chronic Kidney Disease|chronic kidney disease
1583709|NCT00451295|Dialysis|dialysis
1583710|NCT00451295|Hyperphosphatemia|hyperphosphatemia
1583711|NCT00451269|Malaria|malaria
1583712|NCT00451269|Diagnosis|diagnosis
1583714|NCT00451269|pLDH|pldh
1583715|NCT00451269|HRP2|hrp2
1583716|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
1583717|NCT00451269|country|country
1583718|NCT00451256|coronary artery bypass|coronary artery bypass
1583719|NCT00451256|cardiovascular disease|cardiovascular disease
1583720|NCT00451243|psoriatic arthritis|psoriatic arthritis
1583721|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
1583722|NCT00451204|Multiple sclerosis|multiple sclerosis
1583723|NCT00451204|estrogen|estrogen
1583724|NCT00451204|estriol|estriol
1583725|NCT00451204|progesterone|progesterone
1583726|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
1583727|NCT00451191|BPH|bph
1583728|NCT00451191|botulinum toxin|botulinum toxin
1583729|NCT00451191|BoNT/A|bont/a
1583730|NCT00451165|Laparoscopic|laparoscopic
1583731|NCT00451165|Colon|colon
1583732|NCT00451165|Rectal|rectal
1583733|NCT00451165|Surgery|surgery
1583734|NCT00451165|Urinary function|urinary function
1583735|NCT00451165|Sexual function|sexual function
1583736|NCT00451165|Bowel function|bowel function
1583737|NCT00451165|Male|male
1583738|NCT00451152|glaucoma|glaucoma
1583739|NCT00451126|emotion|emotion
1583740|NCT00451126|personality|personality
1583741|NCT00451126|social stress|social stress
1583742|NCT00451126|appraisal|appraisal
1583743|NCT00451113|Type 2 diabetes|type 2 diabetes
1583744|NCT00451113|Older adults|older adults
1583745|NCT00451113|Incretins|incretins
1583746|NCT00451113|Hyperglycemia|hyperglycemia
1583747|NCT00451113|Insulin resistance|insulin resistance
1583748|NCT00451087|mechanical properties|mechanical properties
1583749|NCT00451087|electromechanical delay|electromechanical delay
1583750|NCT00451087|viscoelasticity|viscoelasticity
1583751|NCT00451087|VMO|vmo
1583752|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
1583753|NCT00451074|Stop codon mutations|stop codon mutations
1583754|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
1583755|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
1583756|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
1583757|NCT00451035|adults|adults
1583758|NCT00451035|oral LBH589|oral lbh589
1583759|NCT00451022|Fowlpox|fowlpox
1583760|NCT00451022|Vaccinia|vaccinia
1583761|NCT00451022|PSA|psa
1583762|NCT00451022|CEA|cea
1583763|NCT00451022|MUC-1|muc-1
1583764|NCT00451022|Gene Therapy|gene therapy
1583765|NCT00451022|Long Term Survivor|long term survivor
1583766|NCT00451022|Research Specimen|research specimen
1583767|NCT00451009|IVF|ivf
1583768|NCT00451009|Male factor infertility|male factor infertility
1583769|NCT00451009|Cryopreservation|cryopreservation
1583770|NCT00451009|Cryoprotective agents|cryoprotective agents
1583771|NCT00451009|Egg Freezing|egg freezing
1583772|NCT00450983|graft versus host disease|graft versus host disease
1584309|NCT00448903|bemiparin|bemiparin
1583773|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1583774|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1583775|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1583776|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1583777|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1583778|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1583779|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1583780|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1583781|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1583782|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1583783|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1583784|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1583785|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1583786|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1583787|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1583788|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1583789|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1583790|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1583791|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1583792|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1583793|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1583794|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1583795|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
1583796|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1583797|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
1583798|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1583799|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1583800|NCT00450931|health status unknown|health status unknown
1583801|NCT00450918|Kartagener Syndrome|kartagener syndrome
1583802|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
1583803|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
1583804|NCT00450892|stage II breast cancer|stage ii breast cancer
1583805|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
1583806|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
1583807|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
1583808|NCT00450866|recurrent breast cancer|recurrent breast cancer
1583809|NCT00450866|stage IV breast cancer|stage iv breast cancer
1583810|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
1583811|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
1583812|NCT00450866|male breast cancer|male breast cancer
1583813|NCT00450853|emesis|emesis
1583814|NCT00450853|granisetron|granisetron
1583815|NCT00450853|pharmacokinetics|pharmacokinetics
1583816|NCT00450853|subcutaneous.|subcutaneous.
1583817|NCT00450840|septic shock|septic shock
1583818|NCT00450840|simvastatin|simvastatin
1583819|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
1583820|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1583821|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1583822|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1583823|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1583824|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1583825|NCT00450788|Etiology|etiology
1583826|NCT00450788|Carcinogens|carcinogens
1583827|NCT00450788|Esophageal Cancer|esophageal cancer
1583828|NCT00450762|pretreated|pretreated
1583829|NCT00450762|metastatic|metastatic
1583830|NCT00450736|chondrosarcoma|chondrosarcoma
1583831|NCT00450736|adult angiosarcoma|adult angiosarcoma
1583832|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
1583833|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
1583834|NCT00450736|adult liposarcoma|adult liposarcoma
1583835|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
1583836|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
1583837|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
1583838|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
1583839|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
1583840|NCT00450736|childhood liposarcoma|childhood liposarcoma
1583841|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1583842|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
1583843|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1583844|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1583845|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1583846|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1584310|NCT00448903|neuropathy|neuropathy
1583847|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1583848|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
1583849|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
1583850|NCT00450723|stage I breast cancer|stage i breast cancer
1583851|NCT00450723|stage II breast cancer|stage ii breast cancer
1583852|NCT00450723|male breast cancer|male breast cancer
1583853|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
1583854|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
1583855|NCT00450697|Feeding method in premature infants|feeding method in premature infants
1583856|NCT00450671|Fistula-in-ano|fistula-in-ano
1583857|NCT00450671|Anal fistula|anal fistula
1583858|NCT00450671|Perirectal fistula|perirectal fistula
1583859|NCT00450671|Collagen plug|collagen plug
1583860|NCT00450671|Surgisis|surgisis
1583861|NCT00450671|Seton|seton
1583862|NCT00450658|ibuprofen|ibuprofen
1583863|NCT00450658|famotidine|famotidine
1583864|NCT00450658|ulcers|ulcers
1583865|NCT00450658|NSAIDS|nsaids
1583866|NCT00450658|pain|pain
1583867|NCT00450658|arthritis|arthritis
1583868|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
1583869|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
1583870|NCT00450658|osteoarthritis|osteoarthritis
1583871|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
1583872|NCT00450658|chronic low back pain|chronic low back pain
1583873|NCT00450645|Cancer|cancer
1583874|NCT00450645|Residual vein thrombosis|residual vein thrombosis
1583875|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
1583876|NCT00450645|Optimal duration|optimal duration
1583877|NCT00450632|meningococcal infections|meningococcal infections
1583878|NCT00450632|biotheque|biotheque
1583879|NCT00450632|genetic markers|genetic markers
1583880|NCT00450619|Radionuclide|radionuclide
1583881|NCT00450619|Immunotherapy|immunotherapy
1583882|NCT00450619|Radiation|radiation
1583883|NCT00450619|PSA|psa
1583884|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1583885|NCT00450619|Prostate Cancer|prostate cancer
1583886|NCT00450593|melanoma|melanoma
1583887|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
1583888|NCT00450593|recurrent melanoma|recurrent melanoma
1583889|NCT00450593|stage 0 melanoma|stage 0 melanoma
1583890|NCT00450593|stage IV melanoma|stage iv melanoma
1583891|NCT00450593|stage IA melanoma|stage ia melanoma
1583892|NCT00450593|stage IB melanoma|stage ib melanoma
1583893|NCT00450593|stage IIA melanoma|stage iia melanoma
1583894|NCT00450593|stage IIB melanoma|stage iib melanoma
1583895|NCT00450593|stage IIC melanoma|stage iic melanoma
1583896|NCT00450593|stage IIIA melanoma|stage iiia melanoma
1583897|NCT00450593|stage IIIB melanoma|stage iiib melanoma
1583898|NCT00450593|stage IIIC melanoma|stage iiic melanoma
1583899|NCT00450580|protease inhibitor,|protease inhibitor,
1583900|NCT00450580|HIV-1,|hiv-1,
1583901|NCT00450580|Fosamprenavir,|fosamprenavir,
1583902|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
1583903|NCT00450580|ritonavir,|ritonavir,
1583904|NCT00450580|naive,|naive,
1583905|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1583906|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1583907|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1583908|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1583909|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1583910|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1583911|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
1583912|NCT00450554|Serum bactericidal activity|serum bactericidal activity
1583913|NCT00450554|Menbvac|menbvac
1583914|NCT00450541|Advanced Cancer|advanced cancer
1583915|NCT00450541|Fatigue|fatigue
1583916|NCT00450541|Interview|interview
1583917|NCT00450541|Questionnaire|questionnaire
1583918|NCT00450541|Survey|survey
1583919|NCT00450528|D-dimers|d-dimers
1583920|NCT00450528|surgery|surgery
1583921|NCT00450528|kinetics|kinetics
1583922|NCT00450515|recurrent breast cancer|recurrent breast cancer
1583923|NCT00450515|stage IV breast cancer|stage iv breast cancer
1583924|NCT00450515|male breast cancer|male breast cancer
1583926|NCT00450502|Pharmacokinetics|pharmacokinetics
1583927|NCT00450502|Toxicity|toxicity
1583928|NCT00450502|Neoplasms|neoplasms
1583929|NCT00450502|Pharmacogenomics|pharmacogenomics
1583930|NCT00450502|Solid Tumor|solid tumor
1583931|NCT00450502|Lymphoma|lymphoma
1583932|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1583933|NCT00450489|Quality of Life|quality of life
1583934|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
1583935|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
1583936|NCT00450476|prevention|prevention
1583937|NCT00450476|endotracheal intubation|endotracheal intubation
1583938|NCT00450476|mechanical ventilation|mechanical ventilation
1583939|NCT00450463|Immunotherapy|immunotherapy
1583940|NCT00450463|Hormonal Therapy|hormonal therapy
1584864|NCT00447330|METASTATIC|metastatic
1583941|NCT00450463|Combination Therapy|combination therapy
1583942|NCT00450463|Prostate Specific Antigen|prostate specific antigen
1583943|NCT00450463|Immunoassay|immunoassay
1583944|NCT00450463|Prostate Cancer|prostate cancer
1583945|NCT00450437|Meningococcal|meningococcal
1583946|NCT00450437|meningitis|meningitis
1583947|NCT00450437|vaccine|vaccine
1583948|NCT00450437|adolescents|adolescents
1583949|NCT00450437|adults|adults
1583950|NCT00450424|colon cancer|colon cancer
1583951|NCT00450424|rectal cancer|rectal cancer
1583952|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
1583953|NCT00450424|recurrent colon cancer|recurrent colon cancer
1583954|NCT00450424|stage I colon cancer|stage i colon cancer
1583955|NCT00450424|stage IIA colon cancer|stage iia colon cancer
1583956|NCT00450424|stage IIB colon cancer|stage iib colon cancer
1583957|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
1583958|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
1583959|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
1583960|NCT00450424|stage IVA colon cancer|stage iva colon cancer
1583961|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
1583962|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
1583963|NCT00450424|stage I rectal cancer|stage i rectal cancer
1583964|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
1583965|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
1583966|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
1583967|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
1583968|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
1583969|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
1583970|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
1583971|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
1583972|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1583973|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
1583974|NCT00450411|stage I prostate cancer|stage i prostate cancer
1583975|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
1583976|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
1583977|NCT00450398|Delayed graft function|delayed graft function
1583978|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1583979|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1583980|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1583981|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1583982|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1583983|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1583984|NCT00450372|recurrent melanoma|recurrent melanoma
1583985|NCT00450372|stage IV melanoma|stage iv melanoma
1583986|NCT00450359|breast cancer|breast cancer
1583987|NCT00450333|Chronic|chronic
1583988|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1583989|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1583990|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
1583991|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
1583992|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
1583993|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1583994|NCT00450307|regional neuroblastoma|regional neuroblastoma
1583995|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1583996|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1583997|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1583998|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1583999|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1584000|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1584001|NCT00450268|Graft versus host disease|graft versus host disease
1584002|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
1584003|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
1584004|NCT00450242|vestibulitis|vestibulitis
1584005|NCT00450216|ibuprofen|ibuprofen
1584006|NCT00450216|famotidine|famotidine
1584007|NCT00450216|ulcers|ulcers
1584008|NCT00450216|NSAIDS|nsaids
1584009|NCT00450216|pain|pain
1584010|NCT00450216|arthritis|arthritis
1584011|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
1584012|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
1584013|NCT00450216|osteoarthritis|osteoarthritis
1584014|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
1584015|NCT00450216|chronic low back pain|chronic low back pain
1584016|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1584017|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
1584018|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
1584019|NCT00450190|Growth disorders/drug therapy|growth disorders/drug therapy
1584020|NCT00450177|iron|iron
1584118|NCT00449774|Food effect|food effect
1584021|NCT00450177|critical illness|critical illness
1584022|NCT00450177|anemia|anemia
1584023|NCT00450177|infection|infection
1584024|NCT00450164|Variceal bleeding|variceal bleeding
1584025|NCT00450164|Secondary profilaxis|secondary profilaxis
1584026|NCT00450164|Hemodynamic|hemodynamic
1584027|NCT00450164|Portal hypertension|portal hypertension
1584028|NCT00450151|Pediatric|pediatric
1584029|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
1584030|NCT00450151|Cardiac Surgery|cardiac surgery
1584031|NCT00450151|Platelet|platelet
1584032|NCT00450151|Platelet Activation Markers|platelet activation markers
1584033|NCT00450151|Platelet Factor4|platelet factor4
1584034|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
1584035|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
1584036|NCT00450125|Lung Cancer|lung cancer
1584037|NCT00450125|Lung Resection|lung resection
1584038|NCT00450125|Exercise Stress Test|exercise stress test
1584039|NCT00450125|Six-Minute Walk Test|six-minute walk test
1584040|NCT00450099|Epidural|epidural
1584041|NCT00450099|Labor Analgesia|labor analgesia
1584042|NCT00450099|Bupivacaine|bupivacaine
1584043|NCT00450099|Dose-response|dose-response
1584044|NCT00450099|Minimum effective volume|minimum effective volume
1584045|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
1584046|NCT00450060|atraumatic needle|atraumatic needle
1584047|NCT00450060|Sprotte|sprotte
1584048|NCT00450060|Quincke|quincke
1584049|NCT00450060|lumbar puncture|lumbar puncture
1584050|NCT00450060|headache|headache
1584051|NCT00450060|backache|backache
1584052|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
1584053|NCT00450034|Frail Elderly|frail elderly
1584054|NCT00450034|Patient Education|patient education
1584055|NCT00450034|Drug optimization|drug optimization
1584056|NCT00450034|Underuse|underuse
1584057|NCT00450034|Vulnerable|vulnerable
1584058|NCT00450034|Drug related hospitalization|drug related hospitalization
1584059|NCT00450034|Medical intervention|medical intervention
1584060|NCT00450021|PET|pet
1584061|NCT00450021|CB1 Receptor|cb1 receptor
1584062|NCT00450021|Cannabinoid|cannabinoid
1584063|NCT00450021|[11C] MePPEP|[11c] meppep
1584064|NCT00450021|Brain Imaging|brain imaging
1584065|NCT00450021|Healthy Volunteer|healthy volunteer
1584066|NCT00450021|HV|hv
1584067|NCT00450008|Prostate Cancer|prostate cancer
1584068|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
1584069|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1584070|NCT00449982|Genital warts|genital warts
1584071|NCT00449982|Condylomata acuminata|condylomata acuminata
1584072|NCT00449982|Human Papillomavirus|human papillomavirus
1584073|NCT00449982|Polyphenon E|polyphenon e
1584074|NCT00449982|Green tea extract|green tea extract
1584075|NCT00449982|Vulva|vulva
1584076|NCT00449982|Penis|penis
1584077|NCT00449982|Anus|anus
1584078|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
1584079|NCT00449969|feedback|feedback
1584080|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
1584081|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
1584082|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
1584083|NCT00449943|Computed Tomography Angiography|computed tomography angiography
1584084|NCT00449917|visual caracteristics|visual caracteristics
1584085|NCT00449917|macular pigment optical density|macular pigment optical density
1584086|NCT00449917|visual acuity|visual acuity
1584087|NCT00449917|contrast sensibility|contrast sensibility
1584088|NCT00449917|lutein|lutein
1584089|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
1584090|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
1584091|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
1584092|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
1584093|NCT00449865|Parkinson's disease|parkinson's disease
1584094|NCT00449865|creatine|creatine
1584095|NCT00449865|NET-PD|net-pd
1584096|NCT00449865|neuroprotection|neuroprotection
1584097|NCT00449865|PD|pd
1584098|NCT00449852|Randomized Control Trial|randomized control trial
1584099|NCT00449852|Smoking Cessation|smoking cessation
1584100|NCT00449852|Secondary Prevention|secondary prevention
1584101|NCT00449852|Rehabilitation|rehabilitation
1584102|NCT00449852|Counseling|counseling
1584103|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
1584104|NCT00449839|Absorption|absorption
1584105|NCT00449839|Insulin Aspart|insulin aspart
1584106|NCT00449826|ACS|acs
1584107|NCT00449826|Unstable Angina|unstable angina
1584108|NCT00449826|NSTEMI|nstemi
1584109|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1584110|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
1584111|NCT00449800|Sepsis|sepsis
1584112|NCT00449800|Ceftriaxone|ceftriaxone
1584113|NCT00449800|Pharmacokinetic|pharmacokinetic
1584114|NCT00449800|Intensive care unit|intensive care unit
1584115|NCT00449787|Emergency department|emergency department
1584116|NCT00449787|headache|headache
1584117|NCT00449787|migraine|migraine
1584120|NCT00449774|Tolerability|tolerability
1584121|NCT00449774|Water effect|water effect
1584122|NCT00449774|Bioequivalence|bioequivalence
1584123|NCT00449761|Refractory|refractory
1584124|NCT00449761|Chronic Myeloid|chronic myeloid
1584125|NCT00449761|Leukemia|leukemia
1584126|NCT00449761|accelerated phase|accelerated phase
1584127|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
1584128|NCT00449761|adults|adults
1584129|NCT00449761|oral LBH589|oral lbh589
1584130|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
1584131|NCT00449748|RAD001|rad001
1584132|NCT00449735|positive isolates|positive isolates
1584133|NCT00449735|ecoli|ecoli
1584134|NCT00449735|blood cultures|blood cultures
1584135|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
1584136|NCT00449735|blood stream infections|blood stream infections
1584137|NCT00449709|Pre-term labor,|pre-term labor,
1584138|NCT00449709|modified release formulation|modified release formulation
1584139|NCT00449709|pharmacokinetics,|pharmacokinetics,
1584140|NCT00449683|Depressive Disorders|depressive disorders
1584141|NCT00449683|Excessive Sweating|excessive sweating
1584142|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
1584143|NCT00449670|Influenza|influenza
1584144|NCT00449670|Influenza Vaccine|influenza vaccine
1584145|NCT00449644|Tuberculosis|tuberculosis
1584146|NCT00449644|MDR TB|mdr tb
1584147|NCT00449631|Glaucoma|glaucoma
1584148|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
1584149|NCT00449631|Trabeculectomy|trabeculectomy
1584150|NCT00449618|Aspirin|aspirin
1584151|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1584152|NCT00449618|Chronotherapy|chronotherapy
1584153|NCT00449618|Circadian|circadian
1584154|NCT00449605|Diabetes|diabetes
1584155|NCT00449605|Metformin|metformin
1584156|NCT00449592|Stem cell transplantation|stem cell transplantation
1584157|NCT00449592|Mucositis|mucositis
1584158|NCT00449592|Zinc|zinc
1584159|NCT00449579|Ischemia|ischemia
1584160|NCT00449579|Myocardial|myocardial
1584161|NCT00449579|HF-ECG|hf-ecg
1584162|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
1584163|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
1584164|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
1584165|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
1584166|NCT00449553|Type II Diabetes|type ii diabetes
1584167|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1584168|NCT00449553|Dyslipidemia|dyslipidemia
1584169|NCT00449553|Drug Therapy|drug therapy
1584170|NCT00449540|Migraine with aura|migraine with aura
1584171|NCT00449540|aura|aura
1584172|NCT00449540|TMS|tms
1584173|NCT00449527|Mild asthma|mild asthma
1584174|NCT00449527|Moderate asthma|moderate asthma
1584175|NCT00449514|infertility|infertility
1584176|NCT00449514|ovulation dysfunction|ovulation dysfunction
1584177|NCT00449514|endometrium|endometrium
1584178|NCT00449514|tamoxifen|tamoxifen
1584179|NCT00449514|clomiphene citrate|clomiphene citrate
1584180|NCT00449501|Mild Asthma|mild asthma
1584181|NCT00449501|Moderate Asthma|moderate asthma
1584182|NCT00449488|erythropoietin|erythropoietin
1584183|NCT00449488|myocardial infarction|myocardial infarction
1584184|NCT00449488|PCI|pci
1584185|NCT00449488|left ventricular function|left ventricular function
1584186|NCT00449462|CLA|cla
1584187|NCT00449462|liver|liver
1584188|NCT00449462|kidney|kidney
1584189|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
1584190|NCT00449436|HIV|hiv
1584191|NCT00449436|treatment experienced|treatment experienced
1584192|NCT00449423|Acute heart failure|acute heart failure
1584193|NCT00449423|Metabolic modulation|metabolic modulation
1584194|NCT00449410|Atrial Fibrillation|atrial fibrillation
1584195|NCT00449410|elderly|elderly
1584196|NCT00449410|cholesterol lowering|cholesterol lowering
1584197|NCT00449410|neurocognitive function|neurocognitive function
1584198|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
1584199|NCT00449397|First Episode Psychosis|first episode psychosis
1584200|NCT00449384|Severe Impairment Battery|severe impairment battery
1584201|NCT00449384|Clinical Dementia Rating|clinical dementia rating
1584202|NCT00449358|bcc|bcc
1584203|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
1584204|NCT00449345|Health care workers|health care workers
1584205|NCT00449345|Tuberculin skin test|tuberculin skin test
1584206|NCT00449345|Mantoux skin test|mantoux skin test
1584207|NCT00449345|Interferon gamma|interferon gamma
1584209|NCT00449345|Cost effectiveness|cost effectiveness
1584210|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
1584211|NCT00449319|AML|aml
1584212|NCT00449319|adult|adult
1584213|NCT00449319|Hydroxyurea|hydroxyurea
1584214|NCT00449319|Transplant|transplant
1584215|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
1584216|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
1584304|NCT00448929|Trabeculectomy|trabeculectomy
1585161|NCT00446173|GM-CSF|gm-csf
1584217|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
1584218|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
1584219|NCT00449319|Disease free survival.|disease free survival.
1584220|NCT00449319|Overal survival.|overal survival.
1584221|NCT00449306|Atherosclerosis|atherosclerosis
1584222|NCT00449306|Carotid plaque|carotid plaque
1584223|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
1584224|NCT00449306|Vulnerable plaque|vulnerable plaque
1584225|NCT00449306|Angiogenesis|angiogenesis
1584226|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
1584227|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
1584228|NCT00449293|Smoking cessation|smoking cessation
1584229|NCT00449293|Tobacco dependence|tobacco dependence
1584230|NCT00449293|Mindfulness|mindfulness
1584231|NCT00449293|fMRI|fmri
1584232|NCT00449293|Craving|craving
1584233|NCT00449280|metastatic|metastatic
1584234|NCT00449280|advanced disease|advanced disease
1584235|NCT00449280|phase I|phase i
1584236|NCT00449267|Lenses, Intraocular|lenses, intraocular
1584237|NCT00449267|Prospective Studies|prospective studies
1584238|NCT00449267|Visual acuity|visual acuity
1584239|NCT00449267|Clinical Trial|clinical trial
1584240|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
1584241|NCT00449228|Osteoarthritis,|osteoarthritis,
1584242|NCT00449228|hip replacement,|hip replacement,
1584243|NCT00449228|education,|education,
1584244|NCT00449228|randomized controlled trial,|randomized controlled trial,
1584245|NCT00449228|mini-invasive surgery|mini-invasive surgery
1584246|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
1584247|NCT00449176|Low Back Pain|low back pain
1584248|NCT00449176|Chronic Pain|chronic pain
1584249|NCT00449176|Pain Assessment|pain assessment
1584250|NCT00449176|Tapentadol|tapentadol
1584251|NCT00449163|stage IV colon cancer|stage iv colon cancer
1584252|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
1584253|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
1584254|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1584255|NCT00449150|Cetrorelix|cetrorelix
1584256|NCT00449137|recurrent colon cancer|recurrent colon cancer
1584257|NCT00449137|stage IV colon cancer|stage iv colon cancer
1584258|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
1584259|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
1584260|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
1584261|NCT00449098|Glaucoma|glaucoma
1584262|NCT00449098|Collagen matrix|collagen matrix
1584263|NCT00449098|ologen|ologen
1584264|NCT00449098|OculusGen|oculusgen
1584265|NCT00449098|Trabeculectomy|trabeculectomy
1584266|NCT00449098|anti scarring|anti scarring
1584267|NCT00449098|tissue engineering|tissue engineering
1584268|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
1584269|NCT00449098|Aeon Astron|aeon astron
1584270|NCT00449059|heart transplantation|heart transplantation
1584271|NCT00449059|cyclosporine|cyclosporine
1584272|NCT00449059|hypertension|hypertension
1584273|NCT00449059|nitroglycerin|nitroglycerin
1584274|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
1584275|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
1584276|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1584277|NCT00449033|Cancer|cancer
1584278|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1584279|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1584280|NCT00449007|Major depressive disorder|major depressive disorder
1584281|NCT00449007|Alcohol abuse|alcohol abuse
1584282|NCT00449007|Alcohol dependence|alcohol dependence
1584283|NCT00449007|Suicide|suicide
1584284|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
1584285|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
1584286|NCT00448981|Preventing influenza|preventing influenza
1584287|NCT00448981|Preventing the common cold|preventing the common cold
1584288|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
1584289|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
1584290|NCT00448968|Sepsis|sepsis
1584291|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
1584292|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
1584293|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
1584384|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1584294|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
1584295|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
1584296|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
1584297|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
1584298|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
1584299|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
1584300|NCT00448929|Glaucoma|glaucoma
1584301|NCT00448929|Collagen matrix|collagen matrix
1584302|NCT00448929|ologen|ologen
1584303|NCT00448929|OculusGen|oculusgen
1584761|NCT00447759|Arthritis|arthritis
1584305|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
1584306|NCT00448903|diabetic|diabetic
1584308|NCT00448903|ulcer|ulcer
1584311|NCT00448903|neuroishemic|neuroishemic
1584312|NCT00448903|diabetes|diabetes
1584313|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
1584314|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
1584315|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
1584316|NCT00448851|asthma|asthma
1584317|NCT00448851|allergy|allergy
1584318|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
1584319|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
1584320|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
1584321|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
1584322|NCT00448825|alcohol dependence|alcohol dependence
1584323|NCT00448825|alcoholism|alcoholism
1584324|NCT00448825|cocaine addiction|cocaine addiction
1584325|NCT00448825|cocaine dependence|cocaine dependence
1584326|NCT00448799|neurological|neurological
1584327|NCT00448799|alzheimers|alzheimers
1584328|NCT00448786|gallbladder|gallbladder
1584329|NCT00448786|AMG 706|amg 706
1584330|NCT00448786|solid tumors|solid tumors
1584331|NCT00448786|Phase 1b|phase 1b
1584332|NCT00448786|Amgen|amgen
1584333|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
1584334|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
1584335|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1584336|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
1584337|NCT00448734|metastatic|metastatic
1584338|NCT00448734|hormone-refractory|hormone-refractory
1584339|NCT00448734|prostate cancer|prostate cancer
1584340|NCT00448734|picoplatin|picoplatin
1584341|NCT00448734|platinum drug|platinum drug
1584342|NCT00448734|chemotherapy|chemotherapy
1584343|NCT00448734|docetaxel|docetaxel
1584344|NCT00448721|renal cell carcinoma|renal cell carcinoma
1584345|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
1584346|NCT00448708|Hemodialysis Access|hemodialysis access
1584348|NCT00448695|Laser Thermal Therapy|laser thermal therapy
1584349|NCT00448695|Focal Ablation|focal ablation
1584350|NCT00448695|Prostate Cancer|prostate cancer
1584351|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
1584352|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
1584353|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1584354|NCT00448669|HIV incidence|hiv incidence
1584355|NCT00448669|HIV prevention|hiv prevention
1584356|NCT00448669|Tenofovir|tenofovir
1584357|NCT00448669|Emtricitabine|emtricitabine
1584358|NCT00448669|Botswana|botswana
1584359|NCT00448669|HIV seronegativity|hiv seronegativity
1584360|NCT00448656|atrial fibrillation|atrial fibrillation
1584361|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
1584362|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
1584363|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
1584364|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1584365|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
1584366|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
1584367|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1584368|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
1584369|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
1584370|NCT00448617|inflammation|inflammation
1584371|NCT00448617|flu vaccine|flu vaccine
1584372|NCT00448617|FluMist|flumist
1584373|NCT00448617|smokers|smokers
1584374|NCT00448604|procalcitonin|procalcitonin
1584375|NCT00448604|acute exacerbation|acute exacerbation
1584376|NCT00448604|RT-PCR|rt-pcr
1584377|NCT00448604|Biological Markers|biological markers
1584378|NCT00448578|Acute Mania|acute mania
1584379|NCT00448565|extubation|extubation
1584380|NCT00448565|prediction|prediction
1584381|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1584382|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1584383|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1584385|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1584386|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1584387|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1584388|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1584389|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1584390|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1584391|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1584392|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1584393|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1584394|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1584395|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1584396|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1584397|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1584398|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1584399|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1584400|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1584401|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1584402|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1584403|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1584404|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1584405|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1584406|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1584407|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1584408|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1584409|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1584410|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1584411|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1584412|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1584413|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1584414|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
1584415|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
1584416|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1584417|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1584418|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
1584419|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
1584420|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
1584421|NCT00448513|catechin|catechin
1584422|NCT00448513|oxidative stress|oxidative stress
1584423|NCT00448513|chromosome damage|chromosome damage
1584424|NCT00448513|aged|aged
1584425|NCT00448500|COPD|copd
1584426|NCT00448500|exhaled breath condenate|exhaled breath condenate
1584427|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
1584428|NCT00448487|Diabetes|diabetes
1584429|NCT00448487|Cardiovascular Disease|cardiovascular disease
1584430|NCT00448487|Haptoglobin|haptoglobin
1584431|NCT00448474|Disease self-management|disease self-management
1584432|NCT00448474|Community program|community program
1584433|NCT00448461|coronary artery disease|coronary artery disease
1584434|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
1584435|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1584436|NCT00448448|orthotics|orthotics
1584437|NCT00448448|bracing|bracing
1584438|NCT00448448|partially randomized preference design|partially randomized preference design
1584439|NCT00448435|Salmeterol|salmeterol
1584440|NCT00448435|Fluticasone propionate|fluticasone propionate
1584441|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
1584442|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
1584443|NCT00448422|Traveler's|traveler's
1584444|NCT00448422|Diarrhea|diarrhea
1584445|NCT00448409|Prostate cancer|prostate cancer
1584446|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
1584447|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
1584449|NCT00448396|EPO|epo
1584450|NCT00448396|Patupilone|patupilone
1584451|NCT00448396|Solid tumors|solid tumors
1584452|NCT00448396|Advanced malignancies|advanced malignancies
1584453|NCT00448370|Anemia, sickle cell|anemia, sickle cell
1584454|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
1584455|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1584456|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1584457|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
1584458|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
1584459|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1584460|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1584661|NCT00448188|bleeding risk|bleeding risk
1584461|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1584462|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1584463|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1584464|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1584465|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1584466|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1584467|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1584468|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1584469|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1584470|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1584471|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1584472|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1584793|NCT00447655|Amputation|amputation
1584473|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1584474|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1584475|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1584476|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1584477|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1584478|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1584479|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1584480|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1584481|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1584482|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1584483|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1584484|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1584485|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1584486|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1584487|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1584488|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1584489|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1584490|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1584491|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1584492|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1584493|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1584494|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1584495|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1584496|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1584497|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1584498|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1584499|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1584500|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1584501|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1584502|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1584503|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1584504|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1584505|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1584506|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1584507|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1584508|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1584509|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1584510|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1584511|NCT00448357|primary myelofibrosis|primary myelofibrosis
1584512|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1584513|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1584850|NCT00447369|prevention|prevention
1584514|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1584515|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
1584516|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1584517|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1584518|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1584519|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1584520|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1584521|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1584522|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1584523|NCT00448357|polycythemia vera|polycythemia vera
1584524|NCT00448357|essential thrombocythemia|essential thrombocythemia
1584525|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1584526|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1584527|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1584528|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
1584529|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1584530|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
1584531|NCT00448344|veterans|veterans
1584532|NCT00448344|smoking cessation|smoking cessation
1584533|NCT00448331|Mental Disorders|mental disorders
1584534|NCT00448331|Mentally Ill Persons|mentally ill persons
1584535|NCT00448331|Emergency Medicine|emergency medicine
1584536|NCT00448331|Emergency Department|emergency department
1584537|NCT00448331|Screening|screening
1584538|NCT00448318|Controlled clinical trial|controlled clinical trial
1584539|NCT00448305|breast cancer|breast cancer
1584540|NCT00448305|metastatic|metastatic
1584541|NCT00448305|relapsed|relapsed
1584542|NCT00448305|triple-receptor negative|triple-receptor negative
1584543|NCT00448305|EndoTAG-1|endotag-1
1584544|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
1584545|NCT00448292|Depression|depression
1584546|NCT00448292|Major Depressive Disorder|major depressive disorder
1584547|NCT00448292|Major Depression|major depression
1584549|NCT00448266|Breast cancer|breast cancer
1584550|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
1584551|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
1584552|NCT00448266|Alkylator therapy|alkylator therapy
1584553|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
1584554|NCT00448253|Inhalational Anthrax|inhalational anthrax
1584555|NCT00448253|Human Immune globulin|human immune globulin
1584556|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
1584557|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
1584558|NCT00448214|Atrial fibrillation|atrial fibrillation
1584560|NCT00448214|Ischemic attack|ischemic attack
1584561|NCT00448214|thromboembolism|thromboembolism
1584562|NCT00448214|Prevention and control|prevention and control
1584563|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1584564|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1584565|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1584566|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1584567|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1584568|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
1584569|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1584570|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1584571|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1584572|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1584573|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1584574|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1584575|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1584576|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1584577|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1584578|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1584579|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1584580|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1584581|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1584582|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1584583|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1584584|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1584585|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1584851|NCT00447369|treatment|treatment
1584586|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1584587|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1584588|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1584589|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1584590|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1584591|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1584961|NCT00446875|Pain|pain
1584592|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1584593|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1584594|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1584595|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1584596|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1584597|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1584598|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1584599|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1584600|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1584601|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1584602|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1584603|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1584604|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1584605|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1584606|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1584607|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1584608|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1584609|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1584610|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1584611|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1584612|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1584613|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1584614|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1584615|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1584616|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1584617|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
1584618|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1584619|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1584620|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1584621|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1584622|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
1584623|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
1584624|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1584625|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1584626|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1584627|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1584628|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1584629|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1584630|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1584631|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1584632|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1584633|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1584634|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1584635|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1584636|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1584637|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
1584638|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1584639|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1584640|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1584641|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1584642|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1584643|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1584644|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1584645|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1584646|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1584647|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1584648|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1585512|NCT00445809|Renal|renal
1584649|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1584650|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1584651|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1584652|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1584653|NCT00448201|primary myelofibrosis|primary myelofibrosis
1584654|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1584655|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
1584656|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1584657|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1584658|NCT00448188|central venous catheter|central venous catheter
1584659|NCT00448188|international normalized ratio|international normalized ratio
1584660|NCT00448188|thrombocytes|thrombocytes
1584662|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
1584663|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
1584664|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
1584665|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
1584666|NCT00448149|Kidney cancer|kidney cancer
1584667|NCT00448149|Renal cell carcinoma|renal cell carcinoma
1584668|NCT00448149|Metastatic RCC|metastatic rcc
1584669|NCT00448123|Kidney Stones|kidney stones
1584670|NCT00448123|Ureteral Stones|ureteral stones
1584671|NCT00448123|Flomax|flomax
1584672|NCT00448123|Emergency Medicine|emergency medicine
1584673|NCT00448123|Urology|urology
1584674|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
1584675|NCT00448097|Prostate cancer|prostate cancer
1584676|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
1584677|NCT00448097|Neoadjuvant|neoadjuvant
1584678|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
1584679|NCT00448084|Volition|volition
1584680|NCT00448084|fMRI|fmri
1584681|NCT00448084|Functional MRI|functional mri
1584682|NCT00448084|Functional Movement Disorder|functional movement disorder
1584683|NCT00448084|Healthy Volunteer|healthy volunteer
1584685|NCT00448071|Hypotension|hypotension
1584686|NCT00448071|End Stage Renal Disease|end stage renal disease
1584687|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
1584688|NCT00448071|ESRD|esrd
1584689|NCT00448071|Blood Pressure|blood pressure
1584690|NCT00448071|Dialysis|dialysis
1584691|NCT00448058|Flexible-dose|flexible-dose
1584692|NCT00448058|GSK372475|gsk372475
1584693|NCT00448058|MDD|mdd
1584694|NCT00448058|Venlafaxine XR|venlafaxine xr
1584695|NCT00448058|Major Depressive Disorder|major depressive disorder
1584696|NCT00448045|Spinal cord injuries|spinal cord injuries
1584697|NCT00448045|Cough|cough
1584698|NCT00448045|Peak cough flow|peak cough flow
1584699|NCT00448045|Respiratory therapy|respiratory therapy
1584700|NCT00448045|Rehabilitation|rehabilitation
1584701|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1584702|NCT00448019|Fludarabine|fludarabine
1584703|NCT00448019|Cyclophosphamide|cyclophosphamide
1584704|NCT00448019|Rituximab|rituximab
1584705|NCT00448019|Bevacizumab|bevacizumab
1584706|NCT00448019|CLL|cll
1584707|NCT00448006|common|common
1584708|NCT00448006|bile|bile
1584709|NCT00448006|duct|duct
1584710|NCT00448006|biliary|biliary
1584711|NCT00448006|malignant|malignant
1584712|NCT00448006|obstruction|obstruction
1584713|NCT00448006|stent|stent
1584714|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
1584715|NCT00447993|eye disease|eye disease
1584716|NCT00447993|retinal disorder|retinal disorder
1584717|NCT00447993|CNTF|cntf
1584718|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
1584719|NCT00447980|eye disease|eye disease
1584720|NCT00447980|retinal disorder|retinal disorder
1584721|NCT00447980|CNTF|cntf
1584722|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
1584723|NCT00447967|Oxaliplatin|oxaliplatin
1584724|NCT00447967|Irinotecan|irinotecan
1584725|NCT00447954|eye disease|eye disease
1584726|NCT00447954|retinal disorder|retinal disorder
1584727|NCT00447954|CNTF|cntf
1584728|NCT00447928|tendonitis|tendonitis
1584729|NCT00447928|nitroglycerin|nitroglycerin
1584730|NCT00447928|nitric oxide|nitric oxide
1584731|NCT00447928|lateral epicondylitis|lateral epicondylitis
1584732|NCT00447902|treatment experienced|treatment experienced
1584733|NCT00447837|Chronic Sinusitis|chronic sinusitis
1584734|NCT00447824|Pain|pain
1584735|NCT00447824|Neonates|neonates
1584736|NCT00447824|NIDCAP|nidcap
1584737|NCT00447824|Venous|venous
1584738|NCT00447824|Capillary|capillary
1584739|NCT00447811|Methadone|methadone
1584740|NCT00447798|HIV positive|hiv positive
1584741|NCT00447798|crack cocaine user|crack cocaine user
1584742|NCT00447798|inpatient hospital setting|inpatient hospital setting
1584743|NCT00447798|HIV knowledge|hiv knowledge
1584744|NCT00447798|motivation|motivation
1584745|NCT00447798|perceived self-efficacy|perceived self-efficacy
1584746|NCT00447798|risky sexual behavior|risky sexual behavior
1587100|NCT00441792|Etomidate|etomidate
1584747|NCT00447798|HIV seronegativity|hiv seronegativity
1584748|NCT00447785|alcoholism|alcoholism
1584749|NCT00447785|nutrition|nutrition
1584750|NCT00447785|craving|craving
1584751|NCT00447785|energy supplies|energy supplies
1584752|NCT00447785|water supplies|water supplies
1584753|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
1584754|NCT00447759|Celecoxib|celecoxib
1584755|NCT00447759|Celebrex|celebrex
1584756|NCT00447759|Ibuprofen|ibuprofen
1584757|NCT00447759|Diclofenac|diclofenac
1584758|NCT00447759|NSAID|nsaid
1584759|NCT00447759|Osteoarthritis|osteoarthritis
1584760|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
1584762|NCT00447759|Safety study|safety study
1584763|NCT00447759|Cardiovascular safety|cardiovascular safety
1584764|NCT00447759|Clinical trial|clinical trial
1584765|NCT00447759|PROBE design|probe design
1584766|NCT00447759|University of Dundee|university of dundee
1584767|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
1584769|NCT00447759|Professor Tom MacDonald|professor tom macdonald
1584770|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
1584771|NCT00447733|mental health|mental health
1584772|NCT00447733|substance use|substance use
1584773|NCT00447733|treatment|treatment
1584774|NCT00447720|HIV prevention skills|hiv prevention skills
1584775|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
1584776|NCT00447720|Substance abuse|substance abuse
1584777|NCT00447720|Philadelphia|philadelphia
1584778|NCT00447720|HIV seronegativity|hiv seronegativity
1584779|NCT00447707|Substance use|substance use
1584780|NCT00447707|Unprotected sex|unprotected sex
1584781|NCT00447707|Behavioral intervention|behavioral intervention
1584782|NCT00447707|HIV care|hiv care
1584783|NCT00447707|Prevention with Positives|prevention with positives
1584784|NCT00447707|HIV seronegativity|hiv seronegativity
1584785|NCT00447694|Iron Chelation|iron chelation
1584786|NCT00447694|Deferasirox|deferasirox
1584787|NCT00447694|Chelator|chelator
1584788|NCT00447694|Desferal|desferal
1584789|NCT00447694|beta-thalassemia|beta-thalassemia
1584790|NCT00447694|Iron overload|iron overload
1584791|NCT00447668|Chronic Low Back Pain|chronic low back pain
1584792|NCT00447668|Yoga|yoga
1584794|NCT00447655|Self-management|self-management
1584795|NCT00447655|Rehabilitation|rehabilitation
1584796|NCT00447655|Peer support|peer support
1584797|NCT00447642|immunology|immunology
1584798|NCT00447642|cornea|cornea
1584799|NCT00447642|allograft|allograft
1584800|NCT00447642|corneal allograft rejection|corneal allograft rejection
1584801|NCT00447642|graft failure|graft failure
1584802|NCT00447616|Prostate Cancer|prostate cancer
1584803|NCT00447616|Prostatectomy|prostatectomy
1584804|NCT00447564|opioid dependence|opioid dependence
1584805|NCT00447564|opioid addiction|opioid addiction
1584806|NCT00447564|buprenorphine|buprenorphine
1584807|NCT00447564|methadone|methadone
1584808|NCT00447564|heroin|heroin
1584809|NCT00447564|implant|implant
1584810|NCT00447564|opioid withdrawal|opioid withdrawal
1584811|NCT00447564|opioid pain medication|opioid pain medication
1584812|NCT00447564|suboxone|suboxone
1584813|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
1584814|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
1584815|NCT00447499|Acromegaly|acromegaly
1584816|NCT00447499|Somatostatin Analogs|somatostatin analogs
1584817|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
1584818|NCT00447499|lanreotide|lanreotide
1584819|NCT00447499|growth hormone|growth hormone
1584820|NCT00447499|IGF-1|igf-1
1584821|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
1584822|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
1584823|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
1584824|NCT00447486|Osteoarthritis,|osteoarthritis,
1584825|NCT00447486|knee,|knee,
1584826|NCT00447486|GW842166,|gw842166,
1584827|NCT00447486|pain,|pain,
1584828|NCT00447486|efficacy,|efficacy,
1584829|NCT00447486|safety|safety
1584830|NCT00447473|Prostate Cancer|prostate cancer
1584831|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
1584832|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
1584833|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
1584834|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
1584835|NCT00447460|Allotransplant|allotransplant
1584836|NCT00447460|Allogenic|allogenic
1584837|NCT00447460|Refractory|refractory
1584838|NCT00447460|CSM/EICH2005|csm/eich2005
1584839|NCT00447434|Nattokinase|nattokinase
1584840|NCT00447434|fibrinolytic factors|fibrinolytic factors
1584841|NCT00447434|blood lipids|blood lipids
1584842|NCT00447434|nutrimental supplement|nutrimental supplement
1584843|NCT00447408|hemodialysis|hemodialysis
1584844|NCT00447408|dietary adherence|dietary adherence
1584845|NCT00447408|sodium|sodium
1584846|NCT00447369|pregabalin|pregabalin
1584847|NCT00447369|Valproic acid|valproic acid
1584848|NCT00447369|migraine|migraine
1584849|NCT00447369|prophylaxis|prophylaxis
1584852|NCT00447343|Functional MRI|functional mri
1584853|NCT00447343|Cervical myelopathy|cervical myelopathy
1584854|NCT00447343|Cervical radiculopathy|cervical radiculopathy
1584855|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
1584856|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
1584857|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
1584858|NCT00447330|GASTRIC CANCER|gastric cancer
1584859|NCT00447330|ADENOCARCINOMA|adenocarcinoma
1584860|NCT00447330|TARGTED THERAPY|targted therapy
1584861|NCT00447330|BEVACIZUMAB|bevacizumab
1584862|NCT00447330|CAPECITBAINE|capecitbaine
1584863|NCT00447330|OXALIPLATIN|oxaliplatin
1584865|NCT00447317|peritoneal dialysis|peritoneal dialysis
1584867|NCT00447317|sodium|sodium
1584868|NCT00447304|acute cholecystitis|acute cholecystitis
1584869|NCT00447304|cholecystectomy|cholecystectomy
1584870|NCT00447304|antibiotic treatment|antibiotic treatment
1584871|NCT00447304|moxifloxacin|moxifloxacin
1584872|NCT00447304|intraabdominal infection|intraabdominal infection
1584873|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
1584874|NCT00447291|Overweight|overweight
1584875|NCT00447291|Obesity|obesity
1584876|NCT00447291|Fish Oil|fish oil
1584877|NCT00447252|bereavement|bereavement
1584878|NCT00447252|grief|grief
1584879|NCT00447239|mechanical ventilated|mechanical ventilated
1584880|NCT00447239|surgical patients|surgical patients
1584881|NCT00447239|pneumonia|pneumonia
1584882|NCT00447239|blood glucose|blood glucose
1584883|NCT00447239|insulin infusion|insulin infusion
1584884|NCT00447239|hospital stay|hospital stay
1584885|NCT00447226|Ovarian Cancer|ovarian cancer
1584886|NCT00447226|Bladder Cancer|bladder cancer
1584887|NCT00447226|ErbB2 positive|erbb2 positive
1584888|NCT00447226|Lapatinib|lapatinib
1584889|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
1584890|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
1584891|NCT00447200|Stroke volume|stroke volume
1584892|NCT00447200|SV variation|sv variation
1584893|NCT00447200|Esophagus Doppler|esophagus doppler
1584894|NCT00447200|Goal Directed Therapy|goal directed therapy
1584895|NCT00447187|corneal graft failure|corneal graft failure
1584896|NCT00447187|corneal graft rejection|corneal graft rejection
1584897|NCT00447187|corneal transplant rejection|corneal transplant rejection
1584898|NCT00447174|Grief|grief
1584899|NCT00447174|parental bereavement|parental bereavement
1584900|NCT00447135|Elderly|elderly
1584901|NCT00447135|Trauma|trauma
1584902|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
1584903|NCT00447135|Immunity|immunity
1584904|NCT00447122|Pancreatic Cancer|pancreatic cancer
1584905|NCT00447096|Bipolar Type II|bipolar type ii
1584906|NCT00447096|Depression|depression
1584907|NCT00447096|rTMS|rtms
1584908|NCT00447083|Tanning|tanning
1584909|NCT00447083|Musculoskeletal|musculoskeletal
1584910|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
1584911|NCT00447070|HIV-infection|hiv-infection
1584912|NCT00447070|Dyslipidemia|dyslipidemia
1584913|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
1584914|NCT00447070|Atherosclerosis|atherosclerosis
1584915|NCT00447070|Protease inhibitor|protease inhibitor
1584916|NCT00447070|treatment experienced|treatment experienced
1584917|NCT00447057|nonsquamous|nonsquamous
1584918|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
1585170|NCT00446147|prevention|prevention
1584919|NCT00447031|age related macular degeneration|age related macular degeneration
1584920|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
1584921|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
1584922|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
1584923|NCT00447018|intracranial pressure|intracranial pressure
1584924|NCT00447018|mannitol|mannitol
1584925|NCT00447018|hypertonic saline solution|hypertonic saline solution
1584926|NCT00447018|brain injury|brain injury
1584927|NCT00447018|traumatic brain injury|traumatic brain injury
1584928|NCT00447018|Adult patients|adult patients
1584929|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
1584930|NCT00447005|Safety|safety
1584931|NCT00447005|PK|pk
1584932|NCT00447005|Biomarker|biomarker
1584933|NCT00446992|Schizophrenia|schizophrenia
1584934|NCT00446992|Schizoaffective|schizoaffective
1584935|NCT00446992|psychosis|psychosis
1584936|NCT00446992|olanzapine|olanzapine
1584937|NCT00446979|Microbicides|microbicides
1584938|NCT00446979|HIV seronegativity|hiv seronegativity
1584939|NCT00446966|atrial fibrillation|atrial fibrillation
1584940|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
1584941|NCT00446953|Caesarean section|caesarean section
1584942|NCT00446953|Corticosteroids|corticosteroids
1584943|NCT00446953|Betamethasone|betamethasone
1584944|NCT00446953|Neonatal distress|neonatal distress
1584945|NCT00446927|Pediatrics|pediatrics
1584946|NCT00446927|Cardiology|cardiology
1584947|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
1584948|NCT00446927|Heart Surgery|heart surgery
1584949|NCT00446927|Cardiac Catheterization|cardiac catheterization
1584950|NCT00446927|Echocardiography|echocardiography
1584951|NCT00446927|Imaging|imaging
1584952|NCT00446927|ICG green dye|icg green dye
1584953|NCT00446914|Hypertension|hypertension
1584954|NCT00446914|Blood Pressure|blood pressure
1584955|NCT00446901|Prostate Cancer|prostate cancer
1584956|NCT00446901|Selenium|selenium
1584957|NCT00446901|Chemoprevention|chemoprevention
1584958|NCT00446901|Gene expression|gene expression
1584959|NCT00446888|cancer|cancer
1584960|NCT00446888|metastasis|metastasis
1584962|NCT00446875|Procedural pain|procedural pain
1584963|NCT00446875|Sucrose|sucrose
1584964|NCT00446875|Infant|infant
1584965|NCT00446862|Definition: Fabry disease|definition: fabry disease
1584966|NCT00446862|Definition: Progression|definition: progression
1584967|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
1584968|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
1584969|NCT00446862|Definition: Proteinuria|definition: proteinuria
1584970|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
1584971|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
1584972|NCT00446849|ulcerative colitis|ulcerative colitis
1584973|NCT00446849|compliance|compliance
1584974|NCT00446849|mesalamine|mesalamine
1584975|NCT00446849|clinical study|clinical study
1584976|NCT00446849|clinical trial|clinical trial
1584977|NCT00446849|clinical research|clinical research
1584978|NCT00446849|maintenance|maintenance
1584979|NCT00446849|long term|long term
1584980|NCT00446849|uc study|uc study
1584981|NCT00446849|uc trial|uc trial
1584982|NCT00446849|uc research|uc research
1584983|NCT00446849|open label|open label
1584984|NCT00446849|once a day|once a day
1584985|NCT00446849|once|once
1584986|NCT00446849|daily|daily
1584987|NCT00446849|daily dosing|daily dosing
1584988|NCT00446849|simple|simple
1584989|NCT00446849|oral|oral
1584990|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1584991|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
1584992|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
1584993|NCT00446823|Wound healing|wound healing
1584994|NCT00446823|Venous stasis ulcer|venous stasis ulcer
1584995|NCT00446823|Cellulose dressing|cellulose dressing
1584996|NCT00446823|Gauze dressing|gauze dressing
1584997|NCT00446823|Chronic wound|chronic wound
1584998|NCT00446810|diabetes|diabetes
1584999|NCT00446810|endothelial dysfunction|endothelial dysfunction
1585000|NCT00446810|benfotiamine|benfotiamine
1585001|NCT00446810|postprandial|postprandial
1585002|NCT00446810|autonomic neuropathy|autonomic neuropathy
1585003|NCT00446810|advanced glycation end products|advanced glycation end products
1585004|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
1585005|NCT00446758|Zinc|zinc
1585006|NCT00446758|HIV|hiv
1585007|NCT00446758|Infants|infants
1585008|NCT00446758|Children|children
1585009|NCT00446758|Morbidity|morbidity
1585010|NCT00446758|Child health outcomes|child health outcomes
1585011|NCT00446758|treatment naive|treatment naive
1585012|NCT00446758|treatment experienced|treatment experienced
1585013|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
1585014|NCT00446745|Insulin resistance|insulin resistance
1585015|NCT00446745|Energy Metabolisms|energy metabolisms
1585016|NCT00446745|Skeletal muscle|skeletal muscle
1585017|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
1585018|NCT00446719|major depression|major depression
1585019|NCT00446719|antidepressant|antidepressant
1585020|NCT00446719|quality of life|quality of life
1585021|NCT00446719|anxiety|anxiety
1585022|NCT00446706|Intrinsic PEEP|intrinsic peep
1585023|NCT00446680|Mannitol|mannitol
1585024|NCT00446680|Cystic Fibrosis|cystic fibrosis
1585025|NCT00446680|Mucolytic|mucolytic
1585026|NCT00446680|Exacerbation|exacerbation
1585027|NCT00446680|FEV1|fev1
1585028|NCT00446680|Quality of Life|quality of life
1585029|NCT00446641|Infarction, Cerebral|infarction, cerebral
1585030|NCT00446641|Cilostazol|cilostazol
1585031|NCT00446641|Aspirin Resistance|aspirin resistance
1585032|NCT00446628|Non-pharmaceutical|non-pharmaceutical
1585033|NCT00446628|influenza|influenza
1585034|NCT00446628|pandemic|pandemic
1585035|NCT00446615|computer decision support|computer decision support
1585036|NCT00446615|primary care|primary care
1585037|NCT00446615|kidney disease, chronic|kidney disease, chronic
1585038|NCT00446615|prescribing|prescribing
1585039|NCT00446602|PROCRIT|procrit
1585040|NCT00446602|Epoetin alfa|epoetin alfa
1585041|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
1585042|NCT00446602|MDS|mds
1585043|NCT00446576|Anemia|anemia
1585044|NCT00446576|early renal insufficiency|early renal insufficiency
1585672|NCT00445549|Peritoneal Cancer|peritoneal cancer
1585045|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
1585046|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
1585237|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
1585047|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
1585048|NCT00446511|children|children
1585049|NCT00446511|pediatrics|pediatrics
1585050|NCT00446511|high blood pressure|high blood pressure
1585051|NCT00446511|hypertension|hypertension
1585052|NCT00446511|valsartan|valsartan
1585053|NCT00446511|enalapril|enalapril
1585054|NCT00446485|ginkgo biloba|ginkgo biloba
1585055|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
1585056|NCT00446485|mild cognitive impairment|mild cognitive impairment
1585057|NCT00446485|concentration impairment|concentration impairment
1585058|NCT00446472|diabetes mellitus|diabetes mellitus
1585059|NCT00446472|diabetic neuropathies|diabetic neuropathies
1585060|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
1585061|NCT00446459|CellCept|cellcept
1585062|NCT00446459|Dialysis|dialysis
1585063|NCT00446459|Kidney|kidney
1585064|NCT00446459|Renal|renal
1585065|NCT00446459|Nephropathy|nephropathy
1585066|NCT00446459|Glomerulonephropathy|glomerulonephropathy
1585067|NCT00446459|Immunosuppression|immunosuppression
1585068|NCT00446459|Allograft|allograft
1585069|NCT00446459|Compatibility|compatibility
1585071|NCT00446459|PRA|pra
1585072|NCT00446459|Transplant|transplant
1585073|NCT00446459|Sensitization|sensitization
1585074|NCT00446459|Antibodies|antibodies
1585075|NCT00446459|Diabetes|diabetes
1585076|NCT00446459|Hypertension|hypertension
1585077|NCT00446459|Transplantation, Kidney|transplantation, kidney
1585078|NCT00446407|Depression|depression
1585079|NCT00446407|Primary Care|primary care
1585080|NCT00446407|Developing Countries|developing countries
1585081|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
1585082|NCT00446394|cognition disorder|cognition disorder
1585083|NCT00446394|functional ability|functional ability
1585084|NCT00446394|psychomotor function|psychomotor function
1585085|NCT00446394|psychopathology|psychopathology
1585086|NCT00446394|quality of life|quality of life
1585087|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
1585088|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
1585089|NCT00446381|VEGF|vegf
1585090|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
1585091|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
1585092|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
1585093|NCT00446355|C diff|c diff
1585094|NCT00446355|antibiotics|antibiotics
1585095|NCT00446342|leukemia|leukemia
1585096|NCT00446342|lymphoma|lymphoma
1585097|NCT00446342|myeloma|myeloma
1585098|NCT00446342|non-Hodgkin's|non-hodgkin's
1585099|NCT00446342|CLL|cll
1585100|NCT00446342|MCL|mcl
1585101|NCT00446342|MM|mm
1585102|NCT00446342|Phase 1|phase 1
1585103|NCT00446342|hematological malignancy|hematological malignancy
1585104|NCT00446316|Pharmacokinetics|pharmacokinetics
1585105|NCT00446316|Healthy volunteers|healthy volunteers
1585106|NCT00446316|No condition|no condition
1585107|NCT00446316|Pharmacokinetics study|pharmacokinetics study
1585108|NCT00446303|MDS|mds
1585109|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
1585110|NCT00446303|AML|aml
1585111|NCT00446303|Intensive chemotherapy|intensive chemotherapy
1585112|NCT00446303|azacitidine|azacitidine
1585113|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
1585114|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
1585115|NCT00446277|mellitus type II|mellitus type ii
1585116|NCT00446264|diabetes|diabetes
1585117|NCT00446264|hypoglycemia|hypoglycemia
1585118|NCT00446251|Dialysis|dialysis
1585119|NCT00446251|Kidney|kidney
1585120|NCT00446251|Renal|renal
1585121|NCT00446251|Nephropathy|nephropathy
1585122|NCT00446251|Glomerulonephropathy|glomerulonephropathy
1585123|NCT00446251|Immunosuppression|immunosuppression
1585124|NCT00446251|Graft|graft
1585125|NCT00446251|Compatibility|compatibility
1585126|NCT00446251|Transplant|transplant
1585127|NCT00446251|Diabetes|diabetes
1585128|NCT00446251|Hypertension|hypertension
1585129|NCT00446251|Transplantation, Kidney|transplantation, kidney
1585130|NCT00446238|Depression|depression
1585131|NCT00446238|Physical Illness|physical illness
1585132|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
1585133|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
1585134|NCT00446225|Lung|lung
1585135|NCT00446225|cancer|cancer
1585136|NCT00446225|EGFR|egfr
1585137|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1585138|NCT00446225|tyrosine kinase|tyrosine kinase
1585139|NCT00446225|Tarceva®|tarceva®
1585140|NCT00446225|Erlotinib|erlotinib
1585141|NCT00446212|anaesthesia|anaesthesia
1585142|NCT00446212|propofol|propofol
1585143|NCT00446212|desflurane|desflurane
1585144|NCT00446212|dreaming|dreaming
1585145|NCT00446212|electroencephalography|electroencephalography
1585146|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
1585147|NCT00446199|Postmenopausal women|postmenopausal women
1585508|NCT00445822|bcr-abl|bcr-abl
1585148|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
1585149|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1585150|NCT00446173|Leukemia|leukemia
1585151|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
1585152|NCT00446173|Busulfan|busulfan
1585153|NCT00446173|Busulfex|busulfex
1585154|NCT00446173|Myleran|myleran
1585155|NCT00446173|Cyclophosphamide|cyclophosphamide
1585156|NCT00446173|Cytoxan|cytoxan
1585157|NCT00446173|Neosar|neosar
1585158|NCT00446173|G-CSF|g-csf
1585159|NCT00446173|Filgrastim|filgrastim
1585160|NCT00446173|Neupogen|neupogen
1585162|NCT00446173|Sargramostim|sargramostim
1585163|NCT00446173|Leukine|leukine
1585164|NCT00446160|Congenital Heart Disease|congenital heart disease
1585165|NCT00446160|Surgery|surgery
1585166|NCT00446160|Adult|adult
1585167|NCT00446147|hand-foot syndrome|hand-foot syndrome
1585168|NCT00446147|capecitabine|capecitabine
1585169|NCT00446147|pyridoxine|pyridoxine
1585171|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
1585172|NCT00446121|COPD|copd
1585173|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
1585174|NCT00446108|Right Ventricular Dilation|right ventricular dilation
1585175|NCT00446108|Right Heart Failure|right heart failure
1585176|NCT00446108|Imaging|imaging
1585177|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
1585178|NCT00446095|DLCL|dlcl
1585179|NCT00446095|Nodular lymphoma|nodular lymphoma
1585180|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
1585181|NCT00446095|Syk kinase|syk kinase
1585182|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
1585183|NCT00446082|acromegaly|acromegaly
1585184|NCT00446082|adults|adults
1585185|NCT00446082|pasireotide LAR|pasireotide lar
1585186|NCT00446082|somatostatin analogue|somatostatin analogue
1585187|NCT00446082|SOM230|som230
1585188|NCT00446082|pharmacokinetics|pharmacokinetics
1585189|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
1585190|NCT00446043|Acne Vulgaris|acne vulgaris
1585191|NCT00446043|Adapalene|adapalene
1585192|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
1585193|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
1585194|NCT00446017|inotropes|inotropes
1585195|NCT00446017|metabolism|metabolism
1585196|NCT00446017|renal failure|renal failure
1585197|NCT00446004|Pharmacokinetics|pharmacokinetics
1585198|NCT00446004|Healthy volunteers|healthy volunteers
1585199|NCT00446004|No condition|no condition
1585200|NCT00446004|Pharmacokinetics study|pharmacokinetics study
1585201|NCT00445978|Sickle Cell Disease|sickle cell disease
1585202|NCT00445978|SCD|scd
1585203|NCT00445978|6R-BH4|6r-bh4
1585204|NCT00445978|BH4|bh4
1585205|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
1585206|NCT00445978|endothelial dysfunction|endothelial dysfunction
1585207|NCT00445978|Nitric Oxide|nitric oxide
1585208|NCT00445978|NO|no
1585209|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1585210|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1585211|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1585212|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1585213|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1585214|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1585215|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
1585216|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1585217|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1585218|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1585219|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
1585220|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1585221|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1585222|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1585223|NCT00445965|adult brain stem glioma|adult brain stem glioma
1585224|NCT00445965|adult mixed glioma|adult mixed glioma
1585225|NCT00445965|childhood mixed glioma|childhood mixed glioma
1585226|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1585227|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1585228|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1585229|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1585230|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1585231|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1585232|NCT00445965|regional neuroblastoma|regional neuroblastoma
1585233|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
1585234|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
1585235|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
1585236|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
1585238|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
1585239|NCT00445965|adult ependymoma|adult ependymoma
1585240|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1585241|NCT00445965|adult subependymoma|adult subependymoma
1585242|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1585243|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1585244|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
1585794|NCT00445458|neratinib|neratinib
1585245|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1585246|NCT00445965|recurrent melanoma|recurrent melanoma
1585247|NCT00445965|stage IV melanoma|stage iv melanoma
1585248|NCT00445965|adult medulloblastoma|adult medulloblastoma
1585249|NCT00445965|chondrosarcoma|chondrosarcoma
1585250|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
1585251|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
1585252|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1585253|NCT00445965|ovarian sarcoma|ovarian sarcoma
1585254|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1585255|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1585256|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1585257|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
1585258|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
1585259|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1585260|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1585261|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1585262|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
1585263|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
1585264|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
1585265|NCT00445965|adult gliosarcoma|adult gliosarcoma
1585266|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
1585267|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1585268|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
1585269|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1585270|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1585271|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
1585272|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
1585273|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1585274|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
1585275|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1585276|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
1585277|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
1585278|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
1585279|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
1585280|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
1585281|NCT00445965|iris melanoma|iris melanoma
1585282|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1585283|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1585284|NCT00445965|adult glioblastoma|adult glioblastoma
1585285|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1585286|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1585287|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1585288|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1585289|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1585290|NCT00445965|stage IIIA melanoma|stage iiia melanoma
1585291|NCT00445965|stage IIIB melanoma|stage iiib melanoma
1585292|NCT00445965|stage IIIC melanoma|stage iiic melanoma
1585293|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1585294|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
1585295|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
1585296|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
1585297|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
1585298|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
1585299|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
1585300|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
1585301|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
1585302|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
1585303|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
1585304|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
1585305|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
1585306|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
1585307|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1585308|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1585509|NCT00445822|Response|response
1585309|NCT00445952|breast cancer in situ|breast cancer in situ
1585310|NCT00445952|stage I breast cancer|stage i breast cancer
1585311|NCT00445952|stage II breast cancer|stage ii breast cancer
1585312|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
1585313|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
1585314|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
1585315|NCT00445952|stage IV breast cancer|stage iv breast cancer
1585316|NCT00445952|recurrent breast cancer|recurrent breast cancer
1585317|NCT00445952|male breast cancer|male breast cancer
1585318|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1585319|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1585320|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1585321|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1585322|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1585323|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1585324|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1585325|NCT00445952|recurrent colon cancer|recurrent colon cancer
1585326|NCT00445952|stage I colon cancer|stage i colon cancer
1585327|NCT00445952|stage II colon cancer|stage ii colon cancer
1585328|NCT00445952|stage III colon cancer|stage iii colon cancer
1585329|NCT00445952|stage IV colon cancer|stage iv colon cancer
1585330|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1585331|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1585332|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1585333|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1585334|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1585335|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1585336|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1585337|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1585338|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1585339|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1585340|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1585341|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1585342|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1585343|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1585344|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1585345|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1585346|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1585347|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1585348|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1585349|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1585350|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1585351|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1585352|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1585353|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1585354|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1585355|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1585356|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1585357|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1585358|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1585359|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1585360|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1585361|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1585362|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1585363|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1585364|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1585365|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1585366|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1585367|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1585368|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1585369|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1585370|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1585371|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1585372|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1585510|NCT00445822|Imatinib mesylate|imatinib mesylate
1585373|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1585374|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1585375|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1585376|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1585377|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1585378|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1585379|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1585795|NCT00445458|paclitaxel|paclitaxel
1585380|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1585381|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1585382|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1585383|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1585384|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1585385|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1585386|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1585387|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1585388|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1585389|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1585390|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1585391|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1585392|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
1585393|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
1585394|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
1585395|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1585396|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1585397|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1585398|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1585399|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1585400|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1585401|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1585402|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1585403|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1585404|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1585405|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1585406|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1585407|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1585408|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1585409|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1585410|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1585411|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1585412|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1585413|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1585414|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1585415|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1585416|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1585417|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1585418|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1585419|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1585420|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1585421|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1585422|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1585423|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1585424|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1585425|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1585426|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1585427|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
1585428|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1585429|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1585430|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1585431|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1585432|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1585433|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1585434|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1585435|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1585511|NCT00445809|Kidney|kidney
1585436|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1585437|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1585438|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1585439|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1585440|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1585441|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1585442|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1585443|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1585444|NCT00445952|primary myelofibrosis|primary myelofibrosis
1585445|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1585446|NCT00445952|essential thrombocythemia|essential thrombocythemia
1585447|NCT00445952|polycythemia vera|polycythemia vera
1585448|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1585449|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1585450|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1585451|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1585452|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1585453|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1585454|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
1585455|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1585456|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1585457|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1585458|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1585459|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
1585460|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1585461|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
1585462|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1585463|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1585464|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1585465|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1585466|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1585467|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1585468|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
1585469|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1585470|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
1585471|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1585472|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1585473|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1585474|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1585475|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1585476|NCT00445952|intraocular lymphoma|intraocular lymphoma
1585477|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1585478|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1585479|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1585480|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1585481|NCT00445952|infection|infection
1585482|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
1585483|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1585484|NCT00445913|type 1 diabetes|type 1 diabetes
1585485|NCT00445913|dendritic cells|dendritic cells
1585486|NCT00445913|cell vaccine|cell vaccine
1585487|NCT00445913|safety|safety
1585488|NCT00445913|reversal|reversal
1585489|NCT00445900|primary myelofibrosis|primary myelofibrosis
1585490|NCT00445900|essential thrombocythemia|essential thrombocythemia
1585491|NCT00445900|polycythemia vera|polycythemia vera
1585492|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
1585493|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
1585494|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1585495|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1585496|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
1585497|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
1585498|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1585499|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1585500|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
1585501|NCT00445835|coronary artery disease|coronary artery disease
1585502|NCT00445835|myocardial infarction|myocardial infarction
1585503|NCT00445835|atherothrombosis|atherothrombosis
1585504|NCT00445835|atherosclerosis|atherosclerosis
1585505|NCT00445822|CML|cml
1585506|NCT00445822|Children|children
1585507|NCT00445822|Imatinib|imatinib
1585513|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
1585514|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
1585515|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
1585516|NCT00445783|stage IV melanoma|stage iv melanoma
1585517|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
1585796|NCT00445458|Taxol|taxol
1585518|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
1585519|NCT00445783|stage IA melanoma|stage ia melanoma
1585520|NCT00445783|stage IB melanoma|stage ib melanoma
1585521|NCT00445783|stage IIA melanoma|stage iia melanoma
1585522|NCT00445783|stage IIB melanoma|stage iib melanoma
1585523|NCT00445783|stage IIC melanoma|stage iic melanoma
1585524|NCT00445783|stage IIIA melanoma|stage iiia melanoma
1585525|NCT00445783|stage IIIB melanoma|stage iiib melanoma
1585526|NCT00445783|stage IIIC melanoma|stage iiic melanoma
1585527|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
1585528|NCT00445770|Arthritis|arthritis
1585529|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
1585530|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
1585531|NCT00445731|poor performance status|poor performance status
1585532|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1585533|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1585534|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1585535|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1585536|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1585537|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1585538|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1585539|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1585540|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1585541|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1585542|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1585543|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1585544|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1585545|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1585546|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1585547|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1585548|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1585549|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
1585550|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1585551|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1585552|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1585553|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1585554|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1585555|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1585556|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1585557|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1585558|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1585559|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1585560|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1585561|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1585562|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1585563|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1585564|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1585565|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1585566|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1585567|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1585568|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1585569|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1585570|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1585571|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1585572|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1585573|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1585574|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1585575|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1585576|NCT00445731|recurrent breast cancer|recurrent breast cancer
1587101|NCT00441792|midazolam|midazolam
1585577|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1585578|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1585579|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1585580|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1585581|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1585995|NCT00444678|EGFR|egfr
1585582|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1585798|NCT00445458|Nerlynx|nerlynx
1585583|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1585584|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
1585585|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1585586|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1585587|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1585588|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1585589|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1585590|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
1585591|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
1585592|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1585593|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1585594|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1585595|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1585596|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
1585597|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
1585598|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1585599|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1585600|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1585601|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1585602|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1585603|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1585604|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1585605|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1585606|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1585607|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1585608|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1585609|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1585610|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1585611|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1585612|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
1585613|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1585614|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1585615|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1585616|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
1585617|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
1585618|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
1585619|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1585620|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1585621|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1585622|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1585623|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1585624|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1585625|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1585626|NCT00445731|stage IV breast cancer|stage iv breast cancer
1585627|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1585628|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1585629|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1585630|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1585631|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1585632|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1585633|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1585634|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1585635|NCT00445679|major depressive disorder|major depressive disorder
1585636|NCT00445679|MDD|mdd
1585637|NCT00445679|depression|depression
1585638|NCT00445653|Barrett esophagus|barrett esophagus
1585639|NCT00445627|Type 2 Diabetes|type 2 diabetes
1585640|NCT00445627|Obesity|obesity
1585641|NCT00445627|Overweight|overweight
1585642|NCT00445614|nutrition|nutrition
1585643|NCT00445614|cardiovascular risk|cardiovascular risk
1585644|NCT00445614|inflammation|inflammation
1585645|NCT00445614|vascular function|vascular function
1585646|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1585647|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
1587102|NCT00441792|ketamine|ketamine
1585648|NCT00445601|stage I bladder cancer|stage i bladder cancer
1585649|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
1585650|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
1585651|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
1585652|NCT00445575|bisphosphonates|bisphosphonates
1585653|NCT00445575|risedronate|risedronate
1585654|NCT00445562|male breast cancer|male breast cancer
1585655|NCT00445562|recurrent breast cancer|recurrent breast cancer
1585656|NCT00445562|stage IA breast cancer|stage ia breast cancer
1585657|NCT00445562|stage IB breast cancer|stage ib breast cancer
1585658|NCT00445562|stage II breast cancer|stage ii breast cancer
1585659|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
1585660|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
1585661|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
1585662|NCT00445562|stage IV breast cancer|stage iv breast cancer
1585663|NCT00445549|Ovarian|ovarian
1585664|NCT00445549|VEGFR2|vegfr2
1585665|NCT00445549|EGFR|egfr
1585666|NCT00445549|Angiogenesis|angiogenesis
1585667|NCT00445549|Tyrosine Kinase|tyrosine kinase
1585668|NCT00445549|Protein Phosphorylation|protein phosphorylation
1585669|NCT00445549|Vandetanib|vandetanib
1585670|NCT00445549|Ovarian Cancer|ovarian cancer
1585671|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
1585673|NCT00445523|Advanced renal cancer|advanced renal cancer
1585674|NCT00445523|metastatic renal cancer|metastatic renal cancer
1585675|NCT00445523|RCC|rcc
1585676|NCT00445523|kidney cancer|kidney cancer
1585677|NCT00445523|M3thodist|m3thodist
1585678|NCT00445510|GSK256066,|gsk256066,
1585679|NCT00445510|allergen,|allergen,
1585680|NCT00445510|challenge,|challenge,
1585681|NCT00445510|repeat dose,|repeat dose,
1585682|NCT00445510|AMP,|amp,
1585683|NCT00445510|mild asthmatics|mild asthmatics
1585684|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1585685|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1585686|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1585687|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1585688|NCT00445497|intraocular lymphoma|intraocular lymphoma
1585689|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1585690|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1585691|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1585692|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1585693|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1585694|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1585695|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1585696|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1585697|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1585698|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1585699|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1585700|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1585701|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1585702|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1585703|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1585704|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1585705|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1585706|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1585707|NCT00445497|small intestine lymphoma|small intestine lymphoma
1585708|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1585709|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1585710|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1585711|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1585712|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1585713|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1585714|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1585715|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1585716|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1585717|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1585718|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1585719|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1585720|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1585721|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1585722|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1585723|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1585724|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1585988|NCT00444691|ultra-sonography|ultra-sonography
1585725|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1585726|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1585727|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1585728|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1585729|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1585730|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1585731|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1585797|NCT00445458|breast cancer|breast cancer
1585732|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1585733|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1585734|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1585735|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1585736|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1585737|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1585738|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1585739|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1585740|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1585741|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
1585742|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1585743|NCT00445497|neutropenia|neutropenia
1585744|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1585745|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1585746|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1585747|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1585748|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1585749|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1585750|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1585751|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1585752|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1585753|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1585754|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1585755|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1585756|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1585757|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1585758|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1585759|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1585760|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1585761|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1585762|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1585763|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1585764|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1585765|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1585766|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1585767|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1586008|NCT00444600|Lucentis|lucentis
1585768|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1585769|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1585770|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1585771|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1585772|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1585773|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1585774|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1585775|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1585776|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1585777|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1585778|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1585779|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1585780|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1585781|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1585782|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1585783|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1585784|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1585785|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1585786|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
1585787|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
1585788|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
1585789|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
1585790|NCT00445471|Autistic Disorder|autistic disorder
1585791|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
1585792|NCT00445458|cancer|cancer
1585793|NCT00445458|HKI-272|hki-272
1585799|NCT00445445|stage I breast cancer|stage i breast cancer
1585800|NCT00445445|stage II breast cancer|stage ii breast cancer
1585801|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
1585802|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
1585803|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
1585804|NCT00445445|stage IV breast cancer|stage iv breast cancer
1585805|NCT00445445|recurrent breast cancer|recurrent breast cancer
1585806|NCT00445445|breast cancer in situ|breast cancer in situ
1585807|NCT00445419|Hepatitis C|hepatitis c
1585808|NCT00445419|Liver disease|liver disease
1585809|NCT00445419|Viral infection|viral infection
1585810|NCT00445419|Virosome|virosome
1585811|NCT00445419|Vaccine|vaccine
1585812|NCT00445419|therapeutic vaccine|therapeutic vaccine
1585813|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
1585814|NCT00445406|recurrent breast cancer|recurrent breast cancer
1585815|NCT00445406|stage IV breast cancer|stage iv breast cancer
1585816|NCT00445393|Observation|observation
1585817|NCT00445393|Mental health|mental health
1585818|NCT00445393|Scoliosis|scoliosis
1585819|NCT00445393|Screening|screening
1585820|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
1585821|NCT00445367|Multiple Sclerosis|multiple sclerosis
1585822|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
1585823|NCT00445367|Transverse Myelitis|transverse myelitis
1585824|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
1585825|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
1585826|NCT00445367|Optic Neuritis|optic neuritis
1585827|NCT00445367|Repository|repository
1585828|NCT00445367|Biobank|biobank
1585829|NCT00445354|cinnamon|cinnamon
1585830|NCT00445354|diabetes|diabetes
1585831|NCT00445354|hemoglobin a1c|hemoglobin a1c
1585832|NCT00445341|Microarray|microarray
1585833|NCT00445341|Proteomics|proteomics
1585834|NCT00445341|Hybrid Schedule|hybrid schedule
1585835|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
1585836|NCT00445341|Cyclin D1|cyclin d1
1585837|NCT00445341|Lymphoma|lymphoma
1585838|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
1585840|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1585841|NCT00445341|DLBCL|dlbcl
1585842|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
1585843|NCT00445302|AMD3100|amd3100
1585844|NCT00445289|mechanical ventilation|mechanical ventilation
1585845|NCT00445289|ventilator weaning|ventilator weaning
1585846|NCT00445289|closed-loop|closed-loop
1585847|NCT00445289|ventilation time|ventilation time
1585848|NCT00445276|Osteoarthritis|osteoarthritis
1585849|NCT00445276|Knee|knee
1585850|NCT00445276|Diacerein|diacerein
1585851|NCT00445276|Painful osteoarthritis|painful osteoarthritis
1585852|NCT00445276|Clinical trial|clinical trial
1585853|NCT00445263|CORONARY DISEASE|coronary disease
1585854|NCT00445250|Calcipotriol|calcipotriol
1585855|NCT00445250|Breast|breast
1585856|NCT00445250|Cancer|cancer
1585857|NCT00445250|Radiotherapy|radiotherapy
1585858|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
1585859|NCT00445237|major depression|major depression
1585860|NCT00445237|TMS|tms
1585861|NCT00445224|Knee pain|knee pain
1585862|NCT00445224|Rehabilitation|rehabilitation
1585863|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
1585864|NCT00445211|Heparin|heparin
1585865|NCT00445211|Limb ischemia|limb ischemia
1585866|NCT00445211|Bleeding|bleeding
1585867|NCT00445198|SCLC|sclc
1585868|NCT00445185|Dialysis|dialysis
1585869|NCT00445185|Pre-dialysis|pre-dialysis
1585870|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
1585871|NCT00445185|vaccine|vaccine
1585872|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1585873|NCT00445172|Motor Neurons|motor neurons
1585874|NCT00445172|Muscular Atrophy|muscular atrophy
1585875|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
1585876|NCT00445146|Phase 2|phase 2
1585877|NCT00445146|Open-label|open-label
1585878|NCT00445146|Rollover|rollover
1585879|NCT00445146|Integrase Inhibitor|integrase inhibitor
1585880|NCT00445146|Antiretroviral Agents|antiretroviral agents
1585881|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
1585882|NCT00445146|HAART|haart
1585883|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
1585884|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1585885|NCT00445146|treatment experienced|treatment experienced
1585886|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
1585887|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
1585888|NCT00445120|probiotic|probiotic
1585889|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
1585890|NCT00445120|Children|children
1585891|NCT00445120|Clinical trial|clinical trial
1585892|NCT00445081|atopic dermatitis|atopic dermatitis
1585893|NCT00445081|prednisolone|prednisolone
1585894|NCT00445081|ciclosporine|ciclosporine
1585899|NCT00445068|Multiple myeloma|multiple myeloma
1585900|NCT00445068|adults|adults
1585901|NCT00445068|LBH589|lbh589
1585902|NCT00445068|refractory|refractory
1585903|NCT00445055|Thyroidectomy|thyroidectomy
1585904|NCT00445055|Nausea|nausea
1585905|NCT00445055|Vomiting|vomiting
1585906|NCT00445055|Droperidol|droperidol
1585907|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1585908|NCT00445042|Metastatic RCC|metastatic rcc
1585909|NCT00445042|Kidney Cancer|kidney cancer
1585910|NCT00445042|M3thodist|m3thodist
1585911|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
1585912|NCT00445029|para-phenylenediamine|para-phenylenediamine
1585913|NCT00445029|effector cells|effector cells
1585914|NCT00445029|regulatory cells|regulatory cells
1585915|NCT00445029|pathophysiology|pathophysiology
1585916|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
1585917|NCT00445016|nerve damage|nerve damage
1585918|NCT00445016|adverse effects|adverse effects
1585919|NCT00445016|neurologic complication|neurologic complication
1585920|NCT00445016|neuropathy|neuropathy
1585921|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
1585922|NCT00445003|Diabetic Macular Edema|diabetic macular edema
1585923|NCT00445003|Lucentis|lucentis
1585924|NCT00445003|Ranibizumab|ranibizumab
1585925|NCT00445003|Triamcinolone|triamcinolone
1585926|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
1585927|NCT00445003|Combination Therapy|combination therapy
1585928|NCT00445003|pdr|pdr
1585929|NCT00444990|Lumbar pain|lumbar pain
1585930|NCT00444990|magnets|magnets
1585931|NCT00444990|Reduce low back pain|reduce low back pain
1585932|NCT00444977|HIV positive persons|hiv positive persons
1585933|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
1585934|NCT00444977|treatment naive|treatment naive
1585935|NCT00444977|treatment experienced|treatment experienced
1585936|NCT00444951|N meningitidis|n meningitidis
1585937|NCT00444912|AMD3100|amd3100
1585938|NCT00444912|stem cell mobilization|stem cell mobilization
1585939|NCT00444912|autologous transplant|autologous transplant
1585940|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1585941|NCT00444912|Hodgkin Disease|hodgkin disease
1585942|NCT00444899|Intensive treatment|intensive treatment
1585943|NCT00444899|dietician|dietician
1585944|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
1585945|NCT00444886|Botulinum Toxin|botulinum toxin
1585946|NCT00444886|Botox|botox
1585947|NCT00444886|Pain|pain
1585948|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
1585949|NCT00444847|AIDS|aids
1585950|NCT00444847|HIV|hiv
1585951|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
1585952|NCT00444847|treatment experienced|treatment experienced
1585953|NCT00444821|AAA|aaa
1585954|NCT00444821|Aneurysm|aneurysm
1585955|NCT00444821|AneuRx|aneurx
1585956|NCT00444821|Talent|talent
1585957|NCT00444808|Rib fracture|rib fracture
1585958|NCT00444808|Pain|pain
1585959|NCT00444808|intranasal calcitonin|intranasal calcitonin
1585960|NCT00444795|SUTENE|sutene
1585961|NCT00444795|post-marketing surveillance|post-marketing surveillance
1585962|NCT00444795|GIST|gist
1585963|NCT00444795|RCC|rcc
1585964|NCT00444795|Korea|korea
1585965|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
1585966|NCT00444769|analgesia|analgesia
1585967|NCT00444769|post-operative pain|post-operative pain
1585968|NCT00444769|GW842166|gw842166
1585969|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
1585970|NCT00444769|third molar tooth extraction|third molar tooth extraction
1585971|NCT00444756|local anesthesia|local anesthesia
1585972|NCT00444756|analgesia|analgesia
1585973|NCT00444756|peripheral IV|peripheral iv
1585974|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
1585975|NCT00444730|Prostate Cancer|prostate cancer
1585976|NCT00444730|Prostatectomy|prostatectomy
1585977|NCT00444730|Pelvic pain|pelvic pain
1585978|NCT00444730|urgency|urgency
1585979|NCT00444730|incontinence|incontinence
1585980|NCT00444730|frequency|frequency
1585981|NCT00444717|statin|statin
1585982|NCT00444717|metabolic syndrome|metabolic syndrome
1585983|NCT00444717|oxidative stress|oxidative stress
1585984|NCT00444717|inflammation|inflammation
1585985|NCT00444691|synovitis score|synovitis score
1585986|NCT00444691|sensitivity to change|sensitivity to change
1585987|NCT00444691|clinical examination|clinical examination
1585989|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
1585990|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
1585991|NCT00444678|combined therapy|combined therapy
1585992|NCT00444678|biologics therapy|biologics therapy
1585993|NCT00444678|antibody|antibody
1585994|NCT00444678|chemotherapy|chemotherapy
1585996|NCT00444665|Glaucoma|glaucoma
1585997|NCT00444652|Thromboprophylaxis|thromboprophylaxis
1585998|NCT00444652|Bariatric surgery|bariatric surgery
1585999|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
1586000|NCT00444626|nasolabial folds|nasolabial folds
1586001|NCT00444626|facial wrinkles|facial wrinkles
1586002|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1586003|NCT00444613|motor neurons|motor neurons
1586004|NCT00444613|muscular atrophy|muscular atrophy
1586005|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
1586006|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
1586007|NCT00444600|Diabetic Macular Edema|diabetic macular edema
1586009|NCT00444600|Ranibizumab|ranibizumab
1586010|NCT00444600|Triamcinolone|triamcinolone
1586011|NCT00444600|Laser photocoagulation|laser photocoagulation
1586012|NCT00444600|Combination Therapy|combination therapy
1586013|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1586014|NCT00444561|pramlintide|pramlintide
1586016|NCT00444561|Amylin|amylin
1586017|NCT00444548|Equipment|equipment
1586018|NCT00444548|Supplies|supplies
1586019|NCT00444535|VEGF|vegf
1586020|NCT00444535|Tyrosine kinase|tyrosine kinase
1586021|NCT00444535|ErbB2|erbb2
1586022|NCT00444535|Her2-neu|her2-neu
1586023|NCT00444535|metastatic breast cancer|metastatic breast cancer
1586024|NCT00444535|EGFR|egfr
1586025|NCT00444535|ErbB1|erbb1
1586026|NCT00444535|bevacizumab|bevacizumab
1586027|NCT00444535|lapatinib|lapatinib
1586028|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
1586029|NCT00444509|Asthmatic Patients|asthmatic patients
1586030|NCT00444470|tranexamic acid|tranexamic acid
1586031|NCT00444470|safety|safety
1586032|NCT00444470|efficacy|efficacy
1586033|NCT00444470|spine surgery|spine surgery
1586034|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
1586035|NCT00444470|adult|adult
1586036|NCT00444470|perioperative|perioperative
1586037|NCT00444470|blood loss|blood loss
1586038|NCT00444470|bleeding|bleeding
1586039|NCT00444470|blood transfusion|blood transfusion
1586040|NCT00444457|Vaccine|vaccine
1586041|NCT00444457|Infants|infants
1586042|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
1586043|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
1586044|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
1586045|NCT00444418|Drinking|drinking
1586046|NCT00444418|Alcohol problems|alcohol problems
1586047|NCT00444418|Alcoholism|alcoholism
1586048|NCT00444418|Gay men|gay men
1586049|NCT00444418|Bisexual men|bisexual men
1586050|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
1586051|NCT00444418|Controlled drinking|controlled drinking
1586052|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
1586053|NCT00444405|lumbar|lumbar
1586054|NCT00444405|disc|disc
1586055|NCT00444405|herniation|herniation
1586056|NCT00444405|discectomy|discectomy
1586057|NCT00444405|fusion|fusion
1586058|NCT00444405|spine|spine
1586059|NCT00444392|Obese|obese
1586060|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
1586061|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
1586062|NCT00444392|Risk of CVD|risk of cvd
1586063|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
1586064|NCT00444379|KSHV|kshv
1586065|NCT00444379|AIDS|aids
1586066|NCT00444379|HHV-8|hhv-8
1586067|NCT00444379|treatment naive|treatment naive
1586068|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
1586069|NCT00444301|Heart failure|heart failure
1586070|NCT00444301|Pain|pain
1586071|NCT00444301|Symptoms|symptoms
1586072|NCT00444301|Advanced heart failure|advanced heart failure
1586073|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
1586074|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
1586075|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
1586076|NCT00444288|Cystic Ovaries|cystic ovaries
1586077|NCT00444288|Hyperandrogenism|hyperandrogenism
1586078|NCT00444288|Anovulation|anovulation
1586079|NCT00444288|Concordance Rates|concordance rates
1586080|NCT00444288|Baseline Heritability|baseline heritability
1586081|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
1586082|NCT00444288|POS|pos
1586083|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1586084|NCT00444275|Acid Reflux|acid reflux
1586085|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
1586086|NCT00444262|Esophageal Doppler|esophageal doppler
1586087|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
1586088|NCT00444262|Hip fracture|hip fracture
1586089|NCT00444262|Outcome|outcome
1586090|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
1586091|NCT00444262|General anesthesia|general anesthesia
1586092|NCT00444249|age-related macular degeneration|age-related macular degeneration
1586093|NCT00444249|melatonin|melatonin
1586094|NCT00444249|blue-light filter|blue-light filter
1586095|NCT00444236|asthma|asthma
1586096|NCT00444236|GERD|gerd
1586097|NCT00444236|reflux|reflux
1586098|NCT00444236|exercise|exercise
1586099|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1586100|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1586101|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1586102|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
1586103|NCT00444171|critically ill|critically ill
1586104|NCT00444171|insulin resistance|insulin resistance
1586105|NCT00444171|intensive insulin therapy|intensive insulin therapy
1586106|NCT00444171|computer algorithm|computer algorithm
1586107|NCT00444158|opioids|opioids
1586108|NCT00444158|chronic pain|chronic pain
1586109|NCT00444132|clopidogrel|clopidogrel
1586110|NCT00444132|platelets|platelets
1586111|NCT00444132|acute coronary syndrome|acute coronary syndrome
1586112|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
1586113|NCT00444119|adrenal insufficiency|adrenal insufficiency
1586114|NCT00444119|subjective health status|subjective health status
1586115|NCT00444119|quality of life|quality of life
1586116|NCT00444119|adrenal crisis|adrenal crisis
1586117|NCT00444119|hormone replacement|hormone replacement
1586118|NCT00444119|DHEA|dhea
1586119|NCT00444106|Malaria|malaria
1586120|NCT00444106|hearing|hearing
1586121|NCT00444106|co-artemether|co-artemether
1586122|NCT00444106|auditory|auditory
1586123|NCT00444106|Plasmodium falciparum|plasmodium falciparum
1586124|NCT00444106|marsh fever|marsh fever
1586125|NCT00444106|Plasmodium infections|plasmodium infections
1586126|NCT00444106|remittent fever|remittent fever
1586127|NCT00444106|paludism|paludism
1586128|NCT00444106|artemether|artemether
1586129|NCT00444106|artemisinins|artemisinins
1586130|NCT00444106|benflumetol|benflumetol
1586131|NCT00444106|lumefantrine|lumefantrine
1586132|NCT00444093|radiation therapy|radiation therapy
1586133|NCT00444093|diarrhea|diarrhea
1586134|NCT00444093|enteritis|enteritis
1586135|NCT00444093|supportive therapy|supportive therapy
1586136|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
1586137|NCT00444093|therapy associated enteritis|therapy associated enteritis
1586138|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
1586139|NCT00444080|Ex-PRESS|ex-press
1586140|NCT00444080|TRABECULECTOMY|trabeculectomy
1586141|NCT00444067|Prevention of CSF leak|prevention of csf leak
1586142|NCT00444054|Diet|diet
1586143|NCT00444054|Cancer|cancer
1586144|NCT00444054|Alternative|alternative
1586145|NCT00444054|Breast|breast
1586146|NCT00444054|Colon|colon
1586147|NCT00444054|Cervix|cervix
1586148|NCT00444054|Uterus|uterus
1586149|NCT00444054|Ovary|ovary
1586150|NCT00444054|Metastatic|metastatic
1586151|NCT00444054|Nutrition|nutrition
1586152|NCT00444054|Carbohydrate|carbohydrate
1586153|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
1586154|NCT00444041|surgery|surgery
1586155|NCT00444041|chemotherapy|chemotherapy
1586156|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
1586157|NCT00444015|Erlotinib|erlotinib
1586158|NCT00444015|Dasatinib|dasatinib
1586159|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
1586160|NCT00444015|Tyrosine kinase|tyrosine kinase
1586161|NCT00444015|NSCLC|nsclc
1586162|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
1586163|NCT00444015|Lung|lung
1586164|NCT00444002|Hepatitis C|hepatitis c
1586165|NCT00444002|Steatosis|steatosis
1586166|NCT00444002|Oxidative Stress|oxidative stress
1586167|NCT00444002|Antioxidants|antioxidants
1586168|NCT00444002|Inflammation|inflammation
1586169|NCT00444002|Fatty acids|fatty acids
1586170|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
1586171|NCT00443989|Stroke|stroke
1586172|NCT00443989|Cardiac Death|cardiac death
1586173|NCT00443989|Cardiac Arrest|cardiac arrest
1586174|NCT00443989|Troponin-T|troponin-t
1586175|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
1586176|NCT00443989|Death|death
1586177|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1586178|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1586179|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1586180|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1586181|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1586182|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1586183|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1586184|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1586185|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1586186|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1586187|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1586188|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1586189|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1586190|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1587312|NCT00440960|anesthesia|anesthesia
1586191|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1586192|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1586193|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1586194|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1586195|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1586196|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1586197|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1586198|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1586199|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1586200|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1586201|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1586202|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1586203|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1586204|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1586205|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1586206|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1586207|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1586208|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1586209|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1586210|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1586211|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1586212|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1586213|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1586214|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1586215|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1586216|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1586217|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1586218|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1586219|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1586220|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
1586221|NCT00443950|Arthritis|arthritis
1586222|NCT00443950|Chinese|chinese
1586223|NCT00443937|Kidney Transplantation|kidney transplantation
1586224|NCT00443937|Renal Transplantation|renal transplantation
1586225|NCT00443937|Mycophenolate|mycophenolate
1586226|NCT00443937|Cyclosporine|cyclosporine
1586227|NCT00443937|Everolimus|everolimus
1586228|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
1586229|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
1586230|NCT00443898|Toenail fungus|toenail fungus
1586231|NCT00443898|Onychomycosis|onychomycosis
1586232|NCT00443898|Nail fungus|nail fungus
1586233|NCT00443898|Toenail fungal infection|toenail fungal infection
1586234|NCT00443898|Tinea unguium|tinea unguium
1586235|NCT00443898|Dermatophytes|dermatophytes
1586236|NCT00443898|Foot dermatoses|foot dermatoses
1586237|NCT00443885|meropenem|meropenem
1586238|NCT00443885|imipenem|imipenem
1586239|NCT00443885|gram negative organism|gram negative organism
1586240|NCT00443872|Parkinson's disease|parkinson's disease
1586241|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
1586242|NCT00443872|MAO-B inhibitor|mao-b inhibitor
1586243|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
1586244|NCT00443872|Zelapar|zelapar
1586368|NCT00443378|HIV seronegativity|hiv seronegativity
1586245|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
1586246|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
1586247|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
1586248|NCT00443833|Thyrotoxicosis|thyrotoxicosis
1586249|NCT00443833|genetic association study|genetic association study
1586250|NCT00443833|periodic paralysis|periodic paralysis
1586251|NCT00443833|whole genome scan|whole genome scan
1586252|NCT00443820|Toenail fungus|toenail fungus
1586253|NCT00443820|Onychomycosis|onychomycosis
1586254|NCT00443820|Nail fungus|nail fungus
1586255|NCT00443820|Toenail fungal infection|toenail fungal infection
1586256|NCT00443820|Tinea unguium|tinea unguium
1586257|NCT00443820|Dermatophytes|dermatophytes
1586258|NCT00443820|Foot dermatoses|foot dermatoses
1586259|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
1586260|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
1586261|NCT00443768|Medication|medication
1586262|NCT00443768|Diagnosis|diagnosis
1586263|NCT00443768|Community|community
1586264|NCT00443755|Inflammatory cytokine|inflammatory cytokine
1586265|NCT00443755|Cardiovascular Disease|cardiovascular disease
1586266|NCT00443755|Thrombotic factors|thrombotic factors
1586267|NCT00443755|Dyslipidemia|dyslipidemia
1586268|NCT00443742|Depression|depression
1586269|NCT00443742|Validation|validation
1586271|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
1586272|NCT00443729|treatment experienced|treatment experienced
1586273|NCT00443703|treatment experienced|treatment experienced
1586274|NCT00443690|heart failure|heart failure
1586275|NCT00443690|diuretic|diuretic
1586276|NCT00443690|renal impairment|renal impairment
1586277|NCT00443690|renal function|renal function
1586278|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
1586279|NCT00443651|Rituxan|rituxan
1586280|NCT00443651|RA|ra
1586281|NCT00443651|DMARD|dmard
1586282|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
1586283|NCT00443625|SK3530|sk3530
1586284|NCT00443625|Food effect|food effect
1586285|NCT00443625|Pharmacokinetics|pharmacokinetics
1586286|NCT00443599|Congenital Heart Defects|congenital heart defects
1586287|NCT00443599|Insulin|insulin
1586288|NCT00443599|Euglycemia|euglycemia
1586289|NCT00443599|Normoglycemia|normoglycemia
1586290|NCT00443586|Nurse|nurse
1586291|NCT00443586|Home Visitation|home visitation
1586292|NCT00443586|Welfare|welfare
1586293|NCT00443586|Social Behavior|social behavior
1586294|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
1586295|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
1586296|NCT00443573|tissue factor|tissue factor
1586297|NCT00443573|factor VIIa|factor viia
1586298|NCT00443573|rNAPc2|rnapc2
1586299|NCT00443573|adenocarcinoma|adenocarcinoma
1586300|NCT00443573|targeted therapy|targeted therapy
1586301|NCT00443573|coagulation-dependent|coagulation-dependent
1586302|NCT00443573|RECIST|recist
1586303|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
1586304|NCT00443573|FOLFOX|folfox
1586305|NCT00443573|FOLFIRI|folfiri
1586306|NCT00443573|leucovorin|leucovorin
1586307|NCT00443573|XELOX|xelox
1586308|NCT00443560|Labor|labor
1586309|NCT00443560|Epidural Analgesia|epidural analgesia
1586310|NCT00443560|delivery|delivery
1586311|NCT00443560|vacuum extraction|vacuum extraction
1586312|NCT00443560|obstetrical Forceps|obstetrical forceps
1586313|NCT00443547|Prospective|prospective
1586314|NCT00443547|Degenerative Disc Disease|degenerative disc disease
1586315|NCT00443547|Cervical|cervical
1586316|NCT00443547|Translational Plate|translational plate
1586317|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
1586318|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
1586319|NCT00443521|Triamcinolone|triamcinolone
1586320|NCT00443521|Laser coagulation|laser coagulation
1586321|NCT00443521|Tomography, optical coherence|tomography, optical coherence
1586322|NCT00443508|everolimus|everolimus
1586323|NCT00443508|renal transplant|renal transplant
1586324|NCT00443508|tacrolimus|tacrolimus
1586325|NCT00443508|Certican|certican
1586326|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
1586327|NCT00443508|Renal transplant patients|renal transplant patients
1586328|NCT00443482|Asthma|asthma
1586329|NCT00443482|adults|adults
1586330|NCT00443482|B2 agonist|b2 agonist
1586331|NCT00443482|formoterol|formoterol
1586332|NCT00443469|magnetic stimulation|magnetic stimulation
1586333|NCT00443469|neuropathic pain|neuropathic pain
1586334|NCT00443469|spinal|spinal
1586335|NCT00443469|lower limb|lower limb
1586336|NCT00443469|clinical trial|clinical trial
1586337|NCT00443443|Rituximab|rituximab
1586338|NCT00443443|RA|ra
1586339|NCT00443443|Sunstone|sunstone
1586340|NCT00443443|anti-TNF|anti-tnf
1586341|NCT00443443|Rituxan|rituxan
1586342|NCT00443430|Childhood Arthritis|childhood arthritis
1586343|NCT00443430|Juvenile Arthritis|juvenile arthritis
1586344|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
1586345|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
1586346|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
1586347|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
1586348|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
1586349|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
1586350|NCT00443404|phantom|phantom
1586351|NCT00443404|amputation|amputation
1586352|NCT00443404|analgesia|analgesia
1586353|NCT00443404|pain|pain
1586354|NCT00443404|preemptive|preemptive
1586355|NCT00443404|perioperative|perioperative
1586356|NCT00443404|lower limb amputation|lower limb amputation
1586357|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
1586358|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
1586359|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
1586360|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
1586361|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
1586362|NCT00443391|ADHD|adhd
1586363|NCT00443378|computer counseling|computer counseling
1586364|NCT00443378|HIV|hiv
1586365|NCT00443378|antiretroviral adherence|antiretroviral adherence
1586366|NCT00443378|sexual behavior|sexual behavior
1586367|NCT00443378|prevention with positives|prevention with positives
1586369|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
1586370|NCT00443339|Anemia|anemia
1586371|NCT00020475|adult solid tumor|adult solid tumor
1586372|NCT00020475|body system/site cancer|body system/site cancer
1586373|NCT00020475|cancer|cancer
1586374|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
1586375|NCT00020475|eye cancer|eye cancer
1586376|NCT00020475|intraocular melanoma|intraocular melanoma
1586377|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
1586378|NCT00020475|solid tumor|solid tumor
1586379|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
1586380|NCT00020371|adult solid tumor|adult solid tumor
1586381|NCT00020371|bone marrow suppression|bone marrow suppression
1586382|NCT00020371|cancer|cancer
1586383|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
1586384|NCT00020371|neutropenia|neutropenia
1586385|NCT00020371|solid tumor|solid tumor
1586386|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1586387|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1586388|NCT00020345|adult solid tumor|adult solid tumor
1586389|NCT00020345|body system/site cancer|body system/site cancer
1586390|NCT00020345|cancer|cancer
1586391|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
1586392|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
1586393|NCT00020345|pancreatic cancer|pancreatic cancer
1586394|NCT00020345|solid tumor|solid tumor
1586395|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
1586396|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
1586397|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
1586398|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
1586399|NCT00020267|Ewing's family of tumors|ewing's family of tumors
1586400|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
1586401|NCT00020267|adult solid tumor|adult solid tumor
1586402|NCT00020267|body system/site cancer|body system/site cancer
1586403|NCT00020267|bone cancer|bone cancer
1586404|NCT00020267|breast cancer|breast cancer
1586405|NCT00020267|cancer|cancer
1586406|NCT00020267|childhood cancer|childhood cancer
1586407|NCT00020267|childhood solid tumor|childhood solid tumor
1586408|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1586409|NCT00020267|colon cancer|colon cancer
1586410|NCT00020267|colorectal cancer|colorectal cancer
1586411|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
1586412|NCT00020267|eye cancer|eye cancer
1586413|NCT00020267|female reproductive cancer|female reproductive cancer
1586414|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
1586415|NCT00020267|genetic condition|genetic condition
1586416|NCT00020267|intraocular melanoma|intraocular melanoma
1586417|NCT00020267|lung cancer|lung cancer
1586418|NCT00020267|male breast cancer|male breast cancer
1586419|NCT00020267|melanoma|melanoma
1586420|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
1586421|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
1586422|NCT00020267|muscle cancer|muscle cancer
1586423|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
1586424|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
1586425|NCT00020267|osteosarcoma|osteosarcoma
1586426|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
1586427|NCT00020267|ovarian sarcoma|ovarian sarcoma
1586428|NCT00020267|rectal cancer|rectal cancer
1586429|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1586430|NCT00020267|recurrent breast cancer|recurrent breast cancer
1586431|NCT00020267|recurrent colon cancer|recurrent colon cancer
1586432|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
1586433|NCT00020267|recurrent melanoma|recurrent melanoma
1586434|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1586435|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
1586436|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
1586437|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
1586438|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
1586439|NCT00020267|skin tumor|skin tumor
1586440|NCT00020267|solid tumor|solid tumor
1586441|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
1586442|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1586443|NCT00020267|stage IV breast cancer|stage iv breast cancer
1586444|NCT00020267|stage IV colon cancer|stage iv colon cancer
1586445|NCT00020267|stage IV melanoma|stage iv melanoma
1586446|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1586447|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
1587310|NCT00440973|M3thodist|m3thodist
1586448|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
1586449|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
1586450|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
1586451|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
1586720|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
1586452|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
1586453|NCT00020267|stage, breast cancer|stage, breast cancer
1586454|NCT00020267|stage, colon cancer|stage, colon cancer
1586455|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
1586456|NCT00020267|stage, melanoma|stage, melanoma
1586457|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
1586458|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
1586459|NCT00020267|stage, rectal cancer|stage, rectal cancer
1586460|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
1586461|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
1586462|NCT00020267|uterine sarcoma|uterine sarcoma
1586463|NCT00019643|adult solid tumor|adult solid tumor
1586464|NCT00019643|body system/site cancer|body system/site cancer
1586465|NCT00019643|breast cancer|breast cancer
1586466|NCT00019643|cancer|cancer
1586467|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
1586468|NCT00019643|depression|depression
1586469|NCT00019643|depression and suicide|depression and suicide
1586470|NCT00019643|nutrition|nutrition
1586471|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
1586472|NCT00019643|quality of life|quality of life
1586473|NCT00019643|solid tumor|solid tumor
1586474|NCT00019643|stage I breast cancer|stage i breast cancer
1586475|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
1586476|NCT00019643|stage II breast cancer|stage ii breast cancer
1586477|NCT00019643|stage III breast cancer|stage iii breast cancer
1586478|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
1586479|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
1586480|NCT00019643|stage, breast cancer|stage, breast cancer
1586481|NCT00443326|Psoriasis|psoriasis
1586482|NCT00443326|PASI|pasi
1586483|NCT00443326|Skin Biopsy|skin biopsy
1586484|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
1586485|NCT00443313|Cervical neoplasia|cervical neoplasia
1586486|NCT00443313|Screening|screening
1586488|NCT00443313|Cervical Cancer Screening|cervical cancer screening
1586489|NCT00443300|AML|aml
1586490|NCT00443300|MDS|mds
1586491|NCT00443300|Protected Environment|protected environment
1586492|NCT00443287|Peripheral|peripheral
1586493|NCT00443287|Artery|artery
1586494|NCT00443287|Disease|disease
1586495|NCT00443261|Head and Neck Cancer|head and neck cancer
1586496|NCT00443235|Older patients|older patients
1586497|NCT00443235|untreated patients|untreated patients
1586498|NCT00443222|infliximab|infliximab
1586499|NCT00443222|polymyositis|polymyositis
1586500|NCT00443222|dermatomyositis|dermatomyositis
1586501|NCT00443222|inclusion body myositis|inclusion body myositis
1586502|NCT00443196|Chemosensitivity|chemosensitivity
1586503|NCT00443196|Ovarian Cancer|ovarian cancer
1586504|NCT00443196|Chemotherapy|chemotherapy
1586505|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
1586506|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
1586507|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
1586508|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
1586509|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
1586510|NCT00443170|repeat dose,|repeat dose,
1586511|NCT00443170|GSK626616AC,|gsk626616ac,
1586512|NCT00443170|pharmacokinetic,|pharmacokinetic,
1586513|NCT00443170|single dose,|single dose,
1586514|NCT00443170|cytochrome P450,|cytochrome p450,
1586515|NCT00443170|First time in human,|first time in human,
1586516|NCT00443170|healthy volunteers|healthy volunteers
1586517|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
1586518|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
1586519|NCT00443144|pharmacogenomics|pharmacogenomics
1586520|NCT00443144|growth promoting therapy|growth promoting therapy
1586521|NCT00443131|Adjuvant|adjuvant
1586522|NCT00443131|Malaria|malaria
1586523|NCT00443131|Safety|safety
1586524|NCT00443131|Immunogenicity|immunogenicity
1586525|NCT00443118|Bag and mask|bag and mask
1586526|NCT00443118|Neopuff|neopuff
1586527|NCT00443118|Resuscitation|resuscitation
1586528|NCT00443118|Newborn|newborn
1586529|NCT00443118|Intubation|intubation
1586530|NCT00443118|devices|devices
1586531|NCT00443118|PEEP|peep
1586532|NCT00443092|osteoarthritis|osteoarthritis
1586533|NCT00443092|gout|gout
1586534|NCT00443092|pain|pain
1586535|NCT00443092|uric acid|uric acid
1586536|NCT00443092|tart cherry|tart cherry
1586537|NCT00443092|alternative medicine|alternative medicine
1586538|NCT00443092|knees|knees
1586539|NCT00443079|Clinical Trials|clinical trials
1587311|NCT00440960|alfentanil|alfentanil
1586540|NCT00443079|Pilot Projects|pilot projects
1586541|NCT00443079|Milk Thistle|milk thistle
1586542|NCT00443079|Liver Function Tests|liver function tests
1586543|NCT00443066|pediatric|pediatric
1586544|NCT00443066|neuromuscular disease|neuromuscular disease
1586545|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
1586804|NCT00003552|cancer|cancer
1586546|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
1586547|NCT00443053|fondaparinux|fondaparinux
1586548|NCT00443053|deep vein thrombosis|deep vein thrombosis
1586549|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
1586550|NCT00443053|thrombosis|thrombosis
1586551|NCT00443014|Stimulation therapy|stimulation therapy
1586552|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
1586553|NCT00443014|Synergetic|synergetic
1586554|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
1586555|NCT00443001|Sinus Rhythm|sinus rhythm
1586556|NCT00443001|Oscillometric|oscillometric
1586557|NCT00443001|Invasive Blood Pressure|invasive blood pressure
1586558|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
1586559|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
1586560|NCT00442988|NODAT|nodat
1586561|NCT00442988|OGTT|ogtt
1586562|NCT00442988|FPG|fpg
1586563|NCT00442988|Renal Transplanation|renal transplanation
1586564|NCT00442988|Risk Factors|risk factors
1586565|NCT00442988|Predictive value|predictive value
1586566|NCT00442975|Influenza Vaccine|influenza vaccine
1586567|NCT00442975|CMV|cmv
1586568|NCT00442949|Acute coronary syndrome|acute coronary syndrome
1586569|NCT00442949|Angioplasty|angioplasty
1586570|NCT00442949|Abciximab|abciximab
1586571|NCT00442949|Troponin release|troponin release
1586572|NCT00442923|Methamphetamine|methamphetamine
1586573|NCT00442923|Coreg|coreg
1586574|NCT00442923|Withdrawal|withdrawal
1586575|NCT00442923|anxiety|anxiety
1586576|NCT00442923|Substance Addiction|substance addiction
1586577|NCT00442910|Safety and Acceptability|safety and acceptability
1586578|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
1586579|NCT00442884|glucose control in acute stress|glucose control in acute stress
1586580|NCT00442871|Renal Impairment,|renal impairment,
1586581|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
1586582|NCT00442871|thrombocytopenia,|thrombocytopenia,
1586583|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
1586584|NCT00442858|cardiac disease|cardiac disease
1586585|NCT00442858|cerebrovascular disease|cerebrovascular disease
1586586|NCT00442858|GH deficiency|gh deficiency
1586587|NCT00442858|diabetes mellitus|diabetes mellitus
1586588|NCT00442858|hypertension|hypertension
1586589|NCT00442858|GH therapy|gh therapy
1586590|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
1586591|NCT00020202|adult solid tumor|adult solid tumor
1586592|NCT00020202|body system/site cancer|body system/site cancer
1586593|NCT00020202|cancer|cancer
1586594|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1586595|NCT00020202|genetic condition|genetic condition
1586596|NCT00020202|lung cancer|lung cancer
1586597|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
1586598|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1586599|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
1586600|NCT00020202|small cell lung cancer|small cell lung cancer
1586601|NCT00020202|solid tumor|solid tumor
1586602|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1586603|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1586604|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1586605|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1586606|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
1586607|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
1586608|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
1586609|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1586610|NCT00020046|adult solid tumor|adult solid tumor
1586611|NCT00020046|body system/site cancer|body system/site cancer
1586612|NCT00020046|cancer|cancer
1586613|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
1586614|NCT00020046|genetic condition|genetic condition
1586615|NCT00020046|male reproductive cancer|male reproductive cancer
1586616|NCT00020046|prostate cancer|prostate cancer
1586617|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
1586618|NCT00020046|solid tumor|solid tumor
1586619|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
1586620|NCT00020046|stage, prostate cancer|stage, prostate cancer
1586621|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
1586622|NCT00019968|adult solid tumor|adult solid tumor
1586623|NCT00019968|body system/site cancer|body system/site cancer
1586624|NCT00019968|cancer|cancer
1586625|NCT00019968|muscle cancer|muscle cancer
1586626|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
1586627|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1586628|NCT00019968|solid tumor|solid tumor
1586629|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
1586630|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1586631|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
1586632|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
1586633|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
1586805|NCT00003552|melanoma|melanoma
1586634|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1586635|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1586636|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
1586637|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
1586638|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
1586639|NCT00019890|adult solid tumor|adult solid tumor
1586640|NCT00019890|body system/site cancer|body system/site cancer
1586641|NCT00019890|cancer|cancer
1586642|NCT00019890|melanoma|melanoma
1586643|NCT00019890|recurrent melanoma|recurrent melanoma
1586644|NCT00019890|skin tumor|skin tumor
1586645|NCT00019890|solid tumor|solid tumor
1586646|NCT00019890|stage III melanoma|stage iii melanoma
1586647|NCT00019890|stage IV melanoma|stage iv melanoma
1586648|NCT00019890|stage, melanoma|stage, melanoma
1586649|NCT00019760|adult solid tumor|adult solid tumor
1586650|NCT00019760|body system/site cancer|body system/site cancer
1586651|NCT00019760|cancer|cancer
1586652|NCT00019760|colon cancer|colon cancer
1586653|NCT00019760|colorectal cancer|colorectal cancer
1586654|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
1586655|NCT00019760|genetic condition|genetic condition
1586656|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1586657|NCT00019760|liver metastases|liver metastases
1586658|NCT00019760|metastatic cancer|metastatic cancer
1586659|NCT00019760|rectal cancer|rectal cancer
1586660|NCT00019760|recurrent colon cancer|recurrent colon cancer
1586661|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
1586662|NCT00019760|site, metastatic cancer|site, metastatic cancer
1586663|NCT00019760|solid tumor|solid tumor
1586664|NCT00019760|stage IV colon cancer|stage iv colon cancer
1586665|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
1586666|NCT00019760|stage, colon cancer|stage, colon cancer
1586667|NCT00019760|stage, rectal cancer|stage, rectal cancer
1586668|NCT00019760|unclassified/other cancer|unclassified/other cancer
1586669|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1586670|NCT00019695|adult solid tumor|adult solid tumor
1586671|NCT00019695|body system/site cancer|body system/site cancer
1586672|NCT00019695|bone metastases|bone metastases
1586673|NCT00019695|cancer|cancer
1586674|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
1586675|NCT00019695|genetic condition|genetic condition
1586676|NCT00019695|male reproductive cancer|male reproductive cancer
1586677|NCT00019695|metastatic cancer|metastatic cancer
1586678|NCT00019695|prostate cancer|prostate cancer
1586679|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
1586680|NCT00019695|site, metastatic cancer|site, metastatic cancer
1586681|NCT00019695|solid tumor|solid tumor
1586682|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
1586683|NCT00019695|stage, prostate cancer|stage, prostate cancer
1586684|NCT00019695|unclassified/other cancer|unclassified/other cancer
1586685|NCT00019630|Ewing's family of tumors|ewing's family of tumors
1586686|NCT00019630|Wilms' tumor|wilms' tumor
1586687|NCT00019630|adult solid tumor|adult solid tumor
1586688|NCT00019630|body system/site cancer|body system/site cancer
1586689|NCT00019630|bone cancer|bone cancer
1586690|NCT00019630|brain tumor|brain tumor
1586691|NCT00019630|cancer|cancer
1586692|NCT00019630|central nervous system cancer|central nervous system cancer
1586693|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
1586694|NCT00019630|childhood brain tumor|childhood brain tumor
1586695|NCT00019630|childhood cancer|childhood cancer
1586696|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1586697|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
1586698|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
1586699|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
1586700|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
1586701|NCT00019630|childhood ependymoma|childhood ependymoma
1586702|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1586703|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
1586704|NCT00019630|childhood liver cancer|childhood liver cancer
1586705|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1586706|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1586707|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
1586708|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
1586709|NCT00019630|childhood meningioma|childhood meningioma
1586710|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
1586711|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
1586712|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1586713|NCT00019630|childhood solid tumor|childhood solid tumor
1586797|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
1586714|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
1586715|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
1586716|NCT00019630|endocrine cancer|endocrine cancer
1586717|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
1586718|NCT00019630|genetic condition|genetic condition
1586719|NCT00019630|kidney tumor|kidney tumor
1586721|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1586722|NCT00019630|muscle cancer|muscle cancer
1586723|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
1586724|NCT00019630|neuroblastoma|neuroblastoma
1586725|NCT00019630|osteosarcoma|osteosarcoma
1586726|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
1586727|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
1586728|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1586729|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
1586730|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1586731|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
1586732|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1586733|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1586734|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
1586735|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
1586736|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1586737|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1586738|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1586739|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1586740|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
1586741|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1586742|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
1586743|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
1586744|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
1586745|NCT00019630|solid tumor|solid tumor
1586746|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
1586747|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
1586748|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
1586749|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
1586750|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
1586751|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
1586752|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
1586753|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
1586754|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
1586755|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
1586756|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1586757|NCT00019448|adult solid tumor|adult solid tumor
1586758|NCT00019448|body system/site cancer|body system/site cancer
1586759|NCT00019448|cancer|cancer
1586760|NCT00019448|melanoma|melanoma
1586761|NCT00019448|recurrent melanoma|recurrent melanoma
1586762|NCT00019448|skin tumor|skin tumor
1586763|NCT00019448|solid tumor|solid tumor
1586764|NCT00019448|stage IV melanoma|stage iv melanoma
1586765|NCT00019448|stage, melanoma|stage, melanoma
1586766|NCT00019396|adult solid tumor|adult solid tumor
1586767|NCT00019396|body system/site cancer|body system/site cancer
1586768|NCT00019396|cancer|cancer
1586769|NCT00019396|kidney tumor|kidney tumor
1586770|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
1586771|NCT00019396|melanoma|melanoma
1586772|NCT00019396|recurrent melanoma|recurrent melanoma
1586773|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
1586774|NCT00019396|renal cell cancer|renal cell cancer
1586775|NCT00019396|skin tumor|skin tumor
1586776|NCT00019396|solid tumor|solid tumor
1586777|NCT00019396|stage IV melanoma|stage iv melanoma
1586778|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
1586779|NCT00019396|stage, melanoma|stage, melanoma
1586780|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
1586781|NCT00019188|AIDS-related malignancies|aids-related malignancies
1586782|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
1586783|NCT00019188|adult solid tumor|adult solid tumor
1586784|NCT00019188|body system/site cancer|body system/site cancer
1586785|NCT00019188|cancer|cancer
1586786|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
1586787|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
1586788|NCT00019188|skin tumor|skin tumor
1586789|NCT00019188|solid tumor|solid tumor
1586790|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
1586791|NCT00019097|body system/site cancer|body system/site cancer
1586792|NCT00019097|cancer|cancer
1586793|NCT00019097|genetic condition|genetic condition
1586794|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1586795|NCT00019097|multiple myeloma|multiple myeloma
1586796|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
1586798|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
1586799|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
1586800|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
1586801|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
1586802|NCT00003552|adult solid tumor|adult solid tumor
1586803|NCT00003552|body system/site cancer|body system/site cancer
1586806|NCT00003552|recurrent melanoma|recurrent melanoma
1586807|NCT00003552|skin tumor|skin tumor
1586808|NCT00003552|solid tumor|solid tumor
1586809|NCT00003552|stage IV melanoma|stage iv melanoma
1586810|NCT00003552|stage, melanoma|stage, melanoma
1586812|NCT00442832|Staph|staph
1586814|NCT00442819|Uremic Pruritus|uremic pruritus
1586815|NCT00442819|Cytokines|cytokines
1586816|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
1586817|NCT00442819|Hemodialysis|hemodialysis
1586818|NCT00442806|ADRC|adrc
1586819|NCT00442806|Stem Cells|stem cells
1586820|NCT00442806|Myocardial Infarction|myocardial infarction
1586821|NCT00442806|STEMI|stemi
1586822|NCT00442806|Heart Disease|heart disease
1586823|NCT00442806|Coronary Artery Disease|coronary artery disease
1586824|NCT00442806|Coronary Disease|coronary disease
1586825|NCT00442806|ST-Elevation|st-elevation
1586827|NCT00442806|Interventional Cardiology|interventional cardiology
1586828|NCT00442806|Heart Attack|heart attack
1586829|NCT00442780|early Parkinson's Disease|early parkinson's disease
1586830|NCT00442780|MOBILE|mobile
1586831|NCT00442780|BIIB014|biib014
1586832|NCT00442767|pediatric|pediatric
1586833|NCT00442767|juvenile|juvenile
1586834|NCT00442767|diabetes mellitus|diabetes mellitus
1586835|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
1586836|NCT00442754|dendritic cell|dendritic cell
1586837|NCT00442754|tumor vaccine|tumor vaccine
1586838|NCT00442754|NSCLC|nsclc
1586839|NCT00442741|Cancer|cancer
1586840|NCT00442741|EPO906|epo906
1586841|NCT00442741|Patupilone|patupilone
1586842|NCT00442728|Functional electrical stimulation|functional electrical stimulation
1586843|NCT00442728|muscular atrophy|muscular atrophy
1586844|NCT00442728|intensive care|intensive care
1586845|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
1586846|NCT00442715|early childhood;|early childhood;
1586847|NCT00442715|spirometry,|spirometry,
1586848|NCT00442715|exercise challenge|exercise challenge
1586849|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
1586850|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
1586851|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
1586852|NCT00442689|Metabolic Syndrome|metabolic syndrome
1586853|NCT00442689|PCOS|pcos
1586854|NCT00442689|overweight|overweight
1586855|NCT00442689|infertility|infertility
1586856|NCT00442689|Insulin Resistance|insulin resistance
1586857|NCT00442689|menstrual cycle|menstrual cycle
1586858|NCT00442663|Labor Induction|labor induction
1586859|NCT00442663|Cervical Ripening|cervical ripening
1586860|NCT00442663|Foley Catheter|foley catheter
1586861|NCT00442637|CAIRO3|cairo3
1586862|NCT00442637|DCCG|dccg
1586863|NCT00442637|colorectal cancer|colorectal cancer
1586864|NCT00442637|induction|induction
1586865|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
1586866|NCT00442637|observation|observation
1586867|NCT00442637|capecitabine|capecitabine
1586868|NCT00442637|bevacizumab|bevacizumab
1586869|NCT00442637|oxaliplatin|oxaliplatin
1586870|NCT00442624|insomnia|insomnia
1586871|NCT00442624|glucose metabolism|glucose metabolism
1586872|NCT00442624|insulin resistance|insulin resistance
1586873|NCT00442598|Ovarian|ovarian
1586874|NCT00442598|Cancer|cancer
1586875|NCT00442598|CA-125|ca-125
1586876|NCT00442598|Third-line|third-line
1586877|NCT00442598|Glufosfamide|glufosfamide
1586878|NCT00442546|opioid|opioid
1586879|NCT00442533|Carcinoid|carcinoid
1586880|NCT00442533|Islet Cell Cancer|islet cell cancer
1586881|NCT00442533|Paraganglioma|paraganglioma
1586882|NCT00442533|Pheochromocytoma|pheochromocytoma
1586883|NCT00442507|Esophagus|esophagus
1586884|NCT00442507|Esophagogastric Junction|esophagogastric junction
1586885|NCT00442507|Avastin|avastin
1586886|NCT00442507|Bevacizumab|bevacizumab
1586887|NCT00442507|Erlotinib|erlotinib
1586888|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
1586889|NCT00442481|MDD|mdd
1586890|NCT00442481|Escitalopram|escitalopram
1586891|NCT00442481|Cipralex|cipralex
1586892|NCT00442481|Sleep|sleep
1586893|NCT00442481|REM|rem
1586894|NCT00442481|SWS|sws
1586895|NCT00442481|Polysomnography|polysomnography
1586896|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1586897|NCT00442468|Chronic Bronchitis|chronic bronchitis
1586898|NCT00442468|Spirometry|spirometry
1586899|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
1586900|NCT00442442|Malaria|malaria
1586901|NCT00442442|mosquito control|mosquito control
1586902|NCT00442442|mosquito coils|mosquito coils
1586903|NCT00442442|LLIN|llin
1586904|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
1586905|NCT00019578|adult brain stem glioma|adult brain stem glioma
1586906|NCT00019578|adult brain tumor|adult brain tumor
1586907|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1586908|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
1586909|NCT00019578|adult ependymoma|adult ependymoma
1586910|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
1586911|NCT00019578|adult malignant meningioma|adult malignant meningioma
1586912|NCT00019578|adult medulloblastoma|adult medulloblastoma
1586913|NCT00019578|adult meningioma|adult meningioma
1586914|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
1586915|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
1586916|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1586917|NCT00019578|adult solid tumor|adult solid tumor
1586918|NCT00019578|body system/site cancer|body system/site cancer
1586919|NCT00019578|brain metastases|brain metastases
1586920|NCT00019578|brain tumor|brain tumor
1586921|NCT00019578|cancer|cancer
1586922|NCT00019578|central nervous system cancer|central nervous system cancer
1586923|NCT00019578|genetic condition|genetic condition
1586924|NCT00019578|metastatic cancer|metastatic cancer
1586925|NCT00019578|mixed gliomas|mixed gliomas
1586926|NCT00019578|site, metastatic cancer|site, metastatic cancer
1586927|NCT00019578|solid tumor|solid tumor
1586928|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
1586929|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
1586930|NCT00019578|unclassified/other cancer|unclassified/other cancer
1586931|NCT00019006|adult solid tumor|adult solid tumor
1586932|NCT00019006|body system/site cancer|body system/site cancer
1586933|NCT00019006|cancer|cancer
1586934|NCT00019006|colon cancer|colon cancer
1586935|NCT00019006|colorectal cancer|colorectal cancer
1586936|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1586937|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
1586938|NCT00019006|genetic condition|genetic condition
1586939|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
1586940|NCT00019006|lung cancer|lung cancer
1586941|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
1586942|NCT00019006|pancreatic cancer|pancreatic cancer
1586943|NCT00019006|rectal cancer|rectal cancer
1586944|NCT00019006|recurrent colon cancer|recurrent colon cancer
1586945|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
1586946|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
1586947|NCT00019006|small cell lung cancer|small cell lung cancer
1586948|NCT00019006|solid tumor|solid tumor
1586949|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
1586950|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1586951|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
1586952|NCT00019006|stage III colon cancer|stage iii colon cancer
1586953|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1586954|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
1586955|NCT00019006|stage III rectal cancer|stage iii rectal cancer
1586956|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
1586957|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
1586958|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
1586959|NCT00019006|stage, colon cancer|stage, colon cancer
1586960|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
1586961|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
1586962|NCT00019006|stage, rectal cancer|stage, rectal cancer
1586963|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
1586964|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
1586965|NCT00442403|Malaria|malaria
1586966|NCT00442403|Plasmodium falciparum|plasmodium falciparum
1586967|NCT00442403|Chemotherapy|chemotherapy
1586968|NCT00442403|Chloroquine|chloroquine
1586969|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
1586970|NCT00442390|Cortisol|cortisol
1586971|NCT00442390|adrenal insufficiency|adrenal insufficiency
1586972|NCT00442390|glucose metabolism|glucose metabolism
1586973|NCT00442390|protein metabolism|protein metabolism
1586974|NCT00442390|lipid metabolism|lipid metabolism
1586975|NCT00442390|insulin sensitivity.|insulin sensitivity.
1586976|NCT00442377|Falciparum|falciparum
1586977|NCT00442377|Plasmodium|plasmodium
1586978|NCT00442377|Malaria|malaria
1586979|NCT00442364|PFO|pfo
1586980|NCT00442364|Patent Foramen Ovale|patent foramen ovale
1586981|NCT00442364|Right-to-Left Shunt|right-to-left shunt
1586982|NCT00442364|Sclerotherapy|sclerotherapy
1586983|NCT00442312|Combigan|combigan
1586984|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
1586985|NCT00442286|Hypertension|hypertension
1586986|NCT00442286|High Blood Pressure|high blood pressure
1586987|NCT00442286|Blood Pressure|blood pressure
1586988|NCT00442286|Cardiovascular Disease|cardiovascular disease
1586989|NCT00442286|Resistant Hypertension|resistant hypertension
1586990|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
1586991|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
1586992|NCT00442260|breast cancer|breast cancer
1586993|NCT00442260|advanced breast cancer|advanced breast cancer
1586994|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
1586995|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
1586996|NCT00442234|Acute|acute
1586997|NCT00442234|pulmonary|pulmonary
1586998|NCT00442234|embolism|embolism
1586999|NCT00442234|accompanying|accompanying
1587000|NCT00442234|hemodynamic|hemodynamic
1587001|NCT00442234|instability|instability
1587002|NCT00442221|Migrane headaches|migrane headaches
1587003|NCT00442208|Healthy adults|healthy adults
1587004|NCT00442208|Phase I|phase i
1587005|NCT00442195|Tissue Procurement|tissue procurement
1587006|NCT00442195|Sample Collection|sample collection
1587007|NCT00442195|Biologic Samples|biologic samples
1587008|NCT00442195|Laboratory Research|laboratory research
1587009|NCT00442195|Healthy Volunteer|healthy volunteer
1587010|NCT00442195|HV|hv
1587011|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
1587012|NCT00442169|West Nile Disease|west nile disease
1587013|NCT00442169|Antibody response|antibody response
1587014|NCT00442169|Viremia|viremia
1587015|NCT00442169|Safety|safety
1587016|NCT00442169|Tolerability|tolerability
1587017|NCT00442169|Prevention|prevention
1587018|NCT00442156|Laser photocoagulation|laser photocoagulation
1587019|NCT00442143|CLI|cli
1587020|NCT00442143|PAOD|paod
1587021|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
1587022|NCT00442130|GM-CSF|gm-csf
1587023|NCT00442130|GM-K562|gm-k562
1587024|NCT00442130|vaccine|vaccine
1587025|NCT00442104|infantile spasms|infantile spasms
1587026|NCT00442104|anticonvulsant|anticonvulsant
1587027|NCT00442104|pediatric epilepsy|pediatric epilepsy
1587028|NCT00442104|West Syndrome|west syndrome
1587029|NCT00442104|epileptic spasms|epileptic spasms
1587030|NCT00442091|Dandelion|dandelion
1587031|NCT00442091|herbal remedy|herbal remedy
1587032|NCT00442091|hand eczema|hand eczema
1587033|NCT00442091|Compositae|compositae
1587034|NCT00442078|Incontinence|incontinence
1587035|NCT00442078|Urinary|urinary
1587036|NCT00442078|Male|male
1587037|NCT00442078|Tape|tape
1587038|NCT00442078|Transobturator|transobturator
1587039|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
1587040|NCT00442052|Gastroprotective effects|gastroprotective effects
1587041|NCT00442052|Aspirin|aspirin
1587042|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
1587043|NCT00442026|Cancer|cancer
1587044|NCT00442026|NSCLC|nsclc
1587045|NCT00442026|Elderly|elderly
1587046|NCT00442026|Chemotherapy|chemotherapy
1587047|NCT00442026|Docetaxel|docetaxel
1587048|NCT00442026|Gemcitabine|gemcitabine
1587049|NCT00442000|Prostate Cancer|prostate cancer
1587050|NCT00442000|Prostatectomy|prostatectomy
1587051|NCT00441987|Japanese|japanese
1587052|NCT00441987|Healthy|healthy
1587053|NCT00441987|Alzheimers Disease|alzheimers disease
1587054|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
1587055|NCT00441974|compensated|compensated
1587056|NCT00441974|chronic hepatitis B|chronic hepatitis b
1587057|NCT00441974|Chinese|chinese
1587058|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
1587059|NCT00441948|Hirsutism|hirsutism
1587060|NCT00441948|Hypertrichosis|hypertrichosis
1587061|NCT00441935|Urinary Retention|urinary retention
1587062|NCT00441935|Urinary Incontinence|urinary incontinence
1587063|NCT00441935|Pelvic Pain|pelvic pain
1587064|NCT00441922|Cancer|cancer
1587065|NCT00441922|Elderly|elderly
1587066|NCT00441922|Chemotherapy|chemotherapy
1587067|NCT00441922|Docetaxel|docetaxel
1587068|NCT00441922|Vinorelbine|vinorelbine
1587069|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
1587070|NCT00441909|Healthy Women|healthy women
1587071|NCT00441909|Microbicides|microbicides
1587072|NCT00441909|UC-781|uc-781
1587073|NCT00441909|Vaginal Gel|vaginal gel
1587074|NCT00441909|HIV Seronegativity|hiv seronegativity
1587075|NCT00441896|infantile spasms|infantile spasms
1587076|NCT00441896|anticonvulsant|anticonvulsant
1587077|NCT00441896|pediatric epilepsy|pediatric epilepsy
1587078|NCT00441896|West Syndrome|west syndrome
1587079|NCT00441896|epileptic spasms|epileptic spasms
1587080|NCT00441870|Cancer|cancer
1587081|NCT00441870|Phase 1|phase 1
1587082|NCT00441870|EC0225|ec0225
1587083|NCT00441870|EC20|ec20
1587084|NCT00441870|Refractory|refractory
1587085|NCT00441870|Metastatic|metastatic
1587086|NCT00441870|Experimental|experimental
1587087|NCT00441857|plant sterols|plant sterols
1587088|NCT00441857|plant stanols|plant stanols
1587089|NCT00441857|cholesterol absorption|cholesterol absorption
1587090|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
1587091|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
1587092|NCT00441831|peptic ulcer disease|peptic ulcer disease
1587093|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
1587094|NCT00441831|bile reflux|bile reflux
1587095|NCT00441831|gastritis|gastritis
1587096|NCT00441831|gastrectomy|gastrectomy
1587097|NCT00441805|Acne|acne
1587098|NCT00441805|RadioFrequency|radiofrequency
1587099|NCT00441792|Sepsis|sepsis
1587103|NCT00441779|Microchimerism|microchimerism
1587104|NCT00441779|Injuries|injuries
1587105|NCT00441779|Burns|burns
1587210|NCT00441324|Androgens|androgens
1587106|NCT00441779|Orthopedic Surgery|orthopedic surgery
1587107|NCT00441779|Leukocytes|leukocytes
1587108|NCT00441740|NSCLC|nsclc
1587109|NCT00441740|1st line treatment|1st line treatment
1587110|NCT00441740|Gemcitabine|gemcitabine
1587111|NCT00441740|Vinorelbine|vinorelbine
1587112|NCT00441740|Docetaxel|docetaxel
1587113|NCT00441727|Peptic ulcer|peptic ulcer
1587114|NCT00441727|low-dose ASA|low-dose asa
1587115|NCT00441714|cardiovascular disease|cardiovascular disease
1587116|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
1587117|NCT00441714|postconditioning|postconditioning
1587118|NCT00441714|annexin targeting|annexin targeting
1587119|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
1587120|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
1587121|NCT00441675|Adolescents|adolescents
1587122|NCT00441675|Asthma|asthma
1587123|NCT00441675|long-term follow-up|long-term follow-up
1587124|NCT00441675|symptoms|symptoms
1587125|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1587126|NCT00441662|Melanoma|melanoma
1587127|NCT00441662|Uvea|uvea
1587128|NCT00441662|Macula|macula
1587129|NCT00441662|Edema|edema
1587130|NCT00441662|Plaque radiotherapy|plaque radiotherapy
1587131|NCT00441662|Brachytherapy|brachytherapy
1587132|NCT00441662|Triamcinolone|triamcinolone
1587133|NCT00441649|ADHD|adhd
1587134|NCT00441636|depression|depression
1587135|NCT00441636|CPAP|cpap
1587136|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
1587137|NCT00441623|chronic kidney disease|chronic kidney disease
1587138|NCT00441623|cardiovascular disease|cardiovascular disease
1587139|NCT00441623|risk stratification|risk stratification
1587140|NCT00441610|Gimatecan|gimatecan
1587141|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
1587142|NCT00441610|advanced solid tumors|advanced solid tumors
1587143|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
1587144|NCT00441597|atorvastatine|atorvastatine
1587145|NCT00441597|preconditioning|preconditioning
1587146|NCT00441597|cardiovascular disease|cardiovascular disease
1587147|NCT00441571|prostate cancer|prostate cancer
1587148|NCT00441571|radiolabeled antibody|radiolabeled antibody
1587149|NCT00441532|prostate|prostate
1587150|NCT00441519|Gastroprotective effects|gastroprotective effects
1587151|NCT00441519|Aspirin|aspirin
1587152|NCT00441506|interruption|interruption
1587153|NCT00441506|critically ill|critically ill
1587154|NCT00441506|sedation|sedation
1587155|NCT00441506|pediatrics|pediatrics
1587156|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
1587157|NCT00441493|Hepatitis C|hepatitis c
1587158|NCT00441493|fluvastatin|fluvastatin
1587159|NCT00441480|Hypercholesterolemia|hypercholesterolemia
1587160|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
1587161|NCT00441480|Plant sterol|plant sterol
1587162|NCT00441480|Cholesterol|cholesterol
1587163|NCT00441480|Fish oil|fish oil
1587164|NCT00441454|stress urinary incontinence|stress urinary incontinence
1587165|NCT00441454|surgery|surgery
1587166|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
1587167|NCT00441454|retropubic|retropubic
1587168|NCT00441454|transobturator|transobturator
1587169|NCT00441454|quality-of-life|quality-of-life
1587170|NCT00441441|asthma|asthma
1587171|NCT00441441|fluticasone propionate|fluticasone propionate
1587172|NCT00441441|children|children
1587173|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
1587174|NCT00441389|Bacteria|bacteria
1587175|NCT00441389|Viruses|viruses
1587176|NCT00441389|COPD|copd
1587177|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
1587178|NCT00441376|Radiofrequency ablation|radiofrequency ablation
1587180|NCT00441376|Doxorubicin|doxorubicin
1587181|NCT00441376|Liposome|liposome
1587183|NCT00441376|MLC|mlc
1587184|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
1587185|NCT00441376|liver tumor|liver tumor
1587186|NCT00441376|tumor|tumor
1587187|NCT00441376|ablation|ablation
1587188|NCT00441376|heat therapy|heat therapy
1587189|NCT00441376|anti-tumor|anti-tumor
1587190|NCT00441376|liver cancer|liver cancer
1587191|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
1587192|NCT00441363|diabetes|diabetes
1587193|NCT00441363|diabetes mellitus|diabetes mellitus
1587194|NCT00441337|malignancies|malignancies
1587195|NCT00441337|cancer|cancer
1587196|NCT00441337|non small cell lung cancer|non small cell lung cancer
1587197|NCT00441337|lung cancer|lung cancer
1587198|NCT00441337|colorectal cancer|colorectal cancer
1587199|NCT00441337|adenocarcinoma|adenocarcinoma
1587200|NCT00441337|melanoma|melanoma
1587201|NCT00441337|malignant melanoma|malignant melanoma
1587202|NCT00441337|renal cancer|renal cancer
1587203|NCT00441337|renal carcinoma|renal carcinoma
1587204|NCT00441337|carcinoma|carcinoma
1587205|NCT00441337|prostate cancer|prostate cancer
1587206|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
1587309|NCT00440973|kidney cancer|kidney cancer
1587207|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
1587208|NCT00441324|Ovarian follicle|ovarian follicle
1587209|NCT00441324|Thecal cells|thecal cells
1587211|NCT00441324|FSH sensitivity|fsh sensitivity
1587212|NCT00441311|colorectal cancer screening|colorectal cancer screening
1587213|NCT00441311|primary care physicians|primary care physicians
1587214|NCT00441311|health disparities|health disparities
1587215|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
1587216|NCT00441298|microbicides|microbicides
1587218|NCT00441298|effectiveness|effectiveness
1587219|NCT00441298|Tenofovir gel|tenofovir gel
1587221|NCT00441298|young women|young women
1587222|NCT00441298|HIV Seronegativity|hiv seronegativity
1587223|NCT00441285|neurocysticercosis|neurocysticercosis
1587224|NCT00441285|NCC|ncc
1587225|NCT00441285|praziquantel|praziquantel
1587226|NCT00441285|PZQ|pzq
1587227|NCT00441285|albendazole|albendazole
1587228|NCT00441285|ABZ|abz
1587229|NCT00441285|parasite|parasite
1587230|NCT00441285|pig tapeworm|pig tapeworm
1587231|NCT00441285|Taenia solium|taenia solium
1587232|NCT00441285|epilepsy|epilepsy
1587233|NCT00441285|late-onset epilepsy|late-onset epilepsy
1587234|NCT00441285|acquired epilepsy|acquired epilepsy
1587235|NCT00441272|Pioglitazone|pioglitazone
1587236|NCT00441272|Hepatic Steatosis|hepatic steatosis
1587237|NCT00441272|Liver Toxicity|liver toxicity
1587238|NCT00441272|Liver Biopsy|liver biopsy
1587239|NCT00441272|HIV|hiv
1587240|NCT00441272|Treatment Experienced|treatment experienced
1587241|NCT00441272|Treatment Naive|treatment naive
1587242|NCT00441259|Japanese Encephalitis|japanese encephalitis
1587243|NCT00441246|Acute Respiratory Infection|acute respiratory infection
1587244|NCT00441246|Bronchitis|bronchitis
1587245|NCT00441246|Rhinosinusitis|rhinosinusitis
1587246|NCT00441220|Genetic polymorphisms|genetic polymorphisms
1587247|NCT00441220|Cyclophosphamide|cyclophosphamide
1587248|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
1587249|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
1587250|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
1587251|NCT00441207|IV Vitamin C|iv vitamin c
1587252|NCT00441207|Cancer|cancer
1587253|NCT00441207|Advanced Solid Tumors|advanced solid tumors
1587254|NCT00441194|Perimetry|perimetry
1587255|NCT00441194|Visual Field|visual field
1587256|NCT00441194|Octopus|octopus
1587257|NCT00441181|Neovascular glaucoma|neovascular glaucoma
1587258|NCT00441181|Travoprost|travoprost
1587259|NCT00441168|Multiple Myeloma|multiple myeloma
1587260|NCT00441168|bortezomib|bortezomib
1587261|NCT00441168|Cancer|cancer
1587262|NCT00441168|Hematology|hematology
1587263|NCT00441168|bone marrow|bone marrow
1587264|NCT00441168|immunoglobulin|immunoglobulin
1587265|NCT00441168|relapse|relapse
1587266|NCT00441168|refractory|refractory
1587267|NCT00441168|plasma cell|plasma cell
1587268|NCT00441168|Velcade|velcade
1587269|NCT00441168|adriamycin|adriamycin
1587270|NCT00441168|dexamethasone|dexamethasone
1587271|NCT00441168|vincristine|vincristine
1587272|NCT00441155|Oncology|oncology
1587273|NCT00441155|Cancer|cancer
1587274|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
1587275|NCT00441155|GIST|gist
1587276|NCT00441155|Nilotinib|nilotinib
1587277|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
1587278|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
1587279|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
1587280|NCT00441116|dutasteride|dutasteride
1587281|NCT00441116|Androgenic alopecia|androgenic alopecia
1587282|NCT00441116|phase 3|phase 3
1587283|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
1587284|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
1587285|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1587286|NCT00441090|ITP|itp
1587287|NCT00441077|Genetics|genetics
1587288|NCT00441077|Family History|family history
1587289|NCT00441077|Latino|latino
1587290|NCT00441077|Information Seeking|information seeking
1587291|NCT00441077|Lay Health Advisors|lay health advisors
1587292|NCT00441077|Cancer|cancer
1587293|NCT00441077|Heart Disease|heart disease
1587294|NCT00441077|Diabetes|diabetes
1587295|NCT00441077|Information|information
1587296|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
1587297|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
1587298|NCT00441038|Low back pain|low back pain
1587299|NCT00441038|disability|disability
1587300|NCT00441038|health education|health education
1587301|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
1587302|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
1587303|NCT00440999|P vivax|p vivax
1587304|NCT00440999|malaria|malaria
1587305|NCT00440999|ACT|act
1587306|NCT00440986|Clinical Management|clinical management
1587307|NCT00440986|Phlebotomy|phlebotomy
1587308|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
1587313|NCT00440960|bronchoscopy|bronchoscopy
1587314|NCT00440960|lidocaine|lidocaine
1587315|NCT00440960|midazolam|midazolam
1587316|NCT00440960|propofol.|propofol.
1587317|NCT00440947|NORVIR|norvir
1587318|NCT00440947|ARIES|aries
1587319|NCT00440947|EPZICOM|epzicom
1587320|NCT00440947|REYATAZ|reyataz
1587321|NCT00440947|HIV|hiv
1587322|NCT00440947|simplification|simplification
1587323|NCT00440947|Antiretroviral-naive|antiretroviral-naive
1587324|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
1587325|NCT00440934|electromagnetic fields|electromagnetic fields
1587326|NCT00440921|fibrin sealnat|fibrin sealnat
1587327|NCT00440921|knee replacement|knee replacement
1587328|NCT00440921|hip replacement|hip replacement
1587329|NCT00440921|woud healing|woud healing
1587330|NCT00440921|blood loss|blood loss
1587331|NCT00440921|clinical trial|clinical trial
1587332|NCT00440921|randomized|randomized
1587333|NCT00440908|Dialyzer reuse|dialyzer reuse
1587334|NCT00440908|Inflammatory markers|inflammatory markers
1587335|NCT00440908|Nutritional status|nutritional status
1587336|NCT00440895|Coronary artery stenting|coronary artery stenting
1587337|NCT00440895|Trans-radial|trans-radial
1587338|NCT00440895|Intracoronary|intracoronary
1587339|NCT00440895|Rescue-PCI|rescue-pci
1587340|NCT00440869|N-acetylcysteine|n-acetylcysteine
1587341|NCT00440869|oxidative stress|oxidative stress
1587342|NCT00440869|muscle fatigue|muscle fatigue
1587343|NCT00440869|end-stage renal disease|end-stage renal disease
1587344|NCT00440869|hemodialysis|hemodialysis
1587345|NCT00440856|Intervertebral disc|intervertebral disc
1587346|NCT00440856|Lumbar discectomy|lumbar discectomy
1587347|NCT00440856|Outcome|outcome
1587348|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
1587349|NCT00440843|schizophrenia|schizophrenia
1587350|NCT00440843|attention|attention
1587351|NCT00440843|task engagement|task engagement
1587352|NCT00440843|antipsychotics|antipsychotics
1587353|NCT00440843|cognition|cognition
1587354|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
1587355|NCT00440830|acute pain|acute pain
1587356|NCT00440830|nicotine|nicotine
1587357|NCT00440830|nausea|nausea
1587358|NCT00440830|sedation|sedation
1587359|NCT00440817|Lymphoma|lymphoma
1587360|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
1587361|NCT00440817|Crohn's disease|crohn's disease
1587362|NCT00440817|Remicade|remicade
1587363|NCT00440817|Infliximab|infliximab
1587364|NCT00440804|patent ductus arterious|patent ductus arterious
1587365|NCT00440791|Colon|colon
1587366|NCT00440791|colonic disease|colonic disease
1587367|NCT00440791|capsule endoscopy|capsule endoscopy
1587368|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
1587369|NCT00440778|Coronary artery stenting|coronary artery stenting
1587370|NCT00440778|Trans-radial|trans-radial
1587371|NCT00440778|Intracoronary|intracoronary
1587372|NCT00440765|Multiple Myeloma|multiple myeloma
1587373|NCT00440765|hematological Neoplasms|hematological neoplasms
1587374|NCT00440765|chemotherapy|chemotherapy
1587375|NCT00440765|efficacy|efficacy
1587376|NCT00440765|safety|safety
1587377|NCT00440765|bortezomib|bortezomib
1587378|NCT00440765|proteasome inhibitor|proteasome inhibitor
1587379|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
1587380|NCT00440752|Plasmodium falciparum|plasmodium falciparum
1587381|NCT00440752|drug resistance genes|drug resistance genes
1587382|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
1587383|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
1587384|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1587385|NCT00440726|Pediatrics|pediatrics
1587386|NCT00440726|Relapsed|relapsed
1587387|NCT00440726|Recurrence|recurrence
1587388|NCT00440726|Bortezomib|bortezomib
1587389|NCT00440726|Velcade|velcade
1587390|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
1587391|NCT00440726|Investigational|investigational
1587392|NCT00440726|Childhood|childhood
1587393|NCT00440726|ALL|all
1587394|NCT00440726|Relapsed ALL|relapsed all
1587395|NCT00440726|Refractory ALL|refractory all
1587396|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
1587397|NCT00440726|Refractory pediatric ALL|refractory pediatric all
1587398|NCT00440726|TACL|tacl
1587399|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
1587400|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
1587401|NCT00440713|Depression|depression
1587402|NCT00440713|Anxiety|anxiety
1587403|NCT00440713|Efficacy|efficacy
1587404|NCT00440700|Ventilator|ventilator
1587405|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1587406|NCT00440700|Anxiety|anxiety
1587407|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1587408|NCT00440687|primary care|primary care
1587409|NCT00440687|randomised trials|randomised trials
1587410|NCT00440687|therapeutic interventions|therapeutic interventions
1587411|NCT00440674|Direct Stenting|direct stenting
1587412|NCT00440674|Angioplasty|angioplasty
1587413|NCT00440674|Pre-dilatation|pre-dilatation
1587414|NCT00440674|Drug-eluting stent|drug-eluting stent
1587415|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
1587416|NCT00440635|Multiple myeloma|multiple myeloma
1587417|NCT00440635|bortezomib, Hematology|bortezomib, hematology
1587418|NCT00440622|Cancer|cancer
1587419|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
1587420|NCT00440622|Her-2 expression|her-2 expression
1587422|NCT00440622|Capecitabine|capecitabine
1587423|NCT00440622|Herceptin|herceptin
1587424|NCT00440583|CHOP-Z|chop-z
1587425|NCT00440570|cancer|cancer
1587426|NCT00440570|electromagnetic fields|electromagnetic fields
1587427|NCT00440570|treatment|treatment
1587428|NCT00440557|Anemia|anemia
1587429|NCT00440557|Chronic Kidney disease|chronic kidney disease
1587430|NCT00440557|Kidney disease|kidney disease
1587431|NCT00440557|Epoetin alfa|epoetin alfa
1587432|NCT00440557|Procrit|procrit
1587433|NCT00440544|Tuberculosis|tuberculosis
1587434|NCT00440544|vaccine|vaccine
1587435|NCT00440544|nasal immunization|nasal immunization
1587436|NCT00440518|Lacosamide|lacosamide
1587437|NCT00440518|migraine prophylaxis|migraine prophylaxis
1587438|NCT00440518|Vimpat|vimpat
1587439|NCT00440505|chronic pain|chronic pain
1587440|NCT00440505|pelvic pain|pelvic pain
1587441|NCT00440505|nicotine patch|nicotine patch
1587442|NCT00440479|Multiple Myeloma|multiple myeloma
1587443|NCT00440479|hematological neoplasms|hematological neoplasms
1587444|NCT00440479|chemotherapy|chemotherapy
1587445|NCT00440479|efficacy|efficacy
1587446|NCT00440479|safety|safety
1587447|NCT00440479|bortezomib|bortezomib
1587448|NCT00440479|proteasome inhibitor|proteasome inhibitor
1587449|NCT00440466|Anemia|anemia
1587450|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
1587451|NCT00440466|Hemoglobin low level|hemoglobin low level
1587452|NCT00440466|Red blood cell deficiency|red blood cell deficiency
1587453|NCT00440466|Procrit|procrit
1587454|NCT00440466|Epoetin alfa|epoetin alfa
1587455|NCT00440466|Chronic kidney disease|chronic kidney disease
1587456|NCT00440453|Internal medicine patients|internal medicine patients
1587457|NCT00440440|hypogonadism|hypogonadism
1587458|NCT00440440|diabetes|diabetes
1587459|NCT00440440|visceral fat|visceral fat
1587460|NCT00440440|hepatic fat|hepatic fat
1587461|NCT00440440|lean mass|lean mass
1587462|NCT00440427|Major Depressive Disorder|major depressive disorder
1587463|NCT00440427|MDD|mdd
1587464|NCT00440414|Cancer|cancer
1587465|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
1587466|NCT00440414|Chemotherapy|chemotherapy
1587467|NCT00440414|Pemetrexed|pemetrexed
1587468|NCT00440414|Erlotinib|erlotinib
1587469|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
1587470|NCT00440388|cancer|cancer
1587471|NCT00440388|lymphoma|lymphoma
1587472|NCT00440388|Non-Hodgkin's|non-hodgkin's
1587473|NCT00440388|Non-Hodgkins|non-hodgkins
1587474|NCT00440388|AT-101|at-101
1587475|NCT00440388|AT101|at101
1587476|NCT00440388|Rituxan|rituxan
1587477|NCT00440388|Rituximab|rituximab
1587478|NCT00440362|Influenza|influenza
1587479|NCT00440362|Flu|flu
1587480|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
1587481|NCT00440362|Alphavirus|alphavirus
1587482|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
1587483|NCT00440349|Tamoxifen|tamoxifen
1587484|NCT00440349|Corticosteroids|corticosteroids
1587485|NCT00440349|Obstructive uropathy|obstructive uropathy
1587486|NCT00440349|Periaortic fibrosis|periaortic fibrosis
1587487|NCT00440349|Chronic periaortitis|chronic periaortitis
1587488|NCT00440336|IOP|iop
1587489|NCT00440336|SLT|slt
1587490|NCT00440336|Laser|laser
1587491|NCT00440336|Cosopt|cosopt
1587492|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
1587493|NCT00440323|healthy volunteers|healthy volunteers
1587494|NCT00440323|SB-649868,|sb-649868,
1587495|NCT00440323|Zolpidem,|zolpidem,
1587496|NCT00440310|Liver neoplasms|liver neoplasms
1587497|NCT00440310|Liver metastases|liver metastases
1587498|NCT00440310|MCRC|mcrc
1587499|NCT00440310|Litx™|litx™
1587500|NCT00440310|LS11|ls11
1587501|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
1587502|NCT00440297|hepatitis B virus|hepatitis b virus
1587503|NCT00440284|conventional insulin therapy|conventional insulin therapy
1587504|NCT00440284|intensive insulin therapy|intensive insulin therapy
1587505|NCT00440284|self-management|self-management
1587506|NCT00440284|patient education|patient education
1587507|NCT00440284|RCT|rct
1587508|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
1587509|NCT00440284|hypoglycemia|hypoglycemia
1587510|NCT00440284|patient preference|patient preference
1587511|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
1587512|NCT00440219|Nasal polyps|nasal polyps
1587513|NCT00440219|Steroids|steroids
1587514|NCT00440219|Prednisone|prednisone
1587515|NCT00440219|Nasal polypectomy|nasal polypectomy
1587727|NCT00439517|Colorectal|colorectal
1587730|NCT00439491|Obesity|obesity
1587516|NCT00440219|Blood loss, surgical|blood loss, surgical
1587517|NCT00440206|HIV|hiv
1587518|NCT00440206|Immune Markers|immune markers
1587519|NCT00440180|Obesity|obesity
1587520|NCT00440180|Low sperm count|low sperm count
1587521|NCT00440180|Male infertility|male infertility
1587522|NCT00440167|capecitabine|capecitabine
1587523|NCT00440167|gemcitabine|gemcitabine
1587524|NCT00440167|Erlotinib|erlotinib
1587525|NCT00440167|pancreatic cancer|pancreatic cancer
1587526|NCT00440167|advanced|advanced
1587527|NCT00440128|Casopitant,|casopitant,
1587528|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
1587529|NCT00440128|Drug-Interaction,|drug-interaction,
1587530|NCT00440128|CYP3A|cyp3a
1587531|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
1587532|NCT00440128|GW679769,|gw679769,
1587533|NCT00440128|Docetaxel,|docetaxel,
1587534|NCT00440102|ETOMIDATE|etomidate
1587535|NCT00440102|KETAMINE|ketamine
1587536|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
1587537|NCT00440102|PREHOSPITAL|prehospital
1587538|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
1587539|NCT00440089|Cancer|cancer
1587540|NCT00440089|Fatigue|fatigue
1587541|NCT00440089|Breast Cancer|breast cancer
1587542|NCT00440089|Healing|healing
1587543|NCT00440089|Energy Healing|energy healing
1587544|NCT00440089|Complementary|complementary
1587545|NCT00440089|Alternative|alternative
1587546|NCT00440089|Immune|immune
1587547|NCT00440089|Cytokine|cytokine
1587548|NCT00440089|Hormone|hormone
1587549|NCT00440089|Cortisol|cortisol
1587550|NCT00440089|Placebo|placebo
1587551|NCT00440089|Mock Healing|mock healing
1587552|NCT00440076|MDS|mds
1587553|NCT00440076|Velcade|velcade
1587554|NCT00440050|fish oil|fish oil
1587555|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
1587556|NCT00440050|EPA|epa
1587557|NCT00440037|AMG 531|amg 531
1587558|NCT00440037|ITP|itp
1587559|NCT00440037|Long term treatment|long term treatment
1587560|NCT00440037|Japanese|japanese
1587561|NCT00440037|Romiplostim|romiplostim
1587562|NCT00440024|Sun-Damaged Skin|sun-damaged skin
1587563|NCT00440024|Retinoid Intolerance|retinoid intolerance
1587564|NCT00440024|Tazarotene Cream|tazarotene cream
1587565|NCT00440024|Dove facial cleanser|dove facial cleanser
1587566|NCT00440024|Dove moisturizer|dove moisturizer
1587567|NCT00439998|Ultrasound|ultrasound
1587568|NCT00439998|Obesity|obesity
1587569|NCT00439998|Needle Depth|needle depth
1587570|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1587571|NCT00439985|Metabolic Control|metabolic control
1587572|NCT00439985|Adherence|adherence
1587573|NCT00439985|Optimism|optimism
1587574|NCT00439985|Parent-Child Collaboration|parent-child collaboration
1587575|NCT00439985|Prevention|prevention
1587576|NCT00439972|Lipoproteins|lipoproteins
1587577|NCT00439972|Apolipoproteins|apolipoproteins
1587578|NCT00439972|Insulin sensitivity|insulin sensitivity
1587579|NCT00439972|Inflammation|inflammation
1587580|NCT00439972|Clotting|clotting
1587581|NCT00439972|Antioxidant status|antioxidant status
1587582|NCT00439972|Vascular reactivity|vascular reactivity
1587583|NCT00439972|Metabolism|metabolism
1587584|NCT00439959|GSK625433,|gsk625433,
1587585|NCT00439959|Hepatitis C,|hepatitis c,
1587586|NCT00439959|metabolic probe,|metabolic probe,
1587587|NCT00439959|food-effect,|food-effect,
1587588|NCT00439959|HCV,|hcv,
1587589|NCT00439959|FTIH|ftih
1587590|NCT00439959|polymerase,|polymerase,
1587591|NCT00439946|pulmonary hypertension|pulmonary hypertension
1587592|NCT00439946|PAH|pah
1587593|NCT00439946|Remodulin|remodulin
1587594|NCT00439946|treprostinil|treprostinil
1587595|NCT00439946|Quality of Life|quality of life
1587596|NCT00439946|rapid switch|rapid switch
1587597|NCT00439933|Obesity|obesity
1587598|NCT00439933|Children|children
1587599|NCT00439933|Weight loss|weight loss
1587600|NCT00439933|Endothelial dysfunction|endothelial dysfunction
1587601|NCT00439933|Intervention|intervention
1587602|NCT00439920|ALL|all
1587603|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
1587604|NCT00439907|Primary repair|primary repair
1587605|NCT00439907|End-to-end repair|end-to-end repair
1587606|NCT00439907|Over-lap repair|over-lap repair
1587607|NCT00439907|Anal manometry|anal manometry
1587608|NCT00439907|Anal sonography|anal sonography
1587609|NCT00439907|Weksner Score|weksner score
1587610|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
1587611|NCT00439907|Anal sphincter|anal sphincter
1587612|NCT00439907|Anal sphincter rupture|anal sphincter rupture
1587613|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
1587614|NCT00439894|etanercept|etanercept
1587615|NCT00439894|Enbrel|enbrel
1587616|NCT00439894|Amgen|amgen
1587617|NCT00439881|inflammation,|inflammation,
1587618|NCT00439881|intravenous,|intravenous,
1587619|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
1587620|NCT00439881|P38 inhibitor|p38 inhibitor
1587621|NCT00439881|SB-681323,|sb-681323,
1587622|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
1587728|NCT00439517|Metastatic|metastatic
1587623|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
1587624|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
1587625|NCT00439829|follicle|follicle
1587626|NCT00439829|ovary|ovary
1587627|NCT00439829|poor responder|poor responder
1587628|NCT00439829|stimulation|stimulation
1587629|NCT00439829|follicle wave emergence|follicle wave emergence
1587630|NCT00439816|Hypertension Outcomes|hypertension outcomes
1587631|NCT00439816|Health Outcomes|health outcomes
1587632|NCT00439816|Outpatient|outpatient
1587633|NCT00439816|Racial Preference|racial preference
1587634|NCT00439816|Blood Pressure Control|blood pressure control
1587635|NCT00439816|Clinical Trial|clinical trial
1587636|NCT00439816|Intervention|intervention
1587637|NCT00439816|Lifestyle modifications|lifestyle modifications
1587638|NCT00439816|Ethnic Differences|ethnic differences
1587639|NCT00439816|Randomized|randomized
1587641|NCT00439803|cytomegalovirus|cytomegalovirus
1587642|NCT00439803|Alphavirus|alphavirus
1587643|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1587644|NCT00439790|Heart failure|heart failure
1587645|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
1587646|NCT00439790|appropriate shock|appropriate shock
1587647|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
1587648|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
1587649|NCT00439751|Prostate Cancer|prostate cancer
1587650|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
1587651|NCT00439751|Recurrence|recurrence
1587652|NCT00439751|Biochemical Failure|biochemical failure
1587653|NCT00439751|Goserelin|goserelin
1587654|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
1587655|NCT00439699|Essential Tremor|essential tremor
1587656|NCT00439699|Memantine|memantine
1587657|NCT00439699|Clinical Trial|clinical trial
1587658|NCT00439673|MDS|mds
1587659|NCT00439673|5-Azacytidine|5-azacytidine
1587660|NCT00439673|valproic acid|valproic acid
1587661|NCT00439673|atra|atra
1587662|NCT00439673|intermediate or high risk|intermediate or high risk
1587663|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
1587664|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
1587665|NCT00439647|Osteoporosis|osteoporosis
1587666|NCT00439647|males|males
1587667|NCT00439647|vertebral fractures|vertebral fractures
1587668|NCT00439647|clinical fractures|clinical fractures
1587669|NCT00439647|bone mineral density|bone mineral density
1587670|NCT00439647|bone biomarkers|bone biomarkers
1587671|NCT00439647|zoledronic acid|zoledronic acid
1587672|NCT00439634|psychometrics|psychometrics
1587673|NCT00439634|schizophrenia|schizophrenia
1587674|NCT00439621|immunotherapy|immunotherapy
1587675|NCT00439621|allergy|allergy
1587676|NCT00439608|esophageal cancer|esophageal cancer
1587677|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
1587678|NCT00439608|gastric cancer|gastric cancer
1587679|NCT00439595|Anaemia|anaemia
1587680|NCT00439595|Diagnosis|diagnosis
1587681|NCT00439595|Primary|primary
1587682|NCT00439595|Care|care
1587683|NCT00439595|Treatment|treatment
1587684|NCT00439582|Lipoproteins|lipoproteins
1587685|NCT00439582|Milk fat|milk fat
1587686|NCT00439582|Public health nutrition|public health nutrition
1587687|NCT00439582|trans fatty acid|trans fatty acid
1587688|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
1587689|NCT00439569|SMA type II/III|sma type ii/iii
1587690|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
1587691|NCT00439569|SMA|sma
1587692|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
1587693|NCT00439569|motor neuron disease|motor neuron disease
1587694|NCT00439569|neuromuscular|neuromuscular
1587695|NCT00439569|survival motor neuron|survival motor neuron
1587696|NCT00439569|SMN|smn
1587697|NCT00439569|dose escalation|dose escalation
1587698|NCT00439556|Lymphoma|lymphoma
1587699|NCT00439556|Bortezomib|bortezomib
1587700|NCT00439556|Velcade|velcade
1587701|NCT00439556|LDP-341|ldp-341
1587702|NCT00439556|MLN341|mln341
1587703|NCT00439556|PS-341|ps-341
1587704|NCT00439556|Carmustine|carmustine
1587705|NCT00439556|Cytarabine|cytarabine
1587706|NCT00439556|Etoposide|etoposide
1587707|NCT00439556|Melphalan|melphalan
1587708|NCT00439556|Rituximab|rituximab
1587709|NCT00439556|BEAM|beam
1587710|NCT00439556|BCNU|bcnu
1587711|NCT00439556|BiCNU®|bicnu®
1587712|NCT00439556|ARA-C|ara-c
1587713|NCT00439556|Cytosar|cytosar
1587714|NCT00439556|DepoCyt®|depocyt®
1587715|NCT00439556|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1587716|NCT00439556|VePesid®|vepesid®
1587717|NCT00439556|Rituxan|rituxan
1587718|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
1587719|NCT00439543|pulmonary hypertension|pulmonary hypertension
1587720|NCT00439543|Iloprost|iloprost
1587721|NCT00439543|Efficacy|efficacy
1587722|NCT00439530|oseltamivir|oseltamivir
1587723|NCT00439530|pharmacokinetics|pharmacokinetics
1587724|NCT00439530|probenecid|probenecid
1587725|NCT00439530|avian influenza|avian influenza
1587726|NCT00439517|Cancer|cancer
1587729|NCT00439517|Untreated|untreated
1587731|NCT00439491|Insulin resistance|insulin resistance
1587732|NCT00439491|Hypocaloric diet|hypocaloric diet
1587733|NCT00439491|Adipose tissue|adipose tissue
1587734|NCT00439491|adipocytokine|adipocytokine
1587735|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
1587738|NCT00439387|Healthy Volunteer|healthy volunteer
1587740|NCT00439374|nulliparous|nulliparous
1587741|NCT00439374|pregnancy|pregnancy
1587742|NCT00439374|short cervix|short cervix
1587743|NCT00439374|progesterone|progesterone
1587744|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
1587745|NCT00439361|HL|hl
1587746|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
1587747|NCT00439361|Refractory|refractory
1587748|NCT00439361|Lymphoma|lymphoma
1587749|NCT00439361|Nodular sclerosis|nodular sclerosis
1587750|NCT00439361|Mixed cellularity|mixed cellularity
1587751|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
1587752|NCT00439361|Bortezomib|bortezomib
1587753|NCT00439361|Velcade|velcade
1587754|NCT00439361|LDP-341|ldp-341
1587755|NCT00439361|MLN341|mln341
1587756|NCT00439361|PS-341|ps-341
1587757|NCT00439361|Carboplatin|carboplatin
1587758|NCT00439361|Paraplatin|paraplatin
1587759|NCT00439361|Etoposide|etoposide
1587760|NCT00439361|VePesid®|vepesid®
1587761|NCT00439361|Ifosfamide|ifosfamide
1587762|NCT00439361|Mesna|mesna
1587763|NCT00439361|Mesnex|mesnex
1587764|NCT00439361|ICE|ice
1587765|NCT00439348|Calcium|calcium
1587766|NCT00439348|Compliance|compliance
1587767|NCT00439348|Medication compliance|medication compliance
1587768|NCT00439348|electronic prescription|electronic prescription
1587769|NCT00439348|over-the-counter medications|over-the-counter medications
1587770|NCT00439348|OTC medications|otc medications
1587771|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
1587772|NCT00439322|PTSD|ptsd
1587773|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1587774|NCT00439296|Pediatrics|pediatrics
1587775|NCT00439296|Relapsed|relapsed
1587776|NCT00439296|Recurrence|recurrence
1587777|NCT00439296|ABT-751|abt-751
1587778|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
1587779|NCT00439296|Investigational|investigational
1587780|NCT00439296|Childhood|childhood
1587781|NCT00439296|ALL|all
1587782|NCT00439296|Relapsed ALL|relapsed all
1587783|NCT00439296|Refractory ALL|refractory all
1587784|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
1587785|NCT00439296|Refractory pediatric ALL|refractory pediatric all
1587786|NCT00439296|TACL|tacl
1587787|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
1587788|NCT00439283|infliximab|infliximab
1587789|NCT00439283|Systematic regimen|systematic regimen
1587790|NCT00439283|On-demand regimen|on-demand regimen
1587791|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
1587792|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
1587793|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
1587794|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
1587795|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
1587796|NCT00439244|teriparatide|teriparatide
1587797|NCT00439244|zoledronic acid|zoledronic acid
1587798|NCT00439244|Osteoporosis|osteoporosis
1587799|NCT00439244|postmenopausal women|postmenopausal women
1587800|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
1587801|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
1587802|NCT00439231|CLL|cll
1587803|NCT00439231|SLL|sll
1587804|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
1587805|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1587806|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
1587807|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
1587808|NCT00439218|SMA type I|sma type i
1587809|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
1587810|NCT00439218|SMA|sma
1587811|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
1587812|NCT00439218|motor neuron disease|motor neuron disease
1587813|NCT00439218|neuromuscular|neuromuscular
1587814|NCT00439218|survival motor neuron|survival motor neuron
1587815|NCT00439218|SMN|smn
1587816|NCT00439218|dose escalation|dose escalation
1587817|NCT00439205|Oral Tumors|oral tumors
1587818|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
1587819|NCT00439205|Oral Spectroscopy|oral spectroscopy
1587820|NCT00439205|Optical Spectroscopy|optical spectroscopy
1587821|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
1587822|NCT00439205|FastEEM4 System|fasteem4 system
1587823|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
1587824|NCT00439205|MDM|mdm
1587825|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
1587826|NCT00439192|OAB, proof of concept|oab, proof of concept
1587827|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
1587828|NCT00439192|with incontinence|with incontinence
1587829|NCT00439179|Pancreatic Cancer|pancreatic cancer
1587830|NCT00439166|doxycycline|doxycycline
1587831|NCT00439166|rifampicin|rifampicin
1587832|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
1587833|NCT00439166|biomarkers|biomarkers
1587834|NCT00439166|beta amyloid|beta amyloid
1587835|NCT00439166|tau|tau
1587836|NCT00439127|thyroglobulin|thyroglobulin
1587837|NCT00439127|thyroid carcinoma|thyroid carcinoma
1587838|NCT00439127|tumour marker|tumour marker
1587840|NCT00439127|recombinant human TSH|recombinant human tsh
1587841|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
1587842|NCT00439101|weight loss|weight loss
1587843|NCT00439101|malignancy|malignancy
1587844|NCT00439101|corticosteroids|corticosteroids
1587845|NCT00439101|supplemental feeding|supplemental feeding
1587846|NCT00439101|adrenal insufficiency|adrenal insufficiency
1587847|NCT00439101|diabetes|diabetes
1587848|NCT00439088|Ambulation|ambulation
1587849|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
1587850|NCT00439088|Activities of Daily Living|activities of daily living
1587851|NCT00439088|Pedometer|pedometer
1587852|NCT00439088|Validation Studies [PT]|validation studies [pt]
1587853|NCT00439075|pulmonary disease|pulmonary disease
1587854|NCT00439075|CPO|cpo
1587855|NCT00439075|CPAP|cpap
1587856|NCT00439075|oxygenation|oxygenation
1587857|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
1587858|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
1587859|NCT00439049|Substance Abuse|substance abuse
1587860|NCT00439049|Treatment|treatment
1587861|NCT00439049|Eligibility|eligibility
1587862|NCT00439036|Opiate|opiate
1587863|NCT00439036|Behavior Therapy|behavior therapy
1587864|NCT00439036|Methadone|methadone
1587865|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
1587866|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
1587867|NCT00439010|neurological|neurological
1587868|NCT00439010|alzheimer|alzheimer
1587869|NCT00438971|Panic Disorder|panic disorder
1587870|NCT00438971|Anxiety Disorder|anxiety disorder
1587871|NCT00438971|Duloxetine|duloxetine
1587872|NCT00438958|graft versus host disease|graft versus host disease
1587873|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1587874|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1587875|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1587876|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1587877|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1587878|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1587879|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1587880|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1587881|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1587882|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
1587883|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1587884|NCT00438958|refractory anemia|refractory anemia
1587885|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1587886|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1587887|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1587888|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1587889|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1587890|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1587891|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1587892|NCT00438958|primary myelofibrosis|primary myelofibrosis
1587893|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
1587894|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1587895|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1587896|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1587897|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1587898|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1587899|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1587900|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1587901|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1587902|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1587903|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1587904|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1587905|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1587906|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1587907|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1587908|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1587909|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1587910|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1587911|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1587912|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1587913|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1588292|NCT00437528|Sensor|sensor
1587914|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1587915|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1587916|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1587917|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1587918|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1587919|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1587920|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1587921|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1587922|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1587923|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1587924|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1587925|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1587926|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1587927|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1587928|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1587929|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1587930|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1587931|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1587932|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1587933|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1587934|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1587935|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1587936|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1587937|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1587938|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
1587939|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1587940|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1587941|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
1587942|NCT00438906|pancreatic lesions|pancreatic lesions
1587943|NCT00438906|pancreatic cancer|pancreatic cancer
1587944|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
1587945|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
1587946|NCT00438906|FAMMM/p16|fammm/p16
1587947|NCT00438906|Genes, BRCA2|genes, brca2
1587948|NCT00438893|Viscous dietary fiber|viscous dietary fiber
1587949|NCT00438893|Soy protein|soy protein
1587950|NCT00438893|Nuts|nuts
1587951|NCT00438893|Plant sterols|plant sterols
1587952|NCT00438893|Dietary Portfolio|dietary portfolio
1587953|NCT00438893|Compliance|compliance
1587954|NCT00438893|Blood lipids|blood lipids
1587955|NCT00438893|Blood pressure|blood pressure
1587956|NCT00438867|angina|angina
1587957|NCT00438867|FGF-4|fgf-4
1587958|NCT00438867|angiogenesis|angiogenesis
1587959|NCT00438867|growth factor|growth factor
1587960|NCT00438867|myocardia ischemia|myocardia ischemia
1587961|NCT00438867|revascularization|revascularization
1587962|NCT00438854|dasatinib|dasatinib
1587963|NCT00438854|BMS-354825|bms-354825
1587964|NCT00438854|CLL|cll
1587965|NCT00438854|SLL|sll
1587966|NCT00438854|LYN kinase|lyn kinase
1587967|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
1587968|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
1587969|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
1587970|NCT00438828|radiation therapy|radiation therapy
1587971|NCT00438828|palliative|palliative
1587972|NCT00438828|pain|pain
1587973|NCT00438815|Hereditary angioedema|hereditary angioedema
1587974|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
1587975|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1587976|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1587977|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1587978|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1587979|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1587980|NCT00438763|CMC arthritis|cmc arthritis
1587981|NCT00438763|splint treatment|splint treatment
1587982|NCT00438763|patient satisfaction|patient satisfaction
1587983|NCT00438763|DASH questionnaire|dash questionnaire
1587984|NCT00438750|distal radius fracture|distal radius fracture
1587985|NCT00438750|rehabilitation|rehabilitation
1587986|NCT00438750|volar plate fixation|volar plate fixation
1587987|NCT00438750|DASH questionnaire|dash questionnaire
1587988|NCT00438737|liver metastases|liver metastases
1587989|NCT00438737|stage IV colon cancer|stage iv colon cancer
1587990|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
1587991|NCT00438737|recurrent colon cancer|recurrent colon cancer
1587992|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
1587993|NCT00438724|Caregivers|caregivers
1587994|NCT00438724|Caregiving|caregiving
1587995|NCT00438724|Spousal relationships|spousal relationships
1587996|NCT00438724|cognition disorders|cognition disorders
1587997|NCT00438724|therapy|therapy
1587998|NCT00438724|mental health|mental health
1587999|NCT00438724|psychosocial|psychosocial
1588000|NCT00438698|Nutrition|nutrition
1588001|NCT00438698|Type 2 Diabetes|type 2 diabetes
1588002|NCT00438685|Substance-Related Disorders|substance-related disorders
1588003|NCT00438685|Depressive Disorder|depressive disorder
1588004|NCT00438685|Anxiety Disorder|anxiety disorder
1588005|NCT00438685|Adolescent|adolescent
1588006|NCT00438685|Behavior Therapy|behavior therapy
1588007|NCT00438685|Cognitive Therapy|cognitive therapy
1588008|NCT00438685|Outpatients|outpatients
1588009|NCT00438685|Family Relations|family relations
1588010|NCT00438685|Systems Theory|systems theory
1588011|NCT00438672|lateral elbow pain|lateral elbow pain
1588012|NCT00438672|tennis elbow|tennis elbow
1588013|NCT00438672|pain|pain
1588014|NCT00438672|psychology|psychology
1588015|NCT00438659|dermatologic complications|dermatologic complications
1588016|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
1588017|NCT00438659|radiation toxicity|radiation toxicity
1588018|NCT00438659|breast cancer in situ|breast cancer in situ
1588019|NCT00438659|recurrent breast cancer|recurrent breast cancer
1588020|NCT00438659|stage I breast cancer|stage i breast cancer
1588021|NCT00438659|stage II breast cancer|stage ii breast cancer
1588022|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
1588023|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
1588024|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
1588025|NCT00438659|male breast cancer|male breast cancer
1588026|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1588027|NCT00438659|stage IV breast cancer|stage iv breast cancer
1588028|NCT00438646|Allergy|allergy
1588029|NCT00438646|Asthma|asthma
1588030|NCT00438646|Eczema|eczema
1588031|NCT00438646|Hay Fever|hay fever
1588032|NCT00438646|Epidemiology|epidemiology
1588033|NCT00438633|proximal humerus fracture|proximal humerus fracture
1588034|NCT00438633|rehabilitation|rehabilitation
1588035|NCT00438633|non-operative treatment|non-operative treatment
1588036|NCT00438633|DASH and Constant instruments|dash and constant instruments
1588037|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
1588038|NCT00438594|nurse|nurse
1588039|NCT00438594|paraprofessional|paraprofessional
1588040|NCT00438594|home visits|home visits
1588041|NCT00438594|pregnancy|pregnancy
1588042|NCT00438594|welfare|welfare
1588043|NCT00438594|child development|child development
1588044|NCT00438581|Zevalin|zevalin
1588045|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
1588046|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1588047|NCT00438568|amyloid protein|amyloid protein
1588048|NCT00438568|brain metabolism|brain metabolism
1588049|NCT00438568|glucose metabolism|glucose metabolism
1588050|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
1588051|NCT00438568|cognition disorders|cognition disorders
1588052|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
1588053|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
1588054|NCT00438516|home visits|home visits
1588055|NCT00438516|pregnancy|pregnancy
1588056|NCT00438516|welfare|welfare
1588057|NCT00438516|child development|child development
1588058|NCT00438516|mortality|mortality
1588059|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
1588060|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
1588061|NCT00438490|galactorrhea|galactorrhea
1588062|NCT00438490|prolactin|prolactin
1588063|NCT00438490|bone turnover|bone turnover
1588064|NCT00438490|menstrual cycle|menstrual cycle
1588065|NCT00438490|Control Groups|control groups
1588066|NCT00438490|Women|women
1588067|NCT00438477|recurrent breast cancer|recurrent breast cancer
1588068|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
1588069|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
1588070|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
1588071|NCT00438477|stage II breast cancer|stage ii breast cancer
1588072|NCT00438451|elderly|elderly
1588073|NCT00438451|focal epilepsy|focal epilepsy
1588074|NCT00438451|anticonvulsive|anticonvulsive
1588075|NCT00438451|treatment|treatment
1588076|NCT00438451|levetiracetam|levetiracetam
1588077|NCT00438451|lamotrigine|lamotrigine
1588078|NCT00438451|carbamazepine|carbamazepine
1588079|NCT00438438|forced desynchrony|forced desynchrony
1588080|NCT00438438|circadian rhythms|circadian rhythms
1588081|NCT00438438|sleep restriction|sleep restriction
1588082|NCT00438438|sleep homeostasis|sleep homeostasis
1588083|NCT00438438|neurobehavioral performance|neurobehavioral performance
1588084|NCT00438425|Hyperlipidemia|hyperlipidemia
1588085|NCT00438425|Hypercholesterolemia|hypercholesterolemia
1588086|NCT00438425|Dietary modification|dietary modification
1588087|NCT00438425|Portfolio|portfolio
1588088|NCT00438412|Noradrenalin|noradrenalin
1588089|NCT00438412|Endothelin-1|endothelin-1
1588090|NCT00438412|Angiotensin II|angiotensin ii
1588091|NCT00438412|Arginine vasopressin|arginine vasopressin
1588092|NCT00438412|Aldosterone|aldosterone
1588093|NCT00438412|Renin|renin
1588094|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
1588397|NCT00436995|Dialysis|dialysis
1588095|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
1588096|NCT00438412|Blood pressure|blood pressure
1588097|NCT00438412|Apnea|apnea
1588098|NCT00438399|1 Galderma,|1 galderma,
1588099|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
1588100|NCT00438399|3 Subject preference|3 subject preference
1588101|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
1588102|NCT00438399|5 Shampoo|5 shampoo
1588103|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
1588104|NCT00438386|Panic Disorder|panic disorder
1588105|NCT00438386|Anxiety Disorder|anxiety disorder
1588106|NCT00438386|Aripiprazole|aripiprazole
1588107|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
1588108|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
1588109|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
1588110|NCT00438347|cognition disorders|cognition disorders
1588111|NCT00438347|brain health|brain health
1588112|NCT00438347|psychological aspect of aging|psychological aspect of aging
1588113|NCT00438347|exercise|exercise
1588114|NCT00438347|physical fitness|physical fitness
1588115|NCT00438334|Benefit|benefit
1588116|NCT00438334|Directional microphones|directional microphones
1588117|NCT00438334|Hearing|hearing
1588118|NCT00438334|Hearing aids|hearing aids
1588119|NCT00438334|Hearing loss|hearing loss
1588120|NCT00438334|Noise|noise
1588121|NCT00438334|Objective benefit|objective benefit
1588122|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
1588123|NCT00438334|Speech understanding|speech understanding
1588124|NCT00438334|Subjective benefit|subjective benefit
1588125|NCT00438321|Overweight|overweight
1588126|NCT00438321|obesity|obesity
1588127|NCT00438321|testosterone|testosterone
1588128|NCT00438321|diabetes|diabetes
1588129|NCT00438321|metabolic syndrome|metabolic syndrome
1588130|NCT00438321|aging|aging
1588131|NCT00438308|distal radius fracture|distal radius fracture
1588132|NCT00438308|rehabilitation|rehabilitation
1588133|NCT00438308|volar plate fixation|volar plate fixation
1588134|NCT00438308|DASH questionnaire|dash questionnaire
1588135|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
1588136|NCT00438282|nurse|nurse
1588137|NCT00438282|home visits|home visits
1588138|NCT00438282|pregnancy|pregnancy
1588139|NCT00438282|welfare|welfare
1588140|NCT00438282|child development|child development
1588141|NCT00438269|Infection|infection
1588142|NCT00438269|Empiric|empiric
1588143|NCT00438269|Antibiotics|antibiotics
1588144|NCT00438269|Nosocomial|nosocomial
1588145|NCT00438269|Pyrexia|pyrexia
1588146|NCT00438269|Leukocytosis|leukocytosis
1588147|NCT00438269|Resistance|resistance
1588148|NCT00438256|accelerated short course|accelerated short course
1588149|NCT00438256|proton beam radiation|proton beam radiation
1588150|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
1588151|NCT00438230|Residual vein thrombosis|residual vein thrombosis
1588152|NCT00438230|Optimal duration|optimal duration
1588153|NCT00438230|Oral anticoagulants|oral anticoagulants
1588154|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
1588155|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1588156|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1588157|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
1588158|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1588159|NCT00438204|large cell lung cancer|large cell lung cancer
1588160|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1588161|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
1588162|NCT00438191|splinting|splinting
1588163|NCT00438191|grip strength|grip strength
1588164|NCT00438191|satisfaction|satisfaction
1588165|NCT00438191|DASH questionnaire|dash questionnaire
1588166|NCT00438165|nurse|nurse
1588167|NCT00438165|home visits|home visits
1588168|NCT00438165|pregnancy|pregnancy
1588169|NCT00438165|welfare|welfare
1588170|NCT00438165|child development|child development
1588171|NCT00438152|Lopinavir|lopinavir
1588172|NCT00438152|Saquinavir|saquinavir
1588173|NCT00438152|Lipids|lipids
1588174|NCT00438152|HIV-1|hiv-1
1588175|NCT00438152|Treatment Experienced|treatment experienced
1588176|NCT00438139|marijuana dependence|marijuana dependence
1588177|NCT00438126|diabetes|diabetes
1588178|NCT00438126|Prevention|prevention
1588179|NCT00438126|American Indian|american indian
1588180|NCT00438113|blood pressure|blood pressure
1588181|NCT00438113|atrial fibrillation|atrial fibrillation
1588182|NCT00438113|catheter ablation|catheter ablation
1588183|NCT00438100|Breast Neoplasms|breast neoplasms
1588184|NCT00438100|Drug Therapy|drug therapy
1588185|NCT00438087|Facial palsy|facial palsy
1588186|NCT00438087|Vestibular schwannoma|vestibular schwannoma
1588187|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
1588188|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
1588189|NCT00438087|or of cranial base tumors|or of cranial base tumors
1588190|NCT00438074|Breast Cancer|breast cancer
1588191|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
1588192|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
1588193|NCT00438061|Cardiovascular disease|cardiovascular disease
1588194|NCT00438061|Obesity|obesity
1588195|NCT00438048|Pilocarpine|pilocarpine
1588196|NCT00438048|Artificial saliva|artificial saliva
1588197|NCT00438048|Xerostomia|xerostomia
1588198|NCT00438048|Xerostomy|xerostomy
1588199|NCT00438048|Primary Sjogren|primary sjogren
1588200|NCT00438048|Secondary Sjogren|secondary sjogren
1588201|NCT00438035|Postoperative pain|postoperative pain
1588328|NCT00437359|Breast Neoplasms|breast neoplasms
1588202|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
1588203|NCT00438035|Visual analog pain scale|visual analog pain scale
1588204|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
1588205|NCT00438022|Atopic Dermatitis|atopic dermatitis
1588206|NCT00438022|Eczema Herpeticum|eczema herpeticum
1588207|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
1588208|NCT00438009|oncolytic virus|oncolytic virus
1588209|NCT00438009|melanoma|melanoma
1588210|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
1588211|NCT00437957|histone deacetylase|histone deacetylase
1588212|NCT00437957|unresectable brain metastases|unresectable brain metastases
1588213|NCT00437931|hypothyroidism|hypothyroidism
1588214|NCT00437931|hyperthyroidism|hyperthyroidism
1588215|NCT00437931|thyroid dysfunction|thyroid dysfunction
1588216|NCT00437931|ultrasound|ultrasound
1588217|NCT00437931|doppler|doppler
1588218|NCT00437905|peripheral vascular disease|peripheral vascular disease
1588219|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
1588220|NCT00437905|cutting balloon|cutting balloon
1588221|NCT00437905|balloon angioplasty|balloon angioplasty
1588222|NCT00437905|randomized controlled trial|randomized controlled trial
1588223|NCT00437905|restenosis|restenosis
1588224|NCT00437905|inflammation|inflammation
1588225|NCT00437892|Statins|statins
1588226|NCT00437892|secondary prevention|secondary prevention
1588227|NCT00437892|venous thromboembolism|venous thromboembolism
1588228|NCT00437892|d-dimer|d-dimer
1588229|NCT00437879|Breast Cancer|breast cancer
1588230|NCT00437879|Ultrasound|ultrasound
1588231|NCT00437840|healthy volunteers,|healthy volunteers,
1588232|NCT00437840|tolerability,|tolerability,
1588233|NCT00437840|pharmacokinetics,|pharmacokinetics,
1588234|NCT00437840|pharmacodynamics|pharmacodynamics
1588235|NCT00437840|safety,|safety,
1588236|NCT00437840|smoking,|smoking,
1588237|NCT00437827|Depression|depression
1588238|NCT00437814|Ketamine|ketamine
1588239|NCT00437814|Traumatic Brain Injury|traumatic brain injury
1588240|NCT00437814|Intracranial Hypertension|intracranial hypertension
1588241|NCT00437788|imaging|imaging
1588242|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
1588243|NCT00437775|ACE Inhibitors|ace inhibitors
1588244|NCT00437775|ARBs|arbs
1588245|NCT00437775|Adverse drug effect|adverse drug effect
1588246|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
1588247|NCT00437749|Non small cell lung cancer|non small cell lung cancer
1588248|NCT00437749|Advanced|advanced
1588249|NCT00437749|Inoperable|inoperable
1588250|NCT00437749|taxanes|taxanes
1588251|NCT00437749|carboplatin|carboplatin
1588252|NCT00437749|multi-drug resistance|multi-drug resistance
1588253|NCT00437736|solid tumor|solid tumor
1588254|NCT00437736|phase I study|phase i study
1588255|NCT00437736|dose-escalation|dose-escalation
1588256|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
1588257|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
1588258|NCT00437684|HIV/HCV|hiv/hcv
1588259|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
1588260|NCT00437684|Treatment Experienced|treatment experienced
1588261|NCT00437671|trismus|trismus
1588262|NCT00437671|lockjaw|lockjaw
1588263|NCT00437645|Essential hypertension|essential hypertension
1588264|NCT00437645|blood pressure|blood pressure
1588265|NCT00437645|edema|edema
1588266|NCT00437645|valsartan|valsartan
1588267|NCT00437645|amlodipine|amlodipine
1588268|NCT00437645|combination treatment|combination treatment
1588269|NCT00437632|repeat dose,|repeat dose,
1588270|NCT00437632|placebo,|placebo,
1588271|NCT00437632|Safety,|safety,
1588272|NCT00437632|pharmacodynamics,|pharmacodynamics,
1588273|NCT00437632|tolerability,|tolerability,
1588274|NCT00437632|GSK598809|gsk598809
1588275|NCT00437632|pharmacokinetics,|pharmacokinetics,
1588276|NCT00437593|preretinal membrane|preretinal membrane
1588277|NCT00437593|vitrectomy|vitrectomy
1588278|NCT00437593|uhr-oct|uhr-oct
1588279|NCT00437593|hd-oct|hd-oct
1588280|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
1588281|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
1588282|NCT00437567|prebiotics|prebiotics
1588283|NCT00437567|NEC|nec
1588284|NCT00437541|Insulation|insulation
1588285|NCT00437541|Warmth|warmth
1588286|NCT00437541|Humidity|humidity
1588287|NCT00437541|Damp|damp
1588288|NCT00437541|Cold|cold
1588289|NCT00437541|Respiratory|respiratory
1588290|NCT00437541|Mould|mould
1588291|NCT00437528|Heat flow|heat flow
1588293|NCT00437528|Overactive bladder|overactive bladder
1588294|NCT00437528|Urinary incontinence|urinary incontinence
1588295|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
1588296|NCT00437502|Ovarian cancer|ovarian cancer
1588297|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
1588298|NCT00437502|tubal cancer|tubal cancer
1588299|NCT00437502|peritoneal cancer|peritoneal cancer
1588300|NCT00437502|immunotherapy|immunotherapy
1588301|NCT00437476|HIV/HCV|hiv/hcv
1588302|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
1588303|NCT00437476|Treatment Naive|treatment naive
1588304|NCT00437450|Anemia|anemia
1588305|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
1588306|NCT00437450|Low risk|low risk
1588307|NCT00437450|Bone Marrow diseases|bone marrow diseases
1588308|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
1588309|NCT00437424|Hepatocellular cancer|hepatocellular cancer
1588310|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
1588311|NCT00437411|Fibromyalgia|fibromyalgia
1588312|NCT00437411|Affect|affect
1588313|NCT00437411|Pain|pain
1588314|NCT00437411|Fatigue|fatigue
1588315|NCT00437411|Sleep|sleep
1588316|NCT00437411|Stress|stress
1588317|NCT00437411|Quality of Life|quality of life
1588318|NCT00437411|Stress, Psychological|stress, psychological
1588319|NCT00437411|Psychophysiology|psychophysiology
1588320|NCT00437411|Randomized Controlled Trials|randomized controlled trials
1588321|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
1588322|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
1588323|NCT00437372|solid tumor|solid tumor
1588324|NCT00437372|central nervous system|central nervous system
1588325|NCT00437372|head and neck|head and neck
1588326|NCT00437372|thorax|thorax
1588327|NCT00437372|pelvic area|pelvic area
1588329|NCT00437359|Drug Therapy|drug therapy
1588330|NCT00437346|dyspepsia|dyspepsia
1588331|NCT00437346|functional dyspepsia|functional dyspepsia
1588332|NCT00437346|treatment|treatment
1588333|NCT00437346|drug therapy|drug therapy
1588334|NCT00437346|information|information
1588335|NCT00437333|Insulin sensitivity|insulin sensitivity
1588336|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
1588337|NCT00437333|Metformin|metformin
1588338|NCT00437333|PCOS|pcos
1588339|NCT00437333|Treatment|treatment
1588340|NCT00437320|PDT|pdt
1588341|NCT00437320|Photoaging|photoaging
1588342|NCT00437320|Galderma|galderma
1588343|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
1588344|NCT00437242|interval,|interval,
1588345|NCT00437242|atrial fibrillation|atrial fibrillation
1588346|NCT00437242|QT,|qt,
1588347|NCT00437242|odiparcil,|odiparcil,
1588348|NCT00437229|GW679769,|gw679769,
1588349|NCT00437229|Casopitant,|casopitant,
1588350|NCT00437229|Dexamethasone,|dexamethasone,
1588351|NCT00437229|Healthy Human Volunteer|healthy human volunteer
1588352|NCT00437229|Ondansetron,|ondansetron,
1588353|NCT00437203|Advanced cancer|advanced cancer
1588354|NCT00437190|Cervical Disc Replacement|cervical disc replacement
1588355|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
1588356|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
1588357|NCT00437190|Myelopathy|myelopathy
1588358|NCT00437190|Radiculopathy|radiculopathy
1588359|NCT00437177|alcoholism|alcoholism
1588360|NCT00437177|apomorphine|apomorphine
1588361|NCT00437177|iodobenzamide|iodobenzamide
1588362|NCT00437177|imaging|imaging
1588363|NCT00437177|spect|spect
1588364|NCT00437177|relapse|relapse
1588365|NCT00437164|NaBr|nabr
1588366|NCT00437164|Sodium Bromide|sodium bromide
1588367|NCT00437164|DEXA Deuterium|dexa deuterium
1588368|NCT00437164|Total Body Water|total body water
1588369|NCT00437164|Insulin|insulin
1588370|NCT00437164|D2O|d2o
1588371|NCT00437164|GW677954|gw677954
1588372|NCT00437164|Randomized Withdrawal|randomized withdrawal
1588373|NCT00437164|T2DM|t2dm
1588374|NCT00437138|Air pollution|air pollution
1588375|NCT00437138|Myocardial ischemia|myocardial ischemia
1588376|NCT00437138|Endothelium|endothelium
1588377|NCT00437138|Fibrinolysis|fibrinolysis
1588378|NCT00437138|Pathophysiology|pathophysiology
1588379|NCT00437138|Diesel exhaust|diesel exhaust
1588380|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1588381|NCT00437086|primary myelofibrosis|primary myelofibrosis
1588382|NCT00437073|brain metastases|brain metastases
1588383|NCT00437073|ErbB2|erbb2
1588384|NCT00437073|lapatinib|lapatinib
1588385|NCT00437073|Breast Cancer|breast cancer
1588386|NCT00437073|HYCAMTIN|hycamtin
1588387|NCT00437073|topotecan|topotecan
1588388|NCT00437073|capecitabine|capecitabine
1588389|NCT00437073|metastatic breast cancer|metastatic breast cancer
1588391|NCT00437073|XELODA|xeloda
1588392|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
1588393|NCT00437008|endothelial dysfunction|endothelial dysfunction
1588394|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
1588395|NCT00437008|advanced glycation end products|advanced glycation end products
1588396|NCT00437008|postprandial|postprandial
1588400|NCT00436969|Osteoarthritis|osteoarthritis
1588401|NCT00436969|Shoulder|shoulder
1588402|NCT00436969|Randomized|randomized
1588403|NCT00436956|VEGF|vegf
1588404|NCT00436956|Angiogenesis|angiogenesis
1588405|NCT00436956|Hormone-Refractory|hormone-refractory
1588406|NCT00436956|Bone Metastases|bone metastases
1588407|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
1588408|NCT00436956|Prostate Cancer|prostate cancer
1588409|NCT00436943|smoking cessation|smoking cessation
1588410|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
1588411|NCT00436943|bupropion|bupropion
1588412|NCT00436943|smoking|smoking
1588413|NCT00436930|recurrent melanoma|recurrent melanoma
1588414|NCT00436930|stage IV melanoma|stage iv melanoma
1588415|NCT00436917|stage I breast cancer|stage i breast cancer
1588416|NCT00436917|stage II breast cancer|stage ii breast cancer
1588417|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
1588418|NCT00436917|osteoporosis|osteoporosis
1588419|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1588420|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1588421|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1588422|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1588423|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
1588424|NCT00436878|Eating Behavior|eating behavior
1588425|NCT00436878|Children|children
1588426|NCT00436878|Portion size|portion size
1588427|NCT00436878|Experimental|experimental
1588428|NCT00436826|Multiple Sclerosis|multiple sclerosis
1588429|NCT00436826|Relapsing forms|relapsing forms
1588430|NCT00436826|Interferon-beta therapy|interferon-beta therapy
1588431|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
1588432|NCT00436787|Venous Thrombosis|venous thrombosis
1588433|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
1588434|NCT00436787|Pulmonary Embolism|pulmonary embolism
1588435|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
1588436|NCT00436787|Arixtra|arixtra
1588437|NCT00436787|Pharmakinetics|pharmakinetics
1588438|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1588439|NCT00436774|neurotoxicity|neurotoxicity
1588440|NCT00436774|gastrointestinal complications|gastrointestinal complications
1588441|NCT00436774|pulmonary complications|pulmonary complications
1588442|NCT00436774|sexual dysfunction|sexual dysfunction
1588443|NCT00436774|infertility|infertility
1588444|NCT00436774|urinary complications|urinary complications
1588445|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1588446|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1588447|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1588448|NCT00436774|childhood teratoma|childhood teratoma
1588449|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1588450|NCT00436748|Chronic Kidney Disease|chronic kidney disease
1588451|NCT00436748|Dialysis|dialysis
1588452|NCT00436748|Anemia|anemia
1588453|NCT00436748|Nephrology|nephrology
1588454|NCT00436748|Pediatric|pediatric
1588455|NCT00436748|Hemodialysis|hemodialysis
1588456|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
1588457|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
1588458|NCT00436722|Liver|liver
1588459|NCT00436722|Transplantation|transplantation
1588460|NCT00436722|Tolerance|tolerance
1588461|NCT00436722|Induction|induction
1588462|NCT00436722|Tacrolimus|tacrolimus
1588463|NCT00436722|Liver transplantation|liver transplantation
1588464|NCT00436722|Adult|adult
1588465|NCT00436709|male breast cancer|male breast cancer
1588466|NCT00436709|stage I breast cancer|stage i breast cancer
1588467|NCT00436709|stage II breast cancer|stage ii breast cancer
1588468|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
1588469|NCT00436696|disseminated neuroblastoma|disseminated neuroblastoma
1588470|NCT00436696|localized resectable neuroblastoma|localized resectable neuroblastoma
1588471|NCT00436696|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1588472|NCT00436696|recurrent neuroblastoma|recurrent neuroblastoma
1588473|NCT00436696|regional neuroblastoma|regional neuroblastoma
1588474|NCT00436683|Hyperphosphataemia|hyperphosphataemia
1588475|NCT00436683|Phosphate binder|phosphate binder
1588476|NCT00436670|Asthma|asthma
1588477|NCT00436670|Allergy|allergy
1588478|NCT00436670|IL-13|il-13
1588479|NCT00436670|IL-4|il-4
1588480|NCT00436670|IL-4R|il-4r
1588481|NCT00436657|Children|children
1588482|NCT00436657|Pediatric|pediatric
1588483|NCT00436657|Peritoneal Tumor|peritoneal tumor
1588484|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
1588485|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
1588486|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
1588487|NCT00436657|Neuroblastoma|neuroblastoma
1588488|NCT00436657|Ovarian Germ Cell|ovarian germ cell
1588489|NCT00436657|Sarcoma|sarcoma
1588490|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
1588491|NCT00436657|Wilms' Tumor|wilms' tumor
1588492|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
1588493|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
1588494|NCT00436657|Recurrent Tumors|recurrent tumors
1588495|NCT00436657|Cisplatin|cisplatin
1588496|NCT00436657|Platinol®-AQ|platinol®-aq
1588497|NCT00436657|Platinol®|platinol®
1588498|NCT00436657|CDDP|cddp
1588499|NCT00436657|Abdominal Wash|abdominal wash
1588500|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
1588501|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
1588502|NCT00436657|CHPP|chpp
1588503|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1588504|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
1588505|NCT00436631|epilepsy|epilepsy
1588506|NCT00436631|seizures|seizures
1588507|NCT00436631|intractable|intractable
1588508|NCT00436631|ketosis|ketosis
1588509|NCT00436631|ketogenic|ketogenic
1588510|NCT00436631|diet|diet
1588511|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1588512|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1588513|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1588514|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1588515|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1588516|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1588517|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1588518|NCT00436618|small intestine lymphoma|small intestine lymphoma
1588519|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1588520|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1588521|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1588522|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1588523|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1588524|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1588525|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1588526|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1588527|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1588528|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1588529|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1588530|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1588531|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1588532|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1588533|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1588534|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1588535|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1588536|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1588537|NCT00436592|acute|acute
1588538|NCT00436592|ischemic|ischemic
1588539|NCT00436592|stroke|stroke
1588540|NCT00436592|device|device
1588541|NCT00436592|treatment|treatment
1588542|NCT00436566|cardiac toxicity|cardiac toxicity
1588543|NCT00436566|male breast cancer|male breast cancer
1588544|NCT00436566|stage I breast cancer|stage i breast cancer
1588545|NCT00436566|stage II breast cancer|stage ii breast cancer
1588546|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
1588547|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
1588548|NCT00436553|choroidal neovascularization|choroidal neovascularization
1588549|NCT00436553|verteporfin|verteporfin
1588550|NCT00436553|ranibizumab|ranibizumab
1588551|NCT00436514|patients|patients
1588552|NCT00436514|medium risk|medium risk
1588553|NCT00436514|asymptomatic|asymptomatic
1588554|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
1588555|NCT00436514|high risk|high risk
1588556|NCT00436514|case|case
1588557|NCT00436514|history of neoplastic colic|history of neoplastic colic
1588558|NCT00436514|cancers|cancers
1588559|NCT00436514|polyps|polyps
1588560|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1588561|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
1588562|NCT00436501|Peritoneal Cancer|peritoneal cancer
1588563|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
1588564|NCT00436501|VEGF Trap|vegf trap
1588565|NCT00436501|aflibercept|aflibercept
1588653|NCT00436345|analgesia|analgesia
1588566|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
1588567|NCT00436501|Zaltrap|zaltrap
1588568|NCT00436501|docetaxel|docetaxel
1588569|NCT00436501|RP 56976|rp 56976
1588570|NCT00436501|Taxotere|taxotere
1588572|NCT00436488|ICAM-1|icam-1
1588573|NCT00436488|Obesity|obesity
1588574|NCT00436488|Gene variants|gene variants
1588575|NCT00436475|Glucose intolerance|glucose intolerance
1588576|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
1588577|NCT00436475|Metabolic syndrome|metabolic syndrome
1588578|NCT00436462|Steroid receptors|steroid receptors
1588579|NCT00436462|Endometrium|endometrium
1588581|NCT00436462|Follicular phase|follicular phase
1588582|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
1588583|NCT00436436|adult gliosarcoma|adult gliosarcoma
1588584|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
1588585|NCT00436436|adult glioblastoma|adult glioblastoma
1588586|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
1588587|NCT00436423|drug therapy|drug therapy
1588588|NCT00436423|gemcitabine|gemcitabine
1588589|NCT00436423|TS-1|ts-1
1588590|NCT00436410|stage IV colon cancer|stage iv colon cancer
1588591|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
1588592|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1588593|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
1588594|NCT00436410|male breast cancer|male breast cancer
1588595|NCT00436410|stage IV breast cancer|stage iv breast cancer
1588596|NCT00436410|stage IV melanoma|stage iv melanoma
1588597|NCT00436410|stage I breast cancer|stage i breast cancer
1588598|NCT00436410|stage II breast cancer|stage ii breast cancer
1588599|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
1588600|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
1588601|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
1588602|NCT00436410|recurrent breast cancer|recurrent breast cancer
1588603|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1588604|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
1588605|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
1588606|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
1588607|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1588608|NCT00436410|recurrent colon cancer|recurrent colon cancer
1588609|NCT00436410|stage I colon cancer|stage i colon cancer
1588610|NCT00436410|stage II colon cancer|stage ii colon cancer
1588611|NCT00436410|stage III colon cancer|stage iii colon cancer
1588612|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
1588613|NCT00436410|stage I rectal cancer|stage i rectal cancer
1588614|NCT00436410|stage II rectal cancer|stage ii rectal cancer
1588615|NCT00436410|stage III rectal cancer|stage iii rectal cancer
1588616|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
1588617|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1588618|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1588619|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
1588620|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
1588621|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
1588622|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
1588623|NCT00436410|recurrent melanoma|recurrent melanoma
1588624|NCT00436410|stage I melanoma|stage i melanoma
1588625|NCT00436410|stage II melanoma|stage ii melanoma
1588626|NCT00436410|stage III melanoma|stage iii melanoma
1588627|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
1588628|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
1588629|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
1588630|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
1588631|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
1588632|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1588633|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1588634|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1588635|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1588636|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1588637|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
1588638|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
1588639|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1588640|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1588641|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1588642|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1588643|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1588644|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1588645|NCT00436384|liver transplant|liver transplant
1588646|NCT00436384|lung transplant|lung transplant
1588647|NCT00436384|kidney transplant|kidney transplant
1588648|NCT00436384|heart transplant|heart transplant
1588649|NCT00436384|CMV CMI|cmv cmi
1588650|NCT00436358|Mexico|mexico
1588651|NCT00436358|Intussusception|intussusception
1588652|NCT00436358|Epidemiology|epidemiology
1588654|NCT00436345|Mechanical ventilation|mechanical ventilation
1588655|NCT00436345|pharmaco-economic|pharmaco-economic
1588657|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1588658|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1588659|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1588660|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1588661|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
1588662|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
1588663|NCT00436306|prevention|prevention
1588664|NCT00436306|behavior|behavior
1588665|NCT00436306|risk reduction behavior|risk reduction behavior
1588666|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
1588667|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
1588668|NCT00436267|liver metastases|liver metastases
1588669|NCT00436228|healthy volunteer,|healthy volunteer,
1588670|NCT00436228|Bioavailability,|bioavailability,
1588671|NCT00436228|safety|safety
1588672|NCT00436228|Phase I,|phase i,
1588673|NCT00436215|Sorafenib|sorafenib
1588674|NCT00436215|Ovarian Cancer|ovarian cancer
1588675|NCT00436215|Fallopian Cancer|fallopian cancer
1588676|NCT00436215|Bevacizumab|bevacizumab
1588677|NCT00436215|Peritoneal Cancer|peritoneal cancer
1588678|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
1588679|NCT00436202|Anemia|anemia
1588680|NCT00436202|Iron|iron
1588681|NCT00436202|Supplement|supplement
1588682|NCT00436189|Ovarian|ovarian
1588683|NCT00436189|Cancer|cancer
1588684|NCT00436189|Pelvic|pelvic
1588685|NCT00436189|Mass|mass
1588686|NCT00436189|Tumor|tumor
1588687|NCT00436189|Adnexal|adnexal
1588688|NCT00436189|Proteomics|proteomics
1588689|NCT00436176|Diabetes mellitus|diabetes mellitus
1588690|NCT00436176|Quality of Health Care|quality of health care
1588691|NCT00436176|Cultural Competency|cultural competency
1588692|NCT00436176|Performance Feedback|performance feedback
1588693|NCT00436176|Health navigator|health navigator
1588694|NCT00436176|Health disparities|health disparities
1588695|NCT00436176|Racial disparities|racial disparities
1588696|NCT00436150|Adolescents|adolescents
1588697|NCT00436150|Depression, postpartum|depression, postpartum
1588698|NCT00436137|Colorectal cancer|colorectal cancer
1588699|NCT00436137|Fecal occult blood test|fecal occult blood test
1588700|NCT00436137|Abnormal test result|abnormal test result
1588701|NCT00436137|Missed diagnosis|missed diagnosis
1588702|NCT00436137|Delayed diagnosis|delayed diagnosis
1588703|NCT00436111|hyperprolactinemia|hyperprolactinemia
1588704|NCT00436111|autoantibody|autoantibody
1588705|NCT00436098|congenital heart disease|congenital heart disease
1588706|NCT00436098|exercise training|exercise training
1588707|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
1588708|NCT00436098|children|children
1588709|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
1588710|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
1588711|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
1588712|NCT00436072|ZD6474|zd6474
1588713|NCT00436072|cetuximab|cetuximab
1588714|NCT00436072|irinotecan|irinotecan
1588715|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
1588716|NCT00436020|clinical trial|clinical trial
1588717|NCT00436020|TMS|tms
1588718|NCT00436020|depression|depression
1588719|NCT00436020|bipolar disorder|bipolar disorder
1588720|NCT00436007|Africa|africa
1588721|NCT00436007|Plasmodium falciparum|plasmodium falciparum
1588722|NCT00436007|Malaria|malaria
1588723|NCT00435994|Infant|infant
1588724|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
1588725|NCT00435994|Bronchiolitis|bronchiolitis
1588726|NCT00435981|Type 1 diabetes|type 1 diabetes
1588727|NCT00435981|GAD65|gad65
1588728|NCT00435981|Autoimmunity|autoimmunity
1588729|NCT00435981|C-peptide|c-peptide
1588730|NCT00435981|Children|children
1588731|NCT00435968|NK Cells|nk cells
1588732|NCT00435968|Cytokines|cytokines
1588733|NCT00435968|Lymphocytes|lymphocytes
1588734|NCT00435968|Immunoglobulins|immunoglobulins
1588735|NCT00435968|Th1 response|th1 response
1588736|NCT00435955|Follicular lymphoma|follicular lymphoma
1588737|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
1588738|NCT00435955|IIL score > 2|iil score > 2
1588739|NCT00435955|Molecular remission|molecular remission
1588740|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
1588741|NCT00435955|Rituximab|rituximab
1588742|NCT00435929|Treatment Naive|treatment naive
1588743|NCT00435916|Antigens, CD40|antigens, cd40
1588744|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
1588745|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1588746|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1588747|NCT00435916|Hematologic Diseases|hematologic diseases
1588748|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
1588749|NCT00435916|Lymphatic Diseases|lymphatic diseases
1588750|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
1588751|NCT00435916|Lymphoma|lymphoma
1588752|NCT00435903|smoking|smoking
1588753|NCT00435903|self-monitoring|self-monitoring
1588754|NCT00435903|major mental illness|major mental illness
1588755|NCT00435903|palm pilots|palm pilots
1588756|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
1588757|NCT00435890|ED Overcrowding|ed overcrowding
1588758|NCT00435890|Length of stay|length of stay
1588759|NCT00435890|Emergency triage|emergency triage
1588760|NCT00435890|triage|triage
1588761|NCT00435877|Connective Tissue|connective tissue
1588762|NCT00435877|Stromal Cells|stromal cells
1588763|NCT00435877|Surgical Waste|surgical waste
1588764|NCT00435877|In Vivo Studies|in vivo studies
1588765|NCT00435877|Tissue Analysis|tissue analysis
1588766|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
1588767|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
1588768|NCT00435864|donors are healthy subjects|donors are healthy subjects
1588769|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
1588770|NCT00435812|HBV vaccine|hbv vaccine
1588771|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
1588772|NCT00435812|Hepatitis B|hepatitis b
1588773|NCT00435812|Hepatitis|hepatitis
1588774|NCT00435812|HBV|hbv
1588775|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
1588776|NCT00435799|keratoconus|keratoconus
1588777|NCT00435799|corneal cross-linking|corneal cross-linking
1588778|NCT00435799|riboflavine|riboflavine
1588779|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
1588780|NCT00435773|Osteoarthritis|osteoarthritis
1588781|NCT00435773|Leeching|leeching
1588782|NCT00435773|Randomized Controlled Trial|randomized controlled trial
1588783|NCT00435773|Arthralgia|arthralgia
1588784|NCT00435760|COPD|copd
1588785|NCT00435721|schizophrenia|schizophrenia
1588786|NCT00435721|family psychoeducation|family psychoeducation
1588787|NCT00435708|COPD|copd
1588788|NCT00435708|Fruit|fruit
1588789|NCT00435708|Vegetables|vegetables
1588790|NCT00435708|Oxidative stress|oxidative stress
1588791|NCT00435708|Inflammation|inflammation
1588792|NCT00435695|PET scan|pet scan
1588793|NCT00435695|healthy males|healthy males
1588794|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
1588795|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
1588796|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
1588797|NCT00435643|Sleep apnea,|sleep apnea,
1588798|NCT00435643|adiponectin ,|adiponectin ,
1588799|NCT00435643|HPA axis|hpa axis
1588800|NCT00435630|Education|education
1588801|NCT00435630|Virtual Reality|virtual reality
1588802|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
1588803|NCT00435630|Learning Curve|learning curve
1588804|NCT00435617|stroke rehabilitation|stroke rehabilitation
1588805|NCT00435617|stroke therapy|stroke therapy
1588806|NCT00435617|hand therapy|hand therapy
1588807|NCT00435617|stroke|stroke
1588808|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
1588809|NCT00435617|cerebral stroke|cerebral stroke
1588810|NCT00435604|hyaluronidase|hyaluronidase
1588811|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
1588812|NCT00435604|Volunteer Subjects|volunteer subjects
1588813|NCT00435591|Hyponatremia|hyponatremia
1588814|NCT00435591|Euvolemia|euvolemia
1588815|NCT00435591|Hypervolemia|hypervolemia
1588816|NCT00435591|Conivaptan|conivaptan
1588817|NCT00435591|Vaprisol®|vaprisol®
1588818|NCT00435591|YM087|ym087
1588819|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
1588820|NCT00435539|Vitreomacular Traction|vitreomacular traction
1588821|NCT00435539|Maculopathy|maculopathy
1588822|NCT00435539|VMT|vmt
1588823|NCT00435539|PVD|pvd
1588824|NCT00435526|traveler's diarrhea|traveler's diarrhea
1588825|NCT00435526|ETEC diarrhea|etec diarrhea
1588826|NCT00435526|passive immunization|passive immunization
1588827|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
1588828|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
1588829|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
1588830|NCT00435474|Cancer|cancer
1588831|NCT00435474|Malignant wounds|malignant wounds
1588832|NCT00435474|Quality of life|quality of life
1588833|NCT00435474|Body-Image|body-image
1588834|NCT00435474|Cancer patients|cancer patients
1588835|NCT00435461|once daily|once daily
1588836|NCT00435461|mountain cedar|mountain cedar
1588837|NCT00435461|fexofenadine|fexofenadine
1588838|NCT00435461|allergic rhinitis|allergic rhinitis
1588839|NCT00435461|fluticasone furoate|fluticasone furoate
1588840|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1588841|NCT00435448|BPH|bph
1588842|NCT00435448|Enlarged Prostate|enlarged prostate
1588843|NCT00435435|Alcoholism|alcoholism
1588844|NCT00435435|Dependence|dependence
1588845|NCT00435435|Randomization|randomization
1588846|NCT00435435|Effect|effect
1588847|NCT00435435|Disulfiram|disulfiram
1588848|NCT00435435|Naltrexone|naltrexone
1588849|NCT00435435|Acamprosate|acamprosate
1588850|NCT00435383|Caudal Block|caudal block
1588851|NCT00435383|Oxygen Saturation|oxygen saturation
1588852|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
1588853|NCT00435357|Mobile-bearing|mobile-bearing
1588854|NCT00435357|arthroplasty|arthroplasty
1588855|NCT00435357|fixed-bearing|fixed-bearing
1588856|NCT00435357|knee|knee
1588857|NCT00435357|patella|patella
1588858|NCT00435357|posterior stabilized TKA|posterior stabilized tka
1588859|NCT00435344|Pediatric practice|pediatric practice
1588860|NCT00435344|Smoking cessation|smoking cessation
1588861|NCT00435344|Smoking prevention|smoking prevention
1588862|NCT00435344|Adolescents|adolescents
1588966|NCT00434954|exenatide|exenatide
1588863|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1588865|NCT00435305|continuous infusion|continuous infusion
1588866|NCT00435305|epithelial lining fluid|epithelial lining fluid
1588867|NCT00435305|antibiotics|antibiotics
1588868|NCT00435305|pneumonia|pneumonia
1588869|NCT00435305|critical illness|critical illness
1588870|NCT00435279|Insomnia|insomnia
1588871|NCT00435279|Depression|depression
1588872|NCT00435279|Major Depressive Disorder|major depressive disorder
1588873|NCT00435266|myocardial infarction|myocardial infarction
1588874|NCT00435266|remote|remote
1588875|NCT00435266|preconditioning|preconditioning
1588876|NCT00435266|perconditioning|perconditioning
1588877|NCT00435266|cardioprotection|cardioprotection
1588878|NCT00435253|emphysema|emphysema
1588879|NCT00435253|COPD|copd
1588880|NCT00435253|lung volume reduction|lung volume reduction
1588881|NCT00435253|NETT|nett
1588882|NCT00435253|BLVR|blvr
1588883|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
1588884|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
1588885|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
1588886|NCT00435214|Cytology|cytology
1588887|NCT00435214|papilloma virus|papilloma virus
1588888|NCT00435214|CIN|cin
1588889|NCT00435214|Screening|screening
1588890|NCT00435214|Cervix|cervix
1588891|NCT00435214|Cervical Cancer|cervical cancer
1588892|NCT00435188|Aging|aging
1588893|NCT00435188|Cost analysis|cost analysis
1588894|NCT00435188|Counseling|counseling
1588895|NCT00435188|Disabled Persons|disabled persons
1588896|NCT00435188|Health Promotion|health promotion
1588897|NCT00435188|Mobility Limitation|mobility limitation
1588898|NCT00435188|Physical Activity|physical activity
1588899|NCT00435188|Primary Care|primary care
1588900|NCT00435188|Randomized Clinical Trial|randomized clinical trial
1588901|NCT00435188|Veterans|veterans
1588902|NCT00435175|Estradiol|estradiol
1588903|NCT00435175|Lipolysis|lipolysis
1588904|NCT00435175|Estrogen receptor|estrogen receptor
1588905|NCT00435175|Adrenergic receptors|adrenergic receptors
1588906|NCT00435175|UCP2|ucp2
1588907|NCT00435175|Postmenopausal women|postmenopausal women
1588908|NCT00435162|Children|children
1588909|NCT00435162|pediatrics|pediatrics
1588910|NCT00435162|High Blood Pressure|high blood pressure
1588911|NCT00435162|Hypertension|hypertension
1588912|NCT00435162|Valsartan|valsartan
1588913|NCT00435123|Malnutrition|malnutrition
1588914|NCT00435123|ESRD|esrd
1588915|NCT00435123|Hemodialysis|hemodialysis
1588916|NCT00435110|ARDS|ards
1588917|NCT00435110|ALI|ali
1588918|NCT00435110|Mechanical Ventilation|mechanical ventilation
1588919|NCT00435110|Outcome|outcome
1588920|NCT00435097|colon cancer|colon cancer
1588921|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
1588922|NCT00435097|MRI|mri
1588923|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
1588924|NCT00435097|Early cancer detection|early cancer detection
1588925|NCT00435097|medical image processing|medical image processing
1588926|NCT00435097|machine learning|machine learning
1588927|NCT00435097|disease modeling|disease modeling
1588928|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
1588929|NCT00435084|Refractory B-CLL|refractory b-cll
1588930|NCT00435084|phase I/II|phase i/ii
1588931|NCT00435084|CD38|cd38
1588932|NCT00435058|intraocular pressure|intraocular pressure
1588933|NCT00435058|contrast sensitivity|contrast sensitivity
1588934|NCT00435058|visual function|visual function
1588935|NCT00435045|Lovaza|lovaza
1588936|NCT00435045|Hyperlipidemias|hyperlipidemias
1588937|NCT00435045|Triglycerides|triglycerides
1588938|NCT00435045|Lipids|lipids
1588939|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
1588940|NCT00435045|Hypercholesterolemia|hypercholesterolemia
1588941|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
1588942|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
1588943|NCT00435045|Omacor|omacor
1588944|NCT00435045|Dyslipidemias|dyslipidemias
1588945|NCT00435032|ruptured appendicitis|ruptured appendicitis
1588946|NCT00435032|children|children
1588947|NCT00435032|surgery|surgery
1588948|NCT00435032|randomized trial|randomized trial
1588949|NCT00434993|Acute Lung Injury|acute lung injury
1588950|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1588951|NCT00434993|Albuterol|albuterol
1588952|NCT00434993|Aerosolized|aerosolized
1588953|NCT00434993|Critical Care|critical care
1588954|NCT00434993|Ventilator|ventilator
1588955|NCT00434980|Cognitive adaption|cognitive adaption
1588956|NCT00434980|Schizophrenia|schizophrenia
1588957|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
1588958|NCT00434980|Family treatment|family treatment
1588959|NCT00434980|Cognitive deficits|cognitive deficits
1588960|NCT00434980|Serious mental illness|serious mental illness
1588961|NCT00434967|Blood pressure reduction|blood pressure reduction
1588962|NCT00434967|combination therapy|combination therapy
1588963|NCT00434967|candesartan cilexetil|candesartan cilexetil
1588964|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
1588965|NCT00434954|diabetes|diabetes
1588970|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
1588971|NCT00434941|Her2: negative|her2: negative
1588972|NCT00434928|observational|observational
1588973|NCT00434928|dietary intake|dietary intake
1588974|NCT00434928|nutrient status|nutrient status
1588975|NCT00434928|serum assessors|serum assessors
1588976|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
1588977|NCT00434902|Doppler Echocardiography|doppler echocardiography
1588978|NCT00434902|Pulmonary hypertension|pulmonary hypertension
1588979|NCT00434902|Sickle cell disease|sickle cell disease
1588980|NCT00434889|dementia|dementia
1588981|NCT00434889|falls|falls
1588982|NCT00434889|risk factors|risk factors
1588983|NCT00434876|Alcoholism|alcoholism
1588984|NCT00434876|Insomnia|insomnia
1588985|NCT00434876|Quetiapine|quetiapine
1588986|NCT00434876|Seroquel|seroquel
1588987|NCT00434863|botulinum toxin type A|botulinum toxin type a
1588988|NCT00434863|Dysport®|dysport®
1588989|NCT00434863|Botox®|botox®
1588990|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
1588991|NCT00434863|randomized controlled trial|randomized controlled trial
1588992|NCT00434863|double-blinded trial|double-blinded trial
1588993|NCT00434863|electromyogram (EMG)|electromyogram (emg)
1588994|NCT00434850|Insulin dependence|insulin dependence
1588995|NCT00434850|Hypoglycemia|hypoglycemia
1588996|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
1588997|NCT00434837|Knee|knee
1588998|NCT00434837|Ligament|ligament
1589000|NCT00434837|Reconstruction|reconstruction
1589001|NCT00434837|Cartilage|cartilage
1589002|NCT00434837|Osteoarthritis|osteoarthritis
1589003|NCT00434811|Insulin dependence|insulin dependence
1589004|NCT00434811|Hypoglycemia|hypoglycemia
1589005|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
1589006|NCT00434798|Campylobacter infections|campylobacter infections
1589007|NCT00434772|hypoglycemia|hypoglycemia
1589008|NCT00434772|glucagon|glucagon
1589009|NCT00434772|neonatal|neonatal
1589010|NCT00434772|gestational diabetes|gestational diabetes
1589011|NCT00434772|insulin|insulin
1589012|NCT00434772|glyburide|glyburide
1589013|NCT00434759|randomized controlled trial|randomized controlled trial
1589014|NCT00434759|stepped-care program|stepped-care program
1589015|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
1589016|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
1589017|NCT00434720|GlideScope|glidescope
1589018|NCT00434720|Stylet|stylet
1589019|NCT00434707|glaucoma|glaucoma
1589020|NCT00434707|catarat|catarat
1589021|NCT00434707|small pupils|small pupils
1589022|NCT00434694|Atrial Fibrillation|atrial fibrillation
1589023|NCT00434694|Catheter ablation|catheter ablation
1589024|NCT00434694|Pulmonary Vein|pulmonary vein
1589025|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
1589026|NCT00434668|NSCLC|nsclc
1589027|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
1589028|NCT00434655|Morbid obesity|morbid obesity
1589029|NCT00434655|Bariatric surgery|bariatric surgery
1589030|NCT00434655|Obesity surgery|obesity surgery
1589031|NCT00434655|Gastric banding|gastric banding
1589032|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
1589033|NCT00434642|Avastin|avastin
1589034|NCT00434642|Ovarian carcinoma|ovarian carcinoma
1589035|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
1589036|NCT00434642|Peritoneal cancer|peritoneal cancer
1589037|NCT00434642|Fallopian tube cancer|fallopian tube cancer
1589038|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
1589039|NCT00434642|OCEANS|oceans
1589040|NCT00434629|lymphoma|lymphoma
1589041|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1589042|NCT00434629|B-cell lymphoma|b-cell lymphoma
1589043|NCT00434629|Radioimmunotherapy|radioimmunotherapy
1589044|NCT00434629|Bexxar|bexxar
1589045|NCT00434629|tositumomab|tositumomab
1589046|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
1589047|NCT00434616|angiogenesis|angiogenesis
1589048|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
1589049|NCT00434616|Leg Ulcer|leg ulcer
1589050|NCT00434616|Gangrene|gangrene
1589051|NCT00434616|Ischemia|ischemia
1589052|NCT00434616|PAOD|paod
1589053|NCT00434616|Amputation|amputation
1589054|NCT00434616|bone marrow|bone marrow
1589055|NCT00434590|Kidney Transplantation|kidney transplantation
1589056|NCT00434590|Mycophenolic Acid|mycophenolic acid
1589057|NCT00434590|Immunosuppression|immunosuppression
1589058|NCT00434590|Cyclosporine|cyclosporine
1589059|NCT00434577|GSK Biologicals|gsk biologicals
1589060|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
1589061|NCT00434577|Vaccine|vaccine
1589062|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
1589063|NCT00434577|Shingles|shingles
1589064|NCT00434564|Stress nuclear scan|stress nuclear scan
1589065|NCT00434564|Acute chest pain|acute chest pain
1589066|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
1589067|NCT00434551|capsule endoscopy|capsule endoscopy
1589068|NCT00434551|PillCam SB|pillcam sb
1589177|NCT00434252|Avastin|avastin
1589069|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
1589070|NCT00434538|Diabetic|diabetic
1589071|NCT00434538|Foot|foot
1589072|NCT00434538|Ulcer|ulcer
1589073|NCT00434538|Neuropathic|neuropathic
1589074|NCT00434538|Chitosan|chitosan
1589075|NCT00434525|Morbid obesity|morbid obesity
1589076|NCT00434525|Bariatric Surgery|bariatric surgery
1589077|NCT00434525|Obesity Surgery|obesity surgery
1589078|NCT00434525|Omentectomy|omentectomy
1589079|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
1589080|NCT00434512|Gag|gag
1589081|NCT00434512|vaccine|vaccine
1589082|NCT00434512|adjuvant|adjuvant
1589083|NCT00434512|HIV|hiv
1589084|NCT00434512|Pol|pol
1589085|NCT00434512|Nef|nef
1589086|NCT00434499|Green Tea|green tea
1589087|NCT00434499|Insulin Resistance|insulin resistance
1589088|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
1589089|NCT00434499|Nitric Oxide|nitric oxide
1589090|NCT00434499|Inflammation|inflammation
1589091|NCT00434499|Obesity|obesity
1589092|NCT00434499|Overweight|overweight
1589093|NCT00434499|Diabetes Type 2|diabetes type 2
1589094|NCT00434499|High Blood Pressure|high blood pressure
1589095|NCT00434499|Healthy Volunteer|healthy volunteer
1589096|NCT00434499|HV|hv
1589097|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
1589098|NCT00434460|Knowledge Translation|knowledge translation
1589099|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
1589100|NCT00434460|Education|education
1589101|NCT00434460|Behaviour Change|behaviour change
1589102|NCT00434447|Prostate Cancer|prostate cancer
1589103|NCT00434447|Breast Cancer|breast cancer
1589104|NCT00434447|Multiple Myeloma|multiple myeloma
1589105|NCT00434447|Zoledronic acid|zoledronic acid
1589106|NCT00434447|Bone metastases|bone metastases
1589107|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
1589108|NCT00434447|Renal Impairment|renal impairment
1589109|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
1589110|NCT00434447|Bone involvement|bone involvement
1589111|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
1589112|NCT00434434|AQUA|aqua
1589113|NCT00434434|anti-CD11|anti-cd11
1589114|NCT00434434|CD11a|cd11a
1589115|NCT00434434|Asthma|asthma
1589116|NCT00434434|Allergy|allergy
1589117|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
1589118|NCT00434421|Asthma|asthma
1589119|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
1589120|NCT00434408|omphalitis|omphalitis
1589121|NCT00434408|neonates|neonates
1589122|NCT00434408|umbilical cord|umbilical cord
1589123|NCT00434408|infection|infection
1589124|NCT00434408|infant mortality|infant mortality
1589125|NCT00434408|neonate morbidity|neonate morbidity
1589126|NCT00434408|chlorhexidine|chlorhexidine
1589127|NCT00434382|auditory evoked potentials|auditory evoked potentials
1589128|NCT00434382|sensory processing|sensory processing
1589129|NCT00434382|monitoring|monitoring
1589130|NCT00434382|general anesthesia|general anesthesia
1589131|NCT00434356|Avastin|avastin
1589132|NCT00434356|MBC|mbc
1589133|NCT00434356|Breast Cancer|breast cancer
1589134|NCT00434356|Sutent|sutent
1589135|NCT00434343|Interstitial Cystitis|interstitial cystitis
1589136|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
1589137|NCT00434343|Chronic Prostatitis|chronic prostatitis
1589138|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
1589139|NCT00434330|anemia|anemia
1589140|NCT00434330|chronic kidney disease|chronic kidney disease
1589141|NCT00434330|CKD|ckd
1589142|NCT00434330|chronic renal failure|chronic renal failure
1589143|NCT00434330|CRF|crf
1589144|NCT00434330|dialysis|dialysis
1589145|NCT00434330|erythropoietin|erythropoietin
1589146|NCT00434330|EPO|epo
1589147|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1589148|NCT00434330|ESA|esa
1589149|NCT00434330|Hematide™|hematide™
1589150|NCT00434330|hemodialysis|hemodialysis
1589151|NCT00434330|hemoglobin|hemoglobin
1589152|NCT00434330|Hb|hb
1589153|NCT00434330|Hgb|hgb
1589154|NCT00434330|Omontys|omontys
1589155|NCT00434330|peginesatide|peginesatide
1589156|NCT00434330|red blood cell|red blood cell
1589157|NCT00434330|red blood cell production|red blood cell production
1589158|NCT00434317|Metastasis|metastasis
1589159|NCT00434317|Neoplasm|neoplasm
1589160|NCT00434317|pain|pain
1589161|NCT00434317|breast cancer|breast cancer
1589162|NCT00434317|prostate cancer|prostate cancer
1589163|NCT00434317|bone metastasis|bone metastasis
1589164|NCT00434304|Parkinson's Disease|parkinson's disease
1589165|NCT00434304|PD|pd
1589166|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
1589167|NCT00434291|fluoroquinolone|fluoroquinolone
1589168|NCT00434291|TG-873870|tg-873870
1589169|NCT00434291|Nemonoxacin|nemonoxacin
1589170|NCT00434278|Lung disease|lung disease
1589171|NCT00434278|CF|cf
1589172|NCT00434278|Pulmozyme|pulmozyme
1589173|NCT00434265|Obesity|obesity
1589174|NCT00434265|Exercise|exercise
1589175|NCT00434265|Fat oxidation|fat oxidation
1589176|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
1589179|NCT00434252|Metastatic melanoma|metastatic melanoma
1589180|NCT00434239|Myelodysplasia|myelodysplasia
1589181|NCT00434239|Lenalidomide|lenalidomide
1589182|NCT00434239|Ancestim|ancestim
1589183|NCT00434239|Pilot trial|pilot trial
1589184|NCT00434239|Biomarkers|biomarkers
1589185|NCT00434226|SABER-L|saber-l
1589186|NCT00434226|NSCLC|nsclc
1589187|NCT00434226|Avastin|avastin
1589188|NCT00434226|Sutent|sutent
1589189|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
1589190|NCT00434200|exercise|exercise
1589191|NCT00434200|damage|damage
1589192|NCT00434187|healthy|healthy
1589193|NCT00434174|Lung cancer|lung cancer
1589194|NCT00434174|Non small cell lung cancer|non small cell lung cancer
1589195|NCT00434174|NSCLC|nsclc
1589196|NCT00434174|RAD001|rad001
1589197|NCT00434174|Everolimus|everolimus
1589198|NCT00434174|Afinitor|afinitor
1589199|NCT00434174|Pemetrexed|pemetrexed
1589200|NCT00434161|Palifermin|palifermin
1589202|NCT00434161|Clinical Trial|clinical trial
1589203|NCT00434161|Oncology|oncology
1589204|NCT00434161|Oral Mucositis|oral mucositis
1589205|NCT00434161|Multiple Myeloma|multiple myeloma
1589206|NCT00434161|Cataract|cataract
1589207|NCT00434148|Cushing's Disease|cushing's disease
1589208|NCT00434148|pasireotide|pasireotide
1589209|NCT00434148|SOM230|som230
1589210|NCT00434135|gemcitabine|gemcitabine
1589211|NCT00434135|pemetrexed|pemetrexed
1589212|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
1589213|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
1589214|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
1589215|NCT00434109|Carcinoid|carcinoid
1589216|NCT00434109|Pancreatic|pancreatic
1589217|NCT00434109|Metastatic|metastatic
1589218|NCT00434109|Neuroendocrine|neuroendocrine
1589219|NCT00434109|Tumors|tumors
1589220|NCT00434109|Hepatic|hepatic
1589221|NCT00434109|Artery|artery
1589222|NCT00434109|Embolization|embolization
1589223|NCT00434109|Angiogenesis|angiogenesis
1589224|NCT00434109|Sunitinib|sunitinib
1589225|NCT00434109|Malate|malate
1589226|NCT00434109|Sutent|sutent
1589227|NCT00434109|Tyrosine|tyrosine
1589228|NCT00434109|Kinase|kinase
1589229|NCT00434109|Inhibitor|inhibitor
1589230|NCT00434096|Obesity disease|obesity disease
1589231|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
1589232|NCT00434083|TREXIMA|trexima
1589233|NCT00434083|MIGRAINE HEADACHES|migraine headaches
1589234|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
1589235|NCT00434070|HIV|hiv
1589236|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
1589237|NCT00434070|Resistance|resistance
1589238|NCT00434070|Monitoring|monitoring
1589239|NCT00434070|TAMS|tams
1589240|NCT00434070|Treatment Experienced|treatment experienced
1589241|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
1589242|NCT00434057|Dermatology|dermatology
1589243|NCT00434057|Skin Cancer|skin cancer
1589244|NCT00434057|Melanoma|melanoma
1589245|NCT00434057|MelaFind|melafind
1589246|NCT00434031|locally advanced|locally advanced
1589247|NCT00434031|stage II|stage ii
1589248|NCT00434031|stage IIIa|stage iiia
1589249|NCT00434031|stage IIIb|stage iiib
1589250|NCT00434031|HER-2 positive|her-2 positive
1589251|NCT00434031|primary|primary
1589252|NCT00434018|Wheelchairs|wheelchairs
1589253|NCT00434018|Safety|safety
1589254|NCT00434005|Air pollution|air pollution
1589255|NCT00434005|diesel|diesel
1589256|NCT00434005|antioxidant|antioxidant
1589257|NCT00434005|oxidative stress|oxidative stress
1589258|NCT00434005|endothelial|endothelial
1589259|NCT00434005|HRV|hrv
1589260|NCT00434005|BAR|bar
1589261|NCT00433992|Mitochondria|mitochondria
1589262|NCT00433992|Fat apoptosis|fat apoptosis
1589263|NCT00433992|Lipoatrophy|lipoatrophy
1589264|NCT00433992|Lipodystrophy|lipodystrophy
1589265|NCT00433992|Thymidine|thymidine
1589266|NCT00433992|Treatment experienced|treatment experienced
1589267|NCT00433979|Anti-HIV agents|anti-hiv agents
1589268|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
1589269|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
1589270|NCT00433979|HAART|haart
1589271|NCT00433979|Pharmacokinetics|pharmacokinetics
1589272|NCT00433979|Protease Inhibitors|protease inhibitors
1589273|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
1589274|NCT00433979|Women|women
1589275|NCT00433966|Myocardial Infarction|myocardial infarction
1589276|NCT00433966|Angioplasty|angioplasty
1589277|NCT00433966|Myocardial Ischemia|myocardial ischemia
1589278|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
1589279|NCT00433966|Stents|stents
1589280|NCT00433966|Heart Disease|heart disease
1589281|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
1589282|NCT00433953|Kidney Transplant|kidney transplant
1589283|NCT00433953|CellCept|cellcept
1589284|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
1589285|NCT00433953|Mycophenolic Acid|mycophenolic acid
1589287|NCT00433940|Corticosteroid|corticosteroid
1589288|NCT00433940|Prednisone|prednisone
1589289|NCT00433927|metastatic|metastatic
1589290|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
1589291|NCT00433901|obesity in children|obesity in children
1589292|NCT00433901|childhood disorders|childhood disorders
1589293|NCT00433901|overweight children|overweight children
1589294|NCT00433901|physical activity|physical activity
1589295|NCT00433901|home environment|home environment
1589296|NCT00433862|Polycythemia Vera|polycythemia vera
1589297|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
1589298|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
1589299|NCT00433862|Janus Kinase 2|janus kinase 2
1589300|NCT00433862|CD177|cd177
1589301|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
1589302|NCT00433862|PV|pv
1589303|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
1589304|NCT00433862|ET|et
1589305|NCT00433862|IM|im
1589306|NCT00433836|Children|children
1589307|NCT00433836|pediatrics|pediatrics
1589308|NCT00433836|High Blood Pressure|high blood pressure
1589309|NCT00433836|Hypertension|hypertension
1589310|NCT00433836|Valsartan|valsartan
1589311|NCT00433836|enalapril|enalapril
1589312|NCT00433823|Very low level of LDL|very low level of ldl
1589313|NCT00433823|Steroid hormones|steroid hormones
1589314|NCT00433823|Atorvastatin|atorvastatin
1589315|NCT00433823|Ezetimibe|ezetimibe
1589316|NCT00433823|Lipoprotein-a|lipoprotein-a
1589317|NCT00433810|obesity|obesity
1589318|NCT00433810|bariatric surgery|bariatric surgery
1589319|NCT00433810|30-day mortality|30-day mortality
1589320|NCT00433797|Prostate cancer|prostate cancer
1589321|NCT00433797|PSA|psa
1589322|NCT00433797|antioxidant|antioxidant
1589323|NCT00433797|phytochemical|phytochemical
1589324|NCT00433797|tomatoes|tomatoes
1589325|NCT00433797|PUFA|pufa
1589326|NCT00433797|selenium|selenium
1589327|NCT00433797|soy|soy
1589328|NCT00433797|pomegranate|pomegranate
1589329|NCT00433797|grapes|grapes
1589330|NCT00433784|clopidogrel|clopidogrel
1589331|NCT00433784|platelet aggregation|platelet aggregation
1589332|NCT00433784|CYP3A|cyp3a
1589333|NCT00433784|H2 haplotype|h2 haplotype
1589334|NCT00433784|polymorphisms|polymorphisms
1589335|NCT00433771|Malignant|malignant
1589336|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
1589337|NCT00433771|Biliary obstruction|biliary obstruction
1589338|NCT00433758|Diabetes|diabetes
1589339|NCT00433758|Blood glucose monitoring|blood glucose monitoring
1589340|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
1589341|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1589342|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1589343|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1589344|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1589345|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
1589346|NCT00433745|Leukemia|leukemia
1589347|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
1589348|NCT00433745|MDS|mds
1589349|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
1589350|NCT00433745|AML|aml
1589351|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1589352|NCT00433745|CML|cml
1589353|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1589354|NCT00433745|ALL|all
1589355|NCT00433732|TREXIMA|trexima
1589356|NCT00433732|MIGRAINE HEADACHES|migraine headaches
1589357|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
1589358|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
1589359|NCT00433719|Tuberculous meningitis|tuberculous meningitis
1589360|NCT00433719|Treatment Naive|treatment naive
1589361|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
1589362|NCT00433680|adolescent|adolescent
1589363|NCT00433680|female|female
1589364|NCT00433680|obesity|obesity
1589365|NCT00433680|body dissatisfaction|body dissatisfaction
1589366|NCT00433667|RWJ-333369|rwj-333369
1589367|NCT00433667|anticonvulsants|anticonvulsants
1589368|NCT00433667|antiepileptic drugs|antiepileptic drugs
1589369|NCT00433654|Bradycardia|bradycardia
1589370|NCT00433654|Slow heart beat|slow heart beat
1589371|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
1589372|NCT00433641|obesity|obesity
1589373|NCT00433641|pharmacogenetics|pharmacogenetics
1589374|NCT00433641|sibutramine|sibutramine
1589375|NCT00433641|adrenergic|adrenergic
1589376|NCT00433641|serotonergic|serotonergic
1589377|NCT00433641|body composition|body composition
1589378|NCT00433641|gastric emptying|gastric emptying
1589379|NCT00433628|Hemoglobin A1C|hemoglobin a1c
1589380|NCT00433628|HIV|hiv
1589381|NCT00433628|Diabetes|diabetes
1589382|NCT00433628|Diabetes Type 2|diabetes type 2
1589383|NCT00433628|Hyperglycemia|hyperglycemia
1589384|NCT00433602|thromboembolism|thromboembolism
1589385|NCT00433602|recurrent breast cancer|recurrent breast cancer
1589386|NCT00433602|stage IV breast cancer|stage iv breast cancer
1589387|NCT00433602|recurrent colon cancer|recurrent colon cancer
1589388|NCT00433602|stage I colon cancer|stage i colon cancer
1589389|NCT00433602|stage II colon cancer|stage ii colon cancer
1589390|NCT00433602|stage III colon cancer|stage iii colon cancer
1589391|NCT00433602|stage IV colon cancer|stage iv colon cancer
1589392|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
1589393|NCT00433602|stage I rectal cancer|stage i rectal cancer
1589394|NCT00433602|stage II rectal cancer|stage ii rectal cancer
1589395|NCT00433602|stage III rectal cancer|stage iii rectal cancer
1589396|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
1589397|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
1589398|NCT00433602|stage I gastric cancer|stage i gastric cancer
1589399|NCT00433602|stage II gastric cancer|stage ii gastric cancer
1589400|NCT00433602|stage III gastric cancer|stage iii gastric cancer
1589401|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
1589402|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1589403|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1589404|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1589405|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1589406|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1589407|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1589408|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
1589409|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1589410|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1589411|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1589412|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1589413|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1589414|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1589415|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1589416|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1589417|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1589418|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1589419|NCT00433602|ovarian sarcoma|ovarian sarcoma
1589420|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
1589421|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
1589422|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
1589423|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
1589424|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
1589425|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
1589426|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
1589427|NCT00433602|stage III prostate cancer|stage iii prostate cancer
1589428|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
1589429|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1589430|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
1589431|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
1589432|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
1589433|NCT00433602|male breast cancer|male breast cancer
1589434|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1589435|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1589436|NCT00433589|stage IA breast cancer|stage ia breast cancer
1589437|NCT00433589|stage IB breast cancer|stage ib breast cancer
1589438|NCT00433589|stage II breast cancer|stage ii breast cancer
1589439|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1589550|NCT00433173|insulin resistance|insulin resistance
1589440|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1589441|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
1589442|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1589443|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1589444|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
1589445|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1589446|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1589447|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1589448|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
1589449|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1589450|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
1589451|NCT00433472|adult glioblastoma|adult glioblastoma
1589452|NCT00433472|adult gliosarcoma|adult gliosarcoma
1589453|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1589454|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1589455|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1589456|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1589457|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1589649|NCT00432822|responsive|responsive
1589458|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1589459|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1589460|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1589461|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
1589462|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
1589463|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1589464|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1589465|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1589466|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1589467|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1589468|NCT00433420|stage II breast cancer|stage ii breast cancer
1589469|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
1589470|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
1589471|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
1589472|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1589473|NCT00433407|stage I breast cancer|stage i breast cancer
1589474|NCT00433407|stage II breast cancer|stage ii breast cancer
1589475|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
1589476|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
1589477|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
1589478|NCT00433407|stage IV breast cancer|stage iv breast cancer
1589479|NCT00433407|male breast cancer|male breast cancer
1589480|NCT00433407|recurrent breast cancer|recurrent breast cancer
1589481|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1589482|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1589483|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1589484|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1589485|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1589486|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1589487|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1589488|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1589489|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1589490|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1589491|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1589492|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1589493|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
1589494|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
1589495|NCT00433407|stage I prostate cancer|stage i prostate cancer
1589496|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
1589497|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
1589498|NCT00433407|stage III prostate cancer|stage iii prostate cancer
1589499|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
1589500|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
1589501|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
1589502|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
1589503|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
1589504|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
1589505|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
1589506|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1589507|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
1589508|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
1589509|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
1589510|NCT00433368|liver cirrhosis,|liver cirrhosis,
1589511|NCT00433368|mental state|mental state
1589512|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
1589513|NCT00433355|Epstein-Barr Virus|epstein-barr virus
1589514|NCT00433342|Antibiotic|antibiotic
1589515|NCT00433342|p-cresol|p-cresol
1589516|NCT00433342|peritoneal dialysis|peritoneal dialysis
1589517|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
1589518|NCT00433329|bosentan|bosentan
1589519|NCT00433329|sildenafil|sildenafil
1589520|NCT00433329|combination therapy|combination therapy
1589521|NCT00433329|Compass 3|compass 3
1589522|NCT00433316|ropivacaine|ropivacaine
1589523|NCT00433316|laparoscopy|laparoscopy
1589524|NCT00433316|intraperitoneal|intraperitoneal
1589525|NCT00433316|nebulization|nebulization
1589526|NCT00433316|pain|pain
1589527|NCT00433316|local analgesic|local analgesic
1589528|NCT00433316|gynecology|gynecology
1589529|NCT00433264|peritoneal dialysis|peritoneal dialysis
1589530|NCT00433264|endothelium|endothelium
1589531|NCT00433264|endothelial dysfunction|endothelial dysfunction
1589532|NCT00433238|elderly|elderly
1589533|NCT00433238|Chinese|chinese
1589534|NCT00433238|community living|community living
1589535|NCT00433238|measurement|measurement
1589536|NCT00433238|depression|depression
1589537|NCT00433238|dementia|dementia
1589538|NCT00433238|Geriatric Depression Scale|geriatric depression scale
1589539|NCT00433238|MiniCog|minicog
1589540|NCT00433212|prematurity|prematurity
1589541|NCT00433212|respiratory insufficiency|respiratory insufficiency
1589747|NCT00432432|Infliximab|infliximab
1589542|NCT00433212|non-invasive ventilation|non-invasive ventilation
1589543|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1589544|NCT00433212|hyaline membrane disease|hyaline membrane disease
1589545|NCT00433199|Hypogonadism|hypogonadism
1589546|NCT00433199|Testosterone Deficiency|testosterone deficiency
1589547|NCT00433186|Scleroderma|scleroderma
1589548|NCT00433173|testosterone|testosterone
1589549|NCT00433173|insulin sensitivity|insulin sensitivity
1589551|NCT00433173|metabolic disorders|metabolic disorders
1589552|NCT00433134|renal transplant recipient|renal transplant recipient
1589553|NCT00433134|adherence|adherence
1589554|NCT00433134|compliance|compliance
1589555|NCT00433134|immunosuppression|immunosuppression
1589556|NCT00433121|Antidepressive Agents|antidepressive agents
1589557|NCT00433121|Neuroleptica|neuroleptica
1589558|NCT00433121|Dementia|dementia
1589559|NCT00433121|Discontinuation study|discontinuation study
1589560|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
1589561|NCT00433108|Hepatitis C|hepatitis c
1589562|NCT00433108|antioxidant|antioxidant
1589563|NCT00433108|liver enzymes|liver enzymes
1589565|NCT00433095|Navelbine|navelbine
1589566|NCT00433095|Herceptin|herceptin
1589567|NCT00433095|oral|oral
1589568|NCT00433095|breast cancer|breast cancer
1589569|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
1589570|NCT00433082|Iran|iran
1589571|NCT00433069|Chronic hepatitis C|chronic hepatitis c
1589572|NCT00433069|Insulin resistance|insulin resistance
1589573|NCT00433069|Pioglitazone|pioglitazone
1589574|NCT00433069|Non-responders|non-responders
1589576|NCT00433056|HIV|hiv
1589577|NCT00433056|CD4|cd4
1589578|NCT00433056|HIV-RNA|hiv-rna
1589579|NCT00433056|HAART|haart
1589580|NCT00433043|Heart Failure|heart failure
1589581|NCT00433043|Beta blockers|beta blockers
1589582|NCT00433043|Resynchronization|resynchronization
1589583|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
1589584|NCT00433043|Candidate for BIVPM|candidate for bivpm
1589585|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
1589586|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1589587|NCT00433030|HIV Viral load|hiv viral load
1589588|NCT00433030|HIV drug Resistance|hiv drug resistance
1589589|NCT00433030|Thailand|thailand
1589590|NCT00433017|Age-related macular degeneration|age-related macular degeneration
1589591|NCT00433017|AMD|amd
1589592|NCT00433017|Choroidal neovascularization|choroidal neovascularization
1589593|NCT00433017|Verteporfin|verteporfin
1589594|NCT00433017|Ranibizumab|ranibizumab
1589595|NCT00433004|Teen|teen
1589596|NCT00433004|Plan B|plan b
1589597|NCT00433004|Post Partum|post partum
1589598|NCT00433004|Emergency Contraception|emergency contraception
1589599|NCT00432991|Nausea|nausea
1589600|NCT00432991|Vomiting|vomiting
1589601|NCT00432991|Cesarean Section|cesarean section
1589602|NCT00432978|hypoxia|hypoxia
1589603|NCT00432978|endothelin|endothelin
1589604|NCT00432978|exercise|exercise
1589605|NCT00432965|Wound closure|wound closure
1589606|NCT00432965|Accelerated healing|accelerated healing
1589607|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
1589608|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
1589609|NCT00432926|HIV|hiv
1589610|NCT00432926|STDs|stds
1589611|NCT00432926|Methamphetamine abuse|methamphetamine abuse
1589612|NCT00432926|MSM|msm
1589613|NCT00432926|HIV Seronegativity|hiv seronegativity
1589614|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
1589615|NCT00432913|EPA|epa
1589616|NCT00432913|EPA 99%|epa 99%
1589617|NCT00432913|Fatty acid|fatty acid
1589618|NCT00432913|omega-3|omega-3
1589619|NCT00432913|apoptosis|apoptosis
1589620|NCT00432913|cell proliferation|cell proliferation
1589621|NCT00432913|colonic mucosa|colonic mucosa
1589622|NCT00432913|polyps|polyps
1589623|NCT00432913|adenomatous polyps|adenomatous polyps
1589624|NCT00432913|endoscopy|endoscopy
1589625|NCT00432913|PUFA|pufa
1589626|NCT00432900|Inflammation|inflammation
1589627|NCT00432900|Neuroimmunology|neuroimmunology
1589628|NCT00432900|Multiple Sclerosis|multiple sclerosis
1589629|NCT00432900|MS|ms
1589630|NCT00432900|Healthy Volunteer|healthy volunteer
1589631|NCT00432900|HV|hv
1589632|NCT00432887|caffeine|caffeine
1589633|NCT00432887|coffee|coffee
1589634|NCT00432887|glucose|glucose
1589635|NCT00432887|insulin|insulin
1589636|NCT00432861|cystic fibrosis|cystic fibrosis
1589637|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
1589638|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
1589639|NCT00432861|steatorrhea|steatorrhea
1589640|NCT00432835|Nausea|nausea
1589641|NCT00432835|Vomiting|vomiting
1589642|NCT00432835|Delayed gastric emptying|delayed gastric emptying
1589643|NCT00432835|Diabetes Mellitus|diabetes mellitus
1589644|NCT00432835|Post-Surgical|post-surgical
1589645|NCT00432835|Idiopathic|idiopathic
1589646|NCT00432822|phenylketonuria|phenylketonuria
1589647|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
1589648|NCT00432822|BH4|bh4
1589650|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
1589651|NCT00432822|newborns|newborns
1589652|NCT00432822|infants|infants
1589655|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1589656|NCT00432809|Obesity|obesity
1589657|NCT00432796|Anticoagulation|anticoagulation
1589658|NCT00432796|Prosthetic heart valves|prosthetic heart valves
1589659|NCT00432796|Atrial fibrillation|atrial fibrillation
1589660|NCT00432796|Bridging Therapy|bridging therapy
1589661|NCT00432796|Thromboembolism|thromboembolism
1589662|NCT00432796|Warfarin|warfarin
1589663|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
1589664|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
1589665|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
1589666|NCT00432744|mitochondrial diseases|mitochondrial diseases
1589667|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
1589668|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
1589669|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
1589670|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
1589671|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
1589672|NCT00432731|Prevention of : Varicella|prevention of : varicella
1589673|NCT00432731|Measles|measles
1589674|NCT00432731|Mumps|mumps
1589675|NCT00432731|Rubella|rubella
1589676|NCT00432718|Pneumonia|pneumonia
1589677|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
1589678|NCT00432718|Prevention|prevention
1589679|NCT00432705|ankle|ankle
1589680|NCT00432705|sensorimotor|sensorimotor
1589681|NCT00432705|reflex|reflex
1589682|NCT00432705|training|training
1589683|NCT00432692|osteoporosis|osteoporosis
1589684|NCT00432692|falls|falls
1589685|NCT00432692|prevention|prevention
1589686|NCT00432692|elderly|elderly
1589687|NCT00432692|exercise|exercise
1589688|NCT00432692|incidence|incidence
1589689|NCT00432692|obstacle avoidance|obstacle avoidance
1589690|NCT00432679|rosiglitazone|rosiglitazone
1589691|NCT00432679|Avandia|avandia
1589692|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
1589693|NCT00432679|diabetes|diabetes
1589694|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
1589695|NCT00432653|rituximab|rituximab
1589696|NCT00432653|therapy|therapy
1589697|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
1589698|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
1589699|NCT00432627|Hepatic impairment|hepatic impairment
1589700|NCT00432627|adults|adults
1589701|NCT00432627|deferasirox|deferasirox
1589702|NCT00432614|Mental Disorder|mental disorder
1589703|NCT00432614|Mood Disorder|mood disorder
1589704|NCT00432614|Depressive Disorder|depressive disorder
1589705|NCT00432601|decision aid|decision aid
1589706|NCT00432601|prostate cancer|prostate cancer
1589707|NCT00432601|patient-physician communication|patient-physician communication
1589708|NCT00432601|decision making|decision making
1589709|NCT00432601|literacy|literacy
1589710|NCT00432588|IUFD|iufd
1589711|NCT00432588|POSTTERM|postterm
1589712|NCT00432588|ROM|rom
1589713|NCT00432575|tobacco use cessation|tobacco use cessation
1589714|NCT00432575|cigarette smokers|cigarette smokers
1589715|NCT00432549|Medication overuse|medication overuse
1589716|NCT00432536|Neuro-monitoring|neuro-monitoring
1589717|NCT00432536|Quality Improvement|quality improvement
1589718|NCT00432536|Cerebral emboli|cerebral emboli
1589719|NCT00432536|Cerebral desaturation|cerebral desaturation
1589720|NCT00432536|Hypotension|hypotension
1589721|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
1589722|NCT00432510|Hereditary angioedema|hereditary angioedema
1589723|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
1589724|NCT00432484|Lingzhi|lingzhi
1589725|NCT00432484|Sen Miao San|sen miao san
1589726|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
1589727|NCT00432471|Skin Cancer|skin cancer
1589728|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
1589729|NCT00432471|Optical Imaging|optical imaging
1589730|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
1589731|NCT00432471|MDM|mdm
1589732|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
1589733|NCT00432445|Children with retinoblastoma|children with retinoblastoma
1589734|NCT00432445|Retinoblastoma|retinoblastoma
1589735|NCT00432445|Pediatrics|pediatrics
1589736|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
1589737|NCT00432445|Radiation Therapy|radiation therapy
1589738|NCT00432445|Tumor of the Eye|tumor of the eye
1589739|NCT00432445|Ophthalmic EUA|ophthalmic eua
1589740|NCT00432445|Examination under anesthesia|examination under anesthesia
1589741|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
1589742|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
1589743|NCT00432445|Extraocular disease|extraocular disease
1589744|NCT00432445|Intraocular procedure|intraocular procedure
1589745|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
1589746|NCT00432432|MTX|mtx
1589748|NCT00432419|HIV|hiv
1589749|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1589750|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
1589751|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
1589752|NCT00432406|TNF-α|tnf-α
1589753|NCT00432406|Cardiovascular risk|cardiovascular risk
1589754|NCT00432406|Immunomodulatory activities|immunomodulatory activities
1589755|NCT00432380|Placebo|placebo
1589756|NCT00432380|Double blind|double blind
1589757|NCT00432380|Gastroenteritis|gastroenteritis
1589758|NCT00432380|Randomized|randomized
1589759|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
1589760|NCT00432367|Malaria in pregnancy|malaria in pregnancy
1589761|NCT00432367|Case management|case management
1589762|NCT00432367|Screening|screening
1589763|NCT00432367|RDT|rdt
1589764|NCT00432367|IPTp|iptp
1589765|NCT00432367|Amodiaquine|amodiaquine
1589766|NCT00432367|Artesunate|artesunate
1589767|NCT00432354|statin|statin
1589768|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
1589769|NCT00432354|microcirculation|microcirculation
1589770|NCT00432302|Cancer|cancer
1589771|NCT00432302|Tumor|tumor
1589772|NCT00432302|Malignancy|malignancy
1589773|NCT00432302|Mass Balance|mass balance
1589774|NCT00432302|Chemotherapy|chemotherapy
1589775|NCT00432302|Drug|drug
1589776|NCT00432302|Cancer Treatment|cancer treatment
1589777|NCT00432302|Intravenous Infusion|intravenous infusion
1589778|NCT00432302|Epothilone|epothilone
1589779|NCT00432302|Solid Tumor|solid tumor
1589780|NCT00432289|neurological function|neurological function
1589781|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
1589782|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
1589783|NCT00432276|Type II Diabetes|type ii diabetes
1589784|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1589785|NCT00432276|Dyslipidemia|dyslipidemia
1589786|NCT00432276|Hyperglycemia|hyperglycemia
1589787|NCT00432276|Drug Therapy|drug therapy
1589788|NCT00432250|Preterm labor|preterm labor
1589789|NCT00432250|Cervical ultrasonography|cervical ultrasonography
1589790|NCT00432250|Hospital stay|hospital stay
1589791|NCT00432198|Insomnia|insomnia
1589792|NCT00432198|Zolpidem|zolpidem
1589793|NCT00432198|Adolescent|adolescent
1589794|NCT00432185|sBCC|sbcc
1589795|NCT00432185|Topical|topical
1589796|NCT00432185|Dermatology|dermatology
1589797|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
1589798|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
1589799|NCT00432159|cervical|cervical
1589800|NCT00432159|spinal|spinal
1589801|NCT00432159|arthroplasty|arthroplasty
1589802|NCT00432159|disc|disc
1589803|NCT00432159|surgical|surgical
1589804|NCT00432159|ACDF|acdf
1589805|NCT00432159|DDD|ddd
1589806|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
1589807|NCT00432133|Physical Activity|physical activity
1589808|NCT00432133|Behavior Change|behavior change
1589809|NCT00432133|Mechanism|mechanism
1589810|NCT00432133|Environmental|environmental
1589811|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
1589812|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
1589813|NCT00432107|Phase II study|phase ii study
1589814|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1589815|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1589816|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1589817|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1589818|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1589819|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1589820|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1589821|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1589822|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1589823|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1589824|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1589825|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1589826|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
1589827|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1589828|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1589829|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
1589830|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1589831|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
1589832|NCT00432094|testicular seminoma|testicular seminoma
1589833|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1589834|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1589835|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
1589836|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
1589927|NCT00431782|Anticoagulation|anticoagulation
1589837|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
1589838|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
1589839|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1589840|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
1589841|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1589842|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1589843|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1589844|NCT00432094|adult teratoma|adult teratoma
1589845|NCT00432094|childhood teratoma|childhood teratoma
1589846|NCT00432094|testicular immature teratoma|testicular immature teratoma
1589847|NCT00432094|testicular mature teratoma|testicular mature teratoma
1589848|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1589849|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1589850|NCT00432081|Dementia|dementia
1589851|NCT00432081|Inflammation|inflammation
1589852|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
1589853|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1589854|NCT00432081|Drug Therapy|drug therapy
1589855|NCT00432068|Healthy volunteers|healthy volunteers
1589856|NCT00432068|octreotide pamoate|octreotide pamoate
1589857|NCT00432068|pharmacokinetics|pharmacokinetics
1589859|NCT00432055|Cerebral Palsy|cerebral palsy
1589860|NCT00432055|Spastic contractures|spastic contractures
1589861|NCT00432055|Botulinum toxin type A|botulinum toxin type a
1589862|NCT00432042|Mumps and Rubella|mumps and rubella
1589863|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
1589864|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
1589865|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
1589866|NCT00432029|Forearm blood flow|forearm blood flow
1589867|NCT00432029|Retinal vessel diameter|retinal vessel diameter
1589868|NCT00432029|Endothelial dysfunction|endothelial dysfunction
1589869|NCT00432016|HIV|hiv
1589870|NCT00432016|pharmacokinetics|pharmacokinetics
1589871|NCT00432016|zidovudine|zidovudine
1589872|NCT00432016|amdoxovir|amdoxovir
1589873|NCT00432016|DAPD|dapd
1589874|NCT00432016|AMDX|amdx
1589875|NCT00432016|Treatment Naive|treatment naive
1589876|NCT00432003|Treatment Experienced|treatment experienced
1589877|NCT00432003|HIV|hiv
1589878|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1589879|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
1589880|NCT00431977|Diabetes Mellitus|diabetes mellitus
1589881|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
1589882|NCT00431951|Healthy Volunteers|healthy volunteers
1589883|NCT00431925|head and neck cancer|head and neck cancer
1589884|NCT00431925|radiation therapy|radiation therapy
1589885|NCT00431925|chemotherapy|chemotherapy
1589886|NCT00431925|mucositis|mucositis
1589887|NCT00431925|cytokines|cytokines
1589888|NCT00431925|gastrostomy|gastrostomy
1589889|NCT00431925|radiotherapy|radiotherapy
1589890|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1589891|NCT00431912|mycosis fungoides|mycosis fungoides
1589892|NCT00431912|Sézary syndrome|sézary syndrome
1589893|NCT00431912|APO866|apo866
1589894|NCT00431912|phase II study|phase ii study
1589895|NCT00431899|nutrition|nutrition
1589896|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
1589897|NCT00431899|insulin resistance|insulin resistance
1589898|NCT00431886|Chest pains|chest pains
1589899|NCT00431886|Computed tomography|computed tomography
1589900|NCT00431886|Emergency|emergency
1589901|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
1589902|NCT00431873|Phase II|phase ii
1589903|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
1589904|NCT00431847|Anesthesia, Regional|anesthesia, regional
1589905|NCT00431847|Causalgia|causalgia
1589906|NCT00431847|Trauma|trauma
1589907|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
1589908|NCT00431847|Neuropathic Pain|neuropathic pain
1589909|NCT00431847|PTSD|ptsd
1590782|NCT00428636|ileostomy|ileostomy
1589910|NCT00431847|Combat Stress Disorders|combat stress disorders
1589911|NCT00431847|Afghan War, 2001-|afghan war, 2001-
1589912|NCT00431847|Iraq War, 2003-|iraq war, 2003-
1589913|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
1589914|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
1589915|NCT00431821|Exercise|exercise
1589916|NCT00431821|Rehabilitation|rehabilitation
1589917|NCT00431821|Stroke|stroke
1589918|NCT00431808|Malaria|malaria
1589919|NCT00431808|vaccine|vaccine
1589920|NCT00431808|Apical Membrane Antigene|apical membrane antigene
1589921|NCT00431808|Mali|mali
1589922|NCT00431808|Adults|adults
1589923|NCT00431795|Advanced breast cancer|advanced breast cancer
1589924|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
1589925|NCT00431795|Epirubicin|epirubicin
1589926|NCT00431782|Atrial fibrillation|atrial fibrillation
1589928|NCT00431769|Multiple myeloma|multiple myeloma
1589929|NCT00431769|Bortezomib|bortezomib
1589930|NCT00431769|Dexamethasone|dexamethasone
1589931|NCT00431769|VELCADE|velcade
1589932|NCT00431756|Barrett's esophagus|barrett's esophagus
1589933|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1589934|NCT00431756|esophageal cancer|esophageal cancer
1589935|NCT00431756|DNA methylation|dna methylation
1589936|NCT00431743|Fluid Therapy|fluid therapy
1589937|NCT00431743|Crystalloid|crystalloid
1589938|NCT00431743|Colloid|colloid
1589939|NCT00431743|Perioperative|perioperative
1589940|NCT00431743|Optimization|optimization
1589941|NCT00431743|Goal-directed Therapy|goal-directed therapy
1589942|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
1589943|NCT00431717|Diabetes Mellitus|diabetes mellitus
1589944|NCT00431704|advanced|advanced
1589945|NCT00431704|her-2 positive|her-2 positive
1589946|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
1589947|NCT00431665|Renal Plasma Flow|renal plasma flow
1589948|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
1589949|NCT00431665|Free fatty acids|free fatty acids
1589950|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
1589951|NCT00431639|Pain|pain
1589952|NCT00431639|Oncology|oncology
1589953|NCT00431639|Cancer Pain|cancer pain
1589954|NCT00431626|Benign|benign
1589955|NCT00431626|Prostatic|prostatic
1589956|NCT00431626|Hyperplasia|hyperplasia
1589957|NCT00431626|Lower|lower
1589958|NCT00431626|Urinary|urinary
1589959|NCT00431626|Track|track
1589960|NCT00431626|Symptoms|symptoms
1589961|NCT00431626|Laser|laser
1589962|NCT00431626|Transurethral|transurethral
1589963|NCT00431626|Prostate|prostate
1589964|NCT00431613|NSCLC|nsclc
1589965|NCT00431613|Induction chemotherapy|induction chemotherapy
1589966|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
1589967|NCT00431613|Consolidation therapy|consolidation therapy
1589968|NCT00431613|Docetaxel|docetaxel
1589969|NCT00431613|Gemcitabine|gemcitabine
1589970|NCT00431613|Carboplatin|carboplatin
1589971|NCT00431600|Regional Blood Flow|regional blood flow
1589972|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
1589973|NCT00431600|CDOCT|cdoct
1589974|NCT00431600|Retinal Blood Flow|retinal blood flow
1589975|NCT00431600|Hyperoxia|hyperoxia
1589976|NCT00431600|Vasoconstriction|vasoconstriction
1589977|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
1589978|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
1589979|NCT00431587|morbid obesity|morbid obesity
1589980|NCT00431587|metabolic syndrome|metabolic syndrome
1589981|NCT00431587|visceral fat|visceral fat
1589982|NCT00431587|peripheral fat|peripheral fat
1589983|NCT00431574|schizophrenia|schizophrenia
1589984|NCT00431574|schizoaffective|schizoaffective
1589985|NCT00431574|antipsychotic|antipsychotic
1589986|NCT00431574|randomized control trial|randomized control trial
1589987|NCT00431561|Glioblastoma|glioblastoma
1589988|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
1589989|NCT00431561|Antisense|antisense
1589990|NCT00431561|Cancer|cancer
1589991|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
1589992|NCT00431561|Targeted therapy|targeted therapy
1589993|NCT00431561|Immunotherapy|immunotherapy
1589994|NCT00431561|Brain tumor|brain tumor
1589995|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
1589996|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
1589997|NCT00431561|Locoregional application|locoregional application
1589998|NCT00431535|Fluid|fluid
1589999|NCT00431535|SvO2|svo2
1590000|NCT00431535|Mobilisation|mobilisation
1590001|NCT00431535|Orthostatic function|orthostatic function
1590002|NCT00431509|Osteoarthritis|osteoarthritis
1590003|NCT00431509|Arthroplasty|arthroplasty
1590004|NCT00431509|Replacement|replacement
1590005|NCT00431509|Knee|knee
1590006|NCT00431509|Instrumentation|instrumentation
1590007|NCT00431496|Anemia|anemia
1590008|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
1590009|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1590784|NCT00428636|proctectomy|proctectomy
1590010|NCT00431483|antibacterial agents|antibacterial agents
1590011|NCT00431483|surgery|surgery
1590012|NCT00431483|pharmacist|pharmacist
1590013|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
1590014|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
1590015|NCT00431444|Osteoporosis|osteoporosis
1590016|NCT00431444|Post-menopausal|post-menopausal
1590017|NCT00431444|Bone mineral density|bone mineral density
1590018|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
1590019|NCT00431405|cardiovascular disease|cardiovascular disease
1590020|NCT00431405|coronary disease|coronary disease
1590021|NCT00431392|Choroidal blood flow|choroidal blood flow
1590022|NCT00431392|NO-synthase|no-synthase
1590023|NCT00431392|light/dark transition|light/dark transition
1590024|NCT00431366|Fatigue|fatigue
1590025|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
1590026|NCT00431366|Parkinson's Disease|parkinson's disease
1590027|NCT00431366|Peg Board Test|peg board test
1590028|NCT00431366|Levodopa|levodopa
1590029|NCT00431366|Parkinson Disease|parkinson disease
1590030|NCT00431366|PD|pd
1590031|NCT00431340|Multiple myeloma|multiple myeloma
1590032|NCT00431340|myeloma|myeloma
1590033|NCT00431340|plasma cell myeloma|plasma cell myeloma
1590034|NCT00431340|bone marrow cancer|bone marrow cancer
1590035|NCT00431340|myelomatosis|myelomatosis
1590036|NCT00431340|Kahler's disease|kahler's disease
1590037|NCT00431340|PXD101|pxd101
1590038|NCT00431340|belinostat|belinostat
1590039|NCT00431340|bortezomib|bortezomib
1590040|NCT00431327|patient navigator|patient navigator
1590041|NCT00431327|peer support|peer support
1590042|NCT00431327|colonoscopy|colonoscopy
1590043|NCT00431327|adherence|adherence
1590044|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
1590045|NCT00431314|End Stage Renal Disease|end stage renal disease
1590046|NCT00431314|Hemodialysis|hemodialysis
1590047|NCT00431314|Critical Limb Ischemia|critical limb ischemia
1590048|NCT00431314|Autofluorescence|autofluorescence
1590049|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
1590050|NCT00431301|Epidemiology|epidemiology
1590051|NCT00431301|Case-Control|case-control
1590052|NCT00431301|Genetic|genetic
1590053|NCT00431301|Environmental|environmental
1590054|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
1590055|NCT00431301|Movement Disorders|movement disorders
1590056|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
1590057|NCT00431301|Parkinson Plus|parkinson plus
1590058|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
1590059|NCT00431301|PSP|psp
1590060|NCT00431288|nutrition|nutrition
1590061|NCT00431288|adolescent nutrition|adolescent nutrition
1590062|NCT00431288|blood pressure|blood pressure
1590063|NCT00431288|hypertension|hypertension
1590064|NCT00431288|diet therapy|diet therapy
1590065|NCT00431288|patient education|patient education
1590066|NCT00431262|alcoholism|alcoholism
1590067|NCT00431262|antabuse|antabuse
1590068|NCT00431262|disulfiram|disulfiram
1590069|NCT00431262|abstinence|abstinence
1590070|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
1590071|NCT00431236|cisplatin|cisplatin
1590072|NCT00431236|CINV|cinv
1590073|NCT00431236|highly emetogenic|highly emetogenic
1590074|NCT00431223|fMRI|fmri
1590075|NCT00431223|working memory|working memory
1590076|NCT00431223|schizophrenia|schizophrenia
1590077|NCT00431223|treatment refractory|treatment refractory
1590078|NCT00431223|cognitive skills training|cognitive skills training
1590079|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
1590080|NCT00431223|cognitive remediation|cognitive remediation
1590081|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
1590082|NCT00431210|NPC|npc
1590083|NCT00431210|EPV|epv
1590084|NCT00431184|bipolar disorder|bipolar disorder
1590085|NCT00431184|bipolar mania|bipolar mania
1590086|NCT00431184|schizoaffective disorder|schizoaffective disorder
1590087|NCT00431184|schizoaffective mania|schizoaffective mania
1590088|NCT00431184|mania|mania
1590089|NCT00431184|kappa opiates|kappa opiates
1590090|NCT00431184|opiates|opiates
1590091|NCT00431171|spinal cord injuries|spinal cord injuries
1590092|NCT00431171|lithium|lithium
1590093|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1590094|NCT00431158|ARDS|ards
1590095|NCT00431158|Respiratory failure|respiratory failure
1590096|NCT00431158|Mechanical Ventilation|mechanical ventilation
1590097|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
1590098|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
1590099|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
1590100|NCT00431119|bullous pemphigoid|bullous pemphigoid
1590101|NCT00431119|immunosuppressants|immunosuppressants
1590102|NCT00431119|corticosteroids|corticosteroids
1590103|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
1590104|NCT00431106|Breast cancer|breast cancer
1590105|NCT00431106|Chemotherapy|chemotherapy
1590106|NCT00431106|Vinorelbine|vinorelbine
1590107|NCT00431106|Gemcitabine|gemcitabine
1590108|NCT00431106|Capecitabine|capecitabine
1590109|NCT00431080|Early breast cancer|early breast cancer
1590110|NCT00431080|Axillary node positive|axillary node positive
1590111|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
1590112|NCT00431080|Dose dense|dose dense
1590113|NCT00431080|Docetaxel|docetaxel
1590114|NCT00431080|Paclitaxel|paclitaxel
1590115|NCT00431080|FEC|fec
1590116|NCT00431054|Ovarian Cancer|ovarian cancer
1590117|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
1590118|NCT00431054|Peritoneal Cancer|peritoneal cancer
1590119|NCT00431054|Perifosine|perifosine
1590120|NCT00431054|Docetaxel|docetaxel
1590121|NCT00431054|Taxotere|taxotere
1590122|NCT00431041|Solifenacin succinate|solifenacin succinate
1590123|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
1590124|NCT00431041|Xerostomia|xerostomia
1590125|NCT00431041|Overactive bladder|overactive bladder
1590126|NCT00431028|Cataract|cataract
1590127|NCT00431028|Endophthalmitis|endophthalmitis
1590129|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
1590130|NCT00431028|Drug Delivery Systems|drug delivery systems
1590131|NCT00431015|Lung Cancer|lung cancer
1590132|NCT00431015|Cancer of the lung|cancer of the lung
1590133|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
1590134|NCT00431002|Exercise|exercise
1590135|NCT00431002|Resistance training|resistance training
1590136|NCT00430989|Anaesthesia|anaesthesia
1590137|NCT00430989|Major Surgery|major surgery
1590138|NCT00430989|Coronary artery disease|coronary artery disease
1590139|NCT00430989|Nitrous oxide|nitrous oxide
1590140|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
1590141|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
1590142|NCT00430976|psychomotor function|psychomotor function
1590143|NCT00430976|neuromuscular system|neuromuscular system
1590144|NCT00430976|memory|memory
1590145|NCT00430976|brain electrical activity|brain electrical activity
1590146|NCT00430976|Mental Processes|mental processes
1590147|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
1590148|NCT00430950|Essential Hypertension|essential hypertension
1590149|NCT00430950|Combination Therapy|combination therapy
1590150|NCT00430950|Fixed-Combination Dose|fixed-combination dose
1590151|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
1590152|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
1590153|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
1590154|NCT00430924|Proteinuria|proteinuria
1590155|NCT00430924|Aldosterone|aldosterone
1590156|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
1590157|NCT00430911|malignant gliomas|malignant gliomas
1590158|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
1590159|NCT00430885|Heart failure|heart failure
1590160|NCT00430885|Myocardial infarction|myocardial infarction
1590161|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
1590162|NCT00430872|Spinal Cord Tumor|spinal cord tumor
1590163|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
1590164|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
1590165|NCT00430872|Symptoms|symptoms
1590166|NCT00430872|Survey|survey
1590167|NCT00430859|Sepsis|sepsis
1590168|NCT00430859|Alkaline|alkaline
1590169|NCT00430859|Phosphatase|phosphatase
1590170|NCT00430859|Lipopolysaccharide|lipopolysaccharide
1590171|NCT00430846|Antigens,CD30|antigens,cd30
1590172|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
1590173|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
1590174|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1590175|NCT00430846|Disease, Hodgkin|disease, hodgkin
1590176|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1590177|NCT00430846|Hematologic Diseases|hematologic diseases
1590178|NCT00430846|Lymphoma|lymphoma
1590179|NCT00430820|Biomarkers|biomarkers
1590180|NCT00430820|Proteomics|proteomics
1590181|NCT00430820|Mass spectrometry|mass spectrometry
1590182|NCT00430820|Atherosclerosis|atherosclerosis
1590183|NCT00430820|Acute coronary syndromes|acute coronary syndromes
1590184|NCT00430820|Myocardial infarction|myocardial infarction
1590185|NCT00430820|Coronary artery disease|coronary artery disease
1590186|NCT00430807|giant cell arteritis,|giant cell arteritis,
1590187|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
1590188|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
1590189|NCT00430807|corticodependence|corticodependence
1590190|NCT00430794|resistant hypertension|resistant hypertension
1590191|NCT00430794|Spironolactone|spironolactone
1590192|NCT00430794|double-blind|double-blind
1590193|NCT00430794|randomised controlled trial|randomised controlled trial
1590194|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1590195|NCT00430781|pazopanib|pazopanib
1590196|NCT00430781|ErB1/ErB2|erb1/erb2
1590197|NCT00430781|lapatinib|lapatinib
1590198|NCT00430781|persistent|persistent
1590199|NCT00430781|VEGF|vegf
1590200|NCT00430781|recurrent|recurrent
1590201|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
1590202|NCT00430781|advanced|advanced
1590203|NCT00430781|FIGO Stage IVB|figo stage ivb
1590204|NCT00430768|Gene Transfer Techniques|gene transfer techniques
1590205|NCT00430768|Gene Therapy|gene therapy
1590207|NCT00430768|AAT|aat
1590208|NCT00430768|Phase I|phase i
1590209|NCT00430768|Intramuscular transfer|intramuscular transfer
1590210|NCT00430729|Roflumilast|roflumilast
1590211|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
1590212|NCT00430703|body weight support treadmill training|body weight support treadmill training
1590213|NCT00430703|Electroencephalogram|electroencephalogram
1590214|NCT00430703|Event Related Potentials|event related potentials
1590215|NCT00430664|pleurodesis|pleurodesis
1590216|NCT00430664|talc|talc
1590217|NCT00430664|iodopovidone|iodopovidone
1590218|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
1590219|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
1590220|NCT00430651|Docetaxel|docetaxel
1590221|NCT00430638|Hypertension|hypertension
1590222|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
1590223|NCT00430638|Calcium Channel Blocker|calcium channel blocker
1590224|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
1590225|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
1590226|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
1590227|NCT00430625|VPRIV®|vpriv®
1590228|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
1590229|NCT00430625|Gaucher disease|gaucher disease
1590230|NCT00430625|glucocerebrosidase|glucocerebrosidase
1590231|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
1590232|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
1590233|NCT00430625|glucosylceramidase|glucosylceramidase
1590234|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
1590235|NCT00430625|gene activation|gene activation
1590236|NCT00430625|human|human
1590237|NCT00430612|Myocardial Infarction|myocardial infarction
1590238|NCT00430612|Heart Attack|heart attack
1590239|NCT00430612|Beta Blockers|beta blockers
1590240|NCT00430612|Survival|survival
1590241|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
1590242|NCT00430573|d-cycloserine|d-cycloserine
1590243|NCT00430573|cognitive enhancer|cognitive enhancer
1590244|NCT00430573|drug dependence|drug dependence
1590245|NCT00430573|opiate dependence|opiate dependence
1590246|NCT00430573|exposure|exposure
1590247|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
1590248|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
1590249|NCT00430573|DCS|dcs
1590250|NCT00430560|work therapy|work therapy
1590251|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
1590252|NCT00430560|schizophrenia|schizophrenia
1590253|NCT00430560|schizoaffective disorder|schizoaffective disorder
1590254|NCT00430560|treatment outcome|treatment outcome
1590255|NCT00430534|Epstein Barr Virus|epstein barr virus
1590256|NCT00430534|Belgium|belgium
1590257|NCT00430534|Infectious mononucleosis|infectious mononucleosis
1590258|NCT00430521|Pandemic Flu|pandemic flu
1590259|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
1590260|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
1590261|NCT00430508|Essential Hypertension|essential hypertension
1590262|NCT00430508|Combination Therapy|combination therapy
1590263|NCT00430508|Fixed-Combination Dose|fixed-combination dose
1590264|NCT00430495|atacicept|atacicept
1590265|NCT00430495|arthritis|arthritis
1590266|NCT00430482|Substance Dependence|substance dependence
1590267|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
1590268|NCT00430482|Opiate Dependence|opiate dependence
1590269|NCT00430482|Treatment Moderators|treatment moderators
1590270|NCT00430469|Lactoferrin|lactoferrin
1590271|NCT00430469|hLF|hlf
1590272|NCT00430469|Neutropenia|neutropenia
1590273|NCT00430469|Myeloablative|myeloablative
1590274|NCT00430469|Treatment|treatment
1590275|NCT00430469|Fungal|fungal
1590276|NCT00430469|Bacterial|bacterial
1590277|NCT00430469|Infections|infections
1590278|NCT00430469|Bone marrow transplant|bone marrow transplant
1590279|NCT00430456|Aerobic exercise|aerobic exercise
1590280|NCT00430456|Balance, postural|balance, postural
1590281|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
1590282|NCT00430456|Gait|gait
1590283|NCT00430456|MRI, functional|mri, functional
1590284|NCT00430456|Physical therapy techniques|physical therapy techniques
1590285|NCT00430456|Self Efficacy|self efficacy
1590286|NCT00430456|Treadmill test|treadmill test
1590287|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1590288|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
1590289|NCT00430443|Annamycin|annamycin
1590290|NCT00430443|Liposomal Annamycin|liposomal annamycin
1590291|NCT00430417|Pregnancy|pregnancy
1590292|NCT00430417|Lactation|lactation
1590293|NCT00430417|Endocrine System Diseases|endocrine system diseases
1590294|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
1590295|NCT00430417|Hormone|hormone
1590296|NCT00430417|Physiologic Properties|physiologic properties
1590297|NCT00430391|DVD|dvd
1590298|NCT00430391|Multi-media|multi-media
1590299|NCT00430391|Schizophrenia|schizophrenia
1590300|NCT00430391|Normal Comparison|normal comparison
1590301|NCT00430391|Consent procedures|consent procedures
1590302|NCT00430378|Xerostomia|xerostomia
1590303|NCT00430378|Dry Mouth|dry mouth
1590304|NCT00430378|Mouth Dryness|mouth dryness
1590305|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
1590306|NCT00430378|Acupuncture|acupuncture
1590307|NCT00430365|Myeloma|myeloma
1590308|NCT00430365|Revlimid|revlimid
1590309|NCT00430365|Maintenance therapy|maintenance therapy
1590310|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1590311|NCT00430313|Nausea|nausea
1590312|NCT00430313|Vomiting|vomiting
1590313|NCT00430313|Electro-Stimulation|electro-stimulation
1590314|NCT00430313|ES|es
1590315|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
1590316|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
1590317|NCT00430313|TAI|tai
1590318|NCT00430313|transarterial infusion|transarterial infusion
1590319|NCT00430313|liver metastasis|liver metastasis
1590320|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
1590324|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
1590325|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1590326|NCT00430300|Lung Function testing|lung function testing
1590327|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
1590328|NCT00430287|low tension glaucoma|low tension glaucoma
1590329|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
1590330|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
1590331|NCT00430274|glaucoma|glaucoma
1590332|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
1590333|NCT00430274|optical coherence tomography|optical coherence tomography
1590334|NCT00430274|automated microperimetry|automated microperimetry
1590335|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
1590336|NCT00430261|BAC|bac
1590337|NCT00430261|adenocarcinoma|adenocarcinoma
1590338|NCT00430261|lung cancer|lung cancer
1590339|NCT00430261|oral|oral
1590340|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
1590341|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
1590342|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
1590343|NCT00430248|tophi|tophi
1590344|NCT00430248|hyperuricemia|hyperuricemia
1590345|NCT00430248|uric acid|uric acid
1590346|NCT00430248|Drug Therapy|drug therapy
1590347|NCT00430235|prostate|prostate
1590348|NCT00430235|cancer|cancer
1590349|NCT00430235|BAY 43-9006|bay 43-9006
1590350|NCT00430183|stage I prostate cancer|stage i prostate cancer
1590351|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
1590352|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
1590353|NCT00430183|stage III prostate cancer|stage iii prostate cancer
1590354|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1590355|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
1590356|NCT00430170|adenosine|adenosine
1590357|NCT00430170|dipyridamole|dipyridamole
1590358|NCT00430170|caffeine|caffeine
1590359|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
1590360|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1590361|NCT00430157|Inflammation|inflammation
1590362|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1590363|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1590364|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1590365|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1590366|NCT00430105|Vasculitis|vasculitis
1590367|NCT00430105|ANCA|anca
1590368|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
1590369|NCT00430105|Renal vasculitis|renal vasculitis
1590370|NCT00430105|Cyclophosphamide|cyclophosphamide
1590371|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1590372|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1590373|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1590374|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1590375|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1590376|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1590377|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1590378|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1590379|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1590380|NCT00430040|Hypertension|hypertension
1590381|NCT00430040|Carvedilol CR|carvedilol cr
1590382|NCT00430040|Beta-blocker|beta-blocker
1590383|NCT00430040|Oxidative stress|oxidative stress
1590384|NCT00430040|Inflammation|inflammation
1590385|NCT00430040|Vascular benefits|vascular benefits
1590386|NCT00430027|Esophageal|esophageal
1590387|NCT00430027|Esophagus|esophagus
1590388|NCT00430014|Advanced Cancer|advanced cancer
1590389|NCT00430014|Relapsed|relapsed
1590390|NCT00430014|Atiprimod|atiprimod
1590391|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
1590392|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
1590393|NCT00429988|breast cancer|breast cancer
1590394|NCT00429975|fluorquinolones,|fluorquinolones,
1590395|NCT00429975|b-lactams,|b-lactams,
1590396|NCT00429975|immunomodulation.|immunomodulation.
1590397|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
1590398|NCT00429962|age-related macular degeneration|age-related macular degeneration
1590399|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
1590400|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
1590401|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
1590402|NCT00429962|Visudyne®|visudyne®
1590403|NCT00429962|photodynamic therapy|photodynamic therapy
1590404|NCT00429949|Dasatinib|dasatinib
1590405|NCT00429949|Plateau phase|plateau phase
1590406|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
1590407|NCT00429936|Geographic Atrophy|geographic atrophy
1590504|NCT00429507|Radiation Therapy|radiation therapy
1590408|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1590507|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
1590409|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1590410|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1590411|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1590412|NCT00429897|Hypertension|hypertension
1590413|NCT00429897|Low Renin|low renin
1590414|NCT00429884|Atrial fibrillation|atrial fibrillation
1590415|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
1590416|NCT00429871|First line chemotherapy;|first line chemotherapy;
1590417|NCT00429871|Docetaxel;|docetaxel;
1590418|NCT00429871|Epirubicin;|epirubicin;
1590419|NCT00429871|Capecitabine|capecitabine
1590420|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
1590421|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
1590422|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1590423|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
1590424|NCT00429845|HIV|hiv
1590425|NCT00429845|HAART|haart
1590426|NCT00429845|Nutrition|nutrition
1590427|NCT00429845|Dyslipidemia|dyslipidemia
1590428|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
1590429|NCT00429806|Vaginal atrophy|vaginal atrophy
1590430|NCT00429806|DHEA|dhea
1590431|NCT00429806|Prasterone|prasterone
1590432|NCT00429806|Menopause|menopause
1590433|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
1590434|NCT00429780|Alum-ALM|alum-alm
1590435|NCT00429780|First generation vaccine|first generation vaccine
1590436|NCT00429780|Leishmanin positive|leishmanin positive
1590437|NCT00429780|Healthy Volunteers|healthy volunteers
1590438|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
1590439|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
1590440|NCT00429767|Opioid|opioid
1590441|NCT00429767|Cocaine|cocaine
1590442|NCT00429767|Drug Self Administration|drug self administration
1590443|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
1590444|NCT00429728|Pharmacokinetics,|pharmacokinetics,
1590445|NCT00429728|tolerability,|tolerability,
1590446|NCT00429728|healthy,|healthy,
1590447|NCT00429728|subjects,|subjects,
1590448|NCT00429728|smokers,|smokers,
1590449|NCT00429728|non-smokers|non-smokers
1590450|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
1590451|NCT00429715|Alum-ALM|alum-alm
1590452|NCT00429715|First generation vaccine|first generation vaccine
1590453|NCT00429715|Healthy volunteers|healthy volunteers
1590454|NCT00429715|No response to leishmanin|no response to leishmanin
1590455|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
1590456|NCT00429702|nausea|nausea
1590457|NCT00429702|vomiting|vomiting
1590458|NCT00429702|emetic chemotherapy|emetic chemotherapy
1590459|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1590460|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
1590461|NCT00429689|Male|male
1590462|NCT00429689|18-65|18-65
1590463|NCT00429689|Major Depression|major depression
1590464|NCT00429676|Randomized|randomized
1590465|NCT00429676|Controlled|controlled
1590466|NCT00429676|Trial|trial
1590467|NCT00429676|Delirium|delirium
1590468|NCT00429676|Haloperidol|haloperidol
1590469|NCT00429663|distal femur|distal femur
1590470|NCT00429663|femur fracture|femur fracture
1590471|NCT00429650|Weight maintenance|weight maintenance
1590472|NCT00429650|Weight loss|weight loss
1590473|NCT00429637|EBC pH|ebc ph
1590474|NCT00429637|Airway acidification|airway acidification
1590475|NCT00429637|Condensimetry|condensimetry
1590476|NCT00429637|ARDS|ards
1590477|NCT00429637|RSV|rsv
1590478|NCT00429637|ALI|ali
1590479|NCT00429637|Airway reconstruction|airway reconstruction
1590480|NCT00429624|Neck Pain|neck pain
1590481|NCT00429624|Chiropractic manipulation|chiropractic manipulation
1590482|NCT00429624|Randomized controlled trial|randomized controlled trial
1590483|NCT00429611|biphasic defibrillation|biphasic defibrillation
1590484|NCT00429611|inhospital|inhospital
1590485|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
1590486|NCT00429611|defibrillation efficacy|defibrillation efficacy
1590487|NCT00429611|high energy versus low energy|high energy versus low energy
1590488|NCT00429611|cardiac arrest patients|cardiac arrest patients
1590489|NCT00429585|tibia fracture|tibia fracture
1590490|NCT00429585|proximal tibia|proximal tibia
1590491|NCT00429572|Breast Cancer|breast cancer
1590492|NCT00429572|PBPC Transplantation|pbpc transplantation
1590493|NCT00429572|Stem Cell Infusion|stem cell infusion
1590494|NCT00429572|Fludarabine|fludarabine
1590495|NCT00429572|Melphalan|melphalan
1590497|NCT00429559|Ovarian cancer;|ovarian cancer;
1590498|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
1590499|NCT00429546|Disclosure|disclosure
1590500|NCT00429546|Serostatus|serostatus
1590501|NCT00429507|Breast Cancer|breast cancer
1590502|NCT00429507|Blood Stem Cell|blood stem cell
1590503|NCT00429507|Bone Metastases|bone metastases
1590505|NCT00429507|Gamma Camera|gamma camera
1590506|NCT00429507|Sm-EDTMP|sm-edtmp
1590508|NCT00429507|Stem Cell Transplant|stem cell transplant
1590509|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
1590510|NCT00429507|PBSCT|pbsct
1590511|NCT00429507|Questionnaire|questionnaire
1590512|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1590513|NCT00429494|GnRH Analogue|gnrh analogue
1590514|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
1590515|NCT00429494|GnRH-a|gnrh-a
1590516|NCT00429494|Ovarian Function|ovarian function
1590517|NCT00429494|Fertility|fertility
1590518|NCT00429494|Leuprolide Acetate|leuprolide acetate
1590519|NCT00429494|Lupron Depot|lupron depot
1590520|NCT00429494|premature ovarian failure|premature ovarian failure
1590521|NCT00429494|POF|pof
1590522|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
1590523|NCT00429494|absence of menstruation|absence of menstruation
1590524|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
1590525|NCT00429481|Gastroenteritis|gastroenteritis
1590526|NCT00429481|Vomiting|vomiting
1590527|NCT00429455|Fertility|fertility
1590528|NCT00429455|Menopause|menopause
1590529|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1590530|NCT00429455|Questionnaire|questionnaire
1590531|NCT00429455|Survey|survey
1590532|NCT00429442|Simvastatin|simvastatin
1590533|NCT00429442|CNS Inflammation|cns inflammation
1590534|NCT00429442|Copaxone|copaxone
1590535|NCT00429429|Peanut allergy|peanut allergy
1590536|NCT00429416|Hematologic Malignancies|hematologic malignancies
1590537|NCT00429416|GVHD|gvhd
1590538|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
1590539|NCT00429416|LLME|llme
1590540|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
1590541|NCT00429416|CD34- fraction|cd34- fraction
1590542|NCT00429416|Cyclosporine|cyclosporine
1590543|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
1590544|NCT00429416|HSCT|hsct
1590545|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1590546|NCT00429403|Breast Cancer|breast cancer
1590547|NCT00429403|Chemotherapy|chemotherapy
1590548|NCT00429403|Ovarian Function|ovarian function
1590549|NCT00429403|Goserelin|goserelin
1590550|NCT00429403|Zoladex|zoladex
1590551|NCT00429403|Ovary function|ovary function
1590552|NCT00429403|Fertility|fertility
1590553|NCT00429403|Early Menopause|early menopause
1590554|NCT00429390|Metabolic syndrome|metabolic syndrome
1590555|NCT00429390|Ramadan Fasting|ramadan fasting
1590556|NCT00429390|Insulin sensitivity|insulin sensitivity
1590557|NCT00429390|Iran|iran
1590558|NCT00429377|tacrolimus|tacrolimus
1590559|NCT00429377|FK506|fk506
1590560|NCT00429377|lupus nephritis|lupus nephritis
1590561|NCT00429364|Aortic Root Dissection|aortic root dissection
1590562|NCT00429364|Aortic Root Dilation|aortic root dilation
1590563|NCT00429364|Pediatric Heart Network|pediatric heart network
1590564|NCT00429338|Genitourinary|genitourinary
1590565|NCT00429338|Prostate Cancer|prostate cancer
1590566|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
1590567|NCT00429338|MRI|mri
1590568|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
1590569|NCT00429338|MRSI|mrsi
1590570|NCT00429338|Endorectal MRSI|endorectal mrsi
1590571|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
1590572|NCT00429338|3 Tesla|3 tesla
1590573|NCT00429338|3T Scan|3t scan
1590574|NCT00429338|Endorectal coil|endorectal coil
1590575|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
1590576|NCT00429338|PFC|pfc
1590577|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
1590578|NCT00429338|PFC-MRSI|pfc-mrsi
1590579|NCT00429338|AIR-MRSI|air-mrsi
1590580|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
1590581|NCT00429325|fecal calprotectin,|fecal calprotectin,
1590582|NCT00429325|stool culture,|stool culture,
1590583|NCT00429325|hemoccult test,|hemoccult test,
1590584|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
1590585|NCT00429325|fecal lactoferrin|fecal lactoferrin
1590586|NCT00429312|Melanoma|melanoma
1590587|NCT00429312|Oncolytic virus|oncolytic virus
1590588|NCT00429312|Pexa-Vec|pexa-vec
1590589|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
1590590|NCT00429286|Health Services Research|health services research
1590591|NCT00429273|ADHD|adhd
1590592|NCT00429273|Guanfacine|guanfacine
1590593|NCT00429273|Methylphenidate|methylphenidate
1590594|NCT00429273|Focalin XR|focalin xr
1590595|NCT00429273|Pediatric|pediatric
1590596|NCT00429273|Cognitive function|cognitive function
1590597|NCT00429273|Combination therapy|combination therapy
1590598|NCT00429260|depression|depression
1590599|NCT00429260|antidepressive agents|antidepressive agents
1590600|NCT00429247|Occult tumor cells|occult tumor cells
1590601|NCT00429247|Micrometastatic cells|micrometastatic cells
1590602|NCT00429247|Cytokeratin-19|cytokeratin-19
1590603|NCT00429247|Trastuzumab|trastuzumab
1590705|NCT00428948|Polycystic|polycystic
1590604|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
1590605|NCT00429234|Advanced Cancer|advanced cancer
1590606|NCT00429234|Solid Tumors|solid tumors
1590607|NCT00429234|Dasatinib|dasatinib
1590608|NCT00429234|BMS-354825|bms-354825
1590609|NCT00429234|Sprycel|sprycel
1590610|NCT00429234|Gemcitabine|gemcitabine
1590611|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1590612|NCT00429234|Gemzar|gemzar
1590613|NCT00429221|ADHD|adhd
1590614|NCT00429208|Nicotine Dependence|nicotine dependence
1590615|NCT00429208|Smoking|smoking
1590616|NCT00429208|Tobacco Use Disorder|tobacco use disorder
1590617|NCT00429208|Nicotine Use Disorder|nicotine use disorder
1590618|NCT00429195|LIPGENE|lipgene
1590619|NCT00429195|Fatty acid|fatty acid
1590620|NCT00429195|Dietary intervention|dietary intervention
1590621|NCT00429195|Metabolic syndrome|metabolic syndrome
1590622|NCT00429195|Insulin resistance|insulin resistance
1590623|NCT00429182|Breast Cancer|breast cancer
1590624|NCT00429182|breast carcinoma|breast carcinoma
1590625|NCT00429182|Carboplatin|carboplatin
1590626|NCT00429182|Paraplatin|paraplatin
1590627|NCT00429182|Cyclophosphamide|cyclophosphamide
1590628|NCT00429182|Neosar|neosar
1590629|NCT00429182|Cytoxan|cytoxan
1590630|NCT00429182|Thiotepa|thiotepa
1590631|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
1590632|NCT00429182|Circulating Tumor Cells|circulating tumor cells
1590633|NCT00429182|CTCs|ctcs
1590634|NCT00429169|Major Depressive Disorder|major depressive disorder
1590635|NCT00429169|MDD|mdd
1590636|NCT00429156|Non-invasive ventilation|non-invasive ventilation
1590637|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
1590638|NCT00429156|Home ventilation|home ventilation
1590639|NCT00429156|Domiciliary ventilation|domiciliary ventilation
1590640|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1590641|NCT00429156|COPD|copd
1590642|NCT00429156|Respiratory failure|respiratory failure
1590643|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
1590644|NCT00429156|NIV|niv
1590645|NCT00429156|NIPPV|nippv
1590646|NCT00429156|Type II respiratory failure|type ii respiratory failure
1590647|NCT00429143|Hematologic Malignancies|hematologic malignancies
1590648|NCT00429143|Two Step Approach|two step approach
1590649|NCT00429143|Haploidentical Transplant|haploidentical transplant
1590650|NCT00429117|Spirituality|spirituality
1590651|NCT00429117|Work Related Stress|work related stress
1590652|NCT00429117|Religious Beliefs|religious beliefs
1590653|NCT00429117|Survey|survey
1590654|NCT00429104|Breast Cancer|breast cancer
1590655|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
1590656|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
1590657|NCT00429104|Herceptin|herceptin
1590658|NCT00429104|Trastuzumab|trastuzumab
1590659|NCT00429104|GM-CSF|gm-csf
1590660|NCT00429104|Sargramostim|sargramostim
1590661|NCT00429104|Leukine|leukine
1590662|NCT00429078|Gastric Cancer|gastric cancer
1590663|NCT00429078|T Cells|t cells
1590664|NCT00429078|Gene Transfer|gene transfer
1590665|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
1590666|NCT00429065|rituximab|rituximab
1590667|NCT00429065|immunotherapy|immunotherapy
1590668|NCT00429052|Coronary Disease|coronary disease
1590669|NCT00429052|Coronary Stenosis|coronary stenosis
1590670|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1590671|NCT00429052|Stents|stents
1590672|NCT00429052|Sirolimus|sirolimus
1590673|NCT00429026|Kidney Cancer|kidney cancer
1590674|NCT00429026|Renal Cell Cancer|renal cell cancer
1590675|NCT00429026|Stem Cell Transplant|stem cell transplant
1590676|NCT00429026|Cyclophosphamide|cyclophosphamide
1590677|NCT00429026|Fludarabine|fludarabine
1590678|NCT00429026|Melphalan|melphalan
1590679|NCT00429026|NST|nst
1590680|NCT00429013|Pressure ulcer|pressure ulcer
1590681|NCT00429013|Lingual electric stimulation|lingual electric stimulation
1590682|NCT00429013|Paraplegic patient|paraplegic patient
1590783|NCT00428636|rectal resection|rectal resection
1590683|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
1590684|NCT00429000|Hypothermia|hypothermia
1590685|NCT00429000|Infant mortality|infant mortality
1590686|NCT00429000|Infant morbidity|infant morbidity
1590687|NCT00429000|Intervention|intervention
1590688|NCT00429000|Randomisation|randomisation
1590689|NCT00429000|Longitudinal research.|longitudinal research.
1590690|NCT00429000|Low-income country|low-income country
1590691|NCT00428987|Energy Expenditure|energy expenditure
1590692|NCT00428987|Neurocognitive Function|neurocognitive function
1590693|NCT00428987|Obesity|obesity
1590694|NCT00428987|Metabolism|metabolism
1590695|NCT00428987|Phenotype|phenotype
1590696|NCT00428987|Body Composition|body composition
1590697|NCT00428987|Morbid Obesity|morbid obesity
1590698|NCT00428987|Overweight|overweight
1590699|NCT00428987|Healthy Volunteer|healthy volunteer
1590700|NCT00428974|Psoriasis|psoriasis
1590701|NCT00428961|diabetes mellitus|diabetes mellitus
1590702|NCT00428961|insulin resistance|insulin resistance
1590703|NCT00428961|atherosclerosis|atherosclerosis
1590704|NCT00428948|ADPKD|adpkd
1590706|NCT00428948|kidney|kidney
1590809|NCT00428545|Velcade|velcade
1590707|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
1590708|NCT00428935|Duchenne|duchenne
1590709|NCT00428935|Muscle|muscle
1590710|NCT00428935|Muscular Dystrophy|muscular dystrophy
1590711|NCT00428935|Gene Therapy|gene therapy
1590712|NCT00428935|Dystrophin|dystrophin
1590713|NCT00428935|Adeno-Associated Virus|adeno-associated virus
1590714|NCT00428935|AAV|aav
1590715|NCT00428922|Metastatic|metastatic
1590716|NCT00428922|Breast Cancer|breast cancer
1590717|NCT00428922|MBC|mbc
1590718|NCT00428909|Pharmacokinetic|pharmacokinetic
1590719|NCT00428909|STI571|sti571
1590720|NCT00428909|imatinib|imatinib
1590721|NCT00428909|CML|cml
1590722|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
1590723|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
1590724|NCT00428909|acetaminophen|acetaminophen
1590725|NCT00428896|Breast cancer|breast cancer
1590726|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
1590727|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
1590728|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
1590729|NCT00428870|Shoulder|shoulder
1590730|NCT00428870|impingement|impingement
1590731|NCT00428870|conservative|conservative
1590732|NCT00428870|acromioplasty|acromioplasty
1590733|NCT00428870|arthroscopy|arthroscopy
1590734|NCT00428844|Osteomyelitis|osteomyelitis
1590735|NCT00428844|Prosthetic Hip|prosthetic hip
1590736|NCT00428844|Prosthetic Knee|prosthetic knee
1590737|NCT00428844|MRSA|mrsa
1590738|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
1590739|NCT00428844|Staphylococci|staphylococci
1590740|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
1590741|NCT00428818|MRSA|mrsa
1590742|NCT00428805|body composition|body composition
1590743|NCT00428805|physical activity|physical activity
1590744|NCT00428805|dietary intake|dietary intake
1590745|NCT00428805|children|children
1590746|NCT00428792|ADHD|adhd
1590747|NCT00428792|methylphenidate|methylphenidate
1590748|NCT00428792|children|children
1590749|NCT00428792|food effect|food effect
1590750|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
1590751|NCT00428779|Running during 24 hours|running during 24 hours
1590752|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
1590753|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
1590754|NCT00428779|EMG activity|emg activity
1590755|NCT00428779|Muscle biopsy|muscle biopsy
1590756|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
1590757|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
1590758|NCT00428727|Diabetic foot|diabetic foot
1590759|NCT00428727|Ulcer|ulcer
1590760|NCT00428727|nitric oxide|nitric oxide
1590761|NCT00428727|treatment|treatment
1590762|NCT00428727|donor|donor
1590763|NCT00428727|controlled trial|controlled trial
1590764|NCT00428701|stress ulcer|stress ulcer
1590765|NCT00428701|critically ill|critically ill
1590766|NCT00428701|gastric acid|gastric acid
1590767|NCT00428701|gastric aspirates|gastric aspirates
1590768|NCT00428701|esomeprazole|esomeprazole
1590769|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
1590770|NCT00428688|cardiovascular disease|cardiovascular disease
1590771|NCT00428688|radiation therapy|radiation therapy
1590772|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
1590773|NCT00428675|screening|screening
1590774|NCT00428675|fatigue|fatigue
1590775|NCT00428662|coronary stenting|coronary stenting
1590776|NCT00428662|drug eluting stents|drug eluting stents
1590777|NCT00428662|paclitaxel|paclitaxel
1590778|NCT00428662|nanoporous|nanoporous
1590779|NCT00428649|Selenium supplements|selenium supplements
1590780|NCT00428649|Selenoprotein P|selenoprotein p
1590781|NCT00428649|Optimization|optimization
1590785|NCT00428636|stoma closure|stoma closure
1590786|NCT00428623|Patient comfort|patient comfort
1590787|NCT00428623|Wound dressings|wound dressings
1590788|NCT00428623|infection|infection
1590789|NCT00428623|vascular surgery|vascular surgery
1590790|NCT00428571|Type 2 Diabetes|type 2 diabetes
1590791|NCT00428571|Bariatric surgery|bariatric surgery
1590792|NCT00428571|Obesity|obesity
1590793|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
1590794|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
1590795|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
1590796|NCT00428558|Core Binding Factor|core binding factor
1590797|NCT00428558|t(8;21)|t(8;21)
1590798|NCT00428558|inv(16)|inv(16)
1590799|NCT00428558|timed-sequential induction|timed-sequential induction
1590800|NCT00428545|Advanced Malignancy|advanced malignancy
1590801|NCT00428545|Lymphoma|lymphoma
1590802|NCT00428545|Myeloma|myeloma
1590803|NCT00428545|Solid Tumors|solid tumors
1590804|NCT00428545|Bevacizumab|bevacizumab
1590805|NCT00428545|Avastin|avastin
1590806|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1590807|NCT00428545|rhuMAb-VEGF|rhumab-vegf
1590808|NCT00428545|Bortezomib|bortezomib
1590813|NCT00428519|HIV infection|hiv infection
1590814|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
1590815|NCT00428519|CCR5 expression|ccr5 expression
1590816|NCT00428519|Treatment Naive|treatment naive
1590817|NCT00428506|ascites|ascites
1590818|NCT00428506|cirrhosis|cirrhosis
1590819|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
1590820|NCT00428506|albumin|albumin
1590821|NCT00428506|portal-hypertension|portal-hypertension
1590822|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
1590823|NCT00428467|Heart Failure|heart failure
1590824|NCT00428467|LV Geometry|lv geometry
1590825|NCT00428467|Heart MRT|heart mrt
1590826|NCT00428454|drug-eluting stent|drug-eluting stent
1590827|NCT00428454|chronic total occlusion|chronic total occlusion
1590828|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
1590829|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
1590831|NCT00428441|D-dimer|d-dimer
1590832|NCT00428441|Recurrence|recurrence
1590833|NCT00428441|Venous thromboembolism|venous thromboembolism
1590834|NCT00428428|kidney stone|kidney stone
1590835|NCT00428428|ureteroscopy|ureteroscopy
1590836|NCT00428402|Education|education
1590837|NCT00428402|4th-8th Grade Student|4th-8th grade student
1590838|NCT00428402|MIDAS Project|midas project
1590839|NCT00428402|Focus Group Discussion|focus group discussion
1590840|NCT00428402|Bastrop|bastrop
1590841|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
1590842|NCT00428363|posterior capsule opacification|posterior capsule opacification
1590843|NCT00428363|PCO|pco
1590844|NCT00428363|after cataract|after cataract
1590845|NCT00428363|intraocular lens|intraocular lens
1590846|NCT00428363|optic edge design|optic edge design
1590847|NCT00428363|sharp optic edge|sharp optic edge
1590848|NCT00428337|HIV Seronegativity|hiv seronegativity
1590849|NCT00428337|EP1233|ep1233
1590850|NCT00428337|MVA-mBN32|mva-mbn32
1590851|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
1590852|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
1590853|NCT00428311|Hyperandrogenism|hyperandrogenism
1590854|NCT00428311|Hirsutism|hirsutism
1590855|NCT00428311|Cardiovascular risk|cardiovascular risk
1590856|NCT00428311|Chronic inflammation|chronic inflammation
1590857|NCT00428311|Metformin|metformin
1590858|NCT00428311|Cyproterone acetate|cyproterone acetate
1590859|NCT00428311|Oral contraceptives|oral contraceptives
1590860|NCT00428298|Bipolar|bipolar
1590861|NCT00428298|Cognitive|cognitive
1590862|NCT00428298|Attention|attention
1590863|NCT00428298|Memory|memory
1590864|NCT00428298|Manic Depression|manic depression
1590865|NCT00428298|Bi-polar|bi-polar
1590866|NCT00428285|Human Papilloma Virus|human papilloma virus
1590867|NCT00428285|HIV infected MSM|hiv infected msm
1590868|NCT00428285|Treatment Experienced|treatment experienced
1590869|NCT00428285|Treatment Naive|treatment naive
1590870|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
1590871|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
1590872|NCT00428272|Interferon Gamma|interferon gamma
1590873|NCT00428272|Solid Tumor|solid tumor
1590874|NCT00428272|Phase I|phase i
1590875|NCT00428272|Malignant Tumor|malignant tumor
1590876|NCT00428272|Metastatic Tumor|metastatic tumor
1590877|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
1590878|NCT00428272|Ewing Sarcoma|ewing sarcoma
1590879|NCT00428272|Osteosarcoma|osteosarcoma
1590880|NCT00428272|Neuroblastoma|neuroblastoma
1590881|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
1590882|NCT00428246|Chronic Kidney Disease|chronic kidney disease
1590883|NCT00428246|Endothelial dysfunction|endothelial dysfunction
1590884|NCT00428246|Inflammation|inflammation
1590885|NCT00428246|Hypertension|hypertension
1591084|NCT00427557|GVD|gvd
1590886|NCT00428246|paricalcitol|paricalcitol
1590887|NCT00428246|Blood pressure|blood pressure
1590888|NCT00428246|Vitamin D|vitamin d
1590889|NCT00428246|Glomerular filtration rate|glomerular filtration rate
1590891|NCT00428233|vaccine|vaccine
1590892|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
1590893|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
1590894|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
1590895|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
1590896|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
1590897|NCT00428194|stage III cervical cancer|stage iii cervical cancer
1590898|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
1590899|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1590900|NCT00428181|Brief alcohol intervention|brief alcohol intervention
1590901|NCT00428181|Booster session|booster session
1590902|NCT00428181|Personalized feedback|personalized feedback
1590903|NCT00428181|Motivational interview|motivational interview
1590904|NCT00428181|Injury recidivism|injury recidivism
1590905|NCT00428181|Psychological Interview|psychological interview
1590906|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
1590907|NCT00428168|Betahistine|betahistine
1590908|NCT00428168|Weight Gain Control|weight gain control
1590909|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
1590910|NCT00428168|Obesity|obesity
1590911|NCT00428168|Schizophrenic disorder|schizophrenic disorder
1590912|NCT00428155|hemostasis|hemostasis
1590913|NCT00428155|angioplasty|angioplasty
1590914|NCT00428155|stenting|stenting
1590915|NCT00428155|closure device|closure device
1590916|NCT00428155|angioseal|angioseal
1590917|NCT00428155|starclose|starclose
1590918|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1590919|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1590920|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1590921|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1590922|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1590923|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1590924|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
1590925|NCT00428116|HIV-1|hiv-1
1590926|NCT00428116|Pediatric|pediatric
1590927|NCT00428116|HAART|haart
1590928|NCT00428116|Treatment Naive|treatment naive
1590929|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
1590930|NCT00428090|apolipoprotein E|apolipoprotein e
1590931|NCT00428090|monotherapy|monotherapy
1590932|NCT00428090|cognition|cognition
1590933|NCT00428090|mild|mild
1590934|NCT00428090|rosiglitazone|rosiglitazone
1590935|NCT00428090|Alzheimer's disease|alzheimer's disease
1590936|NCT00428090|moderate|moderate
1590937|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
1590938|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1590939|NCT00428064|Renal allograft|renal allograft
1590940|NCT00428064|Renal|renal
1590941|NCT00428064|Kidney|kidney
1590942|NCT00428064|Transplant|transplant
1590943|NCT00428051|Epidemiology|epidemiology
1590944|NCT00428051|Surveillance|surveillance
1590945|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
1590946|NCT00428038|Infant, Premature|infant, premature
1590947|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1590948|NCT00428038|Asthma|asthma
1590949|NCT00428025|pancreatitis|pancreatitis
1590950|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
1590951|NCT00427999|Hormone-refractory|hormone-refractory
1590952|NCT00427999|prostate cancer|prostate cancer
1590953|NCT00427999|multitargeted|multitargeted
1590954|NCT00427999|tyrosinkinase|tyrosinkinase
1590955|NCT00427986|Diabetes|diabetes
1590956|NCT00427986|Macular oedema|macular oedema
1590957|NCT00427986|Osmosis|osmosis
1590958|NCT00427986|Galactose|galactose
1590959|NCT00427986|Intravenous|intravenous
1590960|NCT00427986|Retinal thickness|retinal thickness
1590961|NCT00427986|Starling|starling
1590962|NCT00427960|cholesterol|cholesterol
1590963|NCT00427960|statin|statin
1590964|NCT00427960|Asian|asian
1590965|NCT00427960|LDL-cholesterol|ldl-cholesterol
1590966|NCT00427947|phantom limb pain|phantom limb pain
1590967|NCT00427947|amputation|amputation
1590968|NCT00427947|anesthetics, local|anesthetics, local
1590969|NCT00427947|postoperative analgesia|postoperative analgesia
1590970|NCT00427947|ropivacaine|ropivacaine
1590971|NCT00427947|analgesia|analgesia
1590972|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
1590973|NCT00427908|Conjugate vaccine|conjugate vaccine
1590974|NCT00427908|Immunogenicity|immunogenicity
1590975|NCT00427908|Meningococcal vaccine|meningococcal vaccine
1590976|NCT00427908|Persistence|persistence
1590977|NCT00427908|Non-inferiority|non-inferiority
1590978|NCT00427895|Vaccine|vaccine
1590979|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
1590980|NCT00427843|osteoarthritis|osteoarthritis
1590981|NCT00427843|knee|knee
1590982|NCT00427843|gait|gait
1590983|NCT00427843|muscle strength|muscle strength
1590985|NCT00427843|exercise|exercise
1590986|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
1590987|NCT00427830|85A antigen|85a antigen
1590988|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
1590989|NCT00427830|Phase I study|phase i study
1590990|NCT00427830|Immunogenicity|immunogenicity
1590991|NCT00427830|BCG|bcg
1590992|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
1590993|NCT00427817|Prostate|prostate
1590994|NCT00427817|Proteomics|proteomics
1590995|NCT00427817|Urology|urology
1590996|NCT00427804|Calcium absorption|calcium absorption
1590997|NCT00427804|Vitamin D|vitamin d
1590998|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1590999|NCT00427791|Leukemia|leukemia
1591000|NCT00427791|Total Body Irradiation|total body irradiation
1591001|NCT00427791|Etoposide|etoposide
1591002|NCT00427791|Rituximab|rituximab
1591003|NCT00427791|Rituxan|rituxan
1591004|NCT00427791|TBI|tbi
1591005|NCT00427791|ALL|all
1591006|NCT00427778|incontinence ring|incontinence ring
1591007|NCT00427778|pessary|pessary
1591008|NCT00427778|urinary incontinence|urinary incontinence
1591009|NCT00427778|urodynamic study|urodynamic study
1591010|NCT00427778|quality of life|quality of life
1591011|NCT00427778|crossover trial|crossover trial
1591012|NCT00427778|randomised trial|randomised trial
1591013|NCT00427765|Multiple Myeloma|multiple myeloma
1591014|NCT00427765|Hodgkin's Disease|hodgkin's disease
1591015|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1591016|NCT00427765|Leukemia|leukemia
1591017|NCT00427765|Lymphoma|lymphoma
1591018|NCT00427765|Busulfan|busulfan
1591019|NCT00427765|Melphalan|melphalan
1591020|NCT00427765|Autologous bone marrow|autologous bone marrow
1591021|NCT00427765|BMT|bmt
1591022|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
1591023|NCT00427765|PBSCT|pbsct
1591024|NCT00427752|Transgastric|transgastric
1591025|NCT00427752|Endoluminal|endoluminal
1591026|NCT00427752|Peritoneoscopy|peritoneoscopy
1591027|NCT00427752|Diagnostic|diagnostic
1591028|NCT00427752|Feasibility|feasibility
1591029|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
1591030|NCT00427739|Cardiac CT|cardiac ct
1591031|NCT00427739|Stage IV heart failure|stage iv heart failure
1591032|NCT00427726|Gene Transfer|gene transfer
1591033|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
1591034|NCT00427726|Follow-Up|follow-up
1591035|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1591036|NCT00427713|stage III rectal cancer|stage iii rectal cancer
1591037|NCT00427713|stage II rectal cancer|stage ii rectal cancer
1591038|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
1591039|NCT00427700|clomiphene citrate|clomiphene citrate
1591040|NCT00427700|Raloxifene|raloxifene
1591041|NCT00427674|Parkinson|parkinson
1591043|NCT00427661|Sickle Cell Disease|sickle cell disease
1591044|NCT00427661|Thalassemia|thalassemia
1591045|NCT00427661|Hemoglobinopathies|hemoglobinopathies
1591046|NCT00427648|Administration, Intravesical|administration, intravesical
1591047|NCT00427648|Anesthetics, Local|anesthetics, local
1591048|NCT00427635|neonates|neonates
1591049|NCT00427635|infants|infants
1591050|NCT00427635|GERD|gerd
1591051|NCT00427635|reflux|reflux
1591052|NCT00427622|hot flashes|hot flashes
1591053|NCT00427609|Treatment|treatment
1591054|NCT00427609|Psoriasis|psoriasis
1591055|NCT00427609|efficacy|efficacy
1591056|NCT00427609|Bicillin|bicillin
1591057|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
1591058|NCT00427596|healthy adult subjects,|healthy adult subjects,
1591059|NCT00427596|food effect|food effect
1591060|NCT00427583|Malignant,|malignant,
1591061|NCT00427583|peripheral,|peripheral,
1591062|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
1591063|NCT00427583|MPNST,|mpnst,
1591064|NCT00427583|neurofibromatosis,|neurofibromatosis,
1591065|NCT00427583|NF1,|nf1,
1591066|NCT00427583|Imatinib mesylate|imatinib mesylate
1591067|NCT00427570|stage II colon cancer|stage ii colon cancer
1591068|NCT00427570|stage III colon cancer|stage iii colon cancer
1591069|NCT00427557|Multiple Myeloma|multiple myeloma
1591070|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
1591071|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
1591072|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1591073|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1591074|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
1591075|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1591076|NCT00427557|Cellular Therapy|cellular therapy
1591077|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
1591078|NCT00427557|Cord Blood Transplantation|cord blood transplantation
1591079|NCT00427557|Stem Cells|stem cells
1591080|NCT00427557|Stem Cell Transplantation|stem cell transplantation
1591081|NCT00427557|Allogeneic|allogeneic
1591082|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1591083|NCT00427557|Graft vs. Host Disease|graft vs. host disease
1591085|NCT00427557|Fludarabine|fludarabine
1591086|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
1591087|NCT00427557|Fludara|fludara
1591088|NCT00427557|Melphalan|melphalan
1591089|NCT00427557|Rituximab|rituximab
1591090|NCT00427557|Rituxan|rituxan
1591091|NCT00427557|Leukemia|leukemia
1591092|NCT00427557|Lymphoma|lymphoma
1591093|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
1591094|NCT00427531|hot flashes|hot flashes
1591095|NCT00427505|Interaction|interaction
1591096|NCT00427505|healthy volunteers|healthy volunteers
1591097|NCT00427505|deferasirox|deferasirox
1591098|NCT00427505|midazolam|midazolam
1591099|NCT00427479|Allergy|allergy
1591100|NCT00427479|Food|food
1591101|NCT00427479|Hay fever|hay fever
1591102|NCT00427479|Screening|screening
1591103|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
1591104|NCT00427453|85A antigen|85a antigen
1591105|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
1591106|NCT00427453|Phase I study|phase i study
1591107|NCT00427453|Immunogenicity|immunogenicity
1591108|NCT00427453|BCG|bcg
1591109|NCT00427440|Glioma|glioma
1591110|NCT00427440|Brain Tumor|brain tumor
1591111|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
1591112|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
1591389|NCT00426556|everolimus|everolimus
1591113|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
1591114|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
1591115|NCT00427427|acceptability rate|acceptability rate
1591116|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
1591117|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1591118|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1591119|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
1591120|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
1591121|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
1591122|NCT00427388|Steroid|steroid
1591123|NCT00427388|Myocardial Infarction|myocardial infarction
1591124|NCT00427388|Randomized Clinical Trial|randomized clinical trial
1591125|NCT00427375|Rectal cancer surgery|rectal cancer surgery
1591126|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
1591127|NCT00427375|Randomized clinical trial|randomized clinical trial
1591128|NCT00427375|Multicenter study|multicenter study
1591129|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1591130|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1591131|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1591132|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1591133|NCT00427349|gastrinoma|gastrinoma
1591134|NCT00427349|insulinoma|insulinoma
1591135|NCT00427349|WDHA syndrome|wdha syndrome
1591136|NCT00427349|glucagonoma|glucagonoma
1591137|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1591138|NCT00427349|somatostatinoma|somatostatinoma
1591139|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1591140|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
1591141|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
1591142|NCT00427336|Bone Marrow Failure|bone marrow failure
1591143|NCT00427336|Stem Cell Transplantation|stem cell transplantation
1591144|NCT00427336|Fludarabine|fludarabine
1591145|NCT00427336|Cyclophosphamide|cyclophosphamide
1591146|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
1591147|NCT00427336|SAA|saa
1591148|NCT00427336|ATG|atg
1591149|NCT00427336|Cytoxan|cytoxan
1591150|NCT00427336|Neosar|neosar
1591151|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
1591152|NCT00427336|Thymoglobulin|thymoglobulin
1591153|NCT00427323|sleep|sleep
1591154|NCT00427323|aging|aging
1591155|NCT00427323|biological rhythm|biological rhythm
1591156|NCT00427323|melatonin|melatonin
1591157|NCT00427323|alertness|alertness
1591158|NCT00427323|early morning awakening|early morning awakening
1591159|NCT00427323|daytime sleepiness|daytime sleepiness
1591160|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
1591161|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
1591162|NCT00427310|stage I colon cancer|stage i colon cancer
1591163|NCT00427310|stage II colon cancer|stage ii colon cancer
1591164|NCT00427310|stage III colon cancer|stage iii colon cancer
1591165|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
1591167|NCT00427297|Pediatric|pediatric
1591168|NCT00427297|nevirapine|nevirapine
1591169|NCT00427297|HAART|haart
1591170|NCT00427297|Resistance|resistance
1591171|NCT00427297|Treatment Naive|treatment naive
1591172|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
1591173|NCT00427271|aspirin|aspirin
1591174|NCT00427271|enalapril|enalapril
1591175|NCT00427271|microalbuminuria|microalbuminuria
1591176|NCT00427271|glomerular filtration rate|glomerular filtration rate
1591177|NCT00427258|healthy subjects|healthy subjects
1591178|NCT00427245|menopausal symptoms|menopausal symptoms
1591179|NCT00427245|infertility|infertility
1591180|NCT00427245|stage IA breast cancer|stage ia breast cancer
1591557|NCT00425919|Diabetes|diabetes
1591181|NCT00427245|stage IB breast cancer|stage ib breast cancer
1591182|NCT00427245|stage II breast cancer|stage ii breast cancer
1591183|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
1591184|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
1591185|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1591186|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1591187|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1591188|NCT00427232|coronary heart disease|coronary heart disease
1591189|NCT00427232|endothelins|endothelins
1591190|NCT00427232|coronary angiography|coronary angiography
1591191|NCT00427232|blood flow velocity|blood flow velocity
1591192|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
1591193|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1591194|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
1591195|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
1591196|NCT00427219|Enlarged Prostate|enlarged prostate
1591197|NCT00427219|Prostatism|prostatism
1591198|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
1591199|NCT00427206|acetaminophen|acetaminophen
1591200|NCT00427206|alcohol|alcohol
1591201|NCT00427206|liver injury|liver injury
1591202|NCT00427193|dietary restriction|dietary restriction
1591203|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
1591204|NCT00427193|nutrition of aging|nutrition of aging
1591205|NCT00427193|bioenergetics|bioenergetics
1591206|NCT00427193|cardiovascular function|cardiovascular function
1591207|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
1591208|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
1591209|NCT00427180|Visual Perception|visual perception
1591210|NCT00427180|Retina|retina
1591211|NCT00427180|Light|light
1591212|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
1591213|NCT00427180|Visual acuity|visual acuity
1591214|NCT00427180|Retinal Implant|retinal implant
1591215|NCT00427180|Electrical stimulation|electrical stimulation
1591216|NCT00427167|Blood Stage|blood stage
1591217|NCT00427167|Investigational|investigational
1591218|NCT00427167|Vaccine|vaccine
1591219|NCT00427167|Malaria|malaria
1591220|NCT00427167|Healthy Volunteer|healthy volunteer
1591221|NCT00427167|HV|hv
1591222|NCT00427141|tolerability,|tolerability,
1591223|NCT00427141|pharmacokinetics,|pharmacokinetics,
1591224|NCT00427141|first time in human,|first time in human,
1591225|NCT00427141|food effect|food effect
1591226|NCT00427141|safety,|safety,
1591227|NCT00427128|Major Depression|major depression
1591228|NCT00427128|"true drug response"|"true drug response"
1591229|NCT00427128|"placebo response pattern"|"placebo response pattern"
1591230|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
1591231|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
1591232|NCT00427102|Oral MRX-1024|oral mrx-1024
1591233|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
1591234|NCT00427102|Standard Radiation Therapy|standard radiation therapy
1591235|NCT00427089|Colon cleansing|colon cleansing
1591236|NCT00427089|Polyethylene Glycol|polyethylene glycol
1591237|NCT00427089|Sodium Phosphate|sodium phosphate
1591238|NCT00427076|vancomycin|vancomycin
1591239|NCT00427076|cotrimoxazole|cotrimoxazole
1591240|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
1591241|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1591242|NCT00427076|Health care association infections|health care association infections
1591243|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
1591244|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
1591245|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
1591246|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
1591247|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
1591248|NCT00427063|retinal vessels|retinal vessels
1591249|NCT00427063|tortuosity|tortuosity
1591250|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
1591251|NCT00427050|PEP005|pep005
1591252|NCT00427050|Topical|topical
1591253|NCT00427050|Dermatology|dermatology
1591254|NCT00427037|Vitamin D deficiency|vitamin d deficiency
1591255|NCT00427037|Chronic Kidney Disease|chronic kidney disease
1591256|NCT00427024|renal transplantation|renal transplantation
1591257|NCT00427024|acute rejection|acute rejection
1591258|NCT00427024|transport|transport
1591259|NCT00427024|transporter|transporter
1591260|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
1591261|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
1591262|NCT00426985|Tendonitis|tendonitis
1591263|NCT00426985|Bursitis|bursitis
1591264|NCT00426985|Pain|pain
1591265|NCT00426985|Shoulder Pain|shoulder pain
1591266|NCT00426985|Elbow Pain|elbow pain
1591267|NCT00426985|Knee Pain|knee pain
1591268|NCT00426985|Tendon Injury|tendon injury
1591269|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
1591270|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1591271|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
1591272|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
1591273|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
1591274|NCT00426946|Depression Children Reboxetine|depression children reboxetine
1591275|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
1591276|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
1591277|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
1591278|NCT00426933|cSSSI|csssi
1591279|NCT00426933|MRSA|mrsa
1591280|NCT00426920|pharmacokinetics|pharmacokinetics
1591281|NCT00426920|pharmacodynamics|pharmacodynamics
1591282|NCT00426920|inhaled|inhaled
1591283|NCT00426920|recombinant human insulin|recombinant human insulin
1591284|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
1591285|NCT00426907|Osteotomy|osteotomy
1591286|NCT00426907|Healing|healing
1591287|NCT00426907|Rehabilitation|rehabilitation
1591288|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
1591289|NCT00426894|surveillance cultures|surveillance cultures
1591290|NCT00426894|children|children
1591291|NCT00426894|cardiac surgery|cardiac surgery
1591292|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
1591293|NCT00426881|Exercise|exercise
1591294|NCT00426881|Resistance training|resistance training
1591295|NCT00426868|ADRC|adrc
1591296|NCT00426868|Stem Cells|stem cells
1591297|NCT00426868|chronic ischemia|chronic ischemia
1591298|NCT00426868|heart disease|heart disease
1591299|NCT00426868|coronary artery disease|coronary artery disease
1591300|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
1591301|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
1591302|NCT00426842|Blood pressure|blood pressure
1591303|NCT00426842|Orthostatic hypotension|orthostatic hypotension
1591304|NCT00426842|Spinal Cord Injury|spinal cord injury
1591305|NCT00426842|Sympathetic vascular control|sympathetic vascular control
1591306|NCT00426842|Midodrine|midodrine
1591307|NCT00426829|Liver Cancer|liver cancer
1591308|NCT00426829|Biliary Tract|biliary tract
1591309|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
1591310|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
1591311|NCT00426829|Bevacizumab|bevacizumab
1591312|NCT00426829|Proton Therapy|proton therapy
1591313|NCT00426829|Radiation Therapy|radiation therapy
1591315|NCT00426829|RT|rt
1591316|NCT00426829|Proton RT|proton rt
1591317|NCT00426829|Avastin|avastin
1591318|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1591319|NCT00426829|rhuMAb-VEGF|rhumab-vegf
1591320|NCT00426816|primary insomnia|primary insomnia
1591321|NCT00426816|PSG sleep recordings|psg sleep recordings
1591322|NCT00426816|daytime cognitive function|daytime cognitive function
1591323|NCT00426816|Insomnia|insomnia
1591324|NCT00426816|SB-649868|sb-649868
1591325|NCT00426777|prostate cancer|prostate cancer
1591326|NCT00426777|prostatic adenoma|prostatic adenoma
1591327|NCT00426777|prostatic neoplasm|prostatic neoplasm
1591328|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1591329|NCT00426764|T-cell lymphoma|t-cell lymphoma
1591330|NCT00426764|romidepsin|romidepsin
1591331|NCT00426751|Eptifibatide|eptifibatide
1591332|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
1591333|NCT00426751|STEMI|stemi
1591334|NCT00426751|Abciximab|abciximab
1591335|NCT00426725|labor|labor
1591336|NCT00426725|pain|pain
1591337|NCT00426725|relief|relief
1591338|NCT00426725|labour|labour
1591339|NCT00426725|device|device
1591340|NCT00426712|Chronic kidney failure|chronic kidney failure
1591341|NCT00426712|Chronic kidney disease|chronic kidney disease
1591342|NCT00426712|Hemodialysis|hemodialysis
1591343|NCT00426712|HBV vaccine|hbv vaccine
1591344|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
1591345|NCT00426712|Hepatitis B|hepatitis b
1591346|NCT00426712|Hepatitis|hepatitis
1591347|NCT00426712|HBV|hbv
1591348|NCT00426712|Prevention & Control|prevention & control
1591349|NCT00426699|enterovirus|enterovirus
1591350|NCT00426699|meningitis|meningitis
1591351|NCT00426699|sepsis|sepsis
1591352|NCT00426699|myocarditis|myocarditis
1591353|NCT00426699|kidney|kidney
1591354|NCT00426699|urine|urine
1591355|NCT00426699|glomerulonephritis|glomerulonephritis
1591356|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
1591357|NCT00426686|prognostic factors|prognostic factors
1591358|NCT00426686|ADAMTS13|adamts13
1591359|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
1591360|NCT00426660|HIV Infections|hiv infections
1591361|NCT00426647|Osteoarthritis|osteoarthritis
1591362|NCT00426647|Pain|pain
1591363|NCT00426647|Norspan|norspan
1591364|NCT00426647|Buprenorphine|buprenorphine
1591365|NCT00426647|Tramadol|tramadol
1591366|NCT00426634|Asthma|asthma
1591367|NCT00426634|Allergens|allergens
1591368|NCT00426634|Mold|mold
1591369|NCT00426634|Asthma Counselor|asthma counselor
1591370|NCT00426634|Environmental Remediation|environmental remediation
1591371|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
1591372|NCT00426621|diclofenac sodium|diclofenac sodium
1591373|NCT00426608|HPA axis,|hpa axis,
1591374|NCT00426608|Healthy volunteers|healthy volunteers
1591375|NCT00426608|hormones,|hormones,
1591376|NCT00426608|GSK561679,|gsk561679,
1591377|NCT00426608|cortisol,|cortisol,
1591378|NCT00426582|Cancer|cancer
1591379|NCT00426582|maximum tolerated dose|maximum tolerated dose
1591380|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
1591381|NCT00426582|patupilone|patupilone
1591382|NCT00426582|carboplatin|carboplatin
1591383|NCT00426582|pharmacokinetics|pharmacokinetics
1591384|NCT00426556|Breast cancer|breast cancer
1591385|NCT00426556|Cancer of the breast|cancer of the breast
1591386|NCT00426556|Human mammary carcinoma|human mammary carcinoma
1591387|NCT00426556|HER-2|her-2
1591388|NCT00426556|Metastatic|metastatic
1591392|NCT00426543|Clinical trial|clinical trial
1591393|NCT00426543|Intervention study|intervention study
1591394|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
1591395|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
1591396|NCT00426530|Breast cancer|breast cancer
1591397|NCT00426530|Cancer of the breast|cancer of the breast
1591398|NCT00426530|Human mammary carcinoma|human mammary carcinoma
1591399|NCT00426530|HER-2|her-2
1591400|NCT00426530|metastatic|metastatic
1591401|NCT00426530|everolimus|everolimus
1591402|NCT00426530|trastuzumab|trastuzumab
1591403|NCT00426530|vinorelbine|vinorelbine
1591404|NCT00426517|MUD Transplant|mud transplant
1591405|NCT00426517|Transplant|transplant
1591406|NCT00426517|AlloPBSC|allopbsc
1591407|NCT00426517|HLA Matched Transplant|hla matched transplant
1591408|NCT00426517|BMT|bmt
1591409|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
1591410|NCT00426517|Bone Marrow Transplant|bone marrow transplant
1591411|NCT00426504|Head,|head,
1591412|NCT00426504|Neck,|neck,
1591413|NCT00426504|Cancer,|cancer,
1591414|NCT00426504|Tomotherapy,|tomotherapy,
1591415|NCT00426504|IMRT,|imrt,
1591416|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
1591417|NCT00426465|Motor Practice|motor practice
1591418|NCT00426465|Magnetic Stimulation|magnetic stimulation
1591419|NCT00426465|Stroke|stroke
1591420|NCT00426465|Spacing Effect|spacing effect
1591421|NCT00426465|Massed Practice|massed practice
1591422|NCT00426465|Healthy Volunteer|healthy volunteer
1591423|NCT00426465|HV|hv
1591424|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
1591425|NCT00426452|Vatalinib|vatalinib
1591426|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
1591427|NCT00426452|Omeprazole|omeprazole
1591428|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
1591429|NCT00426439|malaria|malaria
1591430|NCT00426439|Plasmodium falciparum|plasmodium falciparum
1591431|NCT00426439|children|children
1591432|NCT00426439|Guinea-Bissau|guinea-bissau
1591433|NCT00426439|artemether|artemether
1591434|NCT00426439|lumefantrine|lumefantrine
1591435|NCT00426439|chloroquine|chloroquine
1591436|NCT00426439|Coartem|coartem
1591437|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
1591438|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
1591439|NCT00426413|obesity|obesity
1591440|NCT00426413|insulin dependence|insulin dependence
1591441|NCT00426413|mechanisms|mechanisms
1591442|NCT00426374|HIV|hiv
1591443|NCT00426374|AIDS|aids
1591444|NCT00426374|Troponin|troponin
1591445|NCT00426374|natriuretic peptide|natriuretic peptide
1591446|NCT00426374|heart failure|heart failure
1591447|NCT00426374|heart disease children|heart disease children
1591448|NCT00426374|HIV pediatric|hiv pediatric
1591449|NCT00426374|AIDS pediatric|aids pediatric
1591450|NCT00426361|Human Papillomavirus|human papillomavirus
1591451|NCT00426348|IgA nephropathy|iga nephropathy
1591452|NCT00426348|probucol|probucol
1591453|NCT00426348|valsartan|valsartan
1591454|NCT00426348|treatment|treatment
1591455|NCT00426348|antioxidant|antioxidant
1591456|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
1591457|NCT00426335|breast|breast
1591458|NCT00426335|cancer|cancer
1591459|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
1591460|NCT00426335|psychological|psychological
1591461|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
1591462|NCT00426322|bone graft|bone graft
1591463|NCT00426322|bovine bone mineral|bovine bone mineral
1591464|NCT00426322|dental implants|dental implants
1591466|NCT00426296|Reyataz|reyataz
1591467|NCT00426296|atazanavir|atazanavir
1591468|NCT00426296|Norvir|norvir
1591469|NCT00426296|ritonavir|ritonavir
1591470|NCT00426296|Boosted|boosted
1591471|NCT00426296|Lipodystrophy|lipodystrophy
1591472|NCT00426296|Treatment Experienced|treatment experienced
1591473|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
1591474|NCT00426257|Ovarian Cancer|ovarian cancer
1591475|NCT00426257|stage III|stage iii
1591476|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
1591477|NCT00426257|debulking surgery|debulking surgery
1591478|NCT00426257|HIPEC|hipec
1591479|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1591480|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1591481|NCT00426244|Pregnancy|pregnancy
1591482|NCT00426244|Physiologic|physiologic
1591483|NCT00426244|Gait|gait
1591484|NCT00426244|Low back pain|low back pain
1591485|NCT00426244|Heart rate variability|heart rate variability
1591486|NCT00426231|Randomized Controlled Trials|randomized controlled trials
1591487|NCT00426231|Health Education|health education
1591488|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1591489|NCT00426231|Patient Nonadherence|patient nonadherence
1592481|NCT00422981|Mind|mind
1591490|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
1591491|NCT00426218|Immunogenicity|immunogenicity
1591492|NCT00426218|Pharmacokinetics|pharmacokinetics
1591493|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
1591495|NCT00426218|SJIA|sjia
1591496|NCT00426218|Pediatrics|pediatrics
1591497|NCT00426205|GM-CSF|gm-csf
1591498|NCT00426205|GVAX|gvax
1591499|NCT00426205|Cancer vaccine|cancer vaccine
1591500|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
1591501|NCT00426205|MDS|mds
1591502|NCT00426205|AML|aml
1591503|NCT00426205|CML|cml
1591504|NCT00426192|Immunedefense Suppression|immunedefense suppression
1591505|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
1591506|NCT00426192|Mannitol|mannitol
1591507|NCT00426192|Hemofiltration|hemofiltration
1591508|NCT00426192|Cytokines|cytokines
1591509|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
1591510|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
1591511|NCT00426140|EPO|epo
1591512|NCT00426140|Patupilone|patupilone
1591513|NCT00426140|Solid Tumors|solid tumors
1591514|NCT00426127|Pancreatic|pancreatic
1591515|NCT00426127|Docetaxel|docetaxel
1591516|NCT00426127|Doxorubicin|doxorubicin
1591517|NCT00426127|Enoxaparin|enoxaparin
1591518|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1591519|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
1591520|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
1591521|NCT00426049|Coronary artery disease|coronary artery disease
1591522|NCT00426049|Stents|stents
1591523|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
1591524|NCT00426049|Coronary restenosis|coronary restenosis
1591525|NCT00426049|Safety|safety
1591526|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
1591527|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
1591528|NCT00426023|Cyclosporine|cyclosporine
1591529|NCT00426023|Children|children
1591530|NCT00426023|Clinical trial|clinical trial
1591531|NCT00426010|Placebo effect|placebo effect
1591532|NCT00426010|Caffeine|caffeine
1591533|NCT00426010|Systolic BP|systolic bp
1591534|NCT00426010|VAS|vas
1591535|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
1591536|NCT00425984|HIV|hiv
1591537|NCT00425984|Male circumcision|male circumcision
1591538|NCT00425984|Sexually transmitted infections|sexually transmitted infections
1591539|NCT00425984|Sexual risk behaviors|sexual risk behaviors
1591540|NCT00425984|Adult males|adult males
1591541|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
1591542|NCT00425984|Human papillomavirus|human papillomavirus
1591543|NCT00425984|Rakai|rakai
1591544|NCT00425984|Uganda|uganda
1591545|NCT00425984|HIV seronegativity|hiv seronegativity
1591546|NCT00425984|HPV|hpv
1591547|NCT00425984|STI|sti
1591548|NCT00425958|year and more after TBI|year and more after tbi
1591549|NCT00425958|good vision|good vision
1591550|NCT00425958|at least one functinal hand|at least one functinal hand
1591551|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
1591552|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
1591553|NCT00425932|Rituximab|rituximab
1591554|NCT00425932|Low Field MRI|low field mri
1591555|NCT00425932|Biomarkers|biomarkers
1591556|NCT00425919|Type 2 Diabetes|type 2 diabetes
1591558|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1591559|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1591560|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1591561|NCT00425906|anorexia|anorexia
1591562|NCT00425906|pain|pain
1591563|NCT00425893|influenza|influenza
1591564|NCT00425893|masks|masks
1591565|NCT00425893|transmission|transmission
1591566|NCT00425893|hand hygiene|hand hygiene
1591567|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
1591568|NCT00425880|Pregnancy|pregnancy
1591569|NCT00425880|Asthma|asthma
1591570|NCT00425880|Tobacco Abuse|tobacco abuse
1591571|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
1591572|NCT00425867|PAR1 gene|par1 gene
1591573|NCT00425867|polymorphisms|polymorphisms
1591574|NCT00425867|abortions|abortions
1591575|NCT00425867|reccurent abortions|reccurent abortions
1591576|NCT00425867|premature delivery|premature delivery
1591577|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1591578|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
1591579|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
1591580|NCT00425815|Cognition|cognition
1591581|NCT00425815|Ampakines|ampakines
1591582|NCT00425815|Schizophrenia|schizophrenia
1591651|NCT00425659|Home sleep study|home sleep study
1591831|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
1591583|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1591584|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1591585|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1591586|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1591587|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1591588|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1591589|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1591590|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1591591|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1591592|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1591593|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1591594|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1591595|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1591596|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1591597|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1591598|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1591599|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1591600|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1591601|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1591602|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1591603|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1591604|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1591605|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1591606|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1591607|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1591608|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1591609|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1591610|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1591611|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1591612|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1591613|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1591614|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1591615|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1591616|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1591617|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1591618|NCT00425789|Deep Chemical Peeling|deep chemical peeling
1591619|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
1591620|NCT00425789|post-deep peel|post-deep peel
1591621|NCT00425776|Breast cancer|breast cancer
1591622|NCT00425776|Acupuncture|acupuncture
1591623|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
1591624|NCT00425776|Se-estradiol|se-estradiol
1591625|NCT00425776|Se-endorphine|se-endorphine
1591626|NCT00425763|malaria|malaria
1591627|NCT00425763|efficacy|efficacy
1591628|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
1591629|NCT00425763|drug resistance|drug resistance
1591630|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1591631|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1591802|NCT00424970|pulmonary hypertension|pulmonary hypertension
1591632|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1591633|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1591634|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1591635|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1591636|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1591637|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1591638|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
1591639|NCT00425737|Gastroenteritis|gastroenteritis
1591640|NCT00425724|proteinuria|proteinuria
1591641|NCT00425724|nephritis|nephritis
1591642|NCT00425724|nephrotic syndrome|nephrotic syndrome
1591643|NCT00425724|glomerulonephritis|glomerulonephritis
1591644|NCT00425711|Acamprosate|acamprosate
1591645|NCT00425711|Alcohol Dependence|alcohol dependence
1591646|NCT00425711|Driving Under the Influence|driving under the influence
1591647|NCT00425711|Drug Court|drug court
1591648|NCT00425711|DUI Court|dui court
1591649|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
1591650|NCT00425659|Health utility|health utility
1591652|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1591653|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1591654|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
1591655|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1591656|NCT00425646|large cell lung cancer|large cell lung cancer
1591657|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1591658|NCT00425633|Homeopathic|homeopathic
1591659|NCT00425633|Potassium|potassium
1591660|NCT00425633|Dichromate|dichromate
1591661|NCT00425633|Kalium|kalium
1591662|NCT00425633|Bichromicum|bichromicum
1591663|NCT00425633|Mechanical|mechanical
1591664|NCT00425633|Ventilation|ventilation
1591665|NCT00425633|Secretions|secretions
1591666|NCT00425620|Chronic Sinusitis|chronic sinusitis
1591667|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
1591668|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
1591669|NCT00425607|HGPS|hgps
1591670|NCT00425607|Progeria|progeria
1591671|NCT00425607|FTI|fti
1591672|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
1591673|NCT00425607|Lonafarnib|lonafarnib
1591674|NCT00425594|colonoscopy|colonoscopy
1591675|NCT00425594|bowel preparation|bowel preparation
1591676|NCT00425594|prep|prep
1591677|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
1591678|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
1591679|NCT00425581|Very low birth weight infants|very low birth weight infants
1591680|NCT00425581|hemodynamic instability|hemodynamic instability
1591681|NCT00425581|myocardial dysfunction|myocardial dysfunction
1591682|NCT00425568|hypogonadism|hypogonadism
1591683|NCT00425568|low testosterone level|low testosterone level
1591684|NCT00425568|gonadal deficiency|gonadal deficiency
1591685|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
1591686|NCT00425555|Mycosis Fungoides|mycosis fungoides
1591687|NCT00425555|Sézary Syndrome|sézary syndrome
1591688|NCT00425555|CTCL|ctcl
1591689|NCT00425542|Pulmonary embolism|pulmonary embolism
1591690|NCT00425542|Outpatient care|outpatient care
1591691|NCT00425542|Prognosis|prognosis
1591692|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1591693|NCT00425516|breast cancer|breast cancer
1591694|NCT00425516|sequential treatment|sequential treatment
1591695|NCT00425503|Prostate Cancer|prostate cancer
1591696|NCT00425503|Bortezomib|bortezomib
1591697|NCT00425503|Radical Prostatectomy|radical prostatectomy
1591698|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
1591699|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
1591700|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1591701|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1591702|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1591703|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1591704|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1591705|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1591706|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1591707|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1591708|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1591709|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1591710|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1591711|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1591712|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1591803|NCT00424970|polycythemia|polycythemia
1591713|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1591714|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1591715|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1591716|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1591717|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1591718|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1591719|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1591720|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1591721|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1591722|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1591723|NCT00425451|Periodontitis|periodontitis
1591724|NCT00425451|Dental Care|dental care
1591725|NCT00425451|Efficacy|efficacy
1591726|NCT00425451|Safety|safety
1591727|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1591728|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
1591729|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
1591730|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
1591731|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
1592482|NCT00422981|Aging|aging
1591732|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
1591733|NCT00425399|Schizophrenia|schizophrenia
1591734|NCT00425399|Shiatsu|shiatsu
1591735|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
1591736|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
1591737|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1591738|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
1591739|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
1591740|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
1591741|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
1591742|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1591743|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
1591744|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
1591745|NCT00425334|Blood loss|blood loss
1591746|NCT00425334|Ischemia|ischemia
1591747|NCT00425334|Hemoglobin|hemoglobin
1591748|NCT00425334|Blood Substitutes|blood substitutes
1591749|NCT00425334|Plasma Expanders|plasma expanders
1591750|NCT00425321|Arthritis|arthritis
1591751|NCT00425321|Joints|joints
1591752|NCT00425321|Auto immune|auto immune
1591753|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
1591754|NCT00425282|RWJ-333369|rwj-333369
1591755|NCT00425282|anticonvulsants|anticonvulsants
1591756|NCT00425282|antiepileptic drugs|antiepileptic drugs
1591757|NCT00425269|lifestyle intervention|lifestyle intervention
1591758|NCT00425269|Type 2 Diabetes|type 2 diabetes
1591759|NCT00425269|Metabolic syndrome|metabolic syndrome
1591760|NCT00425269|Pakistani women|pakistani women
1591761|NCT00425269|dietary change|dietary change
1591762|NCT00425269|Physical activity|physical activity
1591763|NCT00425269|Norway|norway
1591764|NCT00425243|primary insomnia|primary insomnia
1591765|NCT00425243|chronic insomnia|chronic insomnia
1591766|NCT00425178|Chronic wounds|chronic wounds
1591767|NCT00425178|Diabetes|diabetes
1591768|NCT00425178|Ulcers|ulcers
1591769|NCT00425178|Arterial bypass|arterial bypass
1591770|NCT00425178|Angioplasty|angioplasty
1591771|NCT00425178|Diabetic ulcers|diabetic ulcers
1591772|NCT00425152|stage II colon cancer|stage ii colon cancer
1591773|NCT00425152|stage III colon cancer|stage iii colon cancer
1591774|NCT00425139|Cancer|cancer
1591775|NCT00425139|Video game|video game
1591776|NCT00425139|Adolescent|adolescent
1591777|NCT00425139|Young adult|young adult
1591778|NCT00425126|Delayed Graft Function|delayed graft function
1591779|NCT00425126|Kidney Transplantation|kidney transplantation
1591780|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
1591781|NCT00425113|Anaerobic|anaerobic
1591782|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
1591783|NCT00425113|HRCT|hrct
1591784|NCT00425113|Lesion Matrix|lesion matrix
1591785|NCT00425113|Tuberculosis|tuberculosis
1591786|NCT00425113|TB|tb
1591787|NCT00425074|slow release ASA|slow release asa
1591788|NCT00425074|platelet functionalism|platelet functionalism
1591789|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
1591790|NCT00425035|Renal Cancer|renal cancer
1591791|NCT00425022|lung cancer|lung cancer
1591792|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
1591793|NCT00425009|Berberine|berberine
1591794|NCT00425009|Type 2 diabetes|type 2 diabetes
1591795|NCT00425009|Treatment|treatment
1591796|NCT00424983|Multiple myeloma|multiple myeloma
1591797|NCT00424983|breast cancer|breast cancer
1591798|NCT00424983|zoledronic acid|zoledronic acid
1591799|NCT00424983|pharmacokinetics|pharmacokinetics
1591800|NCT00424970|high altitude|high altitude
1591801|NCT00424970|hypoxia|hypoxia
1592452|NCT00423072|middle ear|middle ear
1591804|NCT00424970|hypoventilation|hypoventilation
1591805|NCT00424957|Ammonia|ammonia
1591806|NCT00424957|Astrocytes|astrocytes
1591807|NCT00424957|Citric acid cycle|citric acid cycle
1591808|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
1591809|NCT00424944|Malaria|malaria
1591810|NCT00424944|Vaccine|vaccine
1591811|NCT00424944|GMZ2|gmz2
1591812|NCT00424944|Safety|safety
1591813|NCT00424944|African|african
1591814|NCT00424944|immunogenicity|immunogenicity
1591815|NCT00424931|narcolepsy|narcolepsy
1591816|NCT00424931|sleepiness|sleepiness
1591817|NCT00424918|Dance|dance
1591818|NCT00424918|Peers|peers
1591819|NCT00424918|middle school-based|middle school-based
1591820|NCT00424918|feasibility|feasibility
1591821|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
1591822|NCT00424866|Ischemia|ischemia
1591823|NCT00424866|Intermittent Claudication|intermittent claudication
1591824|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
1591825|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
1591826|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
1591827|NCT00424814|HIV Infections|hiv infections
1591828|NCT00424814|Kaletra|kaletra
1591829|NCT00424814|Combivir|combivir
1591830|NCT00424814|HIV Seronegativity|hiv seronegativity
1591832|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1591833|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1591834|NCT00424762|Congestive Heart Failure|congestive heart failure
1591835|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
1591836|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
1591837|NCT00424762|thiazolidinedione|thiazolidinedione
1591838|NCT00424762|rosiglitazone|rosiglitazone
1591839|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
1591840|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
1591841|NCT00424749|Glomerulonephritis|glomerulonephritis
1591842|NCT00424749|Rituximab|rituximab
1591843|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
1591844|NCT00424723|pemetrexed|pemetrexed
1591845|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
1591846|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
1591847|NCT00424710|choroidal neovascularization|choroidal neovascularization
1591848|NCT00424697|Brain imaging,|brain imaging,
1591849|NCT00424697|fMRI,|fmri,
1591850|NCT00424697|stimulation,|stimulation,
1591851|NCT00424697|pharmacodynamics,|pharmacodynamics,
1591852|NCT00424697|tolerability,|tolerability,
1591853|NCT00424697|healthy subjects|healthy subjects
1591854|NCT00424684|TB|tb
1591855|NCT00424684|Chronic Liver Disease|chronic liver disease
1591856|NCT00424658|breathing disorders|breathing disorders
1591857|NCT00424645|Hematologic Malignancy|hematologic malignancy
1591858|NCT00424645|Solid Tumor|solid tumor
1591859|NCT00424645|Glucarpidase|glucarpidase
1591860|NCT00424645|Voraxaze|voraxaze
1591861|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
1591862|NCT00424645|Placebo|placebo
1591863|NCT00424619|Vitamin D|vitamin d
1591864|NCT00424619|Hip fracture|hip fracture
1591865|NCT00424619|Optimal level|optimal level
1591866|NCT00424619|Deficiency|deficiency
1591867|NCT00424619|Functional muscle strength|functional muscle strength
1591868|NCT00424606|High risk node negative|high risk node negative
1591869|NCT00424567|Fracture|fracture
1591870|NCT00424567|non union fracture|non union fracture
1591871|NCT00424567|ununited fracture|ununited fracture
1591872|NCT00424567|pseudarthrosis|pseudarthrosis
1591873|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
1591874|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
1591875|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
1591876|NCT00424515|Imatinib|imatinib
1591877|NCT00424515|Gleevec|gleevec
1591878|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
1591879|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1591880|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
1591881|NCT00424476|Autoimmune Diseases|autoimmune diseases
1591882|NCT00424476|Lupus|lupus
1591883|NCT00424476|SLE|sle
1591884|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
1591885|NCT00424476|Belimumab|belimumab
1591886|NCT00424476|Antibodies|antibodies
1591887|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1591888|NCT00424450|contrast ultrasound|contrast ultrasound
1591889|NCT00424450|muscle perfusion|muscle perfusion
1591890|NCT00424424|Postoperative Dental Pain|postoperative dental pain
1591891|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
1591892|NCT00424385|prostate|prostate
1591893|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
1591894|NCT00424359|Ambulation|ambulation
1591895|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
1591896|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
1591897|NCT00424346|methotrexate|methotrexate
1591898|NCT00424320|Acute kidney failure|acute kidney failure
1591899|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
1591900|NCT00424320|Non-ionic contrast media|non-ionic contrast media
1591901|NCT00424320|Ionic contrast media|ionic contrast media
1591902|NCT00424320|Iopamidol|iopamidol
1591903|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
1591904|NCT00424320|Coronariography|coronariography
1591905|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
1591906|NCT00424268|COPD|copd
1591907|NCT00424268|Roflumilast|roflumilast
1591908|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
1591909|NCT00424255|Neck cancer|neck cancer
1591910|NCT00424255|Adjuvant|adjuvant
1591911|NCT00424255|Head and neck cancer|head and neck cancer
1591912|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
1591913|NCT00424255|Post-surgery|post-surgery
1591914|NCT00424255|Head cancer|head cancer
1591915|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1591916|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
1591917|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
1591983|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1592296|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
1591918|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1591919|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1591920|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1591921|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1591922|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1591923|NCT00424242|primary myelofibrosis|primary myelofibrosis
1591924|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1591925|NCT00424242|essential thrombocythemia|essential thrombocythemia
1591926|NCT00424242|polycythemia vera|polycythemia vera
1591927|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1591928|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1591929|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1591930|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1591931|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1591932|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1591933|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1591934|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1591935|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1591936|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
1591937|NCT00424242|mast cell leukemia|mast cell leukemia
1591938|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1591939|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1591940|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1591941|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1591942|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1591943|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1591944|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1591945|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
1591946|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
1591947|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1591948|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1591949|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1591950|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1591951|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1591952|NCT00424242|intraocular lymphoma|intraocular lymphoma
1591953|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1591954|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
1591955|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1591956|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1591957|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1591958|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1591959|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1591960|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1591961|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1591962|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1591963|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1591964|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1591965|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1591966|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1591967|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1591968|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1591969|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1591970|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1591971|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1591972|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1591973|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1591974|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1591975|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1591976|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1591977|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1591978|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1591979|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1591980|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1591981|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1591982|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1591984|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1591985|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1591986|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1591987|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1591988|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1591989|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1591990|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1591991|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1591992|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1591993|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
1591994|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1591995|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1591996|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1591997|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
1591998|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
1591999|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
1592000|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1592001|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1592002|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
1592003|NCT00424216|Mood|mood
1592004|NCT00424216|Emotion|emotion
1592005|NCT00424216|Judgment|judgment
1592006|NCT00424216|Cortex|cortex
1592007|NCT00424216|Brain Stimulation|brain stimulation
1592008|NCT00424216|Healthy Volunteer|healthy volunteer
1592009|NCT00424216|HV|hv
1592010|NCT00424203|cognitive/functional effects|cognitive/functional effects
1592011|NCT00424203|depression|depression
1592012|NCT00424203|malnutrition|malnutrition
1592013|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1592014|NCT00424203|stage IA breast cancer|stage ia breast cancer
1592015|NCT00424203|stage IB breast cancer|stage ib breast cancer
1592016|NCT00424203|stage II breast cancer|stage ii breast cancer
1592017|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
1592018|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
1592019|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
1592020|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1592021|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1592022|NCT00424190|Abscess|abscess
1592023|NCT00424190|Antibacterial|antibacterial
1592024|NCT00424190|Antibiotic|antibiotic
1592025|NCT00424190|Antimicrobial|antimicrobial
1592026|NCT00424190|Bacterial infection, skin|bacterial infection, skin
1592027|NCT00424190|Ceftaroline|ceftaroline
1592028|NCT00424190|Ceftaroline acetate|ceftaroline acetate
1592029|NCT00424190|Cellulitis|cellulitis
1592030|NCT00424190|Cephalosporin|cephalosporin
1592031|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
1592032|NCT00424190|cSSSI|csssi
1592033|NCT00424190|Intravenous|intravenous
1592034|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1592035|NCT00424190|PPI-0903|ppi-0903
1592036|NCT00424190|Prodrug|prodrug
1592037|NCT00424190|Skin disease, bacterial|skin disease, bacterial
1592038|NCT00424190|Skin infection|skin infection
1592039|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
1592040|NCT00424190|Staphylococcus aureus|staphylococcus aureus
1592041|NCT00424190|Streptococcal skin infection|streptococcal skin infection
1592042|NCT00424190|Surgical site infection|surgical site infection
1592043|NCT00424190|TAK-599|tak-599
1592556|NCT00422695|Neuropathy|neuropathy
1592044|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1592045|NCT00424177|ITP|itp
1592046|NCT00424177|thrombocytopenia|thrombocytopenia
1592047|NCT00424177|platelets|platelets
1592048|NCT00424164|male breast cancer|male breast cancer
1592049|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
1592050|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
1592051|NCT00424164|stage IV breast cancer|stage iv breast cancer
1592052|NCT00424164|recurrent breast cancer|recurrent breast cancer
1592053|NCT00424151|Graves' Disease|graves' disease
1592054|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
1592055|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
1592056|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1592057|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1592058|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1592059|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1592060|NCT00424125|Asthma|asthma
1592061|NCT00424125|Compliance|compliance
1592062|NCT00424125|Randomized clinical trial|randomized clinical trial
1592063|NCT00424112|motivation to change|motivation to change
1592064|NCT00424112|treatment motivation|treatment motivation
1592065|NCT00424112|alcohol use disorders|alcohol use disorders
1592066|NCT00424099|Advanced Cancer|advanced cancer
1592067|NCT00424099|Fatigue|fatigue
1592068|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
1592069|NCT00424099|NTI|nti
1592070|NCT00424099|Methylphenidate|methylphenidate
1592071|NCT00424099|Placebo|placebo
1592072|NCT00424099|Ritalin|ritalin
1592073|NCT00424060|adult glioblastoma|adult glioblastoma
1592074|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
1592075|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
1592076|NCT00424060|adult gliosarcoma|adult gliosarcoma
1592077|NCT00424047|Multiple Myeloma|multiple myeloma
1592078|NCT00424047|Celgene|celgene
1592079|NCT00424047|Revlimid|revlimid
1592080|NCT00424047|CC-5013|cc-5013
1592081|NCT00424034|safety|safety
1592082|NCT00424034|Pharmacokinetics|pharmacokinetics
1592083|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
1592084|NCT00424008|Glucocorticosteroids|glucocorticosteroids
1592085|NCT00424008|Dry Powder Inhaler|dry powder inhaler
1592086|NCT00424008|Bronchodilator|bronchodilator
1592087|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
1592088|NCT00423969|Depression|depression
1592089|NCT00423969|Cognitive Impairment|cognitive impairment
1592090|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
1592091|NCT00423943|cognition|cognition
1592092|NCT00423943|memory|memory
1592093|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1592094|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1592095|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1592096|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1592097|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1592098|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1592099|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1592100|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1592101|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1592102|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1592103|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1592104|NCT00423930|tongue cancer|tongue cancer
1592105|NCT00423917|stage IV breast cancer|stage iv breast cancer
1592106|NCT00423917|male breast cancer|male breast cancer
1592107|NCT00423917|recurrent breast cancer|recurrent breast cancer
1592108|NCT00423904|Early intervention|early intervention
1592109|NCT00423904|Brief intervention|brief intervention
1592110|NCT00423904|alcohol|alcohol
1592111|NCT00423904|general hospital|general hospital
1592112|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1592113|NCT00423865|CISPLATIN|cisplatin
1592114|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
1592115|NCT00423865|06-129|06-129
1592116|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1592117|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1592118|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1592119|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1592120|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1592121|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1592122|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1592123|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1592124|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1592125|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1592126|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
1592127|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1592128|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1592129|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1592130|NCT00423852|adult teratoma|adult teratoma
1592131|NCT00423852|testicular immature teratoma|testicular immature teratoma
1592132|NCT00423852|testicular mature teratoma|testicular mature teratoma
1592133|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
1592134|NCT00423839|Antigen 85A|antigen 85a
1592135|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
1592136|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1592137|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1592138|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1592139|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1592140|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1592141|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1592142|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1592143|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1592144|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1592145|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1592146|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1592147|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1592148|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1592149|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1592150|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1592151|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1592152|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1592153|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1592154|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1592155|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1592156|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1592157|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1592158|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1592159|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1592160|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1592161|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1592162|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1592163|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1592164|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1592165|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1592166|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1592167|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1592168|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1592169|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1592170|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1592171|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1592172|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1592173|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1592174|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1592175|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1592176|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1592177|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1592178|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1592179|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1592180|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1592181|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1592182|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1592183|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1592184|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1592185|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1592186|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1592187|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1592188|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1592189|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1592190|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1592191|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
1592192|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
1592193|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
1592194|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
1592195|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1592196|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1592197|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
1592198|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
1592199|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1592200|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1592201|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1592202|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1592203|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1592480|NCT00422981|Cognition|cognition
1592204|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1592205|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1592206|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1592207|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1592208|NCT00423826|Burkitt lymphoma|burkitt lymphoma
1592209|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1592210|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1592211|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1592212|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1592213|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1592214|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1592215|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
1592217|NCT00423813|Fibro|fibro
1592218|NCT00423813|pain|pain
1592219|NCT00423813|Body pain|body pain
1592220|NCT00423813|tenderness|tenderness
1592221|NCT00423813|stiffness|stiffness
1592222|NCT00423813|muscular pain|muscular pain
1592223|NCT00423813|joint pain|joint pain
1592224|NCT00423787|Allergy|allergy
1592225|NCT00423787|Allergoid|allergoid
1592226|NCT00423787|Specific Immunotherapy|specific immunotherapy
1592227|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1592228|NCT00423774|Psychological Distress|psychological distress
1592229|NCT00423774|Coping|coping
1592230|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
1592231|NCT00423774|Bone Marrow Transplant|bone marrow transplant
1592232|NCT00423774|Coping Skills|coping skills
1592233|NCT00423761|Pharmacokinetics,|pharmacokinetics,
1592234|NCT00423761|tolerability,|tolerability,
1592235|NCT00423761|healthy,|healthy,
1592236|NCT00423761|subjects|subjects
1592237|NCT00423722|Advanced Cancer|advanced cancer
1592238|NCT00423722|Hospice Care|hospice care
1592239|NCT00423722|Caregiver|caregiver
1592240|NCT00423722|Saline|saline
1592241|NCT00423722|Hydration|hydration
1592242|NCT00423722|Dehydration|dehydration
1592243|NCT00423709|Hodgkin's Disease|hodgkin's disease
1592244|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
1592245|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
1592246|NCT00423709|Fludarabine|fludarabine
1592247|NCT00423709|Melphalan|melphalan
1592248|NCT00423696|stage IV colon cancer|stage iv colon cancer
1592249|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
1592250|NCT00423696|recurrent colon cancer|recurrent colon cancer
1592251|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
1592252|NCT00423683|Cancer|cancer
1592253|NCT00423683|thromboembolism|thromboembolism
1592254|NCT00423657|Abscess|abscess
1592255|NCT00423657|Antibacterial|antibacterial
1592256|NCT00423657|Antibiotic|antibiotic
1592257|NCT00423657|Antimicrobial|antimicrobial
1592258|NCT00423657|Bacterial infection, skin|bacterial infection, skin
1592259|NCT00423657|Ceftaroline|ceftaroline
1592260|NCT00423657|Ceftaroline acetate|ceftaroline acetate
1592261|NCT00423657|Cellulitis|cellulitis
1592262|NCT00423657|Cephalosporin|cephalosporin
1592263|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
1592264|NCT00423657|cSSSI|csssi
1592265|NCT00423657|Intravenous|intravenous
1592266|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
1592267|NCT00423657|PPI-0903|ppi-0903
1592268|NCT00423657|Prodrug|prodrug
1592269|NCT00423657|Skin disease, bacterial|skin disease, bacterial
1592270|NCT00423657|Skin infection|skin infection
1592271|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
1592272|NCT00423657|Staphylococcus aureus|staphylococcus aureus
1592273|NCT00423657|Streptococcal skin infection|streptococcal skin infection
1592274|NCT00423657|Surgical site infection|surgical site infection
1592275|NCT00423657|TAK-599|tak-599
1592276|NCT00423644|Multiple Myeloma|multiple myeloma
1592277|NCT00423644|arsenic|arsenic
1592278|NCT00423644|cancer study|cancer study
1592279|NCT00423644|failed treatment|failed treatment
1592280|NCT00423631|Pain|pain
1592281|NCT00423631|Fibromyalgia|fibromyalgia
1592282|NCT00423631|Internet|internet
1592283|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1592284|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1592285|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1592286|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1592287|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
1592288|NCT00423618|adult angiosarcoma|adult angiosarcoma
1592289|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
1592290|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1592291|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
1592292|NCT00423618|adult liposarcoma|adult liposarcoma
1592293|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1592294|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1592295|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
1592297|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
1592298|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1592299|NCT00423605|FMS|fms
1592300|NCT00423605|Fibro|fibro
1592301|NCT00423605|Pain|pain
1592302|NCT00423605|Body Pain|body pain
1592303|NCT00423605|Tenderness|tenderness
1592304|NCT00423605|Joint pain|joint pain
1592305|NCT00423605|Stiffness|stiffness
1592306|NCT00423605|Muscular Pain|muscular pain
1592307|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
1592308|NCT00423566|85A antigen|85a antigen
1592309|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
1592310|NCT00423566|Phase I study|phase i study
1592311|NCT00423566|Immunogenicity|immunogenicity
1592312|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
1592313|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
1592314|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
1592315|NCT00423553|Ischemia|ischemia
1592316|NCT00423540|magnesium infusion|magnesium infusion
1592317|NCT00423540|magnesium sulfate|magnesium sulfate
1592318|NCT00423540|rest cramps|rest cramps
1592319|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
1592320|NCT00423540|muscle cramps|muscle cramps
1592321|NCT00423540|fractional urinary excretion|fractional urinary excretion
1592322|NCT00423540|urinary excretion|urinary excretion
1592323|NCT00423540|24 hour urine|24 hour urine
1592324|NCT00423540|serum magnesium|serum magnesium
1592325|NCT00423540|magnesium deficiency|magnesium deficiency
1592326|NCT00423540|family practice|family practice
1592327|NCT00423540|general practice|general practice
1592328|NCT00423540|richmond|richmond
1592329|NCT00423540|cramp frequency|cramp frequency
1592330|NCT00423540|magnesium status|magnesium status
1592331|NCT00423540|urinary magnesium|urinary magnesium
1592332|NCT00423540|cramp diary|cramp diary
1592333|NCT00423540|sf 36|sf 36
1592334|NCT00423527|multiple sclerosis|multiple sclerosis
1592335|NCT00423527|central pain|central pain
1592336|NCT00423527|levetiracetam|levetiracetam
1592337|NCT00423514|graft versus host disease|graft versus host disease
1592338|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1592339|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1592340|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1592341|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1592342|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1592343|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1592344|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
1592345|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1592346|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1592347|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1592348|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1592349|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1592350|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1592351|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1592352|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1592353|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1592354|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1592355|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1592450|NCT00423072|palatoplasty|palatoplasty
1592451|NCT00423072|otitis|otitis
1592356|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1592357|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1592358|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1592359|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1592360|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1592361|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1592362|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1592363|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1592364|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
1592365|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
1592366|NCT00423475|stage III prostate cancer|stage iii prostate cancer
1592367|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
1592368|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
1592369|NCT00423462|Psychotherapy|psychotherapy
1592370|NCT00423462|Long-term effects|long-term effects
1592371|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
1592372|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
1592373|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
1592374|NCT00423436|Voice Response System|voice response system
1592375|NCT00423436|Questionnaire|questionnaire
1592376|NCT00423436|Survey|survey
1592377|NCT00423436|NSCLC|nsclc
1592378|NCT00423410|Cancer|cancer
1592379|NCT00423410|Tumor|tumor
1592380|NCT00423410|Lymphoma|lymphoma
1592381|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1592382|NCT00423397|recurrent skin cancer|recurrent skin cancer
1592383|NCT00423384|Ibandronate|ibandronate
1592384|NCT00423384|Placebo|placebo
1592385|NCT00423384|Doubleblind|doubleblind
1592386|NCT00423384|Bone|bone
1592387|NCT00423384|loss|loss
1592388|NCT00423384|Kidney|kidney
1592389|NCT00423384|transplant|transplant
1592390|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
1592391|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
1592392|NCT00423358|hypovitaminosis D|hypovitaminosis d
1592393|NCT00423358|bone turnover|bone turnover
1592394|NCT00423358|ergocalciferol|ergocalciferol
1592395|NCT00423332|cancer|cancer
1592396|NCT00423332|tumour|tumour
1592397|NCT00423332|advanced cancer|advanced cancer
1592398|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1592399|NCT00423332|kidney cancer|kidney cancer
1592400|NCT00423332|RECENTIN|recentin
1592401|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
1592402|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
1592403|NCT00423293|stage II anal cancer|stage ii anal cancer
1592404|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
1592405|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
1592406|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1592407|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1592408|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1592409|NCT00423280|Endothelium|endothelium
1592410|NCT00423280|Nitric Oxide|nitric oxide
1592411|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
1592412|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
1592413|NCT00423254|Cancer Vaccine|cancer vaccine
1592414|NCT00423228|Alzheimer's disease|alzheimer's disease
1592415|NCT00423228|cognitive impairment|cognitive impairment
1592416|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
1592417|NCT00423228|sustained-release implants|sustained-release implants
1592418|NCT00423228|long acting treatment|long acting treatment
1592419|NCT00423189|LUV|luv
1592420|NCT00423189|Lucentis|lucentis
1592421|NCT00423189|Visudyne|visudyne
1592422|NCT00423189|PDT|pdt
1592423|NCT00423189|AMD|amd
1592424|NCT00423189|ARMD|armd
1592425|NCT00423189|Age|age
1592426|NCT00423189|Related|related
1592427|NCT00423189|Macular|macular
1592428|NCT00423189|Degeneration|degeneration
1592429|NCT00423163|Aspergillosis/blood|aspergillosis/blood
1592430|NCT00423163|micafungin|micafungin
1592431|NCT00423163|voriconazole|voriconazole
1592432|NCT00423163|Aspergillus|aspergillus
1592433|NCT00423124|Hematological malignancies|hematological malignancies
1592434|NCT00423124|HSV-TK|hsv-tk
1592435|NCT00423124|Haploidentical HCT|haploidentical hct
1592436|NCT00423124|GvHD|gvhd
1592437|NCT00423124|GvL|gvl
1592438|NCT00423111|Multiple sclerosis|multiple sclerosis
1592439|NCT00423111|Memory|memory
1592440|NCT00423111|Cognitive deficits|cognitive deficits
1592441|NCT00423111|MRI|mri
1592442|NCT00423111|Hippocampus|hippocampus
1592443|NCT00423111|Prefrontal cortex|prefrontal cortex
1592444|NCT00423098|Lupus Nephritis|lupus nephritis
1592445|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
1592446|NCT00423098|EC-MPS|ec-mps
1592447|NCT00423098|Myfortic|myfortic
1592448|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
1592449|NCT00423072|cleft palate|cleft palate
1592453|NCT00423072|Eustachian tube|eustachian tube
1592454|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
1592455|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
1592456|NCT00423059|VEGF|vegf
1592457|NCT00423059|PEDF|pedf
1592458|NCT00423046|Vaccines|vaccines
1592459|NCT00423046|Cervical cancer|cervical cancer
1592460|NCT00423046|Immunogenicity|immunogenicity
1592461|NCT00423046|Humans|humans
1592462|NCT00423046|Safety|safety
1592463|NCT00423046|Viral infections|viral infections
1592464|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
1592465|NCT00423046|Comparative study|comparative study
1592466|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
1592467|NCT00423046|Adults|adults
1592468|NCT00423020|Acute myocardial infarction|acute myocardial infarction
1592469|NCT00423020|Restenosis|restenosis
1592470|NCT00423020|erythropoietin|erythropoietin
1592471|NCT00423020|EPOC-AMI|epoc-ami
1592472|NCT00422994|end stage renal impairment|end stage renal impairment
1592473|NCT00422994|tolerability|tolerability
1592474|NCT00422994|ropinirole|ropinirole
1592475|NCT00422994|pharmacokinetics|pharmacokinetics
1592476|NCT00422994|hemodialysis|hemodialysis
1592477|NCT00422981|Dementia|dementia
1592478|NCT00422981|Memory|memory
1592479|NCT00422981|Alzheimers|alzheimers
1592483|NCT00422968|Coronary artery disease|coronary artery disease
1592484|NCT00422968|Stent|stent
1592485|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
1592486|NCT00422955|fluid retention|fluid retention
1592487|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
1592488|NCT00422929|otitis media|otitis media
1592489|NCT00422929|ear|ear
1592490|NCT00422929|acute otitis|acute otitis
1592491|NCT00422929|middle ear|middle ear
1592492|NCT00422929|Eustachian tube|eustachian tube
1592493|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
1592494|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
1592495|NCT00422929|no significant history of otitis media|no significant history of otitis media
1592496|NCT00422903|neo-adjuvant|neo-adjuvant
1592497|NCT00422903|letrozole|letrozole
1592498|NCT00422903|lapatinib|lapatinib
1592499|NCT00422903|primary breast cancer|primary breast cancer
1592500|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
1592501|NCT00422877|Liver Cancer|liver cancer
1592502|NCT00422851|otitis|otitis
1592503|NCT00422851|gas diffusion|gas diffusion
1592504|NCT00422851|Eustachian tube|eustachian tube
1592505|NCT00422851|tympanic membrane|tympanic membrane
1592506|NCT00422838|Hepatitis C|hepatitis c
1592507|NCT00422838|Liver|liver
1592508|NCT00422838|immunology|immunology
1592509|NCT00422838|regulation|regulation
1592510|NCT00422838|Genotype 1,2,3|genotype 1,2,3
1592511|NCT00422838|Treatment|treatment
1592512|NCT00422838|Chronic|chronic
1592513|NCT00422838|Pegylated interferon|pegylated interferon
1592514|NCT00422838|Ribavirin|ribavirin
1592515|NCT00422825|Food effect|food effect
1592516|NCT00422825|bioavailability|bioavailability
1592517|NCT00422825|pharmacokinetic|pharmacokinetic
1592518|NCT00422825|imatinib|imatinib
1592519|NCT00422825|STI571|sti571
1592520|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
1592521|NCT00422825|CML|cml
1592522|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
1592523|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
1592524|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
1592525|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
1592526|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
1592527|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
1592528|NCT00422799|Velcade|velcade
1592529|NCT00422799|WM|wm
1592530|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
1592531|NCT00422786|Phase II|phase ii
1592532|NCT00422786|Thallion|thallion
1592533|NCT00422786|TLN-232|tln-232
1592534|NCT00422786|CAP-232|cap-232
1592535|NCT00422786|M2PK|m2pk
1592536|NCT00422773|phase I/II|phase i/ii
1592537|NCT00422773|cetuximab|cetuximab
1592538|NCT00422773|oxaliplatin|oxaliplatin
1592539|NCT00422773|irinotecan|irinotecan
1592540|NCT00422773|5-FU|5-fu
1592541|NCT00422773|chemotherapy|chemotherapy
1592542|NCT00422773|dose escalation|dose escalation
1592543|NCT00422773|safety|safety
1592544|NCT00422760|esophageal perforation|esophageal perforation
1592545|NCT00422760|COPD|copd
1592546|NCT00422747|asthma|asthma
1592547|NCT00422747|transient wheezing|transient wheezing
1592548|NCT00422747|early diagnosis|early diagnosis
1592549|NCT00422747|exhaled air|exhaled air
1592550|NCT00422747|nitrogen monoxide|nitrogen monoxide
1592551|NCT00422747|airway resistance|airway resistance
1592552|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
1592553|NCT00422721|amaurosis of leber|amaurosis of leber
1592554|NCT00422695|HIV|hiv
1592555|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
1592557|NCT00422695|Treatment Experienced|treatment experienced
1592558|NCT00422695|Treatment Naive|treatment naive
1592559|NCT00422682|Solid tumors|solid tumors
1592560|NCT00422669|Pacemaker|pacemaker
1592561|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
1592562|NCT00422669|AV Conduction Disturbance|av conduction disturbance
1592563|NCT00422669|Select Site Pacing|select site pacing
1592564|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
1592565|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
1592566|NCT00422656|WM|wm
1592567|NCT00422656|perifosine|perifosine
1592568|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
1592569|NCT00422630|Weight loss|weight loss
1592570|NCT00422630|Obesity|obesity
1592571|NCT00422630|Metabolic Syndrome|metabolic syndrome
1592572|NCT00422630|Diet|diet
1592573|NCT00422630|Hypertension|hypertension
1592574|NCT00422630|Diabetes|diabetes
1592575|NCT00422630|Cholesterol|cholesterol
1592576|NCT00422617|psoriasis|psoriasis
1592577|NCT00422617|alefacept|alefacept
1592578|NCT00422604|COPD|copd
1592579|NCT00422604|plethysmography.|plethysmography.
1592580|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
1592581|NCT00422604|anticholinergic|anticholinergic
1592582|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
1592583|NCT00422591|Leukemia|leukemia
1592584|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
1592588|NCT00422578|erectile dysfunction|erectile dysfunction
1592589|NCT00422578|tadalafil|tadalafil
1592590|NCT00422565|Coronary Artery Disease|coronary artery disease
1592592|NCT00422565|Myocardial Infarction|myocardial infarction
1592593|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
1592594|NCT00422539|trichloroacetic acid|trichloroacetic acid
1592595|NCT00422539|varicella scar|varicella scar
1592596|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
1592597|NCT00422500|Lung Cancer|lung cancer
1592598|NCT00422500|Advanced Lung Cancer|advanced lung cancer
1592599|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
1592600|NCT00422500|Disease-Related Symptoms|disease-related symptoms
1592601|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
1592602|NCT00422500|Symptom Management|symptom management
1592603|NCT00422500|Questionnaire|questionnaire
1592604|NCT00422500|Telephone Interactive System|telephone interactive system
1592605|NCT00422500|IVR Telephone System|ivr telephone system
1592606|NCT00422500|DNA Repair Capacity|dna repair capacity
1592607|NCT00422500|DRC|drc
1592608|NCT00422500|Cognitive Symptoms|cognitive symptoms
1592609|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1592610|NCT00422474|Ischemic stroke|ischemic stroke
1592611|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
1592612|NCT00422474|Prognosis|prognosis
1592613|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
1592614|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
1592615|NCT00422448|Dermoscopy|dermoscopy
1592616|NCT00422448|Histopathology|histopathology
1592617|NCT00422448|Genetics|genetics
1592618|NCT00422448|Nevi|nevi
1592619|NCT00422448|Nevogenesis|nevogenesis
1592620|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1592621|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
1592622|NCT00422422|Brivaracetam|brivaracetam
1592623|NCT00422422|Epilepsy|epilepsy
1592624|NCT00422422|Child|child
1592625|NCT00422422|Pharmacokinetics|pharmacokinetics
1592626|NCT00422422|Adolescents|adolescents
1592627|NCT00422409|SEMS|sems
1592628|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
1592629|NCT00422396|Metabolic syndrome|metabolic syndrome
1592630|NCT00422396|Obesity|obesity
1592631|NCT00422396|Fenofibrate|fenofibrate
1592632|NCT00422396|Lipoproteins|lipoproteins
1592633|NCT00422396|Cytokines|cytokines
1592634|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1592635|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
1592636|NCT00422357|Hypoglycemic agents|hypoglycemic agents
1592637|NCT00422344|RAD001|rad001
1592638|NCT00422344|Sunitinib|sunitinib
1592639|NCT00422344|renal|renal
1592640|NCT00422344|kidney|kidney
1592641|NCT00422331|Bipolar I Disorder|bipolar i disorder
1592642|NCT00422331|Bipolar Disorder|bipolar disorder
1592643|NCT00422331|Lithium|lithium
1592644|NCT00422318|Heart Failure|heart failure
1592645|NCT00422318|Insulin|insulin
1592646|NCT00422318|Metabolism|metabolism
1592647|NCT00422318|Pharmacology|pharmacology
1592648|NCT00422318|Uric Acid|uric acid
1592649|NCT00422305|Infant, Premature|infant, premature
1592650|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1592651|NCT00422305|asthma|asthma
1592652|NCT00422292|Menactra vaccine|menactra vaccine
1592653|NCT00422292|Meningococcal meningitis|meningococcal meningitis
1592654|NCT00422292|Measles|measles
1592655|NCT00422292|Mumps|mumps
1592656|NCT00422292|Rubella|rubella
1592657|NCT00422292|Varicella vaccines|varicella vaccines
1592658|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
1592659|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1592660|NCT00422279|Bone Inductive Implant|bone inductive implant
1592661|NCT00422266|Dyslipidemia|dyslipidemia
1592662|NCT00422253|insulin resistance|insulin resistance
1592663|NCT00422253|insulin secretion|insulin secretion
1592664|NCT00422253|advanced glycation end-products|advanced glycation end-products
1592665|NCT00422240|Acne vulgaris|acne vulgaris
1592666|NCT00422240|Adapalene|adapalene
1592667|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
1592668|NCT00422214|Bipolar Disorder|bipolar disorder
1592669|NCT00422214|Bipolar Depression,|bipolar depression,
1592670|NCT00422214|Manic Depression|manic depression
1592671|NCT00422214|Seroquel|seroquel
1592672|NCT00422214|Seroquel SR|seroquel sr
1592673|NCT00422214|quetiapine fumarate|quetiapine fumarate
1592674|NCT00422201|Cortisol|cortisol
1592675|NCT00422201|Cushing's Syndrome|cushing's syndrome
1592676|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
1592677|NCT00422201|Cushing Syndrome|cushing syndrome
1592678|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
1592679|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
1592680|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
1592681|NCT00422136|middle ear|middle ear
1592682|NCT00422136|otitis|otitis
1592683|NCT00422136|genetics|genetics
1592684|NCT00422123|Bipolar Disorder|bipolar disorder
1592685|NCT00422123|Bipolar Mania|bipolar mania
1592686|NCT00422123|Manic Depression|manic depression
1592687|NCT00422123|Seroquel|seroquel
1592688|NCT00422123|Seroquel SR|seroquel sr
1592689|NCT00422123|quetiapine fumarate|quetiapine fumarate
1592690|NCT00422110|Seletracetam|seletracetam
1592691|NCT00422110|Epilepsies|epilepsies
1592692|NCT00422110|Partial|partial
1592693|NCT00422110|Epilepsy|epilepsy
1592694|NCT00422110|Focal|focal
1592695|NCT00422084|Malaria|malaria
1592696|NCT00422084|ACT|act
1592697|NCT00422084|P falciparum|p falciparum
1592698|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1592699|NCT00422071|Dopamine|dopamine
1592700|NCT00422071|Gambling|gambling
1592701|NCT00422071|Healthy Volunteer|healthy volunteer
1592702|NCT00422071|HV|hv
1592703|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
1592704|NCT00422032|Leukemia|leukemia
1592705|NCT00422032|Clofarabine|clofarabine
1592706|NCT00422032|MDS|mds
1592707|NCT00422019|Renal Cancer|renal cancer
1592708|NCT00422019|Kidney Cancer|kidney cancer
1592709|NCT00422006|bariatric surgery planned|bariatric surgery planned
1592710|NCT00421993|Acne vulgaris|acne vulgaris
1592711|NCT00421993|Adapalene|adapalene
1592712|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
1592713|NCT00421967|Postoperative pain|postoperative pain
1592714|NCT00421954|psychosis NOS|psychosis nos
1592715|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
1592716|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
1592717|NCT00421941|enteral feeding|enteral feeding
1592718|NCT00421941|critical care|critical care
1592719|NCT00421941|fish oil|fish oil
1592720|NCT00421941|surgical|surgical
1592721|NCT00421928|Chronic Pain|chronic pain
1592722|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
1592723|NCT00421928|tapentadol|tapentadol
1592724|NCT00421928|Pain Assessment|pain assessment
1592725|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
1592726|NCT00421889|Ovarian cancer|ovarian cancer
1592727|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
1592728|NCT00421889|Primary peritoneal|primary peritoneal
1592729|NCT00421889|Epithelial ovarian|epithelial ovarian
1592730|NCT00421889|Fallopian tube|fallopian tube
1592731|NCT00421889|Bladder cancer|bladder cancer
1592732|NCT00421889|belinostat|belinostat
1592733|NCT00421889|PXD101|pxd101
1592734|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
1592735|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
1592736|NCT00421876|lifestyle management|lifestyle management
1592737|NCT00421876|risk factor management|risk factor management
1592738|NCT00421876|myocardial infarction|myocardial infarction
1592739|NCT00421876|randomized trials|randomized trials
1592740|NCT00421863|hypertension|hypertension
1592741|NCT00421863|systolic blood pressure|systolic blood pressure
1592742|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
1592743|NCT00421811|cancer|cancer
1592744|NCT00421811|tumors|tumors
1592745|NCT00421811|melanoma|melanoma
1592746|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
1592747|NCT00421811|antineoplastic agents|antineoplastic agents
1592748|NCT00421811|cadherins|cadherins
1592749|NCT00421811|solid tumors|solid tumors
1592750|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
1592751|NCT00421785|N-acetylcysteine|n-acetylcysteine
1592752|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
1592753|NCT00421785|ADMA|adma
1592754|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
1592755|NCT00421772|prenatal diagnostic|prenatal diagnostic
1592756|NCT00421772|neuropsychological outcome|neuropsychological outcome
1592757|NCT00421759|Sensory loss|sensory loss
1592758|NCT00421759|psychomotor function|psychomotor function
1592759|NCT00421759|balance|balance
1592760|NCT00421759|gait|gait
1592761|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
1592762|NCT00421720|remifentanil|remifentanil
1592763|NCT00421720|sufentanil|sufentanil
1592764|NCT00421720|propofol|propofol
1592765|NCT00421720|analgesia|analgesia
1592766|NCT00421720|sedation|sedation
1592767|NCT00421720|mechanically ventilated|mechanically ventilated
1592768|NCT00421720|intensive care|intensive care
1592769|NCT00421720|pharmacoeconomic|pharmacoeconomic
1592770|NCT00421720|weaning|weaning
1592771|NCT00421720|delirium|delirium
1592772|NCT00421720|randomized|randomized
1592774|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
1592775|NCT00421681|Aging|aging
1592776|NCT00421681|exercise|exercise
1592777|NCT00421681|health behavior|health behavior
1592778|NCT00421668|HIV|hiv
1592779|NCT00421668|Tanzania|tanzania
1592780|NCT00421668|Micronutrients|micronutrients
1592781|NCT00421668|Infants/children|infants/children
1592782|NCT00421668|Infectious Disease|infectious disease
1592783|NCT00421668|Growth faltering|growth faltering
1592784|NCT00421629|health insurance|health insurance
1592785|NCT00421629|hospitalization insurance|hospitalization insurance
1593180|NCT00419900|synchrotron|synchrotron
1592786|NCT00421629|community based health insurance|community based health insurance
1592787|NCT00421629|health care access|health care access
1592788|NCT00421629|developing countries|developing countries
1592789|NCT00421629|randomized controlled trials|randomized controlled trials
1592790|NCT00421616|Calorimetry|calorimetry
1592791|NCT00421616|Overweight|overweight
1592792|NCT00421616|Weight loss|weight loss
1592793|NCT00421616|Appetite|appetite
1592794|NCT00421603|Cocaine|cocaine
1592795|NCT00421603|Adderall|adderall
1592796|NCT00421603|Topiramate|topiramate
1592797|NCT00421603|ADHD|adhd
1592798|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
1592799|NCT00421577|Caries Diagnosis|caries diagnosis
1592800|NCT00421577|Replica technique|replica technique
1592801|NCT00421564|Menopausal|menopausal
1592802|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
1592803|NCT00421551|HIV Infections|hiv infections
1592804|NCT00421551|darunavir|darunavir
1592805|NCT00421551|Ritonavir|ritonavir
1592806|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
1592807|NCT00421551|treatment experienced|treatment experienced
1592808|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
1592809|NCT00421538|Calf vein thrombosis|calf vein thrombosis
1592810|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
1592811|NCT00421538|Placebo|placebo
1592812|NCT00421538|Elastic contention|elastic contention
1592813|NCT00421538|Compression Ultrasonography|compression ultrasonography
1592814|NCT00421525|multiple myeloma|multiple myeloma
1592815|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
1592816|NCT00421525|PLASMACYTOMA|plasmacytoma
1592817|NCT00421512|Renal cell carcinoma|renal cell carcinoma
1592818|NCT00421512|Metastatic|metastatic
1592819|NCT00421512|Kidney Cancer|kidney cancer
1592820|NCT00421512|Bevacizumab|bevacizumab
1592821|NCT00421512|Sunitinib|sunitinib
1592822|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
1592823|NCT00421486|HIV-infection|hiv-infection
1592824|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
1592825|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
1592826|NCT00421486|Treatment Experienced|treatment experienced
1592827|NCT00421486|Treatment Naive|treatment naive
1592828|NCT00421473|HIV|hiv
1592829|NCT00421473|Malaria prophylaxis|malaria prophylaxis
1592830|NCT00421473|Treatment Experienced|treatment experienced
1592831|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
1592832|NCT00421447|Breast Cancer|breast cancer
1592833|NCT00421447|pQCT|pqct
1592834|NCT00421447|Anastrozole|anastrozole
1592835|NCT00421447|bone geometry|bone geometry
1592836|NCT00421434|Hepatitis C|hepatitis c
1592837|NCT00421421|Acute Urinary Retention|acute urinary retention
1592838|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1592839|NCT00421421|Trial Without Catheter|trial without catheter
1592840|NCT00421408|Dietary protein|dietary protein
1592841|NCT00421408|Calcium|calcium
1592842|NCT00421408|Parathyroid hormone|parathyroid hormone
1592843|NCT00421408|Bone markers|bone markers
1592844|NCT00421408|Bone mineral density|bone mineral density
1592845|NCT00421408|IGF-1|igf-1
1592846|NCT00421408|Urine Calcium|urine calcium
1592847|NCT00421395|NHL|nhl
1592848|NCT00421395|B-cell NHL|b-cell nhl
1592849|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
1592850|NCT00421369|Major depressive disorder|major depressive disorder
1592851|NCT00421369|Antidepressants|antidepressants
1592852|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
1592853|NCT00421369|Thyroid Function|thyroid function
1592854|NCT00421369|Augmentation|augmentation
1592855|NCT00421369|Thyroid pathway genes|thyroid pathway genes
1592856|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
1592857|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
1592858|NCT00421343|osteoporotic fractures|osteoporotic fractures
1592859|NCT00421343|accidental falls|accidental falls
1592860|NCT00421343|aging|aging
1592861|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
1592862|NCT00421330|AAA|aaa
1592863|NCT00421330|randomised controlled trial|randomised controlled trial
1592864|NCT00421330|Endovascular repair|endovascular repair
1592865|NCT00421330|conventional open repair|conventional open repair
1592866|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
1592867|NCT00421265|prostate cancer|prostate cancer
1592868|NCT00421265|active surveillance|active surveillance
1592869|NCT00421265|indolent features|indolent features
1592870|NCT00421252|clopidogrel|clopidogrel
1592871|NCT00421252|hemorrhagic complication|hemorrhagic complication
1592872|NCT00421252|vascular complication|vascular complication
1592873|NCT00421252|antiplatelet agent|antiplatelet agent
1592874|NCT00421252|stenting|stenting
1592875|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
1592876|NCT00421252|risk|risk
1592877|NCT00421252|ischemia|ischemia
1592878|NCT00421252|troponin|troponin
1592879|NCT00421252|sheath size|sheath size
1592880|NCT00421239|hypertensive urgency|hypertensive urgency
1592881|NCT00421239|arterial hypertension|arterial hypertension
1593086|NCT00420355|HIV infection|hiv infection
1592882|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
1592884|NCT00421213|Lymphoma|lymphoma
1592885|NCT00421213|T-cell Lymphoma|t-cell lymphoma
1592886|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1592887|NCT00421200|Hip arthroplasty|hip arthroplasty
1592888|NCT00421200|Anesthesia, spinal|anesthesia, spinal
1592889|NCT00421200|Hypotension|hypotension
1592890|NCT00421200|Ischemia|ischemia
1592891|NCT00421200|Blood substitutes|blood substitutes
1592892|NCT00421200|Plasma expanders|plasma expanders
1592893|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
1592894|NCT00421187|ARNF|arnf
1592895|NCT00421187|Ambisome|ambisome
1592896|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
1592897|NCT00421174|Etanercept|etanercept
1592898|NCT00421174|IPS|ips
1592899|NCT00421161|olive oil|olive oil
1592900|NCT00421161|stasis dermatitis|stasis dermatitis
1592901|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
1592902|NCT00421122|Chinese patients|chinese patients
1592903|NCT00421122|COPD|copd
1592904|NCT00421109|Urticaria|urticaria
1592905|NCT00421109|Hives|hives
1592906|NCT00421109|Wheals|wheals
1592907|NCT00421109|Flare|flare
1592908|NCT00421109|Chronic|chronic
1592909|NCT00421109|Idiopathic|idiopathic
1592910|NCT00421109|Erythema|erythema
1592911|NCT00421109|Skin diseases, vascular|skin diseases, vascular
1592912|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
1592913|NCT00421109|Allergic|allergic
1592914|NCT00421109|Cutaneous|cutaneous
1592915|NCT00421096|uterine cervical cancer|uterine cervical cancer
1592916|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
1592917|NCT00421070|Aggression|aggression
1592918|NCT00421070|Massage|massage
1592919|NCT00421070|Stress|stress
1592920|NCT00421070|Psychiatric inpatient|psychiatric inpatient
1592921|NCT00421057|Breast Cancer|breast cancer
1592922|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
1592923|NCT00421057|Fatigue|fatigue
1592924|NCT00421057|Exercise|exercise
1592925|NCT00421057|Strength Training|strength training
1592926|NCT00421057|Endurance Exercise|endurance exercise
1592927|NCT00421057|Questionnaire|questionnaire
1592928|NCT00421057|Survey|survey
1592929|NCT00421044|EPO|epo
1592930|NCT00421044|Patupilone|patupilone
1592931|NCT00421044|Solid Tumors|solid tumors
1592932|NCT00421018|Asthma|asthma
1592933|NCT00421018|Allergy|allergy
1592934|NCT00421018|Cytokines|cytokines
1592935|NCT00421018|Glucocorticoids|glucocorticoids
1592936|NCT00421018|Inflammation|inflammation
1592937|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
1592938|NCT00421018|Quality of Life|quality of life
1592939|NCT00421018|Self-Rated Health|self-rated health
1592940|NCT00421018|Stress|stress
1592941|NCT00420992|hip|hip
1592942|NCT00420992|knee|knee
1592943|NCT00420992|pain|pain
1592944|NCT00420992|osteoarthritis|osteoarthritis
1592945|NCT00420992|OA|oa
1592946|NCT00420992|Kadian|kadian
1592947|NCT00420992|Alpharma|alpharma
1592948|NCT00420992|naltrexone|naltrexone
1592949|NCT00420992|Opioid|opioid
1592950|NCT00420992|morphine|morphine
1592951|NCT00420992|Embeda|embeda
1592952|NCT00420992|ALO-01|alo-01
1592953|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
1592954|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
1592955|NCT00420966|palivizumab|palivizumab
1592956|NCT00420966|outcomes|outcomes
1592957|NCT00420966|utilization|utilization
1592958|NCT00420966|compliance|compliance
1592959|NCT00420940|vibration|vibration
1592960|NCT00420940|mechanical loading|mechanical loading
1592961|NCT00420940|bone mineral density|bone mineral density
1592962|NCT00420940|women's health|women's health
1592963|NCT00420940|osteoporosis|osteoporosis
1592964|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
1592965|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
1592966|NCT00420914|Thrombocytopenia|thrombocytopenia
1592967|NCT00420914|Platelets|platelets
1592968|NCT00420914|Dose|dose
1592969|NCT00420914|Bleeding|bleeding
1592970|NCT00420901|function|function
1592971|NCT00420901|inhibition|inhibition
1592972|NCT00420875|plantar fasciitis|plantar fasciitis
1592973|NCT00420875|plantar fasciosis|plantar fasciosis
1592974|NCT00420875|Achilles tendinosis|achilles tendinosis
1592975|NCT00420875|Achilles tendinitis|achilles tendinitis
1592976|NCT00420875|heel pain|heel pain
1592977|NCT00420875|fasciosis|fasciosis
1592978|NCT00420875|fasciitis|fasciitis
1592979|NCT00420875|tendinosis|tendinosis
1592980|NCT00420875|tendinitis|tendinitis
1592981|NCT00420875|conservative treatment|conservative treatment
1592982|NCT00420862|Lung neoplasms|lung neoplasms
1592983|NCT00420862|Early diagnosis|early diagnosis
1592984|NCT00420862|Screening|screening
1592985|NCT00420862|Spiral Computed Tomography|spiral computed tomography
1592986|NCT00420862|Randomized Controlled Trial|randomized controlled trial
1593286|NCT00419432|Pediatrics|pediatrics
1592987|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
1592988|NCT00420823|First Episode Psychosis|first episode psychosis
1592989|NCT00420797|Faecal seepage|faecal seepage
1592990|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
1592991|NCT00420797|quality of life|quality of life
1592992|NCT00420797|faecal incontinence|faecal incontinence
1592993|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
1592994|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
1592995|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
1592996|NCT00420797|placebo|placebo
1592997|NCT00420784|Genotype 1|genotype 1
1592998|NCT00420771|Benzodiazepine|benzodiazepine
1592999|NCT00420771|Gabapentin|gabapentin
1593000|NCT00420771|Methadone|methadone
1593001|NCT00420758|Infant|infant
1593002|NCT00420758|Malnutrition|malnutrition
1593003|NCT00420758|Sub-Saharan Africa|sub-saharan africa
1593004|NCT00420758|Treatment|treatment
1593005|NCT00420758|Growth|growth
1593006|NCT00420758|Haemoglobin|haemoglobin
1593007|NCT00420758|Fortified spread|fortified spread
1593008|NCT00420758|Food supplement|food supplement
1593009|NCT00420719|ALS|als
1593010|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1593011|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
1593012|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
1593013|NCT00420719|Diaphragm Pacing|diaphragm pacing
1593014|NCT00420667|unfractionated heparin|unfractionated heparin
1593015|NCT00420667|enoxaparin|enoxaparin
1593016|NCT00420667|low molecular weight heparin|low molecular weight heparin
1593017|NCT00420667|bypass surgery|bypass surgery
1593018|NCT00420667|bleeding|bleeding
1593019|NCT00420654|Turner syndrome|turner syndrome
1593020|NCT00420654|growth hormone treatment|growth hormone treatment
1593021|NCT00420654|positron emission tomography|positron emission tomography
1593022|NCT00420654|heart|heart
1593023|NCT00420641|MDD|mdd
1593024|NCT00420641|flexible-dose|flexible-dose
1593025|NCT00420641|Major Depressive Disorder|major depressive disorder
1593026|NCT00420641|paroxetine|paroxetine
1593027|NCT00420641|GSK372475|gsk372475
1593028|NCT00420615|Cancer|cancer
1593029|NCT00420615|EPO906|epo906
1593030|NCT00420615|Patupilone|patupilone
1593031|NCT00420589|Weight loss|weight loss
1593032|NCT00420589|Weight regain|weight regain
1593033|NCT00420589|Weight maintenance|weight maintenance
1593034|NCT00420576|Post-menopausal|post-menopausal
1593035|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
1593036|NCT00420576|Randomized|randomized
1593037|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
1593038|NCT00420550|Interstitial Cystitis|interstitial cystitis
1593039|NCT00420550|Pelvic pain|pelvic pain
1593040|NCT00420550|Guided Imagery|guided imagery
1593041|NCT00420537|Kidney|kidney
1593042|NCT00420537|Heart Transplantation|heart transplantation
1593043|NCT00420537|Creatinine|creatinine
1593044|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
1593045|NCT00420524|EPO|epo
1593046|NCT00420524|Patupilone|patupilone
1593047|NCT00420524|Solid Tumors|solid tumors
1593048|NCT00420511|Type 2 diabetes|type 2 diabetes
1593049|NCT00420511|beta-cell function|beta-cell function
1593050|NCT00420511|sitagliptin|sitagliptin
1593051|NCT00420511|intensive insulin therapy|intensive insulin therapy
1593052|NCT00420498|Schizophrenia|schizophrenia
1593053|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
1593054|NCT00420498|Smoking|smoking
1593055|NCT00420498|Cognition|cognition
1593056|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
1593057|NCT00420498|Tobacco|tobacco
1593058|NCT00420498|Cigarette Smoking|cigarette smoking
1593059|NCT00420498|Dopamine|dopamine
1593060|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
1593061|NCT00420485|Solid Tumors|solid tumors
1593062|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
1593063|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
1593064|NCT00420433|Breast Cancer|breast cancer
1593065|NCT00420433|Bone Metastases|bone metastases
1593066|NCT00420433|Radiography|radiography
1593067|NCT00420433|X-Ray|x-ray
1593068|NCT00420433|Computed Tomography|computed tomography
1593069|NCT00420433|CT Scan|ct scan
1593070|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
1593071|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1593072|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
1593073|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
1593074|NCT00420381|Recurrent Cancer|recurrent cancer
1593075|NCT00420368|Infant|infant
1593076|NCT00420368|Malnutrition|malnutrition
1593077|NCT00420368|Sub-Saharan Africa|sub-saharan africa
1593078|NCT00420368|Treatment|treatment
1593079|NCT00420368|Growth|growth
1593080|NCT00420368|Haemoglobin|haemoglobin
1593081|NCT00420368|Fortified spread|fortified spread
1593082|NCT00420368|Food supplement|food supplement
1593083|NCT00420355|antiretroviral therapy|antiretroviral therapy
1593084|NCT00420355|protease inhibitors|protease inhibitors
1593085|NCT00420355|drug interactions|drug interactions
1593087|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1593088|NCT00420355|Treatment Experienced|treatment experienced
1593089|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
1593090|NCT00420316|Intussusception|intussusception
1593091|NCT00420316|Gastroenteritis|gastroenteritis
1593092|NCT00420316|Finland|finland
1593093|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
1593094|NCT00420303|Spondylarthropathy|spondylarthropathy
1593095|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
1593096|NCT00420290|inflammation|inflammation
1593097|NCT00420290|end stage renal disease|end stage renal disease
1593098|NCT00420277|Hip arthroplasty|hip arthroplasty
1593099|NCT00420277|Anesthesia, spinal|anesthesia, spinal
1593100|NCT00420277|Hypotension|hypotension
1593101|NCT00420277|Ischemia|ischemia
1593102|NCT00420277|Blood substitutes|blood substitutes
1593103|NCT00420277|Plasma expanders|plasma expanders
1593104|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
1593105|NCT00420238|Adult|adult
1593106|NCT00420225|Cystocele|cystocele
1593107|NCT00420225|surgery|surgery
1593108|NCT00420225|mesh|mesh
1593109|NCT00420225|genital prolapse|genital prolapse
1593110|NCT00420212|relapsing|relapsing
1593111|NCT00420212|oral|oral
1593112|NCT00420212|remitting|remitting
1593113|NCT00420212|multiple sclerosis|multiple sclerosis
1593114|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
1593115|NCT00420173|standardized evaluation|standardized evaluation
1593116|NCT00420173|core set questionnaire|core set questionnaire
1593117|NCT00420173|epidemiological data|epidemiological data
1593118|NCT00420173|laboratory features|laboratory features
1593119|NCT00420160|Smoking cessation|smoking cessation
1593120|NCT00420160|Exercise|exercise
1593121|NCT00420160|Nicotine Patch|nicotine patch
1593122|NCT00420160|Disease Prevention|disease prevention
1593123|NCT00420147|knee osteoarthritis|knee osteoarthritis
1593124|NCT00420147|orthosis|orthosis
1593125|NCT00420147|wedge|wedge
1593126|NCT00420147|gait|gait
1593127|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
1593128|NCT00420134|end stage liver disease|end stage liver disease
1593129|NCT00420134|Cirrhosis|cirrhosis
1593130|NCT00420134|stem cell therapy|stem cell therapy
1593131|NCT00420121|standardized evaluation|standardized evaluation
1593132|NCT00420121|core set questionnaire|core set questionnaire
1593133|NCT00420121|epidemiological data|epidemiological data
1593134|NCT00420121|laboratory analysis|laboratory analysis
1593135|NCT00420108|Heart Failure, Congestive|heart failure, congestive
1593136|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
1593137|NCT00420108|Ventricular Pressure|ventricular pressure
1593138|NCT00420095|diabetes|diabetes
1593139|NCT00420095|type 1|type 1
1593140|NCT00420095|type 2|type 2
1593141|NCT00420082|Rhinitis|rhinitis
1593142|NCT00420082|Seasonal|seasonal
1593143|NCT00420082|Allergic|allergic
1593144|NCT00420082|Pollen allergy|pollen allergy
1593145|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
1593146|NCT00420082|Challenge Chamber|challenge chamber
1593147|NCT00420043|Food effect|food effect
1593148|NCT00420043|bioavailability|bioavailability
1593149|NCT00420043|pharmacokinetic|pharmacokinetic
1593150|NCT00420043|STI571|sti571
1593151|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
1593152|NCT00420043|CML|cml
1593250|NCT00419562|autoantigen|autoantigen
1593153|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
1593154|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
1593155|NCT00420043|imatinib|imatinib
1593156|NCT00420030|upfront abciximab|upfront abciximab
1593157|NCT00420030|PCI|pci
1593158|NCT00420030|cardiogenic shock|cardiogenic shock
1593159|NCT00420017|Amiodarone|amiodarone
1593160|NCT00420017|Atrial fibrillation|atrial fibrillation
1593161|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
1593162|NCT00419991|Tigecycline|tigecycline
1593163|NCT00419991|Staphylococcal Infections|staphylococcal infections
1593164|NCT00419991|Catheter|catheter
1593165|NCT00419952|Moderate Asthma|moderate asthma
1593166|NCT00419952|Severe Asthma|severe asthma
1593167|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
1593168|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
1593169|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
1593170|NCT00419939|Re-learning|re-learning
1593171|NCT00419939|Daily life activities|daily life activities
1593172|NCT00419939|Rehabilitation|rehabilitation
1593173|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
1593174|NCT00419913|Ovulation Induction|ovulation induction
1593175|NCT00419913|In vitro Fertilization|in vitro fertilization
1593176|NCT00419913|Pregnancy|pregnancy
1593177|NCT00419900|breast cancer|breast cancer
1593178|NCT00419900|diagnosis|diagnosis
1593179|NCT00419900|x-ray diffraction|x-ray diffraction
1593182|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
1593183|NCT00419874|Blood-brain barrier|blood-brain barrier
1593184|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
1593185|NCT00419874|Seizures|seizures
1593186|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
1593187|NCT00419848|Acne|acne
1593188|NCT00419848|Azithromycin|azithromycin
1593189|NCT00419848|Doxycycline|doxycycline
1593190|NCT00419835|diabetic nephropathy|diabetic nephropathy
1593191|NCT00419835|proteinuria|proteinuria
1593192|NCT00419835|CKD progression|ckd progression
1593193|NCT00419835|dialysis|dialysis
1593194|NCT00419822|Acupuncture|acupuncture
1593195|NCT00419822|Range of Motion|range of motion
1593196|NCT00419822|Quality of Life|quality of life
1593197|NCT00419809|methotrexate,|methotrexate,
1593198|NCT00419809|SB-681323,|sb-681323,
1593199|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
1593200|NCT00419809|liver function|liver function
1593201|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
1593202|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
1593203|NCT00419783|Allergic rhinitis|allergic rhinitis
1593204|NCT00419783|Urticaria|urticaria
1593205|NCT00419770|zygomycosis|zygomycosis
1593206|NCT00419770|Rhizopus|rhizopus
1593207|NCT00419770|iron|iron
1593208|NCT00419770|iron-chelation|iron-chelation
1593209|NCT00419770|adjunctive therapy|adjunctive therapy
1593210|NCT00419757|Moderate asthma|moderate asthma
1593211|NCT00419757|Severe asthma|severe asthma
1593212|NCT00419744|COPD|copd
1593213|NCT00419731|nicotine|nicotine
1593214|NCT00419731|smoking|smoking
1593215|NCT00419731|addiction|addiction
1593216|NCT00419705|acute stroke|acute stroke
1593217|NCT00419705|infrared laser therapy|infrared laser therapy
1593218|NCT00419705|clinical trial|clinical trial
1593219|NCT00419705|safety|safety
1593220|NCT00419705|effectiveness|effectiveness
1593221|NCT00419692|pharmacokinetic,|pharmacokinetic,
1593222|NCT00419692|RLS|rls
1593223|NCT00419692|formulation,|formulation,
1593224|NCT00419692|food effect,|food effect,
1593225|NCT00419692|controlled release for RLS,|controlled release for rls,
1593226|NCT00419692|SK&F101468,|sk&f101468,
1593227|NCT00419679|breast cancer|breast cancer
1593228|NCT00419679|hair|hair
1593229|NCT00419679|fibre|fibre
1593230|NCT00419679|synchrotron|synchrotron
1593231|NCT00419679|x-ray diffraction|x-ray diffraction
1593232|NCT00419666|Calcitriol|calcitriol
1593233|NCT00419666|Psoriasis|psoriasis
1593234|NCT00419666|PK|pk
1593235|NCT00419666|Adolescents|adolescents
1593236|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
1593237|NCT00419640|Sinus node disease|sinus node disease
1593238|NCT00419640|AV node disease|av node disease
1593239|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
1593240|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
1593241|NCT00419601|of any medical condition|of any medical condition
1593242|NCT00419588|infant, premature|infant, premature
1593243|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
1593244|NCT00419588|asthma|asthma
1593245|NCT00419575|renal|renal
1593246|NCT00419575|transplantation|transplantation
1593247|NCT00419575|immunosuppression|immunosuppression
1593248|NCT00419575|monitoring|monitoring
1593249|NCT00419562|oral insulin|oral insulin
1593251|NCT00419562|self tolerance|self tolerance
1593252|NCT00419562|oral tolerance|oral tolerance
1593254|NCT00419562|prevention|prevention
1593255|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
1593256|NCT00419562|juvenile diabetes|juvenile diabetes
1593257|NCT00419562|T1D|t1d
1593258|NCT00419562|diabetes mellitus|diabetes mellitus
1593259|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
1593260|NCT00419562|TrialNet|trialnet
1593261|NCT00419549|ERCP|ercp
1593262|NCT00419549|Pancreatitis|pancreatitis
1593263|NCT00419549|Nitroglycerine|nitroglycerine
1593264|NCT00419549|Valdecoxib|valdecoxib
1593265|NCT00419536|LBH|lbh
1593266|NCT00419536|LBH589|lbh589
1593267|NCT00419536|Prostate Cancer|prostate cancer
1593268|NCT00419536|HRPC|hrpc
1593269|NCT00419510|Genetic counseling|genetic counseling
1593270|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
1593271|NCT00419510|African American|african american
1593272|NCT00419497|Paleolithic diet|paleolithic diet
1593273|NCT00419497|Mediterranean-style diet|mediterranean-style diet
1593274|NCT00419497|Glucose tolerance|glucose tolerance
1593275|NCT00419497|Diabetes type 2|diabetes type 2
1593276|NCT00419497|Weight loss|weight loss
1593277|NCT00419497|Waist|waist
1593278|NCT00419471|Depression|depression
1593279|NCT00419471|Myocardial infarction|myocardial infarction
1593280|NCT00419471|Angina, unstable|angina, unstable
1593281|NCT00419458|ventilator weaning|ventilator weaning
1593282|NCT00419458|weaning|weaning
1593283|NCT00419458|respiratory failure|respiratory failure
1593485|NCT00418626|PK|pk
1593284|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
1593285|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
1593287|NCT00419432|Cerebral Palsy|cerebral palsy
1593288|NCT00419432|Gait Analysis|gait analysis
1593289|NCT00419432|Orthopedic Surgery|orthopedic surgery
1593290|NCT00419419|Raynaud's|raynaud's
1593291|NCT00419406|UVA1|uva1
1593292|NCT00419406|N-B UVB|n-b uvb
1593293|NCT00419406|phototherapy|phototherapy
1593294|NCT00419406|atopic dermatitis|atopic dermatitis
1593295|NCT00419406|SCORAD index|scorad index
1593296|NCT00419393|Keppra XR|keppra xr
1593297|NCT00419393|Levetiracetam XR|levetiracetam xr
1593298|NCT00419393|long term|long term
1593299|NCT00419393|partial seizures|partial seizures
1593300|NCT00419380|clogged ear tubes|clogged ear tubes
1593301|NCT00419354|Pacemaker|pacemaker
1593302|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
1593303|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
1593304|NCT00419341|SCIG|scig
1593305|NCT00419341|Primary immunodeficiency|primary immunodeficiency
1593306|NCT00419341|PID|pid
1593307|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
1593308|NCT00419315|alcoholism|alcoholism
1593309|NCT00419315|primary care|primary care
1593310|NCT00419315|treatment|treatment
1593311|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
1593312|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
1593313|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
1593314|NCT00419263|influenza|influenza
1593315|NCT00419263|flu|flu
1593316|NCT00419250|relapsed|relapsed
1593317|NCT00419250|refractory|refractory
1593318|NCT00419250|fludarabine|fludarabine
1593319|NCT00419250|Revlimid|revlimid
1593320|NCT00419250|lenalidomide|lenalidomide
1593321|NCT00419250|CLL|cll
1593322|NCT00419250|B-cell CLL|b-cell cll
1593323|NCT00419250|CC-5013|cc-5013
1593324|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1593325|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
1593326|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1593327|NCT00419224|Non-myeloabalative|non-myeloabalative
1593328|NCT00419224|Influenza vaccination|influenza vaccination
1593329|NCT00419224|Humoral immune response|humoral immune response
1593330|NCT00419224|Immunogenicity|immunogenicity
1593331|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
1593332|NCT00419198|Ischemia|ischemia
1593333|NCT00419198|Reperfusion|reperfusion
1593334|NCT00419198|Myocardial infarction|myocardial infarction
1593335|NCT00419198|Postconditioning|postconditioning
1593336|NCT00419185|macular hole surgery|macular hole surgery
1593337|NCT00419185|indocyanine green|indocyanine green
1593338|NCT00419185|trypan blue|trypan blue
1593339|NCT00419185|internal limiting membrane|internal limiting membrane
1593340|NCT00419172|Pharmacokinetics|pharmacokinetics
1593341|NCT00419172|Deferasirox|deferasirox
1593342|NCT00419172|Exjade|exjade
1593343|NCT00419172|ICL670|icl670
1593344|NCT00419172|Rifampicin|rifampicin
1593345|NCT00419172|Healthy, Volunteers|healthy, volunteers
1593346|NCT00419159|Colorectal cancer|colorectal cancer
1593347|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
1593348|NCT00419159|anti-EGFR antibody|anti-egfr antibody
1593349|NCT00419146|Schizophrenia|schizophrenia
1593350|NCT00419146|Schizophreniform disorders|schizophreniform disorders
1593351|NCT00419146|Schizoaffective disorder|schizoaffective disorder
1593352|NCT00419146|Psychotic disorders|psychotic disorders
1593353|NCT00419146|Randomized Controlled Trials|randomized controlled trials
1593354|NCT00419146|Longitudinal Studies|longitudinal studies
1593355|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
1593356|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
1593357|NCT00419146|Vitamins|vitamins
1593358|NCT00419146|Antioxidants|antioxidants
1593359|NCT00419146|Ascorbic Acid|ascorbic acid
1593360|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
1593361|NCT00419146|Placebos|placebos
1593362|NCT00419146|Antipsychotic Agents|antipsychotic agents
1593363|NCT00419146|Oxidative Stress|oxidative stress
1593364|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
1593365|NCT00419146|Phospholipases|phospholipases
1593366|NCT00419146|Niacin|niacin
1593367|NCT00419146|Adverse effects|adverse effects
1593368|NCT00419146|Delusions|delusions
1593369|NCT00419146|Hallucinations|hallucinations
1593370|NCT00419146|Neuropsychological Tests|neuropsychological tests
1593371|NCT00419146|Attention|attention
1593372|NCT00419146|Memory|memory
1593373|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
1593374|NCT00419146|Models, Statistical|models, statistical
1593375|NCT00419133|Cholera|cholera
1593376|NCT00419133|Vaccine|vaccine
1593377|NCT00419133|Kolkata|kolkata
1593378|NCT00419133|West Bengal|west bengal
1593379|NCT00419133|India|india
1593380|NCT00419133|Immunogenicity|immunogenicity
1593381|NCT00419133|Safety|safety
1593382|NCT00419094|Keppra XR|keppra xr
1593580|NCT00418184|ADHD|adhd
1593383|NCT00419094|conversion to monotherapy|conversion to monotherapy
1593384|NCT00419094|partial seizures|partial seizures
1593385|NCT00419081|leukemia|leukemia
1593386|NCT00419081|lymphoma|lymphoma
1593387|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
1593388|NCT00419042|cancer|cancer
1593389|NCT00419042|Lung cancer|lung cancer
1593390|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
1593391|NCT00419029|combat|combat
1593392|NCT00419029|depression|depression
1593393|NCT00419029|PTSD|ptsd
1593394|NCT00419029|substance abuse|substance abuse
1593395|NCT00418990|Multivitamin|multivitamin
1593396|NCT00418990|Academic performance|academic performance
1593397|NCT00418977|Anorexia Nervosa|anorexia nervosa
1593398|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
1593399|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
1593400|NCT00418951|Voriconazole|voriconazole
1593401|NCT00418951|Vfend|vfend
1593402|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
1593403|NCT00418951|Ambisome|ambisome
1593404|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
1593405|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
1593406|NCT00418951|AML|aml
1593407|NCT00418951|MDS|mds
1593408|NCT00418938|EGFR|egfr
1593409|NCT00418938|FOLFIRI|folfiri
1593410|NCT00418938|2nd Line Therapy|2nd line therapy
1593411|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
1593412|NCT00418938|mCRC|mcrc
1593413|NCT00418938|Irinotecan|irinotecan
1593414|NCT00418938|panitumumab|panitumumab
1593415|NCT00418938|bevacizumab|bevacizumab
1593416|NCT00418899|Brain Tumor|brain tumor
1593417|NCT00418899|Glioma|glioma
1593418|NCT00418899|Linkage Study|linkage study
1593419|NCT00418899|Survey|survey
1593420|NCT00418899|Gliogene|gliogene
1593421|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
1593422|NCT00418886|NSCLC|nsclc
1593423|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
1593424|NCT00418873|schizophrenia|schizophrenia
1593425|NCT00418873|zotepine|zotepine
1593426|NCT00418873|risperidone|risperidone
1593427|NCT00418873|second generation antipsychotic|second generation antipsychotic
1593428|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1593429|NCT00418860|Stent thrombosis|stent thrombosis
1593430|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
1593431|NCT00418847|pediatrics|pediatrics
1593432|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
1593433|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
1593434|NCT00418847|Tay-Sachs disease|tay-sachs disease
1593435|NCT00418847|Sandhoff disease|sandhoff disease
1593436|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
1593437|NCT00418847|Miglustat|miglustat
1593438|NCT00418808|motor|motor
1593439|NCT00418808|development|development
1593440|NCT00418808|multiple pregnancies|multiple pregnancies
1593441|NCT00418808|general movement|general movement
1593442|NCT00418808|video recording|video recording
1593443|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
1593444|NCT00418795|treatment|treatment
1593445|NCT00418795|Acute attack|acute attack
1593446|NCT00418769|nilotinib|nilotinib
1593447|NCT00418769|bioavailability|bioavailability
1593448|NCT00418769|tablet|tablet
1593449|NCT00418769|capsule|capsule
1593450|NCT00418769|PK|pk
1593451|NCT00418769|healthy, subject(s),|healthy, subject(s),
1593452|NCT00418756|nilotinib|nilotinib
1593453|NCT00418756|Rifampin|rifampin
1593454|NCT00418756|PK|pk
1593455|NCT00418756|healthy subjects|healthy subjects
1593456|NCT00418743|cancer|cancer
1593457|NCT00418743|Lung cancer|lung cancer
1593458|NCT00418743|small-cell lung cancer|small-cell lung cancer
1593459|NCT00418730|androgenetic alopecia|androgenetic alopecia
1593460|NCT00418730|male pattern hair loss|male pattern hair loss
1593461|NCT00418730|male pattern baldness|male pattern baldness
1593462|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
1593463|NCT00418704|cancer|cancer
1593464|NCT00418704|Lung cancer|lung cancer
1593465|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
1593466|NCT00418691|Brain Tumor|brain tumor
1593467|NCT00418691|Methylphenidate|methylphenidate
1593468|NCT00418691|Ritalin|ritalin
1593469|NCT00418691|Modafinil|modafinil
1593470|NCT00418691|Provigil|provigil
1593471|NCT00418691|Fatigue|fatigue
1593472|NCT00418691|Concentration|concentration
1593473|NCT00418665|Revlimid|revlimid
1593474|NCT00418665|Lenalidomide|lenalidomide
1593475|NCT00418665|Low Platelet Count|low platelet count
1593476|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
1593477|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
1593478|NCT00418665|MDS|mds
1593479|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
1593480|NCT00418652|Normal Controls|normal controls
1593481|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
1593482|NCT00418626|nilotinib|nilotinib
1593483|NCT00418626|hepatic impairment|hepatic impairment
1593484|NCT00418626|Child-Pugh scale|child-pugh scale
1593486|NCT00418626|healthy, subject(s)|healthy, subject(s)
1593487|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
1593781|NCT00417313|knee pain|knee pain
1593488|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
1593489|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
1593490|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
1593491|NCT00418587|Vitamin D|vitamin d
1593492|NCT00418587|Lupus|lupus
1593493|NCT00418574|Ovarian cancer|ovarian cancer
1593494|NCT00418574|Abagovomab|abagovomab
1593495|NCT00418561|rhASA|rhasa
1593496|NCT00418561|MLD|mld
1593497|NCT00418561|Metazym|metazym
1593498|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
1593499|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
1593500|NCT00418509|Dose proportionality|dose proportionality
1593501|NCT00418509|pharmacokinetics|pharmacokinetics
1593502|NCT00418509|mometasone|mometasone
1593503|NCT00418509|formoterol|formoterol
1593504|NCT00418509|Healthy volunteers study|healthy volunteers study
1593505|NCT00418496|Unresectable|unresectable
1593506|NCT00418496|Metastatic|metastatic
1593507|NCT00418483|thrombolytic|thrombolytic
1593508|NCT00418483|thrombolysis|thrombolysis
1593509|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
1593510|NCT00418483|peripheral vascular disease|peripheral vascular disease
1593511|NCT00418483|thrombosis|thrombosis
1593512|NCT00418483|endovascular|endovascular
1593513|NCT00418470|Cystic fibrosis|cystic fibrosis
1593514|NCT00418470|Catheterization, peripheral|catheterization, peripheral
1593515|NCT00418470|Phlebitis|phlebitis
1593516|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
1593517|NCT00418470|Osmolar Concentration|osmolar concentration
1593518|NCT00418457|Breast Cancer|breast cancer
1593519|NCT00418457|Anesthesia; regional|anesthesia; regional
1593520|NCT00418457|cancer recurrence|cancer recurrence
1593521|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
1593522|NCT00418457|Analgesia; opioid|analgesia; opioid
1593523|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
1593524|NCT00418418|Cell transplantation|cell transplantation
1593525|NCT00418418|Heart failure|heart failure
1593526|NCT00418418|Clinical trials|clinical trials
1593527|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
1593528|NCT00418405|Cohort Studies|cohort studies
1593529|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
1593530|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
1593531|NCT00418379|Grass pollen tablet|grass pollen tablet
1593532|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1593533|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
1593534|NCT00418366|End stage renal disease|end stage renal disease
1593535|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
1593536|NCT00418353|Betamethasone|betamethasone
1593537|NCT00418353|Dexamethasone|dexamethasone
1593538|NCT00418353|Premature|premature
1593539|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
1593540|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
1593541|NCT00418340|probiotic therapy,|probiotic therapy,
1593542|NCT00418340|immune response|immune response
1593543|NCT00418327|Tarceva|tarceva
1593544|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
1593545|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
1593546|NCT00418301|Pain|pain
1593547|NCT00418301|Neurostimulation|neurostimulation
1593548|NCT00418288|GLP-1|glp-1
1593549|NCT00418288|glucose metabolism|glucose metabolism
1593550|NCT00418288|Type 2 diabetes|type 2 diabetes
1593551|NCT00418288|brain|brain
1593552|NCT00418288|PET|pet
1593553|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
1593554|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
1593555|NCT00418262|attention deficit disorder|attention deficit disorder
1593556|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
1593557|NCT00418262|ADD|add
1593558|NCT00418262|FAS|fas
1593559|NCT00418262|FASD|fasd
1593560|NCT00418262|ADHD|adhd
1593561|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
1593562|NCT00418249|Telogen effluvium|telogen effluvium
1593563|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
1593564|NCT00418249|Menopause|menopause
1593565|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
1593566|NCT00418223|Urinary retention|urinary retention
1593567|NCT00418223|Child birth|child birth
1593568|NCT00418223|Catheterization|catheterization
1593569|NCT00418223|Ultrasound|ultrasound
1593570|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
1593571|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
1593572|NCT00418210|Feasibility|feasibility
1593573|NCT00418210|Early breast cancer|early breast cancer
1593574|NCT00418197|spinal stenosis|spinal stenosis
1593575|NCT00418197|low back pain|low back pain
1593576|NCT00418197|spondylolisthesis|spondylolisthesis
1593577|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
1593578|NCT00418197|leg pain|leg pain
1593579|NCT00418197|spinal diseases|spinal diseases
1593584|NCT00418184|poor academic performance|poor academic performance
1593585|NCT00418184|poor self-discipline|poor self-discipline
1593586|NCT00418184|low self-esteem|low self-esteem
1593587|NCT00418158|Pulmonary complications|pulmonary complications
1593588|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
1593589|NCT00418132|SSc|ssc
1593590|NCT00418132|Systemic Sclerosis|systemic sclerosis
1593591|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
1593592|NCT00418106|Premature birth|premature birth
1593593|NCT00418106|Pumping breast milk|pumping breast milk
1593594|NCT00418106|Kangaroo holding|kangaroo holding
1593595|NCT00418093|mullerian carcinoma|mullerian carcinoma
1593596|NCT00418067|Coronary Artery Disease|coronary artery disease
1593597|NCT00418067|Stent|stent
1593598|NCT00418028|capecitabine|capecitabine
1593599|NCT00418028|schedule|schedule
1593600|NCT00418028|breast cancer|breast cancer
1593601|NCT00418015|µ-opioid receptor|µ-opioid receptor
1593602|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
1593603|NCT00418015|pharmacogenetics|pharmacogenetics
1593604|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
1593605|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
1593606|NCT00417989|Glycemic control|glycemic control
1593607|NCT00417989|Sensor|sensor
1593608|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
1593609|NCT00417963|Carotid|carotid
1593610|NCT00417963|Artery|artery
1593611|NCT00417963|Stenosis|stenosis
1593612|NCT00417950|diabetes|diabetes
1593613|NCT00417950|acarbose|acarbose
1593614|NCT00417950|alcohol|alcohol
1593615|NCT00417950|inflammation|inflammation
1593616|NCT00417950|oxidative stress|oxidative stress
1593617|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
1593618|NCT00417924|Patient education|patient education
1593619|NCT00417924|Patient satisfaction|patient satisfaction
1593620|NCT00417924|Eye health|eye health
1593621|NCT00417911|multiple myeloma|multiple myeloma
1593622|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
1593623|NCT00417911|high-dose melphalan|high-dose melphalan
1593624|NCT00417911|bortezomib|bortezomib
1593625|NCT00417911|consolidation|consolidation
1593626|NCT00417911|event free survival|event free survival
1593627|NCT00417911|phase III|phase iii
1593628|NCT00417898|Stroke|stroke
1593629|NCT00417898|Cerebral Ischemia|cerebral ischemia
1593630|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
1593631|NCT00417898|Aspirin|aspirin
1593632|NCT00417898|Human|human
1593633|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
1593634|NCT00417872|Clostridium difficile|clostridium difficile
1593635|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
1593636|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
1593637|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
1593638|NCT00417846|Amsler Grid|amsler grid
1593639|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
1593640|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
1593641|NCT00417807|PDGF-R|pdgf-r
1593642|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1593644|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
1593645|NCT00417794|FAS|fas
1593646|NCT00417794|FASD|fasd
1593647|NCT00417794|atomoxetine hcl|atomoxetine hcl
1593648|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
1593649|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
1593650|NCT00417768|intraabdominal|intraabdominal
1593651|NCT00417768|abscess|abscess
1593652|NCT00417768|percutaneous drainage|percutaneous drainage
1593653|NCT00417755|Nutritional intake|nutritional intake
1593654|NCT00417755|Mechanical ventilation|mechanical ventilation
1593655|NCT00417755|Enteral feeding|enteral feeding
1593656|NCT00417742|headache|headache
1593657|NCT00417742|migraine headache|migraine headache
1593658|NCT00417742|tension headache|tension headache
1593659|NCT00417729|Diabetes|diabetes
1593660|NCT00417729|Acarobse|acarobse
1593661|NCT00417729|Metformin|metformin
1593662|NCT00417729|oxidative stress|oxidative stress
1593663|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
1593664|NCT00417729|Meal test|meal test
1593665|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
1593666|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
1593667|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
1593668|NCT00417703|Intraocular Pressure|intraocular pressure
1593669|NCT00417703|Intravitreous Injection|intravitreous injection
1593670|NCT00417703|Ranibizumab|ranibizumab
1593671|NCT00417690|Crohn's Disease|crohn's disease
1593672|NCT00417690|Acute Flare|acute flare
1593673|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
1593674|NCT00417690|Ileocecal distribution|ileocecal distribution
1593675|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
1593676|NCT00417664|cardiac surgery|cardiac surgery
1593677|NCT00417664|valvular surgery|valvular surgery
1593678|NCT00417664|delirium|delirium
1593679|NCT00417664|postoperative delirium|postoperative delirium
1593680|NCT00417664|cognitive dysfunction|cognitive dysfunction
1593681|NCT00417664|altered mental status|altered mental status
1593682|NCT00417651|Bacterial|bacterial
1593683|NCT00417651|contamination|contamination
1593684|NCT00417651|gastrotomy|gastrotomy
1593685|NCT00417651|Complications|complications
1593686|NCT00417638|myocardial infarction|myocardial infarction
1593687|NCT00417638|acute intervention|acute intervention
1593688|NCT00417638|percutaneous intervention|percutaneous intervention
1593689|NCT00417638|endovascular cooling|endovascular cooling
1593690|NCT00417638|endovascular rewarming|endovascular rewarming
1593691|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
1593692|NCT00417625|MRI|mri
1593693|NCT00417625|Fractional Flow Reserve|fractional flow reserve
1593694|NCT00417625|Coronary Flow Reserve|coronary flow reserve
1593695|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
1593696|NCT00417625|Cardiovascular Disease|cardiovascular disease
1593697|NCT00417625|Coronary Artery Disease|coronary artery disease
1593698|NCT00417625|CAD|cad
1593699|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
1593700|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
1593701|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
1593702|NCT00417599|Prevention of overweight|prevention of overweight
1593703|NCT00417599|Prevention of obesity|prevention of obesity
1593704|NCT00417599|Treatment of overweight|treatment of overweight
1593705|NCT00417599|Treatment of obesity|treatment of obesity
1593706|NCT00417586|Stroke|stroke
1593707|NCT00417573|Immunodeficiency|immunodeficiency
1593708|NCT00417573|Gammaglobulin|gammaglobulin
1593709|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
1593710|NCT00417560|Influenza A/H5N1|influenza a/h5n1
1593711|NCT00417560|vaccine|vaccine
1593712|NCT00417560|avian influenza H5N1|avian influenza h5n1
1593713|NCT00417560|H5N1|h5n1
1593714|NCT00417547|Self Concept|self concept
1593715|NCT00417547|Eating Disorder|eating disorder
1593716|NCT00417547|Body Mass Index|body mass index
1593717|NCT00417547|Dressing|dressing
1593718|NCT00417547|Islamic Veil|islamic veil
1593719|NCT00417534|Coronary Disease|coronary disease
1593720|NCT00417534|Inflammation|inflammation
1593721|NCT00417534|Genetics|genetics
1593722|NCT00417534|HLA Antigens|hla antigens
1593723|NCT00417534|Aortic Valve|aortic valve
1593724|NCT00417521|Adolescents|adolescents
1593725|NCT00417521|Anorexia|anorexia
1593726|NCT00417521|Eating disorder|eating disorder
1593727|NCT00417521|Family therapy|family therapy
1593728|NCT00417508|function|function
1593729|NCT00417508|elderly|elderly
1593730|NCT00417508|ADL|adl
1593731|NCT00417508|nutritional supplementation|nutritional supplementation
1593732|NCT00417508|Quality of life|quality of life
1593733|NCT00417508|handgrip strength|handgrip strength
1593734|NCT00417508|Body Composition|body composition
1593735|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
1593736|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
1593737|NCT00417482|discontinuation, placebo|discontinuation, placebo
1593738|NCT00417456|Acne|acne
1593739|NCT00417456|Telemedicine|telemedicine
1593740|NCT00417456|Dermatology|dermatology
1593741|NCT00417443|epidural|epidural
1593742|NCT00417443|clonidine|clonidine
1593743|NCT00417443|hyperalgesia|hyperalgesia
1593744|NCT00417443|laparotomy|laparotomy
1593745|NCT00417417|Endothelium|endothelium
1593746|NCT00417417|Inflammation|inflammation
1593747|NCT00417417|Nitric Oxide|nitric oxide
1593748|NCT00417417|Rilonacept|rilonacept
1593749|NCT00417417|Cytokines|cytokines
1593750|NCT00417417|Coronary Artery Disease|coronary artery disease
1593751|NCT00417417|CAD|cad
1593752|NCT00417417|Atherosclerosis|atherosclerosis
1593753|NCT00417404|preterm|preterm
1593754|NCT00417404|nutrition|nutrition
1593755|NCT00417404|vitamin A|vitamin a
1593756|NCT00417404|electroretinogram|electroretinogram
1593757|NCT00417404|conjunctiva|conjunctiva
1593758|NCT00417404|vitamin A status|vitamin a status
1593759|NCT00417404|conjunctival health|conjunctival health
1593760|NCT00417378|ACS|acs
1593761|NCT00417365|odor|odor
1593762|NCT00417365|douching|douching
1593763|NCT00417365|BV|bv
1593764|NCT00417365|vaginitis|vaginitis
1593765|NCT00417365|vaginal|vaginal
1593766|NCT00417365|yeast|yeast
1593767|NCT00417365|ecosystem|ecosystem
1593768|NCT00417365|Lactobacilli|lactobacilli
1593769|NCT00417365|Nugent|nugent
1593770|NCT00417365|Amsel|amsel
1593771|NCT00417352|no intervention|no intervention
1593772|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
1593773|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
1593774|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
1593775|NCT00417339|hemodialysis|hemodialysis
1593776|NCT00417339|dialysis adequacy|dialysis adequacy
1593777|NCT00417339|uremic retention solute|uremic retention solute
1593779|NCT00417326|acute respiratory failure|acute respiratory failure
1593780|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
1593782|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
1593783|NCT00417313|alternative medicine|alternative medicine
1593784|NCT00417313|analgesia|analgesia
1593785|NCT00417313|arthritis therapy|arthritis therapy
1593786|NCT00417313|chronic pain|chronic pain
1593787|NCT00417313|functional ability|functional ability
1593788|NCT00417300|PTSD|ptsd
1593789|NCT00417300|Cognitive Behavioral Treatment|cognitive behavioral treatment
1593790|NCT00417300|Child Sexual Abuse|child sexual abuse
1593791|NCT00417287|Pancreas|pancreas
1593792|NCT00417287|Cancer|cancer
1593793|NCT00417287|Carcinoma|carcinoma
1593794|NCT00417274|Cancer of Prostate|cancer of prostate
1593795|NCT00417274|Prostate Cancer|prostate cancer
1593796|NCT00417274|Cancer of the Prostate|cancer of the prostate
1593797|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
1593798|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
1593799|NCT00417274|Prostate Neoplasms|prostate neoplasms
1593800|NCT00417274|Prostatic Cancer|prostatic cancer
1593801|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
1593802|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
1593803|NCT00417261|Healthy male and female subjects|healthy male and female subjects
1593804|NCT00417235|catheter related infection|catheter related infection
1593805|NCT00417235|catheter dressing|catheter dressing
1593806|NCT00417235|prevention|prevention
1593807|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
1593808|NCT00417235|Infection|infection
1593809|NCT00417235|catheterization|catheterization
1593810|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
1593811|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
1593812|NCT00417196|Healthy male and female subjects|healthy male and female subjects
1593813|NCT00417183|GnRH antagonist|gnrh antagonist
1593814|NCT00417183|GnRH agonist|gnrh agonist
1593815|NCT00417183|Long protocol|long protocol
1593816|NCT00417183|Flexible|flexible
1593817|NCT00417170|High Blood pressure|high blood pressure
1593818|NCT00417170|Hypertension|hypertension
1593819|NCT00417170|metabolic syndrome|metabolic syndrome
1593820|NCT00417170|insulin resistance|insulin resistance
1593821|NCT00417170|endothelial dysfunction|endothelial dysfunction
1593822|NCT00417170|pre-diabetic|pre-diabetic
1593823|NCT00417170|amlodipine,|amlodipine,
1593824|NCT00417170|aliskiren,|aliskiren,
1593825|NCT00417170|IGT,|igt,
1593826|NCT00417170|IFG,|ifg,
1593827|NCT00417170|MBF|mbf
1593828|NCT00417157|GnRH antagonist|gnrh antagonist
1593829|NCT00417157|Poor responders|poor responders
1593830|NCT00417157|Oocyte donation|oocyte donation
1593831|NCT00417157|Modified natural cycle|modified natural cycle
1593832|NCT00417144|OHSS|ohss
1593833|NCT00417144|PCOS|pcos
1593834|NCT00417144|GnRH antagonist|gnrh antagonist
1593835|NCT00417144|GnRH agonist|gnrh agonist
1593836|NCT00417131|Islet transplantation,|islet transplantation,
1593837|NCT00417131|coagulation,|coagulation,
1593838|NCT00417131|graft destruction,|graft destruction,
1593839|NCT00417131|islet imaging|islet imaging
1593840|NCT00417118|Anxiety|anxiety
1593841|NCT00417118|clinical trials|clinical trials
1593842|NCT00417105|hemodialysis|hemodialysis
1593843|NCT00417105|dialysis adequacy|dialysis adequacy
1593844|NCT00417105|chronic kidney disease|chronic kidney disease
1593845|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
1593846|NCT00417092|reduced left ventricular function|reduced left ventricular function
1593847|NCT00417092|postoperative pacing|postoperative pacing
1593848|NCT00417092|cardiac resynchronization|cardiac resynchronization
1593849|NCT00417079|Cancer|cancer
1593850|NCT00417079|Prostate|prostate
1593851|NCT00417066|poor responders|poor responders
1593852|NCT00417066|GnRH antagonist|gnrh antagonist
1593853|NCT00417066|GnRH agonist|gnrh agonist
1593854|NCT00417066|flare up|flare up
1593855|NCT00417066|short protocol|short protocol
1593856|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
1593857|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
1593858|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1593859|NCT00417053|regional neuroblastoma|regional neuroblastoma
1593860|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
1593861|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1593862|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
1593863|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
1593864|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
1593865|NCT00417027|Labor analgesia|labor analgesia
1593866|NCT00417027|Epidural analgesia|epidural analgesia
1593867|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1593868|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1593869|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1593870|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1594567|NCT00415337|lung|lung
1593871|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1593872|NCT00417001|sedation|sedation
1593873|NCT00417001|colonoscopy|colonoscopy
1593874|NCT00417001|Aroma therapy|aroma therapy
1593875|NCT00416988|melanoma|melanoma
1593876|NCT00416988|weight changes|weight changes
1593877|NCT00416975|breast cancer|breast cancer
1593878|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
1593879|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
1593880|NCT00416949|insular thyroid cancer|insular thyroid cancer
1593881|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1593882|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
1593883|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
1593884|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
1593885|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
1593886|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
1593887|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1593888|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1593889|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
1593890|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
1593891|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
1593892|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
1593893|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
1593894|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
1593895|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1593896|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1593897|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1593898|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1593899|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1593900|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1593901|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1593902|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1593903|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1593904|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1593905|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1593906|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1593907|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1593908|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1593909|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1593910|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1593911|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1593912|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1593913|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1593914|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1593915|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1594528|NCT00415467|Brain Tumor|brain tumor
1593916|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1593917|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1593918|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1593919|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1593920|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
1593921|NCT00416923|intraocular lymphoma|intraocular lymphoma
1593922|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1593923|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
1593924|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1593925|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1593926|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1593927|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1593928|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1593929|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1593930|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1593931|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1593932|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
1593933|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
1593934|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
1593935|NCT00416897|renal failure|renal failure
1593936|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1593937|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1593938|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1593939|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
1593940|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
1593941|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
1594016|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
1594707|NCT00414947|safety|safety
1593942|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
1593943|NCT00416845|Healthy male and female subjects|healthy male and female subjects
1593944|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1593945|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1593946|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1593947|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1593948|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1593949|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1593950|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1593951|NCT00416780|recurrent breast cancer|recurrent breast cancer
1593952|NCT00416780|stage I breast cancer|stage i breast cancer
1593953|NCT00416780|stage II breast cancer|stage ii breast cancer
1593954|NCT00416780|stage IV breast cancer|stage iv breast cancer
1593955|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1593956|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1593957|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1593958|NCT00416767|gastrinoma|gastrinoma
1593959|NCT00416767|insulinoma|insulinoma
1593960|NCT00416767|WDHA syndrome|wdha syndrome
1593961|NCT00416767|glucagonoma|glucagonoma
1593962|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1593963|NCT00416767|somatostatinoma|somatostatinoma
1593964|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1593965|NCT00416754|breast cancer|breast cancer
1593966|NCT00416754|stage I breast cancer|stage i breast cancer
1593967|NCT00416754|stage II breast cancer|stage ii breast cancer
1593968|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
1593969|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
1593970|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
1593971|NCT00416754|stage IV breast cancer|stage iv breast cancer
1593972|NCT00416741|Metabolic Syndrome|metabolic syndrome
1593973|NCT00416741|Obesity|obesity
1593974|NCT00416741|Hyperlipidemia|hyperlipidemia
1593975|NCT00416741|High blood pressure|high blood pressure
1593976|NCT00416741|Diabetes|diabetes
1593977|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
1593978|NCT00416728|Healthy male and female subjects|healthy male and female subjects
1593979|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
1593980|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
1593981|NCT00416689|nausea and vomiting|nausea and vomiting
1593982|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1593983|NCT00416689|recurrent breast cancer|recurrent breast cancer
1593984|NCT00416689|stage I breast cancer|stage i breast cancer
1593985|NCT00416689|stage II breast cancer|stage ii breast cancer
1593986|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
1593987|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
1593988|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
1594765|NCT00414687|Inhaled|inhaled
1593989|NCT00416689|stage IV breast cancer|stage iv breast cancer
1593990|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1593991|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1593992|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1593993|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1593994|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1593995|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1593996|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1593997|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
1593998|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
1593999|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
1594000|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1594001|NCT00416676|regional neuroblastoma|regional neuroblastoma
1594002|NCT00416663|Stem cells|stem cells
1594003|NCT00416663|Progenitor cells|progenitor cells
1594004|NCT00416663|Angina Pectoris|angina pectoris
1594005|NCT00416663|Heart Failure|heart failure
1594006|NCT00416663|Angiogenesis|angiogenesis
1594007|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1594008|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1594009|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1594010|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1594011|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1594012|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1594013|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
1594014|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1594015|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
1594017|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
1594018|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
1594019|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1594020|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1594021|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1594022|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1594023|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1594024|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1594025|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1594026|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1594027|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1594028|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1594029|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1594030|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1594031|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1594032|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1594033|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1594034|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1594035|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1594036|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1594037|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1594038|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1594039|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1594040|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1594041|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1594042|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1594043|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1594044|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1594045|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1594046|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1594047|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1594048|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1594049|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1594050|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1594051|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1594052|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1594053|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1594054|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1594055|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1594056|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1594057|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1594058|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1594059|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1594060|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1594061|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1594062|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1594063|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1594064|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1594065|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1594066|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1594067|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1594068|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1594069|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1594070|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1594071|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1594072|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1594073|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1594074|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1594075|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1594076|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1594143|NCT00416611|Treatment|treatment
1594077|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1594078|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1594079|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1594080|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1594081|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1594082|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1594083|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1594084|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1594085|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1594086|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1594087|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1594088|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1594089|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1594090|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1594091|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1594092|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1594093|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1594094|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1594095|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1594096|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1594097|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1594098|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1594099|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1594100|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1594101|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1594102|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1594103|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1594104|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1594105|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1594106|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1594107|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1594108|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1594109|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1594110|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1594111|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1594112|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1594113|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1594114|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1594115|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1594116|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1594117|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1594118|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1594119|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1594120|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1594121|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1594122|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1594123|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1594124|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1594125|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1594126|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1594127|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1594128|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1594129|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1594130|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
1594131|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1594132|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
1594133|NCT00416624|anemia|anemia
1594134|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1594135|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
1594136|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1594137|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
1594138|NCT00416624|mast cell leukemia|mast cell leukemia
1594139|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1594140|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
1594141|NCT00416611|High blood pressure|high blood pressure
1594142|NCT00416611|Awareness|awareness
1594144|NCT00416611|Effective Control|effective control
1594145|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
1594146|NCT00416611|Hypertension|hypertension
1594147|NCT00416585|acne|acne
1594148|NCT00416585|isotretinoin|isotretinoin
1594149|NCT00416585|calcium. vitamin D|calcium. vitamin d
1594150|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1594151|NCT00416572|stage I breast cancer|stage i breast cancer
1594152|NCT00416572|stage II breast cancer|stage ii breast cancer
1594153|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1594154|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
1594155|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1594156|NCT00416559|regional neuroblastoma|regional neuroblastoma
1594157|NCT00416546|Healthy Caucasians|healthy caucasians
1594158|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
1594159|NCT00416546|Immunosuppressant|immunosuppressant
1594160|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
1594161|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
1594162|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
1594163|NCT00416533|stage III prostate cancer|stage iii prostate cancer
1594164|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
1594165|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1594166|NCT00416520|Chronic Kidney Disease|chronic kidney disease
1594167|NCT00416520|Dialysis|dialysis
1594168|NCT00416520|Hyperphosphatemia|hyperphosphatemia
1594169|NCT00416520|Phosphate binder|phosphate binder
1594170|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1594171|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
1594172|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
1594173|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
1594174|NCT00416494|recurrent colon cancer|recurrent colon cancer
1594175|NCT00416494|stage IV colon cancer|stage iv colon cancer
1594176|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1594177|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
1594178|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
1594179|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1594180|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
1594181|NCT00416468|Healthy male and female subjects|healthy male and female subjects
1594182|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
1594183|NCT00416442|Healthy male and female subjects|healthy male and female subjects
1594184|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
1594185|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
1594186|NCT00416403|breast cancer in situ|breast cancer in situ
1594187|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1594188|NCT00416403|stage IA breast cancer|stage ia breast cancer
1594189|NCT00416403|stage IB breast cancer|stage ib breast cancer
1594190|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
1594191|NCT00416390|stage I prostate cancer|stage i prostate cancer
1595058|NCT00413452|Amgen|amgen
1594192|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
1594193|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
1594194|NCT00416390|stage III prostate cancer|stage iii prostate cancer
1594195|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
1594196|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1594197|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1594198|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1594199|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1594200|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1594201|NCT00416364|hernia|hernia
1594202|NCT00416364|inguinal|inguinal
1594203|NCT00416364|quality of life|quality of life
1594204|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1594205|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1594206|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1594207|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1594208|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1594209|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1594210|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
1594211|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1594212|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1594213|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1594214|NCT00416351|small intestine lymphoma|small intestine lymphoma
1594215|NCT00416338|renal failure|renal failure
1594216|NCT00416338|infection|infection
1594217|NCT00416338|peritonitis|peritonitis
1594218|NCT00416325|prostate cancer|prostate cancer
1594219|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1594220|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1594221|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1594222|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1594223|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1594224|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1594225|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1594226|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1594227|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1594228|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1594229|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1594230|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1594231|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1594232|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1594233|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1594234|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1594235|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1594236|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1594237|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1594238|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1594239|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1594240|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1594241|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1594242|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1594243|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1594244|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1594245|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1594246|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1594247|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1594248|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1594249|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1594250|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1594251|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1594252|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1594253|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1594254|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1594255|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1594256|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1594257|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1594258|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
1594259|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1595835|NCT00410865|INGN 201|ingn 201
1594260|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1594261|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1594262|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1594263|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1594264|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1594265|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1594266|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1594267|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1594268|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1594269|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1594270|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1594271|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1594272|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1594273|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1594274|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1594275|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1594276|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1594277|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1594278|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1594279|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1594708|NCT00414947|LAF237|laf237
1594280|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1594281|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1594282|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1594283|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1594284|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1594285|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1594286|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1594287|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1594288|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1594289|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1594290|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1594291|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1594292|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1594293|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1594294|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1594295|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1594296|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1594297|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1594298|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1594299|NCT00416299|Cardiac biomarker|cardiac biomarker
1594300|NCT00416299|cardiac surgery|cardiac surgery
1594302|NCT00416299|postoperative complications|postoperative complications
1594303|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
1594304|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
1594305|NCT00416286|Sustained release|sustained release
1594306|NCT00416286|orthodontic patients|orthodontic patients
1594307|NCT00416286|streptococcus mutans|streptococcus mutans
1594308|NCT00416286|Lactobacillus|lactobacillus
1594309|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
1594310|NCT00416273|Multiple Myeloma|multiple myeloma
1594311|NCT00416273|Bortezomib|bortezomib
1594312|NCT00416273|PS341|ps341
1594313|NCT00416273|Proteasome inhibitor|proteasome inhibitor
1594314|NCT00416273|Consolidation therapy|consolidation therapy
1594315|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1594316|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
1594317|NCT00416260|Respiration, Artificial|respiration, artificial
1594318|NCT00416247|Hypnosis|hypnosis
1594320|NCT00416247|Cortical excitability|cortical excitability
1594321|NCT00416221|Depression|depression
1594322|NCT00416221|Lexapro|lexapro
1594323|NCT00416208|Multiple Myeloma|multiple myeloma
1594324|NCT00416208|Clinical trial|clinical trial
1594325|NCT00416208|Bortezomib|bortezomib
1594326|NCT00416208|PS341|ps341
1594327|NCT00416208|Proteasome inhibitor|proteasome inhibitor
1594328|NCT00416208|Consolidation therapy|consolidation therapy
1594329|NCT00416182|Cystic fibrosis|cystic fibrosis
1594330|NCT00416182|chronic sinusitis|chronic sinusitis
1594331|NCT00416182|mucolytic|mucolytic
1594332|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
1594333|NCT00416169|Pick Complex|pick complex
1594334|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
1594335|NCT00416156|Obesity|obesity
1594336|NCT00416156|Inflammation|inflammation
1594337|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
1594338|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
1594339|NCT00416130|Vorinostat|vorinostat
1594340|NCT00416130|SAHA|saha
1594341|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
1594342|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
1594343|NCT00416117|Neck pain|neck pain
1594344|NCT00416117|Cervical pain|cervical pain
1594345|NCT00416117|Radicular pain|radicular pain
1594346|NCT00416117|Manual therapy|manual therapy
1594347|NCT00416117|Mobilization|mobilization
1594348|NCT00416117|Manipulation|manipulation
1594349|NCT00416104|analgesia|analgesia
1594350|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
1594351|NCT00416078|technology development and assessment|technology development and assessment
1594352|NCT00416078|internet|internet
1594353|NCT00416078|randomized control trial|randomized control trial
1594354|NCT00416052|calcium|calcium
1594355|NCT00416052|calciuria|calciuria
1594357|NCT00416052|1,25-vitamin D|1,25-vitamin d
1594358|NCT00416052|Calcitriol|calcitriol
1594359|NCT00416052|bone mineral density|bone mineral density
1594360|NCT00416052|osteodensitometry|osteodensitometry
1594361|NCT00416039|midazolam|midazolam
1594362|NCT00416039|sublingual|sublingual
1594363|NCT00416039|oral morphine|oral morphine
1594364|NCT00416039|children|children
1594365|NCT00416039|bone fracture|bone fracture
1594568|NCT00415337|neoplasm|neoplasm
1594366|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
1594367|NCT00416026|Quality improvement|quality improvement
1594368|NCT00416026|Patient-centered care|patient-centered care
1594369|NCT00416026|Acute coronary syndrome|acute coronary syndrome
1594370|NCT00416026|Telephone counseling|telephone counseling
1594371|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
1594372|NCT00416013|Troponin|troponin
1594373|NCT00416013|Hemodialysis|hemodialysis
1594374|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
1594375|NCT00415987|Multiple Myeloma|multiple myeloma
1594376|NCT00415974|Weight Loss|weight loss
1594377|NCT00415974|Obesity|obesity
1594378|NCT00415974|Overweight|overweight
1594379|NCT00415974|Physical Activity|physical activity
1594380|NCT00415974|Nutrition|nutrition
1594381|NCT00415974|Primary Care Physicians|primary care physicians
1594382|NCT00415974|Primary Care|primary care
1594383|NCT00415974|Counseling|counseling
1594384|NCT00415974|Adolescent|adolescent
1594385|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1594386|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
1594387|NCT00415948|Heart|heart
1594388|NCT00415948|Cardiac|cardiac
1594389|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
1594390|NCT00415948|Sample Procurement|sample procurement
1594391|NCT00415922|Bioequivalence|bioequivalence
1594392|NCT00415922|bioavailability|bioavailability
1594393|NCT00415922|carbidopa|carbidopa
1594394|NCT00415922|levodopa|levodopa
1594395|NCT00415922|entacapone|entacapone
1594396|NCT00415922|fasting condition|fasting condition
1594397|NCT00415922|Healthy volunteers study|healthy volunteers study
1594398|NCT00415909|Leukemia|leukemia
1594399|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1594400|NCT00415909|CML|cml
1594401|NCT00415909|Imatinib|imatinib
1594402|NCT00415909|Gleevec|gleevec
1594403|NCT00415909|TALL-104|tall-104
1594404|NCT00415896|weaning|weaning
1594405|NCT00415896|work of breathing|work of breathing
1594406|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
1594407|NCT00415896|rapid shallow breathing|rapid shallow breathing
1594408|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
1594409|NCT00415870|Overweight|overweight
1594410|NCT00415870|Cell Phone|cell phone
1594411|NCT00415870|Technology|technology
1594412|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1594413|NCT00415857|Leukemia|leukemia
1594414|NCT00415857|Peptide Vaccine|peptide vaccine
1594415|NCT00415857|PR1 Peptide|pr1 peptide
1594416|NCT00415857|Imatinib|imatinib
1594417|NCT00415857|Gleevec|gleevec
1594418|NCT00415857|GM-CSF|gm-csf
1594419|NCT00415857|Sargramostim|sargramostim
1594420|NCT00415857|Leukine|leukine
1594421|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
1594422|NCT00415857|Peg-Intron|peg-intron
1594423|NCT00415844|Bioequivalence|bioequivalence
1594424|NCT00415844|bioavailability|bioavailability
1594425|NCT00415844|carbidopa|carbidopa
1594426|NCT00415844|levodopa|levodopa
1594427|NCT00415844|entacapone|entacapone
1594428|NCT00415844|fasting condition|fasting condition
1594429|NCT00415844|Healthy volunteers study|healthy volunteers study
1594430|NCT00415831|Bioequivalence|bioequivalence
1594431|NCT00415831|bioavailability|bioavailability
1594432|NCT00415831|carbidopa|carbidopa
1594433|NCT00415831|levodopa|levodopa
1594434|NCT00415831|entacapone|entacapone
1594435|NCT00415831|fed condition|fed condition
1594436|NCT00415831|Healthy volunteers study|healthy volunteers study
1594437|NCT00415818|Lung Cancer|lung cancer
1594438|NCT00415818|NSCLC|nsclc
1594439|NCT00415818|Cancer Vaccine|cancer vaccine
1594440|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
1594441|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
1594442|NCT00415792|Ovulation induction|ovulation induction
1594443|NCT00415792|hCG|hcg
1594444|NCT00415792|GnRH agonist|gnrh agonist
1594445|NCT00415792|hyper-responders|hyper-responders
1594446|NCT00415779|hormone refractory|hormone refractory
1594447|NCT00415779|bone metastasis|bone metastasis
1594448|NCT00415779|chemotherapy|chemotherapy
1594449|NCT00415779|biphosphonates|biphosphonates
1594450|NCT00415766|recombinant hCG|recombinant hcg
1594451|NCT00415766|urinary hCG|urinary hcg
1594452|NCT00415740|Bioequivalence|bioequivalence
1594453|NCT00415740|bioavailability|bioavailability
1594454|NCT00415740|carbidopa|carbidopa
1594455|NCT00415740|levodopa|levodopa
1594456|NCT00415740|entacapone|entacapone
1594457|NCT00415740|fasting|fasting
1594458|NCT00415740|Healthy volunteers study|healthy volunteers study
1594459|NCT00415714|Primary Insomnia|primary insomnia
1594460|NCT00415714|Chronic Insomnia|chronic insomnia
1594461|NCT00415714|Biofeedback|biofeedback
1594462|NCT00415714|Sleeplessness|sleeplessness
1594463|NCT00415701|Etomidate|etomidate
1594464|NCT00415701|Propofol|propofol
1594465|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
1594466|NCT00415701|Hemodynamic Process|hemodynamic process
1594467|NCT00415701|Vasoactive Agonists|vasoactive agonists
1594468|NCT00415701|Coronary Artery Bypass|coronary artery bypass
1594469|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
1594470|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
1594471|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
1594472|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
1594473|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
1594474|NCT00415688|lifestyle modification|lifestyle modification
1594475|NCT00415688|weight loss|weight loss
1594476|NCT00415688|hyperglycemia|hyperglycemia
1594477|NCT00415688|hypoglycemic agents|hypoglycemic agents
1594478|NCT00415675|Lung Cancer|lung cancer
1594479|NCT00415675|Abdominal Cancer|abdominal cancer
1594480|NCT00415675|Tissue Motion|tissue motion
1594481|NCT00415675|Breathing|breathing
1594482|NCT00415675|Motion CT Scans|motion ct scans
1594483|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
1594484|NCT00415649|HIV Seronegativity|hiv seronegativity
1594485|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
1594486|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
1594487|NCT00415610|stroke|stroke
1594488|NCT00415610|hypertension|hypertension
1594489|NCT00415610|blood pressure|blood pressure
1594490|NCT00415610|nicardipine|nicardipine
1594491|NCT00415610|antihypertensive agent|antihypertensive agent
1594492|NCT00415610|hematoma expansion|hematoma expansion
1594493|NCT00415597|chronic pain|chronic pain
1594494|NCT00415597|joint pain|joint pain
1594495|NCT00415597|back pain|back pain
1594496|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1594497|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
1594498|NCT00415597|ALO-01|alo-01
1594499|NCT00415597|Embeda|embeda
1594500|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
1594501|NCT00415584|hypercalcemia|hypercalcemia
1594502|NCT00415584|transplant|transplant
1594503|NCT00415571|Hypogonadism|hypogonadism
1594504|NCT00415571|Erectile Dysfunction|erectile dysfunction
1594505|NCT00415558|Atrial Fibrillation|atrial fibrillation
1594506|NCT00415545|Heart Failure|heart failure
1594507|NCT00415545|Patient Education|patient education
1594508|NCT00415532|splenectomy|splenectomy
1594509|NCT00415532|platelet|platelet
1594510|NCT00415532|AMG 531|amg 531
1594511|NCT00415532|thrombopoietin|thrombopoietin
1594512|NCT00415532|blood disorder|blood disorder
1594513|NCT00415532|bleeding disorder|bleeding disorder
1594514|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1594515|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1594633|NCT00415064|Multiple Myeloma|multiple myeloma
1594516|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
1594517|NCT00415532|TPO|tpo
1594518|NCT00415532|thrombopoietic protein|thrombopoietic protein
1594519|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1594520|NCT00415519|free radical scavenger|free radical scavenger
1594521|NCT00415493|rhinitis|rhinitis
1594522|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
1594523|NCT00415493|rhinomanometry|rhinomanometry
1594524|NCT00415493|cold air|cold air
1594525|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
1594526|NCT00415493|warm, most air inhalation|warm, most air inhalation
1594527|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
1594529|NCT00415467|Radiation Therapy System|radiation therapy system
1594530|NCT00415467|GliaSite RTS|gliasite rts
1594531|NCT00415454|Pancreatic Cancer|pancreatic cancer
1594532|NCT00415441|physiotherapy|physiotherapy
1594533|NCT00415441|exercise|exercise
1594534|NCT00415441|manual therapy|manual therapy
1594535|NCT00415441|shoulder pain|shoulder pain
1594536|NCT00415441|rotator cuff|rotator cuff
1594537|NCT00415415|Racial Disparities|racial disparities
1594538|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
1594539|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
1594540|NCT00415415|CVD|cvd
1594541|NCT00415415|CHD|chd
1594542|NCT00415402|Vitamin D3|vitamin d3
1594543|NCT00415402|morbidity|morbidity
1594544|NCT00415402|mortality|mortality
1594545|NCT00415402|low birth weight|low birth weight
1594546|NCT00415402|supplementation|supplementation
1594547|NCT00415402|TH1|th1
1594548|NCT00415402|TH2|th2
1594549|NCT00415402|CRP|crp
1594550|NCT00415402|Neopterin|neopterin
1594551|NCT00415402|immune response|immune response
1594552|NCT00415389|Stroke|stroke
1594553|NCT00415389|interactive educational program|interactive educational program
1594554|NCT00415389|acute ischemic stroke|acute ischemic stroke
1594555|NCT00415376|seizure|seizure
1594556|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
1594557|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1594558|NCT00415350|Bronchiectasis|bronchiectasis
1594559|NCT00415350|Macrolide|macrolide
1594560|NCT00415350|Azithromycin|azithromycin
1594561|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
1594562|NCT00415350|Immunomodulation|immunomodulation
1594563|NCT00415350|Inflammation|inflammation
1594564|NCT00415350|Lung function|lung function
1594565|NCT00415350|Sputum|sputum
1594566|NCT00415350|Bacterial colonization|bacterial colonization
1594569|NCT00415337|bronchoscopy|bronchoscopy
1594570|NCT00415337|ultrasonography|ultrasonography
1594571|NCT00415337|histology|histology
1594572|NCT00415311|Liver Transplantation|liver transplantation
1594573|NCT00415311|rhMBL|rhmbl
1594574|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1594575|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1594576|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1594577|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1594578|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1594579|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1594580|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1594581|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1594582|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1594583|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1594584|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1594585|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1594586|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1594587|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1594588|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1594589|NCT00415285|Breast|breast
1594590|NCT00415285|Cancer|cancer
1594591|NCT00415285|Early-Stage|early-stage
1594592|NCT00415285|Chemotherapy|chemotherapy
1594593|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
1594594|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
1594595|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
1594596|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
1594597|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1594598|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1594599|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1594600|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1594601|NCT00415220|Chiropractic|chiropractic
1594602|NCT00415220|Manipulation|manipulation
1594603|NCT00415220|Back surgery|back surgery
1594604|NCT00415220|Herniated lumbar disc|herniated lumbar disc
1594605|NCT00415220|Sciatica|sciatica
1594606|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
1594607|NCT00415220|Cost-effectiveness|cost-effectiveness
1594608|NCT00415207|CYP2C8|cyp2c8
1594609|NCT00415207|MDR1|mdr1
1594610|NCT00415207|Pharmacogenetics|pharmacogenetics
1594611|NCT00415207|Paclitaxel|paclitaxel
1594612|NCT00415181|CYP2C8|cyp2c8
1594613|NCT00415181|MDR1|mdr1
1594614|NCT00415181|Pharmacogenetics|pharmacogenetics
1594615|NCT00415181|Paclitaxel|paclitaxel
1594616|NCT00415142|Depression|depression
1594617|NCT00415142|Major depressive disorders|major depressive disorders
1594618|NCT00415142|Controlled clinical trial|controlled clinical trial
1594619|NCT00415129|Influenza|influenza
1594620|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
1594621|NCT00415129|Influenza Pandemics|influenza pandemics
1594622|NCT00415129|A/H5N1 strain|a/h5n1 strain
1594623|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1594624|NCT00415103|Emesis|emesis
1594625|NCT00415103|Nausea|nausea
1594626|NCT00415103|leukemia|leukemia
1594627|NCT00415103|lymphoma|lymphoma
1594628|NCT00415090|Nevirapine|nevirapine
1594629|NCT00415090|Antiretroviral treatment|antiretroviral treatment
1594630|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
1594631|NCT00415090|HIV|hiv
1594632|NCT00415090|Treatment Experienced|treatment experienced
1594634|NCT00415064|Perifosine|perifosine
1594635|NCT00415064|Lenalidomide|lenalidomide
1594636|NCT00415064|Dexamethasone|dexamethasone
1594637|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
1594638|NCT00415038|hypertension|hypertension
1594639|NCT00415038|pharmacogenomic|pharmacogenomic
1594640|NCT00415038|adducin|adducin
1594641|NCT00415038|ouabain|ouabain
1594642|NCT00415038|rostafuroxin|rostafuroxin
1594643|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1594644|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
1594645|NCT00415025|radiation toxicity|radiation toxicity
1594646|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1594647|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1594648|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1594649|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1594650|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1594706|NCT00414947|Bioequivalence|bioequivalence
1594651|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1594652|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1594653|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1594654|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1594655|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1594656|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1594657|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1594658|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1594659|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1594660|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1594661|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1594662|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1594663|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1594664|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1594665|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1594666|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1594667|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1594668|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1594669|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1594670|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1594671|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1594672|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1594673|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1594674|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1594675|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1594676|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1594677|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1594678|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1594679|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
1594680|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
1594681|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
1594682|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1594766|NCT00414687|Long-term treatment|long-term treatment
1594683|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1594684|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1594685|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1594686|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1594687|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1594688|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1594689|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1594690|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1594691|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1594692|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1594693|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1594694|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1594695|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1594696|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1594697|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1594698|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1594699|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1594700|NCT00414999|Macular degeneration|macular degeneration
1594701|NCT00414999|Vascular diseases|vascular diseases
1594702|NCT00414999|Retinal disorders|retinal disorders
1594703|NCT00414999|Macular edema|macular edema
1594709|NCT00414947|vildagliptin|vildagliptin
1594710|NCT00414947|Chinese|chinese
1594711|NCT00414947|healthy subjects|healthy subjects
1594712|NCT00414934|cancer|cancer
1594713|NCT00414934|bone scan|bone scan
1594714|NCT00414934|NaF bone PET|naf bone pet
1594715|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
1594716|NCT00414921|ADHD|adhd
1594717|NCT00414921|clonidine|clonidine
1594718|NCT00414921|methylphenidate|methylphenidate
1594719|NCT00414921|MPH|mph
1594720|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
1594721|NCT00414908|Pancreatectomy|pancreatectomy
1594722|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
1594723|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
1594724|NCT00414869|Liver|liver
1594725|NCT00414869|Portal pressure|portal pressure
1594726|NCT00414869|Fibrosis|fibrosis
1594727|NCT00414869|Nitric oxide|nitric oxide
1594728|NCT00414856|GERD|gerd
1594729|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
1594730|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
1594731|NCT00414843|Storage|storage
1594732|NCT00414843|Bile|bile
1594733|NCT00414843|Biomarkers|biomarkers
1594734|NCT00414843|biliary malignancies|biliary malignancies
1594735|NCT00414830|prevention|prevention
1594736|NCT00414830|health technology assessment|health technology assessment
1594737|NCT00414830|population based|population based
1594738|NCT00414830|fracture|fracture
1594739|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
1594740|NCT00414817|ICS|ics
1594741|NCT00414817|Adherence|adherence
1594742|NCT00414804|Pain|pain
1594743|NCT00414804|Neurostimulation|neurostimulation
1594744|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
1594745|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1594746|NCT00414765|Metastatic Melanoma|metastatic melanoma
1594747|NCT00414765|Aldesleukin|aldesleukin
1594748|NCT00414765|IL-2|il-2
1594749|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
1594750|NCT00414739|growth of dendritic cells|growth of dendritic cells
1594751|NCT00414739|prevention|prevention
1594752|NCT00414726|ischemic stroke|ischemic stroke
1594753|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
1594754|NCT00414713|Upper GI bleeding|upper gi bleeding
1594755|NCT00414713|Cirrhosis|cirrhosis
1594756|NCT00414713|Portal hypertension|portal hypertension
1594757|NCT00414713|Non-variceal bleeding|non-variceal bleeding
1594758|NCT00414713|Transfusion|transfusion
1594759|NCT00414700|Cartilage|cartilage
1594760|NCT00414700|Articular|articular
1594761|NCT00414700|Femoral|femoral
1594762|NCT00414700|Knee|knee
1594763|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
1594764|NCT00414687|Iloprost|iloprost
1594767|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
1594768|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
1594769|NCT00414648|Lung Disease|lung disease
1594770|NCT00414635|HIV/AIDS|hiv/aids
1594771|NCT00414635|efavirenz|efavirenz
1594772|NCT00414635|tenofovir|tenofovir
1594773|NCT00414635|emtricitabine|emtricitabine
1594774|NCT00414635|FOTO|foto
1594775|NCT00414635|treatment interruption|treatment interruption
1594776|NCT00414635|Atripla|atripla
1594777|NCT00414635|Truvada|truvada
1594778|NCT00414635|Treatment Experienced|treatment experienced
1594779|NCT00414622|Alzheimer|alzheimer
1594780|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
1594781|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
1594782|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
1594783|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
1594784|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1594785|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1594786|NCT00414583|Cerebral Stroke|cerebral stroke
1594787|NCT00414583|Stroke, Acute|stroke, acute
1594788|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
1594789|NCT00414583|Fabry Disease|fabry disease
1594790|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
1594791|NCT00414583|Fabry's Disease|fabry's disease
1594792|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
1594793|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18F]FLT)|3'-deoxy-3'(18f)fluorothymidine ([18f]flt)
1594794|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
1594795|NCT00414557|Joint diseases|joint diseases
1594796|NCT00414544|Nasolabial folds|nasolabial folds
1594797|NCT00414544|Dermal filler|dermal filler
1594798|NCT00414544|Injectable dermal filler|injectable dermal filler
1594799|NCT00414544|Soft tissue augmentation|soft tissue augmentation
1594800|NCT00414518|Acute Infection|acute infection
1594801|NCT00414518|Early HIV Infection|early hiv infection
1594996|NCT00413621|HV|hv
1594802|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
1594803|NCT00414518|Treatment Interruption|treatment interruption
1594804|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
1594805|NCT00414518|ART|art
1594806|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
1594807|NCT00414492|liver metastasis|liver metastasis
1594808|NCT00414492|tumor margins|tumor margins
1594809|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
1594810|NCT00414479|schistosomiasis|schistosomiasis
1594811|NCT00414479|anaemia|anaemia
1594812|NCT00414479|malaria|malaria
1594813|NCT00414479|iron deficiency|iron deficiency
1594814|NCT00414453|Neuropathic pain|neuropathic pain
1594815|NCT00414453|Chronic pain|chronic pain
1594816|NCT00414453|Multiple sclerosis|multiple sclerosis
1594817|NCT00414453|Central neuropathic pain|central neuropathic pain
1594818|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
1594819|NCT00414453|Opioid analgesic|opioid analgesic
1594820|NCT00414453|Lidocaine|lidocaine
1594821|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
1594822|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
1594823|NCT00414427|Ultrasonography|ultrasonography
1594824|NCT00414427|Corticosteroids|corticosteroids
1594825|NCT00414414|TB|tb
1594826|NCT00414414|Tuberculosis|tuberculosis
1594827|NCT00414414|HIV|hiv
1594828|NCT00414414|Co-infection|co-infection
1594829|NCT00414414|Steroid|steroid
1594830|NCT00414414|Prednisone|prednisone
1594831|NCT00414414|oral corticosteroids|oral corticosteroids
1594832|NCT00414414|TB Treatment|tb treatment
1594833|NCT00414414|South Africa|south africa
1594834|NCT00414388|AIPC|aipc
1594835|NCT00414375|Perforated Appendicitis|perforated appendicitis
1594836|NCT00414375|Abscess|abscess
1594837|NCT00414375|Appendectomy|appendectomy
1594838|NCT00414362|Bacteremia|bacteremia
1594839|NCT00414362|Urinary Tract Infections|urinary tract infections
1594840|NCT00414362|Fluoroquinolone|fluoroquinolone
1594841|NCT00414349|Topical analgesic|topical analgesic
1594842|NCT00414349|Multiple dose|multiple dose
1594843|NCT00414336|Blood Stage|blood stage
1594844|NCT00414336|Investigational|investigational
1594845|NCT00414336|Endemic|endemic
1594846|NCT00414336|Malaria|malaria
1594847|NCT00414310|Decitabine|decitabine
1594848|NCT00414310|Dacogen|dacogen
1594849|NCT00414310|5-AZA|5-aza
1594850|NCT00414310|Valproic Acid|valproic acid
1594851|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
1594852|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
1594853|NCT00414310|MDS|mds
1594854|NCT00414310|AML|aml
1594855|NCT00414297|CAD|cad
1594856|NCT00414297|ECP|ecp
1594857|NCT00414297|CFI|cfi
1594858|NCT00414297|CPI|cpi
1594859|NCT00414297|MPR|mpr
1594860|NCT00414284|HIV/AIDS|hiv/aids
1594861|NCT00414284|viremia|viremia
1594862|NCT00414284|Kaletra|kaletra
1594863|NCT00414284|pharmacokinetics|pharmacokinetics
1594864|NCT00414284|viral load|viral load
1594865|NCT00414284|LPV/r|lpv/r
1594866|NCT00414284|Treatment Experienced|treatment experienced
1594867|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
1594868|NCT00414258|Pain Response|pain response
1594869|NCT00414232|Rectal Cancer|rectal cancer
1594870|NCT00414232|Chemoradiation|chemoradiation
1594871|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
1594872|NCT00414206|AMD|amd
1594873|NCT00414206|Wet AMD|wet amd
1594874|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
1594875|NCT00414193|Bacteremia|bacteremia
1594876|NCT00414193|Piperacillin|piperacillin
1594877|NCT00414193|Tazobactam|tazobactam
1594878|NCT00414167|Binge eating|binge eating
1594879|NCT00414167|Obesity|obesity
1594880|NCT00414167|Medication|medication
1594881|NCT00414167|Craving|craving
1594882|NCT00414167|Emotional eating|emotional eating
1594883|NCT00414154|Group based patient education,|group based patient education,
1594884|NCT00414154|multidisciplinary,|multidisciplinary,
1594885|NCT00414154|physical activity,|physical activity,
1594886|NCT00414154|adherence to treatment,|adherence to treatment,
1594887|NCT00414154|quality of life|quality of life
1594888|NCT00414141|Allergy|allergy
1594889|NCT00414141|Allergoid|allergoid
1594890|NCT00414141|Specific Immunotherapy|specific immunotherapy
1594891|NCT00414128|vasculitis|vasculitis
1594892|NCT00414128|ANCA|anca
1594893|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
1594894|NCT00414128|cyclophosphamide|cyclophosphamide
1594895|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
1594896|NCT00414115|Observational controlled study|observational controlled study
1594897|NCT00414115|Genomic biomarkers|genomic biomarkers
1594898|NCT00414115|Adverse drug reaction|adverse drug reaction
1594899|NCT00414115|In children OR adults|in children or adults
1594900|NCT00414102|Chronic Insomnia|chronic insomnia
1594901|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
1594902|NCT00414102|Drug Therapy|drug therapy
1594903|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
1594997|NCT00413608|Human|human
1594904|NCT00414076|Uterine Neoplasm|uterine neoplasm
1594905|NCT00414076|Uterine Sarcomas|uterine sarcomas
1594906|NCT00414076|Uterine Cancer|uterine cancer
1594907|NCT00414076|Uterus|uterus
1594908|NCT00414076|LMS|lms
1594909|NCT00414076|ER Positivity|er positivity
1594910|NCT00414076|Femara|femara
1594911|NCT00414076|Letrozole|letrozole
1594912|NCT00414063|Fecal Energy|fecal energy
1594913|NCT00414063|Urine Energy|urine energy
1594914|NCT00414063|Bomb Calorimetry|bomb calorimetry
1594915|NCT00414063|Gut Maintenance Flora|gut maintenance flora
1594916|NCT00414063|Obesity|obesity
1594917|NCT00414063|Energy Metabolism|energy metabolism
1594918|NCT00414037|insomnia|insomnia
1594919|NCT00414037|lunesta|lunesta
1594920|NCT00414037|eszopiclone|eszopiclone
1594921|NCT00414037|pain|pain
1594922|NCT00414037|fMRI|fmri
1594923|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
1594924|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
1594925|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
1594926|NCT00413985|Low Birth Weight|low birth weight
1594927|NCT00413985|Fortified Human Milk|fortified human milk
1594928|NCT00413985|breastfeeding|breastfeeding
1594929|NCT00413985|infants|infants
1594930|NCT00413985|growth|growth
1594931|NCT00413959|NHL|nhl
1594932|NCT00413946|Premature infant|premature infant
1594933|NCT00413946|developmental outcome|developmental outcome
1594934|NCT00413933|falls|falls
1594935|NCT00413933|prevention|prevention
1594936|NCT00413933|elderly|elderly
1594937|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
1594938|NCT00413933|health care utilization|health care utilization
1594939|NCT00413920|Steroids avoidance,|steroids avoidance,
1594940|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
1594941|NCT00413920|de novo renal transplantation|de novo renal transplantation
1594942|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
1594943|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
1594944|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
1594945|NCT00413855|Abdominal pain|abdominal pain
1594946|NCT00413855|Appendectomy|appendectomy
1594947|NCT00413855|Laparoscopy|laparoscopy
1594948|NCT00413855|Chronic appendicitis|chronic appendicitis
1594949|NCT00413855|Appendicopathy|appendicopathy
1594950|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1594951|NCT00413842|Plasticity|plasticity
1594952|NCT00413842|Primary Motor Cortex|primary motor cortex
1594953|NCT00413842|Cerebellum|cerebellum
1594954|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1594955|NCT00413842|Healthy Volunteer|healthy volunteer
1594956|NCT00413842|HV|hv
1594957|NCT00413829|age related macular degeneration|age related macular degeneration
1594958|NCT00413829|anti-VEGF therapy|anti-vegf therapy
1594959|NCT00413816|Anemia|anemia
1594960|NCT00413816|Critically ill|critically ill
1594961|NCT00413803|Hemodialysis|hemodialysis
1594962|NCT00413803|Nocturnal dialysis|nocturnal dialysis
1594963|NCT00413803|Cardiovascular disease|cardiovascular disease
1594964|NCT00413803|Quality of Life|quality of life
1594965|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
1594966|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
1594967|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
1594968|NCT00413738|Central venous catheter|central venous catheter
1594969|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
1594970|NCT00413738|Heparin|heparin
1594971|NCT00413738|Chlorhexidine|chlorhexidine
1594972|NCT00413738|Sulfadiazine|sulfadiazine
1594973|NCT00413725|HIV Seronegativity|hiv seronegativity
1594974|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
1594975|NCT00413725|Adenovirus|adenovirus
1595103|NCT00413348|Inflammation|inflammation
1594976|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
1594977|NCT00413712|Calcium Channel Blockers|calcium channel blockers
1594978|NCT00413712|Verapamil|verapamil
1594979|NCT00413712|Diltiazem|diltiazem
1594980|NCT00413712|Adenosine|adenosine
1594981|NCT00413699|long-term|long-term
1594982|NCT00413699|open-label|open-label
1594983|NCT00413699|safety|safety
1594984|NCT00413686|Mixed solid tumors|mixed solid tumors
1594985|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
1594986|NCT00413660|DMARD therapy|dmard therapy
1594987|NCT00413647|CardioPET|cardiopet
1594988|NCT00413647|Coronary Artery Disease|coronary artery disease
1594989|NCT00413647|Electrocardiogram|electrocardiogram
1594990|NCT00413647|Radiation Dosimetry|radiation dosimetry
1594991|NCT00413621|MRI|mri
1594992|NCT00413621|Alzheimer Disease|alzheimer disease
1594993|NCT00413621|Amyloid|amyloid
1594994|NCT00413621|AD|ad
1594995|NCT00413621|Healthy Volunteer|healthy volunteer
1595002|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
1595003|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
1595004|NCT00413608|Platelet Function Tests|platelet function tests
1595005|NCT00413608|Pharmacogenetics|pharmacogenetics
1595006|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
1595007|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
1595008|NCT00413608|Healthy subjects|healthy subjects
1595009|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
1595010|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
1595011|NCT00413595|Fabry Disease|fabry disease
1595012|NCT00413595|Fabry's Disease|fabry's disease
1595013|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
1595014|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1595015|NCT00413595|Stroke, acute|stroke, acute
1595016|NCT00413595|Cerebral Stroke|cerebral stroke
1595017|NCT00413582|Pectus Excavatum|pectus excavatum
1595018|NCT00413582|Bar Repair|bar repair
1595019|NCT00413582|Pain Control|pain control
1595020|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
1595021|NCT00413556|Rhinitis|rhinitis
1595022|NCT00413556|Oral tablets|oral tablets
1595023|NCT00413556|Ig G4|ig g4
1595024|NCT00413556|grass pollen|grass pollen
1595025|NCT00413556|inmunotherapy|inmunotherapy
1595026|NCT00413543|COPD|copd
1595027|NCT00413543|exacerbation|exacerbation
1595028|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
1595029|NCT00413543|exercise tolerance|exercise tolerance
1595030|NCT00413543|exacerbations|exacerbations
1595031|NCT00413543|quality of life|quality of life
1595032|NCT00413543|readmissions|readmissions
1595033|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
1595034|NCT00413504|Fondaparinux|fondaparinux
1595035|NCT00413504|Monotherapy|monotherapy
1595036|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
1595037|NCT00413504|Pulmonary Embolism|pulmonary embolism
1595038|NCT00413504|Anticoagulation|anticoagulation
1595039|NCT00413491|Breast Cancer|breast cancer
1595040|NCT00413491|BRCA1 gene|brca1 gene
1595041|NCT00413491|BRCA2 gene|brca2 gene
1595042|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
1595043|NCT00413491|Mammography|mammography
1595044|NCT00413491|Ultrasonography|ultrasonography
1595045|NCT00413478|5-Aza|5-aza
1595046|NCT00413478|Azacytidine|azacytidine
1595047|NCT00413478|Vidaza|vidaza
1595048|NCT00413478|CLL|cll
1595049|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1595050|NCT00413478|Richter's transformation|richter's transformation
1595051|NCT00413478|Leukemia|leukemia
1595052|NCT00413465|Renal Plasma Flow|renal plasma flow
1595053|NCT00413465|Endotoxemia|endotoxemia
1595054|NCT00413465|Type 2 diabetes|type 2 diabetes
1595055|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
1595056|NCT00413452|Etanercept|etanercept
1595057|NCT00413452|Enbrel|enbrel
1595059|NCT00413439|Isavuconazole|isavuconazole
1595060|NCT00413439|BAL8557|bal8557
1595061|NCT00413439|ASP9766|asp9766
1595062|NCT00413439|chemotherapy|chemotherapy
1595063|NCT00413439|prophylaxis|prophylaxis
1595064|NCT00413439|systemic fungal infection|systemic fungal infection
1595065|NCT00413426|Pharmacokinetics|pharmacokinetics
1595066|NCT00413426|oral|oral
1595067|NCT00413426|single dose|single dose
1595068|NCT00413426|table|table
1595069|NCT00413426|suspension|suspension
1595070|NCT00413426|release|release
1595071|NCT00413426|darifenacin|darifenacin
1595072|NCT00413426|healthy subjects|healthy subjects
1595073|NCT00413426|Healthy volunteers study|healthy volunteers study
1595074|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
1595075|NCT00413400|Inflammation|inflammation
1595076|NCT00413400|Visceral adiposity|visceral adiposity
1595077|NCT00413400|TNF|tnf
1595078|NCT00413400|Adiponectin|adiponectin
1595079|NCT00413400|glucose tolerance|glucose tolerance
1595080|NCT00413400|endothelial function|endothelial function
1595081|NCT00413400|metabolic syndrome|metabolic syndrome
1595082|NCT00413387|Asthma|asthma
1595083|NCT00413387|Combinations|combinations
1595084|NCT00413387|Inhaled therapy|inhaled therapy
1595085|NCT00413387|Corticosteroids|corticosteroids
1595086|NCT00413387|Long acting bronchodilators|long acting bronchodilators
1595087|NCT00413387|Beclomethasone|beclomethasone
1595088|NCT00413387|Formoterol|formoterol
1595089|NCT00413387|Budesonide|budesonide
1595090|NCT00413374|Lovenox|lovenox
1595091|NCT00413374|Enoxaparin|enoxaparin
1595092|NCT00413374|Prophylaxis|prophylaxis
1595093|NCT00413374|Pulmonary Embolism|pulmonary embolism
1595094|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
1595095|NCT00413374|Venous Thrombosis|venous thrombosis
1595096|NCT00413374|Thrombosis|thrombosis
1595097|NCT00413374|Anticoagulation|anticoagulation
1595098|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
1595099|NCT00413361|Hydroxychloroquine|hydroxychloroquine
1595100|NCT00413348|Type 2 diabetes|type 2 diabetes
1595101|NCT00413348|Probiotics|probiotics
1595102|NCT00413348|Insulin-resistance|insulin-resistance
1595199|NCT00413231|Endograft|endograft
1595104|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
1595105|NCT00413348|Endotoxin|endotoxin
1595106|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
1595107|NCT00413335|Metabolic phenotype|metabolic phenotype
1595108|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
1595109|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1595110|NCT00413335|Insulin Sensitivity|insulin sensitivity
1595111|NCT00413335|Insulin Resistance|insulin resistance
1595112|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
1595113|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
1595114|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1595115|NCT00413322|Advanced Solid tumor|advanced solid tumor
1595116|NCT00413322|Adenosarcoma|adenosarcoma
1595117|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
1595118|NCT00413322|belinostat|belinostat
1595119|NCT00413322|bladder cancer|bladder cancer
1595120|NCT00413322|bladder neoplasms|bladder neoplasms
1595121|NCT00413322|Breast cancer|breast cancer
1595122|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
1595123|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1595124|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
1595125|NCT00413322|Carcinosarcoma|carcinosarcoma
1595126|NCT00413322|Chondrosarcoma|chondrosarcoma
1595127|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
1595128|NCT00413322|colorectal cancer|colorectal cancer
1595129|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
1595130|NCT00413322|Facial Neoplasms|facial neoplasms
1595131|NCT00413322|Fibrosarcoma|fibrosarcoma
1595132|NCT00413322|head and neck cancer|head and neck cancer
1595133|NCT00413322|Hemangiosarcoma|hemangiosarcoma
1595134|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
1595135|NCT00413322|kidney cancer|kidney cancer
1595136|NCT00413322|Leiomyosarcoma|leiomyosarcoma
1595137|NCT00413322|Liposarcoma|liposarcoma
1595138|NCT00413322|lung cancer|lung cancer
1595139|NCT00413322|lung neoplasms|lung neoplasms
1595140|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
1595141|NCT00413322|mesothelioma|mesothelioma
1595142|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
1595143|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
1595144|NCT00413322|Mouth Neoplasms|mouth neoplasms
1595145|NCT00413322|Myosarcoma|myosarcoma
1595146|NCT00413322|Myxosarcoma|myxosarcoma
1595147|NCT00413322|Osteosarcoma|osteosarcoma
1595148|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
1595149|NCT00413322|Ovarian cancer|ovarian cancer
1595150|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
1595151|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
1595152|NCT00413322|Phyllodes Tumor|phyllodes tumor
1595153|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
1595154|NCT00413322|sarcoma|sarcoma
1595155|NCT00413322|thyroid cancer|thyroid cancer
1595156|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
1595157|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
1595158|NCT00413322|PXD101|pxd101
1595159|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
1595160|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
1595161|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
1595162|NCT00413309|PillCam|pillcam
1595163|NCT00413309|Endoscopy|endoscopy
1595164|NCT00413296|PTSD|ptsd
1595165|NCT00413296|Anxiety|anxiety
1595166|NCT00413296|Pharmacotherapy|pharmacotherapy
1595167|NCT00413296|Levetiracetam|levetiracetam
1595168|NCT00413296|Relapse prevention|relapse prevention
1595169|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1595170|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
1595171|NCT00413283|CIT|cit
1595172|NCT00413283|NSCLC|nsclc
1595173|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
1595174|NCT00413283|Stage IV NSCLC|stage iv nsclc
1595175|NCT00413283|Gemcitabine|gemcitabine
1595176|NCT00413283|Carboplatin|carboplatin
1595177|NCT00413283|Cisplatin|cisplatin
1595178|NCT00413270|Imatinib resistant,|imatinib resistant,
1595179|NCT00413270|Imatinib intolerant,|imatinib intolerant,
1595180|NCT00413270|CML- blast crisis,|cml- blast crisis,
1595181|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
1595182|NCT00413270|CML- chronic phase,|cml- chronic phase,
1595183|NCT00413270|nilotinib,|nilotinib,
1595184|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
1595185|NCT00413270|blast crisis,|blast crisis,
1595186|NCT00413270|accelerated phase,|accelerated phase,
1595187|NCT00413270|chronic phase|chronic phase
1595188|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
1595189|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
1595190|NCT00413257|Nefopam|nefopam
1595191|NCT00413257|Randomized Controlled Trials|randomized controlled trials
1595192|NCT00413257|Pain and chronic disease|pain and chronic disease
1595193|NCT00413244|Hypogonadal|hypogonadal
1595194|NCT00413244|coronary artery disease|coronary artery disease
1595195|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1595196|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
1595197|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
1595198|NCT00413231|Endovascular Stent Graft|endovascular stent graft
1595200|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
1595201|NCT00413231|Endovascular procedure|endovascular procedure
1595202|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
1595203|NCT00413231|Valiant Stent Graft System|valiant stent graft system
1595204|NCT00413218|Invasive Candida infections|invasive candida infections
1595205|NCT00413218|BAL8557|bal8557
1595206|NCT00413218|ASP9766|asp9766
1595207|NCT00413218|Isavuconazole|isavuconazole
1595208|NCT00413218|Candidemia|candidemia
1595209|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
1595210|NCT00413218|Phase III study|phase iii study
1595211|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
1595212|NCT00413179|Chronic Anovulation|chronic anovulation
1595213|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
1595214|NCT00413179|Infertility|infertility
1595215|NCT00413179|Hyperandrogenism|hyperandrogenism
1595216|NCT00413179|Metformin|metformin
1595217|NCT00413179|Ovulation induction|ovulation induction
1595218|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1595219|NCT00413166|APL|apl
1595220|NCT00413166|ATRA|atra
1595221|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
1595222|NCT00413166|Arsenic Trioxide|arsenic trioxide
1595223|NCT00413166|Theophylline|theophylline
1595224|NCT00413166|Gemtuzumab|gemtuzumab
1595225|NCT00413153|HIV|hiv
1595226|NCT00413153|Kaletra|kaletra
1595227|NCT00413153|Reyataz|reyataz
1595228|NCT00413153|Insulin sensitivity|insulin sensitivity
1595229|NCT00413153|Lipids|lipids
1595230|NCT00413153|Body Composition|body composition
1595231|NCT00413153|Receiving Kaletra|receiving kaletra
1595232|NCT00413153|Treatment Experienced|treatment experienced
1595233|NCT00413140|childhood disease|childhood disease
1595234|NCT00413140|cystic fibrosis|cystic fibrosis
1595235|NCT00413140|exhaled breath condensate|exhaled breath condensate
1595236|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
1595237|NCT00413140|airway inflammation|airway inflammation
1595238|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
1595239|NCT00413140|controls|controls
1595240|NCT00413140|children|children
1595241|NCT00413127|Systemic lidocaine|systemic lidocaine
1595242|NCT00413127|peridural lidocaine|peridural lidocaine
1595243|NCT00413127|perioperative analgesia|perioperative analgesia
1595244|NCT00413127|inflammation|inflammation
1595245|NCT00413127|Anesthesia|anesthesia
1595246|NCT00413088|renal insufficency|renal insufficency
1595247|NCT00413088|low molecular weight heparin|low molecular weight heparin
1595248|NCT00413088|pharmacokinetics|pharmacokinetics
1595249|NCT00413088|elderly|elderly
1595250|NCT00413075|Solid tumors|solid tumors
1595251|NCT00413075|Adenosarcoma|adenosarcoma
1595252|NCT00413075|B-cell lymphoma|b-cell lymphoma
1595253|NCT00413075|belinostat|belinostat
1595254|NCT00413075|bladder cancer|bladder cancer
1595255|NCT00413075|Breast cancer|breast cancer
1595256|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1595257|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
1595258|NCT00413075|Chondrosarcoma|chondrosarcoma
1595259|NCT00413075|colorectal cancer|colorectal cancer
1595260|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
1595261|NCT00413075|Fibrosarcoma|fibrosarcoma
1595262|NCT00413075|head and neck cancer|head and neck cancer
1595263|NCT00413075|Hemangiosarcoma|hemangiosarcoma
1595264|NCT00413075|Hodgkins Disease|hodgkins disease
1595265|NCT00413075|kidney cancer|kidney cancer
1595266|NCT00413075|Leiomyosarcoma|leiomyosarcoma
1595267|NCT00413075|Liposarcoma|liposarcoma
1595268|NCT00413075|lung cancer|lung cancer
1595269|NCT00413075|lymphoma|lymphoma
1595270|NCT00413075|mesothelioma|mesothelioma
1595271|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
1595272|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
1595273|NCT00413075|Osteosarcoma|osteosarcoma
1595274|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
1595275|NCT00413075|Ovarian cancer|ovarian cancer
1595276|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
1595277|NCT00413075|Prostate cancer|prostate cancer
1595278|NCT00413075|sarcoma|sarcoma
1595279|NCT00413075|T-cell lymphoma|t-cell lymphoma
1595280|NCT00413075|thyroid cancer|thyroid cancer
1595281|NCT00413075|PXD101|pxd101
1595282|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
1595283|NCT00413036|Celgene|celgene
1595284|NCT00413036|Revlimid|revlimid
1595285|NCT00413036|CC-5013|cc-5013
1595286|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
1595287|NCT00413036|Lenalidomide|lenalidomide
1595288|NCT00413036|CC5013|cc5013
1595290|NCT00413023|depression|depression
1595291|NCT00413023|major depressive disorder|major depressive disorder
1595293|NCT00412997|advanced solid tumor|advanced solid tumor
1595294|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1595295|NCT00412997|Phase I|phase i
1595296|NCT00412997|HDAC inhibitor|hdac inhibitor
1595297|NCT00412997|Adult patients|adult patients
1595298|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
1595299|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
1595300|NCT00412932|Hypertension|hypertension
1595699|NCT00411359|Psychology|psychology
1595301|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
1595302|NCT00412932|Calcium Channel Blocker|calcium channel blocker
1595303|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
1595304|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
1595305|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
1595306|NCT00412919|Myeloma|myeloma
1595307|NCT00412919|Relapsed|relapsed
1595308|NCT00412919|Refractory|refractory
1595309|NCT00412906|Low-grade inflammation|low-grade inflammation
1595310|NCT00412906|insulin resistance|insulin resistance
1595311|NCT00412906|Metabolism|metabolism
1595312|NCT00412906|Type 2 diabetes|type 2 diabetes
1595313|NCT00412906|Endotoxemia|endotoxemia
1595314|NCT00412906|Fat tissue|fat tissue
1595315|NCT00412906|Muscle tissue|muscle tissue
1595316|NCT00412906|RT-PCR|rt-pcr
1595317|NCT00412893|Invasive fungal disease|invasive fungal disease
1595318|NCT00412893|BAL8557|bal8557
1595319|NCT00412893|Isavuconazole|isavuconazole
1595320|NCT00412893|ASP9766|asp9766
1595321|NCT00412893|Filamentous fungi|filamentous fungi
1595322|NCT00412893|Phase III|phase iii
1595323|NCT00412893|Aspergillus species|aspergillus species
1595324|NCT00412867|Cerebral Infarction|cerebral infarction
1595325|NCT00412867|acute ischemic stroke|acute ischemic stroke
1595326|NCT00412867|Brain ischemia|brain ischemia
1595327|NCT00412841|Avascular Necrosis|avascular necrosis
1595328|NCT00412841|Lipitor|lipitor
1595329|NCT00412841|SLE|sle
1595330|NCT00412828|Melanoma|melanoma
1595331|NCT00412828|CR011-vcMMAE|cr011-vcmmae
1595332|NCT00412815|insulin sensitivity|insulin sensitivity
1595333|NCT00412815|coronary artery disease|coronary artery disease
1595334|NCT00412815|exercise training|exercise training
1595335|NCT00412802|enoxaparine|enoxaparine
1595336|NCT00412802|acute coronary syndrome|acute coronary syndrome
1595337|NCT00412802|renal failure|renal failure
1595338|NCT00412802|dose adaptation|dose adaptation
1595339|NCT00412789|Advanced solid tumor|advanced solid tumor
1595340|NCT00412789|Patupilone|patupilone
1595341|NCT00412763|Acute hepatitis|acute hepatitis
1595342|NCT00412763|Acute viral hepatitis|acute viral hepatitis
1595343|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
1595344|NCT00412763|Silymarin|silymarin
1595345|NCT00412763|Milk Thistle|milk thistle
1595346|NCT00412750|hepatitis B|hepatitis b
1595347|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
1595348|NCT00412750|chronic hepatitis B|chronic hepatitis b
1595349|NCT00412750|telbivudine|telbivudine
1595350|NCT00412750|peginterferon|peginterferon
1595351|NCT00412724|diet|diet
1595352|NCT00412724|acceptability|acceptability
1595353|NCT00412724|palatability|palatability
1595354|NCT00412724|food|food
1595355|NCT00412724|questionnaire|questionnaire
1595356|NCT00412724|Food habits|food habits
1595357|NCT00412672|Myocardial infarction|myocardial infarction
1595358|NCT00412672|contrast echocardiography|contrast echocardiography
1595359|NCT00412672|collateral circulation|collateral circulation
1595360|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
1595361|NCT00412659|Pilonidal sinus|pilonidal sinus
1595362|NCT00412659|Pilonidal cysts|pilonidal cysts
1595363|NCT00412659|Pilonidal disease|pilonidal disease
1595364|NCT00412659|midline excision|midline excision
1595365|NCT00412659|Karydakis operation|karydakis operation
1595366|NCT00412659|expertise based study|expertise based study
1595367|NCT00412659|surgery|surgery
1595368|NCT00412659|therapy|therapy
1595369|NCT00412646|HIV|hiv
1595370|NCT00412646|AIDS|aids
1595371|NCT00412646|Dose finding study|dose finding study
1595372|NCT00412646|TMC125-C203|tmc125-c203
1595373|NCT00412646|Treatment Experienced|treatment experienced
1595374|NCT00412633|Obesity|obesity
1595375|NCT00412633|Men|men
1595376|NCT00412633|Overweight|overweight
1595377|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
1595378|NCT00412607|Heart Diseases|heart diseases
1595379|NCT00412607|Arrhythmia|arrhythmia
1595380|NCT00412594|Hairy Cell Leukemia|hairy cell leukemia
1595381|NCT00412594|Leukemia|leukemia
1595382|NCT00412594|2CDA|2cda
1595383|NCT00412594|2-chlorodeoxyadenosine|2-chlorodeoxyadenosine
1595384|NCT00412594|Rituximab|rituximab
1595385|NCT00412594|Rituxan|rituxan
1595386|NCT00412594|HCL|hcl
1595387|NCT00412581|Melanoma|melanoma
1595388|NCT00412581|Lenalidomide|lenalidomide
1595389|NCT00412581|Dacarbazine|dacarbazine
1595390|NCT00412581|CC-5013|cc-5013
1595391|NCT00412581|Revlimid|revlimid
1595392|NCT00412581|DTIC|dtic
1595393|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
1595394|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
1595395|NCT00412542|Glioma|glioma
1595396|NCT00412542|Thalidomide|thalidomide
1595397|NCT00412542|Thalomid|thalomid
1595398|NCT00412542|CPT-11|cpt-11
1595399|NCT00412542|Irinotecan|irinotecan
1595400|NCT00412542|malignant glioma|malignant glioma
1595401|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
1595402|NCT00412529|telbivudine|telbivudine
1595403|NCT00412529|entecavir|entecavir
1595404|NCT00412529|viral kinetics|viral kinetics
1595405|NCT00412516|Japanese Encephalitis|japanese encephalitis
1595406|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
1595407|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
1595408|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
1595409|NCT00412490|Oral Cavity Cancer|oral cavity cancer
1595410|NCT00412490|Body Image|body image
1595412|NCT00412490|Appearance|appearance
1595413|NCT00412490|Questionnaire|questionnaire
1595414|NCT00412490|Interview|interview
1595415|NCT00412477|HIV|hiv
1595416|NCT00412477|Lfn-p24|lfn-p24
1595417|NCT00412477|Anthrax|anthrax
1595418|NCT00412477|IM|im
1595419|NCT00412477|HIV-1|hiv-1
1595420|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
1595421|NCT00412464|fondaparinux|fondaparinux
1595422|NCT00412464|thrombosis|thrombosis
1595423|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1595424|NCT00412464|pediatrics|pediatrics
1595425|NCT00412451|Diabetic Macular Edema|diabetic macular edema
1595426|NCT00412451|PVD|pvd
1595427|NCT00412451|DME|dme
1595428|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
1595429|NCT00412438|Atrial Fibrillation|atrial fibrillation
1595430|NCT00412425|Melanoma|melanoma
1595431|NCT00412425|Nausea|nausea
1595432|NCT00412425|Vomiting|vomiting
1595433|NCT00412425|Palonosetron|palonosetron
1595434|NCT00412425|Cisplatin|cisplatin
1595435|NCT00412425|Vinblastine|vinblastine
1595436|NCT00412425|Loss of Appetite|loss of appetite
1595437|NCT00412425|Weight loss|weight loss
1595438|NCT00412412|Cancer of Breast|cancer of breast
1595439|NCT00412412|Cancer of the Breast|cancer of the breast
1595440|NCT00412399|Employment|employment
1595441|NCT00412399|Negative workplace events|negative workplace events
1595442|NCT00412399|Healthy controls|healthy controls
1595443|NCT00412399|Fatigue|fatigue
1595444|NCT00412399|Physical activity|physical activity
1595445|NCT00412386|Pediatric|pediatric
1595446|NCT00412386|Congenital Heart Disease|congenital heart disease
1595447|NCT00412386|Imaging|imaging
1595448|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
1595449|NCT00412373|antipsychotic|antipsychotic
1595450|NCT00412373|paliperidone|paliperidone
1595451|NCT00412373|placebo|placebo
1595452|NCT00412360|Double cord blood|double cord blood
1595453|NCT00412347|hyperglycemia|hyperglycemia
1595454|NCT00412347|diabetes|diabetes
1595455|NCT00412347|insulin drip|insulin drip
1595456|NCT00412347|hypoglycemia|hypoglycemia
1595457|NCT00412347|general wards|general wards
1595458|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1595459|NCT00412321|Multiple Myeloma|multiple myeloma
1595460|NCT00412321|Castleman's disease|castleman's disease
1595461|NCT00412321|intravenous|intravenous
1595462|NCT00412321|IL-6|il-6
1595463|NCT00412308|spinal cord injury|spinal cord injury
1595464|NCT00412308|ventilator dependency|ventilator dependency
1595465|NCT00412308|ventilator weaning|ventilator weaning
1595466|NCT00412308|tidal volume|tidal volume
1595985|NCT00410579|fatigue|fatigue
1595467|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
1595468|NCT00412295|Wavefront errors|wavefront errors
1595469|NCT00412269|Insulin Sensitivity|insulin sensitivity
1595470|NCT00412269|Total abdominal fat|total abdominal fat
1595471|NCT00412269|Visceral abdominal fat|visceral abdominal fat
1595472|NCT00412269|Reproductive Hormones|reproductive hormones
1595473|NCT00412269|Menopause|menopause
1595474|NCT00412269|Diabetes|diabetes
1595475|NCT00412269|Fat Distribution|fat distribution
1595476|NCT00412269|Sex Hormones|sex hormones
1595477|NCT00412256|Treatment|treatment
1595478|NCT00412256|Disease activity|disease activity
1595479|NCT00412256|Clinical trial|clinical trial
1595480|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
1595481|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1595482|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1595483|NCT00412243|Clofarabine|clofarabine
1595484|NCT00412243|Clofarex|clofarex
1595486|NCT00412243|Cyclophosphamide|cyclophosphamide
1595487|NCT00412243|Neosar|neosar
1595488|NCT00412243|Cytoxan|cytoxan
1595489|NCT00412230|Pre-eclampsia|pre-eclampsia
1595490|NCT00412230|Gestational diabetes|gestational diabetes
1595491|NCT00412230|Insulin resistance|insulin resistance
1595492|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
1595493|NCT00412204|double-blind|double-blind
1595494|NCT00412204|placebo-controlled|placebo-controlled
1595495|NCT00412204|crossover|crossover
1595496|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
1595497|NCT00412204|gas exchange|gas exchange
1595498|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1595499|NCT00412204|exercise.|exercise.
1595500|NCT00412191|healthy volunteers|healthy volunteers
1595501|NCT00412191|bioequivalence|bioequivalence
1595502|NCT00412191|food effects|food effects
1595503|NCT00412178|Internet|internet
1595504|NCT00412178|mobile communication|mobile communication
1595505|NCT00412178|glucose monitoring|glucose monitoring
1595506|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
1595507|NCT00412165|Adolescents|adolescents
1595508|NCT00412165|Obesity|obesity
1595509|NCT00412165|Overweight|overweight
1595510|NCT00412165|Internet Technology|internet technology
1595511|NCT00412165|Cell Phone|cell phone
1595512|NCT00412152|A randomised|a randomised
1595513|NCT00412152|double blind|double blind
1595514|NCT00412152|parallel group|parallel group
1595515|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
1595516|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
1595517|NCT00412139|vascular calcifications|vascular calcifications
1595518|NCT00412139|uremic toxins|uremic toxins
1595519|NCT00412139|renal osteodystrophy|renal osteodystrophy
1595520|NCT00412139|Dialysis|dialysis
1595521|NCT00412126|Diabetes Mellitus|diabetes mellitus
1595522|NCT00412126|Coronary Restenosis|coronary restenosis
1595523|NCT00412126|Insulin|insulin
1595524|NCT00412126|Angioplasty|angioplasty
1595525|NCT00412100|A randomised|a randomised
1595526|NCT00412100|double-blind|double-blind
1595527|NCT00412100|double-dummy|double-dummy
1595528|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
1595529|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
1595530|NCT00412087|vitamin D|vitamin d
1595531|NCT00412087|cholecalciferol|cholecalciferol
1595532|NCT00412087|pregnant women|pregnant women
1595533|NCT00412074|Breastfeeding|breastfeeding
1595534|NCT00412074|Vitamin D|vitamin d
1595535|NCT00412074|Vitamin D deficiency|vitamin d deficiency
1595536|NCT00412061|Cancer|cancer
1595537|NCT00412061|Carcinoid|carcinoid
1595538|NCT00412061|Tumor|tumor
1595539|NCT00412061|Neuroendocrine|neuroendocrine
1595540|NCT00412061|Carcinoma|carcinoma
1595541|NCT00412061|Everolimus|everolimus
1595542|NCT00412061|Octreotide|octreotide
1595543|NCT00412022|early breast cancer|early breast cancer
1595544|NCT00412022|adjuvant therapy|adjuvant therapy
1595545|NCT00412022|premenopause|premenopause
1595546|NCT00412022|premenopausal|premenopausal
1595547|NCT00412022|menopausal status|menopausal status
1595548|NCT00412022|postmenopause|postmenopause
1595549|NCT00412022|bone mineral density|bone mineral density
1595550|NCT00412022|hormone sensitive|hormone sensitive
1595551|NCT00412022|aromatase inhibitors|aromatase inhibitors
1595552|NCT00412022|letrozole|letrozole
1595553|NCT00412022|disease-free survival|disease-free survival
1595554|NCT00412009|tuberculosis|tuberculosis
1595555|NCT00412009|control|control
1595556|NCT00412009|treatment|treatment
1595557|NCT00412009|adherence|adherence
1595558|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
1595559|NCT00411996|HIV/TB|hiv/tb
1595560|NCT00411996|rifampicin|rifampicin
1595561|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
1595562|NCT00411996|Treatment Naive|treatment naive
1595563|NCT00411983|chronic HIV infection|chronic hiv infection
1595564|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
1595565|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
1595566|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
1595567|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
1595568|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
1595569|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
1595570|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
1595571|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
1595572|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
1595573|NCT00411944|P-glycoprotein|p-glycoprotein
1595574|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
1595575|NCT00411944|renal transplantation|renal transplantation
1595576|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
1595577|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
1595578|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
1595579|NCT00411905|Bortezomib|bortezomib
1595580|NCT00411905|Low dose Cytarabine|low dose cytarabine
1595581|NCT00411905|Bone Marrow diseases|bone marrow diseases
1595582|NCT00411879|Heart Arrest|heart arrest
1595583|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1595584|NCT00411879|Epinephrine|epinephrine
1595585|NCT00411879|Vasopressin|vasopressin
1595586|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
1595587|NCT00411866|safety|safety
1595588|NCT00411866|pharmacokinetics,|pharmacokinetics,
1595589|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
1595590|NCT00411840|stem cell therapy|stem cell therapy
1595591|NCT00411840|peripheral arterial disease|peripheral arterial disease
1595592|NCT00411840|limb ischemia|limb ischemia
1595593|NCT00411827|Cytology|cytology
1595594|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
1595595|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
1595596|NCT00411814|melbourne,|melbourne,
1595597|NCT00411814|healthy|healthy
1595598|NCT00411814|antibody,|antibody,
1595599|NCT00411814|male,|male,
1595600|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
1596124|NCT00410059|Erlotinib|erlotinib
1595601|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
1595602|NCT00411814|australia|australia
1595603|NCT00411814|monoclonal|monoclonal
1595604|NCT00411814|female,|female,
1595605|NCT00411814|volunteers,|volunteers,
1595606|NCT00411801|bleeding disorder|bleeding disorder
1595607|NCT00411801|universal plasma|universal plasma
1595608|NCT00411801|plasma|plasma
1595609|NCT00411801|plasma exchange|plasma exchange
1595610|NCT00411788|HER-2 positive|her-2 positive
1595611|NCT00411788|breast cancer|breast cancer
1595612|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
1595613|NCT00411762|Pancreatic|pancreatic
1595614|NCT00411736|Cystic Fibrosis|cystic fibrosis
1595615|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
1595616|NCT00411736|Azithromycin|azithromycin
1595617|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
1595618|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
1595619|NCT00411671|Lung Cancer|lung cancer
1595620|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
1595621|NCT00411671|NSCLC|nsclc
1595622|NCT00411671|Sorafenib|sorafenib
1595623|NCT00411671|BAY 43-9006|bay 43-9006
1595624|NCT00411671|Battle Program|battle program
1595625|NCT00411645|prevention|prevention
1595626|NCT00411645|prophylaxis|prophylaxis
1595627|NCT00411645|Cytomegalovirus|cytomegalovirus
1595628|NCT00411645|CMV|cmv
1595629|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
1595630|NCT00411645|SCT|sct
1595631|NCT00411632|Lung Cancer|lung cancer
1595632|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
1595633|NCT00411632|NSCLC|nsclc
1595634|NCT00411632|Erlotinib|erlotinib
1595635|NCT00411632|Tarceva|tarceva
1595636|NCT00411632|Bexarotene|bexarotene
1595637|NCT00411632|Targretin|targretin
1595638|NCT00411632|OSI-774|osi-774
1595639|NCT00411632|Battle Program|battle program
1595640|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
1595641|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
1595642|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
1595643|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
1595644|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
1595645|NCT00411606|Healthy|healthy
1595646|NCT00411606|Allergy|allergy
1595647|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
1595648|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
1595649|NCT00411593|Lung Cancer|lung cancer
1595650|NCT00411593|NSCLC|nsclc
1595651|NCT00411593|Bortezomib|bortezomib
1595652|NCT00411593|Bevacizumab|bevacizumab
1595653|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
1595654|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
1595834|NCT00410865|Gene Therapy|gene therapy
1595655|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
1595656|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
1595657|NCT00411528|Prostate Cancer|prostate cancer
1595658|NCT00411528|Hormone Refractory|hormone refractory
1595659|NCT00411528|patupilone|patupilone
1595660|NCT00411528|docetaxel|docetaxel
1595661|NCT00411463|Interpersonal Therapy|interpersonal therapy
1595662|NCT00411463|Social Rhythm Therapy|social rhythm therapy
1595663|NCT00411463|Bipolar Disorder|bipolar disorder
1595664|NCT00411463|Depression|depression
1595665|NCT00411463|Seroquel|seroquel
1595666|NCT00411450|k-ras|k-ras
1595667|NCT00411450|biomarker|biomarker
1595668|NCT00411450|colorectal|colorectal
1595669|NCT00411450|colon|colon
1595670|NCT00411450|rectal|rectal
1595671|NCT00411450|FOLFOX|folfox
1595672|NCT00411450|FOLFIRI|folfiri
1595673|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
1595674|NCT00411424|Randomized Control Trial|randomized control trial
1595675|NCT00411424|Treatment outcomes|treatment outcomes
1595676|NCT00411424|Monoclonal antibody|monoclonal antibody
1595677|NCT00411411|GLP-1|glp-1
1595678|NCT00411411|GIP|gip
1595679|NCT00411411|Incretin hormones|incretin hormones
1595680|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
1595681|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
1595682|NCT00411411|Meal test|meal test
1595683|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
1595684|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
1595685|NCT00411385|Hepatitis C|hepatitis c
1595686|NCT00411385|CHC|chc
1595687|NCT00411385|HepC|hepc
1595688|NCT00411385|Genotype 1|genotype 1
1595689|NCT00411385|Hepatitis|hepatitis
1595690|NCT00411385|HCV|hcv
1595691|NCT00411372|Questionnaire|questionnaire
1595692|NCT00411372|COPD|copd
1595693|NCT00411372|Shortness of Breath|shortness of breath
1595694|NCT00411359|Refractory angina|refractory angina
1595695|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
1595696|NCT00411359|Symptomology|symptomology
1595697|NCT00411359|Physical ability|physical ability
1595698|NCT00411359|Exercise|exercise
1595700|NCT00411359|Quality of life|quality of life
1595701|NCT00411359|Risk factors|risk factors
1595702|NCT00411346|Asthma|asthma
1595703|NCT00411346|Self-Monitoring|self-monitoring
1595704|NCT00411346|Cost-effectiveness|cost-effectiveness
1595705|NCT00411333|diabetic retinopathy|diabetic retinopathy
1595706|NCT00411333|fluorescein angiography|fluorescein angiography
1595707|NCT00411333|steroid|steroid
1595708|NCT00411333|anti-angiogenesis|anti-angiogenesis
1595709|NCT00411320|Asthma|asthma
1595710|NCT00411320|Smoking|smoking
1595711|NCT00411320|Steroid Resistance|steroid resistance
1595712|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
1595713|NCT00411307|Analgesia|analgesia
1595714|NCT00411307|Postoperative pain|postoperative pain
1595715|NCT00411294|ergocalciferol|ergocalciferol
1595716|NCT00411294|chronic kidney disease|chronic kidney disease
1595717|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
1595718|NCT00411294|vitamin D deficiency|vitamin d deficiency
1595719|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
1595720|NCT00411268|Chronic low back pain|chronic low back pain
1595721|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
1595722|NCT00411268|Quality of Life|quality of life
1595723|NCT00411255|Blink Reflex|blink reflex
1595724|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1595725|NCT00411255|Dystonia|dystonia
1595726|NCT00411255|Blepharospasm|blepharospasm
1595727|NCT00411255|BSP|bsp
1595728|NCT00411255|Focal Dystonia|focal dystonia
1595729|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
1595730|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
1595731|NCT00411216|vestibular hypofunction|vestibular hypofunction
1595732|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
1595733|NCT00411190|Osteoarthritis|osteoarthritis
1595734|NCT00411190|Postmenopausal|postmenopausal
1595735|NCT00411190|Osteoporosis|osteoporosis
1595736|NCT00411177|end-stage renal disease|end-stage renal disease
1595737|NCT00411177|hemodialysis|hemodialysis
1595738|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
1595739|NCT00411177|high flux dialyser|high flux dialyser
1595740|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
1595741|NCT00411177|arterial stiffness|arterial stiffness
1595742|NCT00411177|inflammation|inflammation
1595743|NCT00411177|life quality|life quality
1595744|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
1595745|NCT00411164|knee pain|knee pain
1595746|NCT00411164|hip pain|hip pain
1595747|NCT00411164|opioid|opioid
1595748|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
1595749|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
1595750|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1595751|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
1595752|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
1595753|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
1595754|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
1595755|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
1595756|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
1595757|NCT00411125|Postmenopausal|postmenopausal
1595758|NCT00411125|osteoporosis|osteoporosis
1595759|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
1595760|NCT00411125|Calcitonin|calcitonin
1595761|NCT00411112|Sentinel node|sentinel node
1595762|NCT00411112|Isosulphan blue|isosulphan blue
1595763|NCT00411112|Isotopic detection|isotopic detection
1595764|NCT00411112|Survival|survival
1595765|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
1595766|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1595767|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1595768|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1595769|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1595770|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1595771|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1595772|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1595773|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1595774|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1595775|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1595776|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1595777|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1595778|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1595779|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1595780|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1596121|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
1595781|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
1595782|NCT00411086|GM-CSF|gm-csf
1595783|NCT00411086|Rituximab|rituximab
1595784|NCT00411086|Rituxan|rituxan
1595785|NCT00411073|darapladib|darapladib
1595786|NCT00411073|moxifloxacin|moxifloxacin
1595787|NCT00411073|QT study|qt study
1595788|NCT00411060|Rotator Cuff Tear|rotator cuff tear
1595789|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1595790|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1595791|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
1595792|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1595793|NCT00411047|large cell lung cancer|large cell lung cancer
1595794|NCT00411034|Opioids|opioids
1595795|NCT00411034|Chronic Cancer Pain|chronic cancer pain
1595796|NCT00411034|analgesic|analgesic
1595797|NCT00410995|Physically fit volunteers|physically fit volunteers
1595798|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
1595799|NCT00410982|Hodgkin's Disease|hodgkin's disease
1595800|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1595801|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1595802|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1595803|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
1595804|NCT00410982|Myeloma|myeloma
1595805|NCT00410982|Leukemia|leukemia
1595806|NCT00410982|Lymphoma|lymphoma
1595807|NCT00410982|Busulfan|busulfan
1595808|NCT00410982|Busulfex|busulfex
1595809|NCT00410982|Myleran|myleran
1595810|NCT00410982|Gemcitabine|gemcitabine
1595811|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1595812|NCT00410982|Gemzar|gemzar
1595813|NCT00410982|Melphalan|melphalan
1595814|NCT00410982|Alkeran|alkeran
1595815|NCT00410969|resuscitation|resuscitation
1595816|NCT00410969|hypothermia|hypothermia
1595817|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1595818|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1595819|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
1595820|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1595821|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1595822|NCT00410943|Cancer pain|cancer pain
1595823|NCT00410943|Oral analgesic|oral analgesic
1595824|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
1595825|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
1595826|NCT00410878|Opioids|opioids
1595827|NCT00410878|Chronic cancer pain|chronic cancer pain
1595828|NCT00410878|Analgesic|analgesic
1595829|NCT00410865|Oral Premalignancies|oral premalignancies
1595830|NCT00410865|Mouth Cancer|mouth cancer
1595831|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
1595832|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
1595833|NCT00410865|Advexin|advexin
1595836|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
1595837|NCT00410852|Insulin|insulin
1595838|NCT00410852|Hyperglycemia|hyperglycemia
1595839|NCT00410852|Hypoglycemia|hypoglycemia
1595840|NCT00410852|Intensive care|intensive care
1595841|NCT00410852|Critical care|critical care
1595842|NCT00410813|stage IV breast cancer|stage iv breast cancer
1595843|NCT00410813|male breast cancer|male breast cancer
1595844|NCT00410813|recurrent breast cancer|recurrent breast cancer
1595845|NCT00410813|bone metastases|bone metastases
1595846|NCT00410800|Insulin Resistance|insulin resistance
1595847|NCT00410800|Body Composition|body composition
1595848|NCT00410800|Kinetic Modeling|kinetic modeling
1595849|NCT00410787|Chronic cancer pain|chronic cancer pain
1595850|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
1595851|NCT00410787|long-term repeated dosing|long-term repeated dosing
1595852|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
1595853|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
1595854|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1595855|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
1595856|NCT00410761|ZD6474|zd6474
1595858|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
1595859|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
1595860|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
1595861|NCT00410748|Chronic cancer pain|chronic cancer pain
1595862|NCT00410748|chronic pain|chronic pain
1595863|NCT00410735|ONO-1078|ono-1078
1595864|NCT00410735|chronic sinusitis|chronic sinusitis
1595865|NCT00410722|Nutrition|nutrition
1595866|NCT00410722|Type 2 Diabetes|type 2 diabetes
1595867|NCT00410709|Pediculosis Capitis|pediculosis capitis
1595868|NCT00410709|Head Lice|head lice
1595869|NCT00410709|Crawlers|crawlers
1595870|NCT00410709|Ova|ova
1595871|NCT00410709|Nits|nits
1595872|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
1595873|NCT00410696|Growth factor|growth factor
1595874|NCT00410696|Pegfilgrastim|pegfilgrastim
1595875|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1596122|NCT00410059|Lung Cancer|lung cancer
1595876|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1595877|NCT00410670|Gene|gene
1595878|NCT00410670|Genetics|genetics
1595879|NCT00410670|Family History|family history
1595880|NCT00410670|Radiation Therapy|radiation therapy
1595881|NCT00410670|Children|children
1595882|NCT00410657|graft versus host disease|graft versus host disease
1595883|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1595884|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1595885|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1595886|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1595887|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1595888|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1595889|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1595890|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1595891|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1595892|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1595893|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1595894|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1595895|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1595896|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1595897|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1595898|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1595899|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1595900|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
1595901|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1595902|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1595903|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1595904|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1595905|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1595906|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1595907|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1595908|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1595909|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1595910|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1595911|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1595912|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1595913|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1595914|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1595915|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1595916|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1595917|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1595918|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1595919|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1595920|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1595921|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1595922|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1595923|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1595924|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1595925|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1595926|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1595927|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1595928|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1595929|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1595930|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1595931|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1595932|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1595933|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1595934|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1595935|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1595936|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1595937|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1595938|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1596123|NCT00410059|NSCLC|nsclc
1595939|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1596131|NCT00410020|diet|diet
1595940|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1595941|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1595942|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1595943|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
1595944|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
1595945|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
1595946|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1595947|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1595948|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1595949|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
1595950|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1595951|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1595952|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1595953|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1595954|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1595955|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
1595956|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
1595957|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
1595958|NCT00410657|stage IV breast cancer|stage iv breast cancer
1595959|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1595960|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1595961|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1595962|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
1595964|NCT00410644|analgesics|analgesics
1595965|NCT00410644|opioid|opioid
1595966|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
1595967|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1595968|NCT00410631|regional neuroblastoma|regional neuroblastoma
1595969|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
1595970|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
1595971|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
1595972|NCT00410618|cognitive/functional effects|cognitive/functional effects
1595973|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1595974|NCT00410618|recurrent colon cancer|recurrent colon cancer
1595975|NCT00410618|stage I colon cancer|stage i colon cancer
1595976|NCT00410618|stage II colon cancer|stage ii colon cancer
1595977|NCT00410618|stage III colon cancer|stage iii colon cancer
1595978|NCT00410618|stage IV colon cancer|stage iv colon cancer
1595979|NCT00410592|GERD|gerd
1595980|NCT00410592|acid reflux|acid reflux
1595981|NCT00410592|heartburn|heartburn
1595982|NCT00410592|PPI|ppi
1595983|NCT00410592|Hispanic|hispanic
1595984|NCT00410579|pain|pain
1595986|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1595987|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1595988|NCT00410579|stage II rectal cancer|stage ii rectal cancer
1595989|NCT00410579|stage III rectal cancer|stage iii rectal cancer
1595990|NCT00410579|stage II colon cancer|stage ii colon cancer
1595991|NCT00410579|stage III colon cancer|stage iii colon cancer
1595992|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
1595993|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
1595994|NCT00410566|Niemann-Pick disease|niemann-pick disease
1595995|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
1595996|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
1595997|NCT00410566|Treatment|treatment
1595998|NCT00410540|Cancer pain|cancer pain
1595999|NCT00410540|Oral analgesic|oral analgesic
1596000|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
1596001|NCT00410540|Morphine sulfate|morphine sulfate
1596002|NCT00410527|Antibacterials|antibacterials
1596003|NCT00410527|Colonization|colonization
1596004|NCT00410527|Infection|infection
1596005|NCT00410527|Pneumonia|pneumonia
1596006|NCT00410527|Resistance|resistance
1596007|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
1596008|NCT00410514|YM178|ym178
1596009|NCT00410514|Men|men
1596010|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
1596011|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
1596012|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
1596013|NCT00410488|Sarcoma|sarcoma
1596014|NCT00410488|Palonosetron|palonosetron
1596015|NCT00410488|Aloxi|aloxi
1596016|NCT00410488|Nausea|nausea
1596017|NCT00410488|Vomiting|vomiting
1596018|NCT00410475|Ionizing Radiation|ionizing radiation
1596019|NCT00410475|Cohort Study|cohort study
1596020|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
1596021|NCT00410475|Radiologic Technologists|radiologic technologists
1596022|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
1596023|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1596024|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1596025|NCT00410462|adult liposarcoma|adult liposarcoma
1596026|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
1596027|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1596028|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
1596029|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1596030|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1596031|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
1596032|NCT00410462|adult angiosarcoma|adult angiosarcoma
1596033|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
1596034|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
1596035|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
1596036|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
1596037|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
1596038|NCT00410462|ovarian sarcoma|ovarian sarcoma
1596039|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1596040|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
1596041|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
1596042|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
1596043|NCT00410449|Vitamin E|vitamin e
1596044|NCT00410449|oxidative markers|oxidative markers
1596045|NCT00410449|pentosidine|pentosidine
1596046|NCT00410449|hydroxynonenal|hydroxynonenal
1596047|NCT00410449|levuglandin|levuglandin
1596048|NCT00410436|Type 1 Diabetes|type 1 diabetes
1596049|NCT00410436|Resistance Exercise|resistance exercise
1596050|NCT00410436|Aerobic Exercise|aerobic exercise
1596051|NCT00410423|Leukemia|leukemia
1596052|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
1596053|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
1596054|NCT00410397|Low back pain|low back pain
1596055|NCT00410397|Hip pain|hip pain
1596056|NCT00410384|Antibodies|antibodies
1596057|NCT00410384|Autoimmune Diseases|autoimmune diseases
1596058|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
1596060|NCT00410384|Belimumab|belimumab
1596061|NCT00410384|Lupus|lupus
1596062|NCT00410371|tolerability|tolerability
1596063|NCT00410371|safety|safety
1596064|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
1596065|NCT00410358|Gimatecan|gimatecan
1596066|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
1596067|NCT00410358|advanced solid tumors|advanced solid tumors
1596068|NCT00410332|tonsillectomy|tonsillectomy
1596069|NCT00410332|pain|pain
1596070|NCT00410332|homeopathy|homeopathy
1596071|NCT00410332|Traumeel|traumeel
1596072|NCT00410306|Hypogonadism|hypogonadism
1596073|NCT00410306|Nebido|nebido
1596074|NCT00410306|Testosterone|testosterone
1596075|NCT00410306|Observational Study|observational study
1596076|NCT00410293|Heart failure|heart failure
1596077|NCT00410293|Diagnostic|diagnostic
1596078|NCT00410293|Natriuretic peptide|natriuretic peptide
1596079|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
1596080|NCT00410293|Length of stay|length of stay
1596081|NCT00410293|Costs|costs
1596082|NCT00410267|glaucoma|glaucoma
1596083|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
1596084|NCT00410241|Genome|genome
1596085|NCT00410241|Cardiovascular Disease|cardiovascular disease
1596086|NCT00410241|Volunteers|volunteers
1596087|NCT00410241|Genes|genes
1596088|NCT00410241|Atherosclerosis|atherosclerosis
1596089|NCT00410241|Coronary Artery Calcification|coronary artery calcification
1596090|NCT00410241|Cardiovascular|cardiovascular
1596091|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
1596092|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
1596093|NCT00410189|NSCLC|nsclc
1596094|NCT00410189|Lung Cancer|lung cancer
1596095|NCT00410189|ZD6474|zd6474
1596096|NCT00410189|Zactima|zactima
1596097|NCT00410189|Vandetanib|vandetanib
1596098|NCT00410189|BATTLE Program|battle program
1596099|NCT00410163|B-cell|b-cell
1596100|NCT00410163|cyclophosphamide|cyclophosphamide
1596101|NCT00410163|fludarabine|fludarabine
1596102|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1596103|NCT00410163|Ofatumumab|ofatumumab
1596104|NCT00410150|Status asthmaticus|status asthmaticus
1596105|NCT00410150|Asthma|asthma
1596106|NCT00410150|Helium|helium
1596107|NCT00410150|Children|children
1596108|NCT00410124|advanced kidney cancer|advanced kidney cancer
1596109|NCT00410124|everolimus|everolimus
1596110|NCT00410124|kidney cancer|kidney cancer
1596111|NCT00410124|oral therapy|oral therapy
1596112|NCT00410111|sepsis|sepsis
1596113|NCT00410111|encephalopathy|encephalopathy
1596114|NCT00410111|cerebral perfusion|cerebral perfusion
1596115|NCT00410111|electroencephalogram|electroencephalogram
1596116|NCT00410098|asthma|asthma
1596117|NCT00410098|yoga|yoga
1596118|NCT00410098|heat|heat
1596119|NCT00410098|humidity|humidity
1596120|NCT00410098|bikram|bikram
1596127|NCT00410059|Battle Program|battle program
1596128|NCT00410020|alpha linolenic acid|alpha linolenic acid
1596129|NCT00410020|atrial fibrillation|atrial fibrillation
1596130|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
1596132|NCT00410020|rapeseed oil|rapeseed oil
1596133|NCT00410020|canola oil|canola oil
1596134|NCT00410020|cardiovascular diseases|cardiovascular diseases
1596135|NCT00410007|ADPKD|adpkd
1596136|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
1596137|NCT00410007|ENaC|enac
1596138|NCT00410007|Fractional sodium excretion|fractional sodium excretion
1596139|NCT00410007|High/low sodium diet|high/low sodium diet
1596140|NCT00409994|Colorectal cancer|colorectal cancer
1596141|NCT00409994|M-tor inhibitor|m-tor inhibitor
1596142|NCT00409994|Rapamycin|rapamycin
1596143|NCT00409981|in stent restenosis|in stent restenosis
1596144|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1596145|NCT00409981|paccocath|paccocath
1596146|NCT00409981|drug eluting balloon|drug eluting balloon
1596147|NCT00409968|Lung Cancer|lung cancer
1596148|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
1596149|NCT00409968|BATTLE Program|battle program
1596150|NCT00409968|Umbrella Trial|umbrella trial
1596151|NCT00409968|Tumor Biopsy|tumor biopsy
1596152|NCT00409968|NSCLC|nsclc
1596153|NCT00409955|Lamellar transplant|lamellar transplant
1596154|NCT00409955|Lyophilization|lyophilization
1596155|NCT00409955|Corneas storage|corneas storage
1596156|NCT00409955|Keratoconus patients|keratoconus patients
1596157|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
1596158|NCT00409955|Signed the consent inform|signed the consent inform
1596159|NCT00409942|Chronic heart failure|chronic heart failure
1596160|NCT00409942|Torasemide prolonged release|torasemide prolonged release
1596161|NCT00409942|Myocardial fibrosis|myocardial fibrosis
1596162|NCT00409942|Loop diuretics|loop diuretics
1596163|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
1596164|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
1596165|NCT00409916|chronic heart failure|chronic heart failure
1596166|NCT00409916|heart failure|heart failure
1596167|NCT00409916|congestive heart failure|congestive heart failure
1596168|NCT00409916|impedance cardiography|impedance cardiography
1596169|NCT00409916|ICG|icg
1596170|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
1596171|NCT00409916|non-invasive|non-invasive
1596172|NCT00409916|TEB|teb
1596173|NCT00409890|Buscopan|buscopan
1596174|NCT00409890|Hyoscine|hyoscine
1596175|NCT00409890|Shortens|shortens
1596176|NCT00409890|Labor|labor
1596177|NCT00409890|Stage|stage
1596178|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
1596377|NCT00409084|varices|varices
1596179|NCT00409864|Endoscopic stenting|endoscopic stenting
1596180|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
1596181|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
1596182|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
1596183|NCT00409799|Bone graft substitute|bone graft substitute
1596184|NCT00409799|Promotion of bone healing|promotion of bone healing
1596186|NCT00409786|Diabetes|diabetes
1596187|NCT00409786|Internet|internet
1596188|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
1596189|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
1596190|NCT00409747|Immunology|immunology
1596191|NCT00409747|Microglia|microglia
1596192|NCT00409747|NF-Kappa-B|nf-kappa-b
1596193|NCT00409747|Antibiotic|antibiotic
1596194|NCT00409747|Autism|autism
1596195|NCT00409747|Minocycline|minocycline
1596196|NCT00409747|Regressive Autism|regressive autism
1596197|NCT00409734|pyloric|pyloric
1596198|NCT00409734|stenosis|stenosis
1596199|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1596200|NCT00409721|ALS|als
1596201|NCT00409721|Motor Neuron Disease|motor neuron disease
1596202|NCT00409721|MND|mnd
1596203|NCT00409721|Memantine|memantine
1596204|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
1596205|NCT00409708|ADHD|adhd
1596206|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
1596207|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
1596208|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
1596209|NCT00409695|aGVHD|agvhd
1596210|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
1596211|NCT00409695|Thymoglobulin|thymoglobulin
1596212|NCT00409695|ATG|atg
1596213|NCT00409682|Crohn's Disease|crohn's disease
1596214|NCT00409669|Barraquer tonometer|barraquer tonometer
1596215|NCT00409669|Intraocular pressure|intraocular pressure
1596216|NCT00409669|Tonometry|tonometry
1596217|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
1596218|NCT00409630|Asthma|asthma
1596219|NCT00409591|Thailand|thailand
1596220|NCT00409591|Developing Countries|developing countries
1596221|NCT00409591|Prophylaxis|prophylaxis
1596222|NCT00409591|Mother-to-child transmission|mother-to-child transmission
1596223|NCT00409591|HIV-1|hiv-1
1596224|NCT00409591|HIV-1 infection|hiv-1 infection
1596225|NCT00409591|HIV Seronegativity|hiv seronegativity
1596624|NCT00407992|Headache|headache
1596226|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
1596227|NCT00409578|Acute|acute
1596228|NCT00409578|coronary syndrome|coronary syndrome
1596229|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
1596230|NCT00409578|N-terminal|n-terminal
1596231|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
1596232|NCT00409578|myocardial infarctions|myocardial infarctions
1596233|NCT00409565|head and neck cancer|head and neck cancer
1596234|NCT00409565|cetuximab|cetuximab
1596235|NCT00409565|bevacizumab|bevacizumab
1596236|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
1596237|NCT00409565|SCCHN|scchn
1596238|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
1596239|NCT00409526|Iloprost|iloprost
1596240|NCT00409526|PPHN|pphn
1596241|NCT00409526|Newborn|newborn
1596242|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
1596243|NCT00409526|Term|term
1596244|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
1596245|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
1596246|NCT00409500|Healthy volunteers study|healthy volunteers study
1596247|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
1596248|NCT00409487|hypertension|hypertension
1596249|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
1596250|NCT00409448|TBI|tbi
1596251|NCT00409448|intracranial edema|intracranial edema
1596252|NCT00409448|brain edema|brain edema
1596253|NCT00409448|craniocerebral trauma|craniocerebral trauma
1596254|NCT00409448|head injury|head injury
1596255|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
1596256|NCT00409448|subdural hematoma|subdural hematoma
1596257|NCT00409448|brain concussion|brain concussion
1596258|NCT00409448|head injuries, closed|head injuries, closed
1596259|NCT00409448|epidural hematoma|epidural hematoma
1596260|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
1596261|NCT00409448|cortical contusion|cortical contusion
1596262|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
1596263|NCT00409422|pediatric obesity|pediatric obesity
1596264|NCT00409422|overweight|overweight
1596265|NCT00409422|insulin resistance|insulin resistance
1596266|NCT00409422|hyperinsulinemia|hyperinsulinemia
1596267|NCT00409422|weight management program|weight management program
1596268|NCT00409422|family-based|family-based
1596269|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
1596270|NCT00409409|Grass pollen tablet|grass pollen tablet
1596271|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1596272|NCT00409396|Ulcerative|ulcerative
1596273|NCT00409396|Colitis|colitis
1596274|NCT00409396|PGE-M|pge-m
1596275|NCT00409396|fecal calprotectin|fecal calprotectin
1596276|NCT00409396|disease biomarkers|disease biomarkers
1596277|NCT00409383|Advanced Melanoma|advanced melanoma
1596278|NCT00409383|Normal baseline LDH|normal baseline ldh
1596279|NCT00409383|Chemotherapy naive|chemotherapy naive
1596280|NCT00409357|urinary tract|urinary tract
1596281|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
1596282|NCT00409344|Dexmedetomidine|dexmedetomidine
1596283|NCT00409344|Mechanical ventilation|mechanical ventilation
1596284|NCT00409331|Head and Neck Cancer|head and neck cancer
1596285|NCT00409331|HNSCC|hnscc
1596286|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
1596287|NCT00409331|Amifostine|amifostine
1596288|NCT00409331|Ethyol|ethyol
1596289|NCT00409331|Radiation Therapy|radiation therapy
1596290|NCT00409318|Inflammation|inflammation
1596291|NCT00409318|Visceral adiposity|visceral adiposity
1596292|NCT00409318|TNF|tnf
1596293|NCT00409318|CRP|crp
1596294|NCT00409318|Adiponectin|adiponectin
1596295|NCT00409318|Insulin resistance|insulin resistance
1596296|NCT00409318|metabolic syndrome|metabolic syndrome
1596297|NCT00409292|RAD001|rad001
1596298|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
1596299|NCT00409279|Aging|aging
1596300|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
1596301|NCT00409279|Family caregivers|family caregivers
1596302|NCT00409279|Alzheimer's|alzheimer's
1596303|NCT00409279|Caregiving|caregiving
1596304|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
1596305|NCT00409240|Group Intervention|group intervention
1596306|NCT00409240|Pharmacotherapy|pharmacotherapy
1596307|NCT00409240|Behavioral Modification|behavioral modification
1596308|NCT00409240|Diabetes|diabetes
1596309|NCT00409227|swl|swl
1596310|NCT00409227|lithotripsy|lithotripsy
1596311|NCT00409227|stone disease|stone disease
1596312|NCT00409227|urolithiasis|urolithiasis
1596313|NCT00409227|nephrolithiasis|nephrolithiasis
1596314|NCT00409214|Glioma|glioma
1596315|NCT00409214|Litx™|litx™
1596316|NCT00409214|LS11|ls11
1596317|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
1596318|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
1596321|NCT00409201|schizophrenia|schizophrenia
1596322|NCT00409201|reboxetine|reboxetine
1596323|NCT00409201|cognitive|cognitive
1596324|NCT00409201|behavior|behavior
1596625|NCT00407992|Migraine|migraine
1596325|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
1596326|NCT00409188|stage III;|stage iii;
1596327|NCT00409188|unresectable;|unresectable;
1596328|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
1596329|NCT00409188|Cyclophosphamide;|cyclophosphamide;
1596330|NCT00409188|placebo controlled;|placebo controlled;
1596331|NCT00409188|randomized;|randomized;
1596332|NCT00409188|double blind;|double blind;
1596333|NCT00409188|immunotherapy;|immunotherapy;
1596334|NCT00409175|FAP|fap
1596335|NCT00409175|Fx-1006A|fx-1006a
1596336|NCT00409175|transthyretin|transthyretin
1596337|NCT00409175|TTR|ttr
1596338|NCT00409175|amyloid|amyloid
1596339|NCT00409175|polyneuropathy|polyneuropathy
1596340|NCT00409175|V30M|v30m
1596341|NCT00409175|familial|familial
1596342|NCT00409175|hereditary|hereditary
1596343|NCT00409175|amyloidosis|amyloidosis
1596344|NCT00409175|FoldRx|foldrx
1596345|NCT00409162|Tattoo removal|tattoo removal
1596346|NCT00409149|Hypertension|hypertension
1596347|NCT00409149|Diet|diet
1596348|NCT00409149|physical exercise|physical exercise
1596349|NCT00409149|naturopathic|naturopathic
1596350|NCT00409149|group therapy|group therapy
1596351|NCT00409149|Qi Gong|qi gong
1596352|NCT00409136|Alert|alert
1596353|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
1596354|NCT00409136|Pulmonary Embolism|pulmonary embolism
1596355|NCT00409136|Venous Thromboembolism|venous thromboembolism
1596356|NCT00409136|Prophylaxis|prophylaxis
1596357|NCT00409136|Anticoagulation|anticoagulation
1596358|NCT00409123|vasospastic women|vasospastic women
1596359|NCT00409123|controls|controls
1596360|NCT00409123|core cooling|core cooling
1596361|NCT00409123|core warming|core warming
1596362|NCT00409123|external cooling|external cooling
1596363|NCT00409123|external warming|external warming
1596364|NCT00409123|LDF|ldf
1596365|NCT00409123|choroidal blood flow|choroidal blood flow
1596366|NCT00409123|temperature|temperature
1596367|NCT00409123|vasospastic subjects|vasospastic subjects
1596368|NCT00409123|normal subjects|normal subjects
1596369|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
1596370|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
1596371|NCT00409110|Pulsatility Index|pulsatility index
1596372|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
1596373|NCT00409110|Finometer|finometer
1596374|NCT00409097|ADMA|adma
1596375|NCT00409097|MOF|mof
1596376|NCT00409097|Critical illness|critical illness
1596378|NCT00409084|band ligation|band ligation
1596379|NCT00409084|portal hypertension|portal hypertension
1596380|NCT00409084|primary prophylaxis|primary prophylaxis
1596381|NCT00409084|cirrhosis|cirrhosis
1596382|NCT00409084|beta blockers|beta blockers
1596383|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
1596384|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
1596385|NCT00409071|Nausea|nausea
1596386|NCT00409071|Vomiting|vomiting
1596387|NCT00409071|Quality of life|quality of life
1596388|NCT00409071|Homeopathy|homeopathy
1596389|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1596390|NCT00409058|Intracranial Edema|intracranial edema
1596391|NCT00409058|Brain Edema|brain edema
1596392|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
1596393|NCT00409058|Head Injury|head injury
1596394|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
1596395|NCT00409058|Subdural Hematoma|subdural hematoma
1596396|NCT00409058|Brain Concussion|brain concussion
1596397|NCT00409058|Head Injuries, Closed|head injuries, closed
1596398|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
1596399|NCT00409045|Pulmonary Embolism|pulmonary embolism
1596400|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
1596401|NCT00409032|osteoporosis|osteoporosis
1596402|NCT00409032|BMD|bmd
1596403|NCT00409032|CTX|ctx
1596404|NCT00409032|Post menopausal|post menopausal
1596405|NCT00409032|strontium|strontium
1596406|NCT00409032|bone turnover|bone turnover
1596407|NCT00409032|clinical development|clinical development
1596408|NCT00408980|diet|diet
1596409|NCT00408980|breast milk fat|breast milk fat
1596410|NCT00408967|Ovarian|ovarian
1596411|NCT00408967|Cancer|cancer
1596412|NCT00408967|Epithelial|epithelial
1596413|NCT00408967|Recurrent|recurrent
1596414|NCT00408967|Platinum|platinum
1596415|NCT00408967|Second-line therapy|second-line therapy
1596416|NCT00408967|Maintenance Therapy|maintenance therapy
1596417|NCT00408967|Biologic|biologic
1596418|NCT00408967|Targeted Therapy|targeted therapy
1596419|NCT00408967|Antibody|antibody
1596420|NCT00408941|EEG|eeg
1596421|NCT00408941|AEP|aep
1596422|NCT00408941|Artefacts|artefacts
1596423|NCT00408941|Propofol|propofol
1596424|NCT00408941|Local Anaesthesia|local anaesthesia
1596425|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
1596426|NCT00408928|bortezomib|bortezomib
1596427|NCT00408915|Lisuride|lisuride
1596428|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
1596429|NCT00408915|Motor Fluctuations|motor fluctuations
1596430|NCT00408915|Off-Times|off-times
1596431|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
1596432|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
1596433|NCT00408889|liver transplantation|liver transplantation
1596434|NCT00408889|organ failure|organ failure
1596435|NCT00408889|outcome|outcome
1596436|NCT00408863|Breast cancer|breast cancer
1596437|NCT00408863|Tibolone|tibolone
1596438|NCT00408863|Climacteric symptoms|climacteric symptoms
1596439|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
1596440|NCT00408824|insulin resistance|insulin resistance
1596441|NCT00408824|adipocytokine|adipocytokine
1596442|NCT00408824|Metabolic syndrome|metabolic syndrome
1596443|NCT00408824|Diabetes|diabetes
1596444|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
1596445|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
1596446|NCT00408785|safety|safety
1596447|NCT00408785|efficacy|efficacy
1596448|NCT00408785|glabellar lines|glabellar lines
1596449|NCT00408772|liver metastases|liver metastases
1596450|NCT00408772|stage IV colon cancer|stage iv colon cancer
1596451|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
1596452|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
1596453|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1596454|NCT00408772|recurrent colon cancer|recurrent colon cancer
1596455|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
1596456|NCT00408759|xerostomia|xerostomia
1596457|NCT00408759|hypnosis|hypnosis
1596458|NCT00408759|dry mouth|dry mouth
1596459|NCT00408759|radiotherapy|radiotherapy
1596460|NCT00408759|head and neck cancer|head and neck cancer
1596461|NCT00408746|stomatognathic system|stomatognathic system
1596462|NCT00408746|maxilla|maxilla
1596463|NCT00408746|palate|palate
1596464|NCT00408746|development|development
1596465|NCT00408720|Spectral OCT|spectral oct
1596466|NCT00408720|SLO|slo
1596467|NCT00408720|Retinal Imagining|retinal imagining
1596468|NCT00408707|local infiltration analgesia|local infiltration analgesia
1596469|NCT00408707|postoperative pain|postoperative pain
1596470|NCT00408707|ropivacaine|ropivacaine
1596471|NCT00408668|Malaria Vaccine|malaria vaccine
1596472|NCT00408642|adherence|adherence
1596473|NCT00408642|treatment|treatment
1596474|NCT00408642|antiretroviral|antiretroviral
1596475|NCT00408642|HAART|haart
1596476|NCT00408642|HIV|hiv
1596477|NCT00408642|Treatment Naive|treatment naive
1596478|NCT00408629|Ulcerative Colitis|ulcerative colitis
1596479|NCT00408629|Adalimumab|adalimumab
1596480|NCT00408629|TNF Antagonist|tnf antagonist
1596481|NCT00408629|Mayo Score|mayo score
1596482|NCT00408603|second line treatment|second line treatment
1596483|NCT00408603|platinum resistant|platinum resistant
1596484|NCT00408603|ovary|ovary
1596485|NCT00408603|ovaries|ovaries
1596486|NCT00408603|cancer|cancer
1596487|NCT00408603|epithelial|epithelial
1596488|NCT00408603|carcinomas|carcinomas
1596489|NCT00408603|tumor|tumor
1596490|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1596491|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1596492|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1596493|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1596494|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1596495|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1596496|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1596497|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1596498|NCT00408590|Brenner tumor|brenner tumor
1596499|NCT00408577|glucose intolerance|glucose intolerance
1596500|NCT00408577|cardiovascular disease|cardiovascular disease
1596501|NCT00408577|insulin resistance|insulin resistance
1596502|NCT00408577|endothelial dysfunction|endothelial dysfunction
1596503|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1596504|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
1596505|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
1596506|NCT00408551|stage IV colon cancer|stage iv colon cancer
1596507|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
1596508|NCT00408551|liver metastases|liver metastases
1596509|NCT00408551|recurrent colon cancer|recurrent colon cancer
1596510|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
1596511|NCT00408538|Microbicide|microbicide
1596512|NCT00408538|HIV|hiv
1596513|NCT00408538|Prevention|prevention
1596514|NCT00408538|Rectal|rectal
1596515|NCT00408538|HIV Prevention|hiv prevention
1596516|NCT00408525|memory loss|memory loss
1596517|NCT00408525|memory problems|memory problems
1596518|NCT00408525|alzheimer's|alzheimer's
1596519|NCT00408525|forgetfulness|forgetfulness
1596520|NCT00408525|forgetting|forgetting
1596521|NCT00408512|treatment|treatment
1596819|NCT00406939|Immunology|immunology
1596522|NCT00408512|adverse events|adverse events
1596523|NCT00408512|adherence|adherence
1596524|NCT00408512|gene|gene
1596626|NCT00407940|Thrombosis|thrombosis
1596525|NCT00408512|polymorphism|polymorphism
1596526|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1596527|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1596528|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1596529|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1596530|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1596531|NCT00408447|stem cell transplant|stem cell transplant
1596532|NCT00408447|sickle cell disease|sickle cell disease
1596533|NCT00408447|thalassemia|thalassemia
1596534|NCT00408447|moderately ablative|moderately ablative
1596535|NCT00408447|cord blood transplant|cord blood transplant
1596536|NCT00408447|matched family donor|matched family donor
1596537|NCT00408434|PPARgamma agonist|ppargamma agonist
1596538|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
1596539|NCT00408434|Tumor|tumor
1596540|NCT00408434|Cancer|cancer
1596541|NCT00408408|stage I breast cancer|stage i breast cancer
1596542|NCT00408408|stage II breast cancer|stage ii breast cancer
1596543|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
1596544|NCT00408395|influenza|influenza
1596545|NCT00408395|children|children
1596546|NCT00408395|vaccine|vaccine
1596547|NCT00408395|influenza disease|influenza disease
1596548|NCT00408382|Lipitor|lipitor
1596549|NCT00408382|atorvastatin|atorvastatin
1596550|NCT00408382|Hypercholesteremia|hypercholesteremia
1596551|NCT00408382|yellow coronary plaque|yellow coronary plaque
1596552|NCT00408369|prophylactic|prophylactic
1596553|NCT00408369|malaria|malaria
1596554|NCT00408369|challenge|challenge
1596555|NCT00408356|Zinc treatment|zinc treatment
1596556|NCT00408356|supplementation|supplementation
1596557|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
1596558|NCT00408356|diarrhoea|diarrhoea
1596559|NCT00408317|Cystic Fibrosis|cystic fibrosis
1596560|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1596561|NCT00408317|Ultrase® MT20|ultrase® mt20
1596562|NCT00408304|interferon alpha|interferon alpha
1596563|NCT00408304|depression|depression
1596564|NCT00408304|omega 3|omega 3
1596565|NCT00408291|fracture|fracture
1596566|NCT00408291|shoulder|shoulder
1596567|NCT00408291|bone density|bone density
1596568|NCT00408291|healing|healing
1596569|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
1596570|NCT00408265|Nicotine Dependence|nicotine dependence
1596571|NCT00408265|Contingency Management|contingency management
1596572|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
1596573|NCT00408252|cytokine failure|cytokine failure
1596574|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
1596575|NCT00408239|Thromboembolism|thromboembolism
1596576|NCT00408239|Arthroplasty|arthroplasty
1596577|NCT00408239|Knee Replacement|knee replacement
1596578|NCT00408239|Prevention and Control|prevention and control
1596579|NCT00408200|Atrial fibrillation|atrial fibrillation
1596580|NCT00408200|Atrial arrhythmia|atrial arrhythmia
1596581|NCT00408187|Randomized Controlled Trials|randomized controlled trials
1596582|NCT00408187|Immunosuppression|immunosuppression
1596583|NCT00408187|Adult|adult
1596584|NCT00408187|Chronic Disease|chronic disease
1596585|NCT00408187|Dermatologic Agents|dermatologic agents
1596586|NCT00408187|Female|female
1596587|NCT00408187|Humans|humans
1596588|NCT00408187|Male|male
1596589|NCT00408187|Middle Aged|middle aged
1596590|NCT00408187|Severity of Illness Index|severity of illness index
1596591|NCT00408187|Treatment Outcome|treatment outcome
1596592|NCT00408187|Quality of Life|quality of life
1596593|NCT00408187|Double-Blind Method|double-blind method
1596594|NCT00408174|IBD|ibd
1596595|NCT00408174|UC|uc
1596596|NCT00408174|Ulcerative Colitis|ulcerative colitis
1596597|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
1596598|NCT00408161|Contingency Management|contingency management
1596599|NCT00408161|Alcohol Dependence|alcohol dependence
1596600|NCT00408135|Respiratory Tract Infections|respiratory tract infections
1596601|NCT00408135|Skin Diseases|skin diseases
1596602|NCT00408135|Sinusitis|sinusitis
1596603|NCT00408109|Avian Influenza|avian influenza
1596604|NCT00408109|Healthy|healthy
1596605|NCT00408109|Immunity|immunity
1596606|NCT00408109|Preventive|preventive
1596607|NCT00408109|Bird Flu|bird flu
1596608|NCT00408109|Healthy Volunteer|healthy volunteer
1596609|NCT00408109|HV|hv
1596610|NCT00408096|osteoarthritis|osteoarthritis
1596611|NCT00408096|shoulder|shoulder
1596612|NCT00408096|resurfacing|resurfacing
1596613|NCT00408096|prosthesis|prosthesis
1596614|NCT00408070|ovarian cancer|ovarian cancer
1596615|NCT00408070|fallopian tube cancer|fallopian tube cancer
1596616|NCT00408070|peritoneal cancer|peritoneal cancer
1596617|NCT00408057|lipid lowering|lipid lowering
1596618|NCT00408057|target achievement|target achievement
1596619|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
1596620|NCT00408031|Major depressive disorder|major depressive disorder
1596621|NCT00408031|NMDA receptor|nmda receptor
1596622|NCT00408031|Treatment-Resistant|treatment-resistant
1596623|NCT00408031|D-cycloserine|d-cycloserine
1596627|NCT00407940|Claudication|claudication
1596628|NCT00407914|wrinkles|wrinkles
1596629|NCT00407914|soft tissue filler|soft tissue filler
1596630|NCT00407914|Aquamid|aquamid
1596631|NCT00407901|Visually Challenged|visually challenged
1596632|NCT00407901|Legally Blind|legally blind
1596633|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
1596634|NCT00407901|Low Functioning|low functioning
1596635|NCT00407901|High Functioning|high functioning
1596636|NCT00407875|Prostate|prostate
1596637|NCT00407875|Cancer|cancer
1596638|NCT00407875|Radiation|radiation
1596639|NCT00407862|insulin resistance|insulin resistance
1596640|NCT00407862|beta cell function|beta cell function
1596641|NCT00407862|endothelial dysfunction|endothelial dysfunction
1596643|NCT00407836|CD4 T cell level|cd4 t cell level
1596644|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
1596645|NCT00407836|Viral load|viral load
1596646|NCT00407836|T cell vaccination|t cell vaccination
1596647|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1596648|NCT00407823|Child|child
1596649|NCT00407823|Septic shock|septic shock
1596650|NCT00407823|Resuscitation|resuscitation
1596651|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
1596652|NCT00407823|Cardiac output|cardiac output
1596653|NCT00407823|Goal-directed therapy|goal-directed therapy
1596654|NCT00407797|Lyrica|lyrica
1596655|NCT00407797|Epilepsies - Partial|epilepsies - partial
1596656|NCT00407784|primary aldosteronism|primary aldosteronism
1596657|NCT00407784|hypertension|hypertension
1596658|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
1596659|NCT00407784|eplerenone|eplerenone
1596660|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
1596661|NCT00407784|screening|screening
1596662|NCT00407771|platelet function assay|platelet function assay
1596663|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
1596664|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
1596665|NCT00407771|Diabetes Mellitus|diabetes mellitus
1596666|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1596667|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1596668|NCT00407745|Pain|pain
1596669|NCT00407745|central neuropathic pain|central neuropathic pain
1596670|NCT00407732|hepatitis C|hepatitis c
1596671|NCT00407732|mental disorder|mental disorder
1596672|NCT00407732|substance use|substance use
1596673|NCT00407732|psychosocial intervention|psychosocial intervention
1596674|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
1596675|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
1596676|NCT00407693|Dosimetry|dosimetry
1596677|NCT00407693|Effective Dose|effective dose
1596678|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
1596679|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
1596680|NCT00407680|Hypertension|hypertension
1596681|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
1596682|NCT00407680|Diabetic nephropathy|diabetic nephropathy
1596683|NCT00407667|hemiparesis|hemiparesis
1596684|NCT00407667|rehabilitation|rehabilitation
1596685|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
1596686|NCT00407667|arm therapy|arm therapy
1596687|NCT00407641|diabetes mellitus|diabetes mellitus
1596688|NCT00407641|chronic hemodialysis|chronic hemodialysis
1596689|NCT00407641|anticoagulation|anticoagulation
1596690|NCT00407641|outcome|outcome
1596691|NCT00407628|Stroke|stroke
1596692|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
1596693|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
1596694|NCT00407628|Lower extremity|lower extremity
1596695|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
1596696|NCT00407602|device|device
1596697|NCT00407602|retinal implant|retinal implant
1596698|NCT00407602|retinal prosthesis|retinal prosthesis
1596700|NCT00407602|outer retinal degeneration|outer retinal degeneration
1596701|NCT00407576|Alzheimer's Disease|alzheimer's disease
1596702|NCT00407576|Positron Emission Tomography|positron emission tomography
1596703|NCT00407576|Brain|brain
1596704|NCT00407576|Neurochemistry|neurochemistry
1596705|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
1596706|NCT00407576|PET|pet
1596707|NCT00407576|MeS-IMPY|mes-impy
1596708|NCT00407576|Alzheimer Disease|alzheimer disease
1596709|NCT00407576|AD|ad
1596710|NCT00407576|Dementia|dementia
1596711|NCT00407576|Healthy Volunteer|healthy volunteer
1596712|NCT00407576|HV|hv
1596713|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1596714|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1596715|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1596716|NCT00407498|P 276-00|p 276-00
1596717|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
1596718|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
1596719|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
1596720|NCT00407498|Pharmacokinetics|pharmacokinetics
1596721|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
1596722|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
1596723|NCT00407446|PDE5 inhibition|pde5 inhibition
1596724|NCT00407446|chronic heart failure|chronic heart failure
1596725|NCT00407446|endothelial function|endothelial function
1596726|NCT00407446|exercise ventilation|exercise ventilation
1596727|NCT00407433|Gemcitabine|gemcitabine
1596728|NCT00407433|Oxaliplatine|oxaliplatine
1596729|NCT00407433|Paediatric solid tumors|paediatric solid tumors
1596730|NCT00407433|Other CNS tumors|other cns tumors
1596731|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
1596732|NCT00407420|Childhood|childhood
1596733|NCT00407420|Obesity|obesity
1596734|NCT00407420|Behavior modification|behavior modification
1596735|NCT00407420|Insulin resistance|insulin resistance
1596736|NCT00407407|Epithelial ovarian|epithelial ovarian
1596737|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
1596738|NCT00407407|Abraxane|abraxane
1596739|NCT00407407|Carboplatin|carboplatin
1596740|NCT00407394|Pneumonia|pneumonia
1596741|NCT00407394|Wheezing|wheezing
1596742|NCT00407394|Treatment|treatment
1596743|NCT00407394|Children|children
1596744|NCT00407394|India|india
1596745|NCT00407381|DME|dme
1596746|NCT00407355|vein occlusion|vein occlusion
1596747|NCT00407355|macular edema|macular edema
1596748|NCT00407342|Psoriasis|psoriasis
1596749|NCT00407342|biologics|biologics
1596750|NCT00407342|alefacept|alefacept
1596751|NCT00407342|Narrowband UVB|narrowband uvb
1596752|NCT00407342|Phototherapy|phototherapy
1596753|NCT00407342|Half-side comparison|half-side comparison
1596754|NCT00407329|BPH|bph
1596755|NCT00407316|Uveitis|uveitis
1596756|NCT00407316|Quality of life|quality of life
1596757|NCT00407316|Visual function|visual function
1596758|NCT00407290|pregnancy|pregnancy
1596759|NCT00407290|vaginal delivery|vaginal delivery
1596760|NCT00407277|nicotine dependence|nicotine dependence
1596761|NCT00407277|smoking|smoking
1596762|NCT00407277|nicotine patch|nicotine patch
1596763|NCT00407277|double-blind|double-blind
1596764|NCT00407277|randomized|randomized
1596765|NCT00407277|placebo|placebo
1596766|NCT00407277|psychosis|psychosis
1596767|NCT00407277|schizophrenia|schizophrenia
1596768|NCT00407277|schizophreniform|schizophreniform
1596769|NCT00407277|schizoaffective disorder|schizoaffective disorder
1596770|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
1596771|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
1596772|NCT00407251|refractory|refractory
1596773|NCT00407251|prostate|prostate
1596774|NCT00407251|hormone|hormone
1596775|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
1596776|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
1596777|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
1596778|NCT00407186|CRITICS|critics
1596779|NCT00407186|gastric cancer|gastric cancer
1596780|NCT00407186|surgery|surgery
1596781|NCT00407186|adjuvant|adjuvant
1596782|NCT00407186|chemotherapy|chemotherapy
1596783|NCT00407186|chemoradiotherapy|chemoradiotherapy
1596784|NCT00407186|capecitabine|capecitabine
1596785|NCT00407186|cisplatin|cisplatin
1596786|NCT00407186|epirubicin|epirubicin
1596787|NCT00407160|Kidney transplant|kidney transplant
1596788|NCT00407160|Tolerance induction|tolerance induction
1596789|NCT00407160|High PRA kidney recipients|high pra kidney recipients
1596790|NCT00407147|bacterial infection|bacterial infection
1596791|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
1596792|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
1596793|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
1596794|NCT00407147|procalcitonin|procalcitonin
1596795|NCT00407147|PCT Kryptor|pct kryptor
1596796|NCT00407147|sepsis|sepsis
1596797|NCT00407147|Intensive Care Unit|intensive care unit
1596798|NCT00407147|antibiotic treatment|antibiotic treatment
1596799|NCT00407121|Neovascular Membrane|neovascular membrane
1596800|NCT00407121|Uveitis|uveitis
1596801|NCT00407121|Bevacizumab|bevacizumab
1596802|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
1596803|NCT00407095|Parkinson Disease|parkinson disease
1596804|NCT00407043|Dry Eye Disease|dry eye disease
1596805|NCT00407043|Lotemax|lotemax
1596806|NCT00407043|Restasis|restasis
1596807|NCT00407043|Loteprednol|loteprednol
1596808|NCT00407043|Cyclosporine|cyclosporine
1596809|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
1596810|NCT00406991|retinal blood flow|retinal blood flow
1596811|NCT00406991|diabetic retinopathy|diabetic retinopathy
1596812|NCT00406991|microthrombosis|microthrombosis
1596813|NCT00406991|aspirin|aspirin
1596814|NCT00406991|clopidogrel|clopidogrel
1596815|NCT00406978|MYELOMA|myeloma
1596816|NCT00406978|THALIDOMIDE|thalidomide
1596817|NCT00406978|DEFIBRODITE|defibrodite
1596818|NCT00406939|Gene Therapy|gene therapy
1596820|NCT00406939|Phase I Clinical Trial|phase i clinical trial
1596821|NCT00406900|uveal melanoma|uveal melanoma
1596822|NCT00406900|metastatic disease|metastatic disease
1596823|NCT00406874|infertility|infertility
1596824|NCT00406874|semen quality|semen quality
1596825|NCT00406874|sexual function|sexual function
1596826|NCT00406874|blood pressure|blood pressure
1596827|NCT00406874|omega 3 fats|omega 3 fats
1596828|NCT00406874|folic acid|folic acid
1596829|NCT00406861|reaction|reaction
1596830|NCT00406861|ENL|enl
1596831|NCT00406861|leprosy|leprosy
1596832|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
1596833|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
1596834|NCT00406835|Brain metastases|brain metastases
1596835|NCT00406822|Glaucoma|glaucoma
1596836|NCT00406822|collagen matrix|collagen matrix
1596837|NCT00406822|OculusGen|oculusgen
1596838|NCT00406822|trabeculectomy|trabeculectomy
1596839|NCT00406822|tissue engineering|tissue engineering
1596840|NCT00406809|Sezary syndrome|sezary syndrome
1596841|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1596842|NCT00406809|follicular lymphoma|follicular lymphoma
1596843|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
1596844|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
1596845|NCT00406809|Navitoclax|navitoclax
1596846|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1596847|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1596848|NCT00406809|ABT-263|abt-263
1596849|NCT00406809|lymphoid malignancies|lymphoid malignancies
1596850|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
1596851|NCT00406809|mycosis fungoides|mycosis fungoides
1596852|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
1596853|NCT00406783|Allergic Rhinitis|allergic rhinitis
1596854|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
1596855|NCT00406770|Obesity|obesity
1596856|NCT00406770|Light therapy|light therapy
1596857|NCT00406770|Hypocaloric diet|hypocaloric diet
1596858|NCT00406757|T-cell|t-cell
1596859|NCT00406757|T-ALL|t-all
1596860|NCT00406757|T-LBL|t-lbl
1596861|NCT00406757|506U78|506u78
1596862|NCT00406757|ara-G|ara-g
1596863|NCT00406757|ara-GTP|ara-gtp
1596864|NCT00406757|Lymphoma|lymphoma
1596865|NCT00406757|Leukemia|leukemia
1596866|NCT00406744|neovascularization|neovascularization
1596867|NCT00406731|Endothelin-1|endothelin-1
1596868|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
1596869|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
1596870|NCT00406718|Medication Adherence|medication adherence
1596871|NCT00406718|Psychosocial Treatment|psychosocial treatment
1596872|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
1596873|NCT00406718|Med-e Monitor|med-e monitor
1596874|NCT00406718|Adaptive Function|adaptive function
1596875|NCT00406705|Exercise Tolerance|exercise tolerance
1596876|NCT00406705|Dyspnea|dyspnea
1596877|NCT00406705|Rehabilitation|rehabilitation
1596878|NCT00406705|Helium|helium
1596879|NCT00406692|Zonisamide|zonisamide
1596880|NCT00406692|Alcoholism|alcoholism
1596881|NCT00406692|Alcohol|alcohol
1596882|NCT00406679|pain, postoperative|pain, postoperative
1596883|NCT00406679|surgery, oral|surgery, oral
1596884|NCT00406679|surgery, dental|surgery, dental
1596886|NCT00406640|Major Depressive Disorder|major depressive disorder
1596887|NCT00406640|Depression|depression
1596888|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
1596889|NCT00406614|High Blood Pressure|high blood pressure
1596890|NCT00406588|Parkinson Disease|parkinson disease
1596891|NCT00406575|Congestive heart failure|congestive heart failure
1596892|NCT00406575|Relaxin|relaxin
1596893|NCT00406575|Hemodynamics|hemodynamics
1596894|NCT00406575|Renal function|renal function
1596895|NCT00406562|uncontrolled|uncontrolled
1596896|NCT00406549|Staphylococcus aureus|staphylococcus aureus
1596897|NCT00406549|Nasal colonization|nasal colonization
1596898|NCT00406549|pre-surgical patients|pre-surgical patients
1596899|NCT00406549|Sensitivity|sensitivity
1596900|NCT00406549|Specificity|specificity
1596901|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
1596902|NCT00406536|Cystic Fibrosis|cystic fibrosis
1596903|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
1596904|NCT00406536|LYM-X-SORB™|lym-x-sorb™
1596905|NCT00406536|LXS|lxs
1596906|NCT00406484|Methadone|methadone
1596907|NCT00406484|Counseling|counseling
1596908|NCT00406484|HIV risk reduction|hiv risk reduction
1596909|NCT00406484|HIV Seronegativity|hiv seronegativity
1596910|NCT00406471|Ischemic|ischemic
1596911|NCT00406471|Central|central
1596912|NCT00406471|Retinal|retinal
1596913|NCT00406471|Vein|vein
1596914|NCT00406471|Occlusion|occlusion
1596915|NCT00406471|Ranibizumab|ranibizumab
1596916|NCT00406471|Lucentis|lucentis
1596917|NCT00406471|CRVO|crvo
1596918|NCT00406471|ISCRVO|iscrvo
1596919|NCT00406458|Diabetic neuropathy|diabetic neuropathy
1596920|NCT00406458|Diabetes Type I or II|diabetes type i or ii
1596921|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
1596922|NCT00406445|Metabolism|metabolism
1597123|NCT00405522|Oncology|oncology
1596923|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
1596924|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
1596925|NCT00406432|pharmacokinetics|pharmacokinetics
1596926|NCT00406432|repeat dose|repeat dose
1596927|NCT00406419|anti-CD20|anti-cd20
1596928|NCT00406419|stage|stage
1596929|NCT00406419|CD20|cd20
1596930|NCT00406419|RA|ra
1596931|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
1596932|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1596933|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1596934|NCT00406380|Telangiectasias|telangiectasias
1596935|NCT00406380|Leakage|leakage
1596936|NCT00406380|Bevacizumab|bevacizumab
1596937|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
1596938|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
1596939|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
1596940|NCT00406302|NSCLC|nsclc
1596941|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
1596942|NCT00406276|Lung Cancer|lung cancer
1596943|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
1596944|NCT00406263|cataract|cataract
1596945|NCT00406211|Rubella|rubella
1596946|NCT00406211|Varicella|varicella
1596947|NCT00406211|Measles|measles
1596948|NCT00406211|Mumps|mumps
1596949|NCT00406211|Germany|germany
1596950|NCT00406211|Austria|austria
1596951|NCT00406198|Sepsis syndrom|sepsis syndrom
1596952|NCT00406198|severe sepsis|severe sepsis
1596953|NCT00406198|septic shock|septic shock
1596954|NCT00406198|hemofiltration|hemofiltration
1596955|NCT00406198|multiple organ failure|multiple organ failure
1596956|NCT00406185|Registry|registry
1596957|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
1596958|NCT00406185|coronary heart disease|coronary heart disease
1596959|NCT00406185|cardiovascular disease|cardiovascular disease
1596960|NCT00406159|Autism|autism
1596961|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
1596962|NCT00406159|Behavioral assessments|behavioral assessments
1596963|NCT00406120|eye|eye
1596964|NCT00406120|uvea|uvea
1596965|NCT00406120|iris|iris
1596966|NCT00406120|choroid|choroid
1596967|NCT00406120|ciliary body|ciliary body
1596968|NCT00406120|melanoma|melanoma
1596969|NCT00406120|iris melanoma|iris melanoma
1596970|NCT00406120|choroidal melanoma|choroidal melanoma
1596971|NCT00406120|ciliary body melanoma|ciliary body melanoma
1596972|NCT00406120|uveal melanoma|uveal melanoma
1596973|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
1596974|NCT00406120|prognosis|prognosis
1596975|NCT00406120|metastasis|metastasis
1596976|NCT00406120|genetic testing|genetic testing
1596977|NCT00406120|molecular testing|molecular testing
1596978|NCT00406120|gene expression profiling|gene expression profiling
1596979|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
1596980|NCT00406107|macular edema|macular edema
1596981|NCT00406107|pegaptanib sodium|pegaptanib sodium
1596982|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
1596983|NCT00406094|NARES|nares
1596984|NCT00406094|eosinophils|eosinophils
1596985|NCT00406094|nasal symptoms|nasal symptoms
1596986|NCT00406068|Bladder neoplasm|bladder neoplasm
1596987|NCT00406068|Intravesical drug administration|intravesical drug administration
1596988|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
1596989|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
1596990|NCT00406068|Carcinoma in situ|carcinoma in situ
1596991|NCT00406068|Mycobacterium|mycobacterium
1596992|NCT00406042|glaucoma|glaucoma
1596993|NCT00406042|trabeculoplasty|trabeculoplasty
1596994|NCT00406042|steroids|steroids
1596995|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
1596996|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
1596997|NCT00406003|pharmacokinetics|pharmacokinetics
1596998|NCT00406003|safety|safety
1596999|NCT00405990|HIV|hiv
1597000|NCT00405990|MTCT|mtct
1597001|NCT00405990|heterosexual behaviour|heterosexual behaviour
1597002|NCT00405990|sexual risk behaviour|sexual risk behaviour
1597003|NCT00405990|couple counselling|couple counselling
1597004|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
1597005|NCT00405990|HIV Seronegativity|hiv seronegativity
1597006|NCT00405977|Neuromuscular block|neuromuscular block
1597007|NCT00405977|Magnesium|magnesium
1597008|NCT00405977|Rocuronium|rocuronium
1597009|NCT00405977|Time course of action|time course of action
1597010|NCT00405938|Breast cancer|breast cancer
1597011|NCT00405938|Metastatic breast cancer|metastatic breast cancer
1597012|NCT00405938|Bevacizumab|bevacizumab
1597013|NCT00405938|Anastrozole|anastrozole
1597014|NCT00405938|Fulvestrant|fulvestrant
1597015|NCT00405925|AIDS|aids
1597016|NCT00405925|Treatment Naive|treatment naive
1597017|NCT00405899|Allergy|allergy
1597018|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1597019|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
1597020|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
1597021|NCT00405873|Liver cancer|liver cancer
1597022|NCT00405873|Tumour response|tumour response
1597023|NCT00405873|Quality of life|quality of life
1597024|NCT00405847|Sleep|sleep
1597025|NCT00405847|Critical illness|critical illness
1597026|NCT00405847|Cytokine|cytokine
1597027|NCT00405834|Pressure Ulcers|pressure ulcers
1597028|NCT00405821|AIDS|aids
1597029|NCT00405821|HIV Disease Progression|hiv disease progression
1597030|NCT00405821|Quality of Life|quality of life
1597031|NCT00405821|HIV Viral Load|hiv viral load
1597032|NCT00405821|Genital Ulcers|genital ulcers
1597033|NCT00405821|HIV|hiv
1597034|NCT00405821|Treatment Naive|treatment naive
1597035|NCT00405795|Pressure Ulcer|pressure ulcer
1597036|NCT00405782|metastatic breast cancer|metastatic breast cancer
1597037|NCT00405782|exercise intervention|exercise intervention
1597038|NCT00405769|statin intolerance|statin intolerance
1597039|NCT00405769|hyperlipidemia|hyperlipidemia
1597040|NCT00405769|lifestyle changes|lifestyle changes
1597041|NCT00405769|red yeast rice|red yeast rice
1597042|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
1597043|NCT00405756|Celgene|celgene
1597044|NCT00405756|CC-5013|cc-5013
1597045|NCT00405756|Revlimid|revlimid
1597046|NCT00405756|Lenalidomide|lenalidomide
1597047|NCT00405756|Melphalan|melphalan
1597048|NCT00405756|Prednisone|prednisone
1597049|NCT00405756|Elderly|elderly
1597050|NCT00405743|CP-4055|cp-4055
1597051|NCT00405743|ELACYT™|elacyt™
1597052|NCT00405743|Cancer|cancer
1597053|NCT00405743|Refractory|refractory
1597054|NCT00405743|Relapsed|relapsed
1597055|NCT00405743|Hematologic Malignancies|hematologic malignancies
1597056|NCT00405743|Leukemia|leukemia
1597057|NCT00405743|ALL|all
1597058|NCT00405743|AML|aml
1597059|NCT00405743|AMM|amm
1597060|NCT00405743|CLL|cll
1597061|NCT00405743|CML|cml
1597062|NCT00405743|CMML|cmml
1597063|NCT00405743|MDS|mds
1597064|NCT00405730|Cataracts|cataracts
1597065|NCT00405717|ischemic heart disease|ischemic heart disease
1597066|NCT00405717|acute coronary syndromes|acute coronary syndromes
1597067|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1597068|NCT00405717|statin|statin
1597069|NCT00405717|clopidogrel|clopidogrel
1597070|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
1597071|NCT00405704|Urinary Tract Infections|urinary tract infections
1597072|NCT00405704|Renal Scarring|renal scarring
1597073|NCT00405704|Antibiotic Resistance|antibiotic resistance
1597074|NCT00405704|Controlled Clinical Trial|controlled clinical trial
1597279|NCT00404885|uveitis|uveitis
1597075|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
1597076|NCT00405704|Children|children
1597077|NCT00405691|Medical Device|medical device
1597078|NCT00405691|Spine|spine
1597079|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
1597080|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
1597081|NCT00405691|Facet Arthrosis|facet arthrosis
1597082|NCT00405691|Back and Leg Pain|back and leg pain
1597083|NCT00405691|Spine Research|spine research
1597084|NCT00405691|Medical Device Research|medical device research
1597085|NCT00405691|Impliant|impliant
1597086|NCT00405691|Lumbar Treatment|lumbar treatment
1597087|NCT00405691|Spinal Treatment|spinal treatment
1597088|NCT00405691|Spinal Device|spinal device
1597089|NCT00405678|Exercise Intervention|exercise intervention
1597090|NCT00405678|Breast Cancer|breast cancer
1597091|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
1597092|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
1597093|NCT00405665|Cystic Fibrosis|cystic fibrosis
1597094|NCT00405665|L-Arginine|l-arginine
1597095|NCT00405665|Pediatrics|pediatrics
1597096|NCT00405665|pulmonary function|pulmonary function
1597097|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
1597098|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
1597099|NCT00405613|Aspirin|aspirin
1597100|NCT00405613|Bleeding|bleeding
1597101|NCT00405613|Clinical Trial|clinical trial
1597102|NCT00405613|Dental Extraction|dental extraction
1597103|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
1597104|NCT00405600|spinal stenosis|spinal stenosis
1597105|NCT00405600|spondylolisthesis|spondylolisthesis
1597106|NCT00405600|non instrumented surgery|non instrumented surgery
1597107|NCT00405600|instrumented surgery|instrumented surgery
1597108|NCT00405600|BMP-2|bmp-2
1597109|NCT00405574|prostate|prostate
1597110|NCT00405574|PSA|psa
1597111|NCT00405574|antiangiogenic|antiangiogenic
1597112|NCT00405574|copper|copper
1597113|NCT00405574|ATN-224|atn-224
1597114|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
1597115|NCT00405535|OCD|ocd
1597116|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
1597117|NCT00405535|Glycine|glycine
1597118|NCT00405522|Lumbar Puncture|lumbar puncture
1597119|NCT00405522|Pediatrics|pediatrics
1597120|NCT00405522|Propofol|propofol
1597121|NCT00405522|Remifentanil|remifentanil
1597122|NCT00405522|sedation|sedation
1597124|NCT00405509|Upper Respiratory Infection|upper respiratory infection
1597125|NCT00405509|Common Cold|common cold
1597126|NCT00405483|arthroplasty|arthroplasty
1597127|NCT00405483|RSA|rsa
1597128|NCT00405483|micromotion|micromotion
1597129|NCT00405483|osteoarthritis|osteoarthritis
1597130|NCT00405483|minimally invasive|minimally invasive
1597131|NCT00405483|ProfemurZ|profemurz
1597132|NCT00405470|arthroplasty|arthroplasty
1597133|NCT00405470|RSA|rsa
1597134|NCT00405470|micromotion|micromotion
1597135|NCT00405470|osteoarthritis|osteoarthritis
1597136|NCT00405444|Pediatrics|pediatrics
1597137|NCT00405444|Pain|pain
1597138|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
1597139|NCT00405444|Catheterization|catheterization
1597140|NCT00405444|Fentanyl|fentanyl
1597141|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
1597142|NCT00405431|restasis|restasis
1597143|NCT00405431|conjunctival inflammation|conjunctival inflammation
1597144|NCT00405405|Head and neck cancer|head and neck cancer
1597145|NCT00405405|Parotid gland cancer|parotid gland cancer
1597146|NCT00405405|thyroid gland cancer|thyroid gland cancer
1597147|NCT00405405|melanoma|melanoma
1597148|NCT00405405|Chemoradiotherapy|chemoradiotherapy
1597149|NCT00405405|bevacizumab|bevacizumab
1597150|NCT00405405|erlotinib|erlotinib
1597151|NCT00405392|risedronate|risedronate
1597152|NCT00405392|Ibandronate|ibandronate
1597153|NCT00405392|preference|preference
1597154|NCT00405392|Osteoporosis|osteoporosis
1597155|NCT00405379|arthroplasty|arthroplasty
1597156|NCT00405379|RSA|rsa
1597157|NCT00405379|Osteoarthritis|osteoarthritis
1597158|NCT00405379|trabecular metal mesh|trabecular metal mesh
1597159|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
1597160|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
1597161|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
1597162|NCT00405353|multiple sclerosis|multiple sclerosis
1597163|NCT00405353|testosterone|testosterone
1597164|NCT00405327|tumor vaccine|tumor vaccine
1597165|NCT00405327|metastatic solid tumors|metastatic solid tumors
1597166|NCT00405327|recurrent tumors|recurrent tumors
1597167|NCT00405314|respiratory failure|respiratory failure
1597168|NCT00405314|non invasive ventilation|non invasive ventilation
1597169|NCT00405314|prehospital|prehospital
1597170|NCT00405314|endotracheal intubation|endotracheal intubation
1597171|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
1597172|NCT00405301|Tuberculosis|tuberculosis
1597173|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
1597280|NCT00404885|calcineurin|calcineurin
1597174|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
1597175|NCT00405301|India|india
1597176|NCT00405288|Hemorrhoids|hemorrhoids
1597177|NCT00405288|Pregnancy|pregnancy
1597178|NCT00405288|antihemorrhoidal|antihemorrhoidal
1597179|NCT00405288|Proctofoam|proctofoam
1597180|NCT00405288|infants|infants
1597181|NCT00405275|antineoplastic|antineoplastic
1597182|NCT00405275|antiparasitics|antiparasitics
1597183|NCT00405275|antirheumatics|antirheumatics
1597184|NCT00405275|chronic diseases|chronic diseases
1597185|NCT00405275|clinical trial|clinical trial
1597186|NCT00405275|connective tissue|connective tissue
1597187|NCT00405275|double-blind|double-blind
1597188|NCT00405275|drug treatment|drug treatment
1597189|NCT00405275|gastric medications|gastric medications
1597190|NCT00405275|joint|joint
1597191|NCT00405275|multi-site trial|multi-site trial
1597192|NCT00405275|musculoskeletal|musculoskeletal
1597193|NCT00405275|randomized|randomized
1597194|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
1597195|NCT00405262|Pediatrics|pediatrics
1597196|NCT00405262|Postoperative Analgesia|postoperative analgesia
1597197|NCT00405262|orthopedic surgery|orthopedic surgery
1597198|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
1597199|NCT00405262|Osteotomy|osteotomy
1597200|NCT00405262|cleft palate|cleft palate
1597201|NCT00405249|HIV-1|hiv-1
1597202|NCT00405249|Treatment Experienced|treatment experienced
1597203|NCT00405236|inflammation|inflammation
1597204|NCT00405236|exacerbations|exacerbations
1597205|NCT00405210|hormone-resistant|hormone-resistant
1597206|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
1597207|NCT00405210|pharmacokinetics|pharmacokinetics
1597208|NCT00405210|naïve patient|naïve patient
1597209|NCT00405197|MUFA|mufa
1597210|NCT00405197|Mediterranean diet|mediterranean diet
1597211|NCT00405197|Insulin resistance|insulin resistance
1597212|NCT00405197|metabolic syndrome X|metabolic syndrome x
1597214|NCT00405184|IVIg|ivig
1597215|NCT00405184|IntragamP|intragamp
1597216|NCT00405171|Efavirenz|efavirenz
1597217|NCT00405171|Nevirapine|nevirapine
1597218|NCT00405171|Dyslipidemia|dyslipidemia
1597219|NCT00405171|HIV|hiv
1597220|NCT00405158|Lactation mastitis|lactation mastitis
1597221|NCT00405158|Breast inflammation|breast inflammation
1597222|NCT00405158|Breastfeeding|breastfeeding
1597223|NCT00405158|Care interventions|care interventions
1597224|NCT00405158|Acupuncture treatment|acupuncture treatment
1597225|NCT00405158|Antibiotic therapy|antibiotic therapy
1597226|NCT00405145|Epilepsy|epilepsy
1597227|NCT00405145|MRI|mri
1597228|NCT00405145|EEG|eeg
1597229|NCT00405145|Neuroimaging|neuroimaging
1597230|NCT00405119|tolerance|tolerance
1597231|NCT00405119|pharmacodynamics|pharmacodynamics
1597232|NCT00405119|ranitidine|ranitidine
1597233|NCT00405119|esomeprazole|esomeprazole
1597336|NCT00404651|Hepatitis B|hepatitis b
1597234|NCT00405119|pharmacokinetics|pharmacokinetics
1597235|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
1597236|NCT00405119|AH23844|ah23844
1597237|NCT00405106|stress|stress
1597238|NCT00405106|anxiety|anxiety
1597239|NCT00405106|myopia progression|myopia progression
1597240|NCT00405106|accommodation|accommodation
1597241|NCT00405106|vergence|vergence
1597242|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
1597243|NCT00405093|circulatory arrest|circulatory arrest
1597244|NCT00405093|aprotinin|aprotinin
1597245|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
1597246|NCT00405080|Rifampin GW679769|rifampin gw679769
1597247|NCT00405067|Cholesterol|cholesterol
1597248|NCT00405015|rosiglitazone|rosiglitazone
1597249|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
1597250|NCT00405015|human|human
1597251|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
1597252|NCT00405015|metabolic syndrome|metabolic syndrome
1597253|NCT00405002|Acute respiratory failure|acute respiratory failure
1597254|NCT00404989|HIV|hiv
1597255|NCT00404989|HBV|hbv
1597256|NCT00404989|Hepatitis|hepatitis
1597257|NCT00404989|Pregnancy|pregnancy
1597258|NCT00404989|Registry|registry
1597259|NCT00404976|inflammometry|inflammometry
1597260|NCT00404976|exhaled breath condensate|exhaled breath condensate
1597261|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
1597262|NCT00404976|asthma|asthma
1597263|NCT00404976|children|children
1597264|NCT00404963|GSK376501,|gsk376501,
1597265|NCT00404963|First Time in Human,|first time in human,
1597266|NCT00404963|Single Dose,|single dose,
1597267|NCT00404963|Dose Escalation,|dose escalation,
1597268|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
1597269|NCT00404950|hyperglycemia|hyperglycemia
1597270|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
1597271|NCT00404950|renal injury|renal injury
1597272|NCT00404950|diabetes|diabetes
1597273|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1597274|NCT00404924|Adenocarcinoma|adenocarcinoma
1597275|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
1597276|NCT00404924|Large Cell Carcinoma|large cell carcinoma
1597277|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
1597278|NCT00404898|World Trade Center dust|world trade center dust
1597281|NCT00404885|inflammation|inflammation
1597282|NCT00404872|Stroke|stroke
1597283|NCT00404859|inflammometry|inflammometry
1597284|NCT00404859|exhaled breath condensate|exhaled breath condensate
1597285|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
1597286|NCT00404859|asthma|asthma
1597287|NCT00404859|cystic fibrosis|cystic fibrosis
1597288|NCT00404859|monitoring|monitoring
1597289|NCT00404859|exacerbations|exacerbations
1597290|NCT00404859|paediatric|paediatric
1597291|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
1597292|NCT00404846|HBOT|hbot
1597293|NCT00404846|Autism|autism
1597294|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
1597295|NCT00404820|osteoporosis|osteoporosis
1597296|NCT00404820|bisphosphonate|bisphosphonate
1597297|NCT00404820|biomarker|biomarker
1597298|NCT00404820|zoledronic acid|zoledronic acid
1597299|NCT00404820|alendronate|alendronate
1597300|NCT00404820|postmenopausal|postmenopausal
1597301|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
1597302|NCT00404807|cardiovascular diseases|cardiovascular diseases
1597303|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
1597304|NCT00404807|sleep breathing disorders|sleep breathing disorders
1597305|NCT00404807|sham CPAP|sham cpap
1597306|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
1597307|NCT00404781|ischemic heart disease|ischemic heart disease
1597308|NCT00404781|acute coronary syndromes|acute coronary syndromes
1597309|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
1597310|NCT00404781|platelet function|platelet function
1597311|NCT00404781|aspirin|aspirin
1597312|NCT00404781|clopidogrel|clopidogrel
1597313|NCT00404781|cilostazol|cilostazol
1597314|NCT00404768|Premature Labor|premature labor
1597315|NCT00404768|Pre Term Labor|pre term labor
1597316|NCT00404768|intravenous|intravenous
1597317|NCT00404768|fetal fibronectin|fetal fibronectin
1597318|NCT00404755|Depression|depression
1597319|NCT00404742|uveitis|uveitis
1597320|NCT00404742|calcineurin|calcineurin
1597321|NCT00404729|Glaucoma|glaucoma
1597322|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
1597323|NCT00404729|Visual Pathways,|visual pathways,
1597324|NCT00404729|Optic nerve|optic nerve
1597325|NCT00404729|Neural conduction|neural conduction
1597326|NCT00404690|Gastroschisis|gastroschisis
1597327|NCT00404690|Silo|silo
1597328|NCT00404690|Operative closure|operative closure
1597329|NCT00404664|influenza vaccine|influenza vaccine
1597330|NCT00404664|influenza immunization|influenza immunization
1597331|NCT00404664|reminder letters|reminder letters
1597332|NCT00404664|raffle prize|raffle prize
1597333|NCT00404651|Diphtheria|diphtheria
1597334|NCT00404651|Tetanus|tetanus
1597335|NCT00404651|Pertussis|pertussis
1597337|NCT00404651|Poliomyelitis|poliomyelitis
1597338|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
1597339|NCT00404638|Enuresis Nocturna|enuresis nocturna
1597340|NCT00404638|Paula Method|paula method
1597341|NCT00404638|Circular muscle exercise|circular muscle exercise
1597342|NCT00404638|Sphincter|sphincter
1597343|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
1597344|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
1597345|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
1597346|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
1597347|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
1597348|NCT00404612|uveitis|uveitis
1597349|NCT00404612|calcineurin|calcineurin
1597350|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
1597351|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
1597352|NCT00404586|GW784568X|gw784568x
1597353|NCT00404586|Intranasal|intranasal
1597354|NCT00404573|Schizophrenia|schizophrenia
1597355|NCT00404560|CTLA4 Mutation|ctla4 mutation
1597356|NCT00404560|Recurrent Infections|recurrent infections
1597357|NCT00404560|Immunodeficiency|immunodeficiency
1597358|NCT00404560|Phagocytes|phagocytes
1597359|NCT00404560|PI3K|pi3k
1597360|NCT00404560|DOCK8|dock8
1597361|NCT00404560|STAT 1|stat 1
1597362|NCT00404560|Genetic Mutation|genetic mutation
1597363|NCT00404560|Cytokines|cytokines
1597364|NCT00404560|Auto-antibodies|auto-antibodies
1597365|NCT00404560|Infection Susceptibility|infection susceptibility
1597366|NCT00404560|Immune Disorders|immune disorders
1597367|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
1597368|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
1597369|NCT00404547|Asthma|asthma
1597370|NCT00404547|Alvesco®|alvesco®
1597371|NCT00404547|Ciclesonide|ciclesonide
1597372|NCT00404534|functional dyspepsia|functional dyspepsia
1597373|NCT00404534|Helicobacter pylori|helicobacter pylori
1597374|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1597375|NCT00404534|Gastritis|gastritis
1597376|NCT00404521|Tumor|tumor
1597377|NCT00404521|PM02734|pm02734
1597378|NCT00404521|PharmaMar|pharmamar
1597379|NCT00404508|Hydralazine|hydralazine
1597380|NCT00404508|Magnesium Valproate|magnesium valproate
1597381|NCT00404508|Chemotherapy resistance|chemotherapy resistance
1597382|NCT00404508|Epigenetic therapy|epigenetic therapy
1597383|NCT00404482|uveitis|uveitis
1597385|NCT00404482|Cyclosporine A|cyclosporine a
1597386|NCT00404482|MTX|mtx
1597387|NCT00404443|Acupuncture|acupuncture
1597388|NCT00404443|Electroacupuncture|electroacupuncture
1597389|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
1597390|NCT00404430|Endothelial function|endothelial function
1597391|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
1597392|NCT00404430|Systemic Inflammation|systemic inflammation
1597393|NCT00404430|Oxidative Stress|oxidative stress
1597394|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
1597395|NCT00404430|Cardiovascular risk|cardiovascular risk
1597396|NCT00404430|COPD severity|copd severity
1597397|NCT00404417|pain|pain
1597398|NCT00404417|lumbar|lumbar
1597399|NCT00404404|recurrent breast cancer|recurrent breast cancer
1597400|NCT00404404|stage IV breast cancer|stage iv breast cancer
1597401|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
1597402|NCT00404378|Healthy subjects|healthy subjects
1597403|NCT00404378|Pharmacokinetics|pharmacokinetics
1597404|NCT00404378|Drug interaction|drug interaction
1597405|NCT00404378|Ketoconazole|ketoconazole
1597406|NCT00404378|Casopitant|casopitant
1597407|NCT00404365|depression|depression
1597408|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1597409|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
1597410|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
1597411|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1597412|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1597413|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1597414|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1597415|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1597416|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1597417|NCT00404352|Rebif New Formulation|rebif new formulation
1597418|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
1597419|NCT00404352|Multiple Sclerosis|multiple sclerosis
1597485|NCT00404157|Lupus|lupus
1597420|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1597421|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1597422|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1597423|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1597424|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1597425|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1597426|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1597427|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1597428|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1597429|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1597430|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1597431|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1597432|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1597433|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1597434|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1597435|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1597436|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1597437|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1597438|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1597439|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1597440|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1597441|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1597442|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1597443|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1597444|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1597539|NCT00403780|Critical limb ischemia|critical limb ischemia
1597445|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1597446|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1597447|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1597448|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1597449|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1597450|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1597451|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1597452|NCT00404339|tongue cancer|tongue cancer
1597453|NCT00404326|Cervical carcinoma|cervical carcinoma
1597454|NCT00404326|Epigenetic therapy|epigenetic therapy
1597455|NCT00404326|Hydralazine|hydralazine
1597456|NCT00404326|Valproate|valproate
1597457|NCT00404326|Microarray analysis|microarray analysis
1597458|NCT00404287|C reactive protein|c reactive protein
1597459|NCT00404287|Inflammation|inflammation
1597460|NCT00404287|Aortic valve stenosis|aortic valve stenosis
1597461|NCT00404287|progression|progression
1597462|NCT00404274|healthy human volunteer|healthy human volunteer
1597463|NCT00404274|GW679769|gw679769
1597464|NCT00404274|warfarin|warfarin
1597465|NCT00404274|casopitant|casopitant
1597466|NCT00404261|Fluticasone Propionate|fluticasone propionate
1597467|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
1597468|NCT00404261|patient satisfaction|patient satisfaction
1597469|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
1597470|NCT00404261|Salmeterol|salmeterol
1597471|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1597472|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1597473|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1597474|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
1597475|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
1597476|NCT00404248|adult glioblastoma|adult glioblastoma
1597477|NCT00404248|adult gliosarcoma|adult gliosarcoma
1597478|NCT00404235|stage IV melanoma|stage iv melanoma
1597479|NCT00404235|recurrent melanoma|recurrent melanoma
1597480|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
1597481|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
1597482|NCT00404170|imaging|imaging
1597483|NCT00404170|Parkinson|parkinson
1597484|NCT00404170|progression|progression
1597487|NCT00404144|small vessel|small vessel
1597488|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1597489|NCT00404144|pepcad|pepcad
1597490|NCT00404144|drug eluting balloon|drug eluting balloon
1597491|NCT00404118|long-term care|long-term care
1597492|NCT00404118|satisfaction|satisfaction
1597493|NCT00404118|cost|cost
1597494|NCT00404105|Excimer laser|excimer laser
1597495|NCT00404092|aspergillosis|aspergillosis
1597496|NCT00404092|caspofungin|caspofungin
1597497|NCT00404092|maximum tolerated dose|maximum tolerated dose
1597498|NCT00404079|Chronic low back pain|chronic low back pain
1597499|NCT00404014|MCI following CABG surgery|mci following cabg surgery
1597500|NCT00404001|Microbia|microbia
1597501|NCT00404001|MD-0727|md-0727
1597502|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
1597503|NCT00404001|Hypercholesterolemia|hypercholesterolemia
1597504|NCT00404001|Hyperlipidemia|hyperlipidemia
1597505|NCT00404001|Dyslipidemia|dyslipidemia
1597506|NCT00404001|Cholesterol|cholesterol
1597507|NCT00404001|LDL|ldl
1597508|NCT00403962|anxiety|anxiety
1597509|NCT00403962|Social Anxiety Disorder|social anxiety disorder
1597510|NCT00403962|SAD|sad
1597511|NCT00403936|osteopathic manipulation|osteopathic manipulation
1597512|NCT00403936|autonomic nervous system|autonomic nervous system
1597513|NCT00403923|Lactose intolerance|lactose intolerance
1597514|NCT00403923|Ulcerative colitis|ulcerative colitis
1597515|NCT00403923|Lactose|lactose
1597516|NCT00403923|Threshold|threshold
1597517|NCT00403897|Constipation|constipation
1597518|NCT00403884|Drusen|drusen
1597519|NCT00403884|Geographic atrophy|geographic atrophy
1597520|NCT00403884|diabetes|diabetes
1597521|NCT00403884|macular edema|macular edema
1597522|NCT00403884|laser|laser
1597523|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
1597524|NCT00403871|Anaesthesia|anaesthesia
1597525|NCT00403871|Pregnency|pregnency
1597526|NCT00403871|Heart disease|heart disease
1597527|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1597528|NCT00403845|COPD|copd
1597529|NCT00403845|QAB149|qab149
1597530|NCT00403845|indacaterol|indacaterol
1597531|NCT00403845|long acting β2-agonist|long acting β2-agonist
1597532|NCT00403806|Adenotonsillectomy|adenotonsillectomy
1597533|NCT00403806|Pediatrics|pediatrics
1597534|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
1597535|NCT00403806|Pain|pain
1597536|NCT00403806|Oral intake|oral intake
1597537|NCT00403806|Dexamethasone|dexamethasone
1597538|NCT00403806|Dose finding|dose finding
1597540|NCT00403780|Pain control|pain control
1597541|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
1597542|NCT00403780|pregabalin|pregabalin
1597543|NCT00403780|randomized controlled study|randomized controlled study
1597544|NCT00403780|Ischemia, therapy|ischemia, therapy
1597545|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
1597546|NCT00403780|Pain, prevention & control|pain, prevention & control
1597547|NCT00403780|Pain, therapy|pain, therapy
1597548|NCT00403767|Atrial Fibrillation|atrial fibrillation
1597549|NCT00403767|Stroke|stroke
1597550|NCT00403767|Embolism|embolism
1597551|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
1597552|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
1597553|NCT00403767|Blood Clot|blood clot
1597554|NCT00403767|Rivaroxaban|rivaroxaban
1597555|NCT00403767|Warfarin|warfarin
1597556|NCT00403767|Anticoagulants|anticoagulants
1597557|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
1597558|NCT00403754|asthma|asthma
1597559|NCT00403754|QAB149|qab149
1597560|NCT00403754|indacaterol|indacaterol
1597561|NCT00403754|long acting β2-agonist|long acting β2-agonist
1597562|NCT00403754|bronchodilator|bronchodilator
1597563|NCT00403741|behavior|behavior
1597564|NCT00403741|physical activity|physical activity
1597565|NCT00403741|motivation|motivation
1597566|NCT00403728|Ischemia|ischemia
1597567|NCT00403728|Reperfusion|reperfusion
1597568|NCT00403728|Myocardial infarction|myocardial infarction
1597569|NCT00403728|ciclosporin A|ciclosporin a
1597570|NCT00403728|acute myocardial infarction|acute myocardial infarction
1597571|NCT00403702|Retinal detachment|retinal detachment
1597572|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
1597573|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
1597574|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
1597575|NCT00403676|nurse practitioner|nurse practitioner
1597576|NCT00403676|rheumatology care|rheumatology care
1597577|NCT00403676|outpatient clinic|outpatient clinic
1597578|NCT00403676|patient satisfaction|patient satisfaction
1597579|NCT00403663|Body mass index|body mass index
1597580|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
1597581|NCT00403663|Cesarean section|cesarean section
1597582|NCT00403663|Obesity|obesity
1597583|NCT00403650|Sarcoidosis|sarcoidosis
1597584|NCT00403650|Dyspnea|dyspnea
1597585|NCT00403650|Interstitial lung disease|interstitial lung disease
1597586|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
1597860|NCT00402766|STI571|sti571
1597587|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
1597588|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
1597589|NCT00403572|Preeclampsia|preeclampsia
1597590|NCT00403572|Trans cranial Doppler|trans cranial doppler
1597591|NCT00403572|Cardiac output|cardiac output
1597867|NCT00402740|PROTECT|protect
1597592|NCT00403572|systemic vascular resistance|systemic vascular resistance
1597593|NCT00403572|blood pressure|blood pressure
1597594|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
1597595|NCT00403546|Schizophrenia|schizophrenia
1597596|NCT00403533|Hepatitis C|hepatitis c
1597597|NCT00403533|viral load|viral load
1597598|NCT00403533|antiviral therapy|antiviral therapy
1597599|NCT00403533|cholesterol|cholesterol
1597600|NCT00403533|atorvastatin|atorvastatin
1597601|NCT00403520|Alzheimer's disease|alzheimer's disease
1597602|NCT00403520|Mild cognitive impairment|mild cognitive impairment
1597603|NCT00403507|Mild Dementia|mild dementia
1597604|NCT00403507|Mild Alzheimer|mild alzheimer
1597605|NCT00403507|Cognitive Impairment|cognitive impairment
1597606|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
1597607|NCT00403507|Exercise|exercise
1597608|NCT00403507|Physical activity|physical activity
1597609|NCT00403507|Behavior|behavior
1597610|NCT00403507|Memory loss|memory loss
1597611|NCT00403494|Intermittent Claudication|intermittent claudication
1597612|NCT00403494|IC|ic
1597613|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
1597614|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
1597615|NCT00403494|PAD|pad
1597616|NCT00403494|6R-BH4|6r-bh4
1597617|NCT00403494|BH4|bh4
1597618|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
1597619|NCT00403494|endothelial dysfunction|endothelial dysfunction
1597620|NCT00403494|Nitric Oxide|nitric oxide
1597621|NCT00403494|NO|no
1597622|NCT00403481|Hypertension|hypertension
1597623|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
1597624|NCT00403481|Calcium Channel Blocker|calcium channel blocker
1597625|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
1597626|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
1597627|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
1597628|NCT00403481|Type II Diabetes|type ii diabetes
1597629|NCT00403455|Clinical|clinical
1597630|NCT00403455|Genetics|genetics
1597631|NCT00403455|Monoamine transporter|monoamine transporter
1597632|NCT00403455|Pharmacogenetics|pharmacogenetics
1597633|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
1597634|NCT00403442|Macular Degeneration|macular degeneration
1597635|NCT00403429|oral chemotherapy|oral chemotherapy
1597636|NCT00403429|platinum resistant|platinum resistant
1597637|NCT00403429|platinum refractory|platinum refractory
1597638|NCT00403429|second line|second line
1597639|NCT00403416|AEB071|aeb071
1597640|NCT00403416|Tacrolimus|tacrolimus
1597641|NCT00403416|Mycophenolic acid|mycophenolic acid
1597642|NCT00403416|Basiliximab|basiliximab
1597643|NCT00403416|Rejection|rejection
1597644|NCT00403416|Kidney function|kidney function
1597645|NCT00403416|Immunosuppression|immunosuppression
1597646|NCT00403403|SCLC|sclc
1597647|NCT00403403|SALUTE|salute
1597648|NCT00403403|Lung Cancer|lung cancer
1597649|NCT00403403|Avastin|avastin
1597650|NCT00403377|melanoma|melanoma
1597651|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1597652|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1597653|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
1597654|NCT00403364|Treatment|treatment
1597655|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
1597656|NCT00403351|Risk|risk
1597657|NCT00403351|Coronary artery disease|coronary artery disease
1597658|NCT00403351|Heart Rate variability|heart rate variability
1597659|NCT00403351|Pulse wave analysis|pulse wave analysis
1597660|NCT00403351|BNP|bnp
1597661|NCT00403351|CRP|crp
1597662|NCT00403338|myocardial ischemia|myocardial ischemia
1597663|NCT00403338|coronary disease|coronary disease
1597664|NCT00403338|heart disease|heart disease
1597665|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
1597666|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
1597667|NCT00403312|Physical Activity|physical activity
1597668|NCT00403312|Wellness Programs|wellness programs
1597669|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
1597670|NCT00403299|Coronary artery disease|coronary artery disease
1597671|NCT00403299|Cardiac transplantation|cardiac transplantation
1597672|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
1597673|NCT00403286|Chronic|chronic
1597674|NCT00403286|Obstructive|obstructive
1597675|NCT00403286|Pulmonary|pulmonary
1597676|NCT00403286|Disease|disease
1597677|NCT00403286|COPD|copd
1597678|NCT00403286|Safety|safety
1597679|NCT00403286|Efficacy|efficacy
1597680|NCT00403286|Pharmacokinetic|pharmacokinetic
1597681|NCT00403286|Dose-finding|dose-finding
1597682|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
1597683|NCT00403273|Botulinum Toxin A|botulinum toxin a
1597684|NCT00403273|Randomized Controlled Trial|randomized controlled trial
1597685|NCT00403273|Pain and Function|pain and function
1597686|NCT00403260|malaria|malaria
1597687|NCT00403260|ACT|act
1597688|NCT00403260|P falciparum|p falciparum
1597689|NCT00403260|pyronaridine|pyronaridine
1597690|NCT00403260|artesunate|artesunate
1597691|NCT00403247|Schizophrenia|schizophrenia
1597692|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
1597693|NCT00403247|Homocysteine|homocysteine
1597694|NCT00403247|Vitamins|vitamins
1597695|NCT00403234|Postoperative pain|postoperative pain
1597696|NCT00403234|opioid|opioid
1597697|NCT00403234|transdermal|transdermal
1597698|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
1597699|NCT00403221|Gene therapy|gene therapy
1597700|NCT00403221|Prostate cancer|prostate cancer
1597701|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
1597702|NCT00403221|Phase I clinical trial|phase i clinical trial
1597703|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
1597704|NCT00403208|Sedation|sedation
1597705|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
1597706|NCT00403182|recurrent breast cancer|recurrent breast cancer
1597707|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
1597708|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
1597709|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
1597710|NCT00403182|stage IV breast cancer|stage iv breast cancer
1597711|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
1597712|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
1597713|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
1597714|NCT00403156|Macular Degeneration|macular degeneration
1597715|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
1597716|NCT00403117|Naltrexone|naltrexone
1597717|NCT00403117|Smoked Marijuana|smoked marijuana
1597718|NCT00403104|ONO-2506PO|ono-2506po
1597719|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1597720|NCT00403104|ALS|als
1597721|NCT00403091|Diabetes mellitus|diabetes mellitus
1597722|NCT00403091|Internet|internet
1597723|NCT00403091|Education, Professional|education, professional
1597724|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
1597725|NCT00403091|Quality of Health Care|quality of health care
1597726|NCT00403091|Hypertension|hypertension
1597727|NCT00403091|Hyperlipidemia|hyperlipidemia
1597728|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
1597729|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1597730|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1597810|NCT00402896|Lung Cancer|lung cancer
1597731|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
1597732|NCT00403052|colorectal|colorectal
1597733|NCT00403052|cancer|cancer
1597734|NCT00403052|carcinoma|carcinoma
1597735|NCT00403052|metastatic|metastatic
1597736|NCT00403052|colon|colon
1597737|NCT00403052|rectal|rectal
1597738|NCT00403052|neoplasm|neoplasm
1597739|NCT00403052|cetuximab|cetuximab
1597740|NCT00403052|irinotecan|irinotecan
1597741|NCT00403052|1018 ISS|1018 iss
1597742|NCT00403052|combination therapy|combination therapy
1597743|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
1597744|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
1597745|NCT00403026|Intravitreal injection|intravitreal injection
1597746|NCT00403026|VEGF|vegf
1597747|NCT00403026|CRVO|crvo
1597748|NCT00403026|BRVO|brvo
1597749|NCT00403026|PDR|pdr
1597750|NCT00403026|CNVM|cnvm
1597751|NCT00403013|nerve block/*methods|nerve block/*methods
1597752|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
1597753|NCT00403013|*Brachial Plexus|*brachial plexus
1597754|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
1597755|NCT00402987|sore throat|sore throat
1597756|NCT00402987|acute pain|acute pain
1597757|NCT00402974|osteocalcin|osteocalcin
1597758|NCT00402974|vitamin K|vitamin k
1597759|NCT00402974|carboxylation|carboxylation
1597760|NCT00402974|healthy children|healthy children
1597761|NCT00402961|Acupuncture|acupuncture
1597762|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
1597763|NCT00402961|Abdominal Surgery|abdominal surgery
1597764|NCT00402961|Colon Surgery|colon surgery
1597765|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
1597766|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1597767|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1597768|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
1597769|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
1597770|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1597771|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1597772|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1597773|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1597774|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1597858|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
1597775|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1597776|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1597777|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1597778|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1597779|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1597780|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1597781|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1597782|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1597903|NCT00402597|Aspirin|aspirin
1597783|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1597784|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1597785|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1597786|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1597787|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1597788|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1597789|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1597790|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1597791|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1597792|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1597793|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1597794|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1597795|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1597796|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1597797|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1597798|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1597799|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1597800|NCT00402922|Coronary Heart Disease|coronary heart disease
1597801|NCT00402909|Type 2 diabetes,|type 2 diabetes,
1597802|NCT00402909|fasting glucose,|fasting glucose,
1597803|NCT00402909|postprandial glucose,|postprandial glucose,
1597804|NCT00402909|blood sugar,|blood sugar,
1597805|NCT00402909|HbA1c,|hba1c,
1597806|NCT00402909|insulin,|insulin,
1597807|NCT00402909|glargine,|glargine,
1597808|NCT00402909|metformin,|metformin,
1597809|NCT00402909|thiazolidinedione|thiazolidinedione
1597811|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
1597812|NCT00402896|Pleural Effusion|pleural effusion
1597813|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
1597814|NCT00402896|ZD6474|zd6474
1597815|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
1597816|NCT00402896|VEGFR|vegfr
1597817|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
1597818|NCT00402896|EGFR|egfr
1597819|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1597820|NCT00402857|Parenting Education|parenting education
1597821|NCT00402857|Child, Preschool|child, preschool
1597822|NCT00402857|Preventive Intervention|preventive intervention
1597823|NCT00402857|Primary Health Care|primary health care
1597824|NCT00402857|Pediatrics|pediatrics
1597825|NCT00402857|Attention Deficit Disorders|attention deficit disorders
1597826|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
1597827|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
1597828|NCT00402844|Multicenter|multicenter
1597829|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
1597830|NCT00402844|Prospective|prospective
1597831|NCT00402844|Transvaginal mesh|transvaginal mesh
1597832|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1597833|NCT00402805|Influenza vaccine|influenza vaccine
1597834|NCT00402805|Intradermal|intradermal
1597835|NCT00402805|Lung transplantation|lung transplantation
1597836|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
1597837|NCT00402779|Oral Cancer|oral cancer
1597838|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
1597839|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
1597840|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
1597841|NCT00402779|Placebo|placebo
1597842|NCT00402779|Erlotinib|erlotinib
1597843|NCT00402779|Tarceva|tarceva
1597844|NCT00402779|OSI-774|osi-774
1597845|NCT00402766|Mesothelioma|mesothelioma
1597846|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
1597847|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
1597848|NCT00402766|PDGF-R|pdgf-r
1597849|NCT00402766|Pemetrexed|pemetrexed
1597850|NCT00402766|Alimta|alimta
1597851|NCT00402766|Cisplatin|cisplatin
1597852|NCT00402766|Imatinib Mesylate|imatinib mesylate
1597853|NCT00402766|Gleevec|gleevec
1597854|NCT00402766|Platinol|platinol
1597855|NCT00402766|Platinol-AQ|platinol-aq
1597856|NCT00402766|CDDP|cddp
1597857|NCT00402766|Ly231514|ly231514
1597859|NCT00402766|NSC-698037|nsc-698037
1597862|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
1597863|NCT00402740|Carotid|carotid
1597864|NCT00402740|Artery|artery
1597865|NCT00402740|Disease|disease
1597866|NCT00402740|Stent|stent
1597868|NCT00402740|XACT|xact
1597869|NCT00402740|EMBOSHIELD|emboshield
1597870|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1597871|NCT00402701|walking|walking
1597872|NCT00402701|motor activity|motor activity
1597873|NCT00402701|students|students
1597874|NCT00402701|schools|schools
1597875|NCT00402701|transportation|transportation
1597876|NCT00402701|motor vehicles|motor vehicles
1597877|NCT00402688|Chronic Prostatitis|chronic prostatitis
1597878|NCT00402688|Prostatitis|prostatitis
1597879|NCT00402688|levofloxacin|levofloxacin
1597880|NCT00402688|Levaquin|levaquin
1597881|NCT00402675|NSTEMI|nstemi
1597882|NCT00402675|infarction|infarction
1597883|NCT00402675|treatment|treatment
1597884|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
1597885|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
1597886|NCT00402662|everolimus|everolimus
1597887|NCT00402662|imatinib|imatinib
1597888|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
1597889|NCT00402623|sarcoidosis|sarcoidosis
1597890|NCT00402623|quercetin|quercetin
1597891|NCT00402623|supplementation|supplementation
1597892|NCT00402623|oxidative stress|oxidative stress
1597893|NCT00402623|inflammation|inflammation
1597895|NCT00402610|Tuberculosis|tuberculosis
1597896|NCT00402610|Chemoprophylaxis|chemoprophylaxis
1597897|NCT00402610|Anergy|anergy
1597898|NCT00402610|AIDS|aids
1597899|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1597900|NCT00402597|Myocardial Ischemia|myocardial ischemia
1597901|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
1597902|NCT00402597|Anti-platelet agents|anti-platelet agents
1597904|NCT00402597|Thienopyridine|thienopyridine
1597905|NCT00402597|Clopidogrel|clopidogrel
1597906|NCT00402571|acetaminophen|acetaminophen
1597907|NCT00402571|alcohol|alcohol
1597908|NCT00402571|liver injury|liver injury
1597909|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
1597910|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1597911|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
1597912|NCT00402558|Leukemia|leukemia
1597913|NCT00402558|NK Cells|nk cells
1597914|NCT00402558|Natural Killer Cells|natural killer cells
1597915|NCT00402558|Fludarabine|fludarabine
1597916|NCT00402558|Busulfan|busulfan
1597917|NCT00402558|Thymoglobulin|thymoglobulin
1597918|NCT00402558|AML|aml
1597919|NCT00402558|CML|cml
1597920|NCT00402558|MDS|mds
1597921|NCT00402558|ATG|atg
1597922|NCT00402558|Antithymocyte globulin|antithymocyte globulin
1597923|NCT00402558|Busulfex|busulfex
1597924|NCT00402558|Myleran®|myleran®
1597925|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
1597926|NCT00402558|G-CSF|g-csf
1597927|NCT00402558|Filgrastim|filgrastim
1597928|NCT00402558|Neupogen|neupogen
1597929|NCT00402558|Interleukin-2|interleukin-2
1597930|NCT00402558|IL-2|il-2
1597931|NCT00402558|Aldesleukin|aldesleukin
1597932|NCT00402558|Proleukin|proleukin
1597933|NCT00402558|Tacrolimus|tacrolimus
1597934|NCT00402558|Prograf|prograf
1597935|NCT00402558|Methotrexate|methotrexate
1597936|NCT00402545|SCCHN|scchn
1597937|NCT00402545|C-TPF|c-tpf
1597938|NCT00402545|5-FU|5-fu
1597939|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1597940|NCT00402532|Lung Transplantation|lung transplantation
1597941|NCT00402532|Immunosuppression|immunosuppression
1597942|NCT00402532|Mortality|mortality
1597943|NCT00402532|Graft rejection|graft rejection
1597944|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
1597945|NCT00402532|Opportunistic infections|opportunistic infections
1597946|NCT00402532|Nephrotoxicity|nephrotoxicity
1597947|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
1597948|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
1597949|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
1597950|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
1597951|NCT00402506|coronary|coronary
1597952|NCT00402506|surgery|surgery
1597953|NCT00402506|ischemia|ischemia
1597954|NCT00402506|reperfusion injury|reperfusion injury
1597955|NCT00402506|cardiac|cardiac
1597956|NCT00402506|heart|heart
1597957|NCT00402506|neurological|neurological
1597958|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
1597959|NCT00402506|cardioprotection|cardioprotection
1597960|NCT00402506|myocardium|myocardium
1597961|NCT00402506|myocardial|myocardial
1597962|NCT00402506|myocardial revascularization|myocardial revascularization
1597963|NCT00402493|Glaucoma|glaucoma
1597964|NCT00402493|Ocular Hypertension|ocular hypertension
1597965|NCT00402493|Xalatan|xalatan
1597966|NCT00402493|Alpahgan|alpahgan
1597967|NCT00402493|Ibuprofen|ibuprofen
1597968|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
1597971|NCT00402493|Eye Pressure|eye pressure
1597972|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
1597973|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
1597974|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
1597975|NCT00402454|HIV|hiv
1597976|NCT00402454|Tuberculosis|tuberculosis
1597977|NCT00402454|Prophylaxis|prophylaxis
1597978|NCT00402454|AIDS|aids
1597979|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
1597980|NCT00402428|Hepatitis C|hepatitis c
1597981|NCT00402428|CHC|chc
1597982|NCT00402428|HepC|hepc
1597983|NCT00402428|Genotype 1|genotype 1
1597984|NCT00402428|Hepatitis|hepatitis
1597985|NCT00402428|HCV|hcv
1597986|NCT00402415|metastatic|metastatic
1597987|NCT00402415|malignancy|malignancy
1597988|NCT00402415|advanced solid tumors|advanced solid tumors
1597989|NCT00402415|unresectable|unresectable
1597990|NCT00402415|Solid Tumors|solid tumors
1597991|NCT00402402|Tuberculin skin test|tuberculin skin test
1597992|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
1597993|NCT00402402|Chronic liver disease|chronic liver disease
1597994|NCT00402402|Liver transplantation|liver transplantation
1597995|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
1597996|NCT00402389|Perinatal Depression|perinatal depression
1597997|NCT00402389|Postpartum Depression|postpartum depression
1597998|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
1597999|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
1598000|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
1598001|NCT00402389|Pregnancy|pregnancy
1598002|NCT00402389|Psychotherapy|psychotherapy
1598003|NCT00402376|End-stage heart failure|end-stage heart failure
1598004|NCT00402376|heart failure;|heart failure;
1598005|NCT00402376|ventricular assist device;|ventricular assist device;
1598006|NCT00402376|statin;|statin;
1598007|NCT00402376|heart transplantation;|heart transplantation;
1598008|NCT00402376|myocardial function;|myocardial function;
1598009|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
1598010|NCT00402363|Lovaza|lovaza
1598011|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
1598012|NCT00402363|Omacor|omacor
1598013|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1598014|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
1598015|NCT00402337|Constipation|constipation
1598016|NCT00402337|Chronic Constipation|chronic constipation
1598017|NCT00402337|Microbia|microbia
1598018|NCT00402337|linaclotide|linaclotide
1598019|NCT00402337|linaclotide acetate|linaclotide acetate
1598020|NCT00402337|MD-1100|md-1100
1598021|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
1598022|NCT00402311|Health Services for the Aged|health services for the aged
1598023|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
1598024|NCT00402298|PTSD|ptsd
1598025|NCT00402298|MDMA|mdma
1598026|NCT00402298|psychotherapy|psychotherapy
1598027|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
1598028|NCT00402298|Israel|israel
1598029|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1598030|NCT00402285|stage I prostate cancer|stage i prostate cancer
1598031|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
1598032|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
1598033|NCT00402272|drug eluting stents|drug eluting stents
1598034|NCT00402272|stents|stents
1598035|NCT00402272|Angioplasty|angioplasty
1598036|NCT00402272|coronary artery disease|coronary artery disease
1598037|NCT00402272|total coronary occlusion|total coronary occlusion
1598038|NCT00402272|coronary artery restenosis|coronary artery restenosis
1598039|NCT00402272|stent thrombosis|stent thrombosis
1598040|NCT00402272|vascular disease|vascular disease
1598041|NCT00402272|myocardial ischemia|myocardial ischemia
1598042|NCT00402272|coronary artery stenosis|coronary artery stenosis
1598043|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
1598044|NCT00402246|Randomized Controlled Trials|randomized controlled trials
1598045|NCT00402246|Defibrillators|defibrillators
1598046|NCT00402246|Remote Consultation|remote consultation
1598047|NCT00402207|asthma|asthma
1598048|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
1598049|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
1598050|NCT00402207|exhaled breath condensate|exhaled breath condensate
1598051|NCT00402207|paediatric|paediatric
1598052|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
1598053|NCT00402207|HFA-fluticasone|hfa-fluticasone
1598054|NCT00402194|Obesity|obesity
1598055|NCT00402194|Insulin resistance|insulin resistance
1598056|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
1598057|NCT00402194|pre-diabetes|pre-diabetes
1598058|NCT00402181|Myeloma|myeloma
1598059|NCT00402181|Intravenous|intravenous
1598060|NCT00402181|Monoclonal antibody|monoclonal antibody
1598061|NCT00402181|Siltuximab|siltuximab
1598062|NCT00402181|Dexamethasone|dexamethasone
1598063|NCT00402181|CNTO 328|cnto 328
1598064|NCT00402155|electroretinogram|electroretinogram
1598065|NCT00402155|visual evoked potential|visual evoked potential
1598170|NCT00401674|elderly|elderly
1598066|NCT00402155|contrast sensitivity|contrast sensitivity
1598067|NCT00402142|HIV Infection|hiv infection
1598068|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
1598069|NCT00402142|Autologous virus|autologous virus
1598070|NCT00402142|Heat inactivated|heat inactivated
1598071|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1598072|NCT00402129|Ethnic Skin|ethnic skin
1598073|NCT00402129|Laser|laser
1598074|NCT00402129|Photobiology|photobiology
1598075|NCT00402129|Quality of life|quality of life
1598076|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
1598077|NCT00402090|thiopurines|thiopurines
1598078|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
1598079|NCT00402090|toxicity|toxicity
1598080|NCT00402090|pharmacogenomics|pharmacogenomics
1598081|NCT00402077|overweight|overweight
1598082|NCT00402077|obesity|obesity
1598083|NCT00402077|pramlintide|pramlintide
1598084|NCT00402077|Symlin|symlin
1598085|NCT00402077|sibutramine|sibutramine
1598086|NCT00402077|Meridia|meridia
1598087|NCT00402077|phentermine|phentermine
1598088|NCT00402077|Amylin|amylin
1598089|NCT00402064|bisphosphonates|bisphosphonates
1598090|NCT00402064|children|children
1598091|NCT00402064|dental|dental
1598092|NCT00402064|Osteomyelitis|osteomyelitis
1598093|NCT00402064|medication|medication
1598094|NCT00402025|Metastatic|metastatic
1598095|NCT00402025|Pancreas|pancreas
1598096|NCT00402025|Adenocarcinoma|adenocarcinoma
1598097|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1598099|NCT00401999|C-11 Raclopride|c-11 raclopride
1598100|NCT00401999|Dopamine|dopamine
1598101|NCT00401999|OPRM1|oprm1
1598102|NCT00401999|Alcohol|alcohol
1598103|NCT00401999|Healthy Volunteer|healthy volunteer
1598105|NCT00401986|Refractory Asthma|refractory asthma
1598106|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
1598107|NCT00401986|Alair System|alair system
1598108|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
1598109|NCT00401960|Enterococcus|enterococcus
1598110|NCT00401960|Daptomycin|daptomycin
1598111|NCT00401960|Endocarditis|endocarditis
1598112|NCT00401947|HCV|hcv
1598113|NCT00401947|Chronic|chronic
1598114|NCT00401947|Hepatitis|hepatitis
1598115|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
1598116|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
1598117|NCT00401908|Acute coronary syndrome|acute coronary syndrome
1598118|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
1598119|NCT00401895|Covered stents|covered stents
1598120|NCT00401895|portal hypertension|portal hypertension
1598121|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
1598122|NCT00401882|Cardiac arrest|cardiac arrest
1598123|NCT00401882|Sudden Cardiac Death|sudden cardiac death
1598124|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
1598125|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
1598126|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1598127|NCT00401869|vigor|vigor
1598128|NCT00401869|function|function
1598129|NCT00401869|well-being|well-being
1598130|NCT00401869|hand-strength|hand-strength
1598131|NCT00401869|surgery|surgery
1598132|NCT00401869|anemia|anemia
1598133|NCT00401869|transfusion|transfusion
1598134|NCT00401869|strength|strength
1598135|NCT00401869|quality-of-life|quality-of-life
1598136|NCT00401856|Cardiomyopathy|cardiomyopathy
1598137|NCT00401856|Fibrosis|fibrosis
1598138|NCT00401856|Magnetic-Resonance|magnetic-resonance
1598139|NCT00401856|Eplerenone|eplerenone
1598140|NCT00401843|multiple myeloma|multiple myeloma
1598141|NCT00401843|Monoclonal Antibody|monoclonal antibody
1598142|NCT00401843|Intravenous|intravenous
1598143|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
1598144|NCT00401843|velcade|velcade
1598145|NCT00401843|bortezomib|bortezomib
1598146|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
1598147|NCT00401830|Lacosamide|lacosamide
1598148|NCT00401830|Vimpat|vimpat
1598149|NCT00401830|Harkoseride|harkoseride
1598150|NCT00401804|Multiple Myeloma|multiple myeloma
1598151|NCT00401804|renal impairment|renal impairment
1598152|NCT00401804|Velcade|velcade
1598153|NCT00401778|Lung Cancer|lung cancer
1598154|NCT00401765|Prostatic neoplasm|prostatic neoplasm
1598155|NCT00401765|intravenous|intravenous
1598156|NCT00401765|docetaxel|docetaxel
1598157|NCT00401765|monoclonal antibody|monoclonal antibody
1598158|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
1598159|NCT00401726|Major Depressive Disorder|major depressive disorder
1598160|NCT00401726|Depression|depression
1598162|NCT00401713|submacular membrane|submacular membrane
1598163|NCT00401713|transplantation of RPE|transplantation of rpe
1598164|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
1598165|NCT00401700|influenza|influenza
1598166|NCT00401700|influenza vaccine|influenza vaccine
1598167|NCT00401700|pregnancy|pregnancy
1598168|NCT00401687|Reduced Heart Function|reduced heart function
1598169|NCT00401674|ovarian cancer|ovarian cancer
1598171|NCT00401674|weekly chemotherapy|weekly chemotherapy
1598172|NCT00401674|first-line|first-line
1598173|NCT00401648|POC|poc
1598174|NCT00401648|photosensitive|photosensitive
1598175|NCT00401648|epileptic|epileptic
1598176|NCT00401648|brivaracetam|brivaracetam
1598177|NCT00401648|PPR|ppr
1598178|NCT00401648|AED|aed
1598179|NCT00401635|advanced|advanced
1598180|NCT00401635|recurrent|recurrent
1598181|NCT00401635|chemotherapy|chemotherapy
1598182|NCT00401635|first-line|first-line
1598183|NCT00401609|elderly|elderly
1598184|NCT00401596|ALTO|alto
1598185|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
1598186|NCT00401570|Antibody|antibody
1598187|NCT00401570|Pancreas|pancreas
1598188|NCT00401570|Carcinoma|carcinoma
1598189|NCT00401570|Cancer|cancer
1598190|NCT00401570|Pancreatic|pancreatic
1598191|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
1598192|NCT00401544|anemia|anemia
1598193|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
1598194|NCT00401544|darbepoetin alfa|darbepoetin alfa
1598195|NCT00401544|cancer|cancer
1598196|NCT00401531|Hepatitis B|hepatitis b
1598197|NCT00401531|Polio|polio
1598198|NCT00401531|Diphtheria|diphtheria
1598199|NCT00401531|Pertussis|pertussis
1598200|NCT00401531|H. influenzae type b|h. influenzae type b
1598201|NCT00401518|Spinal Stenosis|spinal stenosis
1598202|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
1598203|NCT00401518|Facet Arthroplasty|facet arthroplasty
1598204|NCT00401518|Posterior Fusion|posterior fusion
1598205|NCT00401518|Facet Arthritis|facet arthritis
1598206|NCT00401505|rubella|rubella
1598207|NCT00401505|rubella vaccine|rubella vaccine
1598208|NCT00401505|postpartum|postpartum
1598209|NCT00401505|immunity|immunity
1598210|NCT00401492|elderly|elderly
1598211|NCT00401492|chemotherapy|chemotherapy
1598212|NCT00401492|quality of life|quality of life
1598213|NCT00401492|ADL|adl
1598214|NCT00401492|toxicity|toxicity
1598215|NCT00401479|GW427353|gw427353
1598216|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
1598217|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
1598218|NCT00401479|pharmacokinetics|pharmacokinetics
1598219|NCT00401479|tolerability|tolerability
1598220|NCT00401479|gastrointestinal transit|gastrointestinal transit
1598221|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
1598222|NCT00401466|home monitoring|home monitoring
1598223|NCT00401466|follow-up interval|follow-up interval
1598224|NCT00401466|remote follow-up|remote follow-up
1598225|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
1598226|NCT00401440|Induction of abortion|induction of abortion
1598227|NCT00401440|Misoprostol|misoprostol
1598228|NCT00401440|MTP in second trimester|mtp in second trimester
1598229|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
1598230|NCT00401427|HER2 overexpression|her2 overexpression
1598231|NCT00401427|combination therapy|combination therapy
1598232|NCT00401414|Warfarin|warfarin
1598233|NCT00401414|Thrombosis|thrombosis
1598234|NCT00401414|Genetics|genetics
1598235|NCT00401414|Nomogram|nomogram
1598236|NCT00401414|Pulmonary Embolism|pulmonary embolism
1598237|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
1598238|NCT00401414|Dosing|dosing
1598239|NCT00401414|INR|inr
1598240|NCT00401414|Anticoagulation|anticoagulation
1598241|NCT00401414|Therapy|therapy
1598242|NCT00401414|Orthopedic Surgery|orthopedic surgery
1598243|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
1598244|NCT00401388|Chondrosarcomas|chondrosarcomas
1598245|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
1598246|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
1598247|NCT00401388|Perifosine|perifosine
1598248|NCT00401349|Leishmania|leishmania
1598249|NCT00401349|Mif Alleles|mif alleles
1598250|NCT00401349|Colombia|colombia
1598251|NCT00401349|children|children
1598252|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
1598253|NCT00401336|Hepatic iron|hepatic iron
1598254|NCT00401336|Steatosis|steatosis
1598255|NCT00401297|Leishmaniasis|leishmaniasis
1598256|NCT00401297|L. Viannia|l. viannia
1598257|NCT00401297|Leishmania|leishmania
1598258|NCT00401297|Colombia|colombia
1598259|NCT00401258|IBS|ibs
1598260|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
1598261|NCT00401258|irritable bowel|irritable bowel
1598262|NCT00401206|dexmedetomidine|dexmedetomidine
1598263|NCT00401206|sedation|sedation
1598264|NCT00401206|bronchoscopy|bronchoscopy
1598265|NCT00401206|COPD|copd
1598266|NCT00401193|Menorrhagia|menorrhagia
1598267|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
1598268|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1598269|NCT00401167|Alzheimer's disease|alzheimer's disease
1598270|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
1598271|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
1598272|NCT00401167|memantine|memantine
1598273|NCT00401167|agitation|agitation
1598274|NCT00401167|aggression|aggression
1598275|NCT00401154|Spastic Diplegia|spastic diplegia
1598276|NCT00401154|Cerebral Palsy|cerebral palsy
1598277|NCT00401154|Children|children
1598278|NCT00401154|Adolescents|adolescents
1598279|NCT00401154|Strengthening|strengthening
1598280|NCT00401154|Endurance|endurance
1598281|NCT00401141|Systemic lupus|systemic lupus
1598282|NCT00401141|B lymphocytes|b lymphocytes
1598283|NCT00401141|transcriptomas|transcriptomas
1598284|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1598285|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
1598286|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
1598287|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
1598288|NCT00401102|self-injurious behavior|self-injurious behavior
1598289|NCT00401102|depression|depression
1598290|NCT00401102|adolescents|adolescents
1598291|NCT00401102|psychotherapy|psychotherapy
1598292|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
1598293|NCT00401089|Atypical antipsychotics|atypical antipsychotics
1598294|NCT00401089|Neurocognition impairment|neurocognition impairment
1598295|NCT00401089|obesity risk factor|obesity risk factor
1598296|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
1598297|NCT00401076|SA-001|sa-001
1598298|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
1598299|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
1598300|NCT00401076|Pancreatectomy|pancreatectomy
1598301|NCT00401063|Cancer|cancer
1598302|NCT00401063|Acupuncture|acupuncture
1598303|NCT00401063|Cancer Pain|cancer pain
1598304|NCT00401063|Quality of life|quality of life
1598305|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
1598306|NCT00401050|chiropractic|chiropractic
1598307|NCT00401050|knee pain|knee pain
1598308|NCT00401050|chiropractic manipulation|chiropractic manipulation
1598309|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
1598310|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1598311|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
1598312|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1598313|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
1598314|NCT00401024|adult gliosarcoma|adult gliosarcoma
1598315|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
1598316|NCT00401024|adult brain stem glioma|adult brain stem glioma
1598317|NCT00401024|adult mixed glioma|adult mixed glioma
1598318|NCT00401024|adult glioblastoma|adult glioblastoma
1598319|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1598320|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
1598321|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
1598322|NCT00401024|adult ependymoma|adult ependymoma
1598323|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1598324|NCT00401024|adult subependymoma|adult subependymoma
1598325|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1598326|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1598327|NCT00401011|Perifosine|perifosine
1598328|NCT00401011|Bortezomib|bortezomib
1598329|NCT00401011|Dexamethasone|dexamethasone
1598330|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
1598331|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1598332|NCT00400998|Quality of Life|quality of life
1598333|NCT00400998|Efficacy|efficacy
1598334|NCT00400998|Validation|validation
1598335|NCT00400998|Fluticasone Propionate|fluticasone propionate
1598336|NCT00400985|Heart Failure, Congestive|heart failure, congestive
1598337|NCT00400985|Diagnostic|diagnostic
1598338|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
1598339|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
1598340|NCT00400972|GlideScope|glidescope
1598341|NCT00400972|videolaryngoscopy|videolaryngoscopy
1598342|NCT00400972|intubation|intubation
1598343|NCT00400972|nasal|nasal
1598344|NCT00400972|nasotracheal|nasotracheal
1598345|NCT00400972|laryngoscopy|laryngoscopy
1598346|NCT00400972|anesthesia|anesthesia
1598347|NCT00400959|cell therapy|cell therapy
1598348|NCT00400959|acute myocardial infarction|acute myocardial infarction
1598349|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1598350|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1598351|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1598352|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1598353|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1598354|NCT00400933|Psycho-education|psycho-education
1598355|NCT00400933|Eating disorders|eating disorders
1598356|NCT00400933|Personality disorders|personality disorders
1598357|NCT00400933|Relatives and close friends|relatives and close friends
1598358|NCT00400933|Caregiver burden|caregiver burden
1598359|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1598360|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1598361|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1598457|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1598362|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1598363|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1598364|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1598365|NCT00400894|prostate cancer|prostate cancer
1598366|NCT00400894|annexin A3|annexin a3
1598367|NCT00400894|early detection|early detection
1598368|NCT00400894|exprimate urine|exprimate urine
1598369|NCT00400881|mechanical ventilation|mechanical ventilation
1598370|NCT00400881|weaning|weaning
1598371|NCT00400881|respiratory failure|respiratory failure
1598372|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
1598373|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
1598374|NCT00400855|Asthma|asthma
1598375|NCT00400855|AMP challenge|amp challenge
1598376|NCT00400842|SA-001|sa-001
1598377|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
1598378|NCT00400842|Pancreatectomy|pancreatectomy
1598379|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1598380|NCT00400816|adult mixed glioma|adult mixed glioma
1598381|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1598382|NCT00400803|Gemcitabine|gemcitabine
1598383|NCT00400803|Carboplatin|carboplatin
1598384|NCT00400803|Bevacizumab|bevacizumab
1598385|NCT00400803|Biological therapy|biological therapy
1598386|NCT00400803|Drug therapy|drug therapy
1598387|NCT00400790|neurocognitive decline|neurocognitive decline
1598388|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
1598389|NCT00400790|composite morbidity|composite morbidity
1598390|NCT00400790|postoperative care cost|postoperative care cost
1598391|NCT00400777|Valsartan|valsartan
1598392|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
1598393|NCT00400777|amlodipine|amlodipine
1598394|NCT00400777|hypertension|hypertension
1598395|NCT00400777|high blood pressure|high blood pressure
1598396|NCT00400764|NHL|nhl
1598397|NCT00400764|Follicular NHL|follicular nhl
1598398|NCT00400764|Rituxan|rituxan
1598399|NCT00400764|Apo2L/TRAIL|apo2l/trail
1598400|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
1598401|NCT00400738|HIV-1 infection|hiv-1 infection
1598402|NCT00400738|pharmacokinetics|pharmacokinetics
1598403|NCT00400738|protease inhibitor|protease inhibitor
1598404|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
1598405|NCT00400738|PIs|pis
1598406|NCT00400738|Treatment Naive|treatment naive
1598407|NCT00400725|maintenance|maintenance
1598408|NCT00400725|scalp psoriasis|scalp psoriasis
1598409|NCT00400725|Galderma|galderma
1598410|NCT00400712|mobility|mobility
1598411|NCT00400712|strength|strength
1598412|NCT00400712|balance|balance
1598413|NCT00400712|function|function
1598414|NCT00400712|reintegration|reintegration
1598415|NCT00400712|community|community
1598416|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1598417|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1598418|NCT00400686|anemia|anemia
1598419|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
1598420|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
1598421|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
1598422|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
1598423|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
1598424|NCT00400673|Adult patients|adult patients
1598425|NCT00400673|Cytogenetic risk class|cytogenetic risk class
1598426|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
1598427|NCT00400673|Risk-oriented therapy|risk-oriented therapy
1598428|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
1598429|NCT00400647|kidney transplant|kidney transplant
1598430|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
1598431|NCT00400647|quality of life|quality of life
1598432|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
1598433|NCT00400621|acetaminophen|acetaminophen
1598434|NCT00400621|alcohol|alcohol
1598435|NCT00400621|liver injury|liver injury
1598436|NCT00400608|pediatrics|pediatrics
1598437|NCT00400608|ADVAIR Inhaler|advair inhaler
1598438|NCT00400608|Asthma|asthma
1598439|NCT00400608|ADVAIR DISKUS|advair diskus
1598440|NCT00400595|peritonitis|peritonitis
1598441|NCT00400595|catheter related infection|catheter related infection
1598442|NCT00400595|exit site ointments|exit site ointments
1598443|NCT00400595|mupirocin|mupirocin
1598444|NCT00400595|Polysporin Triple|polysporin triple
1598445|NCT00400582|Heart failure|heart failure
1598446|NCT00400582|Gene polymorphism|gene polymorphism
1598447|NCT00400582|Candesartan|candesartan
1598448|NCT00400582|ACE inhibitors|ace inhibitors
1598449|NCT00400582|BNP|bnp
1598450|NCT00400582|Pharmacogenomics|pharmacogenomics
1598451|NCT00400569|Sunitinib malate|sunitinib malate
1598452|NCT00400569|SUTENT|sutent
1598453|NCT00400569|SU011248|su011248
1598454|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
1598455|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
1598456|NCT00400569|MFH|mfh
1598564|NCT00400101|Peptide|peptide
1598458|NCT00400569|Imatinib mesylate|imatinib mesylate
1598459|NCT00400569|Phase II|phase ii
1598460|NCT00400556|mobilization|mobilization
1598461|NCT00400556|ATRA|atra
1598462|NCT00400556|G-CSF|g-csf
1598463|NCT00400556|filgrastim|filgrastim
1598464|NCT00400556|retinoids|retinoids
1598465|NCT00400556|stem cell mobilization|stem cell mobilization
1598466|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
1598467|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
1598468|NCT00400543|arterial stiffness|arterial stiffness
1598469|NCT00400543|atherosclerosis|atherosclerosis
1598470|NCT00400543|CPAP|cpap
1598471|NCT00400543|heart disease|heart disease
1598472|NCT00400517|stage III prostate cancer|stage iii prostate cancer
1598473|NCT00400517|stage II prostate cancer|stage ii prostate cancer
1598474|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1598475|NCT00400517|stage I prostate cancer|stage i prostate cancer
1598476|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
1598477|NCT00400504|Thrombelastograph|thrombelastograph
1598478|NCT00400504|Cancer|cancer
1598479|NCT00400504|Thromboembolism|thromboembolism
1598480|NCT00400504|Hypercoagulable|hypercoagulable
1598481|NCT00400491|diabetes|diabetes
1598482|NCT00400491|insulin|insulin
1598483|NCT00400491|glycated hemoglobin|glycated hemoglobin
1598484|NCT00400491|cholecalciferol|cholecalciferol
1598485|NCT00400491|vitamin D|vitamin d
1598486|NCT00400478|DLBCL|dlbcl
1598487|NCT00400478|NHL 13|nhl 13
1598488|NCT00400478|Rituximab|rituximab
1598489|NCT00400478|maintenance|maintenance
1598490|NCT00400465|thyroid|thyroid
1598491|NCT00400465|thyroidectomy|thyroidectomy
1598492|NCT00400465|dressing|dressing
1598493|NCT00400452|wheelchair|wheelchair
1598494|NCT00400452|skills|skills
1598495|NCT00400452|long-term-care|long-term-care
1598496|NCT00400452|caregivers|caregivers
1598497|NCT00400426|Palliative radiotherapy|palliative radiotherapy
1598498|NCT00400426|Recurrent|recurrent
1598499|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
1598500|NCT00400426|Quality of life|quality of life
1598501|NCT00400413|Neuropsychology|neuropsychology
1598502|NCT00400413|fMRI|fmri
1598503|NCT00400413|Reading|reading
1598504|NCT00400413|Phonology|phonology
1598505|NCT00400413|Deafness|deafness
1598506|NCT00400400|RenalTransplantation|renaltransplantation
1598507|NCT00400400|KidneyTransplantation|kidneytransplantation
1598508|NCT00400400|MPA|mpa
1598509|NCT00400400|EC-MPS|ec-mps
1598510|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
1598511|NCT00400374|Head and Neck Cancer|head and neck cancer
1598512|NCT00400335|Testosterone|testosterone
1598513|NCT00400335|Men|men
1598514|NCT00400335|Hypogonadism|hypogonadism
1598515|NCT00400335|Dutasteride|dutasteride
1598516|NCT00400335|DHT|dht
1598517|NCT00400335|Androgen deficiency|androgen deficiency
1598518|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
1598519|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
1598520|NCT00400322|antiviral treatment|antiviral treatment
1598521|NCT00400322|valganciclovir|valganciclovir
1598522|NCT00400270|Asthma|asthma
1598523|NCT00400270|Randomised controlled trial|randomised controlled trial
1598524|NCT00400270|Breathing exercises|breathing exercises
1598525|NCT00400270|Relaxation exercises|relaxation exercises
1598526|NCT00400270|Primary care|primary care
1598527|NCT00400257|Heart Failure|heart failure
1598528|NCT00400257|BNP|bnp
1598529|NCT00400244|wheelchairs|wheelchairs
1598530|NCT00400244|skills|skills
1598531|NCT00400244|french|french
1598532|NCT00400231|metabolic syndrome|metabolic syndrome
1598533|NCT00400231|Triglycerides|triglycerides
1598534|NCT00400231|Insulin Resistance|insulin resistance
1598535|NCT00400231|inflammation|inflammation
1598536|NCT00400231|Cardiovascular Disease|cardiovascular disease
1598537|NCT00400231|Elevated triglycerides|elevated triglycerides
1598538|NCT00400231|without diabetes|without diabetes
1598539|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
1598540|NCT00400192|Microchimerism|microchimerism
1598541|NCT00400192|Injuries|injuries
1598542|NCT00400192|Leukocytes|leukocytes
1598543|NCT00400192|Immunologic Techniques|immunologic techniques
1598544|NCT00400179|Gastric Cancer|gastric cancer
1598545|NCT00400166|Peer support|peer support
1598546|NCT00400166|Psychiatric disability|psychiatric disability
1598547|NCT00400166|Mutual support|mutual support
1598548|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
1598549|NCT00400140|Myopia, defocus|myopia, defocus
1598550|NCT00400127|transfemoral amputee|transfemoral amputee
1598551|NCT00400127|silicon suspension|silicon suspension
1598552|NCT00400127|balance|balance
1598553|NCT00400127|gait|gait
1598554|NCT00400114|esophageal|esophageal
1598555|NCT00400114|esophagus|esophagus
1598556|NCT00400114|cancer|cancer
1598557|NCT00400114|sutent|sutent
1598558|NCT00400114|sunitinib|sunitinib
1598559|NCT00400101|Malaria|malaria
1598560|NCT00400101|Vaccine|vaccine
1598561|NCT00400101|Plasmodium|plasmodium
1598562|NCT00400101|falciparum|falciparum
1598563|NCT00400101|Phase I|phase i
1598567|NCT00400101|immunogenicity|immunogenicity
1598568|NCT00400088|Major Depressive Disorder|major depressive disorder
1598569|NCT00400088|Depression|depression
1598570|NCT00400088|Bipolar Disorder|bipolar disorder
1598571|NCT00400088|Manic Depressive Illness|manic depressive illness
1598572|NCT00400088|Randomized Trial|randomized trial
1598873|NCT00398684|prophylaxis|prophylaxis
1598573|NCT00400088|Antidepressant Treatment|antidepressant treatment
1598574|NCT00400088|Lithium Treatment|lithium treatment
1598575|NCT00400075|Polyarteritis|polyarteritis
1598576|NCT00400075|Vasculitis|vasculitis
1598577|NCT00400075|Therapy|therapy
1598578|NCT00400075|Cyclophosphamide|cyclophosphamide
1598579|NCT00400075|Azathioprine|azathioprine
1598580|NCT00400062|Critical care|critical care
1598581|NCT00400062|delirium|delirium
1598582|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
1598583|NCT00400062|mechanical ventilation|mechanical ventilation
1598584|NCT00400062|critical illness|critical illness
1598585|NCT00400062|dementia|dementia
1598586|NCT00400062|aging|aging
1598587|NCT00400062|sedatives and analgesics|sedatives and analgesics
1598588|NCT00400036|cod protein|cod protein
1598589|NCT00400036|insulin sensitivity|insulin sensitivity
1598590|NCT00400036|plasma lipids|plasma lipids
1598591|NCT00400036|glucose tolerance|glucose tolerance
1598592|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
1598593|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
1598594|NCT00400036|type 2 diabetes|type 2 diabetes
1598595|NCT00400036|humans|humans
1598596|NCT00400023|Advanced Solid Tumors|advanced solid tumors
1598597|NCT00400010|Expert system|expert system
1598598|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
1598599|NCT00400010|Brief intervention|brief intervention
1598600|NCT00400010|General hospital|general hospital
1598601|NCT00399997|Exercise|exercise
1598602|NCT00399997|Exercise referral|exercise referral
1598603|NCT00399997|Lifestyle diseases|lifestyle diseases
1598604|NCT00399997|Sedentary behavior|sedentary behavior
1598605|NCT00399984|Continuing Medical Education|continuing medical education
1598606|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
1598607|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
1598811|NCT00398996|Opportunistic infections|opportunistic infections
1598608|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
1598609|NCT00399971|C15.378.071.085|c15.378.071.085
1598610|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
1598611|NCT00399932|metabolic syndrome|metabolic syndrome
1598612|NCT00399932|insulin resistance|insulin resistance
1598613|NCT00399932|NASH|nash
1598614|NCT00399932|hepatic fibrosis|hepatic fibrosis
1598615|NCT00399932|Fibroscan|fibroscan
1598616|NCT00399932|elastography by MRI|elastography by mri
1598617|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
1598618|NCT00399919|Claudication|claudication
1598619|NCT00399919|Exercise|exercise
1598620|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
1598621|NCT00399893|Childhood obesity|childhood obesity
1598622|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
1598623|NCT00399893|Octreotide|octreotide
1598624|NCT00399893|Ghrelin|ghrelin
1598625|NCT00399893|Weight loss|weight loss
1598626|NCT00399893|Body composition|body composition
1598627|NCT00399893|Energy expenditure|energy expenditure
1598628|NCT00399880|Clinical Trial|clinical trial
1598629|NCT00399880|Behavioral/Social|behavioral/social
1598630|NCT00399880|Cardiovascular Disease|cardiovascular disease
1598631|NCT00399880|Risk Factors/Analysis|risk factors/analysis
1598632|NCT00399867|multiple myeloma|multiple myeloma
1598633|NCT00399867|refractory|refractory
1598634|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
1598635|NCT00399841|Pain|pain
1598636|NCT00399841|Chronic Pain|chronic pain
1598637|NCT00399841|Neurostimulation|neurostimulation
1598638|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
1598639|NCT00399815|HCV RNA|hcv rna
1598640|NCT00399815|Fibroscan|fibroscan
1598641|NCT00399815|Fibrotest|fibrotest
1598642|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
1598643|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
1598644|NCT00399789|Perifosine|perifosine
1598645|NCT00399776|bone mineral|bone mineral
1598646|NCT00399776|antipsychotic therapy|antipsychotic therapy
1598647|NCT00399776|bone mineral accrual|bone mineral accrual
1598648|NCT00399776|bone mineral content|bone mineral content
1598649|NCT00399763|Adolescent|adolescent
1598650|NCT00399763|ADHD|adhd
1598651|NCT00399763|SUD|sud
1598652|NCT00399737|ACE activity|ace activity
1598653|NCT00399737|Fermented milk peptides|fermented milk peptides
1598654|NCT00399737|Healthy male volunteers|healthy male volunteers
1598655|NCT00399698|Severe conduct problems|severe conduct problems
1598656|NCT00399698|Risperidone|risperidone
1598657|NCT00399698|Risperdal|risperdal
1598658|NCT00399685|HIV|hiv
1598659|NCT00399672|HCV|hcv
1598660|NCT00399672|injection drug users|injection drug users
1598661|NCT00399672|ribavirin|ribavirin
1598662|NCT00399672|pegylated interferon|pegylated interferon
1598663|NCT00399672|illicit drug users|illicit drug users
1598664|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
1598665|NCT00399633|VIP|vip
1598666|NCT00399633|PACAP|pacap
1598667|NCT00399633|CGRP|cgrp
1598668|NCT00399633|Prostanoids|prostanoids
1598669|NCT00399620|Periodontitis|periodontitis
1598670|NCT00399620|Diabetes|diabetes
1598671|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
1598672|NCT00399620|GCF|gcf
1598673|NCT00399620|Saliva|saliva
1598674|NCT00399620|Chromogranin|chromogranin
1598675|NCT00399620|Electrophorèse|electrophorèse
1598676|NCT00399620|Western Blot|western blot
1598677|NCT00399620|RT-HPLC|rt-hplc
1598678|NCT00399607|colonic neoplasms|colonic neoplasms
1598679|NCT00399607|colorectal adenoma|colorectal adenoma
1598680|NCT00399607|calcium|calcium
1598681|NCT00399607|vitamin D|vitamin d
1598682|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
1598683|NCT00399594|Biventricular pacing|biventricular pacing
1598684|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
1598685|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1598686|NCT00399581|Acute Lung Injury|acute lung injury
1598687|NCT00399581|Mechanical Ventilation|mechanical ventilation
1598688|NCT00399581|Lung|lung
1598689|NCT00399568|Pain|pain
1598690|NCT00399568|Gynecologic|gynecologic
1598691|NCT00399568|IV Acetaminophen|iv acetaminophen
1598692|NCT00399568|Postoperative|postoperative
1598693|NCT00399568|Analgesic|analgesic
1598694|NCT00399555|Single Ventricle|single ventricle
1598695|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
1598696|NCT00399555|Developmental|developmental
1598697|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
1598698|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
1598699|NCT00399516|Pain|pain
1598700|NCT00399516|Neurostimulation|neurostimulation
1598701|NCT00399516|Back pain|back pain
1598702|NCT00399516|Chronic Pain|chronic pain
1598703|NCT00399503|Noninvasive assessment|noninvasive assessment
1598704|NCT00399503|Combined parameter|combined parameter
1598705|NCT00399503|Holter|holter
1598706|NCT00399490|Monoclonal antibody|monoclonal antibody
1598707|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1598708|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
1598709|NCT00399464|alfuzosin|alfuzosin
1598710|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
1598711|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
1598712|NCT00399451|polidocanol|polidocanol
1598713|NCT00399451|sclerotherapy|sclerotherapy
1598714|NCT00399451|pharynges|pharynges
1598715|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
1598716|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
1598717|NCT00399425|Bemiparin|bemiparin
1598718|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
1598719|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
1598720|NCT00399425|Primary Health Care|primary health care
1598721|NCT00399412|S-ICD|s-icd
1598722|NCT00399412|ICD|icd
1598723|NCT00399412|ECG signals|ecg signals
1598724|NCT00399412|Resting|resting
1598725|NCT00399399|Churg-Strauss|churg-strauss
1598726|NCT00399399|Vasculitis|vasculitis
1598727|NCT00399399|Therapy|therapy
1598728|NCT00399399|Cyclophosphamide|cyclophosphamide
1598729|NCT00399399|Azathioprine|azathioprine
1598730|NCT00399386|S ICD|s icd
1598731|NCT00399386|ICD|icd
1598732|NCT00399386|Ablation|ablation
1598733|NCT00399386|EP study|ep study
1598734|NCT00399386|Paediatric|paediatric
1598735|NCT00399386|ECG|ecg
1598736|NCT00399373|disease management|disease management
1598737|NCT00399373|substance abuse|substance abuse
1598738|NCT00399360|HIV|hiv
1598739|NCT00399360|Metabolic Syndrome|metabolic syndrome
1598740|NCT00399360|Lifestyle Modification|lifestyle modification
1598741|NCT00399360|Metformin|metformin
1598742|NCT00399360|Treatment Experienced|treatment experienced
1598743|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
1598744|NCT00399334|Schizophrenia|schizophrenia
1598745|NCT00399334|Schizoaffective|schizoaffective
1598746|NCT00399334|relapse|relapse
1598747|NCT00399334|risk factors|risk factors
1598748|NCT00399334|Observational study|observational study
1598749|NCT00399334|Antipsychotic medication|antipsychotic medication
1598750|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
1598751|NCT00399308|wound|wound
1598752|NCT00399308|leg|leg
1598753|NCT00399308|venous|venous
1598754|NCT00399308|chronic|chronic
1598755|NCT00399308|wound healing|wound healing
1598756|NCT00399295|Analgesia|analgesia
1598757|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
1598758|NCT00399282|Health related quality of life|health related quality of life
1598759|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
1598760|NCT00399282|Vitamin E|vitamin e
1598761|NCT00399269|Anemia|anemia
1598762|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
1598763|NCT00399256|Acetylcysteine|acetylcysteine
1598767|NCT00399243|cluster headache|cluster headache
1598768|NCT00399243|sumatriptan|sumatriptan
1598769|NCT00399217|subcutaneous ICD|subcutaneous icd
1598770|NCT00399217|ICD|icd
1598771|NCT00399217|DFT|dft
1598772|NCT00399217|Pacing threshold|pacing threshold
1598773|NCT00399217|Polarity|polarity
1598774|NCT00399191|anemia|anemia
1598775|NCT00399191|iron deficiency anemia|iron deficiency anemia
1598776|NCT00399191|iron deficiency|iron deficiency
1598777|NCT00399191|absorption|absorption
1598778|NCT00399191|iron absorption|iron absorption
1598779|NCT00399191|iron uptake|iron uptake
1598780|NCT00399178|Osteoarthritis|osteoarthritis
1598781|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
1598782|NCT00399178|Randomised|randomised
1598783|NCT00399178|Efficacy and safety|efficacy and safety
1598784|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
1598785|NCT00399165|Oral Contraception for Men|oral contraception for men
1598786|NCT00399165|Contraceptive agent|contraceptive agent
1598787|NCT00399152|Perifosine|perifosine
1598788|NCT00399152|Sunitinib Malate|sunitinib malate
1598789|NCT00399152|Renal cancer|renal cancer
1598790|NCT00399152|GIST|gist
1598791|NCT00399152|advanced cancers|advanced cancers
1598792|NCT00399074|Sickle Cell anemia|sickle cell anemia
1598793|NCT00399074|Malaria|malaria
1598794|NCT00399074|Presumptive treatment|presumptive treatment
1598795|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
1598796|NCT00399074|Children|children
1598797|NCT00399074|Uganda|uganda
1598798|NCT00399048|Pain|pain
1598799|NCT00399048|Osteoarthritis|osteoarthritis
1598800|NCT00399048|knee Osteoarthritis|knee osteoarthritis
1598801|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
1598802|NCT00399035|Colorectal Cancer|colorectal cancer
1598803|NCT00399035|Cediranib|cediranib
1598804|NCT00399035|RECENTIN|recentin
1598805|NCT00399009|Circular stapling devices|circular stapling devices
1598806|NCT00399009|anastomotic leak|anastomotic leak
1598807|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
1598808|NCT00399009|rectal cancer|rectal cancer
1598809|NCT00398996|antiretroviral therapy|antiretroviral therapy
1598810|NCT00398996|HIV|hiv
1598813|NCT00398996|Viral load|viral load
1598814|NCT00398996|TB/HIV co infection|tb/hiv co infection
1598815|NCT00398996|Treatment Naive|treatment naive
1598816|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
1598817|NCT00398983|AML|aml
1598818|NCT00398983|Remission|remission
1598819|NCT00398983|Decitabine|decitabine
1598820|NCT00398983|Maintenance Therapy|maintenance therapy
1598821|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
1598822|NCT00398970|Fluoroscopy|fluoroscopy
1598823|NCT00398970|Guide sheath|guide sheath
1598824|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
1598825|NCT00398970|Transbronchial biopsy|transbronchial biopsy
1598826|NCT00398957|Analgesia|analgesia
1598827|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
1598828|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
1598829|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
1598830|NCT00398892|Glycaemic control|glycaemic control
1598831|NCT00398892|Lipoic acid|lipoic acid
1598832|NCT00398892|Diabetic nephropathy|diabetic nephropathy
1598833|NCT00398879|Capecitabine|capecitabine
1598834|NCT00398866|Hyaluronan|hyaluronan
1598835|NCT00398866|Carpometacarpal|carpometacarpal
1598836|NCT00398866|Outcomes|outcomes
1598837|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
1598838|NCT00398853|insulin|insulin
1598839|NCT00398853|glucose|glucose
1598840|NCT00398853|chromium|chromium
1598841|NCT00398840|Cancer|cancer
1598842|NCT00398840|Solid Tumors|solid tumors
1598843|NCT00398840|advanced solid tumors|advanced solid tumors
1598844|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
1598845|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
1598846|NCT00398827|Aldrete Scoring System|aldrete scoring system
1598847|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
1598848|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
1598849|NCT00398814|Perifosine|perifosine
1598850|NCT00398814|Sorafenib|sorafenib
1598851|NCT00398814|Renal cancer|renal cancer
1598852|NCT00398814|Hepatocellular cancer|hepatocellular cancer
1598853|NCT00398814|other advanced solid tumors|other advanced solid tumors
1598854|NCT00398801|gastroparesis|gastroparesis
1598855|NCT00398788|Pain|pain
1598856|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
1598857|NCT00398775|fever of unknown origin|fever of unknown origin
1598858|NCT00398749|Anemia|anemia
1598859|NCT00398749|Neoplasms|neoplasms
1598860|NCT00398749|Antineoplastic agents|antineoplastic agents
1598861|NCT00398749|Chemotherapy|chemotherapy
1598862|NCT00398749|Efficacy|efficacy
1598863|NCT00398749|Epoetin alfa|epoetin alfa
1598864|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
1598865|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
1598866|NCT00398723|Skin biopsies|skin biopsies
1598867|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
1598868|NCT00398710|Perifosine|perifosine
1598869|NCT00398697|perifosine|perifosine
1598870|NCT00398697|gemcitabine|gemcitabine
1598871|NCT00398684|Thailand|thailand
1598872|NCT00398684|Developing countries|developing countries
1598874|NCT00398684|mother to child transmission|mother to child transmission
1598875|NCT00398684|HIV-1|hiv-1
1598876|NCT00398684|HIV-1 infection|hiv-1 infection
1598877|NCT00398684|HIV Seronegativity|hiv seronegativity
1598878|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
1598879|NCT00398671|pre-hospital setting|pre-hospital setting
1598880|NCT00398658|Endophthalmitis|endophthalmitis
1598881|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
1598882|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
1598883|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
1598884|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
1598885|NCT00398645|GW685698X|gw685698x
1598886|NCT00398645|Adults|adults
1598887|NCT00398645|Pharmacokinetics|pharmacokinetics
1598888|NCT00398645|Pharmacogenetics|pharmacogenetics
1598889|NCT00398645|Asthma|asthma
1598890|NCT00398645|Adolescents|adolescents
1598891|NCT00398593|Adherence with therapy|adherence with therapy
1598892|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
1598893|NCT00398593|Nonadherence|nonadherence
1598894|NCT00398593|Ulcerative colitis|ulcerative colitis
1598895|NCT00398580|DHT|dht
1598896|NCT00398580|Testosterone|testosterone
1598897|NCT00398580|Hypogonadism|hypogonadism
1598898|NCT00398580|Dutasteride|dutasteride
1598899|NCT00398580|Androgen deficiency|androgen deficiency
1598900|NCT00398567|HKI-272|hki-272
1598901|NCT00398567|neratinib|neratinib
1598902|NCT00398567|trastuzumab|trastuzumab
1598903|NCT00398567|breast cancer|breast cancer
1598904|NCT00398567|Nerlynx|nerlynx
1598905|NCT00398567|PB-272|pb-272
1598906|NCT00398567|HER2|her2
1598907|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1598908|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1598909|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1598910|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1598911|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1598912|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1598913|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1598914|NCT00398528|Multiple Sclerosis|multiple sclerosis
1598915|NCT00398528|Disease Modifying Therapy|disease modifying therapy
1598916|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
1598917|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
1598918|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
1598919|NCT00398489|stage II breast cancer|stage ii breast cancer
1598920|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
1598921|NCT00398476|taste|taste
1598922|NCT00398476|questionnaire|questionnaire
1598923|NCT00398476|preference|preference
1598924|NCT00398476|attributes|attributes
1598925|NCT00398476|odor|odor
1598926|NCT00398476|after taste|after taste
1598927|NCT00398476|scent|scent
1598928|NCT00398463|tirofiban|tirofiban
1598929|NCT00398463|aspirin resistance|aspirin resistance
1598930|NCT00398463|clopidogrel resistance|clopidogrel resistance
1598931|NCT00398450|recurrent melanoma|recurrent melanoma
1598932|NCT00398450|stage IV melanoma|stage iv melanoma
1598933|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
1598934|NCT00398437|stage IV breast cancer|stage iv breast cancer
1598935|NCT00398424|Impaired Hepatic Function|impaired hepatic function
1598936|NCT00398411|prophylaxis|prophylaxis
1598937|NCT00398411|bacteremia|bacteremia
1598938|NCT00398411|moxifloxacin|moxifloxacin
1598939|NCT00398411|stem cell transplantation|stem cell transplantation
1598940|NCT00398411|Hodgkin disease|hodgkin disease
1598941|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
1598942|NCT00398411|multiple myeloma|multiple myeloma
1598943|NCT00398411|solid tumor|solid tumor
1598944|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
1598945|NCT00398398|gastric cancer|gastric cancer
1598946|NCT00398398|chemotherapy|chemotherapy
1598947|NCT00398398|cetuximab|cetuximab
1598948|NCT00398398|capecitabine|capecitabine
1598949|NCT00398398|oxaliplatin|oxaliplatin
1598950|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
1598951|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
1598952|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1598953|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1598954|NCT00398385|large cell lung cancer|large cell lung cancer
1598955|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1598956|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
1598957|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
1598958|NCT00398359|Obesity|obesity
1598959|NCT00398359|Overweight|overweight
1598962|NCT00398359|Motivational|motivational
1598963|NCT00398359|Family|family
1598964|NCT00398359|Primary care|primary care
1598965|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
1598966|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
1598967|NCT00398333|Quality of Life|quality of life
1598968|NCT00398333|Nutritional Status|nutritional status
1599057|NCT00397995|Fracture|fracture
1598969|NCT00398307|Renal Impairment|renal impairment
1598970|NCT00398281|prostate cancer|prostate cancer
1598971|NCT00398268|Fracture|fracture
1598972|NCT00398268|Forearm|forearm
1598973|NCT00398268|Distal|distal
1598974|NCT00398268|Child|child
1598975|NCT00398268|Treatment|treatment
1598976|NCT00398255|arthritis|arthritis
1598977|NCT00398255|self management|self management
1598978|NCT00398255|patient education|patient education
1598979|NCT00398242|fracture|fracture
1598980|NCT00398242|forearm|forearm
1598981|NCT00398242|midshaft|midshaft
1598982|NCT00398242|child|child
1598983|NCT00398242|treatment|treatment
1598984|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
1598985|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
1598986|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
1598987|NCT00398229|implantation rate|implantation rate
1598988|NCT00398216|Anti-coagulant|anti-coagulant
1598989|NCT00398216|hip replacement|hip replacement
1598990|NCT00398216|hip replacement surgery|hip replacement surgery
1598991|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
1598992|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
1598993|NCT00398216|Venous Thromboembolism|venous thromboembolism
1598994|NCT00398216|pulmonary embolism|pulmonary embolism
1598995|NCT00398216|Prevention of Blood Clots|prevention of blood clots
1598996|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
1598997|NCT00398203|Small Intestine|small intestine
1598998|NCT00398203|Intestinal Diseases|intestinal diseases
1598999|NCT00398190|Smoking|smoking
1599000|NCT00398190|Tobacco use disorder|tobacco use disorder
1599001|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1599002|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1599003|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1599004|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1599005|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1599006|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1599007|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1599008|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1599009|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1599010|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1599011|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1599012|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1599013|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1599014|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
1599015|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1599016|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1599017|NCT00398125|GSK364735|gsk364735
1599018|NCT00398125|HIV-1|hiv-1
1599019|NCT00398125|integrase inhibitor|integrase inhibitor
1599254|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
1599020|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
1599021|NCT00398073|stage II melanoma|stage ii melanoma
1599022|NCT00398073|stage III melanoma|stage iii melanoma
1599023|NCT00398073|stage IV melanoma|stage iv melanoma
1599024|NCT00398073|recurrent melanoma|recurrent melanoma
1599025|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1599026|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1599027|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
1599028|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
1599029|NCT00398060|life-style counseling|life-style counseling
1599030|NCT00398060|type 2 diabetes|type 2 diabetes
1599031|NCT00398060|prediabetes|prediabetes
1599032|NCT00398060|physical activity|physical activity
1599033|NCT00398060|diet|diet
1599034|NCT00398060|cognitive-behavioral|cognitive-behavioral
1599035|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1599036|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1599037|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
1599038|NCT00398047|refractory anemia|refractory anemia
1599039|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1599040|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1599041|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1599042|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1599043|NCT00398034|opioids|opioids
1599044|NCT00398034|pain|pain
1599045|NCT00398034|hypogonadism|hypogonadism
1599046|NCT00398034|depression|depression
1599050|NCT00398021|constipation|constipation
1599051|NCT00398021|bowel habits|bowel habits
1599052|NCT00398008|Buprenorphine|buprenorphine
1599053|NCT00398008|Naltrexone|naltrexone
1599054|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
1599055|NCT00398008|Counseling|counseling
1599056|NCT00398008|HIV Seronegativity|hiv seronegativity
1599058|NCT00397995|Forearm|forearm
1599059|NCT00397995|Distal|distal
1599060|NCT00397995|Child|child
1599061|NCT00397995|Treatment|treatment
1599062|NCT00397969|colon cancer|colon cancer
1599063|NCT00397969|rectal cancer|rectal cancer
1599064|NCT00397969|precancerous condition|precancerous condition
1599065|NCT00397943|Tuberculosis|tuberculosis
1599066|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
1599067|NCT00397930|fatigue|fatigue
1599068|NCT00397930|sleep disorders|sleep disorders
1599069|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1599070|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1599071|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
1599072|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
1599073|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1599074|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
1599075|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
1599076|NCT00397865|Obesity|obesity
1599077|NCT00397865|Overweight|overweight
1599078|NCT00397852|Fracture|fracture
1599079|NCT00397852|Forearm|forearm
1599080|NCT00397852|Distal|distal
1599081|NCT00397852|Child|child
1599082|NCT00397852|Treatment|treatment
1599083|NCT00397839|male osteoporosis|male osteoporosis
1599084|NCT00397839|osteoporosis|osteoporosis
1599085|NCT00397839|bisphonates|bisphonates
1599086|NCT00397839|bone|bone
1599087|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1599088|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1599089|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1599090|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1599091|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1599092|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1599093|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1599094|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1599095|NCT00397774|Palliative care|palliative care
1599096|NCT00397774|Physical exercise|physical exercise
1599097|NCT00397774|Physical function|physical function
1599098|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
1599099|NCT00397761|stage II breast cancer|stage ii breast cancer
1599100|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
1599101|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
1599102|NCT00397748|Phospholipase A2|phospholipase a2
1599103|NCT00397748|D2 Receptors|d2 receptors
1599104|NCT00397748|Apomorphine|apomorphine
1599105|NCT00397748|Trimethobenzamide|trimethobenzamide
1599106|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1599107|NCT00397748|ADHD|adhd
1599108|NCT00397748|Healthy Volunteer|healthy volunteer
1599109|NCT00397748|HV|hv
1599110|NCT00397735|pregnancy|pregnancy
1599111|NCT00397735|chorioamnionitis|chorioamnionitis
1599112|NCT00397735|preterm labor|preterm labor
1599113|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
1599114|NCT00397735|Intra-amniotic infection|intra-amniotic infection
1599115|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
1599116|NCT00397722|safety|safety
1599117|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
1599118|NCT00397722|effectiveness|effectiveness
1599119|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
1599120|NCT00397709|Isoniazid.|isoniazid.
1599121|NCT00397709|Rifampin.|rifampin.
1599122|NCT00397709|Clinical trial.|clinical trial.
1599123|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
1599124|NCT00397696|Parkinson|parkinson
1599125|NCT00397696|imaging|imaging
1599126|NCT00397696|nicotinic receptors|nicotinic receptors
1599127|NCT00397657|carotid intima media thickness|carotid intima media thickness
1599128|NCT00397657|atherosclerosis|atherosclerosis
1599129|NCT00397657|niacin|niacin
1599130|NCT00397657|coronary heart disease|coronary heart disease
1599131|NCT00397657|HDL-C|hdl-c
1599132|NCT00397657|LDL-C|ldl-c
1599133|NCT00397644|pediatrician|pediatrician
1599134|NCT00397644|well-child care visit|well-child care visit
1599135|NCT00397644|low-income children|low-income children
1599136|NCT00397644|family psychosocial problem|family psychosocial problem
1599137|NCT00397605|bipolar|bipolar
1599138|NCT00397605|therapeutic potential|therapeutic potential
1599139|NCT00397605|neurocognitive performance|neurocognitive performance
1599140|NCT00397605|cannabinoids|cannabinoids
1599141|NCT00397592|Growth Hormone|growth hormone
1599142|NCT00397592|Cardiovascular System|cardiovascular system
1599143|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
1599144|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1599145|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1599146|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1599147|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1599148|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1599149|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1599150|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1599151|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1599152|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1599153|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1599154|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1599155|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
1599156|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
1599157|NCT00397579|CD123+|cd123+
1599158|NCT00397566|HIV|hiv
1599159|NCT00397566|Treatment Experienced|treatment experienced
1599160|NCT00397540|HBV DNA|hbv dna
1599161|NCT00397540|HCC|hcc
1599162|NCT00397540|recurrence|recurrence
1599163|NCT00397540|PEIT|peit
1599164|NCT00397540|RFTA|rfta
1599165|NCT00397514|Biventricular pacing|biventricular pacing
1599166|NCT00397514|Congenital heart disease|congenital heart disease
1599167|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
1599168|NCT00397501|cognitive/functional effects|cognitive/functional effects
1599169|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1599170|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1599171|NCT00397501|recurrent breast cancer|recurrent breast cancer
1599172|NCT00397501|stage IV breast cancer|stage iv breast cancer
1599173|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
1599174|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
1599175|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
1599176|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1599177|NCT00397488|anterior urethral cancer|anterior urethral cancer
1599178|NCT00397488|posterior urethral cancer|posterior urethral cancer
1599179|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
1599180|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1599181|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1599182|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1599183|NCT00397462|Osteoporosis|osteoporosis
1599184|NCT00397462|Sarcopenia|sarcopenia
1599185|NCT00397462|Calf muscle pump|calf muscle pump
1599186|NCT00397462|Venous insufficiency|venous insufficiency
1599187|NCT00397462|DEXA|dexa
1599188|NCT00397462|Soleus muscle|soleus muscle
1599189|NCT00397462|APG|apg
1599190|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
1599191|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1599192|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
1599193|NCT00397423|Randomized Control Trial Study|randomized control trial study
1599194|NCT00397410|hip protectors|hip protectors
1599195|NCT00397410|uptake and adherence|uptake and adherence
1599196|NCT00397410|Nursing home residents|nursing home residents
1599197|NCT00397410|efficacy|efficacy
1599198|NCT00397410|prevention|prevention
1599199|NCT00397397|Urinary Calculi|urinary calculi
1599200|NCT00397397|Rowatinex|rowatinex
1599201|NCT00397397|Alfuzosin|alfuzosin
1599202|NCT00397397|Drug Therapy|drug therapy
1599203|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
1599204|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
1599205|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
1599206|NCT00397345|Renal|renal
1599207|NCT00397345|TroVax|trovax
1599208|NCT00397345|survival|survival
1599209|NCT00397345|metastatic|metastatic
1599210|NCT00397345|Kidney|kidney
1599211|NCT00397345|cancer|cancer
1599212|NCT00397345|immunotherapy|immunotherapy
1599213|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
1599214|NCT00397332|GVHD|gvhd
1599215|NCT00397319|Growth Hormone|growth hormone
1599216|NCT00397319|Cardiovascular System|cardiovascular system
1599217|NCT00397293|AT101|at101
1599218|NCT00397293|AT-101|at-101
1599219|NCT00397293|cancer|cancer
1599220|NCT00397293|lung|lung
1599221|NCT00397293|small-cell|small-cell
1599222|NCT00397293|topotecan|topotecan
1599223|NCT00397280|Neutrophil|neutrophil
1599224|NCT00397280|Immunity|immunity
1599225|NCT00397280|Signal Transduction|signal transduction
1599226|NCT00397280|Lipopolysaccharide|lipopolysaccharide
1599227|NCT00397280|Cholesterol|cholesterol
1599228|NCT00397280|Healthy Volunteer|healthy volunteer
1599236|NCT00397228|dopamine transporter|dopamine transporter
1599237|NCT00397215|H5N1|h5n1
1599238|NCT00397215|influenza|influenza
1599239|NCT00397215|vaccine|vaccine
1599240|NCT00397202|Menstruation|menstruation
1599241|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
1599242|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1599243|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
1599244|NCT00397163|Troponin-T|troponin-t
1599245|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
1599246|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
1599247|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
1599248|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
1599249|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
1599250|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
1599251|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
1599252|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
1599253|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
1599255|NCT00397137|stapled anopexy|stapled anopexy
1599256|NCT00397111|Morphometry|morphometry
1599257|NCT00397111|BOLD|bold
1599258|NCT00397111|fMRI|fmri
1599259|NCT00397111|Spectrometry|spectrometry
1599260|NCT00397111|Relaxometry|relaxometry
1599261|NCT00397111|Healthy Volunteer|healthy volunteer
1599263|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
1599264|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
1599265|NCT00397059|Escitalopram|escitalopram
1599266|NCT00397059|Pharmacokinetics|pharmacokinetics
1599267|NCT00397059|Pharmacodynamics|pharmacodynamics
1599268|NCT00397059|CYP2C19|cyp2c19
1599269|NCT00397059|Pupillometry|pupillometry
1599270|NCT00397059|healthy volunteers|healthy volunteers
1599271|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1599272|NCT00397046|HKI-272|hki-272
1599273|NCT00397046|Neratinib|neratinib
1599274|NCT00397046|Nerlynx|nerlynx
1599275|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
1599276|NCT00397033|antipsychotic|antipsychotic
1599277|NCT00397033|paliperidone|paliperidone
1599278|NCT00397033|placebo|placebo
1599279|NCT00397020|quetiapine|quetiapine
1599280|NCT00397020|divalproex|divalproex
1599281|NCT00397007|tinnitus|tinnitus
1599282|NCT00397007|biofeedback|biofeedback
1599283|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
1599284|NCT00397007|intervention|intervention
1599285|NCT00396994|biomechanics|biomechanics
1599286|NCT00396994|osteogenesis|osteogenesis
1599287|NCT00396994|osteoporosis|osteoporosis
1599288|NCT00396994|bone regeneration|bone regeneration
1599289|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
1599290|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
1599291|NCT00396981|Retreatment|retreatment
1599292|NCT00396981|Raymond scale|raymond scale
1599293|NCT00396981|Matrix|matrix
1599294|NCT00396981|GDC|gdc
1599295|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
1599296|NCT00396968|AMD3100|amd3100
1599297|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
1599298|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
1599299|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1599300|NCT00396955|osteoarthritis|osteoarthritis
1599301|NCT00396955|arthritis|arthritis
1599302|NCT00396955|pain|pain
1599303|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
1599304|NCT00396942|Nerve Conduction Study|nerve conduction study
1599305|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1599306|NCT00396942|Motor Evoked Potential|motor evoked potential
1599307|NCT00396942|Parkinson Disease|parkinson disease
1599308|NCT00396942|PD|pd
1599309|NCT00396942|Healthy Volunteer|healthy volunteer
1599310|NCT00396942|HV|hv
1599311|NCT00396929|Paclitaxel|paclitaxel
1599312|NCT00396929|Restenosis|restenosis
1599313|NCT00396929|Stent|stent
1599314|NCT00396929|Intracoronary Dosis|intracoronary dosis
1599315|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
1599316|NCT00396916|cancer patients|cancer patients
1599317|NCT00396903|Anaesthetic techniques|anaesthetic techniques
1599318|NCT00396903|epidural catheters|epidural catheters
1599319|NCT00396903|paraesthesia|paraesthesia
1599320|NCT00396903|side effects.|side effects.
1599321|NCT00396890|Theta Burst Stimulation|theta burst stimulation
1599322|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
1599323|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1599324|NCT00396890|Primary Motor Cortex|primary motor cortex
1599325|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
1599326|NCT00396890|Healthy Volunteer|healthy volunteer
1599327|NCT00396890|HV|hv
1599328|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
1599329|NCT00396877|shunt palliation|shunt palliation
1599330|NCT00396877|thrombosis|thrombosis
1599331|NCT00396877|clopidogrel|clopidogrel
1599332|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
1599432|NCT00396526|India|india
1599333|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
1599334|NCT00396825|Care giving|care giving
1599335|NCT00396825|Alzheimer's Disease|alzheimer's disease
1599336|NCT00396825|Stress management|stress management
1599337|NCT00396812|Autoimmune disease|autoimmune disease
1599338|NCT00396812|Biologic response modifiers|biologic response modifiers
1599443|NCT00396500|India|india
1599339|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
1599340|NCT00396812|Immune system|immune system
1599341|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1599342|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
1599343|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
1599344|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
1599345|NCT00396760|cardiac surgery|cardiac surgery
1599346|NCT00396760|blood transfusion|blood transfusion
1599347|NCT00396760|antifibrinolytics|antifibrinolytics
1599348|NCT00396760|aprotinin|aprotinin
1599349|NCT00396760|tranexamic acid|tranexamic acid
1599350|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
1599351|NCT00396747|glucocorticoids,|glucocorticoids,
1599352|NCT00396747|pulse therapy,|pulse therapy,
1599353|NCT00396747|infliximab,|infliximab,
1599354|NCT00396747|TNF blockade|tnf blockade
1599355|NCT00396734|Imaging|imaging
1599356|NCT00396734|cocaine|cocaine
1599357|NCT00396734|methadone|methadone
1599358|NCT00396734|craving|craving
1599359|NCT00396734|PET|pet
1599360|NCT00396734|FDG|fdg
1599361|NCT00396734|D2|d2
1599362|NCT00396734|Modafinil|modafinil
1599363|NCT00396734|Topiramate|topiramate
1599364|NCT00396721|Nephropathy, IGA|nephropathy, iga
1599365|NCT00396721|Pilot trial|pilot trial
1599366|NCT00396721|Sirolimus|sirolimus
1599367|NCT00396721|Rapamune|rapamune
1599368|NCT00396708|Robotics|robotics
1599369|NCT00396708|Rehabilitation|rehabilitation
1599370|NCT00396708|Arm|arm
1599371|NCT00396708|Stroke|stroke
1599372|NCT00396708|Weakness|weakness
1599373|NCT00396708|Outpatient|outpatient
1599374|NCT00396708|Chronic|chronic
1599375|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
1599376|NCT00396682|HCC|hcc
1599377|NCT00396682|T cell|t cell
1599378|NCT00396669|Nicotine|nicotine
1599379|NCT00396669|Dopamine|dopamine
1599380|NCT00396669|Imaging|imaging
1599381|NCT00396669|Raclopride|raclopride
1599382|NCT00396669|Addiction|addiction
1599383|NCT00396669|Genetics|genetics
1599384|NCT00396656|hypertension|hypertension
1599385|NCT00396656|valsartan|valsartan
1599386|NCT00396656|atenolol|atenolol
1599387|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
1599388|NCT00396656|microcirculation|microcirculation
1599389|NCT00396656|arterial compliance|arterial compliance
1599390|NCT00396656|pulse wave analysis|pulse wave analysis
1599391|NCT00396643|Ultra-High Risk|ultra-high risk
1599392|NCT00396643|Psychosis|psychosis
1599393|NCT00396643|Schizophrenia|schizophrenia
1599394|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
1599395|NCT00396643|RCT|rct
1599396|NCT00396630|Transmission|transmission
1599397|NCT00396630|Gastroenteritis|gastroenteritis
1599398|NCT00396630|Shedding|shedding
1599399|NCT00396630|rotavirus|rotavirus
1599400|NCT00396630|HRV vaccine|hrv vaccine
1599401|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
1599402|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
1599403|NCT00396617|titanium beads,|titanium beads,
1599404|NCT00396617|cellular colonization|cellular colonization
1599405|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
1599406|NCT00396604|indacaterol|indacaterol
1599407|NCT00396604|long acting beta agonist|long acting beta agonist
1599408|NCT00396591|Ovarian cancer|ovarian cancer
1599409|NCT00396591|malignant ascites|malignant ascites
1599410|NCT00396591|angiogenesis|angiogenesis
1599411|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
1599412|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
1599413|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
1599414|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
1599415|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
1599416|NCT00396578|bacterial resistance|bacterial resistance
1599417|NCT00396565|Schizophrenia|schizophrenia
1599418|NCT00396565|JNS007ER|jns007er
1599419|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
1599420|NCT00396565|Paliperidone|paliperidone
1599421|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
1599422|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
1599423|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
1599424|NCT00396552|randomized|randomized
1599425|NCT00396552|placebo-controlled|placebo-controlled
1599426|NCT00396552|double-blind|double-blind
1599427|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
1599428|NCT00396526|treatment|treatment
1599429|NCT00396526|underfives|underfives
1599430|NCT00396526|children|children
1599431|NCT00396526|Community|community
1599436|NCT00396513|Testosterone|testosterone
1599437|NCT00396513|Menstrual cycle|menstrual cycle
1599438|NCT00396513|Lipids|lipids
1599439|NCT00396500|Deworming|deworming
1599440|NCT00396500|Malnutrition|malnutrition
1599441|NCT00396500|children|children
1599442|NCT00396500|Community|community
1599444|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
1599445|NCT00396487|tailored treatment|tailored treatment
1599446|NCT00396487|genetic markers|genetic markers
1599447|NCT00396487|gene polymorphism|gene polymorphism
1599448|NCT00396487|chemotherapy|chemotherapy
1599449|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
1599450|NCT00396461|Critical Illness|critical illness
1599451|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
1599452|NCT00396461|Superinfection|superinfection
1599453|NCT00396461|Parenteral Nutrition|parenteral nutrition
1599454|NCT00396435|anaemia|anaemia
1599455|NCT00396435|renal transplantation|renal transplantation
1599456|NCT00396435|kidney failure|kidney failure
1599457|NCT00396422|psoriasis|psoriasis
1599458|NCT00396422|skin|skin
1599459|NCT00396422|auto immune|auto immune
1599460|NCT00396396|Creatinine clearance|creatinine clearance
1599461|NCT00396396|Acetylcysteine|acetylcysteine
1599462|NCT00396383|Multiple Myeloma|multiple myeloma
1599463|NCT00396383|Stem cell mobilization|stem cell mobilization
1599464|NCT00396383|apheresis|apheresis
1599465|NCT00396370|tuberculosis, Bacillus Calmette-Guérin, parent protocol|tuberculosis, bacillus calmette-guérin, parent protocol
1599466|NCT00396357|Type 2 diabetes|type 2 diabetes
1599467|NCT00396357|vildagliptin|vildagliptin
1599468|NCT00396357|hemoglobin A1c|hemoglobin a1c
1599469|NCT00396357|metformin|metformin
1599470|NCT00396344|Systemic sepsis|systemic sepsis
1599471|NCT00396331|Multiple Myeloma|multiple myeloma
1599472|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1599473|NCT00396331|autologous transplantation|autologous transplantation
1599474|NCT00396331|AMD3100|amd3100
1599475|NCT00396331|stem cell mobilization|stem cell mobilization
1599476|NCT00396331|plerixafor|plerixafor
1599477|NCT00396318|TNKase|tnkase
1599478|NCT00396318|CVA|cva
1599479|NCT00396318|CVAD|cvad
1599480|NCT00396318|Central venous access catheter|central venous access catheter
1599481|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
1599482|NCT00396292|Anemia|anemia
1599483|NCT00396292|postpartum|postpartum
1599484|NCT00396292|Postpartum anemia|postpartum anemia
1599485|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
1599486|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1599487|NCT00396266|Multiple Myeloma|multiple myeloma
1599488|NCT00396266|stem cell mobilization|stem cell mobilization
1599489|NCT00396266|AMD3100|amd3100
1599490|NCT00396266|autologous transplantation|autologous transplantation
1599491|NCT00396253|HD|hd
1599492|NCT00396253|TNKase|tnkase
1599493|NCT00396253|Hemodialysis|hemodialysis
1599494|NCT00396253|Catheter clearance|catheter clearance
1599495|NCT00396240|rosuvastatin|rosuvastatin
1599496|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
1599497|NCT00396240|cholesterol|cholesterol
1599498|NCT00396240|LDL-C|ldl-c
1599499|NCT00396240|triglyceride|triglyceride
1599500|NCT00396240|plasma lipids|plasma lipids
1599501|NCT00396240|compliance|compliance
1599502|NCT00396227|Type 2 diabetes|type 2 diabetes
1599503|NCT00396227|vildagliptin|vildagliptin
1599504|NCT00396227|hemoglobin A1c|hemoglobin a1c
1599505|NCT00396227|metformin|metformin
1599506|NCT00396214|Schizophrenia|schizophrenia
1599507|NCT00396214|weight changes|weight changes
1599508|NCT00396201|Hodgkin's Disease|hodgkin's disease
1599509|NCT00396201|Stem cell mobilization|stem cell mobilization
1599510|NCT00396201|apheresis|apheresis
1599511|NCT00396188|Keratoconus|keratoconus
1599512|NCT00396188|LASIK|lasik
1599513|NCT00396188|Orthokeratology|orthokeratology
1599514|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
1599515|NCT00396188|Refractive Surgery|refractive surgery
1599516|NCT00396188|normal cornea|normal cornea
1599517|NCT00396188|post myopic LASIK|post myopic lasik
1599518|NCT00396188|post hyperopic LASIK|post hyperopic lasik
1599519|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
1599520|NCT00396149|rBet v 1|rbet v 1
1599521|NCT00396149|Birch pollen allergy|birch pollen allergy
1599522|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
1599523|NCT00396136|Congestive Heart Failure|congestive heart failure
1599524|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1599525|NCT00396136|Left Ventricular Lead|left ventricular lead
1599526|NCT00396123|Chronic Kidney Disease|chronic kidney disease
1599527|NCT00396123|Anemia|anemia
1599528|NCT00396110|cholesterol|cholesterol
1599529|NCT00396110|coronary heart disease|coronary heart disease
1599530|NCT00396110|rosuvastatin|rosuvastatin
1599531|NCT00396110|LDL-C goal|ldl-c goal
1599532|NCT00396110|hypercholesterolemia|hypercholesterolemia
1599533|NCT00396097|ISS|iss
1599534|NCT00396097|human growth hormone|human growth hormone
1599840|NCT00394940|Proteomics|proteomics
1599535|NCT00396084|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, Brazil|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, brazil
1599536|NCT00396071|Type 2 diabetes|type 2 diabetes
1599537|NCT00396071|vildagliptin|vildagliptin
1599538|NCT00396071|incretin effect|incretin effect
1599539|NCT00396071|metformin|metformin
1599540|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
1599541|NCT00396032|HD|hd
1599542|NCT00396032|Hemodialysis|hemodialysis
1599543|NCT00396032|Catheter clearance|catheter clearance
1599544|NCT00396032|TNKase|tnkase
1599545|NCT00396032|Renal Insufficiency|renal insufficiency
1599546|NCT00395993|anemia|anemia
1599547|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
1599548|NCT00395993|menorrhagia|menorrhagia
1599549|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
1599550|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1599551|NCT00395967|Multiple Myeloma|multiple myeloma
1599552|NCT00395967|stem cell mobilization|stem cell mobilization
1599553|NCT00395967|autologous transplantation|autologous transplantation
1599554|NCT00395967|AMD3100|amd3100
1599555|NCT00395954|Lactose Intolerance|lactose intolerance
1599556|NCT00395954|Lactose|lactose
1599557|NCT00395954|Threshold|threshold
1599558|NCT00395928|heart|heart
1599559|NCT00395928|echocardiography|echocardiography
1599560|NCT00395928|diastolic function|diastolic function
1599561|NCT00395928|left ventricle|left ventricle
1599562|NCT00395928|right ventricle|right ventricle
1599563|NCT00395928|cigarette smoking|cigarette smoking
1599565|NCT00395928|Heart Ventricles|heart ventricles
1599566|NCT00395928|Diastole|diastole
1599567|NCT00395928|Doppler Echocardiography|doppler echocardiography
1599568|NCT00395915|schizophrenia|schizophrenia
1599569|NCT00395915|antipsychotics|antipsychotics
1599570|NCT00395915|treatment non response|treatment non response
1599571|NCT00395915|pragmatic trial|pragmatic trial
1599572|NCT00395902|Sensipar|sensipar
1599573|NCT00395902|cinacalcet|cinacalcet
1599574|NCT00395902|Mimpara|mimpara
1599575|NCT00395889|Lung Transplantation|lung transplantation
1599576|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
1599577|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
1599578|NCT00395889|Functional Status|functional status
1599579|NCT00395876|TNKase|tnkase
1599580|NCT00395876|CVA|cva
1599581|NCT00395876|CVAD|cvad
1599582|NCT00395876|Central venous access catheter|central venous access catheter
1599583|NCT00395876|CVA catheter|cva catheter
1599584|NCT00395850|cocaine dependence|cocaine dependence
1599585|NCT00395850|disulfiram|disulfiram
1599586|NCT00395850|clinical trial|clinical trial
1599587|NCT00395850|methadone maintenance|methadone maintenance
1599588|NCT00395850|pharmacogenetics|pharmacogenetics
1599589|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
1599590|NCT00395837|Aging|aging
1599591|NCT00395837|Wellness|wellness
1599592|NCT00395837|Aerobic exercise|aerobic exercise
1599593|NCT00395837|Prevention|prevention
1599594|NCT00395824|citrate|citrate
1599595|NCT00395824|anticoagulation|anticoagulation
1599596|NCT00395824|heparin-coated membrane|heparin-coated membrane
1599597|NCT00395811|Myocardial Infarction|myocardial infarction
1599598|NCT00395811|stem cell therapy|stem cell therapy
1599599|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1599600|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
1599601|NCT00395798|cervical spondylosis|cervical spondylosis
1599602|NCT00395798|radiculopathy|radiculopathy
1599603|NCT00395798|neck collar|neck collar
1599604|NCT00395798|brace|brace
1599605|NCT00395798|physiotherapy|physiotherapy
1599606|NCT00395798|treatment|treatment
1599607|NCT00395798|rehabilitation|rehabilitation
1599608|NCT00395785|Carotid stenosis|carotid stenosis
1599609|NCT00395785|Intracranial Embolism|intracranial embolism
1599610|NCT00395785|Carotid artery|carotid artery
1599611|NCT00395785|Carotid stent|carotid stent
1599612|NCT00395785|Embolic protection|embolic protection
1599613|NCT00395785|TriActiv ProGuard System|triactiv proguard system
1599614|NCT00395785|Carotid angioplasty|carotid angioplasty
1599615|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
1599616|NCT00395759|contrast sensitivity|contrast sensitivity
1599617|NCT00395733|Gadovist|gadovist
1599618|NCT00395733|Gadavist|gadavist
1599619|NCT00395733|MRI Imaging|mri imaging
1599620|NCT00395733|vascular diseases|vascular diseases
1599621|NCT00395733|Chinese|chinese
1599622|NCT00395720|TB|tb
1599623|NCT00395720|Tuberculosis|tuberculosis
1599624|NCT00395720|HIV|hiv
1599625|NCT00395720|Vaccine|vaccine
1599626|NCT00395720|MVA85A|mva85a
1599627|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1599628|NCT00395707|Macular Degeneration|macular degeneration
1599629|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
1599630|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
1599631|NCT00395694|epilepsy|epilepsy
1599632|NCT00395694|Incidence of rash|incidence of rash
1599633|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
1600129|NCT00393731|labor|labor
1599634|NCT00395694|patients with Valproic acid|patients with valproic acid
1599635|NCT00395681|Obesity|obesity
1599636|NCT00395681|Propofol|propofol
1599637|NCT00395681|Morbidly obese|morbidly obese
1599638|NCT00395681|BMI|bmi
1599639|NCT00395668|TETRA|tetra
1599640|NCT00395668|EMF|emf
1599846|NCT00394888|PHACE|phace
1599641|NCT00395668|Human exposure study|human exposure study
1599642|NCT00395668|Symptoms|symptoms
1599643|NCT00395668|Well-being|well-being
1599644|NCT00395668|Cognitive function|cognitive function
1599645|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
1599646|NCT00395655|hydralazine|hydralazine
1599647|NCT00395655|magnesium valproate|magnesium valproate
1599648|NCT00395655|epigenetic therapy|epigenetic therapy
1599649|NCT00395655|gene expression|gene expression
1599650|NCT00395642|Congestive Heart Failure|congestive heart failure
1599651|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1599652|NCT00395642|Home Monitoring|home monitoring
1599653|NCT00395642|Telemonitoring|telemonitoring
1599654|NCT00395642|Remote Monitoring|remote monitoring
1599655|NCT00395629|Deferasirox|deferasirox
1599656|NCT00395629|ICL670A|icl670a
1599657|NCT00395629|Iron chelators|iron chelators
1599658|NCT00395629|Deferiprone|deferiprone
1599659|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
1599660|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
1599661|NCT00395564|Urologic Surgery|urologic surgery
1599662|NCT00395551|choroidal neovascularization|choroidal neovascularization
1599663|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
1599664|NCT00395538|Parathyroid|parathyroid
1599665|NCT00395538|Bone Biopsy|bone biopsy
1599666|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
1599667|NCT00395538|Bone Density|bone density
1599668|NCT00395538|Bone Turnover|bone turnover
1599669|NCT00395538|Hypoparathyroidism|hypoparathyroidism
1599670|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
1599671|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
1599672|NCT00395512|Type II Diabetes|type ii diabetes
1599673|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1599674|NCT00395512|Dyslipidemia|dyslipidemia
1599675|NCT00395512|Drug Therapy|drug therapy
1599676|NCT00395499|Risperidone|risperidone
1599677|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
1599678|NCT00395499|Plasma|plasma
1599679|NCT00395499|Saliva|saliva
1599680|NCT00395499|children|children
1599681|NCT00395486|rosuvastatin|rosuvastatin
1599682|NCT00395486|lipoprotein|lipoprotein
1599683|NCT00395486|metabolic syndrome|metabolic syndrome
1599684|NCT00395460|Gadovist|gadovist
1599685|NCT00395460|Gadavist|gadavist
1599686|NCT00395460|Contrast agent|contrast agent
1599687|NCT00395460|Brain|brain
1599688|NCT00395460|Spine disease|spine disease
1599689|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
1599690|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
1599691|NCT00395447|Defibrillator|defibrillator
1599692|NCT00395447|Replacement|replacement
1599693|NCT00395447|Upgrade|upgrade
1599694|NCT00395434|Advanced Solid Tumors|advanced solid tumors
1599695|NCT00395434|Advanced Solid Tumours|advanced solid tumours
1599696|NCT00395434|Advanced Solid Tumor|advanced solid tumor
1599697|NCT00395434|Advanced Solid Tumour|advanced solid tumour
1599698|NCT00395434|Advanced|advanced
1599699|NCT00395434|Malignant|malignant
1599700|NCT00395434|Solid|solid
1599701|NCT00395434|Tumors|tumors
1599702|NCT00395434|Tumours|tumours
1599703|NCT00395434|Tumor|tumor
1599704|NCT00395434|Tumour|tumour
1599705|NCT00395434|Cancer|cancer
1599706|NCT00395434|Malignant Solid Tumors|malignant solid tumors
1599707|NCT00395434|Malignant Solid Tumours|malignant solid tumours
1599708|NCT00395434|Malignant Solid Tumor|malignant solid tumor
1599709|NCT00395434|Malignant Solid Tumour|malignant solid tumour
1599710|NCT00395434|Metastatic Cancer|metastatic cancer
1599711|NCT00395434|Metastatic Disease|metastatic disease
1599712|NCT00395434|Advanced Cancer|advanced cancer
1599713|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
1599714|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
1599715|NCT00395434|Phase 1|phase 1
1599716|NCT00395421|treatment-naive|treatment-naive
1599717|NCT00395395|Postmenopausal|postmenopausal
1599718|NCT00395395|osteoporosis|osteoporosis
1599719|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
1599720|NCT00395395|Calcitonin|calcitonin
1599721|NCT00395382|Vascular calcification|vascular calcification
1599722|NCT00395382|Arterial stiffness|arterial stiffness
1599723|NCT00395382|Cardiovascular risk|cardiovascular risk
1599724|NCT00395382|Bone mineral metabolism|bone mineral metabolism
1599725|NCT00395382|Calcium|calcium
1599726|NCT00395369|aprotinin|aprotinin
1599727|NCT00395369|cardiac surgery|cardiac surgery
1599728|NCT00395369|neurological dysfunction|neurological dysfunction
1599729|NCT00395369|optical coherance tomography|optical coherance tomography
1599730|NCT00395356|Diet|diet
1599731|NCT00395356|Caloric restriction|caloric restriction
1599732|NCT00395356|Intermittent diet|intermittent diet
1599733|NCT00395356|Obesity|obesity
1599734|NCT00395356|Postmenopausal women|postmenopausal women
1599735|NCT00395330|Respiratory Function Tests|respiratory function tests
1599736|NCT00395330|Oscillometry|oscillometry
1599737|NCT00395330|World Trade Center Disaster|world trade center disaster
1599738|NCT00395330|Environmental Exposure|environmental exposure
1599739|NCT00395330|Distal Airways|distal airways
1599740|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
1599741|NCT00395317|multiple sclerosis|multiple sclerosis
1599742|NCT00395317|SB-683699|sb-683699
1599743|NCT00395291|Chronic kidney disease|chronic kidney disease
1599744|NCT00395291|End stage renal disease|end stage renal disease
1599745|NCT00395278|KSHV|kshv
1599746|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
1599747|NCT00395278|HIV|hiv
1599748|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
1599749|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
1599750|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
1599751|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
1599752|NCT00395265|Blood Coagulation|blood coagulation
1599753|NCT00395265|Inflammation|inflammation
1599754|NCT00395252|pancreatic cancer|pancreatic cancer
1599755|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
1599756|NCT00395252|phase 2|phase 2
1600133|NCT00393705|diabetes|diabetes
1599757|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
1599758|NCT00395239|Asthma|asthma
1599759|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
1599760|NCT00395239|ICS|ics
1599761|NCT00395239|Metabolites|metabolites
1599762|NCT00395239|Induced sputum|induced sputum
1599763|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
1599764|NCT00395226|Rosacea|rosacea
1599765|NCT00395213|Anxiety|anxiety
1599766|NCT00395213|Major Depression|major depression
1599767|NCT00395213|Anorexia|anorexia
1599768|NCT00395213|Bulimia|bulimia
1599769|NCT00395213|OCD|ocd
1599770|NCT00395213|Antidepressant|antidepressant
1599771|NCT00395213|SSRI|ssri
1599772|NCT00395213|SNRI|snri
1599773|NCT00395200|Multiple Sclerosis|multiple sclerosis
1599774|NCT00395200|Safety|safety
1599775|NCT00395200|Therapeutics|therapeutics
1599776|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
1599777|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
1599778|NCT00395200|Optic Neuritis|optic neuritis
1599779|NCT00395174|Influenza|influenza
1599780|NCT00395161|sepsis|sepsis
1599781|NCT00395161|prevention|prevention
1599782|NCT00395161|mineral supplementation|mineral supplementation
1599783|NCT00395135|Obesity|obesity
1599784|NCT00395135|Weight loss|weight loss
1599785|NCT00395135|lorcaserin|lorcaserin
1599786|NCT00395135|APD356|apd356
1599787|NCT00395135|BLOOM|bloom
1599788|NCT00395135|Hypertension|hypertension
1599789|NCT00395135|Dyslipidemia|dyslipidemia
1599790|NCT00395135|Sleep apnea|sleep apnea
1599791|NCT00395135|glucose tolerance|glucose tolerance
1599792|NCT00395135|cardiovascular disease|cardiovascular disease
1599793|NCT00395135|Arena|arena
1599794|NCT00395122|Band Atrophy|band atrophy
1599795|NCT00395122|Optical Coherence Tomography|optical coherence tomography
1599796|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
1599797|NCT00395122|Chiasmal Lesions|chiasmal lesions
1599798|NCT00395109|cancer|cancer
1599799|NCT00395109|hypoxia|hypoxia
1599800|NCT00395109|PET scan|pet scan
1599801|NCT00395109|CT scan|ct scan
1599802|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
1599803|NCT00395096|Asthma|asthma
1599804|NCT00395096|Tobacco Smoke|tobacco smoke
1599805|NCT00395096|Allergen|allergen
1599806|NCT00395070|Melanoma|melanoma
1599807|NCT00395070|DTIC|dtic
1599808|NCT00395070|TMZ|tmz
1599809|NCT00395070|Stage 3|stage 3
1599810|NCT00395070|Stage 4|stage 4
1599811|NCT00395070|Metastatic|metastatic
1599812|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
1599813|NCT00395044|Cannabis treatment|cannabis treatment
1599814|NCT00395044|marijuana treatment|marijuana treatment
1599815|NCT00395031|schizophrenia|schizophrenia
1599816|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
1599817|NCT00395031|metabolic markers|metabolic markers
1599818|NCT00395031|ziprasidone|ziprasidone
1599819|NCT00395031|diabetes|diabetes
1599820|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
1599821|NCT00395005|Kallikrein|kallikrein
1599822|NCT00395005|Cytokines|cytokines
1599823|NCT00395005|Proteinuria|proteinuria
1599824|NCT00395005|Renal function|renal function
1599825|NCT00395005|Chronic kidney disease|chronic kidney disease
1599826|NCT00394992|Colorectal cancer|colorectal cancer
1599827|NCT00394992|Liver metastasis|liver metastasis
1599828|NCT00394992|Radical resection|radical resection
1599829|NCT00394992|Adjuvant therapy|adjuvant therapy
1599830|NCT00394992|Bevacizumab|bevacizumab
1599831|NCT00394992|Capecitabine|capecitabine
1599832|NCT00394992|Oxaliplatin|oxaliplatin
1599833|NCT00394992|Hepatica|hepatica
1599834|NCT00394940|COPD|copd
1599835|NCT00394940|Emphysema|emphysema
1599836|NCT00394940|Chronic Bronchitis|chronic bronchitis
1599837|NCT00394940|Inflammation|inflammation
1599838|NCT00394940|CD14|cd14
1599839|NCT00394940|TLR4|tlr4
1599841|NCT00394927|Non-Interventional|non-interventional
1599842|NCT00394927|Surveillance|surveillance
1599843|NCT00394927|Adverse Effects|adverse effects
1599844|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
1599845|NCT00394888|Hemangioma|hemangioma
1599847|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
1599848|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
1599849|NCT00394875|Randomized controlled trial|randomized controlled trial
1599850|NCT00394875|Delegation, Professional|delegation, professional
1599851|NCT00394875|Nurses|nurses
1599852|NCT00394849|Tonsillectomy|tonsillectomy
1599853|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
1599854|NCT00394849|pain|pain
1599855|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
1599856|NCT00394836|ofatumumab|ofatumumab
1599857|NCT00394836|rituximab|rituximab
1599858|NCT00394836|NHL|nhl
1599859|NCT00394836|CD20|cd20
1599860|NCT00394836|refractory|refractory
1599861|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
1599862|NCT00394784|gram negative bacteria|gram negative bacteria
1599863|NCT00394784|culture|culture
1599864|NCT00394784|infection|infection
1599865|NCT00394771|oral contraceptives|oral contraceptives
1599866|NCT00394771|breakthrough bleeding|breakthrough bleeding
1599867|NCT00394771|spotting|spotting
1600161|NCT00393588|Brain|brain
1599868|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
1599869|NCT00394758|CO2 laser surgery|co2 laser surgery
1599870|NCT00394758|vulvar dysplasia|vulvar dysplasia
1599871|NCT00394758|vaginal dysplasia|vaginal dysplasia
1599872|NCT00394758|recurrence|recurrence
1599873|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
1599874|NCT00394732|chronic low back pain|chronic low back pain
1599875|NCT00394732|total disc replacement|total disc replacement
1599876|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
1599877|NCT00394732|clinical effects|clinical effects
1599878|NCT00394732|cost effectiveness|cost effectiveness
1599879|NCT00394732|randomized controlled trial|randomized controlled trial
1599880|NCT00394732|multicenter study|multicenter study
1599881|NCT00394706|cardiac arrest|cardiac arrest
1599882|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1599883|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
1600134|NCT00393705|type 2|type 2
1599884|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
1599885|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
1599886|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
1599887|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
1599888|NCT00394693|Relapse or active disease|relapse or active disease
1599889|NCT00394680|coronary revascularization|coronary revascularization
1599890|NCT00394680|stent inmplantation|stent inmplantation
1599891|NCT00394680|coronary bypass|coronary bypass
1599892|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
1599893|NCT00394628|Radiotherapy|radiotherapy
1599894|NCT00394628|temozolomide|temozolomide
1599895|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
1599896|NCT00394602|Gastric Cancer|gastric cancer
1599897|NCT00394602|Pancreatic Cancer|pancreatic cancer
1599898|NCT00394602|Cervical Cancer|cervical cancer
1599899|NCT00394602|Vulvar Cancer|vulvar cancer
1599900|NCT00394602|Endometrial Cancer|endometrial cancer
1599901|NCT00394602|Anal Cancer|anal cancer
1599902|NCT00394602|Quality of Life|quality of life
1599903|NCT00394602|Questionnaire|questionnaire
1599904|NCT00394602|Interview|interview
1599905|NCT00394602|Emesis|emesis
1599906|NCT00394602|Nausea|nausea
1599907|NCT00394602|Survey|survey
1599908|NCT00394576|Kidney School|kidney school
1599909|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
1599910|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
1599911|NCT00394576|Short Form 12 version 2|short form 12 version 2
1599912|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
1599913|NCT00394576|Three Day Dietary Diary|three day dietary diary
1599914|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
1599915|NCT00394550|laryngomalacia|laryngomalacia
1599916|NCT00394550|supraglottoplasty|supraglottoplasty
1599917|NCT00394550|Tonsillectomy|tonsillectomy
1599918|NCT00394550|Adenoidectomy|adenoidectomy
1599919|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
1599920|NCT00394550|Laser|laser
1599921|NCT00394550|Polysomnogram|polysomnogram
1599922|NCT00394550|airway obstruction|airway obstruction
1599923|NCT00394524|ICU|icu
1599924|NCT00394524|hyperglycemia|hyperglycemia
1599925|NCT00394524|glucommander|glucommander
1599926|NCT00394498|Myocardial Infarction|myocardial infarction
1599927|NCT00394498|Stem Cells|stem cells
1599928|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1599929|NCT00394485|Procaterol|procaterol
1599930|NCT00394485|Tiotropium|tiotropium
1599931|NCT00394472|Heartburn|heartburn
1599932|NCT00394472|Patient reported symptoms|patient reported symptoms
1599933|NCT00394472|Proton pump inhibitor|proton pump inhibitor
1599934|NCT00394459|Anaesthetic techniques|anaesthetic techniques
1599935|NCT00394459|epidural|epidural
1599936|NCT00394459|catheters|catheters
1599937|NCT00394459|paraesthesia|paraesthesia
1599938|NCT00394459|side effects|side effects
1599939|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
1599940|NCT00394446|Solid Tumors|solid tumors
1599941|NCT00394446|Refractory|refractory
1599943|NCT00394433|TPCA|tpca
1599944|NCT00394433|Taxotere|taxotere
1599945|NCT00394433|Platinum|platinum
1599946|NCT00394433|Avastin|avastin
1599947|NCT00394433|Camptosar|camptosar
1599948|NCT00394433|gastric cancer|gastric cancer
1599949|NCT00394407|inpatient|inpatient
1599950|NCT00394407|diabetes management|diabetes management
1599951|NCT00394407|insulin therapy|insulin therapy
1599952|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
1599953|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
1599954|NCT00394381|autologous CIK cells|autologous cik cells
1599955|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
1599956|NCT00394368|asthma|asthma
1599957|NCT00394368|combinations|combinations
1599958|NCT00394368|inhaled therapy|inhaled therapy
1599959|NCT00394368|corticosteroids|corticosteroids
1599960|NCT00394368|long acting bronchodilators|long acting bronchodilators
1599961|NCT00394368|salmeterol|salmeterol
1599962|NCT00394368|beclomethasone|beclomethasone
1599963|NCT00394368|formoterol|formoterol
1599964|NCT00394368|fluticasone|fluticasone
1599965|NCT00394316|CD34 Stem Cells|cd34 stem cells
1599966|NCT00394316|Busulfan|busulfan
1599967|NCT00394316|Gene Therapy|gene therapy
1599968|NCT00394316|Immune Reconstitution|immune reconstitution
1599969|NCT00394316|Engraftment|engraftment
1599970|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
1599971|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
1599972|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
1599973|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
1599974|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
1599975|NCT00394316|CGD|cgd
1599976|NCT00394303|Open heart surgery|open heart surgery
1599977|NCT00394303|Diabetes mellitus|diabetes mellitus
1599978|NCT00394303|Hyperglycemia|hyperglycemia
1599979|NCT00394303|Surgical site infection|surgical site infection
1599980|NCT00394303|Normoglycemia|normoglycemia
1599981|NCT00394290|Down Syndrome|down syndrome
1599982|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1599983|NCT00394290|Continuous Positive Pressure|continuous positive pressure
1599984|NCT00394290|Hypersomnia|hypersomnia
1599985|NCT00394264|low back pain|low back pain
1599986|NCT00394264|active duty military personnel|active duty military personnel
1599987|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
1599988|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
1599989|NCT00394264|physical medicine|physical medicine
1599990|NCT00394251|Adjuvant therapy|adjuvant therapy
1599991|NCT00394251|Bevacizumab|bevacizumab
1599992|NCT00394251|Abraxane|abraxane
1599993|NCT00394251|Early stage breast cancer|early stage breast cancer
1599994|NCT00394225|6-Minute Walk Test|6-minute walk test
1599995|NCT00394225|COPD|copd
1599996|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
1599997|NCT00394225|Exercise|exercise
1599998|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1599999|NCT00394212|Weight Loss|weight loss
1600000|NCT00394212|Transoral Suturing|transoral suturing
1600001|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
1600002|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
1600003|NCT00394199|Asthma|asthma
1600004|NCT00394199|Fluticasone Propionate|fluticasone propionate
1600005|NCT00394199|formoterol fumarate|formoterol fumarate
1600006|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
1600007|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
1600008|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
1600009|NCT00394186|GW427353|gw427353
1600010|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
1600011|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
1600012|NCT00394186|efficacy|efficacy
1600013|NCT00394186|tolerability|tolerability
1600014|NCT00394186|pharmacokinetics|pharmacokinetics
1600015|NCT00394173|IBS|ibs
1600016|NCT00394173|diarrhea|diarrhea
1600017|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
1600018|NCT00394173|IBS-D|ibs-d
1600019|NCT00394147|advanced|advanced
1600020|NCT00394147|head|head
1600021|NCT00394147|neck|neck
1600022|NCT00394147|cancer|cancer
1600023|NCT00394134|Melanoma|melanoma
1600024|NCT00394134|Sun Exposure|sun exposure
1600025|NCT00394134|Sun Protection|sun protection
1600026|NCT00394134|Interview|interview
1600027|NCT00394121|Asthma|asthma
1600028|NCT00394121|Fluticasone Propionate|fluticasone propionate
1600029|NCT00394121|Formoterol Fumarate|formoterol fumarate
1600030|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
1600031|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
1600032|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
1600033|NCT00394095|Bipolar Disorder|bipolar disorder
1600034|NCT00394095|Weight Gain|weight gain
1600035|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
1600036|NCT00394056|placebo|placebo
1600037|NCT00394056|balanced|balanced
1600038|NCT00394056|paroxetine|paroxetine
1600039|NCT00394056|repeated dose|repeated dose
1600040|NCT00394056|Hearing Loss|hearing loss
1600041|NCT00394056|loudness|loudness
1600042|NCT00394056|combination|combination
1600043|NCT00394056|Tinnitus|tinnitus
1600044|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
1600045|NCT00394056|randomised|randomised
1600046|NCT00394056|annoyance|annoyance
1600047|NCT00394056|crossover|crossover
1600048|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
1600049|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1600050|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1600051|NCT00394043|Physical Medicine|physical medicine
1600052|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
1600053|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
1600054|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
1600446|NCT00392743|Bolus|bolus
1600055|NCT00394017|General Practice|general practice
1600056|NCT00394017|Dementia|dementia
1600057|NCT00394017|education|education
1600058|NCT00394004|Decision Making|decision making
1600059|NCT00394004|Health Disparities|health disparities
1600060|NCT00394004|Hispanic|hispanic
1600061|NCT00394004|African-American|african-american
1600062|NCT00394004|Clinical Trials|clinical trials
1600063|NCT00394004|HIV Positive|hiv positive
1600064|NCT00393991|Asthma|asthma
1600065|NCT00393991|Fluticasone Propionate|fluticasone propionate
1600066|NCT00393991|Formoterol Fumarate|formoterol fumarate
1600067|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
1600068|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
1600069|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
1600070|NCT00393978|Bipolar mania|bipolar mania
1600071|NCT00393978|Cannabis consumption|cannabis consumption
1600072|NCT00393965|Metastases|metastases
1600073|NCT00393965|Refractory|refractory
1600074|NCT00393965|Brain|brain
1600075|NCT00393952|Asthma|asthma
1600076|NCT00393952|Fluticasone Propionate|fluticasone propionate
1600077|NCT00393952|Formoterol Fumarate|formoterol fumarate
1600078|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
1600079|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
1600080|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
1600081|NCT00393939|advanced breast cancer|advanced breast cancer
1600082|NCT00393939|sunitinib|sunitinib
1600083|NCT00393939|docetaxel|docetaxel
1600084|NCT00393939|Phase 3|phase 3
1600085|NCT00393926|Robotics|robotics
1600086|NCT00393926|Rehabilitation|rehabilitation
1600087|NCT00393926|Upper Extremity|upper extremity
1600089|NCT00393913|Sleep Apnea|sleep apnea
1600090|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
1600091|NCT00393913|Snoring|snoring
1600092|NCT00393900|otitis media|otitis media
1600093|NCT00393900|tympanostomy tube|tympanostomy tube
1600094|NCT00393900|eustachian tube function|eustachian tube function
1600095|NCT00393900|gas exchange|gas exchange
1600096|NCT00393900|tympanostomy tubes|tympanostomy tubes
1600097|NCT00393887|Inguinal hernia|inguinal hernia
1600098|NCT00393887|polypropylene|polypropylene
1600099|NCT00393887|Biodesign IHM|biodesign ihm
1600100|NCT00393887|lichtenstein|lichtenstein
1600101|NCT00393874|Anxiety D/O|anxiety d/o
1600102|NCT00393874|Mood D/O|mood d/o
1600103|NCT00393861|Germ Cell Tumor|germ cell tumor
1600104|NCT00393861|Germ Cell Cancer|germ cell cancer
1600105|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
1600106|NCT00393848|Hip Replacement Surgery|hip replacement surgery
1600107|NCT00393848|Hip Surgery|hip surgery
1600108|NCT00393848|Hip Rehabilitation|hip rehabilitation
1600109|NCT00393848|Avascular Necrosis|avascular necrosis
1600110|NCT00393848|Knee replacement surgery|knee replacement surgery
1600111|NCT00393848|Total knee arthroplasty|total knee arthroplasty
1600112|NCT00393822|KGF|kgf
1600113|NCT00393822|Palifermin|palifermin
1600114|NCT00393822|Oral Mucositis|oral mucositis
1600115|NCT00393822|Clinical Trial|clinical trial
1600116|NCT00393822|Amgen|amgen
1600117|NCT00393822|Oncology|oncology
1600118|NCT00393822|Colon Cancer|colon cancer
1600119|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
1600120|NCT00393809|H19 gene|h19 gene
1600121|NCT00393809|plasmid|plasmid
1600122|NCT00393809|diphtheria toxin|diphtheria toxin
1600123|NCT00393783|Breast Cancer|breast cancer
1600124|NCT00393783|Metastatic|metastatic
1600125|NCT00393783|HER2|her2
1600126|NCT00393783|04-101|04-101
1600127|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
1600128|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
1600135|NCT00393692|Age-related macular degeneration|age-related macular degeneration
1600136|NCT00393692|Geographic atrophy|geographic atrophy
1600138|NCT00393679|Children 6-59 months|children 6-59 months
1600139|NCT00393679|P.falciparum|p.falciparum
1600140|NCT00393679|Haemoglobin|haemoglobin
1600141|NCT00393679|Informed consent|informed consent
1600142|NCT00393679|ACT|act
1600143|NCT00393666|Absence|absence
1600144|NCT00393666|Epilepsy|epilepsy
1600145|NCT00393666|Seizure|seizure
1600146|NCT00393666|Brain|brain
1600147|NCT00393653|osteoarthritis|osteoarthritis
1600148|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
1600149|NCT00393653|practice-based research|practice-based research
1600150|NCT00393653|N-of-1 trial|n-of-1 trial
1600151|NCT00393653|prescription|prescription
1600152|NCT00393653|single-patient trial|single-patient trial
1600153|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
1600154|NCT00393627|Dementia|dementia
1600155|NCT00393627|Sleep disturbance|sleep disturbance
1600156|NCT00393627|Behavioral strategies|behavioral strategies
1600157|NCT00393627|Alzheimer's Disease|alzheimer's disease
1600158|NCT00393627|Adult Family Homes|adult family homes
1600159|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
1600160|NCT00393601|Cystectomy|cystectomy
1600162|NCT00393588|Cognitive Deficits|cognitive deficits
1600163|NCT00393588|Cognitive Testing|cognitive testing
1600164|NCT00393588|MRI|mri
1600165|NCT00393588|Multiple Sclerosis|multiple sclerosis
1600166|NCT00393588|MS|ms
1600167|NCT00393588|Healthy Volunteer|healthy volunteer
1600168|NCT00393588|HV|hv
1600169|NCT00393575|HIV Prevention|hiv prevention
1600170|NCT00393575|HIV positive communities|hiv positive communities
1600171|NCT00393562|excessive sleepiness|excessive sleepiness
1600172|NCT00393562|hypersomnolence|hypersomnolence
1600173|NCT00393562|Parkinson's disease|parkinson's disease
1600174|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
1600175|NCT00393536|Depression|depression
1600176|NCT00393536|Guidelines|guidelines
1600177|NCT00393536|Educational outreach visiting|educational outreach visiting
1600178|NCT00393536|Prescribing|prescribing
1600179|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
1600180|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
1600181|NCT00393497|Breast Cancer|breast cancer
1600182|NCT00393497|lymphedema|lymphedema
1600183|NCT00393471|Arthritis|arthritis
1600184|NCT00393471|Rheumatoid|rheumatoid
1600185|NCT00393471|Safety|safety
1600186|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1600187|NCT00393458|COPD|copd
1600188|NCT00393458|indacaterol|indacaterol
1600189|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
1600190|NCT00393445|GLP-1|glp-1
1600191|NCT00393445|Exendin(9-39)|exendin(9-39)
1600192|NCT00393445|Insulin|insulin
1600193|NCT00393445|Glucagon|glucagon
1600194|NCT00393445|Human physiology|human physiology
1600195|NCT00393432|Action Observation|action observation
1600196|NCT00393432|Motor Memory|motor memory
1600197|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1600198|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
1600199|NCT00393432|Healthy Volunteer|healthy volunteer
1600200|NCT00393432|HV|hv
1600201|NCT00393419|hypertension|hypertension
1600202|NCT00393419|hyperlipidemia|hyperlipidemia
1600203|NCT00393419|adherence|adherence
1600204|NCT00393419|pharmacist|pharmacist
1600205|NCT00393419|elderly|elderly
1600206|NCT00393419|medication|medication
1600207|NCT00393406|Objective Risk|objective risk
1600208|NCT00393406|Gail Model|gail model
1600209|NCT00393406|Subjective Risk|subjective risk
1600210|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
1600211|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
1600212|NCT00393406|Breast Cancer Risk|breast cancer risk
1600213|NCT00393393|osteoarthritis|osteoarthritis
1600214|NCT00393393|knee|knee
1600215|NCT00393393|hylan|hylan
1600216|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
1600217|NCT00393380|Myelodysplasia|myelodysplasia
1600218|NCT00393380|Parathyroid Hormone|parathyroid hormone
1600219|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
1600220|NCT00393367|Asthma|asthma
1600221|NCT00393367|Acute|acute
1600222|NCT00393367|Treatment|treatment
1600223|NCT00393367|Children|children
1600224|NCT00393367|Pediatric|pediatric
1600225|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
1600226|NCT00393367|Budesonide|budesonide
1600227|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
1600228|NCT00393367|Asthma score|asthma score
1600229|NCT00393367|Emergency|emergency
1600230|NCT00393367|Emergency Department|emergency department
1600231|NCT00393367|Asthma flare|asthma flare
1600232|NCT00393367|Clinical trial|clinical trial
1600233|NCT00393367|Randomized clinical trial|randomized clinical trial
1600234|NCT00393367|Randomized trial|randomized trial
1600235|NCT00393367|Pulmonary index score|pulmonary index score
1600236|NCT00393367|Hospitalization|hospitalization
1600237|NCT00393367|Moderate asthma|moderate asthma
1600238|NCT00393367|Severe asthma|severe asthma
1600239|NCT00393367|Mixing budesonide|mixing budesonide
1600240|NCT00393367|Budesonide admixture|budesonide admixture
1600241|NCT00393367|Albuterol|albuterol
1600242|NCT00393367|Continuous albuterol|continuous albuterol
1600243|NCT00393367|Ipratropium bromide|ipratropium bromide
1600244|NCT00393341|Breast Cancer|breast cancer
1600245|NCT00393315|in stent restenosis|in stent restenosis
1600354|NCT00392925|overweight|overweight
1600246|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1600247|NCT00393315|pepcad|pepcad
1600248|NCT00393315|drug eluting balloon|drug eluting balloon
1600249|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
1600250|NCT00393289|Calcium absorption|calcium absorption
1600251|NCT00393289|D-vitamin status|d-vitamin status
1600252|NCT00393289|Whole body calcium retention|whole body calcium retention
1600253|NCT00393289|Calcium intake|calcium intake
1600254|NCT00393289|PTH status|pth status
1600255|NCT00393276|Treatment Experienced|treatment experienced
1600256|NCT00393276|Treatment Naive|treatment naive
1600257|NCT00393276|Immunizations|immunizations
1600258|NCT00393250|Hypnosis|hypnosis
1600259|NCT00393250|Symptom Management|symptom management
1600260|NCT00393250|Pain Management|pain management
1600261|NCT00393250|Sickle Cell Disease|sickle cell disease
1600262|NCT00393250|Pain|pain
1600263|NCT00393224|Epidemiology|epidemiology
1600264|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1600265|NCT00393224|Genetic|genetic
1600266|NCT00393224|Viruses|viruses
1600267|NCT00393224|Cancer|cancer
1600268|NCT00393224|NPC|npc
1600269|NCT00393198|Intrauterine System|intrauterine system
1600270|NCT00393198|Contraception|contraception
1600271|NCT00393198|Menorrhagia|menorrhagia
1600272|NCT00393185|Immunosuppression|immunosuppression
1600273|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
1600274|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
1600275|NCT00393172|exercise|exercise
1600276|NCT00393172|breast cancer|breast cancer
1600277|NCT00393172|prevention|prevention
1600278|NCT00393172|obesity|obesity
1600279|NCT00393172|estrogen metabolism|estrogen metabolism
1600280|NCT00393172|oxidative stress|oxidative stress
1600281|NCT00393172|IGF-1|igf-1
1600282|NCT00393159|Effusion|effusion
1600283|NCT00393159|Otitis|otitis
1600284|NCT00393159|Media|media
1600285|NCT00393159|Ear|ear
1600286|NCT00393159|Popper|popper
1600287|NCT00393159|Children|children
1600288|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
1600289|NCT00393146|MRI|mri
1600290|NCT00393120|HIV-infection|hiv-infection
1600291|NCT00393120|viral load|viral load
1600292|NCT00393120|CCR5|ccr5
1600293|NCT00393120|viral tropism|viral tropism
1600294|NCT00393120|HIV-1 infection|hiv-1 infection
1600295|NCT00393120|Treatment Naive|treatment naive
1600296|NCT00393107|follicular lymphoma|follicular lymphoma
1600297|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
1600298|NCT00393107|Fludarabine|fludarabine
1600299|NCT00393107|Cyclophosphamide|cyclophosphamide
1600300|NCT00393107|Rituximab|rituximab
1600301|NCT00393107|combination|combination
1600302|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
1600303|NCT00393107|relapsed|relapsed
1600304|NCT00393094|Brain Tumor|brain tumor
1600305|NCT00393094|Chemotherapy|chemotherapy
1600306|NCT00393094|Progression|progression
1600307|NCT00393094|Radiotherapy|radiotherapy
1600308|NCT00393094|Antiangiogenesis|antiangiogenesis
1600309|NCT00393094|Glioma|glioma
1600310|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1600311|NCT00393042|sleep|sleep
1600312|NCT00393042|side effects|side effects
1600313|NCT00393042|stimulants|stimulants
1600314|NCT00393029|Tumor Regression|tumor regression
1600315|NCT00393029|In Vivo Cell Survival|in vivo cell survival
1600316|NCT00393029|Toxicity Profile|toxicity profile
1600317|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1600318|NCT00393029|Cancer|cancer
1600319|NCT00393029|Metastatic Cancer|metastatic cancer
1600320|NCT00393003|Anesthesia|anesthesia
1600321|NCT00393003|Sedation|sedation
1600322|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1600323|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1600324|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1600325|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1600326|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1600327|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1600328|NCT00392977|Manganese|manganese
1600329|NCT00392977|Neonatal Intensive Care|neonatal intensive care
1600330|NCT00392977|MRI|mri
1600331|NCT00392977|Parenteral Nutrition|parenteral nutrition
1600332|NCT00392977|Prematurity|prematurity
1600333|NCT00392964|Antacids|antacids
1600334|NCT00392964|Proton pump inhibitors|proton pump inhibitors
1600335|NCT00392964|aspirin|aspirin
1600336|NCT00392964|ischemic heart disease|ischemic heart disease
1600337|NCT00392964|Dyspepsia|dyspepsia
1600338|NCT00392951|ALPS|alps
1600339|NCT00392951|Autoimmune|autoimmune
1600340|NCT00392951|Cytopenias|cytopenias
1600346|NCT00392951|Hemolytic Anemia|hemolytic anemia
1600347|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
1600348|NCT00392951|Neutropenia|neutropenia
1600349|NCT00392951|ITP|itp
1600350|NCT00392951|Lupus|lupus
1600351|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
1600352|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
1600353|NCT00392938|bone metastases|bone metastases
1600355|NCT00392925|obesity|obesity
1600356|NCT00392925|pramlintide|pramlintide
1600357|NCT00392925|leptin|leptin
1600358|NCT00392925|Amylin|amylin
1600359|NCT00392912|testosterone|testosterone
1600360|NCT00392912|hypogonadal|hypogonadal
1600361|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
1600362|NCT00392912|PET scan|pet scan
1600363|NCT00392912|Alzheimer's disease|alzheimer's disease
1600364|NCT00392899|stage II colon cancer|stage ii colon cancer
1600365|NCT00392899|stage II rectal cancer|stage ii rectal cancer
1600366|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
1600367|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1600368|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1600369|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1600370|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1600371|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1600372|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1600373|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1600374|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
1600375|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1600376|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
1600377|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1600378|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1600379|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1600380|NCT00392873|Amenorrhea|amenorrhea
1600381|NCT00392873|Energy deficiency|energy deficiency
1600382|NCT00392873|Resting energy expenditure|resting energy expenditure
1600383|NCT00392873|Bone metabolism|bone metabolism
1600384|NCT00392873|Bone mineral density|bone mineral density
1600385|NCT00392873|Exercise|exercise
1600386|NCT00392860|Wheelchair|wheelchair
1600387|NCT00392860|Handrims|handrims
1600388|NCT00392860|Rehabilitation|rehabilitation
1600389|NCT00392860|Upper extremity|upper extremity
1600390|NCT00392847|Child mental disorder|child mental disorder
1600391|NCT00392847|Home visit|home visit
1600392|NCT00392847|Postnatal depression|postnatal depression
1600393|NCT00392847|Social Support|social support
1600394|NCT00392847|Random selection|random selection
1600395|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1600396|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1600397|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1600398|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1600399|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1600400|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1600401|NCT00392808|Meningococcal vaccine|meningococcal vaccine
1600402|NCT00392808|Immunization, secondary|immunization, secondary
1600403|NCT00392808|vaccines conjugated|vaccines conjugated
1600404|NCT00392808|Meningococcal disease|meningococcal disease
1600405|NCT00392795|Critical Care|critical care
1600406|NCT00392795|Delirium|delirium
1600407|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
1600408|NCT00392795|mechanical ventilation|mechanical ventilation
1600409|NCT00392795|Critical illness|critical illness
1600410|NCT00392795|dementia|dementia
1600411|NCT00392795|sedatives and analgesics|sedatives and analgesics
1600412|NCT00392795|aging|aging
1600413|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1600414|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1600415|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1600416|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1600417|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1600418|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1600419|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1600420|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1600421|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1600422|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1600423|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1600424|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1600425|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1600426|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1600427|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1600428|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1600429|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1600430|NCT00392769|Endometrial Cancer|endometrial cancer
1600431|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
1600432|NCT00392769|Cetuximab|cetuximab
1600433|NCT00392769|C225|c225
1600434|NCT00392769|Erbitux™|erbitux™
1600435|NCT00392769|IMC-C225|imc-c225
1600436|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
1600437|NCT00392769|EGFR|egfr
1600438|NCT00392769|Endometrioid Tumor|endometrioid tumor
1600439|NCT00392769|Serous Tumor|serous tumor
1600440|NCT00392769|Clear cell Tumor|clear cell tumor
1600441|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
1600442|NCT00392756|Kallmann Syndrome|kallmann syndrome
1600443|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
1600444|NCT00392756|GnRH deficiency|gnrh deficiency
1600445|NCT00392756|Pulsatile GnRH|pulsatile gnrh
1600447|NCT00392743|11C-Raclopride|11c-raclopride
1600448|NCT00392743|Schizophrenia|schizophrenia
1600449|NCT00392743|123I-IBZM|123i-ibzm
1600451|NCT00392743|Receptor Occupancy|receptor occupancy
1600452|NCT00392743|PET|pet
1600453|NCT00392743|MRI|mri
1600454|NCT00392743|Antipsychotics|antipsychotics
1600455|NCT00392743|Bolus/Infusion|bolus/infusion
1600456|NCT00392730|Manganese|manganese
1600457|NCT00392730|Neonatal Intensive Care|neonatal intensive care
1600458|NCT00392730|MRI|mri
1600459|NCT00392730|Parenteral Nutrition|parenteral nutrition
1600460|NCT00392730|Prematurity|prematurity
1600461|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
1600462|NCT00392717|cardiovascular disease|cardiovascular disease
1600463|NCT00392717|obesity|obesity
1600464|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1600465|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1600466|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1600467|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1600468|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1600469|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1600470|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1600471|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1600472|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1600473|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1600474|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1600475|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1600476|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1600477|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1600478|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1600479|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
1600480|NCT00392678|Type 2 Diabetes|type 2 diabetes
1600481|NCT00392678|Inflammation|inflammation
1600482|NCT00392678|Obesity|obesity
1600483|NCT00392678|Metabolic Syndrome|metabolic syndrome
1600484|NCT00392665|SCCHN|scchn
1600485|NCT00392665|erlotinib|erlotinib
1600486|NCT00392665|tarceva|tarceva
1600487|NCT00392639|Heart arrest|heart arrest
1600488|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1600489|NCT00392639|Humans|humans
1600490|NCT00392639|Hypothermia|hypothermia
1600491|NCT00392639|Brain diseases|brain diseases
1600492|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
1600493|NCT00392639|Cost Benefit Analysis|cost benefit analysis
1600494|NCT00392639|Prospective study|prospective study
1600495|NCT00392639|Comparative study|comparative study
1600496|NCT00392639|Treatment outcome|treatment outcome
1600497|NCT00392639|Hypothermia for|hypothermia for
1600498|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1600499|NCT00392639|from cardiac origin|from cardiac origin
1600500|NCT00392639|successfully resuscitated|successfully resuscitated
1600501|NCT00392587|Pharmacodynamics|pharmacodynamics
1600502|NCT00392587|Pharmacokinetics|pharmacokinetics
1600503|NCT00392587|Tolerability|tolerability
1600504|NCT00392587|COPD|copd
1600505|NCT00392587|Safety|safety
1600506|NCT00392574|Gastroenteritis|gastroenteritis
1600507|NCT00392548|GBM|gbm
1600508|NCT00392548|glioblastoma|glioblastoma
1600509|NCT00392548|urine|urine
1600510|NCT00392548|VEGF|vegf
1600511|NCT00392548|radiation|radiation
1600512|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
1600513|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1600514|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
1600515|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
1600516|NCT00392535|stage III prostate cancer|stage iii prostate cancer
1600517|NCT00392522|Anxiety|anxiety
1600518|NCT00392522|Cough|cough
1600519|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
1600520|NCT00392522|Patients satisfaction|patients satisfaction
1600521|NCT00392522|Chest physician satisfaction|chest physician satisfaction
1600522|NCT00392509|critical limb ischemia|critical limb ischemia
1600523|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
1600524|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
1600525|NCT00392509|peripheral artery disease|peripheral artery disease
1600526|NCT00392509|peripheral vascular disease|peripheral vascular disease
1600527|NCT00392509|leg pain|leg pain
1600528|NCT00392509|PVD|pvd
1600529|NCT00392509|PAD|pad
1600530|NCT00392509|CLI|cli
1600531|NCT00392509|amputation|amputation
1600532|NCT00392509|limb salvage|limb salvage
1600533|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
1600534|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
1600535|NCT00392483|General Practice|general practice
1600536|NCT00392483|Dementia|dementia
1600537|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1600538|NCT00392470|stage III rectal cancer|stage iii rectal cancer
1600539|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
1600540|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
1600541|NCT00392457|Kallmann Syndrome|kallmann syndrome
1600542|NCT00392457|Agonadal|agonadal
1600543|NCT00392418|iron deficiency anemia|iron deficiency anemia
1600544|NCT00392418|hematologic disease|hematologic disease
1600545|NCT00392418|infancy|infancy
1600546|NCT00392418|pediatrics|pediatrics
1600547|NCT00392418|Sprinkles®|sprinkles®
1600548|NCT00392418|iron|iron
1600549|NCT00392418|micronutrient|micronutrient
1600550|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
1600551|NCT00392392|Breast Cancer|breast cancer
1600552|NCT00392379|Tobacco use disorder|tobacco use disorder
1600553|NCT00392379|Tobacco cessation|tobacco cessation
1600554|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
1600555|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
1600556|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
1600557|NCT00392366|Liver Metastasis|liver metastasis
1600558|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
1600559|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
1600560|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
1600561|NCT00392314|PET/CT|pet/ct
1600562|NCT00392314|Therapy|therapy
1600563|NCT00392301|wound healing|wound healing
1600564|NCT00392301|skin|skin
1600565|NCT00392301|graft donor site|graft donor site
1600566|NCT00392301|donor site|donor site
1600567|NCT00392301|transepidermal water loss|transepidermal water loss
1600568|NCT00392288|Bronchial Asthma|bronchial asthma
1600569|NCT00392275|Cataract|cataract
1600570|NCT00392275|Aqueous absorption|aqueous absorption
1600571|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
1600572|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
1600573|NCT00392249|Schizophrenia|schizophrenia
1600574|NCT00392249|Drug adherence|drug adherence
1600575|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
1600576|NCT00392197|OPC-14597|opc-14597
1600577|NCT00392197|Schizophrenia|schizophrenia
1600578|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
1600579|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
1600580|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
1600581|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
1600582|NCT00392145|Pediatrics|pediatrics
1600583|NCT00392145|Gastroenteritis|gastroenteritis
1600584|NCT00392145|Dehydration|dehydration
1600585|NCT00392145|IV Rehydration|iv rehydration
1600586|NCT00392132|HIV|hiv
1600587|NCT00392119|MR-guided therapy|mr-guided therapy
1600588|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
1600589|NCT00392119|brain metastasis|brain metastasis
1600590|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
1600591|NCT00392106|atrial fibrillation|atrial fibrillation
1600592|NCT00392106|arrhythmia|arrhythmia
1600593|NCT00392106|AF ablation|af ablation
1600594|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
1600595|NCT00392106|catheter ablation|catheter ablation
1600596|NCT00392106|pulmonary veins|pulmonary veins
1600597|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
1600598|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
1600599|NCT00392093|Menopausal symptoms|menopausal symptoms
1600600|NCT00392093|Bone mineral density|bone mineral density
1600601|NCT00392054|Atrial Fibrillation|atrial fibrillation
1600602|NCT00392054|Paroxysmal|paroxysmal
1600603|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
1600604|NCT00392054|Ablation Catheter|ablation catheter
1600605|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
1600606|NCT00392054|First Line Therapy|first line therapy
1600607|NCT00392041|Fibromyalgia|fibromyalgia
1600608|NCT00392041|Insomnia|insomnia
1600609|NCT00392041|Sleep|sleep
1600610|NCT00392041|Eszopiclone|eszopiclone
1600611|NCT00392041|Lunesta|lunesta
1600612|NCT00392028|Ertapenem|ertapenem
1600613|NCT00392028|Bone drug level|bone drug level
1600614|NCT00392028|Blood drug level|blood drug level
1600615|NCT00392028|Tissue drug level|tissue drug level
1600616|NCT00392015|Malaria Vaccine|malaria vaccine
1600617|NCT00392015|Adenovirus|adenovirus
1600618|NCT00392015|Plasmodium falciparum|plasmodium falciparum
1600619|NCT00392002|GERD|gerd
1600620|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
1600621|NCT00391989|Dasatinib|dasatinib
1600622|NCT00391989|targeted therapy|targeted therapy
1600623|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
1600624|NCT00391976|Cystic fibrosis|cystic fibrosis
1600625|NCT00391950|Prostate cancer|prostate cancer
1600626|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
1600627|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
1600628|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
1600629|NCT00391937|"conventional position method"|"conventional position method"
1600727|NCT00391469|cardiac arrest|cardiac arrest
1600630|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
1600631|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
1600632|NCT00391924|Fatigue|fatigue
1600633|NCT00391924|Quality of life|quality of life
1600634|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
1600635|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
1600636|NCT00391924|Bone mineral density|bone mineral density
1600637|NCT00391911|Rhabdomyolysis|rhabdomyolysis
1600638|NCT00391911|CRRT|crrt
1600639|NCT00391911|N-Acetylcysteine|n-acetylcysteine
1600640|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
1600642|NCT00391872|Acute coronary syndrome|acute coronary syndrome
1600643|NCT00391872|Heart attack|heart attack
1600644|NCT00391872|Unstable angina|unstable angina
1600645|NCT00391872|Coronary artery disease|coronary artery disease
1600646|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
1600647|NCT00391846|Heart Failure|heart failure
1600648|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
1600649|NCT00391846|NTproBNP|ntprobnp
1600650|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
1600651|NCT00391820|constipation|constipation
1600652|NCT00391820|chronic|chronic
1600653|NCT00391820|bowel function|bowel function
1600654|NCT00391807|Contraception|contraception
1600655|NCT00391794|Memory|memory
1600656|NCT00391794|Alzheimer's disease|alzheimer's disease
1600657|NCT00391794|Dementia|dementia
1600658|NCT00391794|Support Group|support group
1600659|NCT00391794|Psychosocial|psychosocial
1600660|NCT00391781|mechanical infertility|mechanical infertility
1600661|NCT00391781|hysterosalpingogram|hysterosalpingogram
1600662|NCT00391781|hysterosalpingography|hysterosalpingography
1600663|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
1600664|NCT00391755|Migraine Headache|migraine headache
1600665|NCT00391742|Brief intervention|brief intervention
1600666|NCT00391742|Motivational Interviewing|motivational interviewing
1600667|NCT00391742|Primary care|primary care
1600668|NCT00391742|Stepped-care|stepped-care
1600669|NCT00391729|ADHD|adhd
1600670|NCT00391716|Alcohol|alcohol
1600671|NCT00391716|Alcohol treatment|alcohol treatment
1600672|NCT00391716|Alcoholism|alcoholism
1600673|NCT00391716|Alcohol Dependence|alcohol dependence
1600674|NCT00391703|Cystic fibrosis|cystic fibrosis
1600675|NCT00391703|mucoviscidosis|mucoviscidosis
1600676|NCT00391703|electrostimulation|electrostimulation
1600677|NCT00391703|retraining|retraining
1600678|NCT00391690|Serum bone marker|serum bone marker
1600679|NCT00391690|Prostate cancer|prostate cancer
1600680|NCT00391690|Bisphosphonates|bisphosphonates
1600681|NCT00391690|Early detection of metastasis|early detection of metastasis
1600682|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
1600683|NCT00391677|Behavior Therapy|behavior therapy
1600684|NCT00391664|Endometrial cancer|endometrial cancer
1600685|NCT00391664|Ovarian Cancer|ovarian cancer
1600686|NCT00391664|Cervical Cancer|cervical cancer
1600687|NCT00391664|Genital Cancer|genital cancer
1600688|NCT00391664|Vulvar Cancer|vulvar cancer
1600689|NCT00391664|Vaginal Cancer|vaginal cancer
1600690|NCT00391664|Other Gynecological Cancers|other gynecological cancers
1600691|NCT00391651|UTI|uti
1600692|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
1600693|NCT00391638|Peg interferon|peg interferon
1600694|NCT00391638|tenofovir|tenofovir
1600695|NCT00391638|emtricitabine|emtricitabine
1600696|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
1600697|NCT00391638|Treatment Experienced|treatment experienced
1600698|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
1600699|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
1600700|NCT00391612|Emphysema|emphysema
1600701|NCT00391612|Hyperinflation|hyperinflation
1600702|NCT00391612|Minimally Invasive|minimally invasive
1600703|NCT00391599|Cesarean Section,|cesarean section,
1600704|NCT00391599|Enema|enema
1600707|NCT00391586|chemotherapy|chemotherapy
1600708|NCT00391586|platinum|platinum
1600709|NCT00391586|lung|lung
1600710|NCT00391586|lung cancer|lung cancer
1600711|NCT00391560|refractory leukemia|refractory leukemia
1600712|NCT00391547|Gingivitis Disease|gingivitis disease
1600713|NCT00391534|Epilepsy|epilepsy
1600714|NCT00391534|oxcarbazepine|oxcarbazepine
1600715|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
1600716|NCT00391508|Ostomy|ostomy
1601308|NCT00389402|hiv-1|hiv-1
1600717|NCT00391508|Peristomal skin|peristomal skin
1600718|NCT00391508|Skin complication|skin complication
1600719|NCT00391495|ADHD|adhd
1600720|NCT00391495|Cytokines|cytokines
1600721|NCT00391495|CR-P|cr-p
1600722|NCT00391482|IV Drug Users|iv drug users
1600723|NCT00391482|Hepatitis C Virus|hepatitis c virus
1600724|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
1600725|NCT00391482|Intervention|intervention
1600726|NCT00391482|HIV Seronegativity|hiv seronegativity
1600736|NCT00391443|bosentan|bosentan
1600737|NCT00391443|Actelion|actelion
1600738|NCT00391430|PTSD|ptsd
1600739|NCT00391430|Trauma|trauma
1600740|NCT00391430|Sexual Abuse|sexual abuse
1600741|NCT00391430|Sexual Assault|sexual assault
1600742|NCT00391417|hot flush|hot flush
1600743|NCT00391417|hot flash|hot flash
1600744|NCT00391417|estrogen|estrogen
1600745|NCT00391417|vaginal atrophy|vaginal atrophy
1600746|NCT00391404|Childhood cancer survivors|childhood cancer survivors
1600747|NCT00391404|Osteoporosis|osteoporosis
1600748|NCT00391404|Bone mineral density|bone mineral density
1600749|NCT00391404|Therapy|therapy
1600750|NCT00391404|Bisphosphonate|bisphosphonate
1600751|NCT00391404|Randomized controlled trial|randomized controlled trial
1600752|NCT00391391|Influenza|influenza
1600753|NCT00391391|Orthomyxoviruses|orthomyxoviruses
1600754|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1600755|NCT00391391|Infants|infants
1600756|NCT00391391|children.|children.
1600757|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
1600758|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1600759|NCT00391378|Stroke|stroke
1600760|NCT00391378|Cognition|cognition
1600761|NCT00391378|Heart|heart
1600762|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
1600763|NCT00391365|arthritis|arthritis
1600764|NCT00391365|arthrodesis|arthrodesis
1600765|NCT00391365|arthroplasty|arthroplasty
1600766|NCT00391365|Gait|gait
1600767|NCT00391365|step count|step count
1600768|NCT00391365|walking|walking
1600769|NCT00391352|Multiple Sclerosis|multiple sclerosis
1600770|NCT00391352|Disease Modifying Therapy|disease modifying therapy
1600771|NCT00391339|Bryophyllum p.|bryophyllum p.
1600772|NCT00391339|Nifedipine|nifedipine
1600773|NCT00391339|Tocolysis|tocolysis
1600774|NCT00391326|Bivalirudin|bivalirudin
1600775|NCT00391326|Heparin|heparin
1600776|NCT00391326|Bleeding|bleeding
1600777|NCT00391326|TIMI flow|timi flow
1600778|NCT00391326|STEMI|stemi
1600779|NCT00391313|Chikungunya|chikungunya
1600780|NCT00391313|Chikungunya disease|chikungunya disease
1600781|NCT00391300|melanoma|melanoma
1600782|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1600783|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1600784|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
1600785|NCT00391287|Aplastic Anemia|aplastic anemia
1600786|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
1600787|NCT00391287|Surveillance Registry|surveillance registry
1600788|NCT00391287|Registries|registries
1600789|NCT00391261|weight gain|weight gain
1600790|NCT00391261|obesity|obesity
1600791|NCT00391261|metabolism|metabolism
1600792|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
1600793|NCT00391248|palliative radiation|palliative radiation
1600794|NCT00391248|tarceva|tarceva
1600795|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
1600796|NCT00391235|bipolar disorder|bipolar disorder
1600797|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
1600798|NCT00391235|white matter|white matter
1600799|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
1600800|NCT00391235|children|children
1600801|NCT00391235|adolescents|adolescents
1600802|NCT00391222|Bipolar I Disorder|bipolar i disorder
1600803|NCT00391222|Intramuscular injection|intramuscular injection
1600804|NCT00391222|prevention of mood episodes|prevention of mood episodes
1600805|NCT00391222|long acting injectable|long acting injectable
1600806|NCT00391222|risperidone|risperidone
1600807|NCT00391183|Gallbladder cancer|gallbladder cancer
1600808|NCT00391183|Quality of life|quality of life
1600809|NCT00391183|Stenting|stenting
1600810|NCT00391183|Survival|survival
1600811|NCT00391183|Performance status|performance status
1600820|NCT00391157|Múltiple Myeloma|múltiple myeloma
1600821|NCT00391157|Transplant|transplant
1600822|NCT00391157|Patients <65 years.|patients <65 years.
1600823|NCT00391144|Pattern Dystrophy|pattern dystrophy
1600824|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
1600825|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
1600829|NCT00391131|Quality of Life|quality of life
1600830|NCT00391131|Serious Bacterial Infections|serious bacterial infections
1600831|NCT00391105|intubation|intubation
1600832|NCT00391105|Sedation|sedation
1600833|NCT00391105|Analgesia|analgesia
1600834|NCT00391105|preterm neonate|preterm neonate
1600835|NCT00391105|remifentanil|remifentanil
1600836|NCT00391105|morphine|morphine
1600837|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
1601409|NCT00388921|Vitamin A|vitamin a
1600838|NCT00391079|Central Neuropathic Pain|central neuropathic pain
1600839|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
1600840|NCT00391066|CLL|cll
1600841|NCT00391053|Influenza|influenza
1600842|NCT00391053|Orthomyxoviruses|orthomyxoviruses
1600843|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1600844|NCT00391053|Adults|adults
1600845|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
1600846|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
1600847|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
1600848|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
1600849|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
1600850|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
1600851|NCT00391001|mania|mania
1600852|NCT00391001|bipolar disorder|bipolar disorder
1600853|NCT00391001|taurine|taurine
1600854|NCT00391001|adolescents|adolescents
1600855|NCT00390988|blood count|blood count
1600856|NCT00390988|capillary|capillary
1600857|NCT00390988|venous|venous
1600858|NCT00390988|Adult|adult
1600859|NCT00390988|reference values|reference values
1600860|NCT00390975|Tegaserod|tegaserod
1600861|NCT00390975|diabetes|diabetes
1600862|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
1600863|NCT00390975|gastric emptying|gastric emptying
1600864|NCT00390975|gastric retention|gastric retention
1600865|NCT00390975|electrogastrography|electrogastrography
1600866|NCT00390962|copeptin|copeptin
1600867|NCT00390962|vasopressin|vasopressin
1600868|NCT00390962|Adh|adh
1600869|NCT00390962|SIADH|siadh
1600870|NCT00390962|diabetes insipidus|diabetes insipidus
1600871|NCT00390962|stroke|stroke
1600872|NCT00390962|risk factors|risk factors
1600873|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
1600874|NCT00390949|HIV prevention|hiv prevention
1600875|NCT00390949|Zimbabwe|zimbabwe
1600876|NCT00390949|Core groups|core groups
1600877|NCT00390949|Peer education|peer education
1600878|NCT00390949|Syndromic management|syndromic management
1600879|NCT00390949|Commercial sex workers|commercial sex workers
1600880|NCT00390949|Condom distribution|condom distribution
1600881|NCT00390949|HIV Seronegativity|hiv seronegativity
1600882|NCT00390923|smoking|smoking
1600883|NCT00390923|nicotine dependence|nicotine dependence
1600884|NCT00390923|double-blind|double-blind
1600885|NCT00390923|placebo-controlled|placebo-controlled
1600886|NCT00390923|randomized|randomized
1600887|NCT00390923|full substitution therapy|full substitution therapy
1600888|NCT00390923|selegiline|selegiline
1600889|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
1600890|NCT00390910|Preterm|preterm
1600891|NCT00390910|Safety|safety
1600892|NCT00390910|Pneumococcal disease|pneumococcal disease
1600893|NCT00390910|Immunogenicity|immunogenicity
1600894|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
1600895|NCT00390897|Glivec|glivec
1600896|NCT00390897|Interferon|interferon
1600897|NCT00390884|Fluzone®|fluzone®
1600898|NCT00390884|Influenza|influenza
1600899|NCT00390884|Influenza virus infection|influenza virus infection
1600900|NCT00390884|Influenza vaccine|influenza vaccine
1600901|NCT00390871|Patient|patient
1600902|NCT00390871|Must be|must be
1600903|NCT00390871|Under|under
1600904|NCT00390858|β-thalassemia major|β-thalassemia major
1600905|NCT00390858|iron overload|iron overload
1600906|NCT00390858|deferasirox|deferasirox
1600907|NCT00390858|pediatric rare anemia|pediatric rare anemia
1600908|NCT00390845|MAP kinase|map kinase
1600909|NCT00390845|SB681323|sb681323
1600910|NCT00390845|neuropathic pain|neuropathic pain
1600911|NCT00390845|patients|patients
1600912|NCT00390845|P38|p38
1600913|NCT00390845|nerve trauma|nerve trauma
1600914|NCT00390832|STEMI|stemi
1600915|NCT00390819|Community acquired pneumonia|community acquired pneumonia
1600916|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
1600917|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
1600918|NCT00390793|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1600919|NCT00390793|Leukemia|leukemia
1600920|NCT00390793|ALL|all
1600921|NCT00390793|Philadelphia-Positive ALL|philadelphia-positive all
1600922|NCT00390793|BCR-ABL Positive ALL|bcr-abl positive all
1600923|NCT00390793|Dasatinib|dasatinib
1600924|NCT00390793|Hyper-CVAD|hyper-cvad
1600925|NCT00390793|Cyclophosphamide|cyclophosphamide
1600931|NCT00390793|Dexamethasone|dexamethasone
1600932|NCT00390793|Decadron|decadron
1600933|NCT00390793|Sprycel|sprycel
1600934|NCT00390780|Miconazole Lauriad|miconazole lauriad
1600935|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
1600936|NCT00390780|HIV patients|hiv patients
1600937|NCT00390780|Mycology|mycology
1600938|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
1600939|NCT00390780|Candida culture positive|candida culture positive
1600940|NCT00390780|Treatment Experienced|treatment experienced
1600941|NCT00390767|Peripheral arterial disease|peripheral arterial disease
1600942|NCT00390767|Peripheral vascular disease|peripheral vascular disease
1600943|NCT00390767|Claudication|claudication
1600944|NCT00390767|Cell therapy|cell therapy
1600945|NCT00390767|Gene therapy|gene therapy
1600946|NCT00390767|Endothelial cells|endothelial cells
1600947|NCT00390767|Smooth muscle cells|smooth muscle cells
1600948|NCT00390767|Angiogenesis|angiogenesis
1600949|NCT00390754|pregnancy|pregnancy
1600950|NCT00390754|unintended|unintended
1600951|NCT00390754|menses|menses
1600952|NCT00390741|hip fracture|hip fracture
1600953|NCT00390741|bone mineral density|bone mineral density
1600954|NCT00390741|exercise|exercise
1600955|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
1600956|NCT00390702|Ventricular septal defect|ventricular septal defect
1600957|NCT00390702|VSD|vsd
1600958|NCT00390676|cancer|cancer
1600959|NCT00390676|tumors|tumors
1600960|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
1600961|NCT00390676|antineoplastic agents|antineoplastic agents
1600962|NCT00390676|cadherins|cadherins
1600963|NCT00390676|solid tumors|solid tumors
1600964|NCT00390663|Paediatric|paediatric
1600965|NCT00390663|Epistaxis|epistaxis
1600966|NCT00390663|Nose bleed|nose bleed
1600967|NCT00390663|Naseptin|naseptin
1600968|NCT00390650|Anxiety|anxiety
1600969|NCT00390650|clinical trials|clinical trials
1600970|NCT00390637|Diogenes|diogenes
1600971|NCT00390637|Diet Intervention|diet intervention
1600972|NCT00390637|Family|family
1600973|NCT00390637|Glycemic Index|glycemic index
1600974|NCT00390637|Protein|protein
1600975|NCT00390624|Urodilatin|urodilatin
1600976|NCT00390624|Mannitol|mannitol
1600977|NCT00390624|Acute Kidney Failure|acute kidney failure
1600978|NCT00390611|Ovarian Cancer|ovarian cancer
1600979|NCT00390598|colonoscopy|colonoscopy
1600980|NCT00390598|large bowel preparation|large bowel preparation
1600981|NCT00390598|bowel cleansing|bowel cleansing
1600982|NCT00390598|randomized controlled trial|randomized controlled trial
1600983|NCT00390585|Renal Insufficiency|renal insufficiency
1600984|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1600985|NCT00390585|Contrast media|contrast media
1600986|NCT00390572|sleep|sleep
1600987|NCT00390572|consultation and referral|consultation and referral
1600988|NCT00390572|outcome assessment|outcome assessment
1600989|NCT00390572|primary care|primary care
1600990|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
1600991|NCT00390559|Tobacco Smoking|tobacco smoking
1600992|NCT00390559|Smoking stimuli|smoking stimuli
1600994|NCT00390533|Anxiety|anxiety
1600995|NCT00390533|clinical trials|clinical trials
1600996|NCT00390520|Type 2 diabetes|type 2 diabetes
1600997|NCT00390520|vildagliptin|vildagliptin
1600998|NCT00390520|glucagon|glucagon
1600999|NCT00390520|hypoglycemia|hypoglycemia
1601000|NCT00390507|Acceleromyography|acceleromyography
1601001|NCT00390507|TOF-Watch|tof-watch
1601002|NCT00390507|Posttetanic count|posttetanic count
1601003|NCT00390507|Train of four|train of four
1601004|NCT00390507|Neuromuscular blockade|neuromuscular blockade
1601005|NCT00390494|Fibroids|fibroids
1601006|NCT00390494|Leiomyoma|leiomyoma
1601007|NCT00390494|Hysterectomy|hysterectomy
1601008|NCT00390494|Myomectomy|myomectomy
1601009|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
1601010|NCT00390494|Questionnaire|questionnaire
1601011|NCT00390481|Carotid Occlusion|carotid occlusion
1601012|NCT00390481|Cognition|cognition
1601013|NCT00390468|Tandutinib|tandutinib
1601014|NCT00390468|MLN518|mln518
1601015|NCT00390468|CT53518|ct53518
1601016|NCT00390468|pain|pain
1601017|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1601018|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
1601019|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
1601020|NCT00390468|bone metastases|bone metastases
1601021|NCT00390468|hormone-based castration|hormone-based castration
1601022|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
1601023|NCT00390442|non invasive ventilation|non invasive ventilation
1601024|NCT00390442|CPAP|cpap
1601025|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1601026|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1601027|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1601290|NCT00389454|Infants|infants
1601028|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601029|NCT00390416|Metastatic|metastatic
1601030|NCT00390416|Gastroesophageal|gastroesophageal
1601033|NCT00390416|Fluorouracil|fluorouracil
1601034|NCT00390416|Bevacizumab|bevacizumab
1601035|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
1601036|NCT00390416|06-096|06-096
1601037|NCT00390403|adult glioblastoma|adult glioblastoma
1601038|NCT00390403|adult gliosarcoma|adult gliosarcoma
1601039|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
1601309|NCT00389402|antiretroviral therapy|antiretroviral therapy
1601040|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
1601041|NCT00390377|x-ray diffraction|x-ray diffraction
1601042|NCT00390377|hair|hair
1601043|NCT00390377|breast cancer|breast cancer
1601044|NCT00390377|synchrotron|synchrotron
1601045|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
1601046|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1601047|NCT00390364|recurrent colon cancer|recurrent colon cancer
1601048|NCT00390364|stage III colon cancer|stage iii colon cancer
1601049|NCT00390364|stage IV colon cancer|stage iv colon cancer
1601050|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
1601051|NCT00390364|stage III rectal cancer|stage iii rectal cancer
1601052|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
1601053|NCT00390351|Optical coherence tomography|optical coherence tomography
1601054|NCT00390338|recurrent melanoma|recurrent melanoma
1601055|NCT00390338|stage IV melanoma|stage iv melanoma
1601056|NCT00390338|stage IIIA melanoma|stage iiia melanoma
1601057|NCT00390338|stage IIIB melanoma|stage iiib melanoma
1601058|NCT00390338|stage IIIC melanoma|stage iiic melanoma
1601059|NCT00390312|Post operative pain|post operative pain
1601060|NCT00390312|Third molar extraction|third molar extraction
1601061|NCT00390312|Dental surgery|dental surgery
1601062|NCT00390312|Morphine|morphine
1601063|NCT00390286|Telemedicine|telemedicine
1601064|NCT00390273|diabetes|diabetes
1601065|NCT00390273|metformin|metformin
1601066|NCT00390273|hyperlactatemia|hyperlactatemia
1601067|NCT00390221|MS|ms
1601068|NCT00390221|multiple sclerosis|multiple sclerosis
1601069|NCT00390208|Macular Degeneration|macular degeneration
1601070|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
1601071|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
1601072|NCT00390208|Age-Related Maculopathies|age-related maculopathies
1601073|NCT00390208|Age-Related Maculopathy|age-related maculopathy
1601074|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
1601075|NCT00390208|RETINAL DEGENERATION|retinal degeneration
1601076|NCT00390208|ARMD|armd
1601077|NCT00390208|AMD|amd
1601078|NCT00390208|Lucentis|lucentis
1601079|NCT00390208|Visudyne|visudyne
1601080|NCT00390208|Photodynamic Therapy|photodynamic therapy
1601081|NCT00390208|Verteporfin|verteporfin
1601082|NCT00390208|Ranibizumab|ranibizumab
1601083|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
1601084|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
1601085|NCT00390195|RAD001|rad001
1601086|NCT00390195|Rapamycin|rapamycin
1601087|NCT00390195|Randomize|randomize
1601088|NCT00390195|Phase I|phase i
1601089|NCT00390195|Phase II|phase ii
1601090|NCT00390195|Pharmacokinetics|pharmacokinetics
1601091|NCT00390182|GI tumors|gi tumors
1601092|NCT00390182|Locally Advanced|locally advanced
1601093|NCT00390182|Metastatic|metastatic
1601094|NCT00390182|Hepatobiliary|hepatobiliary
1601095|NCT00390182|Ovary|ovary
1601096|NCT00390169|breast neoplasms|breast neoplasms
1601097|NCT00390169|stress|stress
1601098|NCT00390169|personality|personality
1601099|NCT00390169|psychology|psychology
1601100|NCT00390156|refractory|refractory
1601101|NCT00390156|prior treatment|prior treatment
1601102|NCT00390156|solid tumors|solid tumors
1601103|NCT00390156|phase I|phase i
1601104|NCT00390156|phase 1|phase 1
1601105|NCT00390143|Immunogenicity|immunogenicity
1601106|NCT00390143|Meningococcal vaccine|meningococcal vaccine
1601107|NCT00390143|Conjugate vaccine|conjugate vaccine
1601108|NCT00390143|Persistence|persistence
1601109|NCT00390130|Vaccination|vaccination
1601110|NCT00390130|Pediatrics|pediatrics
1601111|NCT00390130|Pain|pain
1601112|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601113|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1601114|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1601115|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1601116|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1601117|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1601118|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1601119|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1601120|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1601291|NCT00389441|VEGFR inhibitor|vegfr inhibitor
1601121|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1601122|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1601123|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1601124|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1601125|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1601126|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1601127|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1601128|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1601129|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1601130|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1601131|NCT00390104|Neuromuscular Disease|neuromuscular disease
1601132|NCT00390104|Muscle weakness|muscle weakness
1601133|NCT00390104|Muscle atrophy|muscle atrophy
1601134|NCT00390091|Lupus|lupus
1601135|NCT00390091|Nephritis|nephritis
1601136|NCT00390091|Kidney|kidney
1601138|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
1601139|NCT00390091|Nephritis, Lupus|nephritis, lupus
1601140|NCT00390078|Vaccine|vaccine
1601141|NCT00390078|Safety|safety
1601142|NCT00390078|T-cell epitope|t-cell epitope
1601143|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1601144|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1601145|NCT00390065|Follow-up|follow-up
1601146|NCT00390065|Premature infants|premature infants
1601147|NCT00390065|Nitric Oxide|nitric oxide
1601148|NCT00390065|Respiratory function testing|respiratory function testing
1601149|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
1601150|NCT00390039|Pain, postoperative|pain, postoperative
1601151|NCT00390039|Surgery, orthopedic|surgery, orthopedic
1601152|NCT00390039|Morphine|morphine
1601153|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
1601154|NCT00390026|Bevacizumab|bevacizumab
1601155|NCT00390026|Photodynamic therapy|photodynamic therapy
1601156|NCT00390013|Vulvar Pain|vulvar pain
1601157|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
1601158|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
1601159|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
1601160|NCT00389935|Angiodysplasia|angiodysplasia
1601161|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
1601162|NCT00389935|Obscure Bleeding|obscure bleeding
1601163|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601164|NCT00389909|Premature infants|premature infants
1601165|NCT00389909|Apnea|apnea
1601166|NCT00389909|Doxapram|doxapram
1601167|NCT00389909|pharmacokinetics|pharmacokinetics
1601168|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
1601169|NCT00389883|propofol|propofol
1601170|NCT00389883|sevoflurane|sevoflurane
1601171|NCT00389883|remifentanil|remifentanil
1601172|NCT00389883|sufentanil.|sufentanil.
1601173|NCT00389870|recurrent colon cancer|recurrent colon cancer
1601174|NCT00389870|stage IV colon cancer|stage iv colon cancer
1601175|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
1601176|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
1601177|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
1601178|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1601179|NCT00389857|Influenza|influenza
1601180|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
1601181|NCT00389857|Fluzone®|fluzone®
1601182|NCT00389844|hip fracture|hip fracture
1601183|NCT00389844|exercise|exercise
1601184|NCT00389844|motivation|motivation
1601185|NCT00389831|Rotigotine|rotigotine
1601186|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
1601187|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
1601188|NCT00389831|Restless Legs Syndrome|restless legs syndrome
1601189|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1601190|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1601191|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1601192|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1601193|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1601194|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1601195|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1601196|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1601197|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1601198|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1601199|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1601200|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1601201|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1601202|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1601203|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1601204|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1601298|NCT00389441|anaplastic|anaplastic
1601205|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1601206|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1601207|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1601208|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1601209|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1601210|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601211|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1601212|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
1601213|NCT00389766|regional neuroblastoma|regional neuroblastoma
1601214|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
1601215|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
1601216|NCT00389753|Scars|scars
1601217|NCT00389753|Hydratation|hydratation
1601218|NCT00389753|After Treatment|after treatment
1601219|NCT00389714|pedodontics|pedodontics
1601220|NCT00389714|carious|carious
1601221|NCT00389714|dental restoration|dental restoration
1601222|NCT00389714|antibacterial|antibacterial
1601223|NCT00389714|nanoparticles|nanoparticles
1601224|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
1601225|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
1601226|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
1601227|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
1601228|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1601229|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1601230|NCT00389649|congestive heart failure|congestive heart failure
1601231|NCT00389649|pacemaker|pacemaker
1601232|NCT00389649|heart rate|heart rate
1601233|NCT00389636|Diabetes|diabetes
1601234|NCT00389636|Foot|foot
1601235|NCT00389636|Extremity|extremity
1601236|NCT00389636|Ulcer|ulcer
1601237|NCT00389636|Wound|wound
1601238|NCT00389636|Gauze|gauze
1601239|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
1601240|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
1601241|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
1601242|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1601243|NCT00389597|degenerative disc disease|degenerative disc disease
1601244|NCT00389597|cervical arthroplasty|cervical arthroplasty
1601245|NCT00389597|Mobi C|mobi c
1601246|NCT00389597|multilevel|multilevel
1601247|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
1601248|NCT00389584|cognitive/functional effects|cognitive/functional effects
1601249|NCT00389584|poor performance status|poor performance status
1601250|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
1601251|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1601252|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
1601253|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601254|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1601255|NCT00389558|Skin colonization|skin colonization
1601256|NCT00389558|Antiseptic|antiseptic
1601257|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
1601258|NCT00389558|Infant|infant
1601259|NCT00389532|Influenza|influenza
1601260|NCT00389532|Influenza Vaccine|influenza vaccine
1601261|NCT00389519|Hypertension/*etiology|hypertension/*etiology
1601262|NCT00389519|Blood Pressure|blood pressure
1601263|NCT00389519|Pediatric|pediatric
1601264|NCT00389519|Adolescent|adolescent
1601265|NCT00389519|Child|child
1601266|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1601267|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1601268|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1601269|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1601271|NCT00389493|Augmentation|augmentation
1601272|NCT00389493|Antipsychotics|antipsychotics
1601273|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1601274|NCT00389480|Solid Tumors|solid tumors
1601275|NCT00389480|Solid Malignancies|solid malignancies
1601276|NCT00389480|Phase I|phase i
1601277|NCT00389467|stroke|stroke
1601278|NCT00389467|ischemic stroke|ischemic stroke
1601279|NCT00389467|blood clot|blood clot
1601280|NCT00389467|Merci Retriever|merci retriever
1601281|NCT00389467|Penumbra System|penumbra system
1601282|NCT00389467|embolectomy|embolectomy
1601283|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
1601284|NCT00389467|MRI|mri
1601285|NCT00389467|CT|ct
1601286|NCT00389467|SPOTRIAS|spotrias
1601287|NCT00389454|Acetaminophen|acetaminophen
1601288|NCT00389454|Fever|fever
1601289|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
1601292|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1601293|NCT00389441|anti-angiogenic|anti-angiogenic
1601294|NCT00389441|carcinoma|carcinoma
1601295|NCT00389441|papillary|papillary
1601296|NCT00389441|follicular|follicular
1601297|NCT00389441|medullary|medullary
1601299|NCT00389428|Hematologic malignancies|hematologic malignancies
1601300|NCT00389428|Malignancies, hematologic|malignancies, hematologic
1601301|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
1601302|NCT00389415|Type 2 Diabetes|type 2 diabetes
1601303|NCT00389415|Vildagliptin|vildagliptin
1601304|NCT00389415|HbA1c|hba1c
1601305|NCT00389402|lipids|lipids
1601306|NCT00389402|lipodystrophy|lipodystrophy
1601307|NCT00389402|fat distribution|fat distribution
1601310|NCT00389402|Treatment Naive|treatment naive
1601311|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
1601312|NCT00389389|Advanced solid tumors|advanced solid tumors
1601313|NCT00389389|Cancer|cancer
1601314|NCT00389389|Phase I|phase i
1601315|NCT00389389|Solid tumors|solid tumors
1601316|NCT00389389|Solid malignancies|solid malignancies
1601317|NCT00389337|Sepsis|sepsis
1601318|NCT00389337|SIRS|sirs
1601319|NCT00389337|Biomarkers|biomarkers
1601320|NCT00389337|xMAP|xmap
1601321|NCT00389324|Primary immune deficiency|primary immune deficiency
1601322|NCT00389311|Microbicide|microbicide
1601323|NCT00389311|Safety|safety
1601324|NCT00389311|HIV prevention|hiv prevention
1601325|NCT00389311|HIV Seronegativity|hiv seronegativity
1601326|NCT00389298|Chronic hepatitis C|chronic hepatitis c
1601327|NCT00389298|Viral kinetics|viral kinetics
1601328|NCT00389298|Phase II|phase ii
1601329|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
1601330|NCT00389298|Safety and tolerability|safety and tolerability
1601331|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
1601332|NCT00389285|interleukin-21|interleukin-21
1601333|NCT00389285|sorafenib|sorafenib
1601334|NCT00389285|Immunotherapy|immunotherapy
1601335|NCT00389259|Insecticides|insecticides
1601336|NCT00389259|Organophosphate|organophosphate
1601337|NCT00389259|Scopolamine|scopolamine
1601338|NCT00389259|randomized control study|randomized control study
1601339|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
1601340|NCT00389246|obesity|obesity
1601341|NCT00389246|genetic consultation|genetic consultation
1601342|NCT00389246|randomized controlled trial|randomized controlled trial
1601343|NCT00389220|Coronary Disease|coronary disease
1601344|NCT00389220|Coronary Stenosis|coronary stenosis
1601345|NCT00389220|Angioplasty|angioplasty
1601346|NCT00389220|Coronary Restenosis|coronary restenosis
1601347|NCT00389220|Drug Eluting Stent|drug eluting stent
1601348|NCT00389194|HIV-1 infection|hiv-1 infection
1601349|NCT00389194|fat distribution|fat distribution
1601350|NCT00389194|lipodystrophy|lipodystrophy
1601351|NCT00389194|lipids|lipids
1601352|NCT00389194|kidney function|kidney function
1601353|NCT00389194|Treatment Experienced|treatment experienced
1601354|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
1601355|NCT00389181|AVM|avm
1601356|NCT00389181|BAVM|bavm
1601357|NCT00389181|Stroke|stroke
1601358|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
1601359|NCT00389168|Hypertension|hypertension
1601360|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
1601361|NCT00389168|Angiotensin|angiotensin
1601362|NCT00389168|Human|human
1601363|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
1601364|NCT00389142|pelvic pain|pelvic pain
1601365|NCT00389142|urinary frequency|urinary frequency
1601366|NCT00389142|painful bladder|painful bladder
1601367|NCT00389142|urinary urgency|urinary urgency
1601368|NCT00389129|Platelets|platelets
1601369|NCT00389129|Aspirin Resistance|aspirin resistance
1601370|NCT00389129|Platelet aggregation|platelet aggregation
1601371|NCT00389090|temozolomide resistant|temozolomide resistant
1601372|NCT00389090|anaplastic glioma|anaplastic glioma
1601373|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
1601374|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
1601375|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
1601376|NCT00389077|perifosine|perifosine
1601377|NCT00389077|solid tumors|solid tumors
1601378|NCT00389077|lymphomas|lymphomas
1601379|NCT00389077|anticancer agent|anticancer agent
1601380|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
1601381|NCT00389064|GAD|gad
1601382|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1601383|NCT00389051|Malignant lymphoma|malignant lymphoma
1601384|NCT00389038|headache|headache
1601385|NCT00389038|coping skills training|coping skills training
1601386|NCT00389038|amitriptyline|amitriptyline
1601387|NCT00389038|attention control|attention control
1601388|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
1601389|NCT00389012|rehabilitation|rehabilitation
1601390|NCT00389012|hemiplegic gait|hemiplegic gait
1601391|NCT00389012|exercise therapy|exercise therapy
1601392|NCT00389012|physical therapy|physical therapy
1601393|NCT00388999|Multiple Myeloma|multiple myeloma
1601394|NCT00388999|Stem Cell Transplant|stem cell transplant
1601395|NCT00388999|rhMBL|rhmbl
1601396|NCT00388973|Major Depressive Disorder|major depressive disorder
1601397|NCT00388973|MDD|mdd
1601601|NCT00388232|prevalence|prevalence
1601398|NCT00388960|small cell lung cancer|small cell lung cancer
1601399|NCT00388960|amrubicin|amrubicin
1601400|NCT00388947|vaginal prolapse|vaginal prolapse
1601401|NCT00388947|cystocele|cystocele
1601402|NCT00388947|rectocele|rectocele
1601403|NCT00388947|enterocele|enterocele
1601404|NCT00388947|apical prolapse|apical prolapse
1601405|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
1601406|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
1601407|NCT00388934|Angina pectoris|angina pectoris
1601408|NCT00388934|Stent|stent
1601410|NCT00388921|Children|children
1601411|NCT00388921|Severe malnutrition|severe malnutrition
1601412|NCT00388921|Retinol|retinol
1601413|NCT00388921|Retinol binding protein|retinol binding protein
1601414|NCT00388921|Diarrhoea|diarrhoea
1601415|NCT00388921|ALRI|alri
1601416|NCT00388921|Age 6-59 months|age 6-59 months
1601417|NCT00388921|Either sex|either sex
1601418|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
1601419|NCT00388921|Bipedal oedema|bipedal oedema
1601420|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
1601421|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
1601422|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
1601423|NCT00388908|vertebral fractures|vertebral fractures
1601424|NCT00388908|osteoporosis|osteoporosis
1601425|NCT00388908|prevention|prevention
1601426|NCT00388908|case-finding|case-finding
1601427|NCT00388908|quality improvement|quality improvement
1601428|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
1601429|NCT00388869|renal artery|renal artery
1601430|NCT00388869|calcium|calcium
1601431|NCT00388869|CT|ct
1601432|NCT00388869|hypertension|hypertension
1601433|NCT00388856|antioxidant supplementation|antioxidant supplementation
1601434|NCT00388856|preeclampsia|preeclampsia
1601435|NCT00388856|prevention|prevention
1601436|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
1601437|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
1601438|NCT00388843|atherosclerosis|atherosclerosis
1601439|NCT00388843|ultrasound|ultrasound
1601440|NCT00388843|inflammation|inflammation
1601441|NCT00388843|statins|statins
1601442|NCT00388843|vulnerable plaque|vulnerable plaque
1601443|NCT00388843|stroke|stroke
1601444|NCT00388830|Gallbladder|gallbladder
1601445|NCT00388830|Ultrasound|ultrasound
1601446|NCT00388830|Emergency Medicine|emergency medicine
1601447|NCT00388817|Hypertension|hypertension
1601448|NCT00388817|Blood pressure|blood pressure
1601449|NCT00388817|Adherence|adherence
1601450|NCT00388817|Compliance|compliance
1601451|NCT00388817|Pharmacist|pharmacist
1601452|NCT00388817|Pharmacy|pharmacy
1601453|NCT00388817|Costs|costs
1601454|NCT00388804|Prostate Cancer|prostate cancer
1601455|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
1601456|NCT00388804|Radiation Therapy|radiation therapy
1601457|NCT00388804|Hormone Therapy|hormone therapy
1601458|NCT00388804|Bicalutamide|bicalutamide
1601459|NCT00388804|Casodex|casodex
1601460|NCT00388804|Leuprolide|leuprolide
1601461|NCT00388804|Lupron|lupron
1601462|NCT00388804|Goserelin|goserelin
1601463|NCT00388804|Zoladex|zoladex
1601464|NCT00388804|Flutamide|flutamide
1601465|NCT00388804|EBRT|ebrt
1601466|NCT00388791|symptomatology|symptomatology
1601467|NCT00388791|Schein questionnaire|schein questionnaire
1601468|NCT00388791|fluoresceien staining|fluoresceien staining
1601469|NCT00388765|bronchoscopy|bronchoscopy
1601470|NCT00388765|sample bank|sample bank
1601471|NCT00388765|research study volunteer|research study volunteer
1601472|NCT00388752|Acupuncture|acupuncture
1601473|NCT00388752|Phantom limb pain|phantom limb pain
1601474|NCT00388752|Residual limb pain|residual limb pain
1601475|NCT00388752|amputation|amputation
1601477|NCT00388752|traumatic|traumatic
1601478|NCT00388752|surgical|surgical
1601479|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
1601480|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
1601481|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
1601482|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
1601483|NCT00388739|Pediatric Asthma|pediatric asthma
1601484|NCT00388739|Pulmicort|pulmicort
1601485|NCT00388739|TEDAS ED|tedas ed
1601486|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
1601487|NCT00388739|Chronic asthma|chronic asthma
1601593|NCT00388271|Xatral|xatral
1601488|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
1601489|NCT00388726|metastatic breast cancer|metastatic breast cancer
1601490|NCT00388713|Radiation therapy|radiation therapy
1601491|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
1601602|NCT00388232|smoke|smoke
1601492|NCT00388713|Carotid Artery Diseases|carotid artery diseases
1601493|NCT00388713|Breast Cancer|breast cancer
1601494|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
1601495|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
1601496|NCT00388687|Hypoxia|hypoxia
1601497|NCT00388687|FAZA|faza
1601499|NCT00388687|Radiochemotherapy|radiochemotherapy
1601500|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
1601501|NCT00388661|sleep problems|sleep problems
1601502|NCT00388661|quality of life|quality of life
1601503|NCT00388661|melatonin|melatonin
1601504|NCT00388661|sleep apnea|sleep apnea
1601505|NCT00388661|medication|medication
1601506|NCT00388661|preload|preload
1601507|NCT00388661|nutritional status|nutritional status
1601508|NCT00388661|ProBNP|probnp
1601509|NCT00388648|Dialysis|dialysis
1601510|NCT00388648|Vegan Diet|vegan diet
1601511|NCT00388648|Mortality|mortality
1601512|NCT00388648|Morbidity|morbidity
1601513|NCT00388648|Treatment outcome|treatment outcome
1601514|NCT00388635|Multiple Myeloma|multiple myeloma
1601515|NCT00388635|Patients over 65 years old|patients over 65 years old
1601516|NCT00388622|Heart failure|heart failure
1601517|NCT00388622|Adherence|adherence
1601518|NCT00388622|Compliance|compliance
1601519|NCT00388622|Pharmacy|pharmacy
1601520|NCT00388622|Pharmacist|pharmacist
1601521|NCT00388622|Health-related quality of life|health-related quality of life
1601522|NCT00388622|Clinical exacerbation|clinical exacerbation
1601523|NCT00388622|Costs|costs
1601524|NCT00388596|SB-751689|sb-751689
1601525|NCT00388596|osteoporosis|osteoporosis
1601526|NCT00388596|drug interaction|drug interaction
1601527|NCT00388596|ketoconazole|ketoconazole
1601528|NCT00388596|atorvastatin|atorvastatin
1601529|NCT00388596|rosuvastatin|rosuvastatin
1601530|NCT00388583|Influenza|influenza
1601531|NCT00388583|Orthomyxoviruses|orthomyxoviruses
1601532|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1601533|NCT00388583|Elderly.|elderly.
1601534|NCT00388570|Asthma|asthma
1601535|NCT00388570|adult|adult
1601536|NCT00388570|paediatric|paediatric
1601537|NCT00388570|NIOX MINO®|niox mino®
1601538|NCT00388570|NIOX®|niox®
1601539|NCT00388570|nitric oxide|nitric oxide
1601540|NCT00388570|airway inflammation|airway inflammation
1601541|NCT00388570|open−label|open−label
1601542|NCT00388570|single−cohort|single−cohort
1601543|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
1601544|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
1601545|NCT00388531|CNS relapse|cns relapse
1601546|NCT00388531|Cytarabine liposome|cytarabine liposome
1601547|NCT00388505|tobramycin|tobramycin
1601548|NCT00388492|HIV Infected|hiv infected
1601549|NCT00388466|whole body vibration|whole body vibration
1601550|NCT00388466|muscle function|muscle function
1601551|NCT00388466|cystic fibrosis|cystic fibrosis
1601552|NCT00388466|mechanography|mechanography
1601553|NCT00388466|chair-rising-test|chair-rising-test
1601554|NCT00388453|Healthy volunteers|healthy volunteers
1601555|NCT00388440|Mumps|mumps
1601556|NCT00388440|Singapore|singapore
1601557|NCT00388440|Rubella|rubella
1601558|NCT00388440|Measles|measles
1601559|NCT00388427|advanced cancer|advanced cancer
1601560|NCT00388427|solid tumor|solid tumor
1601561|NCT00388427|solid malignancies|solid malignancies
1601562|NCT00388427|phase I|phase i
1601563|NCT00388401|Postoperative Ileus|postoperative ileus
1601564|NCT00388388|Remodeling|remodeling
1601565|NCT00388388|Resistance arteries|resistance arteries
1601566|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
1601567|NCT00388388|thiazide diuretic|thiazide diuretic
1601568|NCT00388362|GVHD|gvhd
1601569|NCT00388336|Anemia|anemia
1601570|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
1601571|NCT00388336|PROCRIT|procrit
1601572|NCT00388336|Epoetin alfa|epoetin alfa
1601573|NCT00388323|Alcohol|alcohol
1601574|NCT00388323|Hepatitis|hepatitis
1601575|NCT00388323|Cirrhosis|cirrhosis
1601576|NCT00388323|Inflammation|inflammation
1601577|NCT00388323|Cytokines|cytokines
1601578|NCT00388323|ADIPOKINES|adipokines
1601579|NCT00388323|Adipose tissue|adipose tissue
1601580|NCT00388310|cellulitis|cellulitis
1601581|NCT00388310|furuncles|furuncles
1601582|NCT00388310|carbuncles|carbuncles
1601583|NCT00388310|abscess|abscess
1601584|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
1601585|NCT00388297|Hypothyroxinemia|hypothyroxinemia
1601586|NCT00388297|Thyroid|thyroid
1601587|NCT00388297|Pregnancy|pregnancy
1601588|NCT00388297|Intellectual Development|intellectual development
1601589|NCT00388284|hemostasis|hemostasis
1601590|NCT00388284|arterial sealing|arterial sealing
1601591|NCT00388271|Alpha-blocker|alpha-blocker
1601592|NCT00388271|Alfuzosin|alfuzosin
1601594|NCT00388271|ESWL|eswl
1601595|NCT00388258|Postoperative ileus|postoperative ileus
1601596|NCT00388245|PCI|pci
1601597|NCT00388245|CABG|cabg
1601598|NCT00388245|Ejection Fraction|ejection fraction
1601599|NCT00388245|Myocardial Revascularization|myocardial revascularization
1601600|NCT00388232|COPD|copd
1601604|NCT00388232|occupational|occupational
1601605|NCT00388232|Malatya|malatya
1601606|NCT00388232|Turkey|turkey
1601607|NCT00388219|Buprenorphine|buprenorphine
1601608|NCT00388219|Transdermal patch|transdermal patch
1601609|NCT00388219|Centrally acting analgesic|centrally acting analgesic
1601610|NCT00388219|Plasma level|plasma level
1601611|NCT00388219|Healthy volunteers|healthy volunteers
1601612|NCT00388206|NSCLC|nsclc
1601613|NCT00388206|Avastin|avastin
1601614|NCT00388206|anti-VEGF|anti-vegf
1601615|NCT00388206|lung cancer|lung cancer
1601779|NCT00387738|Allergy|allergy
1601616|NCT00388206|colorectal cancer|colorectal cancer
1601617|NCT00388206|ARIES|aries
1601618|NCT00388206|Colon Cancer|colon cancer
1601619|NCT00388193|ALL (L3)|all (l3)
1601620|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
1601621|NCT00388193|RITUXIMAB|rituximab
1601622|NCT00388180|cholesterol|cholesterol
1601623|NCT00388180|inflammation|inflammation
1601624|NCT00388180|fat|fat
1601625|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
1601626|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
1601627|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
1601628|NCT00388167|Caspofungin acetate|caspofungin acetate
1601629|NCT00388154|Endometrial Cancer|endometrial cancer
1601630|NCT00388154|Gemcitabine|gemcitabine
1601631|NCT00388154|Gemzar|gemzar
1601632|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1601633|NCT00388154|Cisplatin|cisplatin
1601634|NCT00388154|Platinol-AQ|platinol-aq
1601635|NCT00388154|Platinol|platinol
1601636|NCT00388154|CDDP|cddp
1601637|NCT00388141|Preterm Infant;|preterm infant;
1601638|NCT00388141|NIDCAP;|nidcap;
1601639|NCT00388141|Neonatal Care,|neonatal care,
1601640|NCT00388141|Intervention Study;|intervention study;
1601641|NCT00388141|Growth and Development;|growth and development;
1601642|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
1601643|NCT00388141|Maternal Social support|maternal social support
1601644|NCT00388141|NICU|nicu
1601645|NCT00388128|Intermittent Claudication|intermittent claudication
1601646|NCT00388128|PAD|pad
1601647|NCT00388128|Caffeine|caffeine
1601648|NCT00388128|Walking capacity|walking capacity
1601649|NCT00388128|ABI|abi
1601650|NCT00388128|QoL|qol
1601651|NCT00388128|Growth factor|growth factor
1601652|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1601653|NCT00388115|stage I breast cancer|stage i breast cancer
1601654|NCT00388115|stage II breast cancer|stage ii breast cancer
1601655|NCT00388115|breast cancer in situ|breast cancer in situ
1601656|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601657|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1601658|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
1601659|NCT00388076|carboplatin|carboplatin
1601660|NCT00388076|lapatinib|lapatinib
1601661|NCT00388076|TAXOL|taxol
1601662|NCT00388076|PARAPLATIN|paraplatin
1601663|NCT00388076|paclitaxel|paclitaxel
1601664|NCT00388076|TYKERB|tykerb
1601665|NCT00388076|Pazopanib|pazopanib
1601666|NCT00388063|Neuroendocrine|neuroendocrine
1601667|NCT00388063|Carcinoma|carcinoma
1601668|NCT00388063|Atiprimod|atiprimod
1601669|NCT00388063|Carcinoid|carcinoid
1601670|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
1601671|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1601672|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1601673|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1601674|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1601675|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1601676|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1601677|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1601678|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1601679|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1601680|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1601681|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1601682|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1601683|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1601684|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1601758|NCT00387881|Combination product,|combination product,
1601685|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1601686|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1601687|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1601688|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1601689|NCT00388011|Post surgical pain|post surgical pain
1601690|NCT00388011|Bunionectomy|bunionectomy
1601691|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
1601692|NCT00388011|Morphine|morphine
1601693|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601694|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
1601695|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
1601696|NCT00387972|denagliptin|denagliptin
1601697|NCT00387972|diabetes treatment|diabetes treatment
1601698|NCT00387972|glycemic control|glycemic control
1601780|NCT00387738|Allergic|allergic
1601699|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1601700|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1601701|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1601702|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1601703|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1601704|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1601705|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1601706|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1601707|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1601708|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1601709|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1601710|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1601711|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1601712|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1601713|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1601714|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1601715|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1601716|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1601717|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1601718|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1601719|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1601720|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1601721|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1601722|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1601723|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1601724|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1601725|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1601726|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1601727|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1601728|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1601729|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1601730|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1601731|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1601732|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1601733|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1601734|NCT00387946|smoking|smoking
1601735|NCT00387946|cessation|cessation
1601736|NCT00387946|tobacco|tobacco
1601737|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
1601738|NCT00387933|adult glioblastoma|adult glioblastoma
1601739|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1601740|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1601741|NCT00387933|adult gliosarcoma|adult gliosarcoma
1601742|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
1601743|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
1601744|NCT00387933|adult brain stem glioma|adult brain stem glioma
1601745|NCT00387933|adult mixed glioma|adult mixed glioma
1601746|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1601747|NCT00387907|Herceptin|herceptin
1601748|NCT00387907|Taxane|taxane
1601749|NCT00387907|Breast Cancer|breast cancer
1601750|NCT00387894|adult glioblastoma|adult glioblastoma
1601751|NCT00387894|adult gliosarcoma|adult gliosarcoma
1601752|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
1601753|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
1601754|NCT00387881|naproxen sodium,|naproxen sodium,
1601755|NCT00387881|parallel group,|parallel group,
1601756|NCT00387881|double-blind,|double-blind,
1601757|NCT00387881|placebo-controlled,|placebo-controlled,
1601759|NCT00387881|migrainous headache|migrainous headache
1601760|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
1601761|NCT00387881|probable migraine,|probable migraine,
1601762|NCT00387868|Thymoma|thymoma
1601763|NCT00387868|Thymic carcinoma|thymic carcinoma
1601764|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
1601765|NCT00387868|Response rate|response rate
1601768|NCT00387777|Buprenorphine|buprenorphine
1601769|NCT00387777|Transdermal patch|transdermal patch
1601770|NCT00387777|multidose|multidose
1601771|NCT00387777|Centrally acting analgesic|centrally acting analgesic
1601772|NCT00387777|Plasma level|plasma level
1601773|NCT00387777|Healthy volunteers|healthy volunteers
1601774|NCT00387764|renal cell carcinoma|renal cell carcinoma
1601775|NCT00387764|pazopanib|pazopanib
1601776|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
1601777|NCT00387764|open label|open label
1601778|NCT00387738|Ragweed|ragweed
1601781|NCT00387738|Rhinitis|rhinitis
1601782|NCT00387738|Hay Fever|hay fever
1601783|NCT00387738|Seasonal|seasonal
1601784|NCT00387738|Treatment|treatment
1601785|NCT00387738|Immunotherapy|immunotherapy
1601786|NCT00387738|Vaccine|vaccine
1601787|NCT00387725|Adolescent|adolescent
1601788|NCT00387725|Meningococcal|meningococcal
1601789|NCT00387725|Safety|safety
1601790|NCT00387712|exercise|exercise
1601791|NCT00387712|inflammation|inflammation
1601792|NCT00387712|motor performance|motor performance
1601793|NCT00387712|skeletal muscle|skeletal muscle
1601794|NCT00387712|chronic stroke survivors|chronic stroke survivors
1601795|NCT00387712|treadmill exercise|treadmill exercise
1601796|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
1601797|NCT00387673|electrical stimulation|electrical stimulation
1601798|NCT00387673|hand|hand
1601799|NCT00387673|Rehabilitation|rehabilitation
1601800|NCT00387673|spinal cord injury|spinal cord injury
1601801|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1601802|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
1601803|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
1601804|NCT00387647|myeloid|myeloid
1601805|NCT00387647|acute|acute
1601806|NCT00387647|monocytic|monocytic
1601807|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
1601808|NCT00387621|heart failure|heart failure
1601809|NCT00387621|diastolic dysfunction|diastolic dysfunction
1601810|NCT00387621|systolic dysfunction|systolic dysfunction
1601811|NCT00387621|preclinical|preclinical
1601812|NCT00387621|natriuretic peptide|natriuretic peptide
1601813|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
1601814|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
1601815|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601816|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1601817|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1601818|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1601819|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1601820|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1601821|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1601822|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1601823|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1601943|NCT00387231|Myocardial Ischemia|myocardial ischemia
1601824|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1601825|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1601826|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1601827|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1601828|NCT00387595|Family History|family history
1601829|NCT00387595|CAD|cad
1601830|NCT00387595|CAC|cac
1601831|NCT00387595|cIMT|cimt
1601832|NCT00387595|CV Risk Factors|cv risk factors
1601833|NCT00387582|Diabetes|diabetes
1601834|NCT00387582|Macular Edema|macular edema
1601835|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
1601836|NCT00387582|Lucentis|lucentis
1601837|NCT00387582|Ranibizumab|ranibizumab
1601838|NCT00387569|Toddlers|toddlers
1601839|NCT00387569|Vaccine|vaccine
1601840|NCT00387569|Safety|safety
1601841|NCT00387556|ketamine|ketamine
1601842|NCT00387556|children|children
1601843|NCT00387556|emesis|emesis
1601844|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1601845|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1601846|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1601847|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1601848|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1601849|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1601850|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
1601851|NCT00387517|Diastolic|diastolic
1601852|NCT00387517|systolic|systolic
1601853|NCT00387517|hypertension|hypertension
1601854|NCT00387517|aliskiren|aliskiren
1601855|NCT00387517|blood pressure|blood pressure
1601856|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
1601857|NCT00387517|HCTZ|hctz
1601858|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601860|NCT00387478|Specific Immunotherapy|specific immunotherapy
1601861|NCT00387478|Tree|tree
1601862|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
1601863|NCT00387452|Aging|aging
1601864|NCT00387452|Type 2 diabetes|type 2 diabetes
1601865|NCT00387452|exercise|exercise
1601866|NCT00387452|aerobic training|aerobic training
1601867|NCT00387452|strength training|strength training
1601868|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
1601869|NCT00387452|heart rate variability|heart rate variability
1601870|NCT00387452|cerebral autoregulation|cerebral autoregulation
1601965|NCT00387192|Factor VIII|factor viii
1601871|NCT00387452|tilt table study|tilt table study
1601872|NCT00387452|transcranial Doppler|transcranial doppler
1601873|NCT00387452|autonomic nervous system|autonomic nervous system
1601874|NCT00387439|Anal incontinence|anal incontinence
1601875|NCT00387439|Gastroenterology|gastroenterology
1601876|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
1601877|NCT00387439|Randomized clinical trial|randomized clinical trial
1601878|NCT00387413|Duloxetine|duloxetine
1601879|NCT00387413|GSK189254|gsk189254
1601880|NCT00387413|Healthy volunteers|healthy volunteers
1601881|NCT00387413|Phase I.|phase i.
1601882|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
1601883|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
1601884|NCT00387400|adult gliosarcoma|adult gliosarcoma
1601885|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
1601886|NCT00387400|adult glioblastoma|adult glioblastoma
1601887|NCT00387387|pharmacokinetics|pharmacokinetics
1601888|NCT00387387|colorectal cancer|colorectal cancer
1601889|NCT00387387|pazopanib|pazopanib
1601890|NCT00387387|capecitabine|capecitabine
1601891|NCT00387387|CapeOx|capeox
1601892|NCT00387387|5-fluorouracil|5-fluorouracil
1601893|NCT00387387|oxaliplatin|oxaliplatin
1601894|NCT00387387|combination therapy|combination therapy
1601895|NCT00387387|FOLFOX 6|folfox 6
1601896|NCT00387361|Post-Operative Nausea|post-operative nausea
1601897|NCT00387361|Nausea|nausea
1601898|NCT00387361|Anesthesia|anesthesia
1601899|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
1601900|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
1601901|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
1601902|NCT00387361|Osteopathy|osteopathy
1601903|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
1601904|NCT00387348|fatigue|fatigue
1601905|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1601906|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1601907|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1601908|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1601909|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
1601910|NCT00387348|depression|depression
1601911|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
1601912|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
1601913|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
1601914|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
1601915|NCT00387348|stage IVA colon cancer|stage iva colon cancer
1601916|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
1601917|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
1601918|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
1601919|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
1601920|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1601921|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1601922|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1601923|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1601924|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1601925|NCT00387309|Bowel|bowel
1601926|NCT00387283|WNV|wnv
1601927|NCT00387283|West Nile virus|west nile virus
1601928|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
1601929|NCT00387270|Huntington's disease|huntington's disease
1601930|NCT00387270|Dimebon|dimebon
1601931|NCT00387270|dose-escalation|dose-escalation
1601932|NCT00387270|Phase 1-2a|phase 1-2a
1601933|NCT00387270|randomized|randomized
1601934|NCT00387270|controlled|controlled
1601935|NCT00387270|double-blind|double-blind
1601936|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
1601937|NCT00387257|platelet aggregation|platelet aggregation
1601938|NCT00387257|SB-659032|sb-659032
1601939|NCT00387257|rilapladib|rilapladib
1601940|NCT00387244|Pain;|pain;
1601941|NCT00387244|Back Pain;|back pain;
1601942|NCT00387244|Neurostimulation|neurostimulation
1601944|NCT00387231|Randomized Controlled Trials|randomized controlled trials
1601945|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1601946|NCT00387231|Drug Therapy|drug therapy
1601947|NCT00387218|Exercise|exercise
1601948|NCT00387218|Physical Functional Ability|physical functional ability
1601949|NCT00387218|Spinal Range of Motion|spinal range of motion
1601950|NCT00387218|Balance|balance
1601951|NCT00387218|Economy of Movement|economy of movement
1601952|NCT00387218|Aerobic Conditioning|aerobic conditioning
1601953|NCT00387218|Quality of Life|quality of life
1601954|NCT00387218|Adherence|adherence
1601955|NCT00387205|chronic administration|chronic administration
1601956|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
1601958|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
1601959|NCT00387205|malignant tumor|malignant tumor
1601960|NCT00387205|Pazopanib|pazopanib
1601961|NCT00387205|GW786034|gw786034
1601962|NCT00387205|cancer|cancer
1601963|NCT00387205|safety|safety
1601964|NCT00387192|Von Willebrand Disease|von willebrand disease
1601966|NCT00387192|Von Willebrand Factor|von willebrand factor
1601967|NCT00387192|Pharmacokinetics|pharmacokinetics
1601968|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
1601969|NCT00387166|Type 2 Diabetes|type 2 diabetes
1601970|NCT00387166|Cardiovascular|cardiovascular
1601971|NCT00387166|Blood Pressure|blood pressure
1601972|NCT00387166|Hispanic|hispanic
1601973|NCT00387166|Women|women
1601974|NCT00387166|Social Context|social context
1601975|NCT00387166|Psychosocial|psychosocial
1601976|NCT00387153|Oncology|oncology
1601977|NCT00387153|Cancer|cancer
1601978|NCT00387153|Blood Cancers|blood cancers
1601979|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
1601980|NCT00387127|Neck Cancer|neck cancer
1601981|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
1601982|NCT00387127|locally advanced|locally advanced
1601983|NCT00387127|Head and Neck cancer|head and neck cancer
1601984|NCT00387127|lapatinib|lapatinib
1601985|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
1601986|NCT00387127|Head Cancer|head cancer
1601987|NCT00387114|C-reactive protein|c-reactive protein
1601988|NCT00387114|nitrotyrosine|nitrotyrosine
1601989|NCT00387114|oxidative stress|oxidative stress
1601990|NCT00387114|resistin|resistin
1601991|NCT00387114|vitamin C|vitamin c
1601992|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
1601993|NCT00387101|Diabetes Mellitus|diabetes mellitus
1601994|NCT00387101|Debridement|debridement
1601995|NCT00387101|Dermal-LSR|dermal-lsr
1601996|NCT00387101|Standard of Care|standard of care
1601997|NCT00387075|Parkinson Disease|parkinson disease
1601998|NCT00387075|SPECT imaging|spect imaging
1601999|NCT00387062|Breast Cancer|breast cancer
1602000|NCT00387062|Cognitive Impairment|cognitive impairment
1602001|NCT00387062|Chemofog|chemofog
1602002|NCT00387062|Chemobrain|chemobrain
1602003|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
1602004|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
1602005|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1602006|NCT00387023|Orbital Lymphoma|orbital lymphoma
1602007|NCT00387023|Rituximab|rituximab
1602008|NCT00387023|Rituxan|rituxan
1602009|NCT00387023|Zevalin|zevalin
1602010|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
1602011|NCT00387023|IDEC-Y2B8|idec-y2b8
1602012|NCT00387023|Eye|eye
1602013|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
1602014|NCT00386971|L-carnitine|l-carnitine
1602015|NCT00386971|HIV|hiv
1602016|NCT00386971|TGRL metabolism|tgrl metabolism
1602017|NCT00386971|postprandial|postprandial
1602018|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
1602019|NCT00386958|corneal ulcers|corneal ulcers
1602020|NCT00386958|bacterial keratitis|bacterial keratitis
1602021|NCT00386958|childhood blindness|childhood blindness
1602022|NCT00386958|povidone-iodine|povidone-iodine
1602023|NCT00386945|Tobacco|tobacco
1602024|NCT00386945|Cessation.|cessation.
1602025|NCT00386945|Chiropractic patients.|chiropractic patients.
1602026|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
1602027|NCT00386945|Health care providers.|health care providers.
1602028|NCT00386945|Behavioral intervention.|behavioral intervention.
1602029|NCT00386945|Tobacco intervention.|tobacco intervention.
1602030|NCT00386945|Cigarettes.|cigarettes.
1602031|NCT00386945|Smokeless tobacco.|smokeless tobacco.
1602032|NCT00386945|Smoking intervention.|smoking intervention.
1602033|NCT00386906|Melanoma|melanoma
1602034|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
1602035|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
1602036|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
1602037|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
1602038|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
1602039|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
1602040|NCT00386906|Sentinel Lymph Node|sentinel lymph node
1602041|NCT00386906|Lymphatic Mapping|lymphatic mapping
1602042|NCT00386906|Eyelid|eyelid
1602043|NCT00386906|Eyelid Lesion|eyelid lesion
1602044|NCT00386867|medical abortion|medical abortion
1602045|NCT00386867|mifepristone|mifepristone
1602046|NCT00386867|misoprostol|misoprostol
1602047|NCT00386867|buccal administration|buccal administration
1602048|NCT00386854|exercise|exercise
1602049|NCT00386854|lipid metabolism|lipid metabolism
1602050|NCT00386854|lipoproteins|lipoproteins
1602051|NCT00386854|insulin resistance|insulin resistance
1602052|NCT00386854|inflammation|inflammation
1602053|NCT00386841|Major depression|major depression
1602054|NCT00386841|First degree relatives|first degree relatives
1602055|NCT00386841|Escitalopram|escitalopram
1602056|NCT00386841|Cortisol|cortisol
1602057|NCT00386841|Cognition|cognition
1602058|NCT00386841|Personality|personality
1602059|NCT00386841|Endo-phenotype|endo-phenotype
1602060|NCT00386828|colorectal cancer|colorectal cancer
1602061|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
1602062|NCT00386802|Neutropenia|neutropenia
1602063|NCT00386802|Antifungals|antifungals
1602064|NCT00386789|Typhoid Fever|typhoid fever
1602172|NCT00386516|metastasis|metastasis
1602065|NCT00386789|Serological Survey|serological survey
1602066|NCT00386789|Follow-Up|follow-up
1602067|NCT00386789|Protection|protection
1602068|NCT00386776|computers|computers
1602069|NCT00386776|diagnosis|diagnosis
1602070|NCT00386776|medical records|medical records
1602071|NCT00386776|physician patient relations|physician patient relations
1602072|NCT00386776|medical history taking|medical history taking
1602073|NCT00386776|medical informatics applications|medical informatics applications
1602074|NCT00386763|Marsh fever|marsh fever
1602075|NCT00386763|Plasmodium infections|plasmodium infections
1602076|NCT00386763|Remittent fever|remittent fever
1602077|NCT00386763|Paludism|paludism
1602078|NCT00386763|Artemether|artemether
1602079|NCT00386763|Artemisinins|artemisinins
1602081|NCT00386763|Benflumetol|benflumetol
1602082|NCT00386763|Lumefantrine|lumefantrine
1602083|NCT00386750|Malaria|malaria
1602084|NCT00386750|hearing|hearing
1602085|NCT00386750|co-artemether|co-artemether
1602086|NCT00386750|auditory|auditory
1602087|NCT00386750|Plasmodium falciparum|plasmodium falciparum
1602088|NCT00386750|marsh fever|marsh fever
1602089|NCT00386750|Plasmodium infections|plasmodium infections
1602090|NCT00386750|remittent fever|remittent fever
1602091|NCT00386750|paludism|paludism
1602092|NCT00386750|artemether|artemether
1602093|NCT00386750|artemisinins|artemisinins
1602094|NCT00386750|benflumetol|benflumetol
1602095|NCT00386750|lumefantrine|lumefantrine
1602096|NCT00386737|Asthma|asthma
1602097|NCT00386737|Breath Testing|breath testing
1602098|NCT00386737|Laser Spectroscopy|laser spectroscopy
1602099|NCT00386737|eNO|eno
1602100|NCT00386737|Nitric Oxide|nitric oxide
1602101|NCT00386737|Lower Airway Inflammation|lower airway inflammation
1602102|NCT00386737|Carbon Dioxide|carbon dioxide
1602103|NCT00386737|CO2|co2
1602104|NCT00386724|Pain|pain
1602105|NCT00386724|Neurostimulation|neurostimulation
1602106|NCT00386724|Leg Pain|leg pain
1602107|NCT00386724|Back Pain|back pain
1602108|NCT00386711|suicide|suicide
1602109|NCT00386711|depressed patients|depressed patients
1602110|NCT00386711|primary care|primary care
1602111|NCT00386698|Influenza,|influenza,
1602112|NCT00386698|improved vaccine,|improved vaccine,
1602113|NCT00386698|influenza disease|influenza disease
1602114|NCT00386698|elderly|elderly
1602115|NCT00386685|Cancer|cancer
1602116|NCT00386685|Breast|breast
1602117|NCT00386685|metastatic breast cancer|metastatic breast cancer
1602118|NCT00386672|Calcium|calcium
1602119|NCT00386672|Vitamin D|vitamin d
1602120|NCT00386672|Weight Loss|weight loss
1602121|NCT00386672|Overweight|overweight
1602122|NCT00386672|Obesity|obesity
1602123|NCT00386672|Lite Orange Juice|lite orange juice
1602124|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
1602125|NCT00386633|Vaccine|vaccine
1602126|NCT00386633|Safety|safety
1602127|NCT00386633|T-cell epitope|t-cell epitope
1602128|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1602129|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
1602130|NCT00386620|Breast Cancer|breast cancer
1602131|NCT00386620|Cancer Control|cancer control
1602132|NCT00386620|Spousal Relationships|spousal relationships
1602133|NCT00386620|Questionnaire|questionnaire
1602134|NCT00386620|Interview|interview
1602135|NCT00386620|Pain|pain
1602136|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
1602137|NCT00386594|Barrett Esophagus|barrett esophagus
1602138|NCT00386594|High grade dysplasia|high grade dysplasia
1602139|NCT00386594|Carcinoma in situ|carcinoma in situ
1602140|NCT00386594|825A|825a
1602141|NCT00386542|vaccination|vaccination
1602142|NCT00386542|influenza vaccine|influenza vaccine
1602143|NCT00386542|jet injection|jet injection
1602144|NCT00386542|intradermal injection|intradermal injection
1602145|NCT00386542|infancy|infancy
1602146|NCT00386542|children|children
1602356|NCT00385775|antisense|antisense
1602147|NCT00386542|dose-sparing|dose-sparing
1602148|NCT00386542|cutaneous vaccination|cutaneous vaccination
1602149|NCT00386542|Dominican Republic|dominican republic
1602150|NCT00386542|pandemic preparedness|pandemic preparedness
1602151|NCT00386542|jet injector|jet injector
1602152|NCT00386542|reduced dosage|reduced dosage
1602153|NCT00386542|immunogenicity|immunogenicity
1602154|NCT00386542|reactogenicity|reactogenicity
1602155|NCT00386542|safety|safety
1602157|NCT00386542|immune response|immune response
1602158|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
1602159|NCT00386542|Infant|infant
1602160|NCT00386529|low dose aspirin|low dose aspirin
1602161|NCT00386529|Hypertension|hypertension
1602162|NCT00386529|administration time dependent effect|administration time dependent effect
1602163|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
1602164|NCT00386516|bile duct|bile duct
1602165|NCT00386516|biliary|biliary
1602166|NCT00386516|intra-hepatic|intra-hepatic
1602167|NCT00386516|extra-hepatic|extra-hepatic
1602168|NCT00386516|gall bladder|gall bladder
1602169|NCT00386516|cancer|cancer
1602170|NCT00386516|carcinoma|carcinoma
1602171|NCT00386516|metastatic|metastatic
1602173|NCT00386516|advanced|advanced
1602174|NCT00386516|recurrent|recurrent
1602175|NCT00386490|celiac disease|celiac disease
1602176|NCT00386490|larazotide acetate|larazotide acetate
1602177|NCT00386477|Povidone iodine|povidone iodine
1602178|NCT00386477|postoperative infection|postoperative infection
1602179|NCT00386477|presurgical cleansing|presurgical cleansing
1602180|NCT00386464|bipap|bipap
1602181|NCT00386464|lou gehrigs disease|lou gehrigs disease
1602182|NCT00386464|motor neuron disease|motor neuron disease
1602183|NCT00386464|respiratory muscles|respiratory muscles
1602184|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
1602185|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
1602186|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
1602187|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
1602188|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
1602189|NCT00386386|hydration|hydration
1602190|NCT00386386|prehospital|prehospital
1602191|NCT00386386|mass casualty incident|mass casualty incident
1602192|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
1602193|NCT00386373|CML|cml
1602194|NCT00386373|ALL|all
1602195|NCT00386373|AML|aml
1602196|NCT00386373|Leukemia|leukemia
1602197|NCT00386373|Imatinib Mesylate|imatinib mesylate
1602198|NCT00386373|Gleevec|gleevec
1602199|NCT00386373|Philadelphia-Positive|philadelphia-positive
1602200|NCT00386373|Bone marrow transplant|bone marrow transplant
1602201|NCT00386373|BMT|bmt
1602202|NCT00386373|Stem cell transplant|stem cell transplant
1602203|NCT00386373|SCT|sct
1602204|NCT00386347|HIV|hiv
1602205|NCT00386347|repeat dose|repeat dose
1602206|NCT00386347|pharmacokinetics|pharmacokinetics
1602207|NCT00386347|bioavailability|bioavailability
1602208|NCT00386347|single-dose|single-dose
1602209|NCT00386347|food effect|food effect
1602210|NCT00386334|insomnia|insomnia
1602211|NCT00386334|chronic|chronic
1602212|NCT00386334|primary|primary
1602213|NCT00386321|Zevalin|zevalin
1602214|NCT00386321|Zevalin plus CHOP|zevalin plus chop
1602215|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1602216|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
1602217|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
1602218|NCT00386308|Menorrhagia|menorrhagia
1602219|NCT00386282|Mifepristone|mifepristone
1602220|NCT00386282|Misoprostol|misoprostol
1602221|NCT00386282|Buccal administration|buccal administration
1602222|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
1602223|NCT00386256|telehealth|telehealth
1602224|NCT00386256|telerehabilitation|telerehabilitation
1602225|NCT00386256|deconditioning|deconditioning
1602226|NCT00386256|exercise|exercise
1602227|NCT00386243|analgesia|analgesia
1602228|NCT00386243|analgesics|analgesics
1602229|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
1602230|NCT00386243|Pain|pain
1602231|NCT00386243|self-management|self-management
1602232|NCT00386243|stepped care|stepped care
1602233|NCT00386243|musculoskeletal pain|musculoskeletal pain
1602234|NCT00386230|transmission|transmission
1602235|NCT00386230|infant|infant
1602236|NCT00386230|HIV|hiv
1602237|NCT00386230|pregnancy|pregnancy
1602238|NCT00386230|HIV-1 infection|hiv-1 infection
1602239|NCT00386230|HIV Seronegativity|hiv seronegativity
1602240|NCT00386217|Cervical Cancer|cervical cancer
1602241|NCT00386217|Breast Cancer|breast cancer
1602242|NCT00386217|Hodgkin's Disease|hodgkin's disease
1602243|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1602244|NCT00386217|Female Infertility|female infertility
1602245|NCT00386217|Telephone Survey|telephone survey
1602246|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
1602247|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1602248|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
1602249|NCT00386178|vitamin E|vitamin e
1602250|NCT00386178|gamma tocopherol|gamma tocopherol
1602251|NCT00386178|moderate to severe asthma|moderate to severe asthma
1602252|NCT00386178|healthy subjects|healthy subjects
1602253|NCT00386165|larazotide acetate|larazotide acetate
1602254|NCT00386152|Anemia|anemia
1602255|NCT00386152|Cancer|cancer
1602256|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
1602257|NCT00386152|Epoetin alfa|epoetin alfa
1602258|NCT00386152|Darbepoetin alfa|darbepoetin alfa
1602259|NCT00386139|Diastolic|diastolic
1602260|NCT00386139|systolic|systolic
1602261|NCT00386139|hypertension|hypertension
1602262|NCT00386139|aliskiren|aliskiren
1602263|NCT00386139|blood pressure|blood pressure
1602264|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
1602265|NCT00386126|Heart Failure|heart failure
1602266|NCT00386126|Anemia|anemia
1602267|NCT00386126|Treatment|treatment
1602268|NCT00386113|Influenza|influenza
1602269|NCT00386113|improved vaccine|improved vaccine
1602270|NCT00386113|elderly|elderly
1602271|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
1602272|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
1602273|NCT00386100|Drug-naive|drug-naive
1602274|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
1602275|NCT00386100|Bone Mineral Density|bone mineral density
1602276|NCT00386100|Hyperglycemia|hyperglycemia
1602277|NCT00386100|HbA1c|hba1c
1602278|NCT00386087|Breast Cancer|breast cancer
1602279|NCT00386087|Cancer of the Breast|cancer of the breast
1602280|NCT00386074|NaFeEDTA|nafeedta
1602281|NCT00386074|electrolytic iron|electrolytic iron
1602282|NCT00386074|efficacy|efficacy
1602283|NCT00386074|whole maize flour|whole maize flour
1602284|NCT00386074|phytate|phytate
1602285|NCT00386074|school-age children|school-age children
1602286|NCT00386074|controlled trial|controlled trial
1602287|NCT00386074|Africa|africa
1602288|NCT00386061|Obesity|obesity
1602289|NCT00386061|risk factors|risk factors
1602290|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
1602291|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
1602292|NCT00386048|Pain Management|pain management
1602293|NCT00386035|Treatment Experienced|treatment experienced
1602294|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
1602295|NCT00386022|Estrogens|estrogens
1602296|NCT00386022|postmenopausal women|postmenopausal women
1602297|NCT00386022|Pituitary hormones|pituitary hormones
1602298|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1602299|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1602300|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
1602301|NCT00385996|preoperative|preoperative
1602302|NCT00385996|Tarceva|tarceva
1602303|NCT00385996|Response rate|response rate
1602304|NCT00385983|thyroidectomy|thyroidectomy
1602305|NCT00385983|thyroid neoplasm|thyroid neoplasm
1602306|NCT00385983|postoperative complications|postoperative complications
1602307|NCT00385983|cost effectiveness|cost effectiveness
1602308|NCT00385957|Treatment Naive|treatment naive
1602309|NCT00385931|Hypertension|hypertension
1602310|NCT00385931|high cholesterol|high cholesterol
1602311|NCT00385931|valsartan|valsartan
1602312|NCT00385931|simvastatin|simvastatin
1602313|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
1602314|NCT00385918|Exercise|exercise
1602315|NCT00385918|Gait|gait
1602316|NCT00385918|Spinal Cord Injury|spinal cord injury
1602317|NCT00385918|Treadmill Training|treadmill training
1602318|NCT00385892|Healthy volonteers|healthy volonteers
1602319|NCT00385892|Abdominal binder|abdominal binder
1602320|NCT00385892|IAP|iap
1602321|NCT00385892|MAP|map
1602322|NCT00385892|APP|app
1602323|NCT00385866|Patient Navigator|patient navigator
1602324|NCT00385866|Community health|community health
1602325|NCT00385866|Communication|communication
1602326|NCT00385853|PTK|ptk
1602327|NCT00385853|temozolomide|temozolomide
1602328|NCT00385853|glioblastoma|glioblastoma
1602329|NCT00385840|Influenza vaccine|influenza vaccine
1602330|NCT00385840|Influenza|influenza
1602331|NCT00385827|Cancer|cancer
1602332|NCT00385827|Prostate|prostate
1602333|NCT00385827|IL-6|il-6
1602334|NCT00385827|Mitoxantrone|mitoxantrone
1602335|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
1602336|NCT00385801|cocaine|cocaine
1602337|NCT00385801|dependence|dependence
1602338|NCT00385801|risperidal|risperidal
1602339|NCT00385801|MRI|mri
1602340|NCT00385788|Hodgkin's Disease|hodgkin's disease
1602341|NCT00385788|Stem Cell Transplantation|stem cell transplantation
1602342|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
1602343|NCT00385788|Gemcitabine|gemcitabine
1602344|NCT00385788|Gemzar|gemzar
1602345|NCT00385788|Fludarabine|fludarabine
1602346|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
1602347|NCT00385788|Melphalan|melphalan
1602348|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1602349|NCT00385788|AST|ast
1602350|NCT00385788|SCT|sct
1602351|NCT00385788|ATG|atg
1602352|NCT00385788|Thymoglobulin|thymoglobulin
1602353|NCT00385775|Cancer|cancer
1602354|NCT00385775|solid tumours|solid tumours
1602355|NCT00385775|refractory|refractory
1602357|NCT00385775|oligonucleotide|oligonucleotide
1602358|NCT00385762|Human volunteers|human volunteers
1602359|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
1602360|NCT00385749|congestive heart failure|congestive heart failure
1602361|NCT00385749|right ventricular lead placement|right ventricular lead placement
1602362|NCT00385749|select site pacing|select site pacing
1602363|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
1602364|NCT00385736|Double-blind|double-blind
1602366|NCT00385736|Induction of Clinical Remission|induction of clinical remission
1602367|NCT00385723|affect|affect
1602368|NCT00385723|inflammation|inflammation
1602369|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
1602370|NCT00385697|Randomized|randomized
1602371|NCT00385697|Double Blind|double blind
1602372|NCT00385697|Parallel Group|parallel group
1602373|NCT00385697|Controlled Clinical Trial|controlled clinical trial
1602374|NCT00385684|Agitation|agitation
1602375|NCT00385684|Alzheimer Disease|alzheimer disease
1602376|NCT00385684|Analgesics|analgesics
1602377|NCT00385684|Dementia|dementia
1602378|NCT00385684|Narcotics|narcotics
1602379|NCT00385684|Opioid|opioid
1602380|NCT00385684|Pain|pain
1602381|NCT00385684|Palliative Care|palliative care
1602382|NCT00385684|Psychomotor|psychomotor
1602383|NCT00385684|Suffering, Physical|suffering, physical
1602384|NCT00385658|Dyslipidemia|dyslipidemia
1602385|NCT00385658|metabolic syndrome|metabolic syndrome
1602386|NCT00385658|fluvastatin|fluvastatin
1602387|NCT00385658|fenofibrate|fenofibrate
1602388|NCT00385658|simvastatin|simvastatin
1602389|NCT00385658|ezetimibe|ezetimibe
1602390|NCT00385645|HIV seronegativity|hiv seronegativity
1602391|NCT00385632|Treatment Experienced|treatment experienced
1602392|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
1602393|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
1602394|NCT00385567|AIDS|aids
1602395|NCT00385567|Treatment Experienced|treatment experienced
1602396|NCT00385554|Microbicide|microbicide
1602397|NCT00385554|HIV prevention|hiv prevention
1602398|NCT00385554|Botswana|botswana
1602399|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
1602400|NCT00385554|HIV Seronegativity|hiv seronegativity
1602401|NCT00385541|pain|pain
1602402|NCT00385541|morphine|morphine
1602403|NCT00385541|hydromorphone|hydromorphone
1602404|NCT00385541|nausea|nausea
1602405|NCT00385541|vomiting|vomiting
1602406|NCT00385541|pruritis|pruritis
1602407|NCT00385528|Case complexity|case complexity
1602408|NCT00385528|INTERMED|intermed
1602409|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
1602410|NCT00385528|depression|depression
1602411|NCT00385502|toenail|toenail
1602412|NCT00385502|fungus|fungus
1602413|NCT00385502|onychomycosis|onychomycosis
1602414|NCT00385502|antifungal|antifungal
1602415|NCT00385502|anti-fungal|anti-fungal
1602416|NCT00385502|nail|nail
1602417|NCT00385476|Advanced Cancer|advanced cancer
1602418|NCT00385476|Medication Knowledge|medication knowledge
1602419|NCT00385476|Emergency Center|emergency center
1602420|NCT00385476|Questionnaire|questionnaire
1602421|NCT00385476|Survey|survey
1602422|NCT00385463|Asthma|asthma
1602423|NCT00385463|Rhinitis|rhinitis
1602424|NCT00385463|Allergic Asthma|allergic asthma
1602425|NCT00385437|Driving safety|driving safety
1602426|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
1602427|NCT00385437|major depressive disorder|major depressive disorder
1602428|NCT00385437|mirtazapine|mirtazapine
1602429|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
1602430|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1602431|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
1602432|NCT00385372|elimination diet|elimination diet
1602433|NCT00385372|provocation diet|provocation diet
1602434|NCT00385372|oral provocation|oral provocation
1602435|NCT00385372|natural food ingredients|natural food ingredients
1602436|NCT00385372|food additives|food additives
1602437|NCT00385372|flavours|flavours
1602438|NCT00385346|Expressive writing|expressive writing
1602439|NCT00385346|Male infertility|male infertility
1602440|NCT00385333|Mitochondrion|mitochondrion
1602441|NCT00385333|Retina|retina
1602442|NCT00385333|Mitochondria|mitochondria
1602443|NCT00385333|Metabolism|metabolism
1602444|NCT00385333|In Vivo Imaging|in vivo imaging
1602445|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
1602446|NCT00385333|AMD|amd
1602447|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
1602448|NCT00385333|DR|dr
1602449|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
1602450|NCT00385333|VHL|vhl
1602451|NCT00385307|Depression|depression
1602452|NCT00385307|Clinical Trials|clinical trials
1602453|NCT00385307|Major Depressive Disorder|major depressive disorder
1602454|NCT00385294|Genetic|genetic
1602455|NCT00385294|pain|pain
1602456|NCT00385294|obstetrical|obstetrical
1602457|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
1602458|NCT00385268|cocaine|cocaine
1602857|NCT00383318|Jaundice|jaundice
1602459|NCT00385255|Immunogenicity,|immunogenicity,
1602460|NCT00385255|Influenza|influenza
1602461|NCT00385255|Co-administration,|co-administration,
1602462|NCT00385255|Tdap,|tdap,
1602463|NCT00385242|coronary artery disease|coronary artery disease
1602464|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
1602465|NCT00385242|positron emission tomography|positron emission tomography
1602466|NCT00385242|viable myocardium|viable myocardium
1602467|NCT00385242|revascularization|revascularization
1602468|NCT00385242|cost effectiveness|cost effectiveness
1602469|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
1602470|NCT00385229|Birth Injury|birth injury
1602471|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
1602472|NCT00385216|Third Molar|third molar
1602473|NCT00385216|Pain|pain
1602474|NCT00385203|cancer|cancer
1602475|NCT00385203|tumour|tumour
1602476|NCT00385203|advanced cancer|advanced cancer
1602477|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
1602478|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
1602479|NCT00385203|RECENTIN|recentin
1602480|NCT00385190|SAD|sad
1602481|NCT00385164|lung neoplasms|lung neoplasms
1602482|NCT00385164|positron emissions tomography|positron emissions tomography
1602483|NCT00385164|radiotherapy planning|radiotherapy planning
1602484|NCT00385151|Post conditioning|post conditioning
1602485|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1602486|NCT00385138|ACS|acs
1602487|NCT00385125|relapsed|relapsed
1602488|NCT00385125|refractory|refractory
1602489|NCT00385125|CD 20 positive|cd 20 positive
1602490|NCT00385112|Cardiology|cardiology
1602491|NCT00385112|Echocardiograms|echocardiograms
1602492|NCT00385112|Surgery|surgery
1602493|NCT00385112|Valve Disease|valve disease
1602494|NCT00385112|Heart Valve Disease|heart valve disease
1602495|NCT00385099|IBS|ibs
1602496|NCT00385099|stress|stress
1602497|NCT00385099|CRF1|crf1
1602498|NCT00385086|Sciatica|sciatica
1602499|NCT00385086|Pain|pain
1602500|NCT00385086|TNF-alpha|tnf-alpha
1602501|NCT00385086|Discectomy|discectomy
1602502|NCT00385086|Fibrosis|fibrosis
1602503|NCT00385086|Spine|spine
1602504|NCT00385047|malaria|malaria
1602505|NCT00385047|vaccine|vaccine
1602506|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
1602507|NCT00385047|efficacy|efficacy
1602508|NCT00385034|randomized controlled trial|randomized controlled trial
1602509|NCT00385034|RCT|rct
1602510|NCT00385034|partner violence|partner violence
1602511|NCT00385034|IPV|ipv
1602512|NCT00385034|screening|screening
1602513|NCT00385034|family practice|family practice
1602514|NCT00385034|computer|computer
1602515|NCT00385021|Advanced|advanced
1602516|NCT00385021|metastatic|metastatic
1602517|NCT00385021|colorectal|colorectal
1602518|NCT00385021|cancer|cancer
1602519|NCT00385021|Avastin|avastin
1602520|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
1602521|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
1602522|NCT00384995|Chronic Kidney Disease|chronic kidney disease
1602523|NCT00384995|Acute Renal Failure|acute renal failure
1602524|NCT00384995|End-stage Renal Disease|end-stage renal disease
1602525|NCT00384995|Cardiovascular diseases|cardiovascular diseases
1602526|NCT00384995|Coronary catheterization|coronary catheterization
1602527|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
1602528|NCT00384995|Intra-arterial angiography|intra-arterial angiography
1602529|NCT00384995|Bicarbonate|bicarbonate
1602530|NCT00384995|Saline|saline
1602531|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
1602532|NCT00384982|Acute myocardial infarction|acute myocardial infarction
1602533|NCT00384969|RAD001|rad001
1602534|NCT00384969|Sorafenib|sorafenib
1602535|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
1602536|NCT00384969|Metastatic|metastatic
1602537|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
1602538|NCT00384943|postpartum depression|postpartum depression
1602539|NCT00384943|exercise|exercise
1602540|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
1602541|NCT00384891|NMIBC|nmibc
1602542|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
1602543|NCT00384891|Hyperthermia|hyperthermia
1602544|NCT00384891|Bladder instillation|bladder instillation
1602545|NCT00384891|Mitomycin C|mitomycin c
1602546|NCT00384891|RITE|rite
1602547|NCT00384891|SHTC|shtc
1602548|NCT00384891|Intravesical|intravesical
1602549|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1602550|NCT00384852|Fracture|fracture
1602551|NCT00384852|Humerus|humerus
1602552|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
1602553|NCT00384787|HIV Seronegativity|hiv seronegativity
1602554|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
1602555|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
1603858|NCT00379314|Female|female
1602556|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
1602557|NCT00384774|Migraine|migraine
1602558|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
1602559|NCT00384748|Rehabilitation|rehabilitation
1602560|NCT00384748|Telemedicine|telemedicine
1602561|NCT00384735|bone tumor|bone tumor
1602562|NCT00384735|soft tissue tumor|soft tissue tumor
1602563|NCT00384722|Left ventricular lead|left ventricular lead
1602564|NCT00384722|Pacing|pacing
1602565|NCT00384722|Heart Failure|heart failure
1602566|NCT00384709|Elderly|elderly
1602567|NCT00384709|Hospitalization|hospitalization
1602568|NCT00384709|Geriatrics|geriatrics
1602569|NCT00384709|Mortality|mortality
1602570|NCT00384709|Readmission|readmission
1602571|NCT00384709|Length of Stay|length of stay
1602572|NCT00384696|Risk Perception|risk perception
1602573|NCT00384696|Smoking Cessation|smoking cessation
1602574|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
1602575|NCT00384696|Questionnaire|questionnaire
1602576|NCT00384696|Nicotine|nicotine
1602577|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
1602578|NCT00384683|Endothelial Cells|endothelial cells
1602579|NCT00384683|Perioperative Outcome|perioperative outcome
1602580|NCT00384683|Blood Sample|blood sample
1602581|NCT00384670|dengue|dengue
1602582|NCT00384670|vaccine|vaccine
1602583|NCT00384657|chronic heart failure|chronic heart failure
1602584|NCT00384657|chronic kidney disease|chronic kidney disease
1602585|NCT00384657|anemia|anemia
1602586|NCT00384657|intravenous iron|intravenous iron
1602587|NCT00384644|heart failure|heart failure
1602588|NCT00384644|sepsis|sepsis
1602589|NCT00384644|septic shock|septic shock
1602590|NCT00384644|cardiogenic shock|cardiogenic shock
1602591|NCT00384631|Neovascular|neovascular
1602592|NCT00384631|Glaucoma|glaucoma
1602593|NCT00384631|Bevacizumab|bevacizumab
1602594|NCT00384631|Avastin|avastin
1602595|NCT00384631|Intravitreal|intravitreal
1602596|NCT00384631|IOP|iop
1602597|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
1602598|NCT00384592|heartburn|heartburn
1602599|NCT00384592|reflux|reflux
1602600|NCT00384592|proton pump inhibitor|proton pump inhibitor
1602601|NCT00384592|GERD|gerd
1602602|NCT00384592|GORD|gord
1602603|NCT00384579|back|back
1602604|NCT00384579|pain|pain
1602605|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
1602606|NCT00384540|Vasculopathy|vasculopathy
1602607|NCT00384527|Clostridium difficile|clostridium difficile
1602608|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
1602609|NCT00384501|keratoconus|keratoconus
1602610|NCT00384501|Intacs|intacs
1602611|NCT00384488|Diabetes mellitus|diabetes mellitus
1602612|NCT00384488|Weight control|weight control
1602613|NCT00384488|Healthy eating|healthy eating
1602614|NCT00384488|Physical Activity|physical activity
1602615|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1602616|NCT00384475|Ciclesonide|ciclesonide
1602617|NCT00384475|Hay Fever|hay fever
1602618|NCT00384475|SAR|sar
1602619|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
1602620|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
1602621|NCT00384449|Eales|eales
1602622|NCT00384436|Major Depressive Disorder|major depressive disorder
1602623|NCT00384423|Alzheimer's Disease|alzheimer's disease
1602624|NCT00384423|AD|ad
1602625|NCT00384423|PRX-03140|prx-03140
1602626|NCT00384423|Dementia|dementia
1602627|NCT00384423|Epix|epix
1602628|NCT00384423|Predix|predix
1602629|NCT00384423|Cognition enhancing|cognition enhancing
1602630|NCT00384410|Pain|pain
1602631|NCT00384410|Insomnia|insomnia
1602632|NCT00384410|Nabilone|nabilone
1602633|NCT00384397|Menactra vaccine|menactra vaccine
1602634|NCT00384397|Meningococcal meningitis|meningococcal meningitis
1602635|NCT00384397|Measles|measles
1602636|NCT00384397|Mumps|mumps
1602637|NCT00384397|Rubella|rubella
1602638|NCT00384397|Varicella virus|varicella virus
1602639|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
1602640|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1602641|NCT00384384|Dialysis|dialysis
1602642|NCT00384384|Serum potassium|serum potassium
1602643|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
1602644|NCT00384384|insulin sensitivity|insulin sensitivity
1602645|NCT00384371|back|back
1602646|NCT00384371|pain|pain
1602647|NCT00384358|Fractures|fractures
1602648|NCT00384345|bright light treatment|bright light treatment
1602649|NCT00384345|exercise|exercise
1602650|NCT00384345|body fat index|body fat index
1602651|NCT00384345|mood|mood
1602652|NCT00384345|sleep|sleep
1602653|NCT00384345|fatigue|fatigue
1602654|NCT00384332|Bipolar Depression|bipolar depression
1602655|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
1602656|NCT00384332|side effects olanzapine|side effects olanzapine
1602657|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
1602658|NCT00384319|resuscitation|resuscitation
1602659|NCT00384319|hypothermia|hypothermia
1602660|NCT00384306|COPD|copd
1602661|NCT00384306|prednisolone|prednisolone
1602662|NCT00384306|bone biopsy|bone biopsy
1602663|NCT00384306|tetracycline labelling|tetracycline labelling
1602664|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
1602665|NCT00384254|Tobacco.|tobacco.
1602666|NCT00384254|Cessation.|cessation.
1602667|NCT00384254|Dental patients.|dental patients.
1602668|NCT00384254|Dentists.|dentists.
1602669|NCT00384254|Hygienists.|hygienists.
1602670|NCT00384254|Dental assistants.|dental assistants.
1602671|NCT00384254|Health care providers.|health care providers.
1602672|NCT00384254|Behavioral intervention.|behavioral intervention.
1602673|NCT00384254|Tobacco intervention.|tobacco intervention.
1602674|NCT00384254|Cigarettes.|cigarettes.
1602675|NCT00384254|Smokeless tobacco.|smokeless tobacco.
1602676|NCT00384254|Smoking intervention.|smoking intervention.
1602677|NCT00384241|Blood Pressure, High|blood pressure, high
1602678|NCT00384241|Stress|stress
1602679|NCT00384241|Inflammation|inflammation
1602680|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1602681|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1602682|NCT00384202|Tacrolimus|tacrolimus
1602683|NCT00384202|Liver Transplantation|liver transplantation
1602684|NCT00384189|Asthma|asthma
1602685|NCT00384189|Ciclesonide|ciclesonide
1602686|NCT00384189|children|children
1602687|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
1602688|NCT00384176|RECENTIN|recentin
1602689|NCT00384163|cardiac|cardiac
1602690|NCT00384163|adult|adult
1602692|NCT00384150|galiximab|galiximab
1602693|NCT00384150|antibody|antibody
1602694|NCT00384150|refractory|refractory
1602695|NCT00384150|follicular|follicular
1602696|NCT00384150|relapsed|relapsed
1602697|NCT00384150|NHL|nhl
1602698|NCT00384150|rituximab|rituximab
1602699|NCT00384150|retreatment|retreatment
1602700|NCT00384137|Tacrolimus|tacrolimus
1602701|NCT00384137|Kidney Transplantation|kidney transplantation
1602702|NCT00384124|Bowens disease|bowens disease
1602703|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
1602704|NCT00384124|imiquimod|imiquimod
1602705|NCT00384098|Psoriasis|psoriasis
1602706|NCT00384072|postmenopausal|postmenopausal
1602707|NCT00384072|women|women
1602708|NCT00384072|SERM|serm
1602709|NCT00384072|osteoporosis|osteoporosis
1602710|NCT00384033|MDD|mdd
1602711|NCT00384033|Major Depressive Disorder|major depressive disorder
1602712|NCT00384033|Depression|depression
1602713|NCT00384020|Major Depression Disorder|major depression disorder
1602714|NCT00384020|Antidepressant|antidepressant
1602715|NCT00384020|Pharmacogenomics|pharmacogenomics
1602716|NCT00384020|Cytochrome P450|cytochrome p450
1602717|NCT00384020|Serotonin Transporter|serotonin transporter
1602718|NCT00384007|back pain|back pain
1602719|NCT00384007|herniated disc|herniated disc
1602720|NCT00384007|leg pain|leg pain
1602721|NCT00384007|pinched nerves|pinched nerves
1602722|NCT00384007|sciatica|sciatica
1602723|NCT00384007|radiculopathy|radiculopathy
1602724|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1602725|NCT00383994|CLL|cll
1602726|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1602727|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
1602728|NCT00383994|Lymphoma|lymphoma
1602729|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
1602730|NCT00383994|Leukemia|leukemia
1602731|NCT00383994|NK Cells|nk cells
1602732|NCT00383994|Rituximab|rituximab
1602733|NCT00383994|GM-CSF|gm-csf
1602734|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
1602735|NCT00383994|Stem Cell Transplant|stem cell transplant
1602736|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
1602737|NCT00383942|Pregnancy|pregnancy
1602738|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
1602739|NCT00383942|Misoprostol|misoprostol
1602740|NCT00383942|Labor induction|labor induction
1602741|NCT00383929|Blood pressure reduction|blood pressure reduction
1602742|NCT00383929|combination therapy|combination therapy
1602743|NCT00383929|candesartan cilexetil|candesartan cilexetil
1602744|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
1602745|NCT00383916|healthy|healthy
1602746|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
1602747|NCT00383890|Mallampati Score|mallampati score
1602748|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
1602749|NCT00383864|liver fibrosis|liver fibrosis
1602750|NCT00383864|portal pressure|portal pressure
1602751|NCT00383864|antiviral therapy|antiviral therapy
1602752|NCT00383851|ATN-224|atn-224
1602753|NCT00383851|Temozolomide|temozolomide
1602754|NCT00383851|Combination|combination
1602755|NCT00383851|Sequential|sequential
1602756|NCT00383851|Anti-angiogenic|anti-angiogenic
1602757|NCT00383851|Copper|copper
1602758|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
1602759|NCT00383825|conjunctival autografts|conjunctival autografts
1602760|NCT00383825|amniotic membrane|amniotic membrane
1602761|NCT00383825|indocyanine green angiography|indocyanine green angiography
1602762|NCT00383825|pterygium surgery|pterygium surgery
1602763|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1602764|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
1602765|NCT00383799|Ventricular tachycardia|ventricular tachycardia
1602766|NCT00383786|PTSD|ptsd
1602767|NCT00383786|Substance P|substance p
1602768|NCT00383786|Treatment Study|treatment study
1602770|NCT00383786|Controlled|controlled
1602771|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
1602772|NCT00383773|retinal vein occlusion|retinal vein occlusion
1602773|NCT00383773|rTPA|rtpa
1602774|NCT00383747|cognition|cognition
1602775|NCT00383747|nicotine|nicotine
1602776|NCT00383747|schizophrenia|schizophrenia
1602777|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
1602778|NCT00383734|polylactic acid|polylactic acid
1602779|NCT00383734|polyacrylamide gels|polyacrylamide gels
1602780|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1602781|NCT00383695|stage I rectal cancer|stage i rectal cancer
1603178|NCT00382239|exenatide|exenatide
1602782|NCT00383695|stage II rectal cancer|stage ii rectal cancer
1602783|NCT00383695|stage III rectal cancer|stage iii rectal cancer
1602784|NCT00383682|postamputation pain|postamputation pain
1602785|NCT00383682|phantom pain|phantom pain
1602786|NCT00383682|stump pain|stump pain
1602787|NCT00383682|neuroma pain|neuroma pain
1602788|NCT00383682|opioid|opioid
1602789|NCT00383682|mexiletine|mexiletine
1602791|NCT00383669|AIDS|aids
1602792|NCT00383669|Disease Progression|disease progression
1602793|NCT00383669|Multivitamins|multivitamins
1602794|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
1602795|NCT00383669|HAART|haart
1602796|NCT00383669|Tanzania|tanzania
1602797|NCT00383669|Africa|africa
1602798|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
1602799|NCT00383656|GnRH deficiency|gnrh deficiency
1602800|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
1602801|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1602802|NCT00383656|Kallman's syndrome|kallman's syndrome
1602803|NCT00383656|infertility|infertility
1602804|NCT00383630|End Stage Heart Failure|end stage heart failure
1602805|NCT00383630|LVAD|lvad
1602806|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
1602807|NCT00383630|Stem Cell Transplantation|stem cell transplantation
1602808|NCT00383617|pre-radiographic|pre-radiographic
1602809|NCT00383617|screening|screening
1602810|NCT00383617|early diagnosis|early diagnosis
1602811|NCT00383578|Type 2 diabetes|type 2 diabetes
1602812|NCT00383578|vildagliptin|vildagliptin
1602813|NCT00383578|hemoglobin A1c|hemoglobin a1c
1602814|NCT00383578|metformin|metformin
1602815|NCT00383539|Influenza|influenza
1602816|NCT00383539|Orthomyxoviruses|orthomyxoviruses
1602817|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1602818|NCT00383539|Adults|adults
1602819|NCT00383526|Influenza|influenza
1602820|NCT00383526|Orthomyxoviruses|orthomyxoviruses
1602821|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
1602822|NCT00383526|elderly|elderly
1602823|NCT00383513|Lupus|lupus
1602824|NCT00383513|Antibody|antibody
1602825|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
1602826|NCT00383461|tobacco use disorder|tobacco use disorder
1602827|NCT00383448|Stem cell transplantation|stem cell transplantation
1602828|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
1602829|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
1602830|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
1602831|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
1602832|NCT00383448|Tay Sachs|tay sachs
1602833|NCT00383448|Sandhoff|sandhoff
1602834|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
1602835|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
1602836|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
1602837|NCT00383448|I-cell|i-cell
1602838|NCT00383448|mucolipidosis|mucolipidosis
1602839|NCT00383409|breast|breast
1602840|NCT00383409|cancer|cancer
1602841|NCT00383409|fatigue|fatigue
1602842|NCT00383409|multivitamins|multivitamins
1602843|NCT00383357|Performance|performance
1602844|NCT00383357|Gait stability|gait stability
1602845|NCT00383357|sedative|sedative
1602846|NCT00383357|hypnotic|hypnotic
1602847|NCT00383357|quality of life|quality of life
1602848|NCT00383357|sleep disorder|sleep disorder
1602849|NCT00383357|wakefulness|wakefulness
1602850|NCT00383357|sleeping pills|sleeping pills
1602851|NCT00383357|Cognitive function|cognitive function
1602852|NCT00383344|Crohn Disease|crohn disease
1602853|NCT00383344|Positron Emission Tomography|positron emission tomography
1602854|NCT00383344|Colonoscopy|colonoscopy
1602855|NCT00383318|Neonate|neonate
1602856|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
1602858|NCT00383318|G6PD Deficiency|g6pd deficiency
1602859|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
1602860|NCT00383305|neonatal|neonatal
1602861|NCT00383305|hypoxic|hypoxic
1602862|NCT00383305|ischemic|ischemic
1602863|NCT00383305|encephalopathy|encephalopathy
1602864|NCT00383305|HIE|hie
1602865|NCT00383305|birth asphyxia|birth asphyxia
1602866|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
1602867|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
1602868|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
1602869|NCT00383305|brain cooling|brain cooling
1602870|NCT00383305|selective head cooling|selective head cooling
1602871|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
1602872|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
1602873|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
1602874|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
1602875|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
1602876|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
1602877|NCT00383279|stage III cervical cancer|stage iii cervical cancer
1602878|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
1602879|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
1602880|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
1602881|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
1602882|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
1602883|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
1602884|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
1602885|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1602886|NCT00383279|ovarian sarcoma|ovarian sarcoma
1602887|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
1602888|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1602889|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1602890|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1602891|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1602892|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1602893|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1602894|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1602895|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1602896|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1602897|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1602898|NCT00383214|Lupus,|lupus,
1602899|NCT00383214|antibody,|antibody,
1602900|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
1602901|NCT00383201|Contact Lens Care|contact lens care
1602902|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
1602903|NCT00383175|Ocular Accommodation|ocular accommodation
1602904|NCT00383175|Reading|reading
1602905|NCT00383162|Combination Product|combination product
1602906|NCT00383162|naproxen sodium|naproxen sodium
1602907|NCT00383162|sumatriptan succinate|sumatriptan succinate
1602908|NCT00383162|short acting triptan|short acting triptan
1602909|NCT00383162|migraine, acute|migraine, acute
1602910|NCT00383162|Poor response|poor response
1602911|NCT00383136|STEMI|stemi
1602912|NCT00383136|Primary Angioplasty|primary angioplasty
1602913|NCT00383136|Abciximab|abciximab
1602914|NCT00383136|Tirofiban|tirofiban
1602915|NCT00383123|Fluarix|fluarix
1602916|NCT00383123|Influenza|influenza
1602917|NCT00383110|Diabetes|diabetes
1602918|NCT00383110|Health Outcomes|health outcomes
1602919|NCT00383110|Racial Preference|racial preference
1602920|NCT00383110|Clinical Trial|clinical trial
1602921|NCT00383110|Ethnic Differences|ethnic differences
1602922|NCT00383097|CTLs|ctls
1602923|NCT00383097|LMP1|lmp1
1602924|NCT00383097|LMP2|lmp2
1602925|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
1602926|NCT00383097|CD45|cd45
1602927|NCT00383097|ANTIBODY|antibody
1602928|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
1602929|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
1602930|NCT00383084|Pain|pain
1602931|NCT00383084|Physical Activity|physical activity
1602932|NCT00383084|Fatigue|fatigue
1602933|NCT00383084|Lifestyle Activity|lifestyle activity
1602934|NCT00383071|Apheresis|apheresis
1602935|NCT00383071|Avian Flu|avian flu
1602936|NCT00383071|Healthy Volunteers|healthy volunteers
1602937|NCT00383071|Infectious Diseases|infectious diseases
1602938|NCT00383071|IVIG|ivig
1602939|NCT00383071|Healthy Volunteer|healthy volunteer
1602940|NCT00383071|HV|hv
1602941|NCT00383058|obesity|obesity
1602942|NCT00383058|green tea|green tea
1602943|NCT00383045|Buprenorphine|buprenorphine
1602944|NCT00383045|Naltrexone|naltrexone
1602945|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
1602946|NCT00383045|Counseling|counseling
1602947|NCT00383006|Psychotherapy, Group|psychotherapy, group
1602948|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1602949|NCT00383006|Ambulatory Care|ambulatory care
1602950|NCT00382993|migraine with or without aura|migraine with or without aura
1602951|NCT00382993|naproxen sodium|naproxen sodium
1602952|NCT00382993|combination product|combination product
1602953|NCT00382993|sumatriptan succinate|sumatriptan succinate
1602954|NCT00382993|poor response|poor response
1602955|NCT00382993|short acting triptan|short acting triptan
1602956|NCT00382993|migraine, acute|migraine, acute
1602957|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
1602958|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
1602959|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
1602960|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
1602961|NCT00382954|AML|aml
1602962|NCT00382954|Relapse|relapse
1602967|NCT00382928|Randomized Controlled Trials|randomized controlled trials
1602968|NCT00382928|Defibrillators|defibrillators
1602969|NCT00382928|Medical Devices|medical devices
1602970|NCT00382915|Smoking|smoking
1602971|NCT00382915|Topography|topography
1602972|NCT00382915|Nicotine|nicotine
1602973|NCT00382902|Contact Lens Care|contact lens care
1602974|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
1602975|NCT00382889|corticosteroids|corticosteroids
1602976|NCT00382889|symptom-driven|symptom-driven
1602977|NCT00382889|beclomethasone|beclomethasone
1602978|NCT00382889|salbutamol|salbutamol
1602979|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
1602980|NCT00382863|heart failure|heart failure
1602981|NCT00382863|cardiac support|cardiac support
1602982|NCT00382863|Paracor|paracor
1602983|NCT00382863|HeartNet|heartnet
1602984|NCT00382863|PEERLESS-HF|peerless-hf
1602985|NCT00382850|Nissen fundoplication|nissen fundoplication
1602986|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
1602987|NCT00382837|Lupus,|lupus,
1602988|NCT00382837|Antibody,|antibody,
1602989|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
1602990|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
1602991|NCT00382824|Atypical Parkinsonism|atypical parkinsonism
1602992|NCT00382824|CoQ10|coq10
1602993|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
1602994|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
1602995|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
1602996|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
1602997|NCT00382785|online|online
1602998|NCT00382785|support|support
1602999|NCT00382785|breast cancer|breast cancer
1603000|NCT00382772|HRV vaccine|hrv vaccine
1603001|NCT00382772|Diarrhoea|diarrhoea
1603002|NCT00382772|Rotavirus|rotavirus
1603003|NCT00382746|Congestive|congestive
1603004|NCT00382746|Heart|heart
1603005|NCT00382746|Failure|failure
1603006|NCT00382746|CHF|chf
1603007|NCT00382733|Solid Tumors|solid tumors
1603008|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1603009|NCT00382707|low frequency|low frequency
1603010|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
1603011|NCT00382707|brain excitability|brain excitability
1603012|NCT00382707|electromyography|electromyography
1603013|NCT00382694|Myeloma|myeloma
1603014|NCT00382694|Induction therapy|induction therapy
1603015|NCT00382694|High-dose melphalan|high-dose melphalan
1603016|NCT00382694|Autologous stem cell support|autologous stem cell support
1603017|NCT00382694|Fludarabine|fludarabine
1603018|NCT00382694|Cyclophosphamide|cyclophosphamide
1603019|NCT00382694|Dexamethasone|dexamethasone
1603020|NCT00382694|Safety|safety
1603021|NCT00382694|Toxicity|toxicity
1603022|NCT00382681|Contact Lens Care|contact lens care
1603023|NCT00382668|hepatically impaired|hepatically impaired
1603024|NCT00382655|Prevention|prevention
1603025|NCT00382655|Emergency Medical Services|emergency medical services
1603026|NCT00382655|Emergency Medical Technicians|emergency medical technicians
1603027|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
1603028|NCT00382629|Multiple sclerosis|multiple sclerosis
1603029|NCT00382629|MS|ms
1603030|NCT00382629|Bayhill|bayhill
1603031|NCT00382629|BHT-3009|bht-3009
1603032|NCT00382629|immunotherapy|immunotherapy
1603033|NCT00382616|behavioral problems|behavioral problems
1603034|NCT00382616|learning problems|learning problems
1603035|NCT00382616|inattentive|inattentive
1603036|NCT00382616|impulsive|impulsive
1603037|NCT00382616|hyperactive|hyperactive
1603038|NCT00382616|children|children
1603039|NCT00382616|phosphatidylserine|phosphatidylserine
1603040|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
1603041|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
1603042|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
1603043|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
1603044|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
1603045|NCT00382616|Test of Variables of Attention|test of variables of attention
1603046|NCT00382616|ADHD index scores|adhd index scores
1603047|NCT00382603|Contact Lens Care|contact lens care
1603048|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
1603049|NCT00382590|AML|aml
1603859|NCT00379314|Surgery|surgery
1603050|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
1603051|NCT00382590|Leukemia|leukemia
1603052|NCT00382590|MDS|mds
1603053|NCT00382590|Azacytidine|azacytidine
1603054|NCT00382590|5-Azacytidine|5-azacytidine
1603055|NCT00382590|5-aza|5-aza
1603056|NCT00382590|Vidaza|vidaza
1603057|NCT00382590|5-AZC|5-azc
1603058|NCT00382590|AZA-CR|aza-cr
1603059|NCT00382590|Ladakamycin|ladakamycin
1603060|NCT00382590|Ara-C|ara-c
1603061|NCT00382590|Cytarabine|cytarabine
1603062|NCT00382590|Cytosar|cytosar
1603063|NCT00382590|DepoCyt|depocyt
1603064|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1603065|NCT00382590|Valproic Acid|valproic acid
1603066|NCT00382590|VPA|vpa
1603067|NCT00382590|Depakene|depakene
1603068|NCT00382564|Imaging|imaging
1603069|NCT00382564|Arteriosclerosis|arteriosclerosis
1603070|NCT00382564|Hardening of the arteries|hardening of the arteries
1603071|NCT00382564|MRA|mra
1603072|NCT00382564|Narrowing of Vessels|narrowing of vessels
1603073|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
1603074|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
1603075|NCT00382564|Plaque|plaque
1603076|NCT00382564|Arteries|arteries
1603077|NCT00382564|Diabetes|diabetes
1603078|NCT00382564|Hypertension|hypertension
1603079|NCT00382551|Alcohol|alcohol
1603080|NCT00382551|Red wine|red wine
1603081|NCT00382551|Endothelial function|endothelial function
1603082|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
1603083|NCT00382551|Cardiovascular disease|cardiovascular disease
1603084|NCT00382538|mifepristone|mifepristone
1603085|NCT00382538|induction|induction
1603086|NCT00382538|abortion|abortion
1603087|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
1603088|NCT00382525|Bradyarrhythmia|bradyarrhythmia
1603089|NCT00382525|Atrial Fibrillation|atrial fibrillation
1603090|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
1603091|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
1603092|NCT00382525|Heart Failure|heart failure
1603093|NCT00382525|Pacemaker|pacemaker
1603094|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1603095|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1603096|NCT00382525|Loop recorder|loop recorder
1603097|NCT00382525|Registry|registry
1603098|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
1603099|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
1603100|NCT00382499|Lidocaine Infusion|lidocaine infusion
1603101|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
1603102|NCT00382499|Analgesia|analgesia
1603103|NCT00382499|Anesthesia|anesthesia
1603104|NCT00382499|Adjunct|adjunct
1603105|NCT00382486|Intestinal transplant|intestinal transplant
1603106|NCT00382486|Bone marrow|bone marrow
1603107|NCT00382486|Irradiation of allograft|irradiation of allograft
1603108|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1603109|NCT00382473|Overweight|overweight
1603110|NCT00382473|Fatty acid oxidation|fatty acid oxidation
1603111|NCT00382473|Mitochondria|mitochondria
1603112|NCT00382473|Exercise|exercise
1603113|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
1603114|NCT00382447|nebulizer|nebulizer
1603115|NCT00382434|emergency pharmacist|emergency pharmacist
1603116|NCT00382434|emergency medicine|emergency medicine
1603117|NCT00382434|emergency department|emergency department
1603118|NCT00382434|medical error|medical error
1603119|NCT00382434|adverse event|adverse event
1603120|NCT00382434|pharmacist|pharmacist
1603121|NCT00382434|patient safety|patient safety
1603122|NCT00382421|Myocardial Ischemia|myocardial ischemia
1603123|NCT00382421|Randomized Controlled Trials|randomized controlled trials
1603124|NCT00382421|Drug Therapy|drug therapy
1603125|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
1603126|NCT00382408|Adenovirus|adenovirus
1603127|NCT00382395|Glaucoma shunt|glaucoma shunt
1603128|NCT00382395|Ocular implant|ocular implant
1603129|NCT00382395|Gold|gold
1603130|NCT00382395|trabeculectomy|trabeculectomy
1603131|NCT00382382|Autism|autism
1603132|NCT00382382|Asperger Syndrome|asperger syndrome
1603133|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
1603134|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
1603135|NCT00382382|Typically Developing children|typically developing children
1603136|NCT00382382|Human Volunteers|human volunteers
1603137|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
1603138|NCT00382369|genetic screening|genetic screening
1603139|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
1603140|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1603141|NCT00382356|Dutasteride|dutasteride
1603142|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
1603143|NCT00382356|Hormonal therapy|hormonal therapy
1603144|NCT00382343|Prevention|prevention
1603145|NCT00382343|Pyelonephritis|pyelonephritis
1603146|NCT00382343|Renal scars|renal scars
1603147|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
1603148|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
1603149|NCT00382330|Vulva|vulva
1603150|NCT00382317|MSCT indications|msct indications
1603151|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1603152|NCT00382304|C. difficile|c. difficile
1603153|NCT00382304|CDAD|cdad
1603154|NCT00382304|Clostridium difficile|clostridium difficile
1603155|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
1603156|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
1603157|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
1603158|NCT00382304|Infectious diarrhea|infectious diarrhea
1603159|NCT00382291|OCD|ocd
1603160|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
1603161|NCT00382291|Placebos|placebos
1603162|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
1603163|NCT00382291|Child Psychiatry|child psychiatry
1603164|NCT00382291|Activation Syndrome|activation syndrome
1603165|NCT00382291|Psychometrics|psychometrics
1603166|NCT00382278|Stem cell|stem cell
1603167|NCT00382278|Liver cirrhosis|liver cirrhosis
1603168|NCT00382278|Cellular therapy|cellular therapy
1603169|NCT00382278|Autologous|autologous
1603170|NCT00382278|Bone marrow|bone marrow
1603171|NCT00382265|urolithiasis|urolithiasis
1603172|NCT00382265|renal colic|renal colic
1603173|NCT00382265|kidney stones|kidney stones
1603174|NCT00382265|urinary stone disease|urinary stone disease
1603175|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1603176|NCT00382252|lung metastases|lung metastases
1603177|NCT00382239|diabetes|diabetes
1603179|NCT00382239|LY2148568|ly2148568
1603180|NCT00382239|Lilly|lilly
1603181|NCT00382239|Amylin|amylin
1603182|NCT00382239|Japan|japan
1603183|NCT00382226|Glaucoma|glaucoma
1603184|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1603185|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1603186|NCT00382187|influenza|influenza
1603187|NCT00382187|pandemic influenza|pandemic influenza
1603188|NCT00382187|influenza vaccine|influenza vaccine
1603189|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
1603190|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
1603191|NCT00382187|MF59|mf59
1603192|NCT00382187|Pandemic influenza disease|pandemic influenza disease
1603193|NCT00382174|pressure ulcers|pressure ulcers
1603194|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
1603195|NCT00382174|chronic wound-healing|chronic wound-healing
1603196|NCT00382174|Thymosin Beta 4|thymosin beta 4
1603197|NCT00382174|laminin-5|laminin-5
1603198|NCT00382161|impotence|impotence
1603199|NCT00382161|erectile dysfunction|erectile dysfunction
1603200|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
1603201|NCT00382161|statin|statin
1603202|NCT00382148|TOPS|tops
1603203|NCT00382148|Peanut allergy|peanut allergy
1603204|NCT00382148|Peanut-induced allergy|peanut-induced allergy
1603205|NCT00382148|Allergy|allergy
1603206|NCT00382135|Impotence|impotence
1603207|NCT00382135|erectile dysfunction|erectile dysfunction
1603208|NCT00382135|semen|semen
1603209|NCT00382135|sperm|sperm
1603210|NCT00382135|Healthy male volunteers|healthy male volunteers
1603211|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
1603212|NCT00382122|Glaucoma|glaucoma
1603213|NCT00382122|Ocular hypertension|ocular hypertension
1603214|NCT00382122|Dry eye|dry eye
1603215|NCT00382122|Ocular surface disease|ocular surface disease
1603216|NCT00382096|Type 2 diabetes|type 2 diabetes
1603217|NCT00382096|vildagliptin|vildagliptin
1603218|NCT00382096|metformin|metformin
1603219|NCT00382096|hemoglobin A1c|hemoglobin a1c
1603220|NCT00382083|Mammogram|mammogram
1603221|NCT00382083|Pain|pain
1603222|NCT00382083|Discomfort|discomfort
1603223|NCT00382083|Breast|breast
1603224|NCT00382083|Pre-medication|pre-medication
1603225|NCT00382070|stage I breast cancer|stage i breast cancer
1603226|NCT00382070|stage II breast cancer|stage ii breast cancer
1603227|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
1603228|NCT00382057|Testosterone|testosterone
1603229|NCT00382057|Insulin resistance|insulin resistance
1603230|NCT00382057|Insulin sensitivity|insulin sensitivity
1603231|NCT00382057|Metabolic disorders|metabolic disorders
1603232|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
1603233|NCT00382044|Dialysis|dialysis
1603234|NCT00382044|Anemia|anemia
1603235|NCT00382044|epoetin|epoetin
1603236|NCT00382018|recurrent breast cancer|recurrent breast cancer
1603237|NCT00382018|stage IV breast cancer|stage iv breast cancer
1603238|NCT00381992|sexual risk behavior|sexual risk behavior
1603239|NCT00381992|diabetes mellitus|diabetes mellitus
1603240|NCT00381992|hypertension|hypertension
1603241|NCT00381992|obesity|obesity
1603242|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
1603243|NCT00381992|hyperlipidemia|hyperlipidemia
1603244|NCT00381992|chlamydia|chlamydia
1603245|NCT00381979|Depression|depression
1603246|NCT00381979|Anxiety|anxiety
1603247|NCT00381979|Adolescents|adolescents
1603248|NCT00381979|Treatment|treatment
1603249|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
1604432|NCT00377949|PHAROS|pharos
1603254|NCT00381927|Prevention|prevention
1603255|NCT00381927|Anxiety|anxiety
1603256|NCT00381927|BRCA1 mutation|brca1 mutation
1603257|NCT00381927|BRCA2 mutation|brca2 mutation
1603258|NCT00381927|Tamoxifen|tamoxifen
1603259|NCT00381914|Infants|infants
1603260|NCT00381914|Vitamin D|vitamin d
1603261|NCT00381914|Dose-response|dose-response
1603262|NCT00381901|stage II breast cancer|stage ii breast cancer
1603263|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
1603264|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
1603265|NCT00381901|stage IA breast cancer|stage ia breast cancer
1603266|NCT00381901|stage IB breast cancer|stage ib breast cancer
1603267|NCT00381901|recurrent breast cancer|recurrent breast cancer
1603268|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
1603474|NCT00381173|ZYC300|zyc300
1603269|NCT00381888|thromboembolism|thromboembolism
1603270|NCT00381888|cervical cancer|cervical cancer
1603271|NCT00381888|endometrial cancer|endometrial cancer
1603272|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
1603273|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
1603274|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1603275|NCT00381888|ovarian sarcoma|ovarian sarcoma
1603276|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
1603277|NCT00381888|uterine sarcoma|uterine sarcoma
1603278|NCT00381888|vaginal cancer|vaginal cancer
1603279|NCT00381888|vulvar cancer|vulvar cancer
1603280|NCT00381888|fallopian tube cancer|fallopian tube cancer
1603281|NCT00381875|HIV infection|hiv infection
1604481|NCT00377819|alendronate|alendronate
1603282|NCT00381862|nausea and vomiting|nausea and vomiting
1603283|NCT00381862|recurrent colon cancer|recurrent colon cancer
1603284|NCT00381862|stage IV colon cancer|stage iv colon cancer
1603285|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
1603286|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
1603287|NCT00381849|Cystone|cystone
1603288|NCT00381849|Uricare|uricare
1603289|NCT00381849|Computerized tomography|computerized tomography
1603290|NCT00381849|Kidney calculi|kidney calculi
1603291|NCT00381849|Supersaturation|supersaturation
1603292|NCT00381849|Nephrolithiasis|nephrolithiasis
1603293|NCT00381849|Quantitative CT|quantitative ct
1603294|NCT00381836|Prostate Cancer|prostate cancer
1603295|NCT00381836|Anemia|anemia
1603296|NCT00381836|Blood transfusion|blood transfusion
1603297|NCT00381836|Cancer|cancer
1603298|NCT00381836|Critical illness|critical illness
1603299|NCT00381836|Drug efficacy|drug efficacy
1603300|NCT00381836|Drug safety|drug safety
1603301|NCT00381836|Drug tolerability|drug tolerability
1603302|NCT00381836|Erythropoietin|erythropoietin
1603303|NCT00381836|Fatigue|fatigue
1603304|NCT00381836|Hemoglobin|hemoglobin
1603305|NCT00381836|Human|human
1603306|NCT00381836|Male|male
1603307|NCT00381836|Multicenter study|multicenter study
1603308|NCT00381836|Quality of life|quality of life
1603309|NCT00381836|Questionnaire|questionnaire
1603310|NCT00381836|Randomized controlled trial|randomized controlled trial
1603311|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
1603312|NCT00381823|Pregnant women|pregnant women
1603313|NCT00381823|Intervention Studies|intervention studies
1603314|NCT00381823|African Americans|african americans
1603315|NCT00381823|Infant Mortality|infant mortality
1603316|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
1603317|NCT00381823|Depression|depression
1603318|NCT00381823|Partner Abuse|partner abuse
1603319|NCT00381823|Tobacco Smoke|tobacco smoke
1603320|NCT00381810|Rituxan|rituxan
1603321|NCT00381810|SLE|sle
1603322|NCT00381810|Lupus|lupus
1603323|NCT00381784|YMSM|ymsm
1603324|NCT00381784|HIV/AIDS|hiv/aids
1603325|NCT00381784|Condom use|condom use
1603326|NCT00381784|Drug users|drug users
1603327|NCT00381784|Minority women|minority women
1603328|NCT00381771|Globus Pharyngeus|globus pharyngeus
1603329|NCT00381771|Xerostomia|xerostomia
1603330|NCT00381771|Salivary Hypofunction|salivary hypofunction
1603331|NCT00381771|Pharyngoxerosis|pharyngoxerosis
1603332|NCT00381758|ADHD|adhd
1603333|NCT00381758|Methylphenidate|methylphenidate
1603334|NCT00381758|Metadate CD|metadate cd
1603335|NCT00381758|Concerta|concerta
1603336|NCT00381758|COMACS|comacs
1603337|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
1603338|NCT00381732|Impotence|impotence
1603339|NCT00381732|erectile dysfunction|erectile dysfunction
1603340|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1603341|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1603342|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
1603343|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
1603344|NCT00381693|primary myelofibrosis|primary myelofibrosis
1603345|NCT00381693|polycythemia vera|polycythemia vera
1603346|NCT00381693|essential thrombocythemia|essential thrombocythemia
1603347|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
1603348|NCT00381667|safety|safety
1603349|NCT00381667|GW642444M|gw642444m
1603350|NCT00381667|Single Dose|single dose
1603351|NCT00381667|pharmacodynamics|pharmacodynamics
1603352|NCT00381667|pharmacokinetics|pharmacokinetics
1603353|NCT00381667|GW642444H|gw642444h
1603354|NCT00381667|tolerability|tolerability
1603355|NCT00381654|Solid Tumors|solid tumors
1603356|NCT00381654|Tyrosine Kinases|tyrosine kinases
1603357|NCT00381628|Anatomy|anatomy
1603358|NCT00381628|cells|cells
1603359|NCT00381628|epithelial cells|epithelial cells
1603360|NCT00381628|blood cells|blood cells
1603361|NCT00381628|cystic fibrosis|cystic fibrosis
1603362|NCT00381628|equipment and supplies|equipment and supplies
1603363|NCT00381628|disposable equipment|disposable equipment
1603364|NCT00381628|reagent kits|reagent kits
1603365|NCT00381615|Meningococcal disease|meningococcal disease
1603366|NCT00381615|prevention|prevention
1603367|NCT00381615|vaccination|vaccination
1603368|NCT00381602|End stage renal disease|end stage renal disease
1603369|NCT00381602|Hemodialysis|hemodialysis
1603370|NCT00381602|Malnutrition|malnutrition
1603371|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
1603372|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
1603373|NCT00381576|Resistance training|resistance training
1603374|NCT00381576|Strength training|strength training
1603375|NCT00381576|Training adaptations|training adaptations
1603376|NCT00381576|CNS|cns
1603377|NCT00381563|Bracing|bracing
1603378|NCT00381563|Patellofemoral|patellofemoral
1603379|NCT00381563|Osteoarthritis|osteoarthritis
1603380|NCT00381537|childhood epilepsy|childhood epilepsy
1603381|NCT00381537|Active childhood epilepsy|active childhood epilepsy
1603382|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
1603383|NCT00381524|behavior change|behavior change
1603384|NCT00381511|pulmonary embolism,|pulmonary embolism,
1603385|NCT00381511|deferred diagnosis,|deferred diagnosis,
1603386|NCT00381511|protective anticoagulation|protective anticoagulation
1603387|NCT00381511|anticoagulants|anticoagulants
1603388|NCT00381472|Parkinson's Disease|parkinson's disease
1603389|NCT00381472|Dyskinesia|dyskinesia
1603390|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
1603391|NCT00381446|corneal staining|corneal staining
1603392|NCT00381446|contact lens care|contact lens care
1603393|NCT00381446|multipurpose solution|multipurpose solution
1603394|NCT00381433|HCV|hcv
1603395|NCT00381433|Hepatitis C virus|hepatitis c virus
1603396|NCT00381407|ADHD|adhd
1603397|NCT00381407|Organizational Skills|organizational skills
1603398|NCT00381407|Contingency Management|contingency management
1603399|NCT00381394|amphotericin B|amphotericin b
1603400|NCT00381394|safety|safety
1603401|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
1603402|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
1603403|NCT00381381|Alzheimer's disease|alzheimer's disease
1603404|NCT00381368|breast cancer|breast cancer
1603405|NCT00381368|skeletal metastases|skeletal metastases
1603406|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
1603407|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
1603408|NCT00381355|asthma|asthma
1603409|NCT00381355|children|children
1603410|NCT00381355|written action plan|written action plan
1603411|NCT00381355|education|education
1603412|NCT00381355|guided self-management|guided self-management
1603413|NCT00381355|efficacy|efficacy
1603414|NCT00381355|compliance|compliance
1603415|NCT00381355|b2-agonists|b2-agonists
1603416|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
1603417|NCT00381355|oral steroids|oral steroids
1603418|NCT00381355|relapse|relapse
1603419|NCT00381355|randomised controlled trial|randomised controlled trial
1603420|NCT00381355|emergency department|emergency department
1603421|NCT00381342|diabetes|diabetes
1603422|NCT00381342|exenatide|exenatide
1603423|NCT00381342|Amylin|amylin
1603424|NCT00381342|Lilly|lilly
1603425|NCT00381342|monotherapy|monotherapy
1603426|NCT00381329|Motivational Interviewing|motivational interviewing
1603427|NCT00381329|Structured Brief Advice|structured brief advice
1603428|NCT00381329|Adolescent Smoking|adolescent smoking
1603429|NCT00381329|Behavioral Intervention|behavioral intervention
1603430|NCT00381329|Smoking|smoking
1603431|NCT00381329|Primary Care|primary care
1603432|NCT00381329|Tobacco|tobacco
1603433|NCT00381303|HIV|hiv
1603434|NCT00381303|AIDS|aids
1603435|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
1603436|NCT00381303|Females|females
1603437|NCT00381303|Women|women
1603438|NCT00381303|PREZISTA|prezista
1603439|NCT00381303|darunavir|darunavir
1603440|NCT00381303|TMC114|tmc114
1603441|NCT00381303|Protease Inhibitor|protease inhibitor
1603442|NCT00381290|Arthritis|arthritis
1603443|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
1603444|NCT00381290|Knee Health|knee health
1603445|NCT00381290|Obesity|obesity
1603446|NCT00381290|Overweight|overweight
1603447|NCT00381290|Osteoarthritis|osteoarthritis
1603448|NCT00381290|Weight Loss|weight loss
1603449|NCT00381290|Diet|diet
1603450|NCT00381290|Exercise|exercise
1603451|NCT00381290|Knee Pain|knee pain
1603452|NCT00381277|nephrolithiasis|nephrolithiasis
1603453|NCT00381277|citrate|citrate
1603454|NCT00381277|oxalate|oxalate
1603455|NCT00381251|vaginal atrophy|vaginal atrophy
1603456|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
1603457|NCT00381251|menopause|menopause
1603458|NCT00381251|hot flashes|hot flashes
1603459|NCT00381238|Alzheimer's Disease|alzheimer's disease
1603460|NCT00381238|Rosiglitazone|rosiglitazone
1603461|NCT00381225|Radio-frequency ablation; Head and Neck neoplasia.|radio-frequency ablation; head and neck neoplasia.
1603462|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
1603463|NCT00381199|fibromyalgia|fibromyalgia
1603464|NCT00381199|cannabinoid|cannabinoid
1603465|NCT00381199|chronic pain|chronic pain
1603466|NCT00381199|sleep|sleep
1603467|NCT00381199|insomnia|insomnia
1603468|NCT00381199|diffuse widespread pain|diffuse widespread pain
1603469|NCT00381199|antidepressant|antidepressant
1603470|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
1603471|NCT00381186|type 2 diabetes|type 2 diabetes
1603472|NCT00381173|MGI PHARMA|mgi pharma
1603473|NCT00381173|ZYC3-002|zyc3-002
1603476|NCT00381173|cyclophosphamide|cyclophosphamide
1603477|NCT00381173|Cytoxan|cytoxan
1603478|NCT00381173|advanced breast cancer|advanced breast cancer
1603479|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
1603480|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
1603481|NCT00381173|advanced colon cancer|advanced colon cancer
1603482|NCT00381173|advanced renal cancer|advanced renal cancer
1603483|NCT00381173|advanced stage malignancies|advanced stage malignancies
1603484|NCT00381173|immune therapy|immune therapy
1603485|NCT00381173|gene therapy|gene therapy
1603486|NCT00381173|biologic therapy|biologic therapy
1603487|NCT00381173|T-regulatory cells|t-regulatory cells
1604580|NCT00377364|prednisone|prednisone
1603488|NCT00381173|cancer vaccine|cancer vaccine
1603489|NCT00381173|vaccine|vaccine
1603490|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
1603491|NCT00381160|weight loss|weight loss
1603492|NCT00381160|obesity|obesity
1603493|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
1603494|NCT00381160|diet|diet
1603495|NCT00381160|adolescence|adolescence
1603496|NCT00381134|double-blind|double-blind
1603497|NCT00381134|placebo-controlled|placebo-controlled
1603498|NCT00381134|nephropathy|nephropathy
1603499|NCT00381134|blood pressure|blood pressure
1603500|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
1603501|NCT00381134|placebo|placebo
1603502|NCT00381121|Tissue Biobank|tissue biobank
1603503|NCT00381121|molecular markers|molecular markers
1603504|NCT00381121|molecular pathways|molecular pathways
1603506|NCT00381082|Pediculus|pediculus
1603507|NCT00381082|capitis|capitis
1603508|NCT00381082|lice|lice
1603509|NCT00381069|Recreation Centers|recreation centers
1603510|NCT00381069|Families|families
1603511|NCT00381069|Obesity Prevention|obesity prevention
1603512|NCT00381056|labor and delivery care|labor and delivery care
1603513|NCT00381056|teamwork training|teamwork training
1603514|NCT00381056|crew resource management|crew resource management
1603515|NCT00381056|cluster-randomized trial|cluster-randomized trial
1603516|NCT00381043|Alcohol Dependence|alcohol dependence
1603517|NCT00381043|Family Medicine Setting|family medicine setting
1603518|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
1603519|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
1603520|NCT00381030|Disease Management|disease management
1603521|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1603522|NCT00381004|Leukemia|leukemia
1603523|NCT00381004|Cyclophosphamide|cyclophosphamide
1603524|NCT00381004|Fludarabine|fludarabine
1603525|NCT00381004|Sargramostim|sargramostim
1603526|NCT00381004|Rituximab|rituximab
1603527|NCT00381004|GM-CSF|gm-csf
1603528|NCT00381004|FCR|fcr
1603529|NCT00380978|labor pain|labor pain
1603530|NCT00380978|cesarean section|cesarean section
1603531|NCT00380978|epidural analgesia|epidural analgesia
1603532|NCT00380978|opioid analgesics|opioid analgesics
1603533|NCT00380978|local anesthetics|local anesthetics
1603534|NCT00380978|labor induced|labor induced
1603535|NCT00380965|Chemotherapy-induced|chemotherapy-induced
1603536|NCT00380965|neuropathy|neuropathy
1603537|NCT00380965|cancer|cancer
1603538|NCT00380952|IDC|idc
1603539|NCT00380952|DCIS|dcis
1603540|NCT00380952|ILC|ilc
1603541|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
1603542|NCT00380926|nutrition|nutrition
1603543|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
1603544|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
1603545|NCT00380887|bioavailability|bioavailability
1603546|NCT00380887|bioequivalence|bioequivalence
1603547|NCT00380887|marketed product|marketed product
1603548|NCT00380887|Premarin|premarin
1603549|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
1603550|NCT00380887|MPA|mpa
1603551|NCT00380887|Postmenopausal|postmenopausal
1603552|NCT00380887|vasomotor symptoms|vasomotor symptoms
1603553|NCT00380874|Pain|pain
1603554|NCT00380874|chemotherapy|chemotherapy
1603555|NCT00380861|Total Knee Replacement|total knee replacement
1603556|NCT00380861|Flexion|flexion
1603557|NCT00380861|Range of Motion|range of motion
1603558|NCT00380861|Activities of Daily Living|activities of daily living
1603559|NCT00380861|Implant design|implant design
1603560|NCT00380861|Subject Satisfaction|subject satisfaction
1603561|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
1603562|NCT00380848|sleep apnea|sleep apnea
1603563|NCT00380848|end stage renal disease|end stage renal disease
1603564|NCT00380848|hemodiafiltration|hemodiafiltration
1603565|NCT00380835|metastatic breast cancer|metastatic breast cancer
1603566|NCT00380835|amrubicin|amrubicin
1603567|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
1603568|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1603569|NCT00380796|COPD|copd
1603570|NCT00380770|HIV|hiv
1603571|NCT00380770|AIDS|aids
1603572|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
1603573|NCT00380770|Human herpesvirus 8|human herpesvirus 8
1603574|NCT00380757|cardiac arrest|cardiac arrest
1603575|NCT00380757|CPR|cpr
1603576|NCT00380757|resuscitation|resuscitation
1603579|NCT00380731|Social Anxiety Disorder|social anxiety disorder
1603580|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
1603581|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
1603582|NCT00380640|Pediatrics|pediatrics
1603583|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
1603584|NCT00380640|Trimethoprim|trimethoprim
1603585|NCT00380640|Wound Healing|wound healing
1603586|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
1603587|NCT00380575|hyponatremia|hyponatremia
1603588|NCT00380575|hypervolemic|hypervolemic
1603589|NCT00380575|euvolemic|euvolemic
1603590|NCT00380575|vasopressins|vasopressins
1603592|NCT00380562|Quality of life|quality of life
1604883|NCT00376779|randomized|randomized
1603593|NCT00380562|Cognitive Functioning|cognitive functioning
1603594|NCT00380562|Activities of Daily Living|activities of daily living
1603595|NCT00380562|Disability prevention|disability prevention
1603596|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
1603597|NCT00380536|Peer-led Education|peer-led education
1603598|NCT00380510|Family Physicians|family physicians
1603599|NCT00380510|Adolescents|adolescents
1603600|NCT00380510|Preventive Care|preventive care
1603601|NCT00380510|Health Behavior|health behavior
1603602|NCT00380497|Pediatrics|pediatrics
1603603|NCT00380497|Colonoscopy|colonoscopy
1603604|NCT00380497|Bowel cleanout|bowel cleanout
1603605|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
1603606|NCT00380497|Pico-Salax|pico-salax
1603607|NCT00380471|bath PUVA|bath puva
1603608|NCT00380458|Obstructive|obstructive
1603609|NCT00380458|Sleep|sleep
1603610|NCT00380458|Apnea|apnea
1603611|NCT00380458|Pain|pain
1603612|NCT00380458|UPPP|uppp
1603613|NCT00380458|Tonsillectomy|tonsillectomy
1603614|NCT00380458|Narcotics|narcotics
1603615|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
1603616|NCT00380419|Pregnancy|pregnancy
1603617|NCT00380419|Postpartum Depression|postpartum depression
1603618|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
1603619|NCT00380406|GnRH|gnrh
1603620|NCT00380406|Fertility|fertility
1603621|NCT00380406|Fertility preservation|fertility preservation
1603622|NCT00380406|Oncology|oncology
1603623|NCT00380406|Cancer|cancer
1603624|NCT00380406|Chemotherapy|chemotherapy
1603625|NCT00380393|Malaria|malaria
1603626|NCT00380393|Plasmodium|plasmodium
1603627|NCT00380393|RTS|rts
1603628|NCT00380393|S/AS01|s/as01
1603629|NCT00380393|Falciparum|falciparum
1603630|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
1603631|NCT00380354|allergen|allergen
1603632|NCT00380354|methacholine|methacholine
1603633|NCT00380354|GSK256066|gsk256066
1603634|NCT00380354|mild asthmatics|mild asthmatics
1603635|NCT00380354|repeat dose|repeat dose
1603636|NCT00380354|challenge|challenge
1603637|NCT00380354|late asthmatic response|late asthmatic response
1603638|NCT00380328|Pharmacokinetic|pharmacokinetic
1603639|NCT00380328|healthy subjects|healthy subjects
1603640|NCT00380315|Cough|cough
1603641|NCT00380315|Chronic bronchitis|chronic bronchitis
1603642|NCT00380315|PNDs|pnds
1603643|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
1603644|NCT00380315|GERD|gerd
1603645|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
1603646|NCT00380315|bronchiectasis|bronchiectasis
1603647|NCT00380302|Alzheimer's disease|alzheimer's disease
1603648|NCT00380302|symptomatic|symptomatic
1603649|NCT00380302|cognition|cognition
1603650|NCT00380289|Essential hypertension|essential hypertension
1603651|NCT00380289|Glucose metabolism|glucose metabolism
1603652|NCT00380289|Thiazides|thiazides
1603653|NCT00380289|Beta blockers|beta blockers
1603654|NCT00380276|Alzheimer's|alzheimer's
1603655|NCT00380276|Dementia|dementia
1603656|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
1603657|NCT00380237|Bird Flu|bird flu
1603658|NCT00380237|Avian Flu|avian flu
1603659|NCT00380224|schizophrenia|schizophrenia
1603660|NCT00380211|Thimerosal reduced content|thimerosal reduced content
1603661|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
1603662|NCT00380211|Young and elderly adults|young and elderly adults
1603663|NCT00380211|Influenza vaccine|influenza vaccine
1603664|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
1603665|NCT00380185|Atherosclerosis|atherosclerosis
1603666|NCT00380172|AMD|amd
1603667|NCT00380172|Macular Degeneration|macular degeneration
1603668|NCT00380172|Retinal Degeneration|retinal degeneration
1603669|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
1603670|NCT00380146|Malaria|malaria
1603671|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
1603672|NCT00380146|IPT|ipt
1603673|NCT00380146|Pharmacokinetic|pharmacokinetic
1603674|NCT00380146|Efficacy|efficacy
1603675|NCT00380146|Gametocyte|gametocyte
1603676|NCT00380146|Molecular markers|molecular markers
1603677|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
1603678|NCT00380107|Minor surgery|minor surgery
1603679|NCT00380107|Volume optimization|volume optimization
1603680|NCT00380107|Volume deficit|volume deficit
1603681|NCT00380107|Epidural anesthesia|epidural anesthesia
1603682|NCT00380094|ACS|acs
1603683|NCT00380094|NSTEMI|nstemi
1603684|NCT00380094|Myeloperoxidase|myeloperoxidase
1603685|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
1603686|NCT00380081|Insomnia|insomnia
1603687|NCT00380055|Cancer Screening|cancer screening
1603688|NCT00380055|Navigators|navigators
1603689|NCT00380055|Community Outreach|community outreach
1603690|NCT00380055|Behavioral Change|behavioral change
1603691|NCT00380055|Access|access
1603692|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
1603693|NCT00380042|Treatment Resistant Depression|treatment resistant depression
1603694|NCT00380042|Major Depressive Disorder|major depressive disorder
1603695|NCT00380029|stage II bladder cancer|stage ii bladder cancer
1603696|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1603697|NCT00380016|Angioplasty|angioplasty
1603698|NCT00380016|Stent|stent
1603699|NCT00380016|Coronary Artery Disease|coronary artery disease
1603700|NCT00380016|Peripheral Artery Disease|peripheral artery disease
1603701|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
1603702|NCT00380016|CAD|cad
1603703|NCT00380016|PAD|pad
1603704|NCT00380016|Cardiovascular Disease|cardiovascular disease
1603705|NCT00379990|iNOS|inos
1603706|NCT00379990|Exhaled NO|exhaled no
1603707|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
1603708|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
1603709|NCT00379925|Physical Activity|physical activity
1603710|NCT00379925|Exercise|exercise
1603711|NCT00379925|Dietary Habits|dietary habits
1603712|NCT00379899|calcification|calcification
1603713|NCT00379899|vascular calcification|vascular calcification
1603714|NCT00379899|coronary vascular calcification|coronary vascular calcification
1603715|NCT00379899|chronic kidney disease|chronic kidney disease
1603716|NCT00379899|end stage renal disease|end stage renal disease
1603717|NCT00379899|dialysis|dialysis
1603718|NCT00379886|ECT|ect
1603719|NCT00379886|Depression|depression
1603720|NCT00379886|Anesthiticum|anesthiticum
1603721|NCT00379886|Propofol|propofol
1603722|NCT00379886|Thiopental|thiopental
1603723|NCT00379847|hyponatremia|hyponatremia
1603724|NCT00379847|hypervolemic|hypervolemic
1603725|NCT00379847|euvolemic|euvolemic
1603726|NCT00379847|treatment outcomes|treatment outcomes
1603727|NCT00379847|YM087|ym087
1603728|NCT00379834|glaucoma|glaucoma
1603729|NCT00379834|diurnal|diurnal
1603730|NCT00379834|intraocular pressure|intraocular pressure
1603731|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
1603732|NCT00379808|coronary heart disease|coronary heart disease
1603733|NCT00379808|montelukast|montelukast
1603734|NCT00379808|inflammation|inflammation
1603735|NCT00379795|CNV|cnv
1603736|NCT00379795|Lucentis|lucentis
1603737|NCT00379795|AMD|amd
1603738|NCT00379795|Age-related macular degeneration|age-related macular degeneration
1603739|NCT00379795|RVO|rvo
1603740|NCT00379769|diabetes|diabetes
1603741|NCT00379769|CV outcomes|cv outcomes
1603742|NCT00379769|rosiglitazone|rosiglitazone
1603743|NCT00379769|Type II diabetes|type ii diabetes
1603744|NCT00379769|sulfonylurea|sulfonylurea
1603745|NCT00379769|RECORD|record
1603746|NCT00379769|metformin|metformin
1603747|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
1603748|NCT00379730|CT scan|ct scan
1603749|NCT00379730|breathing tests|breathing tests
1603750|NCT00379730|lung function tests|lung function tests
1603751|NCT00379730|biomarkers|biomarkers
1603752|NCT00379730|prednisolone|prednisolone
1603753|NCT00379730|IOS|ios
1603754|NCT00379730|COPD|copd
1603755|NCT00379730|clinical outcomes|clinical outcomes
1603756|NCT00379717|helical tomotherapy|helical tomotherapy
1603757|NCT00379717|dose escalation|dose escalation
1603758|NCT00379717|chemotherapy|chemotherapy
1603759|NCT00379704|Tissue factor|tissue factor
1603760|NCT00379704|Obesity|obesity
1603761|NCT00379704|Adipose tissue|adipose tissue
1603762|NCT00379704|Microparticles|microparticles
1603763|NCT00379691|spinal|spinal
1603764|NCT00379691|Cesarean section|cesarean section
1603765|NCT00379691|hypotension|hypotension
1603766|NCT00379691|nausea|nausea
1603767|NCT00379691|vomiting|vomiting
1603768|NCT00379691|phenylephrine|phenylephrine
1603769|NCT00379678|atopic dermatitis|atopic dermatitis
1603770|NCT00379665|Lung|lung
1603771|NCT00379665|Chemotherapy|chemotherapy
1603772|NCT00379665|Cisplatin|cisplatin
1603773|NCT00379665|Intratumoral|intratumoral
1603774|NCT00379665|Bronchoscope|bronchoscope
1603775|NCT00379665|Brachytherapy|brachytherapy
1603776|NCT00379652|Community Health Centers|community health centers
1603777|NCT00379652|Diabetes|diabetes
1603778|NCT00379652|Blood Pressure, High|blood pressure, high
1603779|NCT00379639|Pancreatic cancer|pancreatic cancer
1603780|NCT00379639|advanced solid tumors|advanced solid tumors
1603781|NCT00379626|Paraphilia|paraphilia
1603782|NCT00379626|Hormonal treatment|hormonal treatment
1603783|NCT00379626|Cognitive treatment|cognitive treatment
1603981|NCT00378859|IGFBP-3|igfbp-3
1603784|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
1603785|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
1603786|NCT00379587|Rituximab|rituximab
1603787|NCT00379587|Chronic GVHD|chronic gvhd
1603788|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1603789|NCT00379574|Bortezomib|bortezomib
1603790|NCT00379574|CHOP|chop
1603791|NCT00379574|Lenograstim|lenograstim
1603792|NCT00379561|Prostate Cancer|prostate cancer
1603793|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
1603794|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
1603795|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
1604884|NCT00376779|phase 2|phase 2
1603796|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
1603797|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
1603798|NCT00379522|hemorrhagic|hemorrhagic
1603799|NCT00379522|shock|shock
1603800|NCT00379522|traumatic|traumatic
1603801|NCT00379522|shock treatment|shock treatment
1603802|NCT00379522|vasopressin|vasopressin
1603803|NCT00379522|Circulatory Collapse|circulatory collapse
1603804|NCT00379522|Hypovolemic Shock|hypovolemic shock
1603805|NCT00379509|recurrent breast cancer|recurrent breast cancer
1603806|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
1603807|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
1603808|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
1603809|NCT00379509|stage IV breast cancer|stage iv breast cancer
1603810|NCT00379509|male breast cancer|male breast cancer
1603811|NCT00379496|Fibromyalgia|fibromyalgia
1603812|NCT00379496|Acupuncture|acupuncture
1603813|NCT00379496|Randomized study|randomized study
1603814|NCT00379483|Transfusional iron overload|transfusional iron overload
1603815|NCT00379483|Deferasirox|deferasirox
1603816|NCT00379470|Brain tumor|brain tumor
1603817|NCT00379470|Treatment|treatment
1603818|NCT00379470|Minimal toxicity|minimal toxicity
1603819|NCT00379470|GBM|gbm
1603820|NCT00379470|Glioblastoma|glioblastoma
1603821|NCT00379470|Recurrent|recurrent
1603822|NCT00379470|TTFields|ttfields
1603823|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1603824|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1603825|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1603826|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1603827|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1603828|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1603829|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
1603830|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
1603831|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
1603832|NCT00379405|Single therapy|single therapy
1603833|NCT00379405|Virological efficacy|virological efficacy
1603834|NCT00379405|Safety|safety
1603835|NCT00379405|HIV-1|hiv-1
1603836|NCT00379392|Stroke|stroke
1603837|NCT00379392|Mental Imagery|mental imagery
1603838|NCT00379392|Constraint Induced Therapy|constraint induced therapy
1603839|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
1603840|NCT00379366|Randomized Controlled Trials|randomized controlled trials
1603841|NCT00379366|Renal Dialysis|renal dialysis
1603842|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
1603843|NCT00379366|Angioplasty|angioplasty
1603844|NCT00379366|Vascular Patency|vascular patency
1603845|NCT00379366|Radiation, Ionizing|radiation, ionizing
1603846|NCT00379353|Advanced Cancers|advanced cancers
1603847|NCT00379353|Anorexia|anorexia
1603848|NCT00379353|Fatigue|fatigue
1603849|NCT00379353|Thalidomide|thalidomide
1603850|NCT00379353|Placebo|placebo
1603851|NCT00379327|Pregnancy|pregnancy
1603852|NCT00379327|Acupuncture|acupuncture
1603853|NCT00379327|Pregnancy Outcome|pregnancy outcome
1603854|NCT00379327|Randomized Controlled Trial|randomized controlled trial
1603855|NCT00379327|Double-Blind Method|double-blind method
1603856|NCT00379314|Incontinence|incontinence
1603857|NCT00379314|Urinary|urinary
1603860|NCT00379314|Complications|complications
1603861|NCT00379301|Atrial Fibrillation|atrial fibrillation
1603862|NCT00379301|A-Fib|a-fib
1603863|NCT00379301|AF|af
1603864|NCT00379301|Persistent|persistent
1603865|NCT00379301|Permanent|permanent
1603866|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
1603867|NCT00379301|Ablation|ablation
1603868|NCT00379275|Sarcoidosis|sarcoidosis
1603869|NCT00379275|Uveitis|uveitis
1603870|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
1603871|NCT00379275|HLA-Typing|hla-typing
1603872|NCT00379275|Cytokines|cytokines
1603873|NCT00379275|Serum Markers|serum markers
1603874|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1603875|NCT00379262|Chemoradiotherapy|chemoradiotherapy
1603876|NCT00379262|Accelerated Fractionation|accelerated fractionation
1603877|NCT00379249|hypercholesterolemia|hypercholesterolemia
1603878|NCT00379249|statin|statin
1603879|NCT00379249|compliance|compliance
1603880|NCT00379236|osteoarthritis|osteoarthritis
1603881|NCT00379236|knee|knee
1603882|NCT00379223|retinal vein occlusion|retinal vein occlusion
1603883|NCT00379223|vitrectomy|vitrectomy
1603884|NCT00379223|surgery|surgery
1603885|NCT00379223|retinal disorders|retinal disorders
1603886|NCT00379223|vascular diseases|vascular diseases
1603887|NCT00379210|Attention|attention
1603889|NCT00379210|event-related potentials|event-related potentials
1603890|NCT00379210|fMRI|fmri
1603891|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
1603892|NCT00379210|MBSR|mbsr
1603893|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
1603894|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
1603895|NCT00379210|MMT|mmt
1603896|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
1603897|NCT00379197|recurrent breast cancer|recurrent breast cancer
1603898|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
1603899|NCT00379184|arthritis|arthritis
1603900|NCT00379171|Children|children
1603901|NCT00379171|Complementary feeding|complementary feeding
1603902|NCT00379171|Breast feeding|breast feeding
1603903|NCT00379171|Cow's milk|cow's milk
1603904|NCT00379171|Formula|formula
1603905|NCT00379171|Protein|protein
1603906|NCT00379171|LCPUFA|lcpufa
1603907|NCT00379171|Fish oil|fish oil
1603908|NCT00379171|Lipid profile|lipid profile
1603909|NCT00379171|Intestinal inflammation|intestinal inflammation
1603910|NCT00379171|Intestinal microbiota|intestinal microbiota
1603911|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
1603912|NCT00379158|home-fortification|home-fortification
1603913|NCT00379158|complementary foods|complementary foods
1603914|NCT00379158|infants|infants
1603915|NCT00379158|Ghana|ghana
1603916|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
1603917|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
1603918|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
1603919|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
1603920|NCT00379132|Glioma|glioma
1603921|NCT00379132|prostatic|prostatic
1603922|NCT00379132|breast|breast
1603923|NCT00379132|non-small cell lung|non-small cell lung
1603924|NCT00379132|melanoma|melanoma
1603925|NCT00379132|colorectal|colorectal
1603926|NCT00379132|pancreatic|pancreatic
1603927|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1603928|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
1603929|NCT00379119|stage I prostate cancer|stage i prostate cancer
1603930|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
1603931|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
1603932|NCT00379119|stage III prostate cancer|stage iii prostate cancer
1603933|NCT00379106|Supportive|supportive
1603934|NCT00379106|Mastectomy|mastectomy
1603935|NCT00379106|Quality of Life|quality of life
1603936|NCT00379106|Arm Function|arm function
1603937|NCT00379093|Alcohol|alcohol
1603938|NCT00379093|Comorbidity|comorbidity
1603939|NCT00379093|Aging|aging
1603940|NCT00379093|Brief Advice|brief advice
1603941|NCT00379093|Randomized Trial|randomized trial
1603942|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1603943|NCT00379067|Nocturia|nocturia
1603944|NCT00379067|Actigraphy|actigraphy
1603945|NCT00379067|Tamsulosin|tamsulosin
1603946|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
1603947|NCT00379054|telephone counseling|telephone counseling
1603948|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1603949|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1603950|NCT00379028|COPD|copd
1603951|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
1603952|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
1603953|NCT00379015|stage IV breast cancer|stage iv breast cancer
1603954|NCT00379002|Interstitial Cystitis|interstitial cystitis
1603955|NCT00379002|Sexual Dysfunction|sexual dysfunction
1603956|NCT00379002|Vulvodynia|vulvodynia
1603957|NCT00379002|Pelvic Pain|pelvic pain
1603958|NCT00379002|incontinence|incontinence
1603959|NCT00378976|HIV infection|hiv infection
1603960|NCT00378976|HIV shedding|hiv shedding
1603961|NCT00378976|HSV suppression|hsv suppression
1603962|NCT00378976|Co-infected|co-infected
1603964|NCT00378976|Reactivation|reactivation
1603965|NCT00378976|Valacyclovir|valacyclovir
1603966|NCT00378950|Congestive Heart Failure|congestive heart failure
1603967|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1603968|NCT00378937|pain|pain
1603969|NCT00378885|HIV-prevention|hiv-prevention
1603970|NCT00378885|Internet Prevention intervention|internet prevention intervention
1603971|NCT00378885|Online randomized controlled trial|online randomized controlled trial
1603972|NCT00378885|Effect evaluation|effect evaluation
1603973|NCT00378885|MSM|msm
1603974|NCT00378885|Steady relationships|steady relationships
1603975|NCT00378859|Children|children
1603976|NCT00378859|Milk|milk
1603977|NCT00378859|Meat|meat
1603978|NCT00378859|Animal Protein|animal protein
1603979|NCT00378859|Growth Factors|growth factors
1603980|NCT00378859|IGF-I|igf-i
1603983|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1603984|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
1603985|NCT00378820|Children|children
1603986|NCT00378820|Whey|whey
1603987|NCT00378820|Casein|casein
1603988|NCT00378820|Milk minerals|milk minerals
1603989|NCT00378820|Growth factors|growth factors
1603990|NCT00378820|IGF-I|igf-i
1603991|NCT00378820|Insulin|insulin
1603992|NCT00378781|infection|infection
1603993|NCT00378781|poor vascular access|poor vascular access
1603994|NCT00378781|thromboembolism|thromboembolism
1603995|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1603996|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1603997|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1603998|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1603999|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1604000|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1604001|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1604002|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1604003|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1604004|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1604005|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1604006|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1604007|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1604008|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1604009|NCT00378781|primary myelofibrosis|primary myelofibrosis
1604010|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1604011|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1604012|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1604013|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1604014|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
1604015|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1604016|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1604017|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1604018|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1604019|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1604020|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1604021|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1604022|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1604023|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1604024|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1604025|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1604026|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1604027|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1604028|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1604029|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1604030|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1604031|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1604032|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1604033|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1604034|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1604035|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1604036|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1604037|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1604038|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1604039|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1604040|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1604041|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1604042|NCT00378781|recurrent breast cancer|recurrent breast cancer
1604043|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1604044|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1604045|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1604046|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1604047|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1604048|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1604049|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1604050|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1604051|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1604052|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1604053|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1604054|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1604055|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1604056|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
1604057|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1604058|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1604059|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1604060|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1604061|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1604062|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1604063|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
1604064|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
1604065|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1604066|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1604067|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1604068|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1604069|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
1604070|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
1604071|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1604072|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1604073|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1604074|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1604075|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1604076|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1604077|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1604078|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1604079|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1604080|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1604081|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1604082|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1604083|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1604084|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1604085|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
1604086|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1604087|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1604088|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1604089|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
1604090|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
1604091|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
1604092|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1604093|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1604094|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1604095|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1604096|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1604097|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1604098|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1604099|NCT00378781|stage IV breast cancer|stage iv breast cancer
1604100|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1604101|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1604102|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1604103|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1604104|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1604105|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1604106|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1604107|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1604108|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
1604109|NCT00378781|mast cell leukemia|mast cell leukemia
1604110|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1604111|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1604112|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1604113|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1604253|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
1604114|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1604115|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1604116|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1604117|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1604118|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1604119|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
1604120|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1604121|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1604122|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1604581|NCT00377351|Public Health|public health
1604123|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1604124|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1604125|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1604126|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1604127|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1604128|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1604129|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1604130|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1604131|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1604132|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1604133|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1604134|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1604135|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1604136|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1604137|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1604138|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1604139|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1604140|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1604141|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1604142|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1604143|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1604144|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1604145|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1604146|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1604147|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1604148|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1604149|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1604150|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1604151|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1604152|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1604153|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1604154|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1604155|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1604156|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1604157|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1604158|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1604159|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1604267|NCT00378547|Tonsillectomy|tonsillectomy
1604160|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1604161|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1604162|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1604163|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1604164|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1604165|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1604166|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1604167|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1604168|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1604169|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1604170|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1604171|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1604172|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1604173|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1604174|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1604254|NCT00378651|Anesthesia, General|anesthesia, general
1604175|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1604176|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1604177|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1604178|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1604179|NCT00378781|intraocular lymphoma|intraocular lymphoma
1604180|NCT00378781|stage I melanoma|stage i melanoma
1604181|NCT00378781|stage II melanoma|stage ii melanoma
1604182|NCT00378781|stage III melanoma|stage iii melanoma
1604183|NCT00378781|stage IV melanoma|stage iv melanoma
1604184|NCT00378781|recurrent melanoma|recurrent melanoma
1604185|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1604186|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1604187|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1604188|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1604189|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1604190|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1604191|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1604192|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1604193|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1604194|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1604195|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1604196|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1604197|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1604198|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1604199|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1604200|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1604201|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
1604202|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
1604203|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
1604204|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
1604205|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
1604206|NCT00378781|localized osteosarcoma|localized osteosarcoma
1604207|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
1604208|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
1604209|NCT00378781|chondrosarcoma|chondrosarcoma
1604210|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1604211|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
1604212|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1604213|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
1604214|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
1604215|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
1604216|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
1604217|NCT00378755|velcade|velcade
1604218|NCT00378755|myeloma|myeloma
1604219|NCT00378755|VAD regimen|vad regimen
1604220|NCT00378755|Transplantation, Autologous|transplantation, autologous
1604221|NCT00378742|Glaucoma|glaucoma
1604222|NCT00378742|Gene|gene
1604223|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
1604224|NCT00378742|Molecular Diagnosis|molecular diagnosis
1604225|NCT00378742|Retinal Degeneration|retinal degeneration
1604226|NCT00378742|Inherited Eye Disease|inherited eye disease
1604227|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
1604228|NCT00378742|Macular Dystrophy|macular dystrophy
1604229|NCT00378742|Congenital Glaucoma|congenital glaucoma
1604230|NCT00378729|PCOS|pcos
1604231|NCT00378729|FERTILOSCOPY|fertiloscopy
1604232|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
1604233|NCT00378729|Multiple pregnancies|multiple pregnancies
1604234|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
1604235|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
1604236|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
1604237|NCT00378729|Spermogram must be normal|spermogram must be normal
1604238|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
1604239|NCT00378716|stage II colon cancer|stage ii colon cancer
1604240|NCT00378716|stage III colon cancer|stage iii colon cancer
1604241|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
1604242|NCT00378690|Prostate Cancer|prostate cancer
1604243|NCT00378690|Prostate Specific Antigen|prostate specific antigen
1604244|NCT00378677|Powder inhalation|powder inhalation
1604245|NCT00378677|Side effects|side effects
1604246|NCT00378677|Nephrotoxicity|nephrotoxicity
1604247|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
1604248|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
1604249|NCT00378677|Forced Expiratory Volume|forced expiratory volume
1604250|NCT00378664|urinary incontinence|urinary incontinence
1604251|NCT00378664|spinal cord injury|spinal cord injury
1604252|NCT00378664|spina bifida|spina bifida
1604261|NCT00378638|angiogenesis|angiogenesis
1604262|NCT00378638|bevacizumab|bevacizumab
1604263|NCT00378638|chemotherapy|chemotherapy
1604264|NCT00378612|trials|trials
1604265|NCT00378612|stents|stents
1604266|NCT00378612|coronary occlusions|coronary occlusions
1604268|NCT00378547|pregabalin|pregabalin
1604269|NCT00378547|dexamethasone|dexamethasone
1604270|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
1604271|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1604272|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1604273|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1604274|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1604275|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1604276|NCT00378534|Leukemia|leukemia
1604277|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1604278|NCT00378534|CML|cml
1604279|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
1604280|NCT00378534|AML|aml
1604281|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1604282|NCT00378534|CLL|cll
1604283|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1604284|NCT00378534|ALL|all
1604285|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
1604286|NCT00378521|Raynaud's|raynaud's
1604287|NCT00378521|Nitroglycerin|nitroglycerin
1604288|NCT00378521|topical gel|topical gel
1604289|NCT00378521|cold hands|cold hands
1604290|NCT00378521|painful hands|painful hands
1604291|NCT00378521|scleroderma|scleroderma
1604292|NCT00378508|immune therapy|immune therapy
1604293|NCT00378508|autoimmunity|autoimmunity
1604294|NCT00378508|insulin secretion|insulin secretion
1604295|NCT00378508|diabetes mellitus|diabetes mellitus
1604296|NCT00378495|miltefosine|miltefosine
1604297|NCT00378495|kala azar|kala azar
1604298|NCT00378495|Brazil|brazil
1604299|NCT00378482|Melanoma and other tumors|melanoma and other tumors
1604300|NCT00378469|Hepcidin|hepcidin
1604301|NCT00378469|Hemojuvelin|hemojuvelin
1604302|NCT00378469|Iron|iron
1604303|NCT00378469|Healthy volunteers|healthy volunteers
1604304|NCT00378417|Otitis Media|otitis media
1604305|NCT00378417|Pneumococcal Infections|pneumococcal infections
1604306|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
1604307|NCT00378417|Proportional Hazards Models|proportional hazards models
1604308|NCT00378417|Prospective Studies|prospective studies
1604309|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
1604310|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
1604311|NCT00378404|NSCLC|nsclc
1604312|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
1604313|NCT00378404|Non-Small Cell|non-small cell
1604314|NCT00378404|Lung Cancer|lung cancer
1604315|NCT00378404|Docetaxel|docetaxel
1604316|NCT00378404|Radiation|radiation
1604317|NCT00378404|Metastatic|metastatic
1604318|NCT00378404|Recurrent|recurrent
1604319|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1604320|NCT00378391|upstream abciximab|upstream abciximab
1604321|NCT00378391|guideline adherence|guideline adherence
1604322|NCT00378391|hospital networking|hospital networking
1604323|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
1604324|NCT00378365|ATRA|atra
1604325|NCT00378365|Idarubicin|idarubicin
1604326|NCT00378365|Arsenic trioxide|arsenic trioxide
1604327|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
1604328|NCT00378365|Unmapped MeSH term|unmapped mesh term
1604329|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
1604330|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
1604331|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1604534|NCT00377533|caregivers|caregivers
1604332|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
1604333|NCT00378352|Infarct Size|infarct size
1604334|NCT00378339|arthrosis|arthrosis
1604335|NCT00378339|gold|gold
1604336|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
1604337|NCT00378313|NSABP|nsabp
1604338|NCT00378313|gemcitabine|gemcitabine
1604339|NCT00378313|epirubicin|epirubicin
1604340|NCT00378313|paclitaxel|paclitaxel
1604341|NCT00378313|Taxol|taxol
1604342|NCT00378313|breast cancer|breast cancer
1604343|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1604344|NCT00378313|primary chemotherapy|primary chemotherapy
1604345|NCT00378300|Atopic Dermatitis|atopic dermatitis
1604346|NCT00378300|Probiotics|probiotics
1604347|NCT00378300|T Regulatory Cells|t regulatory cells
1604348|NCT00378287|Acid Reflux|acid reflux
1604349|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
1604350|NCT00378287|GERD|gerd
1604351|NCT00378274|Neuropathic pain|neuropathic pain
1604352|NCT00378274|Chronic pain|chronic pain
1604353|NCT00378274|Depression|depression
1604354|NCT00378274|Anxiety|anxiety
1604355|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
1604356|NCT00378248|Personality disorders,|personality disorders,
1604357|NCT00378248|Day treatment,|day treatment,
1604358|NCT00378248|Group psychotherapy,|group psychotherapy,
1604359|NCT00378248|Combined psychotherapy,|combined psychotherapy,
1604360|NCT00378248|Outcome,|outcome,
1604361|NCT00378248|Attachment pattern|attachment pattern
1604362|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
1604363|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
1604364|NCT00378235|CNS interstitial infusion|cns interstitial infusion
1604365|NCT00378235|recombinant toxins|recombinant toxins
1604366|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
1604367|NCT00378235|catheter,|catheter,
1604368|NCT00378235|intratumoral therapy|intratumoral therapy
1604369|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
1604370|NCT00378222|Myeloma previously untreated|myeloma previously untreated
1604371|NCT00378222|Single autologous transplantation|single autologous transplantation
1604582|NCT00377351|Elderly Population|elderly population
1604372|NCT00378222|Double autologous transplantation|double autologous transplantation
1604373|NCT00378222|Complete response|complete response
1604374|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
1604375|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
1604376|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
1604377|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
1604378|NCT00378183|weight loss|weight loss
1604379|NCT00378183|behavioral therapy|behavioral therapy
1604380|NCT00378183|risperidone|risperidone
1604381|NCT00378183|switching antipsychotics|switching antipsychotics
1604382|NCT00378183|schizoaffective disorder|schizoaffective disorder
1604383|NCT00378183|Risperdal|risperdal
1604384|NCT00378183|schizophrenia|schizophrenia
1604385|NCT00378183|olanzapine|olanzapine
1604386|NCT00378183|Zyprexa|zyprexa
1604387|NCT00378170|intubation|intubation
1604388|NCT00378170|difficulty|difficulty
1604389|NCT00378170|Macintosh|macintosh
1604390|NCT00378170|dental damage|dental damage
1604391|NCT00378170|complications|complications
1604392|NCT00378157|autism|autism
1604393|NCT00378157|joint attention|joint attention
1604394|NCT00378157|intervention|intervention
1604395|NCT00378157|joint engagement|joint engagement
1604396|NCT00378157|language|language
1604397|NCT00378118|HIV-1|hiv-1
1604398|NCT00378118|HIV-2|hiv-2
1604399|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1604400|NCT00378092|Schizophrenia|schizophrenia
1604401|NCT00378092|Risperidone|risperidone
1604402|NCT00378092|Risperdal consta|risperdal consta
1604403|NCT00378053|Radiation|radiation
1604404|NCT00378053|Exposure|exposure
1604405|NCT00378053|Hand|hand
1604406|NCT00378053|Orthopaedic|orthopaedic
1604407|NCT00378053|Surgeons|surgeons
1604408|NCT00378027|Pulmonary Embolism|pulmonary embolism
1604409|NCT00378027|PE|pe
1604410|NCT00378027|Outpatient|outpatient
1604411|NCT00378027|Anticoagulation|anticoagulation
1604412|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
1604413|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
1604414|NCT00377988|Contraception|contraception
1604415|NCT00377988|Hormonal contraception|hormonal contraception
1604416|NCT00377988|Oral contraception|oral contraception
1604417|NCT00377988|Ethinyl estradiol|ethinyl estradiol
1604418|NCT00377988|Progestin|progestin
1604419|NCT00377988|Transdermal|transdermal
1604420|NCT00377988|Thrombosis|thrombosis
1604421|NCT00377988|Venous thromboembolism|venous thromboembolism
1604422|NCT00377975|UCP-1|ucp-1
1604423|NCT00377975|ephedrine|ephedrine
1604424|NCT00377975|caffeine|caffeine
1604425|NCT00377975|pioglitazone|pioglitazone
1604426|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
1604427|NCT00377962|everolimus|everolimus
1604428|NCT00377962|immunosuppressants|immunosuppressants
1604429|NCT00377949|Systemic Sclerosis|systemic sclerosis
1604430|NCT00377949|Scleroderma|scleroderma
1604431|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
1604434|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
1604435|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
1604436|NCT00377949|Six minute walk tests|six minute walk tests
1604437|NCT00377949|6 minute walk tests|6 minute walk tests
1604438|NCT00377949|Right heart catheterization|right heart catheterization
1604439|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1604440|NCT00377936|Locally advanced|locally advanced
1604441|NCT00377936|Metastatic|metastatic
1604442|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
1604443|NCT00377923|Progesterone|progesterone
1604444|NCT00377923|healthy volunteers|healthy volunteers
1604445|NCT00377923|Endometrial decidualisation|endometrial decidualisation
1604446|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
1604447|NCT00377910|Polidocanol|polidocanol
1604448|NCT00377910|Ultrasound|ultrasound
1604449|NCT00377910|Efficacy|efficacy
1604450|NCT00377910|RCT|rct
1604451|NCT00377897|critical leg ischemia|critical leg ischemia
1604452|NCT00377897|PAD|pad
1604453|NCT00377897|cell therapy|cell therapy
1604454|NCT00377884|THA|tha
1604455|NCT00377871|Stentless|stentless
1604456|NCT00377871|Biological|biological
1604457|NCT00377871|aortic|aortic
1604458|NCT00377871|heart|heart
1604459|NCT00377871|valve|valve
1604460|NCT00377871|prosthesis|prosthesis
1604461|NCT00377871|artificial|artificial
1604467|NCT00377845|cervical dysplasia|cervical dysplasia
1604468|NCT00377832|Fetal tachycardia|fetal tachycardia
1604469|NCT00377832|Fever in labor|fever in labor
1604470|NCT00377832|Acetaminophen|acetaminophen
1604471|NCT00377832|Non reassuring fetal status|non reassuring fetal status
1604472|NCT00377819|RANKL|rankl
1604473|NCT00377819|RANK|rank
1604474|NCT00377819|denosumab|denosumab
1604475|NCT00377819|AMG 162|amg 162
1604476|NCT00377819|osteoporosis|osteoporosis
1604477|NCT00377819|bone turnover|bone turnover
1604478|NCT00377819|bone mineral density|bone mineral density
1604479|NCT00377819|clinical trial|clinical trial
1604480|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
1604482|NCT00377819|total hip bone mineral density|total hip bone mineral density
1604483|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
1604484|NCT00377780|Breast cancer|breast cancer
1604485|NCT00377780|metastatic|metastatic
1604486|NCT00377780|cardiotoxicity|cardiotoxicity
1604487|NCT00377780|liposomal|liposomal
1604488|NCT00377780|doxorubicin|doxorubicin
1604489|NCT00377780|trastuzumab|trastuzumab
1604490|NCT00377780|docetaxel|docetaxel
1604491|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
1604492|NCT00377767|Chronic Care Model|chronic care model
1604493|NCT00377767|Obesity|obesity
1604494|NCT00377767|Overweight|overweight
1604495|NCT00377767|Children|children
1604496|NCT00377767|Body Mass Index|body mass index
1604497|NCT00377767|Primary Care|primary care
1604498|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
1604499|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
1604500|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
1604501|NCT00377702|Coronary Heart Disease|coronary heart disease
1604502|NCT00377702|Risk Factors|risk factors
1604503|NCT00377702|Heart Failure|heart failure
1604504|NCT00377689|Accidental falls|accidental falls
1604505|NCT00377689|Cerebrovascular accident|cerebrovascular accident
1604506|NCT00377689|Balance|balance
1604507|NCT00377689|ADL|adl
1604508|NCT00377689|Self efficacy|self efficacy
1604509|NCT00377689|Quality of Life|quality of life
1604510|NCT00377689|Gait parameters|gait parameters
1604511|NCT00377676|diabetes|diabetes
1604512|NCT00377676|diabetes mellitus|diabetes mellitus
1604513|NCT00377611|Influenza vaccine|influenza vaccine
1604514|NCT00377598|Herpes Zoster|herpes zoster
1604515|NCT00377598|Neuralgia|neuralgia
1604516|NCT00377598|Drug Therapy|drug therapy
1604517|NCT00377585|Elderly|elderly
1604518|NCT00377585|Improved vaccine|improved vaccine
1604519|NCT00377585|Influenza|influenza
1604520|NCT00377585|Influenza disease|influenza disease
1604521|NCT00377572|Immunoglobulins|immunoglobulins
1604522|NCT00377572|Immunoglobulin E|immunoglobulin e
1604523|NCT00377572|omalizumab|omalizumab
1604524|NCT00377572|anti-IgE|anti-ige
1604525|NCT00377559|Breast cancer|breast cancer
1604526|NCT00377559|metastatic|metastatic
1604527|NCT00377559|cardiotoxicity|cardiotoxicity
1604528|NCT00377559|liposomal|liposomal
1604529|NCT00377559|doxorubicin|doxorubicin
1604530|NCT00377559|docetaxel|docetaxel
1604531|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
1604532|NCT00377546|Retinal Surgery|retinal surgery
1604533|NCT00377533|wheelchairs|wheelchairs
1604535|NCT00377533|skills|skills
1604536|NCT00377507|catechin|catechin
1604537|NCT00377507|elderly|elderly
1604538|NCT00377507|mouth washing|mouth washing
1604539|NCT00377507|disabled|disabled
1604540|NCT00377507|colonized|colonized
1604541|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
1604542|NCT00377468|THC|thc
1604543|NCT00377468|CRPS|crps
1604544|NCT00377468|Pain|pain
1604545|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
1604546|NCT00377468|Neuropathic Pain|neuropathic pain
1604547|NCT00377468|Chronic|chronic
1604548|NCT00377468|Prevention|prevention
1604549|NCT00377455|scleroderma|scleroderma
1604550|NCT00377455|systemic sclerosis|systemic sclerosis
1604551|NCT00377455|bosentan|bosentan
1604552|NCT00377455|pulmonary hypertension|pulmonary hypertension
1604553|NCT00377455|PHAROS|pharos
1604554|NCT00377455|PHROS|phros
1604555|NCT00377455|exercise echocardiogram|exercise echocardiogram
1604556|NCT00377429|Epithelial Cancer|epithelial cancer
1604557|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
1604558|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
1604559|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
1604560|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
1604561|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
1604562|NCT00377429|Ovarian Cancer|ovarian cancer
1604563|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
1604564|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
1604565|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
1604566|NCT00377429|Peritoneal Cancer|peritoneal cancer
1604567|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
1604568|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
1604569|NCT00377416|Gene Transfer Techniques|gene transfer techniques
1604570|NCT00377416|Gene Therapy|gene therapy
1604571|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
1604572|NCT00377390|Immunoglobulin|immunoglobulin
1604573|NCT00377390|IgE|ige
1604574|NCT00377390|Omalizumab|omalizumab
1604575|NCT00377377|GH release|gh release
1604576|NCT00377377|Pharmacokinetics|pharmacokinetics
1604577|NCT00377377|Safety|safety
1604578|NCT00377364|Acetaminophen|acetaminophen
1604579|NCT00377364|corticosteroids|corticosteroids
1604583|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
1604584|NCT00377351|Exposure|exposure
1604585|NCT00377351|Lifestyle|lifestyle
1604586|NCT00377338|Bronchoscopy|bronchoscopy
1604587|NCT00377338|Diagnostic imaging|diagnostic imaging
1604588|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
1604589|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
1604590|NCT00377338|Healthy volunteers|healthy volunteers
1604591|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
1604592|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
1604593|NCT00377312|Endocrine System Diseases|endocrine system diseases
1604594|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
1604595|NCT00377312|Hormone|hormone
1604596|NCT00377312|Physiologic Properties|physiologic properties
1604597|NCT00377299|Amphetamine Abuse|amphetamine abuse
1604598|NCT00377299|Amphetamine Dependence|amphetamine dependence
1604599|NCT00377299|Bipolar Disorder|bipolar disorder
1604600|NCT00377299|Major Depressive Disorder|major depressive disorder
1604601|NCT00377299|Citicoline|citicoline
1604602|NCT00377286|Osteoarthritis|osteoarthritis
1604603|NCT00377286|Knee Pain|knee pain
1604604|NCT00377286|Glucosamine|glucosamine
1604605|NCT00377286|MRI|mri
1604606|NCT00377286|CTX-II|ctx-ii
1604607|NCT00377286|Biomarkers|biomarkers
1604608|NCT00377286|Skin quality|skin quality
1604609|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
1604610|NCT00377247|Carcinoma|carcinoma
1604611|NCT00377247|Head|head
1604612|NCT00377247|Neck|neck
1604613|NCT00377247|Oral Cavity|oral cavity
1604614|NCT00377247|Oropharynx|oropharynx
1604615|NCT00377247|Mouth|mouth
1604616|NCT00377208|Blood Pressure, High|blood pressure, high
1604617|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
1604618|NCT00377195|Involved field radiotherapy|involved field radiotherapy
1604619|NCT00377195|H. pylori|h. pylori
1604620|NCT00377169|Treatment Experienced|treatment experienced
1604621|NCT00377156|cognitive/functional effects|cognitive/functional effects
1604622|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
1604623|NCT00377156|stage IV breast cancer|stage iv breast cancer
1604624|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
1604625|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1604626|NCT00377156|male breast cancer|male breast cancer
1604627|NCT00377156|recurrent breast cancer|recurrent breast cancer
1604628|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
1604629|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1604630|NCT00377143|warfarin|warfarin
1604631|NCT00377143|pharmacogenomic|pharmacogenomic
1604632|NCT00377143|CYP2C9|cyp2c9
1604633|NCT00377143|VKORC1|vkorc1
1604634|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
1604635|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1604636|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1604637|NCT00377091|pulmonary embolism|pulmonary embolism
1604638|NCT00377091|venous thromboembolism|venous thromboembolism
1604639|NCT00377091|pharmacoeconomic|pharmacoeconomic
1604641|NCT00377091|unfractionated heparin|unfractionated heparin
1604642|NCT00377091|fondaparinux|fondaparinux
1604643|NCT00377091|length of stay|length of stay
1604644|NCT00377091|costs|costs
1604645|NCT00377091|bleeding|bleeding
1604646|NCT00377091|thrombosis|thrombosis
1604647|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
1604648|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1604649|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
1604650|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
1604651|NCT00377026|weight loss|weight loss
1604652|NCT00377026|postpartum|postpartum
1604653|NCT00377026|weight retention|weight retention
1604654|NCT00376987|renal cell carcinoma|renal cell carcinoma
1604655|NCT00376987|bladder cancer|bladder cancer
1604656|NCT00376987|cervical cancer|cervical cancer
1604657|NCT00376987|esophageal cancer|esophageal cancer
1604658|NCT00376987|gastric cancer|gastric cancer
1604659|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
1604660|NCT00376987|pancreatic cancer|pancreatic cancer
1604661|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
1605342|NCT00375245|GIST|gist
1604662|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
1604663|NCT00376987|laryngeal cancer|laryngeal cancer
1604664|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
1604665|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
1604666|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1604667|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
1604668|NCT00376987|small cell lung cancer|small cell lung cancer
1604669|NCT00376987|adult primary liver cancer|adult primary liver cancer
1604670|NCT00376987|tongue cancer|tongue cancer
1604671|NCT00376987|tobacco use disorder|tobacco use disorder
1604672|NCT00376974|glaucoma|glaucoma
1604673|NCT00376974|compliance|compliance
1604674|NCT00376974|intraocular pressure|intraocular pressure
1604675|NCT00376974|video|video
1604676|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1604677|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1604678|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1604679|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1604680|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1604681|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
1604682|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
1604683|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
1604684|NCT00376935|Treatment Experienced|treatment experienced
1604685|NCT00376922|pain|pain
1604686|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1604687|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1604688|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
1604689|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1604690|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1604691|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1604692|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1604693|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1604694|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1604695|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1604696|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1604697|NCT00376922|primary myelofibrosis|primary myelofibrosis
1604698|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1604699|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1604700|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1604701|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1604702|NCT00376922|essential thrombocythemia|essential thrombocythemia
1604703|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
1604704|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1604705|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1604706|NCT00376922|polycythemia vera|polycythemia vera
1604707|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1604708|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
1604709|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1604710|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
1604711|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1604712|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1604713|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1604714|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1604715|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
1604716|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1604717|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1604718|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1604719|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1604720|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1604721|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1604722|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1604723|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1604724|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1604725|NCT00376922|mast cell leukemia|mast cell leukemia
1604726|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1604727|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1604728|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1604729|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1604730|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1604731|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
1604732|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1604733|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1604734|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
1604735|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1604736|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1604737|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1604738|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1604739|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1604740|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1604741|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1604742|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1604743|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1604881|NCT00376779|Double-blind|double-blind
1604744|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1604745|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1604746|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1604747|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1604748|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1604749|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1604750|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1604751|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1604752|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1604753|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1604754|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
1604755|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1604756|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1604757|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1604758|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1604759|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1604760|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1604761|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1604762|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1604763|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1604764|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1604765|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1604766|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1604767|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1604768|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1604769|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1604770|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1604771|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1604772|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1604773|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1604774|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1604838|NCT00376909|cervical cancer|cervical cancer
1604775|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1604776|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1604777|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1604778|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1604779|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1604780|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1604781|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1604782|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1604783|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1604784|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1604785|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1604786|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1604787|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1604788|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1604789|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1604790|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1604791|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1604867|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
1604792|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1604793|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1604794|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1604795|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1604796|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1604797|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1604798|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1604799|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1604800|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1604882|NCT00376779|Finland|finland
1604801|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1604802|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1604803|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1604804|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1604805|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1604806|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1604807|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1604808|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1604809|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1604810|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1604811|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1604812|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1604813|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1604814|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1604815|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1604816|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1604817|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1604818|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1604819|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1604820|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1604821|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1604822|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1604823|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1604824|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1604825|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1604826|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1604827|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1604828|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1604829|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1604830|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1604831|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1604832|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
1604833|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
1604834|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
1604835|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1604836|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1604837|NCT00376909|breast cancer|breast cancer
1604839|NCT00376909|colon cancer|colon cancer
1604840|NCT00376909|rectal cancer|rectal cancer
1604841|NCT00376896|IBS fMRI|ibs fmri
1604842|NCT00376883|multiple myeloma|multiple myeloma
1604843|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
1604844|NCT00376883|dose comparison|dose comparison
1604845|NCT00376883|quality of life|quality of life
1604846|NCT00376883|skeletal event|skeletal event
1604847|NCT00376883|response|response
1604848|NCT00376883|survival|survival
1604850|NCT00376870|STENT|stent
1604851|NCT00376870|Coronary|coronary
1604852|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1604853|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
1604854|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
1604855|NCT00376831|colonoscopy|colonoscopy
1604856|NCT00376831|conscious sedation|conscious sedation
1604857|NCT00376831|midazolam|midazolam
1604858|NCT00376831|ketamine|ketamine
1604859|NCT00376831|fentanyl|fentanyl
1604860|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1604861|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1604862|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
1604863|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1604864|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
1604865|NCT00376818|adult gliosarcoma|adult gliosarcoma
1604866|NCT00376818|adult medulloblastoma|adult medulloblastoma
1604868|NCT00376818|adult papillary meningioma|adult papillary meningioma
1604869|NCT00376818|adult mixed glioma|adult mixed glioma
1604870|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
1604871|NCT00376818|adult glioblastoma|adult glioblastoma
1604872|NCT00376818|adult grade III meningioma|adult grade iii meningioma
1604873|NCT00376805|stage IV breast cancer|stage iv breast cancer
1604874|NCT00376805|male breast cancer|male breast cancer
1604875|NCT00376805|recurrent breast cancer|recurrent breast cancer
1604876|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
1604877|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
1604878|NCT00376792|stage III prostate cancer|stage iii prostate cancer
1604879|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1604880|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
1604885|NCT00376779|GSK Biologicals|gsk biologicals
1604886|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
1604887|NCT00376766|Cluster seizure|cluster seizure
1604888|NCT00376766|seizure clustering|seizure clustering
1604889|NCT00376766|repetitive seizure|repetitive seizure
1604890|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
1604891|NCT00376766|Levetiracetam|levetiracetam
1604892|NCT00376766|keppra|keppra
1604893|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1604894|NCT00376753|Writer's Cramp|writer's cramp
1604895|NCT00376753|Electromyogram|electromyogram
1604896|NCT00376753|Focal Hand Dystonia|focal hand dystonia
1604897|NCT00376753|FHD|fhd
1604898|NCT00376753|Healthy Volunteer|healthy volunteer
1604899|NCT00376753|HV|hv
1604900|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
1604901|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1604902|NCT00376714|plethysmography|plethysmography
1604903|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
1604904|NCT00376714|COPD|copd
1604905|NCT00376714|repeat dosing|repeat dosing
1604906|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
1604907|NCT00376701|Photodynamic Therapy|photodynamic therapy
1604908|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
1604909|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
1604910|NCT00376701|Avastin|avastin
1604911|NCT00376701|Visudyne|visudyne
1604912|NCT00376675|fatigue|fatigue
1604913|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1604914|NCT00376662|HRT|hrt
1604915|NCT00376662|Etidronate|etidronate
1604916|NCT00376662|Fractures|fractures
1604917|NCT00376662|Osteoporosis|osteoporosis
1604918|NCT00376662|Asthma|asthma
1604919|NCT00376662|Glucocorticoids|glucocorticoids
1604920|NCT00376649|crohns|crohns
1604921|NCT00376649|quality of life|quality of life
1604922|NCT00376649|lifestyle changing|lifestyle changing
1604923|NCT00376649|remmision|remmision
1604924|NCT00376597|lymphedema|lymphedema
1604925|NCT00376597|stage IA breast cancer|stage ia breast cancer
1604926|NCT00376597|stage IB breast cancer|stage ib breast cancer
1604927|NCT00376597|stage II breast cancer|stage ii breast cancer
1604928|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
1604929|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
1604930|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
1604931|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
1604932|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
1604933|NCT00376571|PCI|pci
1604934|NCT00376571|Bifurcation lesion|bifurcation lesion
1604935|NCT00376558|cocaine dependence|cocaine dependence
1604936|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1604937|NCT00376545|Visuomotor|visuomotor
1604938|NCT00376545|Occipital Cortex|occipital cortex
1604939|NCT00376545|Prefrontal Cortex|prefrontal cortex
1604940|NCT00376545|Healthy Volunteer|healthy volunteer
1604941|NCT00376545|HV|hv
1604942|NCT00376532|Cardiac Ischemia|cardiac ischemia
1604943|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
1604944|NCT00376532|Defibrillator|defibrillator
1604945|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
1604946|NCT00376532|Genetic Polymorphism|genetic polymorphism
1604947|NCT00376519|graft versus host disease|graft versus host disease
1604948|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1604949|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1604950|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1604951|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
1604952|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
1604953|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
1604954|NCT00376519|refractory anemia|refractory anemia
1604955|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
1604956|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1604957|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1605043|NCT00376298|incontinence|incontinence
1604958|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1604959|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1604960|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1604961|NCT00376519|follicular lymphoma|follicular lymphoma
1604962|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
1604963|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1604964|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
1604965|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1604966|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1604967|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1604968|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
1604969|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
1604970|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1604971|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
1605061|NCT00376207|HOMA|homa
1604972|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
1604973|NCT00376519|multiple myeloma|multiple myeloma
1604974|NCT00376506|Aspiration|aspiration
1604975|NCT00376506|Rehabilitation|rehabilitation
1604976|NCT00376506|Swallowing Disorders|swallowing disorders
1604977|NCT00376506|Stroke|stroke
1604978|NCT00376506|Parkinson's Disease|parkinson's disease
1604979|NCT00376506|Dysphagia|dysphagia
1604980|NCT00376506|Parkinson Disease|parkinson disease
1604981|NCT00376506|PD|pd
1604982|NCT00376493|Abortion|abortion
1604983|NCT00376493|Infection|infection
1604984|NCT00376493|Antibiotics|antibiotics
1604985|NCT00376493|Treatment|treatment
1604986|NCT00376493|Pregnancy complications|pregnancy complications
1604987|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1604988|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1604989|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
1604990|NCT00376480|refractory anemia|refractory anemia
1604991|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1604992|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1604993|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1604994|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1604995|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1604996|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1604997|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1604998|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1604999|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1605000|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1605001|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1605002|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1605003|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1605004|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1605005|NCT00376467|Philadelphia positive|philadelphia positive
1605006|NCT00376467|Adult|adult
1605007|NCT00376467|Elderly|elderly
1605008|NCT00376467|Imatinib|imatinib
1605009|NCT00376454|neuropathic pain|neuropathic pain
1605010|NCT00376441|vaginal|vaginal
1605011|NCT00376441|incontinence|incontinence
1605012|NCT00376441|sexual function|sexual function
1605213|NCT00375713|Xyzal|xyzal
1605013|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
1605014|NCT00376428|Premature termination codon|premature termination codon
1605015|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
1605016|NCT00376415|Lessertia frutescens|lessertia frutescens
1605017|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
1605018|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
1605019|NCT00376415|Human safety study|human safety study
1605020|NCT00376402|Pandemic|pandemic
1605021|NCT00376402|Influenza|influenza
1605022|NCT00376402|Prevention|prevention
1605023|NCT00376402|Vaccine|vaccine
1605024|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
1605025|NCT00376376|levofloxacin|levofloxacin
1605026|NCT00376376|pharmacodynamic|pharmacodynamic
1605027|NCT00376376|bactericidal|bactericidal
1605028|NCT00376363|glaucoma|glaucoma
1605029|NCT00376363|Ahmed implant|ahmed implant
1605030|NCT00376363|Baerveldt implant|baerveldt implant
1605031|NCT00376350|Low Back Pain|low back pain
1605032|NCT00376350|Chronic|chronic
1605033|NCT00376350|Manipulation|manipulation
1605034|NCT00376350|Chiropractic|chiropractic
1605035|NCT00376350|Massage|massage
1605036|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
1605037|NCT00376337|Salvage Therapy|salvage therapy
1605038|NCT00376337|Micafungin|micafungin
1605039|NCT00376324|pharmacokinetics|pharmacokinetics
1605040|NCT00376324|human bone|human bone
1605041|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
1605042|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
1605044|NCT00376298|prostate cancer|prostate cancer
1605045|NCT00376298|interstitial cystitis|interstitial cystitis
1605046|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
1605047|NCT00376259|lamivudine resistance|lamivudine resistance
1605048|NCT00376259|Hepatitis B virus|hepatitis b virus
1605049|NCT00376233|Schizophrenia,|schizophrenia,
1605050|NCT00376233|Cannabinoids,|cannabinoids,
1605051|NCT00376233|Arachidonic Acid,|arachidonic acid,
1605052|NCT00376233|Niacin,|niacin,
1605053|NCT00376233|Prostaglandins|prostaglandins
1605054|NCT00376220|Bipolar|bipolar
1605055|NCT00376220|Depression|depression
1605056|NCT00376207|Cerebral infarct|cerebral infarct
1605057|NCT00376207|physical exercise|physical exercise
1605058|NCT00376207|insulin sensitivity|insulin sensitivity
1605059|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
1605060|NCT00376207|intervention|intervention
1605062|NCT00376207|PASE|pase
1605063|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
1605064|NCT00376194|Alternative Therapy|alternative therapy
1605065|NCT00376194|Autism|autism
1605066|NCT00376194|Asperger's Disorder|asperger's disorder
1605067|NCT00376194|Clinical Trial|clinical trial
1605068|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
1605070|NCT00376194|Asperger Disorder|asperger disorder
1605071|NCT00376181|type 2 diabetes|type 2 diabetes
1605072|NCT00376181|hypertension|hypertension
1605073|NCT00376181|blood pressure|blood pressure
1605074|NCT00376181|diastolic blood pressure|diastolic blood pressure
1605075|NCT00376155|malaria|malaria
1605076|NCT00376155|prevention|prevention
1605077|NCT00376155|intermittent|intermittent
1605078|NCT00376155|drugs|drugs
1605079|NCT00376142|Intention|intention
1605080|NCT00376142|Behaviour|behaviour
1605081|NCT00376142|Evidence-based practice|evidence-based practice
1605082|NCT00376142|Intervention|intervention
1605083|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1605084|NCT00376116|Pacemaker|pacemaker
1605085|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
1605086|NCT00376116|Heart failure|heart failure
1605087|NCT00376116|Predictor|predictor
1605088|NCT00376116|Mortality|mortality
1605089|NCT00376116|Rehospitalization|rehospitalization
1605090|NCT00376116|Telemedicine|telemedicine
1605091|NCT00376116|Home Monitoring|home monitoring
1605092|NCT00376103|Brain Tumor|brain tumor
1605093|NCT00376103|GBM|gbm
1605094|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
1605095|NCT00376103|Glioblastoma|glioblastoma
1605096|NCT00376103|Brachytherapy|brachytherapy
1605097|NCT00376103|Temozolomide|temozolomide
1605098|NCT00376103|Temodar|temodar
1605099|NCT00376090|MVA vector|mva vector
1605100|NCT00376090|Immunogenicity|immunogenicity
1605101|NCT00376090|HIV vaccine|hiv vaccine
1605102|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
1605103|NCT00376077|Thrombocytopenia|thrombocytopenia
1605104|NCT00376077|pediatric|pediatric
1605105|NCT00376077|methylprednisolone|methylprednisolone
1605106|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
1605107|NCT00376077|intravenous immune globulin|intravenous immune globulin
1605108|NCT00376064|Growth hormone (GH)|growth hormone (gh)
1605109|NCT00376064|IGF-1|igf-1
1605110|NCT00376064|Acromegaly|acromegaly
1605111|NCT00376064|Pituitary adenoma|pituitary adenoma
1605112|NCT00376064|Brain tumor|brain tumor
1605113|NCT00376064|Brain cancer|brain cancer
1605114|NCT00376064|Octreotide acetate|octreotide acetate
1605115|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
1605116|NCT00376051|frontotemporal dementia|frontotemporal dementia
1605117|NCT00376051|serotonin|serotonin
1605118|NCT00376051|dementia|dementia
1605119|NCT00376051|behavioural disturbances|behavioural disturbances
1605120|NCT00376038|GSK189074|gsk189074
1605121|NCT00376038|T2DM|t2dm
1605122|NCT00376038|GSK189075|gsk189075
1605123|NCT00376038|Glucophage|glucophage
1605124|NCT00376038|Obesity|obesity
1605125|NCT00376038|Diabetes|diabetes
1605126|NCT00376038|Metformin|metformin
1605127|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1605128|NCT00376038|Drug Interaction|drug interaction
1605129|NCT00376025|Kashin-Beck Disease|kashin-beck disease
1605130|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
1605131|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
1605132|NCT00375986|Cesarean delivery|cesarean delivery
1605133|NCT00375986|Placental removal|placental removal
1605134|NCT00375986|Blood loss|blood loss
1605135|NCT00375973|Fatigue|fatigue
1605136|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
1605137|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
1605138|NCT00375973|CFS|cfs
1605139|NCT00375973|Fibromyalgia|fibromyalgia
1605140|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
1605141|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
1605142|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
1605143|NCT00375960|Pain|pain
1605144|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
1605145|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
1605146|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
1605147|NCT00375947|exercise|exercise
1605148|NCT00375947|hand disability|hand disability
1605149|NCT00375947|arthritis|arthritis
1605150|NCT00375947|AUSCAN|auscan
1605151|NCT00375934|Bunionectomy|bunionectomy
1605152|NCT00375934|Bunion surgery|bunion surgery
1605153|NCT00375934|Post-operative pain|post-operative pain
1605154|NCT00375921|diet|diet
1605155|NCT00375921|food|food
1605156|NCT00375921|taste|taste
1605157|NCT00375921|smell|smell
1605158|NCT00375921|head and neck|head and neck
1605159|NCT00375921|radiation|radiation
1605160|NCT00375921|chemotherapy|chemotherapy
1605161|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
1605266|NCT00375492|Lilly|lilly
1605162|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
1605163|NCT00375908|Umbilical Cord Blood|umbilical cord blood
1605164|NCT00375908|Proteomics|proteomics
1605165|NCT00375895|Cyclosporin|cyclosporin
1605166|NCT00375895|Peginterferon|peginterferon
1605167|NCT00375895|Ribavirin|ribavirin
1605168|NCT00375895|Chronic hepatitis C|chronic hepatitis c
1605169|NCT00375895|Liver transplantation|liver transplantation
1605170|NCT00375869|Neuroprotection|neuroprotection
1605171|NCT00375869|neuron specific enolase|neuron specific enolase
1605172|NCT00375869|CSF glutamate levels|csf glutamate levels
1605173|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
1605174|NCT00375856|arthroplasty|arthroplasty
1605175|NCT00375856|knee|knee
1605176|NCT00375856|computer-assist|computer-assist
1605177|NCT00375856|gait|gait
1605178|NCT00375856|Total knee arthroplasty|total knee arthroplasty
1605179|NCT00375856|knee prostheses|knee prostheses
1605180|NCT00375804|Endometrial Cancer|endometrial cancer
1605181|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
1605182|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
1605183|NCT00375778|Parkinson's Disease|parkinson's disease
1605184|NCT00375778|Positron Emission Tomography|positron emission tomography
1605185|NCT00375778|Memantine|memantine
1605186|NCT00375778|NMDA antagonists|nmda antagonists
1605187|NCT00375778|Cerebral Blood Flow|cerebral blood flow
1605188|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
1605189|NCT00375765|Dutasteride|dutasteride
1605190|NCT00375765|BPH|bph
1605191|NCT00375765|Prostate cancer|prostate cancer
1605192|NCT00375765|Gene expression|gene expression
1605193|NCT00375765|PSA|psa
1605194|NCT00375752|Breast cancer|breast cancer
1605195|NCT00375752|Anti tumor potential|anti tumor potential
1605196|NCT00375752|Letrozole|letrozole
1605197|NCT00375752|Zoledronic acid|zoledronic acid
1605198|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
1605199|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
1605200|NCT00375739|Actinic Keratosis|actinic keratosis
1605201|NCT00375739|Topical|topical
1605202|NCT00375739|Solar Keratosis|solar keratosis
1605203|NCT00375739|Sun Spots|sun spots
1605204|NCT00375739|Dermatology|dermatology
1605205|NCT00375726|Dengue Fever|dengue fever
1605206|NCT00375726|Dengue Vaccine|dengue vaccine
1605207|NCT00375726|Dengue Virus|dengue virus
1605208|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1605209|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
1605210|NCT00375713|Dermatitis|dermatitis
1605211|NCT00375713|Eczema|eczema
1605212|NCT00375713|Pruritus|pruritus
1605214|NCT00375713|Zyrtec|zyrtec
1605215|NCT00375713|Levocetirizine|levocetirizine
1605216|NCT00375713|Cetirizine|cetirizine
1605217|NCT00375700|food|food
1605218|NCT00375700|diet|diet
1605219|NCT00375700|oral supplement|oral supplement
1605220|NCT00375700|head and neck cancer|head and neck cancer
1605221|NCT00375700|radiation|radiation
1605222|NCT00375687|Prostate cancer|prostate cancer
1605223|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
1605224|NCT00375648|Prostate|prostate
1605225|NCT00375648|Cancer|cancer
1605226|NCT00375648|Bone metastases|bone metastases
1605227|NCT00375648|Zoledronic acid|zoledronic acid
1605228|NCT00375648|Bone metastases-related pain|bone metastases-related pain
1605229|NCT00375648|Prostate cancer|prostate cancer
1605230|NCT00375635|mFPSA|mfpsa
1605231|NCT00375635|Uremic toxins|uremic toxins
1605232|NCT00375635|Protein bound toxins|protein bound toxins
1605233|NCT00375635|Uremia|uremia
1605234|NCT00375635|Chronic hemodialysis|chronic hemodialysis
1605235|NCT00375622|HHT|hht
1605236|NCT00375622|Epistaxis|epistaxis
1605237|NCT00375622|Tamoxifen|tamoxifen
1605238|NCT00375622|Hemoglobin|hemoglobin
1605239|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
1605240|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
1605241|NCT00375583|Diethylcarbamazine|diethylcarbamazine
1605242|NCT00375583|Microfilariae|microfilariae
1605243|NCT00375583|Helminths|helminths
1605244|NCT00375583|Nematode|nematode
1605245|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
1605246|NCT00375544|Osteoarthritis|osteoarthritis
1605247|NCT00375544|Phototherapy|phototherapy
1605248|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
1605249|NCT00375544|Light-emitting diode|light-emitting diode
1605250|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
1605251|NCT00375531|Mindfulness Meditation|mindfulness meditation
1605252|NCT00375518|Thoracic Surgery|thoracic surgery
1605253|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
1605254|NCT00375518|Atorvastatin|atorvastatin
1605255|NCT00375505|Breast Cancer|breast cancer
1605256|NCT00375505|Premenopausal|premenopausal
1605257|NCT00375505|Bone mineral density|bone mineral density
1605258|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
1605259|NCT00375505|zoledronic acid|zoledronic acid
1605260|NCT00375492|diabetes|diabetes
1605261|NCT00375492|overweight|overweight
1605262|NCT00375492|obesity|obesity
1605263|NCT00375492|weight loss|weight loss
1605264|NCT00375492|exenatide|exenatide
1605265|NCT00375492|Amylin|amylin
1605267|NCT00375466|Hemorrhage|hemorrhage
1605268|NCT00375466|Transfusion|transfusion
1605269|NCT00375466|Blood components|blood components
1605270|NCT00375466|Fibrinolysis|fibrinolysis
1605271|NCT00375466|Platelet activation|platelet activation
1605272|NCT00375453|Paclitaxel|paclitaxel
1605273|NCT00375453|Advanced Solid Tumors|advanced solid tumors
1605274|NCT00375440|Tranexamic Acid|tranexamic acid
1605275|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
1605276|NCT00375440|Reduction in Blood Loss|reduction in blood loss
1605277|NCT00375427|Breast cancer|breast cancer
1605278|NCT00375427|Zoledronic acid|zoledronic acid
1605279|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
1605280|NCT00375414|Enteral tube feeding,|enteral tube feeding,
1605281|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
1605282|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
1605283|NCT00375414|PEG|peg
1605284|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
1605285|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
1605286|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
1605287|NCT00375388|Diabetes regulation|diabetes regulation
1605288|NCT00375388|Daily dose of insulin|daily dose of insulin
1605289|NCT00375388|Body Weight|body weight
1605290|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
1605291|NCT00375388|Intensive insulin therapy|intensive insulin therapy
1605292|NCT00375388|Age: 30-80 years|age: 30-80 years
1605293|NCT00375388|Body mass index|body mass index
1605294|NCT00375388|Lipids|lipids
1605295|NCT00375388|Blood Pressure|blood pressure
1605296|NCT00375388|Endothelial function|endothelial function
1605297|NCT00375388|Low grade inflammation|low grade inflammation
1605298|NCT00375388|Fibrinolysis|fibrinolysis
1605299|NCT00375388|Microvascular complications|microvascular complications
1605300|NCT00375388|Macrovascular complications|macrovascular complications
1605301|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
1605302|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
1605303|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
1605304|NCT00375375|Health related quality of life|health related quality of life
1605305|NCT00375362|nitroglycerin|nitroglycerin
1605306|NCT00375362|morphine|morphine
1605307|NCT00375362|patient controlled analgesia|patient controlled analgesia
1605308|NCT00375362|total knee arthroplasty|total knee arthroplasty
1605309|NCT00375349|fatty liver|fatty liver
1605310|NCT00375349|statin|statin
1605311|NCT00375349|non-alcoholic|non-alcoholic
1605312|NCT00375336|Aortic valve|aortic valve
1605313|NCT00375336|Calcification|calcification
1605314|NCT00375336|Endothelial dysfunction|endothelial dysfunction
1605315|NCT00375336|Calcium metabolism|calcium metabolism
1605316|NCT00375336|Coronary artery disease|coronary artery disease
1605317|NCT00375323|factor VIII inhibitor|factor viii inhibitor
1605318|NCT00375310|Phase I|phase i
1605319|NCT00375310|Pancreas Cancer|pancreas cancer
1605320|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
1605321|NCT00375297|antidepressants|antidepressants
1605322|NCT00375297|sexual dysfunction|sexual dysfunction
1605323|NCT00375297|women|women
1605324|NCT00375297|sildenafil|sildenafil
1605325|NCT00375297|PDE5 inhibitors|pde5 inhibitors
1605326|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
1605327|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
1605328|NCT00375271|Hemodynamic Processes|hemodynamic processes
1605329|NCT00375271|Treatment Protocols|treatment protocols
1605330|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
1605331|NCT00375245|phase I|phase i
1605332|NCT00375245|metastatic|metastatic
1605333|NCT00375245|advanced cancer|advanced cancer
1605334|NCT00375245|lung cancer|lung cancer
1605335|NCT00375245|renal cancer|renal cancer
1605336|NCT00375245|kidney cancer|kidney cancer
1605337|NCT00375245|head and neck cancer|head and neck cancer
1605338|NCT00375245|bladder cancer|bladder cancer
1605339|NCT00375245|breast cancer|breast cancer
1605340|NCT00375245|colorectal cancer|colorectal cancer
1605341|NCT00375245|esophagus|esophagus
1605343|NCT00375245|liver cancer|liver cancer
1605344|NCT00375245|melanoma|melanoma
1605345|NCT00375245|mesothelioma|mesothelioma
1605346|NCT00375245|lymphoma|lymphoma
1605347|NCT00375245|ovary cancer|ovary cancer
1605348|NCT00375245|ovarian cancer|ovarian cancer
1605349|NCT00375245|pancreas cancer|pancreas cancer
1605350|NCT00375245|pancreatic cancer|pancreatic cancer
1605351|NCT00375245|prostate cancer|prostate cancer
1605352|NCT00375245|stomach cancer|stomach cancer
1605353|NCT00375245|thyroid cancer|thyroid cancer
1605354|NCT00375245|Metastatic solid tumor|metastatic solid tumor
1605355|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
1605356|NCT00375232|Asthma|asthma
1605357|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
1605358|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
1605359|NCT00375232|Induced sputum|induced sputum
1605360|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
1605362|NCT00375219|HHT|hht
1605363|NCT00375219|Homoharringtonine|homoharringtonine
1605364|NCT00375219|Omacetaxine|omacetaxine
1605365|NCT00375219|T315i|t315i
1605366|NCT00375219|ChemGenex|chemgenex
1605367|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
1605368|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
1605369|NCT00375193|small cell lung cancer|small cell lung cancer
1605370|NCT00375193|amrubicin|amrubicin
1605371|NCT00375180|food|food
1605372|NCT00375180|diet|diet
1605373|NCT00375180|mucositis|mucositis
1605374|NCT00375180|xerostomia|xerostomia
1605375|NCT00375180|dysphagia|dysphagia
1605376|NCT00375180|taste|taste
1605377|NCT00375180|smell|smell
1605378|NCT00375180|head and neck|head and neck
1605379|NCT00375180|radiation|radiation
1605380|NCT00375180|chemotherapy|chemotherapy
1605381|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
1605382|NCT00375154|Acute respiratory failure|acute respiratory failure
1605383|NCT00375154|Prehospital care|prehospital care
1605384|NCT00375154|Noninvasive ventilation|noninvasive ventilation
1605385|NCT00375154|Emergency|emergency
1605386|NCT00375128|Malaria|malaria
1605387|NCT00375128|Vaccine|vaccine
1605388|NCT00375128|Prime-boost|prime-boost
1605389|NCT00375128|Challenge|challenge
1605390|NCT00375102|acupuncture|acupuncture
1605391|NCT00375102|relaxation response|relaxation response
1605392|NCT00375102|homeless|homeless
1605393|NCT00375102|veterans|veterans
1605394|NCT00375102|randomized trials|randomized trials
1605395|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
1605396|NCT00375063|left main stenosis|left main stenosis
1605397|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
1605398|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1605399|NCT00375037|hand washing|hand washing
1605400|NCT00375037|cluster randomized trial|cluster randomized trial
1605401|NCT00375037|performance feedback|performance feedback
1605402|NCT00375037|healthcare workers|healthcare workers
1605403|NCT00375037|Hand hygiene|hand hygiene
1605404|NCT00375037|hand washing adherence|hand washing adherence
1605405|NCT00375024|Patient navigation|patient navigation
1605406|NCT00375024|Breast cancer|breast cancer
1605407|NCT00375024|Colon cancer|colon cancer
1605408|NCT00375024|Questionnaire|questionnaire
1605409|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
1605410|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
1605503|NCT00374660|Irofulven|irofulven
1605504|NCT00374660|Oxaliplatin|oxaliplatin
1605411|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
1605412|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
1605413|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
1605414|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
1605415|NCT00374998|Malaria|malaria
1605416|NCT00374998|Vaccine|vaccine
1605417|NCT00374998|Prime-boost|prime-boost
1605418|NCT00374985|chemoradiation|chemoradiation
1605419|NCT00374985|docetaxel|docetaxel
1605420|NCT00374985|oxaliplatin|oxaliplatin
1605421|NCT00374985|gastric|gastric
1605422|NCT00374985|neoadjuvant|neoadjuvant
1605423|NCT00374985|radiochemotherapy|radiochemotherapy
1605424|NCT00374959|Prevention of pneumonia|prevention of pneumonia
1605425|NCT00374959|ceftriaxone|ceftriaxone
1605426|NCT00374959|continuous aspiration|continuous aspiration
1605427|NCT00374959|subglottic secretions|subglottic secretions
1605428|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
1605429|NCT00374959|Absence of infection|absence of infection
1605430|NCT00374933|AML|aml
1605431|NCT00374933|ALL|all
1605432|NCT00374933|MDS|mds
1605433|NCT00374933|Allogeneic transplant|allogeneic transplant
1605434|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
1605435|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1605436|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
1605437|NCT00374933|Adoptive cell therapy|adoptive cell therapy
1605438|NCT00374933|Non-myeloablative|non-myeloablative
1605439|NCT00374920|bipolar|bipolar
1605440|NCT00374920|mania|mania
1605442|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
1605443|NCT00374894|Blood Lead Levels|blood lead levels
1605444|NCT00374894|children|children
1605445|NCT00374894|multi-nutrients|multi-nutrients
1605446|NCT00374842|Influenza vaccine|influenza vaccine
1605447|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
1605448|NCT00374829|randomised prospective trial|randomised prospective trial
1605449|NCT00374829|medication refill compliance|medication refill compliance
1605450|NCT00374829|hypertension|hypertension
1605451|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1605452|NCT00374829|information technology based patient support system|information technology based patient support system
1605453|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
1605454|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
1605455|NCT00374803|Kidney|kidney
1605456|NCT00374803|Transplant|transplant
1605457|NCT00374803|Corticosteroid|corticosteroid
1605458|NCT00374803|Myfortic|myfortic
1605459|NCT00374790|Lead toxicity|lead toxicity
1605460|NCT00374777|Insomnia|insomnia
1605461|NCT00374777|schizophrenia|schizophrenia
1605462|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
1605463|NCT00374777|zolpidem|zolpidem
1605464|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
1605465|NCT00374751|Samarium|samarium
1605466|NCT00374751|Kyphoplasty|kyphoplasty
1605467|NCT00374751|Pain management|pain management
1605468|NCT00374751|Bone metastases|bone metastases
1605469|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
1605470|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
1605471|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
1605472|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
1605473|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
1605474|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
1605475|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
1605476|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
1605477|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
1605478|NCT00374725|Ulcerative Colitis|ulcerative colitis
1605479|NCT00374725|Probiotic|probiotic
1605480|NCT00374725|Placebo controlled trial|placebo controlled trial
1605481|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
1605482|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
1605483|NCT00374712|Phosphate|phosphate
1605484|NCT00374712|Dialysis|dialysis
1605485|NCT00374712|Klotho|klotho
1605486|NCT00374712|Hemodialysis|hemodialysis
1605487|NCT00374699|Velcade|velcade
1605488|NCT00374699|Bortezomib|bortezomib
1605489|NCT00374699|CHOP|chop
1605490|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
1605491|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
1605492|NCT00374686|cytomegalovirus|cytomegalovirus
1605493|NCT00374686|kidney|kidney
1605494|NCT00374686|transplantation|transplantation
1605495|NCT00374686|valganciclovir|valganciclovir
1605496|NCT00374686|preemptive|preemptive
1605497|NCT00374673|TMS|tms
1605498|NCT00374673|chronic pain|chronic pain
1605499|NCT00374673|fibromyalgia|fibromyalgia
1605500|NCT00374673|IBS|ibs
1605501|NCT00374673|burning mouth syndrome|burning mouth syndrome
1605502|NCT00374673|predictive factors|predictive factors
1605505|NCT00374647|Renal|renal
1605506|NCT00374647|Kidney|kidney
1605507|NCT00374647|Transplant|transplant
1605508|NCT00374608|pediatric|pediatric
1605509|NCT00374608|congenital complete heart block|congenital complete heart block
1605510|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
1605511|NCT00374595|Kidney Transplant|kidney transplant
1605512|NCT00374595|Vascular Risk|vascular risk
1605513|NCT00374595|inflammation|inflammation
1605514|NCT00374595|Diabetes|diabetes
1605515|NCT00374595|Insulin resistance|insulin resistance
1605516|NCT00374595|Chronic kidney disease|chronic kidney disease
1605517|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
1605518|NCT00374582|BIA|bia
1605519|NCT00374582|ESLD|esld
1605520|NCT00374582|LVP|lvp
1605521|NCT00374582|Large volume paracentesis|large volume paracentesis
1605522|NCT00374582|Ascites|ascites
1605523|NCT00374582|Liver|liver
1605524|NCT00374582|Hepatic|hepatic
1605525|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
1605526|NCT00374556|eszopiclone|eszopiclone
1605527|NCT00374556|insomnia|insomnia
1605528|NCT00374543|Bipolar Disorder|bipolar disorder
1605529|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
1605530|NCT00374543|Double-blind|double-blind
1605531|NCT00374543|Placebo-controlled|placebo-controlled
1605532|NCT00374543|Ziprasidone|ziprasidone
1605533|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
1605534|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
1605535|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
1605536|NCT00374517|Hypoxyprobe|hypoxyprobe
1606297|NCT00371865|Meditation|meditation
1605537|NCT00374517|mRNA Expression|mrna expression
1605538|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
1605539|NCT00374491|ACL|acl
1605540|NCT00374491|Bone Screw|bone screw
1605541|NCT00374491|Knee|knee
1605542|NCT00374478|Scopolamine|scopolamine
1605543|NCT00374478|Antiemetic|antiemetic
1605544|NCT00374478|Task performance and analysis|task performance and analysis
1605545|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
1605546|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
1605547|NCT00374465|Heart Failure|heart failure
1605548|NCT00374452|hypertension|hypertension
1605549|NCT00374452|practice guidelines|practice guidelines
1605550|NCT00374452|quality of health care|quality of health care
1605551|NCT00374452|decision support systems|decision support systems
1605552|NCT00374452|evidence-based medicine|evidence-based medicine
1605553|NCT00374452|medical informatics|medical informatics
1605554|NCT00374439|depression|depression
1605555|NCT00374439|adolescents|adolescents
1605556|NCT00374439|prevention|prevention
1605557|NCT00374439|schools|schools
1605558|NCT00374426|depression|depression
1605559|NCT00374426|diabetes mellitus|diabetes mellitus
1605560|NCT00374426|depression recurrence|depression recurrence
1605561|NCT00374413|DDD|ddd
1605562|NCT00374413|artificial disc|artificial disc
1605563|NCT00374400|Kidney|kidney
1605564|NCT00374400|Transplant|transplant
1605565|NCT00374400|Paired donation|paired donation
1605566|NCT00374400|Living donor|living donor
1605567|NCT00374387|Healthy women|healthy women
1605568|NCT00374374|probiotic|probiotic
1605569|NCT00374361|insulin sensitivity|insulin sensitivity
1605570|NCT00374361|endothelial function|endothelial function
1605571|NCT00374361|adolescence|adolescence
1605572|NCT00374361|lipids|lipids
1605573|NCT00374361|puberty|puberty
1605574|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
1605575|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
1605576|NCT00374335|prospective cohort study|prospective cohort study
1605577|NCT00374322|Breast Cancer|breast cancer
1605578|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
1605579|NCT00374322|early-stage breast cancer|early-stage breast cancer
1605580|NCT00374322|adjuvant|adjuvant
1605581|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
1605582|NCT00374309|Healthy|healthy
1605583|NCT00374309|Immunity|immunity
1605584|NCT00374309|T -Cells|t -cells
1605585|NCT00374309|Filovirus|filovirus
1605586|NCT00374309|Healthy Volunteer|healthy volunteer
1605587|NCT00374309|HV|hv
1605588|NCT00374296|Leukemia|leukemia
1605589|NCT00374296|MDS|mds
1605590|NCT00374296|Phase II|phase ii
1605591|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1605592|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
1605593|NCT00374283|Monitoring|monitoring
1605594|NCT00374283|Polyomavirus|polyomavirus
1605595|NCT00374283|Kidney|kidney
1605596|NCT00374283|Pancreas|pancreas
1605597|NCT00374283|Transplant|transplant
1605598|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
1605599|NCT00374257|NB-UVB|nb-uvb
1605600|NCT00374257|cGVHD|cgvhd
1605601|NCT00374244|schizophrenia|schizophrenia
1605602|NCT00374244|pimozide|pimozide
1605603|NCT00374244|clozapine|clozapine
1605604|NCT00374231|Liver|liver
1605605|NCT00374231|Transplant|transplant
1605606|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
1605607|NCT00374231|Tacrolimus|tacrolimus
1605608|NCT00374231|CellCept|cellcept
1605609|NCT00374231|MMF|mmf
1605610|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
1605611|NCT00374218|Carbohydrate|carbohydrate
1605612|NCT00374218|Glycemic index|glycemic index
1605613|NCT00374218|Randomized|randomized
1605614|NCT00374218|Double-blind|double-blind
1605615|NCT00374218|Glucose|glucose
1605616|NCT00374218|Insulin|insulin
1605617|NCT00374218|C-reactive protein|c-reactive protein
1605618|NCT00374205|Ghana|ghana
1605619|NCT00374205|Effectiveness|effectiveness
1605620|NCT00374205|Safety|safety
1605621|NCT00374205|Drug-Resistance|drug-resistance
1605622|NCT00374205|ACT|act
1605623|NCT00374205|Coartem|coartem
1605624|NCT00374205|Arsucam|arsucam
1605625|NCT00374192|Menopause|menopause
1605626|NCT00374192|Insomnia|insomnia
1605627|NCT00374192|Depression|depression
1605628|NCT00374192|Anxiety|anxiety
1605629|NCT00374192|Sleep|sleep
1605630|NCT00374192|Lunesta|lunesta
1605631|NCT00374192|Quality of Life|quality of life
1605632|NCT00374166|Anti-anxiety agents|anti-anxiety agents
1605633|NCT00374166|antidepressive agents|antidepressive agents
1605634|NCT00374166|controlled clinical trial|controlled clinical trial
1605635|NCT00374153|Alcohol|alcohol
1605636|NCT00374153|Drinking|drinking
1605637|NCT00374153|College|college
1605638|NCT00374153|Motivational|motivational
1605639|NCT00374153|Feedback|feedback
1605640|NCT00374153|Assessment|assessment
1605641|NCT00374140|small cell|small cell
1605642|NCT00374140|lung|lung
1605643|NCT00374127|Marijuana|marijuana
1605644|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
1605645|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
1605646|NCT00374114|cervical|cervical
1605647|NCT00374114|dysplasia|dysplasia
1605648|NCT00374101|PPIs,|ppis,
1605649|NCT00374101|endoscopic therapy,|endoscopic therapy,
1605650|NCT00374101|peptic ulcers,|peptic ulcers,
1605651|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
1605652|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
1605653|NCT00374088|N-acetylcysteine|n-acetylcysteine
1605654|NCT00374088|Myocardial dysfunction|myocardial dysfunction
1605655|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
1605656|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
1605657|NCT00374075|Valproic Acid|valproic acid
1605658|NCT00374062|Mohs Surgery|mohs surgery
1605659|NCT00374049|Prostate|prostate
1605660|NCT00374049|vaccine|vaccine
1605661|NCT00374049|immunosuppression|immunosuppression
1605662|NCT00374049|dendritic cells|dendritic cells
1606518|NCT00370890|EBV DNA|ebv dna
1605663|NCT00374036|chemotherapy|chemotherapy
1605664|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
1605665|NCT00374036|Capecitabine|capecitabine
1605666|NCT00374036|Irinotecan|irinotecan
1605667|NCT00374023|Zinc|zinc
1605668|NCT00374023|vitamin A|vitamin a
1605669|NCT00374023|immunity|immunity
1605670|NCT00374023|morbidity|morbidity
1605671|NCT00374023|height gain|height gain
1605672|NCT00374023|weight gain|weight gain
1605673|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
1605674|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
1605675|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
1605676|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
1605677|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
1605678|NCT00374010|end-of-life decision making|end-of-life decision making
1605679|NCT00374010|advance care planning|advance care planning
1605680|NCT00373984|shoulder|shoulder
1605681|NCT00373984|thoracotomy|thoracotomy
1605682|NCT00373971|Activities of daily living|activities of daily living
1605683|NCT00373971|Elderly|elderly
1605684|NCT00373971|Nutrition|nutrition
1605685|NCT00373971|Postoperative|postoperative
1605686|NCT00373971|Hip fractures|hip fractures
1605687|NCT00373971|Hip replacement|hip replacement
1605688|NCT00373971|Knee replacement|knee replacement
1605689|NCT00373945|HLA-B*5701|hla-b*5701
1605690|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
1605691|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
1605692|NCT00373945|retrospective analysis|retrospective analysis
1605693|NCT00373932|Exercise|exercise
1605694|NCT00373932|Physical Activity|physical activity
1605695|NCT00373932|Adherence|adherence
1605696|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
1605697|NCT00373893|Pain|pain
1605698|NCT00373893|Hyperalgesia|hyperalgesia
1605699|NCT00373893|capsaicin|capsaicin
1605700|NCT00373880|Aripiprazole|aripiprazole
1605701|NCT00373880|Cocaine abuse|cocaine abuse
1605702|NCT00373867|Secondary prevention|secondary prevention
1605703|NCT00373867|Physical therapy|physical therapy
1605704|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
1605705|NCT00373867|Disability|disability
1605706|NCT00373854|Hypoglycemia|hypoglycemia
1605707|NCT00373854|Endothelial function|endothelial function
1605708|NCT00373841|Lung|lung
1605709|NCT00373841|Fibrosis|fibrosis
1605710|NCT00373841|Idiopathic|idiopathic
1605711|NCT00373841|Biomarkers|biomarkers
1605712|NCT00373841|Genomics|genomics
1605713|NCT00373841|Longitudinal|longitudinal
1605714|NCT00373828|Chest Pain|chest pain
1605715|NCT00373828|Chest Wall|chest wall
1605716|NCT00373828|Angina Pectoris|angina pectoris
1605717|NCT00373828|Atypical Chest Pain|atypical chest pain
1605718|NCT00373828|Physical Examination|physical examination
1605719|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
1605720|NCT00373828|Observational Study|observational study
1605721|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
1605722|NCT00373828|Ischemic Heart Disease|ischemic heart disease
1605723|NCT00373815|acute GVHD|acute gvhd
1605724|NCT00373815|Immunosuppression|immunosuppression
1605725|NCT00373789|Botulinum Toxin A|botulinum toxin a
1605726|NCT00373789|Urinary Incontinence|urinary incontinence
1605727|NCT00373789|Detrusor Overactivity|detrusor overactivity
1605728|NCT00373776|mucosal|mucosal
1605729|NCT00373776|leishmaniasis|leishmaniasis
1605730|NCT00373776|miltefosine|miltefosine
1605731|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
1605732|NCT00373763|tracheal occlusion|tracheal occlusion
1605733|NCT00373763|fetus|fetus
1605734|NCT00373763|fetal surgery|fetal surgery
1605735|NCT00373763|fetoscopy|fetoscopy
1605736|NCT00373750|Native American health|native american health
1605737|NCT00373750|Teen pregnancy|teen pregnancy
1605738|NCT00373750|Family strengthening|family strengthening
1605739|NCT00373750|Substance abuse prevention|substance abuse prevention
1605740|NCT00373750|Injury prevention|injury prevention
1605741|NCT00373724|sacroiliac joint|sacroiliac joint
1605742|NCT00373724|low back pain|low back pain
1605743|NCT00373724|radiofrequency|radiofrequency
1605744|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
1605745|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
1605746|NCT00373698|Primary Health Care|primary health care
1605747|NCT00373698|Veterans|veterans
1605748|NCT00373698|Depression|depression
1605749|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
1605750|NCT00373672|schizophrenia|schizophrenia
1605751|NCT00373672|cognition|cognition
1605752|NCT00373659|Neovascularization|neovascularization
1605753|NCT00373659|Age-related macular degeneration|age-related macular degeneration
1605754|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
1605755|NCT00373659|Optical coherence tomography|optical coherence tomography
1605756|NCT00373659|Intravitreal injection|intravitreal injection
1605757|NCT00373646|MALT Lymphoma|malt lymphoma
1605758|NCT00373646|thalidomide|thalidomide
1605863|NCT00373282|Retinal detachment|retinal detachment
1605864|NCT00373282|Silicone oil|silicone oil
1605759|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
1605760|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
1605761|NCT00373633|THoracic Surgery|thoracic surgery
1605762|NCT00373633|thoracic epidural|thoracic epidural
1605763|NCT00373633|epidural|epidural
1605764|NCT00373633|thoracotomy|thoracotomy
1605765|NCT00373633|intercostal nerve block|intercostal nerve block
1605766|NCT00373633|intercostal|intercostal
1605767|NCT00373633|nerve block|nerve block
1605768|NCT00373620|endometrial cancer|endometrial cancer
1605769|NCT00373620|high risk|high risk
1605770|NCT00373620|weekly paclitaxel|weekly paclitaxel
1605771|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
1605772|NCT00373607|Non complicated malaria|non complicated malaria
1605773|NCT00373607|Microscopy|microscopy
1605774|NCT00373607|Adult|adult
1605775|NCT00373607|Children|children
1605776|NCT00373594|Cold agglutinin disease|cold agglutinin disease
1605777|NCT00373594|Hemolytic|hemolytic
1605778|NCT00373594|Anemia|anemia
1605779|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
1605780|NCT00373594|Monoclonal antibodies|monoclonal antibodies
1605781|NCT00373594|Rituximab|rituximab
1605782|NCT00373594|Fludarabine|fludarabine
1605783|NCT00373581|Vigabatrin|vigabatrin
1605784|NCT00373581|GABA levels|gaba levels
1605785|NCT00373581|Smoked cocaine|smoked cocaine
1605786|NCT00373568|mucosal|mucosal
1605787|NCT00373568|miltefosine|miltefosine
1605788|NCT00373555|Sarcoidosis|sarcoidosis
1605789|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
1605790|NCT00373555|bronchoscopy|bronchoscopy
1605791|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
1605792|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
1605793|NCT00373542|Restless Legs Syndrome|restless legs syndrome
1605794|NCT00373542|ropinirole|ropinirole
1605795|NCT00373542|polysomnography|polysomnography
1605797|NCT00373542|PSG|psg
1605798|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
1605799|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
1605800|NCT00373529|newly Diagnosed AML|newly diagnosed aml
1605801|NCT00373529|Clofarabine|clofarabine
1605802|NCT00373529|CLASSIC II|classic ii
1605803|NCT00373529|CLO243|clo243
1605804|NCT00373516|psoriasis|psoriasis
1605805|NCT00373516|topical therapy|topical therapy
1605806|NCT00373503|Lofexidine|lofexidine
1605807|NCT00373503|Oral THC|oral thc
1605808|NCT00373503|Cannabinoids|cannabinoids
1605809|NCT00373477|Depression|depression
1605810|NCT00373477|Primary Care|primary care
1605811|NCT00373477|Care Manager|care manager
1605812|NCT00373464|Postoperative pain|postoperative pain
1605813|NCT00373464|Opioid|opioid
1605814|NCT00373464|Etoricoxib|etoricoxib
1605815|NCT00373464|Ketorolac|ketorolac
1605816|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
1605817|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
1605818|NCT00373451|NSTEMI|nstemi
1605819|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
1605820|NCT00373438|tracheal occlusion|tracheal occlusion
1605821|NCT00373438|fetus|fetus
1605822|NCT00373438|fetal surgery|fetal surgery
1605823|NCT00373438|fetoscopy|fetoscopy
1605825|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
1605826|NCT00373425|Tarceva|tarceva
1605827|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
1605828|NCT00373425|Adjuvant|adjuvant
1605829|NCT00373425|RADIANT|radiant
1605830|NCT00373425|NSCLC|nsclc
1605831|NCT00373425|EGFR-positive tumor|egfr-positive tumor
1605832|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
1605833|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
1605834|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
1605835|NCT00373412|cytomegalovirus|cytomegalovirus
1605836|NCT00373412|vaccine|vaccine
1605837|NCT00373412|T cell|t cell
1605838|NCT00373412|antibodies|antibodies
1605839|NCT00373399|Cannabinoids|cannabinoids
1605840|NCT00373399|Risk taking|risk taking
1605841|NCT00373399|Decision making|decision making
1605842|NCT00373386|growth hormone|growth hormone
1605843|NCT00373386|endothelial function|endothelial function
1605844|NCT00373373|Sorafenib|sorafenib
1606298|NCT00371865|Mindfulness|mindfulness
1605845|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
1605846|NCT00373373|Flt3|flt3
1605847|NCT00373373|AML|aml
1605848|NCT00373373|Kinase Inhibitor|kinase inhibitor
1605849|NCT00373360|pulmonary hypertension|pulmonary hypertension
1605850|NCT00373360|PAH|pah
1605851|NCT00373360|Remodulin|remodulin
1605852|NCT00373360|treprostinil|treprostinil
1605853|NCT00373360|Quality of Life|quality of life
1605854|NCT00373360|Rapid Switch|rapid switch
1605855|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
1605856|NCT00373334|GERD|gerd
1605857|NCT00373334|heartburn|heartburn
1605858|NCT00373308|Quality of Life|quality of life
1605859|NCT00373295|Baclofen|baclofen
1605860|NCT00373295|Marijuana Dependence|marijuana dependence
1605861|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
1605862|NCT00373282|PVR|pvr
1606519|NCT00370890|PET CT scan|pet ct scan
1605865|NCT00373282|Triamcinolone|triamcinolone
1605866|NCT00373269|Acute ischemic stroke|acute ischemic stroke
1605867|NCT00373269|Stroke|stroke
1605868|NCT00373269|Hyperglycemia|hyperglycemia
1605869|NCT00373269|Procoagulation|procoagulation
1605870|NCT00373269|Diabetes|diabetes
1605871|NCT00373269|Blood coagulation|blood coagulation
1605872|NCT00373256|Breast cancer|breast cancer
1605873|NCT00373256|advanced|advanced
1605874|NCT00373256|sunitinib|sunitinib
1605875|NCT00373256|bevacizumab|bevacizumab
1605876|NCT00373256|paclitaxel|paclitaxel
1605877|NCT00373256|Phase 3|phase 3
1605878|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
1605879|NCT00373230|weight loss|weight loss
1605880|NCT00373230|telemedicine|telemedicine
1605881|NCT00373230|african-american|african-american
1605882|NCT00373230|rural|rural
1605883|NCT00373217|fallopian tube cancer|fallopian tube cancer
1605884|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1605885|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1605886|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1605887|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1605888|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
1605889|NCT00373204|Lung cancer|lung cancer
1605890|NCT00373204|Metastatic lung cancer|metastatic lung cancer
1605891|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
1605892|NCT00373204|Cancer|cancer
1605893|NCT00373204|Advanced lung cancer|advanced lung cancer
1605894|NCT00373191|stage I breast cancer|stage i breast cancer
1605895|NCT00373191|stage II breast cancer|stage ii breast cancer
1605896|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
1605897|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
1605898|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
1605899|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1605900|NCT00373178|rosiglitazone|rosiglitazone
1605901|NCT00373178|metformin|metformin
1605902|NCT00373165|Renal Transplantation|renal transplantation
1605903|NCT00373165|CMV|cmv
1605904|NCT00373165|Ganciclovir|ganciclovir
1605905|NCT00373165|Prophylaxis|prophylaxis
1605906|NCT00373165|Preemptive Therapy|preemptive therapy
1605907|NCT00373165|Graft Survival|graft survival
1605908|NCT00373165|Proteomics|proteomics
1605909|NCT00373152|stage I breast cancer|stage i breast cancer
1605910|NCT00373152|stage II breast cancer|stage ii breast cancer
1605911|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
1605912|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
1605913|NCT00373152|stage IV breast cancer|stage iv breast cancer
1605914|NCT00373139|Pregnancy,|pregnancy,
1605915|NCT00373139|Screening,|screening,
1605916|NCT00373139|Whole Blood|whole blood
1605917|NCT00373126|nicotine|nicotine
1605918|NCT00373126|schizophrenia|schizophrenia
1605919|NCT00373126|reward|reward
1605920|NCT00373126|withdrawal|withdrawal
1605921|NCT00373113|advanced breast cancer|advanced breast cancer
1605922|NCT00373113|metastatic breast cancer|metastatic breast cancer
1605923|NCT00373113|treatment resistant|treatment resistant
1605924|NCT00373113|treatment failure|treatment failure
1605925|NCT00373100|Zinc|zinc
1605926|NCT00373100|placebo|placebo
1605927|NCT00373100|severe pneumonia|severe pneumonia
1605928|NCT00373100|children|children
1605929|NCT00373087|Parkinson's disease|parkinson's disease
1605930|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
1605931|NCT00373087|Entacapone|entacapone
1605932|NCT00373087|pharmacogenetic|pharmacogenetic
1605933|NCT00373074|Spinal Puncture Headache|spinal puncture headache
1605934|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
1605935|NCT00373035|prostate cancer|prostate cancer
1605936|NCT00373022|depression|depression
1605937|NCT00373022|anxiety disorder|anxiety disorder
1605938|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1605939|NCT00373022|stage II colon cancer|stage ii colon cancer
1605940|NCT00373022|stage III colon cancer|stage iii colon cancer
1605941|NCT00373022|stage II rectal cancer|stage ii rectal cancer
1605942|NCT00373022|stage III rectal cancer|stage iii rectal cancer
1605943|NCT00373009|Low back pain|low back pain
1605944|NCT00373009|Primary prevention|primary prevention
1605945|NCT00373009|Secondary prevention|secondary prevention
1605946|NCT00373009|Lumbar stabilization|lumbar stabilization
1605947|NCT00373009|Psychosocial education|psychosocial education
1605948|NCT00372983|chronic HCV|chronic hcv
1605949|NCT00372983|Failed treatment|failed treatment
1605950|NCT00372983|genotype 1|genotype 1
1605951|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
1605952|NCT00372970|gastroparesis|gastroparesis
1605953|NCT00372970|vomiting|vomiting
1605954|NCT00372970|nausea|nausea
1605955|NCT00372970|bloating|bloating
1605956|NCT00372970|dyspepsia|dyspepsia
1605957|NCT00372957|pharmacodynamics|pharmacodynamics
1605958|NCT00372957|Diabetes|diabetes
1605959|NCT00372957|pharmacokinetics|pharmacokinetics
1605960|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
1606124|NCT00372489|erythropoietin|erythropoietin
1605961|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
1605962|NCT00372944|AZD6244|azd6244
1605963|NCT00372905|follicular lymphoma|follicular lymphoma
1605964|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1605965|NCT00372892|Rituximab|rituximab
1605966|NCT00372892|Feasibility study|feasibility study
1605967|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1605968|NCT00372879|vitamin E|vitamin e
1605969|NCT00372879|muscle cramp|muscle cramp
1605970|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1605971|NCT00372840|stage I breast cancer|stage i breast cancer
1605972|NCT00372840|stage II breast cancer|stage ii breast cancer
1605973|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
1605974|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
1605975|NCT00372840|stage I prostate cancer|stage i prostate cancer
1605976|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
1605977|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
1605978|NCT00372840|stage III prostate cancer|stage iii prostate cancer
1605979|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1605980|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1605981|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1605982|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
1605983|NCT00372840|stage I rectal cancer|stage i rectal cancer
1605984|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
1605985|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
1605986|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
1605987|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
1605988|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1605989|NCT00372840|stage I thymoma|stage i thymoma
1605990|NCT00372840|stage II thymoma|stage ii thymoma
1605991|NCT00372840|stage III thymoma|stage iii thymoma
1605992|NCT00372840|stage I colon cancer|stage i colon cancer
1605993|NCT00372840|stage IIA colon cancer|stage iia colon cancer
1605994|NCT00372840|stage IIB colon cancer|stage iib colon cancer
1605995|NCT00372840|stage IIC colon cancer|stage iic colon cancer
1605996|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1605997|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1605998|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
1605999|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
1606000|NCT00372814|diabetes|diabetes
1606001|NCT00372814|regimen adherence|regimen adherence
1606002|NCT00372814|metabolic control|metabolic control
1606003|NCT00372814|adolescents|adolescents
1606004|NCT00372814|family therapy|family therapy
1606005|NCT00372801|Osteoarthritis|osteoarthritis
1606006|NCT00372801|Ibuprofen|ibuprofen
1606007|NCT00372801|COX2|cox2
1606009|NCT00372801|knee|knee
1606010|NCT00372801|single dose|single dose
1606011|NCT00372788|NSCLC|nsclc
1606012|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1606013|NCT00372788|AZD6244|azd6244
1606014|NCT00372775|brain metastases|brain metastases
1606015|NCT00372775|Sunitinib|sunitinib
1606016|NCT00372775|Phase 2|phase 2
1606017|NCT00372762|Insulin resistance|insulin resistance
1606018|NCT00372762|heart failure|heart failure
1606019|NCT00372762|diuretic therapy|diuretic therapy
1606020|NCT00372749|Alcohol dependence|alcohol dependence
1606021|NCT00372749|Craving|craving
1606022|NCT00372749|Disulfiram|disulfiram
1606023|NCT00372749|Cue exposure|cue exposure
1606024|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1606025|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
1606026|NCT00372723|ten|ten
1606027|NCT00372710|Breast cancer|breast cancer
1606028|NCT00372710|Palliation|palliation
1606029|NCT00372710|Bone metastasis|bone metastasis
1606030|NCT00372710|Zoledronic acid|zoledronic acid
1606031|NCT00372697|acromegaly|acromegaly
1606032|NCT00372697|octreotide acetate|octreotide acetate
1606033|NCT00372697|partial responder patients|partial responder patients
1606034|NCT00372684|Plasmodium falciparum|plasmodium falciparum
1606035|NCT00372684|Malaria|malaria
1606036|NCT00372684|Imported malaria|imported malaria
1606037|NCT00372684|Severe malaria|severe malaria
1606038|NCT00372684|Uncomplicated malaria|uncomplicated malaria
1606039|NCT00372684|Intensive Care Units|intensive care units
1606040|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
1606041|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
1606042|NCT00372684|Inflammation Mediators|inflammation mediators
1606043|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
1606044|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
1606045|NCT00372658|hysterosalpingogram|hysterosalpingogram
1606046|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
1606047|NCT00372658|pain perception|pain perception
1606048|NCT00372658|visual analogue scale|visual analogue scale
1606050|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
1606051|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1606052|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1606125|NCT00372489|EPO|epo
1606053|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
1606054|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1606055|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1606056|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1606057|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1606058|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1606059|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1606060|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1606061|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1606062|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1606063|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1606064|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1606065|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1606066|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1606067|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1606068|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1606069|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1606070|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1606071|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1606072|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1606073|NCT00372606|Obesity|obesity
1606074|NCT00372606|Overweight|overweight
1606075|NCT00372606|Hispanics|hispanics
1606076|NCT00372606|Online|online
1606077|NCT00372606|Weight Loss|weight loss
1606078|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1606079|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1606080|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1606081|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1606082|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1606083|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1606084|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
1606085|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1606086|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1606087|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1606088|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1606089|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1606090|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1606091|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1606092|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1606093|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1606094|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1606095|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1606096|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1606097|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1606098|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1606099|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1606100|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1606101|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1606102|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1606103|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1606104|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1606105|NCT00372541|ceftriaxone|ceftriaxone
1606106|NCT00372541|chloramphenicol|chloramphenicol
1606107|NCT00372541|severe pneumonia|severe pneumonia
1606108|NCT00372541|children|children
1606109|NCT00372515|epidermal growth factor|epidermal growth factor
1606110|NCT00372515|EGFR|egfr
1606111|NCT00372515|lung cancer|lung cancer
1606112|NCT00372515|Iressa|iressa
1606113|NCT00372515|Gefitinib|gefitinib
1606114|NCT00372502|sepsis|sepsis
1606115|NCT00372502|shock|shock
1606116|NCT00372502|emergency department|emergency department
1606117|NCT00372502|resuscitation|resuscitation
1606118|NCT00372489|anemia|anemia
1606119|NCT00372489|chronic kidney disease|chronic kidney disease
1606121|NCT00372489|chronic renal failure|chronic renal failure
1606122|NCT00372489|CRF|crf
1606123|NCT00372489|dialysis|dialysis
1606126|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1606127|NCT00372489|ESA|esa
1606128|NCT00372489|Hematide™|hematide™
1606129|NCT00372489|hemodialysis|hemodialysis
1606130|NCT00372489|hemoglobin|hemoglobin
1606131|NCT00372489|Hb|hb
1606132|NCT00372489|Hgb|hgb
1606133|NCT00372489|Omontys|omontys
1606134|NCT00372489|peginesatide|peginesatide
1606135|NCT00372489|red blood cell|red blood cell
1606136|NCT00372489|red blood cell production|red blood cell production
1606137|NCT00372476|Breast cancer|breast cancer
1606138|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
1606139|NCT00372476|Chemotherapy|chemotherapy
1606140|NCT00372476|Imatinib|imatinib
1606141|NCT00372463|diabetes|diabetes
1606142|NCT00372463|type 2 diabetes|type 2 diabetes
1606143|NCT00372463|type II diabetes|type ii diabetes
1606144|NCT00372463|diabetes mellitus|diabetes mellitus
1606145|NCT00372463|diabetes type 2|diabetes type 2
1606146|NCT00372463|diabetes type II|diabetes type ii
1606147|NCT00372463|diabetes education|diabetes education
1606148|NCT00372463|patient education|patient education
1606149|NCT00372463|workshop|workshop
1606150|NCT00372463|class|class
1606151|NCT00372463|education|education
1606152|NCT00372463|online|online
1606153|NCT00372463|on-line|on-line
1606154|NCT00372463|internet|internet
1606155|NCT00372463|web|web
1606156|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
1606157|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
1606158|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
1606159|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1606160|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1606161|NCT00372450|gastrointestinal complications|gastrointestinal complications
1606162|NCT00372437|Refractory solid tumors|refractory solid tumors
1606163|NCT00372437|Phase I/II|phase i/ii
1606164|NCT00372437|Refractory and solid tumors|refractory and solid tumors
1606165|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
1606166|NCT00372411|Stroke|stroke
1606167|NCT00372411|Rehabilitation|rehabilitation
1606168|NCT00372411|Single-blind|single-blind
1606169|NCT00372411|Clinical Trial|clinical trial
1606170|NCT00372411|Randomized controlled trial|randomized controlled trial
1606171|NCT00372411|Upper extremity|upper extremity
1606172|NCT00372411|Robotics|robotics
1606173|NCT00372398|scleroderma|scleroderma
1606174|NCT00372398|sclerosis|sclerosis
1606175|NCT00372398|atherosclerosis|atherosclerosis
1606176|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
1606177|NCT00372359|Attention Deficit Disorder|attention deficit disorder
1606178|NCT00372359|Hyperactivity|hyperactivity
1606179|NCT00372359|Methylphenidate|methylphenidate
1606180|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
1606181|NCT00372320|Adenovirus|adenovirus
1606182|NCT00372320|Aquaporin-1|aquaporin-1
1606183|NCT00372320|Gene Transfer|gene transfer
1606184|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
1606185|NCT00372320|Salivary Gland|salivary gland
1606186|NCT00372320|Xerostomia|xerostomia
1606187|NCT00372320|Salivary Dysfunction|salivary dysfunction
1606188|NCT00372320|Hyposalivation|hyposalivation
1606189|NCT00372320|Dry mouth|dry mouth
1606190|NCT00372320|head and neck cancer|head and neck cancer
1606191|NCT00372320|side effects radiation damage|side effects radiation damage
1606192|NCT00372294|Toxoplasmosis|toxoplasmosis
1606193|NCT00372294|Chorioretinitis|chorioretinitis
1606194|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
1606195|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
1606196|NCT00372294|Toxoplasmic|toxoplasmic
1606197|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
1606294|NCT00371865|Behavior therapy|behavior therapy
1606295|NCT00371865|Chronic pain|chronic pain
1606296|NCT00371865|Cognitive therapy|cognitive therapy
1606198|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
1606199|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
1606200|NCT00372268|No emergency|no emergency
1606201|NCT00372268|Aged over 18 years|aged over 18 years
1606202|NCT00372242|Mal-nutrition|mal-nutrition
1606203|NCT00372242|Morbidity|morbidity
1606204|NCT00372242|Nutrition Education|nutrition education
1606205|NCT00372242|Complementary Feeding|complementary feeding
1606206|NCT00372242|Weight gain|weight gain
1606207|NCT00372242|Height|height
1606208|NCT00372216|myocardial infarction|myocardial infarction
1606209|NCT00372216|Clopidogrel|clopidogrel
1606210|NCT00372216|primary PCI|primary pci
1606211|NCT00372216|TIMI-flow|timi-flow
1606212|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
1606213|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
1606214|NCT00372203|NSCLC|nsclc
1606215|NCT00372203|EBUS|ebus
1606417|NCT00371306|Pregnancy|pregnancy
1606216|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
1606217|NCT00372203|mediastinoscopy|mediastinoscopy
1606218|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
1606219|NCT00372190|recurrence|recurrence
1606220|NCT00372190|mesh|mesh
1606221|NCT00372190|complications|complications
1606222|NCT00372190|treatment|treatment
1606223|NCT00372177|monoclonal antibody|monoclonal antibody
1606224|NCT00372177|diagnostics|diagnostics
1606225|NCT00372177|RA|ra
1606226|NCT00372177|Immunoglobulins|immunoglobulins
1606227|NCT00372177|molecular target|molecular target
1606228|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
1606229|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
1606230|NCT00372177|Radiopharmaceutical|radiopharmaceutical
1606231|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
1606232|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
1606233|NCT00372164|ASIPP|asipp
1606234|NCT00372164|Guidelines|guidelines
1606235|NCT00372151|Schizophrenia|schizophrenia
1606236|NCT00372151|Schizoaffective disorders|schizoaffective disorders
1606237|NCT00372151|Theonine|theonine
1606238|NCT00372151|Augmentation|augmentation
1606239|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
1606240|NCT00372138|Endoleaks|endoleaks
1606241|NCT00372138|Prevention|prevention
1606242|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
1606243|NCT00372125|Growth hormone|growth hormone
1606244|NCT00372125|Body composition|body composition
1606245|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1606246|NCT00372112|COPD|copd
1606247|NCT00372099|Postmenopausal women|postmenopausal women
1606248|NCT00372099|bone microarchitecture|bone microarchitecture
1606249|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
1606250|NCT00372099|salmon calcitonin|salmon calcitonin
1606251|NCT00372034|contact lenses|contact lenses
1606252|NCT00372034|intolerance|intolerance
1606253|NCT00372034|punctal plugs|punctal plugs
1606254|NCT00372034|tear volume|tear volume
1606255|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
1606256|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
1606257|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
1606258|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
1606259|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
1606260|NCT00371995|kala-azar|kala-azar
1606261|NCT00371995|miltefosine|miltefosine
1606262|NCT00371995|AmBisome|ambisome
1606263|NCT00371982|Fish oil|fish oil
1606264|NCT00371982|Type 2 diabetic women|type 2 diabetic women
1606265|NCT00371982|adiposity|adiposity
1606266|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
1606267|NCT00371982|PAI-1|pai-1
1606268|NCT00371982|Insulin sensitivity|insulin sensitivity
1606269|NCT00371969|Unsafe drinking|unsafe drinking
1606270|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
1606271|NCT00371969|Motivational Interviewing|motivational interviewing
1606272|NCT00371956|raloxifene|raloxifene
1606273|NCT00371956|estrogen|estrogen
1606274|NCT00371956|receptor|receptor
1606275|NCT00371956|modulation|modulation
1606276|NCT00371956|osteoporosis|osteoporosis
1606277|NCT00371956|steroid|steroid
1606278|NCT00371956|Steroids|steroids
1606279|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
1606280|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
1606281|NCT00371904|Rituximab|rituximab
1606282|NCT00371904|donor|donor
1606283|NCT00371904|sensitised|sensitised
1606284|NCT00371904|antibody|antibody
1606285|NCT00371904|rejection|rejection
1606286|NCT00371878|Vaccine|vaccine
1606287|NCT00371878|Lung|lung
1606288|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
1606289|NCT00371878|Lymphocyte|lymphocyte
1606290|NCT00371878|Immunoglobulin|immunoglobulin
1606291|NCT00371878|HIV|hiv
1606292|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
1606293|NCT00371878|Conjugate vaccine|conjugate vaccine
1606299|NCT00371865|Psychotherapy|psychotherapy
1606300|NCT00371839|Hearing Loss|hearing loss
1606301|NCT00371839|Hearing Aids|hearing aids
1606302|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
1606303|NCT00371826|Renal transplantation|renal transplantation
1606304|NCT00371826|everolimus|everolimus
1606305|NCT00371826|Immunosuppressants|immunosuppressants
1606306|NCT00371800|Cinnamon|cinnamon
1606307|NCT00371800|Type 1 Diabetes|type 1 diabetes
1606308|NCT00371800|Adolescent|adolescent
1606309|NCT00371800|HbA1c|hba1c
1606310|NCT00371774|Psoriasis|psoriasis
1606311|NCT00371774|Plaque Psoriasis|plaque psoriasis
1606312|NCT00371774|Amevive®|amevive®
1606313|NCT00371774|alefacept|alefacept
1606314|NCT00371761|Hepatitis B virus|hepatitis b virus
1606315|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
1606316|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
1606317|NCT00371722|Cesarean section|cesarean section
1606318|NCT00371722|Appendectomy|appendectomy
1606418|NCT00371293|Sleep Apnea|sleep apnea
1606319|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
1606320|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
1606321|NCT00371657|obesity|obesity
1606322|NCT00371657|small for gestation age|small for gestation age
1606323|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
1606324|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1606325|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
1606326|NCT00371644|Military sexual trauma|military sexual trauma
1606327|NCT00371644|Psychology, Military|psychology, military
1606328|NCT00371644|Veterans|veterans
1606329|NCT00371644|Rape|rape
1606330|NCT00371644|Veterans, psychology|veterans, psychology
1606331|NCT00371644|Healthcare utilization|healthcare utilization
1606332|NCT00371631|biofilm|biofilm
1606333|NCT00371631|clinical trial|clinical trial
1606334|NCT00371631|Escherichia coli|escherichia coli
1606335|NCT00371631|urinary catheter|urinary catheter
1606336|NCT00371618|Fluoroscopy|fluoroscopy
1606337|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
1606338|NCT00371605|Voriconazole|voriconazole
1606339|NCT00371605|Liver Transplant|liver transplant
1606340|NCT00371605|Fungal Infection|fungal infection
1606341|NCT00371592|Treatment Naive|treatment naive
1606342|NCT00371579|rosuvastatin|rosuvastatin
1606343|NCT00371579|hepatitis C|hepatitis c
1606344|NCT00371579|geranylgeranylation|geranylgeranylation
1606345|NCT00371579|HCV-RNA load|hcv-rna load
1606346|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1606347|NCT00371566|lapatinib|lapatinib
1606348|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
1606349|NCT00371566|apoptosis|apoptosis
1606350|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
1606351|NCT00371553|germ cell cancer|germ cell cancer
1606352|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
1606353|NCT00371540|Africa|africa
1606354|NCT00371540|Antiretrovirals|antiretrovirals
1606355|NCT00371527|Bronchitis|bronchitis
1606356|NCT00371527|Acute bronchitis|acute bronchitis
1606357|NCT00371527|Ipratropium|ipratropium
1606358|NCT00371527|Cough|cough
1606359|NCT00371527|Metered dose inhaler|metered dose inhaler
1606360|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
1606361|NCT00371527|Sputum production|sputum production
1606362|NCT00371501|lupus|lupus
1606363|NCT00371501|atherosclerosis|atherosclerosis
1606364|NCT00371501|thrombosis|thrombosis
1606365|NCT00371501|statin|statin
1606366|NCT00371501|lipid|lipid
1606367|NCT00371488|ErbB2|erbb2
1606368|NCT00371488|Stage IV breast cancer|stage iv breast cancer
1606369|NCT00371488|ErbB1|erbb1
1606370|NCT00371488|breast cancer|breast cancer
1606371|NCT00371488|lapatinib|lapatinib
1606372|NCT00371488|Herceptin|herceptin
1606373|NCT00371488|trastuzumab|trastuzumab
1606374|NCT00371462|intervention study|intervention study
1606375|NCT00371462|technology|technology
1606376|NCT00371462|weight loss|weight loss
1606377|NCT00371449|hearing loss|hearing loss
1606378|NCT00371449|hearing aids|hearing aids
1606379|NCT00371436|Counseling|counseling
1606380|NCT00371436|Education|education
1606381|NCT00371436|Evaluation studies|evaluation studies
1606382|NCT00371436|Quality of health care|quality of health care
1606383|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
1606384|NCT00371436|Triage|triage
1606385|NCT00371410|Vitrectomy|vitrectomy
1606386|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
1606387|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
1606388|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
1606389|NCT00371410|Central macular thickness|central macular thickness
1606390|NCT00371397|yoga|yoga
1606391|NCT00371397|immune function|immune function
1606392|NCT00371397|stress|stress
1606393|NCT00371397|health|health
1606394|NCT00371397|mood|mood
1606395|NCT00371397|skin barrier repair|skin barrier repair
1606396|NCT00371384|massage|massage
1606398|NCT00371384|effectiveness|effectiveness
1606399|NCT00371371|clinical trial|clinical trial
1606400|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
1606401|NCT00371371|leg pain|leg pain
1606402|NCT00371371|cell therapy|cell therapy
1606403|NCT00371371|bone marrow|bone marrow
1606404|NCT00371371|mononuclear|mononuclear
1606405|NCT00371371|progenitor cell|progenitor cell
1606406|NCT00371371|stem cell|stem cell
1606407|NCT00371371|critical limb ischemia|critical limb ischemia
1606408|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
1606409|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
1606410|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
1606411|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
1606412|NCT00371319|lupus|lupus
1606413|NCT00371319|nephritis|nephritis
1606414|NCT00371319|tacrolimus|tacrolimus
1606415|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
1606416|NCT00371306|Diabetes|diabetes
1606419|NCT00371293|C-Reactive Protein|c-reactive protein
1606420|NCT00371293|Obesity|obesity
1606421|NCT00371293|Insulin Resistance|insulin resistance
1606422|NCT00371293|Arterial stiffness|arterial stiffness
1606423|NCT00371280|hydroxyapatite|hydroxyapatite
1606424|NCT00371280|peg|peg
1606425|NCT00371280|prosthetic motility|prosthetic motility
1606426|NCT00371280|orbital implant|orbital implant
1606427|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
1606428|NCT00371267|pain|pain
1606429|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
1606430|NCT00371241|ECMO|ecmo
1606431|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
1606432|NCT00371241|cytokines|cytokines
1606433|NCT00371241|chemokines|chemokines
1606434|NCT00371228|cord clamping|cord clamping
1606435|NCT00371228|hematocrit|hematocrit
1606436|NCT00371228|hemoglobin|hemoglobin
1606437|NCT00371228|timing|timing
1606438|NCT00371215|hemostasis|hemostasis
1606439|NCT00371215|grafting, skin|grafting, skin
1606440|NCT00371215|hemostatics|hemostatics
1606441|NCT00371215|phase 2|phase 2
1606442|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
1606443|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
1606444|NCT00371202|big bubble technique|big bubble technique
1606445|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
1606446|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
1606447|NCT00371176|Cognitive enhancers|cognitive enhancers
1606448|NCT00371176|Combat Disorders|combat disorders
1606449|NCT00371176|D-Cycloserine|d-cycloserine
1606450|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1606451|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
1606452|NCT00371137|FMS|fms
1606453|NCT00371137|Fibro|fibro
1606454|NCT00371137|pain|pain
1606455|NCT00371137|Body pain|body pain
1606456|NCT00371137|tenderness|tenderness
1606457|NCT00371137|joint pain|joint pain
1606458|NCT00371137|stiffness|stiffness
1606459|NCT00371137|muscular pain|muscular pain
1606460|NCT00371124|Myopia treatment|myopia treatment
1606461|NCT00371124|Atropine|atropine
1606462|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
1606757|NCT00369876|Adiponectin|adiponectin
1606463|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
1606464|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
1606465|NCT00371098|influenza vaccination|influenza vaccination
1606466|NCT00371098|coronary artery disease|coronary artery disease
1606467|NCT00371098|prevention|prevention
1606468|NCT00371098|acute coronary syndromes|acute coronary syndromes
1606469|NCT00371085|heart failure|heart failure
1606470|NCT00371085|quality improvement|quality improvement
1606471|NCT00371085|patient education|patient education
1606472|NCT00371085|health care economics|health care economics
1606473|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
1606474|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
1606475|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
1606476|NCT00371059|Agitation|agitation
1606477|NCT00371059|Dementia|dementia
1606478|NCT00371059|Alzheimer's|alzheimer's
1606479|NCT00371046|preterm labor|preterm labor
1606480|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
1606481|NCT00371046|fetal fibronectin|fetal fibronectin
1606482|NCT00371046|preterm birth|preterm birth
1606483|NCT00371020|silicone oil|silicone oil
1606484|NCT00371020|PVR|pvr
1606485|NCT00371020|retinal redetachment|retinal redetachment
1606486|NCT00371020|low molecular weight heparin|low molecular weight heparin
1606487|NCT00371020|5-FU|5-fu
1606488|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
1606489|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
1606490|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
1606491|NCT00370981|investigational drug|investigational drug
1606492|NCT00370981|ejaculation|ejaculation
1606497|NCT00370968|Malnutrition|malnutrition
1606498|NCT00370968|Treatment|treatment
1606499|NCT00370955|Phacoemulsification|phacoemulsification
1606500|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
1606501|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
1606502|NCT00370955|Total ultrasound energy|total ultrasound energy
1606503|NCT00370955|Total infused fluids|total infused fluids
1606504|NCT00370942|GW823093C|gw823093c
1606505|NCT00370942|diabetes|diabetes
1606506|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
1606507|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
1606508|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
1606509|NCT00370916|Continuity of Patient Care|continuity of patient care
1606510|NCT00370916|Medication Errors|medication errors
1606511|NCT00370916|Drug Adverse Effects|drug adverse effects
1606512|NCT00370903|cesarean|cesarean
1606513|NCT00370903|planned|planned
1606514|NCT00370903|emergent|emergent
1606515|NCT00370903|postpartum depression|postpartum depression
1606516|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
1606517|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
1606520|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
1606521|NCT00370877|Arterial embolization|arterial embolization
1606522|NCT00370877|Surgery|surgery
1606523|NCT00370877|Hysterectomy|hysterectomy
1606524|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
1606525|NCT00370864|Pandemic|pandemic
1606526|NCT00370864|Influenza|influenza
1606527|NCT00370864|Prevention|prevention
1606528|NCT00370864|Vaccine|vaccine
1606529|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
1606530|NCT00370851|intravitreal Avastin|intravitreal avastin
1606531|NCT00370851|BRVO|brvo
1606532|NCT00370851|Macular edema|macular edema
1606533|NCT00370838|Tics|tics
1606534|NCT00370838|Tourette syndrome|tourette syndrome
1606535|NCT00370838|levetiracetam|levetiracetam
1606536|NCT00370838|clonidine|clonidine
1606537|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
1606538|NCT00370825|miltefosine|miltefosine
1606539|NCT00370825|AmBisome|ambisome
1606540|NCT00370825|Combination|combination
1606541|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
1606542|NCT00370812|ocular chemical burns|ocular chemical burns
1606543|NCT00370799|Caudal Epidural injections|caudal epidural injections
1606544|NCT00370799|lumbar disc herniation|lumbar disc herniation
1606545|NCT00370799|spinal stenosis|spinal stenosis
1606546|NCT00370799|discogenic pain|discogenic pain
1606547|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
1606548|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1606549|NCT00370786|Bevacizumab|bevacizumab
1606550|NCT00370786|Non AMD|non amd
1606551|NCT00370786|High myopia|high myopia
1606552|NCT00370786|angioid streaks|angioid streaks
1606553|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
1606554|NCT00370786|Idiopathic|idiopathic
1606555|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
1606556|NCT00370773|Back Pain|back pain
1606557|NCT00370773|Chronic Pain|chronic pain
1606558|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
1606559|NCT00370760|PVR|pvr
1606560|NCT00370760|Oral colchicine|oral colchicine
1606561|NCT00370760|Dexamethasone|dexamethasone
1606562|NCT00370760|low molecular weight heparin|low molecular weight heparin
1606563|NCT00370760|5-FU|5-fu
1606564|NCT00370734|botulinum toxin|botulinum toxin
1606565|NCT00370734|thyroid eye disease|thyroid eye disease
1606566|NCT00370734|lid retraction|lid retraction
1606567|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
1606568|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
1606569|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
1606570|NCT00370721|Traction retinal detachment|traction retinal detachment
1606571|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
1606572|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
1606573|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
1606574|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
1606575|NCT00370708|Cesarean|cesarean
1606576|NCT00370708|Oral|oral
1606577|NCT00370708|Intake|intake
1606578|NCT00370695|Chronic back pain|chronic back pain
1606579|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
1606580|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
1606581|NCT00370695|Spinal cord stimulation|spinal cord stimulation
1606582|NCT00370669|Bevacizumab|bevacizumab
1606583|NCT00370669|CSME|csme
1606584|NCT00370669|MPC|mpc
1606585|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
1606586|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1606587|NCT00370643|hyperglycaemia|hyperglycaemia
1606588|NCT00370643|open heart surgery|open heart surgery
1606589|NCT00370643|intensive care unit|intensive care unit
1606590|NCT00370630|CRVO|crvo
1606591|NCT00370630|Intravitreal Avastin|intravitreal avastin
1606592|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
1606593|NCT00370617|chronic hepatitis C|chronic hepatitis c
1606594|NCT00370617|insulin resistance|insulin resistance
1606595|NCT00370617|therapy|therapy
1606596|NCT00370604|Parturient|parturient
1606597|NCT00370604|Obstetrics|obstetrics
1606598|NCT00370604|Pregnancy|pregnancy
1606599|NCT00370604|Labour|labour
1606600|NCT00370604|Labor|labor
1606601|NCT00370604|Headache|headache
1606602|NCT00370604|Epidural|epidural
1606603|NCT00370604|Analgesia|analgesia
1606604|NCT00370604|Anesthesia|anesthesia
1606605|NCT00370604|Anaesthesia|anaesthesia
1606606|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
1606607|NCT00370591|Asthma|asthma
1606608|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
1606609|NCT00370539|Photodynamic therapy,|photodynamic therapy,
1606610|NCT00370539|Bevacizumab,|bevacizumab,
1606611|NCT00370539|Triamcinolone,|triamcinolone,
1606612|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
1606613|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
1606614|NCT00370526|heart failure|heart failure
1606615|NCT00370526|resynchronization|resynchronization
1606616|NCT00370526|CRT|crt
1606617|NCT00370526|Bi-V pacemaker|bi-v pacemaker
1608322|NCT00364195|DPPE|dppe
1606618|NCT00370526|LV lead placement|lv lead placement
1606619|NCT00370526|hemodynamic assessment|hemodynamic assessment
1606620|NCT00370526|CRT Outcomes|crt outcomes
1606621|NCT00370513|pazopanib|pazopanib
1606622|NCT00370513|liver cancer|liver cancer
1606623|NCT00370513|hepatocellular cancer|hepatocellular cancer
1606624|NCT00370500|Schizophrenia|schizophrenia
1606625|NCT00370500|Dopamine transporter gene|dopamine transporter gene
1606626|NCT00370500|DNA methylation|dna methylation
1606627|NCT00370500|Epigenetics|epigenetics
1606628|NCT00370487|Abortion|abortion
1606629|NCT00370487|Midlevel providers|midlevel providers
1606630|NCT00370487|South Africa|south africa
1606631|NCT00370487|Viet Nam|viet nam
1606632|NCT00370474|Bi-V lead|bi-v lead
1606633|NCT00370474|Magnetic Navigation|magnetic navigation
1606634|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1606635|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
1606636|NCT00370461|Termination of Resuscitation|termination of resuscitation
1606637|NCT00370461|Emergency Medical Services|emergency medical services
1606638|NCT00370461|Primary Care Paramedics|primary care paramedics
1606639|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
1606640|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
1606641|NCT00370435|safety|safety
1606642|NCT00370435|GW274150|gw274150
1606643|NCT00370435|pharmacokinetics|pharmacokinetics
1606644|NCT00370435|tolerability|tolerability
1606645|NCT00370422|Cystoid macular edema|cystoid macular edema
1606646|NCT00370422|Diabetic macular edema|diabetic macular edema
1606647|NCT00370422|Hard exudates|hard exudates
1606648|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
1606649|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
1606650|NCT00370422|Macular thickness|macular thickness
1606651|NCT00370409|Rebleeding|rebleeding
1606652|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
1606653|NCT00370409|Cryotherapy|cryotherapy
1606654|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
1606655|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
1606758|NCT00369876|Gherlin|gherlin
1606656|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
1606657|NCT00370370|Bevacizumab,|bevacizumab,
1606658|NCT00370370|Triamcinolone|triamcinolone
1606659|NCT00370370|Age-related macular degeneration|age-related macular degeneration
1606660|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
1606661|NCT00370357|Microbicide|microbicide
1606663|NCT00370357|VivaGel|vivagel
1606664|NCT00370344|Gallbladder diseases|gallbladder diseases
1606665|NCT00370344|gallstones|gallstones
1606666|NCT00370344|cholecystectomy|cholecystectomy
1606667|NCT00370344|minilaparotomy|minilaparotomy
1606668|NCT00370344|laparoscopy|laparoscopy
1606669|NCT00370331|ITP|itp
1606670|NCT00370331|idiopathic|idiopathic
1606671|NCT00370331|platelets|platelets
1606672|NCT00370331|purpura|purpura
1606673|NCT00370331|thrombocytopenia|thrombocytopenia
1606674|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1606675|NCT00370331|thrombocytopenic|thrombocytopenic
1606676|NCT00370318|Pneumococcal Disease|pneumococcal disease
1606677|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
1606678|NCT00370305|rosiglitazone|rosiglitazone
1606679|NCT00370305|insulin sensitivity|insulin sensitivity
1606680|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
1606681|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
1606682|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
1606683|NCT00370279|Scleral buckling,|scleral buckling,
1606684|NCT00370279|Primary vitrectomy,|primary vitrectomy,
1606685|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
1606686|NCT00370266|Macular edema|macular edema
1606687|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
1606688|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
1606689|NCT00370266|Macular thickness|macular thickness
1606690|NCT00370266|Retinal neovascularization|retinal neovascularization
1606691|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
1606692|NCT00370253|ascites|ascites
1606693|NCT00370253|portal hypertension|portal hypertension
1606694|NCT00370253|cirrhosis|cirrhosis
1606695|NCT00370240|Female|female
1606696|NCT00370240|Anesthetics,local|anesthetics,local
1606697|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
1606698|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
1606699|NCT00370214|Lung diseases|lung diseases
1606700|NCT00370214|Heart diseases|heart diseases
1606701|NCT00370214|Pulmonary circulation|pulmonary circulation
1606702|NCT00370214|Vascular resistance|vascular resistance
1606703|NCT00370214|PAH|pah
1606704|NCT00370214|Hypertension|hypertension
1606705|NCT00370201|retinal detachment|retinal detachment
1606706|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
1606707|NCT00370188|problem gambling|problem gambling
1606708|NCT00370188|topiramate|topiramate
1606709|NCT00370123|endometriosis|endometriosis
1606710|NCT00370123|apoptosis|apoptosis
1606711|NCT00370123|regulatory T cells|regulatory t cells
1606712|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
1606713|NCT00370071|MS|ms
1606714|NCT00370058|ect|ect
1606715|NCT00370058|depression|depression
1606716|NCT00370058|homocysteine|homocysteine
1606717|NCT00370058|mthfr genotype|mthfr genotype
1606718|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
1606719|NCT00370019|Premature Ovarian Failure|premature ovarian failure
1606720|NCT00370019|Ovulation|ovulation
1606721|NCT00370019|Fertility|fertility
1606722|NCT00370019|Estrogen Replacement|estrogen replacement
1606723|NCT00370019|Follicle Function|follicle function
1606724|NCT00370019|Premature Menopause|premature menopause
1606725|NCT00370019|POF|pof
1606726|NCT00370006|cytomegalovirus|cytomegalovirus
1606727|NCT00370006|vaccine|vaccine
1606728|NCT00370006|T cell|t cell
1606729|NCT00370006|antibodies|antibodies
1606730|NCT00369993|asthma|asthma
1606731|NCT00369993|spacer|spacer
1606732|NCT00369967|Contraception|contraception
1606733|NCT00369967|Adolescents|adolescents
1606734|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
1606735|NCT00369967|Quick start|quick start
1606736|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1606737|NCT00369954|fallopian tube cancer|fallopian tube cancer
1606738|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
1606739|NCT00369915|Cholinergic|cholinergic
1606740|NCT00369915|Unipolar|unipolar
1606741|NCT00369915|Bipolar|bipolar
1606742|NCT00369915|Depression|depression
1606743|NCT00369915|Muscarinic|muscarinic
1606744|NCT00369915|Scopolamine|scopolamine
1606745|NCT00369915|Major Depressive Disorder|major depressive disorder
1606746|NCT00369915|MDD|mdd
1606747|NCT00369915|Bipolar Disorder|bipolar disorder
1606748|NCT00369915|BP|bp
1606749|NCT00369902|pain|pain
1606750|NCT00369902|acupuncture|acupuncture
1606751|NCT00369889|Thymoma|thymoma
1606752|NCT00369889|Thymic Cancer|thymic cancer
1606753|NCT00369876|Burns|burns
1606754|NCT00369876|Anorexia|anorexia
1606755|NCT00369876|Neuropeptide|neuropeptide
1606756|NCT00369876|Leptin|leptin
1606759|NCT00369863|Cystoid macular edema|cystoid macular edema
1606760|NCT00369863|Diabetic macular edema|diabetic macular edema
1606761|NCT00369863|Hard exudates|hard exudates
1606762|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
1606763|NCT00369863|Macular thickness|macular thickness
1606764|NCT00369850|osteoporosis|osteoporosis
1606765|NCT00369850|stage I breast cancer|stage i breast cancer
1606766|NCT00369850|stage II breast cancer|stage ii breast cancer
1606767|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
1606768|NCT00369824|HPV|hpv
1606769|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
1606770|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
1606771|NCT00369798|Unipolar Depression|unipolar depression
1606772|NCT00369798|Phosphorylation|phosphorylation
1606773|NCT00369798|Affinity States|affinity states
1606774|NCT00369798|Compartment Analysis|compartment analysis
1606775|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
1606776|NCT00369798|Depression|depression
1606777|NCT00369798|Major Depressive Disorder|major depressive disorder
1606778|NCT00369798|MDD|mdd
1606779|NCT00369798|Healthy Volunteer|healthy volunteer
1606780|NCT00369798|HV|hv
1606781|NCT00369785|cognitive/functional effects|cognitive/functional effects
1606782|NCT00369785|fatigue|fatigue
1606783|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1606784|NCT00369785|radiation toxicity|radiation toxicity
1606785|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
1606786|NCT00369785|adult brain stem glioma|adult brain stem glioma
1606787|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1606788|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
1606789|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
1606790|NCT00369785|adult mixed glioma|adult mixed glioma
1606791|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
1606792|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
1606793|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1606794|NCT00369785|adult grade I meningioma|adult grade i meningioma
1606795|NCT00369785|adult grade II meningioma|adult grade ii meningioma
1606796|NCT00369785|adult grade III meningioma|adult grade iii meningioma
1606797|NCT00369785|adult papillary meningioma|adult papillary meningioma
1606798|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1606799|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
1606800|NCT00369785|adult pineoblastoma|adult pineoblastoma
1606801|NCT00369785|adult pineocytoma|adult pineocytoma
1606802|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1606803|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
1606804|NCT00369785|adult glioblastoma|adult glioblastoma
1606805|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
1606806|NCT00369785|adult gliosarcoma|adult gliosarcoma
1606807|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1606808|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
1606809|NCT00369785|adult medulloblastoma|adult medulloblastoma
1606895|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1606810|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1606811|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
1606812|NCT00369785|adult ependymoma|adult ependymoma
1606813|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1606814|NCT00369785|adult subependymoma|adult subependymoma
1606815|NCT00369772|Aranesp|aranesp
1606816|NCT00369772|Anemia|anemia
1606817|NCT00369772|Kidney Disease|kidney disease
1606818|NCT00369772|Hemoglobin|hemoglobin
1606819|NCT00369772|darbepoetin alfa|darbepoetin alfa
1606820|NCT00369772|QoL|qol
1606821|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
1606822|NCT00369759|Retractions|retractions
1606823|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
1606824|NCT00369759|Wheezing|wheezing
1606825|NCT00369759|Rales|rales
1606826|NCT00369759|Crackles|crackles
1606827|NCT00369746|Depression|depression
1606828|NCT00369746|Alcohol Abuse|alcohol abuse
1606829|NCT00369746|Alcohol Dependence|alcohol dependence
1606830|NCT00369733|Aranesp|aranesp
1606831|NCT00369733|Anemia|anemia
1606832|NCT00369733|Kidney Disease|kidney disease
1606833|NCT00369733|Hemoglobin|hemoglobin
1606834|NCT00369733|darbepoetin alfa|darbepoetin alfa
1606835|NCT00369733|QoL|qol
1606836|NCT00369720|Prematurity|prematurity
1606837|NCT00369720|Resuscitation|resuscitation
1606838|NCT00369720|Room Air|room air
1606839|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1606840|NCT00369694|Esophageal varices|esophageal varices
1606841|NCT00369694|Portal Hypertension|portal hypertension
1606842|NCT00369694|Melena|melena
1606843|NCT00369694|Hematemesis|hematemesis
1606844|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
1606845|NCT00369694|Terlipressin|terlipressin
1606846|NCT00369694|Efficacy|efficacy
1606847|NCT00369694|Safety|safety
1606848|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1606849|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1606850|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1606851|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1606852|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1606853|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1606854|NCT00369668|Rehabilitation|rehabilitation
1606855|NCT00369668|Physical Therapy Techniques|physical therapy techniques
1606856|NCT00369668|Occupational Therapy|occupational therapy
1606857|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
1606858|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
1606859|NCT00369642|Children|children
1606860|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
1606861|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
1606862|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
1606863|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1606864|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1606865|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1606866|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1606867|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1606868|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1606869|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1606870|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1606871|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1606872|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1606873|NCT00369603|Alzheimer's Disease|alzheimer's disease
1606874|NCT00369603|fMRI|fmri
1606875|NCT00369603|Functional Neuroimaging|functional neuroimaging
1606876|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
1606877|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
1606878|NCT00369603|Head to head|head to head
1606879|NCT00369603|Dose escalation|dose escalation
1606880|NCT00369603|Biomarker|biomarker
1606881|NCT00369577|Agitation|agitation
1606882|NCT00369577|Schizophrenia|schizophrenia
1606883|NCT00369564|neurotoxicity|neurotoxicity
1606884|NCT00369564|peripheral neuropathy|peripheral neuropathy
1606885|NCT00369564|stage I Wilms tumor|stage i wilms tumor
1606886|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
1606887|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
1606888|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
1606889|NCT00369564|stage V Wilms tumor|stage v wilms tumor
1606890|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1606891|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1606892|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1606893|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1606894|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1607087|NCT00368797|CLI|cli
1606896|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1606897|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1606898|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1606899|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1606900|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1606901|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1606902|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
1606903|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1606904|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1606905|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1606906|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1606907|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1606908|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
1606909|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
1606910|NCT00369512|Phase II|phase ii
1606911|NCT00369512|Erlotinib|erlotinib
1606912|NCT00369512|Radiotherapy|radiotherapy
1606913|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
1606914|NCT00369512|Cutaneous|cutaneous
1606915|NCT00369512|Stage III|stage iii
1606916|NCT00369486|diabetic|diabetic
1606917|NCT00369486|macular|macular
1606918|NCT00369486|edema|edema
1606919|NCT00369486|peribulbar|peribulbar
1606920|NCT00369486|triamcinolone|triamcinolone
1606921|NCT00369486|acetonide|acetonide
1606922|NCT00369486|laser|laser
1606923|NCT00369486|photocoagulation|photocoagulation
1606924|NCT00369486|intraocular|intraocular
1606925|NCT00369486|DME|dme
1606926|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
1606927|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
1606928|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
1606929|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1606930|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
1606931|NCT00369447|Non small cell lung cancer|non small cell lung cancer
1606932|NCT00369447|NSCLC|nsclc
1606933|NCT00369447|Nimotuzumab|nimotuzumab
1606934|NCT00369447|TheraCIM|theracim
1606935|NCT00369447|h-R3|h-r3
1606936|NCT00369447|YM BioSciences|ym biosciences
1606937|NCT00369447|Radiation|radiation
1606938|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
1606939|NCT00369421|Dietary Therapy|dietary therapy
1606940|NCT00369421|Biochemical Defects|biochemical defects
1606941|NCT00369421|Enzyme Defects|enzyme defects
1606942|NCT00369421|Transport|transport
1606943|NCT00369421|Rare Diseases|rare diseases
1606944|NCT00369421|Varied Disorders|varied disorders
1606945|NCT00369421|Screening|screening
1606946|NCT00369421|Relatives|relatives
1606947|NCT00369408|Randomized Trial|randomized trial
1606948|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
1606949|NCT00369408|Naltrexone Treatment|naltrexone treatment
1606950|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
1606951|NCT00369395|melanoma|melanoma
1606952|NCT00369395|antibody|antibody
1606953|NCT00369395|angiogenesis|angiogenesis
1606954|NCT00369395|volociximab|volociximab
1606955|NCT00369382|Heart Transplant|heart transplant
1606956|NCT00369382|Kidney Failure|kidney failure
1606957|NCT00369343|Major Depressive Disorder|major depressive disorder
1606958|NCT00369343|vasomotor symptoms|vasomotor symptoms
1606959|NCT00369343|menopause|menopause
1606960|NCT00369343|diabetic neuropathy|diabetic neuropathy
1606961|NCT00369343|fibromyalgia|fibromyalgia
1606962|NCT00369330|atrial fibrillation|atrial fibrillation
1606963|NCT00369330|early cardioversion|early cardioversion
1606964|NCT00369330|electrical cardioversion|electrical cardioversion
1606965|NCT00369304|Health|health
1606966|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
1606967|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
1606968|NCT00369265|Laryngitis|laryngitis
1606969|NCT00369265|Hoarseness|hoarseness
1606970|NCT00369265|Dysphonia|dysphonia
1606971|NCT00369265|Proton pump inhibitor|proton pump inhibitor
1606972|NCT00369252|Nimotuzumab|nimotuzumab
1606973|NCT00369252|TheraCIM|theracim
1606974|NCT00369252|H-R3|h-r3
1606975|NCT00369252|Solid tumours|solid tumours
1606976|NCT00369252|EGFR|egfr
1606977|NCT00369252|Monoclonal antibody|monoclonal antibody
1606978|NCT00369239|Early psychosis|early psychosis
1606979|NCT00369239|premorbid functioning|premorbid functioning
1606980|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
1606981|NCT00369239|Risperdal Consta|risperdal consta
1606982|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
1606983|NCT00369226|Velcade|velcade
1606984|NCT00369226|Bortezomib|bortezomib
1606985|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1606986|NCT00369226|GVHD|gvhd
1606987|NCT00369213|Crossover trial|crossover trial
1606988|NCT00369213|condom failure|condom failure
1606989|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
1606990|NCT00369148|glinides|glinides
1606991|NCT00369148|premixed insulin|premixed insulin
1606992|NCT00369148|combination therapy|combination therapy
1606993|NCT00369148|glycemic control|glycemic control
1606994|NCT00369135|work|work
1606995|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
1606996|NCT00369109|recurrent colon cancer|recurrent colon cancer
1606997|NCT00369109|stage III colon cancer|stage iii colon cancer
1606998|NCT00369109|stage IV colon cancer|stage iv colon cancer
1606999|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
1607000|NCT00369109|stage III rectal cancer|stage iii rectal cancer
1607001|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
1607002|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
1607003|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
1607004|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
1607005|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
1607006|NCT00369109|recurrent breast cancer|recurrent breast cancer
1607007|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
1607008|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
1607009|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
1607010|NCT00369109|stage IV breast cancer|stage iv breast cancer
1607011|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
1607012|NCT00369096|Bemiparin|bemiparin
1607013|NCT00369096|Icodextrin|icodextrin
1607014|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
1607015|NCT00369083|Frail elderly|frail elderly
1607016|NCT00369083|Hospital at home|hospital at home
1607017|NCT00369070|AMG 706|amg 706
1607018|NCT00369070|Bevacizumab|bevacizumab
1607019|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
1607020|NCT00369070|Randomized|randomized
1607021|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
1607022|NCT00369057|Intraocular pressure|intraocular pressure
1607516|NCT00366977|Quitline|quitline
1607023|NCT00369057|Prostatectomy|prostatectomy
1607024|NCT00369057|Robotic|robotic
1607025|NCT00369057|Glaucoma|glaucoma
1607026|NCT00369057|Carbon dioxide|carbon dioxide
1607027|NCT00369044|decompensated heart failure|decompensated heart failure
1607028|NCT00369044|prednisone|prednisone
1607029|NCT00369044|diuretics|diuretics
1607030|NCT00369044|diuresis|diuresis
1607032|NCT00369031|vaccine|vaccine
1607033|NCT00369031|nasal immunization|nasal immunization
1607034|NCT00369018|photodynamic therapy|photodynamic therapy
1607035|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
1607036|NCT00369018|hexaminolevulinate|hexaminolevulinate
1607037|NCT00369018|dose-finding|dose-finding
1607038|NCT00369018|cervical dysplasia|cervical dysplasia
1607039|NCT00369005|Transfusions|transfusions
1607040|NCT00369005|Erythrocyte|erythrocyte
1607041|NCT00369005|Anemia|anemia
1607042|NCT00369005|Brain|brain
1607043|NCT00369005|Infant, Premature|infant, premature
1607044|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
1607045|NCT00368966|Pneumococcal|pneumococcal
1607046|NCT00368966|Pediatric|pediatric
1607047|NCT00368966|Vaccine|vaccine
1607048|NCT00368940|Memory Deficits|memory deficits
1607049|NCT00368940|Geriatric Depression|geriatric depression
1607050|NCT00368940|Cognitive Impairment|cognitive impairment
1607051|NCT00368940|Executive Dysfunction|executive dysfunction
1607052|NCT00368940|Disability|disability
1607053|NCT00368940|Problem Solving Therapy|problem solving therapy
1607054|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1607055|NCT00368901|Aranesp|aranesp
1607056|NCT00368901|Anemia|anemia
1607057|NCT00368901|Kidney Disease|kidney disease
1607058|NCT00368901|Hemoglobin|hemoglobin
1607059|NCT00368901|darbepoetin alfa|darbepoetin alfa
1607060|NCT00368901|QoL|qol
1607061|NCT00368862|Alcoholism|alcoholism
1607063|NCT00368862|Efficacy study|efficacy study
1607064|NCT00368862|Memantine|memantine
1607065|NCT00368862|Escitalopram|escitalopram
1607066|NCT00368849|Huntington Disease|huntington disease
1607067|NCT00368849|Chorea|chorea
1607068|NCT00368849|Attention|attention
1607069|NCT00368849|ADHD|adhd
1607070|NCT00368849|ADD|add
1607071|NCT00368849|Strattera|strattera
1607072|NCT00368849|Atomoxetine|atomoxetine
1607073|NCT00368836|Capnography|capnography
1607074|NCT00368836|Thromboembolism|thromboembolism
1607075|NCT00368836|Arthroplasty|arthroplasty
1607076|NCT00368836|D-dimer|d-dimer
1607077|NCT00368823|point of care|point of care
1607078|NCT00368823|evidence based medicine|evidence based medicine
1607079|NCT00368810|Children|children
1607080|NCT00368810|Cross-Sectional|cross-sectional
1607081|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
1607082|NCT00368810|Cytokines|cytokines
1607083|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1607084|NCT00368810|Malaria|malaria
1607085|NCT00368797|Gene Therapy|gene therapy
1607086|NCT00368797|PAOD|paod
1607088|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
1607089|NCT00368771|Abdominal Pain|abdominal pain
1607090|NCT00368771|Abdominal Discomfort|abdominal discomfort
1607091|NCT00368771|Diarrhea|diarrhea
1607092|NCT00368771|Constipation|constipation
1607093|NCT00368771|IBS|ibs
1607094|NCT00368758|Meteorism|meteorism
1607095|NCT00368758|Bloating|bloating
1607096|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
1607097|NCT00368758|Probiotics|probiotics
1607098|NCT00368758|Bowel gas|bowel gas
1607099|NCT00368732|Congenital Heart Defects|congenital heart defects
1607100|NCT00368706|solifenacin|solifenacin
1607101|NCT00368706|Overactive bladder|overactive bladder
1607102|NCT00368706|Urinary incontinence|urinary incontinence
1607103|NCT00368706|Treatment outcomes|treatment outcomes
1607104|NCT00368706|VESIcare|vesicare
1607105|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
1607106|NCT00368680|Early Bubble CPAP|early bubble cpap
1607107|NCT00368680|Mechanical Ventilation|mechanical ventilation
1607108|NCT00368680|Surfactant|surfactant
1607109|NCT00368667|Anorexia Nervosa|anorexia nervosa
1607110|NCT00368667|Body Composition|body composition
1607111|NCT00368667|Metabolic Rate|metabolic rate
1607112|NCT00368628|acute ischemic stroke|acute ischemic stroke
1607113|NCT00368628|sleep apnea|sleep apnea
1607114|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
1607115|NCT00368615|melanoma|melanoma
1607116|NCT00368615|malignant melanoma|malignant melanoma
1607117|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
1607118|NCT00368589|USPIO|uspio
1607119|NCT00368589|Atheroma|atheroma
1607120|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
1607121|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
1607122|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
1607123|NCT00368576|SB-480848|sb-480848
1607124|NCT00368576|methacholine challenge|methacholine challenge
1607125|NCT00368576|asthma|asthma
1607126|NCT00368576|inhaled steroid|inhaled steroid
1607127|NCT00368550|Alcohol Drinking|alcohol drinking
1607128|NCT00368550|Alcohol Dependence|alcohol dependence
1607129|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
1607130|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
1607131|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
1607132|NCT00368537|skin infection|skin infection
1607133|NCT00368537|antibiotics|antibiotics
1607134|NCT00368524|cocaine dependence|cocaine dependence
1607135|NCT00368524|mental disorder|mental disorder
1607136|NCT00368524|dual diagnoses|dual diagnoses
1607137|NCT00368524|homelessness|homelessness
1607138|NCT00368511|Fall Prevention|fall prevention
1607139|NCT00368511|Dynamic Posturography|dynamic posturography
1607140|NCT00368511|Nolwenn Effect|nolwenn effect
1607141|NCT00368511|Music Listening|music listening
1607142|NCT00368498|teicoplanin|teicoplanin
1607143|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
1607144|NCT00368485|non invasive ventilation|non invasive ventilation
1607145|NCT00368485|patient ventilator interaction|patient ventilator interaction
1607146|NCT00368472|Refractory|refractory
1607147|NCT00368472|Partial|partial
1607148|NCT00368472|Seizures|seizures
1607149|NCT00368459|raloxifene, women|raloxifene, women
1607150|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
1607151|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1607152|NCT00368446|Cystic Fibrosis|cystic fibrosis
1607153|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
1607154|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
1607155|NCT00368446|Mycobacterial Infection|mycobacterial infection
1607156|NCT00368446|PCD|pcd
1607157|NCT00368446|CF|cf
1607158|NCT00368446|PHA|pha
1607159|NCT00368446|Healthy Volunteer|healthy volunteer
1607160|NCT00368446|HV|hv
1607161|NCT00368433|Sensory Processing|sensory processing
1607162|NCT00368433|Electromyogram|electromyogram
1607163|NCT00368433|Tic Disorder|tic disorder
1607164|NCT00368433|Tourette Syndrome|tourette syndrome
1607165|NCT00368433|Tourette's Syndrome|tourette's syndrome
1607166|NCT00368433|Healthy Volunteer|healthy volunteer
1607167|NCT00368433|HV|hv
1607168|NCT00368420|ovarian cancer|ovarian cancer
1607169|NCT00368420|recurrence|recurrence
1607170|NCT00368420|surgery|surgery
1607171|NCT00368407|308-nm excimer laser|308-nm excimer laser
1607172|NCT00368407|vitiligo|vitiligo
1607173|NCT00368394|Insulin glulisine|insulin glulisine
1607174|NCT00368394|Euglycaemic clamp|euglycaemic clamp
1607175|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
1607176|NCT00368381|sepsis|sepsis
1607177|NCT00368381|septicemia|septicemia
1607178|NCT00368381|sepsis syndrome|sepsis syndrome
1607179|NCT00368381|adrenal insufficiency|adrenal insufficiency
1607180|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
1607181|NCT00368381|hydrocortisone|hydrocortisone
1607182|NCT00368381|fludrocortisone|fludrocortisone
1607183|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
1607184|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1607185|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
1607186|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
1607187|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
1607188|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
1607189|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
1607190|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
1607191|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
1607192|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
1607193|NCT00368316|Dysentery|dysentery
1607194|NCT00368316|S. sonnei|s. sonnei
1607195|NCT00368316|Antibody Response|antibody response
1607196|NCT00368316|Protection|protection
1607197|NCT00368303|Major Depression|major depression
1607198|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
1607199|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
1607200|NCT00368290|cocaine dependence|cocaine dependence
1607201|NCT00368290|hiv prevention|hiv prevention
1607202|NCT00368277|Systolic hypertension|systolic hypertension
1607203|NCT00368277|hypertension|hypertension
1607204|NCT00368277|aliskiren|aliskiren
1607205|NCT00368277|blood pressure|blood pressure
1607206|NCT00368277|ramipril|ramipril
1607207|NCT00368277|HTN|htn
1607208|NCT00368264|lupus|lupus
1607209|NCT00368264|nephritis|nephritis
1607210|NCT00368264|membraneous|membraneous
1607211|NCT00368264|proteinuria|proteinuria
1607212|NCT00368264|TNF|tnf
1607213|NCT00368264|infliximab|infliximab
1607214|NCT00368264|azathioprine|azathioprine
1607215|NCT00368264|autoantibodies|autoantibodies
1607216|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
1607217|NCT00368251|Baltic Myoclonus|baltic myoclonus
1607218|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
1607219|NCT00368251|Myoclonus|myoclonus
1607220|NCT00368251|Brivaracetam|brivaracetam
1607221|NCT00368238|Platelet function tests|platelet function tests
1607222|NCT00368238|Erythropoietin|erythropoietin
1607223|NCT00368238|Aspirin|aspirin
1607224|NCT00368238|Clopidogrel|clopidogrel
1607225|NCT00368225|Viral Hepatitis|viral hepatitis
1607226|NCT00368225|Hepatitis C|hepatitis c
1607227|NCT00368225|HCV|hcv
1607228|NCT00368225|Liver Transplant|liver transplant
1607229|NCT00368225|Renal Transplant|renal transplant
1607230|NCT00368225|Kidney Transplant|kidney transplant
1607231|NCT00368212|Somatization|somatization
1607232|NCT00368212|Refractory Symptoms|refractory symptoms
1607233|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
1607234|NCT00368199|transcranial sonography|transcranial sonography
1607235|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
1607236|NCT00368199|parkinson's disease|parkinson's disease
1607237|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
1607238|NCT00368199|parkinsonism|parkinsonism
1607239|NCT00368199|parkinsonian|parkinsonian
1607240|NCT00368199|diagnostic|diagnostic
1607241|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
1607242|NCT00368160|Next day driving|next day driving
1607243|NCT00368147|Hemodialysis|hemodialysis
1607244|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
1607245|NCT00368147|Arteriovenous Graft|arteriovenous graft
1607246|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
1607247|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
1607248|NCT00368134|Type 2 Diabetes|type 2 diabetes
1607249|NCT00368134|Vildagliptin|vildagliptin
1607250|NCT00368134|HbA1c|hba1c
1607251|NCT00368121|Multiple Myeloma|multiple myeloma
1607252|NCT00368121|Cetuximab|cetuximab
1607253|NCT00368095|DM|dm
1607254|NCT00368095|HT|ht
1607255|NCT00368095|Dyslipidemia|dyslipidemia
1607256|NCT00368095|Obesity|obesity
1607257|NCT00368095|Cardiovascular disease|cardiovascular disease
1607258|NCT00368095|Cerebrovascular disease|cerebrovascular disease
1607259|NCT00368095|Myocardial infarction|myocardial infarction
1607260|NCT00368095|stroke|stroke
1607261|NCT00368095|Metabolic syndrome|metabolic syndrome
1607262|NCT00368095|CVD-CAD|cvd-cad
1607263|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
1607264|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
1607265|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1607266|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
1607267|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
1607268|NCT00368082|lymphoma|lymphoma
1607269|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
1607270|NCT00368082|cytotoxic T cells|cytotoxic t cells
1607271|NCT00368069|Epilepsy|epilepsy
1607272|NCT00368069|Keppra® XR|keppra® xr
1607273|NCT00368069|Levetiracetam XR|levetiracetam xr
1607274|NCT00368069|Extended release|extended release
1607275|NCT00368043|Pituitary|pituitary
1607276|NCT00368043|Adrenal|adrenal
1607277|NCT00368043|Growth|growth
1607278|NCT00368043|Cortisol|cortisol
1607279|NCT00368043|Stress Response|stress response
1607280|NCT00368043|Adoption|adoption
1607281|NCT00368043|Thyroid Hormone|thyroid hormone
1607282|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
1607283|NCT00368043|Healthy Volunteer|healthy volunteer
1607284|NCT00368043|HV|hv
1607285|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
1607286|NCT00368004|Coloboma|coloboma
1607287|NCT00368004|Genetics|genetics
1607288|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
1607289|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
1607290|NCT00368004|Iris Coloboma|iris coloboma
1607291|NCT00368004|Uveal Coloboma|uveal coloboma
1607292|NCT00367991|Platelet function tests|platelet function tests
1607293|NCT00367991|Erythropoietin|erythropoietin
1607294|NCT00367991|Myocardial infarction|myocardial infarction
1607295|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
1607296|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
1607297|NCT00367952|HIV|hiv
1607298|NCT00367952|apricitabine|apricitabine
1607299|NCT00367952|drug resistance|drug resistance
1607300|NCT00367952|reverse transcriptase|reverse transcriptase
1607301|NCT00367952|lamivudine|lamivudine
1607302|NCT00367939|Hypertension|hypertension
1607303|NCT00367926|ginseng|ginseng
1607304|NCT00367926|polysaccharides|polysaccharides
1607305|NCT00367926|postprandial glycemia|postprandial glycemia
1607306|NCT00367926|area under the glucose curve|area under the glucose curve
1607307|NCT00367926|peak incremental glucose|peak incremental glucose
1607308|NCT00367913|pulmonary disease|pulmonary disease
1607309|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
1607310|NCT00367913|Clarithromycin|clarithromycin
1607311|NCT00367913|Ciprofloxacin|ciprofloxacin
1607312|NCT00367913|M.vaccae|m.vaccae
1607313|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
1607314|NCT00367900|Diet|diet
1607315|NCT00367900|Lifestyle|lifestyle
1607316|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
1607317|NCT00367900|Elderly Population|elderly population
1607318|NCT00367900|Public Health|public health
1607319|NCT00367900|Parkinson Disease|parkinson disease
1607320|NCT00367900|Environment|environment
1607321|NCT00367887|Hepatitis C|hepatitis c
1607324|NCT00367874|Polydrug Abuse|polydrug abuse
1607325|NCT00367874|Detoxification|detoxification
1607326|NCT00367874|Withdrawal Treatment|withdrawal treatment
1607327|NCT00367861|GIST|gist
1607328|NCT00367861|Glivec®|glivec®
1607329|NCT00367861|randomized|randomized
1607330|NCT00367861|phase III|phase iii
1607331|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
1607332|NCT00367822|Restless Legs Syndrome|restless legs syndrome
1607333|NCT00367822|dopamine agonist|dopamine agonist
1607334|NCT00367822|lisuride|lisuride
1607335|NCT00367822|ropinirole|ropinirole
1607336|NCT00367809|Meditation|meditation
1607337|NCT00367809|Mindfulness|mindfulness
1607338|NCT00367809|Organ Transplant|organ transplant
1607339|NCT00367809|Transplantation|transplantation
1607340|NCT00367809|Minnesota|minnesota
1607341|NCT00367809|Immune suppressive therapy|immune suppressive therapy
1607342|NCT00367796|Craniosynostosis|craniosynostosis
1607343|NCT00367796|Philadelphia Type|philadelphia type
1607344|NCT00367770|bosentan|bosentan
1607345|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
1607346|NCT00367770|Tracleer|tracleer
1607347|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1607348|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
1607349|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
1607350|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
1607351|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
1607352|NCT00367757|AF trigger|af trigger
1607353|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
1607354|NCT00367757|CFE|cfe
1607355|NCT00367757|CFAE|cfae
1607356|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
1607357|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
1607358|NCT00367757|PVAI|pvai
1607359|NCT00367757|Ensite NavX|ensite navx
1607360|NCT00367757|NavX|navx
1607361|NCT00367757|CoolPath catheter|coolpath catheter
1607362|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
1607363|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
1607364|NCT00367757|candidates for AF ablation|candidates for af ablation
1607365|NCT00367757|symptomatic AF|symptomatic af
1607366|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
1607367|NCT00367744|mitochondria|mitochondria
1607368|NCT00367744|HIV|hiv
1607369|NCT00367744|lipoatrophy|lipoatrophy
1607370|NCT00367731|HIV|hiv
1607371|NCT00367731|AIDS|aids
1607372|NCT00367731|Neurological complications|neurological complications
1607373|NCT00367731|HAART|haart
1607374|NCT00367692|Scleritis|scleritis
1607375|NCT00367679|pazopanib|pazopanib
1607376|NCT00367679|I-ELCAP|i-elcap
1607377|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
1607378|NCT00367679|antiangiogenesis|antiangiogenesis
1607379|NCT00367679|NSCLC|nsclc
1607380|NCT00367679|GW786034|gw786034
1607381|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
1607382|NCT00367640|Grass pollen tablet|grass pollen tablet
1607383|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
1607384|NCT00367627|Children|children
1607385|NCT00367627|Malnutrition|malnutrition
1607386|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
1607387|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
1607388|NCT00367627|Helminthiasis|helminthiasis
1607389|NCT00367627|Children 2-5 years|children 2-5 years
1607390|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
1607391|NCT00367614|Adolescents|adolescents
1607392|NCT00367614|GERD|gerd
1607393|NCT00367588|chemotherapy|chemotherapy
1607394|NCT00367588|diet|diet
1607395|NCT00367588|hematological malignancy|hematological malignancy
1607396|NCT00367588|infection prevention|infection prevention
1607397|NCT00367588|protective isolation|protective isolation
1607398|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
1607399|NCT00367575|alcoholism|alcoholism
1607400|NCT00367575|drinking|drinking
1607401|NCT00367575|randomized|randomized
1607402|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
1607403|NCT00367562|IGA NEPHROPATHY|iga nephropathy
1607404|NCT00367562|STEROIDS|steroids
1607405|NCT00367562|ENALAPRIL|enalapril
1607406|NCT00367562|VALSARTAN|valsartan
1607407|NCT00367562|PROTEINURIA|proteinuria
1607408|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
1607409|NCT00367549|Labor|labor
1607410|NCT00367549|instrumental delivery|instrumental delivery
1607411|NCT00367549|nutrition|nutrition
1607412|NCT00367549|epidural anesthesia|epidural anesthesia
1607413|NCT00367549|oxytocin|oxytocin
1607414|NCT00367536|Health|health
1607517|NCT00366977|Policies|policies
1607421|NCT00367497|salvage chemotherapy|salvage chemotherapy
1607423|NCT00367471|metastatic|metastatic
1607424|NCT00367471|paclitaxel|paclitaxel
1607425|NCT00367471|lapatinib|lapatinib
1607426|NCT00367471|trastuzumab|trastuzumab
1607427|NCT00367471|carboplatin|carboplatin
1607428|NCT00367471|breast cancer|breast cancer
1607429|NCT00367458|Viremia|viremia
1607430|NCT00367458|Statin|statin
1607431|NCT00367458|HIV Replication|hiv replication
1607432|NCT00367458|Cholesterol|cholesterol
1607433|NCT00367458|Lipid Raft|lipid raft
1607434|NCT00367458|HIV Infection|hiv infection
1607435|NCT00367458|HIV Positive|hiv positive
1607436|NCT00367432|Epilepsies|epilepsies
1607437|NCT00367432|Partial|partial
1607438|NCT00367432|Keppra|keppra
1607439|NCT00367432|levetiracetam|levetiracetam
1607440|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
1607441|NCT00367380|Malaria|malaria
1607442|NCT00367380|Sporozoite|sporozoite
1607443|NCT00367380|Challenge Model|challenge model
1607444|NCT00367380|Plasmodium vivax|plasmodium vivax
1607445|NCT00367380|Human Volunteers|human volunteers
1607446|NCT00367367|embryo transfer|embryo transfer
1607447|NCT00367367|hysteroscopy|hysteroscopy
1607448|NCT00367367|curettage|curettage
1607449|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
1607450|NCT00367367|molecular markers|molecular markers
1607451|NCT00367367|endometrial receptivity|endometrial receptivity
1607452|NCT00367367|endometrial dating|endometrial dating
1607453|NCT00367354|Imaging Technology|imaging technology
1607454|NCT00367354|Cardiology|cardiology
1607455|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
1607456|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
1607457|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
1607458|NCT00367302|addiction|addiction
1607459|NCT00367302|jail|jail
1607460|NCT00367302|opiates|opiates
1607461|NCT00367302|buprenorphine|buprenorphine
1607462|NCT00367302|clinical trial|clinical trial
1607463|NCT00367276|Females requiring contraceptives|females requiring contraceptives
1607464|NCT00367263|Asthma|asthma
1607465|NCT00367224|vitiligo|vitiligo
1607467|NCT00367224|ultraviolet B.|ultraviolet b.
1607468|NCT00367211|Gastric Ulcers|gastric ulcers
1607469|NCT00367211|NSAID|nsaid
1607470|NCT00367211|Arthritis|arthritis
1607471|NCT00367185|Multiple myeloma|multiple myeloma
1607472|NCT00367185|Elderly patients|elderly patients
1607473|NCT00367185|Thalidomide|thalidomide
1607474|NCT00367185|Autologous transplantation|autologous transplantation
1607475|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
1607476|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1607477|NCT00367172|substance abuse|substance abuse
1607478|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
1607479|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
1607480|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
1607481|NCT00367146|liver transplantation|liver transplantation
1607482|NCT00367146|children|children
1607483|NCT00367146|immunosuppression|immunosuppression
1607484|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
1607485|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
1607486|NCT00367146|kidney disease|kidney disease
1607487|NCT00367133|diabetic|diabetic
1607488|NCT00367133|macular|macular
1607489|NCT00367133|edema|edema
1607490|NCT00367133|intravitreal|intravitreal
1607491|NCT00367133|triamcinolone|triamcinolone
1607492|NCT00367133|laser|laser
1607493|NCT00367133|photocoagulation|photocoagulation
1607494|NCT00367133|DME|dme
1607495|NCT00367107|Autism spectrum disorders|autism spectrum disorders
1607496|NCT00367107|long-term outcomes|long-term outcomes
1607497|NCT00367107|caregiver burden|caregiver burden
1607498|NCT00367107|birth cohort|birth cohort
1607499|NCT00367107|nested case-control study|nested case-control study
1607500|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
1607501|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
1607502|NCT00367081|AIDS|aids
1607503|NCT00367068|Cerebral palsy|cerebral palsy
1607504|NCT00367068|Spasticity|spasticity
1607505|NCT00367068|Child|child
1607506|NCT00367068|Baclofen|baclofen
1607507|NCT00367068|Intrathecal injection|intrathecal injection
1607508|NCT00367055|Beta cell function|beta cell function
1607509|NCT00367055|Type 2 diabetes|type 2 diabetes
1607510|NCT00367055|Combination treatment|combination treatment
1607511|NCT00367029|Physical Activity|physical activity
1607512|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
1607513|NCT00366990|Arterial Stiffening|arterial stiffening
1607514|NCT00366977|Cessation|cessation
1607515|NCT00366977|Smoking|smoking
1607518|NCT00366977|Counseling|counseling
1607519|NCT00366951|Cervical Ripening|cervical ripening
1607520|NCT00366951|Labor, Induced|labor, induced
1607521|NCT00366951|Balloon Dilation|balloon dilation
1607522|NCT00366951|Oxytocin|oxytocin
1607523|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
1607524|NCT00366912|work of breathing|work of breathing
1607525|NCT00366912|pressure time product|pressure time product
1607526|NCT00366912|muscle pressures|muscle pressures
1607527|NCT00366899|Vaccine|vaccine
1607528|NCT00366899|Infants|infants
1607529|NCT00366886|cardiac|cardiac
1607530|NCT00366886|pediatric|pediatric
1607531|NCT00366886|surgery|surgery
1607532|NCT00366886|blood markers|blood markers
1607533|NCT00366873|Infant|infant
1607534|NCT00366873|Term|term
1607535|NCT00366860|soy|soy
1607536|NCT00366860|isoflavones|isoflavones
1607537|NCT00366860|bone resorption|bone resorption
1607538|NCT00366860|osteogenesis|osteogenesis
1607539|NCT00366860|diet|diet
1607540|NCT00366860|hyperlipidemia|hyperlipidemia
1607541|NCT00366847|cardiac|cardiac
1607542|NCT00366847|MRI|mri
1607543|NCT00366847|pediatrics|pediatrics
1607544|NCT00366834|Anthracycline|anthracycline
1607545|NCT00366834|Cyclophosphamide|cyclophosphamide
1607546|NCT00366834|Moderately|moderately
1607547|NCT00366834|Nausea|nausea
1607548|NCT00366834|Emetogenic|emetogenic
1607549|NCT00366834|Vomiting|vomiting
1607550|NCT00366821|cardiac|cardiac
1607551|NCT00366821|pediatric|pediatric
1607552|NCT00366821|genetic|genetic
1607553|NCT00366782|Respiratory Tract Disease|respiratory tract disease
1607554|NCT00366782|Bovine|bovine
1607555|NCT00366782|Chimeric Vaccine|chimeric vaccine
1607556|NCT00366756|Vision|vision
1607557|NCT00366756|Visual Acuity|visual acuity
1607558|NCT00366730|Amebiasis|amebiasis
1607559|NCT00366730|Entamoeba histolytica|entamoeba histolytica
1607560|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
1607561|NCT00366704|Schizophrenia|schizophrenia
1607562|NCT00366691|cataract|cataract
1607563|NCT00366678|Safety|safety
1607564|NCT00366678|Vaccine|vaccine
1607565|NCT00366652|Healthy|healthy
1607566|NCT00366639|Heart failure, congestive|heart failure, congestive
1607567|NCT00366639|Heart decompensation|heart decompensation
1607568|NCT00366626|Alcohol dependence|alcohol dependence
1607569|NCT00366626|Alcoholism|alcoholism
1607570|NCT00366626|Craving|craving
1607571|NCT00366626|Genetic|genetic
1607573|NCT00366613|Cataract Extraction|cataract extraction
1607574|NCT00366600|Breast Cancer|breast cancer
1607575|NCT00366600|Health|health
1607576|NCT00366600|Pharmacokinetics|pharmacokinetics
1607577|NCT00366600|healthy subjects|healthy subjects
1607578|NCT00366561|neonates|neonates
1607579|NCT00366561|neurological complications|neurological complications
1607580|NCT00366561|surgery|surgery
1607581|NCT00366548|Vaccine|vaccine
1607582|NCT00366548|Infant|infant
1607583|NCT00366535|Muscle Pain|muscle pain
1607584|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
1607585|NCT00366535|Stiffness|stiffness
1607586|NCT00366535|Tender Points|tender points
1607587|NCT00366535|Fibromyalgia|fibromyalgia
1607588|NCT00366522|Safety|safety
1607589|NCT00366522|Healthy|healthy
1607590|NCT00366522|healthy subjects|healthy subjects
1607591|NCT00366509|Vac A Toxin|vac a toxin
1607592|NCT00366509|Lung|lung
1607593|NCT00366509|Bronchoscopy|bronchoscopy
1607594|NCT00366509|Endoscopy|endoscopy
1607595|NCT00366509|Cytotoxin|cytotoxin
1607596|NCT00366509|Pulmonary Disease|pulmonary disease
1607597|NCT00366509|Lung Disease|lung disease
1607598|NCT00366509|Genetic Disease|genetic disease
1607599|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
1607600|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
1607601|NCT00366509|Asthma|asthma
1607602|NCT00366483|healthy young volunteers|healthy young volunteers
1607603|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
1607604|NCT00366483|Alzheimer's disease|alzheimer's disease
1607605|NCT00366483|5HT1A antagonist|5ht1a antagonist
1607606|NCT00366483|Health|health
1607607|NCT00366483|Pharmacokinetics|pharmacokinetics
1607608|NCT00366444|Bunionectomy|bunionectomy
1607609|NCT00366444|Bunion surgery|bunion surgery
1607610|NCT00366444|Post-operative pain|post-operative pain
1607611|NCT00366431|OIBD|oibd
1607612|NCT00366431|OIC|oic
1607613|NCT00366431|Opioid|opioid
1607614|NCT00366431|Constipation|constipation
1607615|NCT00366431|Laxative|laxative
1607616|NCT00366418|CLL|cll
1607617|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
1607618|NCT00366418|Anti CD20|anti cd20
1607619|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
1607620|NCT00366418|Fractionated-Dose|fractionated-dose
1607621|NCT00366418|Low-Dose|low-dose
1607622|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1607623|NCT00366405|cataract|cataract
1607624|NCT00366392|Low Vision|low vision
1607625|NCT00366392|Optical Aids|optical aids
1607626|NCT00366353|Mechanical Ventilation|mechanical ventilation
1607907|NCT00365417|Neoadjuvant|neoadjuvant
1607627|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
1607628|NCT00366353|Sedation|sedation
1607629|NCT00366340|safety|safety
1607630|NCT00366340|Vaccine|vaccine
1607631|NCT00366327|Schizophrenia|schizophrenia
1607632|NCT00366314|Blood samples|blood samples
1607633|NCT00366314|Medication administration|medication administration
1607634|NCT00366314|CICU|cicu
1607635|NCT00366314|PICU|picu
1607636|NCT00366314|NICU|nicu
1607637|NCT00366301|type 2 diabetes|type 2 diabetes
1607638|NCT00366301|insulin|insulin
1607639|NCT00366301|insulin injection|insulin injection
1607640|NCT00366301|metformin|metformin
1607641|NCT00366301|C-reactive protein|c-reactive protein
1607642|NCT00366301|insulin sensitivity|insulin sensitivity
1607643|NCT00366301|glycemic control|glycemic control
1607644|NCT00366301|inflammation|inflammation
1607645|NCT00366288|Healthy|healthy
1607646|NCT00366288|Safety|safety
1607647|NCT00366275|follicular lymphoma|follicular lymphoma
1607648|NCT00366275|rituximab|rituximab
1607649|NCT00366275|immunochemotherapy|immunochemotherapy
1607650|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
1607651|NCT00366275|in vivo purging|in vivo purging
1607652|NCT00366275|autotransplant|autotransplant
1607653|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
1607654|NCT00366275|molecular response|molecular response
1607655|NCT00366262|Health|health
1607656|NCT00366249|Diabetic foot infection|diabetic foot infection
1607657|NCT00366249|Osteomyelitis|osteomyelitis
1607658|NCT00366249|Diabetes Complications|diabetes complications
1607659|NCT00366249|Foot ulcer|foot ulcer
1607660|NCT00366249|Skin infection|skin infection
1607661|NCT00366236|Amebiasis|amebiasis
1607662|NCT00366236|Entamoeba histolytica|entamoeba histolytica
1607663|NCT00366223|infection|infection
1607664|NCT00366223|candida|candida
1607665|NCT00366210|stroke|stroke
1607666|NCT00366210|rehabilitation|rehabilitation
1607667|NCT00366210|physical therapy|physical therapy
1607668|NCT00366210|occupational therapy|occupational therapy
1607669|NCT00366210|arm|arm
1607670|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
1607671|NCT00366197|Mechanical Ventilation|mechanical ventilation
1607672|NCT00366184|Neuromodulation|neuromodulation
1607673|NCT00366184|Stroke|stroke
1607674|NCT00366184|Motor Cortex|motor cortex
1607675|NCT00366184|Motor Learning|motor learning
1607676|NCT00366184|L-Dopa|l-dopa
1607677|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1607678|NCT00366184|Levodopa|levodopa
1607679|NCT00366184|Healthy Volunteer|healthy volunteer
1607680|NCT00366184|HV|hv
1607681|NCT00366171|Schizophrenia|schizophrenia
1607682|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
1607683|NCT00366145|acute GVHD|acute gvhd
1607684|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
1607685|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
1607686|NCT00366145|steroid refractory|steroid refractory
1607687|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
1607688|NCT00366132|Diabetic|diabetic
1607689|NCT00366132|Foot Ulcers|foot ulcers
1607690|NCT00366132|TRT|trt
1607691|NCT00366132|DermaGold|dermagold
1607692|NCT00366132|Shockwave|shockwave
1607693|NCT00366132|ESWT|eswt
1607694|NCT00366132|Diabetes Mellitus|diabetes mellitus
1607695|NCT00366119|hypertension|hypertension
1607696|NCT00366119|ramipril|ramipril
1607697|NCT00366119|blood pressure|blood pressure
1607698|NCT00366119|artery stiffness|artery stiffness
1607699|NCT00366119|BNP|bnp
1607700|NCT00366119|CRP|crp
1607701|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
1607702|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
1607703|NCT00366093|Menopause|menopause
1607704|NCT00366093|Perimenopause|perimenopause
1607705|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
1607706|NCT00366067|Bronchial asthma|bronchial asthma
1607707|NCT00366067|Phenytoin|phenytoin
1607708|NCT00366067|Antiepileptic drugs|antiepileptic drugs
1607709|NCT00366067|Efficacy|efficacy
1607710|NCT00366028|Organization Innovation|organization innovation
1607711|NCT00366028|Diffusion of Innovation|diffusion of innovation
1607712|NCT00366028|Evidence-based Medicine|evidence-based medicine
1607713|NCT00366028|Infection Control|infection control
1607714|NCT00366015|Coronary Artery Disease|coronary artery disease
1607715|NCT00366015|PCI|pci
1607716|NCT00366015|Drug eluting stents|drug eluting stents
1607717|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
1607718|NCT00366015|Robotic CABG|robotic cabg
1607719|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
1607720|NCT00365989|Fibroids|fibroids
1607721|NCT00365989|leiomyoma|leiomyoma
1607722|NCT00365989|neoplasm|neoplasm
1607723|NCT00365989|benign tumors|benign tumors
1607724|NCT00365976|Insomnia|insomnia
1607725|NCT00365976|Low Back Pain|low back pain
1607726|NCT00365976|Hypnotics|hypnotics
1607727|NCT00365976|Eszopiclone|eszopiclone
1607728|NCT00365976|Pain|pain
1607729|NCT00365976|Disability|disability
1607730|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
1607731|NCT00365950|Duration of anticoagulation|duration of anticoagulation
1607732|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
1607733|NCT00365937|immunotherapy|immunotherapy
1607734|NCT00365937|adjuvants|adjuvants
1607735|NCT00365937|IMP321|imp321
1607736|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
1607737|NCT00365937|tumor-specific peptides|tumor-specific peptides
1607738|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
1607739|NCT00365911|No specific condition|no specific condition
1607740|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
1607741|NCT00365885|Medical Informatics|medical informatics
1607742|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
1607743|NCT00365885|Community Health Services|community health services
1607744|NCT00365885|Costs and Cost analysis|costs and cost analysis
1607745|NCT00365872|Sarcoma|sarcoma
1607746|NCT00365872|Intratumoral injection|intratumoral injection
1607747|NCT00365872|Dendritic cells|dendritic cells
1607748|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
1607749|NCT00365872|Immunotherapy|immunotherapy
1607750|NCT00365872|Pheresis|pheresis
1607751|NCT00365872|Radiation|radiation
1607752|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
1607753|NCT00365859|behavioral problems|behavioral problems
1607754|NCT00365846|prevent kidney rejection|prevent kidney rejection
1607755|NCT00365833|Transplantation|transplantation
1607756|NCT00365833|Cardiovascular|cardiovascular
1607757|NCT00365833|Renal|renal
1607758|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
1607759|NCT00365820|Opioid-induced constipation|opioid-induced constipation
1607760|NCT00365807|Obesity|obesity
1607761|NCT00365807|Overweight|overweight
1607762|NCT00365807|Behavioral treatment|behavioral treatment
1607763|NCT00365807|Family involvement|family involvement
1607764|NCT00365794|Aging|aging
1607765|NCT00365794|Older men|older men
1607766|NCT00365794|Abdominal obesity|abdominal obesity
1607767|NCT00365794|Central obesity|central obesity
1607768|NCT00365794|Insulin resistance|insulin resistance
1607769|NCT00365794|Low testosterone|low testosterone
1607770|NCT00365781|Injection Site Reaction|injection site reaction
1607771|NCT00365781|Subcutaneous administration|subcutaneous administration
1607772|NCT00365781|Dermatological effects|dermatological effects
1607774|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1607775|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1607776|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1607777|NCT00365768|stage I Wilms tumor|stage i wilms tumor
1607778|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
1607779|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
1607780|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
1607781|NCT00365768|stage V Wilms tumor|stage v wilms tumor
1607782|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1607783|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1607784|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1607785|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1607786|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1607787|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1608113|NCT00365092|Achievement|achievement
1607788|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1607789|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1607790|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1607791|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1607792|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1607793|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
1607794|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1607795|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1607796|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1607797|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1607798|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
1607799|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
1607800|NCT00365768|neurotoxicity|neurotoxicity
1607801|NCT00365768|peripheral neuropathy|peripheral neuropathy
1607802|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
1607803|NCT00365742|red yeast rice|red yeast rice
1607804|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
1607805|NCT00365742|simvastatin|simvastatin
1607806|NCT00365742|primary prevention|primary prevention
1607807|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
1607808|NCT00365729|HIV infection|hiv infection
1607906|NCT00365417|Locally advanced|locally advanced
1607809|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
1607810|NCT00365703|Infant, Premature|infant, premature
1607811|NCT00365703|Tube feeding|tube feeding
1607812|NCT00365690|AIDS|aids
1607813|NCT00365690|Older Adults|older adults
1607814|NCT00365690|Telephone|telephone
1607815|NCT00365690|Telemedicine|telemedicine
1607816|NCT00365651|obesity|obesity
1607817|NCT00365651|overweight|overweight
1607818|NCT00365638|PCOS|pcos
1607819|NCT00365638|statin|statin
1607820|NCT00365638|testosterone|testosterone
1607821|NCT00365638|lipids|lipids
1607822|NCT00365625|Psoriasis|psoriasis
1607823|NCT00365625|JAM3 protein, human|jam3 protein, human
1607824|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
1607825|NCT00365625|Skin|skin
1607826|NCT00365625|Inflammation|inflammation
1607827|NCT00365625|Lymphocytes|lymphocytes
1607829|NCT00365612|HIV-1|hiv-1
1607830|NCT00365612|AIDS|aids
1607831|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
1607832|NCT00365612|HIV-1 Infection|hiv-1 infection
1607833|NCT00365599|Breast cancer|breast cancer
1607834|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
1607835|NCT00365599|Vorinostat|vorinostat
1607836|NCT00365599|Tamoxifen|tamoxifen
1607837|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
1607838|NCT00365599|Estrogen receptor positive|estrogen receptor positive
1607839|NCT00365599|Progesterone receptor positive|progesterone receptor positive
1607840|NCT00365599|Metastatic disease|metastatic disease
1607841|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
1607842|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
1607843|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
1607844|NCT00365586|Pain|pain
1607845|NCT00365586|Osteoarthritis|osteoarthritis
1607846|NCT00365586|Knee|knee
1607847|NCT00365586|NSAID|nsaid
1607848|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1607849|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1607850|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1607851|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
1607852|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1607853|NCT00365547|large cell lung cancer|large cell lung cancer
1607854|NCT00365534|First colonoscopy examination|first colonoscopy examination
1607855|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
1608095|NCT00365105|pain|pain
1607856|NCT00365508|bladder cancer|bladder cancer
1607857|NCT00365508|cervical cancer|cervical cancer
1607858|NCT00365508|esophageal cancer|esophageal cancer
1607859|NCT00365508|gastric cancer|gastric cancer
1607860|NCT00365508|renal cell carcinoma|renal cell carcinoma
1607861|NCT00365508|adult primary liver cancer|adult primary liver cancer
1607862|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
1607863|NCT00365508|small cell lung cancer|small cell lung cancer
1607864|NCT00365508|pancreatic cancer|pancreatic cancer
1607865|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
1607866|NCT00365508|laryngeal cancer|laryngeal cancer
1607867|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
1607868|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
1607869|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
1607870|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1607871|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
1607872|NCT00365508|tongue cancer|tongue cancer
1607873|NCT00365508|tobacco use disorder|tobacco use disorder
1607874|NCT00365495|Type 2 diabetes|type 2 diabetes
1607875|NCT00365495|physical training|physical training
1607876|NCT00365495|mitochondrial function|mitochondrial function
1607877|NCT00365482|Epilepsy|epilepsy
1607878|NCT00365482|Bipolar Disorder|bipolar disorder
1607879|NCT00365469|Probiotics|probiotics
1607880|NCT00365469|Eczema|eczema
1607881|NCT00365469|Asthma|asthma
1607882|NCT00365469|Allergic Rhinitis|allergic rhinitis
1607883|NCT00365469|Prevention|prevention
1607884|NCT00365469|Immunological responses|immunological responses
1607885|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
1607886|NCT00365443|anogenital warts|anogenital warts
1607887|NCT00365443|premalignancy|premalignancy
1607888|NCT00365443|HPV|hpv
1607889|NCT00365443|Human papillomavirus|human papillomavirus
1607890|NCT00365430|Patient safety|patient safety
1607891|NCT00365430|Adverse event|adverse event
1607892|NCT00365430|Prevention|prevention
1607893|NCT00365430|Knowledge|knowledge
1607894|NCT00365430|Inpatient|inpatient
1607895|NCT00365430|Hospital|hospital
1607896|NCT00365430|Nursing home|nursing home
1607897|NCT00365430|Long term care|long term care
1607898|NCT00365430|Nurse|nurse
1607899|NCT00365417|NSABP|nsabp
1607900|NCT00365417|Doxorubicin|doxorubicin
1607901|NCT00365417|Cyclophosphamide|cyclophosphamide
1607902|NCT00365417|Bevacizumab|bevacizumab
1607903|NCT00365417|Capecitabine|capecitabine
1607904|NCT00365417|Docetaxel|docetaxel
1607905|NCT00365417|Breast cancer|breast cancer
1607908|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
1607909|NCT00365404|Behavioral change|behavioral change
1607910|NCT00365404|Weight management|weight management
1607911|NCT00365404|Physical activity|physical activity
1607913|NCT00365339|Protease Inhibitor|protease inhibitor
1607914|NCT00365326|AC133|ac133
1607915|NCT00365326|coronary|coronary
1607916|NCT00365326|bone marrow|bone marrow
1607917|NCT00365326|autologous|autologous
1607918|NCT00365326|coronary artery disease|coronary artery disease
1607919|NCT00365313|celecoxib|celecoxib
1607920|NCT00365313|oesomeprazole|oesomeprazole
1607921|NCT00365313|arthritis|arthritis
1607922|NCT00365313|ulcer bleeding|ulcer bleeding
1607923|NCT00365300|GERD|gerd
1607924|NCT00365300|Infants|infants
1607925|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
1607926|NCT00365287|stage IV breast cancer|stage iv breast cancer
1607927|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
1607928|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
1607929|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
1607930|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1607931|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1607932|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1607933|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1607934|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1607935|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1607936|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1607937|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1607938|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1607939|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1607940|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1607941|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1607942|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1607943|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1607944|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1607945|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1607946|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1607947|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
1608584|NCT00363051|Tumor|tumor
1607948|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
1607949|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
1607950|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1607951|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1607952|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1607953|NCT00365287|refractory anemia|refractory anemia
1607954|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1607955|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1607956|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1607957|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1607958|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1607959|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1608114|NCT00365040|myopia|myopia
1607960|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1607961|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1607962|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1607963|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1607964|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1607965|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1607966|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1607967|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1607968|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1607969|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1607970|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1607971|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1607972|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1607973|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1607974|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1607975|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1607976|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1607977|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1607978|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1607979|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1607980|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1607981|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1607982|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1607983|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1607984|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1607985|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1607986|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1607987|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1607988|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1607989|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1607990|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1607991|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
1607992|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1607993|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1607994|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1607995|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1607996|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1607997|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1607998|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1607999|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1608000|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1608001|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1608002|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1608003|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1608004|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1608005|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1608006|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1608007|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1608008|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1608009|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1608010|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1608011|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1608012|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1608013|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1608014|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1608015|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1608016|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1608017|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1608018|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1608019|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1608020|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1608115|NCT00365040|excimer laser|excimer laser
1608021|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
1608022|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1608023|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1608024|NCT00365274|NHL|nhl
1608025|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
1608026|NCT00365274|mAb|mab
1608027|NCT00365274|SGN-30|sgn-30
1608028|NCT00365274|CHOP|chop
1608029|NCT00365274|Cyclophosphamide|cyclophosphamide
1608030|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1608031|NCT00365274|Vincristine|vincristine
1608032|NCT00365274|Prednisone|prednisone
1608033|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1608034|NCT00365274|Lymphoma|lymphoma
1608035|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
1608036|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1608037|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
1608038|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
1608039|NCT00365274|Neoplasms|neoplasms
1608040|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
1608041|NCT00365274|Lymphatic Diseases|lymphatic diseases
1608042|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
1608043|NCT00365274|Immune System Diseases|immune system diseases
1608044|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
1608045|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
1608046|NCT00365274|Antibodies|antibodies
1608047|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
1608048|NCT00365274|Immunologic Factors|immunologic factors
1608049|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
1608050|NCT00365274|Pharmacologic Actions|pharmacologic actions
1608051|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
1608052|NCT00365274|Antirheumatic Agents|antirheumatic agents
1608053|NCT00365274|Therapeutic Uses|therapeutic uses
1608054|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1608055|NCT00365274|Alkylating Agents|alkylating agents
1608056|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1608057|NCT00365274|Antineoplastic Agents|antineoplastic agents
1608058|NCT00365274|Myeloablative Agonists|myeloablative agonists
1608059|NCT00365274|Antibiotics|antibiotics
1608060|NCT00365274|Antineoplastic|antineoplastic
1608061|NCT00365261|pain|pain
1608062|NCT00365261|fatigue|fatigue
1608063|NCT00365261|sleep|sleep
1608064|NCT00365261|bone marrow transplant|bone marrow transplant
1608065|NCT00365261|cancer|cancer
1608066|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
1608067|NCT00365222|Temozolomide|temozolomide
1608068|NCT00365222|Temodar|temodar
1608069|NCT00365222|Glioblastoma|glioblastoma
1608070|NCT00365222|Gliosarcoma|gliosarcoma
1608071|NCT00365222|Brain Tumor|brain tumor
1608072|NCT00365222|Quality of Life|quality of life
1608073|NCT00365222|Neurological|neurological
1608074|NCT00365196|Autonomic Nervous System|autonomic nervous system
1608075|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
1608076|NCT00365183|Lung Cancer|lung cancer
1608077|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
1608078|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
1608079|NCT00365183|Advanced Lung Cancer|advanced lung cancer
1608080|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
1608081|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
1608082|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
1608083|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
1608084|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
1608085|NCT00365183|Cancer of the Lung|cancer of the lung
1608086|NCT00365183|Carcinoma|carcinoma
1608087|NCT00365183|Bronchogenic|bronchogenic
1608088|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
1608089|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1608090|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
1608091|NCT00365131|Type I Gaucher disease|type i gaucher disease
1608092|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
1608093|NCT00365118|Port wine stains|port wine stains
1608094|NCT00365118|naevus flammeus|naevus flammeus
1608096|NCT00365105|bone metastases|bone metastases
1608097|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1608098|NCT00365105|recurrent breast cancer|recurrent breast cancer
1608099|NCT00365105|stage IV breast cancer|stage iv breast cancer
1608100|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1608101|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1608102|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
1608103|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
1608104|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
1608105|NCT00365092|Otitis media with effusion|otitis media with effusion
1608106|NCT00365092|Child development|child development
1608107|NCT00365092|Literacy|literacy
1608108|NCT00365092|Attention|attention
1608109|NCT00365092|Middle-ear effusion|middle-ear effusion
1608110|NCT00365092|Educational status|educational status
1608111|NCT00365092|Behavior|behavior
1608112|NCT00365092|Social behavior|social behavior
1608116|NCT00365027|GNRH agonist|gnrh agonist
1608117|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
1608118|NCT00365027|Embryo cryopreservation|embryo cryopreservation
1608119|NCT00365014|aplastic anemia|aplastic anemia
1608120|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
1608121|NCT00365014|cytopenias|cytopenias
1608122|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
1608123|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
1608124|NCT00365014|benzene poisoning|benzene poisoning
1608125|NCT00364988|pioglitazone|pioglitazone
1608126|NCT00364988|losartan|losartan
1608127|NCT00364988|proteinuria|proteinuria
1608128|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
1608129|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
1608130|NCT00364975|quality of life|quality of life
1608131|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
1608132|NCT00364975|weight|weight
1608133|NCT00364975|breast cancer|breast cancer
1608134|NCT00364962|NPC|npc
1608135|NCT00364962|Nasopharyngectomy|nasopharyngectomy
1608136|NCT00364962|KTP laser|ktp laser
1608137|NCT00364962|recurrence|recurrence
1608138|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
1608139|NCT00364949|PCOS|pcos
1608140|NCT00364949|Pregnant|pregnant
1608141|NCT00364949|Cord Blood|cord blood
1608142|NCT00364936|palliative care|palliative care
1608143|NCT00364936|hospice|hospice
1608144|NCT00364936|end-of-life|end-of-life
1608145|NCT00364936|symptom control|symptom control
1608146|NCT00364936|evaluation|evaluation
1608147|NCT00364936|effectiveness|effectiveness
1608148|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
1608149|NCT00364923|T-cell Lymphoma|t-cell lymphoma
1608150|NCT00364923|Lymphoma|lymphoma
1608151|NCT00364923|PDX|pdx
1608152|NCT00364923|Pralatrexate|pralatrexate
1608153|NCT00364923|Vitamin B12|vitamin b12
1608154|NCT00364923|Folic acid|folic acid
1608155|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
1608156|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
1608157|NCT00364910|Adherence|adherence
1608158|NCT00364910|Depression|depression
1608159|NCT00364884|chronic kidney disease|chronic kidney disease
1608160|NCT00364871|Obesity|obesity
1608161|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
1608162|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
1608163|NCT00364845|Quality of Life|quality of life
1608164|NCT00364845|Chronic Kidney Disease|chronic kidney disease
1608165|NCT00364845|Anemia|anemia
1608166|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
1608167|NCT00364806|Migraine|migraine
1608168|NCT00364806|Headache|headache
1608169|NCT00364793|HIV, Pediatric|hiv, pediatric
1608170|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
1608171|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
1608172|NCT00364767|Postprandial glycemic response|postprandial glycemic response
1608173|NCT00364754|Tesmilifene|tesmilifene
1608174|NCT00364754|DPPE|dppe
1608175|NCT00364754|Breast cancer|breast cancer
1608176|NCT00364754|Cyclophosphamide|cyclophosphamide
1608177|NCT00364754|Epirubicin|epirubicin
1608178|NCT00364754|Pharmacokinetic|pharmacokinetic
1608179|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
1608180|NCT00364702|Virtual Reality|virtual reality
1608181|NCT00364702|ADHD|adhd
1608182|NCT00364702|Methylphenidate|methylphenidate
1608183|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
1608184|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
1608185|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
1608186|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
1608187|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
1608188|NCT00364689|Hepatic Coma|hepatic coma
1608189|NCT00364689|Hepatic Stupor|hepatic stupor
1608190|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
1608191|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
1608192|NCT00364676|Vinorelbine|vinorelbine
1608193|NCT00364676|solid tumors|solid tumors
1608194|NCT00364676|Hodgkins|hodgkins
1608195|NCT00364676|Non hodgkins|non hodgkins
1608196|NCT00364676|Lymphoma|lymphoma
1608197|NCT00364676|Advanced solid tumors|advanced solid tumors
1608198|NCT00364663|NSCLC|nsclc
1608199|NCT00364663|staging|staging
1608200|NCT00364663|18F-FDG PET|18f-fdg pet
1608201|NCT00364663|decision tree model|decision tree model
1608202|NCT00364663|cost-effectiveness|cost-effectiveness
1608203|NCT00364650|Renal transplantation|renal transplantation
1608204|NCT00364650|Diarrhea|diarrhea
1608205|NCT00364650|Immunosuppression|immunosuppression
1608206|NCT00364650|Probiotics|probiotics
1608207|NCT00364637|Sevoflurane|sevoflurane
1608208|NCT00364637|Anesthesia|anesthesia
1608209|NCT00364637|Troponin|troponin
1608210|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
1608211|NCT00364637|Surgery, Cardiac|surgery, cardiac
1608212|NCT00364637|Stents|stents
1608213|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
1608214|NCT00364637|Surgery|surgery
1608215|NCT00364624|lung cancer|lung cancer
1608321|NCT00364195|Tesmilifene|tesmilifene
1608216|NCT00364624|adrenal insufficiency|adrenal insufficiency
1608217|NCT00364598|Anginera|anginera
1608218|NCT00364598|LVAD|lvad
1608219|NCT00364598|Transplant|transplant
1608220|NCT00364598|Histology|histology
1608221|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
1608222|NCT00364572|sciatica|sciatica
1608223|NCT00364572|low back pain|low back pain
1608224|NCT00364572|epidural|epidural
1608225|NCT00364572|tumor necrosis factor|tumor necrosis factor
1608226|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
1608227|NCT00364559|statins|statins
1608228|NCT00364559|rosuvastatin|rosuvastatin
1608229|NCT00364559|stroke|stroke
1608230|NCT00364546|Osteoarthritis|osteoarthritis
1608231|NCT00364546|Pain|pain
1608232|NCT00364546|Low Back Pain|low back pain
1608233|NCT00364546|Hip Pain|hip pain
1608234|NCT00364546|Knee Pain|knee pain
1608235|NCT00364546|Backache|backache
1608236|NCT00364546|tapentadol|tapentadol
1608237|NCT00364533|Arthralgia|arthralgia
1608238|NCT00364533|Pain|pain
1608239|NCT00364533|Pain Assessment|pain assessment
1608240|NCT00364533|Hip Replacement|hip replacement
1608241|NCT00364533|Tapentadol|tapentadol
1608242|NCT00364520|Hematologic Diseases|hematologic diseases
1608243|NCT00364520|Benzene|benzene
1608244|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
1608245|NCT00364494|Hematocrit|hematocrit
1608246|NCT00364494|Hemodilution|hemodilution
1608247|NCT00364494|Blood Transfusion|blood transfusion
1608248|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
1608249|NCT00364494|Multiple Organ Failure|multiple organ failure
1608250|NCT00364494|Surgery, Cardiac|surgery, cardiac
1608251|NCT00364494|Kidney Failure|kidney failure
1608252|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
1608253|NCT00364481|apnea|apnea
1608254|NCT00364481|tongue|tongue
1608255|NCT00364481|exercises|exercises
1608256|NCT00364481|reflux|reflux
1608257|NCT00364481|airway|airway
1608258|NCT00364481|upper|upper
1608259|NCT00364481|fatigue|fatigue
1608260|NCT00364468|pegfilgrastim|pegfilgrastim
1608261|NCT00364468|neutropenia|neutropenia
1608262|NCT00364468|cancer patients|cancer patients
1608263|NCT00364468|lymphoma|lymphoma
1608264|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
1608265|NCT00364455|Anemia|anemia
1608266|NCT00364455|Quality-of-life|quality-of-life
1608267|NCT00364442|asthma|asthma
1608268|NCT00364429|schizophrenic patients|schizophrenic patients
1608269|NCT00364429|SPET|spet
1608270|NCT00364429|NMDA receptor|nmda receptor
1608271|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
1608272|NCT00364416|Heart Failure, congestive|heart failure, congestive
1608273|NCT00364416|Heart decompensation|heart decompensation
1608274|NCT00364403|Glycemic index|glycemic index
1608275|NCT00364403|Glycemic load|glycemic load
1608276|NCT00364403|Low fat|low fat
1608277|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
1608278|NCT00364403|Large for gestational age infant|large for gestational age infant
1608279|NCT00364403|Excessive body weight|excessive body weight
1608280|NCT00364390|CABG|cabg
1608281|NCT00364390|Anginera|anginera
1608283|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
1608284|NCT00364351|NSCLC|nsclc
1608285|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
1608286|NCT00364338|quality of life|quality of life
1608287|NCT00364338|preimenopause|preimenopause
1608288|NCT00364338|weight|weight
1608289|NCT00364338|lipids|lipids
1608290|NCT00364325|Heart failure, congestive|heart failure, congestive
1608291|NCT00364325|Heart decompensation|heart decompensation
1608292|NCT00364312|behavior therapy|behavior therapy
1608293|NCT00364312|dietary control|dietary control
1608294|NCT00364312|exercise|exercise
1608295|NCT00364312|diabetes mellitus|diabetes mellitus
1608296|NCT00364312|behavior modification|behavior modification
1608297|NCT00364312|blood glucose|blood glucose
1608298|NCT00364312|clinical trial|clinical trial
1608299|NCT00364312|diabetes education|diabetes education
1608300|NCT00364312|health behavior|health behavior
1608301|NCT00364312|health care service utilization|health care service utilization
1608302|NCT00364312|obesity|obesity
1608303|NCT00364312|quality of life|quality of life
1608304|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
1608305|NCT00364299|Mechanical ventilation|mechanical ventilation
1608306|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
1608307|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1608308|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1608309|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
1608310|NCT00364286|Leukemia|leukemia
1608311|NCT00364286|Lymphoma|lymphoma
1608312|NCT00364286|Dasatinib|dasatinib
1608313|NCT00364286|BMS-354825|bms-354825
1608314|NCT00364273|Asthma|asthma
1608315|NCT00364260|Anemia|anemia
1608316|NCT00364260|epoetin alfa|epoetin alfa
1608317|NCT00364247|Acute pain|acute pain
1608318|NCT00364247|bunionectomy|bunionectomy
1608319|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
1608320|NCT00364195|Metastatic breast cancer|metastatic breast cancer
1608323|NCT00364182|Hemophilia B|hemophilia b
1608324|NCT00364182|BeneFIX|benefix
1608325|NCT00364169|constipation|constipation
1608326|NCT00364169|cancer|cancer
1608327|NCT00364169|surgery|surgery
1608328|NCT00364169|intervention|intervention
1608329|NCT00364169|nursing|nursing
1608330|NCT00364169|postoperative|postoperative
1608331|NCT00364143|Cancer|cancer
1608332|NCT00364143|Advanced Solid Tumor|advanced solid tumor
1608333|NCT00364143|Oncology|oncology
1608334|NCT00364117|150 discharges|150 discharges
1608335|NCT00364117|adults|adults
1608336|NCT00364117|Internal Medicine|internal medicine
1608337|NCT00364104|Iron deficiency|iron deficiency
1608338|NCT00364104|Helicobacter infection|helicobacter infection
1608339|NCT00364104|Epidemiology|epidemiology
1608340|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
1608341|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
1608342|NCT00364078|Uncertainty|uncertainty
1608343|NCT00364078|Locus of Control|locus of control
1608344|NCT00364078|Quality of life|quality of life
1608345|NCT00364078|Transitoriness|transitoriness
1608346|NCT00364078|Cancer care|cancer care
1608347|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
1608348|NCT00364013|Oncology|oncology
1608349|NCT00364013|Cancer|cancer
1608350|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
1608352|NCT00364013|Panitumumab|panitumumab
1608353|NCT00364013|Clinical Trail|clinical trail
1608354|NCT00364013|Amgen|amgen
1608355|NCT00364000|haemodialysis|haemodialysis
1608356|NCT00364000|hyperphosphatemia|hyperphosphatemia
1608357|NCT00364000|sevelamer|sevelamer
1608358|NCT00364000|calcium acetate|calcium acetate
1608359|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
1608360|NCT00363974|AML|aml
1608361|NCT00363974|leukemia|leukemia
1608362|NCT00363974|relapse|relapse
1608363|NCT00363974|refractory|refractory
1608364|NCT00363974|antisense|antisense
1608365|NCT00363974|oligonucleotide|oligonucleotide
1608366|NCT00363961|End stage renal disease|end stage renal disease
1608367|NCT00363961|Maintenance dialysis|maintenance dialysis
1608368|NCT00363961|Resistance exercise|resistance exercise
1608369|NCT00363961|Muscle wasting|muscle wasting
1608370|NCT00363961|Disability|disability
1608371|NCT00363948|MK-0431|mk-0431
1608372|NCT00363948|ONO-5435|ono-5435
1608373|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
1608374|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
1608375|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1608376|NCT00363909|hot flashes|hot flashes
1608377|NCT00363909|breast cancer|breast cancer
1608378|NCT00363896|COPD|copd
1608379|NCT00363896|Lung function|lung function
1608380|NCT00363896|Exacerbations|exacerbations
1608381|NCT00363896|Quality of Life|quality of life
1608382|NCT00363870|Influenza vaccine|influenza vaccine
1608383|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
1608384|NCT00363857|fatigue|fatigue
1608385|NCT00363857|sleep|sleep
1608386|NCT00363857|sleep disorder|sleep disorder
1608387|NCT00363857|Legs|legs
1608388|NCT00363857|RLS|rls
1608389|NCT00363857|Restless Legs Syndrome|restless legs syndrome
1608390|NCT00363857|Ropinirole|ropinirole
1608391|NCT00363844|MK-0431|mk-0431
1608392|NCT00363844|ONO-5435|ono-5435
1608393|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
1608394|NCT00363818|Endothelial function|endothelial function
1608395|NCT00363818|Platelet function|platelet function
1608396|NCT00363818|Coronary artery disease|coronary artery disease
1608397|NCT00363818|Thrombosis|thrombosis
1608398|NCT00363818|Aggregation|aggregation
1608399|NCT00363805|lung cancer|lung cancer
1608400|NCT00363805|prevention|prevention
1608401|NCT00363805|green tea|green tea
1608402|NCT00363805|former smokers|former smokers
1608403|NCT00363792|Healthy subjects|healthy subjects
1608585|NCT00363051|Islet Cell|islet cell
1608404|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
1608405|NCT00363779|LGL|lgl
1608406|NCT00363779|Leukemia|leukemia
1608407|NCT00363779|Cyclosporine|cyclosporine
1608408|NCT00363779|Microarray|microarray
1608409|NCT00363779|Gene Expression|gene expression
1608410|NCT00363779|Cyclosporin|cyclosporin
1608411|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
1608412|NCT00363779|LGL Leukemia|lgl leukemia
1608413|NCT00363753|Transient ischemic attack|transient ischemic attack
1608414|NCT00363753|Stroke|stroke
1608415|NCT00363753|Aspirin|aspirin
1608416|NCT00363753|Clopidogrel|clopidogrel
1608417|NCT00363740|GW685698X|gw685698x
1608418|NCT00363740|allergic rhinitis|allergic rhinitis
1608419|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1608420|NCT00363727|dyskinesia|dyskinesia
1608421|NCT00363727|SINEMET|sinemet
1608422|NCT00363727|Parkinson's disease|parkinson's disease
1608423|NCT00363727|controlled release ropinirole|controlled release ropinirole
1608424|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
1608425|NCT00363701|withdrawal|withdrawal
1608517|NCT00363337|Adults|adults
1608426|NCT00363701|longterm treatment|longterm treatment
1608427|NCT00363701|dyspepsia|dyspepsia
1608428|NCT00363701|functional dyspepsia|functional dyspepsia
1608429|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
1608430|NCT00363701|upper endoscopy|upper endoscopy
1608431|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
1608432|NCT00363688|oral challenge|oral challenge
1608433|NCT00363688|penicillin|penicillin
1608434|NCT00363688|skin testing|skin testing
1608435|NCT00363675|Hand Burns|hand burns
1608436|NCT00363675|Pediatrics|pediatrics
1608437|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1608438|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1608439|NCT00363636|relapsed|relapsed
1608440|NCT00363636|NHL|nhl
1608441|NCT00363636|pharmacokinetics|pharmacokinetics
1608442|NCT00363636|antibody|antibody
1608443|NCT00363636|safety|safety
1608444|NCT00363636|galiximab|galiximab
1608445|NCT00363636|efficacy|efficacy
1608446|NCT00363636|rituximab|rituximab
1608447|NCT00363636|refractory|refractory
1608448|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
1608449|NCT00363597|dyspepsia|dyspepsia
1608450|NCT00363597|gastrointestinal disease|gastrointestinal disease
1608451|NCT00363597|indigestion|indigestion
1608452|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1608932|NCT00361530|cholesterol|cholesterol
1608453|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1608454|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1608455|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1608456|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
1608457|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
1608458|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
1608459|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1608460|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
1608461|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1608462|NCT00363558|skin graft|skin graft
1608463|NCT00363558|fixation|fixation
1608464|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
1608465|NCT00363558|skin staples|skin staples
1608466|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
1608467|NCT00363532|migraine with out aura|migraine with out aura
1608468|NCT00363519|MK-0431|mk-0431
1608469|NCT00363519|ONO-5435|ono-5435
1608470|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
1608471|NCT00363506|nutritional|nutritional
1608472|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
1608473|NCT00363480|Asthma|asthma
1608474|NCT00363480|Asthma Control Test|asthma control test
1608475|NCT00363480|SERETIDE|seretide
1608476|NCT00363467|Busulfan|busulfan
1608477|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1608478|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
1608479|NCT00363467|Dendritic cells|dendritic cells
1608480|NCT00363467|Bone marrow transplantation|bone marrow transplantation
1608481|NCT00363467|PBSC mobilization|pbsc mobilization
1608482|NCT00363467|Autologous stem cells|autologous stem cells
1608484|NCT00363454|Pharmacokinetics|pharmacokinetics
1608485|NCT00363454|TCN-PM|tcn-pm
1608486|NCT00363454|VD-0002|vd-0002
1608487|NCT00363454|Immunohistochemistry|immunohistochemistry
1608488|NCT00363454|Serum tumor marker|serum tumor marker
1608489|NCT00363454|Akt phosphorylation|akt phosphorylation
1608490|NCT00363454|Ex vivo testing|ex vivo testing
1608491|NCT00363454|metastatic|metastatic
1608492|NCT00363441|head and neck neoplasms|head and neck neoplasms
1608493|NCT00363441|squamous cell cancer|squamous cell cancer
1608494|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
1608495|NCT00363428|pulmonary complications|pulmonary complications
1608496|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
1608497|NCT00363428|tobacco use disorder|tobacco use disorder
1608498|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
1608499|NCT00363428|small cell lung cancer|small cell lung cancer
1608500|NCT00363402|Cystic Fibrosis|cystic fibrosis
1608501|NCT00363389|Hysteroscopy|hysteroscopy
1608502|NCT00363389|Misoprostol|misoprostol
1608503|NCT00363389|Uterine hemorrhage|uterine hemorrhage
1608504|NCT00363389|Uterine cervix|uterine cervix
1608505|NCT00363389|Dilatation|dilatation
1608506|NCT00363376|olanzapine|olanzapine
1608507|NCT00363376|zonisamide|zonisamide
1608508|NCT00363376|weight gain|weight gain
1608509|NCT00363376|bipolar disorder|bipolar disorder
1608510|NCT00363376|psychotic disorders|psychotic disorders
1608511|NCT00363363|Pediatrics|pediatrics
1608512|NCT00363363|Fontan Procedure|fontan procedure
1608513|NCT00363363|Physical Activity|physical activity
1608514|NCT00363363|Physical Fitness|physical fitness
1608515|NCT00363363|Congenital Heart Defects|congenital heart defects
1608516|NCT00363363|exercise rehabilitation|exercise rehabilitation
1608518|NCT00363337|Bipolar Depression|bipolar depression
1608519|NCT00363337|Bipolar Disorder|bipolar disorder
1608520|NCT00363337|Bipolar I|bipolar i
1608521|NCT00363337|Bipolar II|bipolar ii
1608522|NCT00363337|Depression|depression
1608523|NCT00363324|stem cell|stem cell
1608524|NCT00363324|acute myocardial infarction|acute myocardial infarction
1608525|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
1608526|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
1608527|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1608528|NCT00363285|stage III prostate cancer|stage iii prostate cancer
1608529|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
1608530|NCT00363246|Elderly|elderly
1608531|NCT00363246|Fall risk|fall risk
1608532|NCT00363246|Veterans|veterans
1608533|NCT00363246|WheelChairs|wheelchairs
1608534|NCT00363246|Injury|injury
1608535|NCT00363233|type 2 diabetes|type 2 diabetes
1608536|NCT00363233|lignans|lignans
1608537|NCT00363233|flaxseed|flaxseed
1608538|NCT00363233|cholesterol|cholesterol
1608539|NCT00363220|Infection|infection
1608540|NCT00363220|E coli|e coli
1608541|NCT00363220|Klebsiella|klebsiella
1608542|NCT00363220|ESBL|esbl
1608543|NCT00363207|behavior|behavior
1608544|NCT00363207|local anesthesia|local anesthesia
1608545|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
1609374|NCT00360139|Dermik|dermik
1608546|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
1608547|NCT00363181|Insulin resistance|insulin resistance
1608548|NCT00363181|Metabolic problems|metabolic problems
1608549|NCT00363181|Weight gain|weight gain
1608550|NCT00363181|Mental health problems|mental health problems
1608551|NCT00363181|Mental disorders|mental disorders
1608552|NCT00363181|Antipsychotic medication|antipsychotic medication
1608553|NCT00363181|Olanzapine|olanzapine
1608554|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
1608555|NCT00363155|chronic|chronic
1608556|NCT00363155|hepatitis b|hepatitis b
1608557|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
1608558|NCT00363129|neurotoxicity|neurotoxicity
1608559|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1608560|NCT00363116|Kidney transplant|kidney transplant
1608561|NCT00363116|Pancreas transplant|pancreas transplant
1608562|NCT00363116|Daclizumab|daclizumab
1608563|NCT00363116|Tacrolimus|tacrolimus
1608564|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
1608565|NCT00363116|Steroids|steroids
1608566|NCT00363116|Immunosuppression|immunosuppression
1608567|NCT00363116|Acute allograft rejection|acute allograft rejection
1608568|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1608569|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1608570|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1608571|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1608572|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1608573|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1608574|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1608575|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1608576|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1608577|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1608578|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1608579|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1608580|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1608581|NCT00363077|Influenza vaccine|influenza vaccine
1608582|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
1608583|NCT00363051|Pancreatic|pancreatic
1608587|NCT00363051|Neuroendocrine|neuroendocrine
1608588|NCT00363051|Endocrine|endocrine
1608589|NCT00363051|Atypical Carcinoid|atypical carcinoid
1608590|NCT00363051|RADIANT1|radiant1
1608591|NCT00363051|RADIANT-1|radiant-1
1608592|NCT00363038|Bruising|bruising
1608593|NCT00363038|Topical 20% arnica|topical 20% arnica
1608594|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
1608595|NCT00363025|Older patients|older patients
1608596|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
1608597|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
1608598|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
1608599|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
1608600|NCT00363012|stage IV breast cancer|stage iv breast cancer
1608601|NCT00363012|male breast cancer|male breast cancer
1608602|NCT00362999|Allergic|allergic
1608603|NCT00362999|Rhinitis|rhinitis
1608604|NCT00362999|Pharmacogenetics|pharmacogenetics
1608605|NCT00362999|Histamine|histamine
1608606|NCT00362986|dermatologic complications|dermatologic complications
1608607|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1608608|NCT00362973|male breast cancer|male breast cancer
1608609|NCT00362973|recurrent breast cancer|recurrent breast cancer
1608610|NCT00362973|stage I breast cancer|stage i breast cancer
1608611|NCT00362973|stage II breast cancer|stage ii breast cancer
1608612|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
1608613|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
1608614|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
1608615|NCT00362973|stage IV breast cancer|stage iv breast cancer
1608616|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1608617|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
1608618|NCT00362960|Inflammatory Markers|inflammatory markers
1608619|NCT00362960|Proteinuria|proteinuria
1608620|NCT00362960|Renal Disease|renal disease
1608621|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
1608622|NCT00362947|thrombophlebitis|thrombophlebitis
1608623|NCT00362947|LMWH|lmwh
1608624|NCT00362947|parnaparin|parnaparin
1608625|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
1608626|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
1608627|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
1608628|NCT00362921|adult gliosarcoma|adult gliosarcoma
1608629|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
1608630|NCT00362908|Obesity|obesity
1608631|NCT00362908|Hypertension|hypertension
1608632|NCT00362908|Insulin Resistance|insulin resistance
1608633|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
1608634|NCT00362856|larazotide acetate|larazotide acetate
1608635|NCT00362843|11C-Leucine|11c-leucine
1608636|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
1608637|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
1608638|NCT00362843|Propofol|propofol
1608639|NCT00362843|Fragile X|fragile x
1608640|NCT00362843|Fragile X Syndrome|fragile x syndrome
1608641|NCT00362817|Recurrent|recurrent
1608642|NCT00362817|Symptomatic|symptomatic
1608643|NCT00362804|tetrabenazine|tetrabenazine
1608644|NCT00362804|partial response|partial response
1608645|NCT00362804|psychosis|psychosis
1608646|NCT00362804|schizophrenia|schizophrenia
1608647|NCT00362804|schizoaffective disorder|schizoaffective disorder
1608648|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
1608649|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
1608650|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
1608651|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
1608652|NCT00362791|counseling efficacy|counseling efficacy
1608653|NCT00362765|Type 2 Diabetes|type 2 diabetes
1608654|NCT00362765|Dyslipidemia|dyslipidemia
1608655|NCT00362765|Hyperinsulinemic|hyperinsulinemic
1608656|NCT00362765|Clamp|clamp
1608657|NCT00362765|Metformin|metformin
1608658|NCT00362765|Fenofibrate|fenofibrate
1608659|NCT00362752|norfloxacin|norfloxacin
1608660|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
1608662|NCT00362687|HIV, HAART|hiv, haart
1608663|NCT00362661|PTSD|ptsd
1608664|NCT00362661|cortisol|cortisol
1608665|NCT00362661|memory|memory
1608666|NCT00362661|treatment|treatment
1608667|NCT00362622|Travalert|travalert
1608668|NCT00362622|open angle glaucoma|open angle glaucoma
1608669|NCT00362609|Safety|safety
1608670|NCT00362596|Acyclovir|acyclovir
1608671|NCT00362596|HIV|hiv
1608672|NCT00362596|HSV|hsv
1608673|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
1608674|NCT00362570|Newly diagnosed|newly diagnosed
1608675|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
1608676|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
1608677|NCT00362544|acute leukaemia|acute leukaemia
1608678|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
1608679|NCT00362518|atherosclerosis|atherosclerosis
1608680|NCT00362518|vitamin C|vitamin c
1608681|NCT00362518|vitamin E|vitamin e
1608683|NCT00362492|Ultrasonography|ultrasonography
1608684|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
1608685|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
1608686|NCT00362492|short duration prophylaxis|short duration prophylaxis
1608687|NCT00362479|pregnancy prevention|pregnancy prevention
1608688|NCT00362479|oral contraceptives|oral contraceptives
1608689|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
1608690|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
1608691|NCT00362440|Leptin|leptin
1608692|NCT00362440|Fat wasting|fat wasting
1608693|NCT00362440|Pioglitazone|pioglitazone
1608694|NCT00362440|Insulin resistance|insulin resistance
1608695|NCT00362427|Hepatitis B|hepatitis b
1608696|NCT00362427|Pertussis|pertussis
1608697|NCT00362427|Diphtheria|diphtheria
1608698|NCT00362427|Tetanus|tetanus
1608699|NCT00362427|H. influenzae type b|h. influenzae type b
1608700|NCT00362427|Polio|polio
1608701|NCT00362414|Stroke|stroke
1608702|NCT00362401|Psychoacoustics|psychoacoustics
1608703|NCT00362401|Quality of Life|quality of life
1608704|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
1608705|NCT00362388|Coronary artery disease|coronary artery disease
1608706|NCT00362388|Ischemic heart disease|ischemic heart disease
1608707|NCT00362388|Angiogenesis|angiogenesis
1608708|NCT00362388|Cells|cells
1608709|NCT00362388|Cardiac surgery|cardiac surgery
1608710|NCT00362375|Adult|adult
1608711|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
1608712|NCT00362375|Female|female
1608713|NCT00362375|Humans|humans
1608714|NCT00362375|Risk-Taking|risk-taking
1608715|NCT00362375|Safe Sex|safe sex
1608716|NCT00362375|Sexual Behavior|sexual behavior
1608717|NCT00362375|HIV Testing|hiv testing
1608718|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1608719|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
1608720|NCT00362362|Genetics|genetics
1608721|NCT00362362|Blood Sample|blood sample
1608722|NCT00362362|PLS|pls
1608723|NCT00362362|ALS|als
1608724|NCT00362349|ITP|itp
1608725|NCT00362349|IVIg|ivig
1608726|NCT00362349|Platelet count|platelet count
1608727|NCT00362349|Bleeding|bleeding
1608728|NCT00362336|Hepatitis B|hepatitis b
1608729|NCT00362336|Polio|polio
1608730|NCT00362336|Diphtheria|diphtheria
1608731|NCT00362336|Pertussis|pertussis
1608732|NCT00362336|H. influenzae type b|h. influenzae type b
1608733|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
1608734|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
1608735|NCT00362310|treatment|treatment
1608736|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
1608737|NCT00362284|Alzheimer's disease|alzheimer's disease
1608738|NCT00362284|coping|coping
1608739|NCT00362284|quality of life|quality of life
1608740|NCT00362284|caregiving|caregiving
1608741|NCT00362271|Healthy Subjects|healthy subjects
1608742|NCT00362245|Amikacin|amikacin
1608743|NCT00362245|Pharmacokinetics|pharmacokinetics
1608744|NCT00362245|Pharmacodynamics|pharmacodynamics
1608745|NCT00362245|Intra-Thecal injection|intra-thecal injection
1608746|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
1608747|NCT00362219|topical|topical
1608748|NCT00362219|morphine|morphine
1608749|NCT00362219|pain|pain
1608750|NCT00362219|skin-wound|skin-wound
1608751|NCT00362219|skin-graft|skin-graft
1608752|NCT00362219|peripheral analgesia|peripheral analgesia
1608753|NCT00362219|burn|burn
1608754|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
1608755|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
1608756|NCT00362193|Diabetes|diabetes
1608757|NCT00362193|Chronic disease management|chronic disease management
1608758|NCT00362193|Relapse|relapse
1608759|NCT00362180|LDL-cholesterol|ldl-cholesterol
1608760|NCT00362180|apoB-100|apob-100
1608761|NCT00362180|apoB-48|apob-48
1608762|NCT00362180|triglyceride|triglyceride
1608763|NCT00362180|HeFH|hefh
1608764|NCT00362180|FHBL|fhbl
1608765|NCT00362167|Clinical Experience|clinical experience
1608766|NCT00362167|Educational Training|educational training
1608767|NCT00362167|Pain Syndromes|pain syndromes
1608768|NCT00362167|Analgesia|analgesia
1608769|NCT00362167|Pain Medicine|pain medicine
1608770|NCT00362167|Therapy|therapy
1608771|NCT00362167|Neuropathic|neuropathic
1608772|NCT00362167|Chronic Pain|chronic pain
1608773|NCT00362167|Acute Pain|acute pain
1608774|NCT00362167|Analgesics|analgesics
1608775|NCT00362167|Medication|medication
1608776|NCT00362167|Evaluation|evaluation
1608777|NCT00362141|levetiracetam|levetiracetam
1608778|NCT00362141|status|status
1608779|NCT00362141|epilepticus|epilepticus
1608780|NCT00362128|Blood Pressure, High|blood pressure, high
1608781|NCT00362128|Obesity|obesity
1608782|NCT00362128|Tobacco Use Disorder|tobacco use disorder
1608783|NCT00362115|hypertension|hypertension
1608784|NCT00362115|blood pressure|blood pressure
1608785|NCT00362115|diastolic blood pressure|diastolic blood pressure
1608786|NCT00362115|drug therapy|drug therapy
1608787|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
1608788|NCT00362089|n-3 fatty acids|n-3 fatty acids
1608789|NCT00362089|n-6 fatty acids|n-6 fatty acids
1608790|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
1608791|NCT00362089|pregnancy|pregnancy
1608792|NCT00362089|lactation|lactation
1608793|NCT00362089|breast feeding|breast feeding
1608794|NCT00362089|breast milk|breast milk
1608795|NCT00362089|adipose tissue|adipose tissue
1608796|NCT00362089|newborn|newborn
1608797|NCT00362089|fetal development|fetal development
1608798|NCT00362076|Perception|perception
1608799|NCT00362076|Development|development
1608800|NCT00362076|Cognition|cognition
1608801|NCT00362076|Vision|vision
1608802|NCT00362076|Infants|infants
1608803|NCT00362076|Autonomic Function|autonomic function
1608804|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
1608805|NCT00362076|Categorization|categorization
1608806|NCT00362076|Habituation|habituation
1608807|NCT00362076|Motion-Carried Information|motion-carried information
1608808|NCT00362063|growth hormone|growth hormone
1608809|NCT00362050|malaria, falciparum|malaria, falciparum
1608810|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
1608811|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
1608812|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
1608813|NCT00361985|Gastric bypass|gastric bypass
1608814|NCT00361985|Anastomotic stricture|anastomotic stricture
1608815|NCT00361985|Morbid obesity|morbid obesity
1608816|NCT00361985|Bariatric surgery|bariatric surgery
1608817|NCT00361985|Omeprazole|omeprazole
1608818|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
1608819|NCT00361959|tiotropium|tiotropium
1608820|NCT00361959|SERETIDE|seretide
1608821|NCT00361959|COPD exacerbation|copd exacerbation
1608822|NCT00361946|Type 2 diabetes|type 2 diabetes
1608823|NCT00361946|Lean|lean
1608824|NCT00361946|Obese|obese
1608825|NCT00361920|steroid resistant asthma|steroid resistant asthma
1608826|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
1608827|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
1608828|NCT00361907|Respiratory Quotients|respiratory quotients
1609375|NCT00360139|SpaMD|spamd
1608829|NCT00361907|Hypoglycemia|hypoglycemia
1608830|NCT00361907|Diabetic Complications|diabetic complications
1608831|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
1608832|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
1608833|NCT00361855|MI|mi
1608834|NCT00361842|Colorectal cancer|colorectal cancer
1608835|NCT00361842|Colorectal carcinoma|colorectal carcinoma
1608836|NCT00361842|Colonic cancer|colonic cancer
1608837|NCT00361842|Rectal cancer|rectal cancer
1608838|NCT00361829|Development|development
1608839|NCT00361829|Childhood Growth|childhood growth
1608840|NCT00361816|Maternal Effect Gene|maternal effect gene
1608841|NCT00361816|Embryonic Development|embryonic development
1608842|NCT00361816|Infertility|infertility
1608843|NCT00361803|chemotherapy|chemotherapy
1608844|NCT00361803|recurrent|recurrent
1608845|NCT00361803|refractory|refractory
1608846|NCT00361803|research|research
1608847|NCT00361803|cancer|cancer
1608848|NCT00361803|pharmacokinetics|pharmacokinetics
1608849|NCT00361790|Healthy Subjects|healthy subjects
1608850|NCT00361777|Obesity|obesity
1608851|NCT00361777|Pseudo-Cushing State|pseudo-cushing state
1608852|NCT00361777|Hypercortisolism|hypercortisolism
1608853|NCT00361777|Cushing's Syndrome|cushing's syndrome
1608854|NCT00361777|Cushing Syndrome|cushing syndrome
1608855|NCT00361751|Glucose metabolism|glucose metabolism
1608856|NCT00361751|Fat Metabolism|fat metabolism
1608857|NCT00361751|Insulin Resistance|insulin resistance
1608858|NCT00361751|Protein Metabolism|protein metabolism
1608859|NCT00361751|Tracer Methodology|tracer methodology
1608860|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1608861|NCT00361725|severe sepsis|severe sepsis
1608862|NCT00361725|organ failure|organ failure
1608863|NCT00361725|activated protein C|activated protein c
1608864|NCT00361725|thrombomodulin|thrombomodulin
1608865|NCT00361725|EPCR|epcr
1608866|NCT00361712|Epidural|epidural
1608867|NCT00361712|analgesia|analgesia
1608868|NCT00361712|labor|labor
1608869|NCT00361712|cytokines|cytokines
1608870|NCT00361699|stroke|stroke
1608871|NCT00361699|brain ischemia|brain ischemia
1608872|NCT00361699|cerebrovascular accident|cerebrovascular accident
1608873|NCT00361699|statin|statin
1608874|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1608875|NCT00361699|cholesterol|cholesterol
1608876|NCT00361699|hypercholesterolemia|hypercholesterolemia
1608877|NCT00361699|hyperlipidemia|hyperlipidemia
1608878|NCT00361699|multicenter studies|multicenter studies
1608879|NCT00361699|prospective studies|prospective studies
1608880|NCT00361699|endpoint determination|endpoint determination
1608881|NCT00361699|randomized controlled trials|randomized controlled trials
1608884|NCT00361699|c-reactive Protein|c-reactive protein
1608885|NCT00361686|tramadol|tramadol
1608886|NCT00361686|remifentanyl|remifentanyl
1608887|NCT00361686|patient controlled analgesia|patient controlled analgesia
1608888|NCT00361686|abortion|abortion
1608889|NCT00361673|Health Disparities|health disparities
1608890|NCT00361673|Built Environments|built environments
1608891|NCT00361660|Motor skills|motor skills
1608892|NCT00361660|Occupational Therapy|occupational therapy
1608893|NCT00361660|Physical Therapy Techniques|physical therapy techniques
1608894|NCT00361660|Rehabilitation|rehabilitation
1608895|NCT00361660|Upper Extremity|upper extremity
1608896|NCT00361660|Stroke|stroke
1608897|NCT00361634|Etanercept|etanercept
1608898|NCT00361634|Enbrel|enbrel
1608899|NCT00361634|DCE-MRI|dce-mri
1608900|NCT00361634|RA|ra
1608901|NCT00361621|VELCADE|velcade
1608902|NCT00361608|diabetes|diabetes
1608903|NCT00361608|hypoglycemia|hypoglycemia
1608904|NCT00361608|monitor|monitor
1608905|NCT00361608|children with Type I Diabetes|children with type i diabetes
1608906|NCT00361595|osteoporosis|osteoporosis
1609871|NCT00358384|GW786034|gw786034
1608907|NCT00361595|zoledronic acid|zoledronic acid
1608908|NCT00361595|forteo|forteo
1608909|NCT00361582|Osteoarthritis|osteoarthritis
1608910|NCT00361582|tapentadol|tapentadol
1608911|NCT00361582|knee-replacement|knee-replacement
1608912|NCT00361582|hip replacement|hip replacement
1608913|NCT00361582|pain|pain
1608914|NCT00361569|vaginal atrophy|vaginal atrophy
1608915|NCT00361569|vaginal dryness|vaginal dryness
1608916|NCT00361569|vaginal itching|vaginal itching
1608917|NCT00361569|vaginal pain|vaginal pain
1608918|NCT00361556|low back pain|low back pain
1608919|NCT00361556|disability|disability
1608920|NCT00361556|health education|health education
1608921|NCT00361556|primary care|primary care
1608922|NCT00361543|Schizophrenia|schizophrenia
1608923|NCT00361543|Mental Illness|mental illness
1608924|NCT00361543|SERM|serm
1608925|NCT00361543|Raloxifene|raloxifene
1608926|NCT00361543|Cognition|cognition
1608927|NCT00361530|stroke|stroke
1608928|NCT00361530|brain ischemia|brain ischemia
1608929|NCT00361530|cerebrovascular accident|cerebrovascular accident
1608930|NCT00361530|statin|statin
1608931|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1608933|NCT00361530|hypercholesterolemia|hypercholesterolemia
1608934|NCT00361530|hyperlipidemia|hyperlipidemia
1608935|NCT00361530|multicenter studies|multicenter studies
1608936|NCT00361530|prospective studies|prospective studies
1608937|NCT00361530|endpoint determination|endpoint determination
1608938|NCT00361530|randomized controlled trials|randomized controlled trials
1608939|NCT00361530|recurrence|recurrence
1608940|NCT00361530|pravastatin|pravastatin
1608941|NCT00361530|plaque|plaque
1608942|NCT00361530|tunica intima|tunica intima
1608943|NCT00361530|tunica media|tunica media
1608944|NCT00361530|ultrasonography|ultrasonography
1608945|NCT00361530|carotid arteries|carotid arteries
1608946|NCT00361517|GM monitoring|gm monitoring
1608947|NCT00361517|Immunocompromised|immunocompromised
1608948|NCT00361517|hematological disorder|hematological disorder
1608949|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
1608950|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
1608951|NCT00361504|Osteoarthritis|osteoarthritis
1608952|NCT00361504|Pain|pain
1608953|NCT00361504|Low Back Pain|low back pain
1608954|NCT00361504|Hip Pain|hip pain
1608955|NCT00361504|Knee Pain|knee pain
1608956|NCT00361504|Backache|backache
1608957|NCT00361504|Tapentadol|tapentadol
1608958|NCT00361491|Depression|depression
1608959|NCT00361491|antidepressive disorders|antidepressive disorders
1608960|NCT00361491|controlled clinical trial|controlled clinical trial
1608961|NCT00361478|exercise|exercise
1608962|NCT00361478|postnatal depression|postnatal depression
1608963|NCT00361478|psychological health|psychological health
1608964|NCT00361478|well-being|well-being
1608965|NCT00361426|COPD|copd
1608966|NCT00361426|Respiration Rate|respiration rate
1608967|NCT00361426|Monitoring|monitoring
1608968|NCT00361413|Stem cell transplantation|stem cell transplantation
1608969|NCT00361413|GVHD|gvhd
1608970|NCT00361413|Graft Versus Host Disease|graft versus host disease
1608971|NCT00361400|pregnancy|pregnancy
1608972|NCT00361400|hormonal contraception|hormonal contraception
1608973|NCT00361387|Sarcoidosis|sarcoidosis
1608974|NCT00361387|Sarcoid|sarcoid
1608975|NCT00361374|Depression|depression
1608976|NCT00361374|Omega-3|omega-3
1608977|NCT00361374|Boston|boston
1608978|NCT00361348|Palifermin|palifermin
1608979|NCT00361348|drug interaction|drug interaction
1608980|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
1608981|NCT00361335|Golimumab|golimumab
1608982|NCT00361335|Methotrexate|methotrexate
1608983|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
1608984|NCT00361335|Immunology|immunology
1608985|NCT00361309|liver cancer|liver cancer
1608986|NCT00361309|HCC|hcc
1608987|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
1608988|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1608989|NCT00361296|refractory anemia|refractory anemia
1608990|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1608991|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1608992|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1608993|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1608994|NCT00361270|Biofeedback|biofeedback
1608995|NCT00361270|Hypnosis|hypnosis
1608996|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
1608997|NCT00361270|Pain beliefs|pain beliefs
1608998|NCT00361270|Pain coping strategies|pain coping strategies
1608999|NCT00361270|Pain intensity|pain intensity
1609000|NCT00361270|Pain interference|pain interference
1609001|NCT00361270|Pain quality|pain quality
1609002|NCT00361270|Self-help treatment|self-help treatment
1609003|NCT00361270|Sleep dysfunction|sleep dysfunction
1609004|NCT00361257|Treatment Experienced|treatment experienced
1609005|NCT00361244|Sutent|sutent
1609006|NCT00361231|Avastin|avastin
1609007|NCT00361231|GEMOX|gemox
1609008|NCT00361218|depression|depression
1609009|NCT00361218|biology|biology
1609010|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
1609011|NCT00361192|temporal arteritis|temporal arteritis
1609012|NCT00361192|duplex of temporal artery|duplex of temporal artery
1609013|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
1609014|NCT00361179|Observation|observation
1609015|NCT00361179|Post-treatment|post-treatment
1609016|NCT00361166|Schizophrenia|schizophrenia
1609017|NCT00361166|psychosis|psychosis
1609018|NCT00361166|delusions|delusions
1609019|NCT00361166|hallucination|hallucination
1609020|NCT00361140|Busulfan|busulfan
1609021|NCT00361140|Fludarabine|fludarabine
1609022|NCT00361140|Chimerism|chimerism
1609023|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
1609024|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
1609025|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
1609026|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
1609027|NCT00361140|Myeloma|myeloma
1609028|NCT00361140|Lymphoma|lymphoma
1609030|NCT00361140|Hematologic malignancies|hematologic malignancies
1609031|NCT00361127|Heart failure|heart failure
1609032|NCT00361127|pulmonary edema|pulmonary edema
1609033|NCT00361127|ACE-inhibitors|ace-inhibitors
1609034|NCT00361127|lung diffusion|lung diffusion
1609035|NCT00361127|exercise capacity|exercise capacity
1609036|NCT00361127|Chronic heart failure|chronic heart failure
1609037|NCT00361101|HIV|hiv
1609038|NCT00361101|X4 tropic virus|x4 tropic virus
1609039|NCT00361088|Velcade (PS-341)|velcade (ps-341)
1609040|NCT00361088|Bortezomib|bortezomib
1609041|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
1609042|NCT00361088|Tipifarnib|tipifarnib
1609043|NCT00361075|Perimenopause|perimenopause
1609044|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
1609045|NCT00361075|Women's health|women's health
1609046|NCT00361075|Cholesterol|cholesterol
1609047|NCT00361075|Lipid Metabolism|lipid metabolism
1609048|NCT00361062|aggressive|aggressive
1609049|NCT00361062|SSRI's|ssri's
1609050|NCT00361062|simulation|simulation
1609051|NCT00361062|behavioral|behavioral
1609052|NCT00361062|Side Effects, Psychological|side effects, psychological
1609053|NCT00361062|adverse effects|adverse effects
1609054|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
1609055|NCT00361062|aggressive behavior|aggressive behavior
1609056|NCT00361062|computer simulation|computer simulation
1609057|NCT00361049|graft versus host disease|graft versus host disease
1609058|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1609059|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1609060|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1609061|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1609062|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1609063|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1609064|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1609065|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1609066|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1609067|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1609068|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1609069|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1609070|NCT00361049|primary myelofibrosis|primary myelofibrosis
1609071|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1609072|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1609073|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1609074|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1609075|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
1609141|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
1609076|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1609077|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1609078|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1609079|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1609080|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1609081|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1609082|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1609083|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1609084|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1609085|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1609086|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1611399|NCT00353015|CDDP|cddp
1609087|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1609088|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1609089|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1609090|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1609091|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1609092|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1609093|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1609094|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1609095|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1609096|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
1609097|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
1609098|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1609099|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1609100|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1609101|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1609102|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1609103|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1609104|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1609105|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1609106|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1609107|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1609108|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1609109|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1609110|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1609111|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1609112|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
1609113|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1609114|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1609115|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1609116|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
1609117|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
1609118|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
1609119|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1609120|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1609121|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1609122|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1609123|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1609124|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1609125|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1609126|NCT00361049|stage IV breast cancer|stage iv breast cancer
1609127|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1609128|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1609129|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1609130|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1609131|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1609132|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1609133|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1609134|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1609135|NCT00361036|Leiomyoma|leiomyoma
1609136|NCT00361036|Leiomyomatosis|leiomyomatosis
1609137|NCT00361036|Uterine Neoplasms|uterine neoplasms
1609138|NCT00361036|BeadBlock|beadblock
1609139|NCT00361036|Embsophere|embsophere
1609140|NCT00361036|Embolization|embolization
1609323|NCT00360399|fMRI|fmri
1609142|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
1609143|NCT00361023|losartan|losartan
1609144|NCT00361023|type 2 diabetes|type 2 diabetes
1609145|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
1609146|NCT00361023|glucose metabolism|glucose metabolism
1609147|NCT00361010|Keppra|keppra
1609148|NCT00361010|Epilepsy|epilepsy
1609149|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
1609150|NCT00361010|Seizures|seizures
1609151|NCT00360997|Stroke rehabilitation|stroke rehabilitation
1609152|NCT00360997|Physical therapy|physical therapy
1609153|NCT00360984|CSII|csii
1609154|NCT00360984|insulin analog|insulin analog
1609155|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
1609156|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
1609157|NCT00360984|diabetes quality of life|diabetes quality of life
1609158|NCT00360984|CGMS|cgms
1609159|NCT00360971|mucositis|mucositis
1609160|NCT00360971|pain|pain
1609161|NCT00360971|radiation toxicity|radiation toxicity
1609241|NCT00360724|minor depression|minor depression
1609162|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1609163|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1609164|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1609165|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1609166|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1609167|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1609168|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1609169|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1609170|NCT00360958|ultrafiltration|ultrafiltration
1609171|NCT00360958|heart failure|heart failure
1609172|NCT00360958|fluid overload|fluid overload
1609173|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
1609174|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1609175|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1609176|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1609177|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1609178|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1609179|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
1609180|NCT00360932|facial lipoatrophy|facial lipoatrophy
1609181|NCT00360932|HIV/AIDs|hiv/aids
1609182|NCT00360919|casomorphin|casomorphin
1609183|NCT00360919|cheese|cheese
1609184|NCT00360919|craving|craving
1609185|NCT00360919|casein|casein
1609186|NCT00360919|milk|milk
1609187|NCT00360906|RRMS|rrms
1609188|NCT00360906|Omega-3|omega-3
1609189|NCT00360906|Treatment|treatment
1609190|NCT00360867|Extension study|extension study
1609191|NCT00360867|solid tumors|solid tumors
1609192|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1609193|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1609194|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1609195|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
1609196|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1609197|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1609198|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1609199|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1609200|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
1609201|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
1609202|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
1609203|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
1609204|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
1609205|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1609206|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1609207|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1609208|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
1609209|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1609210|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1609211|NCT00360841|auricular|auricular
1609212|NCT00360841|acupuncture|acupuncture
1609213|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
1609214|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
1609215|NCT00360828|Oligodendroglioma|oligodendroglioma
1609216|NCT00360828|Irinotecan|irinotecan
1609217|NCT00360828|Brain tumor|brain tumor
1609218|NCT00360828|Nitrosoureas|nitrosoureas
1609219|NCT00360828|Brain and nervous system|brain and nervous system
1609220|NCT00360802|chronic low back pain|chronic low back pain
1609221|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
1609324|NCT00360373|bariatric|bariatric
1609222|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
1609223|NCT00360802|pain clinics|pain clinics
1609224|NCT00360802|anxiety|anxiety
1609225|NCT00360802|quality of life|quality of life
1609226|NCT00360802|chronic pain|chronic pain
1609227|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
1609228|NCT00360789|pHYSICAL THERAPY|physical therapy
1609229|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
1609230|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
1609231|NCT00360737|Clinical Trials|clinical trials
1609232|NCT00360737|Investigational Drug|investigational drug
1609233|NCT00360737|Healthy Volunteers|healthy volunteers
1609234|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
1609235|NCT00360737|Phoenix, Arizona|phoenix, arizona
1609236|NCT00360724|dysthymia|dysthymia
1609237|NCT00360724|dysthymic disorder|dysthymic disorder
1609238|NCT00360724|chronic depression|chronic depression
1609239|NCT00360724|chronic low-grade depression|chronic low-grade depression
1609240|NCT00360724|atypical depression|atypical depression
1609242|NCT00360724|depression NOS|depression nos
1609243|NCT00360724|depression|depression
1609244|NCT00360724|depressive disorder|depressive disorder
1609245|NCT00360724|mood disorder|mood disorder
1609246|NCT00360724|unipolar depression|unipolar depression
1609247|NCT00360724|low-grade depression|low-grade depression
1609248|NCT00360711|Moral Distress|moral distress
1609249|NCT00360711|Nondirectiveness|nondirectiveness
1609250|NCT00360711|Ethical Dilemma|ethical dilemma
1609251|NCT00360685|Tacrolimus|tacrolimus
1609252|NCT00360685|Methotrexate|methotrexate
1609253|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
1609254|NCT00360685|Mucositis|mucositis
1609255|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
1609256|NCT00360685|Engraftment|engraftment
1609257|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
1609258|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
1609259|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
1609260|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
1609261|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
1609262|NCT00360659|Hypertension|hypertension
1609263|NCT00360659|Vasoactive hormones|vasoactive hormones
1609264|NCT00360646|LIVER DIS|liver dis
1609265|NCT00360646|CHEM IND|chem ind
1609266|NCT00360646|Drugs|drugs
1609267|NCT00360646|Drug induced liver injury|drug induced liver injury
1609268|NCT00360646|phenotype|phenotype
1609269|NCT00360646|cholestatic liver injury|cholestatic liver injury
1609270|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
1609271|NCT00360646|mixed liver injury|mixed liver injury
1609272|NCT00360646|genotype|genotype
1609273|NCT00360633|Parkinson's Disease|parkinson's disease
1609274|NCT00360633|Impulse control disorder|impulse control disorder
1609275|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
1609276|NCT00360633|Anxiety|anxiety
1609277|NCT00360633|Depression|depression
1609278|NCT00360633|Healthcare Utilization|healthcare utilization
1609279|NCT00360633|Disability|disability
1609280|NCT00360633|Quality of life|quality of life
1609281|NCT00360633|Cognitive function|cognitive function
1609282|NCT00360633|Psychosis|psychosis
1609283|NCT00360633|Apathy|apathy
1609284|NCT00360633|Dyskinesias|dyskinesias
1609285|NCT00360633|Wearing off|wearing off
1609286|NCT00360594|alcoholism|alcoholism
1609287|NCT00360581|Smoking abstinence|smoking abstinence
1609288|NCT00360568|carbidopa|carbidopa
1609289|NCT00360568|severe motor fluctuations|severe motor fluctuations
1609290|NCT00360568|intestinal gel|intestinal gel
1609291|NCT00360568|levodopa|levodopa
1609292|NCT00360568|efficacy|efficacy
1609293|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
1609294|NCT00360568|dyskinesia|dyskinesia
1609295|NCT00360568|Parkinson's Disease|parkinson's disease
1609296|NCT00360568|Duodopa|duodopa
1609297|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
1609298|NCT00360568|DUOPA|duopa
1609299|NCT00360516|healthy volunteers|healthy volunteers
1609300|NCT00360503|Cystic fibrosis|cystic fibrosis
1609301|NCT00360503|Antibiotic resistance|antibiotic resistance
1609302|NCT00360503|Microbiology|microbiology
1609303|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
1609304|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
1609305|NCT00360451|Prevention|prevention
1609306|NCT00360451|Child|child
1609307|NCT00360451|Adolescent|adolescent
1609308|NCT00360451|Parent|parent
1609309|NCT00360438|Leukemia|leukemia
1609310|NCT00360438|Lymphoma|lymphoma
1609311|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
1609312|NCT00360438|TLS|tls
1609313|NCT00360438|Rasburicase|rasburicase
1609314|NCT00360438|Elitek|elitek
1609315|NCT00360425|anemia|anemia
1609316|NCT00360425|intravenous iron|intravenous iron
1609317|NCT00360425|pharmacokinetics|pharmacokinetics
1609318|NCT00360425|QTc|qtc
1609319|NCT00360399|Escitalopram|escitalopram
1609320|NCT00360399|Duloxetine|duloxetine
1609321|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
1609322|NCT00360399|PET|pet
1609326|NCT00360373|insulin resistance|insulin resistance
1609327|NCT00360373|gastric bypass|gastric bypass
1609328|NCT00360373|adolescent|adolescent
1609329|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
1609330|NCT00360334|diabetes|diabetes
1609331|NCT00360334|exenatide|exenatide
1609332|NCT00360334|insulin glargine|insulin glargine
1609333|NCT00360334|Lilly|lilly
1609334|NCT00360334|Amylin|amylin
1609335|NCT00360282|Migraine|migraine
1609336|NCT00360282|Triptans|triptans
1609337|NCT00360282|Motion Sickness|motion sickness
1609338|NCT00360256|Depression|depression
1609339|NCT00360256|Amplichip P450 tests|amplichip p450 tests
1609340|NCT00360256|Antidepressants|antidepressants
1609341|NCT00360230|Vaccine|vaccine
1609342|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
1609343|NCT00360230|Plasmodium falciparum|plasmodium falciparum
1609344|NCT00360230|Malaria|malaria
1609345|NCT00360217|Omega-3|omega-3
1609346|NCT00360217|Triglyceride|triglyceride
1609347|NCT00360217|Hyperlipidemia|hyperlipidemia
1609660|NCT00359099|Surgery|surgery
1609348|NCT00360217|Coronary Artery Disease|coronary artery disease
1609349|NCT00360217|Fatty Acids|fatty acids
1609350|NCT00360217|Safety|safety
1609351|NCT00360217|Fish Oil|fish oil
1609352|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
1609353|NCT00360204|Infant health|infant health
1609354|NCT00360204|parenting competence|parenting competence
1609355|NCT00360204|Home nurse visit|home nurse visit
1609356|NCT00360204|maternal post-partum care|maternal post-partum care
1609357|NCT00360204|postpartum health utilization|postpartum health utilization
1609358|NCT00360204|Breastfeeding|breastfeeding
1609359|NCT00360178|hypertension|hypertension
1609360|NCT00360178|valsartan|valsartan
1609361|NCT00360178|amlodipine|amlodipine
1609362|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
1609363|NCT00360152|Breast Cancer|breast cancer
1609364|NCT00360152|Axilla|axilla
1609365|NCT00360152|Ultrasound|ultrasound
1609367|NCT00360152|Molecular Analysis|molecular analysis
1609368|NCT00360139|Sculptra|sculptra
1609369|NCT00360139|lipoatrophy|lipoatrophy
1609370|NCT00360139|emaciation|emaciation
1609371|NCT00360139|facial|facial
1609372|NCT00360139|dermal filler|dermal filler
1609373|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
1609376|NCT00360139|Sanofi|sanofi
1609377|NCT00360139|Facial lipoatrophy|facial lipoatrophy
1609378|NCT00360139|Facial emaciation|facial emaciation
1609379|NCT00360126|Lamictal|lamictal
1609380|NCT00360126|lamotrigine|lamotrigine
1609381|NCT00360126|Open-Label Extension Study|open-label extension study
1609382|NCT00360126|Bipolar Disorder|bipolar disorder
1609383|NCT00360087|Treatment Study|treatment study
1609384|NCT00360087|Sickle Cell Anemia|sickle cell anemia
1609385|NCT00360087|6-Minute Walk|6-minute walk
1609386|NCT00360087|Right Heart Catheterization|right heart catheterization
1609387|NCT00360087|Tracleer|tracleer
1609388|NCT00360087|Sickle Cell|sickle cell
1609389|NCT00360087|SCD|scd
1609390|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
1609391|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
1609392|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
1609393|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1609394|NCT00360061|Adolescents|adolescents
1609395|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
1609396|NCT00360048|oxytocin|oxytocin
1609397|NCT00360048|tnf|tnf
1609398|NCT00360048|sepsis|sepsis
1609399|NCT00360048|lps|lps
1609400|NCT00360009|Parkinson's disease|parkinson's disease
1609401|NCT00360009|Parkinson disease|parkinson disease
1609402|NCT00360009|PD|pd
1609403|NCT00360009|deep brain stimulation|deep brain stimulation
1609404|NCT00360009|DBS|dbs
1609405|NCT00360009|subthalamic nucleus|subthalamic nucleus
1609406|NCT00360009|STN|stn
1609407|NCT00360009|globus pallidus interna|globus pallidus interna
1609408|NCT00360009|GPi|gpi
1609409|NCT00360009|mood|mood
1609410|NCT00360009|motor symptoms|motor symptoms
1609411|NCT00360009|cognition|cognition
1609412|NCT00360009|emotion|emotion
1609413|NCT00360009|memory|memory
1609414|NCT00360009|attention|attention
1609415|NCT00360009|tremor|tremor
1609416|NCT00360009|rigidity|rigidity
1609417|NCT00360009|bradykinesia|bradykinesia
1609418|NCT00359996|diabetes|diabetes
1609419|NCT00359996|quality improvement|quality improvement
1609420|NCT00359996|community health center|community health center
1609421|NCT00359996|health disparities|health disparities
1609422|NCT00359983|Humans|humans
1609423|NCT00359983|Meningococcal vaccines|meningococcal vaccines
1609424|NCT00359983|Immunogenicity|immunogenicity
1609425|NCT00359983|Vaccines|vaccines
1609426|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
1609427|NCT00359983|Conjugate|conjugate
1609428|NCT00359983|Toddlers|toddlers
1609429|NCT00359983|Comparative study|comparative study
1609430|NCT00359983|Neisseria meningitidis|neisseria meningitidis
1609431|NCT00359970|Diarrhea|diarrhea
1609432|NCT00359970|Travel|travel
1609433|NCT00359970|Travelers' diarrhea|travelers' diarrhea
1609434|NCT00359970|Azithromycin|azithromycin
1609438|NCT00359957|Pediatric obesity|pediatric obesity
1609439|NCT00359957|Physical activity|physical activity
1609440|NCT00359957|Visceral fat|visceral fat
1609441|NCT00359957|Weight|weight
1609442|NCT00359944|Alzheimer|alzheimer
1609443|NCT00359944|Dementia|dementia
1609444|NCT00359931|Neural Networks|neural networks
1609445|NCT00359931|Mathematical Modeling|mathematical modeling
1609446|NCT00359931|Auditory Processing|auditory processing
1609447|NCT00359931|Tinnitis|tinnitis
1609448|NCT00359931|Hearing Loss|hearing loss
1609449|NCT00359918|infarction|infarction
1609450|NCT00359918|facilitated PCI|facilitated pci
1609451|NCT00359918|primary PCI|primary pci
1609452|NCT00359918|infarct size|infarct size
1609453|NCT00359918|fibrinolysis|fibrinolysis
1609454|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
1609455|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
1609456|NCT00359905|alpha-blockers|alpha-blockers
1609457|NCT00359879|diabetes|diabetes
1609458|NCT00359879|exenatide|exenatide
1609459|NCT00359879|Lilly|lilly
1609460|NCT00359879|Amylin|amylin
1609461|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
1609462|NCT00359840|darbepoetin alfa|darbepoetin alfa
1609463|NCT00359840|anemia|anemia
1609464|NCT00359840|cancer patients|cancer patients
1609465|NCT00359840|chemotherapy|chemotherapy
1609466|NCT00359814|Cyclosporine|cyclosporine
1609467|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
1609468|NCT00359814|long-term care|long-term care
1609469|NCT00359801|Large Simple Trial|large simple trial
1609470|NCT00359775|Coping|coping
1609471|NCT00359775|psychosocial|psychosocial
1609472|NCT00359775|Quality of Life|quality of life
1609473|NCT00359775|problem solving|problem solving
1609474|NCT00359762|exenatide|exenatide
1609475|NCT00359762|diabetes|diabetes
1609476|NCT00359762|Amylin|amylin
1609477|NCT00359762|Lilly|lilly
1609478|NCT00359762|glimepiride|glimepiride
1609479|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
1609480|NCT00359736|exercise, aerobic|exercise, aerobic
1609481|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
1609682|NCT00359021|HIV-1|hiv-1
1609482|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
1609483|NCT00359723|Parkinson's disease|parkinson's disease
1609484|NCT00359723|PD|pd
1609485|NCT00359723|methylphenidate|methylphenidate
1609486|NCT00359723|Ritalin|ritalin
1609487|NCT00359723|MPD|mpd
1609488|NCT00359710|Multiracial Populations|multiracial populations
1609489|NCT00359710|Human Genetic Variation|human genetic variation
1609490|NCT00359710|Family History|family history
1609491|NCT00359710|Admixture|admixture
1609492|NCT00359710|Physician-Patient Communication|physician-patient communication
1609493|NCT00359710|Ancestry|ancestry
1609494|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
1609495|NCT00359710|Interview|interview
1609496|NCT00359684|Cystinosis|cystinosis
1609497|NCT00359684|Cystine|cystine
1609498|NCT00359684|Lysomal Storage Disease|lysomal storage disease
1609499|NCT00359684|Mutation Analysis|mutation analysis
1609500|NCT00359684|Metabolic Disease|metabolic disease
1609501|NCT00359658|Cyclosporine|cyclosporine
1609502|NCT00359658|Glucocorticoids|glucocorticoids
1609503|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
1609504|NCT00359658|long-term care|long-term care
1609505|NCT00359645|Screening|screening
1609506|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
1609507|NCT00359645|Alcohol|alcohol
1609508|NCT00359645|Tobacco|tobacco
1609509|NCT00359645|Randomized trial|randomized trial
1609510|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
1609511|NCT00359619|HPV vaccine|hpv vaccine
1609512|NCT00359606|DNA Methylation|dna methylation
1609513|NCT00359606|Advanced Cancer|advanced cancer
1609514|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
1609515|NCT00359606|Epigenetics|epigenetics
1609516|NCT00359606|Gene Re-Expression|gene re-expression
1609517|NCT00359593|Stroke|stroke
1609518|NCT00359593|Rehabilitation|rehabilitation
1609519|NCT00359593|Knowledge translation|knowledge translation
1609520|NCT00359593|Evidence based practice|evidence based practice
1609521|NCT00359593|Outcomes|outcomes
1609522|NCT00359580|Ancestry|ancestry
1609523|NCT00359567|nausea and vomiting|nausea and vomiting
1609524|NCT00359554|Influenza|influenza
1609525|NCT00359541|CYP2C9|cyp2c9
1609526|NCT00359541|CYP2C19|cyp2c19
1609527|NCT00359541|Pharmacology|pharmacology
1609528|NCT00359541|Genotype|genotype
1609529|NCT00359541|Metabolism|metabolism
1609530|NCT00359515|Archived Samples|archived samples
1609531|NCT00359515|Mutation Screening|mutation screening
1609532|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
1609533|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
1609534|NCT00359515|Cataracts|cataracts
1609535|NCT00359515|Mutation Detection|mutation detection
1609536|NCT00359515|Lowe Syndrome|lowe syndrome
1609537|NCT00359515|Genotype|genotype
1609538|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
1609739|NCT00358813|GW679769|gw679769
1609539|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
1609540|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
1609541|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
1609542|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
1609543|NCT00359463|thrombocytopenia|thrombocytopenia
1609544|NCT00359463|hepatic impairment|hepatic impairment
1609545|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
1609546|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
1609547|NCT00359424|acute ischemic stroke|acute ischemic stroke
1609548|NCT00359424|rt-PA|rt-pa
1609549|NCT00359424|thrombolytic|thrombolytic
1609550|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1609551|NCT00359424|recanalization|recanalization
1609552|NCT00359424|blood clot|blood clot
1609553|NCT00359424|stroke|stroke
1609554|NCT00359424|clot-dissolving|clot-dissolving
1609555|NCT00359424|Activase®|activase®
1609556|NCT00359424|Actilyse®|actilyse®
1609764|NCT00358735|ActiveCare|activecare
1609557|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
1609558|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
1609559|NCT00359424|The Penumbra System™|the penumbra system™
1609560|NCT00359424|Standard microcatheter|standard microcatheter
1609561|NCT00359411|Epstein-Barr Virus|epstein-barr virus
1609562|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
1609563|NCT00359411|Herpes Virus|herpes virus
1609564|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
1609565|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
1609566|NCT00359398|Blood component removal|blood component removal
1609567|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
1609568|NCT00359385|hyperparathyroidism|hyperparathyroidism
1609569|NCT00359385|PHPT|phpt
1609570|NCT00359385|PTH|pth
1609571|NCT00359385|hypercalcemia|hypercalcemia
1609572|NCT00359385|bone density|bone density
1609573|NCT00359385|osteoporosis|osteoporosis
1609574|NCT00359385|bone turnover|bone turnover
1609575|NCT00359385|DXA|dxa
1609576|NCT00359385|pQCT|pqct
1609577|NCT00359385|cQCT|cqct
1609578|NCT00359385|alendronate|alendronate
1609579|NCT00359385|Fosamax|fosamax
1609580|NCT00359385|parathyroid hormone|parathyroid hormone
1609581|NCT00359385|parathyroid surgery|parathyroid surgery
1609582|NCT00359385|parathyroidectomy|parathyroidectomy
1609583|NCT00359385|Silverberg|silverberg
1609584|NCT00359385|Rubin|rubin
1609585|NCT00359385|Bilezikian|bilezikian
1609586|NCT00359385|treatment|treatment
1609587|NCT00359372|Chronic Heart Failure|chronic heart failure
1609588|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
1609589|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
1609590|NCT00359372|Biventricular Pacing|biventricular pacing
1609591|NCT00359372|Heart Function|heart function
1609592|NCT00359372|CRT|crt
1609593|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
1609594|NCT00359346|Plasmapheresis|plasmapheresis
1609595|NCT00359346|Auto-antibodies|auto-antibodies
1609596|NCT00359346|Autonomic Nervous System|autonomic nervous system
1609597|NCT00359346|Dysautonomia|dysautonomia
1609598|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
1609599|NCT00359346|Autonomic Failure|autonomic failure
1609600|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
1609601|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
1609602|NCT00359320|Pancreatic Cancer|pancreatic cancer
1609603|NCT00359307|Genetic|genetic
1609604|NCT00359307|Longitudinal|longitudinal
1609605|NCT00359307|Prospective|prospective
1609606|NCT00359307|Epidemiology|epidemiology
1609607|NCT00359307|Heart Attack|heart attack
1609608|NCT00359294|Tumor|tumor
1609609|NCT00359294|Lymphoma|lymphoma
1609610|NCT00359294|Zalypsis|zalypsis
1609611|NCT00359294|PharmaMar|pharmamar
1609612|NCT00359294|PM00104|pm00104
1609613|NCT00359281|healthy volunteers|healthy volunteers
1609614|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
1609615|NCT00359268|Random Priming|random priming
1609616|NCT00359268|Nucleic Acid|nucleic acid
1609617|NCT00359268|Viral Genome|viral genome
1609618|NCT00359268|Virus|virus
1609619|NCT00359268|Identification|identification
1609620|NCT00359255|Exercise|exercise
1609621|NCT00359255|rehabilitation|rehabilitation
1609622|NCT00359255|upper limb|upper limb
1609623|NCT00359255|inpatient|inpatient
1609624|NCT00359255|RCT|rct
1609625|NCT00359255|activities of daily living|activities of daily living
1609626|NCT00359242|Infant Sleep|infant sleep
1609627|NCT00359242|Infant Diet|infant diet
1609628|NCT00359242|Infant Temperament|infant temperament
1609629|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
1609630|NCT00359242|Infant Development|infant development
1609631|NCT00359242|Parenting Competence|parenting competence
1609632|NCT00359242|infant weight gain|infant weight gain
1609633|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
1609634|NCT00359203|syncope|syncope
1609635|NCT00359203|implantable loop recorder|implantable loop recorder
1609636|NCT00359190|lapatinib|lapatinib
1609637|NCT00359190|breast cancer|breast cancer
1609638|NCT00359190|treatment-naive|treatment-naive
1609639|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
1609641|NCT00359164|Avastin|avastin
1609642|NCT00359164|Visudyne|visudyne
1609643|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
1609644|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
1609645|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
1609646|NCT00359138|Anti-Allergic Agents|anti-allergic agents
1609647|NCT00359125|bipolar|bipolar
1609648|NCT00359125|RU-486|ru-486
1609649|NCT00359125|mifepristone|mifepristone
1609650|NCT00359125|neurocognition|neurocognition
1609651|NCT00359125|mood|mood
1609652|NCT00359125|cortisol|cortisol
1609653|NCT00359125|HPA axis|hpa axis
1609654|NCT00359112|Type 2 diabetes|type 2 diabetes
1609655|NCT00359112|overweight|overweight
1609656|NCT00359112|AVANDAMET|avandamet
1609657|NCT00359112|metformin|metformin
1609658|NCT00359112|sulphonylurea|sulphonylurea
1609659|NCT00359099|Hepatic Medicine|hepatic medicine
1609661|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
1609662|NCT00359086|Phase II|phase ii
1609663|NCT00359073|asthma|asthma
1609664|NCT00359073|leukotrienes|leukotrienes
1609665|NCT00359073|rhinovirus|rhinovirus
1609666|NCT00359060|Physical activity|physical activity
1609667|NCT00359060|Sex steroid hormones|sex steroid hormones
1609668|NCT00359060|Breast cancer risk|breast cancer risk
1609669|NCT00359060|Intervention study|intervention study
1609670|NCT00359060|Postmenopausal women|postmenopausal women
1609671|NCT00359047|Osteoporosis|osteoporosis
1609672|NCT00359047|Fragility fracture|fragility fracture
1609673|NCT00359047|Women|women
1609674|NCT00359047|Randomised control trial|randomised control trial
1609675|NCT00359047|Patient education|patient education
1609676|NCT00359047|Diagnosis|diagnosis
1609677|NCT00359047|Treatment|treatment
1609678|NCT00359034|Doppler ultrasound|doppler ultrasound
1609679|NCT00359034|pulsewave velocity|pulsewave velocity
1609680|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
1609681|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
1609683|NCT00359021|treatment experienced|treatment experienced
1609684|NCT00359021|virologic failure|virologic failure
1609685|NCT00359008|AMD|amd
1609686|NCT00359008|CNV|cnv
1609687|NCT00359008|PHP|php
1609688|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
1609689|NCT00358995|Primary Obsessions|primary obsessions
1609690|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
1609691|NCT00358995|Compulsive Disorder|compulsive disorder
1609692|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
1609693|NCT00358982|Phase II|phase ii
1609694|NCT00358969|borderline personality disorder|borderline personality disorder
1609695|NCT00358969|guanfacine|guanfacine
1609696|NCT00358969|impulsivity|impulsivity
1609697|NCT00358969|aggression|aggression
1609698|NCT00358969|affective instability|affective instability
1609699|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
1609701|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
1609702|NCT00358956|thyroid cancer|thyroid cancer
1609703|NCT00358943|Gaucher Disease|gaucher disease
1609704|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
1609705|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1609706|NCT00358904|Hill Sachs|hill sachs
1609707|NCT00358904|Weber osteotomy|weber osteotomy
1609708|NCT00358904|shoulder dislocation|shoulder dislocation
1609709|NCT00358891|Prematurity|prematurity
1609710|NCT00358891|Chronic Lung Disease|chronic lung disease
1609711|NCT00358891|Respiratory Health|respiratory health
1609712|NCT00358891|Neurodevelopment|neurodevelopment
1609713|NCT00358891|Preschool|preschool
1609714|NCT00358891|Influencing Factors|influencing factors
1609715|NCT00358878|Ascites|ascites
1609716|NCT00358878|Liver Cirrhosis|liver cirrhosis
1609717|NCT00358865|Virtual Reality|virtual reality
1609718|NCT00358865|ABI|abi
1609719|NCT00358865|Projected system|projected system
1609720|NCT00358852|Schizophrenia|schizophrenia
1609721|NCT00358852|Mental disorder|mental disorder
1609722|NCT00358852|Schizoaffective disorder|schizoaffective disorder
1609723|NCT00358852|Schizophreniform disorder|schizophreniform disorder
1609724|NCT00358852|Epidemiological study|epidemiological study
1609725|NCT00358852|Scale validation|scale validation
1609726|NCT00358852|Relapse|relapse
1609727|NCT00358852|Short Term Hospitalization|short term hospitalization
1609728|NCT00358852|PRE-COG|pre-cog
1609729|NCT00358852|RISSCH4075|rissch4075
1609730|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
1609731|NCT00358839|CGRP|cgrp
1609732|NCT00358839|middle cerebral artery|middle cerebral artery
1609733|NCT00358839|superficial temporal artery|superficial temporal artery
1609734|NCT00358839|headache|headache
1609735|NCT00358839|genotype|genotype
1609736|NCT00358839|Healthy Volunteers|healthy volunteers
1609737|NCT00358813|emesis|emesis
1609738|NCT00358813|renal impairment|renal impairment
1609740|NCT00358813|kidney problems|kidney problems
1609741|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
1609742|NCT00358787|Supracondylar fracture|supracondylar fracture
1609743|NCT00358787|humerus|humerus
1609744|NCT00358787|ulnar nerve injury|ulnar nerve injury
1609745|NCT00358787|Baumann's angle|baumann's angle
1609746|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
1609747|NCT00358774|homeopathic|homeopathic
1609748|NCT00358774|common cold|common cold
1609749|NCT00358774|Research Subjects|research subjects
1609750|NCT00358761|Lone Star Tick|lone star tick
1609751|NCT00358761|Borrelia|borrelia
1609752|NCT00358761|Skin Biopsy|skin biopsy
1609753|NCT00358761|Spirochete|spirochete
1609754|NCT00358761|Erythema Migrans|erythema migrans
1609755|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
1609756|NCT00358761|STARI|stari
1609757|NCT00358748|Preterm|preterm
1609758|NCT00358748|hypotension|hypotension
1609759|NCT00358748|steroids|steroids
1609760|NCT00358748|hydrocortisone|hydrocortisone
1609761|NCT00358735|SAFE|safe
1609762|NCT00358735|CECT|cect
1609763|NCT00358735|SFT|sft
1609765|NCT00358735|ActiveCare+SFT|activecare+sft
1609766|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
1609767|NCT00358735|Total Hip Replacement|total hip replacement
1609768|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
1609769|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
1609770|NCT00358735|MCS|mcs
1609771|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
1609772|NCT00358709|symptom management|symptom management
1609773|NCT00358709|first psychotic episode|first psychotic episode
1609774|NCT00358696|tenofovir|tenofovir
1609775|NCT00358696|didanosine|didanosine
1609776|NCT00358696|hiv|hiv
1609777|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
1609778|NCT00358696|treatment|treatment
1609779|NCT00358683|certolizunab pegol|certolizunab pegol
1609780|NCT00358683|long term safety follow-up|long term safety follow-up
1609781|NCT00358683|Chrohn's disease|chrohn's disease
1609782|NCT00358683|infliximab failures patients|infliximab failures patients
1611486|NCT00352664|Sedation|sedation
1609783|NCT00358683|Greek population|greek population
1609784|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
1609785|NCT00358644|AML|aml
1609786|NCT00358644|Decitabine|decitabine
1609787|NCT00358644|Dacogen|dacogen
1609788|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
1609789|NCT00358631|depression|depression
1609790|NCT00358631|antidepressive agents|antidepressive agents
1609791|NCT00358631|controlled clinical trial|controlled clinical trial
1609792|NCT00358618|Randomized|randomized
1609793|NCT00358618|double-blind|double-blind
1609794|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
1609795|NCT00358605|OSAHS|osahs
1609796|NCT00358605|Oral Appliance|oral appliance
1609797|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
1609798|NCT00358592|surgical instruments|surgical instruments
1609799|NCT00358592|cesarean section|cesarean section
1609800|NCT00358592|obesity|obesity
1609801|NCT00358579|Vasopressin|vasopressin
1609802|NCT00358579|Adrenaline|adrenaline
1609803|NCT00358579|Survival|survival
1609804|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
1609805|NCT00358566|Advanced|advanced
1609806|NCT00358566|Unresesctable|unresesctable
1609807|NCT00358566|Adenocarcinoma|adenocarcinoma
1609808|NCT00358566|Pancreatic cancer|pancreatic cancer
1609809|NCT00358553|Human Volunteers|human volunteers
1609810|NCT00358540|sarcoma|sarcoma
1609811|NCT00358540|eltrombopag|eltrombopag
1609812|NCT00358540|thrombopoiesis|thrombopoiesis
1609813|NCT00358540|thrombocytopenia|thrombocytopenia
1609814|NCT00358514|Tibia|tibia
1609815|NCT00358514|fracture|fracture
1609816|NCT00358514|compartment syndrome|compartment syndrome
1609817|NCT00358514|fasciotomy|fasciotomy
1609818|NCT00358501|Defibrotide|defibrotide
1609819|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
1609820|NCT00358501|Multi organ failure|multi organ failure
1609821|NCT00358501|Stem cell transplant|stem cell transplant
1609823|NCT00358501|Regimen related toxicity|regimen related toxicity
1609824|NCT00358501|Day 100 survival|day 100 survival
1609825|NCT00358488|Safety|safety
1609826|NCT00358488|Asthmatic patients|asthmatic patients
1609827|NCT00358488|GSK159797|gsk159797
1609828|NCT00358488|Efficacy|efficacy
1609829|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
1609830|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
1609831|NCT00358449|eosinophilic|eosinophilic
1609832|NCT00358449|mepolizumab|mepolizumab
1609833|NCT00358449|esophagitis|esophagitis
1609834|NCT00358436|COPD|copd
1609835|NCT00358436|Lung function|lung function
1609836|NCT00358436|Exacerbations|exacerbations
1609837|NCT00358436|Quality of Life|quality of life
1609838|NCT00358423|CME|cme
1609839|NCT00358423|Pegaptanib|pegaptanib
1609840|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
1609841|NCT00358410|Functional Dyspepsia|functional dyspepsia
1609846|NCT00358397|Spore-forming bacteria|spore-forming bacteria
1609847|NCT00358397|hypoxia|hypoxia
1609848|NCT00358397|anaerobes|anaerobes
1609849|NCT00358397|Clostridium novyi|clostridium novyi
1609850|NCT00358397|Bacteria|bacteria
1609851|NCT00358397|Bacteriolytic|bacteriolytic
1609852|NCT00358397|Tumor lysis|tumor lysis
1609853|NCT00358397|Necrosis|necrosis
1609854|NCT00358397|Colon Cancer|colon cancer
1609855|NCT00358397|Lung Cancer|lung cancer
1609856|NCT00358397|Sarcoma|sarcoma
1609857|NCT00358397|Bladder Cancer|bladder cancer
1609858|NCT00358397|Rectal Cancer|rectal cancer
1609859|NCT00358397|Gastric Cancer|gastric cancer
1609860|NCT00358397|Pancreatic Cancer|pancreatic cancer
1609861|NCT00358397|Experimental Therapy|experimental therapy
1609862|NCT00358397|Solid Tumors|solid tumors
1609863|NCT00358384|tolerability|tolerability
1609864|NCT00358384|safety|safety
1609865|NCT00358384|angiogenesis|angiogenesis
1609866|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
1609867|NCT00358384|pharmacodynamics|pharmacodynamics
1609868|NCT00358384|pharmacokinetics|pharmacokinetics
1609869|NCT00358384|microplaque|microplaque
1609870|NCT00358384|VEGF|vegf
1609872|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
1609873|NCT00358358|COPD|copd
1609874|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
1609875|NCT00358358|Computerized Tomography|computerized tomography
1609876|NCT00358345|AMD|amd
1609877|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
1609878|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
1609879|NCT00358319|Karenitecin|karenitecin
1609880|NCT00358319|Malignant Melanoma|malignant melanoma
1609881|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
1609882|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
1609883|NCT00358319|metastatic|metastatic
1609884|NCT00358306|Endothelium|endothelium
1609885|NCT00358306|Chronic Kidney Disease|chronic kidney disease
1609886|NCT00358306|Acute Kidney Injury|acute kidney injury
1609887|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
1609888|NCT00358293|Multiple Sclerosis|multiple sclerosis
1609889|NCT00358293|Spasticity|spasticity
1609890|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
1609891|NCT00358293|Ashworth Scores|ashworth scores
1609892|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
1609893|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
1609894|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
1609895|NCT00358280|Spinal Anesthesia|spinal anesthesia
1609896|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
1609897|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
1609898|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
1609899|NCT00358267|NOSE scale|nose scale
1609900|NCT00358267|Nasal Obstruction|nasal obstruction
1609901|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
1609902|NCT00358228|Smoking cessation|smoking cessation
1609903|NCT00358228|Abstinence|abstinence
1609904|NCT00358215|Survival study|survival study
1609905|NCT00358215|morbidity and mortality|morbidity and mortality
1609906|NCT00358215|heart failure hospitalization|heart failure hospitalization
1609907|NCT00358215|all-cause death|all-cause death
1609908|NCT00358215|patient-reported outcomes|patient-reported outcomes
1609909|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
1609910|NCT00358215|anemia treatment|anemia treatment
1609911|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
1609912|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
1609914|NCT00358202|pharmacoeconomics|pharmacoeconomics
1609915|NCT00358202|cefepime|cefepime
1609916|NCT00358202|ceftriaxone|ceftriaxone
1609917|NCT00358189|deep brain stimulation|deep brain stimulation
1609918|NCT00358189|gait|gait
1609919|NCT00358189|manual dexterity|manual dexterity
1609920|NCT00358189|parkinson's disease|parkinson's disease
1609921|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
1609922|NCT00358163|angiogenesis|angiogenesis
1609923|NCT00358163|taxane|taxane
1609924|NCT00358163|tyrosine kinase|tyrosine kinase
1609925|NCT00358163|pharmacokinetics|pharmacokinetics
1609926|NCT00358163|Vatalanib|vatalanib
1609927|NCT00358163|Taxol|taxol
1609928|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
1609929|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
1609930|NCT00358137|Blood Pressure, High|blood pressure, high
1609931|NCT00358111|high-grade disease|high-grade disease
1609932|NCT00358111|Cervical examination|cervical examination
1609933|NCT00358111|targeting biopsies|targeting biopsies
1609934|NCT00358111|dysplasia|dysplasia
1609935|NCT00358111|cancer|cancer
1609936|NCT00358098|PET|pet
1609937|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
1609938|NCT00358085|Endovascular|endovascular
1609939|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
1609940|NCT00358085|Aneurysm|aneurysm
1609941|NCT00358085|Expertise Based Methodology|expertise based methodology
1610125|NCT00357409|Plasticity|plasticity
1609942|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1609943|NCT00358072|Adult patients|adult patients
1609944|NCT00358072|Minimal residual disease|minimal residual disease
1609945|NCT00358072|Risk-oriented therapy|risk-oriented therapy
1609946|NCT00358059|diabetes mellitus|diabetes mellitus
1609947|NCT00358059|adolescence|adolescence
1609948|NCT00358059|adherence|adherence
1609949|NCT00358059|glycemic control|glycemic control
1609950|NCT00358059|adaptation|adaptation
1609951|NCT00358059|communication|communication
1609952|NCT00358046|Hyperphosphatemia|hyperphosphatemia
1609953|NCT00358046|Chronic kidney disease|chronic kidney disease
1609954|NCT00358046|Dialysis|dialysis
1609955|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
1609956|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
1609957|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
1609958|NCT00358007|Cone-beam CT|cone-beam ct
1609959|NCT00358007|CBCT|cbct
1609960|NCT00358007|radiation therapy|radiation therapy
1609961|NCT00358007|head and neck neoplasms|head and neck neoplasms
1609962|NCT00357994|carbidopa|carbidopa
1609963|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
1609964|NCT00357994|levodopa|levodopa
1609965|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
1609966|NCT00357994|dyskinesia|dyskinesia
1609967|NCT00357994|Duodopa|duodopa
1609968|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
1609969|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
1609970|NCT00357994|DUOPA|duopa
1609971|NCT00357981|Contraceptive patch|contraceptive patch
1609972|NCT00357981|menstruation|menstruation
1609973|NCT00357981|economics|economics
1609974|NCT00357942|Morphine|morphine
1609975|NCT00357942|Mouthwash|mouthwash
1609976|NCT00357942|Mucositis|mucositis
1609977|NCT00357942|Pain|pain
1609978|NCT00357942|Cancer|cancer
1609979|NCT00357942|Child|child
1609980|NCT00357942|Adolescent|adolescent
1609981|NCT00357929|permissive hypercarbia|permissive hypercarbia
1609982|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
1609983|NCT00357916|PEP005|pep005
1609984|NCT00357916|Safety|safety
1609985|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
1609986|NCT00357890|type 1 diabetes|type 1 diabetes
1609987|NCT00357890|diabetes|diabetes
1609988|NCT00357890|new onset|new onset
1609989|NCT00357890|CSII|csii
1609990|NCT00357890|insulin glargine|insulin glargine
1609991|NCT00357890|insulin sensitivity|insulin sensitivity
1609992|NCT00357890|beta cell function|beta cell function
1609993|NCT00357890|beta cell preservation|beta cell preservation
1609994|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
1609995|NCT00357838|normal healthy women|normal healthy women
1609996|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
1609997|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
1609998|NCT00357812|Cornea|cornea
1609999|NCT00357812|Dendretic Ulcer|dendretic ulcer
1610000|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
1610001|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
1610002|NCT00357812|Monoclonal Antibody|monoclonal antibody
1610003|NCT00357812|Glycoprotein D|glycoprotein d
1610004|NCT00357812|Glycoprotein C|glycoprotein c
1610005|NCT00357799|Venipuncture|venipuncture
1610006|NCT00357799|Randomized Controlled Trial|randomized controlled trial
1610007|NCT00357799|Intravenous Access|intravenous access
1610008|NCT00357799|Children|children
1610009|NCT00357799|Emergency Department Nursing|emergency department nursing
1610010|NCT00357799|VeinViewer|veinviewer
1610011|NCT00357799|Pediatrics|pediatrics
1610012|NCT00357799|Emergency Nursing|emergency nursing
1610013|NCT00357786|Lysosomal Disease|lysosomal disease
1610014|NCT00357786|Glycolipid|glycolipid
1610015|NCT00357786|Stroke|stroke
1610016|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
1610017|NCT00357786|Storage Disorder|storage disorder
1610018|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1610019|NCT00357760|VEGF Trap|vegf trap
1610020|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1610021|NCT00357734|lung cancer|lung cancer
1610022|NCT00357734|breast cancer|breast cancer
1610023|NCT00357695|Praxis|praxis
1610024|NCT00357695|Grasping|grasping
1610025|NCT00357695|Premotor Cortex|premotor cortex
1610026|NCT00357695|Visuo-Motor Integration|visuo-motor integration
1610027|NCT00357695|Motor Imagination|motor imagination
1610028|NCT00357682|esophageal cancer|esophageal cancer
1610029|NCT00357682|Barrett's esophagus|barrett's esophagus
1610030|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
1610031|NCT00357669|Baltic myoclonus|baltic myoclonus
1610032|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
1610033|NCT00357669|myoclonus|myoclonus
1610034|NCT00357669|brivaracetam|brivaracetam
1610035|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
1610036|NCT00357643|calcium|calcium
1610037|NCT00357643|vitamin D|vitamin d
1610038|NCT00357643|bone loss|bone loss
1610039|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1610040|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1610041|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
1610042|NCT00357630|pain|pain
1610043|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1610044|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1610045|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1610046|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1610047|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1610048|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1610049|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1610050|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1610051|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1610052|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1610150|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1610053|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1610054|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1610055|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1610056|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1610057|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1610058|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1610059|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1610060|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1610061|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1610062|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1610064|NCT00357604|Protease Inhibitor|protease inhibitor
1610065|NCT00357591|Heart Failure|heart failure
1610066|NCT00357591|Acute Decompensation|acute decompensation
1610067|NCT00357591|Chronic Heart Failure|chronic heart failure
1610068|NCT00357578|Macrophages|macrophages
1610069|NCT00357578|Biopsy|biopsy
1610070|NCT00357578|Genetic Analysis|genetic analysis
1610071|NCT00357578|Geographic Atrophy|geographic atrophy
1610072|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
1610073|NCT00357578|Fibroblast|fibroblast
1610074|NCT00357578|Disciform|disciform
1610075|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
1610076|NCT00357565|MDS|mds
1610077|NCT00357565|AML|aml
1610078|NCT00357552|Treatment Experienced|treatment experienced
1610079|NCT00357526|vaginal ring|vaginal ring
1610080|NCT00357526|Oral contraceptive pills|oral contraceptive pills
1610081|NCT00357526|Teenagers|teenagers
1610082|NCT00357526|Young women|young women
1610083|NCT00357526|Patient satisfaction|patient satisfaction
1610084|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
1610085|NCT00357513|Gene Chip|gene chip
1610086|NCT00357513|Inflammation|inflammation
1610087|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
1610088|NCT00357513|Stroke Genomics|stroke genomics
1610089|NCT00357513|Stroke Subtypes|stroke subtypes
1610090|NCT00357513|Neuroimaging|neuroimaging
1610091|NCT00357513|Clinical Outcome Measures|clinical outcome measures
1610092|NCT00357513|Stroke|stroke
1610093|NCT00357513|CVA|cva
1610094|NCT00357513|Healthy Volunteer|healthy volunteer
1610095|NCT00357513|HV|hv
1610096|NCT00357513|Normal Control|normal control
1610097|NCT00357500|Metronomic|metronomic
1610098|NCT00357500|antiangiogenic|antiangiogenic
1610099|NCT00357487|Sentinel lymph node|sentinel lymph node
1610100|NCT00357487|Breast cancer|breast cancer
1610101|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
1610102|NCT00357487|Probe|probe
1610103|NCT00357487|Operative gamma camera|operative gamma camera
1610104|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
1610105|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
1610106|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
1610107|NCT00357487|Use of intraoperative probe|use of intraoperative probe
1610108|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
1610109|NCT00357461|stage IV melanoma|stage iv melanoma
1610110|NCT00357461|recurrent melanoma|recurrent melanoma
1610111|NCT00357435|Cornea|cornea
1610112|NCT00357435|Genetics|genetics
1610113|NCT00357435|Dystrophy|dystrophy
1610114|NCT00357435|Gene|gene
1610115|NCT00357435|Mapping|mapping
1610116|NCT00357435|Molecular|molecular
1610117|NCT00357435|Bietti|bietti
1610118|NCT00357435|Fleck|fleck
1610119|NCT00357435|Positional Cloning|positional cloning
1610120|NCT00357435|Linkage|linkage
1610121|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
1610122|NCT00357409|GABA|gaba
1610123|NCT00357409|Occipital|occipital
1610124|NCT00357409|Vision|vision
1610128|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1610129|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1610130|NCT00357357|Alzheimer's disease|alzheimer's disease
1610131|NCT00357344|Obesity|obesity
1610132|NCT00357344|Gray Matter|gray matter
1610133|NCT00357344|Eating Behavior|eating behavior
1610134|NCT00357344|Brain MRI|brain mri
1610135|NCT00357344|Body Weight Regulation|body weight regulation
1610136|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
1610137|NCT00357331|treatment|treatment
1610138|NCT00357331|bone loss|bone loss
1610139|NCT00357266|Uveitis|uveitis
1610140|NCT00357266|Interleukin 2|interleukin 2
1610141|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
1610142|NCT00357266|Microarrays|microarrays
1610143|NCT00357266|Genetic Expression|genetic expression
1610144|NCT00357266|Daclizumab|daclizumab
1610145|NCT00357266|HAT|hat
1610146|NCT00357266|Zenapax|zenapax
1610147|NCT00357266|Proteins|proteins
1610148|NCT00357266|RNA|rna
1610149|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
1610151|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1610152|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1610153|NCT00357240|Protease inhibitor|protease inhibitor
1610154|NCT00357227|Atrial fibrillation|atrial fibrillation
1610155|NCT00357227|Stroke|stroke
1610156|NCT00357227|Vascular Dementia|vascular dementia
1610157|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
1610158|NCT00357214|bone turnover|bone turnover
1610159|NCT00357214|calcium excretion|calcium excretion
1610160|NCT00357214|nitrogen excretion|nitrogen excretion
1610161|NCT00357214|potassium bicarbonate|potassium bicarbonate
1610162|NCT00357214|muscle loss|muscle loss
1610163|NCT00357214|muscle atrophy|muscle atrophy
1610164|NCT00357214|bone loss|bone loss
1610165|NCT00357123|abdominal sepsis|abdominal sepsis
1610166|NCT00357123|sepsis|sepsis
1610167|NCT00357123|rosuvastatin|rosuvastatin
1610168|NCT00357110|Breast neoplasms|breast neoplasms
1610169|NCT00357110|breast cancer|breast cancer
1610170|NCT00357110|early breast cancer|early breast cancer
1610171|NCT00357110|oncology|oncology
1610172|NCT00357110|cancer|cancer
1610173|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
1610174|NCT00357110|fulvestrant|fulvestrant
1610175|NCT00357097|randomised|randomised
1610176|NCT00357097|ropinirole|ropinirole
1610177|NCT00357097|depression|depression
1610178|NCT00357097|RLS|rls
1610179|NCT00357097|placebo|placebo
1610180|NCT00357097|mood|mood
1610181|NCT00357097|double-blind|double-blind
1610182|NCT00357097|restless legs syndrome|restless legs syndrome
1610183|NCT00357097|germany|germany
1610184|NCT00357084|graft versus host disease|graft versus host disease
1610185|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1610186|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1610187|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1610188|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1610189|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1610190|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1610191|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1610192|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1610193|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1610194|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1610195|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1610196|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1610197|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1610198|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1610199|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1610200|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1610201|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1610202|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1610203|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1610204|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
1610205|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1610206|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1610207|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1610208|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1610209|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1610210|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1610211|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1610212|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1610213|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1610214|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1610215|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1610216|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1610217|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1610218|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1610219|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1610220|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1610221|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1610222|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1610382|NCT00356655|Patient education|patient education
1610223|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1610224|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1610225|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1610226|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1610227|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1610228|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1610229|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1610230|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1610231|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1610232|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1610233|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1610234|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1610235|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1610236|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1610237|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1610238|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1610239|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1610240|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1610241|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1610242|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1610243|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1610244|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1610245|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1610246|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1610247|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1610248|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1610249|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1610250|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
1610251|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
1610252|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1610253|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1610254|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1610255|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1610256|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
1610257|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
1610258|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1610259|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1610260|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1610261|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1610262|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1610263|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1610264|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1610265|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1610266|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1610267|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1610268|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1610269|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1610270|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1610271|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1610272|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
1610460|NCT00356304|Dysthymia|dysthymia
1610273|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1610274|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1610275|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1610276|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1610277|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1610278|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1610279|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1610280|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1610281|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1610282|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1610283|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1610284|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1610285|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1610286|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1610895|NCT00354783|Walking|walking
1610287|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1610288|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1610289|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1610290|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1610291|NCT00357071|Autoimmunity|autoimmunity
1610292|NCT00357071|Cell Mediated Immunity|cell mediated immunity
1610293|NCT00357071|S Antigen|s antigen
1610294|NCT00357071|Cell Proliferation|cell proliferation
1610295|NCT00357071|Uveitis|uveitis
1610296|NCT00357071|Cell Proliferation Assays|cell proliferation assays
1610297|NCT00357071|Auto-Antibody|auto-antibody
1610298|NCT00357071|Auto-Antigens|auto-antigens
1610299|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
1610300|NCT00357058|fMRI|fmri
1611487|NCT00352664|Placebo|placebo
1610301|NCT00357058|Cortical Reorganization|cortical reorganization
1610302|NCT00357058|Tactile Performance|tactile performance
1610303|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1610304|NCT00357058|Tactile Discrimination|tactile discrimination
1610305|NCT00357058|Plasticity|plasticity
1610306|NCT00357058|Healthy Volunteer|healthy volunteer
1610308|NCT00357058|Normal Control|normal control
1610309|NCT00357006|Schizophrenia|schizophrenia
1610310|NCT00357006|Estrogen|estrogen
1610311|NCT00357006|Psychosis|psychosis
1610312|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
1610313|NCT00356993|smoking cessation|smoking cessation
1610314|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1610315|NCT00356967|smoking|smoking
1610316|NCT00356967|cessation|cessation
1610317|NCT00356967|tobacco|tobacco
1610318|NCT00356967|smoking cessation|smoking cessation
1610319|NCT00356967|tobacco use cessation|tobacco use cessation
1610320|NCT00356954|Kidney failure|kidney failure
1610321|NCT00356954|Contrast media|contrast media
1610322|NCT00356954|Antioxidant|antioxidant
1610323|NCT00356954|Prevention|prevention
1610324|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1610325|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1610326|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1610327|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1610328|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1610329|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1610330|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1610331|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1610332|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1610333|NCT00356915|Nail fungus|nail fungus
1610334|NCT00356915|Onychomycosis|onychomycosis
1610335|NCT00356915|Itraconazole|itraconazole
1610336|NCT00356915|Toenail|toenail
1610337|NCT00356863|Intervention|intervention
1610338|NCT00356863|Awareness|awareness
1610339|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
1610340|NCT00356863|Coronary Artery Patients|coronary artery patients
1610341|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
1610342|NCT00356824|Child|child
1610343|NCT00356811|Lapatinib|lapatinib
1610344|NCT00356811|Metastatic breast cancer|metastatic breast cancer
1610345|NCT00356811|Paclitaxel|paclitaxel
1610346|NCT00356811|ErbB2-amplification|erbb2-amplification
1610347|NCT00356811|GW572016|gw572016
1610348|NCT00356798|pandemic|pandemic
1610349|NCT00356798|influenza|influenza
1610350|NCT00356798|H5N1|h5n1
1610351|NCT00356798|vaccine|vaccine
1610352|NCT00356785|lifestyle|lifestyle
1610353|NCT00356785|diet|diet
1610354|NCT00356785|exercise|exercise
1610355|NCT00356785|physical activity|physical activity
1610356|NCT00356785|obesity|obesity
1610357|NCT00356759|warfarin|warfarin
1610358|NCT00356759|prothrombin time|prothrombin time
1610359|NCT00356759|monitoring|monitoring
1610360|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
1610361|NCT00356746|General anesthesia|general anesthesia
1610362|NCT00356746|Toll-Like Receptors|toll-like receptors
1610363|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
1610364|NCT00356733|erythropoietin|erythropoietin
1610365|NCT00356733|Heart Failure, Congestive|heart failure, congestive
1610366|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
1610367|NCT00356707|Body Mass Index|body mass index
1610368|NCT00356681|AMG 706|amg 706
1610369|NCT00356681|Paclitaxel|paclitaxel
1610370|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
1610371|NCT00356681|Antiangiogenic|antiangiogenic
1610372|NCT00356681|Bevacizumab|bevacizumab
1610373|NCT00356668|HFNC|hfnc
1610374|NCT00356668|NCPAP|ncpap
1610375|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
1610376|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
1610377|NCT00356668|esophageal pressure|esophageal pressure
1610378|NCT00356668|gas flow|gas flow
1610379|NCT00356655|Depressive disorder|depressive disorder
1610380|NCT00356655|Patient compliance|patient compliance
1610381|NCT00356655|Antidepressive Agents|antidepressive agents
1610383|NCT00356655|Community pharmacy services|community pharmacy services
1610384|NCT00356655|Counseling|counseling
1610385|NCT00356642|PK|pk
1610386|NCT00356642|GW842470X|gw842470x
1610387|NCT00356642|safety|safety
1610388|NCT00356642|tolerability|tolerability
1610389|NCT00356642|PD|pd
1610390|NCT00356642|Atopic Dermatitis|atopic dermatitis
1610391|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
1610392|NCT00356629|condensate of exhaled air|condensate of exhaled air
1610393|NCT00356629|Mucoviscidosis|mucoviscidosis
1610394|NCT00356629|Asthma|asthma
1610395|NCT00356616|Antiretroviral treatment|antiretroviral treatment
1610396|NCT00356616|virological failure|virological failure
1610397|NCT00356616|HIV|hiv
1610398|NCT00356603|Migraine|migraine
1611665|NCT00352222|occlusive|occlusive
1610399|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
1610400|NCT00356603|Cluster Headache|cluster headache
1610401|NCT00356603|self-injection|self-injection
1610402|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
1610403|NCT00356590|Etanercept|etanercept
1610404|NCT00356590|Long-term Safety|long-term safety
1610405|NCT00356590|Enbrel|enbrel
1610406|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
1610407|NCT00356551|Teen pregnancy|teen pregnancy
1610408|NCT00356551|Family strengthening|family strengthening
1610409|NCT00356551|Substance abuse prevention|substance abuse prevention
1610410|NCT00356551|Depression prevention|depression prevention
1610411|NCT00356551|Parent involvement|parent involvement
1610412|NCT00356512|Phosphate|phosphate
1610413|NCT00356512|Vitamin D|vitamin d
1610414|NCT00356512|Hypoparathyroidism|hypoparathyroidism
1610415|NCT00356512|Phosphatonin|phosphatonin
1610416|NCT00356512|Clamp|clamp
1610417|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
1610418|NCT00356486|Co-infection|co-infection
1610419|NCT00356486|Induction dose|induction dose
1610420|NCT00356486|HIV|hiv
1610421|NCT00356486|HIV Infections|hiv infections
1610422|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
1610423|NCT00356473|Atherosclerosis|atherosclerosis
1610424|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
1610425|NCT00356473|Statins|statins
1610426|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
1610427|NCT00356473|Atorvastatin|atorvastatin
1610428|NCT00356434|deep vein thrombosis|deep vein thrombosis
1610429|NCT00356434|thrombophilia|thrombophilia
1610430|NCT00356434|pregnancy|pregnancy
1610431|NCT00356434|thromboprophylaxis|thromboprophylaxis
1610432|NCT00356434|decreased mobility|decreased mobility
1610433|NCT00356434|hospitalization|hospitalization
1610434|NCT00356408|CDP870|cdp870
1610435|NCT00356408|certolizumab pegol|certolizumab pegol
1610436|NCT00356408|Crohn's Disease|crohn's disease
1610437|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
1610438|NCT00356382|probiotic|probiotic
1610439|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
1610440|NCT00356382|cultured dairy drink|cultured dairy drink
1610441|NCT00356382|Health|health
1610442|NCT00356369|Immunogenicity|immunogenicity
1610443|NCT00356369|Healthy|healthy
1610444|NCT00356369|Persistence|persistence
1610445|NCT00356369|Meningococcal vaccine|meningococcal vaccine
1610446|NCT00356369|Non-inferiority|non-inferiority
1610447|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
1610448|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
1610449|NCT00356343|NMES|nmes
1610450|NCT00356343|Cerebral Palsy|cerebral palsy
1610451|NCT00356343|Spastic Diplegia|spastic diplegia
1610452|NCT00356343|Electrical Stimulation|electrical stimulation
1610453|NCT00356343|Children|children
1610454|NCT00356330|pacemaker|pacemaker
1610455|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
1610456|NCT00356330|safety|safety
1610457|NCT00356317|Culture|culture
1610458|NCT00356317|Family|family
1610459|NCT00356317|Therapy|therapy
1610461|NCT00356304|Major Depression|major depression
1610462|NCT00356304|Hispanics|hispanics
1610463|NCT00356304|Latinos|latinos
1610464|NCT00356304|Motivational Interviewing|motivational interviewing
1610465|NCT00356304|Adherence|adherence
1610466|NCT00356291|HIV|hiv
1610467|NCT00356291|AIDS|aids
1610468|NCT00356291|Prevention|prevention
1610469|NCT00356291|Serious Mental Illness|serious mental illness
1610470|NCT00356278|D-Cycloserine|d-cycloserine
1610471|NCT00356278|Virtual Reality|virtual reality
1610472|NCT00356278|Exposure Therapy|exposure therapy
1610473|NCT00356278|Veterans|veterans
1610474|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
1610475|NCT00356278|Translational Research|translational research
1610476|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
1610477|NCT00356265|L-NMMA|l-nmma
1610478|NCT00356265|Phenylephrine|phenylephrine
1610479|NCT00356265|Vasoreactivity|vasoreactivity
1610480|NCT00356265|Blood Pressure|blood pressure
1610481|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
1610482|NCT00356239|Heart Failure, Congestive|heart failure, congestive
1610483|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
1610484|NCT00356226|norepinephrine|norepinephrine
1610485|NCT00356226|renin|renin
1610486|NCT00356226|aldosterone|aldosterone
1610487|NCT00356226|hemodynamics|hemodynamics
1610488|NCT00356226|spironolactone|spironolactone
1610489|NCT00356213|morbid obesity|morbid obesity
1610490|NCT00356213|bariatric surgery|bariatric surgery
1610491|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
1610492|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
1610493|NCT00356213|outcome|outcome
1610494|NCT00356213|weight loss|weight loss
1610495|NCT00356174|Food Allergy|food allergy
1610496|NCT00356161|colorectal neoplasms|colorectal neoplasms
1610497|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
1610498|NCT00356161|gallbladder cancer|gallbladder cancer
1610499|NCT00356161|bile duct cancer|bile duct cancer
1610500|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
1610501|NCT00356148|breast cancer|breast cancer
1610502|NCT00356148|breast surgery|breast surgery
1610503|NCT00356148|clean wound|clean wound
1610504|NCT00356148|overweight|overweight
1610505|NCT00356148|prophylaxis|prophylaxis
1610506|NCT00356148|antibiotics|antibiotics
1610507|NCT00356122|Lung|lung
1610508|NCT00356122|non-small cell|non-small cell
1610509|NCT00356122|chemotherapy|chemotherapy
1610510|NCT00356122|tumor|tumor
1610511|NCT00356122|advanced|advanced
1610512|NCT00356122|recurrent|recurrent
1610513|NCT00356122|metastatic|metastatic
1610514|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
1610515|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
1610516|NCT00356070|Strattera,|strattera,
1610517|NCT00356070|rehabilitation|rehabilitation
1610518|NCT00356057|atrial fibrillation|atrial fibrillation
1610519|NCT00356057|AV node ablation|av node ablation
1610520|NCT00356057|pacemaker|pacemaker
1610521|NCT00356057|congestive heart failure|congestive heart failure
1610522|NCT00356044|Transradial access|transradial access
1610523|NCT00356044|Femoral access|femoral access
1610524|NCT00356044|Femoral vs radial access|femoral vs radial access
1610525|NCT00356031|Avastin|avastin
1610526|NCT00356018|Epilepsy|epilepsy
1610527|NCT00356018|Compliance|compliance
1610528|NCT00356005|falciparum malaria|falciparum malaria
1610529|NCT00356005|therapy|therapy
1610530|NCT00356005|azithromycin|azithromycin
1610531|NCT00356005|artesunate|artesunate
1610532|NCT00356005|Coartem|coartem
1610533|NCT00356005|Bangladesh|bangladesh
1610534|NCT00355992|Myocardial Ischemia|myocardial ischemia
1610535|NCT00355992|Chest pain|chest pain
1610536|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
1610537|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
1610538|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
1610539|NCT00355966|Premature rupture of membranes|premature rupture of membranes
1610540|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
1610541|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
1610542|NCT00355953|Post-Menopausal Women|post-menopausal women
1610543|NCT00355953|Osteoporosis|osteoporosis
1610544|NCT00355953|Phytoestrogen|phytoestrogen
1610545|NCT00355953|Genistein|genistein
1610546|NCT00355940|endovascular|endovascular
1610547|NCT00355940|aortic|aortic
1610548|NCT00355940|repair|repair
1610549|NCT00355940|navigation|navigation
1610550|NCT00355940|DynaCT|dynact
1610551|NCT00355940|position|position
1610552|NCT00355940|sensor|sensor
1610553|NCT00355927|Deep brain stimulation|deep brain stimulation
1610554|NCT00355927|Microelectrode recordings|microelectrode recordings
1610555|NCT00355927|Basal Ganglia|basal ganglia
1610556|NCT00355927|Sedation|sedation
1610557|NCT00355927|Propofol|propofol
1610558|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
1610559|NCT00355901|Ulcerative Colitis|ulcerative colitis
1610560|NCT00355901|Colitis|colitis
1610561|NCT00355901|Steroid-Refractory|steroid-refractory
1610562|NCT00355901|Visilizumab|visilizumab
1610563|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
1610564|NCT00355888|Cancer|cancer
1610565|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
1610566|NCT00355875|newborn|newborn
1610567|NCT00355875|preterm|preterm
1610568|NCT00355875|resuscitation|resuscitation
1610569|NCT00355875|oxidative injury|oxidative injury
1610570|NCT00355875|protein carbonyl|protein carbonyl
1610571|NCT00355862|Sirolimus|sirolimus
1610572|NCT00355862|mTOR|mtor
1610573|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
1610574|NCT00355862|Liver transplant recipients|liver transplant recipients
1610575|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
1610576|NCT00355836|Motor Imagery|motor imagery
1610577|NCT00355836|Stroke|stroke
1610578|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
1610579|NCT00355836|health psychology|health psychology
1610580|NCT00355836|neuroscience|neuroscience
1610581|NCT00355836|randomised controlled trial|randomised controlled trial
1610582|NCT00355823|electric field|electric field
1610583|NCT00355823|wound current|wound current
1610584|NCT00355823|wound healing|wound healing
1610585|NCT00355823|bioelectric field|bioelectric field
1610586|NCT00355823|chronic ulcer|chronic ulcer
1610587|NCT00355823|diabetic|diabetic
1610588|NCT00355823|Diabetes|diabetes
1610589|NCT00355823|aging|aging
1610590|NCT00355810|Probiotics|probiotics
1610591|NCT00355797|Bradycardia|bradycardia
1610592|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
1610593|NCT00355797|Chronotropic incompetence|chronotropic incompetence
1610594|NCT00355797|Pacemaker|pacemaker
1610595|NCT00355797|Rate adaptive|rate adaptive
1610596|NCT00355784|growth hormone|growth hormone
1610597|NCT00355784|overfeeding|overfeeding
1610598|NCT00355784|energy expenditure|energy expenditure
1610599|NCT00355784|protein metabolism|protein metabolism
1610600|NCT00355784|lipid metabolism|lipid metabolism
1610601|NCT00355771|allergic rhinitis|allergic rhinitis
1610602|NCT00355771|histamine antagonist|histamine antagonist
1610603|NCT00355771|sleep disorder|sleep disorder
1610604|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
1610605|NCT00355745|Breast|breast
1610606|NCT00355745|tumor|tumor
1610607|NCT00355745|ultrasound|ultrasound
1610608|NCT00355745|biopsy|biopsy
1610609|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
1610610|NCT00355732|Respiration|respiration
1610611|NCT00355732|COPD|copd
1610612|NCT00355732|Mechanical Ventilation|mechanical ventilation
1610613|NCT00355732|Ventilator Weaning|ventilator weaning
1610614|NCT00355732|Respiratory Failure|respiratory failure
1610616|NCT00355732|Pressure Support Ventilation|pressure support ventilation
1610617|NCT00355719|Nevirapine|nevirapine
1610618|NCT00355719|Atazanavir|atazanavir
1610619|NCT00355719|Pharmacokinetics|pharmacokinetics
1610620|NCT00355719|Interactions|interactions
1610621|NCT00355706|chronic low back pain|chronic low back pain
1610622|NCT00355706|thoracic facet joint|thoracic facet joint
1610623|NCT00355706|nerve block|nerve block
1610624|NCT00355693|Anxiety|anxiety
1610625|NCT00355693|Dental|dental
1610626|NCT00355693|Oral|oral
1610627|NCT00355693|Surgery|surgery
1610628|NCT00355693|Colonoscopy|colonoscopy
1610629|NCT00355693|Propofol|propofol
1610630|NCT00355693|Sedation|sedation
1610631|NCT00355693|Effect|effect
1610632|NCT00355693|Reaction|reaction
1610633|NCT00355680|Retina|retina
1610634|NCT00355680|Retinal Diseases|retinal diseases
1610635|NCT00355680|Retinal Vessels|retinal vessels
1610636|NCT00355680|Laser Coagulation|laser coagulation
1610637|NCT00355667|diuretics|diuretics
1610638|NCT00355667|furosemide|furosemide
1610639|NCT00355667|azosemide|azosemide
1610640|NCT00355667|congestive heart failure|congestive heart failure
1610641|NCT00355654|Diphtheria|diphtheria
1610642|NCT00355654|Tetanus|tetanus
1610643|NCT00355654|Pertussis|pertussis
1610644|NCT00355654|Poliomyelitis|poliomyelitis
1610645|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
1610646|NCT00355654|Hepatitis B|hepatitis b
1610647|NCT00355641|Ropinirole|ropinirole
1610648|NCT00355641|Restless Legs Syndrome|restless legs syndrome
1610649|NCT00355641|RLS|rls
1610650|NCT00355628|Pain|pain
1610651|NCT00355628|Cancer|cancer
1610652|NCT00355628|Neoplasm|neoplasm
1610653|NCT00355628|Continual Reassessment Method|continual reassessment method
1610654|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
1610655|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1610656|NCT00355602|Antibiotics|antibiotics
1610657|NCT00355602|Controlled Clinical Trial|controlled clinical trial
1610658|NCT00355589|Hypertension|hypertension
1610659|NCT00355589|High Blood Pressure|high blood pressure
1610660|NCT00355589|Diuretic|diuretic
1610661|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1610662|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1610663|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1610670|NCT00355576|Motor Neuron Disease|motor neuron disease
1610671|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
1610672|NCT00355550|Cognition disorders|cognition disorders
1610673|NCT00355550|nutritional supplement|nutritional supplement
1610674|NCT00355550|dietary supplement|dietary supplement
1610676|NCT00355524|Darunavir|darunavir
1610677|NCT00355524|Ritonavir|ritonavir
1610678|NCT00355524|TMC114|tmc114
1610679|NCT00355511|heart failure, congestive|heart failure, congestive
1610680|NCT00355511|patient care team|patient care team
1610681|NCT00355511|randomized controlled trial|randomized controlled trial
1610682|NCT00355511|disease management|disease management
1610683|NCT00355511|drug therapy|drug therapy
1610684|NCT00355511|diet therapy|diet therapy
1610685|NCT00355511|hospitalization|hospitalization
1610686|NCT00355511|mortality|mortality
1610687|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
1610688|NCT00355498|positron emission tomography|positron emission tomography
1610689|NCT00355498|beta-amyloid|beta-amyloid
1610690|NCT00355498|tau|tau
1610691|NCT00355485|Acne|acne
1610692|NCT00355485|Microdermabrasion|microdermabrasion
1610693|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
1610694|NCT00355472|ATL|atl
1610695|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
1610696|NCT00355472|PTCL|ptcl
1610697|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
1610698|NCT00355446|Cataract|cataract
1610699|NCT00355446|Human Aqueous|human aqueous
1610700|NCT00355433|urinary incontinence|urinary incontinence
1610701|NCT00355433|urodynamics|urodynamics
1610702|NCT00355433|temperature|temperature
1610703|NCT00355407|Aranesp|aranesp
1610704|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
1610705|NCT00355381|Information Services|information services
1610706|NCT00355381|Randomized Controlled Trials|randomized controlled trials
1610707|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
1610708|NCT00355381|Internet|internet
1610709|NCT00355381|Librarians|librarians
1610710|NCT00355381|Breast Neoplasms|breast neoplasms
1610711|NCT00355381|Patient Satisfaction|patient satisfaction
1610712|NCT00355381|Health Personnel|health personnel
1610713|NCT00355381|Costs and Cost Analysis|costs and cost analysis
1610714|NCT00355381|Premature Birth|premature birth
1610715|NCT00355368|intubation|intubation
1610716|NCT00355368|intensive care|intensive care
1610717|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
1610718|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
1610719|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
1610720|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
1610721|NCT00355355|HCC|hcc
1610722|NCT00355355|Liver Neoplasms|liver neoplasms
1610723|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
1610724|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
1610725|NCT00355355|Light activation|light activation
1610726|NCT00355342|Osteoporosis|osteoporosis
1610727|NCT00355342|Bone Mineral Density|bone mineral density
1610728|NCT00355342|Osteopenia|osteopenia
1610729|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1610730|NCT00355342|COPD|copd
1610731|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
1610732|NCT00355329|Autism|autism
1610733|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
1610734|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
1610735|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
1610736|NCT00355329|children|children
1610737|NCT00355316|Breast Cancer|breast cancer
1610738|NCT00355316|Peripheral|peripheral
1610739|NCT00355316|Blood|blood
1610740|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
1610741|NCT00355303|Induction of labour|induction of labour
1610742|NCT00355303|Misoprostol|misoprostol
1610743|NCT00355303|PGE2 gel|pge2 gel
1610744|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
1610745|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
1610746|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
1610747|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
1610748|NCT00355277|Neuropathic pain|neuropathic pain
1610749|NCT00355277|Local anaesthesia|local anaesthesia
1610750|NCT00355277|Transcutaneous|transcutaneous
1610751|NCT00355251|Atorvastatin|atorvastatin
1610752|NCT00355251|Viral replication|viral replication
1610753|NCT00355251|HIV-1|hiv-1
1610754|NCT00355251|plasma cholesterol|plasma cholesterol
1610755|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
1610756|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
1610757|NCT00355225|malaria|malaria
1610758|NCT00355225|africa|africa
1610759|NCT00355225|social marketing|social marketing
1610760|NCT00355225|ante-natal care|ante-natal care
1610761|NCT00355225|ITN coverage|itn coverage
1610762|NCT00355225|ITn use|itn use
1610763|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
1610764|NCT00355212|radiofrequency|radiofrequency
1610765|NCT00355212|liver cirrhosis|liver cirrhosis
1610766|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
1610767|NCT00355199|DLBCL|dlbcl
1610768|NCT00355199|R-HDS|r-hds
1610769|NCT00355199|R-CHOP14|r-chop14
1610770|NCT00355186|acute myocardial infarction|acute myocardial infarction
1610771|NCT00355186|MRI|mri
1610772|NCT00355186|bone marrow cells|bone marrow cells
1610773|NCT00355186|stem cells|stem cells
1610774|NCT00355186|remodeling|remodeling
1610775|NCT00355160|Headache|headache
1610776|NCT00355160|Sinusitis|sinusitis
1610777|NCT00355160|Rhinitis|rhinitis
1610778|NCT00355160|Facial Pain|facial pain
1610779|NCT00355147|Ischemic stroke|ischemic stroke
1610780|NCT00355147|Preventive medicine|preventive medicine
1610781|NCT00355147|Transient Ischemic Attack|transient ischemic attack
1610782|NCT00355147|Neurology|neurology
1610783|NCT00355147|Risk management|risk management
1610784|NCT00355134|fingolimod|fingolimod
1610785|NCT00355134|FTY720|fty720
1610786|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1610787|NCT00355134|MS|ms
1610788|NCT00355134|RRMS|rrms
1610789|NCT00355121|Meningococcal meningitis|meningococcal meningitis
1610790|NCT00355121|Tetanus|tetanus
1610791|NCT00355121|Diphtheria|diphtheria
1610792|NCT00355121|Pertussis|pertussis
1610793|NCT00355121|Poliomyelitis|poliomyelitis
1610794|NCT00355121|Neisseria meningitidis|neisseria meningitidis
1610795|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
1610796|NCT00355108|Epistaxis|epistaxis
1610797|NCT00355108|Tranexamic acid|tranexamic acid
1610798|NCT00355108|clinical trial|clinical trial
1610799|NCT00355095|multiple sclerosis|multiple sclerosis
1610800|NCT00355095|add-on Therapy|add-on therapy
1610801|NCT00355095|erythropoietin|erythropoietin
1610802|NCT00355095|methylprednisolone|methylprednisolone
1610803|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
1610804|NCT00355082|epilepsy|epilepsy
1610805|NCT00355082|lamotrigine|lamotrigine
1610806|NCT00355082|Lamictal|lamictal
1610807|NCT00355082|monotherapy|monotherapy
1610808|NCT00355069|pediatric|pediatric
1610809|NCT00355069|asthma|asthma
1610810|NCT00355069|translational research|translational research
1610811|NCT00355069|health information technology|health information technology
1610812|NCT00355056|Migraine|migraine
1610813|NCT00355056|PFO|pfo
1610814|NCT00355056|Migraine Headache|migraine headache
1610815|NCT00355056|patent foramen ovale|patent foramen ovale
1610816|NCT00355043|Zinc treatment|zinc treatment
1610817|NCT00355043|Bronchiolitis|bronchiolitis
1610818|NCT00355043|Wheezing|wheezing
1610819|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
1610820|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
1610821|NCT00355004|colon cancer|colon cancer
1610822|NCT00355004|rectal cancer|rectal cancer
1610823|NCT00354978|Colorectal Cancer|colorectal cancer
1610824|NCT00354978|FOLFIRI|folfiri
1610825|NCT00354978|Irinotecan|irinotecan
1610826|NCT00354978|CPT-11|cpt-11
1610827|NCT00354978|Leucovorin|leucovorin
1610828|NCT00354978|LV|lv
1610829|NCT00354978|Folinic Acid|folinic acid
1610830|NCT00354978|Fluorouracil|fluorouracil
1610831|NCT00354978|5-FU|5-fu
1610832|NCT00354978|Adrucil|adrucil
1610833|NCT00354978|Efudex|efudex
1610834|NCT00354978|Bevacizumab|bevacizumab
1610835|NCT00354978|Avastin|avastin
1610836|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1610837|NCT00354978|rhuMAb-VEGF|rhumab-vegf
1610838|NCT00354965|ABS|abs
1610839|NCT00354965|Acute Bacterial|acute bacterial
1610840|NCT00354965|Sinusitis|sinusitis
1610841|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
1610842|NCT00354952|Healthy volunteers|healthy volunteers
1610843|NCT00354952|Antibiotic exposure|antibiotic exposure
1610844|NCT00354952|Resistance selection|resistance selection
1610845|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1610846|NCT00354926|rituximab|rituximab
1610847|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
1610848|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
1610849|NCT00354913|adult grade I meningioma|adult grade i meningioma
1610850|NCT00354913|adult grade II meningioma|adult grade ii meningioma
1610851|NCT00354913|adult grade III meningioma|adult grade iii meningioma
1610852|NCT00354913|adult papillary meningioma|adult papillary meningioma
1610853|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
1610854|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
1610855|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
1610856|NCT00354913|Imatinib|imatinib
1610857|NCT00354913|Imatinib mesylate|imatinib mesylate
1610858|NCT00354913|Hydroxyurea|hydroxyurea
1610859|NCT00354913|Droxia|droxia
1610860|NCT00354913|Hydrea|hydrea
1610861|NCT00354913|Hydroxycarbamide|hydroxycarbamide
1610862|NCT00354913|Gleevec|gleevec
1610863|NCT00354913|Meningioma|meningioma
1610864|NCT00354900|breast cancer|breast cancer
1610865|NCT00354900|fibrinolysis|fibrinolysis
1610866|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
1610867|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
1610868|NCT00354900|aprotinin|aprotinin
1610869|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
1610870|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
1610871|NCT00354887|Small Bowel Cancer|small bowel cancer
1610872|NCT00354887|Ampulla of Vater|ampulla of vater
1610873|NCT00354887|Capecitabine|capecitabine
1610874|NCT00354887|Xeloda|xeloda
1610875|NCT00354887|Oxaliplatin|oxaliplatin
1610876|NCT00354887|Eloxatin|eloxatin
1610877|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
1610878|NCT00354861|Healthy volunteers|healthy volunteers
1610879|NCT00354861|IMP321|imp321
1610880|NCT00354861|Adjuvant|adjuvant
1610881|NCT00354861|Pharmacodynamics|pharmacodynamics
1610882|NCT00354822|Zevalin|zevalin
1610883|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1610884|NCT00354809|cognition|cognition
1610885|NCT00354809|Primary Insomnia|primary insomnia
1610886|NCT00354809|sleep|sleep
1610887|NCT00354809|polysomnography|polysomnography
1610888|NCT00354796|bleeding|bleeding
1610889|NCT00354796|anticoagulation|anticoagulation
1610890|NCT00354796|LMWH|lmwh
1610891|NCT00354796|Enoxaparin|enoxaparin
1610892|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
1610893|NCT00354783|Kicking|kicking
1610894|NCT00354783|Stepping|stepping
1610896|NCT00354783|Motor development|motor development
1610897|NCT00354783|Kinematics|kinematics
1610898|NCT00354770|Trichotillomania|trichotillomania
1610899|NCT00354770|Hair-pulling|hair-pulling
1610900|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
1610901|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1610993|NCT00354458|renal impairment|renal impairment
1610902|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1610903|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
1610904|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1610905|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1610906|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1610907|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
1610908|NCT00354705|Colon Cancer|colon cancer
1610909|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
1610910|NCT00354705|Cancer Recurrence|cancer recurrence
1610911|NCT00354705|Survey|survey
1610912|NCT00354705|Chemotherapy|chemotherapy
1610913|NCT00354705|Surgery|surgery
1610914|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1610915|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
1610916|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
1610917|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
1610918|NCT00354666|inhaled|inhaled
1610919|NCT00354666|asthmatic subjects|asthmatic subjects
1610920|NCT00354666|GSK159797|gsk159797
1610921|NCT00354666|safety and tolerability|safety and tolerability
1610922|NCT00354666|efficacy|efficacy
1610923|NCT00354666|dry powder|dry powder
1610924|NCT00354653|HBeAg|hbeag
1610925|NCT00354653|HBV|hbv
1610926|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
1610927|NCT00354653|lamivudine|lamivudine
1610928|NCT00354640|breast cancer|breast cancer
1610929|NCT00354640|breast cancer in situ|breast cancer in situ
1610930|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1610931|NCT00354640|stage I breast cancer|stage i breast cancer
1610932|NCT00354640|stage II breast cancer|stage ii breast cancer
1610933|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
1610934|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
1610935|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
1610936|NCT00354627|HIV-1|hiv-1
1610937|NCT00354627|Early Access Program (EAP)|early access program (eap)
1610938|NCT00354627|TMC125|tmc125
1610939|NCT00354627|treatment-experienced|treatment-experienced
1610940|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
1610941|NCT00354627|limited to no treatment options|limited to no treatment options
1610942|NCT00354601|fallopian tube cancer|fallopian tube cancer
1610943|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
1610944|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1610945|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1610946|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1610947|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1610948|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1610949|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1610950|NCT00354588|chronic renal failure|chronic renal failure
1610951|NCT00354588|arterial stiffness|arterial stiffness
1610952|NCT00354588|arterial wave reflections|arterial wave reflections
1610953|NCT00354575|Constipation;|constipation;
1610954|NCT00354575|Chinese herb;|chinese herb;
1610955|NCT00354575|Long-term care;|long-term care;
1610956|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
1610957|NCT00354562|Lung Cancer|lung cancer
1610958|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
1610963|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1610964|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1610965|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1610966|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
1610967|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1610968|NCT00354549|large cell lung cancer|large cell lung cancer
1610969|NCT00354536|GSK716155|gsk716155
1610970|NCT00354536|albiglutide|albiglutide
1610971|NCT00354536|pharmacodynamics|pharmacodynamics
1610972|NCT00354536|pharmacokinetics|pharmacokinetics
1610973|NCT00354523|Solid Tumor|solid tumor
1610974|NCT00354523|Thyroid Cancer|thyroid cancer
1610975|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
1610977|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
1610978|NCT00354523|Capecitabine|capecitabine
1610979|NCT00354523|Dacarbazine|dacarbazine
1610980|NCT00354523|Imatinib|imatinib
1610981|NCT00354523|Gleevec|gleevec
1610982|NCT00354523|Imatinib Mesylate|imatinib mesylate
1610983|NCT00354523|DTIC-Dome|dtic-dome
1610984|NCT00354523|Xeloda|xeloda
1610985|NCT00354510|atopic dermatitis|atopic dermatitis
1610986|NCT00354510|GW842470X|gw842470x
1610987|NCT00354510|PDE4 inhibitor|pde4 inhibitor
1611290|NCT00353366|Rotavirus|rotavirus
1610988|NCT00354497|prostate cancer|prostate cancer
1610989|NCT00354484|anemia|anemia
1610990|NCT00354484|postpartum|postpartum
1610991|NCT00354458|heart failure|heart failure
1610992|NCT00354458|diuretic|diuretic
1611380|NCT00353054|Insulin|insulin
1610994|NCT00354458|renal function|renal function
1610995|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1610996|NCT00354445|pegaptanib sodium|pegaptanib sodium
1610997|NCT00354445|subfoveal CNV|subfoveal cnv
1610999|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
1611000|NCT00354432|stage I prostate cancer|stage i prostate cancer
1611001|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
1611002|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
1611003|NCT00354432|stage III prostate cancer|stage iii prostate cancer
1611004|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
1611005|NCT00354432|hot flashes|hot flashes
1611006|NCT00354406|Abciximab|abciximab
1611007|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
1611008|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1611009|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
1611010|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
1611011|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
1611012|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
1611013|NCT00354380|Malaria|malaria
1611014|NCT00354380|Africa|africa
1611015|NCT00354380|Methalyne-blue|methalyne-blue
1611016|NCT00354380|Artesunate|artesunate
1611017|NCT00354380|Amodiaquine|amodiaquine
1611018|NCT00354367|Crohn Disease|crohn disease
1611019|NCT00354367|Certolizumab pegol|certolizumab pegol
1611020|NCT00354367|Fistula|fistula
1611021|NCT00354354|COPD|copd
1611022|NCT00354354|Combivent|combivent
1611023|NCT00354354|Exercise|exercise
1611024|NCT00354354|Bronchodilator|bronchodilator
1611025|NCT00354354|Kinetics|kinetics
1611026|NCT00354328|HCM|hcm
1611027|NCT00354328|Echocardiography|echocardiography
1611028|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
1611029|NCT00354328|Enalapril|enalapril
1611030|NCT00354315|Shared decision making|shared decision making
1611031|NCT00354315|Optimal drug prescription|optimal drug prescription
1611032|NCT00354302|osteoporosis|osteoporosis
1611033|NCT00354302|stage I breast cancer|stage i breast cancer
1611034|NCT00354302|stage II breast cancer|stage ii breast cancer
1611035|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
1611036|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1611037|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1611038|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1611039|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1611040|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1611041|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1611042|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1611043|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1611044|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1611045|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
1611046|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1611047|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1611048|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1611049|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1611050|NCT00354263|Healthy male volunteers|healthy male volunteers
1611051|NCT00354263|IMP321|imp321
1611052|NCT00354263|Adjuvant|adjuvant
1611054|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
1611055|NCT00354237|diabetes mellitus|diabetes mellitus
1611056|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
1611057|NCT00354237|insulin|insulin
1611058|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
1611059|NCT00354224|stage III gastric cancer|stage iii gastric cancer
1611060|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
1611061|NCT00354211|Cardiac Output|cardiac output
1611062|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
1611063|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
1611064|NCT00354198|pentoxifylline|pentoxifylline
1611065|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1611066|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1611067|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1611068|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1611069|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1611070|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1611071|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1611072|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1611073|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1611074|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1611075|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1611076|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1611077|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1611078|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1611079|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1611080|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1611081|NCT00354159|Intracardiac pressures|intracardiac pressures
1611082|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
1611083|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
1611084|NCT00354133|Parkinson Disease|parkinson disease
1611085|NCT00354133|Deep Brain Stimulation|deep brain stimulation
1611086|NCT00354133|PDQ-39|pdq-39
1611087|NCT00354081|Coronary Artery Disease|coronary artery disease
1611088|NCT00354081|Myocardial Infarction|myocardial infarction
1611089|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
1611090|NCT00354081|Homocysteine|homocysteine
1611091|NCT00354081|Folic Acid|folic acid
1611092|NCT00354081|Vitamin B 12|vitamin b 12
1611093|NCT00354081|Vitamin B 6|vitamin b 6
1611094|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1611095|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
1611096|NCT00354068|adult gliosarcoma|adult gliosarcoma
1611097|NCT00354068|adult mixed glioma|adult mixed glioma
1611098|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1611099|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
1611100|NCT00354068|adult glioblastoma|adult glioblastoma
1611101|NCT00354042|GW597901X|gw597901x
1611102|NCT00354042|Asthma|asthma
1611103|NCT00354042|Crossover|crossover
1611104|NCT00354042|dose ascending|dose ascending
1611105|NCT00354042|repeat dose|repeat dose
1611106|NCT00354042|inhaled|inhaled
1611107|NCT00354029|hemorrhoids|hemorrhoids
1611108|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
1611109|NCT00354029|S (+) ketamine|s (+) ketamine
1611110|NCT00354029|pain|pain
1611111|NCT00354016|influenza|influenza
1611112|NCT00354016|vaccine|vaccine
1611113|NCT00354003|Parkinson|parkinson
1611114|NCT00354003|Imaging|imaging
1611115|NCT00353990|insulin|insulin
1611116|NCT00353990|bioavailability|bioavailability
1611117|NCT00353990|duodenum|duodenum
1611118|NCT00353990|infusion|infusion
1611119|NCT00353990|healthy|healthy
1611120|NCT00353990|diabetes|diabetes
1611121|NCT00353990|absorption|absorption
1611122|NCT00353977|Cytomegalovirus|cytomegalovirus
1611123|NCT00353977|Vaccine|vaccine
1611124|NCT00353977|CMV|cmv
1611125|NCT00353977|Immunization|immunization
1611126|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1611127|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
1611128|NCT00353951|primary care|primary care
1611129|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
1611130|NCT00353951|antibiotics|antibiotics
1611131|NCT00353951|cough|cough
1611132|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
1611133|NCT00353925|Hypertrophy|hypertrophy
1611134|NCT00353925|LVH|lvh
1611135|NCT00353925|Cardiac|cardiac
1611136|NCT00353925|Blood Pressure|blood pressure
1611137|NCT00353925|Papillary Muscle|papillary muscle
1611138|NCT00353912|Blood|blood
1611139|NCT00353912|Venous|venous
1611140|NCT00353912|Systolic|systolic
1611141|NCT00353912|Diastolic|diastolic
1611142|NCT00353912|Pulse|pulse
1611143|NCT00353912|Pressure|pressure
1611144|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
1611146|NCT00353899|Normal Volunteer|normal volunteer
1611147|NCT00353899|Electrocardiogram|electrocardiogram
1611148|NCT00353899|Cardiac|cardiac
1611149|NCT00353899|Healthy Volunteer|healthy volunteer
1611151|NCT00353886|Retrospective|retrospective
1611152|NCT00353886|Epilepsy|epilepsy
1611153|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
1611154|NCT00353886|Behavioral Development|behavioral development
1611155|NCT00353886|Intellectual Development|intellectual development
1611156|NCT00353873|FLIXOTIDE|flixotide
1611157|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
1611158|NCT00353873|SERETIDE|seretide
1611159|NCT00353873|asthma-control|asthma-control
1611160|NCT00353860|Leukemia|leukemia
1611161|NCT00353860|Transplant - Mortality|transplant - mortality
1611162|NCT00353860|Immunosuppression|immunosuppression
1611163|NCT00353860|Radiation|radiation
1611164|NCT00353860|Cure|cure
1611165|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
1611166|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
1611167|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
1611168|NCT00353860|Cyclosporine|cyclosporine
1611169|NCT00353860|Fludarabine|fludarabine
1611170|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
1611171|NCT00353834|endothelial dysfunction|endothelial dysfunction
1611172|NCT00353834|subclinical inflammation|subclinical inflammation
1611173|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
1611190|NCT00353782|Dyslipidemia|dyslipidemia
1611191|NCT00353782|Hypertriglyceridemia|hypertriglyceridemia
1611192|NCT00353782|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
1611193|NCT00353782|Atheroembolism|atheroembolism
1611194|NCT00353782|Atherosclerosis|atherosclerosis
1611195|NCT00353782|Dyslipoproteinemia|dyslipoproteinemia
1611196|NCT00353782|Hypercholesterolemia|hypercholesterolemia
1611197|NCT00353782|hypoalphalipoproteinemia|hypoalphalipoproteinemia
1611198|NCT00353769|scalp laceration|scalp laceration
1611199|NCT00353769|tissue adhesive|tissue adhesive
1611200|NCT00353769|wound care|wound care
1611201|NCT00353769|cost effectiveness|cost effectiveness
1611202|NCT00353743|infected abortion|infected abortion
1611203|NCT00353743|treatment period|treatment period
1611204|NCT00353743|doxycycline|doxycycline
1611205|NCT00353743|metronidazole|metronidazole
1611206|NCT00353743|placebo|placebo
1611207|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
1611208|NCT00353730|Carotid Artery Plaque|carotid artery plaque
1611209|NCT00353730|Atherosclerosis|atherosclerosis
1611210|NCT00353717|breast|breast
1611211|NCT00353717|basal like|basal like
1611212|NCT00353717|carcinoma|carcinoma
1611213|NCT00353717|metastatic|metastatic
1611214|NCT00353717|EGFR|egfr
1611215|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
1611216|NCT00353704|disk prolapse|disk prolapse
1611217|NCT00353704|pregabalin|pregabalin
1611218|NCT00353678|Hip replacement|hip replacement
1611219|NCT00353678|Arthroplasty|arthroplasty
1611220|NCT00353678|Prevention|prevention
1611221|NCT00353678|Thromboembolism|thromboembolism
1611222|NCT00353678|Treatment outcomes|treatment outcomes
1611223|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
1611224|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1611225|NCT00353665|motor neuron disease|motor neuron disease
1611226|NCT00353665|memantine|memantine
1611227|NCT00353665|clinical trial|clinical trial
1611228|NCT00353652|Blood Pressure, High|blood pressure, high
1611229|NCT00353639|Ulcera|ulcera
1611230|NCT00353639|Telomerase|telomerase
1611231|NCT00353639|TERT|tert
1611232|NCT00353639|TERC|terc
1611233|NCT00353639|SBDS|sbds
1611234|NCT00353639|DNA Helicase|dna helicase
1611235|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
1611236|NCT00353639|IBD|ibd
1611237|NCT00353626|Amputation|amputation
1611238|NCT00353626|trans tibial|trans tibial
1611239|NCT00353626|prosthesis|prosthesis
1611240|NCT00353626|motion analysis|motion analysis
1611241|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
1611242|NCT00353600|Proteinuria|proteinuria
1611243|NCT00353600|Renal Failure|renal failure
1611244|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
1611245|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
1611246|NCT00353587|insulin sensitizer|insulin sensitizer
1611247|NCT00353587|type 2 diabetes|type 2 diabetes
1611248|NCT00353587|diabetes|diabetes
1611249|NCT00353587|glucose control|glucose control
1611250|NCT00353574|Resistant Hypertension|resistant hypertension
1611251|NCT00353548|Bulimia Nervosa|bulimia nervosa
1611252|NCT00353548|Binge Eating Disorder|binge eating disorder
1611253|NCT00353548|Obesity|obesity
1611254|NCT00353548|Anorexia Nervosa|anorexia nervosa
1611255|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
1611256|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
1611257|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
1611258|NCT00353535|renal transplant|renal transplant
1611259|NCT00353535|recurrence|recurrence
1611260|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
1611261|NCT00353483|Breast Cancer|breast cancer
1611262|NCT00353483|Neoadjuvant|neoadjuvant
1611263|NCT00353470|PD|pd
1611264|NCT00353470|CBT|cbt
1611265|NCT00353470|PFPP|pfpp
1611266|NCT00353457|Adjuvant therapy|adjuvant therapy
1611267|NCT00353457|Rectal cancer|rectal cancer
1611268|NCT00353457|Capecitabine|capecitabine
1611269|NCT00353457|Oxaliplatin|oxaliplatin
1611270|NCT00353457|Cetuximab|cetuximab
1611271|NCT00353457|Erbitux|erbitux
1611272|NCT00353444|head injury|head injury
1611273|NCT00353444|transcranial Doppler|transcranial doppler
1611485|NCT00352664|Donepezil|donepezil
1611274|NCT00353444|pulsatility index|pulsatility index
1611275|NCT00353444|vasospasm in head injury|vasospasm in head injury
1611276|NCT00353431|Hyperglycaemia|hyperglycaemia
1611277|NCT00353431|algorithm|algorithm
1611278|NCT00353431|emergency|emergency
1611279|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
1611280|NCT00353431|Emergency patient|emergency patient
1611281|NCT00353405|Adolescents|adolescents
1611282|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
1611283|NCT00353405|Gonorrhea|gonorrhea
1611284|NCT00353405|Chlamydia Infections|chlamydia infections
1611285|NCT00353366|safety|safety
1611286|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
1611287|NCT00353366|Rotarix|rotarix
1611288|NCT00353366|oral|oral
1611289|NCT00353366|Filipino|filipino
1611291|NCT00353366|Gastroenteritis|gastroenteritis
1611292|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
1611293|NCT00353353|no specific conditions|no specific conditions
1611294|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
1611295|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
1611296|NCT00353340|contrast nephropathy,|contrast nephropathy,
1611297|NCT00353340|cardiac catheterisation|cardiac catheterisation
1611298|NCT00353327|HIV|hiv
1611299|NCT00353327|Passive immunotherapy|passive immunotherapy
1611300|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
1611301|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
1611302|NCT00353301|mTOR protein|mtor protein
1611303|NCT00353301|Sirolimus|sirolimus
1611304|NCT00353301|Erlotinib|erlotinib
1611305|NCT00353275|Strict glycemic control|strict glycemic control
1611306|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
1611307|NCT00353249|CBT|cbt
1611308|NCT00353249|Homeless Women|homeless women
1611309|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
1611310|NCT00353223|Heart Failure|heart failure
1611311|NCT00353223|Functional Impairment|functional impairment
1611312|NCT00353223|Health-Related Quality of Life|health-related quality of life
1611313|NCT00353223|Telemedicine|telemedicine
1611314|NCT00353210|IVF|ivf
1611315|NCT00353210|embryos|embryos
1611316|NCT00353210|research|research
1611317|NCT00353210|donation|donation
1611318|NCT00353210|surplus|surplus
1611319|NCT00353210|stem cells|stem cells
1611320|NCT00353210|abnormal embryo|abnormal embryo
1611321|NCT00353210|screening|screening
1611322|NCT00353197|IVF|ivf
1611323|NCT00353197|embryos|embryos
1611324|NCT00353197|research|research
1611325|NCT00353197|donation|donation
1611326|NCT00353197|surplus|surplus
1611327|NCT00353197|stem cells|stem cells
1611328|NCT00353184|Acute|acute
1611329|NCT00353184|Asthma|asthma
1611330|NCT00353184|Child|child
1611331|NCT00353184|Pediatric|pediatric
1611332|NCT00353184|Emergency|emergency
1611333|NCT00353184|Oral|oral
1611334|NCT00353184|Montelukast|montelukast
1611335|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
1611336|NCT00353184|FEV1|fev1
1611337|NCT00353171|Smoking|smoking
1611338|NCT00353171|PCB|pcb
1611339|NCT00353171|DDE|dde
1611340|NCT00353171|Menstrual Cycle|menstrual cycle
1611341|NCT00353171|NC Infant Feeding Study|nc infant feeding study
1611342|NCT00353158|Phototesting|phototesting
1611343|NCT00353158|UVR/UVA|uvr/uva
1611344|NCT00353158|Sunburn|sunburn
1611345|NCT00353158|Doxycycline|doxycycline
1611346|NCT00353158|Voriconazole|voriconazole
1611347|NCT00353158|Phototoxicity|phototoxicity
1611348|NCT00353158|Healthy Volunteer|healthy volunteer
1611349|NCT00353158|HV|hv
1611350|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
1611351|NCT00353145|UPC|upc
1611352|NCT00353145|Unknown Primary Cancer|unknown primary cancer
1611353|NCT00353145|Questionnaire|questionnaire
1611354|NCT00353145|Gemcitabine|gemcitabine
1611355|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
1611356|NCT00353145|Gemzar|gemzar
1611357|NCT00353145|Oxaliplatin|oxaliplatin
1611358|NCT00353145|Eloxatin|eloxatin
1611359|NCT00353145|Gemox|gemox
1611360|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
1611361|NCT00353119|Psoriasis|psoriasis
1611362|NCT00353119|Etanercept|etanercept
1611363|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
1611364|NCT00353106|GVHD|gvhd
1611365|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
1611366|NCT00353106|cGVHD|cgvhd
1611367|NCT00353106|Interview|interview
1611368|NCT00353106|Questionnaire|questionnaire
1611371|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
1611372|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
1611373|NCT00353067|unstable angina|unstable angina
1611374|NCT00353067|myocardial infarction|myocardial infarction
1611375|NCT00353067|coronary thrombosis|coronary thrombosis
1611376|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
1611377|NCT00353054|Caltrate|caltrate
1611378|NCT00353054|Lipoproteins|lipoproteins
1611379|NCT00353054|Glucose|glucose
1611381|NCT00353054|Blood pressure|blood pressure
1611382|NCT00353054|Body fat|body fat
1611383|NCT00353054|Body weight|body weight
1611384|NCT00353054|Women|women
1611385|NCT00353054|Diet|diet
1611386|NCT00353054|Macronutrients|macronutrients
1611387|NCT00353041|topical|topical
1611388|NCT00353041|anesthetic|anesthetic
1611389|NCT00353041|pain|pain
1611390|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
1611391|NCT00353028|Depression|depression
1611392|NCT00353028|Children and Adolescents|children and adolescents
1611393|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
1611394|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
1611395|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
1611396|NCT00353015|Cisplatin|cisplatin
1611397|NCT00353015|Platinol-AQ|platinol-aq
1611398|NCT00353015|Platinol|platinol
1611400|NCT00353015|CPT-11|cpt-11
1611401|NCT00353015|Irinotecan|irinotecan
1611402|NCT00353002|Pain|pain
1611403|NCT00353002|Ametop|ametop
1611404|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
1611405|NCT00353002|Venous cannulation|venous cannulation
1611406|NCT00352976|Bone Marrow transplant|bone marrow transplant
1611407|NCT00352976|stem cell transplant|stem cell transplant
1611408|NCT00352976|cord blood transplant|cord blood transplant
1611409|NCT00352976|total body irradiation|total body irradiation
1611410|NCT00352976|thymic shielding|thymic shielding
1611411|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
1611412|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
1611413|NCT00352950|Panitumumab|panitumumab
1611414|NCT00352950|Sirolimus|sirolimus
1611415|NCT00352950|mTOR|mtor
1611416|NCT00352950|Monoclonal antibody|monoclonal antibody
1611417|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
1611418|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
1611419|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
1611420|NCT00352924|Cancer|cancer
1611421|NCT00352924|Pesticides|pesticides
1611422|NCT00352924|Agriculture|agriculture
1611423|NCT00352911|HIV-1|hiv-1
1611424|NCT00352885|Cancer|cancer
1611425|NCT00352885|IL-2 therapy|il-2 therapy
1611426|NCT00352885|Antidepressant|antidepressant
1611427|NCT00352885|Immune system|immune system
1611428|NCT00352885|Neuroendocrine response|neuroendocrine response
1611429|NCT00352872|Pharmacogenetics|pharmacogenetics
1611430|NCT00352872|Toxicity|toxicity
1611431|NCT00352872|Pre-Menopausal|pre-menopausal
1611432|NCT00352872|Women|women
1611433|NCT00352872|Doxorubicin|doxorubicin
1611434|NCT00352872|Cyclophosphamide|cyclophosphamide
1611435|NCT00352872|Breast Cancer|breast cancer
1611436|NCT00352872|Chemotherapy|chemotherapy
1611437|NCT00352859|Cancer|cancer
1611438|NCT00352859|Renal Cell Cancer|renal cell cancer
1611439|NCT00352859|RCC|rcc
1611440|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1611441|NCT00352846|Lymphoma|lymphoma
1611442|NCT00352846|Zoledronic Acid|zoledronic acid
1611443|NCT00352846|Zoledronate|zoledronate
1611444|NCT00352846|Zometa|zometa
1611445|NCT00352846|Vitamin D|vitamin d
1611446|NCT00352846|Calcium Carbonate|calcium carbonate
1611447|NCT00352846|Bone Loss|bone loss
1611448|NCT00352833|gastric cancer|gastric cancer
1611449|NCT00352833|investigational drug|investigational drug
1611450|NCT00352833|adjuvant therapy|adjuvant therapy
1611451|NCT00352833|intraoperative|intraoperative
1611452|NCT00352833|intraperitoneal|intraperitoneal
1611453|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
1611454|NCT00352820|Caregiver|caregiver
1611455|NCT00352820|Brain cancer|brain cancer
1611456|NCT00352820|Glioma|glioma
1611457|NCT00352820|Questionnaire|questionnaire
1611458|NCT00352820|Survey|survey
1611459|NCT00352820|Interview|interview
1611460|NCT00352807|Cataract|cataract
1611461|NCT00352794|Combination chemotherapy|combination chemotherapy
1611462|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
1611463|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
1611464|NCT00352781|smoking cessation|smoking cessation
1611465|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
1611466|NCT00352768|OCD|ocd
1611467|NCT00352768|Children and Adolescents|children and adolescents
1611468|NCT00352742|Multiple myeloma|multiple myeloma
1611469|NCT00352742|bortezomib|bortezomib
1611470|NCT00352742|ATN-224|atn-224
1611471|NCT00352742|refractory|refractory
1611472|NCT00352742|relapsed|relapsed
1611473|NCT00352742|antiangiogenic|antiangiogenic
1611474|NCT00352729|Burns|burns
1611477|NCT00352703|Oral mucositis|oral mucositis
1611478|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1611479|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
1611480|NCT00352703|autologous PBSCT|autologous pbsct
1611481|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
1611482|NCT00352703|Melphalan|melphalan
1611483|NCT00352664|Advanced Cancer|advanced cancer
1611484|NCT00352664|Cancer Pain|cancer pain
1611488|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
1611489|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
1611490|NCT00352651|Pregabalin|pregabalin
1611491|NCT00352651|Lyrica|lyrica
1611492|NCT00352651|Pain|pain
1611493|NCT00352638|colon cancer|colon cancer
1611494|NCT00352638|rectal cancer|rectal cancer
1611495|NCT00352625|Tendonitis|tendonitis
1611496|NCT00352625|Bursitis|bursitis
1611497|NCT00352625|Pain|pain
1611498|NCT00352625|Shoulder Pain|shoulder pain
1611499|NCT00352625|Elbow Pain|elbow pain
1611500|NCT00352625|Knee Pain|knee pain
1611501|NCT00352625|Tendon Injury|tendon injury
1611502|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
1611503|NCT00352612|clinical trial|clinical trial
1611504|NCT00352612|randomized|randomized
1611505|NCT00352612|blinded|blinded
1611506|NCT00352612|controlled|controlled
1611507|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
1611508|NCT00352599|NF1|nf1
1611509|NCT00352599|Lovastatin|lovastatin
1611510|NCT00352599|statin|statin
1611511|NCT00352586|Classical Conditioning|classical conditioning
1611512|NCT00352586|Learning|learning
1611513|NCT00352586|NMDA|nmda
1611514|NCT00352586|Startle|startle
1611515|NCT00352586|Eyeblink|eyeblink
1611516|NCT00352586|Anxiety|anxiety
1611517|NCT00352586|Fear Conditioning|fear conditioning
1611518|NCT00352586|Fear Potentiated Startle|fear potentiated startle
1611519|NCT00352586|Extinction|extinction
1611520|NCT00352586|D-cycloserine|d-cycloserine
1611521|NCT00352586|Healthy Volunteer|healthy volunteer
1611522|NCT00352586|HV|hv
1611523|NCT00352586|Normal Control|normal control
1611524|NCT00352573|Ethics, Clinical|ethics, clinical
1611525|NCT00352573|Physician's Role|physician's role
1611526|NCT00352573|Health Care Rationing|health care rationing
1611527|NCT00352573|Knowledge, Attitudes, Practices|knowledge, attitudes, practices
1611528|NCT00352573|Questionnaires|questionnaires
1611529|NCT00352573|Survey|survey
1611530|NCT00352573|Ethics|ethics
1611531|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
1611532|NCT00352547|Immunosuppresant|immunosuppresant
1611533|NCT00352547|Genetic Polymorphism|genetic polymorphism
1611534|NCT00352547|Drug Metabolism|drug metabolism
1611535|NCT00352547|Pharmacogenetics|pharmacogenetics
1611536|NCT00352547|Rapamycin|rapamycin
1611537|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1611538|NCT00352521|adult mixed glioma|adult mixed glioma
1611539|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
1611540|NCT00352521|adult gliosarcoma|adult gliosarcoma
1611541|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
1611542|NCT00352521|adult glioblastoma|adult glioblastoma
1611543|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
1611544|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1611545|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1611546|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
1611547|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1611548|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1611549|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1611550|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
1611551|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
1611552|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1611553|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1611554|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
1611555|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1611556|NCT00352469|Alcoholism|alcoholism
1611557|NCT00352469|Anxiety|anxiety
1611558|NCT00352469|GAD|gad
1611559|NCT00352469|PTSD|ptsd
1611560|NCT00352469|Panic Disorder|panic disorder
1611561|NCT00352469|OCD|ocd
1611562|NCT00352456|Amygdala|amygdala
1611563|NCT00352456|Facial Affect|facial affect
1611564|NCT00352456|Instrumental Learning|instrumental learning
1611565|NCT00352456|Psychopathy|psychopathy
1611566|NCT00352456|Emotion|emotion
1611567|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
1611568|NCT00352456|Healthy Volunteer|healthy volunteer
1611569|NCT00352456|HV|hv
1611570|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1611571|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1611572|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1611573|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1611574|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1611575|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1611576|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1611577|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1611578|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1611666|NCT00352209|Cyclophosphamide|cyclophosphamide
1611579|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1611580|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1611581|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1611582|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1611583|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1611584|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1611585|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1611586|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1611587|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1611588|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1611589|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1611590|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1611591|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1611592|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1611593|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1611594|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1611595|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1611596|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1611597|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1611598|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1611599|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1611600|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1611601|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1611602|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1611603|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1611604|NCT00352430|Nitric Oxide|nitric oxide
1611605|NCT00352430|PDE Inhibitors|pde inhibitors
1611606|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
1611607|NCT00352430|Sickle Cell|sickle cell
1611608|NCT00352430|Thalassemia|thalassemia
1611609|NCT00352430|Sickle Cell Anemia|sickle cell anemia
1611610|NCT00352404|Endomicroscopy|endomicroscopy
1611611|NCT00352404|Chromoendoscopy|chromoendoscopy
1611612|NCT00352404|Chromoscopy|chromoscopy
1611613|NCT00352404|Ulcerative Colitis|ulcerative colitis
1611614|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
1611615|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
1611616|NCT00352391|Head And Neck Cancer|head and neck cancer
1611617|NCT00352391|Lung Cancer|lung cancer
1611618|NCT00352391|Bronchoscopy|bronchoscopy
1611619|NCT00352391|Laryngoscopy|laryngoscopy
1611620|NCT00352391|NSCLC|nsclc
1611621|NCT00352391|Disease Free Survival|disease free survival
1611622|NCT00352391|Current Smoker|current smoker
1611623|NCT00352391|Former Smoker|former smoker
1611624|NCT00352378|Primary|primary
1611625|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
1611626|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
1611627|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
1611628|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
1611630|NCT00352352|Children|children
1611631|NCT00352339|Schizophrenia|schizophrenia
1611632|NCT00352339|Switching|switching
1611633|NCT00352339|Early stage|early stage
1611634|NCT00352339|Risperidone|risperidone
1611635|NCT00352339|Aripirazole|aripirazole
1611636|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1611637|NCT00352313|adult gliosarcoma|adult gliosarcoma
1611638|NCT00352313|adult mixed glioma|adult mixed glioma
1611639|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1611640|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
1611641|NCT00352313|adult glioblastoma|adult glioblastoma
1611642|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
1611643|NCT00352287|Visceral fat|visceral fat
1611644|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
1611645|NCT00352287|Insulin resistance|insulin resistance
1611646|NCT00352287|Growth hormone|growth hormone
1611647|NCT00352287|Thiazolidinedione|thiazolidinedione
1611648|NCT00352261|Barrett's Esophagus|barrett's esophagus
1611649|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
1611650|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
1611651|NCT00352248|Tongue Acupuncture|tongue acupuncture
1611652|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
1611653|NCT00352248|Autism|autism
1611654|NCT00352248|Children|children
1611655|NCT00352235|Chronic hepatitis C|chronic hepatitis c
1611656|NCT00352235|KRN7000|krn7000
1611658|NCT00352235|immunotherapy|immunotherapy
1611659|NCT00352235|Natural Killer T cells|natural killer t cells
1611660|NCT00352235|interferon|interferon
1611661|NCT00352222|iliac arteries|iliac arteries
1611662|NCT00352222|implantation|implantation
1611663|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
1611664|NCT00352222|stenosed|stenosed
1611667|NCT00352209|Preparative Regimens|preparative regimens
1611668|NCT00352209|Risk Factors|risk factors
1611669|NCT00352209|Chart Review|chart review
1611670|NCT00352209|Incidence|incidence
1611671|NCT00352196|Asperger's Disorder|asperger's disorder
1611672|NCT00352196|Risperidone|risperidone
1611673|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1611674|NCT00352196|Social Skills|social skills
1611675|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
1611676|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
1611677|NCT00352170|calcium|calcium
1611678|NCT00352170|vitamin D|vitamin d
1611679|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
1611680|NCT00352170|osteoporotic fractures|osteoporotic fractures
1611681|NCT00352157|Soy|soy
1611682|NCT00352157|Dermatology|dermatology
1611683|NCT00352157|Skin|skin
1611684|NCT00352157|Hair|hair
1611685|NCT00352157|Finger Nails|finger nails
1611686|NCT00352157|Weight Loss|weight loss
1611687|NCT00352157|Body Mass Index|body mass index
1611973|NCT00351234|Carnitine|carnitine
1611688|NCT00352157|Photoaging of Skin|photoaging of skin
1611689|NCT00352157|Skin Wrinkling|skin wrinkling
1611690|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1611691|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
1611692|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
1611693|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
1611694|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
1611695|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
1611696|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
1611697|NCT00352118|mucositis|mucositis
1611698|NCT00352118|xerostomia|xerostomia
1611699|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1611700|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1611701|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1611702|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1611703|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1611704|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1611705|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1611706|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1611707|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1611708|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1611709|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1611710|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1611711|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1611712|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1611713|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1611714|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1611715|NCT00352092|Kidney disease|kidney disease
1611716|NCT00352092|Renal transplant|renal transplant
1611717|NCT00352092|HLA Identical|hla identical
1611718|NCT00352092|Living Donor|living donor
1611719|NCT00352092|Corticosteroid free|corticosteroid free
1611720|NCT00352092|Calcineurin sparing|calcineurin sparing
1611721|NCT00352092|Adults|adults
1611722|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1611723|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
1611724|NCT00352079|stage I bladder cancer|stage i bladder cancer
1611725|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
1611726|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
1611727|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
1611728|NCT00352066|nucleoside analogue|nucleoside analogue
1611729|NCT00352066|reverse transcriptase|reverse transcriptase
1611730|NCT00352066|apricitabine|apricitabine
1611731|NCT00352066|tipranavir|tipranavir
1611732|NCT00352066|bioequivalence|bioequivalence
1611733|NCT00352066|drug-drug interaction|drug-drug interaction
1611734|NCT00352066|pharmacokinetics|pharmacokinetics
1611735|NCT00352053|Phase 3|phase 3
1611736|NCT00352053|Randomized, Double-Blind|randomized, double-blind
1611737|NCT00352053|Control|control
1611738|NCT00352053|Treatment-Experienced|treatment-experienced
1611739|NCT00352053|OBR|obr
1611740|NCT00352053|Optimized background regimen|optimized background regimen
1611741|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1611742|NCT00352053|HAART|haart
1611746|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
1611747|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
1611748|NCT00352053|Virus|virus
1611749|NCT00352053|Human Immunodeficiency|human immunodeficiency
1611750|NCT00352053|Pediatrics|pediatrics
1611751|NCT00352027|Hodgkin's Disease|hodgkin's disease
1611752|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
1611753|NCT00352014|antiplatelet therapy|antiplatelet therapy
1611754|NCT00352014|platelet function assays|platelet function assays
1611755|NCT00352014|Aspirin|aspirin
1611756|NCT00352014|Clopidogrel|clopidogrel
1611757|NCT00352014|elective PCI|elective pci
1611758|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
1611759|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1611760|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1611761|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1611762|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1611763|NCT00351988|Lung Cancer|lung cancer
1611764|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
1611765|NCT00351988|Breast Cancer|breast cancer
1611766|NCT00351988|Psychosocial|psychosocial
1611767|NCT00351988|Behavioral|behavioral
1611768|NCT00351988|Caregiver|caregiver
1611769|NCT00351988|Interview|interview
1611770|NCT00351988|Questionnaire|questionnaire
1611771|NCT00351988|Minority Caregiver|minority caregiver
1611772|NCT00351988|Non-Minority Caregiver|non-minority caregiver
1611773|NCT00351988|Survey|survey
1611774|NCT00351962|lung neoplasms|lung neoplasms
1611775|NCT00351962|metastatic lung cancer|metastatic lung cancer
1611776|NCT00351962|stereotactic radiation|stereotactic radiation
1611777|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
1611778|NCT00351949|IMP321|imp321
1611779|NCT00351949|Monotherapy|monotherapy
1611780|NCT00351949|LAG-3|lag-3
1611781|NCT00351949|CD223|cd223
1611782|NCT00351936|Schizophrenia|schizophrenia
1611783|NCT00351936|Diabetes|diabetes
1611784|NCT00351936|Obesity|obesity
1611785|NCT00351936|Olanzapine|olanzapine
1611786|NCT00351936|Insulin Resistance|insulin resistance
1611787|NCT00351910|Major Depressive Disorder|major depressive disorder
1611789|NCT00351884|Type 2 diabetes|type 2 diabetes
1611790|NCT00351884|vildagliptin|vildagliptin
1611791|NCT00351884|Hemoglobin A1c|hemoglobin a1c
1611792|NCT00351871|HCV|hcv
1611793|NCT00351858|Breast Cancer|breast cancer
1611794|NCT00351858|investigational drug|investigational drug
1611795|NCT00351858|drug therapy|drug therapy
1611796|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
1611797|NCT00351858|Immunotherapy|immunotherapy
1611798|NCT00351858|Metastatic breast cancer|metastatic breast cancer
1611799|NCT00351858|Advanced breast cancer|advanced breast cancer
1611800|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
1611801|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
1611802|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
1611803|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
1611804|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
1611805|NCT00351832|Type 2 diabetes|type 2 diabetes
1611806|NCT00351832|Vildagliptin|vildagliptin
1611807|NCT00351832|Hemoglobin A1c|hemoglobin a1c
1611808|NCT00351819|Testosterone|testosterone
1611809|NCT00351819|Pain|pain
1611810|NCT00351819|Opioid|opioid
1611811|NCT00351819|Hypogonadism|hypogonadism
1611812|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
1611813|NCT00351780|fractional flow reserve|fractional flow reserve
1611814|NCT00351780|bifurcation|bifurcation
1611815|NCT00351780|stent|stent
1611816|NCT00351767|Diabetes|diabetes
1611817|NCT00351767|Dabetic Feet|dabetic feet
1611818|NCT00351741|Burns|burns
1611819|NCT00351715|Sublingual Methadone|sublingual methadone
1611820|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
1611821|NCT00351715|feasibility study|feasibility study
1611822|NCT00351715|Phase II/open label|phase ii/open label
1611823|NCT00351715|Outpatients|outpatients
1611824|NCT00351715|Safety/ efficacy|safety/ efficacy
1611825|NCT00351715|previously receiving opioids|previously receiving opioids
1611826|NCT00351715|speak English|speak english
1611827|NCT00351702|Preventive therapy|preventive therapy
1611828|NCT00351689|Probiotic bacteria|probiotic bacteria
1611829|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
1611830|NCT00351689|UV radiation|uv radiation
1611831|NCT00351689|dietary supplement|dietary supplement
1611832|NCT00351676|Drug Therapy|drug therapy
1611833|NCT00351676|Hospitals, Teaching|hospitals, teaching
1611834|NCT00351676|Hospitals, Community|hospitals, community
1611835|NCT00351676|Interprofessional relations|interprofessional relations
1611836|NCT00351676|Patient Care Team|patient care team
1611837|NCT00351676|Pharmacists|pharmacists
1611838|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
1611839|NCT00351676|Comparative Study|comparative study
1611840|NCT00351676|Hospitalization|hospitalization
1611841|NCT00351663|Venous Thrombosis|venous thrombosis
1611842|NCT00351663|Critical Illness|critical illness
1611843|NCT00351663|Blood Coagulation|blood coagulation
1611844|NCT00351663|Factor Xa|factor xa
1611845|NCT00351650|Imaging|imaging
1611846|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1611847|NCT00351650|Islet|islet
1611848|NCT00351650|B Cell Mass|b cell mass
1611849|NCT00351650|Pet Scan|pet scan
1611850|NCT00351650|Type 1 Diabetes|type 1 diabetes
1611851|NCT00351650|T1DM|t1dm
1611852|NCT00351650|Pancreas|pancreas
1611853|NCT00351650|Healthy Volunteer|healthy volunteer
1611854|NCT00351650|HV|hv
1611855|NCT00351637|Sublingual methadone|sublingual methadone
1611856|NCT00351637|iatrogenic|iatrogenic
1611857|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
1611858|NCT00351637|feasibility study|feasibility study
1611859|NCT00351637|Phase II/open-label|phase ii/open-label
1611860|NCT00351637|inpatients|inpatients
1611861|NCT00351637|Safety/efficacy|safety/efficacy
1611862|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
1611863|NCT00351637|previously receiving opioids|previously receiving opioids
1611864|NCT00351637|speak English|speak english
1611865|NCT00351624|DHA supplementation|dha supplementation
1611866|NCT00351624|Cognitive function|cognitive function
1611867|NCT00351624|Preschool children|preschool children
1611868|NCT00351624|Attention and behavior|attention and behavior
1611869|NCT00351624|Healthy Children|healthy children
1612170|NCT00350467|PANSS|panss
1611870|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
1611871|NCT00351611|vision testing|vision testing
1611872|NCT00351598|Tumour Volume|tumour volume
1611873|NCT00351598|Prognostic value|prognostic value
1611874|NCT00351585|Vildagliptin|vildagliptin
1611875|NCT00351585|Type 2 diabetes|type 2 diabetes
1611876|NCT00351585|Insulin secretion|insulin secretion
1611877|NCT00351585|Beta cell|beta cell
1611878|NCT00351572|colon cancer|colon cancer
1611879|NCT00351559|allograft|allograft
1611880|NCT00351559|rejection|rejection
1611881|NCT00351559|biopsy|biopsy
1611882|NCT00351559|gene|gene
1611883|NCT00351559|expression|expression
1611884|NCT00351559|cardiac|cardiac
1611885|NCT00351559|heart|heart
1611886|NCT00351559|transplant|transplant
1611887|NCT00351546|Vildagliptin|vildagliptin
1611888|NCT00351546|Type 2 diabetes|type 2 diabetes
1611889|NCT00351546|Insulin sensitivity|insulin sensitivity
1611890|NCT00351546|Insulin action|insulin action
1611891|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
1611892|NCT00351533|Acute lung injury|acute lung injury
1611893|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
1611894|NCT00351533|ARDS, human|ards, human
1611895|NCT00351533|Fish oils|fish oils
1611896|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
1611897|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
1611898|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
1611899|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
1611900|NCT00351520|Glucantime|glucantime
1611901|NCT00351520|Miltefosine|miltefosine
1611902|NCT00351507|Vildagliptin|vildagliptin
1611903|NCT00351507|Type 2 diabetes|type 2 diabetes
1611904|NCT00351494|embolization|embolization
1611905|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
1611906|NCT00351494|myoma|myoma
1611907|NCT00351494|uterine artery|uterine artery
1611908|NCT00351494|microvascularisation|microvascularisation
1611909|NCT00351481|IVF|ivf
1611910|NCT00351481|endometrial receptivity|endometrial receptivity
1611911|NCT00351481|embryo implantation|embryo implantation
1611912|NCT00351481|recurrent implantation failure|recurrent implantation failure
1611913|NCT00351468|eltrombopag olamine|eltrombopag olamine
1611914|NCT00351468|SB-497115-GR|sb-497115-gr
1611915|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
1611916|NCT00351468|thrombocytopenia|thrombocytopenia
1611917|NCT00351468|ITP|itp
1611918|NCT00351468|platelets|platelets
1611919|NCT00351455|hernia|hernia
1611920|NCT00351455|incisional hernia|incisional hernia
1611921|NCT00351455|ventral hernia|ventral hernia
1611922|NCT00351455|umbilical hernia|umbilical hernia
1611923|NCT00351442|Host Resistance|host resistance
1611924|NCT00351429|Glaucoma|glaucoma
1611925|NCT00351429|Trabeculectomy|trabeculectomy
1611926|NCT00351429|Sutures|sutures
1611927|NCT00351416|GnRH deficiency|gnrh deficiency
1611928|NCT00351416|GnRH antagonist|gnrh antagonist
1611929|NCT00351416|Letrozole|letrozole
1611930|NCT00351416|GnRH|gnrh
1611931|NCT00351416|FSH|fsh
1611932|NCT00351416|LH|lh
1611933|NCT00351416|Inhibins|inhibins
1611934|NCT00351403|Chronic HCV infection|chronic hcv infection
1611935|NCT00351403|Genotype 1|genotype 1
1611936|NCT00351403|Individually adapted therapy|individually adapted therapy
1611937|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
1611938|NCT00351403|Ribavirin|ribavirin
1611939|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
1611940|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
1611941|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
1611942|NCT00351390|NT-proBNP testing|nt-probnp testing
1611943|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
1611944|NCT00351364|atherosclerosis|atherosclerosis
1611945|NCT00351364|inflammation|inflammation
1611946|NCT00351364|leukotriene blockade|leukotriene blockade
1611947|NCT00351364|endothelial function|endothelial function
1611948|NCT00351351|Kidney Stones|kidney stones
1611949|NCT00351351|Renal Calculi|renal calculi
1611950|NCT00351312|Pressure ulcers|pressure ulcers
1611952|NCT00351312|foot pressure|foot pressure
1611953|NCT00351299|Delirium|delirium
1611954|NCT00351299|Agitation|agitation
1611955|NCT00351299|Sedation|sedation
1611956|NCT00351299|Dexmedetomidine|dexmedetomidine
1611957|NCT00351299|Surgical|surgical
1611958|NCT00351286|peripheral arterial disease|peripheral arterial disease
1611959|NCT00351286|peripheral vascular disease|peripheral vascular disease
1611960|NCT00351286|claudication|claudication
1611961|NCT00351273|Chlamydia|chlamydia
1611962|NCT00351260|Bifurcation|bifurcation
1611963|NCT00351260|Coronary|coronary
1611964|NCT00351260|Stenosis|stenosis
1611965|NCT00351260|Stent|stent
1611966|NCT00351260|drug elution|drug elution
1611967|NCT00351247|Myocardial Infarction|myocardial infarction
1611968|NCT00351247|Primary PCI|primary pci
1611969|NCT00351247|Postconditioning|postconditioning
1611970|NCT00351247|MRI|mri
1611971|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
1611972|NCT00351234|Hypoglycemia,|hypoglycemia,
1611974|NCT00351208|Spinal cord stimulation|spinal cord stimulation
1611975|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
1611976|NCT00351208|Spinal cord stimulators|spinal cord stimulators
1611977|NCT00351208|Stimulation frequencies|stimulation frequencies
1611978|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
1611979|NCT00351208|Varying settings|varying settings
1611980|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
1611981|NCT00351195|Etoposide|etoposide
1611982|NCT00351195|Oxaliplatin|oxaliplatin
1611983|NCT00351195|Capecitabine|capecitabine
1611984|NCT00351182|Scrub typhus|scrub typhus
1611985|NCT00351182|Telithromycin|telithromycin
1611986|NCT00351182|Doxycycline|doxycycline
1611987|NCT00351182|5 day Course of Telithromycin versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|5 day course of telithromycin versus doxycycline for the treatment of mild to moderate scrub typhus
1611988|NCT00351169|Major Depressive Disorder|major depressive disorder
1611989|NCT00351169|MDD|mdd
1611990|NCT00351156|Gaucher Disease|gaucher disease
1611991|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
1611992|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
1611993|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
1611994|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
1611995|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
1611996|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
1611997|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
1611998|NCT00351156|Metabolic Diseases|metabolic diseases
1611999|NCT00351156|Sphingolipidoses|sphingolipidoses
1612000|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
1612001|NCT00351143|QoL|qol
1612002|NCT00351143|Asthma|asthma
1612003|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
1612004|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
1612005|NCT00351143|Total control|total control
1612006|NCT00351143|SERETIDE|seretide
1612007|NCT00351143|FEV1|fev1
1612008|NCT00351130|Hypertension,|hypertension,
1612009|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
1612010|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
1612011|NCT00351130|valsartan,|valsartan,
1612012|NCT00351130|amlodipine,|amlodipine,
1612013|NCT00351117|St. John's Wort|st. john's wort
1612014|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
1612015|NCT00351117|Microvasculature|microvasculature
1612016|NCT00351117|Natural Health Products|natural health products
1612017|NCT00351104|Sprain|sprain
1612018|NCT00351104|Strain|strain
1612019|NCT00351104|Pain|pain
1612020|NCT00351104|Ankle Pain|ankle pain
1612021|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
1612022|NCT00351078|Cystic fibrosis|cystic fibrosis
1612023|NCT00351078|Nonsense mutation|nonsense mutation
1612024|NCT00351078|Premature stop codon|premature stop codon
1612025|NCT00351078|CF|cf
1612026|NCT00351078|PTC124|ptc124
1612027|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
1612028|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
1612029|NCT00351026|opioid dependence|opioid dependence
1612030|NCT00351026|methadone|methadone
1612031|NCT00351026|HIV|hiv
1612032|NCT00351013|malaria|malaria
1612033|NCT00351013|Plasmodium falciparum|plasmodium falciparum
1612034|NCT00351013|Tropica Nosode|tropica nosode
1612035|NCT00351013|Homeopathy|homeopathy
1612036|NCT00351000|Schizophrenia|schizophrenia
1612037|NCT00351000|Ziprasidone|ziprasidone
1612038|NCT00351000|Diabetes|diabetes
1612039|NCT00351000|Insulin Resistance|insulin resistance
1612040|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
1612042|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
1612043|NCT00350961|Fixed dose rate|fixed dose rate
1612044|NCT00350961|Gemcitabine|gemcitabine
1612045|NCT00350961|Oxaliplatin|oxaliplatin
1612046|NCT00350961|Capecitabine|capecitabine
1612047|NCT00350948|Ovary|ovary
1612048|NCT00350935|fMRI|fmri
1612049|NCT00350935|Visual perception|visual perception
1612050|NCT00350935|Attention|attention
1612051|NCT00350909|drug abuse|drug abuse
1612052|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
1612053|NCT00350896|scaphotrapezial|scaphotrapezial
1612054|NCT00350896|thumb|thumb
1612055|NCT00350896|pain|pain
1612056|NCT00350896|orthoses|orthoses
1612057|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
1612058|NCT00350883|Cognitive Therapy|cognitive therapy
1612059|NCT00350883|Negative Symptoms|negative symptoms
1612060|NCT00350883|Functional Outcomes|functional outcomes
1612061|NCT00350883|Schizophrenia|schizophrenia
1612062|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
1612063|NCT00350870|disulfiram|disulfiram
1612064|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
1612065|NCT00350870|contingency management|contingency management
1612066|NCT00350870|drug abuse therapy|drug abuse therapy
1612067|NCT00350870|educational/resource design/development|educational/resource design/development
1612068|NCT00350844|Sickle Cell Disease|sickle cell disease
1612069|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
1612070|NCT00350831|Solid tumor|solid tumor
1612071|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
1612072|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
1612073|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
1612074|NCT00350818|Leukemia|leukemia
1612075|NCT00350818|Azacitidine|azacitidine
1612076|NCT00350818|Vidaza|vidaza
1612077|NCT00350805|Schizophrenia|schizophrenia
1612078|NCT00350805|Time perception|time perception
1612079|NCT00350805|Cortical synchronization|cortical synchronization
1612080|NCT00350805|Electroencephalography|electroencephalography
1612081|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1612082|NCT00350766|Myocardial Infarction|myocardial infarction
1612083|NCT00350766|Myocardial Ischemia|myocardial ischemia
1612084|NCT00350766|Ventricular Remodeling|ventricular remodeling
1612085|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
1612086|NCT00350766|Stem cells|stem cells
1612087|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
1612088|NCT00350727|relapsed|relapsed
1612089|NCT00350727|lapatinib|lapatinib
1612090|NCT00350727|Pazopanib|pazopanib
1612091|NCT00350727|glioblastoma|glioblastoma
1612092|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
1612093|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
1612094|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
1612095|NCT00350701|DM type 2|dm type 2
1612096|NCT00350701|Hypogonadism|hypogonadism
1612097|NCT00350701|Testosterone|testosterone
1612098|NCT00350701|AndroGel|androgel
1612099|NCT00350688|Bladder,|bladder,
1612100|NCT00350688|Cancer,|cancer,
1612101|NCT00350688|Chemoradiation,|chemoradiation,
1612102|NCT00350688|IMRT,|imrt,
1612103|NCT00350688|tomotherapy|tomotherapy
1612104|NCT00350662|Deferiprone|deferiprone
1612105|NCT00350662|L1|l1
1612106|NCT00350662|Desferrioxamine|desferrioxamine
1612107|NCT00350662|Hemochromatosis|hemochromatosis
1612108|NCT00350662|Iron overload|iron overload
1612109|NCT00350662|Thalassemia|thalassemia
1612110|NCT00350649|behavior modification|behavior modification
1612111|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
1612112|NCT00350649|combination therapy|combination therapy
1612113|NCT00350649|drug abuse therapy|drug abuse therapy
1612114|NCT00350649|drug addition|drug addition
1612115|NCT00350649|human therapy evaluation|human therapy evaluation
1612116|NCT00350649|psychotherapy|psychotherapy
1612117|NCT00350649|clinical trial phase II|clinical trial phase ii
1612118|NCT00350649|coping|coping
1612119|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
1612120|NCT00350649|longitudinal human study|longitudinal human study
1612121|NCT00350649|outcomes research|outcomes research
1612122|NCT00350649|outpatient care|outpatient care
1612123|NCT00350649|psychological reinforcement|psychological reinforcement
1612124|NCT00350649|therapy compliance|therapy compliance
1612125|NCT00350649|behavior and social research tag|behavior and social research tag
1612126|NCT00350649|human subjects|human subjects
1612127|NCT00350649|neuropsychological test|neuropsychological test
1612128|NCT00350649|patient oriented research|patient oriented research
1612129|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
1612130|NCT00350623|AIDS|aids
1612131|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
1612132|NCT00350610|computer assisted instruction|computer assisted instruction
1612133|NCT00350610|drug abuse therapy|drug abuse therapy
1612134|NCT00350610|educational resource design and development|educational resource design and development
1612135|NCT00350597|Malignant Melanoma|malignant melanoma
1612136|NCT00350597|Adjuvant Therapy|adjuvant therapy
1612137|NCT00350597|Cytokine Therapy|cytokine therapy
1612138|NCT00350597|Immunologic Testing|immunologic testing
1612140|NCT00350584|Psychoeducation|psychoeducation
1612141|NCT00350584|Telehealth Intervention|telehealth intervention
1612142|NCT00350571|behavior therapy|behavior therapy
1612143|NCT00350571|counseling|counseling
1612144|NCT00350571|drug abuse therapy|drug abuse therapy
1612145|NCT00350571|outpatient care|outpatient care
1612146|NCT00350571|therapy compliance|therapy compliance
1612147|NCT00350571|clinical trial phase I|clinical trial phase i
1612148|NCT00350571|coping|coping
1612149|NCT00350571|outcomes research|outcomes research
1612150|NCT00350571|satisfaction|satisfaction
1612151|NCT00350571|social psychology|social psychology
1612152|NCT00350571|patient oriented research|patient oriented research
1612153|NCT00350532|pain, chronic pain|pain, chronic pain
1612154|NCT00350532|acetylcholine|acetylcholine
1612155|NCT00350532|clonidine|clonidine
1612156|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
1612157|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
1612158|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
1612159|NCT00350519|Epoetin alfa|epoetin alfa
1612160|NCT00350519|Surgery|surgery
1612161|NCT00350519|Abdomen|abdomen
1612162|NCT00350519|Pelvis|pelvis
1612163|NCT00350519|PROCRIT|procrit
1612164|NCT00350519|pRBC|prbc
1612165|NCT00350519|Blood transfusion|blood transfusion
1612166|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
1612167|NCT00350480|acute uterine bleeding|acute uterine bleeding
1612168|NCT00350467|Schizophrenia|schizophrenia
1612169|NCT00350467|DSM-IV|dsm-iv
1612171|NCT00350467|informed consent|informed consent
1612172|NCT00350441|Sildenafil Citrate|sildenafil citrate
1612173|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
1612174|NCT00350441|Open heart surgery|open heart surgery
1612175|NCT00350428|Acute primary angle closure|acute primary angle closure
1612176|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
1612177|NCT00350428|Phacoemulsification|phacoemulsification
1612178|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
1612179|NCT00350402|Parkinson's disease|parkinson's disease
1612180|NCT00350402|PD|pd
1612181|NCT00350402|masked faces|masked faces
1612182|NCT00350402|diminished facial expressivity|diminished facial expressivity
1612183|NCT00350402|diminished facial expression|diminished facial expression
1612184|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
1612185|NCT00350402|MST|mst
1612186|NCT00350389|Falls, Older persons|falls, older persons
1612187|NCT00350376|asthma|asthma
1612188|NCT00350376|allergies|allergies
1612189|NCT00350376|Xolair|xolair
1612190|NCT00350376|Advair|advair
1612191|NCT00350350|XEROSTOMIA|xerostomia
1612192|NCT00350350|MOUTH DRYNESS|mouth dryness
1612193|NCT00350350|ELDERLY|elderly
1612194|NCT00350350|ORAL LUBRICANT|oral lubricant
1612195|NCT00350298|Monoclonal antibody,|monoclonal antibody,
1612196|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
1612197|NCT00350285|cannabis|cannabis
1612198|NCT00350285|marijuana|marijuana
1612199|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
1612200|NCT00350233|Bone Tumors|bone tumors
1612201|NCT00350233|Bone Cancer|bone cancer
1612202|NCT00350233|Prostate Cancer|prostate cancer
1612203|NCT00350233|lung cancer|lung cancer
1612204|NCT00350220|Single ventricle|single ventricle
1612205|NCT00350220|Bidirectional Glenn|bidirectional glenn
1612206|NCT00350220|Fontan|fontan
1612207|NCT00350220|Congenital cardiac disease|congenital cardiac disease
1612208|NCT00350220|Red blood cell transfusion|red blood cell transfusion
1612209|NCT00350220|oxygen utilization|oxygen utilization
1612210|NCT00350220|lactate level|lactate level
1612211|NCT00350220|hemoglobin level|hemoglobin level
1612212|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
1612213|NCT00350168|Blood pressure|blood pressure
1612214|NCT00350168|Venous pressure|venous pressure
1612215|NCT00350168|Systolic pressure|systolic pressure
1612216|NCT00350168|Diastolic pressure|diastolic pressure
1612217|NCT00350168|Pulse pressure|pulse pressure
1612218|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
1612219|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
1612220|NCT00350142|pancreas cancer|pancreas cancer
1612221|NCT00350142|locally advanced|locally advanced
1612222|NCT00350142|local control|local control
1612223|NCT00350142|Gemcitabine|gemcitabine
1612224|NCT00350129|glucose|glucose
1612225|NCT00350129|vasospasm|vasospasm
1612226|NCT00350129|RVA|rva
1612227|NCT00350129|LDF|ldf
1612228|NCT00350129|vasospastic subjects|vasospastic subjects
1612229|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
1612230|NCT00350116|plaque psoriasis|plaque psoriasis
1612231|NCT00350116|Vitamin B12|vitamin b12
1612232|NCT00350090|Anemia|anemia
1612233|NCT00350090|Neoplasms|neoplasms
1612234|NCT00350090|Hemoglobin values|hemoglobin values
1612235|NCT00350077|Burns|burns
1612236|NCT00350064|Metabolic Syndrome|metabolic syndrome
1612237|NCT00350064|Obesity|obesity
1612238|NCT00350064|Exercise|exercise
1612239|NCT00350064|Diabetes|diabetes
1612240|NCT00350064|Physical Activity|physical activity
1612241|NCT00350051|Prostate cancer|prostate cancer
1612242|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
1612243|NCT00350025|urothelial|urothelial
1612244|NCT00350025|urologic|urologic
1612245|NCT00350025|neoplasm|neoplasm
1612246|NCT00350025|advanced|advanced
1612247|NCT00350025|metastatic|metastatic
1612248|NCT00350012|stroke|stroke
1612249|NCT00350012|visual|visual
1612250|NCT00350012|spatial neglect|spatial neglect
1612251|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
1612252|NCT00349973|Schizophrenia|schizophrenia
1612253|NCT00349973|Positive symptoms|positive symptoms
1612254|NCT00349973|Negative symptoms|negative symptoms
1612255|NCT00349973|Cognitive deficits|cognitive deficits
1612256|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
1612257|NCT00349960|Dosing frequency|dosing frequency
1612258|NCT00349960|Hemodialysis|hemodialysis
1612259|NCT00349960|Therapeutic equivalence|therapeutic equivalence
1612260|NCT00349934|Metastatic breast cancer|metastatic breast cancer
1612261|NCT00349934|IMP321|imp321
1612262|NCT00349934|hLAG-3Ig|hlag-3ig
1612263|NCT00349934|LAG-3|lag-3
1612264|NCT00349934|CD223|cd223
1612265|NCT00349934|Chemotherapy|chemotherapy
1612266|NCT00349934|Paclitaxel|paclitaxel
1612267|NCT00349934|Combination therapy|combination therapy
1612268|NCT00349921|pain|pain
1612269|NCT00349921|chronic pain|chronic pain
1612270|NCT00349921|clonidine|clonidine
1612271|NCT00349921|adenosine|adenosine
1612272|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
1612273|NCT00349921|CRPS|crps
1612274|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
1612275|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
1612276|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
1612277|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1612278|NCT00349895|Stent implantation|stent implantation
1612279|NCT00349869|inflammatory arthritis|inflammatory arthritis
1612280|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
1612281|NCT00349869|knee osteoarthritis|knee osteoarthritis
1612282|NCT00349869|arthritis|arthritis
1612283|NCT00349869|yoga|yoga
1612284|NCT00349804|temperature|temperature
1612285|NCT00349804|Temperature Homeostasis|temperature homeostasis
1612286|NCT00349791|Natural Menopause|natural menopause
1612287|NCT00349765|cardiovascular disease|cardiovascular disease
1612288|NCT00349765|saturated fat|saturated fat
1612289|NCT00349765|trans fat|trans fat
1612290|NCT00349765|polyunsaturated fat|polyunsaturated fat
1612291|NCT00349765|diet|diet
1612292|NCT00349765|intramyocellular lipid|intramyocellular lipid
1612293|NCT00349752|certolizumab pegol|certolizumab pegol
1612294|NCT00349752|Cimzia|cimzia
1612295|NCT00349752|Crohn's Disease|crohn's disease
1612296|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
1612297|NCT00349739|age related macular degeneration|age related macular degeneration
1612298|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
1612299|NCT00349726|Pharmacokinetics|pharmacokinetics
1612300|NCT00349726|Inositol|inositol
1612301|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1612302|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1612303|NCT00349726|Prematurity|prematurity
1612304|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
1612305|NCT00349700|healing|healing
1612306|NCT00349700|skin|skin
1612307|NCT00349700|infection|infection
1612308|NCT00349700|wound therapy|wound therapy
1612309|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
1612310|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
1612311|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
1612312|NCT00349674|methotrexate,|methotrexate,
1612313|NCT00349674|azathioprine|azathioprine
1612314|NCT00349661|clopidogrel|clopidogrel
1612315|NCT00349661|omeprazole|omeprazole
1612316|NCT00349648|subacromial|subacromial
1612317|NCT00349648|impingement|impingement
1612318|NCT00349648|acromioplasty|acromioplasty
1612319|NCT00349648|physiotherapy|physiotherapy
1612320|NCT00349635|Weight loss and diet.|weight loss and diet.
1612321|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1612322|NCT00349622|ALS|als
1612323|NCT00349622|ceftriaxone|ceftriaxone
1612324|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
1612325|NCT00349622|motor neurons|motor neurons
1612326|NCT00349596|Hypomethylating agent|hypomethylating agent
1612327|NCT00349596|Chemotherapy|chemotherapy
1612328|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
1612329|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1612330|NCT00349570|thrombus|thrombus
1612331|NCT00349570|aspiration catheter|aspiration catheter
1612332|NCT00349557|Prostate Cancer|prostate cancer
1612333|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
1612334|NCT00349557|1st line therapy|1st line therapy
1612335|NCT00349544|Neck pain|neck pain
1612336|NCT00349544|Cervicalgia|cervicalgia
1612337|NCT00349544|Quality of life|quality of life
1612339|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
1612340|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
1612341|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
1612342|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
1612343|NCT00349492|Extensive Disease|extensive disease
1612344|NCT00349492|Chemotherapy|chemotherapy
1612345|NCT00349492|Randomisation|randomisation
1612346|NCT00349479|stroke|stroke
1612347|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
1612348|NCT00349479|t-PA|t-pa
1612349|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
1612350|NCT00349479|BA-IEI|ba-iei
1612351|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1612352|NCT00349466|KCS|kcs
1612353|NCT00349466|Dry Eye|dry eye
1612354|NCT00349453|Deferiprone|deferiprone
1612355|NCT00349453|L1|l1
1612356|NCT00349453|Desferrioxamine|desferrioxamine
1612357|NCT00349453|Hemochromatosis|hemochromatosis
1612358|NCT00349453|Iron overload|iron overload
1612359|NCT00349453|Thalassemia|thalassemia
1612360|NCT00349440|Dry eye|dry eye
1612361|NCT00349427|Insulin|insulin
1612362|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
1612363|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1612364|NCT00349414|Advanced glaucoma|advanced glaucoma
1612365|NCT00349414|Refractory glaucoma|refractory glaucoma
1612366|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
1612367|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
1612368|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
1612369|NCT00349401|pain|pain
1612370|NCT00349401|chronic pain|chronic pain
1612371|NCT00349401|morphine|morphine
1612372|NCT00349401|ketorolac|ketorolac
1612373|NCT00349388|Mesalamine|mesalamine
1612374|NCT00349388|Ulcerative Colitis|ulcerative colitis
1612375|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
1612376|NCT00349323|Community directed treatment,|community directed treatment,
1612377|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
1612378|NCT00349323|treatment coverage,|treatment coverage,
1612379|NCT00349323|Zambia|zambia
1612380|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
1612381|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
1612382|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
1612383|NCT00349271|stem cells|stem cells
1612384|NCT00349271|Therapeutics|therapeutics
1612385|NCT00349271|Randomized Controlled Trials|randomized controlled trials
1612386|NCT00349258|OHSS|ohss
1612387|NCT00349258|PCOS|pcos
1612388|NCT00349258|Previous high response|previous high response
1612389|NCT00349258|GnRH antagonist|gnrh antagonist
1612390|NCT00349258|GnRH agonist|gnrh agonist
1612391|NCT00349258|IVF|ivf
1612392|NCT00349245|Endotracheal|endotracheal
1612393|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
1612394|NCT00349245|Dexmedetomidine|dexmedetomidine
1612395|NCT00349245|Remifentanil|remifentanil
1612396|NCT00349232|childhood obesity|childhood obesity
1612397|NCT00349232|lifestyle intervention|lifestyle intervention
1612398|NCT00349232|school health program|school health program
1612399|NCT00349232|special primary education|special primary education
1612400|NCT00349219|first-line|first-line
1612401|NCT00349219|second-line|second-line
1612402|NCT00349219|targeted therapy|targeted therapy
1612403|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1612404|NCT00349180|Total Hip Replacement|total hip replacement
1612405|NCT00349180|Enoxaparin|enoxaparin
1612406|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1612407|NCT00349141|Pandemic influenza|pandemic influenza
1612408|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
1612409|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
1612410|NCT00349102|Breath-hold|breath-hold
1612411|NCT00349102|Radiation pneumonitis|radiation pneumonitis
1612412|NCT00349102|Serum cytokines|serum cytokines
1612413|NCT00349102|LENT-SOMA scale|lent-soma scale
1612414|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
1612415|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
1612416|NCT00349089|adjuvant therapy|adjuvant therapy
1612417|NCT00349089|clinical feasibility rate|clinical feasibility rate
1612418|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
1612419|NCT00349050|neuropathic pain|neuropathic pain
1612420|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
1612421|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
1612422|NCT00349050|pain|pain
1612423|NCT00349050|chronic pain|chronic pain
1612424|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
1612425|NCT00349050|TMS|tms
1612426|NCT00349050|laboratory pain assessment|laboratory pain assessment
1612427|NCT00349037|DNA vaccine|dna vaccine
1612429|NCT00349037|immunogenicity|immunogenicity
1612430|NCT00349037|tolerability|tolerability
1612431|NCT00349037|PMED|pmed
1612432|NCT00349037|efficacy|efficacy
1612433|NCT00349037|challenge virus|challenge virus
1612434|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1612435|NCT00349024|pain|pain
1612436|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1612437|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
1612438|NCT00349024|chondrosarcoma|chondrosarcoma
1612439|NCT00349024|osteosarcoma|osteosarcoma
1612440|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1612441|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
1612442|NCT00349024|neuroblastoma|neuroblastoma
1612443|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1612444|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
1612445|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
1612446|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
1612447|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
1612448|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
1612449|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1612450|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
1612451|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
1612452|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
1612453|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
1612454|NCT00349024|childhood ependymoma|childhood ependymoma
1612455|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
1612456|NCT00349024|childhood meningioma|childhood meningioma
1612457|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
1612458|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1612459|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1612460|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1612461|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
1612462|NCT00349024|chordoma|chordoma
1612463|NCT00349024|mucositis|mucositis
1612464|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
1612465|NCT00349011|menopause|menopause
1612466|NCT00349011|genetic counseling|genetic counseling
1612467|NCT00349011|breast cancer|breast cancer
1612468|NCT00349011|tamoxifen|tamoxifen
1612469|NCT00349011|chemoprevention|chemoprevention
1612470|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1612471|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
1612472|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
1612473|NCT00348998|stage III prostate cancer|stage iii prostate cancer
1612474|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
1612475|NCT00348972|Glargine|glargine
1612476|NCT00348972|prediabetes|prediabetes
1612477|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
1612478|NCT00348972|impaired fasting glucose|impaired fasting glucose
1612479|NCT00348959|Haematological Malignancies|haematological malignancies
1612480|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
1612481|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1612482|NCT00348959|Quality of Life|quality of life
1612483|NCT00348959|Life Threatening Illness|life threatening illness
1612484|NCT00348959|Art in Health Care|art in health care
1612485|NCT00348959|Randomised Controlled Trial|randomised controlled trial
1612486|NCT00348959|Mixed Methods Research|mixed methods research
1612487|NCT00348946|Klinefelter syndrome|klinefelter syndrome
1612488|NCT00348946|androgen|androgen
1612489|NCT00348946|androgen oxandrolone|androgen oxandrolone
1612490|NCT00348933|Developmental Delay|developmental delay
1612491|NCT00348933|Mental Retardation|mental retardation
1612493|NCT00348933|Microcephaly|microcephaly
1612494|NCT00348933|Seizures|seizures
1612495|NCT00348920|Aortic Valve|aortic valve
1612496|NCT00348920|Aortic Stenosis|aortic stenosis
1612497|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
1612498|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
1612499|NCT00348920|Stress Response|stress response
1612500|NCT00348920|Inflammatory Mediators|inflammatory mediators
1612501|NCT00348920|Renal Function|renal function
1612502|NCT00348920|Hemodynamic Stability|hemodynamic stability
1612503|NCT00348907|doppler|doppler
1612504|NCT00348907|CIVIQ quality of life|civiq quality of life
1612505|NCT00348907|Hydrotherapy|hydrotherapy
1612506|NCT00348907|anticoagulants|anticoagulants
1612507|NCT00348881|Diphtheria|diphtheria
1612508|NCT00348881|Tetanus|tetanus
1612509|NCT00348881|Pertussis|pertussis
1612510|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
1612511|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
1612512|NCT00348868|HIV Infection|hiv infection
1612513|NCT00348868|Opioid dependence|opioid dependence
1612514|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
1613012|NCT00346450|Culture|culture
1612515|NCT00348855|High Blood Pressure|high blood pressure
1612516|NCT00348855|High cardiovascular risk|high cardiovascular risk
1612517|NCT00348855|Type 2 diabetes|type 2 diabetes
1612518|NCT00348855|Reaching goals|reaching goals
1612519|NCT00348842|Immunotherapy|immunotherapy
1612520|NCT00348829|CHF|chf
1612521|NCT00348829|mitral insufficiency|mitral insufficiency
1612522|NCT00348829|conductance catheter|conductance catheter
1612523|NCT00348829|mitral valve repair|mitral valve repair
1612524|NCT00348816|stage I prostate cancer|stage i prostate cancer
1612525|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
1612526|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
1612527|NCT00348816|stage III prostate cancer|stage iii prostate cancer
1612528|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
1612529|NCT00348790|adult grade I meningioma|adult grade i meningioma
1612530|NCT00348790|adult grade II meningioma|adult grade ii meningioma
1612531|NCT00348790|adult grade III meningioma|adult grade iii meningioma
1612532|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1612533|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
1612534|NCT00348790|adult papillary meningioma|adult papillary meningioma
1612535|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
1612536|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
1612537|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
1612538|NCT00348777|Womac indice|womac indice
1612539|NCT00348777|SF-36 quality of life|sf-36 quality of life
1612540|NCT00348777|Hydrotherapy|hydrotherapy
1612541|NCT00348764|lauromacrogol|lauromacrogol
1612542|NCT00348764|Sclerotherapy|sclerotherapy
1612543|NCT00348738|radiotherapy|radiotherapy
1612544|NCT00348738|clinical trial|clinical trial
1612545|NCT00348738|erythropoietin|erythropoietin
1612546|NCT00348738|cervix cancer|cervix cancer
1612547|NCT00348738|Phase III|phase iii
1612548|NCT00348738|2 Arms|2 arms
1612549|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
1612550|NCT00348686|LVH|lvh
1612551|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
1612552|NCT00348647|Prevention|prevention
1612553|NCT00348647|Exercise|exercise
1612554|NCT00348647|Overuse|overuse
1612555|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
1612556|NCT00348647|Exertional lower leg pain|exertional lower leg pain
1612557|NCT00348647|Prospective|prospective
1612558|NCT00348647|Risk factors|risk factors
1612559|NCT00348647|Hip|hip
1612560|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
1612561|NCT00348621|cataract surgery|cataract surgery
1612562|NCT00348621|refractive correction|refractive correction
1612563|NCT00348621|low vision services|low vision services
1612564|NCT00348621|nursing home|nursing home
1612565|NCT00348621|visual impairment|visual impairment
1612566|NCT00348608|Coronary|coronary
1612567|NCT00348608|Angiography|angiography
1612568|NCT00348608|X-ray|x-ray
1612569|NCT00348608|CAD|cad
1612570|NCT00348595|Prostate Cancer|prostate cancer
1612571|NCT00348569|CT|ct
1612572|NCT00348569|Coronary|coronary
1612573|NCT00348569|Cardiac|cardiac
1612574|NCT00348569|Angiography|angiography
1612575|NCT00348569|X-ray|x-ray
1612576|NCT00348569|CAD|cad
1612577|NCT00348569|Chest pain|chest pain
1612578|NCT00348543|age-related macula degeneration|age-related macula degeneration
1612579|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
1612580|NCT00348543|exudative complication|exudative complication
1612581|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
1612582|NCT00348491|Dental surgery|dental surgery
1612583|NCT00348491|acute pain|acute pain
1612584|NCT00348491|lumiracoxib|lumiracoxib
1612585|NCT00348491|celecoxib|celecoxib
1612586|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
1612587|NCT00348478|trachoma|trachoma
1612588|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
1612589|NCT00348478|water|water
1612590|NCT00348478|health education|health education
1612591|NCT00348478|face washing|face washing
1612592|NCT00348465|Brachytherapy|brachytherapy
1612593|NCT00348465|Prostate volume|prostate volume
1612594|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
1612595|NCT00348426|Food Borne Botulism|food borne botulism
1612596|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
1612597|NCT00348413|Randomized controlled trial|randomized controlled trial
1612598|NCT00348413|Methylprednisolone|methylprednisolone
1612599|NCT00348413|Methotrexate|methotrexate
1612600|NCT00348387|Imovax polio|imovax polio
1612601|NCT00348387|poliomyelitis|poliomyelitis
1612602|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
1612603|NCT00348361|Hay fever|hay fever
1612604|NCT00348361|biomarkers|biomarkers
1612605|NCT00348309|apolipoprotein E|apolipoprotein e
1612606|NCT00348309|Alzheimer's disease|alzheimer's disease
1612607|NCT00348309|cognition|cognition
1612608|NCT00348309|rosiglitazone|rosiglitazone
1612609|NCT00348309|adjunctive therapy|adjunctive therapy
1612610|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
1612611|NCT00348270|Cataract|cataract
1612612|NCT00348270|Intraocular lens|intraocular lens
1612613|NCT00348270|Aberration|aberration
1612614|NCT00348270|Wavefront|wavefront
1612615|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
1612616|NCT00348218|Neurovision|neurovision
1612617|NCT00348218|Myopia Therapy|myopia therapy
1612618|NCT00348192|Alzheimer's Disease|alzheimer's disease
1612619|NCT00348192|cognition global functioning|cognition global functioning
1612620|NCT00348192|symptomatic|symptomatic
1612621|NCT00348192|SB-742457|sb-742457
1612622|NCT00348179|Vascular abnormalities|vascular abnormalities
1612623|NCT00348179|Type 1 diabetes|type 1 diabetes
1612624|NCT00348179|Healthy control subjects|healthy control subjects
1612625|NCT00348153|Uveitis|uveitis
1612626|NCT00348153|Adalimumab|adalimumab
1612627|NCT00348153|TNF alpha|tnf alpha
1612628|NCT00348140|adjunctive therapy|adjunctive therapy
1612629|NCT00348140|moderate|moderate
1612630|NCT00348140|Alzheimer's disease|alzheimer's disease
1612631|NCT00348140|apolipoprotein E|apolipoprotein e
1612632|NCT00348140|mild|mild
1612633|NCT00348140|rosiglitazone|rosiglitazone
1612634|NCT00348140|cognition|cognition
1612635|NCT00348127|Neurovision|neurovision
1612636|NCT00348127|Myopia Therapy|myopia therapy
1612637|NCT00348114|autologous|autologous
1612638|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
1612639|NCT00348114|limbal deficiency|limbal deficiency
1612640|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
1612641|NCT00348088|Metastatic|metastatic
1612642|NCT00348088|Melanoma|melanoma
1612643|NCT00348088|Untreated|untreated
1612644|NCT00348088|Biomarker|biomarker
1612645|NCT00348075|Neurovision|neurovision
1612646|NCT00348075|Adult myopia|adult myopia
1612647|NCT00348075|Therapy|therapy
1612648|NCT00348049|LASIK|lasik
1612650|NCT00348049|Myopia|myopia
1612651|NCT00348036|Major Depression|major depression
1612652|NCT00348036|Trauma|trauma
1612653|NCT00348036|Primary Care|primary care
1612654|NCT00348036|Low-Income Patients|low-income patients
1612655|NCT00348010|osteoarthritis|osteoarthritis
1612656|NCT00348010|knee pain|knee pain
1612657|NCT00348010|extended release analgesia|extended release analgesia
1612658|NCT00348010|opioid|opioid
1612659|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1612660|NCT00347971|interleukin-21|interleukin-21
1612661|NCT00347971|rituximab|rituximab
1612662|NCT00347971|Immunotherapy|immunotherapy
1612663|NCT00347958|Tetanus,|tetanus,
1612664|NCT00347958|Diphtheria,|diphtheria,
1612665|NCT00347958|Pertussis|pertussis
1612666|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
1612667|NCT00347919|GW786034|gw786034
1612668|NCT00347919|Quality of Life|quality of life
1612669|NCT00347919|GW572016|gw572016
1612670|NCT00347919|Lapatinib|lapatinib
1612671|NCT00347919|Pazopanib|pazopanib
1612672|NCT00347919|Metastatic|metastatic
1612673|NCT00347919|Breast cancer|breast cancer
1612674|NCT00347919|Genetics|genetics
1612675|NCT00347919|FISH|fish
1612676|NCT00347919|Advanced|advanced
1612677|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
1612678|NCT00347893|Ocular hypertension|ocular hypertension
1612679|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
1612680|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
1612681|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
1612682|NCT00347893|intraocular pressure|intraocular pressure
1612683|NCT00347880|Bronchiolitis|bronchiolitis
1612685|NCT00347880|BNP|bnp
1612686|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
1612687|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
1612688|NCT00347880|Vasopressin|vasopressin
1612689|NCT00347880|ADH|adh
1612690|NCT00347880|Pediatric|pediatric
1612691|NCT00347880|Respiratory Distress|respiratory distress
1612692|NCT00347880|Fluid Balance|fluid balance
1612693|NCT00347867|IUGR|iugr
1612694|NCT00347867|PET|pet
1612695|NCT00347867|Pregnancy|pregnancy
1612696|NCT00347867|Viagra|viagra
1612697|NCT00347867|Sildenafil citrate|sildenafil citrate
1612698|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
1612699|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
1612700|NCT00347828|Vigamox|vigamox
1612701|NCT00347828|Moxifloxacin|moxifloxacin
1612702|NCT00347828|Zymar|zymar
1612703|NCT00347828|Gatifloxacin|gatifloxacin
1612704|NCT00347828|Preoperative antibiotic|preoperative antibiotic
1612705|NCT00347828|Eye infection|eye infection
1612706|NCT00347789|glaucoma|glaucoma
1612707|NCT00347789|trabeculectomy|trabeculectomy
1612708|NCT00347789|filtering bleb revision|filtering bleb revision
1612709|NCT00347789|intraocular pressure|intraocular pressure
1612710|NCT00347789|needling procedure|needling procedure
1612711|NCT00347789|mitomycin C|mitomycin c
1612712|NCT00347776|trichiasis|trichiasis
1612713|NCT00347776|azithromycin|azithromycin
1612714|NCT00347776|trichiasis surgery|trichiasis surgery
1612715|NCT00347776|topical tetracycline|topical tetracycline
1612716|NCT00347763|trachoma|trachoma
1612717|NCT00347763|chlamydia|chlamydia
1612718|NCT00347763|flies|flies
1612719|NCT00347763|permethrin|permethrin
1612720|NCT00347750|Lopinavir|lopinavir
1612721|NCT00347750|Pharmacokinetic|pharmacokinetic
1612722|NCT00347750|Pharmacodynamic|pharmacodynamic
1612723|NCT00347750|Ethiopian population|ethiopian population
1612724|NCT00347750|Caucasian population|caucasian population
1612725|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
1612726|NCT00347698|diabetic retinopathy|diabetic retinopathy
1612727|NCT00347698|bevacizumab|bevacizumab
1612728|NCT00347698|photocoagulation|photocoagulation
1612729|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
1612730|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
1612731|NCT00347672|Bird Flu|bird flu
1612732|NCT00347659|Lung volume reduction|lung volume reduction
1612733|NCT00347659|Bronchoscopy|bronchoscopy
1612734|NCT00347659|Emphysema|emphysema
1612735|NCT00347659|COPD|copd
1612736|NCT00347659|NETT|nett
1612737|NCT00347659|Lung disease|lung disease
1612738|NCT00347659|COLD|cold
1612739|NCT00347659|BLVR|blvr
1612740|NCT00347607|trachoma|trachoma
1612741|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
1612742|NCT00347607|surveillance|surveillance
1612743|NCT00347607|azithromycin|azithromycin
1612744|NCT00347594|Corneal surface topography|corneal surface topography
1612745|NCT00347594|Ocular aberrations|ocular aberrations
1612746|NCT00347581|convergence insufficiency|convergence insufficiency
1612747|NCT00347581|base-in prism|base-in prism
1612748|NCT00347581|orthoptics|orthoptics
1612749|NCT00347581|vision therapy|vision therapy
1612750|NCT00347568|decision aids|decision aids
1612751|NCT00347568|high risk|high risk
1612752|NCT00347568|breast cancer|breast cancer
1612753|NCT00347568|breast cancer prevention|breast cancer prevention
1612754|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
1612755|NCT00347542|Vitamin D|vitamin d
1612756|NCT00347542|Diabetes|diabetes
1612757|NCT00347542|Insulin sensitivity|insulin sensitivity
1612758|NCT00347542|Obesity|obesity
1612759|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
1612760|NCT00347516|IOL formula|iol formula
1612761|NCT00347516|High myopia|high myopia
1612762|NCT00347516|axial length|axial length
1612763|NCT00347477|cardiac arrest|cardiac arrest
1612764|NCT00347477|hypothermia|hypothermia
1612765|NCT00347477|neurologic outcome|neurologic outcome
1612766|NCT00347477|edema|edema
1612767|NCT00347464|Kleinfelter|kleinfelter
1612768|NCT00347451|myopia|myopia
1612769|NCT00347451|optical coherence tomography|optical coherence tomography
1612770|NCT00347438|breast cancer|breast cancer
1612771|NCT00347438|neoadjuvant|neoadjuvant
1612772|NCT00347438|locally advanced|locally advanced
1612773|NCT00347425|Switch Study|switch study
1612774|NCT00347425|Schizophrenia|schizophrenia
1612775|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
1612776|NCT00347412|NSCLC|nsclc
1612777|NCT00347412|Stage IIIb|stage iiib
1612778|NCT00347412|Stage IV|stage iv
1612779|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
1612780|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
1612781|NCT00347412|NSCLC Stage IV|nsclc stage iv
1612782|NCT00347399|macular degeneration|macular degeneration
1612783|NCT00347399|antibodies|antibodies
1612784|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
1612785|NCT00347386|Infants|infants
1612786|NCT00347386|India|india
1612787|NCT00347386|Zinc|zinc
1612788|NCT00347386|Bacterial illness|bacterial illness
1612789|NCT00347386|Treatment|treatment
1612790|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
1612791|NCT00347373|obesity|obesity
1612792|NCT00347373|body composition|body composition
1612793|NCT00347373|body fat mass|body fat mass
1612794|NCT00347373|lean body mass|lean body mass
1612795|NCT00347360|carvedilol|carvedilol
1612796|NCT00347360|hypertension|hypertension
1612797|NCT00347360|lisinopril|lisinopril
1612798|NCT00347360|factorial|factorial
1612799|NCT00347334|Torticollis|torticollis
1612800|NCT00347334|infant home positioning|infant home positioning
1612801|NCT00347334|head control|head control
1612802|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
1612803|NCT00347321|Endotracheal intubation|endotracheal intubation
1612804|NCT00347321|Mechanical ventilation|mechanical ventilation
1612805|NCT00347321|Cardiac surgery|cardiac surgery
1612806|NCT00347321|Ventilator-free days|ventilator-free days
1612807|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
1612808|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
1612809|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
1612810|NCT00347282|Prospective studies|prospective studies
1612811|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
1612812|NCT00347269|Anxiety Disorders|anxiety disorders
1612813|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
1612814|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
1612815|NCT00347269|Panic Disorder|panic disorder
1612816|NCT00347269|Social Anxiety Disorder|social anxiety disorder
1612817|NCT00347269|Stress|stress
1612818|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
1612819|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1612820|NCT00347269|Mental Health Disorders|mental health disorders
1612821|NCT00347230|Intacs ring segments|intacs ring segments
1612822|NCT00347230|Keratoconus|keratoconus
1612823|NCT00347217|Cholesterol|cholesterol
1612824|NCT00347217|rosuvastatin|rosuvastatin
1612825|NCT00347217|LDL-C goal|ldl-c goal
1612826|NCT00347217|observational study|observational study
1612827|NCT00347217|primary prevention|primary prevention
1612828|NCT00347217|secondary prevention|secondary prevention
1612829|NCT00347204|PRK|prk
1612830|NCT00347204|laser vision correction|laser vision correction
1612831|NCT00347204|surface ablation|surface ablation
1612832|NCT00347204|pain|pain
1612833|NCT00347204|wound healing|wound healing
1612834|NCT00347204|corneal haze|corneal haze
1612835|NCT00347191|Corneal thickness|corneal thickness
1612836|NCT00347191|Intraocular pressure|intraocular pressure
1612837|NCT00347191|Instrumentation|instrumentation
1612838|NCT00347191|Glaucoma|glaucoma
1612839|NCT00347191|Keratoconus|keratoconus
1612840|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
1612841|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
1612842|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
1612843|NCT00347178|Randomised Controlled Trial|randomised controlled trial
1612844|NCT00347165|macular degeneration|macular degeneration
1612845|NCT00347165|angiogenesis|angiogenesis
1612846|NCT00347165|antibodies|antibodies
1612847|NCT00347152|Intellectual disabilities|intellectual disabilities
1612848|NCT00347152|development disabilities|development disabilities
1612849|NCT00347152|behavior disorders|behavior disorders
1612850|NCT00347152|stable epilepsy|stable epilepsy
1612851|NCT00347139|Tolerability|tolerability
1612852|NCT00347139|Pharmacodynamics|pharmacodynamics
1612853|NCT00347139|Safety|safety
1612854|NCT00347139|Pharmacokinetics|pharmacokinetics
1612855|NCT00347139|GW642444|gw642444
1612856|NCT00347139|Asthmatic patients|asthmatic patients
1612857|NCT00347139|Efficacy|efficacy
1612858|NCT00347126|Glaucoma|glaucoma
1612859|NCT00347126|Latanoprost|latanoprost
1612860|NCT00347126|Travoprost|travoprost
1612861|NCT00347126|Intraocular pressure|intraocular pressure
1612862|NCT00347126|Hyperemia|hyperemia
1612863|NCT00347113|P. falciparum|p. falciparum
1612864|NCT00347113|malaria|malaria
1612865|NCT00347113|schistosome infections|schistosome infections
1612866|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
1612867|NCT00347113|anaemia|anaemia
1612868|NCT00347113|immune response|immune response
1612869|NCT00347113|Tanzania|tanzania
1612870|NCT00347087|Insulin sensitivity|insulin sensitivity
1612871|NCT00347087|chronic heart failure|chronic heart failure
1612872|NCT00347087|metabolism|metabolism
1612873|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
1612874|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
1612875|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
1612876|NCT00347048|Ulcerative colitis|ulcerative colitis
1612877|NCT00347048|tacrolimus|tacrolimus
1612878|NCT00347048|FK506|fk506
1612879|NCT00347048|treatment outcome|treatment outcome
1612880|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
1612881|NCT00347009|Cirrhosis|cirrhosis
1612882|NCT00347009|Advanced Fibrosis|advanced fibrosis
1612883|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
1612884|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
1612885|NCT00346996|diabetes|diabetes
1612886|NCT00346996|insulin|insulin
1612887|NCT00346996|insulin analogues|insulin analogues
1612888|NCT00346996|hypoglycaemia|hypoglycaemia
1612889|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
1612890|NCT00346970|Metabolic Syndrome|metabolic syndrome
1612891|NCT00346970|High Density Lipoprotein|high density lipoprotein
1612892|NCT00346970|Extended-Release Niacin|extended-release niacin
1612893|NCT00346970|Endothelial Function|endothelial function
1612894|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
1612895|NCT00346931|glaucoma|glaucoma
1612896|NCT00346931|cataract|cataract
1612897|NCT00346931|surgery|surgery
1612898|NCT00346931|intraocular pressure|intraocular pressure
1612899|NCT00346931|phacoemulsification|phacoemulsification
1612900|NCT00346931|trabeculotomy|trabeculotomy
1612901|NCT00346918|ADPKD|adpkd
1612902|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
1612903|NCT00346918|Sirolimus|sirolimus
1612904|NCT00346918|volumetry|volumetry
1612905|NCT00346905|GERD|gerd
1613013|NCT00346450|Conjunctiva|conjunctiva
1613286|NCT00345657|Niacin|niacin
1612906|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1612907|NCT00346905|Reflux|reflux
1612908|NCT00346905|Enteryx|enteryx
1612909|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
1612910|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
1612911|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
1612912|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
1612913|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
1612914|NCT00346853|Antizol|antizol
1612915|NCT00346853|Fomepizole|fomepizole
1612916|NCT00346840|Labor induction|labor induction
1612917|NCT00346840|cervical ripening|cervical ripening
1612918|NCT00346840|misoprostol|misoprostol
1612919|NCT00346840|vaginal insert|vaginal insert
1612920|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
1612921|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
1612922|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
1612923|NCT00346801|Lung Cancer|lung cancer
1612924|NCT00346801|Celecoxib|celecoxib
1612925|NCT00346801|Cisplatin|cisplatin
1612926|NCT00346801|Platinol|platinol
1612927|NCT00346801|CPT-11|cpt-11
1612928|NCT00346801|Irinotecan|irinotecan
1612929|NCT00346801|SC-58635|sc-58635
1612930|NCT00346801|Celebrex|celebrex
1612931|NCT00346801|Radiation Therapy|radiation therapy
1612932|NCT00346775|questionnaire|questionnaire
1612933|NCT00346775|nasal spray|nasal spray
1612934|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
1613620|NCT00344279|Albendazole|albendazole
1612935|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
1612936|NCT00346775|allergic rhinitis|allergic rhinitis
1612937|NCT00346762|Former Plasma Donors|former plasma donors
1612938|NCT00346762|Commercial Plasma Donors|commercial plasma donors
1612939|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
1612940|NCT00346762|Host Factors|host factors
1612941|NCT00346762|Viral Factors|viral factors
1612942|NCT00346762|HIV|hiv
1612943|NCT00346749|Inflammation|inflammation
1612944|NCT00346749|FEV1|fev1
1612945|NCT00346749|Sputum|sputum
1612946|NCT00346736|Alternative medicine|alternative medicine
1612947|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
1612948|NCT00346736|Acupuncture|acupuncture
1612949|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
1612950|NCT00346736|Autism|autism
1612951|NCT00346736|Children|children
1612952|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
1612953|NCT00346710|communication|communication
1612954|NCT00346710|patient experience|patient experience
1612955|NCT00346710|fellowship training|fellowship training
1612956|NCT00346697|AIDS|aids
1612957|NCT00346697|HIV|hiv
1612958|NCT00346697|HAART|haart
1612959|NCT00346697|Lipids|lipids
1612960|NCT00346697|Triglycerides|triglycerides
1612961|NCT00346697|Cholesterol|cholesterol
1612962|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
1612963|NCT00346697|bone turnover|bone turnover
1612964|NCT00346697|inflammation|inflammation
1612965|NCT00346697|insulin resistance|insulin resistance
1612966|NCT00346684|Lymphoma|lymphoma
1612967|NCT00346684|LPHD|lphd
1612968|NCT00346684|Rituximab|rituximab
1612969|NCT00346671|Reiki|reiki
1612970|NCT00346671|Stress|stress
1612971|NCT00346671|CAM|cam
1612972|NCT00346658|Osteoporosis|osteoporosis
1612973|NCT00346658|bone density|bone density
1612974|NCT00346658|magnesium|magnesium
1612975|NCT00346658|vitamin D|vitamin d
1612976|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
1612977|NCT00346632|AML|aml
1612978|NCT00346632|ALL|all
1612979|NCT00346632|MDS|mds
1612980|NCT00346632|CML|cml
1612981|NCT00346632|Kinase Inhibitor|kinase inhibitor
1612982|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
1612983|NCT00346606|Desloratadine|desloratadine
1612984|NCT00346606|Denosin|denosin
1612985|NCT00346606|Levocetirizine|levocetirizine
1612986|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
1612987|NCT00346567|PMTCT|pmtct
1612988|NCT00346567|HIV|hiv
1612989|NCT00346567|resistance|resistance
1612990|NCT00346567|NNRTI|nnrti
1612991|NCT00346554|COPD|copd
1612992|NCT00346554|Sleep disorders|sleep disorders
1612993|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
1612994|NCT00346541|glaucoma|glaucoma
1612995|NCT00346541|polymorphism, genetic|polymorphism, genetic
1612996|NCT00346515|carotid artery|carotid artery
1612997|NCT00346515|carotid stenosis|carotid stenosis
1612998|NCT00346515|carotid stenting|carotid stenting
1612999|NCT00346515|embolic protection|embolic protection
1613000|NCT00346489|Trabeculectomy|trabeculectomy
1613001|NCT00346489|5-fluorouracil|5-fluorouracil
1613002|NCT00346489|Mitomycin C|mitomycin c
1613003|NCT00346476|TB|tb
1613004|NCT00346476|Transmission|transmission
1613005|NCT00346476|Genetic Diversity|genetic diversity
1613006|NCT00346476|Genetic Testing|genetic testing
1613007|NCT00346476|RFLP|rflp
1613008|NCT00346463|Allopurinol|allopurinol
1613009|NCT00346463|Fetal Growth Retardation|fetal growth retardation
1613010|NCT00346463|Oxidative Stress|oxidative stress
1613011|NCT00346463|Placental Insufficiency|placental insufficiency
1613014|NCT00346450|transplantation|transplantation
1613015|NCT00346450|pterygium|pterygium
1613016|NCT00346450|ocular surface|ocular surface
1613017|NCT00346437|angina|angina
1613018|NCT00346437|FGF-4|fgf-4
1613019|NCT00346437|angiogenesis|angiogenesis
1613020|NCT00346437|adenovector|adenovector
1613021|NCT00346437|growth factor|growth factor
1613022|NCT00346437|myocardial ischemia|myocardial ischemia
1613023|NCT00346437|revascularization|revascularization
1613024|NCT00346424|occluded central catheter|occluded central catheter
1613025|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
1613026|NCT00346424|withdrawal occlusion|withdrawal occlusion
1613027|NCT00346424|Thrombosis|thrombosis
1613028|NCT00346424|Venous thrombosis|venous thrombosis
1613029|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
1613030|NCT00346411|mood|mood
1613031|NCT00346411|adherence|adherence
1613032|NCT00346411|medication|medication
1613033|NCT00346398|asthma|asthma
1613034|NCT00346398|allergen|allergen
1613035|NCT00346398|allergic disease|allergic disease
1613036|NCT00346398|allergen immunotherapy|allergen immunotherapy
1613037|NCT00346398|allergic sensitization|allergic sensitization
1613038|NCT00346398|atopic dermatitis|atopic dermatitis
1613039|NCT00346398|eczema|eczema
1613040|NCT00346398|food allergy|food allergy
1613041|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
1613042|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
1613043|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
1613044|NCT00346385|ovarian cancer|ovarian cancer
1613045|NCT00346372|Ocular Melanoma|ocular melanoma
1613046|NCT00346372|Optical Coherence Tomography|optical coherence tomography
1613047|NCT00346372|Eye Tumor|eye tumor
1613048|NCT00346372|Choroidal Melanoma|choroidal melanoma
1613049|NCT00346372|Uveal Melanoma|uveal melanoma
1613050|NCT00346359|graft versus host disease|graft versus host disease
1613051|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1613052|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1613053|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1613054|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1613055|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1613056|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1613057|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1613058|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1613059|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1613060|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1613061|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1613062|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1613063|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1613064|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1613065|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1613066|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1613067|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1613068|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1613069|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1613070|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1613071|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1613072|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1613073|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1613074|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1613075|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1613076|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1613077|NCT00346346|Immunity|immunity
1613078|NCT00346346|Memory|memory
1613079|NCT00346346|ELISPOT|elispot
1613080|NCT00346346|Malaria|malaria
1613081|NCT00346346|Prospective|prospective
1613082|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
1613083|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1613084|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1613085|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
1613086|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1613087|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1613088|NCT00346320|large cell lung cancer|large cell lung cancer
1613089|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
1613090|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
1613091|NCT00346294|Device|device
1613092|NCT00346294|Auto-injector|auto-injector
1613093|NCT00346294|SureClick|sureclick
1613094|NCT00346294|Enbrel|enbrel
1613095|NCT00346294|Etanercept|etanercept
1613096|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
1613097|NCT00346281|brachytherapy|brachytherapy
1613098|NCT00346281|32P|32p
1613099|NCT00346281|BioSilicon|biosilicon
1613100|NCT00346281|locally advanced|locally advanced
1613101|NCT00346281|gemcitabine|gemcitabine
1613102|NCT00346281|intratumourally|intratumourally
1613103|NCT00346281|unresectable|unresectable
1613104|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
1613105|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
1613106|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
1613107|NCT00346242|thalassemia|thalassemia
1613108|NCT00346242|zoledronic acid|zoledronic acid
1613109|NCT00346242|skeletal events|skeletal events
1613110|NCT00346229|stage III B breast cancer|stage iii b breast cancer
1613111|NCT00346229|stage III C breast cancer|stage iii c breast cancer
1613112|NCT00346229|stage IV breast cancer|stage iv breast cancer
1613113|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
1613114|NCT00346229|recurrent breast cancer|recurrent breast cancer
1613115|NCT00346177|heart|heart
1613116|NCT00346177|stem Cells|stem cells
1613117|NCT00346177|low EF|low ef
1613118|NCT00346177|heart attack|heart attack
1613119|NCT00346177|cardiomyopathy|cardiomyopathy
1613120|NCT00346177|congestive heart failure|congestive heart failure
1613121|NCT00346177|cardiovascular disease|cardiovascular disease
1613122|NCT00346177|Heart Failure|heart failure
1613123|NCT00346177|Low Ejection Fraction|low ejection fraction
1613124|NCT00346151|renal transplantation|renal transplantation
1613125|NCT00346151|kidney transplantation|kidney transplantation
1613126|NCT00346151|renal allograft recipient|renal allograft recipient
1613127|NCT00346151|anti-rejection drugs|anti-rejection drugs
1613128|NCT00346151|immunosuppression protocol|immunosuppression protocol
1613129|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
1613130|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
1613131|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
1613132|NCT00346125|Liposarcoma|liposarcoma
1613133|NCT00346125|Fibrosarcoma|fibrosarcoma
1613134|NCT00346125|Leiomyosarcoma|leiomyosarcoma
1613135|NCT00346125|Synovial sarcoma|synovial sarcoma
1613136|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
1613137|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
1613138|NCT00346112|ICD|icd
1613139|NCT00346112|distress|distress
1613140|NCT00346112|anxiety|anxiety
1613141|NCT00346112|quality-of-life|quality-of-life
1613142|NCT00346099|NSABP|nsabp
1613143|NCT00346099|panitumumab|panitumumab
1613144|NCT00346099|rectal cancer|rectal cancer
1613145|NCT00346099|colorectal cancer|colorectal cancer
1613146|NCT00346099|oxaliplatin|oxaliplatin
1613147|NCT00346099|capecitabine|capecitabine
1613148|NCT00346099|combined modality therapy|combined modality therapy
1613149|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
1613150|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
1613151|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
1613152|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
1613153|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
1613154|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
1613155|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
1613156|NCT00346060|Retinal Transplant|retinal transplant
1613157|NCT00346060|Fetal Tissue|fetal tissue
1613158|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
1613159|NCT00346060|20/200 or worse.|20/200 or worse.
1613160|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
1613161|NCT00346008|melanoma|melanoma
1613162|NCT00346008|recurrent melanoma|recurrent melanoma
1613163|NCT00346008|stage I melanoma|stage i melanoma
1613164|NCT00346008|stage II melanoma|stage ii melanoma
1613165|NCT00346008|stage III melanoma|stage iii melanoma
1613166|NCT00346008|stage IV melanoma|stage iv melanoma
1613167|NCT00345982|Schizophrenia|schizophrenia
1613168|NCT00345982|Treatment-resistant|treatment-resistant
1613169|NCT00345982|sertindole|sertindole
1613170|NCT00345982|clozapine|clozapine
1613171|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
1613172|NCT00345969|Physical Frailty|physical frailty
1613173|NCT00345969|Hip Fracture|hip fracture
1613174|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
1613175|NCT00345943|Eating Disorders|eating disorders
1613176|NCT00345943|Bulimia Nervosa|bulimia nervosa
1613177|NCT00345943|Bulimia|bulimia
1613178|NCT00345943|fMRI|fmri
1613179|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
1613180|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
1613181|NCT00345930|Complementary therapies|complementary therapies
1613182|NCT00345930|Alternative therapies|alternative therapies
1613183|NCT00345930|Prescription Drugs|prescription drugs
1613184|NCT00345930|Non prescription Drugs|non prescription drugs
1613185|NCT00345930|Liver Disease|liver disease
1613186|NCT00345930|Chemical Ind|chemical ind
1613187|NCT00345930|Phenotype|phenotype
1613188|NCT00345930|Proteomics|proteomics
1613189|NCT00345930|Metabolomics|metabolomics
1613190|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
1613191|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
1613192|NCT00345930|Mixed Liver Injury|mixed liver injury
1613193|NCT00345930|Matched Case Control Studies|matched case control studies
1613194|NCT00345930|Genotype|genotype
1613195|NCT00345930|Liver Dis|liver dis
1613196|NCT00345930|Chem Ind|chem ind
1613197|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
1613198|NCT00345917|Retinal Transplant|retinal transplant
1613199|NCT00345917|Fetal Tissue|fetal tissue
1613200|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
1613201|NCT00345917|20/200 or worse.|20/200 or worse.
1613202|NCT00345904|influenza, vaccine|influenza, vaccine
1613203|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
1613204|NCT00345891|Lung neoplasms|lung neoplasms
1613205|NCT00345891|Family|family
1613206|NCT00345891|Stress|stress
1613207|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
1613208|NCT00345878|Cervical neoplasia|cervical neoplasia
1613209|NCT00345878|Cervical cancer|cervical cancer
1613210|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
1613211|NCT00345878|Double-blind|double-blind
1613212|NCT00345878|AS04|as04
1613213|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
1613214|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
1613215|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
1613216|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
1613313|NCT00345566|protein composition|protein composition
1613217|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
1613218|NCT00345852|amnioreduction|amnioreduction
1613219|NCT00345839|Cinacalcet HCl|cinacalcet hcl
1613220|NCT00345839|Cinacalcet|cinacalcet
1613221|NCT00345839|AMG 073|amg 073
1613222|NCT00345839|Sensipar|sensipar
1613223|NCT00345839|Mimpara|mimpara
1613224|NCT00345839|Calcimimetic|calcimimetic
1613225|NCT00345839|Hemodialysis|hemodialysis
1613227|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
1613228|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1613229|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1613230|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1613231|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1613232|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1613233|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1613234|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1613235|NCT00345813|stage I prostate cancer|stage i prostate cancer
1613236|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
1613237|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
1613238|NCT00345813|stage III prostate cancer|stage iii prostate cancer
1613239|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
1613240|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
1613241|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
1613242|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
1613243|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
1613244|NCT00345774|PH|ph
1613245|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1613246|NCT00345774|PAH|pah
1613247|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1613248|NCT00345774|COPD|copd
1613249|NCT00345774|PRX-08066|prx-08066
1613250|NCT00345774|Predix|predix
1613251|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
1613252|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
1613253|NCT00345722|Strawberry|strawberry
1613254|NCT00345722|Almond|almond
1613255|NCT00345722|Soy protein|soy protein
1613256|NCT00345722|viscous dietary fibre|viscous dietary fibre
1613257|NCT00345722|plant sterols|plant sterols
1613258|NCT00345722|portfolio diet|portfolio diet
1613259|NCT00345722|blood lipids|blood lipids
1613260|NCT00345722|compliance|compliance
1613261|NCT00345722|blood pressure|blood pressure
1613262|NCT00345709|Ovarian Cancer|ovarian cancer
1613263|NCT00345709|Peritoneal Cancer|peritoneal cancer
1613264|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
1613265|NCT00345709|Elizabeth Registry|elizabeth registry
1613266|NCT00345709|Questionnaire|questionnaire
1613267|NCT00345709|Registry|registry
1613268|NCT00345709|Survey|survey
1613269|NCT00345696|Capecitabine|capecitabine
1613270|NCT00345696|Oxaliplatin|oxaliplatin
1613271|NCT00345696|Bevacizumab|bevacizumab
1613272|NCT00345696|First line|first line
1613273|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
1613274|NCT00345683|Infants|infants
1613275|NCT00345683|Neisseria meningitidis|neisseria meningitidis
1613276|NCT00345683|Vaccines, conjugate|vaccines, conjugate
1613277|NCT00345683|Meningococcal vaccines|meningococcal vaccines
1613278|NCT00345683|Prophylaxis|prophylaxis
1613279|NCT00345683|Comparative study|comparative study
1613280|NCT00345683|Safety|safety
1613281|NCT00345683|Humans|humans
1613282|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
1613283|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
1613284|NCT00345657|Hyperlipidemia|hyperlipidemia
1613285|NCT00345657|Dyslipidemia|dyslipidemia
1613287|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1613288|NCT00345657|Combination lipid therapy|combination lipid therapy
1613289|NCT00345657|Lovastatin|lovastatin
1613290|NCT00345644|Postmenopausal|postmenopausal
1613291|NCT00345631|Closure Device|closure device
1613292|NCT00345631|Angiography|angiography
1613293|NCT00345631|Angioplasty|angioplasty
1613294|NCT00345631|Hemostasis|hemostasis
1613295|NCT00345631|Heart Catheterization|heart catheterization
1613296|NCT00345631|Peripheral Angiography|peripheral angiography
1613297|NCT00345631|Femoral Closure|femoral closure
1613298|NCT00345631|Vascular Closure|vascular closure
1613299|NCT00345631|Coronary Angiography|coronary angiography
1613300|NCT00345618|Deep venous thrombosis|deep venous thrombosis
1613301|NCT00345618|pulmonary embolism|pulmonary embolism
1613302|NCT00345618|anticoagulant drugs|anticoagulant drugs
1613303|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
1613304|NCT00345605|ASA|asa
1613305|NCT00345579|Prophylaxis|prophylaxis
1613306|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
1613307|NCT00345579|Infants|infants
1613308|NCT00345579|Meningococcal vaccines|meningococcal vaccines
1613309|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
1613310|NCT00345579|Humans|humans
1613311|NCT00345579|Safety|safety
1613312|NCT00345566|cerebral palsy|cerebral palsy
1613314|NCT00345566|gastric emptying rate|gastric emptying rate
1613315|NCT00345566|tube feeding|tube feeding
1613316|NCT00345553|Biliary Atresia|biliary atresia
1613317|NCT00345553|Cholestasis|cholestasis
1613318|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
1613319|NCT00345527|Problem gambling|problem gambling
1613320|NCT00345527|Clinically significant anger|clinically significant anger
1613321|NCT00345514|Children|children
1613322|NCT00345514|Self-efficacy|self-efficacy
1613323|NCT00345514|Organization|organization
1613324|NCT00345514|Process of care|process of care
1613325|NCT00345501|contrast media|contrast media
1613326|NCT00345501|contrast nephropathy|contrast nephropathy
1613327|NCT00345475|Birth Defects|birth defects
1613328|NCT00345475|Epilepsy|epilepsy
1613329|NCT00345475|High Risk Pregnancy|high risk pregnancy
1613330|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
1613331|NCT00345449|cystic fibrosis,|cystic fibrosis,
1613332|NCT00345449|lung disease,|lung disease,
1613333|NCT00345449|lung transplantation,|lung transplantation,
1613334|NCT00345449|decision aid|decision aid
1613335|NCT00345436|Insulin Sensitivity|insulin sensitivity
1613336|NCT00345436|Moderate intensity|moderate intensity
1613337|NCT00345436|Insulin Resistance|insulin resistance
1613338|NCT00345436|Exercise Intervention|exercise intervention
1613339|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
1613340|NCT00345397|cecostomy|cecostomy
1613341|NCT00345397|colonoscopy|colonoscopy
1613342|NCT00345397|colostomy|colostomy
1613343|NCT00345397|constipation|constipation
1613344|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
1613345|NCT00345397|fecal incontinence|fecal incontinence
1613346|NCT00345397|percutaneous|percutaneous
1613347|NCT00345397|quality of life|quality of life
1613348|NCT00345397|spinal cord injury|spinal cord injury
1613349|NCT00345384|Dexmedetomidine|dexmedetomidine
1613350|NCT00345384|Sedation|sedation
1613351|NCT00345384|Opioid|opioid
1613352|NCT00345384|Respiratory depression|respiratory depression
1613353|NCT00345371|methamphetamine addiction|methamphetamine addiction
1613354|NCT00345358|Booster vaccination|booster vaccination
1613355|NCT00345358|Catch-up vaccination|catch-up vaccination
1613356|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
1613357|NCT00345358|Immunogenicity|immunogenicity
1613358|NCT00345358|Safety|safety
1613359|NCT00345358|Pneumococcal disease|pneumococcal disease
1613360|NCT00345345|Neutropenia|neutropenia
1613361|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
1613362|NCT00345345|Anti-CD52|anti-cd52
1613363|NCT00345345|T-LGL Leukemia|t-lgl leukemia
1613364|NCT00345345|LGL Leukemia|lgl leukemia
1613365|NCT00345345|Anemia|anemia
1613366|NCT00345345|Immunosuppression|immunosuppression
1613367|NCT00345345|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
1613368|NCT00345345|Leukemia|leukemia
1613369|NCT00345319|rabies|rabies
1613370|NCT00345319|vaccine|vaccine
1613371|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
1613372|NCT00345306|endometrial preparation|endometrial preparation
1613373|NCT00345306|Utrogestan|utrogestan
1613374|NCT00345306|Endometrin|endometrin
1613375|NCT00345293|Prostate Cancer|prostate cancer
1613376|NCT00345280|Cystic fibrosis|cystic fibrosis
1613377|NCT00345280|eye|eye
1613378|NCT00345280|inflammation|inflammation
1613379|NCT00345280|apoptosis|apoptosis
1613380|NCT00345280|C11+|c11+
1613381|NCT00345267|Asthma|asthma
1613382|NCT00345267|Children|children
1613383|NCT00345267|Integrated Care Pathway|integrated care pathway
1613384|NCT00345267|Evidence based medicine|evidence based medicine
1613385|NCT00345267|Prescribing errors|prescribing errors
1613386|NCT00345241|Blepharitis|blepharitis
1613388|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
1613389|NCT00345228|Lacquer crack|lacquer crack
1613390|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
1613391|NCT00345228|Indocyanine green angiography|indocyanine green angiography
1613392|NCT00345228|Axial length|axial length
1613393|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
1613394|NCT00345215|High/low Sodium Diet|high/low sodium diet
1613395|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
1613396|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
1613399|NCT00345202|FE|fe
1613400|NCT00345202|CL|cl
1613401|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
1613402|NCT00345189|CNF2024|cnf2024
1613403|NCT00345189|Advanced Solid Tumors|advanced solid tumors
1613404|NCT00345176|age-related macular degeneration|age-related macular degeneration
1613405|NCT00345176|AMD|amd
1613406|NCT00345176|lutein|lutein
1613407|NCT00345176|zeaxanthin|zeaxanthin
1613408|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
1613409|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
1613410|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
1613411|NCT00345163|Avastin|avastin
1613412|NCT00345163|Brain Cancer|brain cancer
1613413|NCT00345163|GBM|gbm
1613414|NCT00345150|hypertension|hypertension
1613415|NCT00345150|nitric oxide|nitric oxide
1613416|NCT00345150|renal hemodynamics|renal hemodynamics
1613417|NCT00345137|Renal hemodynamics|renal hemodynamics
1613418|NCT00345137|Nitric oxide|nitric oxide
1613419|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
1613420|NCT00345124|ENaC|enac
1613421|NCT00345124|fractional sodium excretion|fractional sodium excretion
1613422|NCT00345124|High/low sodium diet|high/low sodium diet
1613423|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
1613424|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
1613425|NCT00345098|Clinical Trial|clinical trial
1613426|NCT00345098|Phase III|phase iii
1613427|NCT00345098|Multicenter study|multicenter study
1613428|NCT00345072|Menopause|menopause
1613429|NCT00345072|Decision aids|decision aids
1613430|NCT00345072|Internet|internet
1613431|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
1613432|NCT00345072|Breast Cancer|breast cancer
1613433|NCT00345072|Cardiovascular Disease|cardiovascular disease
1613434|NCT00345072|Osteoporosis|osteoporosis
1613435|NCT00345059|second line|second line
1613436|NCT00345059|monochemotherapy|monochemotherapy
1613437|NCT00345059|combination chemotherapy|combination chemotherapy
1613438|NCT00345059|platinum refractory|platinum refractory
1613439|NCT00345059|previously treated|previously treated
1613440|NCT00345046|Glaucoma|glaucoma
1613441|NCT00345046|Cataract|cataract
1613442|NCT00345033|Glucose Metabolism|glucose metabolism
1613443|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
1613444|NCT00345007|Retinal detachment|retinal detachment
1613445|NCT00345007|Macular function|macular function
1613446|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
1613447|NCT00344994|Restless Legs Syndrome|restless legs syndrome
1613448|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
1613449|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
1613450|NCT00344994|Dopamine Agonist|dopamine agonist
1613451|NCT00344981|Cell Cycle Agents|cell cycle agents
1613452|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
1613453|NCT00344955|GFR|gfr
1613454|NCT00344955|RPF|rpf
1613455|NCT00344955|FE|fe
1613456|NCT00344955|CL|cl
1613457|NCT00344916|Renal hemodynamics|renal hemodynamics
1613458|NCT00344916|Nitric oxide|nitric oxide
1613459|NCT00344903|Atherosclerosis|atherosclerosis
1613460|NCT00344903|Heart Failure|heart failure
1613461|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
1613462|NCT00344903|Myocardial Infarction|myocardial infarction
1613463|NCT00344903|Screening|screening
1613464|NCT00344903|Hypertension|hypertension
1613465|NCT00344903|Diabetes|diabetes
1613466|NCT00344903|Obesity|obesity
1613467|NCT00344903|Metabolic Syndrome|metabolic syndrome
1613468|NCT00344890|Cervical fusion|cervical fusion
1613469|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
1613470|NCT00344890|ACDF|acdf
1613471|NCT00344877|Epilepsy|epilepsy
1613472|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
1613473|NCT00344877|Cortical Excitability|cortical excitability
1613474|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1613475|NCT00344877|Memory Testing|memory testing
1613476|NCT00344877|Seizures|seizures
1613477|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1613478|NCT00344877|Memory|memory
1613479|NCT00344877|Plasticity|plasticity
1613480|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
1613481|NCT00344851|menstrual cyclicity|menstrual cyclicity
1613482|NCT00344851|insulin resistance|insulin resistance
1613483|NCT00344851|body fat distribution|body fat distribution
1613484|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
1613485|NCT00344851|inflammatory markers|inflammatory markers
1613486|NCT00344851|liver function tests|liver function tests
1613487|NCT00344838|LADARWave™|ladarwave™
1613488|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
1613489|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
1613490|NCT00344799|Choroidal Melanoma|choroidal melanoma
1613491|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
1613492|NCT00344799|Ocular Melanoma|ocular melanoma
1613493|NCT00344799|Uveal Melanoma|uveal melanoma
1613494|NCT00344786|CLL|cll
1613495|NCT00344786|CNF2024|cnf2024
1613496|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
1613497|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
1613498|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
1613499|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
1613500|NCT00344747|intervention program|intervention program
1613501|NCT00344747|diet|diet
1613502|NCT00344747|physical activity|physical activity
1613503|NCT00344747|adolescents|adolescents
1613504|NCT00344747|obesity|obesity
1613505|NCT00344734|Nitric oxide|nitric oxide
1613506|NCT00344734|Renal hemodynamics|renal hemodynamics
1613507|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
1613508|NCT00344721|Blepharitis|blepharitis
1613509|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
1613510|NCT00344682|memantine|memantine
1613511|NCT00344682|Namenda|namenda
1613512|NCT00344682|augmentation|augmentation
1613513|NCT00344682|add-on|add-on
1613514|NCT00344682|depression|depression
1613515|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
1613516|NCT00344682|unipolar depression|unipolar depression
1613517|NCT00344682|NMDA|nmda
1613518|NCT00344682|ketamine|ketamine
1613519|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
1613520|NCT00344669|underweight|underweight
1613521|NCT00344669|preschool|preschool
1613522|NCT00344669|mass deworming|mass deworming
1613523|NCT00344656|Eating Disorders|eating disorders
1613524|NCT00344656|Anorexia Nervosa|anorexia nervosa
1613525|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
1613526|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
1613527|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
1613528|NCT00344617|Intravitreal injection|intravitreal injection
1613529|NCT00344617|Avastin|avastin
1613530|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
1613531|NCT00344591|HIV|hiv
1613532|NCT00344591|AIDS|aids
1613533|NCT00344578|Higher Order Abberations|higher order abberations
1613534|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
1613535|NCT00344526|AL amyloidosis|al amyloidosis
1613536|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
1613537|NCT00344526|Melphalan|melphalan
1613538|NCT00344526|Dexamethasone|dexamethasone
1613539|NCT00344513|registry|registry
1613540|NCT00344513|OPTIMIZE|optimize
1613541|NCT00344513|Heart failure|heart failure
1613542|NCT00344513|OPTIMIZE-HF|optimize-hf
1613543|NCT00344500|Antipsychotic|antipsychotic
1613544|NCT00344500|Bipolar|bipolar
1613545|NCT00344500|Diabetes|diabetes
1613546|NCT00344500|Mental Illness|mental illness
1613547|NCT00344500|Nutrition|nutrition
1613548|NCT00344500|Obesity|obesity
1613549|NCT00344500|Schizoaffective|schizoaffective
1613550|NCT00344500|Schizophrenia|schizophrenia
1613551|NCT00344500|Weight Gain|weight gain
1613552|NCT00344500|Weight Loss|weight loss
1613553|NCT00344474|Prevention|prevention
1613554|NCT00344474|Addiction|addiction
1613555|NCT00344474|Personality|personality
1613556|NCT00344474|Adolescents|adolescents
1613557|NCT00344474|Binge Drinking|binge drinking
1613558|NCT00344474|Alcohol Abuse|alcohol abuse
1613559|NCT00344474|Comorbidity|comorbidity
1613560|NCT00344474|Depression|depression
1613561|NCT00344474|Anxiety|anxiety
1613562|NCT00344474|Antisocial Behaviour|antisocial behaviour
1613563|NCT00344448|Adhesion Molecule|adhesion molecule
1613564|NCT00344448|Interventional Study|interventional study
1613565|NCT00344448|Immunomodulation|immunomodulation
1613566|NCT00344448|Autoimmunity|autoimmunity
1613567|NCT00344448|Sjogren Syndrome|sjogren syndrome
1613568|NCT00344448|SS|ss
1613569|NCT00344435|Hemophilia|hemophilia
1613570|NCT00344435|Antibody|antibody
1613571|NCT00344435|Mutations|mutations
1613572|NCT00344435|SNP|snp
1613573|NCT00344435|clotting|clotting
1613574|NCT00344422|Anthracyclines|anthracyclines
1613575|NCT00344422|Liposomes|liposomes
1613576|NCT00344422|Liposomal|liposomal
1613577|NCT00344422|Vincristine|vincristine
1613578|NCT00344422|Doxorubicin|doxorubicin
1613579|NCT00344422|Dexamethasone|dexamethasone
1613681|NCT00344136|Obesity|obesity
1613588|NCT00344383|breakthrough bleeding|breakthrough bleeding
1613589|NCT00344383|spotting|spotting
1613590|NCT00344370|Pitavastatin|pitavastatin
1613591|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
1613592|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
1613594|NCT00344344|Cockroach|cockroach
1613595|NCT00344344|Dust Mite|dust mite
1613596|NCT00344344|Extermination|extermination
1613597|NCT00344344|Targeted Cleaning|targeted cleaning
1613598|NCT00344344|Allergy|allergy
1613599|NCT00344344|Prevention|prevention
1613600|NCT00344331|Lysosomal Storage|lysosomal storage
1613601|NCT00344331|Biomarkers|biomarkers
1613602|NCT00344331|Longitudinal|longitudinal
1613603|NCT00344331|Niemann Pick Type C|niemann pick type c
1613604|NCT00344331|NPC|npc
1613605|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
1613606|NCT00344318|Immunogenicity|immunogenicity
1613607|NCT00344318|Safety|safety
1613608|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
1613609|NCT00344318|Pneumococcal disease|pneumococcal disease
1613610|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
1613611|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
1613612|NCT00344292|Coronary Artery Disease|coronary artery disease
1613613|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
1613614|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
1613615|NCT00344292|SNPs|snps
1613616|NCT00344279|Coinfection|coinfection
1613617|NCT00344279|AIDS|aids
1613618|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
1613619|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
1613631|NCT00344253|Uveitis|uveitis
1613632|NCT00344253|Macular Edema|macular edema
1613633|NCT00344253|Interferon|interferon
1613634|NCT00344253|Multiple Sclerosis|multiple sclerosis
1613635|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
1613636|NCT00344240|type 2 diabetes|type 2 diabetes
1613637|NCT00344240|exercise|exercise
1613638|NCT00344240|activity guidance|activity guidance
1613639|NCT00344240|health education|health education
1613640|NCT00344227|neovascularization|neovascularization
1613641|NCT00344227|age-related macular degeneration|age-related macular degeneration
1613642|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
1613643|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
1613644|NCT00344227|antiangiogenesis|antiangiogenesis
1613645|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
1613646|NCT00344214|HIV|hiv
1613647|NCT00344214|STDs|stds
1613648|NCT00344214|Methamphetamine|methamphetamine
1613649|NCT00344201|Pterygium|pterygium
1613650|NCT00344201|Fibrin adhesive|fibrin adhesive
1613651|NCT00344201|Conjunctival graft|conjunctival graft
1613652|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
1613653|NCT00344188|Cutaneous|cutaneous
1613654|NCT00344188|Visceral|visceral
1613655|NCT00344188|PCR|pcr
1613656|NCT00344188|Mucocutaneous|mucocutaneous
1613657|NCT00344188|Biopsy|biopsy
1613658|NCT00344188|Leishmanial Infection|leishmanial infection
1613659|NCT00344188|Leishmaniasis|leishmaniasis
1613660|NCT00344175|hypercholesterolemia|hypercholesterolemia
1613661|NCT00344175|dyslipidemia|dyslipidemia
1613662|NCT00344175|CHD|chd
1613663|NCT00344175|pitavastatin|pitavastatin
1613664|NCT00344175|simvastatin|simvastatin
1613665|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
1613666|NCT00344175|combined dyslipidemia|combined dyslipidemia
1613667|NCT00344162|Epidemiology|epidemiology
1613668|NCT00344162|Population|population
1613669|NCT00344162|Pregnancy|pregnancy
1613670|NCT00344162|Preeclampsia|preeclampsia
1613671|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1613672|NCT00344149|Rituximab|rituximab
1613673|NCT00344149|Splenectomy|splenectomy
1613674|NCT00344149|Response|response
1613675|NCT00344149|Treatment|treatment
1613676|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
1613677|NCT00344136|Blood Pressure, High|blood pressure, high
1613678|NCT00344136|Stroke|stroke
1613679|NCT00344136|Hypertension|hypertension
1613680|NCT00344136|Diabetes Mellitus|diabetes mellitus
1613682|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
1613683|NCT00344136|Atherosclerosis|atherosclerosis
1613684|NCT00344123|HIV|hiv
1613685|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
1613686|NCT00344097|soy protein|soy protein
1613687|NCT00344097|pain|pain
1613688|NCT00344097|thoracotomy|thoracotomy
1613689|NCT00344084|Leishmania Major|leishmania major
1613690|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
1613691|NCT00344084|Dermatology|dermatology
1613692|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
1613693|NCT00344084|Africa|africa
1613694|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1613695|NCT00344084|CL|cl
1613696|NCT00344071|Clinical|clinical
1613697|NCT00344071|Tissue|tissue
1613698|NCT00344071|Photographs|photographs
1613699|NCT00344071|Women|women
1613700|NCT00344071|Case-Control|case-control
1613701|NCT00344058|pregnancy|pregnancy
1613702|NCT00344058|preeclampsia|preeclampsia
1613703|NCT00344058|treatment|treatment
1613704|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
1613705|NCT00344032|Double-blind|double-blind
1613706|NCT00344032|Human Papillomavirus|human papillomavirus
1613707|NCT00344032|Phase IIIb|phase iiib
1613708|NCT00344032|Controlled|controlled
1613709|NCT00344032|Randomized|randomized
1613710|NCT00344032|India|india
1613711|NCT00344019|Acute coronary syndrome|acute coronary syndrome
1613712|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
1613713|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
1613714|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
1613715|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
1613716|NCT00343993|acute lung injury|acute lung injury
1613717|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
1613718|NCT00343954|sickle cell disease|sickle cell disease
1613719|NCT00343941|HIV-1 infection|hiv-1 infection
1613720|NCT00343941|Tucaresol|tucaresol
1613721|NCT00343941|Viral suppression|viral suppression
1613722|NCT00343915|Persistence|persistence
1613723|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
1613724|NCT00343902|Hawthorn|hawthorn
1613725|NCT00343902|Crataegus|crataegus
1613726|NCT00343902|Herbs|herbs
1613727|NCT00343889|Diphtheria|diphtheria
1613728|NCT00343889|Tetanus|tetanus
1613729|NCT00343889|Pertussis|pertussis
1613730|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
1613731|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
1613732|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
1613733|NCT00343876|hs-CRP|hs-crp
1613734|NCT00343876|aspirin|aspirin
1613735|NCT00343876|clopidogrel|clopidogrel
1613736|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
1613737|NCT00343850|ulcerative colitis|ulcerative colitis
1613738|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
1613739|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
1613740|NCT00343850|medication adherence|medication adherence
1613741|NCT00343850|Asacol|asacol
1613742|NCT00343850|mesalamine|mesalamine
1613743|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
1613744|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
1613745|NCT00343811|ADHD|adhd
1613746|NCT00343759|Breast cancer|breast cancer
1613747|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
1613748|NCT00343759|Lapatinib|lapatinib
1613749|NCT00343759|Biologic response modifiers|biologic response modifiers
1613750|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
1613751|NCT00343759|Treatment-naive, operable|treatment-naive, operable
1613752|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1613753|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
1613754|NCT00343733|traumatic injury|traumatic injury
1613755|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
1613756|NCT00343733|back pain|back pain
1613757|NCT00343733|neck pain|neck pain
1613758|NCT00343733|fibromyalgia|fibromyalgia
1613759|NCT00343733|chronic pancreatitis|chronic pancreatitis
1613760|NCT00343733|osteoarthritis|osteoarthritis
1613761|NCT00343720|VELCADE|velcade
1613762|NCT00343720|Alimta|alimta
1613763|NCT00343720|locally advanced|locally advanced
1613764|NCT00343720|metastatic|metastatic
1613765|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
1613766|NCT00343720|complete response|complete response
1613767|NCT00343720|partial response|partial response
1613768|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
1613769|NCT00343707|Social Anxiety Disorder|social anxiety disorder
1613770|NCT00343707|brain imaging|brain imaging
1613771|NCT00343707|Positron Emission Tomography|positron emission tomography
1613772|NCT00343707|antidepressant|antidepressant
1613773|NCT00343681|Influenza|influenza
1613774|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
1613775|NCT00343681|Orthomyxoviruses|orthomyxoviruses
1613776|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
1613777|NCT00343668|advanced gastric cancer|advanced gastric cancer
1613778|NCT00343668|First-line therapy|first-line therapy
1613780|NCT00343668|irinotecan|irinotecan
1613781|NCT00343655|Hypercholesterolemia|hypercholesterolemia
1613782|NCT00343642|Crohn's disease|crohn's disease
1613783|NCT00343642|Fructooligosaccharide|fructooligosaccharide
1613784|NCT00343642|Inulin|inulin
1613785|NCT00343642|Diet|diet
1613786|NCT00343642|Treatment|treatment
1613787|NCT00343642|Bacterial flora|bacterial flora
1613788|NCT00343642|Oxidative stress|oxidative stress
1613789|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1613790|NCT00343616|cognitive/functional effects|cognitive/functional effects
1613791|NCT00343616|fatigue|fatigue
1613792|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1613793|NCT00343616|stage I breast cancer|stage i breast cancer
1613794|NCT00343616|stage II breast cancer|stage ii breast cancer
1613795|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
1613796|NCT00343603|maculopathy|maculopathy
1613797|NCT00343577|proteinuria|proteinuria
1613798|NCT00343577|ARBs|arbs
1613799|NCT00343577|agalsidase-beta|agalsidase-beta
1613800|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
1613801|NCT00343577|Chronic kidney disease|chronic kidney disease
1613802|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
1613803|NCT00343525|HCV|hcv
1613804|NCT00343525|monoclonal antibody|monoclonal antibody
1613805|NCT00343525|phase 1|phase 1
1613806|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
1613807|NCT00343512|stage II breast cancer|stage ii breast cancer
1613808|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
1613809|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
1613810|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
1613811|NCT00343499|atrial fibrillation|atrial fibrillation
1613812|NCT00343499|valsartan|valsartan
1613813|NCT00343499|sinus rhythm|sinus rhythm
1613814|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
1613815|NCT00343486|Overactive Bladder|overactive bladder
1613816|NCT00343473|Fuch's dystrophy|fuch's dystrophy
1613817|NCT00343473|corneal disorders|corneal disorders
1613818|NCT00343473|cornea|cornea
1613819|NCT00343473|lasik|lasik
1613820|NCT00343473|refractive surgery|refractive surgery
1613821|NCT00343460|nausea and vomiting|nausea and vomiting
1613915|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
1613822|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1613823|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1613824|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1613825|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1613826|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1613827|NCT00343434|stage I breast cancer|stage i breast cancer
1613828|NCT00343434|stage II breast cancer|stage ii breast cancer
1613829|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
1613830|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
1613831|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
1613832|NCT00343434|obesity|obesity
1613833|NCT00343421|Diphtheria|diphtheria
1613834|NCT00343421|Tetanus|tetanus
1613835|NCT00343421|Pertussis|pertussis
1613836|NCT00343421|Poliomyelitis|poliomyelitis
1613837|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
1613838|NCT00343421|Pneumococcal infections|pneumococcal infections
1613839|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1613840|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1613841|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1613842|NCT00343408|recurrent colon cancer|recurrent colon cancer
1613843|NCT00343408|stage III colon cancer|stage iii colon cancer
1613844|NCT00343408|stage IV colon cancer|stage iv colon cancer
1613845|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
1613846|NCT00343408|stage III rectal cancer|stage iii rectal cancer
1613847|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
1613848|NCT00343395|rosiglitazone|rosiglitazone
1613849|NCT00343395|metformin|metformin
1613850|NCT00343395|hs-CRP|hs-crp
1613851|NCT00343395|inflammation|inflammation
1613852|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
1613853|NCT00343382|sexual dysfunction|sexual dysfunction
1613854|NCT00343382|recurrent breast cancer|recurrent breast cancer
1613855|NCT00343382|stage I breast cancer|stage i breast cancer
1613856|NCT00343382|stage II breast cancer|stage ii breast cancer
1613857|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
1613858|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
1613859|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
1613860|NCT00343382|stage IV breast cancer|stage iv breast cancer
1613861|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1613862|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1613863|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1613865|NCT00343356|Bladder neoplasm;|bladder neoplasm;
1613867|NCT00343356|Epirubicin;|epirubicin;
1613868|NCT00343356|BCG;|bcg;
1613869|NCT00343356|Perfusion|perfusion
1613870|NCT00343317|puerperal sepsis|puerperal sepsis
1613871|NCT00343317|HIV infection|hiv infection
1613872|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
1613873|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
1613874|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
1613875|NCT00343291|Malignant pleural effusions|malignant pleural effusions
1613876|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
1613877|NCT00343278|hemodialysis patient|hemodialysis patient
1613878|NCT00343278|ALDH|aldh
1613879|NCT00343278|pharmacokinetics|pharmacokinetics
1613880|NCT00343278|Japanese|japanese
1613881|NCT00343265|Preterm birth|preterm birth
1613882|NCT00343265|Multiple pregnancy|multiple pregnancy
1613883|NCT00343265|Vaginal progesterone|vaginal progesterone
1613884|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
1613885|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
1613886|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
1613887|NCT00343213|CIN 1|cin 1
1613888|NCT00343213|LSIL|lsil
1613889|NCT00343213|HPV|hpv
1613890|NCT00343187|Tarceva|tarceva
1613891|NCT00343187|Rash|rash
1613892|NCT00343187|EGFR-1 Rash|egfr-1 rash
1613893|NCT00343187|erlotinib|erlotinib
1613894|NCT00343187|Aczone|aczone
1613895|NCT00343187|Dapsone|dapsone
1613896|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
1613897|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
1613898|NCT00343174|stroke|stroke
1613899|NCT00343174|vascular diseases|vascular diseases
1613900|NCT00343161|Nexium|nexium
1613901|NCT00343135|Skin|skin
1613902|NCT00343135|AUGMENTIN|augmentin
1613903|NCT00343135|1gm|1gm
1613904|NCT00343135|Soft|soft
1613905|NCT00343135|tissue|tissue
1613906|NCT00343135|Infections|infections
1613907|NCT00343122|liver|liver
1613908|NCT00343122|cirrhosis|cirrhosis
1613909|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
1613910|NCT00343096|intranasal|intranasal
1613911|NCT00343096|buccal|buccal
1613912|NCT00343096|lorazepam|lorazepam
1613913|NCT00343096|paediatric|paediatric
1613914|NCT00343096|convulsions|convulsions
1613916|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
1613917|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
1613918|NCT00343044|platinum resistant cancer|platinum resistant cancer
1613919|NCT00343031|Insecticides|insecticides
1613920|NCT00343031|Children|children
1613921|NCT00343031|Women|women
1613922|NCT00343031|Infection|infection
1613923|NCT00343031|DDT|ddt
1613924|NCT00343031|Contaminant|contaminant
1613925|NCT00343018|Preschoolers|preschoolers
1613926|NCT00343018|Young Children|young children
1613927|NCT00343018|Eyewitness|eyewitness
1613928|NCT00343018|Memory|memory
1613929|NCT00343005|Blood-Stage|blood-stage
1613930|NCT00343005|Investigational|investigational
1613931|NCT00343005|Endemic|endemic
1613932|NCT00343005|Malaria|malaria
1613933|NCT00343005|Vaccine|vaccine
1613934|NCT00342992|Vitamin E|vitamin e
1613935|NCT00342992|Micronutrients|micronutrients
1613936|NCT00342992|Genetics|genetics
1613937|NCT00342992|Smoking|smoking
1613938|NCT00342992|Biomarkers|biomarkers
1613939|NCT00342966|Metabolism|metabolism
1613940|NCT00342966|Tracer Studies|tracer studies
1613941|NCT00342966|Chemoprevention|chemoprevention
1613942|NCT00342966|Selenomethionine|selenomethionine
1613943|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
1613944|NCT00342953|saline|saline
1613945|NCT00342953|silicone|silicone
1613946|NCT00342953|Breast Implants|breast implants
1613947|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
1613948|NCT00342953|visk|visk
1613949|NCT00342940|influenza|influenza
1613950|NCT00342940|influenza vaccine|influenza vaccine
1613951|NCT00342940|flu|flu
1613952|NCT00342940|vaccination|vaccination
1613953|NCT00342940|immunogenicity|immunogenicity
1613954|NCT00342927|American Indians|american indians
1613955|NCT00342927|Complications|complications
1613956|NCT00342927|Genetics|genetics
1613957|NCT00342927|Linkage|linkage
1613958|NCT00342927|Type 2 Diabetes|type 2 diabetes
1613959|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
1613960|NCT00342888|Childhood Cancer|childhood cancer
1613961|NCT00342888|Pesticides|pesticides
1613962|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
1613963|NCT00342888|Organochlorines|organochlorines
1613964|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
1613968|NCT00342862|Pregnancy|pregnancy
1613969|NCT00342862|Amevive|amevive
1613970|NCT00342862|alefacept|alefacept
1613971|NCT00342862|Registry|registry
1613972|NCT00342862|Psoriasis|psoriasis
1613973|NCT00342849|Clinical Trial|clinical trial
1613974|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
1613975|NCT00342849|Chelation|chelation
1613976|NCT00342849|Developmental Assessment|developmental assessment
1613977|NCT00342849|Succimer|succimer
1613978|NCT00342836|Akt|akt
1613979|NCT00342836|Immunohistochemistry|immunohistochemistry
1613980|NCT00342836|Myoinositol|myoinositol
1613981|NCT00342836|Bronchial Specimens|bronchial specimens
1613982|NCT00342836|Phosphorylation|phosphorylation
1613983|NCT00342823|Linkage Analysis|linkage analysis
1613984|NCT00342823|Canidate Gene Analysis|canidate gene analysis
1613985|NCT00342823|Genome Scan|genome scan
1613986|NCT00342823|L. Chagasi|l. chagasi
1613987|NCT00342823|Visceral Leishmania|visceral leishmania
1613988|NCT00342810|Eye Diseases|eye diseases
1613989|NCT00342797|second primary cancer|second primary cancer
1613990|NCT00342797|retinoblastoma|retinoblastoma
1613991|NCT00342797|RB1 germline mutation|rb1 germline mutation
1613992|NCT00342784|Mutation|mutation
1613993|NCT00342784|Cancer Genetics|cancer genetics
1613994|NCT00342771|Tobacco Use|tobacco use
1613995|NCT00342771|Tumor Biology|tumor biology
1613996|NCT00342771|Biomarker|biomarker
1613997|NCT00342771|Risk Factor|risk factor
1613998|NCT00342771|Health Disparity|health disparity
1613999|NCT00342758|Asthma|asthma
1614000|NCT00342758|Wheeze|wheeze
1614001|NCT00342758|Environment|environment
1614002|NCT00342758|Diet|diet
1614003|NCT00342758|Infection|infection
1614004|NCT00342732|Genetics|genetics
1614005|NCT00342732|Fat Intake|fat intake
1614006|NCT00342732|Pima Indians|pima indians
1614007|NCT00342732|Weight Control|weight control
1614008|NCT00342732|Appetite Control|appetite control
1614009|NCT00342706|Teen Pregnancy|teen pregnancy
1614010|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
1614011|NCT00342693|Radiation|radiation
1614012|NCT00342693|Screening|screening
1614013|NCT00342693|Cancer|cancer
1614014|NCT00342693|Nodules|nodules
1614015|NCT00342693|Nuclear|nuclear
1614016|NCT00342693|Thyroid Screening|thyroid screening
1614017|NCT00342693|Thyroid Gland|thyroid gland
1614018|NCT00342667|Preterm Birth|preterm birth
1614019|NCT00342667|Predictors of Outcome|predictors of outcome
1614020|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
1614021|NCT00342667|Neurologic Development|neurologic development
1614022|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
1614023|NCT00342667|Cerebral Palsy|cerebral palsy
1614024|NCT00342667|Risk Factors|risk factors
1614025|NCT00342654|Epidemiology|epidemiology
1614026|NCT00342654|Cancer|cancer
1614027|NCT00342654|Environment|environment
1614028|NCT00342654|Genetics|genetics
1614029|NCT00342654|Nutrition|nutrition
1614030|NCT00342641|Lymphoma|lymphoma
1614031|NCT00342641|Multiple Myeloma|multiple myeloma
1614032|NCT00342641|Thyroiditis|thyroiditis
1614033|NCT00342641|Cohort Study|cohort study
1614034|NCT00342641|Record linkage study|record linkage study
1614035|NCT00342641|Hepatitis C|hepatitis c
1614036|NCT00342628|Antibody|antibody
1614037|NCT00342628|Reactions|reactions
1614038|NCT00342628|Vaccine|vaccine
1614039|NCT00342628|Conjugate Vaccine|conjugate vaccine
1614040|NCT00342628|Typhoid Fever|typhoid fever
1614041|NCT00342628|Trial|trial
1614042|NCT00342628|Safety|safety
1614043|NCT00342628|Immunogenicity|immunogenicity
1614044|NCT00342628|Comparability|comparability
1614045|NCT00342628|DTP|dtp
1614046|NCT00342602|JC Virus|jc virus
1614047|NCT00342602|Opportunistic Infection|opportunistic infection
1614048|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
1614049|NCT00342602|Genotype|genotype
1614050|NCT00342602|Sequencing|sequencing
1614051|NCT00342589|Pneumocystis|pneumocystis
1614052|NCT00342589|HIV|hiv
1614053|NCT00342589|Oral Wash|oral wash
1614054|NCT00342589|PCR|pcr
1614055|NCT00342589|Drug Resistance|drug resistance
1614056|NCT00342576|Filarial Parasites|filarial parasites
1614057|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
1614058|NCT00342576|Brugia Malayi|brugia malayi
1614059|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
1614060|NCT00342576|Ivermectin|ivermectin
1614061|NCT00342563|mecamylamine|mecamylamine
1614062|NCT00342563|treatment|treatment
1614063|NCT00342563|alcohol dependence|alcohol dependence
1614064|NCT00342563|smoking|smoking
1614065|NCT00342550|Pregnancy|pregnancy
1614066|NCT00342550|Preterm Birth|preterm birth
1614067|NCT00342550|Pregnancy Complications|pregnancy complications
1614068|NCT00342537|Pathology|pathology
1614069|NCT00342537|Genetics|genetics
1614070|NCT00342537|Testicular Cancer|testicular cancer
1614071|NCT00342537|Familial|familial
1614072|NCT00342537|Cancer Epidemiology|cancer epidemiology
1614073|NCT00342524|IVIG|ivig
1614074|NCT00342524|Plasmapheresis|plasmapheresis
1614075|NCT00342524|Blood Collection|blood collection
1614076|NCT00342524|Immune Globulin|immune globulin
1614077|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
1614078|NCT00342524|SARS|sars
1614079|NCT00342511|Pap|pap
1614080|NCT00342511|Hybrid Capture 2|hybrid capture 2
1614081|NCT00342511|HSIL|hsil
1614082|NCT00342511|Colposcopy|colposcopy
1614083|NCT00342511|CIN|cin
1614084|NCT00342511|Specimen Collection|specimen collection
1614085|NCT00342498|DNA|dna
1614086|NCT00342498|Hormone|hormone
1614087|NCT00342498|Resistance|resistance
1614088|NCT00342498|Skeleton|skeleton
1614089|NCT00342485|Cellular Immunity|cellular immunity
1614090|NCT00342485|HIV-infected|hiv-infected
1614091|NCT00342485|Immune Deficiency|immune deficiency
1614092|NCT00342485|Cancer|cancer
1614093|NCT00342485|Transplantation|transplantation
1614094|NCT00342472|Esophageal Cancer|esophageal cancer
1614095|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
1614096|NCT00342446|GONADOTROPIN|gonadotropin
1614097|NCT00342446|CLOMIPHENE|clomiphene
1614098|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
1614099|NCT00342433|Androgens|androgens
1614100|NCT00342433|Serum|serum
1614101|NCT00342433|Tissue|tissue
1614102|NCT00342407|Cancer Risk|cancer risk
1614103|NCT00342407|Cosmic Radiation|cosmic radiation
1614104|NCT00342407|Airlines|airlines
1614105|NCT00342407|Flight Attendants|flight attendants
1614106|NCT00342407|Circadian Rhythm|circadian rhythm
1614107|NCT00342394|Biological Monitoring|biological monitoring
1614108|NCT00342394|Exposure Determinants|exposure determinants
1614109|NCT00342394|Exposure Validation|exposure validation
1614110|NCT00342394|Occupational Exposure|occupational exposure
1614111|NCT00342394|Pesticides|pesticides
1614112|NCT00342394|Agriculture|agriculture
1614113|NCT00342381|Motor fatigue|motor fatigue
1614114|NCT00342381|Cognitive fatigue|cognitive fatigue
1614115|NCT00342368|CPAP|cpap
1614116|NCT00342368|ARDS|ards
1614117|NCT00342368|ALI|ali
1614118|NCT00342368|Hypoxemia|hypoxemia
1614119|NCT00342368|Intubation|intubation
1614120|NCT00342355|Protease Inhibitors|protease inhibitors
1614121|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1614122|NCT00342355|AIDS|aids
1614123|NCT00342355|Opportunistic Infections|opportunistic infections
1614124|NCT00342355|Resource-Poor|resource-poor
1614125|NCT00342342|Genetics|genetics
1614126|NCT00342329|Case-Control|case-control
1614127|NCT00342329|Hydrocarbons|hydrocarbons
1614128|NCT00342329|Metals|metals
1614129|NCT00342329|Silica|silica
1614130|NCT00342329|Tobacco Smoke|tobacco smoke
1614131|NCT00342329|Lupus Nephritis|lupus nephritis
1614132|NCT00342329|Environmental Exposures|environmental exposures
1614133|NCT00342329|Occupational Exposures|occupational exposures
1614134|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
1614242|NCT00342030|Prospective|prospective
1614135|NCT00342316|Stem Cell Transplantation|stem cell transplantation
1614136|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
1614137|NCT00342316|Survival|survival
1614138|NCT00342316|Relapse|relapse
1614139|NCT00342303|Premature Infants|premature infants
1614140|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
1614141|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
1614142|NCT00342303|Infant Formula|infant formula
1614143|NCT00342303|Gas-chromatography|gas-chromatography
1614144|NCT00342303|Mass Spectrometry|mass spectrometry
1614145|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
1614146|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
1614147|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
1614148|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
1614149|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
1614150|NCT00342277|Genetic Risk Factors|genetic risk factors
1614151|NCT00342277|Tissue Specific Expression|tissue specific expression
1614152|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
1614153|NCT00342277|Preterm Birth|preterm birth
1614154|NCT00342277|Expression Profiling|expression profiling
1614155|NCT00342277|Microarrays|microarrays
1614156|NCT00342264|Lung Cancer|lung cancer
1614157|NCT00342264|Smoking|smoking
1614158|NCT00342264|Diesel Exhaust|diesel exhaust
1614159|NCT00342251|Macular Degeneration|macular degeneration
1614160|NCT00342251|Retinal Images|retinal images
1614161|NCT00342251|Risk Factors|risk factors
1614162|NCT00342251|Linkage Analysis|linkage analysis
1614163|NCT00342251|Gene|gene
1614164|NCT00342251|Mutation|mutation
1614165|NCT00342225|Observation|observation
1614166|NCT00342225|Mothers|mothers
1614167|NCT00342225|Description|description
1614168|NCT00342212|Walking|walking
1614169|NCT00342212|Jogging|jogging
1614170|NCT00342212|Bridging Study|bridging study
1614171|NCT00342212|Data Comparability|data comparability
1614172|NCT00342212|Healthy Adults|healthy adults
1614173|NCT00342212|Healthy Volunteer|healthy volunteer
1614174|NCT00342212|HV|hv
1614175|NCT00342199|Incidence|incidence
1614176|NCT00342199|Prevalence|prevalence
1614177|NCT00342199|Immunity|immunity
1614178|NCT00342199|Bacteriology|bacteriology
1614179|NCT00342199|Pathogenesis|pathogenesis
1614180|NCT00342186|China|china
1614181|NCT00342186|Cancer|cancer
1614182|NCT00342186|Hepatitis B|hepatitis b
1614183|NCT00342186|Genetics|genetics
1614184|NCT00342186|Liver Disease|liver disease
1614186|NCT00342173|Cervix|cervix
1614187|NCT00342173|Natural History|natural history
1614188|NCT00342173|Neoplasia|neoplasia
1614189|NCT00342173|HPV|hpv
1614190|NCT00342173|Costa Rica|costa rica
1614191|NCT00342160|AIDS|aids
1614192|NCT00342160|HIV Infectiousness|hiv infectiousness
1614193|NCT00342160|Immunity|immunity
1614194|NCT00342160|CTL|ctl
1614195|NCT00342160|Epidemiology|epidemiology
1614196|NCT00342147|EBV|ebv
1614197|NCT00342147|NPC|npc
1614198|NCT00342134|Demyelination|demyelination
1614199|NCT00342134|Inflammation|inflammation
1614200|NCT00342134|Immunosuppression|immunosuppression
1614201|NCT00342134|Autoimmunity|autoimmunity
1614202|NCT00342134|Bone Marrow|bone marrow
1614203|NCT00342134|Multiple Sclerosis|multiple sclerosis
1614204|NCT00342121|Cancer|cancer
1614205|NCT00342121|NHL|nhl
1614206|NCT00342121|Pesticides|pesticides
1614207|NCT00342121|Atrazine|atrazine
1614208|NCT00342121|Organophosphates|organophosphates
1614209|NCT00342121|Cancer Risk|cancer risk
1614210|NCT00342121|Normal Control|normal control
1614211|NCT00342095|Autoimmune Diseases|autoimmune diseases
1614212|NCT00342095|Estrogen|estrogen
1614213|NCT00342095|Silica|silica
1614214|NCT00342095|Pesticides|pesticides
1614215|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
1614216|NCT00342095|Genetic Susceptibility|genetic susceptibility
1614217|NCT00342082|Zidovudine|zidovudine
1614218|NCT00342082|HIV|hiv
1614219|NCT00342082|Cord Blood|cord blood
1614220|NCT00342069|Decision Making|decision making
1614221|NCT00342069|Genetic Counseling|genetic counseling
1614222|NCT00342069|Pregnancy Options|pregnancy options
1614223|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
1614224|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
1614225|NCT00342069|Down Syndrome Risk|down syndrome risk
1614226|NCT00342069|Pregnancy|pregnancy
1614227|NCT00342056|Pharmacogenetics|pharmacogenetics
1614228|NCT00342056|Transporter Proteins|transporter proteins
1614229|NCT00342056|Drug Exposure|drug exposure
1614230|NCT00342056|Imatinib|imatinib
1614231|NCT00342056|Retrospective|retrospective
1614232|NCT00342056|Cancer|cancer
1614233|NCT00342043|Sickle Trait|sickle trait
1614234|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
1614235|NCT00342043|Hemoglobin C|hemoglobin c
1614236|NCT00342043|Beta-Thalassemia|beta-thalassemia
1614237|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
1614238|NCT00342030|Respiratory|respiratory
1614239|NCT00342030|Polymorphism|polymorphism
1614240|NCT00342030|Fruit|fruit
1614241|NCT00342030|COPD|copd
1614243|NCT00342030|Diet|diet
1614244|NCT00342017|Filarial Infections|filarial infections
1614245|NCT00342017|Helminths|helminths
1614246|NCT00342017|Tuberculosis|tuberculosis
1614247|NCT00342017|Filarial Infection|filarial infection
1614248|NCT00342004|Shanghai|shanghai
1614249|NCT00342004|Residential History|residential history
1614250|NCT00342004|Exposure Assessment|exposure assessment
1614251|NCT00342004|Cohort Study|cohort study
1614252|NCT00342004|Molecular Epidemiology|molecular epidemiology
1614253|NCT00341991|DNA Repair|dna repair
1614254|NCT00341991|Genes|genes
1614255|NCT00341991|Pigmentation|pigmentation
1614256|NCT00341991|Skin Cancer|skin cancer
1614257|NCT00341991|Sun Exposure|sun exposure
1614258|NCT00341965|DDT|ddt
1614259|NCT00341965|DDE|dde
1614260|NCT00341965|Androgen Levels|androgen levels
1614261|NCT00341965|Farming|farming
1614262|NCT00341965|Antiandrogen|antiandrogen
1614263|NCT00341952|Case-Control Study|case-control study
1614264|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1614265|NCT00341939|Drug Therapy|drug therapy
1614266|NCT00341939|Pharmacogenetics|pharmacogenetics
1614267|NCT00341939|Cancer|cancer
1614268|NCT00341939|Pharmacodynamics|pharmacodynamics
1614269|NCT00341939|Parmacokinetics|parmacokinetics
1614270|NCT00341913|Research|research
1614271|NCT00341913|Repository|repository
1614272|NCT00341913|Registry|registry
1614273|NCT00341913|Surveillance|surveillance
1614274|NCT00341913|Databases|databases
1614275|NCT00341900|Chromosome Translocations|chromosome translocations
1614276|NCT00341900|Cosmic Radiation|cosmic radiation
1614277|NCT00341900|Airline Flight Crew|airline flight crew
1614278|NCT00341900|Airlines|airlines
1614279|NCT00341900|Flight Crew|flight crew
1614280|NCT00341900|Occupational Exposure|occupational exposure
1614281|NCT00341887|Screening|screening
1614282|NCT00341887|AIDS|aids
1614283|NCT00341887|Antiretrovirals|antiretrovirals
1614284|NCT00341887|Military|military
1614285|NCT00341887|Force readiness|force readiness
1614286|NCT00341874|DNA Mutations|dna mutations
1614287|NCT00341874|Genetic Variation|genetic variation
1614288|NCT00341874|GENETIC LINKAGE|genetic linkage
1614289|NCT00341874|Gene Expression Patterns|gene expression patterns
1614290|NCT00341874|Hereditary Hearing Disorder|hereditary hearing disorder
1614291|NCT00341861|Bladder Cancer|bladder cancer
1614292|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
1614293|NCT00341861|Lifestyle Factors|lifestyle factors
1614294|NCT00341861|Epidemiology|epidemiology
1614295|NCT00341861|Genetic Susceptibility|genetic susceptibility
1614296|NCT00341848|Apoptosis|apoptosis
1614297|NCT00341848|Environment|environment
1614298|NCT00341848|Infection|infection
1614299|NCT00341848|Inflammation|inflammation
1614300|NCT00341848|Leiomyoma|leiomyoma
1614301|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
1614302|NCT00341848|Uterus|uterus
1614303|NCT00341835|Linkage Analysis|linkage analysis
1614304|NCT00341835|Cancer Susceptibility Alleles|cancer susceptibility alleles
1614305|NCT00341835|Cancer Genetics|cancer genetics
1614306|NCT00341835|Linkage Mapping|linkage mapping
1614307|NCT00341835|Linkage Disequilibrium|linkage disequilibrium
1614308|NCT00341822|Amniocentesis|amniocentesis
1614309|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
1614310|NCT00341822|Fertility|fertility
1614311|NCT00341822|Genetic Counseling|genetic counseling
1614312|NCT00341822|Decisional Conflict|decisional conflict
1614313|NCT00341822|Prenatal Testing|prenatal testing
1614314|NCT00341822|Questionnaire|questionnaire
1614424|NCT00341510|Adolescence|adolescence
1614315|NCT00341809|Natural Killer Cells|natural killer cells
1614316|NCT00341809|Autoimmune Disease|autoimmune disease
1614317|NCT00341809|Chronic Inflammation|chronic inflammation
1614318|NCT00341809|Two-Locus Interaction|two-locus interaction
1614319|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
1614320|NCT00341796|AIDS|aids
1614321|NCT00341796|HIV|hiv
1614322|NCT00341796|Perinatal|perinatal
1614323|NCT00341796|Transmission|transmission
1614324|NCT00341796|Antiretroviral|antiretroviral
1614325|NCT00341796|Outcomes|outcomes
1614326|NCT00341783|Plasmodium|plasmodium
1614327|NCT00341783|Falciparum|falciparum
1614328|NCT00341783|Screening|screening
1614329|NCT00341783|Malaria|malaria
1614330|NCT00341757|Family Reports|family reports
1614331|NCT00341757|Cancer|cancer
1614332|NCT00341757|Questionnaire|questionnaire
1614333|NCT00341757|Validity|validity
1614334|NCT00341757|Surveillance|surveillance
1614335|NCT00341744|Vision|vision
1614336|NCT00341744|Aids|aids
1614337|NCT00341731|Cystic Ovaries|cystic ovaries
1614338|NCT00341731|Environmental Factors|environmental factors
1614339|NCT00341731|Heritability|heritability
1614340|NCT00341731|Hyperandrogenism|hyperandrogenism
1614341|NCT00341731|Twin Study|twin study
1614342|NCT00341718|Interview|interview
1614343|NCT00341718|Genetics|genetics
1614344|NCT00341705|AIDS|aids
1614346|NCT00341705|Hepatitis C Virus|hepatitis c virus
1614347|NCT00341705|HIV|hiv
1614348|NCT00341705|Natural History|natural history
1614349|NCT00341705|Hemophilia|hemophilia
1614350|NCT00341705|Hepatitis C|hepatitis c
1614351|NCT00341692|Mammary|mammary
1614352|NCT00341692|Development|development
1614353|NCT00341692|Cancer|cancer
1614354|NCT00341692|Risk|risk
1614355|NCT00341692|Genes|genes
1614356|NCT00341679|Autoimmune Diseases|autoimmune diseases
1614357|NCT00341679|Genetic Risk Factors|genetic risk factors
1614358|NCT00341679|Polymyositis|polymyositis
1614359|NCT00341679|Dermatomyositis|dermatomyositis
1614360|NCT00341679|Connective Tissue Disorders|connective tissue disorders
1614361|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
1614362|NCT00341679|Inclusion Body Myositis|inclusion body myositis
1614363|NCT00341679|Pathogenesis|pathogenesis
1614364|NCT00341679|Environmental Risk Factor|environmental risk factor
1614365|NCT00341679|IIM|iim
1614366|NCT00341666|Immune Regulation|immune regulation
1614367|NCT00341666|Co-Infection|co-infection
1614368|NCT00341666|Filariasis|filariasis
1614369|NCT00341666|Immunology|immunology
1614370|NCT00341666|Filarial Infection|filarial infection
1614371|NCT00341653|Asthma|asthma
1614372|NCT00341653|Pulmonary Function|pulmonary function
1614373|NCT00341653|Air Pollution|air pollution
1614374|NCT00341653|Genetic Polymorphism|genetic polymorphism
1614375|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
1614376|NCT00341640|Teen Pregnancy|teen pregnancy
1614377|NCT00341627|Bone Tumor|bone tumor
1614378|NCT00341627|Familial Chordoma|familial chordoma
1614379|NCT00341627|Gene Mapping|gene mapping
1614380|NCT00341627|Genetics|genetics
1614381|NCT00341627|Sporadic Chordoma|sporadic chordoma
1614382|NCT00341614|Exercise|exercise
1614383|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1614384|NCT00341614|Postmenopause|postmenopause
1614385|NCT00341614|Diet|diet
1614386|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
1614387|NCT00341601|TLR-2|tlr-2
1614388|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
1614389|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
1614390|NCT00341601|mRNA Expression Profiles|mrna expression profiles
1614391|NCT00341588|Testicular Cancer|testicular cancer
1614392|NCT00341588|Epidemiology|epidemiology
1614393|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
1614394|NCT00341588|TGCT|tgct
1614395|NCT00341588|Healthy Volunteer|healthy volunteer
1614396|NCT00341575|Family Systems|family systems
1614397|NCT00341575|Communication|communication
1614398|NCT00341575|Information Diffusion|information diffusion
1614399|NCT00341575|Social Networks|social networks
1614400|NCT00341575|Family Dynamics|family dynamics
1614401|NCT00341562|Gene Expression Profiling|gene expression profiling
1614402|NCT00341562|Vascular Disease|vascular disease
1614403|NCT00341549|Linkage|linkage
1614404|NCT00341549|Genetics|genetics
1614405|NCT00341549|Mapping|mapping
1614406|NCT00341549|Gene|gene
1614407|NCT00341549|Susceptibility|susceptibility
1614408|NCT00341549|Myopia|myopia
1614409|NCT00341549|Nearsightedness|nearsightedness
1614410|NCT00341549|Refraction|refraction
1614411|NCT00341549|Eye|eye
1614412|NCT00341536|Diet|diet
1614413|NCT00341536|Pilot|pilot
1614414|NCT00341536|Cohort|cohort
1614415|NCT00341536|Environmental|environmental
1614416|NCT00341536|Chronic Disease|chronic disease
1614417|NCT00341523|Cytology|cytology
1614418|NCT00341523|Endoscopy|endoscopy
1614419|NCT00341523|Esophageal Cancer|esophageal cancer
1614420|NCT00341523|Early Detection|early detection
1614421|NCT00341523|Treatment|treatment
1614422|NCT00341510|Risk Behavior|risk behavior
1614423|NCT00341510|Health Status|health status
1614425|NCT00341510|Positive Health Behaviors|positive health behaviors
1614426|NCT00341510|Social Support|social support
1614427|NCT00341510|Health Behavior|health behavior
1614428|NCT00341510|Survey|survey
1614429|NCT00341497|Leukoplakia|leukoplakia
1614430|NCT00341497|Oral Mucosa|oral mucosa
1614431|NCT00341497|Biomarkers|biomarkers
1614432|NCT00341484|Genetics|genetics
1614433|NCT00341484|Liver Cancer|liver cancer
1614434|NCT00341484|HIV|hiv
1614435|NCT00341471|School|school
1614436|NCT00341471|Sixth Grade|sixth grade
1614437|NCT00341471|Curricular|curricular
1614438|NCT00341471|Howard University|howard university
1614439|NCT00341471|D.C.|d.c.
1614440|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
1614441|NCT00341471|Intervention|intervention
1614442|NCT00341458|Breast Cancer|breast cancer
1614443|NCT00341458|Environment|environment
1614444|NCT00341458|Genetics|genetics
1614445|NCT00341458|Epidemiology|epidemiology
1614446|NCT00341445|Environmental Intervention|environmental intervention
1614447|NCT00341445|Indoor Allergens|indoor allergens
1614448|NCT00341445|Environment|environment
1614449|NCT00341432|NRT Study|nrt study
1614450|NCT00341432|Smoking Cessation|smoking cessation
1614451|NCT00341419|ABC Transporter|abc transporter
1614452|NCT00341419|ABCC6|abcc6
1614453|NCT00341419|Slkin Laxity|slkin laxity
1614454|NCT00341419|Genetic Association|genetic association
1614455|NCT00341419|Angiod Streaks|angiod streaks
1614456|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
1614457|NCT00341419|PXE|pxe
1614458|NCT00341406|Obesity|obesity
1614459|NCT00341406|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1614460|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
1614461|NCT00341393|HIV Infection|hiv infection
1614462|NCT00341393|AIDS|aids
1614463|NCT00341393|Viral Load|viral load
1614464|NCT00341393|Retroviral Treatment|retroviral treatment
1614465|NCT00341393|Uganda|uganda
1614466|NCT00341380|Cancer|cancer
1614467|NCT00341380|Lung Cancer|lung cancer
1614468|NCT00341380|Surgical Resection|surgical resection
1614469|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
1614470|NCT00341380|NSCLC|nsclc
1614471|NCT00341367|Analgesic|analgesic
1614472|NCT00341367|Back Pain|back pain
1614473|NCT00341367|Lumbar Disc|lumbar disc
1614474|NCT00341367|Nerve|nerve
1614475|NCT00341367|Radiculopathy|radiculopathy
1614476|NCT00341354|Pneumonia|pneumonia
1614477|NCT00341354|Bacterial Infection|bacterial infection
1614478|NCT00341354|Nosocomial Infection|nosocomial infection
1614479|NCT00341354|Trachea|trachea
1614480|NCT00341354|Biofilm|biofilm
1614481|NCT00341354|Mucus Shaver|mucus shaver
1614482|NCT00341341|Smoking|smoking
1614483|NCT00341341|Smoking Cessation|smoking cessation
1614484|NCT00341341|GSTM1|gstm1
1614485|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
1614486|NCT00341341|Lung Cancer|lung cancer
1614487|NCT00341341|Smokers|smokers
1614488|NCT00341341|Genetic Risk Communication|genetic risk communication
1614489|NCT00341328|India|india
1614490|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
1614491|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
1614492|NCT00341328|Immunomodulator|immunomodulator
1614493|NCT00341328|Mycobacterium w|mycobacterium w
1614494|NCT00341315|Epidemiology|epidemiology
1614495|NCT00341315|DDT|ddt
1614496|NCT00341315|BMI|bmi
1614497|NCT00341315|Serum|serum
1614498|NCT00341315|Case-Control Study|case-control study
1614499|NCT00341302|HIV|hiv
1614500|NCT00341302|AIDS|aids
1614501|NCT00341302|Perinatal|perinatal
1614502|NCT00341302|Transmission|transmission
1614503|NCT00341302|Antiretroviral|antiretroviral
1614504|NCT00341302|Outcomes|outcomes
1614505|NCT00341289|Submersion|submersion
1614506|NCT00341289|Epidemiology|epidemiology
1614507|NCT00341289|Fatal|fatal
1614508|NCT00341289|Child|child
1614509|NCT00341289|Swim|swim
1614510|NCT00341289|Drowning|drowning
1614511|NCT00341289|Survey|survey
1614512|NCT00341276|Esophageal Cancer|esophageal cancer
1614513|NCT00341276|Genetics|genetics
1614514|NCT00341276|Polymorphism|polymorphism
1614515|NCT00341276|Susceptibility Genes|susceptibility genes
1614516|NCT00341276|Tumor|tumor
1614517|NCT00341263|Twins|twins
1614518|NCT00341263|Clinical Research|clinical research
1614519|NCT00341263|Endocrinology|endocrinology
1614520|NCT00341263|Breast Cancer|breast cancer
1614521|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
1614522|NCT00341250|Blood Stage|blood stage
1614523|NCT00341250|Investigational|investigational
1614524|NCT00341250|Endemic|endemic
1614525|NCT00341250|Malaria|malaria
1614526|NCT00341237|Polymorphism|polymorphism
1614527|NCT00341237|Genotype|genotype
1614528|NCT00341237|Phenotype|phenotype
1614529|NCT00341237|Environmental Factor|environmental factor
1614530|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
1614531|NCT00341224|Aggression|aggression
1614532|NCT00341224|Violence|violence
1614533|NCT00341224|Adolescents|adolescents
1614534|NCT00341224|Randomized Trial|randomized trial
1614535|NCT00341224|Behavioral Intervention|behavioral intervention
1614538|NCT00341211|Epidemiology|epidemiology
1614539|NCT00341211|Immunology|immunology
1614540|NCT00341211|Virology|virology
1614541|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
1614542|NCT00341198|Lupus|lupus
1614543|NCT00341198|Scleroderma|scleroderma
1614544|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
1614545|NCT00341198|Farming|farming
1614546|NCT00341198|Autoimmune Disease|autoimmune disease
1614547|NCT00341198|Exposure|exposure
1614548|NCT00341185|Biodosimetry|biodosimetry
1614549|NCT00341185|Dose Reconstruction|dose reconstruction
1614550|NCT00341185|Radioactive Fallout|radioactive fallout
1614551|NCT00341185|Thyroid Screening|thyroid screening
1614552|NCT00341185|Ultrasound|ultrasound
1614553|NCT00341172|Retinitis|retinitis
1614554|NCT00341172|Cytomegalovirus|cytomegalovirus
1614555|NCT00341172|HIV-1|hiv-1
1614556|NCT00341172|Polymorphisms|polymorphisms
1614557|NCT00341172|HAART|haart
1614558|NCT00341159|Breast|breast
1614559|NCT00341159|BRCA1|brca1
1614560|NCT00341159|BRCA2|brca2
1614561|NCT00341159|Inherited|inherited
1614562|NCT00341159|Association|association
1614563|NCT00341159|Breast Cancer|breast cancer
1614564|NCT00341159|Population-Based|population-based
1614565|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
1614566|NCT00341146|Cancer|cancer
1614567|NCT00341146|Catonese Chinese|catonese chinese
1614568|NCT00341146|Genetic Predisposition|genetic predisposition
1614569|NCT00341146|Genotyping|genotyping
1614570|NCT00341146|Triad analysis|triad analysis
1615006|NCT00339911|Repository|repository
1614571|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
1614572|NCT00341146|NPC|npc
1614573|NCT00341133|Laterality|laterality
1614574|NCT00341133|Heterotaxy|heterotaxy
1614575|NCT00341133|Holoprosencephaly|holoprosencephaly
1614576|NCT00341133|Genetic Testing|genetic testing
1614577|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
1614578|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
1614579|NCT00341120|Genotypes|genotypes
1614580|NCT00341120|Mutation|mutation
1614581|NCT00341120|Folate|folate
1614582|NCT00341120|Male Infertility|male infertility
1614583|NCT00341120|Nutrition|nutrition
1614584|NCT00341107|Cancer|cancer
1614585|NCT00341107|Genes|genes
1614586|NCT00341107|Screening|screening
1614587|NCT00341107|Primary Care|primary care
1614588|NCT00341107|Inherited Susceptibility|inherited susceptibility
1614589|NCT00341094|Cohort|cohort
1614590|NCT00341094|Radiation|radiation
1614591|NCT00341094|In Utero|in utero
1614592|NCT00341094|Genomic|genomic
1614593|NCT00341081|Short Tandem Repeat|short tandem repeat
1614594|NCT00341081|Molecular Epidemiology|molecular epidemiology
1614595|NCT00341081|Viral Infection|viral infection
1614596|NCT00341081|Mixture Detection|mixture detection
1614597|NCT00341081|Intervention & Education|intervention & education
1614598|NCT00341081|Intervention|intervention
1614599|NCT00341081|Education|education
1614600|NCT00341068|Birth Defects|birth defects
1614601|NCT00341068|Genetics|genetics
1614602|NCT00341068|Folic Acid|folic acid
1614603|NCT00341068|Gene-Environment Interactions|gene-environment interactions
1614604|NCT00341068|Neural Tube Defects|neural tube defects
1614605|NCT00341068|Cleft Lip|cleft lip
1614606|NCT00341068|Cleft Palate|cleft palate
1614607|NCT00341068|Mutations|mutations
1614608|NCT00341055|Anemia|anemia
1614609|NCT00341055|Hemoglobin|hemoglobin
1614610|NCT00341055|Chemotherapy|chemotherapy
1614611|NCT00341055|Epoetin alfa|epoetin alfa
1614612|NCT00341042|Normal Values|normal values
1614613|NCT00341042|Complete Blood Count|complete blood count
1614614|NCT00341042|HIV|hiv
1614615|NCT00341042|Tuberculosis|tuberculosis
1614616|NCT00341042|Flow Cytometry|flow cytometry
1614617|NCT00341029|Longitudinal Study|longitudinal study
1614622|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1614624|NCT00341016|Radiation|radiation
1614625|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
1614626|NCT00341003|Hemoglobin E|hemoglobin e
1614627|NCT00341003|Mefloquine|mefloquine
1614628|NCT00341003|Artemisinin|artemisinin
1614629|NCT00341003|Piperaquine|piperaquine
1614630|NCT00341003|Malaria|malaria
1614631|NCT00340990|Tuberculosis|tuberculosis
1614632|NCT00340990|HIV|hiv
1614633|NCT00340990|CD4+ T Cell|cd4+ t cell
1614634|NCT00340990|Interferon-Gamma|interferon-gamma
1614635|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
1614636|NCT00340977|Birth Defects|birth defects
1614637|NCT00340977|Case-Control Studies|case-control studies
1614638|NCT00340977|Genetic Susceptibility|genetic susceptibility
1614639|NCT00340964|Photography|photography
1614640|NCT00340964|Self-Esteem|self-esteem
1614641|NCT00340964|Perceived Social Stigma|perceived social stigma
1614642|NCT00340964|Hopefulness|hopefulness
1614643|NCT00340964|Cleft Lip and Palate|cleft lip and palate
1614644|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
1614645|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
1614646|NCT00340964|Mobius Syndrome|mobius syndrome
1614647|NCT00340964|Apert Syndrome|apert syndrome
1614648|NCT00340964|Videography|videography
1614760|NCT00340639|Adolescent|adolescent
1614649|NCT00340964|Craniofacial Differences|craniofacial differences
1614650|NCT00340964|Self -Esteem|self -esteem
1614651|NCT00340951|Regulatory T Cells|regulatory t cells
1614652|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1614653|NCT00340951|Genetic Polymorphism|genetic polymorphism
1614654|NCT00340951|Innate Immunity|innate immunity
1614655|NCT00340951|Transplantation|transplantation
1614656|NCT00340951|Lung Transplantation|lung transplantation
1614662|NCT00340912|Skin Biopsy|skin biopsy
1614663|NCT00340899|Perinatal Mortality|perinatal mortality
1614664|NCT00340899|Perinatal Morbidity|perinatal morbidity
1614665|NCT00340899|Preterm Birth|preterm birth
1614666|NCT00340899|Pregnancy Complications|pregnancy complications
1614667|NCT00340899|Pregnancy|pregnancy
1614668|NCT00340886|Genetic Susceptibility|genetic susceptibility
1614669|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
1614670|NCT00340886|Environmental Risk Factor|environmental risk factor
1614671|NCT00340886|Allelic Variants|allelic variants
1614672|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
1614673|NCT00340873|Molecular Epidemiology|molecular epidemiology
1614674|NCT00340873|Cross-Sectional|cross-sectional
1614675|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
1614676|NCT00340860|Ultrasound|ultrasound
1614677|NCT00340860|Biobank|biobank
1614678|NCT00340860|Urine|urine
1614679|NCT00340860|Blood|blood
1614680|NCT00340860|Exposure|exposure
1614681|NCT00340860|Norway Mother and Child Study|norway mother and child study
1614682|NCT00340847|Molecular Profiling|molecular profiling
1614683|NCT00340847|In Situ Hybridization|in situ hybridization
1614684|NCT00340847|SAGE|sage
1614685|NCT00340847|Tumor Markers|tumor markers
1614686|NCT00340847|IHC|ihc
1614687|NCT00340847|Lung Cancer|lung cancer
1614688|NCT00340847|Genetics|genetics
1614689|NCT00340834|FTY720|fty720
1614690|NCT00340834|Interferon|interferon
1614691|NCT00340834|RRMS|rrms
1614692|NCT00340834|Multiple Sclerosis|multiple sclerosis
1614693|NCT00340834|Efficacy|efficacy
1614694|NCT00340821|HTLV-I|htlv-i
1614695|NCT00340808|Endometrial Cancer|endometrial cancer
1614696|NCT00340808|Epidemiology|epidemiology
1614697|NCT00340808|Questionnaire|questionnaire
1614698|NCT00340808|Etiology|etiology
1614699|NCT00340808|Biomarkers|biomarkers
1614700|NCT00340795|Media Analysis|media analysis
1614701|NCT00340795|Nutrition|nutrition
1614702|NCT00340795|Physical Activity|physical activity
1614703|NCT00340795|After-School|after-school
1614704|NCT00340795|Exercise|exercise
1614705|NCT00340782|Menstrual Cycles|menstrual cycles
1614706|NCT00340782|Early Pregnancy|early pregnancy
1614707|NCT00340782|Reproductive Hormones|reproductive hormones
1614708|NCT00340782|Stress|stress
1614709|NCT00340782|Adrenal Function|adrenal function
1614710|NCT00340769|Cytokines|cytokines
1614711|NCT00340769|Inflammation|inflammation
1614712|NCT00340769|mRNA Stability|mrna stability
1614713|NCT00340769|Pygmy|pygmy
1614714|NCT00340769|Zinc Finger Proteins|zinc finger proteins
1614715|NCT00340769|Ethnic Group|ethnic group
1614716|NCT00340756|GCMS|gcms
1614717|NCT00340756|LCMS-MS|lcms-ms
1614718|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
1614719|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
1614720|NCT00340743|Yogurt|yogurt
1614721|NCT00340743|Chlorophyllin|chlorophyllin
1614722|NCT00340743|Comet Assay|comet assay
1614723|NCT00340743|Diet|diet
1614724|NCT00340743|Healthy Volunteer|healthy volunteer
1614725|NCT00340730|Health Education|health education
1614726|NCT00340730|Mentoring|mentoring
1614727|NCT00340730|Parenting|parenting
1614728|NCT00340730|Social Skills Training|social skills training
1614729|NCT00340730|Violence|violence
1614730|NCT00340730|Intervention|intervention
1614731|NCT00340730|Youth Injury|youth injury
1614732|NCT00340717|Methylation|methylation
1614733|NCT00340717|Genes|genes
1614734|NCT00340717|Screening|screening
1614735|NCT00340717|Prospective|prospective
1614736|NCT00340717|Diagnosis|diagnosis
1614737|NCT00340704|tamsulosin|tamsulosin
1614738|NCT00340704|pediatric|pediatric
1614739|NCT00340704|neurogenic bladder|neurogenic bladder
1614740|NCT00340691|Parasite|parasite
1614741|NCT00340691|Chemotherapy|chemotherapy
1614742|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
1614743|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
1614744|NCT00340678|Therapeutic Trial|therapeutic trial
1614745|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
1614746|NCT00340678|Kidney Biopsy|kidney biopsy
1614747|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
1614748|NCT00340665|Soy|soy
1614749|NCT00340665|Infant Formula|infant formula
1614750|NCT00340665|Sexual Development|sexual development
1614751|NCT00340665|Hormone|hormone
1614752|NCT00340665|Isoflavones|isoflavones
1614753|NCT00340652|Soy|soy
1614754|NCT00340652|Isoflavones|isoflavones
1614755|NCT00340652|Infant Formula|infant formula
1614756|NCT00340652|Sexual Development|sexual development
1614757|NCT00340652|Hormone|hormone
1614758|NCT00340639|Adherence|adherence
1614759|NCT00340639|Chronic Illness|chronic illness
1614762|NCT00340639|Self-Regulation|self-regulation
1614763|NCT00340626|Whole Genome Sequencing|whole genome sequencing
1614764|NCT00340626|Cleft Palate|cleft palate
1614765|NCT00340613|Type 1 Diabetes|type 1 diabetes
1614766|NCT00340613|Poorly controlled glucose|poorly controlled glucose
1614767|NCT00340613|adolescents|adolescents
1614768|NCT00340600|Cancer|cancer
1614769|NCT00340600|DES|des
1614770|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
1614771|NCT00340600|In Utero|in utero
1614772|NCT00340587|Zona Pellucida|zona pellucida
1614773|NCT00340587|Human Eggs|human eggs
1614774|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
1614775|NCT00340587|Fertilization|fertilization
1614776|NCT00340574|Human|human
1614777|NCT00340574|Clinical Trial|clinical trial
1614778|NCT00340574|Mosquito|mosquito
1614779|NCT00340574|Healthy Volunteer|healthy volunteer
1614780|NCT00340574|HV|hv
1614781|NCT00340561|Test Track|test track
1614782|NCT00340561|Distraction|distraction
1614783|NCT00340561|Motor Vehicle|motor vehicle
1614784|NCT00340561|Learning|learning
1614785|NCT00340561|Inexperience|inexperience
1614786|NCT00340548|Genotyping|genotyping
1614787|NCT00340548|Polymorphisms|polymorphisms
1614788|NCT00340548|Co-Infection|co-infection
1614789|NCT00340548|Chemokines|chemokines
1614790|NCT00340548|Associations|associations
1614791|NCT00340548|HIV|hiv
1614792|NCT00340548|HCV|hcv
1614793|NCT00340548|Hepatitis C|hepatitis c
1614794|NCT00340548|Hemophilia|hemophilia
1614795|NCT00340535|Disinfection byproducts|disinfection byproducts
1614796|NCT00340535|Genetic Variation|genetic variation
1614797|NCT00340535|Trihalomethanes|trihalomethanes
1614798|NCT00340522|Sarcoma|sarcoma
1614799|NCT00340522|Brain Tumor|brain tumor
1614800|NCT00340522|Embryonal Tumor|embryonal tumor
1614801|NCT00340522|Tumor Array|tumor array
1614802|NCT00340522|Childhood Cancer|childhood cancer
1614803|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
1614804|NCT00340522|Drug Screening|drug screening
1614805|NCT00340522|Immunohistochemistry|immunohistochemistry
1614806|NCT00340509|Genetics|genetics
1614807|NCT00340509|Population|population
1614808|NCT00340509|CHD Risk|chd risk
1614809|NCT00340509|Epidemiology|epidemiology
1614810|NCT00340509|Gene Mapping|gene mapping
1614811|NCT00340496|Schwannoma|schwannoma
1614812|NCT00340496|Meningioma|meningioma
1614813|NCT00340496|Follow-Up|follow-up
1614814|NCT00340496|Radiation Therapy|radiation therapy
1614815|NCT00340496|Cohort|cohort
1614816|NCT00340483|Smoking Cessation|smoking cessation
1614817|NCT00340483|Young Adults|young adults
1614818|NCT00340483|Quit Smoking|quit smoking
1614819|NCT00340483|Email|email
1614820|NCT00340483|Social Marketing|social marketing
1614821|NCT00340470|Injury|injury
1614822|NCT00340470|Motor Vehicle|motor vehicle
1614823|NCT00340470|Parenting|parenting
1614824|NCT00340470|Randomized Trial|randomized trial
1614825|NCT00340470|Behavioral Intervention|behavioral intervention
1614826|NCT00340457|Case-Control Study|case-control study
1614827|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
1614828|NCT00340457|Kidney Cancer|kidney cancer
1614829|NCT00340457|Diet|diet
1614830|NCT00340457|Occupation|occupation
1614831|NCT00340444|Linkage|linkage
1614832|NCT00340444|Covariates|covariates
1614833|NCT00340444|Association|association
1614834|NCT00340444|Fine Mapping|fine mapping
1614835|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
1614836|NCT00340444|Ulcerative Colitis|ulcerative colitis
1614837|NCT00340444|Crohn's Disease|crohn's disease
1614839|NCT00340431|Clinical Trial|clinical trial
1614840|NCT00340431|Mosquito|mosquito
1614841|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
1614842|NCT00340418|Acute Rejection|acute rejection
1614843|NCT00340418|Chronic Rejection|chronic rejection
1614844|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
1614845|NCT00340418|Innate Immunity|innate immunity
1614846|NCT00340418|Lung Transplantation|lung transplantation
1614847|NCT00340418|Lung Allograft Rejection|lung allograft rejection
1614848|NCT00340405|Blood|blood
1614849|NCT00340405|Lung Cancer|lung cancer
1614850|NCT00340405|Occupational Exposure|occupational exposure
1614851|NCT00340405|Radon|radon
1614852|NCT00340405|Arsenic|arsenic
1614853|NCT00340392|Mammary Stem Cells|mammary stem cells
1614854|NCT00340392|Breast Cancer|breast cancer
1614855|NCT00340392|Cancer Stem Cells|cancer stem cells
1614856|NCT00340392|Gene Expression Profiling|gene expression profiling
1614857|NCT00340379|Psychotic|psychotic
1614858|NCT00340366|Homocysteine|homocysteine
1614859|NCT00340366|Vitamin B12|vitamin b12
1614860|NCT00340366|Birth Defects|birth defects
1614861|NCT00340366|Pregnancy|pregnancy
1614862|NCT00340366|Folate|folate
1614863|NCT00340366|Irish Individuals|irish individuals
1614864|NCT00340353|Gene Expression|gene expression
1614865|NCT00340353|Drug Sensitivity|drug sensitivity
1614866|NCT00340353|TFE3|tfe3
1614867|NCT00340353|ASPL-TFE3|aspl-tfe3
1614868|NCT00340353|NOD-SCID Mice|nod-scid mice
1614869|NCT00340353|Sarcoma|sarcoma
1614870|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
1614871|NCT00340353|ASPS|asps
1614872|NCT00340340|Population-Based Case Control Study|population-based case control study
1614873|NCT00340340|Lung Cancer|lung cancer
1614874|NCT00340340|Epidemiology|epidemiology
1614875|NCT00340340|Smoking|smoking
1614876|NCT00340340|Smokers|smokers
1614877|NCT00340340|Genetics|genetics
1614878|NCT00340327|healthy subjects|healthy subjects
1614879|NCT00340314|symptomatic|symptomatic
1614880|NCT00340314|paroxysmal|paroxysmal
1614881|NCT00340314|atrial fibrillation|atrial fibrillation
1614882|NCT00340301|Polymorphism|polymorphism
1614883|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
1614884|NCT00340301|ALS|als
1614885|NCT00340288|Fibroids|fibroids
1614886|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
1614887|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
1614888|NCT00340288|Molecular Characterization|molecular characterization
1614889|NCT00340288|Symptoms/Clinical Outcome|symptoms/clinical outcome
1614890|NCT00340288|Uterine Fibroids|uterine fibroids
1614891|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
1614892|NCT00340275|Vaginal Infection|vaginal infection
1614893|NCT00340275|Vaginitis|vaginitis
1614894|NCT00340275|Cohort Study|cohort study
1614895|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
1614896|NCT00340262|Supplemental Hormone Use|supplemental hormone use
1614897|NCT00340262|Osteoporosis|osteoporosis
1614898|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
1614899|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
1614900|NCT00340249|Preterm Delivery|preterm delivery
1614901|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
1614902|NCT00340249|Chorioamnionitis|chorioamnionitis
1614903|NCT00340249|Spontaneous Abortion|spontaneous abortion
1614904|NCT00340223|Immunity|immunity
1614905|NCT00340223|Mutations|mutations
1614906|NCT00340223|Viral Selection|viral selection
1614907|NCT00340223|Disease Progression|disease progression
1614908|NCT00340223|RNA|rna
1614909|NCT00340210|Biomarkers|biomarkers
1614910|NCT00340210|Breast Cancer|breast cancer
1614911|NCT00340210|Etiology|etiology
1614912|NCT00340210|Hormones|hormones
1614913|NCT00340210|Prospective Study|prospective study
1614914|NCT00340184|concurrent|concurrent
1614915|NCT00340184|chemoradiation|chemoradiation
1614916|NCT00340184|paclitaxel|paclitaxel
1614917|NCT00340184|carboplatin|carboplatin
1614918|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
1614919|NCT00340171|Macrosomia|macrosomia
1614920|NCT00340171|Fetal Volume|fetal volume
1614921|NCT00340171|Fetal Anatomy|fetal anatomy
1614922|NCT00340171|Prediction of Birthweight|prediction of birthweight
1614923|NCT00340171|3D Ultrasonography|3d ultrasonography
1614924|NCT00340171|Fetus|fetus
1614925|NCT00340171|Prenatal Diagnosis|prenatal diagnosis
1614926|NCT00340158|Mammary|mammary
1614927|NCT00340158|Diagnosis|diagnosis
1614928|NCT00340158|Aggressive|aggressive
1614929|NCT00340158|Pathology|pathology
1614930|NCT00340158|Epidemiology|epidemiology
1614931|NCT00340132|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
1614932|NCT00340132|Insulin Resistance|insulin resistance
1614933|NCT00340132|Insulin Secretion|insulin secretion
1614934|NCT00340132|Glucose Tolerance|glucose tolerance
1614935|NCT00340132|Adipose Tissue|adipose tissue
1614936|NCT00340132|Preadipocytes|preadipocytes
1614937|NCT00340119|CHOICE Cohort|choice cohort
1614938|NCT00340119|End Stage Renal Disease|end stage renal disease
1614939|NCT00340119|Epidemiology|epidemiology
1614940|NCT00340119|Prevention|prevention
1614941|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1614942|NCT00340119|ESRD|esrd
1614943|NCT00340106|Infant Health Study|infant health study
1614944|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
1614945|NCT00340106|Infant Health|infant health
1614946|NCT00340093|Adherence|adherence
1614947|NCT00340093|Behavioral Intervention|behavioral intervention
1614948|NCT00340093|Adolescence|adolescence
1614949|NCT00340093|Self-Regulation|self-regulation
1614950|NCT00340093|Behavioral Medicine|behavioral medicine
1614951|NCT00340093|Diabetes|diabetes
1614952|NCT00340080|Abacavir|abacavir
1614953|NCT00340080|Pharmacogenetics|pharmacogenetics
1614954|NCT00340080|hypersensitivity|hypersensitivity
1614955|NCT00340080|HLA-B*5701|hla-b*5701
1614956|NCT00340054|brain tumor|brain tumor
1614957|NCT00340028|Ovulation|ovulation
1614958|NCT00340028|Diary Record|diary record
1614959|NCT00340028|Urine Collection|urine collection
1614960|NCT00340028|Leutinizing Hormone|leutinizing hormone
1614961|NCT00340028|Blood Collection|blood collection
1614962|NCT00340028|Pregnancy|pregnancy
1614963|NCT00340015|Cancer|cancer
1614964|NCT00340015|Mortality|mortality
1614965|NCT00340015|Lifestyle Factors|lifestyle factors
1614966|NCT00340015|Cohort|cohort
1614967|NCT00340002|Fetal Anatomy|fetal anatomy
1614968|NCT00340002|Pregnancy|pregnancy
1614969|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
1614970|NCT00339989|Molecular Markers|molecular markers
1614971|NCT00339989|Human Papillomavirus|human papillomavirus
1614972|NCT00339989|Cervix|cervix
1614973|NCT00339989|Cancer|cancer
1614974|NCT00339989|Microarray|microarray
1615082|NCT00339651|Progression|progression
1614975|NCT00339976|Case-Control Study|case-control study
1614976|NCT00339976|Death Certificates|death certificates
1614977|NCT00339976|National Death Index|national death index
1614978|NCT00339976|Cause of Death Information|cause of death information
1614979|NCT00339976|Lead Exposure|lead exposure
1614980|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1614981|NCT00339976|ALS|als
1614982|NCT00339963|Microarray|microarray
1614983|NCT00339963|Lymphoma|lymphoma
1614984|NCT00339963|Gene Expression|gene expression
1614985|NCT00339963|Molecular Diagnosis|molecular diagnosis
1614986|NCT00339963|Prognosis|prognosis
1614987|NCT00339963|Leukemia|leukemia
1614988|NCT00339963|Myeloma|myeloma
1614989|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
1614990|NCT00339950|Colorectal adenoma|colorectal adenoma
1614991|NCT00339950|Screening|screening
1614992|NCT00339950|Polyp|polyp
1614993|NCT00339950|Diet|diet
1614994|NCT00339950|Nutrition|nutrition
1614995|NCT00339950|Polymorphism|polymorphism
1614996|NCT00339950|Cooking|cooking
1614997|NCT00339950|Risk Factors|risk factors
1614998|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
1614999|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
1615000|NCT00339924|Clinical Decision-Making|clinical decision-making
1615001|NCT00339924|Physician Bias|physician bias
1615002|NCT00339924|Genetics|genetics
1615003|NCT00339924|Race|race
1615004|NCT00339924|Ethnicity|ethnicity
1615005|NCT00339924|Human Genetic Variation|human genetic variation
1615007|NCT00339911|Phlebotomy|phlebotomy
1615008|NCT00339911|Venipuncture|venipuncture
1615009|NCT00339911|Anemia|anemia
1615010|NCT00339911|Occupational Health Services|occupational health services
1615011|NCT00339898|Minimal Residual Disease|minimal residual disease
1615012|NCT00339898|Ewings Sarcoma|ewings sarcoma
1615013|NCT00339885|Type 2 Diabetes|type 2 diabetes
1615014|NCT00339872|healthy subjects|healthy subjects
1615015|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
1615016|NCT00339859|Health Disparities|health disparities
1615017|NCT00339846|Craniosynostosis|craniosynostosis
1615018|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
1615019|NCT00339846|CFNS|cfns
1615020|NCT00339833|Salsalate|salsalate
1615021|NCT00339833|Insulin Resistance|insulin resistance
1615022|NCT00339833|Diabetes Mellitus|diabetes mellitus
1615023|NCT00339833|Inflammation|inflammation
1615024|NCT00339833|Diabetes|diabetes
1615025|NCT00339833|HCV|hcv
1615026|NCT00339807|Retrovirus|retrovirus
1615027|NCT00339807|Caribbean|caribbean
1615028|NCT00339807|Transmission|transmission
1615029|NCT00339807|Genetic|genetic
1615030|NCT00339807|Viral Markers|viral markers
1615031|NCT00339807|HTLV-1|htlv-1
1615032|NCT00339794|Racial Profiling|racial profiling
1615033|NCT00339794|Genomics|genomics
1615034|NCT00339794|Genetic Testing|genetic testing
1615035|NCT00339794|Family History|family history
1615036|NCT00339794|Family Physician|family physician
1615037|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
1615038|NCT00339781|Cell Trafficking|cell trafficking
1615039|NCT00339781|Discordant Twins|discordant twins
1615365|NCT00338728|Femara|femara
1615040|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
1615041|NCT00339781|Diabetes Type I|diabetes type i
1615043|NCT00339768|Helicobacter Pylori|helicobacter pylori
1615044|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
1615045|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
1615046|NCT00339742|Esophageal Cancer|esophageal cancer
1615047|NCT00339742|Case-Control Study|case-control study
1615048|NCT00339742|Environmental Risk Factors|environmental risk factors
1615049|NCT00339742|Genetic Risk Factors|genetic risk factors
1615050|NCT00339729|Children|children
1615051|NCT00339729|Behavior|behavior
1615052|NCT00339729|Epidemiology|epidemiology
1615053|NCT00339729|Lead|lead
1615054|NCT00339729|Learning Disorder|learning disorder
1615055|NCT00339716|Cohort|cohort
1615056|NCT00339716|Radiation|radiation
1615057|NCT00339716|In Utero|in utero
1615058|NCT00339703|Resistin|resistin
1615059|NCT00339703|Asthma|asthma
1615060|NCT00339703|CRP|crp
1615061|NCT00339703|Diabetes|diabetes
1615062|NCT00339703|FIZZ|fizz
1615063|NCT00339690|Asthma|asthma
1615064|NCT00339690|Allergy|allergy
1615065|NCT00339690|Intervention|intervention
1615066|NCT00339690|Behaviors|behaviors
1615067|NCT00339690|Test-Kit|test-kit
1615068|NCT00339690|Dust Mites Allergen|dust mites allergen
1615069|NCT00339677|Measurement Error|measurement error
1615070|NCT00339677|Dietary Assessment|dietary assessment
1615071|NCT00339677|Dietary Intake|dietary intake
1615072|NCT00339677|Energy|energy
1615073|NCT00339677|Protein|protein
1615074|NCT00339664|Pharmacokinetics|pharmacokinetics
1615075|NCT00339664|Quantify|quantify
1615076|NCT00339664|HPLC|hplc
1615077|NCT00339664|LC/MS|lc/ms
1615078|NCT00339664|Pharmacodynamics|pharmacodynamics
1615079|NCT00339651|Precursors|precursors
1615080|NCT00339651|Endometrial Cancer|endometrial cancer
1615081|NCT00339651|Hyperplasia|hyperplasia
1615083|NCT00339638|Epidemiology|epidemiology
1615084|NCT00339638|Risk Prediction|risk prediction
1615085|NCT00339638|Biomarkers|biomarkers
1615086|NCT00339638|Nested Case Control|nested case control
1615087|NCT00339625|Intervention|intervention
1615088|NCT00339625|Diet|diet
1615089|NCT00339625|Colon|colon
1615090|NCT00339612|Perinatal|perinatal
1615091|NCT00339612|HIV|hiv
1615092|NCT00339612|AIDS|aids
1615093|NCT00339599|Atherosclerosis|atherosclerosis
1615094|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
1615095|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
1615096|NCT00339599|Inflammation|inflammation
1615097|NCT00339599|Eotaxin|eotaxin
1615098|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
1615099|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
1615100|NCT00339586|first-line treatment|first-line treatment
1615101|NCT00339586|mutant EGFR-gene|mutant egfr-gene
1615102|NCT00339573|Asthma|asthma
1615103|NCT00339573|Dust Mite|dust mite
1615104|NCT00339573|Cockroach|cockroach
1615105|NCT00339573|Lead Toxicity|lead toxicity
1615106|NCT00339573|Allergy|allergy
1615107|NCT00339560|Ampulla of Vater|ampulla of vater
1615108|NCT00339560|Gallbaldder|gallbaldder
1615109|NCT00339560|Cancer|cancer
1615110|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
1615111|NCT00339547|Leiomyomas|leiomyomas
1615112|NCT00339547|Ultrasound|ultrasound
1615113|NCT00339547|Hysterectomy|hysterectomy
1615114|NCT00339547|Epidemiology|epidemiology
1615115|NCT00339547|Hyperinsulinemia|hyperinsulinemia
1615116|NCT00339534|African Men|african men
1615117|NCT00339534|Case-Control Study|case-control study
1615118|NCT00339534|Prostate Cancer|prostate cancer
1615119|NCT00339534|Cancer|cancer
1615120|NCT00339521|Asthma|asthma
1615121|NCT00339521|Mexico|mexico
1615122|NCT00339521|Candidate Genes|candidate genes
1615123|NCT00339521|Triads|triads
1615124|NCT00339521|Polymorphism|polymorphism
1615125|NCT00339508|Linkage Analysis|linkage analysis
1615126|NCT00339508|Cancer Genetics|cancer genetics
1615127|NCT00339508|Software|software
1615128|NCT00339508|Bug Reports|bug reports
1615129|NCT00339508|Computer Programs|computer programs
1615130|NCT00339508|Data Analysis|data analysis
1615131|NCT00339495|Prostate|prostate
1615132|NCT00339495|Screening Trail|screening trail
1615133|NCT00339495|Ovarian|ovarian
1615134|NCT00339495|Lung|lung
1615135|NCT00339495|Colorectal|colorectal
1615136|NCT00339482|Epidemiology|epidemiology
1615137|NCT00339482|Type 2 Diabetes|type 2 diabetes
1615138|NCT00339482|Vascular Complications|vascular complications
1615139|NCT00339482|Retinopathy|retinopathy
1615140|NCT00339482|Nephropathy|nephropathy
1615141|NCT00339482|Genetics|genetics
1615142|NCT00339469|Prevention|prevention
1615143|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
1615144|NCT00339469|Insulin Resistance|insulin resistance
1615145|NCT00339469|Inflammation Obesity|inflammation obesity
1615146|NCT00339469|Adenoma|adenoma
1615147|NCT00339456|Therapy|therapy
1615148|NCT00339456|Africa|africa
1615149|NCT00339456|Structured|structured
1615150|NCT00339456|Interruption|interruption
1615151|NCT00339456|Antiretroviral|antiretroviral
1615152|NCT00339456|HIV|hiv
1615153|NCT00339443|Buccal Cells|buccal cells
1615154|NCT00339443|Concordance|concordance
1615155|NCT00339443|DNA Yields|dna yields
1615156|NCT00339443|pH Meter|ph meter
1615157|NCT00339443|Urine pH|urine ph
1615158|NCT00339443|Calibration|calibration
1615159|NCT00339430|Genotyping|genotyping
1615160|NCT00339430|HIV|hiv
1615161|NCT00339430|HPV|hpv
1615162|NCT00339430|HCV|hcv
1615163|NCT00339430|HBV|hbv
1615164|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
1615165|NCT00339417|Chemotherapy|chemotherapy
1615166|NCT00339404|Genotyping|genotyping
1615167|NCT00339404|Linkage Analysis|linkage analysis
1615168|NCT00339404|Cancer|cancer
1615169|NCT00339404|Hereditary Melanoma|hereditary melanoma
1615170|NCT00339391|Adjustment|adjustment
1615171|NCT00339391|Environmental Complexity|environmental complexity
1615172|NCT00339391|Mental Illness|mental illness
1615173|NCT00339391|Non-literate|non-literate
1615174|NCT00339391|West Africa|west africa
1615175|NCT00339391|Stress|stress
1615176|NCT00339391|Knowledge|knowledge
1615177|NCT00339391|Mental Health|mental health
1615178|NCT00339391|AIDS|aids
1615179|NCT00339378|Record Linkage|record linkage
1615180|NCT00339378|Retrospective|retrospective
1615181|NCT00339378|Cohort|cohort
1615182|NCT00339378|Registries|registries
1615183|NCT00339378|Agricultural|agricultural
1615184|NCT00339365|Infants|infants
1615185|NCT00339365|Toddlers|toddlers
1615186|NCT00339365|Attachment|attachment
1615187|NCT00339365|Maltreatment|maltreatment
1615188|NCT00339365|Foster Care|foster care
1615189|NCT00339352|Brain|brain
1615190|NCT00339352|Exposures|exposures
1615191|NCT00339352|Genetics|genetics
1615192|NCT00339352|Glioma|glioma
1615193|NCT00339352|Occupations|occupations
1615194|NCT00339339|Dental Materials|dental materials
1615195|NCT00339339|Resins|resins
1615196|NCT00339339|BisDMA|bisdma
1615199|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
1615200|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
1615201|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
1615202|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
1615204|NCT00339326|KS|ks
1615205|NCT00339313|Obesity|obesity
1615206|NCT00339313|Etiology|etiology
1615207|NCT00339313|Macronutrient Selection|macronutrient selection
1615208|NCT00339313|Taste Preference|taste preference
1615209|NCT00339313|Mixed Meal Test|mixed meal test
1615210|NCT00339300|Etiology|etiology
1615211|NCT00339300|Brain Cancer|brain cancer
1615212|NCT00339300|Epidemiology|epidemiology
1615213|NCT00339300|Brain Tumors|brain tumors
1615214|NCT00339300|Glioma|glioma
1615215|NCT00339287|Inflammation|inflammation
1615216|NCT00339287|Innate Immunity|innate immunity
1615217|NCT00339287|Macrophages|macrophages
1615218|NCT00339287|Neutrophils|neutrophils
1615219|NCT00339287|Pathogenesis|pathogenesis
1615220|NCT00339274|Repositories|repositories
1615221|NCT00339274|Pathology|pathology
1615222|NCT00339274|Belarus|belarus
1615223|NCT00339274|Russia|russia
1615224|NCT00339274|Ukraine|ukraine
1615225|NCT00339261|Cardiovascular|cardiovascular
1615226|NCT00339261|Renal|renal
1615227|NCT00339261|Autoimmune Disease|autoimmune disease
1615228|NCT00339261|Genetics|genetics
1615229|NCT00339261|Mortality|mortality
1615230|NCT00339248|Hyperplasia|hyperplasia
1615231|NCT00339248|Atypia|atypia
1615232|NCT00339248|Polymorphism|polymorphism
1615233|NCT00339248|Progression|progression
1615234|NCT00339248|Epidemiology|epidemiology
1615235|NCT00339235|Preterm Birth Prevention|preterm birth prevention
1615236|NCT00339235|Preterm Birth|preterm birth
1615237|NCT00339235|Pregnancy|pregnancy
1615238|NCT00339235|Pregnancy Complications|pregnancy complications
1615239|NCT00339222|Genetics|genetics
1615240|NCT00339222|Kindreds|kindreds
1615241|NCT00339222|Mediterranean Population|mediterranean population
1615242|NCT00339222|Nevi|nevi
1615243|NCT00339222|Pigmentation|pigmentation
1615244|NCT00339222|Melanoma-Prone Families|melanoma-prone families
1615245|NCT00339222|Sun Exposure|sun exposure
1615246|NCT00339222|Melanoma|melanoma
1615247|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
1615248|NCT00339209|Acute Rejection|acute rejection
1615249|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
1615250|NCT00339209|Transplant Rejection|transplant rejection
1615251|NCT00339209|Innate Immunity|innate immunity
1615252|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
1615253|NCT00339196|AML|aml
1615254|NCT00339196|MDS High risk|mds high risk
1615255|NCT00339196|Demethylating agents|demethylating agents
1615256|NCT00339196|HDAC Inhibitors|hdac inhibitors
1615257|NCT00339183|Oncology|oncology
1615258|NCT00339183|Cancer|cancer
1615259|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
1615260|NCT00339183|EGFr|egfr
1615261|NCT00339183|Panitumumab|panitumumab
1615262|NCT00339183|Clinical Trial|clinical trial
1615263|NCT00339183|Amgen|amgen
1615264|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
1615265|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
1615266|NCT00339170|Psychotic Disorders|psychotic disorders
1615267|NCT00339170|Cognition|cognition
1615268|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
1615269|NCT00339157|PEDIATRICS|pediatrics
1615270|NCT00339157|ORPHAN DISEASE|orphan disease
1615271|NCT00339157|INTERLEUKIN - 1|interleukin - 1
1615272|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
1615273|NCT00339157|ANTAGONISTS|antagonists
1615274|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
1615275|NCT00339131|radiopharmaceutical|radiopharmaceutical
1615276|NCT00339131|radiation dosimetry|radiation dosimetry
1615277|NCT00339131|iodine|iodine
1615278|NCT00339131|MIBG|mibg
1615279|NCT00339131|iobenguane|iobenguane
1615280|NCT00339131|Ultratrace|ultratrace
1615281|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
1615282|NCT00339105|Acute|acute
1615283|NCT00339105|Coronary|coronary
1615284|NCT00339105|Syndrome|syndrome
1615285|NCT00339105|HyperQ|hyperq
1615286|NCT00339105|High|high
1615287|NCT00339105|Frequency|frequency
1615288|NCT00339105|ECG|ecg
1615289|NCT00339105|chest|chest
1615290|NCT00339105|pain|pain
1615291|NCT00339092|HIV|hiv
1615292|NCT00339092|ART|art
1615293|NCT00339066|Late-Life Depression|late-life depression
1615294|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
1615295|NCT00339053|immunonutrition|immunonutrition
1615296|NCT00339053|respiratory failure|respiratory failure
1615297|NCT00339053|lenght of stay ICU|lenght of stay icu
1615298|NCT00339040|HPV|hpv
1615299|NCT00339027|child care centers|child care centers
1615300|NCT00339027|community based research|community based research
1615301|NCT00339027|behavioral health|behavioral health
1615302|NCT00339027|health literacy|health literacy
1615303|NCT00339027|unmet healthcare needs|unmet healthcare needs
1615304|NCT00339001|Erythropoietin|erythropoietin
1615305|NCT00339001|Iron|iron
1615306|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
1615307|NCT00338988|Gastrointestinal|gastrointestinal
1615308|NCT00338988|Capecitabine|capecitabine
1615309|NCT00338988|Oxaliplatin|oxaliplatin
1615310|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
1615311|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
1615312|NCT00338988|Xeloda|xeloda
1615313|NCT00338988|Eloxatin|eloxatin
1615314|NCT00338975|Psychotic Disorders|psychotic disorders
1615315|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
1615316|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
1615317|NCT00338975|Social Skills Training|social skills training
1615318|NCT00338962|SSRI|ssri
1615319|NCT00338962|treatment|treatment
1615320|NCT00338962|naltrexone|naltrexone
1615321|NCT00338962|alcohol dependence|alcohol dependence
1615322|NCT00338962|Desipramine|desipramine
1615323|NCT00338962|depression|depression
1615324|NCT00338962|PTSD|ptsd
1615325|NCT00338949|Ziprasidone|ziprasidone
1615326|NCT00338949|Olanzapine|olanzapine
1615327|NCT00338949|Risperidone|risperidone
1615328|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
1615329|NCT00338949|Insulin Sensitivity|insulin sensitivity
1615330|NCT00338949|Visceral Adiposity|visceral adiposity
1615331|NCT00338949|Metabolic Syndrome|metabolic syndrome
1615332|NCT00338936|Hypertension|hypertension
1615333|NCT00338936|Valsartan|valsartan
1615334|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
1615335|NCT00338910|healthy volunteers|healthy volunteers
1615336|NCT00338897|Venous Thromboembolism|venous thromboembolism
1615337|NCT00338897|Prevention|prevention
1615338|NCT00338897|Arthroplasty|arthroplasty
1615339|NCT00338897|Replacement|replacement
1615340|NCT00338897|Hip|hip
1615341|NCT00338897|orthopedic surgery|orthopedic surgery
1615342|NCT00338845|STDs|stds
1615343|NCT00338832|Lifestyle Intervention|lifestyle intervention
1615344|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
1615345|NCT00338819|DVT prevention|dvt prevention
1615346|NCT00338819|Hemodynamic study|hemodynamic study
1615347|NCT00338819|IPC|ipc
1615348|NCT00338819|CECT|cect
1615349|NCT00338806|Prevention|prevention
1615350|NCT00338806|Mood Disorders|mood disorders
1615351|NCT00338806|Unipolar Depression|unipolar depression
1615352|NCT00338793|Tuberculosis;|tuberculosis;
1615353|NCT00338793|Pleural effusion;|pleural effusion;
1615354|NCT00338793|Corticosteroids.|corticosteroids.
1615355|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
1615356|NCT00338780|Lamivudine|lamivudine
1615357|NCT00338780|HBeAg negative|hbeag negative
1615358|NCT00338767|AIDS|aids
1615359|NCT00338767|DOT|dot
1615360|NCT00338767|Directly Observed Therapy|directly observed therapy
1615361|NCT00338728|Breast Cancer|breast cancer
1615362|NCT00338728|Letrozole|letrozole
1615363|NCT00338728|Imatinib Mesylate|imatinib mesylate
1615364|NCT00338728|Gleevec|gleevec
1615366|NCT00338715|Effectiveness|effectiveness
1615367|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
1615368|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1615369|NCT00338715|Atrial Fibrillation|atrial fibrillation
1615370|NCT00338702|Diabetic|diabetic
1615371|NCT00338702|Foot|foot
1615372|NCT00338702|Ulcer|ulcer
1615373|NCT00338702|Autologous|autologous
1615374|NCT00338702|Platelet|platelet
1615375|NCT00338702|Gel|gel
1615376|NCT00338689|infant formula|infant formula
1615377|NCT00338689|protein content|protein content
1615378|NCT00338689|growth|growth
1615379|NCT00338689|obesity|obesity
1615380|NCT00338689|breast feeding|breast feeding
1615381|NCT00338676|Aortic stenosis|aortic stenosis
1615382|NCT00338676|Elderly|elderly
1615383|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1615384|NCT00338663|knee immobilization|knee immobilization
1615385|NCT00338663|postoperative pain|postoperative pain
1615386|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
1615387|NCT00338624|DITROPAN XL|ditropan xl
1615388|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
1615389|NCT00338611|vision therapy|vision therapy
1615390|NCT00338611|orthoptics|orthoptics
1615391|NCT00338611|pencil push-up therapy|pencil push-up therapy
1615392|NCT00338598|glycine|glycine
1615393|NCT00338598|treatment|treatment
1615394|NCT00338598|alcohol dependence|alcohol dependence
1615395|NCT00338598|schizophrenia|schizophrenia
1615397|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
1615398|NCT00338585|thrombolysis|thrombolysis
1615399|NCT00338585|blood clot|blood clot
1615400|NCT00338585|leg attack|leg attack
1615401|NCT00338585|alfimeprase|alfimeprase
1615402|NCT00338585|thrombus|thrombus
1615403|NCT00338585|embolism|embolism
1615404|NCT00338585|thromboembolism|thromboembolism
1615405|NCT00338585|claudication|claudication
1615406|NCT00338585|thrombolytic|thrombolytic
1615407|NCT00338585|thrombosis|thrombosis
1615408|NCT00338585|plasminogen activator|plasminogen activator
1615409|NCT00338585|arterial flow|arterial flow
1615410|NCT00338572|Inflammation|inflammation
1615411|NCT00338572|Blood Pressure, High|blood pressure, high
1615412|NCT00338559|Strabismus|strabismus
1615413|NCT00338559|LMA|lma
1615414|NCT00338559|ET Tube|et tube
1615415|NCT00338559|POV|pov
1615416|NCT00338546|Cocaine|cocaine
1615417|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
1615418|NCT00338546|Blood pressure|blood pressure
1615419|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
1615420|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
1615421|NCT00338533|childhood glaucoma|childhood glaucoma
1615422|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
1615423|NCT00338507|Chronic Bronchitis|chronic bronchitis
1615424|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1615425|NCT00338468|Anemia|anemia
1615426|NCT00338468|Elderly|elderly
1615427|NCT00338468|Hemoglobin level|hemoglobin level
1615428|NCT00338468|Chronic Kidney Disease|chronic kidney disease
1615429|NCT00338455|Congestive heart failure|congestive heart failure
1615430|NCT00338455|cardiac transplantation|cardiac transplantation
1615431|NCT00338455|renal insufficiency|renal insufficiency
1615432|NCT00338455|renal failure|renal failure
1615433|NCT00338455|dialysis|dialysis
1615434|NCT00338455|ultrafiltration|ultrafiltration
1615435|NCT00338455|vasodilator|vasodilator
1615436|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
1615437|NCT00338442|Immune compromised|immune compromised
1615537|NCT00338104|hospital|hospital
1615438|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
1615439|NCT00338442|Pediatric|pediatric
1615440|NCT00338429|sleep onset latency|sleep onset latency
1615441|NCT00338429|bedtime resistance|bedtime resistance
1615442|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
1615443|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
1615444|NCT00338416|Chemotherapy|chemotherapy
1615445|NCT00338416|Epoetin alfa|epoetin alfa
1615446|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
1615447|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
1615448|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
1615449|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
1615450|NCT00338390|Antiretrovirals|antiretrovirals
1615451|NCT00338390|CD4 cell count|cd4 cell count
1615452|NCT00338390|toxicity|toxicity
1615453|NCT00338377|Melanoma|melanoma
1615454|NCT00338377|Regional nodal disease|regional nodal disease
1615455|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
1615456|NCT00338377|Lymphodepletion|lymphodepletion
1615457|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
1615458|NCT00338377|T Cells|t cells
1615459|NCT00338377|Vaccine|vaccine
1615460|NCT00338377|Cyclosphosphamide|cyclosphosphamide
1615461|NCT00338377|Cytoxan|cytoxan
1615462|NCT00338377|Neosar|neosar
1615463|NCT00338377|Dendritic Cells|dendritic cells
1615464|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1615465|NCT00338377|TIL Cells|til cells
1615466|NCT00338377|MART Peptide|mart peptide
1615467|NCT00338377|Fludarabine|fludarabine
1615468|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
1615469|NCT00338377|Fludara|fludara
1615470|NCT00338377|Proleukin|proleukin
1615471|NCT00338377|IL-2|il-2
1615472|NCT00338377|Interleukin-2|interleukin-2
1615473|NCT00338377|Leptomeningeal disease|leptomeningeal disease
1615474|NCT00338364|Pediatric pain|pediatric pain
1615475|NCT00338364|Pediatric anxiety|pediatric anxiety
1615476|NCT00338364|Painful procedures|painful procedures
1615477|NCT00338338|essential hypertension|essential hypertension
1615478|NCT00338338|Amlodipine|amlodipine
1615479|NCT00338338|blood pressure|blood pressure
1615480|NCT00338338|lacidipine|lacidipine
1615481|NCT00338325|Pediatric Anxiety|pediatric anxiety
1615482|NCT00338325|Pediatric Pain|pediatric pain
1615483|NCT00338312|Natural Menopause|natural menopause
1615484|NCT00338312|HSDD|hsdd
1615485|NCT00338299|Anemia|anemia
1615486|NCT00338299|hemoglobin|hemoglobin
1615487|NCT00338299|chemotherapy|chemotherapy
1615488|NCT00338299|subcutaneous injection|subcutaneous injection
1615489|NCT00338299|Epoetin alfa|epoetin alfa
1615490|NCT00338286|anemia|anemia
1615491|NCT00338286|metastatic breast cancer|metastatic breast cancer
1615492|NCT00338286|Hemoglobin|hemoglobin
1615493|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
1615494|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
1615495|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
1615496|NCT00338247|advanced|advanced
1615497|NCT00338247|TYKERB|tykerb
1615498|NCT00338247|HER2 positive|her2 positive
1615499|NCT00338247|Stage IIIc|stage iiic
1615500|NCT00338247|ErbB2 positive|erbb2 positive
1615501|NCT00338247|GW572016|gw572016
1615502|NCT00338247|metastatic|metastatic
1615503|NCT00338247|Stage IIIb|stage iiib
1615504|NCT00338247|breast cancer|breast cancer
1615505|NCT00338234|anemia|anemia
1615506|NCT00338234|intensive care|intensive care
1615507|NCT00338234|cardiac surgery|cardiac surgery
1615508|NCT00338234|iron metabolism|iron metabolism
1615509|NCT00338234|hepcidin|hepcidin
1615510|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
1615511|NCT00338208|low vision|low vision
1615512|NCT00338208|glaucoma|glaucoma
1615513|NCT00338195|Caffeine dependence|caffeine dependence
1615514|NCT00338195|Caffeine withdrawal|caffeine withdrawal
1615515|NCT00338182|Solid tumor|solid tumor
1615516|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
1615517|NCT00338156|Collagen markers|collagen markers
1615518|NCT00338156|Neurohormones|neurohormones
1615519|NCT00338156|Cardiac MRI|cardiac mri
1615520|NCT00338143|Plaque psoriasis|plaque psoriasis
1615521|NCT00338143|Antipsoriatic|antipsoriatic
1615522|NCT00338130|Melanoma|melanoma
1615523|NCT00338130|Phase II|phase ii
1615524|NCT00338130|AZD6244|azd6244
1615525|NCT00338130|temozolomide|temozolomide
1615526|NCT00338117|Dementia|dementia
1615527|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
1615528|NCT00338117|impairment of memory|impairment of memory
1615529|NCT00338117|galantamine|galantamine
1615530|NCT00338117|galanthamine|galanthamine
1615531|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1615532|NCT00338117|Mini Mental State Examination score|mini mental state examination score
1615533|NCT00338104|insulin|insulin
1615534|NCT00338104|glargine|glargine
1615535|NCT00338104|intravenous|intravenous
1615536|NCT00338104|subcutaneous|subcutaneous
1615538|NCT00338104|diabetes|diabetes
1615539|NCT00338104|glucose|glucose
1615540|NCT00338104|inpatient|inpatient
1615541|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
1615542|NCT00338091|Disease Progression|disease progression
1615543|NCT00338091|Proteinuria|proteinuria
1615544|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
1615545|NCT00338091|Benazepril|benazepril
1615546|NCT00338091|Losartan|losartan
1615547|NCT00338065|Intraocular Pressure|intraocular pressure
1615548|NCT00338052|Contraception|contraception
1615549|NCT00338039|Pancreatic Cancer|pancreatic cancer
1615550|NCT00338039|Cetuximab|cetuximab
1615551|NCT00338039|C225|c225
1615552|NCT00338039|Erbitux|erbitux
1615553|NCT00338039|Gemcitabine|gemcitabine
1615554|NCT00338039|Oxaliplatin|oxaliplatin
1615555|NCT00338039|Eloxatin|eloxatin
1615556|NCT00338039|Capecitabine|capecitabine
1615557|NCT00338039|Xeloda|xeloda
1615558|NCT00338026|Solid Tumors|solid tumors
1615559|NCT00338026|Thallion|thallion
1615560|NCT00338026|TLN-4601|tln-4601
1615561|NCT00338026|Ecopia|ecopia
1615562|NCT00338026|ECO-4601|eco-4601
1615563|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
1615564|NCT00338026|High Grade Glioma|high grade glioma
1615565|NCT00338026|Colorectal|colorectal
1615566|NCT00338026|Lung|lung
1615567|NCT00338026|Breast|breast
1615568|NCT00338026|Ovarian|ovarian
1615569|NCT00338026|Pancreatic|pancreatic
1615570|NCT00338026|Prostate|prostate
1615571|NCT00338013|sleep|sleep
1615572|NCT00338000|Chronic renal failure|chronic renal failure
1615573|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
1615574|NCT00338000|epoetin alfa|epoetin alfa
1615575|NCT00337974|cognitive enhancement|cognitive enhancement
1615576|NCT00337974|memory|memory
1615577|NCT00337974|auditory memory|auditory memory
1615578|NCT00337974|speech|speech
1615579|NCT00337974|computerized|computerized
1615580|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
1615581|NCT00337948|Anemia|anemia
1615582|NCT00337948|Epoetin Alfa|epoetin alfa
1615583|NCT00337948|Chemotherapy|chemotherapy
1615584|NCT00337948|Anemia due to Cancer|anemia due to cancer
1615585|NCT00337935|Long Term Care Facilities|long term care facilities
1615586|NCT00337935|subcutaneous injections|subcutaneous injections
1615587|NCT00337935|PROCRIT|procrit
1615588|NCT00337935|Epoetin alfa|epoetin alfa
1615589|NCT00337935|Anemia|anemia
1615590|NCT00337922|EPZICOM|epzicom
1615591|NCT00337922|Lamivudine|lamivudine
1615592|NCT00337922|Abacavir|abacavir
1615593|NCT00337922|pharmacokinetics|pharmacokinetics
1615594|NCT00337922|Japanese|japanese
1615595|NCT00337909|cognitive enhancement|cognitive enhancement
1615596|NCT00337909|memory|memory
1615597|NCT00337909|auditory memory|auditory memory
1615598|NCT00337909|speech|speech
1615599|NCT00337909|computerized|computerized
1615600|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
1615601|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
1615602|NCT00337883|glioma|glioma
1615603|NCT00337883|Grade IV glioma|grade iv glioma
1615604|NCT00337870|Pediatric Anxiety|pediatric anxiety
1615605|NCT00337870|Pediatric Pain|pediatric pain
1615606|NCT00337870|Emergency room procedures|emergency room procedures
1615607|NCT00337818|Non-inferiority|non-inferiority
1615608|NCT00337818|Immunogenicity|immunogenicity
1615609|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
1615610|NCT00337805|colloid|colloid
1615611|NCT00337805|crystalloid|crystalloid
1615612|NCT00337805|hemodynamics|hemodynamics
1615613|NCT00337805|flow-directed|flow-directed
1615614|NCT00337805|resuscitation|resuscitation
1615615|NCT00337766|Blood Loss|blood loss
1615616|NCT00337766|Postoperative Blood loss|postoperative blood loss
1615617|NCT00337753|Gambling|gambling
1615618|NCT00337714|Central venous catheter,|central venous catheter,
1615619|NCT00337714|bloodstream infections,|bloodstream infections,
1615620|NCT00337714|intensive care unit|intensive care unit
1615621|NCT00337688|Cerebral Palsy|cerebral palsy
1615622|NCT00337688|Spasticity|spasticity
1615623|NCT00337688|Joystick|joystick
1615624|NCT00337688|Wheelchair|wheelchair
1615625|NCT00337688|rehabilitation|rehabilitation
1615626|NCT00337636|NCL|ncl
1615627|NCT00337636|INCL|incl
1615628|NCT00337636|LINCL|lincl
1615629|NCT00337636|Batten disease|batten disease
1615630|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
1615631|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
1615632|NCT00337623|Cataracts|cataracts
1615633|NCT00337623|Corticosteroids|corticosteroids
1615634|NCT00337623|Scheimpflug|scheimpflug
1615635|NCT00337623|Lens autofluorescence|lens autofluorescence
1615636|NCT00337597|Normal saline|normal saline
1615637|NCT00337597|Dextrose 5% in water|dextrose 5% in water
1615638|NCT00337597|neurostimulation|neurostimulation
1615639|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
1615640|NCT00337584|out patient surgery|out patient surgery
1615641|NCT00337584|quality improvement|quality improvement
1615642|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
1615643|NCT00337558|treatment outcomes|treatment outcomes
1615644|NCT00337558|Overactive bladder|overactive bladder
1615645|NCT00337558|Solifenacin succinate|solifenacin succinate
1615646|NCT00337558|urinary incontinence|urinary incontinence
1615647|NCT00337558|urge incontinence|urge incontinence
1615648|NCT00337558|frequency|frequency
1615649|NCT00337545|Metastatic|metastatic
1615650|NCT00337545|Refractory|refractory
1615651|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1615652|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
1615653|NCT00337519|alemtuzumab|alemtuzumab
1615654|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1615655|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
1615656|NCT00337506|Multiple Myeloma|multiple myeloma
1615657|NCT00337480|acute coronary syndrome|acute coronary syndrome
1615658|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
1615659|NCT00337480|smoking habits|smoking habits
1615660|NCT00337480|obesity|obesity
1615661|NCT00337480|sedentary lifestyle|sedentary lifestyle
1615662|NCT00337480|overweight|overweight
1615663|NCT00337480|education|education
1615664|NCT00337480|follow up after hospitalization|follow up after hospitalization
1615665|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
1615666|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
1615667|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
1615668|NCT00337441|Chronic Anemia|chronic anemia
1615669|NCT00337441|Anemia|anemia
1615670|NCT00337441|Chronic Diseases|chronic diseases
1615671|NCT00337441|Elderly|elderly
1615672|NCT00337441|Epoetin alfa|epoetin alfa
1615673|NCT00337441|Fatigue|fatigue
1615674|NCT00337441|Quality of life|quality of life
1615675|NCT00337441|Mobility|mobility
1615676|NCT00337402|Gastrostomy|gastrostomy
1615677|NCT00337402|Quality of life|quality of life
1615678|NCT00337389|Metastatic|metastatic
1615679|NCT00337389|Colorectal|colorectal
1615680|NCT00337389|Cancer|cancer
1615681|NCT00337389|CoFactor|cofactor
1615682|NCT00337389|Stage IV|stage iv
1615683|NCT00337350|Schizophrenia|schizophrenia
1615684|NCT00337350|Glucose Metabolism|glucose metabolism
1615685|NCT00337350|Insulin Resistance|insulin resistance
1615686|NCT00337337|Diabetes|diabetes
1615687|NCT00337337|rice|rice
1615688|NCT00337337|fiber|fiber
1615689|NCT00337324|Diabetic neuropathy|diabetic neuropathy
1615690|NCT00337324|Complications of diabetes|complications of diabetes
1615691|NCT00337324|Neuropathies|neuropathies
1615692|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
1615693|NCT00337324|Neuropathic pain|neuropathic pain
1615694|NCT00337298|Diabetes|diabetes
1615695|NCT00337298|Retinopathy|retinopathy
1615696|NCT00337298|Blood Pressure|blood pressure
1615697|NCT00337298|Amlodipine|amlodipine
1615698|NCT00337298|Lisinopril|lisinopril
1615699|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1615700|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1615701|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
1615702|NCT00337272|chronic insomnia|chronic insomnia
1615703|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
1615704|NCT00337259|gemcitabine|gemcitabine
1615705|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1615706|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1615707|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1615708|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1615709|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1615710|NCT00337233|fatigue|fatigue
1615711|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1615712|NCT00337233|recurrent breast cancer|recurrent breast cancer
1615713|NCT00337233|stage I breast cancer|stage i breast cancer
1615714|NCT00337233|stage II breast cancer|stage ii breast cancer
1615715|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
1615716|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
1615717|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
1615718|NCT00337233|stage IV breast cancer|stage iv breast cancer
1615719|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1615720|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1615721|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1615722|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1615723|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1615724|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1615725|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1615726|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1615727|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1615728|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1615729|NCT00337220|allograft|allograft
1615730|NCT00337220|graft|graft
1615731|NCT00337207|adult glioblastoma|adult glioblastoma
1615732|NCT00337207|adult gliosarcoma|adult gliosarcoma
1615733|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
1615734|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1615735|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
1615736|NCT00337181|HIV-1|hiv-1
1615737|NCT00337181|Natural History|natural history
1615738|NCT00337181|HIV vaccine|hiv vaccine
1615739|NCT00337181|Thailand|thailand
1615740|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1615741|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1615742|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1615743|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1615744|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1615745|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
1615746|NCT00337155|metastatic Cancer|metastatic cancer
1615747|NCT00337142|gestational diabetes|gestational diabetes
1615748|NCT00337142|newborn|newborn
1615749|NCT00337142|hypoglycemia|hypoglycemia
1615750|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1615751|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1615752|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1615753|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1615754|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1615755|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1615756|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1615757|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1615758|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1615870|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
1615759|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1615760|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1615761|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1615762|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1615763|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1615764|NCT00337090|Over Active Bladder|over active bladder
1615765|NCT00337090|Urinary incontinence|urinary incontinence
1615766|NCT00337090|YM178|ym178
1615767|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
1615768|NCT00337077|Eribulin Mesylate|eribulin mesylate
1615769|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
1615770|NCT00337077|Halichondrin B Analog|halichondrin b analog
1615771|NCT00337064|Breast cancer treatment|breast cancer treatment
1615772|NCT00337064|Partial breast radiation|partial breast radiation
1615773|NCT00337064|Radiation Therapy|radiation therapy
1615774|NCT00337064|Adjuvant Treatment|adjuvant treatment
1615775|NCT00337051|Renal transplantation|renal transplantation
1615776|NCT00337051|renal allograft|renal allograft
1615777|NCT00337051|end-stage renal disease|end-stage renal disease
1615778|NCT00337051|renal failure|renal failure
1615779|NCT00337051|general anaesthesia|general anaesthesia
1615780|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
1615781|NCT00337051|Sevoflurane|sevoflurane
1615782|NCT00337051|ischemia|ischemia
1615783|NCT00337051|reperfusion|reperfusion
1615784|NCT00337051|ischemic lesions|ischemic lesions
1615785|NCT00336973|Plaque Psoriasis|plaque psoriasis
1615786|NCT00336973|Raptiva|raptiva
1615787|NCT00336973|Anti-TNF|anti-tnf
1615788|NCT00336960|stage II rectal cancer|stage ii rectal cancer
1615789|NCT00336960|stage III rectal cancer|stage iii rectal cancer
1615790|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1615791|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1615792|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1615793|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1615794|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1615795|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1615796|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1615797|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1615798|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1615799|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1615894|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
1615800|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1615801|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1615802|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
1615803|NCT00336934|stage I prostate cancer|stage i prostate cancer
1615804|NCT00336934|stage II prostate cancer|stage ii prostate cancer
1615805|NCT00336934|stage III prostate cancer|stage iii prostate cancer
1615806|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
1615807|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
1615808|NCT00336908|Parenteral nutrition|parenteral nutrition
1615809|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
1615810|NCT00336895|Liver transplantation|liver transplantation
1615811|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
1615812|NCT00336895|gastrointestinal|gastrointestinal
1615813|NCT00336895|adverse effects|adverse effects
1615814|NCT00336882|traumatic brain injury|traumatic brain injury
1615815|NCT00336882|propofol|propofol
1615816|NCT00336882|oxidative stress|oxidative stress
1615817|NCT00336882|microdialysis|microdialysis
1615818|NCT00336856|Colon Cancer|colon cancer
1615819|NCT00336843|Zevalin|zevalin
1615820|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
1615821|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
1615822|NCT00336843|BuCyE regimen|bucye regimen
1615823|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
1615824|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
1615825|NCT00336830|coronary angioplasty|coronary angioplasty
1615826|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
1615827|NCT00336817|Liver transplantation|liver transplantation
1615828|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
1615829|NCT00336817|gastrointestinal|gastrointestinal
1615830|NCT00336817|adverse effects|adverse effects
1615831|NCT00336791|Breast Cancer|breast cancer
1615832|NCT00336791|Gene Expression|gene expression
1615833|NCT00336791|Fluorouracil|fluorouracil
1615834|NCT00336791|Cyclophosphamide|cyclophosphamide
1615835|NCT00336791|Doxorubicin|doxorubicin
1615836|NCT00336791|Paclitaxel|paclitaxel
1615837|NCT00336765|solid tumors|solid tumors
1615838|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
1615839|NCT00336752|operative intervention|operative intervention
1615840|NCT00336752|non operative intervention|non operative intervention
1615841|NCT00336739|Gastric acidity determination|gastric acidity determination
1615842|NCT00336739|Calcium sensing receptor|calcium sensing receptor
1615843|NCT00336713|depression|depression
1615844|NCT00336713|antidepressive agents|antidepressive agents
1615845|NCT00336713|controlled clinical trial|controlled clinical trial
1615846|NCT00336700|Pancreas|pancreas
1615847|NCT00336700|Cancer|cancer
1615848|NCT00336700|Pancreatic|pancreatic
1615849|NCT00336687|Thrombopenia|thrombopenia
1615850|NCT00336687|Reanimation|reanimation
1615851|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
1615852|NCT00336674|Type 1 diabetes|type 1 diabetes
1615853|NCT00336661|Periodontitis|periodontitis
1615854|NCT00336661|Chronic Periodontitis|chronic periodontitis
1615855|NCT00336661|Gingivitis|gingivitis
1615856|NCT00336661|PERIOWAVE|periowave
1615857|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
1615858|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
1615859|NCT00336648|Bevacizumab|bevacizumab
1615860|NCT00336648|Gemcitabine|gemcitabine
1615861|NCT00336648|Radiation Therapy|radiation therapy
1615862|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
1615863|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
1615864|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
1615865|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
1615866|NCT00336622|Splints|splints
1615867|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
1615868|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
1615869|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
1615871|NCT00336583|oxaliplatin|oxaliplatin
1615872|NCT00336583|ESHAOX|eshaox
1615873|NCT00336583|refractory|refractory
1615874|NCT00336583|relapsed|relapsed
1615875|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
1615876|NCT00336570|Oxidative Stress|oxidative stress
1615877|NCT00336570|Endothelial Function|endothelial function
1615878|NCT00336570|Flow Mediated Dilation|flow mediated dilation
1615879|NCT00336557|High-Dose Interferon|high-dose interferon
1615880|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
1615881|NCT00336544|Pneumonia|pneumonia
1615882|NCT00336544|Respiratory|respiratory
1615883|NCT00336544|Infection|infection
1615884|NCT00336544|Infectious|infectious
1615885|NCT00336544|Advanced|advanced
1615886|NCT00336544|Life|life
1615887|NCT00336544|Sciences|sciences
1615888|NCT00336544|Lung|lung
1615889|NCT00336544|Pulmonary|pulmonary
1615890|NCT00336544|Cethromycin|cethromycin
1615891|NCT00336544|Clarithromycin|clarithromycin
1615892|NCT00336544|Biaxin|biaxin
1615893|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
1616086|NCT00335621|COPD|copd
1615895|NCT00336531|Embryonal brain tumor|embryonal brain tumor
1615896|NCT00336505|Pneumonia|pneumonia
1615897|NCT00336505|Respiratory|respiratory
1615898|NCT00336505|Infection|infection
1615899|NCT00336505|Infectious|infectious
1615900|NCT00336505|Advanced|advanced
1615901|NCT00336505|Life|life
1615902|NCT00336505|Sciences|sciences
1615903|NCT00336505|Lung|lung
1615904|NCT00336505|Pulmonary|pulmonary
1615905|NCT00336505|Cethromycin|cethromycin
1615906|NCT00336505|Restanza|restanza
1615907|NCT00336505|Clarithromycin|clarithromycin
1615908|NCT00336505|Biaxin|biaxin
1615909|NCT00336492|Ulcerative colitis|ulcerative colitis
1615910|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
1615911|NCT00336492|children|children
1615912|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
1615913|NCT00336453|Influenza|influenza
1615914|NCT00336427|MRSA|mrsa
1615915|NCT00336427|Colonization|colonization
1615916|NCT00336427|Pregnancy|pregnancy
1615917|NCT00336427|Neonates|neonates
1615918|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
1615919|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
1615920|NCT00336414|cyclophosphamide|cyclophosphamide
1615921|NCT00336414|prednisone|prednisone
1615922|NCT00336414|azathioprine|azathioprine
1615923|NCT00336414|methylprednisolone|methylprednisolone
1615924|NCT00336401|anesthesia|anesthesia
1615925|NCT00336401|non cardiac surgery|non cardiac surgery
1615926|NCT00336401|cardiac outcomes|cardiac outcomes
1615927|NCT00336388|Malaria|malaria
1615928|NCT00336362|Beta Thalassemia Major|beta thalassemia major
1615929|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
1615930|NCT00336362|Gene Transfer Techniques|gene transfer techniques
1615931|NCT00336349|diabetes mellitus|diabetes mellitus
1615932|NCT00336349|neuropathic pain|neuropathic pain
1615933|NCT00336323|diabetic|diabetic
1615934|NCT00336323|macular|macular
1615935|NCT00336323|edema|edema
1615936|NCT00336323|avastin|avastin
1615937|NCT00336323|bevacizumab|bevacizumab
1615938|NCT00336323|anti-VEGF|anti-vegf
1615939|NCT00336323|retinal thickness|retinal thickness
1615940|NCT00336323|visual acuity|visual acuity
1615941|NCT00336323|DME|dme
1615942|NCT00336310|Diabetes Mellitus|diabetes mellitus
1615943|NCT00336310|Treatment|treatment
1615944|NCT00336310|Repaglinide|repaglinide
1615945|NCT00336297|screening|screening
1615946|NCT00336297|screening methods|screening methods
1615947|NCT00336297|intimate partner violence|intimate partner violence
1615948|NCT00336284|Telemonitoring|telemonitoring
1615949|NCT00336284|ICD|icd
1615950|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
1615951|NCT00336271|coffee|coffee
1615952|NCT00336271|caffeine|caffeine
1615953|NCT00336271|healthy subjects|healthy subjects
1615954|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
1615955|NCT00336258|Cancer|cancer
1615956|NCT00336258|US- Doppler|us- doppler
1615957|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
1615958|NCT00336258|Asymptomatic|asymptomatic
1615959|NCT00336245|Contraception|contraception
1615960|NCT00336245|Women|women
1615961|NCT00336245|HIV/AIDS|hiv/aids
1615962|NCT00336245|IUD|iud
1615963|NCT00336245|IUCD|iucd
1615964|NCT00336232|Vitamin K metabolism|vitamin k metabolism
1615965|NCT00336232|Bone health|bone health
1615966|NCT00336232|Metabolism|metabolism
1615967|NCT00336219|GERD|gerd
1615968|NCT00336219|Pantoprazole|pantoprazole
1615969|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
1615970|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1615971|NCT00336206|B-Cell|b-cell
1615972|NCT00336193|home visitation|home visitation
1615973|NCT00336193|family outcomes|family outcomes
1615974|NCT00336193|competency training|competency training
1615975|NCT00336180|Adolescent|adolescent
1615976|NCT00336180|Adolescent behavior|adolescent behavior
1615977|NCT00336180|Adolescent development|adolescent development
1615978|NCT00336180|Drinking behavior|drinking behavior
1615979|NCT00336180|Health behavior|health behavior
1615980|NCT00336180|Reproductive Behavior|reproductive behavior
1615981|NCT00336180|Sexual Behavior|sexual behavior
1615982|NCT00336180|South Africa|south africa
1615983|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
1615984|NCT00336167|Fatty acid oxidation|fatty acid oxidation
1615985|NCT00336167|Mitochondria|mitochondria
1615986|NCT00336128|infant|infant
1615987|NCT00336128|kindergarten|kindergarten
1615988|NCT00336128|obesity|obesity
1615989|NCT00336128|adiposity|adiposity
1615990|NCT00336115|pertussis|pertussis
1615991|NCT00336115|bone marrow transplant|bone marrow transplant
1615992|NCT00336102|fatigue|fatigue
1615993|NCT00336102|hypothyroidism|hypothyroidism
1615994|NCT00336102|stage I breast cancer|stage i breast cancer
1615995|NCT00336102|stage II breast cancer|stage ii breast cancer
1615996|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
1615997|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
1615998|NCT00336089|fatigue|fatigue
1615999|NCT00336089|pain|pain
1616000|NCT00336089|cancer survivor|cancer survivor
1616001|NCT00336089|breast cancer in situ|breast cancer in situ
1616002|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
1616003|NCT00336089|stage IA breast cancer|stage ia breast cancer
1616004|NCT00336089|stage IB breast cancer|stage ib breast cancer
1616005|NCT00336089|stage II breast cancer|stage ii breast cancer
1616006|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
1616007|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
1616008|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
1616009|NCT00336089|stage IV breast cancer|stage iv breast cancer
1616010|NCT00336089|recurrent breast cancer|recurrent breast cancer
1616011|NCT00336076|Mast cell disease|mast cell disease
1616012|NCT00336076|Anaphylaxis|anaphylaxis
1616013|NCT00336076|c-kit|c-kit
1616014|NCT00336076|Mutation|mutation
1616015|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
1616016|NCT00336050|Air Pollution|air pollution
1616017|NCT00336050|Pulmonary Function|pulmonary function
1616018|NCT00336011|pacemaker|pacemaker
1616019|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
1616020|NCT00336011|safety|safety
1616021|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
1616022|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
1616023|NCT00335985|Venoglobulin-IH|venoglobulin-ih
1616024|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
1616025|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
1616026|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1616027|NCT00335959|stage I gastric cancer|stage i gastric cancer
1616028|NCT00335959|stage II gastric cancer|stage ii gastric cancer
1616029|NCT00335959|stage III gastric cancer|stage iii gastric cancer
1616030|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
1616031|NCT00335920|Sudden Hearing Loss|sudden hearing loss
1616032|NCT00335920|intratympanic|intratympanic
1616033|NCT00335920|steroids|steroids
1616034|NCT00335907|Clinical trial|clinical trial
1616035|NCT00335907|Controlled clinical trial|controlled clinical trial
1616036|NCT00335907|Shock, Septic|shock, septic
1616037|NCT00335894|Infertility|infertility
1616038|NCT00335894|IVF|ivf
1616039|NCT00335894|ART|art
1616040|NCT00335894|hMG|hmg
1616041|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
1616042|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1616043|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1616044|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1616045|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1616046|NCT00335855|Device, influenza|device, influenza
1616047|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1616048|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1616049|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
1616050|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1616051|NCT00335816|stage II rectal cancer|stage ii rectal cancer
1616052|NCT00335816|stage III rectal cancer|stage iii rectal cancer
1616053|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1616054|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1616055|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1616056|NCT00335751|localized osteosarcoma|localized osteosarcoma
1616057|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
1616058|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
1616236|NCT00334971|estradiol|estradiol
1616059|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1616060|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1616061|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1616062|NCT00335725|Ovarian stimulation|ovarian stimulation
1616063|NCT00335725|Infertility|infertility
1616064|NCT00335725|ICSI|icsi
1616065|NCT00335725|FSH|fsh
1616066|NCT00335712|ONO-5129|ono-5129
1616067|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
1616068|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
1616069|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
1616070|NCT00335686|Lopinavir-rtv|lopinavir-rtv
1616071|NCT00335686|Nevirapine|nevirapine
1616072|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
1616073|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
1616074|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
1616075|NCT00335660|Neurokinin|neurokinin
1616076|NCT00335660|Urge Incontinence|urge incontinence
1616077|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
1616078|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
1616079|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
1616080|NCT00335634|Prostate Cancer|prostate cancer
1616081|NCT00335634|Radical Prostatectomy|radical prostatectomy
1616082|NCT00335634|Sexual Dysfunction|sexual dysfunction
1616083|NCT00335634|Intimacy|intimacy
1616084|NCT00335634|Adaptation|adaptation
1616085|NCT00335634|Psychosocial Oncology|psychosocial oncology
1616087|NCT00335621|ipratropium|ipratropium
1616088|NCT00335621|tiotropium|tiotropium
1616089|NCT00335595|colorectal cancer|colorectal cancer
1616090|NCT00335595|Bevacizumab|bevacizumab
1616091|NCT00335595|capecitabine|capecitabine
1616092|NCT00335595|oxaliplatin|oxaliplatin
1616093|NCT00335582|alpha 2 agonists|alpha 2 agonists
1616094|NCT00335582|cardiac events|cardiac events
1616095|NCT00335582|non cardiac surgery|non cardiac surgery
1616096|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
1616097|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1616098|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
1616099|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
1616100|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
1616101|NCT00335517|Lumbar surgery|lumbar surgery
1616102|NCT00335517|Surgery L3-S1|surgery l3-s1
1616103|NCT00335517|DepoDur|depodur
1616104|NCT00335517|Post-operative pain|post-operative pain
1616105|NCT00335517|Pain control|pain control
1616106|NCT00335517|Pain relief|pain relief
1616107|NCT00335491|small cell lung cancer|small cell lung cancer
1616108|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
1616109|NCT00335491|colon cancer|colon cancer
1616110|NCT00335491|prostate cancer|prostate cancer
1616111|NCT00335491|breast cancer|breast cancer
1616112|NCT00335491|male breast cancer|male breast cancer
1616113|NCT00335491|fatigue|fatigue
1616114|NCT00335491|lymphoma|lymphoma
1616115|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
1616116|NCT00335491|bladder cancer|bladder cancer
1616117|NCT00335491|esophageal cancer|esophageal cancer
1616118|NCT00335478|neutropenia|neutropenia
1616119|NCT00335478|infection|infection
1616120|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1616121|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1616122|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
1616123|NCT00335452|acute coronary disease|acute coronary disease
1616124|NCT00335452|percutaneous coronary|percutaneous coronary
1616125|NCT00335413|Renal autoregulation|renal autoregulation
1616126|NCT00335413|Glomerular filtration rate|glomerular filtration rate
1616127|NCT00335413|Type 1 diabetes|type 1 diabetes
1616128|NCT00335374|Parkinson's disease|parkinson's disease
1616129|NCT00335361|Male Contraceptive Devices|male contraceptive devices
1616130|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
1616131|NCT00335361|Male Sterilization|male sterilization
1616132|NCT00335361|Vasectomy|vasectomy
1616133|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
1616134|NCT00335361|Vas Occlusion|vas occlusion
1616135|NCT00335348|Multiple Myeloma|multiple myeloma
1616136|NCT00335348|Relapse|relapse
1616137|NCT00335348|Bortezomib|bortezomib
1616138|NCT00335348|Dexamethasone|dexamethasone
1616139|NCT00335348|Maintenance|maintenance
1616140|NCT00335335|Coronary|coronary
1616141|NCT00335335|Angiography|angiography
1616142|NCT00335335|X-ray|x-ray
1616143|NCT00335335|CAD|cad
1616144|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1616145|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
1616146|NCT00335309|sinus irrigation|sinus irrigation
1616147|NCT00335296|PFO|pfo
1616148|NCT00335296|Migraine|migraine
1616149|NCT00335296|Stroke|stroke
1616150|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
1616151|NCT00335296|Decompression Illness|decompression illness
1616152|NCT00335270|HIV Type 1|hiv type 1
1616153|NCT00335257|Drospirenone|drospirenone
1616154|NCT00335257|Safety|safety
1616155|NCT00335257|INAS|inas
1616156|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
1616157|NCT00335218|Early postmenopausal state|early postmenopausal state
1616158|NCT00335218|Climacteric symptoms|climacteric symptoms
1616159|NCT00335218|Hormone replacement therapy|hormone replacement therapy
1616160|NCT00335205|ropinirole|ropinirole
1616161|NCT00335205|dopamine|dopamine
1616162|NCT00335205|D2|d2
1616163|NCT00335205|depression|depression
1616164|NCT00335205|bipolar|bipolar
1616165|NCT00335192|Intracellular concentrations|intracellular concentrations
1616166|NCT00335192|Plasma concentration|plasma concentration
1616167|NCT00335192|Abacavir|abacavir
1616168|NCT00335192|Tenofovir|tenofovir
1616169|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
1616170|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
1616171|NCT00335179|Actinic keratosis|actinic keratosis
1616172|NCT00335179|AK|ak
1616173|NCT00335179|imiquimod|imiquimod
1616174|NCT00335179|confocal microscopy|confocal microscopy
1616175|NCT00335179|gene microarray|gene microarray
1616176|NCT00335166|Parkinson Disease|parkinson disease
1616177|NCT00335153|severe motor fluctuations|severe motor fluctuations
1616178|NCT00335153|levodopa|levodopa
1616179|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
1616180|NCT00335153|efficacy|efficacy
1616181|NCT00335153|dyskinesia|dyskinesia
1616182|NCT00335153|Parkinson's Disease|parkinson's disease
1616183|NCT00335153|carbidopa|carbidopa
1616184|NCT00335153|DUOPA|duopa
1616185|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1616186|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
1616187|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
1616188|NCT00335088|Prophylaxis,|prophylaxis,
1616189|NCT00335088|Intraocular surgery|intraocular surgery
1616190|NCT00335088|Lacrimal sac|lacrimal sac
1616191|NCT00335088|Eye lid|eye lid
1616192|NCT00335088|No conditions|no conditions
1616193|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
1616194|NCT00335062|Children and Adolescents|children and adolescents
1616195|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
1616196|NCT00335049|myopia progression|myopia progression
1616197|NCT00335049|bifocal|bifocal
1616198|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1616199|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
1616200|NCT00335036|Sudden Cardiac Death|sudden cardiac death
1616201|NCT00335036|Congenital Heart Disease|congenital heart disease
1616202|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
1616203|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
1616204|NCT00335023|red blood cell transfusion|red blood cell transfusion
1616205|NCT00335023|health related quality of life|health related quality of life
1616206|NCT00335010|Nitroglycerine|nitroglycerine
1616207|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
1616208|NCT00335010|microvascular bloodflow|microvascular bloodflow
1616209|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
1616480|NCT00334100|Exercise|exercise
1616210|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1616211|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1616212|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1616213|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
1616214|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1616215|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
1616216|NCT00334984|chondrosarcoma|chondrosarcoma
1616217|NCT00334984|localized osteosarcoma|localized osteosarcoma
1616218|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
1616219|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1616220|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1616221|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1616222|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1616223|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1616224|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1616225|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1616226|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
1616227|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
1616228|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
1616229|NCT00334984|childhood liposarcoma|childhood liposarcoma
1616230|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
1616231|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
1616232|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1616233|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
1616234|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1616235|NCT00334971|African-American|african-american
1616237|NCT00334971|luteinizing hormone|luteinizing hormone
1616238|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
1616239|NCT00334971|androstenedione|androstenedione
1616240|NCT00334971|aromatase|aromatase
1616241|NCT00334971|inhibins|inhibins
1616242|NCT00334971|ovarian|ovarian
1616243|NCT00334971|Healthy volunteers|healthy volunteers
1616244|NCT00334971|Fragile X|fragile x
1616245|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
1616246|NCT00334945|Bone development|bone development
1616247|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
1616248|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
1616249|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
1616250|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
1616251|NCT00334919|Diabetes|diabetes
1616252|NCT00334919|Pre-Diabetes|pre-diabetes
1616253|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
1616254|NCT00334919|Diet Study|diet study
1616255|NCT00334919|Inflammation|inflammation
1616256|NCT00334919|Diabetic Diet|diabetic diet
1616257|NCT00334906|memantine|memantine
1616258|NCT00334906|Alzheimer's disease|alzheimer's disease
1616260|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
1616261|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1616262|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1616263|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
1616352|NCT00334516|PLS|pls
1616353|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1616264|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1616265|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
1616266|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1616267|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1616268|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
1616269|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
1616270|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
1616271|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
1616272|NCT00334854|childhood liposarcoma|childhood liposarcoma
1616273|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1616274|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
1616275|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
1616276|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
1616277|NCT00334854|chondrosarcoma|chondrosarcoma
1616278|NCT00334828|Severe sepsis|severe sepsis
1616279|NCT00334828|septic shock|septic shock
1616280|NCT00334828|sepsis|sepsis
1616281|NCT00334776|recurrent melanoma|recurrent melanoma
1616282|NCT00334776|stage IV melanoma|stage iv melanoma
1616283|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1616284|NCT00334776|iris melanoma|iris melanoma
1616285|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
1616286|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
1616287|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1616288|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1616289|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1616290|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
1616291|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
1616292|NCT00334737|erythropoietin|erythropoietin
1616293|NCT00334737|darbepoetin|darbepoetin
1616294|NCT00334737|transfusions|transfusions
1616295|NCT00334737|neonates|neonates
1616296|NCT00334737|outcomes|outcomes
1616297|NCT00334737|neurodevelopment|neurodevelopment
1616298|NCT00334724|Cardiovascular disease|cardiovascular disease
1616299|NCT00334724|Vascular disease|vascular disease
1616300|NCT00334724|Hypertension|hypertension
1616301|NCT00334724|Home blood pressure measurement|home blood pressure measurement
1616302|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
1616303|NCT00334711|Kir6.2|kir6.2
1616304|NCT00334711|KCNJ11|kcnj11
1616305|NCT00334711|Infancy onset diabetes|infancy onset diabetes
1616306|NCT00334711|Sulfonylurea|sulfonylurea
1616307|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1616308|NCT00334659|HIV-1 Infection|hiv-1 infection
1616309|NCT00334646|cyclophosphamide|cyclophosphamide
1616310|NCT00334646|CINV|cinv
1616311|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
1616312|NCT00334633|bacterial vaginosis|bacterial vaginosis
1616313|NCT00334633|tinidazole|tinidazole
1616314|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
1616315|NCT00334620|rehabilitation|rehabilitation
1616316|NCT00334620|radon spa therapy|radon spa therapy
1616317|NCT00334620|long-term effectiveness|long-term effectiveness
1616318|NCT00334607|HRV vaccine|hrv vaccine
1616319|NCT00334607|diarrhoea|diarrhoea
1616320|NCT00334607|rotavirus|rotavirus
1616321|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
1616322|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
1616323|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1616324|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1616325|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
1616326|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
1616327|NCT00334568|AVANDIA|avandia
1616328|NCT00334568|Alzheimers Disease|alzheimers disease
1616329|NCT00334555|trichomoniasis|trichomoniasis
1616330|NCT00334555|partner notification|partner notification
1616331|NCT00334542|breast cancer|breast cancer
1616332|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1616333|NCT00334542|breast cancer in situ|breast cancer in situ
1616334|NCT00334542|stage I breast cancer|stage i breast cancer
1616335|NCT00334542|stage II breast cancer|stage ii breast cancer
1616336|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
1616337|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
1616338|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
1616339|NCT00334529|Tamiflu|tamiflu
1616340|NCT00334529|Flu|flu
1616341|NCT00334529|Antiviral|antiviral
1616342|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
1616343|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
1616344|NCT00334529|Healthy Volunteer|healthy volunteer
1616345|NCT00334529|HV|hv
1616346|NCT00334516|Motor Neuron Disease|motor neuron disease
1616347|NCT00334516|Cognitive Testing|cognitive testing
1616348|NCT00334516|Movement-Related Potential|movement-related potential
1616349|NCT00334516|MRI|mri
1616350|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
1616351|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
1616354|NCT00334516|ALS|als
1616355|NCT00334516|Healthy Volunteer|healthy volunteer
1616356|NCT00334516|HV|hv
1616357|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
1616358|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
1616359|NCT00334490|Sildenafil|sildenafil
1616360|NCT00334490|Viagra|viagra
1616361|NCT00334490|Cardiac Surgery|cardiac surgery
1616362|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
1616363|NCT00334477|erectile dysfunction|erectile dysfunction
1616364|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
1616365|NCT00334477|tadalafil|tadalafil
1616366|NCT00334464|warfarin metabolism|warfarin metabolism
1616367|NCT00334464|CYP2C0|cyp2c0
1616368|NCT00334464|anticoagulation|anticoagulation
1616369|NCT00334464|genotyping|genotyping
1616370|NCT00334464|DVT|dvt
1616371|NCT00334464|PE|pe
1616372|NCT00334451|Heart Failure|heart failure
1616373|NCT00334451|Remote Monitoring|remote monitoring
1616374|NCT00334451|Implantable Device|implantable device
1616375|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1616376|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1616377|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1616378|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1616379|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1616380|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
1616768|NCT00332813|Drug Abuse|drug abuse
1616381|NCT00334386|Hypertension|hypertension
1616382|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
1616383|NCT00334386|Diuretic|diuretic
1616384|NCT00334373|Myocardial infarction|myocardial infarction
1616385|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
1616386|NCT00334373|Coronary Angioplasty|coronary angioplasty
1616387|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
1616388|NCT00334321|IMRT|imrt
1616389|NCT00334321|Tomotherapy|tomotherapy
1616390|NCT00334321|Post-Hysterectomy|post-hysterectomy
1616391|NCT00334321|Endometrial Cancer|endometrial cancer
1616392|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
1616393|NCT00334282|Metastatic|metastatic
1616394|NCT00334282|Anti-angiogenesis|anti-angiogenesis
1616395|NCT00334282|GW786034|gw786034
1616396|NCT00334282|Pazopanib|pazopanib
1616397|NCT00334269|obesity|obesity
1616398|NCT00334269|physical activity|physical activity
1616399|NCT00334269|daily energy intake|daily energy intake
1616400|NCT00334269|nutrition|nutrition
1616401|NCT00334269|healthy lifestyle|healthy lifestyle
1616402|NCT00334269|Aboriginal|aboriginal
1616403|NCT00334269|body fat|body fat
1616404|NCT00334269|exercise|exercise
1616405|NCT00334269|education|education
1616406|NCT00334269|family|family
1616407|NCT00334269|body mass index|body mass index
1616408|NCT00334269|knowledge|knowledge
1616409|NCT00334269|randomized controlled trial|randomized controlled trial
1616410|NCT00334269|community|community
1616411|NCT00334269|intervention|intervention
1616412|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
1616413|NCT00334269|household|household
1616414|NCT00334269|health counselling|health counselling
1616415|NCT00334256|PMTCT|pmtct
1616416|NCT00334256|Resistance|resistance
1616417|NCT00334256|HIV infection|hiv infection
1616418|NCT00334256|Pregnancy|pregnancy
1616419|NCT00334243|in vitro fertilization|in vitro fertilization
1616420|NCT00334243|infertile|infertile
1616421|NCT00334243|infertility|infertility
1616422|NCT00334243|pregnancy|pregnancy
1616423|NCT00334243|pregnancy rates|pregnancy rates
1616424|NCT00334243|microflare protocol|microflare protocol
1616425|NCT00334243|antagonist protocol|antagonist protocol
1616426|NCT00334243|demi-halt protocol|demi-halt protocol
1616427|NCT00334243|poor responders|poor responders
1616428|NCT00334243|low antral follicle count|low antral follicle count
1616429|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
1616430|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
1616431|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
1616432|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1616433|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1616434|NCT00334230|Locomotion|locomotion
1616435|NCT00334230|Cortical Reorganization|cortical reorganization
1616436|NCT00334230|Rehabilitation|rehabilitation
1616437|NCT00334230|fMRI|fmri
1616438|NCT00334230|Stroke|stroke
1616439|NCT00334230|Healthy Volunteer|healthy volunteer
1616441|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
1616442|NCT00334217|Substance-Related Disorders|substance-related disorders
1616443|NCT00334217|treatment efficacy|treatment efficacy
1616444|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
1616445|NCT00334204|renal failure|renal failure
1616446|NCT00334204|kidney biopsy|kidney biopsy
1616447|NCT00334204|bleeding|bleeding
1616448|NCT00334204|hematoma|hematoma
1616838|NCT00332319|urgency|urgency
1616449|NCT00334191|Cardiac surgery,|cardiac surgery,
1616450|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
1616451|NCT00334191|Oxidative stress,|oxidative stress,
1616452|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
1616453|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
1616454|NCT00334178|Migraine|migraine
1616455|NCT00334178|Migraine prophylaxis|migraine prophylaxis
1616456|NCT00334152|NK-1|nk-1
1616457|NCT00334152|antiemetics|antiemetics
1616458|NCT00334152|casopitant mesylate|casopitant mesylate
1616459|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
1616460|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
1616461|NCT00334152|5HT3|5ht3
1616462|NCT00334152|ZOFRAN|zofran
1616463|NCT00334152|PONV|ponv
1616464|NCT00334139|serum bone markers|serum bone markers
1616465|NCT00334139|bone metastasis|bone metastasis
1616466|NCT00334139|prostate cancer|prostate cancer
1616467|NCT00334139|breast cancer|breast cancer
1616468|NCT00334139|quality of life|quality of life
1616469|NCT00334139|bisphosphonates|bisphosphonates
1616470|NCT00334126|Schizophrenia|schizophrenia
1616471|NCT00334126|Antipsychotic|antipsychotic
1616472|NCT00334126|paliperidone|paliperidone
1616473|NCT00334126|quetiapine|quetiapine
1616474|NCT00334126|Seroquel|seroquel
1616475|NCT00334126|placebo|placebo
1616476|NCT00334113|Diabetes Mellitus|diabetes mellitus
1616477|NCT00334113|Exercise|exercise
1616478|NCT00334113|Obesity|obesity
1616479|NCT00334113|Telemedicine|telemedicine
1616481|NCT00334100|multiple sclerosis|multiple sclerosis
1616482|NCT00334100|treadmill|treadmill
1616483|NCT00334087|primary dental prevention|primary dental prevention
1616484|NCT00334087|early childhood caries|early childhood caries
1616485|NCT00334087|prenatal oral care|prenatal oral care
1616487|NCT00334074|MDS|mds
1616488|NCT00334074|CML|cml
1616489|NCT00334074|Relapsed|relapsed
1616490|NCT00334074|Refractory|refractory
1616491|NCT00334074|Chemo treatment|chemo treatment
1616492|NCT00334074|Clofarabine|clofarabine
1616493|NCT00334074|Cytarabine|cytarabine
1616494|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
1616495|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
1616496|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
1616497|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
1616498|NCT00334061|Penumbra|penumbra
1616499|NCT00334061|Ischemic|ischemic
1616500|NCT00334061|Stroke|stroke
1616501|NCT00334061|Intervention|intervention
1616502|NCT00334061|Neurovascular|neurovascular
1616503|NCT00334061|Thrombus|thrombus
1616504|NCT00334061|Embolectomy|embolectomy
1616505|NCT00334061|Ischemic stroke|ischemic stroke
1616506|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
1616507|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
1616508|NCT00334048|Anorgasmia|anorgasmia
1616509|NCT00334048|Delayed ejaculation|delayed ejaculation
1616510|NCT00334048|Sexual dysfunction|sexual dysfunction
1616511|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
1616512|NCT00334048|Requip|requip
1616513|NCT00334048|Ropinirole|ropinirole
1616514|NCT00334048|Dopamine agonist|dopamine agonist
1616515|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
1616516|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
1616517|NCT00334022|Fuzeon|fuzeon
1616518|NCT00334022|Viral Decay|viral decay
1616519|NCT00334009|Cardiac Surgery|cardiac surgery
1616520|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
1616521|NCT00334009|COMT-Polymorphism|comt-polymorphism
1616522|NCT00334009|Vasoplegia|vasoplegia
1616523|NCT00334009|Catecholamines|catecholamines
1616524|NCT00334009|Acute Renal Failure|acute renal failure
1616525|NCT00333970|cognition|cognition
1616526|NCT00333970|neuropsychology|neuropsychology
1616527|NCT00333970|Rehabilitation|rehabilitation
1616528|NCT00333970|treatment efficacy|treatment efficacy
1616529|NCT00333970|cognitive remediation|cognitive remediation
1616530|NCT00333957|capsule endoscopy|capsule endoscopy
1616531|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
1616532|NCT00333944|Atropine|atropine
1616533|NCT00333944|Pralidoxime|pralidoxime
1616534|NCT00333944|Intermediate syndrome.|intermediate syndrome.
1616535|NCT00333931|Impulsive Aggression|impulsive aggression
1616536|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
1616537|NCT00333918|Cataract Extraction|cataract extraction
1616538|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1616539|NCT00333905|Exercise|exercise
1616540|NCT00333905|Exercise Therapy|exercise therapy
1616541|NCT00333892|primary HIV infection|primary hiv infection
1616542|NCT00333892|chronic HIV infection|chronic hiv infection
1616543|NCT00333879|Rehabilitation|rehabilitation
1616544|NCT00333879|Sensory Aid|sensory aid
1616545|NCT00333840|CML|cml
1616546|NCT00333840|STI571|sti571
1616547|NCT00333840|imatinib|imatinib
1616548|NCT00333840|interferon|interferon
1616549|NCT00333840|interferon alpha|interferon alpha
1617035|NCT00331448|MRI|mri
1616550|NCT00333840|cytosine arabinoside|cytosine arabinoside
1616551|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
1616552|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
1616553|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
1616554|NCT00333827|stem cells|stem cells
1616555|NCT00333827|Therapeutics|therapeutics
1616556|NCT00333827|Randomized Controlled Trials|randomized controlled trials
1616557|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
1616558|NCT00333801|Veterans|veterans
1616559|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
1616560|NCT00333801|Supported Employment|supported employment
1616561|NCT00333801|Individual Placement and Support|individual placement and support
1616562|NCT00333788|Crohn's Disease|crohn's disease
1616563|NCT00333788|Certolizumab pegol|certolizumab pegol
1616564|NCT00333788|CDP870|cdp870
1616565|NCT00333788|Cimzia|cimzia
1616566|NCT00333762|aging|aging
1616567|NCT00333762|blindness|blindness
1616568|NCT00333762|wheelchairs|wheelchairs
1616569|NCT00333762|spinal cord injury|spinal cord injury
1616570|NCT00333749|children|children
1616571|NCT00333736|Injection site reactions|injection site reactions
1616572|NCT00333736|enfuvirtide administration|enfuvirtide administration
1616573|NCT00333723|Rosiglitazone|rosiglitazone
1616574|NCT00333723|Glyburide|glyburide
1616575|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1616576|NCT00333723|African American|african american
1616577|NCT00333723|Hispanic|hispanic
1616578|NCT00333710|Rehabilitation|rehabilitation
1616579|NCT00333710|Telecommunication|telecommunication
1616580|NCT00333697|Deep vein thrombosis|deep vein thrombosis
1616581|NCT00333697|Duplex ultrasound|duplex ultrasound
1616582|NCT00333697|Pulmonary embolism|pulmonary embolism
1616583|NCT00333671|Macular oedema|macular oedema
1616584|NCT00333671|Diabetes|diabetes
1616585|NCT00333671|Pathogenesis|pathogenesis
1616586|NCT00333671|Osmolality|osmolality
1616587|NCT00333671|Retinal thickness|retinal thickness
1616588|NCT00333658|psychotherapy, group|psychotherapy, group
1616589|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
1616590|NCT00333658|treatment outcome|treatment outcome
1616591|NCT00333645|Liver transplantation|liver transplantation
1616592|NCT00333645|Invasive fungal infection|invasive fungal infection
1616593|NCT00333645|Invasive aspergillosis|invasive aspergillosis
1616594|NCT00333645|Prophylaxis|prophylaxis
1616595|NCT00333645|Caspofungin|caspofungin
1616597|NCT00333632|Dexmedetomidine|dexmedetomidine
1616598|NCT00333632|Postoperative care|postoperative care
1616599|NCT00333632|Sedation|sedation
1616600|NCT00333619|sleep disorders|sleep disorders
1616601|NCT00333619|rehabilitation|rehabilitation
1616602|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
1616603|NCT00333593|Dialysis|dialysis
1616604|NCT00333593|Large pore dialyser|large pore dialyser
1616605|NCT00333593|Cytokines|cytokines
1616606|NCT00333593|Noradrenaline|noradrenaline
1616607|NCT00333580|Ethnography|ethnography
1616608|NCT00333580|Psychometrics|psychometrics
1616609|NCT00333580|Qualitative Research|qualitative research
1616610|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
1616611|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
1616612|NCT00333567|lumiracoxib|lumiracoxib
1616614|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
1616615|NCT00333554|DHA|dha
1616616|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
1616617|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
1616618|NCT00333554|fish oil|fish oil
1616619|NCT00333554|pregnancy|pregnancy
1616620|NCT00333554|infancy|infancy
1616621|NCT00333554|prevention|prevention
1616622|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
1616623|NCT00333554|juvenile diabetes|juvenile diabetes
1616624|NCT00333554|T1D|t1d
1616625|NCT00333554|diabetes mellitus|diabetes mellitus
1616626|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
1616627|NCT00333554|TrialNet|trialnet
1616628|NCT00333554|dietary supplementation|dietary supplementation
1616629|NCT00333554|nutrition|nutrition
1616630|NCT00333541|Contraceptive behavior|contraceptive behavior
1616631|NCT00333541|Internet Use|internet use
1616632|NCT00333541|Adolescent pregnancy|adolescent pregnancy
1616633|NCT00333541|Unintended pregnancy|unintended pregnancy
1616634|NCT00333528|Chemical Warfare Agents|chemical warfare agents
1616635|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
1616636|NCT00333528|Chemical Terrorism|chemical terrorism
1616637|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
1616638|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
1616639|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
1616640|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
1616641|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
1616642|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
1616643|NCT00333502|Solid Malignancies|solid malignancies
1616644|NCT00333489|valsartan|valsartan
1616645|NCT00333489|amlodipine|amlodipine
1616646|NCT00333489|hypertension|hypertension
1616647|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
1616648|NCT00333424|HIV|hiv
1616649|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
1616650|NCT00333424|Prophylactic vaccine|prophylactic vaccine
1616651|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
1616652|NCT00333385|Ceftazidime|ceftazidime
1616653|NCT00333385|Continuous infusion|continuous infusion
1616654|NCT00333385|Antibiotic course|antibiotic course
1616655|NCT00333333|Thrombocytopenia|thrombocytopenia
1616656|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
1616657|NCT00333333|Preeclampsia|preeclampsia
1616658|NCT00333320|acute myocardial infarction|acute myocardial infarction
1616659|NCT00333320|postconditioning|postconditioning
1616660|NCT00333320|coronary reserve|coronary reserve
1616661|NCT00333320|ejection fraction|ejection fraction
1616662|NCT00333307|relaxin|relaxin
1616663|NCT00333307|preeclampsia|preeclampsia
1616664|NCT00333281|Healthy Volunteers|healthy volunteers
1616665|NCT00333242|Pain|pain
1616666|NCT00333242|opioid|opioid
1616667|NCT00333242|hyperalgesia|hyperalgesia
1616668|NCT00333242|methadone|methadone
1616669|NCT00333229|Breast Cancer|breast cancer
1616670|NCT00333229|premenopausal|premenopausal
1616671|NCT00333229|Bone Mineral density|bone mineral density
1616672|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
1616673|NCT00333229|zoledronic acid|zoledronic acid
1616674|NCT00333203|epimacular membrane|epimacular membrane
1616675|NCT00333190|stem cell transplant|stem cell transplant
1616676|NCT00333190|graft versus host disease|graft versus host disease
1616677|NCT00333190|GVHD|gvhd
1616678|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
1616679|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
1616680|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
1616681|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
1616682|NCT00333177|Supported Employment|supported employment
1616683|NCT00333177|Cognitive Remediation|cognitive remediation
1616684|NCT00333177|Health Behavior Training|health behavior training
1616685|NCT00333177|Antipsychotic Medication|antipsychotic medication
1616686|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
1616687|NCT00333164|cilostazol|cilostazol
1616688|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
1616689|NCT00333164|Drug therapy, combination|drug therapy, combination
1616690|NCT00333164|Clinical trials|clinical trials
1616691|NCT00333138|FTY720|fty720
1616692|NCT00333138|MS|ms
1616693|NCT00333138|Multiple Sclerosis|multiple sclerosis
1616694|NCT00333138|RRMS|rrms
1616695|NCT00333112|Treatment Outcome|treatment outcome
1616696|NCT00333112|Urology|urology
1616697|NCT00333112|Solifenacin succinate|solifenacin succinate
1616698|NCT00333112|Urinary Incontinence|urinary incontinence
1616699|NCT00333099|Enteral nutrition|enteral nutrition
1616700|NCT00333099|immunonutrients|immunonutrients
1616701|NCT00333099|head and neck cancer|head and neck cancer
1616702|NCT00333099|esophageal cancer|esophageal cancer
1616703|NCT00333099|chemoradiotherapy|chemoradiotherapy
1616704|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
1616705|NCT00333086|Endometrial Cancer|endometrial cancer
1616706|NCT00333086|Aromatase inhibitor|aromatase inhibitor
1616707|NCT00333086|Letrozole|letrozole
1616708|NCT00333073|urinary incontinence|urinary incontinence
1616709|NCT00333073|Bulkamid|bulkamid
1616710|NCT00333047|Metastatic breast cancer|metastatic breast cancer
1617113|NCT00331136|malaria|malaria
1616711|NCT00333047|Aromatase inhibitor|aromatase inhibitor
1616712|NCT00333047|Letrozole|letrozole
1616713|NCT00333034|Psoriasis|psoriasis
1616714|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
1616715|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
1616716|NCT00333008|CDOP|cdop
1616717|NCT00333008|Dose Dense|dose dense
1616718|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
1616719|NCT00333008|Any IPI score|any ipi score
1616720|NCT00332995|HIV Seronegativity|hiv seronegativity
1616721|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
1616722|NCT00332969|Open label|open label
1616723|NCT00332969|phase II|phase ii
1616724|NCT00332969|disease|disease
1616725|NCT00332969|clinical trial|clinical trial
1616726|NCT00332969|Octreotide|octreotide
1616727|NCT00332969|thymoma|thymoma
1616728|NCT00332969|cancer|cancer
1616729|NCT00332969|tumor|tumor
1616730|NCT00332943|colorectal polyps|colorectal polyps
1616731|NCT00332943|colorectal cancer|colorectal cancer
1616732|NCT00332943|Virtual colonoscopy|virtual colonoscopy
1616733|NCT00332943|Fecal tagging|fecal tagging
1616734|NCT00332943|MR colonography|mr colonography
1616735|NCT00332930|HIV|hiv
1616736|NCT00332930|Therapeutic vaccine|therapeutic vaccine
1616737|NCT00332917|Parkinson's disease|parkinson's disease
1616738|NCT00332904|betablocker|betablocker
1616739|NCT00332904|aldosterone antagonist|aldosterone antagonist
1617036|NCT00331448|DXA|dxa
1616740|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
1616741|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
1616742|NCT00332904|oxygenation|oxygenation
1616743|NCT00332891|Anxiety|anxiety
1616744|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
1616745|NCT00332891|controlled Clinical Trials|controlled clinical trials
1616746|NCT00332878|Behavioral Intervention|behavioral intervention
1616747|NCT00332878|HIV|hiv
1616748|NCT00332878|HSV2|hsv2
1616749|NCT00332865|Head and neck cancer|head and neck cancer
1616750|NCT00332865|Radiotherapy|radiotherapy
1616751|NCT00332865|Dysphagia|dysphagia
1616752|NCT00332865|Exercise|exercise
1616753|NCT00332865|Deglutition|deglutition
1616754|NCT00332865|Randomized controlled trial|randomized controlled trial
1616755|NCT00332865|Quality of life|quality of life
1616756|NCT00332865|Tube feeding|tube feeding
1616757|NCT00332852|Postive breast cancer|postive breast cancer
1616758|NCT00332852|postmenopausal|postmenopausal
1616759|NCT00332852|disease free survival|disease free survival
1616760|NCT00332852|letrozole|letrozole
1616761|NCT00332852|early adjuvant treatment|early adjuvant treatment
1616762|NCT00332852|primary hormone receptor|primary hormone receptor
1616763|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
1616764|NCT00332826|Inhaled insulin|inhaled insulin
1616765|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
1616766|NCT00332813|HIV Risk Behavior|hiv risk behavior
1616767|NCT00332813|Pregnancy|pregnancy
1616769|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
1616770|NCT00332787|Major Depressive Disorder|major depressive disorder
1616771|NCT00332735|spinal|spinal
1616772|NCT00332735|anesthesia|anesthesia
1616773|NCT00332735|articaine|articaine
1616774|NCT00332735|bupivacaine|bupivacaine
1616775|NCT00332735|outpatient|outpatient
1616776|NCT00332735|surgery|surgery
1616777|NCT00332735|limbs|limbs
1616778|NCT00332709|Breast cancer|breast cancer
1616779|NCT00332709|postmenopausal|postmenopausal
1616780|NCT00332709|bone mineral density|bone mineral density
1616781|NCT00332709|Zoledronic acid|zoledronic acid
1616782|NCT00332709|Letrozole|letrozole
1616783|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
1616784|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
1616785|NCT00332696|bowel obstruction,|bowel obstruction,
1616786|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
1616787|NCT00332696|Octreotide|octreotide
1616788|NCT00332696|inoperable|inoperable
1616789|NCT00332683|Dysphagia|dysphagia
1616790|NCT00332683|spine surgery|spine surgery
1616791|NCT00332683|cuff pressure|cuff pressure
1616792|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
1616793|NCT00332670|bright light therapy|bright light therapy
1616794|NCT00332670|randomized controlled trial|randomized controlled trial
1616795|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
1616796|NCT00332670|HPA-axis|hpa-axis
1616797|NCT00332670|DHEA|dhea
1616798|NCT00332670|melatonin|melatonin
1616799|NCT00332670|actigraphy|actigraphy
1616800|NCT00332670|elderly|elderly
1616801|NCT00332670|self-efficacy|self-efficacy
1616802|NCT00332670|social support|social support
1616803|NCT00332631|Cardiac surgery,|cardiac surgery,
1616804|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
1616805|NCT00332631|Oxidative stress,|oxidative stress,
1616806|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
1616807|NCT00332631|N-acetylcysteine|n-acetylcysteine
1616808|NCT00332618|MULTICENTER|multicenter
1616809|NCT00332618|CONTROLLED|controlled
1617116|NCT00331136|falciparum|falciparum
1616810|NCT00332618|PARALLEL GROUPS|parallel groups
1616811|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
1616812|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
1616813|NCT00332592|Intragastric microdialysis|intragastric microdialysis
1616814|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
1616815|NCT00332592|Infants|infants
1616816|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
1616817|NCT00332579|Kleptomania|kleptomania
1616818|NCT00332579|Compulsive Stealing|compulsive stealing
1616819|NCT00332514|pharmacist intervention|pharmacist intervention
1616820|NCT00332514|post-discharge telephone call|post-discharge telephone call
1616821|NCT00332514|black hole|black hole
1616822|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
1616823|NCT00332449|early breast feeding|early breast feeding
1616824|NCT00332449|hypoglycemia|hypoglycemia
1616825|NCT00332449|newborn|newborn
1616826|NCT00332410|Voriconazole|voriconazole
1616827|NCT00332410|renal transplant|renal transplant
1616828|NCT00332410|kidney function|kidney function
1616829|NCT00332410|kidneys|kidneys
1616830|NCT00332371|Intensive Care|intensive care
1616831|NCT00332371|Shock, Septic|shock, septic
1616832|NCT00332371|Adsorption|adsorption
1616833|NCT00332371|Sorption Detoxification|sorption detoxification
1616834|NCT00332332|Phase IV|phase iv
1616835|NCT00332332|Psoriasis|psoriasis
1616836|NCT00332332|Inflammation|inflammation
1616837|NCT00332319|spinal cord injury|spinal cord injury
1616839|NCT00332319|Overactive bladder|overactive bladder
1616840|NCT00332319|neurogenic|neurogenic
1616841|NCT00332319|neurometry|neurometry
1616842|NCT00332319|frequency|frequency
1616843|NCT00332319|urge incontinence|urge incontinence
1616844|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
1616845|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
1616846|NCT00332306|HIV Infections|hiv infections
1616847|NCT00332280|solid tumors|solid tumors
1616848|NCT00332280|clinical benefit|clinical benefit
1616849|NCT00332280|quality of life|quality of life
1616850|NCT00332280|esophageal cancer|esophageal cancer
1616851|NCT00332280|colon cancer|colon cancer
1616852|NCT00332280|pancreatic cancer|pancreatic cancer
1616853|NCT00332280|gastric cancer|gastric cancer
1616854|NCT00332280|liver cancer|liver cancer
1616855|NCT00332280|gall bladder cancer|gall bladder cancer
1616856|NCT00332280|prostate cancer|prostate cancer
1616857|NCT00332280|gynecological cancer|gynecological cancer
1616858|NCT00332280|lung cancer|lung cancer
1616859|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
1616860|NCT00332267|Sepsis|sepsis
1616861|NCT00332267|Hypoxia|hypoxia
1616862|NCT00332267|Altitude Sickness|altitude sickness
1616863|NCT00332267|Endotoxin|endotoxin
1616864|NCT00332267|Cytokines|cytokines
1616865|NCT00332267|Cerebral blood flow|cerebral blood flow
1616866|NCT00332267|Cerebral metabolism|cerebral metabolism
1616867|NCT00332267|Reactive oxygen species|reactive oxygen species
1616868|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
1616869|NCT00332254|Meniscus tear|meniscus tear
1616870|NCT00332254|Chondral injury|chondral injury
1616871|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
1616872|NCT00332241|Behavioral Problems|behavioral problems
1616873|NCT00332228|opiate dependence|opiate dependence
1616874|NCT00332228|heroin dependence|heroin dependence
1616875|NCT00332228|naltrexone|naltrexone
1616876|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
1616877|NCT00332215|Cystic Fibrosis|cystic fibrosis
1616878|NCT00332215|Antioxidants|antioxidants
1616879|NCT00332215|Inhalational therapy|inhalational therapy
1616880|NCT00332215|Induced sputum|induced sputum
1616881|NCT00332215|Airway inflammation|airway inflammation
1616882|NCT00332189|PKU|pku
1616883|NCT00332176|Hepatitis C|hepatitis c
1616884|NCT00332176|Celgosivir|celgosivir
1616885|NCT00332176|HCV|hcv
1616886|NCT00332176|Genotype 1|genotype 1
1616887|NCT00332176|Treatment-naive|treatment-naive
1616888|NCT00332176|Early viral kinetics|early viral kinetics
1616889|NCT00332163|STEPP|stepp
1616890|NCT00332163|STEP|step
1616891|NCT00332163|STEEP|steep
1616892|NCT00332163|mCRC|mcrc
1616893|NCT00332163|Skin Toxicities|skin toxicities
1616894|NCT00332163|Skin Rash|skin rash
1616895|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
1616896|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
1616897|NCT00332163|colon cancer|colon cancer
1616898|NCT00332163|colorectal cancer|colorectal cancer
1616899|NCT00332163|rectal cancer|rectal cancer
1616900|NCT00332150|parents|parents
1616901|NCT00332150|newborn|newborn
1616902|NCT00332150|clinical trials|clinical trials
1616903|NCT00332111|transplant|transplant
1616904|NCT00332111|pancreas|pancreas
1616905|NCT00332098|Childhood Mood Disorders|childhood mood disorders
1616906|NCT00332098|Family Treatment|family treatment
1616907|NCT00332098|Psychoeducation|psychoeducation
1616908|NCT00332098|Pharmacotherapy|pharmacotherapy
1616909|NCT00332098|Family Functioning|family functioning
1616910|NCT00332098|Psychosocial Intervention|psychosocial intervention
1616911|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
1616912|NCT00332033|Fibroids|fibroids
1616913|NCT00332033|Leiomyoma|leiomyoma
1616914|NCT00332033|Pirfenidone|pirfenidone
1616915|NCT00332033|Misoprostol|misoprostol
1616916|NCT00332033|Non-Surgical|non-surgical
1616917|NCT00332033|Collagen|collagen
1616918|NCT00332033|Uterus|uterus
1616919|NCT00332033|Uterine Fibroids|uterine fibroids
1616920|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
1616921|NCT00331942|Breast|breast
1616922|NCT00331942|Cancer|cancer
1616923|NCT00331942|Associated|associated
1616924|NCT00331942|Antibodies|antibodies
1616925|NCT00331929|Asthma|asthma
1616926|NCT00331929|Allergy|allergy
1616927|NCT00331929|Respiratory|respiratory
1616928|NCT00331929|Pollution|pollution
1616929|NCT00331929|Children|children
1616930|NCT00331929|Air pollution|air pollution
1616931|NCT00331890|Neuroprotection|neuroprotection
1616932|NCT00331890|Acute ischemic stroke|acute ischemic stroke
1616933|NCT00331890|Cerebral infarction|cerebral infarction
1616934|NCT00331877|family|family
1616935|NCT00331877|end-of-life|end-of-life
1616936|NCT00331877|intensive care unit|intensive care unit
1616937|NCT00331864|AMD, ranibizumab|amd, ranibizumab
1616938|NCT00331838|Prevention|prevention
1616939|NCT00331838|Venous Thrombosis|venous thrombosis
1616940|NCT00331838|Orthopedic Surgery|orthopedic surgery
1616941|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
1616942|NCT00331812|Hypermetabolism|hypermetabolism
1616943|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
1616944|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
1616945|NCT00331799|Depression|depression
1616946|NCT00331799|Pharmacotherapy|pharmacotherapy
1616947|NCT00331799|Duloxetine|duloxetine
1616948|NCT00331786|colon cancer|colon cancer
1616949|NCT00331786|rectal cancer|rectal cancer
1616950|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1616951|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
1616952|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
1616953|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
1616954|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
1616955|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
1616956|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
1616957|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
1616958|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1616959|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
1616960|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
1616961|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
1616962|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
1616963|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1617085|NCT00331214|Surgical menopause|surgical menopause
1616964|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1617475|NCT00329680|EPA|epa
1616965|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
1616967|NCT00331708|Efficacy|efficacy
1616968|NCT00331708|Pharmacokinetic|pharmacokinetic
1616969|NCT00331708|Gametocyte|gametocyte
1616970|NCT00331708|Molecular markers|molecular markers
1616971|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1616972|NCT00331708|Artesunate|artesunate
1616973|NCT00331708|Artemisinin|artemisinin
1616974|NCT00331695|Progesterone|progesterone
1616975|NCT00331695|Preterm delivery|preterm delivery
1616976|NCT00331695|Preterm labor|preterm labor
1616977|NCT00331695|Cervical length|cervical length
1616978|NCT00331695|ultrasonography|ultrasonography
1616979|NCT00331669|deep brain stimulation|deep brain stimulation
1616980|NCT00331669|pallidum|pallidum
1616981|NCT00331669|tardive dystonia|tardive dystonia
1616982|NCT00331669|randomized|randomized
1616983|NCT00331669|double blind|double blind
1616984|NCT00331669|multicenter|multicenter
1616985|NCT00331656|noninvasive|noninvasive
1616986|NCT00331656|positive|positive
1616987|NCT00331656|cuirass|cuirass
1616988|NCT00331656|ventilation|ventilation
1616989|NCT00331656|respiratory|respiratory
1616990|NCT00331656|failure|failure
1616991|NCT00331630|stage I breast cancer|stage i breast cancer
1616992|NCT00331630|stage II breast cancer|stage ii breast cancer
1616993|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
1616994|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
1616995|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
1616996|NCT00331565|Bariatric surgery|bariatric surgery
1616997|NCT00331565|Bioavailability|bioavailability
1616998|NCT00331565|Bioequivalence|bioequivalence
1616999|NCT00331565|Atorvastatin|atorvastatin
1617000|NCT00331565|CYP's|cyp's
1617001|NCT00331565|P-gp|p-gp
1617002|NCT00331565|OATP|oatp
1617003|NCT00331539|Cochlear implant|cochlear implant
1617004|NCT00331539|threshold (T) measurement|threshold (t) measurement
1617005|NCT00331539|comfort (C) level|comfort (c) level
1617006|NCT00331539|profound hearing loss|profound hearing loss
1617007|NCT00331539|auditory stimuli|auditory stimuli
1617114|NCT00331136|pyronaridine|pyronaridine
1617115|NCT00331136|artesunate|artesunate
1617008|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
1617009|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
1617010|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
1617011|NCT00331526|adult glioblastoma|adult glioblastoma
1617012|NCT00331526|adult gliosarcoma|adult gliosarcoma
1617013|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
1617014|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
1617015|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
1617016|NCT00331487|Type II Diabetes|type ii diabetes
1617017|NCT00331487|Diabetes Mellitus|diabetes mellitus
1617018|NCT00331487|Lipoatrophic|lipoatrophic
1617019|NCT00331487|Dyslipidemia|dyslipidemia
1617020|NCT00331487|Drug Therapy|drug therapy
1617022|NCT00331474|HIV|hiv
1617023|NCT00331474|Immune responses|immune responses
1617024|NCT00331474|Delayed vaccination|delayed vaccination
1617025|NCT00331474|Infant morbidity|infant morbidity
1617026|NCT00331474|Nutritional status|nutritional status
1617027|NCT00331474|Morbidity|morbidity
1617028|NCT00331474|Mortality|mortality
1617029|NCT00331448|Treatment Experienced|treatment experienced
1617030|NCT00331448|Lipoatrophy|lipoatrophy
1617031|NCT00331448|Lipohypertrophy|lipohypertrophy
1617032|NCT00331448|Glucose|glucose
1617033|NCT00331448|Cholesterol|cholesterol
1617034|NCT00331448|Triglycerides|triglycerides
1617037|NCT00331448|Carotid IMT|carotid imt
1617038|NCT00331448|LDL|ldl
1617039|NCT00331448|HDL|hdl
1617040|NCT00331435|AMD|amd
1617041|NCT00331435|PCV|pcv
1617042|NCT00331435|PDT|pdt
1617043|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1617044|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1617045|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1617046|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1617047|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1617048|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1617049|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1617050|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1617051|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
1617052|NCT00331422|fallopian tube cancer|fallopian tube cancer
1617053|NCT00331422|Brenner tumor|brenner tumor
1617054|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
1617055|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
1617056|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1617057|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
1617058|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
1617059|NCT00331357|paediatric|paediatric
1617060|NCT00331357|quality of life|quality of life
1617070|NCT00331318|Brain Plasticity|brain plasticity
1617071|NCT00331318|Healthy Volunteer|healthy volunteer
1617073|NCT00331305|Exercise|exercise
1617074|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
1617075|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
1617076|NCT00331279|insulin resistance|insulin resistance
1617077|NCT00331279|cinnamon|cinnamon
1617078|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
1617079|NCT00331253|Neovascular|neovascular
1617080|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
1617081|NCT00331227|flavonoids|flavonoids
1617082|NCT00331227|food supplements|food supplements
1617083|NCT00331227|endothelial function|endothelial function
1617084|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
1617086|NCT00331214|HSDD|hsdd
1617088|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
1617089|NCT00331188|Portal Hypertension|portal hypertension
1617090|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
1617091|NCT00331188|Cirrhosis|cirrhosis
1617092|NCT00331188|Liver Cirrhosis|liver cirrhosis
1617093|NCT00331188|Somatostatin Analog|somatostatin analog
1617094|NCT00331188|Vapreotide|vapreotide
1617095|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
1617096|NCT00331162|Renal Transplantation|renal transplantation
1617097|NCT00331162|Pancreas Transplantation|pancreas transplantation
1617098|NCT00331162|Graft Rejection|graft rejection
1617099|NCT00331162|Immunosuppression|immunosuppression
1617100|NCT00331162|Kidney failure, chronic|kidney failure, chronic
1617101|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1617102|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1617103|NCT00331149|safety|safety
1617104|NCT00331149|efficacy|efficacy
1617105|NCT00331149|L-dopa|l-dopa
1617106|NCT00331149|ropinirole PR|ropinirole pr
1617107|NCT00331149|Parkinson's disease|parkinson's disease
1617108|NCT00331149|ropinirole IR|ropinirole ir
1617109|NCT00331149|adjunctive therapy|adjunctive therapy
1617110|NCT00331149|superiority|superiority
1617111|NCT00331149|REQUIP|requip
1617112|NCT00331149|health outcomes|health outcomes
1617118|NCT00331123|Surgical menopause|surgical menopause
1617119|NCT00331123|HSDD|hsdd
1617120|NCT00331097|elderly|elderly
1617121|NCT00331097|adjuvant therapy|adjuvant therapy
1617122|NCT00331097|intermediate risk|intermediate risk
1617123|NCT00331097|high risk|high risk
1617124|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
1617125|NCT00331071|Contraception|contraception
1617126|NCT00331071|Hormonal contraception|hormonal contraception
1617127|NCT00331071|Oral contraception|oral contraception
1617128|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
1617129|NCT00331071|Transdermal|transdermal
1617130|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
1617131|NCT00331045|Opioids|opioids
1617132|NCT00331045|cancer|cancer
1617133|NCT00331045|constipation|constipation
1617134|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
1617135|NCT00331019|Streptococcus Group B|streptococcus group b
1617136|NCT00331019|Pregnancy|pregnancy
1617137|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
1617138|NCT00330993|mifepristone|mifepristone
1617139|NCT00330993|misoprostol|misoprostol
1617140|NCT00330993|medical abortion|medical abortion
1617141|NCT00330993|buccal administration|buccal administration
1617142|NCT00330980|Cognition|cognition
1617143|NCT00330980|Statins|statins
1617144|NCT00330980|Serotonin|serotonin
1617145|NCT00330980|Cholesterol|cholesterol
1617146|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
1617147|NCT00330967|Free Fatty Acids|free fatty acids
1617148|NCT00330967|Glucose Clamp Technique|glucose clamp technique
1617149|NCT00330967|Inflammation|inflammation
1617150|NCT00330967|Insulin Resistance|insulin resistance
1617151|NCT00330967|Muscle, Skeletal|muscle, skeletal
1617152|NCT00330967|NF-Kappa B|nf-kappa b
1617153|NCT00330954|viral response genes|viral response genes
1617154|NCT00330902|malaria|malaria
1617155|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
1617156|NCT00330902|dry season|dry season
1617157|NCT00330902|primaquine|primaquine
1617158|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
1617159|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
1617160|NCT00330876|pitavastatin|pitavastatin
1617161|NCT00330876|hypercholesterolemia|hypercholesterolemia
1617162|NCT00330876|combined dyslipidemia|combined dyslipidemia
1617163|NCT00330863|Relapse|relapse
1617164|NCT00330863|Prevention|prevention
1617165|NCT00330863|Schizophrenia|schizophrenia
1617166|NCT00330863|Injectable Medication|injectable medication
1617167|NCT00330850|Migraine|migraine
1617168|NCT00330850|Photophobia|photophobia
1617169|NCT00330850|Phonophobia|phonophobia
1617170|NCT00330850|Aura|aura
1617171|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
1617172|NCT00330811|Pediatrics|pediatrics
1617173|NCT00330811|Non-cardiac Illness|non-cardiac illness
1617174|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
1617175|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
1617176|NCT00330772|Cardiac Surger|cardiac surger
1617177|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1617178|NCT00330772|Graft patency|graft patency
1617179|NCT00330772|Aspirin|aspirin
1617180|NCT00330772|Clopidogrel|clopidogrel
1617181|NCT00330772|Hemorrhage|hemorrhage
1617182|NCT00330772|Transfusion|transfusion
1617183|NCT00330759|Bone metastases|bone metastases
1617184|NCT00330759|lytic bone lesions|lytic bone lesions
1617185|NCT00330759|advanced cancer|advanced cancer
1617186|NCT00330759|multiple myeloma|multiple myeloma
1617187|NCT00330759|lymphoma|lymphoma
1617188|NCT00330759|solid tumors|solid tumors
1617189|NCT00330759|skeletal related events|skeletal related events
1617190|NCT00330759|skeletal fractures|skeletal fractures
1617191|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
1617192|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
1617193|NCT00330759|denosumab|denosumab
1617194|NCT00330746|elderly|elderly
1617195|NCT00330746|chemotherapy|chemotherapy
1617196|NCT00330746|targeted therapy|targeted therapy
1617197|NCT00330746|combination therapy|combination therapy
1617198|NCT00330746|sequential therapy|sequential therapy
1617199|NCT00330746|randomized phase II|randomized phase ii
1617200|NCT00330746|one year survival|one year survival
1617201|NCT00330733|Cardiovascular Disease|cardiovascular disease
1617202|NCT00330733|Inflammation|inflammation
1617203|NCT00330733|Insulin Resistance|insulin resistance
1617204|NCT00330733|Type 2 DM|type 2 dm
1617205|NCT00330720|Personal Emergency Response System|personal emergency response system
1617206|NCT00330720|Anxiety|anxiety
1617207|NCT00330720|Fear of Falling|fear of falling
1617208|NCT00330720|RCT|rct
1617209|NCT00330707|bladder cancer|bladder cancer
1617210|NCT00330707|BCG|bcg
1617211|NCT00330707|interferon alpha|interferon alpha
1617212|NCT00330694|Physical Therapy|physical therapy
1617213|NCT00330694|Organisation of care|organisation of care
1617214|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1617215|NCT00330681|free radical scavenger|free radical scavenger
1617216|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
1617217|NCT00330668|IGF-1|igf-1
1617218|NCT00330668|Short Stature|short stature
1617219|NCT00330655|Binge eating|binge eating
1617220|NCT00330655|Obesity|obesity
1617221|NCT00330655|Eating disorder|eating disorder
1617222|NCT00330642|Streptococcus Group B|streptococcus group b
1617223|NCT00330642|Pregnancy|pregnancy
1617224|NCT00330616|WELLBUTRIN|wellbutrin
1617225|NCT00330616|elderly|elderly
1617226|NCT00330616|depression|depression
1617227|NCT00330616|Pharmacokinetics|pharmacokinetics
1617228|NCT00330603|Cough|cough
1617229|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
1617230|NCT00330590|Central Venous|central venous
1617231|NCT00330590|Ultrasonography|ultrasonography
1617232|NCT00330590|Catheterization|catheterization
1617233|NCT00330564|VHL Syndrome|vhl syndrome
1617234|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
1617235|NCT00330564|VHL Disease|vhl disease
1617236|NCT00330564|Kidney|kidney
1617237|NCT00330564|Retina|retina
1617238|NCT00330564|Brain|brain
1617239|NCT00330564|Spinal cord|spinal cord
1617240|NCT00330564|Pancreas|pancreas
1617241|NCT00330564|Inner ear|inner ear
1617242|NCT00330564|Cysts|cysts
1617243|NCT00330564|Tumors|tumors
1617244|NCT00330564|Sunitinib Malate|sunitinib malate
1617245|NCT00330564|SU011248|su011248
1617246|NCT00330564|Sutent|sutent
1617248|NCT00330564|Sunitinib|sunitinib
1617249|NCT00330564|Renal cell carcinoma|renal cell carcinoma
1617250|NCT00330564|Hemangioblastoma|hemangioblastoma
1617251|NCT00330564|Endothelium|endothelium
1617252|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
1617253|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
1617254|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
1617255|NCT00330551|Injectable Risperidone|injectable risperidone
1617256|NCT00330538|Osteoporosis|osteoporosis
1617257|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1617258|NCT00330512|regional anestesia|regional anestesia
1617259|NCT00330512|cesarean section|cesarean section
1617260|NCT00330512|hypotention|hypotention
1617261|NCT00330512|newborn|newborn
1617262|NCT00330499|Locally invasive|locally invasive
1617263|NCT00330499|Bladder cancer|bladder cancer
1617264|NCT00330499|Chemoradiotherapy|chemoradiotherapy
1617265|NCT00330499|Efficacy|efficacy
1617266|NCT00330499|Organ conservation|organ conservation
1617267|NCT00330486|Acamprosate|acamprosate
1617268|NCT00330486|Addiction|addiction
1617269|NCT00330486|Alcoholism|alcoholism
1617270|NCT00330486|Alcohol dependence|alcohol dependence
1617271|NCT00330486|Bipolar disorder|bipolar disorder
1617272|NCT00330486|Depression|depression
1617273|NCT00330486|Impulsivity|impulsivity
1617274|NCT00330486|Mania|mania
1617275|NCT00330486|Substance abuse|substance abuse
1617276|NCT00330460|Osteoporosis|osteoporosis
1617277|NCT00330460|Osteopenia|osteopenia
1617278|NCT00330460|AMG 162|amg 162
1617279|NCT00330460|Fracture - hip|fracture - hip
1617280|NCT00330460|Postmenopausal|postmenopausal
1617281|NCT00330447|pregnancy|pregnancy
1617282|NCT00330447|in utero|in utero
1617283|NCT00330447|chemotherapy|chemotherapy
1617284|NCT00330447|radiotherapy|radiotherapy
1617285|NCT00330447|cancer|cancer
1617286|NCT00330447|offspring|offspring
1617287|NCT00330447|neonatal|neonatal
1617288|NCT00330447|long term|long term
1617289|NCT00330447|follow up|follow up
1617290|NCT00330447|cancer during pregnancy|cancer during pregnancy
1617291|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
1617292|NCT00330447|long term follow up of children|long term follow up of children
1617293|NCT00330434|Alcohol|alcohol
1617294|NCT00330434|Bupropion|bupropion
1617295|NCT00330434|Chlorzoxazone|chlorzoxazone
1617296|NCT00330434|Interaction|interaction
1617297|NCT00330434|Induction|induction
1617298|NCT00330434|Depression|depression
1617299|NCT00330434|Smoking|smoking
1617300|NCT00330434|Drinking|drinking
1617301|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
1617302|NCT00330434|CYP2B6|cyp2b6
1617303|NCT00330434|CYP2E1|cyp2e1
1617304|NCT00330434|Pharmacogenetics|pharmacogenetics
1617305|NCT00330434|Pharmacokinetics|pharmacokinetics
1617306|NCT00330434|Pharmacodynamics|pharmacodynamics
1617307|NCT00330434|Boston|boston
1617308|NCT00330434|Tufts University|tufts university
1617309|NCT00330408|Adherence|adherence
1617310|NCT00330408|GP training|gp training
1617311|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
1617312|NCT00330408|Antihypertensive Medication|antihypertensive medication
1617313|NCT00330408|Hypertension|hypertension
1617314|NCT00330356|Dietary Salt|dietary salt
1617315|NCT00330356|Blood Pressure|blood pressure
1617316|NCT00330356|Normotensives|normotensives
1617317|NCT00330343|morphine|morphine
1617318|NCT00330343|naloxone|naloxone
1617319|NCT00330343|pediatrics|pediatrics
1617320|NCT00330343|adverse effects|adverse effects
1617321|NCT00330343|pain|pain
1617322|NCT00330330|Fasting plasma glucose|fasting plasma glucose
1617323|NCT00330330|HbA1c|hba1c
1617325|NCT00330317|Breast Conserving Surgery|breast conserving surgery
1617326|NCT00330317|NeoAdjuvant|neoadjuvant
1617327|NCT00330317|Early Breast Cancer|early breast cancer
1617328|NCT00330304|Tuberculosis|tuberculosis
1617329|NCT00330304|Child|child
1617330|NCT00330304|HIV|hiv
1617331|NCT00330304|prophylaxis|prophylaxis
1617332|NCT00330304|mortality|mortality
1617333|NCT00330291|PTSD|ptsd
1617334|NCT00330291|Xyrem|xyrem
1617335|NCT00330291|Sleep problems|sleep problems
1617336|NCT00330278|Cesarean section|cesarean section
1617337|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
1617338|NCT00330278|Cefazolin|cefazolin
1617339|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1617340|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
1617341|NCT00330252|Alemtuzumab|alemtuzumab
1617342|NCT00330252|Campath|campath
1617343|NCT00330252|Rituximab|rituximab
1617344|NCT00330252|Rituxan|rituxan
1617345|NCT00330239|Substance Abuse|substance abuse
1617346|NCT00330239|Trauma|trauma
1617347|NCT00330239|Dependence|dependence
1617348|NCT00330226|schizophrenia|schizophrenia
1617349|NCT00330226|bipolar disorder|bipolar disorder
1617350|NCT00330226|atypical antipsychotics|atypical antipsychotics
1617351|NCT00330226|mood stabilizers|mood stabilizers
1617352|NCT00330226|biological markers|biological markers
1617353|NCT00330213|transthoracic|transthoracic
1617354|NCT00330213|echocardiography|echocardiography
1617355|NCT00330213|red wine|red wine
1617356|NCT00330213|cognac|cognac
1617357|NCT00330213|coronary reactivity|coronary reactivity
1617460|NCT00329758|statin|statin
1617358|NCT00330200|Fasting plasma glucose|fasting plasma glucose
1617359|NCT00330200|HbA1c|hba1c
1617360|NCT00330200|Metabolism|metabolism
1617361|NCT00330187|nicotine dependence|nicotine dependence
1617362|NCT00330187|bupropion SR|bupropion sr
1617363|NCT00330187|smoking cessation|smoking cessation
1617364|NCT00330187|adolescents|adolescents
1617365|NCT00330187|contingency management|contingency management
1617366|NCT00330174|Alcoholism|alcoholism
1617367|NCT00330174|Mood|mood
1617368|NCT00330174|Anxiety|anxiety
1617369|NCT00330174|Acamprosate|acamprosate
1617370|NCT00330148|trypanosomiasis|trypanosomiasis
1617371|NCT00330148|gambiense|gambiense
1617476|NCT00329680|GLA|gla
1617372|NCT00330148|combination drug therapy|combination drug therapy
1617373|NCT00330148|sleeping sickness|sleeping sickness
1617374|NCT00330148|Uganda|uganda
1617375|NCT00330135|hip osteoarthritis|hip osteoarthritis
1617376|NCT00330135|Hyaluronic acid|hyaluronic acid
1617377|NCT00330135|Viscosupplementation|viscosupplementation
1617378|NCT00330135|intra-articular injections|intra-articular injections
1617379|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
1617380|NCT00330122|fore locked plate|fore locked plate
1617381|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
1617382|NCT00330109|glioma|glioma
1617383|NCT00330109|machine learning|machine learning
1617384|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
1617385|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
1617386|NCT00330070|8-week treatment|8-week treatment
1617387|NCT00330070|oral tablets|oral tablets
1617388|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
1617389|NCT00330070|AQLQ|aqlq
1617390|NCT00330070|asthma control|asthma control
1617391|NCT00330070|quality of life|quality of life
1617392|NCT00330018|BMT|bmt
1617393|NCT00330018|CMV|cmv
1617394|NCT00330018|GVHD|gvhd
1617395|NCT00330005|psychotherapy|psychotherapy
1617396|NCT00330005|bipolar disorder|bipolar disorder
1617397|NCT00330005|psychodynamic|psychodynamic
1617398|NCT00330005|psychoeducation|psychoeducation
1617399|NCT00330005|illness management|illness management
1617400|NCT00330005|controlled trial|controlled trial
1617401|NCT00330005|pilot study|pilot study
1617402|NCT00329979|aortic stenosis|aortic stenosis
1617403|NCT00329979|radial|radial
1617404|NCT00329979|femoral|femoral
1617405|NCT00329979|vascular access site|vascular access site
1617406|NCT00329979|embolism|embolism
1617407|NCT00329979|cerebral|cerebral
1617408|NCT00329979|MRI|mri
1617409|NCT00329979|stroke|stroke
1617410|NCT00329966|Influenza|influenza
1617411|NCT00329966|adult|adult
1617412|NCT00329966|elderly|elderly
1617413|NCT00329966|vaccine|vaccine
1617414|NCT00329940|Letrozole|letrozole
1617415|NCT00329940|breast cancer|breast cancer
1617416|NCT00329940|critical musculoskeletal|critical musculoskeletal
1617417|NCT00329940|postmenopausal|postmenopausal
1617418|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
1617419|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
1617420|NCT00329914|Preterm delivery|preterm delivery
1617421|NCT00329914|Prevention|prevention
1617422|NCT00329914|Twins|twins
1617423|NCT00329914|Progesterone|progesterone
1617424|NCT00329901|Meningitis|meningitis
1617425|NCT00329901|healthy subject|healthy subject
1617426|NCT00329901|vaccine|vaccine
1617427|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
1617428|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
1617536|NCT00329381|Allergic|allergic
1617429|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
1617430|NCT00329862|Truncal Vagotomy|truncal vagotomy
1617431|NCT00329862|Lap Band|lap band
1617432|NCT00329862|Lap Banding|lap banding
1617433|NCT00329862|Obesity Surgery|obesity surgery
1617434|NCT00329862|Bariatric surgery|bariatric surgery
1617435|NCT00329862|Weight Loss Surgery|weight loss surgery
1617436|NCT00329849|Meningitis|meningitis
1617437|NCT00329849|children|children
1617438|NCT00329849|vaccine|vaccine
1617439|NCT00329849|safety|safety
1617440|NCT00329849|efficacy|efficacy
1617441|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
1617442|NCT00329797|osteoporosis|osteoporosis
1617443|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1617444|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
1617445|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
1617446|NCT00329797|stage III prostate cancer|stage iii prostate cancer
1617447|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
1617448|NCT00329784|peanut allergy|peanut allergy
1617449|NCT00329784|egg allergy|egg allergy
1617450|NCT00329784|eczema|eczema
1617451|NCT00329784|peanut|peanut
1617452|NCT00329784|allergy|allergy
1617453|NCT00329784|allergies|allergies
1617454|NCT00329784|allergic reaction|allergic reaction
1617455|NCT00329784|anaphylaxis|anaphylaxis
1617456|NCT00329784|infants|infants
1617457|NCT00329784|children|children
1617458|NCT00329758|moderate head injury|moderate head injury
1617459|NCT00329758|rosuvastatin|rosuvastatin
1617461|NCT00329758|amnesia|amnesia
1617462|NCT00329758|orientation|orientation
1617463|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
1617464|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
1617465|NCT00329706|mild cognitive impairment|mild cognitive impairment
1617466|NCT00329706|Alzheimer's disease|alzheimer's disease
1617467|NCT00329706|dementia|dementia
1617468|NCT00329706|FDG|fdg
1617469|NCT00329706|PET|pet
1617470|NCT00329680|Sepsis|sepsis
1617471|NCT00329680|Severe Sepsis|severe sepsis
1617472|NCT00329680|Septic Shock|septic shock
1617473|NCT00329680|Enteral Nutrition|enteral nutrition
1617474|NCT00329680|Antioxidants|antioxidants
1617477|NCT00329680|Nutrition|nutrition
1617478|NCT00329680|Intensive Care|intensive care
1617479|NCT00329680|ICU|icu
1617480|NCT00329667|heart valve|heart valve
1617481|NCT00329667|mitral|mitral
1617482|NCT00329667|aortic|aortic
1617483|NCT00329667|valvular disease|valvular disease
1617484|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
1617485|NCT00329628|Prevention|prevention
1617486|NCT00329628|Thromboembolism|thromboembolism
1617487|NCT00329615|Cancer cachexia|cancer cachexia
1617488|NCT00329615|Tumor host metabolism|tumor host metabolism
1617489|NCT00329602|Moderate|moderate
1617490|NCT00329602|Restless Legs Syndrome|restless legs syndrome
1617491|NCT00329602|Severe|severe
1617492|NCT00329602|ropinirole|ropinirole
1617493|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
1617494|NCT00329589|and cervix|and cervix
1617495|NCT00329563|Cardiac Arrest|cardiac arrest
1617496|NCT00329563|Hypothermia|hypothermia
1617497|NCT00329550|Certolizumab pegol|certolizumab pegol
1617498|NCT00329550|Cimzia|cimzia
1617499|NCT00329550|CZP|czp
1617500|NCT00329537|Crohn's Disease|crohn's disease
1617501|NCT00329537|Sargramostim|sargramostim
1617502|NCT00329537|CDAI|cdai
1617503|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
1617504|NCT00329524|Tinnitus|tinnitus
1617505|NCT00329524|TMS|tms
1617506|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1617507|NCT00329511|pregnancy|pregnancy
1617508|NCT00329511|hypertension|hypertension
1617509|NCT00329511|compliance|compliance
1617510|NCT00329511|clonidine patch|clonidine patch
1617511|NCT00329511|methyldopa|methyldopa
1617512|NCT00329498|ascorbic acid|ascorbic acid
1617513|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
1617514|NCT00329459|menstrual migraine|menstrual migraine
1617515|NCT00329459|headache|headache
1617516|NCT00329459|early intervention|early intervention
1617517|NCT00329459|dysmenorrhea|dysmenorrhea
1617518|NCT00329446|GAD|gad
1617519|NCT00329446|anxiety|anxiety
1617520|NCT00329433|Deep venous thrombosis|deep venous thrombosis
1617521|NCT00329433|DVT|dvt
1617522|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
1617523|NCT00329433|HIT|hit
1617524|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
1617525|NCT00329420|Crohn's Disease|crohn's disease
1617526|NCT00329420|CDP870|cdp870
1617527|NCT00329420|Certolizumab pegol|certolizumab pegol
1617528|NCT00329420|CZP|czp
1617529|NCT00329407|Alcoholism|alcoholism
1617530|NCT00329407|Heavy Drinking|heavy drinking
1617531|NCT00329407|Alcohol Dependence|alcohol dependence
1617532|NCT00329394|Ketamine|ketamine
1617533|NCT00329394|Analgesia|analgesia
1617534|NCT00329394|Alcool-dependent|alcool-dependent
1617535|NCT00329394|carcinological surgery|carcinological surgery
1617538|NCT00329381|Immunotherapy|immunotherapy
1617539|NCT00329368|Cancer|cancer
1617540|NCT00329368|Vaccine|vaccine
1617541|NCT00329368|Phase I|phase i
1617542|NCT00329368|FolateImmune|folateimmune
1617543|NCT00329368|Recurrent|recurrent
1617544|NCT00329368|Refractory|refractory
1617545|NCT00329368|Experimental|experimental
1617546|NCT00329355|menstrual migraine|menstrual migraine
1617547|NCT00329355|headache|headache
1617548|NCT00329355|early intervention|early intervention
1617549|NCT00329355|dysmenorrhea|dysmenorrhea
1617550|NCT00329342|Low back pain;|low back pain;
1617551|NCT00329342|Return to work;|return to work;
1617552|NCT00329342|Posture|posture
1617553|NCT00329329|Advanced solid malignancies|advanced solid malignancies
1617554|NCT00329316|Pre-term labor|pre-term labor
1617555|NCT00329316|progesterone|progesterone
1617556|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
1617557|NCT00329303|anti TNF α|anti tnf α
1617558|NCT00329303|CDP 870|cdp 870
1617559|NCT00329303|Cimzia®|cimzia®
1617560|NCT00329303|certolizumab pegol|certolizumab pegol
1617561|NCT00329303|retreatment|retreatment
1617562|NCT00329290|pregnancy|pregnancy
1617563|NCT00329290|anticoagulation|anticoagulation
1617564|NCT00329290|enoxaparin|enoxaparin
1617565|NCT00329290|prosthetic heart valves|prosthetic heart valves
1617566|NCT00329277|age-related macular degeneration|age-related macular degeneration
1617567|NCT00329277|preferred retinal locus|preferred retinal locus
1617568|NCT00329277|macular perimetry|macular perimetry
1617569|NCT00329264|GAD|gad
1617570|NCT00329264|anxiety|anxiety
1617571|NCT00329251|HIV|hiv
1617572|NCT00329251|Viral load|viral load
1617573|NCT00329251|Vaccines|vaccines
1617574|NCT00329251|Immunotherapy|immunotherapy
1617575|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
1617576|NCT00329212|Pharmacokinetics|pharmacokinetics
1617577|NCT00329212|Bioavailability|bioavailability
1617578|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
1617579|NCT00329199|Depression|depression
1617580|NCT00329199|Adolescents|adolescents
1617581|NCT00329199|Family Therapy|family therapy
1617582|NCT00329199|Primary Care|primary care
1617583|NCT00329199|Family Conflict|family conflict
1617584|NCT00329186|Healthy Subjects|healthy subjects
1617585|NCT00329186|Major Depressive Disorder|major depressive disorder
1617586|NCT00329186|Depression|depression
1617587|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
1617588|NCT00329186|Pharmacokinetics|pharmacokinetics
1617589|NCT00329186|Health|health
1617590|NCT00329147|Healthy Subjects|healthy subjects
1617591|NCT00329147|Major Depressive Disorder|major depressive disorder
1617592|NCT00329147|Depression|depression
1617593|NCT00329121|SCCIS|sccis
1617594|NCT00329121|Bowens disease|bowens disease
1617595|NCT00329121|PEP005|pep005
1617596|NCT00329121|Topical|topical
1617597|NCT00329121|Dermatology|dermatology
1617598|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
1617599|NCT00329095|Glaucoma|glaucoma
1617600|NCT00329095|Compliance|compliance
1617601|NCT00329069|statin|statin
1617602|NCT00329069|atorvastatin|atorvastatin
1617603|NCT00329069|hypercholesterolemia|hypercholesterolemia
1617604|NCT00329069|coronary artery disease|coronary artery disease
1617605|NCT00329069|monocyte|monocyte
1617606|NCT00329069|collateral formation|collateral formation
1617607|NCT00329069|arteriogenesis|arteriogenesis
1617608|NCT00329069|chemotaxis|chemotaxis
1617609|NCT00329069|migration|migration
1617610|NCT00329069|growth factors|growth factors
1617611|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
1617612|NCT00329069|placenta growth factor 1|placenta growth factor 1
1617613|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
1617614|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
1617615|NCT00329056|Parkinson's disease|parkinson's disease
1617616|NCT00329056|MitoQ|mitoq
1617617|NCT00329056|UPDRS|updrs
1617618|NCT00329043|Prostate Cancer|prostate cancer
1617619|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
1617620|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
1617621|NCT00329043|Hormonal Ablation|hormonal ablation
1617622|NCT00329043|Radical Prostatectomy|radical prostatectomy
1617623|NCT00329043|LHRH Agonist|lhrh agonist
1617624|NCT00329043|Lupron|lupron
1617625|NCT00329043|Leuprolide|leuprolide
1617626|NCT00329043|Sunitinib Malate|sunitinib malate
1617627|NCT00329043|SU011248|su011248
1617628|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
1617629|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1617630|NCT00329017|SNPs|snps
1617631|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
1617632|NCT00329017|breast atypia|breast atypia
1617633|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
1617634|NCT00329017|high risk for breast cancer|high risk for breast cancer
1617635|NCT00329004|Solid Tumors|solid tumors
1617636|NCT00328991|wart|wart
1617637|NCT00328991|common wart|common wart
1617638|NCT00328991|verruca vulgaris|verruca vulgaris
1617639|NCT00328991|verruca plantaris|verruca plantaris
1617640|NCT00328991|plantar wart|plantar wart
1617641|NCT00328991|duct tape|duct tape
1617642|NCT00328991|occlusion therapy|occlusion therapy
1617643|NCT00328978|schizophrenia|schizophrenia
1617644|NCT00328978|schizoaffective disorders|schizoaffective disorders
1617645|NCT00328965|Korean patients|korean patients
1617646|NCT00328965|Type 2 diabetes|type 2 diabetes
1617647|NCT00328965|Endothelial function|endothelial function
1617648|NCT00328965|lacidipine|lacidipine
1617649|NCT00328965|Essential hypertension|essential hypertension
1617650|NCT00328952|schizophrenia|schizophrenia
1617651|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
1617652|NCT00328952|antipsychotic treatment|antipsychotic treatment
1617653|NCT00328939|ARIXTRA|arixtra
1617654|NCT00328939|prevention of DVT|prevention of dvt
1617655|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
1617656|NCT00328926|Placebo|placebo
1617657|NCT00328926|Luveris® 75 IU|luveris® 75 iu
1617658|NCT00328926|Luveris® 25 IU|luveris® 25 iu
1617659|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
1617660|NCT00328913|satiety|satiety
1617661|NCT00328913|food intake|food intake
1617662|NCT00328913|mood|mood
1617663|NCT00328913|wellness|wellness
1617664|NCT00328913|weight management|weight management
1617665|NCT00328900|Galvanic skin response|galvanic skin response
1617666|NCT00328900|Anesthesia|anesthesia
1617667|NCT00328900|Atropine|atropine
1617668|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
1617669|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
1617670|NCT00328874|Coenzyme Q10|coenzyme q10
1617671|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
1617672|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
1617673|NCT00328861|Clinical Response|clinical response
1617674|NCT00328861|Rate of Repopulation|rate of repopulation
1617675|NCT00328861|Toxicity Profile|toxicity profile
1617676|NCT00328861|Metastatic Melanoma|metastatic melanoma
1617677|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
1617678|NCT00328848|patient care management|patient care management
1617679|NCT00328848|chronic disease|chronic disease
1617680|NCT00328835|Optic Nerve|optic nerve
1617681|NCT00328835|Glaucoma|glaucoma
1617682|NCT00328822|Primary insomnia|primary insomnia
1617683|NCT00328822|Quetiapine|quetiapine
1617684|NCT00328822|Randomized controlled trial|randomized controlled trial
1617685|NCT00328822|Double blind|double blind
1617686|NCT00328796|Perineal|perineal
1617687|NCT00328796|repair|repair
1617688|NCT00328796|episiotomies|episiotomies
1617689|NCT00328796|midwives|midwives
1617690|NCT00328796|pain relief|pain relief
1617691|NCT00328796|Episiotomy|episiotomy
1617692|NCT00328783|Breast cancer|breast cancer
1617693|NCT00328783|Active Breathing Control|active breathing control
1617694|NCT00328783|Active Breathing Coordinator|active breathing coordinator
1617696|NCT00328770|liver transplant|liver transplant
1617697|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
1617698|NCT00328770|sirolimus|sirolimus
1617699|NCT00328757|gynecologic cancer|gynecologic cancer
1617700|NCT00328757|cervical cancer|cervical cancer
1617701|NCT00328757|ovarian cancer|ovarian cancer
1617702|NCT00328757|endometrial cancer|endometrial cancer
1617703|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
1617704|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
1617705|NCT00328757|surgical staging|surgical staging
1617706|NCT00328757|postoperative feeding|postoperative feeding
1617707|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
1617708|NCT00328744|Weight|weight
1617709|NCT00328744|Dietary intake|dietary intake
1617710|NCT00328744|Energy|energy
1617711|NCT00328744|Hedonics|hedonics
1617712|NCT00328744|Behavioral|behavioral
1617713|NCT00328744|Sensory-specific satiety|sensory-specific satiety
1617714|NCT00328744|Monotony|monotony
1617715|NCT00328731|Allergy|allergy
1617716|NCT00328731|NAET|naet
1617717|NCT00328718|Persistent Asthma|persistent asthma
1617718|NCT00328718|pediatric asthmatic|pediatric asthmatic
1617719|NCT00328718|asthma control|asthma control
1617720|NCT00328705|Sensing|sensing
1617721|NCT00328705|Capture Management|capture management
1617722|NCT00328705|Heart Failure|heart failure
1617723|NCT00328705|ICD Indication|icd indication
1617724|NCT00328692|heart failure|heart failure
1617725|NCT00328692|diuretic|diuretic
1617726|NCT00328692|renal impairment|renal impairment
1617727|NCT00328692|renal function|renal function
1617728|NCT00328679|abdominal|abdominal
1617729|NCT00328679|stomach|stomach
1617730|NCT00328679|dyspepsia|dyspepsia
1617731|NCT00328679|food allergy|food allergy
1617732|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
1617733|NCT00328640|CVA|cva
1617734|NCT00328640|Ischemic stroke|ischemic stroke
1617735|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1617736|NCT00328627|Drug Therapy|drug therapy
1617737|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
1617738|NCT00328627|Glucose Intolerance|glucose intolerance
1617739|NCT00328627|Hyperglycemia|hyperglycemia
1618331|NCT00326365|homeopathy|homeopathy
1617740|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
1617741|NCT00328614|positive lymph nodes|positive lymph nodes
1617742|NCT00328588|Treatment Efficacy|treatment efficacy
1617743|NCT00328588|Treatment Effectiveness|treatment effectiveness
1617744|NCT00328588|Disease Management|disease management
1617745|NCT00328588|Treatment|treatment
1617746|NCT00328588|Safety|safety
1617747|NCT00328575|Brain metastases|brain metastases
1617748|NCT00328575|Parenchymal|parenchymal
1617749|NCT00328575|Neoplasm|neoplasm
1617750|NCT00328575|IMRT|imrt
1617751|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
1617752|NCT00328562|Advanced NSCLC|advanced nsclc
1617753|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
1617754|NCT00328562|Stage IV NSCLC|stage iv nsclc
1617755|NCT00328549|Natural History,|natural history,
1617756|NCT00328549|Hepatitis C Infection|hepatitis c infection
1617757|NCT00328549|Ribavirin|ribavirin
1617758|NCT00328549|Pegylated Interferon|pegylated interferon
1617759|NCT00328549|Interferon|interferon
1617760|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
1617761|NCT00328536|endothelial dysfunction|endothelial dysfunction
1617762|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
1617763|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
1617764|NCT00328536|postprandial state|postprandial state
1617765|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
1617766|NCT00328484|COPD|copd
1617767|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1617768|NCT00328484|Exercise|exercise
1617769|NCT00328484|Emphysema|emphysema
1617770|NCT00328484|Chronic Bronchitis|chronic bronchitis
1617771|NCT00328471|patient care management|patient care management
1617772|NCT00328471|cerebrovascular accident|cerebrovascular accident
1617773|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
1617774|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
1617775|NCT00328458|there is on standard therapy or|there is on standard therapy or
1617776|NCT00328458|have failed standard therapy|have failed standard therapy
1617777|NCT00328445|Curriculum|curriculum
1617778|NCT00328445|Classroom management|classroom management
1617779|NCT00328445|School-wide climate|school-wide climate
1617780|NCT00328445|Parent involvement|parent involvement
1617781|NCT00328432|early breast cancer|early breast cancer
1617782|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
1617783|NCT00328432|RCT|rct
1617784|NCT00328432|pre-surgical model|pre-surgical model
1617785|NCT00328432|DCIS model|dcis model
1617786|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
1617787|NCT00328432|celecoxib|celecoxib
1617788|NCT00328432|Ki-67 placebo|ki-67 placebo
1617789|NCT00328419|Photoprotection,|photoprotection,
1617790|NCT00328419|Parenteral nutrition|parenteral nutrition
1617791|NCT00328419|Oxidant stress|oxidant stress
1617792|NCT00328419|Infant, Premature|infant, premature
1617793|NCT00328393|Hypertension|hypertension
1617794|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
1617795|NCT00328380|Xifaxan|xifaxan
1617796|NCT00328380|Rifaximin|rifaximin
1617797|NCT00328380|Escherichia coli|escherichia coli
1617798|NCT00328380|E coli|e coli
1617799|NCT00328380|EAEC|eaec
1617800|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
1617801|NCT00328380|ETEC|etec
1617802|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
1617803|NCT00328367|schizophrenia|schizophrenia
1617804|NCT00328367|aripiprazole|aripiprazole
1617805|NCT00328367|clozapine|clozapine
1617806|NCT00328341|traumatic brain injury|traumatic brain injury
1617807|NCT00328341|hemorrhagic shock|hemorrhagic shock
1617808|NCT00328341|multisystem trauma|multisystem trauma
1617809|NCT00328341|under resuscitation|under resuscitation
1617810|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
1617811|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
1617812|NCT00328302|Diabetes|diabetes
1617813|NCT00328302|Kidney function|kidney function
1617814|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
1617815|NCT00328302|Kidney biopsy|kidney biopsy
1617816|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
1617817|NCT00328289|Urea removal|urea removal
1617818|NCT00328263|Bio-K+CL1285|bio-k+cl1285
1617819|NCT00328263|Probiotics|probiotics
1617820|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
1617821|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1617822|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
1617823|NCT00328263|Clostridium Difficile|clostridium difficile
1617824|NCT00328250|Internet|internet
1617825|NCT00328250|CBT|cbt
1617826|NCT00328250|Insomnia|insomnia
1617827|NCT00328250|Sleep|sleep
1617828|NCT00328237|Cord Blood Transplant|cord blood transplant
1617829|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
1617830|NCT00328237|Transplant|transplant
1617831|NCT00328237|Fludarabine|fludarabine
1617832|NCT00328237|Total Body Irradiation|total body irradiation
1617833|NCT00328237|Cyclophosphamide|cyclophosphamide
1617834|NCT00328224|ritalin|ritalin
1617835|NCT00328224|ADHA|adha
1617836|NCT00328224|dental status|dental status
1617837|NCT00328224|periodontal status|periodontal status
1617838|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
1617839|NCT00328224|Dental trauma|dental trauma
1617840|NCT00328198|CAMPATH|campath
1617841|NCT00328198|Alemtuzumab|alemtuzumab
1617842|NCT00328198|Leukemia|leukemia
1617843|NCT00328198|MabCampath|mabcampath
1617844|NCT00328198|Chronic|chronic
1617845|NCT00328198|Subcutaneous|subcutaneous
1617846|NCT00328198|CLL|cll
1617847|NCT00328198|C-CLL|c-cll
1617848|NCT00328198|Relapsed|relapsed
1617849|NCT00328198|Refractory|refractory
1617850|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1617851|NCT00328185|pediatric|pediatric
1617852|NCT00328185|heart disease|heart disease
1617853|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
1617854|NCT00328185|allograft fibrosis|allograft fibrosis
1617855|NCT00328159|FAO disorders|fao disorders
1617856|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
1617857|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
1617858|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
1617859|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
1617860|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
1617861|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
1617862|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
1617863|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
1617864|NCT00328146|pediatric|pediatric
1617865|NCT00328146|cardiac|cardiac
1617866|NCT00328146|re-operative surgery|re-operative surgery
1617867|NCT00328133|recombinant Factor VIIa|recombinant factor viia
1617868|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
1617869|NCT00328133|hemorrhagic shock|hemorrhagic shock
1617870|NCT00328133|coagulopathy|coagulopathy
1617871|NCT00328120|Advanced breast cancer|advanced breast cancer
1617872|NCT00328120|Faslodex|faslodex
1617873|NCT00328107|Influenza|influenza
1617874|NCT00328094|Tight|tight
1617875|NCT00328094|Glycemic|glycemic
1617876|NCT00328094|control|control
1617877|NCT00328094|outcomes|outcomes
1617878|NCT00328094|peripheral vascular disease|peripheral vascular disease
1617879|NCT00328094|infection|infection
1617880|NCT00328094|cardiovascular|cardiovascular
1617881|NCT00328094|morbidity|morbidity
1617882|NCT00328094|mortality|mortality
1617883|NCT00328081|Obesity|obesity
1617884|NCT00328081|Weight gain|weight gain
1617885|NCT00328081|Anti-obesity medication|anti-obesity medication
1617886|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
1617887|NCT00328081|Body Weight|body weight
1617888|NCT00328068|ASAS classification|asas classification
1617889|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
1617890|NCT00328068|spondyloarthritis|spondyloarthritis
1617891|NCT00328068|spondyloarthropathy|spondyloarthropathy
1617892|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
1617893|NCT00328068|modified New York criteria for AS|modified new york criteria for as
1617894|NCT00328068|ESSG criteria for SpA|essg criteria for spa
1617895|NCT00328068|Amor criteria for SpA|amor criteria for spa
1617896|NCT00328068|arthritis|arthritis
1617897|NCT00328068|enthesitis|enthesitis
1617898|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
1617899|NCT00328055|functional ability|functional ability
1617900|NCT00328055|patient care management|patient care management
1617901|NCT00328055|communication|communication
1617902|NCT00328055|literacy|literacy
1617903|NCT00328042|Self-care|self-care
1617904|NCT00328042|Quality of Life|quality of life
1617905|NCT00328042|Chronic disease|chronic disease
1617906|NCT00328029|Busulfan|busulfan
1617907|NCT00328029|pharmacokinetic|pharmacokinetic
1617908|NCT00328029|respiratory function assessment|respiratory function assessment
1617909|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
1617910|NCT00328016|hypertension|hypertension
1617911|NCT00328016|high blood pressure|high blood pressure
1617912|NCT00328016|meditation|meditation
1617913|NCT00327990|ibandronate|ibandronate
1617914|NCT00327990|osteoporosis|osteoporosis
1617915|NCT00327990|preference|preference
1617916|NCT00327990|case-finding|case-finding
1617917|NCT00327990|post-menopausal|post-menopausal
1617918|NCT00327990|alendronate|alendronate
1617919|NCT00327977|hypoxemia|hypoxemia
1617920|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
1617921|NCT00327964|malaria|malaria
1617922|NCT00327964|fever|fever
1617923|NCT00327964|Uganda|uganda
1617924|NCT00327964|children|children
1617925|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
1617926|NCT00327964|RDTs|rdts
1617927|NCT00327964|Africa|africa
1617928|NCT00327951|pediatric|pediatric
1617929|NCT00327951|cardiac|cardiac
1617930|NCT00327951|weight gain pre-operative|weight gain pre-operative
1617931|NCT00327951|trisomy 21|trisomy 21
1617932|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
1617933|NCT00327938|Remifentanil|remifentanil
1617934|NCT00327938|Skin Conductance|skin conductance
1617935|NCT00327938|Anesthesia|anesthesia
1617936|NCT00327938|Analgesics, Opioid|analgesics, opioid
1617937|NCT00327925|Ovarian|ovarian
1617938|NCT00327925|Cancer|cancer
1617939|NCT00327925|Antibodies|antibodies
1617940|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
1617941|NCT00327912|Obesity|obesity
1617942|NCT00327912|Surgery|surgery
1617943|NCT00327912|Gastric bypass|gastric bypass
1617944|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
1617945|NCT00327912|Laparoscopy|laparoscopy
1617946|NCT00327899|pediatric|pediatric
1617947|NCT00327899|congestive heart failure|congestive heart failure
1617948|NCT00327899|inotropes|inotropes
1617949|NCT00327886|pediatric|pediatric
1617950|NCT00327886|Glenn operation|glenn operation
1617951|NCT00327886|Cyanosis|cyanosis
1617952|NCT00327873|breathlessness|breathlessness
1617953|NCT00327873|shortness of breath|shortness of breath
1617954|NCT00327873|end-of-life care|end-of-life care
1617955|NCT00327873|hospice|hospice
1617956|NCT00327808|Smokers|smokers
1617957|NCT00327808|Adults|adults
1617958|NCT00327808|Inflammatory markers|inflammatory markers
1617959|NCT00327795|congenital heart disease|congenital heart disease
1617960|NCT00327795|pediatric|pediatric
1617961|NCT00327795|surgical outcomes|surgical outcomes
1617962|NCT00327782|pediatric|pediatric
1617963|NCT00327782|palliative care|palliative care
1617964|NCT00327782|end stage heart failure|end stage heart failure
1617965|NCT00327769|Advanced breast cancer|advanced breast cancer
1617966|NCT00327769|fulvestrant|fulvestrant
1617967|NCT00327769|anastrozole|anastrozole
1617968|NCT00327756|Depression|depression
1617969|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1617970|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
1617971|NCT00327756|Manic Depressive|manic depressive
1617972|NCT00327756|Bioenergetics|bioenergetics
1617973|NCT00327756|Bipolar Disorder|bipolar disorder
1617974|NCT00327756|Manic Depression|manic depression
1617975|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
1617976|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
1617977|NCT00327730|Muscle|muscle
1617978|NCT00327730|Spasm|spasm
1617979|NCT00327730|Back|back
1617980|NCT00327730|Pain|pain
1617981|NCT00327717|Epilepsy|epilepsy
1617982|NCT00327717|Partial seizures|partial seizures
1617983|NCT00327704|Septic Shock|septic shock
1617984|NCT00327691|Major cardiovascular event|major cardiovascular event
1617985|NCT00327691|Major Coronary event|major coronary event
1617986|NCT00327691|Revascularization|revascularization
1617987|NCT00327678|ALL,|all,
1617988|NCT00327678|young patients,|young patients,
1617989|NCT00327678|chemotherapy,|chemotherapy,
1617990|NCT00327678|Mabtera,|mabtera,
1617991|NCT00327678|Imatinib,|imatinib,
1617992|NCT00327678|allogeneic transplant|allogeneic transplant
1617993|NCT00327665|pneumonia|pneumonia
1617994|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
1617995|NCT00327665|elderly subjects|elderly subjects
1617996|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
1617997|NCT00327665|Prophylaxis|prophylaxis
1617998|NCT00327652|carcinoma|carcinoma
1617999|NCT00327652|liver|liver
1618000|NCT00327652|hepatic|hepatic
1618001|NCT00327652|metastasis|metastasis
1618002|NCT00327652|Listeria|listeria
1618003|NCT00327626|Fasting plasma glucose|fasting plasma glucose
1618004|NCT00327626|HbA1c|hba1c
1618005|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
1618006|NCT00327613|PEX|pex
1618007|NCT00327613|glaucoma|glaucoma
1618008|NCT00327613|MMP|mmp
1618009|NCT00327613|DNA degradation|dna degradation
1618010|NCT00327613|POAG|poag
1618011|NCT00327613|Healthy subjects|healthy subjects
1618012|NCT00327587|hypertension|hypertension
1618013|NCT00327587|valsartan|valsartan
1618014|NCT00327587|amlodipine|amlodipine
1618015|NCT00327587|HCTZ|hctz
1618016|NCT00327561|Inflammation|inflammation
1618017|NCT00327561|Periodontitis|periodontitis
1618018|NCT00327561|Endothelial function|endothelial function
1618019|NCT00327561|Atherosclerosis|atherosclerosis
1618020|NCT00327561|Controlled trial|controlled trial
1618021|NCT00327509|mRNA|mrna
1618022|NCT00327509|glaucoma|glaucoma
1618023|NCT00327483|Transplant|transplant
1618024|NCT00327483|Medication error|medication error
1618025|NCT00327483|Patient Safety|patient safety
1618026|NCT00327483|Information technology|information technology
1618027|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
1618028|NCT00327470|choroidal neovascularization|choroidal neovascularization
1618029|NCT00327457|colorectal cancer screening|colorectal cancer screening
1618030|NCT00327457|sigmoidoscopy|sigmoidoscopy
1618031|NCT00327457|colonoscopy|colonoscopy
1618032|NCT00327444|Ovarian neoplasm|ovarian neoplasm
1618033|NCT00327444|Ascites|ascites
1618034|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
1618035|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
1618036|NCT00327444|Recombinant fusion protein|recombinant fusion protein
1618037|NCT00327431|Hypertension|hypertension
1618038|NCT00327431|Blood Pressure|blood pressure
1618636|NCT00325078|CGD|cgd
1618039|NCT00327431|Psychosocial Factors|psychosocial factors
1618040|NCT00327405|POAG|poag
1618041|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
1618042|NCT00327405|Trabeculectomy|trabeculectomy
1618043|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
1618044|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
1618045|NCT00327405|Releasable Suture|releasable suture
1618046|NCT00327405|Ocular Compresssion|ocular compresssion
1618047|NCT00327392|Arthroscopy|arthroscopy
1618048|NCT00327392|AV Shunt|av shunt
1618049|NCT00327392|Bunion|bunion
1618050|NCT00327392|Dilatation and Curettage|dilatation and curettage
1618051|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
1618052|NCT00327392|Hysteroscopy|hysteroscopy
1618053|NCT00327392|Lithotripsy|lithotripsy
1618054|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
1618055|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
1618056|NCT00327392|Ureteroscopy|ureteroscopy
1618057|NCT00327392|AQUAVAN|aquavan
1618058|NCT00327392|Sedation|sedation
1618059|NCT00327379|Bloodloss|bloodloss
1618060|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
1618061|NCT00327366|Menstrual Cycle|menstrual cycle
1618062|NCT00327366|Light Therapy|light therapy
1618063|NCT00327366|Sex Hormones|sex hormones
1618064|NCT00327366|Ovulation|ovulation
1618065|NCT00327353|Asthma|asthma
1618066|NCT00327353|Salmeterol|salmeterol
1618067|NCT00327353|Formoterol|formoterol
1618263|NCT00326651|fertility|fertility
1618068|NCT00327353|Airway resistance|airway resistance
1618069|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
1618070|NCT00327301|POAG|poag
1618071|NCT00327301|Parkinson's disease|parkinson's disease
1618072|NCT00327301|cellular proteome|cellular proteome
1618073|NCT00327301|human leucocytes|human leucocytes
1618074|NCT00327301|vasospasm|vasospasm
1618075|NCT00327301|POAG patients|poag patients
1618076|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
1618077|NCT00327301|Healthy subjects|healthy subjects
1618078|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
1618079|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
1618080|NCT00327262|Ph+|ph+
1618081|NCT00327262|bcr/abl+|bcr/abl+
1618082|NCT00327262|imatinib|imatinib
1618083|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
1618084|NCT00327223|Metastatic cancer|metastatic cancer
1618085|NCT00327223|Disseminated malignant disease|disseminated malignant disease
1618086|NCT00327210|BGAT|bgat
1618087|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
1618088|NCT00327210|Diabetes|diabetes
1618089|NCT00327210|T1DM|t1dm
1618090|NCT00327210|Internet|internet
1618091|NCT00327210|Web|web
1618092|NCT00327210|Intervention|intervention
1618093|NCT00327210|Treatment|treatment
1618094|NCT00327210|Behavior|behavior
1618095|NCT00327210|Education|education
1618096|NCT00327210|Awareness|awareness
1618097|NCT00327197|bronchoscopy|bronchoscopy
1618098|NCT00327197|Sputum induction|sputum induction
1618099|NCT00327197|Prednisolone|prednisolone
1618100|NCT00327197|Asthma|asthma
1618101|NCT00327197|biomarkers|biomarkers
1618102|NCT00327171|ovarian cancer|ovarian cancer
1618103|NCT00327171|angiogenesis|angiogenesis
1618104|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
1618105|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
1618106|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
1618107|NCT00327158|Reaming|reaming
1618108|NCT00327158|fracture|fracture
1618109|NCT00327158|emboli|emboli
1618110|NCT00327145|HCTZ|hctz
1618111|NCT00327145|hypertension|hypertension
1618112|NCT00327145|valsartan|valsartan
1618113|NCT00327145|amlodipine|amlodipine
1618114|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
1618115|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
1618116|NCT00327119|EGFR|egfr
1618117|NCT00327119|Fully human|fully human
1618118|NCT00327119|Monoclonal antibody|monoclonal antibody
1618119|NCT00327119|Panitumumab|panitumumab
1618120|NCT00327119|ABX-EGF|abx-egf
1618121|NCT00327119|AMG954|amg954
1618122|NCT00327119|Colorectal Cancer|colorectal cancer
1618123|NCT00327119|Japan|japan
1618124|NCT00327106|hip fracture|hip fracture
1618125|NCT00327106|transfusion|transfusion
1618126|NCT00327106|tranexamic acid|tranexamic acid
1618127|NCT00327106|fondaparinux|fondaparinux
1618128|NCT00327093|Colorectal cancer,|colorectal cancer,
1618129|NCT00327093|immunohistochemistry,|immunohistochemistry,
1618130|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
1618131|NCT00327093|predictive model,|predictive model,
1618132|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
1618133|NCT00327093|medical imaging|medical imaging
1618134|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
1618135|NCT00327080|HIV|hiv
1618136|NCT00327080|AIDS|aids
1618137|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
1618138|NCT00327080|Blood Flow Studies|blood flow studies
1618139|NCT00327080|Right Heart Catheterization|right heart catheterization
1618140|NCT00327080|HIV Infection|hiv infection
1618141|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
1618142|NCT00327080|Healthy Volunteer|healthy volunteer
1618143|NCT00327080|HV|hv
1618144|NCT00327067|Hemoglobin|hemoglobin
1618145|NCT00327067|Iron Supplementation|iron supplementation
1618146|NCT00327067|Donor Retention|donor retention
1618147|NCT00327067|Iron Stores|iron stores
1618148|NCT00327067|Ferritin|ferritin
1618149|NCT00327067|Transferrin Saturation|transferrin saturation
1618150|NCT00327067|Healthy Volunteer|healthy volunteer
1618151|NCT00327067|HV|hv
1618152|NCT00327067|Blood Donors|blood donors
1618153|NCT00327054|Dyslipidaemia|dyslipidaemia
1618154|NCT00327054|Herbal medicine|herbal medicine
1618155|NCT00327054|Home remedy|home remedy
1618156|NCT00327054|Alternative medicine|alternative medicine
1618157|NCT00327054|Metabolic syndrome|metabolic syndrome
1618158|NCT00327041|Aspirin|aspirin
1618159|NCT00327041|Clopidogrel|clopidogrel
1618160|NCT00327041|Balloon Angioplasty|balloon angioplasty
1618161|NCT00327041|Coronary Thrombosis|coronary thrombosis
1618162|NCT00327028|Bronchial asthma|bronchial asthma
1618163|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
1618164|NCT00327028|Antiepileptic drugs|antiepileptic drugs
1618165|NCT00327028|Efficacy|efficacy
1618166|NCT00327002|Low HDL|low hdl
1618167|NCT00327002|Metabolic syndrome|metabolic syndrome
1618168|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
1618169|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
1618170|NCT00326989|Cell therapy|cell therapy
1618171|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1618172|NCT00326976|Myocardial Revascularization|myocardial revascularization
1618173|NCT00326950|Cancer|cancer
1618174|NCT00326950|Tumors|tumors
1618175|NCT00326950|Phase I|phase i
1618176|NCT00326950|E7389|e7389
1618177|NCT00326924|Transfusion|transfusion
1618178|NCT00326898|Sorafenib|sorafenib
1618179|NCT00326898|Sunitinib|sunitinib
1618180|NCT00326898|Renal Carcinoma|renal carcinoma
1618181|NCT00326885|Ascites|ascites
1618182|NCT00326885|Epithelial Cancer|epithelial cancer
1618183|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
1618184|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
1618185|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
1618186|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
1618187|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
1618188|NCT00326885|Malignant Ascites|malignant ascites
1618189|NCT00326885|Ovarian Cancer|ovarian cancer
1618190|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
1618191|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
1618192|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
1618193|NCT00326885|Peritoneal Cancer|peritoneal cancer
1618194|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
1618195|NCT00326885|Recurrent Ascites|recurrent ascites
1618196|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
1618197|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
1618198|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
1618199|NCT00326885|Symptomatic Ascites|symptomatic ascites
1618200|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
1618201|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
1618202|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
1618203|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
1618204|NCT00326859|analgesia strategies|analgesia strategies
1618206|NCT00326859|extensive dressing change|extensive dressing change
1618207|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
1618208|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
1618209|NCT00326833|Holotranscobalamin|holotranscobalamin
1618210|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
1618211|NCT00326820|stage IV breast cancer|stage iv breast cancer
1618212|NCT00326820|bone metastases|bone metastases
1618213|NCT00326820|recurrent breast cancer|recurrent breast cancer
1618214|NCT00326820|male breast cancer|male breast cancer
1618215|NCT00326807|naltrexone|naltrexone
1618216|NCT00326807|alcohol|alcohol
1618217|NCT00326807|gambling|gambling
1618218|NCT00326807|concurrent|concurrent
1618219|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
1618220|NCT00326794|Rehabilitation|rehabilitation
1618221|NCT00326794|Physiotherapy|physiotherapy
1618222|NCT00326794|randomised controlled trial|randomised controlled trial
1618223|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
1618224|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
1618225|NCT00326742|Alcoholism|alcoholism
1618226|NCT00326742|Risk factors|risk factors
1618227|NCT00326742|Adolescence|adolescence
1618228|NCT00326742|Stress test|stress test
1618229|NCT00326742|HPA system|hpa system
1618230|NCT00326742|Family adversity|family adversity
1618231|NCT00326742|Candidate genes|candidate genes
1618232|NCT00326742|Cortisol|cortisol
1618233|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
1618234|NCT00326729|burns|burns
1618235|NCT00326729|thermal injury|thermal injury
1618236|NCT00326729|hemodynamics|hemodynamics
1618237|NCT00326729|microcirculation|microcirculation
1618238|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
1618239|NCT00326703|hypoxia|hypoxia
1618240|NCT00326703|hypobaric|hypobaric
1618241|NCT00326703|altitude|altitude
1618242|NCT00326690|Congestive Heart Failure|congestive heart failure
1618243|NCT00326690|Coronary Artery Disease|coronary artery disease
1618244|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
1618245|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
1618246|NCT00326677|Depression Prevention|depression prevention
1618247|NCT00326677|Prevention of Depression|prevention of depression
1618248|NCT00326677|Depression in the Elderly|depression in the elderly
1618249|NCT00326677|Late Life Depression|late life depression
1618250|NCT00326677|Depression in Old Age|depression in old age
1618251|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
1618252|NCT00326677|Sub syndromal depression|sub syndromal depression
1618253|NCT00326677|Minor Depression|minor depression
1618254|NCT00326651|infertility|infertility
1618255|NCT00326651|pregnancy|pregnancy
1618256|NCT00326651|conception|conception
1618257|NCT00326651|conceive|conceive
1618258|NCT00326651|conceiving|conceiving
1618259|NCT00326651|trying to conceive|trying to conceive
1618260|NCT00326651|get pregnant|get pregnant
1618261|NCT00326651|conception kit|conception kit
1618262|NCT00326651|conception cap|conception cap
1618264|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
1618265|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
1618266|NCT00326612|Seizures|seizures
1618267|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1618268|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1618269|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1618270|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
1618271|NCT00326573|Diabetes|diabetes
1618272|NCT00326573|Teenagers|teenagers
1618273|NCT00326573|Motivational Interviewing|motivational interviewing
1618274|NCT00326560|Pterygium excision|pterygium excision
1618275|NCT00326560|Cut and paste|cut and paste
1618276|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
1618277|NCT00326560|Conjunctival autograft|conjunctival autograft
1618278|NCT00326534|Sarcoidosis|sarcoidosis
1618279|NCT00326534|Rickettsia|rickettsia
1618280|NCT00326534|Serological reactions|serological reactions
1618281|NCT00326534|Polymerase chain reaction|polymerase chain reaction
1618282|NCT00326521|Pregnant Women|pregnant women
1618283|NCT00326521|Epidural Anesthesia|epidural anesthesia
1618284|NCT00326521|Fever|fever
1618285|NCT00326521|Chorioamnionitis|chorioamnionitis
1618286|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
1618287|NCT00326521|Pregnancy|pregnancy
1618288|NCT00326508|T Lymphocytes|t lymphocytes
1618289|NCT00326508|IL-2 Conjugate|il-2 conjugate
1618290|NCT00326508|CD25|cd25
1618291|NCT00326508|T Regulatory Cells|t regulatory cells
1618292|NCT00326508|Autoimmunity|autoimmunity
1618293|NCT00326508|Uveitis|uveitis
1618294|NCT00326508|Daclizumab|daclizumab
1618295|NCT00326508|Denileukin Diftitox|denileukin diftitox
1618296|NCT00326508|Immune Tolerance|immune tolerance
1618297|NCT00326508|T Cell|t cell
1618298|NCT00326495|Sorafenib|sorafenib
1618299|NCT00326495|Cetuximab|cetuximab
1618300|NCT00326495|Advanced Cancer|advanced cancer
1618301|NCT00326495|Phase II|phase ii
1618302|NCT00326495|Colorectal Cancer|colorectal cancer
1618303|NCT00326495|Colon Cancer|colon cancer
1618304|NCT00326495|Rectal Cancer|rectal cancer
1618305|NCT00326495|CRC|crc
1618306|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
1618307|NCT00326482|Drug Toxicity|drug toxicity
1618308|NCT00326482|Steatohepatitis|steatohepatitis
1618309|NCT00326482|Hepatotoxicity|hepatotoxicity
1618310|NCT00326482|Liver Biopsy|liver biopsy
1618311|NCT00326482|Elevated transaminases|elevated transaminases
1618312|NCT00326482|HIV|hiv
1618313|NCT00326482|Liver Fibrosis|liver fibrosis
1618314|NCT00326456|ovarian cancer|ovarian cancer
1618315|NCT00326456|chemotherapy|chemotherapy
1618316|NCT00326456|first-line|first-line
1618317|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
1618318|NCT00326430|Social Phobia|social phobia
1618319|NCT00326430|Cognitive Therapy|cognitive therapy
1618320|NCT00326430|Interpersonal Therapy|interpersonal therapy
1618321|NCT00326430|Efficacy|efficacy
1618322|NCT00326430|Process-Outcome|process-outcome
1618323|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
1618324|NCT00326404|Oral Contraceptives|oral contraceptives
1618325|NCT00326404|Adolescents|adolescents
1618326|NCT00326404|Compliance|compliance
1618327|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
1618328|NCT00326365|mechanical ventilation|mechanical ventilation
1618329|NCT00326365|secretions|secretions
1618330|NCT00326365|viscosity|viscosity
1618332|NCT00326365|kalium bichromate|kalium bichromate
1618333|NCT00326365|extubation|extubation
1618334|NCT00326352|Sedation|sedation
1618335|NCT00326352|Propofol|propofol
1618336|NCT00326352|Remifentanil|remifentanil
1618337|NCT00326352|recovery|recovery
1618338|NCT00326339|R935788|r935788
1618339|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
1618340|NCT00326339|Syk Kinase|syk kinase
1618341|NCT00326313|Group B streptococci|group b streptococci
1618342|NCT00326313|virulent|virulent
1618343|NCT00326313|morbidity|morbidity
1618344|NCT00326313|mortality|mortality
1618345|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
1618346|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
1618347|NCT00326287|Cephalosporins|cephalosporins
1618348|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
1618349|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
1618350|NCT00326235|Opioid withdrawal|opioid withdrawal
1618351|NCT00326235|Buspirone|buspirone
1618352|NCT00326235|Methadone taper|methadone taper
1618353|NCT00326222|Patient Education as a Topic|patient education as a topic
1618354|NCT00326222|Self-Management Program|self-management program
1618355|NCT00326222|Health promotion|health promotion
1618356|NCT00326222|Self Efficacy|self efficacy
1618357|NCT00326222|Quality of life|quality of life
1618359|NCT00326209|Ulcerative colitis|ulcerative colitis
1618360|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
1618361|NCT00326209|IBD|ibd
1618362|NCT00326196|CABG|cabg
1618363|NCT00326196|Coronary Disease|coronary disease
1618364|NCT00326196|Diabetes|diabetes
1618365|NCT00326196|PCI|pci
1618366|NCT00326170|Combination Chemotherapy|combination chemotherapy
1618367|NCT00326170|MDS|mds
1618368|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1618369|NCT00326170|AML|aml
1618370|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
1618371|NCT00326170|valproic acid|valproic acid
1618372|NCT00326170|VPA|vpa
1618373|NCT00326170|Depakene|depakene
1618374|NCT00326170|5-azacytidine|5-azacytidine
1618375|NCT00326170|5-aza|5-aza
1618376|NCT00326170|Azacitidine|azacitidine
1618377|NCT00326170|5-AZC|5-azc
1618378|NCT00326170|Vidaza|vidaza
1618379|NCT00326170|AZA-CR|aza-cr
1618380|NCT00326170|Ladakamycin|ladakamycin
1618381|NCT00326170|NSC-102816|nsc-102816
1618382|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
1618383|NCT00326170|ATRA|atra
1618384|NCT00326170|Tretinoin|tretinoin
1618385|NCT00326170|Vesanoid|vesanoid
1618386|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
1618387|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
1618388|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
1618389|NCT00326144|MDD|mdd
1618390|NCT00326144|Depression|depression
1618391|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
1618392|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
1618393|NCT00326105|MDD|mdd
1618394|NCT00326105|Depression|depression
1618395|NCT00326079|Open angle|open angle
1618396|NCT00326079|Glaucoma|glaucoma
1618397|NCT00326079|Surgery|surgery
1618398|NCT00326066|Open angle|open angle
1618399|NCT00326066|Glaucoma|glaucoma
1618400|NCT00326066|Surgery|surgery
1618401|NCT00326066|Cataract|cataract
1618402|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
1618403|NCT00326053|Acute Asthma|acute asthma
1618404|NCT00326053|Patient Discharge|patient discharge
1618405|NCT00326053|Emergency Service, Hospital|emergency service, hospital
1618406|NCT00326053|Asthma Exacerbation|asthma exacerbation
1618407|NCT00326053|Asthma Relapse|asthma relapse
1618408|NCT00326040|Open angle|open angle
1618409|NCT00326040|Glaucoma|glaucoma
1618410|NCT00326040|Refractory|refractory
1618411|NCT00326040|Surgery|surgery
1618412|NCT00326027|GERD|gerd
1618413|NCT00326027|Pantoprazole|pantoprazole
1618414|NCT00326027|NERD|nerd
1618415|NCT00326014|Open angle|open angle
1618416|NCT00326014|Glaucoma|glaucoma
1618417|NCT00326014|Cataract|cataract
1618418|NCT00326014|Surgery|surgery
1618419|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
1618420|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
1618421|NCT00326001|Atrial flutter|atrial flutter
1618422|NCT00326001|Catheter Ablation|catheter ablation
1618423|NCT00325988|Neuroimmunology|neuroimmunology
1618424|NCT00325988|Demyelinating Disease|demyelinating disease
1618425|NCT00325988|Genetics|genetics
1618426|NCT00325988|Proteins|proteins
1618427|NCT00325975|Smallpox|smallpox
1618428|NCT00325975|Variola|variola
1618429|NCT00325975|Orthopoxvirus|orthopoxvirus
1618430|NCT00325975|Virus|virus
1618431|NCT00325975|Immunogenicity|immunogenicity
1618432|NCT00325975|Smallpox Vaccine|smallpox vaccine
1618433|NCT00325962|Hypertension|hypertension
1618434|NCT00325962|Type 2 Diabetes|type 2 diabetes
1618435|NCT00325962|6R-BH4|6r-bh4
1618436|NCT00325962|BH4|bh4
1618437|NCT00325962|BH4 deficiency|bh4 deficiency
1618438|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
1618439|NCT00325962|endothelial dysfunction|endothelial dysfunction
1618440|NCT00325962|NO|no
1618441|NCT00325962|Nitric Oxide|nitric oxide
1618442|NCT00325936|metabolic syndrome|metabolic syndrome
1618443|NCT00325936|Hypertension|hypertension
1618444|NCT00325936|CCB|ccb
1618445|NCT00325936|cilnidipine|cilnidipine
1618446|NCT00325923|Decision making|decision making
1618447|NCT00325923|Decision support|decision support
1618448|NCT00325923|Decisional conflict|decisional conflict
1618449|NCT00325923|Menopause|menopause
1618450|NCT00325923|Natural health products|natural health products
1618451|NCT00325923|Herbs|herbs
1618452|NCT00325923|Complementary medicine|complementary medicine
1618453|NCT00325923|Complementary therapies|complementary therapies
1618454|NCT00325910|Diabetes|diabetes
1618455|NCT00325910|Heart Failure|heart failure
1618456|NCT00325910|Mortality|mortality
1618457|NCT00325910|Hospitalization|hospitalization
1618458|NCT00325910|Feasability|feasability
1618459|NCT00325884|coronary artery disease|coronary artery disease
1618460|NCT00325884|bifurcation lesions|bifurcation lesions
1618461|NCT00325884|percutaneous interventions|percutaneous interventions
1618462|NCT00325884|stenting|stenting
1618463|NCT00325884|outcomes|outcomes
1618464|NCT00325884|death|death
1618465|NCT00325884|myocardial infarction|myocardial infarction
1618466|NCT00325858|osteoarthritis pain|osteoarthritis pain
1618467|NCT00325858|knee|knee
1618468|NCT00325858|hip|hip
1618469|NCT00325858|extended-release analgesia|extended-release analgesia
1618470|NCT00325858|opioid|opioid
1618471|NCT00325845|Investigational|investigational
1618472|NCT00325845|Therapeutic|therapeutic
1618473|NCT00325845|Efficacy|efficacy
1618474|NCT00325845|Safety|safety
1618475|NCT00325845|Outcomes|outcomes
1618476|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
1618477|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
1618478|NCT00325832|Hypertension|hypertension
1618479|NCT00325832|Blood Pressure|blood pressure
1618480|NCT00325832|Systolic Pressure|systolic pressure
1618481|NCT00325832|Diastolic Pressure|diastolic pressure
1618482|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
1618483|NCT00325819|Acetaminophen|acetaminophen
1618484|NCT00325819|Vaccination|vaccination
1618485|NCT00325819|Immunization|immunization
1618486|NCT00325793|nicardipine|nicardipine
1618487|NCT00325793|hypertension|hypertension
1618488|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
1618489|NCT00325793|ischemic stroke|ischemic stroke
1618490|NCT00325780|Kowa|kowa
1618491|NCT00325780|Hypercholesterolemia|hypercholesterolemia
1618492|NCT00325780|dyslipidemia|dyslipidemia
1618493|NCT00325780|pitavastatin|pitavastatin
1618494|NCT00325780|NK-104|nk-104
1618495|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
1618496|NCT00325767|mucociliary clearance|mucociliary clearance
1618497|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
1618498|NCT00325767|inhalation|inhalation
1618499|NCT00325767|aerosol|aerosol
1618500|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1618501|NCT00325754|COPD|copd
1618502|NCT00325741|Lupus|lupus
1618503|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
1618504|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
1618505|NCT00325728|Chronic Insomnia|chronic insomnia
1618506|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
1618507|NCT00325728|Drug Therapy|drug therapy
1618508|NCT00325728|Alzheimer disease|alzheimer disease
1618509|NCT00325702|HIV|hiv
1618510|NCT00325702|prevention|prevention
1618511|NCT00325676|GERD|gerd
1618512|NCT00325676|Pantoprazole|pantoprazole
1618513|NCT00325676|Complete Remission|complete remission
1618514|NCT00325663|acupuncture|acupuncture
1618515|NCT00325663|double-blind|double-blind
1618516|NCT00325663|sham control|sham control
1618517|NCT00325663|osteoarthritis|osteoarthritis
1618518|NCT00325663|pain|pain
1618519|NCT00325650|Prediabetic state|prediabetic state
1618520|NCT00325650|Impaired fasting glucose|impaired fasting glucose
1618521|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
1618522|NCT00325637|CHERISH|cherish
1618523|NCT00325637|Ischemic Stroke|ischemic stroke
1618524|NCT00325624|Blood Pressure|blood pressure
1618525|NCT00325624|Diabetes mellitus|diabetes mellitus
1618526|NCT00325624|Hypertension|hypertension
1618527|NCT00325624|Home Care|home care
1618528|NCT00325624|Glucometer|glucometer
1618529|NCT00325611|Palliative care|palliative care
1618530|NCT00325611|End of life care|end of life care
1618531|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
1618532|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1618533|NCT00325585|Substance Abuse|substance abuse
1618534|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
1618535|NCT00325585|Intervention Studies|intervention studies
1618536|NCT00325585|Women's Health|women's health
1618537|NCT00325546|Obesity|obesity
1618538|NCT00325533|Blood Pressure, High|blood pressure, high
1618539|NCT00325533|Blacks|blacks
1618540|NCT00325533|African Americans|african americans
1618541|NCT00325507|Renal cell cancer|renal cell cancer
1618542|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
1618543|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
1618544|NCT00325494|Pancreatic Cancer|pancreatic cancer
1618545|NCT00325494|Mesothelioma|mesothelioma
1618546|NCT00325494|Ovarian Cancer|ovarian cancer
1618547|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
1618548|NCT00325494|Mesothelin|mesothelin
1618549|NCT00325468|bone loss|bone loss
1618550|NCT00325468|osteoporosis|osteoporosis
1618551|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1618552|NCT00325429|Type 2 diabetes|type 2 diabetes
1618553|NCT00325429|Vildagliptin|vildagliptin
1618554|NCT00325429|HbA1c|hba1c
1618555|NCT00325416|melphalan|melphalan
1618556|NCT00325416|topotecan|topotecan
1618557|NCT00325416|topoisomerase|topoisomerase
1618558|NCT00325416|bone marrow transplant|bone marrow transplant
1618559|NCT00325416|drug sequence|drug sequence
1618560|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1618561|NCT00325390|SR25990C|sr25990c
1618562|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1618563|NCT00325390|NSTEACS|nsteacs
1618564|NCT00325377|low back pain|low back pain
1618565|NCT00325377|pain|pain
1618566|NCT00325377|magnetism|magnetism
1618567|NCT00325377|electromagnetic fields|electromagnetic fields
1618568|NCT00325377|visual analogue pain scale|visual analogue pain scale
1618569|NCT00325351|Ovarian cancer|ovarian cancer
1618570|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
1618571|NCT00325338|Allergy|allergy
1618572|NCT00325338|Specific Immunotherapy|specific immunotherapy
1618573|NCT00325338|Ragweed|ragweed
1618574|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
1618575|NCT00325325|Kidney Transplantation|kidney transplantation
1618576|NCT00325312|Neck Pain|neck pain
1618577|NCT00325312|Complementary Therapies|complementary therapies
1618578|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
1618579|NCT00325312|Acute Treatment|acute treatment
1618580|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
1618581|NCT00325273|Atopic dermatitis|atopic dermatitis
1618582|NCT00325273|Allergic rhinitis|allergic rhinitis
1618583|NCT00325273|Asthma|asthma
1618584|NCT00325273|Infant|infant
1618585|NCT00325273|Pregnancy|pregnancy
1618586|NCT00325260|influenza|influenza
1618587|NCT00325260|non-inferiority|non-inferiority
1618588|NCT00325260|Influvac|influvac
1618589|NCT00325260|Agrippal|agrippal
1618590|NCT00325260|healthy subjects|healthy subjects
1618591|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
1618592|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
1618593|NCT00325247|UNDER FIVE CHILDREN|under five children
1618594|NCT00325247|RURAL BANGLADESH|rural bangladesh
1618595|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1618596|NCT00325221|telemedicine|telemedicine
1618597|NCT00325221|Home Monitoring|home monitoring
1618598|NCT00325221|psychosomatic|psychosomatic
1618599|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
1618600|NCT00325221|quality of life|quality of life
1618601|NCT00325221|Electric Countershock|electric countershock
1618602|NCT00325182|Alcoholism|alcoholism
1618603|NCT00325169|Cross-over|cross-over
1618604|NCT00325169|Tiotropium|tiotropium
1618605|NCT00325169|Triple|triple
1618606|NCT00325169|COPD|copd
1618607|NCT00325169|SERETIDE 50/500|seretide 50/500
1618608|NCT00325169|Dyspnoea|dyspnoea
1618609|NCT00325169|Impulse oscillometry|impulse oscillometry
1618610|NCT00325169|Plethysmography|plethysmography
1618611|NCT00325117|Type 2 diabetes|type 2 diabetes
1618612|NCT00325117|Vildagliptin|vildagliptin
1618613|NCT00325117|HbA1c|hba1c
1618614|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
1618615|NCT00325104|Gastrinoma|gastrinoma
1618616|NCT00325104|Prolacinoma|prolacinoma
1618617|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
1618618|NCT00325104|Insulinoma|insulinoma
1618619|NCT00325104|MEN1|men1
1618620|NCT00325104|MEN2A|men2a
1618621|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
1618622|NCT00325091|Writer's Cramp|writer's cramp
1618623|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
1618624|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1618625|NCT00325091|Fine Motor Skills|fine motor skills
1618626|NCT00325091|Focal Hand Dystonia|focal hand dystonia
1618627|NCT00325091|Writer Cramp|writer cramp
1618628|NCT00325091|Healthy Volunteer|healthy volunteer
1618629|NCT00325091|HV|hv
1618630|NCT00325078|Remicade|remicade
1618631|NCT00325078|Crohn's Disease|crohn's disease
1618632|NCT00325078|IBD|ibd
1618633|NCT00325078|CGD Infection|cgd infection
1618634|NCT00325078|Infliximab|infliximab
1618635|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
1618637|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
1618638|NCT00325065|Amygdala|amygdala
1618639|NCT00325065|Emotion|emotion
1618640|NCT00325065|Memory|memory
1618641|NCT00325065|Threat|threat
1618642|NCT00325065|Peptides|peptides
1618643|NCT00325065|Neuropeptides|neuropeptides
1618644|NCT00325065|Oxytocin|oxytocin
1618645|NCT00325065|Vasopressin|vasopressin
1618646|NCT00325065|Mood Disorder|mood disorder
1618647|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
1618648|NCT00325039|Surgery|surgery
1618649|NCT00325026|Preterm gestation|preterm gestation
1618650|NCT00325026|Cervical ripening|cervical ripening
1618651|NCT00325026|Labor induction|labor induction
1618652|NCT00325026|Misoprostol|misoprostol
1618653|NCT00325026|Foley bulb|foley bulb
1618654|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1618656|NCT00325013|DHA|dha
1618657|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
1618658|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1618659|NCT00324974|infant|infant
1618660|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
1618661|NCT00324974|PPI|ppi
1618662|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
1618663|NCT00324961|e Antigen negative|e antigen negative
1618664|NCT00324961|chronic hepatitis B|chronic hepatitis b
1618665|NCT00324961|Chinese|chinese
1618666|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
1618667|NCT00324948|Female sexual dysfunction|female sexual dysfunction
1618668|NCT00324922|Vancomycin|vancomycin
1618821|NCT00324519|pregnancy termination|pregnancy termination
1618669|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1618670|NCT00324896|Parkinson's|parkinson's
1618671|NCT00324896|insomnia|insomnia
1618672|NCT00324896|drug|drug
1618673|NCT00324896|eszopiclone|eszopiclone
1618674|NCT00324896|placebo|placebo
1618675|NCT00324883|sodium intake|sodium intake
1618676|NCT00324883|sodium excretion|sodium excretion
1618677|NCT00324883|chloride excretion|chloride excretion
1618678|NCT00324883|creatinine|creatinine
1618679|NCT00324883|hypertension|hypertension
1618680|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
1618681|NCT00324857|race|race
1618682|NCT00324857|ethnicity|ethnicity
1618683|NCT00324857|knee replacement|knee replacement
1618684|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1618685|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1618686|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1618687|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1618688|NCT00324818|bacterial vaginosis|bacterial vaginosis
1618689|NCT00324818|treatment|treatment
1618690|NCT00324805|AJCC v6|ajcc v6
1618691|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1618692|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1618693|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1618694|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1618695|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1618696|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1618697|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1618698|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1618699|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1618700|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1618701|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1618702|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1618703|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1618704|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1618705|NCT00324753|cancer|cancer
1618706|NCT00324753|screening|screening
1618707|NCT00324753|communication|communication
1618708|NCT00324753|prevention|prevention
1618709|NCT00324727|liver metastases|liver metastases
1618710|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
1618711|NCT00324727|stage IV melanoma|stage iv melanoma
1618712|NCT00324727|recurrent melanoma|recurrent melanoma
1618713|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
1618714|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
1618715|NCT00324727|iris melanoma|iris melanoma
1618716|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1618717|NCT00324714|osteoporosis|osteoporosis
1618718|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1618719|NCT00324714|breast cancer in situ|breast cancer in situ
1618720|NCT00324701|Mental Health|mental health
1618721|NCT00324701|Geriatric Medicine|geriatric medicine
1618722|NCT00324701|Depression|depression
1618723|NCT00324701|Health Service Delivery|health service delivery
1618724|NCT00324701|Aged|aged
1618725|NCT00324688|HIV-1|hiv-1
1618727|NCT00324688|HIV-1 infection|hiv-1 infection
1618728|NCT00324675|type 2 diabetes,|type 2 diabetes,
1618729|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
1618730|NCT00324675|renal plasma flow,|renal plasma flow,
1618731|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
1618732|NCT00324675|proteinuria,|proteinuria,
1618733|NCT00324675|diabetic nephropathy|diabetic nephropathy
1618734|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
1618735|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
1618736|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
1618737|NCT00324662|Electric Countershock|electric countershock
1618738|NCT00324649|HIV-1|hiv-1
1618739|NCT00324623|stage IV melanoma|stage iv melanoma
1618740|NCT00324623|recurrent melanoma|recurrent melanoma
1618741|NCT00324610|fluoropyrimidines|fluoropyrimidines
1618742|NCT00324610|metastases|metastases
1618743|NCT00324610|pharmacokinetics|pharmacokinetics
1618744|NCT00324610|phase 1-2 study|phase 1-2 study
1618745|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1618746|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1618747|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1618748|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1618749|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1618750|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1618751|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1618752|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1618753|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1618754|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1618755|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1618756|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1618757|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1618758|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1618759|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1618760|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1618761|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1618762|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1618763|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1618764|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1618765|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1618766|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1618767|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1618768|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1618769|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1618770|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1618771|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1618772|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1618773|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1618774|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1618775|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1618776|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1618777|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1618778|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1618779|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1618780|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
1618781|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1618782|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1618783|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1618784|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1618785|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1618786|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1618787|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1618788|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1618789|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1618790|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1618791|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1618792|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
1618793|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1618794|NCT00324597|large cell lung cancer|large cell lung cancer
1618795|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1618796|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1619025|NCT00324038|OA|oa
1618797|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1618798|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1618799|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1618800|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1618801|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1618802|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1618803|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1618804|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1618805|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1618806|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1618807|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1618808|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1618809|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
1618810|NCT00324584|telecare|telecare
1618811|NCT00324584|telemedicine|telemedicine
1618812|NCT00324584|insulin pump therapy|insulin pump therapy
1618813|NCT00324558|Bemiparin|bemiparin
1618814|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
1618815|NCT00324545|Obesity|obesity
1618816|NCT00324545|Diets|diets
1618817|NCT00324545|Heart Disease|heart disease
1618818|NCT00324545|Randomized controlled trial|randomized controlled trial
1618819|NCT00324545|Ischemia.|ischemia.
1618820|NCT00324519|second trimester|second trimester
1618822|NCT00324519|misoprostol|misoprostol
1618823|NCT00324519|foley bulb|foley bulb
1618824|NCT00324493|Severe Hemophilia|severe hemophilia
1618825|NCT00324493|Musculoskeletal Function|musculoskeletal function
1618826|NCT00324493|Factor Replacement|factor replacement
1618827|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
1618828|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
1618830|NCT00324467|DLBCL|dlbcl
1618831|NCT00324467|R-CHOP|r-chop
1618832|NCT00324467|R-ICE|r-ice
1618833|NCT00324454|motor neuron disease|motor neuron disease
1618834|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
1618835|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
1618836|NCT00324454|cramps|cramps
1618837|NCT00324454|spasticity|spasticity
1618838|NCT00324441|Fibromyalgia|fibromyalgia
1618839|NCT00324441|Rehabilitation|rehabilitation
1618840|NCT00324441|Physical Medicine|physical medicine
1618841|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
1618842|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
1618843|NCT00324428|TMS|tms
1618844|NCT00324428|Visceral Pain|visceral pain
1618845|NCT00324428|Analgesia|analgesia
1618846|NCT00324428|Pancreatic Cancer|pancreatic cancer
1618847|NCT00324428|Cancer|cancer
1618848|NCT00324428|Electric stimulation therapy|electric stimulation therapy
1618849|NCT00324428|Electric stimulation|electric stimulation
1618850|NCT00324428|Pain|pain
1618851|NCT00324428|Safety|safety
1618852|NCT00324415|stage I anal cancer|stage i anal cancer
1618853|NCT00324415|stage II anal cancer|stage ii anal cancer
1618854|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
1618855|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
1618856|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1618857|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1618858|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1618859|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
1618860|NCT00324402|pregnancy|pregnancy
1618861|NCT00324402|biomarker|biomarker
1618862|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
1618863|NCT00324363|exenatide|exenatide
1618864|NCT00324363|diabetes|diabetes
1618865|NCT00324363|Amylin|amylin
1618866|NCT00324363|Lilly|lilly
1618867|NCT00324363|China|china
1618868|NCT00324350|Diabetes Mellitus|diabetes mellitus
1618869|NCT00324350|Fracture|fracture
1618870|NCT00324350|Falls|falls
1618871|NCT00324350|Height Loss|height loss
1618872|NCT00324324|infection|infection
1618873|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1618874|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1618875|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1618876|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1618877|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1618878|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1618879|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1618880|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1619026|NCT00324038|Elderly|elderly
1618881|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1618882|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1618883|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1618884|NCT00324324|primary myelofibrosis|primary myelofibrosis
1618885|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1618886|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1618887|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1618888|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1618889|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
1618890|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1618891|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1618892|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1618893|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1618894|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1618895|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1618896|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1618897|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1618898|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1619057|NCT00323934|Advanced Solid Tumors|advanced solid tumors
1618899|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1618900|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1618901|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1618902|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1618903|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1618904|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1619172|NCT00323440|Remission|remission
1619173|NCT00323440|RNA|rna
1618905|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1618906|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1618907|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1618908|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1618909|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1618910|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1618911|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1618912|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1618913|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1618914|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1618915|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1618916|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1618917|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1618918|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1618919|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1618920|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1618921|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1618922|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1618923|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
1618924|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1618925|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1618926|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1618927|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1618928|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1618929|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
1618930|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
1618931|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1618932|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1618933|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1618934|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1618935|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
1618936|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
1618937|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1618938|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1618939|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1618940|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1618941|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1619024|NCT00324064|Growth hormone deficiency|growth hormone deficiency
1618942|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1618943|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1618944|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1618945|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1618946|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1618947|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1618948|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1618949|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1618950|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1618951|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
1618952|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1618953|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1618954|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1618955|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
1618956|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
1618957|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
1618958|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1618959|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1618960|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1618961|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1619058|NCT00323908|Breast Cancer|breast cancer
1618962|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1618963|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1618964|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1618965|NCT00324324|stage IV breast cancer|stage iv breast cancer
1618966|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1618967|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1618968|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1618969|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1618970|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1619174|NCT00323440|Cytokines|cytokines
1618971|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1618972|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1618973|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1618974|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1618975|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1618976|NCT00324285|Diarrhoea|diarrhoea
1618977|NCT00324285|severe malnutrition|severe malnutrition
1618978|NCT00324285|amylase resistant starch|amylase resistant starch
1618979|NCT00324285|ORS|ors
1618980|NCT00324272|Groin dissection|groin dissection
1618981|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
1618982|NCT00324272|Lymph node dissection|lymph node dissection
1618983|NCT00324272|Lymphadenectomy|lymphadenectomy
1618984|NCT00324272|Seroma|seroma
1618985|NCT00324272|Wound drainage|wound drainage
1618986|NCT00324272|Fibrin sealant|fibrin sealant
1618987|NCT00324272|Malignant melanoma|malignant melanoma
1618988|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
1618989|NCT00324246|vaginal infection|vaginal infection
1618990|NCT00324246|color appearance|color appearance
1618991|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
1618992|NCT00324246|in-vitro|in-vitro
1618993|NCT00324246|vaginal secretion|vaginal secretion
1618994|NCT00324246|elevated pH|elevated ph
1618995|NCT00324233|Residual urine|residual urine
1618996|NCT00324233|Hematuria|hematuria
1618997|NCT00324233|Ultra sound|ultra sound
1618998|NCT00324220|Phase I/II|phase i/ii
1618999|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
1619000|NCT00324207|Insulin mRNA|insulin mrna
1619001|NCT00324194|Leukemia|leukemia
1619002|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
1619003|NCT00324194|Phase I|phase i
1619004|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
1619005|NCT00324181|psychopathology|psychopathology
1619006|NCT00324181|Hong Kong|hong kong
1619007|NCT00324168|Bacterial Infections|bacterial infections
1619008|NCT00324168|Eye Diseases|eye diseases
1619009|NCT00324168|Bacterial Keratitis|bacterial keratitis
1619010|NCT00324168|Visual Acuity|visual acuity
1619011|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
1619012|NCT00324155|Stage IV melanoma|stage iv melanoma
1619013|NCT00324142|Bacterial vaginosis|bacterial vaginosis
1619014|NCT00324142|Tinidazole|tinidazole
1619015|NCT00324142|Vaginitis|vaginitis
1619016|NCT00324129|Leukemia|leukemia
1619017|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
1619018|NCT00324129|Phase I|phase i
1619019|NCT00324103|HIV|hiv
1619020|NCT00324103|Chronic Infection|chronic infection
1619021|NCT00324103|Clinical Trial|clinical trial
1619022|NCT00324103|Structured Treatment Interruption|structured treatment interruption
1619023|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
1619028|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
1619029|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
1619030|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
1619031|NCT00324012|cisplatin|cisplatin
1619032|NCT00324012|taxotere|taxotere
1619033|NCT00323999|Hysteroscopic resection|hysteroscopic resection
1619034|NCT00323999|Menorrhagia|menorrhagia
1619035|NCT00323999|fibroids|fibroids
1619036|NCT00323999|polyps|polyps
1619037|NCT00323986|COPD|copd
1619038|NCT00323986|tracheotomy|tracheotomy
1619039|NCT00323986|azithromycin|azithromycin
1619040|NCT00323986|exacerbation|exacerbation
1619041|NCT00323986|hospitalisation|hospitalisation
1619042|NCT00323986|exhaled breath condensate|exhaled breath condensate
1619043|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
1619044|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
1619045|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
1619046|NCT00323960|prednisone|prednisone
1619047|NCT00323960|cyclosporine|cyclosporine
1619048|NCT00323960|methotrexate|methotrexate
1619049|NCT00323960|effectiveness|effectiveness
1619050|NCT00323947|ADHD|adhd
1619051|NCT00323947|Seizures|seizures
1619052|NCT00323947|Methylphenidate|methylphenidate
1619053|NCT00323947|Stimulant|stimulant
1619054|NCT00323934|metastatic solid tumor|metastatic solid tumor
1619055|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
1619056|NCT00323934|Phase I|phase i
1619059|NCT00323908|prevention|prevention
1619060|NCT00323908|tissue sampling|tissue sampling
1619061|NCT00323908|polymorphisms|polymorphisms
1619062|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
1619063|NCT00323882|Prostate Cancer|prostate cancer
1619064|NCT00323882|Oncology|oncology
1619065|NCT00323882|Prostate|prostate
1619066|NCT00323882|Cancer|cancer
1619067|NCT00323882|Metastatic|metastatic
1619068|NCT00323882|Hormone|hormone
1619960|NCT00320203|open-angle|open-angle
1619070|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
1619071|NCT00323856|Hemophilia A|hemophilia a
1619072|NCT00323856|Plasma-derived treatment|plasma-derived treatment
1619073|NCT00323856|Factor VIII|factor viii
1619074|NCT00323856|Inhibitor|inhibitor
1619075|NCT00323843|Kidney stone|kidney stone
1619076|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
1619077|NCT00323843|renal pelvic pressure|renal pelvic pressure
1619078|NCT00323830|gastric cancer|gastric cancer
1619079|NCT00323830|radiotherapy|radiotherapy
1619080|NCT00323830|postoperative therapy|postoperative therapy
1619081|NCT00323830|chemotherapy|chemotherapy
1619082|NCT00323804|Maintenance therapy|maintenance therapy
1619083|NCT00323804|Non-responder patients|non-responder patients
1619084|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
1619085|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
1619086|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
1619087|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1619088|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
1619089|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
1619090|NCT00323778|hyalgan|hyalgan
1619091|NCT00323778|knee|knee
1619092|NCT00323778|osteoarthritis|osteoarthritis
1619093|NCT00323778|MRI|mri
1619094|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1619095|NCT00323765|Cervical Dystonia|cervical dystonia
1619096|NCT00323765|Plasticity|plasticity
1619097|NCT00323765|Healthy Volunteer|healthy volunteer
1619098|NCT00323765|HV|hv
1619099|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
1619100|NCT00323739|kidney cancer|kidney cancer
1619101|NCT00323739|bevacizumab|bevacizumab
1619102|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
1619103|NCT00323713|CKD stage 4|ckd stage 4
1619104|NCT00323713|CKD stage 5|ckd stage 5
1619105|NCT00323713|Protein intake|protein intake
1619106|NCT00323713|Low protein diet|low protein diet
1619107|NCT00323713|Very low protein diet|very low protein diet
1619108|NCT00323713|Ketoanalogs|ketoanalogs
1619109|NCT00323713|Renal death|renal death
1619110|NCT00323700|ADHD|adhd
1619111|NCT00323700|Effectiveness|effectiveness
1619112|NCT00323700|ODD|odd
1619113|NCT00323687|HIV-1 Infection|hiv-1 infection
1619114|NCT00323674|Hernia Inguinalis|hernia inguinalis
1619115|NCT00323661|Pacing|pacing
1619116|NCT00323661|Rate-adaptive|rate-adaptive
1619117|NCT00323661|Quality of life|quality of life
1619118|NCT00323661|Cognitive performance|cognitive performance
1619119|NCT00323661|Atrial fibrillation|atrial fibrillation
1619120|NCT00323661|Pacemaker sensor|pacemaker sensor
1619121|NCT00323635|nocturia|nocturia
1619122|NCT00323635|urinary incontinence|urinary incontinence
1619123|NCT00323635|overactive bladder|overactive bladder
1619124|NCT00323635|tolterodine|tolterodine
1619125|NCT00323635|sleep|sleep
1619126|NCT00323635|sleep disorder|sleep disorder
1619127|NCT00323635|menopause|menopause
1619128|NCT00323635|midlife women|midlife women
1619129|NCT00323635|psychological tests|psychological tests
1619130|NCT00323609|Kyphoplasty|kyphoplasty
1619131|NCT00323609|Vertebroplasty|vertebroplasty
1619132|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
1619133|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
1619134|NCT00323609|Spine|spine
1619135|NCT00323609|Back Pain|back pain
1619136|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
1619137|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
1619138|NCT00323583|Cancer|cancer
1619139|NCT00323583|Pancreatic Cancer|pancreatic cancer
1619140|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
1619141|NCT00323583|Living with Cancer|living with cancer
1619142|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1619143|NCT00323557|Leukemia|leukemia
1619144|NCT00323557|Sargramostim|sargramostim
1619145|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
1619146|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
1619147|NCT00323557|Prevnar|prevnar
1619148|NCT00323557|GM-CSF|gm-csf
1619150|NCT00323544|HIV 1|hiv 1
1619151|NCT00323544|HIV 1 infection|hiv 1 infection
1619152|NCT00323531|thoracoscopy|thoracoscopy
1619153|NCT00323531|fibrinolysis|fibrinolysis
1619154|NCT00323531|empyema|empyema
1619155|NCT00323531|children|children
1619156|NCT00323518|oral mucositis|oral mucositis
1619157|NCT00323518|hematologic|hematologic
1619158|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
1619159|NCT00323518|velafermin|velafermin
1619160|NCT00323518|stomatitis|stomatitis
1619161|NCT00323518|oncology - supportive care|oncology - supportive care
1619162|NCT00323518|mouth diseases|mouth diseases
1619163|NCT00323492|HIV 1 Infection|hiv 1 infection
1619164|NCT00323479|breast cancer treatment|breast cancer treatment
1619165|NCT00323479|joint disorders|joint disorders
1619166|NCT00323453|Appendectomy|appendectomy
1619167|NCT00323453|Surgery|surgery
1619168|NCT00323453|Infection|infection
1619169|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
1619170|NCT00323440|Inflammation|inflammation
1619171|NCT00323440|Attacks|attacks
1619175|NCT00323440|Inflammatory proteins|inflammatory proteins
1619176|NCT00323440|MEFV|mefv
1619177|NCT00323440|mutations|mutations
1619178|NCT00323440|Colchicine|colchicine
1619179|NCT00323440|Treatment|treatment
1619180|NCT00323440|microarray RNA analysis|microarray rna analysis
1619181|NCT00323427|Audiology|audiology
1619182|NCT00323427|Coping behaviors|coping behaviors
1619183|NCT00323427|Counseling|counseling
1619184|NCT00323427|Hearing aids|hearing aids
1619185|NCT00323427|Hearing impairment|hearing impairment
1619186|NCT00323427|Patient-centered care|patient-centered care
1619187|NCT00323427|Psychological adaptation|psychological adaptation
1619188|NCT00323427|Psychological adjustment|psychological adjustment
1619189|NCT00323427|Rehabilitation|rehabilitation
1619190|NCT00323427|Social adjustment|social adjustment
1619191|NCT00323427|Aural Rehabilitation|aural rehabilitation
1619192|NCT00323414|PUFA|pufa
1619193|NCT00323414|NASH|nash
1619194|NCT00323414|Fatty Liver|fatty liver
1619195|NCT00323414|Insulin resistance|insulin resistance
1619196|NCT00323414|Metabolic syndrome|metabolic syndrome
1619197|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1619198|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1619199|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1619200|NCT00323401|Pregnancy|pregnancy
1619201|NCT00323401|Parturition|parturition
1619202|NCT00323401|Depression|depression
1619203|NCT00323401|Randomized|randomized
1619204|NCT00323401|Antenatal classes|antenatal classes
1619205|NCT00323375|Malaria|malaria
1619206|NCT00323375|Aminoquinolines|aminoquinolines
1619207|NCT00323375|Drug Resistance|drug resistance
1619208|NCT00323375|Chloroquine Resistance|chloroquine resistance
1619209|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1619210|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1619211|NCT00323349|Glucose Tolerance Test|glucose tolerance test
1619212|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
1619213|NCT00323349|Motivation|motivation
1619214|NCT00323349|Communication|communication
1619215|NCT00323349|Health Behavior|health behavior
1619216|NCT00323323|Untreated|untreated
1619217|NCT00323323|CD-20 Negative|cd-20 negative
1619218|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
1619219|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
1619220|NCT00323284|Open angle|open angle
1619221|NCT00323284|Glaucoma|glaucoma
1619222|NCT00323284|Cataract|cataract
1619223|NCT00323284|Surgery|surgery
1619224|NCT00323271|Chronic pain|chronic pain
1619225|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
1619226|NCT00323271|Multiple sclerosis|multiple sclerosis
1619227|NCT00323271|Randomized controlled trial|randomized controlled trial
1619228|NCT00323258|Heart disease|heart disease
1619229|NCT00323258|Coronary disease|coronary disease
1619230|NCT00323258|Patient compliance|patient compliance
1619231|NCT00323258|Treatment refusal|treatment refusal
1619233|NCT00323258|Continuity of patient care|continuity of patient care
1619234|NCT00323258|Evidence-based medicine|evidence-based medicine
1619235|NCT00323258|Patient education|patient education
1619236|NCT00323258|Adherence|adherence
1619237|NCT00323245|Randomized clinical trial|randomized clinical trial
1619238|NCT00323245|osteoporosis|osteoporosis
1619239|NCT00323245|urinary incontinence|urinary incontinence
1619240|NCT00323245|physiotherapy|physiotherapy
1619241|NCT00323245|education|education
1619242|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
1619243|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
1619244|NCT00323206|melanoma|melanoma
1619245|NCT00323206|electroporation|electroporation
1619246|NCT00323206|IL-12|il-12
1619247|NCT00323206|gene therapy|gene therapy
1619248|NCT00323206|gene transfer|gene transfer
1619249|NCT00323193|Behavioral interventions|behavioral interventions
1619250|NCT00323193|Mental Illness|mental illness
1619251|NCT00323193|Obesity|obesity
1619252|NCT00323193|Psycho-educational interventions|psycho-educational interventions
1619253|NCT00323193|Weight management|weight management
1619254|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
1619255|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
1619256|NCT00323154|Morphine, analgesia|morphine, analgesia
1619257|NCT00323141|Hernia umbilicalis|hernia umbilicalis
1619258|NCT00323115|immunotherapy|immunotherapy
1619259|NCT00323115|cancer vaccine|cancer vaccine
1619260|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
1619261|NCT00323089|microcoil|microcoil
1620244|NCT00318981|ADHD|adhd
1619262|NCT00323089|subcentimetre nodules|subcentimetre nodules
1619263|NCT00323063|recurrent breast cancer|recurrent breast cancer
1619264|NCT00323063|stage IV breast cancer|stage iv breast cancer
1619265|NCT00323063|male breast cancer|male breast cancer
1619266|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
1619267|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
1619268|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
1619269|NCT00323037|heart failure|heart failure
1619270|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1619271|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
1619272|NCT00323024|Idiopathic PAH|idiopathic pah
1619273|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
1619274|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
1619275|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
1619276|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
1619277|NCT00322985|T-cell lymphoma|t-cell lymphoma
1619278|NCT00322985|lenalidomide|lenalidomide
1619279|NCT00322972|Bacterial Infections|bacterial infections
1619280|NCT00322972|Chlamydia Infections|chlamydia infections
1619281|NCT00322972|Eye Diseases|eye diseases
1619282|NCT00322959|dendritic cells|dendritic cells
1619283|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
1619284|NCT00322946|Dengue Fever|dengue fever
1619285|NCT00322946|Dengue Vaccine|dengue vaccine
1619286|NCT00322946|Dengue Virus|dengue virus
1619287|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1619288|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
1619289|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
1619290|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
1619291|NCT00322933|acute renal failure|acute renal failure
1619292|NCT00322933|renal recovery|renal recovery
1619293|NCT00322933|mortality|mortality
1619294|NCT00322920|cervical cancer|cervical cancer
1619295|NCT00322920|topotecan|topotecan
1619296|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
1619297|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
1619299|NCT00322907|treatment|treatment
1619300|NCT00322907|cotrifazid|cotrifazid
1619301|NCT00322907|clinical trial|clinical trial
1619302|NCT00322907|efficacy|efficacy
1619303|NCT00322894|Breast cancer|breast cancer
1619304|NCT00322894|Risk factors|risk factors
1619305|NCT00322894|Treatment|treatment
1619306|NCT00322894|Clinico-pathologic|clinico-pathologic
1619307|NCT00322894|Outcomes|outcomes
1619308|NCT00322894|Tissue repository|tissue repository
1619309|NCT00322894|Registry|registry
1619310|NCT00322881|carboplatin|carboplatin
1619311|NCT00322881|paclitaxel|paclitaxel
1619312|NCT00322881|elderly women|elderly women
1619313|NCT00322868|Prescription drugs|prescription drugs
1619314|NCT00322868|Administration, oral|administration, oral
1619315|NCT00322868|Durable medical equipment|durable medical equipment
1619316|NCT00322868|Kinetics|kinetics
1619317|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1619318|NCT00322842|Multiple Myeloma|multiple myeloma
1619319|NCT00322842|Stem cell mobilization|stem cell mobilization
1619320|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
1619321|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
1619322|NCT00322803|panic disorder|panic disorder
1619323|NCT00322803|proof of concept|proof of concept
1619324|NCT00322777|Major depression|major depression
1619325|NCT00322777|Spirituality|spirituality
1619326|NCT00322777|Randomized clinical trial|randomized clinical trial
1619327|NCT00322764|manic depression|manic depression
1619328|NCT00322764|bipolar disorder|bipolar disorder
1619329|NCT00322764|depression|depression
1619330|NCT00322764|uridine|uridine
1619331|NCT00322764|RG2417|rg2417
1619332|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
1619333|NCT00322699|Bladder Cancer|bladder cancer
1619334|NCT00322699|Photodynamic Therapy|photodynamic therapy
1619335|NCT00322699|Photofrin|photofrin
1619336|NCT00322699|Photosensitization|photosensitization
1619337|NCT00322699|Photoradiation|photoradiation
1619338|NCT00322686|oglemilast|oglemilast
1619339|NCT00322686|asthma|asthma
1619340|NCT00322686|allergen|allergen
1619341|NCT00322686|prevention|prevention
1619342|NCT00322686|prophylaxis|prophylaxis
1619343|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
1619344|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
1619346|NCT00322608|Solid Tumors|solid tumors
1619347|NCT00322608|Lymphomas|lymphomas
1619348|NCT00322595|Anxiety|anxiety
1619349|NCT00322595|GAD|gad
1619350|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
1619351|NCT00322582|genetics analysis|genetics analysis
1619352|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1619353|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
1619354|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
1619355|NCT00322556|Agammaglobulinemia|agammaglobulinemia
1620245|NCT00318981|Concerta|concerta
1619356|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
1619357|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
1619358|NCT00322556|Immunoglobulin G|immunoglobulin g
1619359|NCT00322556|Children|children
1619360|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1619361|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
1619362|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1619363|NCT00322491|Multiple Myeloma|multiple myeloma
1619364|NCT00322491|Stem cell mobilization|stem cell mobilization
1619365|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
1619366|NCT00322452|NSCLC|nsclc
1619367|NCT00322452|Gefitinib|gefitinib
1619368|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
1619369|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
1619370|NCT00322426|Freezing of Gait|freezing of gait
1619371|NCT00322426|Parkinson's Disease|parkinson's disease
1619372|NCT00322426|Sensory Cues|sensory cues
1619373|NCT00322413|Epoetin alfa|epoetin alfa
1619374|NCT00322413|Epoetin omega|epoetin omega
1619375|NCT00322413|Comparative efficacy trial|comparative efficacy trial
1619376|NCT00322413|Renal anemia|renal anemia
1619377|NCT00322400|Clinical trial|clinical trial
1619378|NCT00322400|AMG 706|amg 706
1619379|NCT00322400|Anti-angiogenesis|anti-angiogenesis
1619380|NCT00322400|Locally Recurrent|locally recurrent
1619381|NCT00322400|Metastatic|metastatic
1619382|NCT00322400|Breast Cancer|breast cancer
1619383|NCT00322400|VEGF|vegf
1619384|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
1619385|NCT00322400|Oral|oral
1619386|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
1619387|NCT00322400|Anti-tumor|anti-tumor
1619388|NCT00322400|PDGF receptor|pdgf receptor
1619389|NCT00322400|Paclitaxel|paclitaxel
1619390|NCT00322400|Docetaxel|docetaxel
1619391|NCT00322400|Targeted Therapy|targeted therapy
1619392|NCT00322400|Oncology|oncology
1619393|NCT00322400|Amgen|amgen
1619394|NCT00322400|c-Kit|c-kit
1619395|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1619396|NCT00322387|Multiple Myeloma|multiple myeloma
1619397|NCT00322387|Stem cell mobilization|stem cell mobilization
1619398|NCT00322348|oncology|oncology
1619399|NCT00322348|cancer|cancer
1619400|NCT00322348|breast cancer|breast cancer
1619401|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
1619402|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
1619403|NCT00322322|Hemodialysis|hemodialysis
1619404|NCT00322322|Anaemia|anaemia
1619405|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
1619406|NCT00322309|Cocaine|cocaine
1619407|NCT00322309|Substance Abuse|substance abuse
1619408|NCT00322296|Parapsoriasis|parapsoriasis
1619409|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
1619410|NCT00322296|Mycosis fungoides|mycosis fungoides
1619411|NCT00322296|Bexarotene|bexarotene
1619412|NCT00322296|Retinoids|retinoids
1619413|NCT00322283|oglemilast|oglemilast
1619414|NCT00322283|asthma|asthma
1619415|NCT00322283|exercise|exercise
1619416|NCT00322283|prevention|prevention
1619417|NCT00322283|prophylaxis|prophylaxis
1619418|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
1619419|NCT00322270|Occluded Catheters|occluded catheters
1619420|NCT00322270|Thrombosis|thrombosis
1619421|NCT00322270|thrombosis, catheter|thrombosis, catheter
1619422|NCT00322270|alfimeprase|alfimeprase
1619423|NCT00322270|thrombotic occlusion|thrombotic occlusion
1619424|NCT00322270|thrombosis, CVAD|thrombosis, cvad
1619425|NCT00322270|thrombosis, catheters|thrombosis, catheters
1619426|NCT00322244|Osteoarthritis|osteoarthritis
1619427|NCT00322244|Massage therapy|massage therapy
1619428|NCT00322192|Stroke rehabilitation|stroke rehabilitation
1619429|NCT00322192|Physical Therapy|physical therapy
1619430|NCT00322179|Microarray Analysis|microarray analysis
1619431|NCT00322179|Obesity|obesity
1619432|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
1619433|NCT00322166|accidental falls|accidental falls
1619434|NCT00322166|vitamin D|vitamin d
1619435|NCT00322166|parathyroid hormone|parathyroid hormone
1619436|NCT00322166|osteoporosis|osteoporosis
1619437|NCT00322153|memantine|memantine
1619438|NCT00322153|Alzheimer's disease|alzheimer's disease
1619439|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
1619440|NCT00322140|Metastatic|metastatic
1619441|NCT00322140|Triterpenoids|triterpenoids
1619442|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
1619443|NCT00322140|Dose-Limiting|dose-limiting
1619444|NCT00322140|Pharmacokinetic|pharmacokinetic
1619445|NCT00322140|Solid Tumor|solid tumor
1619446|NCT00322140|Lymphoma|lymphoma
1619447|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
1619448|NCT00322127|Stem Cell Mobilization|stem cell mobilization
1619449|NCT00322127|CXCR4|cxcr4
1619450|NCT00322127|SDF-1|sdf-1
1619451|NCT00322127|Healthy Volunteer|healthy volunteer
1619452|NCT00322127|HV|hv
1619453|NCT00322114|prostate cancer|prostate cancer
1619454|NCT00322062|Colon cleansing|colon cleansing
1620347|NCT00318578|outcome|outcome
1619455|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
1619456|NCT00322036|Alzheimer Disease|alzheimer disease
1619457|NCT00322036|Dementia|dementia
1619458|NCT00322023|Negative symptoms|negative symptoms
1619459|NCT00322023|NMDA|nmda
1619460|NCT00322023|Glutamate|glutamate
1619461|NCT00322023|Glycine|glycine
1619462|NCT00322010|mechanical ventilation|mechanical ventilation
1619463|NCT00322010|physical therapy|physical therapy
1619961|NCT00320203|glaucoma|glaucoma
1619464|NCT00322010|occupational therapy|occupational therapy
1619465|NCT00322010|mobilization|mobilization
1619466|NCT00322010|clinical protocols|clinical protocols
1619467|NCT00322010|ICU acquired weakness|icu acquired weakness
1619468|NCT00322010|critical illness myopathy|critical illness myopathy
1619469|NCT00322010|muscle atrophy|muscle atrophy
1619470|NCT00322010|intensive care unit|intensive care unit
1619471|NCT00322010|randomized controlled trial|randomized controlled trial
1619472|NCT00321997|AMD|amd
1619473|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
1619474|NCT00321997|Macular Degeneration|macular degeneration
1619475|NCT00321997|Macugen|macugen
1619476|NCT00321997|pegaptanib sodium|pegaptanib sodium
1619477|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
1619478|NCT00321984|Heartburn|heartburn
1619479|NCT00321971|Anxiety|anxiety
1619480|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
1619481|NCT00321971|MCI|mci
1619482|NCT00321971|Cognitive Impairment|cognitive impairment
1619483|NCT00321971|Alzheimer's Disease|alzheimer's disease
1619484|NCT00321971|Caregiver Burden|caregiver burden
1619485|NCT00321971|Caregiver Stress|caregiver stress
1619486|NCT00321971|Family Dementia Caregiving|family dementia caregiving
1619487|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
1619488|NCT00321958|Barrett Esophagus|barrett esophagus
1619489|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
1619490|NCT00321958|Deglutition disorders|deglutition disorders
1619491|NCT00321958|Cryotherapy|cryotherapy
1619492|NCT00321958|Cryosurgery|cryosurgery
1619493|NCT00321958|GERD|gerd
1619494|NCT00321958|Neoplasm|neoplasm
1619495|NCT00321958|Esophagus|esophagus
1619496|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
1619497|NCT00321945|Atrial Fibrillation|atrial fibrillation
1619498|NCT00321945|Atrial Flutter|atrial flutter
1619499|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
1619500|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
1619501|NCT00321906|Rejection in lung transplant|rejection in lung transplant
1619502|NCT00321893|Small cell lung cancer|small cell lung cancer
1619503|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
1619504|NCT00321893|Budesonide|budesonide
1619505|NCT00321893|Entocort EC|entocort ec
1619506|NCT00321893|Pulmicort Respules|pulmicort respules
1619507|NCT00321893|Rhinocort aqua|rhinocort aqua
1619508|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
1619509|NCT00321893|Smoking|smoking
1619510|NCT00321880|fatigue|fatigue
1619511|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1619512|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1619513|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1619514|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1619515|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1619516|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1619517|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1619518|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1619519|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1619520|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1619521|NCT00321867|rectocele|rectocele
1619522|NCT00321867|pelvic prolapse|pelvic prolapse
1619523|NCT00321867|graft|graft
1619524|NCT00321867|surgical repair|surgical repair
1619525|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
1619526|NCT00321828|stage IV colon cancer|stage iv colon cancer
1619527|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
1619528|NCT00321802|atrial fibrillation|atrial fibrillation
1619529|NCT00321802|statin therapy|statin therapy
1619530|NCT00321802|CRP levels|crp levels
1619531|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1619532|NCT00321789|self care|self care
1619533|NCT00321789|social support|social support
1619534|NCT00321763|Influenza|influenza
1619535|NCT00321763|Influenza vaccine|influenza vaccine
1619536|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
1619537|NCT00321750|pimecrolimus cream|pimecrolimus cream
1619538|NCT00321737|Erosive Esophagitis|erosive esophagitis
1619540|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
1619541|NCT00321711|Refractory Cytopenias|refractory cytopenias
1619542|NCT00321711|Thrombocytopenia|thrombocytopenia
1619543|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1619544|NCT00321698|stage II prostate cancer|stage ii prostate cancer
1619545|NCT00321698|stage III prostate cancer|stage iii prostate cancer
1619546|NCT00321672|Analgesics|analgesics
1619547|NCT00321672|Capsaicin|capsaicin
1619548|NCT00321672|Neuropathic pain|neuropathic pain
1619549|NCT00321672|Neuropathy|neuropathy
1619550|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
1619551|NCT00321672|Peripheral neuropathy|peripheral neuropathy
1619552|NCT00321672|Dermal assessment|dermal assessment
1619553|NCT00321672|Pain measurement|pain measurement
1619554|NCT00321659|fibromyalgia|fibromyalgia
1619555|NCT00321659|self-management|self-management
1619556|NCT00321659|exercise|exercise
1619557|NCT00321659|patient education|patient education
1619558|NCT00321646|prostate cancer|prostate cancer
1619559|NCT00321646|bevacizumab|bevacizumab
1619560|NCT00321646|docetaxel|docetaxel
1619561|NCT00321646|radical prostatectomy|radical prostatectomy
1619562|NCT00321633|stage IV breast cancer|stage iv breast cancer
1619563|NCT00321633|recurrent breast cancer|recurrent breast cancer
1619564|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
1619565|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
1619566|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
1619567|NCT00321620|Bone metastases|bone metastases
1619568|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
1619569|NCT00321620|Skeletal|skeletal
1619570|NCT00321620|Fractures|fractures
1619571|NCT00321620|Compressions|compressions
1619572|NCT00321620|Bisphosphonates|bisphosphonates
1619573|NCT00321581|VEGFR2|vegfr2
1619574|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1619575|NCT00321581|Antiangiogenesis|antiangiogenesis
1619576|NCT00321581|Solid Tumors|solid tumors
1619577|NCT00321581|Childhood Cancer|childhood cancer
1619578|NCT00321581|Solid Tumor|solid tumor
1619579|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
1619580|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
1619581|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
1619583|NCT00321568|Multiple Sclerosis|multiple sclerosis
1619584|NCT00321568|Magnetic Resonance|magnetic resonance
1619585|NCT00321568|MRI|mri
1619586|NCT00321568|Magnetic Field|magnetic field
1619587|NCT00321568|MS|ms
1619588|NCT00321555|Biologic Therapy|biologic therapy
1619589|NCT00321555|Monoclonal Antibody|monoclonal antibody
1619590|NCT00321555|Immunotherapy|immunotherapy
1619591|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
1619592|NCT00321555|Targeted Therapy|targeted therapy
1619593|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
1619594|NCT00321555|HCL|hcl
1619595|NCT00321542|Computed tomography|computed tomography
1619596|NCT00321542|Diabetes mellitus|diabetes mellitus
1619597|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
1619598|NCT00321542|Non-invasive imaging|non-invasive imaging
1619599|NCT00321529|Cervical spine instability|cervical spine instability
1619600|NCT00321529|Penning Study|penning study
1619601|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
1619602|NCT00321503|acid reflux|acid reflux
1619603|NCT00321503|LPR|lpr
1619604|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
1619605|NCT00321503|GERD|gerd
1619606|NCT00321503|pH probe|ph probe
1619607|NCT00321503|proton pump inhibitor|proton pump inhibitor
1619608|NCT00321503|PPI|ppi
1619609|NCT00321490|MDD|mdd
1619610|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
1619611|NCT00321490|Depression|depression
1619612|NCT00321477|Overactive Bladder|overactive bladder
1619613|NCT00321464|Fractures|fractures
1619614|NCT00321464|Compressions|compressions
1619615|NCT00321464|Bisphosphonates|bisphosphonates
1619616|NCT00321464|Bone metastases|bone metastases
1619617|NCT00321464|Breast cancer|breast cancer
1619618|NCT00321464|Skeletal|skeletal
1619619|NCT00321464|Radiation|radiation
1619620|NCT00321464|Surgery to Bone|surgery to bone
1619621|NCT00321451|insomnia|insomnia
1619622|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
1619623|NCT00321438|HIV-1|hiv-1
1619624|NCT00321438|GW873140|gw873140
1619625|NCT00321438|CCR5 antagonist|ccr5 antagonist
1619626|NCT00321438|experienced|experienced
1619627|NCT00321438|treatment experienced|treatment experienced
1619628|NCT00321412|Crohn's disease|crohn's disease
1619629|NCT00321412|IBD|ibd
1619630|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
1619631|NCT00321412|Fistula|fistula
1619632|NCT00321399|CORONARY ANATOMY|coronary anatomy
1619633|NCT00321399|Coronary Artery Disease|coronary artery disease
1619634|NCT00321399|SPECT|spect
1619635|NCT00321399|PET|pet
1619636|NCT00321399|PET/CT|pet/ct
1619637|NCT00321399|CTA|cta
1619638|NCT00321386|Glaucoma|glaucoma
1619639|NCT00321386|Open Angle|open angle
1619640|NCT00321386|Normal Tension|normal tension
1619641|NCT00321373|Influenza|influenza
1619642|NCT00321373|Influenza vaccine|influenza vaccine
1619643|NCT00321360|propofol|propofol
1619644|NCT00321360|sedation|sedation
1619645|NCT00321347|Cancer|cancer
1619646|NCT00321347|Pain|pain
1619647|NCT00321347|Lidocaine|lidocaine
1619648|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
1619649|NCT00321334|Chemotherapy|chemotherapy
1619650|NCT00321334|surgery|surgery
1619651|NCT00321334|neo-adjuvant|neo-adjuvant
1619652|NCT00321334|adjuvant|adjuvant
1619653|NCT00321334|RCT|rct
1619654|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
1619655|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
1620062|NCT00319748|Cervical|cervical
1619656|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
1619657|NCT00321321|insulin secretion|insulin secretion
1619658|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
1619659|NCT00321321|Impaired incretin effect|impaired incretin effect
1619660|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
1619661|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
1619662|NCT00321295|Cardiac Surgery|cardiac surgery
1619663|NCT00321295|Cardiomyopahty|cardiomyopahty
1619664|NCT00321295|Heart Failure|heart failure
1619665|NCT00321282|Atrial Fibrillation|atrial fibrillation
1619666|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
1619667|NCT00321282|Risk Stratification|risk stratification
1619668|NCT00321269|Home Monitoring|home monitoring
1619669|NCT00321269|Heart Failure|heart failure
1619670|NCT00321269|Depression|depression
1619671|NCT00321256|islet transplantation|islet transplantation
1619672|NCT00321256|brittle diabetes|brittle diabetes
1619673|NCT00321256|severe hypoglycemia|severe hypoglycemia
1619674|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
1619676|NCT00321230|Colon cleansing|colon cleansing
1619677|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
1619678|NCT00321217|pharmacogenetics|pharmacogenetics
1619679|NCT00321217|anti-TNF|anti-tnf
1619680|NCT00321217|high throughput genotyping|high throughput genotyping
1619681|NCT00321204|Atrial Fibrillation|atrial fibrillation
1619682|NCT00321204|Atrial Flutter|atrial flutter
1619683|NCT00321204|Cardiac Surgery|cardiac surgery
1619684|NCT00321204|Thiazolidinediones|thiazolidinediones
1619685|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
1619686|NCT00321178|Buruli ulcer|buruli ulcer
1619687|NCT00321178|Ghana|ghana
1619688|NCT00321178|randomized comparison|randomized comparison
1619689|NCT00321178|streptomycin|streptomycin
1619690|NCT00321178|rifampicin|rifampicin
1619691|NCT00321178|clarithromycin|clarithromycin
1619692|NCT00321165|nutrition|nutrition
1619693|NCT00321165|parenteral|parenteral
1619694|NCT00321165|infection|infection
1619695|NCT00321165|katheter|katheter
1619696|NCT00321165|taurolidine|taurolidine
1619697|NCT00321165|acridine orange|acridine orange
1619698|NCT00321165|prevention|prevention
1619699|NCT00321139|biomarkers|biomarkers
1619700|NCT00321139|oxidative stress|oxidative stress
1619701|NCT00321139|intravascular ultrasound|intravascular ultrasound
1619702|NCT00321126|Zinc|zinc
1619703|NCT00321126|Shigella|shigella
1619704|NCT00321126|Children|children
1619705|NCT00321126|Bangladesh|bangladesh
1619706|NCT00321113|MARGINAL KIDNEY|marginal kidney
1619707|NCT00321113|TACROLIMUS|tacrolimus
1619708|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
1619709|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
1619710|NCT00321100|metastatic|metastatic
1619711|NCT00321100|colorectal|colorectal
1619712|NCT00321100|cancer|cancer
1619713|NCT00321100|initial therapy|initial therapy
1619714|NCT00321087|Movement Disorder|movement disorder
1619715|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
1619716|NCT00321074|TACROLIMUS|tacrolimus
1619717|NCT00321074|MARGINAL LIVERS|marginal livers
1619718|NCT00321074|PHARMACOKINETICS|pharmacokinetics
1619719|NCT00321061|HIV Negative|hiv negative
1619720|NCT00321061|Healthy|healthy
1619721|NCT00321061|Immunity|immunity
1619722|NCT00321061|Preventive|preventive
1619723|NCT00321061|Virus|virus
1619724|NCT00321061|Healthy Volunteer|healthy volunteer
1619725|NCT00321061|HV|hv
1619726|NCT00321048|breast cancer|breast cancer
1619727|NCT00321048|SPECT|spect
1619728|NCT00321048|ABC device|abc device
1619729|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
1619730|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
1619731|NCT00321035|Glaucoma|glaucoma
1619732|NCT00321035|Pterygium|pterygium
1619733|NCT00321035|collagen matrix|collagen matrix
1619734|NCT00321035|oculusgen|oculusgen
1619735|NCT00321035|ologen|ologen
1619736|NCT00321035|trabeculectomy|trabeculectomy
1619737|NCT00321035|anti scarring|anti scarring
1619738|NCT00321035|prevent recurrence|prevent recurrence
1619739|NCT00321035|tissue engineering|tissue engineering
1619740|NCT00321035|Aeon Astron|aeon astron
1619741|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
1619742|NCT00321022|Diagnostic Protocol|diagnostic protocol
1619743|NCT00321022|Observational Medicine|observational medicine
1619744|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
1619745|NCT00321009|Myocardial Infarction|myocardial infarction
1619746|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
1619747|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
1619748|NCT00321009|Enoxaparin|enoxaparin
1619749|NCT00321009|Warfarin|warfarin
1619750|NCT00321009|Echocardiograms|echocardiograms
1619751|NCT00320996|Pelvic mass|pelvic mass
1619752|NCT00320983|Cancer|cancer
1619753|NCT00320983|Cervix|cervix
1619754|NCT00320970|TGF-Beta 1|tgf-beta 1
1619755|NCT00320970|Angiotensin II|angiotensin ii
1619756|NCT00320970|Advanced glycation end products|advanced glycation end products
1619757|NCT00320957|Glaucoma|glaucoma
1619758|NCT00320957|Pterygium|pterygium
1619759|NCT00320957|collagen matrix|collagen matrix
1619760|NCT00320957|OculusGen|oculusgen
1619761|NCT00320957|trabeculectomy|trabeculectomy
1619762|NCT00320957|Anti scarring|anti scarring
1619763|NCT00320957|pterygium recurrence|pterygium recurrence
1619764|NCT00320957|tissue engineering|tissue engineering
1619765|NCT00320957|Aeon Astron|aeon astron
1619766|NCT00320957|ologen|ologen
1619767|NCT00320931|Coronary artery disease|coronary artery disease
1619768|NCT00320931|PET CT scan|pet ct scan
1619769|NCT00320931|Stress test|stress test
1619770|NCT00320931|Rubudium|rubudium
1619771|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
1619772|NCT00320918|Cancer|cancer
1619773|NCT00320918|Chart Review|chart review
1619774|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
1619775|NCT00320905|Cognitive functioning|cognitive functioning
1619776|NCT00320905|Cardiovascular disease|cardiovascular disease
1619777|NCT00320892|Death Rattle|death rattle
1619778|NCT00320892|Noise level|noise level
1619779|NCT00320892|Primary Care|primary care
1619780|NCT00320879|diabetes|diabetes
1619781|NCT00320879|microalbuminuria|microalbuminuria
1619782|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
1619783|NCT00320879|irbesartan|irbesartan
1619784|NCT00320879|dose-response|dose-response
1619785|NCT00320879|randomized|randomized
1619786|NCT00320879|double-blind|double-blind
1619787|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1619788|NCT00320879|clinical|clinical
1619789|NCT00320879|hypertension|hypertension
1619790|NCT00320866|Hypodermoclysis|hypodermoclysis
1619791|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
1619792|NCT00320853|Diabetes|diabetes
1619793|NCT00320853|Vitamin D|vitamin d
1619794|NCT00320853|Insulin sensitivity|insulin sensitivity
1619795|NCT00320853|Insulin secretion|insulin secretion
1619796|NCT00320840|preterm infants|preterm infants
1619797|NCT00320840|twins|twins
1619798|NCT00320840|motherhood|motherhood
1619799|NCT00320840|internal resources|internal resources
1619800|NCT00320840|familial resources|familial resources
1619801|NCT00320827|Apoptosis|apoptosis
1619802|NCT00320827|Death receptor 5|death receptor 5
1619803|NCT00320827|Cancer|cancer
1619804|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
1619805|NCT00320801|Chronic pain|chronic pain
1619806|NCT00320801|osteoarthritis|osteoarthritis
1619807|NCT00320801|transdermal|transdermal
1619808|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1619809|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
1619810|NCT00320762|Glaucoma|glaucoma
1619811|NCT00320762|Pterygium|pterygium
1619812|NCT00320762|collagen matrix|collagen matrix
1619813|NCT00320762|OculusGen|oculusgen
1619814|NCT00320762|trabeculectomy|trabeculectomy
1619815|NCT00320762|Anti scarring|anti scarring
1619816|NCT00320762|pterygium recurrence|pterygium recurrence
1619817|NCT00320762|tissue engineering|tissue engineering
1619818|NCT00320762|Aeon Astron|aeon astron
1619819|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
1619820|NCT00320736|schizophrenia|schizophrenia
1619821|NCT00320736|cognitive function|cognitive function
1619822|NCT00320736|cholinergic medication|cholinergic medication
1619823|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
1619824|NCT00320723|schizophrenia|schizophrenia
1619825|NCT00320723|smoking cessation|smoking cessation
1619826|NCT00320723|nicotine|nicotine
1619827|NCT00320723|patch|patch
1619828|NCT00320723|bupropion|bupropion
1619829|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
1619830|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
1619831|NCT00320710|Breast cancer|breast cancer
1619832|NCT00320710|zoledronic acid|zoledronic acid
1619833|NCT00320710|bone metastases|bone metastases
1619834|NCT00320697|schizophrenia|schizophrenia
1619835|NCT00320697|smoking cessation|smoking cessation
1619836|NCT00320697|relapse prevention|relapse prevention
1619837|NCT00320697|nicotine|nicotine
1619838|NCT00320697|bupropion|bupropion
1619839|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
1619840|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
1619841|NCT00320684|Serotonin Transporter|serotonin transporter
1619842|NCT00320684|Positron-Emission Tomography|positron-emission tomography
1619843|NCT00320671|First-episode|first-episode
1619844|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
1619845|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
1619846|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
1619847|NCT00320671|Aripiprazole|aripiprazole
1619848|NCT00320671|Clozapine|clozapine
1619849|NCT00320671|Risperidone|risperidone
1619850|NCT00320658|Plasmodium falciparum|plasmodium falciparum
1619851|NCT00320632|Major Depressive Disorder|major depressive disorder
1619852|NCT00320632|MDD|mdd
1619853|NCT00320619|Aminocaproic Acids|aminocaproic acids
1619854|NCT00320619|Blood Transfusion|blood transfusion
1619855|NCT00320606|allograft function|allograft function
1619856|NCT00320606|anti-rejection|anti-rejection
1619857|NCT00320606|immunosuppression withdrawal|immunosuppression withdrawal
1619858|NCT00320606|liver transplant|liver transplant
1619859|NCT00320606|liver transplantation|liver transplantation
1619860|NCT00320606|living donor transplant|living donor transplant
1619861|NCT00320593|Myopia|myopia
1619862|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
1619863|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
1619864|NCT00320593|Accommodative lags|accommodative lags
1619865|NCT00320593|Near esophoria|near esophoria
1619866|NCT00320593|Refractive error|refractive error
1619867|NCT00320580|Metrorrhagia|metrorrhagia
1619868|NCT00320580|oral contraception|oral contraception
1619869|NCT00320580|breakthrough bleeding|breakthrough bleeding
1619870|NCT00320580|spotting|spotting
1619871|NCT00320567|osteoporosis|osteoporosis
1619872|NCT00320567|anorexia nervosa|anorexia nervosa
1619873|NCT00320567|pediatric|pediatric
1619874|NCT00320541|Breast Cancer|breast cancer
1619875|NCT00320541|Cancer of Breast|cancer of breast
1619876|NCT00320541|Cancer of the breast|cancer of the breast
1619877|NCT00320541|Breast Neoplasms|breast neoplasms
1619878|NCT00320476|Multiple myeloma|multiple myeloma
1619879|NCT00320450|SB-681323|sb-681323
1619880|NCT00320450|CRP|crp
1619881|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
1619882|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
1619883|NCT00320450|RA|ra
1619884|NCT00320437|trauma|trauma
1619885|NCT00320437|anxiety|anxiety
1619886|NCT00320437|antenatal|antenatal
1619887|NCT00320437|mothers|mothers
1619888|NCT00320437|children|children
1619889|NCT00320437|Gene x Environment Interaction|gene x environment interaction
1619890|NCT00320424|Xa factor|xa factor
1619891|NCT00320424|VTE|vte
1619892|NCT00320424|MOSLL|mosll
1619893|NCT00320424|pentasaccharide|pentasaccharide
1619894|NCT00320411|Stage IV breast cancer|stage iv breast cancer
1619895|NCT00320411|Herceptin|herceptin
1619896|NCT00320411|metastatic breast cancer|metastatic breast cancer
1619897|NCT00320411|ErbB1|erbb1
1619898|NCT00320411|ErbB2|erbb2
1619899|NCT00320411|trastuzumab|trastuzumab
1619900|NCT00320411|lapatinib|lapatinib
1619901|NCT00320398|Fondaparinux|fondaparinux
1619902|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
1619903|NCT00320398|VTE|vte
1619904|NCT00320398|THR|thr
1619905|NCT00320398|MOSLL|mosll
1619906|NCT00320398|pentasaccharide|pentasaccharide
1619907|NCT00320398|Xa factor|xa factor
1619908|NCT00320385|lapatinib|lapatinib
1619909|NCT00320385|GW572016|gw572016
1619910|NCT00320385|ErbB2|erbb2
1619911|NCT00320385|EGFR|egfr
1619912|NCT00320385|ErbB1|erbb1
1619913|NCT00320385|MBC|mbc
1619914|NCT00320385|FISH amplification|fish amplification
1619915|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
1619916|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
1619917|NCT00320385|Her-2/neu|her-2/neu
1619918|NCT00320372|Major Depressive Disorder|major depressive disorder
1619919|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
1619920|NCT00320359|First-line Cisplatin|first-line cisplatin
1619921|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
1619922|NCT00320359|topotecan|topotecan
1619923|NCT00320359|etoposide|etoposide
1619924|NCT00320359|Extensive Disease|extensive disease
1619925|NCT00320346|Pandemic|pandemic
1619926|NCT00320346|Influenza|influenza
1619927|NCT00320346|Prevention|prevention
1619928|NCT00320346|Vaccine|vaccine
1619929|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
1619930|NCT00320333|COPD|copd
1619931|NCT00320333|rehabilitation|rehabilitation
1619932|NCT00320333|health services research|health services research
1619933|NCT00320320|No prior chemotherapy|no prior chemotherapy
1619934|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
1619935|NCT00320307|HIV|hiv
1619936|NCT00320307|Abacavir regime|abacavir regime
1619937|NCT00320307|ABC|abc
1619938|NCT00320281|Botox|botox
1619939|NCT00320268|MDD|mdd
1619940|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
1619941|NCT00320268|Depression|depression
1619942|NCT00320255|anticoagulant|anticoagulant
1619943|NCT00320242|Parkinson's disease|parkinson's disease
1619944|NCT00320242|laser cane|laser cane
1619945|NCT00320242|freezing of gait|freezing of gait
1619946|NCT00320242|visual cues|visual cues
1619947|NCT00320229|angioplasty|angioplasty
1619948|NCT00320229|stent|stent
1619949|NCT00320229|abciximab|abciximab
1620607|NCT00317733|Ketoprofen|ketoprofen
1619950|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
1619951|NCT00320229|myocardial infarction|myocardial infarction
1619952|NCT00320216|Psoriasis|psoriasis
1619953|NCT00320216|CNTO 1275|cnto 1275
1619954|NCT00320216|Ustekinumab|ustekinumab
1619955|NCT00320216|Stelara|stelara
1619956|NCT00320216|Interleukin-12|interleukin-12
1619957|NCT00320216|IL-12|il-12
1619958|NCT00320216|Interleukin-23|interleukin-23
1619959|NCT00320216|IL-23|il-23
1619962|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
1619963|NCT00320177|Binge Eating|binge eating
1619964|NCT00320177|Food Intake|food intake
1619965|NCT00320177|Obesity|obesity
1619966|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
1619967|NCT00320177|Child|child
1619968|NCT00320177|Macronutrient Composition|macronutrient composition
1619969|NCT00320164|Healthy Volunteers|healthy volunteers
1619970|NCT00320151|chronic lung disease|chronic lung disease
1619971|NCT00320138|PTSD|ptsd
1619972|NCT00320138|Posttraumatic Stress|posttraumatic stress
1619973|NCT00320138|Acupuncture|acupuncture
1619974|NCT00320138|Randomized Controlled Trial|randomized controlled trial
1619975|NCT00320138|Complementary medicine|complementary medicine
1619976|NCT00320138|Alternative medicine|alternative medicine
1619977|NCT00320138|Chinese medicine|chinese medicine
1619978|NCT00320138|military healthcare|military healthcare
1619979|NCT00320125|Dairy|dairy
1619980|NCT00320125|Calcium|calcium
1619981|NCT00320125|Pregnancy|pregnancy
1619982|NCT00320125|Fetus|fetus
1619983|NCT00320125|Bone mineralization|bone mineralization
1619984|NCT00320112|telemedicine|telemedicine
1619985|NCT00320112|case management|case management
1619986|NCT00320112|insulin|insulin
1619987|NCT00320112|self-care|self-care
1619988|NCT00320099|septic shock|septic shock
1619989|NCT00320099|adrenal insufficiency|adrenal insufficiency
1619990|NCT00320099|glucose control|glucose control
1619991|NCT00320099|mineralocorticoids|mineralocorticoids
1619992|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1619993|NCT00320060|Diabetic nephropathy|diabetic nephropathy
1619994|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
1619995|NCT00320060|Pyridorin|pyridorin
1619996|NCT00320060|Pyridoxamine|pyridoxamine
1619997|NCT00320047|Binge Eating Disorder|binge eating disorder
1619998|NCT00320034|levalbuterol|levalbuterol
1619999|NCT00320034|asthma|asthma
1620000|NCT00320034|allergen provocation|allergen provocation
1620001|NCT00320034|airway inflammation|airway inflammation
1620002|NCT00320034|clinical trial|clinical trial
1620003|NCT00320021|Diabetic nephropathy|diabetic nephropathy
1620004|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
1620005|NCT00320021|Pyridorin|pyridorin
1620006|NCT00320021|Pyridoxamine|pyridoxamine
1620007|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1620008|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
1620009|NCT00319982|Diltiazem|diltiazem
1620010|NCT00319969|small cell lung cancer|small cell lung cancer
1620011|NCT00319969|amrubicin|amrubicin
1620012|NCT00319956|premature infant|premature infant
1620013|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
1620014|NCT00319956|mechanical ventilation|mechanical ventilation
1620015|NCT00319943|Cognitive remediation|cognitive remediation
1620016|NCT00319943|Cognitive impairment|cognitive impairment
1620017|NCT00319943|computer|computer
1620018|NCT00319943|training|training
1620314|NCT00318695|Asthma|asthma
1620019|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1620021|NCT00319930|ZAP-70|zap-70
1620022|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
1620023|NCT00319917|Tacrolimus|tacrolimus
1620024|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
1620025|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
1620026|NCT00319904|Schizophrenia|schizophrenia
1620027|NCT00319904|DNA|dna
1620028|NCT00319891|Alzheimer's|alzheimer's
1620029|NCT00319891|AD|ad
1620030|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
1620031|NCT00319891|Dementia|dementia
1620032|NCT00319891|Cognitive remediation|cognitive remediation
1620033|NCT00319891|computer-based training|computer-based training
1620034|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
1620035|NCT00319852|Diphteria;|diphteria;
1620036|NCT00319852|Tetanus;|tetanus;
1620037|NCT00319852|Pertussis;|pertussis;
1620038|NCT00319852|Poliomyelitis;|poliomyelitis;
1620039|NCT00319852|acellular|acellular
1620040|NCT00319839|Head cancer|head cancer
1620041|NCT00319839|Neck cancer|neck cancer
1620042|NCT00319839|cetuximab|cetuximab
1620043|NCT00319839|abraxane|abraxane
1620044|NCT00319839|erbitux|erbitux
1620045|NCT00319839|IMC-225|imc-225
1620046|NCT00319839|NSC-714692|nsc-714692
1620047|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
1620048|NCT00319774|End-stage renal disease|end-stage renal disease
1620049|NCT00319774|Hemodialysis|hemodialysis
1620050|NCT00319774|Hypertension|hypertension
1620051|NCT00319774|Hypotension|hypotension
1620052|NCT00319774|Blood volume|blood volume
1620053|NCT00319774|Hypervolemia|hypervolemia
1620054|NCT00319774|Quality of life|quality of life
1620055|NCT00319774|Biofeedback system|biofeedback system
1620056|NCT00319761|glomerulonephritis|glomerulonephritis
1620057|NCT00319761|proteinuria|proteinuria
1620058|NCT00319761|chronic kidney diseases|chronic kidney diseases
1620059|NCT00319748|Breast|breast
1620060|NCT00319748|Ovarian|ovarian
1620061|NCT00319748|Endometrial|endometrial
1620063|NCT00319748|Metastatic|metastatic
1620065|NCT00319748|IRM|irm
1620066|NCT00319748|Oncology|oncology
1620067|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
1620068|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
1620069|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
1620070|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
1620071|NCT00319722|autism|autism
1620072|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
1620073|NCT00319722|evoked potentials|evoked potentials
1620074|NCT00319722|EEG|eeg
1620075|NCT00319722|Coherence|coherence
1620076|NCT00319709|depression|depression
1620077|NCT00319709|antidepressive agents|antidepressive agents
1620078|NCT00319709|controlled clinical trial|controlled clinical trial
1620079|NCT00319696|systemic sclerosis|systemic sclerosis
1620080|NCT00319696|digital ulcers|digital ulcers
1620081|NCT00319696|bosentan|bosentan
1620082|NCT00319696|open label|open label
1620083|NCT00319696|finger ulcers|finger ulcers
1620084|NCT00319683|Cancer|cancer
1620085|NCT00319683|Tumors|tumors
1620086|NCT00319683|Neoplasms|neoplasms
1620087|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
1620088|NCT00319683|Antineoplastic Agents|antineoplastic agents
1620089|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
1620090|NCT00319670|constipation|constipation
1620091|NCT00319670|pediatric|pediatric
1620092|NCT00319657|Kidney Transplantation|kidney transplantation
1620093|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
1620094|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
1620095|NCT00319605|Cross sectional study|cross sectional study
1620096|NCT00319605|acceptability|acceptability
1620097|NCT00319605|levetiracetam|levetiracetam
1620098|NCT00319605|oral solution|oral solution
1620099|NCT00319605|Keppra|keppra
1620100|NCT00319592|Japanese encephalitis|japanese encephalitis
1620101|NCT00319592|ChimeriVax™-JE|chimerivax™-je
1620102|NCT00319592|JE-VAX®|je-vax®
1620103|NCT00319579|living kidney donors|living kidney donors
1620104|NCT00319579|prospective|prospective
1620105|NCT00319579|medical|medical
1620106|NCT00319579|psychosocial|psychosocial
1620107|NCT00319566|Coronary Heart Disease|coronary heart disease
1620108|NCT00319566|Hormone replacement therapy|hormone replacement therapy
1620109|NCT00319566|Estrogen|estrogen
1620110|NCT00319566|Postmenopausal women|postmenopausal women
1620111|NCT00319553|Tetanus|tetanus
1620112|NCT00319553|diphtheria|diphtheria
1620113|NCT00319553|acellular pertussis|acellular pertussis
1620114|NCT00319540|Depression|depression
1620115|NCT00319540|psychoeducation|psychoeducation
1620116|NCT00319540|RCT|rct
1620117|NCT00319540|primary health services|primary health services
1620118|NCT00319527|long term outcome|long term outcome
1620119|NCT00319527|living kidney donor|living kidney donor
1620120|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
1620121|NCT00319501|ARS|ars
1620122|NCT00319501|Diazepam|diazepam
1620123|NCT00319501|Cluster Seizures|cluster seizures
1620124|NCT00319488|Wheezing|wheezing
1620416|NCT00318214|foot ulcer|foot ulcer
1620125|NCT00319488|Respiratory Tract Illness|respiratory tract illness
1620126|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
1620127|NCT00319436|parenting intervention|parenting intervention
1620128|NCT00319436|family intervention|family intervention
1620129|NCT00319436|maternal substance abuse|maternal substance abuse
1620130|NCT00319436|mother-child relations|mother-child relations
1620131|NCT00319436|parent-child relations|parent-child relations
1620132|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
1620133|NCT00319410|Menorrhagia|menorrhagia
1620134|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
1620135|NCT00319410|visual analogue scale|visual analogue scale
1620136|NCT00319397|vascular resistance|vascular resistance
1620137|NCT00319397|vasomotion|vasomotion
1620138|NCT00319397|coronary disorder|coronary disorder
1620139|NCT00319397|hemodynamics|hemodynamics
1620140|NCT00319397|physical fitness|physical fitness
1620141|NCT00319384|congestive heart failure|congestive heart failure
1620142|NCT00319384|heart failure|heart failure
1620143|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
1620144|NCT00319384|fluid overload|fluid overload
1620145|NCT00319371|vasospasm|vasospasm
1620146|NCT00319371|circadian|circadian
1620147|NCT00319371|sleep-disorders|sleep-disorders
1620148|NCT00319358|chronic pancreatitis|chronic pancreatitis
1620149|NCT00319358|antioxidant supplementation|antioxidant supplementation
1620150|NCT00319358|oxidative stress|oxidative stress
1620151|NCT00319345|Traumatic brain injury|traumatic brain injury
1620712|NCT00317447|Prednisone|prednisone
1620152|NCT00319345|Intracranial pressure|intracranial pressure
1620153|NCT00319345|Osmotherapy|osmotherapy
1620154|NCT00319345|Glasgow outcome score|glasgow outcome score
1620155|NCT00319345|Mannitol|mannitol
1620156|NCT00319345|Sodium-Lactate|sodium-lactate
1620157|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1620158|NCT00319332|follicular lymphoma|follicular lymphoma
1620159|NCT00319332|BEXXAR|bexxar
1620160|NCT00319332|ZEVALIN|zevalin
1620280|NCT00318812|Ferritin|ferritin
1620161|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1620162|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
1620163|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
1620164|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
1620165|NCT00319319|major depressive disorder,|major depressive disorder,
1620166|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
1620167|NCT00319319|mecamylamine,|mecamylamine,
1620168|NCT00319319|controlled trial,|controlled trial,
1620169|NCT00319319|cigarette smoking|cigarette smoking
1620170|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
1620171|NCT00319306|Bronchial Diseases|bronchial diseases
1620172|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
1620173|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
1620174|NCT00319306|Bronchodilators|bronchodilators
1620175|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
1620176|NCT00319280|Osteotomy|osteotomy
1620177|NCT00319280|Healing|healing
1620178|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
1620179|NCT00319267|bosentan|bosentan
1620180|NCT00319267|children|children
1620181|NCT00319267|pharmacokinetics|pharmacokinetics
1620182|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
1620183|NCT00319254|Advanced Breast Cancer|advanced breast cancer
1620184|NCT00319241|parenting intervention|parenting intervention
1620185|NCT00319241|substance abuse treatment|substance abuse treatment
1620186|NCT00319241|mother-child relations|mother-child relations
1620187|NCT00319241|parent-child relations|parent-child relations
1620188|NCT00319241|child abuse and neglect|child abuse and neglect
1620189|NCT00319228|AT-III deficiency|at-iii deficiency
1620190|NCT00319228|AT-III concentrate|at-iii concentrate
1620191|NCT00319228|Bleeding disorders|bleeding disorders
1620192|NCT00319228|Blood disorders|blood disorders
1620193|NCT00319215|ramelteon|ramelteon
1620194|NCT00319215|zopiclone|zopiclone
1620195|NCT00319215|driving|driving
1620196|NCT00319215|memory|memory
1620197|NCT00319215|balance|balance
1620198|NCT00319215|psychomotor|psychomotor
1620199|NCT00319202|Impaired fasting glucose|impaired fasting glucose
1620200|NCT00319202|Abdominal obesity|abdominal obesity
1620201|NCT00319202|HOMA|homa
1620202|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
1620203|NCT00319189|Nateglinide|nateglinide
1620204|NCT00319189|Renal|renal
1620205|NCT00319189|Kidney|kidney
1620206|NCT00319189|Transplantation|transplantation
1620207|NCT00319189|Diabets|diabets
1620208|NCT00319189|Glucose|glucose
1620209|NCT00319176|Pregnancy|pregnancy
1620210|NCT00319176|Enoxaparin|enoxaparin
1620211|NCT00319176|Anticoagulation|anticoagulation
1620212|NCT00319163|oral contraceptive|oral contraceptive
1620213|NCT00319163|therapeutic equivalency|therapeutic equivalency
1620214|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
1620215|NCT00319150|Erythropoetin resistance|erythropoetin resistance
1620216|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
1620217|NCT00319137|GW274150|gw274150
1620218|NCT00319137|Nitric Oxide|nitric oxide
1620219|NCT00319137|acute migraine|acute migraine
1620220|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
1620221|NCT00319111|pulmonary hypertension|pulmonary hypertension
1620222|NCT00319111|bosentan|bosentan
1620223|NCT00319111|BENEFIT|benefit
1620224|NCT00319111|CTEPH|cteph
1620225|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
1620226|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
1620227|NCT00319098|Influenza|influenza
1620228|NCT00319085|Arthroplasty,|arthroplasty,
1620229|NCT00319085|Hip,|hip,
1620230|NCT00319085|Pre-heating,|pre-heating,
1620231|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
1620232|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
1620233|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
1620234|NCT00319046|miglustat|miglustat
1620235|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
1620236|NCT00319033|interstitial lung disease|interstitial lung disease
1620237|NCT00319033|scleroderma|scleroderma
1620238|NCT00319033|bosentan|bosentan
1620239|NCT00319020|bosentan|bosentan
1620240|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
1620241|NCT00319020|children|children
1620242|NCT00319020|FUTURE 1|future 1
1620243|NCT00318981|Medication trial|medication trial
1620246|NCT00318981|Efficacy trial|efficacy trial
1620247|NCT00318968|Acid Reflux|acid reflux
1620248|NCT00318968|Nexium|nexium
1620249|NCT00318968|Esomeprazole|esomeprazole
1620250|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
1620251|NCT00318942|Sepsis|sepsis
1620252|NCT00318942|Multiple Trauma|multiple trauma
1620613|NCT00317720|RAD001|rad001
1620253|NCT00318942|Hypovolemic Shock|hypovolemic shock
1620254|NCT00318929|Treatment Efficacy|treatment efficacy
1620255|NCT00318929|pharmacokinetics|pharmacokinetics
1620256|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
1620257|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
1620258|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
1620259|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
1620260|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
1620261|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
1620262|NCT00318877|Obesity|obesity
1620263|NCT00318877|Physical activity|physical activity
1620264|NCT00318864|depression|depression
1620265|NCT00318864|cardiovascular risk|cardiovascular risk
1620266|NCT00318864|mechanisms|mechanisms
1620267|NCT00318851|Carotid Artery stenting|carotid artery stenting
1620268|NCT00318851|Stroke|stroke
1620269|NCT00318825|Pain|pain
1620270|NCT00318825|Colonoscopy|colonoscopy
1620271|NCT00318825|Sedation|sedation
1620272|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
1620273|NCT00318812|Prospective Studies|prospective studies
1620274|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
1620275|NCT00318812|Peptides|peptides
1620276|NCT00318812|Heme|heme
1620277|NCT00318812|Iron|iron
1620278|NCT00318812|Erythropoietin,|erythropoietin,
1620279|NCT00318812|Recombinant|recombinant
1620281|NCT00318812|Transferrin|transferrin
1620282|NCT00318812|Treatment Outcome|treatment outcome
1620283|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
1620284|NCT00318773|PMS|pms
1620285|NCT00318773|PMDD|pmdd
1620286|NCT00318773|sertraline|sertraline
1620287|NCT00318773|antidepressant|antidepressant
1620288|NCT00318773|extended treatment|extended treatment
1620289|NCT00318773|relapse|relapse
1620290|NCT00318760|Drug Cue|drug cue
1620291|NCT00318760|Relapse|relapse
1620292|NCT00318760|Stress|stress
1620293|NCT00318760|Craving|craving
1620294|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
1620295|NCT00318747|AIC|aic
1620296|NCT00318747|Amb a I Protein|amb a i protein
1620297|NCT00318747|Ragweed Allergy|ragweed allergy
1620298|NCT00318747|Hay Fever|hay fever
1620299|NCT00318747|Wheeze|wheeze
1620300|NCT00318747|Immunotherapy|immunotherapy
1620301|NCT00318747|Tolerance|tolerance
1620302|NCT00318747|Immunostimulatory|immunostimulatory
1620303|NCT00318747|Ragweed Season|ragweed season
1620304|NCT00318747|Asthma|asthma
1620305|NCT00318747|Asthmatics|asthmatics
1620306|NCT00318747|Asthmatic|asthmatic
1620307|NCT00318721|Leishmania donovani|leishmania donovani
1620308|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
1620309|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
1620310|NCT00318721|Bednets|bednets
1620311|NCT00318721|Sandflies|sandflies
1620312|NCT00318695|Probiotics|probiotics
1620313|NCT00318695|Eczema|eczema
1620315|NCT00318695|Allergic Rhinitis|allergic rhinitis
1620316|NCT00318695|Prevention|prevention
1620317|NCT00318695|Immunological responses|immunological responses
1620318|NCT00318682|biopsy|biopsy
1620319|NCT00318682|FIBROSCAN|fibroscan
1620320|NCT00318669|Anxiety|anxiety
1620322|NCT00318669|Social|social
1620323|NCT00318669|Disorder|disorder
1620324|NCT00318656|type 2 diabetes|type 2 diabetes
1620325|NCT00318656|rosiglitazone|rosiglitazone
1620326|NCT00318656|metformin|metformin
1620327|NCT00318656|glimepiride|glimepiride
1620328|NCT00318656|glycemia|glycemia
1620329|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
1620330|NCT00318643|Chemophase|chemophase
1620331|NCT00318643|Intravesical administration|intravesical administration
1620332|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
1620333|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
1620334|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
1620335|NCT00318617|PPARs,|ppars,
1620336|NCT00318617|Heart Failure,|heart failure,
1620337|NCT00318617|cardiac energetics,|cardiac energetics,
1620338|NCT00318617|MRI,|mri,
1620339|NCT00318617|GW501516X|gw501516x
1620340|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
1620341|NCT00318604|plasma circulating DNA|plasma circulating dna
1620342|NCT00318604|hean and neck cancers|hean and neck cancers
1620343|NCT00318604|esophageal cancer|esophageal cancer
1620344|NCT00318604|localized head and neck cancers|localized head and neck cancers
1620345|NCT00318604|localized esophageal cancer|localized esophageal cancer
1620346|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
1620348|NCT00318578|prognosis factors|prognosis factors
1620349|NCT00318578|seizure duration|seizure duration
1620350|NCT00318578|adult|adult
1620351|NCT00318578|electroencephalogram|electroencephalogram
1620352|NCT00318578|intensive care unit|intensive care unit
1620353|NCT00318565|Heart Disease|heart disease
1620354|NCT00318565|Atrial Flutter|atrial flutter
1620355|NCT00318565|Typical Atrial Flutter|typical atrial flutter
1620356|NCT00318552|Antibiotic Therapy|antibiotic therapy
1620357|NCT00318552|sepsis treatment|sepsis treatment
1620358|NCT00318552|Meropenem|meropenem
1620359|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
1620360|NCT00318513|breast cancer|breast cancer
1620361|NCT00318513|lymphedema|lymphedema
1620362|NCT00318513|extremity|extremity
1620363|NCT00318513|women|women
1620364|NCT00318500|Endometriosis|endometriosis
1620365|NCT00318500|Dysmenorrhea|dysmenorrhea
1620366|NCT00318500|Pelvic pain|pelvic pain
1620367|NCT00318500|Dyspareunia|dyspareunia
1620368|NCT00318487|Dental implants|dental implants
1620369|NCT00318474|Proteinuria|proteinuria
1620370|NCT00318474|Immunoglobulin A|immunoglobulin a
1620371|NCT00318448|Child Psychology|child psychology
1620372|NCT00318448|Pediatric Psychology|pediatric psychology
1620373|NCT00318448|Insomnia|insomnia
1620374|NCT00318448|Sleeplessness|sleeplessness
1620375|NCT00318409|Methamphetamine|methamphetamine
1620377|NCT00318396|THA|tha
1620378|NCT00318383|Vaccine|vaccine
1620379|NCT00318383|Immunogenicity|immunogenicity
1620380|NCT00318383|Randomized Controlled Trial|randomized controlled trial
1620381|NCT00318370|Ovarian Cancer|ovarian cancer
1620382|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
1620383|NCT00318370|Peritoneal Cancer|peritoneal cancer
1620384|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
1620385|NCT00318357|All-cause mortality|all-cause mortality
1620386|NCT00318357|Long-term follow-up|long-term follow-up
1620387|NCT00318331|Glutamine|glutamine
1620388|NCT00318331|Critical Illness|critical illness
1620389|NCT00318331|Enteral Feeding|enteral feeding
1620390|NCT00318331|Blood Volume Analysis|blood volume analysis
1620391|NCT00318318|Premarin,|premarin,
1620392|NCT00318318|HRT,|hrt,
1620393|NCT00318318|RNA,|rna,
1620394|NCT00318318|Gene Expression.|gene expression.
1620395|NCT00318318|Postmenopausal Women|postmenopausal women
1620396|NCT00318292|preemptive analgesia|preemptive analgesia
1620397|NCT00318292|paracervical block|paracervical block
1620398|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
1620399|NCT00318279|Surgical education|surgical education
1620400|NCT00318279|Vascular anastomosis|vascular anastomosis
1620401|NCT00318279|Simulator|simulator
1620402|NCT00318279|Randomized controlled trial|randomized controlled trial
1620403|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
1620404|NCT00318253|Cranberry juice|cranberry juice
1620405|NCT00318253|Antiadhesion|antiadhesion
1620406|NCT00318253|Urinary tract infection|urinary tract infection
1620407|NCT00318253|vaginosis|vaginosis
1620408|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
1620409|NCT00318240|Men|men
1620410|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
1620411|NCT00318227|Postoperative care|postoperative care
1620412|NCT00318227|Cardiac Surgery|cardiac surgery
1620413|NCT00318227|Blood Transfusion|blood transfusion
1620414|NCT00318214|toe ulcer|toe ulcer
1620415|NCT00318214|heel ulcer|heel ulcer
1620417|NCT00318214|diabetic feet|diabetic feet
1620418|NCT00318214|diabetic foot|diabetic foot
1620419|NCT00318214|complications of diabetes|complications of diabetes
1620420|NCT00318201|Healthy Subjects|healthy subjects
1620421|NCT00318188|scleroderma|scleroderma
1620423|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
1620424|NCT00318175|Systemic Scleroderma|systemic scleroderma
1620425|NCT00318175|Dermal Sclerosis|dermal sclerosis
1620426|NCT00318175|Bosentan|bosentan
1620427|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
1620428|NCT00318175|Rodnan Skin Score|rodnan skin score
1620429|NCT00318162|autism|autism
1620430|NCT00318162|PDD|pdd
1620431|NCT00318162|LDN|ldn
1620432|NCT00318162|naltrexone|naltrexone
1620433|NCT00318136|BRIDGE|bridge
1620434|NCT00318136|NSCLC|nsclc
1620435|NCT00318136|Lung Cancer|lung cancer
1620436|NCT00318136|Avastin|avastin
1620437|NCT00318123|Simplification therapy|simplification therapy
1620438|NCT00318123|Efficacy|efficacy
1620439|NCT00318123|Safety|safety
1620440|NCT00318123|Virological effectiveness|virological effectiveness
1620441|NCT00318123|Immunological effectiveness|immunological effectiveness
1620442|NCT00318123|HIV|hiv
1620443|NCT00318110|Metastatic|metastatic
1620444|NCT00318110|Renal|renal
1620445|NCT00318110|Cell|cell
1620446|NCT00318110|Carcinoma|carcinoma
1620447|NCT00318110|Unrelated|unrelated
1620448|NCT00318110|Donor|donor
1620449|NCT00318110|Transplant|transplant
1620450|NCT00318110|stage IV|stage iv
1620451|NCT00318110|clear cell|clear cell
1620452|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
1620453|NCT00318097|Histamine regulation|histamine regulation
1620454|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
1620455|NCT00318084|Heartburn|heartburn
1620456|NCT00318084|Acid-related diseases|acid-related diseases
1620457|NCT00318084|Acid reflux disease|acid reflux disease
1620458|NCT00318084|Nexium|nexium
1620459|NCT00318071|Stroke|stroke
1620460|NCT00318071|Ischemic|ischemic
1620461|NCT00318071|Thrombus|thrombus
1620462|NCT00318071|Embolectomy|embolectomy
1620463|NCT00318071|Thrombectomy|thrombectomy
1620464|NCT00318071|Merci|merci
1620465|NCT00318071|Concentric|concentric
1620466|NCT00318071|Embolus|embolus
1620467|NCT00318071|Embolism|embolism
1620468|NCT00318071|Mechanical|mechanical
1620469|NCT00318045|Refractive error|refractive error
1620470|NCT00318045|Asthenopia|asthenopia
1620471|NCT00318032|Randomised control trial|randomised control trial
1620472|NCT00318032|Screening|screening
1620473|NCT00318032|Intensive management|intensive management
1620474|NCT00318032|Diabetes mellitus|diabetes mellitus
1620475|NCT00318032|Type 2 diabetes|type 2 diabetes
1620476|NCT00318019|Energy|energy
1620477|NCT00318019|Energy Level|energy level
1620478|NCT00318006|chronic|chronic
1620479|NCT00318006|nasal|nasal
1620480|NCT00318006|sinus|sinus
1620481|NCT00318006|symptoms|symptoms
1620482|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
1620483|NCT00317980|Leishmania braziliensis|leishmania braziliensis
1620484|NCT00317980|Pentavalent antimony|pentavalent antimony
1620485|NCT00317980|Meglumine antimoniate|meglumine antimoniate
1620486|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1620487|NCT00317967|Statin therapy|statin therapy
1620488|NCT00317967|Regression|regression
1620489|NCT00317967|Heart failure|heart failure
1620490|NCT00317967|Arrhythmias|arrhythmias
1620491|NCT00317967|Sudden cardiac death|sudden cardiac death
1620492|NCT00317954|Diabetic nephropathy|diabetic nephropathy
1620493|NCT00317954|Spironolactone|spironolactone
1620494|NCT00317954|Aldosterone antagonism|aldosterone antagonism
1620495|NCT00317954|Renoprotection|renoprotection
1620496|NCT00317941|Multiple Sclerosis|multiple sclerosis
1620497|NCT00317941|RRMS|rrms
1620498|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
1620499|NCT00317928|Metformin|metformin
1620500|NCT00317928|Metabolic Syndrome|metabolic syndrome
1620501|NCT00317928|Hyperandrogenism|hyperandrogenism
1620502|NCT00317928|Ovulation|ovulation
1620503|NCT00317902|Anemia|anemia
1620504|NCT00317902|erythropoetin|erythropoetin
1620505|NCT00317902|Epoetin alfa|epoetin alfa
1620506|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
1620507|NCT00317902|HIV, AIDS|hiv, aids
1620508|NCT00317889|THA|tha
1620509|NCT00317876|Fanconi anemia|fanconi anemia
1620510|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
1620511|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
1620512|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
1620513|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
1620514|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1620515|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
1620516|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
1620517|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
1620518|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
1620519|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1620520|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1620521|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1620522|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1620523|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1620524|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1620525|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1620526|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1620527|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1620528|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1620529|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1620530|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1620531|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1620532|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1620533|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1620534|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1620535|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1620536|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1620537|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1620608|NCT00317733|Transfersome|transfersome
1621010|NCT00316147|diphtheria|diphtheria
1620538|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1620539|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1620611|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
1620540|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1620541|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1620542|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1620543|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1620544|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1620545|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1620546|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1620547|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1620548|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1620549|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1620550|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1620551|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1620552|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1620553|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1620554|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1620555|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1620556|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1620557|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1620558|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1620559|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1620560|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1620561|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1620562|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1620563|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1620564|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1620565|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1620566|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1620567|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1620568|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1620569|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1620570|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1620571|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1620572|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1620573|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1620574|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1620575|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1620576|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1620577|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1620578|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1620579|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1620580|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1620581|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1620582|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1620583|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1620584|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1620585|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1620586|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1620587|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1620588|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1620589|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1620590|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1620591|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1620592|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
1620593|NCT00317772|Peritoneal Cancer|peritoneal cancer
1620594|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
1620595|NCT00317772|Epidermal Growth Factor|epidermal growth factor
1620596|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
1620597|NCT00317772|Hycamtin|hycamtin
1620598|NCT00317772|Gefitinib|gefitinib
1620599|NCT00317772|Iressa|iressa
1620600|NCT00317772|Topotecan|topotecan
1620601|NCT00317772|EGFR|egfr
1620602|NCT00317759|stage IV melanoma|stage iv melanoma
1620603|NCT00317759|recurrent melanoma|recurrent melanoma
1620604|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
1620605|NCT00317746|Depression|depression
1620606|NCT00317746|Citalopram|citalopram
1620609|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
1620610|NCT00317720|Breast Cancer|breast cancer
1620612|NCT00317720|Trastuzumab|trastuzumab
1620614|NCT00317720|Herceptin|herceptin
1620615|NCT00317707|cardiovascular risk|cardiovascular risk
1620616|NCT00317707|cardiovascular diseases|cardiovascular diseases
1620617|NCT00317707|cardiovascular prevention|cardiovascular prevention
1620618|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
1620619|NCT00317707|diabetes|diabetes
1620620|NCT00317707|hypertension|hypertension
1620621|NCT00317707|hypercholesterolemia|hypercholesterolemia
1620622|NCT00317707|obesity|obesity
1620623|NCT00317694|Hyperphosphatemia|hyperphosphatemia
1620624|NCT00317694|Phosphate binder|phosphate binder
1620625|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
1620626|NCT00317681|Tacrolimus ointment|tacrolimus ointment
1620627|NCT00317681|Topical treatment|topical treatment
1620628|NCT00317681|Skin lesions|skin lesions
1620629|NCT00317655|back pain|back pain
1620630|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
1620631|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
1620632|NCT00317642|relapsed AML|relapsed aml
1620633|NCT00317642|refractory AML|refractory aml
1620634|NCT00317642|clofarabine|clofarabine
1620635|NCT00317642|cytarabine|cytarabine
1620636|NCT00317642|CLO341|clo341
1620637|NCT00317642|clolar|clolar
1620638|NCT00317629|leishmaniasis|leishmaniasis
1620639|NCT00317629|nitric oxide|nitric oxide
1620640|NCT00317629|treatment|treatment
1620641|NCT00317629|donor|donor
1620642|NCT00317629|controlled trial|controlled trial
1620643|NCT00317616|FALS|fals
1620644|NCT00317616|SOD1|sod1
1620645|NCT00317616|familial|familial
1620646|NCT00317616|genetic testing|genetic testing
1620647|NCT00317616|genetic counseling|genetic counseling
1620648|NCT00317616|ALS|als
1620649|NCT00317616|C9ORF72|c9orf72
1620650|NCT00317616|TARDBP|tardbp
1620651|NCT00317616|VCP|vcp
1620652|NCT00317616|FUS|fus
1620653|NCT00317616|PFN1|pfn1
1620654|NCT00317603|autologous vaccination|autologous vaccination
1620655|NCT00317603|GM-CSF|gm-csf
1620656|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
1620657|NCT00317603|Stage IV breast cancer|stage iv breast cancer
1620658|NCT00317590|Diagnosis|diagnosis
1620659|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
1620660|NCT00317590|Management|management
1620661|NCT00317590|Attributable Fraction|attributable fraction
1620662|NCT00317590|Threshold|threshold
1620663|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
1620664|NCT00317577|Normal tension glaucoma|normal tension glaucoma
1620665|NCT00317577|Neuroprotection|neuroprotection
1620666|NCT00317577|Brimonidine|brimonidine
1620667|NCT00317577|Visual field progression|visual field progression
1620668|NCT00317564|Birth Defects|birth defects
1620669|NCT00317564|High Risk Pregnancy|high risk pregnancy
1620670|NCT00317564|Multiple Sclerosis|multiple sclerosis
1620671|NCT00317551|Aberration control|aberration control
1620672|NCT00317551|Accommodative facility|accommodative facility
1620673|NCT00317551|Accommodative response|accommodative response
1620674|NCT00317551|Peripheral refraction|peripheral refraction
1620675|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
1620676|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
1620677|NCT00317538|Switching|switching
1620678|NCT00317538|Structural Damage|structural damage
1620679|NCT00317538|MRI|mri
1620680|NCT00317525|Refractive error|refractive error
1620681|NCT00317525|Asthenopia|asthenopia
1620682|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
1620683|NCT00317512|HBOC 201|hboc 201
1620684|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
1620685|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
1620686|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
1620687|NCT00317512|Tissue Oxygenation|tissue oxygenation
1620688|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
1620689|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
1620690|NCT00317486|Eisenmenger physiology|eisenmenger physiology
1620691|NCT00317486|bosentan|bosentan
1620692|NCT00317473|Vaccine|vaccine
1620693|NCT00317473|Phase 1|phase 1
1620694|NCT00317473|Plasmodium falciparum|plasmodium falciparum
1620695|NCT00317473|Malaria|malaria
1620696|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
1620697|NCT00317473|MSP-1|msp-1
1620698|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
1620699|NCT00317473|FMP-1|fmp-1
1620700|NCT00317473|AS02A|as02a
1620701|NCT00317460|Drug Abuse|drug abuse
1620702|NCT00317460|Drug Addiction|drug addiction
1620703|NCT00317460|Drug Dependence|drug dependence
1620704|NCT00317460|Drug Use Disorders|drug use disorders
1620705|NCT00317460|Drug Use Disorder|drug use disorder
1620706|NCT00317460|Substance Abuse|substance abuse
1620707|NCT00317460|Substance Use Disorder|substance use disorder
1620708|NCT00317460|Buprenorphine|buprenorphine
1620709|NCT00317460|Opiate Addiction|opiate addiction
1620710|NCT00317447|Sciatica|sciatica
1620711|NCT00317447|Lower back pain|lower back pain
1620713|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
1620809|NCT00317018|translation|translation
1620714|NCT00317434|ovarian cancer|ovarian cancer
1620715|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
1620716|NCT00317421|Sildenafil|sildenafil
1620717|NCT00317421|Hypertension|hypertension
1620718|NCT00317421|Blood pressure|blood pressure
1620719|NCT00317421|Arterial stiffness|arterial stiffness
1620720|NCT00317421|Endothelial function|endothelial function
1620721|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1620722|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1620723|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1620724|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1620725|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
1620726|NCT00317395|Early invasive strategy|early invasive strategy
1620727|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
1620728|NCT00317382|lumbar puncture|lumbar puncture
1620729|NCT00317382|headache|headache
1620730|NCT00317382|traumatic tap|traumatic tap
1620731|NCT00317369|OPC-6535|opc-6535
1620732|NCT00317369|Crohn's disease|crohn's disease
1620733|NCT00317356|OPC-6535|opc-6535
1620734|NCT00317356|ulcerative colitis|ulcerative colitis
1620735|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
1620736|NCT00317317|IVF|ivf
1620737|NCT00317317|Acupuncture|acupuncture
1620738|NCT00317317|Pregnant|pregnant
1620739|NCT00317304|Hot flashes|hot flashes
1620740|NCT00317304|vasomotor symptoms|vasomotor symptoms
1620741|NCT00317304|menopause|menopause
1620742|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
1620743|NCT00317304|meditation|meditation
1620744|NCT00317291|Acupuncture|acupuncture
1620745|NCT00317291|HIV|hiv
1620746|NCT00317291|AIDS|aids
1620747|NCT00317291|Symptom management|symptom management
1620748|NCT00317291|Non-invasive|non-invasive
1620749|NCT00317291|Complementary Therapies|complementary therapies
1620750|NCT00317291|Treatment Experienced|treatment experienced
1620751|NCT00317278|Massage|massage
1620752|NCT00317278|immune system|immune system
1620753|NCT00317278|preterm infants|preterm infants
1620754|NCT00317265|coronary artery disease|coronary artery disease
1620755|NCT00317265|coronary bypass surgery|coronary bypass surgery
1620756|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
1620757|NCT00317265|internal mammary artery|internal mammary artery
1620758|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
1620759|NCT00317252|contrast nephropathy|contrast nephropathy
1620760|NCT00317252|contrast media|contrast media
1620761|NCT00317252|kidney diseases|kidney diseases
1620762|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1620763|NCT00317239|Anemia|anemia
1620764|NCT00317239|Chronic Kidney Disease|chronic kidney disease
1620765|NCT00317239|Iron|iron
1620766|NCT00317226|Anemia|anemia
1620767|NCT00317226|CKD|ckd
1620768|NCT00317226|Chronic Kidney Disease|chronic kidney disease
1620769|NCT00317226|Iron|iron
1620770|NCT00317226|Maintenance Dose|maintenance dose
1620771|NCT00317213|Smoking|smoking
1620774|NCT00317213|Phospholipids|phospholipids
1620775|NCT00317213|Cell membrane fluidity|cell membrane fluidity
1620776|NCT00317213|Smoking cessation|smoking cessation
1620777|NCT00317148|Hot Flashes|hot flashes
1620778|NCT00317148|Menopause|menopause
1620779|NCT00317148|Quality of Life|quality of life
1620780|NCT00317148|Hot flushes|hot flushes
1620781|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
1620782|NCT00317109|tetanus|tetanus
1620783|NCT00317109|hepatitis B|hepatitis b
1620784|NCT00317109|pertussis|pertussis
1620785|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
1620786|NCT00317109|meningococcal vaccine|meningococcal vaccine
1620787|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
1620788|NCT00317096|Drug Therapy|drug therapy
1620789|NCT00317096|Maintenance|maintenance
1620790|NCT00317096|rituximab|rituximab
1620791|NCT00317083|Cough Reflex|cough reflex
1620792|NCT00317083|Citric acid|citric acid
1620793|NCT00317083|Obesity|obesity
1620794|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
1620795|NCT00317070|PBS/IC|pbs/ic
1620796|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
1620797|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1620798|NCT00317057|Outpatient management|outpatient management
1620799|NCT00317057|nurse-lead patient education|nurse-lead patient education
1620800|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
1620801|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1620802|NCT00317044|esomeprazole|esomeprazole
1620803|NCT00317044|GERD|gerd
1620804|NCT00317031|Alcoholism|alcoholism
1620805|NCT00317031|Drug Therapy|drug therapy
1620806|NCT00317018|depression|depression
1620807|NCT00317018|quality improvement|quality improvement
1620808|NCT00317018|implementation|implementation
1620810|NCT00317018|evidence-based practice|evidence-based practice
1620811|NCT00317018|collaborative care|collaborative care
1620812|NCT00317018|adoption|adoption
1620813|NCT00317018|sustainability|sustainability
1620814|NCT00317018|cost-effectiveness|cost-effectiveness
1620815|NCT00317018|rural|rural
1620816|NCT00317005|hemodialysis|hemodialysis
1620817|NCT00317005|chronic uremia|chronic uremia
1620818|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
1620819|NCT00317005|folate|folate
1620820|NCT00316992|Insomnia|insomnia
1620821|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1620822|NCT00316992|Drug Therapy|drug therapy
1620823|NCT00316979|migraine|migraine
1620824|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
1620825|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1620826|NCT00316979|rTMS|rtms
1620827|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
1620828|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
1620829|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
1620830|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
1620831|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
1620832|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1620833|NCT00316927|stage III prostate cancer|stage iii prostate cancer
1620834|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
1620835|NCT00316914|neurotoxicity|neurotoxicity
1620836|NCT00316914|stage II colon cancer|stage ii colon cancer
1620837|NCT00316914|stage III colon cancer|stage iii colon cancer
1620838|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
1620839|NCT00316914|stage II rectal cancer|stage ii rectal cancer
1620840|NCT00316914|stage III rectal cancer|stage iii rectal cancer
1620841|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
1620842|NCT00316914|stage IV colon cancer|stage iv colon cancer
1620843|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1620844|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
1620845|NCT00316901|stage IV melanoma|stage iv melanoma
1620846|NCT00316901|recurrent melanoma|recurrent melanoma
1620847|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
1620848|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1620849|NCT00316888|stage I anal cancer|stage i anal cancer
1620850|NCT00316888|stage II anal cancer|stage ii anal cancer
1620851|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
1620852|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
1620853|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1620854|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1620855|NCT00316875|stage IV breast cancer|stage iv breast cancer
1620856|NCT00316875|recurrent breast cancer|recurrent breast cancer
1620857|NCT00316875|male breast cancer|male breast cancer
1620858|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1620859|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
1620860|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
1620861|NCT00316836|stage I breast cancer|stage i breast cancer
1620862|NCT00316836|stage II breast cancer|stage ii breast cancer
1620863|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
1620864|NCT00316823|thyroid cancer|thyroid cancer
1620865|NCT00316810|Campath 1H|campath 1h
1620868|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
1620869|NCT00316810|immunosuppression|immunosuppression
1620870|NCT00316810|prevention of acute rejection|prevention of acute rejection
1620871|NCT00316797|SPECT|spect
1620872|NCT00316797|Nuclear Medicine|nuclear medicine
1620873|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
1620874|NCT00316745|irinotecan|irinotecan
1620875|NCT00316745|S-1|s-1
1620876|NCT00316745|Oxaliplatin|oxaliplatin
1620877|NCT00316745|l-leucovorin|l-leucovorin
1620878|NCT00316745|Fluorouracil|fluorouracil
1620879|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
1620880|NCT00316745|phase III|phase iii
1620881|NCT00316732|Avodart|avodart
1620882|NCT00316732|IPSS|ipss
1620883|NCT00316732|BPH|bph
1620884|NCT00316732|dutasteride|dutasteride
1620885|NCT00316732|EQ-5D|eq-5d
1620886|NCT00316732|Observational|observational
1620887|NCT00316719|treatment naive|treatment naive
1620888|NCT00316719|CHB|chb
1620889|NCT00316719|adefovir|adefovir
1620890|NCT00316719|monotherapy|monotherapy
1620891|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
1620892|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
1620893|NCT00316667|epidemiology|epidemiology
1620894|NCT00316667|risk factors|risk factors
1620895|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1620896|NCT00316654|vaccines, conjugate|vaccines, conjugate
1620897|NCT00316654|immunology|immunology
1620898|NCT00316654|child|child
1620899|NCT00316654|antibody persistence|antibody persistence
1620900|NCT00316628|influenza|influenza
1620901|NCT00316628|elderly|elderly
1620902|NCT00316628|vaccine|vaccine
1620903|NCT00316615|influenza|influenza
1621011|NCT00316147|tetanus|tetanus
1620904|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
1620905|NCT00316615|vaccine|vaccine
1620906|NCT00316602|Atopic dermatitis|atopic dermatitis
1620907|NCT00316602|Smallpox|smallpox
1620908|NCT00316602|Vaccination|vaccination
1620909|NCT00316589|HIV|hiv
1620910|NCT00316589|treatment experienced|treatment experienced
1620911|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
1620912|NCT00316576|Kidney failure, Acute|kidney failure, acute
1620913|NCT00316576|Genetic Polymorphism|genetic polymorphism
1620914|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
1620915|NCT00316563|cannabinoids|cannabinoids
1620916|NCT00316563|taste disorders|taste disorders
1620917|NCT00316563|olfaction disorders|olfaction disorders
1620918|NCT00316563|cancer|cancer
1620919|NCT00316563|palliative medicine|palliative medicine
1620920|NCT00316563|caloric intake|caloric intake
1620921|NCT00316563|appetite|appetite
1620922|NCT00316563|reward|reward
1620923|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
1620924|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
1620925|NCT00316563|quality of life|quality of life
1620926|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
1620927|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
1620928|NCT00316537|diabetes|diabetes
1620929|NCT00316537|foot ulcers|foot ulcers
1620930|NCT00316537|nicotine gel|nicotine gel
1620931|NCT00316537|wound healing|wound healing
1620932|NCT00316524|Smallpox|smallpox
1620933|NCT00316524|Vaccination|vaccination
1620934|NCT00316524|Prevention|prevention
1620935|NCT00316511|advanced solid malignancies|advanced solid malignancies
1620936|NCT00316511|B-cell lymphoma|b-cell lymphoma
1620937|NCT00316511|Aroplatin|aroplatin
1620938|NCT00316511|L-NDDP|l-nddp
1620939|NCT00316511|MTD|mtd
1620940|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
1620941|NCT00316498|Eye Movement|eye movement
1620942|NCT00316498|Niemann Pick C|niemann pick c
1620943|NCT00316485|Bone|bone
1620944|NCT00316485|Microbiology|microbiology
1620945|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
1620946|NCT00316485|Wisdom Teeth|wisdom teeth
1620947|NCT00316485|Biopsy|biopsy
1620948|NCT00316485|Third Molar Extraction|third molar extraction
1620949|NCT00316472|Hyperphosphatemia|hyperphosphatemia
1620950|NCT00316472|End Stage Renal Disease|end stage renal disease
1620951|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
1620952|NCT00316459|Healthy|healthy
1620953|NCT00316459|Cardiac|cardiac
1620954|NCT00316459|Pharmacokinetics|pharmacokinetics
1620955|NCT00316394|Preventive Health Care|preventive health care
1620956|NCT00316394|Annual Health Check-up|annual health check-up
1620957|NCT00316394|Primary Care|primary care
1620958|NCT00316394|Reminders|reminders
1620959|NCT00316381|stem cells|stem cells
1620960|NCT00316381|acute myocardial infarction|acute myocardial infarction
1620961|NCT00316381|regeneration|regeneration
1620962|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
1620963|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
1620964|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
1620965|NCT00316355|Anxiety|anxiety
1620966|NCT00316355|Behavior therapy|behavior therapy
1620967|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
1620968|NCT00316355|Stepped care|stepped care
1620969|NCT00316355|Cost-effectiveness|cost-effectiveness
1620970|NCT00316342|Low back pain|low back pain
1620971|NCT00316342|Industrial workers|industrial workers
1620972|NCT00316342|Recurrent back pain|recurrent back pain
1620973|NCT00316342|Back supports|back supports
1620974|NCT00316342|Back health education|back health education
1620975|NCT00316342|Rehabilitation|rehabilitation
1620976|NCT00316316|OCD|ocd
1620977|NCT00316303|Serious Mental Illness|serious mental illness
1620978|NCT00316303|Dual Diagnosis|dual diagnosis
1620979|NCT00316303|Mental Disorders|mental disorders
1620980|NCT00316303|Substance-Related Disorders|substance-related disorders
1620981|NCT00316290|ADHD|adhd
1620982|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
1620983|NCT00316290|Parent Training|parent training
1620984|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
1620985|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
1620986|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
1620987|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
1620988|NCT00316264|palivizumab|palivizumab
1620989|NCT00316264|motavizumab|motavizumab
1620990|NCT00316264|RSV|rsv
1620991|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
1620992|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
1620993|NCT00316186|chemonaive|chemonaive
1620994|NCT00316186|small cell lung cancer|small cell lung cancer
1620995|NCT00316186|untreated|untreated
1620996|NCT00316186|Lung cancer|lung cancer
1620997|NCT00316186|HYCAMTIN|hycamtin
1620998|NCT00316186|first-line|first-line
1620999|NCT00316186|extensive disease|extensive disease
1621000|NCT00316173|HYCAMTIN|hycamtin
1621001|NCT00316173|ovarian cancer|ovarian cancer
1621012|NCT00316147|poliomyelitis|poliomyelitis
1621013|NCT00316147|pertussis|pertussis
1621014|NCT00316147|hepatitis B|hepatitis b
1621015|NCT00316147|Prophylaxis|prophylaxis
1621016|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
1621017|NCT00316134|Pleural Diseases|pleural diseases
1621018|NCT00316134|Pleural Effusion|pleural effusion
1621019|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
1621020|NCT00316134|Pleural Neoplasms|pleural neoplasms
1621021|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
1621022|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
1621023|NCT00316108|Carotid|carotid
1621024|NCT00316108|Carotid Artery Stenting|carotid artery stenting
1621025|NCT00316108|Stent|stent
1621026|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
1621027|NCT00316108|Stroke|stroke
1621028|NCT00316108|Transient Ischemic Attack|transient ischemic attack
1621029|NCT00316108|Stenosis|stenosis
1621030|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
1621031|NCT00001675|Brain Imaging|brain imaging
1621032|NCT00001675|Affect|affect
1621033|NCT00001675|Limbic System|limbic system
1621034|NCT00001675|Cerebral Blood Volume|cerebral blood volume
1621035|NCT00001675|Alcoholism|alcoholism
1621036|NCT00001675|Emotion|emotion
1621037|NCT00001675|Brain|brain
1621038|NCT00001675|Operant|operant
1621039|NCT00001675|Autonomic|autonomic
1621040|NCT00001675|Relapse|relapse
1621041|NCT00001675|Normal Volunteer|normal volunteer
1621042|NCT00001673|Alcoholics|alcoholics
1621043|NCT00001673|Screening|screening
1621044|NCT00001673|Healthy Volunteers|healthy volunteers
1621045|NCT00001673|Violent Abusers|violent abusers
1621046|NCT00001673|Illicit Drug Testing|illicit drug testing
1621047|NCT00001673|Blood Tests|blood tests
1621048|NCT00001673|Normal Volunteer|normal volunteer
1621058|NCT00316056|Genetic Literacy|genetic literacy
1621059|NCT00316056|Learning|learning
1621060|NCT00316056|Genetic Knowledge|genetic knowledge
1621061|NCT00316056|Public Understanding of Science|public understanding of science
1621062|NCT00316056|Science Education|science education
1621063|NCT00316056|Healthy Volunteer|healthy volunteer
1621065|NCT00316043|Urinary tract infections|urinary tract infections
1621066|NCT00316043|Renal failure|renal failure
1621067|NCT00316043|Renal scarring|renal scarring
1621068|NCT00316043|Prevention|prevention
1621069|NCT00316043|Primary Care|primary care
1621070|NCT00316043|General Practice|general practice
1621071|NCT00316043|Intervention Studies|intervention studies
1621072|NCT00316043|Children|children
1621073|NCT00316030|AML|aml
1621074|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
1621075|NCT00316030|Bexarotene|bexarotene
1621076|NCT00316030|Leukemia|leukemia
1621077|NCT00316017|Trauma|trauma
1621078|NCT00316017|Shock|shock
1621079|NCT00316004|Traumatic|traumatic
1621080|NCT00316004|Brain injury|brain injury
1621081|NCT00315991|BG perception|bg perception
1621082|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
1621083|NCT00315991|pediatric T1DM|pediatric t1dm
1621084|NCT00315978|Risk Assessment|risk assessment
1621085|NCT00315978|Decision Support Technique|decision support technique
1621086|NCT00315978|Physician-Patient Relations|physician-patient relations
1621087|NCT00315978|Prevention and Control|prevention and control
1621089|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
1621090|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
1621091|NCT00315965|Transfer factor|transfer factor
1621092|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
1621093|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
1621094|NCT00315952|inhaled insulin|inhaled insulin
1621095|NCT00315952|Positron Emission Tomography|positron emission tomography
1621096|NCT00315939|Diabetes|diabetes
1621097|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
1621098|NCT00315926|Cardiac morbidity|cardiac morbidity
1621099|NCT00315926|Melatonin|melatonin
1621100|NCT00315926|Surgery|surgery
1621101|NCT00315926|Postoperative|postoperative
1621102|NCT00315913|Labor|labor
1621103|NCT00315913|Dysfunctional Labor|dysfunctional labor
1621104|NCT00315913|Labor Arrest|labor arrest
1621105|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
1621106|NCT00315900|Seroquel|seroquel
1621107|NCT00315900|Depakote ER|depakote er
1621108|NCT00315900|Nursing Home|nursing home
1621109|NCT00315900|Quetiapine|quetiapine
1621110|NCT00315900|Divalproex ER|divalproex er
1621111|NCT00315900|Agitation|agitation
1621112|NCT00315887|low back pain|low back pain
1621113|NCT00315887|opioid|opioid
1621114|NCT00315887|transdermal|transdermal
1621115|NCT00315874|chronic back pain|chronic back pain
1621116|NCT00315874|opioid|opioid
1621117|NCT00315874|transdermal|transdermal
1621118|NCT00315861|ovarian carcinoma|ovarian carcinoma
1621119|NCT00315861|endometrial carcinoma|endometrial carcinoma
1621120|NCT00315861|cervical carcinoma|cervical carcinoma
1621121|NCT00315861|lung carcinoma|lung carcinoma
1621122|NCT00315848|chronic pain|chronic pain
1621123|NCT00315848|osteoarthritis|osteoarthritis
1621124|NCT00315848|opioid|opioid
1621125|NCT00315848|transdermal|transdermal
1621126|NCT00315835|postoperative pain|postoperative pain
1621127|NCT00315835|opioid|opioid
1621128|NCT00315835|transdermal|transdermal
1621129|NCT00315822|Surgery|surgery
1621130|NCT00315822|colon|colon
1621131|NCT00315809|leprosy, Philippines|leprosy, philippines
1621132|NCT00315796|Mind-Body Intervention|mind-body intervention
1621133|NCT00315796|Distraction|distraction
1621134|NCT00315796|Biophilic|biophilic
1621135|NCT00315796|Cancer|cancer
1621136|NCT00315796|pain|pain
1621137|NCT00315796|Bedscapes|bedscapes
1621138|NCT00315796|procedures|procedures
1621139|NCT00315796|bone marrow aspirate|bone marrow aspirate
1621140|NCT00315796|bone marrow biopsy|bone marrow biopsy
1621141|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1621142|NCT00315783|echocardiography|echocardiography
1621143|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
1621144|NCT00315770|overweight|overweight
1621145|NCT00315770|Metabolic syndrome|metabolic syndrome
1621146|NCT00315744|moderate asthma|moderate asthma
1621147|NCT00315744|fluticasone|fluticasone
1621148|NCT00315744|children|children
1621149|NCT00315744|salmeterol|salmeterol
1621150|NCT00315744|steroid-sparing|steroid-sparing
1621151|NCT00315744|Asthma|asthma
1621152|NCT00315731|Bexxar|bexxar
1621153|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
1621154|NCT00315731|fission|fission
1621155|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1621156|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1621157|NCT00315731|pharmacokinetics|pharmacokinetics
1621158|NCT00315731|tellurium|tellurium
1621159|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
1621160|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
1621161|NCT00315718|HbA1c|hba1c
1621162|NCT00315718|Safety|safety
1621163|NCT00315718|Liver function tests|liver function tests
1621164|NCT00315705|clofarabine|clofarabine
1621165|NCT00315705|acute leukemia|acute leukemia
1621166|NCT00315705|ALL|all
1621167|NCT00315705|AML|aml
1621168|NCT00315705|clolar|clolar
1621169|NCT00315705|CLO218|clo218
1621170|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
1621171|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
1621172|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
1621173|NCT00315679|pentoxifylline|pentoxifylline
1621174|NCT00315679|clinical trial|clinical trial
1621175|NCT00315679|double blind|double blind
1621176|NCT00315679|placebo controlled|placebo controlled
1621177|NCT00315679|randomized|randomized
1621178|NCT00315666|Chronic tension-type headache|chronic tension-type headache
1621179|NCT00315653|Bladder Cancer|bladder cancer
1621180|NCT00315653|Cancer of Bladder|cancer of bladder
1621181|NCT00315653|Bladder Tumors|bladder tumors
1621182|NCT00315653|Cancer of the Bladder|cancer of the bladder
1621183|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
1621184|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
1621185|NCT00315627|Islet Transplantation|islet transplantation
1621186|NCT00315614|Islet Transplantation|islet transplantation
1621187|NCT00315601|Telithromycin (drug)|telithromycin (drug)
1621188|NCT00315601|Azithromycin (drug)|azithromycin (drug)
1621189|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
1621190|NCT00315601|Pharmacokinetics|pharmacokinetics
1621191|NCT00315588|Islet Transplantation|islet transplantation
1621192|NCT00315575|Dementia|dementia
1621193|NCT00315575|brain circulation|brain circulation
1621194|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
1621195|NCT00315575|neuropathology|neuropathology
1621196|NCT00315575|neurophysiology|neurophysiology
1621197|NCT00315575|aging|aging
1621198|NCT00315575|apolipoprotein E|apolipoprotein e
1621199|NCT00315575|genotype|genotype
1621200|NCT00315575|hemodynamics|hemodynamics
1621201|NCT00315575|memory|memory
1621202|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
1621203|NCT00315562|stroke|stroke
1621204|NCT00315562|carotid stenosis|carotid stenosis
1621205|NCT00315562|carotid endarterectomy|carotid endarterectomy
1621206|NCT00315562|timing|timing
1621207|NCT00315549|Tonsillitis|tonsillitis
1621208|NCT00315549|pharyngitis|pharyngitis
1621209|NCT00315549|penicillin|penicillin
1621210|NCT00315549|telithromycin|telithromycin
1621211|NCT00315549|ketolides|ketolides
1621212|NCT00315549|clinical trials|clinical trials
1621213|NCT00315523|Levocetirizine|levocetirizine
1621214|NCT00315523|Xyzal|xyzal
1621215|NCT00315523|Rhinitis|rhinitis
1621216|NCT00315523|Allergic|allergic
1621217|NCT00315523|Seasonal|seasonal
1621218|NCT00315523|Ragweed|ragweed
1621219|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
1621220|NCT00315510|Annexin A5|annexin a5
1621221|NCT00315497|Giant Cell Arteritis|giant cell arteritis
1621222|NCT00315484|Anemia|anemia
1621223|NCT00315484|chemotherapy|chemotherapy
1621224|NCT00315484|hemoglobin level|hemoglobin level
1621225|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
1621226|NCT00315484|epoetin alfa|epoetin alfa
1621227|NCT00315484|darbepoetin alfa|darbepoetin alfa
1621228|NCT00315471|Vasculitis|vasculitis
1621229|NCT00315458|osteoarthritis|osteoarthritis
1621230|NCT00315458|opioid|opioid
1621231|NCT00315458|transdermal|transdermal
1621232|NCT00315445|chronic back pain|chronic back pain
1621233|NCT00315445|opioid|opioid
1621234|NCT00315445|transdermal|transdermal
1621235|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
1621236|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
1621237|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
1621238|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
1621239|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1621241|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
1621242|NCT00315393|GPA|gpa
1621243|NCT00315393|MPA|mpa
1621244|NCT00315393|WG|wg
1621245|NCT00315380|EGPA|egpa
1621246|NCT00315380|CSS|css
1621247|NCT00315367|Multiple Sclerosis|multiple sclerosis
1621248|NCT00315367|Memory impairment|memory impairment
1621249|NCT00315354|obesity|obesity
1621250|NCT00315354|nutrition|nutrition
1621251|NCT00315328|Amblyopia|amblyopia
1621252|NCT00315328|Atropine|atropine
1621253|NCT00315328|Patching|patching
1621254|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
1621255|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
1621256|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
1621257|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
1621258|NCT00315302|Amblyopia|amblyopia
1621259|NCT00315302|Atropine|atropine
1621260|NCT00315302|Plano lens|plano lens
1621261|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
1621262|NCT00315289|Simple probing|simple probing
1621263|NCT00315289|Balloon catheter dilation|balloon catheter dilation
1621264|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
1621265|NCT00315276|ADHD|adhd
1621266|NCT00315263|DNA|dna
1621267|NCT00315263|Genomics|genomics
1621268|NCT00315263|SNPs|snps
1621269|NCT00315263|Neonatology|neonatology
1621270|NCT00315263|Chronic Lung Disease|chronic lung disease
1621271|NCT00315263|Periventricular Brain Injury|periventricular brain injury
1621272|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
1621273|NCT00315250|Parkinson|parkinson
1621274|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
1621275|NCT00315224|exercise|exercise
1621276|NCT00315224|pulse pressure|pulse pressure
1621277|NCT00315224|endothelium|endothelium
1621278|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
1621279|NCT00315198|amblyopia|amblyopia
1621280|NCT00315198|patching|patching
1621281|NCT00315198|visual activities|visual activities
1621282|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
1621283|NCT00315185|First Line Treatment|first line treatment
1621284|NCT00315172|Adipose Tissue|adipose tissue
1621285|NCT00315172|Weight Gain|weight gain
1621286|NCT00315172|Pediatric|pediatric
1621287|NCT00315172|Body Composition|body composition
1621288|NCT00315172|Thermogenesis|thermogenesis
1621289|NCT00315172|Exercise|exercise
1621290|NCT00315172|Healthy Volunteer|healthy volunteer
1621291|NCT00315172|HV|hv
1621292|NCT00315159|Squamous|squamous
1621296|NCT00315159|Sentinel Node|sentinel node
1621297|NCT00315146|Body Composition|body composition
1621298|NCT00315146|Sarcopenia|sarcopenia
1621299|NCT00315146|Weight loss trials|weight loss trials
1621300|NCT00315146|Intervention studies|intervention studies
1621301|NCT00315146|Elderly|elderly
1621302|NCT00315133|Diabetes mellitus|diabetes mellitus
1621303|NCT00315133|Stem cells|stem cells
1621304|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
1621305|NCT00315133|Autoimmune diseases|autoimmune diseases
1621306|NCT00315120|Randomized controlled trial|randomized controlled trial
1621307|NCT00315120|Low back pain|low back pain
1621308|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
1621309|NCT00315120|Spinal manipulation|spinal manipulation
1621310|NCT00315120|Osteopathic manipulation|osteopathic manipulation
1621311|NCT00315120|Osteopathic medicine|osteopathic medicine
1621312|NCT00315120|Physical therapy modalities|physical therapy modalities
1621313|NCT00315094|home parenteral nutrition|home parenteral nutrition
1621314|NCT00315081|Schizophrenia|schizophrenia
1621315|NCT00315081|Hyperprolactinemia|hyperprolactinemia
1621316|NCT00315081|Risperidone|risperidone
1621317|NCT00315081|Bromocriptin|bromocriptin
1621318|NCT00315068|arrythmia|arrythmia
1621319|NCT00315068|atrial fibrillation|atrial fibrillation
1621320|NCT00315068|proteins|proteins
1621321|NCT00315055|Hepatitis B|hepatitis b
1621322|NCT00315055|Polio|polio
1621323|NCT00315055|Diphtheria|diphtheria
1621324|NCT00315055|Pertussis|pertussis
1621325|NCT00315055|H influenzae type b|h influenzae type b
1621326|NCT00315042|Tonsillitis|tonsillitis
1621327|NCT00315042|pharyngitis|pharyngitis
1621328|NCT00315042|penicillin|penicillin
1621329|NCT00315042|telithromycin|telithromycin
1621330|NCT00315042|ketolides|ketolides
1621331|NCT00315042|clinical trials|clinical trials
1621332|NCT00315029|Implementation|implementation
1621333|NCT00315029|Single embryo transfer|single embryo transfer
1621334|NCT00315029|ICSI|icsi
1621335|NCT00315029|IVF|ivf
1621336|NCT00315029|prevention|prevention
1621337|NCT00315016|albuminuria|albuminuria
1621338|NCT00315016|eplerenone|eplerenone
1621339|NCT00315016|ACE inhibition|ace inhibition
1621340|NCT00315016|renal function|renal function
1621341|NCT00315016|endothelial function|endothelial function
1621342|NCT00315003|Otitis Media|otitis media
1621343|NCT00315003|Suppurative|suppurative
1621344|NCT00315003|Purulent|purulent
1621345|NCT00315003|Ketolide|ketolide
1621346|NCT00315003|Azithromycin|azithromycin
1621347|NCT00315003|Telithromycin|telithromycin
1621348|NCT00315003|Controlled Clinical Trials|controlled clinical trials
1621349|NCT00314990|Venous thrombosis|venous thrombosis
1621350|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
1621351|NCT00314990|Pulmonary embolism|pulmonary embolism
1621352|NCT00314990|Homocysteine|homocysteine
1621353|NCT00314990|B-vitamins|b-vitamins
1621354|NCT00314990|Folate|folate
1621355|NCT00314990|Vitamin B12|vitamin b12
1621356|NCT00314990|Vitamin B6|vitamin b6
1621357|NCT00314977|Large resectable breast cancer|large resectable breast cancer
1621358|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
1621359|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
1621360|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
1621361|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
1621362|NCT00314925|advanced carcinoma|advanced carcinoma
1621363|NCT00314925|carcinoid|carcinoid
1621364|NCT00314925|neuroendocrine features|neuroendocrine features
1621365|NCT00314925|oncolytic virus|oncolytic virus
1621366|NCT00314925|phase I study|phase i study
1621367|NCT00314925|dose escalation study|dose escalation study
1621368|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
1621369|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
1621370|NCT00314925|medulloblastoma|medulloblastoma
1621371|NCT00314925|rhabdoid|rhabdoid
1621372|NCT00314925|glioblastoma|glioblastoma
1621373|NCT00314925|ewing's sarcoma|ewing's sarcoma
1621374|NCT00314925|pediatric oncologies|pediatric oncologies
1621375|NCT00314925|neuroblastoma|neuroblastoma
1621376|NCT00314925|wilms' tumor|wilms' tumor
1621377|NCT00314925|retinoblastoma|retinoblastoma
1621378|NCT00314925|Large cell lung cancer|large cell lung cancer
1621379|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
1621380|NCT00314886|Diet|diet
1621381|NCT00314886|Fiber|fiber
1621382|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
1621383|NCT00314886|Colonic Flora|colonic flora
1621384|NCT00314873|Thymic malignancy|thymic malignancy
1621385|NCT00314873|Thymic Carcinoma|thymic carcinoma
1621386|NCT00314860|Restless Legs Syndrome|restless legs syndrome
1621387|NCT00314847|Myocardial infarction|myocardial infarction
1621388|NCT00314847|Cardiogenic shock|cardiogenic shock
1621389|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
1621390|NCT00314834|hemodialysis|hemodialysis
1621391|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
1621392|NCT00314834|oral supplementation|oral supplementation
1621393|NCT00314834|survival|survival
1621394|NCT00314834|hospitalization|hospitalization
1621395|NCT00314834|serum albumin|serum albumin
1621397|NCT00314834|transthyretin|transthyretin
1621398|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
1621399|NCT00314808|primary gliomas|primary gliomas
1621400|NCT00314808|brain tumors|brain tumors
1621401|NCT00314808|vomiting|vomiting
1621402|NCT00314808|appetite suppression|appetite suppression
1621403|NCT00314808|appetite|appetite
1621404|NCT00314795|pure red cell aplasia|pure red cell aplasia
1621405|NCT00314795|PRCA|prca
1621406|NCT00314795|chronic kidney disease|chronic kidney disease
1621407|NCT00314795|CKD|ckd
1621408|NCT00314795|chronic renal failure|chronic renal failure
1621409|NCT00314795|CRF|crf
1621410|NCT00314795|anemia|anemia
1621411|NCT00314795|erythropoietin|erythropoietin
1621412|NCT00314795|EPO|epo
1621413|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1621414|NCT00314795|ESA|esa
1621415|NCT00314795|hemoglobin|hemoglobin
1621416|NCT00314795|Hb|hb
1621417|NCT00314795|Hgb|hgb
1621418|NCT00314795|red blood cell|red blood cell
1621419|NCT00314795|red blood cell production|red blood cell production
1621420|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
1621421|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
1621422|NCT00314769|Motor Learning|motor learning
1621423|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1621424|NCT00314769|Cortical Re-Organization|cortical re-organization
1621425|NCT00314769|Neuroplasticity|neuroplasticity
1621426|NCT00314769|Neurorehabilitation|neurorehabilitation
1621427|NCT00314769|TBI|tbi
1621428|NCT00314769|Stroke|stroke
1621429|NCT00314769|Healthy Volunteer|healthy volunteer
1621430|NCT00314769|HV|hv
1621431|NCT00314756|imiquimod cream|imiquimod cream
1621538|NCT00314327|risperidone|risperidone
1621432|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
1621433|NCT00314756|curettage|curettage
1621434|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
1621435|NCT00314704|shock|shock
1621436|NCT00314704|hypotension|hypotension
1621437|NCT00314704|circulatory failure|circulatory failure
1621438|NCT00314704|septic shock|septic shock
1621439|NCT00314704|cardiogenic shock|cardiogenic shock
1621440|NCT00314691|fetal DNA|fetal dna
1621441|NCT00314691|prenatal diagnosis|prenatal diagnosis
1621442|NCT00314691|maternal plasma|maternal plasma
1621443|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
1621444|NCT00314678|Ovarian|ovarian
1621445|NCT00314678|Peritoneal|peritoneal
1621446|NCT00314665|Sarcoidosis|sarcoidosis
1621447|NCT00314665|Chronic Uveitis|chronic uveitis
1621448|NCT00314665|Uveitis|uveitis
1621449|NCT00314665|Thalidomide|thalidomide
1621450|NCT00314652|Osteoarthritis|osteoarthritis
1621451|NCT00314652|chronic pain|chronic pain
1621452|NCT00314652|opioid|opioid
1621453|NCT00314652|transdermal|transdermal
1621454|NCT00314626|Antiviral efficacy|antiviral efficacy
1621455|NCT00314626|Tolerability|tolerability
1621456|NCT00314626|Immunologic response|immunologic response
1621457|NCT00314626|Virologic response|virologic response
1621458|NCT00314626|HIV|hiv
1621459|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
1621460|NCT00314600|Fracture|fracture
1621461|NCT00314600|Forearm|forearm
1621462|NCT00314600|Midshaft|midshaft
1621463|NCT00314600|Child|child
1621464|NCT00314600|Cast|cast
1621465|NCT00314587|fracture|fracture
1621466|NCT00314587|forearm|forearm
1621467|NCT00314587|midshaft|midshaft
1621468|NCT00314587|child|child
1621469|NCT00314587|treatment|treatment
1621470|NCT00314574|Persistent Asthma|persistent asthma
1621471|NCT00314574|EXTRA|extra
1621472|NCT00314574|Xolair|xolair
1621473|NCT00314574|Difficult Breathing|difficult breathing
1621474|NCT00314561|Rosiglitazone|rosiglitazone
1621475|NCT00314561|Pioglitazone|pioglitazone
1621476|NCT00314561|FMD|fmd
1621477|NCT00314561|PWV|pwv
1621478|NCT00314561|atherosclerosis|atherosclerosis
1621479|NCT00314548|ARDS|ards
1621480|NCT00314548|pulmonary hypertension|pulmonary hypertension
1621481|NCT00314548|prostacyclins|prostacyclins
1621482|NCT00314509|Asthma|asthma
1621483|NCT00314509|Ciclesonide|ciclesonide
1621484|NCT00314509|Formoterol Fumarate|formoterol fumarate
1621485|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
1621486|NCT00314509|LABA|laba
1621487|NCT00314509|Steroids|steroids
1621488|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
1621489|NCT00314483|GVHD|gvhd
1621490|NCT00314483|Treatment|treatment
1621491|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
1621492|NCT00314457|pain control|pain control
1621493|NCT00314457|intra-articular pain control device|intra-articular pain control device
1621494|NCT00314457|ACL repair|acl repair
1621495|NCT00314457|Bankart Repair|bankart repair
1621496|NCT00314444|Psychogenic|psychogenic
1621497|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
1621498|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
1621499|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1621501|NCT00314431|telephone follow up|telephone follow up
1621502|NCT00314431|care coordination|care coordination
1621503|NCT00314431|children with special health care needs|children with special health care needs
1621504|NCT00314418|Colonoscopy|colonoscopy
1621505|NCT00314418|technique|technique
1621506|NCT00314418|time|time
1621507|NCT00314418|duration|duration
1621508|NCT00314418|position|position
1621509|NCT00314418|abdominal pressure|abdominal pressure
1621510|NCT00314405|sentinel lymph node|sentinel lymph node
1621511|NCT00314405|SLN|sln
1621512|NCT00314405|probe|probe
1621513|NCT00314405|breast cancer|breast cancer
1621616|NCT00314028|Men|men
1621514|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
1621515|NCT00314405|methylene blue dye|methylene blue dye
1621516|NCT00314392|Experimental pain|experimental pain
1621517|NCT00314392|Placebo analgesia|placebo analgesia
1621518|NCT00314392|Heart rate variability|heart rate variability
1621519|NCT00314392|Skin conductance|skin conductance
1621520|NCT00314379|Diabetes|diabetes
1621521|NCT00314379|Endothelial Function|endothelial function
1621522|NCT00314379|Haptoglobin|haptoglobin
1621523|NCT00314366|stem cell|stem cell
1621524|NCT00314366|autologous|autologous
1621525|NCT00314366|ischemia|ischemia
1621526|NCT00314353|NSABP|nsabp
1621527|NCT00314353|bevacizumab|bevacizumab
1621528|NCT00314353|capecitabine|capecitabine
1621529|NCT00314353|oxaliplatin|oxaliplatin
1621530|NCT00314353|irinotecan|irinotecan
1621531|NCT00314353|rectal cancer|rectal cancer
1621532|NCT00314353|colon cancer|colon cancer
1621533|NCT00314353|colorectal cancer|colorectal cancer
1621534|NCT00314340|Chronic Pain|chronic pain
1621535|NCT00314340|Opioids|opioids
1621536|NCT00314327|first episode|first episode
1621537|NCT00314327|schizophrenia|schizophrenia
1621539|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
1621540|NCT00314301|cerebral palsy|cerebral palsy
1621541|NCT00314301|resistance|resistance
1621542|NCT00314301|movement|movement
1621543|NCT00314301|biomechanics|biomechanics
1621544|NCT00314288|Parkinson's Disease|parkinson's disease
1621545|NCT00314288|Dyskinesia|dyskinesia
1621546|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
1621547|NCT00314275|Pharmacokinetics|pharmacokinetics
1621548|NCT00314275|Coronary Artery Disease|coronary artery disease
1621549|NCT00314275|PCI|pci
1621550|NCT00314275|Drug Eluting Stent|drug eluting stent
1621551|NCT00314262|Skin Lesions|skin lesions
1621552|NCT00314262|Premalignant Lesion|premalignant lesion
1621553|NCT00314249|Fibromyalgia|fibromyalgia
1621554|NCT00314236|Cartilage repair|cartilage repair
1621555|NCT00314236|Cartilage|cartilage
1621556|NCT00314236|Knee|knee
1621557|NCT00314236|Knee Pain|knee pain
1621558|NCT00314236|Microfracture|microfracture
1621559|NCT00314236|arthroscopy|arthroscopy
1621560|NCT00314236|bone marrow stimulation|bone marrow stimulation
1621561|NCT00314236|Chondrogenesis|chondrogenesis
1621562|NCT00314236|Scaffold|scaffold
1621563|NCT00314236|Chitosan|chitosan
1621564|NCT00314236|A02.165.165|a02.165.165
1621565|NCT00314236|A10.165.382.332|a10.165.382.332
1621566|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
1621567|NCT00314236|A10.165.382.400|a10.165.382.400
1621568|NCT00314236|Articular Cartilage Repair|articular cartilage repair
1621569|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
1621570|NCT00314197|automated counseling system|automated counseling system
1621571|NCT00314197|telephone-based intervention|telephone-based intervention
1621572|NCT00314197|behavior change|behavior change
1621573|NCT00314184|Bipolar I disorder.|bipolar i disorder.
1621574|NCT00314171|open-angle glaucoma|open-angle glaucoma
1621575|NCT00314171|ocular hypertension|ocular hypertension
1621576|NCT00314132|Japanese Encephalitis|japanese encephalitis
1621577|NCT00314132|Encephalitis virus|encephalitis virus
1621578|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
1621579|NCT00314119|Tumor Imaging|tumor imaging
1621580|NCT00314119|NF1|nf1
1621581|NCT00314119|Neurofibromatosis|neurofibromatosis
1621582|NCT00314106|Clinical Response|clinical response
1621583|NCT00314106|Stage IV Melanoma|stage iv melanoma
1621584|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
1621585|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
1621586|NCT00314106|Immunologic Response|immunologic response
1621587|NCT00314106|Metastatic Melanoma|metastatic melanoma
1621588|NCT00314093|Clinical Response|clinical response
1621589|NCT00314093|Stage IV Melanoma|stage iv melanoma
1621590|NCT00314093|Immunotoxin|immunotoxin
1621591|NCT00314093|T Regulatory Cells|t regulatory cells
1621592|NCT00314093|CD25+ Cells|cd25+ cells
1621593|NCT00314093|Metastatic Melanoma|metastatic melanoma
1621594|NCT00314080|Botulism|botulism
1621595|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
1621596|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
1621597|NCT00314080|Respiratory failure|respiratory failure
1621598|NCT00314067|Quality of Health Care|quality of health care
1621599|NCT00314067|Primary Health Care|primary health care
1621600|NCT00314067|Education|education
1621601|NCT00314067|E-Learning|e-learning
1621703|NCT00313677|GMPPB|gmppb
1621602|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
1621603|NCT00314054|Hepatitis C|hepatitis c
1621604|NCT00314054|Hepatic Impairment|hepatic impairment
1621605|NCT00314054|Healthy Volunteer|healthy volunteer
1621606|NCT00314054|Phase 1|phase 1
1621607|NCT00314054|Hepacivirus|hepacivirus
1621608|NCT00314041|Infant|infant
1621609|NCT00314041|Conjugate vaccine|conjugate vaccine
1621610|NCT00314041|Meningococcal|meningococcal
1621611|NCT00314041|Antibody|antibody
1621612|NCT00314041|Immune memory|immune memory
1621613|NCT00314041|Health|health
1621614|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
1621615|NCT00314028|African American|african american
1621617|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
1621618|NCT00314028|Condoms|condoms
1621619|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
1621620|NCT00314002|Catheter thrombectomy|catheter thrombectomy
1621621|NCT00313976|Multiple Sclerosis|multiple sclerosis
1621622|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
1621623|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
1621624|NCT00313963|Magnesium Sulfate|magnesium sulfate
1621625|NCT00313963|pediatric|pediatric
1621626|NCT00313950|measles|measles
1621627|NCT00313950|rubella|rubella
1621628|NCT00313950|mumps|mumps
1621629|NCT00313950|hepatitis A|hepatitis a
1621630|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
1621631|NCT00313924|URGE INCONTINENCE|urge incontinence
1621632|NCT00313911|Diphtheria|diphtheria
1621633|NCT00313911|Tetanus|tetanus
1621634|NCT00313911|Pertussis|pertussis
1621635|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
1621636|NCT00313911|Poliomyelitis|poliomyelitis
1621637|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
1621638|NCT00313911|Tetanus protein|tetanus protein
1621639|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
1621640|NCT00313872|gastric cancer|gastric cancer
1621641|NCT00313872|chemotherapy|chemotherapy
1621642|NCT00313872|irinotecan|irinotecan
1621643|NCT00313872|docetaxel|docetaxel
1621644|NCT00313859|colorectal cancer|colorectal cancer
1621645|NCT00313859|metastatic|metastatic
1621646|NCT00313846|Chronic pain|chronic pain
1621648|NCT00313846|transdermal|transdermal
1621649|NCT00313846|osteoarthritis|osteoarthritis
1621650|NCT00313833|Chronic pain|chronic pain
1621651|NCT00313833|elderly|elderly
1621652|NCT00313833|supervised living|supervised living
1621653|NCT00313833|opioid|opioid
1621654|NCT00313833|transdermal|transdermal
1621655|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
1621656|NCT00313807|contrast nephropathy|contrast nephropathy
1621657|NCT00313807|renal failure|renal failure
1621658|NCT00313807|Travasol|travasol
1621659|NCT00313781|randomized|randomized
1621660|NCT00313781|non-comparative|non-comparative
1621661|NCT00313781|efficacy|efficacy
1621662|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
1621663|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
1621664|NCT00313755|high definition endoscopy|high definition endoscopy
1621665|NCT00313755|colorectal cancer|colorectal cancer
1621666|NCT00313755|dysplasia|dysplasia
1621667|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
1621668|NCT00313755|Lynch Syndrome|lynch syndrome
1621669|NCT00313755|HNPCC|hnpcc
1621670|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
1621671|NCT00313729|adult mixed glioma|adult mixed glioma
1621672|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
1621673|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1621674|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1621675|NCT00313716|anemia|anemia
1621676|NCT00313716|traumatic brain injury|traumatic brain injury
1621677|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
1621678|NCT00313716|rhEpo|rhepo
1621679|NCT00313716|erythropoietin|erythropoietin
1621680|NCT00313716|TBI|tbi
1621681|NCT00313716|Epo|epo
1621682|NCT00313703|headache|headache
1621683|NCT00313703|emergency department|emergency department
1621684|NCT00313703|migraine|migraine
1621685|NCT00313703|recurrent headache|recurrent headache
1621686|NCT00313690|Lung Cancer|lung cancer
1621687|NCT00313677|muscular dystrophy|muscular dystrophy
1621688|NCT00313677|MD|md
1621689|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
1621690|NCT00313677|limb girdle|limb girdle
1621691|NCT00313677|FKRP gene|fkrp gene
1621692|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
1621693|NCT00313677|childhood onset LGMD|childhood onset lgmd
1621694|NCT00313677|adult onset LGMD|adult onset lgmd
1621695|NCT00313677|POMT1|pomt1
1621696|NCT00313677|POMT2|pomt2
1621697|NCT00313677|POMGnT|pomgnt
1621698|NCT00313677|LARGE|large
1621699|NCT00313677|alpha dystroglycan|alpha dystroglycan
1621700|NCT00313677|dystroglycanopathy|dystroglycanopathy
1621701|NCT00313677|ISPD|ispd
1621702|NCT00313677|DPM|dpm
1621711|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
1621712|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
1621713|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
1621714|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
1621715|NCT00313599|recurrent breast cancer|recurrent breast cancer
1621716|NCT00313599|stage IV breast cancer|stage iv breast cancer
1621717|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1621718|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1621719|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
1621720|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
1621721|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
1621722|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
1621723|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
1621724|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
1621725|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
1621726|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
1621727|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1621728|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1621729|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1621730|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
1621731|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
1621732|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1621733|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
1621734|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1621735|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1621736|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1621737|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1621738|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1621739|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1621740|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1621741|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1621742|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1621744|NCT00313573|depression|depression
1621745|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1621746|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
1621747|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
1621748|NCT00313547|Blood pressure|blood pressure
1621749|NCT00313547|Hypertension|hypertension
1621750|NCT00313547|Renin|renin
1621751|NCT00313547|Aldosterone|aldosterone
1621752|NCT00313547|Heart rate variability|heart rate variability
1621753|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
1621754|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
1621755|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
1621756|NCT00313534|stage III prostate cancer|stage iii prostate cancer
1621757|NCT00313534|stage I prostate cancer|stage i prostate cancer
1621758|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1621759|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1621760|NCT00313508|stage IV melanoma|stage iv melanoma
1621761|NCT00313508|recurrent melanoma|recurrent melanoma
1621762|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1621763|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
1621764|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
1621765|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
1621766|NCT00313508|iris melanoma|iris melanoma
1621767|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
1621768|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
1621769|NCT00313469|Elderly|elderly
1621770|NCT00313469|Anticoagulants|anticoagulants
1621771|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
1621772|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
1621773|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
1621774|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
1621775|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
1621776|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
1621777|NCT00313430|Urine concentration ability|urine concentration ability
1621778|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
1621779|NCT00313430|hypertension|hypertension
1621780|NCT00313430|aquaporin2|aquaporin2
1621781|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
1621782|NCT00313430|Patients with hypertension|patients with hypertension
1621783|NCT00313430|Healthy volunteers|healthy volunteers
1621784|NCT00313417|Creatine|creatine
1621785|NCT00313417|major depressive disorders|major depressive disorders
1621786|NCT00313404|Norovirus|norovirus
1621787|NCT00313404|Gastroenteritis|gastroenteritis
1621788|NCT00313404|Clinical Trial|clinical trial
1621789|NCT00313404|Stomach flu|stomach flu
1621790|NCT00313378|Thoracotomy|thoracotomy
1621791|NCT00313378|Neuropathic pain|neuropathic pain
1621792|NCT00313378|Nerve trauma|nerve trauma
1621793|NCT00313378|Ketamine|ketamine
1621794|NCT00313378|NMDA receptors|nmda receptors
1621795|NCT00313352|adult|adult
1621796|NCT00313352|cardiac|cardiac
1621797|NCT00313352|transposition of great arteries|transposition of great arteries
1621798|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
1621799|NCT00313339|myocardial infarction|myocardial infarction
1621800|NCT00313339|bone marrow|bone marrow
1621801|NCT00313339|cd34+|cd34+
1621802|NCT00313339|stem cells|stem cells
1621803|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
1621804|NCT00313326|Weaning|weaning
1621805|NCT00313248|Breast Cancer|breast cancer
1621806|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
1621807|NCT00313235|Dendritic Vaccine|dendritic vaccine
1621808|NCT00313235|Melanoma|melanoma
1621809|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
1621810|NCT00313222|CTEPH|cteph
1621811|NCT00313222|bosentan|bosentan
1621812|NCT00313209|Roflumilast|roflumilast
1621813|NCT00313209|Salmeterol|salmeterol
1621814|NCT00313209|COPD|copd
1621815|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1621816|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
1621817|NCT00313196|Sickle Cell Disease|sickle cell disease
1621818|NCT00313196|Sickle cell anemia|sickle cell anemia
1621819|NCT00313196|bosentan|bosentan
1621820|NCT00313196|ASSET|asset
1621821|NCT00313196|ASSET-2|asset-2
1621822|NCT00313183|Type 1 Diabetes|type 1 diabetes
1621823|NCT00313183|pediatric|pediatric
1621824|NCT00313183|pramlintide|pramlintide
1621825|NCT00313183|Symlin|symlin
1621826|NCT00313183|Amylin|amylin
1621827|NCT00313170|oncology|oncology
1621828|NCT00313170|cancer|cancer
1621829|NCT00313170|breast cancer|breast cancer
1621830|NCT00313157|Atrial fibrillation|atrial fibrillation
1621831|NCT00313131|bacterial vaginosis|bacterial vaginosis
1621832|NCT00313131|vaginal candidiasis|vaginal candidiasis
1621833|NCT00313131|trichomoniasis|trichomoniasis
1621834|NCT00313131|vaginitis|vaginitis
1621835|NCT00313131|Ghana|ghana
1621836|NCT00313131|Togo|togo
1621837|NCT00313131|Mali|mali
1621838|NCT00313131|Guinea|guinea
1621839|NCT00313118|oxidative stress parameters|oxidative stress parameters
1621840|NCT00313105|smoking cessation|smoking cessation
1621841|NCT00313105|smokeless tobacco|smokeless tobacco
1621842|NCT00313105|nicotine patch|nicotine patch
1621843|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
1621844|NCT00313105|retreatment|retreatment
1621845|NCT00313105|adherence|adherence
1621846|NCT00313092|OSAS|osas
1621847|NCT00313092|glaucoma|glaucoma
1621848|NCT00313092|MMP|mmp
1621849|NCT00313066|CTGF|ctgf
1621850|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
1621851|NCT00313066|FGF|fgf
1621852|NCT00313066|pleural fibrosis|pleural fibrosis
1621853|NCT00313040|physical activity|physical activity
1621854|NCT00313040|sedentary|sedentary
1621855|NCT00313040|behavioral medicine|behavioral medicine
1621856|NCT00313040|motivational interviewing|motivational interviewing
1621857|NCT00313014|Low back pain|low back pain
1621858|NCT00313014|opioid|opioid
1621859|NCT00313014|transdermal|transdermal
1621860|NCT00313014|Butrans|butrans
1621861|NCT00312988|Ovarian cancer|ovarian cancer
1621862|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
1621863|NCT00312962|Cognitive Remediation|cognitive remediation
1621864|NCT00312962|fMRI|fmri
1621865|NCT00312949|Patient participation|patient participation
1621866|NCT00312949|Patient education|patient education
1621867|NCT00312949|Consumer involvement|consumer involvement
1621868|NCT00312936|Medication adherence|medication adherence
1621869|NCT00312936|Medication compliance|medication compliance
1621870|NCT00312936|Quality of Life|quality of life
1621871|NCT00312936|Stress reduction|stress reduction
1621872|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
1621873|NCT00312936|HIV/AIDS|hiv/aids
1621874|NCT00312936|treatment experienced|treatment experienced
1621875|NCT00312923|HIV|hiv
1621876|NCT00312923|lipids|lipids
1621877|NCT00312923|dyslipidemia|dyslipidemia
1621878|NCT00312923|policosanol|policosanol
1621879|NCT00312923|treatment experienced|treatment experienced
1621880|NCT00312910|Cirrhosis|cirrhosis
1621881|NCT00312910|Probiotics|probiotics
1621882|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
1621883|NCT00312910|Ammonia|ammonia
1621884|NCT00312897|Adolescents|adolescents
1621885|NCT00312897|Depression|depression
1621886|NCT00312897|Fish Oil|fish oil
1621887|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
1621888|NCT00312897|Psychiatry|psychiatry
1621889|NCT00312884|telemonitoring|telemonitoring
1621890|NCT00312884|heart failure|heart failure
1621891|NCT00312884|randomised|randomised
1621892|NCT00312884|hospitalisation|hospitalisation
1621893|NCT00312884|HomMed|hommed
1621894|NCT00312871|Chronic renal failure|chronic renal failure
1621895|NCT00312871|Anemia|anemia
1621896|NCT00312871|Renal replacement therapy|renal replacement therapy
1621897|NCT00312871|Epoetin|epoetin
1621898|NCT00312871|Epoetin alfa|epoetin alfa
1621899|NCT00312871|erythropoietin|erythropoietin
1621900|NCT00312871|Chronic kidney failure|chronic kidney failure
1621901|NCT00312871|end-stage renal disease|end-stage renal disease
1621902|NCT00312858|Hepatitis A Virus|hepatitis a virus
1621903|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1621906|NCT00312832|TDF|tdf
1621907|NCT00312832|lipoatrophy|lipoatrophy
1621908|NCT00312832|treatment experienced|treatment experienced
1621909|NCT00312832|HIV-infection|hiv-infection
1621910|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
1621911|NCT00312819|chemotherapy|chemotherapy
1621912|NCT00312819|randomized phaseII|randomized phaseii
1621913|NCT00312819|disulfiram|disulfiram
1621914|NCT00312819|antiangiogenesis|antiangiogenesis
1621915|NCT00312819|placebo|placebo
1621916|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1621917|NCT00312806|GERD|gerd
1621918|NCT00312806|Pantoprazole|pantoprazole
1621919|NCT00312806|ReQuestTM|requesttm
1621920|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
1621921|NCT00312780|albuminuria|albuminuria
1621922|NCT00312780|diabetic nephropathy|diabetic nephropathy
1621923|NCT00312780|diabetes|diabetes
1621924|NCT00312767|Agalsidase beta|agalsidase beta
1621925|NCT00312767|alpha Galactosidase A|alpha galactosidase a
1621926|NCT00312767|aGAL|agal
1621927|NCT00312767|rh aGAL|rh agal
1621928|NCT00312767|Fabry|fabry
1621929|NCT00312767|GL3|gl3
1621930|NCT00312767|Fabrazyme|fabrazyme
1621931|NCT00312767|dialysis|dialysis
1621932|NCT00312767|hemodialysis|hemodialysis
1621933|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
1621934|NCT00312741|microbiological tests|microbiological tests
1621935|NCT00312741|urinary antigen|urinary antigen
1621936|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
1621937|NCT00312728|Brain Cancer|brain cancer
1621938|NCT00312728|Brain Metastases|brain metastases
1621939|NCT00312728|Avastin|avastin
1621940|NCT00312728|NSCLC|nsclc
1621941|NCT00312728|Lung Cancer|lung cancer
1621942|NCT00312728|PASSPORT|passport
1621943|NCT00312715|Deiodinase|deiodinase
1621944|NCT00312715|Levothyroxine|levothyroxine
1621945|NCT00312715|Liothyronine|liothyronine
1621946|NCT00312715|Lipid Metabolism|lipid metabolism
1621947|NCT00312715|Healthy Volunteer|healthy volunteer
1621948|NCT00312715|HV|hv
1621949|NCT00312702|Vaccine|vaccine
1621950|NCT00312702|Malaria|malaria
1621951|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
1621952|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
1621953|NCT00312702|AS02A|as02a
1621954|NCT00312702|adjuvant|adjuvant
1621955|NCT00312689|congenital|congenital
1621956|NCT00312689|lacrimal|lacrimal
1621957|NCT00312689|stenosis|stenosis
1621958|NCT00312689|bacteria|bacteria
1621959|NCT00312689|microbiological|microbiological
1621960|NCT00312676|Tolerability|tolerability
1621961|NCT00312676|Depakote DR|depakote dr
1621962|NCT00312676|Depakote ER|depakote er
1621963|NCT00312676|Elderly|elderly
1621964|NCT00312676|Conversion|conversion
1621965|NCT00312663|Vaccine|vaccine
1621966|NCT00312663|Phase I/II|phase i/ii
1621967|NCT00312663|Malaria|malaria
1621968|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
1621969|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
1621970|NCT00312663|AS01B|as01b
1621971|NCT00312663|adjuvant|adjuvant
1621972|NCT00312650|ovarian cancer|ovarian cancer
1621973|NCT00312650|recurrent|recurrent
1621974|NCT00312650|progressive|progressive
1621975|NCT00312637|Breast Cancer Staging|breast cancer staging
1621976|NCT00312624|ICD implantation|icd implantation
1621977|NCT00312624|cardiac MRI|cardiac mri
1621978|NCT00312624|cardiomyopathy|cardiomyopathy
1621979|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
1621980|NCT00312624|LVEF 35% or less|lvef 35% or less
1621981|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
1621982|NCT00312611|Gastric pacing device|gastric pacing device
1621983|NCT00312611|Obesity|obesity
1621984|NCT00312598|schizophrenia|schizophrenia
1621985|NCT00312598|BMI|bmi
1621986|NCT00312598|weight|weight
1621987|NCT00312598|aripiprazole|aripiprazole
1621988|NCT00312598|antipsychotic|antipsychotic
1621989|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
1621990|NCT00312585|pregnancy|pregnancy
1621991|NCT00312585|acupuncture|acupuncture
1621992|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
1621993|NCT00312559|Parkinson's Disease|parkinson's disease
1621994|NCT00312546|Virus Latency|virus latency
1621995|NCT00312546|Valproic Acid|valproic acid
1621996|NCT00312546|Histone Deacetylase|histone deacetylase
1621997|NCT00312533|knee|knee
1621998|NCT00312533|injection|injection
1621999|NCT00312533|function|function
1622000|NCT00312533|osteoarthritis|osteoarthritis
1622001|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
1622002|NCT00312507|Surfactant|surfactant
1622003|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
1622004|NCT00312507|newborns|newborns
1622005|NCT00312468|AIDS|aids
1622006|NCT00312455|Substance abuse|substance abuse
1622007|NCT00312455|Depression|depression
1622008|NCT00312455|Aggression|aggression
1622009|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
1622010|NCT00312429|Hematological Malignancies|hematological malignancies
1622011|NCT00312429|Leukemia|leukemia
1622012|NCT00312429|Lymphoma|lymphoma
1622013|NCT00312429|Myelodysplasia|myelodysplasia
1622014|NCT00312429|Multiple Myeloma|multiple myeloma
1622015|NCT00312416|Choroidal blood flow|choroidal blood flow
1622016|NCT00312416|Clonidin|clonidin
1622017|NCT00312416|Brimonidin|brimonidin
1622018|NCT00312403|Glaucoma|glaucoma
1622019|NCT00312403|Gene Polymorphism|gene polymorphism
1622020|NCT00312403|Metalloproteinase|metalloproteinase
1622021|NCT00312390|Amblyopia|amblyopia
1622022|NCT00312390|Retinal vessel diameters|retinal vessel diameters
1622023|NCT00312390|Retinal blood flow|retinal blood flow
1622024|NCT00312390|Flicker|flicker
1622025|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
1622026|NCT00312377|NSCLC|nsclc
1622027|NCT00312364|toe ulcer|toe ulcer
1622028|NCT00312364|heel ulcer|heel ulcer
1622029|NCT00312364|foot ulcer|foot ulcer
1622030|NCT00312364|diabetic feet|diabetic feet
1622031|NCT00312364|diabetic foot|diabetic foot
1622032|NCT00312364|complications of diabetes|complications of diabetes
1622034|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
1622035|NCT00312351|Macular Degeneration|macular degeneration
1622036|NCT00312351|Macugen|macugen
1622037|NCT00312351|pegaptanib sodium|pegaptanib sodium
1622038|NCT00312351|ERG|erg
1622039|NCT00312351|specular microscopy|specular microscopy
1622040|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
1622041|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
1622042|NCT00312325|Choroidal blood flow|choroidal blood flow
1622043|NCT00312325|Prednisolone|prednisolone
1622044|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
1622045|NCT00312325|optic neuritis|optic neuritis
1622046|NCT00312312|Asthma|asthma
1622047|NCT00312312|Allergic rhinitis|allergic rhinitis
1622048|NCT00312312|Atopy|atopy
1622049|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
1622050|NCT00312312|Specific immunotherapy|specific immunotherapy
1622051|NCT00312312|Atopic diseases|atopic diseases
1622052|NCT00312299|Double-Blind Method|double-blind method
1622053|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
1622054|NCT00312299|Lenses, Intraocular|lenses, intraocular
1622055|NCT00312299|Prospective Studies|prospective studies
1622056|NCT00312299|PMMA|pmma
1622057|NCT00312299|Visual acuity|visual acuity
1622058|NCT00312286|Cervical Neoplasms|cervical neoplasms
1622059|NCT00312286|Drug Therapy|drug therapy
1622060|NCT00312286|Human Papillomavirus|human papillomavirus
1622061|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
1622062|NCT00312286|Cervical Dysplasia|cervical dysplasia
1622063|NCT00312286|Chemoprevention|chemoprevention
1622064|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
1622065|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
1622066|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
1622067|NCT00312273|Heart Arrest|heart arrest
1622068|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1622069|NCT00312273|Aminophylline|aminophylline
1622070|NCT00312273|Bradycardia|bradycardia
1622071|NCT00312273|Humans|humans
1622072|NCT00312273|Emergency Medical Services|emergency medical services
1622073|NCT00312260|Pain|pain
1622074|NCT00312260|Analgesia|analgesia
1622075|NCT00312260|Gabapentin|gabapentin
1622076|NCT00312260|Amitriptyline|amitriptyline
1622077|NCT00312260|Pediatrics|pediatrics
1622078|NCT00312247|Walking|walking
1622079|NCT00312247|Muscle Strength|muscle strength
1622080|NCT00312247|Energy Cost|energy cost
1622081|NCT00312247|Quality of Life|quality of life
1622082|NCT00312234|Muscular Disease|muscular disease
1622083|NCT00312234|Fibromyalgia|fibromyalgia
1622084|NCT00312234|Exercise Therapy|exercise therapy
1622085|NCT00312234|Qigong|qigong
1622086|NCT00312234|Aerobic Exercise|aerobic exercise
1622087|NCT00312234|pediatrics|pediatrics
1622088|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
1622089|NCT00312195|Chronic pain|chronic pain
1622090|NCT00312195|opioid|opioid
1622091|NCT00312195|transdermal|transdermal
1622092|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
1622093|NCT00312169|HIV|hiv
1622094|NCT00312169|NNRTI|nnrti
1622095|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
1622096|NCT00312169|treatment experienced|treatment experienced
1622097|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
1622098|NCT00312130|Vildaglptin|vildaglptin
1622099|NCT00312130|Pre-diabetes|pre-diabetes
1622100|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
1622101|NCT00312117|sodium bicarbonate|sodium bicarbonate
1622102|NCT00312117|cardiac catheterization|cardiac catheterization
1622103|NCT00312091|Pharmacokinetics|pharmacokinetics
1622104|NCT00312091|Treatment Experienced|treatment experienced
1622105|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
1622106|NCT00312078|Cirrhosis|cirrhosis
1622107|NCT00312065|servocontrolled|servocontrolled
1622108|NCT00312065|radiant warmer|radiant warmer
1622109|NCT00312065|thermistor|thermistor
1622110|NCT00312065|heat shield|heat shield
1622111|NCT00312052|Coronary Artery Disease|coronary artery disease
1622112|NCT00312039|HIV-1|hiv-1
1622321|NCT00311116|Vitamin E|vitamin e
1622113|NCT00312039|treatment experienced|treatment experienced
1622114|NCT00312026|Plaque Psoriasis|plaque psoriasis
1622115|NCT00312026|Hands|hands
1622116|NCT00312026|Feet|feet
1622117|NCT00312026|Hand|hand
1622118|NCT00312013|low molecular weight heparin|low molecular weight heparin
1622119|NCT00312013|nadroparin|nadroparin
1622120|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
1622121|NCT00312013|cancer survival|cancer survival
1622122|NCT00312013|prostate cancer|prostate cancer
1622123|NCT00312013|pancreatic cancer|pancreatic cancer
1622124|NCT00312000|colorectal|colorectal
1622125|NCT00312000|cancer|cancer
1622126|NCT00312000|capecitabine|capecitabine
1622127|NCT00312000|irinotecan|irinotecan
1622128|NCT00312000|oxaliplatin|oxaliplatin
1622129|NCT00311987|Hypercholesterolemia|hypercholesterolemia
1622130|NCT00311987|Thyroid hormone|thyroid hormone
1622131|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
1622132|NCT00311987|Therapy|therapy
1622133|NCT00311974|Dihydralazine|dihydralazine
1622134|NCT00311974|Sympathetic activation|sympathetic activation
1622135|NCT00311974|Fractional sodium excretion|fractional sodium excretion
1622136|NCT00311961|COPD|copd
1622137|NCT00311961|Exacerbations|exacerbations
1622138|NCT00311961|Corticosteroids|corticosteroids
1622139|NCT00311961|Oral|oral
1622140|NCT00311961|Intravenous|intravenous
1622141|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1622142|NCT00311948|Teen smokers|teen smokers
1622143|NCT00311948|Quithelper|quithelper
1622144|NCT00311948|Tobacco|tobacco
1622145|NCT00311948|Tobacco Website|tobacco website
1622146|NCT00311948|Website Intervention|website intervention
1622147|NCT00311948|Tobacco counseling|tobacco counseling
1622148|NCT00311948|Tobacco abstinence|tobacco abstinence
1622149|NCT00311935|Hernia|hernia
1622150|NCT00311935|Inguinal|inguinal
1622151|NCT00311935|Groin|groin
1622152|NCT00311935|Laparoscopic|laparoscopic
1622153|NCT00311935|Open|open
1622154|NCT00311935|Abdominal wall|abdominal wall
1622155|NCT00311922|Diabetes|diabetes
1622156|NCT00311922|Education|education
1622157|NCT00311922|Health Literacy|health literacy
1622158|NCT00311909|Tourette Syndrome|tourette syndrome
1622159|NCT00311909|Deep Brain Stimulation|deep brain stimulation
1622160|NCT00311909|Video assessment|video assessment
1622161|NCT00311909|YGTSS|ygtss
1622162|NCT00311909|TSSL|tssl
1622163|NCT00311896|Cancer|cancer
1622164|NCT00311896|Thrombosis|thrombosis
1622165|NCT00311896|Catheter|catheter
1622166|NCT00311896|Bemiparin|bemiparin
1622167|NCT00311896|Prophylaxis|prophylaxis
1622168|NCT00311883|Cystic Fibrosis|cystic fibrosis
1622169|NCT00311883|Induced sputum|induced sputum
1622170|NCT00311883|Lung inflammation|lung inflammation
1622171|NCT00311857|Cetuximab|cetuximab
1622172|NCT00311831|Pediatrics|pediatrics
1622173|NCT00311831|Gastroenteritis|gastroenteritis
1622174|NCT00311831|Education|education
1622175|NCT00311792|training|training
1622176|NCT00311792|teaching|teaching
1622177|NCT00311792|curriculum|curriculum
1622178|NCT00311779|Pediculosis capitis|pediculosis capitis
1622179|NCT00311779|Head Lice|head lice
1622180|NCT00311779|Crawlers|crawlers
1622181|NCT00311779|Ova|ova
1622182|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
1622183|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
1622184|NCT00311766|chronic wound-healing|chronic wound-healing
1622185|NCT00311766|Thymosin Beta 4|thymosin beta 4
1622186|NCT00311766|laminin-5|laminin-5
1622187|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
1622188|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
1622189|NCT00311753|Immobilization|immobilization
1622190|NCT00311740|Hypertension,|hypertension,
1622191|NCT00311740|Valsartan,|valsartan,
1622192|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
1622193|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
1622194|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
1622195|NCT00311701|Influenza, pediatric|influenza, pediatric
1622196|NCT00311688|IL-2|il-2
1622197|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
1622198|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
1622199|NCT00311649|H5N1, Influenza|h5n1, influenza
1622200|NCT00311636|stage I breast cancer|stage i breast cancer
1622201|NCT00311636|stage II breast cancer|stage ii breast cancer
1622202|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
1622203|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
1622204|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
1622205|NCT00311623|stage III prostate cancer|stage iii prostate cancer
1622206|NCT00311623|stage I prostate cancer|stage i prostate cancer
1622207|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
1622208|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
1622209|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1622210|NCT00311610|recurrent colon cancer|recurrent colon cancer
1622211|NCT00311610|stage IV colon cancer|stage iv colon cancer
1622212|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
1622213|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
1622214|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1622215|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
1622217|NCT00311571|spaceflight|spaceflight
1622218|NCT00311571|Weightlessness|weightlessness
1622219|NCT00311571|Countermeasure|countermeasure
1622220|NCT00311558|stage IV melanoma|stage iv melanoma
1622221|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1622222|NCT00311558|recurrent melanoma|recurrent melanoma
1622223|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
1622224|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
1622225|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
1622226|NCT00311519|Subcutaneous hydration|subcutaneous hydration
1622227|NCT00311519|Hylenex|hylenex
1622228|NCT00311519|Hyaluronidase|hyaluronidase
1622229|NCT00311506|Pulmozyme|pulmozyme
1622230|NCT00311493|TBE|tbe
1622231|NCT00311493|vaccine|vaccine
1622232|NCT00311493|adults|adults
1622233|NCT00311480|influenza|influenza
1622234|NCT00311480|pandemic influenza|pandemic influenza
1622235|NCT00311480|influenza vaccine|influenza vaccine
1622236|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
1622237|NCT00311467|renal cell cancer|renal cell cancer
1622238|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
1622239|NCT00311428|Influenza|influenza
1622240|NCT00311428|Children|children
1622241|NCT00311428|Vaccine|vaccine
1622452|NCT00310674|infant|infant
1622242|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1622243|NCT00311415|meningococcal vaccines|meningococcal vaccines
1622244|NCT00311415|conjugate|conjugate
1622245|NCT00311415|immunology|immunology
1622246|NCT00311415|infant|infant
1622247|NCT00311415|antibody persistence|antibody persistence
1622248|NCT00311389|Glaucoma|glaucoma
1622249|NCT00311389|POAG|poag
1622250|NCT00311389|OAG|oag
1622251|NCT00311389|OHT|oht
1622252|NCT00311350|Safety|safety
1622253|NCT00311350|Health|health
1622254|NCT00311350|Pharmacokinetics|pharmacokinetics
1622255|NCT00311350|ileus|ileus
1622256|NCT00311337|VELCADE|velcade
1622257|NCT00311337|bortezomib|bortezomib
1622258|NCT00311337|maintenance treatment|maintenance treatment
1622259|NCT00311337|multiple myeloma|multiple myeloma
1622260|NCT00311337|primary disease|primary disease
1622261|NCT00311324|behavioral intervention|behavioral intervention
1622262|NCT00311311|Kidney transplant|kidney transplant
1622263|NCT00311311|Renal transplant|renal transplant
1622264|NCT00311311|Immunosuppression|immunosuppression
1622265|NCT00311311|Atherosclerosis|atherosclerosis
1622266|NCT00311311|Graft Rejection|graft rejection
1622267|NCT00311298|tuberculosis|tuberculosis
1622269|NCT00311298|diabetes|diabetes
1622270|NCT00311298|protein-energy|protein-energy
1622271|NCT00311298|micronutrients|micronutrients
1622272|NCT00311285|Electromyography|electromyography
1622273|NCT00311285|Glucocorticoids|glucocorticoids
1622274|NCT00311285|Heart Rate|heart rate
1622275|NCT00311285|Physical workload|physical workload
1622276|NCT00311285|Mental workload|mental workload
1622277|NCT00311285|Ergonomics|ergonomics
1622278|NCT00311285|Laparoscopy|laparoscopy
1622279|NCT00311285|Workload|workload
1622280|NCT00311285|Biomechanics|biomechanics
1622281|NCT00311272|dendritic cells|dendritic cells
1622282|NCT00311272|antigens, neoplasm|antigens, neoplasm
1622283|NCT00311246|Sarcoidosis|sarcoidosis
1622284|NCT00311246|Humira|humira
1622285|NCT00311246|Adalimumab|adalimumab
1622286|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
1622287|NCT00311233|child|child
1622288|NCT00311233|psychosocial|psychosocial
1622289|NCT00311233|predictors|predictors
1622290|NCT00311233|cohort|cohort
1622291|NCT00311233|recurrent|recurrent
1622292|NCT00311220|tuberculosis|tuberculosis
1622293|NCT00311220|latent tuberculosis|latent tuberculosis
1622294|NCT00311220|tuberculin skin test|tuberculin skin test
1622295|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
1622296|NCT00311220|contact screening|contact screening
1622297|NCT00311220|elderly|elderly
1622298|NCT00311207|diagnostic kit|diagnostic kit
1622299|NCT00311207|immunochromatography test|immunochromatography test
1622300|NCT00311207|PCR detection kit|pcr detection kit
1622301|NCT00311207|luminex|luminex
1622302|NCT00311194|Heart failure|heart failure
1622303|NCT00311194|Education|education
1622304|NCT00311194|CD-ROM|cd-rom
1622305|NCT00311194|Randomization|randomization
1622306|NCT00311194|Hospitalization|hospitalization
1622307|NCT00311194|Readmission|readmission
1622308|NCT00311194|Death|death
1622309|NCT00311194|Knowledge|knowledge
1622310|NCT00311181|ICD|icd
1622311|NCT00311181|Defibrillation|defibrillation
1622312|NCT00311181|ULV|ulv
1622313|NCT00311181|Tuned|tuned
1622314|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
1622315|NCT00311155|Hypertension|hypertension
1622316|NCT00311142|Sleep pattern|sleep pattern
1622317|NCT00311142|newborn|newborn
1622318|NCT00311142|actigraphy|actigraphy
1622319|NCT00311142|delivery mode|delivery mode
1622320|NCT00311142|Parents' approval|parents' approval
1622322|NCT00311116|Cancer|cancer
1622323|NCT00311116|pediatrics|pediatrics
1622324|NCT00311116|supportive care|supportive care
1622325|NCT00311116|oral mucositis|oral mucositis
1622326|NCT00311116|Bayesian analysis|bayesian analysis
1622327|NCT00311116|N-of-1 trial|n-of-1 trial
1622328|NCT00311116|prophylaxis|prophylaxis
1622329|NCT00311103|Elderly|elderly
1622330|NCT00311103|Disability|disability
1622331|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
1622332|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
1622333|NCT00311051|Asthma|asthma
1622334|NCT00311051|Allergens|allergens
1622335|NCT00311051|house dust mites|house dust mites
1622336|NCT00311051|Ramatroban|ramatroban
1622337|NCT00311051|Montelukast|montelukast
1622338|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
1622339|NCT00311038|ONO-1101|ono-1101
1622340|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
1622341|NCT00311038|Multi-slice CT|multi-slice ct
1622342|NCT00311038|Coronary Artery Disease|coronary artery disease
1622343|NCT00311025|stroke|stroke
1622344|NCT00311025|physical therapy|physical therapy
1622345|NCT00311025|rehabilitation|rehabilitation
1622346|NCT00311025|exercise|exercise
1622347|NCT00311025|longterm follow-up|longterm follow-up
1622348|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
1622349|NCT00310999|Cervical Vertebrae|cervical vertebrae
1622350|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
1622351|NCT00310999|Laryngoscopes|laryngoscopes
1622352|NCT00310999|Fluoroscopy|fluoroscopy
1622353|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1622354|NCT00310986|meditation|meditation
1622355|NCT00310986|breathing meditation|breathing meditation
1622356|NCT00310986|Anapanasathi|anapanasathi
1622357|NCT00310986|randomized controlled trial|randomized controlled trial
1622358|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
1622359|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
1622360|NCT00310973|HIV|hiv
1622361|NCT00310973|Prevention|prevention
1622362|NCT00310973|Risk Behavior Reduction|risk behavior reduction
1622363|NCT00310973|Roma|roma
1622364|NCT00310973|Bulgaria|bulgaria
1622365|NCT00310973|HIV seronegativity|hiv seronegativity
1622366|NCT00310960|infantile esotropia|infantile esotropia
1622367|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
1622368|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
1622369|NCT00310947|Coronary artery disease|coronary artery disease
1622370|NCT00310947|Coronary flow reserve|coronary flow reserve
1622371|NCT00310947|Heart failure|heart failure
1622372|NCT00310947|prospective randomised|prospective randomised
1622373|NCT00310934|heroin dependence|heroin dependence
1622374|NCT00310934|methadone|methadone
1622375|NCT00310934|buprenorphine|buprenorphine
1622376|NCT00310934|contingency management|contingency management
1622377|NCT00310934|relapse prevention|relapse prevention
1622378|NCT00310908|Renal|renal
1622379|NCT00310908|Colic|colic
1622380|NCT00310908|Calculi|calculi
1622381|NCT00310908|Treatment|treatment
1622382|NCT00310895|Refractory|refractory
1622383|NCT00310895|Relapsed|relapsed
1622384|NCT00310882|breast cancer|breast cancer
1622385|NCT00310882|digitalis like compounds|digitalis like compounds
1622386|NCT00310882|prognostic factor|prognostic factor
1622387|NCT00310869|Preterm Birth|preterm birth
1622388|NCT00310869|Prematurity|prematurity
1622389|NCT00310869|NIDCAP|nidcap
1622390|NCT00310869|Adolescence|adolescence
1622391|NCT00310869|Developmental Care|developmental care
1622392|NCT00310869|Follow-up|follow-up
1622393|NCT00310869|Neurobehavior|neurobehavior
1622394|NCT00310856|meningitis|meningitis
1622395|NCT00310856|children|children
1622396|NCT00310856|vaccine|vaccine
1622397|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1622398|NCT00310830|Pulmonary hypertension|pulmonary hypertension
1622399|NCT00310830|Sickle Cell Disease|sickle cell disease
1622400|NCT00310830|Sickle cell anemia|sickle cell anemia
1622401|NCT00310830|ASSET|asset
1622402|NCT00310830|ASSET-1|asset-1
1622403|NCT00310817|meningitis|meningitis
1622404|NCT00310817|children|children
1622405|NCT00310817|vaccine|vaccine
1622406|NCT00310804|Influenza|influenza
1622407|NCT00310804|Flu|flu
1622408|NCT00310804|Cell-Derived|cell-derived
1622409|NCT00310804|Egg-Derived|egg-derived
1622410|NCT00310804|Healthy Adults|healthy adults
1622411|NCT00310804|Safety|safety
1622412|NCT00310804|Immunogenicity|immunogenicity
1622413|NCT00310804|Vaccination|vaccination
1622414|NCT00310791|anorexia nervosa|anorexia nervosa
1622415|NCT00310791|adolescents|adolescents
1622515|NCT00310375|Anticonvulsant|anticonvulsant
1622416|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
1622417|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
1622418|NCT00310791|osteoporosis|osteoporosis
1622419|NCT00310778|High sodium diet|high sodium diet
1622420|NCT00310778|Low sodium diet|low sodium diet
1622421|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
1622422|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
1622423|NCT00310778|ACE inhibition|ace inhibition
1622949|NCT00308711|PGE1|pge1
1622424|NCT00310765|abdominal pain|abdominal pain
1622425|NCT00310765|surgical adhesions|surgical adhesions
1622426|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
1622427|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
1622429|NCT00310726|Breastfeeding|breastfeeding
1622430|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
1622431|NCT00310726|HIV Seronegativity|hiv seronegativity
1622432|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1622433|NCT00310713|vaccines|vaccines
1622434|NCT00310713|conjugate|conjugate
1622435|NCT00310713|immunology|immunology
1622436|NCT00310713|children|children
1622437|NCT00310713|antibody persistence|antibody persistence
1622438|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1622439|NCT00310700|vaccines, conjugate|vaccines, conjugate
1622440|NCT00310700|immunology|immunology
1622441|NCT00310700|infant|infant
1622442|NCT00310700|antibody persistence|antibody persistence
1622443|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1622444|NCT00310687|vaccines|vaccines
1622445|NCT00310687|conjugate|conjugate
1622446|NCT00310687|immunology|immunology
1622447|NCT00310687|antibody persistence|antibody persistence
1622448|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
1622449|NCT00310674|meningococcal vaccines|meningococcal vaccines
1622450|NCT00310674|conjugate|conjugate
1622451|NCT00310674|Immunology|immunology
1622453|NCT00310661|sarizotan|sarizotan
1622454|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
1622455|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
1622456|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
1622457|NCT00310622|HyperQ|hyperq
1622458|NCT00310622|Ischemia|ischemia
1622459|NCT00310622|dobutamine|dobutamine
1622460|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
1622461|NCT00310596|ECG safety|ecg safety
1622462|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
1622463|NCT00310583|neuropathic pain|neuropathic pain
1622464|NCT00310583|enriched design|enriched design
1622465|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
1622466|NCT00310583|plexus lesion|plexus lesion
1622467|NCT00310583|radicular lesion|radicular lesion
1622468|NCT00310583|spinal lesion|spinal lesion
1622469|NCT00310583|polyneuropathy|polyneuropathy
1622470|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
1622471|NCT00310570|distal|distal
1622472|NCT00310570|interphalangeal|interphalangeal
1622473|NCT00310570|extensor tendon|extensor tendon
1622474|NCT00310570|avulsion|avulsion
1622475|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
1622476|NCT00310505|amphotericin B|amphotericin b
1622477|NCT00310505|Kala-azar|kala-azar
1622478|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
1622479|NCT00310479|prostate cancer imaging|prostate cancer imaging
1622480|NCT00310479|3T MRS|3t mrs
1622481|NCT00310479|functional imaging|functional imaging
1622482|NCT00310440|Degenerative disc disease|degenerative disc disease
1622483|NCT00310440|P-15 Bone Putty|p-15 bone putty
1622484|NCT00310440|Bone graft|bone graft
1622485|NCT00310440|Cervical discectomy|cervical discectomy
1622486|NCT00310440|Cervical spine|cervical spine
1622487|NCT00310427|Anxiety|anxiety
1622488|NCT00310427|Alcohol Dependence|alcohol dependence
1622489|NCT00310427|Alcoholism|alcoholism
1622490|NCT00310414|Imaging Studies|imaging studies
1622491|NCT00310414|Botulinum Toxin|botulinum toxin
1622492|NCT00310414|Writer's Cramp|writer's cramp
1622493|NCT00310414|Focal Hand Dystonia|focal hand dystonia
1622494|NCT00310414|FHD|fhd
1622495|NCT00310414|Writer Cramp|writer cramp
1622496|NCT00310414|Healthy Volunteer|healthy volunteer
1622497|NCT00310414|HV|hv
1622498|NCT00310401|brain death|brain death
1622499|NCT00310401|organ donor|organ donor
1622500|NCT00310401|pulmonary edema|pulmonary edema
1622501|NCT00310401|albuterol|albuterol
1622502|NCT00310401|hypoxia|hypoxia
1622503|NCT00310401|lung transplantation|lung transplantation
1622504|NCT00310401|infiltrates|infiltrates
1622505|NCT00310388|Partial Seizures|partial seizures
1622506|NCT00310388|Epilepsy|epilepsy
1622507|NCT00310388|RTG115097|rtg115097
1622508|NCT00310388|Complex Partial Seizures|complex partial seizures
1622509|NCT00310388|Anticonvulsant|anticonvulsant
1622510|NCT00310388|Potassium Channels|potassium channels
1622511|NCT00310388|Epilepsies, Partial|epilepsies, partial
1622512|NCT00310375|Epilepsy|epilepsy
1622513|NCT00310375|Partial Seizures|partial seizures
1622514|NCT00310375|Potassium Channels|potassium channels
1622516|NCT00310375|Complex Partial Seizures|complex partial seizures
1622517|NCT00310375|Epilepsies, Partial|epilepsies, partial
1622518|NCT00310375|RTG115098|rtg115098
1622519|NCT00310362|telephone|telephone
1622520|NCT00310362|telemedicine|telemedicine
1622521|NCT00310362|mass screening|mass screening
1622522|NCT00310362|patient education|patient education
1622523|NCT00310362|Patient compliance|patient compliance
1622524|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
1622525|NCT00310349|clinical trial|clinical trial
1622526|NCT00310349|Indigenous|indigenous
1622527|NCT00310349|Maternal|maternal
1622528|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
1622529|NCT00310323|sleep apnea|sleep apnea
1622530|NCT00310323|phenotyping|phenotyping
1622531|NCT00310323|cytochrome P450|cytochrome p450
1622532|NCT00310323|drug metabolism|drug metabolism
1622533|NCT00310323|child|child
1622534|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
1622535|NCT00310310|Patient compliance|patient compliance
1622536|NCT00310310|Self-care|self-care
1622537|NCT00310284|Insomnia|insomnia
1622538|NCT00310284|Sleep|sleep
1622539|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
1622540|NCT00310245|CD4-guided STI|cd4-guided sti
1622541|NCT00310245|Keywords:|keywords:
1622542|NCT00310245|HAART|haart
1622543|NCT00310245|Clinical outcome|clinical outcome
1622544|NCT00310245|Resistance|resistance
1622545|NCT00310245|Costs|costs
1622546|NCT00310245|Prognostic factors|prognostic factors
1622547|NCT00310245|pulse therapy|pulse therapy
1622548|NCT00310245|treatment experienced|treatment experienced
1622549|NCT00310245|treatment interruption|treatment interruption
1622550|NCT00310232|Quality of Life|quality of life
1622551|NCT00310232|Blood transfusion|blood transfusion
1622552|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1622553|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1622554|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1622555|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1622556|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
1622557|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1622558|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1622559|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1622560|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1622561|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1622562|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1622563|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1622564|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1622565|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1622566|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1622567|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1622568|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1622569|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1622570|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1622571|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1622572|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1622573|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1622574|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1622575|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
1622576|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1622577|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1622578|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1622579|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1622580|NCT00310154|large cell lung cancer|large cell lung cancer
1622581|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
1622582|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
1622583|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
1622584|NCT00310141|small cell lung cancer|small cell lung cancer
1622585|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1622586|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1622587|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1622588|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1622589|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1622590|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1622591|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1622592|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1622593|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1622739|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
1622594|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1622595|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1622596|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1622597|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1622598|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1622599|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1622600|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1622601|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1622602|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
1622603|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
1622604|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
1622605|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
1622606|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
1622607|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
1622608|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1622609|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1622610|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1622611|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1622612|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1622613|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1622614|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1622615|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1622616|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1622617|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1622781|NCT00309660|Enema|enema
1622618|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1622619|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1622620|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1622621|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1622622|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1622852|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
1622623|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1622624|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1622625|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1622626|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1622627|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
1622628|NCT00310115|small cell lung cancer|small cell lung cancer
1622629|NCT00310115|bladder cancer|bladder cancer
1622630|NCT00310115|cervical cancer|cervical cancer
1622631|NCT00310115|esophageal cancer|esophageal cancer
1622632|NCT00310115|gastric cancer|gastric cancer
1622633|NCT00310115|renal cell carcinoma|renal cell carcinoma
1622634|NCT00310115|adult primary liver cancer|adult primary liver cancer
1622635|NCT00310115|pancreatic cancer|pancreatic cancer
1622636|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
1622637|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
1622638|NCT00310115|laryngeal cancer|laryngeal cancer
1622639|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
1622640|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
1622641|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1622642|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
1622643|NCT00310115|tobacco use disorder|tobacco use disorder
1622644|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
1622645|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
1622646|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
1622647|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
1622648|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
1622649|NCT00310076|stage II colon cancer|stage ii colon cancer
1622650|NCT00310076|stage III colon cancer|stage iii colon cancer
1622651|NCT00310076|stage IV colon cancer|stage iv colon cancer
1622652|NCT00310076|recurrent colon cancer|recurrent colon cancer
1622653|NCT00310076|stage II rectal cancer|stage ii rectal cancer
1622654|NCT00310076|stage III rectal cancer|stage iii rectal cancer
1622655|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
1622656|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
1622657|NCT00310063|nausea and vomiting|nausea and vomiting
1622658|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1622659|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
1622660|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
1622661|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
1622662|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1622740|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
1622663|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1622664|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1622665|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1622666|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
1622667|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
1622668|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1622669|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1622670|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
1622671|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1622672|NCT00309998|large cell lung cancer|large cell lung cancer
1622673|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1622674|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
1622675|NCT00309985|docetaxel|docetaxel
1622676|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1622677|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1622678|NCT00309933|cognitive/functional effects|cognitive/functional effects
1622679|NCT00309933|spiritual concerns|spiritual concerns
1622680|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
1622681|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1622682|NCT00309933|cancer survivor|cancer survivor
1622683|NCT00309933|stage I breast cancer|stage i breast cancer
1622684|NCT00309933|stage II breast cancer|stage ii breast cancer
1622685|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
1622686|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
1622687|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
1622688|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
1622689|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
1622690|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1622691|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
1622692|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1622693|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1622694|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1622695|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1622696|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1622697|NCT00309868|heart catheterization|heart catheterization
1622698|NCT00309868|echocardiogram|echocardiogram
1622699|NCT00309868|nesiritide|nesiritide
1622700|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1622701|NCT00309842|primary myelofibrosis|primary myelofibrosis
1622702|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1622703|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
1622704|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1622705|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1622706|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1622707|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
1622708|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1622709|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1622710|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
1622711|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1622712|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1622713|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1622714|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
1622715|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
1622716|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1622717|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1622718|NCT00309842|multiple myeloma|multiple myeloma
1622719|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
1622720|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
1622721|NCT00309842|refractory anemia|refractory anemia
1622722|NCT00309842|Burkitt lymphoma|burkitt lymphoma
1622723|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
1622724|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
1622725|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
1622726|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
1622853|NCT00309218|Cyclosporine A|cyclosporine a
1622727|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1622728|NCT00309816|Exercise stress test|exercise stress test
1622729|NCT00309803|Carotid artery|carotid artery
1622730|NCT00309803|distal protection device|distal protection device
1622731|NCT00309790|exercise stress test|exercise stress test
1622732|NCT00309777|hypercholesterolemia|hypercholesterolemia
1622734|NCT00309777|dyslipidemia|dyslipidemia
1622735|NCT00309777|pitavastatin|pitavastatin
1622736|NCT00309777|NK-104|nk-104
1622737|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
1622738|NCT00309751|Kowa|kowa
1622741|NCT00309751|pitavastatin|pitavastatin
1622742|NCT00309751|NK-104|nk-104
1622743|NCT00309751|Atorvastatin|atorvastatin
1622744|NCT00309738|Kowa|kowa
1622745|NCT00309738|KRE|kre
1622746|NCT00309738|Hypercholesterolemia|hypercholesterolemia
1622747|NCT00309738|combined dyslipidemia|combined dyslipidemia
1622748|NCT00309738|dyslipidemia|dyslipidemia
1622749|NCT00309738|pitavastatin|pitavastatin
1622750|NCT00309738|NK-104|nk-104
1622751|NCT00309738|simvastatin|simvastatin
1622752|NCT00309725|Alzheimer's Disease|alzheimer's disease
1622753|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
1622754|NCT00309712|diabetes|diabetes
1622755|NCT00309712|combination lipid treatment|combination lipid treatment
1622756|NCT00309712|statin|statin
1622757|NCT00309712|fibrate|fibrate
1622758|NCT00309712|hypercholesteremia|hypercholesteremia
1622759|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
1622760|NCT00309699|Affective psychosis|affective psychosis
1622761|NCT00309699|mixed-state|mixed-state
1622762|NCT00309699|bipolar disorder|bipolar disorder
1622763|NCT00309699|manic disorder|manic disorder
1622764|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
1622765|NCT00309699|mania|mania
1622766|NCT00309699|manic state|manic state
1622767|NCT00309699|paliperidone|paliperidone
1622768|NCT00309699|paliperidone ER.|paliperidone er.
1622769|NCT00309686|Affective psychosis|affective psychosis
1622770|NCT00309686|bipolar disorder|bipolar disorder
1622771|NCT00309686|manic disorder|manic disorder
1622772|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
1622773|NCT00309686|mania|mania
1622774|NCT00309686|manic state|manic state
1622775|NCT00309686|paliperidone|paliperidone
1622776|NCT00309686|paliperidone ER|paliperidone er
1622777|NCT00309686|adjunctive therapy|adjunctive therapy
1622778|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
1622779|NCT00309660|PPARgamma ligand|ppargamma ligand
1622780|NCT00309660|Rosiglitazone|rosiglitazone
1622782|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
1622783|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
1622784|NCT00309621|Hand Dermatoses,|hand dermatoses,
1622785|NCT00309621|hand dermatitis|hand dermatitis
1622786|NCT00309621|hand eczema|hand eczema
1622787|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
1622788|NCT00309621|retinoid|retinoid
1622789|NCT00309569|Cyclophosphamide|cyclophosphamide
1622790|NCT00309569|Methotrexate|methotrexate
1622791|NCT00309569|Fluorouracil|fluorouracil
1622792|NCT00309569|Epirubicine|epirubicine
1622793|NCT00309569|Breast Cancer|breast cancer
1622794|NCT00309556|Epirubicin|epirubicin
1622795|NCT00309556|Docetaxel|docetaxel
1622796|NCT00309556|Capecitabine|capecitabine
1622797|NCT00309556|Herceptin|herceptin
1622798|NCT00309556|Breast cancer|breast cancer
1622799|NCT00309543|Fluorouracil|fluorouracil
1622800|NCT00309543|Leucovorin|leucovorin
1622801|NCT00309543|Colon cancer|colon cancer
1622802|NCT00309530|Fluorouracil|fluorouracil
1622803|NCT00309530|Levamisol|levamisol
1622804|NCT00309530|Interferon|interferon
1622805|NCT00309530|Colon cancer|colon cancer
1622806|NCT00309517|Fluorouracil|fluorouracil
1622807|NCT00309517|Leucovorin|leucovorin
1622808|NCT00309517|MAb 17-1A|mab 17-1a
1622809|NCT00309517|Rectal cancer|rectal cancer
1622810|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
1622811|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1622812|NCT00309491|Tamoxifen|tamoxifen
1622813|NCT00309491|Aminoglutethimide|aminoglutethimide
1622814|NCT00309491|Breast cancer|breast cancer
1622815|NCT00309478|Cyclophosphamide|cyclophosphamide
1622816|NCT00309478|Methotrexate|methotrexate
1622817|NCT00309478|Fluorouracil|fluorouracil
1622818|NCT00309478|Goserelin|goserelin
1622819|NCT00309478|Tamoxifen|tamoxifen
1622820|NCT00309478|Breast cancer|breast cancer
1622821|NCT00309465|Diabetes|diabetes
1622822|NCT00309465|Insulin Glargine|insulin glargine
1622823|NCT00309465|Surgery|surgery
1622824|NCT00309452|First episode psychosis|first episode psychosis
1622825|NCT00309452|Specialized care|specialized care
1622826|NCT00309452|Phase-specific treatment|phase-specific treatment
1622827|NCT00309452|Schizophrenia|schizophrenia
1622828|NCT00309452|Disorders with psychotic features|disorders with psychotic features
1622829|NCT00309426|atherosclerosis|atherosclerosis
1622830|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
1622831|NCT00309400|History|history
1622832|NCT00309400|Phenylketonuria|phenylketonuria
1622833|NCT00309400|Galactosemia|galactosemia
1622834|NCT00309400|Screening|screening
1622835|NCT00309400|Treatment|treatment
1622836|NCT00309387|Cataract|cataract
1622837|NCT00309387|Nutritional supplements|nutritional supplements
1622838|NCT00309374|LPS|lps
1622839|NCT00309374|Statins|statins
1622840|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
1622841|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
1622842|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
1623343|NCT00307021|Coccidiosis|coccidiosis
1622843|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
1622844|NCT00309296|smoking cessation|smoking cessation
1622845|NCT00309296|smoking reduction|smoking reduction
1622846|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
1622847|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
1622848|NCT00309231|diabetes mellitus|diabetes mellitus
1622849|NCT00309231|islet transplantation|islet transplantation
1622850|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
1622851|NCT00309218|Steroid withdrawal|steroid withdrawal
1622854|NCT00309218|Stable graft function|stable graft function
1622855|NCT00309218|children|children
1622856|NCT00309218|renal transplantation|renal transplantation
1622857|NCT00309205|HIV seronegativity|hiv seronegativity
1622858|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
1622859|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
1622860|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1622861|NCT00309127|DM Nephropathy|dm nephropathy
1622862|NCT00309127|Structured care|structured care
1622863|NCT00309114|UTI|uti
1622864|NCT00309114|SCI|sci
1622865|NCT00309114|E coli|e coli
1622866|NCT00309114|Prevention|prevention
1622867|NCT00309101|Tacrolimus|tacrolimus
1622868|NCT00309101|Myasthenia Gravis|myasthenia gravis
1622869|NCT00309088|Tacrolimus|tacrolimus
1622870|NCT00309088|Myasthenia Gravis|myasthenia gravis
1622871|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
1622872|NCT00309062|Allergy|allergy
1622873|NCT00309062|Birch pollen|birch pollen
1622874|NCT00309062|Recombinant|recombinant
1622875|NCT00309036|Allergy|allergy
1622876|NCT00309036|Grass pollen|grass pollen
1622877|NCT00309036|Recombinant|recombinant
1622878|NCT00309023|Advanced Solid Tumors|advanced solid tumors
1622879|NCT00309010|Focal Hand Dystonia|focal hand dystonia
1622880|NCT00309010|Motor Planning|motor planning
1622881|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1622882|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1622883|NCT00309010|FHD|fhd
1622884|NCT00309010|Writer's Cramp|writer's cramp
1622885|NCT00309010|Healthy Volunteer|healthy volunteer
1622886|NCT00309010|HV|hv
1622887|NCT00308997|Auditory Hallucinations|auditory hallucinations
1622888|NCT00308997|Schizophrenia|schizophrenia
1622889|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
1622890|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1622891|NCT00308997|Wernicke's Area|wernicke's area
1622892|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
1622893|NCT00308984|Pediatrics|pediatrics
1622894|NCT00308984|Intraoperative Awareness|intraoperative awareness
1622895|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
1622896|NCT00308958|cystic fibrosis|cystic fibrosis
1622897|NCT00308958|chest physiotherapy|chest physiotherapy
1622898|NCT00308958|airway clearance|airway clearance
1622899|NCT00308958|bronchiectasis|bronchiectasis
1622900|NCT00308945|Glaucoma|glaucoma
1622901|NCT00308945|Blood flow|blood flow
1622902|NCT00308945|Choroid|choroid
1622903|NCT00308945|Retina|retina
1622904|NCT00308945|Prostaglandin analogues|prostaglandin analogues
1622905|NCT00308932|fluticasone|fluticasone
1622906|NCT00308932|asthma therapy|asthma therapy
1622907|NCT00308932|spacer inhaler|spacer inhaler
1622908|NCT00308932|HFA-134a|hfa-134a
1622909|NCT00308906|infection|infection
1622910|NCT00308906|renal dysfunction|renal dysfunction
1622911|NCT00308906|aminoglycoside|aminoglycoside
1622912|NCT00308906|protein|protein
1622913|NCT00308906|child|child
1622914|NCT00308893|Antidepressants|antidepressants
1622915|NCT00308893|escitalopram|escitalopram
1622916|NCT00308893|Genetic polymorphism|genetic polymorphism
1622917|NCT00308880|Tranexamic acid|tranexamic acid
1622918|NCT00308880|head neck surgery|head neck surgery
1622919|NCT00308867|PDT|pdt
1622920|NCT00308867|AK|ak
1622921|NCT00308867|Cryosurgery|cryosurgery
1622922|NCT00308854|AK|ak
1622923|NCT00308854|PDT|pdt
1622924|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
1622925|NCT00308815|Resuscitation|resuscitation
1622926|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
1622927|NCT00308815|cardiac arrest|cardiac arrest
1622928|NCT00308815|CPR|cpr
1622929|NCT00308802|Kidney|kidney
1622930|NCT00308802|Transplant|transplant
1622931|NCT00308802|Rejection|rejection
1622932|NCT00308802|Kidney Disease|kidney disease
1622933|NCT00308802|Kidney Failure|kidney failure
1622934|NCT00308802|End Stage Renal Disease|end stage renal disease
1622935|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
1622936|NCT00308789|Infant,newborn|infant,newborn
1622937|NCT00308789|Artificial respiration|artificial respiration
1622938|NCT00308763|Smoking Cessation|smoking cessation
1622939|NCT00308763|Nicotine Dependence|nicotine dependence
1622940|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
1622941|NCT00308724|Geriatric|geriatric
1624577|NCT00303134|transplant|transplant
1622942|NCT00308711|Cervical ripening|cervical ripening
1622943|NCT00308711|Induction of labor|induction of labor
1622944|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
1622945|NCT00308711|Cervidil|cervidil
1622946|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
1622947|NCT00308711|Modified Bishop's Score|modified bishop's score
1622948|NCT00308711|PGE2|pge2
1622950|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
1622951|NCT00308711|Cesarean section|cesarean section
1622952|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
1622953|NCT00308698|adiponectin|adiponectin
1622954|NCT00308698|mortality|mortality
1622955|NCT00308685|Asthma|asthma
1622956|NCT00308685|Pediatric asthma|pediatric asthma
1622957|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
1622958|NCT00308633|Apoptosis|apoptosis
1622959|NCT00308633|Gene Expression|gene expression
1622960|NCT00308633|Nitric Oxide|nitric oxide
1622961|NCT00308633|Reactive Oxygen Species|reactive oxygen species
1622962|NCT00308633|Coronary Artery Disease|coronary artery disease
1622964|NCT00308620|HIV|hiv
1622965|NCT00308620|chloroquine|chloroquine
1622966|NCT00308620|disease progression|disease progression
1622967|NCT00308620|inflammation|inflammation
1622968|NCT00308620|treatment naive|treatment naive
1622969|NCT00308607|melanoma|melanoma
1622970|NCT00308607|metastatic|metastatic
1622971|NCT00308607|bevacizumab|bevacizumab
1622972|NCT00308594|cervical radiculopathy|cervical radiculopathy
1622973|NCT00308594|dexamethasone|dexamethasone
1622974|NCT00308594|corticosteroid|corticosteroid
1622975|NCT00308594|oral|oral
1622976|NCT00308581|Crohn's Disease|crohn's disease
1622977|NCT00308581|Certolizumab pegol|certolizumab pegol
1622978|NCT00308568|screening colonoscopy|screening colonoscopy
1622979|NCT00308568|adherence|adherence
1622980|NCT00308555|Cannabis|cannabis
1622981|NCT00308555|Morphine|morphine
1622982|NCT00308555|Oxycodone|oxycodone
1622983|NCT00308555|Marijuana|marijuana
1623895|NCT00305344|Insulin|insulin
1622984|NCT00308555|chronic pain|chronic pain
1622985|NCT00308542|eye diseases|eye diseases
1622986|NCT00308542|diabetic eye problems|diabetic eye problems
1622987|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
1622988|NCT00308529|Lung Cancer|lung cancer
1622989|NCT00308516|Rectal Cancer|rectal cancer
1622990|NCT00308516|Cancer of the Rectum|cancer of the rectum
1622991|NCT00308516|Colorectal Cancer|colorectal cancer
1622992|NCT00308516|Bevacizumab|bevacizumab
1622993|NCT00308503|Primary Insomnia|primary insomnia
1622994|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
1622995|NCT00308503|Awakening|awakening
1622996|NCT00308477|eye diseases|eye diseases
1622997|NCT00308451|chromium|chromium
1622998|NCT00308451|chromium picolinate|chromium picolinate
1622999|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
1623000|NCT00308451|fructosamine|fructosamine
1623001|NCT00308451|glycemic control|glycemic control
1623002|NCT00308451|OGTT|ogtt
1623003|NCT00308438|Crohn Disease|crohn disease
1623004|NCT00308438|Crohn's Disease|crohn's disease
1623005|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
1623006|NCT00308412|Respiratory Tract Infection|respiratory tract infection
1623007|NCT00308386|Nurse Case Management|nurse case management
1623008|NCT00308386|Diabetes|diabetes
1623009|NCT00308386|Hypertension|hypertension
1623010|NCT00308386|Hyperlipidemia|hyperlipidemia
1623011|NCT00308386|Behavior therapy|behavior therapy
1623012|NCT00308386|Motivational interviewing|motivational interviewing
1623013|NCT00308360|Hostility|hostility
1623014|NCT00308360|Impulsivity|impulsivity
1623015|NCT00308360|Aggression|aggression
1623016|NCT00308334|Domperidone|domperidone
1623017|NCT00308334|breast milk|breast milk
1623018|NCT00308334|breast milk composition|breast milk composition
1623019|NCT00308334|preterm infant|preterm infant
1623020|NCT00308334|neonate|neonate
1623021|NCT00308334|nutrition|nutrition
1623022|NCT00308269|Cancer|cancer
1623023|NCT00308269|Phase I|phase i
1623024|NCT00308269|EC145|ec145
1623025|NCT00308269|Recurrent|recurrent
1623026|NCT00308269|Refractory|refractory
1623027|NCT00308269|Solid Tumors|solid tumors
1623028|NCT00308269|Experimental|experimental
1623029|NCT00308256|Type1 diabetes;|type1 diabetes;
1623030|NCT00308256|nurse-counselling;|nurse-counselling;
1623031|NCT00308256|adolescent|adolescent
1623032|NCT00308243|Cystic Fibrosis|cystic fibrosis
1623033|NCT00308243|Sodium Pyruvate|sodium pyruvate
1623034|NCT00308243|Reactive Oxygen Species|reactive oxygen species
1623035|NCT00308243|Inflammation of Lung|inflammation of lung
1623036|NCT00308230|Congenital, BNP|congenital, bnp
1623037|NCT00308217|Heart Disease, Congenital|heart disease, congenital
1623038|NCT00308217|Single Ventricle|single ventricle
1623039|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
1623040|NCT00308204|discoid lupus|discoid lupus
1623041|NCT00308204|lupus|lupus
1623042|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
1623043|NCT00308204|lupus of the scalp|lupus of the scalp
1623044|NCT00308191|COPD|copd
1623045|NCT00308191|Formoterol|formoterol
1623046|NCT00308191|Tiotropium|tiotropium
1623047|NCT00308178|Abraxane|abraxane
1623048|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
1623049|NCT00308178|taxol|taxol
1623050|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
1623051|NCT00308165|Brain Tumors|brain tumors
1623052|NCT00308165|Neoplasms, Brain|neoplasms, brain
1623053|NCT00308165|Brain Cancer|brain cancer
1623054|NCT00308165|Brain cancer treatment|brain cancer treatment
1623055|NCT00308165|Topotecan|topotecan
1623056|NCT00308152|Colonoscopy|colonoscopy
1623057|NCT00308152|Rehydration|rehydration
1623058|NCT00308152|Sedation|sedation
1623059|NCT00308139|diabetes|diabetes
1623060|NCT00308139|exenatide|exenatide
1623061|NCT00308139|long acting release|long acting release
1623062|NCT00308139|LAR|lar
1623063|NCT00308139|Amylin|amylin
1623064|NCT00308139|Lilly|lilly
1623065|NCT00308126|Abdominal operation|abdominal operation
1623066|NCT00308113|Muscular dystrophy|muscular dystrophy
1623067|NCT00308113|Duchenne|duchenne
1623068|NCT00308113|CoQ10|coq10
1623069|NCT00308113|prednisone|prednisone
1623070|NCT00308100|Liver Transplantation|liver transplantation
1623071|NCT00308087|Sargramostim|sargramostim
1623072|NCT00308087|Leukine|leukine
1623073|NCT00308087|NHL|nhl
1623074|NCT00308074|behavioral problems|behavioral problems
1623075|NCT00308074|aggression|aggression
1623076|NCT00308074|autism|autism
1623077|NCT00308074|aripiprazole|aripiprazole
1623078|NCT00308061|Plasmodium falciparum|plasmodium falciparum
1623079|NCT00308061|malaria|malaria
1623080|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
1623081|NCT00308048|Interferon|interferon
1623082|NCT00308048|Pegylated interferon|pegylated interferon
1623083|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
1623084|NCT00308048|Hepatitis C|hepatitis c
1623085|NCT00308048|Genotype 2|genotype 2
1623086|NCT00308048|Genotype 3|genotype 3
1623087|NCT00308048|Rapid virological response|rapid virological response
1623088|NCT00308048|Short treatment|short treatment
1623089|NCT00308048|14 weeks treatment|14 weeks treatment
1623090|NCT00308048|health related quality of life|health related quality of life
1623091|NCT00308048|sick leave|sick leave
1623092|NCT00308048|Injecting drug use|injecting drug use
1623093|NCT00308022|Acute Lung Injury|acute lung injury
1623094|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1623095|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
1623096|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
1623097|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
1623098|NCT00308009|Urinary stress incontinence|urinary stress incontinence
1623099|NCT00308009|Surgery|surgery
1623100|NCT00307996|CoQ10|coq10
1623101|NCT00307996|hemodialysis|hemodialysis
1623102|NCT00307996|oxidative marker|oxidative marker
1623103|NCT00307996|antioxidant|antioxidant
1623104|NCT00307970|fluticasone|fluticasone
1623105|NCT00307970|asthma therapy|asthma therapy
1623106|NCT00307970|spacer inhaler|spacer inhaler
1623107|NCT00307970|HFA-134a|hfa-134a
1623108|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
1623109|NCT00307957|Daytime Sleepiness|daytime sleepiness
1623110|NCT00307957|Pillar Palatal Implants|pillar palatal implants
1623111|NCT00307944|Acid Reflux|acid reflux
1623112|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
1623113|NCT00307944|Daytime Sleepiness|daytime sleepiness
1623114|NCT00307931|Certolizumab pegol|certolizumab pegol
1623115|NCT00307931|Cimzia|cimzia
1623116|NCT00307931|Crohn's disease|crohn's disease
1623117|NCT00307931|Greek patients|greek patients
1623118|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
1623119|NCT00307905|homeopathy|homeopathy
1623120|NCT00307905|pain|pain
1623121|NCT00307905|traumeel s|traumeel s
1623122|NCT00307905|Fracture of neck of femur|fracture of neck of femur
1623123|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
1623124|NCT00307892|Homeopathy|homeopathy
1623125|NCT00307892|Traumeel S|traumeel s
1623126|NCT00307892|Arthroscopy|arthroscopy
1623127|NCT00307892|Pain management|pain management
1623128|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
1623129|NCT00307879|Myocardial infarction|myocardial infarction
1623130|NCT00307879|revascularization|revascularization
1623131|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
1623132|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
1623133|NCT00307853|homeopathy|homeopathy
1623134|NCT00307853|pain|pain
1623135|NCT00307853|traumeel s|traumeel s
1623136|NCT00307853|total knee arthroplasty|total knee arthroplasty
1623137|NCT00307853|total hip arthroplasty|total hip arthroplasty
1623138|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
1623139|NCT00307827|Steroid-Refractory|steroid-refractory
1623140|NCT00307827|IVSR-UC|ivsr-uc
1623141|NCT00307827|Ulcerative Colitis|ulcerative colitis
1623142|NCT00307814|Anemia|anemia
1623143|NCT00307814|Low Blood Count|low blood count
1623144|NCT00307814|Chronic Kidney Failure|chronic kidney failure
1623145|NCT00307814|Chronic Kidney Disease|chronic kidney disease
1623146|NCT00307814|epoetin alfa|epoetin alfa
1623147|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
1623148|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
1623149|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
1623150|NCT00307788|Acupuncture|acupuncture
1623151|NCT00307788|expectancy|expectancy
1623152|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
1623153|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
1623154|NCT00307762|Stroke|stroke
1623155|NCT00307762|Physiotherapy|physiotherapy
1623156|NCT00307762|Effectiveness|effectiveness
1623157|NCT00307762|Gait trainer|gait trainer
1623158|NCT00307749|Neuropathy|neuropathy
1623159|NCT00307749|Nerve Conduction|nerve conduction
1623160|NCT00307736|Fluorouracil|fluorouracil
1623161|NCT00307736|bevacizumab|bevacizumab
1623162|NCT00307736|erlotinib|erlotinib
1623163|NCT00307736|external beam radiation therapy|external beam radiation therapy
1623164|NCT00307736|EBRT|ebrt
1623165|NCT00307723|EBRT|ebrt
1623166|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
1623167|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1623168|NCT00307710|Influenza Vaccination|influenza vaccination
1623169|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
1623170|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
1623171|NCT00307697|Letter intervention|letter intervention
1623172|NCT00307697|Depression|depression
1623173|NCT00307697|Anxiety|anxiety
1623174|NCT00307697|Primary health care|primary health care
1623175|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1623176|NCT00307684|Adult|adult
1623177|NCT00307684|Long term safety|long term safety
1623178|NCT00307684|Efficacy|efficacy
1623179|NCT00307684|Quality of life|quality of life
1623180|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
1625294|NCT00300534|Diagnosis|diagnosis
1623181|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
1623182|NCT00307671|cyclophosphamide|cyclophosphamide
1623183|NCT00307671|Elderly patients|elderly patients
1623184|NCT00307671|Randomized controlled trial|randomized controlled trial
1623185|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
1623186|NCT00307658|Relapse|relapse
1623187|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
1623188|NCT00307658|Corticosteroid|corticosteroid
1623189|NCT00307658|Immunosuppressant|immunosuppressant
1623190|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
1623191|NCT00307645|Maintenance therapy|maintenance therapy
1623192|NCT00307645|Azathioprine|azathioprine
1623193|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
1623194|NCT00307632|Contraception|contraception
1623195|NCT00307632|Hormonal patch|hormonal patch
1623196|NCT00307632|Norelgestromine|norelgestromine
1623197|NCT00307632|Ethinyl estradiol|ethinyl estradiol
1623198|NCT00307619|Binge-Eating Disorder|binge-eating disorder
1623199|NCT00307606|Mastectomy|mastectomy
1623200|NCT00307606|Seroma|seroma
1623201|NCT00307606|Breast cancer|breast cancer
1623202|NCT00307606|Glucocorticoid|glucocorticoid
1623203|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
1623204|NCT00307593|Relapse|relapse
1623205|NCT00307593|Corticosteroids|corticosteroids
1623206|NCT00307593|Immunosuppressant|immunosuppressant
1623207|NCT00307593|Infliximab/rituximab|infliximab/rituximab
1623208|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
1623209|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
1623210|NCT00307580|CVADS|cvads
1623211|NCT00307502|protease inhibitors|protease inhibitors
1623212|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
1623213|NCT00307502|pharmacokinetic models|pharmacokinetic models
1623214|NCT00307502|treatment experienced|treatment experienced
1623216|NCT00307476|Fecal Incontinence|fecal incontinence
1623217|NCT00307476|Fecal Containment Devices|fecal containment devices
1623218|NCT00307476|Skin Integrity|skin integrity
1623219|NCT00307463|end-stage renal disease|end-stage renal disease
1623220|NCT00307463|hemodialysis|hemodialysis
1623221|NCT00307463|volume control|volume control
1623222|NCT00307463|ultrafiltration|ultrafiltration
1623223|NCT00307463|inflammation|inflammation
1623224|NCT00307463|cardiovascular disease|cardiovascular disease
1623225|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
1623226|NCT00307463|dietary salt restriction|dietary salt restriction
1623227|NCT00307450|Dyskinesias|dyskinesias
1623228|NCT00307450|Parkinson's disease|parkinson's disease
1623229|NCT00307450|Levetiracetam|levetiracetam
1623230|NCT00307450|Treatment|treatment
1623231|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
1623232|NCT00307437|interleukin 23|interleukin 23
1623233|NCT00307437|IL-12|il-12
1623234|NCT00307437|interleukin-12|interleukin-12
1623235|NCT00307437|interleukin-23|interleukin-23
1623236|NCT00307437|CNTO1275|cnto1275
1623237|NCT00307437|biologic|biologic
1623238|NCT00307437|Psoriasis|psoriasis
1623239|NCT00307437|CNTO 1275|cnto 1275
1623240|NCT00307437|IL23|il23
1623241|NCT00307437|interleukin 12|interleukin 12
1623242|NCT00307437|IL-23|il-23
1623243|NCT00307437|IL12|il12
1623244|NCT00307437|ustekinumab|ustekinumab
1623245|NCT00307411|Metabolic syndrome|metabolic syndrome
1623247|NCT00307398|Dry AMD|dry amd
1623248|NCT00307398|Drusen|drusen
1623249|NCT00307398|CNV|cnv
1623250|NCT00307385|Motor Recovery|motor recovery
1623251|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1623252|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
1623253|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
1623254|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
1623255|NCT00307385|Motor Cortex|motor cortex
1623256|NCT00307385|Motor Function|motor function
1623257|NCT00307385|Motor Learning|motor learning
1623258|NCT00307385|Premotor Cortex|premotor cortex
1623259|NCT00307385|Primary Motor Cortex|primary motor cortex
1623260|NCT00307385|Stroke|stroke
1623261|NCT00307385|Healthy Volunteer|healthy volunteer
1623263|NCT00307346|Movement-Related Potential|movement-related potential
1623264|NCT00307346|Electroencephalogram|electroencephalogram
1623265|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
1623266|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
1623267|NCT00307346|Healthy Volunteer|healthy volunteer
1623268|NCT00307346|HV|hv
1623269|NCT00307333|very low birth weight infants|very low birth weight infants
1623270|NCT00307333|heart rate characteristics|heart rate characteristics
1623271|NCT00307320|pregnancy|pregnancy
1623272|NCT00307320|stress|stress
1623273|NCT00307320|anxiety|anxiety
1623274|NCT00307307|atherosclerosis|atherosclerosis
1623275|NCT00307307|HDL cholesterol|hdl cholesterol
1623276|NCT00307307|niacin|niacin
1623277|NCT00307307|MR imaging|mr imaging
1623278|NCT00307294|Prostate|prostate
1623279|NCT00307294|Androgen|androgen
1623280|NCT00307294|AIPC|aipc
1623281|NCT00307294|Doxil|doxil
1623282|NCT00307268|ADHD Effectiveness|adhd effectiveness
1623283|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
1623284|NCT00307255|protocol specific|protocol specific
1623285|NCT00307255|Paclitaxel|paclitaxel
1623286|NCT00307255|Abraxane|abraxane
1623287|NCT00307255|Gemcitabine|gemcitabine
1623288|NCT00307255|Gemzar|gemzar
1623289|NCT00307255|Phase I|phase i
1623290|NCT00307255|Lineberger|lineberger
1623291|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
1623292|NCT00307242|Lamivudine|lamivudine
1623293|NCT00307242|Hepatitis B|hepatitis b
1623294|NCT00307229|metastatic breast cancer|metastatic breast cancer
1623295|NCT00307229|recurrent breast cancer|recurrent breast cancer
1623296|NCT00307216|First Episode Psychosis|first episode psychosis
1623297|NCT00307216|Early Psychosis|early psychosis
1623298|NCT00307216|Psychosocial Intervention|psychosocial intervention
1623299|NCT00307203|Bupropion|bupropion
1623300|NCT00307203|Zyban|zyban
1623301|NCT00307203|Wellbutrin|wellbutrin
1623302|NCT00307203|Smoking cessation|smoking cessation
1623303|NCT00307203|Schizophrenia|schizophrenia
1623304|NCT00307203|Schizoaffective disorder|schizoaffective disorder
1623305|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
1623306|NCT00307190|BED|bed
1623307|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
1623308|NCT00307164|Treatment Experienced|treatment experienced
1623309|NCT00307164|Uridine|uridine
1623310|NCT00307151|Treatment Naive|treatment naive
1623311|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
1623312|NCT00307151|MTCT|mtct
1623313|NCT00307151|Pediatrics|pediatrics
1623314|NCT00307151|Viral resistance|viral resistance
1623315|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
1623316|NCT00307138|Hetastarch|hetastarch
1623317|NCT00307138|Plasma substitutes|plasma substitutes
1623318|NCT00307138|Equivalence|equivalence
1623319|NCT00307125|Organ Transplantation|organ transplantation
1623320|NCT00307125|Graft function/survival|graft function/survival
1623321|NCT00307125|Immunosuppression|immunosuppression
1623322|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
1623323|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
1623324|NCT00307099|bacterial diseases|bacterial diseases
1623325|NCT00307073|Pacemaker|pacemaker
1623326|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
1623327|NCT00307073|Ventricular Pacing|ventricular pacing
1623328|NCT00307047|Stents|stents
1623329|NCT00307047|Angioplasty|angioplasty
1623330|NCT00307047|Total coronary occlusion|total coronary occlusion
1623331|NCT00307047|coronary restenosis|coronary restenosis
1623332|NCT00307047|stent thrombosis|stent thrombosis
1623333|NCT00307034|Primary vaccination|primary vaccination
1623334|NCT00307034|Pneumococcal disease|pneumococcal disease
1623335|NCT00307034|Safety|safety
1623336|NCT00307034|Booster vaccination|booster vaccination
1623337|NCT00307034|Immunogenicity|immunogenicity
1623338|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
1623339|NCT00307034|Dose comparison|dose comparison
1623340|NCT00307021|Parasitic Diseases|parasitic diseases
1623341|NCT00307021|Malaria, Falciparum|malaria, falciparum
1623342|NCT00307021|Malaria|malaria
1623344|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
1623345|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
1623346|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
1623347|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
1623348|NCT00306956|Infant|infant
1623349|NCT00306956|Newborn|newborn
1623350|NCT00306956|pacifier|pacifier
1623351|NCT00306956|dummies|dummies
1623352|NCT00306956|breastfeeding|breastfeeding
1623353|NCT00306956|Sudden Infant Death|sudden infant death
1623354|NCT00306956|SIDS|sids
1623355|NCT00306956|Pacifiers|pacifiers
1623356|NCT00306930|Total Hip Replacement|total hip replacement
1623357|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
1623358|NCT00306917|Total Hip Replacement|total hip replacement
1623359|NCT00306904|Macular|macular
1623360|NCT00306904|Edema|edema
1623361|NCT00306904|Diabetic|diabetic
1623362|NCT00306904|Retinopathy|retinopathy
1623363|NCT00306891|Advanced solid tumours|advanced solid tumours
1623364|NCT00306891|Advanced cancer|advanced cancer
1623365|NCT00306891|tumor|tumor
1623366|NCT00306891|tumour|tumour
1623367|NCT00306891|RECENTIN|recentin
1623368|NCT00306865|Neurotransmitter|neurotransmitter
1623369|NCT00306865|Neuroimaging|neuroimaging
1623370|NCT00306865|Movement Disorder|movement disorder
1623371|NCT00306865|Focal Hand Dystonia|focal hand dystonia
1623372|NCT00306865|FHD|fhd
1623373|NCT00306865|HV|hv
1623374|NCT00306852|Glaucoma|glaucoma
1623375|NCT00306852|Trabeculectomy|trabeculectomy
1623376|NCT00306852|Tube shunt surgery|tube shunt surgery
1623377|NCT00306839|Tissucol|tissucol
1623378|NCT00306839|Tisseel|tisseel
1623379|NCT00306839|Lichtenstein|lichtenstein
1623380|NCT00306839|hernia|hernia
1623381|NCT00306839|inguinal|inguinal
1623382|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
1625400|NCT00300131|angioplasty|angioplasty
1623383|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
1623384|NCT00306813|CC-5013|cc-5013
1623385|NCT00306813|Revlimid|revlimid
1623386|NCT00306813|lenalidomide|lenalidomide
1623387|NCT00306813|RAD|rad
1623388|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
1623389|NCT00306800|Photodynamic therapy|photodynamic therapy
1623390|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
1623391|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
1623392|NCT00306787|Herpes simplex|herpes simplex
1623393|NCT00306787|genital herpes|genital herpes
1623394|NCT00306787|famciclovir|famciclovir
1623395|NCT00306787|valacyclovir|valacyclovir
1623396|NCT00306787|Recurrent genital herpes|recurrent genital herpes
1623397|NCT00306774|osteoarthritis|osteoarthritis
1623398|NCT00306774|vitamin D|vitamin d
1623399|NCT00306774|knee pain|knee pain
1623400|NCT00306774|cartilage loss|cartilage loss
1623401|NCT00306774|WOMAC|womac
1623402|NCT00306774|MRI|mri
1623403|NCT00306774|cartilage volume|cartilage volume
1623404|NCT00306774|OA|oa
1623405|NCT00306774|physical function|physical function
1623406|NCT00306774|web-based|web-based
1623407|NCT00306774|internet-based|internet-based
1623408|NCT00306748|Chronic Constipation|chronic constipation
1623409|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
1623410|NCT00306748|Constipation|constipation
1623411|NCT00306748|CIC|cic
1623412|NCT00306748|CC|cc
1623413|NCT00306748|MD-1100|md-1100
1623414|NCT00306748|MD-1100 Acetate|md-1100 acetate
1623415|NCT00306748|Microbia|microbia
1623416|NCT00306748|Microbia, Inc.|microbia, inc.
1623417|NCT00306748|linaclotide|linaclotide
1623418|NCT00306748|linaclotide acetate|linaclotide acetate
1623419|NCT00306735|Multiple Myeloma|multiple myeloma
1623420|NCT00306735|Stem Cell Transplantation|stem cell transplantation
1623421|NCT00306735|CINV|cinv
1623422|NCT00306722|Bronchoscopy|bronchoscopy
1623423|NCT00306722|Sedation|sedation
1623424|NCT00306722|AQUAVAN|aquavan
1623425|NCT00306722|fospropofol disodium|fospropofol disodium
1623426|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
1623427|NCT00306709|obesity|obesity
1623428|NCT00306709|behavior change|behavior change
1623429|NCT00306709|cultural adaptations|cultural adaptations
1623430|NCT00306709|weight loss|weight loss
1623431|NCT00306696|rosiglitazone|rosiglitazone
1623432|NCT00306696|fluid retention|fluid retention
1623433|NCT00306696|Type 2 diabetes|type 2 diabetes
1623434|NCT00306696|diuretics|diuretics
1623435|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
1623436|NCT00306683|Craniopharyngioma|craniopharyngioma
1623437|NCT00306683|Obesity|obesity
1623438|NCT00306683|Diazoxide|diazoxide
1623439|NCT00306683|Hyperinsulinemia|hyperinsulinemia
1623440|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
1623441|NCT00306683|Oncology|oncology
1623442|NCT00306683|Pituitary|pituitary
1623443|NCT00306683|Hypothalamus|hypothalamus
1623444|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
1623445|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
1623446|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
1623447|NCT00306670|Hemophilia A|hemophilia a
1623448|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
1623449|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
1623450|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
1623451|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
1625363|NCT00300222|capsaicin|capsaicin
1623452|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
1623453|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
1623454|NCT00306657|Beta-Trace Protein|beta-trace protein
1623455|NCT00306644|rosiglitazone|rosiglitazone
1623456|NCT00306644|Type 2 diabetes|type 2 diabetes
1623457|NCT00306644|intima media thickness|intima media thickness
1623458|NCT00306644|Insulin resistance|insulin resistance
1623459|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
1623460|NCT00306605|Emotional experiences|emotional experiences
1623461|NCT00306605|fathers|fathers
1623462|NCT00306605|stress|stress
1623463|NCT00306605|depressive symptomatology|depressive symptomatology
1623464|NCT00306605|NICU|nicu
1623465|NCT00306605|preterm birth|preterm birth
1623466|NCT00306592|Multiple Sclerosis|multiple sclerosis
1623468|NCT00306579|Ischemic Stroke|ischemic stroke
1623469|NCT00306579|Myocardial ischemia|myocardial ischemia
1623470|NCT00306579|Myocardial necrosis|myocardial necrosis
1623471|NCT00306527|Influenza|influenza
1623472|NCT00306527|adult/elderly|adult/elderly
1623473|NCT00306527|flu cell culture|flu cell culture
1623474|NCT00306527|vaccine|vaccine
1623475|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
1623476|NCT00306501|Training|training
1623477|NCT00306501|Cortical Stimulation|cortical stimulation
1623478|NCT00306501|Sensory Stimulation|sensory stimulation
1623479|NCT00306501|Brain Imaging|brain imaging
1623480|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1623481|NCT00306501|Swallowing|swallowing
1623482|NCT00306501|Dysphagia|dysphagia
1623483|NCT00306501|Stroke|stroke
1623484|NCT00306501|CVA|cva
1623485|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
1623486|NCT00306501|Healthy Volunteer|healthy volunteer
1623487|NCT00306501|HV|hv
1623488|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
1623489|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
1623490|NCT00306488|Visual Acuity Decrease|visual acuity decrease
1623491|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
1623492|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
1623493|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
1623494|NCT00306488|AMD|amd
1623495|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
1623496|NCT00306462|Premature Labor|premature labor
1623497|NCT00306462|Premature Birth|premature birth
1623498|NCT00306462|Magnesium sulfate|magnesium sulfate
1623499|NCT00306462|Nifedipine|nifedipine
1623500|NCT00306449|Weight gain|weight gain
1623501|NCT00306449|obesity|obesity
1623502|NCT00306449|overweight|overweight
1623503|NCT00306449|young adults|young adults
1623504|NCT00306449|lipid disorders|lipid disorders
1623505|NCT00306449|insulin resistance|insulin resistance
1623506|NCT00306449|randomized controled study|randomized controled study
1623507|NCT00306436|Diabetes|diabetes
1623508|NCT00306436|renal deficiency|renal deficiency
1623509|NCT00306436|hypertension|hypertension
1623510|NCT00306423|exercise|exercise
1623511|NCT00306410|Vitamin D deficiency|vitamin d deficiency
1623512|NCT00306410|HIV/AIDS|hiv/aids
1623513|NCT00306410|HAART|haart
1623514|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
1623515|NCT00306410|insulin resistance|insulin resistance
1623516|NCT00306410|bone density|bone density
1623517|NCT00306397|Kidney transplantation|kidney transplantation
1623518|NCT00306397|Steroid free|steroid free
1623519|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
1623520|NCT00306397|Tacrolimus|tacrolimus
1623521|NCT00306397|Sirolimus|sirolimus
1623522|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
1623523|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
1623524|NCT00306384|Type II Diabetes|type ii diabetes
1623525|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
1623526|NCT00306384|Lipoatrophic|lipoatrophic
1623527|NCT00306384|Dyslipidemia|dyslipidemia
1623528|NCT00306384|Drug Therapy|drug therapy
1623529|NCT00306371|diode|diode
1623530|NCT00306371|laser|laser
1623531|NCT00306371|acne|acne
1623532|NCT00306371|acne scar|acne scar
1623533|NCT00306358|absorption test|absorption test
1623534|NCT00306358|cobalamin|cobalamin
1623535|NCT00306358|holotranscobalamin|holotranscobalamin
1623536|NCT00306358|vitamin B12|vitamin b12
1623537|NCT00306345|Outreach|outreach
1623538|NCT00306345|Major general surgery|major general surgery
1623539|NCT00306345|Intensive care|intensive care
1623540|NCT00306345|Serious adverse events|serious adverse events
1623541|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
1623542|NCT00306332|T-cell depletion|t-cell depletion
1623543|NCT00306332|B-cell depletion|b-cell depletion
1623544|NCT00306332|Immunomagnetic selection|immunomagnetic selection
1623545|NCT00306319|Tuberculosis|tuberculosis
1623546|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
1623547|NCT00306280|Helicobacter pylori|helicobacter pylori
1623548|NCT00306280|phototherapy|phototherapy
1623549|NCT00306280|peptic ulcer|peptic ulcer
1623550|NCT00306280|gastric cancer|gastric cancer
1623551|NCT00306267|Anemia|anemia
1623552|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
1623553|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
1623554|NCT00306267|cancer|cancer
1623555|NCT00306267|non-myeloid|non-myeloid
1623556|NCT00306241|Cervical neoplasia|cervical neoplasia
1623557|NCT00306241|Cervical cancer|cervical cancer
1623558|NCT00306241|Double-blind|double-blind
1623559|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
1623560|NCT00306241|HPV|hpv
1623561|NCT00306241|AS04|as04
1623562|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
1623563|NCT00306228|Thrombolysis|thrombolysis
1623564|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
1623565|NCT00306228|tirofiban|tirofiban
1623566|NCT00306228|paclitaxel|paclitaxel
1623567|NCT00306215|double-blind|double-blind
1623568|NCT00306215|placebo-controlled|placebo-controlled
1623569|NCT00306215|multicenter|multicenter
1623570|NCT00306215|efficacy|efficacy
1623571|NCT00306215|safety|safety
1623572|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
1623573|NCT00306189|RANKL|rankl
1623574|NCT00306189|RANK|rank
1623575|NCT00306189|denosumab|denosumab
1623576|NCT00306189|AMG 162|amg 162
1623577|NCT00306189|osteoporosis|osteoporosis
1623578|NCT00306189|bone turnover|bone turnover
1623579|NCT00306189|bone mineral density|bone mineral density
1623580|NCT00306189|Japanese|japanese
1623581|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
1623582|NCT00306163|Asthma|asthma
1623583|NCT00306163|AMP|amp
1623584|NCT00306163|Ciclesonide|ciclesonide
1623585|NCT00306163|Fluticasone propionate|fluticasone propionate
1623586|NCT00306150|Prevention of blood loss|prevention of blood loss
1623587|NCT00306150|Blood Loss, Surgical|blood loss, surgical
1623588|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
1623589|NCT00306124|Dementia|dementia
1623590|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
1623591|NCT00306124|MCI|mci
1623592|NCT00306124|levodopa|levodopa
1623593|NCT00306124|learning|learning
1623594|NCT00306124|enhancement|enhancement
1623595|NCT00306111|stem cell transplantation|stem cell transplantation
1623596|NCT00306111|stem cell mobilization|stem cell mobilization
1623597|NCT00306111|high-dose therapy|high-dose therapy
1623598|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
1623599|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
1623600|NCT00306085|blood marrow cells,|blood marrow cells,
1623601|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
1623602|NCT00306046|PETScan|petscan
1623603|NCT00306046|Positron-Emission Tomography|positron-emission tomography
1623604|NCT00306046|Bisphosphonate|bisphosphonate
1623605|NCT00306046|Biochemical Markers|biochemical markers
1623606|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
1623607|NCT00306033|myasthenia gravis|myasthenia gravis
1623608|NCT00306033|immunoglobulin|immunoglobulin
1623609|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
1623610|NCT00306033|treatment|treatment
1623611|NCT00306020|Skin ulcers|skin ulcers
1623612|NCT00306020|Topical morphine|topical morphine
1623613|NCT00306020|Chronic pain|chronic pain
1623614|NCT00306020|Cancer|cancer
1623615|NCT00306007|Pregnancy|pregnancy
1623616|NCT00306007|Unplanned pregnancy|unplanned pregnancy
1623617|NCT00306007|Psychosocial|psychosocial
1623618|NCT00306007|Measure|measure
1623619|NCT00305968|Quality of life|quality of life
1623620|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
1623621|NCT00305968|Health related costs|health related costs
1623622|NCT00305955|amblyopia|amblyopia
1623623|NCT00305955|bilateral amblyopia|bilateral amblyopia
1623624|NCT00305955|refractive error|refractive error
1623625|NCT00305942|Lung Cancer|lung cancer
1623626|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
1623627|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
1623628|NCT00305929|Localized prostate cancer|localized prostate cancer
1623629|NCT00305916|MSCT|msct
1623630|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
1623631|NCT00305916|Sinus rhythm|sinus rhythm
1623632|NCT00305903|Dementia,|dementia,
1623633|NCT00305903|Alzheimer's,|alzheimer's,
1623634|NCT00305903|Rivastigmine,|rivastigmine,
1623635|NCT00305903|Memantine|memantine
1623636|NCT00305851|fatigue|fatigue
1623637|NCT00305851|pain|pain
1623638|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1623639|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1623640|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1623641|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1623642|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1624682|NCT00302679|Pain|pain
1623643|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1623644|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1625459|NCT00299897|antiviral|antiviral
1623645|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1623646|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1623647|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1623648|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1623649|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1623650|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1623651|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1623652|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1623653|NCT00305851|primary myelofibrosis|primary myelofibrosis
1623654|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1623655|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1623656|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1623657|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1623658|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
1623659|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1623660|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1623661|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1623662|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1623663|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1623664|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1623665|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1623666|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1623667|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1623668|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1623669|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1623670|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1623671|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1623672|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1623673|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1623674|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1623675|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1623676|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1623677|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1623678|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1623679|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1623680|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1623681|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1623682|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1623683|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1623684|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1623685|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1623686|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1623687|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1623688|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1623689|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1623690|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1623691|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1623692|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1623693|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1623694|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1623695|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1623696|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1623697|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1623698|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1623699|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1623700|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1623701|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
1623702|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1623703|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1623704|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1623773|NCT00305799|neurotoxicity|neurotoxicity
1623705|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1624054|NCT00304889|Clostridium difficile|clostridium difficile
1623706|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1623707|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1623708|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
1623709|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1623710|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1623711|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1623712|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1623713|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1623714|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1623715|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1623716|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1623717|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1623718|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1623719|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1623720|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1623721|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1623722|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1623723|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1623724|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1625501|NCT00299741|Metastatic|metastatic
1623725|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1623726|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1623727|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1623728|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1623729|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1623730|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1623731|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1623732|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1623733|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1623734|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1623735|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1623736|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1623737|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1623738|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1623739|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1623740|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1623741|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1623742|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1623743|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1623744|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1623745|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1623746|NCT00305851|Ewing sarcoma|ewing sarcoma
1623747|NCT00305851|childhood brain tumor|childhood brain tumor
1623748|NCT00305851|adult brain tumor|adult brain tumor
1623749|NCT00305851|osteosarcoma|osteosarcoma
1623750|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1623751|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1623752|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1623753|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1623754|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1623755|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1623756|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1623757|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1623758|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1623759|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1623760|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1623761|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1623762|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1623763|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1623764|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1623765|NCT00305825|recurrent breast cancer|recurrent breast cancer
1623766|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
1623767|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
1623768|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
1623769|NCT00305825|stage IV breast cancer|stage iv breast cancer
1623770|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
1623771|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
1623772|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
1623774|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1623775|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1623776|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1623777|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1623778|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
1623779|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
1623780|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1623781|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1623782|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
1623783|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
1623784|NCT00305747|stage I prostate cancer|stage i prostate cancer
1623785|NCT00305747|stage II prostate cancer|stage ii prostate cancer
1623786|NCT00305747|stage III prostate cancer|stage iii prostate cancer
1623787|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1623788|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
1623789|NCT00305708|thrombocytopenia|thrombocytopenia
1623790|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1623791|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1623792|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
1623793|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
1623794|NCT00305708|Fanconi anemia|fanconi anemia
1623795|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
1623796|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1623797|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1623798|NCT00305669|stage I prostate cancer|stage i prostate cancer
1623799|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
1623800|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
1623801|NCT00305669|stage III prostate cancer|stage iii prostate cancer
1623802|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
1623803|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
1623804|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1623806|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
1623807|NCT00305643|stage IV breast cancer|stage iv breast cancer
1623808|NCT00305643|male breast cancer|male breast cancer
1623809|NCT00305643|recurrent breast cancer|recurrent breast cancer
1623810|NCT00305643|stage IV colon cancer|stage iv colon cancer
1623811|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
1623812|NCT00305643|recurrent colon cancer|recurrent colon cancer
1623813|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
1623814|NCT00305643|Celecoxib|celecoxib
1623815|NCT00305643|Celebrex|celebrex
1623816|NCT00305643|Capecitabine|capecitabine
1623817|NCT00305643|Xeloda|xeloda
1623818|NCT00305630|Corticosteroids|corticosteroids
1623819|NCT00305630|Triamcinolone|triamcinolone
1623820|NCT00305630|Photodynamic therapy|photodynamic therapy
1623821|NCT00305630|Choroidal neovascularization|choroidal neovascularization
1623822|NCT00305630|Age-related macular degeneration|age-related macular degeneration
1623823|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1623824|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1623825|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
1623826|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1623827|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
1623828|NCT00305591|cirrhosis|cirrhosis
1623829|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
1623830|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
1623831|NCT00305578|Bipolar|bipolar
1623832|NCT00305578|Depression|depression
1623833|NCT00305578|Incomplete Response|incomplete response
1623834|NCT00305565|Depression|depression
1623835|NCT00305565|Chronic Depression|chronic depression
1623836|NCT00305565|Bipolar Disorder|bipolar disorder
1623837|NCT00305552|Randomized controlled trial|randomized controlled trial
1623838|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
1623839|NCT00305552|skin sarcoidosis|skin sarcoidosis
1623840|NCT00305552|Thalidomide|thalidomide
1623841|NCT00305539|Giant Cell Arteritis|giant cell arteritis
1623842|NCT00305539|Placebo|placebo
1623843|NCT00305539|Anti-TNF|anti-tnf
1623844|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
1623845|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
1623846|NCT00305513|right hemispheric CVA|right hemispheric cva
1623847|NCT00305513|neglect|neglect
1623848|NCT00305513|phasic alert treatment|phasic alert treatment
1623849|NCT00305513|PET scan|pet scan
1623850|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
1623852|NCT00305500|Escitalopram|escitalopram
1623853|NCT00305487|Hay Fever|hay fever
1623854|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1623855|NCT00305487|Nasal spray|nasal spray
1623856|NCT00305487|Ciclesonide|ciclesonide
1624683|NCT00302679|Screening|screening
1623857|NCT00305487|Allergic Rhinitis|allergic rhinitis
1623858|NCT00305474|Negative symptoms|negative symptoms
1623859|NCT00305474|neuropsychological deficits|neuropsychological deficits
1623860|NCT00305474|Cognitive function|cognitive function
1623861|NCT00305474|diagnostic|diagnostic
1623862|NCT00305474|prevention|prevention
1623864|NCT00305461|Quality of Life|quality of life
1623865|NCT00305461|Ciclesonide|ciclesonide
1623866|NCT00305448|oncology|oncology
1623867|NCT00305448|cancer|cancer
1623868|NCT00305448|breast cancer|breast cancer
1623869|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
1623870|NCT00305409|Crohn's|crohn's
1623871|NCT00305409|TNF-alpha|tnf-alpha
1623872|NCT00305409|Synbiotic|synbiotic
1623873|NCT00305409|Probiotic|probiotic
1623874|NCT00305396|Kidney transplantation|kidney transplantation
1623875|NCT00305396|immunosuppression|immunosuppression
1623876|NCT00305396|sirolimus|sirolimus
1623877|NCT00305396|Thymoglobulin|thymoglobulin
1623878|NCT00305383|Viramidine|viramidine
1623879|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
1623880|NCT00305383|Valeant|valeant
1623881|NCT00305383|Hepatitis C|hepatitis c
1623882|NCT00305383|Rapid virologic response|rapid virologic response
1623883|NCT00305383|HCV RNA|hcv rna
1623884|NCT00305370|clinical trial|clinical trial
1623885|NCT00305370|aripiprazole|aripiprazole
1623886|NCT00305370|methylphenidate|methylphenidate
1623887|NCT00305370|Bipolar Disorder|bipolar disorder
1623888|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
1623889|NCT00305370|ADHD|adhd
1623890|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
1623891|NCT00305357|Acute Herpes Zoster|acute herpes zoster
1623892|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1623893|NCT00305344|Umbilical Cord|umbilical cord
1623894|NCT00305344|Regeneration|regeneration
1623896|NCT00305344|Islets of Langerhans|islets of langerhans
1623897|NCT00305331|Parkinson's disease|parkinson's disease
1623898|NCT00305331|Domperidone|domperidone
1623899|NCT00305331|Peripheral edema|peripheral edema
1623900|NCT00305331|Pramipexole|pramipexole
1623901|NCT00305331|Ropinirole|ropinirole
1623902|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
1623903|NCT00305305|Polymicrogyria|polymicrogyria
1623904|NCT00305305|Dandy-Walker|dandy-walker
1623905|NCT00305305|Brain Malformation|brain malformation
1623906|NCT00305305|Autism|autism
1623907|NCT00305305|Epilepsy|epilepsy
1623908|NCT00305305|Mental Retardation|mental retardation
1623909|NCT00305305|MRI|mri
1623910|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
1623911|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
1623912|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
1623913|NCT00305266|CIDP|cidp
1623914|NCT00305266|IVIG|ivig
1623915|NCT00305266|gammaglobulin|gammaglobulin
1623916|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
1623917|NCT00305253|maternal mortality|maternal mortality
1623918|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
1623919|NCT00305240|Myocardial Infarction|myocardial infarction
1623920|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
1623921|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1623922|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
1623923|NCT00305227|urinary tract infection|urinary tract infection
1623924|NCT00305227|cystitis|cystitis
1623925|NCT00305227|Lactobacillus|lactobacillus
1623926|NCT00305227|probiotic|probiotic
1623927|NCT00305227|prevention|prevention
1623928|NCT00305214|Myocardial Infarction|myocardial infarction
1623929|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
1623930|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1623931|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
1623932|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
1623933|NCT00305201|Kawasaki disease|kawasaki disease
1623934|NCT00305201|Endothelial dysfunction|endothelial dysfunction
1623935|NCT00305201|Pravastatin|pravastatin
1623936|NCT00305201|Statin therapy|statin therapy
1623937|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
1623938|NCT00305188|Paresthesia|paresthesia
1623939|NCT00305188|Oxaliplatin|oxaliplatin
1623940|NCT00305188|Xaliproden|xaliproden
1623941|NCT00305175|Hydroxyurea|hydroxyurea
1623942|NCT00305175|Sickle Cell Anemia|sickle cell anemia
1623943|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
1623944|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1623945|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
1623946|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
1623947|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
1623948|NCT00305149|BEACOPP|beacopp
1623949|NCT00305149|PET|pet
1623950|NCT00305149|Gallium|gallium
1623951|NCT00305149|Tailored therapy|tailored therapy
1623952|NCT00305136|thoracotomy|thoracotomy
1623953|NCT00305136|post-operative pain|post-operative pain
1623954|NCT00305136|chronic pain|chronic pain
1623955|NCT00305136|endogenous analgesia|endogenous analgesia
1623956|NCT00305136|temporal summation|temporal summation
1623957|NCT00305136|central sensitization|central sensitization
1623958|NCT00305136|prediction|prediction
1623959|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
1623960|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
1623961|NCT00305110|Pain|pain
1623962|NCT00305110|Acute|acute
1623963|NCT00305110|Emergency Department|emergency department
1623964|NCT00305110|Severe|severe
1623965|NCT00305110|Hydromorphone|hydromorphone
1623966|NCT00305110|Dilaudid|dilaudid
1623967|NCT00305110|Adult|adult
1623968|NCT00305097|coffee|coffee
1623969|NCT00305097|caffeine|caffeine
1623970|NCT00305097|glucose tolerance|glucose tolerance
1623971|NCT00305097|body weight|body weight
1623972|NCT00305097|insulin sensitivity|insulin sensitivity
1623973|NCT00305097|randomized controlled trial|randomized controlled trial
1623974|NCT00305084|NGR-hTNF|ngr-htnf
1623975|NCT00305084|doxorubicin|doxorubicin
1623976|NCT00305084|solid tumors|solid tumors
1623977|NCT00305071|pyuria|pyuria
1623978|NCT00305071|urinary tract infections|urinary tract infections
1623979|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
1623980|NCT00305058|Elderly|elderly
1623981|NCT00305058|Hydromorphone|hydromorphone
1623982|NCT00305058|Morphine|morphine
1623983|NCT00305058|Pain|pain
1623984|NCT00305058|Acute|acute
1623985|NCT00305058|Emergency Department|emergency department
1623986|NCT00305045|Major Depressive Disorder|major depressive disorder
1623987|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1623988|NCT00305045|Treatment resistance|treatment resistance
1623989|NCT00305006|cerebral palsy|cerebral palsy
1623990|NCT00305006|constraint-induced therapy|constraint-induced therapy
1623991|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
1623992|NCT00305006|CP|cp
1623993|NCT00305006|hemiplegia|hemiplegia
1623994|NCT00305006|hand|hand
1623995|NCT00305006|forced use|forced use
1623996|NCT00305006|motor control|motor control
1623997|NCT00305006|children|children
1623998|NCT00305006|HABIT|habit
1623999|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
1624000|NCT00305006|Bilateral training|bilateral training
1624001|NCT00305006|Bimanual training|bimanual training
1624002|NCT00305006|functional therapy|functional therapy
1624003|NCT00305006|physical therapy|physical therapy
1624004|NCT00305006|occupational therapy|occupational therapy
1624005|NCT00305006|intensive|intensive
1624006|NCT00305006|pediatric|pediatric
1624007|NCT00305006|development|development
1624008|NCT00305006|upper extremity|upper extremity
1624009|NCT00305006|hemiplegic|hemiplegic
1624010|NCT00304993|fenofibrate|fenofibrate
1624011|NCT00304993|niacin|niacin
1624012|NCT00304993|rosiglitazone|rosiglitazone
1624013|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
1624014|NCT00304993|small, dense LDL|small, dense ldl
1624015|NCT00304993|insulin resistance|insulin resistance
1624016|NCT00304993|Metabolic Syndrome|metabolic syndrome
1624017|NCT00304967|Cataract|cataract
1624018|NCT00304967|Normal Lenses|normal lenses
1624019|NCT00304967|Lens Crystallines|lens crystallines
1624020|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
1624021|NCT00304967|Eye Examinations|eye examinations
1624022|NCT00304967|Healthy Volunteer|healthy volunteer
1624023|NCT00304967|HV|hv
1624024|NCT00304967|Eye Examination|eye examination
1624025|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
1624026|NCT00304954|Rapamycin|rapamycin
1624027|NCT00304954|Remicade|remicade
1624028|NCT00304954|Daclizumab|daclizumab
1624029|NCT00304954|Immunosuppression|immunosuppression
1624030|NCT00304954|Infliximab|infliximab
1624031|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
1624032|NCT00304954|Sirolimus|sirolimus
1624033|NCT00304954|AMD|amd
1624034|NCT00304954|Ocular Inflammation|ocular inflammation
1624035|NCT00304941|Breast Cancer|breast cancer
1624036|NCT00304941|Family History|family history
1624037|NCT00304941|Pre/Post Menopausal|pre/post menopausal
1624038|NCT00304941|Prevention|prevention
1624039|NCT00304941|Risk-Factor|risk-factor
1624040|NCT00304941|Body-Mass-Index|body-mass-index
1624041|NCT00304941|BRCA1|brca1
1624042|NCT00304941|Insulin|insulin
1624043|NCT00304941|Genetic Counseling|genetic counseling
1624044|NCT00304941|Penetrance|penetrance
1624045|NCT00304941|Risk Assessment|risk assessment
1624046|NCT00304941|Healthy Volunteer|healthy volunteer
1624047|NCT00304941|HV|hv
1624048|NCT00304915|HIV, depression|hiv, depression
1624049|NCT00304915|patient care management|patient care management
1624050|NCT00304915|patient care team|patient care team
1624051|NCT00304902|MRSA|mrsa
1624052|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1624053|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
1624055|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
1624056|NCT00304863|CDAD|cdad
1625465|NCT00299897|lipid rafts|lipid rafts
1624057|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
1624058|NCT00304850|polyamines|polyamines
1624059|NCT00304850|pain|pain
1624060|NCT00304850|breast cancer|breast cancer
1624061|NCT00304850|mastectomy|mastectomy
1624062|NCT00304850|post operative pain|post operative pain
1624063|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
1624064|NCT00304837|Ischemic rest pain|ischemic rest pain
1624065|NCT00304824|Glaucoma|glaucoma
1624066|NCT00304824|Olfactory functions|olfactory functions
1624067|NCT00304824|Sniffing Sticks Test|sniffing sticks test
1624068|NCT00304811|MRSA|mrsa
1624069|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1624070|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
1624071|NCT00304798|Stroke.|stroke.
1624072|NCT00304798|Hospital admission.|hospital admission.
1624073|NCT00304772|Candida|candida
1624074|NCT00304772|bloodstream infection|bloodstream infection
1624075|NCT00304772|fluconazole|fluconazole
1624076|NCT00304772|micafungin|micafungin
1624077|NCT00304772|randomized controlled trial|randomized controlled trial
1624078|NCT00304759|prostate cancer|prostate cancer
1624079|NCT00304759|localized prostate cancer|localized prostate cancer
1624080|NCT00304759|intermediate risk|intermediate risk
1624081|NCT00304759|prostate specific antigen|prostate specific antigen
1624082|NCT00304759|PSA|psa
1624083|NCT00304759|radiation fractionation|radiation fractionation
1624084|NCT00304759|shorter schedule|shorter schedule
1624085|NCT00304759|quality of life|quality of life
1624086|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
1624087|NCT00304720|Lymphoma|lymphoma
1624088|NCT00304720|Leukemia|leukemia
1624089|NCT00304694|NPC|npc
1624090|NCT00304694|Induction chemotherapy|induction chemotherapy
1624091|NCT00304694|Therapeutic response|therapeutic response
1624092|NCT00304694|18F-FDG PET|18f-fdg pet
1624093|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1624094|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
1624095|NCT00304668|HIV-1|hiv-1
1624096|NCT00304668|HIV Seronegativity|hiv seronegativity
1624097|NCT00304655|Schizophrenia|schizophrenia
1624098|NCT00304655|Schizoaffective disorder|schizoaffective disorder
1624099|NCT00304655|Aripiprazole|aripiprazole
1624100|NCT00304642|HIV-1|hiv-1
1624101|NCT00304642|HIV Seronegativity|hiv seronegativity
1624102|NCT00304629|Alzheimer's disease|alzheimer's disease
1624103|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
1624104|NCT00304629|galantamine|galantamine
1624105|NCT00304616|Schizophrenia|schizophrenia
1624106|NCT00304616|Aripiprazole|aripiprazole
1624107|NCT00304603|Obesity|obesity
1624108|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1624109|NCT00304603|Topiramate|topiramate
1624110|NCT00304603|Pharmacogenomics|pharmacogenomics
1624111|NCT00304603|DNA Polymorphism|dna polymorphism
1624112|NCT00304577|Strabismus|strabismus
1624113|NCT00304577|Esotropia|esotropia
1624114|NCT00304577|Surgical techniques|surgical techniques
1624115|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
1624116|NCT00304551|CHC with compensated LC|chc with compensated lc
1624117|NCT00304538|diabetes|diabetes
1624118|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
1624119|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
1624120|NCT00304525|Raf inhibitor|raf inhibitor
1624121|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
1624122|NCT00304512|Amicus Therapeutics|amicus therapeutics
1624123|NCT00304512|AT1001|at1001
1624124|NCT00304512|Migalastat|migalastat
1624125|NCT00304512|Pharmacokinetics|pharmacokinetics
1624126|NCT00304512|Substrate|substrate
1624127|NCT00304499|OROS®|oros®
1624128|NCT00304499|middle age|middle age
1624129|NCT00304499|elderly|elderly
1624130|NCT00304499|oxybutynin|oxybutynin
1624131|NCT00304499|urinary incontinenence|urinary incontinenence
1624132|NCT00304499|women|women
1624133|NCT00304473|Schizophrenia|schizophrenia
1624134|NCT00304460|Serum Protein Levels|serum protein levels
1624135|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
1624136|NCT00304460|Predictive Analysis|predictive analysis
1624137|NCT00304460|Serum Cytokines|serum cytokines
1624138|NCT00304460|Kidney Cancer|kidney cancer
1624139|NCT00304460|Renal Cell Cancer|renal cell cancer
1624140|NCT00304460|Melanoma|melanoma
1624141|NCT00304460|Metastatic Melanoma|metastatic melanoma
1624142|NCT00304447|Leukemia|leukemia
1624143|NCT00304447|Mylotarg|mylotarg
1624144|NCT00304447|Safety|safety
1624145|NCT00304447|Adverse Events|adverse events
1624146|NCT00304434|Adverse effects|adverse effects
1624147|NCT00304434|Antiviral|antiviral
1624148|NCT00304434|Clinical trial|clinical trial
1624149|NCT00304434|Oseltamivir|oseltamivir
1624150|NCT00304434|Pharmacokinetics|pharmacokinetics
1624151|NCT00304434|Probenecid|probenecid
1624152|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1624153|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
1624154|NCT00304421|Gastric pH|gastric ph
1624155|NCT00304421|Gastric Acid Secretion|gastric acid secretion
1624156|NCT00304408|Clostridium difficile|clostridium difficile
1624157|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
1624158|NCT00304395|CAP|cap
1624159|NCT00304382|Pneumococcus|pneumococcus
1624160|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
1624161|NCT00304369|Clostridium difficile|clostridium difficile
1624162|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
1624163|NCT00304330|gram negative infection|gram negative infection
1624164|NCT00304317|calculi|calculi
1624165|NCT00304317|ureteral calculi|ureteral calculi
1624166|NCT00304317|ureter|ureter
1624167|NCT00304304|child care centers|child care centers
1624168|NCT00304304|asthma triggers|asthma triggers
1624169|NCT00304304|community-based research|community-based research
1624170|NCT00304291|Novantrone|novantrone
1624171|NCT00304278|Head and Neck Cancer|head and neck cancer
1624172|NCT00304278|Erlotinib|erlotinib
1624173|NCT00304278|RADPLAT|radplat
1624174|NCT00304265|Pertussis,|pertussis,
1624175|NCT00304265|Diphtheria,|diphtheria,
1624176|NCT00304265|Tetanus,|tetanus,
1624177|NCT00304265|Poliomyelitis|poliomyelitis
1624178|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
1624179|NCT00304239|Photodynamic therapy|photodynamic therapy
1624180|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
1624181|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
1624182|NCT00304226|Valsartan,|valsartan,
1624183|NCT00304226|amlodipine,|amlodipine,
1624184|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
1624185|NCT00304213|hypogonadism|hypogonadism
1624186|NCT00304213|testosterone|testosterone
1624187|NCT00304213|aging|aging
1624188|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
1624189|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
1624190|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
1624191|NCT00304187|Binge-Eating Disorder|binge-eating disorder
1624192|NCT00304161|Depression|depression
1624193|NCT00304161|Parkinson's Disease|parkinson's disease
1624194|NCT00304161|Atomoxetine|atomoxetine
1624195|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
1624196|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1624197|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1624198|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
1624199|NCT00304096|recurrent breast cancer|recurrent breast cancer
1624200|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
1624201|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
1624202|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
1624203|NCT00304096|stage IV breast cancer|stage iv breast cancer
1624204|NCT00304096|male breast cancer|male breast cancer
1624205|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1624206|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
1624207|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1624208|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1624209|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1624210|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1624211|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
1624212|NCT00304031|adult glioblastoma|adult glioblastoma
1624213|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
1624214|NCT00304031|adult gliosarcoma|adult gliosarcoma
1624215|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1624216|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1624217|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1624218|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1624219|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1624220|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1624221|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1624222|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1624223|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
1624224|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1624225|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1624226|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1624227|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1624228|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1624229|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
1624230|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
1624231|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1624232|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1624233|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1624234|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1624235|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1624236|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1625466|NCT00299897|cholesterol|cholesterol
1624237|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1624238|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1624239|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1624240|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1624241|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1624242|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1624243|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1624244|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1624245|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1624246|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1624247|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1624248|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1624249|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1624250|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1624251|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
1624252|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1624253|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1624254|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1624255|NCT00303992|stage IV breast cancer|stage iv breast cancer
1624256|NCT00303992|recurrent breast cancer|recurrent breast cancer
1624257|NCT00303979|Systolic Heart Failure|systolic heart failure
1624258|NCT00303979|Quality of Care|quality of care
1624259|NCT00303979|Outcomes|outcomes
1624260|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
1624261|NCT00303979|Recommended Therapies|recommended therapies
1624262|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1624263|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1624264|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1624265|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1624266|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
1624267|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
1624268|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1624269|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1624270|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
1624271|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1624272|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1624273|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1624274|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
1624275|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1624276|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1624277|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1624278|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1624279|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1624280|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
1624281|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
1624282|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1624283|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1624284|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
1624285|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1624286|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
1624287|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1624288|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
1624289|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
1624290|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
1624291|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1624292|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1624293|NCT00303940|childhood teratoma|childhood teratoma
1624294|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
1624295|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
1624297|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1624298|NCT00303914|cognitive/functional effects|cognitive/functional effects
1624299|NCT00303914|recurrent breast cancer|recurrent breast cancer
1624300|NCT00303914|stage I breast cancer|stage i breast cancer
1624301|NCT00303914|stage II breast cancer|stage ii breast cancer
1624302|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
1624303|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
1624304|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
1624305|NCT00303914|stage IV breast cancer|stage iv breast cancer
1624306|NCT00303914|recurrent colon cancer|recurrent colon cancer
1624307|NCT00303914|stage I colon cancer|stage i colon cancer
1624308|NCT00303914|stage II colon cancer|stage ii colon cancer
1624309|NCT00303914|stage III colon cancer|stage iii colon cancer
1624310|NCT00303914|stage IV colon cancer|stage iv colon cancer
1624311|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
1624312|NCT00303914|stage I rectal cancer|stage i rectal cancer
1624313|NCT00303914|stage II rectal cancer|stage ii rectal cancer
1624314|NCT00303914|stage III rectal cancer|stage iii rectal cancer
1624315|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
1624316|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1624317|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
1624318|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
1624319|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1624320|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1624321|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1624322|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1624323|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1624324|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1624325|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
1624326|NCT00303914|stage I prostate cancer|stage i prostate cancer
1624327|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
1624328|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
1624329|NCT00303914|stage III prostate cancer|stage iii prostate cancer
1624330|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
1624331|NCT00303914|male breast cancer|male breast cancer
1624332|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1624333|NCT00303901|lung metastases|lung metastases
1624334|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1624335|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
1624336|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1624337|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1624338|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1624339|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1624340|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1624341|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1624342|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
1624343|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1624344|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1624345|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1624346|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1624347|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1624348|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1624349|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1624350|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1624351|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1624352|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1624353|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1624354|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1624355|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1624356|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1624357|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1624358|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1624359|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
1624360|NCT00303875|stage I prostate cancer|stage i prostate cancer
1624361|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
1624362|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
1624363|NCT00303875|stage III prostate cancer|stage iii prostate cancer
1624364|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
1624365|NCT00303875|recurrent breast cancer|recurrent breast cancer
1624366|NCT00303875|stage I breast cancer|stage i breast cancer
1624367|NCT00303875|stage II breast cancer|stage ii breast cancer
1624368|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
1624369|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
1624370|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
1624371|NCT00303875|stage IV breast cancer|stage iv breast cancer
1624372|NCT00303875|recurrent colon cancer|recurrent colon cancer
1624373|NCT00303875|stage I colon cancer|stage i colon cancer
1624374|NCT00303875|stage II colon cancer|stage ii colon cancer
1624375|NCT00303875|stage III colon cancer|stage iii colon cancer
1624376|NCT00303875|stage IV colon cancer|stage iv colon cancer
1624377|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
1624378|NCT00303875|stage I rectal cancer|stage i rectal cancer
1624379|NCT00303875|stage II rectal cancer|stage ii rectal cancer
1624380|NCT00303875|stage III rectal cancer|stage iii rectal cancer
1624381|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
1624382|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1625467|NCT00299897|chemokine|chemokine
1624383|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1624384|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1624385|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1624386|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1624387|NCT00303784|hot flashes|hot flashes
1624388|NCT00303784|anemia|anemia
1624389|NCT00303784|osteoporosis|osteoporosis
1624390|NCT00303784|cardiovascular complications|cardiovascular complications
1624391|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
1624392|NCT00303784|stage III prostate cancer|stage iii prostate cancer
1624393|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
1624394|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1624395|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1624396|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
1624397|NCT00303771|stage IV colon cancer|stage iv colon cancer
1624398|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
1624399|NCT00303771|recurrent colon cancer|recurrent colon cancer
1624400|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
1624401|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1624402|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
1624403|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
1624404|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
1624405|NCT00303745|recurrent colon cancer|recurrent colon cancer
1624406|NCT00303745|stage IV colon cancer|stage iv colon cancer
1624407|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1624408|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
1624409|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
1624410|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1624411|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
1624412|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
1624413|NCT00303719|leukemia|leukemia
1624414|NCT00303719|lymphoma|lymphoma
1624415|NCT00303719|myeloma|myeloma
1624416|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
1624417|NCT00303706|Radial Artery Conduit|radial artery conduit
1624418|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1624419|NCT00303706|Endoscopic technique|endoscopic technique
1624420|NCT00303667|NK cells|nk cells
1624421|NCT00303667|natural killer cells|natural killer cells
1624422|NCT00303667|immunotherapy|immunotherapy
1624423|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
1624424|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
1624425|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
1624426|NCT00303654|stage I bladder cancer|stage i bladder cancer
1624427|NCT00303654|stage II bladder cancer|stage ii bladder cancer
1624428|NCT00303654|stage III bladder cancer|stage iii bladder cancer
1624429|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
1624430|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
1624431|NCT00303641|Inflammatory reaction|inflammatory reaction
1624432|NCT00303628|Rectal cancer|rectal cancer
1624433|NCT00303628|Bevacizumab|bevacizumab
1624434|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
1624435|NCT00303576|HIV-1|hiv-1
1624436|NCT00303576|HIV Seronegativity|hiv seronegativity
1624437|NCT00303550|skin infection|skin infection
1624438|NCT00303550|complicated skin infection|complicated skin infection
1624439|NCT00303550|skin structure infection|skin structure infection
1624440|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
1624441|NCT00303537|hepatitis|hepatitis
1624442|NCT00303537|metformin|metformin
1624443|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
1624444|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
1624445|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1624446|NCT00303511|adult|adult
1624447|NCT00303511|pacemaker|pacemaker
1624448|NCT00303511|bradycardia|bradycardia
1624449|NCT00303511|tachycardia|tachycardia
1624450|NCT00303511|heart failure|heart failure
1624451|NCT00303472|MDS|mds
1624452|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
1624453|NCT00303472|Refractory Cytopenias|refractory cytopenias
1624454|NCT00303472|Thrombocytopenia|thrombocytopenia
1624455|NCT00303459|sildenafil|sildenafil
1624456|NCT00303459|Combination Drug Therapy|combination drug therapy
1624457|NCT00303459|bosentan|bosentan
1624458|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
1624459|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1624460|NCT00303459|Multicenter Study|multicenter study
1624461|NCT00303459|Antihypertensive Agents|antihypertensive agents
1624462|NCT00303459|Tracleer|tracleer
1624463|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
1624464|NCT00303459|Randomized Controlled Trial|randomized controlled trial
1624465|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
1624466|NCT00303459|Outcome Assessment|outcome assessment
1624467|NCT00303446|Motor Neuron|motor neuron
1624468|NCT00303446|Androgen Receptor|androgen receptor
1624469|NCT00303446|Polyglutamine|polyglutamine
1624470|NCT00303446|X-Linked|x-linked
1624471|NCT00303446|Ligand Dependency|ligand dependency
1624472|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
1624473|NCT00303446|SBMA|sbma
1624474|NCT00303446|Kennedy Disease|kennedy disease
1624475|NCT00303433|Prevention|prevention
1624476|NCT00303433|Post-Operative tates|post-operative tates
1624477|NCT00303433|Delirium|delirium
1624478|NCT00303433|Namenda|namenda
1624479|NCT00303420|catheter|catheter
1624480|NCT00303420|hemodialysis|hemodialysis
1624481|NCT00303420|dysfunction|dysfunction
1624482|NCT00303420|thrombolytic|thrombolytic
1624483|NCT00303420|alteplase|alteplase
1624484|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
1624485|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
1624486|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
1624487|NCT00303355|jugular venous pulse|jugular venous pulse
1624488|NCT00303342|sleep|sleep
1624489|NCT00303342|arousal|arousal
1624490|NCT00303342|stress|stress
1624491|NCT00303342|cortisol|cortisol
1624492|NCT00303342|catecholamines|catecholamines
1624493|NCT00303329|β-thalassemia|β-thalassemia
1624494|NCT00303329|rare chronic anemia|rare chronic anemia
1624495|NCT00303329|iron overload|iron overload
1624496|NCT00303329|deferasirox|deferasirox
1624497|NCT00303329|chronic anemias|chronic anemias
1624498|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
1624499|NCT00303316|Diphtheria|diphtheria
1624500|NCT00303316|Tetanus|tetanus
1624501|NCT00303316|Pertussis|pertussis
1624502|NCT00303316|whooping cough|whooping cough
1624503|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
1624504|NCT00303316|Hepatitis B|hepatitis b
1624505|NCT00303316|Poliomyelitis|poliomyelitis
1624506|NCT00303303|Snake envenomation|snake envenomation
1624507|NCT00303303|Antivenins|antivenins
1624508|NCT00303303|Disability evaluation|disability evaluation
1624509|NCT00303303|Activities of daily living|activities of daily living
1624510|NCT00303290|Early Chronic Phase CML|early chronic phase cml
1624511|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
1624512|NCT00303290|Peg Intron|peg intron
1624513|NCT00303290|Ara-C|ara-c
1624514|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
1624515|NCT00303277|Alzheimer's disease|alzheimer's disease
1624516|NCT00303277|beta-amyloid|beta-amyloid
1624517|NCT00303277|statins|statins
1624518|NCT00303264|functional dyspepsia|functional dyspepsia
1624519|NCT00303264|cholecystokinin|cholecystokinin
1624521|NCT00303264|gastrointestinal|gastrointestinal
1624522|NCT00303264|intestinal transit|intestinal transit
1624523|NCT00303264|GI motility|gi motility
1624524|NCT00303264|bloating|bloating
1624525|NCT00303264|upper GI discomfort|upper gi discomfort
1624526|NCT00303264|upper GI|upper gi
1624527|NCT00303264|early satiety|early satiety
1624528|NCT00303264|nausea|nausea
1624529|NCT00303264|belching|belching
1624530|NCT00303264|retching|retching
1624531|NCT00303264|vomiting|vomiting
1624532|NCT00303264|GERD|gerd
1624533|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
1624534|NCT00303238|Inflammation|inflammation
1624535|NCT00303238|Interleukin-1|interleukin-1
1624536|NCT00303238|C-reactive protein|c-reactive protein
1624537|NCT00303238|Genotype|genotype
1624538|NCT00303238|Rose Hips|rose hips
1624539|NCT00303238|Blueberry|blueberry
1624540|NCT00303238|Blackberry|blackberry
1624541|NCT00303238|Aframomum melegueta|aframomum melegueta
1624542|NCT00303238|Resveravine|resveravine
1624543|NCT00303225|Biodefense|biodefense
1624544|NCT00303225|Smallpox|smallpox
1624545|NCT00303225|Monkeypox|monkeypox
1624546|NCT00303225|Vaccinia|vaccinia
1624547|NCT00303225|Prophylaxis|prophylaxis
1624548|NCT00303225|Healthy Volunteer|healthy volunteer
1624549|NCT00303225|HV|hv
1624550|NCT00303212|heart failure|heart failure
1624551|NCT00303212|CHF|chf
1624552|NCT00303212|telemedicine|telemedicine
1624553|NCT00303212|disease management|disease management
1624554|NCT00303199|Multiple Myeloma|multiple myeloma
1624555|NCT00303199|Arsenic|arsenic
1624556|NCT00303199|Cancer study|cancer study
1624557|NCT00303199|Failed treatment|failed treatment
1624558|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
1624559|NCT00303173|Pre-eclampsia|pre-eclampsia
1624560|NCT00303173|hypertension|hypertension
1624561|NCT00303173|blood pressure|blood pressure
1624562|NCT00303173|pregnancy|pregnancy
1624563|NCT00303173|randomized clinical trial|randomized clinical trial
1624564|NCT00303173|guided imagery|guided imagery
1624565|NCT00303173|relaxation|relaxation
1624566|NCT00303173|psychophysiology|psychophysiology
1624567|NCT00303173|mind-body|mind-body
1624568|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
1624569|NCT00303160|reactive oxygen species|reactive oxygen species
1624570|NCT00303160|antioxidants|antioxidants
1624571|NCT00303147|Expressive Writing|expressive writing
1624572|NCT00303147|Written Emotional Expression|written emotional expression
1624573|NCT00303147|Caregiver Stress|caregiver stress
1624574|NCT00303147|Cognition|cognition
1624575|NCT00303134|islet cell|islet cell
1624576|NCT00303134|diabetes|diabetes
1624578|NCT00303134|immunosuppression|immunosuppression
1624579|NCT00303134|autoimmunity|autoimmunity
1624785|NCT00302185|Acupuncture|acupuncture
1624580|NCT00303134|alloimmunity|alloimmunity
1624581|NCT00303121|Glaucoma|glaucoma
1624582|NCT00303121|Compliance|compliance
1624584|NCT00303121|Administration technique|administration technique
1624585|NCT00303082|Probiotics|probiotics
1624586|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
1624587|NCT00303082|Premature birth|premature birth
1624588|NCT00303082|Intra-uterine Infection|intra-uterine infection
1624589|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
1624590|NCT00303069|S. aureus;|s. aureus;
1624591|NCT00303069|Vaccine|vaccine
1624592|NCT00303069|FIM|fim
1624593|NCT00303056|Osteoarthritis|osteoarthritis
1624594|NCT00303056|knee|knee
1624595|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
1624596|NCT00303043|Mixed venous saturation|mixed venous saturation
1624597|NCT00303043|Critically ill patients|critically ill patients
1624598|NCT00303030|Fecal incontinence|fecal incontinence
1624599|NCT00303030|Biofeedback|biofeedback
1624600|NCT00303030|Patient Satisfaction|patient satisfaction
1624601|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
1624602|NCT00303030|Injections|injections
1624603|NCT00302991|Observational|observational
1624604|NCT00302991|cross-sectional|cross-sectional
1624605|NCT00302991|health-related quality of life|health-related quality of life
1624606|NCT00302991|adverse effects|adverse effects
1624607|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
1624608|NCT00302991|epilepsy|epilepsy
1624609|NCT00302978|Height phobia|height phobia
1624610|NCT00302978|fear of heights|fear of heights
1624611|NCT00302978|specific phobia|specific phobia
1624612|NCT00302965|Plasma|plasma
1624613|NCT00302965|Trauma|trauma
1624614|NCT00302965|Critical Care|critical care
1624615|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
1624616|NCT00302939|Aging|aging
1624617|NCT00302926|Weight loss|weight loss
1624618|NCT00302926|obesity|obesity
1624619|NCT00302926|energy restriction|energy restriction
1624620|NCT00302913|Clopidogrel|clopidogrel
1624621|NCT00302913|Coronary Artery Disease|coronary artery disease
1624622|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
1624623|NCT00302913|Drug Resistance|drug resistance
1624624|NCT00302913|PCI|pci
1624625|NCT00302900|Blood Donation|blood donation
1624626|NCT00302900|Syncope|syncope
1624627|NCT00302900|Vasovagal Reactions|vasovagal reactions
1624628|NCT00302887|fibromyalgia|fibromyalgia
1624629|NCT00302887|connective tissue manipulation|connective tissue manipulation
1624630|NCT00302887|ultrasound therapy|ultrasound therapy
1624631|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
1624632|NCT00302874|diabetes|diabetes
1624633|NCT00302874|hyperglycemia|hyperglycemia
1624634|NCT00302874|hospital|hospital
1624635|NCT00302874|medicine ward|medicine ward
1624636|NCT00302861|B-Cll|b-cll
1624637|NCT00302848|Venous thromboembolism|venous thromboembolism
1624638|NCT00302848|Drospirenone|drospirenone
1624639|NCT00302835|Analgesics|analgesics
1624640|NCT00302835|Chronic Kidney Failure|chronic kidney failure
1624641|NCT00302822|HIV infections|hiv infections
1624642|NCT00302822|Fuzeon|fuzeon
1624643|NCT00302822|Truvada|truvada
1624644|NCT00302822|AIDS|aids
1624645|NCT00302822|Treatment Naive|treatment naive
1624646|NCT00302809|Flavonoids|flavonoids
1624647|NCT00302809|Arterial stiffness|arterial stiffness
1624648|NCT00302809|Blood pressure|blood pressure
1624649|NCT00302809|Endothelium|endothelium
1624650|NCT00302809|Inflammation|inflammation
1624651|NCT00302796|Low Back Pain,|low back pain,
1624652|NCT00302783|Education, Medical|education, medical
1624653|NCT00302783|Education, Competency-Based|education, competency-based
1624654|NCT00302783|Multi-Source Feedback|multi-source feedback
1624655|NCT00302783|Communication|communication
1624656|NCT00302783|Professionalism|professionalism
1624657|NCT00302770|Patients with SAD|patients with sad
1624658|NCT00302757|NHL|nhl
1624659|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
1624660|NCT00302744|Anxiety|anxiety
1624661|NCT00302744|Depression|depression
1624662|NCT00302744|Mood|mood
1624663|NCT00302744|Cancer|cancer
1624664|NCT00302744|Quality of Life|quality of life
1624665|NCT00302744|Psychiatric|psychiatric
1624666|NCT00302744|Psilocybin|psilocybin
1624667|NCT00302744|Alternative|alternative
1624668|NCT00302744|Los Angeles|los angeles
1624669|NCT00302718|Physician Incentive Plan|physician incentive plan
1624670|NCT00302718|Quality of Health Care|quality of health care
1624671|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
1624672|NCT00302718|Randomized Controlled Trial|randomized controlled trial
1624673|NCT00302718|Physicians|physicians
1624674|NCT00302718|Reward|reward
1624675|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1624676|NCT00302705|Valsartan|valsartan
1624677|NCT00302705|Enalapril|enalapril
1624678|NCT00302705|Missing dose|missing dose
1624679|NCT00302679|Colonoscopy|colonoscopy
1624680|NCT00302679|Sigmoidoscopy|sigmoidoscopy
1624681|NCT00302679|Colon cancer screening|colon cancer screening
1624684|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
1624685|NCT00302627|bisphosphonates|bisphosphonates
1624686|NCT00302627|vitamin D|vitamin d
1624687|NCT00302627|calcium supplement|calcium supplement
1624688|NCT00302627|corticosteroid therapy|corticosteroid therapy
1624689|NCT00302627|fractures|fractures
1624690|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
1624692|NCT00302614|collapsibility|collapsibility
1624693|NCT00302614|upper airway|upper airway
1624694|NCT00302601|Pulmonary embolism|pulmonary embolism
1624695|NCT00302601|Right heart strain|right heart strain
1624696|NCT00302601|Lung scintigraphy|lung scintigraphy
1624697|NCT00302601|Pulmonary angiography|pulmonary angiography
1624698|NCT00302588|metastatic carcinoma|metastatic carcinoma
1624699|NCT00302588|cervical lymph nodes|cervical lymph nodes
1624700|NCT00302588|unknown primary|unknown primary
1624701|NCT00302588|diagnosis|diagnosis
1624702|NCT00302588|result|result
1624703|NCT00302575|Substance-Related Disorders|substance-related disorders
1624704|NCT00302575|Prisoners|prisoners
1624705|NCT00302562|laryngeal cancer|laryngeal cancer
1624706|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
1624707|NCT00302562|CXCR4|cxcr4
1624708|NCT00302562|CXCL12|cxcl12
1624709|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
1624710|NCT00302562|metastasis|metastasis
1624711|NCT00302549|Tacrolimus|tacrolimus
1624712|NCT00302549|Cyclophosphamide|cyclophosphamide
1624713|NCT00302549|Treatment|treatment
1624714|NCT00302549|Lupus Nephritis|lupus nephritis
1624715|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
1624716|NCT00302536|Treatment|treatment
1624717|NCT00302536|Steroids|steroids
1624718|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
1624719|NCT00302523|Treatment|treatment
1624720|NCT00302523|Tacrolimus|tacrolimus
1624721|NCT00302523|Cyclophosphamide|cyclophosphamide
1624722|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
1624723|NCT00302510|treatment|treatment
1624724|NCT00302510|immunoadsorption|immunoadsorption
1624725|NCT00302510|apolipoprotein E|apolipoprotein e
1624726|NCT00302458|healthy volunteers|healthy volunteers
1624727|NCT00302432|smoking reduction|smoking reduction
1624728|NCT00302432|group therapy|group therapy
1624729|NCT00302432|cigarette holders|cigarette holders
1624730|NCT00302432|"Flowers Menthol"|"flowers menthol"
1624731|NCT00302419|Acute myocardial infarction|acute myocardial infarction
1624732|NCT00302419|primary angioplasty|primary angioplasty
1624733|NCT00302419|streptokinase|streptokinase
1624734|NCT00302419|microvasculature|microvasculature
1624735|NCT00302393|healthy volunteers|healthy volunteers
1624736|NCT00302341|Pulmonary disease|pulmonary disease
1624737|NCT00302341|Dyspnea|dyspnea
1624738|NCT00302341|Hypoxemia|hypoxemia
1624739|NCT00302341|AIDS|aids
1624740|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
1624741|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
1624742|NCT00302315|incisional pain|incisional pain
1624743|NCT00302315|functional activity|functional activity
1624744|NCT00302315|connective tissue manipulation|connective tissue manipulation
1624745|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1624746|NCT00302302|Blood glucose|blood glucose
1624747|NCT00302302|Insulin|insulin
1624748|NCT00302302|Triglyceride|triglyceride
1624749|NCT00302302|GIP|gip
1624750|NCT00302302|GLP-1|glp-1
1624751|NCT00302302|L-arabinose|l-arabinose
1624752|NCT00302302|Appetite|appetite
1624753|NCT00302302|Energy intake|energy intake
1624754|NCT00302289|green tea|green tea
1624755|NCT00302289|caffeine|caffeine
1624756|NCT00302289|tyrosine|tyrosine
1624757|NCT00302289|energy expenditure|energy expenditure
1624758|NCT00302289|energy intake|energy intake
1624759|NCT00302276|Body fat loss|body fat loss
1624760|NCT00302276|energy expenditure|energy expenditure
1624761|NCT00302276|capsaicin|capsaicin
1624762|NCT00302276|caffeine|caffeine
1624763|NCT00302276|green tea|green tea
1624764|NCT00302276|calcium|calcium
1624765|NCT00302276|fecal fat|fecal fat
1624766|NCT00302276|fecal energy|fecal energy
1624767|NCT00302263|Green tea|green tea
1624768|NCT00302263|capsaicin|capsaicin
1624769|NCT00302263|tyrosine|tyrosine
1624770|NCT00302263|caffeine|caffeine
1624771|NCT00302263|energy expenditure|energy expenditure
1624772|NCT00302263|catecholamines|catecholamines
1624773|NCT00302250|Cardiovascular|cardiovascular
1624774|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
1624775|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
1624776|NCT00302250|Endothelial function|endothelial function
1624777|NCT00302250|Heart failure|heart failure
1624778|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
1624779|NCT00302224|safety|safety
1624780|NCT00302224|type 2 diabetes|type 2 diabetes
1624781|NCT00302211|PAH|pah
1624782|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1624783|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1624784|NCT00302185|Palliative Care|palliative care
1624786|NCT00302185|Symptom Management|symptom management
1624787|NCT00302185|Quality of Life|quality of life
1624788|NCT00302172|Cancer|cancer
1624789|NCT00302172|solid tumor|solid tumor
1624790|NCT00302172|metastatic|metastatic
1624791|NCT00302172|primary tumor|primary tumor
1624792|NCT00302159|Chemotherapy|chemotherapy
1624793|NCT00302159|Radiation|radiation
1624794|NCT00302159|Brain Tumor|brain tumor
1624795|NCT00302159|GBM|gbm
1624796|NCT00302159|Radiosensitizer|radiosensitizer
1624797|NCT00302159|Glioblastoma|glioblastoma
1624798|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
1624799|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
1624800|NCT00302146|Carrier|carrier
1624801|NCT00302146|L-Dopa Uptake|l-dopa uptake
1624802|NCT00302146|Glucocerebrosidase|glucocerebrosidase
1624803|NCT00302146|Pathogenesis|pathogenesis
1624804|NCT00302146|Carbidopa|carbidopa
1624805|NCT00302146|Gaucher Disease|gaucher disease
1624806|NCT00302146|Parkinson Disease|parkinson disease
1624807|NCT00302146|[O-15]-Water|[o-15]-water
1624808|NCT00302146|6-[F-18]Fluoro-L-dopa|6-[f-18]fluoro-l-dopa
1624809|NCT00302146|Healthy Volunteer|healthy volunteer
1624810|NCT00302146|HV|hv
1624811|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
1624812|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
1624813|NCT00302120|Breast Neoplasms|breast neoplasms
1624814|NCT00302120|Diagnostic Trial|diagnostic trial
1624815|NCT00302107|Mirtazapine|mirtazapine
1624816|NCT00302107|PTSD|ptsd
1624817|NCT00302107|Veterans|veterans
1624818|NCT00302107|antidepressant|antidepressant
1624819|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
1624820|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
1624821|NCT00302068|Exercise|exercise
1624822|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
1625605|NCT00299468|home care|home care
1624823|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
1624824|NCT00302016|AMN 107|amn 107
1624825|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
1624826|NCT00302016|nilotinib|nilotinib
1624827|NCT00302016|enact|enact
1624828|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
1624829|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
1624830|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1624831|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1624832|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1624833|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1624834|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1624835|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1624836|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1624837|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1624838|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1624839|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1624840|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1624841|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1624842|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1624843|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1624844|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1624845|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1624846|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1624847|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1624848|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1624849|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1624850|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1624851|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1624852|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1624853|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1624854|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1624855|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1624856|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1624857|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1624858|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1624859|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1624860|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1624861|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1624862|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1624863|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
1624864|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1624865|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1624866|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1624867|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1624868|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
1624869|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
1624870|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1624871|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1624872|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1624873|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1624874|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1624875|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1624876|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1624877|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1624878|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1624879|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
1624880|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1624881|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1624882|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1624883|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1624884|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1624885|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1624886|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1624887|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1624888|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1624889|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1625903|NCT00298350|ART|art
1624890|NCT00301925|stage I breast cancer|stage i breast cancer
1624891|NCT00301925|stage II breast cancer|stage ii breast cancer
1624892|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
1624893|NCT00301925|male breast cancer|male breast cancer
1624894|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1624895|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1624896|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1624897|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1624898|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1624899|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1624900|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1624901|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1624902|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1624903|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1624904|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1624905|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1624906|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1624907|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1624908|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1624909|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1624910|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1624911|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1624912|NCT00301912|anemia|anemia
1624913|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1624914|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1624915|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1624916|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1624917|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
1624918|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
1624919|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
1624920|NCT00301912|polycythemia vera|polycythemia vera
1624921|NCT00301912|essential thrombocythemia|essential thrombocythemia
1624922|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1624923|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1624924|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1624925|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1624926|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1624927|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1624928|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1624929|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1624930|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1624931|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1625360|NCT00300222|shingles|shingles
1625163|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
1624932|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1624933|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1624934|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1624935|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1624936|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1624937|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1624938|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1624939|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1624940|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1624941|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1624942|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1624943|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1624944|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1624945|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1624946|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1624947|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1624948|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1624949|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1624950|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1624951|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1625904|NCT00298350|ARV|arv
1624952|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1624953|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1624954|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1624955|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1624956|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1624957|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1624958|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1624959|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1624960|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1624961|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1624962|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1624963|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1624964|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1624965|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1625065|NCT00301626|nicotine|nicotine
1624966|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1624967|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1624968|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1624969|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1624970|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1624971|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1624972|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1624973|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1624974|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1624975|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1624976|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1624977|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1624978|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
1624979|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1624980|NCT00301899|recurrent breast cancer|recurrent breast cancer
1624981|NCT00301899|male breast cancer|male breast cancer
1624982|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
1624983|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
1624984|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
1624985|NCT00301899|stage IV breast cancer|stage iv breast cancer
1624986|NCT00301886|pain|pain
1624987|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
1624988|NCT00301886|stage IV breast cancer|stage iv breast cancer
1624989|NCT00301886|bone metastases|bone metastases
1624990|NCT00301886|recurrent breast cancer|recurrent breast cancer
1624991|NCT00301873|osteoporosis|osteoporosis
1624992|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1624993|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
1624994|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1624995|NCT00301873|adult gliosarcoma|adult gliosarcoma
1624996|NCT00301873|adult mixed glioma|adult mixed glioma
1624997|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
1624998|NCT00301873|adult glioblastoma|adult glioblastoma
1625361|NCT00300222|neuropathy|neuropathy
1624999|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1625000|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1625001|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1625002|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1625003|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1625004|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1625005|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1625006|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1625007|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1625008|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1625009|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1625010|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1625011|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1625012|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
1625013|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
1625014|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
1625015|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1625016|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1625017|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1625018|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1625019|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1626108|NCT00297362|Dementia|dementia
1625020|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
1625021|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
1625022|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
1625023|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1625024|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1625025|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1625026|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1625027|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1625028|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1625029|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1625030|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1625031|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1625032|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1625033|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1625034|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1625035|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
1625036|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1625037|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1625038|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
1625039|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
1625040|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1625041|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1625042|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1625043|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1625044|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1625045|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1625046|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
1625047|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
1625048|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1625049|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1625050|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1625051|NCT00301782|testicular immature teratoma|testicular immature teratoma
1625052|NCT00301782|testicular mature teratoma|testicular mature teratoma
1625053|NCT00301782|adult teratoma|adult teratoma
1625054|NCT00301730|lung metastases|lung metastases
1625055|NCT00301730|stage IV breast cancer|stage iv breast cancer
1625056|NCT00301730|recurrent breast cancer|recurrent breast cancer
1625057|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1625058|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1625059|NCT00301652|ANCA|anca
1625060|NCT00301652|vasculitis|vasculitis
1625061|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
1625062|NCT00301652|cyclophosphamide|cyclophosphamide
1625063|NCT00301652|treatment|treatment
1625064|NCT00301626|tobacco|tobacco
1625066|NCT00301626|smoking reduction|smoking reduction
1625067|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
1625068|NCT00301613|Cyclophosphamide|cyclophosphamide
1625069|NCT00301613|treatment|treatment
1625070|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
1625071|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
1625072|NCT00301600|Cyclophosphamide|cyclophosphamide
1625073|NCT00301600|treatment|treatment
1625074|NCT00301587|spina bifida|spina bifida
1625075|NCT00301587|birth defects|birth defects
1625076|NCT00301587|folic acid|folic acid
1625077|NCT00301587|nervous system diseases|nervous system diseases
1625078|NCT00301587|folate|folate
1625079|NCT00301587|Vitamin B|vitamin b
1625080|NCT00301574|Alzheimer's disease|alzheimer's disease
1625081|NCT00301574|Cognitive dysfunction|cognitive dysfunction
1625082|NCT00301561|Antiretroviral treatment|antiretroviral treatment
1625083|NCT00301561|Expanded access|expanded access
1625084|NCT00301561|Africa|africa
1625085|NCT00301561|Treatment Naive|treatment naive
1625086|NCT00301548|antineoplastic protocols|antineoplastic protocols
1625087|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
1625088|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
1625089|NCT00301548|fluorouracil|fluorouracil
1625090|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
1625091|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
1625092|NCT00301535|side effects of bypass|side effects of bypass
1625093|NCT00301522|Coronary|coronary
1625094|NCT00301522|Artery|artery
1625095|NCT00301522|Stenosis|stenosis
1625096|NCT00301522|Drug-eluting|drug-eluting
1625097|NCT00301522|stent|stent
1625098|NCT00301522|restenosis|restenosis
1625099|NCT00301522|revascularization|revascularization
1625100|NCT00301483|multiple trauma|multiple trauma
1625101|NCT00301483|bleeding injuries|bleeding injuries
1625102|NCT00301483|gunshot wounds|gunshot wounds
1625103|NCT00301483|stab wounds|stab wounds
1625104|NCT00301483|penetrating injuries|penetrating injuries
1625105|NCT00301483|blunt trauma|blunt trauma
1625106|NCT00301483|multiple wounds|multiple wounds
1625107|NCT00301470|Ureter, obstruction|ureter, obstruction
1625108|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
1625109|NCT00301470|MRI, functional|mri, functional
1625110|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
1625111|NCT00301457|Adjuvant Treatment|adjuvant treatment
1625112|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
1625113|NCT00301444|phantom limb pain|phantom limb pain
1625114|NCT00301444|limb amputation|limb amputation
1625115|NCT00301431|Fibromyalgia|fibromyalgia
1625116|NCT00301431|Adults|adults
1625117|NCT00301431|Outpatients|outpatients
1625118|NCT00301431|Adult|adult
1625119|NCT00301431|Double-Blind Method|double-blind method
1625120|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
1625121|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
1625122|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
1625123|NCT00301418|Brain Tumor|brain tumor
1625124|NCT00301405|prostatitis|prostatitis
1625125|NCT00301405|pelvic pain|pelvic pain
1625126|NCT00301392|Glucose intolerance|glucose intolerance
1625127|NCT00301392|Diabetes mellitus|diabetes mellitus
1625128|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
1625129|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
1625130|NCT00301379|Observational|observational
1625131|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
1625132|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
1625133|NCT00301366|pulmonary emphysema|pulmonary emphysema
1625134|NCT00301353|early menopause|early menopause
1625135|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
1625136|NCT00301353|bone metabolism|bone metabolism
1625137|NCT00301353|bone mineral density|bone mineral density
1625138|NCT00301353|hormones|hormones
1625139|NCT00301249|Diabetes|diabetes
1625140|NCT00301249|Nephropathy|nephropathy
1625141|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
1625142|NCT00301249|Genome Scan|genome scan
1625143|NCT00301249|Genetic Research|genetic research
1625144|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
1625145|NCT00301197|Childhood obesity|childhood obesity
1625146|NCT00301197|intervention|intervention
1625147|NCT00301197|obesity|obesity
1625148|NCT00301197|weight loss|weight loss
1625149|NCT00301197|behavior therapy|behavior therapy
1625150|NCT00301197|peer group|peer group
1625151|NCT00301197|social support network|social support network
1625152|NCT00301197|child|child
1625153|NCT00301197|clinical research|clinical research
1625154|NCT00301197|human subject|human subject
1625155|NCT00301184|HIV Seronegativity|hiv seronegativity
1625156|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
1625157|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
1625158|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
1625159|NCT00301171|Wheezing|wheezing
1625160|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1625161|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1625162|NCT00301119|small cell lung cancer|small cell lung cancer
1625362|NCT00300222|analgesics|analgesics
1625164|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
1625165|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
1625166|NCT00301106|stage IV breast cancer|stage iv breast cancer
1625167|NCT00301106|liver metastases|liver metastases
1625168|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1625169|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1625170|NCT00301080|pain|pain
1625171|NCT00301080|neurotoxicity|neurotoxicity
1625172|NCT00301080|breast cancer|breast cancer
1625173|NCT00301067|stage IV melanoma|stage iv melanoma
1625174|NCT00301067|recurrent melanoma|recurrent melanoma
1625175|NCT00301054|Anaemia|anaemia
1625176|NCT00301054|Malaria|malaria
1625177|NCT00301054|Rural Area in Ghana|rural area in ghana
1625178|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1625179|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1625180|NCT00301041|stage I breast cancer|stage i breast cancer
1625181|NCT00301041|stage II breast cancer|stage ii breast cancer
1625182|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
1625183|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1625184|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1625185|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1625186|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1625187|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1625188|NCT00301002|safety|safety
1626221|NCT00297115|Roflumilast|roflumilast
1625189|NCT00301002|effectiveness|effectiveness
1625190|NCT00301002|Alefacept|alefacept
1625191|NCT00301002|Palmar|palmar
1625192|NCT00301002|Plantar|plantar
1625193|NCT00301002|Pustulosis|pustulosis
1625194|NCT00300976|Blood glucose|blood glucose
1625195|NCT00300976|Blood pressure|blood pressure
1625196|NCT00300976|Lipids|lipids
1625197|NCT00300963|psychosis|psychosis
1625198|NCT00300963|cognition|cognition
1625199|NCT00300950|Pancreas Cancer|pancreas cancer
1625200|NCT00300950|resected pancreas cancer|resected pancreas cancer
1625201|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
1625202|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
1625203|NCT00300911|Heart Failure, Congestive|heart failure, congestive
1625204|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
1625205|NCT00300898|nucleoplasty|nucleoplasty
1625206|NCT00300898|percutaneous decompression|percutaneous decompression
1625207|NCT00300898|Dekompressor|dekompressor
1625208|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
1625209|NCT00300898|IDET|idet
1625210|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
1625211|NCT00300885|NSCLC|nsclc
1625212|NCT00300820|Bipolar Disorder|bipolar disorder
1625213|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
1625214|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
1625215|NCT00300820|Bipolar|bipolar
1625216|NCT00300820|Genes|genes
1625217|NCT00300820|Familial|familial
1625218|NCT00300820|Education|education
1625219|NCT00300820|Testing|testing
1625221|NCT00300820|Adult Siblings|adult siblings
1625222|NCT00300807|Hepatitis C|hepatitis c
1625223|NCT00300807|Monoclonal Antibody|monoclonal antibody
1625224|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
1625225|NCT00300781|phase 2|phase 2
1625226|NCT00300781|HER2+ breast cancer|her2+ breast cancer
1625227|NCT00300781|monotherapy neratinib|monotherapy neratinib
1625228|NCT00300781|HKI-272|hki-272
1625229|NCT00300781|Neratinib|neratinib
1625230|NCT00300781|Nerlynx|nerlynx
1625231|NCT00300781|PB-272|pb-272
1625232|NCT00300768|onchocerciasis|onchocerciasis
1625233|NCT00300768|onchocerca volvulus|onchocerca volvulus
1625234|NCT00300768|river blindness|river blindness
1625235|NCT00300768|ivermectin|ivermectin
1625236|NCT00300768|moxidectin|moxidectin
1625237|NCT00300755|GERD|gerd
1625238|NCT00300755|Children|children
1625239|NCT00300755|Child|child
1625240|NCT00300755|Child, Preschool|child, preschool
1625241|NCT00300742|drinking|drinking
1625242|NCT00300742|eating|eating
1625243|NCT00300742|obesity|obesity
1625244|NCT00300742|alcohol|alcohol
1625245|NCT00300742|binge eating|binge eating
1625246|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
1625247|NCT00300729|Celecoxib|celecoxib
1625248|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
1625249|NCT00300729|Antineoplastic agents|antineoplastic agents
1625250|NCT00300729|Therapy, palliative|therapy, palliative
1625251|NCT00300729|Survival|survival
1625252|NCT00300716|Multiple Sclerosis|multiple sclerosis
1625253|NCT00300716|Cognitive impairment|cognitive impairment
1625254|NCT00300716|Memantine|memantine
1625255|NCT00300716|Placebo|placebo
1625256|NCT00300716|Neuropsychological tests|neuropsychological tests
1625257|NCT00300716|Quality of life|quality of life
1625258|NCT00300716|Fatigue|fatigue
1625259|NCT00300703|Cardiac Arrest|cardiac arrest
1625260|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
1625261|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
1625262|NCT00300690|Dacron material|dacron material
1625263|NCT00300690|PTFE material|ptfe material
1625264|NCT00300677|Pharmacokinetics|pharmacokinetics
1625265|NCT00300677|Voriconazole|voriconazole
1625266|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1625267|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
1625268|NCT00300651|Schizophrenia|schizophrenia
1625269|NCT00300651|Cognitive Biases|cognitive biases
1625270|NCT00300651|Efficacy|efficacy
1625271|NCT00300638|Alcoholism|alcoholism
1625273|NCT00300638|Cognition|cognition
1625274|NCT00300638|Brain scans|brain scans
1625275|NCT00300625|Syncope|syncope
1625276|NCT00300625|Near syncope|near syncope
1625277|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
1625278|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
1625279|NCT00300586|metastatic ;|metastatic ;
1625280|NCT00300586|chemotherapy ;|chemotherapy ;
1625281|NCT00300586|erlotinib|erlotinib
1625282|NCT00300573|dexelvucitabine|dexelvucitabine
1625283|NCT00300573|DFC|dfc
1625284|NCT00300573|Treatment Experienced|treatment experienced
1625285|NCT00300573|HIV-1|hiv-1
1625286|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
1625287|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
1625288|NCT00300560|Colistin|colistin
1625289|NCT00300547|colorectal cancer|colorectal cancer
1625290|NCT00300547|polyps|polyps
1625291|NCT00300547|Virtual colonoscopy|virtual colonoscopy
1625292|NCT00300547|synchronous carcinoma|synchronous carcinoma
1625293|NCT00300547|MR colonography|mr colonography
1625295|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
1625296|NCT00300521|liver transplantation|liver transplantation
1625297|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
1625298|NCT00300521|gene therapy|gene therapy
1625299|NCT00300521|immunosuppression|immunosuppression
1625300|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
1625301|NCT00300495|Atrial fibrillation|atrial fibrillation
1625302|NCT00300495|Lung cancer|lung cancer
1625303|NCT00300495|Pulmonary resection|pulmonary resection
1625304|NCT00300495|Post-operative complications|post-operative complications
1625305|NCT00300482|Dyslipidemia|dyslipidemia
1625306|NCT00300482|Coronary Heart Disease|coronary heart disease
1625307|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
1625308|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
1625309|NCT00300469|Coronary Heart Disease|coronary heart disease
1625310|NCT00300469|Dyslipidemia|dyslipidemia
1625311|NCT00300456|Dyslipidemia|dyslipidemia
1625312|NCT00300456|Coronary Heart Disease|coronary heart disease
1625313|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
1625314|NCT00300417|Flavivirus|flavivirus
1625315|NCT00300417|Mosquito|mosquito
1625316|NCT00300417|Immunity|immunity
1625317|NCT00300417|Preventive|preventive
1625318|NCT00300417|West Nile Fever|west nile fever
1625319|NCT00300417|West Nile Virus|west nile virus
1625320|NCT00300417|Vaccine|vaccine
1625321|NCT00300417|Healthy Volunteer|healthy volunteer
1625322|NCT00300417|HV|hv
1625323|NCT00300404|Schizophrenia|schizophrenia
1625324|NCT00300404|Psychosis|psychosis
1625325|NCT00300404|Depression|depression
1625326|NCT00300404|Affective Disorder|affective disorder
1625327|NCT00300391|Delirium|delirium
1625328|NCT00300391|Mechanical ventilation|mechanical ventilation
1625329|NCT00300391|Intensive care|intensive care
1625330|NCT00300391|Haloperidol|haloperidol
1625331|NCT00300378|Depression|depression
1625332|NCT00300378|Adult|adult
1625333|NCT00300378|Outpatients|outpatients
1625334|NCT00300365|HDL cholesterol|hdl cholesterol
1625335|NCT00300365|Metabolic syndrome|metabolic syndrome
1625336|NCT00300352|Coronary artery disease|coronary artery disease
1625337|NCT00300352|Folic acid|folic acid
1625338|NCT00300352|Endothelial function|endothelial function
1625339|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
1625340|NCT00300287|Type 2 diabetes|type 2 diabetes
1625341|NCT00300287|Vildagliptin|vildagliptin
1625342|NCT00300274|Everolimus|everolimus
1625343|NCT00300274|heart transplant|heart transplant
1625344|NCT00300274|heart disease|heart disease
1625345|NCT00300274|transplantation|transplantation
1625346|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
1625347|NCT00300274|rate of graft loss|rate of graft loss
1625348|NCT00300274|acute rejection episodes|acute rejection episodes
1625349|NCT00300274|survival|survival
1625350|NCT00300261|Heart Failure|heart failure
1625351|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1625352|NCT00300248|Acute Lung Injury|acute lung injury
1625353|NCT00300248|Respiratory Failure|respiratory failure
1625354|NCT00300248|ARDS, Human|ards, human
1625355|NCT00300235|Sickle Cell Anemia|sickle cell anemia
1625356|NCT00300222|dermal assessment|dermal assessment
1625357|NCT00300222|pain measurement|pain measurement
1625358|NCT00300222|diary|diary
1625359|NCT00300222|PHN|phn
1625364|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
1625366|NCT00300196|Fibrinogen|fibrinogen
1625367|NCT00300196|Reperfusion|reperfusion
1625368|NCT00300196|Thrombolysis|thrombolysis
1625369|NCT00300183|HIV|hiv
1625370|NCT00300183|health services accessibility|health services accessibility
1625371|NCT00300183|health services research|health services research
1625372|NCT00300183|homeless|homeless
1625373|NCT00300183|social support|social support
1625374|NCT00300183|AIDS|aids
1625375|NCT00300183|substance abuse|substance abuse
1625376|NCT00300183|mental health|mental health
1625377|NCT00300183|quality of life|quality of life
1625378|NCT00300183|outreach|outreach
1625379|NCT00300183|harm reduction|harm reduction
1625380|NCT00300170|HIV|hiv
1625381|NCT00300170|race|race
1625382|NCT00300170|unstable housing|unstable housing
1625383|NCT00300170|health services accessibility|health services accessibility
1625384|NCT00300170|health services utilization|health services utilization
1625385|NCT00300170|substance abuse|substance abuse
1625386|NCT00300170|AIDS|aids
1625387|NCT00300170|health services research|health services research
1625388|NCT00300170|social support|social support
1625389|NCT00300170|depression|depression
1625390|NCT00300170|trust|trust
1625391|NCT00300170|discrimination|discrimination
1625392|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
1625393|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
1625394|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
1625395|NCT00300131|Bioabsorbable|bioabsorbable
1625396|NCT00300131|Coronary Stent|coronary stent
1625397|NCT00300131|Everolimus|everolimus
1625398|NCT00300131|drug eluting stents|drug eluting stents
1625399|NCT00300131|stents|stents
1625401|NCT00300131|coronary artery disease|coronary artery disease
1625402|NCT00300131|total coronary occlusion|total coronary occlusion
1625403|NCT00300131|coronary artery restenosis|coronary artery restenosis
1625404|NCT00300131|stent thrombosis|stent thrombosis
1625405|NCT00300131|vascular disease|vascular disease
1625406|NCT00300131|myocardial ischemia|myocardial ischemia
1625407|NCT00300131|coronary artery stenosis|coronary artery stenosis
1625408|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
1625409|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
1625410|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
1625411|NCT00300066|Serum Cystatin C|serum cystatin c
1625412|NCT00300066|Body Composition|body composition
1625413|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
1625414|NCT00300053|angina|angina
1625415|NCT00300040|Amputation|amputation
1625416|NCT00300040|Lower limb|lower limb
1625417|NCT00300040|Critical Limb Ischemia|critical limb ischemia
1625418|NCT00300040|residual limb|residual limb
1625419|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
1625420|NCT00300040|re-amputation|re-amputation
1625421|NCT00300040|Lower Limb Ischemia|lower limb ischemia
1625422|NCT00300040|PVD|pvd
1625423|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
1625424|NCT00300014|Post vitrectomy|post vitrectomy
1625425|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
1625426|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
1625427|NCT00300001|Cancer|cancer
1625428|NCT00300001|Symptom Management|symptom management
1625429|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
1625430|NCT00300001|Symptom Severity|symptom severity
1625431|NCT00300001|quality of life|quality of life
1625432|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
1625433|NCT00299988|Immunotherapy|immunotherapy
1625434|NCT00299988|Amyloid beta protein|amyloid beta protein
1625435|NCT00299988|Antibodies|antibodies
1625436|NCT00299988|Alzheimer's|alzheimer's
1625437|NCT00299988|Dementia|dementia
1625438|NCT00299975|Randomized Controlled Trials|randomized controlled trials
1625439|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
1625440|NCT00299975|Medicine, Herbal|medicine, herbal
1625441|NCT00299975|Constipation|constipation
1625442|NCT00299962|gene therapy|gene therapy
1625443|NCT00299962|immunotherapy|immunotherapy
1625444|NCT00299936|hepatitis C|hepatitis c
1625445|NCT00299936|chronic hepatitis C|chronic hepatitis c
1625446|NCT00299936|ribavirin|ribavirin
1625447|NCT00299936|WIN-R|win-r
1625448|NCT00299923|drug therapy|drug therapy
1625449|NCT00299923|Interferon|interferon
1625450|NCT00299897|HIV|hiv
1625451|NCT00299897|AIDS|aids
1625452|NCT00299897|Treatment Resistance|treatment resistance
1625453|NCT00299897|Treatment Failure|treatment failure
1625454|NCT00299897|Mutations|mutations
1625455|NCT00299897|GP120|gp120
1625456|NCT00299897|Entry Inhibitors|entry inhibitors
1625457|NCT00299897|HAART|haart
1625458|NCT00299897|antiretroviral|antiretroviral
1625460|NCT00299897|ARV|arv
1625461|NCT00299897|CCR5|ccr5
1625462|NCT00299897|CXCR4|cxcr4
1625463|NCT00299897|receptors|receptors
1625464|NCT00299897|intracellular fluid|intracellular fluid
1625468|NCT00299897|Treatment Experienced|treatment experienced
1625469|NCT00299884|Randomized|randomized
1625470|NCT00299884|non-blinded|non-blinded
1625471|NCT00299884|prospective|prospective
1625472|NCT00299884|open-label|open-label
1625473|NCT00299884|LDL-C|ldl-c
1625474|NCT00299884|HDL-C|hdl-c
1625475|NCT00299871|Type 2 diabetes|type 2 diabetes
1625476|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1625477|NCT00299858|Theophylline|theophylline
1625478|NCT00299858|Exercise testing|exercise testing
1625479|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
1625480|NCT00299845|children|children
1625481|NCT00299845|lansoprazole|lansoprazole
1625482|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
1625483|NCT00299845|pharmacogenomics|pharmacogenomics
1625484|NCT00299845|genetic polymorphisms|genetic polymorphisms
1625485|NCT00299845|individualized medicine|individualized medicine
1625486|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
1625487|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
1625488|NCT00299819|Lupus|lupus
1625489|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
1625490|NCT00299793|Epilepsy|epilepsy
1625491|NCT00299793|Quality of life|quality of life
1625492|NCT00299780|Mobilization|mobilization
1625493|NCT00299780|Stem Cell|stem cell
1625494|NCT00299780|Parathyroid Hormone|parathyroid hormone
1625495|NCT00299754|Low dose misoprostol|low dose misoprostol
1625496|NCT00299754|dinoprostone|dinoprostone
1625497|NCT00299754|cervical priming|cervical priming
1625498|NCT00299741|Sutent|sutent
1625499|NCT00299741|Sunitinib|sunitinib
1625500|NCT00299741|Bone|bone
1625502|NCT00299741|Hormone-refractory|hormone-refractory
1625503|NCT00299741|Biomarkers|biomarkers
1625504|NCT00299728|NY-ESO-1|ny-eso-1
1625505|NCT00299728|Vaccine|vaccine
1625506|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
1625507|NCT00299728|Several tumor types eligible|several tumor types eligible
1625508|NCT00299715|Affective psychosis|affective psychosis
1625509|NCT00299715|mixed-state|mixed-state
1625510|NCT00299715|bipolar disorder|bipolar disorder
1625511|NCT00299715|manic disorder|manic disorder
1625512|NCT00299715|manic-depressive|manic-depressive
1625513|NCT00299715|psychosis|psychosis
1625514|NCT00299715|mania|mania
1625515|NCT00299715|manic state|manic state
1625516|NCT00299715|paliperidone|paliperidone
1625517|NCT00299715|paliperidone ER.|paliperidone er.
1625518|NCT00299702|Schizophrenia|schizophrenia
1625519|NCT00299702|Relapse|relapse
1625520|NCT00299702|Remission|remission
1625521|NCT00299702|Treatment Outcome|treatment outcome
1625522|NCT00299702|long-acting injectable|long-acting injectable
1625523|NCT00299689|Melanoma|melanoma
1625524|NCT00299689|Metastatic|metastatic
1625525|NCT00299689|Stage IV|stage iv
1625526|NCT00299689|Ontak|ontak
1625527|NCT00299676|Alzheimer's Disease|alzheimer's disease
1625528|NCT00299676|Dementia|dementia
1625529|NCT00299676|Post Marketing|post marketing
1625530|NCT00299676|Prospective Studies|prospective studies
1625531|NCT00299676|Longitudinal Studies|longitudinal studies
1625532|NCT00299676|New Zealand|new zealand
1625533|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
1625534|NCT00299676|Observational|observational
1625535|NCT00299676|Outcomes|outcomes
1625536|NCT00299663|group A streptococcal infection|group a streptococcal infection
1625537|NCT00299663|genital tract|genital tract
1625538|NCT00299663|CARRIER|carrier
1625539|NCT00299663|patients with GAS isolation|patients with gas isolation
1625540|NCT00299663|Streptococcus Group A|streptococcus group a
1625541|NCT00299650|ARDS|ards
1625542|NCT00299650|mortality|mortality
1625543|NCT00299650|mechanical ventilation|mechanical ventilation
1625544|NCT00299650|pneumonia|pneumonia
1625545|NCT00299650|muscle relaxants|muscle relaxants
1625546|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
1625547|NCT00299624|elderly,|elderly,
1625548|NCT00299624|hypercoagulability|hypercoagulability
1625549|NCT00299624|fibrinolysis|fibrinolysis
1625550|NCT00299624|microparticles|microparticles
1625551|NCT00299611|OCD|ocd
1625552|NCT00299611|Anxiety|anxiety
1625553|NCT00299611|Pharmacotherapy|pharmacotherapy
1625554|NCT00299611|Sertraline|sertraline
1625555|NCT00299611|Levetiracetam|levetiracetam
1625556|NCT00299598|antibacterial|antibacterial
1625557|NCT00299598|composite|composite
1625558|NCT00299598|polyethylenimine|polyethylenimine
1625559|NCT00299598|nanoparticle|nanoparticle
1625560|NCT00299585|dental implant|dental implant
1625561|NCT00299585|dental implantation|dental implantation
1625562|NCT00299585|osseointegration|osseointegration
1625563|NCT00299585|bone cement|bone cement
1625564|NCT00299585|osteoconductivity|osteoconductivity
1625565|NCT00299585|brushite|brushite
1625566|NCT00299585|calcium phosphate|calcium phosphate
1625567|NCT00299585|bone augmentation|bone augmentation
1625568|NCT00299585|primary stability|primary stability
1625569|NCT00299585|immediate implantation|immediate implantation
1625570|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
1625571|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
1625572|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
1625573|NCT00299572|alendronate|alendronate
1625574|NCT00299572|peritoneal dialysis|peritoneal dialysis
1625575|NCT00299572|vascular calcification|vascular calcification
1625576|NCT00299572|bone mineral density|bone mineral density
1625577|NCT00299559|common cold|common cold
1625578|NCT00299559|organic chemicals|organic chemicals
1625579|NCT00299559|menthol|menthol
1625580|NCT00299559|cineole|cineole
1625581|NCT00299559|camphor|camphor
1625582|NCT00299559|etheric oils|etheric oils
1625583|NCT00299559|alternative medicine|alternative medicine
1625584|NCT00299559|smart textiles|smart textiles
1625585|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
1625586|NCT00299546|Anti-TNFa agents|anti-tnfa agents
1625587|NCT00299546|subcutaneous injection|subcutaneous injection
1625588|NCT00299520|skin infection|skin infection
1625589|NCT00299520|complicated skin infection|complicated skin infection
1625590|NCT00299520|skin structure infection|skin structure infection
1625591|NCT00299507|exudative AMD|exudative amd
1625592|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
1625593|NCT00299494|Lymphoma|lymphoma
1625594|NCT00299494|NHL|nhl
1625595|NCT00299481|Tissue Bank|tissue bank
1625596|NCT00299481|Endometrial neoplasm|endometrial neoplasm
1625597|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
1625598|NCT00299481|ovarian neoplasm|ovarian neoplasm
1625599|NCT00299481|leiomyoma|leiomyoma
1625600|NCT00299481|DNA|dna
1625601|NCT00299481|RNA|rna
1625602|NCT00299481|Protein|protein
1625603|NCT00299481|Serum|serum
1625604|NCT00299468|hypertension|hypertension
1625606|NCT00299468|patient activation|patient activation
1625607|NCT00299468|stages-of-change|stages-of-change
1625608|NCT00299442|behavior|behavior
1625609|NCT00299442|conduct|conduct
1625610|NCT00299442|child|child
1625611|NCT00299442|parenting|parenting
1625612|NCT00299442|self-help|self-help
1625613|NCT00299442|media-based|media-based
1625614|NCT00299429|Stent|stent
1625615|NCT00299429|drug-eluting stent|drug-eluting stent
1625616|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
1625617|NCT00299429|left anterior descending|left anterior descending
1625618|NCT00299416|Stroke|stroke
1625619|NCT00299416|Nonhemorrhagic|nonhemorrhagic
1625620|NCT00299416|hypothermia|hypothermia
1625621|NCT00299403|Depressive disorder,|depressive disorder,
1625622|NCT00299403|Antidepressant effect,|antidepressant effect,
1625623|NCT00299403|rTMS,|rtms,
1625624|NCT00299403|ECT,|ect,
1625625|NCT00299403|cognition,|cognition,
1625626|NCT00299403|Saliva cortisol|saliva cortisol
1625627|NCT00299403|noninferiority trial|noninferiority trial
1625628|NCT00299390|Sagopilone|sagopilone
1625629|NCT00299390|Epothilone|epothilone
1625630|NCT00299390|SCLC|sclc
1625631|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
1625632|NCT00299390|Lung Cancer|lung cancer
1625633|NCT00299377|STEMI|stemi
1625634|NCT00299377|infarct size|infarct size
1625635|NCT00299377|primary PCI|primary pci
1625636|NCT00299377|no-reflow|no-reflow
1625637|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
1625638|NCT00299364|Climacteric symptoms|climacteric symptoms
1625639|NCT00299364|Black Cohosh|black cohosh
1625640|NCT00299364|Efficacy|efficacy
1625641|NCT00299364|Safety|safety
1625642|NCT00299338|HIV|hiv
1625643|NCT00299338|AIDS|aids
1625644|NCT00299338|CD4|cd4
1625645|NCT00299338|HAART|haart
1625646|NCT00299338|antiretroviral|antiretroviral
1625647|NCT00299338|treatment failure|treatment failure
1625648|NCT00299338|resistance|resistance
1625649|NCT00299338|CCR4|ccr4
1625650|NCT00299338|CXCR5|cxcr5
1625651|NCT00299338|gp120|gp120
1625652|NCT00299338|gp41|gp41
1625653|NCT00299338|cholesterol|cholesterol
1625654|NCT00299338|lipid rafts|lipid rafts
1625655|NCT00299338|intracellular fluid|intracellular fluid
1625656|NCT00299338|receptors|receptors
1625657|NCT00299338|chemokine|chemokine
1625658|NCT00299338|antigens|antigens
1625659|NCT00299338|Treatment Experienced|treatment experienced
1625660|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
1625661|NCT00299312|Loss of Communication|loss of communication
1625662|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
1625663|NCT00299312|MECP2 mutation|mecp2 mutation
1625664|NCT00299312|MECP2 duplication|mecp2 duplication
1625665|NCT00299312|CDKL5 mutation|cdkl5 mutation
1625666|NCT00299312|FOXG1 mutation|foxg1 mutation
1625667|NCT00299286|Ki67|ki67
1625668|NCT00299286|Molecular|molecular
1625669|NCT00299286|antiproliferative|antiproliferative
1625670|NCT00299273|Obesity;|obesity;
1625671|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
1625672|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
1625673|NCT00299273|Weight Loss|weight loss
1625674|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
1625968|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
1625675|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
1625676|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1625677|NCT00299221|immunosuppression|immunosuppression
1625678|NCT00299221|steroid withdrawal|steroid withdrawal
1625679|NCT00299221|rejection|rejection
1625680|NCT00299221|coronary disease|coronary disease
1625681|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
1625683|NCT00299195|Oral Leukoplakia|oral leukoplakia
1625684|NCT00299195|Benign Neoplasms|benign neoplasms
1625685|NCT00299195|Chemoprevention|chemoprevention
1625686|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
1625687|NCT00299195|sulindac|sulindac
1625688|NCT00299195|04-099|04-099
1625689|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1625690|NCT00299182|Lymphoma|lymphoma
1625691|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
1625692|NCT00299182|AMG 531|amg 531
1625693|NCT00299182|Romiplostim|romiplostim
1625694|NCT00299182|Placebo|placebo
1625695|NCT00299182|R-HyperCVAD|r-hypercvad
1625696|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
1625697|NCT00299182|Cyclophosphamide|cyclophosphamide
1625698|NCT00299182|Cytarabine|cytarabine
1625699|NCT00299182|Dexamethasone|dexamethasone
1625700|NCT00299182|Doxorubicin|doxorubicin
1625701|NCT00299182|Methotrexate|methotrexate
1625702|NCT00299182|Rituximab|rituximab
1625703|NCT00299182|Vincristine|vincristine
1625704|NCT00299182|Decadron|decadron
1625705|NCT00299182|Neosar|neosar
1625706|NCT00299182|AD|ad
1625707|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
1625708|NCT00299182|Ara-C|ara-c
1625709|NCT00299182|Cytosar|cytosar
1625710|NCT00299182|DepoCyt|depocyt
1625711|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1625712|NCT00299169|N of 1 trial|n of 1 trial
1625713|NCT00299169|diabetes mellitus|diabetes mellitus
1625714|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
1625715|NCT00299169|cardiovascular disease|cardiovascular disease
1625716|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
1625717|NCT00299156|MDS|mds
1625718|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1625719|NCT00299156|CMML|cmml
1625720|NCT00299156|Clofarabine|clofarabine
1625721|NCT00299156|Clofarex|clofarex
1625722|NCT00299156|Clolar|clolar
1625723|NCT00299156|Chemotherapy|chemotherapy
1625724|NCT00299143|SIPA|sipa
1625725|NCT00299143|acute coronary syndrome|acute coronary syndrome
1625726|NCT00299130|RA|ra
1625727|NCT00299130|Rituxan|rituxan
1625728|NCT00299130|SERENE|serene
1625729|NCT00299117|Smoking cessation|smoking cessation
1625730|NCT00299117|Stress|stress
1625731|NCT00299117|Nicotine dependence|nicotine dependence
1625732|NCT00299117|Complication, postoperative|complication, postoperative
1625733|NCT00299104|Rituxan|rituxan
1625734|NCT00299104|MTX|mtx
1625735|NCT00299104|RA|ra
1625736|NCT00299104|IMAGE|image
1625737|NCT00299104|WA17047|wa17047
1625738|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
1625739|NCT00299091|Treatment Naive|treatment naive
1625740|NCT00299091|Treatment Experienced|treatment experienced
1625741|NCT00299091|HIV|hiv
1625742|NCT00299065|Asthma, bronchial|asthma, bronchial
1625743|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
1625744|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
1625745|NCT00299052|Tibia|tibia
1625746|NCT00299052|Fracture|fracture
1625747|NCT00299052|DBM|dbm
1625748|NCT00299039|Randomized controlled trial|randomized controlled trial
1625749|NCT00299039|Clinical trial|clinical trial
1625750|NCT00299039|Breast tumor surgery|breast tumor surgery
1625751|NCT00299039|Outpatient surgery|outpatient surgery
1625752|NCT00299039|Analgesia|analgesia
1625753|NCT00299039|Outpatient analgesia|outpatient analgesia
1625754|NCT00299039|Post surgical analgesia|post surgical analgesia
1625755|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
1625756|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
1625757|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
1625758|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
1625759|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
1625760|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
1625761|NCT00299026|Coronary Artery Disease|coronary artery disease
1625762|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
1625763|NCT00299026|Stent Implant|stent implant
1625764|NCT00299026|Drug-coated Stent|drug-coated stent
1625765|NCT00299013|Ulcerative colitis|ulcerative colitis
1625766|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
1625767|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
1625768|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
1625769|NCT00298935|Randomized Controlled Trial|randomized controlled trial
1625770|NCT00298935|Pregnant Women|pregnant women
1625771|NCT00298922|Cystic Fibrosis|cystic fibrosis
1625772|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
1625773|NCT00298896|Lung|lung
1625774|NCT00298896|Squamous Cell|squamous cell
1625775|NCT00298896|Small Cell|small cell
1625776|NCT00298896|Carcinoma|carcinoma
1625777|NCT00298896|Cancer|cancer
1625778|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
1625779|NCT00298883|Renal|renal
1625780|NCT00298883|Transplant|transplant
1625781|NCT00298883|PRA|pra
1625782|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
1625783|NCT00298870|isoniazid|isoniazid
1625784|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
1625785|NCT00298870|pharmacogenomics|pharmacogenomics
1625786|NCT00298870|genetic polymorphisms|genetic polymorphisms
1625787|NCT00298870|individualized medicine|individualized medicine
1625788|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
1625789|NCT00298857|Healthy|healthy
1625790|NCT00298857|Obesity|obesity
1625791|NCT00298857|Pharmacokinetics|pharmacokinetics
1625792|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
1625793|NCT00298844|Macrovascular disease|macrovascular disease
1625794|NCT00298844|Diastolic dysfunction|diastolic dysfunction
1625795|NCT00298844|Intima media thickness|intima media thickness
1625796|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
1625797|NCT00298818|Epilepsy|epilepsy
1625798|NCT00298818|Mental Retardation|mental retardation
1625799|NCT00298818|Developmental Disabilities|developmental disabilities
1625800|NCT00298805|Migraine|migraine
1625801|NCT00298805|Headache|headache
1625802|NCT00298805|Depression|depression
1625803|NCT00298805|Quality of Life|quality of life
1625804|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
1625805|NCT00298792|Alcohol Dependence|alcohol dependence
1625806|NCT00298792|Functional Analysis|functional analysis
1625807|NCT00298792|Experience Sampling|experience sampling
1625808|NCT00298792|Interactive Voice Response|interactive voice response
1625809|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
1625810|NCT00298727|Knowledge transfer|knowledge transfer
1625811|NCT00298727|Clinical decision-making|clinical decision-making
1625812|NCT00298727|Outcome measures|outcome measures
1625813|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
1625814|NCT00298701|Allergy|allergy
1625815|NCT00298662|Multiple Sclerosis|multiple sclerosis
1625816|NCT00298662|Betaseron-Prograf|betaseron-prograf
1625817|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
1625818|NCT00298662|Secondary Progressive type|secondary progressive type
1625819|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
1625820|NCT00298649|pesticide safety|pesticide safety
1625821|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
1625822|NCT00298649|Latino/Hispanic|latino/hispanic
1625823|NCT00298649|agricultural health|agricultural health
1625824|NCT00298649|occupational health|occupational health
1625825|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
1625826|NCT00298610|GMP artesunate|gmp artesunate
1625827|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
1625828|NCT00298584|urinary catheterization|urinary catheterization
1625829|NCT00298584|Aspiration|aspiration
1625830|NCT00298584|Neonates|neonates
1625831|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
1625832|NCT00298584|Infant, Newborn|infant, newborn
1625833|NCT00298584|Infant, Premature|infant, premature
1625834|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
1625835|NCT00298571|Cesarean Delivery|cesarean delivery
1625836|NCT00298571|Post-operative|post-operative
1625837|NCT00298571|Pain|pain
1625838|NCT00298571|Local Anesthetic|local anesthetic
1625839|NCT00298558|cognition disorder|cognition disorder
1625840|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
1625841|NCT00298558|functional ability|functional ability
1625842|NCT00298532|Pediatrics|pediatrics
1625843|NCT00298532|Seizure|seizure
1625844|NCT00298532|Trauma|trauma
1625845|NCT00298532|Respiratory|respiratory
1625846|NCT00298532|Cardiac|cardiac
1625847|NCT00298532|Arrest|arrest
1625848|NCT00298506|Tacrolimus|tacrolimus
1625849|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
1625850|NCT00298506|Cyclophosphamide|cyclophosphamide
1625851|NCT00298506|Lupus nephritis|lupus nephritis
1625852|NCT00298506|Treatment|treatment
1625853|NCT00298493|ICU|icu
1625854|NCT00298493|Sedation strategies|sedation strategies
1625855|NCT00298493|Daily sedative interruption|daily sedative interruption
1625856|NCT00298493|Sedation protocols|sedation protocols
1625857|NCT00298480|preterm labor|preterm labor
1625858|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
1625859|NCT00298480|dynamic cervical change|dynamic cervical change
1625860|NCT00298467|ALCL|alcl
1625861|NCT00298467|csALCL|csalcl
1625862|NCT00298467|pcALCL|pcalcl
1625863|NCT00298467|Lymphoma|lymphoma
1625864|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1626378|NCT00296413|epilepsy|epilepsy
1625865|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1625866|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
1625969|NCT00298012|Anterior uveitis|anterior uveitis
1625867|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
1625868|NCT00298454|renal failure|renal failure
1625869|NCT00298454|oliguric|oliguric
1625870|NCT00298454|critically ill|critically ill
1625871|NCT00298454|furosemide|furosemide
1625872|NCT00298441|intravenous iron administration|intravenous iron administration
1625873|NCT00298428|stent|stent
1625874|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
1625875|NCT00298428|platelet aggregation|platelet aggregation
1625876|NCT00298428|clopidogrel|clopidogrel
1625877|NCT00298428|shear|shear
1625878|NCT00298428|metabolic syndrome|metabolic syndrome
1625879|NCT00298415|2-years survival|2-years survival
1625880|NCT00298402|macrophage|macrophage
1625881|NCT00298402|MMP|mmp
1625882|NCT00298402|CT scan|ct scan
1625883|NCT00298389|macrophage|macrophage
1625884|NCT00298389|phagocytosis|phagocytosis
1625885|NCT00298389|exacerbation|exacerbation
1625886|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
1625887|NCT00298376|food allergy|food allergy
1625888|NCT00298376|oral tolerance,|oral tolerance,
1625889|NCT00298376|infant,|infant,
1625890|NCT00298376|regulatory T cells,|regulatory t cells,
1625891|NCT00298376|intestinal microflora|intestinal microflora
1625892|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
1625893|NCT00298350|Phase 2|phase 2
1625894|NCT00298350|Phase II|phase ii
1625895|NCT00298350|Randomized|randomized
1625896|NCT00298350|Controlled|controlled
1625897|NCT00298350|Comparator|comparator
1625898|NCT00298350|Partially Blind|partially blind
1625899|NCT00298350|Protease Inhibitors|protease inhibitors
1625900|NCT00298350|Integrase Inhibitors|integrase inhibitors
1625901|NCT00298350|Antiviral Agents|antiviral agents
1625902|NCT00298350|Antiretroviral Agents|antiretroviral agents
1625905|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
1625906|NCT00298350|HAART|haart
1625907|NCT00298350|Treatment Experienced|treatment experienced
1625908|NCT00298324|GvHD|gvhd
1625909|NCT00298324|graft versus host disease|graft versus host disease
1625910|NCT00298324|extensive|extensive
1625911|NCT00298324|myfortic|myfortic
1625912|NCT00298298|lung cancer|lung cancer
1625913|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
1625914|NCT00298298|vaccine|vaccine
1625915|NCT00298298|immunotherapy|immunotherapy
1625916|NCT00298285|mechanical valve replacement|mechanical valve replacement
1625917|NCT00298285|warfarin|warfarin
1625918|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
1625919|NCT00298246|Neurological Disorder|neurological disorder
1625920|NCT00298246|Children- Onset|children- onset
1625921|NCT00298246|Children|children
1625922|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
1625923|NCT00298246|PDD|pdd
1625924|NCT00298246|Autism|autism
1625925|NCT00298246|Healthy Volunteer|healthy volunteer
1625926|NCT00298246|HV|hv
1625927|NCT00298233|Antibody Response|antibody response
1625928|NCT00298233|Antiviral Efficacy|antiviral efficacy
1625929|NCT00298233|Bird Flu|bird flu
1625930|NCT00298233|Severe Respiratory Distress|severe respiratory distress
1625931|NCT00298233|Viral Replication and Shedding|viral replication and shedding
1625932|NCT00298220|Family Practice|family practice
1625933|NCT00298220|Intervention Studies|intervention studies
1625934|NCT00298220|Prevention and Control|prevention and control
1625935|NCT00298207|high blood pressure|high blood pressure
1625936|NCT00298207|hypertension|hypertension
1625937|NCT00298207|adult|adult
1625938|NCT00298207|African Americans|african americans
1625939|NCT00298207|Walking|walking
1625940|NCT00298168|Delayed Graft Function|delayed graft function
1625941|NCT00298142|Cervicogenic Headache|cervicogenic headache
1625942|NCT00298142|Migraine|migraine
1625943|NCT00298142|Tension Type Headache|tension type headache
1625944|NCT00298103|Antibiotic resistant|antibiotic resistant
1625945|NCT00298103|Infection|infection
1625946|NCT00298090|Oxygenation|oxygenation
1625947|NCT00298077|Infection|infection
1625948|NCT00298077|transplant recipients|transplant recipients
1625949|NCT00298064|Cervical cancer|cervical cancer
1625950|NCT00298064|EGFR|egfr
1625951|NCT00298064|cervical|cervical
1625952|NCT00298064|genomic|genomic
1625953|NCT00298064|DNA|dna
1625954|NCT00298064|markers|markers
1625955|NCT00298064|prognostic|prognostic
1625956|NCT00298064|gene|gene
1625957|NCT00298064|epidermal growth factor|epidermal growth factor
1625958|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
1625959|NCT00298051|Umbilical cord clamping|umbilical cord clamping
1625960|NCT00298051|Infant|infant
1625961|NCT00298025|Infertility|infertility
1625962|NCT00298025|Cetrotide|cetrotide
1625963|NCT00298025|Antagon|antagon
1625964|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
1625965|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
1625966|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
1625967|NCT00298012|Methotrexate|methotrexate
1626172|NCT00297193|HSCT|hsct
1625970|NCT00297947|schizophrenia|schizophrenia
1625971|NCT00297947|quetiapine|quetiapine
1625972|NCT00297947|schizoaffective disorder|schizoaffective disorder
1625973|NCT00297934|dual-task|dual-task
1625974|NCT00297934|postural control|postural control
1625975|NCT00297934|cognitive|cognitive
1625976|NCT00297908|Ethanol levels|ethanol levels
1625977|NCT00297908|Dermal absorbtion|dermal absorbtion
1625978|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
1625979|NCT00297895|complete lymph node dissection|complete lymph node dissection
1625980|NCT00297895|surgical|surgical
1625981|NCT00297882|Efficacy|efficacy
1625983|NCT00297882|Children|children
1625984|NCT00297882|Cameroon|cameroon
1625985|NCT00297856|Boostrix|boostrix
1625986|NCT00297830|Heart Transplantation|heart transplantation
1625987|NCT00297830|Liver Transplantation|liver transplantation
1625988|NCT00297830|Immunosuppression|immunosuppression
1625989|NCT00297830|Bone Density/drug effects|bone density/drug effects
1625990|NCT00297830|Alendronate|alendronate
1625991|NCT00297830|Zoledronic acid|zoledronic acid
1625992|NCT00297830|Comparative study|comparative study
1625993|NCT00297830|Humans|humans
1625994|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
1625995|NCT00297804|Coronary Artery Disease|coronary artery disease
1625996|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
1625997|NCT00297804|Stent Implant|stent implant
1625998|NCT00297804|Drug-coated Stent|drug-coated stent
1625999|NCT00297791|rectal cancer|rectal cancer
1626000|NCT00297791|laparoscopic technique|laparoscopic technique
1626001|NCT00297791|open technique|open technique
1626002|NCT00297791|clinical trial|clinical trial
1626003|NCT00297791|multicenter study|multicenter study
1626004|NCT00297791|randomized controlled trial|randomized controlled trial
1626005|NCT00297791|Tumor Below 15cm|tumor below 15cm
1626222|NCT00297115|COPD|copd
1626006|NCT00297791|curative surgical resection|curative surgical resection
1626007|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
1626008|NCT00297765|Renal Transplantation|renal transplantation
1626009|NCT00297765|Therapeutics|therapeutics
1626010|NCT00297765|Treatment Outcome|treatment outcome
1626011|NCT00297765|Safety|safety
1626012|NCT00297752|facial burns|facial burns
1626013|NCT00297752|cerium flammazine|cerium flammazine
1626014|NCT00297752|quality of life|quality of life
1626015|NCT00297752|randomised clinical trial|randomised clinical trial
1626016|NCT00297739|Aggression|aggression
1626017|NCT00297739|ADHD|adhd
1626018|NCT00297739|Antipsychotic|antipsychotic
1626019|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
1626020|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
1626021|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
1626022|NCT00297726|Arthritis|arthritis
1626023|NCT00297726|Self-Management|self-management
1626024|NCT00297700|Smoking|smoking
1626025|NCT00297700|Dental|dental
1626026|NCT00297700|Cessation|cessation
1626027|NCT00297700|Prevention|prevention
1626028|NCT00297700|Control|control
1626029|NCT00297700|Quitline|quitline
1626030|NCT00297700|5A-Model|5a-model
1626031|NCT00297700|Cost-effective|cost-effective
1626032|NCT00297687|Vaccines|vaccines
1626033|NCT00297687|Healthy Adults|healthy adults
1626034|NCT00297687|Health|health
1626035|NCT00297687|Adult|adult
1626036|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
1626037|NCT00297674|clarithromycin|clarithromycin
1626038|NCT00297674|sepsis|sepsis
1626039|NCT00297674|immunomodulation|immunomodulation
1626040|NCT00297661|Coronary Revascularization|coronary revascularization
1626041|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
1626042|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
1626043|NCT00297648|Certolizumab pegol|certolizumab pegol
1626044|NCT00297648|Crohn's disease|crohn's disease
1626045|NCT00297648|Mucosal healing|mucosal healing
1626046|NCT00297635|Hyperglycemia|hyperglycemia
1626047|NCT00297635|Insulin Infusion Systems|insulin infusion systems
1626048|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1626049|NCT00297609|Resuscitation medication errors|resuscitation medication errors
1626050|NCT00297609|critical care|critical care
1626051|NCT00297609|pediatrics|pediatrics
1626052|NCT00297609|clinical decision support systems|clinical decision support systems
1626053|NCT00297609|computerized physician order entry|computerized physician order entry
1626054|NCT00297596|Metastatic|metastatic
1626055|NCT00297596|HER2/neu+|her2/neu+
1626056|NCT00297570|CML|cml
1626057|NCT00297570|Imatinib|imatinib
1626058|NCT00297570|Pegylated Interferon|pegylated interferon
1626059|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
1626060|NCT00297544|impotence|impotence
1626061|NCT00297544|endothelial function|endothelial function
1626062|NCT00297544|autonomic nervous system|autonomic nervous system
1626063|NCT00297531|Chronic Periodontitis|chronic periodontitis
1626064|NCT00297531|Periodontitis|periodontitis
1626065|NCT00297531|Photodynamic disinfection|photodynamic disinfection
1626067|NCT00297531|PDT|pdt
1626068|NCT00297531|Periowave|periowave
1626069|NCT00297531|Scaling and Root Planing|scaling and root planing
1626070|NCT00297531|SRP|srp
1626173|NCT00297193|Autologous|autologous
1626071|NCT00297518|Adult Periodontitis|adult periodontitis
1626072|NCT00297518|Chronic Periodontitis|chronic periodontitis
1626073|NCT00297518|PDD|pdd
1626074|NCT00297518|PDT|pdt
1626075|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
1626076|NCT00297518|SRP|srp
1626077|NCT00297518|Scaling and Root Planing|scaling and root planing
1626078|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
1626079|NCT00297492|Smoking Cessation|smoking cessation
1626080|NCT00297492|Tobacco|tobacco
1626081|NCT00297479|Tobacco Cessation|tobacco cessation
1626082|NCT00297479|Smoking Cessation|smoking cessation
1626083|NCT00297466|tobacco use|tobacco use
1626084|NCT00297466|smoking cessation|smoking cessation
1626085|NCT00297466|emergency department|emergency department
1626086|NCT00297440|Smoking|smoking
1626087|NCT00297440|Exercise|exercise
1626088|NCT00297440|Adolescent|adolescent
1626089|NCT00297440|Girls|girls
1626090|NCT00297427|urinary incontinence|urinary incontinence
1626091|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
1626092|NCT00297414|Dementia|dementia
1626093|NCT00297414|Galantamine|galantamine
1626094|NCT00297414|Memory disorders|memory disorders
1626095|NCT00297414|Isolated memory impairment|isolated memory impairment
1626096|NCT00297414|Alzheimer's disease|alzheimer's disease
1626097|NCT00297388|schizophrenia|schizophrenia
1626098|NCT00297388|schizoaffective disorder|schizoaffective disorder
1626099|NCT00297388|long-acting risperidone|long-acting risperidone
1626100|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
1626101|NCT00297388|risperidone|risperidone
1626102|NCT00297375|treatment|treatment
1626103|NCT00297375|Pain|pain
1626104|NCT00297375|acute|acute
1626105|NCT00297375|migraine|migraine
1626106|NCT00297375|headache|headache
1626107|NCT00297362|Alzheimer Disease|alzheimer disease
1626109|NCT00297362|Brain Disease|brain disease
1626110|NCT00297362|Memory Loss|memory loss
1626111|NCT00297362|Caregiver|caregiver
1626112|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
1626113|NCT00297362|Nervous System Diseases|nervous system diseases
1626114|NCT00297362|Mental Disorders|mental disorders
1626115|NCT00297349|Seizures|seizures
1626116|NCT00297349|Epilepsy|epilepsy
1626117|NCT00297349|Tonic-clonic|tonic-clonic
1626118|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
1626119|NCT00297349|Focal Epilepsy|focal epilepsy
1626120|NCT00297349|Topiramate|topiramate
1626121|NCT00297349|Epilepsy in Children|epilepsy in children
1626122|NCT00297336|Topiramate|topiramate
1626123|NCT00297336|Migraine|migraine
1626124|NCT00297336|Headache|headache
1626125|NCT00297336|Chronic headache|chronic headache
1626126|NCT00297336|Chronic migraine|chronic migraine
1626127|NCT00297323|Seizures|seizures
1626128|NCT00297323|Epilepsy|epilepsy
1626129|NCT00297323|Topiramate|topiramate
1626130|NCT00297323|Epilepsy in Children|epilepsy in children
1626131|NCT00297310|Tacrolimus|tacrolimus
1626132|NCT00297310|Kidney transplantation|kidney transplantation
1626133|NCT00297310|Transplantation|transplantation
1626134|NCT00297310|Kidney failure|kidney failure
1626135|NCT00297310|chronic|chronic
1626136|NCT00297310|P-Glycoprotein|p-glycoprotein
1626137|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
1626138|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
1626139|NCT00297284|cognitive efficiency|cognitive efficiency
1626140|NCT00297284|cognitive dysfunction|cognitive dysfunction
1626141|NCT00297284|cognition|cognition
1626142|NCT00297284|memory|memory
1626143|NCT00297284|attention|attention
1626144|NCT00297284|modafinil|modafinil
1626145|NCT00297284|provigil|provigil
1626146|NCT00297271|Dementia|dementia
1626147|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
1626148|NCT00297271|Patient Registries|patient registries
1626149|NCT00297271|Prospective Studies|prospective studies
1626150|NCT00297271|Longitudinal Studies|longitudinal studies
1626151|NCT00297271|Australia|australia
1626152|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
1626153|NCT00297271|Observational|observational
1626154|NCT00297271|Non-randomized|non-randomized
1626155|NCT00297258|Sarcoma|sarcoma
1626156|NCT00297258|Synovial sarcoma|synovial sarcoma
1626157|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
1626158|NCT00297258|Adipocytic tumors|adipocytic tumors
1626159|NCT00297258|Leiomyosarcoma|leiomyosarcoma
1626160|NCT00297258|Phase II|phase ii
1626161|NCT00297245|gastrodin|gastrodin
1626162|NCT00297232|Multiple Sclerosis|multiple sclerosis
1626163|NCT00297232|MS|ms
1626164|NCT00297219|Hemodialysis|hemodialysis
1626165|NCT00297219|Coronary artery calcification|coronary artery calcification
1626166|NCT00297219|Adynamic bone disease|adynamic bone disease
1626167|NCT00297219|Dialysate calcium|dialysate calcium
1626168|NCT00297219|Bone mineral density|bone mineral density
1626169|NCT00297219|Bone histomorphometry|bone histomorphometry
1626170|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
1626171|NCT00297193|Crohn's Disease|crohn's disease
1626178|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
1626179|NCT00297180|GW869682|gw869682
1626180|NCT00297180|body composition|body composition
1626181|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
1626182|NCT00297180|weight loss|weight loss
1626184|NCT00297167|Cystic Fibrosis|cystic fibrosis
1626185|NCT00297167|EPI|epi
1626186|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
1626187|NCT00297167|Pancreatic|pancreatic
1626188|NCT00297167|Enzyme|enzyme
1626189|NCT00297167|PEP|pep
1626190|NCT00297154|Heart failure, congestive|heart failure, congestive
1626191|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
1626192|NCT00297154|Obesity|obesity
1626193|NCT00297141|Preoperative|preoperative
1626194|NCT00297141|Radiochemotherapy|radiochemotherapy
1626195|NCT00297141|Newly Diagnosed|newly diagnosed
1626196|NCT00297141|Primary Operable|primary operable
1626197|NCT00297141|Locally Advanced|locally advanced
1626198|NCT00297141|Rectal Carcinoma|rectal carcinoma
1626199|NCT00297141|T3|t3
1626200|NCT00297141|Lower Rectum|lower rectum
1626201|NCT00297141|Middle Rectum|middle rectum
1626202|NCT00297141|ABCSG|abcsg
1626203|NCT00297141|TAKO|tako
1626204|NCT00297141|95|95
1626205|NCT00297141|05|05
1626206|NCT00297128|pilot study|pilot study
1626207|NCT00297128|rectal|rectal
1626208|NCT00297128|cancer|cancer
1626209|NCT00297128|phase II|phase ii
1626210|NCT00297128|preoperative|preoperative
1626211|NCT00297128|chemoradiation|chemoradiation
1626212|NCT00297128|capecitabine|capecitabine
1626213|NCT00297128|cetuximab|cetuximab
1626214|NCT00297128|operable|operable
1626215|NCT00297128|T4|t4
1626216|NCT00297128|ABCSG|abcsg
1626217|NCT00297128|TAKO|tako
1626218|NCT00297128|R03|r03
1626219|NCT00297128|96|96
1626220|NCT00297128|06|06
1626223|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1626224|NCT00297102|Roflumilast|roflumilast
1626225|NCT00297102|COPD|copd
1626226|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1626227|NCT00297089|Lung Cancer|lung cancer
1626228|NCT00297089|ABT-751|abt-751
1626229|NCT00297089|NSCLC|nsclc
1626230|NCT00297089|Alimta|alimta
1626231|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1626232|NCT00297089|pemetrexed|pemetrexed
1626233|NCT00297076|HIV-1|hiv-1
1626234|NCT00297076|GW873140|gw873140
1626235|NCT00297076|CCR5 antagonist|ccr5 antagonist
1626236|NCT00297076|experienced|experienced
1626237|NCT00297076|Treatment Experienced|treatment experienced
1626238|NCT00297063|rosiglitazone|rosiglitazone
1626239|NCT00297063|vandia|vandia
1626240|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
1626241|NCT00297063|diabetes;|diabetes;
1626242|NCT00297050|Influenza Virus|influenza virus
1626243|NCT00297050|Avian Influenza|avian influenza
1626244|NCT00297050|Normal Volunteers|normal volunteers
1626245|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
1626246|NCT00297050|Viral Disease|viral disease
1626247|NCT00297050|Healthy Volunteer|healthy volunteer
1626248|NCT00297050|HV|hv
1626249|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
1626250|NCT00296985|Cardiac surgery|cardiac surgery
1626251|NCT00296985|Cellsaver|cellsaver
1626252|NCT00296985|Neurocognitive Function|neurocognitive function
1626253|NCT00296985|Neuronal Protection|neuronal protection
1626254|NCT00296985|Quality of Life|quality of life
1626255|NCT00296972|peg interferon|peg interferon
1626256|NCT00296972|ribavirin|ribavirin
1626257|NCT00296972|HAART|haart
1626258|NCT00296972|HIV|hiv
1626259|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
1626260|NCT00296972|Treatment Experienced|treatment experienced
1626261|NCT00296959|Dyskinesia|dyskinesia
1626262|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
1626263|NCT00296946|Sialorrhoea|sialorrhoea
1626264|NCT00296933|Major Depression|major depression
1626265|NCT00296933|Antidepressant|antidepressant
1626266|NCT00296933|Pharmacotherapy|pharmacotherapy
1626267|NCT00296933|Memory functioning|memory functioning
1626268|NCT00296933|Memory Impairment|memory impairment
1626269|NCT00296920|Deep Brain Stimulation|deep brain stimulation
1626270|NCT00296920|Treatment failure|treatment failure
1626271|NCT00296907|cancer|cancer
1626272|NCT00296907|siblings|siblings
1626273|NCT00296907|behavior|behavior
1626274|NCT00296907|psychological adaptation|psychological adaptation
1626275|NCT00296907|intervention|intervention
1626276|NCT00296881|Periodontitis|periodontitis
1626277|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
1626278|NCT00296881|PERIOWAVE|periowave
1626279|NCT00296881|Scaling and Root Planing|scaling and root planing
1626280|NCT00296881|SRP|srp
1626281|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
1626282|NCT00296868|ascorbic acid|ascorbic acid
1626283|NCT00296868|primary prevention|primary prevention
1626284|NCT00296868|radius fractures|radius fractures
1626285|NCT00296855|Peripheral artery disease|peripheral artery disease
1626842|NCT00295581|Human|human
1626286|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
1626287|NCT00296842|children|children
1626288|NCT00296842|injury|injury
1626289|NCT00296842|road traffic accident|road traffic accident
1626290|NCT00296829|Influenza;|influenza;
1626291|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
1626292|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
1626293|NCT00296829|Elderly.|elderly.
1626294|NCT00296803|metabolic syndrome|metabolic syndrome
1626295|NCT00296777|Major Depression|major depression
1626296|NCT00296777|Dysthymia|dysthymia
1626297|NCT00296777|f-MRI|f-mri
1626298|NCT00296777|Escitalopram|escitalopram
1626299|NCT00296777|Bupropion|bupropion
1626300|NCT00296777|Imipramine|imipramine
1626301|NCT00296777|Neuropsychologic test|neuropsychologic test
1626302|NCT00296777|Dichotic listening|dichotic listening
1626303|NCT00296777|EEG|eeg
1626304|NCT00296777|ERP|erp
1626305|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
1626306|NCT00296764|Developmental Disorders|developmental disorders
1626307|NCT00296725|Major Depression|major depression
1626308|NCT00296725|Dysthymia|dysthymia
1626309|NCT00296725|Depression NOS|depression nos
1626310|NCT00296725|Dichotic Listening|dichotic listening
1626311|NCT00296725|Fluoxetine|fluoxetine
1626312|NCT00296725|Imipramine|imipramine
1626313|NCT00296725|Placebo|placebo
1626314|NCT00296725|Predictors|predictors
1626315|NCT00296712|Major Depression|major depression
1626316|NCT00296712|Dysthymia|dysthymia
1626317|NCT00296712|Depression NOS|depression nos
1626318|NCT00296712|Escitalopram|escitalopram
1626319|NCT00296712|Bupropion|bupropion
1626320|NCT00296712|Dual Therapy|dual therapy
1626321|NCT00296712|Combination Therapy|combination therapy
1626322|NCT00296699|Atypical Depression|atypical depression
1626323|NCT00296699|Major Depressive Disorder|major depressive disorder
1626324|NCT00296699|Dysthymic Disorder|dysthymic disorder
1626325|NCT00296699|Atypical Features|atypical features
1626326|NCT00296699|Duloxetine|duloxetine
1626327|NCT00296686|Major Depression|major depression
1626328|NCT00296686|Refractory Depression|refractory depression
1626329|NCT00296686|Tranylcypromine|tranylcypromine
1626330|NCT00296686|Dextroamphetamine|dextroamphetamine
1626331|NCT00296686|Triiodothyronine|triiodothyronine
1626332|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
1626333|NCT00296660|Acute Infection|acute infection
1626334|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
1626335|NCT00296621|glutamine|glutamine
1626336|NCT00296621|nutrition|nutrition
1626337|NCT00296621|children|children
1626338|NCT00296621|pediatrics|pediatrics
1626339|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
1626340|NCT00296621|therapy|therapy
1626341|NCT00296621|supplement|supplement
1626342|NCT00296621|oral administration|oral administration
1626343|NCT00296621|handicap|handicap
1626344|NCT00296608|stage II rectal cancer|stage ii rectal cancer
1626345|NCT00296608|stage III rectal cancer|stage iii rectal cancer
1626346|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1626347|NCT00296556|Ulcerative colitis|ulcerative colitis
1626348|NCT00296556|EP4 agonist|ep4 agonist
1626349|NCT00296556|PGE2|pge2
1626350|NCT00296543|hemodialysis|hemodialysis
1626351|NCT00296543|sudden cardiac death|sudden cardiac death
1626352|NCT00296530|Asthma|asthma
1626353|NCT00296530|Allergic Rhinitis|allergic rhinitis
1626354|NCT00296517|depression|depression
1626355|NCT00296517|double-blind|double-blind
1626356|NCT00296517|placebo-controlled|placebo-controlled
1626357|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
1626358|NCT00296517|SSRI|ssri
1626359|NCT00296517|comparative study|comparative study
1626360|NCT00296517|non-responder|non-responder
1626361|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
1626362|NCT00296504|fosamprenavir|fosamprenavir
1626363|NCT00296504|HIV-1|hiv-1
1626364|NCT00296504|protease inhibitor|protease inhibitor
1626365|NCT00296504|pro-drug|pro-drug
1626366|NCT00296504|antiretroviral therapy|antiretroviral therapy
1626367|NCT00296504|LEXIVA|lexiva
1626368|NCT00296504|AGENERASE|agenerase
1626369|NCT00296504|GW433908|gw433908
1626370|NCT00296504|amprenavir|amprenavir
1626371|NCT00296491|Allergic Rhinitis|allergic rhinitis
1626372|NCT00296491|Asthma|asthma
1626373|NCT00296452|cancer|cancer
1626374|NCT00296452|nutrition|nutrition
1626375|NCT00296426|Adverse Drug Event|adverse drug event
1626376|NCT00296426|Inpatients|inpatients
1626377|NCT00296426|Outcome assessment|outcome assessment
1626379|NCT00296413|menstrual cycle|menstrual cycle
1626380|NCT00296413|valproate|valproate
1626381|NCT00296413|lamotrigine|lamotrigine
1626382|NCT00296413|oral contraceptive|oral contraceptive
1626383|NCT00296400|Hyperlipidemia|hyperlipidemia
1626384|NCT00296400|Proteinuria|proteinuria
1626385|NCT00296400|Diabetes Mellitus|diabetes mellitus
1626386|NCT00296374|Hyperlipidemia|hyperlipidemia
1626387|NCT00296374|Proteinuria|proteinuria
1626388|NCT00296374|Diabetes Mellitus|diabetes mellitus
1626389|NCT00296361|Tacrolimus|tacrolimus
1626390|NCT00296361|Kidney Transplantation|kidney transplantation
1626391|NCT00296361|Immunosuppression|immunosuppression
1626392|NCT00296361|Adult|adult
1626393|NCT00296361|Treatment Outcomes|treatment outcomes
1626394|NCT00296348|Tacrolimus|tacrolimus
1626395|NCT00296348|Kidney Transplantation|kidney transplantation
1626396|NCT00296348|Child|child
1626397|NCT00296348|Treatment Outcome|treatment outcome
1626398|NCT00296348|Immunosuppression|immunosuppression
1626399|NCT00296335|Stomach cancer|stomach cancer
1626400|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
1626401|NCT00296335|Mitomycin|mitomycin
1626402|NCT00296335|Cisplatin|cisplatin
1626403|NCT00296335|Doxifluridine|doxifluridine
1626404|NCT00296322|stomach cancer|stomach cancer
1626405|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
1626406|NCT00296322|mitomycin|mitomycin
1626407|NCT00296322|cisplatin|cisplatin
1626408|NCT00296322|doxifluridine|doxifluridine
1626409|NCT00296309|Tacrolimus|tacrolimus
1626410|NCT00296309|Kidney Transplantation|kidney transplantation
1626411|NCT00296309|Immunosuppression|immunosuppression
1626412|NCT00296309|Adult|adult
1626413|NCT00296309|Treatment Outcomes|treatment outcomes
1626414|NCT00296296|kidney Transplant|kidney transplant
1626415|NCT00296296|Type II Diabetes|type ii diabetes
1626416|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
1626417|NCT00296296|Immunosuppression|immunosuppression
1626418|NCT00296296|Cyclosporin|cyclosporin
1626419|NCT00296296|Tacrolimus|tacrolimus
1626420|NCT00296283|Relatives|relatives
1626421|NCT00296283|Bipolar Disorder|bipolar disorder
1626422|NCT00296283|Psychoeducation|psychoeducation
1626423|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
1626424|NCT00296244|liver transplantation|liver transplantation
1626425|NCT00296231|premature infants|premature infants
1626426|NCT00296231|very low birthweight infants|very low birthweight infants
1626427|NCT00296231|high frequency ventilation|high frequency ventilation
1626428|NCT00296231|nasal ventilation|nasal ventilation
1626782|NCT00295789|cisplatin|cisplatin
1626429|NCT00296205|Multiple Sclerosis|multiple sclerosis
1626430|NCT00296205|Cyclophosphamide|cyclophosphamide
1626431|NCT00296205|autoimmune|autoimmune
1626432|NCT00296192|Rotigotine|rotigotine
1626433|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
1626434|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
1626435|NCT00296192|Parkinson's disease|parkinson's disease
1626436|NCT00296166|Atrial fibrillation|atrial fibrillation
1626437|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
1626438|NCT00296166|catheter ablation|catheter ablation
1626439|NCT00296166|thoracoscopy|thoracoscopy
1626440|NCT00296166|Arrhythmia|arrhythmia
1626441|NCT00296166|Heart|heart
1626442|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
1626443|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
1626444|NCT00296153|Ischemic Heart Disease|ischemic heart disease
1626445|NCT00296153|OMACOR|omacor
1626446|NCT00296153|Triglycerides|triglycerides
1626447|NCT00296153|Endothelial function|endothelial function
1626448|NCT00296153|Treatment Experienced|treatment experienced
1626449|NCT00296140|post-stroke depression|post-stroke depression
1626450|NCT00296140|clinical reminder|clinical reminder
1626451|NCT00296140|self-management|self-management
1626452|NCT00296114|Cancer|cancer
1626453|NCT00296114|Pancreas|pancreas
1626454|NCT00296101|Physical Inactivity|physical inactivity
1626455|NCT00296088|Mechanical Ventilation|mechanical ventilation
1626456|NCT00296088|Critical Care|critical care
1626457|NCT00296088|Respiratory Failure|respiratory failure
1626458|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1626459|NCT00296062|stage III colon cancer|stage iii colon cancer
1626460|NCT00296062|stage IV colon cancer|stage iv colon cancer
1626461|NCT00296062|stage III rectal cancer|stage iii rectal cancer
1626462|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
1626463|NCT00296062|recurrent colon cancer|recurrent colon cancer
1626464|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
1626465|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1626466|NCT00296049|infection|infection
1626467|NCT00296049|neutropenia|neutropenia
1626468|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1626469|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1626470|NCT00296036|stage I breast cancer|stage i breast cancer
1626471|NCT00296036|stage II breast cancer|stage ii breast cancer
1626472|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
1626473|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
1626474|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
1626475|NCT00296036|stage IV breast cancer|stage iv breast cancer
1626476|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1626477|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1626478|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1626479|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1626480|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1626481|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1626482|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1626483|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1626484|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1626485|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1626486|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1626487|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1626488|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1626489|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1626490|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1626491|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1626492|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1626493|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1626494|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1626495|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1626496|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1626497|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1626498|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1626499|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1626500|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1626501|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1626502|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1626503|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1626504|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1626505|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1626506|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1626507|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1626508|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1626509|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1626510|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1626511|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1626512|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1626513|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1626514|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1626515|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1626516|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
1626517|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
1626518|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1626519|NCT00296023|primary myelofibrosis|primary myelofibrosis
1626520|NCT00296023|polycythemia vera|polycythemia vera
1626521|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
1626522|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1626523|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1626524|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1626525|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1626526|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1626527|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1626528|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1626529|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
1626530|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1626531|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1626532|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1626533|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
1626534|NCT00296023|essential thrombocythemia|essential thrombocythemia
1626535|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1626536|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1626537|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1626675|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
1626538|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1626539|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1626540|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1626541|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1626542|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
1626543|NCT00296010|stage I breast cancer|stage i breast cancer
1626544|NCT00296010|stage II breast cancer|stage ii breast cancer
1626545|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
1626546|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1626547|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1626548|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1626549|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1626550|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1626551|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1626552|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1626553|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1626554|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1626555|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1626556|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1626557|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1626558|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1626559|NCT00295997|primary myelofibrosis|primary myelofibrosis
1626560|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1626561|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1626562|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1626563|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1626564|NCT00295997|essential thrombocythemia|essential thrombocythemia
1626565|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1626566|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1626567|NCT00295997|polycythemia vera|polycythemia vera
1626783|NCT00295789|carboplatin|carboplatin
1626568|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1626569|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1626570|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
1626571|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1626572|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1626573|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1626574|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1626575|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1626576|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1626577|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1626578|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1626579|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1626580|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1626581|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1626582|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1626583|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1626584|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
1626585|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1626586|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1626587|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1626588|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
1626589|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1626590|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1626591|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1626592|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1626593|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
1626594|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1626595|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1626596|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1626597|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1626598|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
1626599|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
1626600|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1626601|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1626747|NCT00295854|frequency|frequency
1626748|NCT00295854|MN-001|mn-001
1626602|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1626603|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1626604|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1626605|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
1626606|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1626607|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1626608|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1626609|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1626610|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1626611|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1626612|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1626613|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1626614|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1626615|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1626616|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
1626617|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
1626618|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
1626619|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1626620|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1626621|NCT00295958|recurrent melanoma|recurrent melanoma
1626622|NCT00295958|stage IV melanoma|stage iv melanoma
1626623|NCT00295958|skin cancer|skin cancer
1626624|NCT00295945|pain|pain
1626625|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
1626626|NCT00295945|stage III cervical cancer|stage iii cervical cancer
1626627|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
1626628|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
1626629|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
1626630|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
1626631|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
1626632|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
1626633|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
1626634|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
1626635|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
1626636|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
1626637|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1626638|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1626639|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
1626640|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
1626641|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
1626642|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
1626643|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
1626644|NCT00295945|ovarian sarcoma|ovarian sarcoma
1626645|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1626646|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1626647|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1626648|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1626649|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
1626650|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1626651|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
1626652|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
1626653|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
1626654|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
1626655|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
1626656|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
1626657|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1626658|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1626659|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1626660|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1626661|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
1626662|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
1626663|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1626664|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1626665|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1626666|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1626667|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1626668|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1626669|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1626670|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
1626671|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
1626672|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
1626673|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
1626674|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
1626676|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
1626677|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
1626678|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
1626679|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1626680|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1626681|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1626682|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1627609|NCT00293189|genetics|genetics
1626683|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1626684|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1626685|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1626686|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1626687|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1626688|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1626689|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1626690|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1626691|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
1626692|NCT00295906|melanoma|melanoma
1626693|NCT00295906|skin cancer|skin cancer
1626694|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
1626695|NCT00295893|stage II breast cancer|stage ii breast cancer
1626696|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
1626697|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
1626698|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
1626699|NCT00295893|male breast cancer|male breast cancer
1626700|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
1626701|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
1626702|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1626703|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1626704|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
1626705|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
1626706|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1626784|NCT00295789|paclitaxel|paclitaxel
1626707|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1626708|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1626709|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1626710|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1626711|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
1626712|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1626713|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1626714|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1626715|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1626716|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1626717|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1626718|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
1626719|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1626720|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
1626721|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
1626722|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
1626723|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
1626724|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
1626725|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
1626726|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
1626727|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
1626728|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
1626729|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1626730|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1626731|NCT00295880|refractory anemia|refractory anemia
1626732|NCT00295880|refractory cytopenia|refractory cytopenia
1626733|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
1626734|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
1626735|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1626736|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1626737|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1626738|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
1626739|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1626740|NCT00295867|stage I breast cancer|stage i breast cancer
1626741|NCT00295867|stage II breast cancer|stage ii breast cancer
1626742|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
1626743|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
1626744|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
1626745|NCT00295854|Interstitial Cystitis|interstitial cystitis
1626746|NCT00295854|urgency|urgency
1626749|NCT00295854|Global Response Assessment|global response assessment
1626750|NCT00295854|bladder pain/urgency|bladder pain/urgency
1626751|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
1626752|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1626753|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1626754|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1626841|NCT00295594|Immunosuppression|immunosuppression
1626755|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1626756|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1626757|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1626758|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
1626759|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1626760|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1626761|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1626762|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1626763|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1626764|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1626765|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1626766|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1626767|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1626768|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1626769|NCT00295828|VEGF|vegf
1626770|NCT00295828|iris neovascularization|iris neovascularization
1626771|NCT00295828|diabetic retinopathy|diabetic retinopathy
1626772|NCT00295828|Macugen|macugen
1626773|NCT00295802|Prostate Cancer|prostate cancer
1626774|NCT00295802|HIFU|hifu
1626775|NCT00295802|EDAP|edap
1626776|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
1626777|NCT00295789|cervical cancer|cervical cancer
1626778|NCT00295789|palliative chemotherapy|palliative chemotherapy
1626779|NCT00295789|recurrent|recurrent
1626780|NCT00295789|persistent|persistent
1626781|NCT00295789|stageⅣb|stageⅳb
1626785|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
1626786|NCT00295776|Exclusion Criteria:|exclusion criteria:
1626787|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
1626788|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
1626789|NCT00295776|Pregnant and lactating,|pregnant and lactating,
1626790|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
1626791|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
1626792|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
1626793|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
1626794|NCT00295763|recombinant human TSH|recombinant human tsh
1626795|NCT00295763|Thyrogen|thyrogen
1626796|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
1626797|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
1626798|NCT00295763|radioiodine|radioiodine
1626799|NCT00295750|Prostate Cancer|prostate cancer
1626800|NCT00295737|allergic rhinitis|allergic rhinitis
1626801|NCT00295724|bicifadine|bicifadine
1626802|NCT00295724|chronic low back pain|chronic low back pain
1626803|NCT00295711|bicifadine|bicifadine
1626804|NCT00295711|chronic low back pain|chronic low back pain
1626805|NCT00295698|HIV|hiv
1626806|NCT00295698|Lymphatic filariasis|lymphatic filariasis
1626807|NCT00295698|Diethylcarbamazine|diethylcarbamazine
1626808|NCT00295698|Interaction|interaction
1626809|NCT00295698|Tanzania|tanzania
1626810|NCT00295685|Reflux|reflux
1626811|NCT00295685|GERD|gerd
1626812|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
1626813|NCT00295659|Gestational Diabetes|gestational diabetes
1626814|NCT00295659|Screening|screening
1626815|NCT00295659|Cost-effectiveness|cost-effectiveness
1626816|NCT00295659|obstetrical outcomes|obstetrical outcomes
1626817|NCT00295646|ABCSG|abcsg
1626818|NCT00295646|12|12
1626819|NCT00295646|Phase 3|phase 3
1626820|NCT00295646|breast cancer|breast cancer
1626821|NCT00295646|anastrozole|anastrozole
1626822|NCT00295646|tamoxifen|tamoxifen
1626823|NCT00295646|zoledronic acid|zoledronic acid
1626824|NCT00295646|premenopausal|premenopausal
1626825|NCT00295646|hormone receptor-positive|hormone receptor-positive
1626826|NCT00295646|Stage I|stage i
1626827|NCT00295646|Stage II|stage ii
1626828|NCT00295646|bone mineral density|bone mineral density
1626829|NCT00295646|BMD|bmd
1626830|NCT00295646|bisphosphonate|bisphosphonate
1626831|NCT00295646|zoledronate|zoledronate
1626832|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
1626833|NCT00295607|Tacrolimus|tacrolimus
1626834|NCT00295607|Liver Transplantation|liver transplantation
1626835|NCT00295607|Immunosuppression|immunosuppression
1626836|NCT00295607|Adult|adult
1626837|NCT00295607|Treatment Outcome|treatment outcome
1626838|NCT00295594|Tacrolimus|tacrolimus
1626839|NCT00295594|Liver Transplantation|liver transplantation
1626840|NCT00295594|Treatment Outcome|treatment outcome
1626843|NCT00295581|Clinical Trial|clinical trial
1626844|NCT00295581|Mosquito|mosquito
1626845|NCT00295581|Healthy Volunteer|healthy volunteer
1626847|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1626848|NCT00295568|Motor Learning|motor learning
1626849|NCT00295568|Accuracy|accuracy
1626850|NCT00295568|Tracking Motor Task|tracking motor task
1626851|NCT00295568|Healthy Volunteer|healthy volunteer
1626852|NCT00295568|HV|hv
1626853|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1626854|NCT00295555|doxazosin|doxazosin
1626855|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
1626856|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
1626857|NCT00295555|diabetic nephropathy|diabetic nephropathy
1626858|NCT00295555|essential hypertension|essential hypertension
1626859|NCT00295555|power spectral analysis|power spectral analysis
1626860|NCT00295555|morning surge|morning surge
1626987|NCT00294918|Serostim®|serostim®
1626861|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1626862|NCT00295542|cardiovascular risk|cardiovascular risk
1626863|NCT00295542|chronotherapy|chronotherapy
1626864|NCT00295542|circadian pattern|circadian pattern
1626865|NCT00295529|Primary health care|primary health care
1626866|NCT00295529|Breast neoplasm|breast neoplasm
1626867|NCT00295529|Education|education
1626868|NCT00295516|Rhesus|rhesus
1626869|NCT00295516|Isoimmunization|isoimmunization
1626870|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
1626871|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
1626872|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
1626873|NCT00295503|mesothelioma|mesothelioma
1626874|NCT00295503|bevacizumab|bevacizumab
1626875|NCT00295503|chemotherapy|chemotherapy
1626876|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
1626877|NCT00295490|phase II|phase ii
1626878|NCT00295490|Devil's Claw|devil's claw
1626879|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
1626880|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
1626881|NCT00295477|HIV|hiv
1626882|NCT00295477|Treatment Experienced|treatment experienced
1626883|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
1626884|NCT00295464|Premature birth|premature birth
1626885|NCT00295438|robot-based tele-echography|robot-based tele-echography
1626886|NCT00295438|tele-medicine|tele-medicine
1626887|NCT00295425|psoriasis|psoriasis
1626888|NCT00295425|randomized clinical trial|randomized clinical trial
1626889|NCT00295425|cyclosporine A|cyclosporine a
1626890|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
1626891|NCT00295425|immunosuppression|immunosuppression
1626892|NCT00295399|cerebrovascular accident|cerebrovascular accident
1626893|NCT00295399|traumatic brain injury|traumatic brain injury
1626894|NCT00295399|stroke|stroke
1626895|NCT00295399|telerehabilitation|telerehabilitation
1626896|NCT00295373|Hypercholesterolemia|hypercholesterolemia
1626897|NCT00295373|Exercise|exercise
1626898|NCT00295373|Statin|statin
1626899|NCT00295373|Rosuvastatin|rosuvastatin
1626900|NCT00295373|TLR4|tlr4
1626901|NCT00295373|Inflammation|inflammation
1626902|NCT00295360|cholestasis|cholestasis
1626903|NCT00295360|BCRP|bcrp
1626904|NCT00295360|multidrug resistance|multidrug resistance
1626905|NCT00295360|duodenum|duodenum
1626906|NCT00295360|bile acids|bile acids
1626907|NCT00295360|ABCG2|abcg2
1626908|NCT00295334|adherence|adherence
1626909|NCT00295334|glycemic control|glycemic control
1626910|NCT00295308|Opioid Dependence|opioid dependence
1626911|NCT00295308|Clonidine|clonidine
1626912|NCT00295308|Buprenorphine|buprenorphine
1626913|NCT00295308|Opioid Abstinence|opioid abstinence
1626914|NCT00295308|Relapse|relapse
1626915|NCT00295295|vibration|vibration
1626916|NCT00295295|bone density|bone density
1626917|NCT00295282|Ulcerative Colitis|ulcerative colitis
1626918|NCT00295282|UC|uc
1626919|NCT00295282|Colitis|colitis
1626920|NCT00295256|randomized trial|randomized trial
1626921|NCT00295256|diabetes|diabetes
1626922|NCT00295256|pregnancy|pregnancy
1626923|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
1626924|NCT00295230|very low birth weight infant|very low birth weight infant
1626925|NCT00295230|mechanical ventilation|mechanical ventilation
1626926|NCT00295217|Fibroids|fibroids
1626927|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
1626928|NCT00295217|ExAblate|exablate
1626929|NCT00295217|MrgFUS|mrgfus
1626930|NCT00295204|Syncope|syncope
1626931|NCT00295204|pre-syncope|pre-syncope
1626932|NCT00295204|palpitations|palpitations
1626933|NCT00295191|end-stage renal disease|end-stage renal disease
1626934|NCT00295191|hemodialysis|hemodialysis
1626935|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
1626936|NCT00295191|high flux dialyser|high flux dialyser
1626937|NCT00295191|ultrapure dialysate|ultrapure dialysate
1626938|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
1626939|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
1626940|NCT00295191|atherosclerosis|atherosclerosis
1626941|NCT00295152|elderly/aged|elderly/aged
1626942|NCT00295152|occupational therapy|occupational therapy
1626943|NCT00295152|daily activities|daily activities
1626944|NCT00295152|caregivers|caregivers
1626945|NCT00295152|sense of competence|sense of competence
1626946|NCT00295139|treatment|treatment
1626947|NCT00295139|dual diagnosis|dual diagnosis
1626948|NCT00295126|Edentulous|edentulous
1626949|NCT00295126|Tooth Loss|tooth loss
1626950|NCT00295126|APC|apc
1626951|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
1626952|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
1626953|NCT00295113|COPD|copd
1626954|NCT00295113|Cardiac output|cardiac output
1626955|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
1626956|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
1626957|NCT00295100|Tamoxifen|tamoxifen
1626958|NCT00295100|Prevention|prevention
1626959|NCT00295100|Breast Cancer|breast cancer
1626960|NCT00295100|MRI|mri
1626961|NCT00295087|Premature Ovarian Failure|premature ovarian failure
1626962|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
1626963|NCT00295074|traumatic brain injury|traumatic brain injury
1626964|NCT00295074|head injury|head injury
1626965|NCT00295074|concussion|concussion
1626966|NCT00295074|neuropsychologic test|neuropsychologic test
1626967|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
1626968|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
1626969|NCT00295061|pulmonary emphysema|pulmonary emphysema
1626970|NCT00295048|treatment|treatment
1626971|NCT00295048|cognition|cognition
1626972|NCT00295048|schizophrenia|schizophrenia
1626973|NCT00295022|Levocetirizine|levocetirizine
1626974|NCT00295022|Xyzal|xyzal
1626975|NCT00295022|Rhinitis|rhinitis
1626976|NCT00295022|Allergic|allergic
1626977|NCT00295022|Seasonal|seasonal
1626978|NCT00295022|Ragweed|ragweed
1626979|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
1626980|NCT00294996|Myocet|myocet
1627286|NCT00293813|Extreme CT|extreme ct
1626981|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
1626982|NCT00294996|trastuzumab|trastuzumab
1626983|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
1626984|NCT00294931|Extensive|extensive
1626985|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
1626986|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
1626988|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
1626989|NCT00294905|COPD|copd
1626990|NCT00294905|smoking cessation|smoking cessation
1626991|NCT00294905|implementation|implementation
1626992|NCT00294905|patient counseling|patient counseling
1626993|NCT00294905|general practice|general practice
1626994|NCT00294892|HIV|hiv
1626995|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
1626996|NCT00294892|nevirapine resistance|nevirapine resistance
1626997|NCT00294892|pharmacokinetics|pharmacokinetics
1626998|NCT00294892|Treatment Naive|treatment naive
1626999|NCT00294866|End Stage Renal Disease|end stage renal disease
1627000|NCT00294866|Inflammation|inflammation
1627001|NCT00294853|Coronary calcium score|coronary calcium score
1627002|NCT00294853|Coronary artery disease|coronary artery disease
1627003|NCT00294853|Cardiac transplantation|cardiac transplantation
1627004|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
1627005|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
1627006|NCT00294827|Liver transplantation|liver transplantation
1627007|NCT00294814|Cardiac Surgery|cardiac surgery
1627008|NCT00294814|CABG|cabg
1627009|NCT00294814|Microemboli|microemboli
1627010|NCT00294814|Transcranial Doppler|transcranial doppler
1627011|NCT00294814|Cognitive Decline|cognitive decline
1627012|NCT00294814|Anastomotic Device|anastomotic device
1627013|NCT00294814|Proximal Anastomosis|proximal anastomosis
1627014|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
1627015|NCT00294801|knee osteoarthritis|knee osteoarthritis
1627016|NCT00294788|Influenza|influenza
1627017|NCT00294788|bioadjuvant|bioadjuvant
1627018|NCT00294788|probiotic|probiotic
1627019|NCT00294788|HAI|hai
1627020|NCT00294788|immunity|immunity
1627021|NCT00294788|vaccine|vaccine
1627022|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
1627023|NCT00294775|diastolic dysfunction|diastolic dysfunction
1627024|NCT00294775|Reverse Remodelling|reverse remodelling
1627025|NCT00294762|NSCLC|nsclc
1627026|NCT00294762|Erlotinib|erlotinib
1627027|NCT00294762|Tarceva|tarceva
1627028|NCT00294762|Lung Cancer|lung cancer
1627029|NCT00294749|Prostate,|prostate,
1627030|NCT00294749|Infection,|infection,
1627032|NCT00294749|Antibiotic,|antibiotic,
1627033|NCT00294749|Prophylaxis|prophylaxis
1627034|NCT00294736|lung cancer|lung cancer
1627035|NCT00294736|erlotinib|erlotinib
1627036|NCT00294736|NSCLC|nsclc
1627037|NCT00294736|smokers|smokers
1627038|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
1627039|NCT00294697|polymorphisms|polymorphisms
1627040|NCT00294697|innate immune response|innate immune response
1627041|NCT00294697|immunomonitoring|immunomonitoring
1627042|NCT00294697|immuno paralysis|immuno paralysis
1627043|NCT00294684|biliary atresia|biliary atresia
1627044|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
1627045|NCT00294684|corticosteroids|corticosteroids
1627046|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
1627047|NCT00294671|familial amyloidosis|familial amyloidosis
1627048|NCT00294671|diflunisal|diflunisal
1627049|NCT00294671|amyloidosis|amyloidosis
1627050|NCT00294671|transthyretin|transthyretin
1627051|NCT00294671|peripheral neuropathy|peripheral neuropathy
1627052|NCT00294671|autonomic neuropathy|autonomic neuropathy
1627053|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
1627054|NCT00294658|myasthenia gravis|myasthenia gravis
1627055|NCT00294658|thymectomy|thymectomy
1627056|NCT00294658|prednisone|prednisone
1627057|NCT00294658|corticosteroid|corticosteroid
1627058|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
1627059|NCT00294658|ETTX|ettx
1627060|NCT00294658|MG|mg
1627061|NCT00294658|thymus|thymus
1627062|NCT00294658|thymoma|thymoma
1627063|NCT00294645|Remote Follow Up|remote follow up
1627064|NCT00294645|Diagnostic|diagnostic
1627065|NCT00294645|Bradycardia|bradycardia
1627066|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
1627067|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1627068|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
1627069|NCT00294632|Follicular Lymphoma|follicular lymphoma
1627070|NCT00294632|Lymphoma|lymphoma
1627071|NCT00294632|MCL|mcl
1627072|NCT00294632|Lenalidomide|lenalidomide
1627073|NCT00294632|CC-5013|cc-5013
1627074|NCT00294632|Revlimid™|revlimid™
1627075|NCT00294632|Rituximab|rituximab
1627076|NCT00294632|Rituxan|rituxan
1627077|NCT00294619|Growth hormone deficiency|growth hormone deficiency
1627078|NCT00294606|vasopressor agents|vasopressor agents
1627079|NCT00294606|carotid endarterectomy|carotid endarterectomy
1627080|NCT00294606|cardiac function|cardiac function
1627081|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
1627082|NCT00294606|wall motion abnormalities|wall motion abnormalities
1627083|NCT00294593|Down syndrome|down syndrome
1627084|NCT00294593|folinic acid therapy|folinic acid therapy
1627085|NCT00294593|cognitive functions|cognitive functions
1627086|NCT00294580|Malaria|malaria
1627087|NCT00294580|Cognition|cognition
1627088|NCT00294580|Prevention & control|prevention & control
1627089|NCT00294580|Anemia|anemia
1627090|NCT00294580|Chemoprophylaxis|chemoprophylaxis
1627091|NCT00294580|Mortality|mortality
1627092|NCT00294580|Children|children
1627093|NCT00294580|Randomized controlled trial|randomized controlled trial
1627094|NCT00294580|Education|education
1627095|NCT00294580|Long-term effects|long-term effects
1627096|NCT00294580|The Gambia|the gambia
1627097|NCT00294580|Africa, West|africa, west
1627098|NCT00294567|Hypertension|hypertension
1627099|NCT00294567|PCI|pci
1627100|NCT00294567|Calcium Channel Blockers|calcium channel blockers
1627101|NCT00294567|IVUS|ivus
1627102|NCT00294567|Plaque|plaque
1627103|NCT00294554|Parkinson's Disease|parkinson's disease
1627104|NCT00294554|Cognitive Impairment|cognitive impairment
1627105|NCT00294554|Dementia|dementia
1627106|NCT00294554|Memory|memory
1627107|NCT00294541|sickle cell disease|sickle cell disease
1627108|NCT00294541|sickle cell anemia|sickle cell anemia
1627109|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
1627110|NCT00294528|total knee arthroplasty|total knee arthroplasty
1627111|NCT00294528|range of motion|range of motion
1627112|NCT00294528|satisfaction|satisfaction
1627113|NCT00294489|HCV|hcv
1627114|NCT00294489|Fibrosis|fibrosis
1627115|NCT00294489|Breath test|breath test
1627116|NCT00294476|IVIg|ivig
1627117|NCT00294476|Cancer|cancer
1627118|NCT00294476|Melanoma|melanoma
1627119|NCT00294463|postmenopause|postmenopause
1627120|NCT00294463|endometrium|endometrium
1627121|NCT00294463|Gene Expression Profiling|gene expression profiling
1627122|NCT00294463|Histology, Comparative|histology, comparative
1627123|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
1627124|NCT00294463|Hormones|hormones
1627125|NCT00294437|Prostate Cancer|prostate cancer
1627126|NCT00294437|Zometa|zometa
1627127|NCT00294424|Waiting time|waiting time
1627128|NCT00294424|Total hip replacement|total hip replacement
1627129|NCT00294424|Total knee replacement|total knee replacement
1627130|NCT00294424|Quality of life|quality of life
1627131|NCT00294424|The15D|the15d
1627132|NCT00294424|Harris Hip Score|harris hip score
1627133|NCT00294424|Knee Score|knee score
1627134|NCT00294424|Pain measurement|pain measurement
1627135|NCT00294424|Cost-effectiveness|cost-effectiveness
1627136|NCT00294424|Medication|medication
1627137|NCT00294424|Health services|health services
1627138|NCT00294424|Social services|social services
1627139|NCT00294424|Randomized Controlled Trial|randomized controlled trial
1627140|NCT00294398|Asthma, Controller Medications|asthma, controller medications
1627141|NCT00294385|Breast Cancer|breast cancer
1627142|NCT00294385|Docetaxel|docetaxel
1627143|NCT00294359|colorectal neoplasm|colorectal neoplasm
1627144|NCT00294346|Social Anxiety Disorder|social anxiety disorder
1627145|NCT00294346|Social Phobia|social phobia
1627147|NCT00294320|Actinic Keratosis|actinic keratosis
1627148|NCT00294307|Nursing Models of Care|nursing models of care
1627149|NCT00294307|Collaborative Care|collaborative care
1627150|NCT00294307|Care Management|care management
1627151|NCT00294307|Transitional Care|transitional care
1627152|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
1627153|NCT00294307|Cognitive Impairment|cognitive impairment
1627154|NCT00294307|Dementia|dementia
1627155|NCT00294307|Delirium|delirium
1627157|NCT00294294|infant|infant
1627158|NCT00294281|Pain|pain
1627159|NCT00294281|Tenderness|tenderness
1627160|NCT00294281|Depression|depression
1627161|NCT00294281|Work Disability|work disability
1627162|NCT00294281|Physical Function|physical function
1627163|NCT00294281|Quality of Life|quality of life
1627164|NCT00294281|Chronic Pain|chronic pain
1627165|NCT00294268|obesity|obesity
1627166|NCT00294268|CBT|cbt
1627167|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
1627168|NCT00294268|weight loss maintenance|weight loss maintenance
1627169|NCT00294255|mixed mania|mixed mania
1627170|NCT00294255|depression|depression
1627171|NCT00294255|irritability|irritability
1627172|NCT00294242|pregnancy|pregnancy
1627173|NCT00294242|membranes sweeping|membranes sweeping
1627174|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
1627175|NCT00294229|Low back pain|low back pain
1627176|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
1627177|NCT00294229|Randomised controlled trial|randomised controlled trial
1627178|NCT00294216|Omacor|omacor
1627179|NCT00294216|Omega-3 PUFA|omega-3 pufa
1627180|NCT00294216|Endarterectomy|endarterectomy
1627181|NCT00294216|Carotid Plaque stability|carotid plaque stability
1627182|NCT00294216|Structural changes|structural changes
1627183|NCT00294216|inflammation|inflammation
1627184|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
1627287|NCT00293813|XCT|xct
1627185|NCT00294203|Post-Operative Care|post-operative care
1627186|NCT00294203|Fatigue|fatigue
1627187|NCT00294203|Quality of Life|quality of life
1627188|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
1627189|NCT00294203|Esophagectomy|esophagectomy
1627190|NCT00294203|Gastric Cancer|gastric cancer
1627191|NCT00294203|Hepatectomy|hepatectomy
1627192|NCT00294203|Pancreatic Cancer|pancreatic cancer
1627193|NCT00294203|Rectum|rectum
1627194|NCT00294190|Lung Cancer|lung cancer
1627195|NCT00294190|Extensive stage|extensive stage
1627196|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
1627197|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
1627198|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
1627199|NCT00294177|Molecular Conformation|molecular conformation
1627200|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
1627201|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
1627202|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
1627203|NCT00294164|Serostim®|serostim®
1627204|NCT00294164|Placebo|placebo
1627205|NCT00294151|breast cancer|breast cancer
1627206|NCT00294151|prostate cancer|prostate cancer
1627207|NCT00294151|vertebral metastasis|vertebral metastasis
1627208|NCT00294151|vertebroplasty|vertebroplasty
1627209|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
1627210|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
1627211|NCT00294125|Medical Food|medical food
1627212|NCT00294125|Botanicals|botanicals
1627213|NCT00294125|Phytochemicals|phytochemicals
1627214|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
1627215|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
1627216|NCT00294086|valsartan,|valsartan,
1627217|NCT00294086|chronic heart failure,|chronic heart failure,
1627218|NCT00294073|femoral block|femoral block
1627219|NCT00294073|fascia iliaca block|fascia iliaca block
1627220|NCT00294073|ACL repair|acl repair
1627221|NCT00294073|post-operative analgesia|post-operative analgesia
1627222|NCT00294073|knee surgery|knee surgery
1627223|NCT00294073|ACL damage|acl damage
1627224|NCT00294073|knee damage|knee damage
1627225|NCT00294060|Pacemaker|pacemaker
1627226|NCT00294060|Bradycardia|bradycardia
1627227|NCT00294047|Vaccine|vaccine
1627228|NCT00294047|Human papillomavirus|human papillomavirus
1627229|NCT00294047|Cervical Cancer|cervical cancer
1627230|NCT00294047|Cervical Infection|cervical infection
1627231|NCT00294034|Registry|registry
1627232|NCT00294034|Pacemaker|pacemaker
1627233|NCT00294034|Diagnostics|diagnostics
1627234|NCT00294008|Schizophrenia|schizophrenia
1627235|NCT00294008|Treatment adherence|treatment adherence
1627236|NCT00294008|Antipsychotic agents|antipsychotic agents
1627237|NCT00294008|Risperidone|risperidone
1627238|NCT00294008|Long-acting injectable|long-acting injectable
1627239|NCT00294008|Risperdal tablet|risperdal tablet
1627240|NCT00294008|Risperidal Consta|risperidal consta
1627241|NCT00293982|Patient satisfaction|patient satisfaction
1627242|NCT00293982|Patient expectations|patient expectations
1627243|NCT00293982|Pediatric emergency department|pediatric emergency department
1627244|NCT00293969|Pain|pain
1627245|NCT00293969|Morphine|morphine
1627246|NCT00293956|hypothyroxinemia|hypothyroxinemia
1627247|NCT00293956|full term infants|full term infants
1627248|NCT00293956|near term infants|near term infants
1627249|NCT00293956|respiratory distress|respiratory distress
1627250|NCT00293956|thyroid disease|thyroid disease
1627251|NCT00293943|Atrial fibrillation|atrial fibrillation
1627252|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
1627253|NCT00293943|Linear lesions|linear lesions
1627254|NCT00293930|Treatment Outcome|treatment outcome
1627255|NCT00293930|Tacrolimus|tacrolimus
1627257|NCT00293930|Psoriasis|psoriasis
1627258|NCT00293917|Treatment Outcome|treatment outcome
1627259|NCT00293917|Tacrolimus|tacrolimus
1627260|NCT00293917|Safety|safety
1627261|NCT00293917|Psoriasis|psoriasis
1627262|NCT00293904|Allergy|allergy
1627263|NCT00293904|Grass Pollen|grass pollen
1627264|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
1627265|NCT00293891|Treatment Outcome|treatment outcome
1627266|NCT00293891|Tacrolimus|tacrolimus
1627267|NCT00293891|Safety|safety
1627268|NCT00293891|Psoriasis|psoriasis
1627269|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
1627270|NCT00293852|Heart failure, Congestive|heart failure, congestive
1627271|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
1627272|NCT00293852|Ambulatory Care|ambulatory care
1627273|NCT00293852|Health behavior|health behavior
1627274|NCT00293839|bladder|bladder
1627275|NCT00293839|overactive|overactive
1627276|NCT00293826|ACR criteria|acr criteria
1627277|NCT00293826|methotrexate|methotrexate
1627278|NCT00293826|DMARDs|dmards
1627279|NCT00293826|patient reported outcomes|patient reported outcomes
1627280|NCT00293826|joint assessment|joint assessment
1627281|NCT00293813|Post Menopausal|post menopausal
1627282|NCT00293813|Osteoporosis|osteoporosis
1627283|NCT00293813|MicroCT|microct
1627284|NCT00293813|Amgen|amgen
1627285|NCT00293813|denosumab|denosumab
1627288|NCT00293813|Fosamax|fosamax
1627289|NCT00293813|Alendronate|alendronate
1627290|NCT00293800|Open-angle|open-angle
1627291|NCT00293800|glaucoma|glaucoma
1627292|NCT00293800|ocular|ocular
1627293|NCT00293800|hypertension|hypertension
1627294|NCT00293787|Open-angle|open-angle
1627295|NCT00293787|glaucoma|glaucoma
1627296|NCT00293787|ocular|ocular
1627297|NCT00293787|hypertension|hypertension
1627298|NCT00293774|Prospective|prospective
1627299|NCT00293774|Conventional therapy|conventional therapy
1627300|NCT00293774|Registry|registry
1627301|NCT00293774|Metal-on-metal|metal-on-metal
1627302|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
1627303|NCT00293774|Hip Arthroplasty|hip arthroplasty
1627304|NCT00293761|open-angle|open-angle
1627305|NCT00293761|glaucoma|glaucoma
1627306|NCT00293761|ocular|ocular
1627307|NCT00293761|hypertension|hypertension
1627308|NCT00293748|Genomics|genomics
1627309|NCT00293748|Statins|statins
1627310|NCT00293748|Coronary Heart Disease|coronary heart disease
1627311|NCT00293748|Stroke|stroke
1627312|NCT00293748|Inflammation|inflammation
1627313|NCT00293748|Gene Expression|gene expression
1627314|NCT00293748|Vascular Risk|vascular risk
1627315|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1627316|NCT00293748|Atorvastatin|atorvastatin
1627317|NCT00293748|Vascular Disease|vascular disease
1627318|NCT00293748|Vascular Disease Risk|vascular disease risk
1627319|NCT00293735|Preeclampsia|preeclampsia
1627320|NCT00293735|Pregnancy|pregnancy
1627321|NCT00293735|Hypertension|hypertension
1627322|NCT00293735|Eclampsia|eclampsia
1627323|NCT00293735|HELLP Syndrome|hellp syndrome
1627324|NCT00293735|Seizures|seizures
1627325|NCT00293735|Prevention|prevention
1627326|NCT00293722|Arthritis|arthritis
1627327|NCT00293709|Arthritis|arthritis
1627328|NCT00293696|biomarker study|biomarker study
1627329|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
1627330|NCT00293683|cesarean|cesarean
1627331|NCT00293683|closure|closure
1627332|NCT00293683|skin|skin
1627333|NCT00293683|staple|staple
1627334|NCT00293683|absorbable|absorbable
1627335|NCT00293683|metal|metal
1627336|NCT00293644|Pregnancy Complications|pregnancy complications
1627337|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
1627338|NCT00293644|Diclectin|diclectin
1627339|NCT00293644|doxylamine succinate|doxylamine succinate
1627340|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
1627341|NCT00293618|Implementation of prediction rules|implementation of prediction rules
1627342|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
1627343|NCT00293618|PONV|ponv
1627344|NCT00293618|Emesis|emesis
1627345|NCT00293618|Nausea|nausea
1627346|NCT00293618|Vomiting|vomiting
1627347|NCT00293618|Postoperative|postoperative
1627348|NCT00293618|Implementation|implementation
1627349|NCT00293618|prediction rule|prediction rule
1627350|NCT00293618|impact study|impact study
1627351|NCT00293618|decision support|decision support
1627352|NCT00293618|clinical decision support|clinical decision support
1627353|NCT00293605|aseptic loosening|aseptic loosening
1627354|NCT00293605|femoral stem design|femoral stem design
1627355|NCT00293592|Heart surgery|heart surgery
1627356|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
1627357|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
1627358|NCT00293579|head and neck cancer|head and neck cancer
1627359|NCT00293540|metastatic|metastatic
1627360|NCT00293540|secondary|secondary
1627361|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
1627362|NCT00293527|Metastatic|metastatic
1627363|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
1627364|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1627365|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
1627366|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
1627367|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1627368|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1627369|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1627370|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1627371|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1627372|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1627373|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1627374|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1627375|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1627376|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1627377|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1627378|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1627379|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1627380|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1627842|NCT00291902|CHD|chd
1627381|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1627382|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1627383|NCT00293462|mucositis|mucositis
1627384|NCT00293462|radiation toxicity|radiation toxicity
1627385|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
1627386|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
1627387|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
1627388|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
1627389|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1627390|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
1627391|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
1627392|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
1627393|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1627394|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1627395|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1627396|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1627397|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1627398|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1627399|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1627400|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1627401|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1627402|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1627403|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1627404|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1627405|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1627465|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1627406|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1627407|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1627408|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1627409|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1627410|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1627411|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1627412|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1627610|NCT00293189|p2x7|p2x7
1627413|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1627414|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1627415|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1627416|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1627417|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1627418|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1627419|NCT00293462|tongue cancer|tongue cancer
1627420|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1627421|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
1627422|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1627423|NCT00293423|adult glioblastoma|adult glioblastoma
1627424|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
1627425|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1627426|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1627427|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1627428|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1627429|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1627430|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1627431|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1627432|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1627433|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1627434|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1627435|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1627436|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1627437|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1627438|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1627439|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1627440|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
1627441|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1627442|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1627443|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
1627444|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1627445|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1627446|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1627447|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1627448|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1627449|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1627450|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1627451|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1627452|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1627453|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1627454|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1627455|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1627456|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1627457|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1627458|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1627459|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1627460|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1627461|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1627462|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1627463|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1627464|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1627466|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1627467|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1627468|NCT00293384|nausea and vomiting|nausea and vomiting
1627469|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1627470|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1627471|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1627472|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1627473|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1627474|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1627475|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1627476|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1627477|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1627478|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1627479|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1627480|NCT00293384|primary myelofibrosis|primary myelofibrosis
1627481|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1627482|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1627483|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1627484|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1627485|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
1627486|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1627487|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1627488|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1627489|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1627490|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1627491|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1627492|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1627493|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1627494|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1627495|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1627496|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1627497|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1627498|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1627499|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1627500|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1627501|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1627502|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1627503|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1627504|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1627505|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1627506|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1627507|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1627508|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1627509|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1627510|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1627511|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1627512|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1627513|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1627514|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1627515|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1627516|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1627517|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1627518|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1627519|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
1627520|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1627521|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1627522|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1627523|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1627524|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1627525|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
1627526|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
1627527|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1627528|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1627529|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1627530|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1627531|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
1627532|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
1627533|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1627534|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1627535|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1627611|NCT00293176|Cognitive impairment|cognitive impairment
1627536|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1627537|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1627538|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1627539|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1627540|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1627541|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1627542|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1627543|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1627544|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1627545|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1627546|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1627547|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
1627548|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1627549|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1627550|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1627551|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
1627552|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
1627553|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
1627554|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1627555|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1627556|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1627557|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1627558|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1627559|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1627560|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1627561|NCT00293384|stage IV breast cancer|stage iv breast cancer
1627562|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1627563|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1627564|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1627565|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1627566|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1627567|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1627568|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1627569|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1627570|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1627571|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
1627572|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
1627573|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1627574|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1627575|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1627576|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1627577|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1627578|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1627579|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1627580|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1627581|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
1627582|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1627583|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1627584|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1627585|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1627586|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
1627587|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1627588|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1627589|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
1627590|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1627591|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1627592|NCT00293280|large cell lung cancer|large cell lung cancer
1627593|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1627594|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
1627595|NCT00293267|Treatment Experienced|treatment experienced
1627596|NCT00293254|Treatment Experienced|treatment experienced
1627597|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
1627598|NCT00293228|Latent tuberculosis|latent tuberculosis
1627599|NCT00293228|biomarkers|biomarkers
1627600|NCT00293228|isoniazid|isoniazid
1627601|NCT00293228|ELISPOT|elispot
1627602|NCT00293228|PPD positive individuals|ppd positive individuals
1627603|NCT00293202|etanercept|etanercept
1627604|NCT00293202|malnutrition|malnutrition
1627605|NCT00293202|inflammation|inflammation
1627606|NCT00293202|hemodialysis|hemodialysis
1627607|NCT00293189|hip fracture|hip fracture
1627608|NCT00293189|epidemiology|epidemiology
1627613|NCT00293150|diastolic heart failure|diastolic heart failure
1627614|NCT00293150|heart failure|heart failure
1627615|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
1627616|NCT00293137|Heart Failure|heart failure
1627617|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1627618|NCT00293124|Glivec|glivec
1627619|NCT00293111|Multiple Myeloma|multiple myeloma
1627620|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
1627621|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
1627622|NCT00293098|Iron overload|iron overload
1627623|NCT00293098|Thalassemia|thalassemia
1627624|NCT00293098|Iron induced heart disease|iron induced heart disease
1627625|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
1627626|NCT00293098|Deferiprone|deferiprone
1627627|NCT00293085|NSCLC|nsclc
1627628|NCT00293085|Docetaxel|docetaxel
1627629|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
1627630|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
1627631|NCT00293046|Allergy|allergy
1627632|NCT00293033|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
1627633|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
1627634|NCT00292994|Metabolic Syndrome|metabolic syndrome
1627635|NCT00292994|Hyperlipidemia|hyperlipidemia
1627636|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
1627637|NCT00292994|Insulin resistance|insulin resistance
1627638|NCT00292994|Weight loss|weight loss
1627639|NCT00292994|Obesity|obesity
1627640|NCT00292994|Exercise|exercise
1627641|NCT00292994|Hypertension|hypertension
1627642|NCT00292981|C1 Inhibitor|c1 inhibitor
1627643|NCT00292981|Hereditary angioedema|hereditary angioedema
1627644|NCT00292981|Acute HAE attack|acute hae attack
1627645|NCT00292968|Health Behavior|health behavior
1627646|NCT00292968|Prevention|prevention
1627647|NCT00292968|Informatics|informatics
1627648|NCT00292968|Electronic Health Record|electronic health record
1627747|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
1627649|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
1627650|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
1627651|NCT00292942|artesunate|artesunate
1627652|NCT00292942|artemisinin|artemisinin
1627653|NCT00292942|falciparum|falciparum
1627654|NCT00292929|artesunate|artesunate
1627655|NCT00292929|artemisinin|artemisinin
1627656|NCT00292929|falciparum|falciparum
1627657|NCT00292916|whole body vibration|whole body vibration
1627658|NCT00292916|exercise|exercise
1627659|NCT00292916|elderly woman|elderly woman
1627660|NCT00292916|Bone Mineral Density|bone mineral density
1627661|NCT00292916|falls|falls
1627662|NCT00292916|higher age|higher age
1627663|NCT00292903|Perinatal Depression|perinatal depression
1627664|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
1627665|NCT00292890|injection devices|injection devices
1627666|NCT00292890|injection technique|injection technique
1627667|NCT00292890|insulin needles|insulin needles
1627668|NCT00292890|insulin administration|insulin administration
1627669|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
1627670|NCT00292864|Cancer|cancer
1627671|NCT00292864|Carcinoma|carcinoma
1627672|NCT00292864|Adenocarcinoma|adenocarcinoma
1627673|NCT00292864|Tumor|tumor
1627674|NCT00292864|Advanced solid tumors|advanced solid tumors
1627675|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
1627676|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
1627677|NCT00292825|vasovagal syncope|vasovagal syncope
1627678|NCT00292825|syncope|syncope
1627679|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
1627680|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
1627681|NCT00292825|pacing|pacing
1627682|NCT00292825|closed loop pacing|closed loop pacing
1627683|NCT00292825|tilt table|tilt table
1627684|NCT00292812|Infant nutrition|infant nutrition
1627685|NCT00292812|Nucleotides|nucleotides
1627686|NCT00292812|Infant formula|infant formula
1627687|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
1627688|NCT00292799|Obesity|obesity
1627689|NCT00292799|metformin|metformin
1627690|NCT00292799|orlistat|orlistat
1627691|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
1627692|NCT00292786|FES|fes
1627693|NCT00292786|Walking|walking
1627694|NCT00292786|Practice|practice
1627695|NCT00292786|Coordination|coordination
1627696|NCT00292786|Posture|posture
1627697|NCT00292773|Anovulation|anovulation
1627698|NCT00292773|Obesity|obesity
1627699|NCT00292773|bariatric surgery|bariatric surgery
1627700|NCT00292708|Antibiotics|antibiotics
1627701|NCT00292708|Prophylaxis|prophylaxis
1627702|NCT00292708|Surgical wound infection|surgical wound infection
1627703|NCT00292656|Allergy|allergy
1627704|NCT00292591|vitamin D|vitamin d
1627705|NCT00292591|cholecalciferol|cholecalciferol
1627706|NCT00292591|pregnancy|pregnancy
1627707|NCT00292591|bone mineral density|bone mineral density
1627708|NCT00292578|Allergy|allergy
1627709|NCT00292578|Sugar Intolerance|sugar intolerance
1627710|NCT00292578|Fatigue|fatigue
1627711|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1627712|NCT00292552|longitudinal|longitudinal
1627713|NCT00292552|eclipse|eclipse
1627714|NCT00292539|Pacemaker|pacemaker
1627715|NCT00292539|NYHA class|nyha class
1627716|NCT00292539|Ejection fraction|ejection fraction
1627717|NCT00292539|Heart Failure|heart failure
1627718|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
1627719|NCT00292526|Troponin|troponin
1627720|NCT00292526|Heart failure|heart failure
1627721|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
1627722|NCT00292474|coronary artery disease|coronary artery disease
1627723|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
1627724|NCT00292474|stent implant|stent implant
1627725|NCT00292474|drug-coated stent|drug-coated stent
1627726|NCT00292461|Epilepsy|epilepsy
1627727|NCT00292461|seizures|seizures
1627728|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
1627729|NCT00292422|Methotrexate|methotrexate
1627730|NCT00292422|Antirheumatic Agents|antirheumatic agents
1627731|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
1627732|NCT00292383|Atrial Fibrillation|atrial fibrillation
1627733|NCT00292383|Heart failure|heart failure
1627734|NCT00292383|Pacemaker leads|pacemaker leads
1627735|NCT00292383|Lead position|lead position
1627736|NCT00292383|Higher degree AV-Block|higher degree av-block
1627737|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
1627738|NCT00292370|Controlled Trial|controlled trial
1627739|NCT00292370|Paroxetine|paroxetine
1627740|NCT00292370|Quetiapine|quetiapine
1627741|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1627742|NCT00292370|Treatment refractory|treatment refractory
1627743|NCT00292370|Treatment resistant|treatment resistant
1627744|NCT00292344|Travelers' diarrhea|travelers' diarrhea
1627745|NCT00292344|rifaximin|rifaximin
1627746|NCT00292344|loperamide|loperamide
1627748|NCT00292331|gastric varices|gastric varices
1627749|NCT00292331|liver cirrhosis|liver cirrhosis
1627750|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
1627751|NCT00292331|rebleeding|rebleeding
1627752|NCT00292331|long-term|long-term
1627753|NCT00292318|adequate relief|adequate relief
1627754|NCT00292318|anorectal manometry|anorectal manometry
1627755|NCT00292318|biofeedback therapy|biofeedback therapy
1627756|NCT00292318|fecal incontinence|fecal incontinence
1627757|NCT00292305|PCI|pci
1627758|NCT00292305|Bifurcation lesion|bifurcation lesion
1627759|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
1627760|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
1627761|NCT00292279|Carcinoma surgery|carcinoma surgery
1627762|NCT00292279|Digestive System|digestive system
1627763|NCT00292279|Parenteral Nutrition|parenteral nutrition
1627764|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
1627765|NCT00292279|Clinical outcome|clinical outcome
1627766|NCT00292279|SIRS|sirs
1627767|NCT00292279|Infectious complication|infectious complication
1627768|NCT00292279|Postoperative hospital stay|postoperative hospital stay
1627769|NCT00292279|Cost of postoperative period|cost of postoperative period
1627770|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
1627771|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
1627772|NCT00292266|Rebif®|rebif®
1627773|NCT00292266|Avonex®|avonex®
1627774|NCT00292266|interferon-beta-1a|interferon-beta-1a
1627775|NCT00292253|MS|ms
1627776|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
1627777|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
1627778|NCT00292214|paracetamol|paracetamol
1627779|NCT00292214|acetaminophen|acetaminophen
1627780|NCT00292214|pharmacokinetic|pharmacokinetic
1627781|NCT00292214|intravenous|intravenous
1627782|NCT00292214|oral|oral
1627783|NCT00292214|analgesia|analgesia
1627784|NCT00292214|pain|pain
1627785|NCT00292214|opioid|opioid
1627786|NCT00292201|Asthma|asthma
1627787|NCT00292201|Statin|statin
1627788|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
1627789|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
1627790|NCT00292162|Chronic Heart Failure|chronic heart failure
1627791|NCT00292162|Atrial Fibrillation|atrial fibrillation
1627792|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
1627793|NCT00292136|Cocaine Dependence|cocaine dependence
1627794|NCT00292136|Drug Relapse|drug relapse
1627795|NCT00292136|Pharmacokinetics|pharmacokinetics
1627796|NCT00292136|EMA|ema
1627797|NCT00292136|Polydrug Abuse|polydrug abuse
1627798|NCT00292110|HIV|hiv
1627799|NCT00292110|Opiate Substitution|opiate substitution
1627800|NCT00292110|Pharmacokinetics|pharmacokinetics
1627801|NCT00292110|ECG|ecg
1627802|NCT00292110|Polydrug Abuse|polydrug abuse
1627803|NCT00292097|Respiratory failure|respiratory failure
1627804|NCT00292097|Tracheostomy|tracheostomy
1627805|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
1627806|NCT00292097|Endotracheal Conversion|endotracheal conversion
1627807|NCT00292097|Traumatic brain injury|traumatic brain injury
1627808|NCT00292084|Hepatitis C|hepatitis c
1627809|NCT00292084|Celgosivir|celgosivir
1627810|NCT00292084|HCV|hcv
1627811|NCT00292084|Genotype 1|genotype 1
1627812|NCT00292084|Non-responders|non-responders
1627813|NCT00292084|End of Treatment Response|end of treatment response
1627814|NCT00292084|Sustained Viral Response|sustained viral response
1627815|NCT00292058|Telepsychiatry|telepsychiatry
1627816|NCT00292058|Videoconference|videoconference
1627817|NCT00292058|Psychiatric consultation|psychiatric consultation
1627818|NCT00292058|Equivalence trial|equivalence trial
1627819|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
1627820|NCT00292032|cardiac arrest|cardiac arrest
1627821|NCT00292032|diagnosis|diagnosis
1627822|NCT00292032|genetics|genetics
1627823|NCT00292032|testing|testing
1627824|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
1627825|NCT00292006|pediatric|pediatric
1627826|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
1627827|NCT00291993|Vasoactive hormones|vasoactive hormones
1627828|NCT00291993|Blood pressure|blood pressure
1627829|NCT00291980|Dialysis|dialysis
1627830|NCT00291980|Pre-dialysis|pre-dialysis
1627831|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
1627832|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
1627833|NCT00291954|Dialysis|dialysis
1627834|NCT00291954|Pre-dialysis|pre-dialysis
1627835|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
1627836|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
1627837|NCT00291941|Dialysis|dialysis
1627838|NCT00291941|Pre-dialysis|pre-dialysis
1627839|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
1627840|NCT00291941|Prophylaxis|prophylaxis
1627841|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
1627843|NCT00291902|coronary heart disease|coronary heart disease
1627844|NCT00291902|atherosclerosis|atherosclerosis
1627845|NCT00291902|inflammation|inflammation
1627846|NCT00291876|HAVRIX™|havrix™
1627847|NCT00291876|Hepatitis A|hepatitis a
1627848|NCT00291863|end stage renal failure|end stage renal failure
1627849|NCT00291863|peritoneal dialysis|peritoneal dialysis
1627850|NCT00291863|simvastatin|simvastatin
1627851|NCT00291863|endothelium|endothelium
1627852|NCT00291863|vasodilation|vasodilation
1627853|NCT00291850|NSCLC|nsclc
1627854|NCT00291837|ovarian|ovarian
1627855|NCT00291837|CT-2106|ct-2106
1627856|NCT00291824|Cardiovascular risks|cardiovascular risks
1627857|NCT00291824|Motivational interviewing|motivational interviewing
1627858|NCT00291824|Behavior change|behavior change
1627859|NCT00291824|Primary care setting|primary care setting
1627860|NCT00291811|AMD3100|amd3100
1627861|NCT00291811|G-CSF|g-csf
1627862|NCT00291798|pilot study|pilot study
1627863|NCT00291798|exemestane|exemestane
1627864|NCT00291798|endocrinotherapy|endocrinotherapy
1627865|NCT00291798|mamma carcinoma|mamma carcinoma
1627866|NCT00291798|neoadjuvant|neoadjuvant
1627867|NCT00291798|ABCSG|abcsg
1627868|NCT00291798|17|17
1627869|NCT00291785|colorectal cancer|colorectal cancer
1627870|NCT00291785|camptothecin|camptothecin
1627871|NCT00291772|Type 1 Diabetes|type 1 diabetes
1627872|NCT00291772|hypoglycemia|hypoglycemia
1627873|NCT00291772|hyperglycemia|hyperglycemia
1627874|NCT00291746|GERD|gerd
1627875|NCT00291733|Levetiracetam|levetiracetam
1627876|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
1627877|NCT00291733|Parkinson's|parkinson's
1627878|NCT00291720|Aldosterone|aldosterone
1627879|NCT00291720|Spironolactone|spironolactone
1627880|NCT00291720|Chronic Kidney Disease|chronic kidney disease
1627881|NCT00291720|Arterial Stiffness|arterial stiffness
1627882|NCT00291707|head|head
1627883|NCT00291707|neck|neck
1627884|NCT00291707|Cetuximab|cetuximab
1627885|NCT00291707|Pemetrexed|pemetrexed
1627886|NCT00291694|breast atypia|breast atypia
1627887|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
1627888|NCT00291694|RCT|rct
1627889|NCT00291694|celecoxib|celecoxib
1627890|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
1627891|NCT00291694|placebo|placebo
1627892|NCT00291694|high risk for breast cancer|high risk for breast cancer
1627893|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
1627894|NCT00291694|ki-67|ki-67
1627895|NCT00291694|chemoprevention|chemoprevention
1627896|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
1627897|NCT00291681|B cell selection|b cell selection
1627898|NCT00291668|Crohn's Disease|crohn's disease
1627899|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
1627900|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
1627901|NCT00291655|LEVETIRACETAM|levetiracetam
1627902|NCT00291655|KEPPRA|keppra
1627903|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
1627904|NCT00291642|Levocetirizine, Xyzal, Rhinitis, Allergic, Seasonal, Ragweed|levocetirizine, xyzal, rhinitis, allergic, seasonal, ragweed
1627905|NCT00291629|Myocardial infarction|myocardial infarction
1627906|NCT00291629|revascularization|revascularization
1627907|NCT00291629|drug eluting stents|drug eluting stents
1627908|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
1627909|NCT00291603|dialysis|dialysis
1627910|NCT00291603|Renal Dialysis|renal dialysis
1627911|NCT00291603|inflammation|inflammation
1627912|NCT00291603|quality of life|quality of life
1627913|NCT00291603|End Stage Kidney Failure|end stage kidney failure
1627914|NCT00291590|diabetes|diabetes
1627915|NCT00291590|behavioral change|behavioral change
1627916|NCT00291590|chronic care model|chronic care model
1627917|NCT00291590|stage of change|stage of change
1627918|NCT00291590|Medicaid|medicaid
1627919|NCT00291590|Dual eligible|dual eligible
1627920|NCT00291590|ethnic|ethnic
1627921|NCT00291590|self-care|self-care
1627922|NCT00291577|advanced|advanced
1627923|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
1627924|NCT00291577|docetaxel|docetaxel
1627925|NCT00291577|Phase 1B|phase 1b
1627926|NCT00291564|Observational|observational
1627927|NCT00291564|Heart Failure|heart failure
1627928|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
1627929|NCT00291525|valve|valve
1627930|NCT00291525|prosthesis|prosthesis
1627931|NCT00291525|antithrombotics|antithrombotics
1627932|NCT00291525|randomized|randomized
1627933|NCT00291512|HIV|hiv
1627934|NCT00291512|STDs|stds
1627935|NCT00291512|Methamphetamine abuse|methamphetamine abuse
1627936|NCT00291512|MSM|msm
1627937|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
1627938|NCT00291460|COPD|copd
1627939|NCT00291460|respiratory failure|respiratory failure
1627940|NCT00291460|inspiratory muscle training|inspiratory muscle training
1627941|NCT00291434|Head and neck cancer|head and neck cancer
1627942|NCT00291434|Fractionation|fractionation
1627943|NCT00291434|Radiotherapy|radiotherapy
1627944|NCT00291434|Conventional fractionation|conventional fractionation
1627945|NCT00291434|Hyperfractionation|hyperfractionation
1627946|NCT00291434|Accelerated fractionation|accelerated fractionation
1627947|NCT00291421|Alzheimer's Disease|alzheimer's disease
1627948|NCT00291421|Dementia|dementia
1627949|NCT00291421|Brain Disease|brain disease
1627950|NCT00291421|Memory Loss|memory loss
1627951|NCT00291421|Caregiver|caregiver
1627952|NCT00291421|Primary Caregiver|primary caregiver
1627953|NCT00291421|Observation|observation
1627954|NCT00291421|galantamine|galantamine
1627955|NCT00291421|donepezil|donepezil
1627956|NCT00291421|rivastigmine|rivastigmine
1627957|NCT00291421|Quality of life|quality of life
1627958|NCT00291382|Total asthma control|total asthma control
1627959|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
1627960|NCT00291382|adult|adult
1627961|NCT00291382|Asthma|asthma
1627962|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1627963|NCT00291369|Interleukin-2|interleukin-2
1627964|NCT00291369|Interferon alfa|interferon alfa
1627965|NCT00291369|Cytokines|cytokines
1627966|NCT00291369|Survival|survival
1627967|NCT00291356|Diabetes|diabetes
1627968|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
1627969|NCT00291356|SGLT2|sglt2
1627970|NCT00291356|GSK189075|gsk189075
1627971|NCT00291356|GSK189074|gsk189074
1627972|NCT00291356|SGLT1|sglt1
1627973|NCT00291356|GW869683|gw869683
1627974|NCT00291343|hepatitis B|hepatitis b
1627975|NCT00291343|meningococcal vaccine|meningococcal vaccine
1627976|NCT00291343|pertussis|pertussis
1627977|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
1627978|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
1627979|NCT00291343|tetanus|tetanus
1627980|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
1627981|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
1627982|NCT00291317|FES cycling|fes cycling
1627983|NCT00291317|bone mineral density|bone mineral density
1627984|NCT00291317|quality of life|quality of life
1627985|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
1627986|NCT00291304|Pathology|pathology
1627987|NCT00291278|Endometriosis|endometriosis
1627988|NCT00291278|Bone Mineral Density|bone mineral density
1627989|NCT00291278|Osteopenia|osteopenia
1627990|NCT00291278|Osteoporosis|osteoporosis
1627991|NCT00291278|DEXA Scan|dexa scan
1627992|NCT00291278|Menopause|menopause
1627993|NCT00291278|Screening|screening
1627994|NCT00291278|Healthy Volunteer|healthy volunteer
1627996|NCT00291265|Bradykinesia|bradykinesia
1627997|NCT00291265|Tremor|tremor
1627998|NCT00291265|Speech|speech
1627999|NCT00291265|Rigidity|rigidity
1628000|NCT00291265|Neurodegeneration|neurodegeneration
1628001|NCT00291265|Parkinson Disease|parkinson disease
1628002|NCT00291265|PD|pd
1628003|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
1628004|NCT00291200|Psychosis|psychosis
1628005|NCT00291200|Basic Symptoms|basic symptoms
1628006|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
1628007|NCT00291174|Myocardial Infarction|myocardial infarction
1628008|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
1628009|NCT00291174|Coronary Artery Disease|coronary artery disease
1628010|NCT00291174|Structural Heart Disease|structural heart disease
1628011|NCT00291174|Arrhythmia|arrhythmia
1628012|NCT00291174|Cardiomyopathies|cardiomyopathies
1628013|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
1628014|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
1628015|NCT00291161|Dementia|dementia
1628016|NCT00291161|Patient Care Management|patient care management
1628017|NCT00291148|Neuropathic pain|neuropathic pain
1628018|NCT00291148|Multiple Sclerosis|multiple sclerosis
1628019|NCT00291148|pregabalin|pregabalin
1628020|NCT00291148|paroxetine|paroxetine
1628021|NCT00291135|breast atypia|breast atypia
1628022|NCT00291135|open label pilot study|open label pilot study
1628023|NCT00291135|letrozole|letrozole
1628024|NCT00291135|fine needle aspiration|fine needle aspiration
1628025|NCT00291135|high risk for breast cancer|high risk for breast cancer
1628026|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
1628027|NCT00291135|Ki-67|ki-67
1628028|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
1628029|NCT00291135|chemoprevention|chemoprevention
1628030|NCT00291122|breast atypia|breast atypia
1628031|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
1628032|NCT00291122|ki-67|ki-67
1628033|NCT00291122|RTPCR|rtpcr
1628034|NCT00291122|microdissection|microdissection
1628035|NCT00291109|breast atypia|breast atypia
1628036|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
1628037|NCT00291109|Ki-67|ki-67
1628038|NCT00291109|RTPCR|rtpcr
1628039|NCT00291109|microdissection|microdissection
1628040|NCT00291096|breast atypia|breast atypia
1628041|NCT00291096|fine needle aspiration|fine needle aspiration
1628042|NCT00291096|high risk for breast cancer|high risk for breast cancer
1628043|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
1628044|NCT00291083|NAF|naf
1628045|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
1628046|NCT00291083|breast atypia|breast atypia
1628047|NCT00291083|high risk for breast cancer|high risk for breast cancer
1628048|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
1628049|NCT00291083|Ki-67|ki-67
1628050|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
1628051|NCT00291083|chemoprevention|chemoprevention
1628052|NCT00291070|ADHD|adhd
1628053|NCT00291070|attention|attention
1628054|NCT00291070|insomnia|insomnia
1628055|NCT00291070|hyperactivity|hyperactivity
1628056|NCT00291070|anxiety|anxiety
1628057|NCT00291057|Pediculosis|pediculosis
1628058|NCT00291057|Head Lice|head lice
1628059|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
1628060|NCT00291031|nightmare|nightmare
1628061|NCT00291031|sleep disorder|sleep disorder
1628062|NCT00291031|sleep|sleep
1628063|NCT00291031|imagery rehearsal|imagery rehearsal
1628064|NCT00291031|anxiety disorders|anxiety disorders
1628065|NCT00291031|mood disorders|mood disorders
1628066|NCT00291031|personality disorders|personality disorders
1628067|NCT00291018|ProDisc|prodisc
1628068|NCT00291018|ProDisc-C|prodisc-c
1628069|NCT00291018|Spinal Fusion|spinal fusion
1628070|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
1628071|NCT00291018|Cervical spine|cervical spine
1628072|NCT00291018|Disc disease|disc disease
1628073|NCT00291018|Implant|implant
1628074|NCT00291018|Degenerative disc disease|degenerative disc disease
1628075|NCT00291018|Intervertebral disc|intervertebral disc
1628076|NCT00291005|Prostate cancer|prostate cancer
1628077|NCT00291005|HRPC|hrpc
1628078|NCT00291005|AIPC|aipc
1628079|NCT00291005|Hormone refractory|hormone refractory
1628080|NCT00291005|Androgen independent|androgen independent
1628081|NCT00291005|Docetaxel|docetaxel
1628082|NCT00291005|Taxotere|taxotere
1628083|NCT00291005|prednisolone|prednisolone
1628084|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
1628085|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
1628086|NCT00290966|docetaxel|docetaxel
1628087|NCT00290966|stomach neoplasm|stomach neoplasm
1628088|NCT00290953|Metastases|metastases
1628089|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
1628090|NCT00290940|High blood sugar|high blood sugar
1628091|NCT00290940|Hyperglycemia|hyperglycemia
1628092|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
1628093|NCT00290940|CS-917|cs-917
1628094|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
1628095|NCT00290888|Rotator Cuff Tear|rotator cuff tear
1628096|NCT00290888|Tendon Repair|tendon repair
1628097|NCT00290888|Acromioplasty|acromioplasty
1628098|NCT00290888|Arthroscopy|arthroscopy
1628099|NCT00290888|Orthopedic Surgery|orthopedic surgery
1628100|NCT00290875|cspine injury|cspine injury
1628101|NCT00290875|radiography|radiography
1628102|NCT00290875|clinical impact|clinical impact
1628103|NCT00290875|dissemination|dissemination
1628104|NCT00290862|Osteoporosis|osteoporosis
1628105|NCT00290862|Spine fracture|spine fracture
1628106|NCT00290862|Back Pain|back pain
1628107|NCT00290862|Vertebroplasty|vertebroplasty
1628452|NCT00290433|ARA-C|ara-c
1628453|NCT00290433|Cytosar|cytosar
1628108|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
1628110|NCT00290823|Seizures|seizures
1628111|NCT00290823|Tapeworm|tapeworm
1628112|NCT00290823|Parasite|parasite
1628113|NCT00290771|imatinib mesylate|imatinib mesylate
1628114|NCT00290771|hydroxyurea|hydroxyurea
1628115|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
1628116|NCT00290771|glioma|glioma
1628117|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
1628118|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
1628120|NCT00290771|MacDonald criteria|macdonald criteria
1628121|NCT00290745|breast cancer in situ|breast cancer in situ
1628122|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1628123|NCT00290732|stage I breast cancer|stage i breast cancer
1628124|NCT00290732|stage II breast cancer|stage ii breast cancer
1628125|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
1628126|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
1628127|NCT00290732|stage IV breast cancer|stage iv breast cancer
1628128|NCT00290732|breast cancer in situ|breast cancer in situ
1628129|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1628130|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1628131|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1628132|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
1628133|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
1628134|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1628135|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1628136|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1628137|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1628138|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1628139|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1628140|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1628141|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
1628142|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1628143|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
1628144|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1628145|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1628146|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1628147|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1628148|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1628149|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1628150|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1628151|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1628152|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1628153|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1628154|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1628155|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1628156|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1628157|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1628158|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1628159|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1628160|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1628161|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1628162|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1628163|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1628164|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1628165|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1628433|NCT00290498|Cytosar|cytosar
1628166|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1628167|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1628168|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1628169|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1628170|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1628171|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1628172|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1628173|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1628174|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1628175|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1628176|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1628177|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1628178|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1628179|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1628180|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1628181|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1628182|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1628183|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1628184|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1628185|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1628186|NCT00290654|breast cancer in situ|breast cancer in situ
1628187|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1628188|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1628189|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1628190|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1628191|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1628192|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1628193|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1628194|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1628195|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1628196|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1628197|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1628198|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1628199|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
1628385|NCT00290589|low back pain|low back pain
1628200|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1628201|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1628202|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1628203|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1628204|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1628205|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1628206|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1628207|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1628208|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1628209|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1628210|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1628211|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1628212|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1628213|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1628214|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1628215|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1628216|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1628217|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1628218|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1628219|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1628220|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1628221|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1628222|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1628223|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1628224|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1628225|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1628226|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1628227|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1628228|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1628229|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1628230|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1628231|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1628232|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1628233|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1628234|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1628235|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1628295|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1628236|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1628237|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1628238|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1628688|NCT00289484|Mood disorder|mood disorder
1628239|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1628240|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1628241|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1628242|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1628243|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1628244|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1628245|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1628246|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1628247|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1628248|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1628249|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1628250|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1628251|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1628252|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1628253|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1628254|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1628255|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1628256|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1628257|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1629060|NCT00287820|IL-6|il-6
1628258|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1628259|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1628260|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1628261|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1628262|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1628263|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1628264|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1628265|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1628266|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1628267|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1628268|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1628269|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1628270|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1628271|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1628272|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1628273|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1628274|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1628275|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1628276|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1628277|NCT00290628|graft versus host disease|graft versus host disease
1628278|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1628279|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1628280|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1628281|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1628282|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1628283|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1628284|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1628434|NCT00290498|Cytoxan|cytoxan
1628435|NCT00290498|DepoCyt|depocyt
1628285|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1628286|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1628287|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1628288|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1628289|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1628290|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1628291|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1628292|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1628293|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1628294|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1628296|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1628297|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1628298|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1628299|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1628300|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1628301|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1628302|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1628303|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1628304|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1628305|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1628306|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1628307|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1628308|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1628309|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1628310|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1628311|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1628312|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1628313|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1628314|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1628315|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1628316|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1628317|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1628318|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1628319|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1628320|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1628321|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1628322|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1628323|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1628324|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1628325|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1628814|NCT00288834|stroke|stroke
1628326|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1628327|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1628328|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1628329|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1628330|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1628331|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1628332|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1628333|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1628334|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1628335|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1628336|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1628337|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1628338|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
1628339|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
1628340|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1628341|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1628342|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1628343|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1628344|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1628345|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1628346|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1628347|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1628348|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1628349|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1628350|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1628351|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1628352|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1628353|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1628354|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1628355|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1628451|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
1628356|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1628357|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1628358|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1628359|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1628360|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1628361|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1628362|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1628363|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1628364|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1628365|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1628366|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1628367|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1628368|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1628369|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1628370|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1628371|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1628372|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
1628373|NCT00290628|Fanconi anemia|fanconi anemia
1628374|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1628375|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
1628376|NCT00290615|recurrent colon cancer|recurrent colon cancer
1628377|NCT00290615|stage IV colon cancer|stage iv colon cancer
1628378|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1628379|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
1628380|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
1628381|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
1628382|NCT00290602|corticosteroids|corticosteroids
1628383|NCT00290602|postoperative complications|postoperative complications
1628384|NCT00290602|cytokines|cytokines
1628386|NCT00290589|emergency department|emergency department
1628387|NCT00290589|corticosteroids|corticosteroids
1628388|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
1628389|NCT00290576|Safety and Growth|safety and growth
1628390|NCT00290576|Feeding Tolerance|feeding tolerance
1628391|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1628392|NCT00290550|NSCLC|nsclc
1628393|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
1628394|NCT00290537|Lung Cancer|lung cancer
1628395|NCT00290537|Carboplatin|carboplatin
1628396|NCT00290537|Paclitaxel|paclitaxel
1628397|NCT00290537|ZD6474|zd6474
1628398|NCT00290537|NSCLC|nsclc
1628399|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
1628400|NCT00290524|anastomosis|anastomosis
1628401|NCT00290524|laparoscopy|laparoscopy
1628402|NCT00290524|hospitalization stay|hospitalization stay
1628403|NCT00290511|Follicular Lymphoma|follicular lymphoma
1628404|NCT00290511|Zevalin|zevalin
1628405|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
1628406|NCT00290511|IDEC-Y2B8|idec-y2b8
1628407|NCT00290511|Fludarabine|fludarabine
1628408|NCT00290511|Fludara|fludara
1628409|NCT00290511|Dexamethasone|dexamethasone
1628410|NCT00290511|Mitoxantrone|mitoxantrone
1628411|NCT00290511|Rituximab|rituximab
1628412|NCT00290511|Rituxan|rituxan
1628413|NCT00290511|R-FND|r-fnd
1628414|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
1628415|NCT00290511|Decadron|decadron
1628416|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1628417|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
1628418|NCT00290498|Lymphoma|lymphoma
1628419|NCT00290498|Cyclophosphamide|cyclophosphamide
1628420|NCT00290498|Cytarabine|cytarabine
1628421|NCT00290498|Doxorubicin|doxorubicin
1628422|NCT00290498|Hyper-CVAD|hyper-cvad
1628423|NCT00290498|Methotrexate|methotrexate
1628424|NCT00290498|Prednisone|prednisone
1628425|NCT00290498|Rituximab|rituximab
1628426|NCT00290498|Vincristine|vincristine
1628427|NCT00290498|R-CHOP|r-chop
1628428|NCT00290498|R-HCVAD|r-hcvad
1628429|NCT00290498|Dexamethasone|dexamethasone
1628430|NCT00290498|Decadron|decadron
1628431|NCT00290498|Leucovorin|leucovorin
1628432|NCT00290498|Ara-C|ara-c
1628436|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1628437|NCT00290498|AD|ad
1628438|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
1628439|NCT00290498|Neosar|neosar
1628440|NCT00290485|non-resectable tumor|non-resectable tumor
1628441|NCT00290485|high-risk tumor|high-risk tumor
1628442|NCT00290485|metastasis|metastasis
1628443|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
1628444|NCT00290485|Gleevec|gleevec
1628445|NCT00290485|Imatinib mesylate|imatinib mesylate
1628446|NCT00290459|Gynecologic Disease|gynecologic disease
1628447|NCT00290459|Gynecologic Cancer|gynecologic cancer
1628448|NCT00290459|Prognostic Markers|prognostic markers
1628449|NCT00290433|Lymphoma|lymphoma
1628450|NCT00290433|Peripheral T Cell|peripheral t cell
1628455|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1628456|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1628457|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
1628458|NCT00290433|Doxil|doxil
1628459|NCT00290433|Cyclophosphamide|cyclophosphamide
1628460|NCT00290433|Cytoxan|cytoxan
1628461|NCT00290433|Neosar|neosar
1628462|NCT00290433|Dexamethasone|dexamethasone
1628463|NCT00290433|Decadron|decadron
1628464|NCT00290433|Mesna|mesna
1628465|NCT00290433|Methotrexate|methotrexate
1628466|NCT00290433|Vincristine|vincristine
1628467|NCT00290433|G-CSF|g-csf
1628468|NCT00290433|Filgrastim|filgrastim
1628469|NCT00290433|Neupogen|neupogen
1628470|NCT00290420|malaria|malaria
1628471|NCT00290420|Plasmodium vivax|plasmodium vivax
1628472|NCT00290420|pregnancy|pregnancy
1628473|NCT00290420|chemoprophylaxis|chemoprophylaxis
1628474|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1628475|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
1628476|NCT00290407|rituximab|rituximab
1628477|NCT00290407|beta-glucan|beta-glucan
1628478|NCT00290394|Blood Pressure,|blood pressure,
1628479|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
1628480|NCT00290381|Allergic rhinitis|allergic rhinitis
1628481|NCT00290368|Nasal allergen challenge|nasal allergen challenge
1628482|NCT00290368|Allergic rhinitis|allergic rhinitis
1628483|NCT00290368|Timothy grass pollen|timothy grass pollen
1628484|NCT00290368|inflammatory mediators|inflammatory mediators
1628485|NCT00290329|Safety|safety
1628486|NCT00290329|Meningococcal disease|meningococcal disease
1628487|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
1628488|NCT00290329|Meningococcal vaccine|meningococcal vaccine
1628489|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
1628490|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
1628491|NCT00290316|Metastasis|metastasis
1628492|NCT00290316|Liver neoplasm|liver neoplasm
1628493|NCT00290290|Prevention|prevention
1628494|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
1628495|NCT00290290|Postoperative Wound Infection|postoperative wound infection
1628496|NCT00290251|Endometrium|endometrium
1628497|NCT00290251|Progesterone|progesterone
1628498|NCT00290251|Estrogen|estrogen
1628499|NCT00290251|Fibroid|fibroid
1628500|NCT00290251|Hysterectomy|hysterectomy
1628501|NCT00290251|Leiomyoma|leiomyoma
1628502|NCT00290251|Uterine Fibroids|uterine fibroids
1628503|NCT00290251|Fibroids|fibroids
1628504|NCT00290238|Chronic Low Back Pain|chronic low back pain
1628505|NCT00290238|Lower Extremity Pain|lower extremity pain
1628506|NCT00290238|Central Sensitization|central sensitization
1628507|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
1628508|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
1628509|NCT00290225|depression|depression
1628510|NCT00290225|disaster mental health|disaster mental health
1628511|NCT00290225|yoga|yoga
1628512|NCT00290225|Breathwork|breathwork
1628513|NCT00290225|exposure treatments|exposure treatments
1628514|NCT00290212|Women|women
1628515|NCT00290212|Bone density|bone density
1628516|NCT00290212|Menopause|menopause
1628517|NCT00290212|Dietary Supplements|dietary supplements
1628518|NCT00290212|Vitamin K2|vitamin k2
1628519|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
1628520|NCT00290199|Labor, Induced|labor, induced
1628521|NCT00290199|Foley Catheter|foley catheter
1628522|NCT00290186|Cerebral Palsy|cerebral palsy
1628523|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
1628524|NCT00290186|CP|cp
1628525|NCT00290186|Hyperbaric|hyperbaric
1628526|NCT00290186|HBOT|hbot
1628527|NCT00290173|pre term labor|pre term labor
1628528|NCT00290173|therapy|therapy
1628529|NCT00290173|maintenance|maintenance
1628530|NCT00290160|Hyperkalemia|hyperkalemia
1628531|NCT00290160|Protein|protein
1628532|NCT00290160|Hyperglycemia|hyperglycemia
1628533|NCT00290160|ELBW|elbw
1628534|NCT00290147|Dengue|dengue
1628535|NCT00290147|DNA vaccine|dna vaccine
1628536|NCT00290134|Hypogonadism|hypogonadism
1628537|NCT00290134|Testosterone|testosterone
1628538|NCT00290121|Schizophrenia|schizophrenia
1628539|NCT00290121|Atypical antipsychotics|atypical antipsychotics
1628540|NCT00290121|Weight gain|weight gain
1628541|NCT00290121|Appetite|appetite
1628543|NCT00290108|BIS|bis
1628544|NCT00290108|Propofol|propofol
1628545|NCT00290108|hemodynamic|hemodynamic
1628546|NCT00290108|pharmacokinetic|pharmacokinetic
1628547|NCT00290095|Multiple Myeloma|multiple myeloma
1628548|NCT00290095|Quality of Life|quality of life
1628549|NCT00290095|Response Shift|response shift
1628550|NCT00290095|Clinically Important Difference|clinically important difference
1628551|NCT00290082|sedation|sedation
1628552|NCT00290082|midazolam|midazolam
1628553|NCT00290082|loxapine|loxapine
1628554|NCT00290082|agitation|agitation
1628555|NCT00290082|emergency department|emergency department
1628556|NCT00290082|toxicological analysis|toxicological analysis
1628557|NCT00290069|Renal function|renal function
1628558|NCT00290069|Serum creatinine|serum creatinine
1628559|NCT00290069|Immunosuppression|immunosuppression
1628560|NCT00290069|Rejection|rejection
1628561|NCT00290056|CHD|chd
1628562|NCT00290056|Arrhythmia|arrhythmia
1628563|NCT00290056|ICD|icd
1628564|NCT00290056|Omega-3 PUFA|omega-3 pufa
1628565|NCT00290056|Nutrition|nutrition
1628566|NCT00290043|Insulin glulisine|insulin glulisine
1628567|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
1628568|NCT00290043|Postprandial Period|postprandial period
1628569|NCT00290043|Pharmacokinetics|pharmacokinetics
1628570|NCT00290043|Glucodynamics|glucodynamics
1628571|NCT00290030|acute urinary retention|acute urinary retention
1628572|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
1628573|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1628574|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1628575|NCT00290004|Leukemia|leukemia
1628576|NCT00290004|Lymphoma|lymphoma
1628577|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
1628578|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
1628579|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
1628580|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
1628581|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
1628582|NCT00289978|Multiple Sclerosis|multiple sclerosis
1628583|NCT00289978|FTY720|fty720
1628584|NCT00289978|Fingolimod|fingolimod
1628585|NCT00289965|Alcohol Abuse|alcohol abuse
1628586|NCT00289965|Alcohol Drinking|alcohol drinking
1628587|NCT00289965|Intervention Studies|intervention studies
1628588|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
1628589|NCT00289965|College Students|college students
1628590|NCT00289952|HIV infections|hiv infections
1628591|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
1628592|NCT00289952|HIV Reservoirs|hiv reservoirs
1628593|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
1628594|NCT00289952|Valproic Acid|valproic acid
1628595|NCT00289952|Treatment Experienced|treatment experienced
1628596|NCT00289939|women|women
1628597|NCT00289939|women's health|women's health
1628598|NCT00289939|HIV|hiv
1628599|NCT00289939|risk factors|risk factors
1628600|NCT00289939|risk behaviors|risk behaviors
1628601|NCT00289939|prevention|prevention
1628602|NCT00289939|motivational interviewing|motivational interviewing
1628603|NCT00289939|domestic violence|domestic violence
1628604|NCT00289939|partner violence|partner violence
1628605|NCT00289939|behavioral trial|behavioral trial
1628606|NCT00289939|community justice|community justice
1628607|NCT00289939|criminal justice|criminal justice
1628608|NCT00289926|low libido|low libido
1628609|NCT00289926|lack of wellbeing|lack of wellbeing
1628610|NCT00289913|Hepatitis A virus|hepatitis a virus
1628611|NCT00289861|Schizophrenia|schizophrenia
1628612|NCT00289861|risperidone|risperidone
1628613|NCT00289861|prolactin|prolactin
1628614|NCT00289861|clozapine|clozapine
1628615|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1628616|NCT00289835|Drug Eluting Stent|drug eluting stent
1628617|NCT00289835|Saphenous Vein Graft|saphenous vein graft
1628618|NCT00289822|chronic heart failure|chronic heart failure
1628619|NCT00289822|myocardial infarction|myocardial infarction
1628620|NCT00289783|Primary and booster vaccination|primary and booster vaccination
1628621|NCT00289783|Neisseria meningitidis|neisseria meningitidis
1628622|NCT00289783|Hib disease|hib disease
1628623|NCT00289783|Meningococcal vaccine|meningococcal vaccine
1628624|NCT00289783|Meningococcal disease|meningococcal disease
1628625|NCT00289783|Children|children
1628626|NCT00289783|Immunogenicity|immunogenicity
1628627|NCT00289783|Safety|safety
1628628|NCT00289783|Infants|infants
1628629|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
1628630|NCT00289770|Hepatitis A|hepatitis a
1628631|NCT00289770|Hepatitis B|hepatitis b
1628632|NCT00289757|Havrix™|havrix™
1628633|NCT00289757|Hepatitis A|hepatitis a
1628634|NCT00289744|Hepatitis B|hepatitis b
1628635|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
1628636|NCT00289744|Hepatitis A|hepatitis a
1628731|NCT00289250|Gametocytes|gametocytes
1628637|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
1628638|NCT00289731|Hepatitis B|hepatitis b
1628639|NCT00289731|Hepatitis A|hepatitis a
1628640|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
1628641|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
1628642|NCT00289718|Hepatitis A|hepatitis a
1628643|NCT00289718|Hepatitis B|hepatitis b
1628644|NCT00289705|Obesity|obesity
1628645|NCT00289705|Surgery|surgery
1628646|NCT00289705|Adolescent|adolescent
1628647|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
1628648|NCT00289705|Laparoscopic|laparoscopic
1628649|NCT00289666|Sleep Disorder|sleep disorder
1628650|NCT00289666|CPAP|cpap
1628651|NCT00289653|nicotine dependence,|nicotine dependence,
1628652|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
1628653|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
1628654|NCT00289653|comorbidities|comorbidities
1629721|NCT00284778|pemetrexed|pemetrexed
1628655|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
1628656|NCT00289640|Stage IV melanoma|stage iv melanoma
1628657|NCT00289627|Previously treated melanoma|previously treated melanoma
1628658|NCT00289627|Unresectable Stage III|unresectable stage iii
1628659|NCT00289627|Stage IV|stage iv
1628660|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
1628661|NCT00289601|aspirin|aspirin
1628662|NCT00289601|clopidogrel|clopidogrel
1628663|NCT00289601|resistance|resistance
1628664|NCT00289601|angioplasty|angioplasty
1628665|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
1628666|NCT00289601|myocardial infarction|myocardial infarction
1628667|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1628668|NCT00289588|Staphylococcus aureus|staphylococcus aureus
1628669|NCT00289588|MRSA|mrsa
1628670|NCT00289588|CA-MRSA|ca-mrsa
1628671|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
1628672|NCT00289575|Bone reconstruction|bone reconstruction
1628673|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
1628674|NCT00289562|B-cell|b-cell
1628675|NCT00289562|leukemia|leukemia
1628676|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
1628677|NCT00289562|lymphoma|lymphoma
1628678|NCT00289562|B-All|b-all
1628680|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1628681|NCT00289549|leukemia|leukemia
1628682|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
1628683|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
1628684|NCT00289497|Charcot|charcot
1628685|NCT00289497|foot|foot
1628686|NCT00289497|ulceration|ulceration
1628687|NCT00289497|neuropathy|neuropathy
1628689|NCT00289471|Sensitivity and specificity|sensitivity and specificity
1628690|NCT00289471|Physician's practice patterns|physician's practice patterns
1628691|NCT00289471|Health Care costs|health care costs
1628692|NCT00289471|Quality of Health Care|quality of health care
1628693|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
1628694|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1628695|NCT00289419|Anesthetics, Local|anesthetics, local
1628696|NCT00289419|Pain, Postoperative|pain, postoperative
1628697|NCT00289406|hypertension|hypertension
1628698|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
1628699|NCT00289380|Malnutrition|malnutrition
1628700|NCT00289380|Overweight|overweight
1628701|NCT00289380|Obesity|obesity
1628702|NCT00289380|Clinical nutritional support|clinical nutritional support
1628703|NCT00289380|Clinical outcome|clinical outcome
1628704|NCT00289380|Cost effectiveness|cost effectiveness
1628705|NCT00289380|Complication|complication
1628706|NCT00289380|Infective complications|infective complications
1628707|NCT00289354|chromium|chromium
1628708|NCT00289354|chromium picolinate|chromium picolinate
1628709|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
1628710|NCT00289354|HbA1c|hba1c
1628711|NCT00289354|hyperglycemia|hyperglycemia
1628712|NCT00289354|cholesterol|cholesterol
1628713|NCT00289302|Heart Failure|heart failure
1628714|NCT00289302|Cardiac pacing|cardiac pacing
1628715|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
1628716|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1628717|NCT00289289|Atrial Fibrillation|atrial fibrillation
1628718|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
1628719|NCT00289289|Arrhythmia|arrhythmia
1628720|NCT00289289|Bradycardia|bradycardia
1628721|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
1628722|NCT00289289|IPG Indication|ipg indication
1628723|NCT00289289|Pacing|pacing
1628724|NCT00289276|Cardiomyopathy|cardiomyopathy
1628725|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
1628726|NCT00289276|Congestive Heart Failure|congestive heart failure
1628727|NCT00289276|Impedance|impedance
1628728|NCT00289263|metastatic breast cancer|metastatic breast cancer
1628729|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
1628730|NCT00289250|Malaria|malaria
1628732|NCT00289250|Asymptomatic carriers|asymptomatic carriers
1628733|NCT00289237|Lifestyle intervention|lifestyle intervention
1628734|NCT00289237|Behavioural changes|behavioural changes
1628736|NCT00289237|Type 2 diabetes|type 2 diabetes
1628737|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
1628738|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
1628739|NCT00289211|Hereditary angioedema|hereditary angioedema
1628740|NCT00289211|HAE|hae
1628741|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
1628742|NCT00289211|C1INH-nf|c1inh-nf
1628743|NCT00289198|GW685698X|gw685698x
1628744|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
1628745|NCT00289198|allergic rhinitis|allergic rhinitis
1628746|NCT00289185|Coccidiosis|coccidiosis
1628747|NCT00289185|Parasitic Diseases|parasitic diseases
1628748|NCT00289185|Malaria, Falciparum|malaria, falciparum
1628749|NCT00289185|Malaria|malaria
1628750|NCT00289159|aged 18-50|aged 18-50
1628751|NCT00289159|remitting evolution|remitting evolution
1628752|NCT00289159|less than two years of evolution|less than two years of evolution
1628753|NCT00289159|MS patients|ms patients
1628754|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
1628755|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1628756|NCT00289120|urolithiasis, cola|urolithiasis, cola
1628757|NCT00289107|Total Knee Replacement|total knee replacement
1628758|NCT00289107|Knee Prosthesis|knee prosthesis
1628759|NCT00289081|Total Knee Replacement|total knee replacement
1628760|NCT00289068|cataract surgery|cataract surgery
1628761|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
1628762|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
1628763|NCT00289042|atrial fibrillation|atrial fibrillation
1628764|NCT00289042|atrial thrombus|atrial thrombus
1628765|NCT00289042|cardioversion|cardioversion
1628766|NCT00289042|enoxaparin|enoxaparin
1628767|NCT00289042|low molecular weight heparin|low molecular weight heparin
1628768|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
1628769|NCT00289016|gene transfer|gene transfer
1628770|NCT00289016|gene therapy|gene therapy
1628771|NCT00289016|oncolytic virus|oncolytic virus
1628772|NCT00289016|GM-CSF|gm-csf
1628773|NCT00289016|melanoma|melanoma
1628775|NCT00288977|Diabetes|diabetes
1628776|NCT00288977|Islet Transplantation|islet transplantation
1628777|NCT00288964|balloon|balloon
1628778|NCT00288964|fiber|fiber
1628779|NCT00288964|respiratory|respiratory
1628780|NCT00288964|oxygenator|oxygenator
1628781|NCT00288964|Heart Failure|heart failure
1628782|NCT00288964|ARDS|ards
1628783|NCT00288964|COPD|copd
1628784|NCT00288938|Suspicious mole|suspicious mole
1628785|NCT00288938|Congenital Nevus|congenital nevus
1628786|NCT00288938|Skin Cancer|skin cancer
1628787|NCT00288938|Moles|moles
1628788|NCT00288938|Pigmented lesion|pigmented lesion
1628789|NCT00288938|LCMN|lcmn
1628790|NCT00288912|Self-Care|self-care
1628791|NCT00288912|Telemedicine|telemedicine
1628792|NCT00288912|Pain|pain
1628793|NCT00288912|Veterans|veterans
1628794|NCT00288899|Informed Consent|informed consent
1628795|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
1628796|NCT00288899|Comprehension|comprehension
1628797|NCT00288899|Anxiety|anxiety
1628798|NCT00288899|Personal Satisfactin|personal satisfactin
1628799|NCT00288886|Compliance|compliance
1628800|NCT00288886|Aftercare|aftercare
1628801|NCT00288886|Reinforcement, social|reinforcement, social
1628802|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
1628803|NCT00288886|Support Groups|support groups
1628804|NCT00288886|Treatment Outcome|treatment outcome
1628805|NCT00288873|Vitamin D deficiency|vitamin d deficiency
1628806|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
1628807|NCT00288873|Obesity|obesity
1628808|NCT00288860|telemedicine|telemedicine
1628809|NCT00288860|treatment compliance|treatment compliance
1628810|NCT00288860|mental health|mental health
1628811|NCT00288847|Patella Dislocation|patella dislocation
1628812|NCT00288847|Surface EMG|surface emg
1628813|NCT00288847|Gender difference|gender difference
1628815|NCT00288834|dysphagia|dysphagia
1628816|NCT00288834|rehabilitation|rehabilitation
1628817|NCT00288834|biofeedback|biofeedback
1628818|NCT00288821|Gynaecological malignancy|gynaecological malignancy
1628819|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
1628820|NCT00288821|DWIBS|dwibs
1628821|NCT00288821|Lymph Nodes|lymph nodes
1628822|NCT00288821|Metastasis|metastasis
1628823|NCT00288808|Blood|blood
1628824|NCT00288808|Coagulation|coagulation
1628825|NCT00288808|PT/InR|pt/inr
1628826|NCT00288808|Warfarin|warfarin
1628827|NCT00288808|Mechanical Valve|mechanical valve
1628828|NCT00288795|Fatigue|fatigue
1628829|NCT00288795|Polarity|polarity
1628830|NCT00288795|Massage|massage
1628831|NCT00288782|Mirtazapine|mirtazapine
1628832|NCT00288782|Antidepressant|antidepressant
1628833|NCT00288782|Positron Emission Tomography|positron emission tomography
1628834|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
1628835|NCT00288769|vitamin B12|vitamin b12
1628836|NCT00288756|arrythmias|arrythmias
1628837|NCT00288730|Heart Failure|heart failure
1628838|NCT00288730|Renal Dysfunction|renal dysfunction
1628839|NCT00288730|Cardiomyopathy|cardiomyopathy
1628840|NCT00288730|Heart Decompensation|heart decompensation
1628841|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
1628842|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
1628843|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
1628845|NCT00288704|NLRP-3|nlrp-3
1628846|NCT00288704|PYPAF1|pypaf1
1628847|NCT00288704|Cryopyrin|cryopyrin
1628848|NCT00288704|CAPS|caps
1628849|NCT00288704|Interleukin-1|interleukin-1
1628850|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
1628851|NCT00288678|Diabetic shared care|diabetic shared care
1628852|NCT00288678|Health manager|health manager
1628853|NCT00288678|Prospective Study|prospective study
1628854|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
1628855|NCT00288665|Myocardial infarction|myocardial infarction
1628856|NCT00288665|aspiration|aspiration
1628857|NCT00288665|thrombectomy|thrombectomy
1628858|NCT00288665|ventricular remodeling|ventricular remodeling
1628859|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
1628860|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1628861|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
1628862|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
1628863|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
1628864|NCT00288613|ESRD|esrd
1628865|NCT00288613|Daily Hemodialysis|daily hemodialysis
1628866|NCT00288613|Hemodialysis|hemodialysis
1628867|NCT00288613|Kidney Failure|kidney failure
1628868|NCT00288613|Kidney Disease|kidney disease
1628869|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1628870|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
1628871|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
1628872|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
1628873|NCT00288587|Heart Failure|heart failure
1628874|NCT00288587|Congestive Heart Failure|congestive heart failure
1628875|NCT00288587|CHF|chf
1628876|NCT00288574|Depression|depression
1628877|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
1628878|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
1628879|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
1628880|NCT00288444|Advanced malignancies.|advanced malignancies.
1628881|NCT00288431|cancer|cancer
1628882|NCT00288431|sarcoma|sarcoma
1628883|NCT00288418|Colonization of the catheter|colonization of the catheter
1628884|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
1628885|NCT00288405|Intracranial|intracranial
1628886|NCT00288405|Wide-neck|wide-neck
1628887|NCT00288405|Saccular|saccular
1628888|NCT00288405|Aneurysms|aneurysms
1628889|NCT00288379|Asthma|asthma
1628890|NCT00288379|allergen challenge|allergen challenge
1628891|NCT00288379|airway responsiveness|airway responsiveness
1628892|NCT00288379|airway inflammation|airway inflammation
1628893|NCT00288379|Symbicort®|symbicort®
1628894|NCT00288366|schizophrenia|schizophrenia
1628895|NCT00288366|schizoaffective disorder|schizoaffective disorder
1628896|NCT00288366|bipolar disorder|bipolar disorder
1628897|NCT00288366|metabolic syndrome|metabolic syndrome
1628898|NCT00288353|schizophrenia|schizophrenia
1628899|NCT00288353|schizoaffective disorder|schizoaffective disorder
1628900|NCT00288353|bipolar disorder|bipolar disorder
1628901|NCT00288353|metabolic syndrome|metabolic syndrome
1628902|NCT00288340|psychotic disorders|psychotic disorders
1628903|NCT00288340|auditory hallucinations|auditory hallucinations
1628904|NCT00288340|brain structure|brain structure
1628905|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
1628906|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
1628907|NCT00288327|diet|diet
1628908|NCT00288327|physical activity|physical activity
1628909|NCT00288327|smoking cessation|smoking cessation
1628910|NCT00288314|PTSD|ptsd
1628911|NCT00288314|MRI, Functional|mri, functional
1628912|NCT00288314|Anxiety|anxiety
1628913|NCT00288314|Working Memory|working memory
1628914|NCT00288314|Processing speed|processing speed
1628915|NCT00288301|diet|diet
1628916|NCT00288301|physical activity|physical activity
1628917|NCT00288301|weight management|weight management
1628918|NCT00288275|Ovarian Cancer|ovarian cancer
1628919|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
1628920|NCT00288275|Peritoneal Cancer|peritoneal cancer
1628921|NCT00288275|Assay|assay
1628922|NCT00288275|Chemotherapy|chemotherapy
1628923|NCT00288275|Recurrent|recurrent
1628924|NCT00288275|Refractory|refractory
1628925|NCT00288275|Persistent|persistent
1628926|NCT00288275|Chemoresponse|chemoresponse
1628927|NCT00288275|Sensitivity|sensitivity
1628928|NCT00288275|Precision Therapeutics|precision therapeutics
1628929|NCT00288262|hot flashes|hot flashes
1628930|NCT00288262|melatonin|melatonin
1628931|NCT00288262|depression|depression
1628932|NCT00288262|sleep|sleep
1628933|NCT00288262|luteinizing hormone|luteinizing hormone
1628934|NCT00288262|postmenopause|postmenopause
1628935|NCT00288249|Breast Cancer|breast cancer
1628936|NCT00288249|Breast Neoplasms|breast neoplasms
1628937|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
1628938|NCT00288210|Myocardial Infarction|myocardial infarction
1628939|NCT00288210|Stents|stents
1628940|NCT00288210|Sirolimus|sirolimus
1628941|NCT00288210|abciximab|abciximab
1628942|NCT00288145|worksite|worksite
1628943|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
1628944|NCT00288145|obesity (among adults)|obesity (among adults)
1628945|NCT00288145|physical activity|physical activity
1628946|NCT00288145|nutrition|nutrition
1628947|NCT00288132|Diabetes|diabetes
1628948|NCT00288132|self-management|self-management
1628949|NCT00288132|telemedicine|telemedicine
1628950|NCT00288132|retinal|retinal
1628951|NCT00288132|screening|screening
1628952|NCT00288119|Barrett's Esophagus|barrett's esophagus
1628953|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
1628954|NCT00288106|stage I prostate cancer|stage i prostate cancer
1628955|NCT00288106|stage II prostate cancer|stage ii prostate cancer
1628956|NCT00288106|stage III prostate cancer|stage iii prostate cancer
1628957|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
1628958|NCT00288080|stage III prostate cancer|stage iii prostate cancer
1628959|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
1628960|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
1628961|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
1628962|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1628963|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1628964|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
1628965|NCT00288054|large cell lung cancer|large cell lung cancer
1628966|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
1628967|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
1628968|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
1628969|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
1628970|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
1628971|NCT00288015|adult angiosarcoma|adult angiosarcoma
1628972|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1628973|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1628974|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1628975|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1628976|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1628977|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
1628978|NCT00288002|stage II breast cancer|stage ii breast cancer
1628979|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
1628980|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
1628981|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
1628982|NCT00288002|stage IA breast cancer|stage ia breast cancer
1628983|NCT00288002|stage IB breast cancer|stage ib breast cancer
1628984|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1628985|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1628986|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
1628987|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
1628988|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1628989|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1628990|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1628991|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
1628992|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
1628993|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
1628994|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1628995|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1628996|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
1628997|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
1628998|NCT00287963|large cell lung cancer|large cell lung cancer
1628999|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
1629000|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1629001|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
1629002|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
1629003|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
1629004|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
1629005|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1629006|NCT00287950|regional neuroblastoma|regional neuroblastoma
1629007|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
1629008|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1629104|NCT00287690|diet|diet
1629009|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1629010|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1629011|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
1629012|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1629013|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1629014|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
1629015|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
1629016|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
1629017|NCT00287911|stage III cervical cancer|stage iii cervical cancer
1629018|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
1629019|NCT00287898|breast cancer|breast cancer
1629020|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
1629021|NCT00287885|stage III cervical cancer|stage iii cervical cancer
1629022|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
1629023|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
1629024|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
1629722|NCT00284752|Prostate|prostate
1629025|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1629026|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1629027|NCT00287885|fallopian tube cancer|fallopian tube cancer
1629028|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1629029|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1629030|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1629031|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1629032|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1629033|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1629034|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
1629035|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
1629036|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
1629037|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
1629038|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
1629039|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
1629040|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
1629041|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
1629042|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
1629043|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
1629044|NCT00287885|ovarian sarcoma|ovarian sarcoma
1629045|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
1629046|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
1629047|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
1629048|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
1629049|NCT00287859|fallopian tube cancer|fallopian tube cancer
1629050|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
1629051|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1629052|NCT00287846|desmoid tumor|desmoid tumor
1629053|NCT00287820|schizophrenia|schizophrenia
1629054|NCT00287820|diabetes|diabetes
1629055|NCT00287820|metabolic syndrome|metabolic syndrome
1629056|NCT00287820|hyperglycemia|hyperglycemia
1629057|NCT00287820|glucose|glucose
1629058|NCT00287820|insulin|insulin
1629059|NCT00287820|lipids|lipids
1629061|NCT00287820|prolactin|prolactin
1629062|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
1629063|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
1629064|NCT00287807|life style|life style
1629065|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
1629066|NCT00287794|sleep disturbance|sleep disturbance
1629067|NCT00287781|Migraine|migraine
1629068|NCT00287781|Lidocaine|lidocaine
1629069|NCT00287781|Headache|headache
1629070|NCT00287768|gastric cancer|gastric cancer
1629071|NCT00287768|advanced gastric cancer|advanced gastric cancer
1629072|NCT00287768|S-1|s-1
1629073|NCT00287768|docetaxel|docetaxel
1629074|NCT00287768|phase III study|phase iii study
1629075|NCT00287755|gastric cancer|gastric cancer
1629076|NCT00287755|S-1|s-1
1629077|NCT00287755|chemosensitivity|chemosensitivity
1629078|NCT00287755|adjuvant|adjuvant
1629079|NCT00287742|risperidone|risperidone
1629080|NCT00287742|antipsychotic agents|antipsychotic agents
1629081|NCT00287742|Alzheimer's disease|alzheimer's disease
1629082|NCT00287742|dementia|dementia
1629083|NCT00287742|psychosis|psychosis
1629084|NCT00287729|Idiopathic|idiopathic
1629085|NCT00287729|Pulmonary|pulmonary
1629086|NCT00287729|Fibrosis|fibrosis
1629087|NCT00287729|Lung|lung
1629088|NCT00287729|Pirfenidone|pirfenidone
1629089|NCT00287729|InterMune|intermune
1629090|NCT00287716|Idiopathic|idiopathic
1629091|NCT00287716|Pulmonary|pulmonary
1629092|NCT00287716|Fibrosis|fibrosis
1629093|NCT00287716|Lung|lung
1629094|NCT00287716|Pirfenidone|pirfenidone
1629095|NCT00287716|InterMune|intermune
1629096|NCT00287703|Major depression|major depression
1629097|NCT00287703|Treatment resistant|treatment resistant
1629098|NCT00287703|PEMF|pemf
1629099|NCT00287703|AQT|aqt
1629100|NCT00287703|Hamilton|hamilton
1629101|NCT00287690|arteries|arteries
1629102|NCT00287690|blood flow|blood flow
1629103|NCT00287690|coronary artery disease|coronary artery disease
1629110|NCT00287677|Treatment Experienced|treatment experienced
1629111|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
1629113|NCT00287664|albumin|albumin
1629114|NCT00287664|cirrhosis|cirrhosis
1629115|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
1629116|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
1629117|NCT00287651|Respiratory Quotients|respiratory quotients
1629118|NCT00287651|Hypoglycemia|hypoglycemia
1629119|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
1629120|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1629121|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
1629122|NCT00287612|GERD|gerd
1629123|NCT00287612|Hiatal Hernia|hiatal hernia
1629124|NCT00287612|Recurrence|recurrence
1629125|NCT00287599|Surgical wound infections|surgical wound infections
1629126|NCT00287599|Real-time PCR|real-time pcr
1629127|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
1629128|NCT00287599|Cloning|cloning
1629129|NCT00287599|16S rRNA sequencing|16s rrna sequencing
1629130|NCT00287586|Testosterone Replacement|testosterone replacement
1629131|NCT00287586|Heart Disease|heart disease
1629132|NCT00287586|Vascular Disease|vascular disease
1629133|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
1629134|NCT00287586|Cholesterol|cholesterol
1629135|NCT00287586|Obesity|obesity
1629136|NCT00287586|Blood pressure|blood pressure
1629137|NCT00287586|Quality of Life|quality of life
1629138|NCT00287534|Early Breast Cancer|early breast cancer
1629139|NCT00287521|open|open
1629140|NCT00287521|angle|angle
1629141|NCT00287521|glaucoma|glaucoma
1629142|NCT00287521|ocular|ocular
1629143|NCT00287521|hypertension|hypertension
1629144|NCT00287508|Carotid stenting|carotid stenting
1629145|NCT00287508|Carotid endarterectomy|carotid endarterectomy
1629146|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
1629147|NCT00287508|Stroke prevention|stroke prevention
1629148|NCT00287508|cerebral infarction|cerebral infarction
1629156|NCT00287482|Treatment side effects|treatment side effects
1629157|NCT00287482|Quality of Life|quality of life
1629158|NCT00287482|Transition|transition
1629159|NCT00287482|Survivorship|survivorship
1629160|NCT00287469|Hepatitis E|hepatitis e
1629161|NCT00287469|clinical hepatitis|clinical hepatitis
1629162|NCT00287469|vaccine|vaccine
1629163|NCT00287469|efficacy|efficacy
1629164|NCT00287469|Nepal|nepal
1629165|NCT00287417|Nucal translucency|nucal translucency
1629166|NCT00287417|Down syndrome|down syndrome
1629167|NCT00287417|MSS|mss
1629168|NCT00287417|Risk assessment|risk assessment
1629169|NCT00287404|type 2 diabetes|type 2 diabetes
1629170|NCT00287404|hyperlipidemia|hyperlipidemia
1629171|NCT00287404|dyslipidemia|dyslipidemia
1629172|NCT00287404|fasting lipids|fasting lipids
1629173|NCT00287404|postprandial lipids|postprandial lipids
1629174|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
1629175|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
1629176|NCT00287404|ATP III guidelines|atp iii guidelines
1629177|NCT00287391|Insomnia|insomnia
1629178|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1629179|NCT00287391|Sleep Disturbance|sleep disturbance
1629180|NCT00287352|First episode psychosis|first episode psychosis
1629181|NCT00287339|Cough|cough
1629182|NCT00287339|GERD|gerd
1629183|NCT00287326|Epidural|epidural
1629184|NCT00287326|Bupivacaine|bupivacaine
1629185|NCT00287326|Clonidine|clonidine
1629186|NCT00287313|Unstable INRs|unstable inrs
1629187|NCT00287313|Warfarin|warfarin
1629188|NCT00287313|Vitamin K|vitamin k
1629189|NCT00287300|Malaria|malaria
1629190|NCT00287300|Pregnancy|pregnancy
1629191|NCT00287300|Efficacy|efficacy
1629192|NCT00287300|Azithromycin|azithromycin
1629193|NCT00287300|Artesunate|artesunate
1629194|NCT00287287|Lenalidomide|lenalidomide
1629195|NCT00287287|Clinical Trials phase II|clinical trials phase ii
1629196|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
1629197|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
1629198|NCT00287261|myelofibrosis|myelofibrosis
1629199|NCT00287261|D009191|d009191
1629200|NCT00287248|Alzheimer|alzheimer
1629201|NCT00287248|Alzheimer disease|alzheimer disease
1629202|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
1629203|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
1629204|NCT00287235|End Stage Liver Disease|end stage liver disease
1629205|NCT00287235|Cirrhosis|cirrhosis
1629206|NCT00287235|MARS|mars
1629304|NCT00286780|lukemia|lukemia
1629207|NCT00287235|Albumin Dialysis|albumin dialysis
1629208|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
1629209|NCT00287209|RASCABG 1 - study|rascabg 1 - study
1629210|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
1629211|NCT00287209|Randomized, controlled trial|randomized, controlled trial
1629212|NCT00287209|Amiodarone|amiodarone
1629213|NCT00287196|Melanoma|melanoma
1629214|NCT00287196|Lymph node disease|lymph node disease
1629215|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
1629216|NCT00287196|Lymphoedema|lymphoedema
1629217|NCT00287170|Crohn's Disease|crohn's disease
1629218|NCT00287170|Local Ileal Delivery|local ileal delivery
1629219|NCT00287170|Delayed-Release Formulations|delayed-release formulations
1629220|NCT00287170|6-Mercaptopurine|6-mercaptopurine
1629221|NCT00287170|Calcitriol|calcitriol
1629222|NCT00287157|Traumatic Brain Injury|traumatic brain injury
1629223|NCT00287157|Actigraphy|actigraphy
1629224|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
1629225|NCT00287144|Hypothyroidism|hypothyroidism
1629226|NCT00287131|melanoma|melanoma
1629227|NCT00287131|metastatic melanoma|metastatic melanoma
1629228|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
1629229|NCT00287131|IL-2|il-2
1629230|NCT00287105|Chemotherapy|chemotherapy
1629231|NCT00287105|Leukemia|leukemia
1629232|NCT00287105|Children|children
1629233|NCT00287105|Philadelphia chromosome|philadelphia chromosome
1629234|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
1629235|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
1629236|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
1629237|NCT00287092|Clostridium tetani;|clostridium tetani;
1629238|NCT00287092|Bordetella pertussis;|bordetella pertussis;
1629239|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
1629240|NCT00287092|Vero cell;|vero cell;
1629241|NCT00287092|Influenza;|influenza;
1629242|NCT00287092|Diphtheria|diphtheria
1629243|NCT00287053|divalproex sodium|divalproex sodium
1629244|NCT00287053|valproic acid|valproic acid
1629245|NCT00287053|food intake|food intake
1629246|NCT00287053|energy expenditure|energy expenditure
1629247|NCT00287053|posture allocation|posture allocation
1629248|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
1629249|NCT00287040|Breast Cancer|breast cancer
1629250|NCT00287040|Mammography|mammography
1629251|NCT00287027|psychotic disorders|psychotic disorders
1629252|NCT00287027|family burden|family burden
1629253|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
1629254|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
1629255|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
1629256|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
1629257|NCT00287001|Cold air cooling|cold air cooling
1629258|NCT00286988|Preventative|preventative
1629259|NCT00286988|Open-Label|open-label
1629260|NCT00286988|Safety/Efficacy|safety/efficacy
1629261|NCT00286975|Leadership skills|leadership skills
1629262|NCT00286975|Management skills|management skills
1629263|NCT00286975|Postgraduate medical education|postgraduate medical education
1629264|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
1629265|NCT00286962|insulin infusion systems|insulin infusion systems
1629266|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
1629267|NCT00286962|cross-over studies|cross-over studies
1629268|NCT00286949|Parkinson's disease|parkinson's disease
1629269|NCT00286949|executive dysfunction|executive dysfunction
1629270|NCT00286949|impairment|impairment
1629271|NCT00286949|motor skills|motor skills
1629272|NCT00286949|cognitive|cognitive
1629273|NCT00286936|Hip fracture|hip fracture
1629274|NCT00286936|delirium|delirium
1629275|NCT00286936|sleep disturbance|sleep disturbance
1629276|NCT00286936|hypnotic|hypnotic
1629277|NCT00286923|migraine|migraine
1629278|NCT00286923|chronic headache|chronic headache
1629279|NCT00286923|hyperexcitability|hyperexcitability
1629280|NCT00286923|Magnetic stimulation|magnetic stimulation
1629281|NCT00286910|AQP-2|aqp-2
1629282|NCT00286910|NPHS2-gene|nphs2-gene
1629283|NCT00286845|Chemosensitivity|chemosensitivity
1629284|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
1629285|NCT00286845|Apoptosis|apoptosis
1629286|NCT00286845|MiCK Assay|mick assay
1629287|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1629288|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
1629290|NCT00286832|Prognosis|prognosis
1629291|NCT00286819|early breast cancer,|early breast cancer,
1629292|NCT00286819|Fluorouracil|fluorouracil
1629293|NCT00286793|at-101|at-101
1629294|NCT00286793|at101|at101
1629295|NCT00286793|cancer|cancer
1629296|NCT00286793|hormone refractory|hormone refractory
1629297|NCT00286793|prostate|prostate
1629298|NCT00286793|docetaxel|docetaxel
1629299|NCT00286793|prednisone|prednisone
1629300|NCT00286780|AT101|at101
1629301|NCT00286780|AT-101|at-101
1629302|NCT00286780|cancer|cancer
1629303|NCT00286780|lymphoctic|lymphoctic
1629305|NCT00286780|Rituximab|rituximab
1629306|NCT00286767|Opportunistic Infections|opportunistic infections
1629307|NCT00286767|Immune Restoration Disease|immune restoration disease
1629308|NCT00286767|Mycobacterial Infections|mycobacterial infections
1629309|NCT00286767|HIV-1 Infection|hiv-1 infection
1629310|NCT00286767|HIV|hiv
1629311|NCT00286767|ART Naive|art naive
1629312|NCT00286754|Hypertension|hypertension
1629313|NCT00286754|Behavior modification|behavior modification
1629314|NCT00286754|Randomized controlled trial|randomized controlled trial
1629315|NCT00286754|Treatment effectiveness|treatment effectiveness
1629316|NCT00286754|Telemedicine|telemedicine
1629317|NCT00286754|Prevention|prevention
1629318|NCT00286741|Diabetes|diabetes
1629319|NCT00286741|Hypertension|hypertension
1629320|NCT00286741|Randomized controlled trials|randomized controlled trials
1629321|NCT00286741|cost-effectiveness|cost-effectiveness
1629322|NCT00286741|health services|health services
1629323|NCT00286728|self-help groups|self-help groups
1629324|NCT00286728|referral and consultation|referral and consultation
1629325|NCT00286702|splints|splints
1629326|NCT00286702|Occupational Therapy|occupational therapy
1629327|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
1629328|NCT00286650|Paracetamol|paracetamol
1629329|NCT00286637|OCT|oct
1629330|NCT00286637|CSLO|cslo
1629331|NCT00286637|SLP|slp
1629332|NCT00286637|Perimetry|perimetry
1629333|NCT00286637|electrophysiology|electrophysiology
1629334|NCT00286637|glaucoma|glaucoma
1629335|NCT00286637|macular degeneration|macular degeneration
1629336|NCT00286637|retinopathy|retinopathy
1629337|NCT00286637|diabetes|diabetes
1629338|NCT00286637|macular hole|macular hole
1629339|NCT00286611|Amifostine|amifostine
1629340|NCT00286598|foot ulcer|foot ulcer
1629341|NCT00286598|diabetes mellitus|diabetes mellitus
1629342|NCT00286598|motor activity|motor activity
1629343|NCT00286598|randomized controlled trial|randomized controlled trial
1629344|NCT00286598|prevention|prevention
1629345|NCT00286585|preconditioning|preconditioning
1629346|NCT00286585|cardiac protection|cardiac protection
1629347|NCT00286585|morbidity|morbidity
1629348|NCT00286585|mortality|mortality
1629349|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
1629350|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
1629351|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
1629352|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
1629353|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
1629354|NCT00286572|coronary artery disease|coronary artery disease
1629355|NCT00286572|long-term mortality|long-term mortality
1629356|NCT00286559|Coronary artery disease|coronary artery disease
1629357|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1629358|NCT00286559|SPECT|spect
1629359|NCT00286559|Adenosin|adenosin
1629360|NCT00286546|Testosterone|testosterone
1629361|NCT00286546|Major Depression|major depression
1629362|NCT00286546|Men|men
1629363|NCT00286533|Implant|implant
1629364|NCT00286520|Constipation|constipation
1629365|NCT00286520|Fecal incontinence|fecal incontinence
1629366|NCT00286520|Spinal cord injury|spinal cord injury
1629367|NCT00286520|transanal irrigation|transanal irrigation
1629368|NCT00286520|quality of life|quality of life
1629369|NCT00286507|Full thickness macular hole|full thickness macular hole
1629370|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
1629371|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
1629372|NCT00286507|Vitrectomy|vitrectomy
1629373|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
1629374|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
1629375|NCT00286494|Type II Diabetes|type ii diabetes
1629376|NCT00286494|Diabetes Mellitus|diabetes mellitus
1629377|NCT00286494|Lipoatrophic|lipoatrophic
1629378|NCT00286494|Dyslipidemia|dyslipidemia
1629379|NCT00286494|Drug Therapy|drug therapy
1629380|NCT00286481|Hyperlipidemia|hyperlipidemia
1629381|NCT00286481|Drug Therapy|drug therapy
1629382|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
1629383|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
1629384|NCT00286468|Type II Diabetes|type ii diabetes
1629385|NCT00286468|Diabetes Mellitus|diabetes mellitus
1629386|NCT00286468|Lipoatrophic|lipoatrophic
1629387|NCT00286468|Dyslipidemia|dyslipidemia
1629388|NCT00286468|Drug Therapy|drug therapy
1629389|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
1629390|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
1629391|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
1629392|NCT00286455|Lipoatrophic|lipoatrophic
1629393|NCT00286455|Dyslipidemia|dyslipidemia
1629394|NCT00286455|Drug Therapy|drug therapy
1629395|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
1629396|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
1629397|NCT00286442|Type II Diabetes|type ii diabetes
1629398|NCT00286442|Diabetes Mellitus|diabetes mellitus
1629399|NCT00286442|Lipoatrophic|lipoatrophic
1629400|NCT00286442|Dyslipidemia|dyslipidemia
1629401|NCT00286442|Drug Therapy|drug therapy
1629402|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
1629403|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
1629404|NCT00286429|Type II Diabetes|type ii diabetes
1629405|NCT00286429|Diabetes Mellitus|diabetes mellitus
1629406|NCT00286429|Lipoatrophic|lipoatrophic
1629407|NCT00286429|Dyslipidemia|dyslipidemia
1629408|NCT00286429|Drug Therapy|drug therapy
1629409|NCT00286416|AERD|aerd
1629410|NCT00286416|aspirin|aspirin
1629411|NCT00286416|allergy|allergy
1629412|NCT00286416|omalizumab|omalizumab
1629413|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
1629414|NCT00286403|antioxidants|antioxidants
1629415|NCT00286403|Fenoldopam|fenoldopam
1629416|NCT00286338|Fluid therapy|fluid therapy
1629417|NCT00286338|Monitoring|monitoring
1629418|NCT00286312|Acute myocardial infarction|acute myocardial infarction
1629419|NCT00286312|Primary angioplasty|primary angioplasty
1629420|NCT00286312|Reperfusion damage|reperfusion damage
1629421|NCT00286312|Atorvastatin|atorvastatin
1629422|NCT00286312|Placebo|placebo
1629423|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
1629424|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
1629425|NCT00286312|Cardiac MRI|cardiac mri
1629426|NCT00286312|Statin|statin
1629427|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
1629428|NCT00286312|Angioplasty|angioplasty
1629429|NCT00286299|Schizophrenia|schizophrenia
1629430|NCT00286299|Cardiovascular disease|cardiovascular disease
1629431|NCT00286299|Aerobic capacity|aerobic capacity
1629432|NCT00286299|Mortality|mortality
1629433|NCT00286299|Exercise|exercise
1629434|NCT00286286|Laparoscopy|laparoscopy
1629435|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
1629436|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
1629437|NCT00286286|Gastric Bypass|gastric bypass
1629438|NCT00286286|Drug Delivery Systems|drug delivery systems
1629439|NCT00286286|Pain Measurement|pain measurement
1629440|NCT00286273|kidney failure, acute|kidney failure, acute
1629441|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
1629442|NCT00286273|hemorrhage|hemorrhage
1629443|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
1629444|NCT00286273|nadroparin|nadroparin
1629445|NCT00286273|citrates|citrates
1629446|NCT00286260|polyneuropathy|polyneuropathy
1629447|NCT00286260|neuropathic pain|neuropathic pain
1629448|NCT00286260|levetiracetam|levetiracetam
1629449|NCT00286234|triglycerides|triglycerides
1629450|NCT00286234|HDL-cholesterol|hdl-cholesterol
1629451|NCT00286234|insulin resistance|insulin resistance
1629452|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
1629453|NCT00286234|niacin|niacin
1629454|NCT00286208|Medical abortion|medical abortion
1629455|NCT00286208|mifepristone|mifepristone
1629456|NCT00286208|misoprostol|misoprostol
1629457|NCT00286182|Heart Failure|heart failure
1629458|NCT00286182|Elderly|elderly
1629459|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
1629460|NCT00286182|Anemia|anemia
1629461|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
1629462|NCT00286182|Aged|aged
1629463|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
1629464|NCT00286156|ADPKD|adpkd
1629465|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
1629466|NCT00286130|FOLFOX 6|folfox 6
1629467|NCT00286130|FOLFIRI|folfiri
1629468|NCT00286117|Breast Cancer|breast cancer
1629469|NCT00286104|Ventriculitis|ventriculitis
1629470|NCT00286104|External ventricular catheter|external ventricular catheter
1629471|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
1629472|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
1629473|NCT00286091|androgen independent|androgen independent
1629474|NCT00286091|ADT|adt
1629475|NCT00286091|bone metastasis|bone metastasis
1629476|NCT00286078|Headache|headache
1629477|NCT00286078|Migraine|migraine
1629478|NCT00286078|Refractory|refractory
1629479|NCT00286078|Chronic|chronic
1629480|NCT00286078|Pain|pain
1629481|NCT00286065|Pain|pain
1629482|NCT00286065|Fentanyl|fentanyl
1629483|NCT00286065|Analgesics|analgesics
1629484|NCT00286065|Opioid|opioid
1629485|NCT00286065|Inhalation|inhalation
1629486|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
1629487|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
1629488|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
1629489|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
1629490|NCT00285935|Major Depressive Disorder|major depressive disorder
1629491|NCT00285935|MDD|mdd
1629492|NCT00285935|Neurobiology|neurobiology
1629493|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
1629494|NCT00285935|SSRI|ssri
1629495|NCT00285935|Depression|depression
1629496|NCT00285922|myocardial infarction|myocardial infarction
1629497|NCT00285922|electrocardiography|electrocardiography
1629498|NCT00285922|myocardial ischemia|myocardial ischemia
1629499|NCT00285922|emergency medicine|emergency medicine
1629500|NCT00285922|monitoring, physiologic|monitoring, physiologic
1629501|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
1629599|NCT00285337|Laminoplasty|laminoplasty
1629502|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
1629503|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
1629504|NCT00285896|GLP-1|glp-1
1629505|NCT00285896|fasting|fasting
1629506|NCT00285896|hypoglycaemia|hypoglycaemia
1629507|NCT00285883|Invirase|invirase
1629508|NCT00285883|HIV|hiv
1629509|NCT00285883|DOT|dot
1629510|NCT00285883|Treatment Experienced|treatment experienced
1629511|NCT00285857|duct cytology|duct cytology
1629512|NCT00285844|obesity|obesity
1629513|NCT00285844|insulin resistance|insulin resistance
1629514|NCT00285844|thiazolidinedione|thiazolidinedione
1629515|NCT00285844|weight loss|weight loss
1629516|NCT00285844|adipose tissue|adipose tissue
1629517|NCT00285844|metabolic syndrome|metabolic syndrome
1629518|NCT00285844|diabetes prevention|diabetes prevention
1629519|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
1629520|NCT00285805|Rosiglitazone|rosiglitazone
1629521|NCT00285805|Furosemide|furosemide
1629522|NCT00285805|Amiloride|amiloride
1629523|NCT00285805|Epithelial sodium channel|epithelial sodium channel
1629524|NCT00285805|Sodium excretion|sodium excretion
1629525|NCT00285792|Preschool, Physical Activity|preschool, physical activity
1629526|NCT00285766|Depression|depression
1629527|NCT00285753|psychosocial intervention|psychosocial intervention
1629528|NCT00285753|mild cognitive impairment|mild cognitive impairment
1629529|NCT00285753|support group|support group
1629530|NCT00285753|caregivers|caregivers
1629531|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1629532|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
1629723|NCT00284752|Cancer|cancer
1629533|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
1629534|NCT00285714|maxillofacial surgery|maxillofacial surgery
1629535|NCT00285714|cephalometry|cephalometry
1629536|NCT00285714|normative value|normative value
1629537|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
1629538|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
1629539|NCT00285662|IPTi|ipti
1629540|NCT00285662|Malaria|malaria
1629541|NCT00285662|Anemia|anemia
1629542|NCT00285662|Prevention|prevention
1629543|NCT00285662|Infant|infant
1629544|NCT00285662|Artesunate|artesunate
1629545|NCT00285662|SP|sp
1629546|NCT00285662|Amodiaquine|amodiaquine
1629547|NCT00285662|Papua New Guinea|papua new guinea
1629548|NCT00285649|Spinal Manipulation|spinal manipulation
1629549|NCT00285636|Long Term Follow-Up|long term follow-up
1629550|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
1629551|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
1629552|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
1629553|NCT00285584|HIV infection|hiv infection
1629554|NCT00285584|Depression|depression
1629555|NCT00285584|Men who have sex with men|men who have sex with men
1629556|NCT00285584|Drug abuse|drug abuse
1629557|NCT00285558|obesity|obesity
1629558|NCT00285558|adolescent|adolescent
1629559|NCT00285558|weight loss|weight loss
1629560|NCT00285558|body mass index|body mass index
1629561|NCT00285558|evaluation studies|evaluation studies
1629562|NCT00285558|peer group|peer group
1629563|NCT00285558|behavior therapy|behavior therapy
1629564|NCT00285558|diet|diet
1629565|NCT00285558|exercise|exercise
1629566|NCT00285558|self efficacy|self efficacy
1629567|NCT00285558|parents|parents
1629568|NCT00285545|Blood Supply|blood supply
1629569|NCT00285545|Mesentery|mesentery
1629570|NCT00285532|Blood Lead|blood lead
1629571|NCT00285532|Pesticides|pesticides
1629572|NCT00285532|Community-based|community-based
1629573|NCT00285532|Sampling Kits|sampling kits
1629574|NCT00285519|Morning hypertension|morning hypertension
1629575|NCT00285506|Healthy Volunteers|healthy volunteers
1629576|NCT00285493|low back pain|low back pain
1629577|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
1629579|NCT00285428|treatment|treatment
1629580|NCT00285428|NHL|nhl
1629581|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
1629582|NCT00285428|Lymphoma|lymphoma
1629583|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
1629584|NCT00285402|Migraine|migraine
1629585|NCT00285402|Migraine prophylaxis|migraine prophylaxis
1629586|NCT00285402|Migraine prevention|migraine prevention
1629587|NCT00285402|Chronic migraine treatment|chronic migraine treatment
1629588|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
1629589|NCT00285389|Chemotherapy|chemotherapy
1629590|NCT00285389|Autologous PBSCT|autologous pbsct
1629591|NCT00285389|Molecular evaluation|molecular evaluation
1629592|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
1629593|NCT00285363|cancer|cancer
1629594|NCT00285363|quality of life|quality of life
1629595|NCT00285363|adolescents|adolescents
1629596|NCT00285350|myasthenia gravis|myasthenia gravis
1629597|NCT00285337|Myelopathy|myelopathy
1629598|NCT00285337|Laminectomy|laminectomy
1629600|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
1629601|NCT00285337|Cervical Spondylosis|cervical spondylosis
1629602|NCT00285324|Glioma|glioma
1629603|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
1629604|NCT00285324|Brain Cancer|brain cancer
1629605|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
1629606|NCT00285324|Brain Tumor|brain tumor
1629607|NCT00285298|proteinuria|proteinuria
1629608|NCT00285298|Kidney failure, chronic|kidney failure, chronic
1629609|NCT00285285|Point-of-care Testing|point-of-care testing
1629610|NCT00285285|Pediatric Emergency Department|pediatric emergency department
1629611|NCT00285285|Length of Stay|length of stay
1629612|NCT00285285|Efficiency|efficiency
1629613|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
1629614|NCT00285259|infectious disease|infectious disease
1629615|NCT00285259|viremia|viremia
1629616|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
1629617|NCT00285259|stem cell transplant|stem cell transplant
1629618|NCT00285259|allogeneic|allogeneic
1629619|NCT00285259|bone marrow transplant|bone marrow transplant
1629620|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
1629621|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1629622|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1629623|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
1629624|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
1629625|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1629626|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
1629627|NCT00285246|combat disorders|combat disorders
1629628|NCT00285246|stress, psychological|stress, psychological
1629629|NCT00285246|somatoform disorders|somatoform disorders
1629630|NCT00285246|life change events|life change events
1629631|NCT00285246|utilization|utilization
1629632|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1629633|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
1629634|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
1629635|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
1629636|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
1629637|NCT00285181|persons|persons
1629638|NCT00285168|Osteoporosis|osteoporosis
1629639|NCT00285168|Fractures, Bone|fractures, bone
1629640|NCT00285168|Bone Mineral Density|bone mineral density
1629641|NCT00285155|bupropion|bupropion
1629642|NCT00285155|repeated dose|repeated dose
1629643|NCT00285155|healthy volunteers|healthy volunteers
1629644|NCT00285155|cognitive function|cognitive function
1629645|NCT00285155|behaviour|behaviour
1629646|NCT00285155|tolerance|tolerance
1629647|NCT00285155|Persons|persons
1629648|NCT00285142|rosiglitazone|rosiglitazone
1629649|NCT00285142|insulin secretion|insulin secretion
1629650|NCT00285142|clinical trial|clinical trial
1629651|NCT00285142|healthy|healthy
1629652|NCT00285142|persons|persons
1629653|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
1629654|NCT00285090|Burn Injury|burn injury
1629655|NCT00285090|Calcium|calcium
1629656|NCT00285090|Vitamin D|vitamin d
1629657|NCT00285090|Bone Mineral Density|bone mineral density
1629658|NCT00285077|Alzheimer disease|alzheimer disease
1629659|NCT00285077|nerve growth factors|nerve growth factors
1629660|NCT00285077|Clinical Trial|clinical trial
1629661|NCT00285064|MDCT|mdct
1629662|NCT00285064|viability|viability
1629663|NCT00285051|emesis, nausea,|emesis, nausea,
1629664|NCT00285038|Deep vein thrombosis|deep vein thrombosis
1629665|NCT00285038|Gynecological cancer|gynecological cancer
1629666|NCT00285025|Alzheimer disease|alzheimer disease
1629667|NCT00285025|nerve growth factors|nerve growth factors
1629668|NCT00285025|Clinical Trial|clinical trial
1629669|NCT00285012|smoking cessation|smoking cessation
1629670|NCT00285012|smoking cessation in COPD|smoking cessation in copd
1629671|NCT00284986|GVHD|gvhd
1629672|NCT00284986|Graft vs Host Disease|graft vs host disease
1629673|NCT00284986|Graft versus Host Disease|graft versus host disease
1629674|NCT00284973|malaria|malaria
1629675|NCT00284960|erectile dysfunction|erectile dysfunction
1629676|NCT00284960|metabolic syndrome|metabolic syndrome
1629677|NCT00284960|insulin resistance|insulin resistance
1629678|NCT00284960|etiology|etiology
1629679|NCT00284947|Side effects|side effects
1629680|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
1629681|NCT00284947|maintenance|maintenance
1629682|NCT00284947|basiliximab|basiliximab
1629683|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
1629684|NCT00284934|Dose optimization|dose optimization
1629685|NCT00284934|immune suppressive regimen|immune suppressive regimen
1629686|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
1629687|NCT00284934|EC-MPS|ec-mps
1629688|NCT00284934|renal transplantation|renal transplantation
1629689|NCT00284934|kidney|kidney
1629690|NCT00284934|transplant|transplant
1629691|NCT00284934|maintenance patients|maintenance patients
1629692|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
1629791|NCT00284466|coronary artery disease|coronary artery disease
1629693|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
1629694|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
1629695|NCT00284908|Pharmacokinetic|pharmacokinetic
1629696|NCT00284908|intragastric pH recording|intragastric ph recording
1629697|NCT00284908|dose-response|dose-response
1629698|NCT00284895|Obesity|obesity
1629699|NCT00284895|Bariatric Surgery|bariatric surgery
1629700|NCT00284895|Weight Loss Surgery|weight loss surgery
1629701|NCT00284895|Asthma|asthma
1629702|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
1629703|NCT00284869|LPS|lps
1629704|NCT00284869|ethnicity|ethnicity
1629705|NCT00284869|neutrophils|neutrophils
1629706|NCT00284869|TNF|tnf
1629707|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
1629708|NCT00284830|Right Ventricular Pacing|right ventricular pacing
1629709|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
1629710|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
1629711|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
1629712|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
1629713|NCT00284830|Sinus-node Disease|sinus-node disease
1629714|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
1629715|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
1629716|NCT00284778|lung cancer|lung cancer
1629717|NCT00284778|second line treatment|second line treatment
1629718|NCT00284778|cost-minimization trial|cost-minimization trial
1629719|NCT00284778|Pharmaco-economic study|pharmaco-economic study
1629720|NCT00284778|docetaxel|docetaxel
1629725|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
1629726|NCT00284726|Cold storage solutions|cold storage solutions
1629727|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
1629728|NCT00284700|Helicobacter pylori|helicobacter pylori
1629729|NCT00284700|Iron deficiency anemia|iron deficiency anemia
1629730|NCT00284700|children|children
1629731|NCT00284687|bone marrow transplantation|bone marrow transplantation
1629732|NCT00284687|CMV disease|cmv disease
1629733|NCT00284661|Meniscal repair|meniscal repair
1629734|NCT00284661|Meniscal suturing|meniscal suturing
1629735|NCT00284661|Meniscal tear|meniscal tear
1629736|NCT00284648|Achilles tendon|achilles tendon
1629737|NCT00284648|Rupture|rupture
1629738|NCT00284648|Non-operative|non-operative
1629739|NCT00284648|Operative|operative
1629740|NCT00284622|HTO|hto
1629741|NCT00284622|Arthroscopy|arthroscopy
1629742|NCT00284622|Osteoarthritis|osteoarthritis
1629743|NCT00284622|Alignement|alignement
1629744|NCT00284622|Varus gonarthrosis|varus gonarthrosis
1629745|NCT00284609|Type 2 diabetes,|type 2 diabetes,
1629746|NCT00284609|rehabilitation,|rehabilitation,
1629747|NCT00284609|quality of life,|quality of life,
1629748|NCT00284609|glycaemic control,|glycaemic control,
1629749|NCT00284609|lifestyle intervention,|lifestyle intervention,
1629750|NCT00284609|patient education,|patient education,
1629751|NCT00284609|physical training,|physical training,
1629752|NCT00284609|group visits,|group visits,
1629753|NCT00284609|reminders|reminders
1629754|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
1629755|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
1629756|NCT00284596|Locking screw fixation|locking screw fixation
1629757|NCT00284583|Morton's Neuroma|morton's neuroma
1629758|NCT00284583|Alcohol|alcohol
1629759|NCT00284583|Steroid|steroid
1629760|NCT00284570|pediatrics|pediatrics
1629761|NCT00284570|congenital heart disease|congenital heart disease
1629762|NCT00284570|cardiac|cardiac
1629763|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
1629764|NCT00284570|infection|infection
1629765|NCT00284570|sepsis|sepsis
1629766|NCT00284570|postoperative|postoperative
1629767|NCT00284570|marker for infection|marker for infection
1629768|NCT00284570|inflammation|inflammation
1629769|NCT00284570|cardiac surgery|cardiac surgery
1629770|NCT00284557|Behavioral/Social|behavioral/social
1629771|NCT00284557|Obesity|obesity
1629772|NCT00284557|Pediatrics|pediatrics
1629773|NCT00284557|Preventive Medicine|preventive medicine
1629774|NCT00284531|cardiac transplantation|cardiac transplantation
1629775|NCT00284531|allograft rejection|allograft rejection
1629776|NCT00284531|anti-CD25|anti-cd25
1629777|NCT00284505|cytokine|cytokine
1629778|NCT00284505|arachnoiditis|arachnoiditis
1629779|NCT00284505|neuropathic pain|neuropathic pain
1629780|NCT00284505|tumor necrosis factor|tumor necrosis factor
1629781|NCT00284492|Women|women
1629782|NCT00284492|Acupuncture|acupuncture
1629783|NCT00284492|Menopause|menopause
1629784|NCT00284492|Hot flashes|hot flashes
1629785|NCT00284492|Health related quality of life|health related quality of life
1629786|NCT00284479|walking intervention|walking intervention
1629787|NCT00284479|cardiovascular risk|cardiovascular risk
1629788|NCT00284479|inflammatory markers|inflammatory markers
1629789|NCT00284479|aerobic fitness|aerobic fitness
1629790|NCT00284479|fatness|fatness
1629792|NCT00284466|cardiac catheterization|cardiac catheterization
1629793|NCT00284466|CT coronary angiography|ct coronary angiography
1629794|NCT00284466|coronary angiography|coronary angiography
1629795|NCT00284453|ventricular|ventricular
1629796|NCT00284453|arrhythmias|arrhythmias
1629797|NCT00284453|ICD|icd
1629798|NCT00284453|VT storm|vt storm
1629799|NCT00284453|ICD patients with VT storm|icd patients with vt storm
1629800|NCT00284440|Visual field progression|visual field progression
1629801|NCT00284440|Choroidal blood flow|choroidal blood flow
1629802|NCT00284401|Reversed prosthesis|reversed prosthesis
1629803|NCT00284336|breast cancer|breast cancer
1629804|NCT00284336|elderly|elderly
1629805|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
1629806|NCT00284336|Caelyx|caelyx
1629807|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
1629808|NCT00284323|PCI|pci
1629809|NCT00284323|Adenosine|adenosine
1629810|NCT00284323|Postconditioning|postconditioning
1629811|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
1629812|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
1629813|NCT00284271|eldery patients|eldery patients
1629814|NCT00284271|primary diagnosis|primary diagnosis
1629815|NCT00284258|Colorectal Cancer|colorectal cancer
1629816|NCT00284245|Chronic Pain|chronic pain
1629817|NCT00284245|Pain|pain
1629818|NCT00284245|Computer Analysis|computer analysis
1629819|NCT00284245|Pain Diagrams|pain diagrams
1629820|NCT00284232|HbA1c|hba1c
1629821|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
1629822|NCT00284232|Diabetes treatment|diabetes treatment
1629823|NCT00284232|quality of care|quality of care
1629824|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
1629825|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
1629826|NCT00284180|Breast Neoplasms|breast neoplasms
1629827|NCT00284180|Breast Cancer|breast cancer
1629828|NCT00284180|Vinflunine|vinflunine
1629829|NCT00284180|Vinca Alkaloid|vinca alkaloid
1629830|NCT00284180|Javlor|javlor
1629831|NCT00284167|tailored|tailored
1629832|NCT00284167|web-based|web-based
1629833|NCT00284167|weight management|weight management
1629834|NCT00284167|obesity|obesity
1629835|NCT00284167|efficacy|efficacy
1629836|NCT00284154|Extensive stage|extensive stage
1629837|NCT00284154|Relapsed|relapsed
1629838|NCT00284141|lung|lung
1629839|NCT00284141|cancer|cancer
1629840|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
1629841|NCT00284141|metastatic|metastatic
1629842|NCT00284141|carcinoma|carcinoma
1629843|NCT00284141|lung neoplasm|lung neoplasm
1629844|NCT00284141|lung diseases|lung diseases
1629845|NCT00284141|angiogenesis|angiogenesis
1629846|NCT00284141|anti-angiogenesis|anti-angiogenesis
1629847|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
1629848|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
1629849|NCT00284141|respiratory tract|respiratory tract
1629850|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
1629851|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
1629852|NCT00284128|vascular disease C14.907|vascular disease c14.907
1629853|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
1629854|NCT00284115|Gait trainer|gait trainer
1629855|NCT00284115|Hemiplegia|hemiplegia
1629856|NCT00284115|Rehabilitation|rehabilitation
1629857|NCT00284115|Stroke|stroke
1629858|NCT00284102|gas exchange|gas exchange
1629859|NCT00284102|dead space|dead space
1629860|NCT00284102|respiratory failure|respiratory failure
1629861|NCT00284102|ALI/ARDS patients|ali/ards patients
1629862|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
1629863|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
1629864|NCT00284050|DME|dme
1629865|NCT00284050|Diabetic macular edema|diabetic macular edema
1629866|NCT00284050|ranibizumab|ranibizumab
1629867|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
1629868|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
1629869|NCT00284037|baroreceptors|baroreceptors
1629870|NCT00284024|breastfeeding|breastfeeding
1629871|NCT00284024|domperidone|domperidone
1629872|NCT00284024|efficacy|efficacy
1629873|NCT00284024|randomized controlled trial|randomized controlled trial
1629874|NCT00284024|compliance|compliance
1629875|NCT00284011|SAMe|same
1629876|NCT00284011|AdoMet|adomet
1629877|NCT00284011|Methylation|methylation
1629878|NCT00284011|Homocysteine|homocysteine
1629879|NCT00284011|Dietary Supplement|dietary supplement
1629880|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
1629881|NCT00283998|Odontoid|odontoid
1629882|NCT00283998|Type II fractures|type ii fractures
1629883|NCT00283998|Elderly patients|elderly patients
1629884|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
1629885|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
1629886|NCT00283985|Lymphoma|lymphoma
1629887|NCT00283985|L-asparaginase|l-asparaginase
1629888|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
1629889|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
1630786|NCT00281437|adherence|adherence
1629890|NCT00283972|Health Outcome Study|health outcome study
1629891|NCT00283946|zolpidem|zolpidem
1629892|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
1629893|NCT00283946|double-blind study|double-blind study
1629894|NCT00283946|comparative study|comparative study
1629895|NCT00283933|Amicus Therapeutics|amicus therapeutics
1629896|NCT00283933|AT1001|at1001
1629897|NCT00283933|Migalastat|migalastat
1629898|NCT00283933|Pharmacokinetics|pharmacokinetics
1629899|NCT00283933|Substrate|substrate
1629900|NCT00283920|Pharmacokinetics|pharmacokinetics
1629901|NCT00283920|Compartmental Analysis|compartmental analysis
1629902|NCT00283920|Distribution Volume|distribution volume
1629903|NCT00283920|Identitiability|identitiability
1629904|NCT00283920|Healthy Volunteer|healthy volunteer
1629905|NCT00283920|HV|hv
1629906|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
1629907|NCT00283907|Sense of Agency|sense of agency
1629908|NCT00283907|Coherence|coherence
1629909|NCT00283907|Voluntary Movement|voluntary movement
1629910|NCT00283907|Self-Agency|self-agency
1629911|NCT00283907|Healthy Volunteer|healthy volunteer
1629912|NCT00283907|HV|hv
1629913|NCT00283894|Obesity|obesity
1629914|NCT00283894|Leptin|leptin
1629915|NCT00283894|Sleep Attacks|sleep attacks
1629916|NCT00283894|Energy Metabolism|energy metabolism
1629917|NCT00283894|Healthy Control|healthy control
1629918|NCT00283894|Narcolepsy|narcolepsy
1629919|NCT00283894|Healthy Volunteer|healthy volunteer
1629920|NCT00283894|HV|hv
1629921|NCT00283881|Haptic Skills|haptic skills
1629922|NCT00283881|Implicit Tactile Learning|implicit tactile learning
1629923|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1629924|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1629925|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1629926|NCT00283881|Stroke|stroke
1629927|NCT00283881|Healthy Volunteer|healthy volunteer
1629928|NCT00283881|HV|hv
1629929|NCT00283868|stroke|stroke
1629930|NCT00283868|digital video|digital video
1629931|NCT00283868|SPOTRIAS|spotrias
1629932|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
1629933|NCT00283855|Self-Management|self-management
1629934|NCT00283855|Internet|internet
1629935|NCT00283842|neuropathic pain|neuropathic pain
1629936|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1629937|NCT00283829|Immunotherapy|immunotherapy
1629938|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
1629939|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
1629940|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
1629941|NCT00283777|insulin|insulin
1629942|NCT00283777|glucose|glucose
1629943|NCT00283777|body weight|body weight
1629944|NCT00283777|chromium|chromium
1629945|NCT00283738|migraine|migraine
1629946|NCT00283738|aura|aura
1629947|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
1629948|NCT00283738|cardiac defects|cardiac defects
1629949|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
1629950|NCT00283738|Cephalalgia|cephalalgia
1629951|NCT00283725|Dementia|dementia
1629952|NCT00283725|Alzheimer's Disease|alzheimer's disease
1629953|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
1629954|NCT00283725|Galantamine|galantamine
1629955|NCT00283725|Nursing Home Admission|nursing home admission
1629956|NCT00283712|Skin Diseases|skin diseases
1629957|NCT00283712|Autoimmune Diseases|autoimmune diseases
1629958|NCT00283699|neurocysticercosis|neurocysticercosis
1629959|NCT00283699|albendazole|albendazole
1629960|NCT00283699|tape worm|tape worm
1629961|NCT00283686|polycystic kidney disease|polycystic kidney disease
1629962|NCT00283686|polycystic|polycystic
1629963|NCT00283686|kidney|kidney
1629964|NCT00283686|disease|disease
1629965|NCT00283686|adpkd|adpkd
1629966|NCT00283686|halt|halt
1629967|NCT00283686|pkd|pkd
1629968|NCT00283686|blood pressure|blood pressure
1629969|NCT00283686|bp|bp
1629970|NCT00283686|hypertension|hypertension
1629971|NCT00283686|renal|renal
1629972|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
1629973|NCT00283686|RAAS|raas
1629974|NCT00283660|Zinc|zinc
1629975|NCT00283660|Dietary Supplements|dietary supplements
1629976|NCT00283660|Nutritional Supplements|nutritional supplements
1629977|NCT00283660|Child|child
1629978|NCT00283660|Mental Health|mental health
1629979|NCT00283660|School|school
1629980|NCT00283660|Guatemala|guatemala
1629981|NCT00283647|lead exposure|lead exposure
1629982|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
1629983|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1629984|NCT00283647|functional magnetic resonance|functional magnetic resonance
1629985|NCT00283647|brain development|brain development
1629986|NCT00283621|Aranesp|aranesp
1629987|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
1629988|NCT00283621|Pegfilgrastim|pegfilgrastim
1629989|NCT00283621|Neulasta|neulasta
1629990|NCT00283621|Sarcoma|sarcoma
1629991|NCT00283621|Adriamycin|adriamycin
1629992|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
1629993|NCT00283621|Adriamycin PFS|adriamycin pfs
1629994|NCT00283621|Adriamycin RDF|adriamycin rdf
1629995|NCT00283621|Ifosfamide|ifosfamide
1629996|NCT00283608|stage I breast cancer|stage i breast cancer
1629997|NCT00283608|stage II breast cancer|stage ii breast cancer
1629998|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
1629999|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
1630000|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
1630001|NCT00283595|Anorexia Nervosa|anorexia nervosa
1630002|NCT00283595|Eating disorder|eating disorder
1630003|NCT00283595|Bone|bone
1630004|NCT00283595|Growth hormone|growth hormone
1630005|NCT00283595|Osteopenia|osteopenia
1630006|NCT00283595|Osteoporosis|osteoporosis
1630007|NCT00283569|Glioma|glioma
1630008|NCT00283556|High Dose Irinotecan|high dose irinotecan
1630009|NCT00283556|CPT-11|cpt-11
1630010|NCT00283556|Camptosar|camptosar
1630011|NCT00283556|Malignant Glioma|malignant glioma
1630012|NCT00283556|Unresectable|unresectable
1630013|NCT00283543|Glioma|glioma
1630014|NCT00283543|Gliadel Wafer|gliadel wafer
1630015|NCT00283530|Cancer|cancer
1630016|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
1630017|NCT00283530|Tumor biopsy|tumor biopsy
1630018|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
1630019|NCT00283517|Antipsychotic medication|antipsychotic medication
1630020|NCT00283517|Schizophrenia|schizophrenia
1630021|NCT00283517|Treatment retention|treatment retention
1630022|NCT00283517|Observational study|observational study
1630023|NCT00283491|Iron absorption|iron absorption
1630024|NCT00283491|Organic acids|organic acids
1630025|NCT00283491|Lactobacillus|lactobacillus
1630026|NCT00283491|Probiotic|probiotic
1630027|NCT00283478|Advanced stage|advanced stage
1630028|NCT00283478|Lung cancer|lung cancer
1630033|NCT00283465|quality of life|quality of life
1630034|NCT00283465|tumor response|tumor response
1630035|NCT00283465|survival|survival
1630036|NCT00283465|chemotherapy|chemotherapy
1630037|NCT00283465|hemoglobin|hemoglobin
1630038|NCT00283465|standard care|standard care
1630039|NCT00283465|epoetin alfa|epoetin alfa
1630041|NCT00283465|erythropoietin|erythropoietin
1630042|NCT00283452|Physical activity maintenance|physical activity maintenance
1630043|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
1630044|NCT00283452|Older adults|older adults
1630045|NCT00283439|NHL|nhl
1630046|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
1630047|NCT00283439|CIT|cit
1630048|NCT00283439|ICE|ice
1630049|NCT00283439|RICE|rice
1630050|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
1630051|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1630052|NCT00283439|CHOP|chop
1630053|NCT00283439|ESHAP|eshap
1630054|NCT00283439|DHAP|dhap
1630055|NCT00283439|R-CHOP|r-chop
1630056|NCT00283439|R-ESHAP|r-eshap
1630057|NCT00283439|R-DHAP|r-dhap
1630058|NCT00283413|Covered Stent System|covered stent system
1630059|NCT00283413|Saphenous Vein Graft|saphenous vein graft
1630060|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
1630061|NCT00283413|Stents[MeSH]|stents[mesh]
1630062|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
1630063|NCT00283400|SAH|sah
1630064|NCT00283400|human albumin|human albumin
1630065|NCT00283400|HA|ha
1630066|NCT00283400|cerebral vasospasm|cerebral vasospasm
1630067|NCT00283400|aneurysm|aneurysm
1630068|NCT00283400|neuroprotective|neuroprotective
1630069|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
1630070|NCT00283374|Metabolic Syndrome|metabolic syndrome
1630071|NCT00283374|Obesity|obesity
1630072|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1630073|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1630074|NCT00283374|Bariatric Surgery|bariatric surgery
1630075|NCT00283348|Renal Transplantation|renal transplantation
1630076|NCT00283348|Immunosuppression|immunosuppression
1630077|NCT00283348|Chronic Rejection|chronic rejection
1630078|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
1630079|NCT00283322|HIT|hit
1630080|NCT00283322|HITT|hitt
1630081|NCT00283322|Thrombosis|thrombosis
1630082|NCT00283322|Thromboembolism|thromboembolism
1630083|NCT00283309|Corticosteroids|corticosteroids
1630084|NCT00283309|Riluzole|riluzole
1630085|NCT00283309|Memantine|memantine
1630086|NCT00283309|Memory|memory
1630087|NCT00283296|manual wheelchair|manual wheelchair
1630088|NCT00283296|assistive technology|assistive technology
1630089|NCT00283296|travel wheelchair|travel wheelchair
1630090|NCT00283283|Influenza|influenza
1630091|NCT00283270|Mental health|mental health
1630092|NCT00283270|Screening|screening
1630093|NCT00283270|Elderly|elderly
1630094|NCT00283270|Chinese|chinese
1630095|NCT00283270|Problem-solving counselling|problem-solving counselling
1630096|NCT00283257|Problem solving|problem solving
1630097|NCT00283257|psychosocial support|psychosocial support
1630098|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1630099|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1630100|NCT00283231|Hot Flashes|hot flashes
1630101|NCT00283231|Menopausal Symptoms|menopausal symptoms
1630102|NCT00283231|Paced respiration|paced respiration
1630103|NCT00283231|RESPeRATE|resperate
1630104|NCT00283205|Menopausal Symptoms|menopausal symptoms
1630105|NCT00283205|Hot Flashes|hot flashes
1630106|NCT00283205|Yoga|yoga
1630107|NCT00283192|Menopausal Symptoms|menopausal symptoms
1630108|NCT00283192|Hot flashes|hot flashes
1630109|NCT00283179|Aripiprazole|aripiprazole
1630110|NCT00283179|Risperidone|risperidone
1630111|NCT00283179|Schizophrenia|schizophrenia
1630112|NCT00283179|Schizoaffective disorder|schizoaffective disorder
1630113|NCT00283166|Palliative Care|palliative care
1630114|NCT00283153|Traumatic Brain Injury|traumatic brain injury
1630115|NCT00283153|Stroke|stroke
1630116|NCT00283153|Emotion Recognition|emotion recognition
1630117|NCT00283153|Affect|affect
1630118|NCT00283153|Interventions|interventions
1630119|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
1630120|NCT00283127|Mass screening|mass screening
1630121|NCT00283127|Home sampling|home sampling
1630122|NCT00283127|Urine test|urine test
1630123|NCT00283114|Lintuzumab|lintuzumab
1630124|NCT00283114|Antigens, CD33|antigens, cd33
1630125|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
1630126|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1630127|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
1630128|NCT00283114|Hematologic Diseases|hematologic diseases
1630129|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
1630130|NCT00283114|Leukemia|leukemia
1630131|NCT00283101|Antigens, CD40|antigens, cd40
1630132|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
1630133|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
1630134|NCT00283101|Hematologic Diseases|hematologic diseases
1630135|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
1630136|NCT00283101|Lymphatic Diseases|lymphatic diseases
1630137|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
1630138|NCT00283101|Leukemia|leukemia
1630139|NCT00283088|stroke|stroke
1630140|NCT00283088|hypothermia|hypothermia
1630141|NCT00283088|cooling|cooling
1630142|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
1630143|NCT00283088|tPA|tpa
1630144|NCT00283088|thrombolysis|thrombolysis
1630145|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
1630146|NCT00283075|agarose macrobeads|agarose macrobeads
1630147|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
1630148|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
1630149|NCT00283023|All selective craniotomy|all selective craniotomy
1630150|NCT00283010|cognitive enhancement|cognitive enhancement
1630151|NCT00283010|memory|memory
1630152|NCT00283010|auditory memory|auditory memory
1630153|NCT00283010|speech|speech
1630154|NCT00283010|computerized|computerized
1630155|NCT00283010|cognitive decline|cognitive decline
1630156|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
1630157|NCT00282893|aneurysm|aneurysm
1630158|NCT00282893|vasospasm|vasospasm
1630159|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
1630160|NCT00282893|transluminal ballooning|transluminal ballooning
1630161|NCT00282867|stroke|stroke
1630162|NCT00282867|acute ischemic stroke|acute ischemic stroke
1630163|NCT00282867|hyperglycemia|hyperglycemia
1630164|NCT00282867|glucose|glucose
1630165|NCT00282867|insulin|insulin
1630166|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
1630167|NCT00282867|GIK|gik
1630168|NCT00282854|epilepsy|epilepsy
1630169|NCT00282854|Rolandic epilepsy|rolandic epilepsy
1630170|NCT00282841|stroke|stroke
1630171|NCT00282841|ultrasound|ultrasound
1630172|NCT00282841|occlusion|occlusion
1630173|NCT00282841|blockage|blockage
1630174|NCT00282841|contrast solution|contrast solution
1630175|NCT00282828|Social Anxiety Disorder|social anxiety disorder
1630176|NCT00282828|Pharmacotherapy|pharmacotherapy
1630177|NCT00282828|Genetics|genetics
1630178|NCT00282828|Treatment Refractory|treatment refractory
1630179|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
1630180|NCT00282815|stroke|stroke
1630181|NCT00282815|OSA|osa
1630182|NCT00282815|CPAP|cpap
1630183|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
1630184|NCT00282802|Parkinson's Disease|parkinson's disease
1630185|NCT00282802|twins|twins
1630186|NCT00282802|SPECT|spect
1630187|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
1630188|NCT00282802|NAS/NRC|nas/nrc
1630189|NCT00282802|World War II Veteran Twins|world war ii veteran twins
1630190|NCT00282776|Postpartum Depression|postpartum depression
1630191|NCT00282776|Telephone Care Management|telephone care management
1630192|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
1630193|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
1630194|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
1630297|NCT00282243|Immunosuppression|immunosuppression
1630195|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
1630196|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
1630197|NCT00282724|Liarozole|liarozole
1630198|NCT00282724|Investigator's Global Assessment|investigator's global assessment
1630199|NCT00282724|Scaling|scaling
1630200|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
1630201|NCT00282711|Radionuclide Imaging|radionuclide imaging
1630202|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
1630203|NCT00282711|Heart Function tests|heart function tests
1630204|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
1630205|NCT00282672|Barrett's Esophagus|barrett's esophagus
1630206|NCT00282672|Dysplasia|dysplasia
1630207|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
1630208|NCT00282659|Hemodynamics|hemodynamics
1630209|NCT00282659|Hypertension|hypertension
1630210|NCT00282659|Dyslipidemia|dyslipidemia
1630211|NCT00282659|Diabetes|diabetes
1630212|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1630213|NCT00282659|Blood Pressure|blood pressure
1630214|NCT00282646|critical limb ischemia|critical limb ischemia
1630215|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
1630216|NCT00282646|[C14.907.137]|[c14.907.137]
1630217|NCT00282633|Cesarean Delivery|cesarean delivery
1630218|NCT00282633|Wound closure|wound closure
1630219|NCT00282633|Suture|suture
1630220|NCT00282633|Alternative therapy|alternative therapy
1630221|NCT00282633|Surgery|surgery
1630222|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1630223|NCT00282620|Magnesium|magnesium
1630224|NCT00282620|Electrocardiogram|electrocardiogram
1630225|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
1630226|NCT00282607|Erectile Dysfunction|erectile dysfunction
1630227|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
1630228|NCT00282594|General Surgical|general surgical
1630229|NCT00282594|Vascular Surgical|vascular surgical
1630230|NCT00282594|Tight Glycemic Control|tight glycemic control
1630232|NCT00282581|Smallpox|smallpox
1630234|NCT00282568|Pharmacokinetics|pharmacokinetics
1630235|NCT00282568|Therapy|therapy
1630236|NCT00282568|Immunosuppression|immunosuppression
1630237|NCT00282568|Drugs, Investigational|drugs, investigational
1630238|NCT00282568|Adult|adult
1630239|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
1630240|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
1630241|NCT00282555|Heartburn|heartburn
1630242|NCT00282555|Esophageal endoscopy|esophageal endoscopy
1630243|NCT00282542|Hepatocytes|hepatocytes
1630244|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
1630245|NCT00282516|asthma|asthma
1630246|NCT00282516|telemedicine|telemedicine
1630247|NCT00282516|case management|case management
1630248|NCT00282516|clinic|clinic
1630249|NCT00282516|children|children
1630250|NCT00282516|pediatric|pediatric
1630251|NCT00282503|aGvHD|agvhd
1630252|NCT00282490|Overactive bladder|overactive bladder
1630253|NCT00282490|Children|children
1630254|NCT00282490|Nerve stimulation|nerve stimulation
1630255|NCT00282490|TENS|tens
1630256|NCT00282477|cyclist|cyclist
1630257|NCT00282464|Bipolar I Depression|bipolar i depression
1630258|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
1630259|NCT00282399|MGI Pharma|mgi pharma
1630260|NCT00282399|Decitabine|decitabine
1630261|NCT00282399|Dacogen|dacogen
1630262|NCT00282360|coronary artery disease|coronary artery disease
1630263|NCT00282360|diabetes mellitus|diabetes mellitus
1630264|NCT00282347|Class IV LN|class iv ln
1630265|NCT00282347|Lupus|lupus
1630266|NCT00282347|LUNAR|lunar
1630267|NCT00282347|LN|ln
1630268|NCT00282334|Telemedicine|telemedicine
1630269|NCT00282334|Blood pressure|blood pressure
1630270|NCT00282334|Quality of life|quality of life
1630271|NCT00282334|Cost-effectiveness|cost-effectiveness
1630272|NCT00282308|RA|ra
1630273|NCT00282308|Rituxan|rituxan
1630274|NCT00282308|SIERRA|sierra
1630275|NCT00282295|tetanus|tetanus
1630276|NCT00282295|pertussis|pertussis
1630277|NCT00282295|Prophylaxis|prophylaxis
1630278|NCT00282295|meningococcus|meningococcus
1630279|NCT00282295|diptheria|diptheria
1630280|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
1630281|NCT00282282|PBSCT|pbsct
1630282|NCT00282282|tacrolimus|tacrolimus
1630283|NCT00282282|sirolimus|sirolimus
1630284|NCT00282269|Traumatic Brain Injury|traumatic brain injury
1630285|NCT00282269|Children|children
1630286|NCT00282269|Hypothermia|hypothermia
1630287|NCT00282269|Outcome|outcome
1630288|NCT00282269|Intensive Care|intensive care
1630289|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
1630290|NCT00282256|Child|child
1630291|NCT00282256|Pharmacokinetics|pharmacokinetics
1630292|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
1630293|NCT00282256|Hepatic transplant|hepatic transplant
1630294|NCT00282256|Liver Transplantation|liver transplantation
1630295|NCT00282243|Pharmacokinetics|pharmacokinetics
1630296|NCT00282243|Therapy|therapy
1630298|NCT00282243|Drugs, Investigational|drugs, investigational
1630299|NCT00282243|Adult|adult
1630300|NCT00282230|Malononitrilamide|malononitrilamide
1630301|NCT00282230|immunosuppression|immunosuppression
1630302|NCT00282230|treatment efficacy|treatment efficacy
1630303|NCT00282230|treatment outcome|treatment outcome
1630304|NCT00282217|Kidney Failure|kidney failure
1630305|NCT00282217|Kidney Transplant|kidney transplant
1630306|NCT00282217|Graft Rejection|graft rejection
1630307|NCT00282217|Kidney Transplantation|kidney transplantation
1630308|NCT00282204|Hypnosis|hypnosis
1630309|NCT00282204|Hypnotherapy|hypnotherapy
1630310|NCT00282204|Childbirth|childbirth
1630311|NCT00282204|Analgesia|analgesia
1630312|NCT00282191|spasticity|spasticity
1630313|NCT00282191|mental retardation|mental retardation
1630314|NCT00282178|Metabolic|metabolic
1630315|NCT00282178|Hypertension|hypertension
1630316|NCT00282178|Abdominal obesity|abdominal obesity
1630317|NCT00282178|Insulin sensitivity|insulin sensitivity
1630318|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
1630319|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
1630320|NCT00282152|Parkinson's Disease|parkinson's disease
1630321|NCT00282152|Deep Brain Stimulation|deep brain stimulation
1630322|NCT00282152|PD|pd
1630323|NCT00282152|DBS|dbs
1630324|NCT00282126|Calcium balance|calcium balance
1630325|NCT00282113|Probiotic|probiotic
1630326|NCT00282113|Prebiotic|prebiotic
1630327|NCT00282113|NEC|nec
1630328|NCT00282113|Premature infants|premature infants
1630329|NCT00282113|commensal flora|commensal flora
1630330|NCT00282087|early stage|early stage
1630331|NCT00282087|high grade|high grade
1630332|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
1630333|NCT00282087|adjuvant treatment|adjuvant treatment
1630334|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
1630335|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
1630336|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
1630337|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
1630338|NCT00282035|breast cancer|breast cancer
1630339|NCT00282035|breast tumour|breast tumour
1630340|NCT00282035|DCIS|dcis
1630341|NCT00282035|female|female
1630342|NCT00282035|breast conserving surgery|breast conserving surgery
1630343|NCT00282035|irradiation|irradiation
1630344|NCT00282035|whole breast irradiation|whole breast irradiation
1630345|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
1630346|NCT00282035|cosmetic outcome|cosmetic outcome
1630347|NCT00282035|quality of life|quality of life
1630348|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
1630349|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1630350|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
1630351|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1630352|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
1630353|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
1630354|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
1630355|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1630356|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1630357|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630358|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630359|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
1630360|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1630361|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1630362|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1630363|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1630364|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
1630365|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1630366|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1630367|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1630368|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630369|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630370|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1630371|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1630372|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1630373|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1630374|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
1630375|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1630376|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1630377|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1630378|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1630379|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
1630380|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1630787|NCT00281437|lifestyle|lifestyle
1630381|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
1630382|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
1630383|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1630384|NCT00281905|regional neuroblastoma|regional neuroblastoma
1630385|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
1630386|NCT00281892|anemia|anemia
1630387|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1630388|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1630389|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1630390|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1630391|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630392|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630393|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1630394|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1630395|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1630396|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1630397|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1630398|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1630399|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1630400|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1630401|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1630402|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1630403|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1630404|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1630405|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1631407|NCT00278447|Drug use|drug use
1630406|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1630407|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1631167|NCT00279643|Laser Hair Removal|laser hair removal
1630408|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1630409|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1630410|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1630411|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1630412|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1630413|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1630414|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1630415|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1630416|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1630417|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1630418|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1630419|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1630420|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1630421|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1630422|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1630423|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
1630424|NCT00281879|refractory anemia|refractory anemia
1630425|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1630426|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1630427|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1630428|NCT00281879|primary myelofibrosis|primary myelofibrosis
1630429|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1630430|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1630431|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1631152|NCT00279682|suicide|suicide
1630432|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1630433|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1630434|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1630435|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1630436|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1630437|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1630438|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1630439|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1630440|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1630441|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1630442|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1630443|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1630444|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1630445|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1630446|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1630447|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1630448|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1630449|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1630450|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1630451|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1630452|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1630453|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1630454|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1630455|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1630456|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1630457|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1630458|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1630459|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1630460|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1630461|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1630462|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1630463|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
1630464|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
1630465|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1630466|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
1630467|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
1630468|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1630469|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1630470|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1630471|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1630472|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1630473|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1630474|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1630475|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630476|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1630477|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1630478|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1630479|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1630480|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1630481|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
1630482|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1630483|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1630484|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1630485|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1630486|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1630487|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1630488|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1630489|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630490|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1630491|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1630492|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1630493|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1631153|NCT00279682|geriatric|geriatric
1630494|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1630495|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1630496|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1630497|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1630498|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1630499|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1630500|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1630501|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1630502|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1630503|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
1630504|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1630505|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1630506|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1630688|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
1630507|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1630508|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1630509|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1630510|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1630511|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1630512|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1630513|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1630514|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1630515|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1630516|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1630517|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1630518|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1630519|NCT00281853|neurotoxicity|neurotoxicity
1630520|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1630521|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1630522|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1630523|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1630524|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1630525|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1631620|NCT00277992|GT fed|gt fed
1630526|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1630527|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1630528|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1630529|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1630530|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1630531|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
1630532|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
1630533|NCT00281827|large cell lung cancer|large cell lung cancer
1630534|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1630535|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1630536|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1630537|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1630538|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1630539|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1630540|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1630541|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1630542|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1630543|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1630544|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1630545|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1630546|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1630547|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1630548|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1630549|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1630550|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1630551|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1630552|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1630553|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1630554|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1630555|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1630556|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1630557|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1630558|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1630559|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1630560|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1630561|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1630784|NCT00281463|rehabilitation|rehabilitation
1630562|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1630563|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1630564|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1630565|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1630566|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1630567|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1630568|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1630569|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1630570|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1630571|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1630572|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1630573|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1630574|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1630575|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1630576|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1630577|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1630578|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1630579|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1630580|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1630581|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1630582|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1630583|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1630584|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
1630585|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1630586|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1630587|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1630588|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1630589|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
1630590|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
1630591|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1630592|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1630593|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1630594|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1630595|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1630596|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1630597|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1630598|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630599|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1630600|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1630601|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1630602|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1630603|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1630604|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
1630605|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1630606|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1630607|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1630608|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1630609|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1630610|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1630611|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1630612|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1630613|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630614|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1630615|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1630616|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1630617|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1630618|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1630619|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1630620|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1630621|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1630622|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1630623|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1630624|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1630625|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1630626|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1630627|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1630628|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1630629|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1630630|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1630631|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1630632|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1630633|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1630634|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1630635|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1630636|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1630637|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1630638|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1630639|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1630640|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1630641|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1630642|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1630643|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1630644|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1630645|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1630715|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
1630646|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1630647|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1630648|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1630649|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1630650|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1630651|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1630652|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1630653|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1630654|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1630655|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1630656|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1630657|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1630658|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1630659|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1630660|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1630661|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1630662|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1630663|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1630664|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1630665|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1630666|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1630667|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1630668|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
1630669|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1630670|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1630758|NCT00281554|Atrial Fibrillation|atrial fibrillation
1630671|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1630672|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1630673|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
1630674|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
1630675|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1630676|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1630677|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1630678|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1630679|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1630680|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1630681|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1630682|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1630683|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1630684|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1630685|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1630686|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1630687|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1630689|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1630690|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1630691|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1630692|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1630693|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1630694|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1630695|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1630696|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1630697|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1630698|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1630699|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1630700|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1630701|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1630702|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1630703|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1630704|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
1630705|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
1630706|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
1630707|NCT00281762|AQP-2|aqp-2
1630708|NCT00281762|NSAID|nsaid
1630709|NCT00281762|Urinary concentrating ability|urinary concentrating ability
1630710|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
1630711|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
1630712|NCT00281749|FRAILTY|frailty
1630713|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1630714|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
1631621|NCT00277979|pediatric|pediatric
1630716|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
1630717|NCT00281736|precancerous condition|precancerous condition
1630718|NCT00281723|Aphthous|aphthous
1630719|NCT00281723|oral|oral
1630720|NCT00281710|AQP-2|aqp-2
1630721|NCT00281710|Methylprednisolone|methylprednisolone
1630722|NCT00281710|Urinary concentrating ability|urinary concentrating ability
1630723|NCT00281697|Ribbon 2|ribbon 2
1630724|NCT00281697|Avastin|avastin
1630726|NCT00281697|Breast cancer|breast cancer
1630727|NCT00281684|Acute Pain|acute pain
1630728|NCT00281684|Dental Pain|dental pain
1630729|NCT00281684|Vanilloid|vanilloid
1630730|NCT00281684|VR1|vr1
1630731|NCT00281684|TRPV1|trpv1
1630732|NCT00281684|Inflammation|inflammation
1630733|NCT00281671|Nesiritide|nesiritide
1630734|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
1630735|NCT00281671|Heart Defects, Congenital|heart defects, congenital
1630736|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
1630737|NCT00281671|Diuretics|diuretics
1630738|NCT00281658|ErbB2 positive|erbb2 positive
1630739|NCT00281658|Her2+|her2+
1630740|NCT00281658|metastatic breast cancer|metastatic breast cancer
1630741|NCT00281658|FISH positive|fish positive
1630742|NCT00281658|Stage IV|stage iv
1630743|NCT00281632|Pazopanib|pazopanib
1630744|NCT00281632|Fallopian tube cancer|fallopian tube cancer
1630745|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
1630746|NCT00281632|Peritoneal cancer|peritoneal cancer
1630747|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
1630748|NCT00281619|Kidney Transplant|kidney transplant
1630749|NCT00281619|CellCept|cellcept
1630750|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
1630751|NCT00281619|Mycophenolic Acid|mycophenolic acid
1630752|NCT00281619|MPA|mpa
1630753|NCT00281606|Lopinavir|lopinavir
1630754|NCT00281606|antiretroviral therapy|antiretroviral therapy
1630755|NCT00281606|cross-over|cross-over
1630756|NCT00281606|tolerability|tolerability
1630757|NCT00281554|Investigational Therapies|investigational therapies
1630759|NCT00281554|Treatment Efficacy|treatment efficacy
1630760|NCT00281554|Treatment Effectiveness|treatment effectiveness
1630761|NCT00281554|Safety|safety
1630762|NCT00281554|RSD1235|rsd1235
1630763|NCT00281541|Treatment Efficacy|treatment efficacy
1630764|NCT00281541|Treatment Effectiveness|treatment effectiveness
1630765|NCT00281541|Disease Management|disease management
1630766|NCT00281541|Treatment|treatment
1630767|NCT00281541|Safety|safety
1630768|NCT00281541|Malignant Melanoma|malignant melanoma
1630769|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
1630770|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
1630771|NCT00281502|Hepatitis C|hepatitis c
1630772|NCT00281502|Liver Cirrhosis|liver cirrhosis
1630773|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
1630774|NCT00281489|Recall|recall
1630775|NCT00281489|Awareness|awareness
1630776|NCT00281489|BIS|bis
1630777|NCT00281489|Anesthesia|anesthesia
1630778|NCT00281489|Explicit Recall|explicit recall
1630779|NCT00281476|multiple myeloma|multiple myeloma
1630780|NCT00281476|statins|statins
1630781|NCT00281476|bone|bone
1630782|NCT00281463|wheelchair|wheelchair
1630783|NCT00281463|spinal cord injury|spinal cord injury
1630785|NCT00281437|exercise|exercise
1630788|NCT00281437|choice|choice
1630789|NCT00281437|autonomy|autonomy
1630790|NCT00281424|exercise adherence|exercise adherence
1630791|NCT00281424|cardiac patients|cardiac patients
1630792|NCT00281424|walking|walking
1630793|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
1630794|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
1630795|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
1630796|NCT00281411|Computed Tomography Angiography|computed tomography angiography
1630797|NCT00281411|Endoleak|endoleak
1630798|NCT00281398|homelessness|homelessness
1630799|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
1630800|NCT00281385|adherence|adherence
1630801|NCT00281385|lifestyle|lifestyle
1630802|NCT00281385|exercise|exercise
1630803|NCT00281385|pedometer|pedometer
1630804|NCT00281385|training|training
1630805|NCT00281372|sexual dysfunction|sexual dysfunction
1630806|NCT00281372|male|male
1630807|NCT00281372|female|female
1630808|NCT00281372|dental care|dental care
1630809|NCT00281372|need of control|need of control
1630810|NCT00281359|cerebral palsy|cerebral palsy
1630811|NCT00281359|dynamic splinting|dynamic splinting
1630812|NCT00281359|contractures|contractures
1630813|NCT00281359|heat therapy|heat therapy
1630814|NCT00281346|Doppler echocardiography|doppler echocardiography
1630815|NCT00281346|coronary stenosis|coronary stenosis
1630816|NCT00281346|Coronary angiography|coronary angiography
1630817|NCT00281307|Rhinitis|rhinitis
1630818|NCT00281307|Vitamin E|vitamin e
1630819|NCT00281307|Intranasal|intranasal
1630820|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
1630821|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
1630822|NCT00281281|vancomycin|vancomycin
1631622|NCT00277979|cardiac|cardiac
1630823|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1630824|NCT00281242|COPD|copd
1630825|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1630826|NCT00281229|COPD|copd
1630827|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1630828|NCT00281216|COPD|copd
1630829|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1630830|NCT00281203|COPD|copd
1630831|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1630832|NCT00281190|COPD|copd
1630833|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
1630834|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
1630835|NCT00281099|ICD|icd
1630836|NCT00281099|Pacing|pacing
1630837|NCT00281099|Heart Failure|heart failure
1630838|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
1630839|NCT00281073|Cardioversion|cardioversion
1630840|NCT00281060|endovascular|endovascular
1630841|NCT00281060|balloon angioplasty|balloon angioplasty
1630842|NCT00281060|stents|stents
1630843|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
1630844|NCT00281047|FP-10|fp-10
1630845|NCT00281047|amoxicillin|amoxicillin
1630846|NCT00281047|clarithromycin|clarithromycin
1630847|NCT00281047|lansoprazole|lansoprazole
1630848|NCT00281034|brain infarction|brain infarction
1630849|NCT00281034|SF-36|sf-36
1630850|NCT00281034|HRQOL|hrqol
1630851|NCT00281034|Japan|japan
1630852|NCT00281034|Post-stroke syndrome|post-stroke syndrome
1630853|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
1630854|NCT00281021|Erlotinib|erlotinib
1630855|NCT00281021|Digoxin|digoxin
1630856|NCT00281008|LDL-cholesterol|ldl-cholesterol
1630857|NCT00281008|apoB-100|apob-100
1630858|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
1630859|NCT00280995|LDL-cholesterol|ldl-cholesterol
1630860|NCT00280995|apoB-100|apob-100
1630861|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
1630960|NCT00280527|Obesity|obesity
1630862|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
1630863|NCT00280969|HIV infection|hiv infection
1630864|NCT00280969|treatment|treatment
1630865|NCT00280969|efavirenz|efavirenz
1630866|NCT00280969|atazanavir|atazanavir
1630867|NCT00280969|ritonavir|ritonavir
1630868|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
1630869|NCT00280930|letrozole|letrozole
1630870|NCT00280930|breast cancer|breast cancer
1630871|NCT00280930|menopause|menopause
1630872|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
1630873|NCT00280917|RA|ra
1630874|NCT00280904|Hydrocephalus|hydrocephalus
1630875|NCT00280904|Shunt|shunt
1630876|NCT00280891|head and neck|head and neck
1630877|NCT00280891|cancer|cancer
1630878|NCT00280891|palliation|palliation
1630879|NCT00280891|radiotherapy|radiotherapy
1630880|NCT00280878|Lymphoma|lymphoma
1630881|NCT00280878|CD20+|cd20+
1630882|NCT00280865|Tesaglitazar|tesaglitazar
1630883|NCT00280865|type 2 diabetes|type 2 diabetes
1630884|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
1630885|NCT00280852|chemotherapy|chemotherapy
1630886|NCT00280852|radiotherapy|radiotherapy
1630887|NCT00280826|OCT|oct
1630888|NCT00280826|Retinal Disease|retinal disease
1630889|NCT00280826|Adhesion Molecule|adhesion molecule
1630890|NCT00280826|Ocular Inflammation|ocular inflammation
1630891|NCT00280826|Raptiva|raptiva
1630892|NCT00280826|Macular Edema|macular edema
1630893|NCT00280826|Uveitis|uveitis
1630894|NCT00280826|Immunosuppression|immunosuppression
1630895|NCT00280813|treatment|treatment
1630896|NCT00280813|dual diagnosis|dual diagnosis
1630897|NCT00280800|randomized|randomized
1630898|NCT00280800|controlled|controlled
1630899|NCT00280800|double blind|double blind
1630900|NCT00280800|effectiveness|effectiveness
1630901|NCT00280800|auto CPAP|auto cpap
1630902|NCT00280800|treatment|treatment
1630903|NCT00280800|sleep apnea|sleep apnea
1630904|NCT00280787|unresectable|unresectable
1630905|NCT00280787|induction|induction
1630906|NCT00280787|radiotherapy|radiotherapy
1630907|NCT00280787|ZD1839|zd1839
1630908|NCT00280774|corticosteroid|corticosteroid
1630909|NCT00280774|prednisone|prednisone
1630910|NCT00280774|memantine|memantine
1630911|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
1630912|NCT00280774|pulmonary illness|pulmonary illness
1630913|NCT00280774|rheumatic illness|rheumatic illness
1630914|NCT00280774|kidney transplant|kidney transplant
1630915|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1630916|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
1630917|NCT00280761|stage II rectal cancer|stage ii rectal cancer
1630918|NCT00280761|stage III rectal cancer|stage iii rectal cancer
1630919|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
1630920|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1631021|NCT00280267|hip fracture|hip fracture
1630921|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1630922|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
1630923|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1630924|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1630925|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1630926|NCT00280722|Randomised|randomised
1630927|NCT00280722|Intervention|intervention
1630928|NCT00280722|Leaflet|leaflet
1630929|NCT00280722|Information|information
1630930|NCT00280722|Awareness|awareness
1630931|NCT00280722|Behaviour|behaviour
1630932|NCT00280722|Research|research
1630933|NCT00280709|Bile duct|bile duct
1630934|NCT00280709|Bile duct obstruction|bile duct obstruction
1630935|NCT00280709|Biliary stent|biliary stent
1630936|NCT00280709|Metal stent|metal stent
1630937|NCT00280709|ERCP|ercp
1630938|NCT00280709|Patency|patency
1630939|NCT00280709|Complication|complication
1630940|NCT00280709|Stent occlusion|stent occlusion
1630941|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
1630942|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
1630943|NCT00280683|Airway Inflammation|airway inflammation
1630944|NCT00280683|Moderate persistent asthma|moderate persistent asthma
1630945|NCT00280683|Severe Persistent Asthma|severe persistent asthma
1630946|NCT00280657|Acne papulopustulosa|acne papulopustulosa
1630947|NCT00280592|Prophylaxis|prophylaxis
1630948|NCT00280592|Cranberry|cranberry
1630949|NCT00280592|Neurogenic bladder|neurogenic bladder
1630950|NCT00280553|analgesia|analgesia
1630951|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
1630952|NCT00280553|length of stay|length of stay
1630953|NCT00280540|Hypertension|hypertension
1630954|NCT00280540|High blood pressure|high blood pressure
1630955|NCT00280540|Blood pressure control|blood pressure control
1630956|NCT00280540|Blood pressure reduction|blood pressure reduction
1630957|NCT00280540|Valsartan|valsartan
1630958|NCT00280527|NAFLD|nafld
1630959|NCT00280527|NASH|nash
1630961|NCT00280527|Bariatric Surgery|bariatric surgery
1630962|NCT00280527|Weight Reduction|weight reduction
1630963|NCT00280514|abscess|abscess
1630964|NCT00280514|penetration|penetration
1630965|NCT00280514|antibiotics|antibiotics
1630966|NCT00280514|cefpirome|cefpirome
1630967|NCT00280514|moxifloxacin|moxifloxacin
1630968|NCT00280514|abdominal cyst|abdominal cyst
1630969|NCT00280501|Sulpiride|sulpiride
1630970|NCT00280501|Quetiapine|quetiapine
1630971|NCT00280501|Light/dark transition|light/dark transition
1630972|NCT00280501|Choroidal blood flow|choroidal blood flow
1630973|NCT00280488|Motivational Interviewing|motivational interviewing
1630974|NCT00280488|Alcohol Abuse|alcohol abuse
1630975|NCT00280488|Alcohol Dependence|alcohol dependence
1630976|NCT00280488|Emergency Care Setting|emergency care setting
1630977|NCT00280475|Randomized Controlled Trials|randomized controlled trials
1630978|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
1630979|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
1630980|NCT00280475|Radiosurgery|radiosurgery
1630981|NCT00280462|Nifedipine|nifedipine
1630982|NCT00280462|Choroidal blood flow|choroidal blood flow
1630983|NCT00280462|Choroidal autoregulation|choroidal autoregulation
1630984|NCT00280462|Isometric exercise|isometric exercise
1630985|NCT00280449|people living with HIV|people living with hiv
1630986|NCT00280449|quality of life|quality of life
1630987|NCT00280436|Polysomnography|polysomnography
1630988|NCT00280436|Electroencephalography|electroencephalography
1630989|NCT00280436|Primary Insomnia|primary insomnia
1630990|NCT00280436|Cognition|cognition
1630991|NCT00280436|Sleep|sleep
1630992|NCT00280423|Cognition|cognition
1630993|NCT00280423|Polysomnography|polysomnography
1630994|NCT00280423|Primary Insomnia|primary insomnia
1630995|NCT00280423|Electroencephalography|electroencephalography
1630996|NCT00280423|Sleep|sleep
1630997|NCT00280397|Cancer, solid tumors|cancer, solid tumors
1630998|NCT00280371|COPD|copd
1630999|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1631000|NCT00280371|formoterol|formoterol
1631001|NCT00280358|Fluticasone|fluticasone
1631002|NCT00280358|Formoterol|formoterol
1631003|NCT00280358|PK Study|pk study
1631004|NCT00280358|Pharmacokinetics|pharmacokinetics
1631005|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
1631006|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
1631007|NCT00280345|cataract|cataract
1631008|NCT00280345|trabeculectomy|trabeculectomy
1631009|NCT00280345|cataract surgery|cataract surgery
1631010|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
1631011|NCT00280319|randomized controlled trial|randomized controlled trial
1631012|NCT00280319|depression|depression
1631013|NCT00280319|Uganda|uganda
1631014|NCT00280319|adolescents|adolescents
1631015|NCT00280293|Bipolar Disorder|bipolar disorder
1631016|NCT00280293|Cocaine Dependence|cocaine dependence
1631017|NCT00280293|Dual Diagnosis|dual diagnosis
1631018|NCT00280280|spasticity|spasticity
1631019|NCT00280280|Botox|botox
1631020|NCT00280280|baclofen|baclofen
1631211|NCT00279409|ADHD|adhd
1631022|NCT00280267|testosterone|testosterone
1631023|NCT00280267|muscle weakness|muscle weakness
1631024|NCT00280267|frail elderly|frail elderly
1631025|NCT00280267|aging|aging
1631026|NCT00280254|Heart Failure|heart failure
1631027|NCT00280254|Hemodynamics|hemodynamics
1631028|NCT00280254|Echocardiography|echocardiography
1631029|NCT00280241|Chronic|chronic
1631030|NCT00280241|Lymphocytic|lymphocytic
1631031|NCT00280241|Leukemia|leukemia
1631032|NCT00280241|Fludarabine|fludarabine
1631033|NCT00280241|Cyclophosphamide|cyclophosphamide
1631034|NCT00280241|Rituximab|rituximab
1631035|NCT00280228|ADHD|adhd
1631036|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
1631037|NCT00280228|Conduct Disorder|conduct disorder
1631038|NCT00280228|Substance Use|substance use
1631039|NCT00280228|Drug and Alcohol Use|drug and alcohol use
1631040|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
1631041|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
1631042|NCT00280202|Carcinogenesis|carcinogenesis
1631043|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
1631044|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
1631045|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
1631046|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
1631047|NCT00280189|Radiofrequency ablation|radiofrequency ablation
1631048|NCT00280189|Pulmonary malignancies|pulmonary malignancies
1631049|NCT00280189|Primary lung cancer|primary lung cancer
1631050|NCT00280189|Pulmonary metastasis|pulmonary metastasis
1631051|NCT00280189|Primary lung tumors|primary lung tumors
1631052|NCT00280189|Secondary lung tumors|secondary lung tumors
1631053|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
1631054|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
1631055|NCT00280176|stage II rectal cancer|stage ii rectal cancer
1631056|NCT00280176|stage III rectal cancer|stage iii rectal cancer
1631151|NCT00279682|depression|depression
1631057|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
1631058|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1631059|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
1631060|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1631061|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1631062|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1631063|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
1631064|NCT00280137|Quality of Life|quality of life
1631065|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
1631066|NCT00280111|rotavirus|rotavirus
1631067|NCT00280111|vaccine|vaccine
1631068|NCT00280111|safety|safety
1631069|NCT00280111|immunogenicity|immunogenicity
1631070|NCT00280111|infants|infants
1631071|NCT00280072|Renal Failure, Acute|renal failure, acute
1631072|NCT00280072|Acute Kidney Failure|acute kidney failure
1631073|NCT00280072|Acute Renal Failure|acute renal failure
1631074|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
1631075|NCT00280072|Anuria|anuria
1631076|NCT00280072|Renal Dialysis|renal dialysis
1631077|NCT00280072|Acute Kidney Injury|acute kidney injury
1631078|NCT00280059|Epilepsy|epilepsy
1631079|NCT00280059|partial seizures|partial seizures
1631080|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
1631081|NCT00280059|lamotrigine comparator|lamotrigine comparator
1631082|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
1631083|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
1631084|NCT00280020|sleep disorders|sleep disorders
1631085|NCT00280020|meditation|meditation
1631086|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
1631087|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
1631088|NCT00280007|TACE|tace
1631089|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
1631090|NCT00280007|portal hypertension|portal hypertension
1631091|NCT00280007|angiogenesis|angiogenesis
1631092|NCT00280007|VEGF|vegf
1631093|NCT00280007|bevacizumab|bevacizumab
1631094|NCT00279994|Intermittent claudication|intermittent claudication
1631095|NCT00279994|Exercise therapy|exercise therapy
1631096|NCT00279994|Therapy feedback|therapy feedback
1631097|NCT00279994|Accelerometer|accelerometer
1631098|NCT00279994|Physiotherapy|physiotherapy
1631099|NCT00279994|PAD;|pad;
1631100|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
1631101|NCT00279981|Atrial fibrillation|atrial fibrillation
1631102|NCT00279981|Stroke|stroke
1631103|NCT00279981|Pacemaker|pacemaker
1631104|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
1631105|NCT00279981|Resynchronization systems|resynchronization systems
1631106|NCT00279968|ICD|icd
1631107|NCT00279968|Registry|registry
1631108|NCT00279968|Ventricular tachycardia|ventricular tachycardia
1631109|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
1631110|NCT00279955|Heart Failure, Congestive|heart failure, congestive
1631111|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
1631112|NCT00279942|Fibromyalgia|fibromyalgia
1631113|NCT00279942|Dietary Supplements|dietary supplements
1631114|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
1631115|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
1631116|NCT00279851|idiopathic seizure|idiopathic seizure
1631117|NCT00279851|hypoglycemia|hypoglycemia
1631118|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
1631119|NCT00279812|Immune response|immune response
1631120|NCT00279812|Selenomethionine|selenomethionine
1631121|NCT00279812|Selenium enriched foods|selenium enriched foods
1631122|NCT00279812|Selenium status|selenium status
1631123|NCT00279812|Selenium biomarkers|selenium biomarkers
1631124|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
1631125|NCT00279786|pediatric|pediatric
1631126|NCT00279773|Acute|acute
1631127|NCT00279773|Myeloid|myeloid
1631128|NCT00279773|Leukemia|leukemia
1631129|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
1631130|NCT00279721|thyroid neoplasms|thyroid neoplasms
1631131|NCT00279721|intensity modulated radiation|intensity modulated radiation
1631132|NCT00279721|radiotherapy|radiotherapy
1631133|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
1631134|NCT00279708|Steroid-Sparing|steroid-sparing
1631135|NCT00279708|Pulmonary Function|pulmonary function
1631136|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
1631137|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
1631138|NCT00279708|Biomarkers|biomarkers
1631139|NCT00279708|Nitric Oxide|nitric oxide
1631140|NCT00279708|Disease Activity|disease activity
1631141|NCT00279708|Quality of Life|quality of life
1631142|NCT00279708|Corticosteroids|corticosteroids
1631143|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
1631144|NCT00279708|Sarcoidosis|sarcoidosis
1631145|NCT00279695|Glaucoma|glaucoma
1631146|NCT00279695|Accommodation|accommodation
1631147|NCT00279695|Ocular Tumors|ocular tumors
1631148|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
1631149|NCT00279695|Ultrasound|ultrasound
1631150|NCT00279695|Eye|eye
1631154|NCT00279682|elderly|elderly
1631155|NCT00279682|primary care|primary care
1631156|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
1631157|NCT00279669|Ultrasound|ultrasound
1631158|NCT00279669|Eye|eye
1631159|NCT00279656|Frail elderly|frail elderly
1631160|NCT00279656|Pharmaceutical services|pharmaceutical services
1631161|NCT00279656|Drug therapy|drug therapy
1631162|NCT00279656|Geriatrics|geriatrics
1631163|NCT00279656|Randomized controlled trial|randomized controlled trial
1631164|NCT00279656|Hospitals, teaching|hospitals, teaching
1631165|NCT00279643|Laser|laser
1631166|NCT00279643|immunohistochemical staining|immunohistochemical staining
1631168|NCT00279643|follicular stem cells|follicular stem cells
1631169|NCT00279643|keratin 15|keratin 15
1631170|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
1631171|NCT00279578|haemophilia A|haemophilia a
1631172|NCT00279578|thrombelastography|thrombelastography
1631173|NCT00279578|recombinant factor VIII|recombinant factor viii
1631174|NCT00279578|thrombin generation|thrombin generation
1631175|NCT00279565|buprenorphine|buprenorphine
1631176|NCT00279565|methadone|methadone
1631177|NCT00279565|Peg-Intron|peg-intron
1631178|NCT00279565|Rebetol|rebetol
1631179|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
1631180|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
1631181|NCT00279552|Intrinsic factor|intrinsic factor
1631182|NCT00279552|Holotranscobalamin|holotranscobalamin
1631183|NCT00279539|Cardiovascular|cardiovascular
1631184|NCT00279539|Gene Therapy|gene therapy
1631186|NCT00279539|Stem Cells|stem cells
1631187|NCT00279539|Congestive Heart Failure|congestive heart failure
1631188|NCT00279539|Coronary Artery Disease|coronary artery disease
1631189|NCT00279539|CHF|chf
1631190|NCT00279539|Cardiomyopathy|cardiomyopathy
1631191|NCT00279526|Depression|depression
1631192|NCT00279526|Health services utilization|health services utilization
1631193|NCT00279526|Elderly|elderly
1631194|NCT00279526|Primary Care|primary care
1631195|NCT00279513|homeopathy|homeopathy
1631196|NCT00279513|hallux valgus|hallux valgus
1631197|NCT00279513|pain|pain
1631198|NCT00279513|traumeel s|traumeel s
1631199|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
1631200|NCT00279487|IV PCA opioid|iv pca opioid
1631201|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
1631202|NCT00279474|cancer patients|cancer patients
1631203|NCT00279474|family|family
1631204|NCT00279474|cognitive behavior|cognitive behavior
1631205|NCT00279474|distress|distress
1631206|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
1631207|NCT00279461|Vitamin D|vitamin d
1631208|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
1631209|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
1631210|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1631212|NCT00279409|Treatment resistant|treatment resistant
1631213|NCT00279409|Partial responder|partial responder
1631214|NCT00279409|Non-responder|non-responder
1631215|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
1631216|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
1631217|NCT00279370|SSRI Exposure|ssri exposure
1631218|NCT00279370|Pregnancy|pregnancy
1631219|NCT00279370|Infant Development|infant development
1631221|NCT00279357|high risk group for adenomas|high risk group for adenomas
1631222|NCT00279331|HIV Seronegativity|hiv seronegativity
1631223|NCT00279331|Men who have Sex with Men|men who have sex with men
1631224|NCT00279331|MSM|msm
1631225|NCT00279331|Peru|peru
1631226|NCT00279331|Ecuador|ecuador
1631227|NCT00279331|Incidence|incidence
1631228|NCT00279331|Prevalence|prevalence
1631229|NCT00279331|Drug resistance, viral|drug resistance, viral
1631230|NCT00279318|Environment|environment
1631231|NCT00279318|Exposures|exposures
1631232|NCT00279318|Diet|diet
1631233|NCT00279318|Toxins|toxins
1631234|NCT00279318|Psychosocial|psychosocial
1631235|NCT00279318|Infectious Agents|infectious agents
1631236|NCT00279318|Bacterial|bacterial
1631237|NCT00279318|Viral|viral
1631238|NCT00279318|Immunizations|immunizations
1631239|NCT00279318|Autoantibody|autoantibody
1631240|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
1631241|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
1631242|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
1631243|NCT00279305|Type 1 diabetes|type 1 diabetes
1631244|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
1631245|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
1631246|NCT00279305|T1D|t1d
1631247|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
1631248|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1631249|NCT00279279|Sudden Cardiac Death|sudden cardiac death
1631250|NCT00279279|Primary Prevention|primary prevention
1631251|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
1631252|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
1631253|NCT00279266|Diabetes Mellitus|diabetes mellitus
1631254|NCT00279253|clonidine|clonidine
1631255|NCT00279253|glaucoma|glaucoma
1631256|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
1631257|NCT00279240|Intervention|intervention
1631258|NCT00279240|Prevention|prevention
1631259|NCT00279227|coronary artery disease|coronary artery disease
1631260|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
1631261|NCT00279227|epicardial fat|epicardial fat
1631262|NCT00279227|obesity|obesity
1631263|NCT00279201|diabetes|diabetes
1631264|NCT00279201|type 2|type 2
1631265|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
1631266|NCT00279188|Atopy|atopy
1631267|NCT00279188|Inhaled steroids|inhaled steroids
1631268|NCT00279188|Exacerbations|exacerbations
1631269|NCT00279188|Lung function decline|lung function decline
1631270|NCT00279188|Prognosis|prognosis
1631271|NCT00279175|Acute myocardial infarction|acute myocardial infarction
1631272|NCT00279149|Telemedicine|telemedicine
1631273|NCT00279149|TELESTROKE|telestroke
1631274|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
1631275|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
1631276|NCT00279136|lung function,|lung function,
1631277|NCT00279136|airway inflammation,|airway inflammation,
1631278|NCT00279136|deep inspiration,|deep inspiration,
1631279|NCT00279136|bronchial biopsies|bronchial biopsies
1631280|NCT00279136|airway smooth muscle|airway smooth muscle
1631282|NCT00279110|Antiretroviral therapy|antiretroviral therapy
1631283|NCT00279110|Heroin dependence|heroin dependence
1631284|NCT00279110|Methadone|methadone
1631285|NCT00279110|Buprenorphine|buprenorphine
1631286|NCT00279097|Intracranial pressure|intracranial pressure
1631287|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
1631288|NCT00279097|Neurosurgery|neurosurgery
1631289|NCT00279084|Anaemia|anaemia
1631290|NCT00279084|Chronic kidney disease|chronic kidney disease
1631291|NCT00279084|Type 2 diabetes|type 2 diabetes
1631292|NCT00279084|Randomized trial|randomized trial
1631293|NCT00279071|dystocia|dystocia
1631294|NCT00279071|stimulation|stimulation
1631295|NCT00279071|acupuncture|acupuncture
1631296|NCT00279071|oxytocin|oxytocin
1631297|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
1631298|NCT00279032|GW406381|gw406381
1631299|NCT00279032|peripheral nerve injury|peripheral nerve injury
1631300|NCT00279032|patients|patients
1631301|NCT00279032|allodynia|allodynia
1631302|NCT00279032|hyperalgesia|hyperalgesia
1631303|NCT00279032|randomised|randomised
1631304|NCT00279032|placebo-controlled|placebo-controlled
1631305|NCT00279019|GSK233705|gsk233705
1631306|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1631307|NCT00279019|COPD|copd
1631308|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
1631309|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
1631310|NCT00279006|stent retrieval|stent retrieval
1631311|NCT00278993|Prostate cancer|prostate cancer
1631312|NCT00278993|metastatic disease|metastatic disease
1631313|NCT00278967|colonoscopy|colonoscopy
1631314|NCT00278967|preparation|preparation
1631315|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
1631316|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
1631317|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
1631318|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
1631319|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
1631320|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1631321|NCT00278941|Seroquel SR™|seroquel sr™
1631322|NCT00278941|Major Depressive Disorder|major depressive disorder
1631323|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
1631324|NCT00278928|Infant, Premature|infant, premature
1631325|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
1631326|NCT00278915|PPP|ppp
1631327|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
1631328|NCT00278915|MAS|mas
1631329|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
1631330|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
1631331|NCT00278889|Colorectal Cancer|colorectal cancer
1631332|NCT00278889|phase II|phase ii
1631333|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
1631334|NCT00278889|AZD2171|azd2171
1631335|NCT00278889|RECENTIN|recentin
1631336|NCT00278876|GIST|gist
1631337|NCT00278876|Imatinib|imatinib
1631338|NCT00278876|Adjuvant therapy|adjuvant therapy
1631339|NCT00278876|Kit mutation|kit mutation
1631340|NCT00278863|Stomach cancer|stomach cancer
1631341|NCT00278863|Palliative chemotherapy|palliative chemotherapy
1631342|NCT00278863|Capecitabine|capecitabine
1631343|NCT00278863|S-1|s-1
1631344|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
1631345|NCT00278850|Treatment|treatment
1631346|NCT00278850|Education|education
1631347|NCT00278837|Meditation|meditation
1631348|NCT00278837|Stress-reduction|stress-reduction
1631349|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
1631350|NCT00278824|Chronic Pain|chronic pain
1631351|NCT00278824|Pain|pain
1631352|NCT00278811|Mental Health Services|mental health services
1631353|NCT00278811|Suicide|suicide
1631354|NCT00278811|Suicide ideation|suicide ideation
1631355|NCT00278798|tracehelectomy|tracehelectomy
1631356|NCT00278798|radical hysterectomy|radical hysterectomy
1631357|NCT00278785|interviews|interviews
1631358|NCT00278785|brief intervention|brief intervention
1631359|NCT00278785|drinking|drinking
1631360|NCT00278785|alcohol|alcohol
1631361|NCT00278785|injuries|injuries
1631362|NCT00278785|wounds|wounds
1631363|NCT00278785|intervention studies|intervention studies
1631364|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
1631365|NCT00278759|respiratory infection|respiratory infection
1631366|NCT00278759|pediatric emergency department|pediatric emergency department
1631367|NCT00278759|febrile respiratory infection|febrile respiratory infection
1631368|NCT00278746|zinc|zinc
1631369|NCT00278746|diarrhea|diarrhea
1631370|NCT00278746|cluster randomization|cluster randomization
1631371|NCT00278746|hospitalization|hospitalization
1631372|NCT00278733|Randomized controlled trial|randomized controlled trial
1631373|NCT00278733|brief intervention|brief intervention
1631374|NCT00278733|university students|university students
1631375|NCT00278733|physician advice|physician advice
1631376|NCT00278733|high risk drinking|high risk drinking
1631377|NCT00278707|Canavan Disease|canavan disease
1631378|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
1631379|NCT00278707|NAA|naa
1631380|NCT00278707|Acetate|acetate
1631381|NCT00278707|Glyceryltriacetate|glyceryltriacetate
1631382|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
1631383|NCT00278681|zinc|zinc
1631384|NCT00278681|diarrhea|diarrhea
1631385|NCT00278681|hospitalization|hospitalization
1631386|NCT00278681|programme|programme
1631387|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
1631388|NCT00278473|Primarily Inattentive|primarily inattentive
1631389|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
1631390|NCT00278473|Combined Type|combined type
1631391|NCT00278473|ADHD|adhd
1631392|NCT00278473|Adults|adults
1631393|NCT00278473|Psychological|psychological
1631394|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
1631395|NCT00278473|CBT|cbt
1631396|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1631397|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1631398|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
1631399|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1631400|NCT00278460|large cell lung cancer|large cell lung cancer
1631401|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1631402|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
1631403|NCT00278447|Alcohol|alcohol
1631404|NCT00278447|Alcohol use|alcohol use
1631405|NCT00278447|Alcohol dependence|alcohol dependence
1631406|NCT00278447|Drug|drug
1631408|NCT00278447|Drug dependence|drug dependence
1631409|NCT00278447|Utilization|utilization
1631410|NCT00278447|Hospitalization|hospitalization
1631411|NCT00278447|Primary care|primary care
1631412|NCT00278447|Chronic disease management|chronic disease management
1631413|NCT00278447|Care management|care management
1631414|NCT00278447|Comorbidity|comorbidity
1631415|NCT00278434|cervical cancer|cervical cancer
1631416|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1631417|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1631418|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1631419|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1631420|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1631421|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1631422|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1631423|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1631424|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1631425|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1631426|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1631427|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1631428|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1631429|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1631430|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1631431|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1631432|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1631433|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1631434|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1631435|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1631664|NCT00277849|Sickle|sickle
1631436|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1631437|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1631438|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1631439|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1631440|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1631441|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1631442|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1631443|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1631444|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1631445|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1631446|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1631447|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1631448|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1631449|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1631450|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1631451|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1631452|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1631453|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1631454|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1631455|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1631456|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1631457|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1631458|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1631459|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1631460|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1631461|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1631462|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1631463|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1631464|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1631465|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1631466|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1631467|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1631468|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1631469|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1631470|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1631471|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1631538|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
1631472|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1631473|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1631474|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1631475|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1631476|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1631477|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1631478|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1631479|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1631480|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1631481|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1631482|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1631483|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1631484|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1631485|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1631486|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1631487|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1631488|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1631489|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1631490|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1631491|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1631492|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
1631493|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
1631494|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1631495|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
1631496|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1631497|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1631498|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
1631499|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
1631500|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
1631501|NCT00278304|stage III cervical cancer|stage iii cervical cancer
1631502|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
1631503|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
1631504|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1631505|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1631506|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1631610|NCT00278005|pediatric|pediatric
1631507|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1631508|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1631510|NCT00278265|neutropenia|neutropenia
1631511|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
1631512|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1631513|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1631578|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1631514|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1631515|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1631516|NCT00278239|cognitive/functional effects|cognitive/functional effects
1631517|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1631518|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1631519|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
1631520|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1631521|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1631522|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1631523|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1631524|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1631525|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1631526|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1631527|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1631528|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1631529|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1631530|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
1631531|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
1631532|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1631533|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1631534|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1631535|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1631536|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1631537|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1631539|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1631540|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1631541|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1631542|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1631543|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1631544|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1631545|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1631546|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1631547|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1631548|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1631549|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1631550|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1631551|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1631552|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1631553|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1631554|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1631555|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1631556|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
1631557|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1631558|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1631559|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1631560|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1631561|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1631562|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1631563|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1631564|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1631565|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1632107|NCT00275496|SLND|slnd
1631566|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1631567|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1631568|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1631569|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1631570|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1631571|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1631572|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1631573|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1631574|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1631575|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1631576|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1631577|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1631579|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1631580|NCT00278135|Cognition|cognition
1631581|NCT00278135|Memory|memory
1631582|NCT00278135|Nutrition|nutrition
1631583|NCT00278135|Omega-3|omega-3
1631585|NCT00278122|stage III melanoma|stage iii melanoma
1631586|NCT00278122|stage IV melanoma|stage iv melanoma
1631587|NCT00278122|recurrent melanoma|recurrent melanoma
1631588|NCT00278109|stage I breast cancer|stage i breast cancer
1631589|NCT00278109|stage II breast cancer|stage ii breast cancer
1631590|NCT00278096|disability|disability
1631591|NCT00278096|occupational therapy|occupational therapy
1631592|NCT00278083|Pharmacology|pharmacology
1631593|NCT00278083|Asthma|asthma
1631594|NCT00278083|TNF-alpha|tnf-alpha
1631595|NCT00278070|Metronomic-therapy|metronomic-therapy
1631596|NCT00278070|vinorelbine|vinorelbine
1631597|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
1631598|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
1631599|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
1631600|NCT00278057|Blood pressure;|blood pressure;
1631601|NCT00278057|chronic renal failure;|chronic renal failure;
1631602|NCT00278057|diabetes mellitus;|diabetes mellitus;
1631603|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
1631604|NCT00278057|hemodialysis;|hemodialysis;
1631605|NCT00278057|hypertension;|hypertension;
1631606|NCT00278057|uremia.|uremia.
1631607|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
1631608|NCT00278031|Retinoblastoma|retinoblastoma
1631609|NCT00278031|Quality of life|quality of life
1631611|NCT00278005|DiGeorge Syndrome|digeorge syndrome
1631612|NCT00278005|Congenital heart defects|congenital heart defects
1631613|NCT00278005|Infections|infections
1631614|NCT00278005|Cardiac surgery|cardiac surgery
1631615|NCT00277992|Pediatric|pediatric
1631616|NCT00277992|Cardiac|cardiac
1631617|NCT00277992|Norwood operation modification|norwood operation modification
1631618|NCT00277992|GT/Nissen operation|gt/nissen operation
1631619|NCT00277992|Po feed|po feed
1631623|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
1631624|NCT00277979|3D Echocardiography|3d echocardiography
1631625|NCT00277966|Pediatric|pediatric
1631626|NCT00277966|Cardiac Catheterization|cardiac catheterization
1631627|NCT00277966|Fluoroscopy time|fluoroscopy time
1631628|NCT00277953|Pediatric|pediatric
1631629|NCT00277953|Cardiac|cardiac
1631630|NCT00277953|Tracheal Dimensions|tracheal dimensions
1631631|NCT00277953|MRI|mri
1631632|NCT00277940|Pediatric|pediatric
1631633|NCT00277940|Cardiac|cardiac
1631634|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
1631635|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
1631636|NCT00277927|Pediatric|pediatric
1631637|NCT00277927|Cardiac|cardiac
1631638|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
1631639|NCT00277901|cardiac|cardiac
1631640|NCT00277901|pediatric|pediatric
1631641|NCT00277901|MRI|mri
1631642|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
1631643|NCT00277901|Aortic Coarctation|aortic coarctation
1631644|NCT00277888|Dialysis|dialysis
1631645|NCT00277888|Hemodialysis|hemodialysis
1631646|NCT00277888|Catheterization|catheterization
1631647|NCT00277875|Cardiovascular|cardiovascular
1631648|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
1631649|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
1631650|NCT00277875|Endothelial Function|endothelial function
1631651|NCT00277875|Heart Failure|heart failure
1631652|NCT00277875|Local Distensibility|local distensibility
1631653|NCT00277875|Arterial Stiffening|arterial stiffening
1631654|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
1631655|NCT00277875|Aging|aging
1631656|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
1631657|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
1631658|NCT00277875|Vascular Stiffness|vascular stiffness
1631659|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
1631660|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
1631661|NCT00277862|ribavirin,|ribavirin,
1631662|NCT00277862|rapid virologic response,|rapid virologic response,
1631663|NCT00277862|sustained virological response|sustained virological response
1631665|NCT00277849|Hemoglobinopathy|hemoglobinopathy
1631666|NCT00277849|Thalassemia|thalassemia
1631667|NCT00277849|G6PD|g6pd
1631668|NCT00277849|Plasmodium|plasmodium
1631669|NCT00277849|Erythrocyte Variant|erythrocyte variant
1631670|NCT00277849|Hemoglobin Variant|hemoglobin variant
1631671|NCT00277849|Healthy Volunteer|healthy volunteer
1631672|NCT00277849|HV|hv
1631673|NCT00277836|malignant tumor|malignant tumor
1631674|NCT00277823|Depression|depression
1631675|NCT00277823|Adult|adult
1631676|NCT00277823|Outpatients|outpatients
1631677|NCT00277810|Alzheimer's Disease|alzheimer's disease
1631678|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
1631679|NCT00277810|Outpatients|outpatients
1631680|NCT00277797|Low Back Pain|low back pain
1631681|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
1631682|NCT00277784|Ultrasound|ultrasound
1631684|NCT00277784|Eye|eye
1631685|NCT00277771|technology in weight loss|technology in weight loss
1631686|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
1631687|NCT00277758|Interleukin-2|interleukin-2
1631688|NCT00277745|periodontitis|periodontitis
1631689|NCT00277745|microfluidics|microfluidics
1631690|NCT00277745|saliva diagnostics|saliva diagnostics
1631691|NCT00277706|periodontitis|periodontitis
1631692|NCT00277706|bone regeneration|bone regeneration
1631693|NCT00277706|Parathyroid Hormone|parathyroid hormone
1631694|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
1631695|NCT00277693|hemodialysis|hemodialysis
1631696|NCT00277693|aldosterone|aldosterone
1631697|NCT00277693|heart failure|heart failure
1631698|NCT00277693|spironolactone|spironolactone
1631699|NCT00277680|uterine fibroids|uterine fibroids
1631700|NCT00277680|leiomyoma|leiomyoma
1631701|NCT00277680|laparoscopy|laparoscopy
1631702|NCT00277680|menorrhagia|menorrhagia
1631703|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
1631704|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
1631705|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
1631706|NCT00277615|Children|children
1631707|NCT00277615|Bladder volume|bladder volume
1631708|NCT00277615|Ultrasound|ultrasound
1631709|NCT00277576|DNA vaccine|dna vaccine
1631710|NCT00277576|immunotherapy|immunotherapy
1631711|NCT00277576|Hepatitis B Virus|hepatitis b virus
1631712|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
1631713|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
1631714|NCT00277563|Neuropathic Pain|neuropathic pain
1631715|NCT00277563|Neuromodulation|neuromodulation
1631716|NCT00277563|PEMF|pemf
1631717|NCT00277563|Magnetic Field Therapy|magnetic field therapy
1631718|NCT00277563|Magnetotherapy|magnetotherapy
1631719|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
1631720|NCT00277537|Mannitol|mannitol
1631722|NCT00277524|Defibrillator|defibrillator
1631723|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
1631724|NCT00277524|Dysynchrony|dysynchrony
1631725|NCT00277524|Heart failure|heart failure
1631726|NCT00277524|Arrhythmia|arrhythmia
1631727|NCT00277524|Tachycardia|tachycardia
1631728|NCT00277524|Bradycardia|bradycardia
1631729|NCT00277472|Hypertension|hypertension
1631730|NCT00277472|High blood pressure|high blood pressure
1631731|NCT00277472|diuretics|diuretics
1631732|NCT00277472|valsartan|valsartan
1631733|NCT00277446|Asthma|asthma
1631734|NCT00277446|Soy isoflavones|soy isoflavones
1631735|NCT00277446|Eosinophils|eosinophils
1631736|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
1631737|NCT00277433|Atopic Dermatitis|atopic dermatitis
1631738|NCT00277433|Eczema|eczema
1631739|NCT00277433|Genetics|genetics
1631740|NCT00277433|Histamine|histamine
1631741|NCT00277407|NAET|naet
1631742|NCT00277407|Chiropractic procedures|chiropractic procedures
1631743|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
1631744|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
1631745|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
1631746|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
1631747|NCT00277381|Adherence|adherence
1631748|NCT00277381|Hypertension|hypertension
1631749|NCT00277381|Telemedicine|telemedicine
1631750|NCT00277368|Epilepsy|epilepsy
1631751|NCT00277368|Headache|headache
1631752|NCT00277368|Seizure|seizure
1631753|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
1631754|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
1631755|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
1631756|NCT00277342|gluconeogenesis|gluconeogenesis
1631757|NCT00277342|glycogenolysis|glycogenolysis
1631758|NCT00277342|endogenous glucose production|endogenous glucose production
1631759|NCT00277316|Kidney cancer|kidney cancer
1631760|NCT00277316|Metastatic|metastatic
1631761|NCT00277303|Colon Cancer|colon cancer
1631762|NCT00277290|Cancer|cancer
1631763|NCT00277290|Recurrent|recurrent
1631764|NCT00277290|Platinum-resistant|platinum-resistant
1631765|NCT00277290|Platinum-sensitive|platinum-sensitive
1631766|NCT00277277|Telemedicine|telemedicine
1631767|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
1631768|NCT00277277|Body Mass Index|body mass index
1631769|NCT00277277|Blood Glucose|blood glucose
1631770|NCT00277277|Diabetes Management|diabetes management
1631771|NCT00277251|Crohn's disease|crohn's disease
1631772|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
1631773|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
1631774|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
1631775|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
1631776|NCT00277251|vasculitis|vasculitis
1631777|NCT00277238|HCV|hcv
1631778|NCT00277238|Hepatitis c virus|hepatitis c virus
1631779|NCT00277238|Virus diseases|virus diseases
1631780|NCT00277238|Interferon-alpha|interferon-alpha
1631781|NCT00277238|Interferons|interferons
1631782|NCT00277238|Liver diseases|liver diseases
1631783|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
1631784|NCT00277186|Arthroplasty|arthroplasty
1631785|NCT00277186|Health services research|health services research
1631786|NCT00277186|Intent to treat|intent to treat
1631787|NCT00277186|Randomized|randomized
1631788|NCT00277186|Controlled|controlled
1631789|NCT00277173|Medication Safety|medication safety
1631790|NCT00277173|Adverse Drug Events|adverse drug events
1631791|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
1631792|NCT00277173|Culture of Safety|culture of safety
1631793|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
1631794|NCT00277173|Teambuilding|teambuilding
1631795|NCT00277147|Typhoid Fever|typhoid fever
1631796|NCT00277147|Immunogenicity|immunogenicity
1631797|NCT00277147|Safety|safety
1631798|NCT00277147|Vaccine|vaccine
1631799|NCT00277147|Conjugate|conjugate
1631800|NCT00277147|Healthy Volunteer|healthy volunteer
1631801|NCT00277121|Lipid disorder|lipid disorder
1631802|NCT00277121|Gene mutation|gene mutation
1631803|NCT00277108|postpartum depression|postpartum depression
1631804|NCT00277108|postnatal depression|postnatal depression
1631805|NCT00277108|PPD|ppd
1631806|NCT00277095|Urinary Incontinence|urinary incontinence
1631807|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
1631808|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
1631809|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
1631810|NCT00277069|Breast metastatic|breast metastatic
1631811|NCT00277056|leukemia|leukemia
1631812|NCT00277043|Taxane|taxane
1631813|NCT00277043|Test Dose|test dose
1631814|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
1631815|NCT00277030|Surfactant|surfactant
1631816|NCT00277030|Nasal CPAP|nasal cpap
1631817|NCT00277017|Combination Therapy|combination therapy
1631818|NCT00277017|5-Fluorouracil|5-fluorouracil
1631819|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
1631820|NCT00277017|Thalidomide|thalidomide
1631821|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
1631822|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
1631823|NCT00276991|HIV Infections|hiv infections
1631824|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
1631825|NCT00276978|add-on therapy depression|add-on therapy depression
1631826|NCT00276965|Bipolar II Depression|bipolar ii depression
1631827|NCT00276952|Gonyautoxins|gonyautoxins
1631828|NCT00276952|Tension-type Headache|tension-type headache
1631829|NCT00276952|Human Treatment|human treatment
1631830|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1631831|NCT00276939|Diet, Vegetarian|diet, vegetarian
1631832|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
1631833|NCT00276939|Glycemic Index|glycemic index
1631834|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1631835|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
1631836|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
1631837|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
1631838|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
1631839|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
1631840|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
1631841|NCT00276900|Postpartum Depression|postpartum depression
1631842|NCT00276900|Recurrent Depression|recurrent depression
1631843|NCT00276887|Somatization Disorder|somatization disorder
1631844|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
1631845|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
1631846|NCT00276887|Mental Health|mental health
1631847|NCT00276874|Cocaine Addiction|cocaine addiction
1631848|NCT00276874|Cocaine Dependence|cocaine dependence
1631849|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
1631850|NCT00276861|recurrent colon cancer|recurrent colon cancer
1631851|NCT00276861|stage IV colon cancer|stage iv colon cancer
1631852|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1631853|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1631854|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
1631855|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1631856|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
1631857|NCT00276835|recurrent melanoma|recurrent melanoma
1631858|NCT00276835|stage IV melanoma|stage iv melanoma
1631859|NCT00276822|stage I breast cancer|stage i breast cancer
1631860|NCT00276822|stage II breast cancer|stage ii breast cancer
1631861|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
1631862|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
1631863|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
1631864|NCT00276822|stage IV breast cancer|stage iv breast cancer
1631865|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1631866|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1631867|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1631868|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1631869|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1631870|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1631871|NCT00276796|stage III cervical cancer|stage iii cervical cancer
1631872|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
1631873|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
1631874|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1631875|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
1631876|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
1631877|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
1631878|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
1631879|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
1631880|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
1631881|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
1631882|NCT00276783|adult gliosarcoma|adult gliosarcoma
1631883|NCT00276783|adult mixed glioma|adult mixed glioma
1631884|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1631885|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1631886|NCT00276783|adult glioblastoma|adult glioblastoma
1631887|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1631888|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
1631889|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1631890|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
1631891|NCT00276770|adult glioblastoma|adult glioblastoma
1631892|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
1631893|NCT00276770|adult gliosarcoma|adult gliosarcoma
1631894|NCT00276770|adult ependymoma|adult ependymoma
1631895|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
1631896|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
1631897|NCT00276770|adult mixed glioma|adult mixed glioma
1631898|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1631899|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
1631900|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
1631901|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1631902|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
1631903|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
1631904|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
1631905|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1631906|NCT00276731|regional neuroblastoma|regional neuroblastoma
1631907|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1631908|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1631909|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1631910|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1631911|NCT00276718|childhood teratoma|childhood teratoma
1631912|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1631913|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1631914|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
1631915|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1631916|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1631917|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
1631918|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
1631919|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
1631920|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
1631921|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1631922|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
1631923|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
1631924|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1631925|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1631926|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1631927|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1631928|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1631929|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1631930|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1631931|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1631932|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
1631933|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1631934|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1631935|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1632014|NCT00276159|Oncology|oncology
1632714|NCT00273117|hypoxemia|hypoxemia
1631936|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1631937|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
1631938|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
1631939|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
1631940|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1631941|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1631942|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1631943|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1631944|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1631945|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
1631946|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1631947|NCT00276588|large cell lung cancer|large cell lung cancer
1631948|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1631949|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
1631950|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1631951|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1631952|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1631953|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1631954|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
1631955|NCT00276536|stage IV melanoma|stage iv melanoma
1631956|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1631957|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1631958|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1631959|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1631960|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1631961|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1631962|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1631963|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1631964|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1631965|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1631966|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1631967|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1631968|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1631969|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1631970|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1631971|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1631972|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1631973|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
1631974|NCT00276497|Intervention|intervention
1631975|NCT00276497|Prevention|prevention
1631976|NCT00276445|allergy|allergy
1631977|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
1631978|NCT00276445|beta-1-3glucan|beta-1-3glucan
1631979|NCT00276445|Th1/Th2|th1/th2
1631980|NCT00276341|cognitive impairment|cognitive impairment
1631981|NCT00276289|nephrolithiasis|nephrolithiasis
1631982|NCT00276289|hypercalciuria|hypercalciuria
1631983|NCT00276289|hypokalemia|hypokalemia
1631984|NCT00276289|thiazide diuretics|thiazide diuretics
1631985|NCT00276276|relapsed|relapsed
1631986|NCT00276276|lung cancer|lung cancer
1631987|NCT00276276|resistant|resistant
1631988|NCT00276276|small cel|small cel
1631989|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
1631990|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
1631991|NCT00276263|Sarcosine|sarcosine
1631992|NCT00276263|Psychosis|psychosis
1631993|NCT00276263|NMDA receptor|nmda receptor
1631994|NCT00276263|Prevention|prevention
1631995|NCT00276237|Congenital Heart Disease|congenital heart disease
1631996|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
1631997|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
1631998|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
1631999|NCT00276198|Clinical trial, controlled|clinical trial, controlled
1632000|NCT00276198|Micronutrients|micronutrients
1632001|NCT00276198|Dietary Supplementation|dietary supplementation
1632002|NCT00276198|Infants|infants
1632003|NCT00276185|spasticity ;|spasticity ;
1632004|NCT00276185|Botulinum toxin ;|botulinum toxin ;
1632005|NCT00276185|Upper limb ;|upper limb ;
1632006|NCT00276185|motor function.|motor function.
1632007|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
1632008|NCT00276159|Leukemia|leukemia
1632009|NCT00276159|Lymphoma|lymphoma
1632010|NCT00276159|Myeloma|myeloma
1632011|NCT00276159|Hematology|hematology
1632012|NCT00276159|852A|852a
1632015|NCT00276146|dipyridamole|dipyridamole
1632016|NCT00276146|magnesium|magnesium
1632017|NCT00276146|sickle cell|sickle cell
1632018|NCT00276146|anemia|anemia
1632019|NCT00276146|red blood cells|red blood cells
1632020|NCT00276133|small dense LDL|small dense ldl
1632021|NCT00276120|Breast|breast
1632022|NCT00276120|Cancer|cancer
1632023|NCT00276120|Young|young
1632024|NCT00276120|Women|women
1632025|NCT00276107|Vaccine|vaccine
1632026|NCT00276107|Healthy Infants|healthy infants
1632027|NCT00276094|Urogenital atrophy|urogenital atrophy
1632028|NCT00276094|Vaginal atrophy|vaginal atrophy
1632029|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
1632030|NCT00276094|Menopausal symptoms|menopausal symptoms
1632031|NCT00276081|Hot flashes|hot flashes
1632032|NCT00276081|postmenopausal|postmenopausal
1632033|NCT00276081|climacteric symptoms|climacteric symptoms
1632034|NCT00276081|hormone replacement therapy|hormone replacement therapy
1632035|NCT00276081|gabapentin|gabapentin
1632036|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
1632037|NCT00276068|Vulvodynia|vulvodynia
1632038|NCT00276068|Desipramine|desipramine
1632039|NCT00276068|Lidocaine|lidocaine
1632040|NCT00276068|Genetics|genetics
1632041|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
1632042|NCT00276055|Phase I|phase i
1632043|NCT00276055|Gemcitabine|gemcitabine
1632044|NCT00276055|Docetaxel|docetaxel
1632045|NCT00276055|Bevacizumab|bevacizumab
1632046|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
1632048|NCT00276029|Asthma|asthma
1632049|NCT00276029|Refractory|refractory
1632050|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
1632051|NCT00276003|Phase II|phase ii
1632052|NCT00276003|Gemcitabine|gemcitabine
1632053|NCT00276003|Irinotecan|irinotecan
1632054|NCT00275990|coronary thrombectomy|coronary thrombectomy
1632055|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
1632056|NCT00275990|C14.280.647.500|c14.280.647.500
1632057|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
1632058|NCT00275977|"Stem cell"|"stem cell"
1632059|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
1632060|NCT00275977|"Myocardial infarction"|"myocardial infarction"
1632062|NCT00275951|Chemotherapy|chemotherapy
1632063|NCT00275951|Gastric cancer|gastric cancer
1632064|NCT00275938|hepatitis B virus|hepatitis b virus
1632065|NCT00275938|e antigen|e antigen
1632066|NCT00275938|interferon|interferon
1632067|NCT00275938|ribavirin|ribavirin
1632068|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
1632069|NCT00275834|obesity treatment|obesity treatment
1632070|NCT00275834|weight loss|weight loss
1632071|NCT00275834|antiobesity drugs|antiobesity drugs
1632072|NCT00275834|zonisamide|zonisamide
1632073|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
1632074|NCT00275795|NST-NAET testing|nst-naet testing
1632075|NCT00275795|Food Ssensitivities|food ssensitivities
1632076|NCT00275795|Eczema|eczema
1632077|NCT00275795|Acne|acne
1632078|NCT00275795|Indigestion|indigestion
1632079|NCT00275769|Arrhythmia|arrhythmia
1632080|NCT00275769|Bradycardia|bradycardia
1632081|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
1632082|NCT00275756|Ocular Physiology|ocular physiology
1632083|NCT00275756|Brimonidine|brimonidine
1632084|NCT00275756|Timoptic|timoptic
1632085|NCT00275756|Dorzolamide|dorzolamide
1632086|NCT00275756|ocular blood flow|ocular blood flow
1632087|NCT00275756|Regional Blood Flow|regional blood flow
1632088|NCT00275730|indometacine|indometacine
1632089|NCT00275730|retinal blood flow|retinal blood flow
1632090|NCT00275730|choroidal blood flow|choroidal blood flow
1632091|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
1632092|NCT00275561|Fluticasone|fluticasone
1632093|NCT00275561|Dysphagia|dysphagia
1632094|NCT00275535|kidney transplantation|kidney transplantation
1632095|NCT00275535|immunosuppression|immunosuppression
1632096|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
1632097|NCT00275535|sirolimus|sirolimus
1632098|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
1632099|NCT00275509|kidney|kidney
1632100|NCT00275509|transplantation|transplantation
1632101|NCT00275509|positive crossmatch|positive crossmatch
1632102|NCT00275509|antibody mediated rejection|antibody mediated rejection
1632103|NCT00275509|rejection|rejection
1632104|NCT00275509|induction|induction
1632105|NCT00275509|therapy|therapy
1632106|NCT00275509|trial|trial
1632108|NCT00275496|Sentinel|sentinel
1632109|NCT00275496|Melanoma|melanoma
1632110|NCT00275496|Surgical|surgical
1632111|NCT00275431|cancer|cancer
1632112|NCT00275431|AT-101|at-101
1632113|NCT00275431|AT101|at101
1632114|NCT00275431|B-cell malignancies|b-cell malignancies
1632115|NCT00275431|Non-Hodgkin|non-hodgkin
1632116|NCT00275431|lymphoma|lymphoma
1632117|NCT00275431|lukemia|lukemia
1632118|NCT00275418|Crohn's disease|crohn's disease
1632119|NCT00275418|remission|remission
1632120|NCT00275418|beta carotene|beta carotene
1632121|NCT00275405|Effects of Garlic|effects of garlic
1632122|NCT00275392|Dizziness|dizziness
1632123|NCT00275392|Geriatrics|geriatrics
1632124|NCT00275392|Rehabilitation|rehabilitation
1632125|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
1632126|NCT00275379|Cystitis|cystitis
1632127|NCT00275366|cuff, rotator|cuff, rotator
1632128|NCT00275366|Rotator cuff|rotator cuff
1632129|NCT00275340|Pain|pain
1632130|NCT00275340|Depressive Symptoms|depressive symptoms
1632131|NCT00275340|Coronary Artery Bypass|coronary artery bypass
1632132|NCT00275340|Convalescence|convalescence
1632133|NCT00275340|Quality of Life|quality of life
1632134|NCT00275340|Human Activities|human activities
1632135|NCT00275327|antibiotics|antibiotics
1632136|NCT00275314|transplantation|transplantation
1632137|NCT00275301|Borderline Personality Disorder|borderline personality disorder
1632138|NCT00275301|BPD|bpd
1632139|NCT00275301|PET|pet
1632140|NCT00275301|olanzapine|olanzapine
1632141|NCT00275301|brain|brain
1632142|NCT00275288|Borderline Personality Disorder|borderline personality disorder
1632143|NCT00275288|BPD|bpd
1632144|NCT00275288|amygdala|amygdala
1632145|NCT00275288|facial expression response|facial expression response
1632146|NCT00275288|MRI|mri
1632147|NCT00275275|PD|pd
1632148|NCT00275275|Parkinson's|parkinson's
1632149|NCT00275262|Bone marrow transplantation|bone marrow transplantation
1632150|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1632151|NCT00275262|Hodgkin's disease|hodgkin's disease
1632152|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1632153|NCT00275262|multiple myeloma|multiple myeloma
1632154|NCT00275249|Chronic Pain|chronic pain
1632155|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
1632156|NCT00275223|adipose tissue|adipose tissue
1632157|NCT00275223|adipocytokines|adipocytokines
1632158|NCT00275210|Oxaliplatin|oxaliplatin
1632159|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
1632160|NCT00275210|Colonic Neoplasms|colonic neoplasms
1632161|NCT00275184|Bowel preparation|bowel preparation
1632162|NCT00275184|capsule endoscopy|capsule endoscopy
1632163|NCT00275184|randomised|randomised
1632164|NCT00275184|Citramag|citramag
1632165|NCT00275184|Senna|senna
1632166|NCT00275184|Metoclopramide|metoclopramide
1632958|NCT00272051|Xaliproden|xaliproden
1632167|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
1632168|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
1632169|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
1632170|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
1632171|NCT00275171|131I therapy|131i therapy
1632172|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
1632173|NCT00275171|optimal time-interval|optimal time-interval
1632174|NCT00275171|reduced 131I activity|reduced 131i activity
1632175|NCT00275171|goiter reduction|goiter reduction
1632176|NCT00275158|Pre-Eclampsia|pre-eclampsia
1632177|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
1632178|NCT00275158|Inulin clearance|inulin clearance
1632179|NCT00275158|Hypertension|hypertension
1632180|NCT00275158|L-Arginine|l-arginine
1632181|NCT00275158|Nitric Oxide|nitric oxide
1632182|NCT00275158|cGMP|cgmp
1632183|NCT00275158|Endothelin|endothelin
1632184|NCT00275158|ADMA|adma
1632185|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1632186|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1632187|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1632188|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
1632189|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
1632190|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
1632191|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1632192|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1632193|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1632194|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1632195|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1632196|NCT00275067|adult gliosarcoma|adult gliosarcoma
1632197|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1632198|NCT00275067|adult mixed glioma|adult mixed glioma
1632199|NCT00275067|adult glioblastoma|adult glioblastoma
1632200|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
1632201|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
1632202|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1632203|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1632204|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1632205|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1632206|NCT00275041|recurrent breast cancer|recurrent breast cancer
1632207|NCT00275041|stage IV breast cancer|stage iv breast cancer
1632208|NCT00275041|male breast cancer|male breast cancer
1632209|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1632210|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1632211|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1632212|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1632213|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1632214|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1632215|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1632216|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
1632217|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1632218|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
1632219|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
1632220|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1632221|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1632222|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1632223|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1632224|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1632225|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1632226|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1632227|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1632228|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1632229|NCT00274950|childhood teratoma|childhood teratoma
1632230|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
1632231|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1632232|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1632233|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1632234|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1632235|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1632236|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1632237|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1632238|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1633165|NCT00271219|addiction|addiction
1632239|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1632240|NCT00274885|neurotoxicity|neurotoxicity
1632241|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
1632242|NCT00274885|recurrent anal cancer|recurrent anal cancer
1632243|NCT00274885|stage I anal cancer|stage i anal cancer
1632244|NCT00274885|stage II anal cancer|stage ii anal cancer
1632245|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
1632246|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
1632247|NCT00274885|stage IV anal cancer|stage iv anal cancer
1632248|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1632249|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1632250|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1632251|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
1632252|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
1632253|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
1632254|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
1632255|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
1632256|NCT00274885|recurrent colon cancer|recurrent colon cancer
1632257|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
1632258|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
1632259|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1632260|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1632261|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1632262|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1632263|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1632264|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
1632265|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1632266|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1632267|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1632268|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
1632269|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
1632270|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
1632271|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
1632272|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
1632273|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
1632274|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1632275|NCT00274885|small intestine lymphoma|small intestine lymphoma
1632276|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
1632277|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
1632278|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
1632279|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
1632280|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
1632281|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
1632282|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
1632283|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
1632284|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
1632285|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
1632286|NCT00274885|stage I colon cancer|stage i colon cancer
1632287|NCT00274885|stage IIA colon cancer|stage iia colon cancer
1632288|NCT00274885|stage IIB colon cancer|stage iib colon cancer
1632289|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
1632290|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
1632291|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
1632292|NCT00274885|stage IVA colon cancer|stage iva colon cancer
1632293|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
1632294|NCT00274885|stage I rectal cancer|stage i rectal cancer
1632295|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
1632296|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
1632297|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
1632298|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
1632299|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
1632300|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
1632301|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
1632302|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
1632303|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
1632304|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
1632305|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
1632306|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
1632307|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
1632308|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
1632309|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
1632310|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
1632311|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
1632312|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
1632313|NCT00274872|recurrent colon cancer|recurrent colon cancer
1632314|NCT00274872|stage IV colon cancer|stage iv colon cancer
1632315|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
1632316|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1632376|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1632317|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1632318|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1632319|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1632320|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1632321|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1632322|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1632323|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1632324|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1632325|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1632326|NCT00274833|adult glioblastoma|adult glioblastoma
1632327|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
1632328|NCT00274833|adult gliosarcoma|adult gliosarcoma
1632329|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1632330|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1632331|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1632332|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1632333|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1632334|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1632335|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1632336|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1632337|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1632338|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1632339|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1632340|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1632341|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1632342|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1632407|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1632343|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1632344|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1632345|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1632346|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1632347|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1632348|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1632349|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1632350|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1632351|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1632352|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1632353|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1632354|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1632355|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1632356|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1632357|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1632358|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1632359|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1632360|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1632361|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1632362|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1632363|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1632364|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1632365|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1632366|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1632367|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1632368|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1632369|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1632370|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1632371|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1632372|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1632373|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1632374|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1632375|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1632463|NCT00274625|Bypass Surgery|bypass surgery
1632377|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1632378|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1632379|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1632380|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1632381|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1632382|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1632383|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1632384|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1632385|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1632386|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1632387|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1632388|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1632389|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1632390|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1632391|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1632392|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1632393|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
1632394|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1632395|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1632396|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1632397|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1632398|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1632399|NCT00274768|stage IV breast cancer|stage iv breast cancer
1632400|NCT00274768|male breast cancer|male breast cancer
1632401|NCT00274768|recurrent breast cancer|recurrent breast cancer
1632402|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1632403|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
1632404|NCT00274755|adult glioblastoma|adult glioblastoma
1632405|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
1632406|NCT00274755|adult gliosarcoma|adult gliosarcoma
1632408|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
1632409|NCT00274755|adult ependymoma|adult ependymoma
1632410|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1632411|NCT00274755|adult subependymoma|adult subependymoma
1632412|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1632413|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
1632414|NCT00274755|adult mixed glioma|adult mixed glioma
1632415|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1632416|NCT00274742|Cancer immunotherapy|cancer immunotherapy
1632417|NCT00274742|Monoclonal antibody|monoclonal antibody
1632418|NCT00274742|anti-CD19|anti-cd19
1632419|NCT00274742|anti-CD3|anti-cd3
1632420|NCT00274742|BiTE|bite
1632421|NCT00274742|Blinatumomab|blinatumomab
1632422|NCT00274729|Dietary intervention|dietary intervention
1632423|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
1632424|NCT00274729|High-fat diet|high-fat diet
1632425|NCT00274729|Moderate-fat diet|moderate-fat diet
1632426|NCT00274729|Obesity|obesity
1632427|NCT00274729|Weight maintenance|weight maintenance
1632428|NCT00274729|Body composition|body composition
1632429|NCT00274729|Glucose metabolism|glucose metabolism
1632430|NCT00274729|Cardiovascular disease|cardiovascular disease
1632431|NCT00274729|Appetite regulation|appetite regulation
1632432|NCT00274729|Energy expenditure|energy expenditure
1632433|NCT00274703|anti IL-5|anti il-5
1632434|NCT00274703|oesophagitis|oesophagitis
1632435|NCT00274703|eosinophils|eosinophils
1632436|NCT00274703|mepolizumab|mepolizumab
1632437|NCT00274703|adults|adults
1632438|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
1632439|NCT00274690|GW679769|gw679769
1632440|NCT00274690|Post-operative Nausea|post-operative nausea
1632441|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
1632442|NCT00274690|PONV|ponv
1632443|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
1632444|NCT00274690|PDNV|pdnv
1632445|NCT00274690|Vomiting|vomiting
1632446|NCT00274677|Bipolar Disorder|bipolar disorder
1632447|NCT00274664|Amblyopia|amblyopia
1632448|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
1632449|NCT00274664|Refractive adaptation|refractive adaptation
1632450|NCT00274664|Dose-response|dose-response
1632451|NCT00274651|CTCL|ctcl
1632452|NCT00274651|PTCL|ptcl
1632453|NCT00274651|lymphoma|lymphoma
1632454|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1632455|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
1632456|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
1632457|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
1632458|NCT00274651|belinostat|belinostat
1632459|NCT00274625|Biomaterials|biomaterials
1632460|NCT00274625|Bariatric Surgery|bariatric surgery
1632461|NCT00274625|Hernia, Prevention of|hernia, prevention of
1632462|NCT00274625|Obesity|obesity
1632464|NCT00274625|Incisional Hernia|incisional hernia
1632465|NCT00274625|Ventral Hernia|ventral hernia
1632466|NCT00274495|Genotype 1|genotype 1
1632467|NCT00274495|Metabolic syndrome|metabolic syndrome
1632468|NCT00274495|Insulin resistance|insulin resistance
1632469|NCT00274469|oncology|oncology
1632470|NCT00274469|cancer|cancer
1632471|NCT00274469|breast cancer|breast cancer
1632472|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
1632473|NCT00274404|infectious mononucleosis|infectious mononucleosis
1632474|NCT00274404|Epstein-Barr virus|epstein-barr virus
1632475|NCT00274404|valacyclovir|valacyclovir
1632476|NCT00274404|quantitative PCR|quantitative pcr
1632477|NCT00274378|radius fracture|radius fracture
1632478|NCT00274378|fracture fixation|fracture fixation
1632479|NCT00274378|homologous bone transplantation|homologous bone transplantation
1632480|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
1632481|NCT00274352|sarcoidosis|sarcoidosis
1632482|NCT00274352|adalimumab|adalimumab
1632483|NCT00274352|skin diseases|skin diseases
1632484|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
1632485|NCT00274339|Prevacid|prevacid
1632486|NCT00274339|Lifestyle changes|lifestyle changes
1632487|NCT00274339|Reflux Finding Score|reflux finding score
1632488|NCT00274339|Reflux Symptom Index|reflux symptom index
1632489|NCT00274339|Laryngoscopy|laryngoscopy
1632490|NCT00274326|Hyponatremia|hyponatremia
1632491|NCT00274313|Cystic Fibrosis|cystic fibrosis
1632492|NCT00274300|DNA vaccine|dna vaccine
1632493|NCT00274300|immunotherapy|immunotherapy
1632494|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
1632495|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
1632496|NCT00274261|contraception|contraception
1632497|NCT00274235|Malaria|malaria
1632498|NCT00274235|Prevention|prevention
1632499|NCT00274235|Pregnancy|pregnancy
1632500|NCT00274235|Low birthweight|low birthweight
1632501|NCT00274235|Anemia|anemia
1632502|NCT00274235|Africa|africa
1632503|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
1632504|NCT00274209|Ulcerative colitis|ulcerative colitis
1632505|NCT00274209|Crohn's disease|crohn's disease
1632506|NCT00274209|Chromoendoscopy|chromoendoscopy
1632507|NCT00274209|Dysplasia|dysplasia
1632508|NCT00274209|Neoplasia|neoplasia
1632509|NCT00274196|fractures, occult|fractures, occult
1632510|NCT00274196|hip|hip
1632511|NCT00274196|ultrasound examination|ultrasound examination
1632512|NCT00274196|MRI|mri
1632513|NCT00274196|sensitivity|sensitivity
1632514|NCT00274196|specificity|specificity
1632515|NCT00274170|Migraine|migraine
1632516|NCT00274170|Octreotide|octreotide
1632517|NCT00274170|Prochlorperazine|prochlorperazine
1632518|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
1632519|NCT00274157|Intermittent Claudication|intermittent claudication
1632712|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
1632520|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
1632521|NCT00274157|Peripheral angioplasty|peripheral angioplasty
1632522|NCT00274157|Peripheral stenting|peripheral stenting
1632523|NCT00274157|Functional capacity|functional capacity
1632524|NCT00274157|Quality of life|quality of life
1632525|NCT00273949|Lactulose|lactulose
1632526|NCT00273949|Prebiotics|prebiotics
1632527|NCT00273949|Nosocomial infection|nosocomial infection
1632528|NCT00273949|children|children
1632529|NCT00273949|infants|infants
1632530|NCT00273910|Disease Free Survival|disease free survival
1632531|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
1632532|NCT00273910|Immunologic Response|immunologic response
1632533|NCT00273910|Adjuvant Therapy|adjuvant therapy
1632534|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
1632535|NCT00273910|Melanoma|melanoma
1632536|NCT00273897|Dementia Treatment|dementia treatment
1632537|NCT00273897|Hand Function|hand function
1632538|NCT00273897|Clinical Trials|clinical trials
1632539|NCT00273897|Dementia|dementia
1632540|NCT00273897|Cortical Syndrome|cortical syndrome
1632541|NCT00273897|CBS|cbs
1632542|NCT00273897|Apraxia|apraxia
1632543|NCT00273884|AML|aml
1632544|NCT00273884|Secondary AML|secondary aml
1632545|NCT00273884|Leukemia|leukemia
1632546|NCT00273871|kidney transplant|kidney transplant
1632547|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
1632548|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
1632549|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
1632550|NCT00273845|case management|case management
1632551|NCT00273845|substance abuse treatment|substance abuse treatment
1632552|NCT00273845|linkage|linkage
1632553|NCT00273832|Chest pain|chest pain
1632554|NCT00273832|Angina pectoris|angina pectoris
1632555|NCT00273832|Emergency medicine|emergency medicine
1632556|NCT00273832|Spiral computed tomography|spiral computed tomography
1632557|NCT00273832|Length of stay|length of stay
1632558|NCT00273832|Cost analysis|cost analysis
1632559|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
1632560|NCT00273806|Behavioral risk factors|behavioral risk factors
1632561|NCT00273806|Primary Care|primary care
1632956|NCT00272051|Paresthesia|paresthesia
1632562|NCT00273806|Health services research|health services research
1632563|NCT00273780|Patient compliance|patient compliance
1632564|NCT00273767|troponin T|troponin t
1632565|NCT00273767|CK-MB|ck-mb
1632566|NCT00273767|protein S-100|protein s-100
1632567|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
1632568|NCT00273767|Erythropoietin|erythropoietin
1632569|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
1632570|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
1632571|NCT00273754|Postoperative Complications|postoperative complications
1632572|NCT00273754|Recovery|recovery
1632573|NCT00273741|palliative care|palliative care
1632574|NCT00273741|methylphenidate|methylphenidate
1632575|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
1632576|NCT00273728|shock, septic|shock, septic
1632577|NCT00273728|infusion, intravenous|infusion, intravenous
1632578|NCT00273728|mortality|mortality
1632579|NCT00273715|Comparative|comparative
1632580|NCT00273715|Randomized|randomized
1632581|NCT00273715|Suture|suture
1632582|NCT00273715|Staples, surgical|staples, surgical
1632583|NCT00273715|Skin|skin
1632584|NCT00273715|Surgical procedures, operative|surgical procedures, operative
1632585|NCT00273715|Orthopedics|orthopedics
1632586|NCT00273715|Joint, hip|joint, hip
1632587|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
1632588|NCT00273702|Gambling|gambling
1632589|NCT00273702|Gambler|gambler
1632590|NCT00273702|Gamble|gamble
1632591|NCT00273702|Pathological|pathological
1632592|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
1632593|NCT00273676|Treatment|treatment
1632594|NCT00273676|Antibiotics|antibiotics
1632595|NCT00273663|cerebral blood flow|cerebral blood flow
1632596|NCT00273663|electrical stimulation|electrical stimulation
1632597|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
1632598|NCT00273663|Brain Mapping|brain mapping
1632599|NCT00273650|Autism|autism
1632600|NCT00273650|Placebo|placebo
1632601|NCT00273650|B12|b12
1632602|NCT00273650|Controlled|controlled
1632603|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
1632604|NCT00273650|Vitamin Supplement|vitamin supplement
1632605|NCT00273637|heart failure|heart failure
1632606|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
1632607|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
1632608|NCT00273637|pregnancy complications|pregnancy complications
1632609|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
1632610|NCT00273624|Therapy-resistant depression|therapy-resistant depression
1632611|NCT00273624|add-on therapy depression|add-on therapy depression
1632612|NCT00273611|vitamin D deficiency|vitamin d deficiency
1632613|NCT00273611|geriatric patients|geriatric patients
1632614|NCT00273598|Scoliosis|scoliosis
1632615|NCT00273598|spinal disease|spinal disease
1632616|NCT00273598|pediatrics|pediatrics
1632617|NCT00273598|Adolescents|adolescents
1632618|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
1632619|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
1632620|NCT00273598|Orthopedic Surgery|orthopedic surgery
1632621|NCT00273585|Fecal occult blood testing|fecal occult blood testing
1632622|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
1632623|NCT00273585|Colonoscopy|colonoscopy
1632624|NCT00273585|Self-efficacy|self-efficacy
1632625|NCT00273572|Obesity|obesity
1632626|NCT00273572|Women|women
1632627|NCT00273572|Arab|arab
1632628|NCT00273572|Metabolic syndrome|metabolic syndrome
1632629|NCT00273572|Lifestyle intervention|lifestyle intervention
1632630|NCT00273572|Quality of life|quality of life
1632631|NCT00273559|Renal Transplantation|renal transplantation
1632632|NCT00273546|Head and Neck Cancer|head and neck cancer
1632633|NCT00273546|Induction|induction
1632634|NCT00273546|Chemotherapy|chemotherapy
1632635|NCT00273546|Chemoradiotherapy|chemoradiotherapy
1632636|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
1632637|NCT00273507|neoadjuvant|neoadjuvant
1632638|NCT00273507|resection|resection
1632639|NCT00273494|N2 disease|n2 disease
1632640|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
1632641|NCT00273494|Surgery|surgery
1632642|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1632643|NCT00273403|HIV|hiv
1632644|NCT00273403|Minority Groups|minority groups
1632645|NCT00273403|Health Services Accessibility|health services accessibility
1632646|NCT00273403|Quality of Life|quality of life
1632647|NCT00273377|Anesthesia|anesthesia
1632648|NCT00273377|Oxygen|oxygen
1632649|NCT00273377|Carbon dioxide|carbon dioxide
1632650|NCT00273377|Hypercapnia|hypercapnia
1632651|NCT00273377|Hypercarbia|hypercarbia
1632652|NCT00273377|Dexamethasone|dexamethasone
1632653|NCT00273377|Steroid|steroid
1632654|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
1632655|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
1632656|NCT00273351|Parkinson|parkinson
1632657|NCT00273351|family history|family history
1632658|NCT00273351|diagnosis|diagnosis
1632659|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
1632957|NCT00272051|Oxaliplatin|oxaliplatin
1632660|NCT00273338|Prostate Cancer|prostate cancer
1632661|NCT00273338|DN-101|dn-101
1632662|NCT00273338|calcitriol|calcitriol
1632663|NCT00273338|Taxotere|taxotere
1632664|NCT00273338|docetaxel|docetaxel
1632665|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
1632666|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1632667|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1632668|NCT00273325|Prematurity|prematurity
1632669|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
1632670|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
1632671|NCT00273325|Immunogenicity|immunogenicity
1632672|NCT00273325|Vaccine Response|vaccine response
1632673|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
1632674|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
1632675|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
1632676|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
1632677|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
1632678|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
1632679|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
1632680|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
1632681|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
1632682|NCT00273312|Liver cancer|liver cancer
1632683|NCT00273299|hypertension|hypertension
1632684|NCT00273299|high blood pressure|high blood pressure
1632685|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
1632686|NCT00273299|severe hypertension|severe hypertension
1632687|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1632688|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
1632689|NCT00273286|IDDM|iddm
1632690|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1632691|NCT00273273|HIV|hiv
1632692|NCT00273273|Atazanavir|atazanavir
1632693|NCT00273273|ritonavir|ritonavir
1632694|NCT00273273|tenofovir|tenofovir
1632695|NCT00273273|Adolescent|adolescent
1632696|NCT00273273|Treatment Experienced|treatment experienced
1632697|NCT00273234|Venous|venous
1632698|NCT00273234|Ulcer|ulcer
1632699|NCT00273234|autologous|autologous
1632700|NCT00273234|platelet|platelet
1632701|NCT00273234|healing|healing
1632702|NCT00273221|Glaucoma|glaucoma
1632703|NCT00273221|Cataract|cataract
1632704|NCT00273208|breast cancer|breast cancer
1632705|NCT00273208|fatigue|fatigue
1632706|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
1632707|NCT00273182|Heart Failure|heart failure
1632708|NCT00273182|Cardiomyopathy|cardiomyopathy
1632709|NCT00273182|Cardiac pacing|cardiac pacing
1632710|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
1632711|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
1632713|NCT00273117|tachycardia|tachycardia
1632716|NCT00273078|tongue,|tongue,
1632717|NCT00273078|pressure,|pressure,
1632718|NCT00273078|transducer,|transducer,
1632719|NCT00273078|complete denture|complete denture
1632720|NCT00273065|Local Anesthetic|local anesthetic
1632721|NCT00273065|Neosaxitoxin|neosaxitoxin
1632722|NCT00273052|hypertension|hypertension
1632723|NCT00273039|Social Anxiety Disorder|social anxiety disorder
1632724|NCT00273039|Anxiety|anxiety
1632725|NCT00273039|Psychiatry|psychiatry
1632726|NCT00273026|Asthma Advair|asthma advair
1632727|NCT00273013|asthma|asthma
1632728|NCT00273013|allergen challenge|allergen challenge
1632729|NCT00272987|trastuzumab|trastuzumab
1632730|NCT00272987|ErbB2|erbb2
1632731|NCT00272987|paclitaxel|paclitaxel
1632732|NCT00272987|Herceptin|herceptin
1632733|NCT00272987|Taxol|taxol
1632734|NCT00272987|ErbB1|erbb1
1632735|NCT00272987|metastatic breast cancer|metastatic breast cancer
1632736|NCT00272987|Stage IV breast cancer|stage iv breast cancer
1632737|NCT00272987|lapatinib|lapatinib
1632738|NCT00272974|AE adverse event|ae adverse event
1632739|NCT00272974|DCF data collection forms|dcf data collection forms
1632740|NCT00272974|IRB Institutional Review Board|irb institutional review board
1632741|NCT00272974|SAE serious adverse event|sae serious adverse event
1632742|NCT00272948|Venoocclusive disease|venoocclusive disease
1632743|NCT00272948|Pediatric|pediatric
1632744|NCT00272948|myeloablative conditioning|myeloablative conditioning
1632745|NCT00272948|stem cell transplant|stem cell transplant
1632746|NCT00272935|menopause|menopause
1632747|NCT00272935|vasomotor symptoms|vasomotor symptoms
1632748|NCT00272922|Biomaterials|biomaterials
1632749|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
1632750|NCT00272922|Laparoscopy|laparoscopy
1632751|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
1632752|NCT00272909|9-Hour window MRI|9-hour window mri
1632753|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
1632754|NCT00272896|Migraine|migraine
1632755|NCT00272896|VIP|vip
1632756|NCT00272896|Transcranial Doppler|transcranial doppler
1632757|NCT00272896|Headache|headache
1632758|NCT00272883|central core|central core
1632759|NCT00272883|centronuclear|centronuclear
1632760|NCT00272883|multiminicore|multiminicore
1632761|NCT00272883|multicore|multicore
1632762|NCT00272883|minicore|minicore
1632763|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
1632764|NCT00272883|myotubular|myotubular
1632765|NCT00272883|nemaline|nemaline
1632766|NCT00272883|congenital myopathy|congenital myopathy
1632767|NCT00272883|neuromuscular|neuromuscular
1632768|NCT00272883|rigid spine|rigid spine
1632769|NCT00272844|cholesterol|cholesterol
1632770|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
1632771|NCT00272844|mental retardation|mental retardation
1632772|NCT00272844|sterols|sterols
1632773|NCT00272844|congenital anomalies|congenital anomalies
1632774|NCT00272831|Diabetic nephropathy|diabetic nephropathy
1632775|NCT00272831|Macroalbuminuria|macroalbuminuria
1632776|NCT00272831|Pletaal|pletaal
1632777|NCT00272818|Colitis|colitis
1632778|NCT00272818|Esophagitis|esophagitis
1632779|NCT00272818|CD23|cd23
1632780|NCT00272805|chronic heart failure|chronic heart failure
1632781|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
1632782|NCT00272779|HIV|hiv
1632783|NCT00272779|Treatment Naive|treatment naive
1632784|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
1632785|NCT00272766|Macugen|macugen
1632786|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
1632787|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
1632788|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
1632789|NCT00272740|breast cancer|breast cancer
1632790|NCT00272740|fulvestrant|fulvestrant
1632791|NCT00272740|Faslodex|faslodex
1632792|NCT00272740|hormonotherapy|hormonotherapy
1632793|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
1632794|NCT00272740|Advanced breast cancer|advanced breast cancer
1632795|NCT00272727|Asthma|asthma
1632796|NCT00272727|dialog tool|dialog tool
1632797|NCT00272727|compliance|compliance
1632798|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
1632799|NCT00272675|Nosocomial infection,|nosocomial infection,
1632800|NCT00272675|Decontamination,|decontamination,
1632801|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
1632802|NCT00272675|Cardiac surgery,|cardiac surgery,
1632803|NCT00272675|Chlorhexidine,|chlorhexidine,
1632804|NCT00272675|Prevention|prevention
1632805|NCT00272662|anemia|anemia
1632806|NCT00272662|cancer|cancer
1632807|NCT00272662|chemotherapy|chemotherapy
1632808|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
1632809|NCT00272662|CIA|cia
1632810|NCT00272662|hemoglobin|hemoglobin
1632811|NCT00272662|Hb|hb
1632812|NCT00272662|Hgb|hgb
1632813|NCT00272662|erythropoietin|erythropoietin
1632814|NCT00272662|EPO|epo
1632815|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1632816|NCT00272662|ESA|esa
1632817|NCT00272662|Hematide|hematide
1632818|NCT00272662|Omontys|omontys
1632819|NCT00272662|peginesatide|peginesatide
1632820|NCT00272662|red blood cell|red blood cell
1632821|NCT00272662|red blood cell production|red blood cell production
1632822|NCT00272649|Kidney cancer|kidney cancer
1632823|NCT00272649|Renal cancer|renal cancer
1632824|NCT00272636|atrial fibrillation|atrial fibrillation
1632825|NCT00272636|catheter ablation|catheter ablation
1632826|NCT00272636|amiodarone|amiodarone
1632827|NCT00272636|cardioversion|cardioversion
1632828|NCT00272623|Catheter, Indwelling|catheter, indwelling
1632829|NCT00272623|Indwelling Catheter|indwelling catheter
1632830|NCT00272623|Indwelling Catheters|indwelling catheters
1632831|NCT00272623|Implantable Catheters|implantable catheters
1632832|NCT00272623|Catheter, Implantable|catheter, implantable
1632833|NCT00272623|Catheters, Implantable|catheters, implantable
1632834|NCT00272623|Implantable Catheter|implantable catheter
1632835|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
1632836|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
1632837|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
1632838|NCT00272623|In Dwelling Catheters|in dwelling catheters
1632839|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
1632840|NCT00272623|Venous Reservoirs|venous reservoirs
1632841|NCT00272623|Reservoir, Venous|reservoir, venous
1632842|NCT00272623|Reservoirs, Venous|reservoirs, venous
1632843|NCT00272623|Venous Reservoir|venous reservoir
1632844|NCT00272623|Vascular Access Ports|vascular access ports
1632845|NCT00272623|Access Port, Vascular|access port, vascular
1632846|NCT00272623|Access Ports, Vascular|access ports, vascular
1632847|NCT00272623|Port, Vascular Access|port, vascular access
1632848|NCT00272623|Ports, Vascular Access|ports, vascular access
1632849|NCT00272623|Vascular Access Port|vascular access port
1632850|NCT00272610|Skin Aging|skin aging
1632851|NCT00272610|Bateman's Purpura|bateman's purpura
1632852|NCT00272597|Psychosis|psychosis
1632853|NCT00272597|schizophrenia|schizophrenia
1632854|NCT00272597|schizoaffective|schizoaffective
1632855|NCT00272597|risperidone|risperidone
1632856|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
1632857|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
1632858|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
1632859|NCT00272558|Chemotherapy|chemotherapy
1632860|NCT00272545|Anorexia Nervosa|anorexia nervosa
1632861|NCT00272545|Bulimia Nervosa|bulimia nervosa
1632862|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
1632863|NCT00272519|HIV|hiv
1632864|NCT00272519|AIDS|aids
1632865|NCT00272519|Adolescent|adolescent
1632866|NCT00272519|HIV Positive|hiv positive
1632867|NCT00272493|Treatment Experienced|treatment experienced
1632868|NCT00272493|Treatment Naive|treatment naive
1632869|NCT00272480|HAM/TSP|ham/tsp
1632870|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
1632871|NCT00272480|zidovudine|zidovudine
1632872|NCT00272480|lamivudine|lamivudine
1632873|NCT00272480|antiretroviral therapy|antiretroviral therapy
1632874|NCT00272467|Helicobacter pylori|helicobacter pylori
1632875|NCT00272467|Stomach ulcer|stomach ulcer
1632876|NCT00272467|Rebamipide|rebamipide
1632877|NCT00272467|Omeprazole|omeprazole
1632878|NCT00272454|cilostazol|cilostazol
1632879|NCT00272454|aspirin|aspirin
1632880|NCT00272454|cerebral infarction|cerebral infarction
1632881|NCT00272428|Prevention trial|prevention trial
1632882|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
1632883|NCT00272428|Cancer|cancer
1632884|NCT00272428|Ischemic disease|ischemic disease
1632885|NCT00272428|Mortality|mortality
1632886|NCT00272428|Health related quality of life|health related quality of life
1632887|NCT00272415|INO4136g|ino4136g
1632888|NCT00272415|inotek|inotek
1632889|NCT00272415|Parp|parp
1632890|NCT00272415|Temodar|temodar
1632891|NCT00272402|physician decision support|physician decision support
1632892|NCT00272402|diabetes mellitus|diabetes mellitus
1632893|NCT00272402|electronic medical records|electronic medical records
1632894|NCT00272402|office systems redesign|office systems redesign
1632895|NCT00272376|Myopia|myopia
1632896|NCT00272376|Nearsightedness|nearsightedness
1632897|NCT00272363|Glaucoma|glaucoma
1632898|NCT00272350|Brain|brain
1632899|NCT00272350|Tumor|tumor
1632900|NCT00272350|Therapy|therapy
1632901|NCT00272350|Progression|progression
1632902|NCT00272350|Antiangiogenesis|antiangiogenesis
1632903|NCT00272350|Brain Tumor|brain tumor
1632904|NCT00272350|Malignant Glioma|malignant glioma
1632905|NCT00272337|Cardiovascular diseases|cardiovascular diseases
1632906|NCT00272337|Aspirin|aspirin
1632907|NCT00272337|Atherosclerosis|atherosclerosis
1632908|NCT00272337|Myocardial Infarction|myocardial infarction
1632909|NCT00272324|Colorectal neoplasms|colorectal neoplasms
1632910|NCT00272324|Adenomatous polyps|adenomatous polyps
1632911|NCT00272311|Primary prevention|primary prevention
1632912|NCT00272311|Cardiovascular diseases|cardiovascular diseases
1632913|NCT00272311|Aspirin|aspirin
1632914|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
1632915|NCT00272311|Atherosclerosis|atherosclerosis
1632916|NCT00272285|Serotonin antagonists|serotonin antagonists
1632917|NCT00272285|Randomized controlled trial|randomized controlled trial
1632918|NCT00272285|Combination drug therapy|combination drug therapy
1632919|NCT00272285|Double-blind method|double-blind method
1632920|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
1632921|NCT00272246|dystonia|dystonia
1632922|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
1632923|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
1632924|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1632925|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1632926|NCT00272220|Randomized Controlled Trials|randomized controlled trials
1632927|NCT00272220|Africa|africa
1632928|NCT00272220|Adherence|adherence
1632929|NCT00272220|Treatment Naive|treatment naive
1632930|NCT00272207|Fibromyalgia|fibromyalgia
1632931|NCT00272207|Cannabinoids|cannabinoids
1632932|NCT00272207|Nabilone|nabilone
1632933|NCT00272207|Cesamet|cesamet
1632934|NCT00272207|Pain|pain
1632935|NCT00272194|Endotracheal Intubation|endotracheal intubation
1632936|NCT00272194|Supraglottic Airway|supraglottic airway
1632937|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
1632938|NCT00272168|Social Skills training|social skills training
1632939|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
1632940|NCT00272142|mortality|mortality
1632941|NCT00272142|hospitalization|hospitalization
1632942|NCT00272142|diarrhea|diarrhea
1632943|NCT00272142|respiratory infection|respiratory infection
1632944|NCT00272142|low birth weight|low birth weight
1632945|NCT00272142|morbidity|morbidity
1632946|NCT00272116|zinc|zinc
1632947|NCT00272116|diarrhea|diarrhea
1632948|NCT00272116|severe diarrhea|severe diarrhea
1632949|NCT00272116|recurrent diarrhea|recurrent diarrhea
1632950|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
1632951|NCT00272116|pneumonia|pneumonia
1632952|NCT00272103|functional dyspepsia|functional dyspepsia
1632953|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
1632954|NCT00272103|drug treatment|drug treatment
1632955|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
1632959|NCT00272025|Bipolar Depression|bipolar depression
1632960|NCT00272025|Escitalopram|escitalopram
1632961|NCT00272025|Mood Stabilizer|mood stabilizer
1632962|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
1632963|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
1632964|NCT00271999|hemodialysis|hemodialysis
1632965|NCT00271999|End Stage Renal Disease|end stage renal disease
1632966|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
1632967|NCT00271986|Low anterior resection|low anterior resection
1632968|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
1632969|NCT00271986|Anastomotic leakage|anastomotic leakage
1632970|NCT00271960|Pregnancy|pregnancy
1632971|NCT00271960|Birth Weight|birth weight
1632972|NCT00271960|Gestational Age|gestational age
1632973|NCT00271960|Preterm Delivery|preterm delivery
1632974|NCT00271960|HIV Seronegativity|hiv seronegativity
1632975|NCT00271921|eating disorders|eating disorders
1632976|NCT00271921|anorexia nervosa|anorexia nervosa
1632977|NCT00271921|body fat distribution|body fat distribution
1632978|NCT00271921|metabolic syndrome|metabolic syndrome
1632979|NCT00271921|visceral adipose tissue|visceral adipose tissue
1632981|NCT00271908|AIDS|aids
1632982|NCT00271908|Adolescent|adolescent
1632983|NCT00271908|Community|community
1632984|NCT00271908|Structural Changes|structural changes
1632985|NCT00271908|HIV Seronegativity|hiv seronegativity
1632986|NCT00271882|Adolescent Females|adolescent females
1632987|NCT00271882|HIV positive|hiv positive
1632988|NCT00271882|PTSD|ptsd
1632989|NCT00271882|Sexual Abuse|sexual abuse
1632990|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
1632991|NCT00271869|graft-versus-host disease|graft-versus-host disease
1632992|NCT00271869|treatment|treatment
1632993|NCT00271856|HIV|hiv
1632994|NCT00271856|Meditation|meditation
1632995|NCT00271856|Stress|stress
1632996|NCT00271856|Randomized Controlled Trial|randomized controlled trial
1632997|NCT00271856|Complementary Therapies|complementary therapies
1632998|NCT00271856|MBSR|mbsr
1632999|NCT00271856|Not on ART medications|not on art medications
1633000|NCT00271830|renal|renal
1633001|NCT00271830|transplant|transplant
1633002|NCT00271830|sexual dysfunction|sexual dysfunction
1633003|NCT00271830|male|male
1633004|NCT00271830|dialysis free|dialysis free
1633005|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
1633006|NCT00271804|Myelodysplasia|myelodysplasia
1633007|NCT00271804|MDS|mds
1633008|NCT00271804|Velcade|velcade
1633009|NCT00271804|Thalidomide|thalidomide
1633010|NCT00271804|Bortezomib|bortezomib
1633011|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
1633012|NCT00271791|Vestibular Function Tests|vestibular function tests
1633013|NCT00271791|Vestibular Adaptation|vestibular adaptation
1633014|NCT00271791|Steroids|steroids
1633117|NCT00271440|skin flora|skin flora
1633015|NCT00271778|Otitis media suppurative|otitis media suppurative
1633016|NCT00271778|surgery ear|surgery ear
1633017|NCT00271765|Myocardial infarction|myocardial infarction
1633018|NCT00271765|Coronary angioplasty|coronary angioplasty
1633019|NCT00271765|PARP inhibitor|parp inhibitor
1633020|NCT00271765|PARP inhibition|parp inhibition
1633021|NCT00271765|Heart Attack|heart attack
1633022|NCT00271752|Procalcitonin|procalcitonin
1633023|NCT00271752|Sepsis|sepsis
1633024|NCT00271752|Intensive Care Unit|intensive care unit
1633025|NCT00271752|Sepsis and Complications|sepsis and complications
1633026|NCT00271752|Organ Failure|organ failure
1633027|NCT00271739|Telemedicine|telemedicine
1633028|NCT00271739|Diabetes Mellitus|diabetes mellitus
1633029|NCT00271726|distal radius fracture|distal radius fracture
1633030|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
1633031|NCT00271713|bone structure|bone structure
1633032|NCT00271713|ibandronate|ibandronate
1633033|NCT00271700|Diabetes Mellitus|diabetes mellitus
1633034|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
1633035|NCT00271700|Inpatients|inpatients
1633036|NCT00271700|Hospital Information Systems|hospital information systems
1633037|NCT00271700|Education|education
1633038|NCT00271687|exercise|exercise
1633039|NCT00271687|exercise therapy|exercise therapy
1633040|NCT00271687|activities of daily living|activities of daily living
1633041|NCT00271687|quality of life|quality of life
1633042|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
1633043|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
1633044|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
1633045|NCT00271635|Ascorbic Acid|ascorbic acid
1633046|NCT00271635|Vitamin C|vitamin c
1633047|NCT00271622|Screening|screening
1633048|NCT00271622|Pediatric|pediatric
1633049|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
1633050|NCT00271622|Early Development|early development
1633051|NCT00271622|Children|children
1633052|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
1633053|NCT00271622|Healthy Volunteer|healthy volunteer
1633054|NCT00271622|HV|hv
1633055|NCT00271609|AVASTIN|avastin
1633056|NCT00271609|Recurrence|recurrence
1633057|NCT00271609|Chemotherapy|chemotherapy
1633058|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
1633059|NCT00271609|Radiotherapy|radiotherapy
1633060|NCT00271609|Brain Tumor|brain tumor
1633061|NCT00271609|Malignant Glioma|malignant glioma
1633062|NCT00271596|Huntington Disease|huntington disease
1633063|NCT00271596|Citalopram|citalopram
1633064|NCT00271596|Celexa|celexa
1633065|NCT00271596|Chorea|chorea
1633066|NCT00271596|Focus|focus
1633067|NCT00271596|ADD|add
1633068|NCT00271596|ADHD|adhd
1633069|NCT00271596|HD|hd
1633070|NCT00271596|SSRI|ssri
1633071|NCT00271583|emergency contraception|emergency contraception
1633072|NCT00271583|antiprogestin|antiprogestin
1633073|NCT00271557|Heart Failure|heart failure
1633074|NCT00271557|Renal Dysfunction|renal dysfunction
1633075|NCT00271557|Cardiomyopathy|cardiomyopathy
1633076|NCT00271557|Heart Decompensation|heart decompensation
1633077|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
1633078|NCT00271544|heart failure|heart failure
1633079|NCT00271544|cardiac pacing|cardiac pacing
1633080|NCT00271544|left ventricular lead|left ventricular lead
1633081|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
1633082|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
1633083|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
1633084|NCT00271505|Lung Cancer|lung cancer
1633085|NCT00271505|Bevacizumab|bevacizumab
1633086|NCT00271505|Carboplatin|carboplatin
1633087|NCT00271505|Docetaxel|docetaxel
1633088|NCT00271505|Avastin|avastin
1633089|NCT00271505|NSCLC|nsclc
1633090|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1633091|NCT00271505|rhuMAb-VEGF|rhumab-vegf
1633092|NCT00271505|Paraplatin®|paraplatin®
1633093|NCT00271505|Taxotere|taxotere
1633094|NCT00271479|Meningitis|meningitis
1633095|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1633096|NCT00271479|Neisseria meningitidis|neisseria meningitidis
1633097|NCT00271479|Outbreaks|outbreaks
1633098|NCT00271479|Vaccine|vaccine
1633099|NCT00271479|Africa|africa
1633100|NCT00271479|Uganda|uganda
1633101|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
1633102|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
1633103|NCT00271466|opioid|opioid
1633104|NCT00271466|fentanyl|fentanyl
1633105|NCT00271466|Duragesic|duragesic
1633106|NCT00271466|transdermal|transdermal
1633107|NCT00271466|chronic pain|chronic pain
1633108|NCT00271466|morphine|morphine
1633109|NCT00271453|chronic pain|chronic pain
1633110|NCT00271453|opioid|opioid
1633111|NCT00271453|fentanyl|fentanyl
1633112|NCT00271453|transdermal|transdermal
1633113|NCT00271453|Durogesic|durogesic
1633114|NCT00271453|morphine|morphine
1633115|NCT00271440|chlorhexidine|chlorhexidine
1633116|NCT00271440|neonatal|neonatal
1633118|NCT00271440|skin cleansing|skin cleansing
1633119|NCT00271440|bacterial colonization|bacterial colonization
1633120|NCT00271427|Thyroiditis|thyroiditis
1633121|NCT00271427|Autoimmune|autoimmune
1633122|NCT00271427|Hashimoto's|hashimoto's
1633123|NCT00271427|TPOAb|tpoab
1633124|NCT00271427|Selenium|selenium
1633125|NCT00271414|chronic pain|chronic pain
1633126|NCT00271414|opioid|opioid
1633127|NCT00271414|fentanyl|fentanyl
1633128|NCT00271414|transdermal|transdermal
1633129|NCT00271414|Duragesic|duragesic
1633130|NCT00271414|morphine|morphine
1633131|NCT00271401|Stents|stents
1633132|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1633133|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
1633134|NCT00271388|Hemispatial Neglect|hemispatial neglect
1633135|NCT00271388|Stroke|stroke
1633136|NCT00271375|Age|age
1633137|NCT00271375|Caregivers|caregivers
1633138|NCT00271375|Family|family
1633139|NCT00271375|Intervention Studies|intervention studies
1633140|NCT00271362|Exercise|exercise
1633141|NCT00271362|Physical function|physical function
1633142|NCT00271362|Prosthetic mobility|prosthetic mobility
1633143|NCT00271362|Rehabilitation|rehabilitation
1633144|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
1633145|NCT00271349|Budesonide|budesonide
1633146|NCT00271336|NEC|nec
1633147|NCT00271336|Premature Infants|premature infants
1633148|NCT00271336|TNF|tnf
1633149|NCT00271336|Pentoxifylline|pentoxifylline
1633150|NCT00271297|pelvic floor|pelvic floor
1633151|NCT00271297|exercise therapy|exercise therapy
1633152|NCT00271297|prevention|prevention
1633153|NCT00271297|ultrasonography|ultrasonography
1633154|NCT00271297|risk factors|risk factors
1633155|NCT00271245|cirrhosis|cirrhosis
1633156|NCT00271245|liver disease|liver disease
1633157|NCT00271245|selenium|selenium
1633158|NCT00271245|selenoproteins|selenoproteins
1633159|NCT00271245|selenoprotein P|selenoprotein p
1633160|NCT00271245|biomarkers|biomarkers
1633161|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
1633162|NCT00271219|opiate addiction|opiate addiction
1633163|NCT00271219|opiate dependence|opiate dependence
1633164|NCT00271219|substance abuse|substance abuse
1633166|NCT00271219|substance addiction|substance addiction
1633167|NCT00271219|pregnancy|pregnancy
1633168|NCT00271219|buprenorphine|buprenorphine
1633169|NCT00271219|methadone|methadone
1633170|NCT00271219|fetal|fetal
1633171|NCT00271219|neonatal|neonatal
1633172|NCT00271219|post-partum|post-partum
1633173|NCT00271206|Nicotine Dependence|nicotine dependence
1633174|NCT00271206|Tobacco Dependence|tobacco dependence
1633175|NCT00271180|Cardiac Pacing|cardiac pacing
1633176|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1633177|NCT00271180|pacemaker|pacemaker
1633178|NCT00271180|Sinus Bradycardia|sinus bradycardia
1633179|NCT00271167|Cardiac surgery|cardiac surgery
1633180|NCT00271167|PARP inhibitor|parp inhibitor
1633181|NCT00271167|PARP inhibition|parp inhibition
1633182|NCT00271167|Bypass surgery|bypass surgery
1633183|NCT00271167|CPB surgery|cpb surgery
1633184|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
1633185|NCT00271167|Coronary revascularization|coronary revascularization
1633186|NCT00271167|Cardiac valve replacement|cardiac valve replacement
1633187|NCT00271154|Heart Failure|heart failure
1633188|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1633189|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1633190|NCT00271141|Parkinson's disease|parkinson's disease
1633191|NCT00271141|Oxidative stress|oxidative stress
1633192|NCT00271141|Marker|marker
1633193|NCT00271128|NT-proBNP|nt-probnp
1633194|NCT00271128|Heart failure|heart failure
1633195|NCT00271128|Dyspnea|dyspnea
1633196|NCT00271115|Kangaroo holding|kangaroo holding
1633197|NCT00271115|Kangaroo care|kangaroo care
1633198|NCT00271115|Maternal stress levels|maternal stress levels
1633199|NCT00271115|Premature birth|premature birth
1633200|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
1633201|NCT00271076|CAD|cad
1633202|NCT00271076|CEA|cea
1633203|NCT00271076|CAS|cas
1633204|NCT00271076|IVUS|ivus
1633205|NCT00271076|symptomatic|symptomatic
1633206|NCT00271076|asymptomatic|asymptomatic
1633207|NCT00271076|Cerebral Protection Device|cerebral protection device
1633208|NCT00271076|TIA|tia
1633209|NCT00271076|Stroke|stroke
1633210|NCT00271076|plaque morphology|plaque morphology
1633620|NCT00269802|ADHD|adhd
1633211|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
1633212|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1633213|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
1633214|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
1633215|NCT00271050|Zevalin|zevalin
1633216|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
1633217|NCT00271037|Stress urinary incontinence|stress urinary incontinence
1633218|NCT00271037|Surgery|surgery
1633219|NCT00271037|Colpocleisis|colpocleisis
1633220|NCT00271037|Urinary retention|urinary retention
1633221|NCT00271024|Smoking|smoking
1633222|NCT00271024|Smoking Cessation|smoking cessation
1633223|NCT00270998|Stress urinary incontinence|stress urinary incontinence
1633224|NCT00270985|almonds|almonds
1633225|NCT00270985|pre-diabetes|pre-diabetes
1633226|NCT00270985|inflammatory|inflammatory
1633227|NCT00270985|CRP|crp
1633228|NCT00270972|Venous leg ulcer|venous leg ulcer
1633229|NCT00270972|Venous insufficiency|venous insufficiency
1633230|NCT00270972|OrCel|orcel
1633231|NCT00270959|PTSD|ptsd
1633232|NCT00270946|Venous leg ulcer|venous leg ulcer
1633233|NCT00270946|OrCel|orcel
1633234|NCT00270946|Compression therapy|compression therapy
1633235|NCT00270933|defibrillators|defibrillators
1633236|NCT00270933|LLECG|llecg
1633237|NCT00270933|ventricular tachycardia|ventricular tachycardia
1633238|NCT00270933|ventricular fibrillation|ventricular fibrillation
1633239|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
1633240|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
1633241|NCT00270907|Breast Cancer|breast cancer
1633242|NCT00270907|CT-2103|ct-2103
1633243|NCT00270907|Gemcitabine|gemcitabine
1633244|NCT00270907|Xyotax|xyotax
1633245|NCT00270907|Gemzar|gemzar
1633246|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1633247|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
1633248|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
1633249|NCT00270881|cord blood transplantation|cord blood transplantation
1633250|NCT00270881|myeloablative regimen|myeloablative regimen
1633251|NCT00270881|hematologic malignancies|hematologic malignancies
1633252|NCT00270868|Double guide wire technique|double guide wire technique
1633253|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
1633254|NCT00270868|ERCP|ercp
1633255|NCT00270868|Attempts of cannulation|attempts of cannulation
1633256|NCT00270868|Post-ERCP complications.|post-ercp complications.
1633257|NCT00270855|Body Composition|body composition
1633258|NCT00270855|Exercise|exercise
1633259|NCT00270855|Glucose Tolerance|glucose tolerance
1633260|NCT00270855|Insulin Sensitivity|insulin sensitivity
1633261|NCT00270855|Functional Electric Stimulation|functional electric stimulation
1633262|NCT00270842|Education|education
1633263|NCT00270842|Exercise|exercise
1633264|NCT00270842|Gait|gait
1633576|NCT00269958|anemia|anemia
1633265|NCT00270842|Peripheral Nervous System|peripheral nervous system
1633266|NCT00270842|Postural Balance|postural balance
1633267|NCT00270842|Self Efficacy|self efficacy
1633268|NCT00270842|Tai Chi Chuan|tai chi chuan
1633269|NCT00270829|renal function|renal function
1633270|NCT00270816|Multiple Sclerosis|multiple sclerosis
1633271|NCT00270816|Interferon-ß-1b|interferon-ß-1b
1633272|NCT00270816|Therapy|therapy
1633273|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
1633274|NCT00270790|Head and Neck cancer|head and neck cancer
1633275|NCT00270777|Controlled trial|controlled trial
1633276|NCT00270777|Snake bite|snake bite
1633277|NCT00270777|Safety|safety
1633278|NCT00270777|Antivenom|antivenom
1633279|NCT00270764|HIV/AIDS|hiv/aids
1633280|NCT00270764|Antiretroviral therapy|antiretroviral therapy
1633281|NCT00270764|Quality of life|quality of life
1633282|NCT00270764|South Africa|south africa
1633283|NCT00270764|Treatment Naive|treatment naive
1633284|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
1633285|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
1633286|NCT00270751|Pleurectomy|pleurectomy
1633287|NCT00270751|Pleural abrasion|pleural abrasion
1633288|NCT00270751|Minocycline|minocycline
1633289|NCT00270738|urinary incontinence|urinary incontinence
1633290|NCT00270738|transversus abdominis|transversus abdominis
1633291|NCT00270738|pelvic floor muscles|pelvic floor muscles
1633292|NCT00270738|randomized controlled trial|randomized controlled trial
1633293|NCT00270725|HIV|hiv
1633294|NCT00270725|AIDS|aids
1633295|NCT00270725|Labor productivity|labor productivity
1633296|NCT00270725|Antiretroviral therapy|antiretroviral therapy
1633297|NCT00270725|South Africa|south africa
1633298|NCT00270712|kidney|kidney
1633299|NCT00270712|transplant|transplant
1633300|NCT00270712|dysfunction|dysfunction
1633301|NCT00270712|chronic|chronic
1633302|NCT00270712|deterioration|deterioration
1633303|NCT00270712|loss of function|loss of function
1633304|NCT00270699|Dengue Vaccine|dengue vaccine
1633305|NCT00270699|Dengue Virus|dengue virus
1633306|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1633307|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
1633826|NCT00268853|lymphoma|lymphoma
1633308|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1633309|NCT00270686|Stickler Syndrome|stickler syndrome
1633310|NCT00270686|Marfan Syndrome|marfan syndrome
1633311|NCT00270686|Genetics|genetics
1633312|NCT00270686|Aneurysm|aneurysm
1633313|NCT00270673|Lactate|lactate
1633314|NCT00270673|Tissue hypoxia|tissue hypoxia
1633315|NCT00270673|Intensive care|intensive care
1633316|NCT00270673|Goal- directed therapy|goal- directed therapy
1633317|NCT00270660|retraction pockets ear|retraction pockets ear
1633318|NCT00270660|unsafe otitis media|unsafe otitis media
1633319|NCT00270660|otitis media complications|otitis media complications
1633320|NCT00270647|cancer|cancer
1633321|NCT00270647|prostate cancer|prostate cancer
1633322|NCT00270647|colorectal cancer|colorectal cancer
1633323|NCT00270647|cardiovascular disease|cardiovascular disease
1633324|NCT00270647|eye disease|eye disease
1633325|NCT00270647|cognitive decline|cognitive decline
1633326|NCT00270634|Randomized Controlled Trials|randomized controlled trials
1633327|NCT00270634|Immunosuppression|immunosuppression
1633328|NCT00270634|Adult|adult
1633329|NCT00270634|Kidney Transplantation|kidney transplantation
1633330|NCT00270634|Treatment Outcome|treatment outcome
1633331|NCT00270608|Hypertension|hypertension
1633332|NCT00270608|Peripheral vascular disease|peripheral vascular disease
1633333|NCT00270608|Diabetes|diabetes
1633334|NCT00270608|Total body fat percentage|total body fat percentage
1633335|NCT00270556|Treatment Experienced|treatment experienced
1633336|NCT00270543|Stomach Neoplasms|stomach neoplasms
1633337|NCT00270530|Malaria|malaria
1633338|NCT00270530|Placental diseases|placental diseases
1633339|NCT00270530|Birth complications|birth complications
1633340|NCT00270530|Plasmodium falciparum|plasmodium falciparum
1633341|NCT00270530|Zambia|zambia
1633342|NCT00270530|HIV-seropositive|hiv-seropositive
1633343|NCT00270530|HIV|hiv
1633344|NCT00270504|Memokath|memokath
1633345|NCT00270504|Urethral stricture|urethral stricture
1633346|NCT00270504|urethral stent|urethral stent
1633347|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
1633348|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
1633349|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
1633350|NCT00270478|Sickle Cell Disease|sickle cell disease
1633351|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
1633352|NCT00270478|Chronic Kidney Disease|chronic kidney disease
1633353|NCT00270478|SCD|scd
1633354|NCT00270465|HIV-positive|hiv-positive
1633355|NCT00270465|Treatment Interruption|treatment interruption
1633356|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
1633357|NCT00270465|HIV/AIDS|hiv/aids
1633358|NCT00270465|Virologic Response|virologic response
1633359|NCT00270465|HIV Positive|hiv positive
1633360|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
1633361|NCT00270452|Wilm's tumor-1|wilm's tumor-1
1633362|NCT00270452|Proteinase-3|proteinase-3
1633363|NCT00270452|Vaccine Therapy|vaccine therapy
1633364|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
1633365|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
1633366|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
1633367|NCT00270452|MDS|mds
1633368|NCT00270439|Obesity|obesity
1633369|NCT00270439|Omentectomy|omentectomy
1633370|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
1633371|NCT00270439|Laparoscopic|laparoscopic
1633372|NCT00270439|Dyslipidemia|dyslipidemia
1633373|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
1633374|NCT00270426|Benazepril|benazepril
1633375|NCT00270413|breast cancer|breast cancer
1633376|NCT00270413|metastatic|metastatic
1633377|NCT00270413|taxanes|taxanes
1633378|NCT00270413|SU11248|su11248
1633379|NCT00270400|Heart Failure|heart failure
1633380|NCT00270400|Renal Dysfunction|renal dysfunction
1633381|NCT00270400|Cardiomyopathy|cardiomyopathy
1633382|NCT00270400|Heart Decompensation|heart decompensation
1633383|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
1633384|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
1633385|NCT00270387|Heart Failure|heart failure
1633386|NCT00270387|Renal Impairment|renal impairment
1633387|NCT00270387|Kidney Failure|kidney failure
1633388|NCT00270387|Myocardial Infarction.|myocardial infarction.
1633389|NCT00270374|Congestive heart failure|congestive heart failure
1633390|NCT00270374|CHF|chf
1633391|NCT00270374|Left-sided heart failure|left-sided heart failure
1633392|NCT00270374|Right-sided heart failure|right-sided heart failure
1633393|NCT00270374|Systolic Heart Failure|systolic heart failure
1633394|NCT00270361|Heart Failure|heart failure
1633395|NCT00270361|Renal Dysfunction|renal dysfunction
1633396|NCT00270361|Cardiomyopathy|cardiomyopathy
1633397|NCT00270361|Heart Decompensation|heart decompensation
1633398|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
1633399|NCT00270361|Outpatient Therapy.|outpatient therapy.
1633400|NCT00270348|Asthma|asthma
1633401|NCT00270348|Safety|safety
1633402|NCT00270348|Pediatrics|pediatrics
1633403|NCT00270322|total knee replacement|total knee replacement
1633404|NCT00270322|orthopedic surgery|orthopedic surgery
1633405|NCT00270322|post operative analgesia|post operative analgesia
1633406|NCT00270322|continuous epidural|continuous epidural
1633827|NCT00268853|NHL|nhl
1633407|NCT00270322|patients controlled analgesia|patients controlled analgesia
1633408|NCT00270322|morphine|morphine
1633409|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
1633410|NCT00270322|anesthesia|anesthesia
1633411|NCT00270322|analgesia|analgesia
1633412|NCT00270322|epidural marcaine|epidural marcaine
1633413|NCT00270322|epidural fentanyl|epidural fentanyl
1633414|NCT00270322|pain|pain
1633415|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
1633416|NCT00270296|Treatment Naive|treatment naive
1633417|NCT00270296|MTCT|mtct
1633418|NCT00270296|HIV Seronegativity|hiv seronegativity
1633419|NCT00270283|Anemia|anemia
1633420|NCT00270283|AIDS|aids
1633421|NCT00270283|erythropoietin|erythropoietin
1633422|NCT00270283|epoetin alfa|epoetin alfa
1633423|NCT00270283|Quality of Life|quality of life
1633424|NCT00270283|Zidovudine|zidovudine
1633425|NCT00270283|HIV|hiv
1633426|NCT00270270|erythropoietin|erythropoietin
1633427|NCT00270270|Anemia|anemia
1633428|NCT00270270|Quality of Life|quality of life
1633429|NCT00270270|epoetin alfa|epoetin alfa
1633430|NCT00270270|HIV|hiv
1633431|NCT00270270|Zidovudine|zidovudine
1633432|NCT00270270|AIDS|aids
1633433|NCT00270257|HIV Seronegativity|hiv seronegativity
1633434|NCT00270257|Opiate Addiction|opiate addiction
1633435|NCT00270257|Opiate Dependence|opiate dependence
1633436|NCT00270244|Major Depression|major depression
1633437|NCT00270244|Dysthymic Disorder|dysthymic disorder
1633438|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
1633439|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
1633440|NCT00270244|Adolescent|adolescent
1633441|NCT00270244|Psychotherapy|psychotherapy
1633442|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
1633443|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
1633444|NCT00270218|HIV Seronegativity|hiv seronegativity
1633445|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
1633446|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
1633447|NCT00270205|Treatment Experienced|treatment experienced
1633448|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1633449|NCT00270192|Breastfeeding|breastfeeding
1633450|NCT00270192|exclusive|exclusive
1633451|NCT00270192|education|education
1633452|NCT00270192|counseling|counseling
1633453|NCT00270179|Anemia|anemia
1633454|NCT00270179|blood transfusion|blood transfusion
1633455|NCT00270179|epoetin alfa|epoetin alfa
1633456|NCT00270179|erythropoietin|erythropoietin
1633457|NCT00270179|surgery|surgery
1633458|NCT00270179|self-blood donation|self-blood donation
1633459|NCT00270166|cancer|cancer
1633460|NCT00270166|malignancy|malignancy
1633461|NCT00270166|red cell transfusion|red cell transfusion
1633462|NCT00270166|epoetin alfa|epoetin alfa
1633463|NCT00270166|epoetin|epoetin
1633464|NCT00270166|erythropoietin|erythropoietin
1633465|NCT00270166|red blood cells|red blood cells
1633466|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
1633467|NCT00270140|anemia|anemia
1633468|NCT00270140|blood transfusion|blood transfusion
1633469|NCT00270140|epoetin alfa|epoetin alfa
1633470|NCT00270140|erythropoietin|erythropoietin
1633471|NCT00270140|surgery|surgery
1633472|NCT00270140|blood donation|blood donation
1633473|NCT00270140|blood|blood
1633474|NCT00270127|Anemia|anemia
1633475|NCT00270127|cancer|cancer
1633476|NCT00270127|quality of life|quality of life
1633477|NCT00270127|chemotherapy|chemotherapy
1633478|NCT00270127|hemoglobin|hemoglobin
1633479|NCT00270127|transfusion|transfusion
1633480|NCT00270127|epoetin alfa|epoetin alfa
1633481|NCT00270127|epoetin|epoetin
1633482|NCT00270127|erythropoietin|erythropoietin
1633483|NCT00270114|Anemia|anemia
1633484|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
1633485|NCT00270114|epoetin alfa|epoetin alfa
1633486|NCT00270114|epogen|epogen
1633487|NCT00270114|erythropoietin|erythropoietin
1633488|NCT00270114|orthopedic procedures|orthopedic procedures
1633489|NCT00270114|orthopedic surgery|orthopedic surgery
1633490|NCT00270101|anemia|anemia
1633491|NCT00270101|cancer|cancer
1633492|NCT00270101|quality of life|quality of life
1633493|NCT00270101|chemotherapy|chemotherapy
1633494|NCT00270101|hemoglobin|hemoglobin
1633495|NCT00270101|multiple myeloma|multiple myeloma
1633496|NCT00270101|transfusion|transfusion
1633497|NCT00270101|epoetin alfa|epoetin alfa
1633498|NCT00270101|epoetin|epoetin
1633499|NCT00270101|erythropoietin|erythropoietin
1633500|NCT00270088|Anemia|anemia
1633501|NCT00270088|blood transfusion|blood transfusion
1633502|NCT00270088|epoetin alfa|epoetin alfa
1633503|NCT00270088|epogen|epogen
1633504|NCT00270088|erythropoietin|erythropoietin
1633505|NCT00270088|orthopedic procedures|orthopedic procedures
1633506|NCT00270088|orthopedic surgery|orthopedic surgery
1633507|NCT00270075|epogen|epogen
1633508|NCT00270075|erythropoietin|erythropoietin
1633509|NCT00270075|orthopedic procedures|orthopedic procedures
1633510|NCT00270075|orthopedic surgery|orthopedic surgery
1633511|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
1633512|NCT00270075|Blood transfusion|blood transfusion
1633513|NCT00270075|epoetin alfa|epoetin alfa
1633514|NCT00270062|anemia|anemia
1633515|NCT00270062|blood transfusion|blood transfusion
1633516|NCT00270062|epoetin alfa|epoetin alfa
1633517|NCT00270062|erythropoietin|erythropoietin
1633518|NCT00270062|surgery|surgery
1633519|NCT00270062|blood donation|blood donation
1633520|NCT00270062|blood|blood
1633521|NCT00270049|Anemia|anemia
1633522|NCT00270049|cancer|cancer
1633523|NCT00270049|leukemia|leukemia
1633524|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1633525|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
1633526|NCT00270049|epoetin alfa|epoetin alfa
1633527|NCT00270049|erythropoietin|erythropoietin
1633528|NCT00270049|red blood cells|red blood cells
1633529|NCT00270049|transfusions|transfusions
1633530|NCT00270049|quality of life|quality of life
1633531|NCT00270036|Blood transfusion|blood transfusion
1633532|NCT00270036|epoetin alfa|epoetin alfa
1633533|NCT00270036|epogen|epogen
1633534|NCT00270036|erythropoietin|erythropoietin
1633535|NCT00270036|orthopedic procedures|orthopedic procedures
1633536|NCT00270036|orthopedic surgery|orthopedic surgery
1633537|NCT00270023|Blood transfusion|blood transfusion
1633538|NCT00270023|epoetin alfa|epoetin alfa
1633539|NCT00270023|epogen|epogen
1633540|NCT00270023|erythropoietin|erythropoietin
1633541|NCT00270023|orthopedic procedures|orthopedic procedures
1633542|NCT00270023|orthopedic surgery|orthopedic surgery
1633543|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
1633544|NCT00270023|breast reduction|breast reduction
1633545|NCT00270010|Anemia|anemia
1633546|NCT00270010|AIDS|aids
1633547|NCT00270010|HIV|hiv
1633548|NCT00270010|Zidovudine|zidovudine
1633549|NCT00270010|Quality of Life|quality of life
1633550|NCT00270010|erythropoietin|erythropoietin
1633551|NCT00270010|epoetin alfa|epoetin alfa
1633552|NCT00269997|Anemia|anemia
1633553|NCT00269997|chemotherapy|chemotherapy
1633554|NCT00269997|epoetin alfa|epoetin alfa
1633555|NCT00269997|epogen|epogen
1633556|NCT00269997|erythropoietin|erythropoietin
1633557|NCT00269997|neoplasms|neoplasms
1633558|NCT00269997|cancer|cancer
1633559|NCT00269984|Anemia|anemia
1633560|NCT00269984|Blood transfusion|blood transfusion
1633561|NCT00269984|Epoetin alfa|epoetin alfa
1633562|NCT00269984|Erythropoietin|erythropoietin
1633563|NCT00269984|Neoplasm|neoplasm
1633564|NCT00269984|Epogen|epogen
1633565|NCT00269984|Cancer|cancer
1633566|NCT00269971|hip replacement|hip replacement
1633567|NCT00269971|hip replacement surgery|hip replacement surgery
1633568|NCT00269971|surgery|surgery
1633569|NCT00269971|anemia|anemia
1633570|NCT00269971|transfusions|transfusions
1633571|NCT00269971|blood|blood
1633572|NCT00269971|blood transfusions|blood transfusions
1633573|NCT00269958|hip replacement|hip replacement
1633574|NCT00269958|hip replacement surgery|hip replacement surgery
1633575|NCT00269958|surgery|surgery
1633577|NCT00269958|transfusions|transfusions
1633578|NCT00269958|blood transfusions|blood transfusions
1633580|NCT00269945|AIDS|aids
1633581|NCT00269945|HIV|hiv
1633582|NCT00269945|Zidovudine|zidovudine
1633583|NCT00269945|Quality of Life|quality of life
1633584|NCT00269945|erythropoietin|erythropoietin
1633585|NCT00269945|epoetin alfa|epoetin alfa
1633586|NCT00269932|Bronchitis|bronchitis
1633587|NCT00269932|chronic bronchitis|chronic bronchitis
1633588|NCT00269932|lung diseases|lung diseases
1633589|NCT00269932|respiratory tract infections|respiratory tract infections
1633590|NCT00269932|bronchial diseases|bronchial diseases
1633591|NCT00269932|antibacterial agents|antibacterial agents
1633592|NCT00269932|quinolones|quinolones
1633593|NCT00269932|levofloxacin|levofloxacin
1633594|NCT00269919|Schizophrenia|schizophrenia
1633595|NCT00269919|Risperidone|risperidone
1633596|NCT00269919|Risperidal Consta|risperidal consta
1633597|NCT00269906|Angina, unstable|angina, unstable
1633598|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
1633599|NCT00269906|Abciximab|abciximab
1633600|NCT00269893|Abciximab|abciximab
1633601|NCT00269893|Angina, unstable|angina, unstable
1633602|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
1633603|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
1633604|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
1633605|NCT00269867|infliximab|infliximab
1633606|NCT00269867|methotrexate|methotrexate
1633607|NCT00269854|Crohn's Disease|crohn's disease
1633608|NCT00269841|fistulae|fistulae
1633609|NCT00269841|Crohn's Disease|crohn's disease
1633610|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
1633611|NCT00269828|NSCLC|nsclc
1633612|NCT00269828|PS 2|ps 2
1633613|NCT00269828|female|female
1633614|NCT00269828|chemotherapy|chemotherapy
1633615|NCT00269815|ADHD|adhd
1633616|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1633617|NCT00269815|OROS®|oros®
1633618|NCT00269815|children|children
1633619|NCT00269815|methylphenidate|methylphenidate
1633621|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1633622|NCT00269802|OROS®|oros®
1633623|NCT00269802|Ritalin®|ritalin®
1633624|NCT00269802|children|children
1633625|NCT00269802|methylphenidate|methylphenidate
1633626|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1633627|NCT00269789|OROS®|oros®
1633628|NCT00269789|Ritalin®|ritalin®
1633629|NCT00269789|children|children
1633630|NCT00269789|methylphenidate|methylphenidate
1633631|NCT00269789|ADHD|adhd
1633632|NCT00269776|ADHD|adhd
1633633|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1633634|NCT00269776|OROS|oros
1633635|NCT00269776|children|children
1633636|NCT00269776|methylphenidate|methylphenidate
1633637|NCT00269776|Ritalin|ritalin
1633638|NCT00269763|patch|patch
1633639|NCT00269763|pain|pain
1633640|NCT00269763|fentanyl|fentanyl
1633641|NCT00269763|narcotic|narcotic
1633642|NCT00269763|Cancer|cancer
1633643|NCT00269750|Ditropan®|ditropan®
1633644|NCT00269750|OROS®|oros®
1633645|NCT00269750|urge|urge
1633646|NCT00269750|oxybutynin|oxybutynin
1633647|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
1633648|NCT00269737|fentanyl|fentanyl
1633649|NCT00269737|pain|pain
1633650|NCT00269737|Cancer|cancer
1633651|NCT00269737|patch|patch
1633652|NCT00269724|urinary incontinence|urinary incontinence
1633653|NCT00269724|oxybutynin|oxybutynin
1633654|NCT00269724|OROS®|oros®
1633655|NCT00269685|Septic shock|septic shock
1633656|NCT00269685|catecholamine|catecholamine
1633657|NCT00269685|vasopressin|vasopressin
1633658|NCT00269685|tonometria|tonometria
1633659|NCT00269685|lactate|lactate
1633660|NCT00269672|vaccine|vaccine
1633661|NCT00269659|Left Bundle Branch Block|left bundle branch block
1633662|NCT00269659|Regional cardiac function|regional cardiac function
1633663|NCT00269659|Global cardiac function|global cardiac function
1633664|NCT00269659|Mechanical asynchrony|mechanical asynchrony
1633665|NCT00269659|Echocardiography|echocardiography
1633666|NCT00269659|2D echocardiography|2d echocardiography
1633667|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
1633668|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
1633669|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
1633670|NCT00269646|Diet|diet
1633671|NCT00269646|Low-carbohydrate|low-carbohydrate
1633672|NCT00269646|Insulin|insulin
1633673|NCT00269646|Dietary fiber|dietary fiber
1633674|NCT00269646|Diabetes|diabetes
1633675|NCT00269646|Cardiovascular disease|cardiovascular disease
1633676|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
1633677|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
1633678|NCT00269620|contraceptive patch|contraceptive patch
1633679|NCT00269620|oral contraceptives|oral contraceptives
1633680|NCT00269620|acceptability|acceptability
1633681|NCT00269607|Substance abuse|substance abuse
1633682|NCT00269607|Treatment|treatment
1633683|NCT00269607|Relapse prevention|relapse prevention
1633684|NCT00269607|opioid antagonist|opioid antagonist
1633685|NCT00269594|Skin|skin
1633686|NCT00269594|Picking|picking
1633687|NCT00269594|Pick|pick
1633688|NCT00269594|Neurotic Excoriation|neurotic excoriation
1633689|NCT00269581|migraine|migraine
1633690|NCT00269581|tension headaches|tension headaches
1633691|NCT00269581|chronic daily headaches|chronic daily headaches
1633692|NCT00269568|medical abortion|medical abortion
1633693|NCT00269568|mifepristone|mifepristone
1633694|NCT00269568|misoprostol|misoprostol
1633695|NCT00269555|Prostate|prostate
1633696|NCT00269555|Cancer|cancer
1633697|NCT00269555|Prostate Specific Antigen|prostate specific antigen
1633698|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
1633699|NCT00269542|zinc supplementation|zinc supplementation
1633700|NCT00269542|hospitalisations|hospitalisations
1633701|NCT00269542|children|children
1633702|NCT00269542|mortality|mortality
1633703|NCT00269542|iron folic acid|iron folic acid
1633704|NCT00269529|postoperative pain|postoperative pain
1633705|NCT00269529|knee arthroplasty|knee arthroplasty
1633706|NCT00269529|analgesia|analgesia
1633707|NCT00269529|infiltration|infiltration
1633708|NCT00269529|femoral nerve block|femoral nerve block
1633709|NCT00269516|Parkinson's disease|parkinson's disease
1633710|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1633711|NCT00269490|Yoga Nidra|yoga nidra
1633712|NCT00269477|Meningitis|meningitis
1633713|NCT00269477|Meningococcal infection|meningococcal infection
1633714|NCT00269477|Neisseria meningitidis|neisseria meningitidis
1633715|NCT00269477|Menactra®|menactra®
1633716|NCT00269477|Menomune®|menomune®
1633717|NCT00269425|Cardiovascular disease|cardiovascular disease
1633718|NCT00269425|Nutrition|nutrition
1633719|NCT00269425|Mediterranean diet|mediterranean diet
1633720|NCT00269425|Low fat diet|low fat diet
1633721|NCT00269425|American Heart Association diet|american heart association diet
1633722|NCT00269425|Monounsaturated fats|monounsaturated fats
1633723|NCT00269425|Omega-3 fats|omega-3 fats
1633724|NCT00269425|Outcomes|outcomes
1633725|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
1633726|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
1633727|NCT00269399|CDAD|cdad
1633728|NCT00269399|C diff|c diff
1633729|NCT00269386|Clarithromycin|clarithromycin
1633730|NCT00269386|Crohn's|crohn's
1633731|NCT00269373|Unknown primary tumor|unknown primary tumor
1633732|NCT00269373|PET-CT|pet-ct
1633733|NCT00269360|Chiropractic|chiropractic
1633734|NCT00269360|Manual Therapies|manual therapies
1633735|NCT00269360|Exercise|exercise
1633736|NCT00269360|Randomized|randomized
1633737|NCT00269360|Clinical Trial|clinical trial
1633738|NCT00269360|Neck Pain|neck pain
1633739|NCT00269347|Chiropractic|chiropractic
1633740|NCT00269347|Manual Therapy|manual therapy
1633741|NCT00269347|Exercise|exercise
1633742|NCT00269347|Randomized|randomized
1633743|NCT00269347|Clinical Trial|clinical trial
1633744|NCT00269347|Back Pain|back pain
1633745|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
1633746|NCT00269321|Randomized|randomized
1633747|NCT00269321|Clinical Trial|clinical trial
1633748|NCT00269321|Low Back Pain|low back pain
1633749|NCT00269321|Chiropractic|chiropractic
1633750|NCT00269321|Manual Therapies|manual therapies
1633751|NCT00269321|Exercise|exercise
1633752|NCT00269308|Randomized|randomized
1633753|NCT00269308|Clinical Trial|clinical trial
1633754|NCT00269308|Neck Pain|neck pain
1633755|NCT00269308|Chiropractic|chiropractic
1633756|NCT00269308|Manual Therapies|manual therapies
1633757|NCT00269308|Exercise|exercise
1633758|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
1633759|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
1633760|NCT00269191|Arcoxia|arcoxia
1633761|NCT00269178|malaria|malaria
1633762|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
1633763|NCT00269178|bednets|bednets
1633764|NCT00269178|peer health education|peer health education
1633765|NCT00269139|Behavioral crisis|behavioral crisis
1633766|NCT00269139|Perception of social crisis|perception of social crisis
1633767|NCT00269139|Repetition compulsion|repetition compulsion
1633768|NCT00269139|Intrusive mental events|intrusive mental events
1633769|NCT00269139|Uncontrollable urges|uncontrollable urges
1633770|NCT00269126|COPD|copd
1633771|NCT00269126|Chronic Bronchitis|chronic bronchitis
1633772|NCT00269126|Emphysema|emphysema
1633773|NCT00269100|Debridement|debridement
1633774|NCT00269087|Chronic Bronchitis|chronic bronchitis
1633775|NCT00269087|COPD|copd
1633776|NCT00269087|Emphysema|emphysema
1633777|NCT00269061|pioglitazone|pioglitazone
1633778|NCT00269061|diabetes|diabetes
1633779|NCT00269061|fluid|fluid
1633780|NCT00269048|CHD|chd
1633781|NCT00269048|Lp-PLA2|lp-pla2
1633782|NCT00269048|SB-480848|sb-480848
1633786|NCT00269035|pharmacokinetics|pharmacokinetics
1633787|NCT00269035|schizophrenic patients|schizophrenic patients
1633788|NCT00269035|5HT2A RO|5ht2a ro
1633789|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
1633790|NCT00269009|Tobacco use|tobacco use
1633791|NCT00268996|Coronary artery disease|coronary artery disease
1633792|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
1633793|NCT00268996|palpography|palpography
1633794|NCT00268996|hs-CRP|hs-crp
1633795|NCT00268996|endothelial function|endothelial function
1633796|NCT00268996|intravascular ultrasound|intravascular ultrasound
1633797|NCT00268983|rituximab|rituximab
1633798|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
1633799|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
1633800|NCT00268983|radioimmunotherapy|radioimmunotherapy
1633801|NCT00268983|anti-B1 antibody|anti-b1 antibody
1633802|NCT00268983|Bexxar|bexxar
1633803|NCT00268983|NHL|nhl
1633804|NCT00268983|Tositumomab|tositumomab
1633805|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
1633806|NCT00268957|Chronic|chronic
1633807|NCT00268957|Hemodialysis|hemodialysis
1633808|NCT00268957|Kidney|kidney
1633809|NCT00268957|Hyperphosphatemia|hyperphosphatemia
1633810|NCT00268957|Chronic kidney disease|chronic kidney disease
1633811|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
1633812|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
1633813|NCT00268944|GSD-II|gsd-ii
1633814|NCT00268944|Pompe Disease|pompe disease
1633815|NCT00268931|premature birth|premature birth
1633816|NCT00268931|motor skills|motor skills
1633817|NCT00268931|learning|learning
1633818|NCT00268931|reaching|reaching
1633819|NCT00268918|PTK787|ptk787
1633820|NCT00268918|Metastatic breast cancer|metastatic breast cancer
1633821|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
1633822|NCT00268892|Prostate Cancer|prostate cancer
1633823|NCT00268892|Androgen ablation therapy|androgen ablation therapy
1633824|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
1633825|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
1633828|NCT00268853|large cell|large cell
1633829|NCT00268853|phase II|phase ii
1633830|NCT00268853|CHOP R|chop r
1633831|NCT00268853|CPOP R|cpop r
1633832|NCT00268853|non Hodgkins|non hodgkins
1633833|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
1633834|NCT00268827|Kaletra|kaletra
1633835|NCT00268827|Comparison|comparison
1633836|NCT00268827|Quality of Life|quality of life
1633837|NCT00268827|African American|african american
1633838|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
1633839|NCT00268788|subcutaneous|subcutaneous
1633840|NCT00268788|IVIG|ivig
1633841|NCT00268788|gammaglobulin|gammaglobulin
1633842|NCT00268775|community pharmacy services|community pharmacy services
1633843|NCT00268775|patient care|patient care
1633844|NCT00268775|outcome assessment|outcome assessment
1633845|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
1633846|NCT00268762|stroke|stroke
1633847|NCT00268762|thrombin inhibition|thrombin inhibition
1633848|NCT00268762|thrombolysis|thrombolysis
1633849|NCT00268762|bleeding|bleeding
1633850|NCT00268762|outcome|outcome
1633851|NCT00268697|Hyperlipidemia|hyperlipidemia
1633852|NCT00268697|Drug Therapy|drug therapy
1633853|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1633854|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
1633855|NCT00268658|Arthroscopy|arthroscopy
1633856|NCT00268606|fibromyalgia|fibromyalgia
1633857|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
1633858|NCT00268606|tailored treatment|tailored treatment
1633859|NCT00268593|heparanase|heparanase
1633860|NCT00268593|angiogenesis|angiogenesis
1633861|NCT00268580|Asthma|asthma
1633862|NCT00268580|Care map|care map
1633863|NCT00268580|Clinical pathway|clinical pathway
1633864|NCT00268580|Education|education
1633865|NCT00268580|Emergency department|emergency department
1633866|NCT00268554|adenosine|adenosine
1633867|NCT00268554|caffeine|caffeine
1633868|NCT00268554|dipyridamole|dipyridamole
1633869|NCT00268541|exercise|exercise
1633870|NCT00268541|physical activity|physical activity
1633871|NCT00268541|insulin resistance|insulin resistance
1633872|NCT00268541|adipose tissue|adipose tissue
1633873|NCT00268541|gene expression|gene expression
1633874|NCT00268502|fatigue|fatigue
1633875|NCT00268502|depression|depression
1633876|NCT00268502|spiritual concerns|spiritual concerns
1633877|NCT00268502|sexual dysfunction|sexual dysfunction
1633878|NCT00268502|sleep disorders|sleep disorders
1633879|NCT00268502|cancer survivor|cancer survivor
1633880|NCT00268502|stage IA breast cancer|stage ia breast cancer
1633881|NCT00268502|stage IB breast cancer|stage ib breast cancer
1633882|NCT00268502|stage II breast cancer|stage ii breast cancer
1633883|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
1633884|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
1633885|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
1633886|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1633887|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
1633888|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1633889|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1633890|NCT00268476|Stage III Prostate Cancer|stage iii prostate cancer
1633891|NCT00268476|Stage IV Prostate Cancer|stage iv prostate cancer
1633892|NCT00268476|Recurrent Prostate Cancer|recurrent prostate cancer
1633893|NCT00268476|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1633894|NCT00268463|liver metastases|liver metastases
1633895|NCT00268463|stage IV colon cancer|stage iv colon cancer
1633896|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
1633897|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
1633898|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1633899|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1633900|NCT00268450|stage III bladder cancer|stage iii bladder cancer
1633901|NCT00268450|stage II bladder cancer|stage ii bladder cancer
1633902|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
1633903|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1633904|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1633905|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
1633906|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
1633907|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1633908|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
1633909|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
1633910|NCT00268398|stage IV colon cancer|stage iv colon cancer
1633911|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1633912|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
1633913|NCT00268398|resectable metastases|resectable metastases
1633914|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1633915|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1633916|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1633917|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1633918|NCT00268359|adult glioblastoma|adult glioblastoma
1634489|NCT00266058|study|study
1633919|NCT00268359|adult gliosarcoma|adult gliosarcoma
1633920|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
1633921|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
1633922|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1633923|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
1633924|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1634000|NCT00268125|nausea|nausea
1633925|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
1633926|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
1633927|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1633928|NCT00268333|stage IV colon cancer|stage iv colon cancer
1633929|NCT00268333|stage III colon cancer|stage iii colon cancer
1633930|NCT00268333|stage III rectal cancer|stage iii rectal cancer
1633931|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
1633932|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
1633933|NCT00268307|Cell therapy|cell therapy
1633934|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
1633935|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
1633936|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1633937|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1633938|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1633939|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1633940|NCT00268255|large cell lung cancer|large cell lung cancer
1633941|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
1633942|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
1633943|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1633944|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1633945|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1633946|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1633947|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1633948|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1633949|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1633950|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1633951|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1633952|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1633953|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1633954|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1633955|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1633956|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1633957|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1633958|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1633959|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1633960|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1633961|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1633962|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1633963|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1633964|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1633965|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1633966|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1633967|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1633968|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1633969|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1633970|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1633971|NCT00268216|mortality|mortality
1633972|NCT00268216|TORCH|torch
1633973|NCT00268216|SERETIDE|seretide
1633974|NCT00268216|ADVAIR|advair
1633975|NCT00268216|COPD|copd
1633976|NCT00268203|expanded access study|expanded access study
1633977|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
1633978|NCT00268203|Bexxar®|bexxar®
1633979|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1633980|NCT00268203|EAP|eap
1633981|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
1633982|NCT00268177|Airways|airways
1633983|NCT00268177|Pulmonary|pulmonary
1633984|NCT00268177|Obstructive|obstructive
1633985|NCT00268177|Chronic|chronic
1633986|NCT00268177|inflammation|inflammation
1633987|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
1633988|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
1633989|NCT00268151|oxaliplatin|oxaliplatin
1633990|NCT00268151|capecitabine|capecitabine
1633991|NCT00268151|XELOX-RT|xelox-rt
1633992|NCT00268138|amine fluoride|amine fluoride
1633993|NCT00268138|white spot lesions|white spot lesions
1633994|NCT00268138|qlf|qlf
1633995|NCT00268125|Breast Neoplasm|breast neoplasm
1633996|NCT00268125|FEC100|fec100
1633997|NCT00268125|Chemotherapy|chemotherapy
1633998|NCT00268125|acupression|acupression
1633999|NCT00268125|bracelet|bracelet
1634001|NCT00268125|vomiting|vomiting
1634002|NCT00268112|pediatric|pediatric
1634003|NCT00268112|cardiac|cardiac
1634004|NCT00268112|ALCAPA|alcapa
1634005|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
1634006|NCT00268099|pediatric|pediatric
1634007|NCT00268099|cardiac|cardiac
1634008|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
1634009|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
1634010|NCT00268086|constrictive pericarditis|constrictive pericarditis
1634011|NCT00268086|adult congenital patients|adult congenital patients
1634012|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
1634013|NCT00268073|Pediatric|pediatric
1634014|NCT00268073|cardiac|cardiac
1634015|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
1634016|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
1634017|NCT00268073|Norwood Sano procedure|norwood sano procedure
1634018|NCT00268060|pediatric|pediatric
1634019|NCT00268060|cardiac|cardiac
1634020|NCT00268060|Long QT Syndrome|long qt syndrome
1634021|NCT00268060|Pacemaker|pacemaker
1634022|NCT00268060|Herg mutation|herg mutation
1634023|NCT00268047|pediatric|pediatric
1634024|NCT00268047|cardiac|cardiac
1634025|NCT00268047|surgery|surgery
1634026|NCT00268047|transplantation|transplantation
1634027|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
1634028|NCT00268034|pediatric|pediatric
1634029|NCT00268034|cardiac|cardiac
1634030|NCT00268034|aneurysms|aneurysms
1634031|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
1634032|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
1634033|NCT00268021|pediatric|pediatric
1634034|NCT00268021|biventricular pacemaker|biventricular pacemaker
1634035|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
1634036|NCT00268021|AICD|aicd
1634037|NCT00268008|aortic valve replacement|aortic valve replacement
1634038|NCT00268008|mitral valve replacement|mitral valve replacement
1634039|NCT00268008|valvular stenosis|valvular stenosis
1634040|NCT00268008|Ross procedure|ross procedure
1634041|NCT00268008|Homograft valves|homograft valves
1634042|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
1634043|NCT00268008|Mechanical valves|mechanical valves
1634044|NCT00267995|Pediatric|pediatric
1634045|NCT00267995|cardiac|cardiac
1634046|NCT00267995|Ross procedure|ross procedure
1634346|NCT00266604|Epilepsy|epilepsy
1634047|NCT00267995|Aortic valve replacement|aortic valve replacement
1634048|NCT00267995|Proximal buttressing technique|proximal buttressing technique
1634049|NCT00267982|pediatric|pediatric
1634050|NCT00267982|cardiac|cardiac
1634051|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
1634052|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
1634053|NCT00267969|Ustekinumab|ustekinumab
1634054|NCT00267969|CNTO1275|cnto1275
1634055|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
1634056|NCT00267969|Interleukin-23|interleukin-23
1634057|NCT00267969|IL-23|il-23
1634058|NCT00267969|Psoriasis|psoriasis
1634059|NCT00267969|Interleukin 12|interleukin 12
1634060|NCT00267969|IL-12|il-12
1634061|NCT00267956|Psoriatic arthritis|psoriatic arthritis
1634062|NCT00267956|CNTO 1275|cnto 1275
1634063|NCT00267956|Ustekinumab|ustekinumab
1634064|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
1634065|NCT00267956|Monoclonal antibodies|monoclonal antibodies
1634066|NCT00267930|AFib|afib
1634068|NCT00267904|Normal Physiology|normal physiology
1634069|NCT00267904|Catecholamines|catecholamines
1634070|NCT00267904|Catechols|catechols
1634071|NCT00267904|Healthy Volunteer|healthy volunteer
1634072|NCT00267904|HV|hv
1634073|NCT00267891|Healthy Control Subjects|healthy control subjects
1634074|NCT00267891|Aggression|aggression
1634075|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
1634076|NCT00267891|Children and Adolescents|children and adolescents
1634077|NCT00267891|Healthy Volunteer|healthy volunteer
1634078|NCT00267891|HV|hv
1634079|NCT00267865|HIV|hiv
1634080|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
1634081|NCT00267865|High Dose Methotrexate|high dose methotrexate
1634082|NCT00267865|Rituximab|rituximab
1634083|NCT00267865|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1634084|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
1634085|NCT00267865|AR-PCNSL|ar-pcnsl
1634086|NCT00267852|Arthritis|arthritis
1634087|NCT00267839|exercise|exercise
1634088|NCT00267839|intervention|intervention
1634089|NCT00267839|elderly woman|elderly woman
1634090|NCT00267839|risk factors|risk factors
1634716|NCT00265499|Pain|pain
1634091|NCT00267839|health costs|health costs
1634092|NCT00267839|Osteoporosis|osteoporosis
1634093|NCT00267839|cardiovascular diseases|cardiovascular diseases
1634094|NCT00267839|diabetes|diabetes
1634095|NCT00267839|Higher Age|higher age
1634096|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
1634097|NCT00267826|Atopic dermatitis|atopic dermatitis
1634098|NCT00267826|B cells|b cells
1634099|NCT00267826|Cytokines|cytokines
1634100|NCT00267826|Immunopathology|immunopathology
1634101|NCT00267813|craving|craving
1634102|NCT00267813|nicotine|nicotine
1634103|NCT00267813|imaging|imaging
1634104|NCT00267813|FDG|fdg
1634105|NCT00267813|PET|pet
1634106|NCT00267813|smoking|smoking
1634107|NCT00267813|Bupropion|bupropion
1634108|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
1634109|NCT00267800|Sarcoidosis|sarcoidosis
1634110|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
1634111|NCT00267735|pregnancy|pregnancy
1634112|NCT00267735|repeat cesarean|repeat cesarean
1634113|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
1634114|NCT00267696|ovarian cancer|ovarian cancer
1634115|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
1634116|NCT00267696|fallopian tube cancer|fallopian tube cancer
1634117|NCT00267696|peritoneal cancer|peritoneal cancer
1634118|NCT00267670|Fatty Liver Disease|fatty liver disease
1634119|NCT00267670|Liver|liver
1634120|NCT00267670|NASH|nash
1634121|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1634122|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
1634123|NCT00267670|Pentoxifylline|pentoxifylline
1634124|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
1634125|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
1634126|NCT00267553|Atamestane|atamestane
1634127|NCT00267553|Breast neoplasms|breast neoplasms
1634128|NCT00267553|Combined hormonal therapy|combined hormonal therapy
1634129|NCT00267553|Complete estrogen blockade|complete estrogen blockade
1634130|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
1634131|NCT00267553|Estrogen blocker|estrogen blocker
1634132|NCT00267553|Fareston®|fareston®
1634133|NCT00267553|Femara®|femara®
1634134|NCT00267553|First line therapy|first line therapy
1634135|NCT00267553|Letrozole|letrozole
1634136|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
1634137|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
1634138|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
1634139|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
1634140|NCT00267553|Metastatic breast cancer|metastatic breast cancer
1634141|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
1634142|NCT00267553|Receptor-positive|receptor-positive
1634143|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
1634144|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
1634145|NCT00267553|Stage IV breast cancer|stage iv breast cancer
1634146|NCT00267553|Toremifene|toremifene
1634147|NCT00267540|Vitamin D|vitamin d
1634148|NCT00267540|adolescent girls|adolescent girls
1634149|NCT00267540|bone accretion|bone accretion
1634150|NCT00267540|bone turn over|bone turn over
1634151|NCT00267540|vitamin D status|vitamin d status
1634152|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
1634153|NCT00267527|Treatment Experienced|treatment experienced
1634154|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
1634155|NCT00267514|Hemodialysis|hemodialysis
1634156|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
1634157|NCT00267488|Hycamtin|hycamtin
1634158|NCT00267488|endometrial cancer|endometrial cancer
1634159|NCT00267488|topotecan|topotecan
1634160|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
1634161|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
1634162|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
1634163|NCT00267475|eosinophilic colitis|eosinophilic colitis
1634164|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
1634165|NCT00267462|pediatric|pediatric
1634166|NCT00267462|cardiac|cardiac
1634167|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
1634168|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
1634169|NCT00267449|Mammography|mammography
1634170|NCT00267449|Breast Cancer|breast cancer
1634171|NCT00267436|adaptation|adaptation
1634172|NCT00267436|HIV prevention|hiv prevention
1634173|NCT00267436|HIV positive|hiv positive
1634174|NCT00267436|evidence based interventions|evidence based interventions
1634175|NCT00267436|HIV Seronegativity|hiv seronegativity
1634176|NCT00267423|pediatric|pediatric
1634177|NCT00267423|cardiac|cardiac
1634178|NCT00267423|electrophysiology|electrophysiology
1634179|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
1634180|NCT00267410|HIV|hiv
1634181|NCT00267410|Adaptation|adaptation
1634182|NCT00267410|Behavioral interventions|behavioral interventions
1634183|NCT00267410|Seropositive|seropositive
1634184|NCT00267410|MSM|msm
1634185|NCT00267410|HIV Seronegativity|hiv seronegativity
1634186|NCT00267397|infant|infant
1634187|NCT00267397|prenatal|prenatal
1634188|NCT00267397|birth defects|birth defects
1634717|NCT00265486|Divers|divers
1634189|NCT00267397|22Q11 deletion|22q11 deletion
1634190|NCT00267384|Aminoglycosides|aminoglycosides
1634191|NCT00267371|Migraine headache|migraine headache
1634192|NCT00267371|Patent Foramen Ovale|patent foramen ovale
1634193|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
1634194|NCT00267332|Sedation|sedation
1634195|NCT00267332|Pain|pain
1634196|NCT00267332|modafinil|modafinil
1634197|NCT00267332|opioids|opioids
1634198|NCT00267293|fever treatment|fever treatment
1634199|NCT00267293|children|children
1634200|NCT00267241|ARDS|ards
1634201|NCT00267241|ALI|ali
1634202|NCT00267241|respiratory mechanics|respiratory mechanics
1634203|NCT00267241|gas exchange|gas exchange
1634204|NCT00267241|assisted ventilation|assisted ventilation
1634205|NCT00267228|Anorexia Nervosa|anorexia nervosa
1634206|NCT00267228|Eating disorder|eating disorder
1634207|NCT00267228|Quality of life|quality of life
1634208|NCT00267215|Lumiracoxib|lumiracoxib
1634209|NCT00267215|osteoarthritis|osteoarthritis
1634210|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
1634211|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
1634212|NCT00267176|Osteoarthritis,|osteoarthritis,
1634213|NCT00267176|hypertension,|hypertension,
1634214|NCT00267176|lumiracoxib,|lumiracoxib,
1634215|NCT00267176|ibuprofen,|ibuprofen,
1634216|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
1634217|NCT00267163|Alzheimer's disease|alzheimer's disease
1634218|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
1634219|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
1634220|NCT00267150|mycophenolate|mycophenolate
1634221|NCT00267150|GI problems|gi problems
1634222|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
1634223|NCT00267124|cognitive decline|cognitive decline
1634224|NCT00267124|dementia|dementia
1634225|NCT00267124|neuroimaging|neuroimaging
1634226|NCT00267111|Infant,newborn|infant,newborn
1634227|NCT00267111|Topical anesthesia|topical anesthesia
1634228|NCT00267111|Intramuscular injection|intramuscular injection
1634229|NCT00267098|Atrioventricular block|atrioventricular block
1634230|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1634231|NCT00267098|Pacemaker|pacemaker
1634232|NCT00267098|Defibrillator|defibrillator
1634233|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
1634234|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
1634235|NCT00267085|Minimal Residual Disease|minimal residual disease
1634236|NCT00267085|Peptide Vaccine|peptide vaccine
1634237|NCT00267072|Ovarian Cancer|ovarian cancer
1634238|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1634239|NCT00267059|Lenalidomide|lenalidomide
1634240|NCT00267059|Revlimid|revlimid
1634241|NCT00267059|CLL|cll
1634242|NCT00267046|Sarcoma|sarcoma
1634243|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
1634244|NCT00267046|Oral Mucositis|oral mucositis
1634245|NCT00267046|Doxorubicin|doxorubicin
1634246|NCT00267046|Adriamycin|adriamycin
1634247|NCT00267046|Ifosfamide|ifosfamide
1634248|NCT00267046|Palifermin|palifermin
1634249|NCT00267046|Vincristine|vincristine
1634250|NCT00267046|Cisplatin|cisplatin
1634251|NCT00267046|Placebo|placebo
1634252|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
1634253|NCT00267033|Bone Neoplasms|bone neoplasms
1634254|NCT00267033|Pain|pain
1634255|NCT00267033|Radiotherapy|radiotherapy
1634256|NCT00267033|Vertebroplasty|vertebroplasty
1634257|NCT00267033|Combined modality therapy|combined modality therapy
1634258|NCT00267007|Peripheral neuropathy|peripheral neuropathy
1634259|NCT00267007|Chemotherapy-induced|chemotherapy-induced
1634260|NCT00267007|Hemoglobin level|hemoglobin level
1634261|NCT00267007|Cancer|cancer
1634262|NCT00267007|Taxane|taxane
1634263|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
1634264|NCT00266994|Thrombosis|thrombosis
1634265|NCT00266968|pediatric|pediatric
1634266|NCT00266968|cardiac|cardiac
1634267|NCT00266968|single ventricle|single ventricle
1634268|NCT00266955|pediatric|pediatric
1634269|NCT00266955|cardiac|cardiac
1634270|NCT00266955|ADHD|adhd
1634271|NCT00266955|Adderall|adderall
1634272|NCT00266955|Straterra|straterra
1634273|NCT00266942|Fontan procedure|fontan procedure
1634274|NCT00266942|single ventricle physiology|single ventricle physiology
1634275|NCT00266942|intra-atrial|intra-atrial
1634276|NCT00266942|extracardiac technique|extracardiac technique
1634277|NCT00266929|odontoid fx|odontoid fx
1634278|NCT00266929|surgical intervention|surgical intervention
1634279|NCT00266929|conservative treatment|conservative treatment
1634280|NCT00266929|nonunion|nonunion
1634281|NCT00266929|odontoid fractures|odontoid fractures
1634282|NCT00266929|surgical treatment|surgical treatment
1634283|NCT00266916|adult|adult
1634284|NCT00266916|congenital heart disease|congenital heart disease
1634285|NCT00266916|percutaneous occlusion|percutaneous occlusion
1634286|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
1634287|NCT00266916|balloon angioplasty|balloon angioplasty
1634391|NCT00266487|Randomized trial|randomized trial
1634288|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
1634289|NCT00266903|adult|adult
1634290|NCT00266903|congenital heart disease|congenital heart disease
1634291|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
1634292|NCT00266903|Bosentan|bosentan
1634293|NCT00266903|Sitaxsetan|sitaxsetan
1634294|NCT00266903|Sildenafil|sildenafil
1634295|NCT00266877|Lung Cancer|lung cancer
1634296|NCT00266877|HKI-272|hki-272
1634297|NCT00266877|Neratinib|neratinib
1634298|NCT00266877|Nerlynx|nerlynx
1634496|NCT00266045|D-dimer|d-dimer
1634299|NCT00266864|Spinal Cord Injury|spinal cord injury
1634300|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
1634301|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
1634302|NCT00266864|Lean Tissue Mass|lean tissue mass
1634303|NCT00266851|Randomized clinical trial|randomized clinical trial
1634304|NCT00266851|Asthma|asthma
1634305|NCT00266851|Adults|adults
1634306|NCT00266851|Azithromycin|azithromycin
1634307|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
1634308|NCT00266838|Epiphora|epiphora
1634309|NCT00266812|temozolomide|temozolomide
1634310|NCT00266812|radiotherapy|radiotherapy
1634311|NCT00266773|Chronic Pain|chronic pain
1634312|NCT00266773|Cognitive Therapy|cognitive therapy
1634313|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
1634314|NCT00266773|Recurrence|recurrence
1634315|NCT00266773|Relapse Prevention|relapse prevention
1634316|NCT00266773|Educational Technology|educational technology
1634318|NCT00266773|CST|cst
1634319|NCT00266773|IVR|ivr
1634320|NCT00266773|TIVR|tivr
1634321|NCT00266747|Anxiety|anxiety
1634322|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
1634323|NCT00266747|Controlled Clinical Trial|controlled clinical trial
1634324|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
1634325|NCT00266734|Viral conjunctivitis|viral conjunctivitis
1634326|NCT00266734|conjunctivitis|conjunctivitis
1634327|NCT00266721|Pancrelipase|pancrelipase
1634328|NCT00266721|Abdominal bloating|abdominal bloating
1634329|NCT00266721|Abdominal pain|abdominal pain
1634330|NCT00266721|Eructation|eructation
1634331|NCT00266708|renal transplant|renal transplant
1634332|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
1634333|NCT00266682|Bradycardia|bradycardia
1634334|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
1634335|NCT00266669|Raynaud's Disease|raynaud's disease
1634336|NCT00266669|Scleroderma|scleroderma
1634337|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
1634338|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
1634339|NCT00266617|Anemia|anemia
1634340|NCT00266617|chemotherapy|chemotherapy
1634341|NCT00266617|epoetin alfa|epoetin alfa
1634342|NCT00266617|epogen|epogen
1634343|NCT00266617|erythropoietin|erythropoietin
1634344|NCT00266617|neoplasms|neoplasms
1634345|NCT00266617|cancer|cancer
1634348|NCT00266604|new-onset epilepsy|new-onset epilepsy
1634349|NCT00266604|epilepsy relapse|epilepsy relapse
1634350|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
1634351|NCT00266591|Epilepsy|epilepsy
1634352|NCT00266591|Seizures|seizures
1634353|NCT00266591|Topiramate|topiramate
1634354|NCT00266591|Prophylaxis|prophylaxis
1634355|NCT00266591|Antiepileptic|antiepileptic
1634356|NCT00266591|Epileptic seizures|epileptic seizures
1634357|NCT00266591|Partial seizure disorder|partial seizure disorder
1634358|NCT00266591|Brain disease|brain disease
1634359|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
1634360|NCT00266552|conduct disorder|conduct disorder
1634361|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
1634362|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
1634363|NCT00266552|ADHD|adhd
1634364|NCT00266552|risperidone|risperidone
1634365|NCT00266552|antipsychotropic agents|antipsychotropic agents
1634366|NCT00266552|children|children
1634367|NCT00266539|Postoperative pain|postoperative pain
1634368|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
1634369|NCT00266526|Allergy|allergy
1634370|NCT00266526|Birch pollen|birch pollen
1634371|NCT00266526|Recombinant|recombinant
1634372|NCT00266513|CD40 Ligand|cd40 ligand
1634373|NCT00266513|Nemo|nemo
1634374|NCT00266513|Genetics|genetics
1634375|NCT00266513|Hyper-IGM|hyper-igm
1634376|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
1634377|NCT00266513|CVID|cvid
1634378|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
1634379|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
1634380|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
1634381|NCT00266500|Adipose Tissue|adipose tissue
1634382|NCT00266500|Weight Gain|weight gain
1634383|NCT00266500|Overweight|overweight
1634384|NCT00266500|Thermogenesis|thermogenesis
1634385|NCT00266500|Deep Body Temperature|deep body temperature
1634386|NCT00266500|Adult|adult
1634387|NCT00266500|Exercise|exercise
1634388|NCT00266487|Homocysteine|homocysteine
1634389|NCT00266487|B vitamins|b vitamins
1634390|NCT00266487|Folic acid|folic acid
1634392|NCT00266487|Secondary prevention|secondary prevention
1634393|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
1634394|NCT00266461|Postoperative Ileus|postoperative ileus
1634395|NCT00266448|MRSA|mrsa
1634396|NCT00266448|eradication|eradication
1634397|NCT00266448|chlorhexidine|chlorhexidine
1634398|NCT00266435|Asymptomatic subjects|asymptomatic subjects
1634495|NCT00266045|Pulmonary Embolism|pulmonary embolism
1634400|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
1634402|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
1634403|NCT00266396|TKA|tka
1634404|NCT00266396|Total Hip Replacement|total hip replacement
1634405|NCT00266396|THR|thr
1634406|NCT00266396|Total Knee Replacement|total knee replacement
1634407|NCT00266396|TKR|tkr
1634408|NCT00266331|Breast cancer|breast cancer
1634409|NCT00266331|Radiation skin protection|radiation skin protection
1634410|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
1634411|NCT00266318|Genotype 1|genotype 1
1634412|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
1634413|NCT00266318|Consensus Interferon|consensus interferon
1634414|NCT00266318|CIFN|cifn
1634415|NCT00266318|Infergen|infergen
1634416|NCT00266318|Ribavirin|ribavirin
1634417|NCT00266305|n-3 LCPUFA|n-3 lcpufa
1634418|NCT00266305|Infant development|infant development
1634419|NCT00266305|Visual acuity|visual acuity
1634420|NCT00266305|Immune function|immune function
1634421|NCT00266305|Breast milk|breast milk
1634422|NCT00266292|Fish oil|fish oil
1634423|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
1634424|NCT00266292|Immune function|immune function
1634425|NCT00266292|Endothelial function|endothelial function
1634426|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
1634427|NCT00266266|Human Papilloma Virus|human papilloma virus
1634428|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
1634429|NCT00266214|Lidoderm|lidoderm
1634430|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
1634431|NCT00266214|pain|pain
1634432|NCT00266214|nerve compression injury|nerve compression injury
1634433|NCT00266214|topical analgesic|topical analgesic
1634434|NCT00266201|Heart Defects, Congenital|heart defects, congenital
1634435|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
1634436|NCT00266201|Low Cardiac Output|low cardiac output
1634437|NCT00266201|Biochemical markers|biochemical markers
1634438|NCT00266201|Neurohumoral activity|neurohumoral activity
1634439|NCT00266188|Heart Defects, Congenital|heart defects, congenital
1634440|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
1634441|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
1634442|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
1634443|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
1634444|NCT00266188|Heart Catheterization|heart catheterization
1634445|NCT00266188|Echocardiography|echocardiography
1634446|NCT00266175|Pulmonary heart disease|pulmonary heart disease
1636499|NCT00257686|NK-104|nk-104
1634447|NCT00266175|Pulmonary hypertension|pulmonary hypertension
1634448|NCT00266175|Stent implantation|stent implantation
1634449|NCT00266175|Balloon dilatation|balloon dilatation
1634450|NCT00266175|Surgery|surgery
1634451|NCT00266162|Heart Defects, Congenital|heart defects, congenital
1634452|NCT00266162|Eisenmenger Complex|eisenmenger complex
1634453|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
1634454|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
1634455|NCT00266162|Pulmonary Circulation|pulmonary circulation
1634456|NCT00266162|Vascular Resistance|vascular resistance
1634457|NCT00266149|Pharmacokinetics|pharmacokinetics
1634458|NCT00266149|Lamotrigine|lamotrigine
1634459|NCT00266149|Oral Contraceptives|oral contraceptives
1634460|NCT00266149|UGT|ugt
1634461|NCT00266149|Glucuronidation.|glucuronidation.
1634462|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
1634463|NCT00266123|Kidney Failure|kidney failure
1634464|NCT00266123|Kidney Transplant|kidney transplant
1634467|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
1634468|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
1634469|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1634470|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
1634471|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1634472|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1634473|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1634474|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
1634475|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1634476|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
1634477|NCT00266084|Cervix|cervix
1634478|NCT00266084|Uterus|uterus
1634479|NCT00266084|Dysplasia|dysplasia
1634480|NCT00266084|Cancer|cancer
1634481|NCT00266084|Collector|collector
1634482|NCT00266071|skin|skin
1634483|NCT00266071|pressure|pressure
1634484|NCT00266071|age|age
1634485|NCT00266058|healthy|healthy
1634486|NCT00266058|controls|controls
1634487|NCT00266058|research|research
1634488|NCT00266058|clinical|clinical
1634490|NCT00266058|pharmacokinetic|pharmacokinetic
1634491|NCT00266058|PK|pk
1634492|NCT00266058|HIV|hiv
1634493|NCT00266058|malaria|malaria
1634494|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
1634497|NCT00266045|Recurrence|recurrence
1634498|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
1634499|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
1634500|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1634501|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
1634502|NCT00266019|Fatty liver|fatty liver
1634503|NCT00266019|Cirrhosis|cirrhosis
1634504|NCT00266019|Obesity|obesity
1634505|NCT00266019|Weight Reduction|weight reduction
1634506|NCT00266019|Weight Management|weight management
1634507|NCT00265980|Leptin|leptin
1634508|NCT00265980|Obesity|obesity
1634509|NCT00265980|Energy|energy
1634510|NCT00265980|Autonomics|autonomics
1634511|NCT00265980|Neuroendocrine|neuroendocrine
1634512|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1634513|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1634514|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1634515|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1634516|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1634517|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1634518|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1634519|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1634520|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1634521|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1634522|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1634523|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1634524|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1634525|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1634526|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1634527|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1634528|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1634529|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1634530|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1634531|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1634532|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1634533|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1634534|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1636500|NCT00257673|Cognition|cognition
1634535|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1634536|NCT00265902|Kaposi sarcoma|kaposi sarcoma
1634537|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1634538|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1634539|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1634540|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1634541|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
1634542|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
1634543|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
1634544|NCT00265863|malignant ascites|malignant ascites
1634545|NCT00265850|recurrent colon cancer|recurrent colon cancer
1634546|NCT00265850|stage III colon cancer|stage iii colon cancer
1634547|NCT00265850|stage III rectal cancer|stage iii rectal cancer
1634548|NCT00265850|stage IV colon cancer|stage iv colon cancer
1634549|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
1634550|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
1634551|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
1634552|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1634553|NCT00265837|graft versus host disease|graft versus host disease
1634554|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1634555|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1634556|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1634557|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1634558|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1634559|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1634560|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1634561|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1634562|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1634563|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1634564|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1634713|NCT00265499|Internal Thoracic Artery|internal thoracic artery
1634565|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1634566|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1634567|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1634722|NCT00265486|Dive|dive
1634568|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1634569|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1634570|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1634571|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1634572|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1634573|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1634574|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1634575|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1634576|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1634577|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1634578|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1634579|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1634580|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1634581|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
1634582|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
1634583|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
1634584|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
1634585|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1634586|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1634587|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1634588|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1634589|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1634590|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1634591|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1634592|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1634593|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1634594|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1634595|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1634596|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1634597|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1634598|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1634599|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1634600|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1634601|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1634602|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1634603|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1634604|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1634605|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1634606|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1634607|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1634608|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1634609|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1634610|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1634611|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1634612|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1634613|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1634614|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1634615|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1634616|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1634617|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1634618|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1634619|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1634620|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1634621|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1634622|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1634623|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1634624|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1634625|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1634626|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1634627|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1634628|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1634723|NCT00265486|reflex|reflex
1634629|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1634630|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1634631|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1634632|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1634633|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1634634|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1634635|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1634636|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1634637|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1634638|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1634639|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1634640|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1634641|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1634642|NCT00265824|stage IV colon cancer|stage iv colon cancer
1634643|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
1634644|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
1634645|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1634646|NCT00265824|chemotherapy|chemotherapy
1634647|NCT00265811|stage III colon cancer|stage iii colon cancer
1634648|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
1634649|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1634650|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1634651|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1634652|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1634653|NCT00265772|enteral nutrition|enteral nutrition
1634654|NCT00265772|steroids|steroids
1634655|NCT00265772|mucosal healing|mucosal healing
1634656|NCT00265759|stage II breast cancer|stage ii breast cancer
1634657|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
1634658|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
1634659|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
1634660|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1634661|NCT00265746|metformin|metformin
1634662|NCT00265746|gestational diabetes|gestational diabetes
1634663|NCT00265746|lifestyle|lifestyle
1634664|NCT00265733|male breast cancer|male breast cancer
1634665|NCT00265733|recurrent breast cancer|recurrent breast cancer
1634666|NCT00265733|stage IV breast cancer|stage iv breast cancer
1634667|NCT00265720|African Americans|african americans
1634668|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
1634669|NCT00265720|Colorectal Cancer|colorectal cancer
1634670|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
1634671|NCT00265720|Cancer Disparities|cancer disparities
1634672|NCT00265707|Hypertension|hypertension
1634673|NCT00265707|Hypotension|hypotension
1634674|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
1634675|NCT00265681|chewing tobacco|chewing tobacco
1634676|NCT00265681|oral tobacco|oral tobacco
1634677|NCT00265681|smokeless tobacco|smokeless tobacco
1634678|NCT00265681|telephone|telephone
1634679|NCT00265681|counseling|counseling
1634680|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
1634681|NCT00265642|irbesartan|irbesartan
1634682|NCT00265629|Atrial fibrillation|atrial fibrillation
1634683|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
1634684|NCT00265616|coma-induction,|coma-induction,
1634685|NCT00265616|treatment,|treatment,
1634686|NCT00265616|propofol,|propofol,
1634687|NCT00265616|barbiturates,|barbiturates,
1634688|NCT00265616|efficacy,|efficacy,
1634689|NCT00265616|safety.|safety.
1634690|NCT00265590|Aniridia|aniridia
1634691|NCT00265590|PAX6|pax6
1634692|NCT00265590|Keratopathy|keratopathy
1634693|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
1634694|NCT00265590|Molecular Genetics|molecular genetics
1634695|NCT00265564|outcomes assessment|outcomes assessment
1634696|NCT00265564|substance use disorders|substance use disorders
1634697|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
1634698|NCT00265564|screening|screening
1634699|NCT00265551|Schizophrenia|schizophrenia
1634700|NCT00265538|Hypertension|hypertension
1634701|NCT00265538|Diuretics|diuretics
1634702|NCT00265538|Drug Therapy|drug therapy
1634703|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
1634704|NCT00265538|Patient Intervention|patient intervention
1634705|NCT00265525|Randomized Control Trial|randomized control trial
1634706|NCT00265525|Exercise Intervention|exercise intervention
1634707|NCT00265525|Prevention|prevention
1634708|NCT00265525|Rehabilitation|rehabilitation
1634709|NCT00265512|Telemedicine|telemedicine
1634710|NCT00265512|Aftercare|aftercare
1634711|NCT00265499|Coronary Artery Bypass|coronary artery bypass
1634712|NCT00265499|Skeletonization|skeletonization
1634718|NCT00265486|Brain|brain
1634719|NCT00265486|Flow|flow
1634720|NCT00265486|Blood|blood
1634721|NCT00265486|EPO|epo
1634724|NCT00265460|smoking cessation,|smoking cessation,
1634725|NCT00265460|nicotine,|nicotine,
1634726|NCT00265460|smokeless tobacco,|smokeless tobacco,
1634727|NCT00265460|cigarettes|cigarettes
1634728|NCT00265447|knee osteoarthritis|knee osteoarthritis
1634729|NCT00265447|exercise|exercise
1634730|NCT00265447|aerobic exercise|aerobic exercise
1634731|NCT00265447|strengthening exercise|strengthening exercise
1634732|NCT00265447|exercise prescription|exercise prescription
1634733|NCT00265447|rehabilitation|rehabilitation
1634734|NCT00265447|physical disability|physical disability
1634735|NCT00265447|physical function|physical function
1634736|NCT00265447|physical activity|physical activity
1634737|NCT00265447|physical fitness|physical fitness
1634738|NCT00265421|Suture Techniques|suture techniques
1634739|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
1634740|NCT00265382|Adolescent Subjects|adolescent subjects
1634741|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
1634742|NCT00265356|Diagnostic Investigation|diagnostic investigation
1634743|NCT00265356|Colorectal cancer|colorectal cancer
1634744|NCT00265356|Liver metastases|liver metastases
1634745|NCT00265356|Liver surgery|liver surgery
1634746|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
1634747|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
1634748|NCT00265317|sunitinib|sunitinib
1634749|NCT00265317|erlotinib|erlotinib
1634750|NCT00265317|Phase 2|phase 2
1634751|NCT00265304|Osteoarthritis|osteoarthritis
1634752|NCT00265291|Depression|depression
1634753|NCT00265291|mood disorders|mood disorders
1634754|NCT00265291|affective disorders|affective disorders
1634755|NCT00265291|pharmacogenetics|pharmacogenetics
1634756|NCT00265291|pharmacogenomics|pharmacogenomics
1634757|NCT00265265|Cocaine Dependence|cocaine dependence
1634758|NCT00265252|osteonecrosis|osteonecrosis
1634759|NCT00265252|total hip replacement|total hip replacement
1634760|NCT00265239|Edaravone|edaravone
1634761|NCT00265239|Randomized Control Trial|randomized control trial
1634762|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1634763|NCT00265239|Coronary Angioplasty|coronary angioplasty
1634764|NCT00265226|India|india
1634765|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
1634766|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
1634767|NCT00265226|Immunomodulator|immunomodulator
1634768|NCT00265226|Mycobacterium w|mycobacterium w
1634769|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
1634770|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
1634771|NCT00265213|breast conservative surgery|breast conservative surgery
1634772|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
1634773|NCT00265213|disability questionnaire|disability questionnaire
1634774|NCT00265200|Zometa|zometa
1634775|NCT00265200|bone metastasis|bone metastasis
1634776|NCT00265200|lung cancer|lung cancer
1634777|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
1634778|NCT00265200|small cell lung cancer|small cell lung cancer
1634779|NCT00265200|bone metabolic markers|bone metabolic markers
1634780|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
1634781|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
1634782|NCT00265174|SERUM DNA|serum dna
1634783|NCT00265174|LOH|loh
1634784|NCT00265174|METHYLATION|methylation
1634785|NCT00265174|GLIOMA|glioma
1634786|NCT00265174|MGMT|mgmt
1634787|NCT00265161|influenza vaccine|influenza vaccine
1634788|NCT00265161|effectiveness|effectiveness
1634789|NCT00265161|health care worker|health care worker
1634790|NCT00265161|OBSERVATIONAL STUDY|observational study
1634791|NCT00265148|rosiglitazone|rosiglitazone
1634792|NCT00265148|cognition|cognition
1634793|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
1634794|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
1634795|NCT00265148|Alzheimer's Disease|alzheimer's disease
1634796|NCT00265135|Renal cell carcinoma|renal cell carcinoma
1634797|NCT00265135|CNTO 328|cnto 328
1634798|NCT00265135|Infusions|infusions
1634799|NCT00265135|Renal cell cancer|renal cell cancer
1634800|NCT00265122|Crohn Disease|crohn disease
1634801|NCT00265122|Biologic|biologic
1634802|NCT00265122|Infusion|infusion
1634803|NCT00265122|Injection|injection
1634804|NCT00265122|CNTO 1275|cnto 1275
1634805|NCT00265122|Ustekinumab|ustekinumab
1634806|NCT00265122|C01275|c01275
1634807|NCT00265122|IL-12p40|il-12p40
1634808|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
1634809|NCT00265109|levetiracetam|levetiracetam
1634810|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
1634811|NCT00265096|Spondyloarthritis|spondyloarthritis
1634812|NCT00265096|Spondyloarthropathy|spondyloarthropathy
1634813|NCT00265096|subcutaneous injection|subcutaneous injection
1634814|NCT00265083|Spondylitis|spondylitis
1634815|NCT00265083|subcutaneous injection|subcutaneous injection
1634816|NCT00265083|Bechterew's Disease|bechterew's disease
1634817|NCT00265083|Spondyloarthritis|spondyloarthritis
1634818|NCT00265083|Spondyloarthropathy|spondyloarthropathy
1634819|NCT00265057|Cancer;|cancer;
1634820|NCT00265057|Tumors;|tumors;
1634824|NCT00265057|Cadherins;|cadherins;
1634825|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
1634826|NCT00265057|Ovarian Cancer|ovarian cancer
1634827|NCT00265044|Behavior Change|behavior change
1634828|NCT00265044|patient Education|patient education
1634829|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
1634830|NCT00265031|advanced stages|advanced stages
1634831|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
1634832|NCT00265018|early stages|early stages
1634833|NCT00265005|alteplase|alteplase
1634834|NCT00265005|occluded central venous catheter|occluded central venous catheter
1634835|NCT00265005|occluded arterial catheter|occluded arterial catheter
1634836|NCT00265005|occluded PICC|occluded picc
1634837|NCT00265005|neonates|neonates
1634838|NCT00265005|infants|infants
1634839|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
1634840|NCT00264992|cytokine expression|cytokine expression
1634841|NCT00264979|Colorectal cancer|colorectal cancer
1634842|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
1634843|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
1634844|NCT00264966|Mild asthma|mild asthma
1634845|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
1634846|NCT00264953|intermediate stages|intermediate stages
1634847|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
1634848|NCT00264927|Hyponatremia|hyponatremia
1634849|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
1634850|NCT00264914|Hyponatremia|hyponatremia
1634851|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
1634852|NCT00264888|Nonsense mutation|nonsense mutation
1634853|NCT00264888|Premature stop codon|premature stop codon
1634857|NCT00264823|HIV|hiv
1634858|NCT00264823|Mental Illness|mental illness
1634859|NCT00264810|Responsive Stimulation|responsive stimulation
1634860|NCT00264810|Brain Stimulator|brain stimulator
1634861|NCT00264810|Epilepsy|epilepsy
1634862|NCT00264810|Seizures|seizures
1634863|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
1634864|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
1634865|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
1634866|NCT00264758|hemodialysis|hemodialysis
1634867|NCT00264758|end stage renal disease|end stage renal disease
1634868|NCT00264745|Caregiver|caregiver
1634869|NCT00264745|Stroke|stroke
1634870|NCT00264732|cervical lesions|cervical lesions
1634871|NCT00264732|cervical dysplasia|cervical dysplasia
1634872|NCT00264732|Human papilloma virus|human papilloma virus
1634873|NCT00264732|abnormal Pap|abnormal pap
1634874|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
1634875|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
1634876|NCT00264680|quality of life|quality of life
1634877|NCT00264680|qolie-10|qolie-10
1634878|NCT00264680|epilepsy|epilepsy
1634879|NCT00264680|lamotrigine|lamotrigine
1634880|NCT00264680|Validation of questionnaire|validation of questionnaire
1634881|NCT00264667|Dyslipidaemia|dyslipidaemia
1634882|NCT00264654|Social|social
1634883|NCT00264654|(SAD)|(sad)
1634884|NCT00264654|Anxiety|anxiety
1634885|NCT00264654|Disorder|disorder
1634886|NCT00264641|Hypoglycemia|hypoglycemia
1634887|NCT00264641|Cognitive impairment|cognitive impairment
1634888|NCT00264641|PET|pet
1634889|NCT00264641|CalCAP|calcap
1634890|NCT00264628|NK1-antagonist|nk1-antagonist
1634891|NCT00264628|Depression|depression
1634892|NCT00264628|Fibromyalgia|fibromyalgia
1634893|NCT00264628|GW679769|gw679769
1634894|NCT00264628|Outpatient|outpatient
1634895|NCT00264615|once daily dosing|once daily dosing
1634896|NCT00264615|seizure|seizure
1634897|NCT00264615|pharmacokinetics|pharmacokinetics
1634898|NCT00264615|epilepsy|epilepsy
1634899|NCT00264602|Lymphatic mapping|lymphatic mapping
1634900|NCT00264602|nodal targeting|nodal targeting
1634901|NCT00264602|indocyanine green|indocyanine green
1634902|NCT00264602|near infrared imaging|near infrared imaging
1634903|NCT00264589|vascular function|vascular function
1634904|NCT00264589|cardiac function|cardiac function
1634905|NCT00264589|individualized training|individualized training
1634906|NCT00264589|ultrasonography|ultrasonography
1634907|NCT00264589|body composition|body composition
1634908|NCT00264576|influenza|influenza
1634909|NCT00264576|flu|flu
1634910|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
1634911|NCT00264550|Golimumab|golimumab
1634912|NCT00264550|Methotrexate|methotrexate
1634913|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
1634914|NCT00264550|Simpony|simpony
1634915|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
1634916|NCT00264537|Methotrexate Naïve|methotrexate naïve
1634917|NCT00264537|subcutaneous injection|subcutaneous injection
1634918|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
1634919|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
1634920|NCT00264511|Crush injury|crush injury
1634921|NCT00264511|Tibial fracture|tibial fracture
1634922|NCT00264511|Gustillo 3|gustillo 3
1634923|NCT00264511|soft tissue injury|soft tissue injury
1634924|NCT00264511|complications|complications
1634925|NCT00264511|outcomes|outcomes
1634926|NCT00264511|randomised controlled trial|randomised controlled trial
1634927|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1634929|NCT00264498|Lung Cancer|lung cancer
1634930|NCT00264485|Postoperative pain|postoperative pain
1634931|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
1634932|NCT00264472|Cancer|cancer
1634933|NCT00264472|Tumors|tumors
1634934|NCT00264472|Neoplasms|neoplasms
1634935|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
1634936|NCT00264472|Antineoplastic Agents|antineoplastic agents
1634937|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
1634938|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
1634939|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
1634940|NCT00264459|Rhinitis|rhinitis
1634941|NCT00264459|Asthma|asthma
1634942|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
1634943|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
1634944|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
1634945|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
1634946|NCT00264420|bone metastases|bone metastases
1634947|NCT00264420|breast cancer|breast cancer
1634948|NCT00264420|lung cancer|lung cancer
1634949|NCT00264420|prostate cancer|prostate cancer
1634950|NCT00264420|zoledronic acid|zoledronic acid
1634951|NCT00264420|radiation therapy|radiation therapy
1634952|NCT00264407|Hearing Loss, Central|hearing loss, central
1634953|NCT00264407|Presbycusis|presbycusis
1634954|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
1634955|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
1634956|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
1634957|NCT00264407|Sex Steroid Hormones|sex steroid hormones
1634958|NCT00264407|Estradiol|estradiol
1634959|NCT00264394|Computer generated reminder system|computer generated reminder system
1634960|NCT00264394|quality control|quality control
1634961|NCT00264394|dyslipidemia|dyslipidemia
1634962|NCT00264394|antiretroviral therapy|antiretroviral therapy
1634963|NCT00264394|HIV infection|hiv infection
1634964|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
1634965|NCT00264381|STP|stp
1634966|NCT00264381|Fragmin|fragmin
1634967|NCT00264381|Ibuprofen|ibuprofen
1634968|NCT00264381|Superficial Thrombus|superficial thrombus
1634969|NCT00264381|Superficial Phlebitis|superficial phlebitis
1634970|NCT00264381|phlebitis|phlebitis
1634971|NCT00264368|Renal replacement therapy|renal replacement therapy
1634972|NCT00264368|CMV disease|cmv disease
1634973|NCT00264355|cyclosporine|cyclosporine
1634974|NCT00264355|metabolites|metabolites
1634975|NCT00264355|metabolic pattern|metabolic pattern
1634976|NCT00264355|genotypes|genotypes
1634977|NCT00264342|Smoking|smoking
1634978|NCT00264342|Tobacco|tobacco
1634979|NCT00264342|Nicotine|nicotine
1634980|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
1634981|NCT00264316|acute myocardial infarction|acute myocardial infarction
1634982|NCT00264316|left ventricular function|left ventricular function
1634983|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
1634984|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
1634985|NCT00264290|HIV|hiv
1634986|NCT00264290|CMV|cmv
1634987|NCT00264290|T Cell activation|t cell activation
1634988|NCT00264290|Valganciclovir|valganciclovir
1634989|NCT00264277|D-dimer|d-dimer
1634990|NCT00264277|Recurrence|recurrence
1634991|NCT00264277|Venous Thromboembolism|venous thromboembolism
1634992|NCT00264277|Anticoagulation|anticoagulation
1634993|NCT00264277|Duration|duration
1634994|NCT00264264|Closure device|closure device
1634995|NCT00264264|Stenting|stenting
1634996|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
1634997|NCT00264251|HIV|hiv
1634998|NCT00264251|Body composition|body composition
1634999|NCT00264251|Weight reduction|weight reduction
1635000|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
1635001|NCT00264251|Exercise|exercise
1635002|NCT00264251|Diet|diet
1635003|NCT00264251|Visceral adiposity|visceral adiposity
1635004|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
1635005|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
1635006|NCT00264199|Ischemic heart disease|ischemic heart disease
1635007|NCT00264199|insulin resistance|insulin resistance
1635008|NCT00264160|AMN107|amn107
1635009|NCT00264160|CML|cml
1635010|NCT00264160|Bcr Abl|bcr abl
1635011|NCT00264160|cytogenetic response|cytogenetic response
1635012|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1635013|NCT00264160|imatinib mesylate|imatinib mesylate
1635014|NCT00264147|Arcoxia|arcoxia
1635702|NCT00260676|brain death|brain death
1635015|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
1635016|NCT00264121|congenital, high scrotal|congenital, high scrotal
1635017|NCT00264108|Antineoplastic agents|antineoplastic agents
1635018|NCT00264108|Chemotherapy|chemotherapy
1635019|NCT00264108|Cost-effectiveness|cost-effectiveness
1635020|NCT00264108|Epoetin alfa|epoetin alfa
1635021|NCT00264108|Darbepoetin alfa|darbepoetin alfa
1635022|NCT00264095|Anemia|anemia
1635023|NCT00264095|Blood loss|blood loss
1635024|NCT00264095|Transfusion|transfusion
1635025|NCT00264095|Blood transfusion|blood transfusion
1635026|NCT00264095|Erythropoietin|erythropoietin
1635027|NCT00264095|Surgery|surgery
1635028|NCT00264095|Surgical blood loss|surgical blood loss
1635029|NCT00264095|Tumor|tumor
1635030|NCT00264095|Cancer|cancer
1635031|NCT00264095|Surgical resection|surgical resection
1635032|NCT00264095|Tumor resection|tumor resection
1635033|NCT00264069|Adherence|adherence
1635034|NCT00264069|Compliance|compliance
1635035|NCT00264069|Schizophrenia|schizophrenia
1635036|NCT00264069|Bipolar Disorder|bipolar disorder
1635037|NCT00264069|Depression|depression
1635038|NCT00264069|Personality Disorders|personality disorders
1635039|NCT00264069|Registry|registry
1635040|NCT00264056|malignant melanoma|malignant melanoma
1635041|NCT00264056|hyperthermia|hyperthermia
1635042|NCT00264056|chemotherapy|chemotherapy
1635043|NCT00264004|Advanced Solid Tumours|advanced solid tumours
1635044|NCT00264004|phase II|phase ii
1635045|NCT00264004|Hypertension|hypertension
1635046|NCT00264004|RECENTIN|recentin
1635047|NCT00263978|Venous occlusive disease|venous occlusive disease
1635048|NCT00263978|VOD|vod
1635049|NCT00263952|Bee venom allergy|bee venom allergy
1635050|NCT00263952|Specific immunotherapy|specific immunotherapy
1635051|NCT00263939|chronic disease|chronic disease
1635052|NCT00263939|patient education|patient education
1635053|NCT00263939|self-efficacy|self-efficacy
1635054|NCT00263939|self-management|self-management
1635055|NCT00263926|Wasp venom allergy,|wasp venom allergy,
1635056|NCT00263926|specific immunotherapy|specific immunotherapy
1635057|NCT00263900|Influenza A|influenza a
1635058|NCT00263900|Influenza B|influenza b
1635059|NCT00263900|RSV|rsv
1635060|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
1635061|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
1635062|NCT00263887|congenital emphysema|congenital emphysema
1635063|NCT00263887|replacement therapy|replacement therapy
1635064|NCT00263861|neurotoxicity|neurotoxicity
1635065|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1635066|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1635067|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1635068|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1635069|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1635070|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1635071|NCT00263822|fallopian tube cancer|fallopian tube cancer
1635072|NCT00263731|lung cancer|lung cancer
1635073|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
1635074|NCT00263731|small cell lung cancer|small cell lung cancer
1635075|NCT00263731|cancer metabolism|cancer metabolism
1635076|NCT00263640|House dust mite|house dust mite
1635077|NCT00263640|Bronchial Asthma|bronchial asthma
1635078|NCT00263640|Allergy|allergy
1635079|NCT00263640|House Dust Mite Allergy|house dust mite allergy
1635080|NCT00263627|specific immunotherapy|specific immunotherapy
1635081|NCT00263627|birch pollen allergy|birch pollen allergy
1635082|NCT00263627|Allergovit|allergovit
1635083|NCT00263601|Allergovit|allergovit
1635084|NCT00263601|Grass pollen allergy|grass pollen allergy
1635085|NCT00263588|breast cancer brain metastases ErbB2 positive HER2 positive|breast cancer brain metastases erbb2 positive her2 positive
1635086|NCT00263575|EN3267|en3267
1635087|NCT00263575|Breakthrough Pain|breakthrough pain
1635088|NCT00263575|Safety Study|safety study
1635089|NCT00263575|Fentanyl Tablets|fentanyl tablets
1635090|NCT00263562|Sickle cell disease|sickle cell disease
1635091|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
1635092|NCT00263562|steroid treatment|steroid treatment
1635093|NCT00263549|House dust mite,|house dust mite,
1635094|NCT00263549|Allergy|allergy
1635095|NCT00263536|Obesity|obesity
1635096|NCT00263536|Adiposity|adiposity
1635097|NCT00263536|Binge Eating|binge eating
1635098|NCT00263536|Social Functioning|social functioning
1635099|NCT00263536|Eating Disorders|eating disorders
1635100|NCT00263536|Prevention|prevention
1635101|NCT00263536|Adolescence|adolescence
1635102|NCT00263536|Adolescent Weight Gain|adolescent weight gain
1635103|NCT00263536|Overweight|overweight
1635104|NCT00263523|Serotonin|serotonin
1635105|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
1635106|NCT00263523|Brain|brain
1635107|NCT00263523|Neurochemistry|neurochemistry
1635108|NCT00263523|Neurotransmitter|neurotransmitter
1635591|NCT00261131|spasticity|spasticity
1635109|NCT00263523|Healthy Volunteer|healthy volunteer
1635110|NCT00263523|HV|hv
1635111|NCT00263497|Postinjury chronic pain|postinjury chronic pain
1635112|NCT00263497|Transtibial amputation|transtibial amputation
1635113|NCT00263497|Physical rehabilitation|physical rehabilitation
1635114|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
1635115|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
1635116|NCT00263484|Thalidomide|thalidomide
1635117|NCT00263484|Bisphosphonates|bisphosphonates
1635118|NCT00263458|HIV|hiv
1635119|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1635120|NCT00263458|buprenorphine|buprenorphine
1635121|NCT00263458|opioid dependence|opioid dependence
1635122|NCT00263458|opioid-related disorders|opioid-related disorders
1635123|NCT00263458|integrated care|integrated care
1635124|NCT00263458|primary care|primary care
1635125|NCT00263445|Growth hormone dosing|growth hormone dosing
1635126|NCT00263445|IGF-I|igf-i
1635127|NCT00263419|Diabetes Type 2|diabetes type 2
1635128|NCT00263419|Late Complications|late complications
1635129|NCT00263419|Stress relief management|stress relief management
1635130|NCT00263419|psychosocial stress|psychosocial stress
1635131|NCT00263393|Myocardial Infarction|myocardial infarction
1635132|NCT00263393|Angina Pectoris|angina pectoris
1635133|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
1635134|NCT00263393|Diabetes Mellitus|diabetes mellitus
1635135|NCT00263393|Cluster randomized design|cluster randomized design
1635136|NCT00263393|Community-based intervention trial|community-based intervention trial
1635137|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
1635138|NCT00263393|Lifestyle advice|lifestyle advice
1635139|NCT00263380|COPD|copd
1635140|NCT00263380|cytokines|cytokines
1635141|NCT00263380|corticosteroids|corticosteroids
1635142|NCT00263380|beta agonists|beta agonists
1635143|NCT00263380|synergistic effect|synergistic effect
1635144|NCT00263367|Autism|autism
1635145|NCT00263367|Oxidative Stress|oxidative stress
1635146|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
1635147|NCT00263367|Reduced Glutathione|reduced glutathione
1635148|NCT00263367|Lipid Peroxides|lipid peroxides
1635149|NCT00263341|Contraceptive agents|contraceptive agents
1635150|NCT00263341|Female contraception|female contraception
1635151|NCT00263341|Progestins|progestins
1635152|NCT00263328|immunosuppression|immunosuppression
1635153|NCT00263328|JAK3 inhibitor|jak3 inhibitor
1635154|NCT00263328|kidney transplant|kidney transplant
1635155|NCT00263328|tofacitinib|tofacitinib
1635156|NCT00263328|Xeljanz|xeljanz
1635157|NCT00263328|CP-690|cp-690
1635158|NCT00263328|550|550
1635159|NCT00263328|tacromilus|tacromilus
1635160|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
1635161|NCT00263315|aspergillosis|aspergillosis
1635162|NCT00263315|mycosis|mycosis
1635163|NCT00263315|neutropenia|neutropenia
1635164|NCT00263315|primary prevention|primary prevention
1635165|NCT00263315|hematologic diseases|hematologic diseases
1635166|NCT00263315|amphotericin B|amphotericin b
1635167|NCT00263315|AmBisome|ambisome
1635168|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
1635169|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
1635170|NCT00263250|inguinal hernia|inguinal hernia
1635171|NCT00263250|asymptomatic|asymptomatic
1635172|NCT00263250|watchful waiting|watchful waiting
1635173|NCT00263250|tension-free hernia repair|tension-free hernia repair
1635174|NCT00263237|T Cell|t cell
1635175|NCT00263237|Lymphocyte|lymphocyte
1635176|NCT00263237|Lamina Propria|lamina propria
1635177|NCT00263237|Malabsorption|malabsorption
1635178|NCT00263237|Colonoscopy|colonoscopy
1635179|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
1635180|NCT00263237|CVID|cvid
1635181|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
1635182|NCT00263211|Breast Cancer|breast cancer
1635183|NCT00263211|Metastatic|metastatic
1635184|NCT00263211|Platelet|platelet
1635185|NCT00263172|internet|internet
1635186|NCT00263172|weight management|weight management
1635187|NCT00263172|behavior therapy|behavior therapy
1635188|NCT00263172|self-help|self-help
1635189|NCT00263172|commercial program|commercial program
1635190|NCT00263172|obesity|obesity
1635191|NCT00263133|Depression|depression
1635192|NCT00263133|SSRI|ssri
1635193|NCT00263133|Sertraline|sertraline
1635194|NCT00263133|synaptic plasticity|synaptic plasticity
1635195|NCT00263133|visually evoked potentials|visually evoked potentials
1635196|NCT00263107|telerounding|telerounding
1635197|NCT00263107|minimally invasive surgery|minimally invasive surgery
1635198|NCT00263094|Fasting|fasting
1635199|NCT00263094|Headache|headache
1635200|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
1635201|NCT00263094|Pain|pain
1635202|NCT00263094|Prophylaxis|prophylaxis
1635203|NCT00263081|Hyperlipidemia|hyperlipidemia
1635204|NCT00263081|Dyslipidemia|dyslipidemia
1635205|NCT00263081|Drug Therapy|drug therapy
1635206|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
1635207|NCT00263042|Myocardial infarction|myocardial infarction
1635208|NCT00263042|cerebrovascular accident|cerebrovascular accident
1635209|NCT00263042|obesity|obesity
1635210|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
1635211|NCT00262990|fallopian tube cancer|fallopian tube cancer
1635212|NCT00262990|peritoneal cancer|peritoneal cancer
1635213|NCT00262990|primary cancer|primary cancer
1635214|NCT00262990|recurrent cancer|recurrent cancer
1635215|NCT00262990|doxorubicin|doxorubicin
1635216|NCT00262990|taxane chemotherapy|taxane chemotherapy
1635217|NCT00262990|platinum chemotherapy|platinum chemotherapy
1635218|NCT00262990|Patupilone|patupilone
1635219|NCT00262990|taxane platinum resistant|taxane platinum resistant
1635220|NCT00262977|diabetes mellitus|diabetes mellitus
1635221|NCT00262977|cardiovascular diseases|cardiovascular diseases
1635222|NCT00262977|aspirin|aspirin
1635223|NCT00262977|quality of healthcare|quality of healthcare
1635224|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1635225|NCT00262964|obesity|obesity
1635226|NCT00262964|fatty liver disease|fatty liver disease
1635227|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
1635228|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
1635229|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
1635230|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1635231|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
1635232|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
1635233|NCT00262938|weight changes|weight changes
1635234|NCT00262925|MOAD|moad
1635235|NCT00262925|Methotrexate|methotrexate
1635236|NCT00262925|Vincristine|vincristine
1635237|NCT00262925|L-asparaginase|l-asparaginase
1635238|NCT00262925|Dexamethasone|dexamethasone
1635239|NCT00262925|Subcutaneous Campath|subcutaneous campath
1635240|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1635241|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1635242|NCT00262899|breast cancer in situ|breast cancer in situ
1635243|NCT00262899|stage IA breast cancer|stage ia breast cancer
1635244|NCT00262899|stage IB breast cancer|stage ib breast cancer
1635245|NCT00262899|stage II breast cancer|stage ii breast cancer
1635246|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
1635247|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
1635248|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
1635249|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1635250|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
1635251|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1635252|NCT00262873|refractory anemia|refractory anemia
1635253|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1635254|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1635255|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1635256|NCT00262808|stage II colon cancer|stage ii colon cancer
1635257|NCT00262808|stage III colon cancer|stage iii colon cancer
1635258|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
1635259|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1635260|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1635261|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1635262|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1635263|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1635264|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1635265|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1635266|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1635267|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1635268|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1635269|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1635270|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1635271|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1635272|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
1635273|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
1635274|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
1635275|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
1635276|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1635277|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1635278|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1635279|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1635280|NCT00262730|adult glioblastoma|adult glioblastoma
1635281|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
1635282|NCT00262730|adult gliosarcoma|adult gliosarcoma
1635283|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
1635284|NCT00262717|Treatment Experienced|treatment experienced
1635285|NCT00262704|physician intervention|physician intervention
1635286|NCT00262704|diabetes mellitus|diabetes mellitus
1635287|NCT00262704|primary care|primary care
1635288|NCT00262704|quality improvement|quality improvement
1635289|NCT00262704|disease management|disease management
1635290|NCT00262652|sodium pyruvate|sodium pyruvate
1635291|NCT00262652|anti-inflammatory|anti-inflammatory
1635292|NCT00262652|bronchodilation|bronchodilation
1635293|NCT00262652|asthma|asthma
1635294|NCT00262652|asthmatics|asthmatics
1635295|NCT00262639|Alcoholism|alcoholism
1635296|NCT00262639|Alcohol Dependence|alcohol dependence
1635297|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
1635298|NCT00262639|Treatment|treatment
1635299|NCT00262639|Pharmacotherapy|pharmacotherapy
1635300|NCT00262613|Sodium Pyruvate|sodium pyruvate
1635301|NCT00262613|COPD|copd
1635302|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1635303|NCT00262587|Sport|sport
1635304|NCT00262587|Asthma|asthma
1635305|NCT00262587|Treatment|treatment
1635306|NCT00262587|Airway inflammation|airway inflammation
1635307|NCT00262574|endothelial disfunction|endothelial disfunction
1635310|NCT00262574|coronary artery disease|coronary artery disease
1635311|NCT00262561|Intermittent Claudication|intermittent claudication
1635312|NCT00262561|Aspirin resistance|aspirin resistance
1635313|NCT00262561|Clopidogrel resistance|clopidogrel resistance
1635314|NCT00262548|Obesity|obesity
1635315|NCT00262548|Menopause|menopause
1635316|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
1635317|NCT00262509|Rehabilitation|rehabilitation
1635318|NCT00262509|Sensory Aid|sensory aid
1635319|NCT00262496|Botox|botox
1635320|NCT00262496|Overactive bladder|overactive bladder
1635321|NCT00262496|Incontinence|incontinence
1635322|NCT00262496|Spinal Cord Injury|spinal cord injury
1635323|NCT00262470|tachycardia|tachycardia
1635324|NCT00262470|sinus tachycardia|sinus tachycardia
1635325|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
1635326|NCT00262457|electrical stimulation|electrical stimulation
1635327|NCT00262457|Pressure Ulcers|pressure ulcers
1635328|NCT00262457|Spinal Cord Injury|spinal cord injury
1635329|NCT00262431|Tracheostomy|tracheostomy
1635330|NCT00262431|Tracheostomy timing|tracheostomy timing
1635331|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
1635332|NCT00262431|Mechanical ventilation|mechanical ventilation
1635333|NCT00262392|heterotopic ossification,|heterotopic ossification,
1635334|NCT00262392|prevention,|prevention,
1635335|NCT00262392|high risk,|high risk,
1635336|NCT00262392|bisphosphonates,|bisphosphonates,
1635337|NCT00262392|radiotherapy|radiotherapy
1635338|NCT00262379|Chronic hepatitis C|chronic hepatitis c
1635339|NCT00262379|peginterferon|peginterferon
1635340|NCT00262379|ribavirin|ribavirin
1635341|NCT00262379|epoetin beta|epoetin beta
1635342|NCT00262340|Asthma|asthma
1635343|NCT00262340|Pediatrics|pediatrics
1635344|NCT00262340|Airway|airway
1635345|NCT00262340|Inflammation|inflammation
1635346|NCT00262327|antiangiogenesis|antiangiogenesis
1635347|NCT00262327|endostatin|endostatin
1635348|NCT00262327|adenovirus|adenovirus
1635349|NCT00262327|gene therapy|gene therapy
1635350|NCT00262327|cancer|cancer
1635351|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
1635352|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
1635353|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
1635354|NCT00262223|Treatment outcome|treatment outcome
1635355|NCT00262197|Diabetes mellitus|diabetes mellitus
1635356|NCT00262197|Medical error rates|medical error rates
1635357|NCT00262197|Pharmacotherapy|pharmacotherapy
1635358|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
1635359|NCT00262158|smoking status|smoking status
1635360|NCT00262158|cigarette consumption|cigarette consumption
1635361|NCT00262145|glucose|glucose
1635362|NCT00262145|lipid|lipid
1635363|NCT00262145|diabetes|diabetes
1635364|NCT00262145|overweight|overweight
1635365|NCT00262119|Physiological pacing|physiological pacing
1635366|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
1635367|NCT00262106|Administration, intravaginal|administration, intravaginal
1635368|NCT00262106|Anti-infective agents|anti-infective agents
1635369|NCT00262106|Double blind method|double blind method
1635370|NCT00262106|Drug evaluation|drug evaluation
1635371|NCT00262106|Female|female
1635372|NCT00262106|Gels|gels
1635373|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
1635374|NCT00262106|Microbicide|microbicide
1635375|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
1635376|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
1635377|NCT00262106|Sexual behavior|sexual behavior
1635378|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
1635379|NCT00262106|HIV Seronegativity|hiv seronegativity
1635380|NCT00262106|Genital Herpes Infections|genital herpes infections
1635381|NCT00262093|preeclampsia|preeclampsia
1635382|NCT00262093|sFlt1|sflt1
1635383|NCT00262093|PlGF|plgf
1635384|NCT00262093|parity|parity
1635385|NCT00262093|angiogenesis|angiogenesis
1635386|NCT00262054|coronary disease|coronary disease
1635387|NCT00261989|pulse oximetry readings|pulse oximetry readings
1635388|NCT00261989|pediatrics|pediatrics
1635389|NCT00261989|cardiac|cardiac
1635390|NCT00261989|congenital heart disease|congenital heart disease
1635391|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
1635392|NCT00261976|Crohn's disease|crohn's disease
1635393|NCT00261976|Psoriasis|psoriasis
1635394|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
1635395|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
1635396|NCT00261911|Meridia|meridia
1635397|NCT00261911|Sibutramine|sibutramine
1635398|NCT00261911|Obesity|obesity
1635399|NCT00261911|Adolescent|adolescent
1635400|NCT00261911|BMI|bmi
1635401|NCT00261898|Sleep Deprivation|sleep deprivation
1635402|NCT00261898|Obesity|obesity
1635403|NCT00261898|Metabolic Syndrome|metabolic syndrome
1635404|NCT00261898|Hormones|hormones
1635405|NCT00261898|Public Health|public health
1635406|NCT00261898|Overweight|overweight
1635407|NCT00261898|Sleep|sleep
1635408|NCT00261872|Alcoholism|alcoholism
1635409|NCT00261872|Attention Deficit Disorder|attention deficit disorder
1635410|NCT00261872|ADHD|adhd
1635411|NCT00261859|hazardous drinking|hazardous drinking
1635412|NCT00261846|Leukemia|leukemia
1635413|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1635414|NCT00261846|philadelphia chromosome|philadelphia chromosome
1635415|NCT00261846|Myeloid|myeloid
1635416|NCT00261846|Philadelphia Positive|philadelphia positive
1635417|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
1635418|NCT00261833|Emphysema|emphysema
1635419|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
1635420|NCT00261820|Kidney Transplant|kidney transplant
1635421|NCT00261807|severe|severe
1635422|NCT00261807|skin|skin
1635423|NCT00261807|infections|infections
1635424|NCT00261794|cognition|cognition
1635425|NCT00261794|schizophrenia|schizophrenia
1635426|NCT00261794|treatment|treatment
1635427|NCT00261781|Treadmill|treadmill
1635428|NCT00261781|Walking|walking
1635429|NCT00261781|Exercise|exercise
1635430|NCT00261781|Automaticity|automaticity
1635431|NCT00261781|Quality of Life|quality of life
1635432|NCT00261768|Aging|aging
1635433|NCT00261768|hearing aids|hearing aids
1635434|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
1635435|NCT00261768|speech recognition|speech recognition
1635436|NCT00261755|Acupuncture|acupuncture
1635437|NCT00261755|pain relief|pain relief
1635438|NCT00261755|labour|labour
1635439|NCT00261755|randomized controlled trial|randomized controlled trial
1635440|NCT00261755|TENS|tens
1635441|NCT00261742|perianal|perianal
1635442|NCT00261742|dermatitis|dermatitis
1635443|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
1635444|NCT00261729|Paroxetine|paroxetine
1635445|NCT00261729|Prazosin|prazosin
1635446|NCT00261729|Sleep Disorders|sleep disorders
1635447|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1635448|NCT00261716|clinical trial|clinical trial
1635449|NCT00261716|employment|employment
1635450|NCT00261716|schizoaffective disorder|schizoaffective disorder
1635451|NCT00261716|schizophrenia|schizophrenia
1635452|NCT00261690|Virtual Reality Distraction|virtual reality distraction
1635453|NCT00261677|Anemia|anemia
1635454|NCT00261677|cancer|cancer
1635455|NCT00261677|solid tumor|solid tumor
1635456|NCT00261677|Hodgkin's Disease|hodgkin's disease
1635457|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
1635458|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1635459|NCT00261677|Quality of Life|quality of life
1635460|NCT00261677|hemoglobin|hemoglobin
1635461|NCT00261677|Epoetin alfa|epoetin alfa
1635462|NCT00261638|Mental Health Promotion|mental health promotion
1635463|NCT00261638|Mental Health Index|mental health index
1635464|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
1635465|NCT00261638|psychophysical health|psychophysical health
1635466|NCT00261638|education years over 9 years|education years over 9 years
1635467|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
1635468|NCT00261625|peritoneal dialysis|peritoneal dialysis
1635469|NCT00261625|artery calcification|artery calcification
1635470|NCT00261625|bone mineral density|bone mineral density
1635471|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
1635472|NCT00261599|Colonoscopy|colonoscopy
1635473|NCT00261599|Sedation|sedation
1635474|NCT00261599|AQUAVAN|aquavan
1635475|NCT00261599|Fospropofol disodium|fospropofol disodium
1635476|NCT00261599|Colon polyps|colon polyps
1635477|NCT00261599|Endoscopic outcomes|endoscopic outcomes
1635478|NCT00261599|Endoscopic sedation|endoscopic sedation
1635479|NCT00261599|Endoscopy|endoscopy
1635480|NCT00261586|aspirin|aspirin
1635481|NCT00261586|analgesics|analgesics
1635482|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
1635483|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
1635484|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
1635485|NCT00261573|probable vascular dementia|probable vascular dementia
1635486|NCT00261573|galantamine|galantamine
1635487|NCT00261560|ankle sprain|ankle sprain
1635590|NCT00261131|cerebral palsy|cerebral palsy
1635488|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
1635489|NCT00261547|Kidney transplantation|kidney transplantation
1635490|NCT00261547|HLA|hla
1635491|NCT00261534|Chemotherapy|chemotherapy
1635492|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
1635493|NCT00261521|End-stage renal disease|end-stage renal disease
1635494|NCT00261521|Kidney failure|kidney failure
1635495|NCT00261521|Anemia|anemia
1635496|NCT00261521|Dialysis|dialysis
1635497|NCT00261521|Epoetin|epoetin
1635498|NCT00261521|Erythropoetin|erythropoetin
1635499|NCT00261521|Epoetin alfa|epoetin alfa
1635500|NCT00261508|Risperidone|risperidone
1635501|NCT00261508|child development disorders|child development disorders
1635502|NCT00261508|pervasive development disorders|pervasive development disorders
1635503|NCT00261508|autistic disorder|autistic disorder
1635504|NCT00261508|autism|autism
1635505|NCT00261508|developmental disabilities|developmental disabilities
1635506|NCT00261508|antipsychotropic agents|antipsychotropic agents
1635507|NCT00261495|chronic noncancer pain|chronic noncancer pain
1635508|NCT00261495|pain|pain
1635509|NCT00261495|analgesia|analgesia
1635510|NCT00261495|analgesic opioid|analgesic opioid
1635511|NCT00261495|oxycodone|oxycodone
1635512|NCT00261495|hydromorphone|hydromorphone
1635513|NCT00261482|contraception|contraception
1635514|NCT00261482|female contraception|female contraception
1635515|NCT00261482|hormonal contraception|hormonal contraception
1635516|NCT00261482|transdermal contraception|transdermal contraception
1635517|NCT00261482|EVRA|evra
1635518|NCT00261482|estrogen|estrogen
1635519|NCT00261482|progestin|progestin
1635520|NCT00261482|ethinyl estradiol|ethinyl estradiol
1635521|NCT00261482|norelgestromin|norelgestromin
1635522|NCT00261469|Migraine|migraine
1635523|NCT00261469|Headache|headache
1635524|NCT00261456|Prostate cancer|prostate cancer
1635525|NCT00261456|BRCA1|brca1
1635526|NCT00261456|BRCA2|brca2
1635527|NCT00261456|prostate screening|prostate screening
1635528|NCT00261456|PSA|psa
1635529|NCT00261456|prostate biopsy|prostate biopsy
1635530|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
1635531|NCT00261430|Schizophrenia|schizophrenia
1635532|NCT00261430|acceptance|acceptance
1635533|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
1635534|NCT00261430|long-acting risperidone|long-acting risperidone
1635535|NCT00261430|intramuscular injection|intramuscular injection
1635536|NCT00261430|Treatment Guidebook|treatment guidebook
1635537|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
1635538|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
1635539|NCT00261391|Lymphatic Malformation|lymphatic malformation
1635540|NCT00261391|Gorham|gorham
1635541|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
1635542|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
1635543|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1635544|NCT00261339|Pantoprazole|pantoprazole
1635545|NCT00261326|Simvastatin|simvastatin
1636501|NCT00257673|Alzheimer's|alzheimer's
1635546|NCT00261326|Optic Neuritis|optic neuritis
1635547|NCT00261326|Multiple Sclerosis|multiple sclerosis
1635548|NCT00261313|Breast cancer|breast cancer
1635549|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
1635550|NCT00261313|Growth factor support|growth factor support
1635551|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
1635552|NCT00261300|Gastric acid|gastric acid
1635553|NCT00261300|GERD|gerd
1635554|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
1635555|NCT00261300|Pantoprazole|pantoprazole
1635556|NCT00261300|Proton pump inhibitor|proton pump inhibitor
1635557|NCT00261287|Hay Fever|hay fever
1635558|NCT00261287|Allergic Rhinitis|allergic rhinitis
1635559|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
1635560|NCT00261287|Ciclesonide|ciclesonide
1635561|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
1635562|NCT00261261|children|children
1635563|NCT00261261|anxiety|anxiety
1635564|NCT00261261|behavioral preparation|behavioral preparation
1635565|NCT00261261|family|family
1635566|NCT00261261|surgery|surgery
1635567|NCT00261261|parents|parents
1635568|NCT00261248|Phase 2|phase 2
1635569|NCT00261248|Vaccine|vaccine
1635570|NCT00261248|Urinary Tract Infection|urinary tract infection
1635571|NCT00261248|Vaginal Mucosal|vaginal mucosal
1635572|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
1635573|NCT00261235|Virtues|virtues
1635574|NCT00261235|Employment, supported|employment, supported
1635575|NCT00261235|veterans|veterans
1635576|NCT00261235|Mentally Ill Persons|mentally ill persons
1635577|NCT00261222|Amodiaquine|amodiaquine
1635578|NCT00261222|Efficacy|efficacy
1635579|NCT00261222|Malaria|malaria
1635580|NCT00261222|Burkina Faso|burkina faso
1635581|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
1635582|NCT00261209|Zone II of the Hand|zone ii of the hand
1635583|NCT00261196|Frozen Shoulder|frozen shoulder
1635584|NCT00261170|smoking|smoking
1635585|NCT00261157|nephrectomy|nephrectomy
1635586|NCT00261157|Safety|safety
1635587|NCT00261157|Laparoscopy|laparoscopy
1635588|NCT00261157|telerounding|telerounding
1635589|NCT00261157|prostatectomy|prostatectomy
1635592|NCT00261131|diplegia|diplegia
1635594|NCT00261118|rituximab|rituximab
1635595|NCT00261066|Functional outcome|functional outcome
1635596|NCT00261066|Orthopaedic surgery|orthopaedic surgery
1635597|NCT00261040|Osteoarthritis|osteoarthritis
1635598|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
1635599|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
1635600|NCT00261027|ovarian cancer|ovarian cancer
1635601|NCT00261014|Recurrent|recurrent
1635602|NCT00261014|Idiopathic|idiopathic
1635603|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
1635604|NCT00261014|Pulmonary Embolism|pulmonary embolism
1635605|NCT00261014|Clinical Prediction Rule|clinical prediction rule
1635606|NCT00261014|Venous Thromboembolism|venous thromboembolism
1635607|NCT00261014|Risk Factors|risk factors
1635608|NCT00261001|Transcutaneous|transcutaneous
1635609|NCT00261001|Vaccination|vaccination
1635610|NCT00261001|Safety|safety
1635611|NCT00261001|Immunogenicity|immunogenicity
1635613|NCT00261001|Treatment Experienced|treatment experienced
1635614|NCT00260988|Prophylaxis|prophylaxis
1635615|NCT00260988|Thromboembolic disease|thromboembolic disease
1635616|NCT00260988|End stage renal disease|end stage renal disease
1635617|NCT00260988|Hemodialysis|hemodialysis
1635618|NCT00260988|Pharmacokinetics|pharmacokinetics
1635619|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
1635620|NCT00260988|Innohep|innohep
1635621|NCT00260988|Tinzaparin|tinzaparin
1635622|NCT00260988|Fragmin|fragmin
1635623|NCT00260988|Dalteparin|dalteparin
1635624|NCT00260988|Anti Xa|anti xa
1635625|NCT00260988|INR|inr
1635626|NCT00260988|Oral anticoagulation|oral anticoagulation
1635627|NCT00260988|warfarin|warfarin
1635628|NCT00260988|Coumadin|coumadin
1635629|NCT00260975|breast cancer|breast cancer
1635630|NCT00260975|chemotherapy|chemotherapy
1635631|NCT00260975|hormonal therapy|hormonal therapy
1635632|NCT00260975|cognitive function|cognitive function
1635633|NCT00260975|chemo fog|chemo fog
1635634|NCT00260962|Pilot Project,|pilot project,
1635635|NCT00260962|Clinical Trial,|clinical trial,
1635636|NCT00260962|Treatment Outcome,|treatment outcome,
1635637|NCT00260962|Psychopharmacology|psychopharmacology
1635638|NCT00260949|rotator cuff tear|rotator cuff tear
1635639|NCT00260949|arthroscopic repair|arthroscopic repair
1635640|NCT00260936|HIV|hiv
1635641|NCT00260936|AIDS|aids
1635642|NCT00260936|Adolescent Males|adolescent males
1635643|NCT00260936|HIV positive|hiv positive
1635644|NCT00260936|Treatment Naive|treatment naive
1635645|NCT00260936|Treatment Experienced|treatment experienced
1635646|NCT00260923|hypertension|hypertension
1635647|NCT00260923|aliskiren|aliskiren
1635648|NCT00260923|blood pressure|blood pressure
1635649|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
1635650|NCT00260897|genotyping|genotyping
1635651|NCT00260897|linkage analysis|linkage analysis
1635652|NCT00260897|pathogenesis|pathogenesis
1635653|NCT00260897|therapy|therapy
1635654|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
1635655|NCT00260871|genetic epidemiology|genetic epidemiology
1635656|NCT00260871|environmental factors|environmental factors
1635657|NCT00260871|genetic map|genetic map
1635658|NCT00260871|coordination center|coordination center
1635659|NCT00260858|Glycemic index|glycemic index
1635660|NCT00260858|Nutrition|nutrition
1635661|NCT00260858|Carbohydrates|carbohydrates
1635662|NCT00260858|Glycemic responses|glycemic responses
1635663|NCT00260858|Methodology|methodology
1635664|NCT00260858|Healthy human subjects|healthy human subjects
1635665|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
1635667|NCT00260832|Decitabine|decitabine
1635668|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
1635669|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
1635670|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
1635671|NCT00260819|ETA receptor antagonist|eta receptor antagonist
1635672|NCT00260793|Ropinirole|ropinirole
1635673|NCT00260793|Parkinson's disease|parkinson's disease
1635674|NCT00260793|dopamine agonist|dopamine agonist
1635675|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
1635676|NCT00260780|Risk Behavior|risk behavior
1635677|NCT00260754|Risk behavior|risk behavior
1635678|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
1635679|NCT00260741|cannabis|cannabis
1635680|NCT00260741|marijuana|marijuana
1635681|NCT00260741|Multiple Sclerosis|multiple sclerosis
1635682|NCT00260741|Spasticity|spasticity
1635683|NCT00260728|vascular access|vascular access
1635684|NCT00260728|hemodialysis|hemodialysis
1635685|NCT00260715|Risk behavior|risk behavior
1635686|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
1635687|NCT00260702|Phenotype|phenotype
1635688|NCT00260702|Monoclonal|monoclonal
1635689|NCT00260702|Immunoglobulin|immunoglobulin
1635690|NCT00260702|Immunodeficiency|immunodeficiency
1635691|NCT00260702|Dermatitis|dermatitis
1635692|NCT00260702|Job's Syndrome|job's syndrome
1635693|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
1635694|NCT00260702|HIES|hies
1635695|NCT00260689|Immunosuppression|immunosuppression
1635696|NCT00260689|T-cells|t-cells
1635697|NCT00260689|Hematopoiesis|hematopoiesis
1635698|NCT00260689|Autoimmunity|autoimmunity
1635699|NCT00260689|Thrombocytopenia|thrombocytopenia
1635700|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
1635701|NCT00260689|SAA|saa
1635703|NCT00260676|lung transplantation|lung transplantation
1635704|NCT00260676|organ donors|organ donors
1635705|NCT00260676|potential organ donors|potential organ donors
1635706|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
1635707|NCT00260663|Hearing Aids|hearing aids
1635708|NCT00260663|Randomized Controlled Trials|randomized controlled trials
1635709|NCT00260663|Cost Effectiveness|cost effectiveness
1635710|NCT00260663|Quality of life|quality of life
1635711|NCT00260663|Patient Compliance|patient compliance
1635712|NCT00260650|heart failure, congestive|heart failure, congestive
1635713|NCT00260650|self-care|self-care
1635714|NCT00260650|quality of life|quality of life
1635715|NCT00260650|health behavior|health behavior
1635716|NCT00260637|Prostatitis|prostatitis
1635717|NCT00260624|agitation|agitation
1635718|NCT00260624|dementia|dementia
1635719|NCT00260624|Alzheimer's Disease|alzheimer's disease
1635720|NCT00260611|prostate|prostate
1635721|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
1635722|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
1635723|NCT00260598|White light bronchoscopy|white light bronchoscopy
1635724|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
1635725|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
1635727|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
1635728|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
1635729|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
1635730|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
1635731|NCT00260585|GERD|gerd
1635732|NCT00260585|hiatal hernia|hiatal hernia
1635733|NCT00260585|achalasia|achalasia
1635734|NCT00260585|Barrett's metaplasia|barrett's metaplasia
1635735|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
1635736|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
1635737|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
1635738|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
1635739|NCT00260572|GERD|gerd
1635740|NCT00260572|nissen|nissen
1635741|NCT00260572|fundoplication|fundoplication
1635742|NCT00260572|reflux|reflux
1635743|NCT00260572|toupet|toupet
1635744|NCT00260572|QOL|qol
1635745|NCT00260572|dyspepsia|dyspepsia
1635746|NCT00260572|heartburn|heartburn
1635747|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
1635748|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
1635749|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
1635750|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
1635751|NCT00260559|Esophagectomy|esophagectomy
1635752|NCT00260559|Esophageal Cancer|esophageal cancer
1635753|NCT00260559|Quality of Life|quality of life
1635754|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
1635755|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
1635756|NCT00260559|Open Esophagectomy|open esophagectomy
1635757|NCT00260559|Karnofsky Score|karnofsky score
1635758|NCT00260559|Dysphagia score|dysphagia score
1635759|NCT00260559|Heartburn Scale|heartburn scale
1635760|NCT00260559|Nutrition Score|nutrition score
1635761|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
1635762|NCT00260520|Low molecular weight heparin|low molecular weight heparin
1635763|NCT00260520|Preeclampsia|preeclampsia
1635764|NCT00260520|Fetal Growth Restriction|fetal growth restriction
1635765|NCT00260520|Thrombophilia|thrombophilia
1635766|NCT00260520|Factor V Leiden|factor v leiden
1635767|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
1635768|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
1635769|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
1635770|NCT00260494|Postoperative Complications|postoperative complications
1635771|NCT00260494|Surgical Wound Infection|surgical wound infection
1635772|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
1635773|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
1635774|NCT00260481|Pharmacotherapy|pharmacotherapy
1635775|NCT00260468|Major depression|major depression
1635776|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
1635777|NCT00260468|White matter lesions|white matter lesions
1635778|NCT00260468|Perfusion|perfusion
1635779|NCT00260468|Diffusion|diffusion
1635780|NCT00260468|Magnetization transfer|magnetization transfer
1635781|NCT00260468|Vascular risk factors|vascular risk factors
1635782|NCT00260442|sarcopenia|sarcopenia
1635783|NCT00260442|resistance training|resistance training
1635784|NCT00260442|strength training|strength training
1635785|NCT00260442|skeletal muscle|skeletal muscle
1635786|NCT00260442|elderly|elderly
1635787|NCT00260442|cholesterol|cholesterol
1635788|NCT00260442|aging|aging
1635789|NCT00260442|cardiovascular disease|cardiovascular disease
1635790|NCT00260442|nutrition|nutrition
1635791|NCT00260442|inflammation|inflammation
1635792|NCT00260442|lipids|lipids
1635793|NCT00260429|Dupuytren's contracture|dupuytren's contracture
1635794|NCT00260429|fixed flexion contracture|fixed flexion contracture
1635795|NCT00260416|Acute myocardial infarction|acute myocardial infarction
1635796|NCT00260416|Symptom duration|symptom duration
1635797|NCT00260416|Primary angioplasty|primary angioplasty
1635798|NCT00260416|Infarct size|infarct size
1635799|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
1635800|NCT00260390|Dysthymic Disorder|dysthymic disorder
1635801|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
1635802|NCT00260390|Testosterone replacement|testosterone replacement
1635803|NCT00260377|Aspirin treatment|aspirin treatment
1635804|NCT00260377|Aspirin resistance|aspirin resistance
1635805|NCT00260377|Coronary bypass surgery|coronary bypass surgery
1635806|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
1635807|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1635808|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
1635809|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
1635810|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
1635811|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
1635812|NCT00260351|rabies;|rabies;
1635813|NCT00260351|rabies post-exposure;|rabies post-exposure;
1635814|NCT00260351|category III|category iii
1635815|NCT00260338|myocardial ischemia|myocardial ischemia
1635816|NCT00260338|stem cell|stem cell
1635817|NCT00260338|mesenchymal|mesenchymal
1635818|NCT00260338|myocardial perfusion|myocardial perfusion
1635819|NCT00260325|pretreatment|pretreatment
1635820|NCT00260325|healthy volunteers|healthy volunteers
1635821|NCT00260312|inactived|inactived
1635822|NCT00260312|polio|polio
1635823|NCT00260312|vaccine|vaccine
1635824|NCT00260312|cuba|cuba
1635825|NCT00260312|trial|trial
1635826|NCT00260312|randomized|randomized
1635827|NCT00260312|eradication|eradication
1635828|NCT00260299|cholesterol defects|cholesterol defects
1635829|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
1635830|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
1635831|NCT00260299|HIDS|hids
1635832|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
1635833|NCT00260299|MKD|mkd
1635834|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
1635835|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
1635836|NCT00260299|mevalonic acid|mevalonic acid
1635837|NCT00260299|mevalonate kinase|mevalonate kinase
1635838|NCT00260299|cholesterol, dietary|cholesterol, dietary
1635839|NCT00260299|Hyper IgD|hyper igd
1635840|NCT00260299|Multiple malformations|multiple malformations
1635841|NCT00260299|Fever|fever
1635842|NCT00260286|LH pulsatility|lh pulsatility
1635843|NCT00260286|energy availability|energy availability
1635844|NCT00260286|exercise|exercise
1635845|NCT00260286|diet|diet
1635846|NCT00260286|gynecological age|gynecological age
1635847|NCT00260273|Preventive Therapy|preventive therapy
1635848|NCT00260273|Psychoses|psychoses
1635849|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
1635850|NCT00260247|CYP3A4|cyp3a4
1635851|NCT00260247|Induction|induction
1635852|NCT00260247|Oxcarbazepine|oxcarbazepine
1635853|NCT00260247|Carbamazepine|carbamazepine
1635854|NCT00260247|Quinidine|quinidine
1635855|NCT00260247|Human|human
1635856|NCT00260247|In vivo|in vivo
1635857|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
1635858|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1635859|NCT00260234|Insulin Dependent|insulin dependent
1635860|NCT00260234|Islet Transplant|islet transplant
1635861|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
1635862|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
1635863|NCT00260195|Trauma|trauma
1635864|NCT00260195|Violence|violence
1635865|NCT00260195|Adolescent|adolescent
1635866|NCT00260195|Schools|schools
1635867|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
1635868|NCT00260182|Depressive Disorder|depressive disorder
1635869|NCT00260182|Family|family
1635870|NCT00260182|Genetics|genetics
1635871|NCT00260169|Treatment Preferences|treatment preferences
1635872|NCT00260169|Public sector|public sector
1635873|NCT00260169|Latino|latino
1635874|NCT00260156|Type 2 diabetes|type 2 diabetes
1635875|NCT00260156|vildagliptin|vildagliptin
1635876|NCT00260143|HIV+ men|hiv+ men
1635877|NCT00260143|Treatment Experienced|treatment experienced
1635878|NCT00260130|obesity|obesity
1635879|NCT00260130|food intake|food intake
1635880|NCT00260130|human|human
1635881|NCT00260130|energy balance|energy balance
1635882|NCT00260130|beverage|beverage
1635883|NCT00260117|Exercise|exercise
1635884|NCT00260117|Physical activity|physical activity
1635885|NCT00260117|walking|walking
1635886|NCT00260117|running|running
1635887|NCT00260091|Infertility|infertility
1635888|NCT00260091|Advanced maternal age|advanced maternal age
1635889|NCT00260091|Pregnancy|pregnancy
1635890|NCT00260091|Reproductive health|reproductive health
1635891|NCT00260091|Fertility treatment|fertility treatment
1635892|NCT00260091|Reproduction|reproduction
1635893|NCT00260078|Treatment Experienced|treatment experienced
1635894|NCT00260078|Pharmacokinetics|pharmacokinetics
1635895|NCT00260078|PK|pk
1635896|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
1635897|NCT00260065|Decitabine|decitabine
1635898|NCT00260065|Dacogen|dacogen
1635899|NCT00260065|MGI Pharma|mgi pharma
1635900|NCT00260052|traumatic brain injury|traumatic brain injury
1635901|NCT00260026|Lung Cancer|lung cancer
1635902|NCT00260013|chronic mental illness|chronic mental illness
1635903|NCT00260000|mild PKU|mild pku
1635904|NCT00260000|Y414C|y414c
1635905|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
1635906|NCT00260000|treatment without protein restriction|treatment without protein restriction
1635907|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
1635908|NCT00259987|esophagus|esophagus
1635909|NCT00259987|tumors|tumors
1635910|NCT00259987|GE junction|ge junction
1635911|NCT00259987|cancer|cancer
1635912|NCT00259987|lapatinib|lapatinib
1635913|NCT00259987|gastric cardia|gastric cardia
1635914|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
1635915|NCT00259974|Polyneuropathy|polyneuropathy
1635916|NCT00259974|Rituximab|rituximab
1635917|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
1635918|NCT00259935|Any Solid Tumor|any solid tumor
1635919|NCT00259922|constipation|constipation
1635920|NCT00259922|gastrointestinal|gastrointestinal
1635921|NCT00259922|opioids|opioids
1635922|NCT00259922|pain|pain
1635923|NCT00259922|non-cancer pain|non-cancer pain
1635924|NCT00259922|opioid-induced|opioid-induced
1635925|NCT00259922|bowel dysfunction|bowel dysfunction
1635926|NCT00259909|Patient reported outcomes|patient reported outcomes
1635927|NCT00259909|COPD|copd
1635928|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
1635929|NCT00259896|exenatide|exenatide
1635930|NCT00259896|pharmacokinetics|pharmacokinetics
1635931|NCT00259896|pharmacodynamics|pharmacodynamics
1635932|NCT00259883|depressive episodes|depressive episodes
1635933|NCT00259883|paroxetine|paroxetine
1635934|NCT00259883|PAXIL|paxil
1635935|NCT00259883|depression|depression
1635936|NCT00259883|benzodiazepine|benzodiazepine
1635937|NCT00259883|combination|combination
1635938|NCT00259870|Schizophrenia|schizophrenia
1635939|NCT00259870|PANSS|panss
1635940|NCT00259870|Acute|acute
1635941|NCT00259870|Cognition|cognition
1635942|NCT00259857|Fracture|fracture
1635943|NCT00259857|Bone Mineral Density|bone mineral density
1635944|NCT00259857|DXA|dxa
1635945|NCT00259844|Colorectal|colorectal
1635946|NCT00259844|Liver Metastases|liver metastases
1635947|NCT00259844|Vaccine|vaccine
1635948|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
1635949|NCT00259831|cold|cold
1635950|NCT00259831|influenza|influenza
1635951|NCT00259818|Refractory|refractory
1635952|NCT00259818|Solid Tumors|solid tumors
1635953|NCT00259805|encephalitis|encephalitis
1635954|NCT00259805|epilepsy|epilepsy
1635955|NCT00259805|Rasmussens|rasmussens
1635956|NCT00259805|rituximab|rituximab
1635957|NCT00259805|autoimmune|autoimmune
1635958|NCT00259779|COPD|copd
1635959|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
1635960|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
1635961|NCT00259727|Amprenavir|amprenavir
1635962|NCT00259727|Glucagon|glucagon
1635963|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
1635964|NCT00259727|Indinavir|indinavir
1635965|NCT00259727|Lopinavir|lopinavir
1635966|NCT00259727|Ritonavir|ritonavir
1635967|NCT00259714|hypertension|hypertension
1635968|NCT00259714|hemodialysis|hemodialysis
1635969|NCT00259714|sodium|sodium
1635970|NCT00259714|dialysate|dialysate
1635971|NCT00259714|hemodynamics|hemodynamics
1635972|NCT00259701|endothelium|endothelium
1635973|NCT00259701|iontophoresis|iontophoresis
1635974|NCT00259701|acetylcholine|acetylcholine
1635975|NCT00259701|nitroglycerin|nitroglycerin
1635976|NCT00259701|vasodilation|vasodilation
1635977|NCT00259688|Preeclampsia|preeclampsia
1635978|NCT00259688|Sleep Apnea|sleep apnea
1635979|NCT00259688|CPAP|cpap
1635980|NCT00259662|cancer--ovarian|cancer--ovarian
1635981|NCT00259662|cancer--endometria|cancer--endometria
1635982|NCT00259662|deep vein thrombosis|deep vein thrombosis
1635983|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
1635984|NCT00259623|Cardiac surgery|cardiac surgery
1635985|NCT00259623|Radiofrequency ablation|radiofrequency ablation
1635986|NCT00259623|Atrial fibrillation|atrial fibrillation
1635988|NCT00259610|painful joints|painful joints
1635989|NCT00259610|swollen joints|swollen joints
1635990|NCT00259597|nuclear morphology|nuclear morphology
1635991|NCT00259597|image analysis|image analysis
1635992|NCT00259597|lipid peroxidation|lipid peroxidation
1635993|NCT00259597|diet|diet
1636190|NCT00258752|Prevention|prevention
1635994|NCT00259597|proliferative breast disease|proliferative breast disease
1635995|NCT00259571|remission|remission
1635996|NCT00259571|mesalazin|mesalazin
1635997|NCT00259571|non-inferiority study|non-inferiority study
1635998|NCT00259571|relapse|relapse
1635999|NCT00259558|Ulcerative Colitis|ulcerative colitis
1636000|NCT00259558|Dose Finding|dose finding
1636001|NCT00259558|Phosphatidylcholine|phosphatidylcholine
1636002|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
1636003|NCT00259545|chronic active|chronic active
1636004|NCT00259545|steroid|steroid
1636005|NCT00259519|premature or preterm birth|premature or preterm birth
1636006|NCT00259519|chorioamnionitis|chorioamnionitis
1636007|NCT00259519|neonatal sepsis|neonatal sepsis
1636008|NCT00259519|labour|labour
1636009|NCT00259519|Cesarean Section|cesarean section
1636010|NCT00259519|delivery|delivery
1636011|NCT00259519|length of stay|length of stay
1636012|NCT00259519|pregnancy|pregnancy
1636013|NCT00259506|Recurrent depression|recurrent depression
1636014|NCT00259506|Mental Health|mental health
1636015|NCT00259493|Coronary Artery Disease|coronary artery disease
1636016|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
1636017|NCT00259493|Off-pump CABG|off-pump cabg
1636018|NCT00259493|Cardiac CT|cardiac ct
1636019|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
1636020|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
1636021|NCT00259454|Caregivers|caregivers
1636022|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
1636023|NCT00259441|Kidney failure|kidney failure
1636024|NCT00259441|Contrast media|contrast media
1636025|NCT00259441|Prevention|prevention
1636026|NCT00259441|Simvastatin|simvastatin
1636027|NCT00259428|Atrial Fibrillation|atrial fibrillation
1636028|NCT00259428|Atrial Flutter|atrial flutter
1636029|NCT00259428|Arrhythmia|arrhythmia
1636030|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
1636031|NCT00259415|Support groups|support groups
1636032|NCT00259415|Alzheimer's Disease|alzheimer's disease
1636033|NCT00259389|Treatment Experienced|treatment experienced
1636034|NCT00259389|Adherence|adherence
1636035|NCT00259389|Compliance|compliance
1636036|NCT00259389|Directly Observed Therapy|directly observed therapy
1636037|NCT00259389|DOT|dot
1636038|NCT00259389|Treatment Naive|treatment naive
1636039|NCT00259376|Atrial Fibrillation|atrial fibrillation
1636040|NCT00259376|Atrial Flutter|atrial flutter
1636041|NCT00259376|Arrhythmia|arrhythmia
1636042|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
1636043|NCT00259350|Central venous catheter|central venous catheter
1636044|NCT00259350|Skin disinfection|skin disinfection
1636045|NCT00259350|Antisepsis|antisepsis
1636046|NCT00259350|Nosocomial infection|nosocomial infection
1636047|NCT00259350|Catheter infection|catheter infection
1636048|NCT00259337|Diphteria|diphteria
1636049|NCT00259337|Tetanus|tetanus
1636050|NCT00259337|Polio|polio
1636051|NCT00259337|Acellular Pertussis|acellular pertussis
1636052|NCT00259337|Hib|hib
1636053|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
1636054|NCT00259259|Appetite regulation|appetite regulation
1636055|NCT00259259|Hormones|hormones
1636056|NCT00259259|Energy intake|energy intake
1636057|NCT00259220|Bleeding|bleeding
1636058|NCT00259220|Endoscopy|endoscopy
1636059|NCT00259220|Gastric tube|gastric tube
1636060|NCT00259220|Erythromycin|erythromycin
1636061|NCT00259220|Randomized|randomized
1636062|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
1636063|NCT00259207|Valve replacement|valve replacement
1636064|NCT00259207|Hybrid procedure|hybrid procedure
1636065|NCT00259194|Coronary angiography|coronary angiography
1636066|NCT00259194|Complications|complications
1636067|NCT00259194|Observation|observation
1636068|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
1636069|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
1636070|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
1636071|NCT00259168|Postprandial endothelial function|postprandial endothelial function
1636072|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
1636197|NCT00258713|Dermatologic Agents|dermatologic agents
1636073|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
1636074|NCT00259116|Congestive heart failure|congestive heart failure
1636075|NCT00259116|Relaxin|relaxin
1636076|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
1636077|NCT00259103|relaxin|relaxin
1636078|NCT00259103|pregnancy|pregnancy
1636079|NCT00259103|cervical ripening|cervical ripening
1636080|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
1636081|NCT00259038|Carperitide|carperitide
1636082|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
1636083|NCT00259038|Treatment efficacy|treatment efficacy
1636084|NCT00259038|Safety|safety
1636085|NCT00259038|Heart failure, Congestive|heart failure, congestive
1636086|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
1636087|NCT00259025|Renal failure, chronic|renal failure, chronic
1636088|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
1636089|NCT00259025|Heart rate variability|heart rate variability
1636191|NCT00258752|Adolescent|adolescent
1636090|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
1636091|NCT00259025|Ventricular premature complexes|ventricular premature complexes
1636092|NCT00259025|Ventricular repolarization|ventricular repolarization
1636093|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
1636094|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
1636095|NCT00259012|GERD|gerd
1636096|NCT00259012|Infant|infant
1636097|NCT00258999|Skin Cholesterol|skin cholesterol
1636098|NCT00258999|Carotid Plaque|carotid plaque
1636099|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
1636100|NCT00258986|Living donors|living donors
1636101|NCT00258986|Nephrectomy|nephrectomy
1636102|NCT00258986|Kidney transplantation|kidney transplantation
1636103|NCT00258986|Randomized Controlled Trial|randomized controlled trial
1636104|NCT00258986|Laparoscopy|laparoscopy
1636105|NCT00258973|Hand held Ultrasound|hand held ultrasound
1636106|NCT00258973|Office practice|office practice
1636107|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
1636108|NCT00258973|Ultrasound training|ultrasound training
1636109|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
1636110|NCT00258960|Metastatic breast cancer|metastatic breast cancer
1636111|NCT00258947|Smallpox|smallpox
1636112|NCT00258947|Orthopoxvirus|orthopoxvirus
1636113|NCT00258947|Poxvirus|poxvirus
1636114|NCT00258947|Vaccina Virus|vaccina virus
1636115|NCT00258947|LISTER Strain|lister strain
1636116|NCT00258947|Bioterrorism|bioterrorism
1636117|NCT00258934|Influenza|influenza
1636118|NCT00258934|Orthomyxoviruses|orthomyxoviruses
1636119|NCT00258934|Inactivated|inactivated
1636120|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
1636121|NCT00258934|adults|adults
1636122|NCT00258934|Myxovirus Infection|myxovirus infection
1636123|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
1636124|NCT00258908|ADACEL™|adacel™
1636125|NCT00258908|Tetanus|tetanus
1636126|NCT00258908|Diphteria|diphteria
1636127|NCT00258908|Acellular pertussis|acellular pertussis
1636128|NCT00258895|DAPTACEL®|daptacel®
1636129|NCT00258895|Pentacel™|pentacel™
1636130|NCT00258895|Diphtheria|diphtheria
1636131|NCT00258895|Tetanus|tetanus
1636132|NCT00258895|Pertussis|pertussis
1636133|NCT00258895|Whooping cough|whooping cough
1636134|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
1636135|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
1636136|NCT00258882|acellular pertussis,|acellular pertussis,
1636137|NCT00258882|diphtheria toxoid|diphtheria toxoid
1636138|NCT00258869|prospective studies|prospective studies
1636139|NCT00258869|biological assay|biological assay
1636140|NCT00258869|body weights and measures|body weights and measures
1636141|NCT00258869|chemistry, analytical|chemistry, analytical
1636142|NCT00258869|microchip analytical procedures|microchip analytical procedures
1636143|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
1636144|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
1636145|NCT00258869|microbiological techniques|microbiological techniques
1636146|NCT00258869|drug administration schedule|drug administration schedule
1636147|NCT00258869|data collection|data collection
1636148|NCT00258869|statistics|statistics
1636149|NCT00258869|gene expression profiling|gene expression profiling
1636150|NCT00258869|sequence analysis|sequence analysis
1636151|NCT00258869|human experimentation|human experimentation
1636152|NCT00258869|immunoassay|immunoassay
1636153|NCT00258869|Trauma severity indices|trauma severity indices
1636154|NCT00258869|Glasgow Coma score|glasgow coma score
1636155|NCT00258869|Outcome assessment|outcome assessment
1636156|NCT00258869|mortality|mortality
1636157|NCT00258869|computer models|computer models
1636158|NCT00258869|decision modeling|decision modeling
1636159|NCT00258869|linear models|linear models
1636160|NCT00258869|logistic models|logistic models
1636161|NCT00258869|immunologic model|immunologic model
1636162|NCT00258869|mathematical model|mathematical model
1636163|NCT00258869|non-linear models|non-linear models
1636164|NCT00258869|early diagnosis|early diagnosis
1636165|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
1636166|NCT00258869|medical informatics|medical informatics
1636167|NCT00258869|prognosis|prognosis
1636168|NCT00258869|registries|registries
1636169|NCT00258869|computational biology|computational biology
1636170|NCT00258869|systems biology|systems biology
1636171|NCT00258856|Meningitis|meningitis
1636172|NCT00258856|Meningococcal infection|meningococcal infection
1636173|NCT00258856|Neisseria meningitidis|neisseria meningitidis
1636174|NCT00258856|Menactra®|menactra®
1636175|NCT00258856|Menomune®|menomune®
1636176|NCT00258843|IMOVAX;|imovax;
1636177|NCT00258843|poliomyelitis|poliomyelitis
1636178|NCT00258830|Influenza vaccine|influenza vaccine
1636179|NCT00258817|Fluzone®|fluzone®
1636180|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
1636181|NCT00258791|Psychiatric disorders|psychiatric disorders
1636182|NCT00258791|ECT|ect
1636183|NCT00258791|Headache|headache
1636184|NCT00258791|Ibuprofen|ibuprofen
1636185|NCT00258765|zoledronic acid|zoledronic acid
1636186|NCT00258765|prostate cancer|prostate cancer
1636187|NCT00258765|high risk|high risk
1636188|NCT00258765|PSA|psa
1636189|NCT00258765|docetaxel|docetaxel
1636192|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
1636193|NCT00258713|Randomized Controlled Trials|randomized controlled trials
1636194|NCT00258713|Immunosuppression|immunosuppression
1636195|NCT00258713|Adult|adult
1636196|NCT00258713|Chronic Disease|chronic disease
1636198|NCT00258713|Female|female
1636199|NCT00258713|Humans|humans
1636200|NCT00258713|Male|male
1636201|NCT00258713|Middle Aged|middle aged
1636202|NCT00258713|Severity of Illness Index|severity of illness index
1636203|NCT00258713|Treatment Outcome|treatment outcome
1636204|NCT00258713|Quality of Life|quality of life
1636205|NCT00258713|Double-Blind Method|double-blind method
1636206|NCT00258687|GVAX|gvax
1636207|NCT00258687|GM-CSF|gm-csf
1636208|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
1636209|NCT00258687|Pediatric Melanoma|pediatric melanoma
1636210|NCT00258674|Diabetes|diabetes
1636211|NCT00258674|Care coordination|care coordination
1636212|NCT00258674|Case management|case management
1636213|NCT00258674|Physician profiling|physician profiling
1636214|NCT00258661|Pneumonia|pneumonia
1636215|NCT00258661|Osteopathic|osteopathic
1636216|NCT00258661|Manipulation|manipulation
1636217|NCT00258661|Multi-center|multi-center
1636218|NCT00258661|Elderly|elderly
1636219|NCT00258635|Allergy|allergy
1636220|NCT00258635|Specific Immunotherapy|specific immunotherapy
1636221|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
1636222|NCT00258622|Neuropathic pain|neuropathic pain
1636223|NCT00258622|Chronic pain|chronic pain
1636224|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
1636225|NCT00258609|Dysport®,Dysport|dysport®,dysport
1636226|NCT00258609|Migraine without aura,|migraine without aura,
1636227|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
1636228|NCT00258596|drug-eluting stent|drug-eluting stent
1636229|NCT00258596|chronic total occlusion|chronic total occlusion
1636230|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
1636231|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
1636232|NCT00258596|QCA|qca
1636233|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
1636234|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
1636235|NCT00258557|HIV|hiv
1636236|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
1636237|NCT00258557|HIV-1|hiv-1
1636238|NCT00258557|TMC114/r|tmc114/r
1636239|NCT00258557|Treatment naïve patients|treatment naïve patients
1636240|NCT00258544|Lung|lung
1636241|NCT00258544|Fibrosis|fibrosis
1636242|NCT00258544|Idiopathic|idiopathic
1636243|NCT00258544|Microarray|microarray
1636244|NCT00258544|Tissue|tissue
1636245|NCT00258544|Biopsy|biopsy
1636246|NCT00258518|Critically ill patients|critically ill patients
1636247|NCT00258505|Spreading depression|spreading depression
1636248|NCT00258505|Seizures|seizures
1636249|NCT00258505|Blood-brain barrier|blood-brain barrier
1636250|NCT00258492|Restless legs syndrome|restless legs syndrome
1636251|NCT00258492|Insomnia|insomnia
1636252|NCT00258492|Daytime sleepiness|daytime sleepiness
1636253|NCT00258492|Exercise|exercise
1636254|NCT00258479|Nicotine Dependence|nicotine dependence
1636255|NCT00258479|Nicotine Use Disorder|nicotine use disorder
1636256|NCT00258479|Tobacco Dependence|tobacco dependence
1636257|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1636258|NCT00258466|stage I prostate cancer|stage i prostate cancer
1636259|NCT00258466|stage II prostate cancer|stage ii prostate cancer
1636260|NCT00258466|stage III prostate cancer|stage iii prostate cancer
1636261|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1636262|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1636263|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
1636264|NCT00258453|weight changes|weight changes
1636265|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
1636266|NCT00258440|fatigue|fatigue
1636267|NCT00258440|anemia|anemia
1636268|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1636269|NCT00258427|Fanconi anemia|fanconi anemia
1636270|NCT00258401|diarrhea|diarrhea
1636271|NCT00258401|radiation toxicity|radiation toxicity
1636272|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
1636273|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
1636274|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
1636275|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
1636276|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
1636277|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
1636278|NCT00258401|stage I prostate cancer|stage i prostate cancer
1636279|NCT00258401|stage II prostate cancer|stage ii prostate cancer
1636280|NCT00258401|stage III prostate cancer|stage iii prostate cancer
1636281|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
1636282|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
1636283|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
1636284|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
1636285|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
1636286|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
1636287|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
1636288|NCT00258401|stage III cervical cancer|stage iii cervical cancer
1636289|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
1636290|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
1636291|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1636292|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
1636293|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
1636294|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
1636295|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
1636296|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
1636297|NCT00258375|stage IV breast cancer|stage iv breast cancer
1636298|NCT00258375|recurrent breast cancer|recurrent breast cancer
1636299|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1636300|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
1636301|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1636302|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1636303|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1636304|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1636305|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1636306|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1636307|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1636308|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1636309|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1636310|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1636311|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1636312|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1636313|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1636314|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1636315|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1636316|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
1636317|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
1636318|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
1636319|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1636320|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1636321|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1636322|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1636323|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1636324|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1636325|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1636326|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1636327|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1636328|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1636329|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1636330|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1636331|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1636332|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1636333|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1636334|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1636335|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1636336|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1636337|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1636338|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1636339|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
1636340|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
1636341|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
1636342|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1636343|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1636344|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
1636345|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
1636346|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1636635|NCT00257010|Almotriptan Malate|almotriptan malate
1636347|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1636348|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
1636349|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1636350|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1636351|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1637476|NCT00254254|diabetes|diabetes
1636352|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1636353|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1636354|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1636355|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1636356|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1636357|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1636358|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1636359|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1636360|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
1636361|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
1636362|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
1636363|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
1636364|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
1636365|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
1636366|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1636367|NCT00258232|recurrent colon cancer|recurrent colon cancer
1636368|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
1636369|NCT00258232|stage IV colon cancer|stage iv colon cancer
1636370|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
1636371|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
1636372|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
1636373|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
1636374|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
1636376|NCT00258193|IBS-C|ibs-c
1636377|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
1636378|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
1636379|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
1636380|NCT00258193|IBS|ibs
1636381|NCT00258193|Transit|transit
1636382|NCT00258193|Scintigraphy|scintigraphy
1636383|NCT00258193|Gastroenterology|gastroenterology
1636384|NCT00258193|Gastrointestinal|gastrointestinal
1636385|NCT00258193|GC|gc
1636386|NCT00258193|MD-1100 Acetate|md-1100 acetate
1636387|NCT00258193|MD-1100|md-1100
1636388|NCT00258193|linaclotide|linaclotide
1636389|NCT00258193|linaclotide acetate|linaclotide acetate
1636390|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1636391|NCT00258180|gastrointestinal complications|gastrointestinal complications
1636392|NCT00258180|diarrhea|diarrhea
1636393|NCT00258167|Family members|family members
1636394|NCT00258167|Illness burden|illness burden
1636395|NCT00258167|Mental Disorders|mental disorders
1636396|NCT00258167|Family intervention|family intervention
1636397|NCT00258115|Obesity|obesity
1636398|NCT00258115|Metabolic Syndrome|metabolic syndrome
1636399|NCT00258115|Diabetes|diabetes
1636400|NCT00258115|Inflammation|inflammation
1636401|NCT00258102|levofloxacin|levofloxacin
1636402|NCT00258102|urinary tract infections|urinary tract infections
1636403|NCT00258102|bacterial infections|bacterial infections
1636404|NCT00258102|bacteriuria|bacteriuria
1636405|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
1636406|NCT00258102|urinary infections|urinary infections
1636407|NCT00258102|quinolones|quinolones
1636408|NCT00258089|levofloxacin|levofloxacin
1636409|NCT00258089|urinary tract infections|urinary tract infections
1636410|NCT00258089|bacterial infections|bacterial infections
1636411|NCT00258089|bacteriuria|bacteriuria
1636412|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
1636413|NCT00258089|urinary infections|urinary infections
1636414|NCT00258089|quinolones|quinolones
1636415|NCT00258076|Transdermal contraception|transdermal contraception
1636416|NCT00258076|contraceptive|contraceptive
1636417|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
1636418|NCT00258076|ethinyl estradiol|ethinyl estradiol
1636419|NCT00258076|progesterone|progesterone
1636420|NCT00258076|EVRA|evra
1636421|NCT00258063|Transdermal contraception|transdermal contraception
1636422|NCT00258063|contraceptive|contraceptive
1636423|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
1636424|NCT00258063|ethinyl estradiol|ethinyl estradiol
1636425|NCT00258063|progesterone|progesterone
1636426|NCT00258063|EVRA|evra
1636427|NCT00258063|CILEST|cilest
1636428|NCT00258063|ORTHO EVRA|ortho evra
1636429|NCT00258050|midazolam|midazolam
1636430|NCT00258050|pharmacokinetics|pharmacokinetics
1636431|NCT00258050|lapatinib|lapatinib
1636432|NCT00258037|Physiotherapy|physiotherapy
1636433|NCT00258037|Stroke|stroke
1636434|NCT00258037|Urinary Incontinence|urinary incontinence
1636435|NCT00258037|quality of Life|quality of life
1636436|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
1636437|NCT00258011|MPS I Disease|mps i disease
1636438|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
1636439|NCT00257985|GTN|gtn
1636440|NCT00257985|middle cerebral artery|middle cerebral artery
1636441|NCT00257985|superficial temporal artery|superficial temporal artery
1636442|NCT00257985|headache|headache
1636443|NCT00257985|genotype|genotype
1636444|NCT00257972|Bipolar Mania|bipolar mania
1636445|NCT00257946|Diaphragm|diaphragm
1636446|NCT00257946|Hernia|hernia
1636447|NCT00257946|Congenital|congenital
1636448|NCT00257933|Corticosteroids|corticosteroids
1636449|NCT00257933|Treatment|treatment
1636450|NCT00257933|Pediatric|pediatric
1636451|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
1636452|NCT00257907|Latent Tuberculosis|latent tuberculosis
1636453|NCT00257907|PPD|ppd
1636454|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
1636455|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
1636456|NCT00257907|HIV|hiv
1636457|NCT00257907|LPA|lpa
1636458|NCT00257894|Baclofen|baclofen
1636459|NCT00257894|Conditioning, Classical|conditioning, classical
1636460|NCT00257894|Nicotine|nicotine
1636461|NCT00257894|Smoking|smoking
1636462|NCT00257881|Tumor|tumor
1636463|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
1636464|NCT00257855|Neuroprotection|neuroprotection
1636465|NCT00257855|Axonal loss|axonal loss
1636466|NCT00257855|Brain atrophy|brain atrophy
1636467|NCT00257855|MRI|mri
1636468|NCT00257855|Lamotrigine|lamotrigine
1636469|NCT00257855|Sodium Channel Blockers|sodium channel blockers
1636470|NCT00257829|Cervical Cancer|cervical cancer
1636471|NCT00257816|Cervical Cancer|cervical cancer
1636472|NCT00257816|Topotecan|topotecan
1636473|NCT00257816|Cisplatin|cisplatin
1636474|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
1636475|NCT00257790|Fever|fever
1636476|NCT00257790|Neutropenia|neutropenia
1636477|NCT00257790|Tobramycin|tobramycin
1636478|NCT00257790|Aminoglycoside|aminoglycoside
1636479|NCT00257790|Penicillin|penicillin
1636480|NCT00257764|Swallowing disorder|swallowing disorder
1636481|NCT00257764|Stroke|stroke
1636482|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
1636483|NCT00257764|Randomized controlled trial|randomized controlled trial
1636484|NCT00257725|ADHD|adhd
1636485|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
1636486|NCT00257712|Alzheimer's disease|alzheimer's disease
1636487|NCT00257712|cognition disorders|cognition disorders
1636488|NCT00257699|Crohn's Disease|crohn's disease
1636489|NCT00257699|Randomized|randomized
1636490|NCT00257699|Ciprofloxacin|ciprofloxacin
1636491|NCT00257699|Metronidazole|metronidazole
1636492|NCT00257699|Antibiotic|antibiotic
1636493|NCT00257686|Kowa|kowa
1636494|NCT00257686|Hypercholesterolemia|hypercholesterolemia
1636495|NCT00257686|combined|combined
1636496|NCT00257686|dyslipidemia|dyslipidemia
1636497|NCT00257686|elderly|elderly
1636498|NCT00257686|pitavastatin|pitavastatin
1636502|NCT00257673|Cognitive impairment|cognitive impairment
1636503|NCT00257634|lateral epicondylitis|lateral epicondylitis
1636504|NCT00257634|iontophoresis|iontophoresis
1636505|NCT00257634|dexamethasone|dexamethasone
1636506|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
1636507|NCT00257608|NSCLC|nsclc
1636508|NCT00257608|Lung Cancer|lung cancer
1636509|NCT00257608|ATLAS|atlas
1636510|NCT00257608|Avastin|avastin
1636511|NCT00257608|Tarceva|tarceva
1636512|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
1636513|NCT00257582|cetirizine|cetirizine
1636514|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
1636515|NCT00257582|pediatrics|pediatrics
1636516|NCT00257569|Atopic|atopic
1636517|NCT00257569|Pediatric|pediatric
1636518|NCT00257569|Dermatitis|dermatitis
1636519|NCT00257543|sickle cell disease|sickle cell disease
1636520|NCT00257543|bone marrow transplant|bone marrow transplant
1636521|NCT00257517|Congenital heart disease|congenital heart disease
1636522|NCT00257517|Single ventricle|single ventricle
1636523|NCT00257517|Infant feeding|infant feeding
1636524|NCT00257478|Treatment Efficacy|treatment efficacy
1636525|NCT00257478|Treatment Effectiveness|treatment effectiveness
1636526|NCT00257478|Disease Management|disease management
1636527|NCT00257478|Treatment|treatment
1636528|NCT00257478|Safety|safety
1636529|NCT00257465|melanoma|melanoma
1636530|NCT00257465|metastatic|metastatic
1636531|NCT00257465|vaccine|vaccine
1636532|NCT00257465|immunotherapy|immunotherapy
1636533|NCT00257465|autologous|autologous
1636534|NCT00257439|Vitamin B12|vitamin b12
1636535|NCT00257439|Folic Acid|folic acid
1636536|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1636537|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
1636636|NCT00257010|Headache|headache
1636538|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1636539|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1636540|NCT00257400|major depressive disorder|major depressive disorder
1636541|NCT00257400|psychotherapy|psychotherapy
1636542|NCT00257400|childhood sexual abuse|childhood sexual abuse
1636543|NCT00257400|trauma|trauma
1636544|NCT00257387|Kidney|kidney
1636545|NCT00257387|Kidney Transplant|kidney transplant
1636546|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
1637477|NCT00254254|adolescents|adolescents
1636547|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
1636548|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
1636549|NCT00257322|Metastatic colon cancer|metastatic colon cancer
1636550|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
1636551|NCT00257309|Acute myocardial infarction|acute myocardial infarction
1636552|NCT00257309|Elderly|elderly
1636553|NCT00257309|Thrombolysis|thrombolysis
1636554|NCT00257309|Primary angioplasty|primary angioplasty
1636555|NCT00257309|Randomized trial|randomized trial
1636556|NCT00257309|Efficacy|efficacy
1636557|NCT00257309|Safety|safety
1636558|NCT00257283|Chronic renal failure|chronic renal failure
1636559|NCT00257283|Hemodialysis|hemodialysis
1636560|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
1636561|NCT00257283|intervention study|intervention study
1636562|NCT00257283|cardiovascular events|cardiovascular events
1636563|NCT00257283|mortality|mortality
1636564|NCT00257270|Chronic|chronic
1636565|NCT00257270|Tinnitus|tinnitus
1636566|NCT00257270|Acoustic trauma|acoustic trauma
1636567|NCT00257270|Psychophysics|psychophysics
1636568|NCT00257270|Loudness match|loudness match
1636569|NCT00257270|gabapentin|gabapentin
1636570|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
1636571|NCT00257244|Immunity, innate|immunity, innate
1636572|NCT00257244|Inflammation|inflammation
1636573|NCT00257244|Genomics|genomics
1636574|NCT00257244|Proteomics|proteomics
1636575|NCT00257231|Immunity, innate|immunity, innate
1636576|NCT00257231|Inflammation|inflammation
1636577|NCT00257231|Genomics|genomics
1636578|NCT00257231|Proteomics|proteomics
1636579|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
1636580|NCT00257179|Tissue factor|tissue factor
1636581|NCT00257179|Lung cancer|lung cancer
1636582|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
1636583|NCT00257179|Factor VII|factor vii
1636584|NCT00257179|Factor X|factor x
1636585|NCT00257153|Acute myocardial infarction|acute myocardial infarction
1636586|NCT00257153|primary angioplasty|primary angioplasty
1636587|NCT00257153|myocardial reperfusion|myocardial reperfusion
1636588|NCT00257153|thrombus aspiration|thrombus aspiration
1636589|NCT00257140|Bronchitis|bronchitis
1636590|NCT00257140|chronic bronchitis|chronic bronchitis
1636591|NCT00257140|lung diseases|lung diseases
1636592|NCT00257140|respiratory tract infections|respiratory tract infections
1636593|NCT00257140|bronchial diseases|bronchial diseases
1636594|NCT00257140|antibacterial agents|antibacterial agents
1636595|NCT00257140|quinolones|quinolones
1636596|NCT00257140|levofloxacin|levofloxacin
1636597|NCT00257127|Vaccination|vaccination
1636598|NCT00257114|Multiple Myeloma|multiple myeloma
1636602|NCT00257088|epidemiology|epidemiology
1636603|NCT00257088|risk factors|risk factors
1636604|NCT00257088|randomized field trials|randomized field trials
1636605|NCT00257075|risperidone|risperidone
1636606|NCT00257075|antipsychotic agents|antipsychotic agents
1636607|NCT00257075|bipolar disorders|bipolar disorders
1636608|NCT00257075|manic episode|manic episode
1636609|NCT00257062|Infectious skin diseases|infectious skin diseases
1636610|NCT00257062|skin diseases|skin diseases
1636611|NCT00257062|bacterial skin diseases|bacterial skin diseases
1636612|NCT00257062|antibacterial agents|antibacterial agents
1636613|NCT00257062|quinolones|quinolones
1636614|NCT00257062|levofloxacin|levofloxacin
1636615|NCT00257049|Pneumonia|pneumonia
1636616|NCT00257049|lung inflammation|lung inflammation
1636617|NCT00257049|bacterial pneumonia|bacterial pneumonia
1636618|NCT00257049|lung diseases|lung diseases
1636619|NCT00257049|respiratory tract infections|respiratory tract infections
1636620|NCT00257049|antibacterial agents|antibacterial agents
1636621|NCT00257049|quinolones|quinolones
1636622|NCT00257049|levofloxacin|levofloxacin
1636623|NCT00257036|Infectious skin diseases|infectious skin diseases
1636624|NCT00257036|skin diseases|skin diseases
1636625|NCT00257036|bacterial skin diseases|bacterial skin diseases
1636626|NCT00257036|cellulitis|cellulitis
1636627|NCT00257036|quinolones|quinolones
1636628|NCT00257036|levofloxacin|levofloxacin
1636629|NCT00257023|Schizophrenia|schizophrenia
1636630|NCT00257023|Risperidone|risperidone
1636631|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
1636632|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
1636633|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
1636634|NCT00257010|Migraine|migraine
1636637|NCT00257010|Triptan|triptan
1636638|NCT00256997|Schizophrenia|schizophrenia
1636639|NCT00256997|Risperidone|risperidone
1636640|NCT00256997|Risperdal Consta|risperdal consta
1636641|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
1636642|NCT00256984|Colorectal Surgery|colorectal surgery
1636643|NCT00256984|Defecography|defecography
1636644|NCT00256984|Constipation|constipation
1636645|NCT00256984|Rectocele|rectocele
1636646|NCT00256984|Intussusception|intussusception
1636647|NCT00256984|Quality of Life|quality of life
1636648|NCT00256945|biofilm formation|biofilm formation
1636649|NCT00256945|dental plaque|dental plaque
1636650|NCT00256945|surface roughness|surface roughness
1636651|NCT00256945|dental restoration|dental restoration
1636652|NCT00256945|dental materials|dental materials
1636653|NCT00256932|bowel dysfunction|bowel dysfunction
1636654|NCT00256932|constipation|constipation
1636655|NCT00256932|gastrointestinal|gastrointestinal
1636656|NCT00256932|opioids|opioids
1636657|NCT00256932|pain|pain
1636658|NCT00256932|non-cancer pain|non-cancer pain
1636659|NCT00256932|Opioid-induced|opioid-induced
1636660|NCT00256919|GW856553|gw856553
1636661|NCT00256919|biomarkers|biomarkers
1636662|NCT00256919|CRP|crp
1636663|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
1636664|NCT00256906|lateral ventricles|lateral ventricles
1636665|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
1636666|NCT00256893|pain intensity|pain intensity
1636667|NCT00256893|numerical rating scale|numerical rating scale
1636668|NCT00256893|fibromyalgia|fibromyalgia
1636669|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
1636670|NCT00256880|Solid Tumors|solid tumors
1636671|NCT00256880|Myeloma|myeloma
1636672|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
1636673|NCT00256854|RLS|rls
1636674|NCT00256854|Ropinirole|ropinirole
1636675|NCT00256854|Restless Legs Syndrome|restless legs syndrome
1636676|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
1636677|NCT00256841|Taxotere|taxotere
1636678|NCT00256841|5-FU|5-fu
1636679|NCT00256828|HIV infection|hiv infection
1636680|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
1636681|NCT00256828|Treatment Naive|treatment naive
1636682|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
1636683|NCT00256815|Oral Navelbine|oral navelbine
1636684|NCT00256802|Headache|headache
1636685|NCT00256802|migraine|migraine
1636686|NCT00256802|MR-angiography|mr-angiography
1636687|NCT00256802|healthy volunteers|healthy volunteers
1636688|NCT00256802|GTN|gtn
1636689|NCT00256802|Middle cerebral artery|middle cerebral artery
1636690|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
1636691|NCT00256776|Multiple Myeloma|multiple myeloma
1636692|NCT00256776|Velcade|velcade
1636693|NCT00256776|Autologous transplantation|autologous transplantation
1636694|NCT00256776|Relapse|relapse
1636695|NCT00256776|Disease progress|disease progress
1636696|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
1636697|NCT00256724|hypotension|hypotension
1636698|NCT00256724|hypovolemia|hypovolemia
1636699|NCT00256724|dehydration|dehydration
1636700|NCT00256724|sepsis|sepsis
1636701|NCT00256724|blood loss|blood loss
1636702|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
1637224|NCT00255385|Prebiotics|prebiotics
1636703|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
1636704|NCT00256698|Hormone|hormone
1636705|NCT00256698|receptor|receptor
1636706|NCT00256698|positive|positive
1636707|NCT00256698|breast|breast
1636708|NCT00256698|cancer|cancer
1636709|NCT00256698|first|first
1636710|NCT00256698|relapse|relapse
1636711|NCT00256685|Menopause|menopause
1636712|NCT00256672|Spinal Cord Injury|spinal cord injury
1636713|NCT00256672|TLSO brace|tlso brace
1636714|NCT00256672|Spine curvature|spine curvature
1636715|NCT00256672|Child|child
1636716|NCT00256672|Effectiveness of bracing|effectiveness of bracing
1636717|NCT00256659|Medical inpatients|medical inpatients
1636718|NCT00256659|Social Work|social work
1636719|NCT00256659|Physical therapy|physical therapy
1636720|NCT00256659|Occupational therapy|occupational therapy
1636721|NCT00256659|Psychiatry|psychiatry
1636722|NCT00256659|Early intervention|early intervention
1636723|NCT00256659|Iatrogenic complications|iatrogenic complications
1636724|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
1636725|NCT00256620|Coronary artery disease|coronary artery disease
1636726|NCT00256620|Cardiac morbidity|cardiac morbidity
1636727|NCT00256620|Neurologic morbidity|neurologic morbidity
1636728|NCT00256620|Neurocognitive function|neurocognitive function
1636729|NCT00256620|Autoregulation|autoregulation
1636730|NCT00256594|Medical Errors|medical errors
1636731|NCT00256594|Medication Errors|medication errors
1636732|NCT00256594|Prescriptions, Drug|prescriptions, drug
1636733|NCT00256581|myocardial perfusion|myocardial perfusion
1636734|NCT00256581|Imaging|imaging
1636735|NCT00256568|Medical Errors|medical errors
1636736|NCT00256568|Medication Errors|medication errors
1636737|NCT00256568|Prescriptions, Drug|prescriptions, drug
1636738|NCT00256568|Pharmacies|pharmacies
1636739|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
1636740|NCT00256542|interstitial cystitis|interstitial cystitis
1636741|NCT00256542|pelvic pain|pelvic pain
1636742|NCT00256542|urgency|urgency
1636743|NCT00256542|frequency|frequency
1636744|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
1636745|NCT00256529|dysphagia|dysphagia
1636746|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
1636747|NCT00256516|Diet Therapy|diet therapy
1636748|NCT00256503|Primary Insomnia|primary insomnia
1636749|NCT00256503|Insomnia|insomnia
1636750|NCT00256503|Sleep|sleep
1637478|NCT00254254|exenatide|exenatide
1636751|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
1636752|NCT00256490|PET/CT|pet/ct
1636754|NCT00256464|PTSD|ptsd
1636755|NCT00256451|Naltrexone|naltrexone
1636756|NCT00256451|Endophenotype|endophenotype
1636757|NCT00256438|Depression|depression
1636758|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
1636759|NCT00256425|glioma|glioma
1636760|NCT00256425|brain tumor|brain tumor
1636761|NCT00256425|cognit|cognit
1636762|NCT00256425|neuropsycholog|neuropsycholog
1636763|NCT00256425|attention|attention
1636764|NCT00256425|memory|memory
1636765|NCT00256425|executive function|executive function
1636766|NCT00256425|rehabilitation|rehabilitation
1636767|NCT00256425|remediation|remediation
1636768|NCT00256425|training|training
1636769|NCT00256386|Baseline|baseline
1636770|NCT00256386|Laboratory|laboratory
1636771|NCT00256386|Drug|drug
1636772|NCT00256373|Low Back Pain|low back pain
1636773|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
1636774|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
1636775|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
1636776|NCT00256373|SF-36|sf-36
1636777|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
1636778|NCT00256360|breast cancer|breast cancer
1636779|NCT00256360|adjuvant|adjuvant
1636780|NCT00256360|dose dense|dose dense
1636781|NCT00256360|docetaxel|docetaxel
1636782|NCT00256360|pegfilgrastim|pegfilgrastim
1636783|NCT00256334|Colon Cancer|colon cancer
1636784|NCT00256334|Resveratrol|resveratrol
1636785|NCT00256334|Clinical Trial|clinical trial
1636786|NCT00256334|WnT signaling|wnt signaling
1636787|NCT00256334|Grapes|grapes
1636788|NCT00256334|Cancer prevention|cancer prevention
1636789|NCT00256321|Gastric Carcinoma|gastric carcinoma
1636790|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
1636791|NCT00256308|Head and Neck Cancer|head and neck cancer
1636792|NCT00256308|oxaliplatin|oxaliplatin
1636793|NCT00256308|resected squamous cell carcinoma|resected squamous cell carcinoma
1636794|NCT00256308|Eloxatin™|eloxatin™
1636795|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
1636796|NCT00256282|Metastatic Melanoma|metastatic melanoma
1636797|NCT00256269|Esophageal Cancer|esophageal cancer
1637187|NCT00255580|marijuana|marijuana
1636798|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
1636799|NCT00256269|Oxaliplatin|oxaliplatin
1636800|NCT00256269|Irinotecan|irinotecan
1636801|NCT00256256|type 2 diabetes|type 2 diabetes
1636802|NCT00256256|GLP-1|glp-1
1636803|NCT00256256|PET|pet
1636804|NCT00256256|brain|brain
1636805|NCT00256256|heart|heart
1636806|NCT00256204|Parkinson's|parkinson's
1636807|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
1636808|NCT00256191|taxanes|taxanes
1636809|NCT00256191|multidrug resistance|multidrug resistance
1636810|NCT00256191|mutant tubulin binding|mutant tubulin binding
1636811|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
1636812|NCT00256178|Hyperlipidemia|hyperlipidemia
1636813|NCT00256178|Drug Therapy|drug therapy
1636814|NCT00256165|Aortic valve replacement|aortic valve replacement
1636815|NCT00256152|Atrial fibrillation|atrial fibrillation
1636816|NCT00256152|Pacemaker|pacemaker
1636817|NCT00256152|AF suppression pacing|af suppression pacing
1636818|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
1636819|NCT00256113|depression|depression
1636820|NCT00256113|antidepressive agents|antidepressive agents
1636821|NCT00256113|controlled clinical trial|controlled clinical trial
1636822|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
1636823|NCT00256009|Late abortion|late abortion
1636824|NCT00255983|bronchitis|bronchitis
1636825|NCT00255983|AECB|aecb
1636826|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
1636827|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
1636828|NCT00255944|HIV Prevention|hiv prevention
1636829|NCT00255944|Internet Intervention|internet intervention
1636830|NCT00255944|STDs|stds
1636831|NCT00255931|Heart Failure|heart failure
1636832|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
1636833|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
1636834|NCT00255918|Evoked Potentials|evoked potentials
1636835|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
1636836|NCT00255918|DMXB-A|dmxb-a
1636837|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
1636838|NCT00255905|Depression|depression
1636839|NCT00255905|Insomnia|insomnia
1636840|NCT00255892|HIV|hiv
1636841|NCT00255879|Schizophrenia|schizophrenia
1636842|NCT00255879|Neuroleptic|neuroleptic
1636843|NCT00255879|Tardive dyskinesia|tardive dyskinesia
1636844|NCT00255866|Assisted Living Facilities|assisted living facilities
1636845|NCT00255866|Aged|aged
1636846|NCT00255866|Elderly|elderly
1636847|NCT00255866|Caregivers|caregivers
1636848|NCT00255840|Treatment Naive|treatment naive
1636849|NCT00255814|liver metastases|liver metastases
1636850|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1636851|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1636852|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1636853|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1636854|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1636855|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1636856|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1636857|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1636858|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1636859|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1636860|NCT00255788|recurrent breast cancer|recurrent breast cancer
1636861|NCT00255788|stage IV breast cancer|stage iv breast cancer
1636862|NCT00255788|male breast cancer|male breast cancer
1636863|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
1636864|NCT00255775|small cell lung cancer|small cell lung cancer
1636865|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1636866|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1636867|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1636868|NCT00255749|anemia|anemia
1636869|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
1636870|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1636871|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
1636872|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1636873|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
1636874|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
1636875|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
1636876|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
1636877|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1636878|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1636879|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1636880|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1636881|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1636882|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1636883|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1636884|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1636885|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1636886|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1636887|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1636888|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1636889|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1636890|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1636891|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1636892|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1636893|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1636894|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1636895|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1636896|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1636897|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1636898|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1636899|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1636900|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1636901|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1636902|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1636903|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1636904|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1636905|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1636906|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1636907|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1637261|NCT00255138|Children|children
1636908|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1636909|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1636910|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1636911|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1636912|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1636913|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1636914|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1637479|NCT00254254|Amylin|amylin
1636915|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1636916|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1636917|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1636918|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1636919|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1636920|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1636921|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1636922|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1636923|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1636924|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1636925|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1636926|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1636927|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1636928|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1636929|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1636930|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1636931|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1636932|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
1636933|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1636934|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1636935|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1636936|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1636937|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1636938|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1636939|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1636940|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1636941|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1636942|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1636943|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1636944|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1636945|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1636946|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1637225|NCT00255385|Child health|child health
1636947|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1636948|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1636949|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1636950|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1636951|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1636952|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1636953|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1636954|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1636955|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1636956|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1636957|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1636958|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1636959|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1636960|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1636961|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1636962|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1636963|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1636964|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1636965|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1636966|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1636967|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1639154|NCT00248066|Restenosis|restenosis
1636968|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1636969|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1636970|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1636971|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1636972|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1636973|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1636974|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1636975|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1636976|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1636977|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1636978|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1636979|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1636980|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1636981|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1636982|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1636983|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1636984|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
1636985|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
1636986|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1636987|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1636988|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1636989|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1636990|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1636991|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1636992|NCT00255710|graft versus host disease|graft versus host disease
1636993|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1636994|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1637188|NCT00255580|HIV|hiv
1636995|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1636996|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1636997|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1636998|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1636999|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1637000|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1637001|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1637002|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1637003|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1637004|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1637005|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1637006|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1637226|NCT00255385|Milk fortification|milk fortification
1637007|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1637008|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1637009|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1637010|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1637011|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1637012|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
1637013|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1637014|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1637015|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1637016|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1637017|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
1637018|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1637019|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1637020|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1637021|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1637022|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1637023|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1637024|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1637025|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1637026|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1637027|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1637028|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
1637029|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1637030|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
1637031|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1637032|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1637033|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1637034|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1637035|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1637036|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1637037|NCT00255684|graft versus host disease|graft versus host disease
1637038|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1637039|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1637040|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1637041|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1637042|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1637043|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1637044|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1637045|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1637046|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1637047|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1637048|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1637049|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
1637050|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1637051|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1637052|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1637053|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
1637054|NCT00255684|refractory anemia|refractory anemia
1637055|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1637056|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1637057|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1637058|NCT00255684|primary myelofibrosis|primary myelofibrosis
1637059|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
1637060|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
1637061|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
1637062|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
1637063|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
1637064|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1637065|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1637066|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1637067|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1637068|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1637069|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1637070|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1637071|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1637227|NCT00255385|Randomized controlled trial|randomized controlled trial
1637072|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1637073|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1637074|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1637075|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1637076|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1637077|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1637078|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1637079|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1637080|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1637081|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1637082|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1637083|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1637084|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1637085|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1637086|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1637087|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1637088|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1637089|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1637090|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1637091|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1637092|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1637093|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1637094|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1637095|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1639441|NCT00247078|widow|widow
1637096|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1637097|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1637098|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1637099|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1637100|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1637101|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1637102|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1637103|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1637104|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1637105|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1637106|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1637107|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1637108|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1637109|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1637110|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1637111|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1637112|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1637113|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1637114|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1637115|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1637116|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1637117|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1637118|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1637119|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1637120|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1637121|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1637122|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1637123|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1637124|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1637125|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1637126|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1637127|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1637128|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1637129|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1637130|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1637131|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1637425|NCT00254410|Neupogen|neupogen
1637132|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1637133|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1637134|NCT00255671|radiation toxicity|radiation toxicity
1637135|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
1637136|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1637137|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
1637138|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
1637139|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1637140|NCT00255671|adult brain stem glioma|adult brain stem glioma
1637141|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1637142|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
1637143|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
1637144|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
1637145|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
1637146|NCT00255671|adult ependymoma|adult ependymoma
1637147|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
1637148|NCT00255671|adult gliosarcoma|adult gliosarcoma
1637149|NCT00255671|adult medulloblastoma|adult medulloblastoma
1637150|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
1637151|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1637152|NCT00255671|adult meningioma|adult meningioma
1637153|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1637154|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
1637155|NCT00255671|adult papillary meningioma|adult papillary meningioma
1637156|NCT00255671|adult pineoblastoma|adult pineoblastoma
1637157|NCT00255671|adult pineocytoma|adult pineocytoma
1637158|NCT00255671|adult subependymoma|adult subependymoma
1637159|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1637160|NCT00255671|adult grade I meningioma|adult grade i meningioma
1637161|NCT00255671|adult grade II meningioma|adult grade ii meningioma
1637162|NCT00255671|adult grade III meningioma|adult grade iii meningioma
1639442|NCT00247078|spider|spider
1637163|NCT00255671|adult mixed glioma|adult mixed glioma
1637164|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
1637165|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1637166|NCT00255671|adult glioblastoma|adult glioblastoma
1637167|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1637168|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
1637169|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
1637170|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
1637171|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
1637172|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
1637173|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
1637174|NCT00255619|Peritonitis|peritonitis
1637175|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
1637176|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
1637177|NCT00255619|Twin bag System|twin bag system
1637178|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1637179|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
1637180|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
1637182|NCT00255593|Transplantation|transplantation
1637183|NCT00255593|Immunosuppression|immunosuppression
1637184|NCT00255593|Rituximab|rituximab
1637185|NCT00255580|neuropathy|neuropathy
1637186|NCT00255580|cannabis|cannabis
1637189|NCT00255580|DSPN|dspn
1637190|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
1637191|NCT00255567|Combination|combination
1637192|NCT00255554|Borderline Personality Disorder|borderline personality disorder
1637193|NCT00255554|BPD|bpd
1637194|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
1637195|NCT00255554|DBT|dbt
1637196|NCT00255554|Escitalopram|escitalopram
1637197|NCT00255554|Lexapro|lexapro
1637198|NCT00255528|Pediatric hypertension|pediatric hypertension
1637199|NCT00255502|Pediatric hypertension|pediatric hypertension
1637200|NCT00255450|anemia|anemia
1637201|NCT00255411|Conversion Disorder|conversion disorder
1637202|NCT00255411|Somatoform Disorder|somatoform disorder
1637203|NCT00255411|Involuntary Movement|involuntary movement
1637204|NCT00255411|Childhood Abuse|childhood abuse
1637205|NCT00255411|Depression|depression
1637206|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
1637207|NCT00255411|PMD|pmd
1637208|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
1637209|NCT00255411|NES|nes
1637210|NCT00255411|Healthy Volunteer|healthy volunteer
1637211|NCT00255411|HV|hv
1637212|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1637213|NCT00255398|Minimal Change Disease|minimal change disease
1637214|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
1637215|NCT00255398|Mass Spectrometry|mass spectrometry
1637216|NCT00255398|Proteinuria|proteinuria
1637217|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
1637218|NCT00255398|Glomerular Disease|glomerular disease
1637219|NCT00255398|FSG|fsg
1637220|NCT00255398|Kidney Disease|kidney disease
1637221|NCT00255385|Zinc|zinc
1637222|NCT00255385|Iron|iron
1637223|NCT00255385|Probiotics|probiotics
1637228|NCT00255346|targeted therapy|targeted therapy
1637229|NCT00255346|leukemia|leukemia
1637230|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
1637231|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1637232|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
1637233|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
1637234|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
1637235|NCT00255346|Mastocytosis|mastocytosis
1637236|NCT00255346|CMML|cmml
1637237|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
1637238|NCT00255307|cold|cold
1637239|NCT00255307|flu|flu
1637240|NCT00255307|respiratory tract infection|respiratory tract infection
1637241|NCT00255255|Asthma|asthma
1637242|NCT00255242|Cystic Fibrosis|cystic fibrosis
1637243|NCT00255242|Airway Inflammation|airway inflammation
1637244|NCT00255242|Cytokines|cytokines
1637245|NCT00255242|Simvastatin|simvastatin
1637246|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
1637247|NCT00255242|Rho GTP-ase|rho gtp-ase
1637248|NCT00255229|irinotecan|irinotecan
1637249|NCT00255229|5FU|5fu
1637250|NCT00255229|amino acids|amino acids
1637251|NCT00255229|heat shock protein|heat shock protein
1637252|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1637253|NCT00255177|Hepatitis C|hepatitis c
1637254|NCT00255164|Erosive Esophagitis|erosive esophagitis
1637255|NCT00255151|Erosive Esophagitis|erosive esophagitis
1637256|NCT00255138|Cancer|cancer
1637257|NCT00255138|Cognitive Late Effects|cognitive late effects
1637258|NCT00255138|Stimulants|stimulants
1637259|NCT00255138|Atomoxetine|atomoxetine
1637260|NCT00255138|Attention|attention
1637262|NCT00255125|Estrogen Receptor|estrogen receptor
1637263|NCT00255125|Isoflavones|isoflavones
1637264|NCT00255125|Prostate Neoplasm|prostate neoplasm
1637265|NCT00255125|Soy Supplementation|soy supplementation
1637267|NCT00255112|treatment|treatment
1637268|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
1637269|NCT00255112|family|family
1637270|NCT00255112|children|children
1637271|NCT00255112|anxiety|anxiety
1637272|NCT00255099|HIV|hiv
1637273|NCT00255099|HIV-1|hiv-1
1637274|NCT00255099|TMC125|tmc125
1637275|NCT00255047|Pertussis|pertussis
1637276|NCT00255047|Whooping cough|whooping cough
1637480|NCT00254254|Lilly|lilly
1637277|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
1637278|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
1637279|NCT00255047|Pertactin|pertactin
1637280|NCT00255047|Diphtheria|diphtheria
1637281|NCT00255047|Tetanus|tetanus
1637282|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
1637283|NCT00255034|chronic hepatitis C|chronic hepatitis c
1637284|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
1637285|NCT00255034|ribavirin|ribavirin
1637286|NCT00255034|Australia|australia
1637287|NCT00255021|Diphteria|diphteria
1637288|NCT00255021|Tetanus|tetanus
1637289|NCT00255021|Pertussis|pertussis
1637290|NCT00255021|Poliomyelitis|poliomyelitis
1637291|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
1637292|NCT00255021|acellular|acellular
1637293|NCT00255008|chronic hepatitis C|chronic hepatitis c
1637294|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
1637295|NCT00255008|ribavirin|ribavirin
1637296|NCT00255008|Asia|asia
1637297|NCT00254995|Meningitis|meningitis
1637298|NCT00254995|Meningococcal disease|meningococcal disease
1637299|NCT00254995|Menactra vaccine|menactra vaccine
1637300|NCT00254969|Diphteria|diphteria
1637301|NCT00254969|tetanus|tetanus
1637302|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
1637303|NCT00254969|poliomyelitis|poliomyelitis
1637304|NCT00254969|pertussis|pertussis
1637305|NCT00254956|Diseases|diseases
1637306|NCT00254956|respiratory tract diseases|respiratory tract diseases
1637307|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
1637308|NCT00254956|asthma|asthma
1637309|NCT00254930|learning disorder|learning disorder
1637310|NCT00254930|children|children
1637311|NCT00254930|behaviour disorder|behaviour disorder
1637312|NCT00254930|risperidone|risperidone
1637313|NCT00254917|Pentaxim|pentaxim
1637314|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
1637315|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
1637316|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
1637317|NCT00254865|Transdermal contraception|transdermal contraception
1637318|NCT00254865|contraceptive|contraceptive
1637319|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
1637320|NCT00254865|ethinyl estradiol|ethinyl estradiol
1637321|NCT00254865|progesterone|progesterone
1637322|NCT00254865|EVRA|evra
1637323|NCT00254865|CILEST|cilest
1637426|NCT00254397|Melanoma|melanoma
1637324|NCT00254852|Primary lumbar fusion|primary lumbar fusion
1637325|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
1637327|NCT00254852|Optecure|optecure
1637328|NCT00254852|Allograft|allograft
1637329|NCT00254852|Autograft|autograft
1637330|NCT00254852|Lumbar fusion|lumbar fusion
1637331|NCT00254852|Interbody fusion|interbody fusion
1637332|NCT00254852|Instrumented fusion|instrumented fusion
1637333|NCT00254852|Non-instrumented fusion|non-instrumented fusion
1637334|NCT00254852|Exactech|exactech
1637335|NCT00254852|Spinal fusion|spinal fusion
1637336|NCT00254839|Oral malodor|oral malodor
1637337|NCT00254839|Dental implants|dental implants
1637338|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
1637339|NCT00254813|Schizophrenia|schizophrenia
1637340|NCT00254813|Schizoaffective disorder|schizoaffective disorder
1637341|NCT00254800|diabetes|diabetes
1637342|NCT00254800|exenatide|exenatide
1637343|NCT00254800|Amylin|amylin
1637344|NCT00254800|Lilly|lilly
1637345|NCT00254787|Schizophrenia|schizophrenia
1637346|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
1637347|NCT00254761|cannabis|cannabis
1637348|NCT00254761|marijuana|marijuana
1637349|NCT00254761|neuropathy|neuropathy
1637350|NCT00254761|antinociception|antinociception
1637351|NCT00254761|mood|mood
1637352|NCT00254761|cognition|cognition
1637353|NCT00254748|Borderline personality disorder|borderline personality disorder
1637354|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
1637355|NCT00254722|Traumatic Brain Injury|traumatic brain injury
1637356|NCT00254722|Stem Cell|stem cell
1637357|NCT00254709|kidney transplant|kidney transplant
1637358|NCT00254709|elderly|elderly
1637359|NCT00254696|bacterial infection|bacterial infection
1637360|NCT00254683|Rectal Cancer|rectal cancer
1637361|NCT00254683|Positron Emission Tomography|positron emission tomography
1637362|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1637363|NCT00254683|Computed Tomography|computed tomography
1637364|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
1637365|NCT00254683|Chemotherapy|chemotherapy
1637366|NCT00254683|Radiotherapy|radiotherapy
1637367|NCT00254670|Alcohol|alcohol
1637368|NCT00254670|Naltrexone|naltrexone
1637369|NCT00254657|Fibromyalgia|fibromyalgia
1637370|NCT00254657|Fibro|fibro
1637371|NCT00254657|Keppra|keppra
1637372|NCT00254657|Levetiracetam|levetiracetam
1637373|NCT00254644|phonological treatment|phonological treatment
1637374|NCT00254644|language|language
1637375|NCT00254644|fMRI|fmri
1637376|NCT00254631|long bone fracture|long bone fracture
1637377|NCT00254631|open fractures|open fractures
1637378|NCT00254631|closed fractures|closed fractures
1637379|NCT00254631|trauma|trauma
1637380|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
1637381|NCT00254605|imaging|imaging
1637382|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
1637383|NCT00254605|optical coherence tomography|optical coherence tomography
1637384|NCT00254605|electroretinography|electroretinography
1637385|NCT00254592|Inflammatory|inflammatory
1637386|NCT00254592|Breast Cancer|breast cancer
1637387|NCT00254592|Female|female
1637388|NCT00254592|Neo-adjuvant|neo-adjuvant
1637389|NCT00254592|HER-2 positive|her-2 positive
1637390|NCT00254592|Hormone receptor|hormone receptor
1637391|NCT00254579|refractory melanoma|refractory melanoma
1637392|NCT00254579|malignant melanoma|malignant melanoma
1637393|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
1637394|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
1637395|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
1637396|NCT00254527|Children|children
1637397|NCT00254527|Colonization|colonization
1637398|NCT00254527|Risk Factor|risk factor
1637399|NCT00254501|diabetes|diabetes
1637400|NCT00254475|Valsartan|valsartan
1637401|NCT00254475|simvastatin|simvastatin
1637402|NCT00254475|hypertension|hypertension
1637403|NCT00254475|hypercholesterolemia|hypercholesterolemia
1637404|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
1637405|NCT00254462|ADHD|adhd
1637406|NCT00254462|Atomoxetine|atomoxetine
1637407|NCT00254436|Epoetin Alfa|epoetin alfa
1637408|NCT00254436|Epogen|epogen
1637409|NCT00254436|Erythropoietin|erythropoietin
1637410|NCT00254423|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1637411|NCT00254423|CML|cml
1637412|NCT00254423|Dasatinib|dasatinib
1637413|NCT00254423|BMS-354825|bms-354825
1637414|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1637415|NCT00254410|Untreated|untreated
1637416|NCT00254410|Fludarabine|fludarabine
1637417|NCT00254410|Fludara|fludara
1637418|NCT00254410|Cyclophosphamide|cyclophosphamide
1637419|NCT00254410|Cytoxan|cytoxan
1637420|NCT00254410|Mitoxantrone|mitoxantrone
1637421|NCT00254410|Novantrone|novantrone
1637422|NCT00254410|Rituximab|rituximab
1637423|NCT00254410|Rituxan|rituxan
1637424|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
1637427|NCT00254397|Uveal Melanoma|uveal melanoma
1637428|NCT00254397|Peptide Vaccine|peptide vaccine
1637429|NCT00254397|LHRH-agonist|lhrh-agonist
1637430|NCT00254397|Leuprolide|leuprolide
1637432|NCT00254397|MAGE-3 Peptide|mage-3 peptide
1637433|NCT00254397|MAGE-3|mage-3
1637434|NCT00254397|GP100 Peptide|gp100 peptide
1637435|NCT00254397|Melanoma vaccines|melanoma vaccines
1637436|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
1637437|NCT00254397|T cells|t cells
1637438|NCT00254397|Skin Cancer|skin cancer
1637439|NCT00254397|Eye Cancer|eye cancer
1637440|NCT00254384|Non-Small Cell Lung Cancer|non-small cell lung cancer
1637441|NCT00254384|Lung Cancer|lung cancer
1637442|NCT00254384|Cisplatin|cisplatin
1637443|NCT00254384|Platinol|platinol
1637444|NCT00254384|Platinol-AQ|platinol-aq
1637445|NCT00254384|CDDP|cddp
1637446|NCT00254384|Docetaxel|docetaxel
1637447|NCT00254384|Taxotere|taxotere
1637448|NCT00254384|Erlotinib|erlotinib
1637449|NCT00254384|Tarceva|tarceva
1637450|NCT00254384|OSI-774|osi-774
1637451|NCT00254384|NSCLC|nsclc
1637452|NCT00254358|Nicotine|nicotine
1637453|NCT00254358|Dopamine|dopamine
1637454|NCT00254358|IBZM|ibzm
1637455|NCT00254345|biofilm|biofilm
1637456|NCT00254345|adhesion|adhesion
1637457|NCT00254345|liquid polish|liquid polish
1637458|NCT00254345|bonding resin|bonding resin
1637459|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
1637460|NCT00254345|provisional crown|provisional crown
1637461|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
1637564|NCT00253877|hip resurfacing|hip resurfacing
1637462|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
1637463|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1637464|NCT00254332|Sezary Syndrome|sezary syndrome
1637465|NCT00254332|Mycosis Fungoides|mycosis fungoides
1637466|NCT00254332|Denileukin Diftitox|denileukin diftitox
1637468|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
1637469|NCT00254306|IBZM|ibzm
1637470|NCT00254306|MDMA|mdma
1637471|NCT00254280|Warts|warts
1637472|NCT00254280|Intense pulsed light|intense pulsed light
1637473|NCT00254280|RCT|rct
1637474|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
1637475|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
1637481|NCT00254241|Schizophrenia|schizophrenia
1637482|NCT00254228|Balance|balance
1637483|NCT00254228|Vestibular|vestibular
1637484|NCT00254228|Electrotactile|electrotactile
1637485|NCT00254228|BrainPort|brainport
1637486|NCT00254228|Sensory substitution|sensory substitution
1637487|NCT00254228|Tongue|tongue
1637488|NCT00254215|overweight|overweight
1637489|NCT00254215|obesity|obesity
1637490|NCT00254215|glycemic index|glycemic index
1637491|NCT00254215|glycemic load|glycemic load
1637492|NCT00254215|high protein diet|high protein diet
1637493|NCT00254215|blood cholesterol|blood cholesterol
1637494|NCT00254202|Schizophrenia|schizophrenia
1637495|NCT00254202|Atypical antipsychotic|atypical antipsychotic
1637496|NCT00254202|psychosis|psychosis
1637497|NCT00254189|Ovulation|ovulation
1637498|NCT00254189|Oral Contraceptive|oral contraceptive
1637499|NCT00254176|Neonate|neonate
1637500|NCT00254176|Glutathione|glutathione
1637501|NCT00254176|Cysteine|cysteine
1637502|NCT00254176|Sepsis|sepsis
1637503|NCT00254176|Stable Isotope|stable isotope
1637504|NCT00254137|capecitabine|capecitabine
1637505|NCT00254137|irinotecan|irinotecan
1637506|NCT00254137|cetuximab|cetuximab
1637507|NCT00254137|oxaliplatin|oxaliplatin
1637508|NCT00254137|colorectal cancer|colorectal cancer
1637509|NCT00254124|obesity|obesity
1637510|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
1637511|NCT00254124|portion control|portion control
1637512|NCT00254111|osteoarthritis|osteoarthritis
1637513|NCT00254111|hand|hand
1637514|NCT00254111|laser|laser
1637515|NCT00254111|device|device
1637516|NCT00254111|hand pain|hand pain
1637517|NCT00254111|stiffness|stiffness
1637518|NCT00254085|Type 2 diabtes|type 2 diabtes
1637519|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
1637520|NCT00254085|Insulin treatment|insulin treatment
1637521|NCT00254072|Morbid Obesity|morbid obesity
1637522|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
1637523|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
1637524|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
1637525|NCT00254046|HIV|hiv
1637526|NCT00254046|HIV-1|hiv-1
1637527|NCT00254046|TMC125|tmc125
1637528|NCT00254033|Alzheimer's Disease|alzheimer's disease
1637529|NCT00254033|Apathy|apathy
1637530|NCT00254033|Brain Reward System|brain reward system
1637531|NCT00254033|Dopamine|dopamine
1637532|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
1637533|NCT00254033|Methylphenidate|methylphenidate
1637534|NCT00254020|stroke|stroke
1637535|NCT00254020|depression|depression
1637536|NCT00254020|cytokines|cytokines
1637537|NCT00254020|serotonin|serotonin
1637538|NCT00254020|citalopram|citalopram
1637539|NCT00254007|depression|depression
1637540|NCT00254007|traumatic brain injury|traumatic brain injury
1637541|NCT00254007|serotonin transporter|serotonin transporter
1637542|NCT00254007|genetic polymorphisms|genetic polymorphisms
1637543|NCT00254007|citalopram|citalopram
1637544|NCT00253981|Pain, Intractable|pain, intractable
1637545|NCT00253981|Infrared Rays|infrared rays
1637546|NCT00253981|Leg|leg
1637547|NCT00253968|Primary Insomnia|primary insomnia
1637548|NCT00253968|Sleeplessness|sleeplessness
1637549|NCT00253968|Early Awakening|early awakening
1637550|NCT00253968|Chronic Insomnia|chronic insomnia
1637551|NCT00253929|adenosine|adenosine
1637552|NCT00253929|polymorphisms|polymorphisms
1637553|NCT00253929|blood flow|blood flow
1637554|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
1637555|NCT00253929|AMP deaminase|amp deaminase
1637556|NCT00253903|Primary Insomnia|primary insomnia
1637557|NCT00253903|Sleeplessness|sleeplessness
1637558|NCT00253903|Early Awakening|early awakening
1637559|NCT00253903|Chronic Insomnia|chronic insomnia
1637560|NCT00253890|sleep quality|sleep quality
1637561|NCT00253890|methadone|methadone
1637562|NCT00253890|substance use|substance use
1637563|NCT00253877|osteoarthritis|osteoarthritis
1637565|NCT00253864|shoulder surgery|shoulder surgery
1637566|NCT00253864|prospective database|prospective database
1637567|NCT00253864|long term outcome|long term outcome
1637568|NCT00253851|DVT|dvt
1637569|NCT00253851|Osteoarthritis|osteoarthritis
1637570|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
1637571|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
1637572|NCT00253838|bone mineral density|bone mineral density
1637573|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
1637574|NCT00253786|diabetes|diabetes
1637575|NCT00253786|nephropathy|nephropathy
1637576|NCT00253773|sulfer amino acids|sulfer amino acids
1637577|NCT00253773|redox status|redox status
1637578|NCT00253760|redox|redox
1637579|NCT00253760|sulfur amino acids|sulfur amino acids
1637580|NCT00253760|glutathione|glutathione
1637581|NCT00253760|aging|aging
1637582|NCT00253734|Influenza|influenza
1637872|NCT00253227|dementia|dementia
1637583|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1637584|NCT00253721|adult brain stem glioma|adult brain stem glioma
1637585|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
1637586|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1637587|NCT00253721|adult medulloblastoma|adult medulloblastoma
1637588|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1637589|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1637590|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
1637591|NCT00253721|adult pineoblastoma|adult pineoblastoma
1637592|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
1637593|NCT00253721|adult mixed glioma|adult mixed glioma
1637594|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
1637595|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1637596|NCT00253708|depression|depression
1637597|NCT00253708|nausea and vomiting|nausea and vomiting
1637598|NCT00253708|pain|pain
1637599|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1637600|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1637601|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1637602|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1637603|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1637604|NCT00253708|stage III gastric cancer|stage iii gastric cancer
1637605|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
1637606|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1637607|NCT00253708|stage III colon cancer|stage iii colon cancer
1637608|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
1637609|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
1637610|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
1637611|NCT00253708|stage IV breast cancer|stage iv breast cancer
1637612|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1637613|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
1637614|NCT00253708|stage IV melanoma|stage iv melanoma
1637615|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1637616|NCT00253708|ovarian sarcoma|ovarian sarcoma
1637617|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
1637618|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
1637922|NCT00253123|mixed dementia|mixed dementia
1637619|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1637620|NCT00253708|recurrent colon cancer|recurrent colon cancer
1637621|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
1637622|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
1637623|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1637624|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
1637625|NCT00253708|recurrent breast cancer|recurrent breast cancer
1637626|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1637627|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1637628|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
1637629|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
1637630|NCT00253708|recurrent melanoma|recurrent melanoma
1637631|NCT00253669|thromboembolism|thromboembolism
1637632|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1637633|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1637634|NCT00253669|adult glioblastoma|adult glioblastoma
1637635|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
1637636|NCT00253669|adult gliosarcoma|adult gliosarcoma
1637637|NCT00253643|prostate cancer|prostate cancer
1637638|NCT00253643|precancerous condition|precancerous condition
1637639|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1637640|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1637641|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1637642|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1637643|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1637644|NCT00253552|graft versus host disease|graft versus host disease
1637645|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1637646|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1637647|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1637648|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1637649|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1637650|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1637651|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1637652|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1637653|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1637654|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1637655|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1637656|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1637657|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1637658|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1637659|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1637660|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1637661|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1637662|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1637663|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1637664|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1637665|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1637666|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1637667|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1637668|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1637669|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1637670|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1637671|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1637672|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1637673|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1637674|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1637675|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1637676|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1637677|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1637678|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1637679|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1637680|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1637681|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1637682|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1637923|NCT00253123|risperidone|risperidone
1637683|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1637684|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1637685|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1637686|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1637687|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1637688|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1637689|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1637690|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1637691|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1637692|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1637693|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1637694|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1637695|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1637696|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1637697|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1637698|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1637699|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1637700|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1637701|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1637702|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1637703|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1637704|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1637705|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1637706|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
1637707|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
1637708|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1637709|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1637710|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1637711|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1637712|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
1637713|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
1637714|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1637715|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1637716|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1637979|NCT00252928|Ghana|ghana
1637717|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1637718|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1637719|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1637720|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1637721|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1637722|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1637723|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1637724|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1637725|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1637726|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1637727|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
1637728|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1637729|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1637730|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1637731|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1637732|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1637733|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1637734|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1637735|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1637736|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1637737|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1637738|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1637739|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1637740|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1637741|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1637742|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1637743|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1637744|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
1637745|NCT00253539|breast cancer|breast cancer
1637746|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1637747|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1637748|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1637749|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1637750|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1637751|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1637752|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1637753|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1637754|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
1637755|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1637756|NCT00253500|stage II breast cancer|stage ii breast cancer
1637757|NCT00253500|stage I breast cancer|stage i breast cancer
1637758|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
1637759|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
1637760|NCT00253487|adult glioblastoma|adult glioblastoma
1637761|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1637762|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1637763|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
1637764|NCT00253487|adult gliosarcoma|adult gliosarcoma
1637765|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
1637766|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1637767|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1637768|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1637769|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1637770|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
1637771|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1637772|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1637773|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1637774|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
1637775|NCT00253448|adult glioblastoma|adult glioblastoma
1637776|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
1637777|NCT00253448|adult gliosarcoma|adult gliosarcoma
1637778|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
1637779|NCT00253422|recurrent breast cancer|recurrent breast cancer
1637780|NCT00253422|stage IV breast cancer|stage iv breast cancer
1637781|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
1637782|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
1637783|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
1637784|NCT00253396|warfarin|warfarin
1637785|NCT00253396|clinical trial|clinical trial
1637786|NCT00253396|pain measurement|pain measurement
1637787|NCT00253396|heparin|heparin
1637788|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
1637789|NCT00253396|Anticoagulants|anticoagulants
1637790|NCT00253383|transitional care planning|transitional care planning
1637791|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1637792|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1637793|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1637794|NCT00253383|stage IV breast cancer|stage iv breast cancer
1637795|NCT00253383|recurrent breast cancer|recurrent breast cancer
1637796|NCT00253383|male breast cancer|male breast cancer
1637797|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
1637798|NCT00253383|stage IV anal cancer|stage iv anal cancer
1637799|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
1637800|NCT00253383|stage III colon cancer|stage iii colon cancer
1637801|NCT00253383|stage IV colon cancer|stage iv colon cancer
1637802|NCT00253383|stage III rectal cancer|stage iii rectal cancer
1637803|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
1637804|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
1637805|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
1637806|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1637807|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
1637808|NCT00253383|stage III gastric cancer|stage iii gastric cancer
1637809|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
1637810|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1637811|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1637812|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1637813|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
1637814|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1637815|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
1637816|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
1637817|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
1637818|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1637819|NCT00253383|small intestine lymphoma|small intestine lymphoma
1637820|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
1637821|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
1637822|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1637823|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
1637824|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1637825|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1637826|NCT00253383|anterior urethral cancer|anterior urethral cancer
1637827|NCT00253383|posterior urethral cancer|posterior urethral cancer
1637828|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1637829|NCT00253383|stage IV penile cancer|stage iv penile cancer
1637830|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
1637831|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1637832|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1637833|NCT00253383|fallopian tube cancer|fallopian tube cancer
1637834|NCT00253383|ovarian sarcoma|ovarian sarcoma
1637835|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
1637836|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
1637837|NCT00253370|Sorafenib|sorafenib
1637838|NCT00253370|Docetaxel|docetaxel
1637839|NCT00253370|Cisplatin|cisplatin
1637840|NCT00253370|gastric cancer|gastric cancer
1637841|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
1637842|NCT00253357|Heart Failure|heart failure
1637843|NCT00253357|Congestive Heart Failure|congestive heart failure
1637844|NCT00253357|Fluid overload|fluid overload
1637845|NCT00253357|Left sided heart failure|left sided heart failure
1637846|NCT00253357|Pacemaker|pacemaker
1637847|NCT00253357|Defibrillator|defibrillator
1637848|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1637849|NCT00253331|Raynaud's|raynaud's
1637850|NCT00253331|sclerderma|sclerderma
1637851|NCT00253331|systemic sclerosis|systemic sclerosis
1637852|NCT00253331|autoimmune disease|autoimmune disease
1637853|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
1637854|NCT00253318|Breast Cancer|breast cancer
1637855|NCT00253318|Docetaxel|docetaxel
1637856|NCT00253318|RAD001|rad001
1637857|NCT00253318|Taxotere|taxotere
1637858|NCT00253305|tinea unguium|tinea unguium
1637859|NCT00253305|onychomycosis|onychomycosis
1637860|NCT00253292|Burns|burns
1637861|NCT00253292|Trauma|trauma
1637862|NCT00253292|Outcomes|outcomes
1637863|NCT00253292|Quality of Life|quality of life
1637864|NCT00253279|Protein Synthesis Rate|protein synthesis rate
1637865|NCT00253279|Burn Injury|burn injury
1637866|NCT00253279|PET Scan|pet scan
1637867|NCT00253266|Treatment resistant depression|treatment resistant depression
1637868|NCT00253266|Augmentation|augmentation
1637869|NCT00253266|Pharmacogenetics|pharmacogenetics
1637870|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
1637871|NCT00253227|Alzheimer's disease|alzheimer's disease
1637873|NCT00253227|brain disease|brain disease
1637874|NCT00253227|memory loss|memory loss
1637875|NCT00253227|galantamine|galantamine
1637876|NCT00253227|placebo|placebo
1637877|NCT00253214|Alzheimer's disease|alzheimer's disease
1637878|NCT00253214|dementia|dementia
1637879|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
1637880|NCT00253214|controlled-release|controlled-release
1637881|NCT00253214|once-daily dosing|once-daily dosing
1637882|NCT00253201|Alzheimer's disease|alzheimer's disease
1637883|NCT00253201|dementia|dementia
1637884|NCT00253201|brain disease|brain disease
1637885|NCT00253201|memory loss|memory loss
1637886|NCT00253201|galantamine|galantamine
1637887|NCT00253201|placebo|placebo
1637888|NCT00253201|caregiver|caregiver
1637889|NCT00253201|quality of life|quality of life
1637890|NCT00253201|resource utilization|resource utilization
1637891|NCT00253188|Alzheimer's disease|alzheimer's disease
1637892|NCT00253188|dementia|dementia
1637893|NCT00253188|brain disease|brain disease
1637894|NCT00253188|memory loss|memory loss
1637895|NCT00253188|galantamine|galantamine
1637896|NCT00253188|placebo|placebo
1637897|NCT00253188|caregiver|caregiver
1637898|NCT00253188|quality of life|quality of life
1637899|NCT00253188|resource utilization|resource utilization
1637900|NCT00253175|topiramate|topiramate
1637901|NCT00253175|migraine headache|migraine headache
1637902|NCT00253175|migraine prevention|migraine prevention
1637903|NCT00253175|migraine|migraine
1637904|NCT00253162|risperidone|risperidone
1637905|NCT00253162|antipsychotic agents|antipsychotic agents
1637906|NCT00253162|bipolar disorders|bipolar disorders
1637907|NCT00253162|manic episode|manic episode
1637908|NCT00253149|risperidone|risperidone
1637909|NCT00253149|antipsychotic agents|antipsychotic agents
1637910|NCT00253149|bipolar disorders|bipolar disorders
1637911|NCT00253149|manic episode|manic episode
1637912|NCT00253136|schizophrenia|schizophrenia
1637913|NCT00253136|schizoaffective disorder|schizoaffective disorder
1637914|NCT00253136|psychotic disorder|psychotic disorder
1637915|NCT00253136|risperidone|risperidone
1637916|NCT00253136|long-acting injectable|long-acting injectable
1637917|NCT00253136|intramuscular injection|intramuscular injection
1637918|NCT00253136|antipsychotic agents|antipsychotic agents
1637919|NCT00253123|Dementia|dementia
1637920|NCT00253123|Alzheimer's disease|alzheimer's disease
1637921|NCT00253123|vascular dementia|vascular dementia
1637924|NCT00253123|nursing home|nursing home
1637925|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
1637926|NCT00253110|Haloperidol|haloperidol
1637927|NCT00253110|Risperidone|risperidone
1637928|NCT00253110|Schizoaffective disorder|schizoaffective disorder
1637929|NCT00253097|stroke recurrence|stroke recurrence
1637930|NCT00253097|risk factors|risk factors
1637931|NCT00253097|health behavior|health behavior
1637932|NCT00253097|intervention|intervention
1637933|NCT00253097|tertiary prevention|tertiary prevention
1637934|NCT00253071|Prophylactic treatment|prophylactic treatment
1637935|NCT00253071|Pharmacological treatment|pharmacological treatment
1637936|NCT00253071|Psychological treatment|psychological treatment
1637937|NCT00253058|Allergic|allergic
1637938|NCT00253058|pediatric|pediatric
1637939|NCT00253058|Rhinitis|rhinitis
1637940|NCT00253058|Perennial|perennial
1637941|NCT00253045|Motivational Interviewing|motivational interviewing
1637942|NCT00253045|antiretroviral therapy|antiretroviral therapy
1637943|NCT00253045|medication adherence|medication adherence
1637944|NCT00253045|risk reduction behaviors|risk reduction behaviors
1637945|NCT00253045|women|women
1637946|NCT00253045|HIV|hiv
1637947|NCT00253045|AIDS|aids
1637948|NCT00253019|birth control|birth control
1637949|NCT00253019|continuation|continuation
1637950|NCT00253019|abortion|abortion
1637951|NCT00253019|contraception|contraception
1637952|NCT00253006|NO|no
1637953|NCT00253006|mRNA-expression|mrna-expression
1637954|NCT00253006|pathophysiology|pathophysiology
1637955|NCT00253006|painful bladder syndrome|painful bladder syndrome
1637956|NCT00252993|Nausea|nausea
1637957|NCT00252993|Vomiting|vomiting
1637958|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
1637959|NCT00252993|Functional Vomiting|functional vomiting
1637960|NCT00252993|Cyclic Vomiting|cyclic vomiting
1637961|NCT00252980|Cannabis|cannabis
1637962|NCT00252980|Dependence|dependence
1637963|NCT00252980|Marijuana|marijuana
1637964|NCT00252980|Substance Abuse Treatment|substance abuse treatment
1637965|NCT00252980|Psychotherapy,|psychotherapy,
1637966|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
1637967|NCT00252967|Atrial Fibrillation|atrial fibrillation
1637968|NCT00252967|Oxidative Stress|oxidative stress
1637969|NCT00252967|Inflammation|inflammation
1637970|NCT00252954|Spinal cord injury|spinal cord injury
1637971|NCT00252954|Neuropathic pain|neuropathic pain
1637972|NCT00252954|Spasms|spasms
1637973|NCT00252941|prostate cancer|prostate cancer
1637974|NCT00252941|brachytherapy|brachytherapy
1637975|NCT00252941|urethral stenting|urethral stenting
1637976|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
1637977|NCT00252928|water purification|water purification
1637978|NCT00252928|disinfection|disinfection
1637980|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
1637981|NCT00252889|Metastatic cancer|metastatic cancer
1637982|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
1637983|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
1637984|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
1637985|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
1637986|NCT00252850|Parkinson's Disease|parkinson's disease
1637987|NCT00252850|Gene Transfer|gene transfer
1637988|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
1637989|NCT00252785|Asthma|asthma
1637990|NCT00252746|NSCLC|nsclc
1637991|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
1637992|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1637993|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
1637994|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
1637995|NCT00252681|randomized|randomized
1637996|NCT00252681|controlled|controlled
1637997|NCT00252681|trial|trial
1637998|NCT00252681|necrotizing|necrotizing
1637999|NCT00252681|enterocolitis|enterocolitis
1638000|NCT00252681|premature|premature
1638001|NCT00252681|infants|infants
1638002|NCT00252681|laparotomy|laparotomy
1638003|NCT00252681|peritoneal|peritoneal
1638004|NCT00252681|drainage|drainage
1638005|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
1638006|NCT00252642|Hepatitis C|hepatitis c
1638007|NCT00252642|Interferon|interferon
1638008|NCT00252642|Cirrhosis|cirrhosis
1638009|NCT00252642|Liver Disease|liver disease
1638010|NCT00252642|Portal Hypertension|portal hypertension
1638011|NCT00252642|Portal Pressure|portal pressure
1638012|NCT00252629|Fatigue|fatigue
1638013|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
1638014|NCT00252629|Gulf War Syndrome|gulf war syndrome
1638015|NCT00252629|Sleep apnea|sleep apnea
1638016|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
1638017|NCT00252616|Mechanical ventilation|mechanical ventilation
1638018|NCT00252616|acute respiratory failure|acute respiratory failure
1638019|NCT00252616|early nutrition|early nutrition
1638020|NCT00252603|Autism|autism
1638021|NCT00252603|Childhood Autism|childhood autism
1638022|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
1638023|NCT00252577|Lithium|lithium
1638024|NCT00252577|Pharmacogenetics|pharmacogenetics
1638025|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
1638026|NCT00252538|Cortisol|cortisol
1638027|NCT00252538|Depression|depression
1638028|NCT00252538|Hepatitis C|hepatitis c
1638029|NCT00252538|Interferon|interferon
1638030|NCT00252538|Polymorphism|polymorphism
1638031|NCT00252538|Serotonin|serotonin
1638032|NCT00252538|Tryptophan|tryptophan
1638033|NCT00252512|Contingency management interventions|contingency management interventions
1638034|NCT00252512|Substance use disorders treatment|substance use disorders treatment
1638035|NCT00252512|Treatment effectiveness|treatment effectiveness
1638036|NCT00252512|Randomized clinical trial|randomized clinical trial
1638037|NCT00252512|Behavioral research|behavioral research
1638038|NCT00252499|beta cell function|beta cell function
1638039|NCT00252499|fenofibrate|fenofibrate
1638040|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1638041|NCT00252499|rosiglitazone|rosiglitazone
1638042|NCT00252499|insulin sensitivity|insulin sensitivity
1638043|NCT00252486|Bipolar|bipolar
1638044|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
1638045|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
1638046|NCT00252434|methamphetamine use|methamphetamine use
1638047|NCT00252434|drug craving|drug craving
1638048|NCT00252434|addiction behaviors|addiction behaviors
1638049|NCT00252421|osteoporosis|osteoporosis
1638050|NCT00252421|bone mineral density|bone mineral density
1638051|NCT00252421|nitrates|nitrates
1638052|NCT00252408|Fracture|fracture
1638053|NCT00252408|Osteoporosis|osteoporosis
1638054|NCT00252408|Bone mineral density|bone mineral density
1638055|NCT00252408|Hormone replacement therapy|hormone replacement therapy
1638056|NCT00252408|Estrogen|estrogen
1638057|NCT00252408|Breast cancer|breast cancer
1638058|NCT00252395|medication error|medication error
1638059|NCT00252395|electronic prescribing|electronic prescribing
1638060|NCT00252395|patient safety|patient safety
1638061|NCT00252382|Lung|lung
1638062|NCT00252382|Squamous Cell|squamous cell
1638063|NCT00252382|Large Cell|large cell
1638064|NCT00252382|Adenocarcinoma|adenocarcinoma
1638065|NCT00252382|Carcinoma|carcinoma
1638066|NCT00252382|Cancer|cancer
1638067|NCT00252356|major depressive disorder|major depressive disorder
1638068|NCT00252356|depression|depression
1638069|NCT00252356|major depressive episode|major depressive episode
1638070|NCT00252356|antidepressive agents|antidepressive agents
1638071|NCT00252343|anxiety disorder|anxiety disorder
1638072|NCT00252330|major depressive disorder|major depressive disorder
1638073|NCT00252330|depression|depression
1638074|NCT00252330|major depressive episode|major depressive episode
1638075|NCT00252330|antidepressive agents|antidepressive agents
1638076|NCT00252317|Aortic stenosis|aortic stenosis
1638077|NCT00252317|ACE-inhibitores|ace-inhibitores
1638078|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
1638079|NCT00252291|bronchial|bronchial
1638080|NCT00252291|hyperresponsiveness|hyperresponsiveness
1638081|NCT00252239|stroke|stroke
1638082|NCT00252239|tenecteplase|tenecteplase
1638084|NCT00252239|ischemic|ischemic
1638085|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
1638086|NCT00252239|tPA|tpa
1638087|NCT00252226|Quetiapine|quetiapine
1638088|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
1638089|NCT00252187|Heart failure|heart failure
1638090|NCT00252187|Natriuretic peptides|natriuretic peptides
1638091|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
1638092|NCT00252187|Kidney|kidney
1638093|NCT00252187|Nesiritide|nesiritide
1638094|NCT00252187|Natrecor|natrecor
1638095|NCT00252187|CHF|chf
1638096|NCT00252174|MDMA|mdma
1638097|NCT00252174|cancer|cancer
1638098|NCT00252174|anxiety|anxiety
1638099|NCT00252174|psychotherapy|psychotherapy
1638100|NCT00252174|quality of life|quality of life
1638101|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
1638102|NCT00252161|Stomach Neoplasms|stomach neoplasms
1638103|NCT00252161|Cisplatin|cisplatin
1638104|NCT00252161|S-1(combination)|s-1(combination)
1638105|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
1638106|NCT00252135|Moderate to severe asthma|moderate to severe asthma
1638107|NCT00252109|HIV|hiv
1638108|NCT00252109|Seropositive|seropositive
1638109|NCT00252109|MSM|msm
1638110|NCT00252109|African American|african american
1638111|NCT00252109|Popular Opinion Leader|popular opinion leader
1638112|NCT00252096|Diagnosis|diagnosis
1638113|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
1638114|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
1638115|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
1638116|NCT00252096|Rectum|rectum
1638117|NCT00252096|Pharynx|pharynx
1638118|NCT00252083|Seropositive|seropositive
1638119|NCT00252083|MSM|msm
1638120|NCT00252083|Hispanic|hispanic
1638121|NCT00252083|Popular Opinion Leader|popular opinion leader
1638122|NCT00252083|HIV|hiv
1638123|NCT00252070|arthritis|arthritis
1638124|NCT00252070|exercise|exercise
1638125|NCT00252070|function|function
1638127|NCT00252057|rehospitalization|rehospitalization
1638128|NCT00252057|readmission|readmission
1638129|NCT00252057|adverse events|adverse events
1638130|NCT00252057|discharge|discharge
1638131|NCT00252031|Borderline Personality Disorder|borderline personality disorder
1638132|NCT00252031|BPD|bpd
1638133|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
1638134|NCT00252031|DBT|dbt
1638135|NCT00252018|Nutritional supplement|nutritional supplement
1638136|NCT00252018|Prevention|prevention
1638137|NCT00252018|Endothelial function|endothelial function
1638138|NCT00252018|Flow mediated dilation|flow mediated dilation
1638139|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
1638140|NCT00251966|erosive oesophagitis|erosive oesophagitis
1638141|NCT00251966|upper GI symptoms|upper gi symptoms
1638142|NCT00251927|Acid reflux disease|acid reflux disease
1638143|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1638144|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
1638145|NCT00251901|GERD|gerd
1638146|NCT00251888|cervix cancer|cervix cancer
1638147|NCT00251888|advanced cervix cancer|advanced cervix cancer
1638148|NCT00251888|radiochemotherapy|radiochemotherapy
1638149|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
1638150|NCT00251888|campto|campto
1638151|NCT00251888|cisplatin|cisplatin
1638152|NCT00251888|irinotecan|irinotecan
1638153|NCT00251888|cisplatyl|cisplatyl
1638154|NCT00251888|maximum dose search|maximum dose search
1638155|NCT00251875|patient portals|patient portals
1638156|NCT00251875|electronic health records|electronic health records
1638157|NCT00251875|family history|family history
1639443|NCT00247078|antivenom|antivenom
1638158|NCT00251875|health maintenance|health maintenance
1638159|NCT00251875|medications|medications
1638160|NCT00251875|diabetes|diabetes
1638161|NCT00251862|Colorectal cancer screening|colorectal cancer screening
1638162|NCT00251862|Shared decision-making|shared decision-making
1638163|NCT00251862|Decision aid|decision aid
1638164|NCT00251849|Intermittent Claudication|intermittent claudication
1638165|NCT00251836|Kidney donation|kidney donation
1638166|NCT00251836|Organ Donation|organ donation
1638167|NCT00251836|Vascular anatomy|vascular anatomy
1638168|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
1638169|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
1638170|NCT00251810|general anaesthesia|general anaesthesia
1638171|NCT00251810|depth of hypnosis|depth of hypnosis
1638172|NCT00251810|Cerebral State Monitor|cerebral state monitor
1638173|NCT00251810|CSM|csm
1638174|NCT00251810|Bispectral Index|bispectral index
1638175|NCT00251810|BIS|bis
1638176|NCT00251797|Phase I|phase i
1638177|NCT00251797|Brain cancer|brain cancer
1638178|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
1638179|NCT00251771|Thrombolytic therapy|thrombolytic therapy
1638180|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
1638181|NCT00251771|Venous thrombosis|venous thrombosis
1638182|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
1638183|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
1638184|NCT00251745|Heartburn|heartburn
1638185|NCT00251732|acid reflux studies|acid reflux studies
1638186|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
1638187|NCT00251732|failing PPI therapy|failing ppi therapy
1638188|NCT00251732|GERD|gerd
1638189|NCT00251732|Acid Reflux Disease|acid reflux disease
1638190|NCT00251719|Erosive Esophagitis|erosive esophagitis
1638191|NCT00251706|atrial fibrillation|atrial fibrillation
1638192|NCT00251706|atrial flutter|atrial flutter
1638193|NCT00251706|amiodarone|amiodarone
1638194|NCT00251706|post-operative|post-operative
1638195|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
1638196|NCT00251706|valve replacement or repair|valve replacement or repair
1638197|NCT00251693|Erosive Esophagitis|erosive esophagitis
1638198|NCT00251680|Hyperlipidemia|hyperlipidemia
1638199|NCT00251680|Drug Therapy|drug therapy
1638200|NCT00251654|complications|complications
1638201|NCT00251654|adverse events|adverse events
1638202|NCT00251654|regional anesthesia|regional anesthesia
1638203|NCT00251654|adverse effects|adverse effects
1638204|NCT00251628|Tonsils|tonsils
1638205|NCT00251628|Tonsillectomy|tonsillectomy
1638206|NCT00251615|vascular surgery|vascular surgery
1638207|NCT00251615|vascular aging|vascular aging
1638208|NCT00251615|arterial aging|arterial aging
1638209|NCT00251615|surgical tissue|surgical tissue
1638210|NCT00251615|Aging|aging
1638211|NCT00251602|heart rate variability|heart rate variability
1638212|NCT00251602|gene response|gene response
1638213|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
1638214|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
1638215|NCT00251563|Cancer,Risk factors|cancer,risk factors
1638216|NCT00251537|Pilot study|pilot study
1638217|NCT00251537|Randomized|randomized
1638218|NCT00251537|Placebo-controlled|placebo-controlled
1638219|NCT00251537|Double-blind|double-blind
1638220|NCT00251537|Effect on viral load|effect on viral load
1638221|NCT00251537|LTB4|ltb4
1638222|NCT00251537|HIV-1 infection|hiv-1 infection
1638223|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
1638224|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
1638225|NCT00251459|SAILOR|sailor
1638226|NCT00251459|CNV|cnv
1638227|NCT00251459|AMD|amd
1638228|NCT00251459|CNV secondary to AMD|cnv secondary to amd
1638229|NCT00251433|ErbB1|erbb1
1638230|NCT00251433|ErbB2|erbb2
1638231|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
1638232|NCT00251433|lapatinib|lapatinib
1638233|NCT00251433|Stage IV breast cancer|stage iv breast cancer
1638234|NCT00251433|metastatic breast cancer|metastatic breast cancer
1638235|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
1638236|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
1638237|NCT00251420|copd|copd
1638238|NCT00251420|asthma|asthma
1638239|NCT00251420|QoL|qol
1638240|NCT00251420|Perceived health status|perceived health status
1638241|NCT00251420|Trait anxiety|trait anxiety
1638242|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
1638243|NCT00251407|cisplatin|cisplatin
1638244|NCT00251407|CPT-11|cpt-11
1638245|NCT00251407|taxotere|taxotere
1638246|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
1638247|NCT00251394|Rituxan|rituxan
1638248|NCT00251394|Rituximab|rituximab
1638249|NCT00251394|1018 ISS|1018 iss
1638250|NCT00251394|CD 20 +|cd 20 +
1638251|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
1638252|NCT00251381|Cetuximab|cetuximab
1638253|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
1638254|NCT00251368|leukemia|leukemia
1638255|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
1638256|NCT00251368|AML|aml
1638257|NCT00251368|ALL|all
1638258|NCT00251368|refractory leukemia|refractory leukemia
1638259|NCT00251368|relapsed leukemia|relapsed leukemia
1638260|NCT00251355|gemcitabine|gemcitabine
1638261|NCT00251355|5-fluorouracil|5-fluorouracil
1638262|NCT00251355|5-FU|5-fu
1638263|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
1638264|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
1638265|NCT00251342|Postnatal depression|postnatal depression
1638266|NCT00251342|Randomized controlled trial|randomized controlled trial
1638267|NCT00251342|Screening|screening
1638268|NCT00251342|Outcome|outcome
1638269|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
1638270|NCT00251329|Neoadjuvant|neoadjuvant
1638271|NCT00251329|Breast Cancer|breast cancer
1638272|NCT00251329|pCR|pcr
1638273|NCT00251329|Capecitabine|capecitabine
1638274|NCT00251329|Carboplatin|carboplatin
1638275|NCT00251329|Docetaxel|docetaxel
1638276|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
1638277|NCT00251316|I-131|i-131
1638278|NCT00251316|Radiation Dose|radiation dose
1638279|NCT00251316|Radiation Effect|radiation effect
1638280|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
1638281|NCT00251316|Thyroid Cancer|thyroid cancer
1638282|NCT00251303|Clinical Trial|clinical trial
1638283|NCT00251303|Glutamate Antagonist|glutamate antagonist
1638284|NCT00251303|Pediatrics|pediatrics
1638285|NCT00251303|Basal Ganglia|basal ganglia
1638286|NCT00251303|Neuropsychological|neuropsychological
1638287|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
1638288|NCT00251303|OCD|ocd
1638289|NCT00251303|Riluzole|riluzole
1638290|NCT00251303|Rilutek|rilutek
1638291|NCT00251290|transient ischemic attack|transient ischemic attack
1638292|NCT00251290|sleep apnea|sleep apnea
1638293|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
1638294|NCT00251277|TTP|ttp
1638295|NCT00251277|Hematology|hematology
1638296|NCT00251264|Shoulder instability|shoulder instability
1638297|NCT00251264|Traumatic|traumatic
1638298|NCT00251264|Anterior|anterior
1638299|NCT00251264|Unidirectional|unidirectional
1638300|NCT00251264|Open stabilization|open stabilization
1638301|NCT00251264|Arthroscopic|arthroscopic
1638302|NCT00251264|Bankart repair|bankart repair
1638303|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
1638304|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
1638305|NCT00251264|Bankart|bankart
1638306|NCT00251251|Congestive heart failure|congestive heart failure
1638307|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
1638308|NCT00251251|Defibrillator|defibrillator
1638309|NCT00251251|Cardiac resynchronization|cardiac resynchronization
1638310|NCT00251251|Sudden death/mortality|sudden death/mortality
1638311|NCT00251251|Hospitalization|hospitalization
1638312|NCT00251251|ICD indication|icd indication
1638313|NCT00251251|NYHA Class II|nyha class ii
1638314|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
1638315|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
1638316|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
1638317|NCT00251238|Vasospastic attacks|vasospastic attacks
1638318|NCT00251238|Ginkgo biloba|ginkgo biloba
1638319|NCT00251225|prostate|prostate
1638320|NCT00251212|Alcohol|alcohol
1638321|NCT00251212|Violence|violence
1638322|NCT00251212|Alcohol consumption|alcohol consumption
1638323|NCT00251212|Alcohol, drinking|alcohol, drinking
1638324|NCT00251160|Multi-directional instability|multi-directional instability
1638325|NCT00251160|MDI|mdi
1638326|NCT00251160|Ligamentous laxity|ligamentous laxity
1638327|NCT00251160|Multi-directional laxity|multi-directional laxity
1638328|NCT00251160|MDL-AII|mdl-aii
1638329|NCT00251160|Shoulder instability|shoulder instability
1638330|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
1638331|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
1638332|NCT00251160|capsular redundancy|capsular redundancy
1638333|NCT00251147|rotator cuff|rotator cuff
1638334|NCT00251147|open|open
1638335|NCT00251147|arthroscopic|arthroscopic
1638336|NCT00251147|mini-open|mini-open
1638337|NCT00251147|acromioplasty|acromioplasty
1638338|NCT00251147|quality of life|quality of life
1638339|NCT00251147|shoulder|shoulder
1638340|NCT00251134|myocardial infarction|myocardial infarction
1638341|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
1638342|NCT00251121|Electrophysiological study|electrophysiological study
1638343|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
1638344|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
1638345|NCT00251108|'head injury'|'head injury'
1638346|NCT00251108|'brain injuries'|'brain injuries'
1638347|NCT00251108|'exercise therapy'|'exercise therapy'
1638348|NCT00251108|'physical fitness'|'physical fitness'
1638349|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
1638350|NCT00251082|hormone replacement|hormone replacement
1638351|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
1638352|NCT00251082|bleeding pattern|bleeding pattern
1638353|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
1638354|NCT00251043|Pregnancy|pregnancy
1638355|NCT00251043|Antepartum Depression|antepartum depression
1638356|NCT00251043|Major Depression|major depression
1638357|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
1638358|NCT00251017|personalized medicines|personalized medicines
1638359|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
1638360|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
1638361|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
1638362|NCT00251004|Renal transplant rejection|renal transplant rejection
1638363|NCT00250991|stroke|stroke
1638364|NCT00250991|integrilin|integrilin
1638365|NCT00250991|eptifibatide|eptifibatide
1638366|NCT00250991|activase|activase
1638367|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1638368|NCT00250991|rt-PA|rt-pa
1638369|NCT00250991|recombinant t-PA|recombinant t-pa
1638370|NCT00250991|SPOTRIAS|spotrias
1638371|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
1638372|NCT00250952|Clinical Practice Variations|clinical practice variations
1638373|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
1638374|NCT00250939|GSD-II|gsd-ii
1638375|NCT00250939|Pompe Disease|pompe disease
1638376|NCT00250926|bortezomib|bortezomib
1638377|NCT00250926|dexamethasone|dexamethasone
1638378|NCT00250926|rituximab|rituximab
1638379|NCT00250913|motor activity|motor activity
1638380|NCT00250913|determinants|determinants
1638381|NCT00250913|psychology|psychology
1638382|NCT00250913|health care costs|health care costs
1638383|NCT00250913|quality of life|quality of life
1638384|NCT00250913|Angioplasty|angioplasty
1638385|NCT00250900|Otitis|otitis
1638386|NCT00250900|Antibiotic|antibiotic
1638387|NCT00250900|Prescription|prescription
1638388|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
1638389|NCT00250848|Lung Diseases|lung diseases
1638390|NCT00250848|Cancer|cancer
1638391|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
1638392|NCT00250835|Radiation|radiation
1638393|NCT00250835|Neoadjuvant|neoadjuvant
1638394|NCT00250835|Rectum|rectum
1638395|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
1638396|NCT00250835|Cancer|cancer
1638397|NCT00250822|Liver|liver
1638398|NCT00250822|hepatocellular|hepatocellular
1638399|NCT00250822|Gem-Ox|gem-ox
1638400|NCT00250822|Cancer|cancer
1638401|NCT00250796|Phase II|phase ii
1638402|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
1638403|NCT00250783|Corpus Uteri|corpus uteri
1638404|NCT00250783|Endometrium|endometrium
1638405|NCT00250783|Cancer|cancer
1638406|NCT00250770|Corpus Uteri|corpus uteri
1638407|NCT00250770|Endometrium|endometrium
1638408|NCT00250770|Cancer|cancer
1638409|NCT00250757|prostate|prostate
1638410|NCT00250757|NMR Spectroscopy|nmr spectroscopy
1638411|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
1638412|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
1638413|NCT00250744|Pilot Trial|pilot trial
1638414|NCT00250731|diabetes|diabetes
1638415|NCT00250731|relationship|relationship
1638416|NCT00250731|social support|social support
1638417|NCT00250731|behavior change|behavior change
1638418|NCT00250731|telemedicine|telemedicine
1638419|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1638420|NCT00250718|Phase II|phase ii
1638421|NCT00250718|Lymphoid malignancies|lymphoid malignancies
1638422|NCT00250705|Aripiprazole|aripiprazole
1638423|NCT00250679|COPD|copd
1638424|NCT00250679|chronic bronchitis|chronic bronchitis
1638425|NCT00250679|emphysema|emphysema
1638426|NCT00250666|Biological Markers|biological markers
1638427|NCT00250666|Procalcitonin|procalcitonin
1638428|NCT00250666|Critical Care|critical care
1638429|NCT00250666|Diagnosis, Differential|diagnosis, differential
1638430|NCT00250666|Prospective Study|prospective study
1638431|NCT00250666|Sepsis|sepsis
1638432|NCT00250666|Antibiotic stewardship|antibiotic stewardship
1638433|NCT00250666|Antimicrobial resistance|antimicrobial resistance
1638434|NCT00250653|depression|depression
1638435|NCT00250653|antidepressive agents|antidepressive agents
1638436|NCT00250653|clinical trial|clinical trial
1638437|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
1638438|NCT00250627|depression|depression
1638439|NCT00250627|antidepressive agents|antidepressive agents
1638440|NCT00250627|controlled clinical trial|controlled clinical trial
1638441|NCT00250614|depression|depression
1638442|NCT00250614|antidepressive agents|antidepressive agents
1638443|NCT00250614|controlled clinical trial|controlled clinical trial
1638444|NCT00250601|depression|depression
1638445|NCT00250601|antidepressive agents|antidepressive agents
1638446|NCT00250601|controlled clinical trial|controlled clinical trial
1638447|NCT00250588|Asthma|asthma
1638448|NCT00250588|Child|child
1638449|NCT00250588|Problem-solving|problem-solving
1638450|NCT00250588|Quality of Life|quality of life
1638451|NCT00250588|Barriers to Care|barriers to care
1638452|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
1638453|NCT00250562|Hypertension|hypertension
1638454|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
1638455|NCT00250562|fixed combination|fixed combination
1638456|NCT00250562|diuretics|diuretics
1638457|NCT00250549|HIV|hiv
1638458|NCT00250549|Prevention|prevention
1638459|NCT00250549|Rapid HIV testing|rapid hiv testing
1638460|NCT00250523|trauma|trauma
1638461|NCT00250523|critical illness|critical illness
1638462|NCT00250523|injury|injury
1638463|NCT00250510|Obesity treatment|obesity treatment
1638464|NCT00250510|Insurance reimbursement|insurance reimbursement
1638465|NCT00250510|Health care utilization|health care utilization
1638466|NCT00250510|Health care costs|health care costs
1638467|NCT00250497|Adolescent|adolescent
1638468|NCT00250497|Girls|girls
1638469|NCT00250497|Physical Activity|physical activity
1638470|NCT00250497|Exercise|exercise
1638471|NCT00250497|Diet|diet
1638472|NCT00250497|Body image|body image
1638473|NCT00250484|analgesia|analgesia
1638474|NCT00250484|electric stimulation therapy|electric stimulation therapy
1638475|NCT00250484|electric stimulation|electric stimulation
1638476|NCT00250484|pain|pain
1638477|NCT00250484|safety|safety
1638478|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
1638479|NCT00250471|eptifibatide|eptifibatide
1638480|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
1638481|NCT00250445|Arcoxia|arcoxia
1638482|NCT00250406|urolithiasis|urolithiasis
1638483|NCT00250406|ureteral stent|ureteral stent
1638484|NCT00250406|triclosan|triclosan
1638485|NCT00250406|drug eluting|drug eluting
1638486|NCT00250393|Parkinson's disease|parkinson's disease
1638487|NCT00250393|monotherapy|monotherapy
1638488|NCT00250380|Aspirin|aspirin
1638489|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1638490|NCT00250367|risperidone|risperidone
1638491|NCT00250367|antipsychotic agents|antipsychotic agents
1638492|NCT00250367|bipolar disorders|bipolar disorders
1638493|NCT00250367|manic episode|manic episode
1638494|NCT00250354|conduct disorder|conduct disorder
1638495|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
1638496|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
1638497|NCT00250354|ADHD|adhd
1638498|NCT00250354|risperidone|risperidone
1638499|NCT00250354|antipsychotropic agents|antipsychotropic agents
1638500|NCT00250354|children|children
1638501|NCT00250289|malodor|malodor
1638502|NCT00250289|halitosis|halitosis
1638503|NCT00250289|herbal formulation|herbal formulation
1638504|NCT00250289|natural medicinals|natural medicinals
1638505|NCT00250289|slow release delivery system|slow release delivery system
1638506|NCT00250263|rhinitis|rhinitis
1638507|NCT00250263|asthma|asthma
1638508|NCT00250263|atopy|atopy
1638509|NCT00250263|house dust mite|house dust mite
1638510|NCT00250263|immunotherapy|immunotherapy
1638511|NCT00250263|SLIT|slit
1638512|NCT00250237|Post-operative delirium|post-operative delirium
1638513|NCT00250237|hip fracture|hip fracture
1638514|NCT00250224|Radiotherapy|radiotherapy
1638515|NCT00250224|image guided|image guided
1638516|NCT00250224|marker|marker
1638517|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
1638518|NCT00250211|radiation therapy|radiation therapy
1638519|NCT00250211|temozolomide|temozolomide
1638520|NCT00250211|functional imaging|functional imaging
1638521|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
1638522|NCT00250198|T Cell|t cell
1638523|NCT00250198|Lymphocyte|lymphocyte
1638524|NCT00250198|Lamina Propria|lamina propria
1638525|NCT00250198|Colonoscopy|colonoscopy
1638527|NCT00250198|Crohn's Disease|crohn's disease
1638528|NCT00250198|Crohns Disease|crohns disease
1638529|NCT00250185|Ischemia Tolerance|ischemia tolerance
1638530|NCT00250185|Endothelial Function|endothelial function
1638531|NCT00250185|Forearm Blood Flow|forearm blood flow
1638532|NCT00250185|Muscle Recovery|muscle recovery
1638533|NCT00250185|Inflammation|inflammation
1638534|NCT00250185|Healthy Volunteer|healthy volunteer
1638535|NCT00250185|HV|hv
1638536|NCT00250172|Dosimetry|dosimetry
1638537|NCT00250172|Pharmacokinetics|pharmacokinetics
1638538|NCT00250172|Compartment Analysis|compartment analysis
1638539|NCT00250172|Reproducibility|reproducibility
1638540|NCT00250172|Healthy Volunteer|healthy volunteer
1638541|NCT00250172|HV|hv
1638542|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
1638543|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
1638544|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
1638545|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1638546|NCT00250159|CAH|cah
1638547|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
1638548|NCT00250159|FMPP|fmpp
1638549|NCT00250146|Celiac Disease|celiac disease
1638550|NCT00250146|Gluten|gluten
1638551|NCT00250146|Toxicity|toxicity
1638552|NCT00250146|Small bowel morphometry|small bowel morphometry
1638553|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
1638554|NCT00250120|NSCLC|nsclc
1638555|NCT00250120|L9NC|l9nc
1638556|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
1638558|NCT00250094|Ovarian Cancer|ovarian cancer
1638559|NCT00250094|Ovary|ovary
1638560|NCT00250094|Cancer|cancer
1638561|NCT00250081|Cerebral Palsy|cerebral palsy
1638562|NCT00250081|Tendon Transfer|tendon transfer
1638563|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
1638564|NCT00250081|Occupational Therapy|occupational therapy
1638565|NCT00250081|Child|child
1638566|NCT00250068|Phase II|phase ii
1638567|NCT00250068|Aerosol Delivery|aerosol delivery
1638568|NCT00250068|NSCLC|nsclc
1638569|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
1638570|NCT00250055|NIH|nih
1638571|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
1638572|NCT00250055|Los Alamos/NIH|los alamos/nih
1638573|NCT00250029|Colorectal Cancer|colorectal cancer
1638574|NCT00250029|Pilot Study|pilot study
1638575|NCT00250029|Oxaliplatin|oxaliplatin
1638576|NCT00250016|Endometrium|endometrium
1638577|NCT00250016|Tissue|tissue
1638578|NCT00250016|L9NC|l9nc
1638579|NCT00250003|Elderly|elderly
1638580|NCT00250003|Preventive home visits|preventive home visits
1638581|NCT00249990|Uterus|uterus
1638582|NCT00249990|Recurrent disease|recurrent disease
1638583|NCT00249990|Treatment|treatment
1638584|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
1638585|NCT00249990|Endometrium|endometrium
1638586|NCT00249977|Phase I|phase i
1638587|NCT00249977|solid tumors|solid tumors
1638588|NCT00249977|DNA repair|dna repair
1638589|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
1638590|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
1638591|NCT00249951|nephrocalcinosis|nephrocalcinosis
1638592|NCT00249951|premature infants|premature infants
1638593|NCT00249951|hypocitraturia|hypocitraturia
1638594|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
1638595|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
1638596|NCT00249938|Antilipemic agents|antilipemic agents
1638597|NCT00249938|hyperlipidemia|hyperlipidemia
1638598|NCT00249925|Home modification|home modification
1638599|NCT00249925|Occupational Therapy|occupational therapy
1638600|NCT00249925|Physical Therapy|physical therapy
1638601|NCT00249925|Home care|home care
1638602|NCT00249912|Hyperlipidemia|hyperlipidemia
1638603|NCT00249912|Drug Therapy|drug therapy
1638604|NCT00249899|Hyperlipidemia|hyperlipidemia
1638605|NCT00249899|Drug Therapy|drug therapy
1638606|NCT00249873|Atrial fibrillation|atrial fibrillation
1638607|NCT00249873|Anticoagulant therapy|anticoagulant therapy
1638608|NCT00249873|Thromboembolic prevention|thromboembolic prevention
1638609|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
1638610|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
1638611|NCT00249834|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
1638612|NCT00249834|Infertility|infertility
1638613|NCT00249834|Ovarian stimulation|ovarian stimulation
1638614|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
1638615|NCT00249795|Atrial fibrillation|atrial fibrillation
1638616|NCT00249795|Cardiovascular disease|cardiovascular disease
1638617|NCT00249795|angiotensin II blocker|angiotensin ii blocker
1638618|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
1638619|NCT00249769|Japanese Encephalitis|japanese encephalitis
1638620|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
1638621|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
1638622|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
1638623|NCT00249756|Criminal Justice|criminal justice
1638624|NCT00249743|fall prevention|fall prevention
1638625|NCT00249743|fall risk management|fall risk management
1638626|NCT00249743|RCT|rct
1638627|NCT00249743|cost|cost
1638628|NCT00249717|Contingency management|contingency management
1638629|NCT00249717|Substance abuse treatment|substance abuse treatment
1638630|NCT00249691|cocaine addiction|cocaine addiction
1638631|NCT00249691|cocaine dependence|cocaine dependence
1638632|NCT00249678|Behavior Therapy|behavior therapy
1638633|NCT00249678|methamphetamine|methamphetamine
1638634|NCT00249652|End stage liver disease|end stage liver disease
1638635|NCT00249652|End stage renal disease|end stage renal disease
1638636|NCT00249652|Substance-Related Disorders|substance-related disorders
1638637|NCT00249639|Contingency Management|contingency management
1638638|NCT00249639|Substance Abuse Treatment|substance abuse treatment
1638639|NCT00249626|Contingency management|contingency management
1638640|NCT00249626|substance abuse treatment|substance abuse treatment
1638641|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
1638642|NCT00249600|contingency management|contingency management
1638643|NCT00249600|substance abuse|substance abuse
1638644|NCT00249574|heroin addiction|heroin addiction
1638645|NCT00249548|contingency management|contingency management
1638646|NCT00249548|substance abuse|substance abuse
1638647|NCT00249535|Substance Abuse|substance abuse
1638648|NCT00249535|Contingency Management|contingency management
1638649|NCT00249522|contingency management|contingency management
1641204|NCT00239239|Oncology|oncology
1638650|NCT00249522|substance abuse treatment|substance abuse treatment
1638651|NCT00249509|marijuana dependence|marijuana dependence
1638652|NCT00249496|cocaine|cocaine
1638653|NCT00249496|opioids|opioids
1638654|NCT00249496|contingency management|contingency management
1638655|NCT00249496|sexual risk|sexual risk
1638657|NCT00249483|Cocaine Addiction|cocaine addiction
1638658|NCT00249483|Cocaine Dependence|cocaine dependence
1638659|NCT00249470|HIV|hiv
1638660|NCT00249470|HIV risk behaviors|hiv risk behaviors
1638661|NCT00249470|Heroin|heroin
1638662|NCT00249470|Cocaine|cocaine
1638663|NCT00249470|Methadone|methadone
1638664|NCT00249470|Opioid Dependence|opioid dependence
1638665|NCT00249470|Cocaine Abuse|cocaine abuse
1638666|NCT00249470|Contingency management|contingency management
1638667|NCT00249470|alcohol & drug use|alcohol & drug use
1638668|NCT00249470|sexual risk behaviors|sexual risk behaviors
1638669|NCT00249457|Behavior Therapy|behavior therapy
1638670|NCT00249457|Cocaine Abuse|cocaine abuse
1638671|NCT00249457|Cocaine Dependence|cocaine dependence
1638672|NCT00249457|Contingency Management|contingency management
1638673|NCT00249457|Heroin Dependence|heroin dependence
1638674|NCT00249457|Methadone|methadone
1639075|NCT00248391|wheezing|wheezing
1638675|NCT00249457|Opioid Dependence|opioid dependence
1638676|NCT00249444|cocaine dependence|cocaine dependence
1638677|NCT00249444|mirtazipine|mirtazipine
1638678|NCT00249431|Gambling|gambling
1638679|NCT00249431|Alcohol|alcohol
1638680|NCT00249418|Contingency Management|contingency management
1638681|NCT00249418|Substance Abuse Treatment|substance abuse treatment
1638682|NCT00249405|Clinical trial|clinical trial
1638683|NCT00249405|Alcoholism|alcoholism
1638684|NCT00249405|Alcohol|alcohol
1638685|NCT00249405|Pharmacogenetics|pharmacogenetics
1638686|NCT00249405|Citalopram|citalopram
1638687|NCT00249405|Genotype|genotype
1638688|NCT00249405|Therapy compliance|therapy compliance
1638689|NCT00249405|Serotonin inhibitor|serotonin inhibitor
1638690|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
1638691|NCT00249392|ocular diseases|ocular diseases
1638692|NCT00249392|risk factors|risk factors
1638693|NCT00249392|genetic factors|genetic factors
1638694|NCT00249379|Alcohol dependence|alcohol dependence
1638695|NCT00249379|Acamprosate(drug)|acamprosate(drug)
1638696|NCT00249379|Drug Court|drug court
1638697|NCT00249379|Probation|probation
1638698|NCT00249379|Parole|parole
1638699|NCT00249379|Criminal justice|criminal justice
1638700|NCT00249366|Alcohol withdrawal|alcohol withdrawal
1638701|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
1638702|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
1638703|NCT00249366|CIWA-Ar|ciwa-ar
1638704|NCT00249366|Lorazepam (drug)|lorazepam (drug)
1638705|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1638706|NCT00249353|ADHD|adhd
1638707|NCT00249353|Concerta|concerta
1638708|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
1638709|NCT00249340|brief behavioral treatment|brief behavioral treatment
1638710|NCT00249340|commercial weight loss programs|commercial weight loss programs
1638711|NCT00249340|Weight Watchers|weight watchers
1638712|NCT00249327|HIV testing|hiv testing
1638713|NCT00249327|HIV disclosure|hiv disclosure
1638714|NCT00249327|HIV Seronegativity|hiv seronegativity
1638715|NCT00249314|South Asians|south asians
1638716|NCT00249314|European Caucasians|european caucasians
1638717|NCT00249314|ethnic differences|ethnic differences
1638718|NCT00249314|body composition|body composition
1638719|NCT00249314|body fat distribution|body fat distribution
1638720|NCT00249314|adipose tissue|adipose tissue
1638721|NCT00249314|visceral fat|visceral fat
1638722|NCT00249314|myocellular lipids|myocellular lipids
1638723|NCT00249314|skeletal muscle|skeletal muscle
1638724|NCT00249301|Breast Cancer|breast cancer
1638725|NCT00249301|Colon Cancer|colon cancer
1638726|NCT00249301|Pancreatic Cancer|pancreatic cancer
1638727|NCT00249301|Bladder Cancer|bladder cancer
1638728|NCT00249288|Schizophrenia|schizophrenia
1638729|NCT00249288|Negative Symptoms|negative symptoms
1638730|NCT00249288|Folate|folate
1638731|NCT00249275|significant refractive errors|significant refractive errors
1638732|NCT00249275|children|children
1638733|NCT00249275|spectacles|spectacles
1638734|NCT00249275|Africa|africa
1638735|NCT00249249|hypercholesterolemia|hypercholesterolemia
1638736|NCT00249249|dyslipidemia|dyslipidemia
1638737|NCT00249249|kowa|kowa
1638738|NCT00249249|KRE|kre
1638739|NCT00249249|pitavastatin|pitavastatin
1638740|NCT00249249|NK-104|nk-104
1638741|NCT00249236|risperidone|risperidone
1638742|NCT00249236|antipsychotic agents|antipsychotic agents
1638743|NCT00249236|bipolar disorders|bipolar disorders
1638744|NCT00249236|manic episode|manic episode
1638745|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
1638746|NCT00249210|Sinusitis|sinusitis
1638747|NCT00249210|respiratory tract diseases|respiratory tract diseases
1638748|NCT00249210|nose diseases|nose diseases
1638749|NCT00249210|respiratory tract infections|respiratory tract infections
1641516|NCT00237822|MEMS Caps|mems caps
1638750|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
1638751|NCT00249210|antibacterial agents|antibacterial agents
1638752|NCT00249210|quinolones|quinolones
1638753|NCT00249210|levofloxacin|levofloxacin
1638754|NCT00249197|skin infection|skin infection
1638755|NCT00249197|bacterial infection|bacterial infection
1638756|NCT00249197|levofloxacin|levofloxacin
1638757|NCT00249197|quinolones|quinolones
1638759|NCT00249197|infection|infection
1638760|NCT00249171|acute schizophrenia|acute schizophrenia
1638761|NCT00249171|psychosis|psychosis
1638762|NCT00249171|risperidone|risperidone
1638763|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
1638764|NCT00249171|emergency treatment|emergency treatment
1638765|NCT00249158|Dementia|dementia
1638766|NCT00249158|Alzheimer's Disease|alzheimer's disease
1638767|NCT00249158|vascular dementia|vascular dementia
1638768|NCT00249158|mixed dementia|mixed dementia
1638769|NCT00249158|risperidone|risperidone
1638770|NCT00249158|nursing home|nursing home
1638771|NCT00249145|Dementia|dementia
1638772|NCT00249145|Alzheimer's Disease|alzheimer's disease
1638773|NCT00249145|vascular dementia|vascular dementia
1639076|NCT00248391|otitis|otitis
1638774|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
1638775|NCT00249145|nursing home|nursing home
1638776|NCT00249132|chronic schizophrenia|chronic schizophrenia
1638777|NCT00249132|psychotic disorder|psychotic disorder
1638778|NCT00249132|risperidone|risperidone
1638779|NCT00249132|antipsychotic agents|antipsychotic agents
1638780|NCT00249119|chronic schizophrenia|chronic schizophrenia
1638781|NCT00249119|psychotic disorders|psychotic disorders
1638782|NCT00249119|risperidone|risperidone
1638783|NCT00249119|antipsychotic agents|antipsychotic agents
1638784|NCT00249080|3T MRI|3t mri
1638785|NCT00249080|neurodegenerative disease|neurodegenerative disease
1638786|NCT00249080|Alzheimer's disease|alzheimer's disease
1638787|NCT00249080|spectroscopy|spectroscopy
1638788|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
1638789|NCT00249080|Not pregnant|not pregnant
1638790|NCT00249080|MR compatible|mr compatible
1638791|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
1638792|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
1638793|NCT00249015|aerobic exercise|aerobic exercise
1638794|NCT00249015|resistance exercise|resistance exercise
1638795|NCT00249015|physical fitness|physical fitness
1638796|NCT00249015|body composition|body composition
1638797|NCT00249015|quality of life|quality of life
1638798|NCT00249015|rehabilitation|rehabilitation
1638799|NCT00249015|psychosocial oncology|psychosocial oncology
1638800|NCT00249015|adherence|adherence
1638801|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
1638802|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
1638803|NCT00249002|Hemodialysis|hemodialysis
1638804|NCT00248989|Skin aging|skin aging
1638805|NCT00248989|Menopausal symptoms|menopausal symptoms
1638806|NCT00248976|Angioplasty|angioplasty
1638807|NCT00248976|Motivating behavior change|motivating behavior change
1638808|NCT00248976|Reducing risk factors|reducing risk factors
1638809|NCT00248976|Enhancing quality of life|enhancing quality of life
1638810|NCT00248976|Improving treatment outcomes|improving treatment outcomes
1638811|NCT00248963|Oral Contraceptive|oral contraceptive
1638812|NCT00248950|Angioplasty|angioplasty
1638813|NCT00248950|Behavior Change|behavior change
1638814|NCT00248937|African-American|african-american
1638815|NCT00248937|Hypertension|hypertension
1638816|NCT00248937|Medication adherence|medication adherence
1638817|NCT00248937|Risk reduction|risk reduction
1638818|NCT00248924|Social service intervention|social service intervention
1638819|NCT00248924|Social support|social support
1638820|NCT00248924|Elderly|elderly
1638821|NCT00248924|Homebound|homebound
1638822|NCT00248924|Quality of life|quality of life
1638823|NCT00248911|Breast cancer|breast cancer
1638824|NCT00248911|Gynecologic cancers|gynecologic cancers
1638825|NCT00248911|Meditation|meditation
1638826|NCT00248911|Stress-reduction|stress-reduction
1638827|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
1638828|NCT00248898|nonagenarians|nonagenarians
1638829|NCT00248898|quality of life|quality of life
1638830|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
1638831|NCT00248898|long term survival|long term survival
1638832|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1638833|NCT00248885|Perioperative complications|perioperative complications
1638834|NCT00248885|Neurocognitive function|neurocognitive function
1638835|NCT00248885|Quality of life|quality of life
1638836|NCT00248885|Blood pressure|blood pressure
1638837|NCT00248872|African-American|african-american
1638838|NCT00248872|Hypertension|hypertension
1638839|NCT00248872|Medication adherence|medication adherence
1638840|NCT00248872|Risk reduction|risk reduction
1638841|NCT00248859|Coronary artery disease|coronary artery disease
1638842|NCT00248859|Depressive symptoms|depressive symptoms
1638843|NCT00248859|Latino American|latino american
1638844|NCT00248846|Angioplasty patients|angioplasty patients
1638845|NCT00248846|Behavior change|behavior change
1638846|NCT00248846|Physical activity|physical activity
1638847|NCT00248846|Risk reduction|risk reduction
1638848|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
1638849|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
1638850|NCT00248820|Ovarian tumor|ovarian tumor
1638851|NCT00248820|vascularization|vascularization
1638852|NCT00248807|Blood Pressure, Low|blood pressure, low
1638853|NCT00248807|Hypotension, Postural|hypotension, postural
1638854|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
1638855|NCT00248807|Spinal Cord Transection|spinal cord transection
1638856|NCT00248807|Spinal Cord Trauma|spinal cord trauma
1638857|NCT00248794|Cognitive Impairment|cognitive impairment
1638858|NCT00248794|Rehabilitation|rehabilitation
1638859|NCT00248781|Activities of daily living|activities of daily living
1638860|NCT00248781|Aging|aging
1638861|NCT00248781|Exercise|exercise
1638862|NCT00248781|Weight lifting|weight lifting
1638863|NCT00248768|Depression|depression
1638864|NCT00248768|Parkinson Disease|parkinson disease
1638865|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1638866|NCT00248755|cystic fibrosis|cystic fibrosis
1638867|NCT00248755|mucociliary clearance|mucociliary clearance
1638868|NCT00248755|nuclear medicine|nuclear medicine
1638869|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
1638870|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
1638871|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
1638872|NCT00248690|Intracranial hypertension|intracranial hypertension
1638873|NCT00248690|Intracranial pressure|intracranial pressure
1638874|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
1638875|NCT00248690|Compliance|compliance
1638876|NCT00248690|Treatment outcome|treatment outcome
1638877|NCT00248690|Intensive care, surgical|intensive care, surgical
1638878|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
1638879|NCT00248664|Case-Control Studies|case-control studies
1638880|NCT00248664|Risk Factors|risk factors
1638881|NCT00248651|Bloating|bloating
1638882|NCT00248651|Early Fullness|early fullness
1638883|NCT00248651|Nausea|nausea
1638884|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
1638885|NCT00248651|dyspepsia|dyspepsia
1638886|NCT00248651|stomach pain|stomach pain
1638887|NCT00248651|stomach discomfort|stomach discomfort
1638888|NCT00248625|acute liver failure|acute liver failure
1638889|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
1638890|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
1638891|NCT00248625|N-acetylcysteine|n-acetylcysteine
1638892|NCT00248612|Venlafaxine|venlafaxine
1638893|NCT00248612|Alcoholism|alcoholism
1638894|NCT00248612|Anxiety Disorders|anxiety disorders
1638895|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
1638896|NCT00248612|Alcohol Abuse|alcohol abuse
1638897|NCT00248612|Alcohol Dependence|alcohol dependence
1638898|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
1638899|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1638900|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1638901|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1638902|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1638903|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1638904|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1638962|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1638905|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1638906|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1638907|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1638908|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1638909|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1638910|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1638911|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1638912|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1638913|NCT00248547|nausea and vomiting|nausea and vomiting
1638914|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1638915|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1638916|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1638917|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1638918|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1638919|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1638920|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1638921|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1641517|NCT00237796|Behavioral|behavioral
1638922|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1638923|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1638924|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1638925|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1638926|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1638927|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1638928|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1638929|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1638930|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
1638931|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1638932|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1638933|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1638934|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1638935|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1638936|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1638937|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1638938|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1638939|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1638940|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1638941|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1638942|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1638943|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1638944|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1638945|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1638946|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1638947|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1638948|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1638949|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1638950|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1638951|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1638952|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1638953|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1638954|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1638955|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1638956|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1638957|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1638958|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1638959|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1638960|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1638961|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1638963|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1638964|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
1638965|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1638966|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1638967|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1638968|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1638969|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1638970|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
1638971|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
1638972|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1638973|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1638974|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1638975|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1638976|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
1638977|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
1638978|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1638979|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1638980|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1638981|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1638982|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1638983|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1639153|NCT00248066|Coronary artery disease|coronary artery disease
1638984|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1638985|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1638986|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1638987|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1638988|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1638989|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1638990|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1638991|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1638992|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
1638993|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1638994|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1638995|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1638996|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
1638997|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
1638998|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
1638999|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1639000|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1639001|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1639002|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1639003|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1639004|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1639005|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1639006|NCT00248547|stage IV breast cancer|stage iv breast cancer
1639007|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1639008|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1639009|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1639010|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1639011|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1639012|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1639013|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1639014|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1639015|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1639016|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1639017|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1639018|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1639019|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1639020|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1639021|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1639022|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1639023|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
1639024|NCT00248469|Community randomised trial|community randomised trial
1639025|NCT00248469|Sexual behavior|sexual behavior
1639026|NCT00248469|Intervention|intervention
1639027|NCT00248469|Evaluation|evaluation
1639028|NCT00248469|Sexual health education|sexual health education
1639029|NCT00248469|Youth-friendly health services|youth-friendly health services
1639030|NCT00248469|Adolescents|adolescents
1639031|NCT00248469|Behavior change|behavior change
1639032|NCT00248469|HIV Seronegativity|hiv seronegativity
1639034|NCT00248443|Haematology and cancer patients|haematology and cancer patients
1639035|NCT00248443|Acute respiratory failure|acute respiratory failure
1639036|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
1639037|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
1639038|NCT00248443|Mechanical ventilation|mechanical ventilation
1639039|NCT00248443|Intensive Care|intensive care
1639040|NCT00248430|graft versus host disease|graft versus host disease
1639041|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
1639042|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
1639043|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
1639044|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1639045|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1639046|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1639047|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1639048|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1639049|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1639050|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1639051|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1639052|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1639053|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1639054|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1639055|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1639056|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1639057|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1639058|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1639059|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1639060|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1639061|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1639062|NCT00248404|colorectal cancer|colorectal cancer
1639063|NCT00248404|ovarian cancer|ovarian cancer
1639064|NCT00248404|lung cancer|lung cancer
1639065|NCT00248404|breast cancer|breast cancer
1639066|NCT00248404|small bowel cancer|small bowel cancer
1639067|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
1639068|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
1639069|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
1639070|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
1639071|NCT00248391|feeding position|feeding position
1639073|NCT00248391|upright|upright
1639074|NCT00248391|pneumonia|pneumonia
1639077|NCT00248391|adenoid|adenoid
1639078|NCT00248391|tonsil|tonsil
1639079|NCT00248391|caries|caries
1639080|NCT00248378|Multiple Sclerosis|multiple sclerosis
1639081|NCT00248378|Cannabis|cannabis
1639082|NCT00248378|Spasticity|spasticity
1639083|NCT00248378|Tolerability|tolerability
1639084|NCT00248365|Chronic GvHD|chronic gvhd
1639085|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
1639086|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
1639087|NCT00248352|Coronary Artery Disease|coronary artery disease
1639088|NCT00248352|Diabetes Mellitus|diabetes mellitus
1639089|NCT00248352|Type 2|type 2
1639090|NCT00248352|Chronic Disease|chronic disease
1639091|NCT00248339|Hepatitis C|hepatitis c
1639092|NCT00248339|Peginterferon|peginterferon
1639093|NCT00248339|Ribavirin|ribavirin
1639094|NCT00248339|Procrit|procrit
1639095|NCT00248339|Epoetin-alpha|epoetin-alpha
1639096|NCT00248326|atrial fibrillation|atrial fibrillation
1639097|NCT00248326|genetics|genetics
1639098|NCT00248326|genetic polymorphisms|genetic polymorphisms
1639099|NCT00248313|Kidney Disease|kidney disease
1639100|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
1639101|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
1639102|NCT00248274|atrial fibrillation|atrial fibrillation
1639103|NCT00248274|genetics|genetics
1639104|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
1639105|NCT00248248|Consolidation|consolidation
1639106|NCT00248248|Ovarian cancer|ovarian cancer
1639107|NCT00248248|DOXIL|doxil
1639108|NCT00248248|Hand-foot syndrome|hand-foot syndrome
1639109|NCT00248235|exercise|exercise
1639110|NCT00248235|rehabilitation|rehabilitation
1639111|NCT00248235|head and neck neoplasms|head and neck neoplasms
1639112|NCT00248222|Exercise|exercise
1639113|NCT00248222|Rehabilitation|rehabilitation
1639114|NCT00248222|Aerobic training|aerobic training
1639115|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
1639116|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
1639117|NCT00248170|Breast cancer|breast cancer
1639118|NCT00248170|letrozole|letrozole
1639119|NCT00248170|anastrozole|anastrozole
1639120|NCT00248170|adjuvant|adjuvant
1639121|NCT00248170|postmenopausal|postmenopausal
1639122|NCT00248170|FACE|face
1639123|NCT00248157|Diabetic retinopathy|diabetic retinopathy
1639124|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
1639125|NCT00248144|Herpes labialis|herpes labialis
1639126|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
1639127|NCT00248118|Randomized|randomized
1639128|NCT00248118|Double-blind|double-blind
1639129|NCT00248118|Placebo-controlled|placebo-controlled
1639130|NCT00248105|Arthritis|arthritis
1639131|NCT00248105|Physical Activity|physical activity
1639132|NCT00248092|d-Amphetamine|d-amphetamine
1639133|NCT00248092|Diethylpropion|diethylpropion
1639134|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
1639135|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1639136|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1639137|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
1639138|NCT00248092|Amphetamine Abuse|amphetamine abuse
1639139|NCT00248092|Amphetamine Dependence|amphetamine dependence
1639140|NCT00248092|Amphetamine Addiction|amphetamine addiction
1639141|NCT00248092|Amphetamine Users|amphetamine users
1639142|NCT00248092|Drug Abuse|drug abuse
1639143|NCT00248092|Drug Addiction|drug addiction
1639144|NCT00248092|Drug Dependence|drug dependence
1639145|NCT00248092|Drug Habituation|drug habituation
1639146|NCT00248092|Drug Use Disorders|drug use disorders
1639147|NCT00248092|Substance Abuse|substance abuse
1639148|NCT00248092|Substance Dependence|substance dependence
1639149|NCT00248092|Substance Use Disorders|substance use disorders
1639150|NCT00248092|Drug Usage|drug usage
1639151|NCT00248092|Substance Addiction|substance addiction
1639152|NCT00248079|Coronary Disease|coronary disease
1639155|NCT00248066|Coronary stent restenosis|coronary stent restenosis
1639156|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
1639157|NCT00248040|Kidney transplantation|kidney transplantation
1639158|NCT00248040|Reperfusion Injury|reperfusion injury
1639159|NCT00248040|Survival|survival
1639160|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
1639161|NCT00248014|CLASS II|class ii
1639162|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
1639163|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
1639164|NCT00247988|Ovarian|ovarian
1639165|NCT00247988|Relapsed|relapsed
1639166|NCT00247975|L-carnitine|l-carnitine
1639167|NCT00247975|Breast cancer|breast cancer
1639168|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
1639169|NCT00247975|Primary prevention|primary prevention
1639170|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
1639171|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
1639172|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
1639173|NCT00247949|carbon dioxide|carbon dioxide
1639174|NCT00247949|monitoring|monitoring
1639175|NCT00247949|major surgery|major surgery
1639176|NCT00247949|repeated blood gas testing|repeated blood gas testing
1639177|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
1639178|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
1639179|NCT00247923|Endometrial polyps.|endometrial polyps.
1639180|NCT00247923|Angiogenesis.|angiogenesis.
1639181|NCT00247923|Asymptomatic.|asymptomatic.
1639182|NCT00247923|Symptoms.|symptoms.
1639183|NCT00247923|Malignancy.|malignancy.
1639184|NCT00247923|Treatment efficiency.|treatment efficiency.
1639185|NCT00247923|Vaginal bleeding.|vaginal bleeding.
1639186|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
1639187|NCT00247884|Injection drug users|injection drug users
1639188|NCT00247884|pegylated interferon|pegylated interferon
1639189|NCT00247884|ribavirin,|ribavirin,
1639190|NCT00247884|HCV|hcv
1639191|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
1639192|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
1639193|NCT00247845|HIV|hiv
1639194|NCT00247845|Atazanavir|atazanavir
1639195|NCT00247845|quality of life|quality of life
1639196|NCT00247845|Treatment Experienced|treatment experienced
1639197|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
1639198|NCT00247832|Elective lobectomy|elective lobectomy
1639199|NCT00247819|Substance abuse|substance abuse
1639200|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
1639201|NCT00247793|immunonutrition|immunonutrition
1639202|NCT00247793|preoperative optimization|preoperative optimization
1639203|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
1639204|NCT00247793|high risk|high risk
1639205|NCT00247793|cardiac surgery|cardiac surgery
1639206|NCT00247793|arginine|arginine
1639207|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
1639208|NCT00247793|nucleotides|nucleotides
1639209|NCT00247793|glycine|glycine
1639210|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
1639211|NCT00247793|immune enhancing formula|immune enhancing formula
1639212|NCT00247780|Atrial fibrillation|atrial fibrillation
1639213|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
1639214|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
1639215|NCT00247754|Anxiety|anxiety
1639216|NCT00247754|Therapy|therapy
1639217|NCT00247754|Behaviour|behaviour
1639218|NCT00247741|spinal anesthesia|spinal anesthesia
1639219|NCT00247741|lidocaine|lidocaine
1639220|NCT00247741|articaine|articaine
1639221|NCT00247741|intrathecal|intrathecal
1639222|NCT00247728|PI-88|pi-88
1639223|NCT00247728|post resection hepatoma|post resection hepatoma
1639224|NCT00247728|adjuvant therapy|adjuvant therapy
1639225|NCT00247728|hepatectomy|hepatectomy
1639226|NCT00247728|hepatoma|hepatoma
1639227|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
1639228|NCT00247715|cost effectiveness|cost effectiveness
1639229|NCT00247715|acid suppressive medicine|acid suppressive medicine
1639230|NCT00247715|primary care|primary care
1639231|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
1639232|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
1639233|NCT00247702|CYP2C9|cyp2c9
1639234|NCT00247702|VKORC1|vkorc1
1639235|NCT00247702|polymorphism|polymorphism
1639236|NCT00247702|warfarin|warfarin
1639237|NCT00247689|Ritalin|ritalin
1639238|NCT00247689|Substance Abuse|substance abuse
1639239|NCT00247689|Allelic Variants|allelic variants
1639240|NCT00247689|Genotype|genotype
1639241|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
1639242|NCT00247689|Methylphenidate|methylphenidate
1641518|NCT00237796|Cognitive|cognitive
1639243|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
1639244|NCT00247663|Aromatase inhibitor|aromatase inhibitor
1639245|NCT00247663|letrozole|letrozole
1639246|NCT00247663|breast cancer|breast cancer
1639247|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
1639248|NCT00247637|Mental Health|mental health
1639249|NCT00247637|Psychosis|psychosis
1639250|NCT00247637|Genetics|genetics
1639251|NCT00247637|Heredity|heredity
1639252|NCT00247624|Depression|depression
1639253|NCT00247624|Hypnotics|hypnotics
1639254|NCT00247624|Sleep|sleep
1639255|NCT00247624|Quality of Life|quality of life
1639256|NCT00247624|Insomnia|insomnia
1639257|NCT00247624|Suicide|suicide
1639258|NCT00247611|HIV|hiv
1639259|NCT00247611|AIDS|aids
1639260|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
1639261|NCT00247585|Alcohol|alcohol
1639262|NCT00247585|Alcohol abuse|alcohol abuse
1639263|NCT00247585|Alcohol consumption|alcohol consumption
1639264|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
1639265|NCT00247585|Residual effects|residual effects
1639266|NCT00247585|Sleep Stages|sleep stages
1639267|NCT00247585|Respiratory Physiology|respiratory physiology
1639268|NCT00247572|d-Amphetamine|d-amphetamine
1639269|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1639270|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
1639271|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
1639272|NCT00247572|Amphetamine Abuse|amphetamine abuse
1639273|NCT00247572|Amphetamine Dependence|amphetamine dependence
1639274|NCT00247572|Amphetamine Addiction|amphetamine addiction
1639275|NCT00247572|Amphetamine Users|amphetamine users
1639276|NCT00247572|Drug Abuse|drug abuse
1639277|NCT00247572|Drug Addiction|drug addiction
1639278|NCT00247572|Drug Dependence|drug dependence
1639279|NCT00247572|Drug Habituation|drug habituation
1639280|NCT00247572|Drug Use Disorders|drug use disorders
1639281|NCT00247572|Substance Abuse|substance abuse
1639282|NCT00247572|Substance Dependence|substance dependence
1639283|NCT00247572|Substance Use Disorders|substance use disorders
1639284|NCT00247572|Drug Usage|drug usage
1639285|NCT00247572|Substance Addiction|substance addiction
1639286|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
1639287|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
1639288|NCT00247559|crow's feet|crow's feet
1639289|NCT00247559|cosmesis|cosmesis
1639290|NCT00247559|ageing|ageing
1639291|NCT00247546|Falls|falls
1639292|NCT00247546|Accidental falls|accidental falls
1639293|NCT00247546|Prevention|prevention
1639294|NCT00247546|Aged|aged
1639295|NCT00247546|Multifactorial trial|multifactorial trial
1639296|NCT00247533|coronary disease|coronary disease
1639297|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
1639298|NCT00247533|angiography|angiography
1639299|NCT00247533|cerebral ischemia|cerebral ischemia
1639300|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
1639301|NCT00247533|Coronary artery disease|coronary artery disease
1639302|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
1639303|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
1639304|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
1639305|NCT00247533|ischemic stroke|ischemic stroke
1639306|NCT00247533|electrocardiograph|electrocardiograph
1639307|NCT00247533|electroencephalograph|electroencephalograph
1639308|NCT00247533|Nuclear brain scan|nuclear brain scan
1639309|NCT00247533|cognition decline|cognition decline
1639310|NCT00247533|atrial fibrillation|atrial fibrillation
1639438|NCT00247091|children|children
1639311|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
1639312|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
1639313|NCT00247507|Anemia|anemia
1639314|NCT00247507|atherosclerosis|atherosclerosis
1639315|NCT00247507|End-stage renal disease|end-stage renal disease
1639316|NCT00247507|Erythropoietin|erythropoietin
1639317|NCT00247507|Hemodialysis|hemodialysis
1639318|NCT00247507|Oxidative stress|oxidative stress
1639319|NCT00247507|Pro-inflammation|pro-inflammation
1639320|NCT00247494|HIV-1|hiv-1
1639321|NCT00247494|atherosclerosis|atherosclerosis
1639322|NCT00247494|immunomodulation|immunomodulation
1639323|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
1639324|NCT00247455|Human nutrition|human nutrition
1639325|NCT00247455|Dietary fibre|dietary fibre
1639326|NCT00247455|Insulin resistance|insulin resistance
1639327|NCT00247455|Obesity|obesity
1639328|NCT00247455|Glucose|glucose
1639329|NCT00247455|Colonic fermentation|colonic fermentation
1639330|NCT00247455|Short chain fatty acids|short chain fatty acids
1639331|NCT00247455|GLP-1|glp-1
1639332|NCT00247455|Appetite|appetite
1639333|NCT00247455|Abdominal fat|abdominal fat
1639334|NCT00247442|Mammography screening|mammography screening
1639335|NCT00247442|Breast cancer screening|breast cancer screening
1639336|NCT00247442|Screening outcomes|screening outcomes
1639337|NCT00247442|Decision aid|decision aid
1641519|NCT00237796|Functioning|functioning
1639338|NCT00247442|Decision support tool|decision support tool
1639339|NCT00247442|Informed choice|informed choice
1639340|NCT00247429|depression|depression
1639341|NCT00247429|anxiety|anxiety
1639342|NCT00247429|elderly|elderly
1639343|NCT00247416|Untreated|untreated
1639344|NCT00247416|Lung|lung
1639345|NCT00247416|Cancer|cancer
1639346|NCT00247416|non-small cell|non-small cell
1639347|NCT00247416|gemcitabine|gemcitabine
1639348|NCT00247416|gemzar|gemzar
1639349|NCT00247416|carboplatin|carboplatin
1639350|NCT00247416|dexamethasone|dexamethasone
1639351|NCT00247403|Intracranial cancer|intracranial cancer
1639352|NCT00247403|Cancer|cancer
1639353|NCT00247403|2DG|2dg
1639354|NCT00247403|2-deoxyglucose|2-deoxyglucose
1639355|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
1639356|NCT00247390|Chronic Insomnia|chronic insomnia
1639357|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
1639358|NCT00247390|Drug Therapy|drug therapy
1639359|NCT00247377|Morbid Obesity|morbid obesity
1639360|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
1639361|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
1639362|NCT00247364|RLS|rls
1639363|NCT00247338|parenteral nutrition|parenteral nutrition
1639364|NCT00247338|low calorie|low calorie
1639365|NCT00247338|low nitrogen|low nitrogen
1639366|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
1639367|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
1639368|NCT00247338|gastrectomy|gastrectomy
1639369|NCT00247338|colectomy|colectomy
1639370|NCT00247338|rectectomy|rectectomy
1639371|NCT00247338|operations|operations
1639372|NCT00247325|Kidney failure|kidney failure
1639373|NCT00247325|Contrast media|contrast media
1639374|NCT00247325|Iodixanol|iodixanol
1639375|NCT00247325|Ioxaglate|ioxaglate
1639376|NCT00247312|Prostate cancer|prostate cancer
1639377|NCT00247312|brachytherapy|brachytherapy
1639378|NCT00247312|palladium 103|palladium 103
1639379|NCT00247312|I-125|i-125
1639380|NCT00247299|Vascular lesions|vascular lesions
1639381|NCT00247299|Intense pulse light|intense pulse light
1639382|NCT00247299|phototermolysis|phototermolysis
1639383|NCT00247299|wavelength|wavelength
1639384|NCT00247299|filters|filters
1639385|NCT00247299|non coherent|non coherent
1639386|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
1639387|NCT00247286|weighted vaginal cones|weighted vaginal cones
1639388|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
1639389|NCT00247286|randomized controlled trial|randomized controlled trial
1639390|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
1639391|NCT00247260|HCC|hcc
1639392|NCT00247260|Primary Liver Cancer|primary liver cancer
1639393|NCT00247221|Alcohol|alcohol
1639394|NCT00247221|Substance abuse|substance abuse
1639395|NCT00247221|Adolescent|adolescent
1639396|NCT00247221|Family functioning|family functioning
1639397|NCT00247208|Coronary artery bypass|coronary artery bypass
1639398|NCT00247208|Stents|stents
1639399|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1639400|NCT00247208|Coronary Restenosis|coronary restenosis
1639401|NCT00247208|Paclitaxel|paclitaxel
1639402|NCT00247195|Major Depression|major depression
1639403|NCT00247195|MDD|mdd
1639404|NCT00247195|Hispanic|hispanic
1639405|NCT00247195|Primary Care|primary care
1639406|NCT00247195|Cultural Congruence|cultural congruence
1639407|NCT00247182|Stepped Care|stepped care
1639408|NCT00247182|Brief Motivational Intervention|brief motivational intervention
1639409|NCT00247182|Minimal Intervention|minimal intervention
1639410|NCT00247182|Treatment response|treatment response
1639411|NCT00247182|College Students|college students
1639412|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
1639413|NCT00247169|progesterone|progesterone
1639414|NCT00247156|Autism|autism
1639415|NCT00247156|eye contact|eye contact
1639416|NCT00247156|Noncommunicable|noncommunicable
1639417|NCT00247143|Protease Inhibitor|protease inhibitor
1639418|NCT00247143|Antiretroviral Agents|antiretroviral agents
1639419|NCT00247143|Treatment Experienced|treatment experienced
1639420|NCT00247130|Omeprazole|omeprazole
1639421|NCT00247130|Ranitidine|ranitidine
1639422|NCT00247130|Endoscopic treatment|endoscopic treatment
1639423|NCT00247130|Hemostasis|hemostasis
1639424|NCT00247130|Peptic ulcer|peptic ulcer
1639425|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1639426|NCT00247117|insulin resistance|insulin resistance
1639427|NCT00247117|metformin|metformin
1639428|NCT00247104|Urinary tract infection|urinary tract infection
1639429|NCT00247104|Endometritis|endometritis
1639430|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
1639431|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
1639432|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
1639433|NCT00247104|Latent period|latent period
1639434|NCT00247104|Neonatal infection|neonatal infection
1639435|NCT00247091|HIV|hiv
1639436|NCT00247091|measles|measles
1639437|NCT00247091|measles vaccine|measles vaccine
1639439|NCT00247091|Zambia|zambia
1639440|NCT00247078|black|black
1639444|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
1639445|NCT00247052|NSAID|nsaid
1639446|NCT00247039|neutropenia|neutropenia
1639447|NCT00247039|fever|fever
1639448|NCT00247039|garlic|garlic
1639449|NCT00247039|infection|infection
1639450|NCT00247026|myelodysplasia|myelodysplasia
1639451|NCT00247026|curcumin|curcumin
1639452|NCT00247026|coenzyme Q10|coenzyme q10
1639453|NCT00247026|cytopenia|cytopenia
1639454|NCT00247013|automated telephone system|automated telephone system
1639455|NCT00247013|breast cancer|breast cancer
1639456|NCT00247013|cancer prevention|cancer prevention
1639457|NCT00247013|intervention|intervention
1639458|NCT00247013|mammography|mammography
1639459|NCT00247013|screening|screening
1639460|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
1639461|NCT00247000|Heart Disease|heart disease
1639462|NCT00247000|Heart Failure,Congestive|heart failure,congestive
1639463|NCT00247000|Health Outcomes|health outcomes
1639464|NCT00247000|Disease Management|disease management
1639465|NCT00247000|Telehomecare|telehomecare
1639466|NCT00247000|Home Telehealth|home telehealth
1639467|NCT00246974|bladder cancer|bladder cancer
1639468|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
1639469|NCT00246961|Adjuvant|adjuvant
1639470|NCT00246948|Physical therapy|physical therapy
1639471|NCT00246935|COPD|copd
1639472|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
1639473|NCT00246935|Roflumilast|roflumilast
1639474|NCT00246922|Asthma|asthma
1639475|NCT00246922|Roflumilast|roflumilast
1639476|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
1639477|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
1639478|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1639479|NCT00246909|Pantoprazole|pantoprazole
1639480|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
1639481|NCT00246883|Nitric Oxide|nitric oxide
1639482|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
1639483|NCT00246883|Physical Fitness|physical fitness
1639484|NCT00246883|C-reactive Protein|c-reactive protein
1639485|NCT00246883|Exercise|exercise
1639486|NCT00246883|Vascular Function|vascular function
1639487|NCT00246870|Seizures|seizures
1639488|NCT00246870|Development|development
1639489|NCT00246870|Pediatric|pediatric
1639490|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
1639491|NCT00246870|Neurotransmission|neurotransmission
1639492|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
1639493|NCT00246870|Deficiency|deficiency
1639494|NCT00246870|SSADH Deficiency|ssadh deficiency
1639495|NCT00246870|Healthy Volunteer|healthy volunteer
1639496|NCT00246870|HV|hv
1639497|NCT00246857|Apoptosis|apoptosis
1639498|NCT00246857|T-cell|t-cell
1639499|NCT00246857|Autoimmunity|autoimmunity
1639500|NCT00246857|Immunodeficiency|immunodeficiency
1639501|NCT00246857|B-Cell|b-cell
1639502|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
1639503|NCT00246857|Genetic Disease|genetic disease
1639504|NCT00246844|Transplant|transplant
1639505|NCT00246844|Diabetes|diabetes
1639506|NCT00246844|C-Peptide|c-peptide
1639507|NCT00246844|B Cell|b cell
1639508|NCT00246844|Immunosuppression|immunosuppression
1639509|NCT00246844|Type 1 Diabetes|type 1 diabetes
1639510|NCT00246844|Pancreas Transplant|pancreas transplant
1639511|NCT00246831|fMRI|fmri
1639512|NCT00246831|Self-Agency|self-agency
1640673|NCT00242424|safety|safety
1639513|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1639514|NCT00246831|Voluntary Movement|voluntary movement
1639515|NCT00246831|Healthy Volunteer|healthy volunteer
1639516|NCT00246831|HV|hv
1639517|NCT00246818|Mind-Body|mind-body
1639518|NCT00246818|Stress Reduction|stress reduction
1639519|NCT00246818|Complementary Medicine|complementary medicine
1639520|NCT00246818|Quality of Life|quality of life
1639521|NCT00246818|Well-being|well-being
1639522|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
1639523|NCT00246818|Tai Chi|tai chi
1639524|NCT00246818|Aerobic Exercise|aerobic exercise
1639525|NCT00246818|Cancer Survivor|cancer survivor
1639526|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
1639527|NCT00246805|VVI(R) pacing|vvi(r) pacing
1639528|NCT00246805|rate regularization|rate regularization
1639529|NCT00246792|School-based intervention|school-based intervention
1639530|NCT00246792|Learning disabilities|learning disabilities
1639531|NCT00246792|ecological intervention|ecological intervention
1639532|NCT00246779|transfusion|transfusion
1639533|NCT00246779|cardiac surgery|cardiac surgery
1639534|NCT00246779|modified ultrafiltration|modified ultrafiltration
1639535|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
1639536|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
1639537|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
1639538|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1639539|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
1639540|NCT00246753|stage I prostate cancer|stage i prostate cancer
1639541|NCT00246753|stage II prostate cancer|stage ii prostate cancer
1639542|NCT00246753|stage III prostate cancer|stage iii prostate cancer
1639543|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
1639544|NCT00246740|Doxycycline|doxycycline
1639545|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
1639546|NCT00246714|endotoxin tolerance|endotoxin tolerance
1639547|NCT00246714|humans|humans
1639548|NCT00246714|cross-tolerance|cross-tolerance
1639549|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
1639550|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
1639551|NCT00246701|simvastatin|simvastatin
1639552|NCT00246701|Lovaza|lovaza
1639553|NCT00246701|High triglycerides|high triglycerides
1639554|NCT00246662|Leukemia|leukemia
1639555|NCT00246662|Hematologic|hematologic
1639556|NCT00246662|Blood|blood
1639557|NCT00246662|Cancer|cancer
1639558|NCT00246662|Malignancy|malignancy
1639559|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
1639560|NCT00246636|Very high triglycerides|very high triglycerides
1639561|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
1639562|NCT00246636|fenofibrate|fenofibrate
1639563|NCT00246636|Lovaza|lovaza
1639564|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
1639565|NCT00246597|Anemia|anemia
1639566|NCT00246597|Breast cancer|breast cancer
1639567|NCT00246597|Hemoglobin|hemoglobin
1639568|NCT00246597|Quality of Life|quality of life
1639569|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
1639570|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
1639571|NCT00246597|Cognitive and executive function|cognitive and executive function
1639572|NCT00246584|Hypertension|hypertension
1639573|NCT00246584|angiotensin|angiotensin
1639574|NCT00246584|renin|renin
1639575|NCT00246584|aliskiren|aliskiren
1639576|NCT00246558|Tight Achilles Tendon|tight achilles tendon
1639577|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
1639578|NCT00246519|hypertension|hypertension
1639579|NCT00246519|pharmacogenetics|pharmacogenetics
1639580|NCT00246519|pharmacogenomics|pharmacogenomics
1639581|NCT00246519|beta-blocker|beta-blocker
1639582|NCT00246519|atenolol|atenolol
1639583|NCT00246519|diuretic|diuretic
1639584|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
1639585|NCT00246519|blood pressure|blood pressure
1639586|NCT00246519|metabolic adverse effects|metabolic adverse effects
1639587|NCT00246506|Infertility|infertility
1639588|NCT00246506|Fertility|fertility
1639589|NCT00246506|Reproduction|reproduction
1639590|NCT00246506|Advanced Maternal Age|advanced maternal age
1639591|NCT00246506|Reproductive Medicine|reproductive medicine
1639592|NCT00246506|Reproductive Techniques|reproductive techniques
1639593|NCT00246506|Pregnancy|pregnancy
1639594|NCT00246493|Coronary|coronary
1639595|NCT00246493|Endothelial|endothelial
1639596|NCT00246493|Vascular|vascular
1639597|NCT00246493|Atherosclerosis|atherosclerosis
1639598|NCT00246493|Arterial|arterial
1639599|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
1639600|NCT00246467|plague|plague
1639601|NCT00246454|circadian|circadian
1639602|NCT00246454|advanced sleep phase|advanced sleep phase
1639603|NCT00246454|delayed sleep phase|delayed sleep phase
1639604|NCT00246441|Pharmacotherapy|pharmacotherapy
1639605|NCT00246441|Self medication|self medication
1639606|NCT00246428|Motivational Interviewing|motivational interviewing
1639607|NCT00246428|Alcohol Abuse|alcohol abuse
1639608|NCT00246428|Alcohol Dependence|alcohol dependence
1639609|NCT00246428|Emergency Care Setting|emergency care setting
1639610|NCT00246415|Alcohol Dependence|alcohol dependence
1639611|NCT00246415|Alcohol Abuse|alcohol abuse
1639612|NCT00246415|Memantine|memantine
1639613|NCT00246415|Alcohol Treatment|alcohol treatment
1639614|NCT00246389|muscle spasm|muscle spasm
1639615|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
1639616|NCT00246363|HIV|hiv
1639617|NCT00246363|Hepatitis C|hepatitis c
1639618|NCT00246350|Headaches|headaches
1639619|NCT00246350|Spinal manipulation|spinal manipulation
1639620|NCT00246350|Massage|massage
1639621|NCT00246350|chiropractic|chiropractic
1639622|NCT00246298|Anemia|anemia
1639623|NCT00246298|erythropoetin|erythropoetin
1639624|NCT00246298|Epoetin alfa|epoetin alfa
1639625|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
1639626|NCT00246298|HIV infection|hiv infection
1639627|NCT00246298|HIV|hiv
1639628|NCT00246298|AIDS|aids
1639629|NCT00246285|schizophrenia|schizophrenia
1639630|NCT00246285|antipsychotic agents|antipsychotic agents
1639631|NCT00246285|risperidone|risperidone
1639632|NCT00246285|adolescents|adolescents
1639633|NCT00246272|risperidone|risperidone
1639634|NCT00246272|schizophrenia|schizophrenia
1639635|NCT00246272|rapidly-dissolving|rapidly-dissolving
1639636|NCT00246259|Schizophrenia|schizophrenia
1639637|NCT00246259|Schizoaffective disorder|schizoaffective disorder
1639638|NCT00246259|Schizophreniform disorder|schizophreniform disorder
1639639|NCT00246259|Risperidone|risperidone
1639640|NCT00246259|Risperdal Consta|risperdal consta
1639641|NCT00246246|risperidone|risperidone
1639642|NCT00246246|long-acting injectable|long-acting injectable
1639643|NCT00246246|bipolar disorder|bipolar disorder
1639644|NCT00246246|intramuscular injection|intramuscular injection
1639645|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
1639646|NCT00246233|oral tablets|oral tablets
1639647|NCT00246233|Major Depressive Disorder|major depressive disorder
1639648|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
1639649|NCT00246220|methylphenidate|methylphenidate
1639650|NCT00246220|central nervous system stimulants|central nervous system stimulants
1639651|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1639652|NCT00246207|once-day oral tablets|once-day oral tablets
1639653|NCT00246194|Schizophrenia|schizophrenia
1639654|NCT00246194|Mental disorder|mental disorder
1639655|NCT00246194|DSM-IV|dsm-iv
1639656|NCT00246194|RISPERDAL CONSTA|risperdal consta
1639657|NCT00246194|Risperidone|risperidone
1639658|NCT00246194|Long-acting risperidone|long-acting risperidone
1639659|NCT00246194|Disorganized|disorganized
1639660|NCT00246194|Catatonic|catatonic
1639661|NCT00246194|Paranoid|paranoid
1639662|NCT00246181|Lung cancer|lung cancer
1639663|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
1639664|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
1639665|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
1639666|NCT00246168|tramadol|tramadol
1639667|NCT00246168|acetaminophen|acetaminophen
1639668|NCT00246155|chronic|chronic
1639669|NCT00246155|muscular|muscular
1639670|NCT00246129|Kidney Transplantation|kidney transplantation
1639671|NCT00246129|Kidney Disease|kidney disease
1639672|NCT00246129|Kidney Failure|kidney failure
1639673|NCT00246129|Graft Rejection|graft rejection
1639674|NCT00246116|Lung Cancer|lung cancer
1639675|NCT00246116|Radiation Oncology|radiation oncology
1639676|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
1639677|NCT00246103|Valproic Acid|valproic acid
1639678|NCT00246103|Epirubicin|epirubicin
1639679|NCT00246103|Solid Tumor|solid tumor
1639680|NCT00246103|Malignancies|malignancies
1639681|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
1639682|NCT00246077|quality of life|quality of life
1639683|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
1639684|NCT00246064|Infliximab infusions|infliximab infusions
1639685|NCT00246064|Methotrexate|methotrexate
1639686|NCT00246064|Remicade|remicade
1639687|NCT00246051|Police|police
1639688|NCT00246051|Sleep|sleep
1639690|NCT00246051|Work Hours|work hours
1639691|NCT00246051|Sleep disorder|sleep disorder
1639692|NCT00246051|Performance|performance
1639693|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
1639694|NCT00246038|Aortic Aneurysm|aortic aneurysm
1639695|NCT00246038|AAA|aaa
1639696|NCT00246038|Endovascular|endovascular
1639697|NCT00246038|Stent Graft|stent graft
1639698|NCT00246038|Endograft|endograft
1639699|NCT00246038|Vascular Prostheses|vascular prostheses
1639700|NCT00246012|Melanoma|melanoma
1639701|NCT00246012|Neoplasm|neoplasm
1639702|NCT00246012|CNTO 95|cnto 95
1639703|NCT00246012|Dacarbazine|dacarbazine
1639704|NCT00246012|Intetumumab|intetumumab
1639705|NCT00245986|Pharmacokinetics|pharmacokinetics
1639706|NCT00245986|Cytochrome P450|cytochrome p450
1639707|NCT00245986|HIV Resistance|hiv resistance
1639708|NCT00245986|Drug Interaction|drug interaction
1639709|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
1639710|NCT00245986|HIV Positive|hiv positive
1639711|NCT00245986|Healthy Volunteer|healthy volunteer
1639712|NCT00245986|HV|hv
1639713|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
1639714|NCT00245960|Skin Disease|skin disease
1639715|NCT00245960|Joint Disease|joint disease
1639716|NCT00245947|Crohn's Disease|crohn's disease
1639717|NCT00245947|Inflammation|inflammation
1639718|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
1639719|NCT00245921|contraception|contraception
1639720|NCT00245908|Asthma|asthma
1639721|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
1639722|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
1639723|NCT00245908|Azithromycin|azithromycin
1639724|NCT00245895|Anemia,|anemia,
1639725|NCT00245895|Prostate Cancer|prostate cancer
1639726|NCT00245882|Telehealth|telehealth
1639727|NCT00245882|Veterans|veterans
1639728|NCT00245882|Glycemic control|glycemic control
1639729|NCT00245882|Active care management|active care management
1639730|NCT00245882|Care coordination|care coordination
1639731|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
1639732|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
1639733|NCT00245869|breast cancer|breast cancer
1639734|NCT00245869|chemotherapy|chemotherapy
1639735|NCT00245869|vascularization|vascularization
1639736|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
1639737|NCT00245856|DVT|dvt
1639738|NCT00245856|Fragmin|fragmin
1639739|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
1639740|NCT00245856|Thrombosis|thrombosis
1639741|NCT00245843|Premature birth|premature birth
1639742|NCT00245843|moderate preterm|moderate preterm
1641520|NCT00237796|Older|older
1639743|NCT00245843|late preterm|late preterm
1639744|NCT00245843|Joint attention|joint attention
1639745|NCT00245843|Social interaction|social interaction
1639746|NCT00245843|Child development|child development
1639747|NCT00245843|Parent|parent
1639748|NCT00245843|infant|infant
1639749|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
1639750|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
1639751|NCT00245830|Cadaver organ donor|cadaver organ donor
1639752|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
1639753|NCT00245791|Complicated Urinary Infection|complicated urinary infection
1639754|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
1639755|NCT00245765|CDP870, Cimzia|cdp870, cimzia
1639756|NCT00245752|post term pregnancy|post term pregnancy
1639757|NCT00245752|acupuncture|acupuncture
1639758|NCT00245752|induction|induction
1639759|NCT00245739|HIV infections|hiv infections
1639760|NCT00245739|HIV-1|hiv-1
1639761|NCT00245739|TMC114|tmc114
1639762|NCT00245739|Early access|early access
1640727|NCT00242164|Arrhythmia|arrhythmia
1639763|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
1639764|NCT00245739|Anti-retroviral agents|anti-retroviral agents
1639765|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
1639766|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
1639767|NCT00245661|COPD|copd
1639768|NCT00245661|respiratory|respiratory
1639769|NCT00245661|sleep quality|sleep quality
1639770|NCT00245661|temazepam|temazepam
1639771|NCT00245661|dyspnea|dyspnea
1639772|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
1639773|NCT00245635|BDD|bdd
1639774|NCT00245635|BDD treatment|bdd treatment
1639775|NCT00245635|delusionality variant|delusionality variant
1639776|NCT00245635|OCD|ocd
1639777|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
1639778|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
1639779|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
1639780|NCT00245583|Pathological Gambling|pathological gambling
1639781|NCT00245583|Compulsive Gambling|compulsive gambling
1639782|NCT00245583|Gambling|gambling
1639783|NCT00245583|topiramate|topiramate
1639784|NCT00245557|Depression|depression
1639785|NCT00245557|Geriatric|geriatric
1639786|NCT00245557|MRI|mri
1639787|NCT00245557|Sertraline|sertraline
1639788|NCT00245531|endocrine abnormalities|endocrine abnormalities
1639789|NCT00245531|cognitive performance|cognitive performance
1639790|NCT00245518|prostate cancer|prostate cancer
1639791|NCT00245518|soy|soy
1639792|NCT00245518|androgen deprivation|androgen deprivation
1639793|NCT00245518|quality of life|quality of life
1639794|NCT00245518|isoflavones|isoflavones
1639795|NCT00245492|Colonoscopy|colonoscopy
1639796|NCT00245492|Chromoscopy|chromoscopy
1639797|NCT00245492|Prevention|prevention
1639798|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
1639799|NCT00245466|Prostate Cancer|prostate cancer
1639800|NCT00245466|Androgen ablation therapy|androgen ablation therapy
1639801|NCT00245453|pneumonia|pneumonia
1639802|NCT00245453|Spneumoniae|spneumoniae
1639803|NCT00245453|bronchitis|bronchitis
1639804|NCT00245453|telithromycin|telithromycin
1639805|NCT00245453|azithromycin|azithromycin
1639806|NCT00245440|S.pneumonia|s.pneumonia
1639807|NCT00245440|sinusitis|sinusitis
1639808|NCT00245440|ams|ams
1639809|NCT00245440|azithromycin|azithromycin
1639810|NCT00245427|beta-lactam|beta-lactam
1639811|NCT00245427|macrolide|macrolide
1639812|NCT00245427|antibiotics|antibiotics
1639813|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
1639814|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
1639815|NCT00245375|inguinal hernia repair|inguinal hernia repair
1639816|NCT00245375|abdominal hernia repair|abdominal hernia repair
1639817|NCT00245375|umbilical hernia repair|umbilical hernia repair
1639818|NCT00245362|cancer vaccine|cancer vaccine
1639819|NCT00245362|pancreatic cancer|pancreatic cancer
1639820|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
1639821|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
1639822|NCT00245362|immunotherapy|immunotherapy
1639823|NCT00245349|Head and Neck cancer|head and neck cancer
1639824|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
1639826|NCT00245349|Fluorothymidine|fluorothymidine
1639827|NCT00245349|F-18|f-18
1639828|NCT00245336|hemostasis|hemostasis
1639829|NCT00245336|surgery|surgery
1639830|NCT00245336|hemostatics|hemostatics
1639831|NCT00245336|randomized controlled trial|randomized controlled trial
1639832|NCT00245336|phase 3|phase 3
1639833|NCT00245323|smoking|smoking
1639834|NCT00245310|ICG clearance|icg clearance
1639835|NCT00245310|liver cirrhosis|liver cirrhosis
1639836|NCT00245310|acute liver failure|acute liver failure
1639837|NCT00245310|prognosis|prognosis
1639838|NCT00245297|Bleeding disorder|bleeding disorder
1639839|NCT00245297|severe Haemophilia A|severe haemophilia a
1639840|NCT00245297|Prophylaxis|prophylaxis
1639841|NCT00245271|Knee|knee
1639842|NCT00245271|Musculoskeletal System|musculoskeletal system
1639843|NCT00245271|Ligament|ligament
1639844|NCT00245271|ACL reconstruction|acl reconstruction
1639845|NCT00245245|hemophilia A|hemophilia a
1639846|NCT00245245|inhibitor|inhibitor
1639847|NCT00245245|treatment|treatment
1639848|NCT00245232|PTSD|ptsd
1639849|NCT00245232|Cognitive therapy|cognitive therapy
1639850|NCT00245232|Rape|rape
1639851|NCT00245206|Antipsychotic|antipsychotic
1639852|NCT00245206|Diabetes|diabetes
1639853|NCT00245206|Hyperlipidemia|hyperlipidemia
1639854|NCT00245206|Stroke|stroke
1639855|NCT00245193|Major Depression|major depression
1639856|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1639857|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1639858|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1639859|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1639860|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1639861|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1639862|NCT00245128|polycythemia vera|polycythemia vera
1639863|NCT00245128|essential thrombocythemia|essential thrombocythemia
1639864|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1639865|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1639866|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1639867|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1639868|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1639869|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1639870|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1639871|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1639872|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1639873|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1639874|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1639875|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1639876|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1639877|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1639878|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1639879|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1639880|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1639881|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1639882|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1639883|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1639884|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1639885|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1639886|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1639887|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1639888|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1639889|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1639890|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1639891|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1639892|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1639893|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1639894|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1639895|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1639896|NCT00245050|fallopian tube cancer|fallopian tube cancer
1639897|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
1639898|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1639899|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1639900|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
1639901|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1639902|NCT00245050|stage IV breast cancer|stage iv breast cancer
1639903|NCT00245050|male breast cancer|male breast cancer
1639904|NCT00245050|recurrent breast cancer|recurrent breast cancer
1639905|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1639906|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1639907|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1639908|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1639909|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1639910|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
1639911|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1641521|NCT00237796|CBT|cbt
1639912|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1639913|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1639914|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1639915|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1639916|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1639917|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1639918|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
1639919|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
1639920|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
1639921|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
1639922|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1639923|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1639924|NCT00245037|primary myelofibrosis|primary myelofibrosis
1639925|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1641033|NCT00240461|infection|infection
1639926|NCT00245037|essential thrombocythemia|essential thrombocythemia
1639927|NCT00245037|polycythemia vera|polycythemia vera
1639928|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1639929|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
1639930|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
1639931|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1639932|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1639933|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
1639934|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1639935|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1639936|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1639937|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1639938|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1639939|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1639940|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1639941|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1639942|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1639943|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1639944|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1639945|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1639946|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1639947|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1639948|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1639949|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1639950|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1639951|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1639952|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1639953|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1639954|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1639955|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1639956|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1639957|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1639958|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1639959|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1639960|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1639961|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1639962|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1639963|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1639964|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1639965|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1639966|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1639967|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1639968|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1639969|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1639970|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1639971|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1639972|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1639973|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1639974|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1639975|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1639976|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1639977|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1639978|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1639979|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1639980|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1639981|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1639982|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1639983|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1639984|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1639985|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1639986|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1639987|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1641034|NCT00240461|influenza|influenza
1639988|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1639989|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1639990|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1639991|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1639992|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1639993|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1639994|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1639995|NCT00245024|breast cancer|breast cancer
1639996|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1639997|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1639998|NCT00245024|breast cancer in situ|breast cancer in situ
1639999|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
1640000|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
1640001|NCT00245011|localized osteosarcoma|localized osteosarcoma
1640002|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1640003|NCT00244998|stage III prostate cancer|stage iii prostate cancer
1640004|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
1640005|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1640006|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1640007|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1640008|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1640009|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1640010|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1640011|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1640012|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1640013|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1640014|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1640015|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1640016|NCT00244959|stage I breast cancer|stage i breast cancer
1640017|NCT00244959|stage II breast cancer|stage ii breast cancer
1640018|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
1640019|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
1640020|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
1640776|NCT00241618|Treatment|treatment
1640021|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1640022|NCT00244959|breast cancer in situ|breast cancer in situ
1640023|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1640024|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1640025|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1640026|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1640027|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1640028|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1640029|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1640030|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1640031|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1640032|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1640033|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1640034|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1640035|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1640036|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1640037|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1640038|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1640039|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1640040|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1640041|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1640042|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1640043|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1640044|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1640045|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1640046|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1640047|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1640048|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1640049|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1640050|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1640051|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1640052|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1640053|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1640054|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1640055|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1640056|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1640057|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1640058|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1640059|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1640060|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1640061|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1640062|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1640063|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1640064|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1640065|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1640066|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1640067|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1640068|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1640069|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1640070|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1640071|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1640072|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1640073|NCT00244933|stage IV breast cancer|stage iv breast cancer
1640074|NCT00244933|recurrent breast cancer|recurrent breast cancer
1640075|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1640076|NCT00244920|stage III prostate cancer|stage iii prostate cancer
1640077|NCT00244907|Bone Resorption|bone resorption
1640078|NCT00244907|Phytoestrogens|phytoestrogens
1640079|NCT00244907|Calcium|calcium
1640080|NCT00244907|Genistein|genistein
1640081|NCT00244907|Equol|equol
1640082|NCT00244894|fatigue|fatigue
1640083|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
1640084|NCT00244894|stage II prostate cancer|stage ii prostate cancer
1640085|NCT00244894|stage III prostate cancer|stage iii prostate cancer
1640086|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
1640087|NCT00244894|hot flashes|hot flashes
1640378|NCT00243607|climacteric symptoms|climacteric symptoms
1640088|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1640089|NCT00244868|metastatic cancer|metastatic cancer
1640090|NCT00244842|Randomized Controlled Trials|randomized controlled trials
1640091|NCT00244842|Immunosuppression|immunosuppression
1640092|NCT00244842|Adult|adult
1640093|NCT00244842|Chronic Disease|chronic disease
1640094|NCT00244842|Dermatologic Agents|dermatologic agents
1640095|NCT00244842|Female|female
1640096|NCT00244842|Humans|humans
1640097|NCT00244842|Male|male
1640098|NCT00244842|Middle Aged|middle aged
1640099|NCT00244842|Severity of Illness Index|severity of illness index
1640100|NCT00244842|Treatment Outcome|treatment outcome
1640101|NCT00244842|Quality of Life|quality of life
1640102|NCT00244842|Double-Blind Method|double-blind method
1640103|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1640104|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1640105|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1640106|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1640107|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1640108|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1640109|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1640110|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
1640111|NCT00244803|FRAM 1|fram 1
1640112|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
1640113|NCT00244790|proteinuria|proteinuria
1640114|NCT00244777|Seizure|seizure
1640115|NCT00244777|Altered consciousness|altered consciousness
1640116|NCT00244777|Hyponatraemia|hyponatraemia
1640117|NCT00244777|Diarrhoea|diarrhoea
1640118|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
1640119|NCT00244764|Angiogenesis|angiogenesis
1640120|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
1640121|NCT00244764|Solid tumors|solid tumors
1640122|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
1640123|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
1640124|NCT00244738|pregnancy|pregnancy
1640125|NCT00244738|post-date|post-date
1640126|NCT00244738|induction of labor|induction of labor
1640127|NCT00244738|castor oil|castor oil
1640128|NCT00244725|deep vein thrombosis|deep vein thrombosis
1640129|NCT00244725|total knee replacement|total knee replacement
1640130|NCT00244725|PE|pe
1640131|NCT00244725|Venous thromboembolism|venous thromboembolism
1640132|NCT00244725|DVT|dvt
1640133|NCT00244725|pulmonary embolism|pulmonary embolism
1640134|NCT00244725|VTE|vte
1640135|NCT00244712|HEAT|heat
1640136|NCT00244712|Antiretroviral-naive|antiretroviral-naive
1640137|NCT00244712|HIV|hiv
1640138|NCT00244712|EPZICOM|epzicom
1640139|NCT00244712|TRUVADA|truvada
1640140|NCT00244712|KALETRA|kaletra
1640141|NCT00244712|once-daily|once-daily
1640142|NCT00244699|youth|youth
1640143|NCT00244699|drug addiction|drug addiction
1640144|NCT00244699|substance abuse|substance abuse
1640145|NCT00244699|mindfulness|mindfulness
1640146|NCT00244699|motivational interviewing|motivational interviewing
1640147|NCT00244699|brief treatment|brief treatment
1640148|NCT00244699|skills training|skills training
1640149|NCT00244699|group therapy|group therapy
1640150|NCT00244699|emotion regulation|emotion regulation
1640151|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1640152|NCT00244686|Mepo|mepo
1640153|NCT00244686|HES|hes
1640154|NCT00244686|Compassionate Use|compassionate use
1640155|NCT00244686|Mepolizumab|mepolizumab
1640156|NCT00244673|Vaccination|vaccination
1640157|NCT00244673|DTP|dtp
1640158|NCT00244673|Child mortality|child mortality
1640159|NCT00244673|Sex|sex
1640160|NCT00244673|Non-specific effects|non-specific effects
1640161|NCT00244647|restenosis|restenosis
1640162|NCT00244647|in-stent restenosis|in-stent restenosis
1640163|NCT00244621|Pediatric hypertension|pediatric hypertension
1640164|NCT00244595|Pediatric hypertension|pediatric hypertension
1640165|NCT00244595|Hypertension in children|hypertension in children
1640166|NCT00244582|Central Nervous System|central nervous system
1640167|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
1640168|NCT00244582|Convection|convection
1640169|NCT00244582|Gaucher Disease|gaucher disease
1640170|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
1640171|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
1640172|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
1640173|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1640174|NCT00244569|Liver Function|liver function
1640175|NCT00244569|Metabolism|metabolism
1640176|NCT00244569|Cirrhosis|cirrhosis
1640177|NCT00244569|Fibrosis|fibrosis
1640178|NCT00244569|Liver|liver
1640179|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
1640180|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
1640181|NCT00244530|Preventive Therapy|preventive therapy
1640182|NCT00244530|Calcium Channel Blockers|calcium channel blockers
1640183|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
1640184|NCT00244530|Coronary Artery Bypass|coronary artery bypass
1640185|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
1640186|NCT00244517|ventricular function|ventricular function
1640187|NCT00244517|diastolic function|diastolic function
1640188|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
1640189|NCT00244491|care transitions|care transitions
1640190|NCT00244491|geriatric|geriatric
1640191|NCT00244491|care coordination|care coordination
1640192|NCT00244491|self-management|self-management
1640193|NCT00244491|chronic illness|chronic illness
1640194|NCT00244491|patient-centered care|patient-centered care
1640195|NCT00244465|Narcolepsy|narcolepsy
1640196|NCT00244465|Cataplexy|cataplexy
1640197|NCT00244465|Oxybate|oxybate
1640198|NCT00244465|Xyrem|xyrem
1640199|NCT00244465|Misuse|misuse
1640200|NCT00244465|Safety|safety
1640201|NCT00244452|Endometriosis|endometriosis
1640202|NCT00244452|Cetrorelix|cetrorelix
1640203|NCT00244452|Hormone|hormone
1640204|NCT00244452|Symptoms relief|symptoms relief
1640205|NCT00244452|Safety|safety
1640206|NCT00244452|Tolerability|tolerability
1640207|NCT00244452|Pharmacodynamic|pharmacodynamic
1640208|NCT00244452|Pharmacokinetic|pharmacokinetic
1640209|NCT00244439|Head Lice|head lice
1640210|NCT00244439|Pediculosis capitis|pediculosis capitis
1640211|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
1640212|NCT00244413|Myotonia|myotonia
1640213|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
1640214|NCT00244413|Thomsen's Disease|thomsen's disease
1640215|NCT00244400|Femur Head Necrosis|femur head necrosis
1640216|NCT00244400|CYP3A|cyp3a
1640217|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
1640218|NCT00244361|opsoclonus|opsoclonus
1640219|NCT00244361|myoclonus|myoclonus
1640220|NCT00244348|hepatic artery infusion|hepatic artery infusion
1640221|NCT00244348|colorectal cancer|colorectal cancer
1640222|NCT00244348|liver metastasis|liver metastasis
1640223|NCT00244348|oxaliplatin|oxaliplatin
1640224|NCT00244348|5 fluorouracil|5 fluorouracil
1640225|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
1640227|NCT00244309|brachytherapy|brachytherapy
1640228|NCT00244309|urinary symptoms|urinary symptoms
1640229|NCT00244283|Myocardial preconditioning|myocardial preconditioning
1640230|NCT00244283|anesthetics|anesthetics
1640231|NCT00244283|epidural anesthesia|epidural anesthesia
1640232|NCT00244283|sevoflurane|sevoflurane
1640233|NCT00244283|NT proBNP|nt probnp
1640234|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
1640235|NCT00244270|thromboembolism|thromboembolism
1640236|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
1640237|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
1640238|NCT00244231|Niacin|niacin
1640239|NCT00244231|Hyperlipidemia|hyperlipidemia
1640240|NCT00244218|phenylketonuria|phenylketonuria
1640241|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
1640242|NCT00244192|COPD|copd
1640243|NCT00244192|infliximab|infliximab
1640244|NCT00244192|Remicade|remicade
1640245|NCT00244192|inflammation|inflammation
1640246|NCT00244192|cachexia|cachexia
1640247|NCT00244192|fat-free mass|fat-free mass
1640248|NCT00244192|health status|health status
1640249|NCT00244192|exercise capacity|exercise capacity
1640250|NCT00244179|reactive arthritis|reactive arthritis
1640251|NCT00244179|trial|trial
1640252|NCT00244179|interferon-gamma|interferon-gamma
1640253|NCT00244179|infliximab|infliximab
1640254|NCT00244179|chronic|chronic
1640255|NCT00244179|tnf-blocker|tnf-blocker
1640256|NCT00244166|treatment|treatment
1640257|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
1640258|NCT00244166|prednisolone|prednisolone
1640259|NCT00244166|trial|trial
1640260|NCT00244166|steroid|steroid
1640261|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
1640262|NCT00244140|Ultravist 370|ultravist 370
1640263|NCT00244140|CECT|cect
1640264|NCT00244140|CT Scan|ct scan
1640265|NCT00244114|Hemophilia B|hemophilia b
1640266|NCT00244114|Allergic Reaction|allergic reaction
1640267|NCT00244101|Prematurity|prematurity
1640268|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
1640269|NCT00244101|surfactant|surfactant
1640270|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
1640271|NCT00244088|Abdominal infection|abdominal infection
1640272|NCT00244023|Erectile Dysfunction|erectile dysfunction
1640273|NCT00244023|Testosterone|testosterone
1640274|NCT00244023|Testosterone Therapy|testosterone therapy
1640275|NCT00244023|PDE V Inhibitor|pde v inhibitor
1640276|NCT00244023|Tadalafil|tadalafil
1640277|NCT00244010|Aplastic anemia|aplastic anemia
1640278|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
1640279|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
1640280|NCT00244010|Kostmann syndrome|kostmann syndrome
1640281|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1640282|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
1640283|NCT00244010|T-cell depletion|t-cell depletion
1640478|NCT00243152|trigeminal|trigeminal
1640284|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
1640285|NCT00244010|Refractory cytopenia|refractory cytopenia
1640286|NCT00243997|parents|parents
1640287|NCT00243997|fathers|fathers
1640288|NCT00243997|mothers|mothers
1640289|NCT00243984|metabolic syndrome|metabolic syndrome
1640290|NCT00243984|type 2 diabetes|type 2 diabetes
1640291|NCT00243984|topiramate|topiramate
1640292|NCT00243984|weight loss|weight loss
1640293|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
1640294|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1640295|NCT00243932|ALS|als
1640296|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
1640297|NCT00243932|CoQ10|coq10
1640298|NCT00243932|coenzyme Q10|coenzyme q10
1640299|NCT00243932|antioxidants|antioxidants
1640300|NCT00243932|free radicals|free radicals
1640301|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
1640302|NCT00243919|stroke|stroke
1640303|NCT00243919|locomotor|locomotor
1640304|NCT00243919|exercise|exercise
1640305|NCT00243919|walking|walking
1640306|NCT00243919|training program|training program
1640307|NCT00243919|body weight support training|body weight support training
1640308|NCT00243919|physical therapy|physical therapy
1640309|NCT00243906|acute ischemic stroke|acute ischemic stroke
1640310|NCT00243906|stroke|stroke
1640311|NCT00243906|rt-PA|rt-pa
1640312|NCT00243906|thrombolytic|thrombolytic
1640313|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1640314|NCT00243893|giant aneurysms|giant aneurysms
1640315|NCT00243893|arteriovenous malformations|arteriovenous malformations
1640316|NCT00243893|minocycline|minocycline
1640317|NCT00243893|doxycycline|doxycycline
1640318|NCT00243893|BAVM|bavm
1640319|NCT00243880|acute ischemic stroke|acute ischemic stroke
1640320|NCT00243880|lovastatin|lovastatin
1640321|NCT00243880|statin|statin
1640322|NCT00243880|neuroprotection|neuroprotection
1640323|NCT00243880|SPOTRIAS|spotrias
1640324|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1640325|NCT00243854|Pancreatic Cancer|pancreatic cancer
1640326|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
1640327|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1640328|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
1640329|NCT00243828|Acute Respiratory Failure|acute respiratory failure
1640330|NCT00243828|Intubation|intubation
1640331|NCT00243815|randomized controlled trial|randomized controlled trial
1640332|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
1640333|NCT00243815|IUD removal|iud removal
1640334|NCT00243802|Atrial Fibrillation|atrial fibrillation
1640335|NCT00243802|Oxidative Stress|oxidative stress
1640336|NCT00243802|Atrial Flutter|atrial flutter
1640337|NCT00243789|Duchenne|duchenne
1640338|NCT00243789|Genetic|genetic
1640339|NCT00243789|Muscular Dystrophy|muscular dystrophy
1640340|NCT00243789|DMD|dmd
1640341|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
1640342|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
1640343|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
1640344|NCT00243750|trial|trial
1640345|NCT00243750|methotrexate|methotrexate
1640346|NCT00243737|Malaria|malaria
1640347|NCT00243737|falciparum|falciparum
1640348|NCT00243737|Mefloquine|mefloquine
1640349|NCT00243737|Artesunate|artesunate
1640350|NCT00243737|Artemisinin|artemisinin
1640351|NCT00243724|immunohistochemical|immunohistochemical
1640352|NCT00243724|erosive esophagitis|erosive esophagitis
1640353|NCT00243724|Acid reflux disease|acid reflux disease
1640354|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
1640355|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
1640356|NCT00243698|Breast tumors|breast tumors
1640357|NCT00243685|Chemosensitivity|chemosensitivity
1640358|NCT00243685|Chemotherapy|chemotherapy
1640359|NCT00243685|Lung cancer|lung cancer
1640360|NCT00243685|Ovarian Cancer|ovarian cancer
1640361|NCT00243685|Breast Cancer|breast cancer
1640362|NCT00243685|Sarcoma|sarcoma
1640363|NCT00243685|Apoptosis|apoptosis
1640364|NCT00243685|MiCK Assay|mick assay
1640365|NCT00243685|New Technology|new technology
1640366|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
1640367|NCT00243659|Hemophilia A|hemophilia a
1640368|NCT00243659|bleeding disorder|bleeding disorder
1640369|NCT00243646|Radiation therapy|radiation therapy
1640370|NCT00243646|Brachytherapy|brachytherapy
1640371|NCT00243646|Prostatic neoplasm|prostatic neoplasm
1640372|NCT00243633|focal liver lesions|focal liver lesions
1640373|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
1640374|NCT00243633|cirrhosis|cirrhosis
1640375|NCT00243633|suspected liver metastases|suspected liver metastases
1640376|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
1640377|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
1640557|NCT00242879|RTV|rtv
1640379|NCT00243607|breast cancer|breast cancer
1640380|NCT00243607|hydrotherapy|hydrotherapy
1640381|NCT00243594|Dendritic cells|dendritic cells
1640382|NCT00243594|Immunotherapy|immunotherapy
1640383|NCT00243594|Vaccination|vaccination
1640384|NCT00243594|Melanoma|melanoma
1640385|NCT00243594|Peptides|peptides
1640386|NCT00243594|MRI|mri
1640387|NCT00243594|Scintigraphy|scintigraphy
1640388|NCT00243594|Immune response|immune response
1640389|NCT00243568|HIV Infections|hiv infections
1640390|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1640391|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
1640392|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
1640393|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
1640394|NCT00243568|vicriviroc|vicriviroc
1640395|NCT00243568|treatment-experienced|treatment-experienced
1640396|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
1640397|NCT00243555|chemokines|chemokines
1640398|NCT00243555|cytokines|cytokines
1640399|NCT00243555|RNA,messenger|rna,messenger
1640400|NCT00243555|monocytes|monocytes
1640401|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
1640402|NCT00243529|Dendritic cells|dendritic cells
1640403|NCT00243529|Melanoma|melanoma
1640404|NCT00243529|Vaccine|vaccine
1640405|NCT00243529|Immunotherapy|immunotherapy
1640406|NCT00243529|RNA|rna
1640407|NCT00243529|Peptides|peptides
1640408|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
1640409|NCT00243516|Emergency Department|emergency department
1640410|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
1640411|NCT00243516|Overtesting|overtesting
1640412|NCT00243516|Chest Pain Protocol|chest pain protocol
1640413|NCT00243516|Myocardial Infarction|myocardial infarction
1641871|NCT00236873|seizures|seizures
1640414|NCT00243516|Medical Malpractice|medical malpractice
1640415|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
1640416|NCT00243490|Photodynamic therapy|photodynamic therapy
1640417|NCT00243490|Malignant glioma|malignant glioma
1640418|NCT00243490|Photosan|photosan
1640419|NCT00243477|Coronary Artery Bypass|coronary artery bypass
1640420|NCT00243477|Surgery|surgery
1640421|NCT00243425|Major Depressive Disorder;|major depressive disorder;
1640422|NCT00243425|African Americans;|african americans;
1640423|NCT00243425|Disparities;|disparities;
1640424|NCT00243425|Quality Improvement;|quality improvement;
1640425|NCT00243425|Patient Centered Care;|patient centered care;
1640426|NCT00243425|Primary Care;|primary care;
1640427|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
1640428|NCT00243412|Rituxan|rituxan
1640429|NCT00243412|RA|ra
1640430|NCT00243399|Fanconi anemia|fanconi anemia
1640431|NCT00243399|FA|fa
1640432|NCT00243373|Patient safety|patient safety
1640433|NCT00243373|Medication safety|medication safety
1640434|NCT00243373|Barcode technology|barcode technology
1640435|NCT00243360|Urinary tract infections,|urinary tract infections,
1640436|NCT00243360|antibiotic use,|antibiotic use,
1640437|NCT00243360|long term care facilities|long term care facilities
1640438|NCT00243347|RECENTIN|recentin
1640439|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
1640440|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
1640441|NCT00243334|Medication Systems|medication systems
1640442|NCT00243334|Medication Errors|medication errors
1640443|NCT00243334|Reminder Systems|reminder systems
1640444|NCT00243334|Drug Monitoring|drug monitoring
1640445|NCT00243334|Preventive Health Services|preventive health services
1640446|NCT00243334|Time and Motion Studies|time and motion studies
1640447|NCT00243334|Efficiency|efficiency
1640448|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
1640449|NCT00243321|brachytherapy|brachytherapy
1640450|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
1640451|NCT00243321|prostate specific antigen|prostate specific antigen
1640452|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
1640453|NCT00243308|unstable plaque|unstable plaque
1640454|NCT00243308|acute coronary syndrome|acute coronary syndrome
1640455|NCT00243295|osteoarthritis|osteoarthritis
1640456|NCT00243295|deformity of knee|deformity of knee
1640457|NCT00243282|Complementary Therapies|complementary therapies
1640458|NCT00243282|Dyspnea|dyspnea
1640459|NCT00243282|Palliative Care|palliative care
1640460|NCT00243282|Meditation|meditation
1640461|NCT00243282|Quality of Life|quality of life
1640462|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
1640463|NCT00243243|Burns|burns
1640464|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
1640465|NCT00243204|NSCLC|nsclc
1640466|NCT00243204|Lung Cancer|lung cancer
1640467|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
1640468|NCT00243178|Atrial fibrillation|atrial fibrillation
1640469|NCT00243178|Anticoagulant therapy|anticoagulant therapy
1640470|NCT00243178|Thromboembolic prevention|thromboembolic prevention
1640471|NCT00243165|breast cancer|breast cancer
1640472|NCT00243165|honey|honey
1640473|NCT00243165|myelosuppression|myelosuppression
1640474|NCT00243165|chemotherapy|chemotherapy
1640475|NCT00243152|pain|pain
1640476|NCT00243152|neuropathic|neuropathic
1640477|NCT00243152|face|face
1640479|NCT00243139|Oral appliances|oral appliances
1640480|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
1640481|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
1640482|NCT00243139|SF-36|sf-36
1640483|NCT00243126|HIV prevention|hiv prevention
1640484|NCT00243126|HIV Seronegativity|hiv seronegativity
1640485|NCT00243126|HIV negative|hiv negative
1640486|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1640487|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1640488|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1640489|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1640490|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1640491|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1640492|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1640493|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1640494|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1640495|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1640496|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1640497|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1640498|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1640499|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1640500|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1640501|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1640594|NCT00242749|Cancer of the Head|cancer of the head
1640502|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1640503|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1640504|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1640505|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1640506|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1640507|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1640508|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1640509|NCT00243048|stage I prostate cancer|stage i prostate cancer
1640510|NCT00243048|stage II prostate cancer|stage ii prostate cancer
1640511|NCT00243022|cerebral edema|cerebral edema
1640512|NCT00243022|adult glioblastoma|adult glioblastoma
1640513|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
1640514|NCT00243022|adult gliosarcoma|adult gliosarcoma
1640515|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1640516|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1640517|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
1640518|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
1640519|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1640520|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1640521|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
1640522|NCT00242983|large cell lung cancer|large cell lung cancer
1640523|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1640524|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
1640525|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1640526|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1640527|NCT00242957|HIV/AIDS|hiv/aids
1640528|NCT00242957|Gender Based Violence|gender based violence
1640529|NCT00242957|Structural Interventions|structural interventions
1640530|NCT00242957|South Africa|south africa
1640531|NCT00242957|HIV Seronegativity|hiv seronegativity
1640532|NCT00242944|Acute coronary syndrome|acute coronary syndrome
1640533|NCT00242944|Hypercholesterolemia|hypercholesterolemia
1640534|NCT00242944|Primary coronary intervention|primary coronary intervention
1640535|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1640536|NCT00242944|coronary plaque|coronary plaque
1640537|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
1640538|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
1640539|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1640540|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
1640541|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
1640542|NCT00242918|High risk|high risk
1640543|NCT00242918|adenocarcinoma|adenocarcinoma
1640544|NCT00242918|prostate cancer|prostate cancer
1640545|NCT00242918|neoadjuvant|neoadjuvant
1640546|NCT00242905|Memory|memory
1640547|NCT00242905|Epilepsy|epilepsy
1640548|NCT00242905|Children|children
1640549|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
1640550|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
1640551|NCT00242892|Deployment stent optimisation|deployment stent optimisation
1640552|NCT00242892|Fractional Flow Reserve|fractional flow reserve
1640553|NCT00242892|Stent|stent
1640554|NCT00242892|Restenosis|restenosis
1640555|NCT00242892|Coronary|coronary
1640556|NCT00242879|treatment-experienced|treatment-experienced
1640558|NCT00242879|protease inhibitor|protease inhibitor
1640559|NCT00242879|ritonavir|ritonavir
1640560|NCT00242879|GW640385|gw640385
1640561|NCT00242879|HIV-1|hiv-1
1640562|NCT00242866|Productivity|productivity
1640563|NCT00242866|Efficacy|efficacy
1640564|NCT00242866|without aura|without aura
1640565|NCT00242866|iNOS|inos
1640566|NCT00242866|Safety|safety
1640567|NCT00242866|Nitric Oxide|nitric oxide
1640568|NCT00242866|Pharmacokinetics|pharmacokinetics
1640569|NCT00242866|GW274150|gw274150
1640570|NCT00242866|with aura|with aura
1640571|NCT00242866|Migraine|migraine
1640572|NCT00242866|Prophylaxis|prophylaxis
1640573|NCT00242866|Quality of Life|quality of life
1640574|NCT00242853|iNOS|inos
1640575|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
1640576|NCT00242853|Exhaled NO|exhaled no
1640577|NCT00242840|protease inhibitor|protease inhibitor
1640578|NCT00242840|ritonavir|ritonavir
1640579|NCT00242840|GW433908|gw433908
1640580|NCT00242840|HIV-1|hiv-1
1640581|NCT00242840|fosamprenavir|fosamprenavir
1640582|NCT00242788|Colorectal Cancer|colorectal cancer
1640583|NCT00242775|Asthma|asthma
1640584|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
1640585|NCT00242762|Cancer of Head and Neck|cancer of head and neck
1640586|NCT00242762|Head and Neck Cancer|head and neck cancer
1640587|NCT00242762|Head Cancer|head cancer
1640588|NCT00242762|Neck Cancer|neck cancer
1640589|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
1640590|NCT00242749|Head Cancer|head cancer
1640591|NCT00242749|Neck Cancer|neck cancer
1640592|NCT00242749|Cancer of Head|cancer of head
1640593|NCT00242749|Cancer of Neck|cancer of neck
1640607|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
1640608|NCT00242697|anesthesia, general|anesthesia, general
1640609|NCT00242697|anesthesia, spinal|anesthesia, spinal
1640610|NCT00242697|heart-lung machine|heart-lung machine
1640611|NCT00242684|Aging|aging
1640612|NCT00242684|Undernutrition|undernutrition
1640613|NCT00242684|Inflammation|inflammation
1640614|NCT00242684|Frail Elderly|frail elderly
1640615|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
1640616|NCT00242658|Physical Activity|physical activity
1640617|NCT00242658|Wellness Programs|wellness programs
1640618|NCT00242658|Health Promotion|health promotion
1640619|NCT00242658|Blood Pressure, High|blood pressure, high
1640620|NCT00242645|Doctor-Patient relation|doctor-patient relation
1640621|NCT00242645|Physician-Patient relation|physician-patient relation
1640622|NCT00242645|Diabetes|diabetes
1640623|NCT00242645|Office visits|office visits
1640624|NCT00242645|Comparative Study|comparative study
1640625|NCT00242645|Health behavior|health behavior
1640626|NCT00242645|Randomized controlled trials|randomized controlled trials
1640627|NCT00242645|Health Promotion|health promotion
1640628|NCT00242645|Health Education|health education
1640629|NCT00242645|Computer-tailor information|computer-tailor information
1640630|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
1640631|NCT00242606|Initial monotherapy|initial monotherapy
1640632|NCT00242606|Levetiracetam|levetiracetam
1640633|NCT00242606|Lamotrigine|lamotrigine
1640634|NCT00242593|cognition disorders|cognition disorders
1640635|NCT00242593|Alzheimer's disease|alzheimer's disease
1640636|NCT00242593|memory|memory
1640637|NCT00242580|AMD|amd
1640638|NCT00242580|age-related macular degeneration|age-related macular degeneration
1640639|NCT00242580|choroidal neovascularization|choroidal neovascularization
1640640|NCT00242567|zoledronic acid|zoledronic acid
1640641|NCT00242567|bone metastases|bone metastases
1640642|NCT00242567|prostate cancer|prostate cancer
1640643|NCT00242567|hormone-sensitive|hormone-sensitive
1640644|NCT00242554|Prostate Cancer|prostate cancer
1640645|NCT00242554|Bone Metastases|bone metastases
1640646|NCT00242554|Zoledronic acid|zoledronic acid
1640647|NCT00242541|microadenoma|microadenoma
1640648|NCT00242541|macroadenoma|macroadenoma
1640649|NCT00242528|Bone Lesions|bone lesions
1640650|NCT00242528|Multiple Myeloma|multiple myeloma
1640651|NCT00242528|zoledronic acid|zoledronic acid
1640652|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
1640653|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
1640654|NCT00242502|Liver Cancer|liver cancer
1640655|NCT00242502|Bevacizumab|bevacizumab
1640656|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1640657|NCT00242502|rhuMAb-VEGF|rhumab-vegf
1640658|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
1640659|NCT00242502|OSI-774|osi-774
1640660|NCT00242502|Tarceva|tarceva
1640661|NCT00242502|Erlotinib|erlotinib
1640662|NCT00242502|Avastin|avastin
1640663|NCT00242489|Arcoxia|arcoxia
1640664|NCT00242463|malnutrition|malnutrition
1640665|NCT00242463|anabolic steroids|anabolic steroids
1640666|NCT00242463|intensive care unit|intensive care unit
1640667|NCT00242463|rehabilitation|rehabilitation
1640668|NCT00242450|metoclopramide|metoclopramide
1640669|NCT00242450|feeding|feeding
1640670|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
1640671|NCT00242424|influenza vaccine|influenza vaccine
1640672|NCT00242424|infants|infants
1640674|NCT00242424|immunogenicity|immunogenicity
1640675|NCT00242398|Intensive care unit|intensive care unit
1640676|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
1640677|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
1640678|NCT00242398|Blood lost|blood lost
1640679|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
1640680|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
1640681|NCT00242346|Hypertension|hypertension
1640682|NCT00242333|COPD|copd
1640683|NCT00242333|COAD|coad
1640684|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1640685|NCT00242333|emphysema|emphysema
1640686|NCT00242333|chronic bronchitis|chronic bronchitis
1640687|NCT00242320|COPD|copd
1640688|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1640689|NCT00242320|Roflumilast|roflumilast
1640690|NCT00242307|Asthma|asthma
1640691|NCT00242307|Roflumilast|roflumilast
1640692|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
1640693|NCT00242294|COPD|copd
1640694|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
1640695|NCT00242294|Roflumilast|roflumilast
1640696|NCT00242281|Sore Throat|sore throat
1640697|NCT00242281|Pharyngitis|pharyngitis
1640698|NCT00242281|Tonsillitis|tonsillitis
1640699|NCT00242255|Histone|histone
1640700|NCT00242255|Chromatin|chromatin
1640701|NCT00242255|Epigenome|epigenome
1640702|NCT00242255|Senescence|senescence
1640703|NCT00242255|Acetylation|acetylation
1640704|NCT00242255|Aging|aging
1640705|NCT00242255|Tissue Sample|tissue sample
1640706|NCT00242242|Stroke|stroke
1640707|NCT00242242|BCI|bci
1640708|NCT00242242|Healthy Volunteer|healthy volunteer
1640709|NCT00242242|HV|hv
1640710|NCT00242229|Depression|depression
1640711|NCT00242216|HIV-1 infected people|hiv-1 infected people
1640712|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
1640713|NCT00242216|Atazanavir|atazanavir
1640714|NCT00242216|Fosamprenavir|fosamprenavir
1640715|NCT00242216|ARV Treatment Naive|arv treatment naive
1640716|NCT00242203|Breast Cancer|breast cancer
1640717|NCT00242203|Neoadjuvant|neoadjuvant
1640718|NCT00242203|Micrometastasis|micrometastasis
1640719|NCT00242190|drug therapy|drug therapy
1640720|NCT00242190|radiotherapy|radiotherapy
1640721|NCT00242190|clinical trial|clinical trial
1640722|NCT00242177|Multiple Sclerosis|multiple sclerosis
1640723|NCT00242177|Relapsing, Remitting|relapsing, remitting
1640724|NCT00242177|Autoimmune disease|autoimmune disease
1640725|NCT00242164|Hemodialysis|hemodialysis
1640726|NCT00242164|Magnesium|magnesium
1640728|NCT00242164|QTc interval|qtc interval
1640729|NCT00242164|QT dispersion|qt dispersion
1640730|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
1640731|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
1640732|NCT00242125|genes|genes
1640733|NCT00242125|DNA|dna
1640734|NCT00242099|liver transplant|liver transplant
1640735|NCT00242099|HHV-6|hhv-6
1640736|NCT00242099|HHV-7|hhv-7
1640737|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
1640738|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
1640739|NCT00242047|Tuberculosis.|tuberculosis.
1640740|NCT00242047|Children.|children.
1640741|NCT00242047|Vaccine.|vaccine.
1640742|NCT00242047|BCG.|bcg.
1640743|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
1640744|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
1640745|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
1640746|NCT00241982|long circulating liposomes|long circulating liposomes
1640747|NCT00241969|nutrition therapy|nutrition therapy
1640748|NCT00241969|preschool children|preschool children
1640749|NCT00241969|cystic fibrosis|cystic fibrosis
1640750|NCT00241943|Hepatitis C|hepatitis c
1640751|NCT00241943|Heroin|heroin
1640752|NCT00241943|Populations at risk|populations at risk
1640753|NCT00241943|testing|testing
1640754|NCT00241943|vaccination|vaccination
1640755|NCT00241930|Heroin|heroin
1640756|NCT00241930|HIV|hiv
1640757|NCT00241930|buprenorphine|buprenorphine
1640758|NCT00241930|integration|integration
1640759|NCT00241930|drug treatment|drug treatment
1640760|NCT00241917|hepatitis C|hepatitis c
1640761|NCT00241917|heroin|heroin
1640762|NCT00241917|populations at risk|populations at risk
1640763|NCT00241917|testing|testing
1640764|NCT00241917|vaccination|vaccination
1640765|NCT00241722|bowel dysfunction|bowel dysfunction
1640766|NCT00241722|constipation|constipation
1640767|NCT00241722|gastrointestinal|gastrointestinal
1640768|NCT00241722|opioids|opioids
1640769|NCT00241722|pain|pain
1640770|NCT00241722|non-cancer pain|non-cancer pain
1640771|NCT00241722|opioid-induced|opioid-induced
1640772|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
1640773|NCT00241644|HRV vaccine|hrv vaccine
1640774|NCT00241618|Clinical trial|clinical trial
1640775|NCT00241618|Randomized|randomized
1640778|NCT00241618|Parallel Assignment|parallel assignment
1640779|NCT00241618|Efficacy Safety Study|efficacy safety study
1640780|NCT00241605|Metformin|metformin
1640781|NCT00241605|AVANDAMET|avandamet
1640782|NCT00241605|Type 2 diabetes|type 2 diabetes
1640783|NCT00241592|Cannabis|cannabis
1640784|NCT00241592|Marijuana|marijuana
1640785|NCT00241592|Vaporization|vaporization
1640786|NCT00241592|Volcano|volcano
1640787|NCT00241592|THC|thc
1640788|NCT00241579|Pain|pain
1640789|NCT00241579|Cannabis|cannabis
1640790|NCT00241579|Analgesic|analgesic
1640791|NCT00241566|Neuropathic pain|neuropathic pain
1640792|NCT00241566|Electric cortical stimulation|electric cortical stimulation
1640793|NCT00241566|Economic Medical evaluation|economic medical evaluation
1640794|NCT00241540|NSAIDs|nsaids
1640795|NCT00241540|Upper GI symptoms|upper gi symptoms
1640796|NCT00241514|NSAIDs|nsaids
1640797|NCT00241514|Upper GI symptoms|upper gi symptoms
1640798|NCT00241475|Cancer of the Prostate|cancer of the prostate
1640799|NCT00241462|Advanced Breast Cancer|advanced breast cancer
1640800|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
1640801|NCT00241423|exenatide|exenatide
1640802|NCT00241423|diabetes|diabetes
1640803|NCT00241423|Amylin|amylin
1640804|NCT00241423|Lilly|lilly
1640805|NCT00241410|Allergy|allergy
1640806|NCT00241410|Specific Immunotherapy|specific immunotherapy
1640807|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
1640808|NCT00241397|pain|pain
1640809|NCT00241397|depression|depression
1640810|NCT00241397|anxiety disorder|anxiety disorder
1640811|NCT00241384|Prostatic Cancer|prostatic cancer
1640812|NCT00241384|Brachytherapy|brachytherapy
1640813|NCT00241384|Prostatic neoplasm|prostatic neoplasm
1640814|NCT00241384|Radiation therapy|radiation therapy
1640815|NCT00241371|Multiple Myeloma|multiple myeloma
1640816|NCT00241358|Plerixafor|plerixafor
1640817|NCT00241358|Stem cell transplantation|stem cell transplantation
1640818|NCT00241358|Stem cells|stem cells
1640819|NCT00241358|Mobilization|mobilization
1640820|NCT00241345|post transplant|post transplant
1640821|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
1640822|NCT00241332|pain|pain
1640823|NCT00241332|hyperalgesia|hyperalgesia
1640824|NCT00241332|drug tolerance|drug tolerance
1640825|NCT00241332|remifentanil|remifentanil
1640826|NCT00241332|fentanyl|fentanyl
1640827|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
1640828|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
1640829|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
1640830|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
1640831|NCT00241306|aging|aging
1640832|NCT00241306|language|language
1640833|NCT00241306|gender|gender
1640834|NCT00241293|language|language
1640835|NCT00241267|Pulmonary|pulmonary
1640836|NCT00241267|Neoplasms|neoplasms
1640837|NCT00241267|Endobronchial|endobronchial
1640838|NCT00241267|Ultrasonography|ultrasonography
1640839|NCT00241267|Primary|primary
1640840|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
1640841|NCT00241254|Cyclophosphamide|cyclophosphamide
1640842|NCT00241254|Methylprednisolone|methylprednisolone
1640843|NCT00241254|Randomized Controlled Trials|randomized controlled trials
1640844|NCT00241254|Double-Blind Study|double-blind study
1640845|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
1640846|NCT00241241|polycythemia vera|polycythemia vera
1640847|NCT00241241|interferon|interferon
1640848|NCT00241228|Shock, Septic|shock, septic
1640849|NCT00241228|Renal Failure, Acute|renal failure, acute
1640850|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
1640851|NCT00241228|Randomized Controlled Trial|randomized controlled trial
1640852|NCT00241228|Multicenter Study|multicenter study
1640853|NCT00241228|Mortality|mortality
1640854|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
1640855|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
1640856|NCT00241215|Myofascial pain|myofascial pain
1640857|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
1640858|NCT00241215|Propulsion|propulsion
1640859|NCT00241215|Postural abnormality|postural abnormality
1640860|NCT00241202|signs and symptoms|signs and symptoms
1640861|NCT00241202|self care|self care
1640862|NCT00241202|patient compliance|patient compliance
1640863|NCT00241202|quality of life|quality of life
1640864|NCT00241189|Systemic sclerosis|systemic sclerosis
1640865|NCT00241189|Scleroderma|scleroderma
1640866|NCT00241189|Rapamycin|rapamycin
1640867|NCT00241189|Methotrexate|methotrexate
1640868|NCT00241176|Psychiatric|psychiatric
1640869|NCT00241176|Clinical Trial|clinical trial
1640870|NCT00241176|Pediatrics|pediatrics
1640871|NCT00241176|Tourette's Disorder|tourette's disorder
1640872|NCT00241176|Tic Disorder|tic disorder
1640873|NCT00241150|valsartan|valsartan
1640874|NCT00241150|hypertension|hypertension
1640875|NCT00241150|metabolic syndrome|metabolic syndrome
1640978|NCT00240695|galantamine|galantamine
1640876|NCT00241150|endothelial function|endothelial function
1640877|NCT00241137|hypertension|hypertension
1640878|NCT00241137|valsartan|valsartan
1640879|NCT00241124|hypertension|hypertension
1640880|NCT00241124|valsartan|valsartan
1640881|NCT00241124|morning/evening dosing|morning/evening dosing
1640882|NCT00241124|lisinopril|lisinopril
1640883|NCT00241111|Prostate|prostate
1640884|NCT00241111|cancer|cancer
1640885|NCT00241111|bone metastasis|bone metastasis
1640886|NCT00241111|zoledronic acid|zoledronic acid
1640887|NCT00241098|HYPERTENSION|hypertension
1640888|NCT00241098|HEART FAILURE|heart failure
1640889|NCT00241098|PEPTIDE|peptide
1640890|NCT00241098|valsartan|valsartan
1640891|NCT00241085|proteinuria|proteinuria
1640892|NCT00241085|hypertension|hypertension
1640893|NCT00241085|valsartan|valsartan
1640894|NCT00241085|type 2 diabetes|type 2 diabetes
1640895|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
1640896|NCT00241046|Breast cancer|breast cancer
1640897|NCT00241046|Machine learning techniques|machine learning techniques
1640898|NCT00241046|Aromatase inhibitors|aromatase inhibitors
1640899|NCT00241046|1st line treatment|1st line treatment
1640900|NCT00241046|2nd line treatment|2nd line treatment
1640901|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
1640902|NCT00241020|Octreotide|octreotide
1640903|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
1640904|NCT00240994|End stage renal disease|end stage renal disease
1640905|NCT00240994|Kidney transplantation|kidney transplantation
1640906|NCT00240994|Renal transplantation|renal transplantation
1640907|NCT00240994|Kidney failure|kidney failure
1640908|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
1640909|NCT00240994|Alemtuzumab|alemtuzumab
1640910|NCT00240994|Campath|campath
1640911|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
1640912|NCT00240994|MMF|mmf
1640913|NCT00240994|CellCept|cellcept
1640914|NCT00240994|Tacrolimus|tacrolimus
1640915|NCT00240994|Prograf|prograf
1640916|NCT00240994|Sirolimus|sirolimus
1640917|NCT00240994|Rapamycin|rapamycin
1640918|NCT00240981|Andropause|andropause
1640919|NCT00240981|frailty|frailty
1640920|NCT00240981|hormone replacement therapy|hormone replacement therapy
1640921|NCT00240981|Aging|aging
1640922|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
1640923|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
1640924|NCT00240942|Endometriosis|endometriosis
1640925|NCT00240942|GnRH analog|gnrh analog
1640926|NCT00240942|Aromataseinhibitor|aromataseinhibitor
1640927|NCT00240942|Letrozole|letrozole
1640928|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
1640929|NCT00240864|postoperative dental pain|postoperative dental pain
1640930|NCT00240864|acetaminophen|acetaminophen
1640931|NCT00240864|ibuprofen|ibuprofen
1640932|NCT00240851|muscle ache|muscle ache
1640933|NCT00240851|pain|pain
1640934|NCT00240851|soreness|soreness
1640935|NCT00240851|acetaminophen|acetaminophen
1640936|NCT00240838|muscle soreness|muscle soreness
1640937|NCT00240838|pain, acetaminophen|pain, acetaminophen
1640938|NCT00240838|ibuprofen|ibuprofen
1640939|NCT00240825|postoperative dental pain|postoperative dental pain
1640940|NCT00240825|acetaminophen|acetaminophen
1640941|NCT00240825|ibuprofen|ibuprofen
1640942|NCT00240812|nocturnal enuresis|nocturnal enuresis
1640943|NCT00240812|bedwetting|bedwetting
1640944|NCT00240812|ibuprofen|ibuprofen
1640945|NCT00240799|osteoarthritis hip|osteoarthritis hip
1640946|NCT00240799|osteoarthritis knee|osteoarthritis knee
1640947|NCT00240799|acetaminophen|acetaminophen
1640948|NCT00240786|osteoarthritis hip|osteoarthritis hip
1640949|NCT00240786|osteoarthritis knee|osteoarthritis knee
1640950|NCT00240786|acetaminophen|acetaminophen
1640951|NCT00240773|osteoarthritis hip|osteoarthritis hip
1640952|NCT00240773|osteoarthritis knee|osteoarthritis knee
1640953|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
1640954|NCT00240760|Memantine|memantine
1640955|NCT00240760|Down syndrome|down syndrome
1640956|NCT00240760|Dementia|dementia
1640957|NCT00240760|learning Disability|learning disability
1640958|NCT00240760|Treatment of Dementia|treatment of dementia
1640959|NCT00240734|Anemia|anemia
1640960|NCT00240734|Chronic renal failure|chronic renal failure
1640961|NCT00240734|pre-dialysis|pre-dialysis
1640962|NCT00240734|diabetic|diabetic
1640963|NCT00240721|topiramate|topiramate
1640964|NCT00240721|bipolar disorders|bipolar disorders
1640965|NCT00240721|mood disorders|mood disorders
1640966|NCT00240721|manic state|manic state
1640967|NCT00240721|depression|depression
1640968|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
1640969|NCT00240708|Schizophrenia|schizophrenia
1640970|NCT00240708|intramuscular injection|intramuscular injection
1640971|NCT00240708|antipsychotic agents|antipsychotic agents
1640972|NCT00240708|risperidone|risperidone
1640973|NCT00240708|long-acting injectable|long-acting injectable
1640974|NCT00240695|Alzheimer's disease|alzheimer's disease
1640975|NCT00240695|Dementia|dementia
1640976|NCT00240695|Brain Disease|brain disease
1640977|NCT00240695|Memory Loss|memory loss
1640979|NCT00240695|Nervous System Diseases|nervous system diseases
1640980|NCT00240695|open-label|open-label
1640981|NCT00240695|elderly|elderly
1640982|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
1640984|NCT00240682|cetuximab|cetuximab
1640985|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
1640986|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
1640987|NCT00240669|osteosynthesis,|osteosynthesis,
1640988|NCT00240669|resorbable device|resorbable device
1640989|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
1640990|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
1640991|NCT00240643|stroke|stroke
1640992|NCT00240643|aspirin|aspirin
1640993|NCT00240630|acute migraine|acute migraine
1640994|NCT00240630|consistency of response|consistency of response
1640995|NCT00240630|satisfaction|satisfaction
1640996|NCT00240630|migraine|migraine
1640997|NCT00240630|early intervention|early intervention
1640998|NCT00240617|consistency of response|consistency of response
1640999|NCT00240617|migraine|migraine
1641000|NCT00240617|satisfaction|satisfaction
1641001|NCT00240617|early intervention|early intervention
1641002|NCT00240604|corticosteroid treatment|corticosteroid treatment
1641003|NCT00240604|inflammatory diseases|inflammatory diseases
1641004|NCT00240591|BEXXAR|bexxar
1641005|NCT00240591|Tositumomab|tositumomab
1641006|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1641007|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
1641008|NCT00240578|Long-Term Follow-up|long-term follow-up
1641009|NCT00240578|BEXXAR|bexxar
1641010|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1641011|NCT00240578|Low-grade lymphoma|low-grade lymphoma
1641012|NCT00240565|BEXXAR|bexxar
1641013|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1641014|NCT00240565|tositumomab|tositumomab
1641015|NCT00240565|I-131|i-131
1641016|NCT00240552|protease inhibitor|protease inhibitor
1641017|NCT00240552|Treatment Experienced|treatment experienced
1641018|NCT00240552|amprenavir|amprenavir
1641019|NCT00240552|fosamprenavir|fosamprenavir
1641020|NCT00240552|GW433908|gw433908
1641022|NCT00240552|pro drug|pro drug
1641023|NCT00240539|Hepatitis B|hepatitis b
1641024|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
1641025|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
1641026|NCT00240513|Acne|acne
1641027|NCT00240500|Long-term follow-up|long-term follow-up
1641028|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
1641029|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1641030|NCT00240487|ARDS|ards
1641031|NCT00240487|Nitric Oxide|nitric oxide
1641032|NCT00240461|respiratory|respiratory
1641035|NCT00240396|fracture|fracture
1641036|NCT00240396|Tibia|tibia
1641037|NCT00240396|femur|femur
1641038|NCT00240396|humerus|humerus
1641039|NCT00240396|narcotics|narcotics
1641040|NCT00240396|bimodal|bimodal
1641041|NCT00240396|analgesia|analgesia
1641042|NCT00240396|long-bone|long-bone
1641043|NCT00240396|NSAIDS|nsaids
1641044|NCT00240344|High risk patients|high risk patients
1641045|NCT00240344|Crestor|crestor
1641046|NCT00240344|Rosuvastatin|rosuvastatin
1641047|NCT00240344|LDL cholesterol|ldl cholesterol
1641048|NCT00240344|observational|observational
1641049|NCT00240331|End Stage Renal Failure|end stage renal failure
1641050|NCT00240318|Coronary Artery Disease|coronary artery disease
1641051|NCT00240305|Metabolic Syndrome|metabolic syndrome
1641052|NCT00240305|Dyslipidaemia|dyslipidaemia
1641053|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
1641054|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
1641055|NCT00240266|Metabolic Syndrome|metabolic syndrome
1641056|NCT00240266|Dyslipaemia|dyslipaemia
1641057|NCT00240253|diabetes|diabetes
1641058|NCT00240253|Amylin|amylin
1641059|NCT00240253|Symlin|symlin
1641060|NCT00240253|pramlintide|pramlintide
1641061|NCT00240253|insulin glargine|insulin glargine
1641062|NCT00240227|Alcoholism|alcoholism
1641063|NCT00240227|Cocaine Dependence|cocaine dependence
1641064|NCT00240227|Prazosin|prazosin
1641065|NCT00240227|Substance use disorders|substance use disorders
1641066|NCT00240214|Kidney transplants|kidney transplants
1641067|NCT00240188|Hernia|hernia
1641068|NCT00240188|Incisional|incisional
1641069|NCT00240188|Laparoscopic|laparoscopic
1641070|NCT00240188|Mesh|mesh
1641071|NCT00240188|Repair|repair
1641072|NCT00240188|Ventral|ventral
1641073|NCT00240162|Myeloma|myeloma
1641074|NCT00240162|PTK|ptk
1641075|NCT00240136|Early, severe|early, severe
1641076|NCT00240123|ERCP|ercp
1641077|NCT00240123|EUS|eus
1641078|NCT00240110|Bipolar|bipolar
1641079|NCT00240110|Cocaine|cocaine
1641080|NCT00240110|Comorbidity|comorbidity
1641081|NCT00240071|Breast cancer|breast cancer
1641082|NCT00240071|Metastatic breast cancer|metastatic breast cancer
1641083|NCT00240071|Hormonal therapy|hormonal therapy
1641084|NCT00240071|Bevacizumab|bevacizumab
1641085|NCT00240058|Blood Pressure|blood pressure
1641086|NCT00240058|Nitric Oxide|nitric oxide
1641087|NCT00240058|L-NMMA|l-nmma
1641088|NCT00240058|Phenylephrine|phenylephrine
1641089|NCT00240058|Nitroprusside|nitroprusside
1641090|NCT00240058|Vasoreactivity|vasoreactivity
1641091|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
1641092|NCT00240045|Refractory ascites|refractory ascites
1641093|NCT00240045|Midodrine|midodrine
1641094|NCT00240045|Octreotide|octreotide
1641095|NCT00240045|Albumin|albumin
1641096|NCT00240045|Cirrhosis|cirrhosis
1641097|NCT00240006|Multiple Sclerosis|multiple sclerosis
1641098|NCT00240006|Copaxone®|copaxone®
1641099|NCT00240006|Shared Solutions®|shared solutions®
1641100|NCT00239980|antineoplastic agent|antineoplastic agent
1641101|NCT00239980|ovarian cancer|ovarian cancer
1641102|NCT00239980|fragmin|fragmin
1641103|NCT00239980|dalteparin|dalteparin
1641104|NCT00239967|dyslipidemia|dyslipidemia
1641105|NCT00239967|obesity|obesity
1641106|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
1641107|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
1641108|NCT00239889|Forearm fracture|forearm fracture
1641109|NCT00239889|Postmenopausal women|postmenopausal women
1641111|NCT00239889|Grip strength|grip strength
1641112|NCT00239889|Salmon calcitonin|salmon calcitonin
1641113|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
1641114|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
1641115|NCT00239850|obesity|obesity
1641116|NCT00239850|lifestyle|lifestyle
1641117|NCT00239850|treatment|treatment
1641118|NCT00239850|Complications|complications
1641119|NCT00239850|endocrine changes|endocrine changes
1641120|NCT00239850|Lipids|lipids
1641121|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
1641122|NCT00239837|Adolescent|adolescent
1641123|NCT00239837|Foster Care|foster care
1641124|NCT00239837|Female|female
1641125|NCT00239824|urinary incontinence|urinary incontinence
1641126|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
1641127|NCT00239824|radical prostatectomy|radical prostatectomy
1641128|NCT00239824|physiotherapy|physiotherapy
1641129|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
1641130|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
1641131|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
1641132|NCT00239772|Cognitive Therapy|cognitive therapy
1641133|NCT00239772|PTSD|ptsd
1641134|NCT00239772|Females|females
1641135|NCT00239772|Rape|rape
1641136|NCT00239772|Trauma|trauma
1641707|NCT00237549|Screening|screening
1641137|NCT00239759|Epidemiological study|epidemiological study
1641138|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
1641139|NCT00239746|NSAIDS|nsaids
1641140|NCT00239733|HIV|hiv
1641141|NCT00239733|HCV|hcv
1641142|NCT00239733|Hepatitis C|hepatitis c
1641143|NCT00239733|Thrombocytopenia|thrombocytopenia
1641144|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
1641145|NCT00239720|Arthritis|arthritis
1641146|NCT00239720|Psoriasis|psoriasis
1641147|NCT00239720|Psoriatic|psoriatic
1641148|NCT00239720|PsA|psa
1641149|NCT00239707|insulin sensitivity|insulin sensitivity
1641150|NCT00239707|blood sugar|blood sugar
1641151|NCT00239694|Immune response|immune response
1641152|NCT00239694|Antibody response|antibody response
1641153|NCT00239681|Primary prevention|primary prevention
1641154|NCT00239681|Cardiovascular disease|cardiovascular disease
1641155|NCT00239681|Statin therapy|statin therapy
1641156|NCT00239681|C-reactive protein|c-reactive protein
1641157|NCT00239668|Burns|burns
1641158|NCT00239668|Functional|functional
1641159|NCT00239668|Psychosocial|psychosocial
1641160|NCT00239668|Recovery|recovery
1641161|NCT00239668|Long-term|long-term
1641162|NCT00239668|Pediatric|pediatric
1641163|NCT00239668|Surgical|surgical
1641164|NCT00239668|Outcomes|outcomes
1641165|NCT00239668|Benchmarking|benchmarking
1641166|NCT00239642|Iron|iron
1641167|NCT00239642|Anemia|anemia
1641168|NCT00239642|CKD|ckd
1641169|NCT00239616|Anemia|anemia
1641170|NCT00239616|Pharmacokinetics|pharmacokinetics
1641171|NCT00239603|OV-Watch|ov-watch
1641172|NCT00239603|fertility monitor|fertility monitor
1641173|NCT00239603|ovulation induction|ovulation induction
1641174|NCT00239603|clomiphene citrate|clomiphene citrate
1641175|NCT00239603|anovulation|anovulation
1641176|NCT00239603|infertility|infertility
1641177|NCT00239577|Dengue infection|dengue infection
1641178|NCT00239564|IPX054|ipx054
1641179|NCT00239564|Parkinson disease|parkinson disease
1641180|NCT00239564|Levodopa|levodopa
1641181|NCT00239551|gastric stress ulcer|gastric stress ulcer
1641182|NCT00239551|Prevacid|prevacid
1641183|NCT00239551|Prostaglandin|prostaglandin
1641184|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
1641185|NCT00239525|Intracranial Hypertension|intracranial hypertension
1641186|NCT00239512|PDA|pda
1641187|NCT00239512|VLBW infants|vlbw infants
1641188|NCT00239512|Indomethacin|indomethacin
1641189|NCT00239512|Ibuprofen|ibuprofen
1641190|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
1641191|NCT00239317|tamsulosin|tamsulosin
1641192|NCT00239317|urinary tract diseases|urinary tract diseases
1641193|NCT00239317|male|male
1641194|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
1641195|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
1641196|NCT00239265|tamsulosin|tamsulosin
1641197|NCT00239265|urinary tract diseases|urinary tract diseases
1641198|NCT00239265|female|female
1641199|NCT00239252|Interferon alfacon-1|interferon alfacon-1
1641200|NCT00239252|Virus disease|virus disease
1641201|NCT00239252|Hepatitis C|hepatitis c
1641202|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
1641203|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
1641205|NCT00239239|Clinical Trials|clinical trials
1641206|NCT00239239|Pharmacokinetics|pharmacokinetics
1641207|NCT00239239|Darbepoetin alfa|darbepoetin alfa
1641208|NCT00239239|Aranesp|aranesp
1641209|NCT00239239|Amgen|amgen
1641210|NCT00239226|atrial fibrillation|atrial fibrillation
1641211|NCT00239226|interatrial septum|interatrial septum
1641212|NCT00239226|atrial pacing|atrial pacing
1641213|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
1641214|NCT00239226|pacemaker indication class I|pacemaker indication class i
1641215|NCT00239213|catechins|catechins
1641216|NCT00239213|gargling|gargling
1641217|NCT00239213|healthy volunteers|healthy volunteers
1641218|NCT00239187|Type 2 diabetes|type 2 diabetes
1641219|NCT00239174|obesity|obesity
1641220|NCT00239161|Pyelonephritis|pyelonephritis
1641221|NCT00239148|Type 1 diabetes|type 1 diabetes
1641222|NCT00239135|Actinic Keratosis|actinic keratosis
1641223|NCT00239135|Topical|topical
1641224|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
1641225|NCT00239135|Solar Keratosis|solar keratosis
1641226|NCT00239135|Sun Spots|sun spots
1641227|NCT00239135|Dermatology|dermatology
1641228|NCT00239122|Cognitive Therapy|cognitive therapy
1641229|NCT00239122|Psychotic Disorders|psychotic disorders
1641230|NCT00239122|Treatment Outcome|treatment outcome
1641231|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
1641232|NCT00239096|ascites|ascites
1641233|NCT00239096|sodium retention|sodium retention
1641234|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
1641235|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
1641236|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
1641237|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
1641238|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
1641239|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
1641240|NCT00239005|QoL|qol
1641241|NCT00239005|GI Side Effects|gi side effects
1641242|NCT00239005|MPA|mpa
1641243|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
1641244|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
1641245|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
1641246|NCT00238953|Kidney transplantation|kidney transplantation
1641247|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
1641248|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
1641249|NCT00238927|asthma|asthma
1641250|NCT00238927|preschool|preschool
1641251|NCT00238927|viral|viral
1641252|NCT00238927|upper respiratory track infection|upper respiratory track infection
1641253|NCT00238927|fluticasone|fluticasone
1641254|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
1641255|NCT00238927|placebo|placebo
1641256|NCT00238927|exacerbations|exacerbations
1641257|NCT00238927|severity|severity
1641258|NCT00238927|safety|safety
1641259|NCT00238927|growth|growth
1641260|NCT00238927|bone mineral density|bone mineral density
1641261|NCT00238927|adrenal function|adrenal function
1641262|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
1641263|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
1641264|NCT00238888|asthma|asthma
1641265|NCT00238888|children|children
1641266|NCT00238888|adolescent|adolescent
1641267|NCT00238888|education|education
1641268|NCT00238888|medical review|medical review
1641269|NCT00238888|asthma control|asthma control
1641270|NCT00238888|questionnaire|questionnaire
1641271|NCT00238888|quality of life|quality of life
1641272|NCT00238888|emergency department visit|emergency department visit
1641273|NCT00238888|use of medication|use of medication
1641274|NCT00238888|adherence to treatment|adherence to treatment
1641275|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
1641276|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
1641277|NCT00238875|radiotherapy|radiotherapy
1641278|NCT00238862|Diabetes|diabetes
1641279|NCT00238862|Corneal transplant|corneal transplant
1641280|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
1641281|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
1641282|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
1641283|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
1641284|NCT00238823|cryoablation|cryoablation
1641285|NCT00238823|radiofrequency ablation|radiofrequency ablation
1641286|NCT00238823|pediatrics|pediatrics
1641287|NCT00238823|cardiology|cardiology
1641288|NCT00238810|BNP|bnp
1641289|NCT00238810|Pediatrics|pediatrics
1641290|NCT00238810|Congenital heart disease|congenital heart disease
1641291|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
1641292|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
1641293|NCT00238797|Brain tumour|brain tumour
1641294|NCT00238758|Mood Disorder|mood disorder
1641295|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1641296|NCT00238732|Vaginal Atrophy|vaginal atrophy
1641297|NCT00238732|Postmenopause|postmenopause
1641298|NCT00238719|Social Anxiety|social anxiety
1641299|NCT00238719|Children Disorders|children disorders
1641300|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
1641301|NCT00238706|Atrial fibrillation|atrial fibrillation
1641302|NCT00238706|Randomized trial|randomized trial
1641303|NCT00238693|transplant|transplant
1641304|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
1641305|NCT00238680|Overactive bladder|overactive bladder
1641306|NCT00238680|Children|children
1641307|NCT00238680|Bladder rehabilitation|bladder rehabilitation
1641308|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
1641309|NCT00238667|Dissection and stroke|dissection and stroke
1641310|NCT00238550|Diabetes|diabetes
1641311|NCT00238550|Pain|pain
1641312|NCT00238550|Peripheral neuropathy|peripheral neuropathy
1641313|NCT00238537|Stroke|stroke
1641314|NCT00238537|Thrombolysis|thrombolysis
1641315|NCT00238537|MRI|mri
1641316|NCT00238537|Echoplanar|echoplanar
1641317|NCT00238537|Penumbra|penumbra
1641318|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
1641319|NCT00238498|Type 2 diabetes|type 2 diabetes
1641320|NCT00238498|vildagliptin|vildagliptin
1641321|NCT00238498|HbA1c|hba1c
1641322|NCT00238485|Bipolar I Disorder|bipolar i disorder
1641323|NCT00238472|Type 2 diabetes|type 2 diabetes
1641324|NCT00238472|nateglinide|nateglinide
1641325|NCT00238459|Immunity to HIV|immunity to hiv
1641326|NCT00238459|Acute Infection|acute infection
1641327|NCT00238459|Treatment Naive|treatment naive
1641328|NCT00238459|Treatment Interruption|treatment interruption
1641329|NCT00238459|Structured Treatment Interruption|structured treatment interruption
1641330|NCT00238459|STI|sti
1641331|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
1641332|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1641333|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1641334|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1641335|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1641336|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1641337|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1641338|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1641339|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1641340|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1641341|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1641342|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1641343|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1641344|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1641345|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1641346|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1641347|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1641348|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1641349|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1641350|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1641351|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1641352|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1641353|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1641354|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1641355|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1641356|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1641357|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1641358|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1641359|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1641360|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1641361|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1641362|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1641363|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1641364|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1641365|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1641366|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1641367|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1641368|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1641438|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1641369|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1641370|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1641371|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1641372|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1641373|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1641374|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1641375|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1641376|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1641377|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1641378|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1641379|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1641380|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1641381|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1641382|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1641383|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1641384|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1641385|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
1641386|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
1641387|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1641388|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
1641389|NCT00238381|stage I rectal cancer|stage i rectal cancer
1641390|NCT00238381|stage II rectal cancer|stage ii rectal cancer
1641391|NCT00238381|stage III rectal cancer|stage iii rectal cancer
1641392|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
1641393|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
1641394|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1641395|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1641396|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1641397|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1641398|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1641399|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1641400|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1641401|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1641402|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1641403|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1641404|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1641405|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1641406|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1641407|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1641408|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1641409|NCT00238355|infection|infection
1641410|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1641411|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1641412|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1641413|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1641414|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1641415|NCT00238342|fallopian tube cancer|fallopian tube cancer
1641416|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1641417|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1641418|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1641419|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1641420|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1641421|NCT00238329|recurrent melanoma|recurrent melanoma
1641422|NCT00238329|stage IV melanoma|stage iv melanoma
1641423|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1641753|NCT00237367|heartburn|heartburn
1641424|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
1641425|NCT00238329|iris melanoma|iris melanoma
1641426|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
1641427|NCT00238316|breast cancer|breast cancer
1641428|NCT00238290|recurrent breast cancer|recurrent breast cancer
1641429|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
1641430|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
1641431|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
1641432|NCT00238290|stage IV breast cancer|stage iv breast cancer
1641433|NCT00238277|adult glioblastoma|adult glioblastoma
1641434|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
1641435|NCT00238277|adult gliosarcoma|adult gliosarcoma
1641436|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
1641437|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1641515|NCT00237822|Contingency Management|contingency management
1641439|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1641440|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1641441|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1641442|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1641443|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1641444|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1641445|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
1641446|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1641447|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1641448|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1641449|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1641450|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
1641451|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
1641452|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1641453|NCT00238173|bone marrow suppression|bone marrow suppression
1641454|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1641455|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1641456|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1641457|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1641458|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1641459|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1641460|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
1641708|NCT00237549|Intensive treatment|intensive treatment
1641461|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1641462|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1641463|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1641464|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1641465|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1641466|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
1641467|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1641468|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1641469|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
1641470|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1641471|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1641472|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
1641473|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1641474|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
1641475|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1641476|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1641477|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
1641478|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
1641479|NCT00238108|Sleep disorders|sleep disorders
1641480|NCT00238108|High blood pressure|high blood pressure
1641482|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1641483|NCT00238082|Emphysema|emphysema
1641484|NCT00238082|Chronic Bronchitis|chronic bronchitis
1641485|NCT00238069|Asthma|asthma
1641486|NCT00238069|Sleep Apnea|sleep apnea
1641487|NCT00238069|Obesity|obesity
1641488|NCT00238069|CPAP|cpap
1641489|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
1641490|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
1641491|NCT00238043|Renal anaemia|renal anaemia
1641492|NCT00238043|Chronic Kidney Disease|chronic kidney disease
1641493|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
1641494|NCT00238043|Hemodialysis|hemodialysis
1641495|NCT00238030|organ donation|organ donation
1641496|NCT00238030|thyroid replacement|thyroid replacement
1641752|NCT00237367|Nighttime heartburn|nighttime heartburn
1641497|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
1641499|NCT00237965|Skin Self Examination|skin self examination
1641500|NCT00237965|Mole Mapping Diagram|mole mapping diagram
1641501|NCT00237965|Melanoma|melanoma
1641502|NCT00237926|Sleep|sleep
1641503|NCT00237926|Fatigue|fatigue
1641504|NCT00237926|Exercise tolerance|exercise tolerance
1641505|NCT00237926|Quality of life|quality of life
1641506|NCT00237926|Health status|health status
1641507|NCT00237887|Psoriasis|psoriasis
1641508|NCT00237887|adalimumab|adalimumab
1641509|NCT00237874|prodrome|prodrome
1641510|NCT00237874|ultra high risk|ultra high risk
1641511|NCT00237874|aripiprazole|aripiprazole
1641512|NCT00237822|Treatment Adherence|treatment adherence
1641513|NCT00237822|Co-Occurring Disorders|co-occurring disorders
1641514|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
1641522|NCT00237796|Rehabilitation|rehabilitation
1641523|NCT00237796|Schizophrenia|schizophrenia
1641524|NCT00237796|Skills|skills
1641525|NCT00237796|Social|social
1641526|NCT00237796|Training|training
1641527|NCT00237783|Renal dialysis|renal dialysis
1641528|NCT00237783|Hypotension|hypotension
1641529|NCT00237783|Dialysis solutions|dialysis solutions
1641530|NCT00237770|Blood Pressure|blood pressure
1641531|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
1641532|NCT00237770|Nitric Oxide|nitric oxide
1641533|NCT00237770|NOS Inhibitor|nos inhibitor
1641534|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
1641535|NCT00237770|Spinal Cord Injury|spinal cord injury
1641536|NCT00237770|Tetraplegia|tetraplegia
1641537|NCT00237757|Patient Care Team|patient care team
1641538|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
1641539|NCT00237757|Treatment outcomes|treatment outcomes
1641540|NCT00237744|Motor Learning|motor learning
1641541|NCT00237744|Rehabilitation|rehabilitation
1641542|NCT00237744|Robotics|robotics
1641543|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
1641544|NCT00237731|Acute pain|acute pain
1641545|NCT00237731|Morphine titration|morphine titration
1641546|NCT00237731|Analgesia|analgesia
1641547|NCT00237731|Pre-hospital care|pre-hospital care
1641548|NCT00237705|Headache|headache
1641549|NCT00237705|Concussion|concussion
1641550|NCT00237705|Post concussive syndrome|post concussive syndrome
1641551|NCT00237705|Head trauma|head trauma
1641552|NCT00237692|Telemedicine|telemedicine
1641553|NCT00237692|Adherence|adherence
1641554|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
1641555|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
1641556|NCT00237692|cardiovascular disease|cardiovascular disease
1641557|NCT00237679|behavior therapy|behavior therapy
1641558|NCT00237679|combination therapy|combination therapy
1641559|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
1641560|NCT00237679|human therapy evaluation|human therapy evaluation
1641561|NCT00237679|larynx disorder|larynx disorder
1641562|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
1641563|NCT00237679|lansoprazole|lansoprazole
1641564|NCT00237679|reflux esophagitis|reflux esophagitis
1641565|NCT00237679|quality of life|quality of life
1641566|NCT00237679|clinical research|clinical research
1641567|NCT00237679|human subject|human subject
1641568|NCT00237679|laryngoscopy|laryngoscopy
1641569|NCT00237679|patient oriented research|patient oriented research
1641570|NCT00237679|questionnaire|questionnaire
1641571|NCT00237666|Bipolar II Disorder|bipolar ii disorder
1641572|NCT00237666|Major Depressive Episode|major depressive episode
1641573|NCT00237653|Valganciclovir|valganciclovir
1641574|NCT00237653|Cytomegalovirus|cytomegalovirus
1641575|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
1641576|NCT00237653|Crohn Disease|crohn disease
1641577|NCT00237653|colitis, ulcerative|colitis, ulcerative
1641578|NCT00237640|Cinnamon|cinnamon
1641579|NCT00237640|Diabetes mellitus|diabetes mellitus
1641580|NCT00237640|Hyperlipidemia|hyperlipidemia
1641581|NCT00237640|Insulin Resistance|insulin resistance
1641582|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
1641583|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
1641584|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
1641585|NCT00237627|stage IV breast cancer|stage iv breast cancer
1641586|NCT00237627|male breast cancer|male breast cancer
1641587|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1641588|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1641589|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1641590|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1641591|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1641592|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1641593|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1641594|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1641595|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1641596|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1641597|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1641598|NCT00237627|mast cell leukemia|mast cell leukemia
1641599|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1641600|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1641601|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1641602|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1641603|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1641604|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1641605|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1641606|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1641607|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1641608|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1641609|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1641610|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
1641611|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1641612|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1641613|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1641614|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1641615|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1641616|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1641617|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1641618|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1641619|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1641620|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1641621|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1641622|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1641623|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1641624|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1641625|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1641626|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1641627|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1641628|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1641629|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1641630|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1641631|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1641632|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1641633|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1641634|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1641635|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1641636|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1641637|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1641638|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1641639|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1641640|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1641641|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1641642|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1641643|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1641644|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1641645|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1641646|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1641647|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1641648|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1641649|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1641650|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1641651|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1641652|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1641653|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1641654|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1641655|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1641656|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1641657|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1641658|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1641659|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1641660|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1641661|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1641662|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1641663|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1641664|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1641665|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1641666|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1641667|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1641668|NCT00237627|intraocular lymphoma|intraocular lymphoma
1641669|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
1641670|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
1641671|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
1641672|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
1641673|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
1641674|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1641675|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1641676|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1641677|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1641678|NCT00237627|recurrent breast cancer|recurrent breast cancer
1641679|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1641680|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
1641681|NCT00237614|Acute myocardial infarction|acute myocardial infarction
1641682|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
1641683|NCT00237601|Home birth|home birth
1641684|NCT00237601|Hospital birth|hospital birth
1641685|NCT00237601|Midwifery|midwifery
1641686|NCT00237601|Effectivity|effectivity
1641687|NCT00237601|Efficiency|efficiency
1641688|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
1641689|NCT00237588|Amlodipine|amlodipine
1641690|NCT00237588|Calcium Channel Blockers|calcium channel blockers
1641691|NCT00237588|Diabetes Mellitus|diabetes mellitus
1641692|NCT00237588|Hypertension|hypertension
1641693|NCT00237588|Insulin Resistance|insulin resistance
1641694|NCT00237588|Losartan|losartan
1641695|NCT00237575|urothelial|urothelial
1641696|NCT00237575|bladder|bladder
1641697|NCT00237575|gemcitabine|gemcitabine
1641698|NCT00237575|cisplatin|cisplatin
1641699|NCT00237575|leukine|leukine
1641700|NCT00237575|neupogen|neupogen
1641701|NCT00237575|filgrastim|filgrastim
1641702|NCT00237575|sargramostim|sargramostim
1641703|NCT00237575|metastatic|metastatic
1641704|NCT00237575|Regionally Advanced|regionally advanced
1641705|NCT00237575|Advanced|advanced
1641706|NCT00237549|Type 2 diabetes|type 2 diabetes
1641709|NCT00237549|Polypharmacy|polypharmacy
1641710|NCT00237549|Primary care|primary care
1641711|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1641713|NCT00237536|Enlarged Prostate|enlarged prostate
1641714|NCT00237523|Breast pain|breast pain
1641715|NCT00237523|Mastalgia|mastalgia
1641716|NCT00237523|Cyclic mastalgia|cyclic mastalgia
1641717|NCT00237523|Periodic mastalgia|periodic mastalgia
1641718|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
1641719|NCT00237523|Fibrosis|fibrosis
1641720|NCT00237523|Nodularity|nodularity
1641721|NCT00237523|Cysts|cysts
1641722|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
1641723|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
1641724|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
1641725|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
1641726|NCT00237497|Insomnia|insomnia
1641727|NCT00237497|Center of Pressure|center of pressure
1641728|NCT00237497|Postural Sway|postural sway
1641729|NCT00237497|Drug Therapy|drug therapy
1641730|NCT00237497|Balance and Stability|balance and stability
1641731|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
1641732|NCT00237484|ribavirin|ribavirin
1641733|NCT00237484|infliximab|infliximab
1641734|NCT00237484|chronic hepatitis C|chronic hepatitis c
1641735|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
1641736|NCT00237471|Hyperglycaemia|hyperglycaemia
1641737|NCT00237471|Insulin Infusion|insulin infusion
1641738|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
1641739|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
1641740|NCT00237419|Radiographic progression|radiographic progression
1641741|NCT00237406|IVR, methadone|ivr, methadone
1641742|NCT00237406|methadone maintenance|methadone maintenance
1641743|NCT00237393|PTSD|ptsd
1641744|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
1641745|NCT00237393|Treatment|treatment
1641746|NCT00237393|Quetiapine|quetiapine
1641747|NCT00237380|Cystic fibrosis|cystic fibrosis
1641748|NCT00237380|Nonsense mutation|nonsense mutation
1641749|NCT00237380|Premature stop codon|premature stop codon
1641750|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
1641751|NCT00237367|GERD|gerd
1641755|NCT00237367|esophageal acid exposure|esophageal acid exposure
1641756|NCT00237367|EAE|eae
1641757|NCT00237367|Aciphex|aciphex
1641758|NCT00237367|Pariet|pariet
1641759|NCT00237367|rabeprazole|rabeprazole
1641760|NCT00237367|Protonix|protonix
1641761|NCT00237367|pantoprazole|pantoprazole
1641762|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
1641763|NCT00237341|chronic low back pain|chronic low back pain
1641764|NCT00237341|opioid|opioid
1641765|NCT00237341|fentanyl|fentanyl
1641766|NCT00237328|Heparin resistance|heparin resistance
1641767|NCT00237328|Blood clotting|blood clotting
1641768|NCT00237328|Heart surgery|heart surgery
1641769|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
1641770|NCT00237315|Urea|urea
1641771|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
1641772|NCT00237302|pediatric migraine|pediatric migraine
1641773|NCT00237302|migraine headache|migraine headache
1641774|NCT00237302|migraine prophylaxis|migraine prophylaxis
1641775|NCT00237302|migraine prevention|migraine prevention
1641776|NCT00237302|migraine|migraine
1641777|NCT00237289|Manic depression|manic depression
1641778|NCT00237289|Mania|mania
1641779|NCT00237289|Depression|depression
1641780|NCT00237289|Bipolar disorder|bipolar disorder
1641781|NCT00237289|Psychosis|psychosis
1641782|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
1641783|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
1641784|NCT00237250|Pre-diabetes|pre-diabetes
1641785|NCT00237250|vildagliptin|vildagliptin
1641786|NCT00237250|IGT|igt
1641787|NCT00237237|Type 2 diabetes|type 2 diabetes
1641788|NCT00237237|vildagliptin|vildagliptin
1641789|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
1641790|NCT00237211|Aromatase inhibitor|aromatase inhibitor
1641791|NCT00237211|letrozole|letrozole
1641792|NCT00237211|breast cancer|breast cancer
1641793|NCT00237198|Aromatase inhibitor|aromatase inhibitor
1641794|NCT00237198|letrozole|letrozole
1641795|NCT00237198|breast cancer|breast cancer
1641796|NCT00237185|GIST|gist
1641797|NCT00237185|c-kit|c-kit
1641798|NCT00237185|imatinib mesylate|imatinib mesylate
1641799|NCT00237172|GIST|gist
1641800|NCT00237172|Imatinib|imatinib
1641801|NCT00237172|STI571|sti571
1641802|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1641803|NCT00237159|Prostate cancer|prostate cancer
1641804|NCT00237159|Bone metastasis|bone metastasis
1641805|NCT00237159|Skeletal related event|skeletal related event
1641806|NCT00237146|Prostate cancer|prostate cancer
1641807|NCT00237146|Zoledronic acid|zoledronic acid
1641808|NCT00237146|Bone metastasis|bone metastasis
1642015|NCT00236561|Topiramate|topiramate
1641809|NCT00237133|Breast cancer,|breast cancer,
1641810|NCT00237133|Letrozole,|letrozole,
1641811|NCT00237133|Hormonal receptors|hormonal receptors
1641812|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1641813|NCT00237120|Imatinib|imatinib
1641814|NCT00237120|CML|cml
1641815|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
1641816|NCT00237107|Curretage|curretage
1641817|NCT00237107|Photochemotherapy|photochemotherapy
1641818|NCT00237094|Diabetes|diabetes
1641819|NCT00237094|Self Management|self management
1641820|NCT00237094|Interdisciplinary team|interdisciplinary team
1641821|NCT00237081|Interstitial Cystitis|interstitial cystitis
1641822|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
1641823|NCT00237081|Genetics|genetics
1641824|NCT00237081|Risk factors|risk factors
1641825|NCT00237081|Family history|family history
1641826|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
1641827|NCT00237055|Children|children
1641828|NCT00237055|Crohn's disease|crohn's disease
1641829|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
1641830|NCT00237055|Infectious agents|infectious agents
1641831|NCT00237055|Colonoscopy|colonoscopy
1641832|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
1641833|NCT00237042|TMJ Disorders|tmj disorders
1641834|NCT00237003|women|women
1641835|NCT00237003|incarceration|incarceration
1641836|NCT00237003|alcohol use|alcohol use
1641837|NCT00237003|motivational interviewing|motivational interviewing
1641838|NCT00236990|prostatitis|prostatitis
1641839|NCT00236990|Elmiron|elmiron
1641840|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
1641841|NCT00236977|CKD|ckd
1641842|NCT00236977|iron|iron
1641843|NCT00236977|anemia|anemia
1641844|NCT00236964|Anemia|anemia
1641845|NCT00236964|Chronic Kidney Disease|chronic kidney disease
1641846|NCT00236951|Anemia|anemia
1641847|NCT00236951|Cancer|cancer
1641848|NCT00236951|Chemotherapy|chemotherapy
1641849|NCT00236938|iron|iron
1641850|NCT00236938|peritoneal dialysis|peritoneal dialysis
1641851|NCT00236938|anemia|anemia
1641852|NCT00236925|Fibromyalgia|fibromyalgia
1641853|NCT00236925|Cortisol|cortisol
1641854|NCT00236925|Hydrocortisone|hydrocortisone
1641855|NCT00236925|Stress|stress
1641856|NCT00236912|complicated appendicitis|complicated appendicitis
1641857|NCT00236912|antibiotics|antibiotics
1641858|NCT00236912|appendicitis|appendicitis
1641859|NCT00236912|infection|infection
1641860|NCT00236886|Epilepsy|epilepsy
1641861|NCT00236886|Partial Epilepsy|partial epilepsy
1641862|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
1641863|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
1641864|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
1641865|NCT00236886|Topiramate|topiramate
1641866|NCT00236886|Weight Loss|weight loss
1641867|NCT00236873|topiramate|topiramate
1641868|NCT00236873|epilepsy|epilepsy
1641869|NCT00236873|partial epilepsies|partial epilepsies
1641870|NCT00236873|partial epilepsy|partial epilepsy
1641872|NCT00236873|epileptic seizures|epileptic seizures
1641873|NCT00236873|partial seizure disorder|partial seizure disorder
1641874|NCT00236873|brain diseases|brain diseases
1641875|NCT00236860|partial seizure disorder|partial seizure disorder
1641876|NCT00236860|brain diseases|brain diseases
1641877|NCT00236860|topiramate|topiramate
1641878|NCT00236860|epilepsy|epilepsy
1641879|NCT00236860|partial epilepsies|partial epilepsies
1641880|NCT00236860|partial epilepsy|partial epilepsy
1641881|NCT00236860|seizures|seizures
1641882|NCT00236860|epileptic seizures|epileptic seizures
1641883|NCT00236847|topiramate|topiramate
1641884|NCT00236847|epilepsy|epilepsy
1641885|NCT00236847|partial epilepsy|partial epilepsy
1641886|NCT00236847|seizures|seizures
1641887|NCT00236847|epileptic seizures|epileptic seizures
1641888|NCT00236847|partial seizure disorder|partial seizure disorder
1641889|NCT00236847|brain diseases|brain diseases
1641890|NCT00236834|respiratory tract diseases|respiratory tract diseases
1641891|NCT00236834|levofloxacin|levofloxacin
1641892|NCT00236834|pneumonia|pneumonia
1641893|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
1641894|NCT00236834|lung diseases|lung diseases
1641895|NCT00236821|respiratory tract diseases|respiratory tract diseases
1641896|NCT00236821|pneumonia|pneumonia
1641897|NCT00236821|levofloxacin|levofloxacin
1641898|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
1641899|NCT00236821|lung diseases|lung diseases
1641900|NCT00236821|quinolones|quinolones
1641901|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
1641902|NCT00236808|levofloxacin|levofloxacin
1641903|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
1641904|NCT00236808|inflammation|inflammation
1641905|NCT00236808|chronic prostatitis|chronic prostatitis
1641906|NCT00236808|prostatitis|prostatitis
1641907|NCT00236808|prostate|prostate
1641908|NCT00236808|antibiotic|antibiotic
1641909|NCT00236795|contraception|contraception
1641910|NCT00236795|hormonal contraception|hormonal contraception
1641911|NCT00236795|oral contraception|oral contraception
1642013|NCT00236561|Classic Migraine|classic migraine
1641912|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
1641913|NCT00236795|transdermal.|transdermal.
1641914|NCT00236782|contraception|contraception
1641915|NCT00236782|hormonal contraception|hormonal contraception
1641916|NCT00236782|oral contraception|oral contraception
1641917|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
1641918|NCT00236782|transdermal.|transdermal.
1641919|NCT00236769|contraception|contraception
1641920|NCT00236769|transdermal contraception|transdermal contraception
1641921|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
1641922|NCT00236769|ethinyl estradiol|ethinyl estradiol
1641923|NCT00236769|progesterone|progesterone
1641924|NCT00236756|Epilepsy|epilepsy
1641925|NCT00236756|Seizures|seizures
1641926|NCT00236756|Topiramate|topiramate
1641927|NCT00236756|Prophylaxis|prophylaxis
1641928|NCT00236756|Antiepileptic|antiepileptic
1641929|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1641930|NCT00236756|Seizures, tonic|seizures, tonic
1641931|NCT00236743|topiramate|topiramate
1641932|NCT00236743|epilepsy|epilepsy
1641933|NCT00236743|partial epilepsies|partial epilepsies
1641934|NCT00236743|partial epilepsy|partial epilepsy
1641935|NCT00236743|seizures|seizures
1641936|NCT00236743|epileptic seizures|epileptic seizures
1641937|NCT00236743|partial seizure disorder|partial seizure disorder
1641938|NCT00236743|children|children
1641939|NCT00236743|pediatric|pediatric
1641940|NCT00236730|topiramate|topiramate
1641941|NCT00236730|epilepsy|epilepsy
1641942|NCT00236730|partial epilepsies|partial epilepsies
1641943|NCT00236730|partial epilepsy|partial epilepsy
1641944|NCT00236730|seizures|seizures
1641945|NCT00236730|epileptic seizures|epileptic seizures
1641946|NCT00236730|partial seizure disorder|partial seizure disorder
1641947|NCT00236730|brain diseases|brain diseases
1641948|NCT00236717|Epilepsy|epilepsy
1641949|NCT00236717|Seizures|seizures
1641950|NCT00236717|Topiramate|topiramate
1641951|NCT00236717|Prophylaxis|prophylaxis
1641952|NCT00236717|Antiepileptic|antiepileptic
1641953|NCT00236704|Epilepsy|epilepsy
1641954|NCT00236704|Seizures|seizures
1641955|NCT00236704|Topiramate|topiramate
1641956|NCT00236704|Prophylaxis|prophylaxis
1641957|NCT00236704|Antiepileptic|antiepileptic
1641958|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
1641959|NCT00236704|Grand mal seizures|grand mal seizures
1641960|NCT00236691|topiramate|topiramate
1641961|NCT00236691|epilepsy|epilepsy
1641962|NCT00236691|partial epilepsies|partial epilepsies
1641963|NCT00236691|partial epilepsy|partial epilepsy
1641964|NCT00236691|seizures|seizures
1641965|NCT00236691|epileptic seizures|epileptic seizures
1641966|NCT00236691|partial seizure disorder|partial seizure disorder
1641967|NCT00236691|brain diseases|brain diseases
1641968|NCT00236678|Anemia|anemia
1641969|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
1641970|NCT00236678|Hemoglobin level|hemoglobin level
1641971|NCT00236665|Obesity|obesity
1641972|NCT00236665|Essential Hypertension|essential hypertension
1641973|NCT00236665|Mild Hypertension|mild hypertension
1641974|NCT00236665|Moderate Hypertension|moderate hypertension
1641975|NCT00236665|High Blood Pressure|high blood pressure
1641976|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
1641977|NCT00236652|Infection|infection
1641978|NCT00236639|Obesity|obesity
1641979|NCT00236639|Hypertension|hypertension
1641980|NCT00236639|Hyperlipidemia|hyperlipidemia
1641981|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1641982|NCT00236639|Body Mass Index|body mass index
1641983|NCT00236626|Type 2 Diabetes|type 2 diabetes
1641984|NCT00236626|Obesity|obesity
1641985|NCT00236626|Insulin Resistance|insulin resistance
1641986|NCT00236626|Body Mass Index|body mass index
1641987|NCT00236626|Hypertension|hypertension
1641988|NCT00236626|Hyperlipidemia|hyperlipidemia
1641989|NCT00236626|Sulfonylurea|sulfonylurea
1641990|NCT00236626|Topiramate|topiramate
1641991|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
1641992|NCT00236626|Metabolic Syndrome|metabolic syndrome
1641993|NCT00236613|Obesity|obesity
1641994|NCT00236613|Hypertension|hypertension
1641995|NCT00236613|Hyperlipidemia|hyperlipidemia
1641996|NCT00236613|Body Mass Index|body mass index
1641997|NCT00236600|Obesity|obesity
1641998|NCT00236600|Hypertension|hypertension
1641999|NCT00236600|Hyperlipidemia|hyperlipidemia
1642000|NCT00236600|Type 2 Diabetes|type 2 diabetes
1642001|NCT00236600|Life style modification|life style modification
1642002|NCT00236587|Schizophrenia|schizophrenia
1642003|NCT00236587|Intramuscular injection|intramuscular injection
1642004|NCT00236587|Antipsychotic agents|antipsychotic agents
1642005|NCT00236587|Long-acting risperidone|long-acting risperidone
1642006|NCT00236574|Dementia|dementia
1642007|NCT00236574|Alzheimer disease|alzheimer disease
1642008|NCT00236574|Mild cognitive impairment|mild cognitive impairment
1642009|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
1642010|NCT00236574|Memory disorder|memory disorder
1642011|NCT00236561|Migraine|migraine
1642012|NCT00236561|Common Migraine|common migraine
1642014|NCT00236561|Headache|headache
1642016|NCT00236561|Propranolol|propranolol
1642017|NCT00236561|Prophylaxis|prophylaxis
1642018|NCT00236561|Prevention|prevention
1642019|NCT00236548|Schizophrenia|schizophrenia
1642020|NCT00236548|schizoaffective disorder|schizoaffective disorder
1642021|NCT00236548|patient compliance|patient compliance
1642022|NCT00236548|long-acting risperidone|long-acting risperidone
1642023|NCT00236548|intramuscular injection|intramuscular injection
1642024|NCT00236548|Treatment Guidebook|treatment guidebook
1642025|NCT00236535|musculoskeletal|musculoskeletal
1642026|NCT00236535|Pain|pain
1642027|NCT00236535|sprained ankle|sprained ankle
1642028|NCT00236535|ligament|ligament
1642029|NCT00236535|sprain|sprain
1642030|NCT00236535|ankle|ankle
1642031|NCT00236522|sinus infection|sinus infection
1642032|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
1642033|NCT00236522|sinusitis|sinusitis
1642034|NCT00236522|bacterial sinus infection|bacterial sinus infection
1642035|NCT00236509|Migraine|migraine
1642036|NCT00236509|Common Migraine|common migraine
1642037|NCT00236509|Classic Migraine|classic migraine
1642038|NCT00236509|Headache|headache
1642039|NCT00236509|Topiramate|topiramate
1642040|NCT00236509|Prophylaxis|prophylaxis
1642041|NCT00236496|tremor|tremor
1642042|NCT00236496|essential tremor|essential tremor
1642043|NCT00236483|Oral Surgery|oral surgery
1642044|NCT00236483|Analgesics|analgesics
1642045|NCT00236483|Postoperative Pain|postoperative pain
1642046|NCT00236483|dental|dental
1642047|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
1642048|NCT00236470|risperidone|risperidone
1642049|NCT00236470|antipsychotropic agents|antipsychotropic agents
1642050|NCT00236470|child|child
1642051|NCT00236470|adolescent|adolescent
1642052|NCT00236457|Schizophrenia|schizophrenia
1642053|NCT00236457|Intramuscular injection|intramuscular injection
1642054|NCT00236457|Antipsychotic agents|antipsychotic agents
1642055|NCT00236457|Long-acting risperidone|long-acting risperidone
1642056|NCT00236457|Olanzapine|olanzapine
1642057|NCT00236444|Child|child
1642058|NCT00236444|adolescent|adolescent
1642059|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
1642060|NCT00236444|risperidone|risperidone
1642061|NCT00236444|antipsychotropic agents|antipsychotropic agents
1642062|NCT00236431|Mild cognitive impairment|mild cognitive impairment
1642063|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
1642064|NCT00236431|Memory disorders|memory disorders
1642065|NCT00236418|Epilepsy|epilepsy
1642066|NCT00236418|Seizures|seizures
1642067|NCT00236418|Topiramate|topiramate
1642068|NCT00236418|Prophylaxis|prophylaxis
1642069|NCT00236418|Antiepileptic|antiepileptic
1642070|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
1642071|NCT00236418|Grand mal seizures|grand mal seizures
1642072|NCT00236405|Anemia|anemia
1642073|NCT00236405|erythropoetin|erythropoetin
1642074|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
1642374|NCT00234949|Cephalexin|cephalexin
1642075|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
1642076|NCT00236392|Heartburn|heartburn
1642077|NCT00236392|Rabeprazole|rabeprazole
1642078|NCT00236392|Anti-ulcer agents|anti-ulcer agents
1642079|NCT00236392|GERD|gerd
1642080|NCT00236392|Proton pump inhibitor|proton pump inhibitor
1642081|NCT00236392|GORD|gord
1642082|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
1642083|NCT00236392|NERD|nerd
1642084|NCT00236379|schizophrenia|schizophrenia
1642085|NCT00236379|blood glucose|blood glucose
1642086|NCT00236379|glucose metabolism|glucose metabolism
1642087|NCT00236379|diabetes mellitus|diabetes mellitus
1642088|NCT00236379|risperidone|risperidone
1642089|NCT00236379|olanzapine|olanzapine
1642090|NCT00236366|Fentanyl|fentanyl
1642091|NCT00236366|opioid analgesics|opioid analgesics
1642092|NCT00236366|osteoarthritis|osteoarthritis
1642093|NCT00236366|arthritis|arthritis
1642094|NCT00236366|transdermal administration|transdermal administration
1642095|NCT00236353|schizophrenia|schizophrenia
1642096|NCT00236353|schizoaffective disorder|schizoaffective disorder
1642097|NCT00236353|long-acting risperidone|long-acting risperidone
1642098|NCT00236353|intramuscular injection|intramuscular injection
1642099|NCT00236340|Amniodrainage|amniodrainage
1642100|NCT00236340|Pregnancy|pregnancy
1642101|NCT00236340|Amniocentesis|amniocentesis
1642102|NCT00236327|Fentanyl|fentanyl
1642103|NCT00236327|Analgesia|analgesia
1642104|NCT00236327|Pain|pain
1642105|NCT00236327|Cancer pain|cancer pain
1642106|NCT00236327|Opioid analgesia|opioid analgesia
1642107|NCT00236327|Transdermal fentanyl|transdermal fentanyl
1642108|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
1642109|NCT00236301|Hormone|hormone
1642110|NCT00236301|Menopause|menopause
1642111|NCT00236301|Inflammation|inflammation
1642112|NCT00236301|Dose effects|dose effects
1642113|NCT00236301|Apoptosis|apoptosis
1642114|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
1642115|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
1642116|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
1642117|NCT00236262|SDRA|sdra
1642118|NCT00236262|Distress|distress
1642119|NCT00236262|Expiratory|expiratory
1642120|NCT00236262|Pressure|pressure
1642121|NCT00236262|Ventilatory|ventilatory
1642122|NCT00236249|Double blind method|double blind method
1642123|NCT00236249|Prospective study|prospective study
1642124|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
1642125|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
1642126|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
1642127|NCT00236249|Pain, postoperative|pain, postoperative
1642128|NCT00236249|Perioperative care|perioperative care
1642129|NCT00236249|Postoperative care|postoperative care
1642130|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
1642131|NCT00236249|Length of stay|length of stay
1642132|NCT00236249|Survival analysis|survival analysis
1642133|NCT00236249|Patient satisfaction|patient satisfaction
1642134|NCT00236249|Surgery|surgery
1642135|NCT00236249|Middle age|middle age
1642136|NCT00236249|Adult|adult
1642137|NCT00236249|Aged|aged
1642138|NCT00236223|Primary hip replacement|primary hip replacement
1642139|NCT00236223|Gabapentin|gabapentin
1642140|NCT00236223|Dexamethasone|dexamethasone
1642141|NCT00236223|Ketamine|ketamine
1642142|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
1642143|NCT00236210|Vascular Intervention Program|vascular intervention program
1642144|NCT00236210|Vascular Disease|vascular disease
1642145|NCT00236210|Coronary Artery Disease|coronary artery disease
1642146|NCT00236210|Diabetes|diabetes
1642147|NCT00236210|Lifestyle Modification|lifestyle modification
1642148|NCT00236210|Modifiable Risk Factors|modifiable risk factors
1642149|NCT00236197|Heartburn|heartburn
1642150|NCT00236197|Rabeprazole|rabeprazole
1642151|NCT00236171|topical therapy|topical therapy
1642152|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
1642153|NCT00236145|BTP|btp
1642154|NCT00236145|Break through pain|break through pain
1642155|NCT00236145|breakthrough pain|breakthrough pain
1642156|NCT00236093|Sickle Cell|sickle cell
1642157|NCT00236041|Breakthrough Pain|breakthrough pain
1642159|NCT00236041|Sickle Cell|sickle cell
1642160|NCT00236041|Severe Burns|severe burns
1642164|NCT00236041|Sickle Cell Disease|sickle cell disease
1642165|NCT00236041|Non-Cancer|non-cancer
1642166|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
1642167|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
1642168|NCT00235989|interferon beta 1b|interferon beta 1b
1642169|NCT00235989|Betaferon|betaferon
1642170|NCT00235989|Betaseron|betaseron
1642171|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
1642172|NCT00235976|Anesthesia|anesthesia
1642173|NCT00235976|Succinylcholine|succinylcholine
1642174|NCT00235976|Tracheal Intubation|tracheal intubation
1642175|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
1642176|NCT00235950|Coronary Heart Disease|coronary heart disease
1642177|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
1642178|NCT00235937|Premenopausal|premenopausal
1642179|NCT00235937|Advanced Breast Cancer|advanced breast cancer
1642180|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
1642181|NCT00235924|menopause|menopause
1642182|NCT00235924|isoflavone|isoflavone
1642183|NCT00235924|endometrial safety|endometrial safety
1642184|NCT00235924|breast innocuity assessment|breast innocuity assessment
1642185|NCT00235924|hot flushes|hot flushes
1642186|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
1642187|NCT00235885|adalimumab|adalimumab
1642188|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
1642189|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
1642190|NCT00235859|adalimumab|adalimumab
1642191|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
1642192|NCT00235846|Saphenous vein|saphenous vein
1642193|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
1642194|NCT00235820|Psoriasis|psoriasis
1642195|NCT00235820|adalimumab|adalimumab
1642196|NCT00235807|Audiology|audiology
1642197|NCT00235807|Rehabilitation|rehabilitation
1642198|NCT00235807|Tinnitus|tinnitus
1642199|NCT00235781|Kidney Transplantation|kidney transplantation
1642200|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
1642201|NCT00235781|Induction|induction
1642202|NCT00235781|Graft Rejection|graft rejection
1642203|NCT00235768|Ecstasy|ecstasy
1642204|NCT00235768|MDMA|mdma
1642205|NCT00235768|Cognition|cognition
1642206|NCT00235768|Brain function|brain function
1642207|NCT00235768|Neuroimaging|neuroimaging
1642208|NCT00235755|Partial Seizures|partial seizures
1642209|NCT00235755|Complex Partial Seizures|complex partial seizures
1642210|NCT00235755|Epilepsy|epilepsy
1642211|NCT00235755|Potassium Channels|potassium channels
1642212|NCT00235755|Anticonvulsant|anticonvulsant
1642213|NCT00235729|Opiate addiction|opiate addiction
1642214|NCT00235729|Opiate dependence|opiate dependence
1642215|NCT00235729|Withdrawal symptoms|withdrawal symptoms
1642216|NCT00235716|Alzheimer's Disease|alzheimer's disease
1642217|NCT00235716|clinical trial|clinical trial
1642218|NCT00235716|randomized controlled trial|randomized controlled trial
1642219|NCT00235716|alpha-tocopherol|alpha-tocopherol
1642220|NCT00235716|vitamin E|vitamin e
1642221|NCT00235716|Namenda|namenda
1642222|NCT00235716|memantine|memantine
1642223|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
1642224|NCT00235677|GERD|gerd
1642225|NCT00235677|Sham-controlled|sham-controlled
1642226|NCT00235677|Endocinch|endocinch
1642227|NCT00235664|liver transplant recipients|liver transplant recipients
1642228|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
1642229|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
1642230|NCT00235651|Lung transplant recipient|lung transplant recipient
1642231|NCT00235625|Alternative Medicine|alternative medicine
1642232|NCT00235625|Psoriasis|psoriasis
1642233|NCT00235625|Turmeric|turmeric
1642234|NCT00235625|Curcumin|curcumin
1642235|NCT00235625|Dermatology|dermatology
1642236|NCT00235599|Growth|growth
1642237|NCT00235599|Hormone|hormone
1642238|NCT00235599|Deficiency|deficiency
1642239|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
1642240|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
1642241|NCT00235573|Holo-transcobalamin|holo-transcobalamin
1642242|NCT00235560|AML|aml
1642243|NCT00235560|Rapamycin|rapamycin
1642244|NCT00235560|Elderly|elderly
1642245|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
1642246|NCT00235547|abortion|abortion
1642247|NCT00235547|randomized|randomized
1642248|NCT00235547|contraception|contraception
1642249|NCT00235547|pregnancy|pregnancy
1642250|NCT00235547|compliance|compliance
1642251|NCT00235547|continuation|continuation
1642252|NCT00235547|contraceptive patch|contraceptive patch
1642253|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
1642254|NCT00235534|abortion|abortion
1642255|NCT00235534|randomized|randomized
1642256|NCT00235534|contraception|contraception
1642257|NCT00235534|pregnancy|pregnancy
1642258|NCT00235534|compliance|compliance
1642259|NCT00235534|continuation|continuation
1642260|NCT00235534|oral contraceptive pills|oral contraceptive pills
1642261|NCT00235521|Pulmonary hypertension|pulmonary hypertension
1642262|NCT00235521|Cardiac Surgery|cardiac surgery
1642263|NCT00235521|Children|children
1642264|NCT00235521|Pediatric Patients|pediatric patients
1642265|NCT00235521|Iloprost|iloprost
1642266|NCT00235521|NO|no
1642267|NCT00235521|nitric oxide|nitric oxide
1642268|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
1642269|NCT00235508|Insomnia|insomnia
1642270|NCT00235508|Anxiety|anxiety
1642271|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
1642272|NCT00235495|stroke|stroke
1642273|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
1642274|NCT00235456|oxygen|oxygen
1642275|NCT00235456|surgical complications|surgical complications
1642276|NCT00235456|colo-rectal resections|colo-rectal resections
1642277|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
1642278|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
1642279|NCT00235404|Treatment of elderly.|treatment of elderly.
1642280|NCT00235404|Nursing home.|nursing home.
1642281|NCT00235404|Rehabilitation.|rehabilitation.
1642282|NCT00235404|Readmissions.|readmissions.
1642283|NCT00235391|Deferasirox|deferasirox
1642284|NCT00235391|Congenital Anemias|congenital anemias
1642285|NCT00235391|Anemias|anemias
1642286|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
1642287|NCT00235391|Chronic Iron Overload|chronic iron overload
1642288|NCT00235391|Transfusional Iron Overload|transfusional iron overload
1642289|NCT00235391|Iron Chelators|iron chelators
1642290|NCT00235391|Oral Iron Chelators|oral iron chelators
1642291|NCT00235391|Thalassemia|thalassemia
1642292|NCT00235391|Sickle Cell Disease|sickle cell disease
1642293|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
1642294|NCT00235391|Myelofibrosis|myelofibrosis
1642295|NCT00235391|ICL670A|icl670a
1642296|NCT00235378|Lupus|lupus
1642298|NCT00235352|Schizphrenia|schizphrenia
1642299|NCT00235352|Cognition|cognition
1642300|NCT00235352|Negative Symptoms|negative symptoms
1642301|NCT00235339|Oxygen Consumption|oxygen consumption
1642302|NCT00235339|Exercise|exercise
1642303|NCT00235339|Rehabilitation|rehabilitation
1642304|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
1642305|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
1642306|NCT00235313|Smoking|smoking
1642307|NCT00235313|Smoking related diseases|smoking related diseases
1642308|NCT00235313|Saliva cotinine|saliva cotinine
1642309|NCT00235313|Dose adjustment|dose adjustment
1642310|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
1642311|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
1642312|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
1642313|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
1642314|NCT00235300|Induction Therapy|induction therapy
1642315|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1642316|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
1642317|NCT00235287|blood pressure|blood pressure
1642318|NCT00235274|Schizophrenia|schizophrenia
1642319|NCT00235274|Secretin|secretin
1642320|NCT00235261|Total hip replacement|total hip replacement
1642321|NCT00235261|Pregablin|pregablin
1642322|NCT00235261|Dexamethasone|dexamethasone
1642323|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
1642324|NCT00235248|TIA/Brain infarct|tia/brain infarct
1642325|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
1642326|NCT00235248|Or peripheral embolism|or peripheral embolism
1642327|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
1642328|NCT00235222|Stavudine|stavudine
1642329|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
1642330|NCT00235222|Viral load|viral load
1642331|NCT00235222|Peripheral neuropathy|peripheral neuropathy
1642332|NCT00235222|Treatment Experienced|treatment experienced
1642333|NCT00235183|plasma|plasma
1642334|NCT00235183|bleeding|bleeding
1642335|NCT00235183|liver transplantation|liver transplantation
1642336|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
1642337|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
1642338|NCT00235105|spondyloarthritis|spondyloarthritis
1642339|NCT00235105|trial|trial
1642340|NCT00235105|adalimumab|adalimumab
1642341|NCT00235079|Pericarditis|pericarditis
1642342|NCT00235079|Recurrence|recurrence
1642343|NCT00235079|Therapeutics|therapeutics
1642344|NCT00235079|Prevention|prevention
1642345|NCT00235079|Colchicine|colchicine
1642346|NCT00235053|asthma|asthma
1642347|NCT00235053|candidiasis, oral|candidiasis, oral
1642348|NCT00235053|voice disorders|voice disorders
1642349|NCT00235040|Upper Respiratory Infections|upper respiratory infections
1642350|NCT00235040|Respiratory Tract Infections|respiratory tract infections
1642351|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
1642352|NCT00235040|Tree Number C08.730|tree number c08.730
1642353|NCT00235040|Unique ID D012141|unique id d012141
1642354|NCT00235014|hypertension|hypertension
1642355|NCT00235014|diabetes|diabetes
1642356|NCT00235014|trandolapril|trandolapril
1642357|NCT00235014|verapamil|verapamil
1642358|NCT00235014|albuminuria|albuminuria
1642666|NCT00233402|Hexvix|hexvix
1642359|NCT00235001|Hypertension|hypertension
1642360|NCT00235001|Tarka|tarka
1642361|NCT00234988|Sibutramine|sibutramine
1642362|NCT00234988|Obesity|obesity
1642363|NCT00234975|Lopinavir|lopinavir
1642364|NCT00234975|Ritonavir|ritonavir
1642365|NCT00234975|Phase 4|phase 4
1642366|NCT00234975|HIV|hiv
1642367|NCT00234962|HIV Infection|hiv infection
1642368|NCT00234962|HAART|haart
1642369|NCT00234962|Lopinavir|lopinavir
1642370|NCT00234962|Ritonavir|ritonavir
1642371|NCT00234962|Treatment Experienced|treatment experienced
1642372|NCT00234962|Treatment Naive|treatment naive
1642373|NCT00234949|Cefdinir|cefdinir
1642375|NCT00234949|Skin Infection|skin infection
1642376|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
1642377|NCT00234936|adalimumab|adalimumab
1642378|NCT00234936|quality of life|quality of life
1642379|NCT00234923|HIV Infection|hiv infection
1642380|NCT00234923|Kaletra|kaletra
1642381|NCT00234923|Lopinavir|lopinavir
1642382|NCT00234923|Ritonavir|ritonavir
1642383|NCT00234923|Treatment Naive|treatment naive
1642384|NCT00234910|Lopinavir|lopinavir
1642385|NCT00234910|Ritonavir|ritonavir
1642386|NCT00234910|Kaletra|kaletra
1642387|NCT00234910|Tenofovir|tenofovir
1642388|NCT00234910|HIV infection|hiv infection
1642389|NCT00234910|Treatment Naive|treatment naive
1642390|NCT00234897|adalimumab|adalimumab
1642391|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
1642392|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
1642393|NCT00234884|adalimumab|adalimumab
1642394|NCT00234871|Hypertension|hypertension
1642395|NCT00234871|Diabetes|diabetes
1642396|NCT00234871|Proteinuria|proteinuria
1642397|NCT00234871|Tarka|tarka
1642398|NCT00234871|Lotrel|lotrel
1642399|NCT00234858|Hypertension|hypertension
1642400|NCT00234858|Metabolic Syndrome|metabolic syndrome
1642401|NCT00234858|Tarka|tarka
1642402|NCT00234858|Hyzaar|hyzaar
1642403|NCT00234832|Obesity|obesity
1642404|NCT00234832|Sibutramine|sibutramine
1642405|NCT00234819|Menopause|menopause
1642406|NCT00234806|telehealth|telehealth
1642407|NCT00234806|telemedicine|telemedicine
1642408|NCT00234793|childhood cancer|childhood cancer
1642409|NCT00234793|intervention|intervention
1642410|NCT00234793|maternal coping|maternal coping
1642411|NCT00234793|problem solving skills|problem solving skills
1642412|NCT00234793|anxiety|anxiety
1642413|NCT00234793|cope|cope
1642414|NCT00234793|problem solving|problem solving
1642415|NCT00234780|acute home care|acute home care
1642416|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1642417|NCT00234767|ARDS|ards
1642418|NCT00234767|Acute Lung Injury|acute lung injury
1642419|NCT00234767|ALI|ali
1642420|NCT00234767|Cost-effectiveness|cost-effectiveness
1642421|NCT00234767|Pharmacoeconomics|pharmacoeconomics
1642422|NCT00234767|Long-term follow-up|long-term follow-up
1642423|NCT00234754|Incontinence|incontinence
1642424|NCT00234754|Surgery|surgery
1642425|NCT00234754|Trans-vaginal tape|trans-vaginal tape
1642426|NCT00234754|Trans-obturator tape|trans-obturator tape
1642427|NCT00234728|psoriasis|psoriasis
1642428|NCT00234728|hydrogel|hydrogel
1642429|NCT00234728|occlusive dressing|occlusive dressing
1642430|NCT00234728|occlusion|occlusion
1642431|NCT00234728|hydrocortisone|hydrocortisone
1642432|NCT00234728|tacrolimus|tacrolimus
1642433|NCT00234728|Protopic|protopic
1642434|NCT00234728|triamcinolone|triamcinolone
1642435|NCT00234728|calcipotriene|calcipotriene
1642436|NCT00234728|Dovonex|dovonex
1642437|NCT00234728|halobetasol|halobetasol
1642438|NCT00234728|Ultravate|ultravate
1642439|NCT00234715|Breast Cancer|breast cancer
1642440|NCT00234715|Breast Cancer Risk|breast cancer risk
1642441|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
1642442|NCT00234715|Psychosocial|psychosocial
1642443|NCT00234715|Acceptance|acceptance
1642444|NCT00234676|Parkinson disease|parkinson disease
1642445|NCT00234676|women|women
1642446|NCT00234676|postmenopause|postmenopause
1642447|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
1642448|NCT00234676|clinical trials|clinical trials
1642449|NCT00234663|Cystic fibrosis|cystic fibrosis
1642450|NCT00234663|Nonsense mutation|nonsense mutation
1642451|NCT00234663|Premature stop codon|premature stop codon
1642452|NCT00234650|position change|position change
1642453|NCT00234650|adenoma|adenoma
1642454|NCT00234650|colonoscopy|colonoscopy
1642455|NCT00234637|Alzheimer's disease,|alzheimer's disease,
1642456|NCT00234637|switch,|switch,
1642457|NCT00234637|rivastigmine,|rivastigmine,
1642458|NCT00234637|memantine|memantine
1642459|NCT00234598|Pneumonia|pneumonia
1642460|NCT00234598|Dental Health|dental health
1642461|NCT00234598|Critical Care|critical care
1642462|NCT00234559|Angiogenesis|angiogenesis
1642463|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
1642464|NCT00234533|growth|growth
1642465|NCT00234533|child development|child development
1642466|NCT00234533|growth hormone|growth hormone
1642467|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
1642468|NCT00234533|growth failure|growth failure
1642469|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
1642470|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
1642471|NCT00234442|Iressa|iressa
1642472|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
1642473|NCT00234416|Pancreatic Cancer|pancreatic cancer
1642474|NCT00234416|EGF-R|egf-r
1642475|NCT00234403|Advanced breast cancer|advanced breast cancer
1642476|NCT00234403|Metastatic breast cancer|metastatic breast cancer
1642477|NCT00234403|ER positive breast cancer|er positive breast cancer
1642478|NCT00234403|PR positive breast cancer|pr positive breast cancer
1642479|NCT00234377|Schizophrenia|schizophrenia
1642480|NCT00234364|Pergolide|pergolide
1642481|NCT00234364|Ergotamine derivates|ergotamine derivates
1642482|NCT00234364|Valvular heart disease|valvular heart disease
1642483|NCT00234338|Children|children
1642484|NCT00234338|Vaccine|vaccine
1642485|NCT00234338|Prevenar|prevenar
1642486|NCT00234312|Depressive Disorders|depressive disorders
1642487|NCT00234299|Cancer|cancer
1642488|NCT00234299|Prostate|prostate
1642489|NCT00234299|Preventive Therapy|preventive therapy
1642490|NCT00234286|Palliative Care|palliative care
1642491|NCT00234286|Terminal Care|terminal care
1642492|NCT00234286|Hospice Care|hospice care
1642493|NCT00234286|Patient Care Planning|patient care planning
1642494|NCT00234286|Nursing Care Plans|nursing care plans
1642495|NCT00234286|Quality of Health Care|quality of health care
1642496|NCT00234286|Inpatients|inpatients
1642497|NCT00234286|Professional education|professional education
1642498|NCT00234286|Resuscitation orders|resuscitation orders
1642499|NCT00234286|Pastoral Care|pastoral care
1642500|NCT00234273|Adapted Physical Activity|adapted physical activity
1642501|NCT00234273|Quality of life|quality of life
1642502|NCT00234273|cardiovascular risk|cardiovascular risk
1642503|NCT00234273|teaching|teaching
1642504|NCT00234273|Directly Observed Therapy|directly observed therapy
1642505|NCT00234273|Physical activity|physical activity
1642506|NCT00234260|Genetics|genetics
1642507|NCT00234234|Biologics|biologics
1642508|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
1642509|NCT00234208|Pleural empyema|pleural empyema
1642510|NCT00234208|Intervention|intervention
1642511|NCT00234208|Medical thoracoscopy|medical thoracoscopy
1642512|NCT00234208|Chest tube drainage|chest tube drainage
1642513|NCT00234195|Breast Cancer|breast cancer
1642514|NCT00234195|Major Depressive Disorder|major depressive disorder
1642515|NCT00234182|liver cancer|liver cancer
1642516|NCT00234182|hepatectomy|hepatectomy
1642517|NCT00234182|survival|survival
1642518|NCT00234182|recurrence|recurrence
1642519|NCT00234169|Multiple Myeloma|multiple myeloma
1642520|NCT00234169|Lymphoma|lymphoma
1642521|NCT00234156|Fructose|fructose
1642522|NCT00234156|Lipogenesis|lipogenesis
1642523|NCT00234156|Triglycerides|triglycerides
1642524|NCT00234156|Dialysis|dialysis
1642526|NCT00234143|EPO|epo
1642527|NCT00234143|G-CSF|g-csf
1642528|NCT00234143|REGiM|regim
1642529|NCT00234130|Dialysis|dialysis
1642530|NCT00234130|Cytokines|cytokines
1642531|NCT00234130|Triglycerides|triglycerides
1642532|NCT00234130|Insulin|insulin
1642533|NCT00234104|OPC-41061|opc-41061
1642534|NCT00234104|Tolvaptan|tolvaptan
1642535|NCT00234104|Heart Failure|heart failure
1642536|NCT00234104|Edema|edema
1642537|NCT00234104|Extracellular volume expansion|extracellular volume expansion
1642538|NCT00234091|Treatment Naive|treatment naive
1642539|NCT00234091|Treatment Initiation|treatment initiation
1642540|NCT00234091|Infant|infant
1642541|NCT00234091|Preschool Child|preschool child
1642542|NCT00234091|Child|child
1642543|NCT00234091|Zidovudine|zidovudine
1642544|NCT00234091|AZT|azt
1642545|NCT00234091|Retrovir|retrovir
1642546|NCT00234091|3TC|3tc
1642547|NCT00234091|Lamivudine|lamivudine
1642548|NCT00234091|Epivir|epivir
1642549|NCT00234091|Nevirapine|nevirapine
1642550|NCT00234091|NVP|nvp
1642551|NCT00234091|Viramune|viramune
1642552|NCT00234091|Efavirenz|efavirenz
1642553|NCT00234091|EFV|efv
1642554|NCT00234091|Sustiva|sustiva
1642555|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
1642556|NCT00234091|LPV/r|lpv/r
1642557|NCT00234091|Kaletra|kaletra
1642558|NCT00234091|Nelfinavir|nelfinavir
1642559|NCT00234091|NFV|nfv
1642560|NCT00234091|Viracept|viracept
1642561|NCT00234091|ABC|abc
1642562|NCT00234091|Abacavir|abacavir
1642563|NCT00234091|Ziagen|ziagen
1642564|NCT00234078|OPC-12759|opc-12759
1642565|NCT00234078|Dry eye syndromes|dry eye syndromes
1642566|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1642567|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1642568|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1642569|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
1642570|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1642571|NCT00234052|large cell lung cancer|large cell lung cancer
1642572|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
1642573|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
1642574|NCT00234039|stage I bladder cancer|stage i bladder cancer
1642575|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1642576|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1642577|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1642578|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1642579|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1642580|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1642581|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1642582|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1642583|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
1642584|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1642585|NCT00234000|refractory anemia|refractory anemia
1642586|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1642587|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1642588|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1642589|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1642590|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1642591|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
1642592|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
1642593|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
1642594|NCT00233974|stage IV breast cancer|stage iv breast cancer
1642595|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1642596|NCT00233922|orbit|orbit
1642597|NCT00233922|orbital|orbital
1642598|NCT00233922|trauma|trauma
1642599|NCT00233922|fractures|fractures
1642600|NCT00233922|facial|facial
1642601|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
1642602|NCT00233909|Relapse|relapse
1642603|NCT00233909|Chemotherapy|chemotherapy
1642604|NCT00233909|Zosuquidar|zosuquidar
1642605|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
1642606|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
1642607|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
1642608|NCT00233896|Gastrointestinal tract|gastrointestinal tract
1642609|NCT00233896|Randomized trial|randomized trial
1642610|NCT00233896|Topical corticosteroid|topical corticosteroid
1642611|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
1642612|NCT00233896|Prednisone|prednisone
1642613|NCT00233896|Survival|survival
1642614|NCT00233857|Acute pain|acute pain
1642615|NCT00233857|postoperative pain|postoperative pain
1642616|NCT00233857|auricular acupuncture|auricular acupuncture
1642617|NCT00233844|Acute pain|acute pain
1642618|NCT00233844|pain on venipuncture|pain on venipuncture
1642619|NCT00233844|"cough-trick"|"cough-trick"
1642620|NCT00233844|distraction|distraction
1642621|NCT00233831|Postoperative pain|postoperative pain
1642622|NCT00233831|analgesia|analgesia
1642623|NCT00233831|total knee arthroplasty|total knee arthroplasty
1642624|NCT00233753|Intracranial|intracranial
1642625|NCT00233753|Wide-neck|wide-neck
1642626|NCT00233753|Saccular|saccular
1642627|NCT00233753|Aneurysms|aneurysms
1642628|NCT00233727|cervical cancer|cervical cancer
1642629|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1642630|NCT00233727|prevention|prevention
1642631|NCT00233727|cryotherapy|cryotherapy
1642632|NCT00233727|HPV testing|hpv testing
1642633|NCT00233727|cytology|cytology
1642635|NCT00233701|Hydrocephalus|hydrocephalus
1642636|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
1642637|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
1642638|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
1642639|NCT00233610|Casodex monotherapy|casodex monotherapy
1642640|NCT00233597|anemia|anemia
1642641|NCT00233597|iron|iron
1642642|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
1642643|NCT00233545|cutaneous|cutaneous
1642644|NCT00233545|leishmaniasis|leishmaniasis
1642645|NCT00233545|drug|drug
1642646|NCT00233545|miltefosine|miltefosine
1642647|NCT00233532|Hypertension|hypertension
1642648|NCT00233532|Trandolapril|trandolapril
1642649|NCT00233506|CpG 7909|cpg 7909
1642650|NCT00233506|CLL|cll
1642651|NCT00233493|dermatophytes|dermatophytes
1642652|NCT00233480|Randomized Controlled Trial|randomized controlled trial
1642653|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1642654|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
1642655|NCT00233480|Ventricular Remodeling|ventricular remodeling
1642656|NCT00233480|Chemokines|chemokines
1642657|NCT00233467|antipsychotics|antipsychotics
1642658|NCT00233467|PTSD|ptsd
1642659|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
1642660|NCT00233441|Atrial Fibrillation|atrial fibrillation
1642661|NCT00233441|Atrial Flutter|atrial flutter
1642662|NCT00233441|Arrhythmia|arrhythmia
1642663|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
1642664|NCT00233428|Healthy volunteers|healthy volunteers
1642665|NCT00233402|Bladder Cancer|bladder cancer
1642667|NCT00233402|Fluorescence|fluorescence
1642668|NCT00233402|Cystoscopy|cystoscopy
1642669|NCT00233376|Decision support system|decision support system
1642670|NCT00233376|Causal probabilistic network|causal probabilistic network
1642671|NCT00233376|Antibiotics|antibiotics
1642672|NCT00233376|Antibiotic resistance|antibiotic resistance
1642673|NCT00233376|Community-acquired infections|community-acquired infections
1642674|NCT00233376|Cross-infections|cross-infections
1642675|NCT00233350|Neuronavigation|neuronavigation
1642676|NCT00233350|Ultrasound|ultrasound
1642677|NCT00233350|Brain tumour surgery|brain tumour surgery
1642678|NCT00233350|Biopsy|biopsy
1642679|NCT00233350|Histopathology|histopathology
1642680|NCT00233350|Intraoperative imaging|intraoperative imaging
1642681|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
1642682|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
1642683|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
1642684|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1642685|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1642686|NCT00233324|Prematurity|prematurity
1642687|NCT00233324|Mechanical ventilation|mechanical ventilation
1642688|NCT00233324|Surfactant|surfactant
1642689|NCT00233324|Intubation|intubation
1642690|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
1642691|NCT00233324|Pulse oximetry|pulse oximetry
1642692|NCT00233324|Oxygen saturation|oxygen saturation
1642693|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
1642694|NCT00233311|high fat diet|high fat diet
1642695|NCT00233311|inflammation|inflammation
1642696|NCT00233311|inflammatory markers|inflammatory markers
1642697|NCT00233311|C-reactive protein|c-reactive protein
1642698|NCT00233311|Aging|aging
1642699|NCT00233298|Hypoglycemia|hypoglycemia
1642700|NCT00233298|Blood Sugar|blood sugar
1642701|NCT00233298|Blood Glucose Level|blood glucose level
1642702|NCT00233298|Insulin Sensitivity|insulin sensitivity
1642703|NCT00233298|Metabolism|metabolism
1642704|NCT00233298|Type 2 Diabetes|type 2 diabetes
1642705|NCT00233298|Healthy|healthy
1642706|NCT00233272|Frailty|frailty
1642707|NCT00233272|Disease Processes|disease processes
1642708|NCT00233155|Analgesics|analgesics
1642709|NCT00233155|Capsaicin|capsaicin
1642710|NCT00233155|Neuropathic pain|neuropathic pain
1642711|NCT00233155|Neuropathy|neuropathy
1642712|NCT00233155|PHN|phn
1642713|NCT00233155|Shingles|shingles
1642714|NCT00233142|Diabetes|diabetes
1642715|NCT00233142|Emotions|emotions
1642716|NCT00233142|Blood glucose|blood glucose
1642717|NCT00233142|Expressive Writing|expressive writing
1642718|NCT00233129|Day treatment|day treatment
1642719|NCT00233129|executive function|executive function
1642720|NCT00233129|problem solving|problem solving
1642721|NCT00233129|attention|attention
1642722|NCT00233129|participation|participation
1642723|NCT00233129|TBI|tbi
1642724|NCT00233129|brain injury|brain injury
1642725|NCT00233129|traumatic brain injury|traumatic brain injury
1642726|NCT00233103|Sertraline|sertraline
1642727|NCT00233103|TBI|tbi
1642728|NCT00233103|depression|depression
1642729|NCT00233103|SSRI|ssri
1642730|NCT00233103|brain injury|brain injury
1642731|NCT00233090|Fatigue|fatigue
1642732|NCT00233090|TBI|tbi
1642733|NCT00233090|brain injury|brain injury
1642734|NCT00233090|Modafinil|modafinil
1642735|NCT00233090|traumatic brain injury|traumatic brain injury
1642736|NCT00233077|breast cancer|breast cancer
1642737|NCT00233077|adjuvant treatment|adjuvant treatment
1642738|NCT00233077|racial disparities|racial disparities
1642739|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
1642740|NCT00233051|Emphysema|emphysema
1642741|NCT00233051|Chronic Bronchitis|chronic bronchitis
1642742|NCT00233051|Inhaled Steroid|inhaled steroid
1642743|NCT00233051|Salmeterol|salmeterol
1642744|NCT00233038|Pancreatic cancer|pancreatic cancer
1642745|NCT00233038|Pancreatic adenoma|pancreatic adenoma
1642746|NCT00233038|Ethanol|ethanol
1642747|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
1642748|NCT00233038|Cyst ablation|cyst ablation
1642749|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
1642750|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
1642751|NCT00233012|Pharmacokinetics|pharmacokinetics
1642752|NCT00233012|Topiramate|topiramate
1642753|NCT00232999|Allergic asthma|allergic asthma
1642754|NCT00232999|Allergen challenge|allergen challenge
1642755|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
1642756|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
1642757|NCT00232960|surgery|surgery
1642758|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
1642759|NCT00232960|molecular analysis|molecular analysis
1642760|NCT00232960|microsatellite instability|microsatellite instability
1642761|NCT00232947|vaccine|vaccine
1642762|NCT00232947|elderly|elderly
1642763|NCT00232947|immunogenicity|immunogenicity
1642764|NCT00232947|safety|safety
1642765|NCT00232934|Myeloma|myeloma
1642766|NCT00232934|Thalidomide|thalidomide
1642767|NCT00232934|Diagnosis|diagnosis
1642768|NCT00232934|Elderly patients|elderly patients
1642769|NCT00232882|Hypertension|hypertension
1642770|NCT00232882|Blood pressure|blood pressure
1642771|NCT00232882|Antihypertensive drugs|antihypertensive drugs
1642772|NCT00232882|Clinical Pharmacology|clinical pharmacology
1642773|NCT00232882|Autonomic nervous system|autonomic nervous system
1642774|NCT00232882|Renin angiotensin system|renin angiotensin system
1642775|NCT00232882|Oxidative stress|oxidative stress
1642776|NCT00232882|Inflammatory markers|inflammatory markers
1642777|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
1642778|NCT00232817|Postoperative pain|postoperative pain
1642779|NCT00232726|Malignant melanoma|malignant melanoma
1642780|NCT00232726|CP-4055|cp-4055
1642781|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
1642782|NCT00232726|Phase II|phase ii
1642783|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
1642784|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
1642785|NCT00232713|Birth Defects|birth defects
1642786|NCT00232713|Pregnancy|pregnancy
1642787|NCT00232713|Uterine Fibroids|uterine fibroids
1642788|NCT00232713|Fibroids|fibroids
1642789|NCT00232700|Major depressive disorder|major depressive disorder
1642790|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
1642791|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1642792|NCT00232635|RSV|rsv
1642793|NCT00232635|HSCT|hsct
1642794|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
1642795|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
1642796|NCT00232622|Fibrinolysis|fibrinolysis
1642797|NCT00232622|Streptokinase|streptokinase
1642798|NCT00232609|Wheelchair|wheelchair
1642799|NCT00232609|Exercise|exercise
1642800|NCT00232609|Cardiovascular Disease|cardiovascular disease
1642801|NCT00232596|Partial Seizures|partial seizures
1642802|NCT00232596|Anticonvulsant|anticonvulsant
1642803|NCT00232596|Complex Partial Seizures|complex partial seizures
1642804|NCT00232596|Potassium Channels|potassium channels
1642805|NCT00232596|Epilepsy|epilepsy
1642806|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
1642807|NCT00232583|Newly diagnosed|newly diagnosed
1642808|NCT00232583|Beta-cell function|beta-cell function
1642809|NCT00232570|sleep disturbance|sleep disturbance
1642810|NCT00232570|dementia|dementia
1642811|NCT00232557|Asthma|asthma
1642812|NCT00232557|Disease Management|disease management
1642813|NCT00232557|Telecommunications|telecommunications
1642814|NCT00232557|Health Services|health services
1642815|NCT00232557|Quality of Life|quality of life
1642816|NCT00232557|Patient Compliance|patient compliance
1642817|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
1642818|NCT00232544|Quality of Life|quality of life
1642819|NCT00232544|Depression|depression
1642820|NCT00232544|Patient Compliance|patient compliance
1642821|NCT00232518|immune system|immune system
1642822|NCT00232518|infection|infection
1642823|NCT00232518|allergic rhinitis|allergic rhinitis
1642824|NCT00232505|recurrent breast cancer|recurrent breast cancer
1642825|NCT00232505|stage IV breast cancer|stage iv breast cancer
1642826|NCT00232492|Wisdom|wisdom
1642827|NCT00232492|Tooth|tooth
1642828|NCT00232492|Teeth|teeth
1642829|NCT00232492|Third|third
1642830|NCT00232492|Molar|molar
1642831|NCT00232466|Vertebroplasty|vertebroplasty
1642832|NCT00232466|Vertebral fracture|vertebral fracture
1642833|NCT00232466|Actonel|actonel
1642834|NCT00232466|Osteoporotic|osteoporotic
1642835|NCT00232466|vertebral|vertebral
1642836|NCT00232466|fractures|fractures
1642837|NCT00232427|Liver cirrhosis|liver cirrhosis
1642838|NCT00232427|Hemodynamics|hemodynamics
1642839|NCT00232427|Fluid balance|fluid balance
1642840|NCT00232414|bipolar|bipolar
1642841|NCT00232414|with acute depressive episode|with acute depressive episode
1642842|NCT00232401|urine|urine
1642843|NCT00232401|circadian rhythm|circadian rhythm
1642844|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
1642845|NCT00232375|SPIDDM|spiddm
1642846|NCT00232375|LADA|lada
1642847|NCT00232375|GAD antibody|gad antibody
1642848|NCT00232375|Beta cell function|beta cell function
1642849|NCT00232375|Insulin|insulin
1642850|NCT00232349|schizophrenia|schizophrenia
1642851|NCT00232349|galantamine|galantamine
1642852|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
1642853|NCT00232349|quality of life|quality of life
1642854|NCT00232349|cognition|cognition
1642855|NCT00232336|cocaine|cocaine
1642856|NCT00232336|drug|drug
1642857|NCT00232336|substance|substance
1642858|NCT00232336|abuse|abuse
1642859|NCT00232336|addiction|addiction
1642860|NCT00232336|dependence|dependence
1642861|NCT00232336|quetiapine|quetiapine
1642862|NCT00232336|antipsychotic|antipsychotic
1642863|NCT00232336|treatment|treatment
1642864|NCT00232323|intensive care|intensive care
1642865|NCT00232323|stress|stress
1642866|NCT00232323|education|education
1642867|NCT00232323|simulation|simulation
1642868|NCT00232310|Atrial Fibrillation|atrial fibrillation
1642869|NCT00232310|Atrial Flutter|atrial flutter
1642870|NCT00232310|Electric Countershock|electric countershock
1642871|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
1642872|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
1642873|NCT00232297|Defibrillators Implantable|defibrillators implantable
1642874|NCT00232297|Arrhythmia|arrhythmia
1642875|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
1642876|NCT00232258|NK1 Antagonist|nk1 antagonist
1642877|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
1642878|NCT00232258|Mesalamine|mesalamine
1642879|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
1642880|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
1642881|NCT00232206|NSCLC|nsclc
1642882|NCT00232206|Lung|lung
1642883|NCT00232206|Cancer|cancer
1642884|NCT00232206|Metastatic|metastatic
1642885|NCT00232206|Neoadjuvant|neoadjuvant
1642886|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
1642887|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
1642888|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
1642889|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
1642890|NCT00232193|Multiple Sclerosis|multiple sclerosis
1642891|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
1642892|NCT00232193|Pulsed steroids|pulsed steroids
1642893|NCT00232180|Open-label|open-label
1642894|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
1642895|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
1642896|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
1642897|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
1642898|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
1642899|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
1642900|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
1642901|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
1642902|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
1642903|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
1642904|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
1642905|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
1642906|NCT00231985|Behavior Therapy|behavior therapy
1642907|NCT00231985|Supportive Therapy|supportive therapy
1642908|NCT00231972|HIV|hiv
1642909|NCT00231972|MSM|msm
1642910|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
1642911|NCT00231946|gonadotropins|gonadotropins
1642912|NCT00231946|hormone therapy|hormone therapy
1642913|NCT00231946|HRT|hrt
1642914|NCT00231946|Antigonadotropin|antigonadotropin
1642915|NCT00231946|Leuprolide|leuprolide
1642916|NCT00231933|Person-centered Care|person-centered care
1642917|NCT00231933|Recovery|recovery
1642918|NCT00231933|Disparities|disparities
1642919|NCT00231933|Culturally Responsive Care|culturally responsive care
1642920|NCT00231933|Psychosis|psychosis
1642921|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
1642922|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
1642923|NCT00231894|atypical antipsychotics|atypical antipsychotics
1642924|NCT00231894|hyperglycemia|hyperglycemia
1642925|NCT00231894|triglycerides|triglycerides
1642926|NCT00231894|HDL|hdl
1642927|NCT00231894|cholesterol|cholesterol
1642928|NCT00231894|insulin resistance|insulin resistance
1642929|NCT00231894|schizophrenia|schizophrenia
1642930|NCT00231894|verbal memory|verbal memory
1642931|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
1642932|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
1642933|NCT00231868|UPSC|upsc
1642934|NCT00231868|Radiation Therapy|radiation therapy
1642935|NCT00231868|Chemotherapy|chemotherapy
1642936|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
1642937|NCT00231855|Uterine Cancer|uterine cancer
1642938|NCT00231855|Prior Therapy|prior therapy
1642939|NCT00231855|Chemotherapy|chemotherapy
1642940|NCT00231855|Recurrence|recurrence
1642941|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
1642942|NCT00231842|MMT|mmt
1642943|NCT00231842|Uterine Cancer|uterine cancer
1642944|NCT00231842|Radiation Therapy|radiation therapy
1642945|NCT00231842|Chemotherapy|chemotherapy
1642946|NCT00231829|Treatment|treatment
1642947|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
1642948|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
1642949|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
1642950|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
1642951|NCT00231764|Renal transplantation|renal transplantation
1642952|NCT00231764|Immunosuppression|immunosuppression
1642953|NCT00231764|Daclizumab|daclizumab
1642954|NCT00231764|GFR|gfr
1642955|NCT00231751|Hemophilia A|hemophilia a
1642956|NCT00231751|Inhibitors|inhibitors
1642957|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
1642958|NCT00231738|Coronary artery disease|coronary artery disease
1642959|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
1642960|NCT00231712|spectratype|spectratype
1642961|NCT00231712|immunoscope|immunoscope
1642962|NCT00231712|TREC analysis|trec analysis
1642963|NCT00231712|solid tumor|solid tumor
1643767|NCT00228150|levodopa|levodopa
1642964|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
1642965|NCT00231699|Pediatric Patient|pediatric patient
1642967|NCT00231699|Plastic wrap|plastic wrap
1642968|NCT00231686|Lung function test|lung function test
1642969|NCT00231686|Physical conditioning, human|physical conditioning, human
1642970|NCT00231686|Physical fitness|physical fitness
1642971|NCT00231686|Quality of life|quality of life
1642972|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
1642973|NCT00231673|Electrophysiology|electrophysiology
1642974|NCT00231673|Nerve Conduction Study|nerve conduction study
1642975|NCT00231673|Neurological Examination|neurological examination
1642976|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
1642977|NCT00231673|Topiramate|topiramate
1642978|NCT00231660|Type 2 Diabetes|type 2 diabetes
1642979|NCT00231660|Obesity|obesity
1642980|NCT00231660|Metformin|metformin
1642981|NCT00231660|Hemoglobin A1c|hemoglobin a1c
1642982|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
1642983|NCT00231647|Obesity|obesity
1642984|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1642985|NCT00231647|Metformin|metformin
1642986|NCT00231647|Diabetic Diet|diabetic diet
1642987|NCT00231647|Topiramate|topiramate
1642988|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
1642989|NCT00231634|Obesity|obesity
1642990|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1642991|NCT00231634|HbA1c|hba1c
1642992|NCT00231634|Sulfonylurea|sulfonylurea
1642993|NCT00231634|Topiramate|topiramate
1642994|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
1642995|NCT00231621|Obesity|obesity
1642996|NCT00231621|Dyslipidemia|dyslipidemia
1642997|NCT00231621|Hyperlipidemia|hyperlipidemia
1642998|NCT00231621|Triglyceride|triglyceride
1642999|NCT00231621|HDL|hdl
1643000|NCT00231621|LDL|ldl
1643001|NCT00231621|Diabetes|diabetes
1643002|NCT00231608|Obesity|obesity
1643003|NCT00231608|Abdominal Obesity|abdominal obesity
1643004|NCT00231608|Visceral Fat|visceral fat
1643005|NCT00231608|Subcutaneous Fat|subcutaneous fat
1643006|NCT00231608|Dislipidemia|dislipidemia
1643007|NCT00231608|Hypertension|hypertension
1643008|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1643009|NCT00231595|Migraine|migraine
1643010|NCT00231595|Common Migraine|common migraine
1643011|NCT00231595|Classic Migraine|classic migraine
1643012|NCT00231595|Headache|headache
1643013|NCT00231595|Topiramate|topiramate
1643014|NCT00231595|Prophylaxis|prophylaxis
1643015|NCT00231595|Prevention|prevention
1643016|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
1643017|NCT00231569|LDL-cholesterol|ldl-cholesterol
1643018|NCT00231569|apoB-100|apob-100
1643019|NCT00231569|apoB-48|apob-48
1643020|NCT00231556|Epilepsy|epilepsy
1643021|NCT00231556|Seizures|seizures
1643022|NCT00231556|Parital Epilepsies|parital epilepsies
1643023|NCT00231556|Generalized Epilepsy|generalized epilepsy
1643024|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
1643025|NCT00231556|Topiramate|topiramate
1643026|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1643027|NCT00231530|Obesity|obesity
1643028|NCT00231530|Diabetic Diet|diabetic diet
1643029|NCT00231530|Hypertension|hypertension
1643030|NCT00231530|Hyperlipidemia|hyperlipidemia
1643031|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
1643032|NCT00231504|Polymorphism P1|polymorphism p1
1643033|NCT00231504|Polymorphism P2|polymorphism p2
1643034|NCT00231504|FSH Receptor|fsh receptor
1643035|NCT00231504|Antral follicle count|antral follicle count
1643036|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
1643037|NCT00231491|Overactive bladder|overactive bladder
1643038|NCT00231491|Urgency|urgency
1643039|NCT00231491|Urge incontinence|urge incontinence
1643040|NCT00231491|Botulinum toxin A|botulinum toxin a
1643041|NCT00231491|Quality of life|quality of life
1643042|NCT00231465|elderly|elderly
1643043|NCT00231465|malignant pleural effusion|malignant pleural effusion
1643044|NCT00231452|natural acquired immunity,|natural acquired immunity,
1643045|NCT00231452|clinical malaria,|clinical malaria,
1643046|NCT00231452|P. falciparum,|p. falciparum,
1643047|NCT00231452|age,|age,
1643048|NCT00231452|exposure,|exposure,
1643049|NCT00231452|neonatal immunology,|neonatal immunology,
1643050|NCT00231452|infants|infants
1643051|NCT00231439|Post-polio syndrome|post-polio syndrome
1643052|NCT00231439|IvIg|ivig
1643053|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
1643054|NCT00231400|GSD-II|gsd-ii
1643055|NCT00231400|Pompe Disease|pompe disease
1643056|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
1643057|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1643058|NCT00231400|Glycogenosis II|glycogenosis ii
1643059|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
1643060|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
1643061|NCT00231374|pain in cervical spine|pain in cervical spine
1643062|NCT00231374|pain in lumbar spine|pain in lumbar spine
1643063|NCT00231374|myelogram|myelogram
1643064|NCT00231348|Social anxiety disorder|social anxiety disorder
1643065|NCT00231348|social phobia|social phobia
1643066|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
1643067|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
1643068|NCT00231348|nefazodone|nefazodone
1643069|NCT00231348|amygdala|amygdala
1643070|NCT00231335|schizophrenia|schizophrenia
1643071|NCT00231335|depression|depression
1643072|NCT00231335|anxiety|anxiety
1643073|NCT00231335|negative symptoms|negative symptoms
1643074|NCT00231322|Schistosoma haematobium|schistosoma haematobium
1643075|NCT00231322|haematuria|haematuria
1643076|NCT00231322|ultrasonography|ultrasonography
1643078|NCT00231322|Vesical polyps|vesical polyps
1643079|NCT00231309|G-CSF|g-csf
1643080|NCT00231309|Bone Marrow|bone marrow
1643081|NCT00231309|Hematologic malignancies|hematologic malignancies
1643082|NCT00231309|Non-malignancies|non-malignancies
1643083|NCT00231309|Matched sibling donor|matched sibling donor
1643084|NCT00231309|Allogeneic BMT|allogeneic bmt
1643085|NCT00231296|cryoablation|cryoablation
1643086|NCT00231296|atrial fibrillation|atrial fibrillation
1643087|NCT00231218|vitamin c|vitamin c
1643088|NCT00231218|echinacea|echinacea
1643089|NCT00231218|propolis|propolis
1643090|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
1643091|NCT00231218|common cold|common cold
1643092|NCT00231218|gastroenteritis|gastroenteritis
1643093|NCT00231218|dietary supplement|dietary supplement
1643094|NCT00231218|herbal remedy|herbal remedy
1643095|NCT00231205|viability|viability
1643096|NCT00231205|myocardium|myocardium
1643097|NCT00231205|preejection velocity|preejection velocity
1643098|NCT00231205|CAD|cad
1643099|NCT00231205|echocardiography|echocardiography
1643100|NCT00231205|tissue Doppler|tissue doppler
1643101|NCT00231192|Diabetes|diabetes
1643102|NCT00231192|Adolescents|adolescents
1643103|NCT00231192|Cystic Fibrosis|cystic fibrosis
1643104|NCT00231192|Insulin|insulin
1643105|NCT00231192|Repaglinide|repaglinide
1643106|NCT00231179|child, preschool|child, preschool
1643107|NCT00231179|intelligence|intelligence
1643108|NCT00231179|environment|environment
1643109|NCT00231179|home visiting|home visiting
1643110|NCT00231166|dose-finding|dose-finding
1643111|NCT00231166|monoclonal antibody|monoclonal antibody
1643112|NCT00231166|Multiple Myeloma|multiple myeloma
1643113|NCT00231153|catheter site infection|catheter site infection
1643114|NCT00231153|catheter colonization|catheter colonization
1643115|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
1643116|NCT00231153|patients with central venous catheters|patients with central venous catheters
1643117|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
1643118|NCT00231127|COPD|copd
1643119|NCT00231127|Osteoporosis|osteoporosis
1643120|NCT00231127|Osteopenia|osteopenia
1643121|NCT00231127|Glucocorticoids|glucocorticoids
1643122|NCT00231127|GOLD|gold
1643123|NCT00231127|BODE|bode
1643124|NCT00231114|Asthma|asthma
1643125|NCT00231101|Smoking|smoking
1643126|NCT00231101|Schizophrenia|schizophrenia
1643127|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
1643128|NCT00231075|70 years or older|70 years or older
1643129|NCT00231062|sinusitis|sinusitis
1643130|NCT00231062|rhinitis|rhinitis
1643131|NCT00231062|sinus surgery|sinus surgery
1643132|NCT00231062|maxillary|maxillary
1643133|NCT00231062|ethmoid|ethmoid
1643134|NCT00231062|sphenoid|sphenoid
1643135|NCT00231062|frontal|frontal
1643136|NCT00231062|FESS|fess
1643137|NCT00231062|sinuplasty|sinuplasty
1643138|NCT00231049|Genital Herpes|genital herpes
1643139|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
1643140|NCT00231049|Vaccine|vaccine
1643141|NCT00231023|Anterior Subtenon|anterior subtenon
1643142|NCT00231023|Posterior Peribulbar|posterior peribulbar
1643143|NCT00231023|Laser Photocoagulation|laser photocoagulation
1643144|NCT00231023|Diabetes|diabetes
1643145|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
1643146|NCT00231023|Diabetic Macular Edema|diabetic macular edema
1643147|NCT00231023|DME|dme
1643148|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
1643149|NCT00231010|Retinal Degeneration|retinal degeneration
1643150|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
1643151|NCT00231010|RP|rp
1643152|NCT00231010|Usher Syndrome|usher syndrome
1643153|NCT00231010|USH|ush
1643154|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
1643155|NCT00231010|BCD|bcd
1643156|NCT00230997|Galantamine|galantamine
1643157|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
1643158|NCT00230997|Treatment|treatment
1643159|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
1643160|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
1643161|NCT00230984|Nutritional Depletion|nutritional depletion
1643162|NCT00230984|Home|home
1643163|NCT00230984|COPD|copd
1643164|NCT00230984|Oral Dietary Supplements|oral dietary supplements
1643165|NCT00230984|Therapeutic Education|therapeutic education
1643166|NCT00230984|Androgens|androgens
1643167|NCT00230984|Exacerbation|exacerbation
1643168|NCT00230984|Survival|survival
1643169|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
1643170|NCT00230971|Abscess|abscess
1643171|NCT00230958|Viramidine|viramidine
1643172|NCT00230958|Ribavirin|ribavirin
1643173|NCT00230958|Valeant|valeant
1643174|NCT00230958|Hepatitis C|hepatitis c
1643175|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
1643176|NCT00230932|Veterans|veterans
1643177|NCT00230932|Pain|pain
1643178|NCT00230932|Palliative Care|palliative care
1643179|NCT00230932|Cardiology|cardiology
1643180|NCT00230932|Reproducibility of Results|reproducibility of results
1643181|NCT00230932|Health Personnel|health personnel
1643182|NCT00230932|Heart Failure, Congestive|heart failure, congestive
1643183|NCT00230919|Obesity,|obesity,
1643184|NCT00230919|weight loss,|weight loss,
1643185|NCT00230919|diet counseling|diet counseling
1643186|NCT00230919|low-glycemic load|low-glycemic load
1643187|NCT00230893|Antipsychotics|antipsychotics
1643188|NCT00230893|PTSD|ptsd
1643189|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
1643190|NCT00230893|monotherapy|monotherapy
1643191|NCT00230893|adjunct therapy|adjunct therapy
1643192|NCT00230880|Contraception behavior|contraception behavior
1643193|NCT00230880|Condoms|condoms
1643194|NCT00230880|Unsafe sex|unsafe sex
1643195|NCT00230880|Pregnancy unwanted|pregnancy unwanted
1643196|NCT00230880|Adolescent pregnancy|adolescent pregnancy
1643197|NCT00230880|Condom use|condom use
1643198|NCT00230880|Unprotected sex|unprotected sex
1643199|NCT00230880|Unintended pregnancy|unintended pregnancy
1643200|NCT00230867|herpes labialis|herpes labialis
1643201|NCT00230867|cold sore|cold sore
1643202|NCT00230867|acyclovir|acyclovir
1643203|NCT00230867|iontophoresis|iontophoresis
1643204|NCT00230867|topical|topical
1643205|NCT00230854|hepatitis C|hepatitis c
1643206|NCT00230854|genotype 1|genotype 1
1643207|NCT00230854|non-responders|non-responders
1643208|NCT00230854|viral hepatitis|viral hepatitis
1643209|NCT00230841|croup|croup
1643210|NCT00230841|humidity therapy|humidity therapy
1643211|NCT00230841|pediatrics|pediatrics
1643212|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
1643213|NCT00230815|Follitropin alfa|follitropin alfa
1643214|NCT00230815|Pen device|pen device
1643215|NCT00230815|Gonal-f®|gonal-f®
1643216|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
1643217|NCT00230815|Ovidrel®|ovidrel®
1643218|NCT00230802|pregnancy|pregnancy
1643219|NCT00230802|hypothyroidism|hypothyroidism
1643220|NCT00230802|levothyroxine|levothyroxine
1643221|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
1643222|NCT00230737|Aged|aged
1643223|NCT00230737|Sleep|sleep
1643224|NCT00230737|Insomnia|insomnia
1643225|NCT00230737|Melatonin|melatonin
1643226|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
1643227|NCT00230737|Circadian Rhythms|circadian rhythms
1643228|NCT00230737|Human|human
1643229|NCT00230737|Polysomnography|polysomnography
1643230|NCT00230737|Elderly|elderly
1643231|NCT00230724|Exercise maintenance|exercise maintenance
1643232|NCT00230711|Physical activity|physical activity
1643233|NCT00230711|Cancer follow-up care|cancer follow-up care
1643234|NCT00230698|Epilepsy|epilepsy
1643235|NCT00230698|Partial Epilepsies|partial epilepsies
1643236|NCT00230698|Seizures|seizures
1643237|NCT00230698|Topiramate|topiramate
1643238|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
1643239|NCT00230646|cancer recovery|cancer recovery
1643240|NCT00230646|physical activity|physical activity
1643241|NCT00230607|alpha Galactosidase A|alpha galactosidase a
1643242|NCT00230607|aGAL|agal
1643243|NCT00230607|rh aGAL|rh agal
1643244|NCT00230607|Fabry|fabry
1643246|NCT00230607|Fabrazyme|fabrazyme
1643247|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
1643248|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
1643249|NCT00230581|IBS-d, IBS|ibs-d, ibs
1643250|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
1643251|NCT00230568|Hispanic|hispanic
1643252|NCT00230568|Latino|latino
1643253|NCT00230568|Spanish-speaking|spanish-speaking
1643254|NCT00230555|child, preschool|child, preschool
1643255|NCT00230555|environment|environment
1643256|NCT00230555|intelligence|intelligence
1643257|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
1643258|NCT00230542|carboplatin|carboplatin
1643259|NCT00230542|pemetrexed|pemetrexed
1643260|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
1643261|NCT00230529|infliximab|infliximab
1643262|NCT00230529|Remicade|remicade
1643263|NCT00230529|biologics|biologics
1643264|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
1643265|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
1643266|NCT00230503|Hepatitis B Virus|hepatitis b virus
1643267|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
1643268|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
1643269|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
1643270|NCT00230490|Hepatitis B Virus|hepatitis b virus
1643271|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
1643272|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
1643273|NCT00230477|Hepatitis B|hepatitis b
1643274|NCT00230464|diabetes|diabetes
1643275|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
1643276|NCT00230464|insulin secretion|insulin secretion
1643277|NCT00230464|glucagon|glucagon
1643278|NCT00230425|Alcohol Abuse|alcohol abuse
1643279|NCT00230425|Anxiety Disorders|anxiety disorders
1643280|NCT00230425|Mood Disorders|mood disorders
1643281|NCT00230412|Kidney Failure, Acute|kidney failure, acute
1643282|NCT00230412|Acute Renal Failure|acute renal failure
1643283|NCT00230412|Kidney Failure|kidney failure
1643284|NCT00230412|Heat-Shock Proteins|heat-shock proteins
1643285|NCT00230412|Children|children
1643286|NCT00230373|Localized scleroderma|localized scleroderma
1643287|NCT00230360|constipation|constipation
1643288|NCT00230360|fecal incontinence|fecal incontinence
1643289|NCT00230360|diagnosis|diagnosis
1643290|NCT00230360|children|children
1643291|NCT00230308|Head and Neck Cancer|head and neck cancer
1643292|NCT00230243|Aspergillosis|aspergillosis
1643293|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
1643294|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
1643295|NCT00230243|Endemic Fungal infections|endemic fungal infections
1643296|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
1643297|NCT00230217|Relapse|relapse
1643298|NCT00230217|Refracturing|refracturing
1643299|NCT00230217|Leukemia|leukemia
1643300|NCT00230217|Lymphoma|lymphoma
1643301|NCT00230217|Solid Tumor|solid tumor
1643302|NCT00230204|Multiple sclerosis|multiple sclerosis
1643303|NCT00230204|Antibodies|antibodies
1643304|NCT00230204|Serum|serum
1643305|NCT00230204|Infectious agents|infectious agents
1643306|NCT00230204|Immunoglobulin G|immunoglobulin g
1643307|NCT00230204|Immunoglobulin M|immunoglobulin m
1643308|NCT00230191|Oral|oral
1643309|NCT00230191|Mucositis|mucositis
1643310|NCT00230191|Stomatitis|stomatitis
1643311|NCT00230191|Head and Neck Cancer|head and neck cancer
1643312|NCT00230178|Hyperuricemia|hyperuricemia
1643313|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
1643314|NCT00230178|Leukemia|leukemia
1643315|NCT00230178|Lymphoma|lymphoma
1643316|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
1643317|NCT00230178|Solid tumor cancers|solid tumor cancers
1643318|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
1643319|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
1643320|NCT00230165|Platelets|platelets
1643321|NCT00230165|Erythrocytes|erythrocytes
1643322|NCT00230165|Leukocytes|leukocytes
1643323|NCT00230165|Coagulation|coagulation
1643324|NCT00230165|Thrombosis|thrombosis
1643325|NCT00230126|African Americans|african americans
1643326|NCT00230113|NAFLD|nafld
1643327|NCT00230113|NASH|nash
1643328|NCT00230113|Fatty Liver Disease|fatty liver disease
1643329|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
1643330|NCT00230113|Fish oil|fish oil
1643331|NCT00230100|Gender differences|gender differences
1643332|NCT00230100|Women|women
1643333|NCT00230100|Substance use disorders|substance use disorders
1643334|NCT00230100|Alcohol use disorders|alcohol use disorders
1643335|NCT00230100|Treatment outcomes|treatment outcomes
1643336|NCT00230100|Group therapy|group therapy
1643337|NCT00230087|diabetes|diabetes
1643338|NCT00230087|nafld|nafld
1643339|NCT00230087|nash|nash
1643340|NCT00230087|phlebotomy|phlebotomy
1643341|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
1643343|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
1643344|NCT00229996|endometriosis|endometriosis
1643345|NCT00229996|pelvic pain|pelvic pain
1643346|NCT00229996|treatment|treatment
1643347|NCT00229983|Substance use disorders|substance use disorders
1643348|NCT00229983|Substance abuse|substance abuse
1643349|NCT00229983|Alcohol abuse|alcohol abuse
1643350|NCT00229983|Drug abuse|drug abuse
1643351|NCT00229957|Occupational therapy|occupational therapy
1643352|NCT00229957|Physical therapy techniques|physical therapy techniques
1643353|NCT00229957|Primary health care|primary health care
1643354|NCT00229957|Chronic disease|chronic disease
1643355|NCT00229957|Rehabilitation|rehabilitation
1643356|NCT00229957|Disease management|disease management
1643357|NCT00229957|Self care|self care
1643358|NCT00229944|Azithromycin|azithromycin
1643359|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
1643360|NCT00229944|adults|adults
1643361|NCT00229944|Bangladesh|bangladesh
1643362|NCT00229944|Clinical trial|clinical trial
1643363|NCT00229931|CATARACT EXTRACTION|cataract extraction
1643364|NCT00229931|MACULAR EDEMA|macular edema
1643365|NCT00229931|DIABETES|diabetes
1643366|NCT00229931|FOCAL LASER|focal laser
1643367|NCT00229931|TRIAMCINOLONE|triamcinolone
1643368|NCT00229918|Diabetic macular edema|diabetic macular edema
1643369|NCT00229918|Clinically significant macular edema|clinically significant macular edema
1643370|NCT00229905|pediatric health|pediatric health
1643371|NCT00229905|children|children
1643372|NCT00229905|single case study|single case study
1643373|NCT00229892|pediatric health|pediatric health
1643374|NCT00229892|cardiac|cardiac
1643375|NCT00229892|small incisions|small incisions
1643376|NCT00229892|operations|operations
1643377|NCT00229892|minimally invasive|minimally invasive
1643378|NCT00229879|pediatric health|pediatric health
1643379|NCT00229879|rare tumor|rare tumor
1643380|NCT00229879|children|children
1643381|NCT00229879|cardiac|cardiac
1643382|NCT00229866|newborn|newborn
1643383|NCT00229866|pediatric health|pediatric health
1643384|NCT00229866|Feeding difficulty|feeding difficulty
1643385|NCT00229866|discharge with a NG tube|discharge with a ng tube
1643386|NCT00229866|G-tube placement|g-tube placement
1643387|NCT00229866|Nissen fundoplication|nissen fundoplication
1643388|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
1643389|NCT00229853|pediatric|pediatric
1643390|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
1643391|NCT00229853|diverticulopexy|diverticulopexy
1643392|NCT00229853|Vascular Ring Division|vascular ring division
1643393|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
1643394|NCT00229827|pediatric health|pediatric health
1643395|NCT00229827|cardiac|cardiac
1643396|NCT00229827|pediatric population|pediatric population
1643397|NCT00229827|congenital heart surgery|congenital heart surgery
1643398|NCT00229827|left to right shunt lesions|left to right shunt lesions
1643399|NCT00229827|heart surgery|heart surgery
1643400|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
1643401|NCT00229814|Tectal Plate Glioma|tectal plate glioma
1643402|NCT00229814|Tumor|tumor
1643403|NCT00229814|Brain|brain
1643404|NCT00229814|MRI|mri
1643405|NCT00229814|Spectroscopy|spectroscopy
1643406|NCT00229801|Renal Function, MRI|renal function, mri
1643407|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
1643408|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
1643409|NCT00229775|malaria|malaria
1643410|NCT00229775|artemether lumafantrine|artemether lumafantrine
1643411|NCT00229775|chloroquine|chloroquine
1643412|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
1643413|NCT00229775|Coartem|coartem
1643414|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
1643415|NCT00229749|HCV|hcv
1643416|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
1643417|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
1643418|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
1643419|NCT00229723|Squamous Cell Cancer|squamous cell cancer
1643420|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1643421|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1643422|NCT00229697|Breast cancer|breast cancer
1643423|NCT00229697|metastatic breast cancer|metastatic breast cancer
1643424|NCT00229684|Type 2 Diabetes|type 2 diabetes
1643425|NCT00229658|diabetes|diabetes
1643426|NCT00229658|pramlintide|pramlintide
1643427|NCT00229658|Symlin|symlin
1643428|NCT00229658|Amylin|amylin
1643429|NCT00229658|phase 4|phase 4
1643430|NCT00229645|Major Depression|major depression
1643431|NCT00229645|Anxiety|anxiety
1643432|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
1643433|NCT00229632|Idebenone|idebenone
1643434|NCT00229632|Ataxia|ataxia
1643435|NCT00229632|Drug Trial|drug trial
1643436|NCT00229632|Randomized Trial|randomized trial
1643437|NCT00229632|Friedreich Ataxia|friedreich ataxia
1643438|NCT00229632|FA|fa
1643439|NCT00229619|rituxan|rituxan
1643440|NCT00229619|Immunosuppression|immunosuppression
1643441|NCT00229619|Bone Marrow Failure|bone marrow failure
1643442|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
1643443|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
1643444|NCT00229619|T -Cells|t -cells
1643445|NCT00229619|B-Cells|b-cells
1643446|NCT00229619|Hematopoiesis|hematopoiesis
1643447|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
1643448|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
1643449|NCT00229619|DBA|dba
1643450|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
1643451|NCT00229619|PRCA|prca
1643452|NCT00229593|Male contraception|male contraception
1643453|NCT00229593|Androgen|androgen
1643454|NCT00229593|Progestin|progestin
1643455|NCT00229593|Spermatogenesis|spermatogenesis
1643456|NCT00229593|Gonadotropin suppression|gonadotropin suppression
1643457|NCT00229593|Testosterone|testosterone
1643458|NCT00229593|Nestorone|nestorone
1643459|NCT00229580|Brief Intervention|brief intervention
1643460|NCT00229580|Motivational Interviewing|motivational interviewing
1643461|NCT00229580|Health Psychology|health psychology
1643462|NCT00229580|Alcohol|alcohol
1643463|NCT00229580|Hepatitis C|hepatitis c
1643464|NCT00229580|Patient Education|patient education
1643465|NCT00229567|ketamine|ketamine
1643466|NCT00229567|lidocaine|lidocaine
1643467|NCT00229567|postoperative ileus|postoperative ileus
1643468|NCT00229567|randomized controlled trial|randomized controlled trial
1643469|NCT00229567|acute postoperative pain|acute postoperative pain
1643470|NCT00229554|health surveys|health surveys
1643471|NCT00229554|questionnaires|questionnaires
1643942|NCT00227357|AIDS|aids
1643472|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
1643473|NCT00229541|Gainfully employed|gainfully employed
1643474|NCT00229541|Work incapacity|work incapacity
1643475|NCT00229515|Myocardial infarction|myocardial infarction
1643476|NCT00229515|Revascularization|revascularization
1643477|NCT00229515|Stent|stent
1643478|NCT00229515|ST segment elevation|st segment elevation
1643479|NCT00229476|Depression|depression
1643480|NCT00229476|EEG|eeg
1643481|NCT00229476|QEEG|qeeg
1643482|NCT00229476|cordance|cordance
1643483|NCT00229476|Zoloft|zoloft
1643484|NCT00229476|sertraline|sertraline
1643485|NCT00229476|placebo|placebo
1643486|NCT00229476|electroencephalogram|electroencephalogram
1643487|NCT00229476|brain|brain
1643488|NCT00229476|antidepressants|antidepressants
1643489|NCT00229463|Depression|depression
1643490|NCT00229463|genetic|genetic
1643491|NCT00229463|gene|gene
1643492|NCT00229463|antidepressant|antidepressant
1643493|NCT00229463|research|research
1643494|NCT00229450|depression|depression
1643495|NCT00229450|menopause|menopause
1643496|NCT00229450|perimenopause|perimenopause
1643497|NCT00229450|mood|mood
1643498|NCT00229450|memory|memory
1643499|NCT00229450|perimenopausal|perimenopausal
1643500|NCT00229450|antidepressant|antidepressant
1643501|NCT00229450|estrogen|estrogen
1643502|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
1643503|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
1643504|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
1643505|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
1643506|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
1643507|NCT00229437|Drug Therapy|drug therapy
1643508|NCT00229424|lafutidine|lafutidine
1643509|NCT00229424|reflux oesophagitis|reflux oesophagitis
1643510|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
1643511|NCT00229424|famotidine|famotidine
1643512|NCT00229424|Double Blind|double blind
1643513|NCT00229424|Controlled Study|controlled study
1643514|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
1643515|NCT00229424|H2-blocker|h2-blocker
1643516|NCT00229411|intensive care|intensive care
1643517|NCT00229411|teamwork|teamwork
1643518|NCT00229411|medical errors|medical errors
1643519|NCT00229411|education|education
1643520|NCT00229411|simulation|simulation
1643521|NCT00229333|Escitalopram|escitalopram
1643522|NCT00229333|Depression|depression
1643523|NCT00229333|Dementia|dementia
1643524|NCT00229333|Treatment|treatment
1643525|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
1643526|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
1643527|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
1643528|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
1643529|NCT00229268|Healthy Volunteers|healthy volunteers
1643530|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
1643531|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1643532|NCT00229242|Echocardiography|echocardiography
1643533|NCT00229242|Diastolic function|diastolic function
1643534|NCT00229242|Left ventricular mass regression|left ventricular mass regression
1643535|NCT00229229|Obesity|obesity
1643536|NCT00229229|Cardiovascular Disease|cardiovascular disease
1643537|NCT00229229|Metabolic Syndrome|metabolic syndrome
1643538|NCT00229229|Canada Food Guide|canada food guide
1643539|NCT00229229|Glycemic Index|glycemic index
1643540|NCT00229229|Glycemic Load|glycemic load
1643541|NCT00229203|Myeloma|myeloma
1643542|NCT00229203|Aplidin|aplidin
1643543|NCT00229203|Plitidepsin|plitidepsin
1643544|NCT00229203|PharmaMar|pharmamar
1643545|NCT00229190|Nasal lavage fluid|nasal lavage fluid
1643546|NCT00229190|Eosinophils|eosinophils
1643547|NCT00229190|Reproducibility of results|reproducibility of results
1643548|NCT00229177|ONO-2506|ono-2506
1643549|NCT00229177|stroke|stroke
1643550|NCT00229177|Acute ischemic stroke|acute ischemic stroke
1643551|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
1643552|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
1643553|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
1643554|NCT00229138|EC-MPS,|ec-mps,
1643555|NCT00229138|tacrolimus,|tacrolimus,
1643556|NCT00229138|efficacy,|efficacy,
1643557|NCT00229138|safety,|safety,
1643558|NCT00229138|glomerular filtration rate|glomerular filtration rate
1643559|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
1643560|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
1643561|NCT00229125|CIWA-Ar|ciwa-ar
1643562|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
1643563|NCT00229125|Rebound Effect|rebound effect
1643564|NCT00229073|dapoxetine|dapoxetine
1643565|NCT00229073|premature ejaculation|premature ejaculation
1643566|NCT00229073|ejaculation|ejaculation
1643567|NCT00229073|sexual dysfunction|sexual dysfunction
1643568|NCT00229073|orgasmic disorder|orgasmic disorder
1643569|NCT00229073|sexual intercourse|sexual intercourse
1643570|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
1643571|NCT00229060|Appendicitis|appendicitis
1643572|NCT00229060|Cholecystitis|cholecystitis
1643573|NCT00229060|Peritonitis|peritonitis
1643574|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
1643575|NCT00229047|Microvascular Perfusion|microvascular perfusion
1643576|NCT00229047|Inflammation|inflammation
1643577|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
1643578|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
1643579|NCT00229034|Systemic Inflammation|systemic inflammation
1643580|NCT00229034|Microvascular Perfusion|microvascular perfusion
1643581|NCT00229034|Septic Shock|septic shock
1643582|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
1643583|NCT00229021|Pyelonephritis|pyelonephritis
1643584|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
1643585|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
1643586|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1643587|NCT00229008|Cephalosporins|cephalosporins
1643588|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
1643590|NCT00228995|Subcutaneous injection|subcutaneous injection
1643591|NCT00228995|PROCRIT|procrit
1643592|NCT00228995|Erythropoietin|erythropoietin
1643593|NCT00228995|Epoetin Alfa|epoetin alfa
1643594|NCT00228995|Hemoglobin Level|hemoglobin level
1643595|NCT00228995|Elderly|elderly
1643596|NCT00228982|Complicated Skin Infections|complicated skin infections
1643597|NCT00228982|Infectious Skin Diseases|infectious skin diseases
1643598|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
1643599|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
1643600|NCT00228982|Cephalosporin|cephalosporin
1643601|NCT00228956|Breast Cancer|breast cancer
1643602|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
1643603|NCT00228956|Letrozole|letrozole
1643604|NCT00228956|Exemestane|exemestane
1643605|NCT00228943|Breast cancer survivorship|breast cancer survivorship
1643606|NCT00228943|Hot Flashes|hot flashes
1643607|NCT00228943|Serotonin|serotonin
1643608|NCT00228930|Breast Cancer|breast cancer
1643609|NCT00228930|Tamoxifen|tamoxifen
1643610|NCT00228930|Prevention|prevention
1643611|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
1643612|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
1643613|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
1643614|NCT00228904|Respiratory Quotients|respiratory quotients
1643615|NCT00228904|Hypoglycemia|hypoglycemia
1643616|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
1643617|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
1643618|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
1643619|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
1643620|NCT00228891|Respiratory Quotients|respiratory quotients
1643621|NCT00228891|Hypoglycemia|hypoglycemia
1643622|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
1643623|NCT00228878|Diabetes|diabetes
1643624|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
1643625|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
1643626|NCT00228878|Respiratory Quotients|respiratory quotients
1643627|NCT00228878|Hypoglycemia|hypoglycemia
1643628|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
1643629|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
1643630|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
1643631|NCT00228865|Mindstream testing|mindstream testing
1643632|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
1643633|NCT00228865|Respiratory Quotients|respiratory quotients
1643634|NCT00228865|Hypoglycemia|hypoglycemia
1643635|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
1643636|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
1643637|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
1643638|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
1643639|NCT00228696|late effects|late effects
1643640|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1643641|NCT00228670|herpesvirus|herpesvirus
1643642|NCT00228670|lung biopsy|lung biopsy
1643643|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
1643644|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
1643645|NCT00228644|oxidative stress|oxidative stress
1643646|NCT00228644|amino acids|amino acids
1643647|NCT00228644|acetaminophen|acetaminophen
1643648|NCT00228644|dietary requirements|dietary requirements
1643649|NCT00228631|sickle|sickle
1643650|NCT00228631|cell|cell
1643651|NCT00228618|oxidative stress|oxidative stress
1643652|NCT00228618|amino acids|amino acids
1643653|NCT00228618|dietary requirements|dietary requirements
1643654|NCT00228605|Pain|pain
1643655|NCT00228605|Sudden Pain|sudden pain
1643656|NCT00228605|Flares|flares
1643657|NCT00228605|noncancer|noncancer
1643658|NCT00228605|low back pain|low back pain
1643659|NCT00228605|neuropathic pain|neuropathic pain
1643660|NCT00228605|osteoarthritis pain|osteoarthritis pain
1643661|NCT00228605|migraine|migraine
1643662|NCT00228605|chronic headache|chronic headache
1643663|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1643664|NCT00228579|diabetes|diabetes
1643665|NCT00228579|insulin resistance|insulin resistance
1643666|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
1643667|NCT00228462|Schizophrenia|schizophrenia
1643668|NCT00228449|anemia|anemia
1643669|NCT00228449|chronic kidney disease|chronic kidney disease
1643670|NCT00228449|CKD|ckd
1643671|NCT00228449|chronic renal failure|chronic renal failure
1643672|NCT00228449|CRF|crf
1643673|NCT00228449|dialysis|dialysis
1643674|NCT00228449|erythropoietin|erythropoietin
1643675|NCT00228449|EPO|epo
1643676|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1643677|NCT00228449|ESA|esa
1643678|NCT00228449|Hematide™|hematide™
1643679|NCT00228449|hemodialysis|hemodialysis
1643680|NCT00228449|hemoglobin|hemoglobin
1643681|NCT00228449|Hb|hb
1643682|NCT00228449|Hgb|hgb
1643683|NCT00228449|Omontys|omontys
1643684|NCT00228449|peginesatide|peginesatide
1643685|NCT00228449|red blood cell|red blood cell
1643686|NCT00228449|red blood cell production|red blood cell production
1643687|NCT00228436|anemia|anemia
1643688|NCT00228436|chronic kidney disease|chronic kidney disease
1643689|NCT00228436|CKD|ckd
1643690|NCT00228436|chronic renal failure|chronic renal failure
1643691|NCT00228436|CRF|crf
1643692|NCT00228436|dialysis|dialysis
1643693|NCT00228436|erythropoietin|erythropoietin
1643694|NCT00228436|EPO|epo
1643695|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1643696|NCT00228436|ESA|esa
1643697|NCT00228436|Hematide™|hematide™
1643698|NCT00228436|hemoglobin|hemoglobin
1643699|NCT00228436|Hb|hb
1643700|NCT00228436|Hgb|hgb
1643701|NCT00228436|Omontys|omontys
1643702|NCT00228436|peginesatide|peginesatide
1643703|NCT00228436|red blood cell|red blood cell
1643704|NCT00228436|red blood cell production|red blood cell production
1643705|NCT00228423|Saphenous vein|saphenous vein
1643706|NCT00228423|Intimal hyperplasia|intimal hyperplasia
1643707|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1643708|NCT00228423|Antiplatelet therapy|antiplatelet therapy
1643709|NCT00228423|Clopidogrel|clopidogrel
1643710|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
1643711|NCT00228410|Skin Infections|skin infections
1643712|NCT00228410|Skin Disease|skin disease
1643713|NCT00228397|Multiple Sclerosis|multiple sclerosis
1643714|NCT00228371|Epilepsy|epilepsy
1643715|NCT00228371|deep brain stimulation|deep brain stimulation
1643716|NCT00228371|Subthalamic nucleus|subthalamic nucleus
1643717|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
1643718|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
1643719|NCT00228345|abnormal OGTT|abnormal ogtt
1643720|NCT00228293|cardiac arrest|cardiac arrest
1643721|NCT00228293|CPR|cpr
1643722|NCT00228280|Apicoectomy|apicoectomy
1643723|NCT00228280|Retrograde|retrograde
1643724|NCT00228280|MTA|mta
1643725|NCT00228267|Chronic Headache|chronic headache
1643726|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
1643727|NCT00228267|Chronic Daily Headache|chronic daily headache
1643728|NCT00228267|Headache, Intractable|headache, intractable
1643729|NCT00228267|Randomised controlled trial|randomised controlled trial
1643730|NCT00228267|Propofol|propofol
1643731|NCT00228254|acute respiratory infection|acute respiratory infection
1643732|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
1643733|NCT00228254|diarrhea|diarrhea
1643734|NCT00228241|Sick sinus syndrome|sick sinus syndrome
1643735|NCT00228241|AV-block|av-block
1643736|NCT00228228|Multiple Sclerosis|multiple sclerosis
1643737|NCT00228228|T-cell vaccination|t-cell vaccination
1643738|NCT00228228|Autoreactive T cells|autoreactive t cells
1643739|NCT00228215|sleep|sleep
1643740|NCT00228215|neonates|neonates
1643741|NCT00228215|mothers|mothers
1643742|NCT00228215|behavioural intervention|behavioural intervention
1643743|NCT00228202|cytomegalovirus|cytomegalovirus
1643744|NCT00228202|CMV|cmv
1643745|NCT00228202|pregnancy|pregnancy
1643746|NCT00228202|amniotic fluid|amniotic fluid
1643747|NCT00228202|bone marrow|bone marrow
1643748|NCT00228202|transplantation|transplantation
1643749|NCT00228202|viral load|viral load
1643750|NCT00228202|glycoprotein B|glycoprotein b
1643751|NCT00228202|genotyping|genotyping
1643752|NCT00228202|PCR|pcr
1643753|NCT00228202|real-time PCR|real-time pcr
1643754|NCT00228202|CMV disease|cmv disease
1643755|NCT00228202|Congenital CMV infection|congenital cmv infection
1643756|NCT00228189|Dendritic cells|dendritic cells
1643757|NCT00228189|Colorectal cancer|colorectal cancer
1643758|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
1643759|NCT00228189|Vaccine|vaccine
1643760|NCT00228189|Immunotherapy|immunotherapy
1643761|NCT00228176|Metabolic syndrome|metabolic syndrome
1643762|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
1643763|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
1643764|NCT00228163|Secondary Progressive|secondary progressive
1643765|NCT00228163|Progressive Relapsing|progressive relapsing
1643766|NCT00228150|Parkinson Disease|parkinson disease
1643768|NCT00228150|dopamine agonists|dopamine agonists
1643769|NCT00228124|Prostate cancer|prostate cancer
1643770|NCT00228124|Continuous androgen suppression|continuous androgen suppression
1643771|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
1643772|NCT00228124|Bone loss|bone loss
1643773|NCT00228124|Osteoporosis|osteoporosis
1643774|NCT00228111|Computed tomography|computed tomography
1643775|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
1643776|NCT00228111|algorithms|algorithms
1643777|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
1643778|NCT00228072|Hyperhidrosis|hyperhidrosis
1643779|NCT00228072|Axillary|axillary
1643780|NCT00228072|Excision|excision
1643781|NCT00228072|Suction-curettage|suction-curettage
1643782|NCT00228072|Outcome|outcome
1643783|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
1643784|NCT00228046|ADHD|adhd
1643785|NCT00228046|ODD|odd
1643786|NCT00228046|Conduct Disorder|conduct disorder
1643787|NCT00228046|CD|cd
1643788|NCT00228033|Calcium|calcium
1643789|NCT00228033|Pregnancy|pregnancy
1643790|NCT00228033|Postpartum Depression|postpartum depression
1643791|NCT00228033|Depression|depression
1643792|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
1643793|NCT00228007|Injection Drug Use|injection drug use
1643794|NCT00228007|HIV Risk Behavior|hiv risk behavior
1643795|NCT00228007|HIV Seronegativity|hiv seronegativity
1643796|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
1643797|NCT00227994|Elderly|elderly
1643798|NCT00227994|Stroke|stroke
1643799|NCT00227994|Cognition|cognition
1643800|NCT00227981|Depression Relapse|depression relapse
1643801|NCT00227981|Maintenance Therapy|maintenance therapy
1643802|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
1643803|NCT00227968|Depression, bipolar|depression, bipolar
1643804|NCT00227955|Major depression|major depression
1643805|NCT00227942|Women|women
1643806|NCT00227942|Menopause|menopause
1643807|NCT00227942|Depression|depression
1643808|NCT00227942|Hot flash|hot flash
1643809|NCT00227942|Insomnia|insomnia
1643810|NCT00227942|Sleep Disruption|sleep disruption
1643811|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
1643812|NCT00227929|Major Depressive Disorder|major depressive disorder
1643813|NCT00227929|MDD|mdd
1643814|NCT00227916|alcohol, marijuana|alcohol, marijuana
1643815|NCT00227890|substance abuse|substance abuse
1643816|NCT00227877|alcohol abuse|alcohol abuse
1643817|NCT00227877|substance abuse|substance abuse
1643818|NCT00227877|substance related disorders|substance related disorders
1643819|NCT00227864|marijuana|marijuana
1643820|NCT00227864|sexual risk|sexual risk
1643821|NCT00227838|substance abuse|substance abuse
1643822|NCT00227825|Behavioral Intervention|behavioral intervention
1643823|NCT00227812|cocaine dependence|cocaine dependence
1643824|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1643825|NCT00227786|tobacco use disorder|tobacco use disorder
1643826|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1643827|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1643828|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1643829|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1643830|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1643831|NCT00227773|gastrinoma|gastrinoma
1643832|NCT00227773|insulinoma|insulinoma
1643833|NCT00227773|WDHA syndrome|wdha syndrome
1643834|NCT00227773|glucagonoma|glucagonoma
1643835|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1643836|NCT00227773|somatostatinoma|somatostatinoma
1643837|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1643838|NCT00227747|stage II rectal cancer|stage ii rectal cancer
1643839|NCT00227747|stage III rectal cancer|stage iii rectal cancer
1643840|NCT00227734|stage IV colon cancer|stage iv colon cancer
1643841|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
1643842|NCT00227734|recurrent colon cancer|recurrent colon cancer
1643843|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
1643844|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1643845|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
1643846|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
1643847|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1643848|NCT00227708|large cell lung cancer|large cell lung cancer
1643849|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
1643850|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1643851|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1643852|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1643853|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1643854|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1643855|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1643856|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1643857|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1643858|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1643859|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1643860|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1643861|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1643862|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1643863|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1643864|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1643865|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1643866|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1643867|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1643868|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1643869|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1643870|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1643871|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
1643872|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
1643873|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1643874|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1643875|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1643876|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
1643877|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
1643878|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
1643879|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
1643880|NCT00227656|stage IV breast cancer|stage iv breast cancer
1643881|NCT00227656|recurrent breast cancer|recurrent breast cancer
1643882|NCT00227656|male breast cancer|male breast cancer
1643883|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
1643884|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
1643885|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
1643886|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
1643887|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1643888|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1643889|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1643890|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1643891|NCT00227617|gastrinoma|gastrinoma
1643892|NCT00227617|insulinoma|insulinoma
1643893|NCT00227617|WDHA syndrome|wdha syndrome
1643894|NCT00227617|glucagonoma|glucagonoma
1643895|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1643896|NCT00227617|somatostatinoma|somatostatinoma
1643897|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1643898|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1643899|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1644000|NCT00226915|carboplatin|carboplatin
1643900|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1643901|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1643902|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1643903|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1643904|NCT00227526|Colon|colon
1643905|NCT00227526|Surgery|surgery
1643906|NCT00227526|Prehabilitation|prehabilitation
1643907|NCT00227526|Exercise|exercise
1643908|NCT00227500|Hyperlipidaemia|hyperlipidaemia
1643909|NCT00227500|Lipid metabolism|lipid metabolism
1643910|NCT00227500|Glucose metabolism|glucose metabolism
1643911|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
1643912|NCT00227500|Lipodystrophy|lipodystrophy
1643913|NCT00227500|Cardiovascular disease|cardiovascular disease
1643914|NCT00227500|Treatment Experienced|treatment experienced
1643915|NCT00227500|HIV|hiv
1643916|NCT00227487|autism|autism
1643917|NCT00227487|intestine|intestine
1643918|NCT00227487|disaccharidases|disaccharidases
1643919|NCT00227487|inflammation|inflammation
1643920|NCT00227487|permeability|permeability
1643921|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
1643922|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
1643923|NCT00227474|stage IV breast cancer|stage iv breast cancer
1643924|NCT00227461|Aphasia|aphasia
1643925|NCT00227461|Stroke|stroke
1643926|NCT00227448|Ischemic|ischemic
1643927|NCT00227448|Stroke|stroke
1643928|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
1643929|NCT00227422|Hib diseases|hib diseases
1643930|NCT00227409|Repeated chelation therapy|repeated chelation therapy
1643931|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
1643932|NCT00227409|Body lead burden|body lead burden
1643933|NCT00227409|Long-term outcome|long-term outcome
1643934|NCT00227409|Glomerular filtration rate|glomerular filtration rate
1643935|NCT00227383|Diabetes|diabetes
1643936|NCT00227383|gastroparesis|gastroparesis
1643937|NCT00227383|electroacupuncture|electroacupuncture
1643938|NCT00227370|Acute rejection|acute rejection
1643939|NCT00227370|Non-CMV infections|non-cmv infections
1643940|NCT00227370|Resistance|resistance
1643941|NCT00227357|HIV|hiv
1643943|NCT00227357|Buprenorphine|buprenorphine
1643944|NCT00227357|Methadone|methadone
1643945|NCT00227357|Primary care|primary care
1643946|NCT00227357|dual diagnosis|dual diagnosis
1643947|NCT00227357|ptsd|ptsd
1643948|NCT00227331|Pneumonia|pneumonia
1643949|NCT00227305|Schizophrenia|schizophrenia
1643950|NCT00227305|Bipolar I Disorder|bipolar i disorder
1643951|NCT00227292|Low back pain|low back pain
1643952|NCT00227292|Depression|depression
1643953|NCT00227279|Grass pollen allergy|grass pollen allergy
1643954|NCT00227279|Hayfever|hayfever
1643955|NCT00227279|Allergen immunotherapy|allergen immunotherapy
1643956|NCT00227279|Specific immunotherapy|specific immunotherapy
1643957|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
1643958|NCT00227266|SMA Type 2|sma type 2
1643959|NCT00227266|SMA Type 3|sma type 3
1643960|NCT00227253|Phenotype|phenotype
1643961|NCT00227253|Growth|growth
1643962|NCT00227253|Genotype|genotype
1643963|NCT00227253|Chromosome 18|chromosome 18
1643964|NCT00227201|African-American|african-american
1643965|NCT00227201|Hypertension|hypertension
1643966|NCT00227201|Complementary medicine|complementary medicine
1643967|NCT00227201|Medication adherence|medication adherence
1643968|NCT00227175|African American|african american
1643969|NCT00227175|Hypertension|hypertension
1643970|NCT00227175|Medication adherence|medication adherence
1643971|NCT00227175|Risk reduction|risk reduction
1643972|NCT00227162|Asthma|asthma
1643973|NCT00227162|Behavior change|behavior change
1643974|NCT00227162|Physical activity|physical activity
1643975|NCT00227162|Risk reduction|risk reduction
1643976|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
1643977|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
1643978|NCT00227136|Chromogranin A|chromogranin a
1643979|NCT00227136|5HIAA|5hiaa
1643980|NCT00227136|carcinoid|carcinoid
1643981|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
1643982|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
1643983|NCT00227097|therapeutic education|therapeutic education
1643984|NCT00227097|thrombi embolic disease|thrombi embolic disease
1643985|NCT00227084|Mammary glands|mammary glands
1643986|NCT00227084|hemostasis|hemostasis
1643987|NCT00227084|Mammaplasty|mammaplasty
1643988|NCT00227071|accidental falls|accidental falls
1643989|NCT00227071|osteoporosis|osteoporosis
1643990|NCT00227071|risk factors|risk factors
1643991|NCT00227058|allergic rhinitis|allergic rhinitis
1643992|NCT00227045|Kidney Transplantation|kidney transplantation
1643993|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
1643994|NCT00227032|adult gliosarcoma|adult gliosarcoma
1643995|NCT00227032|adult glioblastoma|adult glioblastoma
1643996|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
1643997|NCT00226915|ovarian neoplasms|ovarian neoplasms
1643998|NCT00226915|randomized controlled trial|randomized controlled trial
1643999|NCT00226915|paclitaxel|paclitaxel
1644001|NCT00226902|Diabetes|diabetes
1644002|NCT00226902|Hemoglobin|hemoglobin
1644003|NCT00226902|Dialysis|dialysis
1644004|NCT00226902|Vascular reactivity|vascular reactivity
1644005|NCT00226889|Scleroderma|scleroderma
1644006|NCT00226889|Fibrosis|fibrosis
1644007|NCT00226889|Therapy|therapy
1644008|NCT00226889|Bosentan|bosentan
1644009|NCT00226889|Endothelin-1|endothelin-1
1644010|NCT00226876|dreaming|dreaming
1644011|NCT00226876|anaesthesia|anaesthesia
1644012|NCT00226876|electroencephalography|electroencephalography
1644013|NCT00226876|bispectral index|bispectral index
1644014|NCT00226876|awareness|awareness
1644015|NCT00226824|Tourette's disorder|tourette's disorder
1644016|NCT00226824|tic|tic
1644017|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1644018|NCT00226772|ACL reconstruction|acl reconstruction
1644019|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1644020|NCT00226759|ACL reconstruction|acl reconstruction
1644021|NCT00226746|Pancreatic Cancer|pancreatic cancer
1644022|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
1644023|NCT00226746|Gemcitabine|gemcitabine
1644024|NCT00226746|Paclitaxel|paclitaxel
1644025|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
1644026|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
1644027|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
1644028|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
1644029|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
1644030|NCT00226720|alcoholism|alcoholism
1644031|NCT00226720|Alcohol dependence|alcohol dependence
1644032|NCT00226720|Detoxification|detoxification
1644033|NCT00226720|Abstinence maintain|abstinence maintain
1644034|NCT00226720|Efficacy|efficacy
1644035|NCT00226720|Ambulatory detoxification|ambulatory detoxification
1644036|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
1644037|NCT00226694|Alcoholism|alcoholism
1644039|NCT00226694|Gender Differences|gender differences
1644040|NCT00226694|Addiction|addiction
1644041|NCT00226694|Alcohol Dependence|alcohol dependence
1644042|NCT00226668|peritumoral brain edema|peritumoral brain edema
1644044|NCT00226668|malignant brain tumor|malignant brain tumor
1644045|NCT00226668|astrocytoma|astrocytoma
1644046|NCT00226668|brain tumor|brain tumor
1644047|NCT00226668|dexamethasone|dexamethasone
1644048|NCT00226668|Decadron|decadron
1644049|NCT00226655|peritumoral brain edema|peritumoral brain edema
1644050|NCT00226655|edema|edema
1644051|NCT00226655|malignant brain tumor|malignant brain tumor
1644052|NCT00226655|astrocytoma|astrocytoma
1644053|NCT00226655|brain tumor|brain tumor
1644054|NCT00226655|dexamethasone|dexamethasone
1644055|NCT00226655|Decadron|decadron
1644056|NCT00226642|depression|depression
1644057|NCT00226642|primary care|primary care
1644058|NCT00226616|Zinc|zinc
1644059|NCT00226616|cholera|cholera
1644060|NCT00226616|children|children
1644061|NCT00226616|Bangladesh|bangladesh
1644062|NCT00226603|groin injury|groin injury
1644063|NCT00226603|football|football
1644064|NCT00226603|prevention|prevention
1644065|NCT00226603|traing programme|traing programme
1644066|NCT00226603|cluster randomized study|cluster randomized study
1644067|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
1644068|NCT00226590|carcinoma|carcinoma
1644069|NCT00226590|unresectable|unresectable
1644070|NCT00226590|Stage IIIA|stage iiia
1644071|NCT00226590|Stage IIIB|stage iiib
1644072|NCT00226590|thoracic radiation|thoracic radiation
1644073|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1644074|NCT00226577|resectable|resectable
1644075|NCT00226577|NSCLC|nsclc
1644076|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
1644077|NCT00226473|malignant Melanoma|malignant melanoma
1644078|NCT00226473|Chemotherapy|chemotherapy
1644079|NCT00226473|Metastasis|metastasis
1644080|NCT00226473|standard palliative care|standard palliative care
1644081|NCT00226473|best supportive care|best supportive care
1644082|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
1644083|NCT00226447|Pegylated Interferon|pegylated interferon
1644084|NCT00226447|Lamivudine|lamivudine
1644085|NCT00226434|HIV infection|hiv infection
1644086|NCT00226434|Tuberculosis|tuberculosis
1644087|NCT00226434|Paradoxical reaction|paradoxical reaction
1644088|NCT00226434|Treatment Naive|treatment naive
1644089|NCT00226421|opioid|opioid
1644090|NCT00226421|oxymorphone|oxymorphone
1644091|NCT00226421|chronic pain|chronic pain
1644092|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
1644093|NCT00226421|low back pain|low back pain
1644094|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
1644095|NCT00226408|high dose|high dose
1644096|NCT00226395|oxymorphone|oxymorphone
1644097|NCT00226395|acute pain|acute pain
1644098|NCT00226395|abdominal surgery|abdominal surgery
1644099|NCT00226395|opioids|opioids
1644100|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
1644101|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
1644102|NCT00226382|Pegasys|pegasys
1644103|NCT00226369|Pediatric|pediatric
1644104|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
1644105|NCT00226369|Congenital heart disease|congenital heart disease
1644106|NCT00226369|Reperfusion injury|reperfusion injury
1644107|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
1644108|NCT00226304|Focal Brain Lesions|focal brain lesions
1644109|NCT00226304|AIDS|aids
1644110|NCT00226304|Lymphoma|lymphoma
1644111|NCT00226304|EBV|ebv
1644112|NCT00226304|FDG-PET|fdg-pet
1644113|NCT00226304|HIV Infection|hiv infection
1644114|NCT00226304|Brain Lesion|brain lesion
1644115|NCT00226291|EBM|ebm
1644116|NCT00226291|evidence based medicine|evidence based medicine
1644117|NCT00226291|informationist|informationist
1644118|NCT00226291|clinical medical librarian|clinical medical librarian
1644119|NCT00226265|Cardiac surgery patients|cardiac surgery patients
1644120|NCT00226265|Quality of Life|quality of life
1644121|NCT00226265|Recall bias|recall bias
1644122|NCT00226265|Aortic valve replacement|aortic valve replacement
1644123|NCT00226265|Mitral valve replacement|mitral valve replacement
1644124|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
1644125|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
1644126|NCT00226252|Wheelchair|wheelchair
1644127|NCT00226252|Propulsion|propulsion
1644128|NCT00226252|Biomechanics|biomechanics
1644129|NCT00226239|head|head
1644130|NCT00226239|neck|neck
1644131|NCT00226200|Allergic|allergic
1644132|NCT00226200|Non allergic|non allergic
1644133|NCT00226187|Fatty acids|fatty acids
1644134|NCT00226187|Human milk|human milk
1644135|NCT00226187|Infant development|infant development
1644136|NCT00226187|Very low birthweight infants|very low birthweight infants
1644137|NCT00226174|Curcuminoids|curcuminoids
1644138|NCT00226174|Oral Lichen Planus|oral lichen planus
1644139|NCT00226148|Implant|implant
1644140|NCT00226148|Immediate placement|immediate placement
1644141|NCT00226148|Molar tooth|molar tooth
1644142|NCT00226135|Bipolar disorder|bipolar disorder
1644143|NCT00226135|Treatment|treatment
1644144|NCT00226135|Long-term|long-term
1644145|NCT00226135|Lithium|lithium
1644146|NCT00226135|Lamotrigine|lamotrigine
1644147|NCT00226135|Randomised Clinical Trial|randomised clinical trial
1644148|NCT00226122|Enuresis|enuresis
1644149|NCT00226122|Nocturnal|nocturnal
1644150|NCT00226122|Monosymptomatic|monosymptomatic
1644151|NCT00226122|DDAVP|ddavp
1644152|NCT00226122|Indomethacin|indomethacin
1644153|NCT00226122|Randomized|randomized
1644154|NCT00226109|Alcoholism|alcoholism
1644155|NCT00226109|cardiomyopathy|cardiomyopathy
1644156|NCT00226109|skeletal muscle|skeletal muscle
1644157|NCT00226109|spironolactone|spironolactone
1644158|NCT00226109|Na,K-pumps|na,k-pumps
1644159|NCT00226109|Magnesium|magnesium
1644160|NCT00226096|Clinical Trial|clinical trial
1644161|NCT00226096|Blood Pressure|blood pressure
1644162|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
1644163|NCT00226070|selfrated health,|selfrated health,
1644164|NCT00226070|SF-36,|sf-36,
1644165|NCT00226070|rehabilitation,|rehabilitation,
1644166|NCT00226070|total hip replacement,|total hip replacement,
1644167|NCT00226070|patients above 65|patients above 65
1644168|NCT00226057|Atopic dermatitis|atopic dermatitis
1644169|NCT00226057|Raptiva|raptiva
1644170|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
1644171|NCT00226031|Osteoporosis|osteoporosis
1644172|NCT00226031|Wrist fractures|wrist fractures
1644173|NCT00226031|Knowledge translation|knowledge translation
1644174|NCT00226031|Implementation|implementation
1644175|NCT00226031|Educational reminder|educational reminder
1644176|NCT00226005|pancreas|pancreas
1644177|NCT00226005|adenocarcinoma|adenocarcinoma
1644178|NCT00226005|cancer|cancer
1644179|NCT00226005|metastatic|metastatic
1644180|NCT00226005|advanced cancer|advanced cancer
1644181|NCT00226005|Phase II|phase ii
1644182|NCT00226005|growth factor|growth factor
1644183|NCT00226005|VEGF|vegf
1644184|NCT00226005|angiogenesis|angiogenesis
1644185|NCT00225979|Acromegaly|acromegaly
1644186|NCT00225979|Untreated|untreated
1644187|NCT00225979|Newly diagnosed|newly diagnosed
1644188|NCT00225979|Octreotide LAR|octreotide lar
1644189|NCT00225979|Pituitary surgery|pituitary surgery
1644190|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
1644191|NCT00225927|invasive breast cancer|invasive breast cancer
1644192|NCT00225927|in situ breast cancer|in situ breast cancer
1644193|NCT00225927|radioguided seed localization|radioguided seed localization
1644194|NCT00225927|nonpalpable tumour|nonpalpable tumour
1644195|NCT00225927|needle localization|needle localization
1644196|NCT00225927|margin status|margin status
1644197|NCT00225914|Menopause|menopause
1644198|NCT00225914|Hormone Therapy|hormone therapy
1644199|NCT00225914|Paxil|paxil
1644200|NCT00225914|Hot Flash|hot flash
1644201|NCT00225914|Sleep Disturbance|sleep disturbance
1644202|NCT00225914|Night Sweats|night sweats
1644203|NCT00225914|Antidepressants|antidepressants
1644204|NCT00225888|Diabetes|diabetes
1644205|NCT00225888|Nutrition|nutrition
1644206|NCT00225888|Digital photography|digital photography
1644207|NCT00225888|Self-management|self-management
1644208|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
1644209|NCT00225875|Rituximab|rituximab
1644211|NCT00225862|Restless Legs Syndrome|restless legs syndrome
1644212|NCT00225849|Aspirin|aspirin
1644213|NCT00225849|Primary prevention|primary prevention
1644214|NCT00225836|Dysmenorrhoea|dysmenorrhoea
1644215|NCT00225836|Women|women
1644216|NCT00225836|Pain|pain
1644217|NCT00225836|TENS|tens
1644218|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
1644219|NCT00225797|chronic pain|chronic pain
1644220|NCT00225797|lower back|lower back
1644221|NCT00225797|opioid|opioid
1644222|NCT00225797|efficacy|efficacy
1644223|NCT00225797|safety|safety
1644224|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
1644225|NCT00225784|Radiographically measurable disease|radiographically measurable disease
1644226|NCT00225758|breast cancer|breast cancer
1644227|NCT00225758|endocrine therapy|endocrine therapy
1644228|NCT00225758|drug resistance|drug resistance
1644229|NCT00225758|lapatinib|lapatinib
1644230|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
1644231|NCT00225745|Ghrelin|ghrelin
1644232|NCT00225693|coronary artery|coronary artery
1644233|NCT00225693|restenosis|restenosis
1644234|NCT00225693|patency|patency
1644235|NCT00225693|drug eluting|drug eluting
1644236|NCT00225693|stent|stent
1644237|NCT00225680|coronary artery|coronary artery
1644238|NCT00225680|stent|stent
1644239|NCT00225680|drug eluting|drug eluting
1644240|NCT00225680|patency|patency
1644241|NCT00225680|restenosis|restenosis
1644242|NCT00225667|Atrial Fibrillation|atrial fibrillation
1644243|NCT00225667|Arrhythmia|arrhythmia
1644244|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
1644245|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
1644246|NCT00225667|Electrophysiology|electrophysiology
1644247|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
1644248|NCT00225667|Hypertension|hypertension
1644249|NCT00225667|Cardiac Remodeling|cardiac remodeling
1644250|NCT00225654|coronary artery|coronary artery
1644252|NCT00225654|drug eluting|drug eluting
1644253|NCT00225654|patency|patency
1644254|NCT00225654|restenosis|restenosis
1644255|NCT00225641|Follow-up|follow-up
1644256|NCT00225628|Computerized clinical decision support|computerized clinical decision support
1644257|NCT00225628|Patient Safety|patient safety
1644258|NCT00225628|Quality of Care|quality of care
1644259|NCT00225628|Electronic Medical Records|electronic medical records
1644260|NCT00225628|Chronic Disease Management|chronic disease management
1644261|NCT00225628|Drug Monitoring|drug monitoring
1644262|NCT00225628|Guideline Adherence|guideline adherence
1644263|NCT00225628|Reminder Systems|reminder systems
1644264|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
1644265|NCT00225602|Schizophrenia|schizophrenia
1644266|NCT00225602|Assertive community treatment|assertive community treatment
1644267|NCT00225589|Hypercholesteremia|hypercholesteremia
1644268|NCT00225576|medication errors|medication errors
1644269|NCT00225576|adverse drug events|adverse drug events
1644270|NCT00225576|electronic health records|electronic health records
1644271|NCT00225563|Electronic medical records|electronic medical records
1644272|NCT00225563|Electronic prescribing|electronic prescribing
1644273|NCT00225563|Quality measures|quality measures
1644274|NCT00225550|Cancer;|cancer;
1644275|NCT00225550|Tumors;|tumors;
1644276|NCT00225550|Neoplasms;|neoplasms;
1644277|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
1644278|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
1644279|NCT00225550|Cadherins|cadherins
1644280|NCT00225537|hcv|hcv
1644281|NCT00225537|hbv|hbv
1644282|NCT00225537|methylumbelliferone|methylumbelliferone
1644283|NCT00225537|liver|liver
1644284|NCT00225537|hepatitis|hepatitis
1644285|NCT00225537|viral|viral
1644286|NCT00225537|heparvit|heparvit
1644287|NCT00225537|hiv|hiv
1644288|NCT00225537|aids|aids
1644289|NCT00225524|Depression|depression
1644290|NCT00225511|Depression|depression
1644291|NCT00225485|Depression|depression
1644292|NCT00225459|Religious psychology|religious psychology
1644293|NCT00225459|Anxiety disorder|anxiety disorder
1644294|NCT00225459|Mood disorder|mood disorder
1644295|NCT00225459|Suicide|suicide
1644296|NCT00225446|Orthognathic surgery.|orthognathic surgery.
1644297|NCT00225446|optic repositioning system.|optic repositioning system.
1644298|NCT00225433|infertility|infertility
1644299|NCT00225433|in vitro fertilization|in vitro fertilization
1644300|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1644301|NCT00225420|stage I prostate cancer|stage i prostate cancer
1644302|NCT00225420|stage II prostate cancer|stage ii prostate cancer
1644303|NCT00225420|stage III prostate cancer|stage iii prostate cancer
1644304|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
1644305|NCT00225407|Cannabis|cannabis
1644306|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
1644307|NCT00225407|Pharmacokinetics|pharmacokinetics
1644308|NCT00225407|Psychomotor tests|psychomotor tests
1644309|NCT00225407|Event related potentials|event related potentials
1644310|NCT00225394|CMV|cmv
1644311|NCT00225394|Kidney Transplant|kidney transplant
1644312|NCT00225394|Pancreas Transplant|pancreas transplant
1644313|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
1644314|NCT00225394|Valganciclovir|valganciclovir
1644315|NCT00225394|CMV Disease|cmv disease
1644316|NCT00225381|Oxygen consumption|oxygen consumption
1644317|NCT00225381|CO2 production|co2 production
1644318|NCT00225381|Indirect calorimetry|indirect calorimetry
1644319|NCT00225381|Non steady state|non steady state
1644320|NCT00225381|Anesthesia monitoring|anesthesia monitoring
1644321|NCT00225381|Critical events during anesthesia|critical events during anesthesia
1644322|NCT00225381|Acid base balance|acid base balance
1644323|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
1644324|NCT00225368|Malaria|malaria
1644325|NCT00225368|All-cause mortality|all-cause mortality
1644326|NCT00225368|Africa|africa
1644327|NCT00225368|Burkina Faso|burkina faso
1644328|NCT00225355|Angina pectoris|angina pectoris
1644329|NCT00225355|Metabolic syndrome|metabolic syndrome
1644330|NCT00225355|Ischaemic heart disease|ischaemic heart disease
1644331|NCT00225342|Angina|angina
1644332|NCT00225342|Ischaemic heart disease|ischaemic heart disease
1644333|NCT00225342|Diabetes|diabetes
1644334|NCT00225329|RCT|rct
1644335|NCT00225329|intervention study|intervention study
1644336|NCT00225329|labour management|labour management
1644337|NCT00225329|assessment|assessment
1644338|NCT00225316|RCT|rct
1644339|NCT00225316|intervention study|intervention study
1644340|NCT00225316|addiction|addiction
1644341|NCT00225316|substance use|substance use
1644342|NCT00225316|pregnancy|pregnancy
1644343|NCT00225303|HIV infection|hiv infection
1644344|NCT00225303|TMC125|tmc125
1644345|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1644346|NCT00225303|Protease inhibitor|protease inhibitor
1644347|NCT00225303|TMC125-C227|tmc125-c227
1644349|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
1644350|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
1644351|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
1644352|NCT00225277|Type II Diabetes|type ii diabetes
1644353|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1644354|NCT00225277|Dyslipidemia|dyslipidemia
1644355|NCT00225277|Drug Therapy|drug therapy
1644356|NCT00225277|Atherosclerosis|atherosclerosis
1644357|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
1644358|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
1644359|NCT00225264|Type II Diabetes|type ii diabetes
1644360|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
1644361|NCT00225264|Dyslipidemia|dyslipidemia
1644362|NCT00225264|Drug Therapy|drug therapy
1644363|NCT00225251|Dysthymic Disorder|dysthymic disorder
1644364|NCT00225251|Dysthymia|dysthymia
1644365|NCT00225251|Depression|depression
1644366|NCT00225251|Chronic Depression|chronic depression
1644367|NCT00225251|Wellbutrin XL|wellbutrin xl
1644368|NCT00225238|colonoscopy prep|colonoscopy prep
1644369|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1644370|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
1644371|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
1644372|NCT00225212|transformed lymphoma|transformed lymphoma
1644373|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
1644374|NCT00225212|recurrent lymphoma|recurrent lymphoma
1644375|NCT00225173|nodular sclerosis|nodular sclerosis
1644376|NCT00225173|lymphocyte rich|lymphocyte rich
1644377|NCT00225173|lymphocyte depleted|lymphocyte depleted
1644378|NCT00225173|mixed cellularity|mixed cellularity
1644380|NCT00225160|poly neuropathy|poly neuropathy
1644381|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
1644382|NCT00225160|treatment naïve|treatment naïve
1644383|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
1644384|NCT00225160|Lipid abnormalities|lipid abnormalities
1644385|NCT00225108|Deep vein thrombosis|deep vein thrombosis
1644386|NCT00225108|bleeding|bleeding
1644387|NCT00225095|meniscectomy|meniscectomy
1644388|NCT00225095|Chondrogen|chondrogen
1644389|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
1644390|NCT00225095|Osiris|osiris
1644391|NCT00225082|Lipoatrophy|lipoatrophy
1644392|NCT00225082|Mitochondrial function|mitochondrial function
1644393|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
1644394|NCT00225082|Treatment Experienced|treatment experienced
1644395|NCT00225069|Facial blushing|facial blushing
1644396|NCT00225069|Sympathectomy|sympathectomy
1644397|NCT00225017|Atazanavir|atazanavir
1644398|NCT00225017|Endothelial function|endothelial function
1644399|NCT00225017|Treatment Experienced|treatment experienced
1644400|NCT00225004|Colles Fracture|colles fracture
1644401|NCT00225004|Osteoporosis|osteoporosis
1644402|NCT00225004|BMD|bmd
1644403|NCT00225004|Quality assurance|quality assurance
1644404|NCT00224991|osteoporosis|osteoporosis
1644405|NCT00224991|fall frequency|fall frequency
1644406|NCT00224991|medical treatment|medical treatment
1644407|NCT00224991|compliance|compliance
1644408|NCT00224991|quality of life|quality of life
1644409|NCT00224991|systematic education|systematic education
1644410|NCT00224965|nicotine dependence|nicotine dependence
1644411|NCT00224952|seizures|seizures
1644412|NCT00224952|Epilepsy|epilepsy
1644413|NCT00224926|Tinea Capitis|tinea capitis
1644414|NCT00224913|osteoarthritis|osteoarthritis
1644415|NCT00224913|quadriceps|quadriceps
1644416|NCT00224913|inhibition|inhibition
1644417|NCT00224913|functional outcome|functional outcome
1644418|NCT00224913|electrical stimulation|electrical stimulation
1644419|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
1644420|NCT00224900|Life Skills|life skills
1644421|NCT00224900|Focus Group|focus group
1644422|NCT00224900|Young adolescents|young adolescents
1644423|NCT00224900|Caregivers|caregivers
1644424|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
1644425|NCT00224874|GVHD|gvhd
1644426|NCT00224822|Psychiatry|psychiatry
1644427|NCT00224822|Antipsychotic|antipsychotic
1644428|NCT00224822|Psychopharmacology|psychopharmacology
1644429|NCT00224822|Clinical Trial|clinical trial
1644430|NCT00224822|Open Label|open label
1644431|NCT00224822|Schizophrenia|schizophrenia
1644432|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
1644433|NCT00224822|Bipolar Disorder|bipolar disorder
1644434|NCT00224822|Metabolic Syndrome|metabolic syndrome
1644435|NCT00224796|Wound closure|wound closure
1644436|NCT00224796|Foot salvage|foot salvage
1644437|NCT00224796|Accelerated healing|accelerated healing
1644438|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
1644439|NCT00224757|Echocardiography|echocardiography
1644440|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
1644441|NCT00224744|Skin Neoplasms|skin neoplasms
1644442|NCT00224744|Ultracision|ultracision
1644443|NCT00224744|Lymphadenectomy|lymphadenectomy
1644444|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
1644445|NCT00224731|sleep|sleep
1644446|NCT00224731|stimulants|stimulants
1644447|NCT00224731|actigraphy|actigraphy
1644448|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
1644449|NCT00224718|Endograft|endograft
1644450|NCT00224718|Open repair|open repair
1644451|NCT00224718|Endovascular repair|endovascular repair
1644452|NCT00224718|AAA|aaa
1644453|NCT00224705|Albumin dialysis|albumin dialysis
1644454|NCT00224705|MARS system|mars system
1644455|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
1644456|NCT00224705|Fulminant hepatitis|fulminant hepatitis
1644457|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
1644458|NCT00224705|Acute liver failure|acute liver failure
1644459|NCT00224692|Mucositis|mucositis
1644460|NCT00224692|Pain|pain
1644461|NCT00224692|Morphine|morphine
1644462|NCT00224692|Ketamine|ketamine
1644463|NCT00224679|Colon cancer|colon cancer
1644464|NCT00224679|Aspirin|aspirin
1644465|NCT00224679|Adenomas|adenomas
1644466|NCT00224679|Prevention|prevention
1644467|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
1644468|NCT00224653|Obesity.|obesity.
1644469|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
1644470|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
1644471|NCT00224640|Iron-chelating treatment|iron-chelating treatment
1644472|NCT00224627|Randomized study|randomized study
1644473|NCT00224627|Capsule endoscopy|capsule endoscopy
1644474|NCT00224627|Push enteroscopy|push enteroscopy
1644475|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
1644476|NCT00224627|Endoscopy|endoscopy
1644477|NCT00224614|stem cell transplantation|stem cell transplantation
1644478|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
1644479|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
1644480|NCT00224601|Colorectal cancer|colorectal cancer
1644481|NCT00224601|HNPCC|hnpcc
1644482|NCT00224601|Diagnosis|diagnosis
1644483|NCT00224601|Coloscopy|coloscopy
1644484|NCT00224601|Chromoscopy|chromoscopy
1644485|NCT00224601|Indigo carmine|indigo carmine
1644486|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
1644487|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
1644488|NCT00224588|Ketamine|ketamine
1644489|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
1644490|NCT00224588|NMDA|nmda
1644491|NCT00224588|Post operative|post operative
1644492|NCT00224575|Veterans|veterans
1644493|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
1644494|NCT00224562|infections|infections
1644495|NCT00224562|lymphoma|lymphoma
1644496|NCT00224562|safety|safety
1644497|NCT00224549|Resistant hypertension|resistant hypertension
1644498|NCT00224549|Combined diuretic therapy|combined diuretic therapy
1644499|NCT00224549|Combined RAS blockers|combined ras blockers
1644500|NCT00224536|Myocardial infarction|myocardial infarction
1644501|NCT00224536|Bone marrow cells|bone marrow cells
1644502|NCT00224536|Intracoronary|intracoronary
1644503|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
1644504|NCT00224523|nasal biopsy|nasal biopsy
1644505|NCT00224523|GW685698X|gw685698x
1644506|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
1644900|NCT00222859|HIV|hiv
1644507|NCT00224497|Alzheimer's disease|alzheimer's disease
1644508|NCT00224497|cognition global functioning|cognition global functioning
1644509|NCT00224497|symptomatic|symptomatic
1644510|NCT00224497|B-742457|b-742457
1644511|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
1644512|NCT00224484|Safety|safety
1644513|NCT00224484|Adolescents|adolescents
1644514|NCT00224484|Immunogenicity|immunogenicity
1644515|NCT00224471|Adolescents|adolescents
1644516|NCT00224471|Immunogenicity|immunogenicity
1644517|NCT00224471|Safety|safety
1644518|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
1644519|NCT00224458|Treatment Experienced|treatment experienced
1644520|NCT00224458|HIV-1|hiv-1
1644521|NCT00224445|Treatment Naive|treatment naive
1644522|NCT00224445|HIV-1|hiv-1
1644523|NCT00224432|Atopic Dermatitis|atopic dermatitis
1644524|NCT00224432|SCORAD|scorad
1644525|NCT00224432|probiotics|probiotics
1644526|NCT00224432|cytokines|cytokines
1644527|NCT00224432|Infant|infant
1644528|NCT00224419|Smoking cessation|smoking cessation
1644529|NCT00224419|Pregnancy|pregnancy
1644530|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
1644531|NCT00224419|Motivational interviewing|motivational interviewing
1644532|NCT00224406|Lung transplantation|lung transplantation
1644533|NCT00224406|Reperfusion Injury|reperfusion injury
1644534|NCT00224406|Survival|survival
1644535|NCT00224393|Amyloidosis|amyloidosis
1644536|NCT00224393|Enbrel|enbrel
1644537|NCT00224380|Serious mental illness|serious mental illness
1644538|NCT00224380|medication adherence|medication adherence
1644539|NCT00224367|fracture|fracture
1644540|NCT00224367|hip|hip
1644541|NCT00224367|ambulation|ambulation
1644542|NCT00224354|LYMPHOCYTIC|lymphocytic
1644543|NCT00224354|B-LEUKEMIA|b-leukemia
1644544|NCT00224354|B-CLL|b-cll
1644545|NCT00224341|Pacemaker|pacemaker
1644546|NCT00224341|Atrial Fibrillation|atrial fibrillation
1644547|NCT00224341|Prevention pacing|prevention pacing
1644548|NCT00224341|Algorithms|algorithms
1644549|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
1644550|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
1644551|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
1644552|NCT00224328|Critical Limb Ischemia|critical limb ischemia
1644553|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
1644554|NCT00224315|Schizophrenia,|schizophrenia,
1644645|NCT00223912|Exercise|exercise
1644555|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
1644556|NCT00224315|treatment resistancy|treatment resistancy
1644557|NCT00224315|clozapine,|clozapine,
1644558|NCT00224315|ziprasidone|ziprasidone
1644559|NCT00224315|risperidone|risperidone
1644560|NCT00224315|combination|combination
1644561|NCT00224302|Schizophrenia,|schizophrenia,
1644562|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
1644563|NCT00224302|major depressive episode,|major depressive episode,
1644564|NCT00224302|combination,|combination,
1644565|NCT00224302|duloxetine|duloxetine
1644566|NCT00224289|Latanoprost|latanoprost
1644567|NCT00224289|Glaucoma|glaucoma
1644568|NCT00224289|Intraocular pressure|intraocular pressure
1644569|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
1644570|NCT00224263|Lingzhi|lingzhi
1644571|NCT00224237|Latino patients|latino patients
1644572|NCT00224237|Health practices|health practices
1644573|NCT00224237|Culture influences|culture influences
1644574|NCT00224224|Clinical performance|clinical performance
1644575|NCT00224224|Continuity of care|continuity of care
1644576|NCT00224224|Utilization of resources|utilization of resources
1644577|NCT00224185|Healthy individuals|healthy individuals
1644578|NCT00224185|smokers|smokers
1644579|NCT00224185|ex-smokers|ex-smokers
1644580|NCT00224185|non-smokers|non-smokers
1644581|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
1644582|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
1644583|NCT00224172|Psychosocial measures|psychosocial measures
1644584|NCT00224172|Predict re-hospitalization|predict re-hospitalization
1644585|NCT00224159|Statin therapy|statin therapy
1644586|NCT00224159|Dietary behavior|dietary behavior
1644587|NCT00224159|Attitudes and beliefs|attitudes and beliefs
1644588|NCT00224159|Self efficacy|self efficacy
1644589|NCT00224146|Oxytrol(r)|oxytrol(r)
1644590|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
1644591|NCT00224146|overactive bladder|overactive bladder
1644592|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
1644593|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
1644594|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
1644595|NCT00224094|Menopause|menopause
1644596|NCT00224094|Testosterone|testosterone
1644597|NCT00224094|Androgens|androgens
1644598|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
1644599|NCT00224094|Thyroid function|thyroid function
1644600|NCT00224094|Cortisol|cortisol
1644601|NCT00224081|iron deficiency anemia|iron deficiency anemia
1644602|NCT00224081|ferritin|ferritin
1644603|NCT00224081|hemodialysis|hemodialysis
1644604|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
1644605|NCT00224081|epoetin alfa|epoetin alfa
1644606|NCT00224068|Iron deficiency|iron deficiency
1644607|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
1644608|NCT00224068|anemia|anemia
1644609|NCT00224068|cancer chemotherapy|cancer chemotherapy
1644610|NCT00224068|epoetin alfa|epoetin alfa
1644611|NCT00224068|Anemia/drug therapy|anemia/drug therapy
1644612|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
1644613|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
1644614|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
1644615|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
1644616|NCT00224055|Iron deficiency|iron deficiency
1644617|NCT00224055|Anemia|anemia
1644618|NCT00224055|Chronic kidney disease|chronic kidney disease
1644619|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
1644620|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
1644621|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
1644622|NCT00224042|Iron deficiency|iron deficiency
1644623|NCT00224042|Anemia|anemia
1644624|NCT00224042|Chronic kidney disease|chronic kidney disease
1644625|NCT00224042|Erythropoietic agents|erythropoietic agents
1644626|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
1644627|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
1644628|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
1644629|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
1644630|NCT00224003|Anemia|anemia
1644631|NCT00223990|Plasmodium|plasmodium
1644632|NCT00223990|falciparum|falciparum
1644633|NCT00223990|malaria|malaria
1644634|NCT00223990|vaccine|vaccine
1644635|NCT00223990|AS02A adjuvant|as02a adjuvant
1644636|NCT00223990|FMP1|fmp1
1644637|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
1644638|NCT00223977|Anemia.|anemia.
1644639|NCT00223964|Iron Deficiency|iron deficiency
1644640|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
1644641|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
1644642|NCT00223925|Stem cell transplantation|stem cell transplantation
1644643|NCT00223925|Allogeneic transplantation|allogeneic transplantation
1644644|NCT00223912|Cardiovascular Disease|cardiovascular disease
1644646|NCT00223912|Functional electrical stimulation|functional electrical stimulation
1644647|NCT00223912|hemostasis|hemostasis
1644648|NCT00223912|Spinal cord injury|spinal cord injury
1644649|NCT00223899|Melanoma|melanoma
1644650|NCT00223899|Electroporation|electroporation
1644651|NCT00223899|IL-2|il-2
1644652|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
1644653|NCT00223873|Muscles Spasticity|muscles spasticity
1644654|NCT00223873|Spasms|spasms
1644655|NCT00223873|Ferti Care Vibrator|ferti care vibrator
1644656|NCT00223873|Antispasmotic treatment|antispasmotic treatment
1644657|NCT00223860|Hypogonadal|hypogonadal
1644658|NCT00223860|Hypothalamus|hypothalamus
1644659|NCT00223860|Pituitary|pituitary
1644660|NCT00223860|Spinal Cord Injury|spinal cord injury
1644661|NCT00223860|Testes|testes
1644662|NCT00223860|Testosterone|testosterone
1644663|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
1644664|NCT00223847|Aphasia therapy|aphasia therapy
1644665|NCT00223847|Constraint therapy|constraint therapy
1644666|NCT00223847|Language therapy|language therapy
1644667|NCT00223834|Counseling|counseling
1644668|NCT00223834|Motivation|motivation
1644669|NCT00223834|Psychotherapy, brief|psychotherapy, brief
1644670|NCT00223821|Behavior Therapy|behavior therapy
1644671|NCT00223821|Behavioral Medicine|behavioral medicine
1644672|NCT00223821|Behavioral Research|behavioral research
1644673|NCT00223821|Behavioral Sciences|behavioral sciences
1644674|NCT00223821|Combined Modality Therapy|combined modality therapy
1644675|NCT00223821|Drug Therapy|drug therapy
1644676|NCT00223821|Overactive bladder|overactive bladder
1644677|NCT00223821|Treatment Outcome|treatment outcome
1644678|NCT00223821|Urge incontinence|urge incontinence
1644679|NCT00223821|Urinary incontinence|urinary incontinence
1644680|NCT00223808|Rehabilitation|rehabilitation
1644681|NCT00223808|Robotics|robotics
1644682|NCT00223795|Cane|cane
1644683|NCT00223795|Gait|gait
1644684|NCT00223795|Obesity|obesity
1644685|NCT00223795|Osteoarthritis|osteoarthritis
1644686|NCT00223795|Walking Aids|walking aids
1644687|NCT00223782|Diabetes|diabetes
1644688|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
1644689|NCT00223782|Walking|walking
1644690|NCT00223769|oxandrolone|oxandrolone
1644691|NCT00223769|oxandrin|oxandrin
1644692|NCT00223769|lean body mass|lean body mass
1644693|NCT00223769|functional recovery|functional recovery
1644694|NCT00223769|resistance training|resistance training
1644695|NCT00223756|Vision, Low|vision, low
1644696|NCT00223743|essential tremor|essential tremor
1644697|NCT00223743|zonisamide|zonisamide
1644698|NCT00223743|clinical trial|clinical trial
1644699|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1644700|NCT00223730|Bone Marrow Transplant|bone marrow transplant
1644701|NCT00223730|Citrulline|citrulline
1644702|NCT00223730|Urea Cycle|urea cycle
1644703|NCT00223730|Hepatic Injury|hepatic injury
1644704|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
1644705|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
1644706|NCT00223717|Supine Hypertension|supine hypertension
1644707|NCT00223717|Hypertension|hypertension
1644708|NCT00223717|Treatment|treatment
1644709|NCT00223717|Autonomic failure|autonomic failure
1644710|NCT00223717|Pure autonomic failure|pure autonomic failure
1644711|NCT00223717|Multiple System Atrophy|multiple system atrophy
1644712|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
1644713|NCT00223704|Coronary Artery Bypass|coronary artery bypass
1644714|NCT00223704|Blood Transfusion|blood transfusion
1644715|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
1644716|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
1644717|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
1644718|NCT00223691|orthostatic hypotension|orthostatic hypotension
1644719|NCT00223691|autonomic failure|autonomic failure
1644720|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
1644721|NCT00223665|Intermittent Androgen Suppression|intermittent androgen suppression
1644722|NCT00223665|Biochemical Relapsed Prostate Cancer|biochemical relapsed prostate cancer
1644723|NCT00223665|Androgen Deprivation Therapy|androgen deprivation therapy
1644724|NCT00223665|Localized Prostate Cancer|localized prostate cancer
1644725|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1644726|NCT00223652|Telephone psychotherapy|telephone psychotherapy
1644727|NCT00223652|Clinical Trial|clinical trial
1644728|NCT00223652|Primary Care Clinic|primary care clinic
1644729|NCT00223652|Treatment for Depression|treatment for depression
1644730|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
1644731|NCT00223639|alcoholism antagonist|alcoholism antagonist
1644732|NCT00223639|anticonvulsant|anticonvulsant
1644733|NCT00223639|cognition|cognition
1644734|NCT00223639|neuropharmacology|neuropharmacology
1644837|NCT00223119|perineal trauma|perineal trauma
1644735|NCT00223639|substance abuse related behavior|substance abuse related behavior
1644736|NCT00223639|craving|craving
1644737|NCT00223639|euphoria|euphoria
1644738|NCT00223639|relapse /recurrence|relapse /recurrence
1644739|NCT00223639|patient oriented research|patient oriented research
1644740|NCT00223626|Cocaine Addiction|cocaine addiction
1644741|NCT00223626|Cocaine Dependence|cocaine dependence
1644742|NCT00223613|diabetes|diabetes
1644743|NCT00223613|juvenile diabetes|juvenile diabetes
1644744|NCT00223613|insulin deficiency|insulin deficiency
1644745|NCT00223600|lipids|lipids
1644746|NCT00223600|lipoproproteins|lipoproproteins
1644747|NCT00223600|growth|growth
1644748|NCT00223600|neurological development|neurological development
1644749|NCT00223600|vascular wall|vascular wall
1644750|NCT00223600|blood pressure|blood pressure
1644751|NCT00223600|nutrient intake|nutrient intake
1644752|NCT00223587|driving|driving
1644753|NCT00223587|memory|memory
1644754|NCT00223561|adult|adult
1644755|NCT00223548|prophylaxis|prophylaxis
1644756|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
1644757|NCT00223548|mesna|mesna
1644758|NCT00223548|acute renal failure|acute renal failure
1644759|NCT00223535|Schizophrenia|schizophrenia
1644760|NCT00223535|Cognitive Remediation|cognitive remediation
1644761|NCT00223535|Social Skills Training|social skills training
1644762|NCT00223535|Psychosocial|psychosocial
1644763|NCT00223522|Schizophrenia|schizophrenia
1644764|NCT00223522|Schizoaffective|schizoaffective
1644765|NCT00223522|MEMS|mems
1644766|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
1644767|NCT00223509|mixed mania|mixed mania
1644768|NCT00223509|lamotrigine|lamotrigine
1644769|NCT00223496|Bipolar Depression|bipolar depression
1644770|NCT00223496|Refractory|refractory
1644771|NCT00223483|Hematologic Diseases|hematologic diseases
1644772|NCT00223483|Genomics|genomics
1644773|NCT00223483|Cytokines|cytokines
1644774|NCT00223483|Chemokines|chemokines
1644775|NCT00223483|Receptors|receptors
1644776|NCT00223470|pain|pain
1644777|NCT00223457|multiple sclerosis|multiple sclerosis
1644778|NCT00223457|compliance|compliance
1644779|NCT00223457|adherence|adherence
1644780|NCT00223457|disease modifying therapy|disease modifying therapy
1644781|NCT00223457|depression|depression
1644782|NCT00223457|hope|hope
1644783|NCT00223457|quality of life|quality of life
1644784|NCT00223444|alcohol|alcohol
1644785|NCT00223444|GABA|gaba
1644786|NCT00223444|genetic variation|genetic variation
1644787|NCT00223418|aripiprazole|aripiprazole
1644788|NCT00223418|olanzapine|olanzapine
1644789|NCT00223418|vocational|vocational
1644790|NCT00223418|learning|learning
1644791|NCT00223418|cognition|cognition
1644792|NCT00223418|cognitive|cognitive
1644793|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
1644794|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
1644795|NCT00223366|Pain in teeth|pain in teeth
1644796|NCT00223353|Biomechanics|biomechanics
1644797|NCT00223353|Gait|gait
1644798|NCT00223353|Balance|balance
1644799|NCT00223340|patient activation|patient activation
1644800|NCT00223340|primary care|primary care
1644801|NCT00223340|diabetes|diabetes
1644802|NCT00223340|cardiovascular risk|cardiovascular risk
1644803|NCT00223327|pain|pain
1644804|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
1644805|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
1644806|NCT00223314|HIV|hiv
1644807|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
1644808|NCT00223314|Pregnancy|pregnancy
1644809|NCT00223314|HIV Seronegativity|hiv seronegativity
1644810|NCT00223275|Bipolar Disorder|bipolar disorder
1644811|NCT00223275|Alcohol Dependence|alcohol dependence
1644812|NCT00223275|Dual Diagnosis|dual diagnosis
1644813|NCT00223275|Naltrexone|naltrexone
1644814|NCT00223210|bipolar disorder|bipolar disorder
1644815|NCT00223210|cocaine dependence|cocaine dependence
1644816|NCT00223210|quetiapine|quetiapine
1644817|NCT00223197|Bipolar with depression|bipolar with depression
1644818|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
1644819|NCT00223197|substance abuse dependence|substance abuse dependence
1644820|NCT00223171|Stage T3 T4|stage t3 t4
1644821|NCT00223171|PSA > 20|psa > 20
1644822|NCT00223171|Gleason Score > 7|gleason score > 7
1644823|NCT00223158|Thyroid cancer|thyroid cancer
1644824|NCT00223158|Hypothyroidism|hypothyroidism
1644825|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
1644826|NCT00223158|Liothyronine|liothyronine
1644827|NCT00223158|TSH elevation|tsh elevation
1644828|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
1644829|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
1644830|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
1644831|NCT00223132|bariatric surgery|bariatric surgery
1644832|NCT00223132|body contouring|body contouring
1644833|NCT00223132|skin laxity|skin laxity
1644834|NCT00223132|plastic surgery|plastic surgery
1644835|NCT00223132|suture granuloma|suture granuloma
1644836|NCT00223132|absorbable sutures|absorbable sutures
1644838|NCT00223119|perineal laceration|perineal laceration
1644839|NCT00223119|persistent perineal pain|persistent perineal pain
1644840|NCT00223106|urge incontinence|urge incontinence
1644841|NCT00223106|urinary incontinence|urinary incontinence
1644842|NCT00223106|vault prolapse|vault prolapse
1644843|NCT00223106|stess incontinence|stess incontinence
1644844|NCT00223106|mixed incontinence|mixed incontinence
1644845|NCT00223106|urine leakage|urine leakage
1644846|NCT00223106|enterocele|enterocele
1644847|NCT00223106|rectocele|rectocele
1644848|NCT00223106|cystocele|cystocele
1644849|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
1644850|NCT00223080|HIV Seronegativity|hiv seronegativity
1644851|NCT00223067|renal transplantation|renal transplantation
1644853|NCT00223054|cyclosporin A|cyclosporin a
1644854|NCT00223054|Tacrolimus|tacrolimus
1644855|NCT00223054|Everolimus|everolimus
1644856|NCT00223054|Sirolimus|sirolimus
1644857|NCT00223054|Fluvastatin|fluvastatin
1644858|NCT00223041|renal transplantation|renal transplantation
1644859|NCT00223041|cardiovasculary disease|cardiovasculary disease
1644860|NCT00223041|statin|statin
1644861|NCT00223028|fluvastain|fluvastain
1644862|NCT00223028|sirolimus|sirolimus
1644863|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
1644864|NCT00223028|renal transplantation|renal transplantation
1644865|NCT00223015|renal transplantation|renal transplantation
1644866|NCT00223015|pharmacokinetics|pharmacokinetics
1644867|NCT00223015|Fluvastatin|fluvastatin
1644868|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
1644869|NCT00223015|tacrolimus|tacrolimus
1644870|NCT00222989|GERD|gerd
1644871|NCT00222989|PPI|ppi
1644872|NCT00222989|Functional heartburn|functional heartburn
1644873|NCT00222963|Obesity|obesity
1644874|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1644875|NCT00222963|Children|children
1644876|NCT00222963|Adolescents|adolescents
1644877|NCT00222963|Adenotonsillectomy|adenotonsillectomy
1644878|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
1644879|NCT00222937|Voice Problems|voice problems
1644880|NCT00222937|Voice Disorders|voice disorders
1644881|NCT00222924|Mitochondria|mitochondria
1644882|NCT00222911|plantar fasciitis|plantar fasciitis
1644883|NCT00222911|heel pain|heel pain
1644884|NCT00222911|heel spur|heel spur
1644885|NCT00222911|night splint|night splint
1644886|NCT00222911|arch support|arch support
1644887|NCT00222911|foot orthosis|foot orthosis
1644888|NCT00222911|physical therapy|physical therapy
1644889|NCT00222898|Pancreatic Cyst|pancreatic cyst
1644890|NCT00222898|PANDA Study|panda study
1644891|NCT00222885|PET imaging|pet imaging
1644892|NCT00222885|Skeletal muscle|skeletal muscle
1644893|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
1644894|NCT00222885|Glucose transport|glucose transport
1644895|NCT00222885|Glucose phosphorylation|glucose phosphorylation
1644896|NCT00222872|Endocrine System Diseases|endocrine system diseases
1644897|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
1644898|NCT00222872|Hormone|hormone
1644899|NCT00222872|Postmenopausal Women|postmenopausal women
1644901|NCT00222859|HCV|hcv
1644902|NCT00222846|Clinical trial|clinical trial
1644903|NCT00222846|Behavioral research|behavioral research
1644904|NCT00222846|Patient compliance|patient compliance
1644905|NCT00222833|Schizophrenia|schizophrenia
1644906|NCT00222833|Schizoaffective disorder|schizoaffective disorder
1644907|NCT00222833|Aripiprazole|aripiprazole
1644908|NCT00222833|Obese|obese
1644909|NCT00222833|Overweight|overweight
1644910|NCT00222833|Heart Health|heart health
1644911|NCT00222833|Antipsychotic|antipsychotic
1644912|NCT00222833|Heart Health Factors|heart health factors
1644913|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
1644914|NCT00222833|Cardiovascular health|cardiovascular health
1644915|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
1644916|NCT00222794|Schizophrenia|schizophrenia
1644917|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
1644918|NCT00222794|Negative Symptoms|negative symptoms
1644919|NCT00222794|Atomoxetine|atomoxetine
1644920|NCT00222794|Strattera|strattera
1644921|NCT00222781|Skeletal muscle|skeletal muscle
1644922|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
1644923|NCT00222768|Adipose tissue|adipose tissue
1644924|NCT00222768|PET imaging|pet imaging
1644925|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
1644926|NCT00222755|Disease management|disease management
1644927|NCT00222755|Quality of care|quality of care
1644928|NCT00222742|hypothermia|hypothermia
1644929|NCT00222742|pediatric TBI|pediatric tbi
1644930|NCT00222729|head|head
1644931|NCT00222729|neck|neck
1644932|NCT00222716|Treatment adherence|treatment adherence
1644933|NCT00222716|HIV|hiv
1644934|NCT00222716|Self-efficacy|self-efficacy
1644935|NCT00222716|Treatment Experienced|treatment experienced
1644936|NCT00222703|nicotine addiction|nicotine addiction
1644937|NCT00222703|relapse|relapse
1644938|NCT00222703|smoking|smoking
1644939|NCT00222703|chronic disorders|chronic disorders
1645325|NCT00221104|stroke|stroke
1644940|NCT00222703|randomized controlled trial|randomized controlled trial
1644941|NCT00222703|intervention|intervention
1644942|NCT00222690|qualitative interview|qualitative interview
1644943|NCT00222690|symptom triggers|symptom triggers
1644944|NCT00222690|activity and participation|activity and participation
1644945|NCT00222677|venous thromboembolism|venous thromboembolism
1644946|NCT00222677|deep vein thrombosis|deep vein thrombosis
1644947|NCT00222677|pulmonary embolism|pulmonary embolism
1644948|NCT00222677|antithrombotic agents|antithrombotic agents
1644949|NCT00222664|hepatitis B|hepatitis b
1644950|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
1644951|NCT00222664|prevention|prevention
1644952|NCT00222664|vaccination|vaccination
1644953|NCT00222651|pulmonary embolism|pulmonary embolism
1644954|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
1644955|NCT00222651|thrombolysis|thrombolysis
1644956|NCT00222651|echocardiography|echocardiography
1644957|NCT00222638|Oral anticoagulants|oral anticoagulants
1644958|NCT00222638|Influenza virus|influenza virus
1644959|NCT00222638|Influenza vaccine|influenza vaccine
1644960|NCT00222638|Pharmacological interference|pharmacological interference
1644961|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
1644962|NCT00222625|Oral Anticoagulants|oral anticoagulants
1644963|NCT00222625|Antiplatelet Agents|antiplatelet agents
1644964|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
1644965|NCT00222573|clopidogrel|clopidogrel
1644966|NCT00222573|metoprolol|metoprolol
1644967|NCT00222573|myocardial infarction|myocardial infarction
1644968|NCT00222573|randomised trial|randomised trial
1644969|NCT00222560|physical activity counselling|physical activity counselling
1644970|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
1644971|NCT00222560|prevention|prevention
1644972|NCT00222560|collaborative health care|collaborative health care
1644973|NCT00222560|physical inactivity|physical inactivity
1644974|NCT00222560|motivation|motivation
1644975|NCT00222560|fitness|fitness
1644976|NCT00222560|randomized controlled trial|randomized controlled trial
1644977|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
1644978|NCT00222534|Alkalosis|alkalosis
1644979|NCT00222521|Cystic Fibrosis|cystic fibrosis
1644980|NCT00222521|Diabetes|diabetes
1644981|NCT00222508|Cystic Fibrosis|cystic fibrosis
1644982|NCT00222508|Diabetes|diabetes
1644983|NCT00222508|Complications|complications
1644984|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
1644985|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
1644986|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
1644987|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
1644988|NCT00222482|Borderline Personality Disorder|borderline personality disorder
1644989|NCT00222469|pancreatic cancer|pancreatic cancer
1644990|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
1644991|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
1644992|NCT00222469|bevacizumab|bevacizumab
1644993|NCT00222469|oxaliplatin|oxaliplatin
1644994|NCT00222469|gemcitabine|gemcitabine
1644995|NCT00222469|1st line treatment|1st line treatment
1644996|NCT00222469|first line treatment|first line treatment
1644997|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
1644998|NCT00222456|preterm infants|preterm infants
1644999|NCT00222456|early intervention|early intervention
1645000|NCT00222456|outcome|outcome
1645001|NCT00222456|behavioral problems|behavioral problems
1645002|NCT00222456|parenting stress|parenting stress
1645003|NCT00222443|Recurrent solid tumors|recurrent solid tumors
1645004|NCT00222443|recurrent lymphomas|recurrent lymphomas
1645005|NCT00222443|Pediatrics|pediatrics
1645006|NCT00222443|Adolescents|adolescents
1645007|NCT00222430|Fluoroscopy|fluoroscopy
1645008|NCT00222430|Femoral Artery|femoral artery
1645009|NCT00222430|Arterial Vascular Access|arterial vascular access
1645010|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1645011|NCT00222404|Pharmacogenomic|pharmacogenomic
1645012|NCT00222378|Crohn's disease|crohn's disease
1645013|NCT00222378|ulcerative colitis|ulcerative colitis
1645014|NCT00222378|cytomegalovirus|cytomegalovirus
1645015|NCT00222378|Epstein Bar Virus|epstein bar virus
1645016|NCT00222378|Human Herpes virus 6|human herpes virus 6
1645017|NCT00222365|homeopathy|homeopathy
1645018|NCT00222365|assessment|assessment
1645019|NCT00222365|pain|pain
1645020|NCT00222365|ligamentoplasty|ligamentoplasty
1645021|NCT00222352|Unstable Angina|unstable angina
1645022|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
1645023|NCT00222352|Myocardial Necrosis|myocardial necrosis
1645024|NCT00222352|Troponin I|troponin i
1645025|NCT00222339|Stroke|stroke
1645026|NCT00222339|Hand function|hand function
1645027|NCT00222339|Task-specific training|task-specific training
1645028|NCT00222326|Hysterectomy,|hysterectomy,
1645029|NCT00222326|Prolapse,|prolapse,
1645030|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
1645031|NCT00222326|Bladder,|bladder,
1645032|NCT00222326|Bowel.|bowel.
1645033|NCT00222300|Total hip replacement|total hip replacement
1645034|NCT00222300|Strength training|strength training
1645035|NCT00222300|Gait analysis|gait analysis
1645036|NCT00222287|Feldenkrais Method|feldenkrais method
1645037|NCT00222287|movement class|movement class
1645038|NCT00222287|balance|balance
1645039|NCT00222287|Four square step test|four square step test
1645040|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
1645041|NCT00222287|systems theory|systems theory
1646507|NCT00214656|Factor VIIa|factor viia
1645042|NCT00222274|fibromyalgia|fibromyalgia
1645043|NCT00222274|pain|pain
1645044|NCT00222274|biofeedback|biofeedback
1645045|NCT00222274|heart rate variability|heart rate variability
1645046|NCT00222261|antiplatelet therapy|antiplatelet therapy
1645047|NCT00222261|aspirin non-responders|aspirin non-responders
1645048|NCT00222261|aspirin resistance|aspirin resistance
1645049|NCT00222261|clopidogrel|clopidogrel
1645050|NCT00222261|coronary heart disease|coronary heart disease
1645051|NCT00222261|stable angina pectoris|stable angina pectoris
1645052|NCT00222248|Stress urinary incontinence|stress urinary incontinence
1645053|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
1645054|NCT00222248|Bladder training|bladder training
1645055|NCT00222248|Older women|older women
1645056|NCT00222235|schizophrenia|schizophrenia
1645057|NCT00222235|schizoaffective disorder|schizoaffective disorder
1645058|NCT00222235|negative symptoms|negative symptoms
1645059|NCT00222235|cognitive impairments|cognitive impairments
1645060|NCT00222222|severe sepsis|severe sepsis
1645061|NCT00222222|prognostic markers|prognostic markers
1645062|NCT00222222|polymorphisms|polymorphisms
1645063|NCT00222222|SIRS|sirs
1645064|NCT00222209|Experimental study|experimental study
1645065|NCT00222209|chronic pain|chronic pain
1645066|NCT00222209|operant learning|operant learning
1645067|NCT00222209|comorbidity|comorbidity
1645068|NCT00222209|stress|stress
1645069|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
1645070|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
1645071|NCT00222196|atherosclerosis|atherosclerosis
1645072|NCT00222196|quality of life|quality of life
1645073|NCT00222196|pain-score|pain-score
1645074|NCT00222196|biomarkers|biomarkers
1645075|NCT00222183|Lupus erythematodes|lupus erythematodes
1645076|NCT00222183|Elidel|elidel
1645077|NCT00222183|Pimecrolimus|pimecrolimus
1645078|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
1645079|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
1645080|NCT00222131|Epigastric Pain|epigastric pain
1645081|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
1645082|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
1645083|NCT00222092|prophylaxis|prophylaxis
1645084|NCT00222092|prognosis|prognosis
1645085|NCT00222092|natural course|natural course
1645086|NCT00222092|molecular markers|molecular markers
1645087|NCT00222066|Aspiration|aspiration
1645088|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
1645089|NCT00222066|Ovarian torsion|ovarian torsion
1645090|NCT00222053|Myeloma|myeloma
1645091|NCT00222053|Autologous transplantation|autologous transplantation
1645092|NCT00222053|Maintenance therapy|maintenance therapy
1645093|NCT00222053|Thalidomide|thalidomide
1645094|NCT00222040|Stroke|stroke
1645095|NCT00222040|thrombolysis|thrombolysis
1645096|NCT00222040|ultrasound|ultrasound
1645097|NCT00222040|microbubbles|microbubbles
1645098|NCT00222040|alteplase|alteplase
1645099|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1645100|NCT00222027|adult patient|adult patient
1645101|NCT00222027|chemotherapy|chemotherapy
1645102|NCT00222027|stem cell transplantation|stem cell transplantation
1645103|NCT00222027|Young adult patients|young adult patients
1645104|NCT00222014|Refractory ascites|refractory ascites
1645105|NCT00222014|Cirrhosis|cirrhosis
1645106|NCT00222014|Paracentesesis|paracentesesis
1645107|NCT00221988|Elderly|elderly
1645108|NCT00221988|Epilepsy|epilepsy
1645109|NCT00221988|Cognition|cognition
1645110|NCT00221988|Health Outcome|health outcome
1645111|NCT00221962|ADHD|adhd
1645112|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
1645113|NCT00221923|African American|african american
1645114|NCT00221923|Glaucoma/pathology|glaucoma/pathology
1645115|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
1645116|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
1645117|NCT00221923|Risk factor glaucoma|risk factor glaucoma
1645118|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
1645119|NCT00221897|Glaucoma/pathology|glaucoma/pathology
1645120|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
1645121|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
1645122|NCT00221897|Risk factors glaucoma|risk factors glaucoma
1645123|NCT00221845|Ramipril|ramipril
1645124|NCT00221845|Hypertension|hypertension
1645125|NCT00221845|Chronic renal failure|chronic renal failure
1645126|NCT00221845|Disease progression|disease progression
1645127|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
1645128|NCT00221845|Intima media thickness|intima media thickness
1645129|NCT00221845|Cardiovascular disease|cardiovascular disease
1645130|NCT00221845|Biomarkers|biomarkers
1645131|NCT00221845|Gene polymorphisms|gene polymorphisms
1645132|NCT00221832|Long QT Syndrome|long qt syndrome
1645133|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
1645134|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
1645135|NCT00221832|Short QT Syndrome|short qt syndrome
1645136|NCT00221832|Brugada Syndrome|brugada syndrome
1645137|NCT00221819|Humidification|humidification
1645138|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
1645139|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
1645140|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
1645141|NCT00221793|Parkinson|parkinson
1645142|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
1645143|NCT00221793|pharmacological treatment|pharmacological treatment
1645144|NCT00221780|Heart failure|heart failure
1645145|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
1645146|NCT00221780|Coronary disease|coronary disease
1645147|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
1645148|NCT00221780|Hemodynamics|hemodynamics
1645149|NCT00221780|Randomized Controlled Trials|randomized controlled trials
1645150|NCT00221780|Single-Blind Study|single-blind study
1645151|NCT00221767|Neurogenic bladder|neurogenic bladder
1645152|NCT00221767|electric stimulation therapy|electric stimulation therapy
1645153|NCT00221767|urinary tract infection|urinary tract infection
1645154|NCT00221767|urinary incontinence|urinary incontinence
1645155|NCT00221767|spinal cord injuries|spinal cord injuries
1645156|NCT00221767|spinal nerve roots|spinal nerve roots
1645157|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
1645158|NCT00221767|open Study|open study
1645159|NCT00221754|HIV,|hiv,
1645160|NCT00221754|protease inhibitors|protease inhibitors
1645161|NCT00221754|pravastatin|pravastatin
1645162|NCT00221754|Treatment Experienced|treatment experienced
1645163|NCT00221741|Heart surgery|heart surgery
1645164|NCT00221741|Blood Loss, Surgical|blood loss, surgical
1645165|NCT00221741|Mortality|mortality
1645166|NCT00221741|Blood Transfusion|blood transfusion
1645167|NCT00221741|Cohort Studies|cohort studies
1645168|NCT00221728|Kidney Neoplasms|kidney neoplasms
1645169|NCT00221728|Surgery|surgery
1645170|NCT00221728|Catheter Ablation|catheter ablation
1645171|NCT00221728|Randomized controlled trials|randomized controlled trials
1645172|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
1645173|NCT00221715|arteritis|arteritis
1645174|NCT00221715|lower limb ischemia|lower limb ischemia
1645175|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
1645176|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
1645177|NCT00221715|saphenous vein|saphenous vein
1645178|NCT00221715|vascular permeability|vascular permeability
1645179|NCT00221715|doppler ultrasonography|doppler ultrasonography
1645180|NCT00221715|randomized clinical trials|randomized clinical trials
1645181|NCT00221715|efficacy study|efficacy study
1645182|NCT00221702|Melanoma|melanoma
1645183|NCT00221702|Neoplasm metastasis|neoplasm metastasis
1645184|NCT00221702|Interferon alfa-2b|interferon alfa-2b
1645185|NCT00221702|Adjuvants|adjuvants
1645186|NCT00221702|Randomized clinical trial|randomized clinical trial
1645187|NCT00221702|Disease-free survival time|disease-free survival time
1645188|NCT00221702|Safety|safety
1645189|NCT00221702|Drug toxicity|drug toxicity
1645190|NCT00221702|Quality of life|quality of life
1645191|NCT00221689|Severe brain injury|severe brain injury
1645192|NCT00221689|Coma|coma
1645193|NCT00221689|Hypertonia|hypertonia
1645194|NCT00221689|Dysautonomia|dysautonomia
1645195|NCT00221689|Baclofen|baclofen
1645196|NCT00221689|Randomized Controlled Trials|randomized controlled trials
1645197|NCT00221676|influenza vaccine|influenza vaccine
1645198|NCT00221676|general practitioner|general practitioner
1645199|NCT00221663|Cardiac surgery|cardiac surgery
1645200|NCT00221663|Aortic valve replacement|aortic valve replacement
1645201|NCT00221663|Minimally invasive surgery|minimally invasive surgery
1645202|NCT00221663|Perioperative course|perioperative course
1645203|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
1645204|NCT00221650|HCV infection|hcv infection
1645205|NCT00221650|HIV infection|hiv infection
1645206|NCT00221650|Treatment Failure|treatment failure
1645207|NCT00221650|PEG interferon|peg interferon
1645208|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
1645209|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
1645210|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
1645211|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
1645212|NCT00221650|Drug Therapy, Combination|drug therapy, combination
1645213|NCT00221650|Treatment Experienced|treatment experienced
1645214|NCT00221650|Treatment Naive|treatment naive
1645215|NCT00221637|Neuralgia|neuralgia
1645216|NCT00221637|Valproate|valproate
1645217|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
1645218|NCT00221637|Pain Measurement|pain measurement
1645219|NCT00221637|Randomized Controlled Trials|randomized controlled trials
1645220|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
1645221|NCT00221624|HCV infection|hcv infection
1645222|NCT00221624|Treatment failure|treatment failure
1645223|NCT00221624|PEG Interferon|peg interferon
1645224|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
1645225|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
1645226|NCT00221624|ribavirin|ribavirin
1645227|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
1645228|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
1645229|NCT00221624|Amantadine|amantadine
1646508|NCT00214656|Anaesthesia|anaesthesia
1645230|NCT00221624|Drug Therapy, Combination|drug therapy, combination
1645231|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
1645232|NCT00221507|Vaccination|vaccination
1645233|NCT00221507|Prevention & Control|prevention & control
1645234|NCT00221494|depression|depression
1645235|NCT00221481|Bipolar|bipolar
1645236|NCT00221481|Alcohol|alcohol
1645237|NCT00221468|Adolescents|adolescents
1645238|NCT00221455|Diabetes Mellitus|diabetes mellitus
1645239|NCT00221455|Chronic disease management|chronic disease management
1645240|NCT00221455|Patient portal|patient portal
1645241|NCT00221455|Patient empowerment|patient empowerment
1645242|NCT00221442|Adults|adults
1645243|NCT00221442|Binge eating disorder|binge eating disorder
1645244|NCT00221442|Blood draw|blood draw
1645245|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
1645246|NCT00221442|Eating disorders|eating disorders
1645247|NCT00221442|Electrocardiogram|electrocardiogram
1645248|NCT00221442|Females|females
1645249|NCT00221442|Males|males
1645250|NCT00221442|Physical exam|physical exam
1645251|NCT00221442|Psychiatric evaluation|psychiatric evaluation
1645252|NCT00221442|Questionnaire|questionnaire
1645253|NCT00221429|child|child
1645254|NCT00221429|adolescent|adolescent
1645255|NCT00221416|child|child
1645256|NCT00221416|adolescent|adolescent
1645257|NCT00221403|child|child
1645258|NCT00221403|adolescent|adolescent
1645259|NCT00221403|bipolar disorder|bipolar disorder
1645260|NCT00221390|stroke|stroke
1645261|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
1645262|NCT00221377|intubation|intubation
1645263|NCT00221377|trachea|trachea
1645264|NCT00221377|tube|tube
1645265|NCT00221377|cuff|cuff
1645266|NCT00221377|children|children
1645267|NCT00221364|Trachoma|trachoma
1645268|NCT00221364|Chlamydia|chlamydia
1645269|NCT00221364|Azithromycin|azithromycin
1645271|NCT00221351|acute bronchitis|acute bronchitis
1645272|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
1645273|NCT00221351|pneumonia|pneumonia
1645274|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
1645275|NCT00221338|gabapentin|gabapentin
1645276|NCT00221338|pain|pain
1645277|NCT00221338|surgery|surgery
1645278|NCT00221338|delirium|delirium
1645279|NCT00221338|cognitive decline|cognitive decline
1645280|NCT00221325|Phase I Clinical Trial|phase i clinical trial
1645281|NCT00221325|Pharmacokinetics|pharmacokinetics
1645282|NCT00221325|Pharmacodynamics|pharmacodynamics
1645283|NCT00221325|CNS Lymphoma|cns lymphoma
1645284|NCT00221325|Ocular Lymphoma|ocular lymphoma
1645285|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
1645286|NCT00221299|Osteoporosis|osteoporosis
1645287|NCT00221299|Steroids|steroids
1645288|NCT00221299|Prednisone|prednisone
1645289|NCT00221286|chronic hepatitis B|chronic hepatitis b
1645290|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
1645291|NCT00221286|pegylated interferon|pegylated interferon
1645292|NCT00221286|tenofovir DF|tenofovir df
1645293|NCT00221286|emtricitabine|emtricitabine
1645294|NCT00221260|Analgesia|analgesia
1645295|NCT00221260|anesthesia|anesthesia
1645296|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
1645297|NCT00221234|Diabetes|diabetes
1645298|NCT00221234|Physical Activity|physical activity
1645299|NCT00221221|breast cancer survivors|breast cancer survivors
1645300|NCT00221221|physical activity|physical activity
1645301|NCT00221221|health promotion|health promotion
1645302|NCT00221208|Diabetes|diabetes
1645303|NCT00221208|Resistance Training|resistance training
1645304|NCT00221182|Angina|angina
1645305|NCT00221182|Heart diseases|heart diseases
1645306|NCT00221182|Pain|pain
1645307|NCT00221182|Vascular diseases|vascular diseases
1645308|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
1645309|NCT00221169|Positron emission tomography|positron emission tomography
1645310|NCT00221169|Gross tumor volume|gross tumor volume
1645311|NCT00221169|Radiation therapy|radiation therapy
1645312|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
1645313|NCT00221156|coronary artery disease|coronary artery disease
1645314|NCT00221156|diabetes mellitus|diabetes mellitus
1645315|NCT00221156|clinical outcome|clinical outcome
1645316|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
1645317|NCT00221143|Leg diseases|leg diseases
1645318|NCT00221143|Pain|pain
1645319|NCT00221143|Vascular diseases|vascular diseases
1645320|NCT00221143|Chronic limb ischemia|chronic limb ischemia
1645321|NCT00221143|Peripheral artery disease|peripheral artery disease
1645322|NCT00221130|Regenerative medicine|regenerative medicine
1645323|NCT00221130|Periodontal tissue|periodontal tissue
1645324|NCT00221117|Spinal Cord Injuries|spinal cord injuries
1645326|NCT00221104|brain ischemia|brain ischemia
1645327|NCT00221104|cerebrovascular accident|cerebrovascular accident
1645328|NCT00221104|statin|statin
1645329|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1645330|NCT00221104|cholesterol|cholesterol
1645331|NCT00221104|hypercholesterolemia|hypercholesterolemia
1645332|NCT00221104|hyperlipidemia|hyperlipidemia
1645333|NCT00221104|multicenter studies|multicenter studies
1645334|NCT00221104|prospective studies|prospective studies
1645335|NCT00221104|endpoint determination|endpoint determination
1645336|NCT00221104|randomized controlled trials|randomized controlled trials
1645337|NCT00221104|recurrence|recurrence
1645338|NCT00221104|pravastatin|pravastatin
1645339|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
1645340|NCT00221091|shunt|shunt
1645341|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
1645342|NCT00221078|Stroke|stroke
1645343|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
1645344|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
1645346|NCT00221039|Photopheresis|photopheresis
1645347|NCT00221039|CTCL|ctcl
1645348|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1645349|NCT00221039|Mycosis Fungoides|mycosis fungoides
1645350|NCT00221013|Acute Renal Failure|acute renal failure
1645351|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
1645352|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
1645353|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
1645354|NCT00221013|Renal Replacement Therapy|renal replacement therapy
1645355|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
1645356|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
1645357|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
1645358|NCT00220987|Conventional insulin therapy|conventional insulin therapy
1645359|NCT00220987|Hypoglycaemia|hypoglycaemia
1645360|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
1645361|NCT00220961|Type 2 Diabetes|type 2 diabetes
1645362|NCT00220961|Prevention|prevention
1645363|NCT00220961|Pioglitazone|pioglitazone
1645364|NCT00220948|discogenic pain|discogenic pain
1645365|NCT00220948|myoelectric activity|myoelectric activity
1645366|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
1645367|NCT00220922|Copaxone|copaxone
1645368|NCT00220909|Gastric erosions|gastric erosions
1645369|NCT00220909|Proton pump inhibitors|proton pump inhibitors
1645370|NCT00220896|Delirium|delirium
1645371|NCT00220896|Prevention|prevention
1645372|NCT00220896|Donepezil|donepezil
1645373|NCT00220883|Functional Dyspepsia|functional dyspepsia
1645374|NCT00220883|Electrogastrography|electrogastrography
1645375|NCT00220870|schizophrenia|schizophrenia
1645376|NCT00220870|shared decision making|shared decision making
1645377|NCT00220870|compliance|compliance
1645378|NCT00220870|maintenance therapy|maintenance therapy
1645379|NCT00220857|Rabeprazole|rabeprazole
1645380|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
1645381|NCT00220857|Gastric erosions|gastric erosions
1645382|NCT00220831|Diabetes|diabetes
1645383|NCT00220831|MI|mi
1645384|NCT00220831|CVD disease|cvd disease
1645385|NCT00220818|Pediatric GERD|pediatric gerd
1645386|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
1645387|NCT00220818|lansoprazole|lansoprazole
1645388|NCT00220792|Primary breast cancer|primary breast cancer
1645389|NCT00220792|support groups|support groups
1645390|NCT00220792|mood disturbance|mood disturbance
1645391|NCT00220766|Primary Immune Deficiency|primary immune deficiency
1645392|NCT00220766|IGIV|igiv
1645393|NCT00220766|Immunoglobulin G|immunoglobulin g
1645394|NCT00220753|Dog allergy|dog allergy
1645395|NCT00220753|Pet allergy|pet allergy
1645396|NCT00220753|Air cleaners|air cleaners
1645397|NCT00220753|HEPA filters|hepa filters
1645398|NCT00220753|Air filtration|air filtration
1645399|NCT00220753|Can f1|can f1
1645400|NCT00220753|Asthma|asthma
1645401|NCT00220753|Children|children
1645402|NCT00220753|Adolescents|adolescents
1645403|NCT00220753|Indoor environment|indoor environment
1645404|NCT00220753|Indoor allergy|indoor allergy
1645405|NCT00220753|Perennial allergy|perennial allergy
1645406|NCT00220740|Immunoglobulin G|immunoglobulin g
1645407|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
1645408|NCT00220727|Immunoglobulin G|immunoglobulin g
1645409|NCT00220714|schizophrenia|schizophrenia
1645410|NCT00220714|first-episode|first-episode
1645411|NCT00220714|patient compliance|patient compliance
1645412|NCT00220714|long-acting risperidone|long-acting risperidone
1645413|NCT00220714|relapse|relapse
1645414|NCT00220701|Dysthymic Disorder|dysthymic disorder
1645415|NCT00220701|Depression|depression
1645416|NCT00220701|Chronic Depression|chronic depression
1645417|NCT00220701|Escitalopram|escitalopram
1645418|NCT00220688|nausea|nausea
1645419|NCT00220688|vomiting|vomiting
1645420|NCT00220688|palliative|palliative
1645421|NCT00220688|acupressure|acupressure
1645422|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
1645423|NCT00220675|Erythropoietin|erythropoietin
1645424|NCT00220675|Neuroprotectant|neuroprotectant
1645425|NCT00220675|Radiotherapy|radiotherapy
1645426|NCT00220675|Palliation|palliation
1645427|NCT00220662|anorexia nervosa|anorexia nervosa
1645428|NCT00220662|bulimia nervosa|bulimia nervosa
1645429|NCT00220662|readiness and motivation|readiness and motivation
1645430|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
1645431|NCT00220636|Major Depression|major depression
1645432|NCT00220636|Depression|depression
1645433|NCT00220636|Unipolar Depression|unipolar depression
1645434|NCT00220636|Treatment Resistant Depression|treatment resistant depression
1645435|NCT00220636|Adjunctive treatment|adjunctive treatment
1645436|NCT00220623|major depression|major depression
1645437|NCT00220623|psychotherapy|psychotherapy
1645438|NCT00220623|antidepressant medications|antidepressant medications
1645439|NCT00220623|clincial trial|clincial trial
1645440|NCT00220597|group therapy|group therapy
1645441|NCT00220597|sexual revictimization|sexual revictimization
1645442|NCT00220597|risky sex|risky sex
1645443|NCT00220597|addiction|addiction
1645445|NCT00220571|stent|stent
1645446|NCT00220571|PTCA|ptca
1645447|NCT00220571|abciximab|abciximab
1645448|NCT00220571|reteplase|reteplase
1645449|NCT00220571|combo therapy|combo therapy
1645450|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
1645451|NCT00220558|Bare metal stents|bare metal stents
1645452|NCT00220558|drug eluting stents|drug eluting stents
1645453|NCT00220545|Polycystic ovarY|polycystic ovary
1645454|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
1645455|NCT00220545|Induction of ovulation|induction of ovulation
1645456|NCT00220545|Clomiphene citrate|clomiphene citrate
1645457|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
1645458|NCT00220532|Folic acid|folic acid
1645459|NCT00220532|Riboflavin|riboflavin
1645460|NCT00220532|cervical cancer|cervical cancer
1645461|NCT00220506|provigil|provigil
1645462|NCT00220506|fatigue|fatigue
1645463|NCT00220506|Multiple Sclerosis|multiple sclerosis
1645464|NCT00220506|cognition|cognition
1645465|NCT00220493|MS|ms
1645466|NCT00220493|RITALIN|ritalin
1645467|NCT00220493|PASAT|pasat
1645468|NCT00220493|COGNITION|cognition
1645469|NCT00220493|ATTENTION|attention
1645470|NCT00220493|Relapsing remitting|relapsing remitting
1645471|NCT00220493|Secondary progressive|secondary progressive
1645472|NCT00220493|Primary progressive|primary progressive
1645473|NCT00220467|MCI|mci
1645474|NCT00220467|aging|aging
1645475|NCT00220467|cognition|cognition
1645476|NCT00220467|exercise|exercise
1645477|NCT00220467|aerobic|aerobic
1645478|NCT00220467|insulin|insulin
1645479|NCT00220454|cognition|cognition
1645480|NCT00220454|estradiol|estradiol
1645481|NCT00220454|cortisol|cortisol
1645482|NCT00220454|postmenopause|postmenopause
1645483|NCT00220441|IGT|igt
1645484|NCT00220441|exercise|exercise
1645485|NCT00220441|cognition|cognition
1645486|NCT00220441|insulin|insulin
1645487|NCT00220441|aging|aging
1645488|NCT00220441|aerobic|aerobic
1645489|NCT00220428|T cell|t cell
1645490|NCT00220350|arousal|arousal
1645491|NCT00220350|sex offender|sex offender
1645492|NCT00220350|suppression of arousal|suppression of arousal
1645493|NCT00220350|pedohilia|pedohilia
1645494|NCT00220350|leuprolide acetate|leuprolide acetate
1645495|NCT00220324|Contraception|contraception
1645496|NCT00220285|Antigen|antigen
1645497|NCT00220285|CD20|cd20
1645498|NCT00220272|Parkinson Disease|parkinson disease
1645499|NCT00220272|5-fluorodopa|5-fluorodopa
1645500|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
1645501|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
1645502|NCT00220246|Microsatellite instability|microsatellite instability
1645503|NCT00220246|Chromosomal instability|chromosomal instability
1645504|NCT00220207|Diabetes|diabetes
1645505|NCT00220207|Health Education|health education
1645506|NCT00220207|Information Technology|information technology
1645507|NCT00220207|African Americans|african americans
1645508|NCT00220207|Disease Management|disease management
1645509|NCT00220207|Internet|internet
1645510|NCT00220207|Patient Education|patient education
1645511|NCT00220181|Nutritional status|nutritional status
1645512|NCT00220181|Bowel symptoms|bowel symptoms
1645513|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
1645514|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
1645515|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
1645516|NCT00220090|Cholecystokinin|cholecystokinin
1645517|NCT00220090|Dexloxiglumide|dexloxiglumide
1645518|NCT00220090|Randomized/withdrawal|randomized/withdrawal
1645519|NCT00219999|Hepatitis|hepatitis
1645520|NCT00219999|Hepacivirus|hepacivirus
1645521|NCT00219999|B Lymphocytes|b lymphocytes
1645522|NCT00219999|Chemokines|chemokines
1645523|NCT00219999|Antibodies|antibodies
1645524|NCT00219986|Treatment Experienced|treatment experienced
1645525|NCT00219986|HIV|hiv
1645526|NCT00219973|venous thromboembolism|venous thromboembolism
1645527|NCT00219973|deep vein thrombosis|deep vein thrombosis
1645528|NCT00219973|pulmonary embolism|pulmonary embolism
1645529|NCT00219973|bleeding|bleeding
1645530|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
1645531|NCT00219973|cancer|cancer
1645532|NCT00219973|surgery|surgery
1645533|NCT00219960|Hypertension|hypertension
1645534|NCT00219960|Blood Pressure|blood pressure
1645535|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1645536|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
1645537|NCT00219960|Herbal|herbal
1645538|NCT00219960|North American Ginseng|north american ginseng
1645539|NCT00219960|Panax Quinquefolius|panax quinquefolius
1645540|NCT00219947|HIV Infection|hiv infection
1645541|NCT00219947|Acute HIV Infection|acute hiv infection
1645542|NCT00219947|Primary HIV Infection|primary hiv infection
1645543|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
1645544|NCT00219934|New HIV Infection|new hiv infection
1645545|NCT00219934|Acute HIV Infection|acute hiv infection
1645546|NCT00219934|Primary HIV Infection|primary hiv infection
1645547|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
1645548|NCT00219921|total hip replacement|total hip replacement
1645549|NCT00219921|pain treatment|pain treatment
1645550|NCT00219908|Multiple sclerosis|multiple sclerosis
1645551|NCT00219908|Mitoxantrone|mitoxantrone
1645552|NCT00219908|Methylprednisolone|methylprednisolone
1645553|NCT00219908|Interferon beta1b|interferon beta1b
1645554|NCT00219908|Relapse|relapse
1645555|NCT00219908|MRI|mri
1645556|NCT00219908|EDSS|edss
1645557|NCT00219895|Cystic Fibrosis|cystic fibrosis
1645558|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
1645559|NCT00219895|Ibuprofen|ibuprofen
1645560|NCT00219882|Cystic Fibrosis|cystic fibrosis
1645561|NCT00219882|curcuminoids|curcuminoids
1645562|NCT00219882|turmeric root extract|turmeric root extract
1645563|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
1645564|NCT00219882|sweat chloride|sweat chloride
1645565|NCT00219869|Post|post
1645566|NCT00219869|Traumatic|traumatic
1645567|NCT00219869|Headache|headache
1645568|NCT00219869|Cognitive|cognitive
1645569|NCT00219856|Propofol|propofol
1645570|NCT00219856|Hepatectomy|hepatectomy
1645571|NCT00219856|Oxidative stress|oxidative stress
1645572|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
1645573|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
1645574|NCT00219830|Walking|walking
1645575|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
1645576|NCT00219830|Secondary Prevention|secondary prevention
1645577|NCT00219817|Anorexia|anorexia
1645578|NCT00219817|Cachexia|cachexia
1645579|NCT00219791|methotrexate|methotrexate
1645580|NCT00219791|delayed elimination|delayed elimination
1645581|NCT00219791|renal insufficiency|renal insufficiency
1645582|NCT00219791|CPG2|cpg2
1645583|NCT00219791|Voraxaze|voraxaze
1645584|NCT00219765|CML|cml
1645585|NCT00219765|Acute Phase|acute phase
1645586|NCT00219765|Imatinib mesylate|imatinib mesylate
1645587|NCT00219765|Cytarabine|cytarabine
1645588|NCT00219765|Daunorubicine|daunorubicine
1645589|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
1645590|NCT00219739|CML|cml
1645591|NCT00219739|Imatinib|imatinib
1645592|NCT00219739|Interferon|interferon
1645593|NCT00219739|Cytarabine|cytarabine
1645594|NCT00219726|CML|cml
1645595|NCT00219726|Imatinib mesylate|imatinib mesylate
1645596|NCT00219726|Stem cell transplantation|stem cell transplantation
1645597|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
1645598|NCT00219713|Pain|pain
1645599|NCT00219713|Bone marrow biopsy|bone marrow biopsy
1645600|NCT00219713|Bone marrow aspiration|bone marrow aspiration
1645601|NCT00219700|NSAID-PC|nsaid-pc
1645602|NCT00219700|IBU-PC|ibu-pc
1645603|NCT00219687|Heart arrest|heart arrest
1645604|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
1645605|NCT00219687|Dispatcher|dispatcher
1645606|NCT00219674|education|education
1645607|NCT00219674|training, defibrillators|training, defibrillators
1645608|NCT00219674|home defibrillators|home defibrillators
1645609|NCT00219674|automated external defibrillators|automated external defibrillators
1645610|NCT00219674|psychological adjustment|psychological adjustment
1645611|NCT00219661|randomised control trial|randomised control trial
1645612|NCT00219661|intensive care unit|intensive care unit
1645613|NCT00219661|mechanical ventilation|mechanical ventilation
1645614|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
1645615|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
1645616|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
1645617|NCT00219531|functional MRI|functional mri
1645618|NCT00219531|pain perception|pain perception
1645619|NCT00219531|anxiety|anxiety
1645620|NCT00219531|brain-gut axis|brain-gut axis
1645621|NCT00219518|Defecography|defecography
1645622|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
1645623|NCT00219518|Anismus|anismus
1647488|NCT00210249|Cancer|cancer
1645624|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
1645625|NCT00219505|Acupuncture|acupuncture
1645626|NCT00219505|abdominal pain|abdominal pain
1645627|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
1645628|NCT00219479|seizure prophylaxis|seizure prophylaxis
1646509|NCT00214643|Malaria|malaria
1645629|NCT00219479|enteral nutrition|enteral nutrition
1645630|NCT00219453|Pilot Projects|pilot projects
1645631|NCT00219453|Injections, Jet|injections, jet
1645632|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
1645633|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
1645634|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
1645635|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
1645636|NCT00219427|Low vision|low vision
1645637|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
1645638|NCT00219401|Antibody responses|antibody responses
1645639|NCT00219401|Cellular immunology|cellular immunology
1645640|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
1645641|NCT00219401|Paediatric|paediatric
1645642|NCT00219401|Neonatal|neonatal
1645643|NCT00219401|Infectious diseases|infectious diseases
1645644|NCT00219401|Papua New Guinea|papua new guinea
1645645|NCT00219388|Safety|safety
1645646|NCT00219388|Efficacy|efficacy
1645647|NCT00219388|Levosimendan|levosimendan
1645648|NCT00219388|Dobutamine|dobutamine
1645649|NCT00219388|Intravenous|intravenous
1645650|NCT00219388|Invasive hemodynamics|invasive hemodynamics
1645651|NCT00219388|Decompensated Heart Failure|decompensated heart failure
1645652|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
1645653|NCT00219375|acute lung injury|acute lung injury
1645654|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1645655|NCT00219375|Elaspol|elaspol
1645656|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
1645657|NCT00219362|HIV-1 infection|hiv-1 infection
1645658|NCT00219362|therapeutic vaccine|therapeutic vaccine
1645659|NCT00219362|Treatment Experienced|treatment experienced
1645660|NCT00219349|Anxiety Disorders|anxiety disorders
1645661|NCT00219349|Anxiety Neuroses|anxiety neuroses
1645662|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
1645663|NCT00219349|Escitalopram|escitalopram
1645664|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
1645665|NCT00219336|Reduced Alcohol Used|reduced alcohol used
1645666|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
1645667|NCT00219336|Effective Contraception|effective contraception
1645668|NCT00219336|Contraception|contraception
1645669|NCT00219336|College Students|college students
1645670|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
1645671|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
1645672|NCT00219297|EPO|epo
1645673|NCT00219297|EPO906|epo906
1645674|NCT00219297|Brain cancer|brain cancer
1645675|NCT00219297|Brain metastasis|brain metastasis
1645676|NCT00219297|Lung cancer|lung cancer
1645677|NCT00219297|Lung metastasis|lung metastasis
1645678|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
1645679|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
1645680|NCT00219271|Prostate cancer|prostate cancer
1645681|NCT00219271|molecular staging|molecular staging
1645682|NCT00219271|antitumor potential|antitumor potential
1645683|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
1645684|NCT00219232|Alzheimer's disease|alzheimer's disease
1645685|NCT00219232|Dementia|dementia
1645686|NCT00219219|zoledronic acid|zoledronic acid
1645687|NCT00219219|prostate cancer|prostate cancer
1645688|NCT00219219|SRE|sre
1645689|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
1645690|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
1645691|NCT00219167|hypertension|hypertension
1645692|NCT00219167|aliskiren|aliskiren
1645693|NCT00219167|age|age
1645694|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
1645695|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
1645696|NCT00219102|Hypertension,|hypertension,
1645697|NCT00219102|diabetes,|diabetes,
1645698|NCT00219102|aliskiren,|aliskiren,
1645699|NCT00219102|blood pressure,|blood pressure,
1645700|NCT00219102|valsartan,|valsartan,
1645701|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
1645702|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
1645703|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
1645704|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
1645705|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
1645808|NCT00218517|cannabis use disorder|cannabis use disorder
1647489|NCT00210249|elderly|elderly
1645706|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
1645707|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
1645708|NCT00218998|Exercise|exercise
1645709|NCT00218998|Exercise therapy|exercise therapy
1645710|NCT00218985|Aerobic capacity|aerobic capacity
1645711|NCT00218985|Exercise training|exercise training
1645712|NCT00218985|CABG|cabg
1645713|NCT00218985|Endothelial function|endothelial function
1645714|NCT00218972|Hypertension|hypertension
1645715|NCT00218972|endurance training|endurance training
1645716|NCT00218972|endothelial function|endothelial function
1645717|NCT00218972|left ventricular function|left ventricular function
1645718|NCT00218972|Echocardiography|echocardiography
1645719|NCT00218972|Quality of life|quality of life
1645720|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
1645721|NCT00218959|PTSD|ptsd
1645722|NCT00218959|trauma treatment|trauma treatment
1645723|NCT00218959|refugees|refugees
1645724|NCT00218959|randomized controlled|randomized controlled
1645725|NCT00218946|pain|pain
1645726|NCT00218946|infant, premature|infant, premature
1645727|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
1645728|NCT00218946|Neonatal nursing|neonatal nursing
1645729|NCT00218933|Interval training|interval training
1645730|NCT00218933|Endothelial dysfunction|endothelial dysfunction
1645731|NCT00218933|Aerobic capacity|aerobic capacity
1645732|NCT00218933|Exercise|exercise
1645733|NCT00218920|aerobic capacity|aerobic capacity
1645734|NCT00218920|endothelial function|endothelial function
1645735|NCT00218920|exercise|exercise
1645736|NCT00218907|HIV prevention|hiv prevention
1645737|NCT00218907|HIV counseling|hiv counseling
1645738|NCT00218907|HIV testing|hiv testing
1645739|NCT00218907|Emergency Medicine|emergency medicine
1645740|NCT00218907|HIV Seronegativity|hiv seronegativity
1645741|NCT00218894|Effect|effect
1645742|NCT00218894|Balance|balance
1645743|NCT00218894|Gait|gait
1645744|NCT00218894|Falls|falls
1645745|NCT00218881|HIV prevention|hiv prevention
1645746|NCT00218881|HIV screening|hiv screening
1645747|NCT00218881|Emergency Medicine|emergency medicine
1645748|NCT00218881|HIV counseling and Testing|hiv counseling and testing
1645749|NCT00218881|HIV Seronegativity|hiv seronegativity
1645750|NCT00218868|Cytodiagnosis|cytodiagnosis
1645751|NCT00218868|Skin Scrape|skin scrape
1645752|NCT00218868|Touch Imprint|touch imprint
1645753|NCT00218868|Papanicolaou|papanicolaou
1645754|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
1645755|NCT00218855|Multiple Myeloma|multiple myeloma
1645756|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
1645757|NCT00218855|thalidomide|thalidomide
1645758|NCT00218842|exercise|exercise
1645759|NCT00218842|functioning|functioning
1645760|NCT00218842|frail elderly|frail elderly
1645761|NCT00218829|Photodynamic treatment|photodynamic treatment
1645762|NCT00218829|Basal cell carcinoma|basal cell carcinoma
1645763|NCT00218829|DMSO|dmso
1645764|NCT00218790|Sleep|sleep
1645765|NCT00218790|Renal failure|renal failure
1645766|NCT00218790|Dialysis|dialysis
1645767|NCT00218777|Chronic tic disorder|chronic tic disorder
1645768|NCT00218777|Motor tics|motor tics
1645769|NCT00218777|Vocal tics|vocal tics
1645770|NCT00218751|Child abuse|child abuse
1645771|NCT00218751|Neglect|neglect
1645772|NCT00218751|Home Visitation|home visitation
1645773|NCT00218751|Program Evaluation|program evaluation
1645774|NCT00218725|Cognitive Therapy|cognitive therapy
1645775|NCT00218725|Suicide|suicide
1645776|NCT00218725|Addictions|addictions
1645777|NCT00218725|Substance Abuse|substance abuse
1645779|NCT00218712|AIDS|aids
1645780|NCT00218712|MSM|msm
1645781|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
1645782|NCT00218712|HIV Seronegativity|hiv seronegativity
1645783|NCT00218699|HIV|hiv
1645784|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
1645785|NCT00218699|Men Who Have Sex With Men|men who have sex with men
1645786|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
1645787|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
1645788|NCT00218699|HIV Seronegativity|hiv seronegativity
1645789|NCT00218686|HIV|hiv
1645790|NCT00218686|injection drug use|injection drug use
1645791|NCT00218686|social networks|social networks
1645792|NCT00218673|HIV|hiv
1645793|NCT00218673|injection drug use|injection drug use
1645794|NCT00218673|social networks|social networks
1645795|NCT00218621|Buprenorphine|buprenorphine
1645796|NCT00218621|Methadone|methadone
1645797|NCT00218608|Cocaine Abuse|cocaine abuse
1645798|NCT00218582|12 step groups|12 step groups
1645799|NCT00218582|self help|self help
1645800|NCT00218582|psychiatric day treatment|psychiatric day treatment
1645801|NCT00218582|co-occurring disorders|co-occurring disorders
1645802|NCT00218582|dual diagnosis|dual diagnosis
1645803|NCT00218569|Alcohol Dependence|alcohol dependence
1645804|NCT00218569|Cocaine Dependence|cocaine dependence
1645805|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
1645806|NCT00218543|ADHD|adhd
1645807|NCT00218543|Cocaine Abuse|cocaine abuse
1646082|NCT00216710|Neglect|neglect
1645809|NCT00218465|Drugs, Investigational|drugs, investigational
1645810|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
1645811|NCT00218465|Relapse Prevention|relapse prevention
1645812|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
1645813|NCT00218465|Smoking Cessation|smoking cessation
1645814|NCT00218465|Nicotine Dependence|nicotine dependence
1645815|NCT00218452|Tobacco use cessation|tobacco use cessation
1645816|NCT00218439|Smoking|smoking
1645817|NCT00218413|Vaccine|vaccine
1645818|NCT00218413|Immunogenicity|immunogenicity
1645819|NCT00218413|Randomized Controlled Trial|randomized controlled trial
1645820|NCT00218413|Addiction|addiction
1645821|NCT00218374|Opiate Addiction|opiate addiction
1645822|NCT00218374|Opiate Dependence|opiate dependence
1645823|NCT00218361|Behavioral economics|behavioral economics
1645824|NCT00218361|Drug self administration|drug self administration
1645825|NCT00218361|Opioid|opioid
1645826|NCT00218348|Cocaine Abuse|cocaine abuse
1645827|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
1645828|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
1645829|NCT00218309|opiate dependence|opiate dependence
1645830|NCT00218296|Nicotine Dependence|nicotine dependence
1645831|NCT00218296|Tobacco Dependence|tobacco dependence
1645832|NCT00218283|Nicotine Dependence|nicotine dependence
1645833|NCT00218283|Tobacco Dependence|tobacco dependence
1645834|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
1645835|NCT00218257|Cocaine|cocaine
1645836|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
1645837|NCT00218231|schizophrenia|schizophrenia
1645838|NCT00218231|tobacco dependence|tobacco dependence
1645839|NCT00218231|nicotine|nicotine
1645840|NCT00218218|Nicotine Dependence|nicotine dependence
1645841|NCT00218218|Tobacco Dependence|tobacco dependence
1645842|NCT00218205|Epirubicin|epirubicin
1645843|NCT00218205|Estramustine Phosphate|estramustine phosphate
1645844|NCT00218205|Celecoxib|celecoxib
1645845|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1645846|NCT00218192|hepatitis c|hepatitis c
1645847|NCT00218192|injection drug use|injection drug use
1645848|NCT00218179|Lung Cancer|lung cancer
1645849|NCT00218179|Cotinine|cotinine
1645850|NCT00218179|NNAL|nnal
1645851|NCT00218179|Carcinogens|carcinogens
1645852|NCT00218179|Case-control|case-control
1645853|NCT00218179|SNPs|snps
1645854|NCT00218166|cocaine|cocaine
1645855|NCT00218166|tiagabine|tiagabine
1645856|NCT00218166|baclofen|baclofen
1645857|NCT00218153|nicotine dependence|nicotine dependence
1645858|NCT00218140|tobacco|tobacco
1645859|NCT00218127|Heroin dependence|heroin dependence
1645860|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
1645861|NCT00218101|opioid dependence|opioid dependence
1645862|NCT00218075|Cocaine addiction|cocaine addiction
1645863|NCT00218075|cocaine treatment|cocaine treatment
1645864|NCT00218036|Cocaine Abuse|cocaine abuse
1645865|NCT00218036|Opiate Abuse|opiate abuse
1645866|NCT00218023|cocaine|cocaine
1646244|NCT00215852|Alfa-n3|alfa-n3
1645867|NCT00218023|cocaine addiction|cocaine addiction
1645868|NCT00218023|cocaine abuse|cocaine abuse
1645869|NCT00218023|relapse prevention|relapse prevention
1645870|NCT00218010|methadone|methadone
1645871|NCT00218010|lactation|lactation
1645872|NCT00218010|breastfeeding|breastfeeding
1645873|NCT00218010|maternal opioid dependency|maternal opioid dependency
1645874|NCT00217997|cocaine abuse|cocaine abuse
1645875|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
1645876|NCT00217984|Tobacco use disorder|tobacco use disorder
1645877|NCT00217984|Alcohol dependence|alcohol dependence
1645878|NCT00217971|cannabis dependence|cannabis dependence
1645879|NCT00217971|dronabinol|dronabinol
1645880|NCT00217971|treatment|treatment
1645881|NCT00217932|Behavioral Disorders|behavioral disorders
1645882|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
1645883|NCT00217841|MRSA|mrsa
1645884|NCT00217763|Dementia|dementia
1645885|NCT00217763|Alzheimer's disease|alzheimer's disease
1645886|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1645887|NCT00217724|pain|pain
1645888|NCT00217711|stage III colon cancer|stage iii colon cancer
1645889|NCT00217711|stage IV colon cancer|stage iv colon cancer
1645890|NCT00217711|stage III rectal cancer|stage iii rectal cancer
1645891|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
1645892|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1645893|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1645894|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1645895|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
1645896|NCT00217698|large cell lung cancer|large cell lung cancer
1645897|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
1645898|NCT00217672|stage IV breast cancer|stage iv breast cancer
1645899|NCT00217672|recurrent breast cancer|recurrent breast cancer
1645900|NCT00217659|male breast cancer|male breast cancer
1645901|NCT00217659|recurrent breast cancer|recurrent breast cancer
1645902|NCT00217659|stage IV breast cancer|stage iv breast cancer
1645903|NCT00217620|adult angiosarcoma|adult angiosarcoma
1645904|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
1645905|NCT00217620|adult liposarcoma|adult liposarcoma
1645906|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1645907|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1646404|NCT00215176|atypical depression|atypical depression
1645908|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1645909|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1645910|NCT00217607|adult angiosarcoma|adult angiosarcoma
1645911|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1645912|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1645913|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1645914|NCT00217594|Immunosuppression|immunosuppression
1645915|NCT00217594|T Cells|t cells
1645916|NCT00217594|Hematopoiesis|hematopoiesis
1645917|NCT00217594|Anti-CD52|anti-cd52
1645918|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
1645919|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
1645920|NCT00217581|stage III gastric cancer|stage iii gastric cancer
1645921|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
1645922|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
1645923|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
1645924|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
1645925|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1645926|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1645927|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1645928|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1645929|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
1645930|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1645931|NCT00217555|fallopian tube cancer|fallopian tube cancer
1645932|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
1645933|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1645934|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1645935|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
1645936|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1645937|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1645938|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1645939|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1645940|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1645941|NCT00217529|Brenner tumor|brenner tumor
1645942|NCT00217529|fallopian tube cancer|fallopian tube cancer
1645943|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1645944|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1645945|NCT00217516|stage I prostate cancer|stage i prostate cancer
1645946|NCT00217516|stage II prostate cancer|stage ii prostate cancer
1645947|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1645948|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1646353|NCT00215371|Pediatric|pediatric
1645949|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1645950|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1645951|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
1645952|NCT00217451|Malaria|malaria
1645953|NCT00217451|Fosmidomycin|fosmidomycin
1645954|NCT00217451|Clindamycin|clindamycin
1645955|NCT00217451|Gabon|gabon
1645956|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1645957|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1645958|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1645959|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1645960|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1645961|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
1645962|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1645963|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1645964|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1645965|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1645966|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1645967|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
1645968|NCT00217347|Dyspepsia|dyspepsia
1645969|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
1645970|NCT00217334|Hypertension|hypertension
1645971|NCT00217334|Cardiovascular diseases|cardiovascular diseases
1645972|NCT00217334|Randomized controlled trial|randomized controlled trial
1645973|NCT00217334|Cluster randomization|cluster randomization
1645974|NCT00217334|Primary care|primary care
1645975|NCT00217321|Parkinson's disease|parkinson's disease
1645976|NCT00217321|Parkinson disease|parkinson disease
1645977|NCT00217321|Registry|registry
1645978|NCT00217321|quality of life|quality of life
1645979|NCT00217321|database|database
1645980|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
1645981|NCT00217295|Brain atrophy|brain atrophy
1645982|NCT00217295|Disease progression|disease progression
1645983|NCT00217269|Restenosis|restenosis
1645984|NCT00217256|Restenosis|restenosis
1645985|NCT00217243|Pain|pain
1645986|NCT00217243|Magnetoencephalography|magnetoencephalography
1645987|NCT00217243|Median|median
1645988|NCT00217243|Ulnar|ulnar
1645989|NCT00217243|Causalgia|causalgia
1645990|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
1645991|NCT00217243|Evoked fields|evoked fields
1645992|NCT00217243|Nerve injury|nerve injury
1645993|NCT00217243|Neuropathic pain|neuropathic pain
1645994|NCT00217217|non-pharmaceutical|non-pharmaceutical
1645995|NCT00217217|alternative|alternative
1645996|NCT00217217|imaging|imaging
1645997|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
1645998|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
1645999|NCT00217217|bipolar disorder|bipolar disorder
1646000|NCT00217217|depression|depression
1646001|NCT00217217|bipolar depression|bipolar depression
1646002|NCT00217204|Cystic fibrosis|cystic fibrosis
1646003|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
1646004|NCT00217204|Steatorrhea|steatorrhea
1646005|NCT00217204|Fat malabsorption|fat malabsorption
1646006|NCT00217204|Pancrelipase|pancrelipase
1646007|NCT00217191|Premature Infants|premature infants
1646008|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
1646009|NCT00217191|Renal function|renal function
1646010|NCT00217191|Ibuprofen|ibuprofen
1646011|NCT00217178|Atherosclerosis|atherosclerosis
1646012|NCT00217178|CV Risk Factors|cv risk factors
1646013|NCT00217178|Homocysteine|homocysteine
1646014|NCT00217178|CV disease|cv disease
1646015|NCT00217178|Cardiovascular disease|cardiovascular disease
1646016|NCT00217165|bipolar|bipolar
1646017|NCT00217165|mania|mania
1646018|NCT00217165|depression|depression
1646019|NCT00217165|taurine|taurine
1646020|NCT00217165|alternative|alternative
1646021|NCT00217152|Kidney Transplant|kidney transplant
1646022|NCT00217139|Hepatitis C|hepatitis c
1646023|NCT00217139|Celgosivir|celgosivir
1646024|NCT00217139|HCV|hcv
1646025|NCT00217139|Genotype 1|genotype 1
1646026|NCT00217139|Non-responders|non-responders
1646027|NCT00217139|Early Viral Response|early viral response
1646028|NCT00217139|EVR|evr
1646029|NCT00217035|parenteral nutrition|parenteral nutrition
1646030|NCT00217035|burn injury|burn injury
1646031|NCT00217035|stable isotopes|stable isotopes
1646032|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
1646033|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
1646034|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
1646035|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
1646036|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
1646037|NCT00217022|diarrhea|diarrhea
1646038|NCT00217022|budesonide|budesonide
1646039|NCT00216996|parenteral nutrition|parenteral nutrition
1646040|NCT00216996|burn injury|burn injury
1646041|NCT00216996|stable isotopes|stable isotopes
1646042|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
1646043|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
1646044|NCT00216983|parenteral nutrition|parenteral nutrition
1646045|NCT00216983|burn injury|burn injury
1646046|NCT00216983|stable isotopes|stable isotopes
1646047|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
1646048|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
1646049|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
1646050|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
1646051|NCT00216970|parenteral nutrition|parenteral nutrition
1646052|NCT00216970|burn injury|burn injury
1646053|NCT00216970|stable isotopes|stable isotopes
1646054|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
1646055|NCT00216970|Nitric Oxide Formation|nitric oxide formation
1646056|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
1646057|NCT00216944|Intubation|intubation
1646058|NCT00216944|premedication|premedication
1646059|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
1646060|NCT00216866|Embolism|embolism
1646061|NCT00216866|Thrombosis|thrombosis
1646062|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
1646063|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
1646064|NCT00216788|Sucrose|sucrose
1646065|NCT00216788|Barrett's esophagus|barrett's esophagus
1646066|NCT00216788|Esophagitis|esophagitis
1646067|NCT00216788|GERD|gerd
1646068|NCT00216788|Reflux|reflux
1646069|NCT00216788|Esophagus|esophagus
1646070|NCT00216788|Esomeprazole|esomeprazole
1646071|NCT00216762|Urticaria|urticaria
1646072|NCT00216762|Hives|hives
1646073|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
1646074|NCT00216749|Cilostazol|cilostazol
1646075|NCT00216736|Migraine|migraine
1646076|NCT00216736|Headache|headache
1646077|NCT00216736|Rebound headache|rebound headache
1646078|NCT00216723|Aripiprazole|aripiprazole
1646079|NCT00216723|Schizophrenia|schizophrenia
1646080|NCT00216723|Bipolar Disorder|bipolar disorder
1646081|NCT00216710|Child abuse|child abuse
1646083|NCT00216710|Home visitation|home visitation
1646084|NCT00216710|Program evaluation|program evaluation
1646085|NCT00216697|Multiple myeloma|multiple myeloma
1646086|NCT00216697|Proteasome inhibitor|proteasome inhibitor
1646087|NCT00216697|Ubiquitin|ubiquitin
1646088|NCT00216697|Boronic acids|boronic acids
1646089|NCT00216697|Bortezomib|bortezomib
1646090|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
1646091|NCT00216671|Schizophrenia|schizophrenia
1646092|NCT00216671|intramuscular injection|intramuscular injection
1646093|NCT00216671|antipsychotic agents|antipsychotic agents
1646094|NCT00216671|long-acting risperidone|long-acting risperidone
1646095|NCT00216658|Fentanyl|fentanyl
1646096|NCT00216658|Cancer pain|cancer pain
1646097|NCT00216658|Japanese patients|japanese patients
1646098|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
1646099|NCT00216645|Doxil|doxil
1646100|NCT00216645|Japanese Patients|japanese patients
1646101|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
1646102|NCT00216632|antipsychotic agents|antipsychotic agents
1646103|NCT00216632|long-acting risperidone|long-acting risperidone
1646104|NCT00216632|intramuscular injection|intramuscular injection
1646105|NCT00216619|chronic migraine|chronic migraine
1646106|NCT00216619|Topiramate|topiramate
1646107|NCT00216619|migraine|migraine
1646108|NCT00216619|headache|headache
1646109|NCT00216619|chronic headache|chronic headache
1646110|NCT00216606|Chronic migraine|chronic migraine
1646111|NCT00216606|Migraine|migraine
1646112|NCT00216606|Headache|headache
1646113|NCT00216606|Migraine headache|migraine headache
1646114|NCT00216606|Topiramate|topiramate
1646115|NCT00216593|dementia|dementia
1646116|NCT00216593|cognition function|cognition function
1646117|NCT00216593|Alzheimer disease|alzheimer disease
1646118|NCT00216593|behavioral symptoms|behavioral symptoms
1646119|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
1646120|NCT00216580|Schizophrenia|schizophrenia
1646121|NCT00216580|Intramuscular injection|intramuscular injection
1646122|NCT00216580|Antipsychotic agents|antipsychotic agents
1646123|NCT00216580|Long-acting risperidone|long-acting risperidone
1646124|NCT00216580|Schizophreniform disorders|schizophreniform disorders
1646125|NCT00216580|Schizoaffective disorder|schizoaffective disorder
1646126|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
1646127|NCT00216567|Topiramate|topiramate
1646128|NCT00216554|Bipolar|bipolar
1646129|NCT00216554|risperidone|risperidone
1646130|NCT00216554|Adjunctive therapy|adjunctive therapy
1646131|NCT00216541|Anemia|anemia
1646132|NCT00216541|cancer|cancer
1646133|NCT00216541|transfusion|transfusion
1646134|NCT00216541|chemotherapy|chemotherapy
1646135|NCT00216541|hemoglobin|hemoglobin
1646136|NCT00216541|standard care|standard care
1646137|NCT00216541|epoetin alfa|epoetin alfa
1646138|NCT00216541|epoetin|epoetin
1646139|NCT00216541|erythropoietin|erythropoietin
1646140|NCT00216528|Schizophrenia|schizophrenia
1646141|NCT00216528|risperidone|risperidone
1646142|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
1646143|NCT00216515|Alzheimer's disease|alzheimer's disease
1646144|NCT00216515|galantamine|galantamine
1646145|NCT00216515|attention|attention
1646146|NCT00216515|executive function|executive function
1646147|NCT00216502|Alzheimer's disease|alzheimer's disease
1646148|NCT00216502|Dementia|dementia
1646149|NCT00216502|galantamine|galantamine
1646150|NCT00216502|placebo|placebo
1646151|NCT00216502|Caregiver|caregiver
1646152|NCT00216502|Brain disease|brain disease
1646153|NCT00216502|Memory loss|memory loss
1646154|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
1646155|NCT00216489|heartburn|heartburn
1646156|NCT00216489|rabeprazole|rabeprazole
1646157|NCT00216489|GERD|gerd
1646158|NCT00216489|anti-ulcer agents|anti-ulcer agents
1646159|NCT00216489|proton pump inhibitor|proton pump inhibitor
1646160|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
1646161|NCT00216476|Antipsychotic agents|antipsychotic agents
1646162|NCT00216476|Long-acting risperidone|long-acting risperidone
1646163|NCT00216476|Quetiapine|quetiapine
1646164|NCT00216476|Aripiprazole|aripiprazole
1646165|NCT00216463|LDL-cholesterol|ldl-cholesterol
1646166|NCT00216463|apoB-100|apob-100
1646167|NCT00216463|apoB-48|apob-48
1646168|NCT00216450|rabeprazole|rabeprazole
1646169|NCT00216450|proton pump inhibitor|proton pump inhibitor
1646170|NCT00216450|Helicobacter infections|helicobacter infections
1646171|NCT00216450|Helicobacter pylori|helicobacter pylori
1646172|NCT00216450|H pylori|h pylori
1646173|NCT00216450|bacterial infections|bacterial infections
1646174|NCT00216437|Liver cancer|liver cancer
1646175|NCT00216424|Colon cancer|colon cancer
1646176|NCT00216424|Rectal cancer|rectal cancer
1646177|NCT00216398|acromegaly|acromegaly
1646178|NCT00216398|growth hormone|growth hormone
1646179|NCT00216385|Tuberculosis|tuberculosis
1646180|NCT00216385|Treatment|treatment
1646181|NCT00216385|Quinolone|quinolone
1646182|NCT00216385|Short course chemotherapy|short course chemotherapy
1646183|NCT00216372|carcinomatosis|carcinomatosis
1646287|NCT00215644|Gastric|gastric
1646184|NCT00216359|Treatment Experienced|treatment experienced
1646185|NCT00216333|tuberculosis|tuberculosis
1646186|NCT00216333|fixed dose combination|fixed dose combination
1646187|NCT00216333|DOT|dot
1646188|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
1646189|NCT00216320|electrical stimulation|electrical stimulation
1646190|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
1646191|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
1646192|NCT00216281|Schizophrenia|schizophrenia
1646193|NCT00216281|Clozapine|clozapine
1646194|NCT00216281|Atomoxetine|atomoxetine
1646195|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
1646196|NCT00216242|influenza|influenza
1646197|NCT00216242|vaccine|vaccine
1646198|NCT00216242|efficacy|efficacy
1646199|NCT00216242|safety|safety
1646200|NCT00216242|immunogenicity|immunogenicity
1646201|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
1646202|NCT00216229|hepatitis B virus|hepatitis b virus
1646203|NCT00216229|immunity|immunity
1646204|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
1646205|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
1646206|NCT00216164|Lymphoma|lymphoma
1646207|NCT00216151|Multiple Myeloma|multiple myeloma
1646208|NCT00216151|Bisphosphonates|bisphosphonates
1646209|NCT00216138|Head and Neck Cancer|head and neck cancer
1646210|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
1646211|NCT00216112|Ovarian Cancer|ovarian cancer
1646212|NCT00216099|Prostate Cancer|prostate cancer
1646213|NCT00216086|Rectal Cancer|rectal cancer
1646214|NCT00216073|Breast Cancer|breast cancer
1646215|NCT00216047|Breast Cancer|breast cancer
1646216|NCT00216034|Gastric Cancer|gastric cancer
1646217|NCT00216034|TS-1|ts-1
1646218|NCT00216034|PSK|psk
1646219|NCT00216034|Disease-free survival|disease-free survival
1646220|NCT00216034|Overall survival|overall survival
1646221|NCT00216021|Breast Cancer|breast cancer
1646222|NCT00215995|esophageal cancer|esophageal cancer
1646223|NCT00215995|esophagogastric cancer|esophagogastric cancer
1646224|NCT00215995|gastric cancer|gastric cancer
1646225|NCT00215982|advanced|advanced
1646226|NCT00215982|colon|colon
1646227|NCT00215982|rectal|rectal
1646228|NCT00215969|Pre-eclampsia|pre-eclampsia
1646229|NCT00215969|Pregnancy|pregnancy
1646230|NCT00215969|Hypercoagulation|hypercoagulation
1646231|NCT00215969|Screening|screening
1646232|NCT00215969|Cardiovascular complications|cardiovascular complications
1646233|NCT00215956|Topotecan|topotecan
1646234|NCT00215956|Rectal Neoplasms|rectal neoplasms
1646235|NCT00215956|Radiosensitizing|radiosensitizing
1646236|NCT00215943|hematologic malignancy|hematologic malignancy
1646237|NCT00215930|malignant pleural effusion|malignant pleural effusion
1646238|NCT00215917|Schizophrenia|schizophrenia
1646239|NCT00215917|NMDA|nmda
1646240|NCT00215917|D-serine|d-serine
1646241|NCT00215891|Treatment Experienced|treatment experienced
1646242|NCT00215852|Alferon LDO|alferon ldo
1646243|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
1646245|NCT00215852|Human Leukocyte Derived|human leukocyte derived
1646246|NCT00215852|HIV|hiv
1646247|NCT00215852|Asymptomatic HIV|asymptomatic hiv
1646248|NCT00215852|Treatment Experienced|treatment experienced
1646249|NCT00215839|Treatment Experienced|treatment experienced
1646250|NCT00215826|SARS|sars
1646251|NCT00215826|Alferon LDO|alferon ldo
1646252|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
1646253|NCT00215826|Human Leukocyte Derived|human leukocyte derived
1646254|NCT00215826|Exposure to SARS|exposure to sars
1646255|NCT00215826|Possible SARS|possible sars
1646256|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
1646257|NCT00215813|CFS|cfs
1646258|NCT00215813|ME|me
1646259|NCT00215813|Ampligen|ampligen
1646260|NCT00215813|poly I:poly C12U|poly i:poly c12u
1646261|NCT00215813|Rintatolimod|rintatolimod
1646262|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
1646263|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
1646264|NCT00215800|CFS|cfs
1646265|NCT00215800|Ampligen|ampligen
1646266|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
1646267|NCT00215787|Nasal polyps|nasal polyps
1646268|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
1646269|NCT00215774|Atrial fibrillation|atrial fibrillation
1646270|NCT00215761|Atrial fibrillation|atrial fibrillation
1646271|NCT00215761|Preventive stimulation|preventive stimulation
1646272|NCT00215761|Pacemaker|pacemaker
1646273|NCT00215748|Elderly|elderly
1646274|NCT00215748|Weekly|weekly
1646275|NCT00215735|diabetes|diabetes
1646276|NCT00215735|Ulcer|ulcer
1646277|NCT00215735|APC|apc
1646278|NCT00215709|elderly|elderly
1646279|NCT00215683|Prostate Cancer|prostate cancer
1646280|NCT00215683|Androgen ablation therapy|androgen ablation therapy
1646281|NCT00215670|AMD|amd
1646282|NCT00215670|Macugen|macugen
1646283|NCT00215670|Pharmacokinetics|pharmacokinetics
1646284|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
1646285|NCT00215670|PK|pk
1646286|NCT00215644|Esophagus|esophagus
1646288|NCT00215644|Adenocarcinoma|adenocarcinoma
1646289|NCT00215644|EGFR|egfr
1646290|NCT00215644|matuzumab|matuzumab
1646291|NCT00215644|EMD 72000|emd 72000
1646292|NCT00215644|randomized|randomized
1646293|NCT00215644|Epirubicin|epirubicin
1646294|NCT00215644|cisplatin|cisplatin
1646295|NCT00215644|capecitabine|capecitabine
1646296|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
1646297|NCT00215631|prostate cancer|prostate cancer
1646298|NCT00215631|radiotherapy|radiotherapy
1646299|NCT00215631|erectile dysfunction|erectile dysfunction
1646300|NCT00215631|tadalafil|tadalafil
1646301|NCT00215605|Advanced Malignancies|advanced malignancies
1646302|NCT00215605|Solid Tumor|solid tumor
1646303|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
1646305|NCT00215566|IBS-c|ibs-c
1646306|NCT00215540|Double-blind|double-blind
1646307|NCT00215540|Low Birth Weight|low birth weight
1646308|NCT00215540|Surfactant|surfactant
1646309|NCT00215540|Placebo-Controlled|placebo-controlled
1646310|NCT00215540|Premature Birth|premature birth
1646311|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
1646312|NCT00215527|Hurler-Scheie|hurler-scheie
1646313|NCT00215527|Scheie|scheie
1646314|NCT00215527|laronidase|laronidase
1646315|NCT00215527|spinal cord compression|spinal cord compression
1646316|NCT00215527|central nervous system|central nervous system
1646317|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
1646318|NCT00215527|intrathecal|intrathecal
1646319|NCT00215527|LA Biomed|la biomed
1646320|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
1646321|NCT00215514|GE junction|ge junction
1646322|NCT00215514|epirubicin|epirubicin
1646323|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
1646324|NCT00215501|capecitabine|capecitabine
1646325|NCT00215501|continuous infusion|continuous infusion
1646326|NCT00215501|5-FU|5-fu
1646327|NCT00215501|irinotecan|irinotecan
1646328|NCT00215501|5-fluorouracil|5-fluorouracil
1646329|NCT00215501|cisplatin|cisplatin
1646330|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
1646331|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
1646332|NCT00215462|vinorelbine|vinorelbine
1646333|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1646334|NCT00215449|COPD|copd
1646335|NCT00215449|formoterol|formoterol
1646336|NCT00215449|formoterol fumarate|formoterol fumarate
1646337|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1646338|NCT00215436|COPD|copd
1646339|NCT00215436|formoterol|formoterol
1646340|NCT00215423|COPD|copd
1646341|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1646342|NCT00215423|Formoterol Fumarate|formoterol fumarate
1646343|NCT00215423|Formoterol|formoterol
1646344|NCT00215410|Asthma|asthma
1646345|NCT00215410|Formoterol|formoterol
1646346|NCT00215410|Fumarate|fumarate
1646347|NCT00215397|Asthma|asthma
1646348|NCT00215397|Formoterol|formoterol
1646349|NCT00215397|Fumarate|fumarate
1646350|NCT00215384|COPD|copd
1646351|NCT00215384|formoterol|formoterol
1646352|NCT00215371|Asthma|asthma
1646354|NCT00215371|Formoterol Fumarate|formoterol fumarate
1646355|NCT00215371|Foradil|foradil
1646356|NCT00215358|Asthma|asthma
1646357|NCT00215358|Formoterol|formoterol
1646358|NCT00215358|Fumarate|fumarate
1646359|NCT00215358|Foradil|foradil
1646360|NCT00215345|Celecoxib|celecoxib
1646361|NCT00215345|Taxotere|taxotere
1646362|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1646363|NCT00215332|arthroplasty|arthroplasty
1646364|NCT00215332|lumbar|lumbar
1646365|NCT00215332|disc|disc
1646366|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
1646367|NCT00215306|arthroplasty|arthroplasty
1646368|NCT00215306|lumbar|lumbar
1646369|NCT00215306|spine|spine
1646370|NCT00215293|fusion|fusion
1646371|NCT00215293|cervical|cervical
1646372|NCT00215293|spine|spine
1646373|NCT00215280|Mansonella perstans|mansonella perstans
1646374|NCT00215280|microfilaraemia|microfilaraemia
1646375|NCT00215280|ivermectin|ivermectin
1646376|NCT00215280|albendazole|albendazole
1646377|NCT00215280|Uganda|uganda
1646378|NCT00215267|Schistosoma mansoni|schistosoma mansoni
1646379|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
1646380|NCT00215267|malaria|malaria
1646381|NCT00215267|Uganda|uganda
1646382|NCT00215254|quetiapine|quetiapine
1646383|NCT00215254|social anxiety disorder|social anxiety disorder
1646384|NCT00215254|antipsychotic|antipsychotic
1646385|NCT00215254|pilot study|pilot study
1646386|NCT00215241|PTSD|ptsd
1646387|NCT00215241|sertraline|sertraline
1646388|NCT00215241|risperidone|risperidone
1646389|NCT00215241|antidepressant|antidepressant
1646390|NCT00215241|antipsychotic|antipsychotic
1646391|NCT00215241|anxiety|anxiety
1646392|NCT00215241|trauma|trauma
1646393|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
1646394|NCT00215215|Epilepsies, Partial|epilepsies, partial
1646395|NCT00215215|Seizures|seizures
1646396|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
1646397|NCT00215215|Refractory Partial Seizures|refractory partial seizures
1646398|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
1646400|NCT00215202|Adrenal Cancer|adrenal cancer
1646401|NCT00215189|health|health
1646402|NCT00215189|mental illness|mental illness
1646403|NCT00215189|fitness|fitness
1646405|NCT00215176|psychostimulants|psychostimulants
1646406|NCT00215176|modafinil|modafinil
1646407|NCT00215163|PTSD|ptsd
1646408|NCT00215163|Anxiety|anxiety
1646409|NCT00215163|CBT|cbt
1646410|NCT00215163|Exposure|exposure
1646411|NCT00215163|Paroxetine|paroxetine
1646412|NCT00215163|Paroxetine-CR|paroxetine-cr
1646413|NCT00215150|anxiety disorder|anxiety disorder
1646414|NCT00215150|SAD|sad
1646415|NCT00215150|ziprasidone|ziprasidone
1646416|NCT00215150|sertraline|sertraline
1646417|NCT00215150|antidepressant|antidepressant
1646418|NCT00215150|antipsychotic|antipsychotic
1646419|NCT00215137|OCD|ocd
1646420|NCT00215137|SSRI|ssri
1646421|NCT00215137|escitalopram|escitalopram
1646422|NCT00215137|relapse|relapse
1646423|NCT00215111|childhood obesity|childhood obesity
1646424|NCT00215111|weight management|weight management
1646425|NCT00215111|dietary interventions|dietary interventions
1646426|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
1646427|NCT00215098|pediatric health|pediatric health
1646428|NCT00215098|cardiac|cardiac
1646429|NCT00215098|congenital heart surgery|congenital heart surgery
1646430|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
1646431|NCT00215098|heart defects|heart defects
1646432|NCT00215098|children|children
1646433|NCT00215085|pediatric health|pediatric health
1646434|NCT00215085|cardiac|cardiac
1646435|NCT00215085|cardiac tumor|cardiac tumor
1646436|NCT00215085|children|children
1646437|NCT00215072|Death after heart surgery|death after heart surgery
1646438|NCT00215072|surgical mortality|surgical mortality
1646439|NCT00215072|post-operative mortality|post-operative mortality
1646440|NCT00215072|pediatric health|pediatric health
1646441|NCT00215072|cardiac|cardiac
1646442|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
1646443|NCT00215046|vinblastine|vinblastine
1646444|NCT00215046|methotrexate|methotrexate
1646445|NCT00215033|Epstein-Barr virus|epstein-barr virus
1646446|NCT00215033|pediatric health|pediatric health
1646447|NCT00215033|cardiac|cardiac
1646448|NCT00215033|heart transplant|heart transplant
1646449|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
1646450|NCT00215033|post-transplant|post-transplant
1646451|NCT00215033|pediatric transplant|pediatric transplant
1646452|NCT00215020|Isoprostanes|isoprostanes
1646453|NCT00214981|ADHD|adhd
1646454|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
1646455|NCT00214929|Pulmonary Embolism|pulmonary embolism
1646456|NCT00214929|Therapy|therapy
1646457|NCT00214929|Home Nursing|home nursing
1646458|NCT00214929|Economics|economics
1646459|NCT00214916|Tight glycemic control with|tight glycemic control with
1646460|NCT00214916|intensive insulin treatment|intensive insulin treatment
1646461|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
1646462|NCT00214916|in infant or child in ICU|in infant or child in icu
1646463|NCT00214903|Postmenopause|postmenopause
1646464|NCT00214903|HRT|hrt
1646465|NCT00214890|HIV|hiv
1646466|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
1646467|NCT00214890|drug-drug interaction|drug-drug interaction
1646468|NCT00214890|Treatment Naive|treatment naive
1646469|NCT00214890|Drug resistance|drug resistance
1646470|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
1646471|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
1646472|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
1646473|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
1646474|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
1646475|NCT00214851|Familial Cold Urticaria|familial cold urticaria
1646476|NCT00214851|Kineret (anakinra)|kineret (anakinra)
1646477|NCT00214851|Interleukin 1 beta|interleukin 1 beta
1646478|NCT00214851|C-Reactive Protein|c-reactive protein
1646479|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
1646480|NCT00214838|cancer, atiprimod|cancer, atiprimod
1646481|NCT00214812|HIV Seronegativity|hiv seronegativity
1646482|NCT00214812|HIV|hiv
1646483|NCT00214786|Diabetes Mellitus|diabetes mellitus
1646484|NCT00214786|Hypoglycemia|hypoglycemia
1646485|NCT00214786|Hyperglycemia|hyperglycemia
1646486|NCT00214760|Hip prosthesis|hip prosthesis
1646487|NCT00214760|Centralizer|centralizer
1646488|NCT00214760|Uncemented|uncemented
1646489|NCT00214747|HIV Seronegativity|hiv seronegativity
1646490|NCT00214747|HIV|hiv
1646491|NCT00214708|Tuberculosis|tuberculosis
1646492|NCT00214708|Screening|screening
1646493|NCT00214708|Heaf|heaf
1646494|NCT00214708|BCG|bcg
1646495|NCT00214682|Depression|depression
1646496|NCT00214682|Cognition|cognition
1646497|NCT00214682|Depressive disorder|depressive disorder
1646498|NCT00214682|Mental health literacy|mental health literacy
1646499|NCT00214682|Older adults|older adults
1646500|NCT00214682|Randomzed controlled trial|randomzed controlled trial
1646501|NCT00214669|ethnicity|ethnicity
1646502|NCT00214669|primary care|primary care
1646503|NCT00214669|education|education
1646504|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
1646505|NCT00214656|Surgical blood loss|surgical blood loss
1646506|NCT00214656|Surgical haemostasis|surgical haemostasis
1646510|NCT00214643|Fosmidomycin|fosmidomycin
1646511|NCT00214643|Clindamycin|clindamycin
1646512|NCT00214643|Chemotherapy|chemotherapy
1646513|NCT00214643|Gabon|gabon
1646514|NCT00214617|hypercholesterolemia|hypercholesterolemia
1646515|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
1646516|NCT00214617|tracer kinetics|tracer kinetics
1646517|NCT00214617|Apolipoproteins|apolipoproteins
1646518|NCT00214591|Type 2 diabetes|type 2 diabetes
1646519|NCT00214578|Schizophrenia|schizophrenia
1646520|NCT00214565|Type 2 diabetes|type 2 diabetes
1646521|NCT00214552|GERD|gerd
1646522|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
1646523|NCT00214552|Asthma symptoms|asthma symptoms
1646524|NCT00214539|Asthma|asthma
1646525|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
1646526|NCT00214526|Asthma|asthma
1646527|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
1646528|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
1646529|NCT00214487|Myopia Progression|myopia progression
1646530|NCT00214487|Myopia Control|myopia control
1646531|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
1646532|NCT00214487|Esophoria|esophoria
1646533|NCT00214487|Fixation Disparity|fixation disparity
1646534|NCT00214474|Disease Management|disease management
1646535|NCT00214474|Health Literacy|health literacy
1646536|NCT00214474|Telephone Care|telephone care
1646537|NCT00214474|Group Medical Visits|group medical visits
1646538|NCT00214474|Type 2 Diabetes|type 2 diabetes
1646539|NCT00214474|Access to Care|access to care
1646540|NCT00214474|Technology|technology
1646541|NCT00214474|Language Barriers|language barriers
1646542|NCT00214461|Clostridium difficile|clostridium difficile
1646543|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
1646544|NCT00214435|HIV infection|hiv infection
1646545|NCT00214435|AIDS|aids
1646546|NCT00214435|Adherence|adherence
1646547|NCT00214435|MEMS caps|mems caps
1646548|NCT00214435|Treatment Experienced|treatment experienced
1646549|NCT00214422|Prostate|prostate
1646550|NCT00214422|Radiation|radiation
1646551|NCT00214422|Cancer|cancer
1646552|NCT00214422|Prostate Cancer|prostate cancer
1646553|NCT00214383|pediatric asthma|pediatric asthma
1646554|NCT00214370|pediatric|pediatric
1646555|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
1646556|NCT00214344|dying|dying
1646557|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
1646558|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
1646559|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
1646560|NCT00214045|Voiding dysfunction|voiding dysfunction
1646561|NCT00214045|Cystoscopy|cystoscopy
1646562|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
1646563|NCT00213980|bone mineral density|bone mineral density
1646564|NCT00213980|postmenopausal women|postmenopausal women
1646565|NCT00213967|Influenza vaccine|influenza vaccine
1646566|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
1646567|NCT00213954|ultrasound-guidance|ultrasound-guidance
1646568|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
1646569|NCT00213941|surfactant deficiency|surfactant deficiency
1646570|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
1646571|NCT00213941|lung maturity tests|lung maturity tests
1646572|NCT00213915|L-arginine|l-arginine
1646573|NCT00213915|exercise capacity|exercise capacity
1646574|NCT00213915|renal function|renal function
1646575|NCT00213915|nitric oxide|nitric oxide
1646576|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
1646577|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
1646578|NCT00213902|Heart failure|heart failure
1646579|NCT00213902|Diastolic|diastolic
1646580|NCT00213902|functionClonidine|functionclonidine
1646581|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
1646582|NCT00213889|Facial clefting|facial clefting
1646583|NCT00213889|twist|twist
1646584|NCT00213889|craniofacial development genes|craniofacial development genes
1646585|NCT00213889|Human cleft lip and palate|human cleft lip and palate
1646586|NCT00213889|cleft lip and palate|cleft lip and palate
1646587|NCT00213876|Brain tumours|brain tumours
1646588|NCT00213876|oligodendrogliomas|oligodendrogliomas
1646589|NCT00213876|allelotyping|allelotyping
1646590|NCT00213876|SAGE|sage
1646591|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
1646592|NCT00213863|porous titanium implants|porous titanium implants
1646593|NCT00213863|thyroplasty|thyroplasty
1646594|NCT00213863|vocal cord paralysis|vocal cord paralysis
1646595|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
1646596|NCT00213850|Interrupter technique|interrupter technique
1646597|NCT00213850|Respiratory resistance|respiratory resistance
1646598|NCT00213850|Normal adults|normal adults
1646599|NCT00213837|porous titanium implants|porous titanium implants
1646600|NCT00213837|thyroplasty|thyroplasty
1646694|NCT00213369|aspiration|aspiration
1646601|NCT00213837|vocal cord paralysis|vocal cord paralysis
1646602|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
1646603|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1646604|NCT00213824|Nogo gene|nogo gene
1646605|NCT00213824|reticulon genes|reticulon genes
1646606|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
1646607|NCT00213798|Lung cancer|lung cancer
1646608|NCT00213798|plasma DNA|plasma dna
1646609|NCT00213798|allelotyping|allelotyping
1646610|NCT00213798|follow-up|follow-up
1646611|NCT00213798|Prospective Study|prospective study
1646612|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
1646613|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
1646614|NCT00213785|AreET1|areet1
1646615|NCT00213785|ANP|anp
1646616|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
1646617|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
1646618|NCT00213772|hepatitis C|hepatitis c
1646619|NCT00213772|hemochromatosis|hemochromatosis
1646620|NCT00213759|neutropenia|neutropenia
1646621|NCT00213759|prematurity|prematurity
1646622|NCT00213759|nosocomial infection|nosocomial infection
1646623|NCT00213759|G-CSF|g-csf
1646624|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
1646625|NCT00213746|Heart Failure, Congestive|heart failure, congestive
1646626|NCT00213746|Myocardial Infarction|myocardial infarction
1646627|NCT00213746|Myocardial Revascularization|myocardial revascularization
1646628|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
1646629|NCT00213746|Dobutamine|dobutamine
1646630|NCT00213746|Myocardial Stunning|myocardial stunning
1646631|NCT00213746|Myocardial Hibernation|myocardial hibernation
1646632|NCT00213733|Lung cancer patients|lung cancer patients
1646633|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
1646634|NCT00213733|molecular marker|molecular marker
1646635|NCT00213733|lymph node completed resected|lymph node completed resected
1646636|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
1646637|NCT00213720|Hyperthyroidism|hyperthyroidism
1646638|NCT00213720|atrial fibrillation|atrial fibrillation
1646639|NCT00213720|quality of life|quality of life
1646640|NCT00213720|radioiodine treatment|radioiodine treatment
1646641|NCT00213707|Dendritic cells|dendritic cells
1646642|NCT00213707|liver transplantation|liver transplantation
1646643|NCT00213707|hepatitis C virus|hepatitis c virus
1646644|NCT00213707|quasispecies|quasispecies
1646645|NCT00213707|virological markers|virological markers
1646646|NCT00213707|biochemical markers|biochemical markers
1646647|NCT00213707|immunological markers|immunological markers
1646648|NCT00213707|clinical markers|clinical markers
1646750|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
1646751|NCT00213187|Randomized Control Trial,|randomized control trial,
1646649|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
1646650|NCT00213668|glutamine|glutamine
1646651|NCT00213668|premature neonate|premature neonate
1646652|NCT00213668|gastric emptying|gastric emptying
1646653|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
1646654|NCT00213642|Radionuclide Imaging|radionuclide imaging
1646655|NCT00213642|Cisplatin|cisplatin
1646656|NCT00213642|Kidney failure|kidney failure
1646657|NCT00213642|Drug Toxicity|drug toxicity
1646658|NCT00213642|Cancer|cancer
1646659|NCT00213629|myositis|myositis
1646660|NCT00213629|cDNA arrays|cdna arrays
1646661|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
1646662|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
1646663|NCT00213616|reinnervation|reinnervation
1646664|NCT00213616|phrenic nerve|phrenic nerve
1646665|NCT00213603|precancerous lesions|precancerous lesions
1646666|NCT00213603|Lung cancer|lung cancer
1646667|NCT00213603|Follow-up|follow-up
1646668|NCT00213603|Randomized study|randomized study
1646669|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
1646670|NCT00213603|precancerous conditions|precancerous conditions
1646671|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
1646672|NCT00213499|Mechanical ventilation|mechanical ventilation
1646673|NCT00213499|Weaning|weaning
1646674|NCT00213499|Noninvasive ventilation|noninvasive ventilation
1646675|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
1646676|NCT00213473|acquired haemophilia|acquired haemophilia
1646677|NCT00213434|prospective|prospective
1646678|NCT00213434|randomized|randomized
1646679|NCT00213434|polysomnography|polysomnography
1646680|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
1646681|NCT00213408|Arrhythmia|arrhythmia
1646682|NCT00213408|atrial flutter|atrial flutter
1646683|NCT00213408|catheter ablation|catheter ablation
1646684|NCT00213395|Noninvasive ventilation|noninvasive ventilation
1646685|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
1646686|NCT00213395|Cephalic mask|cephalic mask
1646687|NCT00213395|Facial Mask|facial mask
1646688|NCT00213382|swallowing|swallowing
1646689|NCT00213382|ventilation|ventilation
1646690|NCT00213382|pressure|pressure
1646692|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
1646693|NCT00213382|Brain Mapping|brain mapping
1646695|NCT00213369|stroke|stroke
1646696|NCT00213369|motor evoked potential|motor evoked potential
1646697|NCT00213369|cortical evoked potential|cortical evoked potential
1646698|NCT00213369|neuromodulation|neuromodulation
1646699|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
1646700|NCT00213343|aspiration|aspiration
1646701|NCT00213343|phrenic nerve|phrenic nerve
1646702|NCT00213343|magnetic stimulation|magnetic stimulation
1646703|NCT00213330|cerebral activity|cerebral activity
1646704|NCT00213330|rectal distension|rectal distension
1646705|NCT00213330|colitis ulcerative|colitis ulcerative
1646706|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
1646707|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
1646708|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
1646709|NCT00213317|fecal incontinence|fecal incontinence
1646710|NCT00213317|constipation|constipation
1646711|NCT00213304|organ transplantation|organ transplantation
1646712|NCT00213304|immunosuppression|immunosuppression
1646713|NCT00213304|vaccine|vaccine
1646714|NCT00213304|varicella|varicella
1646715|NCT00213304|pediatrics|pediatrics
1646716|NCT00213291|chronic kidney failure|chronic kidney failure
1646717|NCT00213291|darbepoetin|darbepoetin
1646718|NCT00213291|pediatrics|pediatrics
1646719|NCT00213291|anemia|anemia
1646720|NCT00213278|glioma|glioma
1646721|NCT00213278|brain tumour|brain tumour
1646722|NCT00213278|cancer|cancer
1646723|NCT00213278|pediatrics|pediatrics
1646724|NCT00213278|vinblastine sulfate|vinblastine sulfate
1646725|NCT00213265|organ transplantation|organ transplantation
1646726|NCT00213265|immunosuppression|immunosuppression
1646727|NCT00213265|vaccine|vaccine
1646728|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1646729|NCT00213265|pediatrics|pediatrics
1646730|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
1646731|NCT00213239|spinal puncture|spinal puncture
1646732|NCT00213239|remifentanil|remifentanil
1646733|NCT00213239|propofol|propofol
1646734|NCT00213239|anesthesia|anesthesia
1646735|NCT00213239|dose finding|dose finding
1646736|NCT00213239|pediatrics|pediatrics
1646737|NCT00213226|bronchiolitis|bronchiolitis
1646738|NCT00213226|pediatrics|pediatrics
1646739|NCT00213226|corticosteroids|corticosteroids
1646740|NCT00213213|sucrose|sucrose
1646741|NCT00213213|analgesia|analgesia
1646742|NCT00213213|pain|pain
1646743|NCT00213213|neonates|neonates
1646744|NCT00213213|diabetes|diabetes
1646745|NCT00213200|pain|pain
1646746|NCT00213200|analgesia|analgesia
1646747|NCT00213200|morphine|morphine
1646748|NCT00213200|amethocaine|amethocaine
1646749|NCT00213200|neonate|neonate
1646752|NCT00213187|attention placebo,|attention placebo,
1646753|NCT00213187|exercise testing,|exercise testing,
1646754|NCT00213187|aerobics,|aerobics,
1646755|NCT00213187|Qi Gong,|qi gong,
1646756|NCT00213187|exercise video,|exercise video,
1646757|NCT00213187|activities of daily living,|activities of daily living,
1646758|NCT00213187|quality of life,|quality of life,
1646759|NCT00213187|economy of walking,|economy of walking,
1646760|NCT00213187|fitness|fitness
1646761|NCT00213187|pediatrics|pediatrics
1646762|NCT00213174|pediatrics|pediatrics
1646763|NCT00213174|injury|injury
1646764|NCT00213174|arm fractures|arm fractures
1646765|NCT00213174|trauma|trauma
1646766|NCT00213174|playground surfaces|playground surfaces
1646767|NCT00213174|fractures|fractures
1646768|NCT00213161|anemia|anemia
1646769|NCT00213161|iron deficiency|iron deficiency
1646770|NCT00213161|iron drops|iron drops
1646771|NCT00213161|iron supplement|iron supplement
1646772|NCT00213161|malnutrition|malnutrition
1646773|NCT00213161|pediatrics|pediatrics
1646774|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
1646775|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
1646776|NCT00213096|Contraceptive agents|contraceptive agents
1646777|NCT00213096|female|female
1646778|NCT00213083|Microbicide|microbicide
1646779|NCT00213083|HIV|hiv
1646780|NCT00213083|AIDS|aids
1646781|NCT00213083|STIs|stis
1646782|NCT00213083|STDs|stds
1646783|NCT00213083|Efficacy|efficacy
1646784|NCT00213083|HSV|hsv
1646785|NCT00213083|Women|women
1646786|NCT00213083|South Africa|south africa
1646787|NCT00213083|seroconversion|seroconversion
1646788|NCT00213083|condom|condom
1646789|NCT00213083|safe-sex|safe-sex
1646790|NCT00213083|vaginal intercourse|vaginal intercourse
1646791|NCT00213083|prevention|prevention
1646792|NCT00213083|HIV Seronegativity|hiv seronegativity
1646793|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
1646794|NCT00213057|Microbicides|microbicides
1646795|NCT00213057|HIV prevention|hiv prevention
1646796|NCT00213057|sexually transmitted infections|sexually transmitted infections
1646797|NCT00213057|carrageenan|carrageenan
1646798|NCT00213057|sero-concordant couples|sero-concordant couples
1646799|NCT00213057|HIV Seronegativity|hiv seronegativity
1646800|NCT00213057|HIV|hiv
1646801|NCT00213044|Microbicides|microbicides
1646802|NCT00213044|HIV prevention|hiv prevention
1646803|NCT00213044|HIV-positive women|hiv-positive women
1646804|NCT00213044|safety|safety
1646805|NCT00213044|carrageenan|carrageenan
1646806|NCT00213044|HIV|hiv
1646807|NCT00213031|microbicides|microbicides
1646808|NCT00213031|HIV prevention|hiv prevention
1646809|NCT00213031|sexually transmitted infections|sexually transmitted infections
1646810|NCT00213031|female-initiated protection|female-initiated protection
1646811|NCT00213031|carrageenan|carrageenan
1646812|NCT00213031|expanded safety trial|expanded safety trial
1646813|NCT00213031|HIV Seronegativity|hiv seronegativity
1646814|NCT00213031|HIV|hiv
1646815|NCT00213018|microbicides|microbicides
1646816|NCT00213018|HIV prevention|hiv prevention
1646817|NCT00213018|sexually transmitted infections|sexually transmitted infections
1646818|NCT00213018|female-initiated protection|female-initiated protection
1646819|NCT00213018|carrageenan|carrageenan
1646820|NCT00213018|expanded safety trial|expanded safety trial
1646821|NCT00213018|HIV Seronegativity|hiv seronegativity
1646822|NCT00213018|HIV|hiv
1646823|NCT00213005|Microbicides|microbicides
1646824|NCT00213005|HIV prevention|hiv prevention
1646825|NCT00213005|HIV positive|hiv positive
1646826|NCT00213005|carrageenan|carrageenan
1646827|NCT00213005|safety trial|safety trial
1646828|NCT00213005|Treatment Experienced|treatment experienced
1646829|NCT00213005|HIV|hiv
1646830|NCT00212992|defibrillation|defibrillation
1646831|NCT00212992|ventricular fibrillation|ventricular fibrillation
1646832|NCT00212992|heart arrest|heart arrest
1646833|NCT00212979|glomerular filtration rate|glomerular filtration rate
1646834|NCT00212979|cystatin C|cystatin c
1646835|NCT00212979|creatinine|creatinine
1646836|NCT00212966|psychosocial|psychosocial
1646837|NCT00212953|Chest Pain,|chest pain,
1646838|NCT00212953|Shortness of breath,|shortness of breath,
1646839|NCT00212953|Injury,|injury,
1646840|NCT00212953|Trauma|trauma
1646841|NCT00212940|Treatment Naive|treatment naive
1646842|NCT00212940|HIV|hiv
1646843|NCT00212901|Diabetes|diabetes
1646844|NCT00212901|Proteinuria|proteinuria
1646845|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
1646846|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
1646847|NCT00212888|HIV|hiv
1646848|NCT00212888|Vaccination|vaccination
1646849|NCT00212875|Chronic Kidney disease|chronic kidney disease
1646850|NCT00212875|anemia|anemia
1646851|NCT00212862|Anemia|anemia
1646852|NCT00212862|Cancer|cancer
1646853|NCT00212862|Epoetin alfa|epoetin alfa
1646854|NCT00212862|Darbepoetin alfa|darbepoetin alfa
1646855|NCT00212862|Registry|registry
1646856|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
1646857|NCT00212849|Patellar lesions|patellar lesions
1646858|NCT00212849|Trochlear lesions|trochlear lesions
1646859|NCT00212849|Patellofemoral joint|patellofemoral joint
1646860|NCT00212849|Carticel|carticel
1646861|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
1646862|NCT00212823|Migraine|migraine
1646863|NCT00212810|Migraine|migraine
1646864|NCT00212810|Headache|headache
1646865|NCT00212810|Migraine Headache|migraine headache
1646866|NCT00212758|Short stature|short stature
1646867|NCT00212758|children|children
1646868|NCT00212758|kidney failure, chronic|kidney failure, chronic
1646869|NCT00212758|Growth|growth
1646870|NCT00212745|Behavior Therapy|behavior therapy
1646871|NCT00212745|Relaxation Techniques|relaxation techniques
1646872|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
1646873|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
1646874|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
1646875|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
1646876|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
1646877|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
1646878|NCT00212654|ONO-1101|ono-1101
1646879|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
1646880|NCT00212654|Postoperative|postoperative
1646881|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
1646882|NCT00212628|ONO-5920|ono-5920
1646883|NCT00212628|osteoporosis|osteoporosis
1646884|NCT00212628|bisphosphonate|bisphosphonate
1646885|NCT00212615|Colorectal neoplasm|colorectal neoplasm
1646886|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
1646887|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
1646888|NCT00212615|Advanced disease|advanced disease
1646889|NCT00212615|Metastatic disease|metastatic disease
1646890|NCT00212615|First-line treatment|first-line treatment
1646891|NCT00212615|Phase II study|phase ii study
1646892|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
1646893|NCT00212589|Patients preference|patients preference
1646894|NCT00212589|Colorectal cancer|colorectal cancer
1646895|NCT00212589|Capecitabine|capecitabine
1646896|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
1646897|NCT00212589|Cross-over study|cross-over study
1646898|NCT00212576|Child development|child development
1646899|NCT00212576|Language Development|language development
1646900|NCT00212576|Parenting|parenting
1646901|NCT00212537|Asthma and normal|asthma and normal
1646902|NCT00212485|Hemophilia|hemophilia
1646903|NCT00212485|Factor Deficiency|factor deficiency
1646904|NCT00212485|synovitis|synovitis
1646905|NCT00212485|sonogram|sonogram
1646906|NCT00212459|Bleeding logs|bleeding logs
1646907|NCT00212459|Factor Infusions|factor infusions
1646908|NCT00212446|Tocolysis|tocolysis
1646909|NCT00212446|Electrical Pacemaker|electrical pacemaker
1646910|NCT00212433|colorectal neoplasia|colorectal neoplasia
1646911|NCT00212433|CT colonography|ct colonography
1646912|NCT00212433|faecal tagging|faecal tagging
1646913|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
1646914|NCT00212407|Cord blood transplantation|cord blood transplantation
1646915|NCT00212407|bone marrow transplantation|bone marrow transplantation
1646916|NCT00212394|Tourniquet|tourniquet
1646917|NCT00212394|paresis|paresis
1646918|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
1646919|NCT00212329|Type 1 Diabetes|type 1 diabetes
1646920|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
1646921|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
1646922|NCT00212329|T1D|t1d
1646923|NCT00212316|Huntington's Disease|huntington's disease
1646924|NCT00212316|phenylbutyrate|phenylbutyrate
1646925|NCT00212316|HDAC inhibitors|hdac inhibitors
1646926|NCT00212316|transcription|transcription
1646927|NCT00212303|type 2 diabetes|type 2 diabetes
1646928|NCT00212303|hypertension|hypertension
1646929|NCT00212303|exercise training|exercise training
1646930|NCT00212303|cardiac, peripheral|cardiac, peripheral
1646931|NCT00212303|body composition|body composition
1646932|NCT00212303|physical fitness|physical fitness
1646933|NCT00212303|inflammation|inflammation
1646934|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
1646935|NCT00212264|urinary incontinence|urinary incontinence
1646936|NCT00212264|therapy|therapy
1646937|NCT00212264|prostatectomy|prostatectomy
1646938|NCT00212264|prostate cancer|prostate cancer
1646939|NCT00212251|obesity|obesity
1646940|NCT00212251|postpartum period|postpartum period
1646941|NCT00212251|exercise|exercise
1646942|NCT00212251|diet|diet
1646943|NCT00212251|motivation|motivation
1646944|NCT00212238|obesity|obesity
1646945|NCT00212238|weight loss|weight loss
1646946|NCT00212238|Internet|internet
1646947|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
1646948|NCT00212238|computer assisted patient care|computer assisted patient care
1646949|NCT00212238|human therapy evaluation|human therapy evaluation
1646950|NCT00212238|physical activity|physical activity
1646951|NCT00212238|clinical trial|clinical trial
1647846|NCT00208559|Autism|autism
1646952|NCT00212238|nutrient intake activity|nutrient intake activity
1646953|NCT00212238|outcomes research|outcomes research
1646954|NCT00212238|personal log /diary|personal log /diary
1646955|NCT00212238|reinforcer|reinforcer
1646956|NCT00212238|self care|self care
1646957|NCT00212238|social support network|social support network
1646958|NCT00212238|weight control|weight control
1646959|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
1646960|NCT00212238|clinical research|clinical research
1646961|NCT00212238|human subject|human subject
1646962|NCT00212238|questionnaire|questionnaire
1646963|NCT00212225|gastric disease|gastric disease
1646964|NCT00212225|H. pylori|h. pylori
1646965|NCT00212225|children|children
1646966|NCT00212225|Helicobacter pylori|helicobacter pylori
1646967|NCT00212225|child|child
1646968|NCT00212225|epidemiology|epidemiology
1646969|NCT00212212|selenium supplements|selenium supplements
1646970|NCT00212212|selenate|selenate
1646971|NCT00212212|selenomethionine|selenomethionine
1646972|NCT00212212|biomarkers|biomarkers
1646973|NCT00212212|plasma selenium concentration|plasma selenium concentration
1646974|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
1646975|NCT00212212|selenoprotein P|selenoprotein p
1646976|NCT00212199|Obesity Treatment|obesity treatment
1646977|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
1646978|NCT00212199|Counseling for weight management|counseling for weight management
1646979|NCT00212173|Adolescent|adolescent
1646980|NCT00212173|Weight Management|weight management
1646981|NCT00212173|Obesity Treatment|obesity treatment
1646982|NCT00212173|Behavioral Treatment|behavioral treatment
1646983|NCT00212147|cobalamin|cobalamin
1646984|NCT00212147|anesthesia|anesthesia
1646985|NCT00212147|cognition|cognition
1646986|NCT00212134|cataract surgery|cataract surgery
1646987|NCT00212134|intraocular lens|intraocular lens
1646988|NCT00212134|contact lens|contact lens
1646989|NCT00212134|infants|infants
1646990|NCT00212134|aphakia|aphakia
1646991|NCT00212121|breast cancer|breast cancer
1646992|NCT00212121|radiotherapy|radiotherapy
1646993|NCT00212121|microarrays|microarrays
1646994|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
1646995|NCT00212095|breast cancer|breast cancer
1646996|NCT00212095|docetaxel|docetaxel
1647291|NCT00210925|alcoholism|alcoholism
1646997|NCT00212095|gene expression|gene expression
1646998|NCT00212095|proteomics|proteomics
1646999|NCT00212082|breast cancer|breast cancer
1647000|NCT00212082|chemotherapy response|chemotherapy response
1647001|NCT00212082|gene expression profiles|gene expression profiles
1647002|NCT00212082|proteomics|proteomics
1647003|NCT00212069|breast cancer|breast cancer
1647004|NCT00212069|serum proteomics|serum proteomics
1647005|NCT00212069|gemcitabine|gemcitabine
1647006|NCT00212069|carboplatin|carboplatin
1647007|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
1647008|NCT00212056|Acute myocardial infarction|acute myocardial infarction
1647009|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
1647010|NCT00212056|Data mining|data mining
1647011|NCT00212056|Randomized clinical trial|randomized clinical trial
1647012|NCT00212056|SNPs|snps
1647013|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
1647014|NCT00212030|Acute myocardial infarction|acute myocardial infarction
1647015|NCT00212030|Data mining|data mining
1647016|NCT00212030|Nicorandil|nicorandil
1647017|NCT00212030|Randomized clinical trial|randomized clinical trial
1647018|NCT00212030|SNPs|snps
1647019|NCT00212017|IGT|igt
1647020|NCT00212017|Myocardial Infarction|myocardial infarction
1647021|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
1647022|NCT00212017|re-infarction prevention|re-infarction prevention
1647023|NCT00212004|diabetes mellitus|diabetes mellitus
1647024|NCT00212004|myocardial infarction|myocardial infarction
1647025|NCT00212004|pioglitazone|pioglitazone
1647026|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
1647027|NCT00211965|Knee replacement surgery|knee replacement surgery
1647028|NCT00211965|hip replacement surgery|hip replacement surgery
1647029|NCT00211965|nosocomial infections|nosocomial infections
1647030|NCT00211965|Arthroplasty|arthroplasty
1647031|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
1647032|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
1647033|NCT00211939|kidney dialysis|kidney dialysis
1647034|NCT00211939|hyperphosphatemia|hyperphosphatemia
1647035|NCT00211939|Kidney failure|kidney failure
1647036|NCT00211926|vaccine|vaccine
1647037|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
1647038|NCT00211887|Multiple Sclerosis|multiple sclerosis
1647039|NCT00211887|Clinical trial|clinical trial
1647040|NCT00211887|treatment trial|treatment trial
1647041|NCT00211887|autoimmune disease|autoimmune disease
1647042|NCT00211887|Relapsing Remitting|relapsing remitting
1647043|NCT00211887|MS Treatment|ms treatment
1647044|NCT00211887|interferon beta-1a|interferon beta-1a
1647045|NCT00211887|glatiramer acetate|glatiramer acetate
1647046|NCT00211874|Congestive heart failure|congestive heart failure
1647047|NCT00211874|nurse management|nurse management
1647048|NCT00211874|effectiveness trial|effectiveness trial
1647049|NCT00211874|quality improvement|quality improvement
1647050|NCT00211874|minority communities|minority communities
1647051|NCT00211874|disease management|disease management
1647052|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
1647053|NCT00211848|Human Subjects- adults|human subjects- adults
1647054|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
1647055|NCT00211848|Pathology|pathology
1647056|NCT00211835|TBI|tbi
1647057|NCT00211835|traumatic brain injury|traumatic brain injury
1647058|NCT00211835|depression|depression
1647059|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
1647060|NCT00211835|supportive psychotherapy|supportive psychotherapy
1647061|NCT00211835|psychotherapy|psychotherapy
1647062|NCT00211822|Pathological Gambling|pathological gambling
1647063|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1647064|NCT00211822|Go No-go|go no-go
1647065|NCT00211822|Monetary incentives delay|monetary incentives delay
1647066|NCT00211822|fMRI|fmri
1647067|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
1647068|NCT00211809|SRIs|sris
1647069|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
1647070|NCT00211796|autism|autism
1647071|NCT00211796|divalproex sodium ER|divalproex sodium er
1647072|NCT00211796|aggression|aggression
1647073|NCT00211796|irritability|irritability
1647074|NCT00211783|autism|autism
1647075|NCT00211783|fMRI|fmri
1647076|NCT00211783|response inhibition|response inhibition
1647077|NCT00211783|face processing|face processing
1647078|NCT00211783|linguistic processing|linguistic processing
1647079|NCT00211770|Autism|autism
1647080|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
1647081|NCT00211770|Citalopram|citalopram
1647082|NCT00211757|autism|autism
1647083|NCT00211757|aggression|aggression
1647084|NCT00211757|irritability|irritability
1647085|NCT00211757|divalproex sodium|divalproex sodium
1647086|NCT00211744|OCD|ocd
1647087|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1647088|NCT00211744|OCD treatment|ocd treatment
1647089|NCT00211731|Acute stroke|acute stroke
1647090|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
1647091|NCT00211731|racial disparities|racial disparities
1647092|NCT00211718|shoulder pain|shoulder pain
1647093|NCT00211718|arthritis|arthritis
1647094|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
1647095|NCT00211718|joint pain|joint pain
1647096|NCT00211705|Hyperlipidemia|hyperlipidemia
1647097|NCT00211705|coronary heart disease|coronary heart disease
1647098|NCT00211705|prevention|prevention
1647099|NCT00211705|stroke|stroke
1647100|NCT00211705|pravastatin|pravastatin
1647101|NCT00211692|Hepatitis C|hepatitis c
1647102|NCT00211692|interferon alfa|interferon alfa
1647103|NCT00211692|ribavirin|ribavirin
1647104|NCT00211692|interferon alfacon-1|interferon alfacon-1
1647105|NCT00211692|antiviral therapy|antiviral therapy
1647106|NCT00211679|Joint pain|joint pain
1647107|NCT00211679|Knee Pain|knee pain
1647108|NCT00211679|Arthritis|arthritis
1647109|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
1647110|NCT00211666|Hypertension|hypertension
1647111|NCT00211666|blood pressure|blood pressure
1647112|NCT00211666|self management|self management
1647113|NCT00211666|nurse management|nurse management
1647114|NCT00211666|racial disparities|racial disparities
1647115|NCT00211666|cardiovascular disease|cardiovascular disease
1647116|NCT00211653|Kidney failure|kidney failure
1647117|NCT00211653|Thoracic surgery|thoracic surgery
1647118|NCT00211653|Acetylcysteine|acetylcysteine
1647119|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
1647120|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
1647121|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
1647122|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
1647123|NCT00211614|Quality of Life|quality of life
1647124|NCT00211588|cognition|cognition
1647125|NCT00211562|weight gain|weight gain
1647126|NCT00211562|weight gain supplementation|weight gain supplementation
1647127|NCT00211562|antioxidants|antioxidants
1647128|NCT00211562|olanzapine|olanzapine
1647129|NCT00211549|Osteoarthritis|osteoarthritis
1647130|NCT00211536|Diabetes|diabetes
1647131|NCT00211536|Implantable Insulin Pump|implantable insulin pump
1647132|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
1647133|NCT00211523|acne|acne
1647134|NCT00211523|acne vulgaris|acne vulgaris
1647135|NCT00211523|MBI 226|mbi 226
1647136|NCT00211523|Propionibacterium acnes|propionibacterium acnes
1647137|NCT00211523|lesion counts|lesion counts
1647138|NCT00211523|lesions|lesions
1647139|NCT00211523|inflammatory|inflammatory
1647140|NCT00211523|non-inflammatory|non-inflammatory
1647141|NCT00211523|topical|topical
1647142|NCT00211510|Diabetes|diabetes
1647143|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
1647144|NCT00211510|Glycemic Control|glycemic control
1647145|NCT00211497|acne vulgaris|acne vulgaris
1647146|NCT00211497|acne|acne
1647147|NCT00211497|Propionibacterium acnes|propionibacterium acnes
1647148|NCT00211497|topical|topical
1647149|NCT00211497|inflammatory|inflammatory
1647150|NCT00211497|non-inflammatory|non-inflammatory
1647151|NCT00211497|lesion counts|lesion counts
1647152|NCT00211497|lesions|lesions
1647153|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
1647154|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
1647155|NCT00211419|AMD|amd
1647156|NCT00211380|cognition|cognition
1647157|NCT00211380|schizophrenia|schizophrenia
1647158|NCT00211380|schizoaffective disorder|schizoaffective disorder
1647159|NCT00211367|Radiation Retinopathy|radiation retinopathy
1647160|NCT00211341|Pregnancy|pregnancy
1647161|NCT00211341|Mortality|mortality
1647162|NCT00211341|Maternal|maternal
1647163|NCT00211341|Vitamin A|vitamin a
1647164|NCT00211302|Cognition|cognition
1647165|NCT00211302|Schizophrenia|schizophrenia
1647166|NCT00211302|Schizoaffective disorder|schizoaffective disorder
1647167|NCT00211289|Educational Interventions|educational interventions
1647168|NCT00211289|Heart Failure|heart failure
1647169|NCT00211289|Compliance|compliance
1647170|NCT00211263|Bipolar Disorder|bipolar disorder
1647171|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
1647172|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
1647173|NCT00211237|Cancer|cancer
1647174|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
1647175|NCT00211237|Back Pain|back pain
1647176|NCT00211237|Spine|spine
1647177|NCT00211224|multiple system atrophy|multiple system atrophy
1647178|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
1647179|NCT00211224|riluzole|riluzole
1647180|NCT00211224|MSA|msa
1647181|NCT00211224|PSP|psp
1647182|NCT00211211|Osteopenia|osteopenia
1647183|NCT00211211|Osteoporosis|osteoporosis
1647184|NCT00211211|Multiple Myeloma|multiple myeloma
1647185|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
1647487|NCT00210288|Safety|safety
1647186|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
1647187|NCT00211211|Back Pain|back pain
1647188|NCT00211211|Spine|spine
1647189|NCT00211198|Cutaneous|cutaneous
1647190|NCT00211198|T-cell lymphoma|t-cell lymphoma
1647191|NCT00211198|ONTAK|ontak
1647192|NCT00211198|CD25|cd25
1647193|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
1647194|NCT00211172|Heart Attack|heart attack
1647195|NCT00211172|Adherence|adherence
1647597|NCT00209729|S-1|s-1
1647196|NCT00211172|Beta-blocker|beta-blocker
1647197|NCT00211172|Behavior change|behavior change
1647198|NCT00211159|Alzheimer's disease|alzheimer's disease
1647199|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
1647200|NCT00211159|Dietary supplementation|dietary supplementation
1647201|NCT00211159|Cognition|cognition
1647202|NCT00211159|Safety|safety
1647203|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
1647204|NCT00211133|Anemia|anemia
1647205|NCT00211133|Breast Cancer|breast cancer
1647206|NCT00211133|Breast Tumor|breast tumor
1647207|NCT00211133|Quality of Life|quality of life
1647208|NCT00211133|Women|women
1647209|NCT00211133|Female|female
1647210|NCT00211133|Chemotherapy|chemotherapy
1647211|NCT00211133|Hemoglobin|hemoglobin
1647212|NCT00211133|Survival|survival
1647213|NCT00211133|Epoetin|epoetin
1647214|NCT00211133|Epoetin alfa|epoetin alfa
1647215|NCT00211133|erythropoietin|erythropoietin
1647216|NCT00211120|Anemia|anemia
1647217|NCT00211120|Low Blood Count|low blood count
1647218|NCT00211120|Chronic Kidney Failure|chronic kidney failure
1647219|NCT00211120|Chronic Kidney Disease|chronic kidney disease
1647220|NCT00211107|dapoxetine|dapoxetine
1647221|NCT00211107|rapid ejaculation|rapid ejaculation
1647222|NCT00211107|premature ejaculation|premature ejaculation
1647223|NCT00211107|ejaculation|ejaculation
1647224|NCT00211107|sexual dysfunction|sexual dysfunction
1647225|NCT00211107|orgasmic disorder|orgasmic disorder
1647226|NCT00211107|sexual intercourse|sexual intercourse
1647227|NCT00211094|dapoxetine|dapoxetine
1647228|NCT00211094|premature ejaculation|premature ejaculation
1647229|NCT00211094|ejaculation|ejaculation
1647230|NCT00211094|sexual dysfunction|sexual dysfunction
1647231|NCT00211094|orgasmic disorder|orgasmic disorder
1647232|NCT00211094|sexual intercourse|sexual intercourse
1647233|NCT00211081|Congenital Heart Disease|congenital heart disease
1647234|NCT00211081|Spironolactone|spironolactone
1647235|NCT00211081|>17 years old|>17 years old
1647236|NCT00211081|undergone Fontan procedure|undergone fontan procedure
1647237|NCT00211081|endothelial function|endothelial function
1647238|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
1647239|NCT00211068|Chronic kidney failure|chronic kidney failure
1647240|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
1647241|NCT00211068|Erythropoietin|erythropoietin
1647242|NCT00211068|Kidney disease|kidney disease
1647243|NCT00211068|Anemia|anemia
1647244|NCT00211055|Critically Ill|critically ill
1647245|NCT00211055|Intensive Care Unit|intensive care unit
1647246|NCT00211055|Blood transfusion|blood transfusion
1647247|NCT00211055|Blood loss|blood loss
1647248|NCT00211055|Pediatric|pediatric
1647249|NCT00211055|Children|children
1647250|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
1647251|NCT00211055|Hemoglobin|hemoglobin
1647252|NCT00211055|Transfusion|transfusion
1647253|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
1647254|NCT00211042|Anemia|anemia
1647255|NCT00211042|Red blood cells|red blood cells
1647256|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
1647257|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
1647258|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
1647259|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
1647260|NCT00211029|Epoetin|epoetin
1647261|NCT00211029|erythropoietin|erythropoietin
1647262|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
1647263|NCT00211029|Chronic Renal Failure|chronic renal failure
1647264|NCT00211029|Kidney Failure|kidney failure
1647265|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1647266|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
1647267|NCT00211003|Mechanical Ventilation|mechanical ventilation
1647268|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
1647269|NCT00210990|Pyelonephritis|pyelonephritis
1647270|NCT00210977|Anemia|anemia
1647271|NCT00210977|Erythropoietin|erythropoietin
1647272|NCT00210977|Epoetin alfa|epoetin alfa
1647273|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
1647274|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
1647275|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
1647276|NCT00210977|Pure red cell aplasia|pure red cell aplasia
1647277|NCT00210977|Darbepoetin|darbepoetin
1647278|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
1647279|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
1647280|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
1647281|NCT00210964|Cephalosporins|cephalosporins
1647282|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
1647283|NCT00210951|Epoetin alfa|epoetin alfa
1647284|NCT00210951|Erythropoietin|erythropoietin
1647285|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
1647286|NCT00210951|Chronic Renal Failure|chronic renal failure
1647287|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
1647288|NCT00210938|Appendicitis|appendicitis
1647289|NCT00210938|Cholecystitis|cholecystitis
1647290|NCT00210938|Peritonitis|peritonitis
1647292|NCT00210925|alcohol dependence|alcohol dependence
1647293|NCT00210925|medication treatment.|medication treatment.
1647294|NCT00210912|prevention|prevention
1647295|NCT00210912|Migraine|migraine
1647296|NCT00210912|chronic|chronic
1647297|NCT00210912|headache|headache
1647298|NCT00210899|Complicated Skin Infections|complicated skin infections
1647299|NCT00210899|Infectious Skin Diseases|infectious skin diseases
1647300|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
1647301|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
1647302|NCT00210899|Cephalosporin|cephalosporin
1647303|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
1647304|NCT00210886|urinary tract infection|urinary tract infection
1647305|NCT00210886|acute pyelonephritis|acute pyelonephritis
1647306|NCT00210886|pyelonephritis|pyelonephritis
1647307|NCT00210886|kidney infection|kidney infection
1647308|NCT00210886|bladder infection|bladder infection
1647309|NCT00210873|Migraine|migraine
1647310|NCT00210873|headache|headache
1647311|NCT00210873|chronic|chronic
1647312|NCT00210873|prevention|prevention
1647313|NCT00210860|chronic|chronic
1647314|NCT00210860|headache|headache
1647315|NCT00210860|prevention|prevention
1647316|NCT00210860|Migraine|migraine
1647317|NCT00210847|peripheral neuropathy|peripheral neuropathy
1647318|NCT00210847|Diabetic neuropathy|diabetic neuropathy
1647319|NCT00210847|pain|pain
1647320|NCT00210847|diabetes|diabetes
1647321|NCT00210847|extremities|extremities
1647322|NCT00210847|neuropathy|neuropathy
1647323|NCT00210847|diabetic|diabetic
1647324|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
1647325|NCT00210821|migraine|migraine
1647326|NCT00210821|headache|headache
1647327|NCT00210821|analgesics|analgesics
1647328|NCT00210821|prophylaxis|prophylaxis
1647329|NCT00210821|prevention|prevention
1647330|NCT00210808|Binge-Eating Disorder|binge-eating disorder
1647331|NCT00210808|medication treatment|medication treatment
1647332|NCT00210808|obesity|obesity
1647333|NCT00210808|bingeing|bingeing
1647334|NCT00210795|Anemia|anemia
1647335|NCT00210795|Subcutaneous injection|subcutaneous injection
1647336|NCT00210795|PROCRIT|procrit
1647337|NCT00210795|Erythropoietin|erythropoietin
1647338|NCT00210795|Epoetin Alfa|epoetin alfa
1647339|NCT00210795|Hemoglobin Level|hemoglobin level
1647340|NCT00210795|Elderly|elderly
1647341|NCT00210782|epilepsy|epilepsy
1647342|NCT00210782|seizures|seizures
1647343|NCT00210782|epileptic seizures|epileptic seizures
1647344|NCT00210782|complex partial seizures|complex partial seizures
1647345|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
1647346|NCT00210769|schizophrenia|schizophrenia
1647347|NCT00210769|extended release|extended release
1647348|NCT00210769|oral administration|oral administration
1647349|NCT00210769|antipsychotic agents|antipsychotic agents
1647350|NCT00210769|dementia praecox|dementia praecox
1647351|NCT00210769|mental disorders|mental disorders
1647352|NCT00210769|paliperidone|paliperidone
1647353|NCT00210769|PANSS|panss
1647354|NCT00210756|Anemia|anemia
1647355|NCT00210756|pharmacokinetics|pharmacokinetics
1647356|NCT00210756|erythropoetin|erythropoetin
1647357|NCT00210756|Epoetin alfa|epoetin alfa
1647358|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
1647359|NCT00210756|Critical care|critical care
1647360|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
1647361|NCT00210743|Anemia|anemia
1647362|NCT00210743|chronic kidney disease|chronic kidney disease
1647363|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
1647364|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
1647365|NCT00210743|pre-dialysis|pre-dialysis
1647366|NCT00210730|Anemia|anemia
1647367|NCT00210730|Neoplasm|neoplasm
1647368|NCT00210730|Hemoglobin Level|hemoglobin level
1647369|NCT00210717|schizophrenia|schizophrenia
1647370|NCT00210717|intramuscular injection|intramuscular injection
1647371|NCT00210717|antipsychotic agents|antipsychotic agents
1647372|NCT00210717|risperidone|risperidone
1647373|NCT00210717|paliperidone palmitate|paliperidone palmitate
1647374|NCT00210717|dementia praecox|dementia praecox
1647375|NCT00210717|mental disorders|mental disorders
1647376|NCT00210717|PANSS|panss
1647377|NCT00210704|dapoxetine|dapoxetine
1647378|NCT00210704|premature ejaculation|premature ejaculation
1647379|NCT00210704|ejaculation|ejaculation
1647380|NCT00210704|sexual dysfunction|sexual dysfunction
1647381|NCT00210704|orgasmic disorder|orgasmic disorder
1647382|NCT00210704|sexual intercourse|sexual intercourse
1647383|NCT00210691|Schizophrenia|schizophrenia
1647384|NCT00210691|intramuscular injection|intramuscular injection
1647385|NCT00210691|psychotropic agents|psychotropic agents
1647386|NCT00210691|long-acting risperidone|long-acting risperidone
1647387|NCT00210678|Erectile Dysfunction|erectile dysfunction
1647388|NCT00210678|Dapoxetine|dapoxetine
1647389|NCT00210678|Premature ejaculation|premature ejaculation
1647390|NCT00210678|Ejaculation|ejaculation
1647391|NCT00210678|Sexual dysfunction|sexual dysfunction
1647392|NCT00210678|Orgasmic disorder|orgasmic disorder
1647393|NCT00210665|Sarcoma|sarcoma
1647394|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
1647395|NCT00210665|Standard care|standard care
1647396|NCT00210665|Trabectedin|trabectedin
1647397|NCT00210665|Antitumor agent|antitumor agent
1647398|NCT00210665|Safety|safety
1647399|NCT00210652|Epilepsy|epilepsy
1647400|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
1647401|NCT00210652|seizure disorder|seizure disorder
1647402|NCT00210652|antiepileptic drugs|antiepileptic drugs
1647403|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
1647404|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
1647405|NCT00210639|Childhood Disease|childhood disease
1647406|NCT00210639|Bone Diseases|bone diseases
1647407|NCT00210639|Joint Diseases|joint diseases
1647408|NCT00210639|Levofloxacin|levofloxacin
1647409|NCT00210639|Quinolones|quinolones
1647410|NCT00210639|Bacterial infections|bacterial infections
1647411|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
1647412|NCT00210613|dapoxetine|dapoxetine
1647413|NCT00210613|premature ejaculation|premature ejaculation
1647414|NCT00210613|sexual dysfunction|sexual dysfunction
1647415|NCT00210613|orgasmic disorder|orgasmic disorder
1647416|NCT00210613|sexual intercourse|sexual intercourse
1647417|NCT00210613|ejaculation|ejaculation
1647418|NCT00210600|Anemia|anemia
1647419|NCT00210600|Hemoglobin level|hemoglobin level
1647420|NCT00210587|Anemia|anemia
1647421|NCT00210587|Neoplasms|neoplasms
1647422|NCT00210587|hemoglobin level|hemoglobin level
1647423|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
1647424|NCT00210574|epilepsy|epilepsy
1647425|NCT00210574|seizures|seizures
1647426|NCT00210574|absence seizures|absence seizures
1647427|NCT00210561|Pain|pain
1647428|NCT00210561|Acute Low Back Pain|acute low back pain
1647429|NCT00210561|Back|back
1647430|NCT00210561|Lower back|lower back
1647431|NCT00210548|schizophrenia|schizophrenia
1647432|NCT00210548|intramuscular injection|intramuscular injection
1647433|NCT00210548|antipsychotic agents|antipsychotic agents
1647434|NCT00210548|dementia praecox|dementia praecox
1647435|NCT00210548|paliperidone palmitate|paliperidone palmitate
1647436|NCT00210548|mental disorders|mental disorders
1647437|NCT00210548|PANSS.|panss.
1647438|NCT00210535|Topiramate|topiramate
1647439|NCT00210535|Migraine|migraine
1647440|NCT00210535|Migraine headache|migraine headache
1647441|NCT00210535|Migraine prevention|migraine prevention
1647442|NCT00210535|Pediatric|pediatric
1647443|NCT00210522|RWJ-333369|rwj-333369
1647444|NCT00210522|Anticonvulsants|anticonvulsants
1647445|NCT00210522|Epilepsy|epilepsy
1647446|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
1647447|NCT00210522|Seizure disorder|seizure disorder
1647448|NCT00210522|Antiepileptic drugs|antiepileptic drugs
1647449|NCT00210509|aura|aura
1647450|NCT00210509|Migraine|migraine
1647451|NCT00210509|pain|pain
1647452|NCT00210509|headache|headache
1647453|NCT00210496|Migraine headache|migraine headache
1647454|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
1647455|NCT00210483|pain|pain
1647456|NCT00210483|Migraine|migraine
1647457|NCT00210483|aura|aura
1647458|NCT00210483|headache|headache
1647459|NCT00210470|Head and Neck Cancer|head and neck cancer
1647460|NCT00210470|Immunotherapy|immunotherapy
1647461|NCT00210470|IRX-2|irx-2
1647462|NCT00210470|Mouth Cancer|mouth cancer
1647463|NCT00210470|Throat Cancer|throat cancer
1647464|NCT00210418|Malnutrition|malnutrition
1647465|NCT00210418|Infant nutrition|infant nutrition
1647466|NCT00210418|Food, fortified|food, fortified
1647467|NCT00210418|Growth|growth
1647468|NCT00210418|Randomized controlled trials|randomized controlled trials
1647469|NCT00210418|Evaluation studies|evaluation studies
1647470|NCT00210418|Haiti|haiti
1647471|NCT00210405|Anemia|anemia
1647472|NCT00210405|Infant nutrition|infant nutrition
1647473|NCT00210405|Dietary supplements|dietary supplements
1647474|NCT00210405|Randomized controlled trials|randomized controlled trials
1647475|NCT00210405|Evaluation studies|evaluation studies
1647476|NCT00210405|Haiti|haiti
1647478|NCT00210301|cognition|cognition
1647479|NCT00210301|attention|attention
1647480|NCT00210301|fatigue|fatigue
1647481|NCT00210288|Healthy Volunteer|healthy volunteer
1647482|NCT00210288|Shigella|shigella
1647483|NCT00210288|Oral Vaccine|oral vaccine
1647484|NCT00210288|Double Blind|double blind
1647485|NCT00210288|Placebo|placebo
1647486|NCT00210288|Immunogenicity|immunogenicity
1647490|NCT00210249|geriatric evaluation|geriatric evaluation
1647491|NCT00210249|safety|safety
1647492|NCT00210249|chemotherapy|chemotherapy
1647493|NCT00210236|Breast neoplasms|breast neoplasms
1647494|NCT00210236|Local recurrence|local recurrence
1647495|NCT00210236|Survival|survival
1647496|NCT00210236|Surgery|surgery
1647497|NCT00210223|Radiofrequency|radiofrequency
1647691|NCT00209339|EVEREST I|everest i
1647498|NCT00210223|Percutaneous technique|percutaneous technique
1647499|NCT00210223|breast cancer|breast cancer
1647500|NCT00210223|tolerance|tolerance
1647501|NCT00210210|Post-operative-pain|post-operative-pain
1647502|NCT00210210|Breast cancer|breast cancer
1647503|NCT00210210|Morphine|morphine
1647504|NCT00210210|Analgesia|analgesia
1647505|NCT00210197|Hypercoagulability|hypercoagulability
1647506|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
1647507|NCT00210197|Breast cancer|breast cancer
1647508|NCT00210184|Chemotherapy|chemotherapy
1647509|NCT00210184|gastric cancer|gastric cancer
1647510|NCT00210184|geriatric evaluation|geriatric evaluation
1647511|NCT00210184|efficacy|efficacy
1647512|NCT00210184|safety|safety
1647513|NCT00210171|Carcinoma|carcinoma
1647514|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
1647515|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
1647516|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
1647517|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
1647518|NCT00210158|Current opioid treatment|current opioid treatment
1647519|NCT00210158|Nitrous oxide|nitrous oxide
1647520|NCT00210158|Chronic pain|chronic pain
1647521|NCT00210158|Opioid therapy|opioid therapy
1647522|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
1647523|NCT00210158|Acute opioid tolerance|acute opioid tolerance
1647524|NCT00210145|Aesthetic care,|aesthetic care,
1647525|NCT00210145|Mastectomy,|mastectomy,
1647526|NCT00210145|Breast cancer,|breast cancer,
1647527|NCT00210145|Quality of life,|quality of life,
1647528|NCT00210145|Body image,|body image,
1647529|NCT00210145|Psychological adjustment|psychological adjustment
1647530|NCT00210132|Thoracic surgery|thoracic surgery
1647531|NCT00210132|postoperative pain|postoperative pain
1647532|NCT00210132|ropivacaine|ropivacaine
1647533|NCT00210132|inter pleural analgesia|inter pleural analgesia
1647534|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
1647535|NCT00210119|imatinib mesylate|imatinib mesylate
1647536|NCT00210119|zoledronate|zoledronate
1647537|NCT00210119|molecular response|molecular response
1647538|NCT00210106|Radiofrequency ablation|radiofrequency ablation
1647539|NCT00210106|Colorectal cancer|colorectal cancer
1647540|NCT00210106|Liver metastases|liver metastases
1647541|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
1647542|NCT00210028|Breast Neoplasms|breast neoplasms
1647543|NCT00210028|Zarnestra|zarnestra
1647544|NCT00210028|Tamoxifen|tamoxifen
1647545|NCT00210028|estrogen receptor|estrogen receptor
1647546|NCT00210028|progesterone receptor|progesterone receptor
1647547|NCT00210002|Neoplasms|neoplasms
1647548|NCT00210002|Solid|solid
1647549|NCT00210002|Anemia|anemia
1647550|NCT00210002|darbepoetin alfa|darbepoetin alfa
1647551|NCT00210002|ferric saccharose|ferric saccharose
1647552|NCT00210002|Venofer®|venofer®
1647553|NCT00210002|Aranesp®|aranesp®
1647554|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
1647555|NCT00209989|Zarnestra|zarnestra
1647556|NCT00209989|Radiation therapy|radiation therapy
1647557|NCT00209963|Primary insomnia|primary insomnia
1647558|NCT00209950|Primary insomnia|primary insomnia
1647559|NCT00209937|Primary insomnia|primary insomnia
1647560|NCT00209924|Primary insomnia|primary insomnia
1647561|NCT00209911|atrial volume|atrial volume
1647562|NCT00209911|ventricular volume|ventricular volume
1647563|NCT00209911|atrial function|atrial function
1647564|NCT00209911|ventricular function|ventricular function
1647565|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
1647566|NCT00209911|cardioversion|cardioversion
1647567|NCT00209911|natriuretic peptides|natriuretic peptides
1647568|NCT00209898|Chronic hepatits C|chronic hepatits c
1647569|NCT00209898|peginterferon|peginterferon
1647570|NCT00209898|ribavirin|ribavirin
1647571|NCT00209898|inmate|inmate
1647572|NCT00209898|fast initiation procedure|fast initiation procedure
1647573|NCT00209846|Primary insomnia|primary insomnia
1647574|NCT00209820|low back pain|low back pain
1647575|NCT00209820|randomized clinical trial|randomized clinical trial
1647576|NCT00209820|Nordic walking|nordic walking
1647577|NCT00209820|supervision|supervision
1647578|NCT00209820|Advice to stay active|advice to stay active
1647579|NCT00209807|major depression|major depression
1647580|NCT00209807|pain|pain
1647581|NCT00209807|escitalopram|escitalopram
1647582|NCT00209807|reboxetine|reboxetine
1647583|NCT00209807|visceral sensitivity|visceral sensitivity
1647584|NCT00209807|somatic sensitivity|somatic sensitivity
1647585|NCT00209768|pediatric intensive care|pediatric intensive care
1647586|NCT00209768|critically ill children|critically ill children
1647587|NCT00209768|in-line filtration|in-line filtration
1647588|NCT00209768|prospective randomized study|prospective randomized study
1647589|NCT00209768|complications|complications
1647590|NCT00209768|sepsis|sepsis
1647591|NCT00209768|SIRS|sirs
1647592|NCT00209768|thrombosis|thrombosis
1647593|NCT00209768|organ failure|organ failure
1647594|NCT00209755|chronic hepatitis C|chronic hepatitis c
1647595|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
1647596|NCT00209729|Docetaxel|docetaxel
1647598|NCT00209729|Elderly Patients|elderly patients
1647599|NCT00209729|Gastric cancer|gastric cancer
1647600|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
1647601|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
1647602|NCT00209638|Irinotecan,|irinotecan,
1647604|NCT00209638|Phase I/II,|phase i/ii,
1647605|NCT00209638|gastric cancer|gastric cancer
1647606|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
1647607|NCT00209599|Colonoscopy|colonoscopy
1647608|NCT00209599|Seadation|seadation
1647609|NCT00209586|Bronchoscopy|bronchoscopy
1647610|NCT00209586|Sedation|sedation
1647611|NCT00209573|Colonoscopy|colonoscopy
1647612|NCT00209573|Sedation|sedation
1647613|NCT00209560|AQUAVAN® Injection|aquavan® injection
1647614|NCT00209560|Midazolam|midazolam
1647615|NCT00209560|Minor surgical procedures|minor surgical procedures
1647616|NCT00209560|Sedation|sedation
1647617|NCT00209547|AQUAVAN® Injection|aquavan® injection
1647618|NCT00209547|Midazolam|midazolam
1647619|NCT00209547|Angioplasty|angioplasty
1647620|NCT00209547|Coronary catheterization|coronary catheterization
1647621|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
1647622|NCT00209521|AQUAVAN® Injection|aquavan® injection
1647623|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
1647624|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
1647625|NCT00209508|Parkinson's Disease|parkinson's disease
1647626|NCT00209508|SPECT Scanning|spect scanning
1647627|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
1647628|NCT00209495|Pregabalin|pregabalin
1647629|NCT00209495|Dexamethasone|dexamethasone
1647630|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
1647631|NCT00209456|Lewy Body Dementia|lewy body dementia
1647632|NCT00209456|non-DLB dementia|non-dlb dementia
1647633|NCT00209456|Dopamine Transporter|dopamine transporter
1647634|NCT00209456|Striatal Uptake|striatal uptake
1647635|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
1647636|NCT00209443|Occlusion|occlusion
1647637|NCT00209443|Diagnostic Imaging|diagnostic imaging
1647638|NCT00209443|Omniscan|omniscan
1647639|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
1647640|NCT00209443|Contrast Media|contrast media
1647641|NCT00209430|Iodixanol|iodixanol
1647642|NCT00209430|Iopamidol|iopamidol
1647643|NCT00209430|coronary angiography|coronary angiography
1647644|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
1647645|NCT00209417|Iodixanol|iodixanol
1647646|NCT00209417|Iopamidol|iopamidol
1647647|NCT00209417|computed tomography|computed tomography
1647648|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
1647649|NCT00209404|MDCT|mdct
1647650|NCT00209404|Coronary Artery|coronary artery
1647651|NCT00209404|Heart Rate|heart rate
1647652|NCT00209404|Image Quality|image quality
1647653|NCT00209404|Diagnostic Quality|diagnostic quality
1647654|NCT00209391|Renal Artery Stenosis|renal artery stenosis
1647655|NCT00209391|Occlusion|occlusion
1647656|NCT00209391|Diagnostic Imaging|diagnostic imaging
1647657|NCT00209391|Omniscan|omniscan
1647658|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
1647659|NCT00209391|Contrast Media|contrast media
1647660|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
1647661|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
1647662|NCT00209378|Acute Kidney Injury|acute kidney injury
1647663|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
1647664|NCT00209378|filter survival|filter survival
1647665|NCT00209378|trisodium citrate|trisodium citrate
1647666|NCT00209378|bleeding complication|bleeding complication
1647667|NCT00209378|Hemofiltration|hemofiltration
1647668|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
1647669|NCT00209352|VZV infection|vzv infection
1647670|NCT00209352|Oral Acyclovir|oral acyclovir
1647671|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
1647672|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
1647673|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
1647674|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
1647675|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
1647676|NCT00209339|Mitral Regurgitation|mitral regurgitation
1647677|NCT00209339|Mitral Insufficiency|mitral insufficiency
1647678|NCT00209339|Mitral Valve|mitral valve
1647679|NCT00209339|MR|mr
1647680|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
1647681|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
1647682|NCT00209339|Alfieri Technique|alfieri technique
1647683|NCT00209339|MitraClip|mitraclip
1647684|NCT00209339|Functional MR|functional mr
1647685|NCT00209339|Degenerative MR|degenerative mr
1647686|NCT00209339|Echocardiogram|echocardiogram
1647687|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
1647688|NCT00209339|Heart Failure|heart failure
1647689|NCT00209339|Heart Attack|heart attack
1647690|NCT00209339|EVEREST|everest
1647692|NCT00209339|EVEREST II|everest ii
1647694|NCT00209313|HSV-2|hsv-2
1647695|NCT00209313|Coinfection|coinfection
1647696|NCT00209313|Africa|africa
1647697|NCT00209313|Cameroon|cameroon
1647698|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
1647699|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
1647700|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
1647701|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
1647702|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
1647703|NCT00209274|Mitral Regurgitation|mitral regurgitation
1647704|NCT00209274|Mitral Insufficiency|mitral insufficiency
1647705|NCT00209274|Mitral Valve|mitral valve
1647706|NCT00209274|MR|mr
1647707|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
1647708|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
1647709|NCT00209274|Alfieri Technique|alfieri technique
1647710|NCT00209274|MitraClip|mitraclip
1647711|NCT00209274|Functional MR|functional mr
1647712|NCT00209274|Degenerative MR|degenerative mr
1647713|NCT00209274|Echocardiogram|echocardiogram
1647714|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
1647715|NCT00209274|Heart Failure|heart failure
1647716|NCT00209274|Heart Attack|heart attack
1647717|NCT00209274|EVEREST|everest
1647718|NCT00209274|EVEREST I|everest i
1647719|NCT00209274|EVEREST II|everest ii
1647720|NCT00209274|REALISM|realism
1647721|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
1647722|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
1647723|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
1647724|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1647725|NCT00209222|younger patients|younger patients
1647726|NCT00209222|chemotherapy|chemotherapy
1647727|NCT00209222|high dose therapy|high dose therapy
1647728|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
1647729|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
1647730|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
1647731|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
1647732|NCT00209209|Elderly patients|elderly patients
1647733|NCT00209209|Chemotherapy|chemotherapy
1647734|NCT00209209|Maintenance therapy|maintenance therapy
1647735|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
1647736|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
1647737|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
1647738|NCT00209196|pediatric|pediatric
1647739|NCT00209196|transplantation|transplantation
1647740|NCT00209196|psychosocial|psychosocial
1647741|NCT00209196|kidney transplant recipient|kidney transplant recipient
1647742|NCT00209196|liver transplant recipient|liver transplant recipient
1647743|NCT00209196|heart transplant recipient|heart transplant recipient
1647744|NCT00209196|lung transplant recipient|lung transplant recipient
1647745|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
1647746|NCT00209144|Inflammation|inflammation
1647747|NCT00209144|Thrombosis|thrombosis
1647748|NCT00209144|Hyperglycemia|hyperglycemia
1647749|NCT00209144|Myocardial Infarction|myocardial infarction
1647750|NCT00209144|Angioplasty|angioplasty
1647751|NCT00209131|urolithiasis|urolithiasis
1647752|NCT00209118|Hepatitis C|hepatitis c
1647753|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
1647754|NCT00209118|Antidepressants|antidepressants
1647755|NCT00209118|Prevention|prevention
1647756|NCT00209105|Child Abuse|child abuse
1647757|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
1647758|NCT00209105|Brain Imaging|brain imaging
1647759|NCT00209105|Depression|depression
1647760|NCT00209092|Breast Cancer|breast cancer
1647761|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
1647762|NCT00209066|Major Depressive Disorder|major depressive disorder
1647763|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
1647764|NCT00209066|Platelet Activation|platelet activation
1647765|NCT00209040|PTSD|ptsd
1647766|NCT00209040|Acoustic startle|acoustic startle
1647767|NCT00209027|schizophrenia|schizophrenia
1647768|NCT00209027|reward|reward
1647769|NCT00209027|fMRI|fmri
1647770|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
1647771|NCT00209014|Hodgkin's Disease|hodgkin's disease
1647772|NCT00209001|Breast Cancer|breast cancer
1647773|NCT00208988|Health literacy|health literacy
1647774|NCT00208988|Physician-Patient Relationship|physician-patient relationship
1647775|NCT00208988|Prostate Cancer|prostate cancer
1647776|NCT00208975|Lymphoma|lymphoma
1647777|NCT00208962|Hematologic Diseases|hematologic diseases
1647778|NCT00208949|Hematologic Diseases|hematologic diseases
1647779|NCT00208936|Esophageal Diseases|esophageal diseases
1647780|NCT00208923|Hematologic Malignancies|hematologic malignancies
1647781|NCT00208910|Anxiety|anxiety
1647782|NCT00208910|Mental Health|mental health
1647783|NCT00208897|Early Life Stress|early life stress
1647784|NCT00208897|HPA-axis|hpa-axis
1647785|NCT00208897|CRF|crf
1647786|NCT00208884|pediatric|pediatric
1647787|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
1647788|NCT00208884|graft failure|graft failure
1647789|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
1647790|NCT00208871|Breast cancer detection|breast cancer detection
1647791|NCT00208871|Reduced rate of recall|reduced rate of recall
1647792|NCT00208871|Focal abnormalities detection|focal abnormalities detection
1647793|NCT00208832|Medication Compliance|medication compliance
1647794|NCT00208832|Health Literacy|health literacy
1647795|NCT00208819|Alzheimer's Disease|alzheimer's disease
1647796|NCT00208819|Geriatric|geriatric
1647797|NCT00208819|Dementia|dementia
1647798|NCT00208819|Agitation|agitation
1647799|NCT00208819|Behavioral Disturbances|behavioral disturbances
1647800|NCT00208819|Psychosis|psychosis
1647801|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
1647802|NCT00208806|Pediatric|pediatric
1647803|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
1647804|NCT00208793|colonic polyps|colonic polyps
1647805|NCT00208793|adenomatous polyps|adenomatous polyps
1647806|NCT00208793|colon cancer prevention|colon cancer prevention
1647807|NCT00208793|dietary supplements|dietary supplements
1647808|NCT00208780|Oxidative Stress|oxidative stress
1647809|NCT00208780|Endothelium|endothelium
1647810|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
1647811|NCT00208767|Oxidative stress|oxidative stress
1647812|NCT00208767|Endothelial dysfunction|endothelial dysfunction
1647813|NCT00208754|heart defects|heart defects
1647814|NCT00208754|cardiology|cardiology
1647815|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
1647816|NCT00208741|Social Anxiety Disorder|social anxiety disorder
1647817|NCT00208741|Mental Health|mental health
1647818|NCT00208728|pediatric|pediatric
1647819|NCT00208728|congenital heart disease|congenital heart disease
1647820|NCT00208728|cardiac surgery|cardiac surgery
1647821|NCT00208715|Depression|depression
1647822|NCT00208702|Major Depressive Disorder|major depressive disorder
1647823|NCT00208702|Mental Health|mental health
1647824|NCT00208702|Depression|depression
1647825|NCT00208689|pediatric|pediatric
1647826|NCT00208689|congenital heart disease|congenital heart disease
1647827|NCT00208676|heart defects|heart defects
1647828|NCT00208676|pediatrics|pediatrics
1647829|NCT00208650|pediatrics|pediatrics
1647830|NCT00208650|transplant|transplant
1647831|NCT00208650|cardiac|cardiac
1647832|NCT00208637|Maori|maori
1647833|NCT00208637|insulin sensitivity|insulin sensitivity
1647834|NCT00208637|cardiovascular risk|cardiovascular risk
1647835|NCT00208637|diabetes prevention|diabetes prevention
1647836|NCT00208637|diet modification|diet modification
1647837|NCT00208624|arrhythmia|arrhythmia
1647838|NCT00208624|pediatrics|pediatrics
1647839|NCT00208624|cardiac|cardiac
1647840|NCT00208598|Maori|maori
1647841|NCT00208598|Body Composition|body composition
1647842|NCT00208598|DEXA|dexa
1647843|NCT00208598|Cardiovascular disease|cardiovascular disease
1647844|NCT00208598|Diabetes|diabetes
1647845|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
1647847|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
1647848|NCT00208559|Ziprasidone|ziprasidone
1647849|NCT00208559|Adolescents|adolescents
1647850|NCT00208546|capecitabine|capecitabine
1647851|NCT00208546|oxaliplatin|oxaliplatin
1647852|NCT00208546|bevacizumab|bevacizumab
1647853|NCT00208546|cetuximab|cetuximab
1647854|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
1647855|NCT00208533|Autism|autism
1647856|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
1647857|NCT00208533|Aripiprazole|aripiprazole
1647858|NCT00208533|Antipsychotic medication|antipsychotic medication
1647859|NCT00208533|Adolescents|adolescents
1647860|NCT00208520|Epilepsy|epilepsy
1647861|NCT00208520|Valproate|valproate
1647862|NCT00208520|Levetiracetam|levetiracetam
1647863|NCT00208520|Lamotrigine|lamotrigine
1647864|NCT00208520|Carbamazepine|carbamazepine
1647865|NCT00208507|Joint Diseases|joint diseases
1647866|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
1647867|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
1647868|NCT00208468|Hip|hip
1647869|NCT00208468|Cementless|cementless
1647870|NCT00208455|Arthroplasty|arthroplasty
1647871|NCT00208455|Replacement|replacement
1647872|NCT00208455|Hip|hip
1647873|NCT00208455|Conservative|conservative
1647874|NCT00208455|Anatomic|anatomic
1647875|NCT00208455|Cementless|cementless
1647876|NCT00208442|Hip|hip
1647877|NCT00208442|Cemented|cemented
1647878|NCT00208429|Hip|hip
1647879|NCT00208429|Cementless|cementless
1647881|NCT00208416|Surgical Technique|surgical technique
1647882|NCT00208403|Hip|hip
1647883|NCT00208403|Cement|cement
1647884|NCT00208390|Hip|hip
1647885|NCT00208390|Cementless|cementless
1647886|NCT00208377|Hip|hip
1647887|NCT00208377|Conservative|conservative
1647888|NCT00208377|Metal-on-Metal|metal-on-metal
1647889|NCT00208377|Resurfacing|resurfacing
1647891|NCT00208364|Cementless|cementless
1647892|NCT00208364|Metal-on-Metal|metal-on-metal
1647893|NCT00208351|Hip|hip
1647894|NCT00208351|Cemented|cemented
1647895|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
1647896|NCT00208312|Lexiscan|lexiscan
1647897|NCT00208312|Regadenoson|regadenoson
1647898|NCT00208312|Adenoscan®|adenoscan®
1647899|NCT00208312|Adenosine|adenosine
1647900|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
1647901|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
1647902|NCT00208299|Lexiscan|lexiscan
1647903|NCT00208299|Regadenoson|regadenoson
1647904|NCT00208299|Adenoscan®|adenoscan®
1647905|NCT00208299|Adenosine|adenosine
1647906|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
1647907|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
1647908|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
1647909|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
1647910|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
1647911|NCT00208273|Adjuvant setting|adjuvant setting
1647912|NCT00208234|asthma|asthma
1647913|NCT00208221|Hypertension|hypertension
1647914|NCT00208221|Diabetes|diabetes
1647915|NCT00208221|Microalbuminuria|microalbuminuria
1647916|NCT00208221|Blood pressure|blood pressure
1647917|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
1647918|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
1647919|NCT00208208|PTSD|ptsd
1647920|NCT00208208|Geodon|geodon
1647921|NCT00208208|Ziprasidone|ziprasidone
1647922|NCT00208195|Bipolar Disorder|bipolar disorder
1647923|NCT00208195|Mania|mania
1647924|NCT00208195|Substance Abuse|substance abuse
1647925|NCT00208195|Substance Dependence|substance dependence
1647926|NCT00208195|Comorbid|comorbid
1647927|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
1647928|NCT00208169|Comorbid diagnoses|comorbid diagnoses
1647929|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
1647930|NCT00208156|Depression|depression
1647931|NCT00208156|Major Depression|major depression
1647932|NCT00208156|Psychotic Major Depression|psychotic major depression
1647933|NCT00208156|PMD|pmd
1647934|NCT00208156|Psychosis|psychosis
1647935|NCT00208143|Cocaine Abuse|cocaine abuse
1647936|NCT00208143|Cocaine Dependence|cocaine dependence
1647937|NCT00208143|Amphetamine Abuse|amphetamine abuse
1647938|NCT00208143|Amphetamine Dependence|amphetamine dependence
1647939|NCT00208143|Schizophrenia|schizophrenia
1647940|NCT00208143|Comorbid|comorbid
1647941|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
1647942|NCT00208130|PTSD|ptsd
1647943|NCT00208130|trauma|trauma
1647944|NCT00208117|depression|depression
1647945|NCT00208117|inflammation|inflammation
1647946|NCT00208117|heart disease|heart disease
1647947|NCT00208117|randomized clinical trial|randomized clinical trial
1647948|NCT00208117|sertraline|sertraline
1647949|NCT00208117|simvastatin|simvastatin
1647950|NCT00208117|placebo|placebo
1647951|NCT00208104|Hypertension|hypertension
1647952|NCT00208104|African Americans|african americans
1647953|NCT00208104|Adherence|adherence
1647954|NCT00208104|Motivational Interviewing|motivational interviewing
1647955|NCT00208091|Myloboc|myloboc
1647956|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
1647957|NCT00208091|Focal Dystonia|focal dystonia
1647958|NCT00208091|Musicians|musicians
1647959|NCT00208091|Muscle Relaxants|muscle relaxants
1647960|NCT00208091|Motor Impairments|motor impairments
1647961|NCT00208091|Motor Performance|motor performance
1647962|NCT00208091|Tremor|tremor
1647963|NCT00208091|Abnormal Postures|abnormal postures
1647964|NCT00208078|Hypercapnia|hypercapnia
1647965|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
1647966|NCT00208065|migraine|migraine
1647967|NCT00208065|biological markers|biological markers
1647968|NCT00208065|rhinosinusitis|rhinosinusitis
1647969|NCT00208065|CGRP|cgrp
1647970|NCT00208065|histamine|histamine
1647971|NCT00208065|VIP|vip
1647972|NCT00208039|Prematurity|prematurity
1647973|NCT00208039|Lung Disease|lung disease
1647974|NCT00208039|Hyaline Membrane|hyaline membrane
1647975|NCT00208039|Surfactant|surfactant
1647976|NCT00208013|resting energy expenditure|resting energy expenditure
1647977|NCT00208013|cachexia|cachexia
1647978|NCT00208013|advanced cancer|advanced cancer
1647979|NCT00208013|advanced cancer patients|advanced cancer patients
1647980|NCT00207987|controlled hypotension|controlled hypotension
1647981|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
1647982|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
1647983|NCT00207948|Protease Inhibitors|protease inhibitors
1647984|NCT00207948|Pharmacogenetics|pharmacogenetics
1647985|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
1647986|NCT00207948|Pharmacokinetics|pharmacokinetics
1647987|NCT00207948|Pediatrics|pediatrics
1647988|NCT00207948|Treatment Experienced|treatment experienced
1647989|NCT00207935|Seizures|seizures
1647990|NCT00207935|Depakote|depakote
1647991|NCT00207935|Developmental Delay|developmental delay
1647992|NCT00207935|Mental Retardation|mental retardation
1647993|NCT00207935|Swallow|swallow
1647994|NCT00207922|cytokine|cytokine
1647995|NCT00207922|T-cell|t-cell
1647996|NCT00207922|chemokine|chemokine
1647997|NCT00207922|graft-versus-host disease|graft-versus-host disease
1647998|NCT00207909|Acute Renal Failure|acute renal failure
1647999|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
1648000|NCT00207896|Pediatric Intensive Care|pediatric intensive care
1648001|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
1648002|NCT00207883|Vascular Access|vascular access
1648003|NCT00207883|Ultrasound|ultrasound
1648004|NCT00207883|Pediatric|pediatric
1648005|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
1648006|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
1648007|NCT00207870|Orthopaedics|orthopaedics
1648008|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
1648009|NCT00207857|Scoliosis|scoliosis
1648010|NCT00207844|Selenium|selenium
1648011|NCT00207844|Oxidative stress|oxidative stress
1648012|NCT00207844|Septic shock|septic shock
1648013|NCT00207844|Sodium selenite|sodium selenite
1648014|NCT00207831|rectal cancer|rectal cancer
1648015|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
1648016|NCT00207831|UFT|uft
1648017|NCT00207831|radiochemotherapy|radiochemotherapy
1648018|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
1648019|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
1648020|NCT00207779|central venous catheter|central venous catheter
1648021|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
1648022|NCT00207779|heparin|heparin
1648023|NCT00207766|Crohn's Disease|crohn's disease
1648024|NCT00207766|infusions|infusions
1648025|NCT00207753|ascaris|ascaris
1648026|NCT00207753|trichuris|trichuris
1648027|NCT00207753|strongyloides|strongyloides
1648028|NCT00207753|hookworm|hookworm
1648029|NCT00207753|head lice|head lice
1648030|NCT00207740|Asthma|asthma
1648031|NCT00207740|Severe Persistent Asthma|severe persistent asthma
1648032|NCT00207740|Subcutaneous injections|subcutaneous injections
1648033|NCT00207740|Immunology disorder|immunology disorder
1648034|NCT00207740|Breathlesness|breathlesness
1648035|NCT00207727|Multiple Sclerosis|multiple sclerosis
1648036|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
1648037|NCT00207714|CNTO 148|cnto 148
1648038|NCT00207714|Methotrexate|methotrexate
1648039|NCT00207714|Joint pain|joint pain
1648040|NCT00207714|Arthritis|arthritis
1648041|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
1648042|NCT00207701|infusion|infusion
1648043|NCT00207688|Ulcerative Colitis|ulcerative colitis
1648044|NCT00207688|Infliximab|infliximab
1648045|NCT00207688|Remicade|remicade
1648046|NCT00207688|Safety|safety
1648047|NCT00207675|Crohn's Disease|crohn's disease
1648048|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
1648049|NCT00207662|Crohn's Disease|crohn's disease
1648050|NCT00207649|shared decision-making|shared decision-making
1648051|NCT00207649|prostate cancer screening|prostate cancer screening
1648052|NCT00207649|evidence-based medicine|evidence-based medicine
1648053|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
1648054|NCT00207649|standardized patients|standardized patients
1648055|NCT00207649|randomized controlled trial|randomized controlled trial
1648056|NCT00207649|educational intervention|educational intervention
1648057|NCT00207649|patient education|patient education
1648058|NCT00207649|physician education|physician education
1648059|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
1648060|NCT00207636|Workplace|workplace
1648061|NCT00207636|Screening|screening
1648062|NCT00207623|arthritis|arthritis
1648063|NCT00207623|self management|self management
1648064|NCT00207623|patient education|patient education
1648065|NCT00207610|Anemia|anemia
1648066|NCT00207610|Postpartum|postpartum
1648067|NCT00207610|iron|iron
1648068|NCT00207610|supplements|supplements
1648069|NCT00207571|computer|computer
1648070|NCT00207571|video|video
1648071|NCT00207571|partner notification|partner notification
1648072|NCT00207519|overweight|overweight
1648073|NCT00207519|obesity|obesity
1648074|NCT00207519|adolescent|adolescent
1648075|NCT00207506|Latino|latino
1648076|NCT00207506|Lay Health|lay health
1648077|NCT00207506|Access|access
1648078|NCT00207506|Prevention|prevention
1648079|NCT00207506|HIV Seronegativity|hiv seronegativity
1648080|NCT00207506|HIV|hiv
1648081|NCT00207493|sexually transmitted disease|sexually transmitted disease
1648082|NCT00207493|structural intervention|structural intervention
1648083|NCT00207493|behavioral intervention|behavioral intervention
1648084|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
1648085|NCT00207467|partner referral|partner referral
1648086|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
1648087|NCT00207454|Partner Referral|partner referral
1648088|NCT00207454|Social Cognitive Intervention|social cognitive intervention
1648089|NCT00207454|Partner Delivered Medication|partner delivered medication
1648090|NCT00207441|arthritis|arthritis
1648091|NCT00207441|chronic disease|chronic disease
1648092|NCT00207441|self management|self management
1648093|NCT00207441|self efficacy|self efficacy
1648094|NCT00207428|Bronchial asthma|bronchial asthma
1648095|NCT00207428|Carbamazepine|carbamazepine
1648096|NCT00207428|Efficacy|efficacy
1648097|NCT00207415|arthritis|arthritis
1648098|NCT00207415|self management|self management
1648099|NCT00207402|Hepatitis C|hepatitis c
1648100|NCT00207402|Insulin resistance|insulin resistance
1648101|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
1648102|NCT00207389|Gastric bypass surgery|gastric bypass surgery
1648103|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
1648104|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
1648105|NCT00207363|Hepatitis C|hepatitis c
1648106|NCT00207350|Brain Tumor|brain tumor
1648107|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
1648108|NCT00207337|Emphysema|emphysema
1648109|NCT00207337|Minimally invasive|minimally invasive
1648110|NCT00207311|Hepatitis C|hepatitis c
1648111|NCT00207311|Fatty Liver|fatty liver
1648112|NCT00207311|NASH|nash
1648113|NCT00207311|Steatohepatitis|steatohepatitis
1648114|NCT00207285|Police|police
1648115|NCT00207285|Sleep|sleep
1648116|NCT00207285|Fatigue|fatigue
1648117|NCT00207285|Work Hours|work hours
1648118|NCT00207285|Sleep disorder|sleep disorder
1648119|NCT00207285|Performance|performance
1648120|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
1648121|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
1648122|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
1648123|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
1648124|NCT00207272|Gastric bypass surgery|gastric bypass surgery
1648125|NCT00207259|Prostate Cancer|prostate cancer
1648126|NCT00207259|Reiki|reiki
1648127|NCT00207259|Relaxation Response|relaxation response
1648128|NCT00207259|Cognitive Restructuring|cognitive restructuring
1648129|NCT00207259|Feasibility|feasibility
1648130|NCT00207233|Weight loss|weight loss
1648131|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
1648132|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
1648133|NCT00207233|Gastric Bypass|gastric bypass
1648134|NCT00207220|heart failure|heart failure
1648135|NCT00207220|preserved ejection fraction|preserved ejection fraction
1648136|NCT00207220|vascular stiffness|vascular stiffness
1648137|NCT00207207|Alternate Site|alternate site
1648138|NCT00207207|Blood Glucose Testing|blood glucose testing
1648139|NCT00207207|Blood Sugar Testing|blood sugar testing
1648140|NCT00207207|Hemoglobin A1C|hemoglobin a1c
1648141|NCT00207181|Cancer prevention|cancer prevention
1648142|NCT00207181|Physical activity|physical activity
1648143|NCT00207181|Self-report|self-report
1648144|NCT00207181|Paper diary|paper diary
1648145|NCT00207181|Electronic|electronic
1648146|NCT00207181|Computerized|computerized
1648147|NCT00207181|Measurement|measurement
1648148|NCT00207181|PDA|pda
1648149|NCT00207181|Accelerometer|accelerometer
1648150|NCT00207142|Treatment Naive|treatment naive
1648151|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
1648152|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
1648153|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
1648154|NCT00207077|Advanced Solid Tumors|advanced solid tumors
1648155|NCT00207064|first-episode|first-episode
1648156|NCT00207064|altanserin|altanserin
1648157|NCT00207064|5-HT2A receptors|5-ht2a receptors
1648158|NCT00207064|MRI|mri
1648159|NCT00207064|fMRI|fmri
1648160|NCT00207064|PPI|ppi
1648161|NCT00207064|P300|p300
1648162|NCT00207064|P50 gating|p50 gating
1648163|NCT00207064|endophenotypes|endophenotypes
1648164|NCT00207064|vulnerability indicators|vulnerability indicators
1648165|NCT00207064|quetiapine|quetiapine
1648166|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
1648167|NCT00207038|Asthma|asthma
1648168|NCT00207038|Airway inflammation|airway inflammation
1648169|NCT00207038|Sport|sport
1648170|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
1648171|NCT00206999|Psychophysiology|psychophysiology
1648172|NCT00206999|PPI|ppi
1648173|NCT00206999|P50 suppression|p50 suppression
1648174|NCT00206999|Imipramine|imipramine
1648175|NCT00206986|Schizophrenia|schizophrenia
1648176|NCT00206986|Information processing|information processing
1648177|NCT00206986|PPI|ppi
1648178|NCT00206986|P50 gating|p50 gating
1648179|NCT00206986|P300|p300
1648180|NCT00206986|mismatch negativity|mismatch negativity
1648181|NCT00206986|clonidine|clonidine
1648182|NCT00206960|drug-naive|drug-naive
1648183|NCT00206960|epidepride|epidepride
1648184|NCT00206960|single tomography|single tomography
1648185|NCT00206960|D2 receptor|d2 receptor
1648186|NCT00206960|information processing|information processing
1648187|NCT00206960|PPI|ppi
1648906|NCT00202657|pergolide|pergolide
1648188|NCT00206960|antipsychotic treatment|antipsychotic treatment
1648189|NCT00206960|MRI|mri
1648190|NCT00206960|fMRI|fmri
1648191|NCT00206960|cognitive disturbances|cognitive disturbances
1648192|NCT00206947|Cognitive deficits|cognitive deficits
1648193|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
1648194|NCT00206947|Schizophrenia|schizophrenia
1648196|NCT00206934|P50 suppression|p50 suppression
1648197|NCT00206934|P300|p300
1648198|NCT00206934|mismatch negativity|mismatch negativity
1648199|NCT00206934|escitalopram|escitalopram
1648200|NCT00206921|Telangiectasia|telangiectasia
1648201|NCT00206921|Skin redness|skin redness
1648202|NCT00206882|sunburn|sunburn
1648203|NCT00206882|corticosteroids|corticosteroids
1648204|NCT00206791|bone substitutes|bone substitutes
1648205|NCT00206791|Bone Replacement Materials|bone replacement materials
1648206|NCT00206791|bone void filler|bone void filler
1648207|NCT00206791|Grafting, Bone|grafting, bone
1648208|NCT00206791|Bone Cysts|bone cysts
1648209|NCT00206778|Mixed mania|mixed mania
1648210|NCT00206778|Bipolar Disorder|bipolar disorder
1648211|NCT00206765|panic|panic
1648212|NCT00206739|Malaria|malaria
1648213|NCT00206739|Anemia|anemia
1648214|NCT00206739|IPTi|ipti
1648215|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
1648216|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
1648217|NCT00206739|Chemoprophylaxis|chemoprophylaxis
1648218|NCT00206739|Ghana|ghana
1648219|NCT00206713|Crohn Disease|crohn disease
1648220|NCT00206674|Morbus Crohn|morbus crohn
1648221|NCT00206674|Sargramostim|sargramostim
1648222|NCT00206674|Phase III|phase iii
1648223|NCT00206674|Placebo Controlled|placebo controlled
1648224|NCT00206661|Crohn Disease|crohn disease
1648225|NCT00206609|Cancer|cancer
1648226|NCT00206609|palliative care|palliative care
1648227|NCT00206609|dyspnoea|dyspnoea
1648228|NCT00206609|oxygen|oxygen
1648229|NCT00206570|Schizophrenia|schizophrenia
1648230|NCT00206570|Gender differences|gender differences
1648231|NCT00206570|Hormones|hormones
1648232|NCT00206570|Estradiol|estradiol
1648233|NCT00206570|PANSS|panss
1648234|NCT00206557|Schizophrenia|schizophrenia
1648235|NCT00206557|Mental Illness|mental illness
1648236|NCT00206557|Hormone Therapy|hormone therapy
1648237|NCT00206557|Post-menopausal|post-menopausal
1648238|NCT00206557|SERM|serm
1648239|NCT00206557|Raloxifene|raloxifene
1648240|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
1648241|NCT00206544|Mania|mania
1648242|NCT00206544|Anti-Estrogen|anti-estrogen
1648243|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
1648244|NCT00206544|Mood|mood
1648245|NCT00206531|HIV-1|hiv-1
1648246|NCT00206531|Naive T-cells|naive t-cells
1648247|NCT00206531|CD31|cd31
1648248|NCT00206531|Treatment Naive|treatment naive
1648249|NCT00206518|Breast|breast
1648250|NCT00206518|Cancer|cancer
1648251|NCT00206518|Taxotere|taxotere
1648252|NCT00206518|AC|ac
1648253|NCT00206518|Validation|validation
1648254|NCT00206518|Neoadjuvant|neoadjuvant
1648255|NCT00206505|Breast|breast
1648256|NCT00206505|Cancer|cancer
1648257|NCT00206505|Neoadjuvant|neoadjuvant
1648258|NCT00206505|Taxotere|taxotere
1648259|NCT00206492|Breast|breast
1648260|NCT00206492|Cancer|cancer
1648261|NCT00206492|Neoadjuvant|neoadjuvant
1648262|NCT00206492|HER2|her2
1648263|NCT00206492|Overexpressing|overexpressing
1648264|NCT00206466|neoadjuvant|neoadjuvant
1648265|NCT00206466|chemosensitivity|chemosensitivity
1648266|NCT00206466|chemotherapy|chemotherapy
1648267|NCT00206466|breast cancer|breast cancer
1648268|NCT00206466|tumor|tumor
1648269|NCT00206466|taxotere|taxotere
1648270|NCT00206466|AC|ac
1648271|NCT00206453|Breast|breast
1648272|NCT00206453|Cancer|cancer
1648273|NCT00206453|Gene|gene
1648274|NCT00206453|Expression|expression
1648275|NCT00206453|Taxotere|taxotere
1648276|NCT00206440|chemotherapy|chemotherapy
1648277|NCT00206440|nausea|nausea
1648278|NCT00206440|vomiting|vomiting
1648279|NCT00206440|breast cancer|breast cancer
1648280|NCT00206427|Advanced|advanced
1648281|NCT00206427|Breast|breast
1648282|NCT00206427|Cancer|cancer
1648283|NCT00206427|Neoadjuvant|neoadjuvant
1648284|NCT00206427|HER2|her2
1648285|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
1648286|NCT00206401|Adolescents|adolescents
1648287|NCT00206401|Lantus|lantus
1648288|NCT00206388|NEUROBLASTOMA|neuroblastoma
1648289|NCT00206388|RECURRENT|recurrent
1648290|NCT00206388|REFRACTORY|refractory
1648291|NCT00206388|CORTICAL|cortical
1648292|NCT00206388|BONE|bone
1648293|NCT00206375|Hypothyroidism|hypothyroidism
1648294|NCT00206375|Growth hormone|growth hormone
1648295|NCT00206362|Depression|depression
1648296|NCT00206362|Socioeconomic status|socioeconomic status
1648297|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
1648298|NCT00206362|Children|children
1648299|NCT00206362|Adolescents|adolescents
1648300|NCT00206349|Depression|depression
1648301|NCT00206349|Socioeconomic status|socioeconomic status
1648302|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
1648303|NCT00206349|Children|children
1648304|NCT00206349|Adolescents|adolescents
1648305|NCT00206297|Type 1 diabetes|type 1 diabetes
1648306|NCT00206297|hypoglycemia|hypoglycemia
1648307|NCT00206297|hyperglycemia|hyperglycemia
1648308|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
1648309|NCT00206271|whiplash injuries|whiplash injuries
1648310|NCT00206271|neck pain|neck pain
1648311|NCT00206271|exercise movement techniques|exercise movement techniques
1648312|NCT00206271|immobilisation|immobilisation
1648313|NCT00206258|type 1 diabetes|type 1 diabetes
1648314|NCT00206258|hypoglycemia|hypoglycemia
1648315|NCT00206258|hyperglycemia|hyperglycemia
1648316|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
1648317|NCT00206232|Diastolic Heart Failure|diastolic heart failure
1648318|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1648319|NCT00206193|termination of pregnancy|termination of pregnancy
1648320|NCT00206141|Bipolar disorder|bipolar disorder
1648321|NCT00206141|bipolar depression|bipolar depression
1648322|NCT00206141|depression|depression
1648323|NCT00206128|Schizophrenia|schizophrenia
1648324|NCT00206115|Schizophrenic disorder|schizophrenic disorder
1648325|NCT00206102|Schizophrenia|schizophrenia
1648326|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
1648327|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
1648328|NCT00206076|Liver transplantation|liver transplantation
1648329|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
1648330|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
1648331|NCT00206076|Immunosuppression side effects|immunosuppression side effects
1648332|NCT00206076|Graft rejection|graft rejection
1648333|NCT00206037|Tibia osteotomy|tibia osteotomy
1648334|NCT00206037|Bone healing|bone healing
1648335|NCT00206037|Bone filler|bone filler
1648336|NCT00206037|Equine Protein|equine protein
1648337|NCT00206037|COLLOSS E|colloss e
1648338|NCT00206037|TomoFix|tomofix
1648339|NCT00206011|Condylar neck|condylar neck
1648340|NCT00206011|fractures|fractures
1648341|NCT00206011|endoscopic|endoscopic
1648342|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
1648343|NCT00205998|Locking Compression Plate|locking compression plate
1648344|NCT00205998|Conservative treatment|conservative treatment
1648345|NCT00205998|Surgical treatment|surgical treatment
1648346|NCT00205998|Radius fractures|radius fractures
1648347|NCT00205998|AO 23|ao 23
1648348|NCT00205985|Return to work|return to work
1648349|NCT00205985|Scaphoid fracture|scaphoid fracture
1648350|NCT00205985|Operative treatment|operative treatment
1648351|NCT00205985|Activity level|activity level
1648352|NCT00205972|Fractures|fractures
1648353|NCT00205972|Humerus|humerus
1648354|NCT00205972|Conservative treatment|conservative treatment
1648355|NCT00205972|Operative treatment|operative treatment
1648356|NCT00205959|Humerus|humerus
1648357|NCT00205959|Fractures|fractures
1648358|NCT00205959|Locking Plates|locking plates
1648359|NCT00205959|Nail System|nail system
1648360|NCT00205946|Reward Processing|reward processing
1648361|NCT00205946|Wellbutrin|wellbutrin
1648362|NCT00205946|Bupropion|bupropion
1648363|NCT00205933|Depression|depression
1649080|NCT00201981|dry eye|dry eye
1648364|NCT00205933|Bipolar Disorder|bipolar disorder
1648365|NCT00205933|Reward Processing|reward processing
1648366|NCT00205920|emphysema|emphysema
1648367|NCT00205920|pulmonary emphysema|pulmonary emphysema
1648368|NCT00205920|COPD|copd
1648369|NCT00205920|COLD|cold
1648370|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1648371|NCT00205907|BLVR|blvr
1648372|NCT00205907|emphysema|emphysema
1648373|NCT00205907|COPD|copd
1648374|NCT00205907|COLD|cold
1648375|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1648376|NCT00205907|pulmonary emphysema|pulmonary emphysema
1648377|NCT00205894|Headache|headache
1648378|NCT00205894|Chronic headache|chronic headache
1648379|NCT00205894|Migraine|migraine
1648380|NCT00205894|Pain|pain
1648381|NCT00205894|Cluster headache|cluster headache
1648382|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
1648383|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
1648384|NCT00205881|bilateral implantation|bilateral implantation
1648385|NCT00205868|Back Pain|back pain
1648386|NCT00205868|Low Back Pain|low back pain
1648387|NCT00205868|Chronic Pain|chronic pain
1648388|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
1648389|NCT00205855|Pain|pain
1648390|NCT00205855|Chronic Pain|chronic pain
1648391|NCT00205855|Neurostimulation|neurostimulation
1648392|NCT00205829|Chronic headaches|chronic headaches
1648393|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
1648394|NCT00205816|Bacterial Infections|bacterial infections
1648395|NCT00205803|Infant Vaccine|infant vaccine
1648396|NCT00205777|Osteoporosis|osteoporosis
1648397|NCT00205777|Postmenopause|postmenopause
1648398|NCT00205764|Multiple Myeloma|multiple myeloma
1648399|NCT00205764|first line tretment|first line tretment
1648400|NCT00205764|high dose chemotherapy|high dose chemotherapy
1648401|NCT00205764|stem cell transplantation|stem cell transplantation
1648402|NCT00205764|maintenance therapy|maintenance therapy
1648403|NCT00205751|Multiple Myeloma|multiple myeloma
1648404|NCT00205751|first line treatment|first line treatment
1648405|NCT00205751|thalidomide|thalidomide
1648406|NCT00205751|melphalan|melphalan
1648407|NCT00205738|Schizophrenia|schizophrenia
1648408|NCT00205738|BMI|bmi
1648409|NCT00205738|T2DM|t2dm
1648410|NCT00205725|Schizophrenia|schizophrenia
1648411|NCT00205725|BMI|bmi
1648412|NCT00205725|T2DM|t2dm
1648413|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
1648414|NCT00205712|Children|children
1648415|NCT00205712|Memory Impairment|memory impairment
1648416|NCT00205712|Decreased cognitive function|decreased cognitive function
1648417|NCT00205712|Increased memory impairment|increased memory impairment
1648418|NCT00205699|Antipsychotic treatment|antipsychotic treatment
1648419|NCT00205699|Insulin action/secretion|insulin action/secretion
1648420|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
1648421|NCT00205699|Aggression|aggression
1648422|NCT00205699|Resting metabolic rates|resting metabolic rates
1648423|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
1648424|NCT00205660|Schizophrenia|schizophrenia
1648425|NCT00205660|Obesity|obesity
1648426|NCT00205660|Hyperglycemia|hyperglycemia
1648427|NCT00205660|Dyslipidemia|dyslipidemia
1648428|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1648429|NCT00205647|Chronic Bronchitis|chronic bronchitis
1648430|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
1648431|NCT00205647|Quality of Life|quality of life
1648432|NCT00205647|Mucus|mucus
1648433|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
1648434|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
1648435|NCT00205634|airway inflammation|airway inflammation
1648436|NCT00205621|Alzheimer's disease|alzheimer's disease
1648437|NCT00205621|amyloid|amyloid
1648438|NCT00205621|PET|pet
1648439|NCT00205621|PIB|pib
1648440|NCT00205621|FDDNP|fddnp
1648441|NCT00205608|schizophrenia|schizophrenia
1648442|NCT00205608|microglia|microglia
1648443|NCT00205608|PET|pet
1648444|NCT00205595|microglia|microglia
1648445|NCT00205595|PET|pet
1648446|NCT00205595|PK11195|pk11195
1648447|NCT00205582|Traumatic Brain Injury|traumatic brain injury
1648448|NCT00205582|PET|pet
1648449|NCT00205582|microglia|microglia
1648450|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
1648451|NCT00205556|online hemodiafiltration|online hemodiafiltration
1648452|NCT00205556|low flux hemodialysis|low flux hemodialysis
1648453|NCT00205556|cardiovascular disease|cardiovascular disease
1648454|NCT00205556|endothelial dysfunction|endothelial dysfunction
1648455|NCT00205556|uremic toxicity|uremic toxicity
1648456|NCT00205556|quality of life|quality of life
1648457|NCT00205556|nutritional status|nutritional status
1648458|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
1648459|NCT00205543|airway obstruction|airway obstruction
1648460|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
1648461|NCT00205530|brain injury, family treatment|brain injury, family treatment
1648462|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
1648463|NCT00205491|depression after brain injury|depression after brain injury
1648464|NCT00205491|traumatic brain injury|traumatic brain injury
1648465|NCT00205491|Venlafaxine|venlafaxine
1648466|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
1648467|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
1648468|NCT00205387|echocardiography|echocardiography
1648469|NCT00205387|cardiac elastography|cardiac elastography
1648470|NCT00205387|Normal volunteers|normal volunteers
1648471|NCT00205309|intubated patients|intubated patients
1648472|NCT00205283|HIV|hiv
1648473|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
1648474|NCT00205270|Healthy|healthy
1648475|NCT00205231|HIV|hiv
1648476|NCT00205192|Heart Failure|heart failure
1648477|NCT00205192|Cardiac resynchronization|cardiac resynchronization
1648478|NCT00205192|echocardiography|echocardiography
1648479|NCT00205166|adenosine tracer scans|adenosine tracer scans
1648480|NCT00205166|coronary artery disease|coronary artery disease
1648481|NCT00205166|caffeine|caffeine
1648482|NCT00205153|hypertension in African Americans|hypertension in african americans
1648483|NCT00205127|Cardiac PET imaging|cardiac pet imaging
1648484|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
1648485|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
1648486|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
1648487|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
1648488|NCT00205101|Pseudoarthritis|pseudoarthritis
1648489|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
1648490|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
1648491|NCT00204997|Cervical Cancer|cervical cancer
1648492|NCT00204997|Squamous Cell|squamous cell
1648493|NCT00204997|Laparoscopy|laparoscopy
1649116|NCT00201877|Mantle Cell|mantle cell
1648494|NCT00204997|Ovarian Function|ovarian function
1648495|NCT00204984|arterial stiffness|arterial stiffness
1648496|NCT00204984|echocardiography|echocardiography
1648497|NCT00204984|nesiritide|nesiritide
1648498|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
1648503|NCT00204945|high heart pressures|high heart pressures
1648504|NCT00204945|cardiac catheterization|cardiac catheterization
1648505|NCT00204919|osteoporosis|osteoporosis
1648506|NCT00204919|vitamin D deficiency|vitamin d deficiency
1648507|NCT00204867|colorectal|colorectal
1648508|NCT00204867|polyps|polyps
1648509|NCT00204763|manometry catheters|manometry catheters
1648510|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
1648511|NCT00204763|incontinence|incontinence
1648512|NCT00204750|lower esophageal ring|lower esophageal ring
1648513|NCT00204750|dysphagia|dysphagia
1648514|NCT00204750|electrosurgical incision|electrosurgical incision
1648515|NCT00204750|bougie dilation|bougie dilation
1648516|NCT00204750|GERD|gerd
1648517|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
1648518|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
1648519|NCT00204672|Asthma|asthma
1648520|NCT00204659|Rituximab|rituximab
1648521|NCT00204659|CHOP|chop
1648522|NCT00204659|DLBCL|dlbcl
1648523|NCT00204659|gastric lymphoma|gastric lymphoma
1648524|NCT00204594|mRNA|mrna
1648525|NCT00204594|vaccination|vaccination
1648526|NCT00204594|melanoma|melanoma
1648527|NCT00204581|Melanoma|melanoma
1648528|NCT00204581|Soft tissue metastases|soft tissue metastases
1648529|NCT00204581|Interleukin-2|interleukin-2
1648530|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
1648531|NCT00204555|Imiquimod|imiquimod
1648532|NCT00204555|topical treatment|topical treatment
1648533|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
1648534|NCT00204555|Antineoplastic Agents|antineoplastic agents
1648535|NCT00204555|Interferon Inducers|interferon inducers
1648536|NCT00204542|actinic keratosis|actinic keratosis
1648537|NCT00204542|diclofenac sodium|diclofenac sodium
1648538|NCT00204529|malignant melanoma|malignant melanoma
1648539|NCT00204529|adjuvant therapy|adjuvant therapy
1648540|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
1648541|NCT00204516|vaccination|vaccination
1648542|NCT00204516|mRNA|mrna
1648543|NCT00204503|Bipolar I or II|bipolar i or ii
1648544|NCT00204503|Depression|depression
1648545|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
1648546|NCT00204503|Mental Health Issues|mental health issues
1648548|NCT00204490|isoflavones|isoflavones
1648549|NCT00204490|phytoestrogens|phytoestrogens
1648550|NCT00204490|prevention|prevention
1648551|NCT00204490|mammographic density|mammographic density
1648552|NCT00204490|bone density|bone density
1648558|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1648559|NCT00204464|Exercise|exercise
1648560|NCT00204451|emergency contraception|emergency contraception
1648561|NCT00204451|follicle|follicle
1648562|NCT00204451|ovulation|ovulation
1648563|NCT00204451|blood pressure|blood pressure
1648564|NCT00204451|Fertility Control|fertility control
1648565|NCT00204451|Inhibition of fertilization|inhibition of fertilization
1648566|NCT00204438|female contraception|female contraception
1648567|NCT00204438|oral contraceptive|oral contraceptive
1648568|NCT00204438|emergency contraceptive|emergency contraceptive
1648569|NCT00204438|ovary|ovary
1648570|NCT00204438|follicle|follicle
1648571|NCT00204438|ovulation|ovulation
1648572|NCT00204425|Osteoporosis|osteoporosis
1648573|NCT00204425|Bone|bone
1648574|NCT00204425|Exercise|exercise
1648575|NCT00204425|Soy|soy
1648576|NCT00204425|Isoflavone|isoflavone
1648577|NCT00204425|Phytoestrogen|phytoestrogen
1648578|NCT00204425|Menopause|menopause
1648579|NCT00204425|Lipids|lipids
1648580|NCT00204412|Cholesterol|cholesterol
1648581|NCT00204412|High density lipoprotein|high density lipoprotein
1648582|NCT00204412|Low density lipoprotein|low density lipoprotein
1648583|NCT00204412|Triglyceride|triglyceride
1648584|NCT00204412|Glucose|glucose
1648585|NCT00204412|Exercise|exercise
1648586|NCT00204412|Fitness|fitness
1648587|NCT00204412|Flax|flax
1648588|NCT00204412|Lignan|lignan
1648589|NCT00204412|Phytoestrogen|phytoestrogen
1648590|NCT00204412|bone|bone
1648591|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
1648592|NCT00204360|epilepsy|epilepsy
1648593|NCT00204347|risperidone|risperidone
1648594|NCT00204334|Kidney transplantation|kidney transplantation
1648595|NCT00204334|anemia|anemia
1648596|NCT00204334|vascular endothelium|vascular endothelium
1648597|NCT00204334|monocytes|monocytes
1648598|NCT00204334|apoptosis|apoptosis
1648599|NCT00204321|rejection|rejection
1648600|NCT00204321|vesselwall function|vesselwall function
1648601|NCT00204321|endothelial cell function|endothelial cell function
1648602|NCT00204321|monocytes|monocytes
1648603|NCT00204308|HIV|hiv
1648604|NCT00204308|Pregnancy|pregnancy
1648605|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
1648606|NCT00204308|Drug resistance|drug resistance
1648607|NCT00204308|Nevirapine resistance|nevirapine resistance
1648608|NCT00204308|NNRTI resistance|nnrti resistance
1648609|NCT00204295|Brain neoplasms|brain neoplasms
1648610|NCT00204295|Positron-Emission Tomography|positron-emission tomography
1648611|NCT00204295|Amino Acids|amino acids
1648612|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
1648613|NCT00204282|Diabetes prevention|diabetes prevention
1648614|NCT00204269|Hypogonadism|hypogonadism
1648615|NCT00204269|Testosterone|testosterone
1648616|NCT00204269|Substitution|substitution
1648617|NCT00204256|chronic kidney disease|chronic kidney disease
1648618|NCT00204256|anemia|anemia
1648619|NCT00204256|intravenous iron|intravenous iron
1648620|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
1648621|NCT00204243|naltrexone implant|naltrexone implant
1648622|NCT00204243|methadone|methadone
1648623|NCT00204243|inmates|inmates
1648624|NCT00204243|randomized controlled trial|randomized controlled trial
1648625|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
1648626|NCT00204230|Kidney Transplantation|kidney transplantation
1648627|NCT00204217|cardiac arrest|cardiac arrest
1648628|NCT00204217|resuscitation|resuscitation
1648629|NCT00204217|ventilation|ventilation
1648630|NCT00204217|impedance|impedance
1648631|NCT00204204|multiple trauma|multiple trauma
1648632|NCT00204204|traffic accident|traffic accident
1648633|NCT00204204|outcome|outcome
1648634|NCT00204204|safety|safety
1648635|NCT00204204|injury severity|injury severity
1648636|NCT00204191|kidney transplantation|kidney transplantation
1648637|NCT00204191|Immunosuppression|immunosuppression
1648638|NCT00204191|Cyclosporine|cyclosporine
1648639|NCT00204191|Tacrolimus|tacrolimus
1648640|NCT00204178|Kidney transplantation|kidney transplantation
1648641|NCT00204178|Reperfusion injury|reperfusion injury
1648642|NCT00204152|Early onset depression|early onset depression
1648643|NCT00204152|early adversity|early adversity
1648644|NCT00204126|exercise testing|exercise testing
1648645|NCT00204126|treadmill|treadmill
1648646|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
1648647|NCT00204126|novel methods|novel methods
1648648|NCT00204113|spinal cord injury|spinal cord injury
1648649|NCT00204113|standing|standing
1648650|NCT00204113|balance|balance
1648651|NCT00204113|functional electrical stimulation|functional electrical stimulation
1648652|NCT00204100|paraplegia|paraplegia
1648653|NCT00204100|spinal cord injury|spinal cord injury
1648654|NCT00204100|functional electrical stimulation|functional electrical stimulation
1648655|NCT00204100|cycling|cycling
1648656|NCT00204100|exercise|exercise
1648657|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
1648658|NCT00204087|Schizophrenia|schizophrenia
1648659|NCT00204087|Psychosis|psychosis
1648660|NCT00204087|Prodrome|prodrome
1648661|NCT00204087|Early Initial Prodromal State|early initial prodromal state
1648662|NCT00204087|Early Intervention|early intervention
1648663|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
1648664|NCT00204074|Migraine|migraine
1648665|NCT00204074|Menstrual cycle|menstrual cycle
1648666|NCT00204074|17 beta-estradiol|17 beta-estradiol
1648667|NCT00204074|Transdermal administration|transdermal administration
1648668|NCT00204061|schizophrenia|schizophrenia
1648669|NCT00204061|psychosis|psychosis
1648670|NCT00204061|ultra high risk|ultra high risk
1648671|NCT00204061|prodromal state|prodromal state
1648672|NCT00204061|early intervention|early intervention
1648673|NCT00204061|amisulpride|amisulpride
1648674|NCT00204048|Hospitalists|hospitalists
1648675|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
1648676|NCT00204022|Lupus nephritis|lupus nephritis
1648677|NCT00204022|Treatment|treatment
1648678|NCT00204022|Maintenance therapy|maintenance therapy
1648679|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
1648680|NCT00204022|Azathioprine|azathioprine
1648681|NCT00204009|children and adolescents|children and adolescents
1648682|NCT00204009|epidemiology|epidemiology
1648683|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
1648684|NCT00203996|metabolic syndrome|metabolic syndrome
1648685|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
1648686|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
1648687|NCT00203996|insulin resistance|insulin resistance
1648688|NCT00203970|Thrombosis|thrombosis
1648689|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
1648690|NCT00203957|Parkinson's Disease|parkinson's disease
1648691|NCT00203944|Adoption|adoption
1648692|NCT00203944|Stress Response|stress response
1648693|NCT00203944|Child Development|child development
1648694|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
1648695|NCT00203918|Prostate Cancer|prostate cancer
1648696|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
1648697|NCT00203918|Utility Assessment|utility assessment
1648698|NCT00203905|Head and Neck Cancer|head and neck cancer
1648699|NCT00203892|Adenocarcinoma|adenocarcinoma
1648700|NCT00203892|Pancreas|pancreas
1648701|NCT00203879|metastatic melanoma|metastatic melanoma
1648702|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1648703|NCT00203853|HIV|hiv
1648704|NCT00203853|HAART|haart
1648705|NCT00203853|medication adherance|medication adherance
1648706|NCT00203853|pillbox|pillbox
1648707|NCT00203853|wristwatch|wristwatch
1648708|NCT00203840|Sleep Disorders|sleep disorders
1648709|NCT00203827|Sleep Disorders|sleep disorders
1648710|NCT00203814|Malaria|malaria
1648711|NCT00203814|Efficacy|efficacy
1648712|NCT00203814|Pharmacokinetic|pharmacokinetic
1648713|NCT00203814|Gametocyte|gametocyte
1648714|NCT00203814|Molecular markers|molecular markers
1648715|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1648716|NCT00203814|Artesunate|artesunate
1648717|NCT00203814|Artemisinin|artemisinin
1648718|NCT00203801|Malaria|malaria
1648719|NCT00203801|Efficacy|efficacy
1648720|NCT00203801|Pharmacokinetic|pharmacokinetic
1648721|NCT00203801|Gametocyte|gametocyte
1648722|NCT00203801|Molecular markers|molecular markers
1648723|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1648724|NCT00203801|Artesunate|artesunate
1648725|NCT00203801|Artemisinin|artemisinin
1648726|NCT00203788|work outcome|work outcome
1648727|NCT00203788|supported employment|supported employment
1648728|NCT00203788|social skills training|social skills training
1648729|NCT00203788|risperidone|risperidone
1648730|NCT00203788|cognition|cognition
1648731|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
1648732|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
1648733|NCT00203762|antiretroviral treatment|antiretroviral treatment
1648734|NCT00203762|tuberculosis|tuberculosis
1648735|NCT00203762|childhood immunization|childhood immunization
1648736|NCT00203762|primary care|primary care
1648737|NCT00203762|resource-restricted settings|resource-restricted settings
1648738|NCT00203749|HIV|hiv
1648739|NCT00203749|Testing|testing
1648740|NCT00203749|Counseling|counseling
1648741|NCT00203736|Malaria|malaria
1648742|NCT00203736|Efficacy|efficacy
1648743|NCT00203736|Pharmacokinetic|pharmacokinetic
1648744|NCT00203736|Gametocyte|gametocyte
1648745|NCT00203736|Molecular Markers|molecular markers
1648746|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1648747|NCT00203736|Artesunate|artesunate
1648748|NCT00203736|Artemisinin|artemisinin
1648749|NCT00203723|mood disorder|mood disorder
1648750|NCT00203723|affective disorder|affective disorder
1648751|NCT00203723|depression|depression
1648752|NCT00203723|treatment-resistant|treatment-resistant
1648753|NCT00203710|Concentric Retriever Device|concentric retriever device
1648754|NCT00203710|embolectomy|embolectomy
1648755|NCT00203710|acute ischemic stroke|acute ischemic stroke
1648756|NCT00203710|treatment|treatment
1648757|NCT00203697|Eric Kleerup|eric kleerup
1648758|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1648759|NCT00203671|renal|renal
1648760|NCT00203671|transplant|transplant
1648761|NCT00203671|kidney|kidney
1648762|NCT00203671|rejection|rejection
1648763|NCT00203671|MMF|mmf
1648764|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
1648765|NCT00203671|outcomes|outcomes
1648766|NCT00203671|Kidney Transplantation|kidney transplantation
1648767|NCT00203645|Problem gambling|problem gambling
1648768|NCT00203645|Self-help manual|self-help manual
1648769|NCT00203645|Motivation enhancement|motivation enhancement
1648770|NCT00203645|Telephone support|telephone support
1648771|NCT00203645|Treatment|treatment
1649182|NCT00201474|epilepsy|epilepsy
1648772|NCT00203645|Pathological gambling|pathological gambling
1648773|NCT00203632|diabetes mellitus|diabetes mellitus
1648774|NCT00203632|endothelium|endothelium
1648775|NCT00203632|thiazolidinediones|thiazolidinediones
1648776|NCT00203632|atherosclerosis|atherosclerosis
1648777|NCT00203593|exercise|exercise
1648778|NCT00203593|total peripheral resistance|total peripheral resistance
1648779|NCT00203593|venoconstriction|venoconstriction
1648780|NCT00203593|blood volume expansion|blood volume expansion
1648781|NCT00203593|orthostatic tolerance|orthostatic tolerance
1648782|NCT00203580|venous thromboembolism|venous thromboembolism
1648783|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
1648784|NCT00203567|bipolar depression|bipolar depression
1648785|NCT00203567|carbamazepine ER|carbamazepine er
1648786|NCT00203567|Equetro|equetro
1648787|NCT00203554|osteoporosis|osteoporosis
1648788|NCT00203554|vertebra|vertebra
1648789|NCT00203554|fracture|fracture
1648790|NCT00203554|pain|pain
1648791|NCT00203554|percutaneous|percutaneous
1648792|NCT00203554|vertebroplasty|vertebroplasty
1648793|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
1648794|NCT00203528|divalproex sodium|divalproex sodium
1648795|NCT00203528|risperidone|risperidone
1648796|NCT00203528|dual diagnosis|dual diagnosis
1648797|NCT00203528|substance use|substance use
1648798|NCT00203528|bipolar|bipolar
1648799|NCT00203515|Urinary Catheterization|urinary catheterization
1648800|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
1648801|NCT00203476|ezetimibe|ezetimibe
1648802|NCT00203476|niacin|niacin
1648803|NCT00203476|colestipol|colestipol
1648804|NCT00203476|hyperlipidemia|hyperlipidemia
1648805|NCT00203476|adjunct therapy|adjunct therapy
1648806|NCT00203476|zetia|zetia
1648807|NCT00203463|topiramate|topiramate
1648808|NCT00203463|PTSD|ptsd
1648809|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
1648810|NCT00203463|topamax|topamax
1648811|NCT00203450|obesity|obesity
1648812|NCT00203450|zonisamide|zonisamide
1648813|NCT00203450|zonegran|zonegran
1648814|NCT00203450|psychotropic weight gain|psychotropic weight gain
1648815|NCT00203450|psychotropic|psychotropic
1648816|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
1648817|NCT00203333|Epilepsy|epilepsy
1648818|NCT00203281|renal transplantation|renal transplantation
1648819|NCT00203268|migraine|migraine
1648820|NCT00203268|cutaneous allodynia|cutaneous allodynia
1648821|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
1648822|NCT00203229|Double-Blind|double-blind
1648823|NCT00203229|Placebo-Controlled|placebo-controlled
1648824|NCT00203203|Autologous|autologous
1648825|NCT00203203|Cardiac|cardiac
1648826|NCT00203203|Stem Cell|stem cell
1648827|NCT00203203|Transplant|transplant
1648828|NCT00203047|Multiple Sclerosis|multiple sclerosis
1648829|NCT00203047|brain atrophy|brain atrophy
1648830|NCT00203047|Glatiramer Acetate|glatiramer acetate
1648831|NCT00203047|Copaxone|copaxone
1648832|NCT00203047|Steroids|steroids
1648833|NCT00203047|Prednisone|prednisone
1648834|NCT00202969|Stomach cancer|stomach cancer
1648835|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
1648836|NCT00202930|neuroblastoma|neuroblastoma
1648837|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
1648838|NCT00202930|rituximab|rituximab
1648839|NCT00202917|haploidentical transplantation|haploidentical transplantation
1648840|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
1648841|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
1648842|NCT00202917|dose reduced conditioning|dose reduced conditioning
1648843|NCT00202904|ezetimibe|ezetimibe
1648844|NCT00202904|atorvastatin|atorvastatin
1648845|NCT00202904|hypercholesterolemia|hypercholesterolemia
1648846|NCT00202904|coronary heart disease|coronary heart disease
1648847|NCT00202891|pyoderma|pyoderma
1648848|NCT00202891|sisomicin|sisomicin
1648849|NCT00202891|nadifloxacin|nadifloxacin
1648850|NCT00202878|hypercholesterolemia|hypercholesterolemia
1648851|NCT00202878|myocardial infarction|myocardial infarction
1648852|NCT00202878|cholesterol|cholesterol
1648853|NCT00202878|randomized controlled trials|randomized controlled trials
1648854|NCT00202878|acute coronary syndrome|acute coronary syndrome
1648855|NCT00202878|angina|angina
1648856|NCT00202813|CVC|cvc
1648857|NCT00202813|central venous catheter|central venous catheter
1648858|NCT00202813|infection|infection
1648859|NCT00202813|bloodstream infection|bloodstream infection
1648860|NCT00202813|catheter infection|catheter infection
1648861|NCT00202813|pediatric|pediatric
1648862|NCT00202813|children|children
1648863|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
1648864|NCT00202800|Pancreatic Cancer|pancreatic cancer
1648865|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
1648866|NCT00202800|Ras-mutation|ras-mutation
1648867|NCT00202787|colorectal cancer|colorectal cancer
1648868|NCT00202787|cetuximab|cetuximab
1648869|NCT00202787|FOLFOX4|folfox4
1648870|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
1648871|NCT00202761|Cerebral palsy|cerebral palsy
1648872|NCT00202761|Functional training|functional training
1648873|NCT00202761|preschool children|preschool children
1648874|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
1648875|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
1648876|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
1648877|NCT00202761|Parental Stress Index|parental stress index
1648878|NCT00202748|metabolic syndrome|metabolic syndrome
1648879|NCT00202748|lifestyle|lifestyle
1648880|NCT00202748|obesity|obesity
1648881|NCT00202735|shoulder dislocation|shoulder dislocation
1648882|NCT00202735|anterior|anterior
1648883|NCT00202735|traumatic|traumatic
1648884|NCT00202735|primary|primary
1648885|NCT00202735|first time|first time
1648886|NCT00202735|initial|initial
1648887|NCT00202735|immobilization|immobilization
1648888|NCT00202735|external|external
1648889|NCT00202735|rotation|rotation
1648890|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
1648891|NCT00202709|Anxiety disorder|anxiety disorder
1648892|NCT00202709|Thought Field Therapy|thought field therapy
1648893|NCT00202709|Psychotherapy|psychotherapy
1648894|NCT00202709|Agoraphobia|agoraphobia
1648895|NCT00202709|Social Phobia|social phobia
1648896|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
1648897|NCT00202683|Altitude|altitude
1648898|NCT00202683|Anoxemia|anoxemia
1648899|NCT00202683|Mitochondria|mitochondria
1648900|NCT00202683|Reflex|reflex
1648901|NCT00202683|Genetic research|genetic research
1648902|NCT00202670|coronary artery disease|coronary artery disease
1648903|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
1648904|NCT00202670|stress echocardiography|stress echocardiography
1648905|NCT00202657|parkinson's disease|parkinson's disease
1648907|NCT00202657|heart valve disease|heart valve disease
1648908|NCT00202631|tetraplegia|tetraplegia
1648909|NCT00202631|quadriplegia|quadriplegia
1648910|NCT00202631|spinal cord injury|spinal cord injury
1648911|NCT00202631|functional electrical stimulation|functional electrical stimulation
1648912|NCT00202631|abdominal stimulation|abdominal stimulation
1648913|NCT00202618|Hypertension|hypertension
1648914|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
1648915|NCT00202618|Microalbuminuria|microalbuminuria
1648916|NCT00202618|Amlodipine|amlodipine
1648917|NCT00202618|Calcium channel blocker|calcium channel blocker
1648918|NCT00202618|Valsartan|valsartan
1648919|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
1648920|NCT00202527|Sleep apnea|sleep apnea
1648921|NCT00202527|Hypertension|hypertension
1648922|NCT00202527|CPAP|cpap
1648923|NCT00202514|alcoholism|alcoholism
1648924|NCT00202514|alcohol related disorders|alcohol related disorders
1648925|NCT00202514|mood disorders|mood disorders
1648926|NCT00202514|anticonvulsants|anticonvulsants
1648927|NCT00202514|divalproex sodium|divalproex sodium
1648928|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
1648929|NCT00202488|Helicobacter pylori|helicobacter pylori
1648930|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
1648931|NCT00202462|testosterone|testosterone
1648932|NCT00202462|depression|depression
1648933|NCT00202462|subsyndromal depression|subsyndromal depression
1648934|NCT00202462|quality of life|quality of life
1648935|NCT00202449|Prazosin|prazosin
1648936|NCT00202449|Paroxetine|paroxetine
1648937|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1648938|NCT00202449|Sleep Disorders|sleep disorders
1648939|NCT00202423|Multiple sclerosis|multiple sclerosis
1648940|NCT00202423|Cannabinoids|cannabinoids
1648941|NCT00202423|Spasticity|spasticity
1648942|NCT00202423|fMRI|fmri
1648943|NCT00202423|TMS|tms
1648944|NCT00202410|Multiple Sclerosis|multiple sclerosis
1648945|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
1648946|NCT00202410|Therapy|therapy
1648947|NCT00202397|cerebellar ataxia|cerebellar ataxia
1648948|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
1648949|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
1648950|NCT00202397|riluzole|riluzole
1648951|NCT00202397|Sporadic ataxia|sporadic ataxia
1648952|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
1648953|NCT00202384|Multiple Sclerosis|multiple sclerosis
1648954|NCT00202384|microarrays|microarrays
1648955|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
1648956|NCT00202358|perioperative|perioperative
1648957|NCT00202358|beta-blockers|beta-blockers
1648958|NCT00202358|inflammation|inflammation
1648959|NCT00202358|outcomes|outcomes
1648960|NCT00202345|Creatinine Clearance|creatinine clearance
1648961|NCT00202345|Hemoglobin|hemoglobin
1648962|NCT00202345|Iron sucrose|iron sucrose
1648963|NCT00202345|Oral iron therapy|oral iron therapy
1648964|NCT00202345|Ferritin|ferritin
1648965|NCT00202345|Transferrin saturation|transferrin saturation
1648966|NCT00202345|Iron|iron
1648967|NCT00202319|sedation|sedation
1648968|NCT00202319|mechanical ventilation|mechanical ventilation
1648969|NCT00202319|sedation protocols|sedation protocols
1648970|NCT00202319|critical care|critical care
1648971|NCT00202319|intensive care outcomes|intensive care outcomes
1648972|NCT00202319|staffing|staffing
1648973|NCT00202306|at risk mental state|at risk mental state
1648974|NCT00202306|prodrome|prodrome
1648975|NCT00202306|ultra high risk|ultra high risk
1648976|NCT00202306|first episode psychosis|first episode psychosis
1648977|NCT00202306|schizophrenia|schizophrenia
1648978|NCT00202306|bipolar disorder|bipolar disorder
1648979|NCT00202293|Bipolar|bipolar
1648980|NCT00202293|Mania|mania
1648981|NCT00202293|Drug treatment|drug treatment
1648982|NCT00202293|First episode|first episode
1648983|NCT00202293|Psychosis|psychosis
1648984|NCT00202293|Therapy|therapy
1648985|NCT00202293|Antipsychotic|antipsychotic
1648986|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
1648987|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
1648988|NCT00202254|MS|ms
1648989|NCT00202241|HIV|hiv
1648990|NCT00202241|AIDS|aids
1648991|NCT00202241|testosterone|testosterone
1648992|NCT00202241|anabolic steroid|anabolic steroid
1648993|NCT00202241|body composition|body composition
1648994|NCT00202241|lipodystrophy|lipodystrophy
1648995|NCT00202241|MRI|mri
1648996|NCT00202241|BIA|bia
1648997|NCT00202241|skinfold measurements|skinfold measurements
1648998|NCT00202241|protease inhibitors|protease inhibitors
1648999|NCT00202228|HIV|hiv
1649000|NCT00202228|HIV/AIDS|hiv/aids
1649001|NCT00202228|Lactic Acidosis|lactic acidosis
1649002|NCT00202228|Supplementation|supplementation
1649003|NCT00202228|Lactate Clearance|lactate clearance
1649212|NCT00201370|PCR,|pcr,
1649004|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
1649005|NCT00202228|HAART|haart
1649006|NCT00202215|Day hospital treatment|day hospital treatment
1649007|NCT00202202|personality disorder|personality disorder
1649008|NCT00202202|user satisfaction|user satisfaction
1649009|NCT00202189|COPD|copd
1649010|NCT00202189|Pulmicort|pulmicort
1649011|NCT00202189|Budesonide|budesonide
1649012|NCT00202189|Chronic|chronic
1649013|NCT00202189|Obstructive|obstructive
1649014|NCT00202189|Pulmonary|pulmonary
1649015|NCT00202189|Disease|disease
1649016|NCT00202189|Exercise|exercise
1649017|NCT00202189|Emphysema|emphysema
1649018|NCT00202176|Chronic|chronic
1649019|NCT00202176|Obstructive|obstructive
1649020|NCT00202176|Pulmonary|pulmonary
1649021|NCT00202176|Disease|disease
1649022|NCT00202176|COPD|copd
1649023|NCT00202176|Atrovent|atrovent
1649024|NCT00202176|Ipratropium|ipratropium
1649025|NCT00202176|Bromide|bromide
1649026|NCT00202176|Exercise|exercise
1649027|NCT00202176|Dyspnea|dyspnea
1649028|NCT00202163|ED|ed
1649029|NCT00202163|DHEA|dhea
1649030|NCT00202163|testosterone|testosterone
1649031|NCT00202150|Advanced chronic diseases|advanced chronic diseases
1649032|NCT00202150|Heart failure|heart failure
1649033|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
1649034|NCT00202150|primary care|primary care
1649035|NCT00202150|Chronic Care|chronic care
1649036|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
1649037|NCT00202111|Clinical Trial|clinical trial
1649038|NCT00202111|Colonic Neoplasms|colonic neoplasms
1649039|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
1649040|NCT00202111|Morbidity|morbidity
1649041|NCT00202111|Port Site Metastasis|port site metastasis
1649042|NCT00202111|Disease-Free Survival|disease-free survival
1649043|NCT00202098|ARDS|ards
1649044|NCT00202098|mechanical ventilation|mechanical ventilation
1649045|NCT00202098|variable ventilation|variable ventilation
1649046|NCT00202098|chaotic ventilation|chaotic ventilation
1649047|NCT00202072|lung|lung
1649048|NCT00202072|airway|airway
1649049|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
1649050|NCT00202072|mucus|mucus
1649051|NCT00202059|Breast cancer|breast cancer
1649052|NCT00202059|Bone mineral density|bone mineral density
1649053|NCT00202059|Chemotherapy|chemotherapy
1649054|NCT00202046|Breast cancer|breast cancer
1649055|NCT00202046|Lymphedema|lymphedema
1649056|NCT00202046|Quality of life|quality of life
1649057|NCT00202033|referred to|referred to
1649058|NCT00202033|comprehensive|comprehensive
1649059|NCT00202033|diabetes|diabetes
1649060|NCT00202033|education|education
1649061|NCT00202033|program|program
1649062|NCT00202020|Cerebral infarction|cerebral infarction
1649063|NCT00202020|Prevention|prevention
1649064|NCT00202020|Cilostazol|cilostazol
1649065|NCT00202020|Aspirin|aspirin
1649066|NCT00202020|Stroke|stroke
1649067|NCT00202020|Clinical trial|clinical trial
1649068|NCT00202007|Aripiprazole|aripiprazole
1649069|NCT00202007|Schizophrenia|schizophrenia
1649070|NCT00202007|Clinical trial|clinical trial
1649071|NCT00202007|Risperidone|risperidone
1649072|NCT00201994|Sodium|sodium
1649073|NCT00201994|SIADH|siadh
1649074|NCT00201994|Vasopressin|vasopressin
1649075|NCT00201994|CHF|chf
1649076|NCT00201994|Cirrhosis|cirrhosis
1649077|NCT00201994|salt|salt
1649078|NCT00201994|water|water
1649079|NCT00201994|electrolyte|electrolyte
1649081|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
1649082|NCT00201955|dry eye|dry eye
1649083|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
1649084|NCT00201942|Breast Cancer|breast cancer
1649085|NCT00201942|Diagnosis|diagnosis
1649086|NCT00201942|PET|pet
1649087|NCT00201942|Positronic Emission Tomography|positronic emission tomography
1649088|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
1649089|NCT00201929|breast cancer|breast cancer
1649090|NCT00201929|decision aid|decision aid
1649091|NCT00201929|Decision Board|decision board
1649092|NCT00201929|information transfer|information transfer
1649093|NCT00201916|prostate cancer|prostate cancer
1649094|NCT00201916|prostate specific antigen|prostate specific antigen
1649095|NCT00201916|PSA|psa
1649096|NCT00201916|radiation fractionation|radiation fractionation
1649097|NCT00201903|venous thromboembolism|venous thromboembolism
1649098|NCT00201903|brain tumours|brain tumours
1649099|NCT00201903|glioma|glioma
1649100|NCT00201903|tissue factor|tissue factor
1649101|NCT00201903|blood coagulation|blood coagulation
1649102|NCT00201903|tumour progression|tumour progression
1649103|NCT00201903|low molecular weight heparin|low molecular weight heparin
1649104|NCT00201890|Breast Cancer|breast cancer
1649105|NCT00201890|Lymphedema|lymphedema
1649106|NCT00201890|Treatment|treatment
1649107|NCT00201890|Massage|massage
1649108|NCT00201890|Randomized|randomized
1649109|NCT00201890|DLT therapy|dlt therapy
1649110|NCT00201890|Quality of Life|quality of life
1649111|NCT00201890|Decongestive Therapy|decongestive therapy
1649211|NCT00201370|human papillomavirus,|human papillomavirus,
1649112|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
1649113|NCT00201877|Relapsed/Refractory|relapsed/refractory
1649114|NCT00201877|NHL|nhl
1649115|NCT00201877|Follicular|follicular
1649117|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1649118|NCT00201864|Postmenopausal|postmenopausal
1649119|NCT00201864|Women|women
1649120|NCT00201851|Asian|asian
1649121|NCT00201851|Premenopausal|premenopausal
1649122|NCT00201851|Women|women
1649123|NCT00201851|Oophorectomy|oophorectomy
1649124|NCT00201838|Advanced Stage|advanced stage
1649125|NCT00201838|Chemotherapy Naive|chemotherapy naive
1649126|NCT00201825|Previously Untreated|previously untreated
1649127|NCT00201825|Advanced|advanced
1649128|NCT00201812|Advanced Solid Tumors|advanced solid tumors
1649129|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1649130|NCT00201786|Corticosteroids|corticosteroids
1649131|NCT00201773|Post-Menopause|post-menopause
1649132|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
1649133|NCT00201760|metastatic|metastatic
1649134|NCT00201747|Advanced|advanced
1649135|NCT00201734|Adenocarcinoma|adenocarcinoma
1649136|NCT00201721|Previously Untreated|previously untreated
1649137|NCT00201708|Adjuvant Trial|adjuvant trial
1649138|NCT00201708|Dose-Dense|dose-dense
1649139|NCT00201708|Axillary Node-Positive|axillary node-positive
1649140|NCT00201695|Untreated Patients|untreated patients
1649141|NCT00201695|Symptomatic|symptomatic
1649142|NCT00201682|Leukemia|leukemia
1649143|NCT00201682|Lymphoma|lymphoma
1649144|NCT00201669|Aggressive|aggressive
1649145|NCT00201669|Clofarabine|clofarabine
1649146|NCT00201656|PPROM|pprom
1649147|NCT00201656|Cerclage|cerclage
1649148|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
1649149|NCT00201643|Preterm Labor|preterm labor
1649150|NCT00201643|Preterm delivery|preterm delivery
1649151|NCT00201630|Prostate|prostate
1649152|NCT00201630|cancer|cancer
1649153|NCT00201630|Brachytherapy|brachytherapy
1649154|NCT00201630|Alpha Blocker|alpha blocker
1649155|NCT00201617|Unilateral hearing loss|unilateral hearing loss
1649156|NCT00201617|Unilateral deafness|unilateral deafness
1649157|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
1649158|NCT00201591|Coronary artery disease|coronary artery disease
1649159|NCT00201591|Exercise training|exercise training
1649160|NCT00201591|Intensity|intensity
1649161|NCT00201591|Randomized|randomized
1649162|NCT00201591|echocardiography|echocardiography
1649163|NCT00201591|Aerobic Exercise|aerobic exercise
1649164|NCT00201578|Herbal Drugs|herbal drugs
1649165|NCT00201578|Alternative medicine|alternative medicine
1649166|NCT00201565|pulse wave velocity|pulse wave velocity
1649167|NCT00201565|cardiovascular disease|cardiovascular disease
1649168|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
1649169|NCT00201539|humans|humans
1649170|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
1649171|NCT00201539|neoplasms|neoplasms
1649172|NCT00201539|pain/drugtherapy|pain/drugtherapy
1649173|NCT00201526|Bipolar Disorder|bipolar disorder
1649174|NCT00201513|Muscle, Skeletal|muscle, skeletal
1649175|NCT00201513|Neuromuscular control|neuromuscular control
1649176|NCT00201513|Stability|stability
1649177|NCT00201513|Exercise|exercise
1649178|NCT00201513|Anticipatory muscle control|anticipatory muscle control
1649179|NCT00201474|brief depressive episodes|brief depressive episodes
1649180|NCT00201474|affective disorders|affective disorders
1649181|NCT00201474|EEG and QEEG|eeg and qeeg
1649183|NCT00201474|organic brain disorders|organic brain disorders
1649184|NCT00201474|acute psychiatry|acute psychiatry
1649185|NCT00201461|Patent Foramen Ovale|patent foramen ovale
1649186|NCT00201461|STARFlex|starflex
1649187|NCT00201461|CLOSURE I|closure i
1649188|NCT00201461|Septal Closure System|septal closure system
1649189|NCT00201461|Stroke|stroke
1649190|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
1649191|NCT00201461|Transient Ischemic Attack|transient ischemic attack
1649192|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
1649193|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
1649194|NCT00201435|Breast|breast
1649195|NCT00201435|Cancer|cancer
1649196|NCT00201435|Paclitaxel|paclitaxel
1649197|NCT00201435|Docetaxel|docetaxel
1649198|NCT00201435|Qulaity of life|qulaity of life
1649199|NCT00201422|MALT lymphoma|malt lymphoma
1649200|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
1649201|NCT00201422|stomach|stomach
1649202|NCT00201422|Helicobacter pylori|helicobacter pylori
1649203|NCT00201422|antibiotic therapy|antibiotic therapy
1649204|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
1649205|NCT00201396|Induction Chemotherapy|induction chemotherapy
1649206|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1649207|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
1649208|NCT00201396|randomization|randomization
1649209|NCT00201396|disease-free survival|disease-free survival
1649210|NCT00201370|cervical neoplasia;|cervical neoplasia;
1649213|NCT00201370|risk factors,|risk factors,
1649214|NCT00201370|Taiwan|taiwan
1649215|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
1649216|NCT00201357|thalidomide|thalidomide
1649217|NCT00201357|quality of life|quality of life
1649218|NCT00201344|Radiotherapy|radiotherapy
1649219|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
1649220|NCT00201344|Chemtherapy|chemtherapy
1649221|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
1649222|NCT00201292|Metabolic syndrome|metabolic syndrome
1649223|NCT00201292|Diabetes|diabetes
1649224|NCT00201292|Insulin resistance|insulin resistance
1649225|NCT00201292|pharmacogenetics|pharmacogenetics
1649226|NCT00201201|Older Adults|older adults
1649227|NCT00201201|Primary Care|primary care
1649228|NCT00201201|Hypertension|hypertension
1649229|NCT00201201|Adherence|adherence
1649230|NCT00201136|Behavioral intervention|behavioral intervention
1649231|NCT00201136|Lifestyle modification|lifestyle modification
1649232|NCT00201136|Guidelines|guidelines
1649233|NCT00201110|African Americans|african americans
1649234|NCT00201058|urban|urban
1649235|NCT00201058|adolescents|adolescents
1649236|NCT00201058|African American|african american
1649237|NCT00201058|web-based|web-based
1649238|NCT00201058|computer tailoring|computer tailoring
1649239|NCT00201058|school based|school based
1649240|NCT00201045|Hypertension management|hypertension management
1649241|NCT00201045|Pharmacist management|pharmacist management
1649242|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
1649243|NCT00201045|Blood pressure control|blood pressure control
1649244|NCT00200954|prospective|prospective
1649245|NCT00200954|intervention|intervention
1649246|NCT00200954|randomised|randomised
1649247|NCT00200954|probiotics|probiotics
1649248|NCT00200954|atopy|atopy
1649249|NCT00200941|Restless Legs Syndrome|restless legs syndrome
1649250|NCT00200941|Topiramate|topiramate
1649251|NCT00200941|Actigraphy|actigraphy
1649252|NCT00200941|Polysomnography|polysomnography
1649253|NCT00200928|prospective|prospective
1649254|NCT00200928|randomised|randomised
1649255|NCT00200928|intervention|intervention
1649257|NCT00200928|atopy|atopy
1649258|NCT00200902|Major depressive disorder|major depressive disorder
1649260|NCT00200902|Antidepressant|antidepressant
1649261|NCT00200889|Acupuncture|acupuncture
1649262|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
1649263|NCT00200889|Brain Mapping|brain mapping
1649264|NCT00200889|healthy volunteers|healthy volunteers
1649265|NCT00200889|Neuromodulation|neuromodulation
1649266|NCT00200876|Positron-Emission Tomography|positron-emission tomography
1649267|NCT00200876|Endorphins|endorphins
1649268|NCT00200876|Pain Relief|pain relief
1649269|NCT00200876|Opioid Receptors|opioid receptors
1649270|NCT00200876|Stress|stress
1649271|NCT00200876|Analgesia|analgesia
1649272|NCT00200863|light|light
1649273|NCT00200863|wavelength|wavelength
1649274|NCT00200863|action spectrum|action spectrum
1649275|NCT00200863|circadian|circadian
1649276|NCT00200863|melatonin|melatonin
1649277|NCT00200863|alertness|alertness
1649278|NCT00200863|performance|performance
1649279|NCT00200863|arousal|arousal
1649280|NCT00200850|Breathing|breathing
1649281|NCT00200850|Allergy|allergy
1649282|NCT00200850|Mites, House Dust|mites, house dust
1649283|NCT00200837|oral mucosal pain|oral mucosal pain
1649284|NCT00200837|oral inflammations|oral inflammations
1649285|NCT00200837|anisillo|anisillo
1649286|NCT00200837|cordonsillo|cordonsillo
1649287|NCT00200837|Piperaceae|piperaceae
1649288|NCT00200837|oral ulcers|oral ulcers
1649289|NCT00200837|oral tumors|oral tumors
1649290|NCT00200837|mucosal pain|mucosal pain
1649291|NCT00200837|mucosal inflammations|mucosal inflammations
1649292|NCT00200837|cordoncillo|cordoncillo
1649293|NCT00200824|isoflavones|isoflavones
1649294|NCT00200824|soy|soy
1649295|NCT00200824|postmenopausal|postmenopausal
1649296|NCT00200824|men|men
1649297|NCT00200824|prostate|prostate
1649298|NCT00200824|breast|breast
1649299|NCT00200824|bone|bone
1649300|NCT00200798|Milk Thistle|milk thistle
1649301|NCT00200798|Silymarin|silymarin
1649302|NCT00200798|pharmacokinetics|pharmacokinetics
1649303|NCT00200798|drug interactions|drug interactions
1649304|NCT00200798|Normal volunteers|normal volunteers
1649305|NCT00200785|garlic|garlic
1649306|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
1649307|NCT00200759|Antioxidants|antioxidants
1649308|NCT00200759|Drug Interactions|drug interactions
1649309|NCT00200746|Hepatitis|hepatitis
1649310|NCT00200746|Liver Diseases|liver diseases
1649311|NCT00200746|Alcoholism|alcoholism
1649312|NCT00200746|Arginine|arginine
1649313|NCT00200733|acupuncture|acupuncture
1649314|NCT00200733|patient narratives|patient narratives
1649315|NCT00200733|qualitative methods|qualitative methods
1649316|NCT00200720|Diet|diet
1649317|NCT00200720|Carbohydrates|carbohydrates
1649318|NCT00200720|Weight Loss|weight loss
1649319|NCT00200707|Cell therapy|cell therapy
1649320|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
1649425|NCT00200200|Colon|colon
1649321|NCT00200707|myocardial infarction|myocardial infarction
1649322|NCT00200694|Proteinuria|proteinuria
1649323|NCT00200694|ACEI|acei
1649325|NCT00200694|diuretics|diuretics
1649326|NCT00200694|blood pressure|blood pressure
1649327|NCT00200694|renal failure|renal failure
1649328|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
1649329|NCT00200681|First line treatment|first line treatment
1649330|NCT00200681|Velcade®|velcade®
1649331|NCT00200681|autograft|autograft
1649332|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
1649333|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
1649334|NCT00200629|Women|women
1649335|NCT00200629|Diagnostic Testing|diagnostic testing
1649336|NCT00200629|Radionuclide Imaging|radionuclide imaging
1649337|NCT00200629|Stress Testing|stress testing
1649338|NCT00200629|Adenosine|adenosine
1649339|NCT00200616|Urinary tract infection|urinary tract infection
1649340|NCT00200616|Vesico-renal reflux|vesico-renal reflux
1649341|NCT00200616|Child|child
1649342|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
1649343|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
1649344|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
1649345|NCT00200603|tibial osteotomy|tibial osteotomy
1649346|NCT00200603|osteoarthritis|osteoarthritis
1649347|NCT00200590|prostaglandin|prostaglandin
1649348|NCT00200590|analgesia|analgesia
1649349|NCT00200590|congenital|congenital
1649350|NCT00200590|heart|heart
1649351|NCT00200590|defect|defect
1649352|NCT00200590|induced|induced
1649353|NCT00200577|Adjuvant therapy|adjuvant therapy
1649354|NCT00200577|immunotherapy|immunotherapy
1649355|NCT00200577|TIL|til
1649356|NCT00200577|melanoma|melanoma
1649357|NCT00200564|Pediatrics|pediatrics
1649358|NCT00200564|ketamine|ketamine
1649359|NCT00200564|postoperative analgesia|postoperative analgesia
1649360|NCT00200564|nalbuphine|nalbuphine
1649361|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
1649362|NCT00200538|frontotemporal dementia|frontotemporal dementia
1649363|NCT00200538|Mémantine|mémantine
1649364|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
1649365|NCT00200499|Nebivolol|nebivolol
1649366|NCT00200499|Hypertension|hypertension
1649367|NCT00200499|Beta-Blocker|beta-blocker
1649368|NCT00200486|genetic microarray|genetic microarray
1649369|NCT00200486|head and neck cancer|head and neck cancer
1649370|NCT00200473|Nebivolol|nebivolol
1649371|NCT00200473|Hypertension|hypertension
1649372|NCT00200473|Beta-Blockers|beta-blockers
1649373|NCT00200460|Nebivolol|nebivolol
1649374|NCT00200460|Hypertension|hypertension
1649375|NCT00200460|Beta-Blocker|beta-blocker
1649376|NCT00200447|Parkinson|parkinson
1649377|NCT00200447|brain imaging|brain imaging
1649378|NCT00200434|Nebivolol|nebivolol
1649379|NCT00200434|Beta-Blocker|beta-blocker
1649380|NCT00200434|Hypertension|hypertension
1649381|NCT00200421|Nebivolol|nebivolol
1649382|NCT00200421|Atenolol|atenolol
1649383|NCT00200421|Exercise|exercise
1649384|NCT00200421|Hypertension|hypertension
1649385|NCT00200408|cancer of head and neck|cancer of head and neck
1649386|NCT00200408|smoking|smoking
1649387|NCT00200369|HIV|hiv
1649388|NCT00200369|Adherence|adherence
1649389|NCT00200369|Antiretroviral therapy|antiretroviral therapy
1649390|NCT00200369|Protease inhibitor|protease inhibitor
1649391|NCT00200369|Lopinavir|lopinavir
1649392|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
1649393|NCT00200330|weight loss|weight loss
1649394|NCT00200330|physical activity|physical activity
1649395|NCT00200330|diet|diet
1649396|NCT00200330|home environment|home environment
1649397|NCT00200317|Exercise|exercise
1649398|NCT00200317|Internet|internet
1649399|NCT00200317|Print|print
1649400|NCT00200317|Randomized Controlled Trial|randomized controlled trial
1649401|NCT00200317|Exercise Intervention|exercise intervention
1649402|NCT00200304|Obesity|obesity
1649403|NCT00200304|Weight loss|weight loss
1649404|NCT00200304|Internet|internet
1649405|NCT00200278|Exercise|exercise
1649406|NCT00200278|Intervention studies|intervention studies
1649407|NCT00200278|Decision-making|decision-making
1649408|NCT00200278|computer assisted Expert systems|computer assisted expert systems
1649409|NCT00200278|telephone|telephone
1649410|NCT00200252|oxytocin|oxytocin
1649411|NCT00200252|third stage|third stage
1649412|NCT00200252|dose|dose
1649413|NCT00200252|route|route
1649414|NCT00200252|blood loss|blood loss
1649415|NCT00200226|pain/discomfort|pain/discomfort
1649416|NCT00200226|cervical dilatation|cervical dilatation
1649417|NCT00200226|side effects|side effects
1649418|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
1649419|NCT00200200|DEXAMETHASONE|dexamethasone
1649420|NCT00200200|FLOXURIDINE|floxuridine
1649421|NCT00200200|FLUOROURACIL|fluorouracil
1649422|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
1649423|NCT00200200|LEUCOVORIN|leucovorin
1649424|NCT00200200|OXALIPLATIN|oxaliplatin
1649426|NCT00200200|Rectal|rectal
1649427|NCT00200200|04-086|04-086
1649428|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
1649429|NCT00200187|Prostatectomy|prostatectomy
1649430|NCT00200187|Anesthesia|anesthesia
1649431|NCT00200187|Blood Loss|blood loss
1649432|NCT00200174|Breast cancer|breast cancer
1649433|NCT00200174|estrogen|estrogen
1649434|NCT00200174|postmenopausal|postmenopausal
1649435|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
1649436|NCT00200148|Hepatectomy|hepatectomy
1649437|NCT00200148|Major Hepatic resection|major hepatic resection
1649438|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
1649439|NCT00200135|motorcycle accident|motorcycle accident
1649440|NCT00200135|helmet|helmet
1649441|NCT00200135|traumatic brain injury|traumatic brain injury
1649442|NCT00200135|financial burden|financial burden
1649443|NCT00200096|Cancer|cancer
1649444|NCT00200096|Fatigue|fatigue
1649445|NCT00200083|Obesity|obesity
1649446|NCT00200083|Morbid Obesity|morbid obesity
1649447|NCT00200083|SHAPE|shape
1649448|NCT00200083|IGS|igs
1649449|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
1649450|NCT00200070|Angina Pectoris Pain|angina pectoris pain
1649451|NCT00200057|Fecal Incontinence|fecal incontinence
1649452|NCT00200057|InterStim|interstim
1649453|NCT00200044|GERD|gerd
1649454|NCT00200018|Obesity|obesity
1649455|NCT00200018|Morbid obesity|morbid obesity
1649456|NCT00200018|Diabetes|diabetes
1649457|NCT00200005|Slow transit constipation|slow transit constipation
1649458|NCT00200005|Fecal incontinence|fecal incontinence
1649459|NCT00200005|Constipation|constipation
1649460|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
1649461|NCT00200005|Chronic constipation|chronic constipation
1649462|NCT00199992|acute wounds|acute wounds
1649463|NCT00199992|wounds|wounds
1649464|NCT00199992|platelets|platelets
1649465|NCT00199992|platelet gel|platelet gel
1649466|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
1649467|NCT00199979|Nevirapine|nevirapine
1649468|NCT00199979|HIV Viral Load|hiv viral load
1649469|NCT00199979|Adherence|adherence
1649470|NCT00199979|Quality of Life|quality of life
1649471|NCT00199979|Resistance Mutations|resistance mutations
1649472|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
1649473|NCT00199953|Postnasal drainage|postnasal drainage
1649474|NCT00199953|Extraesophageal reflux|extraesophageal reflux
1649475|NCT00199940|Schizophrenia|schizophrenia
1649476|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
1649477|NCT00199940|Ziprasidone|ziprasidone
1649478|NCT00199914|Diathermy|diathermy
1649479|NCT00199914|Short-wave therapy|short-wave therapy
1649480|NCT00199914|Osteoarthritis|osteoarthritis
1649481|NCT00199914|Knee|knee
1649482|NCT00199901|Phase II|phase ii
1649483|NCT00199901|Randomized Controlled Trial|randomized controlled trial
1649484|NCT00199901|Double-Blind|double-blind
1649485|NCT00199901|Cancer Vaccine|cancer vaccine
1649486|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
1649487|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
1649488|NCT00199888|Kidney Cancer|kidney cancer
1649489|NCT00199888|Renal Cancer|renal cancer
1649490|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
1649491|NCT00199888|cG250|cg250
1649492|NCT00199888|antibody|antibody
1649493|NCT00199888|Iodine 124|iodine 124
1649494|NCT00199875|antibody|antibody
1649495|NCT00199875|renal cell carcinoma|renal cell carcinoma
1649496|NCT00199875|advanced renal cancer|advanced renal cancer
1649497|NCT00199875|cG250|cg250
1649498|NCT00199875|90Y|90y
1649499|NCT00199862|huA33|hua33
1649500|NCT00199862|antibody|antibody
1649501|NCT00199862|colorectal cancer|colorectal cancer
1649502|NCT00199862|Iodine 124|iodine 124
1649503|NCT00199862|124I|124i
1649504|NCT00199862|03-124|03-124
1649505|NCT00199849|NY-ESO-1|ny-eso-1
1649506|NCT00199849|DNA|dna
1649507|NCT00199836|cancer vaccine|cancer vaccine
1649508|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
1649509|NCT00199836|CpG 7909|cpg 7909
1649510|NCT00199836|Montanide ISA-51|montanide isa-51
1649511|NCT00199836|LAGE-1|lage-1
1649512|NCT00199836|immune response|immune response
1649513|NCT00199836|safety|safety
1649514|NCT00199823|Myocardial infarction|myocardial infarction
1649515|NCT00199823|bone marrow cells|bone marrow cells
1649516|NCT00199823|cell transplantation|cell transplantation
1649517|NCT00199810|Cardiac output|cardiac output
1649518|NCT00199810|Preeclamptic women|preeclamptic women
1649519|NCT00199810|systemic vascular resistance|systemic vascular resistance
1649520|NCT00199810|blood pressure|blood pressure
1649521|NCT00199797|Colorectal Cancer|colorectal cancer
1649522|NCT00199797|huA33|hua33
1649523|NCT00199797|antibody|antibody
1649524|NCT00199797|chemotherapy|chemotherapy
1649525|NCT00199784|Hemodynamic|hemodynamic
1649526|NCT00199784|Hypotension|hypotension
1649527|NCT00199784|Spinal|spinal
1649528|NCT00199784|Anesthesia|anesthesia
1649529|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
1649530|NCT00199771|Cardiac Surgery|cardiac surgery
1649531|NCT00199771|Infant|infant
1649532|NCT00199771|Infant, Newborn|infant, newborn
1649533|NCT00199771|Hypertonic Solutions|hypertonic solutions
1649534|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
1649535|NCT00199771|Capillary leak|capillary leak
1649536|NCT00199771|Inflammation Mediators|inflammation mediators
1649537|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
1649538|NCT00199758|Cisplatin|cisplatin
1649539|NCT00199758|Gemcitabine|gemcitabine
1649540|NCT00199758|Paclitaxel|paclitaxel
1649541|NCT00199745|statin|statin
1649542|NCT00199745|statins|statins
1649543|NCT00199745|statin therapy|statin therapy
1649544|NCT00199745|adverse events|adverse events
1649545|NCT00199745|side effect|side effect
1649546|NCT00199745|Myotoxicity|myotoxicity
1649547|NCT00199745|atorvastatin|atorvastatin
1649548|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
1649549|NCT00199732|Chronic hepatitis B|chronic hepatitis b
1649550|NCT00199732|CCC DNA kinetics|ccc dna kinetics
1649551|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
1649552|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
1649553|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
1649554|NCT00199719|drug monitoring|drug monitoring
1649555|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
1649556|NCT00199719|pharmacodynamics|pharmacodynamics
1649557|NCT00199719|chronic hepatitis C|chronic hepatitis c
1649558|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
1649559|NCT00199706|Intracranial Pressure|intracranial pressure
1649560|NCT00199706|Intracranial Hypertension|intracranial hypertension
1649561|NCT00199706|Hypertonic Solutions|hypertonic solutions
1649562|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
1649563|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
1649564|NCT00199693|Healthy pregnant women|healthy pregnant women
1649565|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
1649566|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
1649567|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
1649568|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
1649569|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
1649570|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
1649571|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
1649572|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
1649573|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
1649574|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
1649575|NCT00199589|Spastic equinovarus|spastic equinovarus
1649576|NCT00199589|Botox|botox
1649577|NCT00199589|Ankle foot orthosis|ankle foot orthosis
1649578|NCT00199576|Corticosteroids|corticosteroids
1649579|NCT00199576|Laryngotracheal injury|laryngotracheal injury
1649580|NCT00199576|Intubation-extubation|intubation-extubation
1649581|NCT00199563|Viagra|viagra
1649582|NCT00199563|sildenafil|sildenafil
1649583|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
1649584|NCT00199550|TURP|turp
1649585|NCT00199524|ureteroscopy|ureteroscopy
1649586|NCT00199524|stone free|stone free
1649587|NCT00199511|Brain Tumor|brain tumor
1649588|NCT00199511|Intracranial Pressure|intracranial pressure
1649589|NCT00199511|Osmolarity|osmolarity
1649590|NCT00199511|Seric|seric
1649591|NCT00199511|Hypertonic Solution|hypertonic solution
1649592|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
1649593|NCT00199485|prostate cancer|prostate cancer
1649594|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
1649595|NCT00199485|LHRH|lhrh
1649596|NCT00199459|calculi|calculi
1649597|NCT00199459|proteomics|proteomics
1649598|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
1649599|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
1649600|NCT00199446|Clinical Trial|clinical trial
1649601|NCT00199433|Parkinson's Disease|parkinson's disease
1649602|NCT00199433|Movement Disorder|movement disorder
1649603|NCT00199433|Neurology,|neurology,
1649604|NCT00199433|Clinical Trial|clinical trial
1649605|NCT00199420|levodopa|levodopa
1649606|NCT00199420|end of dose wearing off|end of dose wearing off
1649607|NCT00199420|OFF time|off time
1649608|NCT00199407|Parkinson's disease|parkinson's disease
1649609|NCT00199407|levodopa|levodopa
1649610|NCT00199407|end of dose wearing off|end of dose wearing off
1649611|NCT00199407|OFF time|off time
1649612|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
1649613|NCT00199394|Entacapone|entacapone
1649614|NCT00199394|Placebo|placebo
1649615|NCT00199394|Parkinson's Disease|parkinson's disease
1649616|NCT00199394|Motor Response Complications|motor response complications
1649617|NCT00199394|Levodopa Therapy|levodopa therapy
1649618|NCT00199381|Parkinson's Disease|parkinson's disease
1649619|NCT00199381|levodopa|levodopa
1649620|NCT00199381|end of dose wearing off|end of dose wearing off
1649621|NCT00199381|OFF time|off time
1649622|NCT00199368|Parkinson's disease|parkinson's disease
1649623|NCT00199368|levodopa|levodopa
1649826|NCT00198328|carcinoma|carcinoma
1649624|NCT00199368|end of dose wearing off|end of dose wearing off
1649625|NCT00199368|OFF time|off time
1649626|NCT00199355|Parkinson's Disease|parkinson's disease
1649627|NCT00199355|levodopa|levodopa
1649628|NCT00199355|end of dose wearing off|end of dose wearing off
1649629|NCT00199355|OFF time|off time
1649631|NCT00199342|Monoclonal Antibody|monoclonal antibody
1649632|NCT00199342|Anti-GD-3|anti-gd-3
1649633|NCT00199329|ondansetron|ondansetron
1649634|NCT00199329|PCA|pca
1649635|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
1649636|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
1649637|NCT00199303|pain, post-operative|pain, post-operative
1649638|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
1649639|NCT00199290|Trafermin|trafermin
1649640|NCT00199290|Periodontitis|periodontitis
1649641|NCT00199264|antifungal oral therapy|antifungal oral therapy
1649642|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
1649643|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
1649644|NCT00199238|ANTIHISTAMINE|antihistamine
1649645|NCT00199238|RUPATADINE|rupatadine
1649646|NCT00199238|WHEAL|wheal
1649647|NCT00199238|FLARE|flare
1649648|NCT00199238|DERMATOLOGY|dermatology
1649649|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
1649650|NCT00199225|Cardiac repolarization|cardiac repolarization
1649651|NCT00199225|QT prolongation|qt prolongation
1649652|NCT00199212|HER-2 positive|her-2 positive
1649653|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
1649654|NCT00199173|colorectal cancer|colorectal cancer
1649655|NCT00199173|liver metastasis|liver metastasis
1649656|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
1649657|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
1649658|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
1649659|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
1649660|NCT00199160|Previously treated with platinum|previously treated with platinum
1649661|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
1649662|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
1649663|NCT00199108|CNS relapse|cns relapse
1649664|NCT00199108|ALL|all
1649665|NCT00199108|Treatment|treatment
1649666|NCT00199095|ALL|all
1649667|NCT00199095|Elderly|elderly
1649668|NCT00199095|Chemotherapy|chemotherapy
1649669|NCT00199082|High-grade NHL|high-grade nhl
1649670|NCT00199082|De novo|de novo
1649671|NCT00199082|Mature B-ALL|mature b-all
1649672|NCT00199082|Burkitt'S NHL|burkitt's nhl
1649673|NCT00199082|Chemotherapy|chemotherapy
1649674|NCT00199082|Rituximab|rituximab
1649675|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
1649676|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
1649677|NCT00199069|ALL|all
1649678|NCT00199069|Treatment|treatment
1649679|NCT00199069|De Novo|de novo
1649680|NCT00199069|Adult|adult
1649681|NCT00199056|ALL|all
1649682|NCT00199056|Treatment|treatment
1649683|NCT00199056|De Novo|de novo
1649684|NCT00199056|Adult|adult
1649685|NCT00199030|Relapse|relapse
1649686|NCT00199030|T-ALL|t-all
1649687|NCT00199030|T-LBL|t-lbl
1649688|NCT00199030|MabCampath|mabcampath
1649689|NCT00199030|Minimal residual disease|minimal residual disease
1649690|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
1649691|NCT00199017|T-LBL|t-lbl
1649692|NCT00199017|Treatment|treatment
1649693|NCT00199017|De novo|de novo
1649694|NCT00199017|Chemotherapy|chemotherapy
1649695|NCT00199017|Adult|adult
1649696|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
1649697|NCT00199004|ALL|all
1649698|NCT00199004|Treatment|treatment
1649699|NCT00199004|De novo|de novo
1649700|NCT00199004|Minimal residual disease|minimal residual disease
1649701|NCT00199004|Rituximab|rituximab
1649702|NCT00199004|Adult|adult
1649703|NCT00198991|ALL|all
1649704|NCT00198991|Treatment|treatment
1649705|NCT00198991|de novo|de novo
1649706|NCT00198991|Minimal residual disease|minimal residual disease
1649707|NCT00198991|Adult|adult
1649708|NCT00198978|ALL|all
1649709|NCT00198978|Treatment|treatment
1649710|NCT00198978|Elderly|elderly
1649711|NCT00198978|De novo|de novo
1649712|NCT00198939|drug prevention|drug prevention
1649713|NCT00198939|adolescence|adolescence
1649714|NCT00198939|middle school|middle school
1649715|NCT00198939|randomized trial|randomized trial
1649716|NCT00198939|family therapy|family therapy
1649717|NCT00198939|cognitive-behavioral|cognitive-behavioral
1649718|NCT00198939|efficacy|efficacy
1649719|NCT00198939|selected youth|selected youth
1649720|NCT00198939|indicated youth|indicated youth
1649721|NCT00198887|newborn|newborn
1649722|NCT00198887|operations research|operations research
1649723|NCT00198887|newborn survival|newborn survival
1649724|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
1650314|NCT00195936|Cinacalcet|cinacalcet
1649725|NCT00198887|Delivery complications|delivery complications
1649726|NCT00198874|drug abuse|drug abuse
1649727|NCT00198874|drug dependence|drug dependence
1649728|NCT00198874|treatment|treatment
1649729|NCT00198874|randomized trial|randomized trial
1649730|NCT00198874|stage II study|stage ii study
1649731|NCT00198874|adolescents|adolescents
1649732|NCT00198874|young adults|young adults
1649733|NCT00198874|efficacy study|efficacy study
1649734|NCT00198861|HIV Epidemiology|hiv epidemiology
1649735|NCT00198861|Neurology|neurology
1649736|NCT00198861|Neuropsychological|neuropsychological
1649737|NCT00198861|HIV Risk Factors|hiv risk factors
1649738|NCT00198861|Cognitive Risk Factors|cognitive risk factors
1649739|NCT00198861|HIV|hiv
1649740|NCT00198848|Iron deficiency anemia|iron deficiency anemia
1649741|NCT00198848|Adolescent girls|adolescent girls
1649742|NCT00198848|India|india
1649743|NCT00198835|malnutrition|malnutrition
1649744|NCT00198835|anemia|anemia
1649745|NCT00198835|infants|infants
1649746|NCT00198835|children|children
1649747|NCT00198835|India|india
1649748|NCT00198822|Maternal mortality|maternal mortality
1649749|NCT00198822|Infant mortality|infant mortality
1649750|NCT00198822|Vitamin A|vitamin a
1649751|NCT00198822|Beta-carotene|beta-carotene
1649752|NCT00198822|Micronutrients|micronutrients
1649753|NCT00198822|Bangladesh|bangladesh
1649754|NCT00198822|Neonatal mortality|neonatal mortality
1649755|NCT00198731|maternal health|maternal health
1649756|NCT00198731|Bangladesh|bangladesh
1649757|NCT00198731|care seeking|care seeking
1649758|NCT00198718|Vitamin A supplementation|vitamin a supplementation
1649759|NCT00198718|HIV|hiv
1649760|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
1649761|NCT00198718|Breastfeeding|breastfeeding
1649762|NCT00198692|amputation|amputation
1649763|NCT00198692|depression|depression
1649764|NCT00198692|pain|pain
1649765|NCT00198692|anxiety|anxiety
1649766|NCT00198692|self-management|self-management
1649767|NCT00198692|secondary conditions|secondary conditions
1649768|NCT00198679|skin cleansing|skin cleansing
1649769|NCT00198679|Bangladesh|bangladesh
1649770|NCT00198679|Skin Flora|skin flora
1649771|NCT00198679|Newborn|newborn
1649772|NCT00198679|infectious disease|infectious disease
1649773|NCT00198679|chlorhexidine|chlorhexidine
1649774|NCT00198666|Pneumonia|pneumonia
1649775|NCT00198666|zinc|zinc
1649776|NCT00198653|Hypothermia|hypothermia
1649777|NCT00198653|Newborn|newborn
1649778|NCT00198653|India|india
1649779|NCT00198653|Maternal/Child Health|maternal/child health
1649780|NCT00198653|Infant|infant
1649781|NCT00198653|Kangaroo Mother Care|kangaroo mother care
1649782|NCT00198640|animal antibiotics|animal antibiotics
1649783|NCT00198640|human antibiotics|human antibiotics
1649784|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
1649785|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
1649786|NCT00198614|Carvedilol|carvedilol
1649787|NCT00198614|Metoprolol|metoprolol
1649788|NCT00198614|Coronary Artery Bypass|coronary artery bypass
1649789|NCT00198614|Atrial Fibrillation|atrial fibrillation
1649790|NCT00198601|meningitis|meningitis
1649791|NCT00198601|neonatal deaths|neonatal deaths
1649792|NCT00198601|gentamicin|gentamicin
1649794|NCT00198601|aminoglycoside|aminoglycoside
1649795|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1649796|NCT00198588|argatroban|argatroban
1649797|NCT00198588|cardiac surgery|cardiac surgery
1649798|NCT00198588|acute coronary syndrome|acute coronary syndrome
1649799|NCT00198588|thrombosis|thrombosis
1649800|NCT00198588|amputation|amputation
1649801|NCT00198588|anticoagulation|anticoagulation
1650092|NCT00197080|RLS|rls
1649802|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1649803|NCT00198575|cardiovascular surgery|cardiovascular surgery
1649804|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
1649805|NCT00198562|Antihypertensive therapy|antihypertensive therapy
1649806|NCT00198562|Home blood pressure|home blood pressure
1649807|NCT00198562|Systolic blood pressure|systolic blood pressure
1649808|NCT00198562|Morning blood pressure|morning blood pressure
1649809|NCT00198562|Calcium antagonist|calcium antagonist
1649810|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
1649811|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
1649812|NCT00198549|hyaluronate lyase|hyaluronate lyase
1649813|NCT00198523|Cataract Extraction|cataract extraction
1649814|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
1649815|NCT00198523|Steroids|steroids
1649816|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
1649817|NCT00198484|Spreading Factor|spreading factor
1649818|NCT00198445|Cataract Extraction|cataract extraction
1649819|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
1649820|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
1649821|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
1649822|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
1649823|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
1649824|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
1649825|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
1649827|NCT00198328|head and neck cancer|head and neck cancer
1649828|NCT00198328|larynx|larynx
1649829|NCT00198328|electroporation|electroporation
1649830|NCT00198328|medpulser|medpulser
1649831|NCT00198328|bleomycin|bleomycin
1649832|NCT00198328|cancer|cancer
1650029|NCT00197392|Ventriculostomy|ventriculostomy
1649833|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
1649834|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
1649835|NCT00198315|Carcinoma|carcinoma
1649836|NCT00198315|Head and Neck Cancer|head and neck cancer
1649837|NCT00198315|Oral|oral
1649838|NCT00198315|Soft Palate|soft palate
1649839|NCT00198315|Cancer|cancer
1649840|NCT00198315|Medpulser|medpulser
1649841|NCT00198315|Electroporation|electroporation
1649842|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
1649843|NCT00198302|staphylococcus aureus|staphylococcus aureus
1649844|NCT00198302|bacteremia|bacteremia
1649845|NCT00198302|sepsis|sepsis
1649846|NCT00198289|Cystic Fibrosis|cystic fibrosis
1649847|NCT00198289|Staphylococcus aureus|staphylococcus aureus
1649848|NCT00198289|lungs|lungs
1649849|NCT00198276|cancer|cancer
1649850|NCT00198276|cutaneous|cutaneous
1649851|NCT00198276|subcutaneous|subcutaneous
1649852|NCT00198276|MedPulser|medpulser
1649853|NCT00198276|bleomycin|bleomycin
1649854|NCT00198276|electroporation|electroporation
1649855|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
1649856|NCT00198263|head and neck cancer|head and neck cancer
1649857|NCT00198263|cancer|cancer
1649858|NCT00198263|bleomycin|bleomycin
1649859|NCT00198263|medpulser|medpulser
1649860|NCT00198263|electroporation|electroporation
1649861|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
1649862|NCT00198250|Breast cancer survivorship|breast cancer survivorship
1649863|NCT00198250|hot flashes|hot flashes
1649864|NCT00198250|treatment|treatment
1649865|NCT00198237|Breast Cancer|breast cancer
1649866|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
1649867|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
1649868|NCT00198224|immunosuppression|immunosuppression
1649869|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
1649870|NCT00198172|Germ Cell Tumor|germ cell tumor
1649871|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
1649872|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
1649873|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
1649874|NCT00198159|Germ Cell Tumors|germ cell tumors
1649875|NCT00198133|Thymoma|thymoma
1649876|NCT00198133|Thymic Carcinoma|thymic carcinoma
1649877|NCT00198120|Autistic Disorder|autistic disorder
1649878|NCT00198120|cycloserine|cycloserine
1649879|NCT00198120|pharmacology|pharmacology
1649880|NCT00198120|glutamatergic agents|glutamatergic agents
1649881|NCT00198120|communication|communication
1649882|NCT00198120|social interaction|social interaction
1649883|NCT00198120|Double-Blind Method|double-blind method
1649884|NCT00198107|Children|children
1649885|NCT00198107|Adolescents|adolescents
1649886|NCT00198107|Aripiprazole|aripiprazole
1649887|NCT00198107|Cycloserine|cycloserine
1649888|NCT00198107|Aggression|aggression
1649889|NCT00198107|Irritability|irritability
1649890|NCT00198107|Self-Injurious Behavior|self-injurious behavior
1649891|NCT00198107|Social Interaction|social interaction
1649892|NCT00198107|Antipsychotics|antipsychotics
1649893|NCT00198107|Pharmacology|pharmacology
1649894|NCT00198107|Glutamatergic Agents|glutamatergic agents
1649895|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
1649896|NCT00198068|Pregnancy outcomes|pregnancy outcomes
1649897|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
1649898|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
1649899|NCT00198055|Aggression|aggression
1649900|NCT00198055|Behavioral symptoms|behavioral symptoms
1649901|NCT00198042|ACL|acl
1649902|NCT00198042|Tunnel|tunnel
1649903|NCT00198042|Widening|widening
1649904|NCT00198029|Osteoarthritis|osteoarthritis
1649905|NCT00198029|Hyaluronan|hyaluronan
1649906|NCT00198029|Carpometacarpal|carpometacarpal
1649907|NCT00198029|Outcomes|outcomes
1649908|NCT00198016|coronary fistulas.|coronary fistulas.
1649909|NCT00198016|coils embolization.|coils embolization.
1649910|NCT00198003|hip arthritis|hip arthritis
1649911|NCT00198003|total hip arthroplasty|total hip arthroplasty
1649912|NCT00198003|expectations|expectations
1649913|NCT00198003|education|education
1649914|NCT00197990|total hip arthroplasty|total hip arthroplasty
1649915|NCT00197990|expectations|expectations
1649916|NCT00197990|satisfaction|satisfaction
1649917|NCT00197990|quality of life|quality of life
1649918|NCT00197977|knee arthritis|knee arthritis
1649919|NCT00197977|total knee arthroplasty|total knee arthroplasty
1649920|NCT00197977|expectations|expectations
1649921|NCT00197977|education|education
1649922|NCT00197964|Self-management|self-management
1649923|NCT00197964|Self-efficacy|self-efficacy
1649924|NCT00197964|Quality of life|quality of life
1649925|NCT00197964|Resource utilization|resource utilization
1650030|NCT00197392|EVD|evd
1650529|NCT00194701|sleep|sleep
1649926|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
1649927|NCT00197951|Alcoholism treatment|alcoholism treatment
1649928|NCT00197951|Alcohol craving|alcohol craving
1649929|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
1649930|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
1649931|NCT00197925|breast cancer|breast cancer
1649932|NCT00197925|dendritic cells|dendritic cells
1649933|NCT00197925|vaccine|vaccine
1649934|NCT00197912|dendritic cell|dendritic cell
1649935|NCT00197912|cancer vaccine|cancer vaccine
1649936|NCT00197912|cyclophosphamide|cyclophosphamide
1649937|NCT00197912|melanoma|melanoma
1649938|NCT00197873|colorectal cancer|colorectal cancer
1649939|NCT00197873|probiotics|probiotics
1649940|NCT00197873|chemotherapy|chemotherapy
1649941|NCT00197873|prevention|prevention
1649942|NCT00197873|adverse effects|adverse effects
1649943|NCT00197873|diarrhoea|diarrhoea
1649944|NCT00197860|dendritic cell|dendritic cell
1649945|NCT00197860|vaccine|vaccine
1649946|NCT00197860|renal cell carcinoma|renal cell carcinoma
1649947|NCT00197834|Depakote|depakote
1649948|NCT00197834|Agitation|agitation
1649949|NCT00197834|Dementia|dementia
1649950|NCT00197834|Atypical antipsychotic|atypical antipsychotic
1649951|NCT00197834|Behavioral Symptoms|behavioral symptoms
1649952|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
1649953|NCT00197834|Psychological Symptoms|psychological symptoms
1649954|NCT00197834|Geriatric|geriatric
1649955|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
1649956|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
1649957|NCT00197808|Neisseria meningitidis|neisseria meningitidis
1649958|NCT00197756|HIV|hiv
1649959|NCT00197756|Breastfeeding|breastfeeding
1649960|NCT00197756|Vitamins|vitamins
1649961|NCT00197756|Tanzania|tanzania
1649962|NCT00197756|Children|children
1649963|NCT00197743|HIV|hiv
1649964|NCT00197743|Multivitamins|multivitamins
1649965|NCT00197743|Pregnancy outcomes|pregnancy outcomes
1649966|NCT00197743|Tanzania|tanzania
1649967|NCT00197743|Women|women
1649968|NCT00197730|Birth Outcomes|birth outcomes
1649969|NCT00197730|Nutrition|nutrition
1649970|NCT00197730|HIV|hiv
1649971|NCT00197730|AIDS|aids
1649972|NCT00197730|Vitamins|vitamins
1649973|NCT00197730|Multivitamins|multivitamins
1649974|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
1649975|NCT00197730|Tanzania|tanzania
1649976|NCT00197730|Africa|africa
1649977|NCT00197704|Tuberculosis|tuberculosis
1649978|NCT00197704|HIV|hiv
1649979|NCT00197704|Tanzania|tanzania
1649980|NCT00197704|multivitamins|multivitamins
1649981|NCT00197691|HIV infected mothers|hiv infected mothers
1649982|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
1649983|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
1649984|NCT00197691|Infant bloodstream infection|infant bloodstream infection
1649985|NCT00197678|HIV|hiv
1649986|NCT00197678|AIDS|aids
1649987|NCT00197678|Multivitamins|multivitamins
1649988|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
1649989|NCT00197678|Women|women
1649990|NCT00197678|Tanzania|tanzania
1649991|NCT00197678|Africa|africa
1650093|NCT00196989|Efficacy|efficacy
1649992|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
1649993|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
1649994|NCT00197561|HIV|hiv
1649995|NCT00197561|Selenium|selenium
1649996|NCT00197561|Nutrition|nutrition
1649997|NCT00197561|Women|women
1649998|NCT00197561|Pregnancy|pregnancy
1649999|NCT00197561|Tanzania|tanzania
1650000|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
1650001|NCT00197561|HIV/AIDS|hiv/aids
1650002|NCT00197561|Pregnancy Outcome|pregnancy outcome
1650003|NCT00197548|Women|women
1650004|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
1650005|NCT00197548|Nutrition|nutrition
1650006|NCT00197548|Vitamins|vitamins
1650007|NCT00197548|Tanzania|tanzania
1650008|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
1650009|NCT00197522|breast cancer|breast cancer
1650010|NCT00197522|vaccination|vaccination
1650011|NCT00197522|dendritic cells|dendritic cells
1650012|NCT00197522|HER-2|her-2
1650013|NCT00197522|CD34+ stem cells|cd34+ stem cells
1650014|NCT00197509|Long-Term Care|long-term care
1650015|NCT00197509|Clinical Protocols|clinical protocols
1650016|NCT00197509|Sit-To-Stand|sit-to-stand
1650017|NCT00197483|Pergolide|pergolide
1650018|NCT00197483|Dopamine D1|dopamine d1
1650019|NCT00197483|Schizophrenia|schizophrenia
1650020|NCT00197483|Cognitive disturbance|cognitive disturbance
1650021|NCT00197483|Negative symptoms|negative symptoms
1650022|NCT00197444|esophageal cancer|esophageal cancer
1650023|NCT00197444|Nedaplatin|nedaplatin
1650024|NCT00197444|5-FU|5-fu
1650025|NCT00197444|chemotherapy|chemotherapy
1650026|NCT00197444|radiation|radiation
1650027|NCT00197444|chemoradiotherapy|chemoradiotherapy
1650028|NCT00197418|H. pylori infection|h. pylori infection
1650031|NCT00197379|androgenetic alopecia|androgenetic alopecia
1650032|NCT00197379|roxitromycin|roxitromycin
1650033|NCT00197379|apoptosis|apoptosis
1650034|NCT00197366|pregnancy|pregnancy
1650035|NCT00197366|HIV-positive|hiv-positive
1650036|NCT00197366|HIV resistance|hiv resistance
1650038|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
1650039|NCT00197353|Pharmacology|pharmacology
1650040|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
1650041|NCT00197353|Sympathectomy|sympathectomy
1650042|NCT00197353|Photoplethysmography|photoplethysmography
1650043|NCT00197340|Pre-Eclampsia|pre-eclampsia
1650044|NCT00197340|Fetal Growth Retardation|fetal growth retardation
1650045|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
1650046|NCT00197340|Placental Circulation|placental circulation
1650047|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
1650048|NCT00197327|Labor Pain|labor pain
1650049|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
1650050|NCT00197327|Pharmacology|pharmacology
1650051|NCT00197327|Treatment Outcome|treatment outcome
1650052|NCT00197314|Urinary stress incontinence|urinary stress incontinence
1650053|NCT00197314|Randomized trial|randomized trial
1650054|NCT00197314|circular muscle training|circular muscle training
1650055|NCT00197314|pelvic floor training|pelvic floor training
1650056|NCT00197314|bioequivalence|bioequivalence
1650057|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
1650058|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
1650059|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
1650060|NCT00197275|diphtheria|diphtheria
1650061|NCT00197275|tetanus|tetanus
1650062|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
1650063|NCT00197275|pertussis|pertussis
1650064|NCT00197275|hepatitis B|hepatitis b
1650065|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
1650066|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1650067|NCT00197262|GW685698X|gw685698x
1650068|NCT00197262|allergic rhinitis|allergic rhinitis
1650069|NCT00197262|Hayfever|hayfever
1650070|NCT00197249|Hepatitis A & B|hepatitis a & b
1650071|NCT00197249|Typhoid|typhoid
1650072|NCT00197236|Hepatitis A|hepatitis a
1650073|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
1650074|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
1650075|NCT00197184|Twinrix™|twinrix™
1650076|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
1650077|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
1650078|NCT00197119|Hepatitis B|hepatitis b
1650079|NCT00197119|TWINRIX™ Adult|twinrix™ adult
1650080|NCT00197119|Hepatitis A|hepatitis a
1650081|NCT00197119|TWINRIX™ Junior|twinrix™ junior
1650082|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
1650083|NCT00197106|Asthma|asthma
1650084|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1650085|NCT00197106|Children|children
1650086|NCT00197106|symptom control|symptom control
1650087|NCT00197093|Schizophrenia|schizophrenia
1650088|NCT00197093|safety|safety
1650089|NCT00197093|tolerability|tolerability
1650090|NCT00197093|pharmacokinetics|pharmacokinetics
1650091|NCT00197080|Restless Legs Syndrome|restless legs syndrome
1650094|NCT00196989|PPARpan|pparpan
1650095|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1650096|NCT00196989|Phase IIb|phase iib
1650097|NCT00196989|Safety|safety
1650098|NCT00196989|Pharmacokinetics|pharmacokinetics
1650099|NCT00196989|GW677954|gw677954
1650100|NCT00196989|Pharmacodynamics|pharmacodynamics
1650101|NCT00196989|Tolerability|tolerability
1650102|NCT00196989|Dose-Ranging|dose-ranging
1650103|NCT00196976|Safety|safety
1650104|NCT00196976|Meningococcal vaccine|meningococcal vaccine
1650105|NCT00196976|Dose selection|dose selection
1650106|NCT00196976|Toddlers|toddlers
1650107|NCT00196976|Immunogenicity|immunogenicity
1650108|NCT00196976|Conjugate vaccine|conjugate vaccine
1650109|NCT00196976|Reactogenicity|reactogenicity
1650110|NCT00196976|Children|children
1650111|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
1650112|NCT00196898|Parkinson´s disease|parkinson´s disease
1650113|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
1650114|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
1650115|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
1650116|NCT00196885|cancer cachexia|cancer cachexia
1650117|NCT00196885|muscle wasting|muscle wasting
1650118|NCT00196885|weight loss|weight loss
1650119|NCT00196885|proteolysis|proteolysis
1650120|NCT00196872|dose dense sequence|dose dense sequence
1650121|NCT00196872|dose dense combination|dose dense combination
1650122|NCT00196872|node positive disease|node positive disease
1650123|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
1650124|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
1650125|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
1650126|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
1650127|NCT00196846|P.O.F.|p.o.f.
1650128|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
1650129|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
1650130|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
1650131|NCT00196833|Study|study
1650132|NCT00196820|Metastatic breast cancer|metastatic breast cancer
1650133|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
1650134|NCT00196807|prostate cancer screening|prostate cancer screening
1650135|NCT00196807|medical decision making|medical decision making
1650136|NCT00196807|informed decision making|informed decision making
1650137|NCT00196807|patient education|patient education
1650138|NCT00196807|male|male
1650139|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
1650140|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1650141|NCT00196794|C. difficile|c. difficile
1650142|NCT00196794|CDAD|cdad
1650143|NCT00196781|prostate cancer treatment|prostate cancer treatment
1650144|NCT00196781|medical decision making|medical decision making
1650145|NCT00196781|informed decision making|informed decision making
1650146|NCT00196781|shared decision making|shared decision making
1650147|NCT00196781|decision aid|decision aid
1650148|NCT00196781|patient education|patient education
1650149|NCT00196768|relapsed|relapsed
1650150|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
1650151|NCT00196768|arsenic|arsenic
1650152|NCT00196742|alpha Galactosidase A|alpha galactosidase a
1650153|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
1650154|NCT00196742|Fabry|fabry
1650155|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
1650156|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
1650157|NCT00196742|angiokeratomas|angiokeratomas
1650158|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
1650159|NCT00196742|errors in metabolism|errors in metabolism
1650160|NCT00196716|alpha Galactosidase A|alpha galactosidase a
1650161|NCT00196716|aGAL|agal
1650162|NCT00196716|rh aGAL|rh agal
1650163|NCT00196716|Fabry|fabry
1650165|NCT00196716|Fabrazyme|fabrazyme
1650166|NCT00196703|Aphasia|aphasia
1650167|NCT00196703|Memantine|memantine
1650168|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
1650169|NCT00196703|Event-related potentials|event-related potentials
1650170|NCT00196690|Aphasia|aphasia
1650171|NCT00196690|Donepezil|donepezil
1650172|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
1650173|NCT00196664|Paroxetine|paroxetine
1650174|NCT00196664|Depression|depression
1650175|NCT00196651|HIV infection|hiv infection
1650176|NCT00196651|AIDS Vaccines|aids vaccines
1650177|NCT00196651|ALVAC vaccine|alvac vaccine
1650178|NCT00196651|Interleukin-2|interleukin-2
1650179|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1650180|NCT00196638|HIV infections|hiv infections
1650181|NCT00196638|Primary acute infection|primary acute infection
1650182|NCT00196638|Interferon-alpha|interferon-alpha
1650183|NCT00196625|HIV infections|hiv infections
1650184|NCT00196625|Salvage therapy|salvage therapy
1650185|NCT00196625|Amprenavir|amprenavir
1650186|NCT00196625|Lopinavir|lopinavir
1650187|NCT00196625|Ritonavir|ritonavir
1650188|NCT00196612|HIV Infections|hiv infections
1650189|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1650190|NCT00196612|Treatment simplification|treatment simplification
1650191|NCT00196599|HIV infections|hiv infections
1650192|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1650193|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
1650194|NCT00196586|HIV infection|hiv infection
1650195|NCT00196586|Interleukin-2|interleukin-2
1650196|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
1650197|NCT00196586|ribavirin|ribavirin
1650198|NCT00196573|Rotator Cuff|rotator cuff
1650199|NCT00196573|Tendinosis|tendinosis
1650200|NCT00196573|Impingement Syndrome|impingement syndrome
1650201|NCT00196573|Partial Thickness Tears|partial thickness tears
1650202|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
1650203|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
1650204|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
1650205|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
1650206|NCT00196547|Asthma|asthma
1650207|NCT00196547|Respiratory viral infections|respiratory viral infections
1650208|NCT00196547|Exacerbations|exacerbations
1650209|NCT00196547|Pediatric|pediatric
1650210|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
1650211|NCT00196547|School|school
1650212|NCT00196508|Childbirth|childbirth
1650213|NCT00196482|growth|growth
1650214|NCT00196482|oral feeding|oral feeding
1650215|NCT00196482|nutrition|nutrition
1650216|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
1650217|NCT00196456|Periodontol disease|periodontol disease
1650218|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1650219|NCT00196417|HIT|hit
1650220|NCT00196417|unfractionated heparin|unfractionated heparin
1650221|NCT00196417|UFH|ufh
1650222|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
1650223|NCT00196417|LMWH|lmwh
1650224|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
1650225|NCT00196417|HIT-antibody|hit-antibody
1650226|NCT00196404|overactive bladder|overactive bladder
1650227|NCT00196404|urge incontinence|urge incontinence
1650228|NCT00196404|urinary incontinence|urinary incontinence
1650229|NCT00196391|secondary amenorrhea|secondary amenorrhea
1650230|NCT00196391|progesterone|progesterone
1650231|NCT00196378|vaginal atrophy|vaginal atrophy
1650232|NCT00196378|vaginal dryness|vaginal dryness
1650233|NCT00196378|vaginal itching|vaginal itching
1650234|NCT00196378|vaginal pain|vaginal pain
1650235|NCT00196378|dyspareunia|dyspareunia
1650236|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
1650237|NCT00196365|dysmenorrhea|dysmenorrhea
1650238|NCT00196352|oral contraceptives|oral contraceptives
1650239|NCT00196352|birth control|birth control
1650240|NCT00196352|ethinyl estradiol|ethinyl estradiol
1650241|NCT00196352|pregnancy prevention|pregnancy prevention
1650242|NCT00196339|prostate cancer|prostate cancer
1650243|NCT00196339|hot flashes|hot flashes
1650244|NCT00196339|hot flushes|hot flushes
1650245|NCT00196339|vasomotor symptoms|vasomotor symptoms
1650246|NCT00196326|pregnancy prevention|pregnancy prevention
1650247|NCT00196326|oral contraceptives|oral contraceptives
1650248|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
1650249|NCT00196313|dysmenorrhea|dysmenorrhea
1650250|NCT00196313|oral contraceptives|oral contraceptives
1650251|NCT00196300|Assessment, Risk|assessment, risk
1650252|NCT00196300|Autonomic nervous system|autonomic nervous system
1650253|NCT00196300|Aged|aged
1650254|NCT00196287|Assessment, risk|assessment, risk
1650255|NCT00196287|autonomic nervous system|autonomic nervous system
1650256|NCT00196287|Gender|gender
1650257|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
1650258|NCT00196274|Assessment, Risk|assessment, risk
1650259|NCT00196261|Assessment, Risk|assessment, risk
1650260|NCT00196261|Autonomic nervous system|autonomic nervous system
1650261|NCT00196235|Assessment, Risk|assessment, risk
1650262|NCT00196235|Diabetes mellitus|diabetes mellitus
1650263|NCT00196235|Autonomic nervous system|autonomic nervous system
1650264|NCT00196209|atrial fibrillation|atrial fibrillation
1650265|NCT00196209|catheter ablation|catheter ablation
1650266|NCT00196196|Hydrocephalus|hydrocephalus
1650267|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
1650268|NCT00196196|Programmable Valve|programmable valve
1650269|NCT00196196|Shunt System|shunt system
1650270|NCT00196131|morphine|morphine
1650271|NCT00196131|head injury|head injury
1650272|NCT00196131|SAH|sah
1650273|NCT00196118|Pulmonary Embolism|pulmonary embolism
1650274|NCT00196118|Venous Thromboembolism|venous thromboembolism
1650275|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
1650276|NCT00196118|IVC|ivc
1650277|NCT00196118|PE|pe
1650278|NCT00196105|Stents|stents
1650279|NCT00196105|Stent-graft|stent-graft
1650280|NCT00196105|Minimally invasive|minimally invasive
1650281|NCT00196105|Biliary Tract Cancer|biliary tract cancer
1650282|NCT00196105|Pancreatic Cancer|pancreatic cancer
1650283|NCT00196105|Jaundice|jaundice
1650284|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
1650285|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
1650286|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
1650287|NCT00196105|Zilver|zilver
1650894|NCT00192582|Care plan|care plan
1650288|NCT00196079|coronary artery|coronary artery
1650289|NCT00196079|stenosis|stenosis
1650290|NCT00196079|drug eluting stent|drug eluting stent
1650291|NCT00196079|stent|stent
1650292|NCT00196053|Intrathecal pain management|intrathecal pain management
1650293|NCT00196053|constant flow pump|constant flow pump
1650294|NCT00196014|Registered Nurses|registered nurses
1650295|NCT00196014|Workload|workload
1650296|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
1650297|NCT00196001|Adrenal sufficiency|adrenal sufficiency
1650298|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
1650299|NCT00196001|G proteins|g proteins
1650300|NCT00195988|immunosuppression,|immunosuppression,
1650301|NCT00195988|steroid avoidance,|steroid avoidance,
1650302|NCT00195988|liver transplantation,|liver transplantation,
1650303|NCT00195988|children|children
1650304|NCT00195975|Abdominal Pain|abdominal pain
1650305|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
1650306|NCT00195975|Stress|stress
1650307|NCT00195975|Anxiety|anxiety
1650308|NCT00195975|Autonomic Nervous System|autonomic nervous system
1650309|NCT00195962|Breastfeeding|breastfeeding
1650310|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
1650311|NCT00195949|Pyloric Stenosis|pyloric stenosis
1650312|NCT00195949|Laparoscopy|laparoscopy
1650313|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
1650315|NCT00195936|PTH|pth
1650316|NCT00195936|XLH|xlh
1650317|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
1650318|NCT00195923|appendicitis|appendicitis
1650319|NCT00195923|perforation|perforation
1650320|NCT00195910|Acute|acute
1650321|NCT00195910|Pain|pain
1650322|NCT00195910|Emergency Department|emergency department
1650323|NCT00195910|Morphine|morphine
1650324|NCT00195910|Hydromorphone|hydromorphone
1650325|NCT00195910|Dilaudid|dilaudid
1650326|NCT00195897|Lymphoma|lymphoma
1650327|NCT00195897|Anthracyclines|anthracyclines
1650328|NCT00195897|Heart Failure|heart failure
1650329|NCT00195897|Radionuclide|radionuclide
1650330|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
1650331|NCT00195897|Troponin|troponin
1650332|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
1650333|NCT00195884|Diabetes Mellitus|diabetes mellitus
1650334|NCT00195884|Type 2 Diabetes|type 2 diabetes
1650335|NCT00195884|Aerobic|aerobic
1650336|NCT00195884|Resistance|resistance
1650337|NCT00195884|weight training|weight training
1650338|NCT00195884|Exercise|exercise
1650339|NCT00195871|Non-Hodgkin|non-hodgkin
1650340|NCT00195871|Lymphoma|lymphoma
1650341|NCT00195871|Lymphoblastic|lymphoblastic
1650342|NCT00195858|Youth|youth
1650343|NCT00195858|Exercise|exercise
1650344|NCT00195858|Physical Activity|physical activity
1650345|NCT00195858|Aerobic|aerobic
1650346|NCT00195858|Resistance|resistance
1650347|NCT00195858|Overweight|overweight
1650348|NCT00195858|obese|obese
1650349|NCT00195858|Canada|canada
1650350|NCT00195858|Sigal|sigal
1650351|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
1650352|NCT00195819|adalimumab|adalimumab
1650353|NCT00195806|Migraine|migraine
1650354|NCT00195806|Depakote ER|depakote er
1650355|NCT00195806|Divalproex sodium|divalproex sodium
1650356|NCT00195793|Hyperlipidemia|hyperlipidemia
1650357|NCT00195793|fenofibrate|fenofibrate
1650358|NCT00195793|ezetimibe|ezetimibe
1650359|NCT00195793|atorvastatin|atorvastatin
1650360|NCT00195780|Bipolar I Disorder|bipolar i disorder
1650361|NCT00195780|Depakote|depakote
1650362|NCT00195767|Bipolar I Disorder|bipolar i disorder
1650363|NCT00195767|Depakote ER|depakote er
1650364|NCT00195767|divalproex sodium|divalproex sodium
1650365|NCT00195754|Migraines|migraines
1650366|NCT00195754|Depakote ER|depakote er
1650367|NCT00195754|divalproex sodium|divalproex sodium
1650368|NCT00195741|Migraine|migraine
1650369|NCT00195741|Depakote ER|depakote er
1650370|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
1650371|NCT00195728|Vicodin CR|vicodin cr
1650372|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
1650373|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
1650374|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
1650375|NCT00195637|GNE Gene|gne gene
1650376|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
1650377|NCT00195637|Sialic Acid|sialic acid
1650378|NCT00195637|Glycosylation|glycosylation
1650379|NCT00195637|Dystroglycanopathy|dystroglycanopathy
1650380|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
1650381|NCT00195637|Immune Globulin|immune globulin
1650382|NCT00195637|HIBM|hibm
1650383|NCT00195624|Immunosuppression|immunosuppression
1650384|NCT00195624|Alemtuzumab/Campath|alemtuzumab/campath
1650385|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
1650386|NCT00195624|T-cells|t-cells
1650387|NCT00195624|Hematopoiesis|hematopoiesis
1650388|NCT00195624|Autoimmunity|autoimmunity
1650389|NCT00195624|Thrombocytopenia|thrombocytopenia
1650390|NCT00195624|Neutropenia|neutropenia
1650392|NCT00195611|Middle Ear Infection|middle ear infection
1650393|NCT00195598|Panic Disorders|panic disorders
1650394|NCT00195585|Colon Cancer|colon cancer
1650395|NCT00195572|Gastric Cancer|gastric cancer
1650396|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
1650397|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
1650398|NCT00195559|Hormone Therapy|hormone therapy
1650399|NCT00195546|Menopause|menopause
1650400|NCT00195533|Leukemia|leukemia
1650401|NCT00195533|Lymphoma|lymphoma
1650402|NCT00195533|Myeloma|myeloma
1650403|NCT00195520|Menopause|menopause
1650404|NCT00195520|Sleep Disorder|sleep disorder
1650405|NCT00195520|Hot Flashes|hot flashes
1650406|NCT00195507|Psoriasis|psoriasis
1650407|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
1650408|NCT00195481|Kidney|kidney
1650409|NCT00195481|Transplant|transplant
1650410|NCT00195468|Kidney Failure|kidney failure
1650411|NCT00195468|Transplant|transplant
1650412|NCT00195455|Postmenopause|postmenopause
1650413|NCT00195442|Hemophilia A|hemophilia a
1650414|NCT00195429|Kidney|kidney
1650415|NCT00195429|Transplant|transplant
1650416|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
1650417|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
1650418|NCT00195390|Vaccine|vaccine
1650419|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
1650420|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
1650624|NCT00194298|hypoxia|hypoxia
1650421|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
1650422|NCT00195351|Appendicitis with abscess|appendicitis with abscess
1650423|NCT00195351|Perforated diverticulitis|perforated diverticulitis
1650424|NCT00195351|Purulent peritonitis|purulent peritonitis
1650425|NCT00195351|Complicated cholecystitis|complicated cholecystitis
1650426|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
1650427|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
1650428|NCT00195312|HIV|hiv
1650429|NCT00195312|Vaccine|vaccine
1650430|NCT00195312|Treatment Experienced|treatment experienced
1650431|NCT00195299|Carcinoma|carcinoma
1650432|NCT00195299|Head|head
1650433|NCT00195299|Neck|neck
1650434|NCT00195286|Urinary Infections|urinary infections
1650435|NCT00195273|Kidney|kidney
1650436|NCT00195273|Transplant|transplant
1650437|NCT00195260|Solid tumors|solid tumors
1650438|NCT00195247|Tumors|tumors
1650439|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
1650440|NCT00195234|HIV|hiv
1650441|NCT00195234|Treatment Experienced|treatment experienced
1650442|NCT00195221|Hemophilia B|hemophilia b
1650443|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
1650444|NCT00195195|Transplantation|transplantation
1650445|NCT00195182|Hypertension|hypertension
1650446|NCT00195182|African-American|african-american
1650447|NCT00195182|Perceived Racism|perceived racism
1650448|NCT00195182|Psychological Stress|psychological stress
1650449|NCT00195182|Medication Adherence|medication adherence
1650450|NCT00195169|Myocardial Infarction|myocardial infarction
1650451|NCT00195169|Social support|social support
1650452|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
1650453|NCT00195143|Parkinson's disease|parkinson's disease
1650454|NCT00195143|GABA|gaba
1650455|NCT00195143|Subthalamic nucleus|subthalamic nucleus
1650456|NCT00195143|Adeno-associated virus|adeno-associated virus
1650457|NCT00195143|AAV|aav
1650458|NCT00195143|Gene therapy|gene therapy
1650459|NCT00195130|prognosis|prognosis
1650460|NCT00195130|risk of death|risk of death
1650461|NCT00195130|morbidity|morbidity
1650462|NCT00195130|mortality|mortality
1650463|NCT00195130|quality of life|quality of life
1650464|NCT00195117|Asthma|asthma
1650465|NCT00195117|Behavior change|behavior change
1650466|NCT00195117|Physical activity|physical activity
1650467|NCT00195117|Risk reduction|risk reduction
1650468|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
1650469|NCT00195078|head and neck cancer|head and neck cancer
1650470|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
1650471|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
1650472|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
1650473|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
1650474|NCT00195065|Asthma|asthma
1650475|NCT00195065|Behavior change|behavior change
1650476|NCT00195065|Physical activity|physical activity
1650477|NCT00195065|Risk reduction|risk reduction
1650478|NCT00195052|epilepsy|epilepsy
1650479|NCT00195052|optical imaging|optical imaging
1650480|NCT00195052|optical mapping|optical mapping
1650481|NCT00195039|Prostate Cancer|prostate cancer
1650482|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
1650483|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
1650484|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
1650485|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
1650486|NCT00194974|pregnancy|pregnancy
1650487|NCT00194974|chronic hypertension|chronic hypertension
1650488|NCT00194974|Toxemia|toxemia
1650489|NCT00194974|Blood Pressure|blood pressure
1650490|NCT00194961|Chronic Kidney Disease|chronic kidney disease
1650491|NCT00194961|Growth Failure|growth failure
1650492|NCT00194961|Cytokines|cytokines
1650493|NCT00194961|leptin|leptin
1650494|NCT00194935|Ovarian Cancer|ovarian cancer
1650495|NCT00194935|Cancer of the Ovary|cancer of the ovary
1650496|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
1650497|NCT00194896|autoantibodies|autoantibodies
1650498|NCT00194896|islet proteins|islet proteins
1650499|NCT00194896|rosiglitazone|rosiglitazone
1650500|NCT00194896|glyburide|glyburide
1650501|NCT00194896|c-peptide|c-peptide
1650502|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
1650503|NCT00194883|Leptin|leptin
1650504|NCT00194883|Cytokines|cytokines
1650505|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
1650506|NCT00194883|Children|children
1650507|NCT00194870|EEG|eeg
1650508|NCT00194870|DBS|dbs
1650509|NCT00194857|anemia|anemia
1650510|NCT00194857|dose reduction|dose reduction
1650511|NCT00194857|neutropenia|neutropenia
1650512|NCT00194857|hepatitis C virus|hepatitis c virus
1650513|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
1650514|NCT00194844|caring|caring
1650515|NCT00194844|miscarriage|miscarriage
1650516|NCT00194844|grief|grief
1650517|NCT00194844|couples|couples
1650518|NCT00194844|counseling|counseling
1650519|NCT00194805|Internet|internet
1650520|NCT00194805|Diabetes|diabetes
1650521|NCT00194805|Education|education
1650522|NCT00194805|Social Support|social support
1650523|NCT00194766|Breast cancer|breast cancer
1650524|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
1650525|NCT00194753|Breast cancer|breast cancer
1650526|NCT00194740|Breast cancer|breast cancer
1650527|NCT00194727|Breast cancer|breast cancer
1650528|NCT00194701|heart failure|heart failure
1650531|NCT00194701|heart rate variability|heart rate variability
1650532|NCT00194688|ammonia|ammonia
1650533|NCT00194675|androgen deficiency|androgen deficiency
1650534|NCT00194675|testosterone|testosterone
1650535|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1650536|NCT00194675|hypogonadism|hypogonadism
1650537|NCT00194675|prostate|prostate
1650538|NCT00194675|BPH|bph
1650539|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
1650540|NCT00194636|Prostatitis|prostatitis
1650541|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
1650542|NCT00194623|prostatitis|prostatitis
1650543|NCT00194597|Prostatitis|prostatitis
1650544|NCT00194584|children|children
1650545|NCT00194584|chronic illness|chronic illness
1650546|NCT00194584|parent education|parent education
1650547|NCT00194584|parent support|parent support
1650548|NCT00194571|breast cancer,|breast cancer,
1650549|NCT00194571|child functioning,|child functioning,
1650550|NCT00194571|parenting,|parenting,
1650551|NCT00194571|self-efficacy,|self-efficacy,
1650552|NCT00194571|psychoeducational intervention|psychoeducational intervention
1650553|NCT00194571|counseling|counseling
1650554|NCT00194558|Diabetes|diabetes
1650555|NCT00194558|Health Education|health education
1650556|NCT00194558|Information Technology|information technology
1650557|NCT00194558|Disease Management|disease management
1650558|NCT00194558|Internet|internet
1650559|NCT00194558|Patient Education|patient education
1650560|NCT00194545|HIV-1|hiv-1
1650561|NCT00194545|pediatric adherence|pediatric adherence
1650562|NCT00194545|medication diaries|medication diaries
1650563|NCT00194545|HAART|haart
1650564|NCT00194545|Treatment Naive|treatment naive
1650565|NCT00194532|UTI|uti
1650566|NCT00194519|HIV infection|hiv infection
1650567|NCT00194519|HIV transmission|hiv transmission
1650568|NCT00194519|genital herpes|genital herpes
1650569|NCT00194519|sexual intercourse|sexual intercourse
1650570|NCT00194519|sexual transmitted infection|sexual transmitted infection
1650571|NCT00194519|acyclovir|acyclovir
1650572|NCT00194519|HIV Seronegativity|hiv seronegativity
1650573|NCT00194519|Treatment Naive|treatment naive
1650574|NCT00194519|HIV-discordant couples|hiv-discordant couples
1650575|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
1650576|NCT00194506|Diabetes|diabetes
1650577|NCT00194506|Health Education|health education
1650578|NCT00194506|Information Technology|information technology
1650579|NCT00194506|Disease Management|disease management
1650580|NCT00194506|Internet|internet
1650581|NCT00194506|Patient Education|patient education
1650582|NCT00194493|Cancer|cancer
1650583|NCT00194493|Quality of Life|quality of life
1650584|NCT00194493|Signs and Symptoms|signs and symptoms
1650585|NCT00194493|Computers|computers
1650586|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
1650587|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
1650588|NCT00194454|Depressive symptoms|depressive symptoms
1650589|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
1650590|NCT00194454|Recovery|recovery
1650591|NCT00194441|cerebral circulation|cerebral circulation
1650592|NCT00194441|monitoring, physiologic|monitoring, physiologic
1650593|NCT00194441|informatics|informatics
1650594|NCT00194441|nursing care|nursing care
1650595|NCT00194441|physiologic variability|physiologic variability
1650596|NCT00194441|outcome|outcome
1651689|NCT00187096|Myeloid|myeloid
1650597|NCT00194441|quality adjusted life years|quality adjusted life years
1650598|NCT00194428|Obesity,|obesity,
1650599|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
1650600|NCT00194428|BMI|bmi
1650601|NCT00194402|cholesterol|cholesterol
1650602|NCT00194402|dyslipidemia|dyslipidemia
1650603|NCT00194402|hypercholesterolemia|hypercholesterolemia
1650604|NCT00194402|C-reactive protein|c-reactive protein
1650605|NCT00194363|breast cancer|breast cancer
1650606|NCT00194363|breast cancer survivors|breast cancer survivors
1650607|NCT00194363|lymphedema|lymphedema
1650608|NCT00194363|strength training|strength training
1650609|NCT00194363|breast cancer survivorship|breast cancer survivorship
1650610|NCT00194350|Infertility|infertility
1650611|NCT00194350|Factor V Leiden|factor v leiden
1650612|NCT00194337|stage I breast cancer|stage i breast cancer
1650613|NCT00194337|stage II breast cancer|stage ii breast cancer
1650614|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
1650615|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
1650616|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
1650617|NCT00194337|stage IV breast cancer|stage iv breast cancer
1650618|NCT00194311|HPV|hpv
1650619|NCT00194311|Pregnancy|pregnancy
1650620|NCT00194298|diabetic foot disease|diabetic foot disease
1650621|NCT00194298|osteomyelitis|osteomyelitis
1650622|NCT00194298|charcot|charcot
1650623|NCT00194298|neuropathy|neuropathy
1650625|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
1650626|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
1650627|NCT00194285|Prosthesis|prosthesis
1650628|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
1650629|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
1650630|NCT00194272|Ectopic pregnancy|ectopic pregnancy
1650631|NCT00194272|Methotrexate|methotrexate
1650632|NCT00194233|Endometriosis|endometriosis
1650633|NCT00194220|Infertility|infertility
1650634|NCT00194220|Oxidative stress|oxidative stress
1650635|NCT00194207|Ectopic pregnancy|ectopic pregnancy
1650636|NCT00194194|BMI|bmi
1650637|NCT00194194|RMR|rmr
1650638|NCT00194194|Personal Computer|personal computer
1650639|NCT00194181|dialysis|dialysis
1650640|NCT00194181|fibrin|fibrin
1650641|NCT00194181|sheath|sheath
1650642|NCT00194181|clot|clot
1650643|NCT00194181|tpa|tpa
1650644|NCT00194168|ectopic pregnancy|ectopic pregnancy
1650645|NCT00194155|cytomegalovirus|cytomegalovirus
1650646|NCT00194155|pregnancy|pregnancy
1650647|NCT00194155|placenta|placenta
1650648|NCT00194142|Pregnancy|pregnancy
1650649|NCT00194142|Cytomegalovirus|cytomegalovirus
1650650|NCT00194090|pain|pain
1650651|NCT00194090|osteoarthritis|osteoarthritis
1650652|NCT00194051|obesity|obesity
1650653|NCT00194051|gait biomechanics|gait biomechanics
1650654|NCT00194051|knee osteoarthritis|knee osteoarthritis
1650655|NCT00194038|Bipolar Disorder|bipolar disorder
1650656|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
1650657|NCT00194038|Aripiprazole|aripiprazole
1650658|NCT00194025|Schizophrenia|schizophrenia
1650659|NCT00194025|Anticonvulsants|anticonvulsants
1650660|NCT00194025|Valproic Acid|valproic acid
1650661|NCT00194025|Valproate|valproate
1650662|NCT00194012|bipolar disorder|bipolar disorder
1650663|NCT00193999|Nasogastric Tubes|nasogastric tubes
1650664|NCT00193999|Nausea|nausea
1650665|NCT00193999|Vomiting|vomiting
1650666|NCT00193999|Cardiac surgery|cardiac surgery
1650667|NCT00193986|Prepulse|prepulse
1650668|NCT00193986|Defibrillator|defibrillator
1650669|NCT00193973|Lymphoma|lymphoma
1650670|NCT00193973|PCNSL|pcnsl
1650671|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
1650672|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
1650673|NCT00193934|Women's Health|women's health
1650674|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
1650675|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
1650676|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
1650677|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
1650678|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
1650679|NCT00193934|Patient Management Strategies|patient management strategies
1650680|NCT00193934|Selecting patients for therapy|selecting patients for therapy
1650681|NCT00193921|Chemoradiotherapy|chemoradiotherapy
1650682|NCT00193921|High dose|high dose
1650683|NCT00193921|palliative radiotherapy|palliative radiotherapy
1650684|NCT00193921|Quality of life|quality of life
1650685|NCT00193908|Skin care|skin care
1650686|NCT00193908|Radiotherapy|radiotherapy
1650687|NCT00193895|Skin cancer|skin cancer
1650688|NCT00193895|radiotherapy|radiotherapy
1650689|NCT00193895|chemotherapy|chemotherapy
1650690|NCT00193895|surgery|surgery
1650691|NCT00193882|Oesophageal|oesophageal
1650692|NCT00193882|Dysphagia|dysphagia
1650693|NCT00193882|Palliation|palliation
1650694|NCT00193882|Quality of Life|quality of life
1650695|NCT00193882|Radiotherapy|radiotherapy
1650696|NCT00193882|Chemotherapy|chemotherapy
1650697|NCT00193869|Radiotherapy|radiotherapy
1650698|NCT00193869|Dose fractionation|dose fractionation
1650699|NCT00193856|Prostate Cancer|prostate cancer
1650700|NCT00193856|Androgen Deprivation|androgen deprivation
1650701|NCT00193856|Hormone Therapy|hormone therapy
1650702|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
1650703|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
1650704|NCT00193843|Oral cancer|oral cancer
1650705|NCT00193843|Head and neck surgery|head and neck surgery
1650706|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
1650707|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
1650708|NCT00193830|Cervical Cancer|cervical cancer
1650709|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
1650710|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
1650711|NCT00193830|Acute Toxicities|acute toxicities
1650712|NCT00193830|Late Radiation Sequelae|late radiation sequelae
1650713|NCT00193817|Cancer|cancer
1650714|NCT00193817|Esophagus|esophagus
1650715|NCT00193817|Lymphadenectomy|lymphadenectomy
1650716|NCT00193804|Cervical Cancer|cervical cancer
1650717|NCT00193804|FIGO STAGE IIB|figo stage iib
1650718|NCT00193804|CHEMORADIATION|chemoradiation
1650719|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
1650720|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
1650721|NCT00193804|Cancer of the Cervix|cancer of the cervix
1650722|NCT00193804|Cervix Cancer|cervix cancer
1650723|NCT00193791|Carcinoma Cervix|carcinoma cervix
1650724|NCT00193791|FIGO Stage IIIB|figo stage iiib
1650725|NCT00193791|Radiation therapy|radiation therapy
1650726|NCT00193791|Chemoradiation|chemoradiation
1650727|NCT00193791|Treatment related toxicities|treatment related toxicities
1650728|NCT00193791|Cervical Cancer|cervical cancer
1650729|NCT00193791|Cervix Cancer|cervix cancer
1650730|NCT00193778|Metastatic breast cancer|metastatic breast cancer
1650731|NCT00193778|Locoregional treatment|locoregional treatment
1650732|NCT00193778|Survival|survival
1650733|NCT00193765|neck dissection|neck dissection
1650734|NCT00193765|survival|survival
1650735|NCT00193765|early oral cancer|early oral cancer
1650736|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
1650737|NCT00193752|FDG-PET Imaging|fdg-pet imaging
1650738|NCT00193752|Cervical Cancer|cervical cancer
1650739|NCT00193752|Post-treatment evaluation|post-treatment evaluation
1650740|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
1650741|NCT00193752|Extended field Radiation|extended field radiation
1650742|NCT00193752|Extended field IMRT|extended field imrt
1650743|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1650745|NCT00193739|Cervix cancer|cervix cancer
1650746|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
1650747|NCT00193726|Estrogen|estrogen
1650748|NCT00193726|Priming|priming
1650749|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
1650750|NCT00193726|Breast cancer|breast cancer
1650751|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
1650752|NCT00193700|Hypogonadism|hypogonadism
1650753|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
1650754|NCT00193674|Pregnancy|pregnancy
1650755|NCT00193674|Immunology|immunology
1650756|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
1650757|NCT00193661|Hypogonadism|hypogonadism
1650758|NCT00193648|FSGS|fsgs
1650759|NCT00193648|Pharmacokinetics|pharmacokinetics
1650760|NCT00193648|Rosiglitazone|rosiglitazone
1650761|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
1650762|NCT00193648|Adalimumab|adalimumab
1650763|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
1650764|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
1650765|NCT00193648|Resistant primary FSGS|resistant primary fsgs
1650766|NCT00193635|Congenital uropathies|congenital uropathies
1650767|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
1650769|NCT00193635|Iothalamate clearance|iothalamate clearance
1650770|NCT00193635|Urine cytometry|urine cytometry
1650771|NCT00193635|Children|children
1650772|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
1650773|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
1650774|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
1650775|NCT00193492|Lymphoma|lymphoma
1650776|NCT00193492|Bevacizumab|bevacizumab
1650777|NCT00193492|Rituximab|rituximab
1650778|NCT00193453|Lung Cancer|lung cancer
1650779|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
1650780|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
1650781|NCT00193297|Ovary Cancer|ovary cancer
1650782|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
1650783|NCT00193258|Bevacizumab|bevacizumab
1650784|NCT00193258|Erlotinib|erlotinib
1650785|NCT00193258|Imatinib|imatinib
1650786|NCT00193219|Colon Cancer|colon cancer
1650787|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
1650788|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
1650789|NCT00193206|Breast Cancer|breast cancer
1650790|NCT00193206|Abraxane|abraxane
1650791|NCT00193206|nab Paclitaxel|nab paclitaxel
1650792|NCT00193206|Epirubicin|epirubicin
1650793|NCT00193206|Gemcitabine|gemcitabine
1650794|NCT00193206|Gemzar|gemzar
1650795|NCT00193180|Breast Cancer|breast cancer
1650796|NCT00193154|Kidney Cancer|kidney cancer
1650797|NCT00193128|Esophagus Cancer|esophagus cancer
1650798|NCT00193037|Breast Cancer|breast cancer
1650799|NCT00192998|Affective disorder|affective disorder
1650800|NCT00192998|Alzheimer dementia|alzheimer dementia
1650801|NCT00192998|healthy controls|healthy controls
1650802|NCT00192972|Catheter ablation|catheter ablation
1650803|NCT00192972|Atrial fibrillation|atrial fibrillation
1650804|NCT00192959|Anaesthesia|anaesthesia
1650805|NCT00192959|Surgery|surgery
1650806|NCT00192959|Postoperative|postoperative
1650807|NCT00192959|Neuropsychological test|neuropsychological test
1650808|NCT00192946|Cardiac resynchronization|cardiac resynchronization
1650809|NCT00192946|Heart failure|heart failure
1650810|NCT00192946|open heart surgery|open heart surgery
1650811|NCT00192946|surgery|surgery
1650812|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
1650813|NCT00192881|Balloon angioplasty|balloon angioplasty
1650814|NCT00192881|Restenosis|restenosis
1650815|NCT00192881|Stents|stents
1650816|NCT00192868|primary PCI|primary pci
1650817|NCT00192868|distal protection|distal protection
1650818|NCT00192868|drug eluting stent|drug eluting stent
1650819|NCT00192868|restenosis|restenosis
1650820|NCT00192855|schizophrenia|schizophrenia
1650821|NCT00192855|negative symptoms|negative symptoms
1650822|NCT00192855|entacapone|entacapone
1650823|NCT00192842|carcinoma|carcinoma
1650824|NCT00192842|pancreas|pancreas
1650825|NCT00192842|gemcitabine|gemcitabine
1650826|NCT00192842|curcumin|curcumin
1650827|NCT00192829|Lung cancer|lung cancer
1650829|NCT00192829|Hypercoagulable|hypercoagulable
1650831|NCT00192803|ace2|ace2
1650832|NCT00192803|NIDDM patients|niddm patients
1650833|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
1650834|NCT00192777|Solid Tumors|solid tumors
1650835|NCT00192777|Bone Metastases|bone metastases
1650836|NCT00192777|Radiotherapy|radiotherapy
1650837|NCT00192777|Xeloda|xeloda
1650838|NCT00192777|Concurrent|concurrent
1650839|NCT00192777|Radiosensitization|radiosensitization
1650840|NCT00192764|large cell lymphoma|large cell lymphoma
1650841|NCT00192764|CHOP|chop
1650842|NCT00192764|cyclophosphamide|cyclophosphamide
1650843|NCT00192764|high-dose|high-dose
1650844|NCT00192751|Schizophrenia|schizophrenia
1650845|NCT00192751|Major depression|major depression
1650846|NCT00192751|Bipolar disorder|bipolar disorder
1650847|NCT00192751|Compliance|compliance
1650848|NCT00192751|Relapse prevention|relapse prevention
1650849|NCT00192738|telephone,|telephone,
1650850|NCT00192738|internal medicine,|internal medicine,
1650851|NCT00192738|readmission,|readmission,
1650852|NCT00192738|patients' satisfaction|patients' satisfaction
1650853|NCT00192725|bipolar disorder|bipolar disorder
1650854|NCT00192725|acute mania|acute mania
1650855|NCT00192725|tryptophan depletion|tryptophan depletion
1650856|NCT00192725|placebo controlled add-on|placebo controlled add-on
1650857|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
1650858|NCT00192712|carcinoma|carcinoma
1650859|NCT00192712|pancreas|pancreas
1650860|NCT00192712|chemotherapy|chemotherapy
1650861|NCT00192712|radiotherapy|radiotherapy
1650862|NCT00192699|Osteoarthritis|osteoarthritis
1650863|NCT00192673|Asparaginase|asparaginase
1650864|NCT00192673|intramuscular administration|intramuscular administration
1650865|NCT00192673|Silent antibodies|silent antibodies
1650866|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1650867|NCT00192673|Side effects|side effects
1650868|NCT00192673|5-year EFS|5-year efs
1650869|NCT00192660|HIV|hiv
1650870|NCT00192660|Metabolic abnormality|metabolic abnormality
1650871|NCT00192660|Lipodystrophy|lipodystrophy
1650872|NCT00192660|Cardiovascular disease|cardiovascular disease
1650873|NCT00192660|Treatment Naive|treatment naive
1650874|NCT00192660|Treatment Experienced|treatment experienced
1650875|NCT00192660|HIV Infections|hiv infections
1650876|NCT00192634|HIV|hiv
1650877|NCT00192634|Antiretroviral therapy|antiretroviral therapy
1650878|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
1650879|NCT00192634|fixed dose combination|fixed dose combination
1650880|NCT00192634|Treatment Experienced|treatment experienced
1650881|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
1650882|NCT00192621|Lipid metabolism|lipid metabolism
1650883|NCT00192621|Glucose metabolism|glucose metabolism
1650884|NCT00192621|Metabolic abnormality|metabolic abnormality
1650885|NCT00192621|Lipodystrophy|lipodystrophy
1650886|NCT00192621|Cardiovascular disease|cardiovascular disease
1650887|NCT00192621|Treatment Naive|treatment naive
1650888|NCT00192621|HIV|hiv
1650889|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
1650890|NCT00192595|Hepatitis B|hepatitis b
1650891|NCT00192595|HIV|hiv
1650892|NCT00192595|Treatment Naive|treatment naive
1650893|NCT00192582|Motivational interview|motivational interview
1650895|NCT00192582|Relapse prevention|relapse prevention
1650896|NCT00192582|Psychoeducation|psychoeducation
1650897|NCT00192582|Indigenous mental health|indigenous mental health
1650898|NCT00192569|Acute Hepatitis C|acute hepatitis c
1650899|NCT00192556|tuberculosis|tuberculosis
1650900|NCT00192556|nutrition|nutrition
1650901|NCT00192556|directly observed therapy|directly observed therapy
1650902|NCT00192556|Timor Leste|timor leste
1650903|NCT00192556|cost-effectiveness|cost-effectiveness
1650904|NCT00192543|dialysis|dialysis
1650905|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
1650906|NCT00192543|antioxidants|antioxidants
1650907|NCT00192543|cardiovascular markers|cardiovascular markers
1650908|NCT00192543|Mortality|mortality
1650909|NCT00192543|End-stage renal disease|end-stage renal disease
1650910|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
1650911|NCT00191282|diabetes|diabetes
1650912|NCT00191282|MI|mi
1650913|NCT00191282|heart attack|heart attack
1650914|NCT00191269|after|after
1650915|NCT00191269|anthracycline|anthracycline
1650916|NCT00191269|taxane|taxane
1650917|NCT00191269|regimen|regimen
1650918|NCT00191243|breast cancer|breast cancer
1650919|NCT00191113|syndrome|syndrome
1650920|NCT00191113|Turner|turner
1650921|NCT00191113|Turner's|turner's
1650922|NCT00191113|height|height
1650923|NCT00191113|growth|growth
1650924|NCT00191113|growth hormone|growth hormone
1650925|NCT00191113|somatropin|somatropin
1650926|NCT00191113|short stature|short stature
1650927|NCT00191113|short|short
1650928|NCT00191113|hearing|hearing
1650929|NCT00191113|glucose metabolism|glucose metabolism
1650930|NCT00190671|Advanced Breast Cancer|advanced breast cancer
1650931|NCT00190580|CKD|ckd
1650932|NCT00190580|chronic kidney disease|chronic kidney disease
1650933|NCT00190580|hypertension|hypertension
1650934|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
1650935|NCT00190580|cardiovascular disease|cardiovascular disease
1650936|NCT00190580|valsartan|valsartan
1650937|NCT00190580|KVT|kvt
1650938|NCT00190554|esophageal cancer|esophageal cancer
1650939|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
1650940|NCT00190554|esophagectomy|esophagectomy
1650941|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1650942|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
1650943|NCT00190541|Rectal Cancer|rectal cancer
1650944|NCT00190541|Lymph Node Dissection|lymph node dissection
1650945|NCT00190541|Rectal Surgery|rectal surgery
1650946|NCT00190541|Autonomic Nerves|autonomic nerves
1650947|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
1650948|NCT00190528|cervical cancer|cervical cancer
1650949|NCT00190528|drug therapy|drug therapy
1650950|NCT00190528|cisplatin|cisplatin
1650951|NCT00190528|bleomycin|bleomycin
1650952|NCT00190528|mitomycin|mitomycin
1650953|NCT00190528|vincristine|vincristine
1650954|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
1650955|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
1650956|NCT00190515|5-FU+l-LV|5-fu+l-lv
1650957|NCT00190515|UFT+LV|uft+lv
1650958|NCT00190515|randomized controlled trial|randomized controlled trial
1650959|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
1650960|NCT00190502|Immune intervention|immune intervention
1650961|NCT00190502|Polyclonal antibodies|polyclonal antibodies
1650962|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
1650963|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
1650964|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
1650965|NCT00190489|metastatic breast cancer|metastatic breast cancer
1650966|NCT00190489|drug therapy|drug therapy
1650967|NCT00190489|doxorubicin|doxorubicin
1650968|NCT00190489|docetaxel|docetaxel
1650969|NCT00190476|Elderly|elderly
1650970|NCT00190476|advanced|advanced
1650971|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
1650972|NCT00190476|cisplatin|cisplatin
1650973|NCT00190476|docetaxel|docetaxel
1650974|NCT00190476|weekly|weekly
1650975|NCT00190476|combination|combination
1650976|NCT00190476|chemotherapy|chemotherapy
1650977|NCT00190476|randomized trial|randomized trial
1650978|NCT00190463|aspergillosis|aspergillosis
1650979|NCT00190463|antifungal therapy|antifungal therapy
1650980|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
1650981|NCT00190450|Huntington|huntington
1650982|NCT00190450|graft|graft
1650983|NCT00190450|cellular therapy|cellular therapy
1650984|NCT00190450|striatum|striatum
1650985|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
1650986|NCT00190437|Randomized Clinical Trial|randomized clinical trial
1650987|NCT00190437|Antibiotics|antibiotics
1650988|NCT00190437|Acute Exacerbation|acute exacerbation
1650989|NCT00190437|Mechanical|mechanical
1650990|NCT00190437|Ventilation|ventilation
1650991|NCT00190437|Intensive Care|intensive care
1650992|NCT00190437|Length of Stay|length of stay
1650993|NCT00190437|Mortality|mortality
1650994|NCT00190424|Glioblastoma|glioblastoma
1650995|NCT00190424|Immunotherapy|immunotherapy
1650996|NCT00190411|Arteries|arteries
1650997|NCT00190411|ultrasonography|ultrasonography
1650998|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
1650999|NCT00190411|Cardiovascular disease|cardiovascular disease
1651000|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
1651001|NCT00190398|Prospective|prospective
1651002|NCT00190398|Randomised|randomised
1651003|NCT00190398|Open|open
1651004|NCT00190398|Blinded End-point|blinded end-point
1651005|NCT00190398|PROBE Study|probe study
1651006|NCT00190398|Ischemic stroke|ischemic stroke
1651007|NCT00190385|Cirrhosis|cirrhosis
1651008|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
1651009|NCT00190385|Screening|screening
1651010|NCT00190385|Randomized|randomized
1651011|NCT00190385|HBV|hbv
1651012|NCT00190385|HCV|hcv
1651013|NCT00190385|alcohol|alcohol
1651014|NCT00190385|hemochromatosis|hemochromatosis
1651015|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
1651016|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
1651017|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
1651018|NCT00190359|heart failure|heart failure
1651019|NCT00190359|hormones|hormones
1651020|NCT00190359|growth substances|growth substances
1651021|NCT00190346|Acute respiratory distress|acute respiratory distress
1651022|NCT00190346|with hypercapnia|with hypercapnia
1651023|NCT00190346|with hypoxemia|with hypoxemia
1651024|NCT00190346|requiring NIV|requiring niv
1651025|NCT00190333|pulmonary hypertension|pulmonary hypertension
1651026|NCT00190333|6 minutes walking test|6 minutes walking test
1651027|NCT00190333|serotonin|serotonin
1651028|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
1651029|NCT00190320|Fetal macrosomia|fetal macrosomia
1651030|NCT00190320|Neonatal traumatism|neonatal traumatism
1651031|NCT00190320|Maternal morbidity|maternal morbidity
1651032|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
1651033|NCT00190307|Scheduled surgery|scheduled surgery
1651034|NCT00190294|Pregnancy Complications|pregnancy complications
1651035|NCT00190281|FUNCTIONAL STUDY|functional study
1651036|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
1651037|NCT00190281|PERFUSION|perfusion
1651038|NCT00190268|multiple sclerosis|multiple sclerosis
1651039|NCT00190268|fatigue|fatigue
1651040|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
1651041|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
1651042|NCT00190255|stomach ulcer|stomach ulcer
1651043|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
1651044|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
1651045|NCT00190255|genotype|genotype
1651046|NCT00190255|pharmacogenetics|pharmacogenetics
1651047|NCT00190242|HIV|hiv
1651048|NCT00190242|hepatitis A|hepatitis a
1651049|NCT00190242|vaccine|vaccine
1651050|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
1651051|NCT00190229|Vasculitis|vasculitis
1651052|NCT00190229|Cyclophosphamide|cyclophosphamide
1651053|NCT00190229|Renal failure|renal failure
1651054|NCT00190216|Resistant depression|resistant depression
1651055|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
1651056|NCT00190216|Neuroimaging|neuroimaging
1651057|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
1651058|NCT00190203|Decompressive surgery|decompressive surgery
1651059|NCT00190203|Hemicraniectomy|hemicraniectomy
1651060|NCT00190203|Brain edema|brain edema
1651061|NCT00190190|Macular hole|macular hole
1651062|NCT00190190|internal limiting membrane|internal limiting membrane
1651063|NCT00190190|retina|retina
1651064|NCT00190190|surgery|surgery
1651065|NCT00190164|Macular hole|macular hole
1651066|NCT00190164|Vitrectomy|vitrectomy
1651067|NCT00190164|positioning|positioning
1651068|NCT00190164|retina|retina
1651069|NCT00190164|surgery|surgery
1651070|NCT00190151|ciprofloxacin|ciprofloxacin
1651071|NCT00190151|commensal flora|commensal flora
1651072|NCT00190151|resistance|resistance
1651073|NCT00190151|Pharmacokinetic|pharmacokinetic
1651074|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
1651075|NCT00190138|ventricular resynchronization|ventricular resynchronization
1651076|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
1651077|NCT00190138|heart rate variability|heart rate variability
1651078|NCT00190125|Hemodialysis|hemodialysis
1651079|NCT00190125|Malnutrition|malnutrition
1651080|NCT00190125|Inflammation|inflammation
1651081|NCT00190099|In-stent restenosis,|in-stent restenosis,
1651082|NCT00190099|Drug eluting stent,|drug eluting stent,
1651083|NCT00190099|dexamethasone,|dexamethasone,
1651084|NCT00190099|Acute coronary syndrome|acute coronary syndrome
1651085|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
1651086|NCT00190060|Frailty|frailty
1651087|NCT00190060|Muscle strength|muscle strength
1651088|NCT00190060|Physical performance|physical performance
1651089|NCT00190060|Bone mineral density|bone mineral density
1651090|NCT00190060|Quality of life|quality of life
1651091|NCT00190047|Cerebral Ischemia|cerebral ischemia
1651092|NCT00190047|Ischemic Brain Injury|ischemic brain injury
1651093|NCT00190047|Brain Infarction|brain infarction
1651094|NCT00190047|Brain Ischemia|brain ischemia
1651095|NCT00190034|Acetylcysteine|acetylcysteine
1651096|NCT00190034|cardiac surgery|cardiac surgery
1651097|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
1651098|NCT00190034|acute renal insufficiency|acute renal insufficiency
1651099|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
1651100|NCT00190021|donepezil|donepezil
1651101|NCT00190021|double-blind|double-blind
1651102|NCT00190008|tardive dyskinesia|tardive dyskinesia
1651103|NCT00190008|piracetam|piracetam
1651104|NCT00189995|schizophrenia|schizophrenia
1651105|NCT00189995|aggression|aggression
1651106|NCT00189995|clozapine|clozapine
1651107|NCT00189995|efficacy|efficacy
1651108|NCT00189995|double-blind|double-blind
1651109|NCT00189982|Factor VIII Deficiency|factor viii deficiency
1651110|NCT00189930|Treatment Experienced|treatment experienced
1651111|NCT00189904|HIV|hiv
1651112|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
1651113|NCT00189878|methotrexate|methotrexate
1651114|NCT00189852|Telecare|telecare
1651115|NCT00189852|chronic|chronic
1651116|NCT00189852|older people|older people
1651117|NCT00189852|heart failure|heart failure
1651118|NCT00189839|Tacrolimus|tacrolimus
1651119|NCT00189839|Kidney transplantation|kidney transplantation
1651120|NCT00189839|Transplantation, kidney|transplantation, kidney
1651121|NCT00189839|Renal Transplantation|renal transplantation
1651122|NCT00189839|Transplantation, renal|transplantation, renal
1651123|NCT00189826|Tacrolimus|tacrolimus
1651124|NCT00189826|Liver transplantation|liver transplantation
1651125|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
1651126|NCT00189813|Diarrhea|diarrhea
1651127|NCT00189813|Nasea®|nasea®
1651128|NCT00189813|Irribow®|irribow®
1651129|NCT00189813|ramosetron|ramosetron
1651132|NCT00189800|randomized controlled trial|randomized controlled trial
1651133|NCT00189800|double-blind method|double-blind method
1651134|NCT00189787|Tacrolimus|tacrolimus
1651135|NCT00189787|Immunosuppressant|immunosuppressant
1651136|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
1651137|NCT00189787|Administration, inhalation|administration, inhalation
1651138|NCT00189774|nateglinide|nateglinide
1651139|NCT00189774|pioglitazone|pioglitazone
1651140|NCT00189774|combination drug therapy|combination drug therapy
1651141|NCT00189774|treatment|treatment
1651142|NCT00189761|Tacrolimus|tacrolimus
1651143|NCT00189761|Immunosuppression|immunosuppression
1651144|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
1651145|NCT00189761|Graft versus Host Disease|graft versus host disease
1651146|NCT00189748|Tacrolimus|tacrolimus
1651147|NCT00189748|Immunosuppression|immunosuppression
1651148|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
1651149|NCT00189748|Graft versus Host Disease|graft versus host disease
1651150|NCT00189735|Treatment Efficacy|treatment efficacy
1651151|NCT00189735|Treatment Effectiveness|treatment effectiveness
1651152|NCT00189735|Anti-rejection therapy|anti-rejection therapy
1651153|NCT00189735|Immunosuppression|immunosuppression
1651154|NCT00189735|Antirejection|antirejection
1651155|NCT00189735|Malononitrilamide|malononitrilamide
1651156|NCT00189722|Tacrolimus|tacrolimus
1651157|NCT00189722|Immunosuppressant|immunosuppressant
1651158|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
1651159|NCT00189722|Administration, inhalation|administration, inhalation
1651160|NCT00189709|micafungin|micafungin
1651161|NCT00189709|fluconazole|fluconazole
1651162|NCT00189709|invasive candidiasis|invasive candidiasis
1651163|NCT00189709|candidemia|candidemia
1651164|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
1651165|NCT00189618|Peripheral vascular disease|peripheral vascular disease
1651166|NCT00189618|Peripheral arterial disease|peripheral arterial disease
1651167|NCT00189618|Walking Capacity|walking capacity
1651168|NCT00189618|Aspirin|aspirin
1651169|NCT00189618|Clopidogrel|clopidogrel
1651170|NCT00189605|Plasma disc decompression|plasma disc decompression
1651171|NCT00189605|Intradiscal Pressure|intradiscal pressure
1651172|NCT00189605|Steroid Injection|steroid injection
1651173|NCT00189605|Epidural Steroid Injection|epidural steroid injection
1651174|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
1651175|NCT00189605|Leg Pain|leg pain
1651176|NCT00189605|Radicular Pain|radicular pain
1651177|NCT00189605|Coblation|coblation
1651178|NCT00189605|SNRI|snri
1651179|NCT00189592|plantar fascia|plantar fascia
1651180|NCT00189592|plantar fasciitis|plantar fasciitis
1651181|NCT00189592|Coblation|coblation
1651182|NCT00189592|fasciotomy|fasciotomy
1651183|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
1651184|NCT00189592|heel spur|heel spur
1651185|NCT00189592|heel pain|heel pain
1651186|NCT00189592|aponeurosis|aponeurosis
1651187|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
1651188|NCT00189592|angiogenesis|angiogenesis
1651189|NCT00189579|HERCEPTIN|herceptin
1651190|NCT00189579|Carboplatin|carboplatin
1651191|NCT00189579|Paclitaxel|paclitaxel
1651192|NCT00189579|Relapse|relapse
1651193|NCT00189566|Relapse within 6 months|relapse within 6 months
1651194|NCT00189566|Previously received taxane derivative|previously received taxane derivative
1651195|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
1651196|NCT00189553|Relapse over 6 months|relapse over 6 months
1651197|NCT00189553|Previously received taxane derivative|previously received taxane derivative
1651198|NCT00189540|Ischemic ulcers|ischemic ulcers
1651199|NCT00189540|Critical Limb Ischemia|critical limb ischemia
1651200|NCT00189514|obesity|obesity
1651201|NCT00189514|weight loss|weight loss
1651202|NCT00189514|Amylin|amylin
1651203|NCT00189514|pramlintide|pramlintide
1651204|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
1651205|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
1651206|NCT00189488|Hematological Malignancies|hematological malignancies
1651207|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
1651208|NCT00189488|Oral Mucositis|oral mucositis
1651209|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
1651210|NCT00189475|Cold|cold
1651211|NCT00189475|Upper Respiratory Infection|upper respiratory infection
1651212|NCT00189462|Ear Infections|ear infections
1651213|NCT00189462|Otitis Media|otitis media
1651214|NCT00189449|Allergic Rhinitis|allergic rhinitis
1651215|NCT00189449|Allergy|allergy
1651216|NCT00189449|Growth|growth
1651217|NCT00189436|Asthma|asthma
1651218|NCT00189423|Heart Arrest|heart arrest
1651219|NCT00189423|Cardiac Arrest|cardiac arrest
1651220|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
1651221|NCT00189423|Impedance Threshold Device|impedance threshold device
1651222|NCT00189423|Active Compression Decompression|active compression decompression
1651223|NCT00189423|ResQPOD|resqpod
1651224|NCT00189423|ResQPump|resqpump
1651225|NCT00189423|Survival|survival
1651226|NCT00189423|Out-of-hospital|out-of-hospital
1651227|NCT00189423|Prehospital|prehospital
1651228|NCT00189423|ResQCPR System|resqcpr system
1651229|NCT00189397|Parthenium dermatitis|parthenium dermatitis
1651230|NCT00189384|Neonatal sepsis|neonatal sepsis
1651231|NCT00189384|Neonatal pneumonia|neonatal pneumonia
1651232|NCT00189384|Bacterial infections|bacterial infections
1651233|NCT00189384|Young infants|young infants
1651234|NCT00189384|Neonate|neonate
1651235|NCT00189384|Community|community
1651236|NCT00189384|Developing country|developing country
1651237|NCT00189358|cancer|cancer
1651238|NCT00189358|cancer alternative therapies|cancer alternative therapies
1651239|NCT00189358|ovarian cancer|ovarian cancer
1651240|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
1651241|NCT00189345|Cancer|cancer
1651242|NCT00189345|Cancer alternative therapies|cancer alternative therapies
1651243|NCT00189345|ovarian cancer|ovarian cancer
1651244|NCT00189332|Oncology|oncology
1651245|NCT00189332|Melanoma|melanoma
1651246|NCT00189319|Tambocor|tambocor
1651247|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1651248|NCT00189319|Quality of Life|quality of life
1651249|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
1651250|NCT00189306|Aldara|aldara
1651251|NCT00189293|External Ano-Genital Warts|external ano-genital warts
1651252|NCT00189293|Ablative Therapy|ablative therapy
1651253|NCT00189293|Aldara|aldara
1651254|NCT00189280|Aldara, sBCC|aldara, sbcc
1651255|NCT00189267|Aldara|aldara
1651256|NCT00189267|Actinic Keratosis|actinic keratosis
1651257|NCT00189267|Graft Recipients|graft recipients
1651258|NCT00189254|1 year follow up|1 year follow up
1651259|NCT00189241|Aldara|aldara
1651260|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
1651261|NCT00189241|Long-Term Study|long-term study
1651262|NCT00189215|coronary artery disease|coronary artery disease
1651263|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
1651264|NCT00189215|cognition disorders|cognition disorders
1651265|NCT00189189|prevention|prevention
1651266|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
1651267|NCT00189189|conduct disorder|conduct disorder
1651268|NCT00189163|Hepatitis C|hepatitis c
1651269|NCT00189163|Genotype 1|genotype 1
1651270|NCT00189163|Insulin Resistance|insulin resistance
1651271|NCT00189163|Pioglitazone|pioglitazone
1651272|NCT00189150|Valganciclovir|valganciclovir
1651273|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
1651274|NCT00189150|Pharmacokinetic|pharmacokinetic
1651275|NCT00189150|Interaction|interaction
1651276|NCT00189150|MPA|mpa
1651277|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
1651278|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
1651279|NCT00189124|DHEA|dhea
1651280|NCT00189124|SLE|sle
1651281|NCT00189124|Lupus|lupus
1651282|NCT00189111|peripheral arterial disease|peripheral arterial disease
1651283|NCT00189111|computed tomography|computed tomography
1651284|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
1651285|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
1651286|NCT00189085|Metabolic syndrome|metabolic syndrome
1651287|NCT00189072|gabapentin|gabapentin
1651288|NCT00189072|neuropathic pain|neuropathic pain
1651289|NCT00189072|driving|driving
1651290|NCT00189072|attention|attention
1651291|NCT00189059|neuropathic pain|neuropathic pain
1651292|NCT00189059|erp|erp
1651293|NCT00189059|driving|driving
1651294|NCT00189059|attention|attention
1651295|NCT00189059|amitriptyline|amitriptyline
1651389|NCT00188630|Acute Renal Failure|acute renal failure
1651296|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
1651297|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
1651298|NCT00189033|Diet Therapy|diet therapy
1651299|NCT00189033|Dietary Fiber|dietary fiber
1651300|NCT00189033|Randomized Controlled Trial|randomized controlled trial
1651301|NCT00189033|Family Practice|family practice
1651302|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
1651303|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
1651304|NCT00189020|herd immunity|herd immunity
1651305|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
1651306|NCT00189020|respiratory tract infections|respiratory tract infections
1651307|NCT00189020|National infant vaccination program|national infant vaccination program
1651308|NCT00189007|allopurinol|allopurinol
1651309|NCT00189007|neuroprotection|neuroprotection
1651310|NCT00189007|reperfusion injury|reperfusion injury
1651311|NCT00189007|fetal hypoxia|fetal hypoxia
1651312|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
1651313|NCT00188994|Myocardial Protection|myocardial protection
1651314|NCT00188994|Myocardial Metabolism|myocardial metabolism
1651315|NCT00188994|Ventricular Function|ventricular function
1651316|NCT00188994|Cardiovascular Disease|cardiovascular disease
1651317|NCT00188994|Cardioplegic Additives|cardioplegic additives
1651318|NCT00188981|psychosis|psychosis
1651319|NCT00188981|high risk|high risk
1651320|NCT00188981|prodrome|prodrome
1651321|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
1651322|NCT00188968|Xanthines|xanthines
1651323|NCT00188968|Reintubation|reintubation
1651324|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
1651325|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
1651326|NCT00188955|pediatric|pediatric
1651425|NCT00188305|Prevention|prevention
1651327|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
1651328|NCT00188955|chronic rejection|chronic rejection
1651329|NCT00188955|interstitial fibrosis|interstitial fibrosis
1651330|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
1651331|NCT00188942|Diagnostic Imaging|diagnostic imaging
1651332|NCT00188942|Mood Disorders|mood disorders
1651333|NCT00188942|Major Depressive Disorder|major depressive disorder
1651334|NCT00188942|Antipsychotic|antipsychotic
1651335|NCT00188942|Olanzapine|olanzapine
1651336|NCT00188942|Fluoxetine|fluoxetine
1651337|NCT00188916|Bronchial blockers|bronchial blockers
1651338|NCT00188916|Lung isolation|lung isolation
1651339|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
1651340|NCT00188903|Cardiac Surgery|cardiac surgery
1651341|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
1651342|NCT00188903|Atrial Fibrillation|atrial fibrillation
1651343|NCT00188890|Lung Cancer|lung cancer
1651344|NCT00188890|Mesothelioma|mesothelioma
1651345|NCT00188890|Asbestos|asbestos
1651346|NCT00188890|Screening|screening
1651347|NCT00188890|Early Diagnosis|early diagnosis
1651348|NCT00188851|HIV|hiv
1651349|NCT00188851|salvage regimen|salvage regimen
1651350|NCT00188851|virologic failure|virologic failure
1651351|NCT00188851|treatment interruption|treatment interruption
1651352|NCT00188851|ARV experienced|arv experienced
1651353|NCT00188838|Bipolar Disorder|bipolar disorder
1651354|NCT00188838|Psychosocial Factors|psychosocial factors
1651355|NCT00188838|Mania|mania
1651356|NCT00188838|Depression|depression
1651357|NCT00188838|Social Adjustment|social adjustment
1651358|NCT00188838|Coping Skills|coping skills
1651359|NCT00188825|Lung|lung
1651360|NCT00188825|Transplant|transplant
1651361|NCT00188825|Rejection|rejection
1651362|NCT00188825|BOS|bos
1651363|NCT00188812|dementia|dementia
1651364|NCT00188812|stroke|stroke
1651365|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
1651366|NCT00188773|free fatty acid,|free fatty acid,
1651367|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
1651368|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
1651369|NCT00188773|antioxidant therapy|antioxidant therapy
1651370|NCT00188773|Insulin Resistance|insulin resistance
1651371|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
1651372|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1651373|NCT00188760|Breast Cancer Risk|breast cancer risk
1651374|NCT00188747|Coagulopathy|coagulopathy
1651375|NCT00188747|Cardiac Surgery|cardiac surgery
1651376|NCT00188747|Point of Care|point of care
1651377|NCT00188747|Monitoring|monitoring
1651378|NCT00188734|Lung Cancer|lung cancer
1651379|NCT00188734|Eary Diagnosis|eary diagnosis
1651380|NCT00188734|Screening|screening
1651381|NCT00188721|Breast Cancer Risk|breast cancer risk
1651382|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1651383|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
1651384|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1651385|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
1651386|NCT00188682|Breast Cancer Risk|breast cancer risk
1651387|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
1651388|NCT00188630|Cardiac Surgery|cardiac surgery
1651390|NCT00188630|N-acetylcysteine|n-acetylcysteine
1651391|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
1651392|NCT00188617|LUNG CANCER|lung cancer
1651393|NCT00188617|IRESSA|iressa
1651394|NCT00188617|GEFITINIB|gefitinib
1651395|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
1651396|NCT00188617|NEOADJUVANT|neoadjuvant
1651397|NCT00188617|PHASE 2|phase 2
1651398|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
1651399|NCT00188591|Breast Cancer Risk|breast cancer risk
1651400|NCT00188500|epilepsy|epilepsy
1651401|NCT00188500|atkins diet|atkins diet
1651402|NCT00188396|Major Depressive Disorder|major depressive disorder
1651403|NCT00188396|Women's Mental Health|women's mental health
1651404|NCT00188396|Hormones|hormones
1651405|NCT00188396|Citalopram|citalopram
1651406|NCT00188396|Antidepressive agents|antidepressive agents
1651407|NCT00188396|Mental Health|mental health
1651408|NCT00188383|Hyperalgesia|hyperalgesia
1651409|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
1651410|NCT00188383|Pain|pain
1651411|NCT00188383|Opioid use|opioid use
1651412|NCT00188383|Elderly|elderly
1651413|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
1651414|NCT00188344|pneumatic dilatation|pneumatic dilatation
1651415|NCT00188344|motility disorder|motility disorder
1651416|NCT00188344|dysphasia|dysphasia
1651417|NCT00188344|health-related quality of life|health-related quality of life
1651418|NCT00188331|cognitive function|cognitive function
1651419|NCT00188331|fatigue|fatigue
1651420|NCT00188331|colorectal cancer|colorectal cancer
1651421|NCT00188331|chemotherapy|chemotherapy
1651422|NCT00188331|cognitive impairment|cognitive impairment
1651423|NCT00188305|Risk counselling|risk counselling
1651424|NCT00188305|Health education|health education
1651428|NCT00188305|Intervention|intervention
1651429|NCT00188305|Telephone vs in person|telephone vs in person
1651430|NCT00188292|Human Papillomavirus|human papillomavirus
1651431|NCT00188292|Anal|anal
1651432|NCT00188292|Cancer screening|cancer screening
1651433|NCT00188292|Immunodeficiency|immunodeficiency
1651434|NCT00188292|HIV|hiv
1651435|NCT00188279|ct|ct
1651436|NCT00188279|scan|scan
1651437|NCT00188279|lung|lung
1651438|NCT00188279|follow-up|follow-up
1651439|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1651440|NCT00188253|PET scan|pet scan
1651441|NCT00188253|MRI|mri
1651442|NCT00188253|EBV virus|ebv virus
1651443|NCT00188240|hepatitis C|hepatitis c
1651444|NCT00188240|insulin resistance|insulin resistance
1651445|NCT00188240|antiviral therapy|antiviral therapy
1651446|NCT00188227|Bone marrow puncture|bone marrow puncture
1651447|NCT00188227|Pain|pain
1651448|NCT00188214|perfusion|perfusion
1651449|NCT00188214|CT|ct
1651450|NCT00188214|CAT|cat
1651451|NCT00188214|non-small|non-small
1651452|NCT00188214|lung|lung
1651453|NCT00188201|Hepatitis C|hepatitis c
1651454|NCT00188201|neucognitive functions|neucognitive functions
1651455|NCT00188201|neuropsychological testing|neuropsychological testing
1651456|NCT00188201|antiviral treatment|antiviral treatment
1651457|NCT00188188|Endothelial|endothelial
1651458|NCT00188188|Dysfunction|dysfunction
1651459|NCT00188188|Systemic|systemic
1651460|NCT00188188|Lupus|lupus
1651461|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
1651462|NCT00188149|Chemotherapy|chemotherapy
1651463|NCT00188149|Radiation therapy|radiation therapy
1651464|NCT00188149|PET|pet
1651465|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
1651466|NCT00188123|Myocardial infarction|myocardial infarction
1651467|NCT00188123|MRI late enhancement|mri late enhancement
1651468|NCT00188123|Atrial fibrillation|atrial fibrillation
1651469|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
1651470|NCT00188110|colon tumor|colon tumor
1651471|NCT00188110|coloscopy|coloscopy
1651472|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
1651473|NCT00188110|coloscopy or surgery|coloscopy or surgery
1651474|NCT00188071|medical abortion|medical abortion
1651475|NCT00188071|analgesia|analgesia
1651476|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
1651477|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
1651478|NCT00188058|Acute lung injury|acute lung injury
1651479|NCT00188058|Mechanical ventilation|mechanical ventilation
1651480|NCT00188058|Randomized controlled trial|randomized controlled trial
1651481|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
1651482|NCT00188032|pulmonary embolism|pulmonary embolism
1651483|NCT00188032|clinical practice|clinical practice
1651484|NCT00188032|quality of health care|quality of health care
1651485|NCT00188032|diagnostic criteria|diagnostic criteria
1651486|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
1651487|NCT00188032|reminders|reminders
1651488|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
1651489|NCT00188006|neurologic injury|neurologic injury
1651490|NCT00188006|neurocognitive deficit|neurocognitive deficit
1651491|NCT00188006|biomaterials|biomaterials
1651492|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
1651493|NCT00187993|growth hormone deficiency|growth hormone deficiency
1651494|NCT00187993|growth hormone|growth hormone
1651495|NCT00187993|energy expenditure|energy expenditure
1651496|NCT00187993|body composition|body composition
1651497|NCT00187954|women|women
1651498|NCT00187954|chest pain|chest pain
1651499|NCT00187954|microvascular dysfunction|microvascular dysfunction
1651500|NCT00187954|retinal photography|retinal photography
1651501|NCT00187954|Retinal vascular function|retinal vascular function
1651502|NCT00187941|transplant|transplant
1651503|NCT00187941|renal|renal
1651504|NCT00187941|Cellcept|cellcept
1651505|NCT00187941|therapeutic drug level|therapeutic drug level
1651506|NCT00187941|MMF|mmf
1651507|NCT00187941|MPA|mpa
1651508|NCT00187941|immunosuppression|immunosuppression
1651509|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1651510|NCT00187928|Obsessions|obsessions
1651511|NCT00187928|Compulsions|compulsions
1651810|NCT00185965|lymphoma|lymphoma
1651512|NCT00187928|Adjunctive treatment|adjunctive treatment
1651513|NCT00187915|Renal transplant|renal transplant
1651514|NCT00187915|Cellcept|cellcept
1651515|NCT00187915|Therapeutic drug level|therapeutic drug level
1651516|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
1651517|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
1651518|NCT00187915|Oral Bioavailability|oral bioavailability
1651519|NCT00187915|Immunosuppression|immunosuppression
1651520|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
1651521|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
1651522|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
1651523|NCT00187889|Microvascular Disease|microvascular disease
1651525|NCT00187889|Ischemic Heart Disease|ischemic heart disease
1651526|NCT00187889|WISE|wise
1651527|NCT00187850|Pulp capping|pulp capping
1651528|NCT00187850|partial pulpotomy|partial pulpotomy
1651529|NCT00187850|Exposure of the pulp|exposure of the pulp
1651530|NCT00187837|Stepwise excavation|stepwise excavation
1651531|NCT00187824|prospective|prospective
1651532|NCT00187824|observational|observational
1651533|NCT00187824|hormonal|hormonal
1651534|NCT00187824|inflammatory|inflammatory
1651535|NCT00187824|vioenergetic|vioenergetic
1651536|NCT00187824|immune|immune
1651537|NCT00187824|sepsis|sepsis
1651538|NCT00187811|Angioplasty,|angioplasty,
1651539|NCT00187811|Restenosis,|restenosis,
1651540|NCT00187811|Photodynamic therapy|photodynamic therapy
1651541|NCT00187798|Healthy Control Twins|healthy control twins
1651542|NCT00187785|Hispanic|hispanic
1651543|NCT00187785|communication|communication
1651544|NCT00187772|domestic violence|domestic violence
1651545|NCT00187772|preschoolers|preschoolers
1651546|NCT00187772|trauma|trauma
1651547|NCT00187772|intervention|intervention
1651548|NCT00187759|Abscess|abscess
1651549|NCT00187759|Antibitoics|antibitoics
1651550|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
1651551|NCT00187746|Healthy Control|healthy control
1651552|NCT00187733|L-carnitine|l-carnitine
1651553|NCT00187720|Healthy Control|healthy control
1651554|NCT00187681|Healthy controls|healthy controls
1651555|NCT00187668|Healthy Cohort|healthy cohort
1651556|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
1651557|NCT00187616|adverse events|adverse events
1651558|NCT00187616|clinical trial methodology|clinical trial methodology
1651559|NCT00187603|tobacco|tobacco
1651560|NCT00187603|cessation|cessation
1651561|NCT00187603|smoking|smoking
1651562|NCT00187603|smoking cessation|smoking cessation
1651564|NCT00187590|case management|case management
1651565|NCT00187577|Alopecia areata|alopecia areata
1651566|NCT00187577|Eyelash growth|eyelash growth
1651567|NCT00187577|Latanoprost|latanoprost
1651568|NCT00187577|Bimatoprost|bimatoprost
1651569|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1651570|NCT00187564|lipoic acid|lipoic acid
1651571|NCT00187564|oxidative stress|oxidative stress
1651572|NCT00187551|enfuvirtide|enfuvirtide
1651573|NCT00187551|T20|t20
1651574|NCT00187551|Fuzeon|fuzeon
1651575|NCT00187551|Treatment|treatment
1651576|NCT00187551|Interruption|interruption
1651577|NCT00187551|Resistance|resistance
1651578|NCT00187551|HIV Drug Resistance|hiv drug resistance
1651579|NCT00187551|Antiretroviral Agents|antiretroviral agents
1651580|NCT00187551|Salvage Therapy|salvage therapy
1651581|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
1651582|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
1651583|NCT00187512|HIV|hiv
1651584|NCT00187512|Antiretroviral Agents|antiretroviral agents
1651585|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
1651586|NCT00187512|Long Term Non Progression|long term non progression
1651587|NCT00187512|Long Term Non Progressor|long term non progressor
1651588|NCT00187512|Elite Suppression|elite suppression
1651589|NCT00187512|Elite Suppressor|elite suppressor
1651590|NCT00187512|Natural History|natural history
1651591|NCT00187512|Observational|observational
1651592|NCT00187499|Asthma|asthma
1651688|NCT00187096|Leukemia|leukemia
1651593|NCT00187499|Corticosteroid|corticosteroid
1651594|NCT00187499|Gene expression|gene expression
1651595|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
1651596|NCT00187486|Gliosarcoma|gliosarcoma
1651597|NCT00187486|GBM|gbm
1651598|NCT00187486|GS|gs
1651599|NCT00187486|Tarceva|tarceva
1651600|NCT00187486|Temodar|temodar
1651601|NCT00187486|Radiation|radiation
1651602|NCT00187486|Newly Diagnosed|newly diagnosed
1651603|NCT00187473|hepatitis C|hepatitis c
1651604|NCT00187473|HCV|hcv
1651605|NCT00187473|natural history|natural history
1651606|NCT00187460|Acute myocardial infarction|acute myocardial infarction
1651607|NCT00187460|Congestive heart failure|congestive heart failure
1651608|NCT00187460|Quality of care|quality of care
1651609|NCT00187460|Reperfusion|reperfusion
1651610|NCT00187460|Report cards|report cards
1651611|NCT00187460|Quality indicators|quality indicators
1651612|NCT00187447|prematurity|prematurity
1651613|NCT00187447|chronic lung disease|chronic lung disease
1651614|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
1651615|NCT00187447|indomethacin|indomethacin
1651616|NCT00187447|ductus arteriosus|ductus arteriosus
1651617|NCT00187434|premature infant|premature infant
1651618|NCT00187434|supporting extubation|supporting extubation
1651619|NCT00187421|coronary disease|coronary disease
1651620|NCT00187421|angiography|angiography
1651621|NCT00187421|intraoperative care|intraoperative care
1651622|NCT00187421|vascular patency|vascular patency
1651623|NCT00187408|Thrombosis|thrombosis
1651624|NCT00187408|Pulmonary Embolism|pulmonary embolism
1651625|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
1651626|NCT00187408|Tibial Fractures|tibial fractures
1651627|NCT00187395|hypertension|hypertension
1651628|NCT00187395|blood pressure|blood pressure
1651629|NCT00187395|pregnancy|pregnancy
1651630|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
1651631|NCT00187382|preterm birth|preterm birth
1651632|NCT00187382|multiple versus single doses|multiple versus single doses
1651633|NCT00187382|follow-up|follow-up
1651634|NCT00187369|twins|twins
1651635|NCT00187369|twin births|twin births
1651636|NCT00187369|multiples|multiples
1651637|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
1651638|NCT00187356|Coronary Artery Disease|coronary artery disease
1651639|NCT00187356|Angiography|angiography
1651640|NCT00187356|Arterial Grafts|arterial grafts
1651641|NCT00187356|Radial Artery|radial artery
1651642|NCT00187356|Saphenous Vein|saphenous vein
1651643|NCT00187343|Radiotherapy|radiotherapy
1651644|NCT00187343|IMRT|imrt
1651645|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
1651646|NCT00187330|renal insufficiency|renal insufficiency
1651647|NCT00187330|cardiac surgery|cardiac surgery
1651648|NCT00187330|n-acetylcysteine|n-acetylcysteine
1651649|NCT00187317|Exercise|exercise
1651650|NCT00187317|Rehabilitation|rehabilitation
1651651|NCT00187317|Postural Balance|postural balance
1651652|NCT00187317|Accidental Falls|accidental falls
1651653|NCT00187317|Geriatrics|geriatrics
1651654|NCT00187291|T-Wave Alternans|t-wave alternans
1651655|NCT00187291|ICD|icd
1651656|NCT00187291|Primary Prevention|primary prevention
1651657|NCT00187278|Standard pacing indication|standard pacing indication
1651658|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
1651659|NCT00187239|ICDs|icds
1651660|NCT00187239|Ventricular pacing|ventricular pacing
1651661|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
1651784|NCT00186329|Renal insufficiency|renal insufficiency
1651662|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
1651663|NCT00187239|Patient is medically stable.|patient is medically stable.
1651664|NCT00187226|Brain neoplasm|brain neoplasm
1651665|NCT00187226|Brain cancer|brain cancer
1651666|NCT00187226|Neoplasm intracranial|neoplasm intracranial
1651667|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
1651668|NCT00187174|Brain tumors|brain tumors
1651669|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
1651670|NCT00187174|Refractory solid tumors|refractory solid tumors
1651671|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
1651672|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
1651673|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1651674|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
1651675|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
1651676|NCT00187161|Large cell lymphoma|large cell lymphoma
1651677|NCT00187148|Vaccine|vaccine
1651678|NCT00187148|Prevention|prevention
1651679|NCT00187148|HIV|hiv
1651680|NCT00187148|AIDS|aids
1651681|NCT00187135|Pain Management|pain management
1651682|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
1651683|NCT00187122|Non-Hodgkin|non-hodgkin
1651684|NCT00187122|Lymphoma|lymphoma
1651685|NCT00187109|Thrombocytopenia|thrombocytopenia
1651686|NCT00187109|Platelets|platelets
1651687|NCT00187109|Thrombopoietin|thrombopoietin
1651690|NCT00187096|Acute|acute
1651691|NCT00187083|Leukemia|leukemia
1651692|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1651693|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
1651694|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
1651695|NCT00187057|Ataxia|ataxia
1651696|NCT00187057|alphafetoprotein|alphafetoprotein
1651697|NCT00187044|Vaccine|vaccine
1651698|NCT00187044|Prevention|prevention
1651699|NCT00187044|HIV|hiv
1651700|NCT00187044|AIDS|aids
1651701|NCT00187031|Wilms Tumor|wilms tumor
1651702|NCT00187018|Collagen Disease|collagen disease
1651703|NCT00187005|Leukemia|leukemia
1651704|NCT00186992|Sarcoma|sarcoma
1651705|NCT00186992|radiation therapy|radiation therapy
1651706|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
1651707|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
1651708|NCT00186953|Ultrasound|ultrasound
1651709|NCT00186953|Abdominal tumors|abdominal tumors
1651710|NCT00186953|Pelvic tumors|pelvic tumors
1651711|NCT00186940|leukemia|leukemia
1651713|NCT00186927|Sendai virus vaccine|sendai virus vaccine
1651714|NCT00186914|Bone marrow transplant|bone marrow transplant
1651715|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
1651716|NCT00186914|allogeneic transplant|allogeneic transplant
1651717|NCT00186914|Osteodysplasia|osteodysplasia
1651718|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
1651719|NCT00186914|Gene marking|gene marking
1651720|NCT00186914|Stromal cell|stromal cell
1651721|NCT00186901|Bone Density|bone density
1651722|NCT00186888|Cancer of the Eye|cancer of the eye
1651723|NCT00186888|Eye Enucleation|eye enucleation
1651724|NCT00186875|Leukemia|leukemia
1651725|NCT00186875|Lymphoblastic|lymphoblastic
1651726|NCT00186875|Acute|acute
1651727|NCT00186875|Lymphoma|lymphoma
1651728|NCT00186875|Non-Hodgkin's|non-hodgkin's
1651729|NCT00186862|Neuroblastoma|neuroblastoma
1651730|NCT00186862|Immunotherapy|immunotherapy
1651731|NCT00186862|Gene therapy|gene therapy
1651732|NCT00186849|Neuroblastoma|neuroblastoma
1651733|NCT00186836|Hepatitis A|hepatitis a
1651734|NCT00186836|Hepatitis B|hepatitis b
1651735|NCT00186836|Hemodialysis|hemodialysis
1651736|NCT00186836|Vaccine|vaccine
1651737|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
1651738|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
1651739|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
1651740|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
1651741|NCT00186810|Anemia|anemia
1651742|NCT00186810|Sickle Cell|sickle cell
1651743|NCT00186797|Aplastic Anemia|aplastic anemia
1651744|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1651745|NCT00186784|TMS|tms
1651746|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1651747|NCT00186771|Paired Pulse|paired pulse
1651748|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1651749|NCT00186758|TMS|tms
1651750|NCT00186745|Venous thrombosis|venous thrombosis
1651751|NCT00186745|Pulmonary embolism|pulmonary embolism
1651752|NCT00186745|Kidney failure|kidney failure
1651753|NCT00186745|Anticoagulants|anticoagulants
1651754|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
1651755|NCT00186732|wound closure|wound closure
1651756|NCT00186732|Pfannenstiel incision|pfannenstiel incision
1651757|NCT00186732|surgical staples|surgical staples
1651758|NCT00186732|subcuticular suture|subcuticular suture
1651759|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1651760|NCT00186719|Smoking Related Disease|smoking related disease
1651761|NCT00186719|Immune System Changes|immune system changes
1651762|NCT00186706|Selenium|selenium
1651763|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
1651764|NCT00186706|Cardiovascular Disease|cardiovascular disease
1651765|NCT00186706|Anti-oxidant|anti-oxidant
1651766|NCT00186706|Pulmonary|pulmonary
1651767|NCT00186693|Airway remodeling|airway remodeling
1651768|NCT00186693|Asthma|asthma
1651769|NCT00186693|Hyper-responsiveness|hyper-responsiveness
1651770|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
1651771|NCT00186537|Insulin resistance|insulin resistance
1651772|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
1651773|NCT00186537|dyslipidemia|dyslipidemia
1651774|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
1651775|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
1651776|NCT00186420|Prostate Cancer|prostate cancer
1651777|NCT00186420|Taxotere|taxotere
1651778|NCT00186368|Prostate cancer|prostate cancer
1651779|NCT00186368|Gene expression|gene expression
1651780|NCT00186368|tumor markers|tumor markers
1651781|NCT00186368|microarray analysis|microarray analysis
1651782|NCT00186329|Vasodilation|vasodilation
1651783|NCT00186329|Congestive heart failure|congestive heart failure
1651785|NCT00186329|Diuresis|diuresis
1651786|NCT00186329|Serum creatinine|serum creatinine
1651787|NCT00186199|voiding patterns|voiding patterns
1651788|NCT00186199|flow rate|flow rate
1651789|NCT00186199|ultrasound|ultrasound
1651790|NCT00186173|Obesity|obesity
1651791|NCT00186173|Physical activity|physical activity
1651792|NCT00186134|Physical Activity|physical activity
1651793|NCT00186134|Walking|walking
1651794|NCT00186134|Primary Schools|primary schools
1651795|NCT00186134|Transportation|transportation
1651796|NCT00186108|Oral Triamcinalone|oral triamcinalone
1651797|NCT00186108|Prostate Cancer|prostate cancer
1651798|NCT00186095|Amyloidosis|amyloidosis
1651799|NCT00186095|nonmyeloablative|nonmyeloablative
1651800|NCT00186095|hematopoietic|hematopoietic
1651801|NCT00186095|cell transplantation|cell transplantation
1651802|NCT00186030|HIV|hiv
1651803|NCT00186030|AIDS|aids
1651804|NCT00186030|PTSD|ptsd
1651805|NCT00186030|Prevention|prevention
1651806|NCT00185978|obesity prevention|obesity prevention
1651807|NCT00185978|preadolescents|preadolescents
1651808|NCT00185978|schools|schools
1651809|NCT00185965|non-Hodgkin|non-hodgkin
1651811|NCT00185965|mycosis|mycosis
1651812|NCT00185965|fungoides|fungoides
1651813|NCT00185939|dog bites|dog bites
1651814|NCT00185939|infection|infection
1651815|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
1651816|NCT00185939|cost effectiveness|cost effectiveness
1651817|NCT00185783|Sepsis|sepsis
1651818|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
1651819|NCT00185783|Hydrocortisone|hydrocortisone
1651820|NCT00185783|Gene Expression|gene expression
1651821|NCT00185783|Microarray|microarray
1651822|NCT00185783|RNA|rna
1651823|NCT00185783|Critically Ill|critically ill
1651824|NCT00185770|Obesity prevention|obesity prevention
1651825|NCT00185770|Television|television
1651826|NCT00185770|Screen time|screen time
1651827|NCT00185770|Schools|schools
1651828|NCT00185770|Preadolescents|preadolescents
1651829|NCT00185705|Insulin resistance|insulin resistance
1651830|NCT00185705|obesity|obesity
1651831|NCT00185705|hypertension|hypertension
1651832|NCT00185705|adolescents|adolescents
1651833|NCT00185705|telmisartan|telmisartan
1651834|NCT00185705|lifestyle intervention|lifestyle intervention
1651835|NCT00185562|Osteoarthritis|osteoarthritis
1651836|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
1651837|NCT00185549|patient education,|patient education,
1651838|NCT00185549|Internet|internet
1651839|NCT00185536|Taste|taste
1651840|NCT00185536|preschool children|preschool children
1651841|NCT00185536|fast food|fast food
1651842|NCT00185484|Oral contraception|oral contraception
1651843|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
1651844|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
1651845|NCT00185354|FC patch|fc patch
1651846|NCT00185354|comparator study|comparator study
1651847|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
1651848|NCT00185328|Postmenopause|postmenopause
1651849|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
1651850|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
1651851|NCT00185263|angina|angina
1651852|NCT00185263|FGF-4|fgf-4
1651853|NCT00185263|angiogenesis|angiogenesis
1651854|NCT00185263|adenovector|adenovector
1651855|NCT00185263|growth factor|growth factor
1651856|NCT00185263|myocardial ischemia|myocardial ischemia
1651857|NCT00185263|revascularization|revascularization
1651858|NCT00185250|Cardiomyopathy|cardiomyopathy
1651859|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
1651860|NCT00185250|Adenovirus|adenovirus
1651861|NCT00185250|Enterovirus|enterovirus
1651862|NCT00185250|Parvovirus|parvovirus
1651863|NCT00185237|Menopause|menopause
1651864|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
1651865|NCT00185159|Microalbuminuria|microalbuminuria
1651866|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
1651867|NCT00185120|Hypertension|hypertension
1651868|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
1651869|NCT00185120|calcium channel blocker|calcium channel blocker
1651870|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
1651871|NCT00185107|Safety|safety
1651872|NCT00185107|Efficacy|efficacy
1651873|NCT00185107|WelChol®|welchol®
1651874|NCT00185107|Zocor®|zocor®
1651875|NCT00185107|Zetia®|zetia®
1651876|NCT00185081|colon cancer|colon cancer
1651877|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
1651878|NCT00185081|colon-specific antigen,|colon-specific antigen,
1651879|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
1651880|NCT00185081|radioimmunodetection|radioimmunodetection
1651881|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
1651882|NCT00185055|olmesartan|olmesartan
1651883|NCT00185055|valsartan|valsartan
1651884|NCT00185055|irbesartan|irbesartan
1651885|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
1651886|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
1651887|NCT00185029|prostate|prostate
1651888|NCT00185029|ferumoxtran-10|ferumoxtran-10
1651889|NCT00185029|lymph nodes|lymph nodes
1651890|NCT00185029|USPIO|uspio
1651891|NCT00185016|intimate partner abuse|intimate partner abuse
1651892|NCT00185016|gender|gender
1651893|NCT00185016|education|education
1651894|NCT00185016|attitude|attitude
1651895|NCT00185016|family doctor|family doctor
1651896|NCT00185016|health care utilisation|health care utilisation
1651897|NCT00185016|abused women|abused women
1651898|NCT00185003|Endotoxemia|endotoxemia
1651899|NCT00185003|vascular potassium channels|vascular potassium channels
1651900|NCT00185003|cytokine|cytokine
1651901|NCT00185003|norepinephrine|norepinephrine
1651902|NCT00185003|regional blood flow,|regional blood flow,
1651903|NCT00185003|inflammation,|inflammation,
1651904|NCT00185003|ion channels,|ion channels,
1651905|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
1651906|NCT00185003|pharmacology.|pharmacology.
1651907|NCT00184990|Endotoxemia|endotoxemia
1651908|NCT00184990|Aminoguanidine|aminoguanidine
1653092|NCT00179621|Celgene|celgene
1651909|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1651910|NCT00184977|Randomized Controlled Trial|randomized controlled trial
1651911|NCT00184977|Family Practice|family practice
1651912|NCT00184977|Respiratory Function Tests|respiratory function tests
1651913|NCT00184977|Health Status|health status
1651914|NCT00184951|HIV|hiv
1651915|NCT00184938|opioids|opioids
1651916|NCT00184938|ischemic preconditioning|ischemic preconditioning
1651917|NCT00184938|morphine|morphine
1651918|NCT00184899|free fatty acids|free fatty acids
1651919|NCT00184899|vasodilation|vasodilation
1651920|NCT00184899|sympathetic activity|sympathetic activity
1651921|NCT00184873|randomized controlled trial|randomized controlled trial
1651922|NCT00184873|health-counseling|health-counseling
1651923|NCT00184873|multi-center study|multi-center study
1651924|NCT00184847|acetylcholine|acetylcholine
1651925|NCT00184847|adenosine|adenosine
1651926|NCT00184847|caffeine|caffeine
1651927|NCT00184847|ischemic preconditioning|ischemic preconditioning
1651928|NCT00184834|colorectal|colorectal
1651929|NCT00184834|liver|liver
1651930|NCT00184834|metastases|metastases
1651931|NCT00184834|health-related quality of life|health-related quality of life
1651932|NCT00184834|surgery|surgery
1651933|NCT00184821|Diabetes|diabetes
1651934|NCT00184821|Ischemia|ischemia
1651935|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
1651936|NCT00184795|Hot flashes|hot flashes
1651937|NCT00184782|colorectal cancer|colorectal cancer
1651938|NCT00184782|liver metastases|liver metastases
1651939|NCT00184782|metabolic activity|metabolic activity
1651940|NCT00184587|prophylactic|prophylactic
1651941|NCT00184587|episodic|episodic
1651942|NCT00184587|cluster|cluster
1651943|NCT00184587|candesartan|candesartan
1651944|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
1651945|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
1651946|NCT00184587|headache diary|headache diary
1651947|NCT00184535|Low back pain|low back pain
1651948|NCT00184535|Neuromuscular control|neuromuscular control
1651949|NCT00184535|Anticipatory motor control|anticipatory motor control
1651950|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
1651951|NCT00184535|Muscle, Skeletal|muscle, skeletal
1651952|NCT00184535|Ultrasonography|ultrasonography
1651953|NCT00184535|Electromyography|electromyography
1651954|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
1651955|NCT00184522|Esomeprazole|esomeprazole
1651956|NCT00184522|Drug treatment|drug treatment
1651957|NCT00184509|schizophrenia|schizophrenia
1651958|NCT00184509|psychosocial treatment|psychosocial treatment
1651959|NCT00184509|outcome|outcome
1651960|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
1651961|NCT00184496|Humans|humans
1651962|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
1651963|NCT00184496|Neoplasms/complications|neoplasms/complications
1651964|NCT00184496|pain/drug therapy|pain/drug therapy
1651965|NCT00184483|Surgery|surgery
1651966|NCT00184483|Lichtenstein|lichtenstein
1651967|NCT00184483|Prolene Hernia System|prolene hernia system
1651968|NCT00184483|Postoperative pain|postoperative pain
1651969|NCT00184483|Recurrence|recurrence
1651970|NCT00184470|Adult|adult
1651971|NCT00184470|Child|child
1651972|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
1651973|NCT00184470|Retrospective studies|retrospective studies
1651974|NCT00184457|Cardiac heart failure|cardiac heart failure
1651975|NCT00184457|Leg press|leg press
1651976|NCT00184457|Maximal strength training|maximal strength training
1651977|NCT00184457|Serum testosterone|serum testosterone
1651978|NCT00184457|Work economy|work economy
1651979|NCT00184444|angina pectoris|angina pectoris
1651980|NCT00184444|hyperoxia|hyperoxia
1651981|NCT00184444|endurance training|endurance training
1651982|NCT00184444|stroke volume|stroke volume
1651983|NCT00184444|cardiac perfusion|cardiac perfusion
1651984|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
1651985|NCT00184431|Physical Therapy Techniques|physical therapy techniques
1651986|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
1651987|NCT00184431|Rehabilitation|rehabilitation
1651988|NCT00184418|Immunity|immunity
1651989|NCT00184418|Immune System|immune system
1651990|NCT00184418|Cytokines|cytokines
1651991|NCT00184418|Psychophysiology|psychophysiology
1651992|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
1651993|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
1651994|NCT00184392|Sinus surgery|sinus surgery
1651995|NCT00184392|endoscopic|endoscopic
1651996|NCT00184392|postoperative care|postoperative care
1651997|NCT00184392|debridement|debridement
1651998|NCT00184392|randomized|randomized
1651999|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
1652000|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
1652001|NCT00184392|nasal polyps|nasal polyps
1652002|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
1652003|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
1652004|NCT00184379|Family|family
1652005|NCT00184379|Coping Skills|coping skills
1652006|NCT00184379|Psychoeducation|psychoeducation
1652007|NCT00184379|Stress, Psychological|stress, psychological
1652008|NCT00184379|Health Education|health education
1652009|NCT00184366|drug therapy|drug therapy
1652010|NCT00184366|efalizumab|efalizumab
1652011|NCT00184353|brain metastasis|brain metastasis
1652012|NCT00184353|signal to noise ratio|signal to noise ratio
1652013|NCT00184353|spectral resolution|spectral resolution
1652014|NCT00184340|eTherapy supplementary|etherapy supplementary
1652015|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
1652016|NCT00184301|Eating disorders|eating disorders
1652017|NCT00184301|Anorexia nervosa|anorexia nervosa
1652018|NCT00184301|Bulimia nervosa|bulimia nervosa
1652323|NCT00183092|prion|prion
1652019|NCT00184301|Personality disorders|personality disorders
1652020|NCT00184301|In-patient treatment|in-patient treatment
1652021|NCT00184301|out-patient treatment|out-patient treatment
1652022|NCT00184301|group therapy|group therapy
1652023|NCT00184288|Lipid|lipid
1652024|NCT00184288|choline|choline
1652025|NCT00184288|metastasis|metastasis
1652026|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1652027|NCT00184288|treatment response|treatment response
1652028|NCT00184275|Brain metastasis|brain metastasis
1652029|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
1652030|NCT00184275|Tissue micro array|tissue micro array
1652031|NCT00184275|DNA micro array|dna micro array
1652032|NCT00184249|Catheter ablation|catheter ablation
1652033|NCT00184249|Heart/surgery|heart/surgery
1652034|NCT00184249|Cardial surgical procedures|cardial surgical procedures
1652035|NCT00184236|Exercise Training|exercise training
1652036|NCT00184236|Cardiovascular diseases|cardiovascular diseases
1652037|NCT00184236|Risk factors|risk factors
1652038|NCT00184223|Motivational Interviewing|motivational interviewing
1652039|NCT00184223|Substance abuse|substance abuse
1652040|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
1652041|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
1652042|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1652043|NCT00184197|Injection|injection
1652044|NCT00184197|Headache|headache
1652045|NCT00184197|Cervical muscles|cervical muscles
1652046|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
1652047|NCT00184184|Tobacco use cessation|tobacco use cessation
1652048|NCT00184184|Coffee use cessation|coffee use cessation
1652049|NCT00184184|substance use detection|substance use detection
1652050|NCT00184184|Substance Abuse Detection|substance abuse detection
1652051|NCT00184171|Microscopic colitis|microscopic colitis
1652052|NCT00184171|Drug treatment|drug treatment
1652053|NCT00184171|Diarrhoea|diarrhoea
1652054|NCT00184158|Cubital tunnel|cubital tunnel
1652055|NCT00184158|treatment|treatment
1652056|NCT00184158|nerve compression|nerve compression
1652057|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
1652058|NCT00184145|EMDR|emdr
1652059|NCT00184145|Exposure therapy|exposure therapy
1652060|NCT00184132|Intensive care units|intensive care units
1652061|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
1652062|NCT00184132|Interior Design and Furnishings|interior design and furnishings
1652063|NCT00184132|Intensive Care|intensive care
1652064|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
1652065|NCT00184119|Intensive care units|intensive care units
1652066|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
1652067|NCT00184119|Aggression|aggression
1652068|NCT00184119|Violence|violence
1652069|NCT00184106|Phobic disorders|phobic disorders
1652070|NCT00184106|Therapy, cognitive|therapy, cognitive
1652071|NCT00184106|Paroxetine|paroxetine
1652072|NCT00184093|Cervical Carcinoma|cervical carcinoma
1652073|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
1652074|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
1652075|NCT00183976|Immunoblastic NHL|immunoblastic nhl
1652076|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
1652077|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
1652078|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
1652079|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
1652186|NCT00183456|Sex Education|sex education
1652080|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
1652081|NCT00183859|solid tumor|solid tumor
1652082|NCT00183859|phase I|phase i
1652083|NCT00183859|phase one|phase one
1652084|NCT00183846|pancreas|pancreas
1652085|NCT00183846|stomach|stomach
1652086|NCT00183846|common bile duct cancer|common bile duct cancer
1652087|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
1652088|NCT00183833|phase 1|phase 1
1652089|NCT00183833|phase I|phase i
1652090|NCT00183833|phase one|phase one
1652091|NCT00183833|colon cancer|colon cancer
1652092|NCT00183833|colorectal cancer|colorectal cancer
1652093|NCT00183820|Testicular|testicular
1652094|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
1652095|NCT00183794|Primary Peritoneal|primary peritoneal
1652096|NCT00183781|HIV|hiv
1652097|NCT00183781|Telephone intervention|telephone intervention
1652098|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
1652099|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
1652100|NCT00183768|HIV Risk Behavior|hiv risk behavior
1652101|NCT00183768|Injection Drug Use|injection drug use
1652102|NCT00183755|Reward Processing|reward processing
1652103|NCT00183755|Anhedonia|anhedonia
1652104|NCT00183755|Major Depressive Disorder|major depressive disorder
1652105|NCT00183755|Depression|depression
1652106|NCT00183742|Phase 1|phase 1
1652107|NCT00183742|Phase I|phase i
1652108|NCT00183742|Phase one|phase one
1652109|NCT00183742|Solid tumor|solid tumor
1652110|NCT00183729|Major depressive disorder|major depressive disorder
1652111|NCT00183729|Rehabilitating|rehabilitating
1652112|NCT00183729|Elderly|elderly
1652113|NCT00183729|Apathy|apathy
1652114|NCT00183716|PTSD|ptsd
1652115|NCT00183716|Physical Abuse|physical abuse
1652116|NCT00183716|Sexual Abuse|sexual abuse
1652118|NCT00183716|Trauma|trauma
1652119|NCT00183716|Group Therapy|group therapy
1652120|NCT00183716|Substance Abuse|substance abuse
1652121|NCT00183703|Depression, Bipolar|depression, bipolar
1652122|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
1652123|NCT00183690|PTSD|ptsd
1652124|NCT00183690|Anxiety Disorder|anxiety disorder
1652125|NCT00183690|Trauma|trauma
1652126|NCT00183690|Adolescents|adolescents
1652127|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
1652128|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
1652129|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1652130|NCT00183677|Major Depressive Disorder|major depressive disorder
1652131|NCT00183677|Treatment Response|treatment response
1652132|NCT00183651|Suicide|suicide
1652133|NCT00183651|Women|women
1652134|NCT00183651|Emotions|emotions
1652135|NCT00183651|Psychotherapy, Group|psychotherapy, group
1652136|NCT00183638|Internet|internet
1652137|NCT00183638|Interactive Computer Program|interactive computer program
1652138|NCT00183638|HIV Prevention|hiv prevention
1652139|NCT00183625|Antipsychotic Agents|antipsychotic agents
1652140|NCT00183625|Employment|employment
1652141|NCT00183612|Child|child
1652142|NCT00183612|Adolescent|adolescent
1652143|NCT00183612|Mental Health|mental health
1652144|NCT00183612|Olanzapine|olanzapine
1652145|NCT00183612|Pharmacokinetics|pharmacokinetics
1652146|NCT00183612|Pharmacology|pharmacology
1652147|NCT00183599|Brief interventions|brief interventions
1652148|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
1652149|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
1652150|NCT00183586|Treatment outcomes study|treatment outcomes study
1652151|NCT00183586|Anorexia|anorexia
1652152|NCT00183586|Anorexia nervosa|anorexia nervosa
1652153|NCT00183573|STDs|stds
1652154|NCT00183573|Sexual Behavior|sexual behavior
1652155|NCT00183573|Health Behavior|health behavior
1652156|NCT00183573|HIV Seronegativity|hiv seronegativity
1652157|NCT00183560|Depression Recurrence|depression recurrence
1652158|NCT00183560|Drug Therapy|drug therapy
1652159|NCT00183560|Cognitive Therapy|cognitive therapy
1652160|NCT00183560|Relapse|relapse
1652161|NCT00183560|Antidepressants|antidepressants
1652162|NCT00183547|Postpartum Depression|postpartum depression
1652163|NCT00183547|Postpartum Period|postpartum period
1652164|NCT00183547|Indians, North American|indians, north american
1652165|NCT00183547|Adolescent|adolescent
1652166|NCT00183547|Female|female
1652168|NCT00183521|Hyperventilation|hyperventilation
1652169|NCT00183521|Breathing Exercises|breathing exercises
1652170|NCT00183521|Carbon Dioxide|carbon dioxide
1652171|NCT00183521|Panic Attack|panic attack
1652172|NCT00183508|PTSD|ptsd
1652173|NCT00183508|Occupational Health|occupational health
1652174|NCT00183508|Trauma|trauma
1652175|NCT00183508|Job|job
1652176|NCT00183508|CBT|cbt
1652177|NCT00183495|Depression, Bipolar|depression, bipolar
1652178|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
1652179|NCT00183482|Parents|parents
1652180|NCT00183482|Child|child
1652181|NCT00183482|Stress|stress
1652182|NCT00183482|CBT|cbt
1652183|NCT00183469|Lamotrigine|lamotrigine
1652184|NCT00183469|Divalproex|divalproex
1652185|NCT00183469|Antidepressant|antidepressant
1652187|NCT00183456|Peer Group|peer group
1652188|NCT00183456|Social Identity Theory|social identity theory
1652189|NCT00183456|HIV Seronegativity|hiv seronegativity
1652190|NCT00183456|Intervention|intervention
1652191|NCT00183456|women|women
1652192|NCT00183456|Social Networks|social networks
1652193|NCT00183456|Peer Education|peer education
1652194|NCT00183443|Mania|mania
1652195|NCT00183443|Manic-depressive|manic-depressive
1652196|NCT00183443|Psychotic disorder|psychotic disorder
1652197|NCT00183430|Prazosin|prazosin
1652198|NCT00183430|Sleep Disorders|sleep disorders
1652199|NCT00183417|Adolescent|adolescent
1652200|NCT00183417|CBT|cbt
1652201|NCT00183404|Drug Treatment|drug treatment
1652202|NCT00183404|Child|child
1652203|NCT00183404|Olanzapine|olanzapine
1652204|NCT00183391|ADHD|adhd
1652205|NCT00183391|Child|child
1652206|NCT00183391|Adolescent|adolescent
1652207|NCT00183391|School|school
1652208|NCT00183378|Alzheimer's Disease|alzheimer's disease
1652209|NCT00183378|Insomnia|insomnia
1652210|NCT00183378|Sleep Problems|sleep problems
1652211|NCT00183378|Elderly|elderly
1652212|NCT00183378|Caregivers|caregivers
1652213|NCT00183365|Family|family
1652214|NCT00183365|Parenting|parenting
1652215|NCT00183365|Depression|depression
1652216|NCT00183365|Group Intervention|group intervention
1652217|NCT00183352|Women|women
1652218|NCT00183352|Mood|mood
1652219|NCT00183352|Menarche|menarche
1652220|NCT00183352|Menstruation|menstruation
1652221|NCT00183339|Autism|autism
1652222|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
1652223|NCT00183326|Domestic Violence|domestic violence
1652224|NCT00183326|Children|children
1652225|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
1652226|NCT00183326|CBT|cbt
1652227|NCT00183313|Mental Health|mental health
1652228|NCT00183313|Primary health care|primary health care
1652229|NCT00183313|Case management|case management
1652230|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
1652231|NCT00183300|PTSD|ptsd
1652232|NCT00183300|Prolonged Exposure|prolonged exposure
1652233|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
1652234|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
1652235|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
1652236|NCT00183274|Double-Blind|double-blind
1652237|NCT00183274|Placebo Controlled|placebo controlled
1652238|NCT00183274|Venlafaxine XR|venlafaxine xr
1652239|NCT00183274|Relapse|relapse
1652240|NCT00183261|Treatment Interruption|treatment interruption
1652241|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1652242|NCT00183261|Acute Infection|acute infection
1652243|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
1652244|NCT00183248|kidney|kidney
1652245|NCT00183248|kidney transplant|kidney transplant
1652246|NCT00183248|kidney transplantation|kidney transplantation
1652247|NCT00183248|transplant|transplant
1652248|NCT00183248|transplantation|transplantation
1652249|NCT00183248|renal|renal
1652250|NCT00183248|renal transplant|renal transplant
1652251|NCT00183248|renal transplantation|renal transplantation
1652252|NCT00183248|kidney disease|kidney disease
1652253|NCT00183248|chronic|chronic
1652254|NCT00183248|renal failure|renal failure
1652255|NCT00183248|kidney failure|kidney failure
1652256|NCT00183235|Alcohol dependence|alcohol dependence
1652257|NCT00183235|Alcoholism|alcoholism
1652258|NCT00183235|Craving|craving
1652259|NCT00183222|Alcohol dependence|alcohol dependence
1652260|NCT00183222|Alcoholism|alcoholism
1652261|NCT00183222|Craving|craving
1652262|NCT00183209|Substance use disorders|substance use disorders
1652263|NCT00183209|Parent child relationship|parent child relationship
1652264|NCT00183196|Alcohol dependence|alcohol dependence
1652265|NCT00183196|Alcoholism|alcoholism
1652266|NCT00183196|Heavy drinking|heavy drinking
1652267|NCT00183183|Alcohol Abuse|alcohol abuse
1652268|NCT00183183|Harm Reduction|harm reduction
1652269|NCT00183183|Motivational Interviewing|motivational interviewing
1652270|NCT00183183|Emergency Department|emergency department
1652271|NCT00183183|Risky Drinking|risky drinking
1652272|NCT00183183|Prevention|prevention
1652273|NCT00183170|Alcohol abuse|alcohol abuse
1652274|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
1652275|NCT00183170|Residual effects|residual effects
1652276|NCT00183170|Psychomotor performance|psychomotor performance
1652277|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
1652278|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
1652279|NCT00183170|Family history of alcohol use|family history of alcohol use
1652280|NCT00183170|Alcoholic Consumption|alcoholic consumption
1652281|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
1652282|NCT00183170|Alcohol|alcohol
1652283|NCT00183157|High risk drinking|high risk drinking
1652284|NCT00183157|Alcohol dependence|alcohol dependence
1652285|NCT00183157|Alcohol related injury|alcohol related injury
1652286|NCT00183144|contingency management|contingency management
1652287|NCT00183144|reinforcement|reinforcement
1652288|NCT00183144|employment|employment
1652289|NCT00183144|Therapeutic Workplace|therapeutic workplace
1652291|NCT00183131|Alcohol abuse|alcohol abuse
1652292|NCT00183131|Alcohol dependence|alcohol dependence
1652293|NCT00183131|Alcohol consumption|alcohol consumption
1652294|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
1652295|NCT00183131|Screening|screening
1652296|NCT00183131|Brief Intervention|brief intervention
1652297|NCT00183131|Effectiveness|effectiveness
1652298|NCT00183131|Electronic intervention|electronic intervention
1652299|NCT00183131|Web-based intervention|web-based intervention
1652300|NCT00183131|College students|college students
1652301|NCT00183118|HIV|hiv
1652302|NCT00183118|Russia|russia
1652303|NCT00183118|Prevention|prevention
1652304|NCT00183118|Behavioral intervention|behavioral intervention
1652305|NCT00183118|Alcohol dependence|alcohol dependence
1652306|NCT00183105|Alcohol|alcohol
1652307|NCT00183105|Alcohol abuse|alcohol abuse
1652308|NCT00183105|Alcohol dependence|alcohol dependence
1652309|NCT00183105|Utilization|utilization
1652310|NCT00183105|Alcohol consumption|alcohol consumption
1652311|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
1652312|NCT00183105|Hospitalization|hospitalization
1652313|NCT00183105|Screening|screening
1652314|NCT00183105|Brief Intervention|brief intervention
1652315|NCT00183105|Motivational Interviewing|motivational interviewing
1652316|NCT00183105|Randomized trial|randomized trial
1652317|NCT00183105|Effectiveness|effectiveness
1652318|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
1652319|NCT00183092|dementia|dementia
1652320|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
1652321|NCT00183092|nervous system disorder|nervous system disorder
1652322|NCT00183092|acridine|acridine
1652324|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
1652325|NCT00183079|Depression|depression
1652326|NCT00183079|Alcohol Use|alcohol use
1652327|NCT00183079|Motivational Interviewing|motivational interviewing
1652328|NCT00183053|Hospitalization|hospitalization
1652329|NCT00183053|Fall Risk|fall risk
1652331|NCT00183040|andropause|andropause
1652332|NCT00183040|hormone therapy|hormone therapy
1652333|NCT00183040|HRT|hrt
1652334|NCT00183027|Dietary restriction|dietary restriction
1652335|NCT00183027|Caloric restriction|caloric restriction
1652336|NCT00183014|behavior therapy|behavior therapy
1652337|NCT00183014|exercise|exercise
1652338|NCT00183014|gait|gait
1652339|NCT00183014|physical activity|physical activity
1652340|NCT00183001|nutritional supplement|nutritional supplement
1652341|NCT00183001|dietary supplement|dietary supplement
1652342|NCT00183001|vitamin therapy|vitamin therapy
1652343|NCT00183001|Vitamin K deficiency|vitamin k deficiency
1652344|NCT00183001|bone density|bone density
1652345|NCT00182988|communication behavior|communication behavior
1652346|NCT00182988|coping|coping
1652347|NCT00182988|functional ability|functional ability
1652348|NCT00182988|quality of life|quality of life
1652349|NCT00182988|caregiving|caregiving
1652350|NCT00182975|Metabolic syndrome|metabolic syndrome
1652351|NCT00182962|Activities of Daily Living|activities of daily living
1652352|NCT00182962|Low-income|low-income
1652353|NCT00182962|geriatric medicine|geriatric medicine
1652354|NCT00182962|computer assisted patient care|computer assisted patient care
1652355|NCT00182949|Epidemiology|epidemiology
1652356|NCT00182949|Genetics|genetics
1652357|NCT00182949|Aging|aging
1652358|NCT00182949|Sardinian Population|sardinian population
1652359|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
1652360|NCT00182949|Personality Traits|personality traits
1652361|NCT00182949|Frailty|frailty
1652362|NCT00182936|Cognition disorder|cognition disorder
1652363|NCT00182936|organic brain syndrome|organic brain syndrome
1652364|NCT00182936|patient care management|patient care management
1652365|NCT00182936|long term care|long term care
1652366|NCT00182936|extended care facility|extended care facility
1652367|NCT00182923|Blood pressure|blood pressure
1652368|NCT00182923|genetics|genetics
1652369|NCT00182897|caregiver|caregiver
1652370|NCT00182897|home health care|home health care
1652371|NCT00182897|coping|coping
1652372|NCT00182884|Hospital acquired complications|hospital acquired complications
1652373|NCT00182884|adverse effects|adverse effects
1652374|NCT00182884|Cognitive Impairment|cognitive impairment
1652375|NCT00182884|Aging|aging
1652376|NCT00182871|geriatric medicine|geriatric medicine
1652377|NCT00182871|hormone therapy|hormone therapy
1652378|NCT00182871|HT|ht
1652379|NCT00182871|andropause|andropause
1652380|NCT00182858|Tissue|tissue
1652381|NCT00182858|Procurement|procurement
1652382|NCT00182858|Exploratory Methods|exploratory methods
1652383|NCT00182858|Disease Correlation|disease correlation
1652384|NCT00182858|Sampling|sampling
1652385|NCT00182845|dementia|dementia
1652386|NCT00182845|MCI|mci
1652387|NCT00182845|Aricept|aricept
1652388|NCT00182845|Adverse Effects|adverse effects
1652389|NCT00182845|Hospital Acquired Complications|hospital acquired complications
1652390|NCT00182845|Cognitive Impairment|cognitive impairment
1652391|NCT00182845|Aging|aging
1652392|NCT00182832|Physician Behavior|physician behavior
1652393|NCT00182832|Hospital Acquired Complications|hospital acquired complications
1652394|NCT00182832|MCI|mci
1652395|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
1652396|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
1652397|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
1652398|NCT00182819|adult mixed glioma|adult mixed glioma
1652399|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1652400|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1652401|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1652402|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1652403|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
1652404|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
1652405|NCT00182793|stage IV breast cancer|stage iv breast cancer
1652406|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
1652407|NCT00182793|male breast cancer|male breast cancer
1652408|NCT00182793|recurrent breast cancer|recurrent breast cancer
1652409|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
1652410|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1652411|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1652412|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1652413|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
1652414|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1652415|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1652416|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
1652417|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1652418|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
1652419|NCT00182780|fatigue|fatigue
1652420|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1652421|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1652422|NCT00182754|malignant ascites|malignant ascites
1652423|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
1652424|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
1652425|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1652426|NCT00182728|stage I breast cancer|stage i breast cancer
1652427|NCT00182728|stage II breast cancer|stage ii breast cancer
1652428|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
1652429|NCT00182715|stage IV colon cancer|stage iv colon cancer
1652430|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1652431|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
1652432|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1652433|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1652434|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1652435|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1652436|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1652437|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1652438|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1652439|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1652440|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1652441|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1652442|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1652443|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1652444|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1652445|NCT00182624|Prostate Cancer|prostate cancer
1652446|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
1652447|NCT00182624|Spectroscopy|spectroscopy
1652448|NCT00182611|stage III gastric cancer|stage iii gastric cancer
1652449|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1652450|NCT00182598|buprenorphine|buprenorphine
1652451|NCT00182598|computer|computer
1652452|NCT00182598|treatment|treatment
1652453|NCT00182598|opioid|opioid
1652454|NCT00182598|heroin|heroin
1652456|NCT00182585|hepatitis|hepatitis
1652457|NCT00182585|STDs|stds
1652458|NCT00182585|adolescents|adolescents
1652459|NCT00182585|addiction|addiction
1652460|NCT00182585|treatment|treatment
1652461|NCT00182585|prevention|prevention
1652462|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
1652463|NCT00182572|heroin|heroin
1652464|NCT00182572|opiate|opiate
1652465|NCT00182572|addiction|addiction
1652466|NCT00182572|adolescent|adolescent
1652467|NCT00182572|treatment|treatment
1652468|NCT00182559|kidney|kidney
1652469|NCT00182559|transplantation|transplantation
1652470|NCT00182559|tacrolimus|tacrolimus
1652471|NCT00182559|cyclosporine|cyclosporine
1652472|NCT00182559|conversion|conversion
1652473|NCT00182546|Pulmonary Embolism|pulmonary embolism
1652474|NCT00182546|DVT|dvt
1652475|NCT00182546|Venous Thrombosis|venous thrombosis
1652476|NCT00182546|D dimer|d dimer
1652477|NCT00182546|DD|dd
1652478|NCT00182546|Thrombosis|thrombosis
1652479|NCT00182546|Diagnosis|diagnosis
1652480|NCT00182533|Generalized social phobia|generalized social phobia
1652481|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
1652482|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
1652483|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
1652484|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
1652485|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
1652486|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
1652487|NCT00182481|asthma treatment|asthma treatment
1652488|NCT00182481|induced sputum cell counts|induced sputum cell counts
1652489|NCT00182481|asthma exacerbations|asthma exacerbations
1652490|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
1652491|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
1652492|NCT00182468|Domestic violence|domestic violence
1652493|NCT00182468|Spouse Abuse|spouse abuse
1652494|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
1652495|NCT00182442|Cognitive deficits|cognitive deficits
1652496|NCT00182442|Psychosocial functioning|psychosocial functioning
1652497|NCT00182442|Quality of Life|quality of life
1652498|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
1652499|NCT00182429|C. difficile|c. difficile
1652500|NCT00182429|Metronidazole|metronidazole
1652501|NCT00182429|Rifampin|rifampin
1652502|NCT00182416|pacemakers|pacemakers
1652503|NCT00182416|atrial fibrillation|atrial fibrillation
1652504|NCT00182416|stroke|stroke
1652505|NCT00182416|cardiovascular death|cardiovascular death
1652506|NCT00182403|Unfractionated Heparin|unfractionated heparin
1652507|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
1652508|NCT00182403|Venous Thromboembolism|venous thromboembolism
1652509|NCT00182403|APTT|aptt
1652510|NCT00182403|Treatment|treatment
1652511|NCT00182390|ELBW premature infants|elbw premature infants
1652512|NCT00182390|neonatal transfusion|neonatal transfusion
1652513|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1652514|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
1652515|NCT00182390|ventriculomegaly|ventriculomegaly
1652516|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
1652517|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
1652518|NCT00182364|Critically Ill|critically ill
1652519|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
1652520|NCT00182364|Randomized Control Trial|randomized control trial
1652521|NCT00182364|Pilot Study|pilot study
1652522|NCT00182351|deep vein thrombosis|deep vein thrombosis
1652523|NCT00182351|d-dimer|d-dimer
1652524|NCT00182351|serial compression ultrasound|serial compression ultrasound
1652525|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
1652526|NCT00182338|congestive heart failure|congestive heart failure
1652527|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
1652528|NCT00182338|Arterial stiffening|arterial stiffening
1652529|NCT00182338|Inflammatory markers|inflammatory markers
1652530|NCT00182325|medical record|medical record
1652531|NCT00182325|pregnancy|pregnancy
1652532|NCT00182325|Internet|internet
1652533|NCT00182312|preterm infants|preterm infants
1652534|NCT00182312|very low birthweight|very low birthweight
1652535|NCT00182312|apnea of prematurity|apnea of prematurity
1652536|NCT00182312|methylxanthines|methylxanthines
1652537|NCT00182312|developmental disabilities|developmental disabilities
1652538|NCT00182286|Diabetes|diabetes
1652539|NCT00182286|Continuity of Care|continuity of care
1652540|NCT00182286|Patient Perspective|patient perspective
1652541|NCT00182286|Health Service Organization|health service organization
1652542|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
1652543|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
1652544|NCT00182273|Dizziness|dizziness
1652545|NCT00182273|Primary Care|primary care
1652546|NCT00182247|deep vein thrombosis|deep vein thrombosis
1652548|NCT00182247|pulmonary embolism|pulmonary embolism
1652549|NCT00182247|PE|pe
1652550|NCT00182247|venous thromboembolism|venous thromboembolism
1652551|NCT00182247|VTE|vte
1652552|NCT00182247|d-dimer|d-dimer
1652553|NCT00182247|IPG|ipg
1652554|NCT00182234|unmet supportive care needs|unmet supportive care needs
1652555|NCT00182221|Pulmonary Embolism|pulmonary embolism
1652556|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
1652557|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
1652558|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
1652559|NCT00182208|PTS|pts
1652560|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
1652561|NCT00182208|Activities of Daily Living|activities of daily living
1652562|NCT00182208|Quality of Life|quality of life
1652563|NCT00182182|Heart Failure|heart failure
1652564|NCT00182182|Family physicians|family physicians
1652565|NCT00182182|academic detailing|academic detailing
1652566|NCT00182182|process of care|process of care
1652567|NCT00182169|Severe heart failure|severe heart failure
1652568|NCT00182169|Growth hormone|growth hormone
1652569|NCT00182169|exercise capacity|exercise capacity
1652570|NCT00182169|quality of life|quality of life
1652571|NCT00182169|cardiac function|cardiac function
1652572|NCT00182156|hemodialysis|hemodialysis
1652573|NCT00182156|platelet function analyzer|platelet function analyzer
1652574|NCT00182156|bioimpedance|bioimpedance
1652575|NCT00182156|pulse wave velocity|pulse wave velocity
1652576|NCT00182156|end stage renal disease|end stage renal disease
1652577|NCT00182143|Critically Ill|critically ill
1652578|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
1652579|NCT00182143|Randomized Controlled Trial|randomized controlled trial
1652580|NCT00182130|rectal cancer|rectal cancer
1652581|NCT00182130|surgery|surgery
1653093|NCT00179621|revlimid|revlimid
1652582|NCT00182130|physician behaviour|physician behaviour
1652583|NCT00182130|knowledge translation|knowledge translation
1652584|NCT00182117|bleeding|bleeding
1652585|NCT00182117|end stage renal disease|end stage renal disease
1652586|NCT00182117|antiplatelet therapy|antiplatelet therapy
1652587|NCT00182117|anticoagulant therapy|anticoagulant therapy
1652588|NCT00182117|hemodialysis|hemodialysis
1652589|NCT00182104|Fontan procedure|fontan procedure
1652590|NCT00182104|Anticoagulation|anticoagulation
1652591|NCT00182104|Thrombosis|thrombosis
1652592|NCT00182104|Thromboembolism|thromboembolism
1652593|NCT00182104|Prevention|prevention
1652594|NCT00182091|Acromegaly|acromegaly
1652595|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
1652596|NCT00182091|Cardiovascular Risk|cardiovascular risk
1652597|NCT00182091|Pituitary|pituitary
1652598|NCT00182091|Hypothalamic|hypothalamic
1652599|NCT00182078|sertraline|sertraline
1652600|NCT00182078|children|children
1652601|NCT00182078|adolescents|adolescents
1652602|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
1652603|NCT00182078|depression|depression
1652604|NCT00182078|prevention|prevention
1652605|NCT00182078|burns|burns
1652606|NCT00182078|injuries|injuries
1652607|NCT00182065|Heart failure|heart failure
1652608|NCT00182065|Functional decline|functional decline
1652609|NCT00182065|Cognitive impairment|cognitive impairment
1652610|NCT00182065|Neuropsychiatric health|neuropsychiatric health
1652611|NCT00182065|Longitudinal|longitudinal
1652612|NCT00182065|Long-term care|long-term care
1652613|NCT00182065|Elderly|elderly
1652614|NCT00182052|rosiglitazone|rosiglitazone
1652615|NCT00182052|Avandia|avandia
1652616|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
1652617|NCT00182039|randomized controlled trial|randomized controlled trial
1652618|NCT00182039|blinded|blinded
1652619|NCT00182039|noncardiac surgery|noncardiac surgery
1652620|NCT00182039|cardiovascular events|cardiovascular events
1652621|NCT00182026|diabetes|diabetes
1652622|NCT00182026|community intervention|community intervention
1652623|NCT00182026|self-management|self-management
1652624|NCT00182026|prevention|prevention
1652625|NCT00182000|OCD|ocd
1652626|NCT00181987|ADHD|adhd
1652627|NCT00181987|bipolar disorder|bipolar disorder
1652628|NCT00181987|children|children
1652629|NCT00181987|Concerta|concerta
1652630|NCT00181974|burns|burns
1652631|NCT00181974|hemostasis|hemostasis
1652632|NCT00181974|skin graft|skin graft
1652633|NCT00181974|Surgical Hemostasis|surgical hemostasis
1652634|NCT00181974|Grafting, Skin|grafting, skin
1652635|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
1652636|NCT00181948|ADHD|adhd
1652637|NCT00181948|children|children
1652638|NCT00181948|stimulant non-responders|stimulant non-responders
1652639|NCT00181948|Strattera|strattera
1652640|NCT00181935|bipolar disorder|bipolar disorder
1652641|NCT00181935|preschoolers|preschoolers
1652642|NCT00181935|risperdal|risperdal
1652643|NCT00181935|zyprexa|zyprexa
1652644|NCT00181922|bipolar disorder|bipolar disorder
1652645|NCT00181922|children|children
1652646|NCT00181922|ziprasidone|ziprasidone
1652647|NCT00181922|mania|mania
1652648|NCT00181909|Pregnancy|pregnancy
1652649|NCT00181909|Smoking cessation|smoking cessation
1652650|NCT00181896|depression|depression
1652651|NCT00181896|bipolar disorder|bipolar disorder
1652652|NCT00181896|children|children
1652653|NCT00181896|bupropion SR|bupropion sr
1652654|NCT00181883|children|children
1652655|NCT00181883|bipolar disorder|bipolar disorder
1652656|NCT00181883|quetiapine|quetiapine
1652657|NCT00181883|preschoolers|preschoolers
1652658|NCT00181870|bipolar disorder|bipolar disorder
1652659|NCT00181870|children|children
1652660|NCT00181870|mania|mania
1652661|NCT00181870|Equetro|equetro
1652662|NCT00181857|ADHD NOS|adhd nos
1652663|NCT00181857|familial risk|familial risk
1652664|NCT00181857|children|children
1652665|NCT00181844|bipolar disorder|bipolar disorder
1652666|NCT00181844|lamotrigine|lamotrigine
1652667|NCT00181844|children|children
1652668|NCT00181844|mania|mania
1652669|NCT00181831|SPECT|spect
1652670|NCT00181831|bipolar disorder|bipolar disorder
1652671|NCT00181831|ADHD|adhd
1652672|NCT00181831|children|children
1652673|NCT00181818|Smoking cessation|smoking cessation
1652674|NCT00181818|Bupropion SR|bupropion sr
1652675|NCT00181818|Hospital intervention|hospital intervention
1652676|NCT00181818|Myocardial infarction|myocardial infarction
1652677|NCT00181818|Unstable angina|unstable angina
1652678|NCT00181805|GER|ger
1652679|NCT00181792|ADHD|adhd
1652680|NCT00181792|smoking|smoking
1652681|NCT00181792|familial risk|familial risk
1652682|NCT00181779|mania|mania
1652683|NCT00181779|Abilify|abilify
1652684|NCT00181779|children|children
1652685|NCT00181779|bipolar disorder|bipolar disorder
1652686|NCT00181766|ADHD NOS|adhd nos
1652687|NCT00181766|Adults|adults
1652688|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
1652689|NCT00181766|Open-Label|open-label
1653306|NCT00178607|Inhibitors|inhibitors
1652690|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
1652691|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
1652692|NCT00181753|enteral nutrition|enteral nutrition
1652693|NCT00181753|parenteral nutrition|parenteral nutrition
1652694|NCT00181753|burn injury|burn injury
1652695|NCT00181753|stable isotopes|stable isotopes
1652696|NCT00181740|ADHD NOS|adhd nos
1652697|NCT00181740|Adults|adults
1652698|NCT00181740|Concerta|concerta
1652699|NCT00181740|Open-Label|open-label
1652700|NCT00181727|bipolar disorder|bipolar disorder
1652701|NCT00181727|mania|mania
1652702|NCT00181727|depakote ER|depakote er
1652703|NCT00181727|children|children
1652704|NCT00181714|cigarette smoking|cigarette smoking
1652705|NCT00181714|ADHD|adhd
1652706|NCT00181714|adolescents|adolescents
1652708|NCT00181701|Ovarian cancer|ovarian cancer
1652709|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
1652710|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
1652711|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
1652712|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
1652713|NCT00181701|Tubal carcinoma|tubal carcinoma
1652714|NCT00181688|Iressa|iressa
1652715|NCT00181688|ZD1839|zd1839
1652716|NCT00181688|Anastrozole|anastrozole
1652717|NCT00181688|Arimidex|arimidex
1652718|NCT00181675|Adult|adult
1652719|NCT00181675|ADHD|adhd
1652720|NCT00181675|galantamine|galantamine
1652721|NCT00181675|double-blind|double-blind
1652722|NCT00181662|Curcumin|curcumin
1652723|NCT00181662|Piperine|piperine
1652724|NCT00181662|Silybin|silybin
1652725|NCT00181662|Healthy volunteer|healthy volunteer
1652726|NCT00181662|Female|female
1652727|NCT00181649|Lactation|lactation
1652728|NCT00181649|Breastfeeding|breastfeeding
1652729|NCT00181649|Adoptive mothers|adoptive mothers
1652730|NCT00181649|Prolactin|prolactin
1652731|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
1652732|NCT00181623|Lactation|lactation
1652733|NCT00181623|Breastfeeding|breastfeeding
1652734|NCT00181623|Prolactin|prolactin
1652735|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
1652736|NCT00181610|Lactation|lactation
1652737|NCT00181610|Breastfeeding|breastfeeding
1652738|NCT00181610|Premature infants|premature infants
1652739|NCT00181610|Prolactin|prolactin
1652740|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
1652741|NCT00181597|Trilostane|trilostane
1652742|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
1652743|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
1652744|NCT00181584|bone loss|bone loss
1652745|NCT00181584|prostate cancer|prostate cancer
1652746|NCT00181584|Zoledronic Acid|zoledronic acid
1652747|NCT00181584|Zometa|zometa
1652748|NCT00181571|ADHD|adhd
1652749|NCT00181571|Adults|adults
1652750|NCT00181571|Concerta|concerta
1652751|NCT00181571|Double-Blind|double-blind
1652752|NCT00181558|Prostate Cancer|prostate cancer
1652753|NCT00181558|bone metastases|bone metastases
1652754|NCT00181558|Atrasentan|atrasentan
1652755|NCT00181558|Zometa|zometa
1652756|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
1652757|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
1652758|NCT00181545|radiotherapy|radiotherapy
1652759|NCT00181545|mean lung dose|mean lung dose
1652760|NCT00181532|NSCLC|nsclc
1652761|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
1652762|NCT00181532|radiosensitizer|radiosensitizer
1652763|NCT00181532|radiotherapy|radiotherapy
1652764|NCT00181506|radiotherapy|radiotherapy
1652765|NCT00181506|radiation dose|radiation dose
1652766|NCT00181506|lung cancer|lung cancer
1652767|NCT00181363|Breast cancer|breast cancer
1652768|NCT00181363|Breast conserving surgery|breast conserving surgery
1652769|NCT00181363|Radiotherapy|radiotherapy
1652770|NCT00181363|Pendulous breasts|pendulous breasts
1652771|NCT00181350|brain tumor|brain tumor
1652772|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
1652773|NCT00181350|fixationsystems|fixationsystems
1652774|NCT00181350|repositioning|repositioning
1652775|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
1652776|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
1652777|NCT00181311|complications|complications
1652778|NCT00181311|physical well being|physical well being
1652779|NCT00181311|mental well being|mental well being
1652780|NCT00181298|Memantine|memantine
1652781|NCT00181298|SLE|sle
1652782|NCT00181298|Anti NR2|anti nr2
1652783|NCT00181298|ANAM|anam
1652784|NCT00181298|Cognitive functioning|cognitive functioning
1652785|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1652786|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
1652787|NCT00181246|Neuropathic pain|neuropathic pain
1652788|NCT00181246|Efficacy|efficacy
1652789|NCT00181207|COPD|copd
1652790|NCT00181194|Asthma|asthma
1652791|NCT00181181|Hypertension|hypertension
1652792|NCT00181168|thyroid cancer|thyroid cancer
1652793|NCT00181168|PET scan|pet scan
1652794|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
1652795|NCT00181168|thyroglobulin|thyroglobulin
1652796|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
1652797|NCT00181155|metabolism|metabolism
1652798|NCT00181155|congestive heart failure|congestive heart failure
1652799|NCT00181155|allopurinol|allopurinol
1652800|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
1652801|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
1652802|NCT00181129|Fatigue|fatigue
1652803|NCT00181129|Cancer treatment|cancer treatment
1652804|NCT00181116|Epilepsy|epilepsy
1652805|NCT00181116|Benign rolandic|benign rolandic
1652806|NCT00181116|Levetiracetam|levetiracetam
1652807|NCT00181090|Epilepsy|epilepsy
1652808|NCT00181090|Ketosis|ketosis
1652809|NCT00181090|Atkins|atkins
1652811|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
1652812|NCT00181064|headache|headache
1652814|NCT00181064|ketosis|ketosis
1652815|NCT00181064|intractable|intractable
1652816|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
1652817|NCT00181025|Limbs’ girdle|limbs’ girdle
1652818|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
1652819|NCT00180947|Soft parts tissue|soft parts tissue
1652820|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
1652821|NCT00180908|Osteosarcoma|osteosarcoma
1652822|NCT00180895|Burkitt lymphoma|burkitt lymphoma
1652823|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
1652824|NCT00180895|B-cell ALL|b-cell all
1652825|NCT00180895|Refractory|refractory
1652826|NCT00180895|Relapse|relapse
1652827|NCT00180895|Rituximab|rituximab
1652828|NCT00180895|Children|children
1652829|NCT00180869|cancer|cancer
1652830|NCT00180869|peroperative transfusion|peroperative transfusion
1652831|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
1652832|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
1652833|NCT00180856|Lung metastasis|lung metastasis
1652834|NCT00180856|Lung cancer|lung cancer
1652835|NCT00180856|Radiofrequency ablation|radiofrequency ablation
1652836|NCT00180791|Brain PNET|brain pnet
1652837|NCT00180765|Leukocytes|leukocytes
1652838|NCT00180765|Eosinophils|eosinophils
1652839|NCT00180765|Neutrophils|neutrophils
1652840|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
1652841|NCT00180765|Apoptosis|apoptosis
1652842|NCT00180765|Signal Transduction|signal transduction
1652843|NCT00180739|MR guided FUS|mr guided fus
1652844|NCT00180739|Uterine Fibroids|uterine fibroids
1652845|NCT00180739|Fertility|fertility
1652846|NCT00180739|Pregnancy|pregnancy
1652847|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
1652848|NCT00180713|Pulmonary hypertension|pulmonary hypertension
1652849|NCT00180713|Simvastatin|simvastatin
1652850|NCT00180713|Statins|statins
1652851|NCT00180700|HIV|hiv
1652852|NCT00180700|Stress|stress
1652853|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
1652854|NCT00180700|stress management|stress management
1652855|NCT00180700|hypnosis|hypnosis
1652856|NCT00180700|Johrei|johrei
1652857|NCT00180700|psychological intervention|psychological intervention
1652858|NCT00180687|Pain|pain
1652859|NCT00180687|Nebulisation|nebulisation
1652860|NCT00180687|Cholecystectomy|cholecystectomy
1652861|NCT00180687|Laparoscopic|laparoscopic
1652862|NCT00180687|Bupivacaine|bupivacaine
1652863|NCT00180687|Local Anaesthetic|local anaesthetic
1652864|NCT00180674|Hepatic fibrosis|hepatic fibrosis
1652865|NCT00180674|anticoagulation|anticoagulation
1652866|NCT00180674|Coumarin|coumarin
1652867|NCT00180674|Warfarin|warfarin
1652868|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
1652869|NCT00180661|Severe asthma|severe asthma
1652870|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
1652871|NCT00180648|Short Bowel Syndrome|short bowel syndrome
1652872|NCT00180648|Intestinal Failure|intestinal failure
1652873|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
1652874|NCT00180648|Parenteral Nutrition|parenteral nutrition
1652875|NCT00180518|Carotid artery disease|carotid artery disease
1652876|NCT00180518|High risk|high risk
1652973|NCT00180011|omalizumab|omalizumab
1652877|NCT00180518|High surgical risk|high surgical risk
1652878|NCT00180505|Peripheral Artery Disease|peripheral artery disease
1652879|NCT00180505|Restenosis Rate|restenosis rate
1652880|NCT00180505|Patency Rates|patency rates
1652881|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
1652882|NCT00180505|Stent Fractures|stent fractures
1652883|NCT00180492|Atherosclerotic disease|atherosclerotic disease
1652884|NCT00180479|Everolimus|everolimus
1652885|NCT00180466|drug eluting stents|drug eluting stents
1652886|NCT00180466|stents|stents
1652887|NCT00180466|angioplasty|angioplasty
1652888|NCT00180466|coronary artery disease|coronary artery disease
1652889|NCT00180466|total coronary occlusion|total coronary occlusion
1652890|NCT00180466|coronary artery restenosis|coronary artery restenosis
1652891|NCT00180466|stent thrombosis|stent thrombosis
1652892|NCT00180466|vascular disease|vascular disease
1652893|NCT00180466|myocardial ischemia|myocardial ischemia
1652894|NCT00180466|coronary artery stenosis|coronary artery stenosis
1652895|NCT00180453|Cardiovascular disease|cardiovascular disease
1652896|NCT00180453|Ischemia|ischemia
1652897|NCT00180414|heart failure|heart failure
1652898|NCT00180388|cardiovascular system|cardiovascular system
1652900|NCT00180388|saphenous vein|saphenous vein
1652901|NCT00180336|Heart Failure|heart failure
1652902|NCT00180336|Tachycardia|tachycardia
1652903|NCT00180336|Atrial Fibrillation|atrial fibrillation
1652904|NCT00180336|Atrial Flutter|atrial flutter
1652905|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
1652906|NCT00180310|drug eluting stents|drug eluting stents
1652907|NCT00180310|stents|stents
1652908|NCT00180310|angioplasty|angioplasty
1652909|NCT00180310|coronary artery disease|coronary artery disease
1652910|NCT00180310|total coronary occlusion|total coronary occlusion
1652911|NCT00180310|coronary artery restenosis|coronary artery restenosis
1652912|NCT00180310|stent thrombosis|stent thrombosis
1652913|NCT00180310|vascular disease|vascular disease
1652914|NCT00180310|myocardial ischemia|myocardial ischemia
1652915|NCT00180310|coronary artery stenosis|coronary artery stenosis
1652916|NCT00180284|Pacemaker leads|pacemaker leads
1652917|NCT00180284|Electrodes, implantable|electrodes, implantable
1652918|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
1652919|NCT00180271|Defibrillator|defibrillator
1652920|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1652921|NCT00180271|MADIT|madit
1652922|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
1652923|NCT00180258|Heart Failure|heart failure
1652924|NCT00180258|Defibrillator|defibrillator
1652925|NCT00180258|Pacemaker|pacemaker
1652926|NCT00180245|Radiation therapy|radiation therapy
1652927|NCT00180245|F-18-FDG|f-18-fdg
1652928|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
1652929|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
1652930|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
1652931|NCT00180206|Arthritis|arthritis
1652932|NCT00180206|Hip|hip
1652933|NCT00180206|Hip arthroplasty|hip arthroplasty
1652934|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
1652935|NCT00180193|Radiotherapy|radiotherapy
1652936|NCT00180193|F-18-OMFD|f-18-omfd
1652937|NCT00180180|head-and-neck cancer|head-and-neck cancer
1652938|NCT00180180|radiation therapy|radiation therapy
1652939|NCT00180180|F-18-FMISO|f-18-fmiso
1652940|NCT00180167|Chemotherapy|chemotherapy
1652941|NCT00180167|elderly|elderly
1652942|NCT00180154|radiation therapy|radiation therapy
1652943|NCT00180154|F-18-FDG|f-18-fdg
1652944|NCT00180154|NSCLC|nsclc
1652945|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
1652946|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
1652947|NCT00180128|risk adapted therapy|risk adapted therapy
1652948|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
1652949|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
1652950|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
1652951|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1652952|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
1652953|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
1652954|NCT00180102|risk adapted treatment|risk adapted treatment
1652955|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
1652956|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
1652957|NCT00180089|graft-versus-host disease|graft-versus-host disease
1652958|NCT00180089|budesonide|budesonide
1652959|NCT00180089|stem cell transplantation|stem cell transplantation
1652960|NCT00180076|collagenous colitis|collagenous colitis
1652961|NCT00180076|microscopic colitis|microscopic colitis
1652962|NCT00180076|budesonide|budesonide
1652963|NCT00180050|lymphocytic colitis|lymphocytic colitis
1652964|NCT00180050|microscopic colitis|microscopic colitis
1652965|NCT00180050|budesonide|budesonide
1652966|NCT00180037|Parkinson's disease|parkinson's disease
1652967|NCT00180037|Coenzyme Q10|coenzyme q10
1652968|NCT00180037|Treatment|treatment
1652969|NCT00180037|Neuroprotection|neuroprotection
1652970|NCT00180024|AT1-receptor|at1-receptor
1652971|NCT00180024|AT2-receptor|at2-receptor
1652972|NCT00180024|human pharmacology|human pharmacology
1652974|NCT00180011|severe asthma|severe asthma
1652975|NCT00180011|moderate asthma|moderate asthma
1652976|NCT00180011|injectable asthma medication|injectable asthma medication
1652977|NCT00180011|Xolair|xolair
1652978|NCT00179998|Cystic fibrosis|cystic fibrosis
1652979|NCT00179998|Infants|infants
1652980|NCT00179998|Children|children
1652981|NCT00179998|Pulmozyme|pulmozyme
1652982|NCT00179998|Pulmonary function|pulmonary function
1652983|NCT00179998|Computed tomography|computed tomography
1652984|NCT00179985|Developmental Care|developmental care
1652985|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
1652986|NCT00179972|Pulse oximetry|pulse oximetry
1652987|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
1652988|NCT00179972|Skin Integrity|skin integrity
1652989|NCT00179972|Prematurity|prematurity
1652990|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
1652991|NCT00179972|Infant, premature|infant, premature
1652992|NCT00179933|developmental care|developmental care
1652993|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
1652994|NCT00179894|ADHD|adhd
1652995|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1652996|NCT00179881|Brain stem glioma|brain stem glioma
1652997|NCT00179868|cancer|cancer
1652998|NCT00179868|leukemia|leukemia
1652999|NCT00179868|stem cell transplant|stem cell transplant
1653000|NCT00179868|complications|complications
1653001|NCT00179855|graft versus host disease|graft versus host disease
1653002|NCT00179855|ECP|ecp
1653003|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
1653004|NCT00179855|allogeneic transplantation|allogeneic transplantation
1653006|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
1653007|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
1653008|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
1653009|NCT00179816|wilm's tumor|wilm's tumor
1653010|NCT00179816|stem cell transplantation|stem cell transplantation
1653011|NCT00179816|solid tumor|solid tumor
1653012|NCT00179803|brain tumor|brain tumor
1653013|NCT00179803|medulloblastoma|medulloblastoma
1653014|NCT00179803|germ cell tumor|germ cell tumor
1653015|NCT00179803|CNS tumor|cns tumor
1653016|NCT00179803|glioblastoma|glioblastoma
1653017|NCT00179803|astrocytoma|astrocytoma
1653018|NCT00179803|pineoblastoma|pineoblastoma
1653019|NCT00179803|rhabdoid tumor|rhabdoid tumor
1653020|NCT00179803|supratentorial PNET|supratentorial pnet
1653021|NCT00179803|high grade astrocytoma|high grade astrocytoma
1653022|NCT00179790|cancer|cancer
1653023|NCT00179790|hemoglobinopathy|hemoglobinopathy
1653024|NCT00179790|immune deficiency|immune deficiency
1653025|NCT00179790|photopheresis|photopheresis
1653026|NCT00179790|ECP|ecp
1653027|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
1653028|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1653029|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
1653030|NCT00179777|Infant Nutrition|infant nutrition
1653031|NCT00179777|Primary Prevention|primary prevention
1653032|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
1653033|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
1653034|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
1653035|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
1653036|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1653037|NCT00179751|cc-5013|cc-5013
1653038|NCT00179751|revlimid|revlimid
1653039|NCT00179751|pancreatic cancer|pancreatic cancer
1653040|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
1653041|NCT00179725|cc-5013|cc-5013
1653042|NCT00179725|revlimid|revlimid
1653043|NCT00179725|ovarian cancer|ovarian cancer
1653044|NCT00179725|celgene|celgene
1653045|NCT00179712|cc-5013|cc-5013
1653046|NCT00179712|revlimid|revlimid
1653047|NCT00179712|ovarian cancer|ovarian cancer
1653048|NCT00179712|celgene|celgene
1653049|NCT00179699|cc-5013|cc-5013
1653050|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
1653051|NCT00179699|revlimid|revlimid
1653052|NCT00179699|celgene|celgene
1653053|NCT00179699|cc5013|cc5013
1653054|NCT00179686|celgene|celgene
1653055|NCT00179686|cc-5013|cc-5013
1653056|NCT00179686|NSCLC|nsclc
1653057|NCT00179686|CC5013|cc5013
1653058|NCT00179686|Revlimid|revlimid
1653059|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
1653060|NCT00179673|NHL|nhl
1653061|NCT00179673|CC5013|cc5013
1653062|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1653063|NCT00179673|revlimid|revlimid
1653064|NCT00179673|cc-5013|cc-5013
1653065|NCT00179673|celgene|celgene
1653066|NCT00179660|celgene|celgene
1653067|NCT00179660|cc-5013|cc-5013
1653068|NCT00179660|CC5013|cc5013
1653069|NCT00179660|NHL|nhl
1653070|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
1653071|NCT00179660|Revlimid|revlimid
1653072|NCT00179647|Multiple Myeloma|multiple myeloma
1653073|NCT00179647|MM|mm
1653074|NCT00179647|Revlimid|revlimid
1653075|NCT00179647|CC5013|cc5013
1653076|NCT00179647|celgene|celgene
1653077|NCT00179647|cc-5013|cc-5013
1653078|NCT00179647|relapsed/refractory|relapsed/refractory
1653079|NCT00179647|lenalidomide|lenalidomide
1653080|NCT00179647|dexamethasone|dexamethasone
1653081|NCT00179647|Decadron|decadron
1653082|NCT00179634|Mastectomy|mastectomy
1653083|NCT00179634|Randomized Controlled Trial|randomized controlled trial
1653084|NCT00179634|Imagery|imagery
1653085|NCT00179621|MDS|mds
1653086|NCT00179621|transfusion dependent|transfusion dependent
1653087|NCT00179621|anaemia|anaemia
1653088|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
1653089|NCT00179621|erythroid response|erythroid response
1653090|NCT00179621|leukaemia|leukaemia
1653091|NCT00179621|CC-5013|cc-5013
1653094|NCT00179621|lenalidomide|lenalidomide
1653095|NCT00179608|CC-5013|cc-5013
1653096|NCT00179608|CC5013|cc5013
1653097|NCT00179608|celgene|celgene
1653098|NCT00179608|Melanoma|melanoma
1653099|NCT00179608|Revlimid|revlimid
1653100|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
1653101|NCT00179608|Lenalidomide|lenalidomide
1653102|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
1653103|NCT00179582|IBS|ibs
1653104|NCT00179582|Functional bowel disorder|functional bowel disorder
1653105|NCT00179582|Diarrhea|diarrhea
1653106|NCT00179582|probiotic|probiotic
1653107|NCT00179556|Hot flashes|hot flashes
1653108|NCT00179556|Menopausal symptoms|menopausal symptoms
1653109|NCT00179556|Soybean germ|soybean germ
1653110|NCT00179556|Aglycones|aglycones
1653111|NCT00179556|Menopause|menopause
1653112|NCT00179517|Seizure|seizure
1653113|NCT00179517|Epilepsy|epilepsy
1653114|NCT00179517|Testosterone|testosterone
1653116|NCT00179517|Sexual Dysfunction|sexual dysfunction
1653117|NCT00179517|Hypogonadism|hypogonadism
1653119|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
1653120|NCT00179478|Multiple sclerosis|multiple sclerosis
1653121|NCT00179478|Interferon Beta|interferon beta
1653122|NCT00179478|MRI|mri
1653123|NCT00179478|Optic neuritis|optic neuritis
1653124|NCT00179478|Transverse Myelitis|transverse myelitis
1653125|NCT00179465|Treatment|treatment
1653126|NCT00179465|fMRI|fmri
1653127|NCT00179465|Cognition|cognition
1653128|NCT00179465|Brain development|brain development
1653129|NCT00179452|epilepsy, yoga|epilepsy, yoga
1653130|NCT00179439|PSC|psc
1653131|NCT00179439|IBD|ibd
1653132|NCT00179439|CFTR|cftr
1653133|NCT00179426|Seizure Disorder|seizure disorder
1653134|NCT00179426|Hypogonadism|hypogonadism
1653135|NCT00179426|Sexual Function|sexual function
1653136|NCT00179426|Epilepsy|epilepsy
1653137|NCT00179413|hepatitis C|hepatitis c
1653138|NCT00179413|cirrhosis|cirrhosis
1653139|NCT00179413|interferon|interferon
1653140|NCT00179413|colchicine|colchicine
1653141|NCT00179387|Neoplasms|neoplasms
1653142|NCT00179387|Needs Assessment|needs assessment
1653143|NCT00179387|Adaptation Psychological|adaptation psychological
1653144|NCT00179387|Minority Groups|minority groups
1653145|NCT00179387|Psychotherapy, Group|psychotherapy, group
1653146|NCT00179387|Program Evaluation|program evaluation
1653147|NCT00179387|Spirituality|spirituality
1653148|NCT00179387|Spiritual Therapies|spiritual therapies
1653149|NCT00179374|Medication adherence|medication adherence
1653150|NCT00179374|Self-care behaviors|self-care behaviors
1653151|NCT00179374|Telephonic intervention|telephonic intervention
1653152|NCT00179374|Diabetes|diabetes
1653153|NCT00179374|Nutrition|nutrition
1653154|NCT00179374|Exercise|exercise
1653155|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
1653156|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
1653157|NCT00179335|HIV+|hiv+
1653158|NCT00179322|Sleep Architecture|sleep architecture
1653159|NCT00179322|Sleep Measures|sleep measures
1653160|NCT00179322|Speech Articulation|speech articulation
1653161|NCT00179322|Cerebral Perfusion|cerebral perfusion
1653162|NCT00179322|Neuroimaging|neuroimaging
1653163|NCT00179322|Healthy Volunteer|healthy volunteer
1653164|NCT00179322|HV|hv
1653165|NCT00179309|CEA|cea
1653166|NCT00179309|MUC-1|muc-1
1653167|NCT00179309|Immunotherapy|immunotherapy
1653168|NCT00179309|GM-CSF|gm-csf
1653169|NCT00179309|Vaccine|vaccine
1653170|NCT00179309|Breast Cancer|breast cancer
1653171|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
1653172|NCT00179257|Failure to Escitalopram|failure to escitalopram
1653173|NCT00179244|Treatment Resistant Depression|treatment resistant depression
1653174|NCT00179192|End Stage Renal Disease|end stage renal disease
1653175|NCT00179192|ESRD|esrd
1653176|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
1653177|NCT00179127|Pediatrics|pediatrics
1653178|NCT00179127|Diabetes|diabetes
1653179|NCT00179127|Emergency Care|emergency care
1653180|NCT00179127|Endocrinology|endocrinology
1653181|NCT00179127|Critical Care|critical care
1653182|NCT00179114|Spasticity|spasticity
1653183|NCT00179114|Developmental Disabilities|developmental disabilities
1653184|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
1653185|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
1653186|NCT00179101|Parkinson's Disease|parkinson's disease
1653187|NCT00179101|Depression|depression
1653188|NCT00179101|Quality of Life|quality of life
1653189|NCT00179101|Deep Brain Stimulation|deep brain stimulation
1653190|NCT00179088|Weight-Bearing|weight-bearing
1653191|NCT00179088|Total Hip Replacement|total hip replacement
1653192|NCT00179088|Non-cemented|non-cemented
1653193|NCT00179088|Randomized|randomized
1653194|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
1653195|NCT00179088|Hip|hip
1653196|NCT00179088|Osteoarthritis|osteoarthritis
1653197|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
1653404|NCT00178048|late life|late life
1653405|NCT00178048|elderly|elderly
1653198|NCT00179062|major depression with psychotic features|major depression with psychotic features
1653199|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
1653200|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
1653201|NCT00179036|Blood supply|blood supply
1653202|NCT00179036|Mesentery|mesentery
1653203|NCT00179023|OBESITY|obesity
1653204|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
1653205|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
1653206|NCT00179023|HYPERTENSION|hypertension
1653207|NCT00179023|AUTONOMIC FAILURE|autonomic failure
1653208|NCT00179010|Adenosine|adenosine
1653209|NCT00179010|AMP|amp
1653210|NCT00179010|Microdialysis|microdialysis
1653211|NCT00179010|Blood Flow|blood flow
1653212|NCT00178997|Blood supply|blood supply
1653213|NCT00178997|Mesentery|mesentery
1653214|NCT00178984|Blood supply|blood supply
1653215|NCT00178984|Mesentery|mesentery
1653216|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
1653218|NCT00178919|Trimethaphan|trimethaphan
1653219|NCT00178919|Autonomic Nervous System|autonomic nervous system
1653220|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
1653221|NCT00178906|depression|depression
1653223|NCT00178906|voice|voice
1653224|NCT00178880|depression|depression
1653225|NCT00178880|MRI|mri
1653226|NCT00178880|imaging|imaging
1653227|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1653228|NCT00178841|CTCL|ctcl
1653229|NCT00178841|Mycosis Fungoides|mycosis fungoides
1653230|NCT00178841|Sezary Syndrome|sezary syndrome
1653231|NCT00178841|Bexarotene|bexarotene
1653232|NCT00178841|Targretin|targretin
1653233|NCT00178841|Rosiglitazone|rosiglitazone
1653234|NCT00178841|Avandia|avandia
1653235|NCT00178828|Depression|depression
1653236|NCT00178828|antidepressant|antidepressant
1653237|NCT00178828|SSRI|ssri
1653238|NCT00178802|breast cancer|breast cancer
1653239|NCT00178802|endometrial cancer|endometrial cancer
1653240|NCT00178802|cervical cancer|cervical cancer
1653241|NCT00178802|ovarian cancer|ovarian cancer
1653242|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
1653243|NCT00178789|Blood Clot|blood clot
1653244|NCT00178789|Lower Extremity|lower extremity
1653245|NCT00178789|Sonography|sonography
1653246|NCT00178776|Group|group
1653247|NCT00178776|Therapy|therapy
1653248|NCT00178776|Cocaine|cocaine
1653249|NCT00178776|Drugs|drugs
1653250|NCT00178776|Trial|trial
1653251|NCT00178776|Outcome|outcome
1653252|NCT00178776|Study|study
1653253|NCT00178776|Feasibility|feasibility
1653254|NCT00178776|Transtheoretical|transtheoretical
1653255|NCT00178776|Stages|stages
1653256|NCT00178776|Motivation|motivation
1653257|NCT00178776|Change|change
1653258|NCT00178763|Cancer|cancer
1653259|NCT00178763|Pancreatic Cancer|pancreatic cancer
1653260|NCT00178763|Pancreas|pancreas
1653261|NCT00178763|Neoplasms|neoplasms
1653262|NCT00178750|Epidural placement|epidural placement
1653263|NCT00178750|CompuFlo®|compuflo®
1653264|NCT00178724|spinal cord injury|spinal cord injury
1653265|NCT00178724|SCI|sci
1653266|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
1653267|NCT00178724|acute spinal cord injury|acute spinal cord injury
1653268|NCT00178724|paralysis|paralysis
1653269|NCT00178711|Traumatic Brain Injury|traumatic brain injury
1653270|NCT00178711|Hypothermia|hypothermia
1653271|NCT00178698|thermochemotherapy|thermochemotherapy
1653272|NCT00178698|fever range whole body|fever range whole body
1653273|NCT00178698|cisplatin|cisplatin
1653274|NCT00178698|gemcitabine|gemcitabine
1653275|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
1653276|NCT00178685|Self-determination|self-determination
1653277|NCT00178685|motivation|motivation
1653278|NCT00178685|adherence|adherence
1653279|NCT00178685|competence|competence
1653280|NCT00178685|autonomy|autonomy
1653281|NCT00178685|tobacco dependence|tobacco dependence
1653282|NCT00178685|Tobacco use and dependence|tobacco use and dependence
1653283|NCT00178685|Behavior change|behavior change
1653284|NCT00178672|CVA|cva
1653285|NCT00178672|TIA|tia
1653286|NCT00178672|Carotid disease|carotid disease
1653287|NCT00178672|Stroke|stroke
1653288|NCT00178672|Neurology|neurology
1653289|NCT00178672|Carotid Stenting|carotid stenting
1653290|NCT00178659|Traumatic Brain Injury|traumatic brain injury
1653291|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
1653292|NCT00178659|Proteomics|proteomics
1653293|NCT00178646|Stroke|stroke
1653294|NCT00178646|Brain Injuries|brain injuries
1653295|NCT00178646|Spasticity|spasticity
1653296|NCT00178646|Botulinum Toxins|botulinum toxins
1653297|NCT00178633|Obesity|obesity
1653298|NCT00178633|Insulin Resistance|insulin resistance
1653299|NCT00178633|Free Fatty Acids|free fatty acids
1653300|NCT00178633|Heart Failure|heart failure
1653301|NCT00178620|Heart Disease|heart disease
1653302|NCT00178620|Heart Attack|heart attack
1653303|NCT00178620|Myocardial Infarction|myocardial infarction
1653304|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
1653305|NCT00178620|Emergency Medicine|emergency medicine
1653307|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
1653308|NCT00178594|Thrombotic Disorder|thrombotic disorder
1653309|NCT00178581|Trauma|trauma
1653310|NCT00178581|Critical Illness|critical illness
1653311|NCT00178581|Shock|shock
1653312|NCT00178581|Enteral Nutrition|enteral nutrition
1653313|NCT00178581|Glutamine|glutamine
1653314|NCT00178568|Caregiving|caregiving
1653315|NCT00178568|Spousal|spousal
1653316|NCT00178568|Sleep disturbances|sleep disturbances
1653317|NCT00178568|Progressive dementia|progressive dementia
1653318|NCT00178568|Stress|stress
1653319|NCT00178568|Health outcomes|health outcomes
1653320|NCT00178568|Intervention|intervention
1653321|NCT00178568|Affective self-management|affective self-management
1653322|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
1653323|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
1653324|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
1653325|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
1653326|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
1653327|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
1653328|NCT00178542|von Willebrand Disease|von willebrand disease
1653329|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
1653330|NCT00178529|Stroke|stroke
1653331|NCT00178529|Caregivers|caregivers
1653332|NCT00178516|male|male
1653333|NCT00178516|infertility|infertility
1653334|NCT00178490|Neurocognitive Function|neurocognitive function
1653335|NCT00178464|sickle cell disease|sickle cell disease
1653336|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
1653337|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
1653338|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
1653339|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
1653340|NCT00178464|aspirin|aspirin
1653341|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
1653342|NCT00178464|neurocognitive testing|neurocognitive testing
1653343|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
1653344|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
1653345|NCT00178425|pharmacokinetics|pharmacokinetics
1653346|NCT00178425|tacrolimus|tacrolimus
1653347|NCT00178412|Hospitalized elders|hospitalized elders
1653348|NCT00178412|Family caregivers|family caregivers
1653349|NCT00178412|Acute care|acute care
1653350|NCT00178386|cancer|cancer
1653351|NCT00178386|education|education
1653352|NCT00178386|learning|learning
1653353|NCT00178386|brain tumor|brain tumor
1653354|NCT00178386|school|school
1653355|NCT00178373|cancer-related fatigue|cancer-related fatigue
1653356|NCT00178373|chemotherapy|chemotherapy
1653357|NCT00178373|modafinil|modafinil
1653358|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
1653359|NCT00178321|Sleep|sleep
1653360|NCT00178321|Criticall Ill|criticall ill
1653361|NCT00178321|Children|children
1653362|NCT00178321|Earplugs|earplugs
1653363|NCT00178217|Botulinum Toxin|botulinum toxin
1653364|NCT00178217|Music Therapy|music therapy
1653365|NCT00178217|Cerebral Palsy|cerebral palsy
1653366|NCT00178217|Procedural Support|procedural support
1653367|NCT00178204|delta sleep|delta sleep
1653368|NCT00178204|Cancer-related fatigue|cancer-related fatigue
1653369|NCT00178204|Sleep Disturbance|sleep disturbance
1653370|NCT00178204|chemotherapy|chemotherapy
1653371|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
1653372|NCT00178178|Pain Care 3000|pain care 3000
1653373|NCT00178178|Catheter Placement|catheter placement
1653374|NCT00178178|Pain|pain
1653375|NCT00178178|Breg, Inc|breg, inc
1653376|NCT00178165|Family Caregivers|family caregivers
1653377|NCT00178165|Dementia|dementia
1653378|NCT00178165|Alzheimer Disease|alzheimer disease
1653379|NCT00178165|Randomized Controlled Trial|randomized controlled trial
1653380|NCT00178165|Intervention Studies|intervention studies
1653381|NCT00178139|Music Therapy|music therapy
1653382|NCT00178139|Mechanical ventilation|mechanical ventilation
1653383|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
1653384|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
1653385|NCT00178126|pressure ulcer|pressure ulcer
1653386|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
1653387|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
1653388|NCT00178113|lycopene|lycopene
1653389|NCT00178100|Depression|depression
1653390|NCT00178100|Elderly|elderly
1653391|NCT00178100|Late Life|late life
1653392|NCT00178087|late-life depression|late-life depression
1653393|NCT00178087|mild cognitive impairment|mild cognitive impairment
1653394|NCT00178087|dementia|dementia
1653395|NCT00178074|depression|depression
1653396|NCT00178074|imaging|imaging
1653397|NCT00178074|PET|pet
1653398|NCT00178074|elderly|elderly
1653399|NCT00178074|late life|late life
1653400|NCT00178074|sleep deprivation|sleep deprivation
1653401|NCT00178048|primary insomnia|primary insomnia
1653402|NCT00178048|insomnia|insomnia
1653403|NCT00178048|depression|depression
1653406|NCT00178048|sleep disorders|sleep disorders
1653407|NCT00178035|Depression|depression
1653408|NCT00178035|Unipolar Depression|unipolar depression
1653409|NCT00178035|Elderly depression|elderly depression
1653410|NCT00178035|Late-Life|late-life
1653411|NCT00178022|tbi|tbi
1653412|NCT00178022|intervention|intervention
1653413|NCT00178022|depression|depression
1653414|NCT00178022|anxiety|anxiety
1653415|NCT00178009|computer-assisted instruction|computer-assisted instruction
1653416|NCT00178009|instruction (video)|instruction (video)
1653417|NCT00177996|depression|depression
1653418|NCT00177996|anxiety|anxiety
1653419|NCT00177983|Schizophrenia|schizophrenia
1653420|NCT00177983|Relapse|relapse
1653421|NCT00177983|Psychological distress|psychological distress
1653422|NCT00177957|Gram negative bacteremia|gram negative bacteremia
1653423|NCT00177944|invasive fungal infection|invasive fungal infection
1653424|NCT00177931|Liver transplant|liver transplant
1653425|NCT00177931|cefepime|cefepime
1653426|NCT00177931|antibiotics|antibiotics
1653427|NCT00177918|Lung Transplant|lung transplant
1653428|NCT00177892|Sleep fragmentation|sleep fragmentation
1653429|NCT00177892|Intermittent hypoxia|intermittent hypoxia
1653430|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
1653431|NCT00177892|Metabolic Syndrome|metabolic syndrome
1653432|NCT00177892|Insulin resistance|insulin resistance
1653433|NCT00177879|website|website
1653434|NCT00177879|comparison|comparison
1653435|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
1653436|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
1653437|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
1653438|NCT00177840|cancer-related fatigue|cancer-related fatigue
1653439|NCT00177840|acupuncture|acupuncture
1653440|NCT00177840|breast cancer|breast cancer
1653441|NCT00177814|pipercillin|pipercillin
1653442|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
1653443|NCT00177788|liver transplant|liver transplant
1653444|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
1653445|NCT00177788|liver transplantation|liver transplantation
1653446|NCT00177788|voriconazole|voriconazole
1653447|NCT00177749|invasive fungal infections|invasive fungal infections
1653448|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
1653449|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
1653450|NCT00177671|Depression|depression
1653451|NCT00177671|Dementia|dementia
1653452|NCT00177671|Alzheimer's Disease|alzheimer's disease
1653453|NCT00177671|Cognitive|cognitive
1653454|NCT00177671|Donepezil|donepezil
1653455|NCT00177671|Memory|memory
1653456|NCT00177671|Function|function
1653457|NCT00177671|Elderly|elderly
1653458|NCT00177671|Late-Life|late-life
1653459|NCT00177658|Salmonella|salmonella
1653460|NCT00177645|cystic fibrosis|cystic fibrosis
1653461|NCT00177645|mucus clearance|mucus clearance
1653462|NCT00177619|Prostatic neoplasms|prostatic neoplasms
1653463|NCT00177619|Bisphosphonates|bisphosphonates
1653464|NCT00177619|Hypogonadism|hypogonadism
1653465|NCT00177606|withdrawal|withdrawal
1653466|NCT00177606|life-sustaining|life-sustaining
1653467|NCT00177606|treatments|treatments
1653468|NCT00177606|UNOS|unos
1653469|NCT00177606|organ donation|organ donation
1653470|NCT00177580|schizophrenia|schizophrenia
1653471|NCT00177580|schizoaffective disorder|schizoaffective disorder
1653472|NCT00177580|positive symptoms|positive symptoms
1653473|NCT00177580|negative symptoms|negative symptoms
1653474|NCT00177580|cognitive functioning|cognitive functioning
1653475|NCT00177580|pravastatin|pravastatin
1653476|NCT00177567|Bipolar Disorder|bipolar disorder
1653477|NCT00177567|Manic Depression|manic depression
1653478|NCT00177567|Elderly|elderly
1653479|NCT00177567|Late-Life|late-life
1653480|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1653481|NCT00177541|urge incontinence|urge incontinence
1653482|NCT00177541|biofeedback|biofeedback
1653483|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
1653484|NCT00177541|behavior modification|behavior modification
1653485|NCT00177528|Elderly|elderly
1653486|NCT00177515|emergency contraception|emergency contraception
1653487|NCT00177515|folic acid|folic acid
1653488|NCT00177515|education|education
1653489|NCT00177515|preventive health|preventive health
1653490|NCT00177489|Family Caregivers|family caregivers
1653491|NCT00177489|Dementia|dementia
1653492|NCT00177489|Alzheimer Disease|alzheimer disease
1653493|NCT00177489|Randomized Controlled Trial|randomized controlled trial
1653494|NCT00177489|Intervention Studies|intervention studies
1653495|NCT00177463|L-carnosine|l-carnosine
1653496|NCT00177463|Bipolar I disorder|bipolar i disorder
1653497|NCT00177463|Cognitive enhancement|cognitive enhancement
1653498|NCT00177424|Rehabilitation|rehabilitation
1653499|NCT00177411|Endocrine System Diseases|endocrine system diseases
1653500|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
1653501|NCT00177411|Hormone|hormone
1653502|NCT00177411|Postmenopausal Women|postmenopausal women
1653503|NCT00177398|Type 2 diabetes|type 2 diabetes
1653504|NCT00177398|Hyperglycemia|hyperglycemia
1653505|NCT00177398|Enteral nutrition|enteral nutrition
1653506|NCT00177385|Sleep|sleep
1653507|NCT00177385|Sleep Hygiene|sleep hygiene
1653508|NCT00177385|Modest sleep deprivation|modest sleep deprivation
1653509|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
1653510|NCT00177385|Health Promotion|health promotion
1653511|NCT00177359|gait impairment|gait impairment
1653512|NCT00177333|Abortion, Induced|abortion, induced
1653513|NCT00177333|Doxycycline|doxycycline
1653514|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
1653515|NCT00177333|Vomiting|vomiting
1653516|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
1653517|NCT00177320|Rheumatic Disorders|rheumatic disorders
1653518|NCT00177320|Computer Use|computer use
1653519|NCT00177307|colon|colon
1653520|NCT00177307|rectum|rectum
1653521|NCT00177294|Elderly|elderly
1653522|NCT00177294|Remission|remission
1653523|NCT00177294|Escitalopram|escitalopram
1653524|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
1653525|NCT00177294|Psychotherapy|psychotherapy
1653526|NCT00177294|Caregiving|caregiving
1653528|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1653529|NCT00177268|Sezary Syndrome|sezary syndrome
1653530|NCT00177268|Mycosis Fungoides|mycosis fungoides
1653531|NCT00177268|Blood/tissue banking|blood/tissue banking
1653533|NCT00177268|atopic dermatitis|atopic dermatitis
1653534|NCT00177255|gastric|gastric
1653535|NCT00177255|stomach|stomach
1653536|NCT00177255|esophagus|esophagus
1653537|NCT00177255|esophageal|esophageal
1653538|NCT00177242|pancreas|pancreas
1653539|NCT00177242|pancreatic|pancreatic
1653540|NCT00177216|Primary Insomnia|primary insomnia
1653541|NCT00177216|Insomnia|insomnia
1653542|NCT00177216|Placebo-Controlled|placebo-controlled
1653543|NCT00177216|Double-Blind|double-blind
1653544|NCT00177216|Polysomnography|polysomnography
1653545|NCT00177216|PET Studies|pet studies
1653546|NCT00177216|Escitalopram|escitalopram
1653547|NCT00177216|Zolpidem|zolpidem
1653548|NCT00177203|Insomnia|insomnia
1653549|NCT00177203|Sleep Disorders|sleep disorders
1653550|NCT00177203|Sleeplessness|sleeplessness
1653551|NCT00177203|Chronic Insomnia|chronic insomnia
1653552|NCT00177203|Sleep Studies|sleep studies
1653553|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
1653554|NCT00177203|Primary Care|primary care
1653555|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1653556|NCT00177190|Sezary Syndrome|sezary syndrome
1653557|NCT00177190|Mycosis Fungoides|mycosis fungoides
1653558|NCT00177190|Immune Responses|immune responses
1653559|NCT00177177|L-carnosine|l-carnosine
1653560|NCT00177177|Schizophrenia|schizophrenia
1653561|NCT00177177|Schizoaffective disorder|schizoaffective disorder
1653562|NCT00177177|Cognitive enhancement|cognitive enhancement
1653563|NCT00177164|Bipolar I Disorder|bipolar i disorder
1653564|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
1653565|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
1653566|NCT00177138|Campath Study|campath study
1653567|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
1653568|NCT00177138|Alemtuzumab|alemtuzumab
1653569|NCT00177112|Cystoscopy|cystoscopy
1653570|NCT00177047|stem cell transplantation|stem cell transplantation
1653571|NCT00177047|chemotherapy|chemotherapy
1653572|NCT00177047|multiple myeloma|multiple myeloma
1653573|NCT00177047|autologous|autologous
1653574|NCT00177034|Keratinocyte|keratinocyte
1653575|NCT00177008|Schizophrenia|schizophrenia
1653576|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
1653577|NCT00177008|Social Anxiety Disorder|social anxiety disorder
1653578|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
1653579|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
1653580|NCT00176930|stem cell transplant|stem cell transplant
1653581|NCT00176930|chronic leukemia|chronic leukemia
1653582|NCT00176930|acute leukemia|acute leukemia
1653583|NCT00176930|irradiation|irradiation
1653584|NCT00176930|chemotherapy|chemotherapy
1653585|NCT00176917|stem cell transplant|stem cell transplant
1653586|NCT00176917|storage disease|storage disease
1653587|NCT00176917|errors of metabolism|errors of metabolism
1653588|NCT00176904|Inborn errors|inborn errors
1653589|NCT00176904|Storage disease|storage disease
1653590|NCT00176904|errors of metabolism|errors of metabolism
1653591|NCT00176904|stem cell transplant|stem cell transplant
1653592|NCT00176891|Laronidase ERT|laronidase ert
1653593|NCT00176891|Stem cell transplant|stem cell transplant
1653594|NCT00176891|storage disease|storage disease
1653595|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
1653596|NCT00176891|hurler syndrome|hurler syndrome
1653597|NCT00176891|glycosaminoglycans|glycosaminoglycans
1653598|NCT00176891|enzyme replacement|enzyme replacement
1653599|NCT00176878|Stem cell transplant|stem cell transplant
1653600|NCT00176878|T-cell depletion|t-cell depletion
1653601|NCT00176878|TLI|tli
1653602|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
1653603|NCT00176865|Stem cell transplant|stem cell transplant
1653604|NCT00176865|immunodeficiency|immunodeficiency
1653605|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
1653606|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
1653607|NCT00176852|stem cell transplant|stem cell transplant
1653608|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
1653609|NCT00176852|transfusion dependent|transfusion dependent
1653610|NCT00176852|stem cell donor|stem cell donor
1653611|NCT00176852|cord blood|cord blood
1653612|NCT00176852|marrow|marrow
1653613|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
1653614|NCT00176839|Stem Cell transplant|stem cell transplant
1653615|NCT00176839|retransplant|retransplant
1653616|NCT00176839|hematological malignancies|hematological malignancies
1653617|NCT00176826|Stem Cell Transplant|stem cell transplant
1653618|NCT00176826|T-cell depletion|t-cell depletion
1653619|NCT00176826|immune deficiencies|immune deficiencies
1653620|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
1653621|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
1653622|NCT00176722|Spine Surgery|spine surgery
1653623|NCT00176722|Intraocular Pressure|intraocular pressure
1653624|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
1653625|NCT00176722|and its association with visual change|and its association with visual change
1653626|NCT00176696|general anesthesia|general anesthesia
1653627|NCT00176696|pain|pain
1653628|NCT00176696|depth of anesthesia|depth of anesthesia
1653629|NCT00176683|intubation|intubation
1653630|NCT00176683|capnography|capnography
1653631|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
1653632|NCT00176657|cardiac surgery|cardiac surgery
1653633|NCT00176657|transfusion|transfusion
1653634|NCT00176644|prostate cancer|prostate cancer
1653635|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1653636|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
1653637|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
1653638|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
1653639|NCT00176605|prostate cancer|prostate cancer
1653640|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
1653641|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
1653642|NCT00176592|Multiple Sclerosis|multiple sclerosis
1653643|NCT00176592|Brain|brain
1653644|NCT00176592|Betaseron|betaseron
1653645|NCT00176592|Copaxone|copaxone
1653646|NCT00176592|MRI|mri
1653647|NCT00176579|osteoporosis|osteoporosis
1653648|NCT00176579|stage I prostate cancer|stage i prostate cancer
1653649|NCT00176566|oral leukoplakia|oral leukoplakia
1653650|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
1653651|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1653652|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1653653|NCT00176540|fatigue|fatigue
1653654|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
1653655|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
1653656|NCT00176514|mucositis|mucositis
1653657|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
1653658|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1653659|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
1653660|NCT00176488|recurrent breast cancer|recurrent breast cancer
1653661|NCT00176488|stage II breast cancer|stage ii breast cancer
1653662|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
1653663|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
1653664|NCT00176488|stage IV breast cancer|stage iv breast cancer
1653665|NCT00176488|male breast cancer|male breast cancer
1653666|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1653667|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1653668|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1653669|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1653670|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1653671|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1653672|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1653673|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1653674|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1653675|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
1653676|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
1653677|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1653678|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1653679|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1653680|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1653681|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
1653682|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1653683|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1653684|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1653685|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1653686|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
1653687|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
1653688|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1653689|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1653690|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1653691|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1653692|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1653693|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1653694|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1653695|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1653696|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1653697|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1653698|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1653699|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1653700|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1653701|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1653702|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1653703|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1653704|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1653705|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1653706|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1653707|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1653708|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1653709|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1653710|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1653712|NCT00176462|Leukemia|leukemia
1653713|NCT00176449|Nicotine Dependence|nicotine dependence
1653714|NCT00176449|Nicotine Use Disorder|nicotine use disorder
1653715|NCT00176449|Tobacco Dependence|tobacco dependence
1653716|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
1653717|NCT00176449|Smoking Cessation|smoking cessation
1653718|NCT00176436|Weight loss|weight loss
1653719|NCT00176436|Support group|support group
1653720|NCT00176436|Exercise|exercise
1653721|NCT00176436|Atomoxetine|atomoxetine
1653722|NCT00176423|schizophrenia|schizophrenia
1653723|NCT00176423|acetylcholine|acetylcholine
1653724|NCT00176423|cognitive impairments|cognitive impairments
1653725|NCT00176423|attention|attention
1653726|NCT00176423|processing speed|processing speed
1653727|NCT00176423|sensory gating|sensory gating
1653728|NCT00176423|eye-tracking|eye-tracking
1653729|NCT00176410|aortic valve stenosis|aortic valve stenosis
1653730|NCT00176410|statin therapy|statin therapy
1653731|NCT00176397|left main coronary artery|left main coronary artery
1653732|NCT00176397|coronary artery disease|coronary artery disease
1653733|NCT00176384|chronic heart failure|chronic heart failure
1653734|NCT00176384|exercise training|exercise training
1653736|NCT00176345|exercise training|exercise training
1653737|NCT00176345|endothelial function|endothelial function
1653738|NCT00176332|chronic heart failure|chronic heart failure
1653739|NCT00176332|rosuvastatin|rosuvastatin
1653740|NCT00176332|endothelial function|endothelial function
1653741|NCT00176332|skeletal muscle|skeletal muscle
1653742|NCT00176319|heart failure|heart failure
1653743|NCT00176319|ageing|ageing
1653744|NCT00176293|prostate|prostate
1653745|NCT00176293|prostate cancer|prostate cancer
1653746|NCT00176293|doxil|doxil
1653747|NCT00176293|dexamethasone|dexamethasone
1653748|NCT00176293|metastatic|metastatic
1653749|NCT00176293|hormone refractory|hormone refractory
1653750|NCT00176280|Renal|renal
1653751|NCT00176280|Carcinoma|carcinoma
1653752|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
1653754|NCT00176280|Leukine|leukine
1653755|NCT00176280|Dexamethasone|dexamethasone
1653756|NCT00176280|Gemcitabine|gemcitabine
1653757|NCT00176280|5 Fluorouracil|5 fluorouracil
1653758|NCT00176280|5 FU|5 fu
1653759|NCT00176280|Metastatic|metastatic
1653760|NCT00176267|head and neck|head and neck
1653761|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
1653762|NCT00176267|squamous cell|squamous cell
1653763|NCT00176267|carcinoma|carcinoma
1653764|NCT00176267|paclitaxel|paclitaxel
1653765|NCT00176267|carboplatin|carboplatin
1653766|NCT00176267|radiotherapy|radiotherapy
1653767|NCT00176267|induction therapy|induction therapy
1653768|NCT00176254|head and neck|head and neck
1653769|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
1653770|NCT00176254|squamous cell|squamous cell
1653771|NCT00176254|carcinoma|carcinoma
1653772|NCT00176254|paclitaxel|paclitaxel
1653773|NCT00176254|carboplatin|carboplatin
1653774|NCT00176254|radiotherapy|radiotherapy
1653775|NCT00176254|induction therapy|induction therapy
1653776|NCT00176241|head and neck|head and neck
1653777|NCT00176241|Gemcitabine|gemcitabine
1653778|NCT00176241|Paclitaxel|paclitaxel
1653779|NCT00176241|radiation|radiation
1654465|NCT00172159|Surgery|surgery
1653780|NCT00176241|low-dose radiation|low-dose radiation
1653781|NCT00176241|recurrent|recurrent
1653782|NCT00176241|metastatic|metastatic
1653783|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
1653784|NCT00176176|cerebral circulation|cerebral circulation
1653785|NCT00176163|Fibromyalgia|fibromyalgia
1653786|NCT00176163|Back pain|back pain
1653787|NCT00176163|Behavior Therapy|behavior therapy
1653788|NCT00176163|Operant learning|operant learning
1653789|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
1653790|NCT00176150|anorexia nervosa|anorexia nervosa
1653791|NCT00176150|multidrug resistance|multidrug resistance
1653792|NCT00176150|cholesterol metabolism|cholesterol metabolism
1653793|NCT00176137|multimodality treatment|multimodality treatment
1653794|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
1653795|NCT00176124|infection|infection
1653796|NCT00176124|bacterial infection|bacterial infection
1653797|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
1653798|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
1653800|NCT00176111|local anesthestics|local anesthestics
1653801|NCT00176111|regional anesthestia|regional anesthestia
1653802|NCT00176111|nerve damage|nerve damage
1653803|NCT00176098|Cataract surgery|cataract surgery
1653804|NCT00176098|Hypnosis|hypnosis
1653805|NCT00176098|C11.510.245|c11.510.245
1653806|NCT00176098|F04.754.424.771|f04.754.424.771
1653807|NCT00176098|Suggestion|suggestion
1653808|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
1653809|NCT00176059|kidney transplantation|kidney transplantation
1653810|NCT00176059|acute rejection|acute rejection
1653811|NCT00176059|chronic rejection|chronic rejection
1653812|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
1653813|NCT00176059|Th1|th1
1653814|NCT00176059|Th2|th2
1653815|NCT00176059|B Cell|b cell
1653816|NCT00176059|Monokines|monokines
1653817|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
1653818|NCT00176046|breast cancer|breast cancer
1653819|NCT00176046|mistletoe|mistletoe
1653820|NCT00176046|complementary therapy|complementary therapy
1653821|NCT00176046|quality of life|quality of life
1653822|NCT00176046|immune function|immune function
1653823|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
1653824|NCT00176033|ritonavir|ritonavir
1653825|NCT00176033|lopinavir|lopinavir
1653826|NCT00176033|HIV Infections|hiv infections
1653827|NCT00176020|nicotinic acid|nicotinic acid
1653828|NCT00176020|flush symptom|flush symptom
1653829|NCT00176020|pharmacodynamic|pharmacodynamic
1653830|NCT00176020|pharmacokinetic|pharmacokinetic
1653831|NCT00175994|voriconazole|voriconazole
1653832|NCT00175994|genotype|genotype
1653833|NCT00175994|bioavailability|bioavailability
1653834|NCT00175994|metabolic clearance|metabolic clearance
1653835|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
1653836|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
1653837|NCT00175942|acute myocardial infarction|acute myocardial infarction
1653838|NCT00175942|ventricular fibrillation|ventricular fibrillation
1653839|NCT00175942|coagulation|coagulation
1653840|NCT00175942|inflammation|inflammation
1653841|NCT00175929|Epilepsy|epilepsy
1653842|NCT00175929|Focal Epilepsy|focal epilepsy
1653843|NCT00175929|Partial Onset Seizures|partial onset seizures
1653844|NCT00175929|Brivaracetam|brivaracetam
1653845|NCT00175916|Brivaracetam|brivaracetam
1653846|NCT00175916|Epilepsy|epilepsy
1653847|NCT00175916|long term|long term
1653848|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
1653849|NCT00175903|Levetiracetam|levetiracetam
1653850|NCT00175903|Keppra|keppra
1653851|NCT00175903|Carbamazepine|carbamazepine
1653852|NCT00175903|Valproate|valproate
1653853|NCT00175890|Partial Onset Seizure|partial onset seizure
1653854|NCT00175890|levetiracetam|levetiracetam
1653855|NCT00175890|Video Electroencephalogram|video electroencephalogram
1653856|NCT00175890|Keppra|keppra
1653857|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
1653858|NCT00175877|CDP870|cdp870
1653859|NCT00175877|Certolizumab Pegol|certolizumab pegol
1653860|NCT00175877|Cimzia|cimzia
1653861|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
1653862|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
1653863|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
1653864|NCT00175838|Hydroxyurea|hydroxyurea
1653865|NCT00175838|Randomised|randomised
1653866|NCT00175838|Thrombosis|thrombosis
1653867|NCT00175838|Haemorrhage|haemorrhage
1653868|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
1653869|NCT00175825|brivaracetam|brivaracetam
1653870|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
1653871|NCT00175812|Differentiation|differentiation
1653872|NCT00175812|All trans retinoic acid|all trans retinoic acid
1653873|NCT00175812|Valproic acid|valproic acid
1653874|NCT00175812|Theophyllamin|theophyllamin
1653967|NCT00175370|CNS bloodstream infection|cns bloodstream infection
1653968|NCT00175357|Opiate addiction|opiate addiction
1653969|NCT00175357|medical heroin|medical heroin
1653875|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
1653876|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
1653877|NCT00175786|Glaucoma|glaucoma
1653878|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
1653879|NCT00175786|Neuroradiology|neuroradiology
1653880|NCT00175786|Tumor|tumor
1653881|NCT00175786|MRI|mri
1653882|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
1653883|NCT00175786|Compressive Lesion|compressive lesion
1653884|NCT00175773|Orthostatic stress|orthostatic stress
1653885|NCT00175760|TTG|ttg
1653886|NCT00175760|pediatric|pediatric
1653887|NCT00175760|comparison study|comparison study
1653888|NCT00175747|dysplasia|dysplasia
1653889|NCT00175747|lung cancer|lung cancer
1653890|NCT00175747|chemoprevention|chemoprevention
1653891|NCT00175734|Vascular Reactivity|vascular reactivity
1653892|NCT00175734|Anemia Correction Therapy|anemia correction therapy
1653893|NCT00175734|Hemodialysis patients|hemodialysis patients
1653894|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
1653895|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
1653896|NCT00175721|Combined Clinic|combined clinic
1653897|NCT00175721|Chronic Kidney Disease|chronic kidney disease
1653898|NCT00175721|Diabetes|diabetes
1653899|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
1653900|NCT00175708|clubfoot|clubfoot
1653901|NCT00175708|foot pressure profiles|foot pressure profiles
1653902|NCT00175708|pedobarographs|pedobarographs
1653903|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
1653904|NCT00175682|SCI|sci
1653905|NCT00175682|Vibrostimulation|vibrostimulation
1653906|NCT00175682|Ejaculation|ejaculation
1653907|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
1653908|NCT00175656|Femur fracture|femur fracture
1653909|NCT00175656|titanium elastic nails|titanium elastic nails
1653910|NCT00175643|actinic keratoses|actinic keratoses
1653911|NCT00175643|imiquimod|imiquimod
1653912|NCT00175643|pre-malignant|pre-malignant
1653913|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
1653914|NCT00175643|immunosuppression|immunosuppression
1653915|NCT00175630|ACL reconstruction|acl reconstruction
1653916|NCT00175630|morphine sparing|morphine sparing
1653917|NCT00175630|preemptive analgesia|preemptive analgesia
1653918|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
1653919|NCT00175604|Botox|botox
1653920|NCT00175604|torticollis|torticollis
1653921|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
1653922|NCT00175591|Femur fracture|femur fracture
1653923|NCT00175591|morphine sparing|morphine sparing
1653924|NCT00175591|preemptive analgesia|preemptive analgesia
1653925|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
1653926|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
1653927|NCT00175565|inflammation|inflammation
1653928|NCT00175565|trial|trial
1653929|NCT00175565|fluticasone|fluticasone
1653930|NCT00175552|Depression|depression
1653931|NCT00175552|Adolescents|adolescents
1653932|NCT00175552|IPT|ipt
1653933|NCT00175552|Knowledge translation|knowledge translation
1653934|NCT00175552|Psychotherapy|psychotherapy
1653935|NCT00175539|sexual dysfunction|sexual dysfunction
1653936|NCT00175539|group treatment|group treatment
1653937|NCT00175513|Psychosis|psychosis
1653938|NCT00175513|early psychosis|early psychosis
1653939|NCT00175513|first episode psychosis|first episode psychosis
1653940|NCT00175513|schizophrenia|schizophrenia
1653941|NCT00175513|schizoaffective|schizoaffective
1653942|NCT00175513|schizophreniform|schizophreniform
1653943|NCT00175513|bipolar disorder|bipolar disorder
1653944|NCT00175513|valtrex|valtrex
1653945|NCT00175513|valacyclovir.|valacyclovir.
1653946|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
1653947|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
1653948|NCT00175487|Hip|hip
1653949|NCT00175435|Topical Immune Modulator|topical immune modulator
1653950|NCT00175435|resiquimod gel|resiquimod gel
1653951|NCT00175435|Hepatitis B booster response|hepatitis b booster response
1653952|NCT00175435|Vaccine Evaluation|vaccine evaluation
1653953|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
1653954|NCT00175422|Prevention|prevention
1653955|NCT00175422|Randomized controlled trial|randomized controlled trial
1653956|NCT00175422|Community education|community education
1653957|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
1653958|NCT00175422|Crying|crying
1653959|NCT00175422|Colic|colic
1653960|NCT00175409|Pain Response|pain response
1653961|NCT00175396|ASCENDE-RT|ascende-rt
1653962|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
1653963|NCT00175370|Vancomycin|vancomycin
1653964|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
1653965|NCT00175370|Central Venous Catheter|central venous catheter
1653966|NCT00175370|Bloodstream infection|bloodstream infection
1653970|NCT00175357|methadoneRCT|methadonerct
1653971|NCT00175344|Breast cancer|breast cancer
1653972|NCT00175344|scar massage|scar massage
1653973|NCT00175344|breast conserving surgery|breast conserving surgery
1653974|NCT00175344|scar pain|scar pain
1653975|NCT00175344|quality of life|quality of life
1653976|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
1653977|NCT00175318|Motivational interviewing|motivational interviewing
1653978|NCT00175318|behavioural modification|behavioural modification
1653979|NCT00175318|maternal counseling|maternal counseling
1653980|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
1653981|NCT00175305|Somatostatin|somatostatin
1653982|NCT00175305|Ghrelin|ghrelin
1653983|NCT00175305|Obesity|obesity
1653984|NCT00175305|Hyperphagia|hyperphagia
1653985|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
1653986|NCT00175279|coronary disease|coronary disease
1653987|NCT00175279|heart failure|heart failure
1653988|NCT00175279|quality improvement|quality improvement
1655044|NCT00169624|metformin,|metformin,
1653989|NCT00175279|knowledge translation|knowledge translation
1653990|NCT00175279|opinion leaders|opinion leaders
1653991|NCT00175266|islet|islet
1653992|NCT00175266|transplantation|transplantation
1653993|NCT00175253|islet|islet
1653994|NCT00175253|transplantation|transplantation
1653995|NCT00175240|Coronary disease|coronary disease
1653996|NCT00175240|quality improvement|quality improvement
1653997|NCT00175240|knowledge translation|knowledge translation
1653998|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
1653999|NCT00175227|prevention|prevention
1654000|NCT00175227|renal failure|renal failure
1654001|NCT00175227|cardiac angiogram|cardiac angiogram
1654002|NCT00175214|osteoporosis|osteoporosis
1654003|NCT00175214|wrist fractures|wrist fractures
1654004|NCT00175214|quality improvement|quality improvement
1654005|NCT00175214|knowledge translation|knowledge translation
1654006|NCT00175188|RSA|rsa
1654007|NCT00175188|DEXA|dexa
1654008|NCT00175188|Osteoarthritis|osteoarthritis
1654009|NCT00175188|Finger implant|finger implant
1654010|NCT00175188|Micromotion|micromotion
1654011|NCT00175188|Bone density|bone density
1654012|NCT00175188|Cement|cement
1654013|NCT00175175|osteoporosis treatment|osteoporosis treatment
1654014|NCT00175175|osteoporosis testing|osteoporosis testing
1654015|NCT00175175|hip fracture|hip fracture
1654016|NCT00175175|quality improvement|quality improvement
1654017|NCT00175162|RSA|rsa
1654018|NCT00175162|DEXA|dexa
1654019|NCT00175162|Genoarthrosis|genoarthrosis
1654020|NCT00175162|Knee Arthroplasty|knee arthroplasty
1654021|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
1654022|NCT00175162|Cement|cement
1654023|NCT00175149|CKD 3-4|ckd 3-4
1654024|NCT00175136|RSA|rsa
1654025|NCT00175136|DEXA|dexa
1654026|NCT00175136|Gonarthrosis|gonarthrosis
1654027|NCT00175136|Knee Arthroplasty|knee arthroplasty
1654028|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
1654029|NCT00175136|Stem arthroplasty design|stem arthroplasty design
1654030|NCT00175123|Myelomeningocele|myelomeningocele
1654031|NCT00175123|Neurogenic Bladder|neurogenic bladder
1654032|NCT00175123|Intervention|intervention
1654033|NCT00175123|Botulinum A toxin|botulinum a toxin
1654034|NCT00175123|Oxybutynin|oxybutynin
1654035|NCT00175110|pre-hypertension|pre-hypertension
1654036|NCT00175110|mild hypertension|mild hypertension
1654037|NCT00175097|soy protein|soy protein
1654038|NCT00175097|lipids|lipids
1654039|NCT00175097|lipoproteins|lipoproteins
1654040|NCT00175097|apolipoproteins|apolipoproteins
1654041|NCT00175097|cholesterol|cholesterol
1654042|NCT00175097|endothelial function|endothelial function
1654043|NCT00175058|Heart Attack|heart attack
1654044|NCT00175045|Intravenous|intravenous
1654045|NCT00175045|gastric acid secretion|gastric acid secretion
1654046|NCT00175045|Lansoprazole|lansoprazole
1654047|NCT00175045|Esophagitis|esophagitis
1654048|NCT00175045|reflux|reflux
1654049|NCT00175032|Low dose aspirin|low dose aspirin
1654050|NCT00175032|Peptic Ulcer|peptic ulcer
1654051|NCT00175032|gastric ulcer|gastric ulcer
1654052|NCT00175032|duodenal ulcer|duodenal ulcer
1654053|NCT00175032|NSAIDs|nsaids
1654054|NCT00175019|uric acid|uric acid
1654055|NCT00175019|xanthine oxidase|xanthine oxidase
1654056|NCT00175019|hyperuricemia|hyperuricemia
1654057|NCT00175019|tophi|tophi
1654058|NCT00175019|Drug Therapy|drug therapy
1654059|NCT00175006|Hyperuricemia|hyperuricemia
1654060|NCT00175006|Tophi|tophi
1654061|NCT00175006|Tophus|tophus
1654062|NCT00175006|Drug Therapy|drug therapy
1654063|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
1654251|NCT00173407|invasion|invasion
1654064|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
1654065|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
1654066|NCT00174993|Lipoatrophic|lipoatrophic
1654067|NCT00174993|Dyslipidemia|dyslipidemia
1654068|NCT00174993|Drug Therapy|drug therapy
1654069|NCT00174980|Oxycyte|oxycyte
1654070|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
1654838|NCT00170742|phase III,|phase iii,
1654071|NCT00174980|brain oxygen tension|brain oxygen tension
1654072|NCT00174967|Uric Acid|uric acid
1654073|NCT00174967|xanthine oxidase|xanthine oxidase
1654074|NCT00174967|tophi|tophi
1654075|NCT00174967|Drug Therapy|drug therapy
1654076|NCT00174954|Gout|gout
1654077|NCT00174954|Tophus|tophus
1654078|NCT00174954|MRI|mri
1654079|NCT00174941|Uric acid|uric acid
1654080|NCT00174941|xanthine oxidase|xanthine oxidase
1654081|NCT00174941|tophi|tophi
1654082|NCT00174941|Drug Therapy|drug therapy
1654083|NCT00174928|Pediatric GERD|pediatric gerd
1654084|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
1654085|NCT00174928|Neonates|neonates
1654086|NCT00174928|lansoprazole|lansoprazole
1654087|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
1654088|NCT00174902|Randomized controlled trial|randomized controlled trial
1654089|NCT00174902|Blood platelets|blood platelets
1654090|NCT00174902|Hemostasis|hemostasis
1654091|NCT00174902|Stress, psychological|stress, psychological
1655045|NCT00169624|glyclazide,|glyclazide,
1654092|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
1654093|NCT00174902|Aspirin|aspirin
1654094|NCT00174902|Endothelium|endothelium
1654095|NCT00174902|Arteriosclerosis|arteriosclerosis
1654096|NCT00174889|Schizophrenia|schizophrenia
1654097|NCT00174889|Pregnenolone|pregnenolone
1654098|NCT00174889|Neurosteroids|neurosteroids
1654099|NCT00174876|depression|depression
1654100|NCT00174850|anxiety|anxiety
1654101|NCT00174850|sexual dysfunction|sexual dysfunction
1654102|NCT00174850|ssri|ssri
1654103|NCT00174837|Tirapazamine|tirapazamine
1654104|NCT00174837|Head and Neck Cancer|head and neck cancer
1654105|NCT00174837|Cisplatin|cisplatin
1654106|NCT00174837|Radiation|radiation
1654107|NCT00174824|Diabetes|diabetes
1654108|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
1654109|NCT00174811|acute otitis media|acute otitis media
1654110|NCT00174811|controlled clinical trial|controlled clinical trial
1654111|NCT00174811|telithromycin|telithromycin
1654112|NCT00174811|cefuroxime axetil|cefuroxime axetil
1654113|NCT00174811|middle ear infections|middle ear infections
1654114|NCT00174811|tympanocentecis|tympanocentecis
1654115|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
1654116|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
1654117|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
1654118|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
1654119|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
1654120|NCT00174603|depression|depression
1654121|NCT00174603|psychosis|psychosis
1654122|NCT00174590|depression|depression
1654123|NCT00174538|codeine|codeine
1654124|NCT00174538|pain|pain
1654125|NCT00174538|CYP2D6|cyp2d6
1654126|NCT00174538|genotype|genotype
1654127|NCT00174538|morphine|morphine
1654128|NCT00174538|sickle cell|sickle cell
1654129|NCT00174538|pharmacokinetic|pharmacokinetic
1654130|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
1654131|NCT00174525|Alzheimer disease|alzheimer disease
1654132|NCT00174499|Tooth stain|tooth stain
1654133|NCT00174213|iliotibial tract|iliotibial tract
1654134|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
1654135|NCT00174135|Sarcopenia|sarcopenia
1654136|NCT00174135|exercise|exercise
1654137|NCT00174122|Emergency department|emergency department
1654138|NCT00174122|Blood culture|blood culture
1654139|NCT00174122|Antimicrobial therapy|antimicrobial therapy
1654140|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
1654141|NCT00174096|laryngeal cancer|laryngeal cancer
1654142|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
1654143|NCT00174096|CXCR4|cxcr4
1654144|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
1654145|NCT00174096|metastasis|metastasis
1654146|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
1654147|NCT00174070|Respiratory failure|respiratory failure
1654148|NCT00174070|Community|community
1654149|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
1654150|NCT00174057|real time PCR|real time pcr
1654151|NCT00174057|cytokines|cytokines
1654152|NCT00174057|Tsh receptor|tsh receptor
1654153|NCT00174031|baseball|baseball
1654154|NCT00174031|injury|injury
1654155|NCT00174018|subacrominal space|subacrominal space
1654156|NCT00174005|muscle|muscle
1654157|NCT00174005|tendon|tendon
1654158|NCT00173992|Stroke|stroke
1654159|NCT00173992|Balance|balance
1654160|NCT00173992|Proactive control|proactive control
1654161|NCT00173992|Reactive control|reactive control
1654162|NCT00173992|Recovery|recovery
1654163|NCT00173992|Training|training
1654164|NCT00173992|Fall|fall
1654165|NCT00173979|muscle|muscle
1654166|NCT00173979|tendon|tendon
1654167|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
1654262|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
1654839|NCT00170742|disease,|disease,
1654168|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
1654169|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
1654170|NCT00173927|imaging|imaging
1654171|NCT00173927|biomarkers|biomarkers
1654172|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
1654173|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
1654174|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
1654175|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
1654176|NCT00173901|ceftazidime|ceftazidime
1654177|NCT00173901|safety|safety
1654178|NCT00173901|infection|infection
1654179|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
1654180|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
1654181|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
1654182|NCT00173849|oral cancer|oral cancer
1654183|NCT00173849|CXCR4|cxcr4
1654184|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
1654185|NCT00173849|metastasis|metastasis
1654186|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1654187|NCT00173836|Saliva|saliva
1654188|NCT00173836|Swallowing|swallowing
1654189|NCT00173836|Videofluoroscopy|videofluoroscopy
1654190|NCT00173836|Radiation|radiation
1654191|NCT00173810|stroke|stroke
1654192|NCT00173810|movement|movement
1654193|NCT00173810|psychomterics|psychomterics
1654194|NCT00173797|depression|depression
1654195|NCT00173797|psychometrics|psychometrics
1654196|NCT00173784|psychometrics|psychometrics
1654197|NCT00173784|activities of daily living|activities of daily living
1654198|NCT00173771|stroke|stroke
1654199|NCT00173771|activities of daily living|activities of daily living
1654200|NCT00173771|psychometrics|psychometrics
1654201|NCT00173758|IL-15|il-15
1654202|NCT00173758|IL-15 receptor|il-15 receptor
1654203|NCT00173758|decidual natural killer cells|decidual natural killer cells
1654204|NCT00173758|endometrium|endometrium
1654205|NCT00173745|cerebral palsy|cerebral palsy
1654206|NCT00173745|drooling|drooling
1654207|NCT00173745|botulinum toxin|botulinum toxin
1654208|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
1654209|NCT00173732|single cell|single cell
1654210|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
1654211|NCT00173719|Hemiplegia|hemiplegia
1654212|NCT00173719|Assisstive device|assisstive device
1654213|NCT00173719|Walking|walking
1654214|NCT00173719|Dynamic equilibrium|dynamic equilibrium
1654215|NCT00173719|Reaction time|reaction time
1654216|NCT00173719|Attention|attention
1654217|NCT00173719|Dual task|dual task
1654218|NCT00173706|L-Carnitine|l-carnitine
1654219|NCT00173706|hemodialysis|hemodialysis
1654220|NCT00173706|cardiac complications|cardiac complications
1654221|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
1654222|NCT00173706|muscle symptoms|muscle symptoms
1654223|NCT00173706|intradialytic hypotension|intradialytic hypotension
1654224|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
1654225|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
1654226|NCT00173615|ECMO|ecmo
1654227|NCT00173615|CPR|cpr
1654228|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
1654229|NCT00173563|Immunology|immunology
1654230|NCT00173550|Menopause, premature|menopause, premature
1654231|NCT00173550|Hysterectomy|hysterectomy
1654232|NCT00173550|Ovariectomy|ovariectomy
1654233|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
1654234|NCT00173550|Knowledge|knowledge
1654235|NCT00173550|Perception|perception
1654236|NCT00173550|Attitude|attitude
1654237|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
1654238|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
1654239|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
1654240|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
1654241|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
1654242|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
1654243|NCT00173433|tuberculosis|tuberculosis
1654244|NCT00173433|relapse|relapse
1654245|NCT00173433|reinfection|reinfection
1654246|NCT00173433|reactivation|reactivation
1654247|NCT00173433|dormancy|dormancy
1654248|NCT00173433|tuberculin skin test|tuberculin skin test
1654249|NCT00173420|Normal Controls|normal controls
1654250|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
1654252|NCT00173407|IGFBP-3|igfbp-3
1654253|NCT00173407|transfection|transfection
1654254|NCT00173407|signal transduction|signal transduction
1654255|NCT00173407|PTEN|pten
1654256|NCT00173407|methylation|methylation
1654257|NCT00173394|ovarian cancer|ovarian cancer
1654258|NCT00173394|immunotherapy|immunotherapy
1654259|NCT00173394|mesothelin|mesothelin
1654260|NCT00173394|normal volunteer|normal volunteer
1654261|NCT00173381|lymphangiogenesis|lymphangiogenesis
1654263|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
1654264|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
1654265|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
1654266|NCT00173368|Sphincterotomy|sphincterotomy
1654267|NCT00173368|needle knife|needle knife
1654268|NCT00173368|hemorrhage|hemorrhage
1654269|NCT00173368|complication|complication
1654270|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
1654271|NCT00173342|Right bundle branch block|right bundle branch block
1654272|NCT00173342|Electrocardiography|electrocardiography
1654273|NCT00173342|Ion channel|ion channel
1654274|NCT00173329|HIV|hiv
1654275|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
1654276|NCT00173316|VEGF-CR|vegf-cr
1654277|NCT00173316|lymphangiogenesis|lymphangiogenesis
1654278|NCT00173316|host inflammatory responses|host inflammatory responses
1654279|NCT00173316|oral carcinogenesis|oral carcinogenesis
1654280|NCT00173316|oral cancers|oral cancers
1655046|NCT00169624|MRI.|mri.
1654281|NCT00173316|oral premalignant lesions|oral premalignant lesions
1654282|NCT00173303|Breast neoplasms|breast neoplasms
1654283|NCT00173303|Breast radiography|breast radiography
1654284|NCT00173303|Cancer screening|cancer screening
1654285|NCT00173290|Cervical cancer|cervical cancer
1654286|NCT00173290|Breast cancer|breast cancer
1654287|NCT00173290|T lymphocyte|t lymphocyte
1654288|NCT00173290|NK receptor|nk receptor
1654289|NCT00173277|colorectal cancer screening|colorectal cancer screening
1654290|NCT00173277|colonoscopy|colonoscopy
1654291|NCT00173238|atherosclerosis|atherosclerosis
1654292|NCT00173238|optical coherence tomography|optical coherence tomography
1654293|NCT00173238|polarization|polarization
1654294|NCT00173238|phase retardation|phase retardation
1654295|NCT00173238|birefringence|birefringence
1654296|NCT00173225|nociceptin|nociceptin
1654297|NCT00173225|sunstance P|sunstance p
1654298|NCT00173225|asthma|asthma
1654299|NCT00173225|COPD|copd
1654300|NCT00173225|cough|cough
1654301|NCT00173212|adenomyosis|adenomyosis
1654302|NCT00173212|cell proliferation|cell proliferation
1654303|NCT00173212|Immunocytochemistry|immunocytochemistry
1654304|NCT00173186|ventricular septal defect|ventricular septal defect
1654305|NCT00173186|aortic regurgitation|aortic regurgitation
1654306|NCT00173173|Gifted dance students|gifted dance students
1654307|NCT00173173|eating disorders|eating disorders
1654308|NCT00173173|prevalence|prevalence
1654309|NCT00173173|risk factors|risk factors
1654310|NCT00173173|BITE|bite
1654311|NCT00173160|Eating disorders|eating disorders
1654312|NCT00173160|risk factors|risk factors
1654313|NCT00173160|prospective study|prospective study
1654314|NCT00173160|case-controled study|case-controled study
1654315|NCT00173160|outcome|outcome
1654316|NCT00173160|gifted dance students|gifted dance students
1654317|NCT00173134|diabetes|diabetes
1654318|NCT00173134|erectile dysfunction|erectile dysfunction
1654319|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
1654320|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
1654321|NCT00173108|Prematurity|prematurity
1654322|NCT00173108|Early intervention|early intervention
1654323|NCT00173108|Neurodevelopment|neurodevelopment
1654324|NCT00173108|Cost-effectiveness|cost-effectiveness
1654325|NCT00173082|primary aldosteronism|primary aldosteronism
1654326|NCT00173082|Insulin resistance|insulin resistance
1654327|NCT00173082|Metabolic syndrome|metabolic syndrome
1654328|NCT00173082|OGTT|ogtt
1654329|NCT00173069|Schizophrenia|schizophrenia
1654330|NCT00173069|PPI|ppi
1654331|NCT00173069|P50I|p50i
1654332|NCT00173069|MRS|mrs
1654333|NCT00173069|Niacin|niacin
1654334|NCT00173069|Candidate Genes|candidate genes
1654335|NCT00173056|Peritoneal dialysis|peritoneal dialysis
1654336|NCT00173017|N95 mask|n95 mask
1654337|NCT00173017|medical staff|medical staff
1654338|NCT00173017|hypoxemia|hypoxemia
1654339|NCT00173017|hypercapnia|hypercapnia
1654340|NCT00173017|neurological study|neurological study
1654341|NCT00172965|Optic coherence tomography|optic coherence tomography
1654342|NCT00172965|oral cancer|oral cancer
1654343|NCT00172965|oral precancers|oral precancers
1654344|NCT00172952|high myopia, genomic|high myopia, genomic
1654345|NCT00172926|Physical Constitution|physical constitution
1654346|NCT00172926|Disease Pattern|disease pattern
1654347|NCT00172926|Laboratory Data|laboratory data
1654348|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
1654349|NCT00172913|Wavefront Aberration|wavefront aberration
1654350|NCT00172913|LASIK|lasik
1654351|NCT00172913|Contrast Sensitivity|contrast sensitivity
1654453|NCT00172198|patients|patients
1654352|NCT00172913|Visual Performance|visual performance
1654353|NCT00172913|Ablation Profile|ablation profile
1654354|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
1654355|NCT00172900|MR spectroscopy|mr spectroscopy
1654356|NCT00172900|dementia|dementia
1654357|NCT00172900|white matter|white matter
1654358|NCT00172887|Psychiatrists|psychiatrists
1654359|NCT00172874|cross-cultural,|cross-cultural,
1654360|NCT00172874|eating disorders,|eating disorders,
1654361|NCT00172874|EDI,|edi,
1654362|NCT00172874|psychometrics|psychometrics
1654363|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
1654364|NCT00172835|pleural effusion|pleural effusion
1654365|NCT00172835|procalcitonin|procalcitonin
1654366|NCT00172822|appendicitis|appendicitis
1654367|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
1654368|NCT00172809|End stage renal disease|end stage renal disease
1654369|NCT00172809|Hemodialysis|hemodialysis
1654370|NCT00172809|Interferon|interferon
1654371|NCT00172809|Pegylated interferon|pegylated interferon
1654372|NCT00172796|Metabolic syndrome|metabolic syndrome
1654373|NCT00172783|TB|tb
1654374|NCT00172783|PPD|ppd
1654375|NCT00172783|ELISPOT|elispot
1654376|NCT00172783|BCG|bcg
1654377|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
1654378|NCT00172744|stem cells|stem cells
1654379|NCT00172744|periodontal cells|periodontal cells
1654380|NCT00172744|mechanical stress|mechanical stress
1654381|NCT00172744|differentiation|differentiation
1654382|NCT00172744|periodontal ligament|periodontal ligament
1654383|NCT00172692|Chewing efficiency,|chewing efficiency,
1654384|NCT00172692|Gum chewing|gum chewing
1654385|NCT00172692|Chewing velocity|chewing velocity
1654386|NCT00172692|Occlusal surface area|occlusal surface area
1654387|NCT00172692|EMG|emg
1654388|NCT00172692|Jaw movement|jaw movement
1654389|NCT00172679|Tai Chi|tai chi
1654390|NCT00172679|NK Cells|nk cells
1654391|NCT00172679|T lymphocytes|t lymphocytes
1654392|NCT00172679|Exercise|exercise
1654393|NCT00172666|SLE|sle
1654394|NCT00172666|healthy subjects|healthy subjects
1654395|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
1654396|NCT00172614|metabolic syndrome|metabolic syndrome
1654397|NCT00172588|adenomyosis|adenomyosis
1654398|NCT00172588|apoptosis|apoptosis
1654399|NCT00172588|flowcytometry|flowcytometry
1654400|NCT00172575|Lung neoplasms|lung neoplasms
1654401|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
1654402|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
1654403|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
1654404|NCT00172562|dynamic MRI|dynamic mri
1654405|NCT00172562|bone marrow perfusion|bone marrow perfusion
1654406|NCT00172562|tumor angiogenesis|tumor angiogenesis
1654407|NCT00172497|aggressive acts|aggressive acts
1654408|NCT00172484|cerebrovascular accident|cerebrovascular accident
1654409|NCT00172484|stroke center|stroke center
1654410|NCT00172484|stroke team|stroke team
1654411|NCT00172484|intensive care of stroke|intensive care of stroke
1654412|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
1654413|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
1654414|NCT00172393|EV71,|ev71,
1654415|NCT00172393|CNS,|cns,
1654416|NCT00172393|Outcome,|outcome,
1654417|NCT00172393|Neurological,|neurological,
1654418|NCT00172393|Psychiatric|psychiatric
1654419|NCT00172367|Urothelial carcinoma|urothelial carcinoma
1654420|NCT00172367|Lycopene|lycopene
1654421|NCT00172367|uremia|uremia
1654422|NCT00172367|prevention|prevention
1654423|NCT00172367|biomarker|biomarker
1654424|NCT00172367|progression|progression
1654425|NCT00172367|anti-oxidant|anti-oxidant
1654426|NCT00172328|Hepatitis B|hepatitis b
1654427|NCT00172328|vaccine|vaccine
1654428|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
1654429|NCT00172315|lipodystrophy|lipodystrophy
1654430|NCT00172315|MR spectroscopy|mr spectroscopy
1654431|NCT00172289|pulse wave velocity|pulse wave velocity
1654432|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
1654433|NCT00172289|spinal cord injury|spinal cord injury
1654434|NCT00172289|cerebrovascular accident|cerebrovascular accident
1654435|NCT00172263|Immunology|immunology
1654436|NCT00172237|eye-head coordination|eye-head coordination
1654437|NCT00172237|proprioception|proprioception
1654438|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
1654439|NCT00172237|degenerated cervical spine|degenerated cervical spine
1654440|NCT00172224|osteoporosis|osteoporosis
1654441|NCT00172224|compression fracture|compression fracture
1654442|NCT00172224|bone marrow perfusion|bone marrow perfusion
1654443|NCT00172224|MR spectroscopy|mr spectroscopy
1654444|NCT00172224|hormone therapy|hormone therapy
1654445|NCT00172211|Physioneal|physioneal
1654446|NCT00172211|Peritoneal dialysis|peritoneal dialysis
1654447|NCT00172211|Oxidative stress|oxidative stress
1654448|NCT00172211|insulin resistance|insulin resistance
1654449|NCT00172198|w-3 fish oil|w-3 fish oil
1654450|NCT00172198|Nutrition|nutrition
1654451|NCT00172198|immune|immune
1654452|NCT00172198|intensive care|intensive care
1654454|NCT00172185|Short Bowel Syndrome|short bowel syndrome
1654455|NCT00172185|Parenteral Nutrition|parenteral nutrition
1654456|NCT00172185|SBS|sbs
1654457|NCT00172185|Teduglutide|teduglutide
1654458|NCT00172172|Post-menopausal|post-menopausal
1654459|NCT00172172|Osteoporosis|osteoporosis
1654460|NCT00172172|Parathyroid Hormone|parathyroid hormone
1654461|NCT00172172|PTH|pth
1654462|NCT00172172|ALX1-11|alx1-11
1654463|NCT00172159|Colorectal cancer|colorectal cancer
1654464|NCT00172159|Chemotherapy|chemotherapy
1654466|NCT00172159|Liver metastasis|liver metastasis
1654467|NCT00172146|Hemiplegia|hemiplegia
1654468|NCT00172146|Regular cane|regular cane
1654469|NCT00172146|Volitional stepping|volitional stepping
1654470|NCT00172146|Dynamic equilibrium|dynamic equilibrium
1654471|NCT00172146|Attention|attention
1654472|NCT00172146|Dual task|dual task
1654473|NCT00172133|Post-menopausal|post-menopausal
1654474|NCT00172133|Osteoporosis|osteoporosis
1654475|NCT00172133|Parathyroid Hormone|parathyroid hormone
1654477|NCT00172133|ALX1-11|alx1-11
1654478|NCT00172120|Post-menopausal|post-menopausal
1654479|NCT00172120|Osteoporosis|osteoporosis
1654480|NCT00172120|Parathyroid Hormone|parathyroid hormone
1654481|NCT00172120|PTH|pth
1654482|NCT00172120|ALX1-11|alx1-11
1654483|NCT00172107|Post-menopausal|post-menopausal
1654484|NCT00172107|Osteoporosis|osteoporosis
1654485|NCT00172107|Parathyroid Hormone|parathyroid hormone
1654486|NCT00172107|PTH|pth
1654487|NCT00172107|ALX1-11|alx1-11
1654488|NCT00172094|Migraine|migraine
1654489|NCT00172081|Post-menopausal|post-menopausal
1654490|NCT00172081|Osteoporosis|osteoporosis
1654491|NCT00172081|Parathyroid Hormone|parathyroid hormone
1654492|NCT00172081|PTH|pth
1654493|NCT00172081|ALX1-11|alx1-11
1654494|NCT00172068|Primary breast cancer|primary breast cancer
1654495|NCT00172068|Bone metastases|bone metastases
1654496|NCT00172068|Minimal residual disease|minimal residual disease
1654497|NCT00172068|Bisphosphonates|bisphosphonates
1654498|NCT00172055|Zoledronic acid|zoledronic acid
1654499|NCT00172055|Zometa|zometa
1654500|NCT00172055|prostate cancer|prostate cancer
1654501|NCT00172055|osteoporosis|osteoporosis
1654502|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1654503|NCT00172042|Bisphosphonates|bisphosphonates
1654504|NCT00172042|Zoledronic acid|zoledronic acid
1654505|NCT00172042|Bone metastases|bone metastases
1654506|NCT00172042|Prevention of bone metastases|prevention of bone metastases
1654507|NCT00172029|Zoledronic acid|zoledronic acid
1654508|NCT00172029|Radiotherapy|radiotherapy
1654509|NCT00172029|Bone pain|bone pain
1654510|NCT00172029|Breast cancer|breast cancer
1654511|NCT00172016|Zoledronic acid|zoledronic acid
1654512|NCT00172016|SRE|sre
1654513|NCT00172016|Prostate cancer|prostate cancer
1654514|NCT00172003|Renal Cell Cancer|renal cell cancer
1654515|NCT00172003|Bone metastasis|bone metastasis
1654516|NCT00172003|Skeletal related event|skeletal related event
1654517|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
1654518|NCT00171990|genital herpes|genital herpes
1654519|NCT00171990|herpes|herpes
1654520|NCT00171990|famciclovir|famciclovir
1654521|NCT00171977|GIST|gist
1654522|NCT00171977|Imatinib|imatinib
1654523|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
1654524|NCT00171964|Pain|pain
1654525|NCT00171964|Bone metastasis|bone metastasis
1654526|NCT00171964|Analgesic consumption|analgesic consumption
1654527|NCT00171964|Cancer patients|cancer patients
1654528|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
1654529|NCT00171951|Cushing's disease|cushing's disease
1654530|NCT00171951|ACTH|acth
1654531|NCT00171951|Cortisol|cortisol
1654532|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
1654533|NCT00171938|Glioblastoma|glioblastoma
1654534|NCT00171938|Brain tumors|brain tumors
1654535|NCT00171938|Imatinib|imatinib
1654536|NCT00171938|PDGFR|pdgfr
1654537|NCT00171925|Multiple Myeloma|multiple myeloma
1654538|NCT00171925|Stage I|stage i
1654539|NCT00171925|Zoledronic acid|zoledronic acid
1654540|NCT00171925|Progression|progression
1654541|NCT00171912|Imatinib mesylate|imatinib mesylate
1654542|NCT00171912|tyrosine kinases|tyrosine kinases
1654543|NCT00171912|imatinib sensitivity|imatinib sensitivity
1654544|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
1654545|NCT00171912|or thought to be associated with|or thought to be associated with
1654546|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
1654547|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
1654548|NCT00171912|systemic mastocytosis|systemic mastocytosis
1654549|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
1654550|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
1654551|NCT00171912|Not included:|not included:
1654552|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
1654553|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
1654554|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
1654653|NCT00171535|valsartan|valsartan
1654555|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
1654556|NCT00171912|brain,|brain,
1654557|NCT00171912|prostate,|prostate,
1654558|NCT00171912|breast or lung cancers.|breast or lung cancers.
1654559|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1654560|NCT00171899|Complete cytogenetic response|complete cytogenetic response
1654561|NCT00171899|Imatinib mesylate|imatinib mesylate
1654562|NCT00171899|Major molecular response|major molecular response
1654563|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
1654564|NCT00171886|Acromegaly|acromegaly
1654565|NCT00171886|Otreotide|otreotide
1654566|NCT00171886|Tumor reduction|tumor reduction
1654567|NCT00171873|Double blind|double blind
1654568|NCT00171873|Phase III|phase iii
1654569|NCT00171873|Disease|disease
1654570|NCT00171873|Clinical trial|clinical trial
1654571|NCT00171873|Octreotide|octreotide
1654572|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
1654573|NCT00171873|Cancer|cancer
1654574|NCT00171873|Tumor|tumor
1654575|NCT00171873|Midgut|midgut
1654576|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
1654577|NCT00171860|Imatinib|imatinib
1654578|NCT00171847|Breast cancer|breast cancer
1654579|NCT00171847|Metastatic|metastatic
1654580|NCT00171847|Trastuzumab|trastuzumab
1654581|NCT00171847|Letrozole|letrozole
1654582|NCT00171834|EPO|epo
1654583|NCT00171834|EPO906|epo906
1654584|NCT00171834|Brain metastasis|brain metastasis
1654585|NCT00171834|Lung cancer|lung cancer
1654586|NCT00171834|Lung metastasis|lung metastasis
1654587|NCT00171834|NSCLC|nsclc
1654588|NCT00171821|Thalassemia|thalassemia
1654589|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
1654591|NCT00171821|Sickle cell|sickle cell
1654592|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
1654593|NCT00171821|Transfusion|transfusion
1654594|NCT00171821|Anemia|anemia
1654595|NCT00171821|Fanconi|fanconi
1654596|NCT00171821|Chelation|chelation
1654597|NCT00171821|Deferasirox|deferasirox
1654598|NCT00171808|Endometrial Cancer|endometrial cancer
1654599|NCT00171808|Aromatase inhibitor|aromatase inhibitor
1654600|NCT00171808|Advanced or recurrent|advanced or recurrent
1654601|NCT00171808|hormone receptor positive|hormone receptor positive
1654602|NCT00171795|Traumatic brain injury,|traumatic brain injury,
1654603|NCT00171795|cognitive impairment,|cognitive impairment,
1654604|NCT00171795|rivastigmine|rivastigmine
1654605|NCT00171782|HYPERTENSION|hypertension
1654606|NCT00171782|VALSARTAN|valsartan
1654607|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
1654608|NCT00171782|RISK FACTORS|risk factors
1654609|NCT00171756|hypertension|hypertension
1654610|NCT00171756|valsartan|valsartan
1654611|NCT00171743|Adults|adults
1654612|NCT00171743|Post transplant diabetes|post transplant diabetes
1654613|NCT00171730|Acromegaly|acromegaly
1654614|NCT00171730|Pasireotide|pasireotide
1654615|NCT00171730|GH|gh
1654616|NCT00171730|IGF-1|igf-1
1654617|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
1654618|NCT00171704|Breast Cancer|breast cancer
1654619|NCT00171704|Letrozole|letrozole
1654620|NCT00171704|Bone Mineral Density|bone mineral density
1654621|NCT00171704|Bone Markers|bone markers
1654622|NCT00171704|Serum lipid|serum lipid
1654623|NCT00171704|Postmenopausal|postmenopausal
1654624|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
1654625|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
1654626|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
1654627|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
1654628|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
1654629|NCT00171613|Obesity|obesity
1654630|NCT00171600|valsartan|valsartan
1654631|NCT00171600|lisinopril|lisinopril
1654632|NCT00171600|albuminuria|albuminuria
1654633|NCT00171600|diabetic nephropathy|diabetic nephropathy
1654634|NCT00171587|Metastatic solid tumors|metastatic solid tumors
1654635|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
1654636|NCT00171587|Vatalanib|vatalanib
1654637|NCT00171587|Capecitabine|capecitabine
1654638|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
1654639|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
1654640|NCT00171574|valsartan|valsartan
1654641|NCT00171574|lisinopril|lisinopril
1654642|NCT00171574|antiproteinuric|antiproteinuric
1654643|NCT00171574|diabetic nephropathy|diabetic nephropathy
1654644|NCT00171561|hypertension|hypertension
1654645|NCT00171561|diabetes|diabetes
1654646|NCT00171561|albuminuria|albuminuria
1654647|NCT00171561|valsartan|valsartan
1654648|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
1654649|NCT00171561|amlodipine|amlodipine
1654650|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
1654651|NCT00171535|hypertension|hypertension
1654652|NCT00171535|high blood pressure|high blood pressure
1654654|NCT00171535|amlodipine|amlodipine
1654655|NCT00171522|Constipation|constipation
1654656|NCT00171522|Tegaserod|tegaserod
1654657|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
1654658|NCT00171522|PEG|peg
1654659|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
1654840|NCT00170742|clinical trial,|clinical trial,
1654660|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
1654661|NCT00171483|GERD|gerd
1654662|NCT00171483|PPI|ppi
1654663|NCT00171483|heartburn|heartburn
1654664|NCT00171483|regurgitation|regurgitation
1654665|NCT00171470|dyspepsia|dyspepsia
1654666|NCT00171470|hearburn|hearburn
1654667|NCT00171470|female|female
1654668|NCT00171470|PPI|ppi
1654669|NCT00171457|functional heartburn|functional heartburn
1654670|NCT00171457|dyspepsia|dyspepsia
1654671|NCT00171457|male|male
1654672|NCT00171457|female|female
1654673|NCT00171457|visceral sensitivity|visceral sensitivity
1654674|NCT00171444|hypertension,|hypertension,
1654675|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
1654676|NCT00171431|IBS-C|ibs-c
1654677|NCT00171431|female|female
1654678|NCT00171418|GERD|gerd
1654679|NCT00171418|PPI|ppi
1654680|NCT00171405|hypertension|hypertension
1654681|NCT00171405|aliskiren|aliskiren
1654682|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
1654683|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
1654684|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
1654685|NCT00171366|amlodipine|amlodipine
1654686|NCT00171366|benazepril|benazepril
1654687|NCT00171366|hypertension|hypertension
1654688|NCT00171366|diastolic|diastolic
1654689|NCT00171353|arterial hypertension|arterial hypertension
1654690|NCT00171353|albuminuria|albuminuria
1654691|NCT00171353|valsartan|valsartan
1654692|NCT00171340|Bone Loss|bone loss
1654693|NCT00171340|Osteopenia|osteopenia
1654694|NCT00171340|Breast cancer|breast cancer
1654695|NCT00171340|letrozole|letrozole
1654696|NCT00171340|zoledronic acid|zoledronic acid
1654697|NCT00171340|postmenopausal|postmenopausal
1654698|NCT00171327|arterial hypertension|arterial hypertension
1654699|NCT00171327|dyslipidemia|dyslipidemia
1654700|NCT00171327|valsartan|valsartan
1654701|NCT00171327|fluvastatin|fluvastatin
1654702|NCT00171314|breast cancer|breast cancer
1654703|NCT00171314|letrozole|letrozole
1654704|NCT00171314|zoledronic acid|zoledronic acid
1654705|NCT00171314|adjuvant|adjuvant
1654706|NCT00171314|postmenopausal|postmenopausal
1654707|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
1654708|NCT00171301|Beta-thalassemia major|beta-thalassemia major
1654709|NCT00171301|Deferasirox|deferasirox
1654710|NCT00171301|iron overload|iron overload
1654711|NCT00171301|rare anemia|rare anemia
1654712|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
1654713|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
1654714|NCT00171275|Coronary disease|coronary disease
1654715|NCT00171275|Myocardial infarction|myocardial infarction
1654717|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
1654718|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1654719|NCT00171249|CML|cml
1654720|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
1654721|NCT00171249|Accelerated phase|accelerated phase
1654722|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
1654723|NCT00171249|AML|aml
1654724|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1654725|NCT00171249|ALL|all
1654726|NCT00171249|Imatinib mesylate|imatinib mesylate
1654727|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
1654728|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
1654729|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1654730|NCT00171223|CML|cml
1654731|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
1654732|NCT00171223|Accelerated phase|accelerated phase
1654733|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
1654734|NCT00171223|AML|aml
1654735|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1654736|NCT00171223|ALL|all
1654737|NCT00171223|Imatinib mesylate|imatinib mesylate
1654738|NCT00171210|β-thalassemia|β-thalassemia
1654739|NCT00171210|iron overload|iron overload
1654740|NCT00171210|deferasirox|deferasirox
1654741|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
1654742|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
1654743|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
1654744|NCT00171171|Deferasirox|deferasirox
1654745|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
1654746|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
1654747|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1654748|NCT00171158|CML|cml
1654749|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
1654750|NCT00171158|Blast crisis|blast crisis
1654751|NCT00171158|Imatinib mesylate|imatinib mesylate
1654841|NCT00170742|octreotide,|octreotide,
1654922|NCT00170248|Primary Care|primary care
1654752|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
1654753|NCT00171132|Postmenopausal|postmenopausal
1654755|NCT00171132|overweight|overweight
1654756|NCT00171132|hypertension|hypertension
1654757|NCT00171132|impaired|impaired
1654758|NCT00171132|exercise|exercise
1654759|NCT00171132|capacity|capacity
1654760|NCT00171132|valsartan|valsartan
1654761|NCT00171132|atenolol|atenolol
1654762|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
1654763|NCT00171119|HYPERTENSION|hypertension
1654764|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
1654765|NCT00171119|VALSARTAN|valsartan
1654766|NCT00171119|BENAZAPRIL|benazapril
1654767|NCT00171106|diastolic dysfunction|diastolic dysfunction
1654768|NCT00171106|heart failure|heart failure
1654769|NCT00171106|exercise tolerance|exercise tolerance
1654770|NCT00171106|valsartan|valsartan
1654771|NCT00171093|HYPERTENSION|hypertension
1654772|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
1654773|NCT00171093|BLOOD PRESSURE|blood pressure
1654774|NCT00171093|CHOLESTEROL|cholesterol
1654775|NCT00171093|VALSARTAN|valsartan
1654776|NCT00171093|SIMVASTATIN|simvastatin
1654777|NCT00171080|Hypertension|hypertension
1654778|NCT00171080|Valsartan|valsartan
1654779|NCT00171080|Dialysis|dialysis
1654780|NCT00171080|Renal Disease|renal disease
1654781|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
1654782|NCT00171054|hypertension|hypertension
1654783|NCT00171054|postmenopausal|postmenopausal
1654784|NCT00171054|valsartan|valsartan
1654785|NCT00171054|amlodipine|amlodipine
1654786|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
1654787|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
1654788|NCT00171041|PEDIATRIC|pediatric
1654789|NCT00171041|VALSARTAN|valsartan
1654790|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
1654791|NCT00171028|PEDIATRIC|pediatric
1654792|NCT00171028|VALSARTAN|valsartan
1654793|NCT00171015|VALSARTAN|valsartan
1654794|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
1654795|NCT00171015|OLMESARTAN|olmesartan
1654796|NCT00171015|HYPERTENSION|hypertension
1654797|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
1654798|NCT00170989|hypertension|hypertension
1654799|NCT00170989|high blood pressure|high blood pressure
1654800|NCT00170989|valsartan|valsartan
1654801|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
1654802|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
1654803|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
1654804|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
1654805|NCT00170950|cardiovascular mortality|cardiovascular mortality
1654806|NCT00170950|benazepril|benazepril
1654807|NCT00170950|amlodipine|amlodipine
1654808|NCT00170950|high risk population|high risk population
1654809|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
1654810|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
1654811|NCT00170924|Heart Disease|heart disease
1654812|NCT00170911|Osteoporosis|osteoporosis
1654813|NCT00170911|Postmenopausal women|postmenopausal women
1654814|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
1654815|NCT00170898|Musculoskeletal pain|musculoskeletal pain
1654816|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
1654817|NCT00170898|lumiracoxib|lumiracoxib
1654818|NCT00170898|naproxen|naproxen
1654819|NCT00170885|acute rejection|acute rejection
1654820|NCT00170885|renal function|renal function
1654821|NCT00170885|everolimus|everolimus
1654822|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
1654823|NCT00170872|Osteoarthritis|osteoarthritis
1654824|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
1654825|NCT00170872|Cox-2|cox-2
1654826|NCT00170872|lumiracoxib|lumiracoxib
1654827|NCT00170859|everolimus|everolimus
1654828|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
1654829|NCT00170859|renal function|renal function
1654830|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
1654831|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
1654832|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
1654833|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
1655015|NCT00169741|Renal Calculi|renal calculi
1655121|NCT00169260|behavior therapy|behavior therapy
1654834|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
1654835|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
1654836|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
1654837|NCT00170742|Open label,|open label,
1654842|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
1654843|NCT00170729|Prednisolone acetate,|prednisolone acetate,
1654844|NCT00170729|efficacy,|efficacy,
1654845|NCT00170729|cataract,|cataract,
1654846|NCT00170729|eye drops,|eye drops,
1654847|NCT00170729|tolerability,|tolerability,
1654848|NCT00170729|inflammation|inflammation
1654849|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
1654850|NCT00170716|Ischemic Stroke|ischemic stroke
1654851|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
1654852|NCT00170716|Rehabilitation|rehabilitation
1654853|NCT00170716|Motor Recovery|motor recovery
1654854|NCT00170716|Functional MRI|functional mri
1654855|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
1654856|NCT00170703|Ischemic Stroke|ischemic stroke
1654857|NCT00170703|Broca's Aphasia|broca's aphasia
1654858|NCT00170703|Speech Rehabilitation|speech rehabilitation
1654859|NCT00170703|Functional MRI|functional mri
1654860|NCT00170664|Ovarian neoplasms|ovarian neoplasms
1654861|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
1654862|NCT00170664|clinical trials, phase II|clinical trials, phase ii
1654863|NCT00170664|first-line chemotherapy|first-line chemotherapy
1654864|NCT00170664|weekly therapy schedule|weekly therapy schedule
1654865|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
1654866|NCT00170625|platin-resistant|platin-resistant
1654867|NCT00170612|Pneumococcal infections|pneumococcal infections
1654868|NCT00170612|Fiji|fiji
1654869|NCT00170612|infants|infants
1654870|NCT00170612|vaccine|vaccine
1654871|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
1654872|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
1654873|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
1654874|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
1654875|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
1654876|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
1654877|NCT00170508|Influenza, sub-study|influenza, sub-study
1654878|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
1654879|NCT00170482|influenza vaccine, Fluzone, inactivated, trivalent|influenza vaccine, fluzone, inactivated, trivalent
1654880|NCT00170469|Anthrax|anthrax
1654881|NCT00170456|Anthrax vaccine|anthrax vaccine
1654882|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
1654883|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
1654884|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
1654885|NCT00170391|Insomnia|insomnia
1654886|NCT00170391|Sleep|sleep
1654888|NCT00170391|Behavioural treatment|behavioural treatment
1654889|NCT00170378|Enoxaparin|enoxaparin
1654890|NCT00170378|Safety|safety
1654891|NCT00170365|Stress|stress
1654892|NCT00170365|Yoga|yoga
1654893|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
1654894|NCT00170352|cerebral metabolism|cerebral metabolism
1654895|NCT00170352|hyperoxia|hyperoxia
1654896|NCT00170352|traumatic brain injury|traumatic brain injury
1654897|NCT00170339|Opiate Dependence|opiate dependence
1654898|NCT00170339|Methadone Maintenance|methadone maintenance
1654899|NCT00170339|Osteoporosis|osteoporosis
1654900|NCT00170339|Hypogonadism|hypogonadism
1654901|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
1654902|NCT00170313|Heart Failure|heart failure
1654903|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
1654904|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
1654905|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
1654906|NCT00170313|CRT-D|crt-d
1654907|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
1654908|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
1654909|NCT00170300|all-cause mortality,|all-cause mortality,
1654910|NCT00170300|quality of life assesment,|quality of life assesment,
1654911|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
1654912|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
1654913|NCT00170300|CRT and health economics|crt and health economics
1654914|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
1654915|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
1654916|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
1655120|NCT00169260|tobacco|tobacco
1654917|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
1654918|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
1654919|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
1654920|NCT00170261|Repeated presyncopes|repeated presyncopes
1654921|NCT00170248|Asthma|asthma
1654923|NCT00170248|Computer-Based Decision Support|computer-based decision support
1654924|NCT00170248|Outcome Evaluation|outcome evaluation
1654925|NCT00170235|Breast cancer|breast cancer
1654926|NCT00170235|Prehabilitation|prehabilitation
1654927|NCT00170235|Rehabilitation|rehabilitation
1654928|NCT00170235|Exercise|exercise
1654929|NCT00170222|Acute bronchitis|acute bronchitis
1654930|NCT00170222|antibiotics|antibiotics
1654931|NCT00170209|Tuberculosis|tuberculosis
1654932|NCT00170209|Children|children
1654933|NCT00170196|pneumonia|pneumonia
1654934|NCT00170196|corticosteroids|corticosteroids
1654935|NCT00170183|Heart failure|heart failure
1654936|NCT00170183|Renal dysfunction|renal dysfunction
1654937|NCT00170170|cytomegalovirus|cytomegalovirus
1654938|NCT00170105|Age 18 years or older|age 18 years or older
1654939|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
1654941|NCT00170105|No aphasia|no aphasia
1654942|NCT00170105|English-speaking|english-speaking
1654943|NCT00170053|Kidney Transplantation|kidney transplantation
1654944|NCT00170001|supraesophageal reflux|supraesophageal reflux
1654945|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
1654946|NCT00170001|pharynx|pharynx
1654947|NCT00170001|esophagus|esophagus
1654948|NCT00169988|clinical high risk|clinical high risk
1654949|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
1654950|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
1654951|NCT00169988|cognition|cognition
1654952|NCT00169988|functional status|functional status
1654953|NCT00169988|prodromal psychosis|prodromal psychosis
1654954|NCT00169962|acute disease|acute disease
1654955|NCT00169949|early intervention|early intervention
1654956|NCT00169949|social functioning|social functioning
1654957|NCT00169949|role functioning|role functioning
1654958|NCT00169949|cognition|cognition
1654959|NCT00169910|Renal Transplantation|renal transplantation
1654960|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
1654961|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
1654962|NCT00169910|Cardiovascular Disease|cardiovascular disease
1654963|NCT00169897|COPD|copd
1654964|NCT00169897|Exercise|exercise
1654965|NCT00169897|Self-management|self-management
1654966|NCT00169897|Rehabilitation|rehabilitation
1654967|NCT00169897|Quality of life|quality of life
1654968|NCT00169897|Health economy|health economy
1654969|NCT00169897|Cost effectiveness|cost effectiveness
1654970|NCT00169897|Health care utilization|health care utilization
1654971|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
1654972|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
1654973|NCT00169884|integrative approach|integrative approach
1654974|NCT00169858|Hepatitis B|hepatitis b
1654975|NCT00169858|Vaccination|vaccination
1654976|NCT00169858|Engerix-B|engerix-b
1654977|NCT00169858|Immunogenicity|immunogenicity
1654978|NCT00169858|Long-term immunity|long-term immunity
1654979|NCT00169858|Booster dose|booster dose
1654980|NCT00169858|Safety|safety
1654981|NCT00169845|chemoprevention trial|chemoprevention trial
1654982|NCT00169845|antioxidant|antioxidant
1654983|NCT00169845|alpha-tocopherol|alpha-tocopherol
1654984|NCT00169845|beta-carotene|beta-carotene
1654985|NCT00169845|second primary cancer|second primary cancer
1654986|NCT00169845|head and neck cancer|head and neck cancer
1654987|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
1654988|NCT00169845|quality of life|quality of life
1654989|NCT00169845|mortality|mortality
1654990|NCT00169845|cancer free survival|cancer free survival
1654991|NCT00169845|cancer recurrence|cancer recurrence
1654992|NCT00169832|Atherosclerosis progression|atherosclerosis progression
1654993|NCT00169832|Ischemic heart disease|ischemic heart disease
1654994|NCT00169832|Saphenous vein graft|saphenous vein graft
1654995|NCT00169832|Metabolic risk factors|metabolic risk factors
1654996|NCT00169832|Rosiglitazone|rosiglitazone
1654997|NCT00169819|Same day discharge|same day discharge
1654998|NCT00169819|Trans-radial|trans-radial
1654999|NCT00169819|Coronary artery stenting|coronary artery stenting
1655000|NCT00169819|Abciximab bolus|abciximab bolus
1655001|NCT00169806|Randall's Plaque|randall's plaque
1655002|NCT00169806|Kidney stones|kidney stones
1655003|NCT00169793|Obesity|obesity
1655004|NCT00169793|Nephrolithiasis|nephrolithiasis
1655005|NCT00169780|Renal Calculi|renal calculi
1655006|NCT00169780|Radiology|radiology
1655007|NCT00169780|High Reslolution CT|high reslolution ct
1655008|NCT00169767|Enlarged Prostate|enlarged prostate
1655009|NCT00169767|BPH|bph
1655010|NCT00169754|Nephrolithiasis|nephrolithiasis
1655011|NCT00169754|Renal Calculi|renal calculi
1655012|NCT00169754|Perc|perc
1655013|NCT00169754|Attached Stones|attached stones
1655014|NCT00169741|Nephrolithiasis|nephrolithiasis
1655016|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
1655017|NCT00169728|bone marrow transplantation|bone marrow transplantation
1655018|NCT00169728|children|children
1655019|NCT00169728|vaccination|vaccination
1655020|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
1655021|NCT00169728|tetanus|tetanus
1655022|NCT00169728|diphtheria|diphtheria
1655023|NCT00169728|poliomyelitis|poliomyelitis
1655024|NCT00169728|pertussis|pertussis
1655025|NCT00169728|Hepatitis B|hepatitis b
1655026|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
1655027|NCT00169715|Kidney stones|kidney stones
1655028|NCT00169715|renal Calculi|renal calculi
1655029|NCT00169715|Tic|tic
1655030|NCT00169715|Caliceal Diverticula|caliceal diverticula
1655031|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
1655032|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
1655033|NCT00169676|Prostate Cancer|prostate cancer
1655034|NCT00169663|Brushite Kidney Stones|brushite kidney stones
1655035|NCT00169663|Nephrolithiasis|nephrolithiasis
1655036|NCT00169650|UPJ Obstruction|upj obstruction
1655037|NCT00169650|Renal Obstruction|renal obstruction
1655038|NCT00169650|Delayed Renal Flow|delayed renal flow
1655039|NCT00169637|Short bowel syndrome|short bowel syndrome
1655040|NCT00169637|Growth hormone|growth hormone
1655041|NCT00169637|Children|children
1655042|NCT00169624|Diabetes,|diabetes,
1655043|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
1655047|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
1655048|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
1655049|NCT00169611|methylphenidate|methylphenidate
1655050|NCT00169598|Lymphoma|lymphoma
1655051|NCT00169598|positron emission tomography|positron emission tomography
1655052|NCT00169598|stem cell transplantation|stem cell transplantation
1655053|NCT00169598|therapeutic impact|therapeutic impact
1655054|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
1655055|NCT00169585|PSA|psa
1655056|NCT00169585|DRE|dre
1655057|NCT00169585|Levofloxacin|levofloxacin
1655058|NCT00169572|Nausea|nausea
1655059|NCT00169572|Vomiting|vomiting
1655060|NCT00169572|Emesis|emesis
1655061|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1655062|NCT00169572|CINV|cinv
1655063|NCT00169559|triglycerides|triglycerides
1655064|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
1655065|NCT00169559|cholesterol|cholesterol
1655066|NCT00169559|LDL|ldl
1655067|NCT00169559|HDL|hdl
1655068|NCT00169546|Asthma|asthma
1655069|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
1655070|NCT00169533|safety|safety
1655071|NCT00169533|tolerating lapatinib|tolerating lapatinib
1655072|NCT00169533|Lapatinib|lapatinib
1655073|NCT00169520|Safety|safety
1655074|NCT00169520|tolerability|tolerability
1655075|NCT00169520|dose limiting toxicity|dose limiting toxicity
1655076|NCT00169520|solid tumors|solid tumors
1655077|NCT00169520|docetaxel|docetaxel
1655078|NCT00169468|B Lymphoma|b lymphoma
1655079|NCT00169468|Velcade|velcade
1655080|NCT00169468|Chemotherapy|chemotherapy
1655081|NCT00169416|chicken pox|chicken pox
1655082|NCT00169416|varicella|varicella
1655083|NCT00169416|VZV|vzv
1655084|NCT00169416|pharmacokinetics|pharmacokinetics
1655085|NCT00169403|Idiopathic dystonia|idiopathic dystonia
1655086|NCT00169403|deep brain stimulation|deep brain stimulation
1655087|NCT00169403|globus pallidus|globus pallidus
1655088|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
1655089|NCT00169390|smoking|smoking
1655090|NCT00169390|pregnancy|pregnancy
1655091|NCT00169390|newborns|newborns
1655092|NCT00169390|monoamine oxidases|monoamine oxidases
1655093|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
1655094|NCT00169377|deep brain stimulation|deep brain stimulation
1655095|NCT00169377|subthalamic nucleus|subthalamic nucleus
1655096|NCT00169364|Parkinson's disease|parkinson's disease
1655097|NCT00169364|parkin mutation|parkin mutation
1655098|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
1655099|NCT00169364|positron emission tomography|positron emission tomography
1655100|NCT00169338|Dystonia|dystonia
1655101|NCT00169338|deep brain stimulation|deep brain stimulation
1655102|NCT00169338|globus pallidus|globus pallidus
1655103|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
1655104|NCT00169325|basal ganglia|basal ganglia
1655105|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
1655106|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1655107|NCT00169299|Menopause|menopause
1655108|NCT00169299|Vasomotor|vasomotor
1655109|NCT00169299|Black cohosh|black cohosh
1655110|NCT00169299|Herbs|herbs
1655111|NCT00169299|Hot flashes|hot flashes
1655112|NCT00169299|HT|ht
1655113|NCT00169299|CAM|cam
1655114|NCT00169273|Obesity|obesity
1655115|NCT00169273|Depression|depression
1655116|NCT00169273|Behavioral|behavioral
1655117|NCT00169273|Cognitive|cognitive
1655118|NCT00169273|Treatment|treatment
1655119|NCT00169260|smoking|smoking
1655122|NCT00169247|larynx cancer|larynx cancer
1655123|NCT00169247|hypopharynx cancer|hypopharynx cancer
1655124|NCT00169247|larynx preservation|larynx preservation
1655125|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
1655126|NCT00169247|cisplatin|cisplatin
1655127|NCT00169247|cetuximab|cetuximab
1655128|NCT00169247|randomized trial|randomized trial
1655129|NCT00169234|Pneumococcal disease|pneumococcal disease
1655130|NCT00169234|Vaccination|vaccination
1655131|NCT00169234|Immunization|immunization
1655133|NCT00169234|PCV7|pcv7
1655134|NCT00169208|relapsed/refractory.|relapsed/refractory.
1655135|NCT00169208|lymphoma, follicular|lymphoma, follicular
1655136|NCT00169208|rituximab|rituximab
1655137|NCT00169208|chemotherapy|chemotherapy
1655138|NCT00169195|B-cell lymphoma|b-cell lymphoma
1655139|NCT00169195|Salvage Therapy|salvage therapy
1655140|NCT00169195|rituximab|rituximab
1655141|NCT00169195|oxaliplatine|oxaliplatine
1655142|NCT00169195|gemcitabine|gemcitabine
1655143|NCT00169182|Larynx cancer|larynx cancer
1655144|NCT00169182|Hypopharynx cancer|hypopharynx cancer
1655145|NCT00169182|Chemotherapy|chemotherapy
1655146|NCT00169182|Randomized trial|randomized trial
1655147|NCT00169182|Larynx preservation|larynx preservation
1655148|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1655149|NCT00169169|Rituximab|rituximab
1655150|NCT00169169|Autotransplant|autotransplant
1655254|NCT00168649|TNF-alfa|tnf-alfa
1655151|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
1655152|NCT00169156|Rituximab|rituximab
1655153|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
1655154|NCT00169143|Pegfilgrastim|pegfilgrastim
1655155|NCT00169143|Autotransplant|autotransplant
1655156|NCT00169130|lymphoma|lymphoma
1655157|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
1655158|NCT00169130|chemotherapy|chemotherapy
1655159|NCT00169130|BCL2|bcl2
1655160|NCT00169117|Mosquito nets|mosquito nets
1655161|NCT00169117|Malaria prevention|malaria prevention
1655162|NCT00169117|Songs|songs
1655163|NCT00169117|Posters|posters
1655164|NCT00169117|Net repair|net repair
1655165|NCT00169117|Bednets|bednets
1655166|NCT00169104|Breast cancer|breast cancer
1655167|NCT00169104|Her-2/neu|her-2/neu
1655168|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
1655169|NCT00169104|Trastuzumab|trastuzumab
1655170|NCT00169104|Vinorelbine|vinorelbine
1655171|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
1655172|NCT00169104|Effector cells|effector cells
1655173|NCT00169091|Clozapine|clozapine
1655174|NCT00169091|Haloperidol|haloperidol
1655175|NCT00169091|Schizophrenia|schizophrenia
1655176|NCT00169078|Transmission intensity|transmission intensity
1655177|NCT00169078|Insecticide-treated materials|insecticide-treated materials
1655178|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
1655179|NCT00169065|Clozapine|clozapine
1655180|NCT00169065|olanzapine|olanzapine
1655181|NCT00169052|geriatric,|geriatric,
1655182|NCT00169052|older|older
1655183|NCT00169052|serious mental illness|serious mental illness
1655184|NCT00169052|SMI|smi
1655185|NCT00169039|Clozapine|clozapine
1655186|NCT00169039|Chlorpromazine|chlorpromazine
1655187|NCT00169039|Schizophrenia|schizophrenia
1655188|NCT00169039|Biochemistry|biochemistry
1655189|NCT00169026|Clozapine|clozapine
1655190|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
1655191|NCT00169026|Conventional antipsychotic|conventional antipsychotic
1655192|NCT00169026|Schizophrenia|schizophrenia
1655193|NCT00169026|Dual Diagnosis|dual diagnosis
1655194|NCT00169026|Substance Abuse|substance abuse
1655195|NCT00169026|Alcohol Abuse|alcohol abuse
1655196|NCT00169000|breast cancer|breast cancer
1655197|NCT00169000|capecitabine|capecitabine
1655198|NCT00169000|docetaxel|docetaxel
1655199|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
1655200|NCT00169000|bcl-2|bcl-2
1655201|NCT00169000|bax|bax
1655202|NCT00168987|oral nutritional supplement|oral nutritional supplement
1655203|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
1655204|NCT00168987|gastroenterological tumors|gastroenterological tumors
1655205|NCT00168987|muscle function|muscle function
1655206|NCT00168987|quality of life|quality of life
1655207|NCT00168987|body composition|body composition
1655208|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
1655209|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
1655210|NCT00168948|IPTi|ipti
1655211|NCT00168948|Malaria control|malaria control
1655212|NCT00168948|Ghana|ghana
1655213|NCT00168922|recurrent SCLC|recurrent sclc
1655214|NCT00168909|osteoporosis|osteoporosis
1655215|NCT00168909|frailty|frailty
1655216|NCT00168909|falls|falls
1655217|NCT00168896|SCLC|sclc
1655218|NCT00168883|NSCLC|nsclc
1655219|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
1655220|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
1655221|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
1655222|NCT00168753|Extended dosing|extended dosing
1655223|NCT00168753|alefacept|alefacept
1655224|NCT00168740|rituximab|rituximab
1655225|NCT00168740|Rituxan|rituxan
1655226|NCT00168740|B-cell lymphoma|b-cell lymphoma
1655227|NCT00168740|low-grade|low-grade
1655228|NCT00168740|follicular|follicular
1655229|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
1655230|NCT00168727|Radioimmunotherapy|radioimmunotherapy
1655231|NCT00168727|Antigens, CD20|antigens, cd20
1655232|NCT00168714|AVONEX|avonex
1655233|NCT00168714|Pregnancy|pregnancy
1655234|NCT00168701|Multiple Sclerosis|multiple sclerosis
1655235|NCT00168701|MRI|mri
1655236|NCT00168688|micronutrient supplementation|micronutrient supplementation
1655237|NCT00168688|pregnancy|pregnancy
1655238|NCT00168688|birth weight|birth weight
1655239|NCT00168688|perinatal mortality|perinatal mortality
1655240|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
1655241|NCT00168662|Infant mortality|infant mortality
1655242|NCT00168662|Child mortality|child mortality
1655243|NCT00168662|Mortality|mortality
1655244|NCT00168662|Morbidity|morbidity
1655245|NCT00168662|Measles vaccine|measles vaccine
1655246|NCT00168662|Measles|measles
1655247|NCT00168662|Immunisation|immunisation
1655248|NCT00168662|Low income country|low income country
1655249|NCT00168662|Guinea-Bissau|guinea-bissau
1655250|NCT00168662|Bandim Health Project|bandim health project
1655251|NCT00168662|Immunology|immunology
1655252|NCT00168649|Vitamin A|vitamin a
1655253|NCT00168649|Endotoxin|endotoxin
1655266|NCT00168610|Infant mortality|infant mortality
1655267|NCT00168610|Morbidity|morbidity
1655268|NCT00168610|Low-income country|low-income country
1655269|NCT00168610|Mortality|mortality
1655270|NCT00168597|Vitamin A|vitamin a
1655271|NCT00168597|BCG|bcg
1655272|NCT00168597|Infant mortality|infant mortality
1655273|NCT00168597|Morbidity|morbidity
1655274|NCT00168597|Low-income country|low-income country
1655275|NCT00168584|Vitamin A|vitamin a
1655276|NCT00168584|Mortality|mortality
1655277|NCT00168584|Morbidity|morbidity
1655278|NCT00168584|Doses|doses
1655279|NCT00168584|OPV|opv
1655280|NCT00168571|Measles vaccine|measles vaccine
1655281|NCT00168571|Measles|measles
1655282|NCT00168571|Measles antibodies|measles antibodies
1655283|NCT00168571|Immunisation|immunisation
1655284|NCT00168571|Low income country|low income country
1655285|NCT00168571|Guinea-Bissau|guinea-bissau
1655286|NCT00168571|Bandim Health Project|bandim health project
1655287|NCT00168571|Measles antibody level|measles antibody level
1655288|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
1655289|NCT00168558|Infant mortality|infant mortality
1655290|NCT00168558|Child mortality|child mortality
1655291|NCT00168558|Mortality|mortality
1655292|NCT00168558|Morbidity|morbidity
1655293|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
1655294|NCT00168558|Measles vaccine|measles vaccine
1655295|NCT00168558|Measles|measles
1655296|NCT00168558|Immunisation|immunisation
1655297|NCT00168558|Low income country|low income country
1655298|NCT00168558|Guinea-Bissau|guinea-bissau
1655299|NCT00168558|Bandim Health Project|bandim health project
1655300|NCT00168558|Immunology|immunology
1655301|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
1655302|NCT00168545|Immunology|immunology
1655303|NCT00168545|Cytokines|cytokines
1655304|NCT00168545|Infant mortality|infant mortality
1655305|NCT00168545|Child mortality|child mortality
1655306|NCT00168545|Mortality|mortality
1655307|NCT00168545|Morbidity|morbidity
1655308|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
1655309|NCT00168545|Measles vaccine|measles vaccine
1655310|NCT00168545|Measles|measles
1655311|NCT00168545|Immunisation|immunisation
1655312|NCT00168545|Low income country|low income country
1655313|NCT00168545|Guinea-Bissau|guinea-bissau
1655314|NCT00168545|Bandim Health Project|bandim health project
1655315|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
1655316|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
1655317|NCT00168532|Measles|measles
1655318|NCT00168532|Pneumonia|pneumonia
1655319|NCT00168532|Post-measles pneumonia|post-measles pneumonia
1655320|NCT00168532|Low income country|low income country
1655321|NCT00168532|Guinea-Bissau|guinea-bissau
1655322|NCT00168532|Bandim Health Project|bandim health project
1655323|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1655324|NCT00168519|Blood Glucose|blood glucose
1655325|NCT00168519|Exercise|exercise
1655326|NCT00168519|Muscle Contraction|muscle contraction
1655327|NCT00168519|Nitric Oxide|nitric oxide
1655328|NCT00168519|Nitrates|nitrates
1655329|NCT00168506|panic disorder|panic disorder
1655330|NCT00168506|cardiac risk|cardiac risk
1655331|NCT00168493|Major Depression|major depression
1655332|NCT00168493|Cardiac disease|cardiac disease
1655333|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
1655334|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1655335|NCT00168376|Depression|depression
1655336|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1655337|NCT00168311|Schizophrenia|schizophrenia
1655338|NCT00168311|Negative Symptoms|negative symptoms
1655339|NCT00168285|Exercise|exercise
1655340|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
1655341|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1655342|NCT00168285|Connective tissue disorders|connective tissue disorders
1655343|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1655344|NCT00168272|Depression|depression
1655345|NCT00168259|Treatment Naive|treatment naive
1655346|NCT00168259|HIV|hiv
1655347|NCT00168246|HIV|hiv
1655348|NCT00168233|Treatment Naive|treatment naive
1655349|NCT00168233|HIV|hiv
1655350|NCT00168220|Treatment Experienced|treatment experienced
1655351|NCT00168220|HIV|hiv
1655352|NCT00168207|Treatment Experienced|treatment experienced
1655353|NCT00168207|HIV|hiv
1655354|NCT00168194|HIV|hiv
1655355|NCT00168181|salagen|salagen
1655356|NCT00168181|gland transfer|gland transfer
1655357|NCT00168181|randomized|randomized
1655358|NCT00168181|xerostomia|xerostomia
1655359|NCT00168168|G-CSF|g-csf
1655360|NCT00168168|Filgrastim|filgrastim
1655361|NCT00168168|Engraftment time|engraftment time
1655362|NCT00168168|Autologus transplant|autologus transplant
1655363|NCT00168155|resectable liver metastases|resectable liver metastases
1655364|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
1655365|NCT00168155|survival|survival
1655366|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1655367|NCT00168142|Helical tomotherapy|helical tomotherapy
1656168|NCT00164437|screening|screening
1655368|NCT00168142|Megavoltage imaging|megavoltage imaging
1655369|NCT00168129|tomotherapy|tomotherapy
1655370|NCT00168129|bone metastases|bone metastases
1655371|NCT00168129|radiotherapy|radiotherapy
1655372|NCT00168129|intensity modulated|intensity modulated
1655373|NCT00168116|nasopharynx|nasopharynx
1655374|NCT00168116|xerostomia|xerostomia
1655375|NCT00168116|prevention|prevention
1655376|NCT00168103|C1 Inhibitor|c1 inhibitor
1655377|NCT00168103|Hereditary angioedema|hereditary angioedema
1655378|NCT00168103|Acute HAE attack|acute hae attack
1655379|NCT00168090|von Willebrand Factor|von willebrand factor
1655380|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
1655381|NCT00168090|Factor VIII|factor viii
1655382|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
1655383|NCT00168077|Anticoagulant reversal|anticoagulant reversal
1655384|NCT00168064|Mycosis Fungoides|mycosis fungoides
1655385|NCT00168064|Nitrogen Mustard|nitrogen mustard
1655386|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
1655387|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
1655388|NCT00168051|Hemophilia A|hemophilia a
1655389|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
1655390|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
1655391|NCT00168038|Werlhofs Disease|werlhofs disease
1655392|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
1655393|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
1655394|NCT00168038|Chronic ITP|chronic itp
1655395|NCT00168038|Platelet count|platelet count
1655396|NCT00168038|Thrombocytopenia|thrombocytopenia
1655397|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
1655398|NCT00168025|Agammaglobulinemia|agammaglobulinemia
1655399|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
1655400|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
1655401|NCT00168025|Immunoglobulin G|immunoglobulin g
1655402|NCT00168025|Children|children
1655403|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
1655404|NCT00168012|Agammaglobulinemia|agammaglobulinemia
1655405|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
1655406|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
1655407|NCT00168012|Immunoglobulin G|immunoglobulin g
1655408|NCT00168012|Children|children
1655409|NCT00167999|Bacterial Infections|bacterial infections
1655410|NCT00167986|Bacterial Infections|bacterial infections
1655411|NCT00167973|Hemophilia B|hemophilia b
1655412|NCT00167960|Bacterial Infections|bacterial infections
1655414|NCT00167947|Transplant|transplant
1655415|NCT00167934|Diabetes|diabetes
1655416|NCT00167934|Metabolic|metabolic
1655417|NCT00167895|osteoarthritis|osteoarthritis
1655418|NCT00167895|knee|knee
1655419|NCT00167895|platelet concentrate|platelet concentrate
1655420|NCT00167882|Crohn's disease|crohn's disease
1655421|NCT00167882|Ulcerative colitis|ulcerative colitis
1655422|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
1655423|NCT00167882|azathioprine|azathioprine
1655424|NCT00167882|6-mercaptopurine|6-mercaptopurine
1655425|NCT00167882|5-aminosalicylate|5-aminosalicylate
1655426|NCT00167882|metabolism|metabolism
1655427|NCT00167869|hypertension|hypertension
1655428|NCT00167869|blood pressure|blood pressure
1655429|NCT00167869|dairy peptides|dairy peptides
1655430|NCT00167869|bioactive peptides|bioactive peptides
1655431|NCT00167869|randomized controlled trial|randomized controlled trial
1655432|NCT00167856|Burning pain|burning pain
1655433|NCT00167856|Clinical trial|clinical trial
1655434|NCT00167856|Effexor|effexor
1655435|NCT00167856|Pain|pain
1655436|NCT00167856|Spinal cord injury|spinal cord injury
1655437|NCT00167856|Venalafaxine|venalafaxine
1655438|NCT00167856|Neuropathic Pain|neuropathic pain
1655439|NCT00167843|Malaria|malaria
1655440|NCT00167843|Anemia|anemia
1655441|NCT00167843|Children|children
1655442|NCT00167843|Gabon|gabon
1655443|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
1655444|NCT00167830|Pediatric Overweight,|pediatric overweight,
1655445|NCT00167830|African American;|african american;
1655446|NCT00167830|Adolescent;|adolescent;
1655447|NCT00167830|Intervention,|intervention,
1655448|NCT00167830|Teasing;|teasing;
1655449|NCT00167830|Self-esteem|self-esteem
1655450|NCT00167830|Quality of Life|quality of life
1655451|NCT00167830|Metabolic syndrome|metabolic syndrome
1655452|NCT00167830|Insulin resistance|insulin resistance
1655453|NCT00167830|Diabetes|diabetes
1655454|NCT00167830|Nutrition|nutrition
1655455|NCT00167830|Motivation|motivation
1655456|NCT00167830|Culture|culture
1655457|NCT00167830|BMI|bmi
1655458|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
1655459|NCT00167830|Resistance Training|resistance training
1655460|NCT00167830|Compliance|compliance
1655461|NCT00167817|Schizophrenia|schizophrenia
1655462|NCT00167817|Smoking|smoking
1655463|NCT00167817|Metabolic|metabolic
1655464|NCT00167817|Health|health
1655465|NCT00167817|Glucose|glucose
1655466|NCT00167817|Lipids|lipids
1655467|NCT00167804|Exposure Therapy|exposure therapy
1655468|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
1656272|NCT00163969|Pain|pain
1655469|NCT00167804|Treatment Outcome|treatment outcome
1655470|NCT00167804|Veterans|veterans
1655471|NCT00167804|Virtual Reality|virtual reality
1655472|NCT00167791|transplant|transplant
1655473|NCT00167791|desensitization|desensitization
1655474|NCT00167791|kidney transplant|kidney transplant
1655475|NCT00167778|Amputation|amputation
1655476|NCT00167778|Amputee|amputee
1655477|NCT00167778|Artificial limbs|artificial limbs
1655478|NCT00167778|Gait|gait
1655479|NCT00167778|Locomotion|locomotion
1655480|NCT00167778|Walking|walking
1655481|NCT00167765|stroke, ischemic|stroke, ischemic
1655482|NCT00167765|acute ischemic stroke|acute ischemic stroke
1655483|NCT00167739|Malaria|malaria
1655484|NCT00167739|Quinine|quinine
1655485|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1655486|NCT00167739|Gabon|gabon
1655487|NCT00167713|Malaria|malaria
1655488|NCT00167713|Fever|fever
1655489|NCT00167713|Ibuprofen|ibuprofen
1655490|NCT00167713|Gabon|gabon
1655491|NCT00167700|atopic disease|atopic disease
1655492|NCT00167700|probiotics|probiotics
1655493|NCT00167700|gut microbiota|gut microbiota
1655494|NCT00167700|allergy|allergy
1655495|NCT00167700|nutrition|nutrition
1655496|NCT00167700|growth|growth
1655497|NCT00167700|allergic rhinitis|allergic rhinitis
1655498|NCT00167700|atopic sensitization|atopic sensitization
1655499|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
1655500|NCT00167687|Alcoholism|alcoholism
1655501|NCT00167687|Randomized Controlled Trial|randomized controlled trial
1655502|NCT00167674|breastmilk|breastmilk
1655503|NCT00167674|HIV-1|hiv-1
1655504|NCT00167674|antiretroviral|antiretroviral
1655505|NCT00167674|mother-to-child|mother-to-child
1655506|NCT00167674|transmission|transmission
1655507|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
1655508|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
1655509|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
1655510|NCT00167635|Psychological distress|psychological distress
1655511|NCT00167635|Quality of life|quality of life
1655512|NCT00167622|Guillain Barré|guillain barré
1655513|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
1655514|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
1655515|NCT00167622|Pneumonia|pneumonia
1655516|NCT00167609|myotonic dystrophy|myotonic dystrophy
1655517|NCT00167609|hypersomnia|hypersomnia
1655518|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
1655519|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
1655520|NCT00167596|tissue oxygenation|tissue oxygenation
1655521|NCT00167596|organ dysfunction|organ dysfunction
1655522|NCT00167596|mortality|mortality
1655523|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
1655524|NCT00167583|Panuveitis|panuveitis
1655525|NCT00167583|Posterior Uveitis|posterior uveitis
1655526|NCT00167583|Retinal vasculitis|retinal vasculitis
1655527|NCT00167583|Treatment|treatment
1655528|NCT00167583|Interferon-alpha|interferon-alpha
1655529|NCT00167583|Cyclosporin A|cyclosporin a
1655530|NCT00167570|Artificial Limbs|artificial limbs
1655531|NCT00167570|Amputees|amputees
1655532|NCT00167570|Computer-Aided Design|computer-aided design
1655533|NCT00167557|Liver Transplantation|liver transplantation
1655534|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
1655535|NCT00167544|Encephalomalacia|encephalomalacia
1655732|NCT00166751|ultrasound|ultrasound
1655536|NCT00167544|Brain injury|brain injury
1655537|NCT00167544|Neurosensory impairment|neurosensory impairment
1655538|NCT00167544|Corticosteroids|corticosteroids
1655539|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
1655540|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
1655541|NCT00167544|Premature Birth|premature birth
1655542|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
1655543|NCT00167531|Stroke|stroke
1655544|NCT00167531|health outcomes|health outcomes
1655545|NCT00167531|physiotherapy|physiotherapy
1655546|NCT00167531|rehabilitation|rehabilitation
1655547|NCT00167531|treadmill|treadmill
1655548|NCT00167518|Diabetic macular oedema|diabetic macular oedema
1655549|NCT00167518|Triamcinolone acetate|triamcinolone acetate
1655550|NCT00167518|Intravitreal injection|intravitreal injection
1655551|NCT00167518|Clinical trial|clinical trial
1655552|NCT00167518|Laser treatment|laser treatment
1655553|NCT00167505|adolescents|adolescents
1655554|NCT00167505|sexual health|sexual health
1655555|NCT00167505|HIV|hiv
1655556|NCT00167505|STD|std
1655557|NCT00167505|pregnancy prevention|pregnancy prevention
1655558|NCT00167505|abstinence education|abstinence education
1655559|NCT00167505|HIV Seronegativity|hiv seronegativity
1655560|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
1655561|NCT00167479|Bipolar Anxiety|bipolar anxiety
1655562|NCT00167479|Bipolar Disorder|bipolar disorder
1655563|NCT00167479|Anxiety|anxiety
1655564|NCT00167479|Panic Disorder|panic disorder
1655565|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
1655566|NCT00167479|GAD|gad
1655567|NCT00167479|Risperidone|risperidone
1655568|NCT00167479|Double-Blind|double-blind
1656273|NCT00163969|Wind-up|wind-up
1655569|NCT00167479|Placebo Controlled|placebo controlled
1655570|NCT00167466|periodontal disease|periodontal disease
1655571|NCT00167466|toothbrush|toothbrush
1655572|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
1655573|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
1655574|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
1655575|NCT00167453|Nervous system disease|nervous system disease
1655576|NCT00167453|movement disorder|movement disorder
1655577|NCT00167453|exercise|exercise
1655578|NCT00167453|balance|balance
1655579|NCT00167453|education|education
1655580|NCT00167440|cardiac index|cardiac index
1655581|NCT00167440|cardiac output|cardiac output
1655582|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
1655583|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
1655584|NCT00167414|conformal radiotherapy|conformal radiotherapy
1655585|NCT00167388|anemia|anemia
1655586|NCT00167388|prematurity|prematurity
1655587|NCT00167388|blood flow velocity|blood flow velocity
1655588|NCT00167388|superior mesenteric artery|superior mesenteric artery
1655589|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
1655590|NCT00167375|Insomnia|insomnia
1655591|NCT00167375|polysomnography|polysomnography
1655592|NCT00167375|sleep onset|sleep onset
1655593|NCT00167375|time series analysis|time series analysis
1655594|NCT00167362|Schizophrenia|schizophrenia
1655595|NCT00167362|Cognition|cognition
1655596|NCT00167362|Enhancement|enhancement
1655597|NCT00167362|Randomized|randomized
1655598|NCT00167349|cardiac surgery|cardiac surgery
1655599|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
1655600|NCT00167349|cytokines|cytokines
1655601|NCT00167336|Computer|computer
1655602|NCT00167336|Kinematics|kinematics
1655603|NCT00167336|Instrument development|instrument development
1655604|NCT00167336|Reliability|reliability
1655605|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
1655606|NCT00167323|Bipolar|bipolar
1655607|NCT00167323|Alcoholism|alcoholism
1655608|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
1655609|NCT00167310|Statins|statins
1655610|NCT00167310|Antipsychotic drug|antipsychotic drug
1655611|NCT00167310|Antidepressant drug|antidepressant drug
1655612|NCT00167310|Antimanic drug|antimanic drug
1655613|NCT00167310|Placebos|placebos
1655614|NCT00167310|Double-blind method|double-blind method
1655615|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
1655616|NCT00167297|atomoxetine|atomoxetine
1655617|NCT00167297|cannabis dependence|cannabis dependence
1655618|NCT00167297|treatment|treatment
1655619|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
1655620|NCT00167271|Cognitive therapy|cognitive therapy
1655621|NCT00167245|Topiramate|topiramate
1655622|NCT00167245|alcoholism|alcoholism
1655623|NCT00167245|cocaine dependence|cocaine dependence
1655624|NCT00167232|naltrexone|naltrexone
1655625|NCT00167232|cocaine dependence|cocaine dependence
1655626|NCT00167232|alcohol dependence|alcohol dependence
1655627|NCT00167232|psychosocial treatment|psychosocial treatment
1655628|NCT00167219|Stem cell transplant|stem cell transplant
1655629|NCT00167219|long term survival|long term survival
1655630|NCT00167219|retinoic acid|retinoic acid
1655631|NCT00167206|Stem Cell Transplant|stem cell transplant
1655632|NCT00167206|Thymic Shielding|thymic shielding
1655633|NCT00167206|Total Body Irradiation|total body irradiation
1655634|NCT00167206|Chemotherapy|chemotherapy
1655635|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
1655636|NCT00167180|BMT|bmt
1655637|NCT00167180|bone marrow transplant|bone marrow transplant
1655830|NCT00166205|Obesity|obesity
1655638|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
1655639|NCT00167167|relapse|relapse
1655640|NCT00167167|post-transplant|post-transplant
1655641|NCT00167154|suicidality|suicidality
1655642|NCT00167154|antipsychotic|antipsychotic
1655643|NCT00167154|antidepressant|antidepressant
1655644|NCT00167154|treatment|treatment
1655645|NCT00167141|male fertility|male fertility
1655646|NCT00167141|semen parameters|semen parameters
1655647|NCT00167128|Auditory Processing Disorder|auditory processing disorder
1655648|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
1655649|NCT00167115|Alcohol|alcohol
1655650|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
1655651|NCT00167115|Plama glucose|plama glucose
1655652|NCT00167115|HDL cholesterol|hdl cholesterol
1655653|NCT00167102|Alopecia Areata|alopecia areata
1655654|NCT00167089|Stroke|stroke
1655655|NCT00167089|Hemiplegia|hemiplegia
1655656|NCT00167089|Gait|gait
1655657|NCT00167089|Ambulation training|ambulation training
1655658|NCT00167089|Neurologic physical therapy|neurologic physical therapy
1655659|NCT00167076|Stroke|stroke
1655660|NCT00167076|Foot pressure|foot pressure
1655661|NCT00167076|Walking speed|walking speed
1655662|NCT00167076|Gait|gait
1655663|NCT00167063|Stroke|stroke
1655664|NCT00167063|Fall|fall
1655665|NCT00167063|Fall prediction|fall prediction
1655666|NCT00167063|Clinical manifestations|clinical manifestations
1655667|NCT00167063|Frequent faller|frequent faller
1655668|NCT00167037|Hemiplegia|hemiplegia
1656274|NCT00163969|opioid|opioid
1655669|NCT00167037|Waist pulling perturbation|waist pulling perturbation
1655670|NCT00167037|Reactive balance strategy|reactive balance strategy
1655671|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
1655672|NCT00167037|Parameters of center of pressure|parameters of center of pressure
1655673|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
1655674|NCT00167011|coronary artery|coronary artery
1655675|NCT00166998|Breast neoplasms|breast neoplasms
1655676|NCT00166998|diagnosis|diagnosis
1655677|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
1655678|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
1655679|NCT00166959|Stroke patients|stroke patients
1655680|NCT00166959|Falls|falls
1655681|NCT00166959|Reliability|reliability
1655682|NCT00166959|Validity|validity
1655683|NCT00166933|minimal erythema dose|minimal erythema dose
1655685|NCT00166933|normal|normal
1655686|NCT00166907|Stroke|stroke
1655687|NCT00166907|Balance|balance
1655688|NCT00166907|Proactive control|proactive control
1655689|NCT00166907|Reactive control|reactive control
1655690|NCT00166907|Recovery|recovery
1655691|NCT00166907|Training|training
1655692|NCT00166907|Fall|fall
1655693|NCT00166894|pleural effusion|pleural effusion
1655694|NCT00166894|TREM-1|trem-1
1655695|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
1655696|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
1655697|NCT00166855|angiogenesis|angiogenesis
1655698|NCT00166855|bone marrow perfusion|bone marrow perfusion
1655699|NCT00166855|dynamic MRI|dynamic mri
1655700|NCT00166855|multiple myeloma|multiple myeloma
1655701|NCT00166855|prognosis|prognosis
1655702|NCT00166842|Pharmacokinetics|pharmacokinetics
1655703|NCT00166842|Sirolimus|sirolimus
1655704|NCT00166842|Cyclosporine|cyclosporine
1655705|NCT00166842|Tacrolimus|tacrolimus
1655706|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
1655707|NCT00166842|Immunosuppression|immunosuppression
1655708|NCT00166842|Transplantation|transplantation
1655709|NCT00166842|Kidney Transplantation|kidney transplantation
1655710|NCT00166829|Tacrolimus|tacrolimus
1655711|NCT00166829|Sirolimus|sirolimus
1655712|NCT00166829|Mycophenolic acid|mycophenolic acid
1655713|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
1655714|NCT00166829|Immunosuppression|immunosuppression
1655715|NCT00166829|Kidney Transplantation|kidney transplantation
1655716|NCT00166829|Transplantation|transplantation
1655717|NCT00166816|Sirolimus|sirolimus
1655718|NCT00166816|Tacrolimus|tacrolimus
1655719|NCT00166816|Cyclosporine|cyclosporine
1655720|NCT00166816|Pharmacokinetics|pharmacokinetics
1655721|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
1655722|NCT00166816|Immunosuppression|immunosuppression
1655723|NCT00166816|Kidney Transplantation|kidney transplantation
1655724|NCT00166816|Transplantation|transplantation
1655725|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
1655726|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
1655727|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
1655728|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
1655729|NCT00166764|Psychiatric Disorders|psychiatric disorders
1655730|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
1655731|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
1655733|NCT00166751|laryngeal elevation|laryngeal elevation
1655734|NCT00166751|dysphagia|dysphagia
1655735|NCT00166738|Schizophrenia|schizophrenia
1655736|NCT00166738|multiple genes|multiple genes
1655737|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
1655738|NCT00166738|genomic DNA|genomic dna
1655739|NCT00166738|Chinese Han People|chinese han people
1655740|NCT00166725|HRPC|hrpc
1655741|NCT00166725|octreotide LAR|octreotide lar
1655742|NCT00166725|CgA|cga
1655743|NCT00166712|Kidney Transplant|kidney transplant
1655744|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
1655745|NCT00166699|ultrasonography|ultrasonography
1655746|NCT00166699|obesity|obesity
1655747|NCT00166699|Cesarean Section|cesarean section
1655748|NCT00166699|Anesthesia|anesthesia
1655749|NCT00166699|Epidural|epidural
1655750|NCT00166686|Cancer|cancer
1655751|NCT00166686|Clonidine|clonidine
1655752|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
1655753|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1655754|NCT00166673|Type 1 Diabetes|type 1 diabetes
1655755|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
1655756|NCT00166673|Electronic Data Collection|electronic data collection
1655757|NCT00166660|Preterm infants|preterm infants
1655758|NCT00166660|Developmental Care|developmental care
1655759|NCT00166660|NIDCAP|nidcap
1655760|NCT00166660|Fetal Growth Restriction|fetal growth restriction
1655761|NCT00166660|Neurobehavior|neurobehavior
1655762|NCT00166660|APIB|apib
1655763|NCT00166660|MRI|mri
1655764|NCT00166660|EEG|eeg
1656275|NCT00163969|ketamine|ketamine
1655765|NCT00166660|Parent Stress|parent stress
1655766|NCT00166647|Cancer|cancer
1655767|NCT00166647|Chemotherapy|chemotherapy
1655768|NCT00166647|Hematological disorder|hematological disorder
1655769|NCT00166634|Hypertension|hypertension
1655770|NCT00166634|ABPM|abpm
1655771|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
1655772|NCT00166621|Autism|autism
1655773|NCT00166621|Neuroplasticity|neuroplasticity
1655774|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
1655775|NCT00166608|liver damage|liver damage
1655776|NCT00166608|tylenol overdose|tylenol overdose
1655777|NCT00166595|Risperidone|risperidone
1655778|NCT00166595|Autism|autism
1655779|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
1655780|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
1655781|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
1655782|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
1655783|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
1655784|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
1655785|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
1655786|NCT00166439|C04.557.386|c04.557.386
1655787|NCT00166387|Hemophilia|hemophilia
1655788|NCT00166387|Inhibitors|inhibitors
1655789|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
1655790|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
1655791|NCT00166361|JJ Stent|jj stent
1655792|NCT00166361|Stent|stent
1655793|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
1655794|NCT00166322|IBZM-SPECT|ibzm-spect
1655795|NCT00166322|Amphetamine Challenge|amphetamine challenge
1655796|NCT00166322|Schizophrenia|schizophrenia
1655797|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
1655798|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
1655799|NCT00166322|healthy subjects|healthy subjects
1655800|NCT00166309|Hemophilia A|hemophilia a
1655801|NCT00166309|Inhibitors|inhibitors
1655802|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
1655803|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
1655804|NCT00166296|Escitalopram.|escitalopram.
1655805|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
1655806|NCT00166296|Prophylactic treatment.|prophylactic treatment.
1655807|NCT00166283|memory|memory
1655808|NCT00166283|learning|learning
1655809|NCT00166283|Multiple Sclerosis|multiple sclerosis
1655810|NCT00166283|Cognition|cognition
1655811|NCT00166283|treatment|treatment
1655812|NCT00166283|therapy|therapy
1655813|NCT00166270|Fibroids|fibroids
1655814|NCT00166270|ExAblate|exablate
1655815|NCT00166270|MrgFus|mrgfus
1655816|NCT00166270|Uterine Fibroids|uterine fibroids
1655817|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
1655818|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
1655819|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
1655820|NCT00166244|Adult kidney transplantation|adult kidney transplantation
1655821|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
1655822|NCT00166231|Innocent heart murmurs|innocent heart murmurs
1655823|NCT00166231|Chest pain|chest pain
1655824|NCT00166231|pediatric Cardiology|pediatric cardiology
1655825|NCT00166231|Somatization|somatization
1655826|NCT00166231|life stress|life stress
1655827|NCT00166218|pediatrics|pediatrics
1655828|NCT00166218|cardiac defects|cardiac defects
1655829|NCT00166205|Obesity, Morbid|obesity, morbid
1655831|NCT00166205|Body Weight|body weight
1655832|NCT00166192|Melasma|melasma
1655833|NCT00166192|Jessner's solution|jessner's solution
1655834|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
1655835|NCT00166179|CAD|cad
1655836|NCT00166166|hyperlipidaemia|hyperlipidaemia
1655837|NCT00166166|EDHF|edhf
1655838|NCT00166166|FMD|fmd
1655839|NCT00166153|cardiac transplantation|cardiac transplantation
1655840|NCT00166153|pediatrics|pediatrics
1655841|NCT00166153|cardiology|cardiology
1655842|NCT00166153|drug metabolism|drug metabolism
1655843|NCT00166140|pediatrics|pediatrics
1655844|NCT00166140|cardiac|cardiac
1655845|NCT00166140|surgery|surgery
1655846|NCT00166127|heart failure|heart failure
1655847|NCT00166127|cardiac surgery|cardiac surgery
1655848|NCT00166127|pharmacokinetics|pharmacokinetics
1655849|NCT00166127|pharmacodynamics|pharmacodynamics
1655850|NCT00166114|platelet function|platelet function
1655851|NCT00166114|childhood abuse|childhood abuse
1655852|NCT00166114|depression|depression
1655853|NCT00166114|antidepressants|antidepressants
1655854|NCT00166114|immune function|immune function
1655855|NCT00166114|stress response|stress response
1655856|NCT00166101|pediatric|pediatric
1655857|NCT00166101|cardiac surgery|cardiac surgery
1655858|NCT00166088|Oxidative Stress|oxidative stress
1655859|NCT00166088|Diet, Mediterranean|diet, mediterranean
1655860|NCT00166075|Suicidality|suicidality
1655861|NCT00166075|PTSD|ptsd
1655862|NCT00166075|depression|depression
1655863|NCT00166062|intimate partner violence|intimate partner violence
1655864|NCT00166062|perpetration|perpetration
1655865|NCT00166049|Heart failure|heart failure
1655866|NCT00166049|Family partnership|family partnership
1655867|NCT00166049|Patient family education|patient family education
1655868|NCT00166023|pediatric|pediatric
1655869|NCT00166023|cardiology|cardiology
1655870|NCT00166010|drug|drug
1655871|NCT00166010|pediatrics|pediatrics
1655872|NCT00166010|cardiac|cardiac
1655873|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
1655874|NCT00165997|pediatrics|pediatrics
1655875|NCT00165997|cardiology|cardiology
1655876|NCT00165997|Radiofrequency ablation|radiofrequency ablation
1655877|NCT00165997|structurally normal heart|structurally normal heart
1655878|NCT00165984|cardiac|cardiac
1655879|NCT00165984|hypoplastic|hypoplastic
1655880|NCT00165984|pediatric|pediatric
1655881|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
1655882|NCT00165971|Cognitive decline|cognitive decline
1655883|NCT00165971|Inflammation|inflammation
1655884|NCT00165971|Monitoring|monitoring
1655885|NCT00165971|Recovery|recovery
1655886|NCT00165971|Bispectral index|bispectral index
1655887|NCT00165958|Epidermal cyst|epidermal cyst
1655888|NCT00165958|Epidermoid cyst|epidermoid cyst
1655889|NCT00165958|Sebaceous cyst|sebaceous cyst
1655890|NCT00165958|Pilar cyst|pilar cyst
1655891|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
1655892|NCT00165932|tachycardia|tachycardia
1655893|NCT00165932|pediatrics|pediatrics
1655894|NCT00165919|Hepatitis C|hepatitis c
1655895|NCT00165919|HIV|hiv
1655896|NCT00165919|Immunopathogenesis|immunopathogenesis
1655897|NCT00165919|HIV-1|hiv-1
1655898|NCT00165906|neonates|neonates
1655899|NCT00165906|cardiac|cardiac
1655900|NCT00165906|non-cardiac|non-cardiac
1655901|NCT00165906|surgery|surgery
1655902|NCT00165906|anticoagulation|anticoagulation
1655903|NCT00165893|low back pain|low back pain
1655904|NCT00165893|DDD|ddd
1655905|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
1655906|NCT00165841|GERD|gerd
1655907|NCT00165828|Epilepsy|epilepsy
1655908|NCT00165802|Cancer|cancer
1655909|NCT00165802|malignant tumors|malignant tumors
1655910|NCT00165763|Vascular Dementia|vascular dementia
1655911|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
1655912|NCT00165698|Postmenopausal|postmenopausal
1655913|NCT00165698|osteoporosis|osteoporosis
1655914|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
1655915|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
1655916|NCT00165672|NERD|nerd
1655917|NCT00165672|proton pump inhibitor|proton pump inhibitor
1655918|NCT00165672|rabeprazole|rabeprazole
1655919|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
1655920|NCT00165646|NERD|nerd
1655921|NCT00165646|proton pump inhibitor|proton pump inhibitor
1655922|NCT00165646|rabeprazole|rabeprazole
1655923|NCT00165633|Hepatocellular|hepatocellular
1655924|NCT00165633|Carcinoma|carcinoma
1655925|NCT00165633|Hepatitis C Virus|hepatitis c virus
1655926|NCT00165633|Hepatitis B Virus|hepatitis b virus
1655927|NCT00165633|recurrence|recurrence
1655928|NCT00165633|Vitamin K2|vitamin k2
1655929|NCT00165633|E0167|e0167
1655930|NCT00165594|gastric cancer|gastric cancer
1655931|NCT00165594|Phase I|phase i
1655932|NCT00165594|Phase IIa|phase iia
1655933|NCT00165594|E7070|e7070
1655934|NCT00165594|Indisulam|indisulam
1655935|NCT00165594|Pharmacogenomic|pharmacogenomic
1655936|NCT00165594|2C19|2c19
1655937|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
1655938|NCT00165581|radiation therapy|radiation therapy
1655939|NCT00165581|Stage I breast cancer|stage i breast cancer
1655940|NCT00165581|Stage II breast cancer|stage ii breast cancer
1655941|NCT00165568|Positron emission tomography|positron emission tomography
1655942|NCT00165568|PET|pet
1655943|NCT00165568|bevacizumab|bevacizumab
1655944|NCT00165568|5fluorouracil|5fluorouracil
1655945|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
1655946|NCT00165555|cisplatin|cisplatin
1655947|NCT00165555|pleurectomy|pleurectomy
1655948|NCT00165555|decortication|decortication
1655949|NCT00165555|heated cisplatin|heated cisplatin
1655950|NCT00165542|A-protein level|a-protein level
1655951|NCT00165542|brain tumor|brain tumor
1655952|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
1655953|NCT00165516|cisplatin|cisplatin
1655954|NCT00165516|heated cisplatin|heated cisplatin
1655955|NCT00165503|pleurectomy|pleurectomy
1655956|NCT00165503|decortication|decortication
1655957|NCT00165503|cisplatin|cisplatin
1655958|NCT00165503|ALIMTA|alimta
1655959|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
1655960|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
1655961|NCT00165490|combination chemotherapy|combination chemotherapy
1655962|NCT00165490|cisplatin|cisplatin
1655963|NCT00165490|irinotecan|irinotecan
1655964|NCT00165490|radiation therapy|radiation therapy
1655965|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
1655966|NCT00165477|Glioblastoma|glioblastoma
1655967|NCT00165477|Gliosarcoma|gliosarcoma
1655968|NCT00165477|Malignant Gliomas|malignant gliomas
1655969|NCT00165477|Radiation Therapy|radiation therapy
1655970|NCT00165477|IMiD|imid
1655971|NCT00165477|Lenalidomide|lenalidomide
1655972|NCT00165464|Esophageal Cancer|esophageal cancer
1655973|NCT00165464|Gastric Cancer|gastric cancer
1655974|NCT00165464|GE Junction|ge junction
1655975|NCT00165464|Cisplatin|cisplatin
1655976|NCT00165464|Taxotere|taxotere
1655977|NCT00165464|CPT-11|cpt-11
1655978|NCT00165464|Irinotecan|irinotecan
1655979|NCT00165451|Relapsed tumors|relapsed tumors
1655980|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
1655981|NCT00165451|Thalidomide|thalidomide
1655982|NCT00165451|Celecoxib|celecoxib
1655983|NCT00165451|Etoposide|etoposide
1655984|NCT00165451|Cyclophosphamide|cyclophosphamide
1655985|NCT00165438|Pulmonary function|pulmonary function
1655986|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
1655987|NCT00165438|mediastinal irradiation|mediastinal irradiation
1655988|NCT00165425|Cardiac screening|cardiac screening
1655989|NCT00165425|Cardiac stress test|cardiac stress test
1655990|NCT00165425|Echocardiogram|echocardiogram
1655991|NCT00165412|Breast screening|breast screening
1655992|NCT00165412|Breast MRI|breast mri
1655993|NCT00165412|Mammogram|mammogram
1655994|NCT00165412|Mammography|mammography
1655995|NCT00165399|Prostate cancer|prostate cancer
1655996|NCT00165399|PSA level|psa level
1655997|NCT00165399|docetaxel|docetaxel
1655998|NCT00165399|estramustine|estramustine
1655999|NCT00165399|hormone therapy|hormone therapy
1656000|NCT00165399|androgen withdrawal|androgen withdrawal
1656001|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
1656002|NCT00165373|pediatric solid tumors|pediatric solid tumors
1656003|NCT00165373|rhEndostatin|rhendostatin
1656004|NCT00165360|low-grade glioma|low-grade glioma
1656005|NCT00165360|astrocytoma|astrocytoma
1656006|NCT00165360|oligodendroglioma|oligodendroglioma
1656007|NCT00165360|oligoastrocytoma|oligoastrocytoma
1656008|NCT00165360|temozolomide|temozolomide
1656009|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
1656010|NCT00165347|Multiple myeloma|multiple myeloma
1656011|NCT00165347|PTK|ptk
1656012|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
1656013|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
1656014|NCT00165347|Myeloma|myeloma
1656015|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
1656016|NCT00165334|Cetuximab|cetuximab
1656017|NCT00165334|Vinorelbine|vinorelbine
1656018|NCT00165334|Navelbine|navelbine
1656019|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
1656020|NCT00165308|Hodgkin's disease|hodgkin's disease
1656021|NCT00165308|breast cancer prevention|breast cancer prevention
1656022|NCT00165308|tamoxifen|tamoxifen
1656023|NCT00165295|sildenafil citrate|sildenafil citrate
1656024|NCT00165295|Viagra|viagra
1656025|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1656026|NCT00165282|Meditation|meditation
1656027|NCT00165282|Mindfulness meditation|mindfulness meditation
1656028|NCT00165282|Bone Marrow Transplant|bone marrow transplant
1656029|NCT00165282|Stem Cell Transplant|stem cell transplant
1656030|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
1656031|NCT00165269|mantle irradiation|mantle irradiation
1656032|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
1656033|NCT00165256|DCIS|dcis
1656034|NCT00165256|wide excision|wide excision
1656035|NCT00165243|Axillary Dissection|axillary dissection
1656240|NCT00164138|treatment|treatment
1656036|NCT00165243|Tangential Radiation|tangential radiation
1656037|NCT00165243|Breast Cancer|breast cancer
1656038|NCT00165230|thalidomide|thalidomide
1656039|NCT00165230|temodar|temodar
1656040|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
1656041|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
1656042|NCT00165217|capecitabine|capecitabine
1656043|NCT00165217|thalidomide|thalidomide
1656044|NCT00165217|colorectal cancer|colorectal cancer
1656045|NCT00165204|Tibolone|tibolone
1656046|NCT00165204|High risk women|high risk women
1656047|NCT00165204|Oophorectomy|oophorectomy
1656048|NCT00165204|Breast Density|breast density
1656049|NCT00165204|Bone Density|bone density
1656050|NCT00165191|doxorubicin|doxorubicin
1656051|NCT00165191|cisplatin|cisplatin
1656052|NCT00165191|5-fluorouracil|5-fluorouracil
1656053|NCT00165191|stomach cancer|stomach cancer
1656054|NCT00165191|esophagus cancer|esophagus cancer
1656055|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
1656056|NCT00165178|High Risk ALL|high risk all
1656057|NCT00165178|Standard Risk ALL|standard risk all
1656058|NCT00165178|E. coli asparaginase|e. coli asparaginase
1656059|NCT00165152|Genetic testing|genetic testing
1656060|NCT00165152|BRCA1 gene|brca1 gene
1656061|NCT00165152|BRCA2 gene|brca2 gene
1656062|NCT00165152|Counseling interventions|counseling interventions
1656063|NCT00165152|Genetic counseling|genetic counseling
1656064|NCT00165139|Stem cell transplant|stem cell transplant
1656065|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
1656066|NCT00165126|dosimetric analysis|dosimetric analysis
1656276|NCT00163969|pre-emptive|pre-emptive
1656067|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
1656068|NCT00165100|DAT|dat
1656069|NCT00165100|imaging modality|imaging modality
1656070|NCT00165087|childhood ALL|childhood all
1656071|NCT00165087|standard risk|standard risk
1656072|NCT00165087|high risk|high risk
1656073|NCT00165087|infant/high risk|infant/high risk
1656074|NCT00165074|Prematurity|prematurity
1656075|NCT00165074|Lung Disease|lung disease
1656076|NCT00165074|Hyaline Membrane|hyaline membrane
1656077|NCT00165074|Surfactant|surfactant
1656078|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1656079|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
1656080|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
1656081|NCT00165009|Endoscopic treatment|endoscopic treatment
1656082|NCT00164996|upper endoscopy|upper endoscopy
1656083|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
1656084|NCT00164996|ultrathin endoscope|ultrathin endoscope
1656085|NCT00164944|Colonoscopy|colonoscopy
1656086|NCT00164944|First degree relatives|first degree relatives
1656087|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
1656088|NCT00164931|Omeprazole|omeprazole
1656089|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
1656090|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
1656091|NCT00164905|Doppler ultrasound|doppler ultrasound
1656092|NCT00164879|Obstructing|obstructing
1656093|NCT00164879|Left-sided|left-sided
1656094|NCT00164879|Colorectal neoplasms|colorectal neoplasms
1656095|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
1656096|NCT00164866|Peptic ulcer|peptic ulcer
1656097|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
1656098|NCT00164840|GERD|gerd
1656099|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
1656100|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
1656101|NCT00164762|HIV|hiv
1656102|NCT00164762|drug resistance|drug resistance
1656103|NCT00164762|nevirapine|nevirapine
1656104|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
1656105|NCT00164762|mother-to-child transmission|mother-to-child transmission
1656106|NCT00164762|Treatment Naive|treatment naive
1656107|NCT00164762|pregnancy|pregnancy
1656108|NCT00164749|dementia|dementia
1656109|NCT00164749|cognition|cognition
1656110|NCT00164749|memory|memory
1656111|NCT00164749|neurodegenerative disease|neurodegenerative disease
1656112|NCT00164749|brain|brain
1656113|NCT00164736|HIV|hiv
1656114|NCT00164736|Clinical trial|clinical trial
1656115|NCT00164736|breastfeeding|breastfeeding
1656116|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
1656117|NCT00164736|nutrition|nutrition
1656118|NCT00164736|HIV Seronegativity|hiv seronegativity
1656119|NCT00164723|Capsule Endoscopy|capsule endoscopy
1656120|NCT00164710|antimalarials|antimalarials
1656121|NCT00164697|Child Development|child development
1656122|NCT00164697|Parenting|parenting
1656123|NCT00164697|Child Rearing|child rearing
1656124|NCT00164697|Parent-Child Relations|parent-child relations
1656125|NCT00164684|batterers|batterers
1656126|NCT00164684|prevention|prevention
1656127|NCT00164684|African American|african american
1656128|NCT00164684|Latino|latino
1656129|NCT00164671|Male condoms|male condoms
1656130|NCT00164671|Female condoms|female condoms
1656131|NCT00164671|Self-efficacy|self-efficacy
1656132|NCT00164658|family history|family history
1656133|NCT00164658|familial risk|familial risk
1656134|NCT00164658|behavior change|behavior change
1656135|NCT00164645|Emotional outcomes|emotional outcomes
1656136|NCT00164645|health outcomes|health outcomes
1656137|NCT00164645|traumatic brain injury|traumatic brain injury
1656138|NCT00164645|caregiving|caregiving
1656139|NCT00164619|controlled clinical trial|controlled clinical trial
1656140|NCT00164619|behavioral intervention|behavioral intervention
1656141|NCT00164619|prevention intervention|prevention intervention
1656142|NCT00164606|child maltreatment|child maltreatment
1656143|NCT00164606|child abuse|child abuse
1656144|NCT00164606|prevention|prevention
1656145|NCT00164593|Youth Violence|youth violence
1656146|NCT00164593|Prevention|prevention
1656147|NCT00164580|Homosexuality, Male|homosexuality, male
1656148|NCT00164580|Adolescents|adolescents
1656149|NCT00164580|Minority Groups|minority groups
1656150|NCT00164580|Community Participation|community participation
1656151|NCT00164580|Community Surveys|community surveys
1656152|NCT00164580|HIV Seronegativity|hiv seronegativity
1656153|NCT00164580|HIV|hiv
1656154|NCT00164567|partner abuse|partner abuse
1656155|NCT00164567|screening|screening
1656156|NCT00164567|intimate partner violence|intimate partner violence
1656157|NCT00164554|treatment|treatment
1656158|NCT00164554|control|control
1656159|NCT00164541|dating violence|dating violence
1656160|NCT00164541|violence against women|violence against women
1656161|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
1656162|NCT00164463|tuberculosis|tuberculosis
1656163|NCT00164463|TB|tb
1656164|NCT00164450|tuberculosis|tuberculosis
1656165|NCT00164450|TB|tb
1656166|NCT00164450|pharmacokinetics|pharmacokinetics
1656167|NCT00164450|children|children
1656169|NCT00164437|community healt education|community healt education
1656170|NCT00164437|decision making|decision making
1656171|NCT00164437|computer-assisted decision making|computer-assisted decision making
1656172|NCT00164424|HSV2|hsv2
1656173|NCT00164424|genital ulcer|genital ulcer
1656174|NCT00164424|HIV|hiv
1656175|NCT00164424|South Africa|south africa
1656176|NCT00164424|Treatment|treatment
1656177|NCT00164424|Acyclovir|acyclovir
1656178|NCT00164424|Prevention|prevention
1656179|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
1656180|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
1656181|NCT00164411|Adverse events following vaccination|adverse events following vaccination
1656182|NCT00164411|Immunization|immunization
1656183|NCT00164411|Immunogenicity|immunogenicity
1656184|NCT00164398|HIV|hiv
1656185|NCT00164385|HIV/AIDS|hiv/aids
1656186|NCT00164372|IV Drug users|iv drug users
1656187|NCT00164372|HIV|hiv
1656188|NCT00164372|hepatitis C virus|hepatitis c virus
1656189|NCT00164372|HIV Seronegativity|hiv seronegativity
1656190|NCT00164359|malaria, falciparum|malaria, falciparum
1656191|NCT00164359|antimalarials|antimalarials
1656192|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
1656193|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
1656194|NCT00164281|TB|tb
1656195|NCT00164281|Tuberculosis|tuberculosis
1656196|NCT00164281|INH|inh
1656197|NCT00164281|Isoniazid|isoniazid
1656198|NCT00164281|Preventive therapy|preventive therapy
1656199|NCT00164281|HIV|hiv
1656200|NCT00164281|AIDS|aids
1656201|NCT00164281|Botswana|botswana
1656202|NCT00164281|LTBI|ltbi
1656203|NCT00164281|Latent TB Infection|latent tb infection
1656204|NCT00164268|Intimate partner violence|intimate partner violence
1656205|NCT00164268|Sexual violence|sexual violence
1656206|NCT00164268|Cultural intervention|cultural intervention
1656207|NCT00164268|Native Hawaiian|native hawaiian
1656208|NCT00164255|malaria|malaria
1656209|NCT00164255|birthweight|birthweight
1656210|NCT00164255|placental malaria|placental malaria
1656211|NCT00164255|intermittent protective treatment|intermittent protective treatment
1656212|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
1656213|NCT00164255|artesuate|artesuate
1656214|NCT00164255|combination therapy|combination therapy
1656215|NCT00164255|Pregnancy|pregnancy
1656216|NCT00164242|Tardive dyskinesia|tardive dyskinesia
1656217|NCT00164242|Galantamine|galantamine
1656218|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
1656219|NCT00164229|treatment|treatment
1656220|NCT00164229|control|control
1656221|NCT00164216|malaria|malaria
1656222|NCT00164216|combination therapy|combination therapy
1656223|NCT00164216|mefloquine|mefloquine
1656224|NCT00164216|artesunate|artesunate
1656225|NCT00164216|Peru|peru
1656226|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
1656227|NCT00164190|Myocardial Infarction|myocardial infarction
1656228|NCT00164190|Thrombolysis|thrombolysis
1656229|NCT00164190|Angioplasty|angioplasty
1656230|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1656231|NCT00164177|virtual colonoscopy|virtual colonoscopy
1656232|NCT00164177|colonoscopy preparation|colonoscopy preparation
1656233|NCT00164177|bowel prep|bowel prep
1656234|NCT00164164|colonoscopy preparation|colonoscopy preparation
1656235|NCT00164164|prep|prep
1656236|NCT00164151|colonoscopy preparation|colonoscopy preparation
1656237|NCT00164151|prep|prep
1656238|NCT00164138|Incontinence|incontinence
1656239|NCT00164138|physiotherapy|physiotherapy
1656241|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
1656242|NCT00164138|coughing|coughing
1656243|NCT00164138|forced expirations|forced expirations
1656244|NCT00164138|lung disease|lung disease
1656245|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
1656246|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
1656247|NCT00164112|Drug Interactions|drug interactions
1656248|NCT00164112|Phenotyping|phenotyping
1656249|NCT00164099|Coronary Artery Bypass|coronary artery bypass
1656250|NCT00164099|Postoperative Complications|postoperative complications
1656251|NCT00164099|Probiotics|probiotics
1656252|NCT00164099|Surgical Wound infection|surgical wound infection
1656253|NCT00164099|cystitis|cystitis
1656254|NCT00164099|bacteremia|bacteremia
1656255|NCT00164099|pneumonia|pneumonia
1656256|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
1656257|NCT00164073|HCV and microarray|hcv and microarray
1656258|NCT00164073|HCV|hcv
1656259|NCT00164060|HCV|hcv
1656260|NCT00164060|HIV co-infection|hiv co-infection
1656261|NCT00164047|Nitrous Oxide|nitrous oxide
1656262|NCT00164047|Anaesthesia|anaesthesia
1656263|NCT00164047|Anesthesia|anesthesia
1656264|NCT00164047|Recovery|recovery
1656265|NCT00164047|Quality|quality
1656266|NCT00164034|Trauma|trauma
1656267|NCT00164034|Wounds|wounds
1656268|NCT00164034|Injuries|injuries
1656269|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
1656270|NCT00163995|Chronic Liver Disease|chronic liver disease
1656271|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
1656278|NCT00163956|failed retrieval|failed retrieval
1656279|NCT00163943|Metabolic syndrome|metabolic syndrome
1656280|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
1656281|NCT00163943|Insulin sensitivity|insulin sensitivity
1656282|NCT00163943|weight loss|weight loss
1656283|NCT00163943|aerobic exercise|aerobic exercise
1656284|NCT00163930|Uterine Fibroids|uterine fibroids
1656285|NCT00163930|embolisation|embolisation
1656286|NCT00163930|pain management|pain management
1656287|NCT00163917|Hypnosis|hypnosis
1656288|NCT00163917|Analgesia|analgesia
1656289|NCT00163904|Heart Failure|heart failure
1656290|NCT00163904|Inflammatory mediators|inflammatory mediators
1656291|NCT00163904|insulin sensitivity|insulin sensitivity
1656292|NCT00163904|overweight|overweight
1656293|NCT00163904|high monounsaturated diet|high monounsaturated diet
1656294|NCT00163891|Respiratory Therapy|respiratory therapy
1656295|NCT00163891|Postoperative Care|postoperative care
1656296|NCT00163891|Treatment Outcome|treatment outcome
1656297|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
1656298|NCT00163865|Boredom|boredom
1656299|NCT00163865|Adolescent|adolescent
1656300|NCT00163865|Mental illness|mental illness
1656301|NCT00163865|Depression|depression
1656302|NCT00163865|Anxiety|anxiety
1656303|NCT00163852|Cystic fibrosis|cystic fibrosis
1656304|NCT00163852|Metabolic alkalosis|metabolic alkalosis
1656305|NCT00163852|Hypercapnia|hypercapnia
1656306|NCT00163852|Salt replacement|salt replacement
1656307|NCT00163839|Dietary Intervention|dietary intervention
1656308|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
1656309|NCT00163826|cervical spine injury|cervical spine injury
1656310|NCT00163826|multiple trauma|multiple trauma
1656311|NCT00163813|Mechanically-ventilated|mechanically-ventilated
1656312|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
1656313|NCT00163813|reduced gastric motility|reduced gastric motility
1656314|NCT00163800|Outcome predictors|outcome predictors
1656315|NCT00163800|Acute brain injury|acute brain injury
1656316|NCT00163787|mobility|mobility
1656317|NCT00163787|falls|falls
1656318|NCT00163787|activity level|activity level
1656319|NCT00163761|Lymphoma|lymphoma
1656320|NCT00163748|Lymphoma|lymphoma
1656321|NCT00163735|Food allergy|food allergy
1656322|NCT00163735|wine|wine
1656323|NCT00163735|milk allergy|milk allergy
1656324|NCT00163735|egg allergy|egg allergy
1656325|NCT00163735|nut allergy|nut allergy
1656326|NCT00163735|fish allergy|fish allergy
1656327|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
1656328|NCT00163709|Biochemistry.|biochemistry.
1656329|NCT00163709|Cardiac failure.|cardiac failure.
1656330|NCT00163709|Randomised trials.|randomised trials.
1656331|NCT00163709|Hormones.|hormones.
1656332|NCT00163709|Systolic heart failure.|systolic heart failure.
1656333|NCT00163709|Diastolic heart failure.|diastolic heart failure.
1656334|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
1656335|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
1656336|NCT00163709|AMI|ami
1656337|NCT00163696|MBNW|mbnw
1656338|NCT00163696|Ventilation|ventilation
1656339|NCT00163696|small airways|small airways
1656340|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
1656341|NCT00163683|Dietary Intervention|dietary intervention
1656342|NCT00163657|Hepatitis C Virus|hepatitis c virus
1656343|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
1656344|NCT00163644|Hematological malignancies.|hematological malignancies.
1656345|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
1656346|NCT00163644|Exercise|exercise
1656347|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
1656348|NCT00163605|Sinus augmentation|sinus augmentation
1656349|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
1656350|NCT00163605|Hydroxyl apatite|hydroxyl apatite
1656351|NCT00163592|Vascular reconstruction|vascular reconstruction
1656352|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
1656353|NCT00163579|premature birth|premature birth
1656354|NCT00163579|cerclage|cerclage
1656355|NCT00163579|tocolysis|tocolysis
1656356|NCT00163579|drug therapy|drug therapy
1656357|NCT00163566|libido|libido
1656358|NCT00163566|depression strength|depression strength
1656359|NCT00163566|testosterone|testosterone
1656360|NCT00163566|dihydrotestosterone|dihydrotestosterone
1656361|NCT00163553|spinal surgery|spinal surgery
1656362|NCT00163553|pethidine|pethidine
1656363|NCT00163553|analgesia|analgesia
1656364|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
1656365|NCT00163527|Asthma|asthma
1656366|NCT00163527|Roflumilast|roflumilast
1656367|NCT00163527|Corticosteroids|corticosteroids
1656368|NCT00163514|Allergy|allergy
1656369|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
1656370|NCT00163514|Allergic Rhinitis|allergic rhinitis
1656371|NCT00163514|Hay Fever|hay fever
1656372|NCT00163501|Allergy|allergy
1656373|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
1656374|NCT00163501|Allergic Rhinitis|allergic rhinitis
1656375|NCT00163501|Hay Fever|hay fever
1656376|NCT00163488|Allergy|allergy
1656577|NCT00162552|cirrhosis|cirrhosis
1656377|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
1656378|NCT00163488|Allergic Rhinitis|allergic rhinitis
1656379|NCT00163488|Hay Fever|hay fever
1656380|NCT00163475|Asthma|asthma
1656381|NCT00163475|Roflumilast|roflumilast
1656382|NCT00163462|Asthma|asthma
1656383|NCT00163462|Ciclesonide|ciclesonide
1656384|NCT00163462|Child|child
1656385|NCT00163462|Fluticasone propionate|fluticasone propionate
1656386|NCT00163462|Pediatric|pediatric
1656387|NCT00163449|Asthma|asthma
1656388|NCT00163449|Ciclesonide|ciclesonide
1656389|NCT00163449|Child|child
1656390|NCT00163449|Pediatric|pediatric
1656391|NCT00163436|Asthma|asthma
1656392|NCT00163436|Ciclesonide|ciclesonide
1656393|NCT00163423|Asthma|asthma
1656394|NCT00163423|Ciclesonide|ciclesonide
1656395|NCT00163423|Fluticasone propionate|fluticasone propionate
1656396|NCT00163410|Asthma|asthma
1656397|NCT00163410|Ciclesonide|ciclesonide
1656398|NCT00163410|Child|child
1656399|NCT00163410|Fluticasone propionate|fluticasone propionate
1656400|NCT00163410|Pediatric|pediatric
1656401|NCT00163397|Asthma|asthma
1656402|NCT00163397|Ciclesonide|ciclesonide
1656403|NCT00163397|Budesonide|budesonide
1656404|NCT00163384|Asthma|asthma
1656405|NCT00163384|Ciclesonide|ciclesonide
1656406|NCT00163384|Budesonide|budesonide
1656407|NCT00163371|Asthma|asthma
1656408|NCT00163371|Ciclesonide|ciclesonide
1656409|NCT00163371|Child|child
1656410|NCT00163371|Fluticasone propionate|fluticasone propionate
1656411|NCT00163371|HPA-axis|hpa-axis
1656412|NCT00163371|Pediatric|pediatric
1656413|NCT00163371|Linear growth rate|linear growth rate
1656414|NCT00163358|Asthma|asthma
1656415|NCT00163358|Ciclesonide|ciclesonide
1656416|NCT00163358|Fluticasone propionate|fluticasone propionate
1656417|NCT00163358|Salmeterol|salmeterol
1656418|NCT00163345|Asthma|asthma
1656419|NCT00163345|Ciclesonide|ciclesonide
1656420|NCT00163345|Small Airways|small airways
1656421|NCT00163332|Asthma|asthma
1656422|NCT00163332|Ciclesonide|ciclesonide
1656423|NCT00163332|Fluticasone propionate|fluticasone propionate
1656424|NCT00163319|Asthma|asthma
1656425|NCT00163319|Ciclesonide|ciclesonide
1656426|NCT00163319|Fluticasone propionate|fluticasone propionate
1656427|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
1656428|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1656429|NCT00163306|Pantoprazole|pantoprazole
1656430|NCT00163293|Asthma|asthma
1656431|NCT00163293|Ciclesonide|ciclesonide
1656432|NCT00163293|Exacerbation|exacerbation
1656433|NCT00163280|Mucositis|mucositis
1656434|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
1656435|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
1656436|NCT00163267|atherosclerosis|atherosclerosis
1656437|NCT00163267|platelets|platelets
1656438|NCT00163267|Age above 18|age above 18
1656439|NCT00163254|Chronic limb ischemia|chronic limb ischemia
1656440|NCT00163254|Intervention|intervention
1656441|NCT00163254|Restenosis|restenosis
1656442|NCT00163254|Patients above 18 years|patients above 18 years
1656443|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
1656444|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
1656445|NCT00163176|cell proliferation|cell proliferation
1656446|NCT00163176|PET|pet
1656447|NCT00163176|radiotherapy|radiotherapy
1656448|NCT00163124|chiropractic|chiropractic
1656449|NCT00163124|spinal manipulation|spinal manipulation
1656450|NCT00163124|low back pain|low back pain
1656451|NCT00163072|transdermal|transdermal
1656452|NCT00163072|Megace|megace
1658394|NCT00153998|Oxaliplatin|oxaliplatin
1656453|NCT00163072|pharmacokinetics|pharmacokinetics
1656454|NCT00163033|phase I study|phase i study
1656455|NCT00163020|Preterm Birth|preterm birth
1656456|NCT00163020|Preterm Delivery|preterm delivery
1656457|NCT00163020|Multiple gestation|multiple gestation
1656458|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
1656459|NCT00163020|Progesterone|progesterone
1656460|NCT00162994|recurrent otitis media|recurrent otitis media
1656461|NCT00162994|adenoidectomy|adenoidectomy
1656462|NCT00162994|tympanostomy|tympanostomy
1656463|NCT00162994|young children|young children
1656464|NCT00162994|prevention|prevention
1656465|NCT00162994|quality of life|quality of life
1656466|NCT00162968|polyneuropathies|polyneuropathies
1656467|NCT00162968|pain|pain
1656468|NCT00162968|drug effects|drug effects
1656469|NCT00162968|escitalopram|escitalopram
1656470|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
1656471|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
1656472|NCT00162955|CHOP protocol|chop protocol
1656473|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1656474|NCT00162955|Cardiomyopathy|cardiomyopathy
1656475|NCT00162942|Crohn's Disease|crohn's disease
1656476|NCT00162929|metastatic breast cancer|metastatic breast cancer
1656477|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
1656478|NCT00162916|Traumatic Brain Injury|traumatic brain injury
1656479|NCT00162916|Depression|depression
1656480|NCT00162916|Antidepressant medication|antidepressant medication
1656481|NCT00162916|Double-Blind Study|double-blind study
1656482|NCT00162916|Brain Injuries|brain injuries
1656483|NCT00162916|Antidepressive Agents|antidepressive agents
1656484|NCT00162916|Citalopram|citalopram
1656485|NCT00162916|Double-Blind Method|double-blind method
1656486|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
1656487|NCT00162890|degenerated cervical spine|degenerated cervical spine
1656488|NCT00162890|assessment|assessment
1656489|NCT00162890|physical therapy|physical therapy
1656490|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
1656491|NCT00162864|asthma|asthma
1656492|NCT00162864|COPD|copd
1656493|NCT00162864|montelukast sodium|montelukast sodium
1656494|NCT00162864|leukotriene modifier|leukotriene modifier
1656495|NCT00162864|older adults|older adults
1656496|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
1656497|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1656498|NCT00162812|early breast cancer|early breast cancer
1656499|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
1656500|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
1656501|NCT00162799|insulin sensitibity|insulin sensitibity
1656502|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
1656503|NCT00162799|obesity-diabetes link|obesity-diabetes link
1656504|NCT00162799|salicylate|salicylate
1656505|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
1656506|NCT00162786|Driving performance|driving performance
1656507|NCT00162786|Antihistamine|antihistamine
1656508|NCT00162773|asthma|asthma
1656509|NCT00162747|Pre-term infants|pre-term infants
1656510|NCT00162747|skin infections|skin infections
1656511|NCT00162747|infant skin|infant skin
1656512|NCT00162747|Aquaphor|aquaphor
1656513|NCT00162747|sunflower seed oil|sunflower seed oil
1656514|NCT00162747|nutrition|nutrition
1656515|NCT00162747|skin care|skin care
1656516|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
1656517|NCT00162734|Liver|liver
1656518|NCT00162734|Pegylated|pegylated
1656519|NCT00162734|Interferon|interferon
1656520|NCT00162734|Alpha|alpha
1656521|NCT00162734|Ribavirin|ribavirin
1656522|NCT00162734|Combination|combination
1656523|NCT00162734|Nonresponder|nonresponder
1656524|NCT00162734|HCV|hcv
1656525|NCT00162734|Infergen|infergen
1656526|NCT00162734|SVR|svr
1656527|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
1656528|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1656529|NCT00162708|Radiotherapy|radiotherapy
1656530|NCT00162708|Chemotherapy|chemotherapy
1656531|NCT00162682|HIV|hiv
1656532|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
1656533|NCT00162682|Monitoring|monitoring
1656534|NCT00162682|Viral load|viral load
1656535|NCT00162682|CD4|cd4
1656536|NCT00162682|Thailand|thailand
1656537|NCT00162682|Future Drug Options|future drug options
1656538|NCT00162682|Resistance|resistance
1656539|NCT00162682|Developing Country|developing country
1656540|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1656541|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
1656542|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
1657401|NCT00158665|Vaccination|vaccination
1656543|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1656544|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1656545|NCT00162643|Protease Inhibitors|protease inhibitors
1656546|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1656547|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
1656548|NCT00162617|Hip fracture|hip fracture
1656549|NCT00162617|Rehabilitation|rehabilitation
1656550|NCT00162617|Transfusion|transfusion
1656552|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
1656553|NCT00162604|Postoperative infections|postoperative infections
1656554|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
1656555|NCT00162604|cystocele|cystocele
1656556|NCT00162604|rectocele|rectocele
1656557|NCT00162604|enterocele|enterocele
1656558|NCT00162604|defects of the perineal body|defects of the perineal body
1656559|NCT00162591|Bispectral index|bispectral index
1656560|NCT00162591|sedation|sedation
1656561|NCT00162591|remifentanyl|remifentanyl
1656562|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
1656563|NCT00162591|Intensive care|intensive care
1656564|NCT00162591|Nociceptive stimuli|nociceptive stimuli
1656565|NCT00162591|Sedated patient|sedated patient
1656566|NCT00162591|BIS variation|bis variation
1656567|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
1656568|NCT00162578|intensive care unit|intensive care unit
1656569|NCT00162578|vancomycin|vancomycin
1656570|NCT00162578|dexamethasone|dexamethasone
1656571|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
1656572|NCT00162565|Heart Failure, Congestive|heart failure, congestive
1656573|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
1656574|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
1656575|NCT00162552|pentoxifyllinE|pentoxifylline
1656576|NCT00162552|placebo|placebo
1656578|NCT00162552|liver failure|liver failure
1656579|NCT00162552|cytokine|cytokine
1656580|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
1656581|NCT00162500|Metastatic solid tumors|metastatic solid tumors
1656582|NCT00162474|Healthy Volunteers|healthy volunteers
1656583|NCT00162461|Healthy Volunteers|healthy volunteers
1656584|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
1656585|NCT00162396|Albuterol|albuterol
1656586|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
1656587|NCT00162396|Polymorphism|polymorphism
1656588|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
1656589|NCT00162214|Advanced Solid Tumors|advanced solid tumors
1656590|NCT00162123|ipilimumab|ipilimumab
1656591|NCT00162123|previously treated|previously treated
1656592|NCT00162019|Factor VIII Deficiency|factor viii deficiency
1656593|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
1656594|NCT00161993|Gammaglobulin|gammaglobulin
1656595|NCT00161980|Axillary wound|axillary wound
1656597|NCT00161980|Fistulae|fistulae
1656598|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
1656599|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
1656600|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
1656601|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
1656602|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
1656603|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
1656604|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
1656605|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
1656606|NCT00161915|Liver cirrhosis|liver cirrhosis
1656607|NCT00161902|Arthroplasty|arthroplasty
1656608|NCT00161902|Hip Prosthesis|hip prosthesis
1656609|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
1656610|NCT00161902|Femur Head Necrosis|femur head necrosis
1656611|NCT00161902|Coxarthrosis|coxarthrosis
1656612|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
1656613|NCT00161837|Influenza|influenza
1656614|NCT00161837|Vaccine|vaccine
1656615|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
1656616|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
1656617|NCT00161733|Median sternotomy|median sternotomy
1656618|NCT00161733|Fibrin sealant|fibrin sealant
1656619|NCT00161733|Clot|clot
1656620|NCT00161733|Cardiac surgery|cardiac surgery
1656621|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
1656622|NCT00161694|pain control|pain control
1656623|NCT00161681|Levonorgestrel|levonorgestrel
1656624|NCT00161681|ethinyl estradiol|ethinyl estradiol
1656625|NCT00161681|premenstrual syndrome|premenstrual syndrome
1656626|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
1656627|NCT00161668|Leukemia|leukemia
1656628|NCT00161655|Psoriasis|psoriasis
1656629|NCT00161655|Arthritis|arthritis
1656630|NCT00161642|Malignant Tumors|malignant tumors
1656631|NCT00161629|Distal Radius Fractures|distal radius fractures
1656632|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
1656633|NCT00161603|Angioplasty|angioplasty
1656634|NCT00161603|Behavior change|behavior change
1656635|NCT00161603|Physical activity|physical activity
1656636|NCT00161603|Risk reduction|risk reduction
1656637|NCT00161590|NK cell lymphoma|nk cell lymphoma
1656638|NCT00161590|Null cell lymphoma|null cell lymphoma
1656639|NCT00161577|Ketorolac|ketorolac
1656640|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1656642|NCT00161564|Non-Malignant Hematology|non-malignant hematology
1656643|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
1656644|NCT00161551|Atrial Fibrillation|atrial fibrillation
1656645|NCT00161551|Heart Failure|heart failure
1656646|NCT00161551|Pacemaker leads|pacemaker leads
1656647|NCT00161551|Pacing Mode|pacing mode
1656648|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
1656649|NCT00161538|Atrial fibrillation|atrial fibrillation
1656650|NCT00161538|Pacemaker leads|pacemaker leads
1656651|NCT00161538|Lead positions|lead positions
1656652|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
1656653|NCT00161486|Male contraception|male contraception
1656654|NCT00161486|Prostate|prostate
1656655|NCT00161486|Acyline|acyline
1656656|NCT00161486|Androgen replacement|androgen replacement
1656657|NCT00161473|double-blind|double-blind
1656658|NCT00161473|treatment|treatment
1656659|NCT00161473|prazosin|prazosin
1656660|NCT00161460|Colorectal cancer|colorectal cancer
1656661|NCT00161460|Mass screening|mass screening
1656662|NCT00161447|Male contraception|male contraception
1656663|NCT00161447|testosterone|testosterone
1656664|NCT00161447|acyline|acyline
1656665|NCT00161434|HIV-1|hiv-1
1656666|NCT00161421|Male Contraception|male contraception
1656667|NCT00161421|Testosterone|testosterone
1656668|NCT00161421|Hypogonadism|hypogonadism
1656669|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
1656670|NCT00161395|fertility|fertility
1656671|NCT00161395|pregnancy|pregnancy
1656672|NCT00161382|HIV Seronegativity|hiv seronegativity
1656673|NCT00161382|HIV|hiv
1656674|NCT00161369|homocysteine|homocysteine
1656675|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
1656676|NCT00161369|atherosclerosis|atherosclerosis
1656677|NCT00161369|cardiovascular event|cardiovascular event
1656678|NCT00161369|hemodialysis|hemodialysis
1656679|NCT00161343|HIV|hiv
1656680|NCT00161343|Prevention Intervention|prevention intervention
1656681|NCT00161343|Female|female
1656682|NCT00161343|Adolescents|adolescents
1656683|NCT00161343|STD|std
1656684|NCT00161343|HIV Seronegativity|hiv seronegativity
1656685|NCT00161330|urinary tract infection,|urinary tract infection,
1656686|NCT00161330|antibiotic treatment|antibiotic treatment
1656687|NCT00161330|childhood|childhood
1656688|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
1656689|NCT00161330|ceftriaxone|ceftriaxone
1656690|NCT00161330|renal ultrasonography|renal ultrasonography
1656691|NCT00161330|renal scintigraphy|renal scintigraphy
1656692|NCT00161291|Carcinoma of the breast|carcinoma of the breast
1656693|NCT00161291|Breast cancer|breast cancer
1656694|NCT00161252|Prostate Cancer|prostate cancer
1656695|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
1656696|NCT00161226|endometrial cancer|endometrial cancer
1656697|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
1656698|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
1656699|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
1656700|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1656701|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
1656702|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
1656703|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1656704|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1656705|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
1656706|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1656707|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1656708|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1656709|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1656710|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1656711|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1656712|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1656713|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
1656714|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
1656715|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
1656716|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1656717|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1656718|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1656719|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1656720|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1656721|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1656722|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
1656723|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
1656724|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1656725|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1656726|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1656727|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1656728|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1656729|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1656730|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1656731|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1656732|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1656733|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1656734|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1656735|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
1656736|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
1656737|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
1656738|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
1656739|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
1656740|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
1656741|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1656742|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1656743|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
1656744|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
1656745|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
1656746|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
1656747|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1656748|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1656749|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
1656750|NCT00161187|recurrent colon cancer|recurrent colon cancer
1656751|NCT00161187|stage IV colon cancer|stage iv colon cancer
1656752|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
1656753|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
1656754|NCT00161187|recurrent breast cancer|recurrent breast cancer
1656755|NCT00161187|stage IV breast cancer|stage iv breast cancer
1656756|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1656757|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1656758|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
1656759|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1656760|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1656761|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
1656762|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1656763|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1656764|NCT00161187|chondrosarcoma|chondrosarcoma
1656765|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
1656766|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1656767|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1656768|NCT00161187|ovarian sarcoma|ovarian sarcoma
1656769|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
1656770|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
1656771|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1656772|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1656773|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1656774|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1656775|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1656776|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1656777|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1656778|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1656779|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1656780|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1656781|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1656782|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1656783|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1656784|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
1656785|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
1656786|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
1656787|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
1656788|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
1656789|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
1656790|NCT00161187|stage III cervical cancer|stage iii cervical cancer
1656791|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
1656792|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
1656793|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1656794|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1656930|NCT00161187|Burkitt lymphoma|burkitt lymphoma
1656795|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1656796|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1656797|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1656867|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
1656798|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
1656799|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
1656800|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
1656801|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1656802|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1656803|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
1656804|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
1656805|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1656806|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1656807|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1656808|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1656809|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1656810|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1656811|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1656812|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1656813|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1656814|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1656815|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1656816|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1656964|NCT00161109|Autism|autism
1656817|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1656818|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1656819|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1656820|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1656821|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1656822|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1656823|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1656824|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1656825|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1656826|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1656827|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1656828|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1656829|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1656830|NCT00161187|localized osteosarcoma|localized osteosarcoma
1656831|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
1656832|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1656833|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1656834|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1656835|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1656836|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1656837|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1656838|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1656839|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1656840|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1656841|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
1656842|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
1656843|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1656844|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1656845|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1656846|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1656847|NCT00161187|stage I bladder cancer|stage i bladder cancer
1656848|NCT00161187|stage II bladder cancer|stage ii bladder cancer
1656849|NCT00161187|stage III bladder cancer|stage iii bladder cancer
1656850|NCT00161187|male breast cancer|male breast cancer
1656851|NCT00161187|stage I breast cancer|stage i breast cancer
1656852|NCT00161187|stage II breast cancer|stage ii breast cancer
1656853|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
1656854|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
1656855|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
1656856|NCT00161187|stage I colon cancer|stage i colon cancer
1656857|NCT00161187|stage II colon cancer|stage ii colon cancer
1656858|NCT00161187|stage III colon cancer|stage iii colon cancer
1656859|NCT00161187|stage I gastric cancer|stage i gastric cancer
1656860|NCT00161187|stage II gastric cancer|stage ii gastric cancer
1656861|NCT00161187|stage III gastric cancer|stage iii gastric cancer
1656862|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1656863|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1656864|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1656865|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1656866|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
1656868|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
1656869|NCT00161187|stage I prostate cancer|stage i prostate cancer
1656870|NCT00161187|stage II prostate cancer|stage ii prostate cancer
1656871|NCT00161187|stage III prostate cancer|stage iii prostate cancer
1656872|NCT00161187|stage I rectal cancer|stage i rectal cancer
1656873|NCT00161187|stage II rectal cancer|stage ii rectal cancer
1656874|NCT00161187|stage III rectal cancer|stage iii rectal cancer
1656875|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
1656876|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
1656877|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
1656878|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
1656879|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
1656880|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
1656881|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1656882|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1656883|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1656884|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1656885|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1656886|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1656887|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1656888|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1656889|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1656890|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1656963|NCT00161109|Psychiophysiology|psychiophysiology
1656891|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1656892|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1656893|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1656894|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1656895|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1656896|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1656897|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1656898|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1656899|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1656900|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1656901|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1656902|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1656903|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1656904|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1656905|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1656906|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1656907|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1656908|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1656909|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1656910|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1656911|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1656912|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1656913|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1656914|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1656915|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1656916|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1656917|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1656918|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1656919|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1656920|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1656921|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1656922|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1656923|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1656924|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1656925|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1656926|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1656927|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1656928|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1656929|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1656931|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1656932|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1656933|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1656934|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1656935|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1656936|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1656937|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
1656938|NCT00161187|stage IA melanoma|stage ia melanoma
1656939|NCT00161187|stage IB melanoma|stage ib melanoma
1656940|NCT00161187|stage IIA melanoma|stage iia melanoma
1656941|NCT00161187|stage IIB melanoma|stage iib melanoma
1656942|NCT00161187|stage IIC melanoma|stage iic melanoma
1656943|NCT00161187|stage IIIA melanoma|stage iiia melanoma
1656944|NCT00161187|stage IIIB melanoma|stage iiib melanoma
1656945|NCT00161187|stage IIIC melanoma|stage iiic melanoma
1656946|NCT00161187|stage IV melanoma|stage iv melanoma
1656947|NCT00161187|recurrent melanoma|recurrent melanoma
1656948|NCT00161174|testicular cancer|testicular cancer
1656949|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
1656950|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
1656951|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
1656952|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
1656954|NCT00161148|Liver biochemistry|liver biochemistry
1656955|NCT00161148|Probiotics|probiotics
1656956|NCT00161148|Pruritus|pruritus
1656957|NCT00161135|MRI|mri
1656958|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
1656959|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
1656960|NCT00161109|Psychopathology|psychopathology
1656961|NCT00161109|Psychiatry|psychiatry
1656962|NCT00161109|Neuropsychology|neuropsychology
1656966|NCT00161109|Deletion size|deletion size
1656967|NCT00161109|Candidate genes|candidate genes
1656968|NCT00161109|Psychiatric symptoms|psychiatric symptoms
1656969|NCT00161109|Neuropsychological impairments|neuropsychological impairments
1656970|NCT00161109|Psychophysiological performance|psychophysiological performance
1656971|NCT00161096|on-demand therapy|on-demand therapy
1656972|NCT00161096|pantoprazole|pantoprazole
1656973|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
1656974|NCT00161096|proton pump inhibitor|proton pump inhibitor
1656975|NCT00161096|acid suppression|acid suppression
1656976|NCT00161096|intermittent|intermittent
1656977|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
1656978|NCT00161083|gallstone|gallstone
1656979|NCT00161083|complications|complications
1656980|NCT00161083|pancreatitis|pancreatitis
1656981|NCT00161083|gallbladder motility|gallbladder motility
1656982|NCT00161083|colic|colic
1656983|NCT00161070|secondary prevention|secondary prevention
1656984|NCT00161070|TIA / minor stroke|tia / minor stroke
1656985|NCT00161070|atherosclerotic origin|atherosclerotic origin
1656986|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
1656987|NCT00161070|prevention & control|prevention & control
1656988|NCT00161057|Schizophrenia|schizophrenia
1656989|NCT00161057|Medication-naive|medication-naive
1656990|NCT00161057|Functional MRI|functional mri
1656991|NCT00161057|Working memory|working memory
1656992|NCT00161057|Language lateralization|language lateralization
1656993|NCT00161057|schizoaffective disorder|schizoaffective disorder
1656994|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
1656995|NCT00161005|Acute myocardial infarction|acute myocardial infarction
1656996|NCT00161005|Fibrinolysis|fibrinolysis
1656997|NCT00161005|Health effects /Quality of life|health effects /quality of life
1656998|NCT00160992|Adoptive cell transfer|adoptive cell transfer
1656999|NCT00160992|peptide vaccination|peptide vaccination
1657000|NCT00160992|melanoma|melanoma
1657001|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
1657002|NCT00160966|kidney transplantation|kidney transplantation
1657003|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
1657004|NCT00160966|tacrolimus|tacrolimus
1657005|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
1657006|NCT00160966|everolimus|everolimus
1657007|NCT00160966|cyclosporin A|cyclosporin a
1657008|NCT00160966|BK virus PCR|bk virus pcr
1657009|NCT00160966|viruria screening|viruria screening
1657010|NCT00160966|BK polyomavirus|bk polyomavirus
1657011|NCT00160966|immunosuppression|immunosuppression
1657012|NCT00160940|gene expression|gene expression
1657013|NCT00160940|viral hepatitis|viral hepatitis
1657014|NCT00160940|autoimmune disease|autoimmune disease
1657015|NCT00160927|microcirculation|microcirculation
1657016|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
1657017|NCT00160927|neuropathy|neuropathy
1657018|NCT00160927|endothelial function|endothelial function
1657019|NCT00160914|Childhood obesity|childhood obesity
1657020|NCT00160901|Breast cancer|breast cancer
1657021|NCT00160901|Chemotherapy|chemotherapy
1657022|NCT00160901|Phytotherapy|phytotherapy
1657207|NCT00159926|cell saver|cell saver
1657023|NCT00160901|Nutritional counseling|nutritional counseling
1657024|NCT00160875|esophageal|esophageal
1657025|NCT00160875|esophagus|esophagus
1657026|NCT00160875|irinotecan|irinotecan
1657027|NCT00160875|CPT11|cpt11
1657028|NCT00160875|cisplatin|cisplatin
1657029|NCT00160849|Treatment Experienced|treatment experienced
1657030|NCT00160836|Tissue diagnosis|tissue diagnosis
1657031|NCT00160823|Colon cleansing|colon cleansing
1657032|NCT00160823|Quality|quality
1657033|NCT00160823|Cost-effectiveness|cost-effectiveness
1657034|NCT00160810|distal|distal
1657035|NCT00160810|radius|radius
1657036|NCT00160810|fractures|fractures
1657037|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
1657038|NCT00160732|Islet Cell Transplant|islet cell transplant
1657039|NCT00160732|Human islet cell infusion|human islet cell infusion
1657040|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
1657041|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
1657042|NCT00160693|America College of Rheumatology|america college of rheumatology
1657043|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
1657044|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
1657045|NCT00160680|Persistent Allergic Rhinitis, HDM, Parietaria, sneezing, rhinorrhea, ocular pruritus, Rhinasthma, inflammatory cells, ICAM-1, ATAREAL, Xyzal, Levocetirizine|persistent allergic rhinitis, hdm, parietaria, sneezing, rhinorrhea, ocular pruritus, rhinasthma, inflammatory cells, icam-1, atareal, xyzal, levocetirizine
1657046|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
1657047|NCT00160667|Brivaracetam|brivaracetam
1657048|NCT00160654|Epilepsy|epilepsy
1657049|NCT00160654|Partial Onset Seizures|partial onset seizures
1657050|NCT00160654|Keppra|keppra
1657051|NCT00160654|Levetiracetam|levetiracetam
1657052|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
1657053|NCT00160641|CDP870|cdp870
1657054|NCT00160641|Certolizumab Pegol|certolizumab pegol
1657055|NCT00160641|Cimzia|cimzia
1657056|NCT00160628|Epilepsy|epilepsy
1657057|NCT00160628|Partial Onset Seizures|partial onset seizures
1657059|NCT00160628|Levetiracetam|levetiracetam
1657060|NCT00160615|Epilepsy, Partial,|epilepsy, partial,
1657061|NCT00160615|Keppra, levetiracetam|keppra, levetiracetam
1657062|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
1657063|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
1657064|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
1657065|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
1657066|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
1657067|NCT00160563|Pediatry|pediatry
1657069|NCT00160563|atopic Children|atopic children
1657070|NCT00160563|prevention of asthma|prevention of asthma
1657071|NCT00160563|Levocetirizine|levocetirizine
1657073|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
1657074|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
1657075|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
1657076|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
1657077|NCT00160524|Certolizumab Pegol|certolizumab pegol
1657078|NCT00160524|Cimzia|cimzia
1657079|NCT00160524|CDP870|cdp870
1657080|NCT00160524|CZP|czp
1657081|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
1657082|NCT00160511|Levetiracetam|levetiracetam
1657083|NCT00160511|Keppra|keppra
1657084|NCT00160511|Nerve Pain|nerve pain
1657085|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
1657086|NCT00160485|Gestational Diabetes|gestational diabetes
1657087|NCT00160485|Pregnancy|pregnancy
1657088|NCT00160485|Glyburide|glyburide
1657089|NCT00160485|Insulin|insulin
1657090|NCT00160472|vasopressin|vasopressin
1657091|NCT00160472|ovarian|ovarian
1657092|NCT00160472|neoplasm|neoplasm
1657093|NCT00160459|Fibroid Uterus|fibroid uterus
1657094|NCT00160459|Leiomyoma|leiomyoma
1657095|NCT00160459|Uterine Fibroids|uterine fibroids
1657096|NCT00160459|asoprisnil|asoprisnil
1657097|NCT00160446|Pelvic pain|pelvic pain
1657098|NCT00160446|Dysmenorrhea|dysmenorrhea
1657099|NCT00160446|Dyspareunia|dyspareunia
1657100|NCT00160446|Infertility|infertility
1657101|NCT00160446|Asoprisnil|asoprisnil
1657102|NCT00160433|Pelvic pain|pelvic pain
1657103|NCT00160433|Dysmenorrhea|dysmenorrhea
1657104|NCT00160433|Dyspareunia|dyspareunia
1657105|NCT00160433|Infertility|infertility
1657106|NCT00160433|asoprisnil|asoprisnil
1657107|NCT00160420|Pelvic pain|pelvic pain
1657108|NCT00160420|Dysmenorrhea|dysmenorrhea
1657109|NCT00160420|Dyspareunia|dyspareunia
1657110|NCT00160420|Infertility|infertility
1657111|NCT00160420|asoprisnil|asoprisnil
1657112|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
1657113|NCT00160407|enzyme inhibitors|enzyme inhibitors
1657114|NCT00160407|lipase|lipase
1657115|NCT00160407|obesity|obesity
1657116|NCT00160407|insulin resistance|insulin resistance
1657117|NCT00160394|Mild to Moderate|mild to moderate
1657118|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1657119|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
1657120|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
1657121|NCT00160381|asoprisnil|asoprisnil
1657122|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
1657123|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1657624|NCT00157716|surgery|surgery
1657124|NCT00160355|Immunodeficiency|immunodeficiency
1657125|NCT00160355|Haploidentical transplantation|haploidentical transplantation
1657126|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
1657127|NCT00160303|Prolotherapy|prolotherapy
1657128|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
1657129|NCT00160303|Tennis Elbow|tennis elbow
1657130|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
1657131|NCT00160290|lactulose|lactulose
1657132|NCT00160290|randomised clinical trial|randomised clinical trial
1657133|NCT00160290|hemorrhoids|hemorrhoids
1657134|NCT00160290|anal fissures|anal fissures
1657135|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
1657136|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
1657137|NCT00160251|PEG-Intron|peg-intron
1657138|NCT00160251|Ribavirin|ribavirin
1657139|NCT00160251|Protease Inhibitor|protease inhibitor
1657140|NCT00160238|Meniere's disease|meniere's disease
1657141|NCT00160238|Vestibular neurotomy|vestibular neurotomy
1657142|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
1657143|NCT00160212|blood pressure|blood pressure
1657144|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
1657145|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
1657146|NCT00160160|comparator trial|comparator trial
1657147|NCT00160160|hypertension|hypertension
1657149|NCT00160160|blood pressure|blood pressure
1657150|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
1657151|NCT00160095|larynx carcinoma|larynx carcinoma
1657152|NCT00160095|Tumor hypoxia|tumor hypoxia
1657153|NCT00160095|microregional imaging|microregional imaging
1657154|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
1657155|NCT00160082|Post Polio Syndrome|post polio syndrome
1657157|NCT00160082|Poliomyelitis|poliomyelitis
1657158|NCT00160082|Paralylic Polio|paralylic polio
1657159|NCT00160082|Late effects of polio|late effects of polio
1657160|NCT00160082|Late onset polio sequele|late onset polio sequele
1657161|NCT00160082|Xepol|xepol
1657162|NCT00160082|IvIg|ivig
1657163|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
1657164|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
1657165|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
1657166|NCT00160056|Diabetes|diabetes
1657167|NCT00160056|adrenal receptor|adrenal receptor
1657168|NCT00160056|adrenerg respons|adrenerg respons
1657169|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
1657170|NCT00160056|salbutamol|salbutamol
1657171|NCT00160017|Quality assurance health care|quality assurance health care
1657172|NCT00160017|Diabetes|diabetes
1657173|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
1657174|NCT00160017|Evaluation|evaluation
1657175|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1657176|NCT00160004|Exercise|exercise
1657177|NCT00160004|Fatigue|fatigue
1657178|NCT00160004|Quality-of-life|quality-of-life
1657179|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
1657180|NCT00159991|Total arterial revascularization|total arterial revascularization
1657181|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
1657182|NCT00159991|Radial artery grafting|radial artery grafting
1657183|NCT00159978|head and neck cancer|head and neck cancer
1657184|NCT00159978|hypoxia|hypoxia
1657185|NCT00159978|tumor cell proliferation|tumor cell proliferation
1657186|NCT00159978|PET|pet
1657187|NCT00159965|nonepileptic seizure|nonepileptic seizure
1657188|NCT00159965|pseudoseizure|pseudoseizure
1657189|NCT00159965|conversion disorder|conversion disorder
1657190|NCT00159965|psychogenic|psychogenic
1657191|NCT00159965|Depression|depression
1657192|NCT00159965|Anxiety|anxiety
1657193|NCT00159965|Abuse|abuse
1657194|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
1657195|NCT00159965|sertraline|sertraline
1657196|NCT00159965|serotonin|serotonin
1657197|NCT00159965|randomized controlled trial|randomized controlled trial
1657198|NCT00159952|Sepsis|sepsis
1657199|NCT00159952|Septic shock|septic shock
1657200|NCT00159952|Hyperglycemia|hyperglycemia
1657201|NCT00159952|Fibrinolysis|fibrinolysis
1657202|NCT00159952|PAI 1|pai 1
1657203|NCT00159939|ARDS|ards
1657204|NCT00159939|prone position|prone position
1657205|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
1657206|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
1657208|NCT00159926|interleukins|interleukins
1657209|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
1657210|NCT00159900|Impotence|impotence
1657211|NCT00159874|children|children
1657212|NCT00159627|heart failure, congestive|heart failure, congestive
1657213|NCT00159627|diuretic|diuretic
1657214|NCT00159614|renal insufficiency|renal insufficiency
1657215|NCT00159614|diuretic|diuretic
1657216|NCT00159614|heart failure, congestive|heart failure, congestive
1657217|NCT00159601|Quality of Life|quality of life
1657218|NCT00159601|Mental health|mental health
1657219|NCT00159601|Children|children
1657220|NCT00159601|Adolescents|adolescents
1657221|NCT00159601|Normal population|normal population
1657222|NCT00159588|Medication-overuse headache|medication-overuse headache
1657223|NCT00159588|preventative medication|preventative medication
1657224|NCT00159588|controls|controls
1657225|NCT00159588|follow-up|follow-up
1657226|NCT00159588|randomized|randomized
1657227|NCT00159588|abrupt withdrawal|abrupt withdrawal
1657228|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
1657229|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
1657230|NCT00159575|Oligo- or anovulation|oligo- or anovulation
1657231|NCT00159562|Bipolar Disorder|bipolar disorder
1657232|NCT00159562|Psycho-education|psycho-education
1657233|NCT00159549|Patient education|patient education
1657234|NCT00159536|PCOS|pcos
1657235|NCT00159536|metformin|metformin
1657236|NCT00159536|pregnancy|pregnancy
1657237|NCT00159536|preeclampsia|preeclampsia
1657238|NCT00159536|diabetes|diabetes
1657239|NCT00159536|preterm delivery|preterm delivery
1657240|NCT00159523|Prevention|prevention
1657241|NCT00159523|Probiotics|probiotics
1657242|NCT00159523|Allergy|allergy
1657243|NCT00159523|Hypersensitivity|hypersensitivity
1657244|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
1657245|NCT00159497|THA|tha
1657246|NCT00159484|phase 1|phase 1
1657247|NCT00159484|phase one|phase one
1657251|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
1657252|NCT00159419|Fractures|fractures
1657253|NCT00159419|Pediatric|pediatric
1657254|NCT00159419|Osteoporosis|osteoporosis
1657255|NCT00159419|Juvenile Pagets|juvenile pagets
1657256|NCT00159406|BPH treatment|bph treatment
1657257|NCT00159406|Laser Prostatectomy|laser prostatectomy
1657258|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
1657259|NCT00159406|BPH|bph
1657260|NCT00159393|Kidney stones|kidney stones
1657261|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
1657262|NCT00159380|Healthy Volunteers|healthy volunteers
1657263|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
1657264|NCT00159354|FDG−PET|fdg−pet
1657265|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
1657266|NCT00159354|smoking,|smoking,
1657267|NCT00159354|COPD|copd
1657268|NCT00159354|steroid intervention|steroid intervention
1657269|NCT00159341|cigarette smoke|cigarette smoke
1657270|NCT00159341|nasal|nasal
1657271|NCT00159341|whole blood|whole blood
1657272|NCT00159341|cytokines|cytokines
1657273|NCT00159341|chemokines|chemokines
1657274|NCT00159341|nasal fluid|nasal fluid
1657275|NCT00159341|filter paper|filter paper
1657276|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
1657277|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
1657278|NCT00159328|Uterine Fibroids|uterine fibroids
1657279|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
1657280|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
1657281|NCT00159315|Asthma Patients|asthma patients
1657282|NCT00159315|COPD Patients|copd patients
1657283|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
1657284|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
1657285|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
1657286|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
1657287|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
1657288|NCT00159250|gene restoration;|gene restoration;
1657289|NCT00159250|deletion|deletion
1657290|NCT00159224|HIV|hiv
1657291|NCT00159224|Simplification|simplification
1657292|NCT00159224|Monotherapy|monotherapy
1657293|NCT00159224|Treatment Naive|treatment naive
1657294|NCT00159224|HIV-1 infection|hiv-1 infection
1657295|NCT00159211|type 2 diabetes|type 2 diabetes
1657296|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1657297|NCT00159198|Frontotemporal dementia|frontotemporal dementia
1657298|NCT00159198|Mutations spectrum|mutations spectrum
1657299|NCT00159198|Linkage studies|linkage studies
1657300|NCT00159198|Genetic epidemiology|genetic epidemiology
1657301|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
1657302|NCT00159185|Epidemiology|epidemiology
1657303|NCT00159172|Advanced parkinson disease|advanced parkinson disease
1657304|NCT00159172|Stimulation|stimulation
1657305|NCT00159172|Motor Cortex|motor cortex
1657400|NCT00158665|Influenza|influenza
1657306|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
1657307|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
1657308|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
1657309|NCT00159159|Cardiac Transplant|cardiac transplant
1657310|NCT00159159|ciclosporine|ciclosporine
1657311|NCT00159159|immunosuppressive|immunosuppressive
1657312|NCT00159146|Major Depression|major depression
1657313|NCT00159146|Pindolol|pindolol
1657314|NCT00159146|Venlafaxine|venlafaxine
1657315|NCT00159146|Augmentation|augmentation
1657316|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
1657317|NCT00159133|Schizophrenia|schizophrenia
1657318|NCT00159133|first episode|first episode
1657319|NCT00159133|prodrome based early intervention|prodrome based early intervention
1657320|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
1657321|NCT00159133|maintenance treatment|maintenance treatment
1657322|NCT00159133|drug discontinuation|drug discontinuation
1657323|NCT00159120|Schizophrenia|schizophrenia
1657324|NCT00159120|first episode|first episode
1657325|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
1657326|NCT00159120|drug discontinuation|drug discontinuation
1657327|NCT00159120|prodrome based early intervention|prodrome based early intervention
1657328|NCT00159107|alcoholism|alcoholism
1657329|NCT00159107|abstinence enhancement|abstinence enhancement
1657330|NCT00159107|psychotherapy|psychotherapy
1657331|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
1657332|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
1657333|NCT00159107|multi-center study|multi-center study
1657334|NCT00159081|Schizophrenia|schizophrenia
1657335|NCT00159081|first episode|first episode
1657336|NCT00159081|long-term treatment|long-term treatment
1657337|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
1657338|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
1657339|NCT00158990|major depression|major depression
1657340|NCT00158990|bipolar disorder|bipolar disorder
1657341|NCT00158990|unipolar depression|unipolar depression
1657343|NCT00158990|triiodothyronine|triiodothyronine
1657344|NCT00158977|heart failure|heart failure
1657345|NCT00158977|atrial fibrillation|atrial fibrillation
1657346|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
1657347|NCT00158964|left ventricular lead|left ventricular lead
1657349|NCT00158964|heart failure|heart failure
1657350|NCT00158951|Left Ventricular Lead|left ventricular lead
1657351|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1657352|NCT00158951|Congestive Heart Failure|congestive heart failure
1657353|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
1657354|NCT00158938|Implanted Electrodes|implanted electrodes
1657355|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
1657356|NCT00158925|Implanted Electrodes|implanted electrodes
1657357|NCT00158899|HDLc|hdlc
1657358|NCT00158899|high-density lipoprotein|high-density lipoprotein
1657359|NCT00158899|Dyslipidemia|dyslipidemia
1657360|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
1657361|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
1657362|NCT00158860|VALTREX®|valtrex®
1657363|NCT00158860|valaciclovir|valaciclovir
1657364|NCT00158860|genital herpes|genital herpes
1657365|NCT00158860|HSV-2|hsv-2
1657366|NCT00158860|suppression|suppression
1657367|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
1657368|NCT00158834|Children|children
1657369|NCT00158834|Asthma|asthma
1657370|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
1657371|NCT00158834|symptoms|symptoms
1657372|NCT00158821|HIV|hiv
1657373|NCT00158821|Antiretroviral|antiretroviral
1657374|NCT00158821|Treatment Experienced|treatment experienced
1657375|NCT00158821|HIV-1|hiv-1
1657376|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
1657377|NCT00158769|Hepatic Impairment|hepatic impairment
1657378|NCT00158769|GR270773|gr270773
1657379|NCT00158769|Emulsion|emulsion
1657380|NCT00158756|Diphtheria|diphtheria
1657381|NCT00158756|Pertussis|pertussis
1657382|NCT00158756|Prophylaxis|prophylaxis
1657383|NCT00158756|Hepatitis B diseases|hepatitis b diseases
1657384|NCT00158756|Tetanus|tetanus
1657385|NCT00158743|Pre-eclampsia|pre-eclampsia
1657386|NCT00158743|Hypertension|hypertension
1657387|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
1657388|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
1657389|NCT00158743|Digibind|digibind
1657390|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
1657391|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
1657392|NCT00158691|Head and Neck cancer|head and neck cancer
1657393|NCT00158691|Radiotherapy|radiotherapy
1657394|NCT00158691|Xerostomia|xerostomia
1657395|NCT00158691|Randomized trial|randomized trial
1657396|NCT00158678|oral cancer|oral cancer
1657397|NCT00158678|oropharynx cancer|oropharynx cancer
1657398|NCT00158678|hypopharynx cancer|hypopharynx cancer
1657399|NCT00158678|IMRT|imrt
1657402|NCT00158665|Immunization|immunization
1657403|NCT00158665|Flu|flu
1657404|NCT00158665|Immunogenicity|immunogenicity
1657405|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
1657406|NCT00158652|Radiotherapy|radiotherapy
1657407|NCT00158652|Chemotherapy|chemotherapy
1657408|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
1657409|NCT00158639|Pharmaceutical services|pharmaceutical services
1657410|NCT00158639|Self care|self care
1657411|NCT00158626|physical therapy|physical therapy
1657412|NCT00158626|physiotherapy|physiotherapy
1657625|NCT00157716|ischemia|ischemia
1657413|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
1657414|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
1657415|NCT00158600|GSD-II|gsd-ii
1657416|NCT00158600|Pompe Disease|pompe disease
1657417|NCT00158587|Vivax|vivax
1657418|NCT00158587|Treatment|treatment
1657419|NCT00158587|Primaquine|primaquine
1657420|NCT00158587|Asia|asia
1657421|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
1657422|NCT00158574|malaria|malaria
1657423|NCT00158574|efficacy|efficacy
1657424|NCT00158574|safety|safety
1657425|NCT00158574|drug options|drug options
1657426|NCT00158561|vivax|vivax
1657427|NCT00158561|treatment|treatment
1657428|NCT00158561|Asia|asia
1657429|NCT00158548|Falciparum|falciparum
1657430|NCT00158548|Vivax|vivax
1657431|NCT00158548|Treatment|treatment
1657432|NCT00158548|Asia|asia
1657433|NCT00158535|Liver Transplantation|liver transplantation
1657434|NCT00158535|Hepatitis C|hepatitis c
1657435|NCT00158535|HIV Infections|hiv infections
1657436|NCT00158522|Acute hepatitis C|acute hepatitis c
1657437|NCT00158522|Genotype 4|genotype 4
1657438|NCT00158522|Pegylated Interferon|pegylated interferon
1657439|NCT00158522|Egypt|egypt
1657440|NCT00158509|Valacyclovir|valacyclovir
1657441|NCT00158509|HIV-1|hiv-1
1657442|NCT00158509|HSV-2|hsv-2
1657443|NCT00158509|genital shedding|genital shedding
1657444|NCT00158509|herpes genitalis|herpes genitalis
1657445|NCT00158509|HIV infection|hiv infection
1657446|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
1657448|NCT00158496|Pegylated Interferon|pegylated interferon
1657449|NCT00158496|Ribavirin|ribavirin
1657450|NCT00158496|Egypt|egypt
1657451|NCT00158483|Genital herpes|genital herpes
1657452|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
1657453|NCT00158483|Syndromic treatment|syndromic treatment
1657454|NCT00158483|Genital viral load|genital viral load
1657455|NCT00158483|Ulcer|ulcer
1657456|NCT00158470|HIV infection|hiv infection
1657457|NCT00158470|injecting drug users|injecting drug users
1657458|NCT00158470|HAART|haart
1657459|NCT00158470|once daily regimen|once daily regimen
1657460|NCT00158470|Treatment Naive|treatment naive
1657461|NCT00158457|Simplification regimen|simplification regimen
1657462|NCT00158457|HIV infection|hiv infection
1657463|NCT00158457|Once a day|once a day
1657464|NCT00158457|Naive patients|naive patients
1657465|NCT00158457|Sub-saharian Africa|sub-saharian africa
1657466|NCT00158457|Treatment Naive|treatment naive
1657467|NCT00158431|osteoarthritis|osteoarthritis
1657468|NCT00158431|randomized trial|randomized trial
1657469|NCT00158431|knee|knee
1657470|NCT00158431|quality of life|quality of life
1657471|NCT00158418|osteoarthritis|osteoarthritis
1657472|NCT00158418|shoulder|shoulder
1657473|NCT00158418|randomized trial|randomized trial
1657474|NCT00158418|cement|cement
1657475|NCT00158405|HIV|hiv
1657476|NCT00158405|Structured treatment interruption|structured treatment interruption
1657477|NCT00158405|HAART|haart
1657478|NCT00158405|Sub-saharian africa|sub-saharian africa
1657479|NCT00158405|Treatment Interruption|treatment interruption
1657480|NCT00158405|Treatment Naive|treatment naive
1657481|NCT00158366|Weight Loss|weight loss
1657482|NCT00158353|Mentors|mentors
1657483|NCT00158353|Self-esteem|self-esteem
1657484|NCT00158353|Adolescent|adolescent
1657485|NCT00158353|Mental health|mental health
1657486|NCT00158353|Social support|social support
1657487|NCT00158353|Substance use|substance use
1657488|NCT00158353|Violence|violence
1657489|NCT00158353|Exercise|exercise
1657490|NCT00158353|Nutrition|nutrition
1657491|NCT00158353|Sexual behavior|sexual behavior
1657492|NCT00158353|Female|female
1657493|NCT00158340|Binge Eating|binge eating
1657494|NCT00158340|Overeating|overeating
1657495|NCT00158340|Compulsive Eating|compulsive eating
1657496|NCT00158340|Hyperphagia|hyperphagia
1657497|NCT00158327|Primary Health Care|primary health care
1657498|NCT00158314|Pathological gambling|pathological gambling
1657499|NCT00158314|Gambler's anonymous|gambler's anonymous
1657500|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
1657501|NCT00158314|CBT|cbt
1657502|NCT00158301|Child|child
1657503|NCT00158301|Adolescent|adolescent
1657504|NCT00158301|CBT|cbt
1657505|NCT00158301|Drug Therapy|drug therapy
1657506|NCT00158288|Substance Use Disorders|substance use disorders
1657507|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
1657508|NCT00158275|Problem solving therapy|problem solving therapy
1657509|NCT00158275|CBT|cbt
1657510|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1657511|NCT00158262|Prevention|prevention
1657512|NCT00158262|Propranolol|propranolol
1657513|NCT00158262|Psychophysiology|psychophysiology
1657514|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
1657515|NCT00158236|Opiate Addiction|opiate addiction
1657516|NCT00158236|Opiate Dependence|opiate dependence
1657517|NCT00158223|Schizophrenia|schizophrenia
1657518|NCT00158223|Clozapine|clozapine
1657519|NCT00158223|Treatment|treatment
1657520|NCT00158223|Combination|combination
1657521|NCT00158223|Unresponsive|unresponsive
1657522|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
1657523|NCT00158197|Adherence|adherence
1657524|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
1657525|NCT00158197|Behavior Therapy|behavior therapy
1657526|NCT00158197|Contingency management|contingency management
1657527|NCT00158197|Drug Counseling|drug counseling
1657528|NCT00158197|health behaviors|health behaviors
1657529|NCT00158197|methamphetamine|methamphetamine
1657530|NCT00158197|sexual risk behaviors|sexual risk behaviors
1657531|NCT00158197|substance dependence|substance dependence
1657532|NCT00158184|Opiate|opiate
1657533|NCT00158184|Opioid|opioid
1657534|NCT00158184|Abuse Liability|abuse liability
1657535|NCT00158184|Abuse Potential|abuse potential
1657536|NCT00158171|smoking addiction|smoking addiction
1657537|NCT00158158|smoking addiction|smoking addiction
1657538|NCT00158132|cocaine|cocaine
1657539|NCT00158119|strength training|strength training
1657540|NCT00158119|power training|power training
1657541|NCT00158119|exercise training|exercise training
1657542|NCT00158119|functional performance tasks|functional performance tasks
1657543|NCT00158106|functional communicative ability|functional communicative ability
1657544|NCT00158106|cost effectiveness|cost effectiveness
1657545|NCT00158106|service user preferences|service user preferences
1657546|NCT00158067|Epilepsy|epilepsy
1657547|NCT00158067|Neurostimulation|neurostimulation
1657548|NCT00158054|depression|depression
1657549|NCT00158054|acute coronary syndrome|acute coronary syndrome
1657550|NCT00158054|clinical trials|clinical trials
1657551|NCT00158041|Amifostine|amifostine
1657556|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
1657557|NCT00158028|Risperidone|risperidone
1657558|NCT00158028|Treatment|treatment
1657559|NCT00158028|Cognitive|cognitive
1657560|NCT00158015|Echocardiography|echocardiography
1657561|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
1657562|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1657563|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
1657564|NCT00158002|Prophylaxis|prophylaxis
1657565|NCT00157989|Infant, Premature|infant, premature
1657566|NCT00157976|Macular Degeneration|macular degeneration
1657567|NCT00157976|AMD|amd
1657568|NCT00157976|Visual Acuity|visual acuity
1657569|NCT00157950|Human Papilloma Virus|human papilloma virus
1657570|NCT00157885|Falciparum|falciparum
1657571|NCT00157885|Vivax|vivax
1657572|NCT00157885|Papua|papua
1657573|NCT00157885|Amodiaquine|amodiaquine
1657574|NCT00157885|Artekin|artekin
1657575|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
1657576|NCT00157885|Dihydroartemisinin|dihydroartemisinin
1657577|NCT00157885|Piperaquine|piperaquine
1657578|NCT00157885|Lumefantrine|lumefantrine
1657579|NCT00157885|Artemether|artemether
1657580|NCT00157859|Falciparum|falciparum
1657581|NCT00157859|Vivax|vivax
1657582|NCT00157859|Papua|papua
1657583|NCT00157859|Chloroquine|chloroquine
1657584|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1657585|NCT00157846|Heart Failure|heart failure
1657586|NCT00157846|LVEF < 35%|lvef < 35%
1657587|NCT00157846|Bradycardia|bradycardia
1657588|NCT00157833|Coartemether|coartemether
1657589|NCT00157833|Artekin|artekin
1657590|NCT00157833|Papua|papua
1657591|NCT00157833|Uncomplicated malaria|uncomplicated malaria
1657592|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
1657593|NCT00157820|Atrial Fibrillation|atrial fibrillation
1657594|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
1657595|NCT00157820|Clinical Trial|clinical trial
1657596|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
1657597|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
1657598|NCT00157807|Mitral Valve Defect|mitral valve defect
1657599|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
1657600|NCT00157807|Aortic Valve Defect|aortic valve defect
1657601|NCT00157794|Sinus Node Disease|sinus node disease
1657602|NCT00157794|Pacemaker|pacemaker
1657603|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
1657604|NCT00157781|Atrial Fibrillation|atrial fibrillation
1657605|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
1657606|NCT00157781|Pacing|pacing
1657607|NCT00157781|Electrophysiology|electrophysiology
1657608|NCT00157768|Acute myocardial infarction|acute myocardial infarction
1657609|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
1657610|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
1657611|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
1657612|NCT00157768|ICD|icd
1657613|NCT00157768|Risk-stratification|risk-stratification
1657614|NCT00157755|Nausea and Vomiting|nausea and vomiting
1657615|NCT00157742|Angina Pectoris|angina pectoris
1657616|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
1657617|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
1657618|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
1657619|NCT00157729|Hypertension|hypertension
1657620|NCT00157729|antihypertensive agents|antihypertensive agents
1657621|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
1657622|NCT00157729|metabolic syndrome|metabolic syndrome
1657623|NCT00157716|Coronary|coronary
1657626|NCT00157716|reperfusion injury|reperfusion injury
1657627|NCT00157716|cardiac|cardiac
1657628|NCT00157716|heart|heart
1657629|NCT00157716|neurological|neurological
1657630|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
1657631|NCT00157716|cardioprotection|cardioprotection
1657632|NCT00157703|Malignant glioma|malignant glioma
1657633|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
1657634|NCT00157703|GBM|gbm
1657635|NCT00157703|Gliosarcoma|gliosarcoma
1657636|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
1657637|NCT00157703|Brain cancer|brain cancer
1657638|NCT00157703|Brain tumor|brain tumor
1657639|NCT00157703|Glioma|glioma
1657640|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
1657641|NCT00157690|Alendronate|alendronate
1657642|NCT00157690|Bisphosphonates|bisphosphonates
1657643|NCT00157690|Cystic Fibrosis|cystic fibrosis
1657644|NCT00157690|Osteoporosis|osteoporosis
1657645|NCT00157677|deep vein thrombosis|deep vein thrombosis
1657646|NCT00157677|pulmonary embolism|pulmonary embolism
1657647|NCT00157677|D-dimer testing|d-dimer testing
1657648|NCT00157651|end stage renal disease|end stage renal disease
1657649|NCT00157651|thrombosis|thrombosis
1657650|NCT00157651|bleeding|bleeding
1657651|NCT00157638|pharmacist|pharmacist
1657652|NCT00157638|physician|physician
1657653|NCT00157638|primary care|primary care
1657654|NCT00157638|collaboration|collaboration
1657655|NCT00157638|therapeutics|therapeutics
1657656|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
1657657|NCT00157612|pneumonia|pneumonia
1657658|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
1657659|NCT00157612|clinical pathway|clinical pathway
1657660|NCT00157612|nursing home|nursing home
1657661|NCT00157612|long-term care|long-term care
1657662|NCT00157612|randomized control trial|randomized control trial
1657663|NCT00157599|deep vein thrombosis|deep vein thrombosis
1657664|NCT00157599|DVT|dvt
1657665|NCT00157573|Asymptomatic|asymptomatic
1657666|NCT00157573|Clinical trial|clinical trial
1657667|NCT00157573|Phase II|phase ii
1657668|NCT00157573|GM-CSF|gm-csf
1657669|NCT00157573|Immunotherapy|immunotherapy
1657670|NCT00157547|Depression|depression
1657671|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
1657672|NCT00157547|Antidepressants|antidepressants
1657673|NCT00157534|Hepatitis C|hepatitis c
1657674|NCT00157534|Celgosivir|celgosivir
1657675|NCT00157534|HCV|hcv
1657676|NCT00157534|Genotype 1|genotype 1
1657677|NCT00157378|first episode,|first episode,
1657678|NCT00157378|schizophrenia,|schizophrenia,
1657679|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
1657680|NCT00157378|negative symptoms|negative symptoms
1657681|NCT00157326|High Blood Pressure|high blood pressure
1657682|NCT00157313|Schizophrenia|schizophrenia
1657683|NCT00157313|First episode psychosis|first episode psychosis
1657684|NCT00157313|Psychosocial intervention|psychosocial intervention
1657685|NCT00157300|erythropoietin|erythropoietin
1657686|NCT00157300|kidney transplantation|kidney transplantation
1657687|NCT00157300|delayed graft function|delayed graft function
1657688|NCT00157274|Alemtuzumab|alemtuzumab
1657689|NCT00157274|Mycosis fungoides|mycosis fungoides
1657690|NCT00157274|Sezary|sezary
1657691|NCT00157222|Charcot|charcot
1657692|NCT00157222|Diabetic|diabetic
1657693|NCT00157222|osteoporosis|osteoporosis
1657694|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
1657695|NCT00157183|cystic fibrosis|cystic fibrosis
1657696|NCT00157183|hypoxia|hypoxia
1657697|NCT00157183|oxygen|oxygen
1657698|NCT00157183|noninvasive ventilation|noninvasive ventilation
1657699|NCT00157183|quality of life|quality of life
1657700|NCT00157170|exercise|exercise
1657701|NCT00157170|self efficacy|self efficacy
1657702|NCT00157170|quality of life|quality of life
1657703|NCT00157170|HIV|hiv
1657704|NCT00157157|Factor VIII Deficiency|factor viii deficiency
1657705|NCT00157144|Lung Transplantation|lung transplantation
1657706|NCT00157144|Heart Transplantation|heart transplantation
1657707|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
1657708|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
1657709|NCT00157131|skin grafts|skin grafts
1657710|NCT00157131|burn|burn
1657711|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
1657712|NCT00157079|PID|pid
1657713|NCT00157079|Immunodeficiency|immunodeficiency
1657714|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
1657715|NCT00157079|Kawasaki syndrome|kawasaki syndrome
1657716|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
1657717|NCT00157066|Active tuberculosis infection|active tuberculosis infection
1657718|NCT00157053|Factor VIII Deficiency|factor viii deficiency
1657719|NCT00157040|Factor VIII Deficiency|factor viii deficiency
1657720|NCT00157027|Treatment Experienced|treatment experienced
1657721|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
1657722|NCT00157027|Confirmed by Western Blot|confirmed by western blot
1657723|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
1657724|NCT00157014|Antirejection|antirejection
1657725|NCT00157014|Treatment Outcome|treatment outcome
1657726|NCT00157014|Immunosuppression|immunosuppression
1657727|NCT00157014|Treatment Effectiveness|treatment effectiveness
1657728|NCT00157014|Anti-rejection therapy|anti-rejection therapy
1657729|NCT00156988|burns|burns
1657730|NCT00156988|partial thickness|partial thickness
1657731|NCT00156988|cerium flamazine|cerium flamazine
1657732|NCT00156988|randomised clinical trial|randomised clinical trial
1657733|NCT00156975|Oxaliplatin|oxaliplatin
1657734|NCT00156975|Capecitabine|capecitabine
1657735|NCT00156975|Chemotherapy|chemotherapy
1657736|NCT00156975|Resection|resection
1657737|NCT00156975|Liver metastases|liver metastases
1657738|NCT00156975|Liver resection|liver resection
1657739|NCT00156975|Adjuvant|adjuvant
1657740|NCT00156962|Epogen|epogen
1657741|NCT00156962|Procrit|procrit
1657742|NCT00156962|Chronic Kidney Disease|chronic kidney disease
1657743|NCT00156962|Anemia Treatment|anemia treatment
1657744|NCT00156949|Epogen|epogen
1657745|NCT00156949|Procrit|procrit
1657746|NCT00156949|Chronic Kidney Disease|chronic kidney disease
1657747|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
1657748|NCT00156923|Alcohol dependence|alcohol dependence
1657749|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
1657750|NCT00156897|NIDDM|niddm
1657751|NCT00156897|Type II diabetes|type ii diabetes
1657752|NCT00156897|Obesity|obesity
1657753|NCT00156897|Lipase inhibitor|lipase inhibitor
1657754|NCT00156884|prostate cancer|prostate cancer
1657756|NCT00156884|strontium-89|strontium-89
1657757|NCT00156884|phase II|phase ii
1657758|NCT00156871|transplant|transplant
1657760|NCT00156871|exercise|exercise
1657761|NCT00156871|Malignant disease|malignant disease
1657762|NCT00156858|pharmacokinetics|pharmacokinetics
1657763|NCT00156858|transplantation|transplantation
1657764|NCT00156858|busulfan|busulfan
1657765|NCT00156845|coronary artery disease|coronary artery disease
1657766|NCT00156845|ischemia|ischemia
1657767|NCT00156845|echocardiography|echocardiography
1657768|NCT00156845|cardiac imaging|cardiac imaging
1657769|NCT00156845|heart disease|heart disease
1657770|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
1657771|NCT00156845|myocardial perfusion|myocardial perfusion
1657772|NCT00156845|wall motion|wall motion
1657773|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
1657774|NCT00156819|Asthma|asthma
1657775|NCT00156819|Asthma Control|asthma control
1657776|NCT00156806|aloe|aloe
1657777|NCT00156806|radiation dermatitis|radiation dermatitis
1657778|NCT00156806|radiation therapy|radiation therapy
1657779|NCT00156793|coronary artery disease|coronary artery disease
1657780|NCT00156793|ischemia|ischemia
1657781|NCT00156793|echocardiography|echocardiography
1657782|NCT00156793|cardiac imaging|cardiac imaging
1657783|NCT00156793|heart disease|heart disease
1657784|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
1657785|NCT00156793|myocardial perfusion|myocardial perfusion
1657786|NCT00156793|wall motion|wall motion
1657787|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
1657788|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
1657789|NCT00156780|pharmacokinetics|pharmacokinetics
1657790|NCT00156780|congestive heart failure|congestive heart failure
1657791|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1657792|NCT00156780|safety|safety
1657793|NCT00156767|Critical Care|critical care
1657794|NCT00156767|Adrenal Insufficiency|adrenal insufficiency
1657795|NCT00156767|Septic Shock|septic shock
1657796|NCT00156767|Cortrosyn|cortrosyn
1657797|NCT00156767|Steroids|steroids
1657798|NCT00156767|Cortisol|cortisol
1657799|NCT00156767|Critical Care Unit|critical care unit
1657800|NCT00156767|Adrenal Gland Function|adrenal gland function
1657801|NCT00156741|Refined ventricular pacing|refined ventricular pacing
1657802|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
1657803|NCT00156715|Quetiapine|quetiapine
1657804|NCT00156715|Seroquel|seroquel
1657805|NCT00156715|Schizophrenia|schizophrenia
1657806|NCT00156715|Dual Diagnosis|dual diagnosis
1657807|NCT00156715|Substance Abuse|substance abuse
1657808|NCT00156715|Alcohol Abuse|alcohol abuse
1657809|NCT00156702|Smoking|smoking
1657810|NCT00156702|Adolescents|adolescents
1657811|NCT00156702|Motivational Interviewing|motivational interviewing
1657812|NCT00156689|polyneuropathy|polyneuropathy
1657813|NCT00156676|Disability|disability
1657814|NCT00156676|Gait|gait
1657815|NCT00156676|Multiple Sclerosis|multiple sclerosis
1657816|NCT00156676|Rehabilitation|rehabilitation
1657817|NCT00156676|Robot|robot
1657818|NCT00156663|Women|women
1657819|NCT00156663|Veterans|veterans
1657820|NCT00156663|Delivery of Healthcare|delivery of healthcare
1657821|NCT00156663|Intervention Studies|intervention studies
1657822|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
1657823|NCT00156663|Women's Health|women's health
1657824|NCT00156650|Male contraception|male contraception
1657825|NCT00156650|Testosterone|testosterone
1657826|NCT00156637|schizophrenia|schizophrenia
1657827|NCT00156637|quality of health care|quality of health care
1657828|NCT00156637|quality indicators|quality indicators
1657829|NCT00156637|intervention studies|intervention studies
1657830|NCT00156624|Intervention|intervention
1657831|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
1657832|NCT00156624|Drug|drug
1657833|NCT00156624|Restenosis|restenosis
1657834|NCT00156624|18 years and above|18 years and above
1657835|NCT00156611|peripheral vascular disease|peripheral vascular disease
1657836|NCT00156611|intervention|intervention
1657837|NCT00156611|restenosis|restenosis
1657838|NCT00156611|Age above 18 years|age above 18 years
1657839|NCT00156598|metal ion concentration|metal ion concentration
1657840|NCT00156585|cerebral metastases|cerebral metastases
1657841|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
1657842|NCT00156585|DCE-MRI|dce-mri
1657843|NCT00156585|gamma knife|gamma knife
1657844|NCT00156559|immunization|immunization
1657845|NCT00156559|vaccine|vaccine
1657846|NCT00156559|low birth weight infant|low birth weight infant
1657847|NCT00156559|premature infant|premature infant
1657848|NCT00156546|Urinary tract infections|urinary tract infections
1657849|NCT00156546|Children|children
1657850|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
1657851|NCT00156546|Renal scintigraphy|renal scintigraphy
1657852|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
1657853|NCT00156533|Insomnia|insomnia
1657854|NCT00156533|Sleep|sleep
1657859|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
1657860|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1657861|NCT00156455|Single Ventricle Physiology|single ventricle physiology
1657862|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
1657863|NCT00156442|Cleft lip/palate|cleft lip/palate
1657864|NCT00156442|Children|children
1657865|NCT00156429|genetic testing|genetic testing
1657866|NCT00156416|menopause|menopause
1657867|NCT00156416|hot flash|hot flash
1657868|NCT00156416|night sweat|night sweat
1657869|NCT00156416|meditation|meditation
1657870|NCT00156416|breast cancer|breast cancer
1657871|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
1657872|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
1657873|NCT00156403|pilot study|pilot study
1657874|NCT00156377|Mupirocin|mupirocin
1657875|NCT00156377|Staphylococcus aureus|staphylococcus aureus
1657876|NCT00156377|Nasal Cavity|nasal cavity
1657877|NCT00156377|Preventive measures|preventive measures
1657878|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
1657879|NCT00156364|Kidney Transplant|kidney transplant
1657880|NCT00156364|Pancreas Transplant|pancreas transplant
1657881|NCT00156364|Renal Interstitium|renal interstitium
1657882|NCT00156364|Diabetes Mellitus|diabetes mellitus
1657883|NCT00156364|Cyclosporine|cyclosporine
1657884|NCT00156364|Tacrolimus|tacrolimus
1657885|NCT00156351|African Americans|african americans
1657887|NCT00156351|Internet|internet
1657888|NCT00156351|Telephone Counseling|telephone counseling
1657889|NCT00156338|Fluid therapy|fluid therapy
1657890|NCT00156325|Bipolar Disorder|bipolar disorder
1657891|NCT00156325|Depression|depression
1657892|NCT00156325|Hypomania|hypomania
1657893|NCT00156325|Mood Stabilizer|mood stabilizer
1657894|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1657895|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1657896|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1657897|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1657898|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1657899|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1657900|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1657901|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1658189|NCT00154895|minocycline|minocycline
1657902|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1657903|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1657904|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1657905|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1657906|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1657907|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1657908|NCT00156247|psoriasis|psoriasis
1657909|NCT00156247|etanercept|etanercept
1657910|NCT00156247|acitretin|acitretin
1657911|NCT00156221|Autism|autism
1657912|NCT00156221|MRI|mri
1657913|NCT00156221|Developmental Disorders|developmental disorders
1657914|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1657915|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
1657916|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
1657917|NCT00156208|asoprisnil|asoprisnil
1657918|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1657919|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
1657920|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
1657921|NCT00156195|asoprisnil|asoprisnil
1657922|NCT00156182|Fibroid Uterus|fibroid uterus
1657923|NCT00156182|Leiomyoma|leiomyoma
1657924|NCT00156182|Uterine Fibroids|uterine fibroids
1657925|NCT00156182|asoprisnil|asoprisnil
1657926|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1657927|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
1657928|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
1657929|NCT00156130|Breast Cancer|breast cancer
1657930|NCT00156130|Lumpectomy|lumpectomy
1657931|NCT00156130|Radiotherapy|radiotherapy
1657932|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1657933|NCT00156130|Long Term Outcomes|long term outcomes
1657934|NCT00156052|Breast Cancer|breast cancer
1657935|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
1657936|NCT00156052|Lumpectomy|lumpectomy
1657937|NCT00156039|Breast Cancer|breast cancer
1657938|NCT00156039|Follow-up Strategy|follow-up strategy
1657939|NCT00156039|Follow-up Care|follow-up care
1657940|NCT00156039|Family Physician|family physician
1657941|NCT00156039|Oncologist|oncologist
1657942|NCT00156026|CIN 1|cin 1
1657943|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1657944|NCT00156026|cervix|cervix
1657945|NCT00156026|cancer|cancer
1657946|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
1657947|NCT00156026|LEEP|leep
1657948|NCT00156026|expectant management|expectant management
1657949|NCT00156026|human papilloma virus|human papilloma virus
1657951|NCT00156026|colposcopy|colposcopy
1657952|NCT00156013|B-Cell NHL|b-cell nhl
1657953|NCT00156000|Preterm Delivery|preterm delivery
1657954|NCT00156000|Multifetal pregnancy|multifetal pregnancy
1657955|NCT00156000|Preterm Birth|preterm birth
1657956|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
1657957|NCT00156000|Markers of Preterm Birth|markers of preterm birth
1657958|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
1657959|NCT00155974|Influenza|influenza
1657960|NCT00155974|Vaccination|vaccination
1657961|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
1657962|NCT00155974|Urban|urban
1657963|NCT00155974|Disadvantaged|disadvantaged
1657964|NCT00155961|Androgens|androgens
1657965|NCT00155961|Metabolic syndrome|metabolic syndrome
1657966|NCT00155961|Bone mineral density|bone mineral density
1657967|NCT00155961|Body composition|body composition
1657968|NCT00155961|Questionnaire|questionnaire
1657969|NCT00155948|Ultrasonography|ultrasonography
1657970|NCT00155948|Cervical Multifidus|cervical multifidus
1657971|NCT00155935|ovarian cancer|ovarian cancer
1657972|NCT00155935|immunotherapy|immunotherapy
1657973|NCT00155935|folate receptor|folate receptor
1657974|NCT00155935|Chemotherapy|chemotherapy
1657975|NCT00155922|Diabetes mellitus|diabetes mellitus
1657976|NCT00155922|Monocyte|monocyte
1657977|NCT00155922|Gene expression|gene expression
1657978|NCT00155922|Monocyte gene expression|monocyte gene expression
1657979|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
1657980|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
1657981|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
1657982|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
1657983|NCT00155870|adenomyosis|adenomyosis
1657984|NCT00155870|quality of life|quality of life
1657985|NCT00155857|glaucoma, genetic|glaucoma, genetic
1657986|NCT00155831|Premature infants|premature infants
1657987|NCT00155831|Kicking|kicking
1657988|NCT00155831|Stepping|stepping
1657989|NCT00155831|Walking|walking
1657990|NCT00155831|Motor development|motor development
1657991|NCT00155831|Kinematics|kinematics
1657992|NCT00155818|DISC1|disc1
1657993|NCT00155818|Schizophrenia|schizophrenia
1657994|NCT00155818|Chromosome 1q|chromosome 1q
1657995|NCT00155818|Polymorphism detection|polymorphism detection
1657996|NCT00155818|Association study|association study
1657997|NCT00155818|Balanced translocation|balanced translocation
1657998|NCT00155818|DHPLC|dhplc
1657999|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
1658000|NCT00155805|reflux esophagitis|reflux esophagitis
1658001|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
1658002|NCT00155805|Barrett’s esophagus|barrett’s esophagus
1658003|NCT00155805|hiatus hernia|hiatus hernia
1658004|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
1658005|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
1658006|NCT00155805|Helicobacter pylori|helicobacter pylori
1658007|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
1658008|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
1658009|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
1658010|NCT00155779|polymorphism|polymorphism
1658011|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
1658012|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
1658013|NCT00155740|ovarian cancer|ovarian cancer
1658014|NCT00155740|tumor marker|tumor marker
1658015|NCT00155740|mesothelin|mesothelin
1658016|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
1658017|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
1658018|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
1658019|NCT00155714|Sildenafil|sildenafil
1658020|NCT00155701|DISC1|disc1
1658021|NCT00155701|Schizophrenia|schizophrenia
1658022|NCT00155701|Chromosome 1q|chromosome 1q
1658023|NCT00155701|Polymorphism detection|polymorphism detection
1658024|NCT00155701|Association study|association study
1658025|NCT00155701|Balanced translocation|balanced translocation
1658026|NCT00155701|DHPLC|dhplc
1658027|NCT00155688|Schizophrenia|schizophrenia
1658028|NCT00155688|linkage|linkage
1658029|NCT00155688|Taiwan|taiwan
1658030|NCT00155688|Han Chinese population|han chinese population
1658031|NCT00155662|work hardening|work hardening
1658032|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
1658033|NCT00155649|schizophrenia|schizophrenia
1658034|NCT00155649|vulnerability gene|vulnerability gene
1658035|NCT00155649|positional cloning|positional cloning
1658036|NCT00155649|subtype definition|subtype definition
1658037|NCT00155649|endophenotype|endophenotype
1658038|NCT00155649|genetic marker|genetic marker
1658039|NCT00155649|genetic linkage|genetic linkage
1658040|NCT00155649|candidate genes|candidate genes
1658041|NCT00155636|Schizophrenia|schizophrenia
1658042|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
1658043|NCT00155610|diabetic cystopathy|diabetic cystopathy
1658044|NCT00155610|bladder|bladder
1658045|NCT00155610|voiding dysfunction|voiding dysfunction
1658046|NCT00155610|current perception test|current perception test
1658047|NCT00155597|physical therapy|physical therapy
1658048|NCT00155597|post surgery|post surgery
1658049|NCT00155584|warts|warts
1658050|NCT00155584|photodynamic therapy|photodynamic therapy
1658051|NCT00155584|5-ALA|5-ala
1658052|NCT00155571|betel nut|betel nut
1658053|NCT00155571|periodontitis|periodontitis
1658054|NCT00155571|periodontal microbiology|periodontal microbiology
1658055|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
1658056|NCT00155545|functional scoliosis|functional scoliosis
1658057|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
1658058|NCT00155545|leg length discrepancy|leg length discrepancy
1658059|NCT00155545|motion analysis|motion analysis
1658060|NCT00155545|biomechanics|biomechanics
1658061|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
1658062|NCT00155519|Schizophrenia|schizophrenia
1658063|NCT00155519|Latent Schizophrenia|latent schizophrenia
1658064|NCT00155519|Schizotypal Disorder|schizotypal disorder
1658065|NCT00155519|Psychopathology|psychopathology
1658066|NCT00155519|Neuropsychological Function|neuropsychological function
1658067|NCT00155519|Family History|family history
1658068|NCT00155519|Nosology|nosology
1658069|NCT00155519|basic symptoms|basic symptoms
1658070|NCT00155506|Schizophrenia|schizophrenia
1658071|NCT00155506|Niacin|niacin
1658072|NCT00155506|Genotyping|genotyping
1658073|NCT00155506|candidate gene|candidate gene
1658074|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
1658075|NCT00155480|thoracic aorta|thoracic aorta
1658076|NCT00155480|finite element mesh|finite element mesh
1658077|NCT00155467|CT|ct
1658078|NCT00155467|children|children
1658079|NCT00155467|congenital|congenital
1658080|NCT00155454|Diabetic retinopathy|diabetic retinopathy
1658081|NCT00155454|Vitrectomy|vitrectomy
1658082|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
1658083|NCT00155454|Intravitreal gas injection|intravitreal gas injection
1658084|NCT00155441|sleep disorder|sleep disorder
1658085|NCT00155441|peritoneal dialysis|peritoneal dialysis
1658086|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
1658087|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
1658088|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
1658089|NCT00155428|biomodel|biomodel
1658090|NCT00155428|rapid prototyping|rapid prototyping
1658091|NCT00155428|computed tomograpgy|computed tomograpgy
1658092|NCT00155415|Colonoscopy|colonoscopy
1658093|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
1658094|NCT00155415|Colon neoplasm|colon neoplasm
1658095|NCT00155415|Colon cleansing|colon cleansing
1658096|NCT00155415|Timing|timing
1658097|NCT00155402|fibrin glue|fibrin glue
1658098|NCT00155402|corneal perforation|corneal perforation
1658099|NCT00155402|pterygium|pterygium
1658100|NCT00155402|conjunctiva|conjunctiva
1658101|NCT00155402|corneal ulcer|corneal ulcer
1658102|NCT00155389|Helicobacter pylori|helicobacter pylori
1658103|NCT00155389|Gastric cancer|gastric cancer
1658104|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
1658105|NCT00155350|atherosclerosis|atherosclerosis
1658106|NCT00155350|calcification|calcification
1658107|NCT00155350|coronary|coronary
1658108|NCT00155350|inflammation|inflammation
1658109|NCT00155350|insulin|insulin
1658110|NCT00155350|plaque|plaque
1658111|NCT00155350|Coronary calcification|coronary calcification
1658112|NCT00155350|Plaque vulnerability|plaque vulnerability
1658113|NCT00155337|leukoplakia|leukoplakia
1658114|NCT00155337|erythroleukoplakia|erythroleukoplakia
1658115|NCT00155337|photodynamic therapy|photodynamic therapy
1658116|NCT00155324|plantar fasciitis|plantar fasciitis
1658117|NCT00155324|ultrasonographic examination|ultrasonographic examination
1658118|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
1658120|NCT00155311|RANKL|rankl
1658121|NCT00155285|heart diseases|heart diseases
1658122|NCT00155285|congenital|congenital
1658123|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
1658124|NCT00155272|Radiotherapy|radiotherapy
1658125|NCT00155272|Thalidomide|thalidomide
1658126|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
1658127|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
1658128|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
1658129|NCT00155233|analgeisa|analgeisa
1658130|NCT00155233|postoperatve|postoperatve
1658131|NCT00155233|side effects|side effects
1658132|NCT00155207|Schizophrenia|schizophrenia
1658133|NCT00155207|endophenotype|endophenotype
1658134|NCT00155207|risk genetic mutation|risk genetic mutation
1658135|NCT00155207|vulnerability genes|vulnerability genes
1658136|NCT00155207|affected sib-pairs|affected sib-pairs
1658137|NCT00155207|case-control design|case-control design
1658138|NCT00155207|animal model|animal model
1658139|NCT00155207|functional validity|functional validity
1658140|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
1658141|NCT00155181|Epstein-Barr virus|epstein-barr virus
1658142|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
1658143|NCT00155181|Carcinogenesis|carcinogenesis
1658144|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
1658145|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
1658146|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
1658147|NCT00155168|multiplex PCR|multiplex pcr
1658148|NCT00155168|gene dose|gene dose
1658149|NCT00155168|carrier test|carrier test
1658150|NCT00155129|migraine|migraine
1658151|NCT00155129|CGRP|cgrp
1658152|NCT00155129|nociceptin|nociceptin
1658153|NCT00155103|Hepatitis B|hepatitis b
1658154|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1658155|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
1658156|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
1658157|NCT00155090|breast disease|breast disease
1658158|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
1658159|NCT00155064|Primary aldosteronism|primary aldosteronism
1658160|NCT00155064|kallikrein|kallikrein
1658161|NCT00155064|aldosterone|aldosterone
1658162|NCT00155064|captopril|captopril
1658163|NCT00155038|Breast neoplasms|breast neoplasms
1658164|NCT00155038|breast radiography|breast radiography
1658165|NCT00155038|young women.|young women.
1658166|NCT00155025|Prostatic neoplasms|prostatic neoplasms
1658167|NCT00155025|Family history|family history
1658168|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
1658169|NCT00154999|free radicals|free radicals
1658170|NCT00154999|Health neonate|health neonate
1658171|NCT00154986|invasion|invasion
1658172|NCT00154986|migration|migration
1658173|NCT00154986|metastasis|metastasis
1658174|NCT00154986|IGFBP-3|igfbp-3
1658175|NCT00154986|transfection|transfection
1658176|NCT00154986|signal transduction.|signal transduction.
1658177|NCT00154973|oral precancers|oral precancers
1658178|NCT00154973|oral cancer|oral cancer
1658179|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
1658180|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
1658181|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
1658182|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
1658183|NCT00154960|multiplex PCR|multiplex pcr
1658184|NCT00154960|gene dose|gene dose
1658185|NCT00154960|carrier test|carrier test
1658186|NCT00154960|screen|screen
1658187|NCT00154960|stool|stool
1658188|NCT00154960|microsatellite|microsatellite
1658190|NCT00154895|pleurodesis|pleurodesis
1658191|NCT00154895|thoracoscopy|thoracoscopy
1658192|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
1658193|NCT00154895|clinical trial|clinical trial
1658194|NCT00154882|Breast Cancer|breast cancer
1658195|NCT00154882|First-line|first-line
1658196|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
1658197|NCT00154856|osteogenesis|osteogenesis
1658198|NCT00154856|Ilizarov fixator|ilizarov fixator
1658199|NCT00154856|motion analysis|motion analysis
1658201|NCT00154856|bone stress|bone stress
1658202|NCT00154843|Lycopene|lycopene
1658203|NCT00154843|BPH|bph
1658204|NCT00154843|PSA|psa
1658205|NCT00154843|IPSS|ipss
1658206|NCT00154817|radiotherapy|radiotherapy
1658207|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
1658208|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
1658209|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
1658210|NCT00154804|Esophageal Cancer|esophageal cancer
1658211|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
1658212|NCT00154791|Oxaliplatin|oxaliplatin
1658213|NCT00154791|Gemcitabine|gemcitabine
1658214|NCT00154791|5-FU|5-fu
1658393|NCT00153998|Cetuximab|cetuximab
1658215|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
1658216|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
1658217|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
1658218|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
1658219|NCT00154713|colorectal cancer|colorectal cancer
1658220|NCT00154713|dendritic cell|dendritic cell
1658221|NCT00154713|CEA|cea
1658222|NCT00154713|IL-2|il-2
1658223|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
1658224|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
1658225|NCT00154661|glomerulonephritis|glomerulonephritis
1658226|NCT00154648|MRA|mra
1658227|NCT00154648|DSA|dsa
1658228|NCT00154648|gadovist|gadovist
1658229|NCT00154648|angiography|angiography
1658230|NCT00154635|Alzheimer's disease|alzheimer's disease
1658231|NCT00154635|Fo-ti|fo-ti
1658232|NCT00154635|Chinese herbs|chinese herbs
1658233|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
1658234|NCT00154596|etiology|etiology
1658235|NCT00154596|transmission|transmission
1658236|NCT00154596|vasculitis|vasculitis
1658238|NCT00154596|etiology of disease|etiology of disease
1658239|NCT00154583|cervical cancer|cervical cancer
1658240|NCT00154583|human papillomavirus|human papillomavirus
1658241|NCT00154583|cancer vaccine|cancer vaccine
1658242|NCT00154583|normal volunteer|normal volunteer
1658243|NCT00154570|reflux esophagitis|reflux esophagitis
1658244|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
1658245|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
1658246|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
1658247|NCT00154557|Judo, Performance, Injury|judo, performance, injury
1658248|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
1658249|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
1658250|NCT00154518|Orthodontics|orthodontics
1658251|NCT00154505|Scoliosis|scoliosis
1658252|NCT00154505|Spinal Cord Injury|spinal cord injury
1658253|NCT00154505|Lateral Trunk Support|lateral trunk support
1658254|NCT00154505|Radiography|radiography
1658255|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
1658256|NCT00154479|Cervical cancer|cervical cancer
1658257|NCT00154479|Human papillomavirus|human papillomavirus
1658258|NCT00154479|Human leukocyte antigen|human leukocyte antigen
1658259|NCT00154479|immunologic response|immunologic response
1658260|NCT00154479|healthy volunteers|healthy volunteers
1658261|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
1658262|NCT00154453|Aging|aging
1658263|NCT00154453|Orbicularis oculi|orbicularis oculi
1658264|NCT00154453|Blepharoplasty|blepharoplasty
1658265|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
1658266|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
1658267|NCT00154440|Helicobacter pylori|helicobacter pylori
1658268|NCT00154440|eradication therapy|eradication therapy
1658269|NCT00154440|radiation|radiation
1658270|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
1658271|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
1658272|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
1658273|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
1658274|NCT00154388|adenocarcinoma|adenocarcinoma
1658275|NCT00154388|leiomyosarcoma|leiomyosarcoma
1658276|NCT00154388|angiosarcoma|angiosarcoma
1658277|NCT00154388|synovial sarcoma|synovial sarcoma
1658278|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
1658279|NCT00154388|CMML|cmml
1658280|NCT00154388|multiple myeloma|multiple myeloma
1658281|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
1658282|NCT00154388|endometrial sarcoma|endometrial sarcoma
1658283|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
1658284|NCT00154388|fibromatosis|fibromatosis
1658285|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
1658286|NCT00154388|chondrosarcoma|chondrosarcoma
1658287|NCT00154388|pleural tumor|pleural tumor
1658288|NCT00154388|brenner tumor|brenner tumor
1658289|NCT00154388|ewing sarcoma|ewing sarcoma
1658290|NCT00154388|round cell tumor|round cell tumor
1658291|NCT00154388|seminoma|seminoma
1658292|NCT00154388|thymic carcinoma|thymic carcinoma
1658293|NCT00154388|malignant melanoma|malignant melanoma
1658294|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
1658295|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
1658296|NCT00154388|DFSP|dfsp
1658297|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
1658298|NCT00154388|osteosarcoma|osteosarcoma
1658299|NCT00154388|chorioideal melanoma|chorioideal melanoma
1658300|NCT00154388|hemangiopericytoma|hemangiopericytoma
1658301|NCT00154388|myelofibrosis|myelofibrosis
1658302|NCT00154388|liposarcoma|liposarcoma
1658303|NCT00154388|SCLC|sclc
1658304|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
1658305|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
1658306|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
1658307|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
1658308|NCT00154388|mesothelioma|mesothelioma
1658309|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
1658310|NCT00154388|malignant schwannoma|malignant schwannoma
1658311|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
1658312|NCT00154388|renal cell carcinoma|renal cell carcinoma
1658313|NCT00154388|malignant histocytoma|malignant histocytoma
1658314|NCT00154388|chordoma|chordoma
1658315|NCT00154375|Open label|open label
1658316|NCT00154375|Imatinib mesylate|imatinib mesylate
1658317|NCT00154375|hydroxyurea|hydroxyurea
1658318|NCT00154375|temozolomide|temozolomide
1658319|NCT00154375|resistant|resistant
1658320|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
1658321|NCT00154375|adenocarcinoma|adenocarcinoma
1658322|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
1658323|NCT00154375|astrocytoma|astrocytoma
1658324|NCT00154375|brain tumor|brain tumor
1658325|NCT00154375|brain cancer|brain cancer
1658326|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
1658327|NCT00154349|Ph+ALL|ph+all
1658328|NCT00154349|imatinib mesylate|imatinib mesylate
1658329|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
1658330|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
1658331|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
1658332|NCT00154297|Renal transplantation|renal transplantation
1658333|NCT00154297|everolimus|everolimus
1658334|NCT00154297|immunosuppressants|immunosuppressants
1658335|NCT00154297|wound-healing|wound-healing
1658336|NCT00154284|Renal transplantation,|renal transplantation,
1658337|NCT00154284|everolimus,|everolimus,
1658338|NCT00154284|immunosuppressants,|immunosuppressants,
1658339|NCT00154284|basiliximab,|basiliximab,
1658340|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
1658341|NCT00154271|Hypertension (HTN)|hypertension (htn)
1658342|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
1658343|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
1658344|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
1658345|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
1658346|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
1658347|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
1658348|NCT00154206|de novo,|de novo,
1658349|NCT00154206|renal transplantation,|renal transplantation,
1658350|NCT00154206|pediatric|pediatric
1658351|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
1658352|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
1658353|NCT00154180|Perimenopause|perimenopause
1658354|NCT00154180|Coronary Disease|coronary disease
1658355|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
1658356|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
1658357|NCT00154154|borderline personality disorder|borderline personality disorder
1658358|NCT00154154|BPD|bpd
1658359|NCT00154154|treatment|treatment
1658360|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
1658361|NCT00154154|DBT|dbt
1658362|NCT00154154|general Psychiatric management|general psychiatric management
1658363|NCT00154154|GPM|gpm
1658364|NCT00154154|suicide|suicide
1658365|NCT00154154|parasuicide|parasuicide
1658366|NCT00154154|randomized control trials|randomized control trials
1658367|NCT00154128|temporomandibular disorder|temporomandibular disorder
1658571|NCT00153218|Her2neu|her2neu
1658368|NCT00154128|craniomandibular disorder|craniomandibular disorder
1658369|NCT00154128|occlusal appliance|occlusal appliance
1658370|NCT00154128|clinical trial|clinical trial
1658371|NCT00154115|heart failure|heart failure
1658372|NCT00154115|levosimendan|levosimendan
1658373|NCT00154115|cardiac surgery|cardiac surgery
1658374|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
1658375|NCT00154102|EGFR|egfr
1658376|NCT00154102|Irinotecan|irinotecan
1658377|NCT00154102|cetuximab|cetuximab
1658378|NCT00154102|first-line treatment|first-line treatment
1658379|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1658380|NCT00154089|CIN|cin
1658381|NCT00154089|HPV|hpv
1658382|NCT00154050|restenosis|restenosis
1658383|NCT00154050|intima hyperproliferation|intima hyperproliferation
1658384|NCT00154050|stent angioplasty|stent angioplasty
1658385|NCT00154050|pain-free walking distance|pain-free walking distance
1658386|NCT00154037|vascular reactivity|vascular reactivity
1658387|NCT00154037|venodilation|venodilation
1658388|NCT00154037|pulse wave velocity|pulse wave velocity
1658389|NCT00154024|venoconstriction|venoconstriction
1658390|NCT00154024|venodilation|venodilation
1658391|NCT00154024|pleiotropic effects|pleiotropic effects
1658392|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
1658395|NCT00153998|Irinotecan|irinotecan
1658396|NCT00153998|5-FU|5-fu
1658397|NCT00153998|Chemotherapy|chemotherapy
1658398|NCT00153998|Resection|resection
1658399|NCT00153998|Liver resection|liver resection
1658400|NCT00153998|Neoadjuvant|neoadjuvant
1658401|NCT00153985|Hemoglobinopathies|hemoglobinopathies
1658402|NCT00153985|Sickle cell anemia|sickle cell anemia
1658403|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
1658404|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
1658405|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
1658406|NCT00153985|allogeneic transplant|allogeneic transplant
1658407|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
1658408|NCT00153985|Stem cell transfusion|stem cell transfusion
1658409|NCT00153985|graft vs. host disease|graft vs. host disease
1658410|NCT00153972|Parkinson's disease|parkinson's disease
1658411|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
1658412|NCT00153972|Dopamine agonists|dopamine agonists
1658413|NCT00153972|Cabergoline|cabergoline
1658414|NCT00153972|Surrogate marker|surrogate marker
1658415|NCT00153972|Dopamine turnover|dopamine turnover
1658416|NCT00153946|Free Radical Scavenger|free radical scavenger
1658417|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
1658418|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
1658419|NCT00153933|Multiple Myeloma|multiple myeloma
1658420|NCT00153933|bortezomib|bortezomib
1658421|NCT00153933|Revlimid|revlimid
1658422|NCT00153933|CC-5013|cc-5013
1658423|NCT00153920|multiple myeloma|multiple myeloma
1658424|NCT00153920|Velcade|velcade
1658425|NCT00153920|bortezomib|bortezomib
1658426|NCT00153907|Xeloda|xeloda
1658427|NCT00153907|Navelbine|navelbine
1658428|NCT00153907|capecitabine|capecitabine
1658429|NCT00153907|metastatic breast cancer|metastatic breast cancer
1658430|NCT00153894|Breast cancer survivor|breast cancer survivor
1658431|NCT00153894|Insulin levels|insulin levels
1658432|NCT00153894|exercise regimen|exercise regimen
1658433|NCT00153894|endurance training|endurance training
1658434|NCT00153894|strength training|strength training
1658435|NCT00153881|Esophageal Cancer|esophageal cancer
1658436|NCT00153881|Trimodality|trimodality
1658437|NCT00153881|Capecitabine|capecitabine
1658438|NCT00153881|Xeloda|xeloda
1658439|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
1658440|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
1658441|NCT00153868|Anemia|anemia
1658442|NCT00153868|Cancer|cancer
1658443|NCT00153868|Quality of life|quality of life
1658444|NCT00153868|Web-based|web-based
1658445|NCT00153868|Aranesp|aranesp
1658446|NCT00153868|Darbepoetin alfa|darbepoetin alfa
1658447|NCT00153855|etiology|etiology
1658448|NCT00153855|pathology|pathology
1658449|NCT00153842|NSCLC|nsclc
1658450|NCT00153842|Bexarotene|bexarotene
1658451|NCT00153842|Targretin|targretin
1658452|NCT00153829|Chronic Disease|chronic disease
1658453|NCT00153829|Quality of Life|quality of life
1658454|NCT00153816|Colorectal neoplasms|colorectal neoplasms
1658455|NCT00153816|Adenomatous polyps|adenomatous polyps
1658456|NCT00153803|Erlotinib|erlotinib
1658457|NCT00153803|Tarceva|tarceva
1658458|NCT00153803|Web based|web based
1658459|NCT00153803|Stage III NSCLC|stage iii nsclc
1658460|NCT00153790|green tea|green tea
1658461|NCT00153790|weight|weight
1658462|NCT00153790|women|women
1658463|NCT00153777|HIV prevention|hiv prevention
1658464|NCT00153777|Randomized controlled trial|randomized controlled trial
1658465|NCT00153777|Women|women
1658466|NCT00153777|Sexually transmitted infections|sexually transmitted infections
1658467|NCT00153777|HIV Seronegativity|hiv seronegativity
1658468|NCT00153764|supplement|supplement
1658469|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
1658470|NCT00153764|Homocysteine|homocysteine
1658471|NCT00153764|LDL cholesterol|ldl cholesterol
1658472|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
1658473|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
1658474|NCT00153712|Non-NSAID|non-nsaid
1658475|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
1658476|NCT00153699|Side effects|side effects
1658477|NCT00153699|Topiramate|topiramate
1658478|NCT00153686|Capsule Endoscopy|capsule endoscopy
1658479|NCT00153686|Mesenteric angiogram|mesenteric angiogram
1658480|NCT00153673|celecoxib|celecoxib
1658481|NCT00153673|arthritis|arthritis
1658482|NCT00153673|ulcer healing|ulcer healing
1658483|NCT00153634|Cystic fibrosis|cystic fibrosis
1658484|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
1658485|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
1658486|NCT00153634|Chronic bronchitis|chronic bronchitis
1658487|NCT00153634|Biofilms|biofilms
1658488|NCT00153621|Pediatrics|pediatrics
1658489|NCT00153621|Chronic Kidney Failure|chronic kidney failure
1658490|NCT00153621|HIV|hiv
1658491|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1658492|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
1658493|NCT00153595|Allergic rhinitis|allergic rhinitis
1658494|NCT00153595|EWO1|ewo1
1658495|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
1658496|NCT00153556|Carrier state|carrier state
1658497|NCT00153556|Bacterial Vaccines|bacterial vaccines
1658498|NCT00153556|Anti-PRP antibody|anti-prp antibody
1658499|NCT00153556|Antibody avidity|antibody avidity
1658500|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
1658501|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
1658502|NCT00153556|Case control study|case control study
1658503|NCT00153556|Adult vaccines|adult vaccines
1658504|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
1658505|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
1658506|NCT00153517|Metronidazole|metronidazole
1658507|NCT00153504|HIV|hiv
1658508|NCT00153504|AIDS|aids
1658509|NCT00153504|Homeless|homeless
1658510|NCT00153504|Homelessness|homelessness
1658511|NCT00153504|Housing|housing
1658512|NCT00153504|HIV seropositive|hiv seropositive
1658513|NCT00153504|HIV risk behavior|hiv risk behavior
1658514|NCT00153491|malaria|malaria
1658515|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
1658516|NCT00153491|co-artem|co-artem
1658517|NCT00153491|Tanzania|tanzania
1658518|NCT00153491|adherence|adherence
1658519|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
1658520|NCT00153478|Binge drinking|binge drinking
1658521|NCT00153478|Frequent drinking|frequent drinking
1658522|NCT00153478|Unintended pregnancy|unintended pregnancy
1658523|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
1658524|NCT00153465|Parent training|parent training
1658525|NCT00153465|Child maltreatment|child maltreatment
1658526|NCT00153465|Motivation|motivation
1658527|NCT00153465|Program attrition|program attrition
1658528|NCT00153439|parenting|parenting
1658529|NCT00153439|motivation|motivation
1658530|NCT00153439|child maltreatment|child maltreatment
1658531|NCT00153439|program attrition|program attrition
1658532|NCT00153400|CVD risk|cvd risk
1658533|NCT00153361|HIV Seronegativity|hiv seronegativity
1658534|NCT00153361|HIV|hiv
1658535|NCT00153335|Health Risk Assessment|health risk assessment
1658536|NCT00153335|Behavior Change|behavior change
1658537|NCT00153335|Patient-Provider Interaction|patient-provider interaction
1658538|NCT00153335|Employee Health|employee health
1658539|NCT00153335|Absenteeism|absenteeism
1658540|NCT00153335|Tobacco Use|tobacco use
1658541|NCT00153335|Substance Use|substance use
1658542|NCT00153335|Diet|diet
1658543|NCT00153335|Exercise|exercise
1658544|NCT00153335|Medication Adherence|medication adherence
1658545|NCT00153322|Childhood Obesity|childhood obesity
1658546|NCT00153322|Community-based Participatory Research|community-based participatory research
1658547|NCT00153322|School intervention|school intervention
1658548|NCT00153322|Parental Involvement|parental involvement
1658549|NCT00153309|arthritis|arthritis
1658550|NCT00153309|exercise|exercise
1658551|NCT00153309|physical activity|physical activity
1658552|NCT00153309|physical function|physical function
1658553|NCT00153309|pain|pain
1658554|NCT00153296|Bronchial asthma|bronchial asthma
1658555|NCT00153296|Carbamazepine|carbamazepine
1658556|NCT00153296|Antiepileptic drugs|antiepileptic drugs
1658557|NCT00153296|Efficacy|efficacy
1658558|NCT00153283|Bronchial asthma|bronchial asthma
1658559|NCT00153283|Gabapentin|gabapentin
1658560|NCT00153283|Antiepileptic drug|antiepileptic drug
1658561|NCT00153283|Efficacy|efficacy
1658562|NCT00153270|Bronchial asthma|bronchial asthma
1658563|NCT00153270|Sodium valproate|sodium valproate
1658564|NCT00153270|Antiepileptic drug|antiepileptic drug
1658565|NCT00153270|Efficacy|efficacy
1658566|NCT00153244|Bronchial asthma|bronchial asthma
1658567|NCT00153244|Lamotrigine|lamotrigine
1658568|NCT00153244|Antiepileptic drug|antiepileptic drug
1658569|NCT00153244|Efficacy|efficacy
1658570|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
1658572|NCT00153218|trastuzumab|trastuzumab
1658573|NCT00153205|medication errors|medication errors
1658574|NCT00153205|medical records systems, computerized|medical records systems, computerized
1658575|NCT00153205|patient safety|patient safety
1658576|NCT00153192|Marinol|marinol
1658577|NCT00153192|Dronabinol|dronabinol
1658578|NCT00153192|Cannabinoid|cannabinoid
1658579|NCT00153192|Chronic Pain|chronic pain
1658580|NCT00153179|insulin resistance|insulin resistance
1658581|NCT00153179|insulin signaling|insulin signaling
1658582|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
1658583|NCT00153166|peripheral arterial disease|peripheral arterial disease
1658584|NCT00153166|intermittent claudication|intermittent claudication
1658585|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
1658586|NCT00152945|very low density lipoprotein|very low density lipoprotein
1658587|NCT00152945|free fatty acids|free fatty acids
1658588|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
1658589|NCT00152945|triglycerides|triglycerides
1658590|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
1658591|NCT00152932|Glaucoma|glaucoma
1658592|NCT00152932|Intraocular pressure|intraocular pressure
1658593|NCT00152932|Ocular blood flow|ocular blood flow
1658594|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
1658595|NCT00152893|HIV|hiv
1658596|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
1658597|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
1658598|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
1658599|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
1658600|NCT00152867|quality of life|quality of life
1658601|NCT00152867|dexamethasone|dexamethasone
1658602|NCT00152867|emesis|emesis
1658603|NCT00152854|cancer pain|cancer pain
1658604|NCT00152854|acetaminophen|acetaminophen
1658605|NCT00152854|opioids|opioids
1658606|NCT00152815|HIV|hiv
1658607|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1658608|NCT00152802|liver transplant|liver transplant
1658609|NCT00152802|antibody response|antibody response
1658610|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
1658611|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
1658612|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
1658613|NCT00152776|menopausal symptoms|menopausal symptoms
1658614|NCT00152776|complementary medicine|complementary medicine
1658615|NCT00152763|health anxiety|health anxiety
1658616|NCT00152750|Tourette's Syndrome|tourette's syndrome
1658617|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1658618|NCT00152750|Children|children
1658619|NCT00152750|Sleep disorders|sleep disorders
1658621|NCT00152737|Intermittent Claudication|intermittent claudication
1658622|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
1658623|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
1658624|NCT00152737|Surgery|surgery
1658625|NCT00152724|Physiology|physiology
1658626|NCT00152724|Microcirculation|microcirculation
1658627|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
1658628|NCT00152659|Epilepsy|epilepsy
1658629|NCT00152659|Tumor|tumor
1658630|NCT00152659|Surgery|surgery
1658631|NCT00152659|Brain|brain
1658632|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
1658633|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
1658634|NCT00152607|Liver Transplantation|liver transplantation
1658635|NCT00152607|Living Donors|living donors
1658636|NCT00152607|End Stage Liver Disease|end stage liver disease
1658637|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
1658638|NCT00152568|Car Seat Check|car seat check
1658639|NCT00152555|SLE,|sle,
1658640|NCT00152555|exercize,|exercize,
1658641|NCT00152555|physical therapy,|physical therapy,
1658642|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
1658643|NCT00152555|relaxation therapy|relaxation therapy
1658644|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
1658645|NCT00152542|Lung recruitment,|lung recruitment,
1658646|NCT00152542|Ventilatory approach,|ventilatory approach,
1658647|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
1658648|NCT00152542|School age children|school age children
1658649|NCT00152529|Depression, educational site for depression|depression, educational site for depression
1658650|NCT00152516|Partial Onset Seizures|partial onset seizures
1658651|NCT00152516|levetiracetam|levetiracetam
1658652|NCT00152516|Epilepsy|epilepsy
1658653|NCT00152516|Keppra|keppra
1658654|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
1658655|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
1658656|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
1658657|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
1658658|NCT00152477|carboplatin|carboplatin
1658659|NCT00152477|paclitaxel|paclitaxel
1658660|NCT00152477|VEGF|vegf
1658661|NCT00152477|monoclonal antibody|monoclonal antibody
1658662|NCT00152464|EPAAC , atopic Children, asthma, XYZAL, levocetirizine|epaac , atopic children, asthma, xyzal, levocetirizine
1659735|NCT00147225|Adriamycin|adriamycin
1658663|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
1658664|NCT00152438|Vasomotor symptoms|vasomotor symptoms
1658665|NCT00152438|Menopause|menopause
1658666|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
1658667|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
1658668|NCT00152412|Xyzal|xyzal
1658669|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
1658670|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
1658671|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
1658672|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
1658673|NCT00152360|Obesity|obesity
1658674|NCT00152360|weight loss|weight loss
1658675|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
1658676|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
1658677|NCT00152334|Efficacy study|efficacy study
1658678|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
1658679|NCT00152321|osteoporosis|osteoporosis
1658680|NCT00152321|wrist fractures|wrist fractures
1658681|NCT00152321|quality improvement|quality improvement
1658682|NCT00152321|knowledge translation|knowledge translation
1658683|NCT00152295|Postmenopausal|postmenopausal
1658684|NCT00152295|Amenorrhea|amenorrhea
1658685|NCT00152295|Hormone replacement therapy|hormone replacement therapy
1658686|NCT00152295|HRT|hrt
1658687|NCT00152295|asoprisnil|asoprisnil
1658688|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
1658689|NCT00152282|Postmenopausal|postmenopausal
1658690|NCT00152282|Amenorrhea|amenorrhea
1658691|NCT00152282|Hormone replacement therapy|hormone replacement therapy
1658692|NCT00152282|HRT|hrt
1658693|NCT00152282|asoprisnil|asoprisnil
1658694|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1658695|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
1658696|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
1658697|NCT00152269|asoprisnil|asoprisnil
1658698|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
1658699|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
1658700|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
1658701|NCT00152243|Stomach Cancer|stomach cancer
1658702|NCT00152230|Colorectal Cancer|colorectal cancer
1658703|NCT00152217|Stomach cancer|stomach cancer
1658704|NCT00152204|Use-Effectiveness|use-effectiveness
1658705|NCT00152204|Cost Effectiveness|cost effectiveness
1658706|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
1658707|NCT00152204|Drug Resistance|drug resistance
1658708|NCT00152204|Delivery of Health Care|delivery of health care
1658709|NCT00152191|Breast Cancer|breast cancer
1658710|NCT00152178|Breast Cancer|breast cancer
1658711|NCT00152165|spinal motion|spinal motion
1658712|NCT00152165|tantalum beads|tantalum beads
1658713|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
1658714|NCT00152165|spinal fusion|spinal fusion
1658715|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
1658716|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
1658717|NCT00152152|spinal motion|spinal motion
1658718|NCT00152152|tantalum beads|tantalum beads
1658719|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
1658720|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
1658721|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
1658722|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
1658723|NCT00152139|Bone marrow transplantation|bone marrow transplantation
1658724|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
1658725|NCT00152126|CD133 cell selection|cd133 cell selection
1658726|NCT00152126|CliniMACS device|clinimacs device
1658727|NCT00152126|Tumor marker|tumor marker
1658728|NCT00152126|Tumor purging|tumor purging
1658729|NCT00152113|Sickle Cell Anemia|sickle cell anemia
1658730|NCT00152113|Stem Cell Transplantation|stem cell transplantation
1658731|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
1658732|NCT00152113|T cell depletion|t cell depletion
1658733|NCT00152113|CliniMACS device|clinimacs device
1658734|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
1658735|NCT00152100|Transplantation|transplantation
1658736|NCT00152100|Haploidentical|haploidentical
1658737|NCT00152087|Liver cancer|liver cancer
1658738|NCT00152087|Brachytherapy|brachytherapy
1658739|NCT00152074|Blood pressure|blood pressure
1658740|NCT00152074|Sodium|sodium
1658741|NCT00152074|Dietary|dietary
1658742|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
1658743|NCT00152061|HIV|hiv
1658744|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
1658745|NCT00152061|Treatment Experienced|treatment experienced
1658746|NCT00151905|bronchiolitis|bronchiolitis
1658747|NCT00151905|hypertonic saline|hypertonic saline
1658748|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
1658749|NCT00151866|Thrombopenia|thrombopenia
1658750|NCT00151866|Platelet transfusion|platelet transfusion
1658751|NCT00151866|Increment|increment
1658752|NCT00151866|Transfusion reactions|transfusion reactions
1658753|NCT00151866|Bleeding complication|bleeding complication
1658754|NCT00151853|CPB|cpb
1658755|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
1658756|NCT00151853|plasma|plasma
1658757|NCT00151853|PCC|pcc
1658758|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
1658759|NCT00151840|ITP|itp
1658760|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
1658761|NCT00151814|Olmesartan PK in children|olmesartan pk in children
1658762|NCT00151801|multiple sclerosis|multiple sclerosis
1658763|NCT00151801|estroprogestins|estroprogestins
1658764|NCT00151801|interferon-beta|interferon-beta
1658765|NCT00151801|sex hormones|sex hormones
1658766|NCT00151801|MRI|mri
1658767|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
1658768|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
1658769|NCT00151762|Long term safety study, extension study|long term safety study, extension study
1658770|NCT00151749|Diabetes mellitus|diabetes mellitus
1658771|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1658772|NCT00151736|CLL|cll
1658773|NCT00151736|Leukemia|leukemia
1658774|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
1658775|NCT00151697|diabetes|diabetes
1658776|NCT00151697|failing oral treatment|failing oral treatment
1658777|NCT00151697|weight gain|weight gain
1658778|NCT00151684|Obesity|obesity
1658779|NCT00151684|Hyperinsulinism|hyperinsulinism
1658780|NCT00151684|Diazoxide|diazoxide
1658781|NCT00151671|Surgery|surgery
1658782|NCT00151671|Liver Cancer|liver cancer
1658783|NCT00151671|Cirrhosis|cirrhosis
1658784|NCT00151671|Nutrition|nutrition
1658785|NCT00151658|Coronary complex lesions|coronary complex lesions
1658786|NCT00151658|Restenosis|restenosis
1658787|NCT00151658|Drug eluting stents|drug eluting stents
1658788|NCT00151645|Immunotherapy|immunotherapy
1658789|NCT00151645|Renal cell carcinoma|renal cell carcinoma
1658790|NCT00151645|Metastasis|metastasis
1658791|NCT00151645|Lymphokine activated killers|lymphokine activated killers
1658792|NCT00151645|Cell therapy|cell therapy
1658793|NCT00151632|Immunosuppression|immunosuppression
1658794|NCT00151632|Liver transplantation|liver transplantation
1658795|NCT00151632|Acute graft rejection|acute graft rejection
1658796|NCT00151632|Treatment combination|treatment combination
1658797|NCT00151619|Calcium channel blockers|calcium channel blockers
1658798|NCT00151619|Heart failure|heart failure
1658799|NCT00151619|Hemodynamics|hemodynamics
1658800|NCT00151606|Infection prevention|infection prevention
1658801|NCT00151606|Isolation|isolation
1658802|NCT00151606|Resistant bacteria|resistant bacteria
1658803|NCT00151606|MRSA colonization|mrsa colonization
1658804|NCT00151593|Cold storage|cold storage
1658805|NCT00151593|Liver transplantation|liver transplantation
1658806|NCT00151593|Preservation solution|preservation solution
1658807|NCT00151580|Hepatitis C|hepatitis c
1658808|NCT00151580|Viral recurrence|viral recurrence
1658809|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
1658810|NCT00151567|Ureterolithiasis|ureterolithiasis
1658811|NCT00151567|Alpha1-blocker|alpha1-blocker
1658812|NCT00151567|Lower ureteral stone|lower ureteral stone
1658813|NCT00151554|Anxiety|anxiety
1658814|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
1658815|NCT00151554|Preoperative Information|preoperative information
1658816|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
1658817|NCT00151554|Chronic heart disease|chronic heart disease
1658818|NCT00151541|Acne Vulgaris|acne vulgaris
1658819|NCT00151541|Acne|acne
1658820|NCT00151541|Dermatology|dermatology
1658821|NCT00151541|Dapsone|dapsone
1658822|NCT00151541|Dapsone Topical Gel|dapsone topical gel
1658823|NCT00151515|Alopecia, Balding|alopecia, balding
1658824|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
1658825|NCT00151476|celecoxib|celecoxib
1658826|NCT00151476|IRA|ira
1658827|NCT00151476|IPAA|ipaa
1658828|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
1658829|NCT00151411|Anovulation|anovulation
1658830|NCT00151411|Elevated Testosterone|elevated testosterone
1658831|NCT00151346|Epidural|epidural
1658832|NCT00151346|Labour pain|labour pain
1658833|NCT00151346|Pregnant women|pregnant women
1658834|NCT00151346|Epidural anesthesia|epidural anesthesia
1658835|NCT00151346|Labour, Obstetric|labour, obstetric
1658836|NCT00151346|labor pain|labor pain
1658837|NCT00151346|labor, obstetric|labor, obstetric
1658838|NCT00151346|labor analgesia|labor analgesia
1658839|NCT00151320|diffuse large B cell|diffuse large b cell
1658840|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
1658841|NCT00151307|Heart surgery|heart surgery
1658842|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
1658843|NCT00151307|Neuropsychological function|neuropsychological function
1658844|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
1658845|NCT00151294|Affective symptoms|affective symptoms
1659736|NCT00147225|Doxorubicin|doxorubicin
1658846|NCT00151294|Emotional lability|emotional lability
1658847|NCT00151294|Multiple Sclerosis|multiple sclerosis
1658848|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
1658849|NCT00151268|Batten Disease|batten disease
1658850|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
1658851|NCT00151268|LINCL|lincl
1658852|NCT00151255|age > 60 years|age > 60 years
1658853|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
1658854|NCT00151229|valsartan|valsartan
1658855|NCT00151229|target blood pressure|target blood pressure
1658856|NCT00151216|Batten Disease|batten disease
1658857|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
1658858|NCT00151216|LINCL|lincl
1658859|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1658860|NCT00151177|ischemic stroke|ischemic stroke
1658861|NCT00151177|CPAP ventilation|cpap ventilation
1658862|NCT00151164|transplantation tolerance|transplantation tolerance
1658863|NCT00151164|thymus|thymus
1658864|NCT00151164|bone marrow|bone marrow
1658865|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
1658866|NCT00151151|pregnancy prevention|pregnancy prevention
1658867|NCT00151151|STD prevention|std prevention
1658868|NCT00151151|adolescents|adolescents
1658869|NCT00151151|motivational interviewing|motivational interviewing
1658870|NCT00151151|abstinence|abstinence
1658871|NCT00151151|contraception|contraception
1658872|NCT00151151|transtheoretical model|transtheoretical model
1658873|NCT00151151|sexual behavior|sexual behavior
1658874|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
1658875|NCT00151125|Von Willebrand Disease|von willebrand disease
1658876|NCT00151125|Bleeding|bleeding
1658877|NCT00151125|Coagulation|coagulation
1658878|NCT00151125|Hemostatic agent|hemostatic agent
1658879|NCT00151112|nerve block|nerve block
1658880|NCT00151112|regional anesthesia|regional anesthesia
1658881|NCT00151112|injuries|injuries
1658882|NCT00151112|diverse malformations|diverse malformations
1658883|NCT00151099|preoperative nutrition|preoperative nutrition
1658884|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
1658885|NCT00151099|Dysgnathia|dysgnathia
1658886|NCT00151099|anesthesia|anesthesia
1658887|NCT00151073|Zometa|zometa
1658888|NCT00151073|Prostate Cancer|prostate cancer
1658889|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
1658890|NCT00151034|Urothelial Cancer|urothelial cancer
1658891|NCT00151034|Herceptin|herceptin
1658892|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
1658893|NCT00151021|Diabetes|diabetes
1658903|NCT00150969|bone mineral density|bone mineral density
1658904|NCT00150969|post-menopausal women|post-menopausal women
1658905|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
1658906|NCT00150969|osteoporosis|osteoporosis
1658907|NCT00150969|women's health|women's health
1658908|NCT00150943|Renal artery stenosis|renal artery stenosis
1658909|NCT00150943|Stent|stent
1658910|NCT00150943|Renal failure|renal failure
1658911|NCT00150943|Atorvastatin|atorvastatin
1658912|NCT00150943|Hypertension|hypertension
1658913|NCT00150943|Atherosclerosis|atherosclerosis
1658914|NCT00150930|psoriasis|psoriasis
1658915|NCT00150930|ultraviolet|ultraviolet
1658916|NCT00150930|UVB|uvb
1658917|NCT00150930|phototherapy|phototherapy
1658918|NCT00150930|home care|home care
1658919|NCT00150930|narrowband|narrowband
1658920|NCT00150917|Breast cancer|breast cancer
1658921|NCT00150917|Genetics|genetics
1658922|NCT00150917|Psychotherapy|psychotherapy
1658923|NCT00150917|Group counselling|group counselling
1658924|NCT00150917|Randomized control trial|randomized control trial
1658925|NCT00150917|Risk counselling|risk counselling
1658926|NCT00150917|Women's mental health|women's mental health
1658927|NCT00150917|Familial breast cancer|familial breast cancer
1658928|NCT00150904|HIV|hiv
1658929|NCT00150904|hepatitis C|hepatitis c
1658930|NCT00150904|virologic|virologic
1658931|NCT00150904|immunologic|immunologic
1658932|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
1658933|NCT00150891|Th1|th1
1658934|NCT00150891|Th2|th2
1658935|NCT00150891|B cell|b cell
1658936|NCT00150891|monokines|monokines
1658937|NCT00150891|kidney transplantation|kidney transplantation
1658938|NCT00150891|acute rejection|acute rejection
1658939|NCT00150891|chronic rejection|chronic rejection
1658940|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
1658941|NCT00150878|Fludarabine|fludarabine
1658942|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
1658943|NCT00150878|Treatment-related mortality|treatment-related mortality
1658944|NCT00150865|ropivacaine|ropivacaine
1659042|NCT00150124|Graves' disease|graves' disease
1658945|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
1658946|NCT00150865|hip arthroplasy|hip arthroplasy
1658947|NCT00150865|analgesia|analgesia
1658948|NCT00150865|postoperative|postoperative
1658949|NCT00150852|Gastrostomy|gastrostomy
1658950|NCT00150852|Wound infection|wound infection
1658951|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
1658952|NCT00150839|Depressive Disorder, Major|depressive disorder, major
1658953|NCT00150839|Venlafaxine|venlafaxine
1658954|NCT00150839|Mirtazapine|mirtazapine
1658955|NCT00150839|Double-blind RCT|double-blind rct
1658956|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
1658957|NCT00150839|Hippocampal volume|hippocampal volume
1658958|NCT00150826|microvascular disease|microvascular disease
1658959|NCT00150826|women|women
1658960|NCT00150826|renin angiotensin system|renin angiotensin system
1658961|NCT00150826|WISE|wise
1658962|NCT00150826|ischemic heart disease|ischemic heart disease
1658963|NCT00150813|Monotherapy, epilepsy|monotherapy, epilepsy
1658964|NCT00150813|Keppra, levetiracetam|keppra, levetiracetam
1658965|NCT00150800|Brivaracetam|brivaracetam
1658966|NCT00150800|Epilepsy|epilepsy
1658967|NCT00150800|Partial Onset Seizures|partial onset seizures
1658968|NCT00150800|open label|open label
1658969|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
1658970|NCT00150787|Levetiracetam|levetiracetam
1658971|NCT00150787|Keppra|keppra
1658972|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
1658973|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
1658974|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
1658975|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
1660772|NCT00141986|vitamin D|vitamin d
1658976|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
1658977|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
1658978|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
1658979|NCT00150722|atherosclerosis|atherosclerosis
1658980|NCT00150722|endothelial function|endothelial function
1658981|NCT00150722|HDL|hdl
1658982|NCT00150722|Niacin|niacin
1658983|NCT00150722|statins|statins
1658984|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
1658985|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
1658986|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
1658987|NCT00150696|Osteoporosis|osteoporosis
1658988|NCT00150696|Spinal Cord Injury|spinal cord injury
1658989|NCT00150683|Spinal Cord Injury.|spinal cord injury.
1658990|NCT00150683|Osteoporosis.|osteoporosis.
1658991|NCT00150683|Standing.|standing.
1658992|NCT00150683|Vibration.|vibration.
1658993|NCT00150670|Stomach cancer|stomach cancer
1658994|NCT00150644|Fibroid Uterus|fibroid uterus
1658995|NCT00150644|Leiomyoma|leiomyoma
1658996|NCT00150644|Uterine Fibroids|uterine fibroids
1658997|NCT00150644|Hysterectomy|hysterectomy
1658998|NCT00150644|Asoprisnil|asoprisnil
1658999|NCT00150631|Hypertension|hypertension
1659002|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
1659003|NCT00150527|antidepressive agents|antidepressive agents
1659004|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
1659005|NCT00150488|PBS|pbs
1659006|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
1659007|NCT00150488|Interstitial Cystitis|interstitial cystitis
1659008|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
1659009|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
1659010|NCT00150462|Hematological|hematological
1659011|NCT00150462|Proteasome|proteasome
1659012|NCT00150462|Myeloma|myeloma
1659013|NCT00150462|Lymphoma|lymphoma
1659014|NCT00150371|(D006937)|(d006937)
1659015|NCT00150345|Neutropenia|neutropenia
1659016|NCT00150345|Fever of unknown origin|fever of unknown origin
1659017|NCT00150345|Empirical treatment|empirical treatment
1659018|NCT00150345|Voriconazole|voriconazole
1659019|NCT00150189|Pain|pain
1659020|NCT00150189|Procedural Pain|procedural pain
1659021|NCT00150189|Sucrose|sucrose
1659022|NCT00150189|Infant|infant
1659023|NCT00150189|Newborn|newborn
1659024|NCT00150163|Androgens|androgens
1659025|NCT00150163|Bone|bone
1659026|NCT00150163|Muscle|muscle
1659027|NCT00150163|Estrogens|estrogens
1659028|NCT00150163|Fat|fat
1659029|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
1659030|NCT00150150|Interventional ultrasound|interventional ultrasound
1659031|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
1659032|NCT00150150|tumor ablation|tumor ablation
1659033|NCT00150150|nodule reduction|nodule reduction
1659034|NCT00150150|adverse effects|adverse effects
1659035|NCT00150150|patient satesfaction|patient satesfaction
1659036|NCT00150137|Radioiodine therapy|radioiodine therapy
1659037|NCT00150137|Graves’ disease|graves’ disease
1659038|NCT00150137|toxic nodular goiter|toxic nodular goiter
1659039|NCT00150137|antithyroid drugs|antithyroid drugs
1659040|NCT00150137|radioprotection|radioprotection
1659041|NCT00150124|Radioiodine therapy|radioiodine therapy
1659043|NCT00150124|toxic nodular goiter|toxic nodular goiter
1659044|NCT00150124|antithyroid drugs|antithyroid drugs
1659045|NCT00150124|levothyroxine|levothyroxine
1659046|NCT00150124|radioprotection|radioprotection
1659047|NCT00150111|Graves disease|graves disease
1659049|NCT00150111|ophthalmopathy|ophthalmopathy
1659050|NCT00150111|autoimmunity|autoimmunity
1659051|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
1659052|NCT00150111|rituximab|rituximab
1659053|NCT00150111|immunization|immunization
1659055|NCT00150098|vaccines|vaccines
1659056|NCT00150098|women|women
1659057|NCT00150098|substance use|substance use
1659058|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
1659059|NCT00150072|chordoma|chordoma
1659060|NCT00150072|imatinib|imatinib
1659061|NCT00150072|PDGFR|pdgfr
1659062|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
1659063|NCT00150046|Heart transplantation|heart transplantation
1659064|NCT00150046|Everolimus|everolimus
1659065|NCT00150046|Heart transplant recipient|heart transplant recipient
1659066|NCT00150033|thyroid disease|thyroid disease
1659067|NCT00150033|Quality of Life|quality of life
1659068|NCT00150033|Patient reported outcome|patient reported outcome
1659069|NCT00150033|questionnaire|questionnaire
1659070|NCT00150033|Quality of Life measurement|quality of life measurement
1659071|NCT00150020|Renal/Kidney|renal/kidney
1659072|NCT00150020|Transplantation|transplantation
1659073|NCT00150020|MPA|mpa
1659074|NCT00150020|EC-MPS|ec-mps
1659075|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
1659171|NCT00149604|abdominal adiposity|abdominal adiposity
1659172|NCT00149604|lipolysis|lipolysis
1659076|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
1659077|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
1659078|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
1659079|NCT00149968|Renal transplantation|renal transplantation
1659080|NCT00149968|MMF|mmf
1659081|NCT00149968|EC-MPS|ec-mps
1659082|NCT00149968|GI problems|gi problems
1659083|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
1659084|NCT00149942|transplantation|transplantation
1659085|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
1659086|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
1659087|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
1659088|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
1659089|NCT00149890|pediatric|pediatric
1659090|NCT00149890|liver transplantation|liver transplantation
1659091|NCT00149890|Simulect|simulect
1659092|NCT00149890|Basiliximab|basiliximab
1659093|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
1659094|NCT00149890|steroid reduction|steroid reduction
1659095|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
1659096|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
1659097|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
1659098|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
1659099|NCT00149838|Electric Stimulation|electric stimulation
1659100|NCT00149838|Magnetic Stimulation|magnetic stimulation
1659101|NCT00149838|Prefrontal Cortex|prefrontal cortex
1659102|NCT00149838|Brain|brain
1659103|NCT00149825|Major Depressive Disorder|major depressive disorder
1659104|NCT00149825|Insomnia|insomnia
1659105|NCT00149825|Sleep|sleep
1659106|NCT00149825|Mental Health|mental health
1659107|NCT00149812|Depression|depression
1659108|NCT00149812|Child disruptive behavior|child disruptive behavior
1659109|NCT00149812|Family functioning|family functioning
1659110|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
1659111|NCT00149799|Escitalopram|escitalopram
1659112|NCT00149799|Lexapro|lexapro
1659113|NCT00149799|BDD|bdd
1659114|NCT00149799|Body Image|body image
1659115|NCT00149786|Anorexia Nervosa|anorexia nervosa
1659116|NCT00149786|Adolescents|adolescents
1659117|NCT00149786|Family therapy|family therapy
1659118|NCT00149786|Individual therapy|individual therapy
1659119|NCT00149773|Cognitive therapy|cognitive therapy
1659120|NCT00149773|Suicide|suicide
1659121|NCT00149773|Older men|older men
1659122|NCT00149773|Death ideation|death ideation
1659123|NCT00149773|Primary care|primary care
1659124|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
1659125|NCT00149760|Treatment Outcome|treatment outcome
1659126|NCT00149760|Health Care Utilization|health care utilization
1659127|NCT00149760|Somatization Disorder|somatization disorder
1659128|NCT00149760|Somatoform Disorder|somatoform disorder
1659129|NCT00149747|Sleep|sleep
1659130|NCT00149747|Exercise|exercise
1659131|NCT00149747|Older Adults|older adults
1659132|NCT00149734|Schizophrenia|schizophrenia
1659133|NCT00149734|Ondansetron|ondansetron
1659134|NCT00149734|P50 sensory gating|p50 sensory gating
1659135|NCT00149734|Evoked potentials|evoked potentials
1659136|NCT00149734|5-HT3 receptors|5-ht3 receptors
1659137|NCT00149734|Atypical antipsychotics|atypical antipsychotics
1659138|NCT00149721|hydrocephalus|hydrocephalus
1659139|NCT00149721|pituitary function|pituitary function
1659140|NCT00149721|shunting|shunting
1659141|NCT00149708|Growth hormone|growth hormone
1659142|NCT00149708|Deficiency|deficiency
1659143|NCT00149708|Cardiovascular risk|cardiovascular risk
1659144|NCT00149708|Body composition|body composition
1659145|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
1659146|NCT00149682|Obesity|obesity
1659147|NCT00149669|Behavior Therapy|behavior therapy
1659148|NCT00149669|Cocaine|cocaine
1659149|NCT00149669|Cocaine (IV)|cocaine (iv)
1659150|NCT00149669|Cocaine Abuse|cocaine abuse
1659151|NCT00149669|Cocaine Dependence|cocaine dependence
1659152|NCT00149669|Contingency management|contingency management
1659153|NCT00149669|HIV risk behaviors|hiv risk behaviors
1659154|NCT00149669|Heroin|heroin
1659155|NCT00149669|Naltrexone|naltrexone
1659156|NCT00149669|Opioid Dependence|opioid dependence
1659157|NCT00149669|sexual risk behaviors|sexual risk behaviors
1659158|NCT00149656|Treatment Naive|treatment naive
1659159|NCT00149656|Multivitamins|multivitamins
1659160|NCT00149656|Selenium|selenium
1659161|NCT00149656|Supplementation|supplementation
1659162|NCT00149656|HIV Disease Progression|hiv disease progression
1659163|NCT00149643|Cannabis|cannabis
1659164|NCT00149643|MDD|mdd
1659165|NCT00149630|Opioid Dependence|opioid dependence
1659166|NCT00149630|Substance Related Disorders|substance related disorders
1659167|NCT00149617|Marijuana|marijuana
1659168|NCT00149617|Mood Disorder|mood disorder
1659169|NCT00149604|metabolic syndrome|metabolic syndrome
1659170|NCT00149604|hormone therapy|hormone therapy
1659173|NCT00149591|Myocardial infarction|myocardial infarction
1659174|NCT00149591|Viability|viability
1659175|NCT00149591|Coronary angioplasty|coronary angioplasty
1659176|NCT00149591|Prevention|prevention
1659177|NCT00149591|Prognosis|prognosis
1659178|NCT00149578|pancreatic cancer|pancreatic cancer
1659179|NCT00149578|gemcitabine|gemcitabine
1659180|NCT00149578|oxaliplatin|oxaliplatin
1659181|NCT00149578|5-Fluorouracil|5-fluorouracil
1659182|NCT00149578|radiation|radiation
1659183|NCT00149552|Treatment Naive|treatment naive
1659184|NCT00149552|Treatment Experienced|treatment experienced
1659185|NCT00149461|Asthma Action Plans|asthma action plans
1659186|NCT00149461|African Americans|african americans
1659187|NCT00149461|Latinos|latinos
1659188|NCT00149461|Health Literacy|health literacy
1659189|NCT00149461|Asthma Education|asthma education
1659190|NCT00149422|NT-proBNP|nt-probnp
1659191|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
1659192|NCT00149396|Colorectal Cancer|colorectal cancer
1659193|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
1659194|NCT00149396|Colorectal Tumors|colorectal tumors
1659195|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
1659196|NCT00149396|Rectum Cancer|rectum cancer
1659197|NCT00149396|Rectum tumors|rectum tumors
1659491|NCT00148239|Disability|disability
1659198|NCT00149396|Rectum carcinoma|rectum carcinoma
1659199|NCT00149396|Colon cancer|colon cancer
1659200|NCT00149396|Colon tumors|colon tumors
1659201|NCT00149396|Colon carcinoma|colon carcinoma
1659202|NCT00149396|Rectum Neoplasms|rectum neoplasms
1659203|NCT00149396|Colon Neoplasms|colon neoplasms
1659204|NCT00149396|Liver Neoplasms|liver neoplasms
1659205|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
1659206|NCT00149396|Liver Tumors|liver tumors
1659207|NCT00149396|Liver cancer|liver cancer
1659208|NCT00149396|Hepatic Cancer|hepatic cancer
1659209|NCT00149396|Hepatic tumors|hepatic tumors
1659210|NCT00149396|metastatic to the liver|metastatic to the liver
1659211|NCT00149383|randomized controlled trial|randomized controlled trial
1659212|NCT00149383|malaria|malaria
1659213|NCT00149383|Plasmodium falciparum|plasmodium falciparum
1659214|NCT00149383|thiazolidinediones|thiazolidinediones
1659215|NCT00149383|rosiglitazone|rosiglitazone
1659216|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
1659217|NCT00149370|breast hypertrophy|breast hypertrophy
1659218|NCT00149370|breast reduction surgery|breast reduction surgery
1659219|NCT00149370|health-related quality of life|health-related quality of life
1659220|NCT00149370|Health Utilities Index|health utilities index
1659221|NCT00149370|HUI|hui
1659222|NCT00149370|prospective|prospective
1659223|NCT00149370|SF-36|sf-36
1659224|NCT00149370|quality-adjusted life years|quality-adjusted life years
1659225|NCT00149370|QALY|qaly
1659226|NCT00149357|venous thromboembolism|venous thromboembolism
1659227|NCT00149357|VTE|vte
1659228|NCT00149357|thrombophilia|thrombophilia
1659229|NCT00149357|fetal loss|fetal loss
1659230|NCT00149344|cost-utility analysis;|cost-utility analysis;
1659231|NCT00149344|breast reduction;|breast reduction;
1659232|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
1659233|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
1659234|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
1659235|NCT00149305|Gouty diathesis|gouty diathesis
1659236|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
1659237|NCT00149279|stomach neoplasms|stomach neoplasms
1659238|NCT00149279|lymph node excision|lymph node excision
1659239|NCT00149279|abdominal aorta|abdominal aorta
1659240|NCT00149266|stomach neoplasms|stomach neoplasms
1659241|NCT00149266|lymph node resection|lymph node resection
1659242|NCT00149266|cardia|cardia
1659243|NCT00149266|thoracotomy|thoracotomy
1659244|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
1659245|NCT00149253|Etoricoxib,|etoricoxib,
1659246|NCT00149253|morphine consumption,|morphine consumption,
1659247|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
1659248|NCT00149240|DYSPORT|dysport
1659249|NCT00149240|botulinum toxin A|botulinum toxin a
1659250|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
1659251|NCT00149227|High risk hypertension|high risk hypertension
1659252|NCT00149227|Ischemic heart disease|ischemic heart disease
1659253|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
1659254|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
1659255|NCT00149227|KYOTO HEART Study|kyoto heart study
1659256|NCT00149201|gastric cancer|gastric cancer
1659257|NCT00149201|peritoneal metastasis|peritoneal metastasis
1659258|NCT00149201|randomized trial|randomized trial
1659259|NCT00149201|5-FU|5-fu
1659260|NCT00149201|MTX|mtx
1659261|NCT00149188|Growth Hormone|growth hormone
1659262|NCT00149175|Alzheimer's disease|alzheimer's disease
1659263|NCT00149175|Dementia|dementia
1659264|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
1659265|NCT00149175|Candidate genes|candidate genes
1659266|NCT00149175|Related disorders|related disorders
1659267|NCT00149162|Controlled|controlled
1659268|NCT00149162|Multicenter|multicenter
1659269|NCT00149162|International|international
1659270|NCT00149162|Randomized study|randomized study
1659271|NCT00149162|Direct individual benefit|direct individual benefit
1659272|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
1659273|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
1659274|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
1659275|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
1659276|NCT00149136|Ph+,|ph+,
1659277|NCT00149136|elderly patients,|elderly patients,
1659278|NCT00149136|Imatinib|imatinib
1659279|NCT00149123|Burn|burn
1659280|NCT00149123|adrenal insufficiency|adrenal insufficiency
1659281|NCT00149123|hydrocortisone|hydrocortisone
1659282|NCT00149123|short corticotropin test|short corticotropin test
1659283|NCT00149110|Sleep deprivation|sleep deprivation
1659284|NCT00149110|Exercise|exercise
1659285|NCT00149110|Light therapy|light therapy
1659286|NCT00149110|Major depression|major depression
1659287|NCT00149110|Bipolar depression|bipolar depression
1659288|NCT00149110|Sleep-wake cycle|sleep-wake cycle
1659289|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
1659290|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
1659291|NCT00149084|23S rRNA|23s rrna
1659292|NCT00149084|clarithromycin|clarithromycin
1659293|NCT00149084|Lansoprazole|lansoprazole
1659294|NCT00149084|Amoxicillin|amoxicillin
1659295|NCT00149084|H. pylori infection|h. pylori infection
1659296|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
1659297|NCT00149071|Major depression|major depression
1659298|NCT00149071|treatment resistant major depression|treatment resistant major depression
1659299|NCT00149058|acute myocardial infarction|acute myocardial infarction
1659300|NCT00149058|primary angioplasty|primary angioplasty
1659301|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
1659302|NCT00149032|Metastatic solid tumor|metastatic solid tumor
1659303|NCT00149006|Metastatic solid tumor|metastatic solid tumor
1659304|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
1659305|NCT00148993|Tumor cell vaccine|tumor cell vaccine
1659306|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
1659307|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1659308|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
1659309|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
1659310|NCT00148967|right ventricular pacing|right ventricular pacing
1659311|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
1659312|NCT00148915|Osteoporosis|osteoporosis
1659313|NCT00148915|bisphosphonates|bisphosphonates
1659314|NCT00148915|bone|bone
1659315|NCT00148902|tumor|tumor
1659316|NCT00148889|cervical dystonia|cervical dystonia
1659317|NCT00148889|torticollis|torticollis
1659318|NCT00148889|deep brain stimulation|deep brain stimulation
1659319|NCT00148889|pallidal stimulation|pallidal stimulation
1659320|NCT00148889|globus pallidus internus|globus pallidus internus
1659321|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
1659322|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
1659323|NCT00148876|Palliative Study|palliative study
1659324|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
1659325|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
1659326|NCT00148863|Ribavirin|ribavirin
1659327|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1659633|NCT00147693|Institutionalization|institutionalization
1659328|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
1659329|NCT00148850|pioglitazone|pioglitazone
1659330|NCT00148850|HIV infections|hiv infections
1659331|NCT00148850|Treatment Experienced|treatment experienced
1659332|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
1659333|NCT00148837|Fibrosis|fibrosis
1659334|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
1659335|NCT00148837|Ribavirin|ribavirin
1659336|NCT00148837|Prazosin|prazosin
1659337|NCT00148824|HIV infections|hiv infections
1659338|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
1659339|NCT00148824|Treatment Experienced|treatment experienced
1659340|NCT00148824|Treatment Naive|treatment naive
1659341|NCT00148798|Cetuximab|cetuximab
1659342|NCT00148798|Non small cell lung cancer|non small cell lung cancer
1659343|NCT00148798|Lung cancer|lung cancer
1659344|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
1659345|NCT00148798|Monoclonal antibody|monoclonal antibody
1659346|NCT00148798|Erbitux|erbitux
1659347|NCT00148785|Antiretroviral drugs|antiretroviral drugs
1659348|NCT00148785|Pharmacokinetic|pharmacokinetic
1659349|NCT00148785|Indinavir|indinavir
1659350|NCT00148785|Ritonavir|ritonavir
1659351|NCT00148785|Fosamprenavir|fosamprenavir
1659352|NCT00148772|Prostate Cancer|prostate cancer
1659353|NCT00148772|Rising PSA|rising psa
1659354|NCT00148772|Erlotinib|erlotinib
1659355|NCT00148772|Tarceva|tarceva
1659356|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
1659357|NCT00148772|Hormone Therapy|hormone therapy
1659358|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
1659359|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
1659360|NCT00148759|Sex differences|sex differences
1659361|NCT00148759|Pharmacokinetic|pharmacokinetic
1659362|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
1659363|NCT00148759|Treatment Experienced|treatment experienced
1659364|NCT00148759|HIV-infection|hiv-infection
1659365|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
1659366|NCT00148733|Child|child
1659367|NCT00148733|pneumonia|pneumonia
1659368|NCT00148733|Zinc|zinc
1659369|NCT00148733|clinical trial|clinical trial
1659370|NCT00148733|Nepal|nepal
1659371|NCT00148733|nutrition|nutrition
1659372|NCT00148733|therapeutic|therapeutic
1659373|NCT00148720|Invasive Breast Cancer|invasive breast cancer
1659374|NCT00148720|Operable Breast Cancer|operable breast cancer
1659375|NCT00148720|Capecitabine|capecitabine
1659376|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
1659377|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
1659378|NCT00148707|CT-2103|ct-2103
1659379|NCT00148707|Xyotax|xyotax
1659380|NCT00148694|Cisplatin|cisplatin
1659381|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
1659382|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
1659383|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
1659384|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
1659385|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
1659386|NCT00148681|herceptin|herceptin
1659387|NCT00148681|navelbine|navelbine
1659492|NCT00148239|Paralysis|paralysis
1659388|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
1659389|NCT00148668|herceptin|herceptin
1659390|NCT00148668|navelbine|navelbine
1659391|NCT00148668|taxotere|taxotere
1659392|NCT00148668|carboplatin|carboplatin
1659393|NCT00148668|Early stage Breast Cancer|early stage breast cancer
1659394|NCT00148655|educational intervention|educational intervention
1659395|NCT00148655|decision board|decision board
1659396|NCT00148655|DCIS|dcis
1659397|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
1659398|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
1659399|NCT00148629|Anemia|anemia
1659400|NCT00148629|Birth weight|birth weight
1659401|NCT00148629|Neonatal Mortality|neonatal mortality
1659402|NCT00148629|Tanzania|tanzania
1659403|NCT00148629|Pregnancy|pregnancy
1659404|NCT00148616|Memantine|memantine
1659405|NCT00148616|Negative Syndrome|negative syndrome
1659406|NCT00148616|Schizophrenia|schizophrenia
1659407|NCT00148616|Cognitive impairment|cognitive impairment
1659408|NCT00148603|dyspepsia|dyspepsia
1659409|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
1659410|NCT00148603|montelukast|montelukast
1659411|NCT00148590|Memantine|memantine
1659412|NCT00148590|Negative syndrome|negative syndrome
1659413|NCT00148590|Schizophrenia|schizophrenia
1659414|NCT00148590|Cognitive impairment|cognitive impairment
1659415|NCT00148590|Glutamate|glutamate
1659416|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
1659417|NCT00148564|weight gain|weight gain
1659418|NCT00148564|schizophrenia|schizophrenia
1659419|NCT00148564|atypical antipsychotics|atypical antipsychotics
1659420|NCT00148551|AMD|amd
1659421|NCT00148551|Triamcinolone|triamcinolone
1659422|NCT00148551|Macular Degeneration|macular degeneration
1659423|NCT00148538|Type 1 Diabetes|type 1 diabetes
1659424|NCT00148538|Resistance Exercise|resistance exercise
1659425|NCT00148538|Aerobic Exercise|aerobic exercise
1659426|NCT00148538|Exercise & Disease|exercise & disease
1659427|NCT00148538|Exercise|exercise
1659428|NCT00148538|Diabetes|diabetes
1659429|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
1659430|NCT00148473|Cervical ripening.|cervical ripening.
1659431|NCT00148473|Induction of labor.|induction of labor.
1659432|NCT00148473|Misoprostol.|misoprostol.
1659433|NCT00148447|negative symptoms|negative symptoms
1659434|NCT00148447|depression|depression
1659435|NCT00148447|ssri|ssri
1659436|NCT00148447|schizophrenia|schizophrenia
1659437|NCT00148434|hypertension|hypertension
1659438|NCT00148434|guidelines|guidelines
1659439|NCT00148434|patient empowerment|patient empowerment
1659440|NCT00148434|anxiety|anxiety
1659441|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
1659442|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
1659443|NCT00148408|Asthma|asthma
1659444|NCT00148408|Placebo|placebo
1659445|NCT00148408|Education|education
1659446|NCT00148382|Obesity|obesity
1659447|NCT00148382|Pharmacokinetics|pharmacokinetics
1659448|NCT00148382|Pharmacodynamics|pharmacodynamics
1659449|NCT00148356|drug eluting stents|drug eluting stents
1659450|NCT00148356|stents|stents
1659451|NCT00148356|angioplasty|angioplasty
1659452|NCT00148356|coronary artery disease|coronary artery disease
1659453|NCT00148356|total coronary occlusion|total coronary occlusion
1659454|NCT00148356|coronary artery restenosis|coronary artery restenosis
1659455|NCT00148356|stent thrombosis|stent thrombosis
1659456|NCT00148356|vascular disease|vascular disease
1659457|NCT00148356|myocardial ischemia|myocardial ischemia
1659458|NCT00148356|coronary artery stenosis|coronary artery stenosis
1659459|NCT00148343|hemiplegia|hemiplegia
1659460|NCT00148343|hemiparesis|hemiparesis
1659461|NCT00148343|stroke|stroke
1659462|NCT00148343|foot-drop|foot-drop
1659463|NCT00148343|electrical stimulation|electrical stimulation
1659464|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
1659465|NCT00148330|Diabetic macular oedema|diabetic macular oedema
1659466|NCT00148330|Triamcinolone acetate|triamcinolone acetate
1659467|NCT00148330|Intravitreal injection|intravitreal injection
1659468|NCT00148330|Clinical trial|clinical trial
1659469|NCT00148330|Laser treatment|laser treatment
1659470|NCT00148304|Decision-making|decision-making
1659471|NCT00148304|Insulin|insulin
1659472|NCT00148304|Preference|preference
1659473|NCT00148304|Treatment Variation|treatment variation
1659474|NCT00148304|Provider|provider
1659475|NCT00148304|Patient|patient
1659476|NCT00148278|Catecholamines|catecholamines
1659477|NCT00148278|Septic shock|septic shock
1659478|NCT00148265|Diabetic macular oedema|diabetic macular oedema
1659479|NCT00148265|Triamcinolone acetate|triamcinolone acetate
1659480|NCT00148265|Intravitreal injection|intravitreal injection
1659481|NCT00148265|Clinical trial|clinical trial
1659482|NCT00148265|Laser treatment|laser treatment
1659483|NCT00148252|Calcineurin|calcineurin
1659484|NCT00148252|reduction|reduction
1659485|NCT00148252|immunosuppression|immunosuppression
1659486|NCT00148252|cyclosporine A|cyclosporine a
1659487|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
1659488|NCT00148239|SCI|sci
1659489|NCT00148239|Caregiving|caregiving
1659490|NCT00148239|Aging|aging
1659493|NCT00148226|Decision Aid|decision aid
1659494|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
1659495|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
1659496|NCT00148226|Informed Decision-making|informed decision-making
1659497|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
1659498|NCT00148213|thyroglobulin|thyroglobulin
1659499|NCT00148213|immunoassay|immunoassay
1659500|NCT00148213|thyroidectomy|thyroidectomy
1659501|NCT00148213|radioiodine therapy|radioiodine therapy
1659502|NCT00148200|female sexual dysfunction|female sexual dysfunction
1659503|NCT00148200|desire|desire
1659504|NCT00148200|arousal|arousal
1659505|NCT00148200|lubrification|lubrification
1659506|NCT00148200|orgasm|orgasm
1659507|NCT00148200|satisfaction|satisfaction
1659508|NCT00148200|pain|pain
1659509|NCT00148187|Medication adherence|medication adherence
1659510|NCT00148187|Patient compliance|patient compliance
1659511|NCT00148187|Kidney transplant|kidney transplant
1659512|NCT00148187|Organ rejection|organ rejection
1659513|NCT00148187|Allograft loss|allograft loss
1659514|NCT00148187|Drug monitoring|drug monitoring
1659515|NCT00148174|Medication adherence|medication adherence
1659516|NCT00148174|Patient compliance|patient compliance
1659517|NCT00148174|Kidney transplant|kidney transplant
1659518|NCT00148174|Organ rejection|organ rejection
1659519|NCT00148174|Allograft loss|allograft loss
1659520|NCT00148174|Drug monitoring|drug monitoring
1659521|NCT00148161|Magnetoencephalography|magnetoencephalography
1659522|NCT00148161|Auditory cortex|auditory cortex
1659523|NCT00148161|Stuttering|stuttering
1659524|NCT00148161|Non stuttering|non stuttering
1659525|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1659526|NCT00148148|Caspofungin|caspofungin
1659527|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
1659528|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
1659529|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
1659530|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
1659531|NCT00148096|asthma|asthma
1659532|NCT00148096|house dust mite|house dust mite
1659533|NCT00148096|allergy|allergy
1659534|NCT00148096|housing|housing
1659535|NCT00148096|avoidance|avoidance
1659536|NCT00148096|humidity|humidity
1659537|NCT00148083|Schizophrenia|schizophrenia
1659538|NCT00148083|Cognition|cognition
1659539|NCT00148083|Clinical Trial|clinical trial
1659540|NCT00148057|Diet|diet
1659541|NCT00148057|Dietary fat|dietary fat
1659542|NCT00148057|Breast cancer|breast cancer
1659543|NCT00148057|Prevention|prevention
1659544|NCT00148031|behavior modification|behavior modification
1659545|NCT00148031|health care service utilization|health care service utilization
1659546|NCT00148031|hepatitis C,|hepatitis c,
1659547|NCT00148031|injection drug use|injection drug use
1659548|NCT00148031|therapy compliance|therapy compliance
1659549|NCT00148031|alcoholism|alcoholism
1659550|NCT00148031|alcohol abuse|alcohol abuse
1659551|NCT00148031|prevention|prevention
1659552|NCT00148031|drug abuse|drug abuse
1659553|NCT00148031|liver disorder|liver disorder
1659554|NCT00148031|HCV|hcv
1659555|NCT00148031|methadone|methadone
1659556|NCT00148018|Hodgkin disease|hodgkin disease
1659557|NCT00148018|Bortezomib|bortezomib
1659558|NCT00148018|Relapse|relapse
1659559|NCT00148018|Lymphoma|lymphoma
1659560|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
1659561|NCT00147953|NHL|nhl
1659562|NCT00147953|Lymphoma|lymphoma
1659563|NCT00147953|Radiotherapy|radiotherapy
1659564|NCT00147953|Rituximab|rituximab
1659565|NCT00147953|Palliative treatment|palliative treatment
1659566|NCT00147940|Allergy|allergy
1659567|NCT00147927|email|email
1659568|NCT00147927|internet|internet
1659569|NCT00147927|health promotion|health promotion
1659570|NCT00147927|behavior change|behavior change
1659571|NCT00147927|health status|health status
1659572|NCT00147927|work productivity|work productivity
1659573|NCT00147927|healthcare cost|healthcare cost
1659574|NCT00147927|employee|employee
1659575|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
1659576|NCT00147901|CLL|cll
1659577|NCT00147901|Immunochemotherapy|immunochemotherapy
1659578|NCT00147888|Mucosal congestion|mucosal congestion
1659579|NCT00147888|Acoustic rhinometry|acoustic rhinometry
1659580|NCT00147888|Physiology|physiology
1659581|NCT00147875|Lymphoma|lymphoma
1659582|NCT00147875|Gemcitabine|gemcitabine
1659583|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
1659584|NCT00147875|Elderly|elderly
1659585|NCT00147862|Tranexamic Acid|tranexamic acid
1659586|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
1659587|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
1659588|NCT00147862|Thromboelastography|thromboelastography
1659589|NCT00147849|knowledge translation|knowledge translation
1659590|NCT00147849|health care utilization|health care utilization
1659591|NCT00147849|economic analysis|economic analysis
1659592|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
1659593|NCT00147836|therapy|therapy
1659594|NCT00147836|sulfonylureas|sulfonylureas
1659597|NCT00147823|Bone formation|bone formation
1659598|NCT00147823|Bone lesions|bone lesions
1659599|NCT00147823|Benign bone lesion|benign bone lesion
1659600|NCT00147810|telephone outreach|telephone outreach
1659601|NCT00147810|asthma care|asthma care
1659602|NCT00147797|Atherosclerosis|atherosclerosis
1659603|NCT00147797|intima media thickness|intima media thickness
1659604|NCT00147797|aortic stiffness|aortic stiffness
1659605|NCT00147797|HIV infection|hiv infection
1659606|NCT00147797|Dyslipidemia|dyslipidemia
1659607|NCT00147797|Treatment Experienced|treatment experienced
1659608|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
1659609|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
1659610|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
1659611|NCT00147784|14 weeks treatment|14 weeks treatment
1659612|NCT00147784|Genotype 2 and 3|genotype 2 and 3
1659613|NCT00147771|localized scleroderma|localized scleroderma
1659614|NCT00147771|morphea|morphea
1659615|NCT00147771|imiquimod|imiquimod
1659616|NCT00147771|pediatrics|pediatrics
1659617|NCT00147758|Diabetes Mellitus|diabetes mellitus
1659618|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
1659619|NCT00147732|larynx carcinoma|larynx carcinoma
1659620|NCT00147732|radiotherapy|radiotherapy
1659621|NCT00147732|carbogen|carbogen
1659622|NCT00147732|nicotinamide|nicotinamide
1659623|NCT00147719|Diabetes Mellitus|diabetes mellitus
1659624|NCT00147706|Electronic Health Record|electronic health record
1659625|NCT00147706|Patient Portal|patient portal
1659626|NCT00147706|Chronic Diseases|chronic diseases
1659627|NCT00147693|Dementia|dementia
1659628|NCT00147693|Alzheimer Disease|alzheimer disease
1659629|NCT00147693|Lewy-Body|lewy-body
1659630|NCT00147693|Cost*|cost*
1659631|NCT00147693|Community (dwelling)|community (dwelling)
1659632|NCT00147693|Caregiver(s)|caregiver(s)
1659634|NCT00147693|Quality of life|quality of life
1659635|NCT00147693|Randomized Control Trail|randomized control trail
1659636|NCT00147693|Vascular dementia|vascular dementia
1659637|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
1659638|NCT00147667|COPD|copd
1659639|NCT00147667|EXACERBATIONS|exacerbations
1659640|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
1659641|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
1659642|NCT00147537|chemotherapy|chemotherapy
1659643|NCT00147537|figitumumab|figitumumab
1659644|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
1659645|NCT00147537|IGF-IR|igf-ir
1659646|NCT00147537|monoclonal antibody|monoclonal antibody
1659647|NCT00147498|oral JAK inhibitor|oral jak inhibitor
1659648|NCT00147498|clinical trial|clinical trial
1659649|NCT00147498|joint diseases|joint diseases
1659650|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
1659651|NCT00147498|rheumatic diseases|rheumatic diseases
1659652|NCT00147498|DMARD|dmard
1659653|NCT00147498|Antirheumatic Agents|antirheumatic agents
1659654|NCT00147498|Autoimmune Diseases|autoimmune diseases
1659655|NCT00147498|Immune System Diseases|immune system diseases
1659656|NCT00147472|Head and neck|head and neck
1659657|NCT00147472|Cancer|cancer
1659658|NCT00147472|Diagnosis|diagnosis
1659659|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
1659660|NCT00147472|Positron-Emission Tomography|positron-emission tomography
1659661|NCT00147472|PET|pet
1659662|NCT00147472|Oncology|oncology
1659663|NCT00147459|hepatitis B virus|hepatitis b virus
1659664|NCT00147459|vaccine|vaccine
1659665|NCT00147459|booster|booster
1659666|NCT00147459|liver transplantation|liver transplantation
1659667|NCT00147446|Stress|stress
1659668|NCT00147446|Stress Management|stress management
1659669|NCT00147446|Behavioral Medicine|behavioral medicine
1659670|NCT00147446|Multiple Sclerosis|multiple sclerosis
1659671|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
1659672|NCT00147433|free thyroxine|free thyroxine
1659673|NCT00147433|pregnancy|pregnancy
1659674|NCT00147433|fetal brain development|fetal brain development
1659675|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
1659676|NCT00147433|IQ|iq
1659677|NCT00147420|Tibet|tibet
1659678|NCT00147420|Third Stage Labor|third stage labor
1659679|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
1659680|NCT00147420|Misoprostol|misoprostol
1659681|NCT00147420|Zhi Byed 11|zhi byed 11
1659682|NCT00147420|Global Network|global network
1659683|NCT00147394|Risperidone|risperidone
1659684|NCT00147394|Autism|autism
1659685|NCT00147394|PDD|pdd
1659686|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
1659687|NCT00147381|Campath-1H|campath-1h
1659688|NCT00147381|Alemtuzumab|alemtuzumab
1659689|NCT00147381|Tacrolimus|tacrolimus
1659690|NCT00147381|renal transplantation|renal transplantation
1659691|NCT00147381|immunosuppression|immunosuppression
1659692|NCT00147381|prevention of acute rejection|prevention of acute rejection
1659693|NCT00147368|falciparum|falciparum
1659694|NCT00147368|malaria|malaria
1659695|NCT00147368|arginine|arginine
1659696|NCT00147355|rIL-2-toxicity|ril-2-toxicity
1659697|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
1659698|NCT00147355|HIV|hiv
1660407|NCT00143988|Heart Rate|heart rate
1659699|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
1659700|NCT00147342|exercise|exercise
1659701|NCT00147342|hypoglycemia|hypoglycemia
1659702|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
1659703|NCT00147342|glucose monitoring|glucose monitoring
1659704|NCT00147316|acute stroke|acute stroke
1659705|NCT00147316|thrombolytic therapy|thrombolytic therapy
1659706|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
1659708|NCT00147290|Tachycardia|tachycardia
1659709|NCT00147290|CRT-D|crt-d
1659710|NCT00147277|ATP|atp
1659711|NCT00147277|Thachy|thachy
1659712|NCT00147277|FVT|fvt
1659713|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
1659714|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
1659715|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
1659716|NCT00147251|blood pressure treatment|blood pressure treatment
1659717|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
1659718|NCT00147251|prevent progression of CVD|prevent progression of cvd
1659719|NCT00147238|Bladder Cancer|bladder cancer
1659720|NCT00147238|Genitourinary Cancer|genitourinary cancer
1659721|NCT00147238|Prostate Cancer|prostate cancer
1659722|NCT00147238|MR Lymphangiography|mr lymphangiography
1659723|NCT00147238|Ferumoxtran-10|ferumoxtran-10
1659724|NCT00147238|SPIO|spio
1659725|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
1659726|NCT00147225|Advanced Cancer|advanced cancer
1659727|NCT00147225|Advanced Malignancy|advanced malignancy
1659728|NCT00147225|Solid Tumors|solid tumors
1659729|NCT00147225|Thrombocytopenia|thrombocytopenia
1659730|NCT00147225|AMG 531|amg 531
1659731|NCT00147225|Romiplostim|romiplostim
1659732|NCT00147225|Carboplatin|carboplatin
1659733|NCT00147225|Paraplatin|paraplatin
1659734|NCT00147225|Platelets|platelets
1659737|NCT00147225|Rubex|rubex
1659738|NCT00147225|Ifosfamide|ifosfamide
1659739|NCT00147225|Ifex|ifex
1659740|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
1659741|NCT00147212|Prostate Cancer|prostate cancer
1659742|NCT00147212|Trabectedin|trabectedin
1659743|NCT00147212|ET 743|et 743
1659744|NCT00147212|Yondelis|yondelis
1659745|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1659746|NCT00147147|gastric neoplasm|gastric neoplasm
1659747|NCT00147147|gastrectomy|gastrectomy
1659748|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
1659749|NCT00147147|randomized trial|randomized trial
1659750|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
1659751|NCT00147134|colorectal cancer|colorectal cancer
1659752|NCT00147134|laparoscopic surgery|laparoscopic surgery
1659753|NCT00147134|randomized controlled trial|randomized controlled trial
1659754|NCT00147134|oncological outcome|oncological outcome
1659755|NCT00147121|Rituximab|rituximab
1659756|NCT00147121|CHOP|chop
1659757|NCT00147121|Bi-weekly|bi-weekly
1659758|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
1659759|NCT00147121|advanced stage|advanced stage
1659760|NCT00147121|follicular lymphoma|follicular lymphoma
1659761|NCT00147121|G-CSF|g-csf
1659762|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
1659763|NCT00147108|Breast Cancer|breast cancer
1659764|NCT00147095|macrophages|macrophages
1659765|NCT00147095|neutrophils|neutrophils
1659766|NCT00147095|lymphocytes|lymphocytes
1659767|NCT00147082|chemokine|chemokine
1659768|NCT00147082|chemokine receptor|chemokine receptor
1659769|NCT00147082|neutrophil|neutrophil
1659770|NCT00147082|lymphocyte|lymphocyte
1659771|NCT00147082|monocyte|monocyte
1659772|NCT00147069|sputum|sputum
1659773|NCT00147069|macrophage|macrophage
1659774|NCT00147069|neutrophil|neutrophil
1659775|NCT00147056|Brain tumor|brain tumor
1659776|NCT00147056|Brain Lesions|brain lesions
1659777|NCT00147056|Brain Cancer|brain cancer
1659778|NCT00147056|ExAblate|exablate
1659779|NCT00147043|Adult stem cells|adult stem cells
1659780|NCT00147043|Liver disease|liver disease
1659781|NCT00147043|CD34 positive cells|cd34 positive cells
1659782|NCT00147030|Hypoxia|hypoxia
1659783|NCT00147030|Ischaemia|ischaemia
1659784|NCT00147030|Encephalopathy|encephalopathy
1659785|NCT00147030|Neonatal|neonatal
1659786|NCT00147030|Hypothermia|hypothermia
1659787|NCT00147030|Perinatal|perinatal
1659788|NCT00147030|Cooling|cooling
1659789|NCT00147030|Whole/Total Body|whole/total body
1659790|NCT00147017|macrophage|macrophage
1659791|NCT00147017|inflammation|inflammation
1659792|NCT00147017|COPD|copd
1659793|NCT00147004|Septic shock|septic shock
1659794|NCT00147004|Steroids|steroids
1659795|NCT00147004|Hydrocortisone|hydrocortisone
1659796|NCT00147004|Mortality|mortality
1659797|NCT00147004|Reversal of shock|reversal of shock
1659798|NCT00147004|Adrenal insufficiency|adrenal insufficiency
1659799|NCT00146952|Hemineglects|hemineglects
1659800|NCT00146926|Propofol|propofol
1659801|NCT00146926|pain|pain
1659802|NCT00146926|general anesthesia|general anesthesia
1659803|NCT00146926|prevention|prevention
1659804|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
1659805|NCT00146913|resistant|resistant
1659806|NCT00146913|refractory|refractory
1659807|NCT00146913|Imatinib mesylate|imatinib mesylate
1659808|NCT00146900|Traumatic Events|traumatic events
1659809|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
1659810|NCT00146900|Treatment (psychological)|treatment (psychological)
1659811|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
1659812|NCT00146900|Prevention|prevention
1659813|NCT00146900|SSRIs|ssris
1659814|NCT00146887|Coronary CT|coronary ct
1659815|NCT00146887|sensitivity|sensitivity
1659816|NCT00146887|specificity|specificity
1659817|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
1659818|NCT00146809|Minocycline|minocycline
1659819|NCT00146796|Malaria|malaria
1659820|NCT00146796|Diagnosis|diagnosis
1659821|NCT00146796|RDT|rdt
1659822|NCT00146796|Africa|africa
1659823|NCT00146796|Tanzania|tanzania
1659824|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
1659825|NCT00146783|malaria|malaria
1659826|NCT00146783|pregnancy|pregnancy
1659827|NCT00146783|efficacy|efficacy
1659828|NCT00146783|safety|safety
1659829|NCT00146731|malaria|malaria
1659830|NCT00146731|pregnancy|pregnancy
1659831|NCT00146731|treatment|treatment
1659832|NCT00146731|Africa|africa
1659833|NCT00146731|Tanzania|tanzania
1659834|NCT00146718|malaria|malaria
1659835|NCT00146718|drug resistance|drug resistance
1659836|NCT00146718|antimalarials|antimalarials
1659837|NCT00146705|chronic HBV|chronic hbv
1659838|NCT00146705|Peginterferon|peginterferon
1659839|NCT00146705|long term follow-up|long term follow-up
1659840|NCT00146692|Malaria|malaria
1659841|NCT00146692|Cost|cost
1659842|NCT00146692|Treatment|treatment
1659843|NCT00146692|Diagnosis|diagnosis
1659844|NCT00146692|Africa|africa
1659845|NCT00146692|Ghana|ghana
1659846|NCT00146679|Heart failure|heart failure
1659847|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
1659849|NCT00146679|Psychoeducational intervention|psychoeducational intervention
1659850|NCT00146666|Peak walking time|peak walking time
1659851|NCT00146666|Absolute claudication distance|absolute claudication distance
1659852|NCT00146666|Claudication onset time|claudication onset time
1659853|NCT00146666|Initial claudication distance|initial claudication distance
1659854|NCT00146666|Intermittent compression|intermittent compression
1659855|NCT00146653|pediatrics|pediatrics
1659856|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
1659857|NCT00146653|surgery|surgery
1659858|NCT00146640|active disease|active disease
1659859|NCT00146640|morning stiffness of joints|morning stiffness of joints
1659860|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
1659861|NCT00146640|modified releae prednisone|modified releae prednisone
1659862|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
1659863|NCT00146627|Combination|combination
1659864|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
1659865|NCT00146614|Graft versus Host Disease|graft versus host disease
1659866|NCT00146614|GVHD|gvhd
1659867|NCT00146614|Stem Cell Transplantation|stem cell transplantation
1659868|NCT00146614|Tacrolimus|tacrolimus
1659869|NCT00146614|Sirolimus|sirolimus
1659870|NCT00146614|Methotrexate|methotrexate
1659871|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
1659872|NCT00146601|Fulvestrant|fulvestrant
1659873|NCT00146601|Advanced breast cancer|advanced breast cancer
1659874|NCT00146601|Invasive breast cancer|invasive breast cancer
1659875|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
1659876|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
1659877|NCT00146588|Breast cancer|breast cancer
1659878|NCT00146588|cytoxan|cytoxan
1659879|NCT00146588|epirubicin|epirubicin
1659880|NCT00146588|capecitabine|capecitabine
1659881|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
1659882|NCT00146562|G-CSF|g-csf
1659883|NCT00146562|pegfilgrastim|pegfilgrastim
1659884|NCT00146562|darbepoetin alfa|darbepoetin alfa
1659885|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
1659886|NCT00146549|HER2 overexpressing|her2 overexpressing
1659887|NCT00146549|trastuzumab|trastuzumab
1659888|NCT00146549|Herceptin|herceptin
1659889|NCT00146549|vinorelbine|vinorelbine
1659890|NCT00146549|Navelbine|navelbine
1659891|NCT00146549|Taxotere|taxotere
1659892|NCT00146549|taxol|taxol
1659893|NCT00146536|ALH|alh
1659894|NCT00146536|LCIS|lcis
1659895|NCT00146536|DCIS|dcis
1659896|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
1659897|NCT00146536|core needle biopsy|core needle biopsy
1659898|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
1659899|NCT00146523|Psychotic Major Depression|psychotic major depression
1659900|NCT00146523|PMD|pmd
1659901|NCT00146523|Depression|depression
1659902|NCT00146523|Major Depression|major depression
1659903|NCT00146523|Psychosis|psychosis
1659904|NCT00146510|weight control|weight control
1659905|NCT00146510|compliance|compliance
1659906|NCT00146510|physical activity|physical activity
1659907|NCT00146510|nutrition|nutrition
1659908|NCT00146510|Health Behavior|health behavior
1659909|NCT00146510|Patient Compliance|patient compliance
1659910|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
1659911|NCT00146497|Premature infants|premature infants
1659912|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
1659913|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
1659914|NCT00146497|Cytokines|cytokines
1659915|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
1659916|NCT00146484|Child|child
1659917|NCT00146484|Adolescent|adolescent
1659918|NCT00146484|Disease Management|disease management
1659919|NCT00146484|Newly Diagnosed|newly diagnosed
1659920|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
1659921|NCT00146471|alcohol withdrawal|alcohol withdrawal
1659922|NCT00146471|detoxification|detoxification
1659923|NCT00146471|Inpatients|inpatients
1659924|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
1659925|NCT00146471|withdrawal symptoms|withdrawal symptoms
1659926|NCT00146458|Cervical cancer|cervical cancer
1659927|NCT00146458|FDG-PET|fdg-pet
1659928|NCT00146458|Lymph node metastasis|lymph node metastasis
1659929|NCT00146458|Radiotherapy|radiotherapy
1659930|NCT00146458|Chemotherapy|chemotherapy
1659931|NCT00146445|IV drug users|iv drug users
1659932|NCT00146419|Treatment Experienced|treatment experienced
1659933|NCT00146419|Treatment Naive|treatment naive
1659934|NCT00146406|Adolescent Health|adolescent health
1659935|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
1659936|NCT00146406|Sexual Behavior|sexual behavior
1659937|NCT00146393|exercise|exercise
1659938|NCT00146393|physical activity|physical activity
1659939|NCT00146393|physical conditioning|physical conditioning
1659940|NCT00146393|pain|pain
1659941|NCT00146393|physical function|physical function
1660044|NCT00145977|musculoskeletal|musculoskeletal
1659942|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
1659943|NCT00146380|HIV Seronegativity|hiv seronegativity
1659944|NCT00146367|arthritis|arthritis
1659945|NCT00146367|osteoarthritis|osteoarthritis
1659946|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
1659947|NCT00146367|rheumatic disease|rheumatic disease
1659948|NCT00146367|exercise|exercise
1659949|NCT00146367|physical activity|physical activity
1659950|NCT00146367|physical function|physical function
1659951|NCT00146367|disability|disability
1659952|NCT00146354|Electronic Medical Record|electronic medical record
1659953|NCT00146354|Electronic Results Tracking|electronic results tracking
1659954|NCT00146354|Patient Safety|patient safety
1659955|NCT00146354|Post-Discharge Test Results|post-discharge test results
1659956|NCT00146315|Primary Health Care|primary health care
1659957|NCT00146315|Family Practice|family practice
1659958|NCT00146315|Family Physician|family physician
1659959|NCT00146315|Exercise|exercise
1659960|NCT00146315|Coronary Heart Disease|coronary heart disease
1659961|NCT00146315|Randomized Controlled Trials|randomized controlled trials
1659962|NCT00146315|Multicenter Studies|multicenter studies
1659963|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
1659964|NCT00146302|Infant mortality|infant mortality
1659965|NCT00146302|Morbidity|morbidity
1659966|NCT00146302|Low income country|low income country
1659967|NCT00146302|BCG|bcg
1659968|NCT00146302|Vaccine policy|vaccine policy
1659969|NCT00146302|immunisation|immunisation
1659970|NCT00146302|Low birth weight|low birth weight
1659971|NCT00146302|Tuberculin|tuberculin
1659972|NCT00146302|Mortality|mortality
1659973|NCT00146276|bladder cancer|bladder cancer
1659974|NCT00146276|cystectomy|cystectomy
1659975|NCT00146276|gemcitabine|gemcitabine
1659976|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
1659977|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
1659978|NCT00146263|mild cognitive impairment|mild cognitive impairment
1659979|NCT00146263|dementia|dementia
1659980|NCT00146263|Alzheimer's Disease|alzheimer's disease
1659981|NCT00146263|cognitive training|cognitive training
1659982|NCT00146237|phenytoin|phenytoin
1659983|NCT00146237|SSRI failure|ssri failure
1659984|NCT00146237|depression|depression
1659985|NCT00146224|anemia|anemia
1659986|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
1659987|NCT00146224|hemodialysis|hemodialysis
1659988|NCT00146224|epoetin|epoetin
1659989|NCT00146224|Epogen®|epogen®
1659990|NCT00146211|Trial|trial
1659991|NCT00146211|ethyl-EPA|ethyl-epa
1659992|NCT00146211|Miraxion™|miraxion™
1659993|NCT00146211|treating|treating
1659994|NCT00146211|mild|mild
1659995|NCT00146211|moderate|moderate
1659996|NCT00146211|Huntington's|huntington's
1659997|NCT00146198|Postoperative pain|postoperative pain
1659998|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
1659999|NCT00146198|Capsaicin|capsaicin
1660000|NCT00146185|Needlestick pain|needlestick pain
1660001|NCT00146185|Venipuncture pain|venipuncture pain
1660002|NCT00146185|Procedural pain|procedural pain
1660003|NCT00146172|Tumors|tumors
1660004|NCT00146172|Neratinib|neratinib
1660005|NCT00146172|HKI-272|hki-272
1660006|NCT00146172|Nerlynx|nerlynx
1660007|NCT00146159|Multiple Sclerosis|multiple sclerosis
1660008|NCT00146146|transsexualism|transsexualism
1660009|NCT00146146|testosterone|testosterone
1660010|NCT00146146|dihydrotestosterone|dihydrotestosterone
1660011|NCT00146146|estradiol|estradiol
1660012|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
1660013|NCT00146107|obesity|obesity
1660014|NCT00146107|aging|aging
1660015|NCT00146107|exercise|exercise
1660016|NCT00146107|diet|diet
1660017|NCT00146107|weight loss|weight loss
1660018|NCT00146107|physical function|physical function
1660019|NCT00146107|Obesity in the Elderly|obesity in the elderly
1660020|NCT00146094|Osteopenia|osteopenia
1660021|NCT00146094|osteoporosis|osteoporosis
1660022|NCT00146094|bone mineral density|bone mineral density
1660023|NCT00146094|HIV infection|hiv infection
1660024|NCT00146094|bone metabolism|bone metabolism
1660025|NCT00146094|Treatment Naive|treatment naive
1660026|NCT00146081|African Americans|african americans
1660027|NCT00146081|weight control|weight control
1660028|NCT00146081|social support|social support
1660029|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
1660030|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
1660031|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
1660032|NCT00146016|Amantadine|amantadine
1660033|NCT00146016|Triple therapy|triple therapy
1660034|NCT00146003|eczema|eczema
1660035|NCT00146003|atopic dermatitis|atopic dermatitis
1660036|NCT00146003|efalizumab|efalizumab
1660037|NCT00145990|methacholine PC20|methacholine pc20
1660038|NCT00145990|dosimeter|dosimeter
1660039|NCT00145990|asthma|asthma
1660040|NCT00145977|osteoporosis|osteoporosis
1660041|NCT00145977|bone density|bone density
1660042|NCT00145977|women|women
1660043|NCT00145977|endocrine|endocrine
1660045|NCT00145977|metabolic|metabolic
1660046|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
1660047|NCT00145964|genes|genes
1660048|NCT00145964|autoimmune disease|autoimmune disease
1660049|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
1660050|NCT00145938|PTPH|ptph
1660051|NCT00145938|pulmonary hypertension|pulmonary hypertension
1660052|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
1660053|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1660054|NCT00145925|Blood Pressure|blood pressure
1660055|NCT00145925|Stroke|stroke
1660056|NCT00145925|MI|mi
1660057|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
1660058|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
1660059|NCT00145886|osteopetrosis|osteopetrosis
1660060|NCT00145873|heart failure|heart failure
1660061|NCT00145873|nesiritide|nesiritide
1660062|NCT00145873|heart disease|heart disease
1660063|NCT00145873|cardiovascular disease|cardiovascular disease
1660064|NCT00145860|Colorectal Cancer|colorectal cancer
1660065|NCT00145847|alcohol|alcohol
1660066|NCT00145847|schizophrenia|schizophrenia
1660067|NCT00145847|naltrexone|naltrexone
1660068|NCT00145834|psychosocial factors|psychosocial factors
1660069|NCT00145834|breastfeeding|breastfeeding
1660070|NCT00145834|postnatal intervention|postnatal intervention
1660071|NCT00145834|health visitor|health visitor
1660072|NCT00145808|Ulcerative colitis|ulcerative colitis
1660073|NCT00145795|HIV|hiv
1660074|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
1660075|NCT00145795|no immune response|no immune response
1660076|NCT00145795|Treatment Experienced|treatment experienced
1660077|NCT00145782|multiphasic screening|multiphasic screening
1660078|NCT00145782|primary health care|primary health care
1660079|NCT00145782|randomized controlled trial|randomized controlled trial
1660080|NCT00145782|Risk factors|risk factors
1660081|NCT00145769|rectal cancer|rectal cancer
1660082|NCT00145769|radiotherapy|radiotherapy
1660083|NCT00145769|chemotherapy|chemotherapy
1660084|NCT00145769|chemoradiation|chemoradiation
1660085|NCT00145769|adjuvant therapy|adjuvant therapy
1660086|NCT00145756|Sodium Chloride|sodium chloride
1660087|NCT00145756|Blood Pressure|blood pressure
1660088|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
1660089|NCT00145756|Clinical Trial|clinical trial
1660090|NCT00145743|Quality of Life|quality of life
1660091|NCT00145743|Breast Cancer|breast cancer
1660092|NCT00145743|Referee's Report|referee's report
1660093|NCT00145743|Diagnostics|diagnostics
1660094|NCT00145743|Therapy|therapy
1660095|NCT00145730|osteoarthritis hip|osteoarthritis hip
1660096|NCT00145730|arthroplasty|arthroplasty
1660097|NCT00145730|ectopic bone formation|ectopic bone formation
1660098|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
1660099|NCT00145730|disability|disability
1660100|NCT00145717|Phytosterols|phytosterols
1660101|NCT00145717|Cholesterol|cholesterol
1660102|NCT00145717|China|china
1660103|NCT00145717|Randomized controlled trial|randomized controlled trial
1660104|NCT00145704|osteopenia|osteopenia
1660105|NCT00145704|growth hormone deficiency|growth hormone deficiency
1660106|NCT00145704|pediatric malignancy|pediatric malignancy
1660107|NCT00145678|borderline|borderline
1660108|NCT00145678|alcohol|alcohol
1660109|NCT00145678|substance|substance
1660110|NCT00145678|psychodynamic|psychodynamic
1660111|NCT00145678|psychotherapy|psychotherapy
1660112|NCT00145678|psychoanalytic|psychoanalytic
1660113|NCT00145665|FLT-PET|flt-pet
1660114|NCT00145665|colorectal liver metastases|colorectal liver metastases
1660115|NCT00145665|proliferation|proliferation
1660116|NCT00145665|proliferation markers|proliferation markers
1660117|NCT00145665|recurrence|recurrence
1660118|NCT00145652|erythropoetin|erythropoetin
1660119|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
1660120|NCT00145652|anemia|anemia
1660121|NCT00145652|cancer|cancer
1660122|NCT00145639|Osteosarcoma|osteosarcoma
1660123|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
1660124|NCT00145626|Stem cell transplantation|stem cell transplantation
1660125|NCT00145626|Stem cell transplant|stem cell transplant
1660126|NCT00145626|Haploidentical transplant|haploidentical transplant
1660127|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
1660128|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
1660129|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
1660130|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
1660131|NCT00145600|Lymphoma|lymphoma
1660132|NCT00145600|Hodgkin Disease|hodgkin disease
1660133|NCT00145587|Osteopetrosis|osteopetrosis
1660134|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
1660135|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
1660136|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1660137|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
1660138|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
1660139|NCT00145574|Pediatric|pediatric
1660140|NCT00145574|hypercholesterolemia|hypercholesterolemia
1660141|NCT00145574|colesevelam|colesevelam
1660142|NCT00145561|HIV|hiv
1660143|NCT00145548|COPD|copd
1660144|NCT00145535|Glaucoma|glaucoma
1660145|NCT00145535|Glaucoma, open angle|glaucoma, open angle
1660146|NCT00145535|Intraocular Pressure|intraocular pressure
1660147|NCT00145535|Trabeculoplasty|trabeculoplasty
1660148|NCT00145535|laser|laser
1660149|NCT00145535|laser, surgery|laser, surgery
1660150|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
1660151|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
1660152|NCT00145405|Acromegaly|acromegaly
1660153|NCT00145405|somatostatin analogues|somatostatin analogues
1660154|NCT00145405|lanreotide|lanreotide
1660155|NCT00145405|octreotide|octreotide
1660156|NCT00145405|GH|gh
1660157|NCT00145405|IGF-I|igf-i
1660158|NCT00145405|injection site|injection site
1660159|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
1660160|NCT00145392|growth hormone|growth hormone
1660161|NCT00145392|insulin resistance|insulin resistance
1660162|NCT00145392|overweight|overweight
1660163|NCT00145392|glucose metabolism|glucose metabolism
1660164|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
1660165|NCT00145379|insulin resistance|insulin resistance
1660166|NCT00145379|metformin|metformin
1660167|NCT00145379|randomized, controlled study|randomized, controlled study
1660168|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
1660169|NCT00145366|rhTSH|rhtsh
1660170|NCT00145366|131I|131i
1660171|NCT00145366|goiter reduction|goiter reduction
1660172|NCT00145366|131I kinetic|131i kinetic
1660173|NCT00145366|thyroid size|thyroid size
1660174|NCT00145366|patient satisfaction|patient satisfaction
1660175|NCT00145366|adverse effects|adverse effects
1660176|NCT00145366|BRT|brt
1660177|NCT00145366|Graves' disease|graves' disease
1660178|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
1660179|NCT00145353|hypoglycaemia|hypoglycaemia
1660180|NCT00145353|insulin profiles|insulin profiles
1660181|NCT00145353|growth hormone|growth hormone
1660182|NCT00145353|cortisol|cortisol
1660183|NCT00145353|glucagon|glucagon
1660184|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
1660185|NCT00145340|PPARgamma|ppargamma
1660186|NCT00145340|growth hormone|growth hormone
1660187|NCT00145340|insulin resistance|insulin resistance
1660188|NCT00145340|pioglitazone|pioglitazone
1660189|NCT00145340|glucose metabolism|glucose metabolism
1660190|NCT00145340|microarray|microarray
1660191|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
1660192|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
1660193|NCT00145314|FLOX|flox
1660194|NCT00145314|Cetuximab|cetuximab
1660195|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
1660196|NCT00145288|hirsutism|hirsutism
1660197|NCT00145288|type 2 diabetes|type 2 diabetes
1660198|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
1660199|NCT00145288|metabolism|metabolism
1660200|NCT00145275|zoledronic acid|zoledronic acid
1660201|NCT00145275|bisphosphonate|bisphosphonate
1660202|NCT00145275|Low bone mass|low bone mass
1660203|NCT00145262|critical limb ischemia|critical limb ischemia
1660204|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
1660205|NCT00145262|angiogenesis|angiogenesis
1660206|NCT00145262|vasculogenesis|vasculogenesis
1660207|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
1660208|NCT00145262|Ischemic ulcers|ischemic ulcers
1660209|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
1660210|NCT00145236|Nebivolol|nebivolol
1660211|NCT00145236|Beta-Blocker|beta-blocker
1660212|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
1660213|NCT00145210|Nebivolol|nebivolol
1660214|NCT00145197|breast cancer|breast cancer
1660215|NCT00145197|adjuvant treatment|adjuvant treatment
1660216|NCT00145197|racial disparities|racial disparities
1660217|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
1660218|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
1660219|NCT00145158|Melanoma|melanoma
1660220|NCT00145158|Vaccine|vaccine
1660221|NCT00145158|Peptide|peptide
1660222|NCT00145158|Montanide|montanide
1660223|NCT00145145|Melanoma|melanoma
1660224|NCT00145145|Vaccine|vaccine
1660225|NCT00145145|Peptide|peptide
1660226|NCT00145145|MAGE|mage
1660227|NCT00145145|CpG|cpg
1660228|NCT00145132|depression|depression
1660229|NCT00145132|β-CIT-SPECT|β-cit-spect
1660230|NCT00145132|SERT|sert
1660231|NCT00145132|DAT|dat
1660232|NCT00145132|neurophysiology|neurophysiology
1660233|NCT00145132|LDAEP|ldaep
1660234|NCT00145132|escitalopram|escitalopram
1660235|NCT00145132|SSRI|ssri
1660236|NCT00145119|Acute myocardial infarction|acute myocardial infarction
1660237|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
1660238|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
1660728|NCT00142168|rituximab|rituximab
1660239|NCT00145119|Implantable loop recorder|implantable loop recorder
1660240|NCT00145119|Risk stratifiers|risk stratifiers
1660241|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
1660242|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1660243|NCT00145093|Chromium|chromium
1660244|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
1660245|NCT00145028|Neoplasms|neoplasms
1660246|NCT00145028|Carboplatin|carboplatin
1660247|NCT00145028|optimal exposure|optimal exposure
1660248|NCT00145028|AUC|auc
1660249|NCT00145015|Intervention|intervention
1660250|NCT00145015|Adults|adults
1660251|NCT00145015|Colorectal cancer|colorectal cancer
1660252|NCT00145015|Nutrition|nutrition
1660253|NCT00145015|Fish|fish
1660254|NCT00145015|n-3 fatty acids|n-3 fatty acids
1660255|NCT00145015|Apoptosis|apoptosis
1660256|NCT00145015|Ulcerative colitis|ulcerative colitis
1660257|NCT00145015|Polyps|polyps
1660258|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
1660259|NCT00145002|ATLL|atll
1660260|NCT00145002|chemotherapy|chemotherapy
1660261|NCT00145002|phase III study|phase iii study
1660262|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
1660263|NCT00145002|biweekly-CHOP|biweekly-chop
1660264|NCT00144989|Small-cell lung cancer|small-cell lung cancer
1660265|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
1660266|NCT00144989|Combined modality therapy|combined modality therapy
1660267|NCT00144989|chemotherapy|chemotherapy
1660268|NCT00144989|radiotherapy|radiotherapy
1660269|NCT00144989|Irinotecan|irinotecan
1660270|NCT00144989|Cisplatin|cisplatin
1660271|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
1660272|NCT00144976|Tarceva|tarceva
1660273|NCT00144976|ENT|ent
1660274|NCT00144911|exacerbations|exacerbations
1660275|NCT00144911|breathing|breathing
1660381|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
1660276|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1660277|NCT00144898|Breast cancer|breast cancer
1660278|NCT00144898|sentinel node resection|sentinel node resection
1660279|NCT00144898|survival|survival
1660280|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
1660281|NCT00144885|Endocarditis|endocarditis
1660282|NCT00144885|RMI|rmi
1660283|NCT00144885|Impact measure|impact measure
1660284|NCT00144872|Absence Seizures|absence seizures
1660285|NCT00144872|EEG|eeg
1660286|NCT00144872|LTG|ltg
1660287|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
1660288|NCT00144872|Epilepsy|epilepsy
1660289|NCT00144872|LAMICTAL|lamictal
1660290|NCT00144859|P38 map kinase|p38 map kinase
1660291|NCT00144859|CRP|crp
1660292|NCT00144859|COPD|copd
1660293|NCT00144859|safety|safety
1660294|NCT00144846|wheezing|wheezing
1660295|NCT00144846|bronchospasm|bronchospasm
1660296|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
1660297|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
1660298|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
1660299|NCT00144833|Dual boosted Pis|dual boosted pis
1660300|NCT00144833|fosamprenavir|fosamprenavir
1660301|NCT00144833|lopinavir|lopinavir
1660302|NCT00144820|Hyaluronan|hyaluronan
1660303|NCT00144820|Gonarthrosis|gonarthrosis
1660304|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
1660305|NCT00144820|Double-blinded|double-blinded
1660306|NCT00144820|Placebo controlled|placebo controlled
1660307|NCT00144820|Randomised|randomised
1660308|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
1660309|NCT00144807|rituximab|rituximab
1660310|NCT00144807|chemotherapy|chemotherapy
1660311|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
1660312|NCT00144794|Hurler's Syndrome|hurler's syndrome
1660313|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
1660314|NCT00144794|Scheie Syndrome|scheie syndrome
1660315|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
1660316|NCT00144755|rituximab|rituximab
1660317|NCT00144755|chemotherapy|chemotherapy
1660318|NCT00144755|erythropoetin|erythropoetin
1660319|NCT00144755|darbepoetin alfa|darbepoetin alfa
1660320|NCT00144716|Vector Control|vector control
1660321|NCT00144716|repellent|repellent
1660322|NCT00144716|ITN's|itn's
1660323|NCT00144716|malaria|malaria
1660324|NCT00144716|Amazon|amazon
1660325|NCT00144703|Graft versus host disease|graft versus host disease
1660326|NCT00144703|GVHD|gvhd
1660327|NCT00144703|Stem cell transplantation|stem cell transplantation
1660328|NCT00144703|sirolimus|sirolimus
1660329|NCT00144703|tacrolimus|tacrolimus
1660330|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
1660331|NCT00144677|Graft versus Host Disease|graft versus host disease
1660332|NCT00144677|GVHD|gvhd
1660333|NCT00144677|sirolimus|sirolimus
1660334|NCT00144677|tacrolimus|tacrolimus
1660335|NCT00144677|Stem cell transplant|stem cell transplant
1660336|NCT00144443|Aerobiology|aerobiology
1660337|NCT00144443|Asthma|asthma
1660338|NCT00144443|Indoor Fungi|indoor fungi
1660339|NCT00144443|Allergen|allergen
1660340|NCT00144443|Home Remediation|home remediation
1660829|NCT00141752|stroke|stroke
1660341|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
1660342|NCT00144430|graft|graft
1660343|NCT00144430|host|host
1660344|NCT00144430|transplant|transplant
1660345|NCT00144430|stem cell|stem cell
1660346|NCT00144430|pediatric|pediatric
1660347|NCT00144430|GVH0313|gvh0313
1660348|NCT00144430|leukemia|leukemia
1660349|NCT00144417|tuberculosis|tuberculosis
1660350|NCT00144417|TB|tb
1660351|NCT00144417|treatment|treatment
1660352|NCT00144417|efficacy|efficacy
1660353|NCT00144417|safety|safety
1660354|NCT00144378|gastric cancer|gastric cancer
1660355|NCT00144378|metastatic|metastatic
1660356|NCT00144378|irinotecan|irinotecan
1660357|NCT00144365|HIV|hiv
1660358|NCT00144365|Africa|africa
1660359|NCT00144365|Adherence|adherence
1660360|NCT00144365|HIV viral load|hiv viral load
1660361|NCT00144365|Sexual behavior|sexual behavior
1660362|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
1660363|NCT00144352|Malaria|malaria
1660364|NCT00144352|HIV|hiv
1660365|NCT00144352|AIDS|aids
1660366|NCT00144352|drug efficacy|drug efficacy
1660367|NCT00144352|Kenya|kenya
1660368|NCT00144352|Africa|africa
1660369|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
1660370|NCT00144352|fansidar|fansidar
1660371|NCT00144313|vaccine|vaccine
1660372|NCT00144313|hepatitis B|hepatitis b
1660373|NCT00144313|immune memory|immune memory
1660374|NCT00144144|Hypertension|hypertension
1660375|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1660376|NCT00144144|Calcium Channel Blocker|calcium channel blocker
1660377|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
1660378|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
1660379|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
1660380|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
1660382|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
1660383|NCT00144131|Chemotherapy|chemotherapy
1660384|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
1660385|NCT00144092|low grade lymphoma|low grade lymphoma
1660386|NCT00144092|mantle cell|mantle cell
1660387|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
1660388|NCT00144079|radiotherapy|radiotherapy
1660389|NCT00144079|radioiodine therapy|radioiodine therapy
1660390|NCT00144079|thyroidectomy|thyroidectomy
1660391|NCT00144040|Antibiotics|antibiotics
1660392|NCT00144040|Respiratory Infections|respiratory infections
1660393|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
1660394|NCT00144040|Professional Education|professional education
1660395|NCT00144040|Emergency Services, Medical|emergency services, medical
1660396|NCT00144040|Education, Patient|education, patient
1660397|NCT00144027|patient non-adherence|patient non-adherence
1660398|NCT00144027|intervention studies|intervention studies
1660399|NCT00144014|Acute|acute
1660400|NCT00144014|Ischaemic|ischaemic
1660401|NCT00144014|Stroke|stroke
1660402|NCT00144001|Epilepsy|epilepsy
1660403|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
1660404|NCT00144001|Quality of Care|quality of care
1660405|NCT00144001|Outcomes|outcomes
1660406|NCT00143988|Blood Pressure|blood pressure
1660408|NCT00143988|Sexual Activity|sexual activity
1660409|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
1660410|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
1660411|NCT00143975|refractory disease|refractory disease
1660412|NCT00143962|Weight Loss|weight loss
1660413|NCT00143949|diabetes|diabetes
1660414|NCT00143949|nephropathy|nephropathy
1660415|NCT00143949|kidney|kidney
1660416|NCT00143949|retinopathy|retinopathy
1660417|NCT00143936|Weight Loss|weight loss
1660418|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
1660419|NCT00143923|Ethnic Groups|ethnic groups
1660420|NCT00143923|Risk Factors|risk factors
1660421|NCT00143923|Sleep disordered breathing|sleep disordered breathing
1660422|NCT00143923|Environmental exposures|environmental exposures
1660423|NCT00143923|Cognitive Function|cognitive function
1660424|NCT00143910|Medication adherence|medication adherence
1660425|NCT00143910|Patient compliance|patient compliance
1660426|NCT00143910|Kidney transplant|kidney transplant
1660427|NCT00143910|Organ rejection|organ rejection
1660428|NCT00143910|Allograft loss|allograft loss
1660429|NCT00143910|Drug monitoring|drug monitoring
1660430|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
1660431|NCT00143832|fMRI|fmri
1660432|NCT00143819|psoriasis|psoriasis
1660433|NCT00143819|dry skin|dry skin
1660434|NCT00143819|eczema|eczema
1660435|NCT00143819|atopic dermatitis|atopic dermatitis
1660436|NCT00143806|psoriasis|psoriasis
1660437|NCT00143806|cyclosporine|cyclosporine
1660438|NCT00143806|transition|transition
1660439|NCT00143806|alefacept|alefacept
1660440|NCT00143793|natruretic peptides|natruretic peptides
1660441|NCT00143793|NT-proBNP|nt-probnp
1660442|NCT00143793|new biomarkers|new biomarkers
1660443|NCT00143793|congestive heart failure|congestive heart failure
1660444|NCT00143793|atrial fibrillation|atrial fibrillation
1660445|NCT00143793|acute myocardial infarction|acute myocardial infarction
1660446|NCT00143793|lung embolism|lung embolism
1660447|NCT00143780|Bone Marrow Transplant|bone marrow transplant
1660448|NCT00143780|Pneumonia|pneumonia
1660449|NCT00143780|Vaccine|vaccine
1660450|NCT00143780|Conjugate Vaccine|conjugate vaccine
1660451|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
1660452|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
1660453|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
1660454|NCT00143728|HIV|hiv
1660455|NCT00143728|Treatment Experienced|treatment experienced
1660456|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
1660457|NCT00143715|Randomized controlled trial|randomized controlled trial
1660458|NCT00143715|Warfarin|warfarin
1660459|NCT00143715|Coagulopathy|coagulopathy
1660460|NCT00143715|Bleeding|bleeding
1660461|NCT00143715|Thrombosis|thrombosis
1660462|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
1660463|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
1660464|NCT00143702|Elevated Lactic Acid|elevated lactic acid
1660465|NCT00143676|Hyperlipidemia|hyperlipidemia
1660466|NCT00143676|Dyslipidemia|dyslipidemia
1660467|NCT00143676|Drug Therapy|drug therapy
1660468|NCT00143663|Hypercholesterolemia|hypercholesterolemia
1660469|NCT00143663|Hyperlipidemia|hyperlipidemia
1660470|NCT00143663|Drug Therapy|drug therapy
1660471|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
1660472|NCT00143637|Office dust|office dust
1660473|NCT00143637|Glucan|glucan
1660474|NCT00143637|dose-response|dose-response
1660475|NCT00143637|lung function|lung function
1660476|NCT00143637|peak expiratory flow|peak expiratory flow
1660477|NCT00143637|inflammation|inflammation
1660478|NCT00143637|perception|perception
1660479|NCT00143624|Treatment Experienced|treatment experienced
1660480|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
1660481|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
1660482|NCT00143611|Shock, Septic|shock, septic
1660483|NCT00143611|Sepsis Syndrome|sepsis syndrome
1660484|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
1660485|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
1660486|NCT00143611|Respiratory Failure|respiratory failure
1660487|NCT00143611|Drug Therapy|drug therapy
1660488|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
1660489|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
1660490|NCT00143598|Elastic Stockings|elastic stockings
1660491|NCT00143598|Stockings, Compression|stockings, compression
1660492|NCT00143598|Randomized Controlled Trials|randomized controlled trials
1660493|NCT00143598|Quality of Life|quality of life
1660494|NCT00143585|angiogenesis|angiogenesis
1660495|NCT00143585|VEGF|vegf
1660496|NCT00143572|Hematologic Diseases|hematologic diseases
1660497|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
1660498|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
1660499|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
1660695|NCT00142285|zinc|zinc
1660500|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
1660501|NCT00143559|Bone marrow transplant|bone marrow transplant
1660502|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
1660503|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
1660504|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
1660505|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
1660506|NCT00143533|Solid Tumors|solid tumors
1660507|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
1660508|NCT00143468|gas exchange|gas exchange
1660509|NCT00143468|respiratory mechanics|respiratory mechanics
1660510|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
1660511|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
1660512|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
1660513|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
1660514|NCT00143078|Obesity|obesity
1660515|NCT00143078|Reproduction|reproduction
1660516|NCT00143078|Weight Loss|weight loss
1660517|NCT00143078|Reproductive System|reproductive system
1660518|NCT00143065|Antigens, CD5|antigens, cd5
1660519|NCT00143065|Antigens, CD19|antigens, cd19
1660520|NCT00143065|Antigens, CD20|antigens, cd20
1660521|NCT00143052|Hirsutism|hirsutism
1660522|NCT00143052|Bone status|bone status
1660523|NCT00143052|Androgens|androgens
1660524|NCT00143052|insulin|insulin
1660525|NCT00143039|NIH|nih
1660526|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
1660527|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
1660528|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
1660529|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
1660530|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
1660531|NCT00143013|type 2 diabetes|type 2 diabetes
1660532|NCT00143013|microarray|microarray
1660533|NCT00143013|skeletal muscle|skeletal muscle
1660534|NCT00143013|bioinformatics|bioinformatics
1660535|NCT00143000|Hepatitis C Virus|hepatitis c virus
1660536|NCT00143000|Genotype 2|genotype 2
1660537|NCT00143000|Genotype 3|genotype 3
1660538|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
1660539|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
1660540|NCT00142961|cannabis abuse|cannabis abuse
1660541|NCT00142961|atomoxetine|atomoxetine
1660543|NCT00142948|Heroin Abuse|heroin abuse
1660544|NCT00142948|Heroin Addiction|heroin addiction
1660545|NCT00142935|HIV Prevention|hiv prevention
1660546|NCT00142935|Opioid-Related Disorders|opioid-related disorders
1660547|NCT00142935|Medication Assisted Treatment|medication assisted treatment
1660548|NCT00142935|Methadone|methadone
1660549|NCT00142922|Adherence|adherence
1660550|NCT00142922|self-care|self-care
1660551|NCT00142922|Behavioral intervention|behavioral intervention
1660552|NCT00142922|Diabetes|diabetes
1660553|NCT00142909|Opioid dependence|opioid dependence
1660554|NCT00142896|Opiate Addiction|opiate addiction
1660555|NCT00142896|Opiate Dependence|opiate dependence
1660556|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
1660557|NCT00142870|marijuana|marijuana
1660558|NCT00142870|treatment|treatment
1660559|NCT00142844|cocaine|cocaine
1660560|NCT00142831|nicotine dependence|nicotine dependence
1660561|NCT00142818|Alcohol Abuse|alcohol abuse
1660562|NCT00142818|Cocaine Abuse|cocaine abuse
1660563|NCT00142805|ketones|ketones
1660564|NCT00142805|Apolipoprotein E|apolipoprotein e
1660565|NCT00142805|ApoE genotype|apoe genotype
1660566|NCT00142805|cognitive function|cognitive function
1660567|NCT00142805|glucose metabolism|glucose metabolism
1660568|NCT00142792|stroke|stroke
1660569|NCT00142792|recovery of function|recovery of function
1660570|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
1660571|NCT00142779|Cocaine Addiction|cocaine addiction
1660572|NCT00142779|Cocaine Dependence|cocaine dependence
1660573|NCT00142779|Opiate Addiction|opiate addiction
1660574|NCT00142779|Opiate Dependence|opiate dependence
1660575|NCT00142766|Sedation|sedation
1660576|NCT00142766|Mechanical ventilation|mechanical ventilation
1660577|NCT00142766|Critical illness|critical illness
1660578|NCT00142766|Analgesic|analgesic
1660579|NCT00142766|Opioid Withdrawal|opioid withdrawal
1660580|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
1660581|NCT00142766|Nurse|nurse
1660582|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
1660583|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
1660584|NCT00142753|Hepatitis B infection|hepatitis b infection
1660585|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
1660586|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
1660587|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
1660588|NCT00142740|HIV vaccine trial|hiv vaccine trial
1660589|NCT00142714|sexual response|sexual response
1660590|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
1660591|NCT00142714|spinal cord injury|spinal cord injury
1660592|NCT00142636|Chronic Kideny Disease|chronic kideny disease
1660593|NCT00142636|Hypertension|hypertension
1660594|NCT00142610|alpha tocopherol|alpha tocopherol
1660595|NCT00142610|vitamin E|vitamin e
1660596|NCT00142610|ascorbate|ascorbate
1660597|NCT00142610|vitamin C|vitamin c
1660598|NCT00142610|antioxidant|antioxidant
1660599|NCT00142610|allergic|allergic
1660600|NCT00142610|asthma|asthma
1660601|NCT00142597|acupuncture|acupuncture
1660602|NCT00142597|analgesia|analgesia
1660603|NCT00142597|pain|pain
1660604|NCT00142597|fibromyalgia|fibromyalgia
1660605|NCT00142597|fMRI|fmri
1660606|NCT00142597|PET|pet
1660607|NCT00142584|safety and tolerability study|safety and tolerability study
1660608|NCT00142584|hypertension|hypertension
1660609|NCT00142584|beta-blockers|beta-blockers
1660610|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
1660611|NCT00142571|Gemcitabine|gemcitabine
1660612|NCT00142571|Docetaxel|docetaxel
1660613|NCT00142558|Arcoxia|arcoxia
1660614|NCT00142532|Acupuncture|acupuncture
1660615|NCT00142532|Pain|pain
1660616|NCT00142532|Lung Cancer|lung cancer
1660617|NCT00142532|Thoracotomy|thoracotomy
1660618|NCT00142532|Surgery|surgery
1660619|NCT00142519|Pain|pain
1660620|NCT00142519|Analgesics|analgesics
1660621|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
1660622|NCT00142506|Prostate Cancer|prostate cancer
1660623|NCT00142506|Cancer of the Prostate|cancer of the prostate
1660624|NCT00142506|Prostate Neoplasms|prostate neoplasms
1660625|NCT00142506|Prostatic Cancer|prostatic cancer
1660626|NCT00142506|Viagra|viagra
1660627|NCT00142506|05-007|05-007
1660628|NCT00142493|Episodic Memory|episodic memory
1660629|NCT00142493|Amnesia|amnesia
1660630|NCT00142493|Amnesia, Temporary|amnesia, temporary
1660631|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
1660632|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
1660633|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
1660634|NCT00142480|capecitabine|capecitabine
1660635|NCT00142480|oxaliplatin|oxaliplatin
1660636|NCT00142480|bevacizumab|bevacizumab
1660637|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
1660638|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1660639|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
1660640|NCT00142467|gemcitabine|gemcitabine
1660641|NCT00142467|oxaliplatin|oxaliplatin
1660642|NCT00142467|bevacizumab|bevacizumab
1660643|NCT00142467|Avastin|avastin
1660644|NCT00142454|Malignant melanoma|malignant melanoma
1660645|NCT00142454|Stages IIB-III|stages iib-iii
1660646|NCT00142441|Pulsed dye laser|pulsed dye laser
1660647|NCT00142441|Keloids|keloids
1660648|NCT00142441|Hypertrophic scars|hypertrophic scars
1660649|NCT00142441|Pulse width|pulse width
1660650|NCT00142441|Pulse duration|pulse duration
1660651|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
1660652|NCT00142428|cetuximab|cetuximab
1660653|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
1660654|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
1660655|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1660656|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
1660657|NCT00142415|Lutetium-177|lutetium-177
1660658|NCT00142415|177-Lu|177-lu
1660659|NCT00142415|cG250|cg250
1660660|NCT00142415|DOTA-cG250|dota-cg250
1660661|NCT00142415|Monoclonal Antibody|monoclonal antibody
1660662|NCT00142402|Multiple Sclerosis|multiple sclerosis
1660663|NCT00142402|Memory|memory
1660664|NCT00142402|New Learning|new learning
1660665|NCT00142402|Fatigue|fatigue
1660771|NCT00141999|hepatitis|hepatitis
1660666|NCT00142389|gestational immunization,|gestational immunization,
1660667|NCT00142389|infant antibody,|infant antibody,
1660668|NCT00142389|cord antibody|cord antibody
1660669|NCT00142363|Parkinson's disease|parkinson's disease
1660670|NCT00142363|Parkin|parkin
1660671|NCT00142363|Epilepsy|epilepsy
1660672|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
1660673|NCT00142363|Ionic channels|ionic channels
1660674|NCT00142350|gastric cancer|gastric cancer
1660675|NCT00142350|5-fluorouracil|5-fluorouracil
1660676|NCT00142350|irinotecan|irinotecan
1660677|NCT00142350|cisplatin|cisplatin
1660678|NCT00142350|S-1|s-1
1660679|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
1660680|NCT00142337|zidovudine|zidovudine
1660681|NCT00142337|didanosine|didanosine
1660682|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
1660683|NCT00142337|nevirapine|nevirapine
1660684|NCT00142337|Thailand|thailand
1660685|NCT00142337|Resistance|resistance
1660686|NCT00142337|HIV|hiv
1660687|NCT00142337|Postpartum period|postpartum period
1660688|NCT00142324|Dementia|dementia
1660689|NCT00142311|Parkinson's disease|parkinson's disease
1660690|NCT00142311|Parkin mutations|parkin mutations
1660691|NCT00142311|Metabolic explorations|metabolic explorations
1660692|NCT00142311|Clinics|clinics
1660693|NCT00142311|Genetics|genetics
1660694|NCT00142285|pneumonia|pneumonia
1660699|NCT00142272|Ciprofloxacin|ciprofloxacin
1660700|NCT00142272|children|children
1660701|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
1660702|NCT00142272|drug resistance|drug resistance
1660703|NCT00142272|Bangladesh|bangladesh
1660704|NCT00142259|deep brain stimulation|deep brain stimulation
1660705|NCT00142259|internal globus pallidus|internal globus pallidus
1660706|NCT00142259|dystonia|dystonia
1660708|NCT00142246|anaemia|anaemia
1660709|NCT00142246|school performance|school performance
1660710|NCT00142246|education|education
1660711|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
1660712|NCT00142246|schools|schools
1660713|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard) Hereditary Pancreatitis, Idiopathic chronic pancreatitis.|europac 2, antox (vers)1.2, mgct (magnesiocard) hereditary pancreatitis, idiopathic chronic pancreatitis.
1660714|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
1660715|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
1660716|NCT00142207|malaria|malaria
1660717|NCT00142207|pregnancy|pregnancy
1660718|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
1660719|NCT00142207|insecticide-treated nets|insecticide-treated nets
1660720|NCT00142194|Atrial Fibrillation|atrial fibrillation
1660721|NCT00142194|Oxidative stress|oxidative stress
1660722|NCT00142194|Cardiology|cardiology
1660723|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
1660724|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1660725|NCT00142181|Antibody|antibody
1660726|NCT00142181|Campath-1H|campath-1h
1660727|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
1660729|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1660730|NCT00142155|monoclonal antibody|monoclonal antibody
1660731|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
1660732|NCT00142155|rituximab|rituximab
1660733|NCT00142129|bortezomib|bortezomib
1660734|NCT00142129|Velcade|velcade
1660735|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1660736|NCT00142116|thalidomide|thalidomide
1660737|NCT00142116|rituximab|rituximab
1660738|NCT00142116|Waldenstrom's|waldenstrom's
1660739|NCT00142103|Hepatitis c virus|hepatitis c virus
1660740|NCT00142103|HCV|hcv
1660741|NCT00142103|Liver|liver
1660742|NCT00142090|Brain Concussion|brain concussion
1660743|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
1660744|NCT00142090|Closed Head Injury|closed head injury
1660745|NCT00142090|Traumatic Brain Injury|traumatic brain injury
1660746|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
1660747|NCT00142077|Influenza|influenza
1660748|NCT00142077|Electronic health record|electronic health record
1660749|NCT00142077|Behavior modification|behavior modification
1660750|NCT00142064|Topical analgesia|topical analgesia
1660751|NCT00142064|Urinary catheterization|urinary catheterization
1660752|NCT00142064|FlACC Pain Scale|flacc pain scale
1660753|NCT00142064|Lidocaine jelly|lidocaine jelly
1660754|NCT00142051|sickle cell disease|sickle cell disease
1660755|NCT00142051|pain crisis|pain crisis
1660756|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
1660757|NCT00142051|nitric oxide|nitric oxide
1660758|NCT00142038|gastric cancer|gastric cancer
1660759|NCT00142038|metastatic|metastatic
1660760|NCT00142038|locally advanced|locally advanced
1660761|NCT00142038|docetaxel|docetaxel
1660762|NCT00142038|capecitabine|capecitabine
1660763|NCT00142025|Bronchial asthma|bronchial asthma
1660764|NCT00142025|Oxcarbazepine|oxcarbazepine
1660765|NCT00142025|Antiepileptic drug|antiepileptic drug
1660766|NCT00142025|Efficacy|efficacy
1660767|NCT00142012|School-based|school-based
1660768|NCT00142012|Obesity|obesity
1660769|NCT00142012|Prevention|prevention
1660770|NCT00141999|vaccine|vaccine
1660773|NCT00141986|type 1 diabetes|type 1 diabetes
1660774|NCT00141986|prevention trial|prevention trial
1660775|NCT00141973|Procalcitonin|procalcitonin
1660776|NCT00141973|Sepsis|sepsis
1660777|NCT00141973|Corticosteroids|corticosteroids
1660778|NCT00141960|Treatment efficacy|treatment efficacy
1660779|NCT00141960|Treatment effectiveness|treatment effectiveness
1660780|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
1660781|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
1660782|NCT00141960|GERD|gerd
1660783|NCT00141947|bexarotene|bexarotene
1660784|NCT00141947|schizophrenia|schizophrenia
1660785|NCT00141947|psychopathology|psychopathology
1660786|NCT00141947|cognitive impairment|cognitive impairment
1660787|NCT00141947|quality of life|quality of life
1660788|NCT00141947|open lable trial|open lable trial
1660789|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
1660790|NCT00141934|RA|ra
1660791|NCT00141934|ACR20 endpoint|acr20 endpoint
1660792|NCT00141934|Tender/swollen joints|tender/swollen joints
1660793|NCT00141934|Improvement in pain|improvement in pain
1660794|NCT00141934|Health assessment questionnaire|health assessment questionnaire
1660795|NCT00141934|Profile of mood states|profile of mood states
1660796|NCT00141921|Immunex|immunex
1660797|NCT00141921|Amgen|amgen
1660798|NCT00141921|Pediatric,|pediatric,
1660799|NCT00141921|plaque psoriasis|plaque psoriasis
1660800|NCT00141921|clinical trial|clinical trial
1660801|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
1660802|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
1660803|NCT00141869|Sensory Processing|sensory processing
1660804|NCT00141869|Magnetoencephalogram|magnetoencephalogram
1660805|NCT00141869|Tourete Syndrome|tourete syndrome
1660806|NCT00141869|Trigeminal Nerve|trigeminal nerve
1660807|NCT00141869|Tics|tics
1660808|NCT00141869|TS|ts
1660809|NCT00141869|Healthy Volunteer|healthy volunteer
1660810|NCT00141869|HV|hv
1660811|NCT00141856|Dis Management|dis management
1660812|NCT00141856|Heart Decompensation|heart decompensation
1660813|NCT00141856|Hearts|hearts
1660814|NCT00141856|Veteran (M01.930)|veteran (m01.930)
1660815|NCT00141843|Hemophilia A|hemophilia a
1660816|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
1660817|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
1660818|NCT00141804|renal transplantation|renal transplantation
1660819|NCT00141804|immunosuppression|immunosuppression
1660820|NCT00141804|prevention of acute rejection|prevention of acute rejection
1660821|NCT00141791|Asthma|asthma
1660822|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
1660823|NCT00141791|Receptors|receptors
1660824|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
1660825|NCT00141778|atrial fibrillation|atrial fibrillation
1660826|NCT00141778|cardiac surgery|cardiac surgery
1660827|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
1660828|NCT00141752|Deglutition Disorders|deglutition disorders
1660830|NCT00141752|dysphagia|dysphagia
1660831|NCT00141752|screening|screening
1660832|NCT00141739|Stem Cell Transplantation|stem cell transplantation
1660833|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
1660834|NCT00141739|prophylaxis|prophylaxis
1660835|NCT00141726|Enbrel|enbrel
1660836|NCT00141726|Stem Cell Transplantation|stem cell transplantation
1660837|NCT00141726|Lung Injury|lung injury
1660838|NCT00141687|External cephalic version|external cephalic version
1660839|NCT00141687|Cesarean section|cesarean section
1660840|NCT00141687|pregnancy|pregnancy
1660841|NCT00141687|labour|labour
1660842|NCT00141687|Breech pregnancy|breech pregnancy
1660843|NCT00141674|Blood transfusion|blood transfusion
1660844|NCT00141674|Age of blood|age of blood
1660845|NCT00141674|Traumatic Brain Injury|traumatic brain injury
1660846|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
1660847|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
1660848|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
1660849|NCT00141648|Osteolymphoma|osteolymphoma
1660850|NCT00141648|Chemotherapy|chemotherapy
1660851|NCT00141648|Radiotherapy|radiotherapy
1660852|NCT00141648|Lymphoma|lymphoma
1660853|NCT00141635|Quality of Life|quality of life
1660854|NCT00141635|Breast Cancer|breast cancer
1660855|NCT00141635|Referee's Report|referee's report
1660856|NCT00141635|Diagnostics|diagnostics
1660857|NCT00141635|Therapy|therapy
1660858|NCT00141622|Endothelial dysfunction|endothelial dysfunction
1660859|NCT00141622|ADMA|adma
1660860|NCT00141622|DDAH|ddah
1660861|NCT00141622|Sodium|sodium
1660862|NCT00141609|End-stage renal failure|end-stage renal failure
1660863|NCT00141609|Haemodialysis|haemodialysis
1660864|NCT00141609|Sodium|sodium
1660865|NCT00141609|Blood Pressure|blood pressure
1660866|NCT00141596|Resistant Hypertension|resistant hypertension
1660867|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
1660868|NCT00141583|Renin-angiotensin system|renin-angiotensin system
1660869|NCT00141583|ACE Inhibitor|ace inhibitor
1660870|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
1660964|NCT00140790|Cardiovascular events|cardiovascular events
1660871|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
1660872|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
1660873|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
1660874|NCT00141531|Bladder cancer|bladder cancer
1660875|NCT00141531|Superficial|superficial
1660876|NCT00141531|Carcinoma in situ|carcinoma in situ
1660877|NCT00141531|Intravesical instillation|intravesical instillation
1660878|NCT00141531|Chemotherapy|chemotherapy
1660879|NCT00141531|Adjuvant|adjuvant
1660880|NCT00141518|Health economics,Quality of life|health economics,quality of life
1660881|NCT00141505|drug interaction|drug interaction
1660882|NCT00141505|pharmacokinetics|pharmacokinetics
1660883|NCT00141505|valproate|valproate
1660884|NCT00141505|bipolar|bipolar
1660885|NCT00141492|Type 2 diabetes|type 2 diabetes
1660886|NCT00141492|hypogonadism|hypogonadism
1660887|NCT00141492|testosterone|testosterone
1660888|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
1660889|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
1660890|NCT00141479|Schizophrenia|schizophrenia
1660891|NCT00141479|Schizoaffective disorder|schizoaffective disorder
1660892|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
1660893|NCT00141466|Microsatellite instability|microsatellite instability
1660894|NCT00141466|Physician roles|physician roles
1660895|NCT00141466|Health care implementation|health care implementation
1660896|NCT00141466|Intervention|intervention
1660897|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
1660898|NCT00141453|diabetic nephropathy|diabetic nephropathy
1660899|NCT00141453|end-stage renal disease|end-stage renal disease
1660900|NCT00141453|renal failure|renal failure
1660901|NCT00141453|type 2 diabetes|type 2 diabetes
1660902|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
1660903|NCT00141440|gas exchange|gas exchange
1660904|NCT00141440|pressure support ventilation|pressure support ventilation
1660905|NCT00141440|respiratory mechanics|respiratory mechanics
1660906|NCT00141440|COPD patients|copd patients
1660907|NCT00141297|Advanced cancer|advanced cancer
1660908|NCT00141271|Bipolar I Disorder|bipolar i disorder
1660909|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
1660910|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
1660911|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
1660912|NCT00141076|obesity|obesity
1660913|NCT00141076|glycemic index|glycemic index
1660914|NCT00141076|insulin resistance|insulin resistance
1660915|NCT00141076|cardiovascular disease|cardiovascular disease
1660916|NCT00141076|diabetes|diabetes
1660917|NCT00141063|ADHD, children|adhd, children
1660918|NCT00141050|ADHD, children|adhd, children
1660919|NCT00141037|Organ Rejection|organ rejection
1660920|NCT00141037|Corticosteroids|corticosteroids
1660921|NCT00141037|Child|child
1660922|NCT00141037|Adolescent|adolescent
1661128|NCT00140166|niacinamide|niacinamide
1660923|NCT00141037|Immunosuppression|immunosuppression
1660924|NCT00141037|Steroids|steroids
1660925|NCT00141024|HIV Seronegativity|hiv seronegativity
1660926|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
1660927|NCT00141011|Stroke|stroke
1660928|NCT00141011|Fibrinogen|fibrinogen
1660929|NCT00141011|Reperfusion|reperfusion
1660930|NCT00141011|Thrombolysis|thrombolysis
1660931|NCT00140998|Turner syndrome|turner syndrome
1660932|NCT00140998|Hypogonadism|hypogonadism
1660933|NCT00140998|GH|gh
1660934|NCT00140998|Estrogen|estrogen
1660935|NCT00140998|Estrogen Patches|estrogen patches
1660936|NCT00140998|IGF-I|igf-i
1660937|NCT00140998|Body Composition|body composition
1660938|NCT00140998|Protein Metabolism|protein metabolism
1660939|NCT00140998|Lipolysis|lipolysis
1660940|NCT00140972|Arcoxia|arcoxia
1660941|NCT00140894|Osteoarthritis|osteoarthritis
1660942|NCT00140894|Cancer Pain|cancer pain
1660943|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
1660944|NCT00140868|Large bowel obstruction|large bowel obstruction
1660945|NCT00140868|Stents|stents
1660946|NCT00140868|Laparotomy|laparotomy
1660947|NCT00140868|Palliative Surgery|palliative surgery
1660948|NCT00140868|Surgery, Palliative|surgery, palliative
1660949|NCT00140868|Palliative Therapy|palliative therapy
1660950|NCT00140855|synovial sarcoma|synovial sarcoma
1660951|NCT00140855|immunotherapy|immunotherapy
1660952|NCT00140855|cancer-testis antigen|cancer-testis antigen
1660953|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
1660954|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
1660955|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
1660956|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
1660957|NCT00140829|Cerebellar ataxias|cerebellar ataxias
1660958|NCT00140829|Spastic paraplegias|spastic paraplegias
1660959|NCT00140829|Mutations spectrum|mutations spectrum
1660960|NCT00140829|Linkage studies|linkage studies
1660961|NCT00140829|Genetic counselling|genetic counselling
1660962|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
1660963|NCT00140790|Renal dysfunction|renal dysfunction
1660965|NCT00140790|Valsartan|valsartan
1660966|NCT00140764|Genitourinary symptoms|genitourinary symptoms
1660967|NCT00140751|HIV-1|hiv-1
1660968|NCT00140751|Treatment simplification|treatment simplification
1660969|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
1660970|NCT00140751|Treatment Experienced|treatment experienced
1660971|NCT00140751|HIV Seropositivity|hiv seropositivity
1660972|NCT00140725|HBeAg-positive|hbeag-positive
1660973|NCT00140725|chronic|chronic
1660974|NCT00140725|Hepatitis B|hepatitis b
1660975|NCT00140725|lamivudine|lamivudine
1660976|NCT00140725|seroconversion|seroconversion
1660977|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
1660978|NCT00140712|RLS|rls
1660979|NCT00140712|PLMS|plms
1660980|NCT00140712|Adolescent|adolescent
1660981|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
1660982|NCT00140712|Ropinirole|ropinirole
1660983|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
1660984|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
1660985|NCT00140660|rituximab|rituximab
1660986|NCT00140660|chemotherapy|chemotherapy
1660987|NCT00140647|atherosclerosis|atherosclerosis
1660988|NCT00140647|carotid artery|carotid artery
1660989|NCT00140647|ramipril|ramipril
1660990|NCT00140647|rosiglitazone|rosiglitazone
1661094|NCT00140309|TB|tb
1660991|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
1660992|NCT00140647|impaired fasting glucose|impaired fasting glucose
1660993|NCT00140647|diabetes prevention|diabetes prevention
1660994|NCT00140621|cardiac fabry disease|cardiac fabry disease
1660995|NCT00140608|sinus|sinus
1660996|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
1660997|NCT00140595|rituximab|rituximab
1660998|NCT00140595|chemotherapy|chemotherapy
1660999|NCT00140582|lymphoma|lymphoma
1661000|NCT00140582|follicular|follicular
1661001|NCT00140582|maintenance|maintenance
1661002|NCT00140569|follicular lymphoma|follicular lymphoma
1661003|NCT00140569|CHVP + interferon|chvp + interferon
1661004|NCT00140569|fludarabine|fludarabine
1661005|NCT00140569|autotransplant|autotransplant
1661006|NCT00140556|head and neck cancer|head and neck cancer
1661007|NCT00140556|targeted therapy|targeted therapy
1661008|NCT00140556|bevacizumab|bevacizumab
1661009|NCT00140556|erlotinib|erlotinib
1661010|NCT00140556|Tarceva|tarceva
1661011|NCT00140556|radiotherapy|radiotherapy
1661012|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
1661013|NCT00140556|pharynx cancer|pharynx cancer
1661014|NCT00140556|tonsil cancer|tonsil cancer
1661015|NCT00140556|hyperfractionation|hyperfractionation
1661016|NCT00140556|angiogenesis|angiogenesis
1661017|NCT00140556|epidermal growth factor|epidermal growth factor
1661018|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
1661019|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1661020|NCT00140556|cancer of the head and neck|cancer of the head and neck
1661021|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
1661022|NCT00140556|pharynx neoplasms|pharynx neoplasms
1661023|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
1661024|NCT00140543|Immunosuppression|immunosuppression
1661025|NCT00140517|Plasmodium falciparum|plasmodium falciparum
1661026|NCT00140517|malaria|malaria
1661027|NCT00140517|pregnancy|pregnancy
1661028|NCT00140517|resistance|resistance
1661029|NCT00140504|Adverse drug event|adverse drug event
1661030|NCT00140504|Patient safety|patient safety
1661031|NCT00140504|Internet portal|internet portal
1661032|NCT00140504|PatientSite|patientsite
1661033|NCT00140504|Preventive health|preventive health
1661034|NCT00140504|Primary care|primary care
1661035|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
1661036|NCT00140491|Visual Field Defect|visual field defect
1661037|NCT00140491|Neuroplasticity|neuroplasticity
1661038|NCT00140491|Rehabilitation|rehabilitation
1661039|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
1661040|NCT00140478|Prostate Cancer|prostate cancer
1661041|NCT00140478|Mifepristone|mifepristone
1661042|NCT00140478|RU-486|ru-486
1661043|NCT00140452|ALS|als
1661044|NCT00140439|asthma|asthma
1661045|NCT00140439|emergency department|emergency department
1661046|NCT00140439|compliance|compliance
1661047|NCT00140439|randomized clinical trial|randomized clinical trial
1661048|NCT00140426|Anorexia Nervosa|anorexia nervosa
1661049|NCT00140426|Risperidone|risperidone
1661050|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
1661051|NCT00140426|Dopamine|dopamine
1661052|NCT00140426|Leptin|leptin
1661053|NCT00140426|Body Image|body image
1661054|NCT00140426|Adolescents|adolescents
1661055|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
1661056|NCT00140400|Prostate|prostate
1661057|NCT00140400|Cancer|cancer
1661058|NCT00140400|Advanced prostate cancer|advanced prostate cancer
1661059|NCT00140400|Metastatic|metastatic
1661060|NCT00140400|Hormone-refractory|hormone-refractory
1661061|NCT00140400|GVAX|gvax
1661062|NCT00140400|Vaccine|vaccine
1661063|NCT00140400|Allogeneic cells|allogeneic cells
1661064|NCT00140387|Prostate|prostate
1661065|NCT00140387|Cancer|cancer
1661066|NCT00140387|GVAX|gvax
1661067|NCT00140387|Metastatic|metastatic
1661068|NCT00140387|Vaccine|vaccine
1661069|NCT00140387|Allogeneic cells|allogeneic cells
1661070|NCT00140374|Prostate|prostate
1661071|NCT00140374|Cancer|cancer
1661072|NCT00140374|Vaccine|vaccine
1661073|NCT00140374|GVAX|gvax
1661074|NCT00140374|Allogeneic cells|allogeneic cells
1661075|NCT00140361|malaria|malaria
1661076|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1661077|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
1661078|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
1661079|NCT00140361|combination therapy|combination therapy
1661080|NCT00140348|Prostate|prostate
1661081|NCT00140348|Cancer|cancer
1661082|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
1661083|NCT00140348|Metastatic|metastatic
1661084|NCT00140348|Hormone-refractory|hormone-refractory
1661085|NCT00140348|GVAX|gvax
1661086|NCT00140348|Vaccine|vaccine
1661087|NCT00140348|Allogeneic cells|allogeneic cells
1661088|NCT00140335|handwashing|handwashing
1661089|NCT00140335|communicable diseases|communicable diseases
1661090|NCT00140335|health education|health education
1661091|NCT00140322|falls|falls
1661092|NCT00140322|injury|injury
1661093|NCT00140322|elderly|elderly
1661095|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
1661096|NCT00140309|Tuberculosis|tuberculosis
1661097|NCT00140309|Pulmonary TB|pulmonary tb
1661098|NCT00140283|Effectiveness|effectiveness
1661099|NCT00140283|Educational intervention|educational intervention
1661100|NCT00140283|Primary health care|primary health care
1661101|NCT00140257|Myocardial Infarction|myocardial infarction
1661102|NCT00140244|leptin|leptin
1661103|NCT00140244|lipodystrophy|lipodystrophy
1661104|NCT00140244|insulin resistance|insulin resistance
1661105|NCT00140244|hyperlipidemia|hyperlipidemia
1661106|NCT00140244|metabolic syndrome|metabolic syndrome
1661107|NCT00140231|leptin|leptin
1661108|NCT00140231|fasting|fasting
1661109|NCT00140231|reproductive|reproductive
1661110|NCT00140231|neuroendocrine|neuroendocrine
1661111|NCT00140231|immune function|immune function
1661112|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
1661113|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1661114|NCT00140218|pramipexole|pramipexole
1661115|NCT00140218|oxidative stress|oxidative stress
1661116|NCT00140218|neuroprotection|neuroprotection
1661117|NCT00140205|leptin|leptin
1661118|NCT00140205|fasting|fasting
1661119|NCT00140205|pharmacokinetics|pharmacokinetics
1661120|NCT00140192|creatine metabolism|creatine metabolism
1661121|NCT00140192|schizophrenia|schizophrenia
1661122|NCT00140192|energy metabolism|energy metabolism
1661123|NCT00140179|valnoctamide|valnoctamide
1661124|NCT00140179|teratogenicity|teratogenicity
1661125|NCT00140179|double-blind|double-blind
1661126|NCT00140179|mania|mania
1661127|NCT00140166|schizophrenia|schizophrenia
1661129|NCT00140153|androgel|androgel
1661130|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
1661131|NCT00140153|controlled double-blind|controlled double-blind
1661132|NCT00140153|testosterone|testosterone
1661133|NCT00140140|Breast cancer|breast cancer
1661134|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
1661135|NCT00140101|drug eluting stents|drug eluting stents
1661136|NCT00140101|stents|stents
1661137|NCT00140101|angioplasty|angioplasty
1661138|NCT00140101|coronary artery disease|coronary artery disease
1661139|NCT00140101|total coronary occlusion|total coronary occlusion
1661140|NCT00140101|coronary artery restenosis|coronary artery restenosis
1661141|NCT00140101|stent thrombosis|stent thrombosis
1661142|NCT00140101|vascular disease|vascular disease
1661143|NCT00140101|myocardial ischemia|myocardial ischemia
1661144|NCT00140101|coronary artery stenosis|coronary artery stenosis
1661145|NCT00140088|Needlestick pain|needlestick pain
1661146|NCT00140088|Venipuncture pain|venipuncture pain
1661147|NCT00140010|aneurysm|aneurysm
1661148|NCT00140010|autoregulation|autoregulation
1661149|NCT00140010|erythropoietion|erythropoietion
1661150|NCT00140010|stroke|stroke
1661151|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
1661152|NCT00140010|vasospasm|vasospasm
1661153|NCT00139997|Major Depression|major depression
1661154|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
1661155|NCT00139984|Hypertension|hypertension
1661156|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
1661157|NCT00139984|Blood pressure|blood pressure
1661158|NCT00139984|Risk assessment|risk assessment
1661159|NCT00139958|Acute coronary syndrome|acute coronary syndrome
1661160|NCT00139958|HIV infection|hiv infection
1661161|NCT00139958|Prognosis|prognosis
1661162|NCT00139958|Coronary heart disease|coronary heart disease
1661163|NCT00139958|Revascularization|revascularization
1661164|NCT00139919|Decreasing Titration Study|decreasing titration study
1661165|NCT00139919|Schizophrenia|schizophrenia
1661166|NCT00139919|Bipolar|bipolar
1661167|NCT00139919|Pharmacokinetic|pharmacokinetic
1661168|NCT00139906|Titration Study|titration study
1661720|NCT00137202|pruritus|pruritus
1661169|NCT00139906|Schizophrenia|schizophrenia
1661170|NCT00139906|BID dosing|bid dosing
1661171|NCT00139906|Pharmacokinetic|pharmacokinetic
1661172|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1661173|NCT00139841|Rituximab Refractory|rituximab refractory
1661174|NCT00139841|Rituximab Failure|rituximab failure
1661175|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
1661176|NCT00139828|haemophilia B|haemophilia b
1661177|NCT00139828|factor IX|factor ix
1661178|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
1661179|NCT00139828|plasma products|plasma products
1661180|NCT00139815|unstable angina|unstable angina
1661181|NCT00139815|acute coronary syndrome|acute coronary syndrome
1661182|NCT00139815|fondaparinux sodium|fondaparinux sodium
1661183|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
1661184|NCT00139815|myocardial infarction|myocardial infarction
1661185|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
1661186|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
1661187|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
1661188|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
1661378|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
1661189|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
1661190|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
1661191|NCT00139568|Chronic constipation|chronic constipation
1661192|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
1661193|NCT00139568|functional GI|functional gi
1661194|NCT00139568|China|china
1661195|NCT00139568|tegaserod|tegaserod
1661196|NCT00139555|Hypertension|hypertension
1661197|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
1661198|NCT00139542|human|human
1661199|NCT00139542|ventricular fibrillation|ventricular fibrillation
1661200|NCT00139542|out-of-hospital|out-of-hospital
1661201|NCT00139542|cardiac arrest|cardiac arrest
1661202|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
1661203|NCT00139542|defibrillators|defibrillators
1661204|NCT00139542|electrick countershock|electrick countershock
1661205|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
1661206|NCT00139490|Blood Pressure, High|blood pressure, high
1661207|NCT00139451|GH|gh
1661208|NCT00139451|Delayed Growth|delayed growth
1661209|NCT00139451|Energy Expenditure|energy expenditure
1661210|NCT00139451|Puberty|puberty
1661211|NCT00139451|Nutrition|nutrition
1661212|NCT00139451|Short Stature|short stature
1661213|NCT00139399|Coronary artery bypass|coronary artery bypass
1661214|NCT00139399|Coronary arteries|coronary arteries
1661215|NCT00139399|Atherosclerosis|atherosclerosis
1661216|NCT00139399|Angiography|angiography
1661217|NCT00139399|Blood flow|blood flow
1661218|NCT00139386|Drug-eluting stent|drug-eluting stent
1661219|NCT00139386|Candesartan|candesartan
1661220|NCT00139386|Randomized control study|randomized control study
1661221|NCT00139386|Coronary Angioplasty|coronary angioplasty
1661222|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
1661223|NCT00139373|Frontal lobe|frontal lobe
1661224|NCT00139373|Oculomotor testing|oculomotor testing
1661225|NCT00139373|Neuropsychological scores|neuropsychological scores
1661226|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
1661227|NCT00139373|Distractibility|distractibility
1661228|NCT00139321|Gait disorders|gait disorders
1661229|NCT00139321|Postural instability|postural instability
1661230|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
1661231|NCT00139321|Gait initiation|gait initiation
1661232|NCT00139321|Parkinson's disease|parkinson's disease
1661233|NCT00139321|Adults|adults
1661234|NCT00139308|Tourette's syndrome|tourette's syndrome
1661235|NCT00139308|High frequency stimulation|high frequency stimulation
1661236|NCT00139308|Globus pallidus|globus pallidus
1661237|NCT00139308|Thalamus|thalamus
1661238|NCT00139295|musculoskeletal|musculoskeletal
1661239|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
1661240|NCT00139282|wet AMD|wet amd
1661241|NCT00139282|macular degeneration|macular degeneration
1661242|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
1661243|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
1661244|NCT00139269|SSCHN|sschn
1661245|NCT00139269|Docetaxel|docetaxel
1661246|NCT00139256|Glucocorticoid|glucocorticoid
1661247|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
1661248|NCT00139256|Elective Cesarean Section|elective cesarean section
1661249|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
1661250|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
1661251|NCT00139243|Taxotere|taxotere
1661252|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
1661253|NCT00139243|Cisplatin|cisplatin
1661254|NCT00139243|5-Fluorouracil|5-fluorouracil
1661255|NCT00139243|Leucovorin|leucovorin
1661256|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
1661257|NCT00139230|Compressed TPFL|compressed tpfl
1661258|NCT00139230|Taxotere|taxotere
1661259|NCT00139230|Growth Factor Support|growth factor support
1661260|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
1661261|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
1661262|NCT00139217|iNO|ino
1661263|NCT00139204|Prostate cancer|prostate cancer
1661264|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
1661265|NCT00139204|PET scan|pet scan
1661266|NCT00139204|C11-methionine|c11-methionine
1661267|NCT00139204|positron emission tomography|positron emission tomography
1661268|NCT00139191|Prostate Cancer|prostate cancer
1661269|NCT00139191|positron emission tomography|positron emission tomography
1661270|NCT00139191|carbon 11 acetate|carbon 11 acetate
1661271|NCT00139191|PET|pet
1661272|NCT00139191|fatty acid synthase|fatty acid synthase
1661273|NCT00139191|FAS|fas
1661274|NCT00139165|Collagenous colitis|collagenous colitis
1661275|NCT00139165|Budesonide treatment|budesonide treatment
1661276|NCT00139165|Diarrhea|diarrhea
1661277|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
1661278|NCT00139139|hepatitis A|hepatitis a
1661279|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
1661280|NCT00139139|immune globulin|immune globulin
1661281|NCT00139113|hepatitis A|hepatitis a
1661282|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
1661379|NCT00138632|PTK787|ptk787
1661380|NCT00138619|Type 2 diabetes|type 2 diabetes
1661283|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
1661284|NCT00139048|informed choice|informed choice
1661285|NCT00139048|shared decision making|shared decision making
1661286|NCT00139048|decision aid|decision aid
1661287|NCT00139048|mammography screening|mammography screening
1661288|NCT00139048|decision support|decision support
1661289|NCT00139035|glucose intolerance|glucose intolerance
1661290|NCT00139035|insulin|insulin
1661291|NCT00139035|microvascular function|microvascular function
1661292|NCT00139035|genotyping|genotyping
1661293|NCT00139035|CYP3A5|cyp3a5
1661294|NCT00139035|pharmacokinetics|pharmacokinetics
1661295|NCT00139035|renal transplantation|renal transplantation
1661296|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
1661297|NCT00139009|intracellular concentration|intracellular concentration
1661298|NCT00139009|cyclosporine A|cyclosporine a
1661299|NCT00139009|renal biopsies|renal biopsies
1661300|NCT00139009|heart biopsies|heart biopsies
1661301|NCT00139009|Renal transplant recipients|renal transplant recipients
1661302|NCT00138996|cardiac arrest|cardiac arrest
1661303|NCT00138996|resuscitation|resuscitation
1661304|NCT00138996|quality|quality
1661305|NCT00138996|feedback|feedback
1661306|NCT00138996|training|training
1661307|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
1661308|NCT00138983|rheumatic diseases|rheumatic diseases
1661309|NCT00138983|prevention|prevention
1661310|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
1661311|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
1661312|NCT00138970|Cadaveric donor|cadaveric donor
1661313|NCT00138970|Calcineurine free|calcineurine free
1661314|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
1661315|NCT00138957|Intraperitoneally|intraperitoneally
1661316|NCT00138957|Mesh|mesh
1661317|NCT00138957|Quality of life|quality of life
1661318|NCT00138957|Postoperative pain|postoperative pain
1661319|NCT00138957|Recurrence|recurrence
1661320|NCT00138944|Essential hypertension|essential hypertension
1661321|NCT00138931|Cardiomyopathy|cardiomyopathy
1661322|NCT00138931|Arrhythmia|arrhythmia
1661323|NCT00138931|Muscular Dystrophy|muscular dystrophy
1661324|NCT00138918|Prostate Cancer|prostate cancer
1661325|NCT00138918|Clusterin|clusterin
1661326|NCT00138918|Neoadjuvant|neoadjuvant
1661327|NCT00138918|Phase II|phase ii
1661328|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
1661329|NCT00138892|Quality of life|quality of life
1661330|NCT00138892|waiting time|waiting time
1661331|NCT00138892|total joint replacement|total joint replacement
1661332|NCT00138879|Citrulline|citrulline
1661333|NCT00138879|Parenteral Nutrition|parenteral nutrition
1661334|NCT00138879|functioning intestinal mass|functioning intestinal mass
1661335|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
1661336|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
1661337|NCT00138866|Spinal cord injury|spinal cord injury
1661339|NCT00138853|Genoarthrosis|genoarthrosis
1661340|NCT00138853|Knee arthroplasty|knee arthroplasty
1661341|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
1661342|NCT00138840|Crohn's disease|crohn's disease
1661343|NCT00138840|Gastroenterology|gastroenterology
1661344|NCT00138827|Radiotherapy|radiotherapy
1661345|NCT00138827|Mucositis|mucositis
1661346|NCT00138827|Xerostomia|xerostomia
1661347|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
1661348|NCT00138814|Radiotherapy dosage|radiotherapy dosage
1661349|NCT00138814|Cosmesis|cosmesis
1661350|NCT00138814|Mastectomy, segmental|mastectomy, segmental
1661351|NCT00138801|Neuroborreliosis|neuroborreliosis
1661352|NCT00138788|Radiotherapy|radiotherapy
1661721|NCT00137202|burn wound|burn wound
1661353|NCT00138788|Qualify of life|qualify of life
1661354|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
1661355|NCT00138775|D-serine|d-serine
1661356|NCT00138775|Negative symptoms|negative symptoms
1661357|NCT00138775|Cognition|cognition
1661358|NCT00138775|Schizophrenia|schizophrenia
1661359|NCT00138775|Amino acid|amino acid
1661360|NCT00138736|MBL-deficient|mbl-deficient
1661361|NCT00138736|chemotherapy|chemotherapy
1661362|NCT00138736|neutropenia|neutropenia
1661363|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
1661364|NCT00138710|obesity|obesity
1661365|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
1661366|NCT00138710|aromatase inhibition|aromatase inhibition
1661367|NCT00138697|Agammaglobulinemia|agammaglobulinemia
1661368|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
1661369|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1661370|NCT00138684|insulin resistance|insulin resistance
1661371|NCT00138684|iron overload|iron overload
1661372|NCT00138684|phlebotomy|phlebotomy
1661373|NCT00138684|hepatic iron overload|hepatic iron overload
1661374|NCT00138658|NSCLC|nsclc
1661375|NCT00138658|custirsen sodium|custirsen sodium
1661376|NCT00138658|OGX-011|ogx-011
1661377|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
1661381|NCT00138619|vildagliptin|vildagliptin
1661382|NCT00138606|Type 2 diabetes|type 2 diabetes
1661383|NCT00138606|vildagliptin|vildagliptin
1661384|NCT00138593|Type 2 diabetes|type 2 diabetes
1661385|NCT00138593|vildagliptin|vildagliptin
1661386|NCT00138580|Type 2 diabetes|type 2 diabetes
1661387|NCT00138580|vildagliptin|vildagliptin
1661388|NCT00138567|Type 2 diabetes|type 2 diabetes
1661389|NCT00138567|vildagliptin|vildagliptin
1661390|NCT00138554|Type 2 diabetes|type 2 diabetes
1661391|NCT00138554|vildagliptin|vildagliptin
1661392|NCT00138541|type 2 diabetes|type 2 diabetes
1661393|NCT00138541|vildagliptin|vildagliptin
1661394|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
1661395|NCT00138515|Type 2 diabetes|type 2 diabetes
1661396|NCT00138515|vildagliptin|vildagliptin
1661397|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
1661398|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
1661399|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
1661400|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
1661401|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
1661402|NCT00138437|leprosy|leprosy
1661403|NCT00138437|Colombia|colombia
1661404|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
1661405|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
1661406|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
1661682|NCT00137319|Burns|burns
1661407|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
1661408|NCT00138372|malaria|malaria
1661409|NCT00138372|immunity|immunity
1661410|NCT00138372|MSP-1|msp-1
1661411|NCT00138372|Kenya|kenya
1661412|NCT00138372|infants|infants
1661413|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
1661414|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
1661415|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
1661416|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
1661417|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
1661418|NCT00138294|influenza vaccine|influenza vaccine
1661419|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
1661420|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
1661421|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
1661422|NCT00138294|children|children
1661423|NCT00138294|herd protection|herd protection
1661424|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
1661425|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
1661426|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1661427|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1661428|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1661429|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1661430|NCT00138242|fallopian tube cancer|fallopian tube cancer
1661431|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1661432|NCT00138229|recurrent melanoma|recurrent melanoma
1661433|NCT00138229|stage IV melanoma|stage iv melanoma
1661434|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1661435|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1661722|NCT00137189|Motivation|motivation
1661436|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1661437|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1661438|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
1661439|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
1661440|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1661441|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1661442|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1661443|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
1661444|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
1661445|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
1661446|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1661447|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1661448|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1661449|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1661450|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1661451|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
1661452|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
1661545|NCT00137800|Tarceva|tarceva
1661453|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
1661454|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1661455|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1661456|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1661457|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1661458|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1661459|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1661460|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1661461|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
1661462|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
1661463|NCT00138125|stage IV breast cancer|stage iv breast cancer
1661464|NCT00138125|recurrent breast cancer|recurrent breast cancer
1661465|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
1661466|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1661467|NCT00138112|Hematologic Malignancies|hematologic malignancies
1661468|NCT00138112|Streptococci|streptococci
1661469|NCT00138112|Transplant|transplant
1661470|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
1661471|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
1661472|NCT00138099|Renal Failure|renal failure
1661473|NCT00138099|Critically ill|critically ill
1661474|NCT00138086|lymphoma|lymphoma
1661475|NCT00138086|chemotherapy|chemotherapy
1661476|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
1661477|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
1662272|NCT00134641|vinorelbine|vinorelbine
1661478|NCT00138073|waveform interpretation|waveform interpretation
1661479|NCT00138073|computer-based learning|computer-based learning
1661480|NCT00138073|medical education|medical education
1661481|NCT00138060|genotypic profile|genotypic profile
1661482|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
1661483|NCT00138047|zinc|zinc
1661484|NCT00138047|HIV|hiv
1661485|NCT00138047|children|children
1661486|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
1661487|NCT00138021|Serious mental illness|serious mental illness
1661488|NCT00138021|Supported Employment|supported employment
1661489|NCT00138021|Cognitive remediation|cognitive remediation
1661490|NCT00138021|Cognitive impairments|cognitive impairments
1661491|NCT00138008|prostate cancer|prostate cancer
1661492|NCT00138008|radical prostatectomy|radical prostatectomy
1661493|NCT00138008|PSA failure|psa failure
1661494|NCT00138008|RCT|rct
1661495|NCT00138008|radiation|radiation
1661496|NCT00138008|endocrinotherapy|endocrinotherapy
1661497|NCT00137995|Lymphoma|lymphoma
1661498|NCT00137995|Chemotherapy|chemotherapy
1661499|NCT00137995|rituximab|rituximab
1661500|NCT00137982|Ectopic pregnancy|ectopic pregnancy
1661501|NCT00137982|Surgical treatment|surgical treatment
1661502|NCT00137982|Medical treatment|medical treatment
1661503|NCT00137982|Fertility|fertility
1661504|NCT00137969|Rituxan|rituxan
1661505|NCT00137969|SLE|sle
1661506|NCT00137969|Lupus|lupus
1661507|NCT00137956|Endobronchial Valve|endobronchial valve
1661508|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
1661509|NCT00137956|EBV Procedure|ebv procedure
1661510|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
1661511|NCT00137956|Lung Volume Reduction|lung volume reduction
1661512|NCT00137943|Parent-child communication|parent-child communication
1661513|NCT00137943|Primary prevention|primary prevention
1661514|NCT00137943|sexual risk prevention|sexual risk prevention
1661515|NCT00137943|HIV|hiv
1661516|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
1661517|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
1661518|NCT00137904|multiple sclerosis|multiple sclerosis
1661519|NCT00137904|fatigue|fatigue
1661520|NCT00137904|sleep disorders|sleep disorders
1661521|NCT00137891|Multinodular goiter|multinodular goiter
1661522|NCT00137852|Esophageal Cancer|esophageal cancer
1661523|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
1661524|NCT00137852|Radiation Therapy|radiation therapy
1661525|NCT00137852|Celecoxib|celecoxib
1661526|NCT00137852|Irinotecan|irinotecan
1661527|NCT00137852|Cisplatin|cisplatin
1661528|NCT00137839|Tarceva|tarceva
1661529|NCT00137839|Erlotinib|erlotinib
1661530|NCT00137839|OSI-774|osi-774
1661531|NCT00137839|Adenocarcinoma|adenocarcinoma
1661532|NCT00137839|Advanced Lung Cancer|advanced lung cancer
1661533|NCT00137826|Mesothelioma|mesothelioma
1661534|NCT00137826|Avastin|avastin
1661535|NCT00137826|Bevacizumab|bevacizumab
1661536|NCT00137826|Tarceva|tarceva
1661537|NCT00137826|OSI-774|osi-774
1661538|NCT00137826|Erlotinib|erlotinib
1661539|NCT00137813|Bevacizumab|bevacizumab
1661540|NCT00137813|Docetaxel|docetaxel
1661541|NCT00137813|AvaTax|avatax
1661542|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
1661543|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
1661544|NCT00137800|Elderly Cancer Patients|elderly cancer patients
1661548|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
1661549|NCT00137787|febrile neutropenia|febrile neutropenia
1661550|NCT00137787|hematologic disease|hematologic disease
1661551|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
1661552|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
1661553|NCT00137774|Bevacizumab|bevacizumab
1661554|NCT00137774|Temozolomide|temozolomide
1661555|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
1661556|NCT00137761|Iressa|iressa
1661557|NCT00137761|Docetaxel|docetaxel
1661558|NCT00137748|Lung transplantation|lung transplantation
1661559|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
1661560|NCT00137735|gabapentin|gabapentin
1661561|NCT00137722|Asthma|asthma
1661562|NCT00137722|Disease Management|disease management
1661563|NCT00137722|Outcomes|outcomes
1661564|NCT00137722|Utilization|utilization
1661565|NCT00137709|epilepsy|epilepsy
1661566|NCT00137709|hormone|hormone
1661567|NCT00137696|polio|polio
1661568|NCT00137696|vaccine|vaccine
1661569|NCT00137696|immunogenicity|immunogenicity
1661570|NCT00137683|screening|screening
1661571|NCT00137683|prevention|prevention
1661572|NCT00137683|community health education|community health education
1661573|NCT00137670|Intervention studies|intervention studies
1661574|NCT00137670|HIV|hiv
1661575|NCT00137657|HIV|hiv
1661576|NCT00137657|malaria|malaria
1661577|NCT00137657|E. Coli|e. coli
1661578|NCT00137657|S. pneumoniae|s. pneumoniae
1661579|NCT00137657|drug resistance|drug resistance
1661580|NCT00137657|antifolate|antifolate
1661581|NCT00137657|opportunistic infections|opportunistic infections
1661582|NCT00137657|Africa|africa
1661583|NCT00137657|Kenya|kenya
1661584|NCT00137657|East Africa|east africa
1661585|NCT00137644|Adolescent|adolescent
1661586|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
1661587|NCT00137644|Male|male
1661588|NCT00137644|Humans|humans
1661589|NCT00137644|Risk-Taking|risk-taking
1661590|NCT00137644|Safe Sex|safe sex
1661591|NCT00137644|Sexual Behavior|sexual behavior
1661592|NCT00137644|HIV|hiv
1661593|NCT00137644|HIV Seronegativity|hiv seronegativity
1661594|NCT00137631|Adult|adult
1661595|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
1661596|NCT00137631|Homosexuality, Male|homosexuality, male
1661597|NCT00137631|Humans|humans
1661598|NCT00137631|Male|male
1661599|NCT00137631|Risk-Taking|risk-taking
1661600|NCT00137631|Safe Sex|safe sex
1661601|NCT00137631|Sexual Behavior|sexual behavior
1661602|NCT00137631|HIV|hiv
1661603|NCT00137618|Prostatic neoplasm|prostatic neoplasm
1661604|NCT00137618|Prostate cancer|prostate cancer
1661605|NCT00137618|Informed decision making|informed decision making
1661606|NCT00137618|Prostate cancer screening|prostate cancer screening
1661607|NCT00137618|Prostate specific antigen|prostate specific antigen
1661608|NCT00137605|HIV|hiv
1661609|NCT00137605|HIV Infections|hiv infections
1661610|NCT00137592|screening|screening
1661611|NCT00137592|community health education|community health education
1661612|NCT00137579|Influenza Vaccines|influenza vaccines
1661613|NCT00137579|Acenocoumarol|acenocoumarol
1661614|NCT00137579|Drug Administration Routes|drug administration routes
1661615|NCT00137579|Anticoagulants|anticoagulants
1661616|NCT00137566|malaria|malaria
1661617|NCT00137566|treatment|treatment
1661618|NCT00137566|paracetamol|paracetamol
1661619|NCT00137566|chloroquine|chloroquine
1661620|NCT00137566|Guinea-Bissau|guinea-bissau
1661621|NCT00137566|children|children
1661622|NCT00137566|P.falciparum|p.falciparum
1661623|NCT00137553|Children|children
1661624|NCT00137553|malaria|malaria
1661625|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1661626|NCT00137553|Guinea-Bissau|guinea-bissau
1661627|NCT00137553|treatment|treatment
1661628|NCT00137540|First line ablation therapy|first line ablation therapy
1661629|NCT00137527|Cardiac Surgery|cardiac surgery
1661630|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
1661631|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
1661632|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
1661633|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
1661634|NCT00137527|Neurological manifestations|neurological manifestations
1661635|NCT00137527|Memory loss|memory loss
1661636|NCT00137527|Delirium|delirium
1661637|NCT00137527|Coronary Artery Bypass|coronary artery bypass
1661638|NCT00137514|malaria|malaria
1661639|NCT00137514|Plasmodium falciparum|plasmodium falciparum
1661640|NCT00137514|chloroquine|chloroquine
1661641|NCT00137514|amodiaquine|amodiaquine
1661642|NCT00137514|treatment|treatment
1661643|NCT00137514|Guinea-Bissau|guinea-bissau
1661644|NCT00137514|children|children
1661645|NCT00137488|non-enhancing lesion|non-enhancing lesion
1661646|NCT00137488|low grade glioma|low grade glioma
1661647|NCT00137488|high risk group selection|high risk group selection
1661648|NCT00137475|IMRT|imrt
1661649|NCT00137475|head and neck cancer|head and neck cancer
1661650|NCT00137475|parotid sparing|parotid sparing
1661745|NCT00136890|Positron-Emission Tomography|positron-emission tomography
1661746|NCT00136890|PET Scan|pet scan
1661651|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
1661652|NCT00137384|Magnetoencephalogram|magnetoencephalogram
1661653|NCT00137384|Functional Connectivity|functional connectivity
1661654|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
1661655|NCT00137384|Focal Hand Dystonia|focal hand dystonia
1661656|NCT00137384|Spectral Analysis|spectral analysis
1661657|NCT00137384|Healthy Volunteer|healthy volunteer
1661659|NCT00137371|Postmenopause|postmenopause
1661660|NCT00137371|Vaginitis|vaginitis
1661661|NCT00137358|Cervical|cervical
1661662|NCT00137358|Uterine|uterine
1661663|NCT00137358|Para-aortic|para-aortic
1661664|NCT00137358|Nodes|nodes
1661665|NCT00137358|IMRT|imrt
1661666|NCT00137358|Cancer|cancer
1661667|NCT00137345|Randomized controlled trial|randomized controlled trial
1661668|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
1661669|NCT00137345|Drug therapy|drug therapy
1661670|NCT00137345|Immunosuppression|immunosuppression
1661671|NCT00137345|Treatment outcome|treatment outcome
1661672|NCT00137345|Kidney transplantation|kidney transplantation
1661673|NCT00137345|Kidney function tests|kidney function tests
1661674|NCT00137332|Arrhythmia|arrhythmia
1661675|NCT00137332|antiarrhythmic|antiarrhythmic
1661676|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
1661677|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
1661678|NCT00137319|blood pressure regulation|blood pressure regulation
1661679|NCT00137319|head-up tilt test|head-up tilt test
1661680|NCT00137319|tilt table testing|tilt table testing
1661681|NCT00137319|burn injury|burn injury
1661683|NCT00137306|Guideline Adherence|guideline adherence
1661684|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
1661685|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
1661686|NCT00137280|Randomized Controlled Trial|randomized controlled trial
1661687|NCT00137280|Quality of Health Care|quality of health care
1661688|NCT00137280|Health Services Research|health services research
1661689|NCT00137280|Guidelines|guidelines
1661690|NCT00137280|Medical Informatics Computing|medical informatics computing
1661691|NCT00137280|Services, Mental Health|services, mental health
1661692|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
1661693|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
1661694|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
1661695|NCT00137280|Veterans|veterans
1661696|NCT00137280|Unemployment|unemployment
1661697|NCT00137280|Obesity|obesity
1661698|NCT00137280|Quality Improvement|quality improvement
1661699|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
1661700|NCT00137267|Substance-related disorders|substance-related disorders
1661701|NCT00137267|Community Mental Health Services|community mental health services
1661702|NCT00137267|Case Management|case management
1661703|NCT00137267|Health Education|health education
1661704|NCT00137254|Severe burns|severe burns
1661705|NCT00137254|Hyperinsulinemia|hyperinsulinemia
1661706|NCT00137254|Insulin|insulin
1661707|NCT00137254|Muscle protein kinetics|muscle protein kinetics
1661708|NCT00137254|Immune function|immune function
1661709|NCT00137254|Exercise|exercise
1661710|NCT00137241|health literacy|health literacy
1661711|NCT00137241|screening|screening
1661712|NCT00137241|cancer|cancer
1661713|NCT00137241|health disparities|health disparities
1661714|NCT00137228|Hand Edema|hand edema
1661715|NCT00137228|Figure of eight method|figure of eight method
1661716|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
1661717|NCT00137215|burns|burns
1661718|NCT00137215|donor site care|donor site care
1661719|NCT00137215|Silverlon dressing|silverlon dressing
1661723|NCT00137189|Music Therapy|music therapy
1661724|NCT00137189|Psychotherapy|psychotherapy
1661725|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
1661726|NCT00137163|burns|burns
1661727|NCT00137163|donor site care|donor site care
1661728|NCT00137163|Dermafill dressing|dermafill dressing
1661729|NCT00137124|Essential hypertension|essential hypertension
1661730|NCT00137111|Leukemia|leukemia
1661731|NCT00137085|procedural sedation|procedural sedation
1661732|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
1661733|NCT00136929|AMI|ami
1661734|NCT00136929|MI|mi
1661735|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
1661736|NCT00136903|Graft vs Host Disease|graft vs host disease
1661737|NCT00136903|GVHD|gvhd
1661738|NCT00136903|Graft Versus Host Disease|graft versus host disease
1661739|NCT00136903|Bone marrow transplant|bone marrow transplant
1661740|NCT00136903|Stem cells|stem cells
1661741|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
1661742|NCT00136903|Adult stem cells|adult stem cells
1661743|NCT00136903|Leukemia|leukemia
1661744|NCT00136903|Lymphoma|lymphoma
1661748|NCT00136890|Thoracic Surgery|thoracic surgery
1661749|NCT00136890|Diagnostic|diagnostic
1661750|NCT00136890|Randomized Controlled Trial|randomized controlled trial
1661751|NCT00136890|Oncology|oncology
1661752|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
1661753|NCT00136877|streptococcus|streptococcus
1661754|NCT00136877|tonsillectomy|tonsillectomy
1661755|NCT00136877|prevention|prevention
1661756|NCT00136864|Positron-Emission Tomography|positron-emission tomography
1661757|NCT00136864|PET Scan|pet scan
1661758|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1661759|NCT00136864|Diagnosis|diagnosis
1661760|NCT00136864|Radiation Oncology|radiation oncology
1661761|NCT00136864|Lung Cancer|lung cancer
1661762|NCT00136864|Randomized Controlled Trial|randomized controlled trial
1661763|NCT00136864|Oncology|oncology
1661764|NCT00136864|Radiation Planning|radiation planning
1661765|NCT00136851|Hypertension|hypertension
1661766|NCT00136838|tobacco use|tobacco use
1661768|NCT00136825|treatment|treatment
1661769|NCT00136812|tobacco|tobacco
1661770|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
1661771|NCT00136799|high cholesterol|high cholesterol
1661772|NCT00136799|adults|adults
1661773|NCT00136799|fluvastatin|fluvastatin
1661774|NCT00136786|tobacco use|tobacco use
1661775|NCT00136773|Albuminuria|albuminuria
1661776|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
1661777|NCT00136773|Hypertension|hypertension
1661778|NCT00136760|tobacco|tobacco
1661779|NCT00136747|tobacco use|tobacco use
1661780|NCT00136734|ADHD|adhd
1661781|NCT00136734|Cocaine dependence|cocaine dependence
1661782|NCT00136734|treatment|treatment
1661783|NCT00136734|methylphenidate|methylphenidate
1661784|NCT00136721|Parkinson's disease|parkinson's disease
1661785|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
1661786|NCT00136721|mutations spectrum|mutations spectrum
1661787|NCT00136721|candidate genes|candidate genes
1661788|NCT00136708|Global Network|global network
1661789|NCT00136708|Neonatal mortality|neonatal mortality
1661790|NCT00136708|Asphyxia|asphyxia
1661791|NCT00136708|Maternal and child health|maternal and child health
1661792|NCT00136708|International|international
1661793|NCT00136708|Zambia|zambia
1661794|NCT00136708|Pakistan|pakistan
1661795|NCT00136708|India|india
1661796|NCT00136708|Democratic Republic of Congo|democratic republic of congo
1661797|NCT00136708|Uruguay|uruguay
1661798|NCT00136708|Guatemala|guatemala
1661799|NCT00136708|Argentina|argentina
1661800|NCT00136708|Neonatal resuscitation|neonatal resuscitation
1661801|NCT00136695|Aging|aging
1661802|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
1661803|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
1661804|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
1661805|NCT00136669|Acupuncture|acupuncture
1661806|NCT00136669|Pain|pain
1661807|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
1661808|NCT00136656|infant|infant
1661809|NCT00136656|children|children
1661810|NCT00136656|pyelonephritis|pyelonephritis
1661811|NCT00136656|Renal scars|renal scars
1661812|NCT00136656|DMSA scan|dmsa scan
1661813|NCT00136643|microbicide|microbicide
1661814|NCT00136643|Women|women
1661815|NCT00136643|Prevention|prevention
1661816|NCT00136643|HIV|hiv
1661817|NCT00136643|STIs|stis
1661818|NCT00136643|HIV Seronegativity|hiv seronegativity
1661819|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
1661820|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
1661821|NCT00136630|new rate scales|new rate scales
1661822|NCT00136630|natural history|natural history
1661823|NCT00136630|molecular biology|molecular biology
1661824|NCT00136630|candidate genes|candidate genes
1661825|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
1661826|NCT00136617|Documentation|documentation
1661827|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
1661828|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
1661829|NCT00136591|follicular lymphoma|follicular lymphoma
1661830|NCT00136591|bortezomib|bortezomib
1661831|NCT00136591|relapse|relapse
1661832|NCT00136578|solid tumors|solid tumors
1661833|NCT00136578|dose limiting toxicity|dose limiting toxicity
1661834|NCT00136578|carboplatin|carboplatin
1661835|NCT00136578|tolerability|tolerability
1661836|NCT00136578|Safety|safety
1661837|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
1661838|NCT00136565|bortezomib|bortezomib
1661839|NCT00136565|ACVBP regimen|acvbp regimen
1661840|NCT00136552|lymphoma|lymphoma
1661841|NCT00136552|follicular|follicular
1661842|NCT00136552|B-cell|b-cell
1661843|NCT00136552|rituximab|rituximab
1661844|NCT00136552|interferon|interferon
1661845|NCT00136539|Breast Cancer|breast cancer
1661846|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
1661847|NCT00136539|HER2-positive|her2-positive
1661848|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
1661849|NCT00136539|Herceptin|herceptin
1661850|NCT00136539|Taxol|taxol
1661851|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
1661852|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
1661853|NCT00136526|Prostate Cancer|prostate cancer
1661854|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
1661855|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
1661856|NCT00136513|Safety|safety
1661857|NCT00136513|tolerability|tolerability
1661858|NCT00136513|dose limiting toxicity|dose limiting toxicity
1661859|NCT00136513|solid tumors|solid tumors
1661860|NCT00136500|genetics|genetics
1661861|NCT00136500|biomarkers|biomarkers
1661862|NCT00136500|pre-symptomatic|pre-symptomatic
1661863|NCT00136500|natural history|natural history
1661864|NCT00136487|Prostate Cancer|prostate cancer
1661865|NCT00136487|Cancer of Prostate|cancer of prostate
1661866|NCT00136487|Cancer of the Prostate|cancer of the prostate
1661867|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
1661868|NCT00136474|Lymphoma|lymphoma
1661869|NCT00136474|Radiation therapy|radiation therapy
1661870|NCT00136474|Amifostine|amifostine
1661871|NCT00136461|AML|aml
1661872|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
1661873|NCT00136461|MDS|mds
1661874|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
1661875|NCT00136461|bryostatin 1|bryostatin 1
1661876|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
1661877|NCT00136461|ATRA|atra
1661878|NCT00136448|AML|aml
1661879|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
1661880|NCT00136448|cytarabine|cytarabine
1661881|NCT00136448|interleukin-2|interleukin-2
1661882|NCT00136435|ALL|all
1661883|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1661884|NCT00136435|chemotherapy|chemotherapy
1661885|NCT00136435|asparaginase|asparaginase
1661886|NCT00136422|AML|aml
1661887|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
1661889|NCT00136422|myelodysplasia|myelodysplasia
1661890|NCT00136422|vaccine|vaccine
1661891|NCT00136409|myelofibrosis|myelofibrosis
1661892|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
1661893|NCT00136409|CMML|cmml
1661894|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1661895|NCT00136409|imatinib mesylate|imatinib mesylate
1661896|NCT00136409|Gleevec|gleevec
1661897|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
1661898|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
1661899|NCT00136396|GVHD|gvhd
1661900|NCT00136396|steroid-refractory|steroid-refractory
1661901|NCT00136396|rituximab|rituximab
1661902|NCT00136370|Chlorhexidine|chlorhexidine
1661903|NCT00136370|Prevention|prevention
1661904|NCT00136370|Neonatal sepsis|neonatal sepsis
1661905|NCT00136370|Peripartum infections|peripartum infections
1661906|NCT00136357|posttraumatic stress|posttraumatic stress
1661907|NCT00136357|mind-body techniques|mind-body techniques
1661908|NCT00136357|war|war
1661909|NCT00136357|adolescents|adolescents
1661910|NCT00136344|cataract surgery|cataract surgery
1661911|NCT00136344|phacoemulsification|phacoemulsification
1661912|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
1661913|NCT00136331|Pandemic|pandemic
1661914|NCT00136331|Influenza|influenza
1661915|NCT00136331|Prevention|prevention
1661916|NCT00136331|Vaccine|vaccine
1661917|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
1661918|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
1661919|NCT00136305|pediatric asthma|pediatric asthma
1661920|NCT00136305|asthma action plans|asthma action plans
1661921|NCT00136305|patient education|patient education
1661922|NCT00136305|medication adherence|medication adherence
1661923|NCT00136292|Gram-Positive Infection|gram-positive infection
1661924|NCT00136279|adolescent behavior|adolescent behavior
1661925|NCT00136279|sexual behavior|sexual behavior
1661926|NCT00136279|smoking|smoking
1661927|NCT00136279|parents|parents
1661928|NCT00136279|communication|communication
1661929|NCT00136279|health education|health education
1661930|NCT00136279|schools|schools
1661931|NCT00136279|Sexual initiation|sexual initiation
1661932|NCT00136266|Adherence|adherence
1661933|NCT00136266|Supplements|supplements
1661934|NCT00136266|Iron|iron
1661935|NCT00136266|Iron deficiency|iron deficiency
1661936|NCT00136266|Anemia|anemia
1661937|NCT00136266|Vitamins|vitamins
1661938|NCT00136266|Minerals|minerals
1661939|NCT00136227|screening,|screening,
1661940|NCT00136227|community health education,|community health education,
1661941|NCT00136227|decision making,|decision making,
1661942|NCT00136227|computer-assisted decision making|computer-assisted decision making
1661943|NCT00136201|Peritonitis|peritonitis
1661944|NCT00136201|Community-Acquired Infections|community-acquired infections
1661945|NCT00136201|Cross Infection|cross infection
1661946|NCT00136188|Prediabetes|prediabetes
1661947|NCT00136188|Metabolic Syndrome|metabolic syndrome
1661948|NCT00136188|Healthy Controls|healthy controls
1661949|NCT00136188|Endothelial function|endothelial function
1661950|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
1661951|NCT00136110|ALS|als
1661952|NCT00136110|Sodium Valproate|sodium valproate
1661953|NCT00136110|randomised trial|randomised trial
1662625|NCT00133744|mortality|mortality
1661954|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
1661955|NCT00136097|colonisation of the catheter|colonisation of the catheter
1661956|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
1661957|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
1661958|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
1661959|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
1661960|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
1661961|NCT00136071|TOT,|tot,
1661962|NCT00136071|TVT-O|tvt-o
1661963|NCT00136058|osteoporosis|osteoporosis
1661964|NCT00136058|hip fracture|hip fracture
1661965|NCT00136045|Idiopathic RLS|idiopathic rls
1661966|NCT00136032|Growth Hormone|growth hormone
1661967|NCT00136032|Cardiovascular risk|cardiovascular risk
1661968|NCT00136032|Pituitary|pituitary
1661969|NCT00136032|Hypothalamic|hypothalamic
1661970|NCT00136032|GH Deficiency|gh deficiency
1661971|NCT00136032|Pituitary Tumor|pituitary tumor
1661972|NCT00136032|Pituitary Disease|pituitary disease
1661973|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
1661974|NCT00136006|Epidemiology|epidemiology
1661975|NCT00136006|Lung health|lung health
1661976|NCT00136006|lung function|lung function
1661977|NCT00136006|COPD|copd
1661978|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
1661979|NCT00135967|membranous nephropathy|membranous nephropathy
1661980|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
1661981|NCT00135967|cyclophosphamide|cyclophosphamide
1661982|NCT00135967|prednisone|prednisone
1661983|NCT00135954|membranous nephropathy|membranous nephropathy
1661984|NCT00135954|cyclophosphamide|cyclophosphamide
1661985|NCT00135954|prednisone|prednisone
1661986|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1661987|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
1661988|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
1661989|NCT00135928|stem cells|stem cells
1661990|NCT00135902|Preterm birth|preterm birth
1661991|NCT00135902|Progesterone|progesterone
1661992|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
1661993|NCT00135902|Pregnancy|pregnancy
1661994|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
1661995|NCT00135876|deep vein thrombosis|deep vein thrombosis
1661996|NCT00135876|pulmonary embolism|pulmonary embolism
1661997|NCT00135876|glioma|glioma
1661998|NCT00135876|fragmin|fragmin
1661999|NCT00135876|anticoagulant|anticoagulant
1662000|NCT00135876|prophylaxis|prophylaxis
1662001|NCT00135876|dalteparin|dalteparin
1662002|NCT00135850|Gene therapy|gene therapy
1662003|NCT00135850|VEGF|vegf
1662004|NCT00135850|Stem cells|stem cells
1662005|NCT00135850|myocardial ischemia|myocardial ischemia
1662006|NCT00135850|angiogenesis|angiogenesis
1662007|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
1662008|NCT00135837|AMD,|amd,
1662009|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
1662010|NCT00135837|occult CNV lesion,|occult cnv lesion,
1662011|NCT00135837|verteporfin for injection,|verteporfin for injection,
1662012|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
1662013|NCT00135824|Artificial eye drops|artificial eye drops
1662014|NCT00135824|tolerability|tolerability
1662015|NCT00135824|healthy volunteers|healthy volunteers
1662016|NCT00135824|povidone|povidone
1662017|NCT00135824|healthy subjects|healthy subjects
1662018|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1662019|NCT00135798|Hepatitis C|hepatitis c
1662020|NCT00135798|Ribavirin|ribavirin
1662021|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
1662022|NCT00135772|nicotine dependence|nicotine dependence
1662023|NCT00135759|opiate dependence|opiate dependence
1662024|NCT00135746|tobacco|tobacco
1662025|NCT00135733|Lichen Planus|lichen planus
1662026|NCT00135733|Mucosal lichen planus|mucosal lichen planus
1662027|NCT00135733|Alefacept|alefacept
1662028|NCT00135733|T-cell mediated|t-cell mediated
1662029|NCT00135733|subcutaneous medication|subcutaneous medication
1662030|NCT00135733|Autoimmune disease|autoimmune disease
1662031|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
1662032|NCT00135720|Chronic Pemphigus|chronic pemphigus
1662033|NCT00135720|Etanercept|etanercept
1662034|NCT00135720|Enbrel|enbrel
1662035|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
1662036|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
1662037|NCT00135720|biologic|biologic
1662038|NCT00135720|immunomodulator|immunomodulator
1662039|NCT00135720|subcutaneous medication|subcutaneous medication
1662040|NCT00135707|Antioxidants|antioxidants
1662041|NCT00135707|Preeclampsia|preeclampsia
1662042|NCT00135707|Pregnancy|pregnancy
1662043|NCT00135707|Hypertension|hypertension
1662044|NCT00135694|hepatitis|hepatitis
1662045|NCT00135694|hepatitis C|hepatitis c
1662046|NCT00135694|HCV|hcv
1662047|NCT00135694|liver|liver
1662048|NCT00135694|liver disease|liver disease
1662049|NCT00135694|liver transplant|liver transplant
1662050|NCT00135694|liver transplantation|liver transplantation
1662051|NCT00135694|transplant|transplant
1662052|NCT00135694|hepatic|hepatic
1662053|NCT00135694|hepatic transplantation|hepatic transplantation
1662054|NCT00135694|immunosuppression|immunosuppression
1662055|NCT00135694|rejection|rejection
1662056|NCT00135668|children|children
1662057|NCT00135668|sodium nitroprusside|sodium nitroprusside
1662058|NCT00135668|controlled hypotension|controlled hypotension
1662059|NCT00135668|dose-response|dose-response
1662060|NCT00135668|pharmacokinetics|pharmacokinetics
1662061|NCT00135668|pharmacodynamics|pharmacodynamics
1662063|NCT00135668|efficacy|efficacy
1662064|NCT00135655|macular edema|macular edema
1662065|NCT00135655|post cataract extraction|post cataract extraction
1662066|NCT00135655|cystoid macular edema|cystoid macular edema
1662067|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
1662068|NCT00135642|Hayfever|hayfever
1662069|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
1662070|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
1662071|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
1662072|NCT00135629|Hayfever|hayfever
1662073|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
1662074|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
1662075|NCT00135629|Late cutaneous response|late cutaneous response
1662076|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
1662077|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
1662078|NCT00135616|urinary incontinence|urinary incontinence
1662079|NCT00135616|stress incontinence|stress incontinence
1662080|NCT00135616|urethra|urethra
1662081|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
1662082|NCT00135616|suburethral sling|suburethral sling
1662083|NCT00135603|appendicitis.|appendicitis.
1662084|NCT00135603|adult.|adult.
1662085|NCT00135603|treatment.|treatment.
1662086|NCT00135603|antibiotic therapy.|antibiotic therapy.
1662087|NCT00135603|CT scanning.|ct scanning.
1662088|NCT00135603|randomized trial|randomized trial
1662089|NCT00135603|safety|safety
1662090|NCT00135590|Protein pulse-feeding|protein pulse-feeding
1662091|NCT00135590|Nutritional supplementation|nutritional supplementation
1662092|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
1662093|NCT00135590|Elderly subjects|elderly subjects
1662094|NCT00135590|Body composition|body composition
1662095|NCT00135577|opioids|opioids
1662096|NCT00135577|constipation|constipation
1662097|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
1662098|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
1662099|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
1662100|NCT00135551|Hypertension|hypertension
1662101|NCT00135551|Multicenter clinical trial|multicenter clinical trial
1662102|NCT00135551|PROBE|probe
1662103|NCT00135551|Combination therapy|combination therapy
1662104|NCT00135551|Benidipine|benidipine
1662105|NCT00135551|Essential Hypertension|essential hypertension
1662106|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1662107|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
1662108|NCT00135538|Rehabilitation|rehabilitation
1662109|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
1662110|NCT00135512|MDD|mdd
1662111|NCT00135499|Lymphoma|lymphoma
1662112|NCT00135499|chemotherapy|chemotherapy
1662113|NCT00135499|rituximab|rituximab
1662114|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
1662115|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
1662116|NCT00135473|Severe sepsis|severe sepsis
1662117|NCT00135473|septic shock|septic shock
1662118|NCT00135473|volume substitution|volume substitution
1662119|NCT00135473|intensive insulin therapy|intensive insulin therapy
1662120|NCT00135473|colloids|colloids
1662597|NCT00133835|Lithotripsy|lithotripsy
1662121|NCT00135473|crystalloids|crystalloids
1662122|NCT00135473|outcome|outcome
1662123|NCT00135473|safety|safety
1662124|NCT00135460|HIV|hiv
1662125|NCT00135460|Lipoatrophy|lipoatrophy
1662126|NCT00135460|Lipodystrophy|lipodystrophy
1662127|NCT00135460|Treatment Naive|treatment naive
1662128|NCT00135460|HIV Infections|hiv infections
1662129|NCT00135460|Hypercholesterolemia|hypercholesterolemia
1662130|NCT00135447|HIV/AIDS|hiv/aids
1662131|NCT00135447|Treatment Experienced|treatment experienced
1662132|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
1662133|NCT00135395|HIV/AIDS|hiv/aids
1662134|NCT00135395|Treatment Experienced|treatment experienced
1662135|NCT00135382|HIV/AIDS|hiv/aids
1662136|NCT00135369|HIV-AIDS|hiv-aids
1662137|NCT00135356|HIV infections|hiv infections
1662138|NCT00135343|HIV/AIDS|hiv/aids
1662139|NCT00135330|diabetes|diabetes
1662140|NCT00135330|exenatide|exenatide
1662141|NCT00135330|rosiglitazone|rosiglitazone
1662142|NCT00135330|Amylin|amylin
1662143|NCT00135330|Lilly|lilly
1662144|NCT00135317|oncology|oncology
1662145|NCT00135317|darbepoetin alfa|darbepoetin alfa
1662146|NCT00135317|Aranesp®|aranesp®
1662147|NCT00135317|Amgen|amgen
1662148|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
1662149|NCT00135304|Vitamin D|vitamin d
1662150|NCT00135304|Sensipar®|sensipar®
1662151|NCT00135304|Cinacalcet HCl|cinacalcet hcl
1662152|NCT00135304|Chronic Kidney Disease|chronic kidney disease
1662153|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
1662154|NCT00135291|leukoreduction|leukoreduction
1662155|NCT00135291|surgical site infections|surgical site infections
1662156|NCT00135291|nosocomial infections|nosocomial infections
1662157|NCT00135291|transfusion|transfusion
1662158|NCT00135291|Infection|infection
1662159|NCT00135291|Sepsis|sepsis
1662160|NCT00135291|Hemorrhage|hemorrhage
1662161|NCT00135278|Neuroprotection|neuroprotection
1662162|NCT00135278|inflammation|inflammation
1662163|NCT00135278|cytokines|cytokines
1662165|NCT00135265|smoking cessation|smoking cessation
1662166|NCT00135265|adolescents|adolescents
1662167|NCT00135252|developing chronic lung disease|developing chronic lung disease
1662168|NCT00135239|back|back
1662169|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
1662170|NCT00135239|Rehabilitation|rehabilitation
1662171|NCT00135226|Diabetes Mellitus|diabetes mellitus
1662172|NCT00135226|Cardiovascular Disease|cardiovascular disease
1662173|NCT00135226|Aspirin|aspirin
1662174|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
1662175|NCT00135226|Primary prevention|primary prevention
1662176|NCT00135226|Randomized Controlled Trial|randomized controlled trial
1662177|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
1662178|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1662369|NCT00134134|biologic|biologic
1662179|NCT00135213|passive smoking|passive smoking
1662180|NCT00135213|pediatric practice|pediatric practice
1662181|NCT00135213|smoking cessation|smoking cessation
1662182|NCT00135174|Pacemaker|pacemaker
1662184|NCT00135174|follow-up|follow-up
1662185|NCT00135174|complications|complications
1662186|NCT00135174|Quality of Life|quality of life
1662187|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
1662188|NCT00135135|Cancer|cancer
1662189|NCT00135135|Childhood Tumor|childhood tumor
1662190|NCT00135135|Neoplasms|neoplasms
1662191|NCT00135122|migraine|migraine
1662192|NCT00135122|analgesics|analgesics
1662193|NCT00135122|tension type headache|tension type headache
1662194|NCT00135070|Diabetes Mellitus|diabetes mellitus
1662195|NCT00135044|taurine|taurine
1662196|NCT00135044|intestinal failure|intestinal failure
1662197|NCT00135044|HPN|hpn
1662198|NCT00135044|hepatobiliary complications|hepatobiliary complications
1662199|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
1662200|NCT00135005|GIST|gist
1662201|NCT00135005|AMN107|amn107
1662202|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
1662203|NCT00134992|Prednisolone acetate|prednisolone acetate
1662204|NCT00134992|eye drops|eye drops
1662205|NCT00134992|tolerability|tolerability
1662206|NCT00134992|Healthy volunteers|healthy volunteers
1662207|NCT00134979|COPD, formoterol,|copd, formoterol,
1662208|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
1662209|NCT00134953|Mild cognitive impairment|mild cognitive impairment
1662210|NCT00134953|Alzheimer's disease|alzheimer's disease
1662211|NCT00134953|Dementia|dementia
1662212|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1662213|NCT00134940|Transplantation, heart|transplantation, heart
1662214|NCT00134940|Organ transplant|organ transplant
1662215|NCT00134914|opiate dependence|opiate dependence
1662216|NCT00134901|Cocaine dependence|cocaine dependence
1662217|NCT00134901|treatment|treatment
1662218|NCT00134901|memantine|memantine
1662219|NCT00134888|Opioid Dependence|opioid dependence
1662220|NCT00134875|opioid dependence|opioid dependence
1662221|NCT00134849|hypertension|hypertension
1662222|NCT00134823|Parent Experience of Care|parent experience of care
1662223|NCT00134823|Quality Improvement|quality improvement
1662224|NCT00134823|Medication Errors|medication errors
1662225|NCT00134823|Abnormal Lab Values|abnormal lab values
1662226|NCT00134823|Guideline Adherence|guideline adherence
1662227|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
1662228|NCT00134797|GFR|gfr
1662229|NCT00134797|serum creatinine|serum creatinine
1662230|NCT00134784|parkinson|parkinson
1662231|NCT00134784|brain imaging|brain imaging
1662232|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
1662233|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
1662234|NCT00134771|Singletons|singletons
1662235|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
1662236|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
1662237|NCT00134758|Adenoma|adenoma
1662238|NCT00134745|Turner Syndrome|turner syndrome
1662239|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
1662240|NCT00134745|Bone mineralization|bone mineralization
1662241|NCT00134745|Uterine size|uterine size
1662242|NCT00134745|aortic root dilatation|aortic root dilatation
1662342|NCT00134342|immunologic tests|immunologic tests
1662243|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
1662244|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
1662245|NCT00134706|Prostate Cancer|prostate cancer
1662246|NCT00134706|Cancer of the prostate|cancer of the prostate
1662247|NCT00134706|Cancer of prostate|cancer of prostate
1662248|NCT00134706|Docetaxel|docetaxel
1662249|NCT00134706|Carboplatin|carboplatin
1662250|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
1662251|NCT00134680|estrogen receptor positive|estrogen receptor positive
1662252|NCT00134680|progesterone receptor positive|progesterone receptor positive
1662253|NCT00134680|ErbB2 positive|erbb2 positive
1662254|NCT00134680|metastatic breast cancer|metastatic breast cancer
1662255|NCT00134667|AMD|amd
1662256|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
1662257|NCT00134667|Macular Degeneration|macular degeneration
1662259|NCT00134667|Photodynamic Therapy|photodynamic therapy
1662260|NCT00134667|PDT|pdt
1662261|NCT00134667|Visudyne|visudyne
1662262|NCT00134667|pegaptanib sodium|pegaptanib sodium
1662263|NCT00134667|verteporfin|verteporfin
1662264|NCT00134667|Predominantly Classic|predominantly classic
1662265|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1662266|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
1662267|NCT00134654|Premarin|premarin
1662268|NCT00134654|conjugated estrogen|conjugated estrogen
1662269|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
1662270|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
1662271|NCT00134641|gemcitabine|gemcitabine
1662273|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
1662274|NCT00134628|Radiation injuries|radiation injuries
1662275|NCT00134628|Prophylaxis|prophylaxis
1662276|NCT00134628|Proctitis|proctitis
1662277|NCT00134628|Cystitis|cystitis
1662278|NCT00134628|Enteritis|enteritis
1662279|NCT00134628|Osteoradionecrosis|osteoradionecrosis
1662280|NCT00134615|decision-making|decision-making
1662281|NCT00134615|patient activation|patient activation
1662282|NCT00134615|empowerment|empowerment
1662283|NCT00134615|mental health|mental health
1662284|NCT00134615|Depression|depression
1662285|NCT00134615|Anxiety|anxiety
1662286|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
1662287|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
1662288|NCT00134589|Academic Detailing|academic detailing
1662289|NCT00134589|Decision Aid|decision aid
1662290|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
1662291|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
1662292|NCT00134589|COLONIC POLYPS|colonic polyps
1662293|NCT00134563|Multiple Sclerosis|multiple sclerosis
1662294|NCT00134563|Relapsing Remitting|relapsing remitting
1662295|NCT00134563|Secondary Progressive|secondary progressive
1662296|NCT00134563|Progressive Relapsing|progressive relapsing
1662297|NCT00134550|Diabetes Mellitus|diabetes mellitus
1662298|NCT00134550|Foot ulcers|foot ulcers
1662299|NCT00134550|Complication|complication
1662300|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
1662301|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
1662302|NCT00134524|Magnetics|magnetics
1662303|NCT00134524|Electromagnetics|electromagnetics
1662304|NCT00134524|Diabetic neuropathy|diabetic neuropathy
1662305|NCT00134524|Pain|pain
1662306|NCT00134472|Hypothermia, induced|hypothermia, induced
1662307|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
1662308|NCT00134472|Anesthesia|anesthesia
1662309|NCT00134472|Neuro-intensive care|neuro-intensive care
1662310|NCT00134472|neurochemistry|neurochemistry
1662311|NCT00134459|Depression|depression
1662312|NCT00134459|Bipolar Disorder|bipolar disorder
1662313|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
1662314|NCT00134446|PTSD|ptsd
1662315|NCT00134446|trauma|trauma
1662316|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
1662317|NCT00134446|randomized clinical trial|randomized clinical trial
1662318|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
1662319|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
1662320|NCT00134420|Growth Hormone|growth hormone
1662321|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
1662322|NCT00134420|Child|child
1662323|NCT00134407|Nutrition|nutrition
1662324|NCT00134407|Postoperative|postoperative
1662325|NCT00134407|oral|oral
1662326|NCT00134407|jejunal|jejunal
1662327|NCT00134407|feeding|feeding
1662328|NCT00134407|Surgery|surgery
1662329|NCT00134407|major|major
1662330|NCT00134407|abdominal|abdominal
1662331|NCT00134407|adult|adult
1662332|NCT00134394|psoriasis|psoriasis
1662333|NCT00134394|tacrolimus|tacrolimus
1662334|NCT00134394|etanercept|etanercept
1662335|NCT00134381|Normal volunteer study|normal volunteer study
1662336|NCT00134368|vitiligo|vitiligo
1662337|NCT00134368|etanercept|etanercept
1662338|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
1662339|NCT00134355|vatalanib|vatalanib
1662340|NCT00134342|tuberculosis|tuberculosis
1662341|NCT00134342|tuberculin test|tuberculin test
1662343|NCT00134342|Latent tuberculosis|latent tuberculosis
1662344|NCT00134342|end stage renal disease|end stage renal disease
1662345|NCT00134342|solid organ transplantation|solid organ transplantation
1662346|NCT00134342|bone marrow transplantation|bone marrow transplantation
1662347|NCT00134342|rheumatologic disease|rheumatologic disease
1662348|NCT00134316|sexual dysfunction|sexual dysfunction
1662349|NCT00134251|Parkinson's disease|parkinson's disease
1662350|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
1662351|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
1662352|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
1662353|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
1662354|NCT00134225|Musculoskeletal disease|musculoskeletal disease
1662355|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
1662356|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
1662357|NCT00134186|Kidney cancer|kidney cancer
1662358|NCT00134186|Renal cell carcinoma|renal cell carcinoma
1662359|NCT00134186|Motexafin gadolinium|motexafin gadolinium
1662360|NCT00134160|Aged|aged
1662361|NCT00134160|Hypertension|hypertension
1662362|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
1662363|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1662364|NCT00134160|Calcium Channel Blockers|calcium channel blockers
1662365|NCT00134160|Combination Drug Therapy|combination drug therapy
1662366|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
1662367|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
1662368|NCT00134134|efalizumab|efalizumab
1662370|NCT00134134|Raptiva|raptiva
1662371|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1662372|NCT00134095|stage II gastric cancer|stage ii gastric cancer
1662373|NCT00134095|stage III gastric cancer|stage iii gastric cancer
1662374|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
1662375|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1662376|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1662377|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
1662378|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
1662379|NCT00134056|bone metastases|bone metastases
1662380|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1662381|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
1662382|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1662383|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1662384|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1662385|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1662386|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1662387|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1662388|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1662389|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1662390|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1662391|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1662392|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1662393|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1662394|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1662395|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1662396|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1662397|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1662398|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1663073|NCT00131716|severe|severe
1662399|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1662400|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1662401|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1662402|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1662403|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1662404|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1662405|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1662406|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1662407|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1662408|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
1662409|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
1662410|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1662411|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1662412|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1662413|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1662414|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1662623|NCT00133744|minerals|minerals
1662415|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1662416|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1662417|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1662418|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1662419|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1662420|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1662421|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1662422|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1662423|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1662424|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1662425|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1662426|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1662427|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1662428|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1662429|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1662430|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1662431|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1662432|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1662433|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1662434|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1662435|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1662436|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1662437|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1662438|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1662439|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1662440|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1662441|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1662442|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1662443|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1662444|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1662445|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1662446|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1662447|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1662448|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1662449|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1662450|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1662451|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1662452|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1662453|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1662454|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1662455|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1662456|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1662457|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1662458|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1662459|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1662460|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1662461|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1662462|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1662463|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1662464|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1662465|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1662466|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1662467|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1662468|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
1662469|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1662470|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1662471|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1662472|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1662473|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1662474|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1662475|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1662476|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1662477|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1662478|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1662479|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1662480|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1662481|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1662482|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1662483|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1662484|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1662485|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1662486|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1662487|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1662488|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1662489|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1662490|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1662491|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1662492|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1662493|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1662559|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1662494|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1662495|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1662496|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1662497|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1662498|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1662499|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1662500|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1662501|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1662502|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1662503|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1662504|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1662505|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1662506|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1662507|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1662508|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1662509|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1662510|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1662511|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1662512|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1662513|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1662514|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1662515|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1662516|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1662517|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1662518|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1662519|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
1663074|NCT00131716|anaemia|anaemia
1662520|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1662521|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1662522|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1662523|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
1662524|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
1662525|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
1662526|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1662527|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1662528|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1662529|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1662530|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1662531|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1662532|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1662533|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1662534|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1662535|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1662536|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1662624|NCT00133744|supplements|supplements
1662537|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1662538|NCT00134004|polycythemia vera|polycythemia vera
1662539|NCT00134004|essential thrombocythemia|essential thrombocythemia
1662540|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1662541|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1662542|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1662543|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1662544|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1662545|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1662546|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1662547|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1662548|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1662549|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1662550|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1662551|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1662552|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1662553|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1662554|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1662555|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1662556|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1662557|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1662558|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1662560|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1662561|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1662562|NCT00133978|randomized trial|randomized trial
1662563|NCT00133978|antioxidants|antioxidants
1662564|NCT00133978|glutamine|glutamine
1662565|NCT00133978|organ failure|organ failure
1662566|NCT00133965|Advanced Cancer|advanced cancer
1662567|NCT00133965|Dignity Care|dignity care
1662568|NCT00133965|Supportive Care|supportive care
1662569|NCT00133965|Quality of Life|quality of life
1662570|NCT00133965|Psychotherapy|psychotherapy
1662571|NCT00133965|Palliative Care|palliative care
1662572|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
1662573|NCT00133939|Pressure support ventilation|pressure support ventilation
1662574|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
1662575|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
1662576|NCT00133926|Periodontal disease|periodontal disease
1662577|NCT00133926|Pregnancy|pregnancy
1662578|NCT00133926|Pre-term birth|pre-term birth
1662579|NCT00133926|Fetal growth|fetal growth
1662580|NCT00133926|Pre-eclampsia|pre-eclampsia
1662581|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
1662582|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
1662583|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
1662584|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
1662585|NCT00133887|kidney transplant recipients|kidney transplant recipients
1662586|NCT00133887|rapamycin|rapamycin
1662587|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
1662588|NCT00133874|topical antibacterial|topical antibacterial
1662589|NCT00133874|topical antibiotic|topical antibiotic
1662590|NCT00133874|impetigo|impetigo
1662591|NCT00133861|cerebral palsy children|cerebral palsy children
1662592|NCT00133861|Botulinum toxin|botulinum toxin
1662593|NCT00133848|impetigo|impetigo
1662594|NCT00133848|topical antibacterial|topical antibacterial
1662595|NCT00133848|topical antibiotic|topical antibiotic
1662596|NCT00133835|Randomized controlled trial|randomized controlled trial
1662598|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1662599|NCT00133835|Abdominal pain|abdominal pain
1662600|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1662601|NCT00133822|Sertraline|sertraline
1662602|NCT00133822|Risperidone|risperidone
1662603|NCT00133809|Type 1 Diabetes|type 1 diabetes
1662604|NCT00133809|Islet Transplantation|islet transplantation
1662605|NCT00133809|Immunology|immunology
1662606|NCT00133796|Breast Cancer|breast cancer
1662607|NCT00133796|Advanced Breast Cancer|advanced breast cancer
1662608|NCT00133783|Intermedin|intermedin
1662609|NCT00133783|estradiol|estradiol
1662610|NCT00133783|female hypertension|female hypertension
1662611|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
1662612|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
1662613|NCT00133783|IVF treatment patients|ivf treatment patients
1662614|NCT00133770|IV pantoprazole|iv pantoprazole
1662615|NCT00133770|Esophagitis|esophagitis
1662616|NCT00133757|Tobacco|tobacco
1662617|NCT00133757|Nicotine|nicotine
1662618|NCT00133757|Bupropion|bupropion
1662619|NCT00133757|Cue-reactivity|cue-reactivity
1662620|NCT00133757|Craving|craving
1662621|NCT00133744|pregnancy|pregnancy
1662622|NCT00133744|vitamins|vitamins
1662632|NCT00133744|micronutrients|micronutrients
1662633|NCT00133744|Stillbirths|stillbirths
1662634|NCT00133744|Early neonatal deaths|early neonatal deaths
1662635|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
1662636|NCT00133718|Cardiovascular|cardiovascular
1662637|NCT00133718|Coronary artery disease|coronary artery disease
1662638|NCT00133718|Glycemic control|glycemic control
1662639|NCT00133718|Treatment|treatment
1662640|NCT00133718|Diabetes Mellitus|diabetes mellitus
1662641|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
1662642|NCT00133692|Hypertension|hypertension
1662643|NCT00133692|Coronary Artery Disease|coronary artery disease
1662644|NCT00133692|INVEST|invest
1662645|NCT00133692|Diabetes|diabetes
1662646|NCT00133692|Verapamil SR|verapamil sr
1662647|NCT00133692|Trandolapril|trandolapril
1662648|NCT00133692|Atenolol|atenolol
1662649|NCT00133692|HCTZ|hctz
1662650|NCT00133679|Chronic lung disease|chronic lung disease
1662651|NCT00133679|Nitric oxide|nitric oxide
1662652|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
1662653|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
1662654|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
1662655|NCT00133640|Vitamin D|vitamin d
1662656|NCT00133640|Elderly|elderly
1662657|NCT00133640|Hip fracture|hip fracture
1662658|NCT00133640|Falls|falls
1662659|NCT00133640|Physical Therapy|physical therapy
1662660|NCT00133640|Disability|disability
1662661|NCT00133627|Allergic|allergic
1662662|NCT00133627|Conjunctivitis|conjunctivitis
1662663|NCT00133627|Ketotifen|ketotifen
1662664|NCT00133627|Histamine|histamine
1662665|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
1662666|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
1662667|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
1662668|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
1662669|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
1662670|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
1662671|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
1662672|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
1662673|NCT00133484|Anthrax, rPA|anthrax, rpa
1662674|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
1662675|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
1662676|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
1662798|NCT00132704|Central nervous system gliomas|central nervous system gliomas
1662677|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
1662678|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
1662679|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
1662680|NCT00133367|Hematologic malignancy|hematologic malignancy
1662681|NCT00133367|Cord blood transfusion|cord blood transfusion
1662682|NCT00133367|Graft versus host disease|graft versus host disease
1662683|NCT00133367|tacrolimus|tacrolimus
1662684|NCT00133367|sirolimus|sirolimus
1662685|NCT00133354|Puberty|puberty
1662686|NCT00133354|Growth hormone deficiency|growth hormone deficiency
1662687|NCT00133354|aromatase inhibitors|aromatase inhibitors
1662688|NCT00133354|estrogen|estrogen
1662689|NCT00133354|bone mineral density|bone mineral density
1662690|NCT00133354|short stature|short stature
1662691|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
1662692|NCT00133328|stroke|stroke
1663075|NCT00131703|Screening|screening
1662693|NCT00133328|myocardial infarction|myocardial infarction
1662694|NCT00133328|angina|angina
1662695|NCT00133328|renal damage|renal damage
1662696|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1662697|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
1662698|NCT00133302|high-grade lymphoma|high-grade lymphoma
1662699|NCT00133302|CHOP protocol|chop protocol
1662700|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
1662701|NCT00133276|Hepatitis C|hepatitis c
1662702|NCT00133276|Peg-interferon|peg-interferon
1662703|NCT00133276|Psychiatric side-effects|psychiatric side-effects
1662704|NCT00133263|Randomized controlled trial|randomized controlled trial
1662705|NCT00133263|Primary Care|primary care
1662706|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
1662707|NCT00133224|HRPC|hrpc
1662708|NCT00133224|Prostate|prostate
1662709|NCT00133224|Cancer|cancer
1662710|NCT00133224|Metastatic|metastatic
1662711|NCT00133224|Hormone-refractory|hormone-refractory
1662712|NCT00133224|GVAX|gvax
1662713|NCT00133224|Chemotherapy|chemotherapy
1662714|NCT00133224|Taxotere|taxotere
1662715|NCT00133224|Docetaxel|docetaxel
1662716|NCT00133224|Prednisone|prednisone
1662717|NCT00133224|Vaccine|vaccine
1662718|NCT00133224|Allogeneic cells|allogeneic cells
1662719|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1662720|NCT00133211|Heart arrhythmia|heart arrhythmia
1662721|NCT00133211|Ablation|ablation
1662722|NCT00133211|Drug treatment|drug treatment
1662723|NCT00133172|Treatment Efficacy|treatment efficacy
1662724|NCT00133172|Treatment Effectiveness|treatment effectiveness
1662725|NCT00133172|Anti-rejection therapy|anti-rejection therapy
1662726|NCT00133172|Immunosuppression|immunosuppression
1662727|NCT00133172|Antirejection|antirejection
1662728|NCT00133172|Renal Transplantation|renal transplantation
1662729|NCT00133172|Transplantation, Renal|transplantation, renal
1662730|NCT00133172|Transplantation, Kidney|transplantation, kidney
1662731|NCT00133172|Grafting, Kidney|grafting, kidney
1662732|NCT00133159|Allergy|allergy
1662733|NCT00133159|Specific Immunotherapy|specific immunotherapy
1662734|NCT00133146|Allergy|allergy
1662735|NCT00133146|Specific Immunotherapy|specific immunotherapy
1662736|NCT00133133|Postoperative pain|postoperative pain
1662737|NCT00133133|Open cholecystectomy|open cholecystectomy
1662738|NCT00133133|Capsaicin|capsaicin
1662739|NCT00133094|Hypercholesterolemia|hypercholesterolemia
1662740|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
1662741|NCT00133081|epilepsy|epilepsy
1662742|NCT00133081|antiepileptic drugs|antiepileptic drugs
1662743|NCT00133081|side effects|side effects
1662744|NCT00133081|quality of life|quality of life
1662745|NCT00133068|High Blood Pressure|high blood pressure
1662746|NCT00133068|Health Behaviors|health behaviors
1662747|NCT00133068|Patient Compliance|patient compliance
1662748|NCT00133055|parenting|parenting
1662749|NCT00133055|sleep problems|sleep problems
1662750|NCT00133055|behavior problems|behavior problems
1662751|NCT00133055|brief intervention|brief intervention
1662752|NCT00133055|self-help|self-help
1662753|NCT00133055|preschool-age children|preschool-age children
1662754|NCT00133055|psychosocial|psychosocial
1662755|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
1662756|NCT00133016|Induction of labor|induction of labor
1662757|NCT00132990|Cervical dystonia|cervical dystonia
1662758|NCT00132990|Deep brain stimulation|deep brain stimulation
1662759|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
1662760|NCT00132977|Heart Failure|heart failure
1662761|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
1662762|NCT00132964|pediatric|pediatric
1662763|NCT00132964|ankle fractures|ankle fractures
1662764|NCT00132964|randomized controlled trial|randomized controlled trial
1662765|NCT00132964|management|management
1662766|NCT00132925|allergic rhinitis|allergic rhinitis
1662767|NCT00132912|Platelets|platelets
1662768|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1662769|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
1662770|NCT00132912|Hemorrhage|hemorrhage
1662771|NCT00132899|Crohn's Disease|crohn's disease
1662772|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
1662773|NCT00132899|infliximab|infliximab
1662774|NCT00132899|methotrexate|methotrexate
1662775|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
1662776|NCT00132873|Narcolepsy|narcolepsy
1662777|NCT00132873|Cataplexy|cataplexy
1662778|NCT00132847|Child|child
1662779|NCT00132847|Adolescent|adolescent
1662780|NCT00132847|Urban Health|urban health
1662781|NCT00132821|Nicotine dependence|nicotine dependence
1662782|NCT00132821|Sleep disorders|sleep disorders
1662783|NCT00132821|smoking cessation|smoking cessation
1662784|NCT00132821|Relapse|relapse
1662785|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
1662786|NCT00132808|osteopenia|osteopenia
1662787|NCT00132808|zoledronic acid|zoledronic acid
1662788|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
1662789|NCT00132795|Cognitive Therapy|cognitive therapy
1662790|NCT00132795|Recurrence|recurrence
1662791|NCT00132795|Prevention|prevention
1663076|NCT00131703|Treatment|treatment
1662792|NCT00132795|Educational Technology|educational technology
1662793|NCT00132756|Hormone Refractory|hormone refractory
1662794|NCT00132756|Taxane Refractory|taxane refractory
1662795|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
1662796|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
1662797|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
1662799|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
1662800|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
1662801|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
1662802|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
1662803|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
1662804|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
1662805|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
1662806|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
1662807|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
1662808|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
1662809|NCT00132691|uveitis|uveitis
1662810|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
1662811|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
1662812|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
1662813|NCT00132678|Mood episodes|mood episodes
1662814|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
1662815|NCT00132678|Intramuscular Injectable|intramuscular injectable
1662816|NCT00132678|risperidone|risperidone
1662817|NCT00132678|safety and efficacy|safety and efficacy
1662818|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
1662819|NCT00132665|elderly patients|elderly patients
1662820|NCT00132665|carboplatin|carboplatin
1662821|NCT00132665|chemoradiotherapy|chemoradiotherapy
1662822|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
1662823|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
1662824|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
1662825|NCT00132639|randomized trial|randomized trial
1662826|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
1662827|NCT00132626|parkinson|parkinson
1662828|NCT00132626|diagnosis|diagnosis
1662829|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
1662830|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
1662831|NCT00132613|pericardial drainage|pericardial drainage
1662832|NCT00132613|randomized trial|randomized trial
1662833|NCT00132613|bleomycin|bleomycin
1663327|NCT00130767|apoptosis|apoptosis
1662834|NCT00132613|intrapericardial instillation|intrapericardial instillation
1662835|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
1662836|NCT00132600|Patch testing|patch testing
1662837|NCT00132600|bacitracin|bacitracin
1662838|NCT00132587|Knee arthroplasty|knee arthroplasty
1662839|NCT00132587|Femoral loosening|femoral loosening
1662840|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
1662841|NCT00132574|acne, dairy|acne, dairy
1662842|NCT00132548|Malaria|malaria
1662843|NCT00132548|Children|children
1662844|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
1662845|NCT00132548|Senegal|senegal
1662846|NCT00132535|Malaria in pregnancy|malaria in pregnancy
1662847|NCT00132535|IPT|ipt
1662848|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1662849|NCT00132535|Chloroquine|chloroquine
1662850|NCT00132535|HIV|hiv
1662851|NCT00132535|Viral load|viral load
1662852|NCT00132535|birth weight|birth weight
1662853|NCT00132535|anaemia|anaemia
1662854|NCT00132522|EpCAM|epcam
1662855|NCT00132522|monoclonal-antibody|monoclonal-antibody
1662856|NCT00132522|targeted therapy|targeted therapy
1662857|NCT00132522|colorectal|colorectal
1662858|NCT00132522|prostate|prostate
1662859|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
1662860|NCT00132522|ovarian|ovarian
1662861|NCT00132522|solid tumor|solid tumor
1662862|NCT00132509|rt-PA|rt-pa
1662863|NCT00132509|thrombolysis|thrombolysis
1662864|NCT00132509|Acute ischemic stroke|acute ischemic stroke
1662865|NCT00132496|GERD|gerd
1662866|NCT00132483|Physical activity|physical activity
1662867|NCT00132483|cerebral infarct|cerebral infarct
1662868|NCT00132457|Chlamydia|chlamydia
1662869|NCT00132457|screening|screening
1662870|NCT00132457|Sexually transmitted disease|sexually transmitted disease
1662871|NCT00132444|HIV|hiv
1662872|NCT00132444|topical microbicides|topical microbicides
1662873|NCT00132431|calcimimetic|calcimimetic
1662874|NCT00132431|cinacalcet|cinacalcet
1662875|NCT00132431|hemodialysis|hemodialysis
1662876|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
1662877|NCT00132431|chronic kidney disease|chronic kidney disease
1662878|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
1662879|NCT00132418|RA|ra
1662880|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
1662881|NCT00132405|Needlestick pain|needlestick pain
1662882|NCT00132405|Venipuncture pain|venipuncture pain
1662883|NCT00132405|Procedural pain|procedural pain
1662884|NCT00132392|Arthroplasty|arthroplasty
1662885|NCT00132392|Total knee arthroplasty|total knee arthroplasty
1662886|NCT00132392|Capsaicin|capsaicin
1662887|NCT00132392|Pain|pain
1662888|NCT00132392|Analgesia|analgesia
1662889|NCT00132366|Neurotransmission|neurotransmission
1662890|NCT00132366|Cortical Excitability|cortical excitability
1662891|NCT00132366|GABA|gaba
1662892|NCT00132366|Seizures|seizures
1662893|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
1662894|NCT00132366|SSADH|ssadh
1662895|NCT00132366|Healthy Volunteer|healthy volunteer
1662896|NCT00132366|HV|hv
1662897|NCT00132353|Magnetic Stimulation|magnetic stimulation
1662898|NCT00132353|Single Fiber EMG|single fiber emg
1662899|NCT00132353|Ultrasonography|ultrasonography
1662900|NCT00132353|Quantitative Sensory Testing|quantitative sensory testing
1662901|NCT00132353|Near-nerve recording|near-nerve recording
1662902|NCT00132353|Neurological Disorders|neurological disorders
1662903|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
1662904|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
1662905|NCT00132353|Myelopathy|myelopathy
1662906|NCT00132353|Motor Neuron Disease|motor neuron disease
1662907|NCT00132353|Movement Disorders|movement disorders
1662908|NCT00132353|Healthy Volunteer|healthy volunteer
1662909|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
1662910|NCT00132340|Treatment|treatment
1662911|NCT00132340|Physiology|physiology
1662912|NCT00132340|Surgery|surgery
1662913|NCT00132340|Cervical Dystonia|cervical dystonia
1662914|NCT00132327|Lyme Disease|lyme disease
1662915|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
1662916|NCT00132327|Inflammation|inflammation
1662917|NCT00132327|Skin|skin
1662918|NCT00132327|Host Response|host response
1662919|NCT00132327|Erythema Migrans Rash|erythema migrans rash
1662920|NCT00132327|Healthy Volunteer|healthy volunteer
1662922|NCT00132301|multi-site clinical trial|multi-site clinical trial
1662923|NCT00132301|prostate|prostate
1662924|NCT00132301|radical prostatectomy|radical prostatectomy
1662925|NCT00132301|randomized|randomized
1662926|NCT00132288|Aging|aging
1662927|NCT00132288|Frailty|frailty
1662928|NCT00132288|Sedentary|sedentary
1662929|NCT00132288|Falls|falls
1662930|NCT00132288|Physical Activity|physical activity
1662931|NCT00132275|bacterial|bacterial
1662932|NCT00132275|sinusitis|sinusitis
1662933|NCT00132275|treatment|treatment
1662934|NCT00132275|diagnosis|diagnosis
1662935|NCT00132275|guideline|guideline
1662936|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
1662937|NCT00132262|Screening and Brief Intervention|screening and brief intervention
1662938|NCT00132262|Ethnic Differences|ethnic differences
1662939|NCT00132262|Trauma Center|trauma center
1662940|NCT00132249|Traumatic Brain Injury|traumatic brain injury
1662941|NCT00132249|Penetrating head wound|penetrating head wound
1662942|NCT00132249|Closed head trauma|closed head trauma
1662943|NCT00132249|Vietnam Veteran|vietnam veteran
1662944|NCT00132236|smoking cessation|smoking cessation
1662945|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
1662946|NCT00132236|behaviour support|behaviour support
1662947|NCT00132236|smoking reduction|smoking reduction
1662948|NCT00132236|quality of life|quality of life
1662949|NCT00132236|COPD|copd
1662950|NCT00132236|weight|weight
1662951|NCT00132223|magnetic imaging|magnetic imaging
1662952|NCT00132223|angiography|angiography
1662953|NCT00132223|contrast agent|contrast agent
1662954|NCT00132223|signal/noise ratio|signal/noise ratio
1662955|NCT00132223|contrast/noise ratio|contrast/noise ratio
1662956|NCT00132223|vessel|vessel
1662957|NCT00132210|acute hepatitis C|acute hepatitis c
1662958|NCT00132210|HIV|hiv
1662959|NCT00132210|pegylated interferon|pegylated interferon
1662960|NCT00132197|Functional somatic symptoms|functional somatic symptoms
1662961|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
1662962|NCT00132197|somatization disorder|somatization disorder
1662963|NCT00132197|SF-36|sf-36
1662964|NCT00132197|cost-effectiveness|cost-effectiveness
1662965|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
1662966|NCT00132184|Vitamin D|vitamin d
1662967|NCT00132184|Crohns Disease|crohns disease
1662968|NCT00132171|Helicobacter pylori|helicobacter pylori
1662969|NCT00132171|Eradication|eradication
1662970|NCT00132171|Sequential therapy|sequential therapy
1662971|NCT00132171|Standard therapy|standard therapy
1662972|NCT00132145|Vascular diseases|vascular diseases
1662973|NCT00132145|Computerized decision support systems|computerized decision support systems
1662974|NCT00132145|Shared care|shared care
1662975|NCT00132145|Patient motivation|patient motivation
1662976|NCT00132145|Quality of care|quality of care
1662977|NCT00132132|BMI|bmi
1662978|NCT00132132|obesity|obesity
1662979|NCT00132132|behavioral intervention|behavioral intervention
1662980|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
1662981|NCT00132132|exercise|exercise
1662982|NCT00132132|empowerment|empowerment
1662983|NCT00132132|nutrition|nutrition
1662984|NCT00132093|Left ventricular remodelling|left ventricular remodelling
1662985|NCT00132093|Acute myocardial infarction|acute myocardial infarction
1662986|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
1662987|NCT00132093|Eplerenone|eplerenone
1662988|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
1662989|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1662990|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
1662991|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1662992|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1662993|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
1662994|NCT00132015|multicentric Castleman disease|multicentric castleman disease
1662995|NCT00132015|unicentric Castleman disease|unicentric castleman disease
1662996|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1662997|NCT00132015|polycythemia vera|polycythemia vera
1662998|NCT00132015|essential thrombocythemia|essential thrombocythemia
1662999|NCT00132015|hairy cell leukemia|hairy cell leukemia
1663000|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1663001|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
1663002|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
1663003|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
1663004|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
1663005|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
1663006|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
1663007|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
1663008|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
1663009|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
1663010|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
1663011|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
1663012|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
1663013|NCT00132015|precancerous condition|precancerous condition
1663014|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
1663015|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
1663016|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
1663017|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
1663018|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
1663019|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
1663020|NCT00131950|breast cancer|breast cancer
1663021|NCT00131924|recurrent breast cancer|recurrent breast cancer
1663022|NCT00131924|stage IV breast cancer|stage iv breast cancer
1663023|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
1663024|NCT00131885|Menstruation|menstruation
1663025|NCT00131885|Complementary Therapies|complementary therapies
1663026|NCT00131885|Pharmacokinetics|pharmacokinetics
1663027|NCT00131885|Hypericum|hypericum
1663028|NCT00131885|St. John's wort|st. john's wort
1663029|NCT00131885|Levonorgestrel|levonorgestrel
1663030|NCT00131885|Women|women
1663031|NCT00131872|vascular access graft|vascular access graft
1663032|NCT00131872|hemodialysis|hemodialysis
1663033|NCT00131872|dialysis|dialysis
1663034|NCT00131872|end stage renal disease|end stage renal disease
1663035|NCT00131859|Perinatal brain injury|perinatal brain injury
1663036|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
1663037|NCT00131846|Thiazide diuretics|thiazide diuretics
1663038|NCT00131846|Essential hypertension|essential hypertension
1663039|NCT00131846|Type 2 diabetes|type 2 diabetes
1663040|NCT00131846|Randomized clinical trial|randomized clinical trial
1663041|NCT00131846|Cost-effectiveness|cost-effectiveness
1663042|NCT00131833|salmonella|salmonella
1663043|NCT00131833|typhoid vaccine|typhoid vaccine
1663044|NCT00131833|enteric fever|enteric fever
1663045|NCT00131820|Salmonella|salmonella
1663046|NCT00131820|typhoid vaccine|typhoid vaccine
1663047|NCT00131820|enteric fever|enteric fever
1663048|NCT00131820|socioeconomic costs|socioeconomic costs
1663049|NCT00131807|Blood Pressure|blood pressure
1663050|NCT00131807|HIV|hiv
1663051|NCT00131807|Antiretroviral therapy|antiretroviral therapy
1663052|NCT00131794|Malaria|malaria
1663053|NCT00131794|BCG vaccine|bcg vaccine
1663054|NCT00131794|Guinea Bissau|guinea bissau
1663055|NCT00131781|Borderline personality disorder|borderline personality disorder
1663056|NCT00131781|Controlled trials|controlled trials
1663057|NCT00131781|Cognitive Therapy|cognitive therapy
1663058|NCT00131781|Supportive Therapy|supportive therapy
1663059|NCT00131781|suicide|suicide
1663060|NCT00131781|impulsivity|impulsivity
1663061|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
1663062|NCT00131768|musculoskeletal|musculoskeletal
1663063|NCT00131755|type 1 diabetes|type 1 diabetes
1663064|NCT00131755|beta cell rest|beta cell rest
1663065|NCT00131755|diazoxide|diazoxide
1663066|NCT00131755|insulin secretion|insulin secretion
1663067|NCT00131729|Amblyopia|amblyopia
1663068|NCT00131729|Occlusion therapy|occlusion therapy
1663069|NCT00131729|Compliance|compliance
1663070|NCT00131729|Risk factors|risk factors
1663071|NCT00131716|prevention|prevention
1663072|NCT00131716|recurrence|recurrence
1663077|NCT00131703|Amodiaquine|amodiaquine
1663078|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
1663079|NCT00131703|Malaria in pregnancy|malaria in pregnancy
1663080|NCT00131690|Caffeine|caffeine
1663081|NCT00131690|Coffee|coffee
1663082|NCT00131690|Randomized|randomized
1663083|NCT00131690|Birth weight|birth weight
1663084|NCT00131651|renal|renal
1663085|NCT00131651|cancer|cancer
1663086|NCT00131651|advanced|advanced
1663087|NCT00131651|unresectable|unresectable
1663088|NCT00131651|metastatic|metastatic
1663089|NCT00131651|recurrent|recurrent
1663090|NCT00131651|anti-angiogenic|anti-angiogenic
1663091|NCT00131651|targeted|targeted
1663092|NCT00131651|ATN-161|atn-161
1663093|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
1663094|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
1663095|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
1663096|NCT00131638|Oncology|oncology
1663097|NCT00131638|KGF|kgf
1663098|NCT00131638|Palifermin|palifermin
1663099|NCT00131638|Oral mucositis|oral mucositis
1663100|NCT00131638|Clinical Trial|clinical trial
1663101|NCT00131638|Amgen|amgen
1663102|NCT00131638|head and neck|head and neck
1663103|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
1663104|NCT00131625|Mortality|mortality
1663105|NCT00131625|Morbidity|morbidity
1663106|NCT00131625|Nutrition|nutrition
1663107|NCT00131625|Low income country|low income country
1663108|NCT00131612|adjuvant therapy|adjuvant therapy
1663109|NCT00131612|epirubicin|epirubicin
1663110|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
1663111|NCT00131612|pharmacogenetics|pharmacogenetics
1663112|NCT00131599|5-fluorouracil|5-fluorouracil
1663113|NCT00131599|thymidylate synthase|thymidylate synthase
1663114|NCT00131599|pharmacogenetics|pharmacogenetics
1663115|NCT00131586|platinum analogues|platinum analogues
1663116|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
1663117|NCT00131586|proteomics|proteomics
1663118|NCT00131586|hemoglobin|hemoglobin
1663119|NCT00131573|Urgency-Frequency|urgency-frequency
1663120|NCT00131573|Syndrome|syndrome
1663121|NCT00131573|Urinary|urinary
1663122|NCT00131573|Refractory|refractory
1663123|NCT00131573|Stimulation|stimulation
1663124|NCT00131573|Nerve|nerve
1663125|NCT00131573|Neuromodulation|neuromodulation
1663126|NCT00131573|Microstimulator|microstimulator
1663127|NCT00131573|bion|bion
1663128|NCT00131573|Pudendal|pudendal
1663129|NCT00131573|Overactive bladder|overactive bladder
1663130|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
1663131|NCT00131547|Obesity|obesity
1663132|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
1663133|NCT00131534|Complex trauma|complex trauma
1663134|NCT00131534|Trauma recovery|trauma recovery
1663135|NCT00131534|Resiliency|resiliency
1663136|NCT00131534|Posttraumatic stress|posttraumatic stress
1663137|NCT00131534|Individual psychotherapy|individual psychotherapy
1663138|NCT00131534|Group psychotherapy|group psychotherapy
1663139|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
1663140|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
1663141|NCT00131508|Sickle Cell Anemia|sickle cell anemia
1663142|NCT00131495|Low Libido|low libido
1663143|NCT00131495|Low Desire|low desire
1663144|NCT00131495|Distress|distress
1663145|NCT00131482|Chrysalin|chrysalin
1663146|NCT00131482|TP508|tp508
1663147|NCT00131482|Fracture|fracture
1663148|NCT00131482|Wrist|wrist
1663149|NCT00131482|Healing|healing
1663150|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
1663151|NCT00131469|Brittle Bone Disease|brittle bone disease
1663152|NCT00131469|Fragility Fractures|fragility fractures
1663153|NCT00131456|cannabis dependence|cannabis dependence
1663154|NCT00131456|depression|depression
1663155|NCT00131456|treatment|treatment
1663156|NCT00131456|venlafaxine|venlafaxine
1663157|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
1663158|NCT00131443|Prophylaxis|prophylaxis
1663159|NCT00131417|severe|severe
1663160|NCT00131417|malnutrition|malnutrition
1663161|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
1663162|NCT00131417|children|children
1663163|NCT00131417|Uganda|uganda
1663164|NCT00131378|Visceral obesity|visceral obesity
1663165|NCT00131378|Growth hormone|growth hormone
1663166|NCT00131378|Cardiovascular risk|cardiovascular risk
1663167|NCT00131378|Insulin resistance|insulin resistance
1663168|NCT00131365|fibroids|fibroids
1663169|NCT00131365|Uterine Fibroids|uterine fibroids
1663170|NCT00131365|ExAblate|exablate
1663171|NCT00131365|MrgFUS|mrgfus
1663172|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
1663173|NCT00131352|Musculoskeletal|musculoskeletal
1663174|NCT00131339|panic disorder|panic disorder
1663175|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
1663176|NCT00131339|D-cycloserine|d-cycloserine
1663177|NCT00131339|medication|medication
1663178|NCT00131339|treatment trial|treatment trial
1663179|NCT00131339|placebo-controlled|placebo-controlled
1663180|NCT00131339|double-blind|double-blind
1663181|NCT00131339|randomized|randomized
1663182|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
1663183|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
1663184|NCT00131313|Leukemia|leukemia
1663185|NCT00131313|Cancer|cancer
1663186|NCT00131313|Nipent|nipent
1663187|NCT00131313|Rituxan|rituxan
1663188|NCT00131313|Cytoxan|cytoxan
1663189|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
1663190|NCT00131300|Musculoskeletal|musculoskeletal
1663191|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
1663192|NCT00131287|type II DM|type ii dm
1663193|NCT00131287|insulin index|insulin index
1663194|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
1663195|NCT00131274|Respiratory Diseases|respiratory diseases
1663196|NCT00131274|Interstitial Lung Disease|interstitial lung disease
1663197|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
1663198|NCT00131261|Multiple Myeloma|multiple myeloma
1663199|NCT00131261|Neoplasms|neoplasms
1663200|NCT00131235|Malaria|malaria
1663201|NCT00131235|STI|sti
1663202|NCT00131235|Pregnancy|pregnancy
1663203|NCT00131235|Prevention|prevention
1663204|NCT00131235|Preterm birth|preterm birth
1663205|NCT00131235|Low birth weight|low birth weight
1663206|NCT00131235|Sub-Saharan Africa|sub-saharan africa
1663207|NCT00131222|Infant|infant
1663208|NCT00131222|Malnutrition|malnutrition
1663209|NCT00131222|Sub-Saharan Africa|sub-saharan africa
1663210|NCT00131222|Treatment|treatment
1663211|NCT00131222|Growth|growth
1663212|NCT00131222|Haemoglobin|haemoglobin
1663213|NCT00131222|Fortified spread|fortified spread
1663214|NCT00131222|Food supplement|food supplement
1663215|NCT00131209|Infant|infant
1663216|NCT00131209|Sub-Saharan Africa|sub-saharan africa
1663217|NCT00131209|Complementary feeding|complementary feeding
1663218|NCT00131209|Malnutrition|malnutrition
1663219|NCT00131209|Growth|growth
1663220|NCT00131209|Fortified spread|fortified spread
1663221|NCT00131209|Haemoglobin|haemoglobin
1663222|NCT00131196|pneumonia|pneumonia
1663223|NCT00131196|peritonitis|peritonitis
1663224|NCT00131196|sepsis|sepsis
1663225|NCT00131196|outcome|outcome
1663226|NCT00131196|genomics|genomics
1663227|NCT00131183|Angina Pectoris|angina pectoris
1663228|NCT00131183|Arteriosclerosis|arteriosclerosis
1663229|NCT00131183|Testosterone|testosterone
1663230|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
1663231|NCT00131157|Family Practice|family practice
1663232|NCT00131157|Spirometry|spirometry
1663233|NCT00131157|Decision Support Systems|decision support systems
1663234|NCT00131157|Feedback|feedback
1663235|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
1663236|NCT00131131|physical activity|physical activity
1663237|NCT00131131|cholelithiasis|cholelithiasis
1663238|NCT00131131|pregnancy complication|pregnancy complication
1663239|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
1663240|NCT00131105|Healthy|healthy
1663241|NCT00131105|Caregivers|caregivers
1663242|NCT00131105|Aging|aging
1663243|NCT00131092|exercise|exercise
1663244|NCT00131092|aging|aging
1663245|NCT00131092|physical activity|physical activity
1663246|NCT00131079|Primary Health Care|primary health care
1663247|NCT00131079|Physicians, Family|physicians, family
1663248|NCT00131079|Family Practice|family practice
1663249|NCT00131079|Health Promotion|health promotion
1663250|NCT00131079|Randomized Controlled Trials|randomized controlled trials
1663251|NCT00131079|Multicenter Studies|multicenter studies
1663252|NCT00131079|Physical Fitness|physical fitness
1663253|NCT00131079|Quality of Life|quality of life
1663254|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
1663255|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1663256|NCT00131053|newly diagnosed|newly diagnosed
1663257|NCT00131053|BCR-ABL-negative|bcr-abl-negative
1663258|NCT00131040|Cardiopulmonary|cardiopulmonary
1663259|NCT00131040|Surgery|surgery
1663260|NCT00131040|leukocyte|leukocyte
1663261|NCT00131040|inflammation|inflammation
1663262|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
1663263|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1663264|NCT00131027|newly diagnosed|newly diagnosed
1663265|NCT00131027|BCR-ABL-negative|bcr-abl-negative
1663266|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1663267|NCT00131014|Hodgkin's disease|hodgkin's disease
1663268|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1663269|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
1663270|NCT00131014|Genetics|genetics
1663271|NCT00131001|Carotid artery stenosis|carotid artery stenosis
1663272|NCT00131001|cost effectiveness|cost effectiveness
1663273|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
1663274|NCT00131001|computed tomography angiography|computed tomography angiography
1663275|NCT00131001|digital subtraction angiography|digital subtraction angiography
1663276|NCT00130988|Somatoform Disorders|somatoform disorders
1663277|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
1663278|NCT00130988|Physician-Patient Relations|physician-patient relations
1663279|NCT00130988|Primary Health Care|primary health care
1663280|NCT00130988|Family Physician|family physician
1663281|NCT00130988|psychosocial therapy|psychosocial therapy
1663282|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
1663283|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
1663284|NCT00130975|Atrial fibrillation.|atrial fibrillation.
1663285|NCT00130975|Cardioversion.|cardioversion.
1663286|NCT00130975|Recurrence.|recurrence.
1663287|NCT00130975|Candesartan.|candesartan.
1663288|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
1663289|NCT00130962|Morton's neuroma|morton's neuroma
1663290|NCT00130962|ALGRX 4975|algrx 4975
1663291|NCT00130962|capsaicin|capsaicin
1663292|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
1663293|NCT00130949|Tennis elbow|tennis elbow
1663294|NCT00130949|Capsaicin|capsaicin
1663295|NCT00130936|phase I|phase i
1663296|NCT00130936|epirubicin|epirubicin
1663297|NCT00130936|solid tumors|solid tumors
1663298|NCT00130923|Risperidone|risperidone
1663299|NCT00130923|Schizophrenia|schizophrenia
1663300|NCT00130923|Substance Use Disorder|substance use disorder
1663301|NCT00130923|Alcohol Use Disorder|alcohol use disorder
1663303|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
1663304|NCT00130910|HIV|hiv
1663305|NCT00130910|Helminthiasis|helminthiasis
1663306|NCT00130910|Co-infection|co-infection
1663307|NCT00130910|Intestinal immune activation|intestinal immune activation
1663308|NCT00130910|Treatment Naive|treatment naive
1663309|NCT00130884|levosimendan|levosimendan
1663310|NCT00130884|chronic heart failure|chronic heart failure
1663311|NCT00130884|oral administration|oral administration
1663312|NCT00130871|levosimendan|levosimendan
1663313|NCT00130871|weaning|weaning
1663314|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
1663315|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
1663316|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
1663317|NCT00130819|Drug Dependence|drug dependence
1663318|NCT00130819|Opiate Dependence|opiate dependence
1663319|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
1663320|NCT00130819|Buprenorphine|buprenorphine
1663321|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
1663322|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
1663323|NCT00130780|Bevacizumab|bevacizumab
1663324|NCT00130780|BEACON|beacon
1663325|NCT00130780|05-052|05-052
1663326|NCT00130767|Prostate|prostate
1663328|NCT00130767|finasteride kinetics|finasteride kinetics
1663329|NCT00130728|NSCLC|nsclc
1663330|NCT00130728|Avastin|avastin
1663331|NCT00130728|Tarceva|tarceva
1663332|NCT00130728|Lung Cancer|lung cancer
1663333|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
1663334|NCT00130702|AML|aml
1663335|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
1663336|NCT00130702|gefitinib|gefitinib
1663337|NCT00130702|Iressa|iressa
1663338|NCT00130689|Esophageal Cancer|esophageal cancer
1663339|NCT00130689|Gastric Cancer|gastric cancer
1663340|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
1663341|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
1663342|NCT00130689|Cetuximab|cetuximab
1663343|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
1663344|NCT00130676|PMD|pmd
1663345|NCT00130676|Psychotic Major Depression|psychotic major depression
1663346|NCT00130676|Depression|depression
1663347|NCT00130676|Major Depression|major depression
1663348|NCT00130676|Psychosis|psychosis
1663349|NCT00130650|IV|iv
1663350|NCT00130650|cannulation|cannulation
1663351|NCT00130650|Injections, Intravenous|injections, intravenous
1663352|NCT00130637|Anterior Uveitis|anterior uveitis
1663353|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
1663354|NCT00130637|Daclizumab|daclizumab
1663355|NCT00130637|Iritis|iritis
1663356|NCT00130637|Immunosuppression|immunosuppression
1663357|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
1663358|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1663359|NCT00130624|Falls|falls
1663360|NCT00130624|Elderly|elderly
1663361|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
1663362|NCT00130611|heart failure|heart failure
1663363|NCT00130611|cost effectiveness|cost effectiveness
1663364|NCT00130611|BNP|bnp
1663365|NCT00130611|private practice|private practice
1663366|NCT00130611|Acute dyspnoea|acute dyspnoea
1663367|NCT00130598|contrast nephropathy|contrast nephropathy
1663368|NCT00130598|contrast media|contrast media
1663369|NCT00130598|renal dysfunction|renal dysfunction
1663370|NCT00130585|Folate|folate
1663371|NCT00130585|Bioavailability|bioavailability
1663372|NCT00130585|Stable isotopes|stable isotopes
1663373|NCT00130559|Respiratory failure|respiratory failure
1663374|NCT00130559|BNP|bnp
1663375|NCT00130546|coronary artery disease|coronary artery disease
1663376|NCT00130546|coronary intervention|coronary intervention
1663377|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
1663378|NCT00130546|Cypher - Stent|cypher - stent
1663379|NCT00130546|Sirolimus|sirolimus
1663380|NCT00130546|Taxus - Stent|taxus - stent
1663381|NCT00130546|Paclitaxel|paclitaxel
1663382|NCT00130533|TNBC Triple-Negative Early Breast Cancer|tnbc triple-negative early breast cancer
1663383|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
1663384|NCT00130533|Capecitabine|capecitabine
1663385|NCT00130533|Basal-like genotype|basal-like genotype
1663386|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
1663387|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
1663388|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
1663389|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
1663390|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
1663391|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
1663392|NCT00130481|Diabetes|diabetes
1663393|NCT00130481|Children|children
1663394|NCT00130481|Adolescents|adolescents
1663395|NCT00130481|Arterial Compliance|arterial compliance
1663396|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
1663397|NCT00130442|phase II|phase ii
1663398|NCT00130442|metastatic melanoma|metastatic melanoma
1663399|NCT00130442|dacarbazine|dacarbazine
1663400|NCT00130442|combination|combination
1663404|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
1663405|NCT00130429|paired associated learning|paired associated learning
1663406|NCT00130416|behavior|behavior
1663407|NCT00130416|randomized trial|randomized trial
1663408|NCT00130416|communication|communication
1663409|NCT00130416|patient|patient
1663410|NCT00130416|internet|internet
1663411|NCT00130416|coaching|coaching
1663412|NCT00130416|self-efficacy|self-efficacy
1663413|NCT00130416|nurse|nurse
1663414|NCT00130416|primary care|primary care
1663415|NCT00130416|physician|physician
1663416|NCT00130416|screening|screening
1663417|NCT00130416|survey|survey
1663418|NCT00130416|pain|pain
1663419|NCT00130416|mobility|mobility
1663420|NCT00130416|disability|disability
1663421|NCT00130416|depression|depression
1663422|NCT00130390|Crohn's Disease|crohn's disease
1663423|NCT00130377|Stem Cell|stem cell
1663424|NCT00130377|Heart|heart
1663425|NCT00130377|Lung|lung
1663426|NCT00130377|Vascular|vascular
1663427|NCT00130377|cell therapy registry|cell therapy registry
1663428|NCT00130364|Atopic dermatitis|atopic dermatitis
1663429|NCT00130364|T-cell|t-cell
1663430|NCT00130364|pimecrolimus|pimecrolimus
1663431|NCT00130364|children|children
1663432|NCT00130364|facial|facial
1663433|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
1663434|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
1663435|NCT00130338|Dementia|dementia
1663436|NCT00130338|Vascular|vascular
1663437|NCT00130338|Rivastigmine|rivastigmine
1663438|NCT00130338|Stroke|stroke
1663439|NCT00130338|Memory loss|memory loss
1663440|NCT00130325|ELISPOT,|elispot,
1663441|NCT00130325|tuberculosis,|tuberculosis,
1663442|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
1663443|NCT00130325|Isoniazid|isoniazid
1663444|NCT00130325|Clinical trial|clinical trial
1663445|NCT00130312|Diabetes|diabetes
1663446|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
1663447|NCT00130312|Proteinuria|proteinuria
1663448|NCT00130286|Lipodystrophy|lipodystrophy
1663449|NCT00130286|HIV|hiv
1663450|NCT00130286|Growth hormone|growth hormone
1663451|NCT00130286|Rosiglitazone|rosiglitazone
1663452|NCT00130286|Visceral fat|visceral fat
1663453|NCT00130286|Metabolic syndrome|metabolic syndrome
1663454|NCT00130286|Treatment Experienced|treatment experienced
1663455|NCT00130286|Visceral fat accumulation|visceral fat accumulation
1663456|NCT00130286|fat accumulation|fat accumulation
1663457|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
1663458|NCT00130273|HIV|hiv
1663459|NCT00130273|AIDS|aids
1663460|NCT00130273|Problem Solving|problem solving
1663461|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1663462|NCT00130273|Patient Compliance|patient compliance
1663463|NCT00130260|Staphylococcus aureus|staphylococcus aureus
1663464|NCT00130260|Vaccine|vaccine
1663465|NCT00130260|Randomized Controlled Trial|randomized controlled trial
1663466|NCT00130247|Tuberculosis, Uganda, Brazil, Philippines|tuberculosis, uganda, brazil, philippines
1663467|NCT00130234|urticaria|urticaria
1663468|NCT00130234|hives|hives
1663469|NCT00130234|Xolair|xolair
1663470|NCT00130221|Chlorhexidine|chlorhexidine
1663471|NCT00130221|Blood stream infections|blood stream infections
1663472|NCT00130221|central venous catheter associated|central venous catheter associated
1663473|NCT00130221|Nosocomial infection|nosocomial infection
1663474|NCT00130221|Bacteremia|bacteremia
1663475|NCT00130221|sepsis|sepsis
1663476|NCT00130221|Pneumonia|pneumonia
1663477|NCT00130221|Urinary tract infection|urinary tract infection
1663478|NCT00130221|Clostridium Difficile|clostridium difficile
1663479|NCT00130221|intensive care unit|intensive care unit
1663480|NCT00130221|catheter|catheter
1663481|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
1663482|NCT00130221|Infection control|infection control
1663483|NCT00130208|Diabetes|diabetes
1663484|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1663485|NCT00130208|Albuminuria|albuminuria
1663486|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
1663487|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
1663488|NCT00130195|BCR-ABL|bcr-abl
1663489|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
1663490|NCT00130195|newly diagnosed|newly diagnosed
1663491|NCT00130182|lung disease|lung disease
1663492|NCT00130169|Cancer|cancer
1663493|NCT00130169|malignant tumors|malignant tumors
1663494|NCT00130156|Blood pressure|blood pressure
1663495|NCT00130156|SBP|sbp
1663496|NCT00130156|DBP|dbp
1663497|NCT00130117|leptin|leptin
1663498|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
1663499|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
1663500|NCT00130117|neuroendocrine function|neuroendocrine function
1663501|NCT00130117|bone metabolism|bone metabolism
1663502|NCT00130104|digital block|digital block
1663503|NCT00130104|regional anesthesia|regional anesthesia
1663504|NCT00130104|finger repair|finger repair
1663505|NCT00130104|Fingers|fingers
1663506|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
1663507|NCT00130091|unilateral|unilateral
1663513|NCT00130078|HIV Seronegativity|hiv seronegativity
1663514|NCT00130078|HIV transmission|hiv transmission
1663515|NCT00130065|Malaria|malaria
1663516|NCT00130065|Pregnancy|pregnancy
1663517|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1663518|NCT00130065|Folic acid|folic acid
1663519|NCT00130065|Folate|folate
1663520|NCT00130039|Infarction, Cerebral|infarction, cerebral
1663521|NCT00130039|cilostazol|cilostazol
1663522|NCT00130039|stenosis|stenosis
1663523|NCT00130039|atherosclerosis|atherosclerosis
1663524|NCT00130039|clopidogrel|clopidogrel
1663525|NCT00130013|Children|children
1663526|NCT00130013|Non-severe pneumonia|non-severe pneumonia
1663527|NCT00130013|Oral amoxicillin|oral amoxicillin
1663528|NCT00130000|h5g.1|h5g.1
1663529|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1663530|NCT00130000|SHEPHERD|shepherd
1663531|NCT00130000|PNH|pnh
1663532|NCT00129987|Asthma|asthma
1663533|NCT00129974|Lung cancer|lung cancer
1663534|NCT00129974|Phase II|phase ii
1663535|NCT00129974|Drug Therapy|drug therapy
1663536|NCT00129961|Kidney|kidney
1663537|NCT00129961|Transplant|transplant
1663538|NCT00129961|Skin Cancer|skin cancer
1663539|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
1663540|NCT00129948|AML|aml
1663541|NCT00129948|refractory|refractory
1663542|NCT00129948|relapsed|relapsed
1663543|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
1663544|NCT00129935|Node positive breast cancer|node positive breast cancer
1663545|NCT00129935|Adjuvant treatment|adjuvant treatment
1663546|NCT00129935|Oral chemotherapy|oral chemotherapy
1663547|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
1663548|NCT00129922|Sequential drug administration.|sequential drug administration.
1663549|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
1663550|NCT00129909|hypertension|hypertension
1663551|NCT00129909|family physicians|family physicians
1663552|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
1663553|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
1663554|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
1663555|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
1663556|NCT00129883|quality of care|quality of care
1663557|NCT00129883|antibiotic use|antibiotic use
1663558|NCT00129883|intervention|intervention
1663559|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
1663560|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
1663561|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
1663562|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
1663563|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
1663564|NCT00129844|Lung cancer|lung cancer
1663565|NCT00129844|cancer of the lung|cancer of the lung
1663566|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1663567|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
1663568|NCT00129818|Genital herpes|genital herpes
1663569|NCT00129818|viral shedding|viral shedding
1663570|NCT00129818|famciclovir|famciclovir
1663571|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
1663572|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
1663573|NCT00129792|Blood Glucose|blood glucose
1663574|NCT00129792|Cholesterol|cholesterol
1663575|NCT00129792|Weight Loss|weight loss
1663576|NCT00129792|Insulin|insulin
1663577|NCT00129792|Complementary Therapies|complementary therapies
1663578|NCT00129779|COPD|copd
1663579|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
1663580|NCT00129766|motavizumab|motavizumab
1663581|NCT00129766|palivizumab|palivizumab
1663582|NCT00129766|Synagis|synagis
1663583|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
1663584|NCT00129753|Alemtuzumab|alemtuzumab
1663585|NCT00129753|Campath|campath
1663586|NCT00129753|Campath-1H|campath-1h
1663587|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
1663588|NCT00129753|Lymphoma|lymphoma
1663589|NCT00129740|Chronic phase CML|chronic phase cml
1663590|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
1663591|NCT00129740|AMN107|amn107
1663592|NCT00129727|Carboplatin|carboplatin
1663593|NCT00129727|Paclitaxel|paclitaxel
1663594|NCT00129727|Bevacizumab|bevacizumab
1663595|NCT00129727|Ovarian|ovarian
1663596|NCT00129727|Cancer|cancer
1663597|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
1663598|NCT00129688|febrile neutropenia|febrile neutropenia
1663599|NCT00129688|once-daily|once-daily
1663600|NCT00129688|amikacin|amikacin
1663601|NCT00129688|cloxacillin|cloxacillin
1663602|NCT00129688|children|children
1663603|NCT00129675|parkinson|parkinson
1663604|NCT00129675|diagnosis|diagnosis
1663605|NCT00129610|Agoraphobia|agoraphobia
1663606|NCT00129610|panic disorder|panic disorder
1663607|NCT00129610|Virtual Reality Therapy|virtual reality therapy
1663608|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
1663609|NCT00129610|cognition|cognition
1663610|NCT00129610|spatial cognition|spatial cognition
1663611|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
1663612|NCT00129597|Ketalar|ketalar
1663615|NCT00129597|postoperative chronic pain|postoperative chronic pain
1663616|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
1663617|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
1663618|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
1663619|NCT00129545|Atrial Fibrillation|atrial fibrillation
1663620|NCT00129545|AF|af
1663621|NCT00129545|A Fib|a fib
1663622|NCT00129545|Stroke|stroke
1663623|NCT00129545|Coumadin|coumadin
1663624|NCT00129545|Warfarin|warfarin
1663625|NCT00129545|Blood thinning medication|blood thinning medication
1663626|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
1663627|NCT00129545|WATCHMAN|watchman
1663628|NCT00129545|Left atrial appendage|left atrial appendage
1663629|NCT00129545|LAA isolation|laa isolation
1663630|NCT00129545|LAA occlusion|laa occlusion
1664674|NCT00125788|L-glutamine|l-glutamine
1663631|NCT00129532|HIV transmission|hiv transmission
1663632|NCT00129519|BCC curettage|bcc curettage
1663633|NCT00129506|medical abortion|medical abortion
1663634|NCT00129506|methotrexate|methotrexate
1663635|NCT00129506|misoprostol|misoprostol
1663636|NCT00129493|Practice guidelines|practice guidelines
1663637|NCT00129493|Hypertension|hypertension
1663638|NCT00129493|Primary health care|primary health care
1663639|NCT00129493|Patient-centered care|patient-centered care
1663640|NCT00129493|Healthcare quality|healthcare quality
1663641|NCT00129493|Office visits|office visits
1663642|NCT00129493|Self-efficacy|self-efficacy
1663643|NCT00129493|Self care|self care
1663644|NCT00129493|Guideline adherence|guideline adherence
1663645|NCT00129493|Patient noncompliance|patient noncompliance
1663646|NCT00129480|veterans|veterans
1663647|NCT00129480|pain and chronic disease|pain and chronic disease
1663648|NCT00129480|disease management|disease management
1663649|NCT00129480|depression|depression
1663650|NCT00129480|primary health care|primary health care
1663651|NCT00129480|practice guidelines|practice guidelines
1663652|NCT00129480|guideline adherence|guideline adherence
1663653|NCT00129480|narcotics|narcotics
1663654|NCT00129480|patient compliance|patient compliance
1663655|NCT00129480|randomized controlled trial|randomized controlled trial
1663656|NCT00129467|Depression|depression
1663657|NCT00129467|Hospice Care|hospice care
1663658|NCT00129467|Antidepressive Agents|antidepressive agents
1663659|NCT00129467|Methylphenidate|methylphenidate
1663660|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
1663661|NCT00129467|Pain|pain
1663662|NCT00129467|Caregiver Burden|caregiver burden
1663663|NCT00129467|Cancer|cancer
1663664|NCT00129454|Telemedicine|telemedicine
1663665|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
1663666|NCT00129454|Utilization|utilization
1663667|NCT00129454|Randomized Control Trial|randomized control trial
1663668|NCT00129454|Gulf War Illness|gulf war illness
1663669|NCT00129454|Symptom-Based Illness|symptom-based illness
1663670|NCT00129454|Multisymptom Illness|multisymptom illness
1663671|NCT00129454|High utilization|high utilization
1663672|NCT00129441|schizophrenia|schizophrenia
1663673|NCT00129428|UVB|uvb
1663674|NCT00129428|keloid|keloid
1663675|NCT00129428|scleroderma|scleroderma
1663676|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
1663677|NCT00129428|scars|scars
1663678|NCT00129428|granuloma annulare|granuloma annulare
1663679|NCT00129415|UVA1|uva1
1663680|NCT00129415|UVB|uvb
1663681|NCT00129415|atopic dermatitis|atopic dermatitis
1663682|NCT00129415|psoriasis|psoriasis
1663683|NCT00129415|alopecia|alopecia
1663684|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
1663685|NCT00129415|urticaria|urticaria
1663686|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
1663687|NCT00129415|stretch marks|stretch marks
1663688|NCT00129402|cholesterol|cholesterol
1663689|NCT00129402|drugs|drugs
1663690|NCT00129402|hypercholesterolemia|hypercholesterolemia
1663691|NCT00129402|adolescent|adolescent
1663692|NCT00129402|randomized controlled trials|randomized controlled trials
1663693|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
1663694|NCT00129389|Prognostic gene profile.|prognostic gene profile.
1663695|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
1663696|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
1663697|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
1663698|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
1663699|NCT00129376|Weekly docetaxel.|weekly docetaxel.
1663700|NCT00129363|Adolescent|adolescent
1663701|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
1663702|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
1663703|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
1663704|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
1663705|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
1663706|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
1663707|NCT00129363|Age Factors|age factors
1663803|NCT00129142|Fractures|fractures
1663708|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
1663709|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
1663711|NCT00129363|Child, Preschool|child, preschool
1663712|NCT00129363|Drug Administration Schedule|drug administration schedule
1663713|NCT00129363|Female|female
1663714|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
1663715|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
1663716|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
1663717|NCT00129363|Human|human
1663718|NCT00129363|Infant|infant
1663719|NCT00129363|Infant, Newborn|infant, newborn
1663720|NCT00129363|Male|male
1663721|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
1663722|NCT00129363|Placebos|placebos
1663723|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
1663821|NCT00129064|Electronic medical record|electronic medical record
1663724|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
1663725|NCT00129363|Prospective Studies|prospective studies
1663726|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
1663727|NCT00129363|Treatment Outcome|treatment outcome
1663728|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
1663729|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
1663730|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
1663731|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
1663732|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
1663733|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
1663734|NCT00129337|monoclonal antibody|monoclonal antibody
1663735|NCT00129337|phase 1|phase 1
1663736|NCT00129337|solid tumor|solid tumor
1663737|NCT00129337|anti-angiogenesis|anti-angiogenesis
1663738|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
1663739|NCT00129324|HOME|home
1663740|NCT00129324|Environmental Exposure|environmental exposure
1663741|NCT00129324|Neurobehavior|neurobehavior
1663742|NCT00129324|Child Development|child development
1663743|NCT00129324|Lead Exposure|lead exposure
1663744|NCT00129324|Child Injury|child injury
1663745|NCT00129324|Adolescence|adolescence
1663746|NCT00129324|Adiposity|adiposity
1663747|NCT00129324|Neuroimaging|neuroimaging
1663748|NCT00129311|Tobacco|tobacco
1663749|NCT00129298|cocaine abuse|cocaine abuse
1663750|NCT00129298|opiate dependent|opiate dependent
1663751|NCT00129298|tiagabine|tiagabine
1663752|NCT00129298|methadone|methadone
1663753|NCT00129285|cocaine|cocaine
1663754|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
1663755|NCT00129259|T1D|t1d
1663756|NCT00129259|type 1 diabetes|type 1 diabetes
1663757|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
1663758|NCT00129259|juvenile diabetes|juvenile diabetes
1663759|NCT00129259|autoimmune diabetes|autoimmune diabetes
1663760|NCT00129259|autoimmune|autoimmune
1663761|NCT00129259|anti-CD3 mAb|anti-cd3 mab
1663762|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
1663763|NCT00129259|teplizumab|teplizumab
1663764|NCT00129246|Tobacco|tobacco
1663765|NCT00129246|Smoking|smoking
1663766|NCT00129246|Weight|weight
1663767|NCT00129246|Weight perception|weight perception
1663768|NCT00129246|Naltrexone|naltrexone
1663769|NCT00129246|Bupropion|bupropion
1663770|NCT00129233|cardiovascular disease|cardiovascular disease
1663771|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
1663772|NCT00129233|calcium channel blocker|calcium channel blocker
1663773|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
1663774|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
1663775|NCT00129207|pharmacokinetic|pharmacokinetic
1663776|NCT00129207|pharmacodynamics|pharmacodynamics
1663777|NCT00129207|VELCADE|velcade
1663778|NCT00129207|Ketoconazole|ketoconazole
1663779|NCT00129207|CYP 3A4|cyp 3a4
1663780|NCT00129207|Solid Tumor|solid tumor
1663781|NCT00129207|Advanced Solid Tumors|advanced solid tumors
1663782|NCT00129194|HIV|hiv
1663783|NCT00129194|Treatment Experienced|treatment experienced
1663784|NCT00129181|parkinson|parkinson
1663785|NCT00129181|brain imaging|brain imaging
1663786|NCT00129181|diagnosis|diagnosis
1663787|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
1663788|NCT00129168|Relapse|relapse
1663789|NCT00129168|Chemotherapy|chemotherapy
1663790|NCT00129168|Zosuquidar|zosuquidar
1663791|NCT00129168|Daunorubicin|daunorubicin
1663792|NCT00129168|Cytarabine|cytarabine
1663793|NCT00129168|Acute|acute
1663794|NCT00129168|AML|aml
1663795|NCT00129168|Adult AML|adult aml
1663796|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
1663797|NCT00129155|Treosulfan|treosulfan
1663798|NCT00129155|Haematological malignancies|haematological malignancies
1663799|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
1663800|NCT00129142|Prostate cancer|prostate cancer
1663801|NCT00129142|Bone Loss|bone loss
1663802|NCT00129142|Osteoporosis|osteoporosis
1663804|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
1663805|NCT00129129|Immunogenicity|immunogenicity
1663806|NCT00129129|Primary & booster vaccination|primary & booster vaccination
1663807|NCT00129129|Infants|infants
1663808|NCT00129129|Meningococcal vaccine|meningococcal vaccine
1663809|NCT00129129|Safety|safety
1663810|NCT00129129|Children|children
1663811|NCT00129129|Hib disease|hib disease
1663812|NCT00129129|Meningococcal disease|meningococcal disease
1663813|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
1663814|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
1663815|NCT00129077|Pediatric critical care|pediatric critical care
1663816|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
1663817|NCT00129077|corneal abrasions|corneal abrasions
1663818|NCT00129064|Referrals|referrals
1663819|NCT00129064|Quality of care|quality of care
1663820|NCT00129064|Ambulatory care|ambulatory care
1663822|NCT00129064|Referral communication|referral communication
1663823|NCT00129051|tomotherapy|tomotherapy
1663824|NCT00129051|metastatic carcinoma|metastatic carcinoma
1663825|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
1663826|NCT00129025|localized prostate cancer|localized prostate cancer
1663827|NCT00129012|radiation therapy|radiation therapy
1663828|NCT00129012|carcinoma|carcinoma
1663829|NCT00129012|non-small cell lung|non-small cell lung
1663830|NCT00128999|radiation therapy|radiation therapy
1663831|NCT00128986|radiotherapy|radiotherapy
1663832|NCT00128986|brain|brain
1663833|NCT00128973|CGD|cgd
1663834|NCT00128973|LAD|lad
1663835|NCT00128973|XSCID|xscid
1663836|NCT00128973|cGVHD|cgvhd
1663837|NCT00128973|Infection|infection
1663838|NCT00128973|Abnormal Immune Function|abnormal immune function
1663839|NCT00128973|Recurrent Infection|recurrent infection
1663840|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
1663841|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
1663842|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
1663843|NCT00128973|Healthy Volunteer|healthy volunteer
1663844|NCT00128973|HV|hv
1663845|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
1663846|NCT00128960|Health Related Quality of Life|health related quality of life
1663847|NCT00128960|Symptom Experience|symptom experience
1663848|NCT00128960|Fatigue|fatigue
1663849|NCT00128960|Functional Status|functional status
1663850|NCT00128960|Survey|survey
1663851|NCT00128960|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
1663852|NCT00128947|Immunosuppresant|immunosuppresant
1663853|NCT00128947|Pharmacogenetics|pharmacogenetics
1663854|NCT00128947|Glucuronidation|glucuronidation
1663855|NCT00128947|Metabolism|metabolism
1663856|NCT00128947|UGT|ugt
1663857|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
1663858|NCT00128934|Hormone Therapy|hormone therapy
1663859|NCT00128921|Multiple Myeloma|multiple myeloma
1663860|NCT00128908|HIV-1|hiv-1
1663861|NCT00128908|HAART|haart
1663862|NCT00128908|sequential HAART|sequential haart
1663863|NCT00128908|resistance|resistance
1663864|NCT00128908|salvage therapy|salvage therapy
1663865|NCT00128908|Treatment Experienced|treatment experienced
1663866|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
1663867|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
1663868|NCT00128895|ANCA|anca
1663869|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1663870|NCT00128882|Treatment|treatment
1663871|NCT00128882|Anti-D|anti-d
1663872|NCT00128882|Subcutaneous|subcutaneous
1663873|NCT00128882|Clinical evaluation|clinical evaluation
1663874|NCT00128882|Platelet count|platelet count
1663875|NCT00128882|IVIG|ivig
1663876|NCT00128869|Manipulation|manipulation
1663877|NCT00128869|Mobilization|mobilization
1663878|NCT00128869|Neck Pain|neck pain
1663879|NCT00128869|Physical Therapy|physical therapy
1663880|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
1663881|NCT00128856|Stage III disease.|stage iii disease.
1663882|NCT00128843|Metastatic breast cancer|metastatic breast cancer
1663883|NCT00128843|First line of hormone treatment|first line of hormone treatment
1663884|NCT00128843|Postmenopausal women|postmenopausal women
1663885|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
1663886|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
1663887|NCT00128830|HIV-1 infection|hiv-1 infection
1663888|NCT00128830|TMC125|tmc125
1663889|NCT00128830|Etravirine|etravirine
1663890|NCT00128830|Enfuvirtide|enfuvirtide
1663891|NCT00128830|Antiretroviral therapy|antiretroviral therapy
1663892|NCT00128817|neoplasm|neoplasm
1663893|NCT00128817|larynx|larynx
1663894|NCT00128817|surgery|surgery
1663895|NCT00128817|radiotherapy|radiotherapy
1663896|NCT00128817|chemotherapy|chemotherapy
1663897|NCT00128804|vitamin A|vitamin a
1663898|NCT00128804|beta Carotene|beta carotene
1663899|NCT00128804|diet|diet
1663900|NCT00128804|nutrition|nutrition
1663901|NCT00128804|nutritional requirements|nutritional requirements
1663902|NCT00128791|myocardial infarction|myocardial infarction
1663904|NCT00128791|nitric oxide|nitric oxide
1663905|NCT00128791|prevention|prevention
1663906|NCT00128791|acute myocardial infarction|acute myocardial infarction
1663907|NCT00128778|Breast cancer|breast cancer
1663908|NCT00128778|Metastases|metastases
1663909|NCT00128778|Maintenance treatment|maintenance treatment
1663910|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
1663911|NCT00128765|self-management|self-management
1663912|NCT00128765|practice nurse|practice nurse
1663913|NCT00128765|cost-effectiveness|cost-effectiveness
1663914|NCT00128765|randomized controlled trial|randomized controlled trial
1663915|NCT00128752|vitamin A|vitamin a
1663916|NCT00128752|beta Carotene|beta carotene
1663918|NCT00128752|nutrition|nutrition
1663919|NCT00128752|nutritional requirements|nutritional requirements
1664014|NCT00128362|Sentinel node|sentinel node
1663920|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
1663921|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
1663922|NCT00128713|Blood Transfusion|blood transfusion
1663923|NCT00128713|Blood Platelets|blood platelets
1663924|NCT00128700|adult glioblastoma|adult glioblastoma
1663925|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
1663926|NCT00128700|adult gliosarcoma|adult gliosarcoma
1663927|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1663928|NCT00128661|cervical cancer|cervical cancer
1663929|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1663930|NCT00128635|adult glioblastoma|adult glioblastoma
1663931|NCT00128635|adult gliosarcoma|adult gliosarcoma
1663932|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
1663933|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
1663934|NCT00128622|male breast cancer|male breast cancer
1663935|NCT00128622|recurrent breast cancer|recurrent breast cancer
1663936|NCT00128622|stage IV breast cancer|stage iv breast cancer
1663937|NCT00128622|recurrent colon cancer|recurrent colon cancer
1663938|NCT00128622|stage IV colon cancer|stage iv colon cancer
1663939|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
1663940|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
1663941|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
1663942|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1663943|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1663944|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
1663945|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1663946|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1663947|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
1663948|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1663949|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
1663950|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1663951|NCT00128583|stage III melanoma|stage iii melanoma
1663952|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1663953|NCT00128557|Vitamin A|vitamin a
1663954|NCT00128557|Newborn health|newborn health
1663955|NCT00128557|Infant Mortality|infant mortality
1663956|NCT00128557|Supplementation|supplementation
1663957|NCT00128557|Micronutrients|micronutrients
1663958|NCT00128557|Bangladesh|bangladesh
1663959|NCT00128531|Phase III|phase iii
1663960|NCT00128531|open label|open label
1663961|NCT00128531|multiple dose|multiple dose
1663962|NCT00128531|safety study|safety study
1663963|NCT00128531|pharmacokinetic study|pharmacokinetic study
1663964|NCT00128531|efficacy study|efficacy study
1663965|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
1663966|NCT00128505|PMD|pmd
1663967|NCT00128505|Depression|depression
1663968|NCT00128505|Psychosis|psychosis
1663969|NCT00128505|Psychotic Major Depression|psychotic major depression
1663970|NCT00128505|Major Depression|major depression
1663971|NCT00128492|cystic fibrosis|cystic fibrosis
1663972|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
1663973|NCT00128479|PMD|pmd
1663974|NCT00128479|Psychotic Depression|psychotic depression
1663975|NCT00128479|Psychosis|psychosis
1663976|NCT00128479|Major Depression|major depression
1663977|NCT00128479|Depression|depression
1663978|NCT00128479|Psychotic Major Depression|psychotic major depression
1663979|NCT00128466|bubonic plague|bubonic plague
1663980|NCT00128466|pneumonic plague|pneumonic plague
1663981|NCT00128466|septicemic plague|septicemic plague
1663982|NCT00128466|Yersinia pestis|yersinia pestis
1663983|NCT00128466|Pasteurella pestis|pasteurella pestis
1663984|NCT00128453|Pericarditis|pericarditis
1663985|NCT00128453|Recurrence|recurrence
1663986|NCT00128453|Therapeutics|therapeutics
1663987|NCT00128453|Prevention|prevention
1663988|NCT00128453|Colchicine|colchicine
1663989|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
1663990|NCT00128427|Pericarditis|pericarditis
1663991|NCT00128427|Prevention|prevention
1663992|NCT00128427|Colchicine|colchicine
1663993|NCT00128427|Recurrence|recurrence
1663994|NCT00128414|Pericarditis|pericarditis
1663995|NCT00128414|Recurrence|recurrence
1663996|NCT00128414|Therapeutics|therapeutics
1663997|NCT00128414|Prevention|prevention
1663998|NCT00128414|Colchicine|colchicine
1663999|NCT00128401|Cognitive|cognitive
1664000|NCT00128401|Behavioral|behavioral
1664001|NCT00128401|Adolescent|adolescent
1664002|NCT00128401|Therapy|therapy
1664003|NCT00128401|Extinction|extinction
1664004|NCT00128401|Social Phobia|social phobia
1664005|NCT00128388|panic disorder,|panic disorder,
1664006|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
1664007|NCT00128388|efficacy trial|efficacy trial
1664008|NCT00128375|Smoking Cessation|smoking cessation
1664009|NCT00128375|Work-site|work-site
1664010|NCT00128375|Incentives|incentives
1664011|NCT00128375|Cost Effectiveness|cost effectiveness
1664012|NCT00128375|Health Behavior|health behavior
1664013|NCT00128375|Smoking|smoking
1664015|NCT00128362|Axillary sampling|axillary sampling
1664016|NCT00128362|Operable breast cancer|operable breast cancer
1664017|NCT00128336|Weight|weight
1664018|NCT00128336|Diet|diet
1664019|NCT00128336|exercise|exercise
1664020|NCT00128336|maintenance|maintenance
1664021|NCT00128323|Children|children
1664022|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
1664023|NCT00128323|GV solution|gv solution
1664024|NCT00128323|nystatin drops|nystatin drops
1664025|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
1664026|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
1664027|NCT00128284|gastroparesis|gastroparesis
1664028|NCT00128284|Digestive|digestive
1664029|NCT00128284|Gastrointestinal|gastrointestinal
1664030|NCT00128284|Stomach|stomach
1664031|NCT00128284|Motility|motility
1664032|NCT00128284|Non-Invasive|non-invasive
1664033|NCT00128284|Capsule|capsule
1664034|NCT00128284|GI|gi
1664035|NCT00128284|Device|device
1664036|NCT00128284|Digestive System Diseases|digestive system diseases
1664037|NCT00128271|HCV|hcv
1664038|NCT00128271|monoclonal antibody|monoclonal antibody
1664039|NCT00128271|phase 1|phase 1
1664040|NCT00128258|Stem Cell|stem cell
1664041|NCT00128258|Heart Failure|heart failure
1664042|NCT00128258|Bone Marrow|bone marrow
1664043|NCT00128245|KCS|kcs
1664044|NCT00128245|dry eye|dry eye
1664045|NCT00128245|pimecrolimus|pimecrolimus
1664046|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
1664047|NCT00128232|Acromegaly|acromegaly
1664048|NCT00128232|untreated|untreated
1664049|NCT00128232|newly diagnosed|newly diagnosed
1664050|NCT00128232|octreotide LAR|octreotide lar
1664051|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
1664052|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
1664053|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
1664054|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
1664055|NCT00128154|Chromium|chromium
1664056|NCT00128154|Chromium picolinate|chromium picolinate
1664057|NCT00128154|Blood Glucose|blood glucose
1664058|NCT00128154|Cholesterol|cholesterol
1664059|NCT00128154|Complementary Therapies|complementary therapies
1664060|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
1664061|NCT00128128|Cranberry|cranberry
1664062|NCT00128128|Complementary Therapies|complementary therapies
1664063|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
1664064|NCT00128089|Obesity|obesity
1664065|NCT00128089|Dietary treatment|dietary treatment
1664066|NCT00128089|Fasting as medical therapy|fasting as medical therapy
1664067|NCT00128076|shoulder surgery|shoulder surgery
1664068|NCT00128076|rotator cuff|rotator cuff
1664069|NCT00128076|arthroscopic repair|arthroscopic repair
1664070|NCT00128076|mini-open repair|mini-open repair
1664071|NCT00128063|HIV-1|hiv-1
1664072|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
1664073|NCT00128063|Treatment Naive|treatment naive
1664074|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
1664075|NCT00128050|ICH|ich
1664076|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
1664077|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
1664078|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
1664079|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
1664080|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
1664081|NCT00128037|surgical resection|surgical resection
1664082|NCT00128037|superior sulcus tumor|superior sulcus tumor
1664083|NCT00128037|chest wall invasion|chest wall invasion
1664084|NCT00128037|mytomicin C|mytomicin c
1664085|NCT00128037|vindesine|vindesine
1664086|NCT00128037|cisplatin|cisplatin
1664087|NCT00128024|randomized prospective study|randomized prospective study
1664088|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
1664089|NCT00128024|multicenter study|multicenter study
1664090|NCT00128024|Japanese|japanese
1664091|NCT00128024|acute myocardial infarction|acute myocardial infarction
1664286|NCT00127322|Heart Failure, Congestive|heart failure, congestive
1664092|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
1664093|NCT00128011|watery diarrhea|watery diarrhea
1664094|NCT00128011|cholera vaccine|cholera vaccine
1664095|NCT00127998|malaria|malaria
1664096|NCT00127998|Plasmodium falciparum|plasmodium falciparum
1664097|NCT00127998|drug resistance|drug resistance
1664098|NCT00127998|antimalarials|antimalarials
1664099|NCT00127998|genotype|genotype
1664100|NCT00127998|treatment outcome|treatment outcome
1664101|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
1664102|NCT00127985|corticosteroids|corticosteroids
1664103|NCT00127985|mortality|mortality
1664104|NCT00127972|nevirapine|nevirapine
1664105|NCT00127972|efavirenz|efavirenz
1664106|NCT00127972|hiv-1|hiv-1
1664107|NCT00127972|Treatment Experienced|treatment experienced
1664108|NCT00127959|HIV-1|hiv-1
1664109|NCT00127959|HBV|hbv
1664110|NCT00127959|treatment|treatment
1664111|NCT00127959|tenofovir|tenofovir
1664112|NCT00127959|emtricitabine|emtricitabine
1664113|NCT00127959|Treatment Naive|treatment naive
1664114|NCT00127959|HIV-1 infection|hiv-1 infection
1664115|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
1664116|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
1664117|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
1664118|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
1664119|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
1664120|NCT00127868|Tinea Capitis|tinea capitis
1664121|NCT00127868|Children|children
1664122|NCT00127868|Pediatric|pediatric
1664123|NCT00127868|Treatment|treatment
1664124|NCT00127868|Therapy|therapy
1664125|NCT00127868|Adjunctive|adjunctive
1664126|NCT00127868|Selenium Sulfide|selenium sulfide
1664127|NCT00127868|Ciclopirox|ciclopirox
1664128|NCT00127868|Shampoo|shampoo
1664129|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
1664130|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
1664131|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
1664132|NCT00127842|PsA|psa
1664133|NCT00127842|Commercial product|commercial product
1664134|NCT00127842|American College of Rheumatology|american college of rheumatology
1664135|NCT00127842|ACR/PASI|acr/pasi
1664136|NCT00127829|Solid Tumors|solid tumors
1664137|NCT00127816|brachytherapy|brachytherapy
1664138|NCT00127816|implant radiotherapy|implant radiotherapy
1664139|NCT00127803|Clostridium difficile|clostridium difficile
1664140|NCT00127790|Insomnia|insomnia
1664141|NCT00127790|Sleep|sleep
1664142|NCT00127790|Pain|pain
1664143|NCT00127790|Pain, Chronic|pain, chronic
1664144|NCT00127790|Behavior Therapy|behavior therapy
1664145|NCT00127790|CBT|cbt
1664146|NCT00127790|CBT-I|cbt-i
1664147|NCT00127790|cognitive-behavioral|cognitive-behavioral
1664148|NCT00127777|HCV genotype 1|hcv genotype 1
1664149|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
1664150|NCT00127777|ribavirin|ribavirin
1664151|NCT00127777|amantadine|amantadine
1664152|NCT00127777|treatment-naive|treatment-naive
1664153|NCT00127764|pemphigus|pemphigus
1664154|NCT00127764|dexamethasone|dexamethasone
1664155|NCT00127764|glucocorticoids|glucocorticoids
1664156|NCT00127764|pulse|pulse
1664157|NCT00127764|therapy|therapy
1664158|NCT00127764|randomised|randomised
1664159|NCT00127764|placebo-controlled|placebo-controlled
1664160|NCT00127751|Risk factor reduction|risk factor reduction
1664161|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
1664162|NCT00127738|Hypertension|hypertension
1664163|NCT00127738|Renal artery stenosis|renal artery stenosis
1664164|NCT00127738|Kidney disease|kidney disease
1664165|NCT00127738|Renal vascular disease|renal vascular disease
1664166|NCT00127738|Atherosclerosis|atherosclerosis
1664167|NCT00127725|tibia|tibia
1664168|NCT00127725|fracture|fracture
1664169|NCT00127725|PEMF|pemf
1664170|NCT00127725|electromagnetic|electromagnetic
1664171|NCT00127725|non-union|non-union
1664172|NCT00127725|revision|revision
1664173|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
1664174|NCT00127712|amiodarone|amiodarone
1664175|NCT00127712|atrial fibrillation|atrial fibrillation
1664176|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
1664177|NCT00127699|Umbilical cord|umbilical cord
1664178|NCT00127699|Triple dye|triple dye
1664179|NCT00127699|Infant care|infant care
1664180|NCT00127686|cough|cough
1664181|NCT00127686|nocturnal cough|nocturnal cough
1664182|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
1664183|NCT00127686|sleep quality|sleep quality
1664184|NCT00127686|childhood cough|childhood cough
1664185|NCT00127686|Dextromethorphan|dextromethorphan
1664186|NCT00127686|Honey|honey
1664187|NCT00127673|Antidepressants|antidepressants
1664188|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
1664189|NCT00127660|Behavior|behavior
1664190|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
1664191|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
1664192|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
1664193|NCT00127582|Sudden cardiac death|sudden cardiac death
1664194|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
1664195|NCT00127582|Bradyarrhythmias|bradyarrhythmias
1664196|NCT00127569|HIV infections|hiv infections
1664197|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
1664198|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
1664199|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
1664200|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
1664201|NCT00127556|Transfusion|transfusion
1664202|NCT00127556|Safety|safety
1664203|NCT00127543|Medication Education|medication education
1664204|NCT00127543|Pediatric|pediatric
1664205|NCT00127530|Walking Ability|walking ability
1664206|NCT00127517|Oncology|oncology
1664207|NCT00127517|Palliative Care|palliative care
1664208|NCT00127517|Advanced Cancer|advanced cancer
1664209|NCT00127517|Palliative Cancer Care|palliative cancer care
1664210|NCT00127504|Onchocerciasis|onchocerciasis
1664211|NCT00127504|Wolbachia|wolbachia
1664212|NCT00127504|Therapy|therapy
1664213|NCT00127491|Acute Lung Injury|acute lung injury
1664214|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1664215|NCT00127491|Mechanical Ventilation|mechanical ventilation
1664216|NCT00127491|Esophageal Pressures|esophageal pressures
1664217|NCT00127491|Randomized Controlled Trial|randomized controlled trial
1664218|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1664219|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
1664220|NCT00127465|Medical Informatics|medical informatics
1664221|NCT00127465|Patient education|patient education
1664222|NCT00127465|Social support|social support
1664223|NCT00127465|Cancer|cancer
1664224|NCT00127465|Anxiety|anxiety
1664225|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
1664226|NCT00127452|cardiovascular diseases|cardiovascular diseases
1664227|NCT00127452|coronary heart disease|coronary heart disease
1664228|NCT00127452|coronary patients|coronary patients
1664229|NCT00127452|DHA|dha
1664230|NCT00127452|dietary intervention|dietary intervention
1664231|NCT00127452|dietary supplementation|dietary supplementation
1664232|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
1664233|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
1664234|NCT00127452|EPA|epa
1664235|NCT00127452|fish oil|fish oil
1664236|NCT00127452|fish fatty acids|fish fatty acids
1664237|NCT00127452|human subjects|human subjects
1664238|NCT00127452|ischaemic heart disease|ischaemic heart disease
1664239|NCT00127452|margarine|margarine
1664240|NCT00127452|marine fatty acids|marine fatty acids
1664241|NCT00127452|mortality|mortality
1664242|NCT00127452|myocardial infarction|myocardial infarction
1664243|NCT00127452|n-3 fatty acids|n-3 fatty acids
1664244|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
1664245|NCT00127452|n-3 PUFA|n-3 pufa
1664246|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
1664247|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
1664248|NCT00127452|prevention|prevention
1664249|NCT00127452|randomized controlled trial|randomized controlled trial
1664250|NCT00127452|secondary prevention|secondary prevention
1664251|NCT00127439|Ambulatory Disability|ambulatory disability
1664252|NCT00127439|Disability Ambulation|disability ambulation
1664253|NCT00127439|Locomotion Disorders|locomotion disorders
1664254|NCT00127439|Motor Activity|motor activity
1664255|NCT00127439|Rehabilitation|rehabilitation
1664256|NCT00127439|Spinal Cord Injury|spinal cord injury
1664257|NCT00127413|Chronic pain|chronic pain
1664258|NCT00127413|Co-morbid|co-morbid
1664259|NCT00127413|Intervention|intervention
1664260|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
1664261|NCT00127413|Treatment|treatment
1664262|NCT00127400|anger|anger
1664263|NCT00127400|intermittent|intermittent
1664264|NCT00127400|explosive|explosive
1664265|NCT00127387|Bone metastasis|bone metastasis
1664266|NCT00127387|Radiation therapy|radiation therapy
1664267|NCT00127387|Lung cancer|lung cancer
1664268|NCT00127387|Prostate cancer|prostate cancer
1664269|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
1664270|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
1664271|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
1664272|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
1664273|NCT00127361|doula|doula
1664274|NCT00127361|caregivers|caregivers
1664275|NCT00127361|labor support|labor support
1664276|NCT00127361|being with woman|being with woman
1664277|NCT00127361|continuous labor support|continuous labor support
1664278|NCT00127361|maternal outcomes|maternal outcomes
1664279|NCT00127361|Parturition|parturition
1664280|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
1664281|NCT00127335|myositis,|myositis,
1664282|NCT00127335|myopathy,|myopathy,
1664283|NCT00127335|statin side effects,|statin side effects,
1664284|NCT00127335|fatty acid oxidation|fatty acid oxidation
1664285|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
1664288|NCT00127322|patient admission|patient admission
1664289|NCT00127309|hangover|hangover
1664290|NCT00127309|hangover symptoms|hangover symptoms
1664292|NCT00127270|Overactive Bladder|overactive bladder
1664293|NCT00127270|Bladder hyperactivity|bladder hyperactivity
1664294|NCT00127270|Urge Incontinence|urge incontinence
1664295|NCT00127270|Incontinence|incontinence
1664296|NCT00127270|Bladder|bladder
1664297|NCT00127257|Constipation|constipation
1664298|NCT00127257|Biofeedback|biofeedback
1664299|NCT00127257|Dyssynergia|dyssynergia
1664300|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
1664301|NCT00127257|Outlet dysfunction|outlet dysfunction
1664302|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
1664303|NCT00127231|Alcohol Consumption|alcohol consumption
1664304|NCT00127231|Behavioral Research|behavioral research
1664305|NCT00127231|HIV|hiv
1664306|NCT00127231|Alcohol Abuse|alcohol abuse
1664307|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
1664308|NCT00127218|MRI|mri
1664309|NCT00127218|inflammatory markers|inflammatory markers
1664310|NCT00127218|statins|statins
1664311|NCT00127205|stage I breast cancer|stage i breast cancer
1664312|NCT00127205|stage II breast cancer|stage ii breast cancer
1664313|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
1664314|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
1664315|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
1664316|NCT00127127|Solid tumors|solid tumors
1664317|NCT00127114|Behavioral disturbance|behavioral disturbance
1664318|NCT00127114|Frontotemporal dementia|frontotemporal dementia
1664319|NCT00127114|Dementia|dementia
1664320|NCT00127114|Amantadine|amantadine
1664321|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
1664322|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
1664323|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
1664324|NCT00127062|Exposure to Oxford Street|exposure to oxford street
1664325|NCT00127062|Exposure to Hyde Park|exposure to hyde park
1664326|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
1664327|NCT00127036|colon|colon
1664328|NCT00127036|adenocarcinoma|adenocarcinoma
1664329|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
1664330|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
1664331|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
1664332|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
1664333|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
1664334|NCT00126984|Safety|safety
1664335|NCT00126984|Reactogenicity|reactogenicity
1664336|NCT00126984|Immunogenicity|immunogenicity
1664337|NCT00126984|Meningococcal vaccine|meningococcal vaccine
1664338|NCT00126984|Dose selection|dose selection
1664339|NCT00126984|Conjugate vaccine|conjugate vaccine
1664340|NCT00126971|malaria|malaria
1664341|NCT00126971|pregnancy|pregnancy
1664342|NCT00126971|Plasmodium falciparum|plasmodium falciparum
1664343|NCT00126971|antimalarials|antimalarials
1664344|NCT00126971|pharmacokinetics|pharmacokinetics
1664345|NCT00126971|treatment outcome|treatment outcome
1664346|NCT00126971|safety|safety
1664347|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
1664348|NCT00126958|urinary analysis|urinary analysis
1664349|NCT00126958|Loss of heterozygosity|loss of heterozygosity
1664350|NCT00126958|FGFR3 mutation|fgfr3 mutation
1664351|NCT00126958|follow-up|follow-up
1664352|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
1664353|NCT00126906|Malaria|malaria
1664354|NCT00126906|Pregnancy|pregnancy
1664355|NCT00126906|HIV|hiv
1664356|NCT00126893|Leukemia|leukemia
1664357|NCT00126893|AML|aml
1664358|NCT00126893|CC401|cc401
1664359|NCT00126893|CC-401|cc-401
1664360|NCT00126893|Celgene|celgene
1664361|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
1664362|NCT00126893|Myeloid Leukemia|myeloid leukemia
1664363|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
1664364|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
1664365|NCT00126880|nucleoside analogue|nucleoside analogue
1664366|NCT00126880|reverse transcriptase|reverse transcriptase
1664367|NCT00126880|lamivudine|lamivudine
1664368|NCT00126880|resistance mutation|resistance mutation
1664369|NCT00126880|Treatment Experienced|treatment experienced
1664370|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
1664371|NCT00126867|rapecitabine|rapecitabine
1664372|NCT00126867|adjuvant|adjuvant
1664373|NCT00126867|colon cancer|colon cancer
1664374|NCT00126867|toxicity|toxicity
1664375|NCT00126867|Stage II colon cancer|stage ii colon cancer
1664376|NCT00126867|Stage III colon cancer|stage iii colon cancer
1664377|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
1664378|NCT00126854|brachytherapy|brachytherapy
1664379|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
1664380|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
1664381|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
1664382|NCT00126828|lung neoplasm|lung neoplasm
1664383|NCT00126828|radiotherapy dosage|radiotherapy dosage
1664384|NCT00126815|prostate cancer|prostate cancer
1664385|NCT00126815|prostate specific antigen|prostate specific antigen
1664386|NCT00126815|radiotherapy|radiotherapy
1664387|NCT00126815|mathematical modeling|mathematical modeling
1664388|NCT00126802|tomotherapy|tomotherapy
1664389|NCT00126802|MRSZ|mrsz
1664390|NCT00126802|high risk prostate cancer|high risk prostate cancer
1664391|NCT00126789|Pain Cancer|pain cancer
1664392|NCT00126789|Chronic Pain|chronic pain
1664393|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1664394|NCT00126776|case management|case management
1664395|NCT00126776|self management|self management
1664396|NCT00126763|Chronic Pain|chronic pain
1664397|NCT00126763|Pain|pain
1664398|NCT00126750|Myocardial Infarction|myocardial infarction
1664399|NCT00126750|Comorbidities|comorbidities
1664400|NCT00126750|Guidelines|guidelines
1664401|NCT00126750|Computer Assisted Instruction|computer assisted instruction
1664402|NCT00126750|Physician Practice Instruction|physician practice instruction
1664403|NCT00126750|Online Systems|online systems
1664404|NCT00126737|Elderly|elderly
1664405|NCT00126737|Exercise|exercise
1664406|NCT00126737|lean body mass|lean body mass
1664407|NCT00126737|muscle strength|muscle strength
1664408|NCT00126737|Nutrition program|nutrition program
1664409|NCT00126737|Pain control|pain control
1664410|NCT00126737|stair climb|stair climb
1664411|NCT00126737|walking distance|walking distance
1664412|NCT00126737|weight loss|weight loss
1664413|NCT00126724|tgAAC94|tgaac94
1664414|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
1664415|NCT00126724|Inflammatory arthritis|inflammatory arthritis
1664416|NCT00126724|Arthritis|arthritis
1664417|NCT00126724|Gene therapy|gene therapy
1664418|NCT00126724|AAV|aav
1664419|NCT00126698|Bacteriuria|bacteriuria
1664420|NCT00126698|Urinary Catheter|urinary catheter
1664421|NCT00126698|Urinary tract infection|urinary tract infection
1664422|NCT00126698|Prophylaxis|prophylaxis
1664423|NCT00126698|Urinary catheter removal|urinary catheter removal
1664424|NCT00126685|stage IV melanoma|stage iv melanoma
1664425|NCT00126685|recurrent melanoma|recurrent melanoma
1664426|NCT00126672|angiomyolipoma|angiomyolipoma
1664427|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1664428|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1664429|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1664430|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1664431|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1664432|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1664433|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1664434|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1664435|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1664436|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1664437|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1664438|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1664439|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1664440|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1664441|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1664442|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1664443|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1664444|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1664445|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1664446|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1664447|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1664636|NCT00125957|bupropion|bupropion
1664448|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1664449|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1664450|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1664451|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
1664452|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1664453|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
1664454|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1664455|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
1664456|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1664457|NCT00126555|recurrent skin cancer|recurrent skin cancer
1664458|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
1664459|NCT00126555|Radiation|radiation
1664460|NCT00126555|ZD1839|zd1839
1664461|NCT00126555|Iressa|iressa
1664462|NCT00126555|Gefitinib|gefitinib
1664463|NCT00126516|silent brain infarction|silent brain infarction
1664464|NCT00126516|cognitive decline|cognitive decline
1664557|NCT00126204|doxycycline|doxycycline
1664465|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
1664466|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
1664467|NCT00126516|hypertension|hypertension
1664468|NCT00126477|quality of life|quality of life
1664469|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1664470|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1664471|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1664472|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1664473|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
1664474|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
1664475|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
1664476|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
1664576|NCT00126152|Exercise|exercise
1664477|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1664478|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1664479|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1664480|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1664481|NCT00126464|breast cancer in situ|breast cancer in situ
1664482|NCT00126438|Heart Failure|heart failure
1664483|NCT00126438|nuclear cardiology|nuclear cardiology
1664484|NCT00126438|sympathetic innervation|sympathetic innervation
1664485|NCT00126438|123I-mIBG|123i-mibg
1664486|NCT00126425|Heart Failure|heart failure
1664487|NCT00126425|nuclear cardiology|nuclear cardiology
1664488|NCT00126425|sympathetic innervation|sympathetic innervation
1664489|NCT00126425|123I-mIBG|123i-mibg
1664490|NCT00126412|Phaeochromocytoma|phaeochromocytoma
1664491|NCT00126412|Neuroblastoma|neuroblastoma
1664492|NCT00126412|diagnosis|diagnosis
1664493|NCT00126412|123I-mIBG|123i-mibg
1664494|NCT00126399|rosacea|rosacea
1664495|NCT00126399|acne rosacea|acne rosacea
1664496|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
1664497|NCT00126386|malignant bone pain|malignant bone pain
1664498|NCT00126386|bisphosphonates|bisphosphonates
1664499|NCT00126386|cancer|cancer
1664500|NCT00126386|palliative|palliative
1664501|NCT00126386|Zometa|zometa
1664502|NCT00126386|palliative patient|palliative patient
1664503|NCT00126386|treatment in community|treatment in community
1664504|NCT00126373|Crohn disease|crohn disease
1664505|NCT00126373|TNF-alpha|tnf-alpha
1664506|NCT00126360|Breast Cancer|breast cancer
1664507|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
1664508|NCT00126360|Local Control|local control
1664509|NCT00126347|betaine|betaine
1664510|NCT00126347|serine|serine
1664511|NCT00126347|folic acid|folic acid
1664512|NCT00126347|methionine load|methionine load
1664513|NCT00126347|homocysteine|homocysteine
1664514|NCT00126347|cardiovascular health|cardiovascular health
1664515|NCT00126347|vascular function|vascular function
1664516|NCT00126347|human|human
1664517|NCT00126334|Myocardial Infarction|myocardial infarction
1664518|NCT00126334|Anemia|anemia
1664519|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
1664520|NCT00126321|AML, relapsed|aml, relapsed
1664521|NCT00126321|cladribine|cladribine
1664522|NCT00126321|chemotherapy|chemotherapy
1664524|NCT00126308|Lipodystrophy|lipodystrophy
1664525|NCT00126308|Intervention|intervention
1664526|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
1664527|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
1664528|NCT00126308|Treatment Experienced|treatment experienced
1664529|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
1664530|NCT00126282|behavior therapy|behavior therapy
1664531|NCT00126282|D-Cycloserine|d-cycloserine
1664532|NCT00126282|medication|medication
1664533|NCT00126282|treatment trial|treatment trial
1664534|NCT00126282|placebo-controlled|placebo-controlled
1664535|NCT00126282|double-blind|double-blind
1664536|NCT00126282|randomized|randomized
1664637|NCT00125957|executive function|executive function
1666584|NCT00118430|Hip Pain|hip pain
1664537|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
1664538|NCT00126256|Colorectal cancer|colorectal cancer
1664539|NCT00126256|metastatic|metastatic
1664540|NCT00126256|chemotherapy|chemotherapy
1664541|NCT00126256|randomized trial|randomized trial
1664542|NCT00126243|AIDS related Lymphoma|aids related lymphoma
1664543|NCT00126243|chemotherapy|chemotherapy
1664544|NCT00126243|rituximab|rituximab
1664545|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
1664546|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
1664547|NCT00126217|Infant mortality|infant mortality
1664548|NCT00126217|Morbidity|morbidity
1664549|NCT00126217|Low income country|low income country
1664550|NCT00126217|Malaria|malaria
1664551|NCT00126217|BCG|bcg
1664552|NCT00126217|immunisation|immunisation
1664553|NCT00126217|BCG revaccination|bcg revaccination
1664554|NCT00126217|Tuberculin|tuberculin
1664555|NCT00126217|Mortality|mortality
1664556|NCT00126204|endoleak|endoleak
1664558|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
1664559|NCT00126204|inflammation|inflammation
1664560|NCT00126204|endograft|endograft
1664561|NCT00126204|circulating markers|circulating markers
1664562|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
1664563|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
1664564|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1664565|NCT00126191|rituximab|rituximab
1664566|NCT00126178|Kidney Cancer|kidney cancer
1664567|NCT00126178|Renal|renal
1664568|NCT00126178|Immunotherapy|immunotherapy
1664569|NCT00126178|Vaccine|vaccine
1664570|NCT00126165|prostate cancer|prostate cancer
1664571|NCT00126165|radiotherapy|radiotherapy
1664572|NCT00126165|hypofraction|hypofraction
1664573|NCT00126165|radiosensitivity|radiosensitivity
1664574|NCT00126165|image-guidance|image-guidance
1664575|NCT00126152|Falls|falls
1664577|NCT00126152|Fall Risk Factors|fall risk factors
1664578|NCT00126152|Older Adults|older adults
1664579|NCT00126139|stroke, ischemic|stroke, ischemic
1664580|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
1664581|NCT00126139|Acute ischemic stroke|acute ischemic stroke
1664582|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
1664583|NCT00126126|Artificial Limbs|artificial limbs
1664584|NCT00126126|Evidence based medicine|evidence based medicine
1664585|NCT00126126|Exercise|exercise
1664586|NCT00126126|Outcomes research|outcomes research
1664587|NCT00126126|Physical therapy|physical therapy
1664588|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
1664589|NCT00126113|Counseling|counseling
1664590|NCT00126100|Stem Cells|stem cells
1664591|NCT00126087|dopamine|dopamine
1664592|NCT00126087|NMDA receptor|nmda receptor
1664593|NCT00126087|brain imaging|brain imaging
1664594|NCT00126087|neuroplasticity|neuroplasticity
1664595|NCT00126087|learning|learning
1664596|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
1664597|NCT00126087|rehabilitation|rehabilitation
1664598|NCT00126087|aging|aging
1664599|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
1664600|NCT00126061|Atrial fibrillation|atrial fibrillation
1664601|NCT00126061|atrial flutter|atrial flutter
1664602|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
1664603|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
1664604|NCT00126048|Atopy|atopy
1664605|NCT00126048|Statin|statin
1664606|NCT00126048|Asthma|asthma
1664607|NCT00126048|methacholine|methacholine
1664608|NCT00126048|FEV1|fev1
1664609|NCT00126035|Acute Migraine|acute migraine
1664610|NCT00126035|Device|device
1664611|NCT00126035|Migraid|migraid
1664612|NCT00126035|Treatment|treatment
1664613|NCT00126035|Aura|aura
1664614|NCT00126022|Atrial fibrillation|atrial fibrillation
1664615|NCT00126022|atrial flutter|atrial flutter
1664616|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
1664617|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
1664618|NCT00125996|ANAEMIA|anaemia
1664619|NCT00125996|Iron Deficiency|iron deficiency
1664620|NCT00125983|Birth Control Pills|birth control pills
1664621|NCT00125983|Oral Contraceptives|oral contraceptives
1664622|NCT00125983|Contraceptive Patch|contraceptive patch
1664623|NCT00125983|Pharmacokinetics|pharmacokinetics
1664624|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1664625|NCT00125983|Protease Inhibitor|protease inhibitor
1664626|NCT00125983|Treatment Experienced|treatment experienced
1664627|NCT00125983|Treatment Naive|treatment naive
1664628|NCT00125983|Contraception|contraception
1664629|NCT00125970|HIV Seronegativity|hiv seronegativity
1664630|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
1664631|NCT00125957|depression|depression
1664632|NCT00125957|serotonin|serotonin
1664633|NCT00125957|norepinephrine|norepinephrine
1664634|NCT00125957|SSRI|ssri
1664635|NCT00125957|Wellbutrin|wellbutrin
1664638|NCT00125957|residual symptoms|residual symptoms
1664639|NCT00125931|bipolar disorder|bipolar disorder
1664640|NCT00125931|mania|mania
1664641|NCT00125931|manic state|manic state
1664642|NCT00125931|opiate|opiate
1664643|NCT00125931|kappa|kappa
1664644|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
1664645|NCT00125905|Primary Care|primary care
1664646|NCT00125905|Smoking Cessation|smoking cessation
1664647|NCT00125905|Stages of Change Model|stages of change model
1664648|NCT00125905|Health Education|health education
1664649|NCT00125905|Clinical Practice guideline|clinical practice guideline
1664650|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
1664651|NCT00125879|GSD-II|gsd-ii
1664652|NCT00125879|Pompe Disease|pompe disease
1664653|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
1664654|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1664655|NCT00125879|Glycogenosis 2|glycogenosis 2
1664656|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
1664657|NCT00125866|randomised double blind trial|randomised double blind trial
1664658|NCT00125866|blood pressure|blood pressure
1664659|NCT00125866|cocoa flavonoids|cocoa flavonoids
1664660|NCT00125853|blood pressure|blood pressure
1664661|NCT00125853|insulin sensitivity|insulin sensitivity
1664662|NCT00125853|beta blockers|beta blockers
1664663|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
1664664|NCT00125840|CLO151|clo151
1664665|NCT00125840|Clolar|clolar
1664666|NCT00125840|Pediatric ALL and AML|pediatric all and aml
1664667|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
1664668|NCT00125827|CLO152|clo152
1664669|NCT00125827|Clolar|clolar
1664670|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
1664671|NCT00125814|HIV infections|hiv infections
1664672|NCT00125788|sickle cell disease|sickle cell disease
1664673|NCT00125788|sickle cell anemia|sickle cell anemia
1664675|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
1664676|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
1664677|NCT00125749|Dendritic|dendritic
1664678|NCT00125749|Vaccine|vaccine
1664679|NCT00125749|Melanoma|melanoma
1664680|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
1664681|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
1664682|NCT00125723|Chemotherapy|chemotherapy
1664683|NCT00125723|Neulasta®|neulasta®
1664684|NCT00125723|Oncology|oncology
1664685|NCT00125723|Malignancy|malignancy
1664686|NCT00125710|cryogenic analysis|cryogenic analysis
1664687|NCT00125710|oncogenes|oncogenes
1664688|NCT00125697|malignant glioma|malignant glioma
1664689|NCT00125697|spectroscopy|spectroscopy
1664690|NCT00125697|magnetic resonance|magnetic resonance
1664691|NCT00125684|transdermal morphine|transdermal morphine
1664692|NCT00125684|cancer|cancer
1664693|NCT00125684|pain|pain
1664694|NCT00125684|bioavailability|bioavailability
1664695|NCT00125684|pharmacokinetics|pharmacokinetics
1664696|NCT00125684|cancer related pain|cancer related pain
1664697|NCT00125684|stable baseline pain|stable baseline pain
1664698|NCT00125684|currently taking opioids|currently taking opioids
1664699|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
1664700|NCT00125671|Peripheral vascular disease|peripheral vascular disease
1664701|NCT00125671|Atherosclerosis|atherosclerosis
1664702|NCT00125671|cardiovascular events|cardiovascular events
1664703|NCT00125671|Ischemia|ischemia
1664704|NCT00125671|oral anticoagulants|oral anticoagulants
1664705|NCT00125671|low ankle-brachial index|low ankle-brachial index
1664706|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
1664707|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
1664708|NCT00125658|biomechanics|biomechanics
1664709|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
1664710|NCT00125658|electromyography|electromyography
1664711|NCT00125658|muscular weakness|muscular weakness
1664712|NCT00125658|recovery of function|recovery of function
1664713|NCT00125658|reflex variability stroke|reflex variability stroke
1664714|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
1664716|NCT00125645|Left ventricular function|left ventricular function
1664717|NCT00125645|Myocardial performance index|myocardial performance index
1664718|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
1664719|NCT00125632|Reading|reading
1664720|NCT00125632|Rehabilitation|rehabilitation
1664721|NCT00125632|Treatment Outcomes|treatment outcomes
1664722|NCT00125632|Low vision|low vision
1664723|NCT00125619|biomechanics|biomechanics
1664724|NCT00125619|stroke|stroke
1664725|NCT00125619|electromyography|electromyography
1664726|NCT00125619|Gait disability stroke|gait disability stroke
1664727|NCT00125619|locomotor therapy|locomotor therapy
1664728|NCT00125619|muscular weakness|muscular weakness
1664729|NCT00125619|reflex variability stroke|reflex variability stroke
1664730|NCT00125606|AML|aml
1664731|NCT00125606|allogeneic HSCT|allogeneic hsct
1664732|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
1664733|NCT00125606|randomized trail|randomized trail
1664734|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
1665023|NCT00124358|Drug Abuse|drug abuse
1664735|NCT00125593|LDL cholesterol|ldl cholesterol
1664736|NCT00125593|simvastatin|simvastatin
1664737|NCT00125593|ezetimibe|ezetimibe
1664738|NCT00125593|cardiovascular disease|cardiovascular disease
1664739|NCT00125593|atherosclerosis|atherosclerosis
1664740|NCT00125580|Obesity|obesity
1664741|NCT00125580|Childhood Obesity|childhood obesity
1664742|NCT00125580|Infant Sleep|infant sleep
1664743|NCT00125580|Infant growth|infant growth
1664744|NCT00125580|Infant feeding|infant feeding
1664745|NCT00125554|Clinical trial|clinical trial
1664746|NCT00125554|double-blind|double-blind
1664747|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
1664748|NCT00125554|metyrapone|metyrapone
1664749|NCT00125554|Major Depression|major depression
1664750|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
1664751|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
1664752|NCT00125528|chronic pain|chronic pain
1664753|NCT00125528|low back pain|low back pain
1664754|NCT00125528|D-cycloserine|d-cycloserine
1664759|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
1664760|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
1664761|NCT00125476|Postmenopause|postmenopause
1664762|NCT00125463|Hypertension|hypertension
1664763|NCT00125463|clinical trial|clinical trial
1664764|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
1664765|NCT00125463|candesartan cilexetil|candesartan cilexetil
1664766|NCT00125463|amlodipine besilate|amlodipine besilate
1664767|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
1664768|NCT00125450|Chest Physiotherapy|chest physiotherapy
1664769|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
1664770|NCT00125450|Double Blind Trial|double blind trial
1664771|NCT00125450|Children|children
1664772|NCT00125450|Pediatric|pediatric
1664773|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
1664774|NCT00125437|aldosterone antagonists|aldosterone antagonists
1664775|NCT00125437|spironolactone|spironolactone
1664776|NCT00125437|left ventricular remodeling|left ventricular remodeling
1664777|NCT00125424|Colonoscopy|colonoscopy
1664778|NCT00125424|Sedation|sedation
1664779|NCT00125424|AQUAVAN|aquavan
1664780|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
1664781|NCT00125424|Endoscopic sedation|endoscopic sedation
1664782|NCT00125424|Endoscopic outcomes|endoscopic outcomes
1664783|NCT00125424|Endoscopy|endoscopy
1664784|NCT00125411|satraplatin|satraplatin
1664785|NCT00125411|docetaxel|docetaxel
1664786|NCT00125411|cancer|cancer
1664787|NCT00125411|Phase I|phase i
1664788|NCT00125411|advanced solid tumors|advanced solid tumors
1664789|NCT00125398|AQUAVAN|aquavan
1664790|NCT00125398|GPI 15715|gpi 15715
1664792|NCT00125398|Sedation|sedation
1664793|NCT00125385|IPF|ipf
1664794|NCT00125385|Idiopathic|idiopathic
1664795|NCT00125385|Pulmonary|pulmonary
1664796|NCT00125385|Fibrosis|fibrosis
1664797|NCT00125372|tarceva|tarceva
1664798|NCT00125372|targretin|targretin
1664799|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
1664800|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
1664801|NCT00125372|nsclc|nsclc
1664802|NCT00125359|tarceva|tarceva
1664803|NCT00125359|targretin|targretin
1664804|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
1664805|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
1664806|NCT00125359|NSCLC|nsclc
1664807|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
1664808|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
1664809|NCT00125320|Treatment|treatment
1664810|NCT00125307|SLE|sle
1664811|NCT00125307|glomerulonephritis|glomerulonephritis
1664812|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
1664813|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
1664814|NCT00125294|cancer pain|cancer pain
1664815|NCT00125294|breakthrough pain|breakthrough pain
1664816|NCT00125294|methadone|methadone
1664817|NCT00125294|dose titration|dose titration
1664818|NCT00125294|sublingual route of administration|sublingual route of administration
1664819|NCT00125294|Cancer related pain|cancer related pain
1664820|NCT00125294|currently taking narcotics|currently taking narcotics
1664821|NCT00125281|Fatigue|fatigue
1664822|NCT00125281|Cirrhosis|cirrhosis
1664823|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
1664824|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
1664825|NCT00125281|Pruritus|pruritus
1664826|NCT00125281|Symptomatic Releif|symptomatic releif
1664827|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
1664828|NCT00125281|PBC|pbc
1664829|NCT00125281|Liver Disease|liver disease
1664830|NCT00125268|painful|painful
1664831|NCT00125268|peripheral|peripheral
1664832|NCT00125268|neuropathy|neuropathy
1664833|NCT00125268|light|light
1664834|NCT00125268|therapy|therapy
1664835|NCT00125242|Aphasia|aphasia
1664836|NCT00125242|Language therapy|language therapy
1664837|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
1664838|NCT00125242|Speech-language pathology|speech-language pathology
1664839|NCT00125229|Hypertonic Saline|hypertonic saline
1664840|NCT00125229|Mannitol|mannitol
1664841|NCT00125229|Intracranial hypertension|intracranial hypertension
1664842|NCT00125229|Cerebral blood flow|cerebral blood flow
1664843|NCT00125229|Traumatic brain injury|traumatic brain injury
1664844|NCT00125216|Aphasia|aphasia
1664845|NCT00125216|Language Therapy|language therapy
1664846|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
1664847|NCT00125216|Speech-language pathology|speech-language pathology
1664848|NCT00125203|ALS|als
1664849|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
1664850|NCT00125203|Motor Neuron Disease|motor neuron disease
1664851|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1664852|NCT00125203|Sialorrhea|sialorrhea
1664853|NCT00125203|Hypersalivation|hypersalivation
1664854|NCT00125203|Excessive Drooling|excessive drooling
1664855|NCT00125203|Myobloc|myobloc
1664856|NCT00125203|botulinum toxin type B|botulinum toxin type b
1664857|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
1664858|NCT00125203|botulinum B toxin|botulinum b toxin
1664859|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
1664860|NCT00125203|NeuroBloc|neurobloc
1664861|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
1664862|NCT00125190|IGF-1|igf-1
1664863|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
1664864|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
1664865|NCT00125177|stress incontinence intervention|stress incontinence intervention
1664866|NCT00125177|incontinence intervention|incontinence intervention
1664867|NCT00125177|Incontinence|incontinence
1664869|NCT00125177|Stress Incontinence|stress incontinence
1664870|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
1664871|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
1664872|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
1664873|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
1664874|NCT00125112|binge eating|binge eating
1664875|NCT00125112|weight loss|weight loss
1664876|NCT00125112|obesity|obesity
1664877|NCT00125099|Acute Infection|acute infection
1664878|NCT00125099|Treatment Experienced|treatment experienced
1664879|NCT00125099|Treatment Interruption|treatment interruption
1664880|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1664881|NCT00125086|wounds|wounds
1664882|NCT00125086|healing|healing
1664883|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
1664884|NCT00125073|Standard Care|standard care
1664885|NCT00125073|Nutritional Counseling|nutritional counseling
1664886|NCT00125060|Aorta|aorta
1664887|NCT00125060|Atherosclerosis|atherosclerosis
1664888|NCT00125060|MRI|mri
1664889|NCT00125060|statin|statin
1664890|NCT00125060|inflammatory markers|inflammatory markers
1664891|NCT00125047|Salmonellosis|salmonellosis
1664892|NCT00125047|typhoid vaccine|typhoid vaccine
1664893|NCT00125047|enteric fever|enteric fever
1664894|NCT00125034|FOLFOX-4|folfox-4
1664895|NCT00125034|Cetuximab|cetuximab
1664896|NCT00125034|First-line mCRC|first-line mcrc
1664897|NCT00125034|EGFR positive|egfr positive
1664898|NCT00125034|metastatic CRC|metastatic crc
1664899|NCT00125021|Second Line Therapy|second line therapy
1664900|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
1664901|NCT00125021|Pancreatic Cancer|pancreatic cancer
1664902|NCT00125021|Capecitabine|capecitabine
1664903|NCT00125021|Tarceva|tarceva
1664904|NCT00125021|OSI-774|osi-774
1664905|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
1664906|NCT00125008|Salmonella|salmonella
1664907|NCT00125008|Typhoid vaccine|typhoid vaccine
1664908|NCT00125008|enteric fever|enteric fever
1664909|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
1664910|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
1664911|NCT00124930|olanzapine|olanzapine
1664912|NCT00124930|haldol|haldol
1664913|NCT00124930|cancer|cancer
1664914|NCT00124930|nausea|nausea
1664915|NCT00124930|second line treatment|second line treatment
1664916|NCT00124930|refractory nausea|refractory nausea
1664917|NCT00124917|Prostate Cancer|prostate cancer
1664918|NCT00124917|MRI|mri
1664919|NCT00124917|Fiducial Marker|fiducial marker
1664920|NCT00124917|IMRT|imrt
1664921|NCT00124904|Biofeedback|biofeedback
1664922|NCT00124904|Incontinence|incontinence
1664923|NCT00124891|Arrhythmias|arrhythmias
1664924|NCT00124878|HIV|hiv
1664925|NCT00124878|STDs|stds
1664926|NCT00124878|Male circumcision|male circumcision
1664927|NCT00124878|HIV+ males|hiv+ males
1664928|NCT00124878|HIV-negative males|hiv-negative males
1664929|NCT00124878|Female partners|female partners
1664930|NCT00124878|STDs such as the following:|stds such as the following:
1664931|NCT00124878|HPV|hpv
1664932|NCT00124878|HSV-2|hsv-2
1664933|NCT00124878|HIV Seronegativity|hiv seronegativity
1664934|NCT00124865|Campylobacter|campylobacter
1664935|NCT00124865|Bacterial enteritis|bacterial enteritis
1664936|NCT00124852|cognition|cognition
1664937|NCT00124852|depression|depression
1664938|NCT00124852|elderly|elderly
1664939|NCT00124839|Dissociation|dissociation
1664940|NCT00124839|Flashbacks|flashbacks
1664941|NCT00124839|Self-injurious behavior|self-injurious behavior
1664942|NCT00124826|stroke|stroke
1664943|NCT00124826|cerebrovascular disease|cerebrovascular disease
1664944|NCT00124826|hyperglycemia|hyperglycemia
1664945|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
1664946|NCT00124826|acute ischemic stroke|acute ischemic stroke
1664947|NCT00124800|tinnitus|tinnitus
1664948|NCT00124774|hernia|hernia
1664949|NCT00124774|nucleoplasty|nucleoplasty
1664950|NCT00124774|radicular pain|radicular pain
1664951|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
1664952|NCT00124761|Radiosurgery|radiosurgery
1664953|NCT00124761|Brain metastases|brain metastases
1664954|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
1664955|NCT00124761|Neurosurgery|neurosurgery
1664956|NCT00124761|Solitary Brain Metastases|solitary brain metastases
1664957|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
1664958|NCT00124748|CML|cml
1664959|NCT00124748|Philadelphia positive|philadelphia positive
1664960|NCT00124748|Bcr-abl|bcr-abl
1664961|NCT00124748|imatinib mesylate|imatinib mesylate
1664962|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
1664963|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
1664964|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
1664965|NCT00124696|cocaine dependence|cocaine dependence
1664966|NCT00124683|nicotine dependence|nicotine dependence
1664967|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1664968|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1664969|NCT00124657|adult glioblastoma|adult glioblastoma
1665157|NCT00123851|Xeloda|xeloda
1664970|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
1664971|NCT00124657|adult gliosarcoma|adult gliosarcoma
1664972|NCT00124657|adult mixed glioma|adult mixed glioma
1664973|NCT00124657|childhood mixed glioma|childhood mixed glioma
1664974|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1664975|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1664976|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1664977|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
1664978|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1664979|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1664980|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1664981|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1664982|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1664983|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1664984|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1664985|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
1664986|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
1664987|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
1664988|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
1664989|NCT00124566|Irofulven|irofulven
1664990|NCT00124566|Docetaxel|docetaxel
1664991|NCT00124566|Taxotere|taxotere
1664992|NCT00124553|Type 2 diabetes|type 2 diabetes
1664993|NCT00124553|cardiovascular risk|cardiovascular risk
1664994|NCT00124553|glycaemic control|glycaemic control
1664995|NCT00124553|dietary modification|dietary modification
1664996|NCT00124540|Misoprostol|misoprostol
1664997|NCT00124540|Active management|active management
1664998|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
1664999|NCT00124540|Maternal morbidity|maternal morbidity
1665000|NCT00124540|Anemia|anemia
1665001|NCT00124540|Developing countries|developing countries
1665002|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
1665003|NCT00124514|SLE|sle
1665004|NCT00124514|Lupus|lupus
1665005|NCT00124514|Ovarian damage|ovarian damage
1665006|NCT00124514|Menopause|menopause
1665007|NCT00124501|Biofeedback|biofeedback
1665008|NCT00124488|radiotherapy planning|radiotherapy planning
1665009|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
1665010|NCT00124488|conformal|conformal
1665011|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
1665012|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
1665013|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
1665014|NCT00124410|prostate cancer|prostate cancer
1665015|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
1665016|NCT00124410|osteoporosis|osteoporosis
1665017|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
1665018|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
1665019|NCT00124371|risk factors|risk factors
1665020|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
1665021|NCT00124371|prehabilitation|prehabilitation
1665022|NCT00124371|waiting period|waiting period
1665024|NCT00124358|Drug Addiction|drug addiction
1665025|NCT00124358|Drug Dependence|drug dependence
1665026|NCT00124358|Drug Use Disorders|drug use disorders
1665027|NCT00124358|Drug Use Disorder|drug use disorder
1665028|NCT00124358|Substance Abuse|substance abuse
1665029|NCT00124358|Substance Use Disorder|substance use disorder
1665030|NCT00124358|Buprenorphine|buprenorphine
1665031|NCT00124358|Opiate Addiction|opiate addiction
1665032|NCT00124358|Substance-related disorders|substance-related disorders
1665033|NCT00124358|HIV|hiv
1665034|NCT00124345|temperature|temperature
1665035|NCT00124345|humidity|humidity
1665036|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
1665037|NCT00124319|Biomechanics|biomechanics
1665038|NCT00124319|Neuromuscular|neuromuscular
1665039|NCT00124319|Lower limb|lower limb
1665040|NCT00124319|Injury|injury
1665041|NCT00124319|ACL|acl
1665042|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
1665431|NCT00122590|nelfinavir|nelfinavir
1665043|NCT00124306|painful bladder syndrome|painful bladder syndrome
1665044|NCT00124306|interstitial cystitis|interstitial cystitis
1665045|NCT00124306|newly diagnosed|newly diagnosed
1665046|NCT00124280|Lung cancer|lung cancer
1665047|NCT00124280|non-small cell|non-small cell
1665048|NCT00124280|everolimus|everolimus
1665049|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
1665050|NCT00124267|Cerebral|cerebral
1665051|NCT00124267|malaria|malaria
1665052|NCT00124267|intra-rectal|intra-rectal
1665053|NCT00124267|quinine|quinine
1665054|NCT00124267|children|children
1665055|NCT00124267|Uganda|uganda
1665056|NCT00124267|efficacy|efficacy
1665057|NCT00124267|safety|safety
1665058|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
1665059|NCT00124254|Arthroplasty|arthroplasty
1665060|NCT00124254|Outcomes|outcomes
1665061|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
1665062|NCT00124254|Joint Replacement|joint replacement
1665063|NCT00124228|Cirrhosis|cirrhosis
1665064|NCT00124228|Infection|infection
1665065|NCT00124228|Sepsis|sepsis
1665066|NCT00124228|Renal failure|renal failure
1665067|NCT00124215|Hepatitis|hepatitis
1665068|NCT00124215|HCV|hcv
1665069|NCT00124215|vaccine|vaccine
1665070|NCT00124215|Hepatitis C Infection|hepatitis c infection
1665071|NCT00124202|a fatty meal|a fatty meal
1665072|NCT00124202|ERCP|ercp
1665073|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1665074|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
1665075|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
1665076|NCT00124189|Telomerase|telomerase
1665077|NCT00124189|Telomerase Inhibition|telomerase inhibition
1665078|NCT00124176|Asthma|asthma
1665079|NCT00124176|Levalbuterol|levalbuterol
1665080|NCT00124176|Albuterol|albuterol
1665081|NCT00124176|Children|children
1665082|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
1665083|NCT00124163|Optical Colonoscopy|optical colonoscopy
1665084|NCT00124163|Stool Tagging|stool tagging
1665085|NCT00124163|Patient Preparation|patient preparation
1665086|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
1665087|NCT00124150|magnesium sulfate|magnesium sulfate
1665088|NCT00124137|Ultrafiltration|ultrafiltration
1665089|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
1665090|NCT00124137|fluid overload|fluid overload
1665091|NCT00124137|pulmonary congestion|pulmonary congestion
1665092|NCT00124111|clinical trial|clinical trial
1665093|NCT00124111|pegfilgrastim|pegfilgrastim
1665094|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
1665095|NCT00124111|neutropenia|neutropenia
1665096|NCT00124111|CMF|cmf
1665097|NCT00124111|Cancer|cancer
1665098|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1665099|NCT00124098|anemia, clinical trial|anemia, clinical trial
1665100|NCT00124098|darbepoetin alfa|darbepoetin alfa
1665101|NCT00124098|Aranesp®|aranesp®
1665102|NCT00124098|Amgen|amgen
1665103|NCT00124072|Myocardial infarction|myocardial infarction
1665104|NCT00124072|Coronary heart disease|coronary heart disease
1665105|NCT00124072|Cholesterol|cholesterol
1665106|NCT00124072|Stroke|stroke
1665107|NCT00124059|alcohol dependence|alcohol dependence
1665108|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
1665109|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
1665110|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
1665111|NCT00124046|Urodynamic Scale|urodynamic scale
1665112|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
1665113|NCT00124033|Cholecystectomy|cholecystectomy
1665114|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
1665115|NCT00124007|HIV Seronegativity|hiv seronegativity
1665116|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
1665117|NCT00123994|TaiChi|taichi
1665118|NCT00123994|Hydrotherapy|hydrotherapy
1665119|NCT00123994|Exercise|exercise
1665120|NCT00123994|Joint pain|joint pain
1665121|NCT00123994|Disability|disability
1665122|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
1665123|NCT00123981|Randomization|randomization
1665124|NCT00123981|stroke|stroke
1665125|NCT00123981|myocardial infarction|myocardial infarction
1665126|NCT00123981|mortality|mortality
1665127|NCT00123981|graft patency|graft patency
1665128|NCT00123981|quality of life|quality of life
1665129|NCT00123968|HIV Seronegativity|hiv seronegativity
1665130|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
1665131|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
1665132|NCT00123929|breast cancer|breast cancer
1665133|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
1665134|NCT00123929|genetic signature|genetic signature
1665135|NCT00123929|doxorubicin|doxorubicin
1665136|NCT00123929|docetaxel|docetaxel
1665137|NCT00123916|Chagas Disease|chagas disease
1665138|NCT00123916|Trypanosomiasis|trypanosomiasis
1665139|NCT00123916|Benznidazole|benznidazole
1665140|NCT00123916|Chronic Heart disease|chronic heart disease
1665141|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
1665432|NCT00122590|lopinavir|lopinavir
1665142|NCT00123903|hypertension|hypertension
1665143|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
1665144|NCT00123903|microalbuminuria|microalbuminuria
1665145|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
1665146|NCT00123877|Breast|breast
1665147|NCT00123877|Cancer|cancer
1665148|NCT00123877|Metastasis|metastasis
1665149|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
1665150|NCT00123864|parotid|parotid
1665151|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
1665152|NCT00123851|Colorectal|colorectal
1665153|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
1665154|NCT00123851|Oxaliplatin|oxaliplatin
1665155|NCT00123851|Tarceva|tarceva
1665156|NCT00123851|Capecitabine|capecitabine
1665158|NCT00123838|Prostate|prostate
1665159|NCT00123838|Cancer|cancer
1665160|NCT00123838|Radiotherapy|radiotherapy
1665161|NCT00123838|Neoplasm|neoplasm
1665162|NCT00123838|Localization|localization
1665163|NCT00123838|Tracking|tracking
1665164|NCT00123838|Cancer of Prostate|cancer of prostate
1665165|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
1665166|NCT00123825|Gallbladder|gallbladder
1665167|NCT00123825|Biliary Tract|biliary tract
1665168|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
1665169|NCT00123812|quality assurance|quality assurance
1665170|NCT00123812|frequency of port films|frequency of port films
1665171|NCT00123799|positron emission tomography|positron emission tomography
1665172|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
1665173|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
1665174|NCT00123786|positron emission tomography|positron emission tomography
1665175|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
1665176|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
1665177|NCT00123773|positron emission tomography|positron emission tomography
1665178|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
1665179|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
1665180|NCT00123760|Positron-Emission Tomography|positron-emission tomography
1665181|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1665182|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
1665183|NCT00123747|Positron Emission Tomography|positron emission tomography
1665184|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
1665185|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
1665186|NCT00123708|Spasticity|spasticity
1665187|NCT00123708|Dystonia|dystonia
1665188|NCT00123708|Movement Disorders|movement disorders
1665189|NCT00123708|Walking|walking
1665190|NCT00123708|Muscle Weakness|muscle weakness
1665191|NCT00123708|Resistance|resistance
1665192|NCT00123708|Gait|gait
1665193|NCT00123708|Cerebral Palsy|cerebral palsy
1665195|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
1665196|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
1665197|NCT00123695|Cardiac abnormalities|cardiac abnormalities
1665198|NCT00123695|outcome|outcome
1665199|NCT00123682|Smoking Cessation|smoking cessation
1665200|NCT00123682|Care Management|care management
1665201|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
1665202|NCT00123682|Primary Care|primary care
1665203|NCT00123682|Regional Expansion|regional expansion
1665204|NCT00123682|Telephone|telephone
1665205|NCT00123669|Cancer of the Breast|cancer of the breast
1665206|NCT00123669|Neoplasm|neoplasm
1665207|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
1665208|NCT00123656|esomeprazole|esomeprazole
1665209|NCT00123656|fluticasone|fluticasone
1665210|NCT00123643|thiazolidinedione|thiazolidinedione
1665211|NCT00123643|sulfonylurea|sulfonylurea
1665212|NCT00123643|endothelial function|endothelial function
1665213|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
1665214|NCT00123630|omalizumab|omalizumab
1665215|NCT00123617|Chest pain|chest pain
1665216|NCT00123617|Women|women
1665217|NCT00123617|Syndrome X|syndrome x
1665218|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
1665219|NCT00123617|Psychological morbidity|psychological morbidity
1665220|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
1665221|NCT00123604|beta-blockers|beta-blockers
1665222|NCT00123604|endothelial function|endothelial function
1665223|NCT00123565|Coronary Disease|coronary disease
1665224|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
1665225|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
1665226|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
1665227|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
1665228|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
1665229|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
1665230|NCT00123448|Mirror Neurons|mirror neurons
1665231|NCT00123448|fMRI|fmri
1665232|NCT00123448|Premotor Cortex|premotor cortex
1665233|NCT00123448|gesture|gesture
1665234|NCT00123448|Healthy Volunteer|healthy volunteer
1665235|NCT00123448|HV|hv
1665236|NCT00123435|Behavioral Research|behavioral research
1665433|NCT00122590|indinavir|indinavir
1665237|NCT00123435|Nutritional management|nutritional management
1665238|NCT00123435|Physical activity|physical activity
1665239|NCT00123435|Prevention|prevention
1665240|NCT00123435|Randomized control trial|randomized control trial
1665241|NCT00123435|walking program|walking program
1665242|NCT00123435|Weight loss|weight loss
1665243|NCT00123435|World wide web|world wide web
1665244|NCT00123422|Breathing exercise|breathing exercise
1665245|NCT00123422|Exercise Therapy|exercise therapy
1665246|NCT00123422|Helium|helium
1665247|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
1665248|NCT00123422|Pulmonary emphysema|pulmonary emphysema
1665249|NCT00123422|Pulmonary ventilation|pulmonary ventilation
1665250|NCT00123422|Rehabilitation|rehabilitation
1665251|NCT00123409|Primary Care|primary care
1665252|NCT00123409|Telephone|telephone
1665253|NCT00123409|Quality of Life|quality of life
1665254|NCT00123396|Bioterrorism|bioterrorism
1665255|NCT00123396|Education, Medical, Continuing|education, medical, continuing
1665256|NCT00123396|Internet|internet
1665257|NCT00123383|Modafinil|modafinil
1665258|NCT00123383|Cocaine Dependence|cocaine dependence
1665259|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
1665260|NCT00123370|Modafinil|modafinil
1665261|NCT00123370|Amphetamine Dependence|amphetamine dependence
1665262|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
1665263|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
1665264|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
1665265|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
1665266|NCT00123344|prevention algorithms|prevention algorithms
1665267|NCT00123331|Heart transplantation|heart transplantation
1665268|NCT00123331|Renal failure|renal failure
1665269|NCT00123331|Cyclosporine|cyclosporine
1665270|NCT00123331|Rapamycin|rapamycin
1665271|NCT00123318|Gastric cancer|gastric cancer
1665272|NCT00123318|Radiotherapy|radiotherapy
1665273|NCT00123318|Chemotherapy|chemotherapy
1665274|NCT00123318|Chemoradiation|chemoradiation
1665275|NCT00123305|Stroke|stroke
1665276|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
1665277|NCT00123292|arterial occlusion|arterial occlusion
1665278|NCT00123292|thromboembolism|thromboembolism
1665279|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
1665280|NCT00123279|diabetic macular edema|diabetic macular edema
1665281|NCT00123279|macular hole|macular hole
1665282|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
1665283|NCT00123266|stroke|stroke
1665284|NCT00123266|vertebrobasilar|vertebrobasilar
1665285|NCT00123266|basilar|basilar
1665286|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
1665287|NCT00123253|HIV|hiv
1665288|NCT00123253|Lipodystrophy|lipodystrophy
1665289|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
1665290|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
1665291|NCT00123253|Treatment Experienced|treatment experienced
1665292|NCT00123240|overweight|overweight
1665293|NCT00123240|obese|obese
1665294|NCT00123240|diet|diet
1665295|NCT00123227|Randomised controlled trial|randomised controlled trial
1665296|NCT00123227|Rosiglitazone|rosiglitazone
1665297|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
1665298|NCT00123227|Diabetes Mellitus|diabetes mellitus
1665299|NCT00123227|Vascular Diseases|vascular diseases
1665300|NCT00123227|Hypertension|hypertension
1665301|NCT00123214|Diet|diet
1665302|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
1665303|NCT00123214|Weight|weight
1665304|NCT00123214|Cognitive impairment|cognitive impairment
1665305|NCT00123214|Lipids|lipids
1665306|NCT00123214|Inflammation|inflammation
1665307|NCT00123214|Resting metabolic rate|resting metabolic rate
1665308|NCT00123214|Weight Gain|weight gain
1665309|NCT00123214|Percent Body Fat|percent body fat
1665310|NCT00123214|Hyperlipidemia|hyperlipidemia
1665311|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
1665312|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
1665313|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
1665314|NCT00123162|Sildenafil|sildenafil
1665315|NCT00123149|Anemia|anemia
1665316|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
1665317|NCT00123149|Hemoglobin level|hemoglobin level
1665318|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
1665319|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
1665320|NCT00123136|neuromodulation|neuromodulation
1665321|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
1665322|NCT00123136|sleep benefit|sleep benefit
1665323|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
1665324|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
1665325|NCT00123097|Facial Neoplasms|facial neoplasms
1665326|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
1665327|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
1665328|NCT00123097|Birth Injuries|birth injuries
1665329|NCT00123084|Parkinson's disease|parkinson's disease
1665619|NCT00122044|childhood|childhood
1665330|NCT00123084|Swallowing difficulties|swallowing difficulties
1665331|NCT00123084|speech|speech
1665332|NCT00123084|voice|voice
1665333|NCT00123058|Hypertension|hypertension
1665334|NCT00123058|Cariovascular Diseases|cariovascular diseases
1665335|NCT00123058|Health Illiteracy|health illiteracy
1665336|NCT00122980|Blood Diseases|blood diseases
1665337|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
1665338|NCT00122954|Fish Oils|fish oils
1665339|NCT00122954|Complementary Therapies|complementary therapies
1665340|NCT00122941|multiple|multiple
1665341|NCT00122941|micronutrients|micronutrients
1665342|NCT00122941|supplementation|supplementation
1665343|NCT00122941|HIV|hiv
1665344|NCT00122941|children|children
1665345|NCT00122941|randomised|randomised
1665346|NCT00122941|trial|trial
1665347|NCT00122941|mortality|mortality
1665348|NCT00122941|morbidity|morbidity
1665349|NCT00122941|growth|growth
1665350|NCT00122941|Uganda|uganda
1665351|NCT00122928|Worksite|worksite
1665352|NCT00122928|Workplace|workplace
1665353|NCT00122928|Return on Investment|return on investment
1665354|NCT00122928|Financial Impact|financial impact
1665355|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
1665356|NCT00122915|Pain treatment|pain treatment
1665357|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
1665358|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
1665359|NCT00122915|Facial pain|facial pain
1665360|NCT00122915|Neurostimuation|neurostimuation
1665361|NCT00122915|Cortical lead|cortical lead
1665362|NCT00122915|Neuropathic pain|neuropathic pain
1665363|NCT00122902|HIV|hiv
1665364|NCT00122902|AIDS|aids
1665365|NCT00122902|Spirituality|spirituality
1665366|NCT00122889|Drug Interactions|drug interactions
1665367|NCT00122889|Pharmacokinetics|pharmacokinetics
1665368|NCT00122889|Garlic|garlic
1665369|NCT00122889|Complementary Therapies|complementary therapies
1665370|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
1665371|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
1665372|NCT00122876|HCC|hcc
1665373|NCT00122876|Photodynamic therapy|photodynamic therapy
1665374|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
1665375|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
1665376|NCT00122876|Litx|litx
1665377|NCT00122876|Light Infusion Technology|light infusion technology
1665378|NCT00122811|Aged|aged
1665379|NCT00122811|Hypertension|hypertension
1665380|NCT00122811|Stroke|stroke
1665381|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
1665382|NCT00122785|bronchiolitis|bronchiolitis
1665383|NCT00122785|wheezing|wheezing
1665384|NCT00122785|dexamethasone|dexamethasone
1665385|NCT00122785|young children|young children
1665386|NCT00122759|Mechanical ventilation|mechanical ventilation
1665387|NCT00122759|Agitation|agitation
1665388|NCT00122746|Cervical Cancer|cervical cancer
1665389|NCT00122746|AIDS|aids
1665390|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
1665391|NCT00122746|Brachytherapy|brachytherapy
1665392|NCT00122746|Cisplatin|cisplatin
1665393|NCT00122733|Mechanical ventilation|mechanical ventilation
1665394|NCT00122733|Agitation|agitation
1665395|NCT00122733|Difficult weaning|difficult weaning
1665396|NCT00122720|colorectal cancer|colorectal cancer
1665397|NCT00122720|erythropoietin|erythropoietin
1665398|NCT00122720|rehabilitation|rehabilitation
1665399|NCT00122720|physical capacity|physical capacity
1665400|NCT00122707|catheter-related infection|catheter-related infection
1665401|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
1665402|NCT00122694|carbon monoxide|carbon monoxide
1665403|NCT00122694|COPD|copd
1665404|NCT00122694|inflammation|inflammation
1665405|NCT00122694|sputum induction|sputum induction
1665406|NCT00122694|stable COPD|stable copd
1665407|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
1665408|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
1665409|NCT00122668|HIV infections|hiv infections
1665410|NCT00122655|HIV infections|hiv infections
1665411|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
1665412|NCT00122642|catheterization|catheterization
1665413|NCT00122642|Catheters, Indwelling|catheters, indwelling
1665414|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
1665415|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
1665416|NCT00122629|ribavirin|ribavirin
1665417|NCT00122629|Amantadine|amantadine
1665418|NCT00122616|HIV infections|hiv infections
1665419|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
1665420|NCT00122616|Treatment Failure|treatment failure
1665421|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
1665422|NCT00122616|Treatment Experienced|treatment experienced
1665423|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
1665424|NCT00122603|HIV infections|hiv infections
1665425|NCT00122603|Atazanavir|atazanavir
1665426|NCT00122603|Saquinavir|saquinavir
1665427|NCT00122603|Fosamprenavir|fosamprenavir
1665428|NCT00122603|ritonavir|ritonavir
1665429|NCT00122603|Treatment Naive|treatment naive
1665430|NCT00122590|protease inhibitors|protease inhibitors
1665434|NCT00122590|Pharmacokinetics|pharmacokinetics
1665435|NCT00122577|HIV infections|hiv infections
1665436|NCT00122577|Treatment Failure|treatment failure
1665437|NCT00122577|tenofovir|tenofovir
1665438|NCT00122577|atazanavir|atazanavir
1665439|NCT00122564|HIV Vaccines|hiv vaccines
1665440|NCT00122564|HIV Seronegativity|hiv seronegativity
1665441|NCT00122551|HIV infections|hiv infections
1665442|NCT00122538|HAART|haart
1665443|NCT00122538|once-daily|once-daily
1665444|NCT00122538|child|child
1665445|NCT00122538|africa|africa
1665447|NCT00122538|AIDS|aids
1665448|NCT00122538|Treatment Naive|treatment naive
1665449|NCT00122525|HIV|hiv
1665450|NCT00122525|Male circumcision|male circumcision
1665451|NCT00122525|Prevention|prevention
1665452|NCT00122525|HSV-2|hsv-2
1665453|NCT00122525|Africa|africa
1665454|NCT00122525|Sexual behavior|sexual behavior
1665455|NCT00122512|AE adverse event|ae adverse event
1665456|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1665457|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1665458|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
1665459|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1665460|NCT00122512|DCF data collection forms|dcf data collection forms
1665461|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
1665462|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1665463|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1665464|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1665465|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
1665466|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
1665467|NCT00122512|IRB Institutional Review Board|irb institutional review board
1665468|NCT00122512|IU international units|iu international units
1665469|NCT00122512|mg milligram(s)|mg milligram(s)
1665470|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1665471|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
1665472|NCT00122512|SAE serious adverse event|sae serious adverse event
1665473|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
1665474|NCT00122512|µg microgram|µg microgram
1665475|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
1665476|NCT00122512|WB Western Blot|wb western blot
1665477|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
1665478|NCT00122512|HIV Seronegativity|hiv seronegativity
1665479|NCT00122499|Prostate cancer|prostate cancer
1665480|NCT00122499|Radiotherapy|radiotherapy
1665481|NCT00122499|Erectile dysfunction|erectile dysfunction
1665482|NCT00122499|Tadalafil|tadalafil
1665483|NCT00122486|AE adverse event|ae adverse event
1665484|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1665485|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1665486|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
1665487|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1665488|NCT00122486|DCF data collection forms|dcf data collection forms
1665489|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
1665490|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1665491|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1665492|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1665493|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
1665494|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
1665495|NCT00122486|IRB Institutional Review Board|irb institutional review board
1665496|NCT00122486|IU international units|iu international units
1665497|NCT00122486|mg milligram(s)|mg milligram(s)
1665498|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1665499|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
1665500|NCT00122486|SAE serious adverse event|sae serious adverse event
1665501|NCT00122486|µg microgram|µg microgram
1665599|NCT00122135|values inventory|values inventory
1665502|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
1665503|NCT00122486|WB Western Blot|wb western blot
1665504|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
1665505|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
1665506|NCT00122473|Imatinib|imatinib
1665507|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1665508|NCT00122460|Head and Neck Cancer|head and neck cancer
1665509|NCT00122447|Prediabetic state|prediabetic state
1665510|NCT00122447|Cardiovascular disease|cardiovascular disease
1665511|NCT00122447|Diabetes|diabetes
1665512|NCT00122447|Glucose intolerance|glucose intolerance
1665513|NCT00122421|diabetes|diabetes
1665514|NCT00122421|quality of care|quality of care
1665515|NCT00122421|pharmacist recommendations|pharmacist recommendations
1665516|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
1665517|NCT00122408|probiotic|probiotic
1665518|NCT00122408|mechanical ventilation|mechanical ventilation
1665519|NCT00122408|intensive care|intensive care
1665520|NCT00122395|Domestic violence|domestic violence
1665521|NCT00122395|Screening|screening
1665522|NCT00122395|Emergency department|emergency department
1665523|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
1665524|NCT00122369|Breast|breast
1665525|NCT00122369|Biopsy|biopsy
1665526|NCT00122369|Hypnosis|hypnosis
1665527|NCT00122369|Relaxation|relaxation
1665528|NCT00122369|Anxiety|anxiety
1665529|NCT00122369|Pain|pain
1665530|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
1665531|NCT00122343|Endometrial|endometrial
1665532|NCT00122343|Cancer|cancer
1665533|NCT00122317|transfusion dependent|transfusion dependent
1665534|NCT00122317|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1665535|NCT00122317|hemolytic|hemolytic
1665536|NCT00122291|preoperative|preoperative
1665537|NCT00122291|chemotherapy|chemotherapy
1665538|NCT00122291|radiation therapy|radiation therapy
1665539|NCT00122291|rectal cancer|rectal cancer
1665540|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
1665541|NCT00122291|nodal metastasis|nodal metastasis
1665542|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
1665543|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
1665544|NCT00122265|prostate cancer|prostate cancer
1665545|NCT00122265|radiotherapy|radiotherapy
1665546|NCT00122265|radiation toxicity|radiation toxicity
1665547|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
1665548|NCT00122252|prostate cancer|prostate cancer
1665549|NCT00122252|radiotherapy|radiotherapy
1665550|NCT00122252|biological imaging|biological imaging
1665551|NCT00122239|radiotherapy|radiotherapy
1665552|NCT00122239|radiation toxicity|radiation toxicity
1665553|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
1665554|NCT00122239|breast carcinoma|breast carcinoma
1665555|NCT00122239|prostate carcinoma|prostate carcinoma
1665556|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1665557|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
1665558|NCT00122226|HIV|hiv
1665559|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
1665560|NCT00122213|Prevention|prevention
1665561|NCT00122213|Retirement|retirement
1665562|NCT00122213|Physical activity|physical activity
1665563|NCT00122213|Diet|diet
1665564|NCT00122213|Weight gain|weight gain
1665565|NCT00122213|Body composition|body composition
1665566|NCT00122187|cancer|cancer
1665567|NCT00122187|colonoscopy|colonoscopy
1665568|NCT00122187|mass screening|mass screening
1665569|NCT00122187|colorectal cancer|colorectal cancer
1665570|NCT00122187|colorectal carcinoma|colorectal carcinoma
1665571|NCT00122187|reminder systems|reminder systems
1665572|NCT00122187|rectal cancers|rectal cancers
1665573|NCT00122187|colorectal tumor|colorectal tumor
1665574|NCT00122187|guidelines|guidelines
1665575|NCT00122187|CRC secondary prevention|crc secondary prevention
1665576|NCT00122187|colorectal neoplasms|colorectal neoplasms
1665577|NCT00122187|colonic neoplasms|colonic neoplasms
1665578|NCT00122187|colonic diseases|colonic diseases
1665579|NCT00122187|hemoccult testing|hemoccult testing
1665580|NCT00122174|Caregivers|caregivers
1665581|NCT00122174|Stress|stress
1665582|NCT00122174|Coping|coping
1665583|NCT00122174|Immune|immune
1665584|NCT00122174|Relaxation|relaxation
1665585|NCT00122174|Biofeedback|biofeedback
1665586|NCT00122174|Bioinstrumentation|bioinstrumentation
1665587|NCT00122174|Homecare|homecare
1665588|NCT00122161|Drug therapy|drug therapy
1665589|NCT00122161|Practice guidelines|practice guidelines
1665590|NCT00122161|Reminder systems|reminder systems
1665591|NCT00122161|Ambulatory care|ambulatory care
1665592|NCT00122161|Hypertension|hypertension
1665593|NCT00122161|Clinical protocols|clinical protocols
1665594|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
1665595|NCT00122148|Quality of health care|quality of health care
1665596|NCT00122148|Feedback|feedback
1665597|NCT00122135|end-of-life care|end-of-life care
1665598|NCT00122135|clinical decision-making|clinical decision-making
1665600|NCT00122135|racial disparities|racial disparities
1665601|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
1665602|NCT00122109|Anger Management|anger management
1665603|NCT00122109|Telemedicine modality|telemedicine modality
1665604|NCT00122096|neurosurgery|neurosurgery
1665605|NCT00122096|COX-2|cox-2
1665606|NCT00122096|inflammation|inflammation
1665607|NCT00122096|pain|pain
1665608|NCT00122083|Depression|depression
1665609|NCT00122083|Students|students
1665610|NCT00122083|Health education|health education
1665611|NCT00122070|Borderline Personality Disorder|borderline personality disorder
1665612|NCT00122070|Personality Disorder|personality disorder
1665613|NCT00122070|Quetiapine|quetiapine
1665614|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
1665615|NCT00122070|Seroquel|seroquel
1665616|NCT00122070|Antipsychotics|antipsychotics
1665617|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
1665618|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
1665620|NCT00122044|cerebral palsy|cerebral palsy
1665621|NCT00122044|dystonia|dystonia
1665622|NCT00122044|secondary|secondary
1665623|NCT00122044|trihexyphenidyl|trihexyphenidyl
1665624|NCT00122044|pediatric dystonia|pediatric dystonia
1665625|NCT00122031|Major Depression|major depression
1665626|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
1665627|NCT00122018|Kidney failure|kidney failure
1665628|NCT00122018|Cardiac Surgery|cardiac surgery
1665629|NCT00122018|Fenoldopam|fenoldopam
1665630|NCT00122018|N-acetylcysteine|n-acetylcysteine
1665631|NCT00122005|Metastatic|metastatic
1665632|NCT00122005|Prostate|prostate
1665633|NCT00122005|Advanced|advanced
1665634|NCT00122005|Cancer|cancer
1665635|NCT00122005|GVAX|gvax
1665636|NCT00122005|Vaccine|vaccine
1665637|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
1665638|NCT00121992|Disease-Free survival|disease-free survival
1665639|NCT00121992|Quality of life|quality of life
1665640|NCT00121979|HIV|hiv
1665641|NCT00121979|treatment-experienced|treatment-experienced
1665642|NCT00121979|lamivudine|lamivudine
1665643|NCT00121979|3TC|3tc
1665644|NCT00121966|Type 2 diabetes|type 2 diabetes
1665645|NCT00121966|Insulin Aspart|insulin aspart
1665646|NCT00121966|Insulin NPH|insulin nph
1665647|NCT00121966|Metformin|metformin
1665648|NCT00121966|Rosiglitazone|rosiglitazone
1665649|NCT00121953|Endometriosis|endometriosis
1665650|NCT00121953|Peritoneal fluid|peritoneal fluid
1665651|NCT00121953|Cytokines|cytokines
1665652|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
1665653|NCT00121940|Chronic Disease|chronic disease
1665654|NCT00121940|Nurses|nurses
1665655|NCT00121940|Caregivers|caregivers
1665656|NCT00121940|Support Groups|support groups
1665657|NCT00121927|intractable|intractable
1665658|NCT00121927|ketogenic|ketogenic
1665659|NCT00121927|ketosis|ketosis
1665660|NCT00121927|Atkins|atkins
1665661|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
1665662|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
1665663|NCT00121914|long-acting somatostatin|long-acting somatostatin
1665664|NCT00121901|Pancreatitis|pancreatitis
1665665|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
1665666|NCT00121901|Nitroglycerin|nitroglycerin
1665667|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
1665668|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
1665669|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
1665670|NCT00121888|pharmacotherapy|pharmacotherapy
1665671|NCT00121888|double-blind|double-blind
1665672|NCT00121888|Anxiety Disorder|anxiety disorder
1665673|NCT00121875|short stature|short stature
1665674|NCT00121875|insulin resistance|insulin resistance
1665675|NCT00121875|body composition|body composition
1665676|NCT00121875|Turner syndrome|turner syndrome
1665677|NCT00121875|intramyocellular lipid|intramyocellular lipid
1665678|NCT00121875|glucose tolerance|glucose tolerance
1665679|NCT00121862|Leishmaniasis|leishmaniasis
1665680|NCT00121862|Subunit Vaccine|subunit vaccine
1665681|NCT00121862|Prevention|prevention
1665682|NCT00121862|T cell|t cell
1665683|NCT00121849|Leishmaniasis,|leishmaniasis,
1665684|NCT00121849|Subunit Vaccine,|subunit vaccine,
1665685|NCT00121849|Prevention,|prevention,
1665686|NCT00121849|T cell|t cell
1665687|NCT00121823|Malaria|malaria
1665688|NCT00121823|PCR|pcr
1665689|NCT00121823|Vaccines|vaccines
1665690|NCT00121823|Acceptability|acceptability
1665691|NCT00121797|Postpartum Period|postpartum period
1665692|NCT00121771|Malaria|malaria
1665693|NCT00121771|Vaccines|vaccines
1665694|NCT00121771|Safety|safety
1665695|NCT00121771|Immunogenicity|immunogenicity
1665696|NCT00121758|HIV Vaccines|hiv vaccines
1665697|NCT00121758|HIV Seronegativity|hiv seronegativity
1665698|NCT00121745|gene transfer|gene transfer
1665699|NCT00121745|cell cycle control|cell cycle control
1665700|NCT00121745|cancer gene therapy|cancer gene therapy
1665701|NCT00121745|pathotropic targeting|pathotropic targeting
1665702|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
1665703|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
1665704|NCT00121719|lymphomas|lymphomas
1665705|NCT00121719|hodgkins disease|hodgkins disease
1665706|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
1665707|NCT00121719|neoplasms|neoplasms
1665708|NCT00121693|Fall prevention|fall prevention
1665709|NCT00121693|posturography|posturography
1665710|NCT00121693|music therapy|music therapy
1665711|NCT00121680|cancer|cancer
1665712|NCT00121654|Angina pectoris|angina pectoris
1665713|NCT00121654|Spinal cord stimulation|spinal cord stimulation
1665714|NCT00121654|Refractory angina pectoris|refractory angina pectoris
1665715|NCT00121628|Thyroid cancer|thyroid cancer
1665716|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
1665717|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
1665718|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
1665719|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
1665720|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
1665900|NCT00120952|RSA|rsa
1665721|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
1665722|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
1665723|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
1665724|NCT00121615|Clinical Trials|clinical trials
1665725|NCT00121602|Hemodialysis|hemodialysis
1665726|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
1665727|NCT00121602|Clinical Trials|clinical trials
1665728|NCT00121602|Nephrology|nephrology
1665729|NCT00121602|Amgen|amgen
1665730|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1665731|NCT00121589|AMD|amd
1665732|NCT00121589|Macular Pigment|macular pigment
1665733|NCT00121589|Serum Lutein Levels|serum lutein levels
1665734|NCT00121589|Vitamin Supplementation|vitamin supplementation
1665735|NCT00121589|Carotenoids|carotenoids
1665736|NCT00121589|Lutein|lutein
1665737|NCT00121589|Zeaxanthin|zeaxanthin
1665738|NCT00121589|DHA|dha
1665739|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
1665740|NCT00121563|Cytokines|cytokines
1665741|NCT00121563|Inflammation|inflammation
1665742|NCT00121563|Pain|pain
1665743|NCT00121563|Injury|injury
1665744|NCT00121563|Peripheral|peripheral
1665745|NCT00121563|Wisdom Teeth|wisdom teeth
1665746|NCT00121563|Third Molar Extraction|third molar extraction
1665747|NCT00121550|Coronary heart disease|coronary heart disease
1665748|NCT00121550|Clarithromycin|clarithromycin
1665749|NCT00121550|Macrolides|macrolides
1665750|NCT00121550|Cardiovascular mortality|cardiovascular mortality
1665751|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
1665752|NCT00121537|wounds-open|wounds-open
1665753|NCT00121524|cardiac arrest|cardiac arrest
1665754|NCT00121524|resuscitation|resuscitation
1665755|NCT00121524|epinephrine|epinephrine
1665756|NCT00121524|intravenous|intravenous
1665757|NCT00121524|survival|survival
1665758|NCT00121511|photoaging|photoaging
1665759|NCT00121511|Actinic Keratoses|actinic keratoses
1665760|NCT00121511|Efudex|efudex
1665761|NCT00121511|5 fluorouracil|5 fluorouracil
1665762|NCT00121498|Pain|pain
1665763|NCT00121498|Hysterectomy|hysterectomy
1665764|NCT00121498|Preemptive|preemptive
1665765|NCT00121498|Lidocaine|lidocaine
1665766|NCT00121485|Heart-assist devices|heart-assist devices
1665767|NCT00121472|Heart-assist devices|heart-assist devices
1665768|NCT00121459|Diaphragm|diaphragm
1665769|NCT00121459|HIV prevention|hiv prevention
1665770|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
1665771|NCT00121459|female-controlled methods|female-controlled methods
1665772|NCT00121459|Replens|replens
1665773|NCT00121459|STI prevention|sti prevention
1665774|NCT00121459|HIV Seronegativity|hiv seronegativity
1665775|NCT00121446|Heart Attack|heart attack
1665776|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
1665777|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
1665778|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
1665779|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
1665780|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
1665781|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
1665782|NCT00121420|Brain metastasis|brain metastasis
1665783|NCT00121420|Neoplasm metastasis|neoplasm metastasis
1665784|NCT00121420|Cranial irradiation|cranial irradiation
1665785|NCT00121420|Radiosurgery|radiosurgery
1665786|NCT00121420|Lung Neoplasms|lung neoplasms
1665787|NCT00121420|Breast Neoplasms|breast neoplasms
1665788|NCT00121420|Kidney Neoplasms|kidney neoplasms
1665789|NCT00121420|Melanoma|melanoma
1665790|NCT00121420|Radiotherapy|radiotherapy
1665791|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
1665792|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
1665793|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
1665794|NCT00121407|Visudyne|visudyne
1665795|NCT00121394|Chlorhexidine|chlorhexidine
1665796|NCT00121394|Vaginal wash|vaginal wash
1665797|NCT00121394|Neonatal mortality|neonatal mortality
1665798|NCT00121394|Sepsis|sepsis
1665799|NCT00121394|Global Network|global network
1665800|NCT00121394|Maternal and child health|maternal and child health
1665801|NCT00121394|Women's Health|women's health
1665802|NCT00121394|International|international
1665803|NCT00121394|Pakistan|pakistan
1665804|NCT00121381|Atopic dermatitis|atopic dermatitis
1665805|NCT00121381|T-cell|t-cell
1665806|NCT00121381|pimecrolimus|pimecrolimus
1665807|NCT00121381|children|children
1665808|NCT00121381|topical corticosteroids|topical corticosteroids
1665809|NCT00121368|Global Network|global network
1665810|NCT00121368|Maternal and child health|maternal and child health
1665811|NCT00121368|International|international
1665812|NCT00121368|Women's health|women's health
1665813|NCT00121368|Tobacco|tobacco
1665814|NCT00121368|Smoking|smoking
1665815|NCT00121368|Africa|africa
1665816|NCT00121368|Latin America|latin america
1665817|NCT00121368|South America|south america
1665818|NCT00121368|Guatemala|guatemala
1665819|NCT00121368|Zambia|zambia
1665820|NCT00121368|India|india
1665821|NCT00121368|Argentina|argentina
1665901|NCT00120952|Osteoarthritis|osteoarthritis
1665822|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
1665823|NCT00121329|Pain with procedures|pain with procedures
1665824|NCT00121316|Atopic dermatitis|atopic dermatitis
1665825|NCT00121316|pimecrolimus|pimecrolimus
1665826|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1665827|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1665828|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1665829|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1665830|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1665914|NCT00120939|Advanced Cancer|advanced cancer
1666007|NCT00120666|Stimulation|stimulation
1665831|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1665832|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1665833|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1665834|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1665835|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
1665836|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1665837|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1665838|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1665839|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1665840|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1665841|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1665842|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1665843|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1665844|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1665845|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1665846|NCT00121212|stage I prostate cancer|stage i prostate cancer
1665847|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
1665848|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
1665849|NCT00121212|stage III prostate cancer|stage iii prostate cancer
1665850|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1665851|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1665852|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1665853|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1665854|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1665855|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1665856|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1665857|NCT00121173|cervical cancer|cervical cancer
1665858|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1665859|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1665860|NCT00121160|immune response to vaccines|immune response to vaccines
1665861|NCT00121160|stress management|stress management
1665862|NCT00121160|breast cancer|breast cancer
1665863|NCT00121147|glaucoma|glaucoma
1665864|NCT00121147|pseudoexfoliation|pseudoexfoliation
1665865|NCT00121134|Bevacizumab|bevacizumab
1665866|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
1665867|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
1665868|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
1665869|NCT00121121|HIV Vaccines|hiv vaccines
1665870|NCT00121121|HIV Seronegativity|hiv seronegativity
1665871|NCT00121095|prostate cancer|prostate cancer
1665872|NCT00121069|specific phobia|specific phobia
1665873|NCT00121069|anxiety|anxiety
1665874|NCT00121069|SSRI|ssri
1665875|NCT00121069|clinical trial|clinical trial
1665876|NCT00121069|escitalopram|escitalopram
1665877|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
1665878|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
1665879|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
1665880|NCT00121043|Anakinra, Immunex|anakinra, immunex
1665881|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
1665882|NCT00121030|uterine cancer|uterine cancer
1665883|NCT00121030|ovarian cancer|ovarian cancer
1665884|NCT00121030|darbepoetin alfa|darbepoetin alfa
1665885|NCT00121030|Amgen|amgen
1665886|NCT00121030|Gynecological Malignancies|gynecological malignancies
1665887|NCT00121017|HCV Infection|hcv infection
1665888|NCT00121017|Treatment Naive|treatment naive
1665889|NCT00121004|Advance Directive|advance directive
1665890|NCT00121004|Living Will|living will
1665891|NCT00121004|Terminal Illness|terminal illness
1665892|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
1665893|NCT00120991|OPCAB|opcab
1665894|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
1665895|NCT00120965|Cardiac arrest|cardiac arrest
1665896|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
1665898|NCT00120965|Chest compressions|chest compressions
1665899|NCT00120965|Chest compression device|chest compression device
1665902|NCT00120952|Hip arthroplasty|hip arthroplasty
1665903|NCT00120952|DEXA|dexa
1665904|NCT00120952|Titanium|titanium
1665905|NCT00120952|Cobalt chromium|cobalt chromium
1665906|NCT00120952|Bone cement|bone cement
1665907|NCT00120939|Lung Cancer|lung cancer
1665908|NCT00120939|Breast Cancer|breast cancer
1665909|NCT00120939|Prostate Cancer|prostate cancer
1665910|NCT00120939|Ovarian Cancer|ovarian cancer
1665911|NCT00120939|Head and Neck Cancer|head and neck cancer
1665912|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
1665913|NCT00120939|Metastatic Cancer|metastatic cancer
1665915|NCT00120939|Genitourinary Cancer|genitourinary cancer
1665916|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
1665917|NCT00120939|Recurrent Cancer|recurrent cancer
1665918|NCT00120939|Colon Cancer|colon cancer
1665919|NCT00120939|Gastric Cancer|gastric cancer
1665920|NCT00120939|Stomach Cancer|stomach cancer
1665921|NCT00120939|Pancreatic Cancer|pancreatic cancer
1665922|NCT00120939|Esophageal Cancer|esophageal cancer
1665923|NCT00120939|Throat Cancer|throat cancer
1665924|NCT00120939|Bladder Cancer|bladder cancer
1665925|NCT00120939|Kidney Cancer|kidney cancer
1665926|NCT00120939|Renal Cancer|renal cancer
1665927|NCT00120939|Cervical Cancer|cervical cancer
1665928|NCT00120939|Endometrial Cancer|endometrial cancer
1665929|NCT00120939|Colorectal Cancer|colorectal cancer
1665930|NCT00120926|Premature neonate|premature neonate
1665931|NCT00120926|Parenteral nutrition|parenteral nutrition
1665932|NCT00120926|Growth|growth
1665933|NCT00120926|Amino Acids|amino acids
1665934|NCT00120926|Nutrition|nutrition
1665935|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
1665936|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
1665937|NCT00120900|Knee osteoarthritis|knee osteoarthritis
1665938|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
1665939|NCT00120874|Alzheimer's disease|alzheimer's disease
1665940|NCT00120874|caregiver training|caregiver training
1665941|NCT00120874|caregiver counseling|caregiver counseling
1665942|NCT00120874|individualized management|individualized management
1665943|NCT00120874|memantine|memantine
1665944|NCT00120874|dementia|dementia
1665945|NCT00120861|Genotype-1|genotype-1
1665946|NCT00120861|Previously failed treatment|previously failed treatment
1665947|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
1665948|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
1665949|NCT00120835|Genotype-1|genotype-1
1665950|NCT00120835|Treatment-Naive|treatment-naive
1665951|NCT00120822|Malaria|malaria
1665952|NCT00120822|Pregnancy|pregnancy
1665953|NCT00120822|Folic acid|folic acid
1665954|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1665955|NCT00120809|Malaria|malaria
1665956|NCT00120809|Pregnancy|pregnancy
1665957|NCT00120809|Multigravidae|multigravidae
1665958|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
1665959|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
1665960|NCT00120796|Hepatitis B|hepatitis b
1665961|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
1665962|NCT00120796|Lamivudine|lamivudine
1665963|NCT00120783|Treatment Failure|treatment failure
1665964|NCT00120783|HIV infections|hiv infections
1665965|NCT00120770|AE adverse event|ae adverse event
1665966|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
1665967|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
1665968|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
1665969|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
1665970|NCT00120770|DCF data collection forms|dcf data collection forms
1665971|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
1665972|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
1665973|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
1665974|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
1665975|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
1665976|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
1665977|NCT00120770|IRB Institutional Review Board|irb institutional review board
1665978|NCT00120770|IU international units|iu international units
1665979|NCT00120770|mg milligram(s)|mg milligram(s)
1665980|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
1665981|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
1665982|NCT00120770|SAE serious adverse event|sae serious adverse event
1665983|NCT00120770|µg microgram|µg microgram
1665984|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
1665985|NCT00120770|WB Western Blot|wb western blot
1665986|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
1665987|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
1665988|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
1665989|NCT00120770|HIV Seronegativity|hiv seronegativity
1665990|NCT00120757|Osteoporosis|osteoporosis
1665991|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
1665992|NCT00120731|Potassium Citrate|potassium citrate
1665993|NCT00120731|Hypercalciuria|hypercalciuria
1665994|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
1665995|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
1665996|NCT00120705|anemia|anemia
1665997|NCT00120705|darbepoetin alfa|darbepoetin alfa
1665998|NCT00120705|Amgen|amgen
1665999|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
1666000|NCT00120692|breast cancer|breast cancer
1666001|NCT00120692|darbepoetin alfa|darbepoetin alfa
1666002|NCT00120692|Amgen|amgen
1666003|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
1666004|NCT00120679|darbepoetin alfa|darbepoetin alfa
1666005|NCT00120679|Amgen|amgen
1666006|NCT00120666|Exercise|exercise
1666008|NCT00120666|Nerve|nerve
1666009|NCT00120666|Electrical|electrical
1666010|NCT00120666|Muscle|muscle
1666011|NCT00120666|Healthy Volunteer|healthy volunteer
1666012|NCT00120666|HV|hv
1666013|NCT00120653|Reglan|reglan
1666014|NCT00120653|Prolactin|prolactin
1666015|NCT00120653|MDS|mds
1666016|NCT00120653|Metoclopramide|metoclopramide
1666017|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
1666018|NCT00120640|Premature birth|premature birth
1666019|NCT00120640|Premature labor|premature labor
1666020|NCT00120640|Progesterone|progesterone
1666021|NCT00120627|Randomized Controlled Trial|randomized controlled trial
1666022|NCT00120627|Intervention Study|intervention study
1666023|NCT00120627|Mindfulness|mindfulness
1666024|NCT00120627|Complementary Therapy|complementary therapy
1666025|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
1666026|NCT00120627|Spiritual Therapy|spiritual therapy
1666027|NCT00120627|Meditation|meditation
1666028|NCT00120627|Qualitative Analysis|qualitative analysis
1666029|NCT00120614|Premature Infant|premature infant
1666030|NCT00120614|Premature Birth|premature birth
1666031|NCT00120614|Parenting Interventions|parenting interventions
1666032|NCT00120614|NICU Interventional studies|nicu interventional studies
1666033|NCT00120614|Parental coping|parental coping
1666034|NCT00120614|Low birthweight infant|low birthweight infant
1666035|NCT00120614|Coping Behavior|coping behavior
1666036|NCT00120614|Infant, Premature|infant, premature
1666037|NCT00120601|treatment|treatment
1666038|NCT00120601|alcohol|alcohol
1666039|NCT00120601|dependence|dependence
1666040|NCT00120601|medication|medication
1666041|NCT00120588|brain protection|brain protection
1666042|NCT00120588|white matter injury|white matter injury
1666043|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
1666044|NCT00120588|magnesium sulfate|magnesium sulfate
1666045|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
1666046|NCT00120575|Hemofiltration|hemofiltration
1666047|NCT00120575|Pediatrics|pediatrics
1666048|NCT00120562|weight loss surgery|weight loss surgery
1666049|NCT00120562|gastric bypass surgery|gastric bypass surgery
1666050|NCT00120549|Assisted Hatching|assisted hatching
1666051|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
1666052|NCT00120549|Embryo Transfer|embryo transfer
1666053|NCT00120549|Pregnancy|pregnancy
1666054|NCT00120549|Embryo Implantation|embryo implantation
1666055|NCT00120536|Type 2 diabetes|type 2 diabetes
1666056|NCT00120536|vildagliptin|vildagliptin
1666057|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
1666058|NCT00120510|Treatment Naive|treatment naive
1666059|NCT00120510|TB|tb
1666060|NCT00120497|short stature|short stature
1666061|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
1666062|NCT00120497|insulin resistance|insulin resistance
1666063|NCT00120497|intramyocellular lipid|intramyocellular lipid
1666064|NCT00120497|small for gestational age|small for gestational age
1666065|NCT00120497|glucose tolerance|glucose tolerance
1666066|NCT00120484|Circadian Rhythm|circadian rhythm
1666067|NCT00120484|Biological Clock|biological clock
1666068|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
1666069|NCT00120471|Perinatal Transmission|perinatal transmission
1666070|NCT00120471|MTCT|mtct
1666071|NCT00120471|HIV Seronegativity|hiv seronegativity
1666072|NCT00120458|Black Cohosh|black cohosh
1666073|NCT00120458|Cimicifuga|cimicifuga
1666074|NCT00120458|Anxiety|anxiety
1666075|NCT00120458|Women|women
1666376|NCT00119132|malaria|malaria
1666076|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
1666077|NCT00120445|retinal detachment|retinal detachment
1666078|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
1666079|NCT00120432|single dose|single dose
1666080|NCT00120432|mydriatic drug|mydriatic drug
1666081|NCT00120432|pupillary dilation|pupillary dilation
1666082|NCT00120419|HIV-1 infection|hiv-1 infection
1666083|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
1666084|NCT00120419|Treatment Naive|treatment naive
1666085|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
1666086|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
1666087|NCT00120406|Drug-Eluting Stent|drug-eluting stent
1666088|NCT00120406|Drug-Coated Stent|drug-coated stent
1666089|NCT00120393|Treatment Experienced|treatment experienced
1666090|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
1666091|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
1666092|NCT00120367|HIV infections|hiv infections
1666093|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
1666094|NCT00120354|Hepatitis B Virus|hepatitis b virus
1666095|NCT00120354|Antiviral Resistance|antiviral resistance
1666096|NCT00120354|Drug Withdrawal|drug withdrawal
1666097|NCT00120354|Immune Response|immune response
1666098|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
1666099|NCT00120354|Liver Biopsy|liver biopsy
1666100|NCT00120354|Hepatitis B|hepatitis b
1666101|NCT00120328|serum creatinine|serum creatinine
1666102|NCT00120328|end stage renal disease|end stage renal disease
1666103|NCT00120328|cardiovascular mortality|cardiovascular mortality
1666104|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
1666105|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
1666106|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
1666107|NCT00120315|dyspepsia|dyspepsia
1666108|NCT00120315|discontinuation|discontinuation
1666109|NCT00120315|Primary health care|primary health care
1666110|NCT00120315|Helicobacter pylori|helicobacter pylori
1666111|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
1666112|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
1666113|NCT00120302|Randomised|randomised
1666114|NCT00120302|Placebo-controlled|placebo-controlled
1666115|NCT00120302|Elidel|elidel
1666116|NCT00120302|Quality of Life|quality of life
1666117|NCT00120302|Atopic Eczema|atopic eczema
1666118|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
1666119|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
1666120|NCT00120276|Less invasive repair|less invasive repair
1666121|NCT00120276|Surgical MV repair|surgical mv repair
1666122|NCT00120276|Mitral Valve Repair|mitral valve repair
1666123|NCT00120276|Heart Failure|heart failure
1666124|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
1666125|NCT00120263|Plasma Exchange|plasma exchange
1666126|NCT00120263|Myeloma|myeloma
1666127|NCT00120263|Acute renal failure|acute renal failure
1666128|NCT00120263|Light Chains|light chains
1666129|NCT00120263|Bence Jones Proteins|bence jones proteins
1666130|NCT00120263|Kidney Function|kidney function
1666131|NCT00120250|PTSD|ptsd
1666132|NCT00120250|Sleep disturbance|sleep disturbance
1666133|NCT00120250|Eszopiclone|eszopiclone
1666134|NCT00120250|Double-blind|double-blind
1666135|NCT00120250|Crossover|crossover
1666136|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
1666137|NCT00120237|Misoprostol|misoprostol
1666138|NCT00120237|Maternal morbidity|maternal morbidity
1666139|NCT00120237|Developing countries|developing countries
1666140|NCT00120237|Traditional birth attendants|traditional birth attendants
1666141|NCT00120224|Mifepristone|mifepristone
1666142|NCT00120224|Medical abortion|medical abortion
1666143|NCT00120224|Ultrasound|ultrasound
1666144|NCT00120198|NHL|nhl
1666145|NCT00120198|elderly|elderly
1666146|NCT00120185|HIV Infections|hiv infections
1666147|NCT00120185|Interleukin-2|interleukin-2
1666148|NCT00120172|colorectal|colorectal
1666149|NCT00120172|metastatic|metastatic
1666150|NCT00120172|elderly|elderly
1666151|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
1666152|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
1666153|NCT00120133|Osteoporosis|osteoporosis
1666154|NCT00120133|Bisphosphonates|bisphosphonates
1666155|NCT00120133|Atorvastatin|atorvastatin
1666156|NCT00120120|Radiculopathy|radiculopathy
1666157|NCT00120120|Back Pain|back pain
1666158|NCT00120120|Lumbar Pain|lumbar pain
1666159|NCT00120120|CC-5013|cc-5013
1666160|NCT00120120|Revlimid|revlimid
1666161|NCT00120120|Lenalidomide|lenalidomide
1666162|NCT00120094|Syncope|syncope
1666163|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
1666164|NCT00120081|Vaccine|vaccine
1666165|NCT00120081|Hookworm|hookworm
1666166|NCT00120081|Phase 1|phase 1
1666167|NCT00120081|Human Hookworm Infection|human hookworm infection
1666168|NCT00120081|Na-ASP-2|na-asp-2
1666169|NCT00120042|Abortion|abortion
1666170|NCT00120042|Retained placenta|retained placenta
1666171|NCT00120042|Hemorrhage|hemorrhage
1666172|NCT00120042|Postpartum ultrasound|postpartum ultrasound
1666173|NCT00120029|weight loss|weight loss
1666174|NCT00120029|survivorship|survivorship
1666175|NCT00120029|breast ductal lavage|breast ductal lavage
1666176|NCT00120029|exercise|exercise
1666177|NCT00120029|diet|diet
1666178|NCT00120016|cancer prevention|cancer prevention
1666179|NCT00120016|diet|diet
1666180|NCT00120016|nutrition|nutrition
1666181|NCT00120016|polyunsaturated fat|polyunsaturated fat
1666182|NCT00120016|olive oil|olive oil
1666183|NCT00120003|Acute stroke|acute stroke
1666184|NCT00120003|Elevated blood pressure|elevated blood pressure
1666185|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
1666186|NCT00119990|vasopressin|vasopressin
1666187|NCT00119990|icodextrin|icodextrin
1666188|NCT00119990|cardiac output|cardiac output
1666189|NCT00119977|cartilage thickness|cartilage thickness
1666190|NCT00119977|RSA|rsa
1666191|NCT00119977|DEXA|dexa
1666192|NCT00119977|ultra sound|ultra sound
1666193|NCT00119977|MRI|mri
1666194|NCT00119977|osteoarthritis|osteoarthritis
1666195|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
1666196|NCT00119951|Behavioral|behavioral
1666197|NCT00119938|Disease management|disease management
1666198|NCT00119938|Patient access to records|patient access to records
1666199|NCT00119938|Medical records systems, computerized|medical records systems, computerized
1666200|NCT00119938|Questionnaires|questionnaires
1666201|NCT00119938|Physician-patient relations|physician-patient relations
1666202|NCT00119938|Medical records|medical records
1666203|NCT00119925|infertility|infertility
1666204|NCT00119925|guideline|guideline
1666205|NCT00119925|health care implementation|health care implementation
1666206|NCT00119925|intervention|intervention
1666207|NCT00119925|gynecology|gynecology
1666208|NCT00119912|screening|screening
1666209|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
1666210|NCT00119912|fecal occult blood|fecal occult blood
1666211|NCT00119912|cancer|cancer
1666212|NCT00119912|colon|colon
1666213|NCT00119912|rectum|rectum
1666214|NCT00119899|Colorectal Cancer;|colorectal cancer;
1666215|NCT00119899|Liver;|liver;
1666216|NCT00119899|Metastases;|metastases;
1666217|NCT00119899|Resection;|resection;
1666218|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
1666219|NCT00119899|Tomography;|tomography;
1666220|NCT00119899|Positron-Emission|positron-emission
1666221|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
1666222|NCT00119873|AIDS Vaccines|aids vaccines
1666223|NCT00119873|Adenoviridae|adenoviridae
1666224|NCT00119834|Heart Failure|heart failure
1666225|NCT00119834|Intermacs|intermacs
1666226|NCT00119834|Pedimacs|pedimacs
1666227|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
1666228|NCT00119834|Ventricular Assist Device|ventricular assist device
1666229|NCT00119769|HIV|hiv
1666230|NCT00119769|immune stimulation|immune stimulation
1666231|NCT00119769|lipodystrophy|lipodystrophy
1666232|NCT00119769|growth hormone|growth hormone
1666233|NCT00119769|recombinant growth hormone|recombinant growth hormone
1666234|NCT00119769|Treatment Experienced|treatment experienced
1666235|NCT00119756|Schizophrenia|schizophrenia
1666236|NCT00119756|Intramuscular injection|intramuscular injection
1666237|NCT00119756|Deltoid muscle|deltoid muscle
1666238|NCT00119756|Gluteus muscle|gluteus muscle
1666239|NCT00119756|Paliperidone palmitate|paliperidone palmitate
1666240|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
1666241|NCT00119730|Fludarabine|fludarabine
1666242|NCT00119730|Mitoxantrone|mitoxantrone
1666243|NCT00119730|Rituximab|rituximab
1666244|NCT00119730|Zevalin|zevalin
1666245|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
1666246|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
1666247|NCT00119717|acute|acute
1666248|NCT00119717|ischemic|ischemic
1666249|NCT00119717|stroke|stroke
1666250|NCT00119717|randomized|randomized
1666251|NCT00119717|device|device
1666252|NCT00119717|treatment|treatment
1666253|NCT00119678|SLE|sle
1666254|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
1666255|NCT00119665|Hot Flashes|hot flashes
1666256|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
1666257|NCT00119652|Bipolar disorder|bipolar disorder
1666258|NCT00119652|bipolar depression|bipolar depression
1666259|NCT00119652|depression|depression
1666260|NCT00119626|Stroke, Acute|stroke, acute
1666261|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
1666262|NCT00119613|Oncology|oncology
1666263|NCT00119613|Clinical Trial|clinical trial
1666264|NCT00119613|Hemoglobin|hemoglobin
1666265|NCT00119613|Darbepoetin alfa|darbepoetin alfa
1666266|NCT00119613|Survival|survival
1666267|NCT00119613|Carboplatin|carboplatin
1666268|NCT00119613|Cisplatin|cisplatin
1666269|NCT00119613|Etoposide|etoposide
1666270|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
1666271|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
1666272|NCT00119600|Clinical Trial|clinical trial
1666273|NCT00119587|Hemodialysis|hemodialysis
1666274|NCT00119587|darbepoetin alfa|darbepoetin alfa
1666275|NCT00119587|Clinical Trial|clinical trial
1666276|NCT00119587|Amgen|amgen
1666277|NCT00119574|Randomized Controlled Trial|randomized controlled trial
1666377|NCT00119119|Hepatitis C|hepatitis c
1666278|NCT00119574|Quality of Health Care|quality of health care
1666279|NCT00119574|Health Services Research|health services research
1666280|NCT00119574|Guidelines|guidelines
1666281|NCT00119574|Medical Informatics Computing|medical informatics computing
1666282|NCT00119574|Services, Mental Health|services, mental health
1666283|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
1666284|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
1666285|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
1666286|NCT00119574|Veterans|veterans
1666287|NCT00119561|Caregiver|caregiver
1666288|NCT00119561|Dementia|dementia
1666289|NCT00119561|Alzheimer Disease|alzheimer disease
1666290|NCT00119561|Telephone|telephone
1666291|NCT00119561|Randomized Controlled Trials|randomized controlled trials
1666292|NCT00119548|HIV Rapid Testing|hiv rapid testing
1666293|NCT00119548|Cost-effectiveness|cost-effectiveness
1666294|NCT00119548|HIV Seronegativity|hiv seronegativity
1666295|NCT00119535|Diabetes mellitus|diabetes mellitus
1666296|NCT00119535|Diabetic retinopathy|diabetic retinopathy
1666297|NCT00119535|Organizational change|organizational change
1666298|NCT00119535|Quality improvement|quality improvement
1666299|NCT00119535|Quasi-experimental|quasi-experimental
1666300|NCT00119522|wheelchairs|wheelchairs
1666301|NCT00119522|falls|falls
1666302|NCT00119522|spinal cord injury|spinal cord injury
1666303|NCT00119522|accidental falls|accidental falls
1666304|NCT00119522|safety|safety
1666305|NCT00119509|Cervix Neoplasms|cervix neoplasms
1666306|NCT00119509|Vaginal smears|vaginal smears
1666307|NCT00119509|Papillomavirus - Human|papillomavirus - human
1666308|NCT00119496|Corticosteroid|corticosteroid
1666309|NCT00119496|Rosiglitazone|rosiglitazone
1666310|NCT00119496|Theophylline|theophylline
1666311|NCT00119496|Beclomethasone|beclomethasone
1666312|NCT00119496|Inflammation|inflammation
1666313|NCT00119496|Asthma|asthma
1666314|NCT00119496|Smoking|smoking
1666315|NCT00119496|Pulmonary|pulmonary
1666316|NCT00119483|Men|men
1666317|NCT00119483|testosterone|testosterone
1666318|NCT00119483|hypogonadal|hypogonadal
1666319|NCT00119483|aging|aging
1666320|NCT00119483|body composition|body composition
1666321|NCT00119483|quality og life|quality og life
1666322|NCT00119483|Muscle strength|muscle strength
1666323|NCT00119483|Aging male|aging male
1666324|NCT00119457|antithrombotic agents|antithrombotic agents
1666325|NCT00119457|anticoagulants|anticoagulants
1666326|NCT00119457|prophylaxis|prophylaxis
1666327|NCT00119457|embolism|embolism
1666328|NCT00119457|deep vein thrombosis|deep vein thrombosis
1666329|NCT00119457|hip fracture|hip fracture
1666330|NCT00119444|PET|pet
1666331|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
1666332|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
1666333|NCT00119418|hot flash|hot flash
1666334|NCT00119418|menopause|menopause
1666335|NCT00119418|herbal medicine|herbal medicine
1666336|NCT00119418|kampo|kampo
1666337|NCT00119418|alternative medicine|alternative medicine
1666338|NCT00119405|Lipoatrophy|lipoatrophy
1666339|NCT00119405|Mitochondria|mitochondria
1666340|NCT00119405|Treatment Naive|treatment naive
1666341|NCT00119379|lipoatrophy|lipoatrophy
1666342|NCT00119379|mitochondria|mitochondria
1666343|NCT00119379|HIV|hiv
1666344|NCT00119379|treatment experienced|treatment experienced
1666345|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1666346|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1666347|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1666348|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1666349|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1666350|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1666351|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
1666352|NCT00119210|Tobacco use cessation|tobacco use cessation
1666353|NCT00119210|Bupropion|bupropion
1666354|NCT00119210|Zyban|zyban
1666355|NCT00119210|Puerperium|puerperium
1666356|NCT00119197|watery diarrhea|watery diarrhea
1666357|NCT00119197|cholera vaccine|cholera vaccine
1666358|NCT00119184|anesthesia|anesthesia
1666359|NCT00119184|breech|breech
1666360|NCT00119184|external cephalic version|external cephalic version
1666361|NCT00119184|spinal|spinal
1666362|NCT00119184|success|success
1666363|NCT00119184|anesthesia,spinal|anesthesia,spinal
1666364|NCT00119171|Safety|safety
1666365|NCT00119171|tolerability|tolerability
1666366|NCT00119171|dose limiting toxicity|dose limiting toxicity
1666367|NCT00119171|solid tumors|solid tumors
1666368|NCT00119171|capecitabine|capecitabine
1666369|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
1666370|NCT00119145|antimalarial drugs|antimalarial drugs
1666371|NCT00119145|efficacy|efficacy
1666372|NCT00119145|safety|safety
1666373|NCT00119145|trial|trial
1666374|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
1666375|NCT00119132|effectiveness|effectiveness
1666378|NCT00119119|Liver Cirrhosis|liver cirrhosis
1666379|NCT00119119|Tocopherols|tocopherols
1666380|NCT00119106|HIV|hiv
1666381|NCT00119106|Prevention|prevention
1666382|NCT00119106|Tenofovir|tenofovir
1666383|NCT00119106|HIV Seronegativity|hiv seronegativity
1666384|NCT00119093|Antiretroviral therapy|antiretroviral therapy
1666385|NCT00119093|HIV|hiv
1666386|NCT00119093|Adherence|adherence
1666387|NCT00119093|Viral Load|viral load
1666388|NCT00119093|Opportunistic illness|opportunistic illness
1666389|NCT00119080|Meningococcal carriage|meningococcal carriage
1666390|NCT00119080|Conjugate vaccine|conjugate vaccine
1666391|NCT00119067|Anthrax|anthrax
1666392|NCT00119067|Vaccine|vaccine
1666393|NCT00119067|Immunogenicity|immunogenicity
1666394|NCT00119067|Reactogenicity|reactogenicity
1666395|NCT00119054|Hypertension|hypertension
1666396|NCT00119054|Diabetes Mellitus|diabetes mellitus
1666397|NCT00119054|Telemedicine|telemedicine
1666398|NCT00119054|Nursing Care|nursing care
1666399|NCT00119041|Diabetes Mellitus|diabetes mellitus
1666400|NCT00119041|Telemedicine|telemedicine
1666401|NCT00119041|Referral|referral
1666402|NCT00119041|Consultation|consultation
1666403|NCT00119028|Quality Improvement|quality improvement
1666404|NCT00119028|Cluster Randomized Trial|cluster randomized trial
1666405|NCT00119028|Care Model|care model
1666406|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
1666407|NCT00119002|randomized clinical trial|randomized clinical trial
1666408|NCT00119002|placebo-controlled|placebo-controlled
1666409|NCT00119002|double-blind|double-blind
1666410|NCT00119002|double-masked|double-masked
1666411|NCT00119002|infant|infant
1666412|NCT00119002|dexamethasone|dexamethasone
1666413|NCT00119002|wheezing|wheezing
1666414|NCT00118989|Curcumin|curcumin
1666415|NCT00118989|chemoprevention|chemoprevention
1666416|NCT00118989|adenomatous polyps|adenomatous polyps
1666417|NCT00118989|colorectal cancer|colorectal cancer
1666418|NCT00118976|diabetic nephropathy|diabetic nephropathy
1666419|NCT00118976|type 1 diabetes|type 1 diabetes
1666420|NCT00118976|albuminuria|albuminuria
1666421|NCT00118976|hypertension|hypertension
1666422|NCT00118924|Dengue Vaccine|dengue vaccine
1666423|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
1666424|NCT00118924|Flavivirus|flavivirus
1666425|NCT00118911|Adult|adult
1666426|NCT00118911|ADHD|adhd
1666427|NCT00118911|ADD|add
1666428|NCT00118911|CBT|cbt
1666429|NCT00118911|Relaxation Techniques|relaxation techniques
1666430|NCT00118911|Education|education
1666431|NCT00118898|Treatment Naive|treatment naive
1666432|NCT00118885|Shingles|shingles
1666433|NCT00118885|depression|depression
1666434|NCT00118885|varicella zoster virus|varicella zoster virus
1666435|NCT00118885|alternative medicine|alternative medicine
1666436|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
1666437|NCT00118872|Growth and Development|growth and development
1666438|NCT00118872|Pakistan|pakistan
1666439|NCT00118872|Weaning|weaning
1666440|NCT00118872|Probiotics|probiotics
1666441|NCT00118872|Infant|infant
1666442|NCT00118872|Lactobacillus GG|lactobacillus gg
1666443|NCT00118859|Back Pain|back pain
1666444|NCT00118859|Integrative Care|integrative care
1666445|NCT00118859|Acupuncture|acupuncture
1666446|NCT00118859|Chiropractic|chiropractic
1666447|NCT00118859|Exercise|exercise
1666448|NCT00118859|Massage Therapy|massage therapy
1666449|NCT00118859|Mind-Body Therapy|mind-body therapy
1666450|NCT00118859|Nutritional Counseling|nutritional counseling
1666451|NCT00118859|Complementary Therapies|complementary therapies
1666452|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
1666453|NCT00118846|Women|women
1666454|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
1666455|NCT00118846|CAM|cam
1666456|NCT00118833|Social Anxiety Disorder|social anxiety disorder
1666457|NCT00118833|Social Phobia|social phobia
1666458|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
1666459|NCT00118833|Hypericum|hypericum
1666460|NCT00118833|St. John's wort|st. john's wort
1666461|NCT00118833|Medicine, Herbal|medicine, herbal
1666462|NCT00118833|Complementary Therapies|complementary therapies
1666463|NCT00118820|Dry socket|dry socket
1666464|NCT00118820|Third molar|third molar
1666465|NCT00118820|Infection|infection
1666466|NCT00118820|postop-infection|postop-infection
1666467|NCT00118820|Antibiotic efficacy|antibiotic efficacy
1666468|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
1666469|NCT00118807|malaria treatment|malaria treatment
1666470|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
1666471|NCT00118807|Plasmodium falciparum|plasmodium falciparum
1666472|NCT00118807|pragmatic trial|pragmatic trial
1666473|NCT00118807|effectiveness|effectiveness
1666474|NCT00118794|uncomplicated malaria|uncomplicated malaria
1666475|NCT00118794|G6PD deficiency|g6pd deficiency
1666476|NCT00118794|haemolytic anaemia|haemolytic anaemia
1666477|NCT00118794|Lapdap|lapdap
1666478|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
1666479|NCT00118794|compliance|compliance
1666480|NCT00118794|pragmatic trials|pragmatic trials
1666481|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
1666482|NCT00118781|VAP|vap
1666483|NCT00118781|pneumonia|pneumonia
1666484|NCT00118781|ICU infection|icu infection
1666485|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
1666486|NCT00118729|Ragweed|ragweed
1666487|NCT00118729|GW685698X|gw685698x
1666720|NCT00117936|growth factor|growth factor
1666488|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
1666489|NCT00118729|onset|onset
1666490|NCT00118716|asthma|asthma
1666491|NCT00118716|bronchospasm|bronchospasm
1666492|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
1666493|NCT00118703|GW685698X|gw685698x
1666494|NCT00118703|VMR|vmr
1666495|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
1666496|NCT00118690|bronchospasm|bronchospasm
1666497|NCT00118690|asthma|asthma
1666498|NCT00118677|HIV Infections|hiv infections
1666499|NCT00118664|Septic Shock|septic shock
1666500|NCT00118664|Thrombocytopenia|thrombocytopenia
1666771|NCT00117793|Amputee|amputee
1666501|NCT00118664|Multiple Organ Failure|multiple organ failure
1666502|NCT00118664|Pediatric|pediatric
1666503|NCT00118651|pneumonia|pneumonia
1666504|NCT00118651|chest x-ray|chest x-ray
1666505|NCT00118651|diagnosis|diagnosis
1666506|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
1666507|NCT00118638|Darbepoetin alfa|darbepoetin alfa
1666508|NCT00118638|Clinical Trial|clinical trial
1666509|NCT00118625|Allergy|allergy
1666510|NCT00118625|Specific Immunotherapy|specific immunotherapy
1666511|NCT00118625|Adjuvant|adjuvant
1666512|NCT00118625|Allergy Vaccination|allergy vaccination
1666877|NCT00117429|HAART|haart
1666513|NCT00118625|Allergenicity|allergenicity
1666514|NCT00118612|Allergy|allergy
1666515|NCT00118612|Specific Immunotherapy|specific immunotherapy
1666516|NCT00118612|Allergy Vaccination|allergy vaccination
1666517|NCT00118612|Allergenicity|allergenicity
1666518|NCT00118586|Neuroanatomy|neuroanatomy
1666519|NCT00118586|Brain Damage|brain damage
1666520|NCT00118586|Dystonia|dystonia
1666521|NCT00118586|Pathology|pathology
1666522|NCT00118586|Brain Imaging|brain imaging
1666523|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
1666524|NCT00118586|SD|sd
1666525|NCT00118586|Focal Dystonia|focal dystonia
1666526|NCT00118586|Healthy Volunteer|healthy volunteer
1666527|NCT00118586|HV|hv
1666528|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
1666529|NCT00118573|randomized controlled trial|randomized controlled trial
1666530|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
1666531|NCT00118560|Collateral Circulation|collateral circulation
1666532|NCT00118560|Exercise Therapy|exercise therapy
1666533|NCT00118560|Microcirculation|microcirculation
1666534|NCT00118560|Oxygen|oxygen
1666535|NCT00118560|Positron-emission tomography|positron-emission tomography
1666536|NCT00118560|Walking|walking
1666537|NCT00118547|Adherence|adherence
1666538|NCT00118547|Medication|medication
1666539|NCT00118547|Multiple Sclerosis|multiple sclerosis
1666540|NCT00118534|addictive disorders|addictive disorders
1666541|NCT00118534|clinical trial|clinical trial
1666542|NCT00118534|cost effectiveness|cost effectiveness
1666543|NCT00118534|mental health|mental health
1666544|NCT00118534|military or environmental exposure|military or environmental exposure
1666545|NCT00118534|multi-site trial|multi-site trial
1666546|NCT00118534|nicotine|nicotine
1666547|NCT00118534|nicotine replacement|nicotine replacement
1666548|NCT00118534|post traumatic stress|post traumatic stress
1666549|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
1666550|NCT00118534|psychiatric|psychiatric
1666551|NCT00118534|psychological|psychological
1666552|NCT00118534|PTSD|ptsd
1666553|NCT00118534|smoking cessation|smoking cessation
1666554|NCT00118534|smoking cessation medications|smoking cessation medications
1666555|NCT00118534|substance abuse|substance abuse
1666556|NCT00118521|Anterior Knee Pain|anterior knee pain
1666557|NCT00118495|female sexual dysfunction|female sexual dysfunction
1666558|NCT00118495|FSD|fsd
1666559|NCT00118495|arousal|arousal
1666560|NCT00118495|orgasm|orgasm
1666561|NCT00118495|desire|desire
1666562|NCT00118495|Zestra|zestra
1666563|NCT00118495|Mixed FSD|mixed fsd
1666564|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
1666565|NCT00118495|Sexual arousal disorder|sexual arousal disorder
1666566|NCT00118495|Orgasmic disorder|orgasmic disorder
1666567|NCT00118482|vasovagal syncope|vasovagal syncope
1666568|NCT00118482|randomized clinical trial|randomized clinical trial
1666569|NCT00118482|quality of life|quality of life
1666570|NCT00118469|Adolescent|adolescent
1666571|NCT00118469|CBT|cbt
1666572|NCT00118469|Parents|parents
1666573|NCT00118456|Advanced cancers|advanced cancers
1666574|NCT00118456|EGFR|egfr
1666575|NCT00118456|Her2|her2
1666576|NCT00118456|VEGFR|vegfr
1666577|NCT00118443|Suicide Prevention|suicide prevention
1666578|NCT00118443|Depression|depression
1666579|NCT00118443|Adolescent|adolescent
1666580|NCT00118443|Students|students
1666581|NCT00118443|School Teachers|school teachers
1666582|NCT00118430|Back Pain|back pain
1666583|NCT00118430|Knee Pain|knee pain
1666585|NCT00118430|Stepped Care|stepped care
1666586|NCT00118430|Antidepressant|antidepressant
1666587|NCT00118430|Relaxation Techniques|relaxation techniques
1666588|NCT00118430|Exercise|exercise
1666589|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
1666590|NCT00118417|Anxiety|anxiety
1666591|NCT00118417|Pharmacotherapy|pharmacotherapy
1666592|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
1666593|NCT00118417|CBT|cbt
1666594|NCT00118404|Cognitive therapy|cognitive therapy
1666595|NCT00118404|Antidepressants|antidepressants
1666596|NCT00118404|Psychotherapy|psychotherapy
1666597|NCT00118391|Pathological Gambling|pathological gambling
1666598|NCT00118391|CBT|cbt
1666599|NCT00118391|CM|cm
1666600|NCT00118378|HIV|hiv
1666601|NCT00118378|AIDS|aids
1666602|NCT00118378|Modafinil|modafinil
1666603|NCT00118378|Depression|depression
1666604|NCT00118339|oral complications|oral complications
1666605|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1666606|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
1666607|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
1666608|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
1666609|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1666610|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
1666611|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1666612|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
1666613|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1666690|NCT00118001|Psychotherapy|psychotherapy
1666614|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1666721|NCT00117923|Warts|warts
1666615|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1666616|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1666617|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1666618|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1666619|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1666620|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1666621|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1666622|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1666623|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1666624|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1666625|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1666626|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1666627|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1666628|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1666629|NCT00118313|stage II melanoma|stage ii melanoma
1666630|NCT00118313|stage III melanoma|stage iii melanoma
1666631|NCT00118313|stage IV melanoma|stage iv melanoma
1666632|NCT00118300|stage III cervical cancer|stage iii cervical cancer
1666633|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
1666634|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
1666635|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
1666636|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1666637|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1666638|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1666639|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1666640|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1666641|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
1666642|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
1666643|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
1666644|NCT00118300|ovarian sarcoma|ovarian sarcoma
1666645|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
1666646|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1666647|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
1666648|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
1666649|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
1666650|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
1666651|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
1666652|NCT00118274|stage II melanoma|stage ii melanoma
1666653|NCT00118274|stage III melanoma|stage iii melanoma
1666654|NCT00118274|stage IV melanoma|stage iv melanoma
1666655|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
1666656|NCT00118261|stage IV colon cancer|stage iv colon cancer
1666657|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
1666658|NCT00118261|recurrent colon cancer|recurrent colon cancer
1666659|NCT00118222|adult mixed glioma|adult mixed glioma
1666660|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1666661|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
1666662|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
1666663|NCT00118222|adult gliosarcoma|adult gliosarcoma
1666664|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1666665|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1666666|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1666667|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1666668|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1666669|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1666670|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1666671|NCT00118105|recurrent colon cancer|recurrent colon cancer
1666672|NCT00118105|stage IV colon cancer|stage iv colon cancer
1666673|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
1666674|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
1666675|NCT00118105|liver metastases|liver metastases
1666676|NCT00118066|prostate cancer|prostate cancer
1666677|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
1666678|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
1666679|NCT00118053|stage II breast cancer|stage ii breast cancer
1666680|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
1666681|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
1666682|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
1666683|NCT00118027|Malaria in pregnancy|malaria in pregnancy
1666684|NCT00118027|Anaemia|anaemia
1666685|NCT00118027|Low birth weight|low birth weight
1666686|NCT00118014|Trichotillomania|trichotillomania
1666687|NCT00118014|Habit Reversal Training|habit reversal training
1666688|NCT00118014|Sertraline|sertraline
1666689|NCT00118014|Zoloft|zoloft
1666691|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
1666692|NCT00118001|randomized-controlled trial|randomized-controlled trial
1666693|NCT00118001|worry exposure|worry exposure
1666694|NCT00118001|applied relaxation|applied relaxation
1666695|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1666696|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1666697|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1666698|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1666699|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1666700|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1666701|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1666702|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1666703|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1666704|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1666705|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1666706|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1666707|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1666708|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1666709|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
1666710|NCT00117962|large cell lung cancer|large cell lung cancer
1666711|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
1666712|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1666713|NCT00117949|Prostate Cancer|prostate cancer
1666714|NCT00117949|Androgen ablation therapy|androgen ablation therapy
1666715|NCT00117936|Angiogenesis|angiogenesis
1666716|NCT00117936|No-option heart patients|no-option heart patients
1666717|NCT00117936|Blocked coronary artery|blocked coronary artery
1666718|NCT00117936|Revascularization|revascularization
1666719|NCT00117936|FGF-1|fgf-1
1666722|NCT00117923|Adults|adults
1666723|NCT00117923|Common Warts|common warts
1666724|NCT00117923|Resiquimod|resiquimod
1666725|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
1666726|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
1666727|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
1666728|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
1666729|NCT00117910|Breast Cancer, Female|breast cancer, female
1666730|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1666731|NCT00117897|R-CHOP-14|r-chop-14
1666732|NCT00117897|pegfilgrastim|pegfilgrastim
1666733|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
1666734|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
1666735|NCT00117884|Papillomavirus infections;|papillomavirus infections;
1666736|NCT00117884|Cervix Dysplasia|cervix dysplasia
1666737|NCT00117871|Warts|warts
1666738|NCT00117871|Adults|adults
1666739|NCT00117871|Common Warts|common warts
1666740|NCT00117871|Resiquimod|resiquimod
1666741|NCT00117858|Frontal Lobe|frontal lobe
1666742|NCT00117858|Language|language
1666743|NCT00117858|Behavior|behavior
1666744|NCT00117858|Degenerative Diseases|degenerative diseases
1666745|NCT00117858|Pick's Disease|pick's disease
1666746|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
1666748|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
1666749|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
1667038|NCT00116870|CAD|cad
1666750|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
1666751|NCT00117845|CD25 Positive|cd25 positive
1666752|NCT00117845|IL-2R|il-2r
1666754|NCT00117845|Ontak|ontak
1666755|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
1666756|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
1666757|NCT00117832|allergic rhinitis|allergic rhinitis
1666758|NCT00117819|parkinson|parkinson
1666759|NCT00117819|family history|family history
1666760|NCT00117819|diagnosis|diagnosis
1666761|NCT00117806|Adult|adult
1666762|NCT00117806|Depression|depression
1666763|NCT00117806|Employment, supported|employment, supported
1666764|NCT00117806|Health Service/ut|health service/ut
1666765|NCT00117806|Humans|humans
1666766|NCT00117806|Outcomes|outcomes
1666767|NCT00117806|Quality of life|quality of life
1666768|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
1666769|NCT00117806|Workplace|workplace
1666770|NCT00117806|Spinal Cord Injuries|spinal cord injuries
1666772|NCT00117793|Artificial limbs|artificial limbs
1666773|NCT00117793|Gait|gait
1666774|NCT00117793|Walking|walking
1666775|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
1666776|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
1666777|NCT00117741|Opiate Dependence|opiate dependence
1666778|NCT00117741|DBT|dbt
1666779|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
1666780|NCT00117741|Drug Counseling|drug counseling
1666781|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
1666782|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
1666783|NCT00117728|Drug Resistance|drug resistance
1666784|NCT00117728|HIV Seronegativity|hiv seronegativity
1666785|NCT00117728|Treatment Naive|treatment naive
1666786|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
1666787|NCT00117715|Ontogeny|ontogeny
1666788|NCT00117715|pharmacokinetics|pharmacokinetics
1666789|NCT00117715|drug biotransformation|drug biotransformation
1666790|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
1666791|NCT00117702|GvHD|gvhd
1666792|NCT00117702|Tacrolimus|tacrolimus
1666793|NCT00117702|Everolimus|everolimus
1666794|NCT00117702|Stem cell transplantation|stem cell transplantation
1666795|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
1666796|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
1666797|NCT00117689|Liver Transplant Rejection|liver transplant rejection
1666798|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
1666799|NCT00117689|Primary Liver Transplantation|primary liver transplantation
1666800|NCT00117689|Primary Transplant Rejection|primary transplant rejection
1666801|NCT00117689|Transplantation, Liver|transplantation, liver
1666802|NCT00117689|Rejection, Transplant|rejection, transplant
1666803|NCT00117676|tenofovir|tenofovir
1666804|NCT00117676|adefovir|adefovir
1666805|NCT00117676|hepatitis B virus|hepatitis b virus
1666806|NCT00117676|HBeAg Negative|hbeag negative
1666807|NCT00117663|Randomized controlled trial|randomized controlled trial
1666808|NCT00117663|Mammography|mammography
1666809|NCT00117663|health care setting|health care setting
1666810|NCT00117663|hormone replacement therapy|hormone replacement therapy
1666811|NCT00117663|breast density|breast density
1666812|NCT00117663|mammography performance|mammography performance
1666813|NCT00117663|Breast Carcinoma|breast carcinoma
1666814|NCT00117650|leg pain|leg pain
1666815|NCT00117650|gene transfer|gene transfer
1666816|NCT00117650|angiogenesis|angiogenesis
1666817|NCT00117650|Phase 2|phase 2
1666818|NCT00117650|Genzyme|genzyme
1666819|NCT00117650|peripheral arterial disease|peripheral arterial disease
1666820|NCT00117637|Renal Cell Cancer|renal cell cancer
1666822|NCT00117637|Cancer|cancer
1666823|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
1666824|NCT00117624|Darbepoetin alfa|darbepoetin alfa
1666825|NCT00117624|Clinical Trial|clinical trial
1666826|NCT00117611|chronic sinusitis|chronic sinusitis
1666827|NCT00117598|Lymphoma|lymphoma
1666828|NCT00117585|Aging|aging
1666829|NCT00117585|Blood pressure|blood pressure
1666830|NCT00117585|Hypotension|hypotension
1666831|NCT00117585|Orthostatic|orthostatic
1666832|NCT00117585|Rehabilitation|rehabilitation
1666833|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
1666834|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
1666835|NCT00117559|Psychotherapy,group|psychotherapy,group
1666836|NCT00117559|Rehabilitation|rehabilitation
1666837|NCT00117559|Telecommunications|telecommunications
1666838|NCT00117546|CAPACITY trial|capacity trial
1666839|NCT00117546|preeclampsia|preeclampsia
1666840|NCT00117546|plasma volume|plasma volume
1666841|NCT00117546|sympathetic activity|sympathetic activity
1666842|NCT00117546|hypertension|hypertension
1666843|NCT00117546|cardiovascular system|cardiovascular system
1666844|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
1666845|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
1666846|NCT00117533|treatment;|treatment;
1666847|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
1666848|NCT00117533|ribavirin|ribavirin
1666849|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
1666850|NCT00117507|MDS|mds
1666851|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
1666852|NCT00117507|ICL-670|icl-670
1666853|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
1666854|NCT00117494|Hyperlipidemia|hyperlipidemia
1666855|NCT00117494|HIV infections|hiv infections
1666856|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
1666857|NCT00117494|Protease Inhibitor|protease inhibitor
1666858|NCT00117494|Treatment Experienced|treatment experienced
1666859|NCT00117481|endometriosis|endometriosis
1666860|NCT00117481|pelvic pain|pelvic pain
1666861|NCT00117481|hormonal treatment|hormonal treatment
1666862|NCT00117468|luteal phase replacement|luteal phase replacement
1666863|NCT00117468|oocyte donation|oocyte donation
1666864|NCT00117468|infertility|infertility
1667060|NCT00116792|glitazone|glitazone
1666865|NCT00117468|progesterone|progesterone
1666866|NCT00117455|ICE|ice
1666867|NCT00117455|BEAM|beam
1666868|NCT00117455|PBPC transplant|pbpc transplant
1666869|NCT00117442|solid tumour|solid tumour
1666870|NCT00117442|unknown primary tumour|unknown primary tumour
1666871|NCT00117442|carboplatin|carboplatin
1666872|NCT00117442|paclitaxel|paclitaxel
1666873|NCT00117429|HIV-1|hiv-1
1666874|NCT00117429|therapeutic vaccination|therapeutic vaccination
1666875|NCT00117429|cellular immunity|cellular immunity
1666876|NCT00117429|humoral immunity|humoral immunity
1666878|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
1666879|NCT00117429|Treatment Experienced|treatment experienced
1666880|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1666881|NCT00117403|dementia|dementia
1666882|NCT00117403|anti-oxidant|anti-oxidant
1666883|NCT00117403|biomarkers|biomarkers
1666884|NCT00117403|alpha-tocopherol|alpha-tocopherol
1666885|NCT00117403|CoQ|coq
1666886|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
1666887|NCT00117364|chronic ulcer|chronic ulcer
1666888|NCT00117364|poor healing|poor healing
1666889|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
1666890|NCT00117351|Adenocarcinoma|adenocarcinoma
1666891|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
1666892|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
1666893|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1666894|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
1666895|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
1666896|NCT00117325|VMR|vmr
1666897|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
1666898|NCT00117325|GW685698X|gw685698x
1666899|NCT00117312|Prostate Cancer|prostate cancer
1666900|NCT00117312|Androgen ablation therapy|androgen ablation therapy
1666901|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1666902|NCT00117299|GIST|gist
1666903|NCT00117299|Sarcoma|sarcoma
1666904|NCT00117299|PTK787|ptk787
1666905|NCT00117299|ZK 222584|zk 222584
1666906|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1666907|NCT00117299|Tyrosine kinase|tyrosine kinase
1666908|NCT00117299|VEGF|vegf
1666909|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
1666910|NCT00117299|VEGFR|vegfr
1666911|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
1666912|NCT00117299|KDR|kdr
1666913|NCT00117299|KIT|kit
1666914|NCT00117299|c-KIT|c-kit
1666915|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
1666916|NCT00117299|PDGFR|pdgfr
1666917|NCT00117286|Prostate Cancer|prostate cancer
1666918|NCT00117286|Androgen ablation therapy|androgen ablation therapy
1666919|NCT00117260|osteopenia|osteopenia
1666920|NCT00117260|bone mineral density|bone mineral density
1666921|NCT00117260|amenorrhea|amenorrhea
1666922|NCT00117260|adolescents|adolescents
1666923|NCT00117247|Heart Failure|heart failure
1666924|NCT00117234|chronic heart failure|chronic heart failure
1666925|NCT00117234|congestive heart failure|congestive heart failure
1666926|NCT00117234|low hemoglobin|low hemoglobin
1666927|NCT00117234|anemia|anemia
1666928|NCT00117234|CHF|chf
1666929|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
1666930|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
1666931|NCT00117221|Functional Imaging|functional imaging
1666932|NCT00117221|Cerebral Blood Flow|cerebral blood flow
1666933|NCT00117221|BOLD Effect|bold effect
1666934|NCT00117221|Sleep|sleep
1666935|NCT00117208|cystic fibrosis|cystic fibrosis
1666936|NCT00117195|parkinson|parkinson
1666937|NCT00117195|diagnosis|diagnosis
1666938|NCT00117195|screening|screening
1666939|NCT00117169|Pulmonary embolism|pulmonary embolism
1666940|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
1666941|NCT00117169|clinical score|clinical score
1666942|NCT00117156|Fludarabine|fludarabine
1666943|NCT00117156|Rituximab|rituximab
1666944|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
1666945|NCT00117156|MALT lymphoma|malt lymphoma
1666946|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1666947|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1666948|NCT00117143|ITP|itp
1666949|NCT00117143|Thrombocytopenia|thrombocytopenia
1666950|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
1666951|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
1666952|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
1666953|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
1666954|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
1666955|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
1666956|NCT00117117|Amgen|amgen
1666957|NCT00117117|Aranesp®|aranesp®
1666958|NCT00117117|darbepoetin alfa|darbepoetin alfa
1666959|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1667164|NCT00116467|Autologous|autologous
1666960|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
1666961|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
1666962|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
1666963|NCT00117104|Dosing, Amgen|dosing, amgen
1666964|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
1666965|NCT00117091|RA|ra
1666966|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
1666967|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
1666968|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
1668041|NCT00113633|Emergency|emergency
1666969|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
1666970|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
1666971|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
1666972|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
1666973|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
1666974|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
1666975|NCT00117052|Clinical trial|clinical trial
1666976|NCT00117052|Amgen|amgen
1666977|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1666978|NCT00117052|Dialysis|dialysis
1666979|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1666980|NCT00117052|KDOQI|kdoqi
1666981|NCT00117052|Cinacalcet|cinacalcet
1666982|NCT00117039|anemia|anemia
1666983|NCT00117039|fatigue|fatigue
1666984|NCT00117039|Aranesp®|aranesp®
1666985|NCT00117039|clinical trial|clinical trial
1666986|NCT00117026|Diabetes Complications|diabetes complications
1666987|NCT00117026|benfotiamine|benfotiamine
1666988|NCT00117026|type 1 diabetes|type 1 diabetes
1666989|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
1666990|NCT00117026|nerve function|nerve function
1666991|NCT00117026|advanced glycation end products|advanced glycation end products
1666992|NCT00117013|Phase I|phase i
1666993|NCT00117013|Antiangiogenesis|antiangiogenesis
1666994|NCT00117013|Targeted Therapy|targeted therapy
1666995|NCT00117013|Chronic Schedule|chronic schedule
1666996|NCT00117013|VEGF|vegf
1666997|NCT00117013|Cancer|cancer
1666998|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
1666999|NCT00117000|testosterone|testosterone
1667000|NCT00117000|food, formulated|food, formulated
1667001|NCT00117000|malnutrition|malnutrition
1667002|NCT00117000|undernutrition|undernutrition
1667003|NCT00117000|aging|aging
1667004|NCT00117000|aged|aged
1667005|NCT00117000|aged, 80 and over|aged, 80 and over
1667006|NCT00117000|frail elderly|frail elderly
1667007|NCT00116987|physiologic pacing|physiologic pacing
1667008|NCT00116987|ventricular pacing|ventricular pacing
1667009|NCT00116987|hospitalizations|hospitalizations
1667010|NCT00116974|Dental scaling|dental scaling
1667011|NCT00116948|Osteoarthrosis|osteoarthrosis
1667012|NCT00116948|RSA|rsa
1667013|NCT00116948|DEXA|dexa
1667014|NCT00116948|Hip arthroplasty|hip arthroplasty
1667015|NCT00116948|Metal ion|metal ion
1667016|NCT00116948|Inflammatory response|inflammatory response
1667017|NCT00116948|Gait analysis|gait analysis
1667018|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
1667019|NCT00116935|GIST|gist
1667020|NCT00116935|Sarcoma|sarcoma
1667021|NCT00116935|Imatinib|imatinib
1667022|NCT00116935|Adjuvant therapy|adjuvant therapy
1667023|NCT00116935|KIT|kit
1667024|NCT00116935|PDGFRA|pdgfra
1667025|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
1667026|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
1667027|NCT00116922|Diabetes|diabetes
1667028|NCT00116922|Prevention.|prevention.
1667029|NCT00116922|Rosiglitazone|rosiglitazone
1667030|NCT00116922|Metformin|metformin
1667031|NCT00116922|Lifestyle|lifestyle
1667032|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
1667033|NCT00116883|GW685698X|gw685698x
1667034|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
1667035|NCT00116883|pediatric|pediatric
1667036|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
1667037|NCT00116883|HPA axis function|hpa axis function
1667039|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
1667040|NCT00116844|viral shedding|viral shedding
1667041|NCT00116844|Recurrent|recurrent
1667042|NCT00116844|herpes|herpes
1667043|NCT00116844|genital herpes|genital herpes
1667044|NCT00116831|atheroma|atheroma
1667045|NCT00116831|IVUS|ivus
1667046|NCT00116831|Intravascular ultrasound|intravascular ultrasound
1667047|NCT00116831|atherosclerosis|atherosclerosis
1667048|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
1667049|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
1667050|NCT00116818|HPA axis function|hpa axis function
1667051|NCT00116818|GW685698X|gw685698x
1667052|NCT00116805|tenofovir|tenofovir
1667053|NCT00116805|adefovir|adefovir
1667054|NCT00116805|hepatitis B|hepatitis b
1667055|NCT00116805|HBeAg Positive|hbeag positive
1667056|NCT00116792|CAD|cad
1667057|NCT00116792|Diabetes Mellitus|diabetes mellitus
1667058|NCT00116792|Restenosis|restenosis
1667059|NCT00116792|ppar gamma|ppar gamma
1667061|NCT00116779|Prostate Cancer|prostate cancer
1667062|NCT00116779|Androgen ablation therapy|androgen ablation therapy
1667063|NCT00116766|mosquitoes|mosquitoes
1667064|NCT00116766|malaria|malaria
1667065|NCT00116766|vector control|vector control
1667066|NCT00116766|plant-based|plant-based
1667067|NCT00116753|Prostate Cancer|prostate cancer
1667068|NCT00116753|Androgen ablation therapy|androgen ablation therapy
1667069|NCT00116740|Serotonin|serotonin
1667070|NCT00116740|5-HT2c|5-ht2c
1667071|NCT00116740|Satiety|satiety
1667072|NCT00116740|Obesity|obesity
1667073|NCT00116740|Appetite suppressant|appetite suppressant
1667074|NCT00116740|Weight Loss|weight loss
1667075|NCT00116740|Overweight|overweight
1667076|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
1667077|NCT00116727|DMARD|dmard
1667078|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
1667079|NCT00116714|RA|ra
1667080|NCT00116714|DMARD|dmard
1667081|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1667082|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
1667083|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
1667084|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1667085|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
1667086|NCT00116701|Anaemia|anaemia
1667087|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
1667088|NCT00116701|Haemodialysis|haemodialysis
1667089|NCT00116701|Clinical Trial|clinical trial
1667090|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
1667091|NCT00116688|Thrombocytopenic|thrombocytopenic
1667092|NCT00116675|Common Wart(s)|common wart(s)
1667093|NCT00116675|Pediatric|pediatric
1667094|NCT00116675|Wart(s)|wart(s)
1667095|NCT00116675|Children|children
1667096|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
1667097|NCT00116675|Resiquimod|resiquimod
1667098|NCT00116662|Wart(s)|wart(s)
1667099|NCT00116662|Common Wart(s)|common wart(s)
1667100|NCT00116662|Children|children
1667101|NCT00116662|Pediatric|pediatric
1667102|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
1667103|NCT00116662|Resiquimod|resiquimod
1667104|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
1667105|NCT00116649|actinic keratosis|actinic keratosis
1667106|NCT00116636|HIV|hiv
1667107|NCT00116636|Treatment Naive|treatment naive
1667108|NCT00116610|small cell lung cancer|small cell lung cancer
1667109|NCT00116610|resistant|resistant
1667110|NCT00116610|refractory|refractory
1667111|NCT00116610|platinum|platinum
1667112|NCT00116610|chemotherapy|chemotherapy
1667113|NCT00116610|second-line|second-line
1667114|NCT00116610|relapse|relapse
1667115|NCT00116610|sensitive|sensitive
1667116|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
1667117|NCT00116597|Intranodal|intranodal
1667118|NCT00116597|Cancer|cancer
1667119|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
1667120|NCT00116597|Gene Therapy|gene therapy
1667121|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
1667122|NCT00116597|HLA-A2|hla-a2
1667123|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
1667124|NCT00116597|Clinical Trial|clinical trial
1667125|NCT00116597|Phase I/II|phase i/ii
1667126|NCT00116584|heliox|heliox
1667127|NCT00116584|bronchiolitis|bronchiolitis
1667128|NCT00116584|racemic epinephrine|racemic epinephrine
1667129|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
1667130|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
1667131|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
1667132|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1667133|NCT00116558|ALS|als
1667134|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
1667135|NCT00116558|nutrition|nutrition
1667136|NCT00116558|NIPPV|nippv
1667137|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
1667138|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
1667139|NCT00116558|PEG|peg
1667140|NCT00116545|IDDM|iddm
1667141|NCT00116545|Insulin|insulin
1667142|NCT00116545|cardiovascular disease|cardiovascular disease
1667143|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
1667144|NCT00116532|Escitalopram|escitalopram
1667145|NCT00116532|SSRI|ssri
1667146|NCT00116532|Open Label|open label
1667147|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
1667148|NCT00116506|Bevacizumab|bevacizumab
1667149|NCT00116506|Erlotinib|erlotinib
1667150|NCT00116506|FOLFOX|folfox
1667151|NCT00116493|severe anemia|severe anemia
1667152|NCT00116493|anthelminthic|anthelminthic
1667153|NCT00116493|multivitamins|multivitamins
1667154|NCT00116493|pregnancy|pregnancy
1667155|NCT00116493|children|children
1667156|NCT00116493|Pakistan|pakistan
1667157|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
1667158|NCT00116480|Misoprostol|misoprostol
1667159|NCT00116467|AML|aml
1667160|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
1667161|NCT00116467|GVAX|gvax
1667162|NCT00116467|Vaccine|vaccine
1667163|NCT00116467|Stem Cell Transplant|stem cell transplant
1667165|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1667166|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
1667167|NCT00116441|Multiple Myeloma|multiple myeloma
1667168|NCT00116441|Cancer|cancer
1667169|NCT00116441|PSCT|psct
1667170|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
1667171|NCT00116441|Chemotherapy|chemotherapy
1667172|NCT00116441|GVAX|gvax
1667173|NCT00116428|Atrial Fibrillation|atrial fibrillation
1668465|NCT00112203|Bloating|bloating
1667174|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
1667175|NCT00116415|HIV/AIDS|hiv/aids
1667176|NCT00116402|COPD|copd
1667177|NCT00116402|Chronic Obstructive|chronic obstructive
1667178|NCT00116402|Pulmonary Disease|pulmonary disease
1667179|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
1667180|NCT00116402|Airway Inflammation|airway inflammation
1667181|NCT00116402|Bronchoscopy|bronchoscopy
1667182|NCT00116389|pancreatic cancer|pancreatic cancer
1667183|NCT00116389|cancer of the pancreas|cancer of the pancreas
1667184|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1667185|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
1667186|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
1667187|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
1667188|NCT00116376|GBM|gbm
1667189|NCT00116376|recurrent/relapse|recurrent/relapse
1667190|NCT00116376|EGFR|egfr
1667191|NCT00116376|VEGFR|vegfr
1667192|NCT00116363|gene therapy|gene therapy
1667193|NCT00116363|melanoma|melanoma
1667194|NCT00116363|adenovirus|adenovirus
1667195|NCT00116363|in-transit melanoma|in-transit melanoma
1667196|NCT00116363|metastatic melanoma|metastatic melanoma
1667197|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
1667198|NCT00116350|Misoprostol|misoprostol
1667199|NCT00116350|Developing countries|developing countries
1667200|NCT00116350|Maternal morbidity|maternal morbidity
1667201|NCT00116350|Randomized controlled trial|randomized controlled trial
1667202|NCT00116337|spinal cord injury|spinal cord injury
1667203|NCT00116337|paralysis|paralysis
1667204|NCT00116337|cough|cough
1667205|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
1667206|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
1667207|NCT00116324|Asthma|asthma
1667208|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
1667209|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
1667210|NCT00116311|Adenosine receptors|adenosine receptors
1667211|NCT00116311|asthma|asthma
1667212|NCT00116311|sputum|sputum
1667213|NCT00116311|peripheral blood|peripheral blood
1667214|NCT00116311|healthy|healthy
1667215|NCT00116298|Antivirals|antivirals
1667216|NCT00116298|HIV|hiv
1667217|NCT00116285|allergy|allergy
1667218|NCT00116285|skin prick test|skin prick test
1667219|NCT00116285|allergoid|allergoid
1667220|NCT00116285|allergenicity|allergenicity
1667221|NCT00116285|specific immunotherapy|specific immunotherapy
1667222|NCT00116272|pregnancy|pregnancy
1667223|NCT00116272|Autoimmune Disease|autoimmune disease
1667224|NCT00116259|clinical trial|clinical trial
1667225|NCT00116259|aripiprazole|aripiprazole
1667226|NCT00116259|Bipolar Disorder|bipolar disorder
1667227|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
1667228|NCT00116259|ADHD|adhd
1667229|NCT00116246|Labour|labour
1667230|NCT00116246|vaginal delivery|vaginal delivery
1667231|NCT00116246|primigravida|primigravida
1667232|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
1667233|NCT00116246|operative delivery|operative delivery
1667234|NCT00116233|post operative adhesions|post operative adhesions
1667235|NCT00116220|Prostate Cancer|prostate cancer
1667236|NCT00116220|Total Androgen Suppression|total androgen suppression
1667237|NCT00116220|endorectal coil MRI|endorectal coil mri
1667238|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
1667239|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
1667240|NCT00116207|Type 1 Diabetes|type 1 diabetes
1667241|NCT00116207|Oxidative Stress|oxidative stress
1667242|NCT00116207|Diabetic Complications|diabetic complications
1667243|NCT00116207|Neuropathy|neuropathy
1667244|NCT00116194|exercise|exercise
1667245|NCT00116194|activities of daily living|activities of daily living
1667246|NCT00116194|ADL|adl
1667247|NCT00116194|loss of mobility|loss of mobility
1667248|NCT00116194|risk of disability|risk of disability
1667249|NCT00116194|physical activity|physical activity
1667250|NCT00116194|mobility disability|mobility disability
1667251|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
1667252|NCT00116142|Prostate Cancer|prostate cancer
1667253|NCT00116142|Hormone Refractory|hormone refractory
1667254|NCT00116142|Metastatic|metastatic
1667255|NCT00116142|Localized|localized
1667256|NCT00116142|Locally Advanced|locally advanced
1667257|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
1667258|NCT00116129|Fibromyalgia|fibromyalgia
1667259|NCT00116129|Treatment|treatment
1667260|NCT00116129|Growth hormone|growth hormone
1667261|NCT00116129|IGF-1|igf-1
1667263|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
1667264|NCT00116116|HIV/AIDS|hiv/aids
1667265|NCT00116103|Treatment Effectiveness|treatment effectiveness
1667266|NCT00116103|Treatment Efficacy|treatment efficacy
1667267|NCT00116103|Investigational, Therapies|investigational, therapies
1667268|NCT00116103|Asthma|asthma
1667269|NCT00116103|Antiasthmatics|antiasthmatics
1667270|NCT00116103|Antiasthmatic agents|antiasthmatic agents
1667271|NCT00116090|Uveitis|uveitis
1667272|NCT00116090|Immunosuppression|immunosuppression
1667273|NCT00116090|Cancer|cancer
1667274|NCT00116090|Infections|infections
1667275|NCT00116090|Mortality|mortality
1667276|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
1667277|NCT00116090|Scleritis|scleritis
1667278|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
1667279|NCT00116077|PET|pet
1667280|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
1667281|NCT00116077|[F-18] Fallypride|[f-18] fallypride
1667282|NCT00116077|Dopamine Receptors|dopamine receptors
1667283|NCT00116077|Mood Disorders|mood disorders
1667284|NCT00116077|DA Receptors|da receptors
1667285|NCT00116077|Major Depressive Disorder|major depressive disorder
1667286|NCT00116077|Bipolar Disorder|bipolar disorder
1667287|NCT00116077|MDD|mdd
1667288|NCT00116077|Bipolar Depression|bipolar depression
1667289|NCT00116077|Healthy Volunteer|healthy volunteer
1667290|NCT00116077|HV|hv
1667291|NCT00116064|intranasal|intranasal
1667292|NCT00116064|lorazepam|lorazepam
1667293|NCT00116064|paediatric|paediatric
1667294|NCT00116064|convulsions|convulsions
1667295|NCT00116051|RSA|rsa
1667296|NCT00116051|DEXA|dexa
1667297|NCT00116051|Osteoarthritis|osteoarthritis
1667298|NCT00116051|Hip arthroplasty|hip arthroplasty
1667299|NCT00116038|RSA|rsa
1667300|NCT00116038|Osteoarthritis|osteoarthritis
1667301|NCT00116038|Hip arthroplasty|hip arthroplasty
1667302|NCT00116038|DEXA|dexa
1667303|NCT00116012|acute coronary syndrome|acute coronary syndrome
1667304|NCT00116012|rNAPc2|rnapc2
1667305|NCT00116012|unstable angina|unstable angina
1667306|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
1667307|NCT00116012|ST elevation|st elevation
1667308|NCT00116012|cardiac enzymes|cardiac enzymes
1667309|NCT00116012|acute coronary syndromes|acute coronary syndromes
1667310|NCT00116012|factor VIIa|factor viia
1667311|NCT00116012|tissue factor|tissue factor
1667312|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
1667313|NCT00116012|anticoagulants|anticoagulants
1667314|NCT00116012|thrombin inhibitors|thrombin inhibitors
1667315|NCT00116012|thrombosis|thrombosis
1667316|NCT00115999|PAO|pao
1667317|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
1667318|NCT00115999|thrombolysis|thrombolysis
1667319|NCT00115999|blood clot|blood clot
1667320|NCT00115999|leg attack|leg attack
1667321|NCT00115999|alfimeprase|alfimeprase
1667322|NCT00115999|thrombus|thrombus
1667323|NCT00115999|embolism|embolism
1667324|NCT00115999|thromboembolism|thromboembolism
1667325|NCT00115999|claudication|claudication
1667326|NCT00115999|thrombolytic|thrombolytic
1667327|NCT00115999|thrombosis|thrombosis
1667328|NCT00115999|plasminogen activator|plasminogen activator
1667329|NCT00115999|arterial flow|arterial flow
1667330|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
1667331|NCT00115973|Pump|pump
1667332|NCT00115973|Diabetes|diabetes
1667333|NCT00115960|IL-12|il-12
1667334|NCT00115960|IL-15|il-15
1667335|NCT00115960|HIV Seronegativity|hiv seronegativity
1667336|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
1667337|NCT00115921|Home-based care|home-based care
1667338|NCT00115921|Malaria|malaria
1667339|NCT00115921|Africa|africa
1667340|NCT00115908|Hepatitis C|hepatitis c
1667341|NCT00115895|radioiodine|radioiodine
1667342|NCT00115895|serum thyroglobulin|serum thyroglobulin
1667343|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
1667344|NCT00115882|Adolescent|adolescent
1667345|NCT00115882|smoking|smoking
1667346|NCT00115882|smoking cessation|smoking cessation
1667347|NCT00115882|counseling|counseling
1667643|NCT00114868|mortality|mortality
1667348|NCT00115869|smoking prevention|smoking prevention
1667349|NCT00115869|tobacco use prevention|tobacco use prevention
1667350|NCT00115869|adolescent tobacco use|adolescent tobacco use
1667351|NCT00115869|prevention intervention|prevention intervention
1667352|NCT00115856|Arterial Disease|arterial disease
1667353|NCT00115843|Atrial fibrillation|atrial fibrillation
1667354|NCT00115843|Arrhythmia|arrhythmia
1667355|NCT00115843|Tachycardia|tachycardia
1667356|NCT00115804|Fibromyalgia|fibromyalgia
1667357|NCT00115804|Juvenile|juvenile
1667358|NCT00115791|Atrial Flutters|atrial flutters
1667359|NCT00115791|Atrial Fibrillations|atrial fibrillations
1667361|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
1667362|NCT00115778|Lung Transplantation|lung transplantation
1667363|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
1667364|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
1667365|NCT00115765|Cancer|cancer
1667366|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
1667367|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
1667368|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1667369|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
1667370|NCT00115765|Oncology|oncology
1667371|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
1667372|NCT00115752|Analgesic Efficacy|analgesic efficacy
1667373|NCT00115752|Oral Surgery Model|oral surgery model
1667374|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
1667375|NCT00115752|Gene Expression Profile|gene expression profile
1667376|NCT00115752|Wisdom Teeth|wisdom teeth
1667377|NCT00115752|Third Molar Extraction|third molar extraction
1667378|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
1667379|NCT00115726|anesthesia|anesthesia
1667380|NCT00115726|hypotension|hypotension
1667381|NCT00115726|furosemide|furosemide
1667382|NCT00115726|blood pressure|blood pressure
1667383|NCT00115726|peripheral edema|peripheral edema
1667384|NCT00115726|diuretic|diuretic
1667385|NCT00115726|surgery|surgery
1667386|NCT00115726|congestive heart failure|congestive heart failure
1667387|NCT00115713|Aerobic Exercise|aerobic exercise
1667388|NCT00115713|Weight Lifting|weight lifting
1667389|NCT00115713|Breast Cancer|breast cancer
1667390|NCT00115713|Quality of Life|quality of life
1667391|NCT00115700|Radiotherapy|radiotherapy
1667392|NCT00115700|Chemotherapy|chemotherapy
1667393|NCT00115700|Rituximab|rituximab
1667394|NCT00115700|Randomised Trial|randomised trial
1667395|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
1667396|NCT00115687|nicotine addiction|nicotine addiction
1667397|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
1667398|NCT00115661|treatment of endometriosis|treatment of endometriosis
1667399|NCT00115648|HIV|hiv
1667400|NCT00115648|MTCT|mtct
1667401|NCT00115648|Infants|infants
1667402|NCT00115648|africa|africa
1667403|NCT00115648|HIV Seronegativity|hiv seronegativity
1667404|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
1667405|NCT00115622|GW685698X|gw685698x
1667406|NCT00115622|once daily|once daily
1667407|NCT00115622|mountain cedar|mountain cedar
1667408|NCT00115622|allergic rhinitis|allergic rhinitis
1667409|NCT00115622|fluticasone furoate|fluticasone furoate
1667410|NCT00115609|HIV infections|hiv infections
1667411|NCT00115609|tuberculosis|tuberculosis
1667412|NCT00115609|tuberculosis agents|tuberculosis agents
1667413|NCT00115609|Anti HIV agents|anti hiv agents
1667414|NCT00115609|Treatment Naive|treatment naive
1667415|NCT00115596|Procedure|procedure
1667416|NCT00115596|Training|training
1667417|NCT00115596|Simulation|simulation
1667418|NCT00115596|Pediatrics|pediatrics
1667419|NCT00115596|Curriculum|curriculum
1667420|NCT00115596|Evaluation|evaluation
1667421|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
1667422|NCT00115557|translational research|translational research
1667423|NCT00115557|prevention|prevention
1667424|NCT00115557|primary care|primary care
1667425|NCT00115557|practice-based research network|practice-based research network
1667426|NCT00115544|neonatal|neonatal
1667427|NCT00115544|jaundice|jaundice
1667428|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
1667429|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
1667430|NCT00115505|stage IA breast cancer|stage ia breast cancer
1667431|NCT00115505|stage II breast cancer|stage ii breast cancer
1667432|NCT00115505|stage IB breast cancer|stage ib breast cancer
1667433|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1667434|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1667435|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1667436|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1667437|NCT00115492|Breathing|breathing
1667438|NCT00115492|Exacerbation|exacerbation
1667439|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1667440|NCT00115479|critical illness|critical illness
1667441|NCT00115479|intensive care|intensive care
1667442|NCT00115479|outcome|outcome
1667443|NCT00115479|insulin|insulin
1667444|NCT00115479|blood glucose|blood glucose
1667445|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
1667446|NCT00115466|Fistula|fistula
1667447|NCT00115466|Cell Therapy|cell therapy
1667448|NCT00115466|Complex perianal fistula|complex perianal fistula
1667449|NCT00115453|glioblastoma|glioblastoma
1667450|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
1667451|NCT00115453|boronophenylalanine|boronophenylalanine
1667452|NCT00115453|brain tumor|brain tumor
1667453|NCT00115440|glioblastoma|glioblastoma
1667454|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
1667455|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
1667456|NCT00115440|radiation therapy|radiation therapy
1667457|NCT00115440|boronophenylalanine|boronophenylalanine
1667458|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
1667459|NCT00115414|Neulasta®|neulasta®
1667460|NCT00115414|Chemotherapy|chemotherapy
1667463|NCT00019500|breast cancer|breast cancer
1667465|NCT00115401|Compensation|compensation
1667466|NCT00115401|Leg Weakness|leg weakness
1667467|NCT00115401|Orthotics|orthotics
1667468|NCT00115401|Joint Impairment|joint impairment
1667469|NCT00115401|Healthy Volunteer|healthy volunteer
1667470|NCT00115401|HV|hv
1667471|NCT00115401|Joint Inmpairment|joint inmpairment
1667472|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
1667473|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
1667474|NCT00115388|Screening|screening
1667475|NCT00115375|THROMBOSIS|thrombosis
1667476|NCT00115375|PLATELET AGGREGATION|platelet aggregation
1667477|NCT00115375|Pediatrics|pediatrics
1667478|NCT00115362|functional dyspepsia;|functional dyspepsia;
1667479|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
1667480|NCT00115362|Antidepressive Agents.|antidepressive agents.
1667481|NCT00115336|Blood Diseases|blood diseases
1667482|NCT00115336|Sickle Cell Anemia|sickle cell anemia
1667483|NCT00115310|dermal assessment|dermal assessment
1667484|NCT00115310|pain measurement|pain measurement
1667485|NCT00115310|diary|diary
1667486|NCT00115310|PHN|phn
1667487|NCT00115310|shingles|shingles
1667488|NCT00115310|neuropathy|neuropathy
1667489|NCT00115310|analgesics|analgesics
1667490|NCT00115310|capsaicin|capsaicin
1667491|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
1667492|NCT00115284|Asthma|asthma
1667493|NCT00115284|Education, Medical, Continuing|education, medical, continuing
1667494|NCT00115284|American Board of Internal Medicine|american board of internal medicine
1667495|NCT00115284|Recertification|recertification
1667496|NCT00115284|Continuous Professional Development|continuous professional development
1667497|NCT00115284|Practice improvement|practice improvement
1667498|NCT00115271|Micronutrients|micronutrients
1667499|NCT00115271|Supplementation|supplementation
1667500|NCT00115271|Pregnancy|pregnancy
1667501|NCT00115271|Birth weight|birth weight
1667502|NCT00115271|Infant mortality|infant mortality
1667503|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
1667504|NCT00115258|Body Composition|body composition
1667505|NCT00115258|Energy Expenditure|energy expenditure
1667506|NCT00115232|cardiovascular disease|cardiovascular disease
1667507|NCT00115232|metabolic syndrome|metabolic syndrome
1667508|NCT00115232|hypercholesterolemia|hypercholesterolemia
1667509|NCT00115232|child|child
1667510|NCT00115232|family history|family history
1667511|NCT00115232|inflammation|inflammation
1667512|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
1667513|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
1667514|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
1667515|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
1667516|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
1667517|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
1667518|NCT00115206|NSCLC|nsclc
1667519|NCT00115206|Fever|fever
1667520|NCT00115206|Neutropenia|neutropenia
1667521|NCT00115206|Neulasta®|neulasta®
1667522|NCT00115206|Quality of Life|quality of life
1667523|NCT00115206|Chemotherapy|chemotherapy
1667524|NCT00115206|Amgen|amgen
1667525|NCT00115193|Oncology|oncology
1667526|NCT00115193|NHL|nhl
1667527|NCT00115193|Mantle cell|mantle cell
1667528|NCT00115193|Diffuse large B-cell|diffuse large b-cell
1667529|NCT00115193|Chemotherapy|chemotherapy
1667530|NCT00115193|RCHOP|rchop
1667531|NCT00115193|Neulasta®|neulasta®
1667532|NCT00115193|Neutropenia|neutropenia
1667533|NCT00115193|Pegfilgrastim|pegfilgrastim
1667534|NCT00115193|Amgen|amgen
1667535|NCT00115180|analgesia|analgesia
1667536|NCT00115180|adult|adult
1667537|NCT00115180|opioid|opioid
1667538|NCT00115180|Long Bone Fractures|long bone fractures
1667539|NCT00115167|Oncology|oncology
1667540|NCT00115167|Cancer-related anemia|cancer-related anemia
1667541|NCT00115154|Actinic Keratosis|actinic keratosis
1667542|NCT00115154|AK|ak
1667543|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
1667544|NCT00115154|Aldara|aldara
1667545|NCT00115154|Imiquimod|imiquimod
1667546|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
1667547|NCT00115141|Wart(s)|wart(s)
1667548|NCT00115141|Adults|adults
1667549|NCT00115141|Common Wart(s)|common wart(s)
1667550|NCT00115128|normal PBPC donors|normal pbpc donors
1667551|NCT00115115|Donor dopamine|donor dopamine
1667552|NCT00115115|Immediate graft function|immediate graft function
1667553|NCT00115115|Kidney transplantation|kidney transplantation
1667554|NCT00115102|Atypical odontalgia|atypical odontalgia
1667555|NCT00115102|capsaicin|capsaicin
1667556|NCT00115102|pain|pain
1667557|NCT00115102|neuropathic pain|neuropathic pain
1667558|NCT00115089|Allergic Rhinitis|allergic rhinitis
1667559|NCT00115089|Nasal Spray|nasal spray
1667560|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1667561|NCT00115076|skin|skin
1667562|NCT00115076|psoriasis|psoriasis
1667563|NCT00115063|obesity|obesity
1667564|NCT00115063|Low Calorie Diet|low calorie diet
1667565|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
1667566|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
1667567|NCT00115050|HIV infections|hiv infections
1667568|NCT00115050|Antiretroviral|antiretroviral
1667569|NCT00115050|TMC114|tmc114
1667570|NCT00115050|Ritonavir|ritonavir
1667571|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
1667572|NCT00115037|Alcoholism|alcoholism
1667573|NCT00115037|alcohol abuse|alcohol abuse
1667574|NCT00115037|therapy|therapy
1668466|NCT00112203|Indigestion|indigestion
1667575|NCT00115037|drug resistance|drug resistance
1667576|NCT00115037|naltrexone|naltrexone
1667577|NCT00115037|patient care management|patient care management
1667578|NCT00115037|human subject|human subject
1667579|NCT00115024|cardiovascular disease|cardiovascular disease
1667580|NCT00115024|CVD|cvd
1667581|NCT00115024|estrogen|estrogen
1667582|NCT00115024|cholesterol|cholesterol
1667583|NCT00115024|LDL|ldl
1667584|NCT00115024|lipids|lipids
1667585|NCT00115024|postmenopausal|postmenopausal
1667586|NCT00115011|Skin Picking|skin picking
1667587|NCT00115011|Escitalopram|escitalopram
1667588|NCT00115011|Lexapro|lexapro
1667589|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
1667590|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
1667591|NCT00114985|Total Androgen Suppression|total androgen suppression
1667592|NCT00114985|Simulation|simulation
1667593|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
1667594|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
1667595|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
1667596|NCT00114985|Rectal Bleeding|rectal bleeding
1667597|NCT00114985|Late effects|late effects
1667598|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
1667599|NCT00114972|Left main coronary artery disease|left main coronary artery disease
1667600|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
1667601|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
1667602|NCT00114959|ChemGenex|chemgenex
1667603|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
1667604|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
1667605|NCT00114959|Leukemia|leukemia
1667606|NCT00114959|Myeloid Leukemia|myeloid leukemia
1667607|NCT00114959|Chronic Phase|chronic phase
1667608|NCT00114959|Accelerated Phase|accelerated phase
1667609|NCT00114959|Blast Phase|blast phase
1667610|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
1667611|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
1667612|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
1667613|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
1667614|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
1667615|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
1667616|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
1667617|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
1667618|NCT00114959|Homoharringtonine|homoharringtonine
1667619|NCT00114959|Omacetaxine|omacetaxine
1667620|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
1667621|NCT00114933|HIV|hiv
1667622|NCT00114933|AIDS|aids
1667623|NCT00114933|Treatment Experienced|treatment experienced
1667624|NCT00114920|Wart(s)|wart(s)
1667625|NCT00114920|Adults|adults
1667626|NCT00114920|Common Wart(s)|common wart(s)
1667627|NCT00114907|Tea|tea
1667628|NCT00114907|Oxidative stress markers|oxidative stress markers
1667629|NCT00114907|cardiovascular disease|cardiovascular disease
1667630|NCT00114907|polyphenolics|polyphenolics
1667631|NCT00114907|double blind|double blind
1667632|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
1667633|NCT00114894|Jellyfish|jellyfish
1667634|NCT00114894|Stings|stings
1667635|NCT00114894|Marine|marine
1667636|NCT00114894|Envenomation|envenomation
1667637|NCT00114894|Jellyfish stings|jellyfish stings
1667638|NCT00114881|Children|children
1667639|NCT00114881|Urban Health|urban health
1667640|NCT00114881|Pregnancy|pregnancy
1667641|NCT00114881|Asthma|asthma
1667642|NCT00114868|vitamin A|vitamin a
1667644|NCT00114868|newborn|newborn
1667645|NCT00114868|liveborn infants|liveborn infants
1667646|NCT00114855|Hypocol|hypocol
1667647|NCT00114855|Red yeast rice|red yeast rice
1667648|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
1667649|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
1667650|NCT00114842|colorectal polyps|colorectal polyps
1667651|NCT00114842|colorectal cancer|colorectal cancer
1667652|NCT00114842|Virtual colonoscopy|virtual colonoscopy
1667653|NCT00114842|Fecal tagging|fecal tagging
1667654|NCT00114842|MR colonography|mr colonography
1667655|NCT00114829|Colorectal cancer|colorectal cancer
1667656|NCT00114829|Colorectal tumor|colorectal tumor
1667657|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
1667658|NCT00114829|MR colonography|mr colonography
1667659|NCT00114816|breast cancer|breast cancer
1667660|NCT00114816|chemotherapy|chemotherapy
1667661|NCT00114816|adjuvant|adjuvant
1667662|NCT00114816|capecitabine|capecitabine
1667663|NCT00114816|docetaxel|docetaxel
1667664|NCT00114803|bone mineral density|bone mineral density
1667665|NCT00114803|osteoporosis|osteoporosis
1667666|NCT00114803|osteopenia|osteopenia
1667667|NCT00114803|children|children
1667668|NCT00114803|adolescents|adolescents
1667669|NCT00114803|DXA|dxa
1667670|NCT00114790|head and neck cancer|head and neck cancer
1667671|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
1667672|NCT00114790|radiation therapy|radiation therapy
1667673|NCT00114790|boronophenylalanine|boronophenylalanine
1667674|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
1667675|NCT00114764|Pegfilgrastim|pegfilgrastim
1667676|NCT00114764|Neulasta®|neulasta®
1667677|NCT00114764|Neutropenia|neutropenia
1667678|NCT00114764|Induction chemotherapy|induction chemotherapy
1667679|NCT00114764|Consolidation|consolidation
1667680|NCT00114738|Proteasome Inhibition|proteasome inhibition
1667681|NCT00114738|NF-Kappa-B|nf-kappa-b
1667682|NCT00114738|Gene Expression Signature|gene expression signature
1667683|NCT00114738|Cyclin D1|cyclin d1
1667684|NCT00114738|Translational Studies|translational studies
1667685|NCT00114738|Lymphoma|lymphoma
1667686|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
1667687|NCT00114738|MCL|mcl
1667688|NCT00114725|In Vitro Fertilization|in vitro fertilization
1667689|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
1667690|NCT00114725|Oocytes|oocytes
1667691|NCT00114725|Zona Pellucida|zona pellucida
1667692|NCT00114725|Oolemma|oolemma
1667693|NCT00114725|Fertilization|fertilization
1667694|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
1667695|NCT00114712|Birth Defects|birth defects
1667696|NCT00114712|Pregnancy|pregnancy
1667697|NCT00114712|Ribavirin|ribavirin
1667698|NCT00114712|Hepatitis C|hepatitis c
1667699|NCT00114699|HIV|hiv
1667700|NCT00114699|Treatment Naive|treatment naive
1667701|NCT00114686|Bipolar I Disorder|bipolar i disorder
1667702|NCT00114686|Alcohol Dependency|alcohol dependency
1667703|NCT00114673|Uneven skin color|uneven skin color
1667704|NCT00114673|Wrinkles|wrinkles
1667705|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
1667706|NCT00114660|striae gravidarum|striae gravidarum
1667707|NCT00114660|stretch marks|stretch marks
1667708|NCT00114660|cocoa butter|cocoa butter
1667709|NCT00114660|prevention|prevention
1667710|NCT00114647|Plasmapheresis|plasmapheresis
1667711|NCT00114647|Leukapheresis|leukapheresis
1667712|NCT00114647|Lymphocytes|lymphocytes
1667713|NCT00114647|Apheresis|apheresis
1667714|NCT00114634|SLOS|slos
1667715|NCT00114634|RSH syndrome|rsh syndrome
1667716|NCT00114634|ABC Checklist|abc checklist
1667717|NCT00114634|Cholesterol supplementation|cholesterol supplementation
1667718|NCT00114634|Egg yolk|egg yolk
1667719|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1667720|NCT00114621|PA|pa
1667721|NCT00114621|Phase I|phase i
1667722|NCT00114621|Phase 2|phase 2
1667723|NCT00114621|Safety|safety
1667724|NCT00114621|Immunogenicity|immunogenicity
1667725|NCT00114608|Electrical foot stimulation|electrical foot stimulation
1667726|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
1667727|NCT00114608|Venous thromboembolism|venous thromboembolism
1667728|NCT00114608|Immobilization|immobilization
1667729|NCT00114608|Total hip replacement|total hip replacement
1667730|NCT00114608|Prolonged travel|prolonged travel
1667731|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
1667732|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
1667733|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
1667734|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
1667735|NCT00114595|tardive dyskinesia|tardive dyskinesia
1667736|NCT00114595|omega-3|omega-3
1667737|NCT00114595|schizophrenia|schizophrenia
1667738|NCT00114582|family style dinner|family style dinner
1667739|NCT00114582|quality of life|quality of life
1667740|NCT00114582|nutritional status|nutritional status
1667741|NCT00114582|nursing home residents|nursing home residents
1667742|NCT00114569|children|children
1668214|NCT00113165|lamotrigine|lamotrigine
1667743|NCT00114569|status epilepticus|status epilepticus
1667744|NCT00114569|lorazepam|lorazepam
1667745|NCT00114569|safety|safety
1667746|NCT00114569|pharmacokinetics|pharmacokinetics
1667747|NCT00114569|status epilepticus in children|status epilepticus in children
1667748|NCT00114556|osteoporosis|osteoporosis
1667749|NCT00114556|liver transplantation|liver transplantation
1667750|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
1667751|NCT00114543|Bilirubin|bilirubin
1667752|NCT00114543|Phototherapy|phototherapy
1667753|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1667754|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1667755|NCT00114543|Prematurity|prematurity
1667756|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
1667757|NCT00114530|systemic sclerosis|systemic sclerosis
1667758|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
1667759|NCT00114530|clinical trial|clinical trial
1667760|NCT00114530|global rank composite score|global rank composite score
1667761|NCT00114517|atherosclerosis|atherosclerosis
1667763|NCT00114517|cardiac computed tomography|cardiac computed tomography
1667764|NCT00114517|cardiovascular disease|cardiovascular disease
1667765|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
1667766|NCT00114517|cognitive function|cognitive function
1667767|NCT00114517|computed tomography|computed tomography
1667768|NCT00114517|coronary artery calcium|coronary artery calcium
1667769|NCT00114517|coronary artery disease|coronary artery disease
1667770|NCT00114517|coronary artery lesions|coronary artery lesions
1667771|NCT00114517|CVD|cvd
1667772|NCT00114517|estrogen|estrogen
1667773|NCT00114517|estrogen therapy|estrogen therapy
1667774|NCT00114517|hormone therapy|hormone therapy
1667775|NCT00114517|postmenopausal|postmenopausal
1667776|NCT00114517|subclinical vascular disease|subclinical vascular disease
1667777|NCT00114517|timing hypothesis|timing hypothesis
1667778|NCT00114517|ultrasonography|ultrasonography
1667779|NCT00114504|atherosclerosis|atherosclerosis
1667780|NCT00114504|inflammation|inflammation
1667781|NCT00114504|statins|statins
1667782|NCT00114504|PET|pet
1667783|NCT00114504|carotid ultrasonography|carotid ultrasonography
1667784|NCT00114491|Aortic Stenosis|aortic stenosis
1667785|NCT00114491|Statins|statins
1667786|NCT00114491|Hypercholesterolemia|hypercholesterolemia
1667787|NCT00114478|Bronchiolitis|bronchiolitis
1667788|NCT00114478|disposition|disposition
1667789|NCT00114478|pediatric|pediatric
1667790|NCT00114478|epinephrine|epinephrine
1667791|NCT00114478|albuterol|albuterol
1667792|NCT00114465|Randomized|randomized
1667793|NCT00114465|Double-Blind|double-blind
1667794|NCT00114465|Probiotic|probiotic
1667795|NCT00114465|Remission|remission
1667796|NCT00114465|Crohn's Disease|crohn's disease
1667797|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
1667798|NCT00114452|Heart Attack|heart attack
1667799|NCT00114452|Cardiovascular Disease|cardiovascular disease
1667800|NCT00114452|Stem cells|stem cells
1667801|NCT00114452|Congestive Heart Failure|congestive heart failure
1667802|NCT00114452|Heart Attack Repair|heart attack repair
1667803|NCT00114439|cannabis withdrawal|cannabis withdrawal
1667804|NCT00114439|lithium|lithium
1667805|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
1667806|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
1667807|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
1667808|NCT00114413|Lung|lung
1667809|NCT00114413|Urban Health|urban health
1667810|NCT00114413|Child|child
1667811|NCT00114413|Adolescent|adolescent
1667812|NCT00114400|cardiovascular disease|cardiovascular disease
1667813|NCT00114400|CVD|cvd
1667814|NCT00114387|vitamin E|vitamin e
1667815|NCT00114374|Acute Stress Disorder|acute stress disorder
1667816|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
1667817|NCT00114374|Escitalopram|escitalopram
1667818|NCT00114374|Double-Blind|double-blind
1667819|NCT00114361|HBeAg-negative|hbeag-negative
1667820|NCT00114361|chronic|chronic
1667821|NCT00114361|hepatitis B|hepatitis b
1667822|NCT00114361|viral|viral
1667823|NCT00114348|non-B ALL|non-b all
1667824|NCT00114348|relapse|relapse
1667825|NCT00114348|treatment|treatment
1667826|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
1667827|NCT00114335|low molecular weight heparin|low molecular weight heparin
1667828|NCT00114335|unfractionated heparin|unfractionated heparin
1667829|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
1667830|NCT00114309|Phase II|phase ii
1667831|NCT00114309|Multi-Center|multi-center
1667832|NCT00114309|Open label|open label
1667833|NCT00114309|Multiple dose|multiple dose
1667834|NCT00114309|Brain Cancer|brain cancer
1667835|NCT00114309|Brain Tumor|brain tumor
1667836|NCT00114309|GBM|gbm
1667837|NCT00114309|glioma|glioma
1667838|NCT00114296|breast cancer|breast cancer
1667839|NCT00114270|breast cancer|breast cancer
1667840|NCT00114270|osteoporosis|osteoporosis
1667841|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1667842|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1667843|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1667844|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1667845|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1667846|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1667847|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1667848|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1667849|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1667850|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1667851|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1667852|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1667853|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1667854|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1668032|NCT00113659|Asthma|asthma
1667855|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1667856|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1667857|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1667858|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1667859|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1667860|NCT00114257|primary myelofibrosis|primary myelofibrosis
1667861|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1667862|NCT00114257|essential thrombocythemia|essential thrombocythemia
1667863|NCT00114257|polycythemia vera|polycythemia vera
1667864|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1667865|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1667866|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1667867|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1667868|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1667869|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1667870|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1667871|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1667872|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1667873|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1667874|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1667875|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
1667876|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1667877|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1667878|NCT00114231|stage I rectal cancer|stage i rectal cancer
1667879|NCT00114205|malignant pleural effusion|malignant pleural effusion
1667880|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1667881|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1667882|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1667883|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1667884|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1667885|NCT00114166|fallopian tube cancer|fallopian tube cancer
1667886|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1667887|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1667888|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1667889|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1667890|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1667891|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1667892|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1667893|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
1667894|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
1667895|NCT00114140|adult mixed glioma|adult mixed glioma
1667896|NCT00114127|social anxiety disorder|social anxiety disorder
1667897|NCT00114127|social phobia|social phobia
1667898|NCT00114127|duloxetine|duloxetine
1667899|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
1667901|NCT00114127|double blind|double blind
1667902|NCT00114114|Testosterone|testosterone
1667903|NCT00114114|Bone turnover|bone turnover
1667904|NCT00114114|Aging|aging
1667905|NCT00114114|Body composition|body composition
1667906|NCT00114114|Hypogonadism|hypogonadism
1667907|NCT00114114|Sexual function|sexual function
1667908|NCT00114088|Hysterectomy,|hysterectomy,
1667909|NCT00114088|Endometrial ablation,|endometrial ablation,
1667910|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
1667911|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
1667912|NCT00114088|DUB|dub
1667913|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
1667914|NCT00114075|gait|gait
1667915|NCT00114075|walking|walking
1667916|NCT00114075|orthopedic surgery|orthopedic surgery
1667917|NCT00114075|orthopaedic surgery|orthopaedic surgery
1667918|NCT00114062|uveitis|uveitis
1667919|NCT00114062|macular edema|macular edema
1667920|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
1667921|NCT00114049|Dental Pain|dental pain
1667922|NCT00114049|Dental Surgery|dental surgery
1667923|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
1667924|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
1667925|NCT00114036|Surgical wound infections|surgical wound infections
1667926|NCT00114023|AK|ak
1667927|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
1667928|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
1667929|NCT00114023|Aldara|aldara
1667930|NCT00114023|Actinic Keratosis|actinic keratosis
1667931|NCT00114010|B Cells|b cells
1667932|NCT00114010|T Cells|t cells
1667933|NCT00114010|Erythrocyte Stage|erythrocyte stage
1667934|NCT00114010|Antibody|antibody
1667935|NCT00114010|Immunogenicity|immunogenicity
1667936|NCT00114010|Healthy Volunteer|healthy volunteer
1667937|NCT00113997|Anticoagulant|anticoagulant
1667938|NCT00113997|Antidote|antidote
1667939|NCT00113997|Pharmacokinetics|pharmacokinetics
1667940|NCT00113997|Pharmacodynamics|pharmacodynamics
1667941|NCT00113997|Healthy Volunteer|healthy volunteer
1667943|NCT00113984|Monoclonal Antibody|monoclonal antibody
1667944|NCT00113984|Vaccine|vaccine
1667945|NCT00113984|Cytokines|cytokines
1667946|NCT00113984|Immunotherapy|immunotherapy
1667947|NCT00113984|Elispot Assay|elispot assay
1667948|NCT00113984|Prostate Cancer|prostate cancer
1667949|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
1667950|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
1667951|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
1667952|NCT00113971|SLE|sle
1667953|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1667954|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1667955|NCT00113958|hemodialysis|hemodialysis
1667956|NCT00113958|biPTH|bipth
1667957|NCT00113958|AMG 073, Amgen|amg 073, amgen
1667958|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
1667959|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
1667960|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
1667961|NCT00113945|AMG 073, Amgen|amg 073, amgen
1667962|NCT00113932|Myeloma|myeloma
1667963|NCT00113919|Myeloma, MM|myeloma, mm
1667964|NCT00113906|melatonin,|melatonin,
1667965|NCT00113906|fatigue,|fatigue,
1667966|NCT00113906|sleep quality,|sleep quality,
1667967|NCT00113906|circadian,|circadian,
1667968|NCT00113906|postoperative|postoperative
1667969|NCT00113906|Postoperative fatigue|postoperative fatigue
1667970|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
1667971|NCT00113906|general wellbeing|general wellbeing
1667972|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
1667973|NCT00113893|p38 MAP kinase|p38 map kinase
1667974|NCT00113893|Bone marrow diseases|bone marrow diseases
1667975|NCT00113893|SCIO-469|scio-469
1667976|NCT00113867|IVF|ivf
1667977|NCT00113867|in vitro fertilization|in vitro fertilization
1667978|NCT00113867|hormones|hormones
1667979|NCT00113867|stress|stress
1667980|NCT00113867|memory|memory
1667981|NCT00113867|Cognitive Function|cognitive function
1667982|NCT00113867|adoption|adoption
1667983|NCT00113854|cerebral|cerebral
1667984|NCT00113854|malaria|malaria
1667985|NCT00113854|children|children
1667986|NCT00113854|mannitol|mannitol
1667987|NCT00113854|adjunct|adjunct
1667988|NCT00113854|therapy|therapy
1667989|NCT00113854|Uganda|uganda
1667990|NCT00113841|Multiple Myeloma|multiple myeloma
1667991|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
1667992|NCT00113841|Curcumin|curcumin
1667993|NCT00113841|Bioperine|bioperine
1667994|NCT00113828|Non-Myeloablative|non-myeloablative
1667995|NCT00113828|Stem Cell Transplantation|stem cell transplantation
1667996|NCT00113828|T-cell Depletion|t-cell depletion
1667997|NCT00113828|HLA-Matched|hla-matched
1667998|NCT00113815|Partial seizure disorder|partial seizure disorder
1667999|NCT00113815|Topiramate|topiramate
1668000|NCT00113815|Epilepsy|epilepsy
1668001|NCT00113815|Infants|infants
1668002|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
1668003|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
1668004|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
1668005|NCT00113802|Hematologic Disease|hematologic disease
1668006|NCT00113802|Hematologic Diseases|hematologic diseases
1668007|NCT00113802|Paraproteinemias|paraproteinemias
1668008|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
1668009|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
1668010|NCT00113789|ovarian cancer|ovarian cancer
1668011|NCT00113789|topotecan|topotecan
1668012|NCT00113789|neutropenia|neutropenia
1668013|NCT00113789|Neulasta®|neulasta®
1668014|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
1668015|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
1668016|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
1668017|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
1668018|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1668019|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
1668020|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
1668021|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
1668022|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
1668023|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1668024|NCT00113750|Allergy|allergy
1668025|NCT00113750|Allergoid|allergoid
1668026|NCT00113750|Specific Immunotherapy|specific immunotherapy
1668027|NCT00113724|taxane|taxane
1668028|NCT00113724|multi-drug resistance|multi-drug resistance
1668029|NCT00113724|mutant tubulin binding|mutant tubulin binding
1668030|NCT00113724|Advanced malignancies|advanced malignancies
1668031|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
1668036|NCT00113646|Non-Myeloablative|non-myeloablative
1668037|NCT00113646|T-cell Depleted|t-cell depleted
1668038|NCT00113646|Mismatched|mismatched
1668039|NCT00113646|Stem Cell Transplantation|stem cell transplantation
1668040|NCT00113633|Asthma|asthma
1668042|NCT00113633|Primary Care|primary care
1668043|NCT00113633|Children|children
1668044|NCT00113620|distal symmetrical|distal symmetrical
1668045|NCT00113620|pain|pain
1668046|NCT00113620|lower extremities|lower extremities
1668047|NCT00113620|dextromethorphan|dextromethorphan
1668048|NCT00113607|Ovarian cancer|ovarian cancer
1668049|NCT00113607|Trabectedin|trabectedin
1668050|NCT00113607|Yondelis|yondelis
1668051|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
1668052|NCT00113607|DOXIL|doxil
1668053|NCT00113607|CAELYX|caelyx
1668054|NCT00113581|EMD 72000|emd 72000
1668055|NCT00113581|matuzumab|matuzumab
1668056|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
1668057|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
1668058|NCT00113568|Menorrhagia|menorrhagia
1668059|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
1668060|NCT00113555|urinary incontinence|urinary incontinence
1668061|NCT00113542|Psoriasis|psoriasis
1668062|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
1668063|NCT00113516|Lung Neoplasms|lung neoplasms
1668064|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
1668065|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
1668066|NCT00113490|Rezield, MEDI-524|rezield, medi-524
1668067|NCT00113477|Q10|q10
1668068|NCT00113477|CoQ10|coq10
1668069|NCT00113477|Coenzyme Q10|coenzyme q10
1668070|NCT00113477|selen|selen
1668071|NCT00113477|selenoprotein|selenoprotein
1668072|NCT00113477|selenoproteins|selenoproteins
1668073|NCT00113477|adverse events|adverse events
1668074|NCT00113477|adverse effects|adverse effects
1668075|NCT00113477|AE|ae
1668076|NCT00113477|myalgia|myalgia
1668077|NCT00113477|muscle|muscle
1668078|NCT00113477|statin therapy|statin therapy
1668079|NCT00113477|Indication for statin therapy|indication for statin therapy
1668080|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
1668081|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
1668082|NCT00113464|Bone Marrow Transplant|bone marrow transplant
1668083|NCT00113464|Dried Blood Spots|dried blood spots
1668084|NCT00113464|Early Detection|early detection
1668085|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
1668086|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
1668087|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
1668088|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
1668089|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
1668090|NCT00113464|SCID|scid
1668091|NCT00113451|radial artery|radial artery
1668092|NCT00113451|angina pectoris|angina pectoris
1668093|NCT00113451|infarction|infarction
1668094|NCT00113451|bypass|bypass
1668095|NCT00113451|angiography|angiography
1668096|NCT00113438|cancer|cancer
1668097|NCT00113438|tumor|tumor
1668098|NCT00113438|imageable|imageable
1668099|NCT00113438|CA4P|ca4p
1668100|NCT00113438|Combretastatin|combretastatin
1668101|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
1668102|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
1668103|NCT00113438|Carboplatin|carboplatin
1668104|NCT00113438|Paclitaxel|paclitaxel
1668105|NCT00113438|carbo|carbo
1668106|NCT00113438|taxol|taxol
1668107|NCT00113425|non-ablative laser|non-ablative laser
1668108|NCT00113425|acne|acne
1668109|NCT00113425|photosensitizer|photosensitizer
1668110|NCT00113425|photodynamic therapy|photodynamic therapy
1668111|NCT00113412|HIV|hiv
1668112|NCT00113412|Treatment Experienced|treatment experienced
1668113|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1668114|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1668115|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1668116|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1668117|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1668118|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1668119|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1668120|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
1668121|NCT00113386|large cell lung cancer|large cell lung cancer
1668122|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
1668123|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1668124|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
1668125|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
1668126|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
1668127|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
1668128|NCT00113360|RAD001|rad001
1668129|NCT00113360|Everolimus|everolimus
1668130|NCT00113360|Octreotide Depot|octreotide depot
1668131|NCT00113360|Sandostatin LAR|sandostatin lar
1668132|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
1668133|NCT00113360|Octreotide LAR|octreotide lar
1668134|NCT00113347|Head and Neck Cancer|head and neck cancer
1668135|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
1668136|NCT00113347|Erlotinib|erlotinib
1668137|NCT00113347|Docetaxel|docetaxel
1668138|NCT00113347|Radiation|radiation
1668139|NCT00113347|Radiotherapy|radiotherapy
1668140|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
1668141|NCT00113334|Head and Neck Cancer|head and neck cancer
1668142|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
1668144|NCT00113334|Antiangiogenic agent|antiangiogenic agent
1668145|NCT00113334|Lung|lung
1668146|NCT00113334|Skin|skin
1668147|NCT00113334|Thyroid|thyroid
1668148|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
1668149|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1668150|NCT00113321|Azacytidine Failure|azacytidine failure
1668151|NCT00113321|Decitabine|decitabine
1668152|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
1668153|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
1668154|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
1668155|NCT00113295|pharmacotherapy|pharmacotherapy
1668156|NCT00113295|treatment refractory|treatment refractory
1668157|NCT00113295|double-blind|double-blind
1668158|NCT00113282|Treatment failure|treatment failure
1668159|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1668160|NCT00113282|Interleukin-2|interleukin-2
1668161|NCT00113282|Treatment Experienced|treatment experienced
1668162|NCT00113269|Treatment Effectiveness|treatment effectiveness
1668163|NCT00113269|Treatment Efficacy|treatment efficacy
1668164|NCT00113269|Anti-rejection therapy|anti-rejection therapy
1668165|NCT00113269|Immunosuppression|immunosuppression
1668166|NCT00113269|Therapy, antirejection|therapy, antirejection
1668167|NCT00113269|Renal Transplantation|renal transplantation
1668168|NCT00113269|Transplantation, Kidney|transplantation, kidney
1668169|NCT00113269|Transplantation, Renal|transplantation, renal
1668170|NCT00113269|Grafting, Kidney|grafting, kidney
1668171|NCT00113256|rubitecan|rubitecan
1668172|NCT00113256|Orathecin|orathecin
1668173|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
1668174|NCT00113256|gemcitabine|gemcitabine
1668175|NCT00113256|Gemzar|gemzar
1668176|NCT00113256|pancreatic cancer|pancreatic cancer
1668177|NCT00113256|adenocarcinoma|adenocarcinoma
1668178|NCT00113256|RFS 2000|rfs 2000
1668179|NCT00113230|Rectal Cancer|rectal cancer
1668180|NCT00113230|Bevacizumab|bevacizumab
1668181|NCT00113230|RHUMAB VEGF|rhumab vegf
1668182|NCT00113230|Avastin|avastin
1668183|NCT00113230|Capecitabine|capecitabine
1668184|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
1668185|NCT00113230|Xeloda|xeloda
1668186|NCT00113230|Radiation|radiation
1668187|NCT00113230|Radiotherapy|radiotherapy
1668188|NCT00113230|Radiation Therapy|radiation therapy
1668189|NCT00113230|XRT|xrt
1668190|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
1668191|NCT00113217|Kidney Cancer|kidney cancer
1668192|NCT00113217|Bevacizumab|bevacizumab
1668193|NCT00113217|Avastin|avastin
1668194|NCT00113217|RCC|rcc
1668195|NCT00113204|Multiple myeloma|multiple myeloma
1668196|NCT00113204|Relapsed|relapsed
1668197|NCT00113204|Relapsed refractory|relapsed refractory
1668198|NCT00113204|Hematologic cancer|hematologic cancer
1668199|NCT00113204|hematologic disease|hematologic disease
1668200|NCT00113204|plasma cells|plasma cells
1668201|NCT00113191|late onset sepsis|late onset sepsis
1668202|NCT00113191|premature infants|premature infants
1668203|NCT00113191|staphylococcus|staphylococcus
1668204|NCT00113191|candida|candida
1668205|NCT00113191|prevention|prevention
1668206|NCT00113178|atrial flutter|atrial flutter
1668207|NCT00113178|cryoablation|cryoablation
1668208|NCT00113165|partial seizures|partial seizures
1668209|NCT00113165|Epilepsy|epilepsy
1668210|NCT00113165|antiepileptic drugs|antiepileptic drugs
1668211|NCT00113165|anticonvulsants|anticonvulsants
1668212|NCT00113165|LAMICTAL|lamictal
1668213|NCT00113165|seizures|seizures
1668215|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
1668216|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
1668217|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
1668218|NCT00113152|Sickle Cell Anemia|sickle cell anemia
1668219|NCT00113152|Sudden Death|sudden death
1668220|NCT00113152|Thalassemia|thalassemia
1668221|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
1668222|NCT00113126|STI|sti
1668223|NCT00113113|rubitecan|rubitecan
1668224|NCT00113113|Orathecin|orathecin
1668225|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
1668226|NCT00113113|solid tumors|solid tumors
1668227|NCT00113113|organ dysfunction|organ dysfunction
1668228|NCT00113113|renal dysfunction|renal dysfunction
1668229|NCT00113113|hepatic dysfunction|hepatic dysfunction
1668230|NCT00113113|RFS 2000|rfs 2000
1668231|NCT00113100|skin|skin
1668232|NCT00113100|estrogen|estrogen
1668233|NCT00113100|sun damage|sun damage
1668234|NCT00113100|Photodamaged Skin|photodamaged skin
1668235|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
1668236|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
1668237|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
1668238|NCT00113035|GSD-II|gsd-ii
1668239|NCT00113035|Pompe Disease|pompe disease
1668240|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
1668241|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
1668242|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
1668243|NCT00113035|Glycogenosis 2|glycogenosis 2
1668244|NCT00113022|Depression|depression
1668245|NCT00113022|Glutamate|glutamate
1668246|NCT00113022|Ampakine|ampakine
1668247|NCT00113022|Treatment|treatment
1668248|NCT00113022|Memory|memory
1668249|NCT00113022|Major Depressive Disorder|major depressive disorder
1668250|NCT00113022|AMPA Receptor Activation|ampa receptor activation
1668251|NCT00113022|BDNF|bdnf
1668252|NCT00113009|Peripheral arterial disease|peripheral arterial disease
1668253|NCT00112996|neurotoxicity|neurotoxicity
1668254|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1668255|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1668256|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1668257|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
1668258|NCT00112957|fallopian tube cancer|fallopian tube cancer
1668259|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1668260|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1668261|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1668262|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
1668263|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1668264|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1668265|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1668266|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1668267|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1668268|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1668269|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1668270|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1668271|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1668272|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1668273|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1668274|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1668275|NCT00112918|stage II colon cancer|stage ii colon cancer
1668276|NCT00112918|stage III colon cancer|stage iii colon cancer
1668277|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1668278|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1668279|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1668280|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1668281|NCT00112749|stage I breast cancer|stage i breast cancer
1668282|NCT00112749|stage II breast cancer|stage ii breast cancer
1668283|NCT00112749|breast cancer in situ|breast cancer in situ
1668284|NCT00112749|fatigue|fatigue
1668285|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1668286|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1668287|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1668288|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
1668289|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1668290|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
1668291|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1668292|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
1668293|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1668440|NCT00112255|Family practice|family practice
1668294|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1668295|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1668296|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1668297|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1668298|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1668299|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1668300|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1668301|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1668302|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1668303|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1668304|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1668305|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1668306|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1668307|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1668308|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1668309|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1668310|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1668311|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1668312|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1668313|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1668314|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
1668315|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
1668316|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
1668317|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1668318|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1668319|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1668320|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1668321|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
1668322|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
1668323|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1668324|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1668325|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
1668326|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1668327|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
1668328|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1668329|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
1668330|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1668331|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1668332|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1668333|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1668334|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1668335|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1668336|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1668337|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1668338|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1668339|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1668340|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1668341|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1668342|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1668343|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1668344|NCT00112619|meningeal leukemia|meningeal leukemia
1668345|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
1668346|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
1668347|NCT00112593|HIV|hiv
1668348|NCT00112593|Lymphoma|lymphoma
1668349|NCT00112593|Leukemia|leukemia
1668350|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
1668351|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1668352|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
1668353|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1668354|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1668355|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1668356|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1668357|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1668358|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1668359|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1668360|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1668361|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1668362|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1668363|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1668364|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1668365|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1668366|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1668367|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1668368|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1668369|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1668370|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1668371|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
1668372|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1668373|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1668374|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1668375|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1668376|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1668377|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1668378|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1668379|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1668380|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1668381|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1668382|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1668383|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
1668384|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
1668385|NCT00112515|depression|depression
1668386|NCT00112515|cognitive/functional effects|cognitive/functional effects
1668387|NCT00112515|fatigue|fatigue
1668388|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1668389|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
1668390|NCT00112502|adult gliosarcoma|adult gliosarcoma
1668391|NCT00112502|adult glioblastoma|adult glioblastoma
1668392|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
1668393|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
1668394|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
1668395|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
1668396|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
1668397|NCT00112424|Glenn operation|glenn operation
1668398|NCT00112424|Congenital heart defects|congenital heart defects
1668399|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
1668400|NCT00112398|Head injuries|head injuries
1668401|NCT00112398|Prehospital|prehospital
1668402|NCT00112398|Advanced Interventions|advanced interventions
1668403|NCT00112385|dermatomyositis|dermatomyositis
1668404|NCT00112385|etanercept|etanercept
1668405|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
1668406|NCT00112372|unresectable|unresectable
1668407|NCT00112372|metastatic|metastatic
1668408|NCT00112372|cancer|cancer
1668409|NCT00112372|recurrent|recurrent
1668410|NCT00112372|malignancies|malignancies
1668411|NCT00112372|progressive|progressive
1668412|NCT00112359|Cystic Fibrosis|cystic fibrosis
1668413|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
1668414|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1668415|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
1668416|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
1668417|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
1668418|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
1668419|NCT00112320|Heart Diseases|heart diseases
1668421|NCT00112307|Brachytherapy|brachytherapy
1668422|NCT00112307|Carcinoma|carcinoma
1668423|NCT00112307|Cervix|cervix
1668424|NCT00112307|Uterus|uterus
1668425|NCT00112307|Vagina|vagina
1668426|NCT00112307|Vulva|vulva
1668427|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
1668428|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
1668429|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
1668430|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
1668431|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
1668432|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
1668433|NCT00112268|randomized controlled trial|randomized controlled trial
1668434|NCT00112268|primary health care|primary health care
1668435|NCT00112268|smoking cessation|smoking cessation
1668436|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
1668437|NCT00112255|Chlamydia infections|chlamydia infections
1668438|NCT00112255|Randomized controlled trials|randomized controlled trials
1668439|NCT00112255|Contact tracing|contact tracing
1668545|NCT00111930|DHEAS|dheas
1668441|NCT00112242|Immunotherapy|immunotherapy
1668442|NCT00112242|Vaccination|vaccination
1668443|NCT00112242|Melanoma|melanoma
1668444|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
1668445|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
1668446|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
1668447|NCT00112242|Montanide|montanide
1668448|NCT00112229|Immunotherapy|immunotherapy
1668449|NCT00112229|Vaccination|vaccination
1668450|NCT00112229|Melanoma|melanoma
1668451|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
1668452|NCT00112229|Tyrosinase peptide|tyrosinase peptide
1668453|NCT00112229|CpG|cpg
1668454|NCT00112229|Montanide|montanide
1668455|NCT00112216|Immunotherapy|immunotherapy
1668456|NCT00112216|Vaccination|vaccination
1668457|NCT00112216|Melanoma|melanoma
1668458|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
1668459|NCT00112216|Flu peptide|flu peptide
1668460|NCT00112216|Mage-A10 peptide|mage-a10 peptide
1668461|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
1668462|NCT00112216|Montanide adjuvant|montanide adjuvant
1668463|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
1668464|NCT00112203|Fullness|fullness
1668467|NCT00112203|Functional dyspepsia|functional dyspepsia
1668468|NCT00112190|Functional dyspepsia|functional dyspepsia
1668469|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
1668470|NCT00112190|Fullness|fullness
1668471|NCT00112190|Bloating|bloating
1668472|NCT00112190|Indigestion|indigestion
1668473|NCT00112177|Functional dyspepsia|functional dyspepsia
1668474|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
1668475|NCT00112177|Fullness|fullness
1668476|NCT00112177|Bloating|bloating
1668477|NCT00112177|Indigestion|indigestion
1668478|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
1668479|NCT00112151|andropause|andropause
1668480|NCT00112151|hypogonadism|hypogonadism
1668481|NCT00112151|AndroGel|androgel
1668482|NCT00112151|exercise|exercise
1668483|NCT00112151|PRT|prt
1668484|NCT00112151|Testosterone|testosterone
1668485|NCT00112151|T supplementation|t supplementation
1668486|NCT00112138|gabapentin|gabapentin
1668487|NCT00112138|hot flashes or flushes|hot flashes or flushes
1668488|NCT00112138|menopause|menopause
1668489|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
1668490|NCT00112125|heart failure|heart failure
1668491|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
1668492|NCT00112125|chronic heart disease|chronic heart disease
1668493|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
1668494|NCT00112099|gastric neoplasm|gastric neoplasm
1668495|NCT00112099|gastrectomy|gastrectomy
1668496|NCT00112099|splenectomy|splenectomy
1668497|NCT00112099|randomized trial|randomized trial
1668498|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
1668499|NCT00112086|ovarian neoplasms|ovarian neoplasms
1668500|NCT00112086|laparoscopy|laparoscopy
1668501|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
1668502|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
1668503|NCT00112073|Alzheimer's disease|alzheimer's disease
1668504|NCT00112073|immunotherapy|immunotherapy
1668505|NCT00112073|beta amyloid|beta amyloid
1668506|NCT00112060|Talotrexin|talotrexin
1668507|NCT00112060|PT-523|pt-523
1668508|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
1668509|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
1668510|NCT00112034|Multiple Sclerosis|multiple sclerosis
1668511|NCT00112034|Relapsing-Remitting|relapsing-remitting
1668512|NCT00112034|AVONEX|avonex
1668513|NCT00112034|Combination|combination
1668514|NCT00112034|Methotrexate|methotrexate
1668515|NCT00112034|IV Methylprednisolone|iv methylprednisolone
1668516|NCT00112034|IVMP|ivmp
1668517|NCT00112034|ACT|act
1668518|NCT00112034|MTX|mtx
1668519|NCT00112021|obesity|obesity
1668520|NCT00112021|weight loss|weight loss
1668521|NCT00112021|Amylin|amylin
1668522|NCT00112021|pramlintide|pramlintide
1668523|NCT00112021|Symlin|symlin
1668524|NCT00112008|Anemia|anemia
1668525|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
1668526|NCT00111995|Anemia|anemia
1668527|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
1668528|NCT00111969|Heart failure|heart failure
1668529|NCT00111969|Immune modulation therapy|immune modulation therapy
1668530|NCT00111969|Inflammation|inflammation
1668531|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
1668532|NCT00111956|TNF|tnf
1668533|NCT00111956|metabolic syndrome|metabolic syndrome
1668534|NCT00111956|inflammation|inflammation
1668535|NCT00111956|CRP|crp
1668536|NCT00111956|adiponectin|adiponectin
1668537|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
1668538|NCT00111943|HIV Seronegativity|hiv seronegativity
1668539|NCT00111943|Tenofovir|tenofovir
1668540|NCT00111943|Vaginal gel|vaginal gel
1668541|NCT00111943|Microbicide|microbicide
1668542|NCT00111943|Vaginal Microbicide|vaginal microbicide
1668543|NCT00111943|PMPA|pmpa
1668544|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
1668546|NCT00111930|bone mineral density|bone mineral density
1668547|NCT00111930|body composition|body composition
1668548|NCT00111930|lean mass|lean mass
1668549|NCT00111930|fat mass|fat mass
1668550|NCT00111930|bone mass|bone mass
1668551|NCT00111930|decreased DHEAS levels|decreased dheas levels
1668552|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
1668553|NCT00111917|Berylliosis|berylliosis
1668554|NCT00111917|Beryllium Disease|beryllium disease
1668555|NCT00111917|CBD|cbd
1668556|NCT00111917|Infliximab|infliximab
1668557|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
1668558|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
1668559|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
1668560|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
1668561|NCT00111865|physical exercise|physical exercise
1668562|NCT00111865|quality of life|quality of life
1668563|NCT00111865|lymphoma|lymphoma
1668564|NCT00111852|Desmoteplase|desmoteplase
1668565|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
1668566|NCT00111852|Stroke, Acute|stroke, acute
1668567|NCT00111839|Lung cancer|lung cancer
1668568|NCT00111826|Intermittent Claudication|intermittent claudication
1668569|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
1668570|NCT00111826|Immune modulation therapy|immune modulation therapy
1668571|NCT00111826|Inflammation|inflammation
1668572|NCT00111800|NIDDM|niddm
1668573|NCT00111787|breast cancer|breast cancer
1668574|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
1668575|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
1668576|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
1668577|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
1668578|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
1668579|NCT00111774|Metastatic Colorectal|metastatic colorectal
1668580|NCT00111761|Immunex|immunex
1668581|NCT00111761|Panitumumab|panitumumab
1668582|NCT00111761|ABX-EGF|abx-egf
1668583|NCT00111761|Abgenix|abgenix
1668584|NCT00111748|Myeloma|myeloma
1668585|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
1668586|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
1668587|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
1668588|NCT00111657|Gout|gout
1668589|NCT00111657|Tophi|tophi
1668590|NCT00111657|Tophaceous gout|tophaceous gout
1668591|NCT00111657|Allergy to allopurinol|allergy to allopurinol
1668592|NCT00111657|Post-transplant gout|post-transplant gout
1668593|NCT00111618|vascular disrupting agent|vascular disrupting agent
1668594|NCT00111618|safety|safety
1668595|NCT00111618|tolerability|tolerability
1668596|NCT00111618|efficacy|efficacy
1668597|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
1668598|NCT00111605|AIDS Vaccines|aids vaccines
1668599|NCT00111605|HIV Vaccines|hiv vaccines
1668600|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
1668601|NCT00111605|HIV Seronegativity|hiv seronegativity
1668602|NCT00111592|BPH|bph
1668603|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
1668604|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
1668605|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
1668606|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
1668607|NCT00111553|Leishmaniasis|leishmaniasis
1668608|NCT00111553|Subunit vaccine|subunit vaccine
1668609|NCT00111553|Therapeutic|therapeutic
1668610|NCT00111553|T cell|t cell
1668611|NCT00111553|Antimony|antimony
1668612|NCT00111540|exenatide|exenatide
1668613|NCT00111540|diabetes|diabetes
1668614|NCT00111540|Amylin|amylin
1668615|NCT00111540|exendin-4|exendin-4
1668616|NCT00111527|Heart failure|heart failure
1668617|NCT00111527|Atrial fibrillation|atrial fibrillation
1668618|NCT00111527|Cardiac resynchronization|cardiac resynchronization
1668619|NCT00111527|Cardiac pacing|cardiac pacing
1668620|NCT00111527|Catheter ablation|catheter ablation
1668621|NCT00111527|Quality of life|quality of life
1668622|NCT00111527|Echocardiography|echocardiography
1668623|NCT00111514|Leishmaniasis|leishmaniasis
1668624|NCT00111514|Subunit vaccine|subunit vaccine
1668625|NCT00111514|therapeutic|therapeutic
1668626|NCT00111514|T-cell|t-cell
1668627|NCT00111514|pentavalent antimony|pentavalent antimony
1668628|NCT00111501|smoking|smoking
1668629|NCT00111501|tobacco|tobacco
1668630|NCT00111488|atrial fibrillation|atrial fibrillation
1668631|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1668632|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
1668633|NCT00111475|Thrombocytopenic|thrombocytopenic
1668634|NCT00111475|Thrombocytopenia|thrombocytopenia
1668635|NCT00111475|ITP|itp
1668636|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
1668637|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
1668638|NCT00111449|Psoriasis, adults|psoriasis, adults
1668639|NCT00111449|skin, Phase 3|skin, phase 3
1668640|NCT00111449|clinical trial, Amgen|clinical trial, amgen
1668641|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
1668747|NCT00111163|infants|infants
1668642|NCT00111449|moderate, severe|moderate, severe
1668643|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
1668644|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
1668645|NCT00111436|Amgen, etanercept|amgen, etanercept
1668646|NCT00111436|Enbrel®, moderate|enbrel®, moderate
1668647|NCT00111436|severe, extension|severe, extension
1668648|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
1668649|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
1668650|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
1668651|NCT00111423|Clinical Trials|clinical trials
1668652|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
1668653|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
1668654|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
1668655|NCT00111410|Anakinra, Immunex|anakinra, immunex
1668656|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
1668657|NCT00111397|Mycobacterial|mycobacterial
1668658|NCT00111397|Interferon|interferon
1668659|NCT00111397|GM-CSF|gm-csf
1668662|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
1668663|NCT00111397|MAC|mac
1668664|NCT00111384|Phenotype|phenotype
1668665|NCT00111384|NF1-associated tumors|nf1-associated tumors
1668666|NCT00111384|NF1|nf1
1668667|NCT00111384|EQTL|eqtl
1668668|NCT00111384|Modifier Genes|modifier genes
1668669|NCT00111384|Neurofibroma|neurofibroma
1668670|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
1668671|NCT00111371|artificial grammar learning|artificial grammar learning
1668672|NCT00111371|dyslexia|dyslexia
1668673|NCT00111371|healthy subjects|healthy subjects
1668674|NCT00111371|levodopa|levodopa
1668675|NCT00111371|drug|drug
1668676|NCT00111371|treatment|treatment
1668677|NCT00111371|intervention|intervention
1668678|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
1668679|NCT00111345|Acute|acute
1668680|NCT00111345|myeloid|myeloid
1668681|NCT00111345|leukemia|leukemia
1668682|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
1668683|NCT00111319|Front Line|front line
1668684|NCT00111319|Multiple Myeloma|multiple myeloma
1668685|NCT00111319|Untreated|untreated
1668686|NCT00111306|Lupus|lupus
1668687|NCT00111306|Antibody|antibody
1668688|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
1668689|NCT00111293|Attention|attention
1668690|NCT00111293|Executive Function|executive function
1668691|NCT00111293|Vision|vision
1668692|NCT00111293|fMRI|fmri
1668693|NCT00111293|Top-Down|top-down
1668694|NCT00111293|Visual Processing|visual processing
1668695|NCT00111293|Lesion|lesion
1668696|NCT00111293|Prefrontal|prefrontal
1668697|NCT00111293|Parietal|parietal
1668698|NCT00111293|Focal Brain Lesion|focal brain lesion
1668699|NCT00111293|Healthy Volunteer|healthy volunteer
1668700|NCT00111280|HIV infection|hiv infection
1668701|NCT00111280|TMC125|tmc125
1668702|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
1668703|NCT00111280|roll-over trial|roll-over trial
1668704|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
1668705|NCT00111267|vitamin B12|vitamin b12
1668706|NCT00111267|cognitive function|cognitive function
1668707|NCT00111267|oral supplementation|oral supplementation
1668708|NCT00111267|elderly|elderly
1668709|NCT00111254|microdermabrasion|microdermabrasion
1668710|NCT00111254|skin|skin
1668711|NCT00111254|wrinkles|wrinkles
1668712|NCT00111254|collagen|collagen
1668713|NCT00111254|photoaging|photoaging
1668714|NCT00111254|wrinkled skin|wrinkled skin
1668715|NCT00111241|bone fracture|bone fracture
1668716|NCT00111241|cartilage|cartilage
1668717|NCT00111241|osteoporosis|osteoporosis
1668718|NCT00111241|breast cancer|breast cancer
1668719|NCT00111241|aromatase inhibitors|aromatase inhibitors
1668720|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
1668721|NCT00111228|Diabetes|diabetes
1668722|NCT00111215|Menorrhagia|menorrhagia
1668723|NCT00111215|Von Willebrand's Disease|von willebrand's disease
1668724|NCT00111215|Platelet Disorder|platelet disorder
1668725|NCT00111202|Genetic counseling|genetic counseling
1668726|NCT00111202|Genetic counselling|genetic counselling
1668727|NCT00111202|Genetics|genetics
1668728|NCT00111202|Schizophrenia|schizophrenia
1668729|NCT00111189|Schizophrenia|schizophrenia
1668730|NCT00111189|Paliperidone palmitate|paliperidone palmitate
1668731|NCT00111189|R092670|r092670
1668732|NCT00111189|antipsychotic|antipsychotic
1668733|NCT00111189|recurrence prevention|recurrence prevention
1668734|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
1668735|NCT00111176|Descending|descending
1668736|NCT00111176|minimally invasive|minimally invasive
1668737|NCT00111176|endovascular|endovascular
1668738|NCT00111176|rupture|rupture
1668739|NCT00111176|back pain|back pain
1668740|NCT00111176|stent graft|stent graft
1668741|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
1668742|NCT00111176|aortic aneurysm|aortic aneurysm
1668743|NCT00111176|thoracic|thoracic
1668744|NCT00111163|malaria|malaria
1668745|NCT00111163|anemia|anemia
1668746|NCT00111163|Plasmodium falciparum|plasmodium falciparum
1668748|NCT00111163|prevention|prevention
1668749|NCT00111163|safety|safety
1668750|NCT00111163|efficacy|efficacy
1668751|NCT00111163|antimalarials|antimalarials
1668752|NCT00111150|HIV incidence|hiv incidence
1668753|NCT00111150|HIV prevention|hiv prevention
1668754|NCT00111137|darbepoetin alfa|darbepoetin alfa
1668755|NCT00111137|anemia|anemia
1668756|NCT00111137|Amgen|amgen
1668757|NCT00111137|Chemotherapy|chemotherapy
1668758|NCT00111124|psoriasis|psoriasis
1668759|NCT00111124|arthritis|arthritis
1668760|NCT00111124|Enbrel®|enbrel®
1668761|NCT00111124|etanercept|etanercept
1668762|NCT00111111|Psoriasis|psoriasis
1668763|NCT00111098|Anemia|anemia
1668764|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
1668765|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
1668766|NCT00111085|vasospasm|vasospasm
1668767|NCT00111085|clazosentan|clazosentan
1668768|NCT00111085|cerebral vasospasm|cerebral vasospasm
1668769|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
1668770|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
1668771|NCT00111085|endothelin A receptor|endothelin a receptor
1668772|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
1668773|NCT00111059|obesity|obesity
1668774|NCT00111059|cardiovascular disease|cardiovascular disease
1668775|NCT00111059|depression|depression
1668776|NCT00111059|stress|stress
1668777|NCT00111046|Pain Relief|pain relief
1668778|NCT00111046|Choroidal melanoma|choroidal melanoma
1668779|NCT00111046|plaque radiotherapy|plaque radiotherapy
1668780|NCT00110981|psoriasis|psoriasis
1668781|NCT00110981|dermatology|dermatology
1668782|NCT00110981|plaque psoriasis|plaque psoriasis
1668783|NCT00110981|skin|skin
1668784|NCT00110981|etanercept|etanercept
1668785|NCT00110981|ENBREL|enbrel
1668786|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
1668787|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
1668788|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
1668789|NCT00110968|Fullness|fullness
1668790|NCT00110968|Bloating|bloating
1668791|NCT00110968|Indigestion|indigestion
1668792|NCT00110968|Functional dyspepsia|functional dyspepsia
1668793|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
1668794|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
1668795|NCT00110942|Intra-articular|intra-articular
1668796|NCT00110942|Osteoarthritis|osteoarthritis
1668797|NCT00110942|OA|oa
1668798|NCT00110942|anakinra|anakinra
1668799|NCT00110942|Amgen|amgen
1668800|NCT00110929|Sensipar®|sensipar®
1668801|NCT00110929|Secondary HPT|secondary hpt
1668802|NCT00110929|Mimpara®|mimpara®
1668803|NCT00110929|Cinacalcet|cinacalcet
1668804|NCT00110929|calcimimetic|calcimimetic
1668805|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
1668806|NCT00110916|Intra-articular|intra-articular
1668807|NCT00110916|Osteoarthritis|osteoarthritis
1668808|NCT00110916|OA|oa
1668809|NCT00110916|anakinra|anakinra
1668810|NCT00110916|Amgen|amgen
1668811|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
1668812|NCT00110903|RA|ra
1668813|NCT00110903|etanercept|etanercept
1668814|NCT00110903|Immunex|immunex
1668815|NCT00110903|Amgen|amgen
1668816|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
1668817|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
1668818|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
1668819|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
1668820|NCT00111072|Mucosal Disease|mucosal disease
1668821|NCT00111072|Topical Steroids|topical steroids
1668822|NCT00111072|Salivary Diagnostics|salivary diagnostics
1668823|NCT00111072|Oral Pain|oral pain
1668824|NCT00111072|Quality of Life Indicators|quality of life indicators
1668825|NCT00111072|Oral Lichen Planus|oral lichen planus
1668826|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
1668827|NCT00110877|Treatment Experienced|treatment experienced
1668828|NCT00110877|TMC114-C214|tmc114-c214
1668829|NCT00110864|diabetes, type 2|diabetes, type 2
1668830|NCT00110851|diabetes, type 2|diabetes, type 2
1668831|NCT00110838|fish oil|fish oil
1668832|NCT00110838|n-3 fatty acids|n-3 fatty acids
1668833|NCT00110838|n-3 PUFA|n-3 pufa
1668834|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
1668835|NCT00110838|arrhythmia|arrhythmia
1668836|NCT00110838|ICD|icd
1668837|NCT00110838|human|human
1668838|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
1668839|NCT00110812|Treatment Naive|treatment naive
1668840|NCT00110812|IL-2|il-2
1668841|NCT00110812|rIL-2|ril-2
1668842|NCT00110799|thrombopoietin|thrombopoietin
1668843|NCT00110799|platelets|platelets
1668844|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
1668845|NCT00110799|Hepatitis C|hepatitis c
1668846|NCT00110786|Allergy|allergy
1668847|NCT00110786|Specific Immunotherapy|specific immunotherapy
1668848|NCT00110786|Ragweed|ragweed
1668849|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
1668850|NCT00110721|colorectal cancer|colorectal cancer
1668851|NCT00110721|DAVANAT|davanat
1668852|NCT00110721|5-fluorouracil|5-fluorouracil
1668853|NCT00110708|autism|autism
1668854|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
1668855|NCT00110708|autistic disorder|autistic disorder
1668856|NCT00110708|diarrhea|diarrhea
1668857|NCT00110708|constipation|constipation
1668858|NCT00110708|abdominal pain|abdominal pain
1668859|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
1668860|NCT00110708|immune globulin|immune globulin
1668861|NCT00110708|immunoglobulin|immunoglobulin
1668862|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1668863|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
1668864|NCT00110708|Administration, Oral|administration, oral
1668865|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
1668866|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
1669366|NCT00109772|Pain|pain
1668867|NCT00110708|Constipation/drug therapy|constipation/drug therapy
1668868|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
1668869|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
1668870|NCT00110695|NSABP|nsabp
1668871|NCT00110695|Abraxis|abraxis
1668872|NCT00110695|Abraxane|abraxane
1668873|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
1668874|NCT00110695|Fluorouracil|fluorouracil
1668875|NCT00110695|Epirubicin|epirubicin
1668876|NCT00110695|Cyclophosphamide|cyclophosphamide
1668877|NCT00110695|FEC|fec
1668878|NCT00110682|Actinic Keratosis|actinic keratosis
1668879|NCT00110682|Cryotherapy|cryotherapy
1668880|NCT00110682|Imiquimod|imiquimod
1668881|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
1668882|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
1668883|NCT00110656|Kidney transplant|kidney transplant
1668884|NCT00110643|Acne|acne
1668885|NCT00110643|laser|laser
1668886|NCT00110630|nicotine dependence|nicotine dependence
1668887|NCT00110617|Sickle Cell Disease|sickle cell disease
1668888|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
1668889|NCT00110617|Iron Overload|iron overload
1668890|NCT00110617|Blood Transfusions|blood transfusions
1668891|NCT00110604|Folic acid|folic acid
1668892|NCT00110604|Atherosclerosis|atherosclerosis
1668893|NCT00110604|Cognitive function|cognitive function
1668894|NCT00110604|Hearing|hearing
1668895|NCT00110604|Inflammation|inflammation
1668896|NCT00110604|Hemostasis|hemostasis
1668897|NCT00110604|Arterial stiffness|arterial stiffness
1668898|NCT00110578|Treatment Naive|treatment naive
1668899|NCT00110578|Treatment Experienced|treatment experienced
1668900|NCT00110565|Magnetics|magnetics
1668901|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
1668902|NCT00110565|Magnetic Field|magnetic field
1668903|NCT00110565|Electromagnetic Field|electromagnetic field
1668904|NCT00110565|Women|women
1668905|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
1668906|NCT00110539|Medicine, Herbal|medicine, herbal
1668907|NCT00110539|Dietary Supplements|dietary supplements
1668908|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
1668909|NCT00110539|Physicians|physicians
1668910|NCT00110526|Prostate Cancer|prostate cancer
1668911|NCT00110526|Radiation Therapy|radiation therapy
1668912|NCT00110526|Local recurrence|local recurrence
1668913|NCT00110526|Gene Therapy|gene therapy
1668914|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
1668915|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
1668916|NCT00110513|ATIII|atiii
1668917|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
1668918|NCT00110500|Diabetes|diabetes
1668919|NCT00110500|Neuropathy|neuropathy
1668920|NCT00110487|Endometriosis|endometriosis
1668921|NCT00110474|Glucosamine sulfate|glucosamine sulfate
1668922|NCT00110474|Osteoarthritis|osteoarthritis
1668923|NCT00110474|Acetaminophen|acetaminophen
1668924|NCT00110474|Paracetamol|paracetamol
1668925|NCT00110474|Clinical trial|clinical trial
1668926|NCT00110461|Aripiprazole|aripiprazole
1668927|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
1668928|NCT00110448|type 2 diabetes|type 2 diabetes
1668929|NCT00110448|coronary heart diseases|coronary heart diseases
1668930|NCT00110448|primary prevention|primary prevention
1668931|NCT00110448|atherosclerosis|atherosclerosis
1668932|NCT00110448|aspirin|aspirin
1668933|NCT00110422|Metabolic Syndrome|metabolic syndrome
1668934|NCT00110396|Multiple Sclerosis|multiple sclerosis
1668935|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
1668936|NCT00110344|Cancer|cancer
1668937|NCT00110331|Encephalopathy|encephalopathy
1668938|NCT00110331|Neuroimaging|neuroimaging
1668939|NCT00110331|Cognition|cognition
1668940|NCT00110331|Neuroinflammation|neuroinflammation
1668941|NCT00110331|Opportunistic Infections|opportunistic infections
1668942|NCT00110331|HIV|hiv
1668943|NCT00110331|Central Nervous System Disease|central nervous system disease
1668944|NCT00110331|Bipolar Disorder|bipolar disorder
1668945|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1668946|NCT00110331|ADHD|adhd
1668947|NCT00110331|Major Depression|major depression
1668948|NCT00110331|Psychosis|psychosis
1668949|NCT00110318|Tennis Elbow|tennis elbow
1668950|NCT00110318|Physical Therapy Techniques|physical therapy techniques
1668951|NCT00110318|Evidence-Based Medicine|evidence-based medicine
1668952|NCT00110318|Primary Health Care|primary health care
1668953|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
1668954|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
1668955|NCT00110305|Antiretroviral|antiretroviral
1668956|NCT00110305|Antiviral|antiviral
1668957|NCT00110305|ARV|arv
1668958|NCT00110305|TMC278|tmc278
1668959|NCT00110305|Efavirenz|efavirenz
1668960|NCT00110305|Combivir|combivir
1668961|NCT00110305|Truvada|truvada
1668962|NCT00110305|Zidovudine|zidovudine
1668963|NCT00110305|Lamivudine|lamivudine
1669367|NCT00109772|CC-5013|cc-5013
1668964|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1668965|NCT00110305|Emtricitabine|emtricitabine
1668966|NCT00110292|Public health|public health
1668967|NCT00110292|Primary care|primary care
1668968|NCT00110292|Parenting education|parenting education
1668969|NCT00110292|Child rearing|child rearing
1668970|NCT00110292|Parenting newsletters|parenting newsletters
1668971|NCT00110292|Child development|child development
1668972|NCT00110292|Language delay|language delay
1668973|NCT00110279|Bird Flu|bird flu
1668974|NCT00110266|ICL670|icl670
1668975|NCT00110266|Deferasirox|deferasirox
1668976|NCT00110266|Iron chelation|iron chelation
1668977|NCT00110266|Chelator|chelator
1668978|NCT00110266|Desferal|desferal
1668979|NCT00110240|Type 2 diabetes|type 2 diabetes
1668980|NCT00110240|vildagliptin|vildagliptin
1668981|NCT00110227|Complementary Therapies|complementary therapies
1668982|NCT00110227|Tai Chi|tai chi
1668983|NCT00110201|Acute renal failure|acute renal failure
1668984|NCT00110201|Nesiritide|nesiritide
1668985|NCT00110201|Cardiovascular surgery|cardiovascular surgery
1668986|NCT00110188|prostate|prostate
1668987|NCT00110188|cancer|cancer
1668988|NCT00110175|Cortical Reorganization|cortical reorganization
1668989|NCT00110175|Motor Function|motor function
1668990|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
1668991|NCT00110175|Rehabilitation|rehabilitation
1668992|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1668993|NCT00110175|Direct Current Stimulation|direct current stimulation
1668994|NCT00110175|Stroke|stroke
1668995|NCT00110175|Healthy Volunteer|healthy volunteer
1668996|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1668997|NCT00110162|stage I prostate cancer|stage i prostate cancer
1668998|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
1668999|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
1669000|NCT00110162|stage III prostate cancer|stage iii prostate cancer
1669001|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
1669002|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
1669003|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1669004|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1669005|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1669006|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1669007|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1669008|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1669009|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1669010|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1669011|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1669012|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1669013|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1669014|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1669015|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1669016|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1669017|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1669018|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1669019|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1669020|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1669021|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1669022|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1669023|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1669024|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1669025|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1669026|NCT00110136|recurrent breast cancer|recurrent breast cancer
1669027|NCT00110136|stage I breast cancer|stage i breast cancer
1669028|NCT00110136|stage II breast cancer|stage ii breast cancer
1669862|NCT00108134|Topical|topical
1669029|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
1669030|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
1669031|NCT00110136|breast cancer in situ|breast cancer in situ
1669032|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1669033|NCT00110136|hot flashes|hot flashes
1669034|NCT00110123|liver metastases|liver metastases
1669035|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1669036|NCT00110123|iris melanoma|iris melanoma
1669037|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
1669038|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
1669039|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
1669040|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
1669041|NCT00110084|recurrent breast cancer|recurrent breast cancer
1669042|NCT00110084|stage IV breast cancer|stage iv breast cancer
1669043|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1669368|NCT00109772|Revlimid|revlimid
1669044|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1669045|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1669172|NCT00110045|intraocular lymphoma|intraocular lymphoma
1669046|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1669047|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1669048|NCT00110045|infection|infection
1669049|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
1669050|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1669051|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
1669052|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1669053|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1669054|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1669055|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1669056|NCT00110045|primary myelofibrosis|primary myelofibrosis
1669057|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1669058|NCT00110045|essential thrombocythemia|essential thrombocythemia
1669059|NCT00110045|polycythemia vera|polycythemia vera
1669060|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1669061|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1669062|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1669063|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1669064|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1669065|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1669066|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1669067|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1669068|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1669069|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1669070|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1669071|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1669072|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1669073|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1669074|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1669075|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1669076|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1669077|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1669078|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1669079|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1669080|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
1669081|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
1669082|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1669083|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1669084|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1669085|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1669086|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1669087|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1669088|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1669089|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1669090|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1669091|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1669092|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1669093|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1669094|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1669095|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1669096|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1669097|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1669098|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1669099|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1669100|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1669101|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1669102|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1669103|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1669104|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1669105|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1669106|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1669568|NCT00109291|peginesatide|peginesatide
1669107|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1669108|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1669109|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1669110|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1669111|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1669112|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1669113|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1669114|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1669115|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1669116|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1669117|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1669118|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1669119|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1669120|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1669121|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1669122|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1669123|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1669124|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1669125|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1669126|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1669127|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1669128|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1669129|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1669130|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1669131|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1669132|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1669133|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1669134|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1669135|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1669136|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1669137|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1669138|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1669139|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1669140|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1669141|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1669142|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1669143|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1669144|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1669145|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1669146|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1669147|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1669148|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1669149|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1669150|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1669151|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1669152|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1669153|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1669154|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1669155|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1669156|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1669157|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1669158|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1669159|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1669160|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1669161|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1669162|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1669163|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1669164|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1669165|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1669166|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1669167|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1669168|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1669169|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1669170|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1669171|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1669880|NCT00108082|cardiac MRI|cardiac mri
1669173|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1669174|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1669175|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
1669176|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1669177|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1669178|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
1669179|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
1669180|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
1669181|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
1669182|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
1669183|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1669184|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1669185|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1669186|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1669187|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1669188|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1669189|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
1669190|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1669191|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
1669192|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1669193|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1669194|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1669195|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1669196|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1669197|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1669198|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1669199|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1669200|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
1669201|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
1669202|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
1669203|NCT00110045|stage IV breast cancer|stage iv breast cancer
1669204|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1669205|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1669206|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1669207|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1669208|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1669209|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1669210|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1669211|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1669212|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1669213|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1669214|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1669215|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1669216|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1669217|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1669218|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1669219|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1669220|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1669863|NCT00108134|Dermatology|dermatology
1669221|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1669222|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1669223|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1669224|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1669225|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1669226|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1669227|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1669228|NCT00109993|graft versus host disease|graft versus host disease
1669229|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1669230|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1669231|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1669232|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1669233|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1669234|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1669235|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1669298|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1669236|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1669237|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1669238|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1669239|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1669240|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1669241|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1669242|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1669243|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1669244|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1669245|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
1669246|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1669247|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1669248|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1669249|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1669250|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1669251|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1669252|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1669253|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1669254|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1669255|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1669256|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1669257|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1669258|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1669259|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1669260|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1669261|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1669262|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1669263|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1669264|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1669265|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1669266|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1669267|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1669268|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1669269|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1669270|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1669271|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1669272|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1669273|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1669274|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1669275|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1669276|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1669277|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1669278|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1669279|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
1669280|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1669281|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1669282|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1669283|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1669284|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1669285|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
1669286|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
1669287|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1669288|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1669289|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1669290|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1669291|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
1669292|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1669293|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1669294|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1669295|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1669296|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1669297|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1669299|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1669300|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1669301|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1669302|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1669303|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1669304|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1669305|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
1669306|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1669307|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1669308|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1669309|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
1669310|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
1669311|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
1669312|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1669313|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1669314|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1669315|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1669316|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1669317|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1669318|NCT00109993|stage IV breast cancer|stage iv breast cancer
1669319|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1669320|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1669321|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1669322|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1669323|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1669324|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1669325|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1669326|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1669327|NCT00109980|Complementary Therapies|complementary therapies
1669328|NCT00109980|Plants, Medicinal|plants, medicinal
1669329|NCT00109980|Dominican Republic|dominican republic
1669330|NCT00109980|Hispanic Americans|hispanic americans
1669331|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1669332|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
1669333|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1669334|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1669335|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
1669336|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
1669337|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
1669338|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1669339|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1669340|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1669341|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1669342|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1669343|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1669344|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1669345|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1669346|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1669347|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
1669348|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1669349|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1669350|NCT00109863|recurrent melanoma|recurrent melanoma
1669351|NCT00109863|stage IV melanoma|stage iv melanoma
1669352|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1669353|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1669354|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
1669355|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1669356|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1669357|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1669358|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1669359|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1669360|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
1669361|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
1669362|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
1669363|NCT00109785|male breast cancer|male breast cancer
1669365|NCT00109772|RSDS|rsds
1669369|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
1669370|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
1669371|NCT00109772|Lenalidomide|lenalidomide
1669372|NCT00109772|CRPS Type I|crps type i
1669374|NCT00109759|allergy|allergy
1669375|NCT00109759|allergoid|allergoid
1669376|NCT00109759|specific immunotherapy|specific immunotherapy
1669377|NCT00109759|ragweed|ragweed
1669378|NCT00109746|HIV|hiv
1669379|NCT00109746|Treatment Experienced|treatment experienced
1669380|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
1669381|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1669382|NCT00109746|Picolinic acid|picolinic acid
1669383|NCT00109746|Dietary Supplements|dietary supplements
1669384|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
1669385|NCT00109733|Saizen®|saizen®
1669386|NCT00109720|Diabetes|diabetes
1669387|NCT00109720|Self Management|self management
1669388|NCT00109720|Type 2 diabetes|type 2 diabetes
1669389|NCT00109707|CML in blast crisis|cml in blast crisis
1669390|NCT00109707|CML in chronic phase|cml in chronic phase
1669391|NCT00109707|CML in accelerated phase|cml in accelerated phase
1669392|NCT00109707|Gleevec resistance|gleevec resistance
1669393|NCT00109707|Gleevec intolerant|gleevec intolerant
1669394|NCT00109707|Gleevec and CML|gleevec and cml
1669395|NCT00109707|imatinib resistance|imatinib resistance
1669396|NCT00109707|imatinib intolerant|imatinib intolerant
1669397|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1669398|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
1669399|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
1669400|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
1669401|NCT00109707|HES|hes
1669402|NCT00109707|CEL|cel
1669403|NCT00109707|CML|cml
1669404|NCT00109707|SM|sm
1669405|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
1669406|NCT00109707|Ph+ALL relapsed|ph+all relapsed
1669407|NCT00109707|AMN107A|amn107a
1669408|NCT00109681|ACTIVE|active
1669409|NCT00109681|iloprost|iloprost
1669410|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1669411|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
1669412|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
1669413|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
1669414|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
1669415|NCT00109655|Gene Therapy|gene therapy
1669416|NCT00109655|Vaccine|vaccine
1669417|NCT00109655|Adenovirus|adenovirus
1669418|NCT00109655|Carcinoma in situ|carcinoma in situ
1669419|NCT00109642|Amygdala|amygdala
1669420|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
1669421|NCT00109642|Yohimbine|yohimbine
1669422|NCT00109642|Emotion|emotion
1669423|NCT00109642|Guanfacine|guanfacine
1669424|NCT00109642|Norepinephrine|norepinephrine
1669425|NCT00109642|Healthy Volunteer|healthy volunteer
1669426|NCT00109629|HIV-Negative|hiv-negative
1669427|NCT00109629|Healthy|healthy
1669428|NCT00109629|Immunity|immunity
1669429|NCT00109629|Preventive|preventive
1669430|NCT00109629|Virus|virus
1669431|NCT00109629|Healthy Volunteer|healthy volunteer
1669432|NCT00109616|neonatal mortality|neonatal mortality
1669433|NCT00109616|chlorhexidine|chlorhexidine
1669434|NCT00109616|newborn cleansing|newborn cleansing
1669435|NCT00109616|umbilical cord care|umbilical cord care
1669436|NCT00109616|community-based trial|community-based trial
1669437|NCT00109616|prevention trial|prevention trial
1669438|NCT00109616|omphalitis|omphalitis
1669439|NCT00109603|Treatment Experienced|treatment experienced
1669440|NCT00109603|TDF|tdf
1669441|NCT00109590|HIV Seronegativity|hiv seronegativity
1669442|NCT00109590|Treatment Naive|treatment naive
1669443|NCT00109590|Pregnancy|pregnancy
1669444|NCT00109590|Perinatal Transmission|perinatal transmission
1669445|NCT00109590|Vertical Transmission|vertical transmission
1669446|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
1669447|NCT00109590|MTCT|mtct
1669448|NCT00109577|bipolar disorder|bipolar disorder
1669449|NCT00109577|mood disorders|mood disorders
1669450|NCT00109577|manic depression|manic depression
1669451|NCT00109577|nutrition|nutrition
1669452|NCT00109564|AAMI|aami
1669453|NCT00109564|Memory Impairment|memory impairment
1669454|NCT00109564|Decline in Cognitive Function|decline in cognitive function
1669455|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
1669456|NCT00109551|zinc|zinc
1669457|NCT00109551|child mortality|child mortality
1669458|NCT00109551|child morbidity|child morbidity
1669459|NCT00109551|community trial|community trial
1669460|NCT00109551|prevention trial|prevention trial
1669461|NCT00109551|dietary supplement|dietary supplement
1669462|NCT00109538|Lonafarnib|lonafarnib
1669463|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
1669464|NCT00109525|Fungal Infection|fungal infection
1669465|NCT00109525|Mycosis|mycosis
1669466|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1669467|NCT00109525|Prematurity|prematurity
1669468|NCT00109525|Clinical Judgement|clinical judgement
1669469|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
1669470|NCT00109525|Beta-glucan assay|beta-glucan assay
1669471|NCT00109525|Mass Spectrometry|mass spectrometry
1669472|NCT00109525|Lumbar puncture|lumbar puncture
1669473|NCT00109512|endometriosis|endometriosis
1669474|NCT00109512|pelvic pain|pelvic pain
1669475|NCT00109512|painful periods|painful periods
1669476|NCT00109512|dysmenorrhea|dysmenorrhea
1669477|NCT00109512|painful menstruation|painful menstruation
1669478|NCT00109512|GnRH|gnrh
1669479|NCT00109512|agonist|agonist
1669480|NCT00109512|antagonist|antagonist
1669481|NCT00109512|menstrual pain|menstrual pain
1669482|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
1669483|NCT00109499|Age-Related Maculopathies|age-related maculopathies
1669484|NCT00109486|GW685698X|gw685698x
1669485|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
1669486|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
1669487|NCT00109486|knemometry|knemometry
1669488|NCT00109486|children|children
1669489|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
1669490|NCT00109473|Pediatric|pediatric
1669491|NCT00109473|Crohn's Disease|crohn's disease
1669492|NCT00024635|Screening|screening
1669493|NCT00024635|Psychiatric History|psychiatric history
1669494|NCT00024635|Medical History|medical history
1669495|NCT00024635|Diagnostic Evaluation|diagnostic evaluation
1669496|NCT00024635|Natural History|natural history
1669497|NCT00024635|Anxiety|anxiety
1669499|NCT00024635|Healthy Volunteer|healthy volunteer
1669500|NCT00024635|Normal Control|normal control
1669501|NCT00024635|Mood Disorder|mood disorder
1669502|NCT00024635|PTSD|ptsd
1669503|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1669504|NCT00109460|Tobacco|tobacco
1669505|NCT00109434|exercise|exercise
1669506|NCT00109434|hypoglycemia|hypoglycemia
1669507|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
1669508|NCT00109434|glucose monitoring|glucose monitoring
1669509|NCT00109421|adolescent|adolescent
1669510|NCT00109421|female|female
1669511|NCT00109421|community-based|community-based
1669512|NCT00109421|social network|social network
1669513|NCT00109421|HIV/STI intervention|hiv/sti intervention
1669514|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
1669515|NCT00109395|Lorazepam|lorazepam
1669516|NCT00109395|Midazolam|midazolam
1669517|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
1669518|NCT00109395|Critically ill|critically ill
1669519|NCT00109395|pediatrics|pediatrics
1669520|NCT00109395|mechanical ventilation|mechanical ventilation
1669521|NCT00109395|sedation|sedation
1669522|NCT00109382|Transient Ischemic Attack|transient ischemic attack
1669523|NCT00109382|Stroke|stroke
1669524|NCT00109382|Stroke Prevention|stroke prevention
1669525|NCT00109382|Recurrence|recurrence
1669526|NCT00109382|Neuroprotection|neuroprotection
1669527|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
1669528|NCT00109382|Statins|statins
1669529|NCT00109369|Chronic Disease|chronic disease
1669530|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
1669531|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
1669532|NCT00109369|Reminder Systems|reminder systems
1669533|NCT00109369|Registries|registries
1669534|NCT00109369|Quality of Healthcare|quality of healthcare
1669535|NCT00109369|Guideline Adherence|guideline adherence
1669536|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1669537|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
1669538|NCT00109369|Primary Health Care|primary health care
1669539|NCT00109369|Hypercholesterolemia|hypercholesterolemia
1669540|NCT00109369|Hypertension|hypertension
1669541|NCT00109369|Hyperglycemia|hyperglycemia
1669542|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1669543|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1669544|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
1669545|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
1669546|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
1669547|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
1669548|NCT00109317|Topical|topical
1669549|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
1669550|NCT00109304|VEE|vee
1669551|NCT00109304|Vaccine|vaccine
1669552|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
1669553|NCT00109291|anemia|anemia
1669554|NCT00109291|chronic kidney disease|chronic kidney disease
1669555|NCT00109291|CKD|ckd
1669556|NCT00109291|chronic renal failure|chronic renal failure
1669557|NCT00109291|CRF|crf
1669558|NCT00109291|dialysis|dialysis
1669559|NCT00109291|erythropoietin|erythropoietin
1669560|NCT00109291|EPO|epo
1669561|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1669562|NCT00109291|ESA|esa
1669563|NCT00109291|Hematide™|hematide™
1669564|NCT00109291|hemoglobin|hemoglobin
1669565|NCT00109291|Hb|hb
1669566|NCT00109291|Hgb|hgb
1669567|NCT00109291|Omontys|omontys
1669569|NCT00109291|red blood cell|red blood cell
1669570|NCT00109291|red blood cell production|red blood cell production
1669571|NCT00109278|Prevention of Measles|prevention of measles
1669572|NCT00109265|Advanced Breast Cancer|advanced breast cancer
1669573|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
1669574|NCT00109265|Cancer|cancer
1669575|NCT00109252|Plaque Psoriasis|plaque psoriasis
1669576|NCT00109252|Topical|topical
1669577|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
1669578|NCT00109239|Metastatic|metastatic
1669579|NCT00109239|Cancer|cancer
1669580|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
1669581|NCT00109226|Cancer|cancer
1669582|NCT00109213|Spinal Stenosis|spinal stenosis
1669583|NCT00109213|Lumbar Spine|lumbar spine
1669584|NCT00109213|Decompression|decompression
1669585|NCT00109213|Fusion|fusion
1669586|NCT00109213|Spondylolisthesis|spondylolisthesis
1669587|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
1669588|NCT00109200|Allergic Asthma|allergic asthma
1669589|NCT00109200|Severe Allergic Asthma|severe allergic asthma
1669590|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
1669591|NCT00109187|Severe Persistent Asthma|severe persistent asthma
1669592|NCT00109174|Glutamate|glutamate
1669593|NCT00109174|Excitatory Amino Acid|excitatory amino acid
1669594|NCT00109174|Neurochemistry|neurochemistry
1669595|NCT00109174|GABA|gaba
1669596|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1669597|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
1669598|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
1669599|NCT00109083|Migraine|migraine
1669600|NCT00109083|Headaches|headaches
1669601|NCT00109083|Migraine headaches|migraine headaches
1669602|NCT00109083|Head pain|head pain
1669603|NCT00109070|Metastatic|metastatic
1669604|NCT00109057|Cancer|cancer
1669605|NCT00109057|Advanced malignancies|advanced malignancies
1669606|NCT00109044|Depression|depression
1669607|NCT00109044|Major Depressive Disorder|major depressive disorder
1669608|NCT00109044|Escitalopram|escitalopram
1669609|NCT00109031|Cancer|cancer
1669610|NCT00109031|Oncology|oncology
1669611|NCT00109018|Risk Assessment|risk assessment
1669612|NCT00109018|Coronary Heart Disease|coronary heart disease
1669613|NCT00109018|Vascular Function|vascular function
1669614|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
1669615|NCT00109018|Blood Tests|blood tests
1669616|NCT00109018|Nitrite|nitrite
1669617|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
1669618|NCT00109018|Biomarker|biomarker
1669619|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
1669620|NCT00109018|Coronary Artery Disease|coronary artery disease
1669622|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
1669623|NCT00109018|Healthy Volunteer|healthy volunteer
1669624|NCT00109005|Response Rate|response rate
1669625|NCT00109005|Toxicity|toxicity
1669626|NCT00109005|Progression-Free Survival|progression-free survival
1669627|NCT00109005|Overall Survival|overall survival
1669628|NCT00109005|Pharmacokinetic|pharmacokinetic
1669629|NCT00109005|Ocular Melanoma|ocular melanoma
1669630|NCT00108992|topical NSAID|topical nsaid
1669631|NCT00108992|topical diclofenac|topical diclofenac
1669632|NCT00108979|Depression|depression
1669633|NCT00108979|Major Depressive Disorder|major depressive disorder
1669634|NCT00108979|Escitalopram|escitalopram
1669635|NCT00108953|Cancer|cancer
1669636|NCT00108953|Liver Cancer|liver cancer
1669637|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
1669638|NCT00108953|HCC|hcc
1669639|NCT00108940|stroke|stroke
1669640|NCT00108940|ischemic stroke|ischemic stroke
1669641|NCT00108940|siblings|siblings
1669642|NCT00108927|Clinical trial|clinical trial
1669643|NCT00108927|Diabetes|diabetes
1669644|NCT00108927|Quality Improvement|quality improvement
1669645|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
1669646|NCT00108914|pediatric|pediatric
1669647|NCT00108901|prevention|prevention
1669648|NCT00108901|children|children
1669649|NCT00108901|diabetes|diabetes
1669650|NCT00108901|overweight|overweight
1669651|NCT00108901|obesity|obesity
1669652|NCT00108901|metabolic syndrome|metabolic syndrome
1669653|NCT00108901|exercise|exercise
1669654|NCT00108901|insulin resistance|insulin resistance
1669655|NCT00108901|female|female
1669656|NCT00108901|male|male
1669657|NCT00108901|black, African-American|black, african-american
1669658|NCT00108901|white, Caucasian|white, caucasian
1669659|NCT00108901|cognition|cognition
1669660|NCT00108901|executive function|executive function
1669661|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
1669662|NCT00108875|Survivin|survivin
1669663|NCT00108862|Treatment Naive|treatment naive
1669664|NCT00108862|TB|tb
1669665|NCT00108862|HIV|hiv
1669666|NCT00108862|Antiretroviral Agents|antiretroviral agents
1669667|NCT00108862|Strategy Study|strategy study
1669668|NCT00108836|GAD|gad
1669669|NCT00108836|Anxiety|anxiety
1669670|NCT00108836|XBD173|xbd173
1669671|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
1669673|NCT00108810|Osteoarthritis|osteoarthritis
1669675|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
1669676|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
1669677|NCT00108784|fat-restricted diet|fat-restricted diet
1669678|NCT00108784|fruit|fruit
1669679|NCT00108784|vegetables|vegetables
1669680|NCT00108784|ad libitum intake|ad libitum intake
1669681|NCT00108784|weight loss|weight loss
1669682|NCT00108784|obesity|obesity
1669683|NCT00108771|Pain|pain
1669684|NCT00108771|Chronic Pain|chronic pain
1669685|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
1669686|NCT00108771|Osteoarthritis|osteoarthritis
1669687|NCT00108706|Acute Stroke|acute stroke
1669688|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
1669689|NCT00108706|Ischaemic Stroke|ischaemic stroke
1669690|NCT00108706|Candesartan|candesartan
1669691|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
1669692|NCT00108680|Hemiparesis|hemiparesis
1669693|NCT00108680|Rehabilitation|rehabilitation
1669694|NCT00108680|Reaching|reaching
1669695|NCT00108680|Interlimb Coupling|interlimb coupling
1669696|NCT00108680|Cortical Excitability|cortical excitability
1669697|NCT00108680|Stroke|stroke
1669698|NCT00108667|Parkinson's Disease|parkinson's disease
1669699|NCT00108667|AMPA Antagonist|ampa antagonist
1669700|NCT00108667|Dyskinesias|dyskinesias
1669701|NCT00108667|Glutamate Antagonist|glutamate antagonist
1669702|NCT00108667|Parkinson Disease|parkinson disease
1669703|NCT00108667|PD|pd
1669704|NCT00108654|HIV-Negative|hiv-negative
1669705|NCT00108654|Healthy|healthy
1669706|NCT00108654|Immunity|immunity
1669707|NCT00108654|Preventive|preventive
1669708|NCT00108654|Virus|virus
1669709|NCT00108654|Healthy Volunteer|healthy volunteer
1669710|NCT00108628|Imagery|imagery
1669711|NCT00108628|Nightmares|nightmares
1669712|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1669713|NCT00108628|Psychotherapy|psychotherapy
1669714|NCT00108602|sleep apnea|sleep apnea
1669715|NCT00108602|stroke|stroke
1669716|NCT00108602|ventilatory control|ventilatory control
1669717|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
1669718|NCT00108589|fatty liver|fatty liver
1669719|NCT00108589|obesity|obesity
1669720|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
1669721|NCT00108576|anticonvulsant|anticonvulsant
1669722|NCT00108576|anxiety|anxiety
1669723|NCT00108576|divalproex|divalproex
1669724|NCT00108576|PTSD|ptsd
1669725|NCT00108563|Hepatitis C|hepatitis c
1669726|NCT00108563|Depression|depression
1669727|NCT00108563|Interferon-alpha|interferon-alpha
1669728|NCT00108563|Citalopram|citalopram
1669729|NCT00108563|ribavirin|ribavirin
1669730|NCT00108563|antidepressive agents|antidepressive agents
1669731|NCT00108550|analgesia|analgesia
1669732|NCT00108550|antidepressant agents|antidepressant agents
1669733|NCT00108550|back pain|back pain
1669734|NCT00108550|pain|pain
1669735|NCT00108537|smoking|smoking
1669736|NCT00108537|nicotine|nicotine
1669737|NCT00108537|drug therapy|drug therapy
1669738|NCT00108537|smoking cessation|smoking cessation
1669739|NCT00108524|anti-obesity agents|anti-obesity agents
1669740|NCT00108524|diet therapy|diet therapy
1669741|NCT00108524|diet, reducing|diet, reducing
1669742|NCT00108524|obesity|obesity
1669743|NCT00108524|overweight|overweight
1669744|NCT00108524|risk factors|risk factors
1669745|NCT00108524|weight loss|weight loss
1669746|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
1669747|NCT00108511|lipoproteins|lipoproteins
1669748|NCT00108511|triglycerides|triglycerides
1669749|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
1669750|NCT00108498|sleep apnea|sleep apnea
1669751|NCT00108498|mirtazapine|mirtazapine
1669752|NCT00108498|sleep|sleep
1669753|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1669754|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
1669755|NCT00108485|Hyperlipidemia|hyperlipidemia
1669756|NCT00108485|Randomized Controlled Trials|randomized controlled trials
1669757|NCT00108459|Obesity|obesity
1669758|NCT00108459|Type 2 Diabetes|type 2 diabetes
1669759|NCT00108459|Hyperlipidemia|hyperlipidemia
1669760|NCT00108459|Insulin resistance|insulin resistance
1669761|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
1669762|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
1669763|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
1669764|NCT00108446|lidocaine|lidocaine
1669765|NCT00108420|Prazosin|prazosin
1669766|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
1669767|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
1669768|NCT00108407|Alcohol Use Disorders|alcohol use disorders
1669769|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
1669770|NCT00108407|Depression|depression
1669771|NCT00108407|Dual diagnosis|dual diagnosis
1669772|NCT00108407|Dysthymia|dysthymia
1669773|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
1669774|NCT00108407|Substance Use Disorders|substance use disorders
1669775|NCT00108394|Uremia|uremia
1669777|NCT00108394|Clinical Trials|clinical trials
1669778|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
1669779|NCT00108394|adynamic bone disease|adynamic bone disease
1669780|NCT00108394|low bone turnover|low bone turnover
1669781|NCT00108381|chronic back pain|chronic back pain
1669782|NCT00108381|cognitive-behavioral|cognitive-behavioral
1669783|NCT00108381|pain|pain
1669784|NCT00108381|stages of change|stages of change
1669785|NCT00108368|schizophrenia|schizophrenia
1669786|NCT00108368|cognition|cognition
1669787|NCT00108368|antipsychotic medication|antipsychotic medication
1669788|NCT00108368|information processing|information processing
1669789|NCT00108368|social cognition|social cognition
1669790|NCT00108368|Psychotic|psychotic
1669791|NCT00108355|albumin|albumin
1669792|NCT00108355|ascites|ascites
1669793|NCT00108355|paracentesis|paracentesis
1669794|NCT00108342|nicotine|nicotine
1669795|NCT00108342|drug therapy|drug therapy
1669796|NCT00108342|Smoking Cessation|smoking cessation
1669797|NCT00108329|aging|aging
1669798|NCT00108329|exercise|exercise
1669799|NCT00108329|metabolic syndrome|metabolic syndrome
1669800|NCT00108329|insulin resistance|insulin resistance
1669801|NCT00108316|Depressive Disorder|depressive disorder
1669802|NCT00108316|DNA|dna
1669803|NCT00108316|Serotonin|serotonin
1669804|NCT00108303|schizophrenia|schizophrenia
1669805|NCT00108290|Prostate cancer|prostate cancer
1669806|NCT00108290|chemotherapy|chemotherapy
1669807|NCT00108290|hormone therapy|hormone therapy
1669808|NCT00108290|surgery|surgery
1669809|NCT00108290|PSA|psa
1669810|NCT00108290|Gleason score|gleason score
1669811|NCT00108277|Anxiety|anxiety
1669812|NCT00108277|Breathing Training|breathing training
1669813|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
1669814|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
1669815|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
1669816|NCT00108264|Immunotherapy|immunotherapy
1669817|NCT00108264|Active|active
1669818|NCT00108264|Dendritic Cells|dendritic cells
1669819|NCT00108251|controlled clinical trial|controlled clinical trial
1669820|NCT00108251|Diastole|diastole
1669821|NCT00108251|Echocardiography|echocardiography
1669822|NCT00108251|exercise tolerance|exercise tolerance
1669823|NCT00108251|Heart Failure, Congestive|heart failure, congestive
1669824|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
1669825|NCT00108238|endothelial function|endothelial function
1669826|NCT00108238|hormone replacement therapy|hormone replacement therapy
1669827|NCT00108238|coronary flow reserve|coronary flow reserve
1669828|NCT00108238|posmenopausal women|posmenopausal women
1669829|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
1669830|NCT00108225|Cholesterol|cholesterol
1669831|NCT00108225|Creatinine Clearance|creatinine clearance
1669832|NCT00108225|Diabetes|diabetes
1669833|NCT00108225|Glycohemoglobin|glycohemoglobin
1669834|NCT00108225|High Protein Diet|high protein diet
1669835|NCT00108212|Diet|diet
1669836|NCT00108212|triglyceride|triglyceride
1669837|NCT00108212|inflammation|inflammation
1669838|NCT00108212|Genetic polymorphism|genetic polymorphism
1669839|NCT00108199|Schizophrenia|schizophrenia
1669840|NCT00108199|vocational rehabilitation|vocational rehabilitation
1669841|NCT00108199|neuropsychology|neuropsychology
1669842|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
1669843|NCT00108186|lung cancer|lung cancer
1669844|NCT00108186|lymphocytes|lymphocytes
1669845|NCT00108186|non small cell|non small cell
1669846|NCT00108186|therapeutics|therapeutics
1669847|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
1669848|NCT00108173|Nicotine dependence|nicotine dependence
1669849|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
1669850|NCT00108173|cigarette cues|cigarette cues
1669851|NCT00108160|mupirocin|mupirocin
1669852|NCT00108160|prevention and control|prevention and control
1669853|NCT00108160|s. aureus|s. aureus
1669854|NCT00108147|Aged|aged
1669855|NCT00108147|Congestive Heart Failure|congestive heart failure
1669856|NCT00108147|Exercise|exercise
1669857|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
1669858|NCT00108134|basal cell carcinoma|basal cell carcinoma
1669859|NCT00108134|sBCC|sbcc
1669860|NCT00108134|BCC|bcc
1669861|NCT00108134|PEP005|pep005
1669864|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
1669865|NCT00108121|basal cell carcinoma|basal cell carcinoma
1669866|NCT00108121|nBCC|nbcc
1669867|NCT00108121|BCC|bcc
1669868|NCT00108121|PEP005|pep005
1669869|NCT00108121|Topical|topical
1669870|NCT00108121|Dermatology|dermatology
1669871|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
1669872|NCT00108095|emesis|emesis
1669873|NCT00108095|nausea|nausea
1669874|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
1669875|NCT00108095|vomiting|vomiting
1669876|NCT00108095|PONV|ponv
1669877|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
1669878|NCT00108082|echocardiogram|echocardiogram
1669879|NCT00108082|left ventricular mass regression|left ventricular mass regression
1670249|NCT00106782|Stimulation|stimulation
1669881|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
1669882|NCT00108069|Brain|brain
1669883|NCT00108069|Tumor|tumor
1669884|NCT00108069|Malignant|malignant
1669885|NCT00108069|Therapy|therapy
1669886|NCT00108069|Progression|progression
1669887|NCT00108069|Chemotherapy|chemotherapy
1669888|NCT00108069|Antiangiogenesis|antiangiogenesis
1669889|NCT00108069|Radiation|radiation
1669890|NCT00108069|Malignant Brain Tumor|malignant brain tumor
1669891|NCT00108069|Malignant Glioma|malignant glioma
1669892|NCT00108069|Glioma|glioma
1669893|NCT00108056|Brain|brain
1669894|NCT00108056|Tumor|tumor
1669895|NCT00108056|Malignant|malignant
1669896|NCT00108056|Therapy|therapy
1669897|NCT00108056|Progression|progression
1669898|NCT00108056|Malignant Brain Tumor|malignant brain tumor
1669899|NCT00108056|Malignant Glioma|malignant glioma
1669900|NCT00108056|Glioma|glioma
1669901|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
1669902|NCT00108043|Gait|gait
1669903|NCT00108043|Blood pressure|blood pressure
1669904|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
1669905|NCT00108043|Cardiovascular responses|cardiovascular responses
1669906|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
1669907|NCT00108030|PBWST training|pbwst training
1669908|NCT00108030|Strength training|strength training
1669909|NCT00108030|6-min walking endurance|6-min walking endurance
1669910|NCT00108030|Cardiovascular fitness|cardiovascular fitness
1669911|NCT00108030|Psychosocial attributes|psychosocial attributes
1669912|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
1669913|NCT00108004|Diabetes|diabetes
1669914|NCT00108004|Amylin|amylin
1669915|NCT00108004|Symlin|symlin
1669916|NCT00108004|pramlintide acetate|pramlintide acetate
1669917|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
1669918|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
1669919|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
1669920|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
1669921|NCT00107965|Actinic Keratosis|actinic keratosis
1669922|NCT00107965|Solar Keratosis|solar keratosis
1669924|NCT00107965|Sun spots|sun spots
1669925|NCT00107965|PEP005|pep005
1669926|NCT00107965|Topical|topical
1669927|NCT00107965|Dermatology|dermatology
1669928|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
1669929|NCT00107952|MRSA|mrsa
1669930|NCT00107939|bipolar disorder|bipolar disorder
1669931|NCT00107939|manic episode|manic episode
1669932|NCT00107939|treatment|treatment
1669933|NCT00107939|licarbazepine|licarbazepine
1669934|NCT00107926|bipolar disorder|bipolar disorder
1669935|NCT00107926|manic episode|manic episode
1669936|NCT00107926|treatment|treatment
1669937|NCT00107926|licarbazepine|licarbazepine
1669938|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
1669939|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
1669940|NCT00107900|Anticoagulant,|anticoagulant,
1669941|NCT00107900|Venous thromboembolic|venous thromboembolic
1669942|NCT00107887|TST|tst
1669943|NCT00107887|isoniazid|isoniazid
1669944|NCT00107887|HAART|haart
1669945|NCT00107887|Brazil|brazil
1669946|NCT00107887|HIV|hiv
1669947|NCT00107874|Maternal|maternal
1669948|NCT00107874|morbidity|morbidity
1669949|NCT00107874|mortality|mortality
1669950|NCT00107874|pregnancy|pregnancy
1669951|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
1669952|NCT00107874|Cesarean Section|cesarean section
1669953|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
1669954|NCT00107848|Pediatric OSA|pediatric osa
1669955|NCT00107848|CPAP|cpap
1669956|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
1669957|NCT00107835|Pain|pain
1669958|NCT00107822|Pain|pain
1669959|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
1669960|NCT00107809|Excessive sleepiness|excessive sleepiness
1669961|NCT00107809|CPAP|cpap
1669962|NCT00107809|Pediatric OSAHS|pediatric osahs
1669963|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
1669964|NCT00107796|Excessive sleepiness|excessive sleepiness
1669965|NCT00107783|Arthritis|arthritis
1669966|NCT00107783|Homogentisic Acid|homogentisic acid
1669967|NCT00107783|Corneal Damage|corneal damage
1669968|NCT00107783|Tyrosine|tyrosine
1669969|NCT00107783|Alkaptonuria|alkaptonuria
1669970|NCT00107783|Photophobia|photophobia
1669971|NCT00107783|Nitisinone|nitisinone
1669972|NCT00107770|ALS|als
1669973|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
1669974|NCT00107770|open label|open label
1669975|NCT00107770|safety study|safety study
1669976|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
1669977|NCT00107757|pediatric|pediatric
1669978|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
1669979|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
1669980|NCT00107731|Bipolar I Disorder|bipolar i disorder
1669981|NCT00107731|Manic Depressive Disorder|manic depressive disorder
1669982|NCT00107731|Manic Depression|manic depression
1669983|NCT00107718|IL-18|il-18
1669984|NCT00107718|treatment naive|treatment naive
1669985|NCT00107718|Phase 2|phase 2
1669986|NCT00107718|melanoma|melanoma
1669987|NCT00107705|allergy|allergy
1669988|NCT00107705|skin prick test|skin prick test
1669989|NCT00107705|allergoid|allergoid
1669990|NCT00107705|allergenicity|allergenicity
1669991|NCT00107705|specific immunotherapy|specific immunotherapy
1669992|NCT00107692|Child Obesity|child obesity
1669993|NCT00107692|Physical activity|physical activity
1669994|NCT00107692|community intervention study|community intervention study
1669995|NCT00107692|competence|competence
1669996|NCT00107692|diet and nutrition|diet and nutrition
1669997|NCT00107692|Nutrition|nutrition
1669998|NCT00107679|Treatment Experienced|treatment experienced
1670000|NCT00107679|HPV|hpv
1670001|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1670002|NCT00107679|Papillomavirus, Human|papillomavirus, human
1670003|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
1670004|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
1670005|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
1670006|NCT00107666|Oxidative stress|oxidative stress
1670007|NCT00107666|Inflammation|inflammation
1670008|NCT00107666|Endotoxemia|endotoxemia
1670009|NCT00107640|At-risk drinking|at-risk drinking
1670010|NCT00107640|Alcohol education|alcohol education
1670011|NCT00107640|Effectiveness|effectiveness
1670012|NCT00107640|Cost-effectiveness|cost-effectiveness
1670013|NCT00107627|Gynaecological Cancer|gynaecological cancer
1670014|NCT00107627|Surgical Staples|surgical staples
1670015|NCT00107627|Subcuticular Sutures|subcuticular sutures
1670016|NCT00107614|Waldenstrom|waldenstrom
1670017|NCT00107601|Glucose|glucose
1670018|NCT00107601|Glucose Control|glucose control
1670019|NCT00107601|Insulin|insulin
1670020|NCT00107601|Insulin therapy|insulin therapy
1670021|NCT00107601|Critically ill|critically ill
1670022|NCT00107601|Intensive Care|intensive care
1670023|NCT00107588|marijuana dependence|marijuana dependence
1670024|NCT00107588|self-efficacy|self-efficacy
1670025|NCT00107588|coping skills|coping skills
1670026|NCT00107588|attendance|attendance
1670027|NCT00107588|marijuana abstinence|marijuana abstinence
1670028|NCT00107575|tobacco|tobacco
1670029|NCT00107575|alcohol|alcohol
1670030|NCT00107562|risk behavior|risk behavior
1670031|NCT00107562|social networks|social networks
1670032|NCT00107562|behavior|behavior
1670033|NCT00107549|Treatment Experienced|treatment experienced
1670034|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1670035|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1670036|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1670037|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1670038|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1670039|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1670040|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1670041|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1670042|NCT00107510|stage II breast cancer|stage ii breast cancer
1670043|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
1670044|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
1670045|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
1670046|NCT00107510|male breast cancer|male breast cancer
1670047|NCT00107497|stage I breast cancer|stage i breast cancer
1670048|NCT00107497|stage II breast cancer|stage ii breast cancer
1670049|NCT00107484|stage IV breast cancer|stage iv breast cancer
1670050|NCT00107484|stage I breast cancer|stage i breast cancer
1670051|NCT00107484|stage II breast cancer|stage ii breast cancer
1670052|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
1670053|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
1670054|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
1670055|NCT00107484|male breast cancer|male breast cancer
1670056|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1670057|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1671073|NCT00103779|Lymphoma|lymphoma
1670058|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
1670059|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1670060|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1670061|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
1670062|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1670063|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1670064|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1670065|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1670066|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1670067|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1670139|NCT00107159|stage III melanoma|stage iii melanoma
1670068|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1670069|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1670070|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1670071|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
1670072|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
1670073|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
1670074|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
1670075|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1670076|NCT00107419|chondrosarcoma|chondrosarcoma
1670077|NCT00107393|recurrent breast cancer|recurrent breast cancer
1670078|NCT00107393|stage IV breast cancer|stage iv breast cancer
1670079|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1670080|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1670081|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1670082|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1670083|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
1670084|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1670085|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1670086|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1670087|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1670088|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1670089|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1670090|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
1670091|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1670092|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1670093|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1670094|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1670095|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1670096|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1670097|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1670098|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1670099|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1670100|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1670101|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1670102|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1670103|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1670104|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1670105|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
1670106|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
1670107|NCT00107315|recurrent colon cancer|recurrent colon cancer
1670108|NCT00107315|stage IV colon cancer|stage iv colon cancer
1670109|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
1670110|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
1670111|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
1670112|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
1670113|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
1670114|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
1670115|NCT00107289|04-148|04-148
1670116|NCT00107276|stage IV breast cancer|stage iv breast cancer
1670117|NCT00107276|recurrent breast cancer|recurrent breast cancer
1670118|NCT00107263|osteoporosis|osteoporosis
1670119|NCT00107263|stage I breast cancer|stage i breast cancer
1670120|NCT00107263|stage II breast cancer|stage ii breast cancer
1670121|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
1670122|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1670123|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1670124|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1670125|NCT00107250|stage IV colon cancer|stage iv colon cancer
1670126|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
1670127|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1670128|NCT00107237|adult glioblastoma|adult glioblastoma
1670129|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
1670130|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
1670131|NCT00107237|adult gliosarcoma|adult gliosarcoma
1670132|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1670133|NCT00107211|breast cancer in situ|breast cancer in situ
1670134|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1670135|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1670136|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
1670137|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1670138|NCT00107159|recurrent melanoma|recurrent melanoma
1670243|NCT00106795|Lymphocytes|lymphocytes
1670140|NCT00107159|stage IV melanoma|stage iv melanoma
1670141|NCT00107120|Major Depressive Disorder|major depressive disorder
1670142|NCT00107120|Depression|depression
1670143|NCT00107120|Adolescents|adolescents
1670144|NCT00107120|Escitalopram|escitalopram
1670145|NCT00107120|Pediatrics|pediatrics
1670146|NCT00107107|Diabetes|diabetes
1670147|NCT00107107|Amylin|amylin
1670148|NCT00107107|pramlintide|pramlintide
1670149|NCT00107107|Symlin|symlin
1670150|NCT00107094|Breast Cancer|breast cancer
1670151|NCT00107094|Adriamycin|adriamycin
1670152|NCT00107094|Cyclophosphamide|cyclophosphamide
1670153|NCT00107094|Abraxane|abraxane
1670154|NCT00107081|children|children
1670155|NCT00107081|oral antibiotics|oral antibiotics
1670156|NCT00107081|outpatient treatment|outpatient treatment
1670157|NCT00107081|fever and neutropenia|fever and neutropenia
1670158|NCT00107068|Stroke|stroke
1670159|NCT00107068|Exercise|exercise
1670160|NCT00107068|Aerobic|aerobic
1670161|NCT00107068|PRT|prt
1670162|NCT00107068|Walking ability|walking ability
1670163|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
1670164|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
1670165|NCT00107055|Anti-TNF alpha|anti-tnf alpha
1670166|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
1670167|NCT00107042|Hepatitis B|hepatitis b
1670168|NCT00107042|HIV vaccine trial|hiv vaccine trial
1670169|NCT00107029|HIV infection|hiv infection
1670170|NCT00107029|CD8+ T-cells|cd8+ t-cells
1670171|NCT00107029|HIV-1 genotype|hiv-1 genotype
1670172|NCT00107016|Breast Cancer|breast cancer
1670173|NCT00107016|Cancer of the Breast|cancer of the breast
1670174|NCT00107016|Neo-adjuvant|neo-adjuvant
1670175|NCT00107016|Primary breast cancer|primary breast cancer
1670176|NCT00107016|postmenopausal|postmenopausal
1670177|NCT00107016|pre-operative|pre-operative
1670178|NCT00107003|Brain|brain
1670179|NCT00107003|Tumor|tumor
1670180|NCT00107003|Surgery|surgery
1670181|NCT00107003|Therapy|therapy
1670182|NCT00107003|Trial|trial
1670183|NCT00107003|Brain Tumor|brain tumor
1670184|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
1670185|NCT00107003|GBM|gbm
1670186|NCT00107003|Gliosarcoma|gliosarcoma
1670187|NCT00107003|GS|gs
1670188|NCT00106977|Craniosynostosis|craniosynostosis
1670189|NCT00106977|Hearing Loss|hearing loss
1670190|NCT00106977|Genectic Disorders|genectic disorders
1670191|NCT00106977|Muenke Syndrome|muenke syndrome
1670192|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
1670193|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
1670194|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
1670195|NCT00106951|Surveillance|surveillance
1670196|NCT00106951|coronary heart disease|coronary heart disease
1670197|NCT00106951|neighborhood SES|neighborhood ses
1670198|NCT00106938|Carotid stenting|carotid stenting
1670199|NCT00106938|Carotid endarterectomy|carotid endarterectomy
1670200|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
1670201|NCT00106938|Stroke prevention|stroke prevention
1670202|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
1670203|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
1670204|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
1670205|NCT00106925|Whole Body Irradiation|whole body irradiation
1670206|NCT00106925|Leukemic Relapse|leukemic relapse
1670207|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
1670208|NCT00106912|Genetic|genetic
1670209|NCT00106912|Stroke|stroke
1670210|NCT00106912|Heart|heart
1670211|NCT00106912|Lysosomal|lysosomal
1670212|NCT00106912|Glycolipid|glycolipid
1670213|NCT00106912|Fabry Disease|fabry disease
1670214|NCT00106899|neuroimaging|neuroimaging
1670215|NCT00106899|brain metabolism|brain metabolism
1670216|NCT00106899|biomarkers|biomarkers
1670217|NCT00106899|cognition disorder|cognition disorder
1670218|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
1670219|NCT00106886|homocysteine|homocysteine
1670220|NCT00106886|folic acid|folic acid
1670221|NCT00106886|micronutrients|micronutrients
1670222|NCT00106886|multivitamins|multivitamins
1670223|NCT00106886|vitamin supplements|vitamin supplements
1670224|NCT00106860|Anxiety|anxiety
1670225|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
1670226|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
1670227|NCT00106847|psoriasis|psoriasis
1670228|NCT00106847|drug safety|drug safety
1670229|NCT00106847|drug efficacy|drug efficacy
1670230|NCT00106847|maintenance therapy|maintenance therapy
1670231|NCT00106847|induction therapy|induction therapy
1670232|NCT00106847|remicade|remicade
1670233|NCT00106834|Psoriasis|psoriasis
1670234|NCT00106834|Infliximab|infliximab
1670235|NCT00106834|Remicade|remicade
1670236|NCT00106808|Type 2 Diabetes|type 2 diabetes
1670237|NCT00106795|Antiretrovirals|antiretrovirals
1670238|NCT00106795|Adipocytes|adipocytes
1670239|NCT00106795|Skeletal Muscle|skeletal muscle
1670240|NCT00106795|Fatigue|fatigue
1670241|NCT00106795|HIV|hiv
1670242|NCT00106795|AIDS|aids
1670247|NCT00106795|HV|hv
1670248|NCT00106782|Electrical|electrical
1670252|NCT00106782|Focal Hand Dystonia|focal hand dystonia
1670254|NCT00106769|Flavivirus|flavivirus
1670255|NCT00106769|Mosquito|mosquito
1670256|NCT00106769|Immunity|immunity
1670257|NCT00106769|Preventive|preventive
1670258|NCT00106769|Virus|virus
1670259|NCT00106769|West Nile Fever|west nile fever
1670260|NCT00106769|Healthy Volunteer|healthy volunteer
1670261|NCT00106769|HV|hv
1670262|NCT00106756|Exudation|exudation
1670263|NCT00106756|Avascular Retina|avascular retina
1670264|NCT00106756|Retina Fold|retina fold
1670268|NCT00106717|Cancer pain|cancer pain
1670269|NCT00106717|Quality of life|quality of life
1670270|NCT00106717|Narrative medicine|narrative medicine
1670271|NCT00106717|Pain relief|pain relief
1670272|NCT00106691|neoplasia|neoplasia
1670273|NCT00106691|chemoprevention|chemoprevention
1670274|NCT00106691|cancer|cancer
1670275|NCT00106691|premalignant|premalignant
1670276|NCT00106691|precancerous|precancerous
1670277|NCT00106691|Chemoprophylaxis|chemoprophylaxis
1670278|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
1670279|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
1670280|NCT00106678|HIV|hiv
1670281|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
1670282|NCT00106678|HAART|haart
1670283|NCT00106678|Adherence|adherence
1670284|NCT00106678|Barriers|barriers
1670285|NCT00106665|ICU acquired weakness|icu acquired weakness
1670286|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
1670287|NCT00106665|Critical care myopathy|critical care myopathy
1670288|NCT00106652|autism|autism
1670289|NCT00106652|neurodevelopment|neurodevelopment
1670290|NCT00106652|neurotoxicology|neurotoxicology
1670291|NCT00106652|perinatology|perinatology
1670292|NCT00106652|teratology|teratology
1670293|NCT00106639|tofacitinib|tofacitinib
1670294|NCT00106639|CP-690550|cp-690550
1670295|NCT00106639|kidney transplant|kidney transplant
1670296|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
1670297|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
1670298|NCT00106613|Metastatic Cancer|metastatic cancer
1670299|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1670300|NCT00106600|Relapsed|relapsed
1670301|NCT00106600|Refractory|refractory
1670302|NCT00106587|in stent restenosis|in stent restenosis
1670303|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
1670304|NCT00106587|paccocath|paccocath
1670305|NCT00106587|drug eluting balloon|drug eluting balloon
1670306|NCT00106561|spironolactone|spironolactone
1670307|NCT00106561|proteinuria|proteinuria
1670308|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
1670309|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
1670310|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
1670311|NCT00106561|aldosterone|aldosterone
1670312|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
1670313|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
1670314|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
1670315|NCT00106509|C. difficile|c. difficile
1670316|NCT00106509|CDAD|cdad
1670317|NCT00106496|Treatment Effectiveness|treatment effectiveness
1670318|NCT00106496|Treatment Efficacy|treatment efficacy
1670319|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
1670320|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
1670321|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
1670322|NCT00106496|Eczema, Atopic|eczema, atopic
1670323|NCT00106496|Atopic Dermatitis|atopic dermatitis
1670324|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
1670325|NCT00106483|Coronary Disease|coronary disease
1670326|NCT00106483|Heart Diseases|heart diseases
1670327|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1670328|NCT00106431|romidepsin|romidepsin
1670329|NCT00106418|Prostate Cancer|prostate cancer
1670330|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
1670331|NCT00106418|romidepsin|romidepsin
1670332|NCT00106405|Bipolar I Disorder|bipolar i disorder
1670333|NCT00106405|Mania|mania
1670334|NCT00106405|Memantine HCl|memantine hcl
1670335|NCT00106392|Treatment effectiveness|treatment effectiveness
1670336|NCT00106392|Treatment efficacy|treatment efficacy
1670337|NCT00106392|Investigational, Therapies|investigational, therapies
1670338|NCT00106392|Immunosuppressant|immunosuppressant
1670339|NCT00106392|Erectile dysfunction|erectile dysfunction
1670340|NCT00106392|Prostatectomy|prostatectomy
1670341|NCT00106379|HIV-1|hiv-1
1670342|NCT00106379|Treatment Naive|treatment naive
1670343|NCT00106379|Treatment Experienced|treatment experienced
1670344|NCT00106366|Diabetes, Type 2|diabetes, type 2
1670345|NCT00106353|Pediatric Tumors|pediatric tumors
1670346|NCT00106340|type 2 diabetes|type 2 diabetes
1670347|NCT00106340|vildagliptin|vildagliptin
1670348|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
1670349|NCT00106314|DHEA|dhea
1670350|NCT00106314|Crohn's disease|crohn's disease
1670351|NCT00106314|C-reactive protein|c-reactive protein
1670352|NCT00106314|CRP|crp
1670353|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
1670354|NCT00106314|CDAI|cdai
1670355|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
1670356|NCT00106314|IBDQ|ibdq
1670357|NCT00106301|FK228|fk228
1670358|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
1670359|NCT00106288|Candidaemia|candidaemia
1670360|NCT00106288|Micafungin|micafungin
1670361|NCT00106275|Fibromyalgia|fibromyalgia
1670362|NCT00106275|Meditation|meditation
1670363|NCT00106275|Stress, Psychological|stress, psychological
1670364|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
1670365|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
1670366|NCT00106275|Psychophysiology|psychophysiology
1670367|NCT00106262|advanced cervical cancer|advanced cervical cancer
1670368|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
1670369|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
1670370|NCT00106236|Exercise|exercise
1670371|NCT00106236|Fitness Club|fitness club
1670372|NCT00106236|Randomized Controlled Trial|randomized controlled trial
1670373|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
1670374|NCT00106236|Overweight|overweight
1670375|NCT00106236|Inactivity|inactivity
1670376|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
1670377|NCT00106223|CBT|cbt
1670378|NCT00106223|BDD|bdd
1670379|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
1670380|NCT00106210|Child|child
1670381|NCT00106197|Sleep, REM|sleep, rem
1670382|NCT00106197|Antidepressant|antidepressant
1670383|NCT00106197|Adolescent|adolescent
1670384|NCT00106197|Cortisol|cortisol
1670385|NCT00106184|rituximab|rituximab
1670386|NCT00106184|myositis|myositis
1670387|NCT00106184|dermatomyositis|dermatomyositis
1670388|NCT00106184|polymyositis|polymyositis
1670389|NCT00106184|refractory|refractory
1670390|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
1670391|NCT00106171|HIV|hiv
1670392|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
1670393|NCT00106171|Acute Infection|acute infection
1670394|NCT00106171|Treatment Naive|treatment naive
1670395|NCT00106171|Primary HIV Infection|primary hiv infection
1670396|NCT00106158|cancer/testis antigen|cancer/testis antigen
1670397|NCT00106158|cancer vaccine|cancer vaccine
1670398|NCT00106158|recombinant protein|recombinant protein
1670399|NCT00106145|Advanced Breast Cancer|advanced breast cancer
1670400|NCT00106145|Solid Tumors|solid tumors
1670401|NCT00106145|Advanced Solid Tumors|advanced solid tumors
1670402|NCT00106132|Macular Edema|macular edema
1670403|NCT00106132|Steroid|steroid
1670404|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
1670405|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
1670406|NCT00106132|Laser|laser
1670407|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
1670408|NCT00106119|Levothyroxine|levothyroxine
1670409|NCT00106119|Liothyronine|liothyronine
1670410|NCT00106119|Lipid Metabolism|lipid metabolism
1670411|NCT00106119|Gluconeogensis|gluconeogensis
1670412|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
1670413|NCT00106119|Deiodinase|deiodinase
1670414|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
1670415|NCT00106119|Thyroidectomy|thyroidectomy
1670416|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
1670417|NCT00106106|Alcoholism|alcoholism
1670418|NCT00106106|Acamprosate|acamprosate
1670419|NCT00106106|Withdrawal|withdrawal
1670420|NCT00106106|Glutamate|glutamate
1670421|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1670422|NCT00106106|Alcohol Dependence|alcohol dependence
1670423|NCT00106106|Healthy Volunteer|healthy volunteer
1670424|NCT00106106|HV|hv
1670425|NCT00106093|Alcohol|alcohol
1670426|NCT00106093|Alcohol Treatment|alcohol treatment
1670427|NCT00106093|DNA|dna
1670428|NCT00106093|Treatment|treatment
1670429|NCT00106093|Alcohol Dependence|alcohol dependence
1670430|NCT00106093|Alcoholism|alcoholism
1670431|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
1670432|NCT00106080|Communication|communication
1670433|NCT00106080|Palliative Care|palliative care
1670434|NCT00106067|aging|aging
1670435|NCT00106067|behavioral research|behavioral research
1670436|NCT00106067|quality of life|quality of life
1670437|NCT00106067|end of life|end of life
1670438|NCT00106067|family relations|family relations
1670439|NCT00106067|supportive care|supportive care
1670440|NCT00106067|advanced care|advanced care
1670441|NCT00106067|bereavement|bereavement
1670442|NCT00106041|end of life care|end of life care
1670443|NCT00106041|evaluation studies|evaluation studies
1670444|NCT00106041|quality of death and dying|quality of death and dying
1670445|NCT00106041|palliative care|palliative care
1670446|NCT00106041|coordination of care|coordination of care
1670447|NCT00106041|satisfaction with care|satisfaction with care
1670448|NCT00106041|healthcare cost|healthcare cost
1670449|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
1670450|NCT00106041|caregivers|caregivers
1670451|NCT00106041|veterans|veterans
1670551|NCT00105495|Chelation|chelation
1670452|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
1670453|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
1670454|NCT00105963|abuse|abuse
1670455|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
1670456|NCT00105950|ErbB1 expressing|erbb1 expressing
1670457|NCT00105950|relapsed breast cancer|relapsed breast cancer
1670458|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
1670459|NCT00105937|Cancer|cancer
1670460|NCT00105937|Pain|pain
1670461|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
1670462|NCT00105898|Diabetes mellitus|diabetes mellitus
1670463|NCT00105898|Hypertension|hypertension
1670464|NCT00105898|Telemedicine|telemedicine
1670465|NCT00105898|Case management|case management
1670466|NCT00105885|Telephone|telephone
1670467|NCT00105885|Telemedicine|telemedicine
1670468|NCT00105885|Psychopharmacology|psychopharmacology
1670469|NCT00105872|insomnia|insomnia
1670470|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
1670471|NCT00105820|Evaluation|evaluation
1670472|NCT00105820|Quality improvement|quality improvement
1670473|NCT00105820|Cluster randomized trial|cluster randomized trial
1670474|NCT00105820|Care model|care model
1670475|NCT00105820|Collaborative care|collaborative care
1670476|NCT00105820|Informatics|informatics
1670477|NCT00105794|advance directives|advance directives
1670478|NCT00105794|advance directive adherence|advance directive adherence
1670479|NCT00105794|patient-centered care|patient-centered care
1670480|NCT00105794|patient satisfaction|patient satisfaction
1670481|NCT00105794|coercion|coercion
1670482|NCT00105794|informed consent|informed consent
1670483|NCT00105794|commitment of mentally ill|commitment of mentally ill
1670484|NCT00105794|physician-patient relations|physician-patient relations
1670485|NCT00105781|Nurses|nurses
1670486|NCT00105781|Telephone|telephone
1670487|NCT00105781|Counseling|counseling
1670488|NCT00105781|Exercise|exercise
1670489|NCT00105755|Activity Cycles|activity cycles
1670490|NCT00105755|Amputation|amputation
1670491|NCT00105755|Prevention|prevention
1670492|NCT00105755|Temperature|temperature
1670493|NCT00105729|Self-help groups|self-help groups
1670494|NCT00105729|Referral and consultation|referral and consultation
1670495|NCT00105716|hypertension|hypertension
1670496|NCT00105716|adherence|adherence
1670497|NCT00105716|cardiovascular diseases|cardiovascular diseases
1670498|NCT00105703|Nurse practitioners|nurse practitioners
1670499|NCT00105703|Case management|case management
1670500|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
1670501|NCT00105677|Attitudes|attitudes
1670502|NCT00105677|Osteoarthritis Management|osteoarthritis management
1670503|NCT00105677|Patient Perceptions|patient perceptions
1670504|NCT00105664|Outcomes Assessment|outcomes assessment
1670505|NCT00105664|Primary Health Care|primary health care
1670506|NCT00105664|Group Process|group process
1670507|NCT00105638|Intervention studies|intervention studies
1670508|NCT00105638|Health Care Costs|health care costs
1670509|NCT00105638|Telephone|telephone
1670510|NCT00105638|Caregivers|caregivers
1670511|NCT00105625|Geriatrics|geriatrics
1670512|NCT00105625|Nutrition|nutrition
1670513|NCT00105625|Immune function|immune function
1670514|NCT00105625|Infection|infection
1670515|NCT00105625|Rehabilitation|rehabilitation
1670516|NCT00105625|Inpatient|inpatient
1670517|NCT00105612|Informed Consent|informed consent
1670518|NCT00105612|Memory Aid|memory aid
1670519|NCT00105586|Anxiety|anxiety
1670520|NCT00105586|Elderly|elderly
1670521|NCT00105586|Aged|aged
1670522|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
1670523|NCT00105586|SSRI|ssri
1670524|NCT00105586|SERT|sert
1670525|NCT00105573|Mother-Child Relations|mother-child relations
1670526|NCT00105573|Infant|infant
1670527|NCT00105573|Child Development|child development
1670528|NCT00105573|Poverty|poverty
1670529|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1670530|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1670531|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1670532|NCT00105547|Alzheimer's|alzheimer's
1670533|NCT00105547|Dementia|dementia
1670534|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
1670535|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
1670536|NCT00105534|Pink Eye|pink eye
1670537|NCT00105534|Conjunctivitis|conjunctivitis
1670538|NCT00105534|Eye Infection|eye infection
1670539|NCT00105534|Eye Discharge|eye discharge
1670540|NCT00105521|Parkinson's Disease|parkinson's disease
1670541|NCT00105521|Dyskinesia|dyskinesia
1670542|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
1670543|NCT00105508|Parkinson's Disease|parkinson's disease
1670544|NCT00105508|Dyskinesia|dyskinesia
1670545|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
1670546|NCT00105495|Iron Overload|iron overload
1670547|NCT00105495|Thalassemia|thalassemia
1670548|NCT00105495|Haemosiderosis|haemosiderosis
1670549|NCT00105495|Cardiac|cardiac
1670550|NCT00105495|Deferiprone|deferiprone
1670555|NCT00105482|Weight perception|weight perception
1670556|NCT00105482|Naltrexone|naltrexone
1670557|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
1670558|NCT00105469|Pink Eye|pink eye
1670559|NCT00105469|Conjunctivitis|conjunctivitis
1670560|NCT00105469|Eye Infection|eye infection
1670561|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
1670562|NCT00105456|HER2|her2
1670563|NCT00105443|Liver Cancer|liver cancer
1670564|NCT00105443|Cancer|cancer
1670565|NCT00105430|Surgery|surgery
1670566|NCT00105430|Treatment|treatment
1670567|NCT00105430|Physiology|physiology
1670568|NCT00105430|Pediatric|pediatric
1670569|NCT00105430|Neurosurgery|neurosurgery
1670570|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
1670571|NCT00105417|Immune Reconstitution|immune reconstitution
1670572|NCT00105417|Thymus|thymus
1670573|NCT00105417|Cytokines|cytokines
1670574|NCT00105417|HIV|hiv
1670575|NCT00105404|Steroid|steroid
1670576|NCT00105404|Diabetic Macular Edema|diabetic macular edema
1670577|NCT00105404|DME|dme
1670578|NCT00105378|health care services research|health care services research
1670579|NCT00105378|frail elderly|frail elderly
1670580|NCT00105378|intermediate care|intermediate care
1670581|NCT00105378|patient centered care|patient centered care
1670582|NCT00105378|comprehensive health care|comprehensive health care
1670583|NCT00105378|geriatric nursing|geriatric nursing
1670584|NCT00105378|Behavioral symptoms|behavioral symptoms
1670585|NCT00105365|lateral wedge inserts|lateral wedge inserts
1670586|NCT00105365|shoe inserts|shoe inserts
1670587|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
1670588|NCT00105352|TrialNet|trialnet
1670589|NCT00105352|type 1 diabetes|type 1 diabetes
1670590|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
1670591|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
1670592|NCT00105339|Simplified consent form|simplified consent form
1670593|NCT00105326|Schizophrenia|schizophrenia
1670594|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
1670595|NCT00105326|insomnia|insomnia
1670596|NCT00105326|paliperidone|paliperidone
1670597|NCT00105326|placebo|placebo
1670598|NCT00105326|polysomnography|polysomnography
1670599|NCT00105287|cancer|cancer
1670600|NCT00105287|pain|pain
1670601|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
1670602|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
1670603|NCT00105274|Susceptibility Genes|susceptibility genes
1670604|NCT00105274|Neuroimaging|neuroimaging
1670605|NCT00105274|22q11.2|22q11.2
1670606|NCT00105274|Psychosis|psychosis
1670607|NCT00105274|Mircodeletion|mircodeletion
1670608|NCT00105274|DiGeorge Syndrome|digeorge syndrome
1670609|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
1670610|NCT00105248|acute repiratory infections|acute repiratory infections
1670611|NCT00105248|antibiotic therapy|antibiotic therapy
1670612|NCT00105248|patient-centred communication|patient-centred communication
1670613|NCT00105248|randomized controlled trial|randomized controlled trial
1670614|NCT00105235|transplantation|transplantation
1670615|NCT00105235|liver transplant|liver transplant
1670616|NCT00105235|rejection|rejection
1670617|NCT00105235|tolerance|tolerance
1670618|NCT00105235|antibody induction|antibody induction
1670619|NCT00105222|Cycle Ergometer|cycle ergometer
1670620|NCT00105222|Exercise Physiology|exercise physiology
1670621|NCT00105222|Nitric Oxide|nitric oxide
1670622|NCT00105222|Sodium Nitrite|sodium nitrite
1670623|NCT00105222|Healthy Volunteers|healthy volunteers
1670624|NCT00105222|Normal Volunteer|normal volunteer
1670625|NCT00105222|Healthy Volunteer|healthy volunteer
1670626|NCT00105222|HV|hv
1670627|NCT00105209|Platelets|platelets
1670628|NCT00105196|Single or recurrent|single or recurrent
1670629|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
1670630|NCT00105183|pulmonary transplantation|pulmonary transplantation
1670631|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
1670632|NCT00105170|Monoclonal antibody|monoclonal antibody
1670633|NCT00105170|Advanced solid tumors|advanced solid tumors
1670634|NCT00105170|Tumors|tumors
1670635|NCT00105170|hCBE-11|hcbe-11
1670636|NCT00105144|Treatment Effectiveness|treatment effectiveness
1670637|NCT00105144|Treatment Efficacy|treatment efficacy
1671074|NCT00103766|Alteplase|alteplase
1670638|NCT00105144|Investigational, Therapies|investigational, therapies
1670639|NCT00105144|Antifungal, Systemic|antifungal, systemic
1670640|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
1670641|NCT00105144|Micafungin|micafungin
1670642|NCT00105131|Parkinson's Disease|parkinson's disease
1670877|NCT00104533|Pain|pain
1670643|NCT00105131|Movement Disorders|movement disorders
1670644|NCT00105131|Tremor|tremor
1670645|NCT00105131|Alpha-Synuclein|alpha-synuclein
1670646|NCT00105131|Lewy Bodies|lewy bodies
1670647|NCT00105131|Parkinson Disease|parkinson disease
1670648|NCT00105131|PD|pd
1670649|NCT00105131|Movement Disorder|movement disorder
1670650|NCT00105131|Healthy Volunteer|healthy volunteer
1670651|NCT00105131|HV|hv
1670652|NCT00105118|Cognition|cognition
1670653|NCT00105118|Alpha|alpha
1670654|NCT00105118|Schizophrenia|schizophrenia
1671360|NCT00102609|Yondelis|yondelis
1670655|NCT00105118|Functional Connectivity|functional connectivity
1670656|NCT00105118|Oscillatory Potential|oscillatory potential
1670657|NCT00105105|Alzheimers|alzheimers
1670658|NCT00105105|cognition|cognition
1670659|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
1670660|NCT00105105|GR-II antagonist|gr-ii antagonist
1670661|NCT00105066|Metabolic Syndrome|metabolic syndrome
1670662|NCT00105066|triglycerides|triglycerides
1670664|NCT00105066|LDL|ldl
1670665|NCT00105066|High Blood Pressure|high blood pressure
1670666|NCT00105066|High Cholesterol|high cholesterol
1670667|NCT00105066|High Blood Sugar|high blood sugar
1670668|NCT00105040|Partial onset seizures|partial onset seizures
1670669|NCT00105040|epilepsy|epilepsy
1670670|NCT00105040|levetiracetam|levetiracetam
1670671|NCT00105040|Keppra|keppra
1670672|NCT00105040|cognition|cognition
1670673|NCT00105040|behavior|behavior
1670674|NCT00105040|pediatry|pediatry
1670675|NCT00105027|macular edema|macular edema
1670676|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
1670677|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
1670678|NCT00104988|stage IV melanoma|stage iv melanoma
1670679|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1670680|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1670681|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1670682|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1670683|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1670684|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1670685|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1670686|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1670687|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
1670688|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1670689|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1670690|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1670691|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1670692|NCT00104975|primary myelofibrosis|primary myelofibrosis
1670693|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1670694|NCT00104975|essential thrombocythemia|essential thrombocythemia
1670695|NCT00104975|polycythemia vera|polycythemia vera
1670696|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1670697|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1670698|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1670699|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1670700|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1670701|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1670702|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1670703|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1670704|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1670705|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1670706|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1670707|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1670708|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1670709|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1670710|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1670711|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1670712|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1670713|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
1670714|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1670715|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1670716|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1670717|NCT00104936|adult grade I meningioma|adult grade i meningioma
1670718|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1670719|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1670720|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1670721|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1670722|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1670723|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1670724|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1670725|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1670726|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1670727|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1670728|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1670729|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1670730|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1670731|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1670732|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1670733|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1670734|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1670735|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1670736|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1670737|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
1670738|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1670739|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1670740|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1670741|NCT00104923|primary myelofibrosis|primary myelofibrosis
1670742|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1670743|NCT00104923|essential thrombocythemia|essential thrombocythemia
1670744|NCT00104923|polycythemia vera|polycythemia vera
1670745|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
1670746|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
1670747|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1670748|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1670749|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1670750|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1670751|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1670752|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1670753|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1670754|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1670755|NCT00104897|recurrent melanoma|recurrent melanoma
1670756|NCT00104897|stage IV melanoma|stage iv melanoma
1670757|NCT00104884|stage III melanoma|stage iii melanoma
1670758|NCT00104884|stage IV melanoma|stage iv melanoma
1670759|NCT00104884|Depsipeptide|depsipeptide
1670760|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
1670762|NCT00104871|bortezomib|bortezomib
1670764|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
1670765|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
1670766|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
1670767|NCT00104871|papillary|papillary
1670768|NCT00104871|oxyphilic cell|oxyphilic cell
1670769|NCT00104871|Hurthle cell|hurthle cell
1670770|NCT00104871|insular cell|insular cell
1670771|NCT00104871|columnar cell|columnar cell
1670772|NCT00104871|tall cell|tall cell
1670773|NCT00104845|stage II melanoma|stage ii melanoma
1670774|NCT00104845|stage III melanoma|stage iii melanoma
1670775|NCT00104845|stage IV melanoma|stage iv melanoma
1670776|NCT00104845|recurrent melanoma|recurrent melanoma
1670777|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1670778|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1670779|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1670780|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1670781|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1670782|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1670783|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1670784|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1670785|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
1670786|NCT00104806|refractory anemia|refractory anemia
1670787|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1670788|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1671075|NCT00103766|Empyema|empyema
1670789|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1670790|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1670791|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1670792|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1670793|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1670794|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1670795|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1670796|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1670797|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1670798|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1670799|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
1670800|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
1670801|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
1670802|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
1670803|NCT00104741|stage III prostate cancer|stage iii prostate cancer
1670804|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1670805|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1670806|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
1670807|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
1670808|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1670809|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
1670810|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
1670811|NCT00104702|stage I breast cancer|stage i breast cancer
1670812|NCT00104702|stage II breast cancer|stage ii breast cancer
1670813|NCT00104689|stage IV colon cancer|stage iv colon cancer
1670814|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
1670815|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
1670816|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1670817|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1670818|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1670819|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1670820|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1670821|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1670822|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
1670823|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1670824|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1670825|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
1670826|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1670827|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
1670828|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
1670829|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
1670830|NCT00104676|testicular immature teratoma|testicular immature teratoma
1670831|NCT00104676|testicular mature teratoma|testicular mature teratoma
1670832|NCT00104676|adult teratoma|adult teratoma
1670833|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
1670834|NCT00104663|inherited|inherited
1670835|NCT00104663|sporadic|sporadic
1670836|NCT00104663|acquired|acquired
1670837|NCT00104663|new variant CJD|new variant cjd
1670838|NCT00104650|Bone Metastases|bone metastases
1670839|NCT00104650|AMG 162|amg 162
1670840|NCT00104650|Bisphosphonates|bisphosphonates
1670841|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
1670842|NCT00104650|Advanced|advanced
1670843|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1670844|NCT00104637|Emphysema|emphysema
1670845|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
1670846|NCT00104637|Sildenafil|sildenafil
1670847|NCT00104637|Exercise testing|exercise testing
1670848|NCT00104637|Quality of life|quality of life
1670849|NCT00104624|stage IV breast cancer|stage iv breast cancer
1670850|NCT00104624|recurrent breast cancer|recurrent breast cancer
1670851|NCT00104611|Major Depressive Disorder|major depressive disorder
1670852|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1670853|NCT00104611|rTMS|rtms
1670854|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
1670855|NCT00104611|Antidepressant|antidepressant
1670856|NCT00104585|Parkinson's disease|parkinson's disease
1670857|NCT00104585|PD|pd
1670858|NCT00104585|gene|gene
1670859|NCT00104585|environment|environment
1670860|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
1670861|NCT00104572|Estrogen|estrogen
1670862|NCT00104572|Glucose Tolerance|glucose tolerance
1670863|NCT00104572|Bone Density|bone density
1670864|NCT00104572|Quality-of-Life|quality-of-life
1670865|NCT00104572|Sarcopenia|sarcopenia
1670866|NCT00104559|HIV|hiv
1670867|NCT00104559|Informed Consent|informed consent
1670868|NCT00104546|Dysmenorrhea|dysmenorrhea
1670869|NCT00104546|Acupuncture|acupuncture
1670870|NCT00104546|Vitamin K|vitamin k
1670871|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
1670872|NCT00104546|Women|women
1670873|NCT00104546|Menstruation|menstruation
1670874|NCT00104546|Pain, Menstrual|pain, menstrual
1670875|NCT00104546|China|china
1670876|NCT00104533|Static magnetic therapy|static magnetic therapy
1670878|NCT00104533|Analgesia|analgesia
1670879|NCT00104533|Opioids|opioids
1670880|NCT00104520|Cystic Fibrosis|cystic fibrosis
1670881|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
1670882|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
1670883|NCT00104507|Serotonin|serotonin
1670884|NCT00104507|5-HT2c|5-ht2c
1670885|NCT00104507|Satiety|satiety
1670886|NCT00104507|Obesity|obesity
1670887|NCT00104507|Appetite suppressant|appetite suppressant
1670888|NCT00104507|Weight Loss|weight loss
1670889|NCT00104507|Overweight|overweight
1670890|NCT00104494|Cystic Fibrosis|cystic fibrosis
1670891|NCT00104494|Zinc supplementation|zinc supplementation
1670892|NCT00104494|Nutrition|nutrition
1670893|NCT00104494|Zinc absorption|zinc absorption
1670894|NCT00104494|Zinc excretion|zinc excretion
1670895|NCT00104494|Zinc status|zinc status
1670896|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
1670897|NCT00104481|coping|coping
1670898|NCT00104481|smoking cessation|smoking cessation
1670899|NCT00104481|acceptance|acceptance
1670900|NCT00104481|expectancies|expectancies
1670901|NCT00104481|quit smoking|quit smoking
1670902|NCT00104481|quitting smoking|quitting smoking
1670903|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
1670904|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
1670905|NCT00104455|rFVIIa|rfviia
1670906|NCT00104455|Punch Biopsy|punch biopsy
1670907|NCT00104455|Dose Response|dose response
1670908|NCT00104455|Healthy People Programs|healthy people programs
1670909|NCT00104442|Alzheimer's disease|alzheimer's disease
1670910|NCT00104442|memory loss|memory loss
1670911|NCT00104442|dementia|dementia
1670912|NCT00104442|senility|senility
1670913|NCT00104442|forgetful|forgetful
1670914|NCT00104442|geriatric|geriatric
1670915|NCT00104442|behavior|behavior
1670916|NCT00104442|mood swings|mood swings
1670917|NCT00104429|HIV infections|hiv infections
1670918|NCT00104429|therapy naive|therapy naive
1670919|NCT00104416|antiepileptic drugs|antiepileptic drugs
1670920|NCT00104416|seizures|seizures
1670921|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
1670922|NCT00104416|Epilepsy|epilepsy
1670923|NCT00104416|lamotrigine|lamotrigine
1670924|NCT00104416|anticonvulsants|anticonvulsants
1670925|NCT00104416|LAMICTAL|lamictal
1670926|NCT00104403|Vomiting|vomiting
1670927|NCT00104403|CINV|cinv
1670928|NCT00104403|Emesis|emesis
1670929|NCT00104403|Nausea|nausea
1670930|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1670931|NCT00104390|allergy|allergy
1670932|NCT00104390|skin prick test|skin prick test
1670933|NCT00104390|allergoid|allergoid
1670934|NCT00104390|allergenicity|allergenicity
1670935|NCT00104390|specific immunotherapy|specific immunotherapy
1670936|NCT00104377|Allergy|allergy
1670937|NCT00104377|Allergoid|allergoid
1670938|NCT00104377|Specific Immunotherapy|specific immunotherapy
1670939|NCT00104338|Investigational Therapies|investigational therapies
1670940|NCT00104338|Treatment Effectiveness|treatment effectiveness
1670941|NCT00104338|Treatment Efficacy|treatment efficacy
1670942|NCT00104338|Immunosuppressant|immunosuppressant
1670943|NCT00104338|BK Nephropathy|bk nephropathy
1670944|NCT00104338|Polyomavirus, BK|polyomavirus, bk
1670945|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
1670946|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
1670947|NCT00104325|Cytapheresis|cytapheresis
1670948|NCT00104325|Blood Collection|blood collection
1670949|NCT00104325|Volunteer Donor|volunteer donor
1670950|NCT00104325|White Blood Cells|white blood cells
1670951|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
1670952|NCT00104312|Muscle|muscle
1670953|NCT00104312|Cytokine|cytokine
1670954|NCT00104312|Mobility|mobility
1670955|NCT00104312|Function|function
1670956|NCT00104299|ANCA|anca
1670957|NCT00104299|Vasculitis|vasculitis
1670958|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
1670959|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
1670960|NCT00104299|ANCA-positive|anca-positive
1670961|NCT00104299|ANCA-associated|anca-associated
1670962|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
1670963|NCT00104299|MPA|mpa
1670964|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
1670965|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
1670966|NCT00104195|Anxiety|anxiety
1670967|NCT00104195|Adolescence|adolescence
1670968|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
1670969|NCT00104169|Anemia|anemia
1670970|NCT00104169|Frailty|frailty
1670971|NCT00104169|Epoetin|epoetin
1671239|NCT00102999|Learning|learning
1670972|NCT00104169|Erythropoietin|erythropoietin
1670973|NCT00104169|EPO|epo
1670974|NCT00104156|Knee pain|knee pain
1670975|NCT00104156|Arthritis|arthritis
1670976|NCT00104156|Qigong|qigong
1670977|NCT00104156|Qi|qi
1670978|NCT00104156|Meditation|meditation
1670979|NCT00104156|Breathing Exercises|breathing exercises
1670980|NCT00104130|prostate|prostate
1670981|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
1670982|NCT00104091|Gross Total Resection|gross total resection
1670983|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
1670984|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
1670985|NCT00104065|oral mucositis|oral mucositis
1670986|NCT00104065|oncology - supportive care|oncology - supportive care
1670987|NCT00104065|mouth diseases|mouth diseases
1670988|NCT00104039|Amygdala|amygdala
1670989|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
1670990|NCT00104039|Serotonin|serotonin
1670991|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
1670992|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1670994|NCT00104039|Anti-Social Behavior|anti-social behavior
1670995|NCT00104039|Healthy Volunteer|healthy volunteer
1670997|NCT00104026|Periodontal Disease|periodontal disease
1670998|NCT00104026|Dilantin|dilantin
1670999|NCT00104026|Cyclosporin|cyclosporin
1671000|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
1671001|NCT00104026|Genetics|genetics
1671002|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
1671003|NCT00104026|HGF|hgf
1671004|NCT00104026|Gingival Overgrowth|gingival overgrowth
1671005|NCT00104026|Gum Overgrowth|gum overgrowth
1671006|NCT00104000|Neuromuscular|neuromuscular
1671007|NCT00104000|Elevation|elevation
1671008|NCT00104000|Current|current
1671009|NCT00104000|Videofluoroscopy|videofluoroscopy
1671010|NCT00104000|Nasoendoscopy|nasoendoscopy
1671011|NCT00104000|Healthy Volunteer|healthy volunteer
1671012|NCT00104000|HV|hv
1671013|NCT00103987|Panic Disorder|panic disorder
1671014|NCT00103987|Norepinephrine|norepinephrine
1671015|NCT00103987|Yohimbine|yohimbine
1671016|NCT00103987|Genes|genes
1671017|NCT00103987|Pathophysiology|pathophysiology
1671018|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
1671019|NCT00103987|PET Imaging|pet imaging
1671020|NCT00103987|PD|pd
1671021|NCT00103987|Healthy Volunteer|healthy volunteer
1671022|NCT00103987|HV|hv
1671023|NCT00103974|multiple sclerosis|multiple sclerosis
1671024|NCT00103974|relapsing-remitting|relapsing-remitting
1671025|NCT00103974|secondary progressive|secondary progressive
1671026|NCT00103961|Acute Infection|acute infection
1671027|NCT00103961|HIV|hiv
1671028|NCT00103961|AIDS|aids
1671029|NCT00103961|Acute HIV|acute hiv
1671030|NCT00103961|Early HIV|early hiv
1671031|NCT00103935|diabetes|diabetes
1671032|NCT00103935|exenatide|exenatide
1671033|NCT00103935|long acting release|long acting release
1671034|NCT00103935|Amylin|amylin
1671035|NCT00103935|Lilly|lilly
1671036|NCT00103922|smokers cough|smokers cough
1671037|NCT00103896|High-risk youth|high-risk youth
1671038|NCT00103896|HIV infected youth|hiv infected youth
1671039|NCT00103896|Community mobilization|community mobilization
1671040|NCT00103896|HIV serosurveys|hiv serosurveys
1671041|NCT00103883|HIV|hiv
1671042|NCT00103883|Detuned Assay|detuned assay
1671043|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
1671044|NCT00103883|HIV Incidence|hiv incidence
1671045|NCT00103883|Laboratory assay|laboratory assay
1671046|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
1671047|NCT00103883|Acute Infection|acute infection
1671048|NCT00103870|Music Therapy|music therapy
1671049|NCT00103870|Electric Stimulation|electric stimulation
1671050|NCT00103870|Electric Shock|electric shock
1671051|NCT00103870|Analgesics|analgesics
1671052|NCT00103870|Distraction|distraction
1671053|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
1671054|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
1671055|NCT00103805|language acquisition|language acquisition
1671056|NCT00103805|plasticity|plasticity
1671057|NCT00103805|stroke recovery|stroke recovery
1671058|NCT00103805|associative learning|associative learning
1671059|NCT00103792|Induction therapy|induction therapy
1671060|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
1671061|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
1671062|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
1671063|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
1671064|NCT00103792|cyclophosphamide|cyclophosphamide
1671065|NCT00103779|Antigens, CD40|antigens, cd40
1671066|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
1671067|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1671068|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
1671069|NCT00103779|Hematologic Diseases|hematologic diseases
1671070|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
1671071|NCT00103779|Lymphatic Diseases|lymphatic diseases
1671072|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
1671076|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
1671077|NCT00103753|Randomized Controlled Trial|randomized controlled trial
1671078|NCT00103753|Deferiprone|deferiprone
1671079|NCT00103753|Deferoxamine|deferoxamine
1671080|NCT00103753|Iron chelation|iron chelation
1671081|NCT00103753|Beta Thalassemia Major|beta thalassemia major
1671082|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
1671083|NCT00103727|paranoid|paranoid
1671084|NCT00103727|catatonic|catatonic
1671085|NCT00103727|undifferentiated types|undifferentiated types
1671086|NCT00103727|disorganized|disorganized
1671087|NCT00103714|lung disease|lung disease
1671177|NCT00103181|stage II breast cancer|stage ii breast cancer
1671088|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
1671089|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
1671090|NCT00103675|Acupuncture|acupuncture
1671091|NCT00103636|Phlebitis/etiology|phlebitis/etiology
1671092|NCT00103636|Infusions|infusions
1671093|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
1671094|NCT00103636|Randomised controlled trial|randomised controlled trial
1671095|NCT00103636|Phlebitis/prevention|phlebitis/prevention
1671096|NCT00103636|Adult|adult
1671097|NCT00103636|Time factors|time factors
1671098|NCT00103623|Advanced|advanced
1671099|NCT00103623|Symptomatic|symptomatic
1671100|NCT00103623|Prostate|prostate
1671101|NCT00103623|Cancer|cancer
1671102|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
1671103|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1671104|NCT00103610|Stem cell mobilization|stem cell mobilization
1671105|NCT00103597|Orthostatic hypotension|orthostatic hypotension
1671106|NCT00103597|Parkinson's Disease|parkinson's disease
1671107|NCT00103545|Ovarian Cancer|ovarian cancer
1671108|NCT00103545|ACA 125|aca 125
1671109|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
1671110|NCT00103545|immune response|immune response
1671111|NCT00103545|Fallopian tube cancer|fallopian tube cancer
1671112|NCT00103545|Peritoneal cancer|peritoneal cancer
1671113|NCT00103532|motivational enhancement|motivational enhancement
1671114|NCT00103532|health behaviors|health behaviors
1671115|NCT00103532|risk behaviors|risk behaviors
1671116|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
1671117|NCT00103506|Multiple Myeloma|multiple myeloma
1671118|NCT00103506|Doxil|doxil
1671119|NCT00103506|Caelyx|caelyx
1671120|NCT00103506|Doxorubicin|doxorubicin
1671121|NCT00103506|Velcade|velcade
1671122|NCT00103506|Bortezomib|bortezomib
1671123|NCT00103454|allergic rhinitis|allergic rhinitis
1671124|NCT00103454|GW685698X|gw685698x
1671125|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
1671126|NCT00103428|chemotherapy|chemotherapy
1671127|NCT00103428|prostate cancer|prostate cancer
1671128|NCT00103428|cancer|cancer
1671129|NCT00103428|metastatic|metastatic
1671130|NCT00103428|hormone refractory|hormone refractory
1671131|NCT00103428|chemotherapy naive|chemotherapy naive
1671132|NCT00103428|dose escalation|dose escalation
1671133|NCT00103415|Depression|depression
1671134|NCT00103415|Exercise|exercise
1671135|NCT00103415|Job|job
1671136|NCT00103402|Prostatitis|prostatitis
1671137|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
1671138|NCT00103402|Prostatodynia|prostatodynia
1671139|NCT00103402|Alfuzosin|alfuzosin
1671140|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
1671141|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1671142|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1671143|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1671144|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1671145|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
1671146|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
1671147|NCT00103363|small cell lung cancer|small cell lung cancer
1671148|NCT00103350|myocardial infarction|myocardial infarction
1671149|NCT00103350|infarct size|infarct size
1671150|NCT00103350|angioplasty|angioplasty
1671151|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
1671152|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
1671153|NCT00103298|recurrent colon cancer|recurrent colon cancer
1671154|NCT00103298|stage IV colon cancer|stage iv colon cancer
1671155|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
1671156|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
1671157|NCT00103298|liver metastases|liver metastases
1671158|NCT00103246|skin cancer|skin cancer
1671159|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1671160|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1671161|NCT00103246|recurrent skin cancer|recurrent skin cancer
1671162|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1671163|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1671164|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1671165|NCT00103246|actinic keratosis|actinic keratosis
1671166|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1671167|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1671168|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1671169|NCT00103233|stage IV breast cancer|stage iv breast cancer
1671170|NCT00103233|recurrent breast cancer|recurrent breast cancer
1671171|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
1671172|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
1671173|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1671174|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1671175|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1671176|NCT00103207|cetuximab|cetuximab
1671178|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1671179|NCT00103181|breast cancer in situ|breast cancer in situ
1671180|NCT00103181|stage IA breast cancer|stage ia breast cancer
1671181|NCT00103181|stage IB breast cancer|stage ib breast cancer
1671182|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1671183|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
1671184|NCT00103142|liver metastases|liver metastases
1671185|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
1671186|NCT00103142|recurrent colon cancer|recurrent colon cancer
1671187|NCT00103142|stage IV colon cancer|stage iv colon cancer
1671188|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1671189|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
1671190|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
1671191|NCT00103142|lung metastases|lung metastases
1671192|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1671193|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1671194|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1671195|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1671196|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1671197|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
1671198|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
1671199|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1671200|NCT00103090|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1671201|NCT00103090|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1671202|NCT00103090|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1671203|NCT00103090|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1671204|NCT00103090|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1671205|NCT00103090|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1671206|NCT00103090|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1671207|NCT00103090|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1671208|NCT00103090|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1671209|NCT00103090|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1671210|NCT00103090|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1671211|NCT00103090|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1671212|NCT00103090|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1671213|NCT00103090|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1671214|NCT00103090|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1671215|NCT00103090|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1671216|NCT00103090|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1671217|NCT00103090|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1671218|NCT00103090|recurrent salivary gland cancer|recurrent salivary gland cancer
1671219|NCT00103090|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1671220|NCT00103090|stage III salivary gland cancer|stage iii salivary gland cancer
1671221|NCT00103090|stage IV salivary gland cancer|stage iv salivary gland cancer
1671222|NCT00103090|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1671223|NCT00103090|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1671224|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1671225|NCT00103025|Vasodilation|vasodilation
1671226|NCT00103025|Hypotension|hypotension
1671227|NCT00103025|Hypertension|hypertension
1671228|NCT00103025|EDRF|edrf
1671229|NCT00103025|Methemoglobinemia|methemoglobinemia
1671230|NCT00103025|Healthy Volunteer|healthy volunteer
1671232|NCT00103012|Antiretrovirals|antiretrovirals
1671233|NCT00103012|Protease Inhibitors|protease inhibitors
1671234|NCT00103012|Herbal Supplements|herbal supplements
1671235|NCT00103012|Drug Interactions|drug interactions
1671236|NCT00103012|Metabolism|metabolism
1671237|NCT00103012|Healthy Volunteer|healthy volunteer
1671238|NCT00103012|HV|hv
1671240|NCT00102999|PAS|pas
1671241|NCT00102999|Upper Limb|upper limb
1671242|NCT00102999|TMS|tms
1671243|NCT00102999|Somatosensory|somatosensory
1671244|NCT00102999|Dystonia|dystonia
1671245|NCT00102999|Upper Limb Dystonia|upper limb dystonia
1671246|NCT00102999|Healthy Volunteer|healthy volunteer
1671247|NCT00102999|HV|hv
1671248|NCT00102986|Kaletra|kaletra
1671249|NCT00102986|Treatment Experienced|treatment experienced
1671250|NCT00102973|Ovary|ovary
1671251|NCT00102960|Infant|infant
1671252|NCT00102960|Perinatal|perinatal
1671253|NCT00102960|HIV|hiv
1671254|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
1671255|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
1671256|NCT00102960|Treatment Interruption|treatment interruption
1671257|NCT00102960|Treatment Naive|treatment naive
1671258|NCT00102960|Acute Infection|acute infection
1671259|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
1671260|NCT00102947|renal impairment|renal impairment
1671261|NCT00102947|daptomycin|daptomycin
1671262|NCT00102947|Cubist|cubist
1671263|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
1671264|NCT00102934|HIV|hiv
1671265|NCT00102934|Drug Resistance|drug resistance
1671266|NCT00102934|Viral Fitness|viral fitness
1671267|NCT00102934|HIV Specific Immunity|hiv specific immunity
1671268|NCT00102934|T Cell Activation|t cell activation
1671269|NCT00102934|Drug Resistant Viremia|drug resistant viremia
1671270|NCT00102934|Treatment Experienced|treatment experienced
1671271|NCT00102921|Crohn Disease|crohn disease
1671272|NCT00102921|oral medication|oral medication
1671273|NCT00102908|Bone Metabolism|bone metabolism
1671274|NCT00102908|Osteopenia|osteopenia
1671275|NCT00102908|Osteoporosis|osteoporosis
1671276|NCT00102908|Treatment Experienced|treatment experienced
1671277|NCT00102882|genotype|genotype
1671278|NCT00102882|Salmeterol|salmeterol
1671279|NCT00102882|ADVAIR|advair
1671280|NCT00102869|language acquisition|language acquisition
1671281|NCT00102869|plasticity|plasticity
1671282|NCT00102869|stroke recovery|stroke recovery
1671283|NCT00102869|aphasia treatment|aphasia treatment
1671284|NCT00102869|naming|naming
1671285|NCT00102869|levodopa|levodopa
1671286|NCT00102869|stroke|stroke
1671287|NCT00102856|language acquisition|language acquisition
1671288|NCT00102856|plasticity|plasticity
1671289|NCT00102856|stroke recovery|stroke recovery
1671290|NCT00102856|associative learning|associative learning
1671291|NCT00102843|folic acid|folic acid
1671292|NCT00102843|betaine|betaine
1671293|NCT00102843|homocysteine|homocysteine
1671294|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
1671295|NCT00102843|human|human
1671296|NCT00102843|Cardiovascular health|cardiovascular health
1671297|NCT00102830|Solid Tumor|solid tumor
1671298|NCT00102830|Metastatic Cancer|metastatic cancer
1671299|NCT00102830|Advanced Solid Tumors|advanced solid tumors
1671300|NCT00102817|Growth Hormone Disorder|growth hormone disorder
1671301|NCT00102791|Sickle Cell Anemia|sickle cell anemia
1671302|NCT00102778|HIV infected|hiv infected
1671303|NCT00102778|therapy-naive subjects|therapy-naive subjects
1671304|NCT00102765|asthma exacerbation|asthma exacerbation
1671305|NCT00102765|asthma|asthma
1671306|NCT00102752|Pancreas|pancreas
1671307|NCT00102752|Cancer|cancer
1671308|NCT00102752|Metastatic|metastatic
1671309|NCT00102752|Glufosfamide|glufosfamide
1671310|NCT00102752|Advanced|advanced
1671311|NCT00102752|Solid|solid
1671312|NCT00102752|Tumor|tumor
1671313|NCT00102752|Advanced Solid Tumors|advanced solid tumors
1671314|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1671315|NCT00102739|thrombopoietin|thrombopoietin
1671316|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1671317|NCT00102739|platelets|platelets
1671318|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
1671319|NCT00102726|chemotherapy|chemotherapy
1671320|NCT00102726|thrombopoietin|thrombopoietin
1671321|NCT00102726|platelets|platelets
1671322|NCT00102726|chemotherapy induced|chemotherapy induced
1671323|NCT00102713|Partial Seizures|partial seizures
1671324|NCT00102700|cancer|cancer
1671325|NCT00102700|solid tumor|solid tumor
1671326|NCT00102700|advanced solid tumor|advanced solid tumor
1671327|NCT00102700|pancreas|pancreas
1671328|NCT00102700|pancreatic cancer|pancreatic cancer
1671329|NCT00102700|cancer of the pancreas|cancer of the pancreas
1671330|NCT00102674|cangrelor|cangrelor
1671331|NCT00102674|clopidogrel|clopidogrel
1671332|NCT00102648|Glioblastoma Multiforme|glioblastoma multiforme
1671333|NCT00102648|Gliosarcoma|gliosarcoma
1671334|NCT00102648|Brain Tumors|brain tumors
1671335|NCT00102648|Sarasar|sarasar
1671336|NCT00102648|Temodar|temodar
1671337|NCT00102648|Temozolomide|temozolomide
1671338|NCT00102648|Lonafarnib|lonafarnib
1671339|NCT00102648|SCH 66336|sch 66336
1671340|NCT00102635|apoptotic activity|apoptotic activity
1671341|NCT00102635|4-HPR|4-hpr
1671342|NCT00102635|FTI|fti
1671343|NCT00102635|Fenretinide|fenretinide
1671344|NCT00102635|SCH66336|sch66336
1671345|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
1671346|NCT00102635|HNC|hnc
1671347|NCT00102622|Ovary|ovary
1671735|NCT00101387|Aged|aged
1671348|NCT00102622|ovarian cancer|ovarian cancer
1671349|NCT00102622|biologic therapy|biologic therapy
1671350|NCT00102622|platinum-resistant|platinum-resistant
1671351|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
1671352|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
1671353|NCT00102622|paclitaxel|paclitaxel
1671354|NCT00102622|tgDCC-E1A|tgdcc-e1a
1671355|NCT00102622|E1A|e1a
1671356|NCT00102622|Taxol|taxol
1671357|NCT00102609|Doxorubicin|doxorubicin
1671358|NCT00102609|Adriamycin|adriamycin
1671359|NCT00102609|Trabectedin|trabectedin
1671361|NCT00102609|Ecteinascidin 743|ecteinascidin 743
1671362|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
1671363|NCT00102609|Antineoplastic Agents|antineoplastic agents
1671364|NCT00102609|Pharmacologic Actions|pharmacologic actions
1671365|NCT00102609|Alkylating Agents|alkylating agents
1671366|NCT00102596|Ethanol|ethanol
1671367|NCT00102596|Alcohol Responsive|alcohol responsive
1671368|NCT00102596|Movement Disorder|movement disorder
1671369|NCT00102596|Gas Chromatography|gas chromatography
1671370|NCT00102596|Bioavailability|bioavailability
1671371|NCT00102596|Pharmacokinetics|pharmacokinetics
1671372|NCT00102596|Essential Tremor|essential tremor
1671373|NCT00102583|Dry Eye|dry eye
1671374|NCT00102583|Lacrimal Gland|lacrimal gland
1671375|NCT00102583|Tear Deficiency|tear deficiency
1671376|NCT00102583|Keratitis Sicca|keratitis sicca
1671377|NCT00102583|GVHD|gvhd
1671378|NCT00102583|Ocular GVHD|ocular gvhd
1671379|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
1671380|NCT00102570|Pediatric|pediatric
1671381|NCT00102570|Atopic|atopic
1671382|NCT00102570|Asthma|asthma
1671383|NCT00102570|Rhinitis|rhinitis
1671384|NCT00102570|Outpatient|outpatient
1671385|NCT00102570|Allergy|allergy
1671386|NCT00102570|Pediatric Allergy|pediatric allergy
1671387|NCT00102570|Food Allergy|food allergy
1671388|NCT00102570|Stinging Insect Allergy|stinging insect allergy
1671389|NCT00102570|Atopic Dermatitis|atopic dermatitis
1671390|NCT00102570|Insect Sting|insect sting
1671391|NCT00102557|Vesiculobullous|vesiculobullous
1671392|NCT00102557|Mucosal Lesions|mucosal lesions
1671393|NCT00102557|Oral Health|oral health
1671394|NCT00102557|Dermatology|dermatology
1671395|NCT00102557|Plaquenil|plaquenil
1671396|NCT00102557|Oral Lichen Planus|oral lichen planus
1671397|NCT00102557|Mouth Lesions|mouth lesions
1671398|NCT00102557|Oral Lesions|oral lesions
1671399|NCT00102544|CT-Guided|ct-guided
1671400|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
1671401|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
1671402|NCT00102544|Ablation|ablation
1671403|NCT00102544|Surgical Navigation|surgical navigation
1671404|NCT00102531|Osteosarcoma|osteosarcoma
1671405|NCT00102531|relapsed|relapsed
1671406|NCT00102531|progressive|progressive
1671407|NCT00102531|metastatic|metastatic
1671408|NCT00102531|lung|lung
1671409|NCT00102518|Open Label|open label
1671410|NCT00102518|Aripiprazole|aripiprazole
1671411|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
1671412|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
1671413|NCT00102505|Lung Cancer|lung cancer
1671414|NCT00102505|Metastatic lung cancer|metastatic lung cancer
1671415|NCT00102505|Inoperable lung cancer|inoperable lung cancer
1671416|NCT00102505|Advanced lung cancer|advanced lung cancer
1671417|NCT00102505|Large-cell lung cancer|large-cell lung cancer
1671418|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
1671419|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
1671420|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
1671421|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
1671422|NCT00102505|Bronchogenic|bronchogenic
1671423|NCT00102492|Major Depressive Disorder|major depressive disorder
1671424|NCT00102492|Major Depression|major depression
1671425|NCT00102492|Mood Disorders|mood disorders
1671426|NCT00102492|Major Depressive Episode|major depressive episode
1671427|NCT00102479|Pharmacokinetics,|pharmacokinetics,
1671428|NCT00102479|Aripiprazole|aripiprazole
1671429|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
1671430|NCT00102466|type 2 diabetes|type 2 diabetes
1671431|NCT00102466|vildagliptin|vildagliptin
1671432|NCT00102453|Duchenne|duchenne
1671433|NCT00102453|Genetics|genetics
1671434|NCT00102440|uric Acid|uric acid
1671435|NCT00102440|xanthine oxidase|xanthine oxidase
1671436|NCT00102440|tophi|tophi
1671437|NCT00102440|Drug Therapy|drug therapy
1671438|NCT00102427|Anxiety|anxiety
1671439|NCT00102427|Panic|panic
1671440|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
1671441|NCT00102414|Ovarian cancer|ovarian cancer
1671442|NCT00102414|Recurrence or progression|recurrence or progression
1671443|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
1671444|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1671445|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
1671446|NCT00102401|Lung disease, obstructive|lung disease, obstructive
1671447|NCT00102401|Self-care|self-care
1671448|NCT00102401|Self-management|self-management
1671449|NCT00102401|Patient education|patient education
1671450|NCT00102388|type 2 diabetes|type 2 diabetes
1671451|NCT00102388|vildagliptin|vildagliptin
1671452|NCT00102375|Ovarian Cancer|ovarian cancer
1671453|NCT00102375|first-line|first-line
1671454|NCT00102375|Topotecan|topotecan
1671455|NCT00102362|behavioral intervention|behavioral intervention
1671456|NCT00102349|behavioral intervention|behavioral intervention
1671457|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
1671458|NCT00102336|pre-splenectomy|pre-splenectomy
1671460|NCT00102336|Thrombopenia|thrombopenia
1671461|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
1671462|NCT00102323|post-splenectomy|post-splenectomy
1671463|NCT00102323|ITP|itp
1671464|NCT00102323|Thrombopenia|thrombopenia
1671465|NCT00102310|Nausea|nausea
1671466|NCT00102310|Indigestion|indigestion
1671467|NCT00102310|Bloating|bloating
1671468|NCT00102310|Functional Dyspepsia|functional dyspepsia
1671469|NCT00102310|Fullness after Meals|fullness after meals
1671470|NCT00102297|Incipient Nephropathy|incipient nephropathy
1671471|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
1671472|NCT00102284|language acquisition|language acquisition
1671473|NCT00102284|plasticity|plasticity
1671474|NCT00102284|stroke recovery|stroke recovery
1671475|NCT00102284|associative learning|associative learning
1671476|NCT00102271|Sodium Nitrite|sodium nitrite
1671477|NCT00102271|Oxypurinol|oxypurinol
1671478|NCT00102271|Ascorbic Acid|ascorbic acid
1671479|NCT00102271|Hypoxic Gas|hypoxic gas
1671480|NCT00102271|Forearm Blood Flow|forearm blood flow
1671481|NCT00102271|Healthy Volunteer|healthy volunteer
1671482|NCT00102271|HV|hv
1671483|NCT00102258|Short Stature|short stature
1671484|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
1671485|NCT00102258|Body Composition|body composition
1671486|NCT00102258|Energy Expenditure|energy expenditure
1671487|NCT00102258|Dietary Supplements|dietary supplements
1671488|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
1671489|NCT00102258|CDGM|cdgm
1671490|NCT00102245|Hemoglobin|hemoglobin
1671491|NCT00102245|Hemoglobinapathies|hemoglobinapathies
1671492|NCT00102245|Human Genome|human genome
1671493|NCT00102245|Recombinant DNA Technology|recombinant dna technology
1671494|NCT00102245|Sequencing|sequencing
1671495|NCT00102245|Erythrocyte|erythrocyte
1671496|NCT00102232|phosphatidylcholine|phosphatidylcholine
1671497|NCT00102232|choline|choline
1671498|NCT00102232|homocysteine|homocysteine
1671499|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
1671500|NCT00102232|human|human
1671501|NCT00102232|cardiovascular health|cardiovascular health
1671502|NCT00102206|Treatment Experienced|treatment experienced
1671503|NCT00102206|Child|child
1671504|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
1671505|NCT00102141|Postmenopausal|postmenopausal
1671506|NCT00102141|vasomotor symptoms|vasomotor symptoms
1671507|NCT00102141|essential hypertension|essential hypertension
1671508|NCT00102115|Macular disease|macular disease
1671509|NCT00102115|Wet AMD|wet amd
1671510|NCT00102115|AMD|amd
1671511|NCT00102115|Age-Related Macular Disease|age-related macular disease
1671512|NCT00102115|PDT|pdt
1671513|NCT00102115|Photodynamic Therapy|photodynamic therapy
1671514|NCT00102102|Substance P|substance p
1671515|NCT00102102|Neurokinin|neurokinin
1671516|NCT00102102|Tachykinin|tachykinin
1671517|NCT00102102|Anxiety|anxiety
1671518|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
1671519|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1671520|NCT00102102|PTSD|ptsd
1671521|NCT00102102|Healthy Volunteer|healthy volunteer
1671522|NCT00102102|HV|hv
1671523|NCT00102089|HIV-Negative|hiv-negative
1671524|NCT00102089|Healthy|healthy
1671525|NCT00102089|Immunity|immunity
1671526|NCT00102089|Preventive|preventive
1671527|NCT00102089|Virus|virus
1671528|NCT00102089|Healthy Volunteer|healthy volunteer
1671529|NCT00102089|HV|hv
1671530|NCT00102076|Minimal|minimal
1671531|NCT00102076|Risk|risk
1671532|NCT00102076|Regulations|regulations
1671533|NCT00102076|Parents|parents
1671534|NCT00102076|IRB|irb
1671535|NCT00102076|Surgery|surgery
1671536|NCT00102076|Assent Requirement|assent requirement
1671537|NCT00102063|Schizophrenia|schizophrenia
1671538|NCT00102063|Aripiprazole|aripiprazole
1671539|NCT00102050|NM-702 tablets|nm-702 tablets
1671540|NCT00102050|intermittent claudication|intermittent claudication
1671541|NCT00102050|peripheral|peripheral
1671542|NCT00102050|arterial|arterial
1671543|NCT00102050|vascular|vascular
1671544|NCT00102050|peripheral arterial disease|peripheral arterial disease
1671545|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
1671546|NCT00102024|Anti TAG-72|anti tag-72
1671547|NCT00102024|Monoclonal Antibody|monoclonal antibody
1671548|NCT00102011|colon cancer|colon cancer
1671549|NCT00102011|rectal cancer|rectal cancer
1671550|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
1671551|NCT00101998|cancer pain|cancer pain
1671552|NCT00101998|pain medication|pain medication
1671553|NCT00101998|constipation|constipation
1671554|NCT00101998|bowel|bowel
1671555|NCT00101998|bowel dysfunction|bowel dysfunction
1671556|NCT00101985|Quality of Life|quality of life
1671557|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
1671558|NCT00101985|IBS|ibs
1671559|NCT00101985|SB223412|sb223412
1671560|NCT00101985|Qol|qol
1671561|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1671562|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
1671563|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1671564|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1671565|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1671566|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
1671567|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1671568|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1671569|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1671570|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1671571|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
1671572|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
1671573|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
1671574|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1671575|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1671576|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1671577|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
1671578|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
1671579|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
1671580|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1671581|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1671582|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1671583|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
1671584|NCT00101972|stage IV breast cancer|stage iv breast cancer
1671585|NCT00101972|stage IV colon cancer|stage iv colon cancer
1671586|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1671587|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
1671588|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
1671589|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1671590|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1671591|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
1671592|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
1671593|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
1671594|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
1671595|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
1671596|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
1671597|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
1671598|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
1671599|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
1671600|NCT00101972|recurrent breast cancer|recurrent breast cancer
1671601|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
1671602|NCT00101972|recurrent colon cancer|recurrent colon cancer
1671603|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1671604|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
1671605|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1671606|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
1671607|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
1671608|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1671609|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1671610|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
1671611|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
1671612|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
1671613|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
1671614|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
1671615|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
1671616|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
1671617|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1671618|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
1671619|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
1671620|NCT00101946|CD|cd
1671621|NCT00101946|Crohn's Disease|crohn's disease
1671622|NCT00101933|Deep brain stimulation, DBS, SANTE|deep brain stimulation, dbs, sante
1671623|NCT00101907|Advanced Cancer|advanced cancer
1671624|NCT00101907|AMG 706|amg 706
1671625|NCT00101907|Panitumumab|panitumumab
1671626|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
1671627|NCT00101894|AMG 706|amg 706
1671628|NCT00101894|Panitumumab|panitumumab
1671629|NCT00101881|Cardiac arrest|cardiac arrest
1671630|NCT00101881|Defibrillation|defibrillation
1671631|NCT00101881|Biphasic defibrillation|biphasic defibrillation
1671632|NCT00101881|Monophasic defibrillation|monophasic defibrillation
1671633|NCT00101881|Ventricular fibrillation|ventricular fibrillation
1671634|NCT00101868|Aged|aged
1671635|NCT00101868|Hospitalists|hospitalists
1671636|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
1671637|NCT00101868|Human|human
1671638|NCT00101868|Hospitals, teaching|hospitals, teaching
1671639|NCT00101868|Physicians, family|physicians, family
1671640|NCT00101868|Medical records|medical records
1671641|NCT00101868|Quality assurance, health care|quality assurance, health care
1671642|NCT00101868|Medical errors|medical errors
1671643|NCT00101855|prevention|prevention
1671644|NCT00101855|internet|internet
1671645|NCT00101855|quality of care|quality of care
1671646|NCT00101829|Autoimmune Diseases|autoimmune diseases
1671647|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
1671648|NCT00101803|type 2 diabetes|type 2 diabetes
1671649|NCT00101803|vildagliptin|vildagliptin
1671650|NCT00101790|low back pain|low back pain
1671651|NCT00101790|pamidronate|pamidronate
1671652|NCT00101777|Anxiety|anxiety
1671653|NCT00101777|Ventilation|ventilation
1671654|NCT00101777|Panic Disorder|panic disorder
1671655|NCT00101777|Children|children
1671656|NCT00101777|Healthy Volunteer|healthy volunteer
1671657|NCT00101777|HV|hv
1671658|NCT00101777|Normal Control|normal control
1671659|NCT00101764|AMD|amd
1671660|NCT00101764|CRVO|crvo
1671661|NCT00101764|BRVO|brvo
1671662|NCT00101764|Uveitis|uveitis
1671663|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
1671664|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
1671665|NCT00101764|Macular Edema|macular edema
1671666|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
1671667|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
1671668|NCT00101764|Inflammation|inflammation
1671669|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
1671670|NCT00101764|Retinal Disorder|retinal disorder
1671671|NCT00101738|MPA|mpa
1671672|NCT00101738|Kidney Transplantation|kidney transplantation
1671673|NCT00101738|Acute rejection|acute rejection
1671674|NCT00101738|Kidney function|kidney function
1671675|NCT00101725|Diarrhea|diarrhea
1671676|NCT00101725|IBS|ibs
1671677|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
1671678|NCT00101725|Abdominal pain|abdominal pain
1671679|NCT00101712|type 2 diabetes|type 2 diabetes
1671680|NCT00101712|vildagliptin|vildagliptin
1671681|NCT00101699|Women|women
1671682|NCT00101699|Soy Foods|soy foods
1671683|NCT00101699|Middle Aged|middle aged
1671684|NCT00101673|type 2 diabetes|type 2 diabetes
1671685|NCT00101673|vildagliptin|vildagliptin
1671686|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
1671687|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
1671688|NCT00101634|Schizophrenia|schizophrenia
1671689|NCT00101634|Paliperidone palmitate|paliperidone palmitate
1671690|NCT00101634|R092670|r092670
1671691|NCT00101634|antipsychotic|antipsychotic
1671692|NCT00101621|cancer|cancer
1671693|NCT00101621|pain|pain
1671694|NCT00101621|Cancers, Pain|cancers, pain
1671695|NCT00101608|urothelium|urothelium
1671696|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
1671697|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
1671698|NCT00101582|SCCHN|scchn
1671699|NCT00101582|Palifermin|palifermin
1671700|NCT00101582|Mucositis|mucositis
1671701|NCT00101582|Oral Cavity|oral cavity
1671702|NCT00101582|Oropharynx|oropharynx
1671703|NCT00101582|Nasopharynx|nasopharynx
1671704|NCT00101582|Hypopharynx|hypopharynx
1671705|NCT00101582|Larynx|larynx
1671706|NCT00101582|Mouth Pain|mouth pain
1671707|NCT00101582|Mouth Sores|mouth sores
1671708|NCT00101582|Radiation Therapy|radiation therapy
1671709|NCT00101582|Radiotherapy|radiotherapy
1671710|NCT00101582|Radiochemotherapy|radiochemotherapy
1671711|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
1671712|NCT00101582|Xerostomia|xerostomia
1671713|NCT00101582|Stomatitis|stomatitis
1671714|NCT00101582|Mucosa|mucosa
1671715|NCT00101582|KGF|kgf
1671716|NCT00101582|rHuKGF|rhukgf
1671717|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
1671718|NCT00101582|HNC|hnc
1671719|NCT00101582|Head and Neck Cancer|head and neck cancer
1671720|NCT00101582|Oral Mucositis|oral mucositis
1671721|NCT00101543|Gait Training|gait training
1671722|NCT00101543|Motor learning|motor learning
1671723|NCT00101543|Electrical stimulation|electrical stimulation
1671724|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
1671725|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
1671726|NCT00101465|Heart Failure|heart failure
1671727|NCT00101452|Depression|depression
1671728|NCT00101452|Antidepressive Agents|antidepressive agents
1671729|NCT00101452|Complementary Therapies|complementary therapies
1671730|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
1671731|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
1671732|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
1671733|NCT00101413|NSCLC|nsclc
1671734|NCT00101400|Cancer|cancer
1671736|NCT00101387|Acupuncture|acupuncture
1671737|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
1671738|NCT00101374|Antiviral|antiviral
1671739|NCT00101374|Ki67+|ki67+
1671740|NCT00101374|Immune Activation|immune activation
1671741|NCT00101374|T Cell Proliferation|t cell proliferation
1671742|NCT00101374|HIV|hiv
1671743|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
1671744|NCT00101374|Proliferation|proliferation
1671745|NCT00101361|dermatologic|dermatologic
1671746|NCT00101361|skin|skin
1671747|NCT00101361|clinical trial|clinical trial
1671748|NCT00101361|androgen/anabolic|androgen/anabolic
1671749|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
1671750|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
1671751|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
1671752|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
1671753|NCT00101335|tongue cancer|tongue cancer
1671754|NCT00101335|oral leukoplakia|oral leukoplakia
1671755|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
1671756|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1671757|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
1671758|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1671759|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1671760|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1671761|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1671762|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
1671763|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
1671764|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
1671765|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1671766|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
1671767|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1671768|NCT00101192|stage III cervical cancer|stage iii cervical cancer
1671769|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
1671770|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
1671771|NCT00101166|recurrent melanoma|recurrent melanoma
1671772|NCT00101166|stage III melanoma|stage iii melanoma
1671773|NCT00101166|stage IV melanoma|stage iv melanoma
1671774|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
1671775|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1671776|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1671777|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1671778|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1671779|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1671780|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1671781|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1671782|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1671783|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1671784|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1671785|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1671786|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1671787|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1671788|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1671789|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1671790|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1671791|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1671792|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1671793|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1671794|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1671795|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1671796|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1671797|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1671798|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1671799|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1671800|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1671801|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1671802|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
1671803|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
1671804|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
1671805|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
1671806|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1671807|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1671991|NCT00100451|Aging|aging
1671808|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1671809|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1671810|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1671811|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1671812|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1671813|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1671814|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1671815|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1671816|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1671817|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1671818|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1671819|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
1671820|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
1671821|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
1671822|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
1671823|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
1671824|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
1671825|NCT00101062|stage IV breast cancer|stage iv breast cancer
1671826|NCT00101062|recurrent breast cancer|recurrent breast cancer
1671827|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1671828|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1671829|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1671830|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1671831|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1671832|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1671833|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1671834|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1671835|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1671836|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1671837|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1671838|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1671839|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1671840|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1671841|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1671842|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
1671843|NCT00100919|Kinesithesia|kinesithesia
1671844|NCT00100919|Sensorimotor Function|sensorimotor function
1671845|NCT00100919|Somatosensory|somatosensory
1671846|NCT00100919|Muscle Spindles|muscle spindles
1671847|NCT00100919|Sensory Feedback|sensory feedback
1671848|NCT00100919|Healthy Volunteer|healthy volunteer
1671849|NCT00100919|HV|hv
1671850|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
1671851|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
1671852|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1671853|NCT00100893|breast cancer|breast cancer
1671854|NCT00100867|Perinatal Transmission|perinatal transmission
1671855|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
1671856|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1671857|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1671858|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1671859|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1671860|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
1671861|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1671862|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
1671863|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
1671864|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1671865|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1671866|NCT00100789|Recurrent|recurrent
1671867|NCT00100789|stage IV|stage iv
1671868|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
1671869|NCT00100789|hypopharynx|hypopharynx
1671870|NCT00100789|larynx|larynx
1671871|NCT00100789|lip|lip
1671872|NCT00100789|oral cavity|oral cavity
1671873|NCT00100789|nasopharynx|nasopharynx
1671874|NCT00100789|oropharynx|oropharynx
1671875|NCT00100789|paranasal|paranasal
1671876|NCT00100789|nasal cavity|nasal cavity
1671877|NCT00100789|metastatic|metastatic
1671878|NCT00100789|neck cancer|neck cancer
1671879|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
1671880|NCT00100737|interleukin-2|interleukin-2
1671881|NCT00100737|rituximab|rituximab
1671882|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
1671883|NCT00100724|Anthrax|anthrax
1671884|NCT00100724|rPA102|rpa102
1671885|NCT00100724|vaccine|vaccine
1671886|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1671887|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
1671888|NCT00100711|Leukemia|leukemia
1671889|NCT00100711|Lymphoma|lymphoma
1671890|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
1671891|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
1671892|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
1671893|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
1671894|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
1671895|NCT00100698|HIV|hiv
1671896|NCT00100698|lipodystrophy|lipodystrophy
1671897|NCT00100698|growth hormone|growth hormone
1671898|NCT00100698|visceral fat|visceral fat
1671899|NCT00100698|IGF-I|igf-i
1671900|NCT00100698|Treatment Experienced|treatment experienced
1671901|NCT00100685|Kidney|kidney
1671902|NCT00100685|renal|renal
1671903|NCT00100685|cancer|cancer
1671904|NCT00100685|carcinoma|carcinoma
1671905|NCT00100685|cell|cell
1671906|NCT00100685|metastatic|metastatic
1671907|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
1671908|NCT00100685|RCC|rcc
1671909|NCT00100672|LErafAON-ETU|lerafaon-etu
1671910|NCT00100672|Signal transduction|signal transduction
1671911|NCT00100672|Neoplasm|neoplasm
1671912|NCT00100672|Cancer|cancer
1671913|NCT00100672|NeoPharm|neopharm
1671914|NCT00100672|Liposomes|liposomes
1671915|NCT00100672|Antisense|antisense
1671916|NCT00100672|Anti-cancer|anti-cancer
1671917|NCT00100672|Advanced neoplasm|advanced neoplasm
1671918|NCT00100672|Advanced cancer|advanced cancer
1671919|NCT00100672|Chemotherapy|chemotherapy
1671920|NCT00100672|Refractory cancer|refractory cancer
1671921|NCT00100672|Metastatic cancer|metastatic cancer
1671922|NCT00100659|pediatric|pediatric
1671923|NCT00100659|hepatitis|hepatitis
1671924|NCT00100659|children|children
1671925|NCT00100659|HCV|hcv
1671926|NCT00100659|PEG|peg
1671927|NCT00100659|PEG-2a|peg-2a
1671928|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
1671929|NCT00100659|Pegylated Interferon|pegylated interferon
1671930|NCT00100659|RV|rv
1671931|NCT00100659|ribavirin|ribavirin
1671932|NCT00100659|Pegasys|pegasys
1671933|NCT00100659|CHC|chc
1671934|NCT00100659|chronic hepatitis C|chronic hepatitis c
1671935|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
1671936|NCT00100659|hepatitis c|hepatitis c
1671937|NCT00100659|pediatric hepatitis|pediatric hepatitis
1671938|NCT00100659|pediatric HCV|pediatric hcv
1671939|NCT00100646|Treatment Interruption|treatment interruption
1671940|NCT00100646|Treatment Naive|treatment naive
1671941|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
1671942|NCT00100633|Treatment Experienced|treatment experienced
1671943|NCT00100633|Treatment Naive|treatment naive
1671944|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
1671945|NCT00100620|prevention|prevention
1671946|NCT00100620|treatment|treatment
1671947|NCT00100620|zoledronic acid|zoledronic acid
1671948|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
1671949|NCT00100594|Treatment Naive|treatment naive
1671950|NCT00100581|Treatment Naive|treatment naive
1671951|NCT00100568|Treatment Naive|treatment naive
1671952|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
1671953|NCT00100542|Treatment Experienced|treatment experienced
1671954|NCT00100542|Treatment Naive|treatment naive
1671955|NCT00100542|Psychopathology|psychopathology
1671956|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
1671957|NCT00100542|Child|child
1671958|NCT00100542|Adolescent|adolescent
1671959|NCT00100529|Facial Imaging|facial imaging
1671960|NCT00100529|Genetics|genetics
1671961|NCT00100529|Growth|growth
1671962|NCT00100529|Development|development
1671963|NCT00100529|Diagnostics|diagnostics
1671964|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
1671965|NCT00100529|Facial Features|facial features
1671966|NCT00100516|Renal|renal
1671967|NCT00100516|Allografts|allografts
1671968|NCT00100516|Nephrectomy|nephrectomy
1671969|NCT00100516|Pneumoperitoneum|pneumoperitoneum
1671970|NCT00100516|LaparoscopIC|laparoscopic
1671971|NCT00100516|Kidney Donation|kidney donation
1671972|NCT00100503|Rehabilitation|rehabilitation
1671973|NCT00100503|Forced Use|forced use
1671974|NCT00100503|Hemiplegia|hemiplegia
1671975|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
1671977|NCT00100503|Cerebral Palsy|cerebral palsy
1671978|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
1671979|NCT00100503|Healthy Volunteer|healthy volunteer
1671980|NCT00100503|HV|hv
1671981|NCT00100477|Multiple Myeloma|multiple myeloma
1671982|NCT00100477|Lymphoma|lymphoma
1671983|NCT00100477|Leukemia|leukemia
1671984|NCT00100477|Etoposide|etoposide
1671985|NCT00100477|Drug Therapy|drug therapy
1671986|NCT00100477|Clinical Trials|clinical trials
1671987|NCT00100464|Serotonin|serotonin
1671988|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
1671989|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
1671990|NCT00100451|Adipose tissue|adipose tissue
1671992|NCT00100451|Exercise|exercise
1671993|NCT00100451|Lipolysis|lipolysis
1671994|NCT00100451|Estrogens|estrogens
1671995|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
1671996|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
1671997|NCT00100425|Visceral Pain|visceral pain
1671998|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
1671999|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
1672000|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
1672001|NCT00100360|Gonadal Steroids|gonadal steroids
1672002|NCT00100360|GnRH Agonist|gnrh agonist
1672003|NCT00100360|Depression|depression
1672004|NCT00100360|Menstrual Cycle|menstrual cycle
1672005|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
1672006|NCT00100360|MRMD|mrmd
1672007|NCT00100360|Healthy Volunteer|healthy volunteer
1672008|NCT00100360|HV|hv
1672009|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
1672010|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
1672011|NCT00100347|NHL|nhl
1672012|NCT00100347|MetAP2|metap2
1672013|NCT00100347|Solid Tumors|solid tumors
1672014|NCT00100334|Alzheimer's Disease|alzheimer's disease
1672015|NCT00100321|Tumor Antigen Identification|tumor antigen identification
1672016|NCT00100321|Standard Treatment|standard treatment
1672017|NCT00100321|Tissue Acquisition|tissue acquisition
1672018|NCT00100321|Surgery|surgery
1672019|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
1672020|NCT00100321|Pancreatic Cancer|pancreatic cancer
1672021|NCT00100321|Pancreatic Tumor|pancreatic tumor
1672022|NCT00100308|sepsis|sepsis
1672023|NCT00100308|Randomized clinical trial|randomized clinical trial
1672024|NCT00100308|Heparin|heparin
1672025|NCT00100308|Therapy|therapy
1672026|NCT00100295|Adolescent|adolescent
1672027|NCT00100295|Child|child
1672028|NCT00100295|Phytotherapy|phytotherapy
1672029|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
1672030|NCT00100269|Male infertility|male infertility
1672031|NCT00100269|sperm|sperm
1672032|NCT00100269|pregnancy|pregnancy
1672033|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
1672034|NCT00100269|oxidative stress|oxidative stress
1672035|NCT00100269|free radicals|free radicals
1672036|NCT00100269|DNA damage|dna damage
1672037|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
1672038|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
1672039|NCT00100243|androgen-independent|androgen-independent
1672040|NCT00100243|prostate cancer|prostate cancer
1672041|NCT00100230|retina|retina
1672042|NCT00100230|electroretinography|electroretinography
1672043|NCT00100230|clinical trial|clinical trial
1672044|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
1672045|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
1672046|NCT00100230|x-linked inheritance|x-linked inheritance
1672047|NCT00100217|Training|training
1672048|NCT00100217|Critical Care|critical care
1672049|NCT00100217|Heart Failure|heart failure
1672050|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
1672051|NCT00100217|Infectious Diseases|infectious diseases
1672052|NCT00100204|Head and Neck Radiation|head and neck radiation
1672053|NCT00100204|Diabetes|diabetes
1672054|NCT00100204|Sarcoidosis|sarcoidosis
1672055|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
1672056|NCT00100204|Caries|caries
1672057|NCT00100204|Healthy Volunteer|healthy volunteer
1672058|NCT00100204|HV|hv
1672059|NCT00100204|Saliva Sample|saliva sample
1672060|NCT00100191|hysterectomy|hysterectomy
1672061|NCT00100191|fibroids|fibroids
1672062|NCT00100191|uterine artery embolization|uterine artery embolization
1672063|NCT00100191|therapeutic embolization|therapeutic embolization
1672064|NCT00100191|uterus|uterus
1672065|NCT00100191|menorrhagia|menorrhagia
1672066|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
1672067|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
1672068|NCT00100178|TrialNet|trialnet
1672069|NCT00100178|POPPII|poppii
1672070|NCT00100178|POPPII-1|poppii-1
1672071|NCT00100165|Schizophrenia|schizophrenia
1672072|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
1672073|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
1672074|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
1672075|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
1672076|NCT00100139|Neoplasm|neoplasm
1672077|NCT00100139|Cancer|cancer
1672078|NCT00100139|NeoPharm|neopharm
1672079|NCT00100139|Liposomes|liposomes
1672080|NCT00100139|Taxol|taxol
1672081|NCT00100139|Paclitaxel|paclitaxel
1672082|NCT00100139|Anti-cancer|anti-cancer
1672083|NCT00100139|Advanced neoplasm|advanced neoplasm
1672084|NCT00100139|Advanced cancer|advanced cancer
1672085|NCT00100139|Chemotherapy|chemotherapy
1672086|NCT00100139|Refractory cancer|refractory cancer
1672087|NCT00100139|Metastatic cancer|metastatic cancer
1672088|NCT00100126|Pharyngitis|pharyngitis
1672089|NCT00100126|Strep throat|strep throat
1672090|NCT00100113|cocaine dependence|cocaine dependence
1672091|NCT00100100|cocaine dependence|cocaine dependence
1672092|NCT00100087|macular degeneration|macular degeneration
1672093|NCT00100087|brachytherapy|brachytherapy
1672094|NCT00100087|choroidal neovascularization|choroidal neovascularization
1672095|NCT00100087|retinal degeneration|retinal degeneration
1672096|NCT00100087|retinal diseases|retinal diseases
1672097|NCT00100061|Cranberry|cranberry
1672098|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
1672099|NCT00100035|Caregivers|caregivers
1672100|NCT00100035|Complementary Therapies|complementary therapies
1672102|NCT00100009|Inflammation|inflammation
1672103|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
1672104|NCT00100009|Intravitreal Injection|intravitreal injection
1672105|NCT00100009|Verteporfin|verteporfin
1672106|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
1672107|NCT00100009|Photodynamic Therapy|photodynamic therapy
1672108|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
1672109|NCT00100009|AMD|amd
1672110|NCT00099996|Sitosterolemia|sitosterolemia
1672111|NCT00099996|Sitosterol|sitosterol
1672112|NCT00099996|Ezetimibe|ezetimibe
1672113|NCT00099996|Absorption|absorption
1672114|NCT00099996|Intestine|intestine
1672115|NCT00099996|Cholesterol|cholesterol
1672116|NCT00099996|Atherosclerosis|atherosclerosis
1672117|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
1672118|NCT00099983|PTSD|ptsd
1672119|NCT00099970|Solid tumors|solid tumors
1672120|NCT00099970|Metastatic melanoma|metastatic melanoma
1672121|NCT00099957|type 2 diabetes|type 2 diabetes
1672122|NCT00099957|vildagliptin|vildagliptin
1672123|NCT00099944|type 2 diabetes|type 2 diabetes
1672124|NCT00099944|vildagliptin|vildagliptin
1672125|NCT00099931|type 2 diabetes|type 2 diabetes
1672126|NCT00099931|vildagliptin|vildagliptin
1672127|NCT00099918|type 2 diabetes|type 2 diabetes
1672128|NCT00099918|vildagliptin|vildagliptin
1672129|NCT00099905|type 2 diabetes|type 2 diabetes
1672130|NCT00099905|vildagliptin|vildagliptin
1672131|NCT00099892|type 2 diabetes|type 2 diabetes
1672132|NCT00099892|vildagliptin|vildagliptin
1672133|NCT00099866|type 2 diabetes|type 2 diabetes
1672134|NCT00099866|vildagliptin|vildagliptin
1672135|NCT00099853|type 2 diabetes|type 2 diabetes
1672136|NCT00099853|vildagliptin|vildagliptin
1672137|NCT00099840|common cold|common cold
1672138|NCT00099840|pharyngitis|pharyngitis
1672139|NCT00099840|tonsillitis|tonsillitis
1672140|NCT00099840|rhinosinusitis|rhinosinusitis
1672141|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
1672142|NCT00099840|otitis media|otitis media
1672143|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
1672144|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
1672145|NCT00099840|community acquired pneumonia|community acquired pneumonia
1672146|NCT00099827|Depression|depression
1672147|NCT00099814|tooth movement|tooth movement
1672148|NCT00099814|orthodontics|orthodontics
1672149|NCT00099814|force|force
1672150|NCT00099814|humans|humans
1672151|NCT00099814|clinical trial|clinical trial
1672152|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
1672153|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
1672154|NCT00099788|Myocardial Infarction|myocardial infarction
1672155|NCT00099788|Heart Attack|heart attack
1672156|NCT00099788|Angina|angina
1672157|NCT00099788|Chest pain|chest pain
1672158|NCT00099788|Ischemia|ischemia
1672159|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
1672160|NCT00099775|Mycoses|mycoses
1672161|NCT00099775|Candida|candida
1672162|NCT00099775|Echinocandin|echinocandin
1672163|NCT00099775|Immunocompromised Host|immunocompromised host
1672164|NCT00099775|Invasive Fungal Infection|invasive fungal infection
1672165|NCT00099775|Fungal Infection|fungal infection
1672166|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
1672167|NCT00099762|FGF-23|fgf-23
1672168|NCT00099762|Phosphatonin|phosphatonin
1672169|NCT00099762|Hypophosphatemia|hypophosphatemia
1672170|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
1672171|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
1672172|NCT00099762|TIO|tio
1672173|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
1672174|NCT00099762|OOM|oom
1672175|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
1672176|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
1672177|NCT00099723|Hepatic steatosis|hepatic steatosis
1672178|NCT00099723|adult-onset diabetes|adult-onset diabetes
1672179|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
1672180|NCT00099710|Curcumin|curcumin
1672181|NCT00099710|Turmeric|turmeric
1672182|NCT00099710|Curry|curry
1672183|NCT00099710|NSAID|nsaid
1672184|NCT00099710|anti-inflammatory|anti-inflammatory
1672185|NCT00099710|Cholesterol|cholesterol
1672186|NCT00099710|anti-oxidant|anti-oxidant
1672187|NCT00099697|abdominal fat|abdominal fat
1672188|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
1672189|NCT00099697|Insulin sensitivity|insulin sensitivity
1672190|NCT00099684|Treatment Experienced|treatment experienced
1672191|NCT00099671|Treatment Experienced|treatment experienced
1672192|NCT00099658|MTCT|mtct
1672193|NCT00099645|Mifepristone|mifepristone
1672194|NCT00099645|Mifeprex|mifeprex
1672195|NCT00099645|RU486|ru486
1672196|NCT00099645|VGX-410|vgx-410
1672197|NCT00099645|Abortion Pill|abortion pill
1672198|NCT00099645|Investigational Drug|investigational drug
1672199|NCT00099632|Treatment Naive|treatment naive
1672200|NCT00099619|exenatide|exenatide
1672201|NCT00099619|exendin-4|exendin-4
1672205|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
1672206|NCT00099593|Sezary Syndrome|sezary syndrome
1672207|NCT00099593|Mycosis Fungoides|mycosis fungoides
1672208|NCT00099593|Vaccine|vaccine
1672209|NCT00099580|Congestive Heart Failure|congestive heart failure
1672210|NCT00099580|AC2592|ac2592
1672211|NCT00099580|GLP-1|glp-1
1672212|NCT00099580|Amylin|amylin
1672213|NCT00099580|metabolic abnormality|metabolic abnormality
1672214|NCT00099567|Metabolic Syndrome|metabolic syndrome
1672215|NCT00099567|Alzheimer's Disease|alzheimer's disease
1672216|NCT00099567|Cognitive Impairment|cognitive impairment
1672217|NCT00099567|Inflammation|inflammation
1672218|NCT00099541|Lung Cancer|lung cancer
1672219|NCT00099541|Bone Metastases|bone metastases
1672220|NCT00099541|Bone Markers|bone markers
1672222|NCT00099541|zoledronic acid|zoledronic acid
1672223|NCT00099541|Registry|registry
1672224|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
1672225|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
1672226|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
1672227|NCT00099528|Shingles|shingles
1672228|NCT00099528|Herpes Zoster|herpes zoster
1672229|NCT00099528|Neuropathic pain|neuropathic pain
1672230|NCT00099528|Neuralgia|neuralgia
1672231|NCT00099528|Anti-TNF agents|anti-tnf agents
1672232|NCT00099528|Inflammatory cytokines|inflammatory cytokines
1672233|NCT00099528|Hyperalgesia|hyperalgesia
1672234|NCT00099528|Allodynia|allodynia
1672235|NCT00099528|Irritable nociceptor|irritable nociceptor
1672236|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
1672237|NCT00099502|interferon beta 1b|interferon beta 1b
1672238|NCT00099502|Betaferon|betaferon
1672239|NCT00099502|Betaseron|betaseron
1672240|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
1672241|NCT00099489|CIDP|cidp
1672242|NCT00099489|IVIg|ivig
1672243|NCT00099489|AVONEX|avonex
1672244|NCT00099476|Epicatechin|epicatechin
1672245|NCT00099476|Polyphenols|polyphenols
1672246|NCT00099476|Chocolate|chocolate
1672247|NCT00099476|Insulin Resistance|insulin resistance
1672248|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
1672249|NCT00099476|Hypertension|hypertension
1672250|NCT00099463|Coronavirus|coronavirus
1672251|NCT00099463|Healthy|healthy
1672252|NCT00099463|Immunity|immunity
1672253|NCT00099463|Preventive|preventive
1672254|NCT00099463|Virus|virus
1672255|NCT00099463|Healthy Volunteer|healthy volunteer
1672256|NCT00099463|HV|hv
1672257|NCT00099450|bleeding|bleeding
1672258|NCT00099450|blood transfusion|blood transfusion
1672259|NCT00099450|surgeries|surgeries
1672260|NCT00099437|Advanced Breast Cancer|advanced breast cancer
1672261|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
1672262|NCT00099424|exercise training|exercise training
1672263|NCT00099424|resistance training|resistance training
1672264|NCT00099424|endurance training|endurance training
1672265|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
1672266|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
1672267|NCT00099385|social development|social development
1672268|NCT00099385|risk behaviors|risk behaviors
1672269|NCT00099385|social emotional education|social emotional education
1672270|NCT00099385|classroom instruction|classroom instruction
1672271|NCT00099372|sacrocolpopexy|sacrocolpopexy
1672272|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
1672273|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
1672274|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
1672275|NCT00099372|urinary incontinence|urinary incontinence
1672276|NCT00099372|stress urinary incontinence|stress urinary incontinence
1672277|NCT00099359|HIV|hiv
1672278|NCT00099359|Perinatal|perinatal
1672279|NCT00099359|Prevention|prevention
1672280|NCT00099359|Transmission|transmission
1672281|NCT00099359|Nevirapine|nevirapine
1672282|NCT00099359|Epivir|epivir
1672283|NCT00099359|Zidovudine|zidovudine
1672284|NCT00099359|Nelfinavir|nelfinavir
1672285|NCT00099359|ZDV|zdv
1672286|NCT00099359|NVP|nvp
1672287|NCT00099359|3TC|3tc
1672288|NCT00099359|NFV|nfv
1672289|NCT00099359|Viracept|viracept
1672290|NCT00099359|Viramune|viramune
1672291|NCT00099359|HIV Seronegativity|hiv seronegativity
1672292|NCT00099359|Treatment Naive|treatment naive
1672293|NCT00099333|exenatide|exenatide
1672294|NCT00099333|exendin-4|exendin-4
1672295|NCT00099333|Amylin|amylin
1672296|NCT00099333|Eli Lilly|eli lilly
1672297|NCT00099333|diabetes|diabetes
1672298|NCT00099320|exenatide|exenatide
1672299|NCT00099320|exendin-4|exendin-4
1672300|NCT00099320|diabetes|diabetes
1672301|NCT00099320|Amylin|amylin
1672302|NCT00099320|Lilly|lilly
1672303|NCT00099307|White Matter|white matter
1672304|NCT00099307|Grey Matter|grey matter
1672305|NCT00099307|Brain|brain
1672306|NCT00099307|Disability|disability
1672307|NCT00099307|Lesions|lesions
1672308|NCT00099307|Multiple Sclerosis|multiple sclerosis
1672309|NCT00099307|MS|ms
1672310|NCT00099307|Healthy Volunteer|healthy volunteer
1672311|NCT00099307|HV|hv
1672314|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
1672315|NCT00099294|Metastatic|metastatic
1672316|NCT00099294|Glufosfamide|glufosfamide
1672317|NCT00099281|Metastatic breast cancer|metastatic breast cancer
1672318|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
1672319|NCT00099255|Keyword?|keyword?
1672320|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
1672519|NCT00098384|prophylaxis|prophylaxis
1672321|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
1672322|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
1672323|NCT00099242|Alzheimer's Disease|alzheimer's disease
1672324|NCT00099242|Dementia|dementia
1672325|NCT00099229|bipolar disorder|bipolar disorder
1672326|NCT00099229|manic episode|manic episode
1672327|NCT00099229|treatment|treatment
1672328|NCT00099229|licarbazepine|licarbazepine
1672329|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
1672330|NCT00099190|cancer|cancer
1672331|NCT00099190|solid tumor|solid tumor
1672332|NCT00099190|advanced solid tumor|advanced solid tumor
1672333|NCT00099164|preterm birth|preterm birth
1672334|NCT00099164|pregnancy|pregnancy
1672335|NCT00099164|multifetal|multifetal
1672336|NCT00099164|Progesterone|progesterone
1672337|NCT00099151|Longevity|longevity
1672338|NCT00099151|Dietary restriction|dietary restriction
1672339|NCT00099151|Physical activity|physical activity
1672340|NCT00099151|Weight Loss|weight loss
1672341|NCT00099151|Diabetes|diabetes
1672342|NCT00099138|Diet|diet
1672343|NCT00099138|Caloric Restriction|caloric restriction
1672344|NCT00099138|Exercise|exercise
1672345|NCT00099138|Energy Metabolism|energy metabolism
1672346|NCT00099138|Primary Aging|primary aging
1672347|NCT00099138|Secondary Aging|secondary aging
1672348|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
1672349|NCT00099125|adult gliosarcoma|adult gliosarcoma
1672350|NCT00099125|adult glioblastoma|adult glioblastoma
1672351|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1672352|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1672353|NCT00099112|actinic keratosis|actinic keratosis
1672354|NCT00099099|Longevity|longevity
1672355|NCT00099099|Calorie restriction|calorie restriction
1672356|NCT00099099|Physical activity|physical activity
1672357|NCT00099099|Weight loss|weight loss
1672358|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1672359|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
1672360|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
1672361|NCT00099086|stage III prostate cancer|stage iii prostate cancer
1672362|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
1672363|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
1672364|NCT00099060|adult gliosarcoma|adult gliosarcoma
1672365|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
1672366|NCT00099008|breast cancer|breast cancer
1672367|NCT00099008|endometrial cancer|endometrial cancer
1672368|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
1672369|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
1672370|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
1672371|NCT00098995|stage III cervical cancer|stage iii cervical cancer
1672372|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
1672373|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
1672374|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1672375|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1672376|NCT00098982|stage III colon cancer|stage iii colon cancer
1672377|NCT00098982|stage IV colon cancer|stage iv colon cancer
1672378|NCT00098982|stage III rectal cancer|stage iii rectal cancer
1672379|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
1672380|NCT00098982|recurrent colon cancer|recurrent colon cancer
1672381|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
1672382|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1672383|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1672384|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
1672385|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
1672386|NCT00098943|stage IV colon cancer|stage iv colon cancer
1672387|NCT00098943|recurrent colon cancer|recurrent colon cancer
1672388|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
1672389|NCT00098943|insular thyroid cancer|insular thyroid cancer
1672390|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1672391|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1672392|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1672393|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
1672394|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1672395|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1672396|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1672397|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1672398|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1672399|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1672400|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1672401|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1672402|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1672403|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1672404|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1672405|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1672406|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1672407|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1672408|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1672409|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1672410|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1672411|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1672412|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1672413|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1672414|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1672415|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1672416|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1672417|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1672418|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1672419|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1672420|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1672421|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1672422|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1672520|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
1672423|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1672424|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1672425|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1672426|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
1672427|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
1672428|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
1672429|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
1672430|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1672431|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1672432|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1672433|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1672434|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1672435|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1672436|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1672437|NCT00098878|fallopian tube cancer|fallopian tube cancer
1672438|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1672439|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
1672440|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
1672441|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1672442|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
1672443|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1672444|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
1672611|NCT00098072|PPH|pph
1672445|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
1672446|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
1672447|NCT00098787|recurrent colon cancer|recurrent colon cancer
1672448|NCT00098787|stage IV colon cancer|stage iv colon cancer
1672449|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
1672450|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
1672451|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
1672452|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1672453|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1672454|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1672455|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1672456|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1672457|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1672458|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
1672459|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1672460|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1672461|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1672462|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
1672463|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
1672464|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1672465|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
1672466|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
1672467|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
1672468|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1672469|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1672470|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
1672471|NCT00098709|pregnancy|pregnancy
1672472|NCT00098709|labor, obstetric|labor, obstetric
1672473|NCT00098709|fetal monitoring|fetal monitoring
1672474|NCT00098709|oximetry|oximetry
1672475|NCT00098709|fetal heart rate|fetal heart rate
1672476|NCT00098709|cardiotocography|cardiotocography
1672477|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
1672478|NCT00098683|refractory anemia|refractory anemia
1672479|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1672480|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1672481|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1672482|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1672483|NCT00098566|quality of life|quality of life
1672484|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1672485|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1672486|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1672487|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1672488|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1672489|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1672490|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1672491|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1672492|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1672493|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1672494|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1672495|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1672496|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1672497|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1672498|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1672499|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1672500|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1672501|NCT00098553|stage IV melanoma|stage iv melanoma
1672502|NCT00098553|recurrent melanoma|recurrent melanoma
1672503|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1672504|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1672505|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1672506|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1672507|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1672508|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1672509|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1672510|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1672511|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1672512|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1673490|NCT00094978|NSCLC|nsclc
1672513|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1672514|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1672515|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1672516|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1672517|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
1672518|NCT00098384|rifaximin|rifaximin
1672521|NCT00098358|Leukotrienes|leukotrienes
1672522|NCT00098358|inflammation|inflammation
1672523|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
1672524|NCT00098345|ZD6474|zd6474
1672525|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1672526|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1672527|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1672528|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1672529|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1672530|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1672531|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1672532|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1672533|NCT00098319|Cleft palate|cleft palate
1672534|NCT00098319|Cleft lip|cleft lip
1672535|NCT00098319|Folic acid|folic acid
1672536|NCT00098319|Global Network|global network
1672537|NCT00098319|Maternal and child health|maternal and child health
1672538|NCT00098319|International|international
1672539|NCT00098319|Women's health|women's health
1672540|NCT00098319|Brazil|brazil
1672541|NCT00098319|Brasil|brasil
1672542|NCT00098319|Latin America|latin america
1672543|NCT00098319|ECLAMC|eclamc
1672544|NCT00098319|Congenital defects|congenital defects
1672545|NCT00098319|Pregnancy|pregnancy
1672546|NCT00098293|Aids|aids
1672548|NCT00098280|H5g1|h5g1
1672549|NCT00098280|PNH|pnh
1672550|NCT00098280|TRIUMPH|triumph
1672551|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1672552|NCT00098267|Bacteria|bacteria
1672553|NCT00098267|Biofilm Formation|biofilm formation
1672554|NCT00098267|Secretory Antibodies|secretory antibodies
1672555|NCT00098267|Teeth|teeth
1672556|NCT00098267|Health and Disease|health and disease
1672557|NCT00098254|Non-Small Cell|non-small cell
1672558|NCT00098254|Molecular|molecular
1672559|NCT00098254|Targeted|targeted
1672560|NCT00098254|Therapies|therapies
1672561|NCT00098254|Cancer|cancer
1672562|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
1672563|NCT00098254|NSCLC|nsclc
1672564|NCT00098241|pediatric|pediatric
1672565|NCT00098241|renal|renal
1672566|NCT00098241|transplant recipients|transplant recipients
1672567|NCT00098241|de novo|de novo
1672568|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
1672569|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
1672570|NCT00098215|Residency training|residency training
1672571|NCT00098202|Global Network|global network
1672572|NCT00098202|Micronutrients|micronutrients
1672573|NCT00098202|Zinc|zinc
1672574|NCT00098202|Maternal and child health|maternal and child health
1672575|NCT00098202|Women's health|women's health
1672576|NCT00098202|International|international
1672577|NCT00098202|Guatemala|guatemala
1672578|NCT00098202|Nutrition|nutrition
1672579|NCT00098202|Corn|corn
1672580|NCT00098202|Maize|maize
1672581|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
1672582|NCT00098163|HIV Seronegativity|hiv seronegativity
1672583|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
1672584|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
1672585|NCT00098137|atrial fibrillation|atrial fibrillation
1672586|NCT00098137|angiotensin II|angiotensin ii
1672587|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
1672588|NCT00098137|drug|drug
1672589|NCT00098137|controlled clinical trial|controlled clinical trial
1672590|NCT00098124|NSRI|nsri
1672591|NCT00098124|milnacipran|milnacipran
1672592|NCT00098124|fibromyalgia|fibromyalgia
1672593|NCT00098111|Crohn's disease|crohn's disease
1672594|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
1672595|NCT00098111|IMURAN|imuran
1672596|NCT00098111|azathioprine|azathioprine
1672597|NCT00098098|Botulinum|botulinum
1672598|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
1672599|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
1672600|NCT00098085|Lung cancer|lung cancer
1672601|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
1672602|NCT00098085|Pulmonary|pulmonary
1672603|NCT00098085|Immunotherapy|immunotherapy
1672604|NCT00098085|Vaccine|vaccine
1672605|NCT00098072|Cytometry|cytometry
1672606|NCT00098072|Genes|genes
1672607|NCT00098072|Hypertension|hypertension
1672608|NCT00098072|Lung|lung
1672609|NCT00098072|Proteomics|proteomics
1672610|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
1672612|NCT00098072|Healthy Volunteers|healthy volunteers
1672614|NCT00098059|herpes simplex|herpes simplex
1672615|NCT00098059|cold sores|cold sores
1672616|NCT00098059|fever blisters|fever blisters
1672617|NCT00098059|children|children
1672618|NCT00098059|Famvir|famvir
1672619|NCT00098059|famciclovir|famciclovir
1672620|NCT00098046|chickenpox|chickenpox
1672621|NCT00098046|herpes zoster|herpes zoster
1672622|NCT00098046|children|children
1672623|NCT00098046|Famvir|famvir
1672624|NCT00098046|varicella zoster virus|varicella zoster virus
1672625|NCT00098033|clinical|clinical
1672626|NCT00098033|pharmacodynamics|pharmacodynamics
1672627|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
1672628|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
1672629|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
1672732|NCT00097669|stroke|stroke
1672630|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
1672631|NCT00098020|Glomerulosclerosis|glomerulosclerosis
1672632|NCT00098020|Proteinuria|proteinuria
1672633|NCT00098020|Fibrosis|fibrosis
1672634|NCT00098020|Chronic Kidney Disease|chronic kidney disease
1672635|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
1672636|NCT00098007|Heart transplantation|heart transplantation
1672637|NCT00098007|Everolimus|everolimus
1672638|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
1672639|NCT00097994|Menopause|menopause
1672640|NCT00097994|Quality of Life|quality of life
1672641|NCT00097994|Health Services|health services
1672642|NCT00097994|Complementary Therapies|complementary therapies
1672643|NCT00097981|Multiple myeloma|multiple myeloma
1672644|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
1672645|NCT00097981|Thalidomide|thalidomide
1672646|NCT00097981|Dexamethasone|dexamethasone
1672647|NCT00097981|DOXIL|doxil
1672648|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
1672649|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
1672650|NCT00097968|allograft rejection|allograft rejection
1672651|NCT00097955|diabetes|diabetes
1672652|NCT00097955|nephropathy|nephropathy
1672653|NCT00097955|hypertension|hypertension
1672654|NCT00097955|aliskiren|aliskiren
1672655|NCT00097955|losartan|losartan
1672656|NCT00097942|memantine|memantine
1672657|NCT00097942|adjunctive therapy|adjunctive therapy
1672658|NCT00097942|schizophrenia|schizophrenia
1672659|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
1672660|NCT00097916|memantine HCl|memantine hcl
1672661|NCT00097916|Dementia|dementia
1672662|NCT00097916|Agitation|agitation
1672663|NCT00097916|Alzheimer Disease|alzheimer disease
1672664|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1672665|NCT00097903|Solid Tumors|solid tumors
1672666|NCT00097903|Oral|oral
1672667|NCT00097890|Lysosomes|lysosomes
1672668|NCT00097890|Storage|storage
1672669|NCT00097890|Glycolipid|glycolipid
1672670|NCT00097890|Fabry Disease|fabry disease
1672671|NCT00097890|Stroke|stroke
1672672|NCT00097877|Type 2 Diabetes|type 2 diabetes
1672673|NCT00097851|second-line|second-line
1672674|NCT00097851|combination|combination
1672675|NCT00097851|chemotherapy|chemotherapy
1672676|NCT00097851|anti-angiogenic|anti-angiogenic
1672677|NCT00097838|HIV Seronegativity|hiv seronegativity
1672678|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
1672679|NCT00097825|Male Osteoporosis|male osteoporosis
1672680|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
1672681|NCT00097786|Prevention|prevention
1672682|NCT00097786|Diabetes type 2|diabetes type 2
1672683|NCT00097786|valsartan|valsartan
1672684|NCT00097786|nateglinide|nateglinide
1672685|NCT00097773|Lung Diseases|lung diseases
1672686|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1672687|NCT00097760|Multiple Sclerosis|multiple sclerosis
1672688|NCT00097760|MS|ms
1672689|NCT00097747|anemia|anemia
1672690|NCT00097747|chronic kidney disease|chronic kidney disease
1672691|NCT00097747|CKD|ckd
1672692|NCT00097747|chronic renal failure|chronic renal failure
1672693|NCT00097747|CRF|crf
1672694|NCT00097747|erythropoietin|erythropoietin
1672695|NCT00097747|EPO|epo
1672696|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
1672697|NCT00097747|ESA|esa
1672698|NCT00097747|Hematide™|hematide™
1672699|NCT00097747|hemoglobin|hemoglobin
1672700|NCT00097747|Hb|hb
1672701|NCT00097747|Hgb|hgb
1672702|NCT00097747|Omontys|omontys
1672703|NCT00097747|peginesatide|peginesatide
1672704|NCT00097747|red blood cell|red blood cell
1672705|NCT00097747|red blood cell production|red blood cell production
1672706|NCT00097734|diverticulitis|diverticulitis
1672707|NCT00097734|Invanz|invanz
1672708|NCT00097734|Ertapenem|ertapenem
1672709|NCT00097734|acute attacks|acute attacks
1672710|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
1672711|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
1672712|NCT00097721|breast neoplasm|breast neoplasm
1672713|NCT00097721|breast cancer|breast cancer
1672714|NCT00097721|breast tumor|breast tumor
1672715|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
1672716|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
1672717|NCT00097695|Hereditary Angioedema|hereditary angioedema
1672718|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
1672719|NCT00097695|HAE|hae
1672720|NCT00097695|Icatibant|icatibant
1672721|NCT00097695|Bradykinin antagonist|bradykinin antagonist
1672722|NCT00097695|acute attack|acute attack
1672723|NCT00097695|subcutaneous|subcutaneous
1672724|NCT00097682|Financial Ties|financial ties
1672725|NCT00097682|Institution|institution
1672726|NCT00097682|Research Doctor|research doctor
1672727|NCT00097682|Oncology|oncology
1672728|NCT00097682|Attitudes|attitudes
1672729|NCT00097682|Cancer|cancer
1672730|NCT00097682|Survey|survey
1672731|NCT00097669|VITATOPS|vitatops
1672734|NCT00097669|multivitamins|multivitamins
1672735|NCT00097669|homocysteine|homocysteine
1672736|NCT00097643|exercise|exercise
1672737|NCT00097643|health promotion|health promotion
1672738|NCT00097643|independent living|independent living
1672739|NCT00097643|affective aspects|affective aspects
1672740|NCT00097630|mechanical ventilation|mechanical ventilation
1672741|NCT00097630|delirium|delirium
1672742|NCT00097630|sedation scoring|sedation scoring
1672743|NCT00097630|cognitive impairment|cognitive impairment
1672744|NCT00097630|ventilation weaning|ventilation weaning
1672745|NCT00097604|Sleep|sleep
1672746|NCT00097604|Aged|aged
1672747|NCT00097604|Valerian|valerian
1672748|NCT00097604|Complementary Therapies|complementary therapies
1672749|NCT00097604|Medicine, Herbal|medicine, herbal
1672750|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
1672751|NCT00097539|Pediatric growth disorders|pediatric growth disorders
1672752|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
1672753|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
1672754|NCT00097500|diabetes|diabetes
1672755|NCT00097500|exenatide|exenatide
1672756|NCT00097500|exendin-4|exendin-4
1672757|NCT00097500|Amylin|amylin
1672758|NCT00097500|Lilly|lilly
1672759|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
1672760|NCT00097474|Cortisol|cortisol
1672761|NCT00097474|Travel|travel
1672762|NCT00097474|Saliva|saliva
1672763|NCT00097474|Body Clock|body clock
1672764|NCT00097474|Sleep|sleep
1672765|NCT00097474|Healthy Volunteer|healthy volunteer
1672766|NCT00097474|HV|hv
1672767|NCT00097474|Jet Lag|jet lag
1672768|NCT00097461|Employee Health|employee health
1672769|NCT00097461|Insurance Benefit|insurance benefit
1672770|NCT00097461|Fringe Benefit|fringe benefit
1672771|NCT00097461|Health Status|health status
1672772|NCT00097461|Socioeconomic Factors|socioeconomic factors
1672773|NCT00097448|sudden hearing loss|sudden hearing loss
1672774|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
1672775|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
1672776|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
1672777|NCT00097422|CDAD, diarrhea|cdad, diarrhea
1672778|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
1672779|NCT00097409|ovarian cancer|ovarian cancer
1672780|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
1672781|NCT00097409|Persistent|persistent
1672782|NCT00097409|Recurrent|recurrent
1672783|NCT00097396|plague|plague
1672784|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
1672785|NCT00097396|vaccine|vaccine
1672786|NCT00097396|plague vaccine|plague vaccine
1672787|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
1672788|NCT00097370|Mepolizumab|mepolizumab
1672789|NCT00097370|Open-label|open-label
1672790|NCT00097370|Anti-IL-5|anti-il-5
1672791|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1672792|NCT00097370|Hypereosinophilia|hypereosinophilia
1672793|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
1672794|NCT00097357|Preventive therapy|preventive therapy
1672795|NCT00097344|Aromatase inhibitor|aromatase inhibitor
1672796|NCT00097344|Atamestane|atamestane
1672797|NCT00097344|Breast neoplasms|breast neoplasms
1672798|NCT00097344|Combined hormonal therapy|combined hormonal therapy
1672799|NCT00097344|Complete estrogen blockade|complete estrogen blockade
1672800|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
1672801|NCT00097344|Estrogen blocker|estrogen blocker
1672802|NCT00097344|Fareston®|fareston®
1672803|NCT00097344|Femara®|femara®
1672804|NCT00097344|First line therapy|first line therapy
1672805|NCT00097344|Letrozole|letrozole
1672806|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
1672807|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
1672808|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
1672809|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
1672810|NCT00097344|Metastatic breast cancer|metastatic breast cancer
1672811|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
1672812|NCT00097344|Receptor-positive|receptor-positive
1672813|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
1672814|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
1672815|NCT00097344|Stage IV breast cancer|stage iv breast cancer
1672816|NCT00097344|Toremifene|toremifene
1672817|NCT00097331|multiple sclerosis|multiple sclerosis
1672818|NCT00097331|relapsing|relapsing
1672819|NCT00097331|remitting|remitting
1672820|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
1672821|NCT00097318|Ischemic|ischemic
1672822|NCT00097318|Brain|brain
1672823|NCT00097318|Inflammation|inflammation
1672824|NCT00097318|Clinical Trial|clinical trial
1672825|NCT00097318|Stroke|stroke
1672826|NCT00097305|Mental Health|mental health
1672827|NCT00097305|Psychotherapy|psychotherapy
1672828|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
1672829|NCT00097292|T1DM|t1dm
1672830|NCT00097292|T1D|t1d
1672939|NCT00097032|sedation|sedation
1672831|NCT00097292|juvenile diabetes|juvenile diabetes
1672832|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
1672833|NCT00097292|TrialNet|trialnet
1672834|NCT00097266|Bipolar Mania|bipolar mania
1672835|NCT00097253|Aromatherapy|aromatherapy
1672836|NCT00097253|Smell|smell
1672837|NCT00097240|FOLLOW|follow
1672838|NCT00097240|Psoriasis|psoriasis
1672839|NCT00097240|Pregnancy|pregnancy
1672840|NCT00097227|NSCLC|nsclc
1672841|NCT00097227|non-small|non-small
1672842|NCT00097227|lung|lung
1672843|NCT00097227|IIIb|iiib
1672844|NCT00097227|IV|iv
1672845|NCT00097227|Carboplatin|carboplatin
1672846|NCT00097227|Paclitaxel|paclitaxel
1672847|NCT00097227|Cetuximab|cetuximab
1672848|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
1672849|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
1672850|NCT00097214|NSCLC|nsclc
1672851|NCT00097214|Non-small|non-small
1672852|NCT00097214|Lung|lung
1672853|NCT00097214|IIIB|iiib
1672854|NCT00097214|IV|iv
1672855|NCT00097214|Carboplatin|carboplatin
1672856|NCT00097214|Cetuximab|cetuximab
1672857|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1672858|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1672859|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1672860|NCT00097175|Major Depressive Disorder|major depressive disorder
1672861|NCT00097175|Serotonin|serotonin
1672862|NCT00097175|Functional MRI|functional mri
1672863|NCT00097175|Genotype|genotype
1672864|NCT00097175|Negative Affect|negative affect
1672865|NCT00097175|MDD|mdd
1672866|NCT00097175|Healthy Volunteer|healthy volunteer
1672867|NCT00097175|HV|hv
1672868|NCT00097162|Anisometropia|anisometropia
1672869|NCT00097162|Strabismus|strabismus
1672870|NCT00097162|Cortical Suppression|cortical suppression
1672871|NCT00097162|Impaired Vision|impaired vision
1672872|NCT00097162|Cortical Plasticity|cortical plasticity
1672873|NCT00097162|Amblyopia|amblyopia
1672874|NCT00097162|Adult Amblyopia|adult amblyopia
1672875|NCT00097149|Congenital birth defects|congenital birth defects
1672876|NCT00097149|Cleft lip|cleft lip
1672877|NCT00097149|Cleft palate|cleft palate
1672878|NCT00097149|Global Network|global network
1672879|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
1672880|NCT00097149|Maternal and child health|maternal and child health
1672881|NCT00097149|International|international
1672882|NCT00097149|Women's health|women's health
1672883|NCT00097149|Brazil|brazil
1672884|NCT00097149|Brasil|brasil
1672885|NCT00097149|Latin America|latin america
1672886|NCT00097149|ECLAMC|eclamc
1672887|NCT00097149|Argentina|argentina
1672888|NCT00097149|Bolivia|bolivia
1672889|NCT00097149|Chile|chile
1672890|NCT00097149|Colombia|colombia
1672891|NCT00097149|Ecuador|ecuador
1672892|NCT00097149|Venezuela|venezuela
1672893|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
1672894|NCT00097123|PPH|pph
1672895|NCT00097123|Misoprostol|misoprostol
1672896|NCT00097123|Global Network|global network
1672897|NCT00097123|Uterotonics|uterotonics
1672898|NCT00097123|India|india
1672899|NCT00097123|Maternal and child health|maternal and child health
1672900|NCT00097123|International|international
1672901|NCT00097123|Women's health|women's health
1672902|NCT00097110|Vitamin C|vitamin c
1672903|NCT00097110|Vitamin E|vitamin e
1672904|NCT00097110|Preeclampsia|preeclampsia
1672905|NCT00097110|Antioxidants|antioxidants
1672906|NCT00097110|Global Network|global network
1672907|NCT00097110|Preterm birth|preterm birth
1672908|NCT00097110|Low birth weight infants|low birth weight infants
1672909|NCT00097110|Brazil|brazil
1672910|NCT00097110|Brasil|brasil
1672911|NCT00097110|Maternal and child health|maternal and child health
1672912|NCT00097110|International|international
1672913|NCT00097110|Women's health|women's health
1672914|NCT00097097|Asphyxia|asphyxia
1672915|NCT00097097|Neonatal mortality|neonatal mortality
1672916|NCT00097097|Neonatal morbidity|neonatal morbidity
1673585|NCT00094601|PET|pet
1672917|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
1672918|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
1672919|NCT00097097|Neonatal resuscitation|neonatal resuscitation
1672920|NCT00097097|Global Network|global network
1672922|NCT00097097|Africa|africa
1672923|NCT00097097|Cerebral palsy|cerebral palsy
1672924|NCT00097097|Child health|child health
1672925|NCT00097097|International|international
1672926|NCT00097071|Diabetes, Type 1|diabetes, type 1
1672927|NCT00097058|Aging|aging
1672928|NCT00097058|Menopause|menopause
1672929|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
1672930|NCT00097058|Cognitive Decline|cognitive decline
1672931|NCT00097045|Hepatitis C|hepatitis c
1672932|NCT00097045|HCV|hcv
1672933|NCT00097045|Omega Interferon|omega interferon
1672934|NCT00097045|Interferon|interferon
1672935|NCT00097045|HCV genotype 1|hcv genotype 1
1672936|NCT00097032|Bipolar I Disorder|bipolar i disorder
1672937|NCT00097032|risperidone|risperidone
1672938|NCT00097032|quetiapine|quetiapine
1672941|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
1672942|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
1672943|NCT00096993|Omnitarg|omnitarg
1672944|NCT00096993|Cancer|cancer
1672945|NCT00096993|Platinum-Resistant|platinum-resistant
1672946|NCT00096967|Metastatic breast cancer|metastatic breast cancer
1672947|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
1672948|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
1672949|NCT00096954|Atopic Asthma|atopic asthma
1672950|NCT00096941|Advanced solid cancers|advanced solid cancers
1672951|NCT00096941|HER2|her2
1672952|NCT00096941|EGFR|egfr
1672953|NCT00096928|Plaque Psoriasis|plaque psoriasis
1672954|NCT00096928|RESPONSE|response
1672955|NCT00096928|Raptiva|raptiva
1672956|NCT00096928|efalizumab|efalizumab
1672957|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
1672958|NCT00096915|renal failure|renal failure
1672959|NCT00096915|anemia|anemia
1672960|NCT00096915|hemodialysis|hemodialysis
1672961|NCT00096915|peritoneal dialysis|peritoneal dialysis
1672962|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
1672963|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
1672964|NCT00096902|Hypnosis|hypnosis
1672965|NCT00096902|Cold Pressor|cold pressor
1672966|NCT00096902|Isometric Exercise|isometric exercise
1672967|NCT00096902|Behavior|behavior
1672968|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
1672969|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
1672970|NCT00096863|Delirium|delirium
1672971|NCT00096863|Cognition Disorders|cognition disorders
1672972|NCT00096863|Antipsychotics|antipsychotics
1672973|NCT00096863|Mechanical Ventilation|mechanical ventilation
1672974|NCT00096863|Critical Illness|critical illness
1672975|NCT00096850|HIV Seronegativity|hiv seronegativity
1672976|NCT00096850|Antitubercular agents|antitubercular agents
1672977|NCT00096837|Myeloma|myeloma
1672978|NCT00096837|Multiple Myeloma|multiple myeloma
1672979|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
1672980|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
1672981|NCT00096824|Acute Infection|acute infection
1672982|NCT00096824|Treatment Naive|treatment naive
1672983|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
1672984|NCT00096798|Antidepressive Agents|antidepressive agents
1672985|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
1672986|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
1672987|NCT00096772|Genetic Testing|genetic testing
1672988|NCT00096772|Genomics|genomics
1672989|NCT00096772|Human Genetic Factors|human genetic factors
1672990|NCT00096759|Arthritis|arthritis
1672991|NCT00096759|Tai Chi|tai chi
1672992|NCT00096759|Meditation|meditation
1672993|NCT00096759|Relaxation Techniques|relaxation techniques
1672994|NCT00096746|Treatment Experienced|treatment experienced
1672995|NCT00096733|Living donors|living donors
1672996|NCT00096733|Organ procurement|organ procurement
1672997|NCT00096733|Liver transplantation|liver transplantation
1672998|NCT00096733|Hepatitis C|hepatitis c
1672999|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
1673000|NCT00096733|Hepatectomy|hepatectomy
1673001|NCT00096733|Liver regeneration|liver regeneration
1673002|NCT00096733|Graft rejection|graft rejection
1673003|NCT00096733|Quality of life|quality of life
1673004|NCT00096733|Informed consent|informed consent
1673005|NCT00096720|parkinson|parkinson
1673006|NCT00096720|brain imaging|brain imaging
1673007|NCT00096720|diagnosis|diagnosis
1673008|NCT00096707|advanced solid tumors|advanced solid tumors
1673009|NCT00096707|cancer|cancer
1673010|NCT00096707|docetaxel|docetaxel
1673011|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
1673012|NCT00096707|phase 1|phase 1
1673013|NCT00096694|Intrauterine Device|intrauterine device
1673014|NCT00096694|IUD|iud
1673015|NCT00096694|Contraceptive|contraceptive
1673016|NCT00096694|Levonorgestrel|levonorgestrel
1673017|NCT00096668|Breast cancer|breast cancer
1673018|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
1673019|NCT00096655|Ulcerative colitis|ulcerative colitis
1673020|NCT00096655|Infliximab|infliximab
1673021|NCT00096655|Remicade|remicade
1673022|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
1673023|NCT00096642|depression|depression
1673024|NCT00096642|group therapy|group therapy
1673025|NCT00096642|parenting|parenting
1673026|NCT00096642|children and adolescents|children and adolescents
1673027|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
1673028|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
1673029|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
1673030|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
1673031|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
1673032|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
1673033|NCT00096590|thromboembolism|thromboembolism
1673034|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673035|NCT00096564|Mirror Neuron|mirror neuron
1673036|NCT00096564|Urge|urge
1673037|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
1673038|NCT00096564|Healthy Volunteer|healthy volunteer
1673039|NCT00096564|HV|hv
1673040|NCT00096551|Biochemical Failure|biochemical failure
1673041|NCT00096551|Immunotherapy|immunotherapy
1673042|NCT00096551|TRICOM|tricom
1673043|NCT00096551|Pox-virus|pox-virus
1673044|NCT00096551|Fowlpox|fowlpox
1673045|NCT00096551|Prostate Cancer|prostate cancer
1673046|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
1673047|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1673048|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
1673049|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
1673050|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
1673051|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1673052|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1673053|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1673054|NCT00096473|Alzheimer's Disease|alzheimer's disease
1673055|NCT00096473|dementia|dementia
1673056|NCT00096473|acetylcholinesterase|acetylcholinesterase
1673057|NCT00096473|donepezil|donepezil
1673058|NCT00096473|Aricept|aricept
1673059|NCT00096473|memory loss|memory loss
1673060|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
1673061|NCT00096421|Critical illness|critical illness
1673062|NCT00096421|Critical care|critical care
1673063|NCT00096421|Hyperglycemia|hyperglycemia
1673064|NCT00096421|Intensive care|intensive care
1673065|NCT00096421|Intensive Care Units|intensive care units
1673066|NCT00096421|Insulin resistance|insulin resistance
1673067|NCT00096421|Intensive insulin therapy|intensive insulin therapy
1673068|NCT00096421|Conventional insulin therapy|conventional insulin therapy
1673069|NCT00096408|Endometrial|endometrial
1673070|NCT00096408|Endometrium|endometrium
1673071|NCT00096408|Uterus|uterus
1673072|NCT00096408|Cancer|cancer
1673073|NCT00096408|Carcinoma|carcinoma
1673074|NCT00096408|Adenocarcinoma|adenocarcinoma
1673075|NCT00096408|Stage 1|stage 1
1673076|NCT00096408|Hysterectomy|hysterectomy
1673077|NCT00096408|Laparoscopy|laparoscopy
1673078|NCT00096408|Abdominal|abdominal
1673079|NCT00096408|Total|total
1673080|NCT00096408|Surgery|surgery
1673081|NCT00096408|Quality of Life|quality of life
1673082|NCT00096408|Disease-free survival|disease-free survival
1673083|NCT00096382|stage IV melanoma|stage iv melanoma
1673084|NCT00096382|recurrent melanoma|recurrent melanoma
1673085|NCT00096369|breast cancer|breast cancer
1673086|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1673087|NCT00096369|breast cancer in situ|breast cancer in situ
1673088|NCT00096356|fatigue|fatigue
1673089|NCT00096356|stage I breast cancer|stage i breast cancer
1673090|NCT00096356|stage II breast cancer|stage ii breast cancer
1673091|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
1673092|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
1673093|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
1673094|NCT00096356|stage IV breast cancer|stage iv breast cancer
1673095|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1673096|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1673097|NCT00096343|stage II breast cancer|stage ii breast cancer
1673098|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
1673099|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
1673100|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
1673101|NCT00096330|colon cancer|colon cancer
1673102|NCT00096330|rectal cancer|rectal cancer
1673103|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673104|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1673105|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
1673106|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
1673107|NCT00096291|stage II breast cancer|stage ii breast cancer
1673108|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
1673109|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
1673110|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
1674188|NCT00091676|idiotype|idiotype
1673111|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1673112|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1673113|NCT00096239|fallopian tube cancer|fallopian tube cancer
1673114|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1673115|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1673116|NCT00096213|chondrosarcoma|chondrosarcoma
1673244|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
1673117|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
1673118|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
1673119|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
1673120|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1673121|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1673122|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1673123|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1673124|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1673412|NCT00095381|BCX-1777|bcx-1777
1673125|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1673126|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1673127|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
1673128|NCT00096096|graft versus host disease|graft versus host disease
1673129|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1673130|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1673131|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1673132|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
1673133|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1673134|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1673135|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1673136|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1673137|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1673138|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1673139|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1673140|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1673141|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1673142|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1673143|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1673144|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1673145|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1673146|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1673147|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1673148|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1673149|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1673150|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1673151|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
1673152|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1673153|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
1673154|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1673155|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1673156|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1673157|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1673158|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1673159|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1673160|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1673161|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1673162|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1673163|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1673164|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1673165|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1673166|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1673167|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1673168|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1673169|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1673170|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1673171|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1673172|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1673173|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1673174|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1673175|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1673176|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1673177|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1673245|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
1673178|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1673179|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1673180|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1673181|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1673182|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1673183|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1673184|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
1673185|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
1673186|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
1673187|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1673188|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1673189|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1673190|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1673191|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1673192|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1673193|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1673194|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1673195|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1673196|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1673197|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1673198|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1673199|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1673200|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1673201|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1673202|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1673203|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1673204|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1673205|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1673206|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1673207|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1673208|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1673209|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1673210|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1673211|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1673212|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1673213|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1673214|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1673215|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1673216|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1673217|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1673218|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1673219|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1673220|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1673221|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1673222|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1673223|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
1673224|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1673225|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1673226|NCT00096083|liver metastases|liver metastases
1673227|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
1673228|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1673229|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1673230|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1673231|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1673232|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1673233|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1673234|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
1673235|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
1673236|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
1673237|NCT00096083|recurrent colon cancer|recurrent colon cancer
1673238|NCT00096083|stage IV colon cancer|stage iv colon cancer
1673239|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
1673240|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
1673241|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1673242|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1673243|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
1673246|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
1673247|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
1673248|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
1673249|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1673250|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
1673251|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
1673252|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1673253|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1673254|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1673255|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1673256|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
1673257|NCT00096083|insulinoma|insulinoma
1673258|NCT00096083|WDHA syndrome|wdha syndrome
1673259|NCT00096083|glucagonoma|glucagonoma
1673260|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1673261|NCT00096083|somatostatinoma|somatostatinoma
1673262|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
1673263|NCT00096083|intraocular melanoma|intraocular melanoma
1673264|NCT00096083|conjunctival melanoma|conjunctival melanoma
1673265|NCT00096083|iris melanoma|iris melanoma
1673266|NCT00096083|recurrent melanoma|recurrent melanoma
1673267|NCT00096083|stage IV melanoma|stage iv melanoma
1673268|NCT00096057|recurrent breast cancer|recurrent breast cancer
1673269|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
1673270|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
1673271|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
1673272|NCT00096057|stage IV breast cancer|stage iv breast cancer
1673273|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1673274|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1673275|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
1673276|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
1673277|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1673278|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1673279|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1673280|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1673281|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1673282|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1673283|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
1673284|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1673285|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1673286|NCT00095953|recurrent melanoma|recurrent melanoma
1673287|NCT00095953|stage IV melanoma|stage iv melanoma
1673288|NCT00095927|radiation toxicity|radiation toxicity
1673289|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
1673290|NCT00095927|mucositis|mucositis
1673291|NCT00095927|xerostomia|xerostomia
1673292|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1673293|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1673294|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1673295|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1673296|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1673297|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1673298|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1673299|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1673300|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1673301|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1673302|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1673303|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1673304|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1673305|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1673306|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1673307|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1673308|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1674189|NCT00091676|vaccine|vaccine
1673309|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673310|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1673311|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1673312|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1673313|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1673314|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1673315|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1673316|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1673317|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1673318|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1673319|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1673411|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
1673320|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1673321|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1673322|NCT00095862|recurrent breast cancer|recurrent breast cancer
1673323|NCT00095862|stage IV breast cancer|stage iv breast cancer
1673324|NCT00095862|male breast cancer|male breast cancer
1673325|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673326|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
1673327|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1673328|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1673329|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1673330|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1673331|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
1673332|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1673333|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
1673334|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1673335|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1673336|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
1673337|NCT00095732|Cystic Fibrosis|cystic fibrosis
1673339|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
1673340|NCT00095706|Metastatic breast cancer|metastatic breast cancer
1673341|NCT00095706|HER2|her2
1673342|NCT00095706|Trastuzumab|trastuzumab
1673343|NCT00095706|Herceptin|herceptin
1673344|NCT00095706|VEGF|vegf
1673345|NCT00095706|Bevacizumab|bevacizumab
1673346|NCT00095706|Avastin|avastin
1673347|NCT00095680|Multiple Myeloma|multiple myeloma
1673348|NCT00095680|SCIO-469|scio-469
1673349|NCT00095680|Bortezomib|bortezomib
1673350|NCT00095680|p38 MAP kinase|p38 map kinase
1673351|NCT00095654|diabetes prevention|diabetes prevention
1673352|NCT00095654|ramipril|ramipril
1673353|NCT00095654|rosiglitazone|rosiglitazone
1673354|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
1673355|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
1673356|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
1673357|NCT00095589|bladder cancer|bladder cancer
1673358|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
1673359|NCT00095589|stage I bladder cancer|stage i bladder cancer
1673360|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1673361|NCT00095550|Moderate Hypertension|moderate hypertension
1673362|NCT00095537|Solid tumors|solid tumors
1673363|NCT00095537|cancer|cancer
1673364|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
1673365|NCT00095524|Patient weight change|patient weight change
1673366|NCT00095524|changes in metabolic status|changes in metabolic status
1673367|NCT00095511|Bipolar Mania|bipolar mania
1673368|NCT00095498|arthritis|arthritis
1673369|NCT00095498|joint pain|joint pain
1673370|NCT00095498|Methotrexate|methotrexate
1673371|NCT00095485|Activity Level|activity level
1673372|NCT00095485|Musculoskeletal|musculoskeletal
1673373|NCT00095485|Healthy Volunteer|healthy volunteer
1673374|NCT00095485|Physical Activity|physical activity
1673375|NCT00095472|Blood Flow|blood flow
1673376|NCT00095472|Nitric Oxide|nitric oxide
1673377|NCT00095472|Vascular Function|vascular function
1673378|NCT00095472|Vasodilation|vasodilation
1673379|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
1673380|NCT00095472|Sickle Cell Disease|sickle cell disease
1673381|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
1673382|NCT00095459|Combinatorial Therapy|combinatorial therapy
1673383|NCT00095459|Pathway Profiling|pathway profiling
1673384|NCT00095459|VEGFR|vegfr
1673385|NCT00095459|Bevacizumab|bevacizumab
1673386|NCT00095459|Sorafenib|sorafenib
1673387|NCT00095459|Advanced Solid Tumors|advanced solid tumors
1673388|NCT00095459|Angiogenesis|angiogenesis
1673389|NCT00095459|Targeted Therapy|targeted therapy
1673390|NCT00095459|VEGF|vegf
1673391|NCT00095459|Cancer|cancer
1673392|NCT00095459|Solid Tumor|solid tumor
1673393|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
1673394|NCT00095446|Diabetes Mellitus|diabetes mellitus
1673395|NCT00095446|Diabetes|diabetes
1673396|NCT00095433|AMD|amd
1673397|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
1673398|NCT00095420|Interpersonal Relationships|interpersonal relationships
1673399|NCT00095420|Child|child
1673400|NCT00095407|Social Cognition|social cognition
1673401|NCT00095407|Semantic Memory|semantic memory
1673402|NCT00095407|Prefrontal Cortex|prefrontal cortex
1673403|NCT00095407|Temporal Cortex|temporal cortex
1673404|NCT00095407|Conceptual Self|conceptual self
1673405|NCT00095394|Severe Hypertension|severe hypertension
1673406|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
1673407|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
1673408|NCT00095381|T-Cell Leukemia|t-cell leukemia
1673409|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
1673410|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
1673413|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
1673414|NCT00095381|BioCryst|biocryst
1673415|NCT00095368|Pharyngitis|pharyngitis
1673416|NCT00095368|Tonsillitis|tonsillitis
1673417|NCT00095355|BDNF|bdnf
1673418|NCT00095355|Lithium|lithium
1673419|NCT00095355|Divalproex|divalproex
1673420|NCT00095355|Huntington Disease|huntington disease
1673422|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
1673423|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
1673424|NCT00095329|sirolimus|sirolimus
1673425|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
1673426|NCT00095303|BSFT|bsft
1673427|NCT00095303|Family Therapy|family therapy
1673428|NCT00095303|Adolescents|adolescents
1673429|NCT00095303|Substance Abuse|substance abuse
1673430|NCT00095290|Albuminuria|albuminuria
1673431|NCT00095290|Hypertension|hypertension
1673432|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
1673433|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
1673434|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
1673435|NCT00095277|myeloma|myeloma
1673436|NCT00095277|Anemia of Cancer|anemia of cancer
1673437|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
1673438|NCT00095251|Delirium|delirium
1673439|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
1673440|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
1673441|NCT00095251|efficacy of sedation|efficacy of sedation
1673442|NCT00095251|cognitive impairment|cognitive impairment
1673443|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
1673444|NCT00095212|HIV|hiv
1673445|NCT00095212|women|women
1673446|NCT00095212|androgen|androgen
1673447|NCT00095212|Treatment Experienced|treatment experienced
1673448|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
1673449|NCT00095199|Second-line therapy|second-line therapy
1673450|NCT00095199|Docetaxel|docetaxel
1673451|NCT00095199|Pemetrexed|pemetrexed
1673452|NCT00095199|Cetuximab|cetuximab
1673453|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
1673454|NCT00095199|NSCLC|nsclc
1673455|NCT00095186|Cancer|cancer
1673456|NCT00095186|Metastatic|metastatic
1673457|NCT00095186|Kidney|kidney
1673458|NCT00095186|Refractive|refractive
1673459|NCT00095186|Lactoferrin|lactoferrin
1673460|NCT00095186|Oral|oral
1673461|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
1673462|NCT00095160|Solid Organ Tumors|solid organ tumors
1673463|NCT00095121|Hepatitis B|hepatitis b
1673464|NCT00095121|Children|children
1673465|NCT00095121|Pediatric|pediatric
1673466|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
1673467|NCT00095108|Metastatic Melanoma|metastatic melanoma
1673468|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1673469|NCT00095095|Spine|spine
1673470|NCT00095095|Lumbar spine|lumbar spine
1673471|NCT00095095|Spinal fusion|spinal fusion
1673472|NCT00095095|Low back pain|low back pain
1673473|NCT00095095|Fusion cage|fusion cage
1673474|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
1673475|NCT00095095|Bioresorbable|bioresorbable
1673476|NCT00095095|Peek|peek
1673477|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
1673478|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
1673479|NCT00095030|Diabetes|diabetes
1673480|NCT00095017|Arcoxia|arcoxia
1673481|NCT00094991|Type 2 diabetes|type 2 diabetes
1673482|NCT00094978|Apoptosis|apoptosis
1673483|NCT00094978|Toxicity|toxicity
1673484|NCT00094978|Pharmacokinetic|pharmacokinetic
1673485|NCT00094978|Gene Induction|gene induction
1673486|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
1673487|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
1673488|NCT00094978|SCLC|sclc
1673489|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
1673491|NCT00094978|Esophageal Cancer|esophageal cancer
1673492|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
1673493|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
1673494|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
1673495|NCT00094952|Alzheimer's disease|alzheimer's disease
1673496|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
1673497|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
1673498|NCT00094939|mild cognitive impairment|mild cognitive impairment
1673499|NCT00094939|Alzheimer disease|alzheimer disease
1673500|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
1673501|NCT00094939|CSF tau protein|csf tau protein
1673502|NCT00094939|Hippocampus|hippocampus
1673503|NCT00094926|Risperidal CONSTA|risperidal consta
1673504|NCT00094926|Bipolar disorder|bipolar disorder
1673505|NCT00094926|mood episodes|mood episodes
1673506|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
1673507|NCT00094913|Aging|aging
1673508|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
1673509|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
1673510|NCT00094913|Hippocampal formation|hippocampal formation
1673511|NCT00094913|Glucose metabolism|glucose metabolism
1673512|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
1673513|NCT00094900|NOMID|nomid
1673514|NCT00094900|Adult Stills Disease|adult stills disease
1673515|NCT00094900|Familial Mediterranean|familial mediterranean
1673516|NCT00094900|Treatment Trial/Fever|treatment trial/fever
1673517|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
1673518|NCT00094887|Blood Flow|blood flow
1673519|NCT00094887|Nitric Oxide|nitric oxide
1673520|NCT00094887|Pain Crisis|pain crisis
1673521|NCT00094887|Sickle Cell Anemia|sickle cell anemia
1673522|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
1673523|NCT00094887|Sickle Cell Disease|sickle cell disease
1673524|NCT00094887|SCD|scd
1673525|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
1673526|NCT00094861|dysphagia|dysphagia
1673527|NCT00094861|palifermin, KGF|palifermin, kgf
1673528|NCT00094861|chemoradiotherapy|chemoradiotherapy
1673529|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
1673530|NCT00094861|lung cancer|lung cancer
1673531|NCT00094861|supportive care|supportive care
1673532|NCT00094861|clinical trial|clinical trial
1673533|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
1673534|NCT00094861|radiotherapy|radiotherapy
1673535|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
1673536|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
1673537|NCT00094835|Anti-angiogenesis|anti-angiogenesis
1673538|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1673539|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
1673540|NCT00094822|Metastatic Cancer|metastatic cancer
1673541|NCT00094822|Neulasta®|neulasta®
1673542|NCT00094822|pegfilgrastim|pegfilgrastim
1673543|NCT00094809|Neulasta®|neulasta®
1673544|NCT00094809|pegfilgrastim|pegfilgrastim
1673545|NCT00094809|Advanced|advanced
1673546|NCT00094809|Chemotherapy|chemotherapy
1673547|NCT00094796|Insulin Resistance|insulin resistance
1673548|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
1673549|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
1673550|NCT00094796|Metabolic Stress Test|metabolic stress test
1673551|NCT00094796|Mitochondrial Function|mitochondrial function
1673552|NCT00094796|Type 2 Diabetes|type 2 diabetes
1673553|NCT00094796|T2DM|t2dm
1673554|NCT00094796|Pre-Diabetes|pre-diabetes
1673555|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
1673556|NCT00094783|Interventional MRI|interventional mri
1673557|NCT00094783|Arterial Stenosis|arterial stenosis
1673558|NCT00094783|Revascularization|revascularization
1673559|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
1673560|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
1673561|NCT00094783|Cardiovascular Disease|cardiovascular disease
1673562|NCT00094731|Aging|aging
1673563|NCT00094731|Memory|memory
1673564|NCT00094731|Mental Recall|mental recall
1673565|NCT00094731|Mental Processes|mental processes
1673566|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
1673567|NCT00094718|West Nile Virus|west nile virus
1673568|NCT00094718|Dengue Virus|dengue virus
1673569|NCT00094705|Dengue Vaccine|dengue vaccine
1673570|NCT00094705|Dengue Virus|dengue virus
1673571|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1673572|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
1673573|NCT00094692|Amblyopia|amblyopia
1673574|NCT00094692|Patching|patching
1673575|NCT00094692|Spectacles|spectacles
1673576|NCT00094653|melanoma|melanoma
1673577|NCT00094653|metastatic melanoma|metastatic melanoma
1673578|NCT00094653|skin cancer|skin cancer
1673579|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
1673580|NCT00094601|[18F] FDOPA|[18f] fdopa
1673581|NCT00094601|[11C] NNC-112|[11c] nnc-112
1673582|NCT00094601|Dopamine|dopamine
1673583|NCT00094601|Molecular Imaging|molecular imaging
1673584|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
1673586|NCT00094601|Parkinson's Disease|parkinson's disease
1673587|NCT00094601|Cognition|cognition
1673588|NCT00094601|Parkinson Disease|parkinson disease
1673589|NCT00094601|PD|pd
1673590|NCT00094601|Healthy Volunteer|healthy volunteer
1673591|NCT00094601|HV|hv
1673592|NCT00094575|Abdominal|abdominal
1673593|NCT00094575|Aortic Aneurysm|aortic aneurysm
1673594|NCT00094575|cost of AAA repair|cost of aaa repair
1673595|NCT00094575|Endovascular Repair|endovascular repair
1673596|NCT00094575|Grafts|grafts
1673597|NCT00094575|Long-term survival|long-term survival
1673598|NCT00094575|secondary outcomes|secondary outcomes
1673599|NCT00094562|Cancer|cancer
1673600|NCT00094562|Cancer Cachexia|cancer cachexia
1673601|NCT00094562|Weight Loss|weight loss
1673602|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1673603|NCT00094562|Chronic Heart Failure|chronic heart failure
1673604|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
1673605|NCT00094536|Menorrhagia|menorrhagia
1673606|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
1673607|NCT00094536|Cryoablation|cryoablation
1673608|NCT00094536|Menstrual disorder|menstrual disorder
1673609|NCT00094536|Endometrial ablation|endometrial ablation
1673610|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
1673611|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
1673612|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
1673613|NCT00094510|Prefrontal GABA|prefrontal gaba
1673614|NCT00094510|Stress|stress
1673615|NCT00094510|Emotion Recognition|emotion recognition
1673616|NCT00094510|Differential Reward|differential reward
1673617|NCT00094510|Gabapentin|gabapentin
1673618|NCT00094510|GABA|gaba
1673619|NCT00094510|Prefrontal Cortex|prefrontal cortex
1673620|NCT00094510|Emotional Processing|emotional processing
1673621|NCT00094510|Healthy Humans|healthy humans
1673622|NCT00094510|Healthy Volunteer|healthy volunteer
1673623|NCT00094510|HV|hv
1673624|NCT00094484|Sensipar®|sensipar®
1673625|NCT00094484|Mimpara®|mimpara®
1673626|NCT00094484|Cinacalcet|cinacalcet
1673627|NCT00094484|Calcimimetic|calcimimetic
1673628|NCT00094484|Chronic Kidney Disease|chronic kidney disease
1673629|NCT00094458|Crohn's Disease|crohn's disease
1673630|NCT00094458|infliximab|infliximab
1673631|NCT00094458|azathioprine|azathioprine
1673632|NCT00094458|Remicade|remicade
1673633|NCT00094458|SONIC|sonic
1673634|NCT00094445|Pancreatic Cancer|pancreatic cancer
1673635|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1673636|NCT00094445|Alternative therapy|alternative therapy
1673637|NCT00094445|Pancreas|pancreas
1673638|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
1673639|NCT00094445|Cancer of the pancreas|cancer of the pancreas
1673640|NCT00094432|depressed|depressed
1673641|NCT00094419|Complementary Therapies|complementary therapies
1673642|NCT00094406|Lung Permeability|lung permeability
1673643|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
1673644|NCT00094406|Bronchoscopy|bronchoscopy
1673645|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
1673646|NCT00094393|Ageing|ageing
1673647|NCT00094393|Atherosclerosis|atherosclerosis
1673648|NCT00094393|Lamin A|lamin a
1673649|NCT00094393|Lipodystrophy|lipodystrophy
1673650|NCT00094393|Growth Impairment|growth impairment
1673651|NCT00094393|Premature Aging|premature aging
1673652|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
1673653|NCT00094393|HGPS|hgps
1673654|NCT00094380|SLE|sle
1673655|NCT00094380|Lupus|lupus
1673656|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
1673657|NCT00094380|Lupus Nephritis|lupus nephritis
1673658|NCT00094367|1592U89|1592u89
1673659|NCT00094367|GR109714|gr109714
1673660|NCT00094367|abacavir|abacavir
1673661|NCT00094367|lamivudine|lamivudine
1673662|NCT00094367|fixed-dose combination|fixed-dose combination
1673663|NCT00094367|once-daily|once-daily
1673664|NCT00094367|twice-daily|twice-daily
1673665|NCT00094367|HIV infection|hiv infection
1673666|NCT00094367|naive|naive
1673667|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
1673668|NCT00094354|Needs assessment|needs assessment
1673669|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
1673670|NCT00094354|In-depth interview|in-depth interview
1673671|NCT00094354|Focus Groups|focus groups
1673672|NCT00094341|Arthritis|arthritis
1673673|NCT00094341|Rheumatology|rheumatology
1673674|NCT00094328|Testotoxicosis|testotoxicosis
1673675|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
1673676|NCT00094302|Heart Failure|heart failure
1673677|NCT00094302|Diastolic Heart Failure|diastolic heart failure
1673678|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
1673679|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
1673680|NCT00094172|MS|ms
1673681|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
1673682|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
1673683|NCT00094146|PIH|pih
1673684|NCT00094146|Obesity|obesity
1673685|NCT00094133|cancer survivor|cancer survivor
1673686|NCT00094133|stage IA breast cancer|stage ia breast cancer
1673687|NCT00094133|stage IB breast cancer|stage ib breast cancer
1673688|NCT00094133|stage II breast cancer|stage ii breast cancer
1673689|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
1673690|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
1673691|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
1673692|NCT00094133|stage IV breast cancer|stage iv breast cancer
1673693|NCT00094133|breast cancer in situ|breast cancer in situ
1673694|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
1673695|NCT00094133|hot flashes|hot flashes
1673696|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
1673697|NCT00094107|melanoma|melanoma
1673698|NCT00094107|antiangiogenesis|antiangiogenesis
1673699|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
1673700|NCT00094081|oropharynx|oropharynx
1673701|NCT00094081|oral cavity|oral cavity
1673702|NCT00094081|larynx|larynx
1673703|NCT00094081|hypopharynx|hypopharynx
1673704|NCT00091468|Age-Related Memory Loss|age-related memory loss
1673705|NCT00091468|Nicotine|nicotine
1673706|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
1673708|NCT00094068|White Matter|white matter
1673709|NCT00094068|Cerebral Blood Flow|cerebral blood flow
1673710|NCT00094068|Cerebral Blood Volume|cerebral blood volume
1673711|NCT00094068|Lesion|lesion
1673712|NCT00094068|MRI|mri
1673713|NCT00094068|Multiple Sclerosis|multiple sclerosis
1673714|NCT00094068|Perfusion|perfusion
1673715|NCT00094068|Imaging|imaging
1673716|NCT00094068|Sildenafil|sildenafil
1673717|NCT00094068|MS|ms
1673718|NCT00094068|Healthy Volunteer|healthy volunteer
1673719|NCT00094068|HV|hv
1673720|NCT00094042|Socioeconomic Factors|socioeconomic factors
1673721|NCT00094042|Dietary Supplementation|dietary supplementation
1673722|NCT00094003|Liver metastases|liver metastases
1673723|NCT00094003|Colorectal cancer|colorectal cancer
1673724|NCT00094003|Gastric cancer|gastric cancer
1673725|NCT00094003|Esophagus cancer|esophagus cancer
1673726|NCT00094003|Breast cancer|breast cancer
1673727|NCT00094003|Lung cancer|lung cancer
1673728|NCT00094003|Skin cancer|skin cancer
1673729|NCT00094003|Renal Cancer|renal cancer
1673730|NCT00094003|Liver metastasis|liver metastasis
1673731|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
1673732|NCT00093990|Tipifarnib|tipifarnib
1673733|NCT00093990|Bone marrow aspirate|bone marrow aspirate
1673734|NCT00093977|Chronic Kidney Disease|chronic kidney disease
1673735|NCT00093977|Dialysis|dialysis
1673736|NCT00093977|Anemia|anemia
1673737|NCT00093977|Nephrology|nephrology
1673738|NCT00093964|brain cancer|brain cancer
1673739|NCT00093964|brain tumor|brain tumor
1673740|NCT00093951|Alzheimer disease|alzheimer disease
1673741|NCT00093951|memory|memory
1673742|NCT00093951|cognition|cognition
1673743|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
1673744|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
1673745|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
1673746|NCT00093925|Postoperative hypertension|postoperative hypertension
1673747|NCT00093912|Perioperative Hypertension|perioperative hypertension
1673748|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
1673749|NCT00093886|Preoperative hypertension|preoperative hypertension
1673750|NCT00093873|Cancer|cancer
1673751|NCT00093873|antiangiogenesis|antiangiogenesis
1673752|NCT00093873|Solid Tumors|solid tumors
1673753|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
1673754|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
1673755|NCT00093847|SSRI|ssri
1673756|NCT00093847|SAMe|same
1673757|NCT00093834|stage IV breast cancer|stage iv breast cancer
1673758|NCT00093834|recurrent breast cancer|recurrent breast cancer
1673759|NCT00093808|recurrent breast cancer|recurrent breast cancer
1673760|NCT00093808|stage IV breast cancer|stage iv breast cancer
1673761|NCT00093808|male breast cancer|male breast cancer
1673762|NCT00093795|stage II breast cancer|stage ii breast cancer
1673763|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
1673764|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
1673765|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1673766|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1673767|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1673768|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1673769|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1673770|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1673771|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1673772|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673773|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1673774|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1673775|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1673776|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1673777|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1673778|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1673779|NCT00093678|pain|pain
1673780|NCT00093678|cachexia|cachexia
1673781|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1673782|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
1673783|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
1673784|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
1673785|NCT00093678|ovarian sarcoma|ovarian sarcoma
1675126|NCT00090493|vaccines|vaccines
1673786|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1673787|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1673788|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1673789|NCT00093678|recurrent melanoma|recurrent melanoma
1673790|NCT00093678|stage III melanoma|stage iii melanoma
1673791|NCT00093678|stage IV melanoma|stage iv melanoma
1673792|NCT00093678|chondrosarcoma|chondrosarcoma
1673793|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
1673794|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
1673795|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
1673796|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1673797|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1673798|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1673799|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1673800|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1673801|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1673802|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1673803|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1673804|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1673805|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1673806|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1673807|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1673808|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1673809|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1673810|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1673811|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1673812|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1673813|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1673814|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1673815|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1673816|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1673817|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1673818|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1673819|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1673820|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1673821|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1673822|NCT00093678|intraocular lymphoma|intraocular lymphoma
1673823|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1673824|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1673825|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1673826|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1673827|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1673828|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1673829|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1673830|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1673831|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1673832|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1673833|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1673834|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1673835|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
1673836|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1673837|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1673838|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1673839|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1673840|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1673841|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1673842|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1673843|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1673844|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1673845|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1673846|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679012|NCT00086268|US75|us75
1673847|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1673848|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1673849|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1673850|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1673851|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1673852|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1673853|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1673854|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1673855|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1673856|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1673857|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1673858|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
1673859|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1674007|NCT00093067|endocarditis|endocarditis
1673860|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1673861|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1673862|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1673863|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1673864|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1673865|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1673866|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
1673867|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
1673868|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
1673869|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
1673870|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1673871|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1673872|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1673873|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1673874|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1673875|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1673876|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1673877|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1673878|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1673879|NCT00093587|graft versus host disease|graft versus host disease
1673880|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1673881|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1673882|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1673883|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1673884|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1673885|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1673886|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1673887|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1673888|NCT00093561|prostate cancer|prostate cancer
1673889|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1673890|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
1673891|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1673892|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1673893|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
1673894|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
1673895|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1673896|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1673897|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1673898|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1673899|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
1673900|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1673901|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1673902|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1673903|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1673904|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1673905|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1673906|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1673907|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1673908|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1674542|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
1673909|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1673910|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1673911|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1673912|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1673995|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1673913|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1673914|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1673915|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1673916|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
1673917|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
1673918|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1673919|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
1673920|NCT00093444|liver metastases|liver metastases
1673921|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1674008|NCT00093067|bacteremia|bacteremia
1673922|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1673923|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
1673924|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
1673925|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1673926|NCT00093379|stage II anal cancer|stage ii anal cancer
1673927|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
1673928|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
1673929|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1673930|NCT00093379|Capecitabine|capecitabine
1673931|NCT00093379|Xeloda|xeloda
1673932|NCT00093379|Oxaliplatin|oxaliplatin
1673933|NCT00093379|Eloxatin|eloxatin
1673934|NCT00093379|Radiotherapy|radiotherapy
1673936|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1673937|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1673938|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1673939|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1673940|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1673941|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1673942|NCT00093353|diarrhea|diarrhea
1673943|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1673944|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
1673945|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
1673946|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1673947|NCT00093314|B-cell Lymphoma|b-cell lymphoma
1673948|NCT00093860|Adrenaline|adrenaline
1673949|NCT00093860|Norepinephrine|norepinephrine
1673950|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
1673951|NCT00093860|Fainting|fainting
1673952|NCT00093860|Hypotension|hypotension
1673953|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
1673954|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
1673955|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
1673956|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
1673957|NCT00093860|SAI|sai
1673958|NCT00093860|Children|children
1673959|NCT00093301|Shock|shock
1673960|NCT00093301|Levosimendan|levosimendan
1673961|NCT00093301|Inotropes|inotropes
1673962|NCT00093301|Dobutamine|dobutamine
1673963|NCT00093301|Heart failure|heart failure
1673964|NCT00093301|Sepsis|sepsis
1673965|NCT00093288|MDD|mdd
1673966|NCT00093288|bupropion|bupropion
1673967|NCT00093288|Depression|depression
1673968|NCT00093262|Postoperative Hypertension|postoperative hypertension
1673969|NCT00093249|Pre-operative hypertension|pre-operative hypertension
1673970|NCT00093223|In-Stent Restenosis|in-stent restenosis
1673971|NCT00093184|ST-Segment Elevation|st-segment elevation
1673972|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
1673973|NCT00093184|PCI|pci
1673974|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
1673975|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
1673976|NCT00093145|Advanced Breast Cancer|advanced breast cancer
1673977|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1673978|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
1673979|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
1673980|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1673981|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1673982|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1673983|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1673984|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1673985|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1673986|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1673987|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1673988|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1673989|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1673990|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1673991|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
1673992|NCT00093132|NSCLC|nsclc
1673993|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
1673994|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
1673996|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1673997|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
1673998|NCT00093119|Metastatic Melanoma|metastatic melanoma
1673999|NCT00093093|Viramidine|viramidine
1674000|NCT00093093|Ribavirin|ribavirin
1674001|NCT00093093|Valeant|valeant
1674002|NCT00093093|Hepatitis C|hepatitis c
1674003|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
1674004|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
1674005|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
1674006|NCT00093067|Staph Aureus|staph aureus
1674010|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
1674011|NCT00093041|Head and neck cancer|head and neck cancer
1674012|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
1674013|NCT00093028|Myeloma|myeloma
1674014|NCT00093028|Revlimid|revlimid
1674015|NCT00093028|bortezomib|bortezomib
1674016|NCT00093028|CC-5013|cc-5013
1674017|NCT00093028|Dexamethasone|dexamethasone
1674018|NCT00091520|Congestive heart failure|congestive heart failure
1674019|NCT00091520|Nesiritide|nesiritide
1674020|NCT00093002|Early Breast Cancer|early breast cancer
1674021|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
1674022|NCT00093002|hormonal treatment|hormonal treatment
1674023|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
1674024|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
1674025|NCT00093002|treatment naïve|treatment naïve
1674026|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
1674027|NCT00093002|neoadjuvant setting|neoadjuvant setting
1674028|NCT00093002|invasive breast cancer|invasive breast cancer
1674029|NCT00092976|Hemophilia A|hemophilia a
1674030|NCT00092898|Sitosterolemia|sitosterolemia
1674031|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
1674032|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
1674033|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
1674034|NCT00092781|Arcoxia|arcoxia
1674035|NCT00092768|Arcoxia|arcoxia
1674036|NCT00092755|Arcoxia|arcoxia
1674037|NCT00092742|Arcoxia|arcoxia
1674038|NCT00092703|Arcoxia|arcoxia
1674039|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
1674040|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
1674041|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
1674042|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
1674043|NCT00092560|high cholesterol|high cholesterol
1674044|NCT00092560|high triglycerides|high triglycerides
1674045|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
1674046|NCT00092508|ulcerative|ulcerative
1674047|NCT00092508|colitis|colitis
1674048|NCT00092508|remission|remission
1674049|NCT00092508|relapse|relapse
1674050|NCT00092508|Asacol®|asacol®
1674051|NCT00092508|maintain|maintain
1674052|NCT00092508|maintenance|maintenance
1674053|NCT00092508|flare|flare
1674054|NCT00092508|rectal|rectal
1674055|NCT00092508|bleeding|bleeding
1674056|NCT00092508|bowel|bowel
1674057|NCT00092300|dental surgery|dental surgery
1674058|NCT00092300|molar removal|molar removal
1674059|NCT00092950|Exercise|exercise
1674060|NCT00092950|Pedometer|pedometer
1674061|NCT00092950|Physician Prescription|physician prescription
1674062|NCT00092950|Biomarkers|biomarkers
1674063|NCT00092950|Compliance|compliance
1674064|NCT00092950|Breast Cancer Survivor|breast cancer survivor
1674065|NCT00092950|Breast Cancer Risk|breast cancer risk
1674066|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
1674067|NCT00092937|Nonmyeloablative|nonmyeloablative
1674068|NCT00092937|CD34 Positive Cells|cd34 positive cells
1674069|NCT00092937|Donor Engraftment|donor engraftment
1674070|NCT00092937|Myeloid Chimerism|myeloid chimerism
1674071|NCT00092638|Elevated Cholesterol|elevated cholesterol
1674072|NCT00092625|Elevated Cholesterol|elevated cholesterol
1674073|NCT00092612|Elevated Cholesterol|elevated cholesterol
1674074|NCT00092599|Elevated Cholesterol|elevated cholesterol
1674075|NCT00092378|Bunionectomy|bunionectomy
1674076|NCT00092339|dental surgery|dental surgery
1674077|NCT00092339|molar removal|molar removal
1674078|NCT00092326|dental surgery|dental surgery
1674079|NCT00092326|molar removal|molar removal
1674080|NCT00092313|dental surgery|dental surgery
1674081|NCT00092313|molar removal|molar removal
1674082|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
1674083|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
1674084|NCT00092274|Follicular Lymphoma|follicular lymphoma
1674085|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
1674086|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
1674087|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1674088|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
1674089|NCT00092170|Intra-abdominal infections|intra-abdominal infections
1674090|NCT00092170|Acute pelvic infections|acute pelvic infections
1674091|NCT00092157|High cholesterol|high cholesterol
1674092|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
1674093|NCT00092053|Postmenopausal|postmenopausal
1674094|NCT00092053|Osteoporosis|osteoporosis
1674095|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
1674096|NCT00092235|Allo-HSCT controls|allo-hsct controls
1674097|NCT00092235|Leukapheresis|leukapheresis
1674098|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
1674099|NCT00092235|cGVHD|cgvhd
1674100|NCT00092222|HHV-8|hhv-8
1674102|NCT00092222|Malignancy|malignancy
1674103|NCT00092222|Lymphoproliferation|lymphoproliferation
1674104|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
1674105|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
1674106|NCT00092222|MCD|mcd
1674108|NCT00092222|KSHV Associated MCD|kshv associated mcd
1674109|NCT00092222|HIV Infections|hiv infections
1674110|NCT00092222|Herpes Viruses|herpes viruses
1674111|NCT00091988|Urinary Incontinence|urinary incontinence
1674112|NCT00091988|Weight Loss|weight loss
1674113|NCT00091988|Obesity|obesity
1674114|NCT00091988|Motivation|motivation
1674115|NCT00091975|Chronic Kidney Disease|chronic kidney disease
1674116|NCT00091949|stroke|stroke
1674117|NCT00091949|heart attack|heart attack
1674118|NCT00091949|diabetes|diabetes
1674119|NCT00091949|pioglitazone|pioglitazone
1674120|NCT00091949|insulin resistance|insulin resistance
1674121|NCT00091936|Treatment Naive|treatment naive
1674122|NCT00091936|Directly Observed Therapy|directly observed therapy
1674123|NCT00091936|DOT|dot
1674124|NCT00091936|TB|tb
1674125|NCT00091910|Anemia|anemia
1674126|NCT00091910|Epoetin alfa|epoetin alfa
1674127|NCT00091910|Erythropoietin|erythropoietin
1674128|NCT00091910|Blood transfusion|blood transfusion
1674129|NCT00091910|Intensive care units|intensive care units
1674130|NCT00091858|Cancer-related anemia|cancer-related anemia
1674131|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
1674132|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
1674133|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
1674134|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
1674135|NCT00091832|Breast Cancer|breast cancer
1674136|NCT00091832|Cancer|cancer
1674137|NCT00091819|staph|staph
1674138|NCT00091819|MRSA|mrsa
1674139|NCT00091819|cSSSI|csssi
1674140|NCT00091806|Targeted Therapy|targeted therapy
1674141|NCT00091806|Solid tumors|solid tumors
1674142|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
1674143|NCT00091806|EGFr|egfr
1674144|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1674145|NCT00091806|Monoclonal Antibody|monoclonal antibody
1674146|NCT00091793|Osteoporosis|osteoporosis
1674147|NCT00091793|Postmenopausal|postmenopausal
1674148|NCT00091897|RITUXAN|rituxan
1674149|NCT00091897|GABA|gaba
1674150|NCT00091897|B Cells|b cells
1674151|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
1674152|NCT00091897|GAD|gad
1674153|NCT00091897|Stiff Person Syndrome|stiff person syndrome
1674154|NCT00091897|SPS|sps
1674155|NCT00091884|HIV|hiv
1674156|NCT00091884|Immune Recovery|immune recovery
1674157|NCT00091884|Reactivation|reactivation
1674158|NCT00091884|Anti-Viral Medication|anti-viral medication
1674159|NCT00091884|HAART|haart
1674160|NCT00091884|CMV Retinitis|cmv retinitis
1674161|NCT00091884|Retinal Disease|retinal disease
1674162|NCT00091871|Genetic|genetic
1674163|NCT00091871|Eosinophils|eosinophils
1674164|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
1674165|NCT00091871|Hypereosinophilia|hypereosinophilia
1674166|NCT00091871|FE|fe
1674167|NCT00091741|HIV|hiv
1674168|NCT00091741|Treatment Experienced|treatment experienced
1674169|NCT00091741|Complementary Therapies|complementary therapies
1674170|NCT00091728|epidemiology|epidemiology
1674171|NCT00091728|relative risk|relative risk
1674172|NCT00091728|cervical ectopy|cervical ectopy
1674173|NCT00091728|hormonal contraceptives|hormonal contraceptives
1674174|NCT00091728|sexually transmitted infections|sexually transmitted infections
1674175|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
1674176|NCT00091715|PAH|pah
1674177|NCT00091715|PPH|pph
1674178|NCT00091715|bosentan|bosentan
1674179|NCT00091715|early|early
1674180|NCT00091702|FluMist|flumist
1674181|NCT00091702|Influenza Vaccine|influenza vaccine
1674182|NCT00091702|Adolescent|adolescent
1674183|NCT00091702|Treatment Experienced|treatment experienced
1674184|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
1674185|NCT00091676|follicular|follicular
1674186|NCT00091676|lymphoma|lymphoma
1674187|NCT00091676|Non-Hodgkins|non-hodgkins
1674190|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
1674191|NCT00091676|tumor-derived|tumor-derived
1674192|NCT00091676|B-cell|b-cell
1674193|NCT00091676|cancer|cancer
1674194|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1674195|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674196|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674197|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1674198|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1675125|NCT00090493|DTPACE|dtpace
1674199|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1674200|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1674201|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1674202|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1674203|NCT00004195|stage I colon cancer|stage i colon cancer
1674204|NCT00004195|stage II colon cancer|stage ii colon cancer
1674205|NCT00004195|stage III colon cancer|stage iii colon cancer
1674206|NCT00004195|stage IV colon cancer|stage iv colon cancer
1674207|NCT00004195|stage I rectal cancer|stage i rectal cancer
1674208|NCT00004195|stage II rectal cancer|stage ii rectal cancer
1674209|NCT00004195|stage III rectal cancer|stage iii rectal cancer
1674210|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
1674211|NCT00004195|recurrent colon cancer|recurrent colon cancer
1674212|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
1674213|NCT00004194|graft versus host disease|graft versus host disease
1674214|NCT00004184|stage III melanoma|stage iii melanoma
1674215|NCT00004184|stage IV melanoma|stage iv melanoma
1674216|NCT00004184|recurrent melanoma|recurrent melanoma
1674217|NCT00004172|stage IV breast cancer|stage iv breast cancer
1674218|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
1674219|NCT00004172|recurrent breast cancer|recurrent breast cancer
1674220|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
1674221|NCT00091624|CC-5013|cc-5013
1674222|NCT00091624|CC5013|cc5013
1674223|NCT00091624|Revlimid|revlimid
1674224|NCT00091624|Lenalidomide|lenalidomide
1674225|NCT00091624|Multiple myeloma|multiple myeloma
1674226|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1674227|NCT00091572|Metastatic Melanoma|metastatic melanoma
1674228|NCT00091559|CTCL|ctcl
1674229|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
1674230|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1674231|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1674232|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
1674233|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674234|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674235|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674236|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674237|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674238|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674239|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674240|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674241|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674242|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674243|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674244|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674245|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674246|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674247|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674248|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674249|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674250|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674251|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674252|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674253|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674254|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1674255|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674256|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1674257|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1674258|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1674259|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674260|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674261|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674262|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674263|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674543|NCT00003441|recurrent colon cancer|recurrent colon cancer
1674264|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1674265|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1674266|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674267|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674268|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674269|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1674270|NCT00003858|stage I prostate cancer|stage i prostate cancer
1674271|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
1674272|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
1674273|NCT00003858|stage III prostate cancer|stage iii prostate cancer
1674274|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
1674275|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
1674276|NCT00003842|adult glioblastoma|adult glioblastoma
1674277|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1674278|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
1674279|NCT00003842|adult gliosarcoma|adult gliosarcoma
1674280|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
1674281|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
1674282|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
1674283|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
1674284|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1674285|NCT00003775|adult mixed glioma|adult mixed glioma
1674286|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1674287|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
1674288|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1674289|NCT00003714|liver metastases|liver metastases
1674290|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674291|NCT00091611|Clinical Response|clinical response
1674292|NCT00091611|Intravenous|intravenous
1674293|NCT00091611|Intra-Arterial|intra-arterial
1674294|NCT00091611|Lymphodepletion|lymphodepletion
1674295|NCT00091611|Traffic of Cells|traffic of cells
1674296|NCT00091611|T-Cell Transfer|t-cell transfer
1674297|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
1674298|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
1674299|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
1674300|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
1674301|NCT00091442|Breast Cancer|breast cancer
1674302|NCT00091442|Advanced breast cancer|advanced breast cancer
1674303|NCT00091442|Breast Tumors|breast tumors
1674304|NCT00091442|Cancer of Breast|cancer of breast
1674305|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
1674306|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
1674307|NCT00091442|DOXIL|doxil
1674308|NCT00091442|Docetaxel|docetaxel
1674309|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674310|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674311|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674312|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674313|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674314|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674315|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674316|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674317|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674318|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674319|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674320|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674321|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674322|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674323|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674324|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674325|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674326|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674327|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674328|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674329|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1674330|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674331|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1674332|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674333|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1674334|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
1674335|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
1674336|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
1674337|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
1674338|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1674339|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1674340|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674341|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674342|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1674343|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1674344|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674345|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1674346|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1674347|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1674348|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1674349|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1674350|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1674351|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1674352|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1674353|NCT00004036|polycythemia vera|polycythemia vera
1674354|NCT00004036|primary myelofibrosis|primary myelofibrosis
1674355|NCT00004036|essential thrombocythemia|essential thrombocythemia
1674356|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
1674357|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1674358|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
1674359|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1674360|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1674361|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
1674362|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1674363|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1674364|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1674365|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1674366|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1674367|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1674368|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1674369|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1674370|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1674371|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674372|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674373|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674374|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674375|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674376|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674377|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674378|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674379|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674380|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674381|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674382|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674383|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674384|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674385|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674386|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674387|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674388|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674389|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1674390|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1674391|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674392|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1674393|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1674394|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1674395|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1674396|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1674397|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
1674398|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1674399|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1674400|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
1674401|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1674402|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1674403|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674404|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674405|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674406|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674407|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674408|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1674409|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1674410|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1674411|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1674412|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674413|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674414|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674415|NCT00004022|stage III melanoma|stage iii melanoma
1674416|NCT00004022|stage IV melanoma|stage iv melanoma
1674417|NCT00004022|recurrent melanoma|recurrent melanoma
1674418|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674419|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1674420|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1674421|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1674422|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
1674423|NCT00003666|large cell lung cancer|large cell lung cancer
1674424|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
1674425|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1674426|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1674427|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1674428|NCT00003634|fallopian tube cancer|fallopian tube cancer
1674429|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1674430|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1674431|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
1674432|NCT00003599|small cell lung cancer|small cell lung cancer
1674433|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
1674434|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
1674435|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
1674436|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
1674437|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1674438|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1674439|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
1674440|NCT00003587|large cell lung cancer|large cell lung cancer
1674441|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1674442|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1674443|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
1674444|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
1674445|NCT00003564|adult glioblastoma|adult glioblastoma
1674446|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1674447|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1674448|NCT00003564|adult mixed glioma|adult mixed glioma
1674449|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
1674450|NCT00003564|adult gliosarcoma|adult gliosarcoma
1674451|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
1674452|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
1674453|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
1674454|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
1674455|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
1674456|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
1674457|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1674458|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1674459|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674460|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1674461|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674462|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1674463|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
1674464|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
1674465|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
1674466|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
1674467|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1674468|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674469|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674470|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1674471|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1674472|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674473|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1674474|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1674475|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1674544|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
1674476|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1674477|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1674478|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1674479|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1674480|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1674481|NCT00003451|polycythemia vera|polycythemia vera
1674482|NCT00003451|primary myelofibrosis|primary myelofibrosis
1674483|NCT00003451|essential thrombocythemia|essential thrombocythemia
1674484|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
1674485|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1674486|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
1674487|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1674488|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1674489|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
1674490|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1674491|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1674492|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1674493|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1674494|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1674495|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1674496|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1674497|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1674498|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1674499|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674500|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674501|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674502|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674503|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674504|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674505|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674506|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674507|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674508|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674509|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674510|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674511|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674512|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674513|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674514|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674515|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674516|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674517|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1674518|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1674519|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674520|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1674521|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1674522|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1674523|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1674524|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
1674525|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
1674526|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1674527|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1674528|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674529|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674530|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674531|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674532|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674533|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1674534|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1674535|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1674536|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1674537|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674538|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674539|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674540|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1674541|NCT00003441|stage IV colon cancer|stage iv colon cancer
1674545|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
1674546|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1674547|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
1674548|NCT00003441|MGI-114|mgi-114
1674549|NCT00003441|Irofulven|irofulven
1674550|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1674551|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674552|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1674553|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1674554|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
1674555|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1674556|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1674557|NCT00003428|stage IV breast cancer|stage iv breast cancer
1674558|NCT00003428|recurrent breast cancer|recurrent breast cancer
1674559|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
1674560|NCT00003344|stage II colon cancer|stage ii colon cancer
1674561|NCT00003344|stage III colon cancer|stage iii colon cancer
1674562|NCT00003344|stage II rectal cancer|stage ii rectal cancer
1674563|NCT00003344|stage III rectal cancer|stage iii rectal cancer
1674564|NCT00003344|recurrent colon cancer|recurrent colon cancer
1674565|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
1674566|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
1674567|NCT00003339|stage III melanoma|stage iii melanoma
1674568|NCT00003339|stage IV melanoma|stage iv melanoma
1674569|NCT00003339|recurrent melanoma|recurrent melanoma
1674570|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1674571|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674572|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1674573|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674574|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1674575|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
1674576|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
1674577|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1674578|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
1674579|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1674580|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674581|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674582|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1674583|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1674584|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674585|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1674586|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1674587|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1674588|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1674589|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1674590|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1674591|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1674592|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1674593|NCT00003331|polycythemia vera|polycythemia vera
1674594|NCT00003331|primary myelofibrosis|primary myelofibrosis
1674595|NCT00003331|essential thrombocythemia|essential thrombocythemia
1674596|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
1674597|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1674598|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
1674599|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1674600|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1674601|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
1674602|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1674603|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1674604|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1674605|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1674606|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1674607|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1674608|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1674609|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1674610|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1674611|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674612|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674613|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674614|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674615|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674616|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674617|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674618|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674619|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674620|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674621|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674622|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674623|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674624|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674625|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674626|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674627|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674628|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674629|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1674630|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1674701|NCT00091351|adult angiosarcoma|adult angiosarcoma
1674631|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674632|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1674633|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1674634|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1674635|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1674636|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
1674637|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1674638|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1674639|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
1674640|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1674641|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1674642|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674643|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674644|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674645|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674646|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674647|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1674648|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1674649|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1674650|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1674651|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674652|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674653|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674654|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1674655|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
1674656|NCT00091533|fMRI|fmri
1674657|NCT00091533|Mirror Neuron System|mirror neuron system
1674658|NCT00091533|Bimodal Neurons|bimodal neurons
1674659|NCT00091533|Somatosensory Cortex|somatosensory cortex
1674660|NCT00091533|Rehabilitation|rehabilitation
1674661|NCT00091533|Healthy Volunteer|healthy volunteer
1674662|NCT00091533|HV|hv
1674663|NCT00091429|Angina|angina
1674664|NCT00091429|Chest Pain|chest pain
1674665|NCT00091429|Coronary Artery Disease|coronary artery disease
1674666|NCT00091429|Heart Disease|heart disease
1674667|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1674668|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1674669|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1674670|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1674671|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1674672|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1674673|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1674674|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674675|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1674676|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1674677|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1674678|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1674679|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1674680|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1674681|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
1674682|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1674683|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1674684|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1674685|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1674686|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1674687|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1674688|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1674689|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
1674690|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
1674691|NCT00091416|HIV Seronegativity|hiv seronegativity
1674692|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
1674693|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1674694|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
1674695|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
1674696|NCT00091390|stage III prostate cancer|stage iii prostate cancer
1674697|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1674698|NCT00091377|fallopian tube cancer|fallopian tube cancer
1674699|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1674700|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1674702|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
1674703|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
1674704|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
1674705|NCT00091351|adult liposarcoma|adult liposarcoma
1674706|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
1674707|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
1674708|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1674709|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1674710|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1674711|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1674712|NCT00091338|recurrent melanoma|recurrent melanoma
1674713|NCT00091338|stage IV melanoma|stage iv melanoma
1674714|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674715|NCT00091312|stage II colon cancer|stage ii colon cancer
1674716|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
1674717|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674718|NCT00091286|recurrent colon cancer|recurrent colon cancer
1674719|NCT00091286|stage IIB colon cancer|stage iib colon cancer
1674720|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
1674721|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
1674722|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
1674723|NCT00091286|stage IVA colon cancer|stage iva colon cancer
1674724|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
1674725|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
1674726|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
1674727|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
1674728|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
1674729|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
1674730|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
1674731|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
1674732|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1674733|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1674734|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1674735|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1674736|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1674737|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
1674738|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674739|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1674740|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1674741|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1674742|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1674743|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1674744|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1674745|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
1674746|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1674747|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1674748|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1674749|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1674750|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1674751|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1674752|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1674753|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1674754|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1674755|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1674756|NCT00091169|fatigue|fatigue
1674757|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674758|NCT00091169|levocarnitine|levocarnitine
1674759|NCT00091169|depression|depression
1674760|NCT00091169|pain|pain
1674761|NCT00091169|carnitine deficiency|carnitine deficiency
1674762|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1674763|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1674764|NCT00091143|recurrent melanoma|recurrent melanoma
1674765|NCT00091143|stage III melanoma|stage iii melanoma
1674766|NCT00091143|stage IV melanoma|stage iv melanoma
1674767|NCT00091104|stage IV melanoma|stage iv melanoma
1674768|NCT00091104|recurrent melanoma|recurrent melanoma
1674769|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1674770|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1674771|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1674772|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1674773|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1674774|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674861|NCT00003088|stage II breast cancer|stage ii breast cancer
1674775|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1674776|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1674777|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1674778|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1674779|NCT00090974|stage I breast cancer|stage i breast cancer
1674780|NCT00090974|stage II breast cancer|stage ii breast cancer
1674781|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
1674782|NCT00090961|pulmonary complications|pulmonary complications
1674783|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1674784|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1674785|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
1674786|NCT00090961|large cell lung cancer|large cell lung cancer
1674787|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
1674788|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1674789|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
1674790|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674791|NCT00090896|recurrent melanoma|recurrent melanoma
1674792|NCT00090896|stage III melanoma|stage iii melanoma
1674793|NCT00090896|stage IV melanoma|stage iv melanoma
1674794|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
1674795|NCT00090857|breast cancer|breast cancer
1674796|NCT00090857|stage I breast cancer|stage i breast cancer
1674797|NCT00090857|stage II breast cancer|stage ii breast cancer
1674798|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
1674799|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
1674800|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
1674801|NCT00090857|stage IV breast cancer|stage iv breast cancer
1674802|NCT00090857|breast cancer in situ|breast cancer in situ
1674803|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1674804|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1674805|NCT00090844|hormone changes|hormone changes
1674806|NCT00090844|stage I breast cancer|stage i breast cancer
1674807|NCT00090844|stage II breast cancer|stage ii breast cancer
1674808|NCT00090831|Emotional Learning|emotional learning
1674809|NCT00090831|Neurotransmitter|neurotransmitter
1674810|NCT00090831|Neural Systems|neural systems
1674811|NCT00090831|Response Control|response control
1674812|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
1674813|NCT00090831|Amygdala|amygdala
1674814|NCT00090831|Serotonin|serotonin
1674815|NCT00090831|Healthy Volunteer|healthy volunteer
1674817|NCT00090818|Dental Abnormalities|dental abnormalities
1674818|NCT00090818|Lichen Planus|lichen planus
1674819|NCT00090818|Oral Mucosal Disease|oral mucosal disease
1674820|NCT00090818|Genetic Disease|genetic disease
1674821|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
1674822|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
1674823|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
1674824|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
1674825|NCT00090779|Acute Infection|acute infection
1674826|NCT00090779|Treatment Naive|treatment naive
1674827|NCT00090727|diffuse|diffuse
1674828|NCT00090727|follicular|follicular
1674829|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1674830|NCT00090727|colorectal cancer|colorectal cancer
1674831|NCT00090727|pancreatic cancer|pancreatic cancer
1674832|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
1674833|NCT00090727|head and neck cancer|head and neck cancer
1674834|NCT00090727|breast cancer|breast cancer
1674835|NCT00090727|prostate cancer|prostate cancer
1674836|NCT00090727|ovarian cancer|ovarian cancer
1674837|NCT00090727|bladder cancer|bladder cancer
1674838|NCT00090727|hypoxia|hypoxia
1674839|NCT00090727|refractory|refractory
1674840|NCT00090727|metastatic|metastatic
1674841|NCT00090714|DNA|dna
1674842|NCT00090714|Circular|circular
1674843|NCT00090714|Gene Therapy|gene therapy
1674844|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
1674845|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1674846|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1674847|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1674848|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1674849|NCT00003172|stage III gastric cancer|stage iii gastric cancer
1674850|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
1674851|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
1674852|NCT00003139|oral complications|oral complications
1674853|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
1674854|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
1674855|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
1674856|NCT00003134|adult brain stem glioma|adult brain stem glioma
1674857|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
1674858|NCT00003134|adult mixed glioma|adult mixed glioma
1674859|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
1674860|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674862|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
1674863|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1674864|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1674865|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1674866|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1674867|NCT00003072|neurotoxicity|neurotoxicity
1674868|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1674869|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1674870|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1674871|NCT00003048|Amifostine|amifostine
1674872|NCT00003048|Ethyol|ethyol
1674873|NCT00003048|Ethiofos|ethiofos
1674874|NCT00003048|Gammaphos|gammaphos
1674875|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674876|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674877|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674878|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674879|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674880|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674881|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674882|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674883|NCT00090688|diarrhea|diarrhea
1674884|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674885|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1674886|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
1674887|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
1674888|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
1674889|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
1674890|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674891|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1674892|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674893|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1674894|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
1674895|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
1674896|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
1674897|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1674898|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1674899|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1674900|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1674901|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1674902|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674903|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1674904|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1674905|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1674906|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1674907|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1674908|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1674909|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1674910|NCT00002980|polycythemia vera|polycythemia vera
1674911|NCT00002980|primary myelofibrosis|primary myelofibrosis
1674912|NCT00002980|essential thrombocythemia|essential thrombocythemia
1674913|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
1674914|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1675115|NCT00002703|stage I prostate cancer|stage i prostate cancer
1674915|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
1674916|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1674917|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1674918|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
1674919|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674920|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674921|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674922|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674923|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674924|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674925|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674926|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674927|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674928|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674929|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677051|NCT00088582|Sandostatin|sandostatin
1674930|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1674931|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674932|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674933|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674934|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674935|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1674936|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1674937|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1674938|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1674939|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1674940|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1674941|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1674942|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1674943|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
1674944|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
1674945|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1674946|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1674947|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1674948|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1674949|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1674950|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1674951|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1674952|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1674953|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1674954|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1674955|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1674956|NCT00002967|stage I breast cancer|stage i breast cancer
1674957|NCT00002967|stage II breast cancer|stage ii breast cancer
1674958|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1674959|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1674960|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1674961|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1674962|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1674963|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1674964|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1674965|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1674966|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1674967|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1674968|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1674969|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1674970|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1674971|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1674972|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1674973|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1674974|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1674975|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1674976|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1674977|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1674978|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1674979|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1674980|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1674981|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1674982|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1674983|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1674984|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1674985|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1674986|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1674987|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1674988|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1674989|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1674990|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1674991|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1674992|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1674993|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1674994|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675616|NCT00090025|Tumor of biliary tree|tumor of biliary tree
1674995|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1674996|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1674997|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1674998|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1674999|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675000|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675001|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1675002|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1675003|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1675004|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1675005|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675006|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1675007|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1675008|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1675009|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1675010|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1675011|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1675012|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1675013|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1675014|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1675015|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1675016|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1675017|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1675018|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1675019|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1675020|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1675021|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1675022|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1675023|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1675024|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1675025|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1675026|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1675027|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1675028|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1675029|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1675030|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1675031|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675032|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1675033|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1675034|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1675035|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1675036|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675037|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675038|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1675039|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1675040|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1675041|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1675042|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1675043|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1675044|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1675045|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1675046|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675047|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675048|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675049|NCT00002942|stage II breast cancer|stage ii breast cancer
1675050|NCT00002942|stage IV breast cancer|stage iv breast cancer
1675051|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
1675052|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
1675053|NCT00002937|recurrent breast cancer|recurrent breast cancer
1675054|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1675055|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1675617|NCT00089999|lapatinib|lapatinib
1675056|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1675057|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1675058|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675059|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
1675060|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
1675061|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1675062|NCT00090662|Normal Volunteer|normal volunteer
1675063|NCT00090662|Eosinophilopoiesis|eosinophilopoiesis
1675064|NCT00090662|Healthy Volunteer|healthy volunteer
1675066|NCT00002873|stage I breast cancer|stage i breast cancer
1675067|NCT00002873|stage II breast cancer|stage ii breast cancer
1675068|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
1675069|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
1675070|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1675071|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
1675072|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
1675073|NCT00002872|malignant pleural effusion|malignant pleural effusion
1675074|NCT00002811|actinic keratosis|actinic keratosis
1675075|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1675076|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1675077|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1675078|NCT00002793|stage IV colon cancer|stage iv colon cancer
1675079|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
1675080|NCT00002793|recurrent colon cancer|recurrent colon cancer
1675081|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
1675082|NCT00002793|liver metastases|liver metastases
1675083|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1675084|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1675085|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1675086|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1675087|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1675088|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1675089|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
1675090|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
1675091|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1675092|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
1675093|NCT00002790|graft versus host disease|graft versus host disease
1675094|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1675095|NCT00002781|stage III melanoma|stage iii melanoma
1675096|NCT00002781|recurrent melanoma|recurrent melanoma
1675097|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675098|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
1675099|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
1675100|NCT00002767|stage IV melanoma|stage iv melanoma
1675101|NCT00002767|recurrent melanoma|recurrent melanoma
1675102|NCT00090623|Subfoveal neovascular|subfoveal neovascular
1675103|NCT00090623|Age-related macular degeneration|age-related macular degeneration
1675105|NCT00090623|Wet AMD|wet amd
1675106|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1675107|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1675108|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1675109|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1675110|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1675111|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1675112|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1675113|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
1675114|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675116|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
1675117|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
1675118|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
1675119|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
1675120|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
1675121|NCT00090493|Myeloma|myeloma
1675122|NCT00090493|Mage-A3|mage-a3
1675123|NCT00090493|Transplant|transplant
1675124|NCT00090493|Peptide|peptide
1675127|NCT00090493|Immunotherapy|immunotherapy
1675128|NCT00090493|NY-ESO-1|ny-eso-1
1675129|NCT00090480|Cancer|cancer
1675130|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1675131|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1675132|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1675133|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1675618|NCT00089999|advanced|advanced
1675134|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1675135|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1675136|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
1675137|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
1675138|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
1675139|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1675140|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1675141|NCT00002628|stage IV breast cancer|stage iv breast cancer
1675142|NCT00002628|recurrent breast cancer|recurrent breast cancer
1675143|NCT00002622|malignant pleural effusion|malignant pleural effusion
1675144|NCT00002616|stage IV breast cancer|stage iv breast cancer
1675145|NCT00002616|recurrent breast cancer|recurrent breast cancer
1675146|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
1675147|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
1675148|NCT00002593|stage II colon cancer|stage ii colon cancer
1675149|NCT00002593|stage III colon cancer|stage iii colon cancer
1675150|NCT00002570|stage III colon cancer|stage iii colon cancer
1675151|NCT00002570|stage IV colon cancer|stage iv colon cancer
1675152|NCT00002570|stage III rectal cancer|stage iii rectal cancer
1675153|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
1675154|NCT00002570|recurrent colon cancer|recurrent colon cancer
1675155|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
1675156|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675157|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1675158|NCT00002527|colon cancer|colon cancer
1675159|NCT00002527|rectal cancer|rectal cancer
1675160|NCT00002509|stage II breast cancer|stage ii breast cancer
1675161|NCT00002509|stage IV breast cancer|stage iv breast cancer
1675162|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
1675163|NCT00002509|recurrent breast cancer|recurrent breast cancer
1675164|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
1675165|NCT00090571|JRA ASPs|jra asps
1675166|NCT00090571|Genomics|genomics
1675167|NCT00090376|Erectile Dysfunction|erectile dysfunction
1675168|NCT00090376|Impotence|impotence
1675169|NCT00090376|Prostate Cancer|prostate cancer
1675170|NCT00090376|Prostatectomy|prostatectomy
1675171|NCT00090363|rising PSA|rising psa
1675172|NCT00090363|bone metastases|bone metastases
1675173|NCT00090363|Clinical study|clinical study
1675174|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
1675175|NCT00090324|Schizophrenia|schizophrenia
1675176|NCT00090311|Bipolar I Mania|bipolar i mania
1675177|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1675178|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1675179|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1675180|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1675181|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675182|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675183|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
1675184|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
1675185|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1675186|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1675187|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1675188|NCT00002489|ovarian teratoma|ovarian teratoma
1675189|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
1675190|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675191|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675192|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675193|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675194|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675195|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681445|NCT00083382|Pamidronate|pamidronate
1675197|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1675198|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
1675199|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1675200|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1675201|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1675202|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1677183|NCT00002832|Filgrastim|filgrastim
1675203|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
1675204|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1675205|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1675206|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1675207|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1675208|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1675209|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1675210|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1675211|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675212|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675213|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675214|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675215|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1675216|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1675217|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1675218|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1675219|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1675220|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
1675221|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
1675222|NCT00090558|Atherosclerosis|atherosclerosis
1675223|NCT00090558|Bone Marrow|bone marrow
1675224|NCT00090558|Exercise|exercise
1675225|NCT00090558|Endothelium|endothelium
1675226|NCT00090558|Nitroglycerin|nitroglycerin
1675227|NCT00090558|Coronary Artery Disease|coronary artery disease
1675228|NCT00090558|CAD|cad
1675229|NCT00090545|Hormone-Refractory|hormone-refractory
1675230|NCT00090545|Proteomics|proteomics
1675231|NCT00090545|Angiogenesis|angiogenesis
1675232|NCT00090545|VEGFR|vegfr
1675233|NCT00090545|Prostate Cancer|prostate cancer
1675234|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
1675235|NCT00090506|Yoga|yoga
1675236|NCT00090506|Meditation|meditation
1675237|NCT00090428|Autism|autism
1675238|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
1675239|NCT00090428|Gluten|gluten
1675240|NCT00090428|Casein|casein
1675241|NCT00090415|Autism|autism
1675242|NCT00090415|Developmental Delay Disorders|developmental delay disorders
1675244|NCT00090181|Arcoxia|arcoxia
1675245|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675246|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
1675247|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
1675248|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675249|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675250|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1675251|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1675252|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1675253|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1675254|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1675255|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1675256|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1675257|NCT00003989|stage III melanoma|stage iii melanoma
1675258|NCT00003989|stage IV melanoma|stage iv melanoma
1675259|NCT00003989|recurrent melanoma|recurrent melanoma
1675260|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1675261|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1675262|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1675263|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1675264|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1675265|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
1675266|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
1675267|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
1675268|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
1675269|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1675270|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1675271|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675272|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675273|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1675274|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1675275|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
1675276|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675277|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675278|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675685|NCT00004042|stage III rectal cancer|stage iii rectal cancer
1675279|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675280|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675281|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675282|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675283|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675284|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675285|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1675619|NCT00089999|metastatic breast cancer|metastatic breast cancer
1675286|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1675287|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1675288|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1675289|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675290|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675291|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675292|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675293|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675294|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675295|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1675296|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
1675297|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
1675298|NCT00003778|ovarian sarcoma|ovarian sarcoma
1675299|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1675300|NCT00090402|Fish Oils|fish oils
1675301|NCT00090402|Thioctic Acid|thioctic acid
1675302|NCT00090402|Antioxidants|antioxidants
1675303|NCT00090402|Dietary Supplements|dietary supplements
1675304|NCT00090389|Acupuncture|acupuncture
1675305|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
1675306|NCT00090337|pain|pain
1675307|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1675308|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1675309|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1675310|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1675311|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1675312|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1675313|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1675314|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1675315|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1675316|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1675317|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1675318|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1675319|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1675320|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1675321|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1675322|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1675323|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1675324|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1675325|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1675326|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1675327|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1675328|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1675329|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1675330|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1675331|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1675332|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1675333|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1675334|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1681446|NCT00083382|Aredia|aredia
1675335|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1675336|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1675337|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1675338|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1675339|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1675340|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1675341|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1675342|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1675343|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1675344|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1675345|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1675346|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1675347|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1675348|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1675349|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1675350|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1675351|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1677379|NCT00088309|Treatment Experienced|treatment experienced
1675352|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1675353|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1675354|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1675355|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1675356|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1675357|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1675358|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1675359|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1675360|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1675361|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1675362|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1675363|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1675364|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1675365|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1675366|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1675367|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1675368|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1675369|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1675370|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1675371|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1675372|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1675373|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1675374|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1675375|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1675376|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1675377|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1675378|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1675379|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1675380|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1675381|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1675382|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1675383|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1675459|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1675384|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1675385|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1675386|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1675387|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1675388|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1675389|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
1675390|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
1675391|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
1675392|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
1675393|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
1675394|NCT00090194|Kidney Transplantation|kidney transplantation
1675395|NCT00090194|Transplantation, Homologous|transplantation, homologous
1675396|NCT00090194|HLA Antigens|hla antigens
1675397|NCT00090194|Autoantibodies|autoantibodies
1675398|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1675399|NCT00090194|Living Donors|living donors
1675400|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1675401|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
1675402|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
1675403|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
1675404|NCT00090129|Onercept|onercept
1675405|NCT00090129|Placebo|placebo
1675406|NCT00090116|Neramexane|neramexane
1675407|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
1675408|NCT00090116|Memory Loss|memory loss
1675409|NCT00090116|Alzheimer Disease|alzheimer disease
1675410|NCT00090103|Combination Therapy|combination therapy
1675411|NCT00090103|dutasteride|dutasteride
1675413|NCT00090077|GW695634G|gw695634g
1675414|NCT00090077|GW695634X|gw695634x
1675415|NCT00090077|GW678248X|gw678248x
1675416|NCT00090077|pharmacokinetics|pharmacokinetics
1675417|NCT00090077|NNRTI|nnrti
1675418|NCT00090077|HIV|hiv
1675419|NCT00003654|stage I breast cancer|stage i breast cancer
1675420|NCT00003654|stage II breast cancer|stage ii breast cancer
1675421|NCT00003601|melanoma|melanoma
1675422|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1675423|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1675424|NCT00003519|stage II breast cancer|stage ii breast cancer
1675425|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
1675426|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
1675427|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1675428|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1675429|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1675430|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1675431|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1675432|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
1675433|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
1675434|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1675435|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
1675436|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1675437|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1675438|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675439|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675440|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1675441|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1675442|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675443|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1675444|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1675445|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1675446|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1675447|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1675448|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1675449|NCT00003406|polycythemia vera|polycythemia vera
1675450|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1675451|NCT00003406|essential thrombocythemia|essential thrombocythemia
1675452|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1675453|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
1675454|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1675455|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1675456|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
1675457|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1675458|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1675530|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
1675460|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1675461|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1675462|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1675463|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1675464|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1677184|NCT00002832|G-CSF|g-csf
1675465|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1675466|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1675467|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1675468|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1675469|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1675470|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1675471|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1675472|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1675620|NCT00089999|GW572016|gw572016
1675473|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1675474|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1675475|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675476|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675477|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675478|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675479|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675480|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675481|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675482|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675483|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675484|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1675485|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1675486|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675487|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1675488|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1675489|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1675490|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1675491|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
1675492|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1675493|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1675494|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
1675495|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
1675496|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1675497|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1675498|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675499|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1675500|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1675501|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675502|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675503|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1675504|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1675505|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1675506|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1675507|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675508|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675509|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675510|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1675511|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
1675512|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
1675513|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1675514|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1675515|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1675516|NCT00003362|stage III melanoma|stage iii melanoma
1675517|NCT00003362|stage IV melanoma|stage iv melanoma
1675518|NCT00003362|recurrent melanoma|recurrent melanoma
1675519|NCT00003315|infection|infection
1675520|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
1675521|NCT00090064|MDMA|mdma
1675522|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
1675523|NCT00090064|PTSD|ptsd
1675524|NCT00090064|psychotherapy|psychotherapy
1675525|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
1675526|NCT00003260|stage IV colon cancer|stage iv colon cancer
1675527|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
1675528|NCT00003260|recurrent colon cancer|recurrent colon cancer
1675529|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
1675531|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1675532|NCT00003237|stage II gastric cancer|stage ii gastric cancer
1675533|NCT00003237|stage III gastric cancer|stage iii gastric cancer
1675534|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
1675535|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
1675536|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1675537|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1675538|NCT00003229|stage IV melanoma|stage iv melanoma
1675539|NCT00003229|recurrent melanoma|recurrent melanoma
1675540|NCT00003224|stage II melanoma|stage ii melanoma
1675541|NCT00003224|stage III melanoma|stage iii melanoma
1675542|NCT00003224|stage IV melanoma|stage iv melanoma
1675543|NCT00003224|recurrent melanoma|recurrent melanoma
1675544|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1675545|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1675546|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1675547|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1675548|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675549|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1675550|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1675551|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1675552|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1675553|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675554|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1675555|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1675556|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1675557|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1675558|NCT00002960|malignant ascites|malignant ascites
1675559|NCT00002960|fallopian tube cancer|fallopian tube cancer
1675560|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1675561|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1675562|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1675563|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1675564|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1675565|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1675566|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1675567|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1675568|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1675569|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1675570|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1675571|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1675572|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1675573|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1675574|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1675575|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1675576|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675577|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
1675578|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
1675579|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
1675580|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1675581|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1675582|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1675583|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1675584|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1675585|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675586|NCT00002845|stage IV melanoma|stage iv melanoma
1675587|NCT00002845|recurrent melanoma|recurrent melanoma
1675588|NCT00002783|stage II gastric cancer|stage ii gastric cancer
1675589|NCT00002783|stage III gastric cancer|stage iii gastric cancer
1675590|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
1675591|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1675592|NCT00002755|stage II breast cancer|stage ii breast cancer
1675593|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
1675594|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
1675595|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
1675596|NCT00002742|leukemia|leukemia
1675597|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
1675598|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
1682367|NCT00083317|Competition|competition
1675599|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
1675600|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
1675601|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
1675602|NCT00002742|infection|infection
1675603|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
1677185|NCT00002832|Neupogen|neupogen
1675604|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1675605|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
1675606|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
1675607|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
1675608|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
1675609|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1675610|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1675611|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
1675612|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
1675613|NCT00090025|Gall bladder tumor|gall bladder tumor
1675614|NCT00090025|Gall bladder cancer|gall bladder cancer
1675615|NCT00090025|Bile duct tumor|bile duct tumor
1675622|NCT00089986|severe sepsis|severe sepsis
1675623|NCT00089986|septic shock|septic shock
1675624|NCT00089986|Gram-negative infection|gram-negative infection
1675625|NCT00089986|phospholipid emulsion|phospholipid emulsion
1675626|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675627|NCT00004906|stage IV breast cancer|stage iv breast cancer
1675628|NCT00004906|recurrent breast cancer|recurrent breast cancer
1675629|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1675630|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1675631|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1675632|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1675633|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
1675634|NCT00002634|regional neuroblastoma|regional neuroblastoma
1675635|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
1675636|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
1675637|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1675638|NCT00002579|stage I breast cancer|stage i breast cancer
1675639|NCT00002579|stage II breast cancer|stage ii breast cancer
1675640|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
1675641|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1675642|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675643|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675644|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675645|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675646|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1675647|NCT00002498|stage IV breast cancer|stage iv breast cancer
1675648|NCT00002498|recurrent breast cancer|recurrent breast cancer
1675649|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
1675650|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1675651|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
1675652|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1675653|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
1675654|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1675655|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1675656|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1675657|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1675658|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1675659|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1675660|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1675661|NCT00089973|breast cancer|breast cancer
1675662|NCT00089960|GIST|gist
1675663|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
1675664|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
1675665|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
1675666|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
1675667|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
1675668|NCT00089921|DMARDs|dmards
1675669|NCT00089921|Methotrexate|methotrexate
1675670|NCT00089921|p38 kinase|p38 kinase
1675671|NCT00004900|stage IV breast cancer|stage iv breast cancer
1675672|NCT00004900|recurrent breast cancer|recurrent breast cancer
1675673|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
1675674|NCT00004182|stage IV breast cancer|stage iv breast cancer
1675675|NCT00004182|recurrent breast cancer|recurrent breast cancer
1675676|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
1682987|NCT00082121|CABG|cabg
1675677|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
1675678|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
1675679|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1675680|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
1675681|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1675682|NCT00004136|liver metastases|liver metastases
1675683|NCT00004042|stage III colon cancer|stage iii colon cancer
1675684|NCT00004042|stage IV colon cancer|stage iv colon cancer
1677351|NCT00088361|Liver|liver
1675686|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
1675687|NCT00004042|recurrent colon cancer|recurrent colon cancer
1675688|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
1675689|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1675690|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1675691|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
1675692|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1675693|NCT00089908|Dengue Vaccine|dengue vaccine
1675694|NCT00089908|Dengue Virus|dengue virus
1675695|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
1675696|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
1680820|NCT00083616|ABX-EGF|abx-egf
1675697|NCT00089895|myocardial infarction|myocardial infarction
1675698|NCT00089895|acute coronary syndrome|acute coronary syndrome
1675699|NCT00089895|non-ST-segment elevation|non-st-segment elevation
1675700|NCT00089895|eptifibatide|eptifibatide
1675701|NCT00089895|Integrilin|integrilin
1675702|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
1675703|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
1675704|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
1675705|NCT00089895|catheterization|catheterization
1675706|NCT00089895|angina|angina
1675707|NCT00089895|ischemia|ischemia
1675708|NCT00089895|cardiac ischemia|cardiac ischemia
1675709|NCT00089895|cardiovascular disease|cardiovascular disease
1675710|NCT00089882|Alzheimer disease|alzheimer disease
1675711|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
1675712|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
1675713|NCT00089856|Prostate|prostate
1675714|NCT00089856|Cancer|cancer
1675715|NCT00089856|Metastatic|metastatic
1675716|NCT00089856|Hormone-refractory|hormone-refractory
1675717|NCT00089856|GVAX|gvax
1675718|NCT00089856|Chemotherapy|chemotherapy
1675719|NCT00089856|Taxotere|taxotere
1675720|NCT00089856|Docetaxel|docetaxel
1675721|NCT00089856|Prednisone|prednisone
1675722|NCT00089856|Vaccine|vaccine
1675723|NCT00089856|Allogeneic cells|allogeneic cells
1675724|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
1675725|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
1675726|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1675727|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
1675728|NCT00003897|stage IV melanoma|stage iv melanoma
1675729|NCT00003897|recurrent melanoma|recurrent melanoma
1675730|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1675731|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
1675732|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
1675733|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
1675734|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675735|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675736|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1675737|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675738|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675739|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675740|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675741|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675742|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675743|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675744|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675745|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675746|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675747|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1675748|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675749|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675750|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675751|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675752|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675753|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675754|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
1675755|NCT00003751|adult glioblastoma|adult glioblastoma
1675756|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
1675757|NCT00003751|adult gliosarcoma|adult gliosarcoma
1675758|NCT00089843|Eating Disorders|eating disorders
1675759|NCT00089843|Osteopenia|osteopenia
1675760|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
1675761|NCT00089830|Squalamine Lactate|squalamine lactate
1675763|NCT00089804|Nephritis|nephritis
1675764|NCT00089804|Kidney|kidney
1675766|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
1675767|NCT00089804|Nephritis, Lupus|nephritis, lupus
1675768|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675769|NCT00003686|oral complications|oral complications
1675770|NCT00003686|quality of life|quality of life
1675771|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675772|NCT00003684|pulmonary complications|pulmonary complications
1675773|NCT00003684|quality of life|quality of life
1675774|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
1675775|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
1675776|NCT00003556|stage IV melanoma|stage iv melanoma
1675777|NCT00003556|recurrent melanoma|recurrent melanoma
1675778|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
1675779|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675780|NCT00003543|stage IV colon cancer|stage iv colon cancer
1675781|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
1675782|NCT00003543|recurrent colon cancer|recurrent colon cancer
1675783|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
1675784|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1675785|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
1675786|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
1675787|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1675788|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1675789|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1675790|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1675791|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
1675792|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
1675793|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
1675794|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1675795|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675796|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675797|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1675798|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1675799|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1675800|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1675801|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1675802|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1675803|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1675804|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1675805|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1675806|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1675807|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1675808|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1675809|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
1675810|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1675811|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1675812|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
1675813|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
1675814|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1675815|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1675816|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1675817|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1675818|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1675819|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1675820|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1675821|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1675822|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1675823|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675824|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675825|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675826|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675827|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675828|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675829|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675830|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675831|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675832|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1675833|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675834|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1675835|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1675836|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1675837|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1675838|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1675839|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1675840|NCT00003395|intraocular lymphoma|intraocular lymphoma
1675841|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1675842|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675843|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1675844|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1675845|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1675846|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1675847|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675848|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675849|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1675850|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1675953|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
1675851|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675852|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675853|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675854|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1675855|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1675856|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1675857|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1675858|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1675859|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1675860|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1675861|NCT00003380|fallopian tube cancer|fallopian tube cancer
1675862|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1675863|NCT00003380|Brenner tumor|brenner tumor
1675864|NCT00003360|stage IV colon cancer|stage iv colon cancer
1675865|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
1675866|NCT00003360|recurrent colon cancer|recurrent colon cancer
1675867|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
1675868|NCT00003357|stage I breast cancer|stage i breast cancer
1675869|NCT00003357|stage II breast cancer|stage ii breast cancer
1675870|NCT00003357|stage III breast cancer|stage iii breast cancer
1675871|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
1675872|NCT00003348|adult glioblastoma|adult glioblastoma
1675873|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1675874|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
1675875|NCT00003348|adult gliosarcoma|adult gliosarcoma
1675876|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675877|NCT00003312|stage I prostate cancer|stage i prostate cancer
1675878|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
1675879|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
1675880|NCT00089778|Clinical Response|clinical response
1675881|NCT00089778|Toxicity|toxicity
1675882|NCT00089778|Immunologic Response|immunologic response
1675883|NCT00089778|Adjuvant|adjuvant
1675885|NCT00089778|Renal Cancer|renal cancer
1675886|NCT00089765|Retinal Angioma|retinal angioma
1675888|NCT00089765|Anti-VEGF|anti-vegf
1675889|NCT00089765|Monoclonal Antibody|monoclonal antibody
1675890|NCT00089765|Macular Edema|macular edema
1675891|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
1675892|NCT00089765|VEGF|vegf
1675893|NCT00089765|Ranibizumab|ranibizumab
1675894|NCT00089765|VHL|vhl
1675895|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1675896|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1675897|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1675898|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1675899|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1675900|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1675901|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1675902|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1675903|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1675904|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1675905|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1675906|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1675907|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1675908|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1675909|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1675910|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1675911|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
1675912|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1675913|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
1675914|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1675915|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1675916|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1675917|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1675918|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1675919|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1675920|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1675921|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1675922|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1675923|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1675924|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1675925|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1675926|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1675927|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1675928|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1675929|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1675930|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1675931|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1675932|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1675933|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1675934|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1675935|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1675936|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
1675937|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1675938|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1675939|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1675940|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1675941|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1675942|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1675943|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1675944|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1675945|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1675946|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1675947|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1675948|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1675949|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1675950|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1675951|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
1675952|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1675954|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1675955|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1675956|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1675957|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1675958|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1675959|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1675960|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
1675961|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
1675962|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
1675963|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1675964|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1675965|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1675966|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1675967|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1675968|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1675969|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1675970|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1675971|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
1675972|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
1675973|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
1675974|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1675975|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1675976|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1675977|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1675978|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1675979|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1675980|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1675981|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1675982|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1675983|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1675984|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1675985|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1675986|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1675987|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1675988|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1675989|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1675990|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1675991|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1675992|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1675993|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1675994|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1675995|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1675996|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1675997|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1675998|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1675999|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1676000|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1676001|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1676002|NCT00003251|radiation toxicity|radiation toxicity
1676003|NCT00003220|stage IV colon cancer|stage iv colon cancer
1676004|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
1676005|NCT00003220|recurrent colon cancer|recurrent colon cancer
1676006|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
1676007|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
1676008|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1676009|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1676010|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1676011|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1676012|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1676013|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1676014|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1676015|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1676016|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1676017|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1676018|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1676019|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1676020|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1676021|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1676022|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1676023|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1676024|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1676025|NCT00089739|Uveitis|uveitis
1676026|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
1676027|NCT00089739|GITR|gitr
1676028|NCT00089739|Immunosuppression|immunosuppression
1676029|NCT00089739|GITR Ligand|gitr ligand
1676030|NCT00089739|Intraocular Inflammation|intraocular inflammation
1676031|NCT00089726|cancer vaccine|cancer vaccine
1676032|NCT00089726|NSCLC|nsclc
1676033|NCT00089726|immunotherapy|immunotherapy
1676034|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
1676035|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
1676036|NCT00089713|blood pressure|blood pressure
1676037|NCT00089700|HIV|hiv
1676038|NCT00089700|AIDS|aids
1676039|NCT00089700|Treatment Experienced|treatment experienced
1676040|NCT00089700|Optimized Background Therapy|optimized background therapy
1676041|NCT00089700|HIV-1|hiv-1
1676042|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1676043|NCT00003123|refractory anemia|refractory anemia
1676044|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1676045|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
1676046|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1676047|NCT00003115|prostate cancer|prostate cancer
1676048|NCT00003115|pain|pain
1676049|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
1676050|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
1676051|NCT00003058|adult liposarcoma|adult liposarcoma
1676332|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
1676052|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1676053|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1676054|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
1676055|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
1676056|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676057|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1676058|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1676059|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
1676060|NCT00002933|stage IV colon cancer|stage iv colon cancer
1676061|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
1676062|NCT00002933|recurrent colon cancer|recurrent colon cancer
1676063|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
1676064|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
1676065|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1676066|NCT00089674|Prostate Cancer|prostate cancer
1676067|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
1676068|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
1676069|NCT00089661|Breast Cancer|breast cancer
1676070|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
1676071|NCT00089661|osteopenia|osteopenia
1676072|NCT00089661|Low bone density|low bone density
1676073|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
1676074|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
1676075|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
1676076|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
1676077|NCT00089635|Vectibix|vectibix
1676078|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
1676079|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1676080|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1676081|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1676082|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
1676083|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1676084|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1676085|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1676086|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1676087|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1676088|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676089|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676090|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676091|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676092|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1676093|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1676094|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1676095|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1676096|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1676097|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676098|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676099|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676100|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676101|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1676102|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1692063|NCT00074386|Organ|organ
1676103|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1676104|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1676105|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1676106|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676107|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676108|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676109|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1676110|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1676111|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1676112|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1676113|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1676114|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1676115|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1676116|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1676117|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676118|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676119|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1676120|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1676121|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1676122|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676123|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676124|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676125|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676126|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676127|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676128|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676129|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676130|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676131|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1676132|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1676133|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1676134|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1676135|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
1676136|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1676137|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1676138|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676139|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676140|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1676141|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1676142|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1676143|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
1676144|NCT00002749|adult brain stem glioma|adult brain stem glioma
1676145|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
1676146|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1676147|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1676148|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1676149|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1676150|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1676151|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1676152|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1676153|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1676154|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
1676155|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1676156|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1676157|NCT00002655|liver metastases|liver metastases
1676158|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1676159|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1676160|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1676161|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1676162|NCT00002619|adult brain stem glioma|adult brain stem glioma
1676163|NCT00002619|adult glioblastoma|adult glioblastoma
1676164|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1676165|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1676166|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
1676167|NCT00002619|adult gliosarcoma|adult gliosarcoma
1676168|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1676169|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1676170|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1676171|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1676172|NCT00002585|stage IV breast cancer|stage iv breast cancer
1676173|NCT00002585|recurrent breast cancer|recurrent breast cancer
1676174|NCT00089596|umbilical cord blood|umbilical cord blood
1676175|NCT00089596|transplant|transplant
1676176|NCT00089596|ALL|all
1676177|NCT00089596|AML|aml
1676178|NCT00089596|MDS|mds
1676179|NCT00089596|NHL|nhl
1676180|NCT00089596|CML|cml
1677352|NCT00088361|Heart|heart
1676181|NCT00089583|antiretroviral therapy|antiretroviral therapy
1676182|NCT00089583|pediatrics|pediatrics
1676183|NCT00089583|AGENERASE|agenerase
1676184|NCT00089583|amprenavir|amprenavir
1676185|NCT00089583|fosamprenavir|fosamprenavir
1676186|NCT00089583|HIV Infection|hiv infection
1676187|NCT00089583|ritonavir|ritonavir
1676188|NCT00089583|protease inhibitor|protease inhibitor
1676189|NCT00089583|LEXIVA|lexiva
1676190|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1676191|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1676192|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1676193|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1676194|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1676195|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676196|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676197|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676198|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676199|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676200|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676201|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
1676202|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1676203|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1676204|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1676205|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1676206|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1676207|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1676208|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1676209|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676210|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676211|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1676212|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1676213|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1676214|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676215|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676216|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1676217|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1676218|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676219|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676220|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676221|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676222|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1676223|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1676224|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676225|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676226|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676227|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
1676228|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
1676229|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
1676230|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
1676231|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1676232|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1676233|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1676234|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1676235|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
1676236|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
1676237|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
1676238|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
1676239|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1676240|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1676241|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1676311|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676242|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1676243|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1676244|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1676245|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1676246|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1676247|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1676248|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1676249|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1676250|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1676251|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1676252|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1676253|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1676254|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1680821|NCT00083616|Immunex|immunex
1676255|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1676256|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1676257|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1676258|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1676259|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1676260|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1676261|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1676262|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1676263|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1676264|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1676265|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1676266|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1676267|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1676268|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1676269|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1676270|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1676271|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1676272|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1676273|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1676274|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1676275|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1676276|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1676277|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1676278|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1676279|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1676280|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1676281|NCT00089622|Parkinson's Disease|parkinson's disease
1676282|NCT00089622|Motor Fluctuations|motor fluctuations
1676283|NCT00089622|Intravenous Levodopa|intravenous levodopa
1676284|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
1676285|NCT00089622|Lisuride Patch|lisuride patch
1676286|NCT00089622|Parkinson Disease|parkinson disease
1676287|NCT00089622|PD|pd
1676288|NCT00089609|Hormones|hormones
1676289|NCT00089609|Angiogenesis|angiogenesis
1676290|NCT00089609|Markers|markers
1676291|NCT00089609|Tumor|tumor
1676292|NCT00089609|Prostate Cancer|prostate cancer
1676293|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
1676294|NCT00089570|terlipressin|terlipressin
1676295|NCT00089557|Dermal assessment|dermal assessment
1676296|NCT00089557|Pain assessment|pain assessment
1676297|NCT00089557|Diary|diary
1676298|NCT00089557|Analgesics|analgesics
1676299|NCT00089557|Capsaicin|capsaicin
1676300|NCT00089557|Herpes zoster|herpes zoster
1676301|NCT00089557|Neuralgia|neuralgia
1676302|NCT00089557|Pain|pain
1676303|NCT00089557|HIV Infections|hiv infections
1676304|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
1676305|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
1676306|NCT00089557|Diabetes Mellitus|diabetes mellitus
1676307|NCT00089557|Polyneuropathies|polyneuropathies
1676308|NCT00089557|Complementary Therapies|complementary therapies
1676309|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
1676310|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
1676312|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
1676313|NCT00005076|stage III colon cancer|stage iii colon cancer
1676314|NCT00005076|stage IV colon cancer|stage iv colon cancer
1676315|NCT00005076|stage III rectal cancer|stage iii rectal cancer
1676316|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
1676317|NCT00005076|recurrent colon cancer|recurrent colon cancer
1676318|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
1676319|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
1676320|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
1676414|NCT00089323|stage II breast cancer|stage ii breast cancer
1676321|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1676322|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
1676323|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1676324|NCT00005057|stage IV melanoma|stage iv melanoma
1676325|NCT00005057|recurrent melanoma|recurrent melanoma
1676326|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
1676327|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
1676328|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
1676329|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
1676330|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
1676331|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
1676333|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
1676334|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
1676335|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
1676336|NCT00004937|adult glioblastoma|adult glioblastoma
1676337|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
1676338|NCT00004937|adult gliosarcoma|adult gliosarcoma
1676339|NCT00004219|nausea and vomiting|nausea and vomiting
1676340|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1676341|NCT00004219|testicular seminoma|testicular seminoma
1676342|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1676343|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1676344|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1676345|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1676346|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1676347|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1676348|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1676349|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1676351|NCT00004215|neutropenia|neutropenia
1676352|NCT00004215|thrombocytopenia|thrombocytopenia
1676353|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1676354|NCT00004207|stage IV breast cancer|stage iv breast cancer
1676355|NCT00004207|recurrent breast cancer|recurrent breast cancer
1676356|NCT00089531|Healthy|healthy
1676357|NCT00089531|Virus|virus
1676358|NCT00089531|T-Cells|t-cells
1676359|NCT00089531|HIV-Negative|hiv-negative
1676360|NCT00089531|Immunity|immunity
1676361|NCT00089531|Healthy Volunteer|healthy volunteer
1676362|NCT00089531|HV|hv
1676363|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
1676364|NCT00089531|HIV Seronegativity|hiv seronegativity
1676365|NCT00089518|Treatment Experienced|treatment experienced
1676366|NCT00089505|Treatment Experienced|treatment experienced
1676367|NCT00089505|Treatment Naive|treatment naive
1676368|NCT00089505|MTCT|mtct
1676369|NCT00089505|HIV Seronegativity|hiv seronegativity
1676370|NCT00089466|Entry Inhibitors|entry inhibitors
1676371|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
1676372|NCT00089466|Treatment Experienced|treatment experienced
1676373|NCT00089466|Treatment Naive|treatment naive
1676374|NCT00089453|Myeloma|myeloma
1676375|NCT00089453|Transplant|transplant
1676376|NCT00089453|Relapsed|relapsed
1676377|NCT00089453|Donor|donor
1676378|NCT00089453|Stem Cell|stem cell
1676379|NCT00089453|Thalidomide|thalidomide
1676380|NCT00089453|Dexamethasone|dexamethasone
1676381|NCT00089453|Cisplatin|cisplatin
1676382|NCT00089453|Adriamycin|adriamycin
1676383|NCT00089453|Cyclophosphamide|cyclophosphamide
1676384|NCT00089453|Etoposide|etoposide
1676385|NCT00089453|Melphalan|melphalan
1676386|NCT00089427|brain tumor|brain tumor
1676387|NCT00089427|malignant glioma|malignant glioma
1676388|NCT00089427|brain neoplasm|brain neoplasm
1676389|NCT00089427|central nervous system|central nervous system
1676390|NCT00089427|surgery|surgery
1676391|NCT00089427|resection|resection
1676392|NCT00089427|temozolomide|temozolomide
1676393|NCT00089427|infusion|infusion
1676394|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
1676395|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
1676396|NCT00089427|oligoastrocytoma|oligoastrocytoma
1676397|NCT00089427|Temodar|temodar
1676398|NCT00089427|radiation|radiation
1676399|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
1676400|NCT00089427|GBM|gbm
1676401|NCT00089414|Depression|depression
1676402|NCT00089414|Menstrual Cycle|menstrual cycle
1676403|NCT00089414|Gonadal Steroids|gonadal steroids
1676404|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
1676405|NCT00089414|Drospirenone|drospirenone
1676406|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
1676407|NCT00089414|MRMD|mrmd
1676408|NCT00089401|recurrent colon cancer|recurrent colon cancer
1676409|NCT00089401|stage IV colon cancer|stage iv colon cancer
1676410|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
1676411|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
1676412|NCT00089401|liver metastases|liver metastases
1676413|NCT00089323|stage IA breast cancer|stage ia breast cancer
1676415|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
1676416|NCT00089323|male breast cancer|male breast cancer
1676417|NCT00089323|stage IB breast cancer|stage ib breast cancer
1676418|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1676419|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
1676420|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
1676421|NCT00089297|Cetuximab|cetuximab
1676422|NCT00089297|Paclitaxel|paclitaxel
1676423|NCT00089297|Carboplatin|carboplatin
1676424|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1676425|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
1676426|NCT00089258|regional neuroblastoma|regional neuroblastoma
1676427|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
1676428|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
1676429|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
1676430|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
1676431|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
1676432|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
1676433|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1676434|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1676435|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1676436|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
1676437|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1676438|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1676439|NCT00089245|adult medulloblastoma|adult medulloblastoma
1676440|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1676441|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1676442|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
1676443|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1676444|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1676445|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1676446|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1676447|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1676448|NCT00089219|stage III melanoma|stage iii melanoma
1676449|NCT00089219|stage IV melanoma|stage iv melanoma
1676450|NCT00089219|recurrent melanoma|recurrent melanoma
1676451|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1676452|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
1676453|NCT00089219|iris melanoma|iris melanoma
1676454|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
1676455|NCT00089206|stage III melanoma|stage iii melanoma
1676456|NCT00089206|stage IV melanoma|stage iv melanoma
1676457|NCT00089206|recurrent melanoma|recurrent melanoma
1676458|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
1676459|NCT00089206|iris melanoma|iris melanoma
1676460|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
1676461|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1676462|NCT00089193|stage II melanoma|stage ii melanoma
1676463|NCT00089193|stage III melanoma|stage iii melanoma
1676464|NCT00089193|stage IV melanoma|stage iv melanoma
1676465|NCT00089193|recurrent melanoma|recurrent melanoma
1676466|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
1676467|NCT00089141|graft versus host disease|graft versus host disease
1676468|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1676469|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1676470|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1676471|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1676472|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1676473|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1676474|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1676475|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1676476|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1676477|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1676478|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1676479|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1692517|NCT00073515|thrombosis|thrombosis
1676480|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1676481|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676482|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
1676483|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676484|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1676485|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1676486|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676673|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
1676487|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1676488|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1676489|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1676490|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1676491|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1676492|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1676493|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1676494|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1676495|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1676496|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1676497|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1676498|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1676499|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1676500|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1676501|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676502|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1676503|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1676504|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676505|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
1676506|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
1676507|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1676508|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1676509|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1676510|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1676511|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676512|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1676513|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1676514|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1676515|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676516|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676517|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676518|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676519|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676520|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
1676521|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1676522|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676523|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1676524|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
1676525|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
1676526|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
1676527|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1676528|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1676529|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1676530|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676531|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1676532|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1676533|NCT00089141|stage IV breast cancer|stage iv breast cancer
1676534|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1676535|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676536|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676537|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676538|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676539|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676540|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1676541|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676542|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1676543|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1676544|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
1676545|NCT00089128|stage III bladder cancer|stage iii bladder cancer
1676546|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
1676547|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1676548|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1676549|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1676550|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1676551|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1676552|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1676553|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1676554|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1676555|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1676556|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676557|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676558|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676685|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
1676559|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676560|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676561|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676562|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676563|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676564|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676565|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
1676566|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
1676567|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
1676568|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1676569|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1676570|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1676571|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1676572|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1676573|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1676574|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1676575|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1676576|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1676577|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1676578|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
1676579|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1676580|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1676581|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1676582|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1676583|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1676584|NCT00089037|graft versus host disease|graft versus host disease
1676585|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1676586|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1676587|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1676588|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1676589|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1676590|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1676591|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1676592|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1676593|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676594|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1676595|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676596|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676597|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676598|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1676599|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1676600|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1676601|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1676602|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1676603|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1676604|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1676605|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1692749|NCT00073008|Her-2/neu|her-2/neu
1676606|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1676607|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1676608|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1676609|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1676610|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676611|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677031|NCT00088686|Acute Pain|acute pain
1676612|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676613|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1676614|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1676615|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676616|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1676617|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
1676618|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
1676619|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1676620|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1676621|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1676622|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1676623|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1676624|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1676625|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1676626|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1676627|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1676628|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1676629|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1676630|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1676631|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1676632|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1676633|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1676634|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1676635|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1676636|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1676637|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1676638|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676639|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1676640|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1676641|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676642|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1676643|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1676644|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676645|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676646|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676647|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676648|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676649|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676650|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676651|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676652|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676653|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676654|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676655|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676656|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1676657|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1676658|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1676659|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1676660|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1676661|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1676662|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1676663|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1676664|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1676665|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1676666|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1693075|NCT00072592|Vasculitis|vasculitis
1676667|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1676668|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1676669|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1676670|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1676671|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
1676672|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
1677032|NCT00088686|Orofacial|orofacial
1676674|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1676675|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1676676|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676677|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676678|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
1676679|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
1676680|NCT00088998|male breast cancer|male breast cancer
1676681|NCT00088998|recurrent breast cancer|recurrent breast cancer
1676682|NCT00088998|stage IV breast cancer|stage iv breast cancer
1676683|NCT00088985|recurrent breast cancer|recurrent breast cancer
1676684|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
1676686|NCT00088985|stage IV breast cancer|stage iv breast cancer
1676687|NCT00088972|breast cancer|breast cancer
1676688|NCT00088972|breast cancer in situ|breast cancer in situ
1676689|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1676690|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
1676691|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1676692|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
1676693|NCT00088946|stage I bladder cancer|stage i bladder cancer
1676694|NCT00088907|docetaxel|docetaxel
1676695|NCT00088907|gefitinib|gefitinib
1676696|NCT00088907|head and neck cancer|head and neck cancer
1676697|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1676698|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1676699|NCT00088868|intraocular lymphoma|intraocular lymphoma
1676700|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676701|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676702|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676703|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1676704|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676705|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676706|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1676707|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1676708|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1676709|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676710|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1676711|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1676712|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1676713|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676714|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676715|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676716|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676717|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676718|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676719|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1676720|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1676721|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1676722|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676723|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1676724|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1676725|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1676726|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676727|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676728|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676729|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676730|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676731|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676732|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1676733|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1676734|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1676735|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1676736|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1676812|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
1676737|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1676738|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1676739|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1676740|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1676741|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1676742|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1676743|NCT00088868|small intestine lymphoma|small intestine lymphoma
1676744|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
1676745|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1676746|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1676747|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1676748|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1676749|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1676750|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1676751|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677049|NCT00088582|Acromegaly|acromegaly
1676752|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676753|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676754|NCT00088829|stage II breast cancer|stage ii breast cancer
1676755|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
1676756|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
1676757|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
1676758|NCT00088829|stage IV breast cancer|stage iv breast cancer
1676759|NCT00088829|stage IA breast cancer|stage ia breast cancer
1676760|NCT00088829|stage IB breast cancer|stage ib breast cancer
1676761|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
1676762|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
1676763|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
1676764|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1676765|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1676766|NCT00088803|stage I Wilms tumor|stage i wilms tumor
1676767|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
1676768|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
1676769|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
1676770|NCT00088803|stage V Wilms tumor|stage v wilms tumor
1676771|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
1676772|NCT00088764|Stress|stress
1676773|NCT00088764|Coping|coping
1676774|NCT00088764|Expressive Writing|expressive writing
1676775|NCT00088764|Self-Efficacy|self-efficacy
1676776|NCT00088764|Disclosure|disclosure
1676777|NCT00004193|stage IV colon cancer|stage iv colon cancer
1676778|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
1676779|NCT00004193|recurrent colon cancer|recurrent colon cancer
1676780|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
1676781|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
1676782|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1676783|NCT00004187|stage III colon cancer|stage iii colon cancer
1676784|NCT00004187|stage IV colon cancer|stage iv colon cancer
1676785|NCT00004187|stage III rectal cancer|stage iii rectal cancer
1676786|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
1676787|NCT00004187|recurrent colon cancer|recurrent colon cancer
1676788|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
1676789|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
1676790|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1676791|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
1676792|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1676793|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1676794|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1676795|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1676796|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1676797|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1676798|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1676799|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1676800|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
1676801|NCT00004080|adult glioblastoma|adult glioblastoma
1676802|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1676803|NCT00004080|adult mixed glioma|adult mixed glioma
1676804|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
1676805|NCT00004080|adult gliosarcoma|adult gliosarcoma
1676806|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1676807|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1676808|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1676809|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1676810|NCT00004064|fallopian tube cancer|fallopian tube cancer
1676811|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1676813|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
1676814|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
1676815|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1676816|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1676817|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1676818|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1676819|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1676820|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1676821|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1676822|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1676823|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1676824|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1676825|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1676826|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1676827|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676828|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1677050|NCT00088582|SOM230|som230
1676829|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676830|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676831|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1676832|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1676833|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1676834|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1676835|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676836|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676837|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676838|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676839|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1676840|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1676841|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1676842|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1676843|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1676844|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1676845|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676846|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677153|NCT00003002|stage III breast cancer|stage iii breast cancer
1676847|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1676848|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1676849|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1676850|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1676851|NCT00003828|stage IV melanoma|stage iv melanoma
1676852|NCT00003828|recurrent melanoma|recurrent melanoma
1676853|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1676854|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
1676855|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
1676856|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
1676857|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676858|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
1676859|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
1676860|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676861|NCT00003786|stage IV colon cancer|stage iv colon cancer
1676862|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
1676863|NCT00003786|recurrent colon cancer|recurrent colon cancer
1676864|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
1676865|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
1676866|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1676867|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
1676868|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676869|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676870|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676871|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676872|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676873|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676874|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1676875|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1676876|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1676877|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1676878|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1676879|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1676880|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
1676881|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
1676882|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
1676883|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1676884|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1676885|NCT00003681|refractory anemia|refractory anemia
1677033|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
1676886|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1676887|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
1676888|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676889|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676890|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1676891|NCT00003681|anemia|anemia
1676892|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1676893|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676894|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676895|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676896|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676897|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676898|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676899|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676900|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676901|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676902|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676903|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676904|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676905|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676906|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676907|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676908|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676909|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676910|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676911|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
1676912|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1676913|NCT00003662|refractory anemia|refractory anemia
1676914|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1676915|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676916|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676917|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1676918|NCT00003662|graft versus host disease|graft versus host disease
1676919|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1676920|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1676921|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
1676922|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1676923|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1676924|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1676925|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1676926|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1676927|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1676928|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1676929|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1676930|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
1676931|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1676932|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1676933|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1676934|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1676935|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1676936|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1676937|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1676938|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1676939|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1676940|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1676941|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1676942|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676943|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676944|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1676945|NCT00003661|graft versus host disease|graft versus host disease
1676946|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1676947|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1676948|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1676949|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1677182|NCT00002832|Dacogen|dacogen
1676950|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1676951|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1676952|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1676953|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676954|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676955|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676956|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1676957|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1676958|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1676959|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1676960|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1676961|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1676962|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1676963|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1676964|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1676965|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1676966|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1676967|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1676968|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1676969|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1676970|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1676971|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1676972|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1676973|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
1676974|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
1676975|NCT00003539|stage IV breast cancer|stage iv breast cancer
1676976|NCT00003539|recurrent breast cancer|recurrent breast cancer
1676977|NCT00003431|stage IV colon cancer|stage iv colon cancer
1676978|NCT00003431|lung metastases|lung metastases
1676979|NCT00003431|liver metastases|liver metastases
1676980|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1676981|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
1676982|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1676983|NCT00088673|Alzheimer Disease|alzheimer disease
1676984|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
1676985|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
1676986|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1676987|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1676988|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1676989|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1676990|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1676991|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1676992|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1676993|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
1676994|NCT00088751|Alzheimer's Disease|alzheimer's disease
1676995|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
1676996|NCT00088751|Stimulant|stimulant
1676997|NCT00088751|Apathy|apathy
1676998|NCT00088751|Disinhibition|disinhibition
1676999|NCT00088751|Antipsychotic|antipsychotic
1677000|NCT00088751|Biomarkers|biomarkers
1677001|NCT00088751|Dementia|dementia
1677002|NCT00088751|FTD|ftd
1677003|NCT00088738|Tachykinin|tachykinin
1677004|NCT00088738|Anxiety|anxiety
1677005|NCT00088738|Neuroreceptor|neuroreceptor
1677006|NCT00088738|Internalization|internalization
1677007|NCT00088738|Carbon Dioxide|carbon dioxide
1677008|NCT00088738|Healthy Volunteer|healthy volunteer
1677009|NCT00088738|HV|hv
1677010|NCT00088738|Panic Disorder|panic disorder
1677011|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
1677012|NCT00088712|Functional Brian Activity|functional brian activity
1677013|NCT00088712|Visual Perception|visual perception
1677014|NCT00088712|Selective Attention|selective attention
1677015|NCT00088712|Information Processing|information processing
1677016|NCT00088712|Age Differences|age differences
1677017|NCT00088712|Childhood Growth and Development|childhood growth and development
1677018|NCT00088712|Cognitive Development|cognitive development
1677019|NCT00088712|Brain Connectivity|brain connectivity
1677020|NCT00088712|Healthy Volunteer|healthy volunteer
1677021|NCT00088712|HV|hv
1677022|NCT00088699|Depression|depression
1677023|NCT00088699|NMDA Antagonist|nmda antagonist
1677024|NCT00088699|Treatment Resistant|treatment resistant
1677025|NCT00088699|Glutamatergic System|glutamatergic system
1677026|NCT00088699|Bipolar Disorder|bipolar disorder
1677027|NCT00088699|Major Depression|major depression
1677028|NCT00088686|Preemptive Analgesia|preemptive analgesia
1677029|NCT00088686|Vanilloid|vanilloid
1677030|NCT00088686|Capsaicin|capsaicin
1677034|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
1677035|NCT00088686|Wisdom Teeth|wisdom teeth
1677036|NCT00088686|Third Molar Extraction|third molar extraction
1677037|NCT00088660|Metastatic|metastatic
1677038|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
1677039|NCT00088647|breast cancer|breast cancer
1677040|NCT00088634|Schizophrenia|schizophrenia
1677041|NCT00088634|Latuda|latuda
1677042|NCT00088634|Lurasidone|lurasidone
1677043|NCT00088621|Schizophrenia|schizophrenia
1677044|NCT00088621|Latuda|latuda
1677045|NCT00088621|Lurasidone|lurasidone
1677046|NCT00088595|SOM230|som230
1677047|NCT00088595|Sandostatin|sandostatin
1677048|NCT00088595|Carcinoid syndrome|carcinoid syndrome
1677052|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1677053|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1677054|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1677154|NCT00003002|stage IV breast cancer|stage iv breast cancer
1677055|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1677056|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1677057|NCT00003358|fallopian tube cancer|fallopian tube cancer
1677058|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1677059|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1677060|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1677061|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677062|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677063|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
1677064|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1677065|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
1677066|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1677067|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1677068|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677069|NCT00003213|nausea and vomiting|nausea and vomiting
1677070|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1677071|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1677072|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1677073|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
1677074|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
1677075|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
1677076|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1677077|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1677078|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1677079|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1677080|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1677081|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1677082|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1677083|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
1677084|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
1677085|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
1677086|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1677087|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1677088|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1677089|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1677090|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1677091|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1677092|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1677093|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1677094|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1677095|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1677096|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1677097|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1677098|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1677099|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1677100|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1677101|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1677102|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1677103|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1677104|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1677105|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1677106|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1677107|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1677108|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1677109|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1677110|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1677111|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1677112|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1677113|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687375|NCT00080171|Knee Pain|knee pain
1677114|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1677115|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1677116|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1677117|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1677118|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1677119|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1677120|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1677121|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
1677122|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
1677123|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1677124|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1677125|NCT00003068|stage IV breast cancer|stage iv breast cancer
1677126|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
1677127|NCT00003068|recurrent breast cancer|recurrent breast cancer
1677128|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
1677129|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1677130|NCT00088569|Frontal Lobe|frontal lobe
1677131|NCT00088569|Working Memory|working memory
1677132|NCT00088569|Treatment|treatment
1677133|NCT00088569|Transcranial|transcranial
1677134|NCT00088569|Electrical|electrical
1677135|NCT00088569|Healthy Volunteer|healthy volunteer
1677137|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
1677138|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
1677139|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
1677140|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
1677141|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
1677142|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
1677143|NCT00003055|stage III gastric cancer|stage iii gastric cancer
1677144|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
1677145|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
1677146|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
1677147|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
1677148|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
1677149|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1677150|NCT00003050|stage II breast cancer|stage ii breast cancer
1677151|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
1677152|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
1677155|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1677156|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1677157|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1677158|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1677159|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
1677160|NCT00003000|pain|pain
1677161|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
1677162|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
1677163|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
1677164|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1677165|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1677166|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
1677167|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1677168|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677169|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677170|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1677171|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1677172|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677173|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1677174|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1677175|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
1677176|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1677177|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1677178|NCT00002833|graft versus host disease|graft versus host disease
1677179|NCT00088530|Pixantrone|pixantrone
1677180|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
1677181|NCT00002832|Decitabine|decitabine
1677186|NCT00002832|Cyclosporine|cyclosporine
1677187|NCT00002832|Sandimmune|sandimmune
1677188|NCT00002832|CYA|cya
1677189|NCT00002832|Cyclosporin A|cyclosporin a
1677190|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
1677191|NCT00002832|PBSC|pbsc
1677192|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
1677193|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1677194|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1677195|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677196|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677197|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1677198|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677199|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677200|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1677201|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677202|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1677203|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677204|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
1677205|NCT00002824|adult glioblastoma|adult glioblastoma
1677206|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1677207|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
1677208|NCT00002824|adult gliosarcoma|adult gliosarcoma
1677209|NCT00002784|stage II breast cancer|stage ii breast cancer
1677210|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
1677211|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
1677212|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677213|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677214|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677215|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677216|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677217|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677218|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677219|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
1677220|NCT00002754|adult glioblastoma|adult glioblastoma
1677221|NCT00002754|stage IV melanoma|stage iv melanoma
1677222|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
1677223|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1677224|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1677225|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1677226|NCT00002754|adult mixed glioma|adult mixed glioma
1677227|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1677228|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
1677229|NCT00002754|adult gliosarcoma|adult gliosarcoma
1677230|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1677231|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
1677232|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
1677233|NCT00002753|adult glioblastoma|adult glioblastoma
1677234|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1677235|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1677236|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
1677237|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1677238|NCT00002753|adult mixed glioma|adult mixed glioma
1677239|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
1677240|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1677241|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
1677242|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
1677243|NCT00002753|adult gliosarcoma|adult gliosarcoma
1677244|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677245|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
1677246|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1677247|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1677331|NCT00088400|Immunotherapy|immunotherapy
1677248|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1677249|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1677250|NCT00002665|neutropenia|neutropenia
1677251|NCT00002665|thrombocytopenia|thrombocytopenia
1677252|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
1677253|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
1677254|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
1677255|NCT00002627|stage II breast cancer|stage ii breast cancer
1677256|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
1677257|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
1677258|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
1677259|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1677260|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1677261|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1677262|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1677263|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1677264|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1677265|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1677266|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1677267|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677268|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677269|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677270|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677271|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677272|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1677273|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1677274|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1677275|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1677276|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1677277|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1677278|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1677279|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1677280|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1677281|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1677282|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1677283|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1677284|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
1677285|NCT00002572|adult glioblastoma|adult glioblastoma
1677286|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1677287|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1677288|NCT00002572|adult mixed glioma|adult mixed glioma
1677289|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
1677290|NCT00002572|adult gliosarcoma|adult gliosarcoma
1677291|NCT00002542|stage I breast cancer|stage i breast cancer
1677292|NCT00002542|stage II breast cancer|stage ii breast cancer
1677293|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
1677294|NCT00002535|stage III melanoma|stage iii melanoma
1677295|NCT00002535|stage IV melanoma|stage iv melanoma
1677296|NCT00002535|recurrent melanoma|recurrent melanoma
1677297|NCT00002529|stage II breast cancer|stage ii breast cancer
1677298|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
1677299|NCT00088517|Biodistribution|biodistribution
1677301|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
1677302|NCT00088517|Healthy|healthy
1677303|NCT00088517|Prefrontal Cortex|prefrontal cortex
1677304|NCT00088517|Radiation Exposure|radiation exposure
1677305|NCT00088517|PET|pet
1677306|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
1677307|NCT00088517|(11C)NNC-112|(11c)nnc-112
1677308|NCT00088517|Healthy Volunteer|healthy volunteer
1677309|NCT00088517|HV|hv
1677310|NCT00088504|Hepatitis|hepatitis
1677311|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
1677312|NCT00088452|CAE|cae
1677313|NCT00088452|petit mal epilepsy|petit mal epilepsy
1677314|NCT00088452|epilepsy|epilepsy
1677315|NCT00088452|seizures|seizures
1677316|NCT00088452|ethosuximide|ethosuximide
1677317|NCT00088452|lamotrigine|lamotrigine
1677318|NCT00088452|valproic acid|valproic acid
1677319|NCT00088426|Holoprosencephaly|holoprosencephaly
1677320|NCT00088426|HPE|hpe
1677321|NCT00088413|CEA|cea
1677322|NCT00088413|Vaccine|vaccine
1677323|NCT00088413|Immunotherapy|immunotherapy
1677324|NCT00088413|MUC-1|muc-1
1677325|NCT00088413|Cancer|cancer
1677326|NCT00088413|Adenocarcinoma|adenocarcinoma
1677327|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
1677328|NCT00088400|Transferrin|transferrin
1677329|NCT00088400|Brain Tumor|brain tumor
1677330|NCT00088400|Convection|convection
1677332|NCT00088400|Targeted Protein Toxin|targeted protein toxin
1677333|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
1677335|NCT00088387|Tau|tau
1677336|NCT00088387|T181|t181
1677337|NCT00088387|T231|t231
1677338|NCT00088387|Amyloid Beta|amyloid beta
1677339|NCT00088387|Beta-Catenin|beta-catenin
1677340|NCT00088387|Alzheimer Disease|alzheimer disease
1677341|NCT00088387|AD|ad
1677342|NCT00088374|Kidney Cancer|kidney cancer
1677343|NCT00088374|VHL|vhl
1677344|NCT00088374|17 AAG|17 aag
1677345|NCT00088374|Chemotherapy|chemotherapy
1677346|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
1677347|NCT00088374|Renal Tumor|renal tumor
1677348|NCT00088361|Reconstruction|reconstruction
1677349|NCT00088361|PET Artifacts|pet artifacts
1677350|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
1677353|NCT00088361|Respiratory Motion|respiratory motion
1677354|NCT00088348|Cornea|cornea
1677355|NCT00088348|Conjunctiva|conjunctiva
1677356|NCT00088348|Keratitis|keratitis
1677357|NCT00088348|Ocular Surface|ocular surface
1677358|NCT00088348|Inflammation|inflammation
1677359|NCT00088348|Evaluation|evaluation
1677360|NCT00088348|Screening|screening
1677361|NCT00088348|Ocular Surface Disease|ocular surface disease
1677362|NCT00088348|Eye|eye
1677363|NCT00088348|Ocular Disease|ocular disease
1677364|NCT00088348|Anterior Segment Disease|anterior segment disease
1677365|NCT00088335|Parkinsonism|parkinsonism
1677366|NCT00088335|Biomarker|biomarker
1677367|NCT00088335|Proteomics|proteomics
1677368|NCT00088335|Parkinson's Disease|parkinson's disease
1677369|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
1677370|NCT00088335|Parkinson Disease|parkinson disease
1677371|NCT00088335|PD|pd
1677372|NCT00088309|Drug Resistance|drug resistance
1677373|NCT00088309|HAART|haart
1677374|NCT00088309|Pamidronate|pamidronate
1677375|NCT00088309|Osteopenia|osteopenia
1677376|NCT00088309|Pediatric|pediatric
1677377|NCT00088309|HIV|hiv
1677378|NCT00088309|Pediatrics|pediatrics
1677380|NCT00088296|Osteoarthritis|osteoarthritis
1677381|NCT00088296|MS Contin|ms contin
1677383|NCT00088296|Cortisol|cortisol
1677384|NCT00088296|Testosterone|testosterone
1677385|NCT00088296|Degenerative Joint Disease|degenerative joint disease
1677386|NCT00088296|OA|oa
1677387|NCT00088296|Arthritis|arthritis
1677388|NCT00088296|Joint Pain|joint pain
1677389|NCT00088296|Arthritic Pain|arthritic pain
1677390|NCT00088296|Opioid|opioid
1677391|NCT00088283|CRVO|crvo
1677392|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
1677393|NCT00088283|RVO|rvo
1677394|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
1677395|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1677396|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1677397|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1677398|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677399|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1677400|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
1677401|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
1677402|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
1677403|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
1677404|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1677405|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1677406|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677407|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677408|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677409|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1677410|NCT00005852|primary myelofibrosis|primary myelofibrosis
1677411|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1677412|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
1677413|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1677414|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677415|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677416|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1677417|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1677418|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677419|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1677420|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1677421|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1677422|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1677423|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677424|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1677425|NCT00005852|graft versus host disease|graft versus host disease
1677426|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1677427|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1677428|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677429|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677430|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677431|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677432|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677433|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1677434|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1677435|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1677436|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1677437|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1677438|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1677439|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1677440|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677441|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1677442|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1687376|NCT00080171|Knee Health|knee health
1677443|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1677444|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1677445|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1677446|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
1677447|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1677448|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
1677449|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
1677450|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1677451|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
1677452|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
1677453|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
1677454|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
1677455|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1677456|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1677457|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1677458|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1677459|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1677460|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677461|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677462|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677463|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1677464|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677465|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1677466|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1677467|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677468|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1677469|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1677470|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1677471|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1677472|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1677473|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1677474|NCT00005805|polycythemia vera|polycythemia vera
1677475|NCT00005805|primary myelofibrosis|primary myelofibrosis
1677476|NCT00005805|essential thrombocythemia|essential thrombocythemia
1677477|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
1677478|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1677479|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
1677480|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1677481|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1677482|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1677483|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1677484|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1677485|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1677486|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1677487|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1677488|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1677489|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1677490|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1677491|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1677492|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1677493|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1677494|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1677495|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
1677496|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
1677497|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1677498|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1677499|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1677500|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1677501|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1677502|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1677503|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1677504|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1677505|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1677506|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1677507|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1677971|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
1677508|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1677509|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1677510|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1677511|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1677512|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1677513|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1677514|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1677515|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1677516|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1677517|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1677518|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1677519|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1677520|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1677521|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1677522|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1677523|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1677524|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1677525|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1677526|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1677527|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677528|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677529|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677530|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1677531|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1677532|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677533|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1677534|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1677535|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1677536|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1677537|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1677538|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1677539|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1677540|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1677541|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1677542|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1677543|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677544|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1677545|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1677547|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1677548|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1677549|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
1677550|NCT00005805|intraocular lymphoma|intraocular lymphoma
1677551|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1677552|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
1677553|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1677554|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1677555|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1677556|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1677557|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1677558|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1677559|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1677560|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1677561|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1677562|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1677563|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
1677564|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1677565|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1677566|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1677567|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1677568|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1677569|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1677570|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1677571|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1677572|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1677573|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1677574|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1677575|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1677576|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677577|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1677578|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1677579|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1677580|NCT00005805|multiple myeloma|multiple myeloma
1677581|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1677582|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1677583|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677584|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1677585|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1677586|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1677587|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1677588|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1677589|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1677590|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677591|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677592|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1677593|NCT00005633|stage III melanoma|stage iii melanoma
1677594|NCT00005633|stage IV melanoma|stage iv melanoma
1677595|NCT00005633|recurrent melanoma|recurrent melanoma
1677596|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
1677597|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
1677598|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
1677599|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
1677600|NCT00005614|stage IV breast cancer|stage iv breast cancer
1677601|NCT00005614|recurrent breast cancer|recurrent breast cancer
1677602|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677603|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
1677604|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
1677605|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
1677606|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
1677607|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1677608|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1677609|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1677610|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1677611|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1677612|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1677613|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1677614|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1677615|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1677616|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1677617|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1677618|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1677619|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1677620|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1677621|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1677622|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1677623|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1677624|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1677625|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1677626|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1677627|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1677628|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1677629|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1677630|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1677631|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
1677632|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
1677633|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
1677972|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
1677634|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1677635|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1677636|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1677637|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1677638|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1677639|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1677640|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677641|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677642|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1677643|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1677644|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1677645|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1677646|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1677647|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1677648|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1677649|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1677650|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1677651|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1677652|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1677653|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1677654|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1677655|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1677656|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1677657|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1677658|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1677659|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1677660|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1677661|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1677662|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1677952|NCT00003781|pain|pain
1677663|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1677664|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1677665|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1677666|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677667|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677668|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1677669|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1677670|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677671|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1677672|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1677673|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1677674|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1677675|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1677676|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1677677|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1677678|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1677679|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1677680|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1677681|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1677682|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1677683|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1677684|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1677685|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1677686|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1677687|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1677688|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1677689|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1677690|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1677691|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1677692|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1677693|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1678713|NCT00086645|SSRI|ssri
1677694|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1677695|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1677696|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1677697|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677698|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1677699|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1677700|NCT00004875|thromboembolism|thromboembolism
1677701|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1677702|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1677703|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677704|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677705|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1677706|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1677707|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1677708|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1677709|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1677710|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1677711|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1677712|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1677713|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677714|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677715|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1677716|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1677717|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1677718|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1677719|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1677720|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677721|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
1677722|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1677723|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677724|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1677725|NCT00004263|Ara-C|ara-c
1677726|NCT00004263|Cytosar|cytosar
1677727|NCT00004263|DepoCyt|depocyt
1677728|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1677729|NCT00004263|cytarabine|cytarabine
1677730|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
1677731|NCT00004263|UCN-01|ucn-01
1677732|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1677733|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1677734|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1677735|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677736|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1677737|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1677738|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1677739|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1677740|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1677741|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1677742|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
1677743|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
1677744|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1677745|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
1677746|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1677747|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1677748|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677749|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677750|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677751|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1677752|NCT00004258|small intestine lymphoma|small intestine lymphoma
1677753|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678043|NCT00087867|p38 MAP kinase|p38 map kinase
1677754|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1677755|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677756|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1677757|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1677758|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1677759|NCT00004258|polycythemia vera|polycythemia vera
1677760|NCT00004258|essential thrombocythemia|essential thrombocythemia
1677761|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
1677762|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1677763|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
1677764|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1677765|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1677766|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1677767|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1677768|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1677769|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1677770|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1677771|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1677772|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1677773|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1677774|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1677775|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1677776|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1677777|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1677778|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1677779|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1677780|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1677781|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1677782|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1677783|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1677784|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677785|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677786|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1677787|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1677788|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677789|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1677790|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1677791|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1677792|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1677793|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1677794|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1677795|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1677796|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1677797|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1677798|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677799|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1677800|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
1677801|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
1677802|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1677803|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1677804|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677805|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1677806|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1677807|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677808|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677809|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1677810|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1677811|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1677812|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1677813|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677814|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677815|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1677816|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677817|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1677818|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1678044|NCT00087867|myeloma|myeloma
1677819|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1677820|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1677821|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1677822|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1677823|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1677824|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1677825|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1677826|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1677827|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677828|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
1677829|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1677830|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1677831|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
1677832|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
1677833|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
1677834|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1677835|NCT00002506|recurrent penile cancer|recurrent penile cancer
1677836|NCT00002506|recurrent skin cancer|recurrent skin cancer
1677837|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1677838|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1677839|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
1677840|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1677841|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1677842|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1677843|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1677844|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1677845|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1677846|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1677847|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1677848|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1677849|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1677850|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
1677851|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
1677852|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1677853|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1677854|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1677855|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1677856|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1677857|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1677858|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677859|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1677860|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1677861|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1677862|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1677863|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1677864|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1677865|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1677866|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1677867|NCT00002504|polycythemia vera|polycythemia vera
1677868|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1677869|NCT00002504|essential thrombocythemia|essential thrombocythemia
1677870|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
1677871|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1677872|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
1677873|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1677874|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1677875|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
1677876|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1677877|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1677878|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1677879|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1677880|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1677881|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1677882|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1677883|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1677884|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1677885|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1677886|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1677887|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1677888|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1677889|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1677890|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1677891|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1677892|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1677893|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1677894|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1677895|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1677896|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1677897|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1677898|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1677899|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1677900|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
1677901|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
1677902|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1677903|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1677904|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1677905|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1677906|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1677907|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1677908|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1677909|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1677910|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1677911|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1677912|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1677913|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1677914|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1677915|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1677916|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
1677917|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
1677918|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
1677919|NCT00088218|AML|aml
1677920|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
1677921|NCT00088218|MDS|mds
1677922|NCT00088218|Clofarabine|clofarabine
1677923|NCT00088218|Cytarabine|cytarabine
1677924|NCT00088218|ara-C|ara-c
1677925|NCT00088179|CABG|cabg
1677926|NCT00088179|CPB|cpb
1677927|NCT00087997|sarcoma|sarcoma
1677928|NCT00088192|AMD|amd
1677929|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
1677930|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
1677931|NCT00088166|peritumoral brain edema|peritumoral brain edema
1677932|NCT00088166|edema|edema
1677933|NCT00088166|malignant brain tumor|malignant brain tumor
1677934|NCT00088166|astrocytoma|astrocytoma
1677935|NCT00088166|brain tumor|brain tumor
1677936|NCT00088166|dexamethasone|dexamethasone
1677937|NCT00088166|Decadron|decadron
1677938|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
1677939|NCT00003884|pain|pain
1677940|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1677941|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
1677942|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1677943|NCT00003884|bone metastases|bone metastases
1677944|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
1677945|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1677946|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1677947|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1677948|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1677949|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1677950|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
1677951|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
1677953|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1677954|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1677955|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1677956|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1677957|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1677958|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
1677959|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1678045|NCT00087867|bone marrow|bone marrow
1677960|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1677961|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1677962|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1677963|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1677964|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1677965|NCT00003763|ovarian sarcoma|ovarian sarcoma
1677966|NCT00003748|stage I gastric cancer|stage i gastric cancer
1677967|NCT00003748|stage II gastric cancer|stage ii gastric cancer
1677968|NCT00003748|stage III gastric cancer|stage iii gastric cancer
1677969|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
1677970|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
1678714|NCT00086645|Serotonin|serotonin
1677973|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
1677974|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
1677975|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
1677976|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1677977|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1677978|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
1677979|NCT00003725|stage I bladder cancer|stage i bladder cancer
1677980|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
1677981|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1677982|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
1677983|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1677984|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
1677985|NCT00003675|refractory anemia|refractory anemia
1677986|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1677987|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
1677988|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1677989|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1677990|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1677991|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1677992|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1677993|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1677994|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
1677995|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
1677996|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
1677997|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1677998|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
1677999|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
1678000|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1678001|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1678002|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1678003|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1678004|NCT00003392|stage IV breast cancer|stage iv breast cancer
1678005|NCT00003392|recurrent breast cancer|recurrent breast cancer
1678006|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1678007|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
1678008|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
1678009|NCT00003267|stage I cervical cancer|stage i cervical cancer
1678010|NCT00003267|stage II cervical cancer|stage ii cervical cancer
1678011|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
1678012|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
1678013|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
1678014|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
1678015|NCT00003267|infection|infection
1678016|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
1678017|NCT00088153|Anorexia Nervosa|anorexia nervosa
1678018|NCT00088153|Amenorrhea|amenorrhea
1678019|NCT00088153|Bone Mass|bone mass
1678020|NCT00088153|Growth hormone|growth hormone
1678021|NCT00088101|Hematological Malignancies|hematological malignancies
1678022|NCT00088101|Leukemia|leukemia
1678023|NCT00088101|Lymphoma|lymphoma
1678024|NCT00088101|Metastatic|metastatic
1678025|NCT00088101|Unresectable solid tumors|unresectable solid tumors
1678026|NCT00088075|Schizophrenia|schizophrenia
1678027|NCT00088075|Risperidone|risperidone
1678028|NCT00088075|Adolescents|adolescents
1678029|NCT00088062|Crohn's Disease|crohn's disease
1678030|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
1678031|NCT00003225|stage IV colon cancer|stage iv colon cancer
1678032|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
1678033|NCT00003225|recurrent colon cancer|recurrent colon cancer
1678034|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
1678035|NCT00088023|Solid tumors|solid tumors
1678036|NCT00087984|Kidney cancer|kidney cancer
1678037|NCT00087984|Renal cancer|renal cancer
1678038|NCT00087958|Metastatic breast cancer|metastatic breast cancer
1678039|NCT00087945|Treatment Experienced|treatment experienced
1678040|NCT00087880|smoking cessation|smoking cessation
1678041|NCT00087867|Multiple Myeloma|multiple myeloma
1678042|NCT00087867|SCIO-469|scio-469
1678046|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678047|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1678048|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1678049|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1678050|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1678051|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
1678052|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1678053|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
1679100|NCT00086177|Pregnancy,|pregnancy,
1678054|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1678055|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1678056|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1678057|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1678058|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1678059|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1678060|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1678061|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1678062|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1678063|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1678064|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1678065|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
1678066|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
1678067|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
1678068|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
1678069|NCT00004104|stage III melanoma|stage iii melanoma
1678070|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1678071|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1678072|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1678073|NCT00004060|fallopian tube cancer|fallopian tube cancer
1678074|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1678075|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1678076|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1678077|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1678078|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678079|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1678080|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678081|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1678082|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
1678083|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1678084|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1678085|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1678086|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
1678087|NCT00004041|adult glioblastoma|adult glioblastoma
1678088|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1678089|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1678090|NCT00004041|adult mixed glioma|adult mixed glioma
1678091|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
1678092|NCT00004041|adult gliosarcoma|adult gliosarcoma
1678093|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1678094|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1678095|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1678096|NCT00003219|stage IV breast cancer|stage iv breast cancer
1678097|NCT00003219|recurrent breast cancer|recurrent breast cancer
1678098|NCT00003171|refractory anemia|refractory anemia
1678099|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1678100|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
1678101|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1678102|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1678103|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1678104|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1678105|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1678106|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1678107|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1678108|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1678109|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1678110|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1678111|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
1678112|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
1678113|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1678114|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
1678115|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1678116|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1678117|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1678118|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678119|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1678120|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678121|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678122|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1678123|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1678124|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1678125|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1678126|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1678127|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1678128|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1678129|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1678130|NCT00003082|polycythemia vera|polycythemia vera
1678131|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1678132|NCT00003082|essential thrombocythemia|essential thrombocythemia
1678133|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
1678134|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1678135|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
1678136|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1678137|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1678138|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
1678139|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1678140|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1678141|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1678142|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1678143|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1678144|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1678145|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1678146|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1678147|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1678148|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678149|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678150|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1678151|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1678152|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1678153|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1678154|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1678155|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1678156|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1678157|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678158|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678159|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678160|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678161|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678162|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678163|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678164|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678165|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678166|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1678167|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1678168|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1678169|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1678170|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1678171|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1678172|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1678173|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
1678174|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1678175|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1678176|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
1678177|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1678178|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1678179|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678180|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1678181|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1678182|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678183|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678184|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1678185|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1678186|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1678187|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678188|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1688066|NCT00004109|cancer|cancer
1678189|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678190|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678191|NCT00003057|colon cancer|colon cancer
1678192|NCT00003057|rectal cancer|rectal cancer
1678193|NCT00003057|diarrhea|diarrhea
1678194|NCT00002998|stage IV breast cancer|stage iv breast cancer
1678195|NCT00002998|recurrent breast cancer|recurrent breast cancer
1678196|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678197|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1678198|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1678199|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1678200|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1678201|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1678202|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1678203|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678204|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678205|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678206|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678207|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678208|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678209|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678210|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678211|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678212|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1678213|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1678214|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678215|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678216|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678217|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678218|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678219|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678220|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1678221|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1678222|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1678223|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1678224|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1678225|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1678226|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1678227|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1678228|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1678229|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678230|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678231|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678232|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678233|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678234|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678235|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678236|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678688|NCT00087672|Revlimid|revlimid
1678237|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678238|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678239|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678240|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678241|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678242|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678243|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678244|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678245|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
1678246|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1678247|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1678248|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678249|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678250|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678251|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1678252|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1678253|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1678254|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1678255|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1678256|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1678257|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1678258|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678259|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678260|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678261|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678262|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678263|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678264|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678265|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678266|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678267|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1678268|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1678269|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1678270|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678271|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1678272|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1678273|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678274|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678275|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1678276|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678277|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678278|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678279|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678280|NCT00002763|stage III melanoma|stage iii melanoma
1678281|NCT00002763|recurrent melanoma|recurrent melanoma
1678282|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1678283|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
1678284|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1678285|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1678286|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1678287|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1678288|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1678289|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1678290|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1678291|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1678292|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1678293|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1678294|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1678295|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1678296|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1678297|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1678298|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1678299|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1678300|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1678301|NCT00002545|adult glioblastoma|adult glioblastoma
1679010|NCT00086268|lung cancer|lung cancer
1678302|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
1678303|NCT00002545|adult gliosarcoma|adult gliosarcoma
1678304|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1678305|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1678306|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1678307|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1678308|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1678309|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1678310|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1678311|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1678312|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1678313|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1678314|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1678315|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
1678316|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
1678317|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
1678318|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
1678319|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
1678320|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
1678321|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1678322|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1678323|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1678324|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1678325|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1678326|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1678327|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1678328|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678329|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1678330|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1678331|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1678332|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1678333|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1678334|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1678335|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1678336|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1678337|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1678338|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1678339|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1678340|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1678341|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1678342|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1678343|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1678344|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1678345|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1679532|NCT00085904|Advanced cancer|advanced cancer
1678346|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1678347|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1678348|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1678349|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1678350|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1678351|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1678352|NCT00002502|refractory anemia|refractory anemia
1678353|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1678354|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
1678355|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1678356|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1678357|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1678358|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1678359|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1678360|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1678361|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1678362|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1678363|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1678364|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1678365|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678366|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678367|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1678368|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1678369|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1678370|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1678371|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1678372|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1678373|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1678374|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678375|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678376|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678377|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678378|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678379|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678380|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678381|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678382|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678383|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1678384|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1678385|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1678386|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1678387|NCT00002502|intraocular lymphoma|intraocular lymphoma
1678388|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1678389|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1678390|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1678391|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1678392|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1678393|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1678394|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1678395|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1678396|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1678397|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1678398|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1678399|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1678400|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1678401|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1678402|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1678403|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1678404|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1678405|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1678406|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1678407|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1678408|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1678409|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1678410|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1678411|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1678412|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1678413|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1678414|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1678415|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1678416|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1678417|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1678418|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1678419|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1678420|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1678421|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678422|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1678423|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1678424|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1678425|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1678426|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678427|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678428|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1678429|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1678430|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1678431|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1678432|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1678433|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678434|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1678435|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1679533|NCT00085904|IL-18|il-18
1678436|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678437|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678438|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678439|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1678440|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1678441|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1678442|NCT00002465|stage IV breast cancer|stage iv breast cancer
1678443|NCT00002465|recurrent breast cancer|recurrent breast cancer
1678444|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
1678445|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1678446|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1678447|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1678448|NCT00087932|Complementary Therapies|complementary therapies
1678449|NCT00087841|Hypnosis|hypnosis
1678450|NCT00087841|Analgesia|analgesia
1678451|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
1678452|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
1678453|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
1678454|NCT00087815|cognitive/functional effects|cognitive/functional effects
1678455|NCT00087815|radiation toxicity|radiation toxicity
1678456|NCT00087815|adult brain tumor|adult brain tumor
1678457|NCT00087815|childhood brain tumor|childhood brain tumor
1678458|NCT00087789|Alzheimer's Disease|alzheimer's disease
1678459|NCT00087789|Gene Transfer|gene transfer
1678461|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
1678462|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
1678463|NCT00082511|Lupus|lupus
1678464|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
1678465|NCT00082511|SLE|sle
1678466|NCT00082511|Bone Loss|bone loss
1678467|NCT00082511|DHEA|dhea
1678468|NCT00003877|stage IV breast cancer|stage iv breast cancer
1678469|NCT00003877|recurrent breast cancer|recurrent breast cancer
1678470|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1678471|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1678472|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1678473|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678474|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678475|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1678476|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1678477|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1678478|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678479|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678480|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678481|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678482|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678483|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678484|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678485|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678486|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678487|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1678488|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1678489|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678490|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678491|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678492|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678493|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678494|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678495|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
1678496|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1678497|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1678498|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1678499|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1678500|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1678501|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1678502|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1678503|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1678504|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1678505|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1678506|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1678507|NCT00003805|Burkitt lymphoma|burkitt lymphoma
1678508|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1678509|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1678510|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
1678511|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
1678512|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
1678513|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1678514|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1678515|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1678516|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1678517|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1678518|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1678519|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1678520|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1678521|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1678522|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1678523|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1678524|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678525|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1678526|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678527|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1678528|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1678529|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1678530|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678531|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1678532|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1678533|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1679534|NCT00085904|repeat dosing|repeat dosing
1678534|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1678535|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1678536|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1678537|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1678538|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1678539|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1678540|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1678541|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
1678542|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1678543|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1678544|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1678545|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1678546|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1678547|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1678548|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1678549|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1678550|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1678551|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1678552|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1678553|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1678554|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1678555|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1678556|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1678557|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1678558|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1678559|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1678560|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1678561|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1678562|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1678563|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1678564|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678565|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678566|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1678567|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1678568|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1678569|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1678570|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1678571|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1678572|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1678573|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678574|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678575|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1678576|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678577|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1678578|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1678579|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1678580|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1678581|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1678582|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1678583|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1678584|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1678585|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1678586|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1678587|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1678588|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1678589|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1678590|NCT00003805|infection|infection
1678591|NCT00003805|bone marrow suppression|bone marrow suppression
1678592|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1678593|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1678594|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1678595|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1678596|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1678597|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1678598|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1678599|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1678600|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1678601|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1678602|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1678603|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1678604|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1678605|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1678606|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1678607|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1678608|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1678609|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1678610|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1678611|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1678612|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1678613|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1678614|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1678615|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1678616|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1678617|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1678618|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1678619|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1678620|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679011|NCT00086268|ZPACT|zpact
1678621|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1678622|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1678623|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1678624|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1678625|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1678626|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1678627|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1678628|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1678629|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1678630|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678631|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678632|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1678633|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1678634|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1678635|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1678636|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688145|NCT00079677|nCPAP|ncpap
1678637|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678638|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678639|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678640|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678641|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1678642|NCT00003804|stage I Wilms tumor|stage i wilms tumor
1678643|NCT00003792|stage IV melanoma|stage iv melanoma
1678644|NCT00003792|recurrent melanoma|recurrent melanoma
1678645|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
1678646|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
1678647|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
1678648|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1678649|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1678650|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678651|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678652|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1678653|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1678654|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1678655|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1678656|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1678657|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1678658|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1678659|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1678660|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1678661|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678662|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1678663|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1678664|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1678665|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1678666|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1678667|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
1678668|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
1678669|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678670|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
1678671|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1678672|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1678673|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1678674|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1678675|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1678676|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1678677|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1678678|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1678679|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
1678680|NCT00087685|Endometrial|endometrial
1678681|NCT00087685|Endometrioid|endometrioid
1678682|NCT00087685|RAD001|rad001
1678683|NCT00087685|Uterine Cancer|uterine cancer
1678684|NCT00087672|Myelofibrosis|myelofibrosis
1678685|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
1678686|NCT00087672|CC-5013|cc-5013
1678687|NCT00087672|Lenalidomide|lenalidomide
1678689|NCT00087672|Antiangiogenesis|antiangiogenesis
1678690|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
1678691|NCT00087555|Fibromyalgia|fibromyalgia
1678692|NCT00087555|Pain|pain
1678693|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
1678694|NCT00087529|PPMS|ppms
1678695|NCT00087529|Primary progressive MS|primary progressive ms
1678696|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
1678697|NCT00087529|Rituxan|rituxan
1678698|NCT00087529|MS|ms
1678699|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
1678700|NCT00087464|Acute Infection|acute infection
1678701|NCT00087464|Treatment Naive|treatment naive
1678702|NCT00087464|Treatment Interruption|treatment interruption
1678703|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
1678704|NCT00086645|Autism|autism
1678705|NCT00086645|Asperger Syndrome|asperger syndrome
1678706|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
1678707|NCT00086645|PDD|pdd
1678708|NCT00086645|Rituals|rituals
1678709|NCT00086645|Compulsions|compulsions
1678710|NCT00086645|Stereotypy|stereotypy
1678711|NCT00086645|Routines|routines
1678712|NCT00086645|Repetitive behavior|repetitive behavior
1678715|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
1678716|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1678717|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1678718|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1678719|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1678720|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
1678721|NCT00087438|large cell lung cancer|large cell lung cancer
1678722|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
1678723|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1678724|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1678725|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1679535|NCT00085904|Phase 1|phase 1
1678726|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1678727|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1678728|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1678729|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1678730|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1678731|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1678732|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1678733|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1678734|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1678735|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1678736|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1678737|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1678738|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1678739|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1678740|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1678741|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1678742|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1678743|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1678744|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678745|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
1678746|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1678747|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1678748|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1678749|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1678750|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1678751|NCT00087399|breast cancer|breast cancer
1678752|NCT00087399|hot flashes|hot flashes
1678753|NCT00087360|colon cancer|colon cancer
1678754|NCT00087360|rectal cancer|rectal cancer
1678755|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
1678756|NCT00087347|stage I prostate cancer|stage i prostate cancer
1678757|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
1678758|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
1678759|NCT00087347|stage III prostate cancer|stage iii prostate cancer
1678760|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
1678761|NCT00087347|stage I breast cancer|stage i breast cancer
1678762|NCT00087347|stage II breast cancer|stage ii breast cancer
1678763|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
1678764|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
1678765|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
1678766|NCT00087347|stage IV breast cancer|stage iv breast cancer
1678767|NCT00087347|recurrent breast cancer|recurrent breast cancer
1678768|NCT00087334|recurrent colon cancer|recurrent colon cancer
1678769|NCT00087334|stage IV colon cancer|stage iv colon cancer
1678770|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
1678771|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
1678772|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
1678773|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
1678774|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1678775|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1678776|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1678777|NCT00087295|anterior urethral cancer|anterior urethral cancer
1678778|NCT00087295|posterior urethral cancer|posterior urethral cancer
1678779|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
1678780|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1678781|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1678782|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
1678783|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1688146|NCT00079677|Cephalon|cephalon
1678784|NCT00087256|stage I colon cancer|stage i colon cancer
1678785|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
1678786|NCT00087178|stage I breast cancer|stage i breast cancer
1678787|NCT00087178|stage II breast cancer|stage ii breast cancer
1678788|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1678789|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
1678790|NCT00087152|stage IV breast cancer|stage iv breast cancer
1678791|NCT00087152|recurrent breast cancer|recurrent breast cancer
1678792|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
1678793|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1678794|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1678795|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
1678796|NCT00087113|stage III cervical cancer|stage iii cervical cancer
1678797|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
1678798|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
1678799|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1678800|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
1678801|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
1678802|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1678803|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1678804|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1678805|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1678806|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
1678807|NCT00087061|adult glioblastoma|adult glioblastoma
1678808|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1678809|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
1678810|NCT00087061|adult gliosarcoma|adult gliosarcoma
1678811|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1678812|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
1678813|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1678814|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
1678815|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1678816|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
1678817|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
1678818|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
1678819|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
1678820|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1678821|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1678822|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1678823|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1678824|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1678825|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1678826|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1678827|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1678828|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1678829|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
1678830|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
1678831|NCT00086957|stage IV breast cancer|stage iv breast cancer
1678832|NCT00086957|male breast cancer|male breast cancer
1678833|NCT00086957|recurrent breast cancer|recurrent breast cancer
1678834|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1678835|NCT00086931|stage III rectal cancer|stage iii rectal cancer
1678836|NCT00086931|stage II rectal cancer|stage ii rectal cancer
1678837|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1678838|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1678839|NCT00086879|adult glioblastoma|adult glioblastoma
1678840|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
1678841|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
1678842|NCT00086879|adult gliosarcoma|adult gliosarcoma
1678843|NCT00086866|stage III melanoma|stage iii melanoma
1678844|NCT00086866|stage IV melanoma|stage iv melanoma
1678845|NCT00086866|recurrent melanoma|recurrent melanoma
1678846|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1678847|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1678848|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1678849|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1678850|NCT00086762|nausea and vomiting|nausea and vomiting
1678851|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678852|NCT00086762|mindfulness relaxation|mindfulness relaxation
1678853|NCT00086749|breast cancer|breast cancer
1678854|NCT00086749|stage I breast cancer|stage i breast cancer
1678855|NCT00086749|stage II breast cancer|stage ii breast cancer
1678856|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
1678857|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
1678858|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
1678859|NCT00086736|stage I prostate cancer|stage i prostate cancer
1678860|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
1678861|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
1678862|NCT00086736|stage III prostate cancer|stage iii prostate cancer
1678863|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678864|NCT00086684|Interstitial Cystitis|interstitial cystitis
1678865|NCT00086684|Urinary Bladder Pain|urinary bladder pain
1678866|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
1678867|NCT00086658|mepolizumab|mepolizumab
1678868|NCT00086658|anti IL-5|anti il-5
1678869|NCT00086632|oregovomab|oregovomab
1678870|NCT00086632|ovarex|ovarex
1678871|NCT00086632|ovarian cancer|ovarian cancer
1678872|NCT00086632|ovary|ovary
1678873|NCT00086632|ovarian carcinoma|ovarian carcinoma
1678874|NCT00086632|front-line|front-line
1678875|NCT00086606|Peanut|peanut
1678876|NCT00086619|Osteoporosis|osteoporosis
1678877|NCT00086619|Parathyroid hormone|parathyroid hormone
1678878|NCT00086619|Teriparatide|teriparatide
1678879|NCT00086619|Bone formation|bone formation
1678880|NCT00086619|Bone resorption|bone resorption
1678881|NCT00086593|adjunctive|adjunctive
1678882|NCT00086593|atypical antipsychotics|atypical antipsychotics
1678883|NCT00086593|add-on|add-on
1678884|NCT00086593|Schizophrenia|schizophrenia
1678885|NCT00086593|psychosis|psychosis
1678886|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1678887|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1678888|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1678889|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1678890|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1678891|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
1678892|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1678893|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
1678894|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
1678895|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
1678896|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1678897|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1678898|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1678899|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1678900|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1678901|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1678902|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1678903|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1678904|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1678905|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1678906|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1678907|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1678908|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678909|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1678910|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
1678911|NCT00086541|Liver|liver
1678912|NCT00086541|Pegylated|pegylated
1678913|NCT00086541|Interferon|interferon
1678914|NCT00086541|Alpha|alpha
1678915|NCT00086541|Ribavirin|ribavirin
1678916|NCT00086541|Combination|combination
1678917|NCT00086541|Nonresponder|nonresponder
1678919|NCT00086541|Infergen|infergen
1678921|NCT00086528|Solid Tumors|solid tumors
1678922|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
1678923|NCT00086385|Smoking cessation|smoking cessation
1678924|NCT00086385|Tobacco|tobacco
1678925|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
1678926|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
1678927|NCT00003091|stage IV melanoma|stage iv melanoma
1678928|NCT00003091|recurrent melanoma|recurrent melanoma
1678929|NCT00002953|stage IV breast cancer|stage iv breast cancer
1678930|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1678931|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1679864|NCT00085696|B-Cell|b-cell
1678932|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1678933|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1678934|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1678935|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1678936|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1678937|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1678938|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1678939|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1678940|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1678941|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1678942|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1678943|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1678944|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1678945|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1678946|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1678947|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1678948|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1678949|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1678950|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1678953|NCT00086567|Gynecologic|gynecologic
1678954|NCT00086567|Urine|urine
1678955|NCT00086567|CA125|ca125
1678956|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
1678957|NCT00086567|Peritoneal Cancer|peritoneal cancer
1678958|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
1678959|NCT00086554|Surgery|surgery
1678960|NCT00086554|Intestinal Resection|intestinal resection
1678961|NCT00086554|Blood Sample|blood sample
1678962|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1678963|NCT00086489|metastatic melanoma|metastatic melanoma
1678964|NCT00086489|multiple dose|multiple dose
1678965|NCT00086463|STEP|step
1678966|NCT00086463|PAH|pah
1678967|NCT00086463|iloprost|iloprost
1678968|NCT00086463|inhalation|inhalation
1678969|NCT00086463|prostacyclin|prostacyclin
1678970|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1678971|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1678972|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
1678973|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
1678974|NCT00086476|Storage Pool Deficiency|storage pool deficiency
1678975|NCT00086476|Organelle Formation|organelle formation
1678976|NCT00086476|Megakaryocyte Development|megakaryocyte development
1678977|NCT00086476|Megakaryocytes|megakaryocytes
1678978|NCT00086476|Platelets|platelets
1678979|NCT00086476|Dense Granules|dense granules
1678980|NCT00086476|Alpha Granules|alpha granules
1678981|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
1678982|NCT00086476|GPS|gps
1678983|NCT00086476|HPS|hps
1678984|NCT00086476|Griscelli Disease|griscelli disease
1678985|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
1678986|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
1678987|NCT00086476|Platelet|platelet
1678988|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
1678989|NCT00086476|SAC|sac
1678990|NCT00086476|Vesicle|vesicle
1678991|NCT00086346|Liver|liver
1678992|NCT00086346|Transplant|transplant
1678993|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1678994|NCT00086333|Taxotere|taxotere
1678995|NCT00086333|docetaxel|docetaxel
1678996|NCT00086333|taxanes|taxanes
1678997|NCT00086372|Acute Infection|acute infection
1678998|NCT00086372|Treatment Experienced|treatment experienced
1678999|NCT00086372|Treatment Naive|treatment naive
1679000|NCT00086359|Treatment Naive|treatment naive
1679001|NCT00086359|Perinatal Transmission|perinatal transmission
1679002|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
1679003|NCT00086359|MTCT|mtct
1679004|NCT00086359|Treatment Experienced|treatment experienced
1679005|NCT00086320|Schizophrenia|schizophrenia
1679006|NCT00086320|paliperidone|paliperidone
1679007|NCT00086320|Risperidone|risperidone
1679008|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
1679009|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
1679013|NCT00086268|Bone Metastases|bone metastases
1679014|NCT00002837|stage IV breast cancer|stage iv breast cancer
1679015|NCT00002837|recurrent breast cancer|recurrent breast cancer
1679016|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1679017|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1679018|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
1679019|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
1679020|NCT00002733|stage IV melanoma|stage iv melanoma
1679577|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
1679021|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679022|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1679023|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1679024|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1679025|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1679026|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1679027|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1679028|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
1679029|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1679030|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1679236|NCT00086073|Parkinson disease|parkinson disease
1679031|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1679032|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1679033|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1679034|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1679035|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1679036|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1679037|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1679038|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1679039|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1679040|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1679041|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1679042|NCT00086307|Pramipexole|pramipexole
1679043|NCT00086307|Escitalopran|escitalopran
1679044|NCT00086307|Antidepressant|antidepressant
1679045|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
1679046|NCT00086307|Depression|depression
1679047|NCT00086307|Major Depression|major depression
1679048|NCT00086294|Non-Dopaminergic|non-dopaminergic
1679049|NCT00086294|Dyskinesias|dyskinesias
1679050|NCT00086294|Fluctuations|fluctuations
1679051|NCT00086294|Inverse Agonist|inverse agonist
1679052|NCT00086294|ACP-103|acp-103
1679053|NCT00086294|Parkinson Disease|parkinson disease
1679054|NCT00086294|PD|pd
1679055|NCT00086255|cocaine dependence|cocaine dependence
1679056|NCT00086216|Multiple myeloma|multiple myeloma
1679057|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
1679058|NCT00002642|large cell lung cancer|large cell lung cancer
1679059|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1679060|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679061|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
1679062|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1679063|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1679064|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1679065|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1679066|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1679067|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1679068|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1679069|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1679070|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1679071|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1679072|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1679073|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1679074|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1679075|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1679076|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1679077|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1679078|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1679079|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1679080|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1679215|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679081|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1679082|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1679083|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1679084|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1679865|NCT00085696|Indolent|indolent
1679085|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1679086|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679087|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1679088|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
1679089|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
1679090|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
1679091|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
1679092|NCT00086242|stage III cervical cancer|stage iii cervical cancer
1679093|NCT00086229|Complementary Therapies|complementary therapies
1679094|NCT00086190|Parkinson disease|parkinson disease
1679095|NCT00086190|depression|depression
1679096|NCT00086190|Parkinson's disease|parkinson's disease
1679097|NCT00086190|paroxetine|paroxetine
1679098|NCT00086190|venlafaxine|venlafaxine
1679099|NCT00086190|antidepressant|antidepressant
1679101|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
1679102|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
1679103|NCT00086164|edifoligide|edifoligide
1679104|NCT00086164|E2F Decoy|e2f decoy
1679105|NCT00086164|Chronic Renal failure|chronic renal failure
1679106|NCT00086164|hemodialysis|hemodialysis
1679107|NCT00086164|AV Graft|av graft
1679108|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
1679109|NCT00086138|Alzheimer's disease|alzheimer's disease
1679110|NCT00086138|Depression|depression
1679111|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
1679112|NCT00086112|Anxiety|anxiety
1679113|NCT00086112|antipsychotic|antipsychotic
1679114|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1679115|NCT00006041|fallopian tube cancer|fallopian tube cancer
1679116|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1679117|NCT00005975|stage I breast cancer|stage i breast cancer
1679118|NCT00005975|stage II breast cancer|stage ii breast cancer
1679119|NCT00005975|hot flashes|hot flashes
1679120|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1679121|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
1679122|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
1679123|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
1679124|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
1679125|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1679126|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1679127|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1679128|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1679129|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1679130|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1679131|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1679132|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1679133|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1679134|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1679135|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1679136|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1679137|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1679138|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1679139|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1679140|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679141|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679142|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679143|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679144|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679145|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679146|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679147|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679148|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679149|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1679150|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1679151|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1679152|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1693076|NCT00072592|Treatment|treatment
1679153|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1679154|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1679155|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679156|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679157|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685064|NCT00081588|TMC114-C213|tmc114-c213
1679158|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679159|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679160|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679161|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1679162|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679163|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679164|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1679165|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1679166|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1679167|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679168|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679169|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679170|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679171|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679172|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679173|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679174|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679175|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679176|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679177|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679178|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679179|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679180|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679181|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1679182|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1679183|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679184|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1679185|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1679186|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1679187|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1679188|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1679189|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1679190|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1679191|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1679192|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1679193|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1679194|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1679195|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1679196|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1679197|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1679198|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1679199|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1679200|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1679201|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1679202|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1679203|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1679204|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1679205|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1679206|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679207|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1679208|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1679209|NCT00004192|neutropenia|neutropenia
1679210|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1679211|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679212|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679213|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679214|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679216|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679217|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679218|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679219|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679220|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679221|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679222|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679223|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679224|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679225|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679226|NCT00003995|stage IV colon cancer|stage iv colon cancer
1679227|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
1679228|NCT00003995|recurrent colon cancer|recurrent colon cancer
1679229|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
1679230|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679231|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1679232|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
1679234|NCT00086086|Anaemia|anaemia
1679235|NCT00086086|Anemia|anemia
1688625|NCT00079313|CMML|cmml
1679237|NCT00086073|Parkinson's disease|parkinson's disease
1679238|NCT00086073|PD|pd
1679239|NCT00086073|genetics|genetics
1679240|NCT00086073|genes|genes
1679241|NCT00086073|siblings|siblings
1679242|NCT00086073|family|family
1679243|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1679244|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679245|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1679246|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
1679247|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
1679248|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
1679249|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
1679250|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679251|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1679252|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1679253|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1679254|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
1679255|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1679256|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1679257|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1679258|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679259|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
1679260|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
1679261|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
1679262|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
1679263|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
1679264|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1679265|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1679266|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1679267|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679268|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1679269|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
1679270|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1679271|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1679272|NCT00086060|Internal-External Control|internal-external control
1679273|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
1679274|NCT00086060|fMRI|fmri
1679275|NCT00086060|Exercise|exercise
1679276|NCT00086060|Relaxation|relaxation
1679277|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
1679278|NCT00086047|JPFS|jpfs
1679279|NCT00086047|Fibromyalgia|fibromyalgia
1679280|NCT00086047|Chronic Pain|chronic pain
1679281|NCT00086047|Pediatric Pain|pediatric pain
1679282|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
1679283|NCT00086034|Lymphoma|lymphoma
1679284|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1679285|NCT00086034|Indolent lymphoma|indolent lymphoma
1679286|NCT00086034|Relapsed lymphoma|relapsed lymphoma
1679287|NCT00086034|Refractory lymphoma|refractory lymphoma
1679288|NCT00086034|Motexafin gadolinium|motexafin gadolinium
1679289|NCT00003078|stage III cervical cancer|stage iii cervical cancer
1679290|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
1679291|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
1679292|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1679293|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
1679294|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1679295|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1679296|NCT00002844|Cyclophosphamide|cyclophosphamide
1679297|NCT00002844|Cytoxan|cytoxan
1679298|NCT00002844|Neosar|neosar
1679299|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
1679300|NCT00002844|total body irradiation|total body irradiation
1679301|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1679302|NCT00002844|allogeneic|allogeneic
1679303|NCT00002844|autologous|autologous
1679304|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1679305|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1679306|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1679307|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1679308|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679309|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679310|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679311|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679312|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679313|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679314|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679315|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679316|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679317|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679318|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679319|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679320|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679321|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679322|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679323|NCT00086021|Headache|headache
1679324|NCT00086021|Acupuncture|acupuncture
1679325|NCT00085969|diabetes|diabetes
1679326|NCT00085969|exenatide|exenatide
1679328|NCT00085969|Lilly|lilly
1679329|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679330|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679331|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679332|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679333|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679334|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679335|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679336|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679337|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679338|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679339|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679340|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679341|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1679342|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1679343|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1679536|NCT00085904|pharmacokinetics|pharmacokinetics
1679344|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1679345|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1679346|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1679347|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1679348|NCT00006235|fallopian tube cancer|fallopian tube cancer
1679349|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1679350|NCT00006235|Brenner tumor|brenner tumor
1679351|NCT00006214|prostate cancer|prostate cancer
1679352|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
1679353|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
1679354|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1679355|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1679356|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
1679357|NCT00006116|large cell lung cancer|large cell lung cancer
1679358|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679359|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1679360|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
1679361|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679362|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1679363|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1679364|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1679365|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1679366|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1679367|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1679368|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1679369|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1679716|NCT00003894|graft versus host disease|graft versus host disease
1679370|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1679371|NCT00002717|Brenner tumor|brenner tumor
1679372|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1679373|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
1679374|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
1679375|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1679376|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
1679377|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
1679378|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
1679379|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1679380|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1679381|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1679382|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1679383|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1679384|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1679385|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1679386|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1679387|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1679388|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1679389|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1679390|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1679391|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1679392|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1679393|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1679394|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1679395|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1679396|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1679397|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1679398|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1679399|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1679400|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1679401|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1679402|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1679403|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1679404|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1679405|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1679406|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1679407|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1679408|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1679409|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1679410|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1679411|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1679412|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1679413|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1679414|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1679415|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679416|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679417|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679418|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679419|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679420|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679421|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679422|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679423|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679424|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1679425|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1679426|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1679427|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1679428|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1679429|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1679430|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1679431|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1679432|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1679499|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1679433|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1679434|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1679435|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1679436|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1679437|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1679438|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679439|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1679440|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1679441|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1679442|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679443|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1679444|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1679445|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1679446|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1679447|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1679448|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679449|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679450|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679451|NCT00085995|Syndesmophyte|syndesmophyte
1679452|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
1679454|NCT00085995|Spondyloarthropathy|spondyloarthropathy
1679455|NCT00085995|Spondyloarthritis|spondyloarthritis
1679456|NCT00085982|Rabson Mendenhall|rabson mendenhall
1679457|NCT00085982|Type B Insulin Resistance|type b insulin resistance
1679458|NCT00085982|Type A Insulin Resistance|type a insulin resistance
1679459|NCT00085982|Diabetes|diabetes
1679460|NCT00085943|ritonavir|ritonavir
1679461|NCT00085943|abacavir|abacavir
1679462|NCT00085943|HIV|hiv
1679463|NCT00085943|lopinavir|lopinavir
1679464|NCT00085943|lamivudine|lamivudine
1679465|NCT00085943|fosamprenavir|fosamprenavir
1679466|NCT00085943|Epzicom|epzicom
1679467|NCT00085930|Neuroblastoma|neuroblastoma
1679468|NCT00006035|stage III melanoma|stage iii melanoma
1679469|NCT00006035|stage IV melanoma|stage iv melanoma
1679470|NCT00006035|recurrent melanoma|recurrent melanoma
1679471|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1679472|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1679473|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1679474|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1679475|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1679476|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1679477|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1679478|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1679479|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1679480|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1679481|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1679482|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1679483|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1679484|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1679485|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1679486|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1679487|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1679488|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1679489|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1679490|NCT00005993|stage IV breast cancer|stage iv breast cancer
1679491|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
1679492|NCT00005993|recurrent breast cancer|recurrent breast cancer
1679493|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
1679494|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1679495|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1679496|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1679497|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1679498|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1679500|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1679501|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1679502|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1679503|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1679504|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1679505|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1679506|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1679507|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679508|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679509|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679510|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679511|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679512|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679513|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679514|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679515|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679516|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1679517|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1679518|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1679519|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1679520|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679521|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1679522|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1679523|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1679524|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1679525|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679526|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679527|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679528|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679529|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679530|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679531|NCT00005968|stage IV melanoma|stage iv melanoma
1679537|NCT00085904|oncology|oncology
1679538|NCT00085891|Schizophrenia|schizophrenia
1679539|NCT00085891|Schizophrenic disorder|schizophrenic disorder
1679540|NCT00085878|IL-18|il-18
1679541|NCT00085878|subcutaneous|subcutaneous
1679542|NCT00085878|pharmacokinetics|pharmacokinetics
1679543|NCT00085878|Phase 1|phase 1
1679544|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1679545|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1679546|NCT00005826|adult glioblastoma|adult glioblastoma
1679547|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
1679548|NCT00005826|adult gliosarcoma|adult gliosarcoma
1679549|NCT00005616|stage I colon cancer|stage i colon cancer
1679550|NCT00005616|stage II colon cancer|stage ii colon cancer
1679551|NCT00005616|stage III colon cancer|stage iii colon cancer
1679552|NCT00005616|stage IV colon cancer|stage iv colon cancer
1679553|NCT00005616|stage I rectal cancer|stage i rectal cancer
1679554|NCT00005616|stage II rectal cancer|stage ii rectal cancer
1679555|NCT00005616|stage III rectal cancer|stage iii rectal cancer
1679556|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
1679557|NCT00005616|recurrent colon cancer|recurrent colon cancer
1679558|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
1679559|NCT00005616|liver metastases|liver metastases
1679560|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1679561|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1679562|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679563|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1679564|NCT00005073|stage I prostate cancer|stage i prostate cancer
1679565|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
1679566|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
1679567|NCT00005073|stage III prostate cancer|stage iii prostate cancer
1679568|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
1679569|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1693077|NCT00072592|Remission|remission
1679570|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
1679571|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1679572|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
1679573|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
1679574|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
1679575|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
1679576|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1679578|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1679579|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1679580|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1679581|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1679582|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1679583|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1679584|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1679585|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1679586|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1679587|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1679588|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688626|NCT00079313|CML|cml
1679589|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1679590|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1679591|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1679592|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1679593|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1679594|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1679595|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1679596|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1679597|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1679598|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1679599|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1679600|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1679601|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1679602|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1679603|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1679604|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1679605|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679606|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679607|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679608|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679609|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679610|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679611|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679612|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679613|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679614|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1679615|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1679616|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1679617|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1679618|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1679619|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1679620|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1679621|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1679622|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1679623|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1679624|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1679625|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1679626|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1679627|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1679628|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1679629|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1679630|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1679631|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1679632|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1679633|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1679634|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1679635|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1679636|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1679637|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679638|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1679639|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1679640|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679641|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679642|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1679643|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1679644|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1679645|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1679646|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1679647|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1679648|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1679799|NCT00003254|stage IV colon cancer|stage iv colon cancer
1679649|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1679650|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679651|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679652|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679653|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1679654|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1679655|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1679656|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1679657|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1679658|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1679659|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1679660|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1679661|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1679663|NCT00085917|Ribavirin|ribavirin
1679664|NCT00085917|Early Virological Response|early virological response
1679665|NCT00085917|Hepatitis C|hepatitis c
1679666|NCT00085917|HIV|hiv
1679667|NCT00085852|emphysema|emphysema
1679668|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1679669|NCT00085852|lung volume reduction|lung volume reduction
1679670|NCT00085852|bronchoscopic|bronchoscopic
1679671|NCT00085852|bronchoscopy|bronchoscopy
1679672|NCT00085852|bronchoscope|bronchoscope
1679673|NCT00085839|Tarceva|tarceva
1679674|NCT00085839|NSCLC|nsclc
1679675|NCT00085839|EGFR|egfr
1679676|NCT00085839|ECOG Performance Status 2|ecog performance status 2
1679677|NCT00085839|erlotinib|erlotinib
1679678|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
1679679|NCT00085839|OSI-774|osi-774
1679680|NCT00085826|Lung Cancer|lung cancer
1679681|NCT00085826|NSCLC|nsclc
1679682|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
1679683|NCT00085813|Platinum-Refractory|platinum-refractory
1679684|NCT00085813|Platinum-Relapsed|platinum-relapsed
1679685|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
1679686|NCT00085774|albuterol|albuterol
1679687|NCT00085774|aerosol inhaler|aerosol inhaler
1679688|NCT00085774|metered-dose inhaler|metered-dose inhaler
1679689|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
1679690|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
1679691|NCT00085761|Dermal assessment|dermal assessment
1679692|NCT00085761|Pain measurement|pain measurement
1679693|NCT00085761|Diary|diary
1679694|NCT00085761|Neuropathy|neuropathy
1679695|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
1679696|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1679697|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
1679698|NCT00085761|Pain|pain
1679699|NCT00085761|Complementary Therapies|complementary therapies
1679700|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679701|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1679702|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
1679703|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1679704|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679705|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1679706|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
1679707|NCT00003996|adult glioblastoma|adult glioblastoma
1679708|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
1679709|NCT00003996|adult gliosarcoma|adult gliosarcoma
1679710|NCT00003920|stage IV breast cancer|stage iv breast cancer
1679711|NCT00003920|recurrent breast cancer|recurrent breast cancer
1679712|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1679713|NCT00003898|oral complications|oral complications
1679714|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1679715|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679717|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679718|NCT00085865|5 HT|5 ht
1679719|NCT00085865|Neuroreceptors|neuroreceptors
1679720|NCT00085865|Radiotracer|radiotracer
1679721|NCT00085865|Neuroimaging|neuroimaging
1679722|NCT00085865|Serotonin Transporter|serotonin transporter
1679723|NCT00085865|Alcoholism|alcoholism
1679724|NCT00085865|PET|pet
1679725|NCT00085865|Healthy Volunteer|healthy volunteer
1679726|NCT00085865|HV|hv
1679727|NCT00085748|schizophrenia|schizophrenia
1679728|NCT00085748|geriatric|geriatric
1679729|NCT00085748|elderly|elderly
1679730|NCT00085722|Injection Therapy|injection therapy
1679731|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1679732|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1688627|NCT00079313|Gleevec|gleevec
1679733|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
1679734|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1679735|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1679736|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1679737|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1679738|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1679739|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1679740|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1679741|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1679742|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1679743|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1679744|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1679745|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1679746|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
1679747|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
1679748|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1679749|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
1679750|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
1679751|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1679752|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1679753|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1679754|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1679755|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1679756|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1679757|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1679758|NCT00003624|stage I cervical cancer|stage i cervical cancer
1679759|NCT00003624|stage II cervical cancer|stage ii cervical cancer
1679760|NCT00003624|stage III cervical cancer|stage iii cervical cancer
1679761|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
1679762|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1679763|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1679764|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1679765|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1679766|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
1679767|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
1679768|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
1679769|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679770|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
1679771|NCT00003624|fallopian tube cancer|fallopian tube cancer
1679772|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1679773|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
1679774|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
1679775|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
1679776|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
1679777|NCT00003624|neurotoxicity|neurotoxicity
1679778|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
1679779|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
1679780|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1679781|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1679782|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1679783|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1679784|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1679785|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1679786|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1679787|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1679862|NCT00085696|Non-Hodgkin's|non-hodgkin's
1679788|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1679789|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1679790|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1679791|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1679792|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1679793|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
1679794|NCT00003574|adult glioblastoma|adult glioblastoma
1679795|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1679796|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1679797|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
1679798|NCT00003574|adult gliosarcoma|adult gliosarcoma
1679800|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
1679801|NCT00003254|recurrent colon cancer|recurrent colon cancer
1679802|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
1679803|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679804|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1679805|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1679806|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1679807|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
1679808|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679809|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679810|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679811|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679812|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679813|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679814|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679815|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1679816|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679817|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679818|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679819|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679820|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1679821|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1679822|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1679823|NCT00003099|breast cancer|breast cancer
1679824|NCT00003099|Tamoxifen|tamoxifen
1679825|NCT00003099|Fenretinide|fenretinide
1679826|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
1679827|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
1679828|NCT00003099|4-HPR|4-hpr
1679829|NCT00003099|Breast Neoplasia|breast neoplasia
1679830|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
1679831|NCT00003099|Surgery|surgery
1679832|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
1679833|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
1679834|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679835|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679836|NCT00002973|stage III melanoma|stage iii melanoma
1679837|NCT00002973|stage IV melanoma|stage iv melanoma
1679838|NCT00002973|recurrent melanoma|recurrent melanoma
1679839|NCT00002949|stage II cervical cancer|stage ii cervical cancer
1679840|NCT00002949|stage III cervical cancer|stage iii cervical cancer
1679841|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
1679842|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
1679843|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
1679844|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
1679845|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
1679846|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
1679847|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
1679848|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679849|NCT00002949|stage II bladder cancer|stage ii bladder cancer
1679850|NCT00002949|stage III bladder cancer|stage iii bladder cancer
1679851|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
1679852|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1679853|NCT00002864|stage I breast cancer|stage i breast cancer
1679854|NCT00002864|stage II breast cancer|stage ii breast cancer
1679855|NCT00002864|stage III breast cancer|stage iii breast cancer
1679856|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1679857|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1679858|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1679859|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1679860|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
1679861|NCT00085696|Lymphoma|lymphoma
1679866|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1679867|NCT00085683|Lumbar Puncture|lumbar puncture
1679868|NCT00085683|Healthy Control Subjects|healthy control subjects
1679869|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
1679870|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
1679871|NCT00085683|Seizure Disorder|seizure disorder
1679872|NCT00085683|Epilepsy|epilepsy
1679873|NCT00085683|Healthy Volunteer|healthy volunteer
1679874|NCT00085683|HV|hv
1679875|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
1679876|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
1679877|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
1679878|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
1688628|NCT00079313|Glivec|glivec
1679879|NCT00085670|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
1679880|NCT00085670|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
1679881|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
1679882|NCT00085670|Bone Marrow Failure|bone marrow failure
1679883|NCT00085670|Aplastic Anemia|aplastic anemia
1679884|NCT00085670|Myelodysplastic Syndrome|myelodysplastic syndrome
1679885|NCT00085670|MDS|mds
1679886|NCT00085670|Pure Red Cell Aplasia|pure red cell aplasia
1679887|NCT00085670|PRCA|prca
1679888|NCT00085657|Direct Current Stimulation|direct current stimulation
1679889|NCT00085657|Cortical Reorganization|cortical reorganization
1679890|NCT00085657|Rehabilitation|rehabilitation
1679891|NCT00085657|Acute Stroke|acute stroke
1679892|NCT00085657|Stroke|stroke
1679893|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
1679894|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
1679895|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
1679896|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
1679897|NCT00085631|stage III cervical cancer|stage iii cervical cancer
1679898|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
1679899|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
1679900|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1679901|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1679902|NCT00085579|stage III melanoma|stage iii melanoma
1679903|NCT00085579|stage IV melanoma|stage iv melanoma
1679904|NCT00085566|adult glioblastoma|adult glioblastoma
1679905|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
1679906|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
1679907|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
1679908|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
1679909|NCT00085566|adult gliosarcoma|adult gliosarcoma
1679910|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1679911|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1679912|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1679913|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1679914|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1679915|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1679916|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
1679917|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
1679918|NCT00085501|large cell lung cancer|large cell lung cancer
1679919|NCT00085488|recurrent melanoma|recurrent melanoma
1679920|NCT00085488|stage III melanoma|stage iii melanoma
1679921|NCT00085488|stage IV melanoma|stage iv melanoma
1679922|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1679923|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1679924|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1679925|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
1679926|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1679927|NCT00085462|recurrent melanoma|recurrent melanoma
1679928|NCT00085462|stage IV melanoma|stage iv melanoma
1679929|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1679930|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1679931|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1679932|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1679933|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1679934|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1679935|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1679936|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1679937|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1679938|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1679939|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1679940|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1679941|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1679942|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1679943|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1679944|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1679945|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1679946|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1680048|NCT00084721|stage III rectal cancer|stage iii rectal cancer
1679947|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1679948|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1679949|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1679950|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1679951|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1679952|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1688629|NCT00079313|STI-571|sti-571
1679953|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1679954|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
1679955|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1679956|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1679957|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1679958|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1679959|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1679960|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1679961|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1679962|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
1679963|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
1679964|NCT00085423|recurrent melanoma|recurrent melanoma
1679965|NCT00085423|stage IV melanoma|stage iv melanoma
1679966|NCT00085397|recurrent melanoma|recurrent melanoma
1679967|NCT00085397|stage III melanoma|stage iii melanoma
1679968|NCT00085397|stage IV melanoma|stage iv melanoma
1679969|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1679970|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
1679971|NCT00085384|fallopian tube cancer|fallopian tube cancer
1679972|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1679973|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
1679974|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1679975|NCT00085306|recurrent melanoma|recurrent melanoma
1679976|NCT00085306|stage IV melanoma|stage iv melanoma
1679977|NCT00085306|iris melanoma|iris melanoma
1679978|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1679979|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
1679980|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
1679981|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1679982|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
1679983|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
1679984|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1679985|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1679986|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1679987|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
1679988|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1679989|NCT00085176|neurotoxicity|neurotoxicity
1679990|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1679991|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1679992|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
1679993|NCT00085163|stage III colon cancer|stage iii colon cancer
1679994|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1679995|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1679996|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
1679997|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1679998|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1679999|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1680000|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1680001|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1680002|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1680003|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1680004|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
1680005|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1680006|NCT00085059|stage IV melanoma|stage iv melanoma
1680007|NCT00085059|recurrent melanoma|recurrent melanoma
1680008|NCT00085020|stage IV breast cancer|stage iv breast cancer
1680009|NCT00085020|male breast cancer|male breast cancer
1680010|NCT00085020|recurrent breast cancer|recurrent breast cancer
1680011|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1680155|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
1680012|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
1680013|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
1680014|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1680015|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1680016|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1680017|NCT00084929|colon cancer|colon cancer
1680018|NCT00084929|rectal cancer|rectal cancer
1680019|NCT00084903|cervical cancer|cervical cancer
1680020|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
1680021|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
1680022|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
1680023|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1680024|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1680025|NCT00084864|stage II prostate cancer|stage ii prostate cancer
1680026|NCT00084864|stage III prostate cancer|stage iii prostate cancer
1680027|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1680028|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1680029|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
1680030|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
1680032|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680033|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
1680034|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680035|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
1680036|NCT00084773|stage II rectal cancer|stage ii rectal cancer
1680037|NCT00084773|stage III rectal cancer|stage iii rectal cancer
1680038|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1680039|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
1680040|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
1680041|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680042|NCT00084721|diarrhea|diarrhea
1680043|NCT00084721|recurrent colon cancer|recurrent colon cancer
1680044|NCT00084721|stage IV colon cancer|stage iv colon cancer
1680045|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
1680046|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
1680047|NCT00084721|stage III colon cancer|stage iii colon cancer
1680049|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680050|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1680051|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1680052|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1680053|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1680054|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1680055|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
1680056|NCT00084695|regional neuroblastoma|regional neuroblastoma
1680057|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
1680058|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1680059|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1680060|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1680061|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1680062|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1680063|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
1680064|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1680065|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1680066|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1680067|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1680068|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1680069|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1680070|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1680071|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1680072|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1680073|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1680074|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1680075|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1680076|NCT00084695|Fanconi anemia|fanconi anemia
1680077|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1680078|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1680079|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1680080|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1680081|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1680082|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1680803|NCT00083681|Thalidomide|thalidomide
1680083|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1680084|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1680085|NCT00084669|hot flashes|hot flashes
1680086|NCT00084669|sleep disorders|sleep disorders
1680087|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1680088|NCT00084669|breast cancer in situ|breast cancer in situ
1680089|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1680090|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
1680091|NCT00084669|recurrent breast cancer|recurrent breast cancer
1680092|NCT00084669|stage I breast cancer|stage i breast cancer
1680093|NCT00084669|stage II breast cancer|stage ii breast cancer
1680094|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
1680095|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
1680096|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
1680097|NCT00084669|stage IV breast cancer|stage iv breast cancer
1680098|NCT00084656|stage III melanoma|stage iii melanoma
1680099|NCT00084656|stage IV melanoma|stage iv melanoma
1680100|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1680101|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
1680102|NCT00084656|iris melanoma|iris melanoma
1680103|NCT00084656|recurrent melanoma|recurrent melanoma
1680104|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
1680105|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
1680106|NCT00084591|stage II rectal cancer|stage ii rectal cancer
1680107|NCT00084591|stage III rectal cancer|stage iii rectal cancer
1680108|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1680109|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
1680110|NCT00084578|stage I bladder cancer|stage i bladder cancer
1680111|NCT00084578|stage II bladder cancer|stage ii bladder cancer
1680112|NCT00084578|stage III bladder cancer|stage iii bladder cancer
1680113|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
1680114|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1680115|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
1680116|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1680117|NCT00084552|sexual dysfunction|sexual dysfunction
1680118|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
1680119|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1680120|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
1680121|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
1680122|NCT00084539|stage I breast cancer|stage i breast cancer
1680123|NCT00084539|stage II breast cancer|stage ii breast cancer
1680124|NCT00084539|breast cancer in situ|breast cancer in situ
1680125|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
1680126|NCT00084526|stage I prostate cancer|stage i prostate cancer
1680127|NCT00084526|stage II prostate cancer|stage ii prostate cancer
1680128|NCT00084526|stage III prostate cancer|stage iii prostate cancer
1680129|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
1680130|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680131|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1680132|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1680133|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1680134|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680135|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1680136|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1680137|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
1680138|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
1680139|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1680140|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680141|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680142|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680143|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1680144|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680145|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1680146|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
1680566|NCT00083876|Cyclophosphamide|cyclophosphamide
1680147|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
1693435|NCT00071344|Trastuzumab|trastuzumab
1680148|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
1680149|NCT00084396|stage II breast cancer|stage ii breast cancer
1680150|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
1680151|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
1680152|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
1680153|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
1680154|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1680804|NCT00083681|G-CSF|g-csf
1680156|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
1680157|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
1680158|NCT00084344|breast cancer|breast cancer
1680159|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1680160|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680161|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1680162|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680163|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680164|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680165|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1680166|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1680167|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
1680168|NCT00084279|Liver|liver
1680169|NCT00084279|Pegylated|pegylated
1680170|NCT00084279|Interferon|interferon
1680171|NCT00084279|Alpha|alpha
1680172|NCT00084279|Gamma|gamma
1680173|NCT00084279|Ribavirin|ribavirin
1680174|NCT00084279|Combination|combination
1680175|NCT00084279|Nonresponder|nonresponder
1680176|NCT00084279|Pegasys|pegasys
1680177|NCT00084279|PegIntron|pegintron
1680178|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
1680179|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
1680180|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
1680181|NCT00084253|HIV|hiv
1680182|NCT00084253|Treatment Naive|treatment naive
1680183|NCT00084305|Bronchoscopy|bronchoscopy
1680184|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
1680185|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
1680186|NCT00084305|Hereditary Pulmonary Fibrosis|hereditary pulmonary fibrosis
1680187|NCT00084305|Healthy Volunteer|healthy volunteer
1680188|NCT00084305|HV|hv
1680189|NCT00084292|Ischemia|ischemia
1680190|NCT00084292|Pediatric|pediatric
1680191|NCT00084292|Etiology|etiology
1680192|NCT00084292|Treatment|treatment
1680193|NCT00084292|Outcome|outcome
1680194|NCT00084292|Childhood Stroke|childhood stroke
1680195|NCT00084292|Pediatric Stroke|pediatric stroke
1680196|NCT00084292|Ischemic Stroke|ischemic stroke
1680197|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
1680198|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
1680199|NCT00084214|metastatic|metastatic
1680200|NCT00084214|increased antitumor effect|increased antitumor effect
1680201|NCT00002682|Antibiotic Treatment|antibiotic treatment
1680202|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
1680203|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1680204|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1680205|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1680206|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1680207|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1680208|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680209|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1680210|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1680211|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680212|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1680213|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1680214|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680215|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1680216|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680217|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680218|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1680219|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1680220|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1680221|NCT00002646|stage II breast cancer|stage ii breast cancer
1680222|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
1680223|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
1680224|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
1680225|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
1680226|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1680227|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1680228|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1680229|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1680230|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1680231|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1680232|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
1680233|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1680234|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1680235|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1680236|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
1680237|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1680238|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1680239|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1680240|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1680241|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1680242|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1680243|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1680244|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1680245|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1680246|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1680247|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1680248|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1680249|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1680250|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1680251|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1680252|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1680253|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1680254|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1680255|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1680256|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1680257|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1680258|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1680259|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1680260|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1680261|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1680262|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1680263|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1680264|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1680265|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1680266|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1680267|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1680268|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1680269|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1680270|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1680271|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1680272|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1680273|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1680274|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1680275|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1680276|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1680277|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1680278|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1680279|NCT00002551|stage II rectal cancer|stage ii rectal cancer
1680280|NCT00002551|stage III rectal cancer|stage iii rectal cancer
1680281|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1680282|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1680283|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1680284|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1680285|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1680286|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1680287|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1680288|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1680289|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1680290|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1680291|NCT00002538|fallopian tube cancer|fallopian tube cancer
1680292|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1680293|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
1680294|NCT00084188|behavioral intervention|behavioral intervention
1680295|NCT00084175|behavioral intervention|behavioral intervention
1680296|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1680297|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1680298|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1680299|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680300|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680301|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1680302|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1680303|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1680304|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1680305|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
1680306|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1680307|NCT00006451|graft versus host disease|graft versus host disease
1680308|NCT00006387|stage IV colon cancer|stage iv colon cancer
1680309|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
1680310|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
1680311|NCT00006387|recurrent colon cancer|recurrent colon cancer
1680312|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
1680313|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
1680314|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1680315|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1680316|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
1680317|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
1680318|NCT00006382|small cell lung cancer|small cell lung cancer
1680319|NCT00006380|stage III prostate cancer|stage iii prostate cancer
1680320|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
1680321|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
1680322|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
1680323|NCT00006378|large cell lung cancer|large cell lung cancer
1680324|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1680325|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1680326|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
1680327|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1680328|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1680329|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1680330|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
1680331|NCT00005994|nausea and vomiting|nausea and vomiting
1680332|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680333|NCT00005790|adult brain stem glioma|adult brain stem glioma
1680334|NCT00005790|adult ependymoma|adult ependymoma
1680335|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
1680336|NCT00005790|adult medulloblastoma|adult medulloblastoma
1680337|NCT00005790|adult meningioma|adult meningioma
1680338|NCT00005790|adult glioblastoma|adult glioblastoma
1680339|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
1680340|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1680341|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1680342|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
1680343|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1680344|NCT00005790|adult mixed glioma|adult mixed glioma
1680345|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1680346|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1680347|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1680348|NCT00005790|adult subependymoma|adult subependymoma
1680568|NCT00083876|Etoposide|etoposide
1680349|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
1680350|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
1680351|NCT00005790|adult pineocytoma|adult pineocytoma
1680352|NCT00005790|adult pineoblastoma|adult pineoblastoma
1680353|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1680354|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
1680355|NCT00005790|adult grade III meningioma|adult grade iii meningioma
1680356|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
1680357|NCT00005790|adult gliosarcoma|adult gliosarcoma
1680358|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1680359|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1680360|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1680361|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
1680362|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
1680363|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
1680364|NCT00004236|stage III gastric cancer|stage iii gastric cancer
1693436|NCT00071344|Carcinoma|carcinoma
1680365|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
1680366|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
1680367|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
1680368|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
1680369|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
1680370|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1680371|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1680372|NCT00003992|stage II breast cancer|stage ii breast cancer
1680373|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
1680374|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1680375|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1680376|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1680377|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1680378|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1680379|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
1680380|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
1680381|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680382|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1680383|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1680384|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1680385|NCT00003410|adult glioblastoma|adult glioblastoma
1680386|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
1680387|NCT00003410|adult gliosarcoma|adult gliosarcoma
1680388|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
1680389|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1680390|NCT00003372|adult mixed glioma|adult mixed glioma
1680391|NCT00003236|recurrent breast cancer|recurrent breast cancer
1680392|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1680393|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680394|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680395|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
1680396|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1680397|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1680398|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1680399|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1680400|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1680401|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680402|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1680403|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1680404|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1680405|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680406|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1680407|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1680408|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1680409|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1680410|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1680411|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680412|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1680413|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1680414|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680415|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1680416|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680417|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1680418|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1680419|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1680420|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1680421|NCT00002460|stage I breast cancer|stage i breast cancer
1680422|NCT00002460|stage II breast cancer|stage ii breast cancer
1680423|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
1680424|NCT00084162|PET|pet
1680425|NCT00084162|Heart Rate Variability|heart rate variability
1680426|NCT00084162|N-Back Task|n-back task
1680427|NCT00084162|Isometric Handgrip|isometric handgrip
1680428|NCT00084162|MRI|mri
1680429|NCT00084162|Depression|depression
1680430|NCT00084162|MDD|mdd
1680431|NCT00084162|Heart|heart
1680432|NCT00084149|Acute Infection|acute infection
1680433|NCT00084149|Treatment Naive|treatment naive
1680434|NCT00084136|Treatment Naive|treatment naive
1680435|NCT00084136|Adherence|adherence
1680436|NCT00084136|Drug Resistance|drug resistance
1680437|NCT00084136|Treatment Failure|treatment failure
1680438|NCT00084123|Relaxation Techniques|relaxation techniques
1680439|NCT00084123|Radiation|radiation
1680440|NCT00084123|Drug Therapy|drug therapy
1680441|NCT00084123|Healing Touch|healing touch
1680442|NCT00084110|Aged|aged
1680443|NCT00084110|Mexican Americans|mexican americans
1680444|NCT00084110|Complementary Therapies|complementary therapies
1680445|NCT00083993|Breast Cancer|breast cancer
1680446|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1680447|NCT00005960|stage I prostate cancer|stage i prostate cancer
1680448|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
1680449|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
1680569|NCT00083876|Filgrastim|filgrastim
1680450|NCT00005960|stage III prostate cancer|stage iii prostate cancer
1680451|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
1680452|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
1680453|NCT00005960|pain|pain
1680536|NCT00083941|Renal Cell Cancer|renal cell cancer
1680454|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1680455|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
1680456|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1680457|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
1680458|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
1680459|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
1680460|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1680461|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1680462|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1680463|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1680464|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1680465|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680466|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680467|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1680468|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1680469|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1680470|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1680471|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1680472|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1680473|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1680474|NCT00005641|polycythemia vera|polycythemia vera
1680475|NCT00005641|primary myelofibrosis|primary myelofibrosis
1680476|NCT00005641|essential thrombocythemia|essential thrombocythemia
1680477|NCT00005641|refractory anemia|refractory anemia
1680478|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1680479|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
1680480|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1680481|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1680482|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1680483|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1680484|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1680485|NCT00005641|graft versus host disease|graft versus host disease
1680486|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1680487|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1680488|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1680489|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1680490|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1680491|NCT00005054|stage IV breast cancer|stage iv breast cancer
1680492|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
1680493|NCT00005054|recurrent breast cancer|recurrent breast cancer
1680494|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
1680495|NCT00005050|stage III colon cancer|stage iii colon cancer
1680496|NCT00005050|stage IV colon cancer|stage iv colon cancer
1680497|NCT00005050|stage III rectal cancer|stage iii rectal cancer
1680498|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
1680499|NCT00005050|recurrent colon cancer|recurrent colon cancer
1680500|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
1680501|NCT00084097|Allergy|allergy
1680503|NCT00084097|Eosinophil|eosinophil
1680504|NCT00084097|Monoclonal Antibody|monoclonal antibody
1680505|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
1680506|NCT00084097|EG|eg
1680507|NCT00084084|Lysosomes|lysosomes
1680508|NCT00084084|Storage|storage
1680509|NCT00084084|Glycolipid|glycolipid
1680510|NCT00084084|Fabry disease|fabry disease
1680511|NCT00084084|Stroke|stroke
1680512|NCT00084084|Children|children
1680513|NCT00084084|Pediatrics|pediatrics
1680514|NCT00084058|Dose Intensification|dose intensification
1680515|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
1680516|NCT00084058|Treatment Experienced|treatment experienced
1680517|NCT00084058|Child|child
1680518|NCT00084045|HIV Seronegativity|hiv seronegativity
1680519|NCT00084045|Treatment Naive|treatment naive
1680520|NCT00084045|Pediatric HIV|pediatric hiv
1680521|NCT00084045|Perinatal Transmission|perinatal transmission
1680522|NCT00084032|Acute Infection|acute infection
1680523|NCT00084032|Treatment Interruption|treatment interruption
1680524|NCT00084032|Treatment Naive|treatment naive
1680525|NCT00084032|Primary HIV Infection|primary hiv infection
1680526|NCT00084032|PHI|phi
1680527|NCT00084019|Treatment Experienced|treatment experienced
1680528|NCT00083980|Kava|kava
1680529|NCT00083980|Complementary Therapies|complementary therapies
1680530|NCT00083980|Medicine, Herbal|medicine, herbal
1680531|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
1680532|NCT00083967|detached retina|detached retina
1680533|NCT00083967|retinal tear|retinal tear
1680534|NCT00083967|retinal break|retinal break
1680535|NCT00083954|Bipolar I Disorder|bipolar i disorder
1680537|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
1680538|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
1680539|NCT00083928|Asymptomatic|asymptomatic
1680540|NCT00083928|subcutaneous|subcutaneous
1680541|NCT00083928|CA125 Progression|ca125 progression
1680542|NCT00083928|Angstrom|angstrom
1680543|NCT00083928|Ångstrom|ångstrom
1680544|NCT00083928|ovarian cancer|ovarian cancer
1680545|NCT00083915|Multiple Myeloma|multiple myeloma
1680546|NCT00083915|DTPACE|dtpace
1680547|NCT00083915|Tandem Transplant|tandem transplant
1680548|NCT00083915|Cisplatin|cisplatin
1680549|NCT00083915|Cyclophosphamide|cyclophosphamide
1680550|NCT00083915|Dexamethasone|dexamethasone
1680551|NCT00083915|Doxorubicin|doxorubicin
1680552|NCT00083915|Etoposide|etoposide
1680553|NCT00083915|Sargramostim|sargramostim
1680554|NCT00083915|Thalidomide|thalidomide
1680555|NCT00083915|Melphalan|melphalan
1680556|NCT00083902|Myeloma|myeloma
1680557|NCT00083902|Thalidomide|thalidomide
1680558|NCT00083902|Dexamethasone|dexamethasone
1680559|NCT00083876|Multiple Myeloma|multiple myeloma
1680560|NCT00083876|D.T. PACE|d.t. pace
1680561|NCT00083876|Melphalan|melphalan
1680562|NCT00083876|Transplant|transplant
1680563|NCT00083876|Thalidomide|thalidomide
1680564|NCT00083876|Dexamethasone|dexamethasone
1680565|NCT00083876|Cisplatin|cisplatin
1680570|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
1680571|NCT00083876|Sargramostim|sargramostim
1680572|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
1680573|NCT00005030|stage IV colon cancer|stage iv colon cancer
1680574|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
1680575|NCT00005030|recurrent colon cancer|recurrent colon cancer
1680576|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
1680577|NCT00005030|liver metastases|liver metastases
1680578|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680579|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680580|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680581|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
1680582|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
1680583|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
1680584|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1680585|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1680586|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1680587|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680588|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1680589|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1680590|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680591|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1680592|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1680593|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1680594|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1680595|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1680596|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680597|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1680598|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1680599|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680727|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
1680600|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1680601|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1680602|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1680603|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1680604|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1680805|NCT00083681|Cisplatin|cisplatin
1680605|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1680606|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
1680607|NCT00083772|Heart failure|heart failure
1680608|NCT00083772|Diastolic heart failure|diastolic heart failure
1680609|NCT00083772|Congestive heart failure|congestive heart failure
1680610|NCT00083772|Nesiritide|nesiritide
1680611|NCT00083772|Natrecor|natrecor
1680612|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
1680613|NCT00083772|Fatigue|fatigue
1680614|NCT00083772|Shortness of breath|shortness of breath
1680615|NCT00083772|Edema|edema
1680616|NCT00083772|Heart disease|heart disease
1680617|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1680618|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1680619|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1680620|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1680621|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1680622|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1680623|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680624|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680625|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1680626|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1680627|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1680628|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1680629|NCT00003939|adult angiosarcoma|adult angiosarcoma
1680630|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
1680631|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
1680632|NCT00003939|adult liposarcoma|adult liposarcoma
1680633|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
1680634|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
1680635|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1680636|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1680637|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1680638|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1680639|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
1680640|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1680641|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1680642|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
1680643|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1680644|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
1680645|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
1680646|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
1680647|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
1680648|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
1680649|NCT00003939|ovarian sarcoma|ovarian sarcoma
1680650|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1680651|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1680652|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
1680653|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1680654|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1680655|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1680656|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1680657|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1680658|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1680659|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1680660|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1680661|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1680662|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680663|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1680872|NCT00083538|Multiple Myeloma|multiple myeloma
1680664|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680665|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1680666|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1680667|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1680668|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680669|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1680670|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680671|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1680806|NCT00083681|Etoposide|etoposide
1680672|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1680673|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1680674|NCT00003787|stage I breast cancer|stage i breast cancer
1680675|NCT00003787|stage II breast cancer|stage ii breast cancer
1680676|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
1680677|NCT00003787|recurrent breast cancer|recurrent breast cancer
1680678|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1680679|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1680680|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680681|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
1680682|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
1680683|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1680684|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1680685|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1680686|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1680687|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1680688|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
1680689|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1680690|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1680691|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1680692|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1680693|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1680694|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1680695|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1680696|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1680697|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1680698|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1680699|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680700|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
1680701|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
1680702|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1680703|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1680704|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1680705|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1680706|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1680707|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1680708|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1680709|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1680710|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1680711|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1680712|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1680713|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1680714|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
1680715|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
1680716|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
1680717|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
1680718|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
1680719|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
1680720|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
1680721|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
1680722|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1680723|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1680724|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
1680725|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1680726|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
1680728|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
1680729|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1680730|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1680731|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680732|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680733|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1680734|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1680735|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1680736|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1680737|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1680738|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1680739|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1680740|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1680741|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1680819|NCT00083616|Panitumumab|panitumumab
1680742|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1680743|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1680744|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1680745|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1680746|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
1680747|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1680748|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1680749|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1680750|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1680751|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1680873|NCT00083538|DTPACE|dtpace
1680752|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1680753|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1680754|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1680755|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1680756|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1680757|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1680758|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1680759|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1680760|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1680761|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1680762|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1680763|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1680764|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1680765|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1680766|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1680767|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1680768|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1680769|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1680770|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1680771|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1680772|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1680773|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1680774|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1680775|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1680776|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1680777|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
1680778|NCT00003293|adult glioblastoma|adult glioblastoma
1680779|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
1680780|NCT00003293|adult gliosarcoma|adult gliosarcoma
1680781|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680782|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
1680783|NCT00003231|large cell lung cancer|large cell lung cancer
1680784|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1680785|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
1680786|NCT00083720|EGFR-undetectable|egfr-undetectable
1680787|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
1680788|NCT00083733|Gene Expression|gene expression
1680789|NCT00083733|Microarray|microarray
1680790|NCT00083733|Stem Cell|stem cell
1680791|NCT00083733|Proteomics|proteomics
1680792|NCT00083733|Metastases|metastases
1680793|NCT00083733|Breast Tissue|breast tissue
1680794|NCT00083733|Normal Breast Tissue|normal breast tissue
1680795|NCT00083733|Breast Cancer|breast cancer
1680796|NCT00083707|Macroglobulinemia|macroglobulinemia
1680797|NCT00083707|Waldenstrom|waldenstrom
1680798|NCT00083707|Thalidomide|thalidomide
1680799|NCT00083694|Leukemia|leukemia
1680800|NCT00083694|Thalidomide|thalidomide
1680801|NCT00083694|relapsed|relapsed
1680802|NCT00083681|Multiple Myeloma|multiple myeloma
1680807|NCT00083681|Dexamethasone|dexamethasone
1680808|NCT00083681|Cytoxan|cytoxan
1680809|NCT00083681|DCEP|dcep
1680810|NCT00083681|Relapse|relapse
1680811|NCT00083668|Schizophrenia|schizophrenia
1680812|NCT00083668|Paliperidone|paliperidone
1680813|NCT00083668|Olanzapine|olanzapine
1680814|NCT00083668|PANSS|panss
1680815|NCT00083668|Extended release|extended release
1680816|NCT00083668|Atypical neuroleptic|atypical neuroleptic
1680817|NCT00083616|EGFr|egfr
1680818|NCT00083616|Clinical Trial|clinical trial
1680822|NCT00083616|Metastatic Cancer|metastatic cancer
1680823|NCT00083616|Vectibix|vectibix
1680825|NCT00083616|Amgen|amgen
1680826|NCT00083564|Multiple myeloma|multiple myeloma
1680827|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
1680828|NCT00083564|STR|str
1680829|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
1680830|NCT00083564|Holmium-166|holmium-166
1680831|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
1680832|NCT00083642|Brain Plasticity|brain plasticity
1680833|NCT00083642|Functional MRI|functional mri
1680834|NCT00083642|Finger Movement|finger movement
1680835|NCT00083642|Rehabilitation|rehabilitation
1680836|NCT00083642|Improvement|improvement
1680837|NCT00083642|Stroke|stroke
1680838|NCT00083642|Motor Recovery|motor recovery
1680839|NCT00083642|Observation|observation
1680840|NCT00083642|fMRI|fmri
1680841|NCT00083642|Healthy Volunteer|healthy volunteer
1680842|NCT00083642|HV|hv
1680843|NCT00083629|[18F]FECNT|[18f]fecnt
1680844|NCT00083629|Biodistribution|biodistribution
1680845|NCT00083629|Dosimetry|dosimetry
1680846|NCT00083629|Dopamine Transporter|dopamine transporter
1680847|NCT00083629|MIRD|mird
1680848|NCT00083629|Kinetic Analysis|kinetic analysis
1680849|NCT00083629|Compartment Analysis|compartment analysis
1680850|NCT00083629|Healthy Volunteer|healthy volunteer
1680851|NCT00083629|HV|hv
1680852|NCT00083603|HIV Seronegativity|hiv seronegativity
1680853|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
1680854|NCT00083603|Vaccinia vector|vaccinia vector
1680855|NCT00083603|Pox vector|pox vector
1680856|NCT00083590|Alzheimer disease|alzheimer disease
1680857|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
1680858|NCT00083577|Multiple Myeloma|multiple myeloma
1680859|NCT00083577|Thalidomide|thalidomide
1680860|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
1680861|NCT00083551|Multiple Myeloma|multiple myeloma
1680862|NCT00083551|Cancer|cancer
1680863|NCT00083551|Therapy|therapy
1680864|NCT00083551|Thalidomide|thalidomide
1680865|NCT00083551|DTPACE|dtpace
1680866|NCT00083551|Transplant|transplant
1680867|NCT00083551|VAD|vad
1680868|NCT00083551|DCEP|dcep
1680869|NCT00083551|CAD|cad
1680870|NCT00083551|Consolidation|consolidation
1680871|NCT00083551|Melphalan|melphalan
1680874|NCT00083538|Dexamethasone|dexamethasone
1680875|NCT00083538|Thalidomide|thalidomide
1680876|NCT00083538|Cisplatin|cisplatin
1680877|NCT00083538|Cytoxan|cytoxan
1680878|NCT00083538|Doxorubicin|doxorubicin
1680879|NCT00083538|Etoposide|etoposide
1680880|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
1680881|NCT00083538|Leukapheresis|leukapheresis
1680882|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1680883|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1680884|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1680885|NCT00003160|fallopian tube cancer|fallopian tube cancer
1680886|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1680887|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680888|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680889|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1680890|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1680891|NCT00003075|cervical cancer|cervical cancer
1680892|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1680893|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1680894|NCT00003031|infection|infection
1680895|NCT00003031|pulmonary complications|pulmonary complications
1680896|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1680897|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
1681106|NCT00005640|stage III rectal cancer|stage iii rectal cancer
1680898|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
1680899|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1680900|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
1680901|NCT00083473|Pivanex,|pivanex,
1680902|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
1680903|NCT00083460|Multiple Myeloma|multiple myeloma
1680904|NCT00083460|Thalidomide|thalidomide
1680905|NCT00083460|Velcade|velcade
1680906|NCT00083460|PS-341|ps-341
1680907|NCT00083460|Refractory|refractory
1680908|NCT00083460|Bortezomid|bortezomid
1680909|NCT00083447|brain tumor|brain tumor
1680910|NCT00083447|GBM|gbm
1680911|NCT00083447|glioblastoma|glioblastoma
1680912|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
1680913|NCT00083447|brain cancer|brain cancer
1680914|NCT00083447|treatment|treatment
1680915|NCT00083434|Anemia|anemia
1680916|NCT00083434|Cancer|cancer
1680917|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1680918|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
1680919|NCT00006877|large cell lung cancer|large cell lung cancer
1680920|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1680921|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
1680922|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
1680923|NCT00006358|adult glioblastoma|adult glioblastoma
1680924|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
1680925|NCT00006358|adult gliosarcoma|adult gliosarcoma
1680926|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1680927|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1680928|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1680929|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1680930|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1680931|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1680932|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1680933|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1680934|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1680935|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1680936|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1680937|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1680938|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1680939|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1680940|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1680941|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1680942|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1680943|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1680944|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
1680945|NCT00006083|Burkitt lymphoma|burkitt lymphoma
1680946|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1680947|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
1680948|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
1680949|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1680950|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
1680951|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
1680952|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
1680953|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1680954|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1680955|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1680956|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1680957|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1680958|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1680959|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1680960|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1680961|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1680962|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1680963|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1680964|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1680965|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1680966|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1680967|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1680968|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1680969|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1680970|NCT00006083|essential thrombocythemia|essential thrombocythemia
1680971|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
1680972|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1680973|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
1680974|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1680975|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1680976|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1680977|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1683723|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
1680978|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1680979|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1680980|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1694051|NCT00069914|HIV|hiv
1680981|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1680982|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1680983|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1680984|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1680985|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
1680986|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1680987|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1680988|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1680989|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1680990|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1680991|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1680992|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1680993|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1680994|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1680995|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1680996|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1680997|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1680998|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1680999|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681000|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1681001|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1681002|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681003|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1681004|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681005|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681006|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681007|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681008|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681009|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681010|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681011|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681012|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681013|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1681014|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1681015|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1681016|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1681017|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1681018|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1681019|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1681020|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1681021|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1681022|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
1681023|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
1681024|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
1681025|NCT00006083|veno-occlusive disease|veno-occlusive disease
1681026|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1681027|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1681028|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1681029|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1681030|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1681031|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1681032|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1681033|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1681034|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1681035|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1681036|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1681037|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1681038|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1681039|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1681040|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1681041|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1681042|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1681043|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1681044|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1681045|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1681046|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1681047|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681048|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681049|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681050|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1681051|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1681052|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1681053|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1681054|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681055|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681056|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1681057|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1681058|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681059|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681060|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681061|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681062|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1681063|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1681064|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681065|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681066|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681067|NCT00006079|cervical cancer|cervical cancer
1681068|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1683724|NCT00081991|Cataract|cataract
1681069|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1681070|NCT00006079|Eflornithine|eflornithine
1681071|NCT00006001|stage III colon cancer|stage iii colon cancer
1681072|NCT00006001|stage IV colon cancer|stage iv colon cancer
1681073|NCT00006001|stage III rectal cancer|stage iii rectal cancer
1681074|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
1681075|NCT00006001|recurrent colon cancer|recurrent colon cancer
1681076|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
1681077|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
1681078|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1681079|NCT00005939|stage I prostate cancer|stage i prostate cancer
1681080|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
1681081|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
1681082|NCT00005939|stage III prostate cancer|stage iii prostate cancer
1681083|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
1681084|NCT00005841|iris melanoma|iris melanoma
1681085|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1681086|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1681087|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
1681088|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
1681089|NCT00005841|stage III melanoma|stage iii melanoma
1681090|NCT00005841|stage IV melanoma|stage iv melanoma
1681091|NCT00005841|recurrent melanoma|recurrent melanoma
1681092|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681093|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681094|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681095|NCT00005645|liver metastases|liver metastases
1681096|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
1681097|NCT00005645|malignant pleural effusion|malignant pleural effusion
1681098|NCT00005645|malignant ascites|malignant ascites
1681099|NCT00005645|fallopian tube cancer|fallopian tube cancer
1681100|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681101|NCT00005640|stage I colon cancer|stage i colon cancer
1681102|NCT00005640|stage II colon cancer|stage ii colon cancer
1681103|NCT00005640|stage III colon cancer|stage iii colon cancer
1681104|NCT00005640|stage I rectal cancer|stage i rectal cancer
1681105|NCT00005640|stage II rectal cancer|stage ii rectal cancer
1681107|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
1681108|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
1681109|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1681110|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1681111|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1681112|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1681113|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1681114|NCT00005578|cardiac toxicity|cardiac toxicity
1681115|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1681116|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1681117|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1681118|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1681119|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1681120|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1681463|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
1681121|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1681122|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1681123|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
1681124|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
1681125|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1681126|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1681127|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681128|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
1681129|NCT00002917|stage I bladder cancer|stage i bladder cancer
1681130|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1681131|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1681132|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681133|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1681134|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681135|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681136|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681137|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681138|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
1681139|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
1681140|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681141|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681142|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1681143|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1681144|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1681145|NCT00002827|cardiac toxicity|cardiac toxicity
1681146|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681147|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681148|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1681149|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1681150|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1681151|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1681152|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1681153|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1681154|NCT00002819|Brenner tumor|brenner tumor
1681155|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
1681156|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
1681157|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
1681158|NCT00002639|adult glioblastoma|adult glioblastoma
1681159|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1681160|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1681161|NCT00002639|adult mixed glioma|adult mixed glioma
1681162|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
1681163|NCT00002639|adult gliosarcoma|adult gliosarcoma
1681164|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1681165|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
1681166|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
1681167|NCT00002602|stage III prostate cancer|stage iii prostate cancer
1681168|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1681169|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1681170|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1681171|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1681172|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1681173|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1681174|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1681175|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1681176|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1681177|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1681178|NCT00083512|Blood|blood
1681179|NCT00083512|Urine|urine
1681180|NCT00083512|GBM|gbm
1681181|NCT00083512|Radiation|radiation
1681182|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
1681183|NCT00083499|Pental of Cantrell|pental of cantrell
1681184|NCT00083499|TAS Syndrome|tas syndrome
1681185|NCT00083499|Midline Defects|midline defects
1681186|NCT00083499|Contractile Proteins|contractile proteins
1681187|NCT00083499|Herniation|herniation
1681188|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
1681189|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
1681190|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
1681191|NCT00083408|Multiple Myeloma|multiple myeloma
1681192|NCT00083408|Pamidronate|pamidronate
1681193|NCT00083408|Thalidomide|thalidomide
1681194|NCT00083408|refractory myeloma|refractory myeloma
1681195|NCT00083408|bisphosphonates|bisphosphonates
1681196|NCT00083408|Aredia|aredia
1681197|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681198|NCT00004200|adult glioblastoma|adult glioblastoma
1681199|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
1681200|NCT00004200|adult gliosarcoma|adult gliosarcoma
1681201|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
1681202|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
1681203|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1681204|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
1681205|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
1681206|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1681207|NCT00004176|radiation toxicity|radiation toxicity
1681208|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1681209|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
1681210|NCT00004139|large cell lung cancer|large cell lung cancer
1681211|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681212|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1681213|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
1681214|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1681215|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1681216|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1681217|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1681218|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681219|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681220|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1681221|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1681222|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681223|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1681224|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681225|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681226|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1681227|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1681228|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1681229|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1681230|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681231|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681232|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681233|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681234|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681235|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681236|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681237|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1681238|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1681239|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681240|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1681241|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1681242|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681243|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681244|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
1681245|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681246|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681247|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1681248|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681442|NCT00083395|HV|hv
1681443|NCT00083382|Myeloma|myeloma
1681249|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681250|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1681251|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1681252|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1681253|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1681254|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1681255|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1681256|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1681257|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1681258|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681259|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1681260|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1681261|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681262|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1681263|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681264|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681265|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681266|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681267|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681268|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681269|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683725|NCT00081991|Blindness|blindness
1681270|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681271|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681272|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1681273|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1681274|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1681275|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681276|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681277|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681278|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681279|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681280|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681281|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681282|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681283|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681284|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681285|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681286|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681287|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1681288|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1681289|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1681290|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1681291|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681292|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1681293|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1681294|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1681295|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1681296|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1681297|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681298|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1681299|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1681300|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1681301|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1681302|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1681303|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1681304|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1681305|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1681306|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1681307|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681308|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1681309|NCT00004061|oral complications|oral complications
1681310|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1681311|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1681312|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1681444|NCT00083382|Thalidomide|thalidomide
1681313|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1681314|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1681315|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1681316|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1681317|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1681318|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1681319|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681320|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681321|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1681322|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681323|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681324|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1681325|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1681464|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
1681326|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1681327|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1681328|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1681329|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1681330|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1681331|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1681332|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681333|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1681334|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1681335|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681336|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1681337|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681338|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681339|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681340|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681341|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681342|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681343|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681344|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681345|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681346|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1681347|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1681348|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1681349|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1681350|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1681351|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1681352|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1681353|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1681354|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1681355|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1681356|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1681357|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1681358|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1681359|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1681360|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1681361|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1681362|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1681363|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1681364|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1681365|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1681366|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1681367|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1681368|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681369|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681370|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681371|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1681372|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1681373|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681374|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681375|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1681376|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1681377|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681378|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681379|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681380|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681381|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1681382|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1681383|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681384|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681385|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681916|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
1681386|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681387|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681388|NCT00004012|fallopian tube cancer|fallopian tube cancer
1681389|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681390|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
1681391|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681392|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
1681393|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1681394|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1681395|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1681396|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1681397|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681398|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1681399|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681400|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681401|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681402|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1681403|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1681404|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1681405|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1681406|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1681407|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1681408|NCT00003944|fallopian tube cancer|fallopian tube cancer
1681409|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
1681410|NCT00003846|regional neuroblastoma|regional neuroblastoma
1681411|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
1681412|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
1681413|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1681414|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1681415|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1681416|NCT00003752|stage IV breast cancer|stage iv breast cancer
1681417|NCT00003752|recurrent breast cancer|recurrent breast cancer
1681418|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1681419|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1681421|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1681422|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1681423|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1681424|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1681425|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1681426|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1681427|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1681428|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1681429|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1681430|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1681431|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1681432|NCT00003580|radiation toxicity|radiation toxicity
1681433|NCT00083395|ARVC/ARVD|arvc/arvd
1681434|NCT00083395|Genetics|genetics
1681435|NCT00083395|Sudden Death|sudden death
1681436|NCT00083395|Heart|heart
1681437|NCT00083395|MRI|mri
1681438|NCT00083395|Cardiomyopathy|cardiomyopathy
1681439|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
1681440|NCT00083395|ARVC|arvc
1681441|NCT00083395|Healthy Volunteer|healthy volunteer
1681447|NCT00083382|Bisphosphonate|bisphosphonate
1681448|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
1681449|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
1681450|NCT00083382|Zometa|zometa
1681451|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
1681452|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
1681453|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
1681454|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681455|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
1681456|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1681457|NCT00006269|stage IV colon cancer|stage iv colon cancer
1681458|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
1681459|NCT00006269|recurrent colon cancer|recurrent colon cancer
1681460|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
1681461|NCT00006269|diarrhea|diarrhea
1681462|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1681465|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681466|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681467|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1681468|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1681469|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1681470|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1681471|NCT00003444|stage III melanoma|stage iii melanoma
1681472|NCT00003444|stage IV melanoma|stage iv melanoma
1681473|NCT00003444|recurrent melanoma|recurrent melanoma
1681474|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1681475|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1681476|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1681477|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1681478|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1681479|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1681480|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1681481|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1681482|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1681483|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1681484|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1681485|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1681486|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1681487|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1681488|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1681489|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1681490|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681491|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1681492|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1681493|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1681494|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1681495|NCT00003269|stage I breast cancer|stage i breast cancer
1681496|NCT00003269|stage II breast cancer|stage ii breast cancer
1681497|NCT00003269|stage IV breast cancer|stage iv breast cancer
1681498|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
1681499|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1681500|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1681501|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
1681502|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1681503|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1681504|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1681505|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1681506|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1681507|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1681508|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681509|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681510|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1681511|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
1681512|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1681513|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1681514|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681515|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1682365|NCT00002503|bone metastases|bone metastases
1681516|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681517|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1681518|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1681519|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1681520|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1681521|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1681522|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1694053|NCT00069914|HV|hv
1681523|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1681524|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1681525|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1681526|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681527|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681528|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1681589|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1681529|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681530|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681531|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1681532|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1681533|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1681534|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1681535|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1681536|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1681537|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1681538|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1681539|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681540|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1681541|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1681542|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681543|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1681544|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1681545|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1681546|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1681547|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1681548|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1681549|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1681550|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1681551|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1681552|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1681553|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1681554|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1683726|NCT00081991|Clinical|clinical
1681555|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1681556|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1681557|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1681558|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1681559|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1681560|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1681561|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1681562|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1681563|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1681564|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1681565|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1681566|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1681567|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1681568|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1681569|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1681570|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681571|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681572|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1681573|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1681574|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1681575|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1681576|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681577|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681578|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681579|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681580|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1681581|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1681582|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681583|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681584|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681585|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
1681586|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
1681587|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
1681588|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1681590|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1681591|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681592|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1681593|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1681594|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1681595|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1681596|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1681597|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1681598|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1681599|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1681600|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681601|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1681602|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1681603|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1681604|NCT00003187|refractory anemia|refractory anemia
1681605|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1681606|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
1681607|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1681608|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1681609|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
1681610|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681611|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1681612|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1681613|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1681614|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1681615|NCT00003098|breast cancer|breast cancer
1681616|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1681617|NCT00003084|stage I prostate cancer|stage i prostate cancer
1681618|NCT00003084|stage II prostate cancer|stage ii prostate cancer
1681619|NCT00003084|stage III prostate cancer|stage iii prostate cancer
1681620|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
1681621|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
1681622|NCT00003084|Chemotherapy|chemotherapy
1681623|NCT00003084|Ketoconazole|ketoconazole
1681624|NCT00003084|Estramustine|estramustine
1681625|NCT00003084|Etoposide|etoposide
1681626|NCT00003084|Paclitaxel|paclitaxel
1681627|NCT00003084|Doxorubicin|doxorubicin
1681628|NCT00003084|Vinblastine|vinblastine
1681629|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681630|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681631|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681632|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1681633|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1681634|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681635|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681636|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681637|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1681638|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681639|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681640|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681641|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1681642|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681643|NCT00003056|graft versus host disease|graft versus host disease
1681644|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681645|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681646|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681647|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681739|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1681648|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1694520|NCT00068822|RDQ|rdq
1681649|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681650|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681651|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681652|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681653|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1681654|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
1681655|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681847|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
1681656|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1681658|NCT00002780|recurrent breast cancer|recurrent breast cancer
1681659|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
1681660|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1681661|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681662|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
1681663|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1681664|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1681665|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1681666|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681667|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1681668|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1681669|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1681670|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
1681671|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681672|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681673|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681674|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681675|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681676|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681677|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681678|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681679|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681680|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
1681681|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
1681682|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1681683|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1681684|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681685|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681686|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681687|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681688|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681689|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681690|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681691|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681692|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681693|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681694|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681695|NCT00002664|recurrent colon cancer|recurrent colon cancer
1681696|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
1681697|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1681698|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1681699|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1681700|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1681701|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1681702|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1681703|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1681704|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1681705|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1681706|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1681707|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681708|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1681709|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1681710|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1681711|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1681712|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681713|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1698344|NCT00061165|overweight|overweight
1681714|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1681715|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1681716|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1681717|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1681718|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1681719|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1681720|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1681721|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1681722|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1681723|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1681724|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1681725|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1681726|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1681727|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1681728|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1681729|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1681730|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1681731|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1681732|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1681733|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681734|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1681735|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1681736|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1681737|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1681738|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1681740|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1681741|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1681742|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1681743|NCT00002567|bone marrow ablation|bone marrow ablation
1681744|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1681745|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681746|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
1681747|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681748|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681749|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681750|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681751|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681752|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681753|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681754|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681755|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1681756|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681757|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681758|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681759|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681760|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681761|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1681762|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
1681763|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
1681764|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1681765|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681766|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1681767|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1681768|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681769|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1681770|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1681771|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1681772|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1681773|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1682447|NCT00082927|bone metastases|bone metastases
1681774|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1681775|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1681776|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1681777|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1681778|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1681779|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1681848|NCT00003562|large cell lung cancer|large cell lung cancer
1681780|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1681781|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1681782|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1681783|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1681784|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1681785|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
1681786|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1681787|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1681788|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1681789|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1681790|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1681791|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1681792|NCT00083356|Pain|pain
1681793|NCT00083356|Kinins|kinins
1681794|NCT00083356|Inflammation|inflammation
1681795|NCT00083356|Gene Expression|gene expression
1681796|NCT00083356|Oral Surgey|oral surgey
1681797|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
1681798|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
1681799|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
1681800|NCT00083356|Wisdom Teeth|wisdom teeth
1681801|NCT00083356|Third Molar Extraction|third molar extraction
1681802|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
1681803|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
1681804|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
1681805|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1681806|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
1681807|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681808|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681809|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1681810|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1681811|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1681812|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681813|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1681814|NCT00004122|stage I bladder cancer|stage i bladder cancer
1681815|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
1681816|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1681817|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
1681818|NCT00004113|adult glioblastoma|adult glioblastoma
1681819|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1681820|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1681821|NCT00004113|adult mixed glioma|adult mixed glioma
1681822|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
1681823|NCT00004113|adult gliosarcoma|adult gliosarcoma
1681824|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681825|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1681826|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1681827|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1681828|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1681829|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1681830|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1681831|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1681832|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1681833|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1682808|NCT00002893|stage IV colon cancer|stage iv colon cancer
1681834|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1681835|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1681836|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1681837|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1681907|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681838|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1681839|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681840|NCT00003747|stage IV melanoma|stage iv melanoma
1681841|NCT00003747|recurrent melanoma|recurrent melanoma
1681842|NCT00003724|lung metastases|lung metastases
1681843|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681844|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681845|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681846|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1681849|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681850|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1681851|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
1681852|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
1681853|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
1681854|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
1681855|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
1681856|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1681857|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1681858|NCT00003365|colon cancer|colon cancer
1681859|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681860|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681861|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1681862|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1681863|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1681864|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1681865|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1681866|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1681867|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1681868|NCT00003322|Brenner tumor|brenner tumor
1681869|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1681870|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1681871|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1681872|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1681873|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681874|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
1681875|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681876|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681877|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1681878|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681879|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681880|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1681881|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1681882|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1681883|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1681884|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1681885|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681886|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681887|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681888|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681889|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
1681890|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1681891|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1681892|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1681893|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1681894|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1681895|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1681896|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1681897|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1681898|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1681899|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1681900|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1681901|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682102|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1681902|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1681903|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
1681904|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1681905|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1681906|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682448|NCT00082927|pain|pain
1681908|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1681909|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1681910|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1681911|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1681912|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1681913|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1681914|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
1681915|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1681917|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
1681918|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
1681919|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1681920|NCT00002707|stage I breast cancer|stage i breast cancer
1681921|NCT00002707|stage II breast cancer|stage ii breast cancer
1681922|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
1681923|NCT00002692|stage IV colon cancer|stage iv colon cancer
1681924|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
1681925|NCT00002692|recurrent colon cancer|recurrent colon cancer
1681926|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
1681927|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
1681928|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1681929|NCT00002692|liver metastases|liver metastases
1681930|NCT00002673|stage IV breast cancer|stage iv breast cancer
1681931|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
1681932|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
1681933|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1681934|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1681935|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1681936|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1681937|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1681938|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1681939|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1681940|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1681941|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
1681942|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
1681943|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1681944|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
1681945|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
1681946|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
1681947|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1681948|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1681949|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1681950|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1681951|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1681952|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1681953|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1681954|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1681955|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1681956|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1681957|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1681958|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1681959|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1681960|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1681961|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1681962|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1681963|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1681964|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1681965|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
1681966|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
1681967|NCT00002673|testicular teratoma|testicular teratoma
1681968|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
1681969|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1681970|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1682366|NCT00083317|PFC|pfc
1681971|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1681972|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1681973|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1681974|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1681975|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1682906|NCT00082355|Clot|clot
1681976|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1681977|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1681978|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1681979|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1681980|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
1681981|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1681982|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
1681983|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1681984|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
1681985|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1681986|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
1681987|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
1681988|NCT00002673|ovarian teratoma|ovarian teratoma
1681989|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
1681990|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
1681991|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1681992|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1681993|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1681994|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1681995|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1681996|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1681997|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1681998|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1681999|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1682000|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1682001|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1682002|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1682003|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1682004|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1682005|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682006|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682007|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682008|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682009|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682010|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682011|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682012|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1682013|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682014|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682015|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682016|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682017|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682018|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682019|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682020|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682021|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1682022|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1682023|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1682025|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1682026|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1682027|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1682028|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1682029|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1682030|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1682031|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1682032|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1682033|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1682034|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1682035|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1682036|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1682037|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1682038|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682039|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1682040|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1682041|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1682042|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682043|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682044|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1682045|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1682046|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1682047|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1682048|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1682049|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682050|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682051|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1682052|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
1682053|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
1682054|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
1682055|NCT00083330|Healthy|healthy
1682056|NCT00083330|T Cells|t cells
1682057|NCT00083330|Immunity|immunity
1682058|NCT00083330|Healthy Volunteer|healthy volunteer
1682059|NCT00083330|HV|hv
1682060|NCT00083278|Breast Cancer|breast cancer
1682061|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
1682062|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
1682063|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
1682064|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
1682065|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
1682066|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
1682067|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
1682068|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1682069|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1682070|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1682071|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
1682072|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1682073|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1682074|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1682075|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
1682076|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1682077|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1682078|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1682079|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1682080|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
1682081|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1682082|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1682083|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1682084|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1682085|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1682086|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1682087|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1682088|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1682089|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682090|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682091|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682092|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682093|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682094|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682095|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682096|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682097|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682098|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682099|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682100|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682101|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682103|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1682104|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1682105|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682106|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682107|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1682108|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1683531|NCT00003239|DepotCyt|depotcyt
1682109|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1682110|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1682111|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1682112|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1682113|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1682114|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1682115|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1682116|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1682117|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1682118|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1682119|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1682120|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1682121|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1682122|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1682123|NCT00005581|stage II breast cancer|stage ii breast cancer
1682124|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
1682125|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
1682126|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
1682127|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
1682128|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
1682129|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
1682130|NCT00004156|stage I breast cancer|stage i breast cancer
1682131|NCT00004156|stage II breast cancer|stage ii breast cancer
1682132|NCT00004156|stage IV breast cancer|stage iv breast cancer
1682133|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
1682134|NCT00004156|recurrent breast cancer|recurrent breast cancer
1682135|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
1682136|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1682137|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1682138|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1682139|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1682140|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1682141|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
1682142|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
1682143|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1682144|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
1682145|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
1682146|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
1682147|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1682148|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1682149|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1682150|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1682151|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1682152|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1682153|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1682154|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1682155|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1682156|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1682157|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1682158|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1682159|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1682160|NCT00004132|oral complications|oral complications
1682161|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1682162|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1682163|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1682164|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1682165|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1682166|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1682167|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1682168|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1682169|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1682170|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1682171|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1682172|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1682173|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1682174|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1682175|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1682176|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1682177|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1682178|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1682179|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1682180|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1682181|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1682182|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682183|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682184|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682185|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682186|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682187|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682188|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682189|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1682190|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682191|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682192|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682193|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682194|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682195|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682196|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682197|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682198|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1682199|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1682200|NCT00004132|radiation toxicity|radiation toxicity
1682201|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1682202|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1682203|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1682204|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1682205|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1682206|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1682207|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1682208|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1682209|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1682210|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1682211|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1682212|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1682809|NCT00002893|stage III rectal cancer|stage iii rectal cancer
1682213|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1682214|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1682215|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1682216|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1682217|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1682218|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1682219|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1682220|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1682221|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1682222|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1682223|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1682224|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1682225|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682226|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682227|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1682228|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1682229|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1682230|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682231|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682232|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1682233|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1682234|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1682235|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1682236|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1682237|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1682238|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1682239|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1682240|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1682456|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
1682241|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682242|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682243|NCT00004073|adult glioblastoma|adult glioblastoma
1682244|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
1682245|NCT00004073|adult gliosarcoma|adult gliosarcoma
1682246|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1682247|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
1682248|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1682249|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1682250|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1682251|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1682252|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1682253|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1682254|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682255|NCT00004038|stage I breast cancer|stage i breast cancer
1682256|NCT00004038|stage II breast cancer|stage ii breast cancer
1682257|NCT00004038|stage IV breast cancer|stage iv breast cancer
1682258|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
1682259|NCT00004038|recurrent breast cancer|recurrent breast cancer
1682260|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
1682261|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1682262|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
1682263|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1682264|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682265|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682266|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682267|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682268|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682269|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682270|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682271|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682272|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682273|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682274|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682275|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1682276|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682277|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682278|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
1682279|NCT00003876|adult brain stem glioma|adult brain stem glioma
1682280|NCT00003876|adult glioblastoma|adult glioblastoma
1682281|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1682282|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1682283|NCT00003876|adult mixed glioma|adult mixed glioma
1682284|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
1682285|NCT00003876|adult gliosarcoma|adult gliosarcoma
1682286|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1682287|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1682288|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
1682289|NCT00003731|adult mixed glioma|adult mixed glioma
1682290|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1682291|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1682292|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1682293|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682294|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682295|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1682296|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1682297|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
1682298|NCT00003685|large cell lung cancer|large cell lung cancer
1682299|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1682300|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
1682301|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1682302|NCT00003685|fatigue|fatigue
1682303|NCT00003685|nausea and vomiting|nausea and vomiting
1682304|NCT00003685|pain|pain
1682305|NCT00003685|pulmonary complications|pulmonary complications
1682306|NCT00003685|quality of life|quality of life
1682307|NCT00003640|stage II bladder cancer|stage ii bladder cancer
1682810|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
1682308|NCT00003640|stage III bladder cancer|stage iii bladder cancer
1682457|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
1682309|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1682310|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1682311|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1682312|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1682313|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1682314|NCT00003439|stage IV colon cancer|stage iv colon cancer
1682315|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
1682316|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
1682317|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
1682318|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
1682319|NCT00003439|recurrent colon cancer|recurrent colon cancer
1682320|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
1682321|NCT00003439|stage IV anal cancer|stage iv anal cancer
1682322|NCT00003439|recurrent anal cancer|recurrent anal cancer
1682323|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1682324|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1682325|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1682326|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1682327|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
1682328|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1682329|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1682330|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1682331|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
1682332|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
1682333|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
1682334|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1682335|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1682336|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
1682337|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
1682338|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
1682339|NCT00003439|fallopian tube cancer|fallopian tube cancer
1682340|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1682341|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
1682342|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1682343|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1682344|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1682345|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1682346|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1682347|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1682348|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1682349|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1682350|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682351|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
1682352|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
1682353|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1682354|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1682355|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1682356|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1682357|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1682358|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1682359|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1682360|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1682361|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1682362|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1682363|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1682364|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
1682369|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
1682370|NCT00083317|fMRI|fmri
1682371|NCT00083317|Healthy Volunteer|healthy volunteer
1682372|NCT00083317|HV|hv
1682373|NCT00083304|Breast|breast
1682374|NCT00083304|Brain|brain
1682375|NCT00083304|RSR13|rsr13
1682376|NCT00083304|efaproxiral|efaproxiral
1682377|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
1682378|NCT00083304|Brain metastases|brain metastases
1682379|NCT00083304|Metastatic breast cancer|metastatic breast cancer
1682380|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1682381|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1682382|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682383|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1682384|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682385|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682386|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682387|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682388|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682389|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682390|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682391|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682392|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682393|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682394|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682395|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682396|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682397|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682398|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682399|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682400|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682401|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1682402|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1682403|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
1682404|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
1682405|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
1682406|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
1682407|NCT00083213|fallopian tube cancer|fallopian tube cancer
1682811|NCT00002893|recurrent colon cancer|recurrent colon cancer
1682409|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1682410|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1682411|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1682412|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1682413|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
1682414|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
1682415|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1682416|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1682417|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
1682418|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
1682419|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
1682420|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
1682421|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
1682422|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
1682423|NCT00083213|recurrent penile cancer|recurrent penile cancer
1682424|NCT00083213|stage IV penile cancer|stage iv penile cancer
1682425|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1682426|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1682427|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
1682428|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
1682429|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
1682430|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
1682431|NCT00083213|distal urethral cancer|distal urethral cancer
1682432|NCT00083213|proximal urethral cancer|proximal urethral cancer
1682433|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
1682434|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1682435|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1682436|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682437|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682438|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1682439|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1682440|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1694101|NCT00069693|Baroreflex|baroreflex
1682441|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682442|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682443|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1682444|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1682445|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1682446|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
1682449|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
1682450|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
1682451|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
1682452|NCT00082914|recurrent melanoma|recurrent melanoma
1682453|NCT00082914|stage IV melanoma|stage iv melanoma
1682454|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
1682455|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
1682458|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1682459|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1682460|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1682461|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682462|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1682463|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682464|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682465|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682466|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682467|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682468|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682469|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682470|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682471|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682472|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682473|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682474|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682475|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682476|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682477|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682478|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682479|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682480|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1682481|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
1682482|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1682483|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
1682484|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
1682485|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
1682486|NCT00082823|fallopian tube cancer|fallopian tube cancer
1682487|NCT00082823|ovarian sarcoma|ovarian sarcoma
1682488|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1682489|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1682490|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1682491|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1682492|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
1682493|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
1682494|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1682495|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1682496|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
1682497|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
1682498|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
1682499|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
1682500|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
1682501|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
1682502|NCT00082823|recurrent penile cancer|recurrent penile cancer
1682503|NCT00082823|stage IV penile cancer|stage iv penile cancer
1682504|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1682505|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1682506|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
1682507|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
1682508|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
1682509|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
1682510|NCT00082823|distal urethral cancer|distal urethral cancer
1682511|NCT00082823|proximal urethral cancer|proximal urethral cancer
1682512|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
1682513|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1682514|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1682515|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682516|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682517|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1682518|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1682519|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1682520|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682521|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682522|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1682523|NCT00082797|adult glioblastoma|adult glioblastoma
1682524|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
1682525|NCT00082797|adult gliosarcoma|adult gliosarcoma
1682526|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
1682527|NCT00082732|stage I prostate cancer|stage i prostate cancer
1682528|NCT00082732|stage II prostate cancer|stage ii prostate cancer
1682529|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1682530|NCT00082719|stage II bladder cancer|stage ii bladder cancer
1682531|NCT00082719|stage III bladder cancer|stage iii bladder cancer
1682532|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
1682533|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1682534|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1682535|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1682536|NCT00082719|anterior urethral cancer|anterior urethral cancer
1682537|NCT00082719|posterior urethral cancer|posterior urethral cancer
1682538|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1682539|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1682540|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
1682541|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
1682542|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
1682543|NCT00082706|anterior urethral cancer|anterior urethral cancer
1682544|NCT00082706|posterior urethral cancer|posterior urethral cancer
1682545|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1682546|NCT00082706|stage III bladder cancer|stage iii bladder cancer
1682547|NCT00082667|breast cancer in situ|breast cancer in situ
1682548|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1682549|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1682550|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1682551|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1682552|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1682553|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1682554|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1682555|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1682556|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1682557|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1682558|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1682559|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1682560|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1682561|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
1682562|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1682563|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1682564|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1682565|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1682566|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1682567|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1682568|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1682569|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1682570|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1682571|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1682572|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1682573|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1682574|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1682575|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1682576|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1682577|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1682578|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1682579|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1682580|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1682581|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1682582|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1682583|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1682584|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1682585|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1698345|NCT00061165|children|children
1682586|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1682587|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1682588|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1682589|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1682590|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
1682591|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1682592|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1682593|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1682594|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1682595|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
1682596|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
1682597|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1682598|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1682599|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1682600|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
1682601|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
1682602|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1682603|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1682604|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1682605|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1682606|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1682607|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1682608|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1682609|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1682610|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1682611|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1682612|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1682613|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1682614|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
1682615|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1682616|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1682617|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
1682618|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
1682619|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
1682620|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1682621|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1682622|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1682623|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1682624|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1682625|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1682626|NCT00082654|stage IV breast cancer|stage iv breast cancer
1682627|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1682628|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1682629|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1682630|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1682631|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1682632|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1682633|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1682634|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1682635|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1682636|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1682637|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1682638|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1682639|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1682640|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1682641|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1682642|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1682643|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1682644|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1682645|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1682646|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1682647|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1682648|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1682649|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1682650|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1682651|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
1682652|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
1682653|NCT00003186|stage I colon cancer|stage i colon cancer
1682654|NCT00003186|stage II colon cancer|stage ii colon cancer
1682655|NCT00003186|stage III colon cancer|stage iii colon cancer
1682656|NCT00003186|stage IV colon cancer|stage iv colon cancer
1682657|NCT00003186|stage I rectal cancer|stage i rectal cancer
1682658|NCT00003186|stage II rectal cancer|stage ii rectal cancer
1682659|NCT00003186|stage III rectal cancer|stage iii rectal cancer
1682660|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
1682661|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
1682662|NCT00003186|liver metastases|liver metastases
1682663|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1682664|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
1682665|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
1682666|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1682667|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1682668|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
1682669|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
1682670|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
1682671|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1682672|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1682673|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1682674|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
1682675|NCT00003117|large cell lung cancer|large cell lung cancer
1682676|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1682677|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1682678|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
1682679|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1682680|NCT00003095|stage II breast cancer|stage ii breast cancer
1682681|NCT00003095|stage III breast cancer|stage iii breast cancer
1682682|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
1682683|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
1682684|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1682685|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1682686|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1682687|NCT00083291|Dry Eyes|dry eyes
1682688|NCT00083291|Conjunctiva|conjunctiva
1682689|NCT00083291|Infection|infection
1682690|NCT00083291|Antibodies|antibodies
1682691|NCT00083291|Inflammation|inflammation
1682692|NCT00083291|Ocular Surface Disease|ocular surface disease
1682693|NCT00083291|Helicobacter Pylori|helicobacter pylori
1682694|NCT00083265|Adenosine Receptor|adenosine receptor
1682695|NCT00083265|Panic Disorder|panic disorder
1682696|NCT00083265|Polymorphism|polymorphism
1682697|NCT00083265|Challenge Study|challenge study
1682698|NCT00083265|Caffeine|caffeine
1682699|NCT00083265|Healthy Volunteer|healthy volunteer
1682700|NCT00083265|HV|hv
1682701|NCT00083226|doxorubicin|doxorubicin
1682702|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
1682703|NCT00083226|bortezomib|bortezomib
1682704|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
1682705|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1682706|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1682812|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
1682707|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1682708|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1682709|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1682710|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1682711|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1682712|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1682713|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1682714|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1682715|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1682716|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1682717|NCT00083174|breast cancer|breast cancer
1682718|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1682719|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
1682720|NCT00083148|recurrent breast cancer|recurrent breast cancer
1682721|NCT00083148|stage IV breast cancer|stage iv breast cancer
1682722|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
1682723|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
1682724|NCT00083096|adult mixed glioma|adult mixed glioma
1682725|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1682726|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1682727|NCT00083096|adult glioblastoma|adult glioblastoma
1682728|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1682729|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
1682730|NCT00083096|adult subependymoma|adult subependymoma
1682731|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1682732|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
1682733|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
1682734|NCT00083096|adult gliosarcoma|adult gliosarcoma
1682735|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
1682736|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1682737|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1682738|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1682739|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1682740|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1682741|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1682742|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1682743|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1682744|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1682745|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1682746|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1682747|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1682748|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1682749|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1682750|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1682751|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1682752|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1682753|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1682754|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1682755|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1682756|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1682757|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1682758|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1682759|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1682760|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1682761|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1682762|NCT00083044|breast cancer|breast cancer
1682763|NCT00083044|breast cancer in situ|breast cancer in situ
1682764|NCT00083044|stage I breast cancer|stage i breast cancer
1682765|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1682766|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1682767|NCT00083031|recurrent breast cancer|recurrent breast cancer
1682768|NCT00083031|stage IV breast cancer|stage iv breast cancer
1682769|NCT00083018|stage II breast cancer|stage ii breast cancer
1682770|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
1682771|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
1682772|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
1682773|NCT00083018|stage IA breast cancer|stage ia breast cancer
1682774|NCT00083018|stage IB breast cancer|stage ib breast cancer
1682775|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1682776|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
1682777|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
1682778|NCT00082979|breast cancer|breast cancer
1682779|NCT00082628|growth hormone|growth hormone
1682780|NCT00082628|Serostim®|serostim®
1682781|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
1682782|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
1682783|NCT00082628|Treatment Experienced|treatment experienced
1682784|NCT00082602|galantamine|galantamine
1682785|NCT00082602|Alzheimer's disease|alzheimer's disease
1682786|NCT00082615|Movement Disorders|movement disorders
1682787|NCT00082615|Recovery Cycle|recovery cycle
1682788|NCT00082615|Blink Reflex|blink reflex
1682789|NCT00082615|Cervical Dystonia|cervical dystonia
1682790|NCT00082615|Blepharospasm|blepharospasm
1682791|NCT00082615|Dystonia|dystonia
1682792|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
1682793|NCT00082615|Healthy Volunteer|healthy volunteer
1682795|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1682796|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1682797|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1682798|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1682799|NCT00002903|testicular seminoma|testicular seminoma
1682800|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1682801|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
1682802|NCT00002896|stage II rectal cancer|stage ii rectal cancer
1682803|NCT00002896|stage III rectal cancer|stage iii rectal cancer
1682804|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
1682805|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1682806|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
1682807|NCT00002893|stage III colon cancer|stage iii colon cancer
1682813|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
1682814|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1682815|NCT00002892|stage II melanoma|stage ii melanoma
1682816|NCT00002892|stage III melanoma|stage iii melanoma
1682817|NCT00002892|recurrent melanoma|recurrent melanoma
1682818|NCT00082550|Genetics|genetics
1682819|NCT00082550|Serotonin Transporter|serotonin transporter
1682820|NCT00082550|Brain Imaging|brain imaging
1682821|NCT00082550|Neurotransmitter|neurotransmitter
1682823|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1682824|NCT00082550|PET|pet
1682825|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
1682826|NCT00082550|Healthy Volunteer|healthy volunteer
1682827|NCT00082550|HV|hv
1682828|NCT00082498|SCH-D|sch-d
1682829|NCT00082498|Schering D|schering d
1682830|NCT00082498|Treatment Experienced|treatment experienced
1682831|NCT00082498|Entry Inhibitors|entry inhibitors
1682832|NCT00082498|Fusion Inhibitors|fusion inhibitors
1682833|NCT00082498|Vicriviroc|vicriviroc
1682834|NCT00082485|Cocaine Dependence|cocaine dependence
1682835|NCT00082472|NSCLC|nsclc
1682836|NCT00082472|Metastatic|metastatic
1682837|NCT00082472|Unresectable|unresectable
1682838|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
1682839|NCT00082459|Kidney Cancer|kidney cancer
1682840|NCT00082459|Renal|renal
1682841|NCT00082459|Tumor|tumor
1682842|NCT00082459|Immunotherapy|immunotherapy
1682843|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
1682844|NCT00082420|low vitamin A status|low vitamin a status
1682845|NCT00002870|stage IV breast cancer|stage iv breast cancer
1682846|NCT00002870|recurrent breast cancer|recurrent breast cancer
1682847|NCT00002826|stage IV breast cancer|stage iv breast cancer
1682848|NCT00002826|recurrent breast cancer|recurrent breast cancer
1682849|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
1682850|NCT00002803|regional neuroblastoma|regional neuroblastoma
1682851|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
1682852|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1682853|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
1682854|NCT00002802|regional neuroblastoma|regional neuroblastoma
1682855|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
1682856|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
1682857|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1682858|NCT00082446|Smallpox, vaccine|smallpox, vaccine
1682859|NCT00082381|Diabetes|diabetes
1682860|NCT00082381|Insulin glargine|insulin glargine
1682861|NCT00082381|comparator|comparator
1682862|NCT00082381|Amylin|amylin
1682863|NCT00082381|Lilly|lilly
1682864|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1682865|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1682866|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1682867|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1682868|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
1682869|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
1682870|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
1682871|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
1682872|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682873|NCT00002644|breast cancer|breast cancer
1682874|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682875|NCT00082407|diabetes|diabetes
1682876|NCT00082407|exendin|exendin
1682877|NCT00082407|Amylin|amylin
1682878|NCT00082407|Lilly|lilly
1682879|NCT00082407|insulin aspart|insulin aspart
1682880|NCT00082394|safety|safety
1682881|NCT00082394|drug efficacy|drug efficacy
1682882|NCT00082394|TRIZIVIR|trizivir
1682883|NCT00082394|tolerability|tolerability
1682884|NCT00082394|COMBIVIR|combivir
1682885|NCT00082394|HIV|hiv
1682886|NCT00082394|atazanavir|atazanavir
1682887|NCT00082316|Dermal assessment|dermal assessment
1682888|NCT00082316|Pain assessment|pain assessment
1682889|NCT00082316|Diary|diary
1682890|NCT00082316|Analgesics|analgesics
1682891|NCT00082316|Capsaicin|capsaicin
1682892|NCT00082316|Herpes zoster|herpes zoster
1682893|NCT00082316|Neuralgia|neuralgia
1682894|NCT00082316|HIV Infections|hiv infections
1682895|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
1682896|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
1682897|NCT00082316|Diabetes Mellitus|diabetes mellitus
1682898|NCT00082316|Polyneuropathies|polyneuropathies
1682899|NCT00082316|Complementary Therapies|complementary therapies
1682900|NCT00082368|Tariquidar|tariquidar
1682901|NCT00082368|PET|pet
1682902|NCT00082368|Sestamibi|sestamibi
1682903|NCT00082368|Cancer|cancer
1682904|NCT00082355|r-tPA|r-tpa
1682905|NCT00082355|Thrombolysis|thrombolysis
1682907|NCT00082355|Anticoagulation|anticoagulation
1682908|NCT00082355|Fibrinolysis|fibrinolysis
1682909|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
1682910|NCT00082355|DVT|dvt
1682911|NCT00082342|Human Brain|human brain
1682912|NCT00082342|Electrical Stimulation|electrical stimulation
1682913|NCT00082342|Parkinson Disease|parkinson disease
1682914|NCT00082342|PD|pd
1682915|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
1682917|NCT00082329|Mobilization|mobilization
1682918|NCT00082329|Alloreactivity|alloreactivity
1682919|NCT00082329|T Cell Polarization|t cell polarization
1682920|NCT00082329|Dendritic Cells|dendritic cells
1682921|NCT00082329|CXCR4|cxcr4
1682922|NCT00082329|Plerixafor|plerixafor
1682923|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
1682924|NCT00082303|Music Therapy|music therapy
1682925|NCT00082303|Anxiety|anxiety
1682926|NCT00082303|Depression|depression
1682927|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682928|NCT00082290|pain|pain
1682929|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
1682930|NCT00082277|Osteopenia|osteopenia
1682931|NCT00082277|Osteoporosis|osteoporosis
1682932|NCT00082277|risk of fracture|risk of fracture
1682933|NCT00082277|bone loss|bone loss
1682934|NCT00082251|Dyslipidemia|dyslipidemia
1682935|NCT00082251|High Blood Cholesterol|high blood cholesterol
1682936|NCT00082251|Coronary Heart Disease|coronary heart disease
1682937|NCT00082251|Hypertension|hypertension
1682938|NCT00082251|National Cholesterol Education Program|national cholesterol education program
1682939|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
1682940|NCT00082251|Niacin|niacin
1682941|NCT00082251|Simvastatin|simvastatin
1682942|NCT00082251|Diabetes|diabetes
1682943|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
1682944|NCT00082251|Cerebrovascular disease|cerebrovascular disease
1682945|NCT00082251|Stroke|stroke
1682946|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
1682947|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
1682948|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
1682949|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
1682950|NCT00082251|Lipoprotein (a)|lipoprotein (a)
1682951|NCT00082251|Lipoprotein A-I|lipoprotein a-i
1682952|NCT00082251|Total Cholesterol|total cholesterol
1682953|NCT00082251|Triglycerides|triglycerides
1682954|NCT00082225|Hodgkins|hodgkins
1682955|NCT00082225|Non-Hodgkins|non-hodgkins
1682956|NCT00082225|Lymphoma|lymphoma
1682957|NCT00082212|ovarian|ovarian
1682958|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
1682959|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
1682960|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
1682961|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
1682962|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
1682963|NCT00010322|stage IV breast cancer|stage iv breast cancer
1682964|NCT00010322|recurrent breast cancer|recurrent breast cancer
1682965|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
1682966|NCT00008255|small cell lung cancer|small cell lung cancer
1682967|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1682968|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1682969|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1682970|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1682971|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1682972|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1682973|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1682974|NCT00002568|Brenner tumor|brenner tumor
1682975|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1682976|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1682977|NCT00082160|Meditation|meditation
1682978|NCT00082160|Relaxation|relaxation
1682979|NCT00082134|Prostate cancer|prostate cancer
1682980|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
1682981|NCT00082134|HRPC|hrpc
1682982|NCT00082134|Prostate|prostate
1682983|NCT00082134|Docetaxel|docetaxel
1682984|NCT00082134|PSA progression|psa progression
1682985|NCT00082134|PSA progressed|psa progressed
1682986|NCT00082121|cardiac bypass|cardiac bypass
1682988|NCT00082121|complement activation|complement activation
1682989|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1682990|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1682991|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1682992|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1682993|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
1682994|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
1682995|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1682996|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
1682997|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
1682998|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
1682999|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
1683000|NCT00006682|stage IV breast cancer|stage iv breast cancer
1683001|NCT00006682|recurrent breast cancer|recurrent breast cancer
1683002|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683003|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683004|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683005|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683006|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1683007|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1683008|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1683009|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1683010|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683011|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1683012|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1683013|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1683014|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1683015|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1683016|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1683017|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1683018|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1683019|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1683020|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1683021|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1683022|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1683023|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1683024|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1683025|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1683026|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1683027|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1683028|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1683029|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1683030|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
1683031|NCT00006112|stage IV colon cancer|stage iv colon cancer
1683032|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
1683033|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
1683034|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1683035|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
1683036|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1683037|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1683038|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1683039|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1683040|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683041|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1683042|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1683043|NCT00006039|small intestine lymphoma|small intestine lymphoma
1683044|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1683045|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1683046|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1683047|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1683048|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683049|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683050|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1683051|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1683052|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1683053|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1683054|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1683055|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1683056|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1683057|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683058|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1683059|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1683060|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1683061|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1698346|NCT00061165|adolescents|adolescents
1683062|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1683063|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1683064|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684774|NCT00004013|recurrent breast cancer|recurrent breast cancer
1683065|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1683066|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1683067|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1683068|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683069|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
1683070|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
1683071|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
1683072|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
1683073|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1683074|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1683075|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1683076|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1683077|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1683078|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1683079|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1683080|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1683081|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1683082|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1683083|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1683084|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1683085|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1683086|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1683087|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1683088|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1683089|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1683090|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1683091|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1683092|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1683093|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1683094|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1683095|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1683096|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1683097|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1683098|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1683099|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1683100|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1683101|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1683102|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1683103|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1683104|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1683105|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1683106|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1683107|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1683108|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1683109|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683110|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683111|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683112|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683113|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683114|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683115|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683116|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1683117|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1683118|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1683119|NCT00005988|graft versus host disease|graft versus host disease
1683120|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1683121|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1683122|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1683123|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1683124|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1683125|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1683126|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1683127|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1683128|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1683129|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1683130|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1683131|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1683132|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1683133|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1683134|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1683135|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1683136|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1683137|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1683138|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1683139|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1683140|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1683141|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1683142|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1683143|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1683144|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1683145|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1683146|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1683147|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1683148|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
1683149|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1683150|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1683151|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1683152|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1683153|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
1683154|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1683155|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
1683156|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
1683157|NCT00005081|adult glioblastoma|adult glioblastoma
1683158|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1683159|NCT00005081|adult mixed glioma|adult mixed glioma
1683160|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
1683161|NCT00005081|adult gliosarcoma|adult gliosarcoma
1683162|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1683163|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1683164|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1683165|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1683166|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
1683167|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
1683168|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1683169|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
1683170|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1683171|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1683172|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683173|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1683174|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1683175|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1683176|NCT00005021|small intestine lymphoma|small intestine lymphoma
1683177|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683178|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1683179|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1683180|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1683181|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1683182|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1683183|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1683184|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1683185|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1683186|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1683187|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1683188|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1683189|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1683190|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1683191|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1683192|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1683193|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1683194|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1683195|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1683196|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683197|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683198|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683199|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683200|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683201|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683202|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683203|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683204|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683205|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1683206|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1683207|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1683208|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1683209|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1683210|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1683212|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1683213|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1683214|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1683215|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1683216|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1683217|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1683218|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1683219|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1683220|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1683221|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683222|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1683223|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1683224|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1683225|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1683324|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1683226|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1683227|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1683228|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1683229|NCT00004893|stage IV breast cancer|stage iv breast cancer
1683230|NCT00004893|recurrent breast cancer|recurrent breast cancer
1683231|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
1683232|NCT00004892|adult brain stem glioma|adult brain stem glioma
1683233|NCT00004892|adult ependymoma|adult ependymoma
1683234|NCT00004892|adult glioblastoma|adult glioblastoma
1683235|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
1683236|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1683237|NCT00004892|adult mixed glioma|adult mixed glioma
1683238|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
1683239|NCT00004892|adult gliosarcoma|adult gliosarcoma
1683240|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
1683241|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
1683242|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1683243|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
1683244|NCT00004246|Radiation Therapy|radiation therapy
1683246|NCT00004246|Radiotherapy|radiotherapy
1683247|NCT00004246|Fludarabine|fludarabine
1683248|NCT00004246|Fludara|fludara
1683249|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
1683314|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1683250|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1683251|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1683252|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1683253|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1683254|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1683255|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1683757|NCT00005796|adult medulloblastoma|adult medulloblastoma
1683256|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1683257|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1683258|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1683259|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1683260|NCT00004230|pulmonary complications|pulmonary complications
1683261|NCT00004230|stage IV breast cancer|stage iv breast cancer
1683262|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
1683263|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
1683264|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1683265|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683266|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1683267|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
1683268|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1683269|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1683270|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1683271|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1683272|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1683273|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
1683274|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
1683275|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1683276|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
1683277|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
1683278|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
1683279|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1683280|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1683281|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1683282|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1683283|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1683284|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1683285|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1683286|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1683287|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1683288|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1683289|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683290|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1683291|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1683292|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1683293|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1683294|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1683295|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
1683296|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
1683297|NCT00004230|testicular teratoma|testicular teratoma
1683298|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
1683299|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1683300|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1683301|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1683302|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1683303|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1683304|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1683305|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1683306|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1683307|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1683308|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1683309|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1683310|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
1683311|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1683312|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1683313|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
1683315|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
1683316|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
1683317|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
1683318|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
1683319|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1683320|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1683321|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1683322|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1699671|NCT00059670|UES|ues
1683323|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1683325|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1683326|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1683387|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683327|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1683328|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1683329|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1683330|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1683331|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1683332|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1683333|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1683334|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1683335|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1683336|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1683337|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1683338|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1683339|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683340|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683341|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683342|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683343|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683344|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683345|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683346|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683347|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683348|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1683349|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1683350|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1683351|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1683352|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1683353|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1683354|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1683355|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1683356|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1683357|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1683358|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1683359|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1683360|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1683361|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1683362|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1683363|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1683364|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1683365|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1683366|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1683367|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1683368|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1683369|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1683370|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1683371|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1683372|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1683373|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683374|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1683375|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1683376|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1683377|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1683662|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
1683378|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1683379|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1683380|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1683381|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1683382|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699672|NCT00059670|Dysphagia|dysphagia
1683383|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683384|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683385|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683386|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683388|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683389|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683390|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683391|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683392|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1683393|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1683394|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683395|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1683396|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1683397|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1683398|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683399|NCT00003972|stage II breast cancer|stage ii breast cancer
1683400|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
1683401|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
1683402|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
1683403|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1683404|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1683405|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1683406|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1683407|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683408|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1683409|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1683410|NCT00003825|radiation enteritis|radiation enteritis
1683411|NCT00003825|diarrhea|diarrhea
1683412|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683413|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1683414|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
1683415|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683416|NCT00003680|stage III breast cancer|stage iii breast cancer
1683417|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
1683418|NCT00003646|adult solid tumor|adult solid tumor
1683419|NCT00003646|body system/site cancer|body system/site cancer
1683421|NCT00003646|melanoma|melanoma
1683422|NCT00003646|recurrent melanoma|recurrent melanoma
1683423|NCT00003646|skin tumor|skin tumor
1683424|NCT00003646|solid tumor|solid tumor
1683425|NCT00003646|stage III melanoma|stage iii melanoma
1683426|NCT00003646|stage IV melanoma|stage iv melanoma
1683427|NCT00003646|stage, melanoma|stage, melanoma
1683428|NCT00003638|stage IV breast cancer|stage iv breast cancer
1683429|NCT00003638|recurrent breast cancer|recurrent breast cancer
1683430|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1683431|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
1683432|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
1683435|NCT00082147|Fiducial Marker|fiducial marker
1683436|NCT00082147|Prostate Cancer|prostate cancer
1683437|NCT00082108|Registry|registry
1683438|NCT00082108|FSHD|fshd
1683439|NCT00082108|DM|dm
1683440|NCT00082108|Muscular Dystrophy|muscular dystrophy
1683441|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
1683442|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
1683443|NCT00082108|DM1|dm1
1683444|NCT00082108|DM2|dm2
1683445|NCT00082108|FSH|fsh
1683446|NCT00082108|MMD|mmd
1683447|NCT00082095|Metastatic breast cancer|metastatic breast cancer
1683448|NCT00082095|Breast Cancer|breast cancer
1683449|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
1683450|NCT00082095|Capecitabine|capecitabine
1683451|NCT00082095|DOXIL|doxil
1683452|NCT00082095|Xeloda|xeloda
1683453|NCT00082069|Shigella|shigella
1683454|NCT00082069|diarrhea|diarrhea
1683455|NCT00081978|HIV infection|hiv infection
1683456|NCT00081978|TMC125|tmc125
1683457|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
1683458|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
1683459|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1683460|NCT00003583|radiation toxicity|radiation toxicity
1683461|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
1683462|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
1683463|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
1683464|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
1683465|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1683466|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1683758|NCT00005796|adult glioblastoma|adult glioblastoma
1683467|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1683468|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1683469|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1683470|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1683471|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1683472|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1683473|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1683474|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1683475|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1683476|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1683477|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1683478|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1683479|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1683480|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1683481|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1683482|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1683483|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1683484|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1683485|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1683486|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683487|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683488|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683489|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683490|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683491|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683492|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683493|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1683494|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1683495|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1683496|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1683497|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1683498|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1683499|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1683500|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1683501|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1683502|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1683503|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1683504|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1683505|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1683506|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1683507|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1683508|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1683509|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1683510|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1683511|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1683512|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1683513|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1683514|NCT00003394|stage I prostate cancer|stage i prostate cancer
1683515|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
1683516|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
1683517|NCT00003394|stage III prostate cancer|stage iii prostate cancer
1683518|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
1683519|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
1683520|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
1683521|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
1684287|NCT00002866|recurrent breast cancer|recurrent breast cancer
1683522|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683523|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1683524|NCT00003239|Homoharringtonine|homoharringtonine
1683525|NCT00003239|HHT|hht
1683526|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
1683527|NCT00003239|cytarabine|cytarabine
1683528|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
1683529|NCT00003239|Roferon-A|roferon-a
1683530|NCT00003239|Ara-C|ara-c
1683532|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1683533|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
1683534|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
1683535|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
1683763|NCT00005796|adult mixed glioma|adult mixed glioma
1683536|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1683537|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
1683538|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1683539|NCT00003165|stage IV breast cancer|stage iv breast cancer
1683540|NCT00003165|recurrent breast cancer|recurrent breast cancer
1683541|NCT00003133|stage III bladder cancer|stage iii bladder cancer
1683542|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
1683543|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1683544|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1683545|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1683546|NCT00003038|stage IV colon cancer|stage iv colon cancer
1683547|NCT00003038|stage IV breast cancer|stage iv breast cancer
1683548|NCT00003038|recurrent breast cancer|recurrent breast cancer
1683549|NCT00003038|recurrent colon cancer|recurrent colon cancer
1683550|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1683551|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1683552|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
1683553|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
1683554|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683555|NCT00003019|desmoid tumor|desmoid tumor
1683557|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1683558|NCT00081926|RIGHT Trial|right trial
1683559|NCT00081926|US177|us177
1683560|NCT00081926|CSTI571|csti571
1683561|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683562|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
1683563|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
1683564|NCT00006483|lung metastases|lung metastases
1683565|NCT00006261|stage IV breast cancer|stage iv breast cancer
1683566|NCT00006261|recurrent breast cancer|recurrent breast cancer
1683567|NCT00006106|adult solid tumor|adult solid tumor
1683568|NCT00006106|body system/site cancer|body system/site cancer
1683569|NCT00006106|cancer|cancer
1683570|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
1683571|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
1683572|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
1683573|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
1683574|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
1683575|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
1683576|NCT00006106|head and neck cancer|head and neck cancer
1683577|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
1683578|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
1683579|NCT00006106|laryngeal cancer|laryngeal cancer
1683580|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
1683581|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
1683582|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
1683583|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
1683584|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
1683585|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
1683586|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
1683587|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
1683588|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1683589|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
1683590|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1683591|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
1683592|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1683593|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1683594|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1683595|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1683596|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1684288|NCT00002866|neutropenia|neutropenia
1683597|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1683598|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1683599|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1683600|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1683601|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1699860|NCT00059423|HV|hv
1683602|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1683603|NCT00006106|solid tumor|solid tumor
1683604|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1683605|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
1683606|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1683607|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1683608|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1683609|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1683610|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1683611|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1683612|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1683613|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1683614|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1683615|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1683616|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1683617|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
1683618|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1683619|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1683620|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1683621|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1683622|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1683623|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1683624|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1683625|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1683626|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1683627|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1683628|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
1683629|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
1683630|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
1683631|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
1683632|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
1683633|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
1683634|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
1683635|NCT00003001|stage IV colon cancer|stage iv colon cancer
1683636|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
1683637|NCT00003001|recurrent colon cancer|recurrent colon cancer
1683638|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
1683639|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1683640|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1683641|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1683642|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1683643|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1683644|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1683645|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1683646|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1683647|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1683648|NCT00002977|Brenner tumor|brenner tumor
1683649|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683650|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1683651|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1683652|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1683653|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
1683654|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
1683655|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
1683656|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1683657|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1683658|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
1683659|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
1683660|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
1683661|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1683663|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1683664|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1683665|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1683666|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1683667|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1699861|NCT00059397|Hepatitis C|hepatitis c
1683668|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1683669|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1683670|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1683671|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1683672|NCT00002719|neutropenia|neutropenia
1683673|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1683674|NCT00002680|stage IV breast cancer|stage iv breast cancer
1683675|NCT00002680|recurrent breast cancer|recurrent breast cancer
1683676|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1683677|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1683678|NCT00002564|recurrent breast cancer|recurrent breast cancer
1683679|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683680|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683681|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683682|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683683|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683684|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683685|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683686|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683687|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683688|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1683689|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1683690|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683691|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1683692|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1683693|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1683694|NCT00082043|Neurosteroids|neurosteroids
1683695|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
1683696|NCT00082043|Depression|depression
1683697|NCT00082043|Menstrual Cycle|menstrual cycle
1683698|NCT00082043|Gonadal Steroids|gonadal steroids
1683699|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
1683701|NCT00082043|Healthy Volunteer|healthy volunteer
1683702|NCT00082030|Depression|depression
1683703|NCT00082030|PET|pet
1683704|NCT00082030|fMRI|fmri
1683705|NCT00082030|Dopamine|dopamine
1683706|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
1683707|NCT00082030|Emotional Stimuli|emotional stimuli
1683708|NCT00082030|Anhedonia|anhedonia
1683709|NCT00082030|Norepinephrine|norepinephrine
1683710|NCT00082030|Dopamine Depletion|dopamine depletion
1683711|NCT00082030|Major Depressive Disorder|major depressive disorder
1683712|NCT00082030|MDD|mdd
1683713|NCT00082030|Healthy Volunteer|healthy volunteer
1683714|NCT00082030|HV|hv
1683715|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
1683716|NCT00082017|Soluble Tac|soluble tac
1683717|NCT00082017|Gene Expression Profiling|gene expression profiling
1683718|NCT00082017|ALK Expression|alk expression
1683719|NCT00082017|Apoptosis|apoptosis
1683720|NCT00082017|Lymphoma|lymphoma
1683721|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1683722|NCT00082017|ALCL|alcl
1683727|NCT00081991|Human Aging|human aging
1683728|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
1683729|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
1683730|NCT00081991|Early Cataract|early cataract
1683731|NCT00081991|Lens|lens
1683732|NCT00081991|AREDS Grading|areds grading
1683733|NCT00081991|In Vivo|in vivo
1683734|NCT00081991|Healthy Volunteer|healthy volunteer
1683735|NCT00081965|breast cancer in situ|breast cancer in situ
1683736|NCT00081965|stage I breast cancer|stage i breast cancer
1683737|NCT00081965|stage II breast cancer|stage ii breast cancer
1683738|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
1683739|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
1683740|NCT00081965|stage IV breast cancer|stage iv breast cancer
1683741|NCT00081965|recurrent breast cancer|recurrent breast cancer
1683742|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
1683743|NCT00081965|hot flashes|hot flashes
1683744|NCT00081952|Postmenopause|postmenopause
1683745|NCT00081913|Apheresis|apheresis
1683746|NCT00081913|Cell Transfer|cell transfer
1683747|NCT00081913|Chest Pain|chest pain
1683748|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
1683749|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1683750|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683751|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1683752|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
1683753|NCT00005883|small cell lung cancer|small cell lung cancer
1683754|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
1683755|NCT00005796|adult brain stem glioma|adult brain stem glioma
1683756|NCT00005796|adult ependymoma|adult ependymoma
1700232|NCT00058890|pruritus|pruritus
1683759|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1683760|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
1683761|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1683762|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1683764|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1683765|NCT00005796|bone marrow suppression|bone marrow suppression
1683766|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1683767|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1683768|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1683769|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1683770|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1683771|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1683772|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1683773|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
1683774|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
1683775|NCT00005796|adult gliosarcoma|adult gliosarcoma
1683776|NCT00005649|stage IV breast cancer|stage iv breast cancer
1683777|NCT00005649|recurrent breast cancer|recurrent breast cancer
1683778|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1683779|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683780|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1683781|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683782|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
1683783|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
1683784|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
1683785|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
1683786|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683787|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1683788|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1683789|NCT00004878|graft versus host disease|graft versus host disease
1683790|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1683791|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1683792|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1683793|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1683794|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683795|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683796|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683797|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683798|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683799|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683800|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683801|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683802|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683803|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1683804|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1683805|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1683806|NCT00004604|stage IV colon cancer|stage iv colon cancer
1683807|NCT00004604|stage IV breast cancer|stage iv breast cancer
1683808|NCT00004604|recurrent breast cancer|recurrent breast cancer
1683809|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
1683810|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
1683811|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1683812|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
1683813|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
1683814|NCT00004604|recurrent colon cancer|recurrent colon cancer
1683815|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
1683816|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
1683817|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1683818|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1683819|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1695629|NCT00066885|Lung Cancer|lung cancer
1683820|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
1683821|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
1683822|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
1683823|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1683824|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1683825|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1683826|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1683827|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1683828|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1683829|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
1683830|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
1684230|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
1683831|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
1683832|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1683833|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
1683834|NCT00004604|lung metastases|lung metastases
1683835|NCT00004604|liver metastases|liver metastases
1683836|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1683837|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1683838|NCT00004604|male breast cancer|male breast cancer
1683839|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
1683840|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
1683841|NCT00004174|stage IV breast cancer|stage iv breast cancer
1683842|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
1683843|NCT00004174|recurrent breast cancer|recurrent breast cancer
1683844|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
1683845|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
1683846|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683847|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1683848|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1683849|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
1683850|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1683851|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
1683852|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1683853|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1683854|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1683855|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1683856|NCT00003953|stage II breast cancer|stage ii breast cancer
1683857|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
1683858|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
1683859|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1683860|NCT00081887|CLL|cll
1683861|NCT00081887|Leukemia|leukemia
1683862|NCT00081887|Clofarabine|clofarabine
1683863|NCT00081887|Clofarex|clofarex
1683864|NCT00081887|Clolar|clolar
1683865|NCT00081874|Leukemia|leukemia
1683866|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
1683867|NCT00081874|Myelofibrosis|myelofibrosis
1683868|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
1683869|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1683870|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
1683871|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
1683872|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1683873|NCT00081874|T-Cell Leukemia|t-cell leukemia
1683874|NCT00081874|RAD001|rad001
1683875|NCT00081874|Everolimus|everolimus
1683876|NCT00081874|Afinitor|afinitor
1683877|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1683878|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
1683879|NCT00081861|Lymphoma|lymphoma
1683880|NCT00081861|Avastin|avastin
1683881|NCT00081861|Bevacizumab|bevacizumab
1683882|NCT00081861|Rituximab|rituximab
1683883|NCT00081861|Rituxan|rituxan
1683884|NCT00003950|stage IV colon cancer|stage iv colon cancer
1683885|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
1683886|NCT00003950|recurrent colon cancer|recurrent colon cancer
1683887|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
1683888|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
1683889|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1683890|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
1683891|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
1683892|NCT00003887|stage IV breast cancer|stage iv breast cancer
1683893|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
1683894|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
1683895|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1683896|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1683897|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1683898|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
1695630|NCT00066885|NSCLC|nsclc
1683899|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1683900|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1683901|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1683902|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1683903|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1683904|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
1683905|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
1684298|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
1683906|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1683907|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
1683908|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
1683909|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
1684231|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
1683910|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1683911|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1683912|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1683913|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1683914|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1683915|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1683916|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1683917|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1683918|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1683919|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1683920|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1683921|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1683922|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1683923|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1683924|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1683925|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1683926|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
1683927|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
1683929|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
1683930|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1683931|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1683932|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1683933|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1683934|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1683935|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1683936|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1683937|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1683938|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1683939|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1683940|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1683941|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
1683942|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1683943|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1683944|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
1683945|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1683946|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
1683947|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
1683948|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
1683949|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
1683950|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1683951|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1683952|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1683953|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1683954|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1683955|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1683956|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1683957|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1683958|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1683959|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1683960|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1683961|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1683962|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1683963|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1683964|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1683965|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1683966|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1683967|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1683968|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1683969|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1683970|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1683971|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1683972|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1683973|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1683974|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1683975|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1683976|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1683977|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1683978|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1683979|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1683980|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1683981|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1683982|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1683983|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1683984|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1683985|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1683986|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1683987|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1683988|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1683989|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1683990|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1683991|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1683992|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1683993|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1683994|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1683995|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1683996|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1683997|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1683998|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1683999|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684000|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1684001|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1684002|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1684003|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1684004|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1684005|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684006|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1684007|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1684008|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1684009|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1684010|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684011|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684012|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684013|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1684014|NCT00003819|stage I prostate cancer|stage i prostate cancer
1684015|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
1684016|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
1684017|NCT00003819|stage III prostate cancer|stage iii prostate cancer
1684018|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
1684019|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1684020|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1684021|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1684022|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1684023|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
1684024|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1684025|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
1684026|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
1684311|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
1684027|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1684028|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1684029|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1684030|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1684031|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1684299|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
1684032|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1684033|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
1684034|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684035|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684036|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684037|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684038|NCT00003619|polycythemia vera|polycythemia vera
1684039|NCT00003619|primary myelofibrosis|primary myelofibrosis
1684040|NCT00003619|refractory anemia|refractory anemia
1684041|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1684042|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
1684043|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1684044|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1684045|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1684046|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684047|NCT00003619|thrombocytopenia|thrombocytopenia
1684048|NCT00003544|stage IV colon cancer|stage iv colon cancer
1684049|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
1684050|NCT00003544|recurrent colon cancer|recurrent colon cancer
1684051|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
1684052|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
1684053|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
1684054|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
1684055|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1684056|NCT00003427|stage IV colon cancer|stage iv colon cancer
1684057|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
1684058|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
1684059|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
1684060|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
1684061|NCT00003427|recurrent colon cancer|recurrent colon cancer
1684062|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
1684063|NCT00003427|stage IV anal cancer|stage iv anal cancer
1684064|NCT00003427|recurrent anal cancer|recurrent anal cancer
1684065|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
1684066|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
1684067|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1684068|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1684069|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
1684070|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1684071|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
1684072|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
1684073|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1684074|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1684075|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
1684076|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
1684077|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684078|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684079|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1684080|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1684081|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1684082|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684083|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684084|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1684085|NCT00003407|neutropenia|neutropenia
1684086|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1684087|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1684088|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684089|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684090|NCT00003398|Burkitt lymphoma|burkitt lymphoma
1684091|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
1684092|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1684093|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
1684094|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
1684095|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
1684096|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1684097|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1684098|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1695631|NCT00066885|Taxotere|taxotere
1684099|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1684100|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1684101|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1684102|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1684103|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1700233|NCT00058890|cholestasis|cholestasis
1684104|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1684105|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684106|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684107|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684108|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1684109|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1684110|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1684111|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1684112|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1684113|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684114|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1684115|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1684116|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1684117|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1684118|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1684119|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1684120|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1684121|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1684122|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1684123|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1684124|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
1684125|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1684126|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1684127|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1684128|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1684129|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1684130|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1684131|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1684132|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1684133|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1684134|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1684135|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1684136|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1684137|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1684138|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1684139|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1684140|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1684141|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1684142|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1684143|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1684144|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1684145|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1684146|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1684147|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1684148|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1684149|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1684150|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1684151|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1684152|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1684153|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1684154|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1684155|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1684156|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1684157|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1684158|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1684159|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1684160|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1684161|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1684162|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684163|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684164|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684165|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684166|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684167|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1684168|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684169|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1684170|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684172|NCT00003398|graft versus host disease|graft versus host disease
1684173|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1684174|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1684175|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1684176|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1684177|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1684178|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1684179|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1684180|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1684181|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1684182|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1684183|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1684184|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1684185|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1684186|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1684187|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1684188|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1684189|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1684190|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1684191|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1684192|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1684193|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1684194|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1684195|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1684196|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1684197|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1684198|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1684199|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1684200|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1684201|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1684202|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1684203|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1684204|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1684205|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1684206|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1684207|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1684208|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684209|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1684210|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1684211|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1684212|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684213|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1684214|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1684215|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1684216|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1684217|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1684218|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1684219|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1684220|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1684289|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684221|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684222|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684223|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684224|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1684225|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684226|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684228|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
1684229|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
1684232|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1684233|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684234|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684235|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684236|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684237|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1684238|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1684239|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1684240|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1684241|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684242|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1684243|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1684244|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1684245|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1684246|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1684247|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1684248|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684249|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684250|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1684251|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684252|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684253|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684254|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684255|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684256|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1684257|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1684258|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684259|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1684260|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684261|NCT00003270|graft versus host disease|graft versus host disease
1684262|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1684263|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1684264|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684265|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1684266|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684267|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684268|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684269|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684270|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1684271|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1684272|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1684273|NCT00003094|cervical cancer|cervical cancer
1684274|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1684275|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1684276|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1684277|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1684278|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
1684279|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1684280|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
1684281|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1684282|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1684283|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1684284|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
1684285|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1684286|NCT00002866|stage IV breast cancer|stage iv breast cancer
1684290|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684291|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1684292|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1684293|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1684294|NCT00006357|adult angiosarcoma|adult angiosarcoma
1684295|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
1684296|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
1684297|NCT00006357|adult liposarcoma|adult liposarcoma
1684300|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1684301|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1684302|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1684303|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
1684304|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1684305|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1684306|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
1684307|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1684308|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
1684309|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
1684310|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
1684312|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
1684313|NCT00006357|ovarian sarcoma|ovarian sarcoma
1684314|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1684315|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1684316|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1684317|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
1684318|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
1684319|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1684320|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1684321|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1684322|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1684323|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1684324|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1684325|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
1684326|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1684327|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1684328|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1684329|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1684330|NCT00005842|stage III colon cancer|stage iii colon cancer
1684331|NCT00005842|stage IV colon cancer|stage iv colon cancer
1684332|NCT00005842|stage IV breast cancer|stage iv breast cancer
1684333|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
1684334|NCT00005842|recurrent breast cancer|recurrent breast cancer
1684335|NCT00005842|stage III gastric cancer|stage iii gastric cancer
1684336|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
1684337|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
1684338|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
1684339|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
1684340|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1684341|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
1684342|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
1684343|NCT00005842|stage III rectal cancer|stage iii rectal cancer
1684344|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
1684345|NCT00005842|recurrent colon cancer|recurrent colon cancer
1684346|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
1684347|NCT00005842|stage IV anal cancer|stage iv anal cancer
1684348|NCT00005842|recurrent anal cancer|recurrent anal cancer
1684349|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
1684350|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
1684351|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
1684352|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
1684353|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
1684354|NCT00005842|stage III cervical cancer|stage iii cervical cancer
1684355|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
1684356|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
1684357|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
1684358|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
1684359|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
1684360|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
1684361|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
1684362|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
1684363|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
1684364|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
1684365|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
1684366|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
1684367|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
1684368|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
1684369|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
1684370|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
1684371|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1684372|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1684373|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1684374|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
1684375|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1684376|NCT00005842|gastrinoma|gastrinoma
1684377|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
1684378|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1684379|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1684380|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
1684381|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
1684382|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
1684383|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1684384|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1684385|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
1684386|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
1684387|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1684388|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1684389|NCT00005842|stage III bladder cancer|stage iii bladder cancer
1684390|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
1684391|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
1684392|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1684393|NCT00005842|stage III prostate cancer|stage iii prostate cancer
1684394|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
1684395|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
1684396|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1684397|NCT00005842|insulinoma|insulinoma
1684398|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1684399|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1684400|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1684401|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1684402|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
1684403|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
1684404|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1684405|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1684406|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1684407|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
1684408|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
1684409|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
1684410|NCT00005842|WDHA syndrome|wdha syndrome
1684411|NCT00005842|somatostatinoma|somatostatinoma
1684412|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1684413|NCT00005842|glucagonoma|glucagonoma
1684414|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1684415|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1684416|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
1684417|NCT00005842|distal urethral cancer|distal urethral cancer
1684418|NCT00005842|proximal urethral cancer|proximal urethral cancer
1684419|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1684420|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1684421|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1684422|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1684423|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1684424|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1684425|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1684426|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1684427|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1684428|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
1684429|NCT00005842|lung metastases|lung metastases
1684430|NCT00005842|liver metastases|liver metastases
1684431|NCT00005842|bone metastases|bone metastases
1684432|NCT00005842|skin metastases|skin metastases
1684433|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
1684434|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
1684435|NCT00005842|malignant pleural effusion|malignant pleural effusion
1684436|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1684437|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1684438|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
1684439|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1684568|NCT00002466|localized osteosarcoma|localized osteosarcoma
1684440|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1684441|NCT00005842|male breast cancer|male breast cancer
1684442|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
1684443|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
1684444|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
1684445|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1684446|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1684447|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
1684448|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
1684449|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1684849|NCT00002889|stage II prostate cancer|stage ii prostate cancer
1684450|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684451|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684452|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1684453|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1684454|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1684455|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684456|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684457|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684458|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684459|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1684460|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1684461|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684462|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1684463|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1684464|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1684465|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1684466|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1684467|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1684468|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1684469|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1684470|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1684471|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1684472|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
1684473|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684474|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684475|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1684476|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684477|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684478|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684479|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684480|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684481|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1684482|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1684483|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1684484|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1684485|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1684486|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684487|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1684488|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684489|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684490|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684491|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684492|NCT00002485|localized osteosarcoma|localized osteosarcoma
1684493|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
1684494|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684495|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1684496|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1684497|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1684498|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
1684499|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
1684500|NCT00002485|regional neuroblastoma|regional neuroblastoma
1684501|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
1684502|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
1684503|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
1684504|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
1684505|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
1684506|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
1684507|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
1684508|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
1684509|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
1684510|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1684511|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1684512|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1684513|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1700304|NCT00058721|Dopamine|dopamine
1684514|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1685067|NCT00081380|Manic Depressive Disorder|manic depressive disorder
1684515|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1684516|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684517|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
1684518|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1684519|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
1684520|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1684521|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1684522|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1684523|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1684524|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1684525|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1684526|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1684527|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1684528|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1684529|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1684530|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1684531|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1684532|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
1684533|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1684534|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
1684535|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
1684536|NCT00002485|childhood meningioma|childhood meningioma
1684537|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1684538|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1684539|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1684540|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1684541|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1684542|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1684543|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1684544|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1684545|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1684546|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1684547|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1684548|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1684549|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1684550|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1684551|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1684552|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1684553|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1684554|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1684555|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1684556|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1684557|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1684558|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1684559|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1684560|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1684561|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
1684562|NCT00002485|childhood teratoma|childhood teratoma
1684563|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1684564|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1684565|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1684566|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1684567|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1696480|NCT00065182|NSCLC|nsclc
1684569|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
1684570|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1684571|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
1684572|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
1684573|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1684574|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1684575|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1684850|NCT00002889|stage III prostate cancer|stage iii prostate cancer
1684576|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1684644|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684577|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1684578|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1684579|NCT00002466|Askin tumor|askin tumor
1684580|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
1684581|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684582|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
1684583|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1684584|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684585|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684586|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684587|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684588|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1684589|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
1684590|NCT00002456|graft versus host disease|graft versus host disease
1684591|NCT00081822|Foran|foran
1684592|NCT00081822|clofarabine|clofarabine
1684593|NCT00081822|cytosine arabinoside|cytosine arabinoside
1684594|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
1684595|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1684596|NCT00081809|Brill-Symmers Disease|brill-symmers disease
1684597|NCT00081809|Follicular Lymphoma|follicular lymphoma
1684598|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
1684599|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
1684600|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
1684601|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
1684602|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
1684603|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
1684604|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
1684605|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
1684606|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
1684607|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
1684608|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
1684609|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
1684610|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
1684611|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
1684612|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
1684613|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
1684614|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
1684615|NCT00081809|MALT Lymphoma|malt lymphoma
1684616|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
1684617|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
1684618|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
1684619|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
1684620|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
1684621|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1684622|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1684623|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684624|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684625|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1684626|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1684627|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1684628|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
1684629|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
1684630|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1684631|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1684632|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1684633|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1684634|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1684635|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684636|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684637|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684638|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684639|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1684640|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1684641|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1700305|NCT00058721|Lewy Body|lewy body
1684642|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1684643|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1684773|NCT00004013|stage IV breast cancer|stage iv breast cancer
1684645|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1684646|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
1684647|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
1684648|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1684649|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1684650|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1684651|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1684652|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1684653|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1684654|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1684655|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1684656|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1684657|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
1684658|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
1684659|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
1684660|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
1684661|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1684662|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1684663|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1684664|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1684665|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1684666|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
1684667|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
1684668|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
1684669|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
1684670|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
1684671|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
1684672|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
1684673|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
1684674|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1684675|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1684676|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1684677|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1684678|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1684679|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1684680|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1684681|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
1684682|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1684683|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1684684|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1684685|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1684686|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1684687|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1684688|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1684689|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1684690|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1684691|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1684692|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1684693|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
1684694|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1684695|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
1684696|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1684697|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1684698|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1684699|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1684700|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1684701|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1684702|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1684703|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1684704|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1684705|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1684706|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1684707|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1684708|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1684709|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1684710|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1684711|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684712|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1684713|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684714|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684715|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684716|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684717|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684718|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1684719|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1684720|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1684721|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1684722|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684723|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1684724|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1684725|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684726|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
1684727|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1684728|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1684729|NCT00005092|intraocular lymphoma|intraocular lymphoma
1684730|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1684731|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1684732|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1684733|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
1684734|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1684735|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1684736|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684737|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1684738|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1684739|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1684740|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1684741|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1684742|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1684743|NCT00005082|adult medulloblastoma|adult medulloblastoma
1684744|NCT00005082|adult glioblastoma|adult glioblastoma
1684745|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1684746|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1684747|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
1684748|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1684749|NCT00005082|adult mixed glioma|adult mixed glioma
1684750|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1684751|NCT00005082|adult subependymoma|adult subependymoma
1684752|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
1684753|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
1684754|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
1684755|NCT00005082|adult gliosarcoma|adult gliosarcoma
1684756|NCT00005023|stage IV breast cancer|stage iv breast cancer
1684757|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
1684758|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1684759|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
1684760|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1684761|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1684762|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696481|NCT00065156|MDS|mds
1684763|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
1684764|NCT00004870|stage IV colon cancer|stage iv colon cancer
1684765|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
1684766|NCT00004870|recurrent colon cancer|recurrent colon cancer
1684767|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
1684768|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
1700886|NCT00056628|Dementia|dementia
1684769|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1684770|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
1684771|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
1684772|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1684775|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1684776|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1684777|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1684778|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1684779|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1684780|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1684781|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1684782|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1684783|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684784|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1684785|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684786|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1684787|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1684788|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684789|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684790|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684791|NCT00003715|stage III melanoma|stage iii melanoma
1684792|NCT00003701|stage III bladder cancer|stage iii bladder cancer
1684898|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
1684793|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1684794|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1684795|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1684796|NCT00003445|stage III cervical cancer|stage iii cervical cancer
1684797|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
1684798|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
1684799|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1684800|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1684801|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1684802|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684803|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
1684804|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
1684805|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
1684806|NCT00003076|esophageal cancer|esophageal cancer
1684807|NCT00003041|recurrent breast cancer|recurrent breast cancer
1684808|NCT00081848|Colon Cancer|colon cancer
1684809|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
1684810|NCT00081848|Cytokines|cytokines
1684811|NCT00081848|Immunotherapy|immunotherapy
1684812|NCT00081848|Cancer|cancer
1684813|NCT00081848|Solid Tumor|solid tumor
1684814|NCT00081848|Liver Metastasis|liver metastasis
1684815|NCT00081835|Smallpox|smallpox
1684816|NCT00081835|Cowpox|cowpox
1684817|NCT00081835|Corneal Ulcer|corneal ulcer
1684818|NCT00081835|Keratitis|keratitis
1684819|NCT00081835|Immune Response, Vaccine|immune response, vaccine
1684820|NCT00081835|Cornea|cornea
1684821|NCT00081835|Vaccinia|vaccinia
1684822|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
1684823|NCT00081835|Conjunctivitis|conjunctivitis
1684824|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
1684825|NCT00081835|Smallpox Vaccination|smallpox vaccination
1684826|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
1684827|NCT00081783|T Cells|t cells
1684828|NCT00081783|Immunotherapy|immunotherapy
1684829|NCT00081783|NHL|nhl
1684830|NCT00081783|Xcellerated T Cells|xcellerated t cells
1684831|NCT00081757|Advanced|advanced
1684832|NCT00081757|Refractory|refractory
1684833|NCT00081757|Plasmacytoma|plasmacytoma
1684834|NCT00081757|Myeloma Proteins|myeloma proteins
1684835|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1684836|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1684837|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
1684838|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
1684839|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1684840|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
1684841|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
1696482|NCT00065156|CC-5013|cc-5013
1684842|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1684843|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
1684844|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1684845|NCT00002952|stage IV melanoma|stage iv melanoma
1684846|NCT00002952|recurrent melanoma|recurrent melanoma
1684847|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1684848|NCT00002889|stage I prostate cancer|stage i prostate cancer
1700993|NCT00056355|Pheresis|pheresis
1684851|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
1684852|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684853|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
1684854|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684855|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684856|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1684857|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684858|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684859|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684860|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1684861|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684862|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684863|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684864|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684865|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684866|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1684867|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1684868|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684869|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1684870|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684871|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684872|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684873|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684874|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1684875|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1684876|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1684877|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
1684878|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1684879|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1684880|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1684881|NCT00002800|neutropenia|neutropenia
1684882|NCT00002772|stage II breast cancer|stage ii breast cancer
1684883|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
1684884|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1684885|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1684886|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1684887|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1684888|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1684889|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1684890|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1684891|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1684892|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1684893|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1684894|NCT00002764|adult angiosarcoma|adult angiosarcoma
1684895|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
1684896|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
1684897|NCT00002764|adult liposarcoma|adult liposarcoma
1684899|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
1684900|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1684901|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1684902|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1684903|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
1684904|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
1684905|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
1684906|NCT00002764|lung metastases|lung metastases
1684907|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
1684908|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
1684909|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
1684910|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
1684911|NCT00002764|ovarian sarcoma|ovarian sarcoma
1684912|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1684913|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1684914|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1684915|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684916|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684917|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684918|NCT00002722|stage III gastric cancer|stage iii gastric cancer
1684919|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
1684920|NCT00002595|desmoid tumor|desmoid tumor
1685062|NCT00081588|HIV infections|hiv infections
1684921|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1684922|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1684923|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1684924|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1684925|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1684926|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1684927|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1684928|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1684929|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1684930|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1684931|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
1684932|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1684933|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1684934|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1684935|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1684936|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684937|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684938|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1684939|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1684940|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1684941|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1684942|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1684943|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1684944|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1684945|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1684946|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1684947|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1684948|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1684949|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1684950|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1684951|NCT00081744|Bacterial Infections|bacterial infections
1684952|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1684953|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1684954|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1684955|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1684956|NCT00019344|small intestine lymphoma|small intestine lymphoma
1684957|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
1684958|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
1684959|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1684960|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1684961|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1684962|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1684963|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1684964|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1684965|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1684966|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1684967|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1684968|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1684969|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1684970|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1684971|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1684972|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1684973|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1684974|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1684975|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1684976|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1684977|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1684978|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1684979|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1684980|NCT00019344|intraocular lymphoma|intraocular lymphoma
1684981|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1684982|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1684983|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1684984|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1685063|NCT00081588|TMC114-C202|tmc114-c202
1684985|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1684986|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1684987|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685068|NCT00081380|Manic Depression, Mixed|manic depression, mixed
1684988|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1684989|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1684990|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1684991|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1684992|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1684993|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1684994|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
1684995|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1684996|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1684997|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
1684998|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
1684999|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
1685000|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1685001|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1685002|NCT00010010|stage IV breast cancer|stage iv breast cancer
1685003|NCT00010010|recurrent breast cancer|recurrent breast cancer
1685004|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685005|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
1685006|NCT00081549|Pancreatic Cancer|pancreatic cancer
1685007|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
1685009|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
1685010|NCT00081549|Pancreatic Tumor|pancreatic tumor
1685011|NCT00081549|Pancreas Tumor|pancreas tumor
1685012|NCT00081549|Unresectable|unresectable
1685013|NCT00081549|Metastatic|metastatic
1685014|NCT00081549|Refractory|refractory
1685015|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
1685016|NCT00081536|Colorectal Cancer|colorectal cancer
1685017|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
1685018|NCT00081536|Colorectal Tumor|colorectal tumor
1685019|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
1685020|NCT00081536|Unresectable|unresectable
1685021|NCT00081536|Metastatic|metastatic
1685022|NCT00081536|Refractory|refractory
1685023|NCT00012129|stage IV breast cancer|stage iv breast cancer
1685024|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
1685025|NCT00012129|recurrent breast cancer|recurrent breast cancer
1685026|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
1685027|NCT00012129|male breast cancer|male breast cancer
1685028|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685029|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685030|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685031|NCT00005958|stage III bladder cancer|stage iii bladder cancer
1685032|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
1685033|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
1685034|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1685035|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1685036|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1685037|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1685038|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
1685039|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
1685040|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
1685041|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1685042|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1685043|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1685044|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
1685045|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1685046|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1685047|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1685048|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
1685049|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
1685050|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685051|NCT00005827|stage II prostate cancer|stage ii prostate cancer
1685052|NCT00005827|stage III prostate cancer|stage iii prostate cancer
1685053|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
1685054|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
1685055|NCT00081640|HIV Seronegativity|hiv seronegativity
1685056|NCT00081640|Vaginal Microbicide|vaginal microbicide
1685057|NCT00081601|prostate cancer|prostate cancer
1685058|NCT00081601|prostate specific antigen|prostate specific antigen
1685059|NCT00081601|PSA|psa
1685060|NCT00081588|TMC114-C215|tmc114-c215
1685061|NCT00081588|Ritonavir|ritonavir
1685065|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
1685066|NCT00081380|Bipolar I Disorder|bipolar i disorder
1685069|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685070|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
1685071|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
1685072|NCT00005809|colon cancer|colon cancer
1685073|NCT00005809|rectal cancer|rectal cancer
1685074|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
1685075|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
1685076|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
1685077|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
1685078|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
1685079|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
1685080|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
1685081|NCT00005608|stage IV breast cancer|stage iv breast cancer
1685082|NCT00005608|recurrent breast cancer|recurrent breast cancer
1685083|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1685084|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1685085|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
1685086|NCT00004252|stage IV colon cancer|stage iv colon cancer
1685087|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
1685088|NCT00004252|recurrent colon cancer|recurrent colon cancer
1685089|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
1685090|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
1685091|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685092|NCT00004178|stage III colon cancer|stage iii colon cancer
1685093|NCT00004178|stage IV colon cancer|stage iv colon cancer
1685094|NCT00004178|stage III gastric cancer|stage iii gastric cancer
1685095|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
1685096|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
1685097|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685098|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
1685099|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
1685100|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
1685101|NCT00004178|stage III rectal cancer|stage iii rectal cancer
1685102|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
1685103|NCT00004178|recurrent colon cancer|recurrent colon cancer
1685104|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
1685105|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
1685106|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
1685107|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
1685108|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
1685109|NCT00004178|stage III cervical cancer|stage iii cervical cancer
1685110|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
1685111|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
1685112|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
1685113|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685114|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
1685115|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
1685116|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
1685117|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685118|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685119|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685120|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1685121|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1685122|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
1685123|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
1685124|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
1685125|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
1685126|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
1685127|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1685128|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
1685129|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1685130|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
1685131|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1685132|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1685133|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
1685134|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
1696483|NCT00065156|Revlimid|revlimid
1685135|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
1685136|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1685137|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1685138|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
1685139|NCT00004178|stage III bladder cancer|stage iii bladder cancer
1685140|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
1685141|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
1685142|NCT00004178|stage III prostate cancer|stage iii prostate cancer
1685143|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
1685144|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
1700994|NCT00056355|Cytokine|cytokine
1685145|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685146|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
1685147|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
1685148|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
1685149|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1685150|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1685151|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
1685152|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1685153|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
1685154|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
1685155|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
1685156|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
1685157|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
1685158|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
1685159|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685160|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1685161|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
1685162|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
1685163|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
1685164|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1685165|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1685166|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1685167|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1685168|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1685169|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
1685170|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
1685171|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
1685172|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
1685173|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1685174|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1685175|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1685176|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1685177|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
1685178|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
1685179|NCT00081497|a-GAL|a-gal
1685180|NCT00081497|r-haGAL|r-hagal
1685181|NCT00081497|Fabry|fabry
1685182|NCT00081497|GL-3|gl-3
1685183|NCT00081497|Fabrazyme|fabrazyme
1685184|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685185|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1685186|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1685187|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
1685188|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1685189|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1685190|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1685191|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1685192|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685193|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1685194|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1685195|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685196|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685197|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685198|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685199|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685200|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685201|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685202|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685203|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685204|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685205|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685782|NCT00005875|recurrent melanoma|recurrent melanoma
1685206|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685207|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685208|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685209|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685210|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685211|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685212|NCT00004087|stage IV colon cancer|stage iv colon cancer
1685213|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
1700995|NCT00056355|Lymphocyte|lymphocyte
1685214|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
1685215|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
1685216|NCT00004087|recurrent colon cancer|recurrent colon cancer
1685217|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
1685218|NCT00081523|Hemoglobin|hemoglobin
1685219|NCT00081523|Pain Crisis|pain crisis
1685220|NCT00081523|Treatment Options|treatment options
1685221|NCT00081523|Sickle Cell Disease|sickle cell disease
1685222|NCT00081523|Sickle Cell Trait|sickle cell trait
1685223|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
1685224|NCT00081523|Thalassemia|thalassemia
1685225|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1685226|NCT00081523|Hemolytic Disorders|hemolytic disorders
1685227|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1685228|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685229|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1685230|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
1685231|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685232|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685233|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685234|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685235|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685236|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685237|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685238|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685239|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685240|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685241|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685242|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685243|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685244|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685245|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685246|NCT00004085|stage IV breast cancer|stage iv breast cancer
1685247|NCT00004085|recurrent breast cancer|recurrent breast cancer
1685248|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1685249|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1685250|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1685251|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1685252|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685253|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1685254|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1685255|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1685256|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1685257|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1685258|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1685259|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1685260|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1685261|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1685262|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1685263|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1685264|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1685265|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1685266|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1685267|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1685268|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1685269|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1685270|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1685271|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1685272|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1685273|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1685274|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1685275|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1685276|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1685277|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1685278|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1685279|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685280|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685281|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685413|NCT00003674|recurrent colon cancer|recurrent colon cancer
1685282|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685283|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685284|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685285|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685286|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685287|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685288|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1685289|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1685290|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1685291|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1685292|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1685293|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1685294|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1685295|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1685296|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1685297|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1685298|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1685299|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1685300|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1685301|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1685302|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1685303|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1685304|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1685305|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1685306|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1685307|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1685308|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1685309|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1685310|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685311|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1685312|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1685313|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1685314|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1685315|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685316|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685317|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1685318|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1685319|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1685320|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1685321|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1685322|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1685323|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685324|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685325|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685326|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1685327|NCT00004046|stage IV breast cancer|stage iv breast cancer
1685328|NCT00004046|recurrent breast cancer|recurrent breast cancer
1685329|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
1685330|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
1685331|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
1685332|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
1685333|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1685334|NCT00004016|stage III melanoma|stage iii melanoma
1685335|NCT00004016|stage IV melanoma|stage iv melanoma
1685336|NCT00004016|recurrent melanoma|recurrent melanoma
1685403|NCT00003718|ovarian sarcoma|ovarian sarcoma
1685337|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685338|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1685339|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1685340|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1685341|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
1685342|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1685343|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1685344|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1685345|NCT00081458|Short Bowel Syndrome|short bowel syndrome
1685346|NCT00081458|Parenteral Nutrition|parenteral nutrition
1685347|NCT00081458|SBS|sbs
1685348|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
1685349|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1685350|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
1685351|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1685352|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1685353|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1685354|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1685355|NCT00003834|stage IV colon cancer|stage iv colon cancer
1685356|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
1685357|NCT00003834|recurrent colon cancer|recurrent colon cancer
1685358|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
1685359|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
1685360|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685361|NCT00003834|liver metastases|liver metastases
1685362|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
1685363|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
1685364|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1685365|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1685366|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1685367|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1685368|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1685369|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1685370|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1685371|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1685372|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1685373|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1685374|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1685375|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1685376|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1685377|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1685378|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1685379|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1685380|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1685381|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1685382|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1685383|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1685384|NCT00003718|adult angiosarcoma|adult angiosarcoma
1685385|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
1685386|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
1685387|NCT00003718|adult liposarcoma|adult liposarcoma
1685388|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
1685389|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
1685390|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1685391|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
1685392|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1685393|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
1685394|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1685395|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1685396|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
1685397|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1685398|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
1685399|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
1685400|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
1685401|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
1685402|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
1685404|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1685405|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685406|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
1685407|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
1685408|NCT00003674|stage IV colon cancer|stage iv colon cancer
1685409|NCT00003674|stage IV breast cancer|stage iv breast cancer
1685410|NCT00003674|recurrent breast cancer|recurrent breast cancer
1685411|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685412|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
1685414|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
1685415|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1685416|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
1685417|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
1685418|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
1685419|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685420|NCT00003674|veno-occlusive disease|veno-occlusive disease
1685421|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
1685422|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
1685423|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
1685424|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
1685425|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685426|NCT00003307|stage I prostate cancer|stage i prostate cancer
1685427|NCT00003307|stage II prostate cancer|stage ii prostate cancer
1685428|NCT00003307|stage III prostate cancer|stage iii prostate cancer
1685429|NCT00003307|radiation toxicity|radiation toxicity
1685430|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
1685431|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1685432|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
1685433|NCT00003235|large cell lung cancer|large cell lung cancer
1685434|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1685435|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685436|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
1685437|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
1685438|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
1685439|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1685440|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
1685441|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1685442|NCT00003125|stage IV breast cancer|stage iv breast cancer
1685443|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
1685444|NCT00003125|stage III gastric cancer|stage iii gastric cancer
1685445|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
1685446|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
1685447|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
1685448|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
1685449|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
1685450|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
1685451|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1685452|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685453|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685454|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
1685455|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685456|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685457|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685458|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1685459|NCT00003032|stage IV breast cancer|stage iv breast cancer
1685460|NCT00003032|recurrent breast cancer|recurrent breast cancer
1685461|NCT00003010|recurrent breast cancer|recurrent breast cancer
1685462|NCT00021398|stage II rectal cancer|stage ii rectal cancer
1685463|NCT00021398|stage III rectal cancer|stage iii rectal cancer
1685464|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685465|NCT00021281|stage IV colon cancer|stage iv colon cancer
1685466|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
1685467|NCT00021281|recurrent colon cancer|recurrent colon cancer
1685468|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
1685469|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
1685470|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685471|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685472|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
1685473|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685474|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685475|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685476|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1685477|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1685478|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1685479|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1685480|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685481|NCT00019552|fallopian tube cancer|fallopian tube cancer
1685482|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1685483|NCT00019474|stage III gastric cancer|stage iii gastric cancer
1685484|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
1685485|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
1685486|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
1685487|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
1685488|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
1685489|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1685490|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1685491|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1685492|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1685493|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
1685494|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1685495|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
1685496|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1685497|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1685498|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
1685499|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1685500|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
1685501|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1685502|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1685503|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1685504|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1685505|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1685506|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1685507|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1685509|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
1685510|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
1685511|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1685512|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1685513|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1685514|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
1685515|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1685516|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1685517|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685518|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685519|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685520|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
1685521|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
1685522|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1685523|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
1685524|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
1685525|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
1685526|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1685527|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1685528|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1685529|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1685530|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1685531|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1685532|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1685533|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685534|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1685535|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1685536|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1685537|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1685538|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1685539|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1685540|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1685541|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1685542|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
1685543|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
1685544|NCT00014391|testicular teratoma|testicular teratoma
1685545|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
1685546|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1685547|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1685548|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1685549|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1685550|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1685551|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1685552|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1685553|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1685554|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1685555|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1685556|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1685557|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
1685558|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1685559|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1685560|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
1685561|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1685562|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
1685563|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
1685564|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
1685565|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
1685566|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1685567|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1685568|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1685569|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1685570|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1685571|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1685572|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1685573|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1685574|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1685575|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1685576|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1685577|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1685578|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1685579|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1685580|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1685581|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1685582|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1685583|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1685584|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1685585|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1685586|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685587|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685588|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685589|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685590|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685591|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685592|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685593|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685783|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
1685594|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685595|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1685596|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1685597|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1685598|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1685599|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1685600|NCT00014391|infection|infection
1685601|NCT00014391|pulmonary complications|pulmonary complications
1685602|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1685603|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1685604|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1685605|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1685606|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1685607|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1685608|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1685609|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1685817|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
1685610|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1685611|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1685612|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1685613|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1685614|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1685615|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1685616|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685617|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1685618|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1685619|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1685620|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685621|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685622|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1685623|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1685624|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1685625|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1685626|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685627|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685628|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685629|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1685630|NCT00012311|stage IV breast cancer|stage iv breast cancer
1685631|NCT00012311|recurrent breast cancer|recurrent breast cancer
1685632|NCT00010283|stage III breast cancer|stage iii breast cancer
1685633|NCT00010283|stage IV breast cancer|stage iv breast cancer
1685634|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
1685635|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
1685636|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1685637|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1685638|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1685639|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1685640|NCT00010283|Burkitt lymphoma|burkitt lymphoma
1685641|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
1685642|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
1685643|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1685644|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685645|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685646|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1685647|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
1685648|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
1685649|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1685650|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
1685651|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
1685652|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
1685653|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1685654|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1685655|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1685656|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1685657|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1685658|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1685659|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1685660|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1685661|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1685662|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1685663|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1685664|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1685665|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1685666|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1685667|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1685668|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1685669|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1685670|NCT00010283|essential thrombocythemia|essential thrombocythemia
1685671|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
1685672|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
1685673|NCT00010283|testicular teratoma|testicular teratoma
1685674|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
1685675|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1685676|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1685677|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1685678|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1685679|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1685680|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1685681|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1685682|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1685683|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1685968|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
1685684|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1685685|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1685686|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
1685687|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1685688|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1685689|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1685690|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
1685691|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1685692|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
1685693|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
1685694|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
1685695|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
1685696|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1685697|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1685698|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
1685699|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1685700|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1685701|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1685702|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1685703|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1685704|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1685705|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1685706|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1685707|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1685708|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1685709|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1685710|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1685711|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1685712|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1685713|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1685714|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1685715|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1685716|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1685717|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685718|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685719|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685720|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685721|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685722|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685723|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685724|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685725|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685726|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1685727|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1685728|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1685729|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1685730|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1685731|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1685732|NCT00010283|graft versus host disease|graft versus host disease
1685733|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
1685734|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
1685735|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1685736|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1685737|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1685738|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1685739|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1685740|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1685741|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1685742|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1685743|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1685744|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1685745|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1685746|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1685747|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1685748|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1685749|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685750|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1685751|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1685752|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1685753|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1685754|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1685755|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685756|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685757|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1685758|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1685759|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1685760|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1685761|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685762|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685763|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685764|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1685765|NCT00007943|stage III colon cancer|stage iii colon cancer
1685766|NCT00007943|stage IV colon cancer|stage iv colon cancer
1685767|NCT00007943|stage III rectal cancer|stage iii rectal cancer
1685768|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
1685769|NCT00007943|recurrent colon cancer|recurrent colon cancer
1685770|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
1685771|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1685772|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1685773|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1685774|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1685775|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1685776|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1685777|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1685778|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1685779|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1685780|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1685781|NCT00005875|stage IV melanoma|stage iv melanoma
1685784|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1685785|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1685786|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1685787|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1685788|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1685789|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
1685790|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1685791|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1685792|NCT00005873|stage IV breast cancer|stage iv breast cancer
1685793|NCT00005873|recurrent breast cancer|recurrent breast cancer
1685794|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
1685795|NCT00081432|Seizures|seizures
1685796|NCT00081432|Language|language
1685797|NCT00081432|Memory|memory
1685798|NCT00081432|Brain|brain
1685799|NCT00081432|Imaging|imaging
1685800|NCT00081432|Epilepsy|epilepsy
1685801|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
1685802|NCT00081419|Bereitschaftspotential|bereitschaftspotential
1685803|NCT00081419|Timing of Volition|timing of volition
1685804|NCT00081419|Urge|urge
1685805|NCT00081419|Conscious Will|conscious will
1685806|NCT00081419|Libet's Clock|libet's clock
1685807|NCT00081419|Tourette Syndrome|tourette syndrome
1685808|NCT00081419|Tic Disorder|tic disorder
1685809|NCT00081419|Healthy Volunteer|healthy volunteer
1685810|NCT00081419|HV|hv
1685811|NCT00081367|Minority Groups|minority groups
1685812|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685813|NCT00005833|stage IV colon cancer|stage iv colon cancer
1685814|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
1685815|NCT00005833|recurrent colon cancer|recurrent colon cancer
1685816|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
1697184|NCT00063388|Non|non
1685818|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685819|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685820|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
1685821|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
1685822|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1685823|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1685824|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1685825|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1700996|NCT00056355|Remission|remission
1685826|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1685827|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1685828|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1685829|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1685830|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685831|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1685832|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1685833|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685834|NCT00005058|stage I breast cancer|stage i breast cancer
1685835|NCT00005058|stage II breast cancer|stage ii breast cancer
1685836|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
1685837|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
1685838|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
1685839|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1685840|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685841|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685842|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685843|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685844|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685845|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685846|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685847|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1685848|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685849|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1685850|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1685851|NCT00004885|stage IV colon cancer|stage iv colon cancer
1685852|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
1685853|NCT00004885|recurrent colon cancer|recurrent colon cancer
1685854|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
1685855|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
1685856|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685857|NCT00004860|stage III colon cancer|stage iii colon cancer
1685858|NCT00004860|stage IV colon cancer|stage iv colon cancer
1685859|NCT00004860|stage III rectal cancer|stage iii rectal cancer
1685860|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
1685861|NCT00004860|recurrent colon cancer|recurrent colon cancer
1685862|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
1685863|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
1685864|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685865|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1685866|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685867|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1685868|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1685869|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1685870|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685871|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685872|NCT00004166|quality of life|quality of life
1685873|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1685874|NCT00004102|stage IV colon cancer|stage iv colon cancer
1685875|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
1685876|NCT00004102|recurrent colon cancer|recurrent colon cancer
1685877|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
1685878|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
1685879|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685880|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1685881|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1685882|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
1685883|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1685884|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
1685885|NCT00004082|fallopian tube cancer|fallopian tube cancer
1685886|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1685887|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1685888|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1685889|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1685992|NCT00081237|recurrent colon cancer|recurrent colon cancer
1685890|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1685891|NCT00004002|small intestine lymphoma|small intestine lymphoma
1685892|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685893|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1685894|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1685895|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1685896|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1685897|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1685898|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1685899|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1685900|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1685901|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1685902|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1685903|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1685904|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1685905|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1685906|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1685907|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1685908|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1685909|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1685910|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1685911|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1685912|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1685913|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1685914|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1685915|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1685916|NCT00004002|intraocular lymphoma|intraocular lymphoma
1685917|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1685918|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1685919|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1685920|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1685921|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1685922|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1685923|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1685924|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1685925|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1685926|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1685927|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1685928|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1685929|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1685930|NCT00003911|stage IV melanoma|stage iv melanoma
1685931|NCT00003911|recurrent melanoma|recurrent melanoma
1685932|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
1685933|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1685934|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1685935|NCT00081354|Esophageal Adenocarcinoma|esophageal adenocarcinoma
1685936|NCT00081354|Dysplasia|dysplasia
1685937|NCT00081354|Surveillance|surveillance
1685938|NCT00081354|Proteomics|proteomics
1685939|NCT00081354|SNP's|snp's
1685940|NCT00081354|Barrett Esophagus|barrett esophagus
1685941|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
1685942|NCT00081354|GERD|gerd
1685943|NCT00081354|Dysphagia|dysphagia
1685944|NCT00081354|Swallowing Difficulty|swallowing difficulty
1685945|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
1685946|NCT00005943|stage IV melanoma|stage iv melanoma
1685947|NCT00005943|recurrent melanoma|recurrent melanoma
1685948|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1685949|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685950|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
1685951|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1685952|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1685953|NCT00003642|stage II bladder cancer|stage ii bladder cancer
1685954|NCT00003642|stage III bladder cancer|stage iii bladder cancer
1685955|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1685956|NCT00003446|stage IV colon cancer|stage iv colon cancer
1685957|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
1685958|NCT00003446|recurrent colon cancer|recurrent colon cancer
1685959|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
1685960|NCT00003376|stage III bladder cancer|stage iii bladder cancer
1685961|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
1685962|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1685963|NCT00003376|anterior urethral cancer|anterior urethral cancer
1685964|NCT00003376|posterior urethral cancer|posterior urethral cancer
1685965|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1685966|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1685967|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1685969|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
1685970|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
1685971|NCT00003301|adult glioblastoma|adult glioblastoma
1685972|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1685973|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
1685974|NCT00003301|adult gliosarcoma|adult gliosarcoma
1685975|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1685976|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
1685977|NCT00003232|pain|pain
1685978|NCT00003232|quality of life|quality of life
1685979|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1685980|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1685981|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
1685982|NCT00081302|large cell lung cancer|large cell lung cancer
1685983|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
1685984|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1685985|NCT00081289|stage III rectal cancer|stage iii rectal cancer
1685986|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685987|NCT00081289|stage II rectal cancer|stage ii rectal cancer
1685988|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1685989|NCT00081250|cachexia|cachexia
1685990|NCT00081250|anorexia|anorexia
1685991|NCT00081250|weight changes|weight changes
1685993|NCT00081237|stage III colon cancer|stage iii colon cancer
1685994|NCT00081237|stage IV colon cancer|stage iv colon cancer
1685995|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
1685996|NCT00081237|stage III rectal cancer|stage iii rectal cancer
1685997|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
1685998|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1685999|NCT00081224|stage II rectal cancer|stage ii rectal cancer
1686000|NCT00081224|stage III rectal cancer|stage iii rectal cancer
1686001|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1686002|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
1686003|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
1686004|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
1686005|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
1686006|NCT00081159|bone metastases|bone metastases
1686007|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686008|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1686009|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1686010|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1686011|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686012|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1686013|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1686014|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1686015|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1686016|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1686017|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
1686018|NCT00081055|graft versus host disease|graft versus host disease
1686019|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1686020|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1686021|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1686022|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1686023|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686024|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686025|NCT00081055|refractory anemia|refractory anemia
1686026|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
1686027|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1686028|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1686029|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1686030|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1686031|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1686032|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1686033|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1697185|NCT00063388|Small|small
1686034|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1686035|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1686036|NCT00081042|recurrent melanoma|recurrent melanoma
1686037|NCT00081042|stage III melanoma|stage iii melanoma
1686038|NCT00081042|stage IV melanoma|stage iv melanoma
1686039|NCT00081029|xerostomia|xerostomia
1686040|NCT00081029|radiation toxicity|radiation toxicity
1686041|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1686042|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1686043|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1686185|NCT00080743|recurrent breast cancer|recurrent breast cancer
1686044|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1686045|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1686046|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1686047|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1686048|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1686049|NCT00081003|breast cancer|breast cancer
1686050|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
1686051|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
1686052|NCT00080951|stage IV colon cancer|stage iv colon cancer
1686053|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
1686054|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
1686055|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1686056|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686057|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1686058|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
1686059|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
1686060|NCT00080938|large cell lung cancer|large cell lung cancer
1686061|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1686062|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1686063|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
1686064|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
1686065|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686066|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686067|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1686068|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1686069|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1686070|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1686071|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1686072|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1686073|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1686074|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1686075|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
1686076|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
1686077|NCT00080925|primary myelofibrosis|primary myelofibrosis
1686078|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686079|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1686080|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1686081|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686082|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686083|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1686084|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1686085|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686086|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1686087|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686088|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1686089|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1686090|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1686091|NCT00080925|polycythemia vera|polycythemia vera
1686092|NCT00080925|essential thrombocythemia|essential thrombocythemia
1686093|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
1686094|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
1686095|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1686096|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1686097|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1686098|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1686099|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1686100|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1686101|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1686102|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1686103|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1686104|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1686105|NCT00080912|bone metastases|bone metastases
1686107|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1686108|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686109|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1686110|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1686111|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686112|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686113|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1686114|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1686115|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686116|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686117|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1686118|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1686119|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1686120|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1686121|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1686122|NCT00080873|oral complications|oral complications
1686123|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
1686124|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1686125|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1686126|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1686127|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1686128|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1686129|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1686130|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1686131|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1686132|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1686133|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1686134|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1686135|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1686136|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1686137|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1686138|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1686139|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
1686140|NCT00080860|stage II breast cancer|stage ii breast cancer
1686141|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
1686142|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
1686143|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
1686144|NCT00080860|stage IV breast cancer|stage iv breast cancer
1686145|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
1686146|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1686147|NCT00080834|recurrent colon cancer|recurrent colon cancer
1686148|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
1686149|NCT00080834|stage III colon cancer|stage iii colon cancer
1686150|NCT00080834|stage IV colon cancer|stage iv colon cancer
1686151|NCT00080834|stage III rectal cancer|stage iii rectal cancer
1686152|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
1686153|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
1686154|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
1686155|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
1686156|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1686157|NCT00080808|stage I prostate cancer|stage i prostate cancer
1686158|NCT00080808|stage II prostate cancer|stage ii prostate cancer
1686159|NCT00080808|prostaglandin E1|prostaglandin e1
1686160|NCT00080808|papaverine|papaverine
1686161|NCT00080808|phentolamine|phentolamine
1686162|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
1686163|NCT00080808|nerve grafting|nerve grafting
1686164|NCT00080795|stage III bladder cancer|stage iii bladder cancer
1686165|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1686166|NCT00080795|anterior urethral cancer|anterior urethral cancer
1686167|NCT00080795|posterior urethral cancer|posterior urethral cancer
1686168|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1686169|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
1686170|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
1697186|NCT00063388|Cell|cell
1686171|NCT00080782|bone metastases|bone metastases
1686172|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
1686173|NCT00080782|Metastron|metastron
1686174|NCT00080782|Sr-89|sr-89
1686175|NCT00080782|Strontium-89|strontium-89
1686176|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
1686177|NCT00080782|Celecoxib|celecoxib
1686178|NCT00080782|Celebrex|celebrex
1686179|NCT00080782|Doxorubicin|doxorubicin
1686180|NCT00080782|Rubex|rubex
1686181|NCT00080782|Adriamycin|adriamycin
1686182|NCT00080756|breast cancer|breast cancer
1686183|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
1686184|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
1686186|NCT00080743|stage IV breast cancer|stage iv breast cancer
1686187|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1686188|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
1686189|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
1686190|NCT00080678|bone metastases|bone metastases
1686191|NCT00080665|male breast cancer|male breast cancer
1686192|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
1686193|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
1686194|NCT00080665|stage IV breast cancer|stage iv breast cancer
1686195|NCT00080665|recurrent breast cancer|recurrent breast cancer
1686196|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
1686197|NCT00080626|stage I breast cancer|stage i breast cancer
1686198|NCT00080626|stage II breast cancer|stage ii breast cancer
1686199|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
1686200|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
1686201|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
1686202|NCT00080626|stage IV breast cancer|stage iv breast cancer
1686203|NCT00080600|Post Polio Syndrome|post polio syndrome
1686204|NCT00080600|Magnetic Stimulation|magnetic stimulation
1686205|NCT00080600|Fatigue|fatigue
1686206|NCT00080600|Exercise|exercise
1686207|NCT00080600|Weakness|weakness
1686208|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1686209|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
1686210|NCT00080600|Motor Neuron Disease|motor neuron disease
1686211|NCT00080600|Cortical Reorganization|cortical reorganization
1686212|NCT00080600|Intracortical Facilitation|intracortical facilitation
1686213|NCT00080600|Polio|polio
1686214|NCT00080600|Healthy Volunteer|healthy volunteer
1686215|NCT00080600|HV|hv
1686216|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
1686217|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
1686218|NCT00080587|Hyperlipidemia|hyperlipidemia
1686219|NCT00080587|Cholesterol|cholesterol
1686220|NCT00080587|Coronary Artery Disease|coronary artery disease
1686221|NCT00080574|Pharmacokinetics|pharmacokinetics
1686222|NCT00080574|Drug Metabolism|drug metabolism
1686223|NCT00080574|Levothyroxine|levothyroxine
1686224|NCT00080574|Hypothyroidism|hypothyroidism
1686225|NCT00080574|Hyperthyroidism|hyperthyroidism
1686226|NCT00080574|Drug Interactions|drug interactions
1686227|NCT00080574|Cytochrome P450|cytochrome p450
1686228|NCT00080574|P-Glycoprotein|p-glycoprotein
1686229|NCT00080574|Drug Transport Proteins|drug transport proteins
1686230|NCT00080574|Thyroid Hormone|thyroid hormone
1686231|NCT00080574|Thyroid Cancer|thyroid cancer
1686232|NCT00080548|Bereitschafts Potential|bereitschafts potential
1686233|NCT00080548|Timing of Volition|timing of volition
1686234|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
1686235|NCT00080548|Conscious Will|conscious will
1686236|NCT00080548|Libet's Clock|libet's clock
1686237|NCT00080548|Schizophrenia|schizophrenia
1686238|NCT00080548|Healthy Volunteer|healthy volunteer
1686239|NCT00080548|HV|hv
1686240|NCT00080535|LMB-2|lmb-2
1686241|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1686242|NCT00080535|CTCL|ctcl
1686243|NCT00080535|Immunotoxin|immunotoxin
1686244|NCT00080535|Oncology|oncology
1686245|NCT00080522|Treatment Naive|treatment naive
1686246|NCT00080522|Resource Poor Setting|resource poor setting
1686247|NCT00080522|Drug Delivery|drug delivery
1686248|NCT00080522|Household|household
1686249|NCT00080522|South Africa|south africa
1686250|NCT00080496|Pneumonia|pneumonia
1686251|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
1686252|NCT00003176|adult glioblastoma|adult glioblastoma
1686253|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1686254|NCT00003176|adult mixed glioma|adult mixed glioma
1686255|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
1686256|NCT00003176|adult gliosarcoma|adult gliosarcoma
1686257|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
1686258|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
1686259|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1686260|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1686261|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686262|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1686263|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1697187|NCT00063388|Lung|lung
1686264|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686265|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686266|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686267|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1686268|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1686269|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1686270|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1687234|NCT00080275|Atherosclerosis|atherosclerosis
1686271|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1686272|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1686273|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1686274|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1686275|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1686276|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1686277|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686278|NCT00002997|stage IV colon cancer|stage iv colon cancer
1686279|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
1686280|NCT00002997|recurrent colon cancer|recurrent colon cancer
1686281|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
1686282|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
1686283|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1686284|NCT00002997|liver metastases|liver metastases
1686285|NCT00024063|stage III colon cancer|stage iii colon cancer
1686286|NCT00024063|stage IV colon cancer|stage iv colon cancer
1686287|NCT00024063|stage IV breast cancer|stage iv breast cancer
1686288|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
1686289|NCT00024063|recurrent breast cancer|recurrent breast cancer
1686290|NCT00024063|stage III gastric cancer|stage iii gastric cancer
1686291|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
1686292|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
1686293|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
1686294|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686295|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
1686296|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
1686297|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
1686298|NCT00024063|stage III rectal cancer|stage iii rectal cancer
1686299|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
1686300|NCT00024063|recurrent colon cancer|recurrent colon cancer
1686301|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
1686302|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
1686303|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
1686304|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
1686305|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
1686306|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
1686307|NCT00024063|stage III prostate cancer|stage iii prostate cancer
1686308|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
1686309|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
1686310|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1686311|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1686312|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1686313|NCT00024063|male breast cancer|male breast cancer
1686314|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
1686315|NCT00003107|stage IV breast cancer|stage iv breast cancer
1686316|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
1686317|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
1686318|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1686319|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1686320|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
1686321|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1686322|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1686323|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1686324|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1686325|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
1686326|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
1686327|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1686328|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
1686329|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
1686330|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
1686331|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1686332|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1686333|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1686334|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1686335|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1686336|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1699807|NCT00059553|walking|walking
1686337|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1686338|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1686339|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686340|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686341|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1686342|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1686343|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1701230|NCT00055562|CC5013|cc5013
1686344|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
1686345|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
1686346|NCT00003107|testicular teratoma|testicular teratoma
1686347|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
1686348|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1686349|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1686350|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1686351|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1686352|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1686353|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1686354|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1686355|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1686356|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1686357|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1686358|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1686359|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
1686360|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1686361|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
1686362|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1686363|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
1686364|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
1686365|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
1686366|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
1686367|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1686368|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1686369|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1686370|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1686371|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1686372|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1686373|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1686374|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1686375|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1686376|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1686377|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1686378|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1686379|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1686380|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1686381|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1686382|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1686383|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1686384|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1686385|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1686386|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1686387|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1686388|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1686389|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686390|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1686391|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1686392|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686393|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686394|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686395|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1686396|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1686397|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1686398|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1686399|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1686400|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1687383|NCT00080119|INH Prophylaxis|inh prophylaxis
1686401|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1686402|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1686403|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1686404|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1686405|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1686406|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1686407|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1686408|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1686409|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1686410|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1686411|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1686412|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1686413|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686414|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1686415|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1686416|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1686417|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1686418|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1686419|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1686420|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1686421|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1686422|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1686423|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1686424|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1686425|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1686426|NCT00003103|stage III colon cancer|stage iii colon cancer
1686427|NCT00003103|stage IV colon cancer|stage iv colon cancer
1686428|NCT00003103|stage IV breast cancer|stage iv breast cancer
1686429|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
1686430|NCT00003103|recurrent breast cancer|recurrent breast cancer
1686431|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
1686432|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686433|NCT00003103|stage III rectal cancer|stage iii rectal cancer
1686434|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
1686435|NCT00003103|recurrent colon cancer|recurrent colon cancer
1686436|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
1686437|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
1686438|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
1686439|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
1686440|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
1686441|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
1686442|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
1686443|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
1686444|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1686445|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1686446|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1686447|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
1686448|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
1686449|NCT00003103|stage V Wilms tumor|stage v wilms tumor
1686450|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1686451|NCT00003103|stage III bladder cancer|stage iii bladder cancer
1686452|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
1686453|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
1686454|NCT00003103|stage III prostate cancer|stage iii prostate cancer
1686455|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
1686456|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
1686457|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1686458|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1686459|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1686460|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1686461|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1686462|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1686463|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
1686464|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1686465|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1686466|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1686467|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1686468|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1686469|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1686470|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1686471|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1686472|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1686473|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1686474|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1686475|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1686476|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1686477|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1686478|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1686479|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1686480|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1686481|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1686482|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1686483|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1686484|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1686485|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1686486|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1686487|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1686488|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1686489|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1686490|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1686491|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1686492|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1686493|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1686494|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1686495|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1686496|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1686497|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1686498|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1686499|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1686500|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1686501|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1686502|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1686503|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1686504|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1686505|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1686506|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1686507|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1686508|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1686509|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1686510|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1686511|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1686512|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1686513|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1686514|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1686515|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1686516|NCT00003103|ovarian sarcoma|ovarian sarcoma
1686517|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1686518|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1686519|NCT00003012|stage II breast cancer|stage ii breast cancer
1686520|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
1686521|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1686522|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1686523|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
1686524|NCT00002814|adult glioblastoma|adult glioblastoma
1686525|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1686526|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
1686527|NCT00002814|adult gliosarcoma|adult gliosarcoma
1686528|NCT00002774|stage III|stage iii
1686529|NCT00002774|stage IV|stage iv
1686530|NCT00002774|recurrent|recurrent
1686531|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1686532|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1686533|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1686534|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1686535|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1686536|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1686537|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1686538|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1686539|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1686540|NCT00002600|fallopian tube cancer|fallopian tube cancer
1686541|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1686542|NCT00002525|stage II colon cancer|stage ii colon cancer
1686543|NCT00002525|stage III colon cancer|stage iii colon cancer
1686544|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1686545|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1686546|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1686547|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1686548|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1686549|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1686550|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1686551|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1686553|NCT00080470|Refractory|refractory
1686554|NCT00080470|Urinary|urinary
1686555|NCT00080470|Urge|urge
1686556|NCT00080470|Stimulation|stimulation
1686557|NCT00080470|Nerve|nerve
1686558|NCT00080470|Microstimulator|microstimulator
1686559|NCT00080470|Neuromodulation|neuromodulation
1686560|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
1686561|NCT00080457|Scleroderma|scleroderma
1686562|NCT00080457|Connective tissue disease|connective tissue disease
1686563|NCT00080457|Congenital heart defects|congenital heart defects
1686564|NCT00080457|Lupus|lupus
1686565|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1686566|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1686567|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1686568|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1686569|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1686570|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1686571|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1686572|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1686573|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1686574|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1686575|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1686576|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1686577|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1686578|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1686579|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1686580|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1686581|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1686582|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686583|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1686584|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1686585|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686586|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686587|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686588|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687384|NCT00080119|HIV Seronegativity|hiv seronegativity
1686589|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1686590|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1686591|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1686592|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1686593|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1686594|NCT00023816|intraocular lymphoma|intraocular lymphoma
1686595|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1686596|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686597|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1686598|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1686599|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1686600|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1686601|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1686602|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1686603|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1686604|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1686605|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1686606|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1686607|NCT00022386|stage I breast cancer|stage i breast cancer
1686608|NCT00022386|stage II breast cancer|stage ii breast cancer
1686609|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
1686610|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
1686611|NCT00022386|anemia|anemia
1686612|NCT00022386|fatigue|fatigue
1686613|NCT00022256|adult glioblastoma|adult glioblastoma
1686614|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
1686615|NCT00022256|adult gliosarcoma|adult gliosarcoma
1686616|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1686617|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1686618|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
1686619|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
1686620|NCT00020540|stage IV melanoma|stage iv melanoma
1686621|NCT00020540|recurrent melanoma|recurrent melanoma
1686622|NCT00019071|adult glioblastoma|adult glioblastoma
1686623|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1686624|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
1686625|NCT00019071|adult gliosarcoma|adult gliosarcoma
1686626|NCT00019058|adult glioblastoma|adult glioblastoma
1686627|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
1686628|NCT00019058|adult gliosarcoma|adult gliosarcoma
1686629|NCT00016042|stage IV colon cancer|stage iv colon cancer
1686630|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
1686631|NCT00016042|recurrent colon cancer|recurrent colon cancer
1686632|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
1686633|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
1686634|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
1686635|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1686636|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1686637|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1686638|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
1686639|NCT00014573|adult brain stem glioma|adult brain stem glioma
1686640|NCT00014573|adult medulloblastoma|adult medulloblastoma
1686641|NCT00014573|adult glioblastoma|adult glioblastoma
1686642|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1686643|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1686644|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
1686645|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
1686646|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
1686647|NCT00014573|adult mixed glioma|adult mixed glioma
1686648|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1686649|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
1686650|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1686651|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1686652|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1686653|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1686654|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
1686655|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
1686656|NCT00014573|adult grade III meningioma|adult grade iii meningioma
1686657|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
1686658|NCT00014573|adult gliosarcoma|adult gliosarcoma
1686659|NCT00080418|neoplasm|neoplasm
1686660|NCT00080418|cancer|cancer
1686661|NCT00080418|NeoPharm|neopharm
1686662|NCT00080418|liposomes|liposomes
1686663|NCT00080418|Taxol|taxol
1686664|NCT00080418|paclitaxel|paclitaxel
1686665|NCT00080418|anti-cancer|anti-cancer
1686666|NCT00080418|advanced neoplasm|advanced neoplasm
1686667|NCT00080418|advanced cancer|advanced cancer
1686668|NCT00080418|chemotherapy|chemotherapy
1686669|NCT00080418|refractory cancer|refractory cancer
1686670|NCT00080418|metastatic cancer|metastatic cancer
1686671|NCT00080405|Relapsed|relapsed
1686672|NCT00080405|Multiple Myeloma|multiple myeloma
1686673|NCT00080405|Pharmacokinetic|pharmacokinetic
1686674|NCT00080405|Pharmacodynamic|pharmacodynamic
1686675|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1686738|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
1686676|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1686677|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1686678|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1686679|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1686680|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1686748|NCT00006368|recurrent breast cancer|recurrent breast cancer
1686681|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1686682|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1686683|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1686684|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1686685|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1686686|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1686687|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1686688|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1686689|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1686690|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1686691|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
1686692|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
1686693|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
1686694|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
1686695|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
1686696|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
1686697|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
1686698|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
1686699|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1686700|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1686701|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1686702|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
1686703|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1686704|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1686705|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
1686706|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
1686707|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
1686708|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
1686709|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1686710|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1686711|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1686712|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1686713|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1686714|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1686715|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1686716|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
1686717|NCT00007813|childhood teratoma|childhood teratoma
1686718|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1686719|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1686720|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1686721|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1686722|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1686723|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
1686724|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686725|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
1686726|NCT00006458|large cell lung cancer|large cell lung cancer
1686727|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
1686728|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1686729|NCT00006376|stage II bladder cancer|stage ii bladder cancer
1686730|NCT00006376|stage III bladder cancer|stage iii bladder cancer
1686731|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
1686732|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
1686733|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1686734|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1686735|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1686736|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1686737|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1686739|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
1686740|NCT00006370|stage IV breast cancer|stage iv breast cancer
1686741|NCT00006370|recurrent breast cancer|recurrent breast cancer
1686742|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
1686743|NCT00006370|male breast cancer|male breast cancer
1686744|NCT00006369|stage IV breast cancer|stage iv breast cancer
1686745|NCT00006369|recurrent breast cancer|recurrent breast cancer
1686746|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1686747|NCT00006368|stage IV breast cancer|stage iv breast cancer
1686749|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1686750|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1686751|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1686752|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
1686753|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1686754|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1686755|NCT00006368|gastrinoma|gastrinoma
1686756|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
1686757|NCT00006368|insulinoma|insulinoma
1686758|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1686759|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1686760|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
1686761|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
1686762|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
1686763|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
1686764|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
1686765|NCT00006368|adult brain stem glioma|adult brain stem glioma
1686766|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
1686767|NCT00006368|adult medulloblastoma|adult medulloblastoma
1686768|NCT00006368|adult meningioma|adult meningioma
1686769|NCT00006368|adult glioblastoma|adult glioblastoma
1686770|NCT00006368|stage IV melanoma|stage iv melanoma
1686771|NCT00006368|recurrent melanoma|recurrent melanoma
1686772|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1686773|NCT00006368|WDHA syndrome|wdha syndrome
1686774|NCT00006368|somatostatinoma|somatostatinoma
1686775|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1686776|NCT00006368|glucagonoma|glucagonoma
1686777|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1686778|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1686779|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1686780|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1686781|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1686782|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1686783|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1686784|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1686785|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1686786|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1686787|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1686788|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1686789|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1686790|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687385|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1686791|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1686792|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1686793|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1686794|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1686795|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1686796|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1686797|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1686798|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
1686799|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1686800|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1686801|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1686802|NCT00006368|adult subependymoma|adult subependymoma
1686803|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
1686804|NCT00006368|adult pineocytoma|adult pineocytoma
1686805|NCT00006368|adult pineoblastoma|adult pineoblastoma
1686806|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1686807|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1686808|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1686809|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
1686810|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1686811|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1686812|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1686813|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1686814|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1686815|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1686816|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1686817|NCT00006368|adult grade III meningioma|adult grade iii meningioma
1686818|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
1686819|NCT00006368|adult gliosarcoma|adult gliosarcoma
1686820|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686821|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1686822|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1686823|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1686824|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1686825|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1686826|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1686827|NCT00006032|stage IV breast cancer|stage iv breast cancer
1686828|NCT00006032|recurrent breast cancer|recurrent breast cancer
1686829|NCT00006031|biopsy|biopsy
1686830|NCT00006031|radioactive seed|radioactive seed
1686831|NCT00006031|nonpalpable lesions|nonpalpable lesions
1686832|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1686833|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686834|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686835|NCT00005860|stage IV colon cancer|stage iv colon cancer
1686836|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
1686837|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
1686838|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
1686839|NCT00005860|recurrent colon cancer|recurrent colon cancer
1686840|NCT00005860|regional neuroblastoma|regional neuroblastoma
1686841|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
1686842|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
1686843|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1686844|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1686845|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1686846|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
1686847|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1686848|NCT00005860|gastrinoma|gastrinoma
1686849|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
1686850|NCT00005860|small intestine lymphoma|small intestine lymphoma
1686851|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1686852|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
1686853|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
1686854|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1686855|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1686856|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
1686857|NCT00005860|insulinoma|insulinoma
1686858|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1686859|NCT00005860|WDHA syndrome|wdha syndrome
1686860|NCT00005860|somatostatinoma|somatostatinoma
1686861|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1686862|NCT00005860|glucagonoma|glucagonoma
1686863|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
1686864|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
1686865|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
1686866|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
1686867|NCT00005860|liver metastases|liver metastases
1686868|NCT00005860|malignant ascites|malignant ascites
1686869|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1686870|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
1686871|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
1686872|NCT00005860|fallopian tube cancer|fallopian tube cancer
1686873|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1686874|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1686875|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1686876|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
1686877|NCT00005798|stage II breast cancer|stage ii breast cancer
1686878|NCT00005798|stage IV breast cancer|stage iv breast cancer
1686879|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
1686880|NCT00005798|recurrent breast cancer|recurrent breast cancer
1686881|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
1686882|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
1686883|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1686884|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1686885|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1686886|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686887|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686888|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1686889|NCT00005615|stage III melanoma|stage iii melanoma
1686890|NCT00005615|recurrent melanoma|recurrent melanoma
1686891|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1686892|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1686893|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1686894|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
1686895|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
1687233|NCT00080275|Dyslipidemia|dyslipidemia
1686896|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1686897|NCT00080431|Reservoir|reservoir
1686898|NCT00080431|Viral Load|viral load
1686899|NCT00080431|Immunosuppression|immunosuppression
1686900|NCT00080431|Activation|activation
1686901|NCT00080431|Latency|latency
1686902|NCT00080431|HIV|hiv
1686903|NCT00080431|HAART|haart
1686904|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
1686905|NCT00080431|Viral Reservoirs|viral reservoirs
1686906|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1686907|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1686908|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1686909|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1686910|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1686911|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1686912|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1686913|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1686914|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1686915|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1686916|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1686917|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1686918|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1686919|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1686920|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1686921|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
1686922|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
1686923|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
1686924|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1686925|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1686926|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1686927|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1686928|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1686929|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1686930|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1686931|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1686932|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1686933|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1686934|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1686935|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1686936|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1686937|NCT00003967|fallopian tube cancer|fallopian tube cancer
1686938|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1686939|NCT00003967|Brenner tumor|brenner tumor
1686940|NCT00003883|stage IV breast cancer|stage iv breast cancer
1686941|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
1686942|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
1686943|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1686944|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1686945|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1686946|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
1686947|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1686948|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1686949|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1686950|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1686951|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1686952|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
1686953|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
1686954|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1686955|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
1686956|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
1686957|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
1686958|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1686959|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1686960|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1686961|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1686962|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1686963|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1686964|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1686965|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1686966|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1686967|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1686968|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1686969|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1686970|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1686971|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1686972|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1686973|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1686974|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
1686975|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
1686976|NCT00003883|testicular teratoma|testicular teratoma
1686977|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
1686978|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1686979|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1686980|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1686981|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1686982|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1686983|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1686984|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1686985|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1686986|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1686987|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1686988|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1686989|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
1686990|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1686991|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1686992|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
1686993|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1686994|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
1686995|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
1686996|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
1686997|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
1686998|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1686999|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1687000|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1687001|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687002|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1687003|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1687004|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1687005|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1687006|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1687007|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1687008|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1687009|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687010|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687011|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1687012|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1687013|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1687014|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1687015|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1687016|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1687017|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1687018|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687019|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687020|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687021|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687022|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687023|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687024|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687025|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687026|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687027|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1687028|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1687029|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1687030|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1687031|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1687032|NCT00003883|infection|infection
1687033|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1687034|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1687035|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1687036|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1687037|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1687038|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1687039|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1687040|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1687041|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1687042|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1687043|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1687044|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1687045|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1687046|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687047|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687048|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1687049|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1687050|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1687051|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1687052|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687053|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687054|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1687055|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1687056|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1687057|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1687058|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687059|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687060|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687061|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1687062|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
1687063|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
1687064|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1687065|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
1687066|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1687067|NCT00003657|chondrosarcoma|chondrosarcoma
1687068|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1687069|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1687070|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1687071|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1687072|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1687073|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1687074|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
1687075|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
1687076|NCT00003657|stage III bladder cancer|stage iii bladder cancer
1687077|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
1687078|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
1687079|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1687080|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1687081|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1687082|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687083|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
1687084|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
1687085|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1687086|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1687087|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1687088|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1687089|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
1687090|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1687091|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1687092|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1687093|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1687094|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1687095|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1687096|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1687097|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1687098|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1687099|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1687100|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1687101|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1687102|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1687103|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1687104|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1687105|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1687106|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1687107|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1687108|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1687109|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1687110|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1687111|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1687112|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1687113|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1687114|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1687115|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1687116|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1687117|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1687118|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1687119|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1687120|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1687121|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1687122|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1687123|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1687124|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1687125|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1687126|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1687127|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1687128|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1687129|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1687130|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1687131|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1687132|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687133|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1687134|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1687135|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1687136|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687137|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1687138|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1687139|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1687140|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687141|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
1687220|NCT00080288|Excessive Sleepiness|excessive sleepiness
1687142|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1687143|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
1687144|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
1687145|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
1687146|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1687147|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1687148|NCT00003657|ovarian sarcoma|ovarian sarcoma
1687149|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1687150|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1687151|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1687152|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1687153|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1687154|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687155|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1687156|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1687157|NCT00003412|stage IV breast cancer|stage iv breast cancer
1687158|NCT00003412|recurrent breast cancer|recurrent breast cancer
1687159|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1687160|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1687161|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1687162|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687163|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1687164|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687165|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687166|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687167|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687168|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687169|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1687170|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687171|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687172|NCT00080392|Gene Transfer|gene transfer
1687173|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
1687174|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
1687175|NCT00080392|Perfusion|perfusion
1687176|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
1687177|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
1687178|NCT00080392|Claudication|claudication
1687179|NCT00080392|PAD|pad
1687180|NCT00080392|Leg Claudication|leg claudication
1687181|NCT00080392|Intermittent Claudication|intermittent claudication
1687182|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
1687183|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
1687184|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1687185|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1687186|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1687187|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1687188|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1687189|NCT00003345|fallopian tube cancer|fallopian tube cancer
1687190|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1687191|NCT00003192|stage III gastric cancer|stage iii gastric cancer
1687192|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
1687193|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
1687194|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
1687195|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
1687196|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
1687197|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1687198|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
1687199|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
1687200|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
1687201|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
1687202|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
1687203|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
1687204|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
1687205|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1687206|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1687207|NCT00080366|Essential Tremor|essential tremor
1687208|NCT00080366|Cross over Design|cross over design
1687209|NCT00080366|Accelerometry|accelerometry
1687210|NCT00080366|Placebo|placebo
1687211|NCT00080366|Alcohol Responsive|alcohol responsive
1687212|NCT00080366|Double Blind|double blind
1687213|NCT00080366|1-Octanol|1-octanol
1687214|NCT00080353|Complete Tumor Regression|complete tumor regression
1687215|NCT00080353|Cell Survival|cell survival
1687216|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
1687217|NCT00080353|IL-2|il-2
1687218|NCT00080353|Toxicity|toxicity
1687219|NCT00080353|Metastatic Melanoma|metastatic melanoma
1687221|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
1687222|NCT00080288|Chronic SWSD|chronic swsd
1687223|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
1687224|NCT00080288|Shift Worker|shift worker
1687225|NCT00080288|Cephalon|cephalon
1687226|NCT00080288|Cephalon, Inc|cephalon, inc
1687227|NCT00080288|Nuvigil|nuvigil
1687228|NCT00080275|Niacin|niacin
1687229|NCT00080275|Statin|statin
1687230|NCT00080275|Zocor|zocor
1687231|NCT00080275|Simvastatin|simvastatin
1687232|NCT00080275|Coronary Heart Disease|coronary heart disease
1687235|NCT00080275|Hypercholesterolemia|hypercholesterolemia
1687236|NCT00080275|Stroke|stroke
1687237|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
1687238|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
1687239|NCT00080275|Lipoprotein|lipoprotein
1687240|NCT00080275|Lipid|lipid
1687241|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
1687242|NCT00080275|Total Cholesterol|total cholesterol
1687243|NCT00080275|Triglycerides|triglycerides
1687244|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
1687245|NCT00080236|Liver Transplantation|liver transplantation
1687246|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
1687247|NCT00080223|respiratory diseases|respiratory diseases
1687248|NCT00080158|Dysthymic Disorder|dysthymic disorder
1687249|NCT00080158|Adolescent|adolescent
1687250|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
1687251|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687252|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
1687253|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
1687254|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1687255|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
1687256|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1687257|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1687258|NCT00002947|gastrinoma|gastrinoma
1687259|NCT00002947|insulinoma|insulinoma
1687260|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1687261|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1687262|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
1687263|NCT00002947|iris melanoma|iris melanoma
1687264|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1687265|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
1687266|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
1687267|NCT00002947|stage IV melanoma|stage iv melanoma
1687268|NCT00002947|recurrent melanoma|recurrent melanoma
1687269|NCT00002947|WDHA syndrome|wdha syndrome
1687270|NCT00002947|somatostatinoma|somatostatinoma
1687271|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1687272|NCT00002947|glucagonoma|glucagonoma
1687273|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1687274|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
1687275|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
1687276|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1687277|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687278|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687279|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
1687280|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
1687281|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1687282|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1687283|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1687284|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1687285|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1687286|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1687287|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1687288|NCT00002759|small intestine lymphoma|small intestine lymphoma
1687289|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687290|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1687291|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687292|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1687293|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1687294|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1687295|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1687296|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1687297|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1687298|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1687299|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687300|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687301|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1687302|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1687303|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1687304|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1687305|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1687374|NCT00080171|Osteoarthritis|osteoarthritis
1687377|NCT00080145|Autistic Disorder|autistic disorder
1687306|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1687307|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1687308|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687309|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687310|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687311|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687312|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687313|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687314|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687315|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687316|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687317|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1687318|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1687319|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1687320|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1687321|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1687322|NCT00002759|neutropenia|neutropenia
1687323|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1687324|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1687325|NCT00002759|intraocular lymphoma|intraocular lymphoma
1687326|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1687327|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687328|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687329|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1687330|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1687331|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1687332|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1687333|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1687334|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687335|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687336|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1687337|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1687338|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1687339|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1687340|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687341|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687342|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687343|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687344|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687345|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1687346|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
1687347|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1687348|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1687349|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1687350|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1687351|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1687352|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687353|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687354|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687355|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687356|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687357|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687358|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687359|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687360|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687361|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687362|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687363|NCT00080210|elevated uric acid|elevated uric acid
1687364|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
1687365|NCT00080210|Symptomatic gout|symptomatic gout
1687366|NCT00080197|Breast Cancer|breast cancer
1687367|NCT00080197|Cancer of the Breast|cancer of the breast
1687368|NCT00080184|Fibromyalgia|fibromyalgia
1687369|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
1687370|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
1687371|NCT00080184|Neurofeedback|neurofeedback
1687372|NCT00080184|Neurotherapy|neurotherapy
1687373|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
1687378|NCT00080145|Asperger Syndrome|asperger syndrome
1687379|NCT00080132|HTG|htg
1687380|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
1687381|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
1687386|NCT00080106|Treatment Experienced|treatment experienced
1687387|NCT00080106|Treatment Interruption|treatment interruption
1687388|NCT00080106|Adenovirus Vector|adenovirus vector
1687389|NCT00008320|stage IV breast cancer|stage iv breast cancer
1687390|NCT00008320|recurrent breast cancer|recurrent breast cancer
1687391|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1687392|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687393|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
1687394|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1687395|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1687396|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1687397|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1687398|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1687399|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1687400|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1687401|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1687402|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1687403|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1687404|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1687405|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1687406|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
1687407|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
1687408|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
1687409|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
1687410|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1687411|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1687412|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1687413|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1687414|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687415|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1687416|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687417|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687418|NCT00006348|small intestine lymphoma|small intestine lymphoma
1687419|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1687420|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687421|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687422|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1687423|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1687424|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1687425|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1687426|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1687427|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1687428|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1687429|NCT00006348|polycythemia vera|polycythemia vera
1687430|NCT00006348|primary myelofibrosis|primary myelofibrosis
1687431|NCT00006348|essential thrombocythemia|essential thrombocythemia
1687432|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
1687433|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1687434|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
1687435|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1687436|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1687437|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1687438|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1687439|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
1687440|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687441|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687442|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1687443|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1687444|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1687445|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1687446|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1687447|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1687646|NCT00080002|gastric neoplasms|gastric neoplasms
1687448|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1687449|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687450|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687451|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687452|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687453|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687454|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687455|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687456|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687457|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687458|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1687459|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1687460|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1687461|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1687462|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1687463|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1687464|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1687465|NCT00006348|nausea and vomiting|nausea and vomiting
1687466|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
1687467|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1687468|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1687469|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
1687470|NCT00006348|intraocular lymphoma|intraocular lymphoma
1687471|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1687472|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1687473|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1687474|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1687475|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687476|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687477|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1687478|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1687479|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1687480|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1687481|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687482|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687483|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1687484|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1687485|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687486|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687487|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687488|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1687489|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1687490|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1687491|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1687492|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1687493|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1687494|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1687495|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687496|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1687497|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687498|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1687499|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1687500|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1687501|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1687502|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1687503|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1687504|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1687505|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1687506|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1687507|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1687508|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1687509|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1687510|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1687645|NCT00080002|gastric cancer|gastric cancer
1687511|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1687512|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1687513|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1687514|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1687515|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1687516|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1687517|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1687518|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1687519|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1687520|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1687521|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1687522|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1687523|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1687524|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1687525|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1687526|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1687527|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1687528|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
1687529|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1687530|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1687531|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1687532|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1687533|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687534|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1687535|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1687536|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
1687537|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1687538|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1687539|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1687540|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1687541|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1687542|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1687543|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1687544|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1687545|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1687546|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1687547|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1687548|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1687549|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1687550|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1687551|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1687552|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1687553|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1687554|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1687555|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1687556|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1687557|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1687558|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1687559|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1687560|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1699808|NCT00059553|training|training
1687561|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1687562|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1687563|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1687564|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1687565|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1687566|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1687567|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1687568|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1687569|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1687570|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1687571|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1687572|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1687573|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1687574|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1687575|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1687576|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1687577|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1687578|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1687579|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687580|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1687581|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1687582|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1687583|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687584|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1687585|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1687586|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1687587|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1687588|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1687589|NCT00006036|ovarian sarcoma|ovarian sarcoma
1687590|NCT00006030|stage I breast cancer|stage i breast cancer
1687592|NCT00080093|HIV Seronegativity|hiv seronegativity
1687593|NCT00080093|HIV Prevention|hiv prevention
1687594|NCT00080093|Behavioral Intervention|behavioral intervention
1687595|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
1687596|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
1687597|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
1687598|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
1687599|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
1687600|NCT00005944|recurrent colon cancer|recurrent colon cancer
1687601|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
1687602|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
1687603|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1687604|NCT00005944|liver metastases|liver metastases
1687605|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1687606|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1687607|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1687608|NCT00080067|Movement|movement
1687609|NCT00080067|Anticipation|anticipation
1687610|NCT00080067|Stimulation|stimulation
1687611|NCT00080067|Timing|timing
1687612|NCT00080067|Execution|execution
1687613|NCT00080067|Perception|perception
1687614|NCT00080067|Rhythm|rhythm
1687615|NCT00080067|Healthy Volunteer|healthy volunteer
1687616|NCT00080067|HV|hv
1687617|NCT00080054|Malignant Glioma|malignant glioma
1687618|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
1687619|NCT00080054|GBM|gbm
1687620|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
1687621|NCT00080054|AA|aa
1687622|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1687623|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
1687624|NCT00080054|Brain tumor|brain tumor
1687625|NCT00080054|Brain neoplasm|brain neoplasm
1687626|NCT00080054|Glioma|glioma
1687627|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
1687628|NCT00080028|Head and Neck Cancer|head and neck cancer
1687629|NCT00080028|SCCHN|scchn
1687630|NCT00080028|Oropharynx Cancer|oropharynx cancer
1687631|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
1687632|NCT00080028|Larynx Cancer|larynx cancer
1687633|NCT00080028|Soft palate Cancer|soft palate cancer
1687634|NCT00080028|Tonsil Cancer|tonsil cancer
1687635|NCT00080028|Base of tongue Cancer|base of tongue cancer
1687636|NCT00080028|Supraglottic Cancer|supraglottic cancer
1687637|NCT00080028|Glottic Cancer|glottic cancer
1687638|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
1687639|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
1687640|NCT00080028|Throat cancer|throat cancer
1687642|NCT00080002|gastric|gastric
1687643|NCT00080002|gastroesophageal junction|gastroesophageal junction
1687644|NCT00080002|neoplasms|neoplasms
1687647|NCT00079989|Bacterial Infections|bacterial infections
1687648|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
1687649|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
1687650|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
1687651|NCT00004123|adult liposarcoma|adult liposarcoma
1687652|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1687653|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1687654|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1687655|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687656|NCT00003817|nausea and vomiting|nausea and vomiting
1687657|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687658|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1687659|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687660|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1687661|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
1687662|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1687663|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1687664|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1687665|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1687666|NCT00003647|adult solid tumor|adult solid tumor
1687667|NCT00003647|body system/site cancer|body system/site cancer
1687669|NCT00003647|melanoma|melanoma
1687670|NCT00003647|recurrent melanoma|recurrent melanoma
1687671|NCT00003647|skin tumor|skin tumor
1687672|NCT00003647|solid tumor|solid tumor
1687673|NCT00003647|stage III melanoma|stage iii melanoma
1687674|NCT00003647|stage IV melanoma|stage iv melanoma
1687675|NCT00003647|stage, melanoma|stage, melanoma
1687676|NCT00079976|Staphylococcus aureus|staphylococcus aureus
1687677|NCT00079976|Bacterial Infections|bacterial infections
1687678|NCT00079950|soft|soft
1687679|NCT00079950|sarcoma|sarcoma
1687680|NCT00079950|metastatic|metastatic
1687681|NCT00079937|allergic|allergic
1687682|NCT00079937|asthma|asthma
1687683|NCT00079937|atopic|atopic
1687684|NCT00079937|omalizumab|omalizumab
1687685|NCT00079937|immunoglobulin E|immunoglobulin e
1687686|NCT00079937|IgE|ige
1687687|NCT00079937|anti-IgE|anti-ige
1687688|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687689|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1687690|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1687691|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1687692|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1687693|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1687694|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687695|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687696|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687697|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687698|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687699|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1687700|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1687701|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1687702|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1687703|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1687704|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1687705|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1687706|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1687707|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687708|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687709|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1687710|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1687711|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687712|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687713|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1687714|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1687715|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1687716|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1687717|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1687718|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1687719|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1687720|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1687721|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687722|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687723|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687724|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1687725|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1687726|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1687727|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1687728|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1687729|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1687730|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
1687731|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
1687732|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1687733|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1687734|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1687735|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1687736|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
1687737|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
1687738|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
1687739|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
1687740|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
1687741|NCT00003274|stage II melanoma|stage ii melanoma
1687742|NCT00079911|Herpes|herpes
1687743|NCT00079911|Genital Herpes|genital herpes
1687744|NCT00079911|HIV|hiv
1687745|NCT00079911|HSV|hsv
1687746|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
1687747|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
1687748|NCT00022360|adult glioblastoma|adult glioblastoma
1687749|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1687750|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
1687751|NCT00022360|adult gliosarcoma|adult gliosarcoma
1687752|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687753|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
1687754|NCT00021138|small cell lung cancer|small cell lung cancer
1687755|NCT00021138|esophageal cancer|esophageal cancer
1687756|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
1687757|NCT00021138|laryngeal cancer|laryngeal cancer
1687758|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
1687759|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
1687760|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
1687761|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1687762|NCT00021138|tongue cancer|tongue cancer
1687763|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687764|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1687765|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1687766|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
1687767|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
1687768|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
1687769|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
1687770|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
1687771|NCT00079820|Smallpox|smallpox
1687772|NCT00079820|Smallpox Vaccine|smallpox vaccine
1687773|NCT00079820|Variola virus|variola virus
1687774|NCT00079820|Smallpox Virus|smallpox virus
1687775|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
1687776|NCT00079820|MVA|mva
1687777|NCT00079820|Dryvax|dryvax
1687778|NCT00079820|Dryvax vaccine|dryvax vaccine
1687779|NCT00079820|Protection against smallpox|protection against smallpox
1687780|NCT00020930|stage IV colon cancer|stage iv colon cancer
1687781|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
1687782|NCT00020930|recurrent colon cancer|recurrent colon cancer
1687783|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
1687784|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1687785|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1687786|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1687787|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1687914|NCT00014300|adult gliosarcoma|adult gliosarcoma
1687788|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1687789|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1687790|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1687791|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1687792|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1687793|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1687794|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1687795|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1687796|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1687797|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1687925|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
1687798|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1687799|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687800|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1687801|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687802|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687803|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687804|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687805|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1687806|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1687807|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1687808|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1687809|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1687810|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1687811|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1687812|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
1687813|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1687814|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1687815|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1687816|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1687817|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1687818|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1687819|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1687820|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1687821|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1687822|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1687823|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1687824|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
1687825|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1687826|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1687827|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1687828|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1687829|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1687830|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1687831|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1687832|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1687833|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1687834|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1687835|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1687836|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1687837|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1687838|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1687839|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1687840|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1687841|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1687842|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1687843|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687844|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687845|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687846|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687847|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687848|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687849|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687850|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687851|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687852|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1687853|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1687854|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1687855|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1687856|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1687857|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1687858|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1687859|NCT00020865|neutropenia|neutropenia
1687860|NCT00020865|infection|infection
1688063|NCT00004109|Doxorubicin|doxorubicin
1687861|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
1687862|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1687863|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1687864|NCT00020865|intraocular lymphoma|intraocular lymphoma
1687865|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1687866|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1687867|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1687868|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1687869|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1687870|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1687871|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1687872|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1687873|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1687874|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1687875|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1687876|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1687877|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1687878|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1687879|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1687880|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1687881|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1687882|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1687883|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1687884|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1687885|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1687886|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1687887|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1687888|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687889|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1687890|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1687891|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1687892|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1687893|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1687894|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1687895|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1687896|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1687897|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1687898|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687899|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687900|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1687901|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1687902|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1687903|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1687904|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1687905|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1687906|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1687907|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1687908|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687909|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687910|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687911|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
1687912|NCT00014300|adult glioblastoma|adult glioblastoma
1687913|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
1687915|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
1687916|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
1687917|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1687918|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1687919|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687920|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687921|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687922|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1687923|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1687924|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1688149|NCT00079664|Tai Ji|tai ji
1687926|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1687927|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1687928|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687929|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1687930|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
1687931|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1687932|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1687933|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1687934|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1687935|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1687936|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1687937|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1687938|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1687939|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1687940|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1687941|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1687942|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1687943|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1687944|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1687945|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1687946|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1687947|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1687948|NCT00079807|HIV|hiv
1687949|NCT00079807|Peripheral neuropathy|peripheral neuropathy
1687950|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
1687951|NCT00079807|ALA|ala
1687952|NCT00079807|Complementary Therapies|complementary therapies
1687953|NCT00079794|lung cancer|lung cancer
1687954|NCT00079794|herbal medicine|herbal medicine
1687955|NCT00079794|non-small cell cancer|non-small cell cancer
1687956|NCT00079794|Iscar|iscar
1687957|NCT00079794|mistletoe|mistletoe
1687958|NCT00079781|Responsive Stimulation|responsive stimulation
1687959|NCT00079781|Brain Stimulator|brain stimulator
1687960|NCT00079781|Epilepsy|epilepsy
1687961|NCT00079781|Seizures|seizures
1687962|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
1687963|NCT00079755|Lymphoma|lymphoma
1687964|NCT00079755|antigens, CD30|antigens, cd30
1687965|NCT00079755|Monoclonal Antibody|monoclonal antibody
1687966|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
1687967|NCT00079716|Antigens, CD40|antigens, cd40
1687968|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
1687969|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
1687970|NCT00079716|Hematologic Diseases|hematologic diseases
1687971|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
1687972|NCT00079716|Hemostatic Disorders|hemostatic disorders
1687973|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
1687974|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
1687975|NCT00079716|Paraproteinemias|paraproteinemias
1687976|NCT00079716|Vascular Diseases|vascular diseases
1687977|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
1687978|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1687979|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1687980|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1687981|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1687982|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
1687983|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
1687984|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1687985|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1687986|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1687987|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
1687988|NCT00006026|anterior urethral cancer|anterior urethral cancer
1687989|NCT00006026|posterior urethral cancer|posterior urethral cancer
1687990|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1687991|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1687992|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1687993|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1687994|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1687995|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
1687996|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1688064|NCT00004109|External-Beam RT|external-beam rt
1687997|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1687998|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1687999|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1688000|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1688001|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1688002|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1688003|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
1688004|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
1688005|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
1688006|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
1688007|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
1688008|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
1688009|NCT00005635|stage IV breast cancer|stage iv breast cancer
1688010|NCT00005635|recurrent breast cancer|recurrent breast cancer
1688011|NCT00005085|stage IV colon cancer|stage iv colon cancer
1688012|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
1688013|NCT00005085|recurrent colon cancer|recurrent colon cancer
1688014|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
1688015|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
1688016|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1688017|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688018|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688019|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688020|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688021|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688022|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688023|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
1688024|NCT00004909|quality of life|quality of life
1688025|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1688026|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1688027|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1688028|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1688029|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1688030|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1688031|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1688032|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1688033|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1688034|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1688035|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1688036|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1688037|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1688038|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1688039|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688040|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688041|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
1688042|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
1688043|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
1688044|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1688045|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1688046|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1688047|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1688048|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1688049|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1688050|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1688051|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1688052|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688053|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1688054|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688055|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688056|NCT00004142|stage IV colon cancer|stage iv colon cancer
1688057|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
1688058|NCT00004142|recurrent colon cancer|recurrent colon cancer
1688059|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
1688060|NCT00004142|liver metastases|liver metastases
1688061|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1688062|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1689536|NCT00078377|Sleep Attacks|sleep attacks
1688150|NCT00079651|Aged|aged
1688067|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
1688068|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
1688069|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
1688070|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
1688071|NCT00004109|Surgical Resection|surgical resection
1688072|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
1688073|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
1688074|NCT00003959|refractory anemia|refractory anemia
1688075|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1688076|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
1688077|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1688078|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1688079|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1688080|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1688081|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
1688082|NCT00003779|stage I bladder cancer|stage i bladder cancer
1688083|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1688084|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1688085|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688086|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1688087|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688088|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688089|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688090|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688091|NCT00003704|stage III colon cancer|stage iii colon cancer
1688092|NCT00003704|stage III rectal cancer|stage iii rectal cancer
1688093|NCT00003704|recurrent colon cancer|recurrent colon cancer
1688094|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
1688095|NCT00003704|recurrent anal cancer|recurrent anal cancer
1688096|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
1688097|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
1688098|NCT00003704|stage III cervical cancer|stage iii cervical cancer
1688099|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
1688100|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688101|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688102|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
1688103|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
1688104|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
1688105|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
1688106|NCT00003704|stage III penile cancer|stage iii penile cancer
1688107|NCT00003704|recurrent penile cancer|recurrent penile cancer
1688108|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
1688109|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1688110|NCT00003704|stage III bladder cancer|stage iii bladder cancer
1688111|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
1688112|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1688113|NCT00003704|stage III prostate cancer|stage iii prostate cancer
1688114|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
1688115|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1688116|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
1688117|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
1688118|NCT00003704|distal urethral cancer|distal urethral cancer
1688119|NCT00003704|proximal urethral cancer|proximal urethral cancer
1688120|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1688121|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1688122|NCT00003704|fallopian tube cancer|fallopian tube cancer
1688123|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1688124|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
1688125|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
1688126|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1688127|NCT00003704|ovarian sarcoma|ovarian sarcoma
1688128|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688129|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1688130|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688131|NCT00079768|Inflammation|inflammation
1688132|NCT00079768|Myositis|myositis
1688133|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
1688134|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
1688135|NCT00079768|Endomysial T Cells|endomysial t cells
1688136|NCT00079768|Alemtuzumab|alemtuzumab
1688137|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
1688139|NCT00079768|Anti-CD 52|anti-cd 52
1688140|NCT00079768|Inclusion Body Myositis|inclusion body myositis
1688141|NCT00079729|Treatment Experienced|treatment experienced
1688142|NCT00079677|Excessive Sleepiness|excessive sleepiness
1688143|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
1688144|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
1688147|NCT00079677|Cephalon, Inc|cephalon, inc
1688151|NCT00079651|Nursing Homes|nursing homes
1688152|NCT00079651|Assisted Living Facilities|assisted living facilities
1688153|NCT00079638|Niaspan|niaspan
1688154|NCT00079638|Niacin|niacin
1688155|NCT00079638|Statin|statin
1688156|NCT00079638|Cholesterol|cholesterol
1688157|NCT00079638|Triglycerides|triglycerides
1688158|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
1688159|NCT00079638|Dyslipidemia|dyslipidemia
1688160|NCT00079638|Coronary Heart Disease|coronary heart disease
1688161|NCT00079638|Atherosclerosis|atherosclerosis
1688162|NCT00079638|Stroke|stroke
1688163|NCT00079638|VA-HIT|va-hit
1688164|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
1688165|NCT00079638|High Density Lipoprotein|high density lipoprotein
1688166|NCT00079638|Low Density Lipoprotein|low density lipoprotein
1688167|NCT00079638|Hypertension|hypertension
1688168|NCT00079638|Diabetes|diabetes
1688169|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
1688170|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
1688171|NCT00003617|stage I gastric cancer|stage i gastric cancer
1688172|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
1688173|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1688174|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1688175|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1688176|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1688177|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1690054|NCT00003046|recurrent anal cancer|recurrent anal cancer
1688178|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1688179|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1688180|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1688181|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1688182|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1688183|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1688184|NCT00003368|small intestine lymphoma|small intestine lymphoma
1688185|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688186|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1688187|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688188|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688189|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1688190|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1688191|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688192|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1688193|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1688194|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1688195|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1688196|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1688197|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688198|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1688199|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1688200|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688201|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1688202|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1688203|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1688204|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1688205|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1688206|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1688207|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1688208|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1688209|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688210|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1688211|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1688212|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688213|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1688214|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1688215|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1688216|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1688217|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1688218|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1688219|NCT00003368|intraocular lymphoma|intraocular lymphoma
1688220|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1688221|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1688910|NCT00078611|Regional Enteritis|regional enteritis
1688222|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1688223|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1688224|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1688225|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1688226|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1688227|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1688228|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1688229|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1688230|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1688231|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1688232|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688233|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1688234|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1688235|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1688236|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1688237|NCT00003361|refractory anemia|refractory anemia
1688238|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1688239|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
1688240|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1688241|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1688242|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1688243|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1688244|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1688245|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1688246|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1688247|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1688248|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1688249|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1688250|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1688251|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1688252|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1688253|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1688254|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1688255|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1688256|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688257|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688258|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1688259|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1688260|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688261|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1688262|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1688263|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1688264|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1688265|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1688266|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688267|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1688268|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1688269|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688270|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1688271|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1688272|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1688273|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1688274|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1688275|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1688276|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1688277|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1688278|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688279|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1688280|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1688281|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688282|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1688283|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1688405|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1688284|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1688911|NCT00078611|Colitis|colitis
1688285|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1688286|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1688287|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1688288|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1688289|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1688290|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1688291|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1688292|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1688293|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1688294|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1688295|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1688296|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1688297|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1688298|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1688299|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1688300|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1688301|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1688302|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1688303|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1688304|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1688305|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1688306|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1688307|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1688308|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1688309|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1688310|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1688311|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1688312|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1688313|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1688314|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688315|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1688316|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1688317|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1688318|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1688319|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1688320|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1688321|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1688322|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1688323|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1688324|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1688325|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1688326|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1688327|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1688328|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1688329|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1688330|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1688331|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688332|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688520|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
1688333|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1688334|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1688335|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688336|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1688337|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1688338|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1688339|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1688340|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1688341|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688342|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1688406|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
1688343|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1688344|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688345|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1688346|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1688347|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1688348|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1688349|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1688350|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1688351|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1688352|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1688353|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688354|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1688355|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1688356|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688357|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1688358|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1688359|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1688360|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1688361|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1688362|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1688363|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1688364|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1688365|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1688366|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1688367|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1688368|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1688369|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1688370|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1688371|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1688372|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1688373|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1688374|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1688375|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1688376|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1688377|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1688378|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1688379|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1688380|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1688381|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1688382|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1688383|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1688384|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1688385|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1688386|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1688387|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1688388|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1688389|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688390|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1688391|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1688392|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1699809|NCT00059553|treadmill|treadmill
1688393|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1688394|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1688395|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1688396|NCT00003212|adult angiosarcoma|adult angiosarcoma
1688397|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
1688398|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
1688399|NCT00003212|adult liposarcoma|adult liposarcoma
1688400|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
1688401|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
1688402|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1688403|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1688404|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1688407|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
1688408|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1688409|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688410|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1688411|NCT00003014|testicular seminoma|testicular seminoma
1688412|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1688413|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1688414|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
1688415|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
1688416|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
1688417|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1688418|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688419|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688420|NCT00002919|stage II bladder cancer|stage ii bladder cancer
1688421|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1688422|NCT00002901|stage IV breast cancer|stage iv breast cancer
1688423|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
1688424|NCT00002901|recurrent breast cancer|recurrent breast cancer
1688425|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
1688426|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688427|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688428|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1688429|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688430|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1688431|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1688432|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688433|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688434|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688435|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1688436|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
1688437|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1688438|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1688439|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1688440|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1688441|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1688442|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1688443|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1688444|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1688445|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1688446|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1688447|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1688448|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1688449|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1688450|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1688451|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1688452|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1688453|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1688454|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1688455|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1688456|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1688457|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1714207|NCT00050804|Emotion|emotion
1688458|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1688459|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1688460|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1688461|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1688462|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1688463|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1688464|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1688465|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1688466|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1688467|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1688468|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1713182|NCT00002850|infection|infection
1688469|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1688470|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1688471|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1688472|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1688473|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1688474|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1688475|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1688476|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1688477|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1688478|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1688479|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1688480|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1688481|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1688482|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1688483|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1688484|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1688485|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1688486|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1688487|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1688488|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1688489|NCT00002901|ovarian sarcoma|ovarian sarcoma
1688490|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
1688491|NCT00079612|Renal Cell Cancer|renal cell cancer
1688493|NCT00079612|Cancer|cancer
1688494|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
1688495|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
1688496|NCT00079508|HIT/HITTS|hit/hitts
1688497|NCT00079508|Heparin anti-body positive|heparin anti-body positive
1688498|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
1688499|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
1688500|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
1688501|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1688502|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1688503|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1688504|NCT00016978|stage IV colon cancer|stage iv colon cancer
1688505|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
1688506|NCT00016978|recurrent colon cancer|recurrent colon cancer
1688507|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
1688508|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
1688509|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1688510|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1688511|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
1688512|NCT00007969|stage III melanoma|stage iii melanoma
1688513|NCT00007969|stage IV melanoma|stage iv melanoma
1688514|NCT00007969|recurrent melanoma|recurrent melanoma
1688515|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1688516|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1688517|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1688518|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
1688519|NCT00002823|large cell lung cancer|large cell lung cancer
1688521|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1688522|NCT00002650|colon cancer|colon cancer
1688523|NCT00002650|rectal cancer|rectal cancer
1688524|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
1688525|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1688526|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1688527|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
1688528|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1688529|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1688530|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1688531|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1688532|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1688624|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
1688533|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1714032|NCT00051532|liver|liver
1688534|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1688535|NCT00002581|stage I breast cancer|stage i breast cancer
1688536|NCT00002581|stage II breast cancer|stage ii breast cancer
1688537|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
1688538|NCT00002580|stage I breast cancer|stage i breast cancer
1688539|NCT00002580|stage II breast cancer|stage ii breast cancer
1688540|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
1688541|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688542|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1688543|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688544|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688545|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1688546|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1688547|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
1688548|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
1688549|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
1688550|NCT00002526|ovarian sarcoma|ovarian sarcoma
1688551|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1688552|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1688553|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1688554|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
1688555|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1688556|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
1688557|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
1688558|NCT00002480|stage III prostate cancer|stage iii prostate cancer
1688559|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
1688560|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
1688561|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
1688562|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
1688563|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
1688564|NCT00079625|Engraftment|engraftment
1688565|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
1688566|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
1688567|NCT00079625|MBC|mbc
1688568|NCT00079599|Carnitine Deficiency|carnitine deficiency
1688569|NCT00079599|Fatigue|fatigue
1688570|NCT00079599|Complementary Therapies|complementary therapies
1688571|NCT00079573|Weight Loss|weight loss
1688572|NCT00079573|Obesity|obesity
1688573|NCT00079573|Overweight|overweight
1688574|NCT00079573|Premenopausal women|premenopausal women
1688575|NCT00079573|Diet|diet
1688576|NCT00079560|HIV|hiv
1688577|NCT00079560|Marijuana|marijuana
1688578|NCT00079560|Marinol|marinol
1688579|NCT00079560|Oral THC|oral thc
1688580|NCT00079560|Appetite|appetite
1688581|NCT00079560|Complementary Therapies|complementary therapies
1688582|NCT00079547|Weight Loss|weight loss
1688583|NCT00079534|AIDS|aids
1688584|NCT00079534|HIV|hiv
1688585|NCT00079534|Prayer|prayer
1688586|NCT00079534|Healing|healing
1688587|NCT00079534|Complementary Therapies|complementary therapies
1688588|NCT00079521|Bone Metabolism|bone metabolism
1688589|NCT00079521|Therapeutic Touch|therapeutic touch
1688590|NCT00079495|MS|ms
1688591|NCT00079495|Autoimmune disease|autoimmune disease
1688592|NCT00079495|relapsing|relapsing
1688593|NCT00079495|progressive|progressive
1688594|NCT00079495|Myelin|myelin
1688595|NCT00079495|Myelin Basic Protein|myelin basic protein
1688596|NCT00079495|MBP|mbp
1688597|NCT00079495|acute fulminating|acute fulminating
1688598|NCT00079495|chronic progressive|chronic progressive
1688599|NCT00079495|Altered Peptide Ligand|altered peptide ligand
1688600|NCT00079495|APL|apl
1688601|NCT00079495|Neurocrine|neurocrine
1688602|NCT00079495|NBI-5788|nbi-5788
1688603|NCT00079495|Relapse|relapse
1688604|NCT00079482|AML|aml
1688605|NCT00079469|cancer survivor|cancer survivor
1688606|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688607|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1688608|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1688609|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1688610|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1688611|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
1688612|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
1688613|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
1688614|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
1688615|NCT00079391|Cyclosporine|cyclosporine
1688616|NCT00079391|Fludarabine|fludarabine
1688617|NCT00079391|Leukemia|leukemia
1688618|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
1688619|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
1688620|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
1688621|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1688622|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
1688623|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
1688630|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1714033|NCT00051532|cancer|cancer
1688631|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1688632|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
1688633|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
1688634|NCT00079313|Leukemia|leukemia
1688635|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1688636|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
1688637|NCT00079287|large cell lung cancer|large cell lung cancer
1688638|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688639|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
1688640|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688641|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688642|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1688643|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1688644|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688645|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688646|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1688647|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1688648|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688649|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688650|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1688651|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1688652|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1688653|NCT00079261|small intestine lymphoma|small intestine lymphoma
1688654|NCT00079248|osteoporosis|osteoporosis
1688655|NCT00079248|stage I breast cancer|stage i breast cancer
1688656|NCT00079248|stage II breast cancer|stage ii breast cancer
1688657|NCT00079248|menopausal symptoms|menopausal symptoms
1688658|NCT00079248|hot flashes|hot flashes
1688659|NCT00079222|infection|infection
1688660|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1688661|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1688662|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1688663|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1688664|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1688665|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1688666|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1688667|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1688668|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1688669|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1688670|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1688671|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1688672|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1688673|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1688674|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1688675|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1688676|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1688677|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1688678|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1688679|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1688680|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1688681|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1688682|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1688683|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1688684|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1688685|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1688686|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1688687|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1688688|NCT00079222|primary myelofibrosis|primary myelofibrosis
1688689|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1688690|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
1688691|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
1688692|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
1688693|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
1688694|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
1688695|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688696|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688697|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1688912|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
1688698|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1688699|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1688700|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1688701|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1688702|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1688703|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1688704|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1688705|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1688706|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1688707|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1688708|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1688709|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1688710|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1688711|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1688712|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1688713|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1688714|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1688715|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1688716|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1688717|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1688718|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1688719|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1688720|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1688721|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1688722|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688723|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1688724|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1688725|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1688726|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1688727|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1688728|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688729|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688730|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1688731|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1688732|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688733|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1688734|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1688735|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1688736|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1688737|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1688738|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1688739|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688740|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1688741|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1688742|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1688743|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1688744|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688816|NCT00079066|recurrent colon cancer|recurrent colon cancer
1688745|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1688746|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688747|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1688748|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1688749|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
1688750|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
1688751|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1688752|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1688753|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1688754|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1688755|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
1688756|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
1688757|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
1688758|NCT00079222|stage IV breast cancer|stage iv breast cancer
1688759|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1688760|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1688761|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1688762|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1688763|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1688764|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1688765|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1688766|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688767|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1688768|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1688769|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1688770|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1688771|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1688772|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1688773|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1688774|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1688775|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1688776|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1688777|NCT00079170|male breast cancer|male breast cancer
1688778|NCT00079170|recurrent breast cancer|recurrent breast cancer
1688779|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
1688780|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
1688781|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
1688782|NCT00079170|stage IV breast cancer|stage iv breast cancer
1688783|NCT00079157|recurrent breast cancer|recurrent breast cancer
1688784|NCT00079157|stage IV breast cancer|stage iv breast cancer
1688785|NCT00079144|recurrent melanoma|recurrent melanoma
1688786|NCT00079144|stage IV melanoma|stage iv melanoma
1688787|NCT00079118|stage IV breast cancer|stage iv breast cancer
1688788|NCT00079118|recurrent breast cancer|recurrent breast cancer
1688789|NCT00079118|male breast cancer|male breast cancer
1688790|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1688791|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1688792|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1688793|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1688794|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
1688795|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1688796|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1688797|NCT00079092|adult glioblastoma|adult glioblastoma
1688798|NCT00079092|adult mixed glioma|adult mixed glioma
1688799|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
1688800|NCT00079092|adult gliosarcoma|adult gliosarcoma
1688801|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
1688802|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
1688803|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
1688804|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
1688805|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1688806|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1688807|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1688808|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1688809|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1688810|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1688811|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1688812|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1688813|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1688814|NCT00079066|quality of life|quality of life
1688815|NCT00079066|stage IV colon cancer|stage iv colon cancer
1688817|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
1688818|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
1688819|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1688820|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1688821|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1688822|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1688823|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1688824|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1688825|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1688826|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1688827|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1688828|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1688829|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1688830|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1688831|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1688832|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
1688833|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
1688834|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
1688835|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1688836|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1688837|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
1688838|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
1688839|NCT00079001|bone metastases|bone metastases
1688840|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1688841|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1688842|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1688843|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1688844|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
1688845|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
1688846|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
1688847|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
1688848|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1688849|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688850|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688851|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1688852|NCT00078923|stage I prostate cancer|stage i prostate cancer
1688853|NCT00078923|stage II prostate cancer|stage ii prostate cancer
1688854|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1688855|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1688856|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
1688857|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
1688858|NCT00078910|stage III prostate cancer|stage iii prostate cancer
1688859|NCT00078897|colon cancer|colon cancer
1688860|NCT00078897|rectal cancer|rectal cancer
1688861|NCT00078897|colorectal cancer|colorectal cancer
1688862|NCT00078897|adenomatous polyp|adenomatous polyp
1688863|NCT00078845|neurotoxicity|neurotoxicity
1688864|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1688865|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
1688866|NCT00078845|stage I prostate cancer|stage i prostate cancer
1688867|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
1688868|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
1688869|NCT00078845|stage III prostate cancer|stage iii prostate cancer
1688870|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
1688871|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1688872|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1688873|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1688874|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1688875|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1688876|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1688877|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
1688878|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1688879|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
1688880|NCT00078845|recurrent breast cancer|recurrent breast cancer
1688881|NCT00078845|stage I breast cancer|stage i breast cancer
1688882|NCT00078845|stage II breast cancer|stage ii breast cancer
1688883|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
1688884|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
1688885|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
1688886|NCT00078845|stage IV breast cancer|stage iv breast cancer
1688887|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1688888|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1688889|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1688890|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1688891|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1688892|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
1688893|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
1688894|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthiritis|systemic onset juvenile rheumatoid arthiritis
1688896|NCT00078806|Fever|fever
1688897|NCT00078806|Rash|rash
1688898|NCT00078806|Joint Pain|joint pain
1688899|NCT00078793|JRA|jra
1688900|NCT00078793|Registry|registry
1688901|NCT00078767|PTSD|ptsd
1688902|NCT00078767|Depression|depression
1688903|NCT00078767|Anxiety|anxiety
1688904|NCT00078741|Psychotic Disorders|psychotic disorders
1688905|NCT00078728|Anxiety|anxiety
1688906|NCT00078611|Crohn's disease|crohn's disease
1688907|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
1688908|NCT00078611|IBD|ibd
1688909|NCT00078611|Gastroenterology|gastroenterology
1688913|NCT00007007|radiation toxicity|radiation toxicity
1688914|NCT00007007|cognitive/functional effects|cognitive/functional effects
1688915|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
1688916|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
1688917|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
1688918|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
1688919|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
1688920|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
1688921|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1688922|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1688923|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
1688924|NCT00006452|adult glioblastoma|adult glioblastoma
1688925|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
1688926|NCT00006452|adult gliosarcoma|adult gliosarcoma
1688927|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1688928|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
1688929|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
1688930|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
1688931|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
1688932|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1688933|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1688934|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1688935|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1688936|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1688937|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1688938|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1688939|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1688940|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1688941|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1688942|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1688943|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1688944|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1688945|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1688946|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1688947|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1688948|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1688949|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1688950|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1688951|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1688952|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1688953|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1688954|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1688955|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1688956|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1688957|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1688958|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1688959|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1688960|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1688961|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1688962|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1688963|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689108|NCT00005096|stage II prostate cancer|stage ii prostate cancer
1688964|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1688965|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1688966|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1688967|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1688968|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1688969|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1688970|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1688971|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1688972|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1688973|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1688974|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1688975|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1688976|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1688977|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1689520|NCT00078390|Non small cell lung cancer|non small cell lung cancer
1688978|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1688979|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1688980|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1688981|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1688982|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1688983|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1688984|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1688985|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1688986|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1688987|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1688988|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1688989|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1688990|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1688991|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1688992|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1688993|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1688994|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1688995|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1688996|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1688997|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1688998|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1688999|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689000|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1689001|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1689002|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689003|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689004|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689005|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
1689006|NCT00006253|symptom management|symptom management
1689007|NCT00006253|cancer|cancer
1689008|NCT00006253|chemotherapy treatment|chemotherapy treatment
1689009|NCT00006253|Behavioral Research|behavioral research
1689010|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
1689011|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
1689012|NCT00006126|stage IV breast cancer|stage iv breast cancer
1689013|NCT00006126|recurrent breast cancer|recurrent breast cancer
1689014|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
1689015|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
1689016|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1689017|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
1689018|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1689019|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1689020|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1689021|NCT00006126|stage IV melanoma|stage iv melanoma
1689022|NCT00006126|recurrent melanoma|recurrent melanoma
1689023|NCT00006115|stage IV colon cancer|stage iv colon cancer
1689024|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
1689025|NCT00006115|recurrent colon cancer|recurrent colon cancer
1689026|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
1689027|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
1689028|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1689029|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689030|NCT00078715|Yohimbine|yohimbine
1689031|NCT00078715|Sleep Deprivation|sleep deprivation
1689032|NCT00078715|Depression|depression
1689033|NCT00078715|Mood Disorder|mood disorder
1689034|NCT00078715|Fast|fast
1689035|NCT00078715|Affective Disorder|affective disorder
1689036|NCT00078715|Rapid Onset|rapid onset
1689037|NCT00078715|Major Depression|major depression
1689038|NCT00078715|MDD|mdd
1689039|NCT00078689|Sirolimus|sirolimus
1689040|NCT00078689|Daclizumab|daclizumab
1689041|NCT00078689|Inflammation|inflammation
1689042|NCT00078689|Induce Tolerance|induce tolerance
1689043|NCT00078689|Uveitis|uveitis
1689044|NCT00078689|Immune Tolerance|immune tolerance
1689045|NCT00078689|T Cell|t cell
1689046|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689047|NCT00005965|stage III cervical cancer|stage iii cervical cancer
1689048|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
1689049|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
1689050|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
1689680|NCT00078351|Synvisc|synvisc
1689051|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1689052|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
1689053|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1689054|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1689055|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
1689056|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
1689057|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1689058|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689059|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
1689060|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1689061|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1689062|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1689063|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1689064|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1689065|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1689066|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1689067|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1689068|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1689069|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1689070|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689071|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689072|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689073|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689074|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689075|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689076|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689077|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1689078|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1689079|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1689080|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1689081|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1689082|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1689083|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1689084|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689085|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689086|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689087|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689088|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689089|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1689090|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
1689091|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1689092|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
1689093|NCT00078663|Oral Care|oral care
1689095|NCT00078663|Pneumonia|pneumonia
1689096|NCT00078663|Pathogens|pathogens
1689097|NCT00078663|Intubation|intubation
1689098|NCT00078663|Intubated|intubated
1689099|NCT00078663|Oral Hygiene|oral hygiene
1689100|NCT00078663|Intensive Care|intensive care
1689101|NCT00078624|Osteoarthritis|osteoarthritis
1689102|NCT00078624|Knee Joint|knee joint
1689103|NCT00078624|Joint Stability|joint stability
1689104|NCT00078624|Motor Control|motor control
1689105|NCT00078624|Exercise Therapy|exercise therapy
1689106|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689107|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1689109|NCT00005096|stage III prostate cancer|stage iii prostate cancer
1689110|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1689111|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1689112|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1689113|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1689114|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1689115|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1689116|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1689117|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1689118|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1689119|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1689188|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
1689120|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1689121|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1689122|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1689123|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1689124|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1689125|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1689126|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1689127|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1689128|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1689129|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689130|NCT00004914|anemia|anemia
1689131|NCT00004914|fatigue|fatigue
1689132|NCT00078598|Relapsed|relapsed
1689133|NCT00078598|Follicular|follicular
1689134|NCT00078572|XELODA|xeloda
1689135|NCT00078572|Metastatic|metastatic
1689136|NCT00078572|Breast Cancer|breast cancer
1689137|NCT00078572|Advanced|advanced
1689138|NCT00078572|HERCEPTIN|herceptin
1689139|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
1689140|NCT00078507|Behavior Control|behavior control
1689141|NCT00078507|Sensation|sensation
1689142|NCT00078507|Randomized Controlled Trials|randomized controlled trials
1689143|NCT00078507|Adolescent|adolescent
1689144|NCT00078507|Adult|adult
1689145|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689146|NCT00004912|fatigue|fatigue
1689147|NCT00004912|cachexia|cachexia
1689148|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689149|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1689150|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689151|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689152|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689153|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689154|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689155|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689156|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689157|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1689158|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689159|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689160|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689161|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689162|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689163|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1689164|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1689165|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1689166|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1689167|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1689168|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
1689169|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
1689170|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1689171|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
1689172|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1689173|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1689315|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
1689174|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1689175|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1689176|NCT00004904|small intestine lymphoma|small intestine lymphoma
1689177|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1689178|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1689179|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1689180|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1689181|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1689182|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1689183|NCT00004904|polycythemia vera|polycythemia vera
1689184|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1689185|NCT00004904|essential thrombocythemia|essential thrombocythemia
1689186|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
1689187|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1689189|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1689190|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1689191|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1689192|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1689193|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1689194|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1689195|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1689196|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1689197|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1689198|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1689199|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1689200|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1689201|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1689202|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1689203|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1689204|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1689205|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1689206|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1689207|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689208|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689209|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689210|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689211|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689212|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689213|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689214|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1689215|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1689216|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1689217|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1689218|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1689219|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1689220|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1689221|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1689222|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1689223|NCT00004904|graft versus host disease|graft versus host disease
1689224|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
1689225|NCT00004904|intraocular lymphoma|intraocular lymphoma
1689226|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1689227|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1689228|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1689229|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1689230|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1689231|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1689232|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1689233|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1689234|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689235|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689236|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1689237|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1689238|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1689240|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689241|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689242|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689243|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1689244|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1689245|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1689246|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1689247|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1689248|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1689249|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1689250|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1689251|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1689252|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1689519|NCT00078390|Lung carcinoma|lung carcinoma
1689253|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1689254|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1689255|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1689256|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1689257|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1689258|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1689259|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1689260|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1689261|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1689262|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1689263|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1689264|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1689265|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689266|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1689267|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1689268|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1689269|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1689270|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1689271|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1689272|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1689273|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1689274|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1689275|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1689276|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1689277|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1689278|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
1689279|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
1689280|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
1689281|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
1689282|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
1689283|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
1689284|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1689285|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1689286|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
1689287|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
1689291|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
1689293|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
1689294|NCT00078533|Allogeneic|allogeneic
1689295|NCT00078533|Transplant|transplant
1689296|NCT00078533|CMV|cmv
1689297|NCT00078533|Stem Cell|stem cell
1689298|NCT00078533|Donor|donor
1689299|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
1689300|NCT00078520|Leukemia|leukemia
1689301|NCT00078494|Immunization|immunization
1689302|NCT00078494|Vaccine|vaccine
1689303|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
1689304|NCT00078494|Immunotherapy|immunotherapy
1689305|NCT00078494|Cancer|cancer
1689306|NCT00078494|NPC|npc
1689307|NCT00078481|Neurodegeneration|neurodegeneration
1689308|NCT00078481|Anti-Oxidant|anti-oxidant
1689309|NCT00078481|Neuropathy|neuropathy
1689310|NCT00078481|Hereditary|hereditary
1689311|NCT00078481|Spinocerebellar|spinocerebellar
1689312|NCT00078481|Friedreich Ataxia|friedreich ataxia
1689313|NCT00078481|FRDA|frda
1689314|NCT00078455|NSCLC|nsclc
1689316|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
1689317|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
1689318|NCT00078455|Metastatic NSCLC|metastatic nsclc
1689319|NCT00078221|Dry AMD|dry amd
1689320|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
1689321|NCT00078221|Rheopheresis|rheopheresis
1689322|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689323|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1689324|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1689325|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689326|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689327|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689328|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689329|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689330|NCT00004091|cervical cancer|cervical cancer
1689331|NCT00003351|stage IV breast cancer|stage iv breast cancer
1689332|NCT00003302|breast cancer|breast cancer
1689333|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
1689334|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
1714356|NCT00005926|Cancer|cancer
1689335|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1689336|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1689337|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1689338|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1689339|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1689340|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1689341|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1689342|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1689343|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1689344|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1689345|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1689346|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1689347|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1689348|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1689349|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1689350|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1689351|NCT00003070|cardiac toxicity|cardiac toxicity
1689352|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1689353|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1689354|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1689355|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1689356|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
1689357|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
1689358|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1689359|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1689360|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1689361|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1689362|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1689363|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1689364|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1689365|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
1689366|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
1689367|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1689368|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1689369|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1689370|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1689371|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1689372|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1689373|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1689374|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1689375|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1689376|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1689377|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1689378|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1689379|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1689380|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1689381|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1689382|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1689383|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1689384|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1689385|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1689386|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1689387|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1689388|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1689389|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1689390|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1689391|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689392|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689393|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689394|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689395|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689396|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689397|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1689398|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1689399|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1689400|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1689401|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1689402|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1689403|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1689404|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1689405|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1689406|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1689407|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1689408|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1689409|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1689410|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1689411|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1689412|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1689413|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1689414|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1689415|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1689416|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1689417|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689418|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689419|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1689420|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1689421|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1689422|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1689423|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1689424|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689425|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1689426|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1689427|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689428|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1689429|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1689431|NCT00024037|oral complications|oral complications
1689432|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1689433|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1689434|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1689435|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1689436|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
1689437|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1689438|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1689439|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1690444|NCT00077922|Lymphocytes|lymphocytes
1689583|NCT00078312|Excessive Sleepiness|excessive sleepiness
1689440|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1689441|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1689442|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1689443|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1689444|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1689445|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1689446|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1689447|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1689448|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1689449|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1689450|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1689451|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
1689452|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1689453|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689454|NCT00021996|pain|pain
1714357|NCT00005926|Gemzar|gemzar
1689455|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689456|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689457|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689458|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689459|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689460|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689461|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689462|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1689463|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1689464|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1689465|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689466|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689467|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689468|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689469|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689470|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689471|NCT00020618|pain|pain
1689472|NCT00020098|breast cancer|breast cancer
1689473|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1689474|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1689475|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1689476|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1689477|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1689478|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1689479|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1689480|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1689481|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1689482|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1689483|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1689484|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1689485|NCT00017303|Brenner tumor|brenner tumor
1689486|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1689487|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1689488|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1689489|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1689490|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1689491|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1689492|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1689493|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1689494|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1689495|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1689496|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1689497|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1689498|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1689499|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1689584|NCT00078312|Narcolepsy|narcolepsy
1689585|NCT00078312|Cataplexy|cataplexy
1689500|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1689501|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1689502|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1689503|NCT00002597|stage I prostate cancer|stage i prostate cancer
1689504|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
1689505|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
1689506|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1689507|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1689508|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1689509|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
1689510|NCT00002577|large cell lung cancer|large cell lung cancer
1689511|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1689512|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1689513|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
1689514|NCT00002454|lung papilloma|lung papilloma
1689515|NCT00078442|Treatment Experienced|treatment experienced
1689516|NCT00078442|Treatment Interruption|treatment interruption
1689517|NCT00078442|Treatment Naive|treatment naive
1689518|NCT00078390|Lung cancer|lung cancer
1689521|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
1689522|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
1689523|NCT00078390|NSCLC|nsclc
1689524|NCT00078390|Stage III|stage iii
1689525|NCT00078390|chemotherapy|chemotherapy
1689526|NCT00078390|radiation|radiation
1689527|NCT00078390|chemoradiation|chemoradiation
1689528|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
1689529|NCT00078390|neovascularization|neovascularization
1689530|NCT00078390|antiangiogenesis|antiangiogenesis
1689531|NCT00078390|type IV collagenases|type iv collagenases
1689532|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
1689533|NCT00078377|Narcolepsy|narcolepsy
1689534|NCT00078377|Excessive Sleepiness|excessive sleepiness
1689535|NCT00078377|Cataplexy|cataplexy
1689537|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
1689538|NCT00078377|Cephalon|cephalon
1689539|NCT00078377|Cephalon, Inc|cephalon, inc
1689541|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1689542|NCT00014690|fallopian tube cancer|fallopian tube cancer
1689543|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1689544|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
1689545|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
1689546|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1689547|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1689548|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1689549|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1689550|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1689551|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1689552|NCT00010179|fallopian tube cancer|fallopian tube cancer
1689553|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
1689554|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
1689555|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
1689556|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
1689557|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1689558|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1689559|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1689560|NCT00006365|stage I prostate cancer|stage i prostate cancer
1689561|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
1689562|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
1689563|NCT00006108|stage IV breast cancer|stage iv breast cancer
1689564|NCT00006108|recurrent breast cancer|recurrent breast cancer
1689565|NCT00006037|stage IV colon cancer|stage iv colon cancer
1689566|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
1689567|NCT00006037|recurrent colon cancer|recurrent colon cancer
1689568|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
1689569|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
1689570|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1689571|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
1689572|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1689573|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
1689574|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
1689575|NCT00078403|Treatment Experienced|treatment experienced
1689576|NCT00078325|Excessive Sleepiness|excessive sleepiness
1689577|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
1689578|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
1689579|NCT00078325|nCPAP|ncpap
1689580|NCT00078325|Cephalon|cephalon
1689581|NCT00078325|Cephalon, Inc|cephalon, inc
1689582|NCT00078325|NUVIGIL|nuvigil
1689586|NCT00078312|Sleep Attacks|sleep attacks
1689587|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
1689588|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
1689589|NCT00078312|nCPAP|ncpap
1689590|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
1689591|NCT00078312|Chronic SWSD|chronic swsd
1689592|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
1689593|NCT00078312|Shift Worker|shift worker
1689594|NCT00078312|Cepahlon|cepahlon
1689595|NCT00078312|Cephalon, Inc|cephalon, inc
1689596|NCT00078312|Nuvigil|nuvigil
1689597|NCT00005991|stage IV breast cancer|stage iv breast cancer
1689598|NCT00005991|recurrent breast cancer|recurrent breast cancer
1689599|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
1689600|NCT00005880|small cell lung cancer|small cell lung cancer
1689601|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
1689602|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
1689603|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
1689604|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1689605|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
1689606|NCT00005864|stage IV colon cancer|stage iv colon cancer
1689607|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
1689608|NCT00005864|recurrent colon cancer|recurrent colon cancer
1689609|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
1689610|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1689611|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1689612|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1689613|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1689614|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1689615|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1689616|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1689617|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1689618|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1689619|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1689620|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1689621|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1689622|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1689623|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1689624|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1689625|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1689626|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1689627|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1689628|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1689629|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1689630|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1689631|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1689632|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1689633|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1689634|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1689635|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
1689636|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1689637|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1689638|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1689639|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1689640|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1689641|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1689642|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1689643|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1689644|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1689645|NCT00005075|stage I prostate cancer|stage i prostate cancer
1689646|NCT00005075|stage II prostate cancer|stage ii prostate cancer
1689647|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
1689648|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1689649|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1689650|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1689651|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1689652|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1689653|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1689654|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1689655|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1689656|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1689657|NCT00005026|Brenner tumor|brenner tumor
1689658|NCT00004223|stage III bladder cancer|stage iii bladder cancer
1689659|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
1689660|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
1689661|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1689662|NCT00004223|posterior urethral cancer|posterior urethral cancer
1689663|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1689664|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1689665|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689666|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
1689667|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
1689668|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1689669|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
1689670|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
1689671|NCT00078364|MRI|mri
1689672|NCT00078364|NSAID Analgesia|nsaid analgesia
1689674|NCT00078364|SNP's|snp's
1689675|NCT00078364|Acute Pain|acute pain
1689676|NCT00078364|Wisdom Teeth|wisdom teeth
1689677|NCT00078364|Third Molar Extraction|third molar extraction
1689678|NCT00078364|Third Molar Impaction|third molar impaction
1689679|NCT00078351|Chronic Pain|chronic pain
1689681|NCT00078351|Temporomandibular Joint|temporomandibular joint
1689682|NCT00078351|Osteoarthritis|osteoarthritis
1689683|NCT00078351|TMD|tmd
1689684|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
1689685|NCT00078351|TMJ OA|tmj oa
1689686|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
1689687|NCT00078351|TMJ|tmj
1689688|NCT00078286|Antidepressive Agents|antidepressive agents
1689689|NCT00078273|Gambling|gambling
1689690|NCT00078273|Pathological Gambling|pathological gambling
1689691|NCT00078273|Problem Gambling|problem gambling
1689692|NCT00078273|College Students|college students
1689693|NCT00078273|Prevention|prevention
1689694|NCT00078299|Cortical|cortical
1689695|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
1689696|NCT00078299|Posterior Subcapsular|posterior subcapsular
1689697|NCT00078299|Photographic Methods|photographic methods
1689698|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
1689699|NCT00078299|Cataract|cataract
1689700|NCT00078299|Agreement|agreement
1689701|NCT00078299|Grading System|grading system
1689702|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
1689703|NCT00078247|Africa|africa
1689704|NCT00078234|CLL|cll
1689705|NCT00078234|Leukemia|leukemia
1689706|NCT00078234|Chronic|chronic
1689707|NCT00078234|Cancer|cancer
1689708|NCT00078234|Adult|adult
1689709|NCT00078234|Lymphocytic|lymphocytic
1689710|NCT00078234|Genasense|genasense
1689711|NCT00078234|G3139|g3139
1689712|NCT00078234|Genta|genta
1689713|NCT00078234|Bcl-2|bcl-2
1689714|NCT00078234|Antisense|antisense
1689715|NCT00078234|Oligonucleotide|oligonucleotide
1689716|NCT00078234|oblimersen|oblimersen
1689717|NCT00078169|behavioral intervention|behavioral intervention
1689718|NCT00078156|behavioral intervention|behavioral intervention
1689719|NCT00078143|behavioral intervention|behavioral intervention
1689720|NCT00078208|Pediatric|pediatric
1689721|NCT00078208|Non-Invasive|non-invasive
1689722|NCT00078208|Anti-Inflammatory|anti-inflammatory
1689723|NCT00078208|pH|ph
1689724|NCT00078208|Mediators|mediators
1689725|NCT00078208|Asthma|asthma
1689726|NCT00078208|Childhood Asthma|childhood asthma
1689727|NCT00078208|Healthy Volunteer|healthy volunteer
1689728|NCT00078208|HV|hv
1689729|NCT00078195|Ragweed|ragweed
1689730|NCT00078195|Immunotherapy|immunotherapy
1689731|NCT00078195|Rush Immunotherapy|rush immunotherapy
1689732|NCT00078195|RIT|rit
1689733|NCT00078195|Hayfever|hayfever
1689734|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1689735|NCT00078182|HIV Prevention|hiv prevention
1689736|NCT00078130|opioid dependence|opioid dependence
1689737|NCT00078130|behavioral intervention|behavioral intervention
1689738|NCT00078117|opiate dependence|opiate dependence
1689739|NCT00078065|multiple myeloma|multiple myeloma
1689740|NCT00078065|fludarabine|fludarabine
1689741|NCT00078065|Xcellerated T Cells|xcellerated t cells
1689742|NCT00004148|stage III melanoma|stage iii melanoma
1689743|NCT00004148|stage IV melanoma|stage iv melanoma
1689744|NCT00004148|recurrent melanoma|recurrent melanoma
1689745|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1689746|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
1689747|NCT00003814|stage I bladder cancer|stage i bladder cancer
1689748|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
1689749|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1689750|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689751|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
1689752|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1689753|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1689754|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1689755|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1689756|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1689757|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1690445|NCT00077922|Hematological Disease|hematological disease
1689758|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1689759|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1689760|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1689761|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1689762|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1689763|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1689764|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1689765|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689766|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689767|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689768|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689769|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1689770|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1689771|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1689772|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1689773|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1689774|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1689775|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1689776|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1689777|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1689778|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1689779|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1689780|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1689781|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689782|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689783|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1689784|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1689785|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1689786|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689787|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689788|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689789|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689790|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1689791|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1689792|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1689793|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1689794|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1689795|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689796|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1689797|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
1689798|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
1689799|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
1689800|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1689801|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1689802|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1689803|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1689804|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1689805|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1689806|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1689807|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1689808|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1689809|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1689810|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1689811|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1689812|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1689813|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1689814|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1689876|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
1689815|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1689816|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1689817|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1689818|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1689819|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1689820|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1689821|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1689822|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1689823|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1689824|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1689825|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1689826|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1689827|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1690041|NCT00003046|gastric cancer|gastric cancer
1689828|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1689829|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1689830|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1689831|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1689832|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1714358|NCT00005926|Her-2/Neu|her-2/neu
1689833|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1689834|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1689835|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1689836|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1689837|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1689838|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1689839|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1689840|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1689841|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1689842|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1689843|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1689844|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1689845|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1689846|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1689847|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1689848|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1689849|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1689850|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1689851|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1689852|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1689853|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1689854|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1689855|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1689856|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1689857|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1689858|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1689859|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1689860|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1689861|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1689862|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1689863|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1689864|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1689865|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689866|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1689867|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1689868|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689869|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689870|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689871|NCT00003548|stage IV colon cancer|stage iv colon cancer
1689872|NCT00003548|stage IV breast cancer|stage iv breast cancer
1689873|NCT00003548|recurrent breast cancer|recurrent breast cancer
1689874|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
1689875|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
1714417|NCT00004576|Levodopa|levodopa
1689877|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
1689878|NCT00003548|recurrent colon cancer|recurrent colon cancer
1689879|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
1689880|NCT00003548|stage IV anal cancer|stage iv anal cancer
1689881|NCT00003548|recurrent anal cancer|recurrent anal cancer
1689882|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
1689883|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
1689884|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
1689885|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
1689886|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1689887|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1689888|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
1689889|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
1689890|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
1689891|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
1689892|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
1689893|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1689894|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1689895|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
1689896|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1689897|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
1689898|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1689899|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1689900|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
1689901|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
1689902|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1689903|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1689904|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
1689905|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
1689906|NCT00003548|fallopian tube cancer|fallopian tube cancer
1689907|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
1689908|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
1689909|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1689910|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
1689911|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1689912|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1689913|NCT00003425|stage IV breast cancer|stage iv breast cancer
1689914|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
1689915|NCT00003425|recurrent breast cancer|recurrent breast cancer
1689916|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
1689917|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1689918|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
1689919|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1689920|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1689921|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1689922|NCT00003425|regional neuroblastoma|regional neuroblastoma
1689923|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
1689924|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
1689925|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
1689926|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
1689927|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1689928|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1689929|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1689930|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1689931|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1689932|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1689933|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1689934|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
1689935|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1689936|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1689937|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1689938|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
1689939|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1689940|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1689941|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1689942|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1689943|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1689944|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1689945|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1689946|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1689947|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1689948|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1714633|NCT00001797|Therapy|therapy
1689949|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1689950|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1689951|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1689952|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1689953|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1689954|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1689955|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1689956|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1689957|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1689958|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1689959|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1689960|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1689961|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1689962|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1689963|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1689964|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1689965|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1689966|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1689967|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1689968|NCT00003425|ovarian sarcoma|ovarian sarcoma
1689969|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1689970|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1689971|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1689972|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1689973|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1689974|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1689975|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1689976|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1689977|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1689978|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1689979|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1689980|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1689981|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1689982|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1689983|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1689984|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
1689985|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
1689986|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
1689987|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1689988|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
1689989|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1689990|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1689991|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1689992|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1689993|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1689994|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1689995|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1689996|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1689997|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1689998|NCT00003120|fallopian tube cancer|fallopian tube cancer
1689999|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
1690000|NCT00078104|Prostanoid|prostanoid
1690001|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
1690002|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
1690003|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
1690004|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
1690006|NCT00078104|Coxibs|coxibs
1690007|NCT00078104|Wisdom Teeth|wisdom teeth
1690008|NCT00078104|Third Molar Extraction|third molar extraction
1690009|NCT00078104|Third Molar Impaction|third molar impaction
1690010|NCT00078091|Obesity|obesity
1690011|NCT00078091|Retinopathy|retinopathy
1690012|NCT00078091|Dyslipidemia|dyslipidemia
1690013|NCT00078091|Insulin Resistance|insulin resistance
1690014|NCT00078091|Hypogonadism|hypogonadism
1690015|NCT00078091|Polydactyly|polydactyly
1690016|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
1690018|NCT00078078|Vitamin B12|vitamin b12
1690019|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
1690020|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
1690021|NCT00078078|MMA|mma
1690022|NCT00078078|Metabolic Disease|metabolic disease
1690023|NCT00078026|Apomine|apomine
1715055|NCT00001523|Serostomia|serostomia
1690024|NCT00078026|Osteoporosis|osteoporosis
1690025|NCT00078026|Bone Mass|bone mass
1690026|NCT00078026|Postmenopausal|postmenopausal
1690027|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1690028|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
1690029|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1690030|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
1690031|NCT00003089|large cell lung cancer|large cell lung cancer
1690032|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1690033|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690034|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
1690035|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1690036|NCT00003046|anal cancer|anal cancer
1690037|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
1690038|NCT00003046|colorectal cancer|colorectal cancer
1690039|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
1690040|NCT00003046|gallbladder cancer|gallbladder cancer
1690042|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
1690043|NCT00003046|malignant mesothelioma|malignant mesothelioma
1690044|NCT00003046|pancreatic cancer|pancreatic cancer
1690045|NCT00003046|small intestine cancer|small intestine cancer
1690046|NCT00003046|stage IV colon cancer|stage iv colon cancer
1690047|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
1690048|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
1714359|NCT00005926|Pancreatic|pancreatic
1690049|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
1690050|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
1690051|NCT00003046|recurrent colon cancer|recurrent colon cancer
1690052|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
1690053|NCT00003046|stage IV anal cancer|stage iv anal cancer
1690055|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1690056|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1690057|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
1690058|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1690059|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
1690060|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
1690061|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
1690062|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1690063|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1690064|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
1690065|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
1690066|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
1690067|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
1690069|NCT00078013|STEMI|stemi
1690070|NCT00078013|Infarct|infarct
1690071|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
1690072|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1690073|NCT00077961|NHL|nhl
1690074|NCT00077961|CAMPATH|campath
1690075|NCT00077961|alemtuzumab|alemtuzumab
1690076|NCT00077948|positive inotrope|positive inotrope
1690077|NCT00077948|enoximone|enoximone
1690078|NCT00077948|beta-blocker|beta-blocker
1690079|NCT00077948|intolerant|intolerant
1690080|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
1690081|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
1690082|NCT00077727|Schizophrenia|schizophrenia
1690083|NCT00077727|cognitive impairment|cognitive impairment
1690084|NCT00077727|galantamine|galantamine
1690085|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
1690086|NCT00077727|antipsychotic drugs|antipsychotic drugs
1690087|NCT00077727|BACS|bacs
1690088|NCT00077714|Schizophrenia|schizophrenia
1690089|NCT00077714|Paliperidone|paliperidone
1690090|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
1690091|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1690092|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1690093|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1690094|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1690095|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1690096|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1690097|NCT00027924|refractory anemia|refractory anemia
1690098|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1690099|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
1690100|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1690101|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1690102|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1690103|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1690104|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1690105|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1690106|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1690107|NCT00023647|stage IV melanoma|stage iv melanoma
1690108|NCT00023647|recurrent melanoma|recurrent melanoma
1690109|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1690110|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1690111|NCT00021294|actinic keratosis|actinic keratosis
1690112|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1690113|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1690114|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1690115|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1690116|NCT00021034|fallopian tube cancer|fallopian tube cancer
1690117|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1690118|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
1690119|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1690120|NCT00020917|stage IV colon cancer|stage iv colon cancer
1690121|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
1690122|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1690123|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690124|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690125|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690126|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1690127|NCT00017199|gastrinoma|gastrinoma
1690128|NCT00017199|insulinoma|insulinoma
1690129|NCT00017199|somatostatinoma|somatostatinoma
1690130|NCT00017199|glucagonoma|glucagonoma
1690131|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
1690132|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
1690133|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
1690134|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
1690135|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1690136|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1690137|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1690138|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1690139|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1690140|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1690141|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1690142|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1690143|NCT00016172|small intestine lymphoma|small intestine lymphoma
1690144|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690145|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1690146|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1690147|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1690148|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1690149|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1690150|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1690151|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1690152|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1690153|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1690154|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1690155|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1690156|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1690157|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1690158|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1690159|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1690160|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1690161|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1690162|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1690163|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1690164|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1690165|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1690166|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1690167|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1690168|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690169|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690170|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1690171|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690172|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1690173|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1690174|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1715056|NCT00001523|Xerostomia|xerostomia
1690175|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1690176|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1690177|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1690178|NCT00016172|intraocular lymphoma|intraocular lymphoma
1690179|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1690180|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1690181|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690182|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1690183|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1690184|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1690185|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1690186|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1690187|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1690188|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1690189|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1690190|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1690191|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1690192|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1690193|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1690829|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
1690194|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1690195|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1690196|NCT00014625|stage IV melanoma|stage iv melanoma
1690197|NCT00014625|recurrent melanoma|recurrent melanoma
1690198|NCT00014430|stage IV breast cancer|stage iv breast cancer
1690199|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
1690200|NCT00014430|recurrent breast cancer|recurrent breast cancer
1690201|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
1690202|NCT00008281|stage IV colon cancer|stage iv colon cancer
1690203|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
1690204|NCT00008281|recurrent colon cancer|recurrent colon cancer
1690205|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
1690206|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
1690207|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1690208|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1690209|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1690210|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1690211|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1690212|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1690213|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1690214|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1690215|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1690216|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1690217|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1690218|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1690219|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1690220|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1690221|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1690222|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1690223|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1690224|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1690225|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1690226|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1690227|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1690228|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1690229|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690230|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690231|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690232|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1690233|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
1690234|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1690235|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1690236|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1690237|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1690238|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1690239|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1690240|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1690590|NCT00005877|stage III rectal cancer|stage iii rectal cancer
1690241|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1690242|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1690243|NCT00004152|stage III melanoma|stage iii melanoma
1690244|NCT00004152|stage IV melanoma|stage iv melanoma
1690245|NCT00004152|recurrent melanoma|recurrent melanoma
1690246|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1690247|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1690248|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1690249|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
1690250|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
1690251|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
1690252|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
1690253|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1690254|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1690255|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1690256|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1690257|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1690258|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1690259|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1690260|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1690261|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1690262|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1690263|NCT00004145|refractory anemia|refractory anemia
1690264|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1690265|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
1690266|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1690267|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1690268|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1690269|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1690270|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1690271|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1690272|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1690273|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1690274|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1690275|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1690276|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1690277|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1690278|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1690279|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1690280|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1690281|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1690282|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1690283|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1690284|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1690285|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1690286|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1690287|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1690288|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1690289|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1690290|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1690291|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690292|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690293|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1690294|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690295|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1690296|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1690297|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1690298|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1690299|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1690300|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1690301|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690302|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1690303|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1690304|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1690305|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1690306|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1690307|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1690308|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1690309|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1690310|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1690311|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1690312|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1690313|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1690314|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1690315|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1690316|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1690317|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1690318|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1690319|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1690320|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1690321|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1690322|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1690323|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690324|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690325|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1690326|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690327|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1690328|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1690329|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1690330|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690331|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1690332|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1690333|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1690334|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1690335|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1690336|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1690337|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1690338|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1690339|NCT00003916|adult glioblastoma|adult glioblastoma
1690340|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1690341|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
1690342|NCT00003916|adult gliosarcoma|adult gliosarcoma
1690343|NCT00003867|stage III colon cancer|stage iii colon cancer
1690344|NCT00003867|stage IV colon cancer|stage iv colon cancer
1690345|NCT00003867|stage IV breast cancer|stage iv breast cancer
1690346|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
1690347|NCT00003867|recurrent breast cancer|recurrent breast cancer
1690348|NCT00003867|stage III gastric cancer|stage iii gastric cancer
1690349|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
1690350|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
1690351|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
1690352|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
1690353|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
1690354|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
1690355|NCT00003867|stage III rectal cancer|stage iii rectal cancer
1690356|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
1690357|NCT00003867|recurrent colon cancer|recurrent colon cancer
1690358|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
1690359|NCT00003867|stage IV anal cancer|stage iv anal cancer
1690360|NCT00003867|recurrent anal cancer|recurrent anal cancer
1690361|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
1690362|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
1690363|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
1690364|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
1690365|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
1690366|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
1690367|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1690368|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1690369|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1690370|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1690371|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
1690372|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1690373|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
1690374|NCT00003867|small intestine lymphoma|small intestine lymphoma
1690375|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1690376|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
1690377|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
1690378|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1690379|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1690380|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
1690381|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690382|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1690383|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
1690384|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1690385|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
1690386|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1690387|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1690388|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1690389|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1690390|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1690391|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1690392|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1690393|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1690394|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1690395|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1690396|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1690397|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1690398|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1690399|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1690400|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1690401|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1690402|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1690403|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1690404|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1690405|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1690406|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1690407|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690408|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1690409|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1690410|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1690411|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1690412|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1690413|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1690414|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1690415|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1690416|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1690417|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1690418|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1690419|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1690420|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1690421|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1690422|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1690423|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1690424|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1690425|NCT00003066|stage IV breast cancer|stage iv breast cancer
1690426|NCT00003066|recurrent breast cancer|recurrent breast cancer
1690427|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690428|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690429|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
1690430|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1690431|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1690432|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1690433|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1690434|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1690435|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1690436|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1690437|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1690438|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
1690439|NCT00077922|LMB-2|lmb-2
1690440|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1690442|NCT00077922|Immunotoxin|immunotoxin
1690446|NCT00077922|Monoclonal Antibody|monoclonal antibody
1690447|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
1690448|NCT00077909|Proteomics|proteomics
1690449|NCT00077909|Infection|infection
1690450|NCT00077909|Pneumonia|pneumonia
1690451|NCT00077909|Mass Spectrometry|mass spectrometry
1690452|NCT00077909|BAL|bal
1690453|NCT00077909|Lung|lung
1690454|NCT00077909|Pulmonary Disease|pulmonary disease
1690455|NCT00077909|Lung Infiltrates|lung infiltrates
1690456|NCT00077896|Treatment|treatment
1690457|NCT00077896|Transcranial Stimulation|transcranial stimulation
1690458|NCT00077896|Frontal Lobe|frontal lobe
1690459|NCT00077896|Pick's Disease|pick's disease
1690460|NCT00077896|Cognitive Impairment|cognitive impairment
1690462|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
1690463|NCT00077896|FTD|ftd
1690464|NCT00077675|Abscess|abscess
1690465|NCT00077675|Burns|burns
1690466|NCT00077675|Cellulitis|cellulitis
1690467|NCT00077675|Ulcer|ulcer
1690468|NCT00077675|Wound infections|wound infections
1690469|NCT00077662|Pompe Disease|pompe disease
1690830|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
1690470|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
1690471|NCT00077662|GSD-II|gsd-ii
1690472|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1690473|NCT00077662|Glycogenosis 2|glycogenosis 2
1690474|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1690475|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1690476|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1690477|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1690478|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1690479|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1690480|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1690481|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
1690482|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
1690483|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1690484|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1690485|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1690486|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1690487|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1690488|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1690489|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1690490|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1690491|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1690492|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1690493|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1690494|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1690495|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1690496|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
1690497|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1690498|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1690499|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1690500|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1690501|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1690502|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1690503|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1690504|NCT00077532|stage IV melanoma|stage iv melanoma
1690505|NCT00077532|recurrent melanoma|recurrent melanoma
1690506|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
1690507|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
1690508|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
1690509|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1690510|NCT00077493|Burkitt lymphoma|burkitt lymphoma
1690511|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1690512|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1690513|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
1690514|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690515|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1690516|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690517|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690518|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
1690519|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1690520|NCT00077415|large cell lung cancer|large cell lung cancer
1690521|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
1690522|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
1690523|NCT00077402|stage III prostate cancer|stage iii prostate cancer
1690524|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
1690525|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1690526|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
1690527|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
1690528|NCT00077337|recurrent colon cancer|recurrent colon cancer
1690529|NCT00077337|stage III colon cancer|stage iii colon cancer
1690530|NCT00077337|stage IV colon cancer|stage iv colon cancer
1690531|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
1690532|NCT00077337|stage III rectal cancer|stage iii rectal cancer
1690533|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
1690534|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1690535|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1690536|NCT00077311|anemia|anemia
1690537|NCT00077311|neutropenia|neutropenia
1690538|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690539|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690831|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
1690540|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690541|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
1690542|NCT00077311|large cell lung cancer|large cell lung cancer
1690543|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
1690544|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1690545|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1690546|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1690547|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1690548|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1690549|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1690550|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1691298|NCT00076310|OSI-774|osi-774
1690551|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690552|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690553|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690554|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690555|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1690556|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1690557|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1690558|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1690559|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1690560|NCT00006786|stage IV colon cancer|stage iv colon cancer
1690561|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
1690562|NCT00006786|recurrent colon cancer|recurrent colon cancer
1690563|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
1690564|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
1690565|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1690566|NCT00006459|stage IV breast cancer|stage iv breast cancer
1690567|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
1690568|NCT00006459|recurrent breast cancer|recurrent breast cancer
1690569|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
1690570|NCT00006388|adult glioblastoma|adult glioblastoma
1690571|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
1690572|NCT00006388|adult gliosarcoma|adult gliosarcoma
1690573|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690574|NCT00006123|stage IV breast cancer|stage iv breast cancer
1690575|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690576|NCT00006038|stage II gastric cancer|stage ii gastric cancer
1690577|NCT00006038|stage III gastric cancer|stage iii gastric cancer
1690578|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
1690579|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
1690580|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
1690581|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1690582|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1690583|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
1690584|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
1690585|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1690586|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1690587|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1690588|NCT00005877|stage III colon cancer|stage iii colon cancer
1690589|NCT00005877|stage IV colon cancer|stage iv colon cancer
1690797|NCT00076986|brain tumor|brain tumor
1690591|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
1690592|NCT00005877|recurrent colon cancer|recurrent colon cancer
1690593|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
1690594|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1690595|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1690596|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1690597|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1690598|NCT00005610|stage IV melanoma|stage iv melanoma
1690599|NCT00005610|recurrent melanoma|recurrent melanoma
1690600|NCT00005610|lung metastases|lung metastases
1690601|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1690602|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
1690603|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
1690604|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1690605|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1690739|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690606|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1690607|NCT00004157|stage IV breast cancer|stage iv breast cancer
1690608|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
1690609|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
1690610|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1690611|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1690612|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1690613|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1690614|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1690615|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1690616|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
1690617|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
1690618|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1690619|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1690620|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1690621|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1690622|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
1690623|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
1690624|NCT00004157|testicular teratoma|testicular teratoma
1690625|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
1690626|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1690627|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1690628|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1690629|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1690630|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1690631|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1690632|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1690633|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1690634|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1690635|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1690636|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1690637|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1690638|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1690639|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
1690640|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1690641|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
1690642|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
1690643|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
1690644|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
1690645|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1690646|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1690647|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1690648|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1690649|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1690650|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1690651|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1690652|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1690653|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1690654|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1690655|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1690656|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1690657|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1690658|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1690659|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1690660|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1690661|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1690662|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1690663|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1690664|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1690665|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1690666|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1690667|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1690668|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1690669|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1690670|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1690671|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1690672|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1690673|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690674|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1690675|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1691138|NCT00076609|botanical|botanical
1690676|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1690677|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1690678|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1690679|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1690680|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1690681|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1690682|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1690683|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1690684|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1690685|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1690686|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1690687|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1690688|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1690689|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690690|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1690691|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1690692|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1690693|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1690694|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1690695|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1690696|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1690697|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1690698|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1690699|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1690700|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1690701|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1690702|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
1690703|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
1690704|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
1690706|NCT00077584|Finger Ulcers|finger ulcers
1690707|NCT00077584|Digital Ulcers|digital ulcers
1690708|NCT00077584|Systemic Sclerosis|systemic sclerosis
1690709|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1690710|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1690711|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1690712|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1690713|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1690714|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1690715|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1690716|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1690717|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
1690718|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1690719|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1690720|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1690721|NCT00077259|recurrent colon cancer|recurrent colon cancer
1690722|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
1690723|NCT00077259|stage III colon cancer|stage iii colon cancer
1690724|NCT00077259|stage III rectal cancer|stage iii rectal cancer
1690725|NCT00077259|stage IV colon cancer|stage iv colon cancer
1690726|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
1690727|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
1690728|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1690729|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690730|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690731|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
1690732|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1690733|NCT00077233|recurrent colon cancer|recurrent colon cancer
1690734|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
1690735|NCT00077233|stage IV colon cancer|stage iv colon cancer
1690736|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
1690737|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1690738|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1690740|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1690741|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1690742|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1690743|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
1690744|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1690745|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1691139|NCT00076609|herbal|herbal
1690746|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1690747|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1690748|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1690749|NCT00077168|breast cancer in situ|breast cancer in situ
1690750|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
1690751|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1690752|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1690753|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1690754|NCT00077142|Oral TAC-101|oral tac-101
1690755|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
1690756|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
1690757|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
1690758|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1690759|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
1690760|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1690761|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1690762|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1690763|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1690764|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1690765|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1690766|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1690767|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1690768|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1690769|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1690770|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
1690771|NCT00077090|lymphedema|lymphedema
1690772|NCT00077090|radiation fibrosis|radiation fibrosis
1690773|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
1690774|NCT00077090|stage I breast cancer|stage i breast cancer
1690775|NCT00077090|stage II breast cancer|stage ii breast cancer
1690776|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
1690777|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690778|NCT00077064|radiation fibrosis|radiation fibrosis
1690779|NCT00077064|pulmonary complications|pulmonary complications
1690780|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
1690781|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1690782|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1690783|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690784|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1690785|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1690786|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1690787|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1690788|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1690789|NCT00077025|metastatic breast cancer|metastatic breast cancer
1690791|NCT00077038|Visual Feedback|visual feedback
1690792|NCT00077038|Cortical Connectivity|cortical connectivity
1690793|NCT00077038|Magnetoencephalography|magnetoencephalography
1690794|NCT00077038|Eye Tracking|eye tracking
1690795|NCT00077038|Healthy Volunteer|healthy volunteer
1690798|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
1690799|NCT00076986|brain neoplasm|brain neoplasm
1690800|NCT00076986|central nervous system|central nervous system
1690801|NCT00076986|surgery|surgery
1690802|NCT00076986|resection|resection
1690803|NCT00076986|GLIADEL|gliadel
1690804|NCT00076986|infusion|infusion
1690805|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
1690806|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
1690807|NCT00076986|first recurrence|first recurrence
1690808|NCT00076986|recurrent GBM|recurrent gbm
1690809|NCT00076986|GBM|gbm
1690810|NCT00076986|supratentorial GBM|supratentorial gbm
1690811|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
1690812|NCT00076960|jaundice|jaundice
1690813|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
1690814|NCT00076960|stannsoporfin|stannsoporfin
1690815|NCT00076960|exchange transfusion|exchange transfusion
1690816|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
1690817|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
1690818|NCT00076947|HIV Seronegativity|hiv seronegativity
1690819|NCT00076947|Protein|protein
1690820|NCT00076934|Ataxia|ataxia
1690821|NCT00076934|MRI|mri
1690822|NCT00076934|MS|ms
1690823|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
1690824|NCT00076934|Costimulatory Signals|costimulatory signals
1690825|NCT00076934|Autoimmune Disorders|autoimmune disorders
1690826|NCT00003937|localized osteosarcoma|localized osteosarcoma
1690827|NCT00003937|cardiac toxicity|cardiac toxicity
1690828|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
1690832|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
1690833|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
1690834|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
1690835|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1690836|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1690837|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1690838|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1690839|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1690840|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690841|NCT00003665|stage IV melanoma|stage iv melanoma
1690842|NCT00003665|recurrent melanoma|recurrent melanoma
1690843|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
1690844|NCT00003616|adult brain stem glioma|adult brain stem glioma
1690845|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
1690846|NCT00003616|adult mixed glioma|adult mixed glioma
1690847|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
1690848|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1690849|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1690850|NCT00003367|stage I prostate cancer|stage i prostate cancer
1690851|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
1690852|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
1690853|NCT00003367|stage III prostate cancer|stage iii prostate cancer
1690854|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
1690855|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
1690856|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1690857|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1690858|NCT00003334|fallopian tube cancer|fallopian tube cancer
1690859|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
1690860|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
1690861|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
1690862|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
1690863|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
1690864|NCT00003334|ovarian sarcoma|ovarian sarcoma
1690865|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
1690866|NCT00003222|stage III melanoma|stage iii melanoma
1690867|NCT00003222|stage IV melanoma|stage iv melanoma
1690868|NCT00003222|recurrent melanoma|recurrent melanoma
1690869|NCT00003185|adult glioblastoma|adult glioblastoma
1690870|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1690871|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
1690872|NCT00003185|adult gliosarcoma|adult gliosarcoma
1690873|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1690874|NCT00003086|stage IV breast cancer|stage iv breast cancer
1690875|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
1690876|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
1690877|NCT00076817|ALVAC Vaccine|alvac vaccine
1690878|NCT00076817|Immunization Site|immunization site
1690879|NCT00076817|Deltoid|deltoid
1690880|NCT00076817|Groin|groin
1690881|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
1690882|NCT00076817|TILN|tiln
1690883|NCT00076804|Directly Observed Therapy|directly observed therapy
1690884|NCT00076804|DOT|dot
1690885|NCT00076791|HIV Seronegativity|hiv seronegativity
1690886|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
1690887|NCT00033592|small cell lung cancer|small cell lung cancer
1690888|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1690889|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
1690890|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
1690891|NCT00026377|stage III prostate cancer|stage iii prostate cancer
1690892|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
1690893|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
1690894|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1690895|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
1690896|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
1690897|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1690898|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1690899|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1690900|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1690901|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1690902|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1690903|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1690904|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
1690905|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1690906|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1690907|NCT00002801|stage II colon cancer|stage ii colon cancer
1690908|NCT00002801|stage III colon cancer|stage iii colon cancer
1690909|NCT00002801|stage I rectal cancer|stage i rectal cancer
1690910|NCT00002801|stage II rectal cancer|stage ii rectal cancer
1690911|NCT00002801|stage III rectal cancer|stage iii rectal cancer
1690912|NCT00002679|stage II breast cancer|stage ii breast cancer
1690913|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
1690914|NCT00002679|male breast cancer|male breast cancer
1690915|NCT00076843|Interleukin-15|interleukin-15
1690916|NCT00076843|CD8+ T-cells|cd8+ t-cells
1690917|NCT00076843|HAM/TSP|ham/tsp
1690918|NCT00076843|HTLV-1|htlv-1
1690919|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
1690920|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
1690921|NCT00076830|Errors of Bone Matrix and Metabolism|errors of bone matrix and metabolism
1690922|NCT00076830|Connective Tissue Disorders|connective tissue disorders
1690923|NCT00076726|Giant Cell Arteritis|giant cell arteritis
1690924|NCT00076726|infliximab|infliximab
1690925|NCT00076544|Intrathecal|intrathecal
1690926|NCT00076518|Treatment Experienced|treatment experienced
1690927|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1690928|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1690929|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1690930|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1690931|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
1690932|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
1690933|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
1690934|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
1690935|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
1690936|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1690937|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1690938|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1690939|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1690940|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1690941|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1690942|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1690943|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1690944|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1690945|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1690946|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1690947|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1690948|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1690949|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1690950|NCT00022373|radiation toxicity|radiation toxicity
1690951|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
1690952|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690953|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1690954|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690955|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690956|NCT00022204|stage I breast cancer|stage i breast cancer
1690957|NCT00022204|stage II breast cancer|stage ii breast cancer
1690958|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
1690959|NCT00022204|lymphedema|lymphedema
1690960|NCT00022204|male breast cancer|male breast cancer
1691200|NCT00076505|Genetic|genetic
1690961|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1690962|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1690963|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1690964|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
1690965|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1690966|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1690967|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1690968|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1690969|NCT00021385|ovarian sarcoma|ovarian sarcoma
1690970|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1690971|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1690972|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690973|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1690974|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1690975|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
1690976|NCT00014105|adult glioblastoma|adult glioblastoma
1690977|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
1690978|NCT00014105|adult gliosarcoma|adult gliosarcoma
1690979|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1690980|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1690981|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
1690982|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
1690983|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1690984|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
1690985|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
1690986|NCT00010244|stage III prostate cancer|stage iii prostate cancer
1690987|NCT00076752|Refractory SLE|refractory sle
1690988|NCT00076752|Immunoablation|immunoablation
1690989|NCT00076752|Immunological Recovery|immunological recovery
1690990|NCT00076752|Efficacy|efficacy
1690991|NCT00076752|Mechanism of Disease|mechanism of disease
1690993|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
1690995|NCT00076739|Prefrontal Cortex|prefrontal cortex
1690996|NCT00076739|Semantic Memory|semantic memory
1690997|NCT00076739|Semantic Relations|semantic relations
1690998|NCT00076739|Priming Paradigm|priming paradigm
1690999|NCT00076739|fMRI|fmri
1691000|NCT00076739|Healthy Volunteer|healthy volunteer
1691001|NCT00076739|HV|hv
1691002|NCT00076713|Antiphospholipid|antiphospholipid
1691003|NCT00009997|stage II breast cancer|stage ii breast cancer
1691004|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
1691005|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
1691006|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1691007|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691008|NCT00008034|stage II breast cancer|stage ii breast cancer
1691009|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
1691010|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
1691011|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
1691012|NCT00006460|adult glioblastoma|adult glioblastoma
1691013|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
1691014|NCT00006460|adult gliosarcoma|adult gliosarcoma
1691015|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1691016|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1691017|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1691018|NCT00006454|fallopian tube cancer|fallopian tube cancer
1691019|NCT00006111|stage II bladder cancer|stage ii bladder cancer
1691020|NCT00006111|stage III bladder cancer|stage iii bladder cancer
1691021|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
1691022|NCT00006111|anterior urethral cancer|anterior urethral cancer
1691023|NCT00006111|posterior urethral cancer|posterior urethral cancer
1691024|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1691025|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1691026|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1691027|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
1691028|NCT00076700|Functional MRI|functional mri
1691029|NCT00076700|Behavior|behavior
1691030|NCT00076700|Memory|memory
1691031|NCT00076700|Blind|blind
1691032|NCT00076700|Blindness|blindness
1691033|NCT00076700|Healthy Volunteer|healthy volunteer
1691034|NCT00076700|HV|hv
1691035|NCT00006050|stage IV colon cancer|stage iv colon cancer
1691036|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
1691037|NCT00006050|liver metastases|liver metastases
1691038|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1691039|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
1691040|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1691041|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1691042|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1691043|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1691044|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1691045|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1691046|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1691047|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1691048|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1691049|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1691050|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1691051|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1691052|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1691053|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1691054|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1691055|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1691056|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1691057|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1691058|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1691059|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1691060|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1691061|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1691062|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1692382|NCT00073801|Neuroimmune|neuroimmune
1691063|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1691064|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1691065|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
1691066|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
1691067|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
1691068|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
1691069|NCT00076635|Idiopathic|idiopathic
1691070|NCT00076635|Pulmonary|pulmonary
1691071|NCT00076635|Fibrosis|fibrosis
1691073|NCT00076635|Lung|lung
1691074|NCT00076635|Actimmune|actimmune
1691075|NCT00076635|Interferon|interferon
1691076|NCT00076635|Gamma|gamma
1691077|NCT00076635|InterMune|intermune
1691078|NCT00076674|Parkinson's Disease|parkinson's disease
1691079|NCT00076674|Keppra|keppra
1691080|NCT00076674|Motor Fluctuations|motor fluctuations
1691081|NCT00076674|Intravenous Levodopa|intravenous levodopa
1691082|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
1691083|NCT00076674|Parkinson Disease|parkinson disease
1691085|NCT00076622|Antidepressant drugs|antidepressant drugs
1691086|NCT00076622|Nursing Homes|nursing homes
1691087|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
1691088|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1691089|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1691090|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1691091|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1691092|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
1691093|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1691094|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
1691095|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1691096|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1691097|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1691098|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1691099|NCT00004239|polycythemia vera|polycythemia vera
1691100|NCT00004239|primary myelofibrosis|primary myelofibrosis
1691101|NCT00004239|essential thrombocythemia|essential thrombocythemia
1691102|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
1691103|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1691104|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1691105|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1691106|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1691107|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1691108|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1691109|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1691110|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1691111|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1691112|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1691113|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1691114|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1691115|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
1691116|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
1691117|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1691118|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1691119|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1691120|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1691121|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1691122|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1691123|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1691124|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1691125|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1691126|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1691127|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1691128|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1691129|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1691130|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1691131|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1691132|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1691133|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
1691134|NCT00076609|advanced|advanced
1691135|NCT00076609|unresectable|unresectable
1691136|NCT00076609|liver cancer|liver cancer
1691137|NCT00076609|systemic chemotherapy|systemic chemotherapy
1691140|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
1691141|NCT00076609|capecitabine|capecitabine
1691142|NCT00076609|PHY906|phy906
1691143|NCT00076609|oral|oral
1691144|NCT00076609|HCC|hcc
1691145|NCT00076609|traditional chinese medicine|traditional chinese medicine
1691146|NCT00076609|tcm|tcm
1691147|NCT00076609|QOL|qol
1691148|NCT00076609|quality of life|quality of life
1691149|NCT00076557|Hemophilia B|hemophilia b
1691150|NCT00076557|Factor IX|factor ix
1691151|NCT00076557|Gene Transfer|gene transfer
1691152|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
1691153|NCT00076596|Corticospinal Tracts|corticospinal tracts
1691154|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
1691155|NCT00076596|Spastic Diplegia|spastic diplegia
1691156|NCT00076596|Cortical Re-Organization|cortical re-organization
1691157|NCT00076596|Functional Outcome|functional outcome
1691158|NCT00076596|Cerebral Palsy|cerebral palsy
1691159|NCT00076583|Motor Learning|motor learning
1691160|NCT00076583|Co-contraction|co-contraction
1691161|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
1691162|NCT00076583|Spinal Plasticity|spinal plasticity
1691163|NCT00076583|Rhythmic Movement|rhythmic movement
1691164|NCT00076583|Healthy Volunteer|healthy volunteer
1691165|NCT00076583|HV|hv
1691166|NCT00076570|Tolerance|tolerance
1691167|NCT00076570|Kidney|kidney
1691168|NCT00076570|Transplant|transplant
1691169|NCT00076570|Polyclonal|polyclonal
1691170|NCT00076570|Antibody|antibody
1691171|NCT00076570|Kidney Transplant|kidney transplant
1691172|NCT00076531|Prostate|prostate
1691173|NCT00076531|Cancer|cancer
1691174|NCT00076531|PSA|psa
1691175|NCT00076531|Leuprolide|leuprolide
1691176|NCT00076492|Parkinson's disease|parkinson's disease
1691177|NCT00076492|Parkinson disease|parkinson disease
1691178|NCT00076492|CoQ10|coq10
1691179|NCT00076492|GPI 1485|gpi 1485
1691180|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691181|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1691182|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
1691183|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1691184|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
1691185|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
1691186|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
1691187|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
1691188|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1691189|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1691190|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1691191|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1691192|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1691193|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1691194|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1691195|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1691196|NCT00076505|Mitochondria|mitochondria
1691197|NCT00076505|Proteasome|proteasome
1691198|NCT00076505|Lipid|lipid
1691199|NCT00076505|Polymorphism|polymorphism
1691201|NCT00076505|Parkinson's Disease|parkinson's disease
1691202|NCT00076505|Parkinson Disease|parkinson disease
1691203|NCT00076505|PD|pd
1691204|NCT00076505|Heredity|heredity
1691205|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
1691206|NCT00076505|Healthy Volunteer|healthy volunteer
1691207|NCT00076505|HV|hv
1691208|NCT00076453|Knee Pain|knee pain
1691209|NCT00076453|Degenerative Arthritis|degenerative arthritis
1691210|NCT00076453|Cartilage Disease|cartilage disease
1691211|NCT00076453|Non-drug Therapy|non-drug therapy
1691212|NCT00076440|Alzheimer disease|alzheimer disease
1691213|NCT00076401|CLL|cll
1691214|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
1691215|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
1691216|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1691217|NCT00076401|Leukemia|leukemia
1691218|NCT00076401|Motexafin gadolinium|motexafin gadolinium
1691219|NCT00076401|Chronic leukemia|chronic leukemia
1691220|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
1691221|NCT00076479|Aphasia|aphasia
1691222|NCT00076479|Rehabilitation|rehabilitation
1691223|NCT00076479|Neuroplasticity|neuroplasticity
1691224|NCT00076479|Picture Naming|picture naming
1691225|NCT00076479|Transcranial Magnetic|transcranial magnetic
1691226|NCT00076479|Stroke|stroke
1691227|NCT00076479|Healthy Volunteer|healthy volunteer
1691228|NCT00076479|HV|hv
1691229|NCT00076466|Brain Excitability|brain excitability
1691230|NCT00076466|Reaction Time|reaction time
1691231|NCT00076466|Plasticity|plasticity
1691232|NCT00076466|Motor Evoked Potential|motor evoked potential
1691233|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1691234|NCT00076466|Healthy Volunteer|healthy volunteer
1691235|NCT00076466|HV|hv
1691236|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1691237|NCT00076375|Atopic Dermatitis|atopic dermatitis
1691238|NCT00076375|Eczema|eczema
1691239|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1691240|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1691241|NCT00003418|stage I breast cancer|stage i breast cancer
1691242|NCT00003418|stage II breast cancer|stage ii breast cancer
1691243|NCT00003418|stage III breast cancer|stage iii breast cancer
1691244|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
1691245|NCT00003298|stage II gastric cancer|stage ii gastric cancer
1691246|NCT00003298|stage III gastric cancer|stage iii gastric cancer
1691247|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
1691248|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1691249|NCT00003287|stage IV colon cancer|stage iv colon cancer
1691250|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
1691251|NCT00003287|recurrent colon cancer|recurrent colon cancer
1691252|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
1691253|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
1691254|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1691255|NCT00076427|Immunity|immunity
1691256|NCT00076427|Liver|liver
1691257|NCT00076427|Apheresis|apheresis
1691258|NCT00076427|Cytokine|cytokine
1691259|NCT00076427|Virology|virology
1691260|NCT00076427|Hepatitis C|hepatitis c
1691261|NCT00076427|HCV|hcv
1691262|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
1691263|NCT00076414|Endothelial Function|endothelial function
1691264|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
1691265|NCT00076414|HIV|hiv
1691266|NCT00076414|Blood Flow Studies|blood flow studies
1691267|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
1691268|NCT00076414|Healthy Volunteer|healthy volunteer
1691269|NCT00076414|HV|hv
1691270|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1691271|NCT00076349|NHL|nhl
1691272|NCT00076349|Rituxan|rituxan
1691273|NCT00076349|Mantle Cell|mantle cell
1691274|NCT00076349|mabs|mabs
1691275|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
1691276|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
1691277|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1691278|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
1691279|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
1691280|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
1691281|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
1691282|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
1691283|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
1691284|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1691285|NCT00002840|adult mixed glioma|adult mixed glioma
1691286|NCT00002817|stage III melanoma|stage iii melanoma
1691287|NCT00002817|stage IV melanoma|stage iv melanoma
1691288|NCT00002817|recurrent melanoma|recurrent melanoma
1691289|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
1691290|NCT00076323|G6PD|g6pd
1691291|NCT00076323|Favism|favism
1691292|NCT00076323|G6PD Deficiency|g6pd deficiency
1691293|NCT00076323|hemolysis|hemolysis
1691294|NCT00076323|drug reaction|drug reaction
1691295|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
1691296|NCT00076310|Head and Neck Cancer|head and neck cancer
1691297|NCT00076310|Squamous Cell Cancer|squamous cell cancer
1691299|NCT00076310|Cisplatin|cisplatin
1691300|NCT00076310|Platinol®-AQ|platinol®-aq
1691301|NCT00076310|Platinol®|platinol®
1691302|NCT00076310|CDDP|cddp
1691303|NCT00076310|Docetaxel|docetaxel
1691304|NCT00076310|Taxotere|taxotere
1691305|NCT00076310|Tarceva|tarceva
1691306|NCT00076310|HNSCC|hnscc
1691307|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
1691308|NCT00076284|CCR5 Antagonist|ccr5 antagonist
1691309|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
1691310|NCT00076284|Fusion Inhibitor|fusion inhibitor
1691311|NCT00076284|Entry Inhibitor|entry inhibitor
1691312|NCT00076284|Antiretroviral|antiretroviral
1691313|NCT00076284|HIV|hiv
1691314|NCT00076271|Strabismus|strabismus
1691315|NCT00076271|Cataract, Pediatric|cataract, pediatric
1691316|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
1691317|NCT00076271|Coloboma|coloboma
1691318|NCT00076271|Evaluation and Treatment|evaluation and treatment
1691319|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
1691320|NCT00076271|Genetic Eye Disease|genetic eye disease
1691321|NCT00076271|Nystagmus|nystagmus
1691322|NCT00076271|Pediatric Eye Disease|pediatric eye disease
1691323|NCT00076271|Developmental Eye Condition|developmental eye condition
1691324|NCT00076271|Cataract|cataract
1691325|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
1691326|NCT00076271|Eye Movement Disorder|eye movement disorder
1691327|NCT00076258|Exercise therapy|exercise therapy
1691328|NCT00076258|Complementary Therapies|complementary therapies
1691329|NCT00076245|Phototherapy|phototherapy
1691330|NCT00076219|Acute Renal Failure|acute renal failure
1691331|NCT00076219|Renal Replacement Therapy|renal replacement therapy
1691332|NCT00076219|multi-site randomization trial|multi-site randomization trial
1691333|NCT00076219|Hemodialysis|hemodialysis
1691334|NCT00076219|Hemofiltration|hemofiltration
1691335|NCT00076219|Critical Illness|critical illness
1691336|NCT00076219|Hemodiafiltration|hemodiafiltration
1691337|NCT00076232|HIV Seronegativity|hiv seronegativity
1691338|NCT00076154|ALS|als
1691339|NCT00076141|relatively healthy male|relatively healthy male
1691340|NCT00076115|Bipolar|bipolar
1691341|NCT00076115|Mania|mania
1691342|NCT00076115|Manic|manic
1691343|NCT00076115|Depressive|depressive
1691344|NCT00076115|Manic Depressive|manic depressive
1691345|NCT00076115|Bipolar mania|bipolar mania
1691346|NCT00076115|risperidone|risperidone
1691347|NCT00076115|adolescents|adolescents
1691348|NCT00076115|children|children
1691349|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
1691350|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
1691351|NCT00076180|T-LGL Leukemia|t-lgl leukemia
1691352|NCT00076180|Natural Killer Cells|natural killer cells
1691353|NCT00076180|Leukemia|leukemia
1691354|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
1691355|NCT00076180|T-LGL|t-lgl
1691356|NCT00076089|Roflumilast|roflumilast
1691357|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1691358|NCT00076089|COPD|copd
1691359|NCT00076076|Roflumilast|roflumilast
1691360|NCT00076076|Asthma|asthma
1691361|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
1691362|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1691363|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
1691364|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1691365|NCT00024401|stage IV colon cancer|stage iv colon cancer
1691366|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
1691367|NCT00024401|recurrent colon cancer|recurrent colon cancer
1691368|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
1691369|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1691370|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
1691371|NCT00076102|Side Effect|side effect
1691372|NCT00076102|Oral Administration|oral administration
1691373|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
1691374|NCT00076102|Antifibrotic Agent|antifibrotic agent
1691375|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
1691376|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
1691377|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
1691378|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
1691379|NCT00076102|Time to Progression|time to progression
1691380|NCT00076102|NF1|nf1
1691381|NCT00076063|HIV Seronegativity|hiv seronegativity
1691382|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
1691383|NCT00076063|ALVAC Vaccine|alvac vaccine
1691384|NCT00076063|HIV-1|hiv-1
1691385|NCT00076063|Normal Values|normal values
1691386|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
1691387|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
1691388|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1691389|NCT00076037|AIDS Vaccines|aids vaccines
1691390|NCT00076037|HIV-1|hiv-1
1691391|NCT00076037|HIV Seronegativity|hiv seronegativity
1691392|NCT00076037|Injections, Intramuscular|injections, intramuscular
1691393|NCT00076037|RC529|rc529
1691394|NCT00076037|Epitopes|epitopes
1691395|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1691396|NCT00076024|metastatic breast cancer|metastatic breast cancer
1691397|NCT00075998|Idiopathic|idiopathic
1691398|NCT00075998|Pulmonary|pulmonary
1691399|NCT00075998|Fibrosis|fibrosis
1691400|NCT00075998|IPF|ipf
1691401|NCT00075998|Lung|lung
1691402|NCT00075998|Interferon|interferon
1691403|NCT00075998|Gamma|gamma
1691404|NCT00075998|Actimmune|actimmune
1691405|NCT00075998|INSPIRE|inspire
1691406|NCT00075998|InterMune|intermune
1691407|NCT00075959|Stroke|stroke
1691408|NCT00075959|cerebral vascular accident|cerebral vascular accident
1691409|NCT00075959|CVA|cva
1691410|NCT00075959|Hemorrhage|hemorrhage
1691411|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
1691412|NCT00075959|Brain Attack|brain attack
1691413|NCT00075959|Cataplexy|cataplexy
1691414|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1691415|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1693556|NCT00070759|Uveitis|uveitis
1691416|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1691417|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1691418|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1691419|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1691420|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1691421|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1691520|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
1691422|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1691423|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1691424|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1691425|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
1691426|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
1691427|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
1691428|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1691429|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1691430|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1691431|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1691432|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1691433|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1691434|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1691435|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1691436|NCT00022347|fallopian tube cancer|fallopian tube cancer
1691437|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1691438|NCT00022321|refractory anemia|refractory anemia
1691439|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1691440|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
1691441|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1691442|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1691443|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1691444|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
1691445|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
1691446|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
1691447|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1691448|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1691449|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1691450|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1691451|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1691452|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1691453|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1691454|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1691455|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1691456|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1691457|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1691458|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1691459|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1691460|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1691461|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1691462|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1691463|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
1691464|NCT00021307|adult glioblastoma|adult glioblastoma
1691465|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
1692062|NCT00074386|Kidney|kidney
1691466|NCT00021307|adult gliosarcoma|adult gliosarcoma
1691467|NCT00075907|Acute Infection|acute infection
1691468|NCT00075907|Treatment Experienced|treatment experienced
1691469|NCT00075907|Treatment Naive|treatment naive
1691470|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1691471|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1691472|NCT00075894|adult glioblastoma|adult glioblastoma
1691473|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
1691474|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
1691475|NCT00075894|adult gliosarcoma|adult gliosarcoma
1691476|NCT00075868|radiation enteritis|radiation enteritis
1691477|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1691478|NCT00075868|stage I rectal cancer|stage i rectal cancer
1691479|NCT00075868|stage II rectal cancer|stage ii rectal cancer
1691480|NCT00075868|stage III rectal cancer|stage iii rectal cancer
1691481|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
1691482|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
1691483|NCT00075868|recurrent anal cancer|recurrent anal cancer
1691484|NCT00075868|stage I anal cancer|stage i anal cancer
1691485|NCT00075868|stage II anal cancer|stage ii anal cancer
1691486|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
1691487|NCT00075855|sexual dysfunction|sexual dysfunction
1691488|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691489|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
1691490|NCT00075855|cancer survivor|cancer survivor
1691491|NCT00075842|sleep disorders|sleep disorders
1691492|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691493|NCT00075842|fatigue|fatigue
1691494|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
1691495|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
1691496|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
1691497|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
1691498|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1691499|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1691500|NCT00075764|stage IV breast cancer|stage iv breast cancer
1691501|NCT00075764|recurrent breast cancer|recurrent breast cancer
1691502|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
1691503|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
1691504|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1691505|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1691506|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1691507|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1691508|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1691509|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1691510|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1691511|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1691512|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1691513|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1691514|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1691515|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1691516|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1691517|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1691518|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1691519|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1691521|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
1691522|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
1691523|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1691524|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
1691525|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
1691526|NCT00075920|Heart|heart
1691527|NCT00075920|Function|function
1691528|NCT00075920|Ultrasound|ultrasound
1691529|NCT00075920|MRI|mri
1691530|NCT00075920|Left Ventricle|left ventricle
1691531|NCT00075920|Healthy Volunteer|healthy volunteer
1691532|NCT00075920|HV|hv
1691533|NCT00075920|Heart Disease|heart disease
1691534|NCT00075673|recurrent breast cancer|recurrent breast cancer
1691535|NCT00075673|stage IV breast cancer|stage iv breast cancer
1691536|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
1691537|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
1691538|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
1691539|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
1691540|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
1691541|NCT00075595|stage IV colon cancer|stage iv colon cancer
1691542|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
1691543|NCT00075595|recurrent colon cancer|recurrent colon cancer
1691544|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
1691545|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
1691546|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1691547|NCT00075569|cervical cancer|cervical cancer
1691548|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1691549|NCT00075556|stage III colon cancer|stage iii colon cancer
1691550|NCT00075556|stage IV colon cancer|stage iv colon cancer
1691551|NCT00075556|stage III rectal cancer|stage iii rectal cancer
1691552|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
1691553|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1691554|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
1691555|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1691556|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1691557|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1691558|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1691559|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691560|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
1691561|NCT00075517|large cell lung cancer|large cell lung cancer
1691562|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
1691563|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1691564|NCT00075465|stage III gastric cancer|stage iii gastric cancer
1691565|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
1691566|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1691567|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
1691568|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
1691569|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
1691570|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1691571|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1691572|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691573|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1691574|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
1691575|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
1691576|NCT00075413|stage IV breast cancer|stage iv breast cancer
1691577|NCT00075413|recurrent breast cancer|recurrent breast cancer
1691578|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
1691579|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1691580|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691581|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1691582|NCT00075348|renal cell carcinoma|renal cell carcinoma
1691583|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
1691584|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
1691585|NCT00075335|Mobilization|mobilization
1691586|NCT00075335|Alloreactivity|alloreactivity
1691587|NCT00075335|T Cell Polarization|t cell polarization
1691588|NCT00075335|Dendritic Cells|dendritic cells
1691589|NCT00075335|Plerixafor|plerixafor
1691591|NCT00075335|Healthy Volunteer (HV)|healthy volunteer (hv)
1691592|NCT00075296|Major Depressive Disorder|major depressive disorder
1691593|NCT00075296|Bipolar Disorder|bipolar disorder
1691594|NCT00075296|Negative Feedback|negative feedback
1691595|NCT00075296|Cognitive Performance|cognitive performance
1691596|NCT00075296|Negative Affect|negative affect
1691597|NCT00075296|Depression|depression
1691598|NCT00075296|Major Depression|major depression
1691599|NCT00075296|MDD|mdd
1691600|NCT00075296|Healthy Volunteer|healthy volunteer
1691601|NCT00075296|HV|hv
1691602|NCT00075283|Physical Therapy|physical therapy
1691603|NCT00075283|Locomotion therapy|locomotion therapy
1691604|NCT00075283|Gait training|gait training
1691605|NCT00075283|Stroke|stroke
1691606|NCT00075283|Robotics|robotics
1691607|NCT00075283|Rehabilitation|rehabilitation
1691608|NCT00075283|Treadmill|treadmill
1691609|NCT00075283|Hemiparetic stroke|hemiparetic stroke
1691610|NCT00075283|Unilateral brain lesion|unilateral brain lesion
1691611|NCT00075270|metastatic breast cancer|metastatic breast cancer
1691612|NCT00075270|ErbB1|erbb1
1691613|NCT00075270|kinase inhibitor|kinase inhibitor
1691614|NCT00075270|ErbB2|erbb2
1691615|NCT00075270|EGFR|egfr
1691616|NCT00075270|lapatinib|lapatinib
1691617|NCT00075270|Her2-neu|her2-neu
1691618|NCT00075231|Treatment Naive|treatment naive
1691619|NCT00075153|ADOLESCENCE|adolescence
1691620|NCT00075153|HIV INFECTION|hiv infection
1691621|NCT00075153|PEDIATRIC AIDS|pediatric aids
1691622|NCT00075153|QUALITY OF LIFE|quality of life
1691623|NCT00075153|HIV|hiv
1691624|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
1691625|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
1691626|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
1691627|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
1691628|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1691629|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1691630|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1691631|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
1691632|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
1691633|NCT00017537|stage IV breast cancer|stage iv breast cancer
1691634|NCT00017537|recurrent breast cancer|recurrent breast cancer
1691635|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
1691636|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
1691637|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1691638|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1691639|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1691640|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1691641|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691642|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691643|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
1691644|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
1691645|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
1691646|NCT00075244|Lysosomes|lysosomes
1691647|NCT00075244|Storage|storage
1691648|NCT00075244|Glycolipid|glycolipid
1691649|NCT00075244|Fabry Disease|fabry disease
1691650|NCT00075244|Stroke|stroke
1691651|NCT00017082|stage IV colon cancer|stage iv colon cancer
1691652|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
1691653|NCT00017082|recurrent colon cancer|recurrent colon cancer
1691654|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
1691655|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
1691656|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1691657|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1691658|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
1691659|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
1691660|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
1691661|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1691662|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
1691663|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
1691664|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
1692885|NCT00072631|Tarceva|tarceva
1691665|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1691666|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1691667|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1691668|NCT00016198|stage IV colon cancer|stage iv colon cancer
1691669|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
1691670|NCT00016198|recurrent colon cancer|recurrent colon cancer
1691671|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
1691672|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
1691673|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1691674|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
1691675|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
1691676|NCT00014287|stage I bladder cancer|stage i bladder cancer
1691677|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
1691678|NCT00075205|Alcohol Consumption|alcohol consumption
1691679|NCT00075205|Alcohol Treatment|alcohol treatment
1691680|NCT00075205|Medication Trial|medication trial
1691681|NCT00075205|Craving|craving
1691682|NCT00075205|Cannabinoids|cannabinoids
1691683|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
1691684|NCT00075205|SR141716|sr141716
1691685|NCT00075205|Alcoholism|alcoholism
1691686|NCT00075179|Pulmonary hypertension|pulmonary hypertension
1691687|NCT00075179|cancer|cancer
1691688|NCT00075179|lung cancer|lung cancer
1691689|NCT00075179|lung disease|lung disease
1691690|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
1691691|NCT00075179|Nesiritide|nesiritide
1691692|NCT00075179|Natrecor|natrecor
1691693|NCT00075179|CV Surgery|cv surgery
1691694|NCT00075179|Lung Tumor|lung tumor
1691695|NCT00075166|Stereotactic|stereotactic
1691696|NCT00075166|Carcinoma|carcinoma
1691697|NCT00075166|Melanoma|melanoma
1691698|NCT00075166|Surgical Resection|surgical resection
1691699|NCT00075166|Metastases|metastases
1691700|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
1691701|NCT00075166|Surgery|surgery
1691702|NCT00075166|Radiosurgery|radiosurgery
1691703|NCT00075166|Treatment|treatment
1691704|NCT00075140|Patient Care Management|patient care management
1691705|NCT00075140|Family|family
1691706|NCT00075140|Huntington's Disease|huntington's disease
1691707|NCT00075114|Self Care|self care
1691708|NCT00075114|Behavior Modification|behavior modification
1691709|NCT00075101|Drug Adverse Effect|drug adverse effect
1691710|NCT00075101|Pediatric Cancer|pediatric cancer
1691711|NCT00075088|Telemedicine|telemedicine
1691712|NCT00075088|Emergency Care|emergency care
1691713|NCT00075088|Cardiac|cardiac
1691714|NCT00075075|Infliximab|infliximab
1691715|NCT00075075|Scleritis|scleritis
1691716|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
1691717|NCT00075075|Corticosteroids|corticosteroids
1691718|NCT00075075|Immunosuppressives|immunosuppressives
1691719|NCT00075049|malaria|malaria
1691720|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
1691721|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
1691722|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
1691723|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1691724|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
1691725|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1691726|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
1691727|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
1691728|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1691729|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1691730|NCT00075036|Health Disparities|health disparities
1691731|NCT00075036|Transplantation|transplantation
1691732|NCT00075036|Trust|trust
1691733|NCT00075036|Interview|interview
1691734|NCT00075036|Ethnic Bias|ethnic bias
1691735|NCT00075023|Stomatitis|stomatitis
1691736|NCT00075023|Oropharyngeal pain|oropharyngeal pain
1691737|NCT00075023|TNF-alpha|tnf-alpha
1691738|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
1691739|NCT00075023|Inflammation|inflammation
1691740|NCT00075023|Thalidomide|thalidomide
1691741|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
1691742|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
1691743|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
1691744|NCT00074997|Gene Therapy|gene therapy
1691745|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
1691747|NCT00074997|HIV-1 Infections|hiv-1 infections
1691748|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1691749|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1691750|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1691751|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1691752|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1691871|NCT00074711|Bone Mineral Density|bone mineral density
1691753|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1691754|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1691755|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1691756|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1691757|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1691758|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1691759|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1691760|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
1691761|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
1691762|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
1691763|NCT00074984|a-Galactosidase A|a-galactosidase a
1691764|NCT00074984|aGAL|agal
1691765|NCT00074984|r-haGAL|r-hagal
1691766|NCT00074984|Fabry|fabry
1691767|NCT00074984|GL-3|gl-3
1691768|NCT00074984|Fabrazyme|fabrazyme
1691769|NCT00074971|a-Galactosidase A|a-galactosidase a
1691770|NCT00074971|aGAL|agal
1691771|NCT00074971|r-haGAL|r-hagal
1691772|NCT00074971|Fabry|fabry
1691773|NCT00074971|GL-3|gl-3
1691774|NCT00074971|Fabrazyme|fabrazyme
1691775|NCT00074958|a-Galactosidase A|a-galactosidase a
1691776|NCT00074958|aGal|agal
1691777|NCT00074958|r-haGAL|r-hagal
1691778|NCT00074958|Fabry|fabry
1691779|NCT00074958|GL-3|gl-3
1691780|NCT00074958|Fabrazyme|fabrazyme
1691781|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
1691782|NCT00074932|GSD-II|gsd-ii
1691783|NCT00074932|Pompe Disease|pompe disease
1691784|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1691785|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
1691786|NCT00074919|GSD-II|gsd-ii
1691787|NCT00074919|Pompe Disease|pompe disease
1691788|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
1691789|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
1691790|NCT00074945|Obesity|obesity
1691791|NCT00074945|Resting Energy Expenditure|resting energy expenditure
1691792|NCT00074945|Metabolic Rate|metabolic rate
1691793|NCT00074945|Visceral Fat|visceral fat
1691794|NCT00074945|Body Fat Distribution|body fat distribution
1691795|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
1691796|NCT00074893|Vibration Damping|vibration damping
1691797|NCT00074893|Protective Brace|protective brace
1691798|NCT00074893|Piezoelectric|piezoelectric
1691799|NCT00074893|SmartWear|smartwear
1691800|NCT00074841|MALARIA|malaria
1691801|NCT00074841|INDIA|india
1691802|NCT00074841|CHLOROQUINE|chloroquine
1691803|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
1691804|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
1691805|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
1691806|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
1691807|NCT00006353|adult glioblastoma|adult glioblastoma
1691808|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
1691809|NCT00006353|adult gliosarcoma|adult gliosarcoma
1691810|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
1691811|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1691812|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
1691813|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
1691814|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
1691815|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
1691816|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
1691817|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1691818|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1691819|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1691820|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1691821|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
1691822|NCT00006104|stage IV breast cancer|stage iv breast cancer
1691823|NCT00006104|recurrent breast cancer|recurrent breast cancer
1691824|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
1691825|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
1691826|NCT00074880|Cardiac Glycosides|cardiac glycosides
1691827|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
1691828|NCT00074880|Atrial Systole|atrial systole
1691829|NCT00074828|elective|elective
1691830|NCT00074828|primary unilateral|primary unilateral
1691831|NCT00074763|Leukemia|leukemia
1691832|NCT00074763|Lymphoma|lymphoma
1691833|NCT00074763|ALL|all
1691834|NCT00074763|CLL|cll
1691835|NCT00074763|AML|aml
1691836|NCT00074763|CML|cml
1691837|NCT00074763|MDS|mds
1691838|NCT00074763|Remission|remission
1691839|NCT00074763|Hematologic Disorder|hematologic disorder
1691840|NCT00074763|Transfusion|transfusion
1691841|NCT00074763|Thrombosol|thrombosol
1691842|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
1691843|NCT00074763|Platelet Transfusion|platelet transfusion
1691844|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
1691845|NCT00074763|Cryopreservation|cryopreservation
1691846|NCT00074763|Thrombocytopenia|thrombocytopenia
1691847|NCT00074750|AML|aml
1691848|NCT00074750|CMML|cmml
1691849|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
1691850|NCT00074737|Antisense|antisense
1691851|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
1691852|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
1691853|NCT00006087|small cell lung cancer|small cell lung cancer
1691854|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
1691855|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1691856|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1691857|NCT00006080|adult mixed glioma|adult mixed glioma
1691858|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
1691859|NCT00005978|regional neuroblastoma|regional neuroblastoma
1691860|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
1691861|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
1691862|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
1691863|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1691864|NCT00005963|stage IV breast cancer|stage iv breast cancer
1691865|NCT00005963|recurrent breast cancer|recurrent breast cancer
1691866|NCT00074815|Child|child
1691867|NCT00074815|Adolescent|adolescent
1691868|NCT00074802|Social Phobia|social phobia
1691869|NCT00074789|Early Head Start Program|early head start program
1691870|NCT00074776|Bipolar Depression|bipolar depression
1691872|NCT00074711|Calcium|calcium
1691873|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1691874|NCT00074698|IPF|ipf
1691875|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
1691876|NCT00074698|Respiratory disease|respiratory disease
1691877|NCT00074685|Congenital|congenital
1691878|NCT00074685|Epidermal nevus|epidermal nevus
1691879|NCT00074685|Erythroderma|erythroderma
1691880|NCT00074685|Darier|darier
1691881|NCT00074685|Hailey-Hailey|hailey-hailey
1691882|NCT00074685|Harlequin|harlequin
1691883|NCT00074685|Ichthyosiform|ichthyosiform
1691884|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
1691885|NCT00074685|Keratoderma|keratoderma
1691886|NCT00074685|Keratosis|keratosis
1691887|NCT00074685|Pachyonychia|pachyonychia
1691888|NCT00074685|Sjogren-Larsson|sjogren-larsson
1691889|NCT00074646|CC-8490|cc-8490
1691890|NCT00074646|CC8490|cc8490
1691891|NCT00074646|Glio|glio
1691892|NCT00074646|Glioblastoma|glioblastoma
1691893|NCT00074646|Malignant Gliomas|malignant gliomas
1691894|NCT00074633|Type 2 Diabetes|type 2 diabetes
1691895|NCT00074633|Self-Esteem|self-esteem
1691896|NCT00074620|Haemodialysis|haemodialysis
1691897|NCT00074620|PEG-Hirudin|peg-hirudin
1691898|NCT00074620|Vascular graft occlusion|vascular graft occlusion
1691899|NCT00074620|Renal replacement therapy|renal replacement therapy
1691900|NCT00074620|Hemodialysis|hemodialysis
1691901|NCT00074672|Prepulse Inhibition|prepulse inhibition
1691902|NCT00074672|PPI|ppi
1691903|NCT00074672|Dopamine|dopamine
1691904|NCT00074672|Sensorimotor Integration|sensorimotor integration
1691905|NCT00074672|Dopaminergic|dopaminergic
1691906|NCT00074607|Neoplastic meningitis|neoplastic meningitis
1691907|NCT00074581|HIV Infections|hiv infections
1691908|NCT00074581|HIV Seronegativity|hiv seronegativity
1691909|NCT00074568|Genetic Study|genetic study
1691910|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
1691911|NCT00074568|Genome Wide Scan|genome wide scan
1691912|NCT00074568|Family Study|family study
1691913|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
1691914|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1691915|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1691916|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1691917|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1691918|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1691919|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1691920|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1691921|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1691922|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1691923|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1691924|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1691925|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1691926|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1691927|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1691928|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1691929|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1691930|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1691931|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1691932|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1691933|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1691934|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1691935|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1691936|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1691937|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1691938|NCT00005876|stage III gastric cancer|stage iii gastric cancer
1691939|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
1691940|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
1691941|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
1691942|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
1691943|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
1691944|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1691945|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1691946|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1691947|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691948|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1691949|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1691950|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1691951|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
1691952|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
1691953|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1691954|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1691955|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1691956|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1691957|NCT00005634|small intestine lymphoma|small intestine lymphoma
1691958|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
1691959|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1691960|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1691961|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
1691962|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1691963|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1691964|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1691965|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1691966|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1691967|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1691968|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1691969|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1691970|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1691971|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1691972|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1691973|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1691974|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1691975|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1691976|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1691977|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1691978|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1691979|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1691980|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1691981|NCT00074542|Crohn's|crohn's
1691982|NCT00074542|colon|colon
1691983|NCT00074542|small bowel|small bowel
1691984|NCT00074542|inflammation|inflammation
1691985|NCT00074542|steroid therapy|steroid therapy
1691986|NCT00074542|free fatty acids|free fatty acids
1691987|NCT00005598|refractory anemia|refractory anemia
1693557|NCT00070759|Active|active
1691988|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1691989|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1691990|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1691991|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1691992|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1691993|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1691994|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1691995|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1691996|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1691997|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1691998|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1691999|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1692000|NCT00005083|adult glioblastoma|adult glioblastoma
1692001|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1692002|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1692003|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
1692004|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1692005|NCT00005083|adult mixed glioma|adult mixed glioma
1692006|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1692007|NCT00005083|adult subependymoma|adult subependymoma
1692008|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
1692009|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
1692010|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
1692011|NCT00005083|adult gliosarcoma|adult gliosarcoma
1692012|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
1692013|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
1692014|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
1692015|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
1692016|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
1692017|NCT00004890|drug extravasation|drug extravasation
1692018|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1692019|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1692020|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1692021|NCT00074516|Immunosuppression|immunosuppression
1692022|NCT00074516|Kidney|kidney
1692023|NCT00074516|Cysteamine|cysteamine
1692024|NCT00074516|Steroid-Free|steroid-free
1692025|NCT00074516|Outcomes|outcomes
1692026|NCT00074503|Positron Emission Tomography|positron emission tomography
1692027|NCT00074503|Phospholipids|phospholipids
1692028|NCT00074503|Alcoholism|alcoholism
1692029|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
1692030|NCT00074503|[150]Water|[150]water
1692031|NCT00074503|Brain|brain
1692032|NCT00074503|Fatty Acids|fatty acids
1692033|NCT00074503|Blood Flow|blood flow
1692034|NCT00074503|Healthy|healthy
1692035|NCT00074490|Leukemia|leukemia
1692036|NCT00074490|Lymphoma|lymphoma
1692037|NCT00074490|Multiple Myeloma|multiple myeloma
1692038|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
1692039|NCT00074490|Immune Therapy|immune therapy
1692040|NCT00074477|Schizophrenia|schizophrenia
1692041|NCT00074477|Paliperidone palmitate|paliperidone palmitate
1692042|NCT00074477|R092670|r092670
1692043|NCT00074477|antipsychotic|antipsychotic
1692044|NCT00074438|Rituxan|rituxan
1692045|NCT00074438|RA|ra
1692046|NCT00074425|HIV Seronegativity|hiv seronegativity
1692047|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
1692048|NCT00074425|BufferGel|buffergel
1692049|NCT00074425|PRO 2000|pro 2000
1692050|NCT00074425|Vagina|vagina
1692051|NCT00074425|Risk Factors|risk factors
1692052|NCT00074412|HIV Seronegativity|hiv seronegativity
1692053|NCT00074412|Treatment Experienced|treatment experienced
1692054|NCT00074412|Treatment Naive|treatment naive
1692055|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
1692056|NCT00074399|Vertical Transmission|vertical transmission
1692057|NCT00074399|Pregnancy|pregnancy
1692058|NCT00074399|HIV Seronegativity|hiv seronegativity
1692059|NCT00074386|HIV|hiv
1692060|NCT00074386|Transplant|transplant
1692061|NCT00074386|Liver|liver
1692064|NCT00074386|Treatment Experienced|treatment experienced
1692065|NCT00074386|Kidney Transplant|kidney transplant
1692066|NCT00074386|Liver Transplant|liver transplant
1692067|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
1692068|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
1692069|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
1692070|NCT00074360|Ethanol|ethanol
1692071|NCT00074360|fMRI|fmri
1692072|NCT00074360|Blood Flow|blood flow
1692073|NCT00074360|Conditioning|conditioning
1692074|NCT00074360|Reinforcement|reinforcement
1692075|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1692076|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1692077|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
1692078|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1692079|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
1692080|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
1692081|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1692082|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692083|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1692084|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1692085|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1692086|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1692087|NCT00074269|recurrent breast cancer|recurrent breast cancer
1692088|NCT00074269|stage IV breast cancer|stage iv breast cancer
1692089|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1692090|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1692091|NCT00074243|adult glioblastoma|adult glioblastoma
1692886|NCT00072631|erlotinib|erlotinib
1692092|NCT00074243|adult mixed glioma|adult mixed glioma
1692093|NCT00074243|adult brain stem glioma|adult brain stem glioma
1692094|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
1692095|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
1692096|NCT00074243|adult gliosarcoma|adult gliosarcoma
1692097|NCT00074230|stage IV melanoma|stage iv melanoma
1692098|NCT00074230|recurrent melanoma|recurrent melanoma
1692099|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692100|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1692101|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1692102|NCT00074191|intraocular lymphoma|intraocular lymphoma
1692103|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
1692104|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
1692105|NCT00074178|intraocular lymphoma|intraocular lymphoma
1692106|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1692107|NCT00074165|thrombocytopenia|thrombocytopenia
1692108|NCT00074165|intraocular lymphoma|intraocular lymphoma
1692109|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1692110|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1692111|NCT00074152|recurrent breast cancer|recurrent breast cancer
1692112|NCT00074152|stage I breast cancer|stage i breast cancer
1692113|NCT00074152|stage II breast cancer|stage ii breast cancer
1692114|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
1692115|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
1692116|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
1692117|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
1692118|NCT00074139|recurrent breast cancer|recurrent breast cancer
1692119|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
1692120|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
1692121|NCT00074139|stage IV breast cancer|stage iv breast cancer
1692122|NCT00074100|stage IV breast cancer|stage iv breast cancer
1692123|NCT00074100|recurrent breast cancer|recurrent breast cancer
1692124|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1692125|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1692126|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1692127|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1692128|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1692129|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1692130|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
1692131|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1692132|NCT00074074|refractory anemia|refractory anemia
1692133|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1692134|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1692135|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1692136|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
1692137|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
1692138|NCT00074009|stage III gastric cancer|stage iii gastric cancer
1692139|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
1692140|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1715057|NCT00001523|Head Cancer|head cancer
1692141|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1692142|NCT00073983|chondrosarcoma|chondrosarcoma
1692143|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
1692144|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
1692145|NCT00073970|stage I prostate cancer|stage i prostate cancer
1692146|NCT00073970|stage II prostate cancer|stage ii prostate cancer
1692147|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1692148|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1692149|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692150|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1692151|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
1692152|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1692153|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1692154|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1692155|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1692156|NCT00073944|primary myelofibrosis|primary myelofibrosis
1692157|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1692158|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1692159|NCT00073944|essential thrombocythemia|essential thrombocythemia
1692160|NCT00073944|intraocular lymphoma|intraocular lymphoma
1692161|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1692162|NCT00073944|polycythemia vera|polycythemia vera
1692163|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1692164|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1692165|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
1692166|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1692167|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1692168|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1692169|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1692170|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1692171|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1692172|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1692173|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1692174|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692175|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1692176|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1692177|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1692178|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1692179|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1692180|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1692181|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1692182|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
1692183|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
1692184|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1692185|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1692186|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1692187|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
1692188|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
1692189|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1692190|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1692191|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1692506|NCT00003253|recurrent breast cancer|recurrent breast cancer
1692192|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
1692193|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1692194|NCT00073944|recurrent colon cancer|recurrent colon cancer
1692195|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
1692196|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
1692197|NCT00073944|recurrent melanoma|recurrent melanoma
1692198|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692199|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
1692200|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
1692201|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1692202|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1692203|NCT00073944|adult glioblastoma|adult glioblastoma
1692204|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1692205|NCT00073944|adult subependymoma|adult subependymoma
1692206|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1692207|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1692208|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1692209|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1692210|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1692211|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1692212|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1692213|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1692214|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1692215|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1692216|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1692217|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1692218|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1692219|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1693558|NCT00070759|Acute|acute
1692220|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
1692221|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
1692222|NCT00073944|adult gliosarcoma|adult gliosarcoma
1692223|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1692224|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1692225|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1692226|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1692227|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1692228|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692229|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1692230|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1692887|NCT00072631|NSCLC|nsclc
1692231|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1692232|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1692233|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1692234|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
1692235|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1692236|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1692237|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1692238|NCT00073905|pain|pain
1692239|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
1692240|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1692241|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1692242|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
1692243|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1692244|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1692245|NCT00073892|stage IV melanoma|stage iv melanoma
1692246|NCT00073892|recurrent melanoma|recurrent melanoma
1692247|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
1692248|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
1692249|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1692250|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692251|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1692252|NCT00073853|paraplegia|paraplegia
1692253|NCT00073853|quadraplegia|quadraplegia
1692254|NCT00073853|tetraplegia|tetraplegia
1692255|NCT00073853|paralysis|paralysis
1692256|NCT00073853|nerve regeneration|nerve regeneration
1692257|NCT00073853|Acute, Complete SCI|acute, complete sci
1692258|NCT00073840|levalbuterol|levalbuterol
1692259|NCT00073840|asthma|asthma
1692260|NCT00073840|bronchoconstriction|bronchoconstriction
1692261|NCT00073840|adolescent|adolescent
1692262|NCT00073840|adult|adult
1692263|NCT00073827|adolescent|adolescent
1692264|NCT00073827|adult|adult
1692265|NCT00073827|asthma|asthma
1692266|NCT00073827|levalbuterol|levalbuterol
1692267|NCT00073827|bronchoconstriction|bronchoconstriction
1692268|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1692269|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1692270|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1692271|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1692272|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1692273|NCT00004261|stage I breast cancer|stage i breast cancer
1692274|NCT00004261|stage II breast cancer|stage ii breast cancer
1692275|NCT00004261|stage IV breast cancer|stage iv breast cancer
1692276|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
1692277|NCT00004261|breast cancer in situ|breast cancer in situ
1692278|NCT00004261|recurrent breast cancer|recurrent breast cancer
1692279|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
1692280|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
1692281|NCT00004261|stage III cervical cancer|stage iii cervical cancer
1692282|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
1692283|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
1692284|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
1692285|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
1715058|NCT00001523|Neck Cancer|neck cancer
1692286|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
1692287|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
1692288|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
1692289|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
1692290|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1692291|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1692292|NCT00004261|stage I prostate cancer|stage i prostate cancer
1692293|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
1692294|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
1692295|NCT00004261|stage III prostate cancer|stage iii prostate cancer
1692507|NCT00003253|male breast cancer|male breast cancer
1692296|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
1692297|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
1692298|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1692299|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1692300|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1692301|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1692302|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1692303|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
1692304|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
1692305|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
1692306|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1692307|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
1692308|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
1692309|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
1692310|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
1692311|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
1692312|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
1692313|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1692314|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1692315|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1692316|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1692317|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1692318|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1692319|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1692320|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1692321|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1692322|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1692323|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1692324|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1692325|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1692326|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1692327|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
1692328|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
1692329|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
1692330|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
1692331|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
1692332|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
1692333|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
1692334|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1692335|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1692336|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1692337|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1692338|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1692339|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1692340|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1692341|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1692342|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1692343|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1692344|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1692345|NCT00003927|stage II breast cancer|stage ii breast cancer
1692346|NCT00003927|stage IV breast cancer|stage iv breast cancer
1692347|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
1692348|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
1692349|NCT00073814|levalbuterol|levalbuterol
1692350|NCT00073814|pediatric|pediatric
1692351|NCT00073814|asthma|asthma
1692352|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1692353|NCT00003811|childhood teratoma|childhood teratoma
1692354|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1692355|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1692356|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1692357|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1692358|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1692359|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1692360|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1692361|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1692362|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1692363|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1692364|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
1692365|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
1692366|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
1692367|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1692368|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1692369|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1692370|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1692371|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1692372|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1692373|NCT00003761|stage IV breast cancer|stage iv breast cancer
1692374|NCT00003761|recurrent breast cancer|recurrent breast cancer
1692375|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1692376|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1692377|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1692378|NCT00073801|Neuromusculoskeletal Pain|neuromusculoskeletal pain
1692379|NCT00073801|Laparoscopy|laparoscopy
1692380|NCT00073801|Cytokines|cytokines
1692381|NCT00073801|HPA Axis|hpa axis
1692383|NCT00073801|Endometriosis|endometriosis
1692384|NCT00073801|Surgical Excision|surgical excision
1692385|NCT00073801|Inflammatory Cytokines|inflammatory cytokines
1692386|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1692387|NCT00003734|stage I prostate cancer|stage i prostate cancer
1692388|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
1692389|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
1692390|NCT00003734|stage III prostate cancer|stage iii prostate cancer
1692391|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
1692392|NCT00073749|B-Cell|b-cell
1692393|NCT00073749|Non-Hodgkin's|non-hodgkin's
1692394|NCT00073749|Lymphoma|lymphoma
1692395|NCT00073736|Hepatocellular|hepatocellular
1692396|NCT00073736|Carcinoma|carcinoma
1692397|NCT00073736|Liver|liver
1692398|NCT00073736|Cancer|cancer
1692399|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
1692400|NCT00073723|Taxol|taxol
1692401|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1692402|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
1692403|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1692404|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1692405|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1692406|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692407|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1692408|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1692409|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1692410|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1692411|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1692412|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
1692413|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
1692414|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
1692415|NCT00003598|cervical cancer|cervical cancer
1692416|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1692417|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1692418|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1692419|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692420|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
1692421|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
1692422|NCT00073697|Psychotherapy|psychotherapy
1692423|NCT00073697|Depressive disorder|depressive disorder
1692424|NCT00073697|Antidepressive agents|antidepressive agents
1692425|NCT00073697|Citalopram|citalopram
1692426|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1692427|NCT00073684|Depression|depression
1692428|NCT00073684|Anxiety|anxiety
1692429|NCT00073671|Adolescent|adolescent
1692430|NCT00073658|Alzheimer disease|alzheimer disease
1692431|NCT00073658|Aggression|aggression
1692432|NCT00073658|Delusions|delusions
1692433|NCT00073658|Paranoid behavior|paranoid behavior
1692434|NCT00073619|Violence|violence
1692435|NCT00073619|School based|school based
1692436|NCT00073619|Urban Youth|urban youth
1692437|NCT00073619|Prevention|prevention
1692438|NCT00073619|Community|community
1692439|NCT00073606|Spinal Reflexes|spinal reflexes
1692440|NCT00073606|Locomotion|locomotion
1692441|NCT00073606|Motor Practice|motor practice
1692442|NCT00073606|Healthy Volunteer|healthy volunteer
1692444|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
1692445|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
1692446|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1692447|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1692448|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1692449|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1692450|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1692451|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1692452|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1692532|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
1692453|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1692454|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1692455|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1692456|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692457|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1692458|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1692459|NCT00003414|graft versus host disease|graft versus host disease
1692460|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1692461|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1692462|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1692463|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1692464|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1692465|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1692466|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1692467|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1692468|NCT00003409|adult glioblastoma|adult glioblastoma
1692469|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
1692470|NCT00003409|adult gliosarcoma|adult gliosarcoma
1692471|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1692472|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1692473|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1692474|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1692475|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1692476|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1692477|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1692478|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1692479|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
1692480|NCT00073593|CABG|cabg
1692481|NCT00073593|OPCAB|opcab
1692482|NCT00073593|Heparin|heparin
1692483|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
1692485|NCT00073580|HITTS|hitts
1692486|NCT00073580|Heparin-antibodies|heparin-antibodies
1692487|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
1692488|NCT00073580|CABG|cabg
1692489|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1692490|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
1692491|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
1692492|NCT00073528|metastatic|metastatic
1692493|NCT00073528|advanced breast cancer|advanced breast cancer
1692494|NCT00073528|breast cancer|breast cancer
1692495|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1692496|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
1692497|NCT00003387|large cell lung cancer|large cell lung cancer
1692498|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
1692499|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1692500|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1692501|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692502|NCT00003313|oral complications|oral complications
1692503|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1692504|NCT00003313|radiation toxicity|radiation toxicity
1692505|NCT00003253|stage IV breast cancer|stage iv breast cancer
1692508|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
1692509|NCT00003202|large cell lung cancer|large cell lung cancer
1692510|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1692511|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692512|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
1692513|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1692514|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
1692515|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1692516|NCT00073515|central venous access device|central venous access device
1692518|NCT00073515|central venous catheter|central venous catheter
1692519|NCT00073515|thrombolysis|thrombolysis
1692520|NCT00073515|fibrinolysis|fibrinolysis
1692521|NCT00073489|chronic leukemia|chronic leukemia
1692522|NCT00073489|leukemia|leukemia
1692523|NCT00073489|CLL|cll
1692524|NCT00073463|Gene Transfer|gene transfer
1692525|NCT00073463|Pulmonary function|pulmonary function
1692526|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1692527|NCT00003060|recurrent melanoma|recurrent melanoma
1692528|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1692529|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1692530|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
1692531|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
1692533|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1692534|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1692535|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1692536|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1692537|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1692538|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1692539|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1692540|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1692541|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1692542|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1692543|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1692544|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1692545|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1692546|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1692547|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1692548|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1692549|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1692550|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1692551|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1692552|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1692553|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1692554|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1692555|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1692556|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1692557|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1692558|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1692559|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1692560|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1692561|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1692562|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1692563|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1692564|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1692565|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1692566|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1692567|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1692568|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1692569|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1692570|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1692571|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1692572|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1692573|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1692574|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1692575|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1692576|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1692577|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1692578|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1692579|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1692580|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1692581|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1692582|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1692583|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1692584|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1692585|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1692586|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1692587|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1692588|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1692589|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1692590|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1692591|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1692592|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1692593|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1692594|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1692595|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1692596|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1692597|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1692598|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1692599|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1692600|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1692601|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1692602|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1692603|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1692604|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1692605|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1692606|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1692607|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1692608|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1692609|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1692610|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1692611|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1692612|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1692613|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1692614|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1692615|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
1692616|NCT00073437|Sarcoidosis|sarcoidosis
1692617|NCT00073437|Infliximab|infliximab
1692618|NCT00073437|Pulmonary involvement|pulmonary involvement
1692619|NCT00073437|Remicade|remicade
1692620|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1692621|NCT00002836|recurrent breast cancer|recurrent breast cancer
1692622|NCT00002828|stage III colon cancer|stage iii colon cancer
1692623|NCT00002828|stage IV colon cancer|stage iv colon cancer
1692624|NCT00002828|stage III rectal cancer|stage iii rectal cancer
1692625|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
1692626|NCT00002828|recurrent colon cancer|recurrent colon cancer
1692627|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
1692628|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1692629|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1692630|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1692631|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1692632|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1692633|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1692634|NCT00073424|Treatment Experienced|treatment experienced
1692635|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
1692636|NCT00073372|Acute ischemic stroke|acute ischemic stroke
1692637|NCT00073372|abciximab|abciximab
1692638|NCT00073372|ReoPro|reopro
1692639|NCT00073372|drug safety|drug safety
1692640|NCT00073372|drug efficacy|drug efficacy
1692641|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
1692642|NCT00073372|stroke|stroke
1692643|NCT00073359|Adolescent|adolescent
1692644|NCT00073346|Compulsive Hoarding|compulsive hoarding
1692645|NCT00073333|Phobic Disorders|phobic disorders
1692646|NCT00073320|Schizophrenia|schizophrenia
1692647|NCT00073320|Paliperidone palmitate|paliperidone palmitate
1692648|NCT00073320|R092670|r092670
1692649|NCT00073320|antipsychotic|antipsychotic
1692650|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
1692651|NCT00073307|Cancer|cancer
1692652|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1692653|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
1692654|NCT00036920|large cell lung cancer|large cell lung cancer
1692655|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1715161|NCT00001462|Emphysema|emphysema
1692656|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1692657|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
1692658|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1692659|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1692660|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
1692661|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1692662|NCT00025532|stage III colon cancer|stage iii colon cancer
1692663|NCT00025532|stage IV colon cancer|stage iv colon cancer
1692664|NCT00025532|stage III gastric cancer|stage iii gastric cancer
1692665|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
1692666|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
1692667|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
1692668|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
1692769|NCT00072917|overfeeding|overfeeding
1692669|NCT00025532|stage III rectal cancer|stage iii rectal cancer
1692670|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
1692671|NCT00025532|recurrent colon cancer|recurrent colon cancer
1692672|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
1692673|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
1692674|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
1692675|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
1692676|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1692677|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1692678|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
1692679|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1692680|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1692681|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
1692682|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1692683|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1692684|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1692685|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1692686|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1692687|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1692688|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
1692689|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
1692690|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
1692691|NCT00073398|Hyperacute Lung|hyperacute lung
1692692|NCT00073398|NSCLC|nsclc
1692693|NCT00073398|Lung Cancer|lung cancer
1692694|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
1692695|NCT00073294|diabetes|diabetes
1692696|NCT00073281|diabetes|diabetes
1692697|NCT00073281|autoimmunity|autoimmunity
1692698|NCT00073268|diabetes|diabetes
1692699|NCT00073268|adolescent|adolescent
1692700|NCT00073242|leptin|leptin
1692701|NCT00073242|obesity|obesity
1692702|NCT00073229|AIDS|aids
1692703|NCT00073229|Vertical Transmission|vertical transmission
1692704|NCT00073229|Acute Infection|acute infection
1692705|NCT00073216|HIV Seronegativity|hiv seronegativity
1692706|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
1692707|NCT00073190|Patient Education|patient education
1692708|NCT00073190|Physician Education|physician education
1692709|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
1692710|NCT00073047|Ulcerative Colitis|ulcerative colitis
1692711|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
1692712|NCT00073047|Gastrointestinal|gastrointestinal
1692713|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
1692714|NCT00073034|Neuropathic Pain|neuropathic pain
1692715|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
1692716|NCT00073099|Dry Eye|dry eye
1692717|NCT00073099|Lissamine Green|lissamine green
1692718|NCT00073099|Fluorescein|fluorescein
1692719|NCT00073099|Conjunctiva|conjunctiva
1692720|NCT00073099|Cornea|cornea
1692721|NCT00073099|Digital Photography|digital photography
1692722|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
1692723|NCT00073086|Coronavirus|coronavirus
1692724|NCT00073086|Pneumonia|pneumonia
1692725|NCT00073086|Asia|asia
1692726|NCT00073086|China|china
1692727|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
1692728|NCT00073086|SARS|sars
1692729|NCT00073086|Suspected SARS|suspected sars
1692730|NCT00073073|Chemoprevention|chemoprevention
1692731|NCT00073073|Mammographic Density|mammographic density
1692732|NCT00073073|Bone Mineral Density|bone mineral density
1692733|NCT00073073|Biomarkers|biomarkers
1692734|NCT00073073|Safety|safety
1692735|NCT00073073|Breast Cancer|breast cancer
1692736|NCT00073073|Postmenopausal|postmenopausal
1692737|NCT00073060|Plateletpheresis|plateletpheresis
1692738|NCT00073060|Lymphocytapheresis|lymphocytapheresis
1692739|NCT00073060|Apheresis|apheresis
1692740|NCT00073060|Citrate|citrate
1692741|NCT00073060|Bone Density|bone density
1692742|NCT00073060|Healthy Volunteer|healthy volunteer
1692743|NCT00073060|HV|hv
1692744|NCT00073008|EGFR|egfr
1692745|NCT00073008|ErbB1|erbb1
1692746|NCT00073008|ErbB2|erbb2
1692747|NCT00073008|metastatic|metastatic
1692748|NCT00073008|lapatinib|lapatinib
1692750|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
1692752|NCT00073008|GW572016|gw572016
1692753|NCT00073008|Advanced|advanced
1692754|NCT00073008|NSCLC|nsclc
1692755|NCT00072982|Fish oil|fish oil
1692756|NCT00072982|Borage oil|borage oil
1692757|NCT00072943|Crohn's Disease|crohn's disease
1692758|NCT00072943|Colitis|colitis
1692759|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
1692760|NCT00072943|anti-interferon gamma|anti-interferon gamma
1692761|NCT00072917|obesity|obesity
1692762|NCT00072917|thinness|thinness
1692763|NCT00072917|weight gain|weight gain
1692764|NCT00072917|physical activity|physical activity
1692765|NCT00072917|diet|diet
1692766|NCT00072917|fat oxidation|fat oxidation
1692767|NCT00072917|hunger|hunger
1692768|NCT00072917|feeding behavior|feeding behavior
1692770|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
1692771|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
1692772|NCT00072891|Diabetes|diabetes
1692773|NCT00072969|Immunosuppression|immunosuppression
1692774|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
1692775|NCT00072969|MDS|mds
1692776|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1692777|NCT00072956|Torticollis|torticollis
1692778|NCT00072956|Cervical Dystonia|cervical dystonia
1692779|NCT00072956|Surround Inhibition|surround inhibition
1692780|NCT00072956|Sensory Tricks|sensory tricks
1692781|NCT00072787|gastric cancer|gastric cancer
1692782|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
1692783|NCT00072774|Depressive Disorder, Major|depressive disorder, major
1692784|NCT00072774|Melancholia, Involutional|melancholia, involutional
1692785|NCT00072774|Depression, Involutional|depression, involutional
1692786|NCT00072761|silent cerebral infarct|silent cerebral infarct
1692787|NCT00072761|silent stroke|silent stroke
1692788|NCT00072761|sickle cell anemia|sickle cell anemia
1692789|NCT00072761|stroke|stroke
1692790|NCT00072761|transfusion therapy|transfusion therapy
1692791|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
1692792|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
1692793|NCT00072748|Colorectal Tumors|colorectal tumors
1692794|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
1692795|NCT00072722|Prostate Cancer|prostate cancer
1692796|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
1692797|NCT00072722|CC4047|cc4047
1692798|NCT00072722|CC-4047|cc-4047
1692799|NCT00072722|Prostate Carcinoma|prostate carcinoma
1692800|NCT00072722|Celgene|celgene
1692801|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692802|NCT00017017|fallopian tube cancer|fallopian tube cancer
1692803|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1692804|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
1692805|NCT00014677|adult glioblastoma|adult glioblastoma
1692806|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
1692807|NCT00014677|adult gliosarcoma|adult gliosarcoma
1692808|NCT00014638|stage IV breast cancer|stage iv breast cancer
1692809|NCT00014638|recurrent breast cancer|recurrent breast cancer
1692810|NCT00014352|stage III prostate cancer|stage iii prostate cancer
1692811|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
1692812|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
1692813|NCT00014352|thromboembolism|thromboembolism
1692814|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
1692815|NCT00072826|Inhibitors|inhibitors
1692816|NCT00072826|Endothelial Function|endothelial function
1692817|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
1692818|NCT00072826|Statins|statins
1692819|NCT00072826|Atorvastatin|atorvastatin
1692820|NCT00072826|Sickle Cell Disease|sickle cell disease
1692821|NCT00072813|Genetics|genetics
1692822|NCT00072813|Seizures|seizures
1692823|NCT00072813|Brain Imaging|brain imaging
1692824|NCT00072813|Diffusion|diffusion
1692825|NCT00072813|Temporal Lobe|temporal lobe
1692826|NCT00072800|Reliability|reliability
1692827|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
1692828|NCT00072800|Spasticity|spasticity
1692829|NCT00072800|Dystonia|dystonia
1692830|NCT00072800|Rigidity|rigidity
1692831|NCT00072800|Cerebral Palsy|cerebral palsy
1692832|NCT00072800|CP|cp
1692833|NCT00072800|Children|children
1692834|NCT00072709|ALS|als
1692835|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
1692836|NCT00072683|Sodium|sodium
1692837|NCT00072683|SIADH|siadh
1692838|NCT00072683|Vasopressin|vasopressin
1692839|NCT00072683|CHF|chf
1692840|NCT00072683|Cirrhosis|cirrhosis
1692841|NCT00072683|salt|salt
1692842|NCT00072683|water|water
1692843|NCT00072683|electrolyte|electrolyte
1692844|NCT00072670|Prostate cancer|prostate cancer
1692845|NCT00072670|Advanced prostate cancer|advanced prostate cancer
1692846|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
1692847|NCT00072670|Trabectedin|trabectedin
1692848|NCT00072670|Yondelis|yondelis
1692849|NCT00072670|ET-743|et-743
1692850|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692851|NCT00012090|fallopian tube cancer|fallopian tube cancer
1692852|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1692853|NCT00010309|stage II melanoma|stage ii melanoma
1692854|NCT00010309|stage III melanoma|stage iii melanoma
1692855|NCT00010309|stage IV melanoma|stage iv melanoma
1692856|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1692857|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
1692858|NCT00006367|polycythemia vera|polycythemia vera
1692859|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1692860|NCT00006367|essential thrombocythemia|essential thrombocythemia
1692861|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
1692862|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
1692863|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1692864|NCT00072735|Use Dependent Plasticity|use dependent plasticity
1693092|NCT00071812|RA|ra
1692865|NCT00072735|Cortical Reorganization|cortical reorganization
1692866|NCT00072735|Rehabilitation|rehabilitation
1692867|NCT00072735|Somatosensory Nerve|somatosensory nerve
1692868|NCT00072735|Amphetamine|amphetamine
1692869|NCT00072735|Stroke|stroke
1692870|NCT00072735|Healthy Volunteer|healthy volunteer
1692871|NCT00072735|HV|hv
1692872|NCT00072657|Arthritis|arthritis
1692873|NCT00072657|Pain|pain
1692874|NCT00072657|Meditation|meditation
1692875|NCT00072657|Tai Chi|tai chi
1692876|NCT00072657|Chronic Illness|chronic illness
1692877|NCT00072657|Depression|depression
1692878|NCT00072644|HIV|hiv
1692879|NCT00072644|Osteonecrosis|osteonecrosis
1692880|NCT00072644|Drug Interaction|drug interaction
1692881|NCT00072644|P-Glycoprotein|p-glycoprotein
1692882|NCT00072644|Cytochrome P 450|cytochrome p 450
1692883|NCT00072644|Healthy Volunteer|healthy volunteer
1692884|NCT00072644|HV|hv
1692888|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
1692889|NCT00072631|EGFR|egfr
1692890|NCT00072631|OSI-774|osi-774
1692891|NCT00072501|breast cancer|breast cancer
1692892|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
1692893|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
1692894|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1692895|NCT00072488|regional neuroblastoma|regional neuroblastoma
1692896|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
1692897|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1692898|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1692899|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1692900|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1692901|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1692902|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1692903|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1692904|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1692905|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1692906|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1692907|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1692908|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1692909|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1692910|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1692911|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1692912|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1692913|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1692914|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1692915|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1692916|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1692917|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
1692918|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1692919|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1692920|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1692921|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1692922|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1692923|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1692924|NCT00072475|refractory anemia|refractory anemia
1692925|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1692926|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1692927|NCT00072462|breast cancer in situ|breast cancer in situ
1692928|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1693074|NCT00072592|B Lymphocyte|b lymphocyte
1692929|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692930|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1692931|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
1692932|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1692933|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
1692934|NCT00072358|regional neuroblastoma|regional neuroblastoma
1692935|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
1692936|NCT00072345|stage III melanoma|stage iii melanoma
1692937|NCT00072345|stage IV melanoma|stage iv melanoma
1692938|NCT00072345|recurrent melanoma|recurrent melanoma
1692939|NCT00072345|iris melanoma|iris melanoma
1692940|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1692941|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1695253|NCT00067496|Sleep Apnea|sleep apnea
1692942|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
1692943|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
1692944|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1692945|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
1692946|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
1692947|NCT00072319|stage I breast cancer|stage i breast cancer
1692948|NCT00072319|stage II breast cancer|stage ii breast cancer
1692949|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
1692950|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
1692951|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
1692952|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
1692953|NCT00072293|stage IA breast cancer|stage ia breast cancer
1692954|NCT00072293|stage IB breast cancer|stage ib breast cancer
1692955|NCT00072293|stage II breast cancer|stage ii breast cancer
1692956|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1693196|NCT00071734|Adult|adult
1692957|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1692958|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1692959|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1692960|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
1692961|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1692962|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1692963|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1692964|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1692965|NCT00072267|fallopian tube cancer|fallopian tube cancer
1692966|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1692967|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1692968|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1692969|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1692970|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1692971|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1692972|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1692973|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
1692974|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1692975|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1692976|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1692977|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1692978|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1692979|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
1692980|NCT00072215|testicular seminoma|testicular seminoma
1692981|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1692982|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1692983|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
1692984|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1692985|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1692986|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1692987|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1692988|NCT00072215|testicular immature teratoma|testicular immature teratoma
1692989|NCT00072215|testicular mature teratoma|testicular mature teratoma
1692990|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1692991|NCT00072124|stage IV melanoma|stage iv melanoma
1692992|NCT00072124|recurrent melanoma|recurrent melanoma
1692993|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1692994|NCT00072098|stage IV colon cancer|stage iv colon cancer
1692995|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
1692996|NCT00072098|liver metastases|liver metastases
1692997|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
1692998|NCT00072098|recurrent colon cancer|recurrent colon cancer
1692999|NCT00072085|stage IV melanoma|stage iv melanoma
1693000|NCT00072085|recurrent melanoma|recurrent melanoma
1693001|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1693002|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1693003|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1693005|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1693006|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1693007|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1693008|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
1693009|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1693010|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
1693011|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
1693012|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
1693013|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1693014|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1693015|NCT00072020|bone metastases|bone metastases
1693016|NCT00072020|stage II breast cancer|stage ii breast cancer
1693017|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
1693018|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
1693019|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
1693020|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1693021|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1693022|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1693023|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1693024|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1693025|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1693026|NCT00071981|stage IV melanoma|stage iv melanoma
1693027|NCT00071981|recurrent melanoma|recurrent melanoma
1693197|NCT00071734|BOLD|bold
1693028|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1693029|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
1693030|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
1693031|NCT00071968|stage I prostate cancer|stage i prostate cancer
1693032|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1693033|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1693034|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1693035|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1693036|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1693037|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1693038|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1693039|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1693040|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1693041|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1693042|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1693043|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1693044|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
1693045|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
1693046|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1693047|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1693048|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
1693049|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1693050|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1693051|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1693052|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1693053|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1693054|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1693055|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
1693056|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1693057|NCT00003141|regional neuroblastoma|regional neuroblastoma
1693058|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1693059|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1693060|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1693061|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1693062|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1693063|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
1693064|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1693065|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
1693066|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1693068|NCT00072605|T Cells|t cells
1693069|NCT00072605|Immunity|immunity
1693070|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
1693071|NCT00072605|Healthy Volunteer|healthy volunteer
1693072|NCT00072605|HV|hv
1693073|NCT00072592|ANCA|anca
1693078|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
1693079|NCT00072592|WG|wg
1693080|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1693081|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1693082|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
1693083|NCT00072553|stage IV colon cancer|stage iv colon cancer
1693084|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
1693085|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693086|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
1693087|NCT00072553|recurrent colon cancer|recurrent colon cancer
1693088|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
1693089|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
1693090|NCT00071851|HIV Seronegativity|hiv seronegativity
1693091|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
1693093|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1693094|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1693095|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1693096|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1693097|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1693098|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1693099|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1693100|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1693101|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1693102|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1693103|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1693104|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1693105|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1693106|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1693107|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1693108|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1693109|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1693110|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1693111|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1693112|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1693113|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1693114|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1693115|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1693116|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1693117|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1693118|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1693119|NCT00071903|Thrombophilia|thrombophilia
1693120|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
1693121|NCT00071903|Kidney Involvement|kidney involvement
1693122|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
1693123|NCT00071903|Cystine|cystine
1693124|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
1693125|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
1693126|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
1693128|NCT00071903|Intracranial Hypertension|intracranial hypertension
1693129|NCT00071890|Interleukin 2|interleukin 2
1693130|NCT00071890|Treatment Interruption|treatment interruption
1693131|NCT00071890|HIV|hiv
1693132|NCT00071877|Lysosomal Disease|lysosomal disease
1693133|NCT00071877|Hypohidrosis|hypohidrosis
1693134|NCT00071877|Pain|pain
1693135|NCT00071877|Neuropathy|neuropathy
1693136|NCT00071877|X-Linked|x-linked
1693137|NCT00071877|Fabry Disease|fabry disease
1693138|NCT00071877|Children|children
1693139|NCT00005072|stage I prostate cancer|stage i prostate cancer
1693140|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
1693141|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
1693142|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
1693143|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1693144|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1693145|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1693146|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1693147|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1693148|NCT00071838|Neuroimmunology|neuroimmunology
1693149|NCT00071838|Therapy|therapy
1693150|NCT00071838|Demyelinating Disease|demyelinating disease
1693151|NCT00071838|Immunological Mechanism|immunological mechanism
1693152|NCT00071838|MRI|mri
1693153|NCT00071838|Multiple Sclerosis|multiple sclerosis
1693155|NCT00071773|diabetic macular edema|diabetic macular edema
1693156|NCT00071773|laser photocoagulation|laser photocoagulation
1693157|NCT00071773|etdrs|etdrs
1693158|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
1693159|NCT00071773|DME|dme
1693160|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
1693161|NCT00071786|Migraine|migraine
1693162|NCT00071786|Behavior Genetics|behavior genetics
1693163|NCT00071786|Genetic Epidemiology|genetic epidemiology
1693164|NCT00071786|Family Study|family study
1693165|NCT00071760|pediatrics|pediatrics
1693166|NCT00071760|ritonavir|ritonavir
1693167|NCT00071760|amprenavir|amprenavir
1693168|NCT00071760|AGENERASE|agenerase
1693169|NCT00071760|HIV|hiv
1693170|NCT00071760|Lexiva|lexiva
1693171|NCT00071760|protease inhibitors|protease inhibitors
1693172|NCT00071760|HIV Infection|hiv infection
1693173|NCT00071760|fosamprenavir|fosamprenavir
1693174|NCT00071747|schizophrenia|schizophrenia
1693175|NCT00071747|lamotrigine|lamotrigine
1693176|NCT00071721|Alzheimer disease|alzheimer disease
1693177|NCT00071721|Agitation|agitation
1693178|NCT00071721|Psychosis|psychosis
1693179|NCT00071682|herbal medicine|herbal medicine
1693180|NCT00071682|alternative medicines|alternative medicines
1693181|NCT00071682|anticoagulation|anticoagulation
1693182|NCT00071682|side effects|side effects
1693183|NCT00071682|bleeding|bleeding
1693184|NCT00071682|clotting|clotting
1693185|NCT00071669|Mood Disorder|mood disorder
1693186|NCT00071669|Acupuncture|acupuncture
1693187|NCT00071643|Stroke|stroke
1693188|NCT00071630|Adolescent|adolescent
1693189|NCT00071617|Suicide|suicide
1693190|NCT00071617|Adolescence|adolescence
1693191|NCT00071578|Psychotherapy|psychotherapy
1693192|NCT00071578|Treatment|treatment
1693193|NCT00071734|fMRI|fmri
1693194|NCT00071734|Auditory Feedback|auditory feedback
1693195|NCT00071734|Motor Control|motor control
1693198|NCT00071734|Healthy Volunteer|healthy volunteer
1693199|NCT00071734|HV|hv
1693200|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
1693201|NCT00071565|intracranial aneurysm|intracranial aneurysm
1693202|NCT00071565|brain aneurysm|brain aneurysm
1693203|NCT00071565|aneurysm|aneurysm
1693204|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
1693205|NCT00071565|stroke|stroke
1693206|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
1693207|NCT00071539|gross total resection|gross total resection
1693208|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
1693209|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
1693210|NCT00004050|stage III prostate cancer|stage iii prostate cancer
1693211|NCT00004025|stage III melanoma|stage iii melanoma
1693212|NCT00004025|stage IV melanoma|stage iv melanoma
1693213|NCT00004025|recurrent melanoma|recurrent melanoma
1693214|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
1693215|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1693216|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1693217|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1693218|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1693219|NCT00003648|stage I colon cancer|stage i colon cancer
1693220|NCT00003648|stage II colon cancer|stage ii colon cancer
1693221|NCT00003648|stage III colon cancer|stage iii colon cancer
1693222|NCT00003648|stage IV colon cancer|stage iv colon cancer
1693223|NCT00003648|stage I rectal cancer|stage i rectal cancer
1693224|NCT00003648|stage II rectal cancer|stage ii rectal cancer
1693225|NCT00003648|stage III rectal cancer|stage iii rectal cancer
1693226|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
1693227|NCT00003648|recurrent colon cancer|recurrent colon cancer
1693228|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
1693229|NCT00071526|Vitamin C|vitamin c
1693230|NCT00071526|Diabetes Mellitus|diabetes mellitus
1693231|NCT00071526|Proteinuria|proteinuria
1693232|NCT00071526|Renal Threshold|renal threshold
1693233|NCT00071526|Healthy Volunteer|healthy volunteer
1693234|NCT00071513|Adolescent|adolescent
1693235|NCT00071513|Substance Abuse|substance abuse
1693236|NCT00071513|At-risk|at-risk
1693237|NCT00071500|Compliance|compliance
1693238|NCT00071500|Adherence|adherence
1693239|NCT00071500|Computerized|computerized
1693240|NCT00071500|Electronic Pillbox|electronic pillbox
1693241|NCT00071500|Treatment Experienced|treatment experienced
1693242|NCT00071487|SLE|sle
1693243|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
1693244|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1693245|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1693246|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1693247|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1693248|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1693249|NCT00003266|fatigue|fatigue
1693250|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1693251|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
1715267|NCT00001415|IL-1|il-1
1693252|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1693253|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1693254|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1693255|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1693256|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1693257|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
1693258|NCT00003126|renal cell cancer|renal cell cancer
1693259|NCT00003126|renal cell carcinoma|renal cell carcinoma
1693260|NCT00003126|interleukin-2|interleukin-2
1693261|NCT00071474|temporomandibular disroders|temporomandibular disroders
1693262|NCT00071474|shamanism|shamanism
1693263|NCT00071474|chronic pain|chronic pain
1693356|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
1693264|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1693265|NCT00071461|Interstitial lung disease|interstitial lung disease
1693266|NCT00071461|Bosentan|bosentan
1693267|NCT00071461|BUILD|build
1693268|NCT00071435|EEG|eeg
1693269|NCT00071435|Voluntary Movement|voluntary movement
1693270|NCT00071435|Motor Cortex|motor cortex
1693271|NCT00071435|Reaction Time|reaction time
1693272|NCT00071435|Corticospinal|corticospinal
1693273|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
1693274|NCT00071435|PLS|pls
1693275|NCT00071435|Healthy Volunteer|healthy volunteer
1693276|NCT00071435|HV|hv
1693277|NCT00071422|Type 2 diabetes|type 2 diabetes
1693278|NCT00071409|Type 1 diabetes|type 1 diabetes
1693279|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1693280|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
1693281|NCT00071396|Refractory|refractory
1693282|NCT00071396|Relapsed|relapsed
1693283|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
1693284|NCT00033527|small cell lung cancer|small cell lung cancer
1693285|NCT00025350|stage IV colon cancer|stage iv colon cancer
1693286|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
1693287|NCT00025350|recurrent colon cancer|recurrent colon cancer
1693288|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
1693289|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
1693290|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693291|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
1693292|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1693293|NCT00002723|stage III prostate cancer|stage iii prostate cancer
1693294|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
1693295|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
1693296|NCT00071331|chronic heart failure|chronic heart failure
1693297|NCT00071331|heart failure|heart failure
1693298|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
1693299|NCT00071292|stress reduction|stress reduction
1693300|NCT00071292|meditation|meditation
1693301|NCT00071292|mindfulness|mindfulness
1693303|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
1693304|NCT00071292|mind-body skills|mind-body skills
1693305|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1693306|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1693307|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1693308|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1693309|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
1693310|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1693311|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1693312|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1693313|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1693314|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1693315|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1693316|NCT00071370|Magnetoencephalography|magnetoencephalography
1693317|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
1693318|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
1693319|NCT00071370|Epilepsy|epilepsy
1693320|NCT00071370|Sleep Deprivation|sleep deprivation
1693321|NCT00071370|Seizure|seizure
1693322|NCT00071305|Magnetoencephalography|magnetoencephalography
1693323|NCT00071305|Electroencephalography|electroencephalography
1693324|NCT00071305|Epilepsy|epilepsy
1693325|NCT00071305|Dipole Modeling|dipole modeling
1693326|NCT00071305|Surgery|surgery
1693327|NCT00071266|Intermittent Claudication|intermittent claudication
1693328|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
1693329|NCT00071266|Atherosclerosis|atherosclerosis
1693330|NCT00071266|Niacin|niacin
1693331|NCT00071266|Lovastatin|lovastatin
1693332|NCT00071266|PAD|pad
1693333|NCT00071266|IC|ic
1693334|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
1693335|NCT00071240|Growth Hormone|growth hormone
1693336|NCT00071240|HIV|hiv
1693337|NCT00071240|AIDS|aids
1693338|NCT00071240|Thymus|thymus
1693339|NCT00071240|CD4 Cell|cd4 cell
1693340|NCT00071240|Immune System|immune system
1693341|NCT00071240|Treatment Experienced|treatment experienced
1715268|NCT00001415|IL-6|il-6
1693342|NCT00071214|Staphylococcal infection|staphylococcal infection
1693343|NCT00071214|Gram positive bacteria|gram positive bacteria
1693344|NCT00071214|Staphylococcus|staphylococcus
1693345|NCT00071214|Staphylococcus aureus|staphylococcus aureus
1693346|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
1693347|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
1693348|NCT00064428|fondaparinux|fondaparinux
1693349|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
1693350|NCT00064428|acute coronary syndrome|acute coronary syndrome
1693351|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
1693352|NCT00071227|Macular Edema|macular edema
1693353|NCT00071227|Inflammation|inflammation
1693354|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
1693355|NCT00071227|CRVO|crvo
1693555|NCT00070759|Daclizumab|daclizumab
1693357|NCT00071227|Age Related Macular Edema|age related macular edema
1693359|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1693360|NCT00071175|Lupus|lupus
1693361|NCT00071175|Genetics|genetics
1693362|NCT00071162|Pain|pain
1693363|NCT00071162|Fatigue|fatigue
1693364|NCT00071162|Sleep|sleep
1693365|NCT00071162|Depression|depression
1693366|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
1693367|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
1693368|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
1693369|NCT00071149|TCM|tcm
1693370|NCT00071149|Diagnosis|diagnosis
1693371|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
1693372|NCT00071149|Complementary Therapies|complementary therapies
1693373|NCT00071110|Acupuncture|acupuncture
1693374|NCT00071110|Electroacupuncture|electroacupuncture
1693375|NCT00071110|Alternative therapy|alternative therapy
1693376|NCT00071097|HIV|hiv
1693377|NCT00071097|TMC114|tmc114
1693378|NCT00071097|Ritonavir|ritonavir
1715001|NCT00001546|EEG|eeg
1693379|NCT00071097|Tolerability|tolerability
1693380|NCT00071097|Safety and efficacy|safety and efficacy
1693381|NCT00071097|TMC114-C211|tmc114-c211
1693382|NCT00071084|Skin cancer|skin cancer
1693383|NCT00071084|Lymphoma|lymphoma
1693384|NCT00071084|Mycosis fungoides|mycosis fungoides
1693385|NCT00071084|Sezary syndrome|sezary syndrome
1693386|NCT00071071|Skin cancer|skin cancer
1693387|NCT00071071|Lymphoma|lymphoma
1693388|NCT00071071|Mycosis fungoides|mycosis fungoides
1693389|NCT00071071|Sezary syndrome|sezary syndrome
1693390|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1693391|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1693392|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1693393|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
1693394|NCT00016250|stage IV colon cancer|stage iv colon cancer
1693395|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
1693396|NCT00016250|recurrent colon cancer|recurrent colon cancer
1693397|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
1693398|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
1693399|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693400|NCT00015886|stage IV breast cancer|stage iv breast cancer
1693401|NCT00015886|recurrent breast cancer|recurrent breast cancer
1693402|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
1693403|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
1693404|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
1693405|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1693406|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
1693407|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1693408|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1693409|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1693410|NCT00014144|anterior urethral cancer|anterior urethral cancer
1693411|NCT00014144|posterior urethral cancer|posterior urethral cancer
1693412|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1693413|NCT00071383|Herceptin|herceptin
1693414|NCT00071383|Trastuzumab|trastuzumab
1693415|NCT00071383|Microdissection|microdissection
1693416|NCT00071383|Proteomics|proteomics
1693417|NCT00071383|Microarrays|microarrays
1693418|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
1693419|NCT00071383|Breast Cancer|breast cancer
1693420|NCT00071383|Brain|brain
1693421|NCT00071383|Carcinoma|carcinoma
1693422|NCT00071383|Genomics|genomics
1693423|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
1693424|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
1693425|NCT00071357|Microarray|microarray
1693426|NCT00071357|Herceptin|herceptin
1693427|NCT00071357|Trastuzumab|trastuzumab
1693428|NCT00071357|Carcinoma|carcinoma
1693429|NCT00071357|Proteomics|proteomics
1693430|NCT00071357|Breast Cancer|breast cancer
1693431|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
1693432|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
1693433|NCT00071344|Microarray|microarray
1693434|NCT00071344|Genomics|genomics
1693437|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
1693438|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
1693439|NCT00071344|Brain|brain
1693440|NCT00071344|Microarrays|microarrays
1693441|NCT00071344|Microdissection|microdissection
1693442|NCT00071344|Lung Cancer|lung cancer
1693443|NCT00071344|NSCLC|nsclc
1693444|NCT00071123|fMRI|fmri
1693445|NCT00071123|Habituation|habituation
1693446|NCT00071123|Extinction|extinction
1693447|NCT00071123|Amygdala|amygdala
1693448|NCT00071123|Emotion|emotion
1693449|NCT00071123|Major Depressive Disorder|major depressive disorder
1693450|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
1693451|NCT00071123|Backward Masking|backward masking
1693452|NCT00071123|Depression|depression
1693453|NCT00071123|MDD|mdd
1693454|NCT00071123|Healthy Volunteer|healthy volunteer
1693455|NCT00071123|HV|hv
1693456|NCT00071032|Blood Disease|blood disease
1693457|NCT00071032|blood transfusion|blood transfusion
1693459|NCT00070993|Creatine|creatine
1693460|NCT00070980|Complementary Therapies|complementary therapies
1693461|NCT00070967|Acupuncture|acupuncture
1693462|NCT00070967|Quality of Life|quality of life
1693463|NCT00070967|Complementary Therapies|complementary therapies
1693464|NCT00070967|TCM|tcm
1693465|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
1693466|NCT00070954|ECT|ect
1693467|NCT00070954|Memory|memory
1693468|NCT00070954|Ginkgo biloba|ginkgo biloba
1693469|NCT00070941|Parkinsons Disease|parkinsons disease
1693470|NCT00070941|Depression|depression
1693471|NCT00070941|SAM-e|sam-e
1693472|NCT00070928|Sleep|sleep
1693473|NCT00070902|Spinal Manipulation|spinal manipulation
1693474|NCT00070902|Chiropractic|chiropractic
1693475|NCT00070902|Zygapophysial Joints|zygapophysial joints
1693476|NCT00070889|Complementary Therapies|complementary therapies
1693477|NCT00070850|Screening|screening
1693478|NCT00070850|Prenatal|prenatal
1693479|NCT00070850|Amniocentesis|amniocentesis
1693480|NCT00070824|Acupuncture|acupuncture
1693481|NCT00070824|SPECT|spect
1693482|NCT00070824|f-MRI|f-mri
1693483|NCT00070824|Functional brain imaging|functional brain imaging
1693484|NCT00070824|RCT|rct
1693485|NCT00070811|Facial form|facial form
1693486|NCT00070811|Facial animation|facial animation
1693487|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
1693488|NCT00070811|Lip form|lip form
1693489|NCT00070811|Lip function|lip function
1693490|NCT00070720|Behavior change|behavior change
1693491|NCT00070720|Change in practitioner behavior|change in practitioner behavior
1693492|NCT00070720|Episiotomy|episiotomy
1693493|NCT00070720|Active management of third stage of labor|active management of third stage of labor
1693494|NCT00070720|Global Network|global network
1693495|NCT00070720|Latin America|latin america
1693496|NCT00070720|Uruguay|uruguay
1693497|NCT00070720|Argentina|argentina
1693498|NCT00070720|Maternal and child health|maternal and child health
1693499|NCT00070720|International|international
1693500|NCT00070720|Women's health|women's health
1693501|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
1693502|NCT00071058|Drug Resistance Reversal|drug resistance reversal
1693503|NCT00071058|Pharmacodynamics|pharmacodynamics
1693504|NCT00071058|Molecular Target|molecular target
1693505|NCT00071058|Endocrine Cancer|endocrine cancer
1693506|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
1693507|NCT00071058|ACC|acc
1693508|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
1693509|NCT00071045|Tissue Procurement|tissue procurement
1693510|NCT00071045|Sample Collection|sample collection
1693511|NCT00071045|Laboratory Research|laboratory research
1693512|NCT00071045|Tissue Sample|tissue sample
1693513|NCT00071045|Solid Tumor|solid tumor
1693514|NCT00071045|Blood Disorder|blood disorder
1693515|NCT00071045|HLA Donor|hla donor
1693516|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
1693517|NCT00070746|Neonatal mortality|neonatal mortality
1693518|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
1693519|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
1693520|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
1693521|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
1693522|NCT00070746|Global Network|global network
1693523|NCT00070746|Pakistan|pakistan
1693524|NCT00070746|Maternal and child health|maternal and child health
1693525|NCT00070746|International|international
1693526|NCT00070746|Women's health|women's health
1693527|NCT00070733|Testosterone|testosterone
1693528|NCT00070733|5-alpha Reductase|5-alpha reductase
1693529|NCT00070733|Muscle Strength|muscle strength
1693531|NCT00070733|Sexual Function|sexual function
1693532|NCT00070733|Muscle Mass|muscle mass
1693533|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
1693534|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
1693535|NCT00070707|Concomitant Asthma|concomitant asthma
1693536|NCT00070876|Child|child
1693537|NCT00070876|Adolescent|adolescent
1693538|NCT00069433|Psychotic Disorders|psychotic disorders
1693539|NCT00017368|regional neuroblastoma|regional neuroblastoma
1693540|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
1693541|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1693542|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
1693543|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1693544|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
1693545|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1693546|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1693547|NCT00003907|liver metastases|liver metastases
1693548|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
1693549|NCT00070785|EBV Virus|ebv virus
1693550|NCT00070785|Epitope Mapping|epitope mapping
1693551|NCT00070785|Epstein-Barr Virus|epstein-barr virus
1693552|NCT00070785|Latent Protein-2|latent protein-2
1693553|NCT00070785|Healthy Volunteer|healthy volunteer
1693554|NCT00070785|HV|hv
1693559|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
1693560|NCT00070629|Immunotherapy|immunotherapy
1693561|NCT00070629|lung cancer|lung cancer
1693562|NCT00070616|mucositis|mucositis
1693563|NCT00070616|chemotherapy|chemotherapy
1693564|NCT00070616|radiation therapy|radiation therapy
1693565|NCT00070590|Scleroderma|scleroderma
1693566|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
1693567|NCT00070590|Build|build
1693568|NCT00070590|bosentan|bosentan
1693569|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1693570|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1693571|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1693572|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1693573|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1693574|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1693575|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1694052|NCT00069914|Healthy Volunteer|healthy volunteer
1693576|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1693577|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1693578|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1693579|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1693580|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1693581|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1693582|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1693583|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1693584|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1693585|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1693586|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1693587|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1693588|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1693589|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1693590|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1693591|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1693592|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1693593|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1693594|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1693595|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1693596|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1693597|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1693598|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1693599|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1693600|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1693601|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1693602|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
1693603|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
1693604|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
1693605|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1693606|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1693607|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1693608|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
1693609|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
1693610|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
1693611|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
1693612|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
1693613|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1715575|NCT00001193|Stage III|stage iii
1693614|NCT00006121|stage III breast cancer|stage iii breast cancer
1693615|NCT00006121|stage IV breast cancer|stage iv breast cancer
1693616|NCT00006121|recurrent breast cancer|recurrent breast cancer
1693617|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1693618|NCT00006012|radiation toxicity|radiation toxicity
1693619|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
1693620|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1693621|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1693622|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1693623|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1693624|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1693625|NCT00006009|small intestine lymphoma|small intestine lymphoma
1693626|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1697290|NCT00063245|Reward|reward
1693627|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1693628|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1693629|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1693630|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1693631|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1693632|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1693633|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1693634|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1693635|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1693636|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1693637|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1693638|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1693639|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1693640|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1693641|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1693642|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1693643|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1693644|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1693645|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1693646|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1693647|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1693648|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1693649|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1693650|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1693651|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1693652|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
1693653|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
1693654|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
1693655|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1693656|NCT00070694|Affective Disorders|affective disorders
1693657|NCT00070694|Refractory|refractory
1693658|NCT00070694|Augmentation|augmentation
1693659|NCT00070694|Polysomogram|polysomogram
1693660|NCT00070694|Combination Therapy|combination therapy
1693661|NCT00070694|Affective Disorder|affective disorder
1693662|NCT00070694|Depression|depression
1693663|NCT00070694|Major Depression|major depression
1693664|NCT00070564|stage II breast cancer|stage ii breast cancer
1693665|NCT00070564|stage IA breast cancer|stage ia breast cancer
1693666|NCT00070564|stage IB breast cancer|stage ib breast cancer
1693667|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
1693668|NCT00070564|male breast cancer|male breast cancer
1693669|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
1693670|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1693671|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1693672|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1693673|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1693674|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1693675|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1693676|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1693677|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1693678|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1693679|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
1693680|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1693681|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1693682|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1715893|NCT00048763|circulatory|circulatory
1693683|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1693684|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1693685|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1693686|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1693687|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1693688|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1693689|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1693690|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1693691|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1693692|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
1693693|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
1693694|NCT00070486|large cell lung cancer|large cell lung cancer
1693695|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1693696|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1693697|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1693698|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1693699|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1693700|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1693701|NCT00070434|stage II rectal cancer|stage ii rectal cancer
1693702|NCT00070434|stage III rectal cancer|stage iii rectal cancer
1693703|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693704|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1693705|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1693706|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1693770|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1693707|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1693708|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1693709|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1693710|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1693711|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1693712|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1693713|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1693714|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1693715|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1693716|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1693717|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1693718|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1693719|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1693720|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1693721|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1694124|NCT00069628|Type 1 Diabetes|type 1 diabetes
1693722|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1693723|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1693724|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1693725|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1693726|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1693727|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1693728|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1693729|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1693730|NCT00070382|anemia|anemia
1693731|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1693732|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1693733|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1693734|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
1693735|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1693736|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
1693737|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
1693738|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
1693739|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
1693740|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
1693741|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1693742|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1693743|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1693744|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1693745|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1693746|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1693747|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1693748|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1693749|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1693750|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1693751|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1693752|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1693753|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1693754|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1693755|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1693756|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1693757|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1693954|NCT00069992|primary myelofibrosis|primary myelofibrosis
1693758|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1693759|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1693760|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1693761|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1693762|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1693763|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1693764|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1693765|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1693766|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1693767|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1693768|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1693769|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1693771|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
1693772|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1693773|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1693774|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1693775|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1693776|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1693777|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1693778|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1693779|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1693780|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1693781|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1693782|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1693783|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1693784|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1693785|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1693786|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1693787|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1693788|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1693789|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1693790|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1693791|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1693792|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1693793|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1693794|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1693795|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1693796|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1693797|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1693798|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1693799|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1693800|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1693801|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1693802|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1693803|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1693804|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1693805|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1693806|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1693807|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1693808|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1693809|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1693810|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1693811|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1693812|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1693813|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1693814|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1693815|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1693816|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1693817|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1693818|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1694029|NCT00069901|carboplatin|carboplatin
1693819|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1693820|NCT00070343|stage IV melanoma|stage iv melanoma
1693821|NCT00070343|stage III melanoma|stage iii melanoma
1693822|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1693823|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
1693824|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1693825|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1693826|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1693827|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1693828|NCT00070278|stage II breast cancer|stage ii breast cancer
1693829|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
1693830|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
1693831|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
1693832|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
1693833|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693834|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
1693835|NCT00070213|stage IV colon cancer|stage iv colon cancer
1693836|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
1693837|NCT00070213|recurrent colon cancer|recurrent colon cancer
1693838|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
1693839|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
1693840|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1693841|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
1693842|NCT00070200|regional neuroblastoma|regional neuroblastoma
1693843|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
1693844|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1693845|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1693846|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1693847|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1693848|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1693849|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1693850|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1693851|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1693852|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1693853|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1693854|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1693855|NCT00070161|radiation toxicity|radiation toxicity
1693856|NCT00070161|adult mixed glioma|adult mixed glioma
1693857|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1693858|NCT00070161|adult brain stem glioma|adult brain stem glioma
1693859|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
1693860|NCT00070161|adult medulloblastoma|adult medulloblastoma
1693861|NCT00070161|adult meningioma|adult meningioma
1693862|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
1693863|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
1693864|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1693865|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1693866|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1693867|NCT00070161|adult subependymoma|adult subependymoma
1693868|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1693869|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
1693870|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
1693871|NCT00070161|adult pineoblastoma|adult pineoblastoma
1693872|NCT00070161|adult pineocytoma|adult pineocytoma
1693873|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1693874|NCT00070161|adult glioblastoma|adult glioblastoma
1693875|NCT00070161|adult grade III meningioma|adult grade iii meningioma
1693876|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
1693877|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
1693878|NCT00070161|adult gliosarcoma|adult gliosarcoma
1693879|NCT00070161|adult ependymoma|adult ependymoma
1693880|NCT00070148|weight changes|weight changes
1693881|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1693882|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1693883|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1693884|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1693885|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1693886|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1693887|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1693888|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1693889|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1693890|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1693891|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1693892|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1693893|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1693894|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1693895|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1693896|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1693897|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1693898|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1693899|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1693900|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1693901|NCT00070096|testicular seminoma|testicular seminoma
1694049|NCT00069914|Antibodies|antibodies
1693902|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1693903|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1693904|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1693905|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1693906|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
1693907|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1693908|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1693909|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1694125|NCT00069628|Diabetes in Children|diabetes in children
1693910|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1693911|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1693912|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
1693913|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1693914|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1693915|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
1693916|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1693917|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1693918|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1693919|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1693920|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1693921|NCT00070096|testicular immature teratoma|testicular immature teratoma
1693922|NCT00070096|testicular mature teratoma|testicular mature teratoma
1693923|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1693924|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1693925|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1693926|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1693927|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1693928|NCT00070070|stage I bladder cancer|stage i bladder cancer
1693929|NCT00070031|recurrent breast cancer|recurrent breast cancer
1693930|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
1693931|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
1693932|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
1693933|NCT00070031|stage IV breast cancer|stage iv breast cancer
1693934|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1693935|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1693936|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1693937|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1693938|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1693939|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1693940|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1693941|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1693942|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1693943|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1693944|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
1693945|NCT00070005|stage I rectal cancer|stage i rectal cancer
1693946|NCT00070005|stage II rectal cancer|stage ii rectal cancer
1693947|NCT00070005|stage III rectal cancer|stage iii rectal cancer
1693948|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1693949|NCT00069992|polycythemia vera|polycythemia vera
1693950|NCT00069992|essential thrombocythemia|essential thrombocythemia
1693951|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1693952|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1693953|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1694494|NCT00068926|Emergent|emergent
1693955|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
1693956|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1693957|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1693958|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1693959|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1693960|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1693961|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1693962|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1693963|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1693964|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1693965|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1694050|NCT00069914|Titers|titers
1693966|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1693967|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1693968|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1693969|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1693970|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
1693971|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
1693972|NCT00069940|adult glioblastoma|adult glioblastoma
1693973|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1693974|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1693975|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
1693976|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
1693977|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
1693978|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
1693979|NCT00069940|adult liposarcoma|adult liposarcoma
1693980|NCT00069940|childhood liposarcoma|childhood liposarcoma
1693981|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1693982|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
1693983|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
1693984|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1693985|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1693986|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1693987|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
1693988|NCT00069940|adult gliosarcoma|adult gliosarcoma
1693989|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1693990|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
1693991|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1693992|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
1693993|NCT00069940|adult mixed glioma|adult mixed glioma
1693994|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1693995|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
1693996|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1693997|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1693998|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1693999|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1694000|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1694001|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1694002|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
1694003|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
1694004|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1694005|NCT00069927|depression|depression
1694006|NCT00069927|neurotoxicity|neurotoxicity
1694007|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
1694424|NCT00069134|glutathione kinetics|glutathione kinetics
1694008|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
1694009|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1694010|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1694011|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1694012|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1694013|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1694014|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1694015|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1694016|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1694017|NCT00070577|Alcohol Clamp|alcohol clamp
1694018|NCT00070577|Pharmacokinetics|pharmacokinetics
1694019|NCT00070577|Pharmacodynamics|pharmacodynamics
1694020|NCT00070577|Alcohol|alcohol
1694021|NCT00070577|Metabolism|metabolism
1694022|NCT00070577|Response|response
1694023|NCT00070577|Age|age
1694024|NCT00070577|Sex|sex
1694025|NCT00070577|Healthy Volunteer|healthy volunteer
1694026|NCT00070577|HV|hv
1694027|NCT00069901|ovarian cancer|ovarian cancer
1694028|NCT00069901|paclitaxel|paclitaxel
1694030|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
1694031|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
1694032|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
1694033|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
1694034|NCT00069745|Antineoplastic protocols|antineoplastic protocols
1694035|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
1694036|NCT00069719|open-angle|open-angle
1694037|NCT00069719|glaucoma|glaucoma
1694039|NCT00069719|hypertension|hypertension
1694040|NCT00069719|POAG|poag
1694041|NCT00069706|open-angle|open-angle
1694042|NCT00069706|glaucoma|glaucoma
1694043|NCT00069706|ocular|ocular
1694044|NCT00069706|hypertension|hypertension
1694045|NCT00069706|POAG|poag
1694046|NCT00069914|Immunization|immunization
1694047|NCT00069914|Immune Activation|immune activation
1694048|NCT00069914|Flu|flu
1694054|NCT00069862|Beta Thalassemia|beta thalassemia
1694055|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
1694056|NCT00069732|Overweight|overweight
1694057|NCT00069732|Weight loss maintenance|weight loss maintenance
1694058|NCT00069732|CAM therapy|cam therapy
1694059|NCT00069732|Qigong|qigong
1694060|NCT00069732|Acupressure|acupressure
1694061|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
1694062|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
1694063|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
1694064|NCT00069641|MPS II|mps ii
1694065|NCT00069641|Hunter Syndrome|hunter syndrome
1694066|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
1694067|NCT00069641|I2S|i2s
1694068|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
1694069|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
1694070|NCT00069524|Ritonavir|ritonavir
1694071|NCT00069524|Oyster mushrooms|oyster mushrooms
1694072|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
1694073|NCT00069524|Complementary Therapies|complementary therapies
1694074|NCT00069524|Treatment Experienced|treatment experienced
1694075|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1694076|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1694077|NCT00005630|large cell lung cancer|large cell lung cancer
1694078|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1694079|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1694080|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1694081|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
1694082|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1694083|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1694084|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1694085|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
1694086|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1694087|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1694088|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1694089|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1694090|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
1694091|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
1694092|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
1694093|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1694094|NCT00069693|Dysautonomia|dysautonomia
1694095|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
1694096|NCT00069693|Autonomic Nervous System|autonomic nervous system
1694097|NCT00069693|Syncope|syncope
1694098|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
1694099|NCT00069693|POTS|pots
1694100|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
1694102|NCT00069693|Norepinephrine|norepinephrine
1694103|NCT00069693|Epinephrine|epinephrine
1694104|NCT00069693|Neurocardiology|neurocardiology
1694105|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
1694106|NCT00069693|COI|coi
1694107|NCT00069693|Healthy Volunteer|healthy volunteer
1694108|NCT00069693|HV|hv
1694109|NCT00069680|Gene Identification|gene identification
1694110|NCT00069680|Linkage Analysis|linkage analysis
1694111|NCT00069680|Homozygosity Mapping|homozygosity mapping
1694112|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
1694113|NCT00069680|GPS|gps
1694114|NCT00069680|Platelet Function Defect|platelet function defect
1694115|NCT00069680|Bleeding Disorder|bleeding disorder
1694116|NCT00069654|Endothelium|endothelium
1694117|NCT00069654|Atherosclerosis|atherosclerosis
1694118|NCT00069654|Vasodilation|vasodilation
1694119|NCT00069654|Ischemia|ischemia
1694120|NCT00069654|Exercise|exercise
1694121|NCT00069654|Coronary Artery Disease|coronary artery disease
1694122|NCT00069654|CAD|cad
1694123|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1694126|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
1694127|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1694128|NCT00069615|Type 1 Diabetes|type 1 diabetes
1694129|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
1694130|NCT00069615|Electronic Data Collection|electronic data collection
1694131|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
1694132|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
1694133|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
1694134|NCT00069589|Baldness|baldness
1694135|NCT00069589|Autoimmunity|autoimmunity
1694136|NCT00069589|Hair|hair
1694137|NCT00069589|Alopecia Areata|alopecia areata
1694138|NCT00069589|Alopecia Partialis|alopecia partialis
1694139|NCT00069589|Alopecia Totalis|alopecia totalis
1694140|NCT00069589|Alopecia Universalis|alopecia universalis
1694141|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
1694142|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
1694143|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
1694144|NCT00069563|Internalizing psychopathology|internalizing psychopathology
1694145|NCT00069563|Externalizing psychopathology|externalizing psychopathology
1694146|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
1694147|NCT00069550|Cholinergic upregulation|cholinergic upregulation
1694148|NCT00069550|Dextromethorphan|dextromethorphan
1694149|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
1694150|NCT00069550|Aricept|aricept
1694151|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
1694152|NCT00069537|Type 1 Diabetes|type 1 diabetes
1694153|NCT00069537|Diabetes in Children|diabetes in children
1694154|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
1694155|NCT00069511|Hepatitis C|hepatitis c
1694156|NCT00069498|Mucosa|mucosa
1694157|NCT00069498|Inflammation|inflammation
1694158|NCT00069498|Tissue Viral Load|tissue viral load
1694159|NCT00069498|Anti-inflammatory|anti-inflammatory
1694160|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
1694161|NCT00069498|Mucosal Inflammation|mucosal inflammation
1694162|NCT00069498|Treatment Experienced|treatment experienced
1694163|NCT00069485|HIV Seronegativity|hiv seronegativity
1694164|NCT00003930|stage II bladder cancer|stage ii bladder cancer
1694165|NCT00003930|stage III bladder cancer|stage iii bladder cancer
1694166|NCT00069472|Genetics|genetics
1694167|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
1694168|NCT00069446|Diabetes|diabetes
1694169|NCT00069446|Diabetic|diabetic
1694170|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
1694171|NCT00069368|Healthy|healthy
1694172|NCT00069407|Bipolar Disorder|bipolar disorder
1694173|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
1694174|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1694175|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1694176|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1694177|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1694178|NCT00003594|stage III colon cancer|stage iii colon cancer
1694179|NCT00003594|stage IV colon cancer|stage iv colon cancer
1694180|NCT00003594|stage III rectal cancer|stage iii rectal cancer
1694181|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
1694182|NCT00003594|recurrent colon cancer|recurrent colon cancer
1694183|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
1694184|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
1694185|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1694186|NCT00003540|stage IV breast cancer|stage iv breast cancer
1694187|NCT00003540|recurrent breast cancer|recurrent breast cancer
1694188|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
1694189|NCT00003463|adult brain stem glioma|adult brain stem glioma
1694190|NCT00003463|adult glioblastoma|adult glioblastoma
1694191|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1694192|NCT00003463|adult mixed glioma|adult mixed glioma
1694193|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
1694194|NCT00003463|adult gliosarcoma|adult gliosarcoma
1694195|NCT00069355|PTSD|ptsd
1694196|NCT00069355|Catecholamines|catecholamines
1694197|NCT00069355|Conditioning|conditioning
1694198|NCT00069355|Memory|memory
1694199|NCT00069355|Psychophysiology|psychophysiology
1694200|NCT00069355|Acute Stress Disorder|acute stress disorder
1694201|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1694202|NCT00069342|Chronic Pain|chronic pain
1694203|NCT00069342|Pain|pain
1694204|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
1694205|NCT00069342|Depression|depression
1694206|NCT00069342|Function|function
1694207|NCT00069342|Rheumatic Disease|rheumatic disease
1694208|NCT00069277|Cancer, tumors|cancer, tumors
1694209|NCT00069264|Metastatic Tumors|metastatic tumors
1694210|NCT00069264|Advanced Solid Tumors|advanced solid tumors
1694211|NCT00069264|Stage IV Tumors|stage iv tumors
1694212|NCT00069264|Solid Tumors|solid tumors
1694213|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
1694214|NCT00069251|amphetamine dependence|amphetamine dependence
1694215|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1694216|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
1694217|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1694218|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1694219|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1694220|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1694221|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1694222|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1694223|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
1694224|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1694225|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1694226|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1694227|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1694228|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1694229|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1694230|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1694231|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1694232|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1694233|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1694234|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1694235|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1694236|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1694237|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1694238|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1694239|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1694240|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1694241|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1694242|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1694243|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1694244|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1694245|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1694246|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1694247|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1694248|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1694249|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1694250|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1694251|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1694252|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1694253|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1694254|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1694255|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1694256|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1694257|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1694258|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1694259|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1694260|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1694261|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1694262|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1694473|NCT00068991|Randomized Prevention Trial|randomized prevention trial
1694263|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1694264|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1694265|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1694266|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1694267|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1694268|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1694269|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1694270|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1694271|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1694495|NCT00068926|Virus|virus
1694272|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1694273|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1694274|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1694275|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1694276|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1694277|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1694278|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1694279|NCT00069329|Central Nervous System|central nervous system
1694280|NCT00069329|Abnormalities|abnormalities
1694281|NCT00069329|Arthropathy|arthropathy
1694282|NCT00069329|Urticaria|urticaria
1694283|NCT00069329|Papilledema|papilledema
1694284|NCT00069329|Auto-Inflammation|auto-inflammation
1694285|NCT00069329|Inflammatory Disease|inflammatory disease
1694286|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
1694287|NCT00069329|NOMID|nomid
1694288|NCT00069329|CINCA Syndrome|cinca syndrome
1694289|NCT00069316|West Nile Virus|west nile virus
1694290|NCT00069316|Encephalitis|encephalitis
1694291|NCT00069316|Virus|virus
1694292|NCT00069316|Mosquito|mosquito
1694293|NCT00069316|Fever|fever
1694294|NCT00069316|WNV|wnv
1694295|NCT00069316|Myelitis|myelitis
1694296|NCT00069303|West Nile Virus|west nile virus
1694297|NCT00069303|Encephalitis|encephalitis
1694298|NCT00069303|Virus|virus
1694299|NCT00069303|Mosquito|mosquito
1694300|NCT00069303|Fever|fever
1694301|NCT00069303|WNV|wnv
1694302|NCT00069303|Myelitis|myelitis
1694303|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1694304|NCT00069186|ALS|als
1694305|NCT00069186|Creatine|creatine
1694306|NCT00069186|Creatine Monohydrate|creatine monohydrate
1694307|NCT00069186|Muscle Strength|muscle strength
1694308|NCT00069238|Lymphoma|lymphoma
1694309|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
1694310|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
1694311|NCT00069225|fMRI|fmri
1694312|NCT00069225|Prolonged Exposure|prolonged exposure
1694313|NCT00069225|Brain Activation|brain activation
1694314|NCT00069225|Conditioning|conditioning
1694315|NCT00069225|Paroxetine|paroxetine
1694316|NCT00069225|PTSD|ptsd
1694317|NCT00069225|Differential Fear Conditioning|differential fear conditioning
1694318|NCT00069225|Masked Faces|masked faces
1694319|NCT00069225|Amygdala|amygdala
1694320|NCT00069225|Hippocampus|hippocampus
1694321|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1694322|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1694323|NCT00069212|Neural Circuits|neural circuits
1694324|NCT00069212|Fear|fear
1694325|NCT00069212|Emotional Regulation|emotional regulation
1694326|NCT00069212|Reward|reward
1694327|NCT00069212|PTSD|ptsd
1694328|NCT00069199|Reproducibility|reproducibility
1694329|NCT00069199|Macular Edema|macular edema
1694330|NCT00069199|OCT2|oct2
1694331|NCT00069199|OCT3|oct3
1694332|NCT00069199|Retina|retina
1694333|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1694334|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1694335|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1694336|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1694337|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1694338|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1694339|NCT00002533|oral complications|oral complications
1694340|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1694341|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1694342|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1694343|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1694344|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1694474|NCT00068991|China|china
1694345|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1694346|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1694347|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1694348|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1694349|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1694350|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1694351|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1694352|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1694353|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1694354|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1694355|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1694356|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1694357|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1694358|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1694359|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1694360|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1694361|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1694362|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1694363|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1694364|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1694365|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1715002|NCT00001546|EKG|ekg
1694366|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1694367|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1694368|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1694369|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1694370|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1694371|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1694372|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1694373|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1694374|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1694375|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1694376|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1694377|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1694378|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1694379|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1694380|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1694381|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1694382|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1694383|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1694384|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1694385|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1694386|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1694387|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1694388|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1694389|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1694390|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1694391|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1694392|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1694393|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1694394|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1694395|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1694396|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1694397|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1694398|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1694399|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1694475|NCT00068991|Condom Use|condom use
1694476|NCT00068991|STDs|stds
1694400|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1694401|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1694402|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1694403|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1694404|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1694405|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1694406|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1694407|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1694408|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1694409|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1694410|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1694411|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1694412|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1694413|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1694414|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1694415|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1694521|NCT00068809|Treatment experienced|treatment experienced
1694416|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1694417|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1694418|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1694419|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1694420|NCT00002533|infection|infection
1694421|NCT00069173|Females|females
1694422|NCT00069173|Sedentary|sedentary
1694423|NCT00069173|School-based|school-based
1694425|NCT00069134|oxidant damage|oxidant damage
1694426|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
1694427|NCT00069134|oxidative stress|oxidative stress
1694428|NCT00069134|cysteine kinetics|cysteine kinetics
1694429|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
1694430|NCT00026286|stage I breast cancer|stage i breast cancer
1694431|NCT00026286|stage II breast cancer|stage ii breast cancer
1694432|NCT00026286|breast cancer in situ|breast cancer in situ
1694433|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
1694434|NCT00026286|hot flashes|hot flashes
1694435|NCT00026286|menopausal symptoms|menopausal symptoms
1694436|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1694437|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
1694438|NCT00069160|Pharmacokinetics|pharmacokinetics
1694439|NCT00069160|Pharmacodynamics|pharmacodynamics
1694440|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
1694441|NCT00069160|Molecular Target|molecular target
1694442|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
1694443|NCT00069160|Lung Cancer|lung cancer
1694444|NCT00069160|Ovarian Cancer|ovarian cancer
1694445|NCT00069160|Cervical Cancer|cervical cancer
1694446|NCT00069160|Renal Cancer|renal cancer
1694447|NCT00069082|Headache|headache
1694448|NCT00069082|Cluster|cluster
1694449|NCT00069082|EC|ec
1694450|NCT00069082|Episodic Cluster|episodic cluster
1694451|NCT00069030|HIV Seronegativity|hiv seronegativity
1694452|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
1694453|NCT00069030|HIV-1|hiv-1
1694454|NCT00069030|AIDS Vaccines|aids vaccines
1694455|NCT00069030|Vaccines, DNA|vaccines, dna
1694456|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1694457|NCT00069030|Cytokines|cytokines
1694458|NCT00069030|Plasmids|plasmids
1694459|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
1694460|NCT00069030|Drug Administration Schedule|drug administration schedule
1694461|NCT00069030|Interleukin|interleukin
1694462|NCT00069030|IL2|il2
1694463|NCT00069030|Ig|ig
1694464|NCT00069030|IL@/Ig|il@/ig
1694465|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
1694466|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
1694467|NCT00069004|Treatment Experienced|treatment experienced
1694468|NCT00069004|Lipodystrophy|lipodystrophy
1694469|NCT00069004|Dyslipidemia|dyslipidemia
1694470|NCT00069004|Osteoporosis|osteoporosis
1694471|NCT00069004|Osteopenia|osteopenia
1694472|NCT00068991|Behavioral Intervention Study|behavioral intervention study
1694714|NCT00068159|HH|hh
1694477|NCT00068991|Sexual Partners|sexual partners
1694478|NCT00068991|HIV Seronegativity|hiv seronegativity
1694479|NCT00068978|HIV Seronegativity|hiv seronegativity
1694480|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
1694481|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1694482|NCT00069069|Stroke|stroke
1694483|NCT00069069|TIA|tia
1694484|NCT00069056|Grid Laser|grid laser
1694485|NCT00069056|Focal Laser|focal laser
1694486|NCT00069056|Glycemic Control|glycemic control
1694487|NCT00069056|Diabetes|diabetes
1694488|NCT00069056|Diabetic Macular Edema|diabetic macular edema
1694489|NCT00069056|Macular Edema|macular edema
1694490|NCT00068887|type 2 diabetes|type 2 diabetes
1694491|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
1694492|NCT00068926|Biodefense|biodefense
1694493|NCT00068926|Prevention|prevention
1694496|NCT00068926|Immune Response|immune response
1694497|NCT00068926|Healthy Volunteer|healthy volunteer
1694499|NCT00068913|Lactic Acidosis|lactic acidosis
1694500|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
1694501|NCT00068913|Stroke|stroke
1694502|NCT00068913|Seizure|seizure
1694503|NCT00068874|African American|african american
1694504|NCT00068874|Adolescent|adolescent
1694505|NCT00068874|Coping|coping
1694506|NCT00068874|Adjustment|adjustment
1694507|NCT00068874|Quality of Life|quality of life
1694508|NCT00068848|Oral Contraceptives|oral contraceptives
1694509|NCT00068848|Initiation|initiation
1694510|NCT00068848|Continuation|continuation
1694511|NCT00068835|Reading|reading
1694512|NCT00068835|Brain imaging|brain imaging
1694513|NCT00068822|Vertebroplasty|vertebroplasty
1694514|NCT00068822|Crushed Vertebrae|crushed vertebrae
1694515|NCT00068822|Back Pain|back pain
1694516|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
1694517|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
1694518|NCT00068822|INVEST|invest
1694519|NCT00068822|PMMA|pmma
1694522|NCT00068809|Treatment interruption|treatment interruption
1694523|NCT00068770|adult glioblastoma|adult glioblastoma
1694524|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
1694525|NCT00068770|adult gliosarcoma|adult gliosarcoma
1694526|NCT00068757|recurrent breast cancer|recurrent breast cancer
1694527|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
1694528|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
1694529|NCT00068757|stage IV breast cancer|stage iv breast cancer
1694530|NCT00068757|male breast cancer|male breast cancer
1694531|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
1694532|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1694533|NCT00068744|stage II anal cancer|stage ii anal cancer
1694534|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
1694535|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
1694536|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
1694537|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
1694538|NCT00068666|stage IV melanoma|stage iv melanoma
1694539|NCT00068666|recurrent melanoma|recurrent melanoma
1694540|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
1694541|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1694542|NCT00068614|stage IV breast cancer|stage iv breast cancer
1694543|NCT00068614|stage II breast cancer|stage ii breast cancer
1694544|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
1694545|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
1694546|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
1694547|NCT00068601|infertility|infertility
1694548|NCT00068601|menopausal symptoms|menopausal symptoms
1694549|NCT00068601|stage II breast cancer|stage ii breast cancer
1694550|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
1694551|NCT00068601|stage IA breast cancer|stage ia breast cancer
1694552|NCT00068601|stage IB breast cancer|stage ib breast cancer
1694553|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1694554|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1694555|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
1694556|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
1694557|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
1694558|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1694559|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
1694560|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1694561|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1694562|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1694563|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1694564|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1694565|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1694566|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1694567|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1694568|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1694569|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1694570|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1694571|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1694572|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1694573|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1694574|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1694575|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1694576|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1694577|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1694578|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1694579|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1694580|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1694581|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
1694582|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1694583|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1694584|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1694585|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1694586|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1694587|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1694588|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1694589|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1694590|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1694591|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1694592|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1694593|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1694594|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1694595|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1694596|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1694597|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1694598|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1694599|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1694600|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1694601|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1694602|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1694603|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1694604|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1694605|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1694606|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1694607|NCT00068510|adult glioblastoma|adult glioblastoma
1694608|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1694609|NCT00068510|adult brain tumor|adult brain tumor
1694610|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
1694611|NCT00068510|adult gliosarcoma|adult gliosarcoma
1694612|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1694613|NCT00068471|infection|infection
1694614|NCT00068471|neutropenia|neutropenia
1694615|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1694616|NCT00068458|weight changes|weight changes
1694617|NCT00068458|depression|depression
1694618|NCT00068458|stage I breast cancer|stage i breast cancer
1694619|NCT00068458|stage II breast cancer|stage ii breast cancer
1694620|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
1694621|NCT00068445|neurotoxicity|neurotoxicity
1694622|NCT00068445|pain|pain
1694623|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1694624|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
1694625|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
1694626|NCT00068393|Sarcomatoid|sarcomatoid
1694627|NCT00068393|Gemcitabine|gemcitabine
1694628|NCT00068393|Doxorubicin|doxorubicin
1694629|NCT00068393|Renal cell cancer|renal cell cancer
1694630|NCT00068393|Kidney cancer|kidney cancer
1694631|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
1694632|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1694633|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1694634|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1694635|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1694636|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
1694637|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
1715894|NCT00048763|vascular|vascular
1694638|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
1694639|NCT00068341|stage II breast cancer|stage ii breast cancer
1694640|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1694641|NCT00068328|stage II breast cancer|stage ii breast cancer
1694642|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
1694643|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
1694644|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
1694645|NCT00068328|stage IA breast cancer|stage ia breast cancer
1694646|NCT00068328|stage IB breast cancer|stage ib breast cancer
1694647|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1694648|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1694649|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1694731|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
1694650|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1694651|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1694652|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1694653|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1694654|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1694655|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
1694656|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1694657|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1694658|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1694659|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1694660|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1694661|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1694662|NCT00068263|stage I breast cancer|stage i breast cancer
1694663|NCT00068263|stage II breast cancer|stage ii breast cancer
1694664|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1694665|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
1694666|NCT00068237|xerostomia|xerostomia
1694667|NCT00068237|radiation toxicity|radiation toxicity
1694668|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1694669|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1694670|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1694671|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1694672|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1694673|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1694674|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1694675|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1694676|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1694677|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1694678|NCT00068211|Metastatic Melanoma|metastatic melanoma
1694679|NCT00068211|Melanoma|melanoma
1694680|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
1694681|NCT00068224|Caroli's Syndrome|caroli's syndrome
1694682|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
1694683|NCT00068224|Ductal Plate Malformation|ductal plate malformation
1694684|NCT00068224|Ciliopathy|ciliopathy
1694685|NCT00068224|Polycystic Kidney|polycystic kidney
1694686|NCT00068224|Polycystic Liver|polycystic liver
1694687|NCT00068224|Nephronophthisis|nephronophthisis
1694688|NCT00068224|Molar Tooth Sign|molar tooth sign
1694689|NCT00068224|Dandy-Walker Malformation|dandy-walker malformation
1694690|NCT00068224|Retinopathy|retinopathy
1694691|NCT00068224|Situs Inversus|situs inversus
1694692|NCT00068224|Heterotaxia|heterotaxia
1694693|NCT00068224|Cerebellar Vermis Hypoplasia|cerebellar vermis hypoplasia
1694694|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
1694695|NCT00068224|ARPKD|arpkd
1694696|NCT00068224|Kidney|kidney
1694697|NCT00068224|Liver|liver
1694698|NCT00068185|Black cohosh|black cohosh
1694699|NCT00068185|Pharmacokinetics|pharmacokinetics
1694700|NCT00068185|Alternative therapies|alternative therapies
1694701|NCT00068185|Natural product|natural product
1694702|NCT00021268|stage IV colon cancer|stage iv colon cancer
1694703|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
1694704|NCT00021268|recurrent colon cancer|recurrent colon cancer
1694705|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
1694706|NCT00020904|stage IV breast cancer|stage iv breast cancer
1694707|NCT00020904|recurrent breast cancer|recurrent breast cancer
1694708|NCT00068159|Hereditary Disease|hereditary disease
1694709|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
1694710|NCT00068159|Exercise Tolerance|exercise tolerance
1694711|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
1694712|NCT00068159|MRI|mri
1694713|NCT00068159|Hereditary Hemochromatosis|hereditary hemochromatosis
1694715|NCT00068159|Iron Overload|iron overload
1694716|NCT00068146|Adenopathy|adenopathy
1694717|NCT00068146|Genetic Disorder|genetic disorder
1694718|NCT00068146|Apoptosis|apoptosis
1694719|NCT00068146|Diagnostic Imaging|diagnostic imaging
1694720|NCT00068146|Hodgkins|hodgkins
1694721|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
1694722|NCT00068146|Syndrome|syndrome
1694723|NCT00068146|ALPS|alps
1694724|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
1694725|NCT00068120|Urinary tract infection|urinary tract infection
1694726|NCT00068094|Probiotics|probiotics
1694727|NCT00068094|Bacteria|bacteria
1694728|NCT00068081|Dermal assessment|dermal assessment
1694729|NCT00068081|Pain measurement|pain measurement
1694730|NCT00068081|Diary|diary
1697474|NCT00062751|breast|breast
1694732|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1694733|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
1694734|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
1694735|NCT00068081|Pain|pain
1694736|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
1694737|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
1694738|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
1694739|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
1694740|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
1694741|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1694742|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1694743|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
1694744|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
1694745|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
1694746|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1694747|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
1694748|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1715003|NCT00001546|Melatonin|melatonin
1694749|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1694750|NCT00068107|Lysosomal Storage|lysosomal storage
1694751|NCT00068107|Renal Insufficiency|renal insufficiency
1694752|NCT00068107|Stroke|stroke
1694753|NCT00068107|Hypohidrosis|hypohidrosis
1694754|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
1694755|NCT00068107|Fabry Disease|fabry disease
1694756|NCT00068068|Photodynamic therapy|photodynamic therapy
1694757|NCT00068068|Liver metastases|liver metastases
1694758|NCT00068068|Colorectal cancer|colorectal cancer
1694760|NCT00068068|Light Infusion Technology™|light infusion technology™
1694761|NCT00068068|Talaporfin sodium|talaporfin sodium
1694762|NCT00068068|LS11|ls11
1694763|NCT00068068|Liver mets|liver mets
1694764|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
1694765|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
1694766|NCT00068068|Tumor ablation|tumor ablation
1694767|NCT00068068|Combination therapy|combination therapy
1694768|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
1694769|NCT00067899|cigarette smoking|cigarette smoking
1694770|NCT00067899|tocopherol|tocopherol
1694771|NCT00067899|bioavailability|bioavailability
1694772|NCT00067899|metabolism|metabolism
1694773|NCT00067899|oxidative stress|oxidative stress
1694774|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
1694775|NCT00067990|post transplant proteinuria|post transplant proteinuria
1694776|NCT00067951|Hyperglycemia|hyperglycemia
1694777|NCT00067951|HbA1c|hba1c
1694778|NCT00067951|Hemoglobin A1c|hemoglobin a1c
1694779|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
1694780|NCT00067938|bipolar disorder|bipolar disorder
1694781|NCT00067938|lamotrigine|lamotrigine
1694782|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
1694783|NCT00068003|Screening|screening
1694784|NCT00068003|Cell Harvest|cell harvest
1694785|NCT00068003|Blood|blood
1694786|NCT00068003|Tumor Tissue|tumor tissue
1694787|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
1694788|NCT00067925|Calcium intake|calcium intake
1694789|NCT00067925|School-based health education|school-based health education
1694790|NCT00067925|Adolescent girls|adolescent girls
1694791|NCT00067925|Child nutrition|child nutrition
1694792|NCT00067925|Diet|diet
1694793|NCT00010036|adult glioblastoma|adult glioblastoma
1694794|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
1694795|NCT00010036|adult gliosarcoma|adult gliosarcoma
1694796|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1694797|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1694798|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1694799|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1694800|NCT00008359|stage IV breast cancer|stage iv breast cancer
1694801|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
1694802|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1694803|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
1694804|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1694805|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1694806|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1694807|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1694808|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1694809|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1694810|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1694811|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
1694812|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
1694813|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1694814|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1694815|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1694816|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1694817|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
1694818|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
1694819|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1694820|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1694821|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1694822|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
1694823|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
1694824|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
1694825|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1694826|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1694827|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1694828|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1694829|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1694830|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1694831|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1694832|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1694833|NCT00008359|small intestine lymphoma|small intestine lymphoma
1694834|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1694835|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1694836|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1694837|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1694838|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1694839|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1694840|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1694841|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1694842|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1694843|NCT00008359|polycythemia vera|polycythemia vera
1694844|NCT00008359|primary myelofibrosis|primary myelofibrosis
1694845|NCT00008359|essential thrombocythemia|essential thrombocythemia
1694846|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1694847|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
1694848|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
1694849|NCT00008359|testicular teratoma|testicular teratoma
1694850|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
1694851|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1694852|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1694853|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1694854|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1694855|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1694856|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1694857|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1694858|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1694859|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1694860|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1694861|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1694862|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1694863|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
1694864|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1694865|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1694866|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1694867|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1694868|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1694869|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1695002|NCT00006346|stage IV breast cancer|stage iv breast cancer
1694870|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1694871|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1694872|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1694873|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1694874|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1694875|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1694876|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
1694877|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1694878|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
1694879|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
1694880|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
1694881|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
1697475|NCT00062751|neoplasms|neoplasms
1694882|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1694883|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1694884|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
1694885|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1694886|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1694887|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1694888|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1694889|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1694890|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1694891|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1694892|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1694893|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1694894|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1694895|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1695029|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
1694896|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1694897|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1694898|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1694899|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1694900|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1694901|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1694902|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1694903|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1694904|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1694905|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1694906|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1694907|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1694908|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1694909|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1694910|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1694911|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1694912|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1694913|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1694914|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1694915|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1694916|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1694917|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1694918|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1694919|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1694920|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1694921|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1694922|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1694923|NCT00008359|neutropenia|neutropenia
1694924|NCT00008359|infection|infection
1694925|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
1694926|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1694927|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1694928|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
1694929|NCT00008359|intraocular lymphoma|intraocular lymphoma
1694930|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1694931|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1694932|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1694933|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1694934|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1694935|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1694936|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1694937|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1694938|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1694939|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1694940|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1694941|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1694942|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1694943|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1695012|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1694944|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1694945|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1694946|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1694947|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1694948|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1694949|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1694950|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1694951|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1694952|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1694953|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1695277|NCT00067392|Bone atrophy|bone atrophy
1694954|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1694955|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1695274|NCT00067405|vitamins|vitamins
1694956|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1694957|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1694958|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1694959|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1694960|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1694961|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1694962|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1694963|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1694964|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1694965|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1694966|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1694967|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1694968|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1694969|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1694970|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1694971|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1694972|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1694973|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1694974|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1694975|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1694976|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1694977|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
1694978|NCT00008086|adult brain stem glioma|adult brain stem glioma
1694979|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
1694980|NCT00008086|adult medulloblastoma|adult medulloblastoma
1694981|NCT00008086|adult meningioma|adult meningioma
1694982|NCT00008086|adult glioblastoma|adult glioblastoma
1694983|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1694984|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1694985|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1694986|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
1694987|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1694988|NCT00008086|adult mixed glioma|adult mixed glioma
1694989|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1694990|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1694991|NCT00008086|adult subependymoma|adult subependymoma
1694992|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
1694993|NCT00008086|adult pineocytoma|adult pineocytoma
1694994|NCT00008086|adult pineoblastoma|adult pineoblastoma
1694995|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1694996|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
1694997|NCT00008086|adult grade III meningioma|adult grade iii meningioma
1694998|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
1694999|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
1695000|NCT00008086|adult gliosarcoma|adult gliosarcoma
1695001|NCT00006346|stage II breast cancer|stage ii breast cancer
1715895|NCT00048763|idiopathic|idiopathic
1695003|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
1695004|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
1695005|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1695006|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1695007|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1695008|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1695009|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1695010|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1695011|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1695013|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1695014|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1695015|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1695016|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1695017|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1695018|NCT00006103|stage III colon cancer|stage iii colon cancer
1695019|NCT00006103|stage IV colon cancer|stage iv colon cancer
1695020|NCT00006103|stage III rectal cancer|stage iii rectal cancer
1695021|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
1695022|NCT00006103|recurrent colon cancer|recurrent colon cancer
1695023|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
1695024|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
1695025|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1695026|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
1695027|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
1695028|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
1695030|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
1695031|NCT00067847|obesity|obesity
1695032|NCT00067847|food policy|food policy
1695033|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
1695034|NCT00067847|academic achievement|academic achievement
1695035|NCT00067834|Electromagnetic Fields|electromagnetic fields
1695036|NCT00067834|Bone|bone
1695037|NCT00067834|Forelimb|forelimb
1695038|NCT00067834|Radius|radius
1695039|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1695040|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
1695041|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1695042|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
1695043|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1695044|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1695045|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1695046|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1695047|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1695048|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1695049|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1695050|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1695051|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1695052|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1695053|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1695054|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1695055|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1695056|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1695057|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1695058|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1695059|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1695060|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1695061|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1695062|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
1695063|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
1695064|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
1695065|NCT00005886|stage I breast cancer|stage i breast cancer
1695066|NCT00005886|stage II breast cancer|stage ii breast cancer
1695067|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1695068|NCT00005886|breast cancer in situ|breast cancer in situ
1695069|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
1695070|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
1695071|NCT00067821|Brain Tumor|brain tumor
1695072|NCT00067821|Children|children
1695073|NCT00067821|Metabolic|metabolic
1695074|NCT00067821|Spectroscopy|spectroscopy
1695075|NCT00067821|PET|pet
1695076|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
1695077|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1695078|NCT00067808|MDS|mds
1695079|NCT00067808|Decitabine|decitabine
1695080|NCT00067808|Dacogen|dacogen
1695081|NCT00067808|Methylation|methylation
1695082|NCT00067795|Treatment Experienced|treatment experienced
1695083|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1695084|NCT00067795|HIV Antigens|hiv antigens
1695085|NCT00067795|Cohort Studies|cohort studies
1695086|NCT00067795|Immunity, Cellular|immunity, cellular
1695087|NCT00067795|T-Lymphocytes|t-lymphocytes
1695088|NCT00067782|HIV|hiv
1695089|NCT00067782|Treatment Experienced|treatment experienced
1695090|NCT00067769|Encopresis|encopresis
1695091|NCT00067769|Internet|internet
1695092|NCT00067769|Web|web
1695093|NCT00067769|Treatment|treatment
1695094|NCT00067769|Intervention|intervention
1695095|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1695096|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1695097|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1695098|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1695099|NCT00005804|Burkitt lymphoma|burkitt lymphoma
1695100|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1695101|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
1695102|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
1695103|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1695104|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
1695105|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1695106|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1695107|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1695108|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1715004|NCT00001546|Mood|mood
1695109|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1695110|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1695111|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1695112|NCT00005804|small intestine lymphoma|small intestine lymphoma
1695113|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1695114|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1695115|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1695116|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1695117|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1695118|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1695119|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1695120|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1695121|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1695122|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1695123|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1695124|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1695125|NCT00005804|polycythemia vera|polycythemia vera
1695126|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1695127|NCT00005804|essential thrombocythemia|essential thrombocythemia
1695128|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1695129|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
1695130|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1695131|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1695132|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1695133|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
1695134|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1695135|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1695136|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1695137|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1695138|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1695139|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1695140|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1695141|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1695142|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1695143|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1695144|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1695145|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1695146|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1695147|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1695237|NCT00004256|oral complications|oral complications
1695148|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1695149|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1695150|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
1695151|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
1695152|NCT00005804|intraocular lymphoma|intraocular lymphoma
1695153|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1695154|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1695155|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1695278|NCT00067392|Bone healing|bone healing
1695156|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1695157|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1695158|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1695159|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1695160|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1695161|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1695162|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1695163|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1695164|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1695165|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1695166|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1695167|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1695168|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1695169|NCT00067756|Pulmonary Disease|pulmonary disease
1695170|NCT00067756|Liver Disease|liver disease
1695171|NCT00067743|Pain|pain
1695172|NCT00067743|Pain syndrome|pain syndrome
1715322|NCT00001377|Linkage|linkage
1695173|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
1695174|NCT00067743|CC-5013|cc-5013
1695175|NCT00067743|CC5013|cc5013
1695176|NCT00067743|Revlimid|revlimid
1695177|NCT00067743|Celgene|celgene
1695178|NCT00067743|CRPS|crps
1695179|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
1695180|NCT00067717|prayer|prayer
1695181|NCT00067717|distance healing|distance healing
1695182|NCT00067717|wound healing|wound healing
1695183|NCT00067704|Complementary Therapies|complementary therapies
1695184|NCT00067691|Lung cancer|lung cancer
1695185|NCT00067691|Breast cancer|breast cancer
1695186|NCT00067691|Shortness of breath|shortness of breath
1695187|NCT00067691|Dyspnea|dyspnea
1695188|NCT00067691|Metastasis|metastasis
1695189|NCT00067691|Breathlessness|breathlessness
1695190|NCT00067691|Acupuncture|acupuncture
1695191|NCT00067678|diabetic nephropathy|diabetic nephropathy
1695192|NCT00067678|nephropathy|nephropathy
1695193|NCT00067678|diabetes|diabetes
1695194|NCT00067678|diabetes mellitus|diabetes mellitus
1695195|NCT00067678|type I diabetes|type i diabetes
1695196|NCT00067678|soy protein|soy protein
1695197|NCT00067665|hemodialysis|hemodialysis
1695198|NCT00067639|Multiple Myeloma|multiple myeloma
1695199|NCT00067639|PBSC mobilization|pbsc mobilization
1695200|NCT00067639|Pegfilgrastim|pegfilgrastim
1695201|NCT00067639|Neulasta|neulasta
1695202|NCT00067639|PEG-G-CSF|peg-g-csf
1695203|NCT00067626|glucose tolerance test|glucose tolerance test
1695204|NCT00067626|minerals|minerals
1695205|NCT00067626|chromium|chromium
1695206|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
1695207|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
1695208|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1695209|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1695210|NCT00067613|Prematurity|prematurity
1695211|NCT00067613|Mechanical ventilation|mechanical ventilation
1695212|NCT00067613|Benchmarking|benchmarking
1695213|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
1695214|NCT00067587|Treatment experienced|treatment experienced
1695215|NCT00067587|Treatment naive|treatment naive
1695216|NCT00067574|Structured treatment interruption|structured treatment interruption
1695217|NCT00067574|Treatment experienced|treatment experienced
1695218|NCT00067561|Dose-ranging|dose-ranging
1695219|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
1695220|NCT00067561|d-IBS|d-ibs
1695221|NCT00067561|IBS|ibs
1695222|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
1695223|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1695224|NCT00067535|cocaine dependence|cocaine dependence
1695225|NCT00067522|Family Planning|family planning
1695226|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
1695227|NCT00067522|HIV|hiv
1695228|NCT00067522|Africa|africa
1695229|NCT00067522|Zambia|zambia
1695230|NCT00067522|AIDS|aids
1695231|NCT00067522|Contraception|contraception
1695232|NCT00067522|HIV Prevention|hiv prevention
1695233|NCT00067509|Female|female
1695234|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
1695235|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
1695236|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
1695238|NCT00004256|radiation toxicity|radiation toxicity
1695239|NCT00004233|stage III gastric cancer|stage iii gastric cancer
1695240|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
1695241|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
1695242|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
1695243|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
1695244|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
1695245|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1695246|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1695247|NCT00004125|stage II breast cancer|stage ii breast cancer
1695248|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
1695250|NCT00067496|Weakness|weakness
1695251|NCT00067496|Depression|depression
1695252|NCT00067496|Poliomyelitis|poliomyelitis
1695254|NCT00067496|Post-Polio Syndrome|post-polio syndrome
1695255|NCT00067496|PPS|pps
1695256|NCT00067483|Cataract|cataract
1695257|NCT00067483|Pre-Senile|pre-senile
1695258|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
1695259|NCT00067483|Light Scattering|light scattering
1695260|NCT00067483|Lens|lens
1695261|NCT00067483|Cataracts|cataracts
1695262|NCT00067457|PRN|prn
1695263|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
1695264|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
1695265|NCT00067444|Elderly|elderly
1695266|NCT00067444|Major Depressive Disorder|major depressive disorder
1695267|NCT00067444|MDD|mdd
1695268|NCT00067431|Partial Seizures|partial seizures
1695269|NCT00067405|Fibromyalgia|fibromyalgia
1695270|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
1695271|NCT00067405|IVMT|ivmt
1695272|NCT00067405|alternative medicine|alternative medicine
1695273|NCT00067405|complementary medicine|complementary medicine
1695275|NCT00067405|vitamin supplements|vitamin supplements
1695276|NCT00067392|Partial edentulism|partial edentulism
1695279|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
1695280|NCT00004004|adult glioblastoma|adult glioblastoma
1695281|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1695282|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1695283|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
1695284|NCT00004004|adult gliosarcoma|adult gliosarcoma
1695285|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1695286|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1695287|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1695288|NCT00003736|breast cancer|breast cancer
1695289|NCT00003464|adult glioblastoma|adult glioblastoma
1695290|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
1695291|NCT00003464|adult gliosarcoma|adult gliosarcoma
1695292|NCT00067418|Glioma|glioma
1695293|NCT00067418|Brain Tumor|brain tumor
1695294|NCT00067418|Spectroscopy|spectroscopy
1695295|NCT00067353|Early Childhood Caries|early childhood caries
1695296|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
1695297|NCT00067327|Multiple sclerosis|multiple sclerosis
1695298|NCT00067327|Peroxynitrite|peroxynitrite
1695299|NCT00067327|Uric acid|uric acid
1695300|NCT00067327|Inosine|inosine
1695301|NCT00067301|depression|depression
1695302|NCT00067301|citalopram|citalopram
1695303|NCT00067301|Celexa|celexa
1695304|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
1695305|NCT00067301|omega-3|omega-3
1695306|NCT00067301|EPA|epa
1695307|NCT00067301|antidepressants|antidepressants
1695308|NCT00067288|Stage 3 cancer;|stage 3 cancer;
1695309|NCT00067288|Stage 4 cancer;|stage 4 cancer;
1695310|NCT00067288|solid tumor cancer;|solid tumor cancer;
1695311|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
1695312|NCT00067288|solid tumors;|solid tumors;
1695313|NCT00067288|end-stage cancer;|end-stage cancer;
1695314|NCT00067288|group psychotherapy;|group psychotherapy;
1695315|NCT00067288|psychotherapy;|psychotherapy;
1695316|NCT00067288|emotional support;|emotional support;
1695317|NCT00067288|support groups|support groups
1695318|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
1695319|NCT00067249|Race|race
1695320|NCT00067249|Ethnicity|ethnicity
1695321|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
1695322|NCT00067249|Women's health|women's health
1695323|NCT00067249|Social determinants of Health|social determinants of health
1695324|NCT00067275|Stroke|stroke
1695325|NCT00067275|Motor Training|motor training
1695326|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
1695327|NCT00067275|Plasticity|plasticity
1695328|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1695329|NCT00067275|Healthy Volunteer|healthy volunteer
1695330|NCT00067275|HV|hv
1695331|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
1695332|NCT00067223|Unilateral Finger Movement|unilateral finger movement
1695333|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
1695334|NCT00067223|Motor Training|motor training
1695335|NCT00067223|Plasticity|plasticity
1695336|NCT00067223|Healthy Volunteer|healthy volunteer
1695338|NCT00067210|Brain|brain
1695339|NCT00067210|Epilepsy|epilepsy
1695340|NCT00067210|Core|core
1695341|NCT00067210|Temperature|temperature
1695342|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
1695343|NCT00067197|Cortical Reorganization|cortical reorganization
1695344|NCT00067197|Rehabilitation|rehabilitation
1695345|NCT00067197|Motor Learning|motor learning
1695346|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
1695347|NCT00067197|Stroke|stroke
1695348|NCT00067197|Healthy Volunteer|healthy volunteer
1695349|NCT00067197|HV|hv
1695350|NCT00067184|methadone|methadone
1695351|NCT00067184|fetus|fetus
1695352|NCT00067171|behavioral intervention|behavioral intervention
1695353|NCT00067158|nicotine dependence|nicotine dependence
1695354|NCT00067119|Graft Failure|graft failure
1695355|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
1695356|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
1695357|NCT00067119|Fistula Failure|fistula failure
1695358|NCT00067119|Hemodialysis|hemodialysis
1695359|NCT00067119|Vascular Access|vascular access
1695360|NCT00067106|HIV|hiv
1695361|NCT00067106|Women|women
1695362|NCT00067106|Genital tract|genital tract
1695363|NCT00067106|Treatment experienced|treatment experienced
1695364|NCT00067106|Drug resistance|drug resistance
1695365|NCT00067080|Sickle cell disease|sickle cell disease
1695366|NCT00067080|iron overload|iron overload
1695367|NCT00067080|deferoxamine|deferoxamine
1695368|NCT00067080|hemosiderosis|hemosiderosis
1695369|NCT00067041|Critical Limb Ischemia|critical limb ischemia
1695370|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
1695371|NCT00067041|CLI|cli
1695372|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
1695373|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
1715525|NCT00001232|Depression|depression
1695374|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
1695375|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
1695376|NCT00067028|Clofarabine|clofarabine
1695377|NCT00067028|Clofarex|clofarex
1695378|NCT00067028|Clolar|clolar
1695379|NCT00067028|Ara-C|ara-c
1695380|NCT00067028|Cytarabine|cytarabine
1695381|NCT00067028|Cytosar|cytosar
1695382|NCT00067028|DepoCyt|depocyt
1695383|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
1695384|NCT00067028|Idarubicin|idarubicin
1695385|NCT00067028|Idamycin|idamycin
1695386|NCT00003433|stage IV colon cancer|stage iv colon cancer
1695387|NCT00003433|liver metastases|liver metastases
1695388|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1695389|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
1695390|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
1695391|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
1695392|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1695393|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1695394|NCT00067067|Glioma|glioma
1695395|NCT00067067|Brain Tumor|brain tumor
1695396|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
1695397|NCT00067054|Volunteer|volunteer
1695398|NCT00067054|Plasmapheresis|plasmapheresis
1695399|NCT00067054|Leukapheresis|leukapheresis
1695400|NCT00067054|Immunology|immunology
1695401|NCT00067054|Leukocyte|leukocyte
1695402|NCT00067054|Healthy Volunteer|healthy volunteer
1695403|NCT00067054|HV|hv
1695404|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1695405|NCT00067015|stage III prostate cancer|stage iii prostate cancer
1695406|NCT00067002|ALL|all
1695407|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
1695408|NCT00067002|AML|aml
1695409|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
1695410|NCT00067002|CML|cml
1695411|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
1695412|NCT00067002|NHL|nhl
1695413|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1695414|NCT00067002|double cord blood transplant|double cord blood transplant
1695415|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
1695416|NCT00067002|Rituxan|rituxan
1695417|NCT00067002|Rituximab|rituximab
1695418|NCT00067002|Melphalan|melphalan
1695419|NCT00067002|Alkeran|alkeran
1695420|NCT00067002|Thiotepa|thiotepa
1695421|NCT00067002|Fludarabine|fludarabine
1695422|NCT00067002|Fludarabine phosphate|fludarabine phosphate
1695423|NCT00067002|Fludara|fludara
1695424|NCT00067002|Cyclophosphamide|cyclophosphamide
1695425|NCT00067002|Cytoxan|cytoxan
1695426|NCT00067002|Neosar|neosar
1695427|NCT00067002|Mesna|mesna
1695428|NCT00067002|Mesnex|mesnex
1695429|NCT00066989|Staphylococcal infection|staphylococcal infection
1695430|NCT00066989|Gram positive bacteria|gram positive bacteria
1695431|NCT00066989|Staphylococcus|staphylococcus
1695432|NCT00066989|Staphylococcus aureus|staphylococcus aureus
1695433|NCT00046878|adult glioblastoma|adult glioblastoma
1695434|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
1695435|NCT00046878|adult gliosarcoma|adult gliosarcoma
1695436|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1695437|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1695438|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1695439|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1695440|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1695441|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1695442|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1695443|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1695444|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1695445|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1695446|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1695447|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1695448|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1695449|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1695450|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1695451|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1695452|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1695453|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1695454|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1695455|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1695456|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1695457|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1695578|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1695458|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1695459|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1695460|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
1695461|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
1695462|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
1695463|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1695464|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1695465|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1695466|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1695467|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1695468|NCT00002520|stage I colon cancer|stage i colon cancer
1695469|NCT00002520|stage II colon cancer|stage ii colon cancer
1695470|NCT00002520|stage I breast cancer|stage i breast cancer
1695471|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1695472|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1695473|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1695474|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1695475|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1695476|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1695477|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1695478|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1695479|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1695480|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1695481|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1695482|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1695483|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1695484|NCT00002520|intraocular lymphoma|intraocular lymphoma
1695485|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
1695486|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1695487|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1695488|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1695489|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1695490|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1695491|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1695492|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1695493|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1695494|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1695495|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1695627|NCT00066885|DN101|dn101
1695496|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
1695497|NCT00002520|tobacco use disorder|tobacco use disorder
1695498|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1695499|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1695500|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1695501|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1695890|NCT00066378|stage IV breast cancer|stage iv breast cancer
1695502|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1695503|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1695504|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1695505|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1695506|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1695565|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1695507|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1695508|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1695509|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1695510|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1695511|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1695512|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1695513|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1695514|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1695515|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1695516|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1695517|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1695518|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1695519|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1695520|NCT00002520|stage I prostate cancer|stage i prostate cancer
1695521|NCT00002520|stage I rectal cancer|stage i rectal cancer
1695522|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1695523|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1695524|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1695525|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1695526|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1695527|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1695528|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1695529|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1695530|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1695531|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1695532|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1695533|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1695534|NCT00002520|stage II bladder cancer|stage ii bladder cancer
1695535|NCT00002520|stage II breast cancer|stage ii breast cancer
1695536|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1695537|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1695538|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1695539|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1695540|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1695541|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1695542|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1695543|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1695544|NCT00002520|stage I bladder cancer|stage i bladder cancer
1695545|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1695546|NCT00002520|stage II prostate cancer|stage ii prostate cancer
1695547|NCT00002520|stage II rectal cancer|stage ii rectal cancer
1695548|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1695549|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1695550|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1695551|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1695552|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1695553|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1695628|NCT00066885|Calcitriol|calcitriol
1695554|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1695555|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1695556|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1695557|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1695558|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1695559|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1695560|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1695561|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1695562|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1695563|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1695564|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1695566|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1695567|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1695568|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1695569|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1695570|NCT00002520|stage III prostate cancer|stage iii prostate cancer
1695571|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1695572|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
1695573|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
1695574|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1695575|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1695576|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1695577|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1695579|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1695580|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1695581|NCT00002520|stage IV breast cancer|stage iv breast cancer
1695582|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1695583|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1695584|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1695585|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1695586|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1695587|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1695588|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
1695589|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1695590|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1695891|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
1695591|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1695592|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1695593|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1695594|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1695595|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1695596|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1695597|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1695598|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1695599|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1695600|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1695601|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1695602|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1695603|NCT00066976|Prenatal|prenatal
1695604|NCT00066976|Respiration|respiration
1695605|NCT00066976|Ultrasound|ultrasound
1695606|NCT00066976|Prematurity|prematurity
1695607|NCT00066976|Diagnoses|diagnoses
1695608|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
1695609|NCT00066976|Doppler Sonography|doppler sonography
1695610|NCT00066976|Amniotic Fluid|amniotic fluid
1695611|NCT00066976|Oligohydraminos|oligohydraminos
1695612|NCT00066976|Polyhydraminos|polyhydraminos
1695613|NCT00066976|Pregnancy|pregnancy
1695614|NCT00066963|Early Childhood Caries|early childhood caries
1695615|NCT00066950|Early childhood caries|early childhood caries
1695616|NCT00066924|spirituality|spirituality
1695617|NCT00066924|religiosity|religiosity
1695618|NCT00066924|immune functioning|immune functioning
1695619|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
1695620|NCT00066924|cytokines|cytokines
1695621|NCT00066924|cancer|cancer
1695622|NCT00066924|death|death
1695623|NCT00066924|depression|depression
1695624|NCT00066898|succinobucol|succinobucol
1695625|NCT00066898|AGI-1067|agi-1067
1695626|NCT00066898|coronary artery disease|coronary artery disease
1695632|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
1695633|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
1695634|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
1695635|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
1695636|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
1695637|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
1695638|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1695639|NCT00066911|Vocalization|vocalization
1695640|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
1695641|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
1695642|NCT00066911|Topical Lidocaine|topical lidocaine
1695643|NCT00066911|Voice Disorders|voice disorders
1695644|NCT00066911|Vocal Tremor|vocal tremor
1695645|NCT00066911|Healthy Volunteer|healthy volunteer
1695646|NCT00066911|HV|hv
1695647|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1695648|NCT00066859|depression|depression
1696168|NCT00065741|zidovudine|zidovudine
1695649|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1695650|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
1695651|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1695652|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
1695653|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
1695654|NCT00066846|stage IV colon cancer|stage iv colon cancer
1695655|NCT00066846|recurrent colon cancer|recurrent colon cancer
1695656|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
1695657|NCT00066807|stage I breast cancer|stage i breast cancer
1695658|NCT00066807|stage II breast cancer|stage ii breast cancer
1695659|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1695660|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1695661|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1695662|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1695663|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1695664|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1695665|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1695666|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1695667|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1695668|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1695669|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1695670|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1695671|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
1695672|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1695673|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1695674|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1695675|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1695676|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
1695677|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1695678|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1695679|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1695680|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1695681|NCT00066729|fallopian tube cancer|fallopian tube cancer
1695682|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1695683|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1695684|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
1695685|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
1695686|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
1695687|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
1695688|NCT00066703|stage II breast cancer|stage ii breast cancer
1695689|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
1695690|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
1695691|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
1695692|NCT00066703|stage IA breast cancer|stage ia breast cancer
1695693|NCT00066703|stage IB breast cancer|stage ib breast cancer
1695694|NCT00066690|tamoxifen|tamoxifen
1695695|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
1695696|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
1695697|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1695698|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
1695699|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
1695700|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1695701|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1695702|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1695703|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1695704|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1695705|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1695706|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1695707|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1695708|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1695709|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1695710|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
1695711|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1695712|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1695713|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1695714|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1695715|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1696169|NCT00065741|abacavir|abacavir
1695716|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1695717|NCT00066651|Brenner tumor|brenner tumor
1695718|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1695719|NCT00066651|fallopian tube cancer|fallopian tube cancer
1695720|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
1695721|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1695722|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
1695723|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1695724|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
1695725|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1695726|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
1695727|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1695728|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1695790|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
1695729|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1695730|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
1695731|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1695732|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1695733|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1695734|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1695735|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1695736|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
1695737|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
1695738|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1695739|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1695740|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1695741|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1695742|NCT00066612|anterior urethral cancer|anterior urethral cancer
1695743|NCT00066612|posterior urethral cancer|posterior urethral cancer
1695744|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
1695745|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1695746|NCT00066599|neutropenia|neutropenia
1695747|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1695748|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1695749|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1695750|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1695751|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1695752|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1695753|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1695754|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1695755|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1695756|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1695757|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1695758|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1695759|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1695760|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1695761|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1695762|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1695763|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1695764|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1695765|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1695766|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1695767|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1695768|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1695769|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1695770|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1695771|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1695772|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1695773|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1695774|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1695775|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1695776|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1695777|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1698551|NCT00061022|TIA|tia
1695778|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1695779|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1695780|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1695781|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1695782|NCT00066599|intraocular lymphoma|intraocular lymphoma
1695783|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1695784|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1695785|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
1695786|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1695787|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1695788|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1695789|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1695791|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1695792|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1695793|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1695794|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
1695795|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
1695796|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
1695797|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
1695798|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1695799|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1695800|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1695801|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1695802|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
1695803|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1695804|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1695805|NCT00066586|breast cancer|breast cancer
1695806|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
1695807|NCT00066573|stage I breast cancer|stage i breast cancer
1695808|NCT00066573|stage II breast cancer|stage ii breast cancer
1695809|NCT00066547|recurrent breast cancer|recurrent breast cancer
1695810|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
1695811|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
1695812|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
1695813|NCT00066547|stage IV breast cancer|stage iv breast cancer
1695814|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1695815|NCT00066482|childhood teratoma|childhood teratoma
1695816|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1695817|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1695818|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
1695819|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
1695820|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
1695821|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
1695822|NCT00066430|anal cancer|anal cancer
1695823|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
1695824|NCT00066417|essential thrombocythemia|essential thrombocythemia
1695825|NCT00066417|polycythemia vera|polycythemia vera
1695826|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1695827|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1695828|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1695829|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1695830|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1695831|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1695832|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1695833|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1695834|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1696054|NCT00066118|renal disease|renal disease
1695835|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1695836|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1695837|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1695838|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1695839|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1695840|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1695841|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1695842|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1695843|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1695844|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1696170|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
1695845|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1695846|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1695847|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1695848|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
1695849|NCT00066404|male breast cancer|male breast cancer
1695850|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
1695851|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
1695852|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
1695853|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
1695854|NCT00066404|recurrent breast cancer|recurrent breast cancer
1695855|NCT00066404|recurrent penile cancer|recurrent penile cancer
1695856|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
1695857|NCT00066404|recurrent anal cancer|recurrent anal cancer
1695858|NCT00066404|recurrent colon cancer|recurrent colon cancer
1696190|NCT00065702|EEG|eeg
1695859|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
1695860|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
1695861|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
1695862|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
1695863|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1695864|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
1695865|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
1695866|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1695867|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1695868|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1695869|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
1695870|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1695871|NCT00066404|recurrent melanoma|recurrent melanoma
1695872|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1695873|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1695874|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
1695875|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1695876|NCT00066404|fallopian tube cancer|fallopian tube cancer
1695877|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
1695878|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
1695879|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
1695880|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1695881|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1695882|NCT00066404|malignant pleural effusion|malignant pleural effusion
1695883|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
1695884|NCT00066391|stage III penile cancer|stage iii penile cancer
1695885|NCT00066391|stage IV penile cancer|stage iv penile cancer
1695886|NCT00066378|recurrent breast cancer|recurrent breast cancer
1695887|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
1695888|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
1695889|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
1695892|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
1695893|NCT00066365|lung metastases|lung metastases
1695894|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
1695895|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
1695896|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1695897|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1695898|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1695899|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1695900|NCT00066339|stage IV breast cancer|stage iv breast cancer
1695901|NCT00066339|recurrent breast cancer|recurrent breast cancer
1695902|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1695903|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1695904|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1695905|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1695906|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1695907|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1695908|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
1695909|NCT00066274|stage IV colon cancer|stage iv colon cancer
1695910|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
1695911|NCT00066248|cachexia|cachexia
1695912|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
1695913|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1695914|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1695915|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1695916|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1695917|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1695918|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1695919|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1695920|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1695921|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
1695922|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1695923|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1695924|NCT00066248|hypothalamic glioma|hypothalamic glioma
1695925|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1695926|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
1695927|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
1695928|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
1695929|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1695930|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1696191|NCT00065702|EKG|ekg
1715526|NCT00001232|FSH|fsh
1695931|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1695932|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
1695933|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
1695934|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1695935|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1695936|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1695937|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1695938|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1695939|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1695940|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
1695941|NCT00066248|other myeloid malignancies|other myeloid malignancies
1695942|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1695943|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1695944|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1695945|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1695946|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1695947|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1695948|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1695949|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1695950|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1695951|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1695952|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1695953|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1695954|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1695955|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1695956|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1695957|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1695958|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1695959|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1695960|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1695961|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
1695962|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
1695963|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1695964|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1695965|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1695966|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1695967|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1695968|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1695969|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1695970|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1695971|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1696477|NCT00065182|HYCAMTIN|hycamtin
1695972|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1695973|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1695974|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1695975|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1695976|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1695977|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1695978|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
1695979|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1695980|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
1695981|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1695982|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1695983|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1695984|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1695985|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1695986|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
1695987|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1695988|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1695989|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1695990|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1695991|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1695992|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1695993|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1715527|NCT00001232|GnRH|gnrh
1695994|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1695995|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1695996|NCT00019721|stage IV melanoma|stage iv melanoma
1695997|NCT00019721|recurrent melanoma|recurrent melanoma
1695998|NCT00019383|recurrent melanoma|recurrent melanoma
1695999|NCT00066209|Inflammation|inflammation
1696000|NCT00066209|Coronavirus|coronavirus
1696001|NCT00066209|Immunity|immunity
1696002|NCT00066209|Interferon|interferon
1696003|NCT00066209|Cytokine|cytokine
1696004|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
1696005|NCT00066209|SARS|sars
1696006|NCT00066209|Healthy Volunteer|healthy volunteer
1696007|NCT00066209|HV|hv
1696008|NCT00066170|Narcolepsy|narcolepsy
1696009|NCT00066170|Daytime Sleepiness|daytime sleepiness
1696010|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
1696011|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1696012|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
1696013|NCT00033722|large cell lung cancer|large cell lung cancer
1696014|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696015|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696016|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
1696017|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1696018|NCT00033306|stage IV colon cancer|stage iv colon cancer
1696019|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
1696020|NCT00033306|recurrent colon cancer|recurrent colon cancer
1696021|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
1696022|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
1696023|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1696024|NCT00031811|stage I breast cancer|stage i breast cancer
1696025|NCT00031811|stage II breast cancer|stage ii breast cancer
1696026|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
1696027|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
1696028|NCT00031811|osteoporosis|osteoporosis
1696029|NCT00031811|menopausal symptoms|menopausal symptoms
1696030|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1696031|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1696032|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
1696033|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1696034|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696035|NCT00031785|anorexia|anorexia
1696036|NCT00031785|cachexia|cachexia
1696037|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
1696038|NCT00066183|FGF-23|fgf-23
1696039|NCT00066183|Hypophosphatemia|hypophosphatemia
1696040|NCT00066183|Phosphaturia|phosphaturia
1696041|NCT00066183|Phosphorus|phosphorus
1696042|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
1696043|NCT00066157|Alzheimer disease|alzheimer disease
1696044|NCT00066157|Hormone replacement therapy|hormone replacement therapy
1696045|NCT00066157|Postmenopausal women|postmenopausal women
1696046|NCT00066144|menopause|menopause
1696047|NCT00066144|hot flashes|hot flashes
1696048|NCT00066144|red clover|red clover
1696049|NCT00066144|black cohosh|black cohosh
1696050|NCT00066144|sexual dysfunction|sexual dysfunction
1696051|NCT00066118|neurologic|neurologic
1696052|NCT00066118|nerve conduction|nerve conduction
1696053|NCT00066118|neurobehavioral|neurobehavioral
1696055|NCT00066092|PBPC transplant|pbpc transplant
1696056|NCT00066092|Hodgkin's Disease|hodgkin's disease
1696057|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1696058|NCT00066092|NHL|nhl
1696059|NCT00066092|mobilization|mobilization
1696060|NCT00066079|Sickle Cell Pain|sickle cell pain
1696061|NCT00066079|Sickle Cell Disease|sickle cell disease
1696062|NCT00066079|Chronic Pain|chronic pain
1696063|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
1696064|NCT00066079|Complementary Medicine|complementary medicine
1696065|NCT00066079|Massage Therapy|massage therapy
1696066|NCT00066079|Relaxation Technique|relaxation technique
1696067|NCT00066079|Home-based Therapy|home-based therapy
1696068|NCT00066053|Heart attacks|heart attacks
1696069|NCT00066053|Stroke|stroke
1696070|NCT00066053|Angina|angina
1696071|NCT00066040|mutans streptococci infections|mutans streptococci infections
1696072|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
1696073|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
1696074|NCT00066014|Dentures|dentures
1696075|NCT00066014|Dental Prostheses|dental prostheses
1696076|NCT00066014|Denture, Implant-Supported|denture, implant-supported
1696077|NCT00065975|chronic low back pain|chronic low back pain
1696078|NCT00065975|acupuncture|acupuncture
1696079|NCT00065975|chiropractic|chiropractic
1696080|NCT00065975|massage therapy|massage therapy
1696081|NCT00065975|CAM therapies|cam therapies
1696082|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
1696083|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
1696084|NCT00065962|Secretin, biological porcine|secretin, biological porcine
1696192|NCT00065702|chronic pain|chronic pain
1696193|NCT00065689|Alzheimer's disease|alzheimer's disease
1696085|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
1696086|NCT00065962|Rimland Questionnaire|rimland questionnaire
1696087|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
1696088|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
1696089|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
1696090|NCT00065949|Low birthweight infants|low birthweight infants
1696091|NCT00065949|Magnesium supplementation|magnesium supplementation
1696092|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
1696093|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
1696094|NCT00065949|Mental retardation|mental retardation
1696095|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
1696096|NCT00065936|Naltrexone|naltrexone
1696097|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
1696098|NCT00065936|Substance P|substance p
1696099|NCT00065936|Met-enkephalin|met-enkephalin
1696100|NCT00065936|Cortisol|cortisol
1696101|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
1696102|NCT00065923|Self-Injurious Behavior|self-injurious behavior
1696103|NCT00065910|Joint attention|joint attention
1696104|NCT00065910|Developmental delay|developmental delay
1696105|NCT00065910|Caregiver interaction|caregiver interaction
1696106|NCT00065897|Amniocentesis|amniocentesis
1696107|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
1696108|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
1696109|NCT00065897|Alpha fetoprotein|alpha fetoprotein
1696110|NCT00065897|Acetylcholinesterase|acetylcholinesterase
1696111|NCT00065897|Prenatal testing|prenatal testing
1696112|NCT00065897|Prenatal diagnosis|prenatal diagnosis
1696113|NCT00065884|Adolescents|adolescents
1696114|NCT00065871|Pharmacist prescribers|pharmacist prescribers
1696115|NCT00065871|Increased access|increased access
1696116|NCT00065871|Hormonal contraception|hormonal contraception
1696117|NCT00065871|Birth control pills|birth control pills
1696118|NCT00065871|Birth control patch|birth control patch
1696119|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
1696120|NCT00065858|Contraception|contraception
1696121|NCT00065858|Nonoxynol 9|nonoxynol 9
1696122|NCT00065858|Microbicide|microbicide
1696123|NCT00065858|Spermicide|spermicide
1696124|NCT00065845|Urinary incontinence|urinary incontinence
1696125|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
1696126|NCT00065845|Stress incontinence|stress incontinence
1696127|NCT00065845|Sacrocolpopexy|sacrocolpopexy
1696128|NCT00065845|Burch urethropexy|burch urethropexy
1696129|NCT00065845|Surgical Trials|surgical trials
1696130|NCT00031707|anorexia|anorexia
1696131|NCT00031707|cachexia|cachexia
1696132|NCT00026273|stage III colon cancer|stage iii colon cancer
1696133|NCT00026273|stage III rectal cancer|stage iii rectal cancer
1696134|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
1696135|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1696136|NCT00025688|stage IV breast cancer|stage iv breast cancer
1696137|NCT00025688|recurrent breast cancer|recurrent breast cancer
1696138|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1696139|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1696140|NCT00022477|stage IV colon cancer|stage iv colon cancer
1696141|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
1696142|NCT00022477|recurrent colon cancer|recurrent colon cancer
1696143|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
1696144|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
1696478|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
1696151|NCT00065819|Symptom Management|symptom management
1696152|NCT00065806|Pediatric lupus|pediatric lupus
1696153|NCT00065806|Atherosclerosis|atherosclerosis
1696154|NCT00065806|SLE|sle
1696155|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
1696156|NCT00065767|Alzheimer disease|alzheimer disease
1696157|NCT00065767|Postmenopausal women|postmenopausal women
1696158|NCT00065767|Hormone therapy|hormone therapy
1696159|NCT00065754|Placebo|placebo
1696160|NCT00065754|Analgesia|analgesia
1696161|NCT00065754|Pain|pain
1696162|NCT00065754|Brain mechanism|brain mechanism
1696163|NCT00065754|Expectation|expectation
1696164|NCT00065741|Milk thistle|milk thistle
1696165|NCT00065741|silymarin|silymarin
1696166|NCT00065741|piperine|piperine
1696167|NCT00065741|glucarate|glucarate
1696172|NCT00065741|pharmacokinetics|pharmacokinetics
1696173|NCT00065741|interaction|interaction
1696174|NCT00065741|glucuronidation|glucuronidation
1696175|NCT00065741|Healthy|healthy
1696176|NCT00065741|Complementary Therapies|complementary therapies
1696177|NCT00065728|AMD|amd
1696178|NCT00065728|age-related macular degeneration|age-related macular degeneration
1696179|NCT00065728|Anecortave|anecortave
1696180|NCT00065728|Acetate|acetate
1696181|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
1696182|NCT00065728|CNV|cnv
1696183|NCT00065728|Anecortave Acetate|anecortave acetate
1696184|NCT00065715|head cold|head cold
1696185|NCT00065715|common cold|common cold
1696186|NCT00065715|echinacea|echinacea
1696187|NCT00065715|placebo|placebo
1696188|NCT00065702|fibromyalgia|fibromyalgia
1696189|NCT00065702|homeopathy|homeopathy
1696194|NCT00065689|light therapy|light therapy
1696195|NCT00065689|long-term care|long-term care
1696196|NCT00065689|depression|depression
1696197|NCT00065689|sleep|sleep
1696198|NCT00065689|agitation|agitation
1696206|NCT00065663|gene transfer|gene transfer
1696207|NCT00065663|adenovirus|adenovirus
1696208|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
1696209|NCT00065663|collagen|collagen
1696210|NCT00065663|diabetic ulcer|diabetic ulcer
1696211|NCT00065663|foot|foot
1696212|NCT00065663|wounds|wounds
1696213|NCT00065663|diabetic|diabetic
1696214|NCT00065663|ulcers|ulcers
1696215|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
1696216|NCT00065650|Vedic medicine|vedic medicine
1696217|NCT00065650|Ayurveda|ayurveda
1696218|NCT00065650|Transcendental Meditation|transcendental meditation
1696219|NCT00065624|Lipoic acid|lipoic acid
1696220|NCT00065624|F2-isoprostanes|f2-isoprostanes
1696221|NCT00065624|endothelial dysfunction|endothelial dysfunction
1696222|NCT00065624|natural product|natural product
1696223|NCT00065585|low back pain|low back pain
1696224|NCT00065585|acupuncture|acupuncture
1696225|NCT00065572|Kidney Cancer|kidney cancer
1696226|NCT00065572|Metastatic|metastatic
1696227|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
1696228|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1696432|NCT00065286|Barnes test|barnes test
1696229|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1696230|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1696231|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1696232|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1696233|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1696234|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1696235|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1696236|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1696237|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1696238|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1696239|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1696240|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1696241|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1696242|NCT00014248|cachexia|cachexia
1696243|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1696244|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1696245|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1696246|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1696247|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1696248|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1696249|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
1696250|NCT00065611|Steroids|steroids
1696251|NCT00065611|Osteoporosis|osteoporosis
1696252|NCT00065611|Proteinuria|proteinuria
1696253|NCT00065611|Minimal Change Disease|minimal change disease
1696254|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1696255|NCT00065611|FSGS|fsgs
1696256|NCT00065611|MCD|mcd
1696257|NCT00065611|Kidney Disease|kidney disease
1696258|NCT00065507|hepatic decompensation|hepatic decompensation
1696259|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1696260|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1696261|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1696262|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1696263|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1696264|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1696265|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1696266|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1696267|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1696268|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1696269|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1696270|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1696271|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1696272|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1696273|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1696274|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1696325|NCT00006799|anorexia|anorexia
1696326|NCT00006799|cachexia|cachexia
1696275|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1696276|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1696277|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1696278|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1696279|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1696280|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1696281|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1696282|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1696283|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1696284|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1696285|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1696286|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1696287|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1696288|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1696289|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1696290|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1696291|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1696292|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1696293|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1696294|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1696295|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1696296|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1696297|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1696298|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1696299|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1696300|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1696301|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1696302|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1696479|NCT00065182|Advanced|advanced
1696303|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1696304|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1696305|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1696306|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1696307|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1696308|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1696309|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1696310|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1696311|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1696312|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1696313|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1696314|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1696315|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1696560|NCT00064909|Perfusion|perfusion
1696316|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1696513|NCT00065052|Reduce TV|reduce tv
1696317|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1696318|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1696319|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1696320|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1696321|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1696322|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1696323|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1696324|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1696327|NCT00006799|quality of life|quality of life
1696328|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1696329|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
1696330|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1696331|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1696332|NCT00065468|Kidney Cancer|kidney cancer
1696333|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696334|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696335|NCT00006081|stage III gastric cancer|stage iii gastric cancer
1696336|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
1696337|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
1696338|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
1696339|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1696340|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1696341|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
1696342|NCT00065455|Vitamin A|vitamin a
1696343|NCT00065455|ERG|erg
1696344|NCT00065455|RP|rp
1696345|NCT00065442|prostate cancer|prostate cancer
1696346|NCT00065442|prostate|prostate
1696347|NCT00065442|AIPC|aipc
1696348|NCT00065442|androgen-independent|androgen-independent
1696349|NCT00065442|androgen independent|androgen independent
1696350|NCT00065442|hormone insensitive|hormone insensitive
1696351|NCT00065442|hormone-insensitive|hormone-insensitive
1696352|NCT00065442|PSA|psa
1696353|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
1696354|NCT00065442|hormone-refractory|hormone-refractory
1696355|NCT00065442|hormone refractory|hormone refractory
1696356|NCT00065442|HRPC|hrpc
1696357|NCT00065442|LHRH|lhrh
1696358|NCT00065442|immune therapy|immune therapy
1696359|NCT00065442|immunotherapy|immunotherapy
1696360|NCT00065442|vaccine|vaccine
1696361|NCT00065442|dendritic cells|dendritic cells
1696362|NCT00065442|antigen-presenting cells|antigen-presenting cells
1696363|NCT00065442|antigen presenting cells|antigen presenting cells
1696364|NCT00065442|cancer vaccine|cancer vaccine
1696365|NCT00065442|therapeutic vaccine|therapeutic vaccine
1696366|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
1696367|NCT00065442|recombinant|recombinant
1696368|NCT00065442|biological|biological
1696369|NCT00065442|biopharmaceutical|biopharmaceutical
1696370|NCT00065442|biotechnology|biotechnology
1696371|NCT00065442|biotech|biotech
1696372|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1696373|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696374|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696375|NCT00065416|neck pain|neck pain
1696376|NCT00065416|cervicalgia|cervicalgia
1696377|NCT00065416|massage|massage
1696378|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
1696379|NCT00065403|Acupuncture|acupuncture
1696380|NCT00065364|Preterm infant|preterm infant
1696381|NCT00065364|Premature infant|premature infant
1696382|NCT00065364|Developmental care|developmental care
1696383|NCT00065364|MRI|mri
1696384|NCT00065364|qEEG|qeeg
1696385|NCT00065364|Neurodevelopment|neurodevelopment
1696386|NCT00065364|Behavior|behavior
1696387|NCT00065364|Infants|infants
1696388|NCT00065364|NICU|nicu
1696389|NCT00065351|Multiple Myeloma|multiple myeloma
1696390|NCT00065351|CC-5013|cc-5013
1696391|NCT00065351|Revlimid|revlimid
1696392|NCT00065351|MM|mm
1696393|NCT00065351|CC5013|cc5013
1696394|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
1696395|NCT00065338|Physical activity|physical activity
1696396|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
1696397|NCT00065325|metastatic breast cancer|metastatic breast cancer
1696398|NCT00065325|Breast Cancer|breast cancer
1696399|NCT00065325|Cancer of Breast|cancer of breast
1696400|NCT00065325|Cancer of the Breast|cancer of the breast
1696401|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1696402|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1699177|NCT00060320|hot flashes|hot flashes
1696403|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696404|NCT00065390|ALPS|alps
1696405|NCT00065390|Pyrimethamine|pyrimethamine
1696406|NCT00065390|Folinic Acid|folinic acid
1696407|NCT00065390|Lymphadenopathy|lymphadenopathy
1696408|NCT00065390|Splenomegaly|splenomegaly
1696409|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
1696410|NCT00065377|Diabetes|diabetes
1696411|NCT00065377|Insulin Resistance|insulin resistance
1696412|NCT00065377|Capillary Blood Flow|capillary blood flow
1696413|NCT00065377|Osteoarthritis|osteoarthritis
1696414|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
1696415|NCT00065377|Obesity|obesity
1696416|NCT00065377|Healthy Volunteer|healthy volunteer
1696417|NCT00065377|HV|hv
1696418|NCT00065312|Type 2 diabetes|type 2 diabetes
1696419|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
1696420|NCT00065299|PKU|pku
1696421|NCT00065299|Maternal PKU|maternal pku
1696422|NCT00065299|Pregnancy outcome|pregnancy outcome
1697405|NCT00062881|Lymphoma|lymphoma
1696423|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
1696424|NCT00065299|Tyrosine supplementation|tyrosine supplementation
1696425|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
1696426|NCT00065286|Akathisia|akathisia
1696427|NCT00065286|Mental retardation|mental retardation
1696428|NCT00065286|Schizophrenia|schizophrenia
1696429|NCT00065286|Neuroleptic medication|neuroleptic medication
1696430|NCT00065286|Tardive dyskinesia|tardive dyskinesia
1696431|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
1696433|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
1696434|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
1696435|NCT00065273|Severe aberrant behavior|severe aberrant behavior
1696436|NCT00065273|Risperidone|risperidone
1696437|NCT00065273|Clozapine|clozapine
1696438|NCT00065273|Haloperidol|haloperidol
1696439|NCT00065273|Laboratory operant tasks|laboratory operant tasks
1696440|NCT00065273|Simple acquisition procedures|simple acquisition procedures
1696441|NCT00065273|Matching to sample task|matching to sample task
1696442|NCT00065273|Lag sequential analysis|lag sequential analysis
1696443|NCT00065247|Bone|bone
1696444|NCT00065247|Children|children
1696445|NCT00065247|After-school program|after-school program
1696446|NCT00065247|Osteoporosis|osteoporosis
1696447|NCT00065247|Calcium|calcium
1696448|NCT00065247|Physical activity|physical activity
1696449|NCT00065234|Colostomy|colostomy
1696450|NCT00065234|Ileostomy|ileostomy
1696451|NCT00065221|Ginger|ginger
1696452|NCT00065221|Plant preparation|plant preparation
1696453|NCT00065221|Herbal medicine|herbal medicine
1696454|NCT00065221|Chemotherapy|chemotherapy
1696455|NCT00065221|Nausea|nausea
1696456|NCT00065208|Prostate cancer|prostate cancer
1696457|NCT00065208|Reiki|reiki
1696458|NCT00065208|Energy Healing|energy healing
1696459|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
1696460|NCT00065260|Rabbit ATG|rabbit atg
1696461|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
1696462|NCT00065260|Cyclosporine|cyclosporine
1696463|NCT00065260|Thrombocytopenia|thrombocytopenia
1696464|NCT00065260|Leukopenia|leukopenia
1696465|NCT00065260|Neutropenia|neutropenia
1696466|NCT00065260|Autoimmunity|autoimmunity
1696467|NCT00065260|Relapse|relapse
1696468|NCT00065260|Anemia|anemia
1696469|NCT00065195|Massage|massage
1696470|NCT00065195|Palliative Care|palliative care
1696471|NCT00065195|Hospices|hospices
1696472|NCT00065195|Cancer|cancer
1696473|NCT00065182|Stage IIIB/IV|stage iiib/iv
1696474|NCT00065182|topotecan|topotecan
1696475|NCT00065182|docetaxel|docetaxel
1696476|NCT00065182|TAXOTERE|taxotere
1696485|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
1696486|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
1696487|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
1696488|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1696489|NCT00065117|metastatic|metastatic
1696490|NCT00065117|colorectal|colorectal
1696491|NCT00065117|first-line|first-line
1696492|NCT00065117|adjuvant|adjuvant
1696493|NCT00065117|cancer|cancer
1696494|NCT00065117|Colorectal Cancer|colorectal cancer
1696495|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
1696496|NCT00065117|Colorectal Tumors|colorectal tumors
1696497|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
1696498|NCT00065104|HIV|hiv
1696499|NCT00065104|DHEA|dhea
1696500|NCT00065104|immune system|immune system
1696501|NCT00065104|hormones|hormones
1696502|NCT00065104|body composition|body composition
1696503|NCT00065104|quality of life|quality of life
1696504|NCT00065078|Home-visits|home-visits
1696505|NCT00065078|Community nurse|community nurse
1696506|NCT00065078|Unintended pregnancy|unintended pregnancy
1696507|NCT00065065|Rosiglitazone|rosiglitazone
1696508|NCT00065065|Ulcerative|ulcerative
1696509|NCT00065065|Colitis|colitis
1696510|NCT00065052|physical activity|physical activity
1696511|NCT00065052|television|television
1696512|NCT00065052|child obesity|child obesity
1696514|NCT00065052|Usual control|usual control
1696515|NCT00065013|obesity|obesity
1696516|NCT00065013|gastric bypass|gastric bypass
1696517|NCT00065013|obesity surgery|obesity surgery
1696518|NCT00065013|bariatric surgery|bariatric surgery
1696519|NCT00065013|exercise|exercise
1696520|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
1696521|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1696522|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1696523|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
1696524|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
1696525|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
1696526|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1696527|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1696528|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
1696529|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
1696530|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
1696531|NCT00003759|stage I bladder cancer|stage i bladder cancer
1696532|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
1696533|NCT00064987|Male reproduction hormones|male reproduction hormones
1696534|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
1696535|NCT00064987|FSH|fsh
1696536|NCT00064987|LH|lh
1696537|NCT00064987|GnRH|gnrh
1696538|NCT00064974|MDS|mds
1696539|NCT00064974|CC-5013|cc-5013
1696540|NCT00064974|Revlimid|revlimid
1696541|NCT00064974|Celgene|celgene
1696542|NCT00064961|Smoking Cessation|smoking cessation
1696543|NCT00064935|Endometrium|endometrium
1696544|NCT00064935|Luteal phase|luteal phase
1696545|NCT00064935|Endometrial biopsy|endometrial biopsy
1696546|NCT00064922|nicotine dependence|nicotine dependence
1696547|NCT00064870|Alzheimer disease|alzheimer disease
1696548|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
1696549|NCT00064870|Genetics|genetics
1696550|NCT00064870|Initiative|initiative
1696551|NCT00064870|Dementia|dementia
1696552|NCT00064857|lymphedema|lymphedema
1696553|NCT00064857|breast|breast
1696554|NCT00064857|cancer|cancer
1696555|NCT00064857|plant preparation|plant preparation
1696556|NCT00064857|herbal preparation|herbal preparation
1696557|NCT00064857|pine bark extract|pine bark extract
1696558|NCT00064909|Multiple Sclerosis|multiple sclerosis
1696559|NCT00064909|MRI|mri
1696561|NCT00064909|Imaging|imaging
1696562|NCT00064909|Cerebral Blood Flow|cerebral blood flow
1696563|NCT00064909|Cerebral Blood Volume|cerebral blood volume
1696564|NCT00064909|CO2 Inhalation|co2 inhalation
1696565|NCT00064909|Contrast Agent|contrast agent
1696566|NCT00064909|Healthy Volunteer|healthy volunteer
1696567|NCT00064909|HV|hv
1696568|NCT00064896|Blood Flow|blood flow
1696569|NCT00064896|Revascularization|revascularization
1696570|NCT00064896|Image Fusion|image fusion
1696571|NCT00064896|Fluoroscopy|fluoroscopy
1696572|NCT00064896|MRI|mri
1696573|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
1696574|NCT00064896|Claudication|claudication
1696575|NCT00064896|Safety|safety
1696576|NCT00064896|Atherosclerosis|atherosclerosis
1696577|NCT00064896|Cardiovascular Disease|cardiovascular disease
1696578|NCT00064883|Radiation Therapy|radiation therapy
1696579|NCT00064883|Children|children
1696580|NCT00064883|Cancer|cancer
1696581|NCT00064883|Late Effects|late effects
1696582|NCT00064883|Natural History|natural history
1696583|NCT00064883|Radiation|radiation
1696584|NCT00064844|Smoking|smoking
1696585|NCT00064844|Alcoholism|alcoholism
1715896|NCT00048789|Psoralen|psoralen
1696586|NCT00064831|estrogen stimulation|estrogen stimulation
1696587|NCT00064831|relief of hot flashes|relief of hot flashes
1696588|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
1696589|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
1696590|NCT00064818|connective tissue|connective tissue
1696591|NCT00064818|ultrasound|ultrasound
1696592|NCT00064818|acupuncture|acupuncture
1696593|NCT00064805|Cognitive therapy|cognitive therapy
1696594|NCT00064805|Aphasia therapy|aphasia therapy
1696595|NCT00064805|Alexia|alexia
1696596|NCT00064805|Acquired dyslexia|acquired dyslexia
1696597|NCT00064805|Phonological deficits|phonological deficits
1696598|NCT00064805|Orthographic deficits|orthographic deficits
1696599|NCT00064805|Brain disorders|brain disorders
1696600|NCT00064805|Brain injury|brain injury
1696601|NCT00064805|Stroke|stroke
1696602|NCT00064779|CNS neoplasms|cns neoplasms
1696603|NCT00064779|Brain neoplasms|brain neoplasms
1696604|NCT00064779|neurosurgery|neurosurgery
1696605|NCT00064779|intralesional infusion|intralesional infusion
1696606|NCT00064779|recombinant proteins|recombinant proteins
1696607|NCT00064779|immunotoxins|immunotoxins
1696608|NCT00064766|Norplant|norplant
1696609|NCT00064766|Periodontal disease|periodontal disease
1696610|NCT00064766|Endometrial bleeding|endometrial bleeding
1696611|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
1696612|NCT00064753|homocysteine|homocysteine
1696613|NCT00064753|multi-vitamin|multi-vitamin
1696614|NCT00064753|cardiovascular disease|cardiovascular disease
1696615|NCT00064753|renal transplant recipients|renal transplant recipients
1696616|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
1696617|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1696618|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
1696619|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1696620|NCT00003645|stage I prostate cancer|stage i prostate cancer
1696621|NCT00003645|stage II prostate cancer|stage ii prostate cancer
1696622|NCT00003571|stage III colon cancer|stage iii colon cancer
1696623|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
1696624|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1696625|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1696626|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1696627|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1696628|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1697406|NCT00062881|Solid Tumor|solid tumor
1696629|NCT00003382|fallopian tube cancer|fallopian tube cancer
1696630|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1696631|NCT00064792|Cholesterol|cholesterol
1696632|NCT00064792|SLOS|slos
1696633|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
1696634|NCT00064792|Malformation Syndrome|malformation syndrome
1696635|NCT00064792|Mental Retardation|mental retardation
1696636|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1696637|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
1696638|NCT00064740|Relaxation|relaxation
1696639|NCT00064740|Acupuncture|acupuncture
1696640|NCT00064740|Complementary therapies|complementary therapies
1696641|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
1696642|NCT00064701|cyclosporine|cyclosporine
1696643|NCT00064701|Prograf®|prograf®
1696644|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
1696645|NCT00064701|tacrolimus|tacrolimus
1696646|NCT00006073|Evaluation|evaluation
1696647|NCT00006073|Endocrinology|endocrinology
1696648|NCT00006073|Hormones|hormones
1696649|NCT00006073|Metabolism|metabolism
1696650|NCT00006073|Teaching|teaching
1696651|NCT00006073|Endocrine Disorder|endocrine disorder
1696652|NCT00064727|Ventricular Contractile Function|ventricular contractile function
1696653|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
1696654|NCT00064727|PPAR gamma|ppar gamma
1696655|NCT00064727|Gene Expression Patterns|gene expression patterns
1696656|NCT00064727|Insulin Sensitization|insulin sensitization
1696657|NCT00064727|Glucose Intolerance|glucose intolerance
1696658|NCT00064727|Intolerance|intolerance
1696659|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
1696660|NCT00064714|Beta-Cell|beta-cell
1696661|NCT00064714|C-Peptide|c-peptide
1696662|NCT00064714|Immunosuppression|immunosuppression
1696663|NCT00064714|Insulin|insulin
1696664|NCT00064714|Islet|islet
1696665|NCT00064714|Function|function
1696666|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
1696667|NCT00064714|Diabetes Mellitus|diabetes mellitus
1696668|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
1696669|NCT00064714|T1DM|t1dm
1696670|NCT00064662|Stress urinary incontinence|stress urinary incontinence
1696671|NCT00064662|Surgery|surgery
1696672|NCT00064649|prostate|prostate
1696673|NCT00064649|benign disease|benign disease
1696674|NCT00064649|TUNA|tuna
1696675|NCT00064649|TUMT|tumt
1696676|NCT00064649|medical therapy|medical therapy
1696677|NCT00064623|Dermal assessment|dermal assessment
1696678|NCT00064623|Pain measurement|pain measurement
1696679|NCT00064623|Diary|diary
1715897|NCT00048789|Refractory|refractory
1696680|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
1696681|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1696682|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
1696873|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
1696683|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
1696684|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
1696685|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
1696686|NCT00064597|Fetal cells|fetal cells
1696687|NCT00064597|Prenatal diagnosis|prenatal diagnosis
1696688|NCT00064597|Cytogenetic disorders|cytogenetic disorders
1696689|NCT00064597|Chromosomal disorders|chromosomal disorders
1696690|NCT00064597|Single gene mutation detection|single gene mutation detection
1696691|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
1696692|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
1696693|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
1696694|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
1696695|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
1696696|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
1696697|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
1696698|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
1699746|NCT00059618|MLN341|mln341
1696699|NCT00003184|stage IV breast cancer|stage iv breast cancer
1696700|NCT00003184|recurrent breast cancer|recurrent breast cancer
1696701|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1696702|NCT00003045|stage II prostate cancer|stage ii prostate cancer
1696703|NCT00003045|stage III prostate cancer|stage iii prostate cancer
1696704|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1696705|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1696706|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
1696707|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
1696708|NCT00064467|lethargic|lethargic
1696709|NCT00064467|decreased interest|decreased interest
1696710|NCT00064467|decreased motivation|decreased motivation
1696711|NCT00064467|depression|depression
1696712|NCT00064454|Ulcerative Colitis|ulcerative colitis
1696713|NCT00064441|Ulcerative Colitis|ulcerative colitis
1696714|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1697407|NCT00062868|Lymphoma|lymphoma
1696715|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1696716|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1696717|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1696718|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
1696719|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1696720|NCT00064376|refractory anemia|refractory anemia
1696721|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1696722|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
1696723|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1696724|NCT00064363|adult glioblastoma|adult glioblastoma
1696725|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1696726|NCT00064363|adult mixed glioma|adult mixed glioma
1696727|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
1696728|NCT00064363|adult gliosarcoma|adult gliosarcoma
1696729|NCT00064363|adult brain stem glioma|adult brain stem glioma
1696730|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1696731|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696732|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696733|NCT00064350|sorafenib|sorafenib
1696734|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
1696735|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
1696736|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
1696737|NCT00064311|infection|infection
1696738|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1696739|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1696740|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1696741|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1696742|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1696743|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1696744|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1696745|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1696746|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1696747|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1696748|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1696749|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1696750|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1696878|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1696751|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1696752|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1696753|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1696754|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1696755|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1696756|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1696757|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1696758|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1696759|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1696760|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1696761|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1696762|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1696763|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1696764|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1696765|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1696766|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1696767|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1696972|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
1696768|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1696769|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1696770|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1696771|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1696772|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1696773|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1696774|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1696775|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1696776|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1696777|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1696778|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1696779|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
1696780|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1697188|NCT00063388|Cancer|cancer
1696781|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1696782|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1696783|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
1696784|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
1696785|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
1696786|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1696787|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1696788|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
1696789|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
1696790|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1696791|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1696792|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1696793|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1696794|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1696795|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
1696796|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
1696797|NCT00064311|stage IV breast cancer|stage iv breast cancer
1696798|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1696799|NCT00064311|primary myelofibrosis|primary myelofibrosis
1696800|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1696801|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1696802|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1696803|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1696804|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1696805|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1696806|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1696807|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
1696808|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1696809|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1696810|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1696811|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1696812|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1696813|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1696814|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1696815|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1696816|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1696817|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1696818|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1696819|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1696820|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1696821|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1696822|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1696823|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1696824|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1696825|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1696826|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1696827|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1696828|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1696829|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1696830|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1696831|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1696832|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1696833|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1696834|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1696835|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1696836|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1696837|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1696838|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1696839|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1696840|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1696841|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1696842|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1696843|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1696844|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1696845|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1696846|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1696847|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1696848|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1696849|NCT00064272|nausea and vomiting|nausea and vomiting
1696850|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1696851|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1696852|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1696853|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1696854|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
1696855|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1696856|NCT00064220|adult liposarcoma|adult liposarcoma
1696857|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1696858|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
1696859|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
1696860|NCT00064220|adult angiosarcoma|adult angiosarcoma
1696861|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1696862|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1696863|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1696864|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1696865|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
1696866|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
1696867|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
1696868|NCT00064194|prostate cancer|prostate cancer
1696869|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
1696870|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
1696871|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1696872|NCT00064181|stage IV colon cancer|stage iv colon cancer
1696874|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1696875|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1696876|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1696877|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1696879|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1696880|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1696881|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1696882|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1696883|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1696884|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1696885|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1696886|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
1696887|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1696888|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1696889|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1696890|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1696891|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1696892|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1696893|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1696894|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1697118|NCT00063609|Bone Loss|bone loss
1696895|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1696896|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696897|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
1696898|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
1696899|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
1696900|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
1696901|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
1696902|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
1696903|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
1696904|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1696905|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1696906|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1696907|NCT00063986|esophageal cancer|esophageal cancer
1696908|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
1696909|NCT00063960|stage IV colon cancer|stage iv colon cancer
1696910|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
1696911|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1696912|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
1696913|NCT00063960|liver metastases|liver metastases
1696914|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
1696915|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
1696916|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1696917|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1696918|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
1696919|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
1696920|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
1696921|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1696922|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1696923|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1696924|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1696925|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
1696926|NCT00063856|Smallpox, wetvax|smallpox, wetvax
1696927|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
1696928|NCT00063830|Ulcerative Colitis|ulcerative colitis
1696929|NCT00063817|End-stage renal disease|end-stage renal disease
1696930|NCT00063817|Renal Transplant|renal transplant
1696931|NCT00063817|Bone Marrow Transplant|bone marrow transplant
1696932|NCT00063817|nonmyeloablative conditioning regimen|nonmyeloablative conditioning regimen
1696933|NCT00063804|HIV Seronegativity|hiv seronegativity
1696934|NCT00063804|CXCR4|cxcr4
1696935|NCT00063804|AMD11070|amd11070
1696936|NCT00063791|Relapsed or Refractory|relapsed or refractory
1696937|NCT00063778|HIV Seronegativity|hiv seronegativity
1696938|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
1696939|NCT00063778|AIDS Vaccines|aids vaccines
1696940|NCT00063778|Gene Products, gag|gene products, gag
1696941|NCT00063778|HIV-1|hiv-1
1696942|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1696943|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
1696944|NCT00045357|recurrent melanoma|recurrent melanoma
1696945|NCT00045357|stage IV melanoma|stage iv melanoma
1696946|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1696947|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1696948|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1696949|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
1696950|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1696951|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
1696952|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1696953|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1696954|NCT00042900|primary myelofibrosis|primary myelofibrosis
1696955|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1696956|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1696957|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1696958|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1696959|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1696960|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1696961|NCT00042900|essential thrombocythemia|essential thrombocythemia
1696962|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
1696963|NCT00042900|intraocular lymphoma|intraocular lymphoma
1696964|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1696965|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1696966|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1696967|NCT00042900|polycythemia vera|polycythemia vera
1696968|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1696969|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1696970|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
1696971|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1696973|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1697189|NCT00063362|Depression|depression
1696974|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1696975|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1696976|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1696977|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1696978|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1696979|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1696980|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1696981|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1696982|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1696983|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1696984|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1696985|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1696986|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1696987|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1696988|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1696989|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1696990|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
1696991|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
1696992|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1696993|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1696994|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1696995|NCT00042900|small intestine lymphoma|small intestine lymphoma
1696996|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1696997|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1696998|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1696999|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1697000|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1697001|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1697002|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1697003|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1697004|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1697005|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1697006|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1697007|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1697008|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1697009|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1697010|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
1697011|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1697012|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1697013|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1697014|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1697015|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1697016|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1697017|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1697182|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
1697018|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1697019|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1697020|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1697021|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1697022|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1697023|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1697024|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1697025|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1697026|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1697027|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
1697028|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1697029|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1697030|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697031|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697032|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697033|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1697034|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1697035|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1697036|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1697037|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697038|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1697039|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1697040|NCT00040820|stage III colon cancer|stage iii colon cancer
1697041|NCT00040820|stage IV colon cancer|stage iv colon cancer
1697042|NCT00040820|stage III rectal cancer|stage iii rectal cancer
1697043|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
1697044|NCT00040820|recurrent colon cancer|recurrent colon cancer
1697045|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
1697046|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
1697047|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1697048|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
1697049|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
1697050|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
1697051|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
1697052|NCT00036660|adult glioblastoma|adult glioblastoma
1697053|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1697054|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
1697055|NCT00036660|adult gliosarcoma|adult gliosarcoma
1697056|NCT00033384|stage III colon cancer|stage iii colon cancer
1697057|NCT00033384|stage IV colon cancer|stage iv colon cancer
1697058|NCT00033384|stage IV breast cancer|stage iv breast cancer
1697059|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
1697060|NCT00033384|recurrent breast cancer|recurrent breast cancer
1697061|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
1697062|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1697063|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
1697064|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
1697065|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
1697066|NCT00033384|recurrent colon cancer|recurrent colon cancer
1697067|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697068|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1697069|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1697070|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1697071|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
1697072|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1697073|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
1697074|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
1697075|NCT00002752|adult medulloblastoma|adult medulloblastoma
1697076|NCT00002752|adult glioblastoma|adult glioblastoma
1697077|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
1697078|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1697079|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1697080|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1697081|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
1697082|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1697083|NCT00002752|adult mixed glioma|adult mixed glioma
1697084|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1697085|NCT00002752|adult subependymoma|adult subependymoma
1697086|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
1697087|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1697088|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1697089|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1697090|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1697183|NCT00063401|fallopian tube cancer|fallopian tube cancer
1697091|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1697092|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
1697093|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
1697094|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
1697095|NCT00002752|adult gliosarcoma|adult gliosarcoma
1697096|NCT00002582|stage I breast cancer|stage i breast cancer
1697097|NCT00002582|stage II breast cancer|stage ii breast cancer
1697098|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
1697099|NCT00063765|NT-501|nt-501
1697100|NCT00063765|CNTF|cntf
1697101|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
1697102|NCT00063765|RP|rp
1697103|NCT00063700|obesity in school aged children|obesity in school aged children
1697104|NCT00063674|exercise|exercise
1697105|NCT00063674|eating|eating
1697106|NCT00063674|dance|dance
1697107|NCT00063674|health education|health education
1697108|NCT00063674|obesity prevention|obesity prevention
1697109|NCT00063674|diabetes prevention|diabetes prevention
1697110|NCT00063674|children|children
1697111|NCT00063648|PTLD|ptld
1697112|NCT00063648|CTL Therapy|ctl therapy
1697113|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1697114|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
1697115|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
1697116|NCT00063622|Steatohepatitis|steatohepatitis
1697117|NCT00063609|Prostate Cancer|prostate cancer
1697119|NCT00063609|Osteoporosis|osteoporosis
1697120|NCT00063609|Bone Mineral Density|bone mineral density
1697121|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
1697122|NCT00063661|fMRI|fmri
1697123|NCT00063661|Brain Activity|brain activity
1697124|NCT00063661|Overlearned|overlearned
1697125|NCT00063661|Dual-Task|dual-task
1697126|NCT00063661|Mechanism|mechanism
1697127|NCT00063661|Parkinson Disease|parkinson disease
1697128|NCT00063661|PD|pd
1697129|NCT00063596|Vitamin A|vitamin a
1697130|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
1697131|NCT00063596|Immune responses|immune responses
1697132|NCT00063596|T-cell subsets|t-cell subsets
1697133|NCT00063596|Chronic lung disease|chronic lung disease
1697134|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
1697135|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
1697136|NCT00063583|Kidney disease|kidney disease
1697137|NCT00063570|Cancer of Breast|cancer of breast
1697138|NCT00063570|Cancer of the Breast|cancer of the breast
1697139|NCT00063323|Maintenance treatment|maintenance treatment
1697140|NCT00063323|Smoking relapse|smoking relapse
1697141|NCT00063323|Bupropion|bupropion
1697142|NCT00063323|Nicotine replacement|nicotine replacement
1697143|NCT00033319|colon cancer|colon cancer
1697144|NCT00033319|rectal cancer|rectal cancer
1697145|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1697146|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1697147|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1697148|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1697149|NCT00031954|fallopian tube cancer|fallopian tube cancer
1697150|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1697151|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1697152|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
1697153|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
1697154|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1697155|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697156|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1697157|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1697158|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1697159|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
1697160|NCT00028938|large cell lung cancer|large cell lung cancer
1697161|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697162|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1697163|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
1697164|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1697165|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
1697166|NCT00063479|OI|oi
1697167|NCT00063479|bone markers|bone markers
1697168|NCT00063479|fracture|fracture
1697169|NCT00063479|bone loss|bone loss
1697170|NCT00063479|pediatric|pediatric
1697171|NCT00063479|bisphosphonate|bisphosphonate
1697172|NCT00063479|brittle bone disease|brittle bone disease
1697173|NCT00063479|pamidronate|pamidronate
1697174|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1697175|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697176|NCT00063427|Colorectal Cancer|colorectal cancer
1697177|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
1697178|NCT00063427|Colorectal Tumors|colorectal tumors
1697179|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
1697180|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
1697181|NCT00063401|ovarian|ovarian
1697190|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1697191|NCT00030446|fallopian tube cancer|fallopian tube cancer
1697192|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
1697193|NCT00028483|stage IV breast cancer|stage iv breast cancer
1697194|NCT00028483|recurrent breast cancer|recurrent breast cancer
1697195|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
1697196|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
1697197|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
1697198|NCT00003352|stage IV breast cancer|stage iv breast cancer
1697199|NCT00003352|recurrent breast cancer|recurrent breast cancer
1697200|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
1697201|NCT00063310|Alzheimer disease|alzheimer disease
1697202|NCT00063310|Aging Women|aging women
1697203|NCT00063310|Hormone therapy|hormone therapy
1697204|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
1697205|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697206|NCT00063284|Electrical Stimulation|electrical stimulation
1697207|NCT00063284|Human Brain|human brain
1697208|NCT00063284|Parkinson Disease|parkinson disease
1697209|NCT00063284|PD|pd
1697210|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
1697211|NCT00063258|Lung Cancer|lung cancer
1697212|NCT00063258|OSI-774|osi-774
1697213|NCT00063258|Tarceva|tarceva
1697214|NCT00063258|Carboplatin|carboplatin
1697215|NCT00063258|Paclitaxel|paclitaxel
1697216|NCT00063258|NSCLC|nsclc
1697217|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1697218|NCT00063219|Lung Cancer|lung cancer
1697219|NCT00063219|Cancer of Lung|cancer of lung
1697220|NCT00063206|Depressive Disorder, Major|depressive disorder, major
1697221|NCT00063206|Depression, Involutional|depression, involutional
1697222|NCT00063193|Parkinson's disease|parkinson's disease
1697223|NCT00063193|minocycline|minocycline
1697224|NCT00063193|creatine|creatine
1697225|NCT00063193|neuroprotection|neuroprotection
1697226|NCT00063154|Lung cancer|lung cancer
1697227|NCT00030797|stage III colon cancer|stage iii colon cancer
1697228|NCT00030797|stage IV colon cancer|stage iv colon cancer
1697229|NCT00030797|stage III rectal cancer|stage iii rectal cancer
1697230|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
1697231|NCT00026520|stage IV melanoma|stage iv melanoma
1697232|NCT00026520|recurrent melanoma|recurrent melanoma
1697233|NCT00026364|stage IV colon cancer|stage iv colon cancer
1697234|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
1697235|NCT00026364|recurrent colon cancer|recurrent colon cancer
1697236|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
1697237|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
1697238|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1697239|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1697240|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1697241|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1697242|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1697243|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1697244|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1697245|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1697246|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1697247|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1697248|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1697249|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1697250|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1697251|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1697252|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1697253|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1697254|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1697255|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1697256|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1697257|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
1697258|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1697259|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1697260|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1697261|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1697262|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1697263|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1697264|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1697265|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1697266|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697267|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697268|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1716004|NCT00048204|Depression|depression
1697269|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1697270|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1697271|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1697272|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1697273|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1697274|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1697275|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1697276|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697277|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
1697278|NCT00025571|large cell lung cancer|large cell lung cancer
1697279|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
1697280|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1697281|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1697282|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
1697283|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1697284|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1697285|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1697286|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
1697287|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
1697288|NCT00063245|Motor Cortex|motor cortex
1697289|NCT00063245|Mood|mood
1697291|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1697292|NCT00063245|Magnetic Coil|magnetic coil
1697293|NCT00063245|Healthy Volunteer|healthy volunteer
1697295|NCT00063232|Insulin|insulin
1697296|NCT00063232|Obesity|obesity
1697297|NCT00063232|Fatty Liver|fatty liver
1697298|NCT00063232|Diabetes|diabetes
1697299|NCT00063232|Cirrhosis|cirrhosis
1697300|NCT00063232|Metformin|metformin
1697301|NCT00063232|Insulin Resistance|insulin resistance
1697302|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1697303|NCT00063232|Hepatitis|hepatitis
1697304|NCT00063232|NASH|nash
1697305|NCT00063180|Diaschisis|diaschisis
1697306|NCT00063180|Glucose|glucose
1697307|NCT00063180|GABA|gaba
1697308|NCT00063180|N-Acetylaspartate|n-acetylaspartate
1697309|NCT00063180|Glutamate|glutamate
1697310|NCT00063180|Stroke|stroke
1715528|NCT00001232|LH|lh
1697311|NCT00063180|Healthy Volunteer|healthy volunteer
1697313|NCT00063115|Praxis Movements|praxis movements
1697314|NCT00063115|Pantomime|pantomime
1697315|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
1697316|NCT00063115|Functional Connectivity|functional connectivity
1697317|NCT00063115|Path Analysis|path analysis
1697318|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
1697319|NCT00063115|Healthy Volunteer|healthy volunteer
1697320|NCT00063115|HV|hv
1697321|NCT00063089|Staphylococcal infection|staphylococcal infection
1697322|NCT00063089|Gram positive bacteria|gram positive bacteria
1697323|NCT00063089|Staphylococcus|staphylococcus
1697324|NCT00063089|Staphylococcus aureus|staphylococcus aureus
1697325|NCT00063076|Alopecia Areata|alopecia areata
1697326|NCT00063076|Alopecia Totalis|alopecia totalis
1697327|NCT00063076|Alopecia Universalis|alopecia universalis
1697328|NCT00063076|Targretin Gel|targretin gel
1697329|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
1697330|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1697331|NCT00063063|Prematurity|prematurity
1697332|NCT00063050|Bone density|bone density
1697333|NCT00063050|Children|children
1697334|NCT00063050|Adolescents|adolescents
1697335|NCT00063050|Behavior|behavior
1697336|NCT00063050|Health education|health education
1697337|NCT00063050|Health promotion|health promotion
1697338|NCT00063050|Physical fitness|physical fitness
1697339|NCT00063050|Diet|diet
1697340|NCT00063050|Parent training|parent training
1697341|NCT00063050|Injury control|injury control
1697342|NCT00063037|Bone mass|bone mass
1697343|NCT00063037|Calcium intake|calcium intake
1697344|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
1697345|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
1697346|NCT00063037|Bone mineral density|bone mineral density
1697347|NCT00063024|Bone health|bone health
1697348|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
1697349|NCT00063024|Calcium|calcium
1697350|NCT00063011|Weight-bearing exercise|weight-bearing exercise
1697351|NCT00063011|Calcium-rich diet|calcium-rich diet
1697352|NCT00063011|Adolescents|adolescents
1697353|NCT00063011|Females|females
1697354|NCT00063011|Bone mass|bone mass
1697355|NCT00063011|Osteopenia|osteopenia
1697356|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1697357|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1697358|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1697359|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1697360|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1697361|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1697362|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
1697363|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1697364|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697365|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697366|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1697367|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697368|NCT00062985|obesity treatment|obesity treatment
1697369|NCT00062985|weight management|weight management
1697370|NCT00062985|managed care|managed care
1697371|NCT00062972|Multiple Sclerosis|multiple sclerosis
1697372|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
1697373|NCT00062972|Treatment Interventions|treatment interventions
1697374|NCT00062972|Verbal memory deficits|verbal memory deficits
1697375|NCT00062959|Adolescence|adolescence
1697376|NCT00062959|Parenting|parenting
1697377|NCT00062959|School|school
1697378|NCT00062959|Primary Prevention|primary prevention
1697379|NCT00062959|School-based intervention|school-based intervention
1697380|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1697381|NCT00062894|BEXXAR|bexxar
1697382|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1697383|NCT00062946|Thalamus|thalamus
1697384|NCT00062946|Cerebral Cortices|cerebral cortices
1697385|NCT00062946|Quantification|quantification
1697386|NCT00062946|Reproducibility|reproducibility
1697387|NCT00062946|Dopamine Release|dopamine release
1697388|NCT00062946|(18F) Fallypride|(18f) fallypride
1697389|NCT00062946|D-Amphetamine|d-amphetamine
1697390|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
1697391|NCT00062946|PET|pet
1697392|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
1697393|NCT00062946|Healthy Volunteer|healthy volunteer
1697394|NCT00062946|HV|hv
1697395|NCT00062933|Clinical Response|clinical response
1697396|NCT00062933|Duration of Response|duration of response
1697397|NCT00062933|Quality of Life|quality of life
1697398|NCT00062933|Hyperthermia|hyperthermia
1697399|NCT00062933|Survival|survival
1697400|NCT00062933|Melanoma|melanoma
1697401|NCT00062933|Ocular Melanoma|ocular melanoma
1697402|NCT00062933|Eye Cancer|eye cancer
1697403|NCT00062881|Cancer|cancer
1697404|NCT00062881|Leukemia|leukemia
1697408|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
1697409|NCT00062868|Severe Chronic EBV|severe chronic ebv
1697410|NCT00062868|LMP1/2|lmp1/2
1697411|NCT00062868|CTL|ctl
1697412|NCT00062868|EBV|ebv
1697413|NCT00062868|Relapse|relapse
1697414|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
1697415|NCT00062855|Gene Therapy|gene therapy
1697416|NCT00062829|Teen driving|teen driving
1697417|NCT00062829|Adolescent risk behavior|adolescent risk behavior
1697418|NCT00062829|Parenting|parenting
1697419|NCT00062829|Checkpoints Program|checkpoints program
1697420|NCT00062829|Health Education|health education
1697421|NCT00062816|Hepatitis|hepatitis
1697422|NCT00062816|Chronic|chronic
1697423|NCT00002643|neutropenia|neutropenia
1697424|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1697425|NCT00062790|Testosterone|testosterone
1697426|NCT00062790|DHT|dht
1697427|NCT00062790|TURP|turp
1697428|NCT00027612|adult glioblastoma|adult glioblastoma
1697429|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
1697430|NCT00027612|adult gliosarcoma|adult gliosarcoma
1697431|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
1697432|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
1697433|NCT00023868|stage IV colon cancer|stage iv colon cancer
1697434|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
1697435|NCT00023868|recurrent colon cancer|recurrent colon cancer
1697436|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
1697437|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
1697438|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1697439|NCT00023868|liver metastases|liver metastases
1697440|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1697441|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1697442|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1697443|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1697444|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1697445|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1697446|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1697447|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1697448|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1697449|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1697450|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1697451|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1697452|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1697453|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1697454|NCT00062777|Genetics|genetics
1697455|NCT00062777|Populations|populations
1697456|NCT00062777|CVD Risk|cvd risk
1697457|NCT00062777|Gene Mapping|gene mapping
1697458|NCT00062777|Epidemiology|epidemiology
1697459|NCT00062777|Framingham Study|framingham study
1697460|NCT00062777|Vascular Diseases|vascular diseases
1697461|NCT00062764|Insulin Resistance|insulin resistance
1697462|NCT00062764|Obesity|obesity
1697463|NCT00062764|Fatty Liver|fatty liver
1697464|NCT00062764|Cirrhosis|cirrhosis
1697465|NCT00062764|Diabetes|diabetes
1697466|NCT00062764|Pioglitazone|pioglitazone
1697467|NCT00062764|Thiazolidinediones|thiazolidinediones
1697468|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
1697469|NCT00062764|PPAR Gama|ppar gama
1697470|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1697471|NCT00062764|Hepatitis|hepatitis
1697472|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1697473|NCT00062764|NASH|nash
1697476|NCT00062738|Parkinson's disease|parkinson's disease
1697477|NCT00062738|Parkinson disease|parkinson disease
1697478|NCT00062738|depression|depression
1697479|NCT00062738|antidepressants|antidepressants
1697480|NCT00062738|nortriptyline|nortriptyline
1697481|NCT00062738|paroxetine|paroxetine
1697482|NCT00062712|Immunosuppression|immunosuppression
1697483|NCT00062712|Transplant|transplant
1697484|NCT00062712|Kidney Transplant|kidney transplant
1697485|NCT00062686|Lapatinib|lapatinib
1697486|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
1697487|NCT00062686|HERCEPTIN refractory|herceptin refractory
1697488|NCT00062634|Female condom use|female condom use
1697489|NCT00062634|Male condom use|male condom use
1697490|NCT00062634|AIDS education|aids education
1697491|NCT00062634|AIDS prevention|aids prevention
1697492|NCT00062634|HIV Seronegativity|hiv seronegativity
1697493|NCT00062621|Immune tolerance|immune tolerance
1697494|NCT00062621|Graft vs host disease|graft vs host disease
1697495|NCT00062621|Kidney Failure|kidney failure
1697496|NCT00062621|Kidney diseases|kidney diseases
1697497|NCT00062621|End Stage Renal Disease|end stage renal disease
1697498|NCT00062621|Multiple Myeloma|multiple myeloma
1697499|NCT00062621|Bone Marrow Transplant|bone marrow transplant
1697500|NCT00062621|Kidney Transplant|kidney transplant
1697501|NCT00062621|Renal Transplant|renal transplant
1697502|NCT00062621|Tolerance|tolerance
1697503|NCT00062621|Chimerism|chimerism
1697504|NCT00062621|ESRD|esrd
1697505|NCT00062608|Abdominal|abdominal
1697506|NCT00062595|Menopause|menopause
1697507|NCT00062595|Vitamin K|vitamin k
1697508|NCT00062595|Bone turnover|bone turnover
1697509|NCT00062595|Bone Density|bone density
1697510|NCT00062569|Alzheimer disease|alzheimer disease
1697511|NCT00062569|Resistiveness to baths|resistiveness to baths
1697512|NCT00062569|Caregiver stress|caregiver stress
1697513|NCT00062569|Bathing support intervention|bathing support intervention
1697514|NCT00062569|Reminiscence|reminiscence
1697515|NCT00062569|Agitated behavior|agitated behavior
1697516|NCT00062569|Resistiveness to care|resistiveness to care
1697517|NCT00062556|Intermittent Claudication|intermittent claudication
1697518|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
1697519|NCT00062556|Atherosclerosis|atherosclerosis
1697520|NCT00062556|Niacin|niacin
1697521|NCT00062556|Lovastatin|lovastatin
1697523|NCT00062556|IC|ic
1697524|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
1697525|NCT00062543|Stem Cell Transplantation|stem cell transplantation
1697526|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
1697527|NCT00062543|Liver Diseases|liver diseases
1697528|NCT00062543|CD34+ Cells|cd34+ cells
1697529|NCT00062543|SCT|sct
1697530|NCT00062530|AIDS|aids
1697531|NCT00062530|HIV seronegativity|hiv seronegativity
1697532|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
1697533|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697534|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1697535|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1697536|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1697537|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1697538|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1697539|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1698292|NCT00019734|stage IV melanoma|stage iv melanoma
1697540|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1697541|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1697542|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1697543|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1697544|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1697545|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1697546|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1697547|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1697548|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1697549|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1697550|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1697551|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1697552|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1697553|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1697554|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1697555|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1697556|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1697557|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1697558|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1697559|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1697560|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1697561|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1697562|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1697563|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1697564|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1697565|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1697566|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1697567|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1697568|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1697569|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1697570|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1697766|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
1697571|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1697572|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1697573|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1697574|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1697575|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1697576|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1697577|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1697578|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1697579|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1697580|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1697581|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1697582|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1697583|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1697584|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1697585|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1697586|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1697587|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1697588|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1697589|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1697590|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1697591|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1697592|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1697593|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1697594|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1697595|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697596|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1697597|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1697598|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1697599|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1697600|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1697601|NCT00017316|stage IV melanoma|stage iv melanoma
1697602|NCT00017316|recurrent melanoma|recurrent melanoma
1697603|NCT00062582|Roflumilast|roflumilast
1697604|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
1697605|NCT00062582|COPD|copd
1697606|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1697607|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1697608|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1697609|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697610|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697611|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697612|NCT00014534|stage III bladder cancer|stage iii bladder cancer
1697613|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
1697614|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1697615|NCT00062517|Amygdala|amygdala
1697616|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
1697617|NCT00062517|Anxiety Disorder|anxiety disorder
1697618|NCT00062517|GAD|gad
1697619|NCT00062517|Social Anxiety Disorder|social anxiety disorder
1697620|NCT00062517|SAD|sad
1697621|NCT00012155|stage IV colon cancer|stage iv colon cancer
1697622|NCT00012155|recurrent colon cancer|recurrent colon cancer
1697623|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
1697624|NCT00012155|liver metastases|liver metastases
1697625|NCT00062465|DMARD|dmard
1697626|NCT00062465|Clinical Trial|clinical trial
1697627|NCT00062465|Thunder God Vine|thunder god vine
1697628|NCT00062465|Chinese Herb|chinese herb
1697629|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
1697630|NCT00062465|RA|ra
1697631|NCT00062452|Esophageal|esophageal
1697632|NCT00062452|Airway|airway
1697633|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1697634|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697635|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1697636|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
1697637|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1697638|NCT00062426|recurrent colon cancer|recurrent colon cancer
1697639|NCT00062426|stage IV colon cancer|stage iv colon cancer
1697640|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
1697641|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
1697642|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
1697643|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
1697644|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1697645|NCT00062400|stage II breast cancer|stage ii breast cancer
1697646|NCT00062400|stage IA breast cancer|stage ia breast cancer
1697647|NCT00062400|stage IB breast cancer|stage ib breast cancer
1697648|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1697649|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1697650|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1697651|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1697652|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1697653|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1697654|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1697655|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1697656|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1697657|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1697658|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1697659|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1697660|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1697661|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1697662|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
1697663|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1697664|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
1697665|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1697666|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1697667|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1697668|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1697669|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1698293|NCT00019734|recurrent melanoma|recurrent melanoma
1697670|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1697671|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1697672|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1697673|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1697674|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1697675|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1697676|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1697677|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1697678|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
1697679|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1697680|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1697681|NCT00062348|stage IVA colon cancer|stage iva colon cancer
1697682|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
1697683|NCT00062348|recurrent colon cancer|recurrent colon cancer
1697684|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
1697685|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
1697686|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
1697687|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
1697688|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1697689|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
1699747|NCT00059618|Carboplatin|carboplatin
1697690|NCT00062348|insular thyroid cancer|insular thyroid cancer
1697691|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1697692|NCT00062348|liver metastases|liver metastases
1697693|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1697694|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1697695|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1697696|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1697697|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1697698|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1697699|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1697700|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1697701|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1697702|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1697703|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1697704|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1697705|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1697706|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1697707|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1697708|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1697709|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1697710|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1697711|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
1697712|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
1697713|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
1697714|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
1697715|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
1697716|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1697717|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1697718|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
1697719|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1697720|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
1697721|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
1697722|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
1697723|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
1697724|NCT00062348|tongue cancer|tongue cancer
1697725|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1697726|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1697727|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697728|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
1697729|NCT00062309|stage II prostate cancer|stage ii prostate cancer
1697730|NCT00062309|stage III prostate cancer|stage iii prostate cancer
1697731|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1697732|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1697733|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1697734|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697735|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1697736|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1697737|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1697738|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1697739|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1697740|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1697741|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1697742|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1697743|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1697744|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697745|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697746|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697747|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1697748|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1697749|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
1697750|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1697751|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
1697752|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
1697753|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1697754|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1697755|NCT00062283|chondrosarcoma|chondrosarcoma
1697756|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1697757|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1697758|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1697759|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1697760|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
1697761|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1697762|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1697763|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
1697764|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697765|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1715529|NCT00001232|Menopause|menopause
1697767|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
1697768|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1697769|NCT00062231|infection|infection
1697770|NCT00062231|neutropenia|neutropenia
1697771|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1697772|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1697773|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1697774|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1697775|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1697776|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1697777|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1697778|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1697779|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1697780|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1697781|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1697782|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1697783|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1697784|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1697785|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
1697786|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
1697787|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1697788|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1697789|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
1697790|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
1697791|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
1697792|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1697793|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1697794|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1697795|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1697796|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1697797|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1697798|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1697799|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1697800|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1697801|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1697802|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1697803|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1697804|NCT00062231|polycythemia vera|polycythemia vera
1697805|NCT00062231|primary myelofibrosis|primary myelofibrosis
1697806|NCT00062231|essential thrombocythemia|essential thrombocythemia
1697807|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1697808|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
1697809|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1697810|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1697811|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1697812|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1697813|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1697814|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1697815|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1697816|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1697817|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1697818|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1697819|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1697820|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1698006|NCT00062023|stage II colon cancer|stage ii colon cancer
1697821|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1697822|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1697823|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1697824|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1697825|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1697826|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1697827|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1697828|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1697829|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1697830|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1697831|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1697832|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1697833|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1697834|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1697835|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697836|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1697837|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1697838|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1697839|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1697840|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1697841|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1697842|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1697843|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1697844|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1697845|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1697846|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1697847|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1697848|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1697849|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1697850|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1697851|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1697852|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1697853|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1697854|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1697855|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
1697856|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1697857|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1697858|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1697859|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1697860|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1697861|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1697862|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1697863|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1697864|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1697865|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1697866|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1697867|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1697868|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1697869|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1697870|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
1697871|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
1697872|NCT00062231|intraocular lymphoma|intraocular lymphoma
1697873|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1697874|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1697875|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1697876|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1697877|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1697878|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1697879|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1697880|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1697881|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1697882|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1697883|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1697884|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1697885|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1697886|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1697887|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1697888|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1697889|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1697890|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1697891|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1697892|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1697893|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1697894|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1697895|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1697896|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1697897|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1697898|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1697899|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1697900|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697901|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1697902|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1697903|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697904|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697905|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1697906|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1697907|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1697908|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1697909|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1697910|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1697911|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1697912|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1697913|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1697914|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1697915|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1697916|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1697917|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1697918|NCT00062166|Imaging Studies|imaging studies
1697919|NCT00062166|Rate of Tumor Growth|rate of tumor growth
1697920|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
1697921|NCT00062166|Surgical Resection|surgical resection
1697922|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697923|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1697924|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1697925|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1697926|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1698289|NCT00061295|Body Weight Supported Walking|body weight supported walking
1697927|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1697928|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1697929|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1697930|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1697931|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1697932|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1697933|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1697934|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1697935|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1697936|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1697937|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1697938|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1697939|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1697940|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1697941|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1697942|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1697943|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1698550|NCT00061022|Hemorrhage|hemorrhage
1697944|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1697945|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1697946|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1697947|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1697948|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1697949|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1697950|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1697951|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1697952|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1697953|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1697954|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1698021|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1697955|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1697956|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1697957|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1697958|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1697959|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1697960|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1697961|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1697962|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1697963|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1697964|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1697965|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1697966|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1697967|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1697968|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1697969|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1697970|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1697971|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1697972|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1697973|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1697974|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1697975|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1697976|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1697977|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1697978|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1697979|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1697980|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1697981|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1697982|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1697983|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1697984|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1697985|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1697986|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1697987|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1698290|NCT00045149|recurrent melanoma|recurrent melanoma
1697988|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1697989|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1697990|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1697991|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1697992|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1697993|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1697994|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1697995|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1697996|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1697997|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1697998|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1697999|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1698000|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1698001|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698002|NCT00062036|stage IV melanoma|stage iv melanoma
1698003|NCT00062036|recurrent melanoma|recurrent melanoma
1698004|NCT00062023|colorectal cancer|colorectal cancer
1698005|NCT00062023|stage I colon cancer|stage i colon cancer
1698007|NCT00062023|stage III colon cancer|stage iii colon cancer
1698008|NCT00062023|stage IV colon cancer|stage iv colon cancer
1698009|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
1698010|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
1698011|NCT00061997|small cell lung cancer|small cell lung cancer
1698012|NCT00061997|precancerous condition|precancerous condition
1698013|NCT00061984|adult angiosarcoma|adult angiosarcoma
1698014|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
1698015|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
1698016|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
1698017|NCT00061984|adult liposarcoma|adult liposarcoma
1698018|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1698019|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
1698020|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1715637|NCT00050388|Lip cancer|lip cancer
1698022|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
1698023|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1698024|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1698025|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1698026|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
1698027|NCT00061906|insular thyroid cancer|insular thyroid cancer
1698028|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
1698029|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
1698030|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
1698031|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1698032|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1698033|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1698034|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1698035|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1698036|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1698037|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1698038|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1698039|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1698040|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1698041|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1698042|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1698043|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1698044|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1698045|NCT00061867|stage III prostate cancer|stage iii prostate cancer
1698046|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
1698047|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1698048|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1698049|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1698050|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1698051|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1698052|NCT00010231|stage III prostate cancer|stage iii prostate cancer
1698053|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
1698054|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
1698055|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1698056|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
1698294|NCT00061373|Alteplase|alteplase
1698057|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1698058|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1698059|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1698060|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698061|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698062|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1698063|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
1698064|NCT00009789|large cell lung cancer|large cell lung cancer
1698065|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
1698066|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1698067|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1698068|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1698069|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1698070|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1698071|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1698072|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1698073|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1698074|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
1698075|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
1698076|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
1698077|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
1698078|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
1698079|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1698080|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1698081|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1698082|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1698083|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1698084|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1698085|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1698086|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1698087|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1698237|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
1698088|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1698089|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1698090|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1698091|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1698092|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
1698093|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
1698094|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1698095|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1698096|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1698097|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1698098|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1698099|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1698100|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1698101|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1698102|NCT00008398|oral complications|oral complications
1698103|NCT00008398|radiation toxicity|radiation toxicity
1698104|NCT00008203|stage II breast cancer|stage ii breast cancer
1698105|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
1698106|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
1698107|NCT00008112|stage III cervical cancer|stage iii cervical cancer
1698108|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
1698109|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
1698110|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1698111|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
1698112|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1698113|NCT00061789|Schizophrenia|schizophrenia
1698114|NCT00061789|SPECT|spect
1698115|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
1698116|NCT00061789|Cigarette Smoking|cigarette smoking
1698117|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
1698118|NCT00061789|Reproducibility|reproducibility
1698119|NCT00061789|Quantification|quantification
1698120|NCT00061789|Healthy Volunteer|healthy volunteer
1698122|NCT00061776|Dermal assessment|dermal assessment
1698123|NCT00061776|Pain measurement|pain measurement
1698124|NCT00061776|Diary|diary
1698125|NCT00061776|Shingles|shingles
1698126|NCT00061776|Neuropathy|neuropathy
1698127|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
1698128|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1698129|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
1698130|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
1698131|NCT00061776|Pain|pain
1698132|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
1698133|NCT00061763|beta-thalassemia|beta-thalassemia
1698134|NCT00061763|iron overload|iron overload
1698135|NCT00061763|deferoxamine|deferoxamine
1698136|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
1698137|NCT00061763|Fanconi Syndrome|fanconi syndrome
1698138|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
1698139|NCT00061763|Anemia, Aplastic|anemia, aplastic
1698140|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
1698141|NCT00061737|Pediatric IBD|pediatric ibd
1698142|NCT00061737|Inflammatory|inflammatory
1698143|NCT00061737|Bowel|bowel
1698144|NCT00061724|Esophageal|esophageal
1698145|NCT00061724|Reflux|reflux
1698146|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1698147|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
1698148|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
1698149|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
1698150|NCT00051714|Social Behavior Disorders|social behavior disorders
1698151|NCT00061620|Investigational|investigational
1698152|NCT00061620|Chemotherapy|chemotherapy
1698153|NCT00061620|Hematologic Malignancies|hematologic malignancies
1698154|NCT00061620|Nucleoside analogue|nucleoside analogue
1698155|NCT00059462|Treatment experienced|treatment experienced
1698156|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1698157|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1698158|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1698159|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1698160|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1698161|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1698162|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1698163|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1698164|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1698165|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1698166|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1698238|NCT00061568|Donor Apheresis|donor apheresis
1698167|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1698168|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1698169|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1698170|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1698171|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
1698172|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
1698173|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1698174|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1698175|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
1698176|NCT00006484|large cell lung cancer|large cell lung cancer
1698177|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1698178|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1698179|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
1698180|NCT00061607|Motor Neuron Disease|motor neuron disease
1698181|NCT00061607|Neuromuscular Disease|neuromuscular disease
1698182|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
1698183|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
1698185|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
1698186|NCT00061542|Glaucoma|glaucoma
1698187|NCT00061542|Ocular Hypertension|ocular hypertension
1698188|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
1698189|NCT00061529|Ocular Hypertension|ocular hypertension
1698190|NCT00061516|Glaucoma|glaucoma
1698191|NCT00061516|Ocular Hypertension|ocular hypertension
1698192|NCT00061503|Glaucoma|glaucoma
1698193|NCT00061503|Ocular Hypertension|ocular hypertension
1698194|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698195|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
1698196|NCT00006457|small cell lung cancer|small cell lung cancer
1698197|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1698198|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1698199|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1698200|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1698201|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
1698202|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1698203|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1698204|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1698205|NCT00006361|recurrent skin cancer|recurrent skin cancer
1698206|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1698207|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1698291|NCT00045149|stage IV melanoma|stage iv melanoma
1698208|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1698209|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1698210|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1698211|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1698212|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1698213|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1698214|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1698215|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1698216|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1698217|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1698218|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1698219|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1698220|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1698221|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1698222|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1698223|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1698224|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1698225|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1698226|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1698227|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
1698228|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1698229|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
1698230|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
1698231|NCT00061581|Cyclosporine|cyclosporine
1698232|NCT00061581|Fludarabine|fludarabine
1698233|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
1698234|NCT00061568|Stem Cell Transplant|stem cell transplant
1698235|NCT00061568|Low Dose Radiation|low dose radiation
1698236|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
1698239|NCT00061568|Graft-Versus-Host Disease|graft-versus-host disease
1698240|NCT00061568|Graft-Versus-Marrow|graft-versus-marrow
1698241|NCT00061568|Host-Donor Chimerism|host-donor chimerism
1698242|NCT00061568|Peripheral Blood Stem Cells|peripheral blood stem cells
1698243|NCT00061568|Low Dose Irradiation|low dose irradiation
1698244|NCT00061568|Sickle Cell Anemia|sickle cell anemia
1698246|NCT00061568|Thalassemia|thalassemia
1698247|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
1698248|NCT00061568|DBA|dba
1698249|NCT00061490|Osteoarthritis|osteoarthritis
1698250|NCT00061490|Arthritis|arthritis
1698251|NCT00061490|Weight Loss|weight loss
1698252|NCT00006349|depression|depression
1698253|NCT00006349|delirium|delirium
1698254|NCT00006349|cognitive/functional effects|cognitive/functional effects
1698255|NCT00006349|radiation toxicity|radiation toxicity
1698256|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
1698257|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1698258|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
1698259|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1698260|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1698261|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1698262|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
1698263|NCT00061438|pancreatic infection|pancreatic infection
1698264|NCT00061438|peripancreatic infection|peripancreatic infection
1698265|NCT00061425|NHL|nhl
1698266|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
1698267|NCT00061412|Low reading and writing achievement|low reading and writing achievement
1698268|NCT00061412|At-risk students|at-risk students
1698269|NCT00061412|Reading Disability|reading disability
1698270|NCT00061412|Writing Disability|writing disability
1698271|NCT00061399|TBI|tbi
1698272|NCT00061399|Prospective memory|prospective memory
1698273|NCT00061386|Postpartum|postpartum
1698274|NCT00061386|Low income|low income
1698275|NCT00061386|Diet|diet
1698276|NCT00061386|Physical activity|physical activity
1698277|NCT00061321|Nevirapine|nevirapine
1698278|NCT00061321|Pregnancy|pregnancy
1698279|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
1698280|NCT00061321|Infant|infant
1698281|NCT00061321|Breastfeeding|breastfeeding
1698282|NCT00061321|HIV Seronegativity|hiv seronegativity
1698283|NCT00061308|Ovarian cancer|ovarian cancer
1698284|NCT00061308|peritoneal cancer|peritoneal cancer
1698285|NCT00061308|cancer|cancer
1698286|NCT00061308|Fallopian cancer|fallopian cancer
1698287|NCT00061295|Locomotion|locomotion
1698288|NCT00061295|Spinal Cord Injury|spinal cord injury
1698295|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
1698296|NCT00061373|Reperfusion therapy|reperfusion therapy
1698297|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
1698298|NCT00061373|Clinical Trial|clinical trial
1698299|NCT00061373|Tinzaparin|tinzaparin
1698300|NCT00061373|Eptifibatide|eptifibatide
1698301|NCT00061373|Ischemic Stroke|ischemic stroke
1698302|NCT00061360|Bone Marrow Failure|bone marrow failure
1698303|NCT00061360|Cyclosporine|cyclosporine
1698304|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
1698305|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
1698306|NCT00061347|Fiducial Marker|fiducial marker
1698307|NCT00061347|MRI|mri
1698308|NCT00061347|Prostate Cancer|prostate cancer
1698309|NCT00061347|Radiation|radiation
1698310|NCT00061334|Attitudes|attitudes
1698311|NCT00061334|fMRI|fmri
1698312|NCT00061334|Development|development
1698313|NCT00061334|Stereotypes|stereotypes
1698314|NCT00061334|Memory|memory
1698315|NCT00061334|Healthy Volunteer|healthy volunteer
1698316|NCT00061334|HV|hv
1698317|NCT00061282|Pouchitis|pouchitis
1698318|NCT00061282|Colitis|colitis
1698319|NCT00061282|Ileitis|ileitis
1698320|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1698321|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1698322|NCT00019175|stage IV melanoma|stage iv melanoma
1698323|NCT00019175|recurrent melanoma|recurrent melanoma
1698324|NCT00002786|stage IV melanoma|stage iv melanoma
1698325|NCT00002786|recurrent melanoma|recurrent melanoma
1698326|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
1698327|NCT00061256|Bone Mineral Density|bone mineral density
1698328|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
1698329|NCT00061256|Treatment Experienced|treatment experienced
1698330|NCT00061243|HIV|hiv
1698331|NCT00061243|Vaccine|vaccine
1698332|NCT00061243|DNA prime|dna prime
1698333|NCT00061243|Protein boost|protein boost
1698334|NCT00061243|HIV Seronegativity|hiv seronegativity
1698335|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
1698336|NCT00061230|Relaxation training|relaxation training
1698337|NCT00061217|Transtibial amputees|transtibial amputees
1698338|NCT00061217|Rectified sockets|rectified sockets
1698339|NCT00061217|Unrectified sockets|unrectified sockets
1698340|NCT00061217|Gait|gait
1698341|NCT00061217|Energy expenditure|energy expenditure
1698342|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
1698343|NCT00061165|obesity|obesity
1698347|NCT00061165|African American|african american
1698348|NCT00061165|diet|diet
1698349|NCT00061165|nutrition|nutrition
1698350|NCT00061165|physical activity|physical activity
1698351|NCT00061165|Chicago|chicago
1698352|NCT00019084|stage IV colon cancer|stage iv colon cancer
1698353|NCT00019084|stage IV breast cancer|stage iv breast cancer
1698354|NCT00019084|recurrent breast cancer|recurrent breast cancer
1698355|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1698356|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
1698357|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
1698358|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
1698359|NCT00019084|recurrent colon cancer|recurrent colon cancer
1698360|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
1698361|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
1698362|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1698363|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1698364|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1698365|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
1698366|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1698367|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
1698368|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
1698369|NCT00004868|adult meningioma|adult meningioma
1698370|NCT00004868|adult glioblastoma|adult glioblastoma
1698371|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1698372|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1698373|NCT00004868|adult mixed glioma|adult mixed glioma
1698374|NCT00004868|adult grade III meningioma|adult grade iii meningioma
1698375|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
1698376|NCT00004868|adult gliosarcoma|adult gliosarcoma
1698377|NCT00003408|stage IV breast cancer|stage iv breast cancer
1698378|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1698379|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1698380|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1698381|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
1698382|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1698383|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1698384|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1698385|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1698520|NCT00061126|PSA|psa
1698386|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1698387|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
1698388|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
1698389|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1698390|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
1698391|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
1698392|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
1698393|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1698394|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1698395|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1698396|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1698397|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1698398|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1698399|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1698400|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1698401|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1698402|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1698403|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1698404|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1698405|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1698406|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1698407|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1698408|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1698409|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
1698410|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
1698411|NCT00003408|testicular teratoma|testicular teratoma
1698412|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
1698413|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1698414|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1698415|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1698416|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1698417|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1698418|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1698419|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1698420|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1698421|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1698422|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1698423|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1698424|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
1698425|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1698426|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1698427|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
1698428|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1698429|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
1698430|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
1698431|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
1698432|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
1698433|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1698434|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1698435|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1698436|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1698437|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1698438|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1698439|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1698440|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1698441|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1698442|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1698443|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1698444|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1698445|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1698446|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1698447|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1698448|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1698449|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1698450|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1716005|NCT00048204|Psychiatry|psychiatry
1698451|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1698452|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1698453|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1698454|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1698455|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1698456|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1698457|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1698458|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1698459|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1698460|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1698461|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1698462|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1698463|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1698464|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1698465|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1698466|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1698467|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1698468|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1698469|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1698470|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1698471|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1698472|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1698473|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1698474|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1698475|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1698476|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1698477|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1698478|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1698479|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1698480|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1698481|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1698482|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1698483|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1698484|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1698485|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1698486|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1698487|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1698488|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1698489|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1698490|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1698491|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1698492|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1698493|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1698494|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1698495|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1698496|NCT00061204|fMRI|fmri
1698497|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
1698498|NCT00061204|Prefrontal Cortex|prefrontal cortex
1698499|NCT00061204|Temporal Lobes|temporal lobes
1698500|NCT00061204|Methodology|methodology
1698501|NCT00061204|Healthy Volunteer|healthy volunteer
1698502|NCT00061204|HV|hv
1698503|NCT00061152|Pain Measurement|pain measurement
1698504|NCT00061152|Diary|diary
1698505|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
1698506|NCT00061152|HIV Neuropathy|hiv neuropathy
1698507|NCT00061152|Capsaicin|capsaicin
1698508|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
1698509|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1698510|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
1698511|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
1698512|NCT00061152|Pain|pain
1698513|NCT00061139|Cerebral palsy|cerebral palsy
1698514|NCT00061139|Hemiparesis|hemiparesis
1698515|NCT00061139|Pediatric CI therapy|pediatric ci therapy
1698516|NCT00061139|Upper extremity|upper extremity
1698517|NCT00061139|Training|training
1698518|NCT00061139|Limb restraint|limb restraint
1698519|NCT00061126|Prostate Cancer|prostate cancer
1698521|NCT00061126|Hormone refractory|hormone refractory
1698522|NCT00061126|Rising PSA|rising psa
1698523|NCT00061113|alcohol dependence|alcohol dependence
1698524|NCT00061113|marijuana dependence|marijuana dependence
1698525|NCT00061100|HIV|hiv
1698526|NCT00061100|methadone maintenance|methadone maintenance
1698527|NCT00061087|ADHD|adhd
1698528|NCT00061087|Cocaine|cocaine
1698529|NCT00061087|Treatment|treatment
1698530|NCT00061087|Methadone|methadone
1698531|NCT00061074|Smoking|smoking
1698532|NCT00061061|Tobacco Cessation|tobacco cessation
1698533|NCT00061061|Postmenopausal Women|postmenopausal women
1698534|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
1698535|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1698536|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698537|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1698538|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
1698539|NCT00061048|Monoclonal Antibody|monoclonal antibody
1698540|NCT00061048|HTLV-1|htlv-1
1698541|NCT00061048|CD52|cd52
1698542|NCT00061048|Flow Cytometry|flow cytometry
1698543|NCT00061048|Antibody Saturation|antibody saturation
1698544|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
1698546|NCT00061022|Stroke|stroke
1698547|NCT00061022|cerebral vascular accident|cerebral vascular accident
1698548|NCT00061022|CVA|cva
1698549|NCT00061022|Ischemia|ischemia
1698552|NCT00061022|Transient Ischemic Attack|transient ischemic attack
1698553|NCT00061022|Brain Attack|brain attack
1698554|NCT00061022|Cataplexy|cataplexy
1698555|NCT00006046|stage IV colon cancer|stage iv colon cancer
1698556|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
1698557|NCT00006046|recurrent colon cancer|recurrent colon cancer
1698558|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
1698559|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
1698560|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
1698561|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1698562|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
1698563|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
1698564|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1698565|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1698566|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1698567|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1698568|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1698569|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1698570|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1698571|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1698572|NCT00005971|stage IV melanoma|stage iv melanoma
1698573|NCT00005956|stage II breast cancer|stage ii breast cancer
1698574|NCT00005956|stage IV breast cancer|stage iv breast cancer
1698575|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
1698576|NCT00005956|stage II gastric cancer|stage ii gastric cancer
1698577|NCT00005956|stage III gastric cancer|stage iii gastric cancer
1698578|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
1698579|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
1698580|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1698581|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1698582|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1698583|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
1698584|NCT00061009|Dysautonomia|dysautonomia
1698585|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
1698586|NCT00061009|Neurocardiogenic|neurocardiogenic
1698587|NCT00061009|Syncope|syncope
1698588|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
1698589|NCT00061009|COI|coi
1698590|NCT00061009|POTS|pots
1698591|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
1698592|NCT00061009|NCS|ncs
1698593|NCT00061009|Healthy Volunteer|healthy volunteer
1698594|NCT00061009|HV|hv
1698595|NCT00060996|Critical Limb Ischemia|critical limb ischemia
1698596|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
1698597|NCT00060996|UT-15|ut-15
1698598|NCT00060996|Remodulin|remodulin
1698599|NCT00060996|treprostinil|treprostinil
1698600|NCT00005813|adult glioblastoma|adult glioblastoma
1698601|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
1698602|NCT00005813|adult gliosarcoma|adult gliosarcoma
1698603|NCT00060983|Locomotion|locomotion
1698604|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
1698605|NCT00060983|Body weight support (BWS)|body weight support (bws)
1698606|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
1698607|NCT00060983|Gait|gait
1698608|NCT00060983|Treadmill training|treadmill training
1698609|NCT00060983|Physical Therapy|physical therapy
1698610|NCT00060970|Disuse atrophy|disuse atrophy
1698611|NCT00060970|Ankle fracture|ankle fracture
1698612|NCT00060970|Exercise, therapy|exercise, therapy
1698613|NCT00060970|Cast immobilization|cast immobilization
1698614|NCT00060970|Deconditioning|deconditioning
1698615|NCT00060970|Sarcopenia|sarcopenia
1698616|NCT00060957|Cerebral Palsy|cerebral palsy
1698617|NCT00060957|Spasticity|spasticity
1698618|NCT00060957|Botulinum toxin|botulinum toxin
1698619|NCT00060957|BOTOX|botox
1698620|NCT00060944|Trabectedin|trabectedin
1698621|NCT00060944|Yondelis|yondelis
1698622|NCT00060944|ET-743|et-743
1698623|NCT00060944|Ecteinascidin|ecteinascidin
1698624|NCT00060944|Anthracycline|anthracycline
1698625|NCT00060944|Ifosfamide|ifosfamide
1698626|NCT00060944|Dexamethasone|dexamethasone
1698627|NCT00060944|Intravenous|intravenous
1698628|NCT00060944|Cancer|cancer
1698629|NCT00060944|Malignant|malignant
1698630|NCT00060944|Metastatic|metastatic
1698631|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
1698632|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1698633|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1698634|NCT00005588|stage I breast cancer|stage i breast cancer
1698635|NCT00005588|stage II breast cancer|stage ii breast cancer
1698636|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
1698637|NCT00005587|stage I breast cancer|stage i breast cancer
1698638|NCT00005587|stage II breast cancer|stage ii breast cancer
1698639|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
1698640|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1698724|NCT00004911|quality of life|quality of life
1698641|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1698642|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1698643|NCT00003203|regional neuroblastoma|regional neuroblastoma
1698644|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
1698645|NCT00060931|hypertension|hypertension
1698646|NCT00060931|beta-blockers|beta-blockers
1698647|NCT00060931|Type 2 diabetes|type 2 diabetes
1698648|NCT00060918|Type 2 diabetes|type 2 diabetes
1698649|NCT00060918|hypertension|hypertension
1698650|NCT00060918|beta-blockers|beta-blockers
1698651|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
1698652|NCT00060892|Critical Limb Ischemia|critical limb ischemia
1698653|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
1698654|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1698655|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1698656|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
1698657|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
1698658|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
1698659|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
1698660|NCT00060866|Neurocardiogenic|neurocardiogenic
1698661|NCT00060866|Dysautonomia|dysautonomia
1698662|NCT00060866|Autonomic Nervous System|autonomic nervous system
1698663|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
1698664|NCT00060866|NCS|ncs
1698665|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
1698666|NCT00060866|SAI|sai
1698667|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
1698668|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
1698669|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
1698670|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
1698671|NCT00060853|Amygdala|amygdala
1698672|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
1698673|NCT00060853|Emotion|emotion
1698674|NCT00060853|Cognition|cognition
1698675|NCT00060853|Theory of Mind|theory of mind
1698676|NCT00060853|Healthy Volunteer|healthy volunteer
1698677|NCT00060853|HV|hv
1698678|NCT00060801|Cystic Fibrosis|cystic fibrosis
1698679|NCT00060801|BIIL 284|biil 284
1698680|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
1698681|NCT00060788|Antisocial behavior|antisocial behavior
1698682|NCT00060788|Mauritius Child Health Project|mauritius child health project
1698683|NCT00060788|Intergenerational transmission|intergenerational transmission
1698684|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1698685|NCT00004928|stage I prostate cancer|stage i prostate cancer
1698686|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
1698687|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
1698688|NCT00004928|stage III prostate cancer|stage iii prostate cancer
1698689|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
1698690|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
1698691|NCT00004925|stage IV breast cancer|stage iv breast cancer
1698692|NCT00004925|recurrent breast cancer|recurrent breast cancer
1698693|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
1698694|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
1698695|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1698696|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1698697|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1698698|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1698699|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1698700|NCT00004911|stage I colon cancer|stage i colon cancer
1698701|NCT00004911|stage II colon cancer|stage ii colon cancer
1698702|NCT00004911|stage III colon cancer|stage iii colon cancer
1698703|NCT00004911|stage IV colon cancer|stage iv colon cancer
1698704|NCT00004911|stage I gastric cancer|stage i gastric cancer
1698705|NCT00004911|stage II gastric cancer|stage ii gastric cancer
1698706|NCT00004911|stage III gastric cancer|stage iii gastric cancer
1698707|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
1698708|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
1698709|NCT00004911|stage I rectal cancer|stage i rectal cancer
1698710|NCT00004911|stage II rectal cancer|stage ii rectal cancer
1698711|NCT00004911|stage III rectal cancer|stage iii rectal cancer
1698712|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
1698713|NCT00004911|recurrent colon cancer|recurrent colon cancer
1698714|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
1698715|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1698716|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1698717|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1698718|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1698719|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
1698720|NCT00004911|small intestine lymphoma|small intestine lymphoma
1698721|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1698722|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
1698723|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1698725|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1698726|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
1698727|NCT00060775|fMRI|fmri
1698728|NCT00060775|Emotion|emotion
1698729|NCT00060775|Children|children
1698730|NCT00060775|Adolescence|adolescence
1698731|NCT00060775|Affective Neuroscience|affective neuroscience
1698732|NCT00060775|Neuroimaging|neuroimaging
1698733|NCT00060775|Behavioral Inhibition|behavioral inhibition
1698734|NCT00060775|Depression|depression
1698735|NCT00060775|Anxiety|anxiety
1698736|NCT00060775|Normal Volunteers|normal volunteers
1698737|NCT00060775|Healthy Volunteer|healthy volunteer
1698738|NCT00060775|HV|hv
1698739|NCT00060762|Weight Loss|weight loss
1698740|NCT00060723|Polysomnography|polysomnography
1698741|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
1698742|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
1698743|NCT00060723|Hyperactivity|hyperactivity
1698744|NCT00060723|Sleep|sleep
1698745|NCT00060723|Child|child
1698746|NCT00060710|melanoma|melanoma
1698747|NCT00060749|Stargardt|stargardt
1698748|NCT00060749|Macular Dystrophy|macular dystrophy
1698749|NCT00060749|ELOVL4|elovl4
1698750|NCT00060749|DHA|dha
1698751|NCT00060749|Stargardt's Disease|stargardt's disease
1698752|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
1698753|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
1698754|NCT00060736|Hormone Replacement|hormone replacement
1698755|NCT00060736|Gonadal Steroids|gonadal steroids
1698756|NCT00060736|Estrogen|estrogen
1698757|NCT00060736|Major Depression|major depression
1698758|NCT00060736|Minor Depression|minor depression
1698759|NCT00060736|Perimenopause|perimenopause
1698760|NCT00060736|Estradiol|estradiol
1698761|NCT00060736|Depression|depression
1698762|NCT00060736|Perimenopausal Depression|perimenopausal depression
1698763|NCT00060697|Sexual risk taking|sexual risk taking
1698764|NCT00060697|Mother-child communication|mother-child communication
1698765|NCT00060697|Problem behaviors|problem behaviors
1698766|NCT00060684|Pixantrone|pixantrone
1698767|NCT00060684|BBR 2778|bbr 2778
1698768|NCT00060684|chemotherapy|chemotherapy
1698769|NCT00060684|DNA Intercalator|dna intercalator
1698770|NCT00060684|mitoxantrone|mitoxantrone
1698771|NCT00060684|fludarabine|fludarabine
1698772|NCT00060684|dexamethasone|dexamethasone
1698773|NCT00060684|Rituximab|rituximab
1698774|NCT00060684|Rituxan|rituxan
1698775|NCT00060684|Mabthera|mabthera
1698776|NCT00060684|monoclonal antibody|monoclonal antibody
1698777|NCT00060684|antibody|antibody
1698778|NCT00060684|NHL|nhl
1698779|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1698780|NCT00060684|indolent|indolent
1698781|NCT00060684|low grade|low grade
1698782|NCT00060684|Novuspharma|novuspharma
1698783|NCT00060671|Pixantrone|pixantrone
1698784|NCT00060671|BBR 2778|bbr 2778
1698785|NCT00060671|chemotherapy|chemotherapy
1698786|NCT00060671|DNA Intercalator|dna intercalator
1698787|NCT00060671|Anthracycline|anthracycline
1698788|NCT00060671|Rituximab|rituximab
1698789|NCT00060671|Rituxan|rituxan
1698790|NCT00060671|Mabthera|mabthera
1698791|NCT00060671|monoclonal antibody|monoclonal antibody
1698792|NCT00060671|antibody|antibody
1698793|NCT00060671|NHL|nhl
1698794|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1698795|NCT00060671|indolent|indolent
1698796|NCT00060671|low grade|low grade
1698797|NCT00060671|Novuspharma|novuspharma
1698798|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
1698799|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
1698800|NCT00060619|Migraine|migraine
1698801|NCT00060619|Functional abdominal pain|functional abdominal pain
1698802|NCT00060619|Biofeedback|biofeedback
1698803|NCT00060619|Psychological assessment|psychological assessment
1698804|NCT00060658|Prefrontal Cortex|prefrontal cortex
1698805|NCT00060658|Calculation|calculation
1698806|NCT00060658|Mathematician|mathematician
1698807|NCT00060658|Cognition|cognition
1698808|NCT00060658|Brain Mapping|brain mapping
1698809|NCT00060658|Healthy Volunteer|healthy volunteer
1698810|NCT00060658|HV|hv
1698811|NCT00060606|Maternal fetal surgery|maternal fetal surgery
1698812|NCT00060606|Fetal diagnosis|fetal diagnosis
1698813|NCT00060606|Myelomeningocele|myelomeningocele
1698814|NCT00060606|Meningomyelocele|meningomyelocele
1698815|NCT00060606|Open neural tube defect|open neural tube defect
1698816|NCT00060606|ONTD|ontd
1698817|NCT00060606|Spina bifida|spina bifida
1698818|NCT00060567|E7070|e7070
1698819|NCT00060567|Irinotecan|irinotecan
1698820|NCT00060567|hydrochloride|hydrochloride
1698821|NCT00060567|gastrointestinal|gastrointestinal
1698822|NCT00060567|cancer|cancer
1698823|NCT00004910|stage I colon cancer|stage i colon cancer
1698824|NCT00004910|stage II colon cancer|stage ii colon cancer
1698825|NCT00004910|stage III colon cancer|stage iii colon cancer
1698826|NCT00004910|stage IV colon cancer|stage iv colon cancer
1698827|NCT00004910|stage I gastric cancer|stage i gastric cancer
1698828|NCT00004910|stage II gastric cancer|stage ii gastric cancer
1698829|NCT00004910|stage III gastric cancer|stage iii gastric cancer
1698830|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
1698831|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
1698832|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
1698833|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
1698834|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
1698835|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
1698836|NCT00004910|recurrent colon cancer|recurrent colon cancer
1698837|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1698838|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1698839|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1698840|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1698841|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
1698842|NCT00004910|small intestine lymphoma|small intestine lymphoma
1698843|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1698844|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1698845|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1698846|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1698847|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
1698848|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1698849|NCT00004910|quality of life|quality of life
1698850|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1698851|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
1698852|NCT00004895|stage I colon cancer|stage i colon cancer
1698853|NCT00004895|stage II colon cancer|stage ii colon cancer
1698854|NCT00004895|stage III colon cancer|stage iii colon cancer
1698855|NCT00004895|stage IV colon cancer|stage iv colon cancer
1698856|NCT00004895|stage I gastric cancer|stage i gastric cancer
1698857|NCT00004895|stage II gastric cancer|stage ii gastric cancer
1698858|NCT00004895|stage III gastric cancer|stage iii gastric cancer
1698859|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
1698860|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
1698861|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
1698862|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
1698863|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
1698864|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
1698865|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
1698866|NCT00004895|stage I rectal cancer|stage i rectal cancer
1698867|NCT00004895|stage II rectal cancer|stage ii rectal cancer
1698868|NCT00004895|stage III rectal cancer|stage iii rectal cancer
1698869|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
1698870|NCT00004895|recurrent colon cancer|recurrent colon cancer
1698871|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
1698872|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1698873|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1698874|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1698875|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1698876|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1698877|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
1698878|NCT00004895|small intestine lymphoma|small intestine lymphoma
1698879|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1698880|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1698881|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1698882|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1698883|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
1698884|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
1698885|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
1698886|NCT00004895|nausea and vomiting|nausea and vomiting
1698887|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1698888|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1698889|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1698890|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1698891|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1698892|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1698893|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1698894|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1698895|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1698896|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1698897|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1698898|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
1698899|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1698900|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1698901|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1698902|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1698903|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1698904|NCT00004255|graft versus host disease|graft versus host disease
1698905|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1698906|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1698907|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1698908|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1698909|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1698910|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1698911|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1698912|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1698913|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1698914|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1698915|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1698916|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1698917|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1698918|NCT00004232|Burkitt lymphoma|burkitt lymphoma
1698919|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1698920|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
1698921|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
1698922|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1698923|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
1698924|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
1698925|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
1698926|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1698927|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1698928|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1698929|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1698930|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1698931|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1698932|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1698933|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1698934|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1698935|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1698936|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1698937|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1698938|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1698939|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1698940|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1698941|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1698942|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1698943|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1698944|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1698945|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1698946|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1699009|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1698947|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1698948|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1698949|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1698950|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1698951|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1698952|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1698953|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1698954|NCT00004232|essential thrombocythemia|essential thrombocythemia
1698955|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
1698956|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1698957|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
1698958|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1698959|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1698960|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1698961|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1698962|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1698963|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1698964|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1698965|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1698966|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1698967|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1698968|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1698969|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1698970|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1698971|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1699167|NCT00060333|recurrent melanoma|recurrent melanoma
1698972|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1698973|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1698974|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
1698975|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1698976|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1698977|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1698978|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1698979|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1698980|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1698981|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1698982|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1698983|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1698984|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1698985|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1698986|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1698987|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1698988|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1698989|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1698990|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1698991|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1698992|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1698993|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1698994|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1698995|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1698996|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1698997|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1698998|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1698999|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699000|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1699001|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1699002|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1699003|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1699004|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1699005|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1699006|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1699007|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1699008|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1699010|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1699011|NCT00004232|graft versus host disease|graft versus host disease
1699012|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
1699013|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1699014|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
1699015|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1699016|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1699017|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1699018|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1699019|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1699020|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1699021|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1699022|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1699023|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1699024|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1699025|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1699026|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1699027|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1699028|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1699175|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
1699029|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1699030|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1699031|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1699032|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1699033|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1699034|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1699035|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1699036|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1699037|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1699038|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1699039|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1715638|NCT00050388|Oral Cavity|oral cavity
1699040|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1699041|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1699042|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1699043|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1699044|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1699045|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1699046|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1699047|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1699048|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699049|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1699050|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1699051|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1699052|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1699053|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1699054|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1699055|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1699056|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1699057|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1699058|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699059|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1699060|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1699061|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1699062|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1699063|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1699064|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1699065|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1699066|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1699067|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1699068|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699069|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699070|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699071|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1699072|NCT00004180|adult liposarcoma|adult liposarcoma
1699073|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1699075|NCT00060593|Functional Connectivity|functional connectivity
1699076|NCT00060593|Healthy Volunteer|healthy volunteer
1699077|NCT00060593|HV|hv
1699078|NCT00060580|Retinal Measurements|retinal measurements
1699079|NCT00060580|Lutein in Vivo|lutein in vivo
1699080|NCT00060580|Raman Spectroscopy|raman spectroscopy
1699081|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
1699082|NCT00060580|Healthy Volunteer|healthy volunteer
1699083|NCT00060580|HV|hv
1699084|NCT00060554|Elective PCI|elective pci
1699085|NCT00060554|Heart catherization|heart catherization
1699086|NCT00060554|Acute coronary syndromes|acute coronary syndromes
1699087|NCT00060502|cachexia|cachexia
1699088|NCT00060502|pancreatic cancer|pancreatic cancer
1699089|NCT00060502|infliximab|infliximab
1699090|NCT00060502|anorexia|anorexia
1699091|NCT00060502|anemia|anemia
1699092|NCT00060502|Remicade.|remicade.
1699093|NCT00060489|Bipolar Depression|bipolar depression
1699094|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1699095|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1699096|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1699176|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
1699097|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1699098|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1699099|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1699100|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1699101|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1699102|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1699103|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1699104|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
1699105|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
1699106|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1699107|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1699108|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699109|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1699110|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1699111|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1699112|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1699113|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1699114|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1699115|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1699116|NCT00060541|Brain Tumor|brain tumor
1699117|NCT00060541|Epilepsy|epilepsy
1699118|NCT00060541|Pituitary Adenoma|pituitary adenoma
1699119|NCT00060541|Parkinson's Disease|parkinson's disease
1699120|NCT00060541|Vascular Malformation|vascular malformation
1699121|NCT00060541|Neurosurgery|neurosurgery
1699122|NCT00060541|Glioblastoma|glioblastoma
1699123|NCT00060541|Astrocytoma|astrocytoma
1699124|NCT00060541|Oligodendroglioma|oligodendroglioma
1699125|NCT00060541|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
1699126|NCT00060541|Oncogenes|oncogenes
1699127|NCT00060541|Proteomics|proteomics
1699128|NCT00060528|Immunotherapy|immunotherapy
1699129|NCT00060528|Cytokines|cytokines
1699130|NCT00060528|Immune Assays|immune assays
1699131|NCT00060528|Prostate Cancer|prostate cancer
1699132|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
1699133|NCT00060463|Pregnancy|pregnancy
1699134|NCT00060463|Sexually transmitted infection|sexually transmitted infection
1699135|NCT00060463|Chlamydia|chlamydia
1699136|NCT00060463|Gonorrhea|gonorrhea
1699137|NCT00060463|Trichomonas|trichomonas
1699138|NCT00060463|Contraception|contraception
1699139|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
1699140|NCT00060450|IRLI|irli
1699141|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
1699142|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
1699143|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1699144|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
1699145|NCT00060398|anemia|anemia
1699146|NCT00060398|fatigue|fatigue
1699147|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1699148|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1699149|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1699150|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1699151|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1699152|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1699153|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1699154|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1699155|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1699156|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1699157|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1699158|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1699159|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1699160|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1699161|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1699162|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1699163|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1699164|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1699165|NCT00060346|Rituximab|rituximab
1699166|NCT00060346|CHOP|chop
1699168|NCT00060333|stage I melanoma|stage i melanoma
1699169|NCT00060333|stage II melanoma|stage ii melanoma
1699170|NCT00060333|stage III melanoma|stage iii melanoma
1699171|NCT00060320|stage IV breast cancer|stage iv breast cancer
1699172|NCT00060320|stage I breast cancer|stage i breast cancer
1699173|NCT00060320|stage II breast cancer|stage ii breast cancer
1699174|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
1699178|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
1699179|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
1699180|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
1699181|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
1699182|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
1699183|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
1699184|NCT00060255|stage IV breast cancer|stage iv breast cancer
1699185|NCT00060255|male breast cancer|male breast cancer
1699186|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1699187|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1699188|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1699189|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1699190|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1699191|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1715639|NCT00050388|Oropharynx|oropharynx
1699192|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1699193|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1699194|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1699195|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1699196|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1699197|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1699198|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699199|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699200|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1699201|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1699202|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699203|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699204|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1699205|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1699206|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1699207|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1699208|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1699209|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1699210|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699211|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1699212|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699213|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1699214|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
1699215|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
1699216|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
1699217|NCT00060255|recurrent breast cancer|recurrent breast cancer
1699218|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
1699219|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
1699220|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1699221|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1699222|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699223|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1716117|NCT00047515|open-angle|open-angle
1699224|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699225|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699226|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699227|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1699228|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1699229|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1699230|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1699231|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1699232|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
1699233|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
1699234|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
1699235|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
1699236|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699237|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
1699238|NCT00060138|stage IV breast cancer|stage iv breast cancer
1699239|NCT00060138|recurrent breast cancer|recurrent breast cancer
1699240|NCT00060138|bone metastases|bone metastases
1699241|NCT00060138|pain|pain
1699242|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1699243|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1699244|NCT00060099|human papilloma virus infection|human papilloma virus infection
1699245|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1699246|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
1699247|NCT00060021|oral complications|oral complications
1699248|NCT00060021|pain|pain
1699249|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1699250|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1699251|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1699252|NCT00060021|primary myelofibrosis|primary myelofibrosis
1699253|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1699254|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1699255|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1699256|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
1699257|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1699258|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1699259|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1699260|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1699261|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1699262|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1699263|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1699264|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1699265|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1699266|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1699267|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1699268|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
1699269|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1699270|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
1699271|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
1699272|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
1699273|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1699274|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
1699275|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1699276|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1699277|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1699278|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1699279|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699280|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699281|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1699282|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1699283|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699284|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699285|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1699286|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1699287|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1699288|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1699289|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1699290|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699291|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1699292|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
1699293|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1699294|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1699295|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1699296|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1699297|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1699298|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
1699299|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
1699300|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1699301|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1699302|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
1699303|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
1699304|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
1699305|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1699306|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1699307|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1699308|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1699309|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1699310|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1699311|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1699312|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1699313|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1699314|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1699315|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1699316|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1699317|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1699318|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1699319|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
1699320|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
1699321|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
1699322|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1699323|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1715640|NCT00050388|Pharynx|pharynx
1699324|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1699325|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1699326|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1699327|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1699328|NCT00060021|stage IV breast cancer|stage iv breast cancer
1699329|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1699330|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1699331|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1699332|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1699333|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1699334|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1699335|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1699336|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1699337|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1699338|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1699339|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1699340|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1699341|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1699342|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1699343|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1699344|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
1699345|NCT00060021|testicular teratoma|testicular teratoma
1699346|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1699347|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1699348|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
1699349|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1699350|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
1699351|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1699352|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1699353|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1699354|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1699430|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
1699355|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699356|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1699357|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1699358|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1699658|NCT00059683|Cervical length|cervical length
1699359|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1699360|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1699361|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699362|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699363|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699364|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
1699365|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
1699366|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699367|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1699368|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1699369|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699370|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1699371|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1699372|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1699373|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
1699374|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
1699375|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
1699376|NCT00059943|stage IV breast cancer|stage iv breast cancer
1699377|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1699378|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1699379|NCT00059943|recurrent breast cancer|recurrent breast cancer
1699380|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
1699381|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
1699382|NCT00059930|liver metastases|liver metastases
1699383|NCT00059930|stage IV colon cancer|stage iv colon cancer
1699384|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
1699385|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
1699386|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1699387|NCT00059930|recurrent colon cancer|recurrent colon cancer
1699388|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
1699389|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699390|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699391|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699392|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699393|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
1699394|NCT00059891|stage II anal cancer|stage ii anal cancer
1699395|NCT00059891|stage I anal cancer|stage i anal cancer
1699396|NCT00059891|stage III anal cancer|stage iii anal cancer
1699397|NCT00059891|stage I rectal cancer|stage i rectal cancer
1699398|NCT00059891|stage II rectal cancer|stage ii rectal cancer
1699399|NCT00059891|stage III rectal cancer|stage iii rectal cancer
1699400|NCT00059878|infection|infection
1699401|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699402|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
1699403|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
1699404|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1699405|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1699406|NCT00059852|male breast cancer|male breast cancer
1699407|NCT00059852|recurrent breast cancer|recurrent breast cancer
1699408|NCT00059852|stage IV breast cancer|stage iv breast cancer
1699409|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1699410|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
1699411|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
1699412|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
1699413|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1699414|NCT00059800|recurrent melanoma|recurrent melanoma
1699415|NCT00059800|stage 0 melanoma|stage 0 melanoma
1699416|NCT00059800|stage I melanoma|stage i melanoma
1699417|NCT00059800|stage II melanoma|stage ii melanoma
1699418|NCT00059800|stage III melanoma|stage iii melanoma
1699419|NCT00059800|stage IV melanoma|stage iv melanoma
1699420|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
1699421|NCT00059735|kidney cancer|kidney cancer
1699422|NCT00059735|kidney neoplasms|kidney neoplasms
1699423|NCT00059735|renal cell cancer|renal cell cancer
1699424|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1699425|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1699426|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1699427|NCT00030524|stage III colon cancer|stage iii colon cancer
1699428|NCT00030524|stage IV colon cancer|stage iv colon cancer
1699429|NCT00030524|stage III rectal cancer|stage iii rectal cancer
1716118|NCT00047515|glaucoma|glaucoma
1699431|NCT00030524|recurrent colon cancer|recurrent colon cancer
1699432|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
1699433|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
1699434|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1699435|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1699436|NCT00027599|stage I prostate cancer|stage i prostate cancer
1699437|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
1699438|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
1699439|NCT00027599|stage III prostate cancer|stage iii prostate cancer
1699440|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
1699441|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
1699442|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
1699443|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1699444|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1699445|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1699446|NCT00006225|stage IV breast cancer|stage iv breast cancer
1699447|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
1699448|NCT00006225|recurrent breast cancer|recurrent breast cancer
1699449|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
1699450|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
1699451|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699452|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1699453|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1699454|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1699455|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1699456|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1699457|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
1699458|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
1699459|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1699460|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
1699461|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
1699462|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
1699463|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1699464|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1699465|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1699466|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1715641|NCT00050388|Larynx|larynx
1699467|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1699468|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1699469|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
1699470|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1699471|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1699472|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1699473|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1699474|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1699475|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1699476|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1699477|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1699478|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1699479|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1699480|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1699481|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1699482|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1699483|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1699484|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1699485|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1699486|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1699487|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1699488|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1699489|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1699490|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1699491|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1699492|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699493|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699494|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699495|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1699496|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1699497|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1699498|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1716119|NCT00047515|ocular|ocular
1699499|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1699500|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1699501|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1699502|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
1699503|NCT00006225|male breast cancer|male breast cancer
1699504|NCT00006225|intraocular lymphoma|intraocular lymphoma
1699505|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1699506|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1699507|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1699508|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1699509|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1699510|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1699511|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1699512|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1699513|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1699514|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1699515|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1699516|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1699517|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1699518|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1699519|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1699520|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1699521|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1699522|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1699523|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1699524|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1699525|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1699526|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1699527|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1699528|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699529|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1699530|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1699531|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1699532|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1699533|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1699534|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1699535|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1699536|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1699537|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1699538|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1699539|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1699540|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1699541|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699542|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1699543|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1699544|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1699545|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1699546|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1699547|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1699548|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1699549|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699550|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699551|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699552|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1699553|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1699554|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1699555|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1699556|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1699557|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1699558|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1699804|NCT00059579|Healthy Volunteer|healthy volunteer
1699559|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1699560|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1699561|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1699562|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1699563|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1699564|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1699565|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
1699566|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
1699567|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
1699568|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
1699569|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1699570|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1699571|NCT00004095|stage IV colon cancer|stage iv colon cancer
1699572|NCT00004095|stage IV breast cancer|stage iv breast cancer
1699573|NCT00004095|recurrent breast cancer|recurrent breast cancer
1699574|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1699575|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
1699576|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
1699577|NCT00004095|recurrent colon cancer|recurrent colon cancer
1699578|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
1699579|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
1699748|NCT00059618|Paraplatin|paraplatin
1699580|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
1699581|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1699582|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
1699583|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
1699584|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
1699585|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1699586|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
1699587|NCT00059748|Central Nervous System Abnormalities|central nervous system abnormalities
1699588|NCT00059748|Arthropathy|arthropathy
1699589|NCT00059748|Urticaria|urticaria
1699590|NCT00059748|Papilledema|papilledema
1699591|NCT00059748|Autoinflammation|autoinflammation
1699592|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
1699593|NCT00059748|Disease|disease
1699594|NCT00059748|NOMID|nomid
1699595|NCT00019435|stage IV colon cancer|stage iv colon cancer
1699596|NCT00019435|stage IV breast cancer|stage iv breast cancer
1699597|NCT00019435|recurrent breast cancer|recurrent breast cancer
1699598|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
1699599|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
1699600|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1699601|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
1699602|NCT00019435|recurrent colon cancer|recurrent colon cancer
1699603|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
1699604|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
1699605|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
1699606|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
1699607|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1699608|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
1699609|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699610|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1699611|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1699612|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
1699613|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1699614|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1699615|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1699616|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1699617|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
1699618|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1699619|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1699620|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1699621|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1699622|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1699623|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699624|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699625|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699626|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1699627|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1699628|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1699629|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1699630|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1699631|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1699805|NCT00059579|HV|hv
1699632|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1699633|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
1699634|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699635|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1699636|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1699637|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699638|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699639|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699640|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699641|NCT00059722|NSCLC|nsclc
1699642|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
1699643|NCT00059722|second-line|second-line
1699644|NCT00059709|Conflict Resolution training|conflict resolution training
1699645|NCT00059709|Children|children
1699646|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
1699647|NCT00059696|CI therapy|ci therapy
1699648|NCT00059696|Rehabilitation|rehabilitation
1699649|NCT00059696|Cerebrovascular accident|cerebrovascular accident
1699650|NCT00059696|Upper extremity|upper extremity
1699651|NCT00059696|Concentrated, extended practice|concentrated, extended practice
1699652|NCT00059696|Limb restraint|limb restraint
1699653|NCT00059696|Motor Deficits|motor deficits
1699654|NCT00059683|Preterm Birth|preterm birth
1700649|NCT00057421|Safety|safety
1699655|NCT00059683|Premature Birth|premature birth
1699656|NCT00059683|Cervical cerclage|cervical cerclage
1699657|NCT00059683|Vaginal ultrasound|vaginal ultrasound
1699659|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
1699660|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
1699661|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
1699662|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1699663|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1699664|NCT00005025|fallopian tube cancer|fallopian tube cancer
1699665|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1699666|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
1699667|NCT00002971|adult glioblastoma|adult glioblastoma
1699668|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1699669|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
1699670|NCT00002971|adult gliosarcoma|adult gliosarcoma
1699673|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
1699674|NCT00059657|CLI|cli
1699675|NCT00059657|peripheral, vascular|peripheral, vascular
1699676|NCT00059657|amputation|amputation
1699677|NCT00059657|Angioplasty|angioplasty
1699678|NCT00059657|by-pass|by-pass
1699679|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
1699680|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
1699681|NCT00059644|CLI|cli
1699682|NCT00059644|peripheral|peripheral
1699683|NCT00059644|vascular|vascular
1699684|NCT00059644|amputation|amputation
1699685|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
1699686|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1699687|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
1699688|NCT00003926|regional neuroblastoma|regional neuroblastoma
1699689|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
1699690|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
1699691|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
1699692|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
1699693|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1699694|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
1699695|NCT00003926|chordoma|chordoma
1699696|NCT00003926|ovarian sarcoma|ovarian sarcoma
1699697|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
1699698|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
1699699|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
1699700|NCT00003926|Ewing sarcoma|ewing sarcoma
1699701|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
1699702|NCT00003926|teratoma|teratoma
1699703|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
1699704|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
1699705|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
1699706|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
1699707|NCT00003926|hepatoblastoma|hepatoblastoma
1699708|NCT00003926|liver cancer|liver cancer
1699709|NCT00003926|medulloblastoma|medulloblastoma
1699710|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
1699711|NCT00003926|brain stem glioma|brain stem glioma
1699712|NCT00003926|glioma|glioma
1699713|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
1699714|NCT00003926|ependymoma|ependymoma
1699715|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1699716|NCT00003802|iris melanoma|iris melanoma
1699717|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1699806|NCT00059553|spinal cord injury|spinal cord injury
1699718|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1699719|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
1699720|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
1699721|NCT00003802|stage IV melanoma|stage iv melanoma
1699722|NCT00003802|recurrent melanoma|recurrent melanoma
1699723|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
1699724|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
1699725|NCT00059631|Prostate Cancer|prostate cancer
1699726|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
1699727|NCT00059631|AI-PCa|ai-pca
1699728|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
1699729|NCT00059631|Novantrone|novantrone
1699730|NCT00059631|Mitoxantrone|mitoxantrone
1699731|NCT00059631|PS-341|ps-341
1699732|NCT00059631|Bortezomib|bortezomib
1699733|NCT00059631|Velcade|velcade
1699734|NCT00059631|LDP-341|ldp-341
1699735|NCT00059631|MLN341|mln341
1699736|NCT00059631|20S proteasome|20s proteasome
1699737|NCT00059618|Platinum Resistant|platinum resistant
1699738|NCT00059618|Taxane Resistant|taxane resistant
1699739|NCT00059618|Ovarian Cancer|ovarian cancer
1699740|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
1699741|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
1699742|NCT00059618|Bortezomib|bortezomib
1699743|NCT00059618|PS-341|ps-341
1699744|NCT00059618|Velcade|velcade
1699745|NCT00059618|LDP-341|ldp-341
1699749|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
1699750|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
1699751|NCT00059605|Lung Cancer|lung cancer
1699752|NCT00059605|NSCLC|nsclc
1699753|NCT00059605|SCLC|sclc
1699754|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
1699755|NCT00059605|gene|gene
1699756|NCT00059605|gene transfer|gene transfer
1699757|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1699758|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
1699759|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1699760|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1699761|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1699762|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1699763|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1699862|NCT00003432|stage IV breast cancer|stage iv breast cancer
1699764|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1699765|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1699766|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1699767|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
1699768|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
1699769|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
1699770|NCT00003484|adult medulloblastoma|adult medulloblastoma
1699771|NCT00003484|adult meningioma|adult meningioma
1699772|NCT00003484|adult glioblastoma|adult glioblastoma
1699773|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
1699774|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1699775|NCT00003484|adult mixed glioma|adult mixed glioma
1699776|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1699777|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1699778|NCT00003484|adult grade III meningioma|adult grade iii meningioma
1699779|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1699780|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
1699781|NCT00003484|adult gliosarcoma|adult gliosarcoma
1699782|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1699783|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1699784|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
1699785|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1699786|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1699787|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1699788|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1699789|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1699790|NCT00059579|Reward|reward
1699791|NCT00059579|Cortex|cortex
1699792|NCT00059579|Dopamine|dopamine
1699793|NCT00059579|Neuroimaging|neuroimaging
1699794|NCT00059579|Strirtum|strirtum
1699795|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
1699796|NCT00059579|Melancholic Features|melancholic features
1699797|NCT00059579|Brain Imaging|brain imaging
1699798|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
1699799|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
1699800|NCT00059579|Anhedonia|anhedonia
1699801|NCT00059579|Depression|depression
1699802|NCT00059579|Major Depressive Disorder|major depressive disorder
1699803|NCT00059579|MDD|mdd
1699810|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
1699811|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
1699812|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
1699813|NCT00059540|Cocaine abuse|cocaine abuse
1699814|NCT00059540|Cocaine dependence|cocaine dependence
1699815|NCT00059540|Opiate abuse|opiate abuse
1699816|NCT00059540|Opiate dependence|opiate dependence
1699817|NCT00059540|Follow-up|follow-up
1699818|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
1699819|NCT00059540|Substance-related disorders|substance-related disorders
1699820|NCT00059527|Physical Activity|physical activity
1699821|NCT00059527|Nutrition|nutrition
1699822|NCT00059527|Self Efficacy|self efficacy
1699823|NCT00059527|Middle School|middle school
1699824|NCT00059527|Intervention|intervention
1699825|NCT00059514|Youth|youth
1699826|NCT00059514|Adolescents|adolescents
1699827|NCT00059514|Smoking cessation|smoking cessation
1699828|NCT00059514|Smoking prevention|smoking prevention
1699829|NCT00059514|Risk factors|risk factors
1699830|NCT00059514|Arab Americans|arab americans
1699831|NCT00059449|Enterocolitis|enterocolitis
1699832|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1699833|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1699834|NCT00059501|Postural Stability|postural stability
1699835|NCT00059501|EEG|eeg
1699836|NCT00059501|Aging|aging
1699837|NCT00059501|Falls|falls
1699838|NCT00059501|Healthy Volunteer|healthy volunteer
1699839|NCT00059501|HV|hv
1699840|NCT00059475|Adjuvant Therapy|adjuvant therapy
1699841|NCT00059475|MART-1 Peptides|mart-1 peptides
1699842|NCT00059475|GP100 Peptide|gp100 peptide
1699843|NCT00059475|Immunologic Response|immunologic response
1699844|NCT00059475|Melanoma|melanoma
1699845|NCT00059436|Muscle strengthening|muscle strengthening
1699846|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
1699847|NCT00059436|Rehabilitative exercise|rehabilitative exercise
1699848|NCT00059410|Alzheimer disease|alzheimer disease
1699849|NCT00059410|Caregivers|caregivers
1699850|NCT00059410|African Americans|african americans
1699851|NCT00059410|Perceptions|perceptions
1699852|NCT00059410|Cultural Competency|cultural competency
1699853|NCT00059423|Leukapheresis|leukapheresis
1699854|NCT00059423|G-CSF|g-csf
1699855|NCT00059423|Dexamethasone|dexamethasone
1699856|NCT00059423|mRNA|mrna
1699857|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
1699858|NCT00059423|BEN|ben
1699859|NCT00059423|Healthy Volunteer|healthy volunteer
1699863|NCT00003346|stage III melanoma|stage iii melanoma
1699864|NCT00003346|stage IV melanoma|stage iv melanoma
1699865|NCT00003346|recurrent melanoma|recurrent melanoma
1699866|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1699867|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1699868|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1699869|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1699870|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
1699871|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
1699872|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
1699873|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
1699874|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1699875|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1699876|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1699877|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1699878|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1699879|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1699880|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1699881|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1699882|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1699883|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1699884|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1699885|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1699886|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1699887|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1699888|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1699889|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1699890|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1699891|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1699892|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1699893|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1699894|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1699967|NCT00059306|lacunar stroke|lacunar stroke
1699895|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1699896|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1699897|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1699898|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1699899|NCT00003341|anemia|anemia
1699900|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1699901|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1699902|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1699903|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1699904|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1699905|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1699906|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1699907|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1699908|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1699909|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1699910|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1699911|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1715202|NCT00001446|Sedation|sedation
1699912|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1699913|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1699914|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1699915|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1699916|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1699917|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1699918|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1699919|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1699920|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1699921|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1699922|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1699923|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1699924|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1699925|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1699926|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1699927|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1699928|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1699929|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1699930|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1699931|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1699932|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
1699933|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1699934|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1699935|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1699936|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1699937|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1699938|NCT00059384|Treatment experienced|treatment experienced
1699939|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
1699940|NCT00059371|Male circumcision|male circumcision
1699941|NCT00059371|HIV acquisition|hiv acquisition
1699942|NCT00059371|Sexually transmitted infection|sexually transmitted infection
1699943|NCT00059371|HIV Seronegativity|hiv seronegativity
1699945|NCT00059358|HCV|hcv
1699946|NCT00059358|Ribavirin|ribavirin
1699947|NCT00059358|Interferon|interferon
1699948|NCT00059358|Co-infection|co-infection
1699949|NCT00059358|Treatment experienced|treatment experienced
1699950|NCT00059345|Acupuncture|acupuncture
1699951|NCT00059345|Arthritis|arthritis
1699952|NCT00059332|stroke|stroke
1699953|NCT00059332|brain attack|brain attack
1699954|NCT00059332|magnesium sulfate|magnesium sulfate
1699955|NCT00059332|neuroprotection|neuroprotection
1699956|NCT00059332|prehospital care|prehospital care
1699957|NCT00059332|emergency medical services|emergency medical services
1699958|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
1699959|NCT00059319|CABG surgery|cabg surgery
1699960|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
1699961|NCT00059319|aorta clamping|aorta clamping
1699962|NCT00059319|aorta manipulation|aorta manipulation
1699963|NCT00059319|microemboli|microemboli
1699964|NCT00059306|stroke|stroke
1699965|NCT00059306|hypertension|hypertension
1699966|NCT00059306|high blood pressure|high blood pressure
1700620|NCT00057629|Rape|rape
1699968|NCT00059306|subcortical stroke|subcortical stroke
1699969|NCT00059306|aspirin|aspirin
1699970|NCT00059306|clopidogrel|clopidogrel
1699971|NCT00058981|Diabetes|diabetes
1699972|NCT00058981|LADA|lada
1699973|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
1699974|NCT00059280|Pompe disease|pompe disease
1699975|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
1699976|NCT00059280|GSD-II|gsd-ii
1699977|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
1699978|NCT00059280|Glycogenosis 2|glycogenosis 2
1699979|NCT00059254|fatty acids|fatty acids
1699980|NCT00059254|oleic acid|oleic acid
1699981|NCT00059254|palmitic acid|palmitic acid
1699982|NCT00059254|fat oxidation|fat oxidation
1699983|NCT00059254|energy expenditure|energy expenditure
1699984|NCT00059254|body composition|body composition
1699985|NCT00059254|monounsaturated fat|monounsaturated fat
1699986|NCT00059254|human|human
1699987|NCT00059241|Early sexual initiation|early sexual initiation
1699988|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
1699989|NCT00059241|Middle childhood|middle childhood
1699990|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
1699991|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
1699992|NCT00003290|stage III prostate cancer|stage iii prostate cancer
1699993|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1699994|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1700191|NCT00059033|Parkinson's Disease|parkinson's disease
1699995|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1699996|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1699997|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1699998|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1699999|NCT00003205|stage IV breast cancer|stage iv breast cancer
1700000|NCT00003205|recurrent breast cancer|recurrent breast cancer
1700001|NCT00003193|oral complications|oral complications
1700002|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1700003|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1700004|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1700005|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1700006|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1700007|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1700008|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1700009|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1700010|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1700011|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1700012|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1700013|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1700014|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
1700015|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
1700016|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1700017|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1700018|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1700019|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1700020|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700021|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
1700022|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1700023|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1700024|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1700025|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
1700026|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1700027|NCT00003173|childhood teratoma|childhood teratoma
1700028|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1700029|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1700030|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1700031|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1700032|NCT00059228|Pregnancy|pregnancy
1700033|NCT00059228|Gonadal Steroids|gonadal steroids
1700034|NCT00059228|Antidepressants|antidepressants
1700035|NCT00059228|Puerperium|puerperium
1700036|NCT00059228|Depression|depression
1700037|NCT00059228|Postpartum|postpartum
1700038|NCT00059228|Estradiol|estradiol
1700039|NCT00059228|Estrogen Response Element|estrogen response element
1700040|NCT00059228|Postpartum Depression|postpartum depression
1700041|NCT00059202|Urso|urso
1700042|NCT00059202|PSC|psc
1700826|NCT00056849|Disability|disability
1700043|NCT00059189|Occipital Cortex|occipital cortex
1700044|NCT00059189|Prefrontal Cortex|prefrontal cortex
1700045|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1700046|NCT00059189|Inhibition|inhibition
1700047|NCT00059189|Cortical Excitability|cortical excitability
1700048|NCT00059189|Blindness|blindness
1700049|NCT00059189|Healthy Volunteer|healthy volunteer
1700050|NCT00059189|HV|hv
1700051|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700052|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700053|NCT00059137|Gating|gating
1700054|NCT00059137|Respiratory Misregistration|respiratory misregistration
1700055|NCT00059137|Abdominal Belt|abdominal belt
1700056|NCT00059137|Percutaneous|percutaneous
1700057|NCT00059137|CT Guided Biopsy|ct guided biopsy
1700058|NCT00059137|Respiratory Cycle|respiratory cycle
1700059|NCT00059137|Needle Biopsy|needle biopsy
1700060|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
1700061|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
1700062|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
1700063|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1700064|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1700065|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700066|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1715727|NCT00050141|R115777|r115777
1700067|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
1700068|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
1700069|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
1700070|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1700071|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
1700072|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1700073|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
1700074|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
1700075|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1700076|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
1700077|NCT00003597|recurrent melanoma|recurrent melanoma
1700078|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1700079|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
1700080|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1700081|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1700230|NCT00058903|hepatitis C|hepatitis c
1700082|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
1700083|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
1700084|NCT00003597|neutropenia|neutropenia
1700085|NCT00003597|thrombocytopenia|thrombocytopenia
1700086|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1700087|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1700088|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1700089|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1700090|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1700091|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1700092|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1700093|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
1700094|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
1700095|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
1700096|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
1700097|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
1700098|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1700099|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1700100|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1700101|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1700102|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1700103|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1700104|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1700105|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1700106|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1700107|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1700108|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1700109|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1700110|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1700111|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1700112|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1700113|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1700114|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1700115|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1700116|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1700117|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1700118|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1700119|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1700120|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1700121|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1700122|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1700123|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1700124|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1700125|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
1700126|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1700127|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1700128|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1700129|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1700130|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1700131|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1700132|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1700133|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1700134|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1700135|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1700136|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1700137|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1700138|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1700139|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1700140|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1700141|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1700142|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1700231|NCT00058890|itching|itching
1700143|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1700144|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1700145|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1700146|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1700147|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1700148|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1700149|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1700150|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1700151|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1700152|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1700153|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1700154|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1700155|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1700156|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1700157|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1700158|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1700159|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1700160|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1700161|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1700162|NCT00003162|stage IV breast cancer|stage iv breast cancer
1700163|NCT00003162|recurrent breast cancer|recurrent breast cancer
1700164|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
1700165|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
1700166|NCT00003162|bone metastases|bone metastases
1700167|NCT00003162|pain|pain
1700168|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
1700169|NCT00003129|stage I bladder cancer|stage i bladder cancer
1700170|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1700171|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1700172|NCT00003124|stage I prostate cancer|stage i prostate cancer
1700173|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
1700174|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
1700175|NCT00003124|stage III prostate cancer|stage iii prostate cancer
1700176|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1700177|NCT00003064|fallopian tube cancer|fallopian tube cancer
1700178|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1716431|NCT00044889|CLO221|clo221
1700179|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1700180|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1700181|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1700182|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
1700183|NCT00059046|Neuroreceptors|neuroreceptors
1700184|NCT00059046|PET Measurements|pet measurements
1700185|NCT00059046|Kinetic Analysis|kinetic analysis
1700186|NCT00059046|Test/Retest|test/retest
1700187|NCT00059046|Healthy Volunteer|healthy volunteer
1700188|NCT00059046|HV|hv
1700189|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
1700190|NCT00059033|Autonomic Failure|autonomic failure
1700192|NCT00059033|Multiple System Atrophy|multiple system atrophy
1700193|NCT00059033|Pure Autonomic Failure|pure autonomic failure
1700194|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
1700195|NCT00059033|CAF|caf
1700196|NCT00059020|Glioma|glioma
1700197|NCT00059020|Brain Tumor|brain tumor
1700198|NCT00059020|Epidermal Growth Factor|epidermal growth factor
1700199|NCT00059020|Polymorphisms|polymorphisms
1700200|NCT00058994|AMD|amd
1700201|NCT00058994|anecortave acetate|anecortave acetate
1700202|NCT00058994|wet AMD|wet amd
1700203|NCT00058994|age-related macular degeneration|age-related macular degeneration
1700204|NCT00058994|Macular Degeneration|macular degeneration
1700205|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
1700206|NCT00058994|Age-Related Maculopathies|age-related maculopathies
1700207|NCT00058994|Age-Related Maculopathy|age-related maculopathy
1700208|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
1700209|NCT00058968|neuropathy|neuropathy
1700211|NCT00058968|diabetes|diabetes
1700212|NCT00058968|chronic pain|chronic pain
1700213|NCT00058968|persistent pain|persistent pain
1700214|NCT00058968|leg pain|leg pain
1700215|NCT00058968|peripheral neuropathy|peripheral neuropathy
1700216|NCT00058968|foot pain|foot pain
1700217|NCT00058968|painful neuropathy|painful neuropathy
1700218|NCT00058968|diabetic neuropathy|diabetic neuropathy
1700219|NCT00058955|ghb|ghb
1700220|NCT00058955|Xyrem|xyrem
1700221|NCT00058955|triazolam|triazolam
1700222|NCT00058955|pentobarbital|pentobarbital
1700223|NCT00058955|sedative|sedative
1700224|NCT00058955|abuse|abuse
1700225|NCT00058942|Drinking Water|drinking water
1700226|NCT00058903|Cholestatic|cholestatic
1700227|NCT00058903|Pruritus|pruritus
1700228|NCT00058903|Sertraline|sertraline
1700229|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
1700234|NCT00058890|liver disease|liver disease
1700235|NCT00058890|hepatitis|hepatitis
1700236|NCT00058890|cirrhosis|cirrhosis
1700237|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1700238|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
1700239|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1700240|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1700241|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1700242|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1700243|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1700244|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1700245|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1700246|NCT00002934|breast cancer in situ|breast cancer in situ
1700247|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
1700248|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1700249|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1700250|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1700251|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1700252|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1700253|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1700254|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1700255|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1700256|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1700257|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1700258|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1700259|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1700260|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1700261|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1700262|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1700263|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1700264|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1700265|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1700266|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1700267|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1700268|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1700269|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1700270|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1700271|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1700272|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1700273|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
1700274|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1700275|NCT00058851|Manual lymph drainage|manual lymph drainage
1700276|NCT00058851|Combined physiotherapy|combined physiotherapy
1700278|NCT00058825|stem cell transplant|stem cell transplant
1700279|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
1700280|NCT00058812|bone marrow transplant|bone marrow transplant
1700281|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
1700282|NCT00058773|Hodgkin disease|hodgkin disease
1700283|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
1700284|NCT00058773|bone marrow transplant|bone marrow transplant
1700285|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
1700286|NCT00058760|NIA intervention|nia intervention
1700287|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
1700288|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
1700289|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
1700290|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
1700291|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
1700292|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
1700293|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
1700294|NCT00058734|Dendritic Cell|dendritic cell
1700295|NCT00058734|Immunotherapy|immunotherapy
1700296|NCT00058734|Acute HIV|acute hiv
1700297|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
1700298|NCT00058734|AIDS|aids
1700299|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1700300|NCT00058734|Treatment Experienced|treatment experienced
1700301|NCT00058734|Treatment Interruption|treatment interruption
1700302|NCT00058721|Dementia|dementia
1700303|NCT00058721|Feasibility|feasibility
1700306|NCT00058721|Parkinson Disease|parkinson disease
1700307|NCT00058721|PD|pd
1700308|NCT00058721|Healthy Volunteer|healthy volunteer
1700309|NCT00058721|HV|hv
1700310|NCT00058695|Macualar Degeneration|macualar degeneration
1700311|NCT00058695|AMD|amd
1700312|NCT00058695|Healthy Volunteer|healthy volunteer
1700313|NCT00058695|HV|hv
1700314|NCT00058682|Fungal Infection|fungal infection
1700315|NCT00058682|Mycoses|mycoses
1700316|NCT00058682|Candida Species|candida species
1700317|NCT00058682|Candidiasis|candidiasis
1700318|NCT00002777|stage IV breast cancer|stage iv breast cancer
1700319|NCT00002777|recurrent breast cancer|recurrent breast cancer
1700320|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1700321|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1700322|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1700323|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1700324|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1700325|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1700326|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1700327|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1700328|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1700329|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1700330|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1700331|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1700332|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1700333|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1700334|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1700335|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1700336|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1700337|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1700338|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1700339|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1700340|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1700341|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1700342|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1700343|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1700344|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1700345|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1700346|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1700347|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1700348|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1700349|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1700350|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1700650|NCT00057421|Immune activation|immune activation
1700351|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1700352|NCT00002693|neutropenia|neutropenia
1700353|NCT00002669|stage IV melanoma|stage iv melanoma
1700354|NCT00002669|recurrent melanoma|recurrent melanoma
1700355|NCT00058656|Immunotherapy|immunotherapy
1700356|NCT00058656|T Cell Therapy|t cell therapy
1700357|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
1700358|NCT00058656|Xcellerate|xcellerate
1700359|NCT00058656|Xcellerated|xcellerated
1700360|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1700361|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1700362|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1700363|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1700364|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1700365|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1700366|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1700367|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1700368|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1700369|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1700370|NCT00002658|neutropenia|neutropenia
1700510|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1700371|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1700372|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
1700373|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
1700374|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
1700375|NCT00002575|stage I colon cancer|stage i colon cancer
1700376|NCT00002575|stage II colon cancer|stage ii colon cancer
1700377|NCT00002575|stage III colon cancer|stage iii colon cancer
1700378|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
1700379|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
1700380|NCT00002550|large cell lung cancer|large cell lung cancer
1700381|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1700382|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
1700383|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1700384|NCT00002539|localized osteosarcoma|localized osteosarcoma
1700385|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
1700386|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
1700387|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
1700388|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
1700389|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
1700390|NCT00058526|Immunotherapeutic|immunotherapeutic
1700391|NCT00058526|Dose escalation|dose escalation
1700392|NCT00058526|Breast cancer|breast cancer
1700393|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1700394|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
1700395|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1700396|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1700397|NCT00058474|stage II rectal cancer|stage ii rectal cancer
1700398|NCT00058474|stage III rectal cancer|stage iii rectal cancer
1700399|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1700400|NCT00058448|stage II penile cancer|stage ii penile cancer
1700401|NCT00058448|stage III penile cancer|stage iii penile cancer
1700402|NCT00058448|stage IV penile cancer|stage iv penile cancer
1700403|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1700404|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1700405|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1700406|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1700407|NCT00058435|fallopian tube cancer|fallopian tube cancer
1700408|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1700409|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1700410|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1700411|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1700412|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1700413|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1700414|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1700415|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1700416|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1700417|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1700418|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1700419|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1700420|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1700421|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1700422|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1700423|NCT00058370|adult medulloblastoma|adult medulloblastoma
1700651|NCT00057460|Antiepileptic Drug|antiepileptic drug
1700424|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1700425|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700426|NCT00058357|pain|pain
1700427|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
1700428|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
1700429|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1700430|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1700431|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1700432|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1700433|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1700434|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1700435|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1700436|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1700437|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1700438|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1700439|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1700440|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1700678|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
1700441|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1700442|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1700443|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1700444|NCT00058279|stage IV melanoma|stage iv melanoma
1700445|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
1700446|NCT00058279|recurrent melanoma|recurrent melanoma
1700447|NCT00058279|iris melanoma|iris melanoma
1700448|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1700449|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1700450|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
1700451|NCT00058266|stage I prostate cancer|stage i prostate cancer
1700452|NCT00058266|stage II prostate cancer|stage ii prostate cancer
1700453|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
1700454|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1700455|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
1700456|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
1700457|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
1700458|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
1700459|NCT00058188|osteoporosis|osteoporosis
1700460|NCT00058188|stage III prostate cancer|stage iii prostate cancer
1700461|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
1700462|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
1700463|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
1700464|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1700465|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
1700466|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1700467|NCT00058123|adult mixed glioma|adult mixed glioma
1700468|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1700469|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
1700470|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
1700471|NCT00058071|peripheral neuropathy|peripheral neuropathy
1700472|NCT00058071|neurotoxicity|neurotoxicity
1700473|NCT00058071|hydatidiform mole|hydatidiform mole
1700474|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700475|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1700476|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
1700477|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
1700478|NCT00058058|breast cancer in situ|breast cancer in situ
1700479|NCT00058058|stage I breast cancer|stage i breast cancer
1700480|NCT00058058|stage II breast cancer|stage ii breast cancer
1700481|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
1700482|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
1700483|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
1700484|NCT00058058|stage IV breast cancer|stage iv breast cancer
1700485|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1700486|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
1700487|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1700488|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1700489|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1700490|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1700491|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1700492|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1700493|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1700494|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1700495|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1700496|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1700497|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1700593|NCT00057707|Catecholamines|catecholamines
1700498|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1700499|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1700500|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1700501|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
1700502|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
1700503|NCT00057993|stage IV breast cancer|stage iv breast cancer
1700504|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
1700505|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
1700506|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
1700507|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
1700508|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1700509|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1700679|NCT00057395|Colorectal Tumor|colorectal tumor
1700511|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1700512|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1700513|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1700514|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1700515|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1700516|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1700517|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1700518|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1700519|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1700520|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1700521|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1700522|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1700523|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1700524|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1700525|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1700526|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1700527|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1700528|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1700529|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1700530|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1700531|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1700532|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1700533|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1700534|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1700535|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1700536|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1700537|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1700538|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1700539|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
1700540|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
1716432|NCT00044889|clolar|clolar
1700541|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700542|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1700543|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
1700544|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
1700545|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
1700546|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1700547|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1700548|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1700549|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1700550|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1700551|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1700552|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1700553|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1700554|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1700555|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1700556|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1700557|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
1700558|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1700559|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
1700560|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1700561|NCT00057837|Topotecan|topotecan
1700562|NCT00057837|Etoposide|etoposide
1700563|NCT00057837|Cisplatin|cisplatin
1700564|NCT00057837|Irinotecan|irinotecan
1700565|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1700566|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1700567|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1700568|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1700569|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
1700570|NCT00057785|radiation toxicity|radiation toxicity
1700571|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1700572|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1700573|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1700780|NCT00056901|Pregnancy|pregnancy
1700574|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1700575|NCT00057759|sexual dysfunction|sexual dysfunction
1700576|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
1700577|NCT00057759|radiation toxicity|radiation toxicity
1700578|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
1700579|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
1700580|NCT00057759|stage III prostate cancer|stage iii prostate cancer
1700581|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1700582|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
1700583|NCT00057733|anxiety disorder|anxiety disorder
1700584|NCT00057733|depression|depression
1700585|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1700586|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
1700587|NCT00023673|large cell lung cancer|large cell lung cancer
1700588|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1700589|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1700590|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
1700591|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1700592|NCT00057720|ovary|ovary
1700594|NCT00057707|Dopamine|dopamine
1700595|NCT00057707|fMRI|fmri
1700596|NCT00057707|Working Memory|working memory
1700597|NCT00057707|Clinical Trial|clinical trial
1700598|NCT00057707|Stabilization|stabilization
1700599|NCT00057707|Inpatients|inpatients
1700600|NCT00057707|Placebo|placebo
1700601|NCT00057707|Modafinil|modafinil
1700602|NCT00057707|Normal Volunteers|normal volunteers
1700603|NCT00057707|Schizophrenia|schizophrenia
1700604|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
1700605|NCT00057707|Healthy Volunteer|healthy volunteer
1700606|NCT00057707|HV|hv
1700607|NCT00057694|Qualitative|qualitative
1700608|NCT00057694|Telephone Interviews|telephone interviews
1700609|NCT00057694|Genetic Counseling|genetic counseling
1700610|NCT00057694|Family History|family history
1700611|NCT00057694|Health Information|health information
1700612|NCT00057694|Adult Adoptees|adult adoptees
1700613|NCT00057694|Adult Adoptee|adult adoptee
1700614|NCT00057694|Interview|interview
1700615|NCT00057681|Mania|mania
1700616|NCT00057655|Social Welfare|social welfare
1700617|NCT00057655|Mentally Ill Persons|mentally ill persons
1700618|NCT00057655|Mental Health Services|mental health services
1700619|NCT00057642|Hispanic Americans|hispanic americans
1700621|NCT00057629|Sex Offenses|sex offenses
1700622|NCT00057616|Metastatic Melanoma|metastatic melanoma
1700623|NCT00057616|Melanoma|melanoma
1700624|NCT00057616|Revimid|revimid
1700625|NCT00057616|CC5013|cc5013
1700626|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
1700627|NCT00057564|Multiple Myeloma|multiple myeloma
1700629|NCT00057538|Randomized Trial|randomized trial
1700630|NCT00057538|Stress|stress
1700631|NCT00057538|Spirituality|spirituality
1700632|NCT00057538|Quality of Life|quality of life
1700633|NCT00057538|Complementary Therapies|complementary therapies
1700634|NCT00057525|Anthrax|anthrax
1700635|NCT00057499|Juvenile diabetes|juvenile diabetes
1700636|NCT00057499|Diabetes|diabetes
1700637|NCT00057499|Insulin|insulin
1700638|NCT00057499|Vaccine|vaccine
1700639|NCT00057499|Type 1 Diabetes|type 1 diabetes
1700640|NCT00057499|Diabetes Mellitus|diabetes mellitus
1700641|NCT00057486|Chronic Diarrhea|chronic diarrhea
1700642|NCT00057486|Interleukin 12|interleukin 12
1700643|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1700644|NCT00057447|lymphoma|lymphoma
1700645|NCT00057434|Vitamin A|vitamin a
1700646|NCT00057421|Tuberculosis|tuberculosis
1700647|NCT00057421|HIV infection|hiv infection
1700648|NCT00057421|Prednisolone|prednisolone
1700652|NCT00057460|Neuroprotection|neuroprotection
1700653|NCT00057460|Seizure Disorder|seizure disorder
1700654|NCT00057460|TMS Stimulation|tms stimulation
1700656|NCT00057460|AMPA Antagonist|ampa antagonist
1700657|NCT00057460|Dosing|dosing
1700658|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1700659|NCT00057460|Healthy Volunteer|healthy volunteer
1700660|NCT00057460|HV|hv
1700661|NCT00057408|Autism|autism
1700662|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
1700663|NCT00057408|Treatment|treatment
1700664|NCT00057408|Olanzapine|olanzapine
1700665|NCT00057408|Antipsychotic|antipsychotic
1700666|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
1700667|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
1700668|NCT00057395|Esophagus Cancer|esophagus cancer
1700669|NCT00057395|Esophageal Cancer|esophageal cancer
1700670|NCT00057395|Esophageal Tumors|esophageal tumors
1700671|NCT00057395|Esophagus Tumors|esophagus tumors
1700672|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
1700673|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
1700674|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
1700675|NCT00057395|Hepatoma|hepatoma
1700676|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
1700677|NCT00057395|Colorectal Cancer|colorectal cancer
1700680|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
1700681|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
1700682|NCT00057395|Ovary Neoplasms|ovary neoplasms
1700683|NCT00057395|Ovary Cancer|ovary cancer
1700684|NCT00057395|Ovary Carcinoma|ovary carcinoma
1700685|NCT00057395|Ovarian Cancer|ovarian cancer
1700686|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
1700687|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
1700688|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
1700689|NCT00057395|Pancreatic Cancer|pancreatic cancer
1700690|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
1700691|NCT00057395|Pancreas Cancer|pancreas cancer
1700692|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
1700693|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
1700694|NCT00057395|and other solid tumors|and other solid tumors
1700695|NCT00057382|liver cancer|liver cancer
1700696|NCT00057356|Chronic Heart Failure|chronic heart failure
1700697|NCT00057356|YM078|ym078
1700698|NCT00057291|Orphanage|orphanage
1700699|NCT00057291|Caregiving|caregiving
1700700|NCT00057291|Training|training
1700701|NCT00057291|Child development|child development
1700702|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
1700703|NCT00057031|MDS|mds
1700704|NCT00057278|Gabapentin|gabapentin
1700705|NCT00057200|Home Care|home care
1700706|NCT00057252|Diagnostic Radiology|diagnostic radiology
1700707|NCT00057252|Imaging|imaging
1700708|NCT00057252|Algorithms|algorithms
1700709|NCT00057252|Healthy Volunteer|healthy volunteer
1700710|NCT00057252|HV|hv
1700711|NCT00057239|GW353162|gw353162
1700712|NCT00057239|Major Depressive Disorder|major depressive disorder
1700713|NCT00057239|MDD|mdd
1700714|NCT00057226|GW353162,|gw353162,
1700715|NCT00057226|Major depressive disorder,|major depressive disorder,
1700716|NCT00057226|flexible|flexible
1700717|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
1700718|NCT00057213|Flexible|flexible
1700719|NCT00057213|GW353162,|gw353162,
1700720|NCT00057174|Proton pump inhibitor|proton pump inhibitor
1700721|NCT00057148|massage therapy|massage therapy
1700722|NCT00057148|pain management|pain management
1700723|NCT00057148|post-surgical|post-surgical
1700724|NCT00057148|complementary therapy|complementary therapy
1700725|NCT00057135|Schizophrenia|schizophrenia
1700726|NCT00057135|Treatment Refusal|treatment refusal
1700727|NCT00057135|Drug Packaging|drug packaging
1700728|NCT00057135|Reminder Systems|reminder systems
1700729|NCT00057135|Antipsychotic Agents|antipsychotic agents
1700730|NCT00057122|Preventive therapy|preventive therapy
1700731|NCT00057083|Telemedicine|telemedicine
1700732|NCT00057083|Remote consultation|remote consultation
1700733|NCT00057083|Patient Satisfaction|patient satisfaction
1700734|NCT00057083|Physician patient relations|physician patient relations
1700735|NCT00057083|Provider satisfaction|provider satisfaction
1700736|NCT00057083|Doctor-patient relations|doctor-patient relations
1700737|NCT00057018|stroke|stroke
1700738|NCT00057018|cerebrovascular accident|cerebrovascular accident
1700739|NCT00057018|upper extremity|upper extremity
1700740|NCT00057018|physical therapy|physical therapy
1700741|NCT00057018|constraint-induced therapy|constraint-induced therapy
1700742|NCT00057005|LEUKEMIA|leukemia
1700743|NCT00056979|Metabolic diseases|metabolic diseases
1700744|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
1700745|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
1700746|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
1700747|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
1700748|NCT00056966|Hodgkin's disease|hodgkin's disease
1700749|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
1700750|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
1700751|NCT00056966|Multiple myeloma|multiple myeloma
1700752|NCT00056966|Severe aplastic anemia|severe aplastic anemia
1700753|NCT00056953|health behavior|health behavior
1700754|NCT00056953|adolescent behavior|adolescent behavior
1700755|NCT00056953|peer mentoring|peer mentoring
1700756|NCT00056940|Prevention|prevention
1700757|NCT00056940|Parenting strategies|parenting strategies
1700758|NCT00056940|Media use|media use
1700759|NCT00056940|Discipline|discipline
1700760|NCT00056940|Firearm storage|firearm storage
1700761|NCT00056927|Smoking|smoking
1700762|NCT00056927|Primary Prevention|primary prevention
1700763|NCT00056927|Health Education|health education
1700764|NCT00056927|Child|child
1700765|NCT00056927|Parents|parents
1700766|NCT00056927|Parenting Education|parenting education
1700767|NCT00056927|Communication|communication
1700768|NCT00056875|graft versus host disease|graft versus host disease
1700769|NCT00056875|bone marrow transplant|bone marrow transplant
1700770|NCT00056875|alternative donor|alternative donor
1700771|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
1700772|NCT00056914|Functional Imaging|functional imaging
1700773|NCT00056914|Cerebral Blood Flow|cerebral blood flow
1700774|NCT00056914|Parallel Imaging|parallel imaging
1700775|NCT00056914|BOLD Effect|bold effect
1700776|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
1700777|NCT00056914|Healthy Volunteer|healthy volunteer
1700778|NCT00056914|HV|hv
1700779|NCT00056901|Puerperium|puerperium
1700781|NCT00056901|Mood Disorders|mood disorders
1700782|NCT00056901|Estradiol|estradiol
1700783|NCT00056901|Progesterone|progesterone
1700784|NCT00056901|Mood|mood
1700785|NCT00056901|Behavior|behavior
1700786|NCT00056901|Cognition|cognition
1700787|NCT00056901|Perimenopause|perimenopause
1700788|NCT00056901|Menopause|menopause
1700789|NCT00056901|Post Partum Depression|post partum depression
1700790|NCT00056901|PPD|ppd
1700791|NCT00056901|Healthy Volunteer|healthy volunteer
1700792|NCT00056901|HV|hv
1700793|NCT00056888|Electroencephalogram|electroencephalogram
1700794|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
1700795|NCT00056888|Startle Reflex|startle reflex
1700796|NCT00056888|Electromyogram|electromyogram
1700797|NCT00056888|Psychogenic|psychogenic
1700798|NCT00056888|Paroxysmal|paroxysmal
1700799|NCT00056888|Dyskinesia|dyskinesia
1700800|NCT00056888|Kinesiogenic|kinesiogenic
1700801|NCT00056888|EEG|eeg
1700802|NCT00056888|Movement-Related Potential|movement-related potential
1700803|NCT00056888|Movement Disorder|movement disorder
1700804|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
1700805|NCT00056888|Disorder|disorder
1700806|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
1700807|NCT00056836|AMD|amd
1700808|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
1700809|NCT00056823|AMD|amd
1700810|NCT00056862|Hepatitis C Virus|hepatitis c virus
1700811|NCT00056862|Antiviral Agents|antiviral agents
1700812|NCT00056862|Hemolysis|hemolysis
1700813|NCT00056862|Neutropenia|neutropenia
1700814|NCT00056862|Cirrhosis|cirrhosis
1700815|NCT00056862|Hemolytic Anemia|hemolytic anemia
1700816|NCT00056862|Viral Hepatitis|viral hepatitis
1700817|NCT00056862|Ribavirin|ribavirin
1700818|NCT00056862|Alfa Interferon|alfa interferon
1700819|NCT00056862|Pegylated Interferon|pegylated interferon
1700820|NCT00056862|Hepatitis C|hepatitis c
1700821|NCT00056862|HCV|hcv
1700822|NCT00056849|Arthritis|arthritis
1700823|NCT00056849|Spondyloarthropathy|spondyloarthropathy
1700824|NCT00056849|Spine|spine
1700825|NCT00056849|Hereditary|hereditary
1700827|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
1700829|NCT00056849|Spondyloarthritis|spondyloarthritis
1700830|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
1700831|NCT00056810|4-aminopyridine|4-aminopyridine
1700832|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
1700833|NCT00056797|IL-2|il-2
1700834|NCT00056797|Structured Treatment Interruption|structured treatment interruption
1700835|NCT00056797|Treatment Experienced|treatment experienced
1700836|NCT00056784|TGF-Beta|tgf-beta
1700837|NCT00056784|Kidney|kidney
1700838|NCT00056784|Transplantation|transplantation
1700839|NCT00056784|Rejection|rejection
1700840|NCT00056784|Immunosuppression|immunosuppression
1700841|NCT00056784|Kidney Transplant|kidney transplant
1700842|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
1700843|NCT00056784|CAN|can
1700844|NCT00056771|Cataract|cataract
1700845|NCT00056771|Congenital Cataracts|congenital cataracts
1700846|NCT00056771|Hereditary Cataracts|hereditary cataracts
1700847|NCT00056758|HIV-1|hiv-1
1700848|NCT00056758|HAART|haart
1700849|NCT00056758|Therapeutic immunization|therapeutic immunization
1700850|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1700851|NCT00056758|Treatment Experienced|treatment experienced
1700852|NCT00056745|HIV seronegativity|hiv seronegativity
1700853|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
1700854|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
1700855|NCT00056680|Prematurity|prematurity
1715830|NCT00049816|knee|knee
1700856|NCT00056680|low birthweight|low birthweight
1700857|NCT00056680|parenting|parenting
1700858|NCT00056680|intervention|intervention
1700859|NCT00056667|Treatment|treatment
1700860|NCT00056667|Pain|pain
1700861|NCT00056667|Relaxation Response|relaxation response
1700862|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
1700863|NCT00056654|Leuprolide|leuprolide
1700864|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
1700865|NCT00056654|Testosterone|testosterone
1700866|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
1700867|NCT00056654|Pharmacokinetics|pharmacokinetics
1700868|NCT00056654|luprolide acetate|luprolide acetate
1700869|NCT00056719|Arthritis|arthritis
1700870|NCT00056719|Spondylarthropathy|spondylarthropathy
1700871|NCT00056719|Spine|spine
1700872|NCT00056719|Hereditary|hereditary
1700873|NCT00056719|Disability|disability
1700874|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
1700875|NCT00056719|Spondyloarthropathy|spondyloarthropathy
1700876|NCT00056719|Spondyloarthritis|spondyloarthritis
1700877|NCT00056719|AS|as
1700878|NCT00056706|Motor Deficit|motor deficit
1700879|NCT00056706|Somatosensory Deficit|somatosensory deficit
1700880|NCT00056706|Cortical Reorganization|cortical reorganization
1700881|NCT00056706|Disinhibition|disinhibition
1700882|NCT00056706|Rehabilitation|rehabilitation
1700883|NCT00056706|Plasticity|plasticity
1700884|NCT00056706|Stroke|stroke
1700885|NCT00056628|Alzheimer disease|alzheimer disease
1700887|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
1700888|NCT00056628|Tau|tau
1700889|NCT00056628|ABeta|abeta
1700890|NCT00056602|Utility|utility
1700891|NCT00056602|Health Status|health status
1700892|NCT00056602|Preferences|preferences
1700893|NCT00056602|Response Criteria|response criteria
1700894|NCT00056602|Treatment|treatment
1700895|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
1700896|NCT00056602|RA|ra
1700897|NCT00056576|Monotherapy|monotherapy
1700898|NCT00056576|Complex Partial Seizures|complex partial seizures
1700899|NCT00056576|Epilepsy|epilepsy
1700900|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
1700901|NCT00056576|AED|aed
1700902|NCT00056563|Parkinson's disease|parkinson's disease
1700903|NCT00056563|levo-dopa|levo-dopa
1700904|NCT00056563|tremor|tremor
1700905|NCT00056563|dyskinesia|dyskinesia
1700906|NCT00056563|subthalamic nucleus|subthalamic nucleus
1700907|NCT00056563|globus pallidus|globus pallidus
1700908|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
1700909|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
1700910|NCT00056524|ALS|als
1700911|NCT00056524|MS|ms
1700912|NCT00056524|CNS|cns
1700913|NCT00056524|AD|ad
1700914|NCT00056524|TBI|tbi
1700915|NCT00056524|Dextromethorphan|dextromethorphan
1700916|NCT00056524|IEED|ieed
1700917|NCT00056524|Emotional|emotional
1700918|NCT00056511|Garlic|garlic
1700919|NCT00056511|Supplements|supplements
1700920|NCT00056511|Adults|adults
1700921|NCT00056511|Hypercholesterolemics|hypercholesterolemics
1700922|NCT00056511|Randomized Clinical Trial|randomized clinical trial
1700923|NCT00056485|Nursing homes|nursing homes
1700924|NCT00056485|Aging|aging
1700925|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
1700926|NCT00056472|Delusional Depression|delusional depression
1700927|NCT00056472|Randomized Trial|randomized trial
1700928|NCT00056472|Combination Treatment|combination treatment
1700929|NCT00056472|SSRI|ssri
1700930|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
1700931|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
1700933|NCT00012454|Prevention|prevention
1700934|NCT00012454|Mucosal Tolerance|mucosal tolerance
1700935|NCT00012454|E-selectin|e-selectin
1700936|NCT00056459|Colorectal Cancer|colorectal cancer
1700937|NCT00056459|PTK787|ptk787
1700938|NCT00056459|Vatalanib|vatalanib
1700939|NCT00056459|VEGF inhibitor|vegf inhibitor
1700940|NCT00056459|Oxaliplatin|oxaliplatin
1700941|NCT00056459|Angiogenesis|angiogenesis
1700942|NCT00056459|Rectal Cancer|rectal cancer
1700943|NCT00056459|Colon Cancer|colon cancer
1700944|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
1700945|NCT00056459|Colorectal Tumor|colorectal tumor
1700946|NCT00056446|Colorectal Cancer|colorectal cancer
1700947|NCT00056446|Oxaliplatin|oxaliplatin
1700948|NCT00056446|VEGF inhibitor|vegf inhibitor
1700949|NCT00056446|Vatalanib|vatalanib
1700950|NCT00056446|PTK787|ptk787
1700951|NCT00056446|Colon Cancer|colon cancer
1700952|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
1700953|NCT00056446|Rectal Cancer|rectal cancer
1700954|NCT00056446|Colorectal Tumor|colorectal tumor
1700955|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
1700956|NCT00056433|L-Arginine|l-arginine
1700957|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
1700958|NCT00056433|Sickle Cell Disease|sickle cell disease
1700959|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
1700960|NCT00056433|Sickle Cell Anemia|sickle cell anemia
1700961|NCT00056420|Tourette's Syndrome|tourette's syndrome
1700962|NCT00056420|Tic Disorder|tic disorder
1700963|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
1700964|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
1700965|NCT00056420|Coherence|coherence
1700966|NCT00056420|Tourette's|tourette's
1700967|NCT00056420|Tourette Syndrome|tourette syndrome
1700968|NCT00056420|Healthy Volunteer|healthy volunteer
1700970|NCT00056407|Prostate cancer prevention|prostate cancer prevention
1700971|NCT00056407|prostate|prostate
1700972|NCT00056407|BPH|bph
1700973|NCT00056407|enlarged prostate|enlarged prostate
1700974|NCT00056407|PSA|psa
1700975|NCT00056407|prostate cancer|prostate cancer
1700976|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
1700977|NCT00056394|Coping Skills Training|coping skills training
1700978|NCT00056394|Pain|pain
1700979|NCT00056394|Physical Disability|physical disability
1700980|NCT00056394|Psychological Disability|psychological disability
1700981|NCT00056394|Daily Diary Measures|daily diary measures
1700982|NCT00056381|neutropenia|neutropenia
1700983|NCT00056381|fever|fever
1700984|NCT00056381|febrile neutropenia|febrile neutropenia
1700985|NCT00056368|Candida blood stream infections|candida blood stream infections
1700986|NCT00056368|Candida infections|candida infections
1700987|NCT00056368|Candidemia|candidemia
1700988|NCT00056368|Invasive Candidiasis|invasive candidiasis
1700989|NCT00056329|Aging Persons|aging persons
1700990|NCT00056329|Down Syndrome|down syndrome
1700991|NCT00056329|Vitamin E|vitamin e
1700992|NCT00056329|Alzheimer disease|alzheimer disease
1700997|NCT00056355|Ultraviolet A Light|ultraviolet a light
1700998|NCT00056355|Crohn's Disease|crohn's disease
1700999|NCT00056355|Crohn Disease|crohn disease
1701000|NCT00056316|Caregiving|caregiving
1701001|NCT00056316|Dementia|dementia
1701002|NCT00056316|Alzheimer's|alzheimer's
1701003|NCT00056316|Depression|depression
1701004|NCT00056316|Technology|technology
1701005|NCT00056316|Treatment|treatment
1701006|NCT00056303|Attachment|attachment
1701007|NCT00056303|Intervention|intervention
1701008|NCT00056303|Prevention|prevention
1701009|NCT00056290|Diabetes Mellitus|diabetes mellitus
1701010|NCT00056290|Neuropathy|neuropathy
1701011|NCT00056290|Peripheral Artery Disease|peripheral artery disease
1701012|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1701013|NCT00056264|COPD|copd
1701014|NCT00056264|Infliximab|infliximab
1701015|NCT00056264|Remicade|remicade
1701016|NCT00056251|Interstitial Cystitis|interstitial cystitis
1701017|NCT00056251|Bladder|bladder
1701018|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
1701019|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
1701020|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
1701021|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
1701022|NCT00056225|homocysteine|homocysteine
1701023|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
1701024|NCT00056199|Vision Loss|vision loss
1701025|NCT00056199|Optic Nerve Tumors|optic nerve tumors
1701026|NCT00056199|Macular Edema|macular edema
1701027|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
1701028|NCT00056199|VEGF|vegf
1701029|NCT00056199|EYE001|eye001
1701030|NCT00056199|VHL|vhl
1701031|NCT00056186|Adaptation|adaptation
1701032|NCT00056186|Neurodegenerative|neurodegenerative
1701033|NCT00056186|Health Care Provider|health care provider
1701034|NCT00056186|Psychosocial|psychosocial
1701035|NCT00056186|Chronic Illness/Disability|chronic illness/disability
1701036|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
1701037|NCT00056186|Friedreich Ataxia|friedreich ataxia
1701038|NCT00056186|FA|fa
1701039|NCT00056160|Multiple Myeloma|multiple myeloma
1701040|NCT00056160|Refractory and Relapsed|refractory and relapsed
1701041|NCT00056160|Revlimid|revlimid
1701042|NCT00056160|CC5013|cc5013
1701043|NCT00056147|cystic fibrosis|cystic fibrosis
1701044|NCT00056134|recurrent melanoma|recurrent melanoma
1701045|NCT00056134|stage IV melanoma|stage iv melanoma
1701046|NCT00056134|stage IIIA melanoma|stage iiia melanoma
1701047|NCT00056134|stage IIIB melanoma|stage iiib melanoma
1701048|NCT00056134|stage IIIC melanoma|stage iiic melanoma
1701049|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
1701050|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
1701051|NCT00056082|breast cancer|breast cancer
1701052|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1701053|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1701054|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1701055|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1701056|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1701057|NCT00056030|liver metastases|liver metastases
1701058|NCT00056030|stage IV colon cancer|stage iv colon cancer
1701059|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
1701060|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
1701061|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1701062|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
1701063|NCT00056004|small cell lung cancer|small cell lung cancer
1701064|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1701065|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1701066|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1701067|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1701068|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1701069|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1701070|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1701071|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1701072|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1701073|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1701074|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1701075|NCT00055991|breast cancer|breast cancer
1701076|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
1701077|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1701078|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1701079|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701080|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1701081|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1701082|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1701083|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1701084|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1701085|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1701086|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1701087|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1701088|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1701089|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1701090|NCT00055926|recurrent breast cancer|recurrent breast cancer
1701091|NCT00055926|stage IV breast cancer|stage iv breast cancer
1701092|NCT00055926|male breast cancer|male breast cancer
1701093|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701094|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1701095|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
1701096|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
1701097|NCT00055887|large cell lung cancer|large cell lung cancer
1701098|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701099|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1701100|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1701101|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
1701102|NCT00055848|stage I colon cancer|stage i colon cancer
1701103|NCT00055848|stage II colon cancer|stage ii colon cancer
1701104|NCT00055848|stage III colon cancer|stage iii colon cancer
1701105|NCT00055848|stage IV colon cancer|stage iv colon cancer
1716433|NCT00044863|EGFr|egfr
1701106|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
1701107|NCT00055835|stage III bladder cancer|stage iii bladder cancer
1701108|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1701109|NCT00055835|stage II bladder cancer|stage ii bladder cancer
1701110|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
1701111|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1701112|NCT00055835|distal urethral cancer|distal urethral cancer
1701113|NCT00055835|proximal urethral cancer|proximal urethral cancer
1701114|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
1701115|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1701116|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
1701117|NCT00055822|recurrent colon cancer|recurrent colon cancer
1701118|NCT00055822|stage III colon cancer|stage iii colon cancer
1701119|NCT00055822|stage IV colon cancer|stage iv colon cancer
1701120|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1701121|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
1701122|NCT00055822|stage III rectal cancer|stage iii rectal cancer
1701123|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
1701124|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1701125|NCT00055731|stage III prostate cancer|stage iii prostate cancer
1701126|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
1701127|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
1701128|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1701129|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1701130|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1701131|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1701132|NCT00055705|fallopian tube cancer|fallopian tube cancer
1701133|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1701134|NCT00055705|recurrent colon cancer|recurrent colon cancer
1701135|NCT00055705|stage IV colon cancer|stage iv colon cancer
1701136|NCT00055705|ovarian sarcoma|ovarian sarcoma
1701137|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1701138|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1701139|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1701140|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1701141|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
1701142|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
1701143|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
1701144|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
1701145|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
1701146|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1701147|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1701148|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1701149|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
1701150|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1701151|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
1701152|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
1701153|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
1701154|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
1701155|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1701156|NCT00055705|small intestine lymphoma|small intestine lymphoma
1701157|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
1701158|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
1701159|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
1701160|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
1701161|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1701162|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1701163|NCT00055679|stage I breast cancer|stage i breast cancer
1701164|NCT00055666|graft versus host disease|graft versus host disease
1701165|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1701166|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
1701167|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1701168|NCT00055653|refractory anemia|refractory anemia
1701169|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1701170|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1701171|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1701172|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1701173|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1701174|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1701175|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1701176|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1701177|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701178|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
1701265|NCT00055380|Small Molecule|small molecule
1701179|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1701180|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1701181|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1701182|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1701183|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1701184|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1701185|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1701186|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701187|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1701188|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1701189|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701190|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1701191|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1701192|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1701193|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1701194|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1701195|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1701196|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1701197|NCT00055614|fallopian tube cancer|fallopian tube cancer
1701198|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1701199|NCT00055601|stage II bladder cancer|stage ii bladder cancer
1701200|NCT00055601|stage III bladder cancer|stage iii bladder cancer
1701201|NCT00022139|stage III gastric cancer|stage iii gastric cancer
1701202|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
1701203|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
1701204|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1701205|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1701206|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1701207|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1701208|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
1701209|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
1701210|NCT00055588|Spinal Reflexes|spinal reflexes
1701211|NCT00055588|Motor Practice|motor practice
1701212|NCT00055588|Spinal Cord Injury|spinal cord injury
1701213|NCT00055588|Locomotion|locomotion
1701214|NCT00055588|Healthy Volunteer|healthy volunteer
1701216|NCT00055575|Scopolamine|scopolamine
1701217|NCT00055575|Depression|depression
1701218|NCT00055575|fMRI|fmri
1701219|NCT00055575|Cognition|cognition
1701220|NCT00055575|Emotion|emotion
1701221|NCT00055575|Brain|brain
1701222|NCT00055575|Bipolar Disorder|bipolar disorder
1701223|NCT00055575|Major Depressive Disorder|major depressive disorder
1701224|NCT00055575|MDD|mdd
1701225|NCT00055575|Healthy Volunteer|healthy volunteer
1701226|NCT00055575|HV|hv
1701227|NCT00055562|Metastatic Melanoma|metastatic melanoma
1701228|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
1701229|NCT00055562|Revimid|revimid
1701231|NCT00055549|Dextromethorphan|dextromethorphan
1701232|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
1701233|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
1701234|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
1701235|NCT00055549|Voice Tremor|voice tremor
1701236|NCT00055549|Lorazepam|lorazepam
1701237|NCT00055549|Dysphonia|dysphonia
1701238|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
1701239|NCT00055510|BO-653|bo-653
1701240|NCT00055510|Coronary restenosis|coronary restenosis
1701241|NCT00055510|Stent restenosis|stent restenosis
1701242|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
1701243|NCT00055510|Antioxidant|antioxidant
1701244|NCT00055484|Migraine Headache|migraine headache
1701245|NCT00055484|prophylaxis|prophylaxis
1701246|NCT00055484|AED|aed
1701247|NCT00055484|migraine prophylaxis|migraine prophylaxis
1701248|NCT00055471|prostate cancer|prostate cancer
1701249|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
1701250|NCT00055471|bone metastases|bone metastases
1701251|NCT00055445|Complementary Therapies|complementary therapies
1701252|NCT00055445|IdB 1016|idb 1016
1701253|NCT00055445|Silybin|silybin
1701254|NCT00055445|Antioxidant|antioxidant
1701255|NCT00055445|Hepatitis C Virus|hepatitis c virus
1701256|NCT00055445|Phosphatidylcholine|phosphatidylcholine
1701257|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
1701258|NCT00055432|platinum-resistant|platinum-resistant
1701259|NCT00055432|platinum-sensitive|platinum-sensitive
1701260|NCT00055432|folate receptor antagonist|folate receptor antagonist
1701261|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
1701262|NCT00055380|Molecular Targets|molecular targets
1701263|NCT00055380|Keratinocytes|keratinocytes
1701264|NCT00055380|Cell Cycle|cell cycle
1701280|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
1701281|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1701282|NCT00055289|Counting|counting
1701283|NCT00055289|Sensorimotor Integration|sensorimotor integration
1701284|NCT00055289|Superior Temporal Cortex|superior temporal cortex
1701285|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
1701286|NCT00055289|Healthy Volunteer|healthy volunteer
1701288|NCT00055237|Angiogenesis|angiogenesis
1701289|NCT00055237|Cancer|cancer
1701290|NCT00055237|HHV-8|hhv-8
1701291|NCT00055237|KSHV|kshv
1701292|NCT00055237|Skin|skin
1701293|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
1701294|NCT00055237|KS|ks
1701295|NCT00055224|Anxiety Disorder|anxiety disorder
1701296|NCT00055224|Fear|fear
1701297|NCT00055224|Aversive Conditioning|aversive conditioning
1701298|NCT00055224|Psychophysiology|psychophysiology
1701299|NCT00055224|Predictability|predictability
1701300|NCT00055224|Startle|startle
1701301|NCT00055224|Context Conditioning|context conditioning
1701302|NCT00055224|Fear Conditioning|fear conditioning
1701303|NCT00055224|Agoraphobia|agoraphobia
1701304|NCT00055224|Panic Disorder|panic disorder
1701305|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
1701306|NCT00055224|GAD|gad
1701307|NCT00055224|Healthy Volunteer|healthy volunteer
1701308|NCT00055224|HV|hv
1701309|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
1701310|NCT00055198|expanded access program|expanded access program
1701311|NCT00055198|resistant infections|resistant infections
1701312|NCT00055198|bacteremia|bacteremia
1701313|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
1701314|NCT00055198|bacterial infections|bacterial infections
1701315|NCT00055185|Treatment Experienced|treatment experienced
1701316|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
1701317|NCT00055133|Paxceed|paxceed
1701318|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
1701319|NCT00055172|Cytokines|cytokines
1701320|NCT00055172|Mutation|mutation
1701321|NCT00055172|DNA|dna
1701322|NCT00055172|Phenotype|phenotype
1701323|NCT00055172|T Cell|t cell
1701324|NCT00055172|Immunodeficiency|immunodeficiency
1701325|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
1701326|NCT00055159|RT PA|rt pa
1701327|NCT00055159|Blood Clots|blood clots
1701328|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
1701329|NCT00055159|Alteplase|alteplase
1701330|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
1701331|NCT00055159|DVT|dvt
1701332|NCT00055120|Anti-HIV Agents|anti-hiv agents
1701333|NCT00055120|Disease Progression|disease progression
1701334|NCT00055120|Drug Administration Schedule|drug administration schedule
1701335|NCT00055120|Viral Load|viral load
1701336|NCT00055120|HIV-1|hiv-1
1701337|NCT00055120|Treatment Outcome|treatment outcome
1701338|NCT00055120|Survival Analysis|survival analysis
1701339|NCT00055120|Treatment Naive|treatment naive
1701340|NCT00055107|Nitazoxanide|nitazoxanide
1701341|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
1701342|NCT00055107|Cryptosporidiosis|cryptosporidiosis
1701343|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
1701344|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1701345|NCT00055107|Pharmacokinetics|pharmacokinetics
1701346|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
1701347|NCT00055094|Immune system|immune system
1701348|NCT00055094|Helper T-Cells|helper t-cells
1701349|NCT00055094|Acute Infection|acute infection
1701350|NCT00055094|Treatment naive|treatment naive
1701351|NCT00055081|Homeless Persons|homeless persons
1701373|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
1701374|NCT00055042|Diabetes Type I|diabetes type i
1701375|NCT00055042|Diabetes Type II|diabetes type ii
1701376|NCT00055042|Diabetic Macular Edema|diabetic macular edema
1701377|NCT00055029|Retinoschisis|retinoschisis
1701378|NCT00055029|Genomic DNA|genomic dna
1701379|NCT00055029|Pedigree Analysis|pedigree analysis
1701380|NCT00055029|Genetic Analysis|genetic analysis
1701381|NCT00055029|Macular Degeneration|macular degeneration
1701382|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
1701383|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
1701384|NCT00055029|XLRS|xlrs
1701385|NCT00055016|Lysosomal Disease|lysosomal disease
1701386|NCT00055016|Renal Function|renal function
1701387|NCT00055016|Stroke|stroke
1701388|NCT00055016|Cardiac Disease|cardiac disease
1701389|NCT00055016|Natural History|natural history
1701390|NCT00055016|Fabry Disease|fabry disease
1701391|NCT00055003|Amygdala|amygdala
1701392|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
1701393|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
1701394|NCT00055003|Cortisol|cortisol
1701395|NCT00055003|Memory|memory
1701396|NCT00055003|Glucocorticoid|glucocorticoid
1701397|NCT00055003|Hydrocortisone|hydrocortisone
1701398|NCT00055003|Stress|stress
1701399|NCT00055003|Perception|perception
1701400|NCT00055003|Affect|affect
1701401|NCT00055003|Healthy Volunteer|healthy volunteer
1701402|NCT00055003|HV|hv
1701403|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
1701404|NCT00054990|Cortical Excitability|cortical excitability
1701405|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1701406|NCT00054990|Epilepsy|epilepsy
1701407|NCT00054990|TMS|tms
1701408|NCT00054990|Healthy Volunteer|healthy volunteer
1701409|NCT00054990|HV|hv
1701410|NCT00054977|cancer|cancer
1701411|NCT00054977|tumor|tumor
1701412|NCT00054951|Hepatoma|hepatoma
1701413|NCT00054951|Liver Cancer|liver cancer
1701414|NCT00054938|SLE|sle
1701415|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
1701416|NCT00054938|Cholesterol|cholesterol
1701417|NCT00054912|vaccine|vaccine
1701418|NCT00054912|colon|colon
1701419|NCT00054912|cancer|cancer
1701420|NCT00054912|colorectal|colorectal
1701421|NCT00054912|neoplasm|neoplasm
1701422|NCT00054912|Colonic Cancer|colonic cancer
1701423|NCT00054912|Colon Cancer|colon cancer
1701424|NCT00054912|Cancer of the Colon|cancer of the colon
1701425|NCT00054899|vaccine|vaccine
1701426|NCT00054899|lung|lung
1701427|NCT00054899|cancer|cancer
1701428|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
1701429|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
1701430|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
1701431|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
1701432|NCT00054860|HIV Seronegativity|hiv seronegativity
1701433|NCT00054860|HIV-1|hiv-1
1701434|NCT00054860|AIDS Vaccines|aids vaccines
1701435|NCT00054860|Vaccines, DNA|vaccines, dna
1701436|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1701437|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1701438|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1701439|NCT00054860|Epitopes|epitopes
1701440|NCT00054847|CABG|cabg
1701441|NCT00054847|cardiovascular|cardiovascular
1701442|NCT00054847|chronic diseases|chronic diseases
1701443|NCT00054847|clinical trial|clinical trial
1701444|NCT00054847|heart|heart
1701445|NCT00054847|multi-site trial|multi-site trial
1701446|NCT00054847|prospective|prospective
1701447|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
1701448|NCT00054821|Ankle Distraction|ankle distraction
1701449|NCT00054808|Gallium Nitrate|gallium nitrate
1701450|NCT00054808|Ganite|ganite
1701451|NCT00054808|NHL|nhl
1701452|NCT00054808|Relapsed|relapsed
1701453|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
1701454|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
1701455|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
1701456|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
1701457|NCT00054795|Combined Modality Therapy,|combined modality therapy,
1701458|NCT00054795|Drug therapy,|drug therapy,
1701459|NCT00054795|Quality of Life,|quality of life,
1701460|NCT00054795|Cranial Irradiation,|cranial irradiation,
1701461|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
1701462|NCT00054795|Prospective Studies,|prospective studies,
1701463|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
1701464|NCT00054795|Treatment Outcome|treatment outcome
1701465|NCT00054795|Brain metastases|brain metastases
1701466|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
1701467|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
1701468|NCT00054769|Pediatrics|pediatrics
1701469|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
1701470|NCT00054730|Fragile X Syndrome|fragile x syndrome
1701472|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
1701473|NCT00054756|Neuropeptide|neuropeptide
1701474|NCT00054756|Diagnostic Testing|diagnostic testing
1701475|NCT00054756|Pituitary Tumors|pituitary tumors
1701476|NCT00054756|Central Hypothyroidism|central hypothyroidism
1701477|NCT00054756|Pituitary Disorder|pituitary disorder
1701478|NCT00054756|Thyroid Disorder|thyroid disorder
1701479|NCT00054756|Healthy Volunteer|healthy volunteer
1701480|NCT00054756|HV|hv
1701481|NCT00054743|Race|race
1701482|NCT00054743|Ethnicity|ethnicity
1701483|NCT00054743|Pharmacogenetics|pharmacogenetics
1701484|NCT00054743|Cytochrome P450|cytochrome p450
1701485|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
1701486|NCT00054743|HIV|hiv
1701487|NCT00054704|Riluzole|riluzole
1701488|NCT00054704|Neuroprotective|neuroprotective
1701489|NCT00054704|Open-Label Study|open-label study
1701490|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
1701491|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
1701492|NCT00054704|Bipolar Disorder|bipolar disorder
1701493|NCT00054704|Mood Disorder|mood disorder
1701494|NCT00054691|Skin Cancer|skin cancer
1701495|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
1701496|NCT00054691|Gefitinib|gefitinib
1701497|NCT00054691|ZD1839|zd1839
1701498|NCT00054691|Iressa|iressa
1701499|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
1701500|NCT00054691|EGFR|egfr
1701501|NCT00054678|Myocardial infarction|myocardial infarction
1701502|NCT00054678|Heart disease|heart disease
1701503|NCT00054678|Endoventricular|endoventricular
1701504|NCT00054678|Cardiovascular|cardiovascular
1701505|NCT00054678|Interventional|interventional
1701506|NCT00054678|ICD|icd
1701507|NCT00054678|Heart failure|heart failure
1701508|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1701509|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1701510|NCT00050531|CML|cml
1701511|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
1701512|NCT00050531|Imatinib Mesylate|imatinib mesylate
1701513|NCT00050531|Gleevec|gleevec
1701514|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
1701515|NCT00050531|Peg-Intron|peg-intron
1701516|NCT00050531|Sargramostim|sargramostim
1701517|NCT00050531|GM-CSF|gm-csf
1701518|NCT00054665|BCL-2|bcl-2
1701519|NCT00054665|NFK-B|nfk-b
1701520|NCT00054665|Drug Resistance|drug resistance
1701521|NCT00054665|Translational|translational
1701522|NCT00054665|Lymphoma|lymphoma
1701523|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
1701524|NCT00054652|Geste Antagoniste|geste antagoniste
1701525|NCT00054652|TMS|tms
1701526|NCT00054652|Sensorimotor Integration|sensorimotor integration
1701527|NCT00054652|Writer's Cramp|writer's cramp
1701528|NCT00054652|Sensory Input|sensory input
1701529|NCT00054652|Focal Dystonia|focal dystonia
1701530|NCT00054626|stage II bladder cancer|stage ii bladder cancer
1701531|NCT00054626|stage III bladder cancer|stage iii bladder cancer
1701532|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
1701533|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1701534|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
1701535|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
1701536|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
1701537|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
1701538|NCT00054587|stage II breast cancer|stage ii breast cancer
1701539|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
1701540|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
1701541|NCT00054574|stage I prostate cancer|stage i prostate cancer
1701542|NCT00054574|stage II prostate cancer|stage ii prostate cancer
1701543|NCT00054574|stage III prostate cancer|stage iii prostate cancer
1701544|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1701545|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1701546|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1701547|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1701548|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1701549|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1701550|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1701551|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1701552|NCT00054535|stage IV melanoma|stage iv melanoma
1701553|NCT00054535|recurrent melanoma|recurrent melanoma
1701554|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1701555|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
1701556|NCT00054496|adult glioblastoma|adult glioblastoma
1701557|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
1701847|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
1701823|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
1701558|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
1701559|NCT00054496|adult gliosarcoma|adult gliosarcoma
1701560|NCT00054470|stage IV breast cancer|stage iv breast cancer
1701561|NCT00054470|recurrent breast cancer|recurrent breast cancer
1701562|NCT00054470|male breast cancer|male breast cancer
1701563|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1701564|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1701565|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
1701566|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
1701567|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
1701568|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
1701569|NCT00054418|osteoporosis|osteoporosis
1701570|NCT00054418|stage I breast cancer|stage i breast cancer
1701571|NCT00054418|stage II breast cancer|stage ii breast cancer
1701572|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
1701573|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
1701574|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1701575|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1701576|NCT00054392|large cell lung cancer|large cell lung cancer
1701577|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1701578|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
1701579|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701580|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1701581|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
1701582|NCT00054340|graft versus host disease|graft versus host disease
1701583|NCT00054340|polycythemia vera|polycythemia vera
1701584|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1701585|NCT00054340|essential thrombocythemia|essential thrombocythemia
1701586|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1701587|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701588|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1701589|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1701590|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1701591|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701592|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1701593|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1701594|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1701595|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701596|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701597|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701598|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701599|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701600|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701601|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1701602|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1701603|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1701604|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701956|NCT00053456|Myocardial Ischemia|myocardial ischemia
1701605|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1701606|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1701607|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1701608|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1701609|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
1701610|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1701611|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1701612|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1701613|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1701614|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1701615|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1701616|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1701617|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1701618|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1701619|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1701620|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701621|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1701622|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1701623|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1701624|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1701625|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1701626|NCT00054327|refractory anemia|refractory anemia
1701627|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1701628|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1701629|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701630|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1701631|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1701632|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1701633|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1701634|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1701635|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701636|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1701637|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701638|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701639|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701640|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701641|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701642|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1701643|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1701644|NCT00054301|stage I breast cancer|stage i breast cancer
1701645|NCT00054301|stage II breast cancer|stage ii breast cancer
1701646|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
1701647|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1701648|NCT00054301|breast cancer in situ|breast cancer in situ
1701649|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1701650|NCT00054275|recurrent breast cancer|recurrent breast cancer
1701651|NCT00054275|stage IV breast cancer|stage iv breast cancer
1701652|NCT00054275|male breast cancer|male breast cancer
1701653|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1701654|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
1701655|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1701656|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
1701657|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1701658|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
1701659|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1701660|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1701661|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701662|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1701663|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
1701664|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1701665|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1701666|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1701667|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1701668|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1701669|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1701670|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1701671|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1701672|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1701673|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1701674|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701675|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701676|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1701677|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
1701678|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
1701679|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
1701680|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1701681|NCT00054236|polycythemia vera|polycythemia vera
1701682|NCT00054236|primary myelofibrosis|primary myelofibrosis
1701683|NCT00054236|essential thrombocythemia|essential thrombocythemia
1701684|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
1701685|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1701686|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1701687|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1701688|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1701822|NCT00053911|stage II breast cancer|stage ii breast cancer
1701689|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1701690|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1701691|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1701692|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1701693|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1701694|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1701695|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1701696|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1701697|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1701698|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1701699|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1701700|NCT00054236|Burkitt lymphoma|burkitt lymphoma
1701701|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1701702|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1701703|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1701704|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1701705|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1701706|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701707|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1701708|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1701709|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1701710|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1701711|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1701712|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1701713|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701714|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701715|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701716|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701717|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701718|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1701719|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1701720|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1701721|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1701722|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701723|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1701724|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1701725|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701726|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1701727|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1701728|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1701729|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1701730|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1701731|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1701957|NCT00053456|Exercise|exercise
1701732|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1701733|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1701734|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1701735|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
1701736|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
1701737|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
1701738|NCT00054145|male breast cancer|male breast cancer
1701739|NCT00054145|recurrent breast cancer|recurrent breast cancer
1701740|NCT00054145|stage IV breast cancer|stage iv breast cancer
1701741|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
1701742|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
1701743|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
1701744|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1701745|NCT00054106|stage III prostate cancer|stage iii prostate cancer
1701746|NCT00054106|stage II prostate cancer|stage ii prostate cancer
1701747|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
1701748|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1701749|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1701750|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
1701751|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1701752|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1701753|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1701754|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1701824|NCT00053898|breast cancer in situ|breast cancer in situ
1701755|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1701756|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1701757|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
1701758|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
1701759|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
1701760|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1701761|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
1701762|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
1701763|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1701764|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1701765|NCT00053989|primary myelofibrosis|primary myelofibrosis
1701766|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1701767|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701768|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1701769|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
1701770|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
1701771|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
1701772|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
1701773|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1701774|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1701775|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1701776|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1701777|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1701778|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1701779|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1701780|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1701781|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1701782|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1701783|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701784|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1701785|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1701786|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1701787|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
1701788|NCT00053989|refractory anemia|refractory anemia
1701789|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1701790|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701791|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1701792|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
1701793|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
1701794|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1701795|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1701796|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1701797|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1701798|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1701799|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1701800|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701801|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1701802|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1701803|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1701804|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1701805|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1701806|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701807|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701808|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701809|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701810|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701811|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1701812|NCT00053976|graft versus host disease|graft versus host disease
1701813|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
1701814|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
1701815|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
1701816|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
1701817|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1701818|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
1701819|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
1701820|NCT00053911|recurrent breast cancer|recurrent breast cancer
1701821|NCT00053911|stage I breast cancer|stage i breast cancer
1716757|NCT00043810|Transplant|transplant
1701825|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1701826|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
1701827|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
1701828|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1701829|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
1701830|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1701831|NCT00053846|dyspnea|dyspnea
1701832|NCT00053846|pulmonary complications|pulmonary complications
1701833|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1701834|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1701835|NCT00053833|fallopian tube cancer|fallopian tube cancer
1701836|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1701837|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1701838|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1701839|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
1701840|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
1701841|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
1701842|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1701843|NCT00053794|adult angiosarcoma|adult angiosarcoma
1701844|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
1701845|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
1701846|NCT00053794|adult liposarcoma|adult liposarcoma
1701848|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
1701849|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
1701850|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1701851|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1701852|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
1701853|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
1701854|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1701855|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
1701856|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1701857|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
1701858|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1701859|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1701860|NCT00053781|recurrent melanoma|recurrent melanoma
1701861|NCT00053781|stage IV melanoma|stage iv melanoma
1701862|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1701863|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1701864|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1701865|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1701866|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1701867|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1701868|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1701869|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1701870|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1701871|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1701872|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1701873|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1701874|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1701875|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1701876|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1701877|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1701878|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1701879|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1701880|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1701881|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1701882|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1701883|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1701884|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1701885|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1701886|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1701887|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1701888|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1701889|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1701890|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1701891|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1701892|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1701893|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1715854|NCT00049725|Platelets|platelets
1701894|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1701895|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1701896|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1701897|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
1701898|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1701899|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
1701900|NCT00028678|adult glioblastoma|adult glioblastoma
1701901|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
1701902|NCT00028678|adult gliosarcoma|adult gliosarcoma
1701903|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701904|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701905|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701906|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701907|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701908|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701909|NCT00053742|Smallpox|smallpox
1701910|NCT00053742|Vaccine|vaccine
1701911|NCT00053742|Vaccination|vaccination
1701912|NCT00053742|Variola|variola
1701913|NCT00053742|Adults|adults
1701914|NCT00053742|Healthy Volunteer|healthy volunteer
1701915|NCT00053742|HV|hv
1701916|NCT00053742|Smallpox Vaccine|smallpox vaccine
1701917|NCT00053703|Psychotic Disorders|psychotic disorders
1701918|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
1701919|NCT00053690|Comorbidity|comorbidity
1701920|NCT00053690|Schizophrenia|schizophrenia
1701921|NCT00053690|Bipolar Disorder|bipolar disorder
1701922|NCT00053690|Depression|depression
1701923|NCT00053677|Impulse Control Disorders|impulse control disorders
1701924|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
1701925|NCT00053625|Parkinson's disease|parkinson's disease
1701926|NCT00053625|PD|pd
1701927|NCT00053625|deep brain stimulation|deep brain stimulation
1701928|NCT00053625|DBS|dbs
1701929|NCT00053612|HIV-1|hiv-1
1701930|NCT00053612|Women|women
1701931|NCT00053612|Vitamin A|vitamin a
1701932|NCT00053612|Shedding|shedding
1701933|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
1701934|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
1701935|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
1701936|NCT00053573|GSD-II|gsd-ii
1701937|NCT00053573|Pompe Disease|pompe disease
1701938|NCT00053560|lupus|lupus
1701939|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
1701940|NCT00053560|SLE|sle
1701941|NCT00053560|bone loss|bone loss
1701942|NCT00053560|DHEA|dhea
1701943|NCT00053495|Smallpox|smallpox
1701944|NCT00053482|Smallpox vaccines|smallpox vaccines
1701945|NCT00053482|Dryvax®|dryvax®
1701946|NCT00053482|Orthopoxvirus|orthopoxvirus
1701947|NCT00053482|Vaccinia virus|vaccinia virus
1701948|NCT00053482|ACAM2000|acam2000
1701949|NCT00053469|Cognitive Development|cognitive development
1701950|NCT00053469|Motor Planning|motor planning
1701951|NCT00053469|Categorization|categorization
1701952|NCT00053469|Perception|perception
1701953|NCT00053469|Adaptation|adaptation
1701954|NCT00053456|Endothelium|endothelium
1701955|NCT00053456|Nitric Oxide|nitric oxide
1701958|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
1701959|NCT00053443|Adherence|adherence
1701960|NCT00053443|Treatment Experienced|treatment experienced
1701961|NCT00053430|Immune Modulation|immune modulation
1701962|NCT00053430|Thalidomide|thalidomide
1701963|NCT00053430|Immune reconstitution|immune reconstitution
1701964|NCT00053430|Treatment Experienced|treatment experienced
1701965|NCT00053417|Walking Ability|walking ability
1701966|NCT00053417|Muscle strength|muscle strength
1701967|NCT00053417|Spasticity|spasticity
1701968|NCT00053404|Treatment Experienced|treatment experienced
1701969|NCT00053404|Drug Resistance|drug resistance
1701970|NCT00053391|stage III melanoma|stage iii melanoma
1701971|NCT00053391|stage IV melanoma|stage iv melanoma
1701972|NCT00053391|recurrent melanoma|recurrent melanoma
1701973|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
1701974|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1701975|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1701976|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1701977|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
1701978|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1701979|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1701980|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1701981|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1702848|NCT00049296|chondrosarcoma|chondrosarcoma
1701982|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1701983|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1701984|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1701985|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1701986|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1701987|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1701988|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1701989|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1701990|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1701991|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1701992|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1701993|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
1701994|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
1701995|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1701996|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1701997|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
1701998|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
1701999|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
1702000|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1702001|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
1702002|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1702003|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1702004|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1702005|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1702006|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
1702007|NCT00053209|stage III bladder cancer|stage iii bladder cancer
1702008|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
1702009|NCT00053209|anterior urethral cancer|anterior urethral cancer
1702010|NCT00053209|posterior urethral cancer|posterior urethral cancer
1702011|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
1702012|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1702013|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702014|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
1702015|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702016|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
1702017|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
1702018|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
1702019|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
1702020|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702021|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702022|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702023|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702024|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702025|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702026|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702027|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702028|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702029|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702030|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702031|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702032|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1702033|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1702034|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1702035|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1702036|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1702037|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1702038|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1702039|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702040|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702041|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702042|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702043|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702044|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1716963|NCT00042536|HV|hv
1702045|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1702046|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1702047|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1702048|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1702049|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1702050|NCT00053183|adult glioblastoma|adult glioblastoma
1702051|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
1702052|NCT00053183|adult gliosarcoma|adult gliosarcoma
1702053|NCT00053157|graft versus host disease|graft versus host disease
1702054|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1702055|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1702056|NCT00053157|primary myelofibrosis|primary myelofibrosis
1702057|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
1702058|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1702059|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1702060|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1702061|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1702062|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1702063|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1702064|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1702065|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702066|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702067|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702068|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1702069|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1702070|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1702071|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1702072|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1702073|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1702074|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1702075|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1702076|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1702077|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1702078|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1702079|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702080|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702081|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702082|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702083|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702084|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702085|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1702086|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702087|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702088|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702089|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702090|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702091|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702092|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702093|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1702094|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702095|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702096|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1702097|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1702098|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1702099|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1702100|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1702101|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1702102|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702103|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702104|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1702105|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702849|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
1702106|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1702107|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702108|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702109|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702110|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702111|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702112|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702113|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702114|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702115|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702116|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702117|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1702118|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1702119|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1702120|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1702121|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1702122|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1702123|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1702124|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1702125|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1702126|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1702127|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1702128|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1702129|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702130|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702131|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702132|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702133|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702134|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702135|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702136|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702137|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702138|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1702139|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1702329|NCT00052728|recurrent breast cancer|recurrent breast cancer
1702140|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1702141|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1702142|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1702143|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1702144|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702145|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1702146|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702689|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
1702147|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1702148|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1702149|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1702150|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1702151|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1702152|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1702153|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1702154|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1702155|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1702156|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1702157|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1702158|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702159|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1702160|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1702161|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1702162|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1702163|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
1702164|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
1702165|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
1717482|NCT00039780|Weekly|weekly
1702166|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
1715964|NCT00048464|Xcellerate|xcellerate
1702167|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
1702168|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1702169|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1702170|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1702171|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
1702172|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1702173|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1702174|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
1702175|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
1702176|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
1702177|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1702178|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1702179|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702180|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702181|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702182|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702183|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1702184|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1702185|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1702186|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702187|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702188|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702189|NCT00053053|cachexia|cachexia
1702190|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702191|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702192|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702193|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702194|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702195|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702196|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702197|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702198|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702199|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702200|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702201|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1702202|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1702203|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1702204|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1702205|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1702206|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1702207|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1702208|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1702209|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702210|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702211|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1702212|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702213|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702214|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702215|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702216|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702217|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1702218|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702219|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702220|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1702221|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702222|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702223|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702224|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702225|NCT00053053|intraocular lymphoma|intraocular lymphoma
1702226|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1702227|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702228|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1702229|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1702230|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702709|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
1702231|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702330|NCT00052715|adult glioblastoma|adult glioblastoma
1702232|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702233|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702234|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702235|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702236|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702237|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702238|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702239|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
1702240|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1702241|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1702242|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1702243|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702244|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702245|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1702246|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1702247|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1702248|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1702249|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1702250|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702251|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702252|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702254|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1702255|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1702256|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1702257|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1702258|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
1702259|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1702260|NCT00003830|stage I breast cancer|stage i breast cancer
1702261|NCT00003830|stage II breast cancer|stage ii breast cancer
1702262|NCT00052962|Appendiceal Cancer|appendiceal cancer
1702263|NCT00052962|Regional Therapy|regional therapy
1702264|NCT00052962|Carcinomatosis|carcinomatosis
1702265|NCT00052962|Hyperthermia|hyperthermia
1702266|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1702267|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1702268|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702269|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1702270|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702271|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1702272|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1702273|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1702274|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1702275|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1703285|NCT00046969|stage III cervical cancer|stage iii cervical cancer
1702276|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1702277|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1702278|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1702279|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702280|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1702281|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1702282|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1702283|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1702284|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702285|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1702286|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1702287|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1702288|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702289|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702290|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1702291|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1702292|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1702293|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1702294|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702295|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1702296|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1702297|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702298|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702299|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702300|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1702301|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702302|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702303|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702304|NCT00052910|stage I gastric cancer|stage i gastric cancer
1702305|NCT00052910|stage II gastric cancer|stage ii gastric cancer
1702306|NCT00052910|stage III gastric cancer|stage iii gastric cancer
1702307|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1702308|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1702309|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
1702310|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
1702311|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
1702312|NCT00052897|anal cancer|anal cancer
1702313|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1702314|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
1702315|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1702316|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
1702317|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
1702318|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1702319|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702320|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702321|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702322|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1702323|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1702324|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
1702325|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1702326|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1702327|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1702328|NCT00052728|stage IV breast cancer|stage iv breast cancer
1702331|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
1702332|NCT00052715|adult gliosarcoma|adult gliosarcoma
1702333|NCT00052676|stage I breast cancer|stage i breast cancer
1702334|NCT00052676|stage II breast cancer|stage ii breast cancer
1702335|NCT00052637|bladder cancer|bladder cancer
1702336|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
1702337|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
1702338|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1702339|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
1702340|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
1702341|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
1702342|NCT00052611|laryngeal cancer|laryngeal cancer
1702343|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
1702344|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
1702345|NCT00052611|salivary gland cancer|salivary gland cancer
1702346|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702347|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1702348|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1716051|NCT00047931|Healthy|healthy
1702349|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702350|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702351|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
1702352|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702353|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702354|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702355|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702356|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702357|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702358|NCT00052507|stage IV colon cancer|stage iv colon cancer
1702359|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
1702360|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
1702361|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1702362|NCT00052507|recurrent colon cancer|recurrent colon cancer
1702363|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
1702364|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1702365|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
1702366|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
1702367|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
1702368|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1702369|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1702370|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1716077|NCT00047879|Toxicities|toxicities
1702371|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1702372|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1702373|NCT00052468|fallopian tube cancer|fallopian tube cancer
1702374|NCT00052455|adult glioblastoma|adult glioblastoma
1702375|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1702376|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
1702377|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
1702378|NCT00052455|adult gliosarcoma|adult gliosarcoma
1702379|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702380|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702381|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702382|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702383|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702384|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702385|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702386|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702387|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1702388|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1702389|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1702390|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1702391|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1702392|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1702393|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1702394|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1702395|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1702396|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1702397|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1702398|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1702399|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1702400|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702401|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702402|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1702403|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1702404|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1702405|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1702406|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1702407|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702408|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702409|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
1702410|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1702411|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1702412|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1702413|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1702414|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1702415|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1716476|NCT00044668|Lilly|lilly
1702416|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702417|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702418|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702419|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702420|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702421|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702422|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702423|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1702424|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1702425|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1702426|NCT00052351|stage II breast cancer|stage ii breast cancer
1702427|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
1702428|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
1702429|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1702430|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1702431|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1702432|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
1702433|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1702434|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1702435|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1702436|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1702437|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1717483|NCT00039780|BNP7787|bnp7787
1702438|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1702439|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1702440|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1702441|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1702442|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1702443|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1702444|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702445|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1702446|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1702447|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1702448|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1702449|NCT00052286|adult brain tumor|adult brain tumor
1702450|NCT00052286|fatigue|fatigue
1702451|NCT00052286|cognitive/functional effects|cognitive/functional effects
1702452|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
1702453|NCT00052273|protocol specific|protocol specific
1702454|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702455|NCT00052221|fatigue|fatigue
1702456|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
1702458|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
1702459|NCT00052195|SRL-172|srl-172
1702460|NCT00052195|DAR-901|dar-901
1702461|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1702462|NCT00052182|CTL Epitope|ctl epitope
1702463|NCT00052182|Treatment Experienced|treatment experienced
1702464|NCT00052169|metastatic breast cancer|metastatic breast cancer
1702465|NCT00052169|docetaxel|docetaxel
1702466|NCT00052169|Taxotere|taxotere
1702467|NCT00052169|ZD 1839|zd 1839
1702468|NCT00052169|gefitinib|gefitinib
1702469|NCT00052169|NSABP|nsabp
1702470|NCT00052169|advanced breast cancer|advanced breast cancer
1702471|NCT00052169|AstraZeneca|astrazeneca
1702472|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1702473|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1702474|NCT00049712|intraocular lymphoma|intraocular lymphoma
1702475|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
1702476|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702477|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702478|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702479|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702480|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702481|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702482|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702483|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1702484|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702485|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702486|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702487|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702488|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702489|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1702490|NCT00049712|small intestine lymphoma|small intestine lymphoma
1702491|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702492|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702493|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702494|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702495|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1702496|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702497|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1702498|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1702499|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702500|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702501|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702502|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702503|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1702504|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702505|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702506|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1702507|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1702508|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1702509|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1702510|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1702511|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1702512|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1702513|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1702514|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702515|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702516|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1702517|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702518|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1702519|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1702520|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702521|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702522|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702523|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702524|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702525|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702526|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702527|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702528|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702529|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1702530|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1702531|NCT00049699|intraocular lymphoma|intraocular lymphoma
1702532|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1702533|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702534|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702535|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702536|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702537|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702538|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702539|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702540|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1702541|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702542|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702543|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702544|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702545|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702546|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1702547|NCT00049699|small intestine lymphoma|small intestine lymphoma
1702548|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702549|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702550|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702551|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702552|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1716477|NCT00044642|Anxiety|anxiety
1702553|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702554|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702555|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1702556|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1702557|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702558|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702559|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702560|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702561|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1702562|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702563|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702564|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702565|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702566|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702567|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702568|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702569|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702570|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
1702571|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1702572|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702573|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
1702574|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1702575|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702576|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702577|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
1702578|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1702579|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
1702580|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1702581|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702582|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702583|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1702584|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1702585|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
1702586|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
1702587|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
1702588|NCT00049660|stage IV breast cancer|stage iv breast cancer
1702589|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1702590|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702591|NCT00049634|essential thrombocythemia|essential thrombocythemia
1702592|NCT00049634|polycythemia vera|polycythemia vera
1702593|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702594|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
1702595|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1702596|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702597|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702598|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1702599|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1702600|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1702601|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1702602|NCT00049608|male breast cancer|male breast cancer
1702603|NCT00049608|recurrent breast cancer|recurrent breast cancer
1702604|NCT00049608|recurrent colon cancer|recurrent colon cancer
1702605|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1702606|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
1702607|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
1702608|NCT00049608|stage III colon cancer|stage iii colon cancer
1702609|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
1702610|NCT00049608|stage III rectal cancer|stage iii rectal cancer
1702611|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
1702612|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
1702613|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
1702614|NCT00049608|stage IV breast cancer|stage iv breast cancer
1702615|NCT00049608|stage IV colon cancer|stage iv colon cancer
1702616|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1702617|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
1702618|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1702619|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1702620|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
1702621|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1703286|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
1702622|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1702623|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1702624|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1702625|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1702626|NCT00049556|fallopian tube cancer|fallopian tube cancer
1702627|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1702628|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1702629|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
1702630|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1702631|NCT00049530|recurrent melanoma|recurrent melanoma
1702632|NCT00049530|stage IV melanoma|stage iv melanoma
1702633|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
1702634|NCT00049517|autologous transplantation|autologous transplantation
1702635|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
1702636|NCT00049465|depression|depression
1702637|NCT00049465|fatigue|fatigue
1702638|NCT00049465|menopausal symptoms|menopausal symptoms
1702639|NCT00049465|transitional care planning|transitional care planning
1702640|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1702641|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1702642|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1702643|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1702644|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1702645|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1702646|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
1702647|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1702648|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1702649|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1702650|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1702651|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1702652|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1702653|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1702654|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1702655|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1702656|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1702657|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1702658|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
1702659|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1702660|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
1702661|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
1702662|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
1702663|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1702664|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
1702665|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1702666|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1702667|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1702668|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1702669|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1702670|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702671|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702672|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702673|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702674|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702675|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702676|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702677|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702678|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702679|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702680|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702681|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702682|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1702683|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
1702684|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1702685|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1702686|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1702687|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702688|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
1702690|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1702691|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1702692|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1702693|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
1702694|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
1702695|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1702696|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1702697|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1702698|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1702699|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1702700|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1702701|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1702702|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1702703|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1702704|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1702705|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1702706|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1702707|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1702708|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1702710|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
1702711|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
1702712|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702713|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702714|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702715|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702716|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702717|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702718|NCT00049465|stage IV breast cancer|stage iv breast cancer
1702719|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1702720|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702721|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702722|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702723|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702724|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1702725|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1702726|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1702727|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1702728|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1702729|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
1702730|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1702731|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1702732|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1702733|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1702734|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1702735|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
1702736|NCT00049465|testicular teratoma|testicular teratoma
1702737|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1702738|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1702739|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
1702740|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
1702741|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1702742|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1702743|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1702744|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1702745|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1702746|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1702747|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702748|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702749|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702750|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1702751|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702752|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702753|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702754|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1716693|NCT00043888|ritonavir|ritonavir
1702755|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702756|NCT00049452|osteoporosis|osteoporosis
1702757|NCT00049452|stage I breast cancer|stage i breast cancer
1702758|NCT00049452|stage II breast cancer|stage ii breast cancer
1702759|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1702760|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1702761|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1702762|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1702763|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1702764|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1702765|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1702766|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1702767|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1702768|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1702769|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1702770|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1702771|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1702772|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1702773|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702774|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1702775|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1702776|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702777|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702778|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1702779|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1702780|NCT00049400|intraocular lymphoma|intraocular lymphoma
1702781|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
1702782|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702783|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1702784|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702785|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1702786|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1702787|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
1702788|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702789|NCT00049400|small intestine lymphoma|small intestine lymphoma
1702790|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
1702791|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702792|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
1702793|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702794|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702795|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1702796|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1702797|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
1702798|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702799|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702800|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702801|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702802|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702803|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
1702804|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702805|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702806|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702807|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702808|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702809|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702810|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
1702811|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
1702812|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702813|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1702814|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
1702815|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
1702816|NCT00049335|recurrent colon cancer|recurrent colon cancer
1702817|NCT00049335|stage IV colon cancer|stage iv colon cancer
1702818|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
1702819|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
1702820|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1703878|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
1702821|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1702822|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1702823|NCT00049309|stage I prostate cancer|stage i prostate cancer
1702824|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
1702825|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
1702826|NCT00049309|stage III prostate cancer|stage iii prostate cancer
1702827|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1702828|NCT00049296|male breast cancer|male breast cancer
1702829|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1702830|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1702831|NCT00049296|adult brain stem glioma|adult brain stem glioma
1702832|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1702833|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
1702834|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
1702835|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
1702836|NCT00049296|adult glioblastoma|adult glioblastoma
1702837|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1702838|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
1702839|NCT00049296|adult medulloblastoma|adult medulloblastoma
1702840|NCT00049296|adult meningioma|adult meningioma
1702841|NCT00049296|adult pineoblastoma|adult pineoblastoma
1702842|NCT00049296|adult pineocytoma|adult pineocytoma
1702843|NCT00049296|adult subependymoma|adult subependymoma
1702844|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1702845|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
1702846|NCT00049296|anterior urethral cancer|anterior urethral cancer
1702847|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
1702850|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1702851|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
1702852|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1702853|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1702854|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
1702855|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1702856|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1702857|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1702858|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
1702859|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1702860|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1702861|NCT00049296|adult mixed glioma|adult mixed glioma
1702862|NCT00049296|ovarian sarcoma|ovarian sarcoma
1702863|NCT00049296|posterior urethral cancer|posterior urethral cancer
1702864|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
1702865|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1702866|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1702867|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
1702868|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1702869|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1702870|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1702871|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1702872|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1702873|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1702874|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1702875|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1702876|NCT00049296|recurrent anal cancer|recurrent anal cancer
1702877|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1702878|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
1702879|NCT00049296|recurrent breast cancer|recurrent breast cancer
1702880|NCT00049296|recurrent colon cancer|recurrent colon cancer
1702881|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
1702882|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1702883|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1702884|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
1702885|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
1702886|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1702887|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1702888|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1702889|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1702890|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1702891|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1702892|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1702893|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1702894|NCT00049296|recurrent melanoma|recurrent melanoma
1702895|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1702896|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1702897|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1702898|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
1702899|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1702900|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
1702901|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
1702902|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
1702903|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
1702904|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
1702905|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
1702906|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1702907|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1702908|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1702909|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1702910|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1702911|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1716078|NCT00047879|Efficacy|efficacy
1702912|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1702913|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1702914|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
1702915|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
1702916|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1702917|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1702918|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
1702919|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1702920|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
1702921|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1702922|NCT00049296|small intestine lymphoma|small intestine lymphoma
1702923|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
1702924|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
1702925|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
1702926|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
1702927|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
1702928|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1702929|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1702930|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1702931|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1702932|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1702933|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1702934|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1702935|NCT00049296|stage IV anal cancer|stage iv anal cancer
1702936|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1702937|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
1702938|NCT00049296|stage IV breast cancer|stage iv breast cancer
1702939|NCT00049296|stage IV colon cancer|stage iv colon cancer
1702940|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
1702941|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1702942|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
1702943|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1702944|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1702945|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1702946|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1702947|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1702948|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1702949|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1702950|NCT00049296|stage IV melanoma|stage iv melanoma
1702951|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1702952|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1702953|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1702954|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
1702955|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
1702956|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1702957|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1702958|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1702959|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1702960|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1702961|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1702962|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
1702963|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1702964|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1702965|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1702966|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
1702967|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1702968|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1702969|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
1702970|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
1702971|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1702972|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1702973|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1702974|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1702975|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1702976|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1702977|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1702978|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1717484|NCT00039780|7787|7787
1702979|NCT00049296|adult grade III meningioma|adult grade iii meningioma
1702980|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
1702981|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
1702982|NCT00049296|adult gliosarcoma|adult gliosarcoma
1702983|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
1702984|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1702985|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
1702986|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
1702987|NCT00049244|recurrent breast cancer|recurrent breast cancer
1702988|NCT00049244|stage IV breast cancer|stage iv breast cancer
1702989|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
1702990|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1702991|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1702992|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
1702993|NCT00049231|stage III cervical cancer|stage iii cervical cancer
1702994|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
1702995|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1702996|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1702997|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1702998|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1702999|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1703000|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1703001|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1703002|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1703003|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1703004|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1703005|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1703006|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1703007|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1703008|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1703009|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1703010|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1703011|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1703012|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1703013|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1703014|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1703015|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1703016|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1703017|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1703018|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1703019|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1703020|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1716694|NCT00043888|COMBIVIR|combivir
1703021|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1703022|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1703023|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1703024|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1703025|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1703026|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1703027|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1703028|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1703029|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1703030|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1703031|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1703032|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1703033|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
1703034|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
1703035|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
1703036|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
1703037|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1703038|NCT00049101|recurrent colon cancer|recurrent colon cancer
1703039|NCT00049101|stage IV colon cancer|stage iv colon cancer
1703040|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
1703041|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
1703042|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1703043|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1703044|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1703045|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1703046|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1703047|NCT00049062|recurrent breast cancer|recurrent breast cancer
1703048|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
1703049|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
1703050|NCT00049062|stage IV breast cancer|stage iv breast cancer
1703051|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
1703052|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
1703053|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1703054|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
1703055|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1703056|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
1703057|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1703058|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
1703059|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
1703060|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1703061|NCT00049023|regional neuroblastoma|regional neuroblastoma
1703062|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
1703063|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1703064|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
1703065|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1703066|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1703067|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1703068|NCT00049023|gastrinoma|gastrinoma
1703069|NCT00049023|insulinoma|insulinoma
1703070|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1703071|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1703072|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1703073|NCT00049010|stage I melanoma|stage i melanoma
1703074|NCT00049010|stage II melanoma|stage ii melanoma
1703075|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1703076|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1703077|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
1703078|NCT00048971|stage III colon cancer|stage iii colon cancer
1703079|NCT00048971|diarrhea|diarrhea
1703080|NCT00048971|neutropenia|neutropenia
1703081|NCT00047385|small cell lung cancer|small cell lung cancer
1703082|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
1703083|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1703084|NCT00047320|childhood teratoma|childhood teratoma
1703085|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1703086|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1703087|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1703088|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
1703089|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1703090|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
1703091|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1703092|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
1703093|NCT00047294|adult mixed glioma|adult mixed glioma
1703094|NCT00047294|adult glioblastoma|adult glioblastoma
1703095|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
1703096|NCT00047294|adult gliosarcoma|adult gliosarcoma
1703097|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1703098|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1703099|NCT00047281|adult glioblastoma|adult glioblastoma
1703100|NCT00047281|adult mixed glioma|adult mixed glioma
1703101|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
1703102|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
1703103|NCT00047281|adult gliosarcoma|adult gliosarcoma
1703104|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1703392|NCT00045474|adult glioblastoma|adult glioblastoma
1703105|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1703106|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1703107|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1703108|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1703109|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
1703110|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
1703111|NCT00047255|stage IV breast cancer|stage iv breast cancer
1703112|NCT00047255|recurrent breast cancer|recurrent breast cancer
1703113|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703114|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1703115|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
1703116|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1703117|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1703118|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
1703119|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
1703120|NCT00047216|stage I bladder cancer|stage i bladder cancer
1703121|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1703122|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1703123|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1703124|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
1703125|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1703126|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703127|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703128|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1703129|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1703130|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1703131|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1703132|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1703133|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1703134|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1703135|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703136|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1703137|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1703138|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1703139|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1703140|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1703141|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1703142|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1703143|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1703144|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703145|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1703146|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1703147|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1703148|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1703149|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1703150|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703151|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1703152|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1703153|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1703154|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1703155|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1703156|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1703157|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1703158|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1703159|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1703160|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1703161|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1703162|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1703163|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1703164|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1703165|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1703166|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1703167|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1703168|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703169|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1703170|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1703171|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1703172|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1703173|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1703174|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1717485|NCT00039780|Tavocept|tavocept
1703175|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1703176|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1703177|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703178|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1703179|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1703180|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1703181|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1703182|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1703183|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1703184|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1703185|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1703186|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1703187|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1703188|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1703189|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1703190|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1703191|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1703192|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1703193|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703194|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1703195|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1703196|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1703197|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1703198|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1703199|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1703200|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1703201|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1703202|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1703203|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1703204|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1703205|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1703206|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1703207|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
1703208|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
1703209|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
1703210|NCT00047138|stage I Wilms tumor|stage i wilms tumor
1703211|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
1703212|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
1703213|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
1703214|NCT00047138|stage V Wilms tumor|stage v wilms tumor
1703215|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
1703216|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1703217|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
1703218|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1703219|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1703220|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
1703221|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
1703222|NCT00047099|stage II breast cancer|stage ii breast cancer
1703223|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
1703224|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
1703225|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
1703226|NCT00047073|adult glioblastoma|adult glioblastoma
1703227|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
1703228|NCT00047073|adult gliosarcoma|adult gliosarcoma
1703229|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
1703230|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
1703231|NCT00047060|Low Intensity Regimen|low intensity regimen
1703232|NCT00047060|Mycosis Fungoides|mycosis fungoides
1703233|NCT00047060|Sezary Syndrome|sezary syndrome
1703235|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1703236|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1703237|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1703238|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1703239|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1716194|NCT00046774|Nephritis|nephritis
1703240|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703241|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703242|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1703243|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1717486|NCT00039780|Prevention|prevention
1703244|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1703245|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1703246|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1703247|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1703248|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1703249|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1703250|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1703251|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703252|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703253|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703254|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703255|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1703256|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1703257|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1703258|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1703259|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1703260|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1703261|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703262|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1703263|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1703264|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1703265|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1703266|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1703267|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1703268|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1703269|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1703270|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1703271|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1703272|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1703273|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1703274|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1703275|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1703276|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1703277|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1703278|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
1703279|NCT00046995|stage IIB colon cancer|stage iib colon cancer
1703280|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
1703281|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
1703282|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
1703283|NCT00046969|anemia|anemia
1703284|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
1703287|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1703288|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1703289|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
1703290|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1703291|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
1703292|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
1703293|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
1703294|NCT00046943|stage III prostate cancer|stage iii prostate cancer
1703295|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
1703296|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1703297|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1703298|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1703299|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1703300|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1703301|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1703302|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1703303|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1703304|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
1716729|NCT00043875|epilepsy|epilepsy
1703305|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1703306|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1703307|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703907|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
1703308|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1703309|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1703310|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1703311|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1703312|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1703313|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703314|NCT00046904|anorexia|anorexia
1703315|NCT00046904|cachexia|cachexia
1703316|NCT00046891|neurotoxicity|neurotoxicity
1703317|NCT00046891|stage I breast cancer|stage i breast cancer
1703318|NCT00046891|stage II breast cancer|stage ii breast cancer
1703319|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
1703320|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
1703321|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
1703322|NCT00046865|nausea and vomiting|nausea and vomiting
1703323|NCT00046865|stage I breast cancer|stage i breast cancer
1703324|NCT00046865|stage II breast cancer|stage ii breast cancer
1703325|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
1703326|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
1703327|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
1703328|NCT00046865|stage IV breast cancer|stage iv breast cancer
1703329|NCT00046852|infection|infection
1703330|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
1703331|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
1703332|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
1703333|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
1703334|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1703335|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1703336|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1703337|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1703338|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
1703339|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
1703340|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1703341|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
1703342|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
1703343|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1703344|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1703345|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
1703346|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1703347|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
1703348|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
1703349|NCT00045630|anterior urethral cancer|anterior urethral cancer
1703350|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1703351|NCT00045630|posterior urethral cancer|posterior urethral cancer
1703352|NCT00045630|stage II bladder cancer|stage ii bladder cancer
1703353|NCT00045630|stage III bladder cancer|stage iii bladder cancer
1703354|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1703355|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1703356|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1716695|NCT00043888|TRIZIVIR|trizivir
1703357|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
1703358|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1703359|NCT00045591|recurrent breast cancer|recurrent breast cancer
1703360|NCT00045591|stage IV breast cancer|stage iv breast cancer
1703361|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1703362|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1703363|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703364|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1703365|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1703366|NCT00045500|intraocular lymphoma|intraocular lymphoma
1703367|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1703368|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1703369|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1703370|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703371|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703372|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703373|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1716730|NCT00043862|Hycamtin|hycamtin
1703374|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1703375|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1703376|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703377|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703908|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
1703378|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703379|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703380|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1703381|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703382|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1703383|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703384|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1703385|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1703386|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1703387|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
1703388|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
1703389|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
1703390|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1703391|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1703393|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
1703394|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
1703395|NCT00045474|adult gliosarcoma|adult gliosarcoma
1703396|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1703397|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
1703398|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
1703399|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
1703400|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
1703401|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
1703402|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
1703403|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
1703404|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
1703405|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
1703406|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
1703407|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1703408|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1703409|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1703410|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1703411|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703412|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1703413|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1703414|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1703415|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
1703416|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
1703417|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
1703418|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
1703419|NCT00045331|stage I prostate cancer|stage i prostate cancer
1703420|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
1703421|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
1703422|NCT00045331|stage III prostate cancer|stage iii prostate cancer
1703423|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
1703424|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1716696|NCT00043888|abacavir|abacavir
1703425|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1703426|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703427|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703428|NCT00045305|refractory anemia|refractory anemia
1703429|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
1703430|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1703431|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703432|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1703433|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1703434|NCT00045292|infection|infection
1703435|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1703436|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1703437|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1703438|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1703439|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1703440|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1703754|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
1703441|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1703442|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1703443|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1703444|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1703445|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1703446|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1703447|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1703448|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1703449|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1703450|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1703451|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1703452|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1703453|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1703454|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1703455|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1703456|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1703457|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1703458|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1703459|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703460|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1703461|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703462|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703463|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
1703464|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
1703465|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1703466|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703467|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1703468|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1703469|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1703470|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1703471|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1703472|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1703473|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1703474|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703475|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1703476|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1703477|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1703478|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703479|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1703480|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1703481|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1703482|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1703483|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1703484|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1705552|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
1703485|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1703486|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1703487|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1703488|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1703489|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1703490|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1703491|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1703492|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1703493|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703494|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703495|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703496|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1703497|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1703498|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1703499|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1703500|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1703501|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1703502|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1703503|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703504|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1703505|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1703506|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1703507|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1703508|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1703509|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1703510|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1703511|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1703512|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1703513|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1703514|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1703515|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1703516|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1703517|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1703518|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1703519|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1703520|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1703521|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1703522|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1703523|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1703524|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1703525|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1703526|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
1703527|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
1703528|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
1703529|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
1703530|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
1703531|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
1703532|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
1703533|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
1703534|NCT00045292|stage IV breast cancer|stage iv breast cancer
1703535|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1703536|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1703537|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1703538|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703539|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1703540|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1703541|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1703542|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1703543|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1703544|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1703545|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1703546|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1703547|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
1703548|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703549|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703550|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1716697|NCT00043888|lamivudine|lamivudine
1703551|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1703552|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1703553|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1703554|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703555|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703556|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703557|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703558|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1703559|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1703560|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1703561|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1703562|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1703563|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1703564|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1703565|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1703566|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1703567|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1703568|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703569|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1703570|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703571|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1703572|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1703573|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1703574|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1703575|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1703576|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1703577|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
1703578|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
1703579|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1703580|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1703581|NCT00045175|fallopian tube cancer|fallopian tube cancer
1703582|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1703583|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
1703584|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
1703585|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
1703586|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
1703587|NCT00045097|male breast cancer|male breast cancer
1703588|NCT00045097|recurrent breast cancer|recurrent breast cancer
1703589|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
1703590|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
1703591|NCT00045097|stage IV breast cancer|stage iv breast cancer
1703592|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1703593|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
1703594|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1703595|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1703596|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1703597|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1703598|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1703599|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1703600|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1703601|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1703602|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1703603|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
1703604|NCT00045045|testicular teratoma|testicular teratoma
1703605|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1703606|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1703607|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
1703608|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703609|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
1703610|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703611|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1703612|NCT00045006|ovarian sarcoma|ovarian sarcoma
1703613|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
1703614|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703615|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
1703616|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1703617|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1704144|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1703618|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1703619|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1703620|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703621|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703622|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703623|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
1703624|NCT00045006|recurrent breast cancer|recurrent breast cancer
1703625|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1703626|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703627|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703628|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703629|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1703630|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1703631|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1703826|NCT00042887|stage I bladder cancer|stage i bladder cancer
1703632|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1703633|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1703634|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
1703635|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
1703636|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1703637|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
1703638|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
1703639|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1703640|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1703641|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703642|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
1703643|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1703644|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1703645|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1703646|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1703647|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703648|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1703649|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1703650|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1703651|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1703652|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1703653|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1703654|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1703655|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1703656|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1703657|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1703658|NCT00045006|stage III bladder cancer|stage iii bladder cancer
1703659|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
1703660|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
1703661|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
1703662|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
1703663|NCT00045006|stage IV breast cancer|stage iv breast cancer
1703664|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1703665|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1703666|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1703667|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1703668|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1703669|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1703670|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1703671|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1703672|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1703673|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1703674|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1703675|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1703676|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1703677|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1703678|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1703679|NCT00045006|stage III prostate cancer|stage iii prostate cancer
1703680|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
1703681|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
1703682|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
1703683|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1703684|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1703685|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
1703686|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
1703687|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
1703688|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1703689|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1703690|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1703691|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1703692|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1703693|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1703694|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1703695|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1703696|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1703697|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1703755|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1703698|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1703699|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1703700|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1703701|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1703702|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1703703|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1703704|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1717487|NCT00039819|Spinal Cord|spinal cord
1703705|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1703706|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1703707|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1703708|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1703709|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1703710|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1703711|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1703712|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703713|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1703714|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1703715|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1703716|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703717|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1703718|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1703719|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1703720|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703721|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1703722|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1703723|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1703724|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1703725|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1703726|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1703727|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1703728|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1703729|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1703730|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1703731|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1703732|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1703733|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1703734|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1703735|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1703736|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1703877|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1703737|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1703738|NCT00045006|male breast cancer|male breast cancer
1703739|NCT00044993|male breast cancer|male breast cancer
1703740|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
1703741|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
1703742|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
1703743|NCT00044993|stage IV breast cancer|stage iv breast cancer
1703744|NCT00044980|malnutrition|malnutrition
1703745|NCT00044980|stage I prostate cancer|stage i prostate cancer
1703746|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
1703747|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
1703748|NCT00044967|stage I colon cancer|stage i colon cancer
1703749|NCT00044967|stage II colon cancer|stage ii colon cancer
1703750|NCT00044967|stage III colon cancer|stage iii colon cancer
1703751|NCT00044967|stage I rectal cancer|stage i rectal cancer
1703752|NCT00044967|stage II rectal cancer|stage ii rectal cancer
1703753|NCT00044967|stage III rectal cancer|stage iii rectal cancer
1703756|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1703757|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
1703758|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
1703759|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
1703760|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1703761|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1703762|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1703763|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703764|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703765|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703766|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703767|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703768|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1703769|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1703770|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1703771|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
1703772|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1703773|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1703774|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1703775|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1703776|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1703777|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1703778|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1703779|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1703780|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1703781|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1703782|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1703783|NCT00043147|graft versus host disease|graft versus host disease
1703784|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1703785|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1703786|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703787|NCT00043134|refractory anemia|refractory anemia
1703788|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
1703789|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1703790|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1703791|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1703792|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703793|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1703794|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1703795|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703796|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
1703797|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1703798|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1703799|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1703800|NCT00043069|osteoporosis|osteoporosis
1703801|NCT00043069|stage I prostate cancer|stage i prostate cancer
1703802|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
1703803|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
1703804|NCT00043069|stage III prostate cancer|stage iii prostate cancer
1703805|NCT00043043|colorectal cancer|colorectal cancer
1703806|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1716698|NCT00043888|zidovudine|zidovudine
1703807|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703808|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
1703809|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
1703810|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
1703811|NCT00043004|liver metastases|liver metastases
1703812|NCT00043004|stage IV colon cancer|stage iv colon cancer
1703813|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
1703814|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
1703815|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
1703816|NCT00042939|pancreatic cancer|pancreatic cancer
1703817|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
1703819|NCT00042939|irinotecan|irinotecan
1703820|NCT00042939|docetaxel|docetaxel
1703821|NCT00042939|cetuximab|cetuximab
1703822|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1703823|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1703824|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703825|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
1703827|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
1703828|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1703829|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703830|NCT00042848|fatigue|fatigue
1703831|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703832|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1703833|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
1703834|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1703835|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1703836|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1703837|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1703838|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1703839|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1703840|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703841|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703842|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1703843|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1703844|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703845|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1703846|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1703847|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1703848|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1703849|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1703850|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1703851|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1703852|NCT00042783|stage IV melanoma|stage iv melanoma
1703853|NCT00042783|recurrent melanoma|recurrent melanoma
1703854|NCT00042770|malignant pleural effusion|malignant pleural effusion
1703855|NCT00042770|pulmonary complications|pulmonary complications
1703856|NCT00042731|stage I prostate cancer|stage i prostate cancer
1703857|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
1703858|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
1703859|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
1703860|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1703861|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1703862|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1703863|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1703864|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1703865|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1703866|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1703867|NCT00041301|stage I prostate cancer|stage i prostate cancer
1703868|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
1703869|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
1703870|NCT00041301|stage III prostate cancer|stage iii prostate cancer
1703871|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
1703872|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1703873|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1703874|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1703875|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1703876|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1703879|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
1703880|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
1703881|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1703882|NCT00041249|adult angiosarcoma|adult angiosarcoma
1703883|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
1703884|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
1703885|NCT00041249|adult liposarcoma|adult liposarcoma
1703886|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
1703887|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
1703888|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1703889|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1703890|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1703891|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1703892|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1703893|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1703894|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1703895|NCT00041236|adult angiosarcoma|adult angiosarcoma
1703896|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
1703897|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
1703898|NCT00041236|adult liposarcoma|adult liposarcoma
1703899|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
1703900|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
1703901|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1703902|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1703903|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1703904|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1703905|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1703906|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
1703909|NCT00041223|radiation fibrosis|radiation fibrosis
1703910|NCT00041223|stage I breast cancer|stage i breast cancer
1703911|NCT00041223|stage II breast cancer|stage ii breast cancer
1703912|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
1703913|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1703914|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1703915|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1703916|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1703917|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1703918|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1703919|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1703920|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1703921|NCT00041171|stage IV breast cancer|stage iv breast cancer
1703922|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
1703923|NCT00041171|recurrent breast cancer|recurrent breast cancer
1703924|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
1703925|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1703926|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1703927|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
1703928|NCT00041171|stage III bladder cancer|stage iii bladder cancer
1703929|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
1703930|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
1703931|NCT00041171|stage III prostate cancer|stage iii prostate cancer
1703932|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
1703933|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
1703934|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1703935|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1703936|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1703937|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1703938|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1703939|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1703940|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1703941|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1703942|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1703943|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1703944|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1703945|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1703946|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1703947|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1703948|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1703949|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1703950|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1716699|NCT00043888|HIV|hiv
1703951|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1703952|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1703953|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1703954|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1703955|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1703956|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1703957|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1703958|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1703959|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1703960|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1703961|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1703962|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1703963|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1703964|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1703965|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1703966|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1703967|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1703968|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1703969|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1704173|NCT00039234|stage IV melanoma|stage iv melanoma
1703970|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1703971|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1703972|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1703973|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1703974|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1703975|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1703976|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1703977|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1703978|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
1703979|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1703980|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703981|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1703982|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
1703983|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1703984|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703985|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1703986|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
1703987|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1703988|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1703989|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
1703990|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
1703991|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
1703992|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1703993|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1703994|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1703995|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1703996|NCT00041119|stage IB breast cancer|stage ib breast cancer
1703997|NCT00041119|stage II breast cancer|stage ii breast cancer
1703998|NCT00041067|stage IV breast cancer|stage iv breast cancer
1703999|NCT00041067|recurrent breast cancer|recurrent breast cancer
1704000|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1704001|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1704002|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1704003|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704004|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704005|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1716908|NCT00043186|bone loss|bone loss
1704006|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
1704007|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1704008|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1704009|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704010|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1704011|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704012|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704013|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704014|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1704015|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704016|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704017|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704018|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704019|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704020|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704021|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704022|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
1704023|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
1704024|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
1704025|NCT00040911|nausea and vomiting|nausea and vomiting
1704026|NCT00040911|localized osteosarcoma|localized osteosarcoma
1704027|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
1704028|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1704029|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1705162|NCT00027963|pain|pain
1704030|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1704031|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1704032|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1704033|NCT00040911|childhood teratoma|childhood teratoma
1704034|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1704035|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1704036|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1704037|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1704038|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
1704039|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1704040|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
1704041|NCT00040911|regional neuroblastoma|regional neuroblastoma
1704042|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
1704043|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1704044|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1704045|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1704046|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1704047|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1704048|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1704049|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1704050|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1704051|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1704052|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1704053|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1704054|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1704055|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1704056|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1704057|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1704058|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1704059|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1704060|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
1704061|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1704062|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1704063|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1704064|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704065|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704066|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1704068|NCT00040885|anorexia|anorexia
1704069|NCT00040885|cachexia|cachexia
1704070|NCT00040872|regional neuroblastoma|regional neuroblastoma
1704071|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
1704072|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
1717427|NCT00039975|Diltiazem|diltiazem
1704073|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1704074|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
1704075|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
1704076|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
1704077|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
1704078|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
1704079|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1704080|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1704081|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
1704082|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
1704083|NCT00040833|pain|pain
1704084|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
1704085|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1704086|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1704087|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1704088|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1704089|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1704090|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1704091|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1704092|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1704093|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1704094|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1704095|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1717593|NCT00038896|Panic|panic
1704096|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1704097|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1704098|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1704099|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
1704100|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1704101|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
1704102|NCT00040742|nausea|nausea
1704103|NCT00040742|vomiting|vomiting
1704104|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1704105|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1704106|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1704107|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1704108|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1704109|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1704110|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1704111|NCT00039611|stage III colon cancer|stage iii colon cancer
1704112|NCT00039611|stage IV colon cancer|stage iv colon cancer
1704113|NCT00039611|stage III rectal cancer|stage iii rectal cancer
1704114|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
1704115|NCT00039611|recurrent colon cancer|recurrent colon cancer
1704116|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
1704117|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1704118|NCT00039585|fallopian tube cancer|fallopian tube cancer
1704119|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1704120|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1704121|NCT00039572|adult glioblastoma|adult glioblastoma
1704122|NCT00039572|stage IV melanoma|stage iv melanoma
1704123|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
1704124|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
1704125|NCT00039572|adult gliosarcoma|adult gliosarcoma
1704126|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
1704127|NCT00039546|stage I breast cancer|stage i breast cancer
1704128|NCT00039546|stage II breast cancer|stage ii breast cancer
1704129|NCT00039520|stage IV breast cancer|stage iv breast cancer
1704130|NCT00039520|recurrent breast cancer|recurrent breast cancer
1704131|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1704132|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1704133|NCT00039468|adult glioblastoma|adult glioblastoma
1704134|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
1704135|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
1704136|NCT00039468|adult gliosarcoma|adult gliosarcoma
1704137|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
1704138|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
1704139|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
1704140|NCT00039364|adult glioblastoma|adult glioblastoma
1704141|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1704142|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1704143|NCT00039364|adult mixed glioma|adult mixed glioma
1704145|NCT00039364|adult subependymoma|adult subependymoma
1704146|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
1704147|NCT00039364|adult gliosarcoma|adult gliosarcoma
1704148|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
1704149|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1704150|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1704151|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704152|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1704153|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1704154|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1704155|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
1704156|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
1704157|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
1704158|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1704159|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
1704160|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1704161|NCT00039325|stage IV melanoma|stage iv melanoma
1704162|NCT00039325|recurrent melanoma|recurrent melanoma
1704163|NCT00039312|cervical cancer|cervical cancer
1704164|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1704165|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
1704166|NCT00039286|stage II breast cancer|stage ii breast cancer
1704167|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
1704168|NCT00039286|recurrent breast cancer|recurrent breast cancer
1704169|NCT00039273|stage IV colon cancer|stage iv colon cancer
1704170|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
1704171|NCT00039273|recurrent colon cancer|recurrent colon cancer
1704172|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
1704174|NCT00039234|recurrent melanoma|recurrent melanoma
1704175|NCT00039234|liver metastases|liver metastases
1704176|NCT00039208|stage III colon cancer|stage iii colon cancer
1704177|NCT00039208|stage IV colon cancer|stage iv colon cancer
1704178|NCT00039208|stage III rectal cancer|stage iii rectal cancer
1704179|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
1704180|NCT00039208|recurrent colon cancer|recurrent colon cancer
1704181|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
1704182|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1704183|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1704184|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704185|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1704186|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1704187|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704188|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704189|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704190|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704191|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1704192|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704193|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704194|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1704195|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
1704196|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1704197|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1704198|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1704199|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1704200|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1704201|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1704202|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1704203|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1704204|NCT00039052|stage IV breast cancer|stage iv breast cancer
1704205|NCT00039052|recurrent breast cancer|recurrent breast cancer
1704206|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1704207|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
1704208|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
1704209|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1704210|NCT00039052|male breast cancer|male breast cancer
1704211|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1704212|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704213|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704214|NCT00037037|stage III melanoma|stage iii melanoma
1704215|NCT00037037|stage IV melanoma|stage iv melanoma
1704216|NCT00037037|recurrent melanoma|recurrent melanoma
1704217|NCT00037024|stage I breast cancer|stage i breast cancer
1704218|NCT00037024|stage II breast cancer|stage ii breast cancer
1704219|NCT00037024|stage I prostate cancer|stage i prostate cancer
1704220|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
1704221|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
1704222|NCT00037024|male breast cancer|male breast cancer
1704223|NCT00037024|fatigue|fatigue
1704224|NCT00037024|malnutrition|malnutrition
1704225|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1704226|NCT00037024|depression|depression
1704227|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
1704228|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
1704229|NCT00036998|stage I breast cancer|stage i breast cancer
1704230|NCT00036998|stage II breast cancer|stage ii breast cancer
1704231|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
1704232|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
1704233|NCT00036972|adult glioblastoma|adult glioblastoma
1704234|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1704235|NCT00036972|adult mixed glioma|adult mixed glioma
1704236|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
1704237|NCT00036972|adult gliosarcoma|adult gliosarcoma
1704238|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
1704239|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1704240|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1704587|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
1704241|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1704242|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
1704243|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
1704244|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
1704245|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
1704246|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
1704247|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1704248|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
1717594|NCT00038896|Disorder|disorder
1704249|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1704250|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
1704251|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1704252|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
1704253|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1704254|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1704255|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1704256|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
1704257|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
1704258|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
1704259|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
1704260|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
1704261|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1704262|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1704263|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1704264|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1704265|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1704266|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1704267|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1704268|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
1704269|NCT00036959|childhood teratoma|childhood teratoma
1704270|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1704271|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1704272|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1704273|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1704274|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704275|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1704276|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1704277|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1704278|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1704279|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1704280|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704281|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1704282|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1704283|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1704284|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1704285|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1704286|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704287|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1704288|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704289|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704290|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704291|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1704292|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704293|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1704294|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704295|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704296|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704297|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1704298|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1704299|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704300|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704301|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704302|NCT00036933|stage III prostate cancer|stage iii prostate cancer
1704303|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
1704304|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
1704305|NCT00036894|adult glioblastoma|adult glioblastoma
1704306|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1704307|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1704308|NCT00036894|adult mixed glioma|adult mixed glioma
1704309|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
1704310|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
1704311|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1704312|NCT00036894|adult meningioma|adult meningioma
1704313|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1704314|NCT00036894|adult brain stem glioma|adult brain stem glioma
1704315|NCT00036894|adult grade III meningioma|adult grade iii meningioma
1704316|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
1704317|NCT00036894|adult gliosarcoma|adult gliosarcoma
1704318|NCT00036868|stage IV breast cancer|stage iv breast cancer
1704319|NCT00036868|recurrent breast cancer|recurrent breast cancer
1704320|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1704321|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
1704322|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704323|NCT00036829|pain|pain
1704324|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1704325|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1704326|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1704327|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1704328|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1704329|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1704330|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1704331|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1704332|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
1704333|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
1704334|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1704335|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
1704336|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1704337|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1704338|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1704339|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1704340|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1704341|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1704342|NCT00036790|small intestine lymphoma|small intestine lymphoma
1704343|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704344|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1704345|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1704346|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1704347|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1704348|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1704349|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1704350|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
1704351|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1704352|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1704353|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
1704354|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1704355|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1704356|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1704357|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1704426|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
1704358|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1704359|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1704360|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1704361|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1704362|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1704363|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1704364|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1704365|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1704366|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1704367|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1704368|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704369|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1704370|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1704371|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1704372|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1716731|NCT00043862|oral|oral
1704373|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1704374|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704375|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1704376|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704377|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704378|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704379|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1704380|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704381|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1704382|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1704383|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1704384|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1704385|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
1704386|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1704387|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1704388|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704389|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1704390|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1704391|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1704392|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1704393|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1704394|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1704395|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1704396|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1704397|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
1704398|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704399|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704400|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1704401|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1704402|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
1704403|NCT00036790|recurrent breast cancer|recurrent breast cancer
1704404|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
1704405|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
1704406|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
1704407|NCT00036790|stage IV breast cancer|stage iv breast cancer
1704408|NCT00036790|recurrent colon cancer|recurrent colon cancer
1704409|NCT00036790|stage III colon cancer|stage iii colon cancer
1704410|NCT00036790|stage IV colon cancer|stage iv colon cancer
1704411|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
1704412|NCT00036790|stage III prostate cancer|stage iii prostate cancer
1704413|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
1704414|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
1704415|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1704416|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
1704417|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
1704418|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1704419|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
1704420|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1704421|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1704422|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1704423|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
1704424|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
1704425|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
1704427|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
1704428|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1704429|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
1704430|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1704431|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1704432|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1704433|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1704434|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1704435|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704436|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704437|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1704438|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1704439|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1704440|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1704441|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704588|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
1704442|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704443|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704444|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1704445|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1704446|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1704447|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1704448|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1704449|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1704450|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
1704451|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1704452|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
1704453|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
1704454|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1704455|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1704456|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1704457|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1704458|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1704459|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1704460|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1704461|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1704462|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1704463|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1704464|NCT00036712|primary myelofibrosis|primary myelofibrosis
1704465|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1704466|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
1704467|NCT00036712|oral complications|oral complications
1704468|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1704469|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1704470|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1704471|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1704472|NCT00036712|pain|pain
1704473|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1704474|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1704475|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1704476|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1704477|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1704478|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1704479|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1704480|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1704481|NCT00036686|stage I breast cancer|stage i breast cancer
1704482|NCT00036686|stage II breast cancer|stage ii breast cancer
1704483|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
1704484|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
1704485|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
1704486|NCT00036686|recurrent breast cancer|recurrent breast cancer
1704487|NCT00036686|stage IV breast cancer|stage iv breast cancer
1704488|NCT00033748|stage IV colon cancer|stage iv colon cancer
1704489|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
1704490|NCT00033748|recurrent colon cancer|recurrent colon cancer
1704491|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
1704492|NCT00033748|liver metastases|liver metastases
1704493|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
1704494|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1704495|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1704496|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
1704497|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
1704498|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
1704499|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
1704500|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1704501|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
1704502|NCT00033683|stage I breast cancer|stage i breast cancer
1704503|NCT00033683|stage II breast cancer|stage ii breast cancer
1704504|NCT00033657|stage I gastric cancer|stage i gastric cancer
1704505|NCT00033657|stage II gastric cancer|stage ii gastric cancer
1704506|NCT00033657|stage III gastric cancer|stage iii gastric cancer
1704507|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
1704508|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
1704509|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
1704510|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
1704511|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
1704512|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1716937|NCT00042549|ESWL|eswl
1704513|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1704514|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
1704515|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
1704516|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
1704517|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1704518|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
1704519|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
1704520|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704521|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
1704522|NCT00033553|large cell lung cancer|large cell lung cancer
1704523|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704524|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704525|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
1704526|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1704527|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
1704528|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
1704529|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1704530|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1704531|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1704532|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
1704533|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
1704534|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1704535|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1704536|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1704537|NCT00033514|stage IV breast cancer|stage iv breast cancer
1704538|NCT00033514|recurrent breast cancer|recurrent breast cancer
1704539|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
1704540|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
1704541|NCT00033436|stage I bladder cancer|stage i bladder cancer
1704542|NCT00033436|stage II bladder cancer|stage ii bladder cancer
1704543|NCT00033436|stage III bladder cancer|stage iii bladder cancer
1704544|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1704545|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1704546|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1704547|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704548|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704549|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704550|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704551|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704552|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704553|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1704554|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
1704555|NCT00033410|large cell lung cancer|large cell lung cancer
1704556|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704557|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704558|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
1704559|NCT00033397|stage II breast cancer|stage ii breast cancer
1704560|NCT00033397|stage IV breast cancer|stage iv breast cancer
1704561|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
1704562|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
1704563|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
1704564|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
1704565|NCT00033345|breast cancer|breast cancer
1704566|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
1704567|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
1704568|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
1704569|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1704570|NCT00033280|adult mixed glioma|adult mixed glioma
1704571|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
1704572|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
1704573|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
1704574|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704575|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
1704576|NCT00033228|stage IV melanoma|stage iv melanoma
1704577|NCT00033228|recurrent melanoma|recurrent melanoma
1704578|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
1704579|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
1704580|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
1704581|NCT00032162|stage III cervical cancer|stage iii cervical cancer
1704582|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
1704583|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
1704584|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
1704585|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
1704586|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
1704589|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
1704590|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
1704591|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
1704592|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1704593|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1704594|NCT00032162|fallopian tube cancer|fallopian tube cancer
1704595|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
1704596|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
1704597|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
1704598|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
1704599|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
1704600|NCT00032162|ovarian sarcoma|ovarian sarcoma
1704601|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
1704602|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1704603|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1704604|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1704605|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1704606|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1704607|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1704608|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1704609|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1704610|NCT00032136|stage I breast cancer|stage i breast cancer
1704611|NCT00032136|stage II breast cancer|stage ii breast cancer
1704612|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
1704613|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
1704614|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1704615|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1704616|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
1704617|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
1704618|NCT00032097|adult glioblastoma|adult glioblastoma
1704619|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
1704620|NCT00032097|adult gliosarcoma|adult gliosarcoma
1704621|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
1704622|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1704623|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1704624|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1704625|NCT00032058|stage I prostate cancer|stage i prostate cancer
1704626|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
1704627|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
1704628|NCT00032045|iris melanoma|iris melanoma
1704629|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1704630|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1704631|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
1704632|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
1704633|NCT00032045|stage IV melanoma|stage iv melanoma
1704634|NCT00032045|recurrent melanoma|recurrent melanoma
1704635|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1704636|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1704637|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704638|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704639|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1704640|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1704641|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704642|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1704643|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1704644|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1704645|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1704646|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1704647|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1704648|NCT00032006|stage I prostate cancer|stage i prostate cancer
1704649|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
1704650|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
1704651|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
1704652|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1704653|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1704654|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1704655|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1704656|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1704657|NCT00031980|anemia|anemia
1704658|NCT00031980|neutropenia|neutropenia
1704659|NCT00031980|thrombocytopenia|thrombocytopenia
1704660|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1716938|NCT00042549|Shock wave|shock wave
1704661|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
1704662|NCT00031967|radiation toxicity|radiation toxicity
1704663|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1704664|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1704665|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1704666|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1704667|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1704668|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1704669|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1704670|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1704671|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1704672|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1704673|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1704674|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1704675|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1704676|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1704677|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1704678|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1704679|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704680|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1704681|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704682|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704683|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704684|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1704685|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704686|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1704687|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1704688|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1704689|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704690|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1704691|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1704692|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1704693|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1704694|NCT00031941|small intestine lymphoma|small intestine lymphoma
1704695|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704696|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704697|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1704698|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1704699|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704700|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704701|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704702|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
1704703|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
1704704|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1704705|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
1704706|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1704707|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1704708|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
1704709|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1704710|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1704711|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
1704712|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
1704713|NCT00031915|childhood liposarcoma|childhood liposarcoma
1704714|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1704715|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1704716|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
1704717|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
1704718|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1704719|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1704720|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1704721|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
1704722|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1704723|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1704724|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1704725|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1704803|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
1704726|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1704727|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1704728|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1704729|NCT00031876|stage IV breast cancer|stage iv breast cancer
1704730|NCT00031876|recurrent breast cancer|recurrent breast cancer
1704731|NCT00031863|stage II colon cancer|stage ii colon cancer
1704732|NCT00031863|stage III colon cancer|stage iii colon cancer
1704733|NCT00031863|stage II rectal cancer|stage ii rectal cancer
1704734|NCT00031863|stage III rectal cancer|stage iii rectal cancer
1704735|NCT00031850|breast cancer|breast cancer
1704736|NCT00031837|thromboembolism|thromboembolism
1704737|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
1704738|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
1704739|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1704740|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
1704741|NCT00031824|graft versus host disease|graft versus host disease
1704742|NCT00031798|fatigue|fatigue
1704743|NCT00031798|depression|depression
1704744|NCT00031798|quality of life|quality of life
1704745|NCT00031798|cognitive/functional effects|cognitive/functional effects
1704746|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
1704747|NCT00031798|adult brain stem glioma|adult brain stem glioma
1704748|NCT00031798|adult glioblastoma|adult glioblastoma
1704749|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
1704750|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1704751|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1704752|NCT00031798|adult mixed glioma|adult mixed glioma
1704753|NCT00031798|adult meningioma|adult meningioma
1704754|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
1704755|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1704756|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
1704757|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1704758|NCT00031798|adult subependymoma|adult subependymoma
1704759|NCT00031798|adult grade III meningioma|adult grade iii meningioma
1704760|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
1704761|NCT00031798|adult gliosarcoma|adult gliosarcoma
1704762|NCT00031798|adult grade II meningioma|adult grade ii meningioma
1704763|NCT00031772|recurrent breast cancer|recurrent breast cancer
1704764|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1704765|NCT00031759|cervical cancer|cervical cancer
1704766|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
1704767|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
1704768|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
1704769|NCT00031746|prostate cancer|prostate cancer
1704770|NCT00031733|iris melanoma|iris melanoma
1704771|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1704772|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1704773|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
1704774|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
1704775|NCT00031733|stage II melanoma|stage ii melanoma
1704776|NCT00031733|stage III melanoma|stage iii melanoma
1704777|NCT00031733|stage IV melanoma|stage iv melanoma
1704778|NCT00031733|recurrent melanoma|recurrent melanoma
1704779|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1704780|NCT00031720|stage I breast cancer|stage i breast cancer
1704781|NCT00031720|stage II breast cancer|stage ii breast cancer
1704782|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
1704783|NCT00031720|recurrent breast cancer|recurrent breast cancer
1704784|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1704785|NCT00031720|hot flashes|hot flashes
1704786|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1704787|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1717428|NCT00039975|Amlodipine|amlodipine
1704788|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1704789|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1704790|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1704791|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1704792|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1704793|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1704794|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704795|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1704796|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1704797|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1704798|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1704799|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1704800|NCT00031616|stage IV colon cancer|stage iv colon cancer
1704801|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
1704802|NCT00031616|recurrent colon cancer|recurrent colon cancer
1704804|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
1704805|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1704806|NCT00031590|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1704807|NCT00031590|PNET|pnet
1704808|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
1704809|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1704810|NCT00031564|stage IV|stage iv
1704811|NCT00031564|renal cell carcinoma|renal cell carcinoma
1704812|NCT00030914|hot flashes|hot flashes
1704813|NCT00030901|prostate cancer|prostate cancer
1705292|NCT00027742|stage IV melanoma|stage iv melanoma
1704814|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
1704815|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
1704816|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
1704817|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
1704818|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1704819|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1704820|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1704821|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1704822|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1704823|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1704824|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
1704825|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
1704826|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
1704827|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1704828|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1704829|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1704830|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1704831|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1704832|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1704833|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1704834|NCT00030823|stage I breast cancer|stage i breast cancer
1704835|NCT00030823|stage II breast cancer|stage ii breast cancer
1704836|NCT00030823|stage IV breast cancer|stage iv breast cancer
1704837|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
1704838|NCT00030823|recurrent breast cancer|recurrent breast cancer
1704839|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
1704840|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
1704841|NCT00030823|male breast cancer|male breast cancer
1704842|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
1704843|NCT00030810|large cell lung cancer|large cell lung cancer
1704844|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704845|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1704846|NCT00030784|adult angiosarcoma|adult angiosarcoma
1704847|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
1704848|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
1704849|NCT00030784|adult liposarcoma|adult liposarcoma
1704850|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
1704851|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
1704852|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1704853|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1704854|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
1706217|NCT00020579|intraocular lymphoma|intraocular lymphoma
1704855|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1704856|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1704857|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
1704858|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1704859|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1704860|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
1717429|NCT00039962|hepatitis C|hepatitis c
1704861|NCT00030771|large cell lung cancer|large cell lung cancer
1704862|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1704863|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1704864|NCT00030758|neutropenia|neutropenia
1704865|NCT00030758|stage I breast cancer|stage i breast cancer
1704866|NCT00030758|stage II breast cancer|stage ii breast cancer
1704867|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
1704868|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
1704869|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
1704870|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
1704871|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
1704872|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
1704873|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1704874|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
1704875|NCT00030719|regional neuroblastoma|regional neuroblastoma
1704876|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
1704877|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
1704878|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1705146|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
1704879|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1704880|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1704881|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1704882|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
1704883|NCT00030680|desmoid tumor|desmoid tumor
1704884|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1704885|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
1704886|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
1704887|NCT00030654|stage III prostate cancer|stage iii prostate cancer
1704888|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
1704889|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
1704890|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1704891|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704892|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1704893|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
1704894|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1704895|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1704896|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1704897|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1704898|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1704899|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1704900|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
1704901|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
1704902|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1704903|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1704904|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1704905|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1704906|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1704907|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1704908|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1704909|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1704910|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1704911|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1704912|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
1704913|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
1704914|NCT00030563|liver metastases|liver metastases
1704915|NCT00030563|stage IV colon cancer|stage iv colon cancer
1704916|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
1704917|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
1704918|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1704919|NCT00030563|recurrent colon cancer|recurrent colon cancer
1704920|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
1704921|NCT00030550|refractory anemia|refractory anemia
1704922|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1704923|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
1704924|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1704925|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1704926|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1704927|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1704928|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1717650|NCT00038818|CLL|cll
1704929|NCT00030537|stage IV breast cancer|stage iv breast cancer
1704930|NCT00030537|recurrent breast cancer|recurrent breast cancer
1704931|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
1704932|NCT00030537|male breast cancer|male breast cancer
1704933|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1704934|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1704935|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1704936|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1704937|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1704938|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1704939|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
1704940|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1704941|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
1704942|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
1704943|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1704944|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
1705147|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
1704945|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
1704946|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1704947|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1704948|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1704949|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1704950|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1704951|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1704952|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1706611|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
1704953|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1717807|NCT00038402|Taxol|taxol
1704954|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1704955|NCT00030342|stage IV colon cancer|stage iv colon cancer
1704956|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
1704957|NCT00030342|recurrent colon cancer|recurrent colon cancer
1704958|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
1704959|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
1704960|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
1704961|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1704962|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1704963|NCT00030290|stage I prostate cancer|stage i prostate cancer
1704964|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
1704965|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
1704966|NCT00030277|stage I prostate cancer|stage i prostate cancer
1704967|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
1704968|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
1704969|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
1704970|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
1704971|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
1704972|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1704973|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
1704974|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
1704975|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
1704976|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1704977|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1704978|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
1704979|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1704980|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
1704981|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1704982|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
1704983|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
1704984|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
1704985|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
1704986|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
1704987|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1704988|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1704989|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1704990|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1704991|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1704992|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1704993|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
1704994|NCT00030108|childhood teratoma|childhood teratoma
1704995|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1704996|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1704997|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1705260|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
1704998|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1704999|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1705000|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
1705001|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
1705002|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1705003|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1705004|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1705005|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1705006|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1705007|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1705008|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
1705009|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
1716939|NCT00042549|Shock waves|shock waves
1705010|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
1705011|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1705012|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1705013|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
1705014|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
1705015|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1705016|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1705017|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705018|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1705293|NCT00027742|recurrent melanoma|recurrent melanoma
1705019|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
1705020|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1705021|NCT00030082|liver metastases|liver metastases
1705022|NCT00029029|bone metastases|bone metastases
1705024|NCT00028990|stage IV breast cancer|stage iv breast cancer
1705025|NCT00028990|recurrent breast cancer|recurrent breast cancer
1705026|NCT00028990|male breast cancer|male breast cancer
1705027|NCT00028977|stage IV breast cancer|stage iv breast cancer
1705028|NCT00028977|recurrent breast cancer|recurrent breast cancer
1705029|NCT00028964|stage I breast cancer|stage i breast cancer
1705030|NCT00028964|stage II breast cancer|stage ii breast cancer
1705031|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
1705032|NCT00028964|recurrent breast cancer|recurrent breast cancer
1705033|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1705034|NCT00028951|lymphedema|lymphedema
1705035|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
1705036|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
1705037|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
1705038|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
1705039|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
1705040|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1705041|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1705042|NCT00028912|fallopian tube cancer|fallopian tube cancer
1705043|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1705044|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1705045|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1705046|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
1705047|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
1705048|NCT00028873|stage IV breast cancer|stage iv breast cancer
1705049|NCT00028873|recurrent breast cancer|recurrent breast cancer
1705050|NCT00028860|stage III bladder cancer|stage iii bladder cancer
1705051|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
1705052|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1705053|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1705054|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1705055|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1705056|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1705057|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
1705058|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1705059|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1705060|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1705061|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705062|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
1705063|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
1705064|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1705065|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1705495|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
1705066|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1705067|NCT00028743|fallopian tube cancer|fallopian tube cancer
1705068|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
1705069|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1705070|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1705071|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1705072|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1705073|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1705074|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1705075|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1705076|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1705077|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1705078|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1716940|NCT00042549|shockwaves|shockwaves
1705079|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1705080|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1705081|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1705082|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1705083|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1705084|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1705085|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1705086|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1705087|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1705088|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1705089|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1705294|NCT00027729|recurrent colon cancer|recurrent colon cancer
1705090|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1705091|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1705092|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1705093|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1705094|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1705095|NCT00028704|stage II breast cancer|stage ii breast cancer
1705096|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
1705097|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
1705098|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
1705099|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1705100|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1705101|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1705102|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1705103|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1705104|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1705105|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1705106|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1705107|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1705108|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1705109|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1705110|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1705111|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1705112|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1705113|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1705114|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1705115|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1705116|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1705117|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1705118|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1705119|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1705120|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1705121|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1705122|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1705123|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1705124|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1705125|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1705126|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1705127|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1705128|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1705129|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1705130|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1705131|NCT00028652|skin metastases|skin metastases
1705132|NCT00028639|stage IV breast cancer|stage iv breast cancer
1705133|NCT00028639|recurrent breast cancer|recurrent breast cancer
1705134|NCT00028626|liver metastases|liver metastases
1705135|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
1705136|NCT00028626|recurrent colon cancer|recurrent colon cancer
1705137|NCT00028626|stage IV colon cancer|stage iv colon cancer
1705138|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705139|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
1705140|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
1705141|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
1705142|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
1705143|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
1705144|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
1705145|NCT00028574|stage I prostate cancer|stage i prostate cancer
1705148|NCT00028574|stage III prostate cancer|stage iii prostate cancer
1705149|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
1705150|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
1705151|NCT00028574|hot flashes|hot flashes
1705152|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705153|NCT00028509|neurotoxicity|neurotoxicity
1705154|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1705155|NCT00028015|stage IV colon cancer|stage iv colon cancer
1705156|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
1705157|NCT00028015|recurrent colon cancer|recurrent colon cancer
1705158|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
1705159|NCT00027989|stage IV breast cancer|stage iv breast cancer
1705160|NCT00027976|actinic keratosis|actinic keratosis
1705161|NCT00027963|neurotoxicity|neurotoxicity
1705163|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1705164|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1705165|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1705166|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1705167|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1705168|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1705169|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705170|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1705171|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1705172|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1705173|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1705174|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1705175|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1705176|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1705177|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1705178|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1705179|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1705180|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1705181|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1705182|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1705183|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1705184|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1705185|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1705186|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1705187|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1705188|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1705189|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1705190|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1705191|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1705192|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1705193|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1705194|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1705195|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1705196|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1705197|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1705198|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1705199|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1705200|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1705201|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1705202|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1705203|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1705204|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1705205|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1705206|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1705207|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1705208|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1705209|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1705210|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1705211|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1705212|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1705213|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1705214|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1705277|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
1705215|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1705216|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1705217|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1705218|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1705219|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1705220|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1705221|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1705222|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1705223|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1705224|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1705290|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
1705225|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1705226|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1705227|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1705228|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1705229|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1705230|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1705231|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1705232|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1705233|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1705234|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1705235|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1705236|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1705237|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1705238|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1705239|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1707366|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
1705240|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1705241|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1705242|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1705243|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1705244|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1705245|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1705246|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1705247|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1705248|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1705249|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1705250|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1705251|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1705252|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1705253|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1705254|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1705255|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1705256|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1705257|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1705258|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1705259|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1705261|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1705262|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1705263|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1705264|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1705265|NCT00027885|stage IV breast cancer|stage iv breast cancer
1705266|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
1705267|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
1705268|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
1705269|NCT00027885|male breast cancer|male breast cancer
1705270|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705271|NCT00027859|stage III prostate cancer|stage iii prostate cancer
1705272|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1705273|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1705274|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1705275|NCT00027833|stage IV colon cancer|stage iv colon cancer
1705276|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
1716941|NCT00042549|shockwave|shockwave
1705278|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705279|NCT00027807|stage IV breast cancer|stage iv breast cancer
1705280|NCT00027807|recurrent breast cancer|recurrent breast cancer
1705281|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
1705282|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705283|NCT00027794|stage III prostate cancer|stage iii prostate cancer
1705284|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705285|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
1705286|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1705287|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1705288|NCT00027742|iris melanoma|iris melanoma
1705289|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
1705291|NCT00027742|stage III melanoma|stage iii melanoma
1705295|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
1705296|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
1705297|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1705298|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
1705299|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1705300|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1705301|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1705302|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1705303|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705304|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
1705305|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1705306|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1705307|NCT00027638|gastrinoma|gastrinoma
1705308|NCT00027638|insulinoma|insulinoma
1705309|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1705310|NCT00027638|WDHA syndrome|wdha syndrome
1705311|NCT00027638|somatostatinoma|somatostatinoma
1705312|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
1705313|NCT00027638|glucagonoma|glucagonoma
1705314|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1705315|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
1705316|NCT00027625|adult glioblastoma|adult glioblastoma
1705317|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1705318|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1705319|NCT00027625|adult mixed glioma|adult mixed glioma
1705320|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
1705321|NCT00027625|adult gliosarcoma|adult gliosarcoma
1705322|NCT00027586|stage IV melanoma|stage iv melanoma
1705323|NCT00027586|recurrent melanoma|recurrent melanoma
1705324|NCT00027586|Imatinib Mesylate|imatinib mesylate
1705325|NCT00027586|Gleevec|gleevec
1705326|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
1705328|NCT00027586|Gleevec targets|gleevec targets
1705329|NCT00027586|metastatic melanoma|metastatic melanoma
1705330|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
1705331|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
1705332|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1705333|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
1705334|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1705335|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1705336|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
1705337|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
1705338|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
1705339|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1705340|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1705341|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1705342|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1705343|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1705344|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1705345|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1705346|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1705347|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1705348|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1705349|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1705350|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1705351|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1705352|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1705353|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1705354|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1705355|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1705356|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1716942|NCT00042627|Cataracts|cataracts
1705357|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1705358|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1705359|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
1705360|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1705361|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1705362|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1705363|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1705364|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1705365|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1705366|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1717808|NCT00038402|FEC|fec
1705367|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1705368|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1705369|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1705370|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1705371|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1705372|NCT00027534|recurrent colon cancer|recurrent colon cancer
1705373|NCT00027534|stage III colon cancer|stage iii colon cancer
1705374|NCT00027534|stage IV colon cancer|stage iv colon cancer
1705375|NCT00027534|recurrent breast cancer|recurrent breast cancer
1705376|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
1705377|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
1705378|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
1705379|NCT00027534|stage IV breast cancer|stage iv breast cancer
1705380|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
1705381|NCT00027534|stage III gastric cancer|stage iii gastric cancer
1705382|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
1705383|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
1705384|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
1705385|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
1705386|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
1705387|NCT00027534|stage III rectal cancer|stage iii rectal cancer
1705388|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
1705389|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
1705390|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1705391|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
1705392|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
1705393|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1705394|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
1705395|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
1705396|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
1705397|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
1705398|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
1705399|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1705400|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
1705401|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
1705402|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
1705403|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
1705404|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1705405|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705406|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1705407|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1705408|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1705409|NCT00027534|male breast cancer|male breast cancer
1705410|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1717867|NCT00038142|Vincristine|vincristine
1705411|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1705412|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1705413|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1705414|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
1705415|NCT00027495|colon cancer|colon cancer
1705416|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1705417|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1705418|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1705419|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
1705420|NCT00026533|insular thyroid cancer|insular thyroid cancer
1705421|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
1705422|NCT00026468|colon cancer|colon cancer
1705423|NCT00026468|rectal cancer|rectal cancer
1705424|NCT00026468|small intestine cancer|small intestine cancer
1705425|NCT00026442|stage IV breast cancer|stage iv breast cancer
1705426|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
1705427|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
1705428|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
1705429|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1705430|NCT00026416|localized osteosarcoma|localized osteosarcoma
1705431|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
1705432|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1705433|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1705434|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
1705435|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1705436|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
1705437|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
1705438|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1705439|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
1705440|NCT00026299|stage IV colon cancer|stage iv colon cancer
1705441|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
1718017|NCT00037583|Acute|acute
1705442|NCT00026299|recurrent colon cancer|recurrent colon cancer
1705443|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
1705444|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
1705445|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705446|NCT00026247|bone metastases|bone metastases
1705448|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705449|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705450|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1705451|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
1705452|NCT00026156|large cell lung cancer|large cell lung cancer
1705453|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1705454|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1705455|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
1705456|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
1705457|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
1705458|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1705459|NCT00026117|stage IV colon cancer|stage iv colon cancer
1705460|NCT00026117|stage IV breast cancer|stage iv breast cancer
1705461|NCT00026117|recurrent breast cancer|recurrent breast cancer
1705462|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
1705463|NCT00026117|recurrent colon cancer|recurrent colon cancer
1705464|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
1705465|NCT00026117|male breast cancer|male breast cancer
1705466|NCT00026078|stage IV breast cancer|stage iv breast cancer
1705467|NCT00026078|recurrent breast cancer|recurrent breast cancer
1705468|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
1705469|NCT00025675|adult meningioma|adult meningioma
1705470|NCT00025675|adult glioblastoma|adult glioblastoma
1705471|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1705472|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1705473|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1705474|NCT00025675|adult subependymoma|adult subependymoma
1705475|NCT00025675|adult mixed glioma|adult mixed glioma
1705476|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1705477|NCT00025675|adult grade III meningioma|adult grade iii meningioma
1705478|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
1705479|NCT00025675|adult gliosarcoma|adult gliosarcoma
1705480|NCT00025675|adult grade I meningioma|adult grade i meningioma
1705481|NCT00025675|adult grade II meningioma|adult grade ii meningioma
1705482|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
1705483|NCT00025662|Melphalan|melphalan
1705484|NCT00025662|Fludarabine|fludarabine
1705485|NCT00025662|Donor Apheresis|donor apheresis
1705486|NCT00025662|Non-Myeloablative|non-myeloablative
1705488|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
1705489|NCT00025662|CML|cml
1705490|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1705491|NCT00025662|CLL|cll
1705492|NCT00025662|Lymphoma|lymphoma
1705493|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1705494|NCT00025662|Hodgkin's Disease|hodgkin's disease
1705496|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1705497|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
1705498|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1705499|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
1705500|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1705501|NCT00025662|Bone Marrow Transplant|bone marrow transplant
1705502|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
1705503|NCT00025649|regional neuroblastoma|regional neuroblastoma
1705504|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
1705505|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
1705506|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1705507|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1705508|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
1705509|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
1705510|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
1705511|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1705582|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
1705512|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1705513|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
1705514|NCT00025558|adult medulloblastoma|adult medulloblastoma
1705515|NCT00025558|adult glioblastoma|adult glioblastoma
1705516|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1705517|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1705518|NCT00025558|adult mixed glioma|adult mixed glioma
1705519|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1705520|NCT00025558|adult pineoblastoma|adult pineoblastoma
1705521|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1705522|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1705523|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
1705596|NCT00025181|recurrent melanoma|recurrent melanoma
1705524|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
1705525|NCT00025558|adult gliosarcoma|adult gliosarcoma
1705526|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
1705527|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1705528|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
1705529|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
1705530|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
1705531|NCT00025493|stage IV breast cancer|stage iv breast cancer
1705532|NCT00025493|recurrent breast cancer|recurrent breast cancer
1705533|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1705534|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1705535|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705536|NCT00025441|chondrosarcoma|chondrosarcoma
1705537|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1705538|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
1705539|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1705540|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1705541|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
1705542|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
1705543|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1705544|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1705545|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
1705546|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
1705547|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
1705548|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
1705549|NCT00025441|childhood liposarcoma|childhood liposarcoma
1705550|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1705551|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
1705553|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
1705554|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1705555|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
1705556|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
1705557|NCT00025441|ovarian sarcoma|ovarian sarcoma
1705558|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1705559|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1705560|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1705561|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1705562|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1705563|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1705564|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1705565|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1705566|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1717868|NCT00038142|Doxorubicin|doxorubicin
1705567|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1705568|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1705569|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1705570|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1705571|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
1705572|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1705573|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1705574|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1705575|NCT00025298|oral complications|oral complications
1705576|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1705577|NCT00025298|radiation toxicity|radiation toxicity
1705578|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
1705579|NCT00025285|large cell lung cancer|large cell lung cancer
1705580|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1705581|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1705583|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1705584|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1705585|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1705586|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705587|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
1705588|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
1705589|NCT00025181|iris melanoma|iris melanoma
1705590|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1705591|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1705592|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
1705593|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
1705594|NCT00025181|stage III melanoma|stage iii melanoma
1705595|NCT00025181|stage IV melanoma|stage iv melanoma
1705597|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
1705598|NCT00025142|stage IV colon cancer|stage iv colon cancer
1705599|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
1705600|NCT00025142|recurrent colon cancer|recurrent colon cancer
1705601|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
1705602|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
1705603|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705604|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1705605|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1705606|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1705607|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1705608|NCT00025129|small intestine lymphoma|small intestine lymphoma
1705609|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705610|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1705611|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1705612|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1705613|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1705614|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1705615|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1705616|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1705617|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1705618|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1705619|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1705620|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1705621|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1705622|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1705623|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1705624|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1705625|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1705626|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1705627|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1705628|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1705629|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1705630|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1705631|NCT00025129|intraocular lymphoma|intraocular lymphoma
1705632|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1705633|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1705634|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1705635|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1705636|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1705637|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1705638|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1705639|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1705640|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1705641|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1705642|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1705643|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1705644|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1705645|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1705646|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1705647|NCT00025090|stage I anal cancer|stage i anal cancer
1705648|NCT00025090|stage II anal cancer|stage ii anal cancer
1705649|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
1705650|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
1705651|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1705652|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1705653|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1705654|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1705655|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1705656|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1705657|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1705658|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1705659|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1705660|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1705661|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1705662|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1705663|NCT00025025|colon cancer|colon cancer
1705664|NCT00025025|rectal cancer|rectal cancer
1705665|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
1705666|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
1705667|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
1705668|NCT00024453|infection|infection
1705669|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1705670|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1705671|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1705672|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
1705673|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
1705674|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
1705675|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1705676|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
1705677|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705678|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
1705679|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
1705680|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
1705681|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
1705682|NCT00024349|stage II bladder cancer|stage ii bladder cancer
1705683|NCT00024349|stage III bladder cancer|stage iii bladder cancer
1705684|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1705685|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1705686|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1705687|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1705688|NCT00024297|thromboembolism|thromboembolism
1705689|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1705690|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
1705691|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
1705692|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1705693|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
1705694|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1705695|NCT00024258|regional neuroblastoma|regional neuroblastoma
1705696|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
1705697|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
1705698|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
1705699|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
1705700|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
1705701|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
1705702|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
1705703|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
1705704|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
1705705|NCT00024258|stage V Wilms tumor|stage v wilms tumor
1705706|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1705707|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
1705708|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
1705709|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
1705710|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
1705711|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
1717869|NCT00038142|Adriamycin|adriamycin
1705712|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1705713|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1705714|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1705715|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1705716|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1705717|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1705718|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1705719|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1705720|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1705721|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1705722|NCT00024258|childhood teratoma|childhood teratoma
1705723|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1705724|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1705725|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1705726|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1705727|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705728|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
1705729|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
1705730|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
1705731|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
1705732|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1705733|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1705734|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1705735|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1705736|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1705737|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1705738|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705739|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
1705740|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
1705741|NCT00024167|Strontium-89|strontium-89
1705742|NCT00024167|Induction Chemotherapy|induction chemotherapy
1705743|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
1705744|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1705745|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1705746|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
1705747|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
1705748|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1705749|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
1705750|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
1708401|NCT00007826|stage III colon cancer|stage iii colon cancer
1705751|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1705752|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
1705753|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
1705754|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
1705755|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1705756|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1705757|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1705758|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1705759|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1705760|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
1705761|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
1705762|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
1705763|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
1705764|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1705765|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
1705766|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
1705767|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1705768|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
1705769|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
1705832|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1705770|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
1705771|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
1705772|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
1705773|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1705774|NCT00024102|stage I breast cancer|stage i breast cancer
1705775|NCT00024102|stage II breast cancer|stage ii breast cancer
1705776|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
1705777|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
1705778|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
1705779|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1705780|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1705781|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1705844|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1705782|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1705783|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1705784|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1705785|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1705786|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1705787|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1705788|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1705789|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1705790|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1705791|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1705856|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1705792|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1705793|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1705794|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1705795|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
1705796|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1705797|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1705798|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1705799|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1705800|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1705801|NCT00024076|lung metastases|lung metastases
1705802|NCT00024050|refractory anemia|refractory anemia
1705803|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1705804|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1705805|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1705806|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1705807|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1705808|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1705809|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1705810|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1705811|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
1705812|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
1705813|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1705814|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1705815|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1705816|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1705817|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1705818|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705819|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
1705820|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
1705821|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1705822|NCT00023829|stage III prostate cancer|stage iii prostate cancer
1705823|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
1705824|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
1705825|NCT00023790|stage IV breast cancer|stage iv breast cancer
1705826|NCT00023790|recurrent breast cancer|recurrent breast cancer
1705827|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1705828|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1705829|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1705830|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1705831|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1717870|NCT00038142|Rubex|rubex
1705833|NCT00023790|recurrent skin cancer|recurrent skin cancer
1705834|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
1705835|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
1705836|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1705837|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1705838|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1705839|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1708402|NCT00007826|stage IV colon cancer|stage iv colon cancer
1705840|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1705841|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1705842|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1705843|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1705980|NCT00022425|recurrent breast cancer|recurrent breast cancer
1705845|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1705846|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1705847|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1705848|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1705849|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1705850|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1705851|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1705852|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1705853|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1705854|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1705855|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1705857|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1705858|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1705859|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1705860|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1705861|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1705862|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1705863|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1705864|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1705865|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1705866|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1705867|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1705868|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1705869|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1705870|NCT00023790|skin metastases|skin metastases
1705871|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1705872|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1705873|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1705874|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1705875|NCT00023790|male breast cancer|male breast cancer
1705876|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1705877|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1705878|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1705879|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1705880|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1705881|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1705882|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
1705883|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
1705884|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1705885|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1705886|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1705887|NCT00023751|stage I rectal cancer|stage i rectal cancer
1705888|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705889|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705890|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
1718086|NCT00037102|autoimmune|autoimmune
1705891|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
1705892|NCT00023660|stage III cervical cancer|stage iii cervical cancer
1705893|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
1705894|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
1705895|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
1705896|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
1705897|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1705898|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
1705899|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1705900|NCT00023634|stage II gastric cancer|stage ii gastric cancer
1705901|NCT00023634|stage III gastric cancer|stage iii gastric cancer
1705902|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
1705903|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
1705904|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705905|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1705906|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1705907|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1705908|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
1705909|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
1705910|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
1705911|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1705912|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1705913|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
1705914|NCT00022724|adult glioblastoma|adult glioblastoma
1705915|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1705916|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1705917|NCT00022724|adult mixed glioma|adult mixed glioma
1705918|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
1705919|NCT00022724|adult gliosarcoma|adult gliosarcoma
1705920|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
1705921|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
1705922|NCT00022698|stage III colon cancer|stage iii colon cancer
1705923|NCT00022698|stage IV colon cancer|stage iv colon cancer
1705924|NCT00022698|stage III rectal cancer|stage iii rectal cancer
1705925|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
1705926|NCT00022698|recurrent colon cancer|recurrent colon cancer
1705927|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
1705928|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
1705929|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1705930|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1705931|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1705932|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1705933|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1705934|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
1705935|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
1705936|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1705937|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1705938|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1705939|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
1705940|NCT00022633|anterior urethral cancer|anterior urethral cancer
1705941|NCT00022633|posterior urethral cancer|posterior urethral cancer
1705942|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1705943|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1705944|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1705945|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1705946|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1705947|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1705948|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
1705949|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
1705950|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
1705951|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
1705952|NCT00022568|stage IV melanoma|stage iv melanoma
1705953|NCT00022568|recurrent melanoma|recurrent melanoma
1705954|NCT00022516|stage IA breast cancer|stage ia breast cancer
1705955|NCT00022516|stage II breast cancer|stage ii breast cancer
1705956|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
1705957|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
1705958|NCT00022516|stage IB breast cancer|stage ib breast cancer
1705959|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
1705960|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
1705961|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
1705962|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
1705963|NCT00022516|stroma|stroma
1705964|NCT00022516|angiogenesis|angiogenesis
1705965|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1706428|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
1705966|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1705967|NCT00022464|stage IV melanoma|stage iv melanoma
1705968|NCT00022464|recurrent melanoma|recurrent melanoma
1705969|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1705970|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1705971|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1705972|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1705973|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1705974|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1705975|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
1705976|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1705977|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1705978|NCT00022438|stage IV melanoma|stage iv melanoma
1705979|NCT00022438|recurrent melanoma|recurrent melanoma
1705981|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705982|NCT00022412|stage I prostate cancer|stage i prostate cancer
1705983|NCT00022412|stage II prostate cancer|stage ii prostate cancer
1705984|NCT00022399|stage I prostate cancer|stage i prostate cancer
1705985|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
1705986|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
1705987|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1705988|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1705989|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1705990|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
1705991|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1705992|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1705993|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1705994|NCT00022230|stage II breast cancer|stage ii breast cancer
1718018|NCT00037583|Myeloid|myeloid
1705995|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
1705996|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
1705997|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
1705998|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
1705999|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1706000|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1706001|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1706002|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1706003|NCT00022152|stage IV breast cancer|stage iv breast cancer
1706004|NCT00022152|recurrent breast cancer|recurrent breast cancer
1706005|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1706006|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1706007|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1706008|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
1706009|NCT00022087|osteoporosis|osteoporosis
1706010|NCT00022087|stage I breast cancer|stage i breast cancer
1706011|NCT00022087|stage II breast cancer|stage ii breast cancer
1706012|NCT00022087|stage IV breast cancer|stage iv breast cancer
1706013|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
1706014|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
1706015|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
1706016|NCT00022074|stage I breast cancer|stage i breast cancer
1706017|NCT00022074|stage II breast cancer|stage ii breast cancer
1706018|NCT00022074|stage IV breast cancer|stage iv breast cancer
1706019|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
1706020|NCT00022074|recurrent breast cancer|recurrent breast cancer
1706021|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
1706022|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
1706023|NCT00022074|anxiety disorder|anxiety disorder
1706024|NCT00022074|depression|depression
1706025|NCT00022074|hot flashes|hot flashes
1706026|NCT00022048|refractory anemia|refractory anemia
1706027|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1706028|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
1706029|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1706030|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1706031|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1706032|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1706033|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1706034|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1706035|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1706036|NCT00022035|infection|infection
1718296|NCT00035802|Pediatric|pediatric
1706037|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706038|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706039|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706040|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
1706041|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
1706042|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706043|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706044|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706045|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706046|NCT00021424|skin metastases|skin metastases
1706047|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
1706048|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
1706049|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
1706050|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
1717050|NCT00042133|aging|aging
1706051|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1706052|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1706053|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1706054|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1706055|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1706056|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1706057|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1706058|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1706059|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1706060|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1706061|NCT00021164|stage IV melanoma|stage iv melanoma
1706062|NCT00021164|recurrent melanoma|recurrent melanoma
1706063|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706064|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1718019|NCT00037583|Leukemia|leukemia
1706065|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1706066|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1706067|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1706068|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706069|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1706070|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1706071|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1706072|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706073|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1706074|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1706075|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1706076|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1706077|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1706078|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1706079|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1706080|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706081|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1706082|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1706083|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1706084|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706085|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1706086|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
1706087|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
1706088|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
1706089|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
1706090|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706091|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
1706092|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
1706093|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
1706094|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
1706095|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
1706096|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
1706097|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
1707202|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
1706098|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706099|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1706100|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1706101|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706102|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1706103|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1706104|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706105|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1706106|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1706107|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1706108|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1706109|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706110|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1706111|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1706112|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1706113|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1706114|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706115|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1706116|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706117|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1706118|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1706119|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1706120|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1706121|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1706122|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1708403|NCT00007826|stage II rectal cancer|stage ii rectal cancer
1706123|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1706124|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706125|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1706126|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1706127|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1706128|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706129|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1706130|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1706131|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706132|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1706133|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1706134|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1706135|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706136|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
1706137|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
1706138|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1706139|NCT00020995|stage I prostate cancer|stage i prostate cancer
1706140|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
1706141|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
1706142|NCT00020995|stage III prostate cancer|stage iii prostate cancer
1706143|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
1706144|NCT00020969|refractory anemia|refractory anemia
1706145|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1706146|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
1706147|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1706148|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1706149|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1706150|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1706151|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1706152|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1706153|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1706154|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1706155|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1706156|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1706157|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1706158|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1706159|NCT00020891|stage I prostate cancer|stage i prostate cancer
1706160|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
1706161|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
1706162|NCT00020891|stage III prostate cancer|stage iii prostate cancer
1706163|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
1706164|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
1706165|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
1706166|NCT00020852|stage I breast cancer|stage i breast cancer
1706167|NCT00020852|stage II breast cancer|stage ii breast cancer
1706168|NCT00020839|stage IV melanoma|stage iv melanoma
1706169|NCT00020839|recurrent melanoma|recurrent melanoma
1706170|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
1706171|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1706172|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
1706173|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
1706174|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
1706175|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
1706176|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
1706177|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1706178|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1706179|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706180|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1706181|NCT00020735|stage I prostate cancer|stage i prostate cancer
1706182|NCT00020735|stage II prostate cancer|stage ii prostate cancer
1706183|NCT00020722|stage IV breast cancer|stage iv breast cancer
1706184|NCT00020722|recurrent breast cancer|recurrent breast cancer
1706185|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1706186|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1706462|NCT00020332|male breast cancer|male breast cancer
1706187|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1706188|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1706189|NCT00020657|nausea and vomiting|nausea and vomiting
1706190|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706191|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706192|NCT00020631|radiation fibrosis|radiation fibrosis
1706193|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1706194|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1706195|NCT00020579|small intestine lymphoma|small intestine lymphoma
1706196|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1706197|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1706198|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1706199|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1706200|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1706201|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1706202|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1706203|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1706204|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1706205|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1706206|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1706207|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1706208|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1706209|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1706210|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1706211|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1706212|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1706213|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1706214|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1706215|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1706216|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1706218|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1706219|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1706220|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1706221|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1706222|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1706223|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1706224|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1706225|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1706226|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1706227|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1706228|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1706229|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1706230|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1706231|NCT00020579|male breast cancer|male breast cancer
1706232|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
1706233|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
1706234|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
1706235|NCT00020579|stage IV breast cancer|stage iv breast cancer
1706236|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
1706237|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
1706238|NCT00020579|recurrent colon cancer|recurrent colon cancer
1706239|NCT00020579|stage III colon cancer|stage iii colon cancer
1706240|NCT00020579|stage IV colon cancer|stage iv colon cancer
1706241|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
1706242|NCT00020579|stage III rectal cancer|stage iii rectal cancer
1706243|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
1706244|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1706245|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1706246|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1706247|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1706248|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1706249|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1706250|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1706251|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1706252|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
1706253|NCT00020579|stage III cervical cancer|stage iii cervical cancer
1706254|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
1706255|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
1706256|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1706257|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
1706258|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1706259|NCT00020579|fallopian tube cancer|fallopian tube cancer
1706260|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1706261|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
1706262|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
1706263|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
1706264|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
1706265|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
1706266|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
1706267|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
1706268|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
1706269|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
1706270|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
1706271|NCT00020579|recurrent anal cancer|recurrent anal cancer
1706272|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
1706273|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
1706274|NCT00020579|stage IV anal cancer|stage iv anal cancer
1706275|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
1706276|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
1706277|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
1706278|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
1706279|NCT00020579|stage III gastric cancer|stage iii gastric cancer
1706280|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
1706281|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1706282|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1706283|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
1706284|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1706285|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706286|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1706287|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1706288|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1706289|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1706290|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706291|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1706292|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1706293|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706294|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1706295|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1706296|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1706297|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706298|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1706299|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706300|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1706301|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1706302|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1706303|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706304|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1706305|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1706306|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1706307|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1706308|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1706309|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1706310|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706311|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1706312|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1706313|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1708404|NCT00007826|stage III rectal cancer|stage iii rectal cancer
1706314|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706315|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1706316|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1706317|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1718020|NCT00037570|Peptic|peptic
1706318|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706319|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1706320|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1706321|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706322|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
1706323|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
1706324|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
1706325|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
1706326|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
1706327|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
1706328|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
1706329|NCT00020579|stage III bladder cancer|stage iii bladder cancer
1706330|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
1706331|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
1706332|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
1706333|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
1706334|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
1706335|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
1706336|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
1706337|NCT00020579|stage V Wilms tumor|stage v wilms tumor
1706338|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1706339|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1706340|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1706341|NCT00020579|anterior urethral cancer|anterior urethral cancer
1706342|NCT00020579|posterior urethral cancer|posterior urethral cancer
1706343|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
1706344|NCT00020579|recurrent penile cancer|recurrent penile cancer
1706345|NCT00020579|stage III penile cancer|stage iii penile cancer
1706346|NCT00020579|stage IV penile cancer|stage iv penile cancer
1706347|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
1706348|NCT00020579|stage III prostate cancer|stage iii prostate cancer
1706349|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
1706350|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1706351|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1706352|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
1706353|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
1706354|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1706355|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1706356|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1706357|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
1706358|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1706359|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1706360|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1706361|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1706362|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1706363|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
1706364|NCT00020579|iris melanoma|iris melanoma
1706365|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
1706366|NCT00020579|recurrent melanoma|recurrent melanoma
1706367|NCT00020579|stage III melanoma|stage iii melanoma
1706368|NCT00020579|stage IV melanoma|stage iv melanoma
1706369|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706441|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
1706370|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706371|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
1706372|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1706373|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706374|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706375|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
1706376|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
1706377|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1706378|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1706379|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
1706380|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1706381|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1706382|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1706383|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1706384|NCT00020579|desmoid tumor|desmoid tumor
1706385|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1706386|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1706387|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
1706388|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
1706389|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1706390|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1706391|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
1706392|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1706393|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
1706394|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
1706395|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1706396|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1706397|NCT00020579|adult brain stem glioma|adult brain stem glioma
1706398|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
1706399|NCT00020579|adult mixed glioma|adult mixed glioma
1706400|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1706401|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
1706402|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
1706403|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
1706404|NCT00020579|adult subependymoma|adult subependymoma
1706405|NCT00020579|adult medulloblastoma|adult medulloblastoma
1706406|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1706407|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
1706408|NCT00020579|adult ependymoma|adult ependymoma
1706409|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1706410|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
1708405|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
1706411|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1706412|NCT00020579|adult meningioma|adult meningioma
1706413|NCT00020579|adult papillary meningioma|adult papillary meningioma
1706414|NCT00020579|adult grade I meningioma|adult grade i meningioma
1706415|NCT00020579|adult grade II meningioma|adult grade ii meningioma
1706416|NCT00020579|adult grade III meningioma|adult grade iii meningioma
1706417|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1706418|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
1706419|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
1706420|NCT00020579|stage III thymoma|stage iii thymoma
1706421|NCT00020579|stage IVA thymoma|stage iva thymoma
1706422|NCT00020579|stage IVB thymoma|stage ivb thymoma
1706423|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1706424|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1706425|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1706426|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1706427|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
1706429|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1706430|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1706431|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1706432|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1706433|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1706434|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1706435|NCT00020527|neutropenia|neutropenia
1706436|NCT00020527|infection|infection
1706437|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1706438|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1706439|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1706440|NCT00020501|stage IV colon cancer|stage iv colon cancer
1717051|NCT00042133|disability|disability
1706442|NCT00020501|recurrent colon cancer|recurrent colon cancer
1706443|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
1706444|NCT00020501|liver metastases|liver metastases
1706445|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706446|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1706447|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1706448|NCT00020410|stage IV breast cancer|stage iv breast cancer
1706449|NCT00020410|recurrent breast cancer|recurrent breast cancer
1706450|NCT00020410|male breast cancer|male breast cancer
1706451|NCT00020397|recurrent melanoma|recurrent melanoma
1706452|NCT00020397|stage IV melanoma|stage iv melanoma
1706453|NCT00020358|stage I melanoma|stage i melanoma
1706454|NCT00020358|stage II melanoma|stage ii melanoma
1706455|NCT00020358|stage III melanoma|stage iii melanoma
1706456|NCT00020358|stage IV melanoma|stage iv melanoma
1706457|NCT00020358|recurrent melanoma|recurrent melanoma
1706458|NCT00020332|stage IV breast cancer|stage iv breast cancer
1706459|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
1706460|NCT00020332|recurrent breast cancer|recurrent breast cancer
1706461|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
1718021|NCT00037570|Ulcer|ulcer
1706463|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1706464|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
1706465|NCT00020189|thromboembolism|thromboembolism
1706466|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1706467|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1706468|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1706469|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706470|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706471|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706472|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706473|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1706474|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1706475|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706476|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1706477|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706478|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1706479|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
1706480|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1706481|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
1706482|NCT00020176|stage IV breast cancer|stage iv breast cancer
1706483|NCT00020176|recurrent breast cancer|recurrent breast cancer
1706484|NCT00020176|male breast cancer|male breast cancer
1706485|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1706486|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
1706487|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
1706488|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
1706489|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
1706490|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1706491|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1706492|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
1706493|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1706494|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
1706495|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1706496|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
1706497|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
1706498|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
1706499|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
1706500|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
1706501|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1706502|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1706503|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1706504|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1706505|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1706506|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1706507|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
1706508|NCT00020150|childhood teratoma|childhood teratoma
1710868|NCT00004065|recurrent breast cancer|recurrent breast cancer
1706509|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1717357|NCT00040261|Memantine|memantine
1706510|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1706511|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
1706512|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1706513|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706514|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706515|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
1706516|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
1706517|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1706518|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706519|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706520|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1706521|NCT00020124|lung metastases|lung metastases
1706522|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1706523|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1706524|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1706525|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1706526|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1706527|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1706528|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1706529|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1706530|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1706531|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
1706532|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
1706533|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706534|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
1706535|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706536|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
1706537|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1706538|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706539|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706540|NCT00020007|lung metastases|lung metastases
1706541|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1706542|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1706543|NCT00019994|stage IV melanoma|stage iv melanoma
1706544|NCT00019994|recurrent melanoma|recurrent melanoma
1706545|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
1706546|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
1706547|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1706548|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706549|NCT00019916|stage IV breast cancer|stage iv breast cancer
1706550|NCT00019916|recurrent breast cancer|recurrent breast cancer
1706551|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1706552|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1706553|NCT00019864|cardiac toxicity|cardiac toxicity
1706554|NCT00019864|localized osteosarcoma|localized osteosarcoma
1706555|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
1706556|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
1706557|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
1706558|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1706559|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
1706560|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1706561|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1706562|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1706563|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1706564|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1706565|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1707203|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
1706566|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1706567|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1706568|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706569|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
1706570|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
1706571|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
1706572|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
1706573|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706574|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
1706575|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
1706576|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1706577|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706578|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706579|NCT00019825|malignant pleural effusion|malignant pleural effusion
1706580|NCT00019812|stage IV breast cancer|stage iv breast cancer
1706581|NCT00019812|male breast cancer|male breast cancer
1706582|NCT00019786|stage IV colon cancer|stage iv colon cancer
1706583|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
1706584|NCT00019786|recurrent colon cancer|recurrent colon cancer
1706585|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
1706586|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1706587|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706588|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
1706589|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1706590|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
1706591|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1706592|NCT00019786|liver metastases|liver metastases
1706593|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1706594|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
1706595|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
1706596|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1706597|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
1706598|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
1706599|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
1706600|NCT00019773|stage I colon cancer|stage i colon cancer
1706601|NCT00019773|stage II colon cancer|stage ii colon cancer
1706602|NCT00019773|stage III colon cancer|stage iii colon cancer
1706603|NCT00019773|stage IV colon cancer|stage iv colon cancer
1706604|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
1706605|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
1706606|NCT00019773|stage I rectal cancer|stage i rectal cancer
1706607|NCT00019773|stage II rectal cancer|stage ii rectal cancer
1706608|NCT00019773|stage III rectal cancer|stage iii rectal cancer
1706609|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
1706610|NCT00019773|recurrent colon cancer|recurrent colon cancer
1706612|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
1706613|NCT00019773|small intestine lymphoma|small intestine lymphoma
1706614|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1706615|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
1706616|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
1706617|NCT00019747|stage IV colon cancer|stage iv colon cancer
1706618|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
1706619|NCT00019747|recurrent colon cancer|recurrent colon cancer
1706620|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
1706621|NCT00019669|stage IV melanoma|stage iv melanoma
1706622|NCT00019669|recurrent melanoma|recurrent melanoma
1706623|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1706624|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1706625|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706626|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1706627|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1706628|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1706629|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1706630|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1706631|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1706632|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1706633|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1706634|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1706635|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1706636|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1706637|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1706638|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1706639|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1706640|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1718297|NCT00035802|Children|children
1706641|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1706642|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1706643|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1706644|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1706645|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1706646|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1706647|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1706648|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1706649|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1706650|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1706651|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1706844|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
1706652|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1706653|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1706654|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1706655|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1706656|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1706657|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1706658|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1706659|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1706660|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1706661|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1706662|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706663|NCT00019604|liver metastases|liver metastases
1706664|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706665|NCT00019591|stage III colon cancer|stage iii colon cancer
1706666|NCT00019591|stage IV colon cancer|stage iv colon cancer
1706667|NCT00019591|stage III rectal cancer|stage iii rectal cancer
1706668|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
1706669|NCT00019591|recurrent colon cancer|recurrent colon cancer
1706670|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
1706671|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706672|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1706673|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1706674|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1706675|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1706676|NCT00019513|small intestine lymphoma|small intestine lymphoma
1706677|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706678|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1706679|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1706680|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1706681|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1706682|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1706683|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1706684|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1706685|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1706686|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1706687|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1706688|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1706689|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1706690|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1706691|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1706692|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1706693|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1706694|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1706695|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1706696|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1706697|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1706698|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1706699|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1706700|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1706701|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1706702|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1706703|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706704|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
1706705|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1718298|NCT00035802|Adolescent|adolescent
1706706|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706707|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706708|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706709|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
1706710|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
1706711|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
1706712|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
1706713|NCT00019513|recurrent colon cancer|recurrent colon cancer
1706714|NCT00019513|stage IV colon cancer|stage iv colon cancer
1706715|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
1706716|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
1706717|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1717691|NCT00038688|Peer Group|peer group
1706718|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1706719|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1706720|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1706721|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1706722|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1706723|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1706724|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1706725|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1706726|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1706727|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1706728|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
1706729|NCT00019487|stage IV melanoma|stage iv melanoma
1706730|NCT00019487|recurrent melanoma|recurrent melanoma
1706731|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1706732|NCT00019461|fallopian tube cancer|fallopian tube cancer
1706733|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1706734|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1706735|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1706987|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
1706736|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1706737|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1706738|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1706739|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1706740|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1706741|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
1706742|NCT00019331|stage IV colon cancer|stage iv colon cancer
1706743|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706744|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
1706745|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
1706746|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
1706747|NCT00019331|recurrent colon cancer|recurrent colon cancer
1706748|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1706749|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
1706750|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
1706751|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1706752|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1706753|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1706754|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1706755|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1706756|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1706757|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1706758|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1706759|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
1706760|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
1706761|NCT00019331|stage IV melanoma|stage iv melanoma
1706762|NCT00019331|recurrent melanoma|recurrent melanoma
1706763|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706764|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706765|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1706766|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1706767|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1706768|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1706769|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706770|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1706771|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1706772|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1706773|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1706774|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706775|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1706776|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1706777|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1706778|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1706779|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706780|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1706845|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
1706781|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706782|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1706783|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1706784|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1706785|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1706786|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1706787|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1706788|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1706789|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706790|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1706791|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1706792|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1706793|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706794|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1706795|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1707246|NCT00016380|recurrent colon cancer|recurrent colon cancer
1706796|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706797|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1706798|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1706799|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1706800|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706801|NCT00019331|insular thyroid cancer|insular thyroid cancer
1706802|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
1706803|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
1706804|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
1706805|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1706806|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1706807|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1706808|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1706809|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1706810|NCT00019227|radiation toxicity|radiation toxicity
1706811|NCT00019214|recurrent melanoma|recurrent melanoma
1706812|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1706813|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1706814|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1706815|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
1706816|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
1706817|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1706818|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1706819|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
1706820|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1706821|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1706822|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
1706823|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1706824|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1706825|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
1706826|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
1706827|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
1706828|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
1706829|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
1706830|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1706831|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
1718299|NCT00035802|Topiramate|topiramate
1706832|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1706833|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1706834|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1706835|NCT00019110|stage IV anal cancer|stage iv anal cancer
1706836|NCT00019110|recurrent anal cancer|recurrent anal cancer
1706837|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
1706838|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
1706839|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
1706840|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
1706841|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
1706842|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
1706843|NCT00019110|stage III cervical cancer|stage iii cervical cancer
1706846|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
1706847|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
1706848|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
1706849|NCT00019110|stage III penile cancer|stage iii penile cancer
1706850|NCT00019110|stage IV penile cancer|stage iv penile cancer
1706851|NCT00019110|recurrent penile cancer|recurrent penile cancer
1706852|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1706853|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1706854|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1706855|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1706856|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1706857|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1706858|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1706859|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1706860|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1706861|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1706988|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1706862|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1706863|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1706864|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1706865|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1706866|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1706867|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1706868|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1706869|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1706870|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1706871|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1706872|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1706873|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1706874|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1706875|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1706876|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1706877|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1706878|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1706879|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1706880|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1706881|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1706882|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1706883|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1706884|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1706885|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1706886|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1706887|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1706888|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1706889|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1706890|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1706986|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1718408|NCT00035165|cancer|cancer
1706891|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1706892|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706893|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1706894|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1706895|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1706896|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706897|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1717692|NCT00038688|Risk-Taking|risk-taking
1706898|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1706899|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1706900|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1706901|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
1706902|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
1706903|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
1706904|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1706905|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1706906|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1706907|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1706908|NCT00019019|stage IV breast cancer|stage iv breast cancer
1706909|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
1706910|NCT00019019|recurrent breast cancer|recurrent breast cancer
1706911|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
1706912|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1706913|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1706914|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1706915|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1707242|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
1706916|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1706917|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
1706918|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
1706919|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
1706920|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1706921|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1706922|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1706923|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
1706924|NCT00019019|small intestine lymphoma|small intestine lymphoma
1706925|NCT00019019|adult brain stem glioma|adult brain stem glioma
1706926|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
1706927|NCT00019019|adult medulloblastoma|adult medulloblastoma
1706928|NCT00019019|adult meningioma|adult meningioma
1706929|NCT00019019|adult glioblastoma|adult glioblastoma
1706930|NCT00019019|stage III melanoma|stage iii melanoma
1706931|NCT00019019|stage IV melanoma|stage iv melanoma
1706932|NCT00019019|recurrent melanoma|recurrent melanoma
1706933|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1706934|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1706935|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
1706936|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1706937|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1706938|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1706939|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1706940|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1706941|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1706942|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1706943|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1706944|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1706945|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1706946|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1706947|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1706948|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1706949|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1706950|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1706951|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1706952|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1706953|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1706954|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1706955|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1706956|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1706957|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1706958|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1706959|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1706960|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1706961|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1706962|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1706963|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1707216|NCT00016432|stage II breast cancer|stage ii breast cancer
1706964|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1706965|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1706966|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1706967|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1706968|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1706969|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1706970|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
1706971|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1706972|NCT00019019|adult mixed glioma|adult mixed glioma
1706973|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1706974|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1706975|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1706976|NCT00019019|adult subependymoma|adult subependymoma
1706977|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
1706978|NCT00019019|adult pineocytoma|adult pineocytoma
1706979|NCT00019019|adult pineoblastoma|adult pineoblastoma
1706980|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1706981|NCT00019019|intraocular lymphoma|intraocular lymphoma
1706982|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1706983|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1706984|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1706985|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1718022|NCT00037570|Hemorrhage|hemorrhage
1706989|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1706990|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1706991|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1706992|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1706993|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1706994|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1706995|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1706996|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1706997|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1706998|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1706999|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1707000|NCT00019019|adult grade III meningioma|adult grade iii meningioma
1707001|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
1707002|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
1707003|NCT00019019|adult gliosarcoma|adult gliosarcoma
1707004|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1707005|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1707006|NCT00018967|neurotoxicity|neurotoxicity
1707007|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
1707008|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
1707009|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
1707010|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
1707011|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707012|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1707013|NCT00017563|stage II prostate cancer|stage ii prostate cancer
1707014|NCT00017563|stage III prostate cancer|stage iii prostate cancer
1707015|NCT00017550|refractory anemia|refractory anemia
1707016|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
1707017|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1707018|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707019|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1707020|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
1707021|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
1707022|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
1707023|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
1707024|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
1707025|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1718409|NCT00035165|tumor|tumor
1707026|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1707027|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1707028|NCT00017511|oral complications|oral complications
1707029|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1707030|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
1707031|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
1707032|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
1707033|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
1707217|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
1707034|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1707035|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
1707036|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
1707037|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
1707038|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
1707039|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707040|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1707041|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1707042|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1707043|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1707044|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707045|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1707046|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1707047|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1707048|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1707049|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1707050|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1707243|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
1707051|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1707052|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1707053|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1707054|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1707055|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
1707056|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1707057|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
1707058|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707059|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1707060|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707061|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1707062|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1707063|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1707064|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1707065|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
1707066|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1707067|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
1707068|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1707069|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1707070|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1707071|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1707072|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1707073|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1707074|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1707075|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1707365|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
1707076|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1707077|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1707078|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1707204|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1707079|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1707080|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
1707081|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1707082|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
1707083|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707084|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1707085|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707086|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1707218|NCT00016419|refractory anemia|refractory anemia
1707087|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1707088|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1707089|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1707090|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
1707091|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1707092|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707093|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1707094|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
1707095|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1707096|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707097|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1707098|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1707099|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1707100|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707101|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1707244|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
1707102|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1707103|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1707104|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707105|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1707106|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1707107|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1707108|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707109|NCT00017511|radiation toxicity|radiation toxicity
1707110|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
1707111|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
1707112|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1707113|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1707114|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1707115|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1707116|NCT00017485|recurrent skin cancer|recurrent skin cancer
1707117|NCT00017355|stage IV melanoma|stage iv melanoma
1707118|NCT00017355|recurrent melanoma|recurrent melanoma
1707119|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
1707120|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1707121|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1707122|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1707123|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1707124|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1707125|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1707126|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1707127|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1707128|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707129|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707130|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1707205|NCT00016926|stage III cervical cancer|stage iii cervical cancer
1707131|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1707132|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707133|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707134|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1707135|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1707136|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1707137|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1717799|NCT00038415|Idiotypic|idiotypic
1707138|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1707139|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1707140|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707141|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707142|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
1707143|NCT00017264|adult glioblastoma|adult glioblastoma
1707144|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707145|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1707146|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
1707147|NCT00017264|adult gliosarcoma|adult gliosarcoma
1707148|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
1707149|NCT00017225|regional neuroblastoma|regional neuroblastoma
1707150|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
1707151|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
1707152|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
1707153|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1707154|NCT00017212|stage III gastric cancer|stage iii gastric cancer
1707155|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
1707156|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
1707157|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
1707158|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
1707159|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
1707160|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707161|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707162|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
1707163|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
1707164|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1707245|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
1707165|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707166|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707167|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707168|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707169|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1707170|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707171|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1707172|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1707173|NCT00017147|adult glioblastoma|adult glioblastoma
1707174|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
1707175|NCT00017147|adult gliosarcoma|adult gliosarcoma
1707176|NCT00017121|stage IV melanoma|stage iv melanoma
1707177|NCT00017121|recurrent melanoma|recurrent melanoma
1707178|NCT00017121|lung metastases|lung metastases
1707179|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1707180|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1707181|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1707182|NCT00017095|stage II breast cancer|stage ii breast cancer
1707183|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
1707184|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
1707185|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
1707186|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
1707187|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
1707188|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
1707189|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
1707190|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
1707191|NCT00016991|adult glioblastoma|adult glioblastoma
1707192|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
1707193|NCT00016991|adult gliosarcoma|adult gliosarcoma
1707194|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
1707195|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
1707196|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
1707197|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707198|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
1707199|NCT00016952|stage IV colon cancer|stage iv colon cancer
1707200|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
1707201|NCT00016952|recurrent colon cancer|recurrent colon cancer
1707206|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
1707207|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
1707208|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
1707209|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1707210|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1707211|NCT00016913|stage III prostate cancer|stage iii prostate cancer
1707212|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1707213|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1707214|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1707215|NCT00016432|stage I breast cancer|stage i breast cancer
1707219|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1707220|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
1707221|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1707222|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1707223|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1707224|NCT00016406|stage II breast cancer|stage ii breast cancer
1707225|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
1707226|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
1707227|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
1707228|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
1707229|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1707230|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
1707231|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
1707232|NCT00016380|nausea and vomiting|nausea and vomiting
1707233|NCT00016380|stage I colon cancer|stage i colon cancer
1707234|NCT00016380|stage II colon cancer|stage ii colon cancer
1707235|NCT00016380|stage III colon cancer|stage iii colon cancer
1707236|NCT00016380|stage IV colon cancer|stage iv colon cancer
1707237|NCT00016380|stage I gastric cancer|stage i gastric cancer
1707238|NCT00016380|stage II gastric cancer|stage ii gastric cancer
1707239|NCT00016380|stage III gastric cancer|stage iii gastric cancer
1707240|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
1707241|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
1707247|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
1707248|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
1707249|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
1707250|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
1707251|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
1707252|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
1707253|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
1707254|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1707255|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1707256|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1707257|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1707258|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1707259|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
1707260|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1707261|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1707262|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1707263|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
1707264|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1707265|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
1707266|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1707267|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
1707268|NCT00016380|small intestine lymphoma|small intestine lymphoma
1707269|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1707270|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
1707271|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
1707272|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
1707273|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1707274|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1707275|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1707276|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
1707277|NCT00016380|testicular seminoma|testicular seminoma
1707278|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
1707279|NCT00016380|quality of life|quality of life
1707280|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
1707281|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1707282|NCT00016263|stage III melanoma|stage iii melanoma
1707283|NCT00016263|stage IV melanoma|stage iv melanoma
1707284|NCT00016263|recurrent melanoma|recurrent melanoma
1707285|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1707286|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1707287|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1707288|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1707289|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1707290|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1707291|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1707292|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1707293|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
1707294|NCT00016133|stage II colon cancer|stage ii colon cancer
1707295|NCT00016133|stage III colon cancer|stage iii colon cancer
1707296|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
1707297|NCT00016081|infection|infection
1707298|NCT00016068|infection|infection
1707299|NCT00016055|stage IV melanoma|stage iv melanoma
1707300|NCT00016055|recurrent melanoma|recurrent melanoma
1707301|NCT00016029|colon cancer|colon cancer
1707302|NCT00016029|rectal cancer|rectal cancer
1707303|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1707304|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
1707305|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
1707306|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707307|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707308|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707309|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
1707310|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1707311|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1707312|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1707313|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707314|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1707315|NCT00015938|stage IV breast cancer|stage iv breast cancer
1707316|NCT00015938|recurrent breast cancer|recurrent breast cancer
1707317|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
1707318|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707319|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1707320|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707321|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1707322|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1707323|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707324|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1707325|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1707326|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1707327|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
1707328|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1707329|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1707330|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1707331|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1707332|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707333|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1707334|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1707335|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1707336|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1707337|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1707338|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1707339|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1707340|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
1707341|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1707342|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
1707343|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
1707344|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
1707345|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
1707346|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
1707347|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1707348|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1707349|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1707350|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1707351|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
1707352|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1707353|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
1707610|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
1707354|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1707355|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1707356|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707357|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707358|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707359|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1707360|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1707361|NCT00014612|stage IA breast cancer|stage ia breast cancer
1707362|NCT00014612|stage IB breast cancer|stage ib breast cancer
1707363|NCT00014612|stage II breast cancer|stage ii breast cancer
1707364|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
1707367|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
1707368|NCT00014586|stage I prostate cancer|stage i prostate cancer
1707369|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
1707370|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
1707371|NCT00014586|stage III prostate cancer|stage iii prostate cancer
1707372|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
1707373|NCT00014521|adult glioblastoma|adult glioblastoma
1707374|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707375|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1707376|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
1707377|NCT00014521|adult gliosarcoma|adult gliosarcoma
1707378|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
1707379|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
1707380|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
1707381|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
1707382|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1707383|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707384|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1707385|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707386|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1707387|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1718132|NCT00036569|Interferon|interferon
1707388|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
1707389|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1707390|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1707391|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707392|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1707393|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1707394|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1707395|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1707396|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1707397|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1707398|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1707399|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1707400|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1707401|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1707402|NCT00014482|anxiety disorder|anxiety disorder
1707403|NCT00014482|depression|depression
1707404|NCT00014482|pain|pain
1707405|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1707406|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1707407|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
1707408|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
1707409|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
1707410|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
1707411|NCT00014482|primary myelofibrosis|primary myelofibrosis
1707412|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1707413|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1707414|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1707415|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1707416|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1707417|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1707418|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1707419|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1707420|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1707421|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1707422|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1707423|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1707424|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1707425|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1707426|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1707427|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1707428|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1707429|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1707430|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1707431|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1707432|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1707621|NCT00014092|stage IV melanoma|stage iv melanoma
1707433|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1707434|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1707435|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1707436|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1707437|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1707438|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1707439|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1707440|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707441|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1707442|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1707443|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1707444|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1707445|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1707446|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1707447|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1707448|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1707449|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1707574|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
1707450|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1707451|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1707452|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1707453|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1707454|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1707455|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1707456|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1707457|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1707458|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1707459|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1707460|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1707461|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1707462|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1707463|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1707464|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1707465|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1707466|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1707467|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1707468|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1707469|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707470|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1707471|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707472|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1707473|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1707474|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1707475|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707476|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1707477|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1707478|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1707479|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1707480|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
1707481|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1707482|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1707483|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
1707484|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1707485|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1707486|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1707487|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1707488|NCT00014469|graft versus host disease|graft versus host disease
1707489|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1707490|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1707491|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1707492|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1717800|NCT00038415|Genetic|genetic
1707493|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1707494|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1707495|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1707496|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1707497|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1707498|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1707499|NCT00014456|stage IV breast cancer|stage iv breast cancer
1707500|NCT00014456|recurrent breast cancer|recurrent breast cancer
1707501|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
1707502|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
1707503|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
1707504|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1707505|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
1707506|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
1707507|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
1707508|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
1707509|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
1707510|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
1707511|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
1707512|NCT00014456|chondrosarcoma|chondrosarcoma
1707513|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1707514|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1707575|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
1707515|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1707516|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1707517|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
1707518|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
1707519|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
1707520|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
1707521|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
1707522|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
1707523|NCT00014456|stage IV melanoma|stage iv melanoma
1707524|NCT00014456|recurrent melanoma|recurrent melanoma
1707525|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1707526|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
1707527|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
1707528|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
1707529|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1707530|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
1707531|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1707532|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1707533|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1707534|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
1707535|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
1707536|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1707537|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1707538|NCT00014456|ovarian sarcoma|ovarian sarcoma
1707539|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1707540|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1707541|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1707542|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1707543|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1707544|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1707545|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707546|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1707547|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1707548|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707549|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1707550|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1707551|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1707552|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1707553|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1707554|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1707555|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1707556|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707557|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1718128|NCT00036582|BPD|bpd
1707558|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1707559|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1707560|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1707561|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707562|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1707563|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1707564|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1707565|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1707566|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1707567|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1707568|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1707569|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1707570|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1707571|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1707572|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1707573|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1707576|NCT00014443|adult glioblastoma|adult glioblastoma
1707577|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707578|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
1707579|NCT00014443|adult gliosarcoma|adult gliosarcoma
1707580|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1707581|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1707582|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1707583|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1707584|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1707585|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1707586|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1707587|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1707588|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1707589|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1707590|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1707591|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1707592|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1707593|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1707594|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1707595|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1707596|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1707597|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1707598|NCT00014274|stage III bladder cancer|stage iii bladder cancer
1707599|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
1707600|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1707601|NCT00014274|anterior urethral cancer|anterior urethral cancer
1707602|NCT00014274|posterior urethral cancer|posterior urethral cancer
1707603|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1707604|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1707605|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1707606|NCT00014222|stage I breast cancer|stage i breast cancer
1707607|NCT00014222|stage II breast cancer|stage ii breast cancer
1707608|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
1707609|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
1718410|NCT00035165|tumour|tumour
1707611|NCT00014196|large cell lung cancer|large cell lung cancer
1707612|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1707613|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
1707614|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
1707615|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
1707616|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
1707617|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707618|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707619|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707620|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707622|NCT00014092|recurrent melanoma|recurrent melanoma
1707623|NCT00014079|colon cancer|colon cancer
1707624|NCT00014079|rectal cancer|rectal cancer
1707625|NCT00012389|stage IV colon cancer|stage iv colon cancer
1707626|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
1707627|NCT00012389|recurrent colon cancer|recurrent colon cancer
1707628|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
1707629|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
1707630|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
1707631|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
1707632|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
1707633|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707634|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1707635|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707636|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1707637|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
1707638|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1707639|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1707640|NCT00012246|stage II colon cancer|stage ii colon cancer
1707641|NCT00012246|stage III colon cancer|stage iii colon cancer
1707642|NCT00012246|stage IV colon cancer|stage iv colon cancer
1707643|NCT00012246|stage II gastric cancer|stage ii gastric cancer
1707644|NCT00012246|stage III gastric cancer|stage iii gastric cancer
1707645|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
1707646|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
1707647|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
1707648|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
1707649|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
1707650|NCT00012246|stage II rectal cancer|stage ii rectal cancer
1707651|NCT00012246|stage III rectal cancer|stage iii rectal cancer
1707652|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
1707653|NCT00012246|recurrent colon cancer|recurrent colon cancer
1707654|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
1707655|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
1707656|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
1707657|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
1707658|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
1707659|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707660|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
1707661|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
1707662|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
1707663|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
1707664|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
1707665|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1707666|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1707667|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
1707668|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707669|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
1707670|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1707671|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
1707672|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
1707673|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707674|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
1707675|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707676|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
1707677|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1707678|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1707679|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1707680|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1707681|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1707682|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1707683|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1707684|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
1707685|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
1707885|NCT00009945|stage I breast cancer|stage i breast cancer
1707686|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1707687|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1707688|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707689|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707690|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1707691|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1707692|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707693|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707694|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
1707695|NCT00012103|small cell lung cancer|small cell lung cancer
1707696|NCT00012064|stage IV melanoma|stage iv melanoma
1707697|NCT00012064|recurrent melanoma|recurrent melanoma
1707698|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1707699|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1707700|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
1707701|NCT00012038|adult glioblastoma|adult glioblastoma
1707702|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707703|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1707704|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
1707705|NCT00012038|adult gliosarcoma|adult gliosarcoma
1707706|NCT00012025|stage IV breast cancer|stage iv breast cancer
1707707|NCT00012025|recurrent breast cancer|recurrent breast cancer
1707708|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
1707709|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
1707710|NCT00012012|radiation toxicity|radiation toxicity
1707711|NCT00012012|stage III cervical cancer|stage iii cervical cancer
1707712|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
1707713|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1707714|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
1707715|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1707716|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707717|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707796|NCT00010023|recurrent breast cancer|recurrent breast cancer
1707718|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707719|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707720|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1707721|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1707722|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707723|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707724|NCT00011960|stage I gastric cancer|stage i gastric cancer
1707725|NCT00011960|stage II gastric cancer|stage ii gastric cancer
1707726|NCT00011960|stage III gastric cancer|stage iii gastric cancer
1707727|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
1707728|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
1707729|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
1707730|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707731|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707732|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
1707733|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1707734|NCT00010270|stage IV colon cancer|stage iv colon cancer
1707735|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
1707736|NCT00010270|recurrent colon cancer|recurrent colon cancer
1707737|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
1707738|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
1707739|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
1707740|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
1707741|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
1707742|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707743|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
1707744|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707745|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
1707746|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707747|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
1707748|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
1707749|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
1707750|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
1707751|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1707752|NCT00010270|stage III colon cancer|stage iii colon cancer
1707753|NCT00010270|stage III rectal cancer|stage iii rectal cancer
1707754|NCT00010270|stage III gastric cancer|stage iii gastric cancer
1707755|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
1707756|NCT00010257|thymoma|thymoma
1707757|NCT00010257|thymic carcinoma|thymic carcinoma
1707758|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1707759|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
1707760|NCT00010218|large cell lung cancer|large cell lung cancer
1707761|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
1707762|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1707763|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1707764|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
1707765|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707766|NCT00010153|stage I breast cancer|stage i breast cancer
1707767|NCT00010153|stage II breast cancer|stage ii breast cancer
1707768|NCT00010140|stage II breast cancer|stage ii breast cancer
1707769|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
1707770|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
1707771|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
1707772|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
1707773|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1707774|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1707775|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
1707776|NCT00010075|stage IV breast cancer|stage iv breast cancer
1707777|NCT00010075|recurrent breast cancer|recurrent breast cancer
1707778|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
1707779|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
1707780|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
1707781|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1707782|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
1707783|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
1707784|NCT00010049|adult meningioma|adult meningioma
1707785|NCT00010049|adult glioblastoma|adult glioblastoma
1707786|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707787|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1707788|NCT00010049|adult mixed glioma|adult mixed glioma
1707789|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1707790|NCT00010049|adult subependymoma|adult subependymoma
1707791|NCT00010049|adult grade III meningioma|adult grade iii meningioma
1707792|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
1707793|NCT00010049|adult gliosarcoma|adult gliosarcoma
1707794|NCT00010023|stage IV breast cancer|stage iv breast cancer
1707795|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
1707797|NCT00010023|stage III gastric cancer|stage iii gastric cancer
1707798|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
1707799|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
1707800|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
1707801|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
1707802|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1707803|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
1707804|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
1707805|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
1707806|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
1707807|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
1707808|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1707809|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
1707810|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1707811|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1707812|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1707813|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
1707814|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1707815|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
1707816|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
1707817|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
1707818|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1707819|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1707820|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
1707821|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1707822|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1707823|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1707824|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1707825|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1707826|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1707827|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1707828|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1707829|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1707830|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1707886|NCT00009945|stage II breast cancer|stage ii breast cancer
1707831|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1707832|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1707833|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1707834|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1707835|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1707836|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1707837|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1707838|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1707839|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1707840|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1707841|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1707842|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1707843|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1707844|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1707845|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1707846|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1707847|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1707848|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1707849|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1707850|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1707851|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1707852|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1707853|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1707854|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1707855|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1707856|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1707857|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1707858|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1707859|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1707860|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1707861|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1707862|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1707863|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1707864|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1707865|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707866|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1707867|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1707868|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1707869|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707870|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1707871|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1707872|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1707873|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1707874|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1707875|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
1707876|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1707877|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1707878|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
1707879|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
1707880|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
1707881|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
1707882|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
1707883|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1707884|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
1718411|NCT00035165|malignant|malignant
1707887|NCT00009880|stage I gastric cancer|stage i gastric cancer
1707888|NCT00009880|stage II gastric cancer|stage ii gastric cancer
1707889|NCT00009880|stage III gastric cancer|stage iii gastric cancer
1707890|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
1707891|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
1707892|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
1707893|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1707894|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1707895|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1707896|NCT00009854|adult glioblastoma|adult glioblastoma
1707897|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
1719075|NCT00032383|Tai Chi|tai chi
1707898|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1707899|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
1707900|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1707901|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
1707902|NCT00009854|adult gliosarcoma|adult gliosarcoma
1707903|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1707904|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1707905|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1707906|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1707907|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1707908|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1707909|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1707910|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1707911|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1707912|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1707913|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1707914|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1707915|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1707916|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1707917|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1707918|NCT00009763|stage IV breast cancer|stage iv breast cancer
1707919|NCT00009763|recurrent breast cancer|recurrent breast cancer
1707920|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
1707921|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
1707922|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
1707923|NCT00009711|pulmonary complications|pulmonary complications
1707924|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1707925|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707926|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1707927|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1707928|NCT00008437|stage I breast cancer|stage i breast cancer
1707929|NCT00008437|stage II breast cancer|stage ii breast cancer
1707930|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
1707931|NCT00008411|stage IV breast cancer|stage iv breast cancer
1707932|NCT00008411|recurrent breast cancer|recurrent breast cancer
1707933|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1707934|NCT00008346|breast cancer|breast cancer
1707935|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1707936|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1707937|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1707938|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1707939|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1707940|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1707941|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1707942|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1707943|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1707944|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1707945|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1707946|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
1707947|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
1707948|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
1707949|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
1707950|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1707951|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1707952|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1707953|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1707954|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1707955|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1707956|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1707957|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1707958|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1707959|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1707960|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1707961|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1707962|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1707963|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1707964|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1708087|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
1707965|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1707966|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1707967|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1707968|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1707969|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1707970|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1707971|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1707972|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1707973|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1707974|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1707975|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1707976|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1707977|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1707978|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1707979|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1707980|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1707981|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1707982|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1707983|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1707984|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1707985|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1707986|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1707987|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1707988|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1707989|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1707990|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1707991|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1707992|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1707993|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1707994|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1707995|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1707996|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1707997|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1707998|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1707999|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708000|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1708001|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1708002|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1708003|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1708004|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1708005|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708006|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708007|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708008|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708009|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708010|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708011|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708012|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708013|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708014|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1708015|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1708016|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1708017|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1708018|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1708019|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1708020|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1708021|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1708022|NCT00008307|intraocular lymphoma|intraocular lymphoma
1708023|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1708024|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1708025|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1708026|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1708088|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
1708027|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708028|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1708029|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1708030|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1708031|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1708123|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708032|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1708033|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1708034|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1708035|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1708036|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1708037|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1708038|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1708039|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1708040|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1708041|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1708042|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1708043|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1708044|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1708045|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1708046|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1708047|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1708048|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1708049|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708050|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708051|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708052|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1708053|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1708054|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1708055|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1708056|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1708057|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1708058|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1708059|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1708060|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1708061|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1708062|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1708063|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1708064|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708065|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708066|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708067|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708068|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708069|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1708070|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1708071|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1708072|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1708073|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708074|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708075|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1708076|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1708077|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1708530|NCT00006474|adult mixed glioma|adult mixed glioma
1708078|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1708079|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1708080|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1708081|NCT00008294|stage IV colon cancer|stage iv colon cancer
1708082|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
1708083|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
1708084|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1708085|NCT00008294|liver metastases|liver metastases
1708086|NCT00008294|recurrent colon cancer|recurrent colon cancer
1708089|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
1708090|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
1708091|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1708092|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708093|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1708094|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1708095|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
1708096|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
1708097|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
1708098|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
1708099|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1708100|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1708101|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1708102|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1708103|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708104|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1708105|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1708106|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1708107|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1708108|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1708109|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1708110|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1708111|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1708112|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1708113|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1708114|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1708115|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1708116|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1708117|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1708118|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1708119|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1708120|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1708121|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1708122|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1708124|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708125|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708126|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1708127|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1708128|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1708129|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1708130|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1708131|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1708132|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1708133|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708134|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708135|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708136|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708137|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1708138|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1708139|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1708140|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1708141|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1708142|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708531|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
1708143|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708144|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708145|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708146|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708147|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708148|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708149|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708150|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708151|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1708152|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1708153|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1708154|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1708155|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1708156|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1708157|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1708158|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1708159|NCT00008216|intraocular lymphoma|intraocular lymphoma
1708160|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1708161|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1708162|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1708163|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1708164|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1708165|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1708166|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1708167|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708168|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1708169|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1708170|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1708171|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1708172|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1708173|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1708174|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1708175|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1708176|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1708177|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1708178|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1708179|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1708180|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1708181|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1708182|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1708183|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1708184|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1708185|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1708186|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1708187|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1708188|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708189|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708190|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708191|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1708192|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1708193|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1708194|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1708195|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1708196|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1708197|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1708198|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1708199|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1708200|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1708201|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1708202|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1708203|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708204|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708205|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708206|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708207|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708208|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1708209|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1708210|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708211|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708212|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1708400|NCT00007826|stage II colon cancer|stage ii colon cancer
1708213|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1708214|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1708215|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1708216|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1708217|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1708218|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
1708219|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708220|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708221|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1708222|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1708223|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1708224|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1708225|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1708226|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1708227|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1708228|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708229|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1708230|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1708231|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
1708232|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
1718133|NCT00036569|MR Imaging|mr imaging
1708233|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
1708234|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
1708235|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1708236|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708237|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1708238|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1708239|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1708240|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
1708241|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1708242|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1708243|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1708244|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1708245|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1708246|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1708247|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1708248|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1708249|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708250|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1708251|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708252|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708253|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1708254|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1708255|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1708256|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1708257|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1708258|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1708259|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1708260|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708261|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708262|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708263|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708264|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1708265|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1708266|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1708267|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1708268|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1708269|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708270|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708271|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708334|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
1708272|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708273|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708274|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708275|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708276|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708277|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708278|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1708279|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1708280|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1708281|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1708282|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708283|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1708284|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1708285|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1708286|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1708287|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1708288|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1708289|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1708290|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1708291|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1708292|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1708759|NCT00006340|small intestine lymphoma|small intestine lymphoma
1708293|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1708294|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1708295|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708296|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708297|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708298|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1708299|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1708300|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1708301|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1708302|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1708303|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1708304|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708305|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708306|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1708307|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1708308|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708309|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708310|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708311|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708312|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708313|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1708314|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1708315|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1708316|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1708317|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1708318|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1708319|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1708320|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1708321|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1708322|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1708323|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1708324|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1708325|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1708326|NCT00008138|fallopian tube cancer|fallopian tube cancer
1708327|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
1708328|NCT00008060|stage IV colon cancer|stage iv colon cancer
1708329|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
1708330|NCT00008060|recurrent colon cancer|recurrent colon cancer
1708331|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
1708332|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
1708333|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1708335|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
1708336|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1708337|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1708338|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
1708339|NCT00008008|adult medulloblastoma|adult medulloblastoma
1708340|NCT00008008|adult glioblastoma|adult glioblastoma
1708341|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
1708342|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1708343|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
1708344|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1708345|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
1708346|NCT00008008|adult mixed glioma|adult mixed glioma
1708347|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1708348|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1708349|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1708350|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
1708351|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
1708352|NCT00008008|adult gliosarcoma|adult gliosarcoma
1708353|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1708354|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
1708355|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
1708356|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
1708357|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
1708358|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
1708359|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
1708360|NCT00007982|adult medulloblastoma|adult medulloblastoma
1708361|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
1718236|NCT00036179|Anti-Fungal|anti-fungal
1708362|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1708363|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1708364|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1708365|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1708366|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1708367|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708368|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708369|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708370|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708371|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708372|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708373|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708374|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708375|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708376|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708377|NCT00007930|stage I rectal cancer|stage i rectal cancer
1708378|NCT00007930|stage II rectal cancer|stage ii rectal cancer
1708379|NCT00007930|stage III rectal cancer|stage iii rectal cancer
1708380|NCT00007904|stage II breast cancer|stage ii breast cancer
1708381|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
1708382|NCT00007904|male breast cancer|male breast cancer
1708383|NCT00007891|stage IV breast cancer|stage iv breast cancer
1708384|NCT00007891|recurrent breast cancer|recurrent breast cancer
1708385|NCT00007891|male breast cancer|male breast cancer
1708386|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708387|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708388|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708389|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708390|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708391|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708392|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708393|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708394|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709182|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
1708395|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708396|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708397|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708398|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708399|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708406|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
1708407|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1708408|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
1708409|NCT00006994|pain|pain
1708410|NCT00006994|radiation toxicity|radiation toxicity
1708411|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1708412|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1708413|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1708414|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1708415|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1708416|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1708417|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1708418|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1708419|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1708420|NCT00006981|stage III cervical cancer|stage iii cervical cancer
1708421|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
1708422|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
1708423|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
1708424|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
1708425|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1708426|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1708427|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1708428|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
1708429|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1708430|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1708431|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1708432|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1708433|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1718237|NCT00036166|Aspergillus|aspergillus
1708434|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1708435|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1708436|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1708437|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1708438|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1708439|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1708440|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1708441|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1708442|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1708443|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1708444|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1708445|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1708446|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1708447|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1708448|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1708449|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1708450|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1708451|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1708452|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1708453|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1708454|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1708455|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1708456|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1708457|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1708458|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1708459|NCT00006981|fallopian tube cancer|fallopian tube cancer
1718412|NCT00035165|metastatic|metastatic
1708460|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1708461|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
1708462|NCT00006981|Brenner tumor|brenner tumor
1708463|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1708464|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
1708465|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1708466|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
1708467|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
1708468|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
1719174|NCT00031304|AIDS|aids
1708469|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
1708470|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
1708471|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1708472|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1708473|NCT00006981|ovarian sarcoma|ovarian sarcoma
1708474|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
1708475|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
1708476|NCT00006916|adult glioblastoma|adult glioblastoma
1708477|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
1708478|NCT00006916|adult gliosarcoma|adult gliosarcoma
1708479|NCT00006825|stage IV breast cancer|stage iv breast cancer
1708480|NCT00006825|recurrent breast cancer|recurrent breast cancer
1708481|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708482|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
1708483|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
1708484|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
1708485|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
1708486|NCT00006747|graft versus host disease|graft versus host disease
1708487|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1708488|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1708489|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1708490|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708491|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708492|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708493|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1708494|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708495|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708496|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1708497|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708498|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708499|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708500|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1708501|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1708502|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1708503|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1708504|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1708505|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1708506|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708507|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708508|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708509|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
1708510|NCT00006656|adult glioblastoma|adult glioblastoma
1708511|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
1708512|NCT00006656|adult gliosarcoma|adult gliosarcoma
1708513|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708514|NCT00006479|stage IV colon cancer|stage iv colon cancer
1708515|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
1708516|NCT00006479|recurrent colon cancer|recurrent colon cancer
1708517|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
1708518|NCT00006479|liver metastases|liver metastases
1708519|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708520|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708521|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708522|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708523|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
1708524|NCT00006476|stage I bladder cancer|stage i bladder cancer
1708525|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
1708526|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
1708527|NCT00006474|adult glioblastoma|adult glioblastoma
1708528|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1708529|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1718413|NCT00035165|intravenous|intravenous
1708532|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
1708533|NCT00006474|adult gliosarcoma|adult gliosarcoma
1708534|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1708535|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1708536|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1708537|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1710293|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
1708538|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1708539|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1708540|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1708541|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1708542|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1708543|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1708544|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1708545|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1708546|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1708547|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1708548|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1708549|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1708550|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1708551|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1708552|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1708553|NCT00006468|stage IV colon cancer|stage iv colon cancer
1708554|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
1708555|NCT00006468|recurrent colon cancer|recurrent colon cancer
1708556|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
1708557|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
1708558|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1708559|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708560|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708561|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708562|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708563|NCT00006456|lung metastases|lung metastases
1708564|NCT00006456|liver metastases|liver metastases
1708565|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
1708566|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
1708567|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
1708568|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
1708569|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
1708570|NCT00006392|prostate cancer|prostate cancer
1708571|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1708572|NCT00006391|fallopian tube cancer|fallopian tube cancer
1708573|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
1708574|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1708575|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1708576|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1708577|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1708578|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1708579|NCT00006386|adult glioblastoma|adult glioblastoma
1708580|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
1708581|NCT00006386|adult gliosarcoma|adult gliosarcoma
1708582|NCT00006385|stage IV melanoma|stage iv melanoma
1708583|NCT00006385|recurrent melanoma|recurrent melanoma
1708584|NCT00006381|stage IV breast cancer|stage iv breast cancer
1708585|NCT00006381|recurrent breast cancer|recurrent breast cancer
1708586|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1708587|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708588|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1708589|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1708590|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1708591|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
1708592|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
1708593|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1708594|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1708595|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708596|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1708597|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1708598|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1708599|NCT00006379|small intestine lymphoma|small intestine lymphoma
1708600|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1708601|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1708602|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1708603|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1708604|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1708605|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1708606|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1708607|NCT00006379|polycythemia vera|polycythemia vera
1708608|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1708609|NCT00006379|essential thrombocythemia|essential thrombocythemia
1708610|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1708611|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1708612|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1708613|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1708614|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708615|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
1708616|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1708617|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1708618|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
1708619|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708620|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708621|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708622|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708623|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708624|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708625|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708626|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708627|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708628|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1708629|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1708630|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1708631|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1708632|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1708633|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
1708634|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
1708635|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1708636|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1708637|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1708638|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708639|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708640|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1708641|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1708642|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1708643|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1708644|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1708645|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1708646|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1708647|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1708648|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1708649|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708650|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708651|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708652|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708653|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708654|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1708655|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1708656|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1708657|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1708658|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1708659|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1708660|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1708661|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1708662|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1708663|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708664|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708665|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708666|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1719175|NCT00031304|Vaccine|vaccine
1708667|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708668|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708669|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708670|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708671|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708672|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708673|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708674|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708675|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708676|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708677|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708678|NCT00006366|stage II rectal cancer|stage ii rectal cancer
1708679|NCT00006366|stage III rectal cancer|stage iii rectal cancer
1708680|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1708681|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1708682|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1708683|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
1708684|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
1708685|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1708686|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
1708687|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1708688|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1708689|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708690|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1708691|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
1708692|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1718238|NCT00036166|Anti-Fungal|anti-fungal
1708693|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
1708694|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708695|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708696|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708697|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708698|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1708699|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1708700|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1708701|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1708702|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1708703|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708704|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708705|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708706|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708707|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708708|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708709|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708710|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708711|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708712|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
1708713|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708714|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708715|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708716|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708717|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708718|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708719|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708720|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708721|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708722|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1708723|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1708724|NCT00006360|radiation toxicity|radiation toxicity
1708725|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1708726|NCT00006359|stage I prostate cancer|stage i prostate cancer
1708727|NCT00006359|stage II prostate cancer|stage ii prostate cancer
1708728|NCT00006359|stage III prostate cancer|stage iii prostate cancer
1708729|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1708730|NCT00006355|adult glioblastoma|adult glioblastoma
1708731|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
1708732|NCT00006355|adult gliosarcoma|adult gliosarcoma
1719176|NCT00031304|Screening|screening
1708733|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708734|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
1708735|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
1708736|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1708737|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
1708738|NCT00006351|anterior urethral cancer|anterior urethral cancer
1708739|NCT00006351|posterior urethral cancer|posterior urethral cancer
1708740|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1708741|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1708742|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1708743|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
1708744|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1708745|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1708746|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1708747|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1708748|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1708749|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1708750|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1708751|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1708752|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1708753|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1708754|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1708755|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1708756|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1708757|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1708758|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1708760|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1708761|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
1708762|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
1708763|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
1708764|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1708765|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
1708766|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
1708767|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
1708768|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
1708769|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1708770|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1708771|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1708772|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1708773|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708774|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1708775|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1708776|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1708777|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1708778|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1708779|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1708780|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1708781|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1708782|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1708783|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1708784|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
1708785|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
1708786|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
1708787|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
1708788|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
1708789|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
1708790|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
1708791|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1708792|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
1708793|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708794|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708795|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1708796|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1708797|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1708798|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1708799|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1708800|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1708801|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1708802|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708803|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708804|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708805|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708806|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1708807|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1708808|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1708809|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1708810|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1708811|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708812|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708813|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1708814|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708815|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1708816|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1708817|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1708818|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1708819|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1708820|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1708821|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1708891|NCT00006256|stage II breast cancer|stage ii breast cancer
1708822|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1708823|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1708824|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1708825|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1708826|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1708827|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1708828|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1708829|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1708830|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1708831|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1708832|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1708833|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1708834|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1708835|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1708836|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708837|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1708838|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708839|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708840|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708841|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1708842|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1708843|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1708844|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1708845|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1708846|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1708847|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1708848|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1708849|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708850|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708851|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1708852|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1708853|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1718414|NCT00035165|epothilone|epothilone
1708854|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1708855|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1708856|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1708857|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708858|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708927|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1719177|NCT00031304|Prevention|prevention
1708859|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708860|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708861|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708862|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
1708863|NCT00006268|adult glioblastoma|adult glioblastoma
1708864|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1708865|NCT00006268|adult mixed glioma|adult mixed glioma
1708866|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
1708867|NCT00006268|adult gliosarcoma|adult gliosarcoma
1708868|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1708869|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1708870|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1708871|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1708872|NCT00006263|adult brain stem glioma|adult brain stem glioma
1708873|NCT00006263|adult glioblastoma|adult glioblastoma
1708874|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1708875|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1708876|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1708877|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
1708878|NCT00006263|adult gliosarcoma|adult gliosarcoma
1708879|NCT00006260|stage IV breast cancer|stage iv breast cancer
1708880|NCT00006260|recurrent breast cancer|recurrent breast cancer
1708881|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1708882|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1708883|NCT00006258|adult medulloblastoma|adult medulloblastoma
1708884|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1708885|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
1708886|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
1708887|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1708888|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1708889|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1708890|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1708892|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
1708893|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
1708894|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
1708895|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
1708896|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
1708897|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
1708898|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1708899|NCT00006255|liver metastases|liver metastases
1708900|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1708901|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1708902|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1708903|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1708904|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708905|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708906|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1708907|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708908|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708909|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1708910|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1708911|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1708912|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1708913|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
1708914|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1708915|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1708916|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1708917|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1708918|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1708919|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1708920|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1708921|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1708922|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1709183|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
1708923|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1708924|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1708925|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1708926|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1709317|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
1708928|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1708929|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1708930|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1708931|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1708932|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1708933|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1708934|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1708935|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1708936|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1708937|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1708938|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1708939|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1708940|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1708941|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1708942|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1708943|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1708944|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1708945|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1708946|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1708947|NCT00006249|stage III melanoma|stage iii melanoma
1708948|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1708949|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1708950|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1708951|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1708952|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1708953|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1708954|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1709086|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
1708955|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1708956|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1708957|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1708958|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1708959|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1708960|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1708961|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1708962|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1708963|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
1708964|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
1708965|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1708966|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1708967|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1708968|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1708969|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
1708970|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1708971|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
1708972|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
1708973|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
1708974|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
1708975|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
1708976|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1708977|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1708978|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1708979|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1708980|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1708981|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1708982|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1708983|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
1718522|NCT00034736|Pneumonia|pneumonia
1708984|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
1708985|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
1708986|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
1708987|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
1708988|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1708989|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1708990|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1708991|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1708992|NCT00006239|refractory anemia|refractory anemia
1708993|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1708994|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
1708995|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1708996|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1708997|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1708998|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1708999|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1709000|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709001|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709002|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709003|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709004|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1709005|NCT00006237|stage III melanoma|stage iii melanoma
1709006|NCT00006237|recurrent melanoma|recurrent melanoma
1709007|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1709008|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1709009|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1709010|NCT00006234|bone metastases|bone metastases
1709011|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1709012|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1709013|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1709014|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1709015|NCT00006233|stage IV melanoma|stage iv melanoma
1709016|NCT00006233|recurrent melanoma|recurrent melanoma
1709017|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
1709018|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
1718455|NCT00035087|epothilone|epothilone
1709019|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
1709020|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
1709021|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
1709022|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1709023|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1709024|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1709025|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1709026|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709027|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1709028|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1709029|NCT00006221|small intestine lymphoma|small intestine lymphoma
1709030|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1709031|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1709032|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1709033|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709034|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1709035|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709036|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709037|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709038|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1709039|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1709040|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709041|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709042|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709043|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709044|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1709045|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709046|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709047|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709048|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709049|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1709050|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1709051|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1709052|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1719178|NCT00031304|HV|hv
1709053|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1709054|NCT00006221|intraocular lymphoma|intraocular lymphoma
1709055|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1709056|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709057|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1709058|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1709059|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1709060|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1709061|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1709062|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709063|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1711338|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
1709064|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1709065|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1709066|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1709067|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1709068|NCT00006219|multiple myeloma|multiple myeloma
1709069|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709070|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709071|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709072|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1709073|NCT00006120|stage IV breast cancer|stage iv breast cancer
1709074|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
1709075|NCT00006120|recurrent breast cancer|recurrent breast cancer
1709076|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
1709077|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
1709078|NCT00006119|adult grade III meningioma|adult grade iii meningioma
1709079|NCT00006119|adult grade I meningioma|adult grade i meningioma
1709080|NCT00006119|adult grade II meningioma|adult grade ii meningioma
1709081|NCT00006118|stage III bladder cancer|stage iii bladder cancer
1709082|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
1709083|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1709084|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1709085|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
1709087|NCT00006113|stage III melanoma|stage iii melanoma
1709088|NCT00006113|stage IV melanoma|stage iv melanoma
1709089|NCT00006113|recurrent melanoma|recurrent melanoma
1709090|NCT00006110|stage II breast cancer|stage ii breast cancer
1709091|NCT00006110|stage IV breast cancer|stage iv breast cancer
1709092|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
1709093|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
1709094|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
1709095|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
1709096|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1709097|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1709098|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1709099|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1709100|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1709101|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1709102|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1709103|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1709104|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1709105|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1709106|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1709107|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1709108|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1709109|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1709110|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1709111|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1709112|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1709113|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1709184|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
1709114|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1709115|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1709116|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
1709318|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
1709117|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
1709118|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
1709119|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1709120|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1709121|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1709122|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1709123|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1709124|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1709125|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1709126|NCT00006105|stage II bladder cancer|stage ii bladder cancer
1709127|NCT00006105|stage III bladder cancer|stage iii bladder cancer
1709128|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
1709129|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1709130|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1709131|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1709132|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1709133|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
1709134|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
1709135|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
1709136|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
1709137|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
1709138|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1709139|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1709140|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1709141|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1709142|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1709143|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1709144|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
1709145|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
1709146|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
1709147|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
1709148|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
1709149|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1709150|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1709151|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1709152|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1709153|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1709154|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1709155|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1709156|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1709157|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1709158|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1709159|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1709160|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1709161|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
1709162|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
1709163|NCT00006101|stage I prostate cancer|stage i prostate cancer
1709164|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709165|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
1709166|NCT00006093|adult glioblastoma|adult glioblastoma
1709167|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709168|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709169|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
1709170|NCT00006093|adult gliosarcoma|adult gliosarcoma
1709171|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709172|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1709173|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1709174|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1709175|NCT00006092|lymphoid leukemia|lymphoid leukemia
1709176|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
1709177|NCT00006078|prostate cancer|prostate cancer
1709178|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
1709179|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
1709180|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709181|NCT00006042|Burkitt lymphoma|burkitt lymphoma
1709185|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1709186|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1709187|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1709319|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
1709188|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1709189|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1709190|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1709191|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1709192|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1709193|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1709194|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1709195|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1709196|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1709197|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1709198|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1709199|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1709200|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1709201|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1709202|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1709203|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1709204|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1709205|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709206|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709207|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709208|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709209|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1709210|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1709211|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709212|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709213|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709214|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709215|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1718556|NCT00034710|shingles|shingles
1709216|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709217|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709218|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709219|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709220|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1709221|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709222|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709223|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1709224|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1709225|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1709226|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1709227|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1709228|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1709229|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1709230|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1709231|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1709232|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1709233|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1709234|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709235|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1709236|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1709237|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1709238|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1709239|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709240|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1709241|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1709242|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1709243|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1709244|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1709245|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1718625|NCT00034372|monoclonal|monoclonal
1709246|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1709247|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709320|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
1709248|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709249|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709250|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1713960|NCT00051831|Virus Replication|virus replication
1709251|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1709252|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1709253|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709254|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709255|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1709256|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1709257|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1709258|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709259|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1709260|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1709261|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709262|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1709263|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1709264|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1709265|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
1709266|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
1709267|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
1709268|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1709269|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
1709270|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1709271|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1709272|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
1709273|NCT00006025|adult glioblastoma|adult glioblastoma
1709274|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709275|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709276|NCT00006025|adult mixed glioma|adult mixed glioma
1709277|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
1709278|NCT00006025|adult gliosarcoma|adult gliosarcoma
1709279|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1709280|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
1709281|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
1709282|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
1709283|NCT00006022|stage III melanoma|stage iii melanoma
1709284|NCT00006022|stage IV melanoma|stage iv melanoma
1709285|NCT00006022|recurrent melanoma|recurrent melanoma
1709286|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
1709287|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
1709288|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
1709289|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709290|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
1709291|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
1709292|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1709293|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
1709294|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1709295|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1709296|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1709297|NCT00006015|stage IV colon cancer|stage iv colon cancer
1709298|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
1709299|NCT00006015|recurrent colon cancer|recurrent colon cancer
1709300|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
1709301|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
1709302|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1709303|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1709304|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
1709305|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1709306|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1709307|NCT00006007|stage IV breast cancer|stage iv breast cancer
1709308|NCT00006007|recurrent breast cancer|recurrent breast cancer
1709309|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1709310|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
1709311|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1709312|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1709313|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
1709314|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
1709315|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
1709316|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
1720769|NCT00017758|Nelfinavir|nelfinavir
1709321|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1709322|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
1709323|NCT00006004|large cell lung cancer|large cell lung cancer
1709324|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1709325|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1709326|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
1709327|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1709328|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1709329|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1709330|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
1709331|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
1709332|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
1709333|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
1709334|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
1709335|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
1709336|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
1709337|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1709338|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
1709339|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
1709340|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
1709341|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1709342|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1709343|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1709344|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1709345|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709346|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1709347|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1709348|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1709349|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1709350|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1709351|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1709352|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1709353|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1709354|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1709355|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1709356|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1709357|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1709358|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1709359|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1709360|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1709361|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1709362|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1709363|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1709364|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1709365|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1709366|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709367|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1709368|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709369|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709370|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709371|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1709372|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1709373|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709374|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709375|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709376|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709377|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1709378|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709379|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709380|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709381|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709382|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1709383|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1709384|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1709385|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1709644|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
1709386|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1709387|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1709388|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1709389|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1709390|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1709391|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1709392|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1709393|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1709394|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1709395|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1709396|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1709397|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1709398|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1709399|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1709400|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1709401|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1709402|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1709403|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1709404|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1709405|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1709406|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1709407|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709408|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1709409|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1709479|NCT00005967|polycythemia vera|polycythemia vera
1709410|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1709411|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
1709412|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
1709413|NCT00005983|stage II breast cancer|stage ii breast cancer
1709414|NCT00005981|stage IV colon cancer|stage iv colon cancer
1709415|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
1709416|NCT00005981|recurrent colon cancer|recurrent colon cancer
1709417|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
1709418|NCT00005980|stage IV breast cancer|stage iv breast cancer
1709419|NCT00005980|recurrent breast cancer|recurrent breast cancer
1709420|NCT00005979|stage III colon cancer|stage iii colon cancer
1709421|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
1709422|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
1709423|NCT00005976|adult glioblastoma|adult glioblastoma
1709424|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709425|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709426|NCT00005976|adult mixed glioma|adult mixed glioma
1709427|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
1709428|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
1709429|NCT00005976|adult gliosarcoma|adult gliosarcoma
1709430|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1709431|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1709432|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709433|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
1709434|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
1709435|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1709436|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1709437|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709438|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709439|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1709440|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1709441|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1709442|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1709443|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1709444|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
1709445|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1718626|NCT00034372|antibody|antibody
1709446|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1709447|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1709448|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1709449|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1709450|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1709451|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1709452|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1709453|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1709454|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1709455|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1709456|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1709457|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1709458|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709459|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1709460|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709461|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709462|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709463|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1709464|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1709465|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709466|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709467|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709468|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709469|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1709470|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709471|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709472|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709473|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709474|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709475|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709476|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1709477|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1709478|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709480|NCT00005967|primary myelofibrosis|primary myelofibrosis
1709481|NCT00005967|essential thrombocythemia|essential thrombocythemia
1709482|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1709483|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1709484|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1709485|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709486|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1709487|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1709488|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1709489|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1709490|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1709491|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1709492|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1709493|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
1709494|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
1709495|NCT00005961|stage III melanoma|stage iii melanoma
1709496|NCT00005961|stage IV melanoma|stage iv melanoma
1709497|NCT00005961|recurrent melanoma|recurrent melanoma
1709498|NCT00005957|stage I breast cancer|stage i breast cancer
1709499|NCT00005957|stage II breast cancer|stage ii breast cancer
1709500|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1709501|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1709502|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1709503|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
1709504|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
1709505|NCT00005955|regional neuroblastoma|regional neuroblastoma
1709506|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
1709507|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
1709508|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1709509|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
1709510|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
1709511|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
1709512|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
1709513|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
1709514|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1718723|NCT00034086|Ritonavir|ritonavir
1709515|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1709516|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1709517|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1720869|NCT00014937|Nevirapine|nevirapine
1709518|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1709519|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1709520|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1709521|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1709522|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
1709523|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1709524|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
1709525|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1709526|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1709527|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
1709528|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
1709529|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
1709530|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
1709531|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
1709532|NCT00005952|stage V Wilms tumor|stage v wilms tumor
1709533|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1709534|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1709535|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1709536|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1709537|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1709538|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
1709539|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
1709540|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1709541|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1709542|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1709543|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1709544|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1709545|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
1709546|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
1709547|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1709548|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1709748|NCT00005815|stage IV melanoma|stage iv melanoma
1709549|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1709550|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1709551|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1709552|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1709553|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1709554|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1709555|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1709556|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1709557|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1709558|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1709559|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1709560|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1709561|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1709562|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
1709563|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
1709564|NCT00005951|adult glioblastoma|adult glioblastoma
1709565|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709566|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709567|NCT00005951|adult mixed glioma|adult mixed glioma
1709568|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
1709569|NCT00005951|adult gliosarcoma|adult gliosarcoma
1709570|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1709571|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1709572|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1709573|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1709574|NCT00005941|stage III cervical cancer|stage iii cervical cancer
1709575|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
1709576|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
1709577|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
1709578|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
1709579|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
1709580|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
1709581|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
1709582|NCT00005879|breast cancer|breast cancer
1709583|NCT00005878|esophageal cancer|esophageal cancer
1720870|NCT00014937|Stavudine|stavudine
1709584|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1709585|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1709586|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1709587|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1709588|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1709589|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1709590|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1709591|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1709592|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709593|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709594|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709595|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709596|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1709597|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1709598|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1709599|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1709600|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1709601|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1709602|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1709603|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1709604|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1709605|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709606|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1709607|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1709608|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1709609|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1709610|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1709749|NCT00005815|recurrent melanoma|recurrent melanoma
1709611|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1709612|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1709613|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1709614|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1709615|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1709616|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1709617|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1709618|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1709619|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1709620|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1709621|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1709622|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1709623|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1709624|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709625|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709626|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1709627|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1709628|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1709629|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1709630|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709631|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709632|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709633|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709634|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1709635|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
1709636|NCT00005859|adult glioblastoma|adult glioblastoma
1709637|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
1709638|NCT00005859|adult gliosarcoma|adult gliosarcoma
1709639|NCT00005858|stage III colon cancer|stage iii colon cancer
1709640|NCT00005858|stage IV colon cancer|stage iv colon cancer
1709641|NCT00005858|stage IV breast cancer|stage iv breast cancer
1709642|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
1709643|NCT00005858|recurrent breast cancer|recurrent breast cancer
1709645|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1709646|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
1709647|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
1709648|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
1709649|NCT00005858|recurrent colon cancer|recurrent colon cancer
1709650|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1709651|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1709652|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1709653|NCT00005858|stage III bladder cancer|stage iii bladder cancer
1709654|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
1709655|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
1709656|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1709657|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1709658|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1709659|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
1709660|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1709661|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1709662|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1709663|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1709664|NCT00005858|ovarian sarcoma|ovarian sarcoma
1709665|NCT00005858|male breast cancer|male breast cancer
1709666|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
1709667|NCT00005855|adult glioblastoma|adult glioblastoma
1709668|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709669|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709670|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
1709671|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
1709672|NCT00005855|adult gliosarcoma|adult gliosarcoma
1709673|NCT00005853|refractory anemia|refractory anemia
1709674|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1709675|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
1709676|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1709677|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1709678|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709679|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709680|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1709681|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1709682|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1709683|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1709684|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1709685|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
1709686|NCT00005850|large cell lung cancer|large cell lung cancer
1709687|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1709688|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1709689|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1709690|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
1709691|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1709692|NCT00005850|fatigue|fatigue
1709693|NCT00005850|anxiety disorder|anxiety disorder
1709694|NCT00005850|depression|depression
1709695|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1709696|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
1709697|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
1709698|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1709699|NCT00005835|regional neuroblastoma|regional neuroblastoma
1709700|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
1709701|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
1709702|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1709703|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1709704|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1709705|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1709706|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
1709707|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
1709708|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
1709709|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1709710|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
1709711|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
1709712|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
1710754|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
1709713|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1709714|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1709715|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1721277|NCT00006412|Pravastatin|pravastatin
1709716|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1709717|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1709718|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1709719|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1709720|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
1709721|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1709722|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1709723|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1709724|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1709725|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1709726|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709727|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1709728|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1709729|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1709730|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709731|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709732|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709733|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709734|NCT00005822|stage IV breast cancer|stage iv breast cancer
1709735|NCT00005822|recurrent breast cancer|recurrent breast cancer
1709736|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
1709737|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
1709738|NCT00005822|male breast cancer|male breast cancer
1709739|NCT00005821|stage I breast cancer|stage i breast cancer
1709740|NCT00005821|stage II breast cancer|stage ii breast cancer
1709741|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1709742|NCT00005815|iris melanoma|iris melanoma
1709743|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1709744|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1709745|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
1709746|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
1709747|NCT00005815|stage III melanoma|stage iii melanoma
1709750|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
1709751|NCT00005812|temozolomide|temozolomide
1709752|NCT00005807|stage IV breast cancer|stage iv breast cancer
1709753|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
1709754|NCT00005807|recurrent breast cancer|recurrent breast cancer
1709755|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
1709756|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1709757|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1709758|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1709759|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1709760|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
1709761|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1709762|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1709763|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1709764|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1709765|NCT00005807|ovarian sarcoma|ovarian sarcoma
1709766|NCT00005807|male breast cancer|male breast cancer
1709767|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1709768|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1709769|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709770|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709771|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709772|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709773|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709774|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709775|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1709776|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
1709777|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
1709778|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
1709779|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1709780|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1709781|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709782|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709783|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1709784|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1709785|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1709786|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1709787|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1709788|NCT00005797|polycythemia vera|polycythemia vera
1709789|NCT00005797|primary myelofibrosis|primary myelofibrosis
1709790|NCT00005797|essential thrombocythemia|essential thrombocythemia
1709791|NCT00005797|refractory anemia|refractory anemia
1709792|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1709793|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
1709794|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1709795|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1709796|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709797|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1709798|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1709799|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1709800|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1709801|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1709802|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709803|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709804|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709805|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709806|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1709807|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1709808|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1709809|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1709810|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1709811|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1709812|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1709813|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1709814|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1709815|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1709816|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1709817|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1709818|NCT00005787|neutropenia|neutropenia
1709819|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709820|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709821|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709822|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709823|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1709824|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709825|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709826|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709827|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1709828|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709829|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1709830|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709831|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1709832|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1709833|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1709834|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1709835|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
1709836|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
1709837|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
1709838|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1709839|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
1709840|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1709841|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
1709842|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1709843|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1709844|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1709845|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1709846|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1709847|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1709848|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1709849|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1709850|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1709851|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1709852|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1709853|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1709854|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1709855|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1709856|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1709857|NCT00005644|stage III bladder cancer|stage iii bladder cancer
1709858|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
1709859|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
1709860|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1709861|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
1709862|NCT00005644|distal urethral cancer|distal urethral cancer
1709863|NCT00005644|proximal urethral cancer|proximal urethral cancer
1709864|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1709865|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1709866|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1709867|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1709868|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1709869|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1709870|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709871|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1709872|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1709873|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1709874|NCT00005639|small intestine lymphoma|small intestine lymphoma
1718557|NCT00034710|varicella|varicella
1709875|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1709876|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1709877|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1709878|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1709879|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1709880|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1709881|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1709882|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1709883|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1709884|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1709885|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1709886|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1709887|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1709888|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1709889|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1709890|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1709891|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1709892|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1709893|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1709894|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1709895|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1709896|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1709897|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1709898|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1709899|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1709900|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1709901|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1709902|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710755|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
1709903|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1709904|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1709905|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710292|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
1709906|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1709907|NCT00005639|intraocular lymphoma|intraocular lymphoma
1709908|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1709909|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1709910|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1709911|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1709912|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1709913|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1709914|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1709915|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1709916|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1709917|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1709918|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1709919|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1709920|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1709921|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1709922|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1709923|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1709924|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1709925|NCT00005638|stage II gastric cancer|stage ii gastric cancer
1709926|NCT00005638|stage III gastric cancer|stage iii gastric cancer
1709927|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
1709928|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
1709929|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1709930|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1709931|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1709932|NCT00005637|adult glioblastoma|adult glioblastoma
1709933|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1709934|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1709935|NCT00005637|adult mixed glioma|adult mixed glioma
1709936|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
1709937|NCT00005637|adult gliosarcoma|adult gliosarcoma
1709938|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
1709939|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1709940|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
1709941|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
1718558|NCT00034697|Brain mets|brain mets
1709942|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
1709943|NCT00005623|hot flashes|hot flashes
1709944|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1709945|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
1709946|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
1709947|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
1709948|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
1709949|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1709950|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1709951|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1709952|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1709953|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1709954|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1709955|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1709956|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1709957|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1709958|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1709959|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1709960|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1709961|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1709962|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1709963|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1709964|NCT00005622|polycythemia vera|polycythemia vera
1709965|NCT00005622|primary myelofibrosis|primary myelofibrosis
1709966|NCT00005622|essential thrombocythemia|essential thrombocythemia
1709967|NCT00005622|refractory anemia|refractory anemia
1709968|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1709969|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
1709970|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1709971|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1718824|NCT00033969|HV|hv
1709972|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1709973|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1709974|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1709975|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1709976|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1709977|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1709978|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1709979|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1709980|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1709981|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1709982|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1709983|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1709984|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1709985|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1709986|NCT00005617|stage IV melanoma|stage iv melanoma
1709987|NCT00005617|recurrent melanoma|recurrent melanoma
1709988|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1709989|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1709990|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1709991|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1709992|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1709993|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1709994|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1709995|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1709996|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1709997|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1709998|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1709999|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1710000|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
1710001|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1710002|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
1710003|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
1710004|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
1710005|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1710006|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1710007|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1718855|NCT00033839|EC|ec
1710008|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1710009|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1710010|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1710011|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1710012|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1710013|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1710014|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1710015|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
1710016|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1710017|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
1710018|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1710019|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1710020|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1710021|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1710022|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1710023|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1710024|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1710025|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1710026|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1710027|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1710028|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710029|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1710030|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1710031|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1710032|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1710033|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710034|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1710756|NCT00004135|stage IV melanoma|stage iv melanoma
1710035|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1710036|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710037|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710038|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1710039|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1710040|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1710041|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1710042|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1710043|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1710044|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1710045|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1710046|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1710047|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710048|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710049|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710050|NCT00005605|osteoporosis|osteoporosis
1710051|NCT00005605|stage I breast cancer|stage i breast cancer
1710052|NCT00005605|stage II breast cancer|stage ii breast cancer
1710053|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1710054|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1710055|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1710056|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710057|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710058|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710059|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710060|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710061|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1710062|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710063|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1710064|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710065|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710066|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710067|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710068|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710069|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710070|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710071|NCT00005600|stage I breast cancer|stage i breast cancer
1719158|NCT00031343|Eradication|eradication
1710072|NCT00005600|stage II breast cancer|stage ii breast cancer
1710073|NCT00005600|lymphedema|lymphedema
1710074|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
1710075|NCT00005599|stage III gastric cancer|stage iii gastric cancer
1710076|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
1710077|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
1710078|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
1710079|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
1710080|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
1710081|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1710082|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1710083|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1710084|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1710085|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1710086|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1710087|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1710088|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1710089|NCT00005590|recurrent breast cancer|recurrent breast cancer
1710090|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1710091|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1710092|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1710093|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1710094|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1710095|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710096|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
1710097|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1710098|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
1710099|NCT00005590|small intestine lymphoma|small intestine lymphoma
1710100|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1710101|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1710102|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710103|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1710104|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1710105|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1710106|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1710107|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1710108|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1710109|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1710110|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1710111|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
1710112|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1710113|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1710114|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1710115|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1710116|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1710117|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1710118|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1710119|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1710120|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1710121|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1710122|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1710123|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1710124|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1710125|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1710126|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1710127|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1710128|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1710129|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1710130|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1710131|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1710132|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710133|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710134|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710135|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710136|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710137|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1710138|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710139|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1710140|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710141|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1710142|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1710143|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1710144|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1710145|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710146|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
1710147|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1710148|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1710149|NCT00005590|infection|infection
1710150|NCT00005590|intraocular lymphoma|intraocular lymphoma
1710151|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1710152|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1710153|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1710154|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1710155|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1710156|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1710157|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1710158|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1710159|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1710160|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1710161|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1710162|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1710163|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1719554|NCT00029445|LTNP|ltnp
1710164|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1710165|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1710166|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1710167|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1710168|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1710169|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1710170|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1710171|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1710172|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1710173|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1710174|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710175|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1710176|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1710177|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1710178|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1710179|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1710180|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1710181|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710182|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1710183|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1710184|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1710185|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1710186|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710187|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710188|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1710189|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1710190|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
1710191|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
1710192|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1710193|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1710194|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1710195|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1710196|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710197|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710198|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710334|NCT00004936|stage III cervical cancer|stage iii cervical cancer
1710199|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710200|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710201|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710202|NCT00005586|stage II colon cancer|stage ii colon cancer
1710203|NCT00005586|stage III colon cancer|stage iii colon cancer
1710204|NCT00005586|stage II rectal cancer|stage ii rectal cancer
1710205|NCT00005586|stage III rectal cancer|stage iii rectal cancer
1710206|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1710207|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1710208|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1710209|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1710210|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1710211|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
1710212|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
1710213|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
1710214|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1710215|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1710216|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710217|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1710218|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1710219|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1710220|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1710221|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1710222|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1710223|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1710224|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1710225|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
1710226|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710227|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710228|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710229|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710230|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
1710231|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710232|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710233|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710234|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710235|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710236|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710237|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710238|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
1710239|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1710240|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1710241|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1710242|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1710243|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1710244|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1710245|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1710246|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1710247|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1710248|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1710249|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1710250|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710251|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710252|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710253|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710254|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1710255|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1710256|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
1710257|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
1710258|NCT00005095|fallopian tube cancer|fallopian tube cancer
1710259|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
1710260|NCT00005095|ovarian sarcoma|ovarian sarcoma
1710261|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
1710262|NCT00005095|endometrial cancer|endometrial cancer
1710263|NCT00005095|uterine sarcoma|uterine sarcoma
1710264|NCT00005095|vaginal cancer|vaginal cancer
1710265|NCT00005095|cervical cancer|cervical cancer
1710266|NCT00005095|vulvar cancer|vulvar cancer
1710267|NCT00005095|uterine leiomyomata|uterine leiomyomata
1710335|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
1710268|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1710269|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
1710270|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1710271|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1710272|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1710273|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1710274|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1710275|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1710276|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1710277|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1710278|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1710279|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1710280|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1710281|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1710282|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1710283|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1710284|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1710285|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1710286|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1710287|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1710288|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1710289|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1710290|NCT00005079|stage I breast cancer|stage i breast cancer
1710291|NCT00005079|stage II breast cancer|stage ii breast cancer
1710294|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1710295|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1710296|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1710297|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710298|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
1710299|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
1710300|NCT00005060|stage II gastric cancer|stage ii gastric cancer
1710301|NCT00005060|stage III gastric cancer|stage iii gastric cancer
1710302|NCT00005052|stage II melanoma|stage ii melanoma
1710303|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1710304|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1710305|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710306|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710307|NCT00005049|stage II colon cancer|stage ii colon cancer
1710308|NCT00005049|stage III colon cancer|stage iii colon cancer
1710309|NCT00005049|stage II gastric cancer|stage ii gastric cancer
1710310|NCT00005049|stage III gastric cancer|stage iii gastric cancer
1710311|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
1710312|NCT00005049|stage II rectal cancer|stage ii rectal cancer
1710313|NCT00005049|stage III rectal cancer|stage iii rectal cancer
1710314|NCT00005049|recurrent colon cancer|recurrent colon cancer
1710315|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710316|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1710317|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
1710318|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
1710319|NCT00005049|small intestine lymphoma|small intestine lymphoma
1710320|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1710321|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
1710322|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
1710323|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1710324|NCT00005047|stage I bladder cancer|stage i bladder cancer
1710325|NCT00005047|stage II bladder cancer|stage ii bladder cancer
1710326|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1710327|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1710328|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
1710329|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
1710330|NCT00005044|stage III prostate cancer|stage iii prostate cancer
1710331|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
1710332|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
1710333|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
1710336|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
1710337|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
1710338|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
1710339|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
1710340|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1710341|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
1710342|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1710343|NCT00004935|stage IV breast cancer|stage iv breast cancer
1710344|NCT00004935|recurrent breast cancer|recurrent breast cancer
1710345|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1710346|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710347|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710348|NCT00004934|fallopian tube cancer|fallopian tube cancer
1710349|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1710350|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1710351|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1710352|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1710353|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1710354|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1710355|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1710356|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1710357|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
1710358|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1710359|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1710360|NCT00004930|lung metastases|lung metastases
1710361|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1710362|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1710363|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1710364|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710365|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710366|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
1710367|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
1710368|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1710369|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1721675|NCT00005001|Viral Load|viral load
1710370|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1710371|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1710372|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1710373|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1710374|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1710375|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1710376|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1710377|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1710378|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1710379|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1710380|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1710381|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1710382|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1710383|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1710384|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1710386|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1710387|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710388|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710389|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710390|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710391|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710392|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710393|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1710394|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710395|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710396|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710397|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710398|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710399|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710400|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710401|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1710402|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1710403|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1710404|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1710405|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1710406|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1710407|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1710408|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1710409|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1710410|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1710411|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1710412|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1710413|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1710414|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1710415|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1710416|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1710417|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1710418|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1710419|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1710420|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710421|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1710422|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1710423|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1710424|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1710757|NCT00004135|recurrent melanoma|recurrent melanoma
1710425|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1710426|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1710427|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1721676|NCT00005001|remune|remune
1710428|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1710429|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1710430|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1710431|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1710432|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1710433|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1710434|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
1710435|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1710436|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1710437|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1710438|NCT00004896|refractory anemia|refractory anemia
1710439|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1710440|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
1710441|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1710442|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1710443|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1710444|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710445|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1710446|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1710447|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1710448|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1710449|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1710450|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1710451|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1710452|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1710453|NCT00004891|stage II rectal cancer|stage ii rectal cancer
1710454|NCT00004891|stage III rectal cancer|stage iii rectal cancer
1710455|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
1710456|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
1710457|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
1710458|NCT00004879|recurrent colon cancer|recurrent colon cancer
1710459|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
1710460|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1710461|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
1719263|NCT00031057|Lactic Acid|lactic acid
1710462|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
1710463|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710464|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
1710465|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
1710466|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1710467|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1710468|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1710469|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1710470|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1710471|NCT00004873|stage III gastric cancer|stage iii gastric cancer
1710472|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
1710473|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
1710474|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1710475|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1710476|NCT00004871|refractory anemia|refractory anemia
1710477|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1710478|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
1710479|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1710480|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1710481|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1710482|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710483|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1710484|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1710485|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1710486|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
1710487|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
1710488|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
1710489|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
1710490|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
1710491|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1710492|NCT00004866|stage III cervical cancer|stage iii cervical cancer
1710493|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
1710494|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
1721677|NCT00005000|HIV-1|hiv-1
1710495|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1710496|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
1710497|NCT00004859|large cell lung cancer|large cell lung cancer
1710498|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1710499|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1710500|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
1710501|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1710502|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1710503|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1710504|NCT00004259|adult mixed glioma|adult mixed glioma
1710505|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1710506|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1710507|NCT00004250|stage III melanoma|stage iii melanoma
1710508|NCT00004250|stage IV melanoma|stage iv melanoma
1710509|NCT00004250|recurrent melanoma|recurrent melanoma
1710510|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1710511|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1710512|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1710513|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1710514|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
1710515|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1710516|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1710517|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710518|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1710519|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1710520|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1710521|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1710522|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1710523|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1710524|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1710525|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
1710526|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
1710527|NCT00004244|stage IV melanoma|stage iv melanoma
1710528|NCT00004244|recurrent melanoma|recurrent melanoma
1710529|NCT00004237|stage I breast cancer|stage i breast cancer
1710530|NCT00004237|stage II breast cancer|stage ii breast cancer
1710531|NCT00004234|oral complications|oral complications
1719264|NCT00031044|HIV-1|hiv-1
1710532|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
1710533|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1710534|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1710535|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1710536|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1710537|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
1710538|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1710539|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1710540|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1710541|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1710542|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
1710543|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
1710544|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1710545|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1710546|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1710547|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
1710548|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1710549|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1710550|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1710551|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1710552|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
1710553|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1710554|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1710555|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1710556|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1710557|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1710558|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1710559|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710560|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1710561|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1710562|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1710563|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1710564|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1710565|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1710566|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1710567|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1710568|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1710569|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1710570|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1710571|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1710572|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1710573|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1710574|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1710575|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1710576|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1710577|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1710578|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1710579|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1710580|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1710581|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1710582|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1710583|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1710584|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1710585|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1710586|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1710587|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1710588|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
1710589|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1710590|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1710591|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1710592|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1710593|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1710594|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1710595|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1710596|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1710597|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1710598|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
1710599|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
1710600|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1710601|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1710602|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1710603|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1710604|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1710605|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1710606|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1710607|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1710608|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1710609|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1710610|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
1710611|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1710612|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1710613|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1719654|NCT00028418|Fludarabine|fludarabine
1710614|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1710615|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1710683|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1710616|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1710617|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1710618|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
1710619|NCT00004210|colon cancer|colon cancer
1710620|NCT00004210|rectal cancer|rectal cancer
1710621|NCT00004208|refractory anemia|refractory anemia
1710622|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1710623|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
1710624|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1710625|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710626|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1710627|NCT00004205|stage I breast cancer|stage i breast cancer
1710628|NCT00004205|stage II breast cancer|stage ii breast cancer
1710629|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
1710630|NCT00004205|breast cancer in situ|breast cancer in situ
1710631|NCT00004205|recurrent breast cancer|recurrent breast cancer
1710632|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
1710633|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1710634|NCT00004196|stage I melanoma|stage i melanoma
1710635|NCT00004196|stage II melanoma|stage ii melanoma
1710636|NCT00004196|stage III melanoma|stage iii melanoma
1710637|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1710638|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1710639|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1710640|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1710641|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1710642|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710643|NCT00004189|small intestine lymphoma|small intestine lymphoma
1710644|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710645|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1710646|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1710647|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1710648|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1710649|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1710650|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1710651|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1710652|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1710653|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1710654|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1710655|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1710656|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1710657|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1710658|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1710659|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1710660|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1710661|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1710662|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1710663|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710664|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710665|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710666|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710667|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710668|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1710669|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710670|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1710671|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710672|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1710673|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1710674|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710675|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1710676|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1710677|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1710678|NCT00004189|intraocular lymphoma|intraocular lymphoma
1710679|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1710680|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1720088|NCT00026936|DVH|dvh
1710681|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710682|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1721971|NCT00002432|Foscarnet|foscarnet
1710684|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1710685|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1710686|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710687|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710688|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710689|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1710690|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1710691|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1710692|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1710693|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710694|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710695|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710696|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
1710697|NCT00004188|regional neuroblastoma|regional neuroblastoma
1710698|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
1710699|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
1710700|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1710701|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
1710702|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
1710703|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
1710704|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
1710705|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1710706|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1710707|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1710708|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1710709|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1710710|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1710711|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1710712|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1710713|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1710714|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710715|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710716|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710717|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710718|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
1710719|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
1710720|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
1719685|NCT00029107|Hepatitis|hepatitis
1710721|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
1710722|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
1710723|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
1710724|NCT00004154|stage I bladder cancer|stage i bladder cancer
1710725|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1710726|NCT00004153|stage I melanoma|stage i melanoma
1710727|NCT00004153|stage II melanoma|stage ii melanoma
1710728|NCT00004153|stage III melanoma|stage iii melanoma
1710729|NCT00004153|stage IV melanoma|stage iv melanoma
1710730|NCT00004150|stage III colon cancer|stage iii colon cancer
1710731|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
1710732|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
1710733|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
1710734|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
1710735|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
1710736|NCT00004147|adult glioblastoma|adult glioblastoma
1710737|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1710738|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1710739|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
1710740|NCT00004147|adult gliosarcoma|adult gliosarcoma
1710741|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710742|NCT00004143|sickle cell anemia|sickle cell anemia
1710743|NCT00004143|severe aplastic anemia|severe aplastic anemia
1710744|NCT00004141|stage III melanoma|stage iii melanoma
1710745|NCT00004141|stage IV melanoma|stage iv melanoma
1710746|NCT00004141|recurrent melanoma|recurrent melanoma
1710747|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1710748|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1710749|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
1710750|NCT00004138|large cell lung cancer|large cell lung cancer
1710751|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1710752|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
1710753|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1710758|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
1710759|NCT00004129|adult glioblastoma|adult glioblastoma
1710760|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
1710761|NCT00004129|adult gliosarcoma|adult gliosarcoma
1710762|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1710763|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1710764|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1710765|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1710766|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1710767|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
1710768|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1710769|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
1710770|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1710771|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1710772|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1710773|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1710774|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1710775|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1710776|NCT00004124|stage I prostate cancer|stage i prostate cancer
1710777|NCT00004124|stage II prostate cancer|stage ii prostate cancer
1710778|NCT00004124|stage III prostate cancer|stage iii prostate cancer
1710779|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1710780|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1710781|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710782|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710783|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1710784|NCT00004110|regional neuroblastoma|regional neuroblastoma
1710785|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
1710786|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
1710787|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1710788|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1710789|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1710790|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1710791|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1710792|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710793|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1710794|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1710795|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1710796|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1710797|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710798|NCT00004103|stage I gastric cancer|stage i gastric cancer
1710799|NCT00004103|stage II gastric cancer|stage ii gastric cancer
1710800|NCT00004103|stage III gastric cancer|stage iii gastric cancer
1710801|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
1710802|NCT00004099|stage II gastric cancer|stage ii gastric cancer
1710803|NCT00004099|stage III gastric cancer|stage iii gastric cancer
1710804|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
1710805|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
1710806|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
1710807|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
1710808|NCT00004092|stage II breast cancer|stage ii breast cancer
1710809|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
1710810|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
1710811|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
1710812|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
1710813|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
1710814|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1710815|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
1710816|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1710817|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1710818|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
1710819|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
1710820|NCT00004077|testicular teratoma|testicular teratoma
1710821|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
1710822|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1710823|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1710824|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1710825|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1711016|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1710826|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1710827|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1710828|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710829|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710830|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1710831|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710832|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710833|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1710834|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710835|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1710836|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710837|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710838|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710839|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710840|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710841|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710842|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1710843|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
1710844|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1710845|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1710846|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1710847|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1710848|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1710849|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
1710850|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
1710851|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
1710852|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
1710853|NCT00004067|stage II breast cancer|stage ii breast cancer
1710854|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
1710855|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
1710856|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1710857|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
1710858|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
1710859|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
1710860|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
1710861|NCT00004066|ovarian sarcoma|ovarian sarcoma
1710862|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
1710863|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1710864|NCT00004065|stage III colon cancer|stage iii colon cancer
1710865|NCT00004065|stage IV colon cancer|stage iv colon cancer
1710866|NCT00004065|stage IV breast cancer|stage iv breast cancer
1710867|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
1710869|NCT00004065|stage III gastric cancer|stage iii gastric cancer
1710870|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
1710871|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
1710872|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
1710873|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
1710874|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1710875|NCT00004065|recurrent colon cancer|recurrent colon cancer
1710876|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
1710877|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
1710878|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
1710879|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1710880|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1710881|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1710882|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1710883|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1710884|NCT00004065|stage III bladder cancer|stage iii bladder cancer
1710885|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
1710886|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
1710887|NCT00004065|stage III prostate cancer|stage iii prostate cancer
1710888|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
1710889|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
1710890|NCT00004065|stage III melanoma|stage iii melanoma
1710891|NCT00004065|stage IV melanoma|stage iv melanoma
1710892|NCT00004065|recurrent melanoma|recurrent melanoma
1710893|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1710894|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1710895|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1710896|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710897|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711085|NCT00003993|small intestine lymphoma|small intestine lymphoma
1710898|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1710899|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1710900|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1710901|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1710902|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
1710903|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1710904|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1710905|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1710906|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1710907|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1710908|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1710909|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1710910|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1710911|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1710912|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1710913|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1710914|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1710915|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1710916|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1710917|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1710918|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1710919|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1710920|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1710921|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1710922|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1710923|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1710924|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1710925|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1710926|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1710927|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1710928|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1710929|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1710930|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1710931|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1710932|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1710933|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1710934|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1710935|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1710936|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1710937|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1710938|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1710939|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1710940|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1710941|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1710942|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1710943|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1710944|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1710945|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1710946|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1710947|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1710948|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1710949|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1710950|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1710951|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1711552|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
1710952|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1710953|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
1710954|NCT00004065|ovarian sarcoma|ovarian sarcoma
1710955|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1710956|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
1710957|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
1710958|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
1710959|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1710960|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1710961|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1710962|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1710963|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1710964|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
1710965|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
1710966|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1710967|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1710968|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1710969|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1710970|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1710971|NCT00004058|polycythemia vera|polycythemia vera
1710972|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1710973|NCT00004058|essential thrombocythemia|essential thrombocythemia
1710974|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
1710975|NCT00004058|refractory anemia|refractory anemia
1710976|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1710977|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
1710978|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1710979|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1710980|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1710981|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
1710982|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1710983|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1710984|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1710985|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1710986|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1710987|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1719686|NCT00029107|Vasculitis|vasculitis
1710988|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1710989|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1710990|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1710991|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1710992|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1710993|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1710994|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1710995|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
1710996|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
1710997|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
1710998|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1710999|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1711000|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711001|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1711002|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1711003|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1711004|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1711005|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1711006|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1711007|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1711008|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1711009|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1711010|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1711011|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1711012|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
1711013|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
1711014|NCT00004054|stage III prostate cancer|stage iii prostate cancer
1711015|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
1711017|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1722552|NCT00002326|Zidovudine|zidovudine
1711018|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1711019|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1711020|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1711021|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1711022|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1711023|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1711024|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711025|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711026|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711027|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1711028|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1711029|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1711030|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1711031|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1711032|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1711033|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1711034|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1711035|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1711036|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1711037|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1711038|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1711039|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1711040|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
1711041|NCT00004028|adult glioblastoma|adult glioblastoma
1711042|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1711043|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
1711044|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1711045|NCT00004028|adult mixed glioma|adult mixed glioma
1711046|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
1711047|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
1711048|NCT00004028|adult gliosarcoma|adult gliosarcoma
1711049|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
1711050|NCT00004024|adult glioblastoma|adult glioblastoma
1711051|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1711052|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1711053|NCT00004024|adult subependymoma|adult subependymoma
1711054|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
1711055|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
1711056|NCT00004024|adult gliosarcoma|adult gliosarcoma
1711057|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
1711058|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
1711059|NCT00004017|adult glioblastoma|adult glioblastoma
1711060|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1711061|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
1711062|NCT00004017|adult gliosarcoma|adult gliosarcoma
1711063|NCT00004015|adult glioblastoma|adult glioblastoma
1711064|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
1711065|NCT00004015|adult gliosarcoma|adult gliosarcoma
1711066|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1711067|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1711068|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1711069|NCT00004005|stage III colon cancer|stage iii colon cancer
1711070|NCT00004005|stage IV colon cancer|stage iv colon cancer
1711071|NCT00004005|stage III rectal cancer|stage iii rectal cancer
1711072|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
1711073|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1711074|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711075|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1711076|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1711077|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
1711078|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1711079|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
1711080|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
1711081|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1711082|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1711083|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1711084|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1720089|NCT00026936|NTCP|ntcp
1711086|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711087|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1711088|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1711089|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1711090|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1711091|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711092|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711093|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711094|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1711095|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1711096|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711097|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711098|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1711099|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711100|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711101|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711102|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711103|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711104|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711105|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1711106|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1711107|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1711108|NCT00003993|intraocular lymphoma|intraocular lymphoma
1711109|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1711110|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711111|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1711112|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711113|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1711114|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1711115|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1711116|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711117|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1711118|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1711119|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1711120|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1711121|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1711122|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711123|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711124|NCT00003977|stage III cervical cancer|stage iii cervical cancer
1711125|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
1711126|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
1711127|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
1711128|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
1711129|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
1711130|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
1711131|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
1711132|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711133|NCT00003966|veno-occlusive disease|veno-occlusive disease
1711134|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1711135|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711136|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711137|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1711138|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711139|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711140|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711141|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711142|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711143|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711144|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711145|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1711146|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711147|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1714093|NCT00051155|OAG|oag
1711148|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1711149|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1711150|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
1711151|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1711152|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711153|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711154|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1711155|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711156|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1711157|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1711158|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1711159|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1711160|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1711161|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1711162|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1711163|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1711164|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1711165|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
1711166|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1711167|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
1711168|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
1711169|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1711170|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
1711171|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1711172|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1711173|NCT00003941|mediastinal cancer|mediastinal cancer
1711174|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
1711175|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
1711176|NCT00003941|testicular teratoma|testicular teratoma
1711177|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
1711178|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1711179|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1711180|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1711181|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1711182|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1711183|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1711184|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1711185|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1711186|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1711187|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1711188|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1711189|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
1711190|NCT00003941|liver metastases|liver metastases
1711191|NCT00003941|bone metastases|bone metastases
1711192|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1711193|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1711194|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1711195|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1711196|NCT00003938|stage IV breast cancer|stage iv breast cancer
1711197|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
1711198|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1711199|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
1711200|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1711201|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1711202|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1711203|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1711204|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1711205|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1711206|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1711207|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1711208|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
1711209|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
1711210|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1711211|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1711212|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1711213|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1711214|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1711215|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
1711216|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
1711217|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1711550|NCT00003833|stage II colon cancer|stage ii colon cancer
1711218|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1711219|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1711220|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
1711221|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
1711222|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
1711223|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1711224|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1711225|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1711226|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1711227|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1711228|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1711229|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1711230|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711231|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711232|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1711233|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1711234|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1711235|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1711236|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1711237|NCT00003938|small intestine lymphoma|small intestine lymphoma
1711238|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1711239|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1711240|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1711241|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711242|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711243|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1711244|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1711245|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1711246|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1711247|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1711248|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1711249|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1711250|NCT00003938|polycythemia vera|polycythemia vera
1711251|NCT00003938|primary myelofibrosis|primary myelofibrosis
1711252|NCT00003938|essential thrombocythemia|essential thrombocythemia
1711253|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1719687|NCT00029107|Rituximab|rituximab
1711254|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1711255|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
1711256|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
1711257|NCT00003938|testicular teratoma|testicular teratoma
1711258|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
1711259|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1711260|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1711261|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1711262|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1711263|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1711264|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1711265|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1711266|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1711267|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1711268|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1711269|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1711270|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1711271|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
1711272|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1711273|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1711274|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1711275|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1711276|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1711277|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1711278|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1711279|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1711280|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1711281|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1711282|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1711283|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1711284|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1711285|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1711286|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1711287|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711288|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1711289|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
1711290|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
1711291|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
1711292|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
1711293|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
1711294|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
1711295|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1711296|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
1711297|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
1711298|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1711299|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1711300|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1711301|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1711302|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1711303|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1711304|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1711305|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1711306|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1711307|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1711308|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1711309|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1711310|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1711311|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711312|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711313|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711314|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1711315|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1711316|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711317|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711318|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1719893|NCT00028080|Lyme|lyme
1711319|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711320|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711321|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711322|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711323|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711324|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711325|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1711326|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1711327|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1711328|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1711329|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1711330|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711331|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
1711332|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1711333|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711334|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1711335|NCT00003938|neutropenia|neutropenia
1711336|NCT00003938|infection|infection
1711337|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1711339|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
1711340|NCT00003938|intraocular lymphoma|intraocular lymphoma
1711341|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1711342|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1711343|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1711344|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1711345|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1711346|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1711347|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1711348|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1711349|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1711350|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1711351|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1711352|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1711353|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1711354|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1711355|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1711356|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1711357|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1711358|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1711359|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1711360|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1711361|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1711362|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1711363|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1711364|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1711365|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1711366|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1711367|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1711368|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1711369|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1711370|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1711371|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1711372|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1711373|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1711374|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711375|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1711376|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711377|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1711378|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1711379|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1711380|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1711381|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1711382|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1711383|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1711384|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1711385|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1711386|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1711387|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1711388|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1711389|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1711390|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1711391|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711392|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1711393|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1711394|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1711395|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1711396|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1711397|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1711398|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1711399|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1711400|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1711401|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1711402|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
1711403|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
1711404|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1711405|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1711406|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1711407|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1711408|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711409|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1711410|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1711411|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1711412|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1711413|NCT00003913|refractory anemia|refractory anemia
1711414|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1711415|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
1711416|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1711417|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711418|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
1711419|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1711420|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711421|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1711422|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711423|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1711424|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1711425|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1711426|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1711427|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1711428|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1714094|NCT00051155|OHT|oht
1711429|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1711430|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
1711431|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
1711432|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
1711433|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
1711434|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
1711435|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
1711436|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
1711437|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1711438|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1711439|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711440|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711441|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1711442|NCT00003910|LGL clone|lgl clone
1711443|NCT00003906|breast cancer|breast cancer
1711444|NCT00003903|stage I prostate cancer|stage i prostate cancer
1711445|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
1711446|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
1720209|NCT00026637|seizures|seizures
1711447|NCT00003903|stage III prostate cancer|stage iii prostate cancer
1711448|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
1711449|NCT00003903|osteoporosis|osteoporosis
1711450|NCT00003902|stage IV breast cancer|stage iv breast cancer
1711451|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1711452|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1711453|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
1711454|NCT00003901|large cell lung cancer|large cell lung cancer
1711455|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1711456|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
1711457|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1711458|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
1711459|NCT00003896|fallopian tube cancer|fallopian tube cancer
1711460|NCT00003893|stage I breast cancer|stage i breast cancer
1711461|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711462|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
1711463|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1711464|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1711465|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1711466|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1711467|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1711468|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1711469|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1711470|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1711471|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1711472|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1711473|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1711474|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1711475|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1711476|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711477|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711478|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711479|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1711480|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711481|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711482|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711483|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711484|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711485|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1711486|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1711487|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1711488|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1711489|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1711490|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1711491|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1711492|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1711493|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1711494|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1711495|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1711496|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1711497|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1711498|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1711499|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1711500|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711501|NCT00003862|stage I gastric cancer|stage i gastric cancer
1711502|NCT00003862|stage II gastric cancer|stage ii gastric cancer
1711503|NCT00003862|stage III gastric cancer|stage iii gastric cancer
1711504|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
1711505|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1711506|NCT00003857|breast cancer in situ|breast cancer in situ
1711507|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1711508|NCT00003855|stage IA breast cancer|stage ia breast cancer
1711509|NCT00003855|stage IB breast cancer|stage ib breast cancer
1711510|NCT00003855|stage II breast cancer|stage ii breast cancer
1711511|NCT00003854|stage IA breast cancer|stage ia breast cancer
1711512|NCT00003854|stage IB breast cancer|stage ib breast cancer
1711513|NCT00003854|stage II breast cancer|stage ii breast cancer
1711514|NCT00003851|malnutrition|malnutrition
1711515|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
1711516|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
1711517|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
1711518|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1711519|NCT00003843|stage IV colon cancer|stage iv colon cancer
1711520|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
1711521|NCT00003843|recurrent colon cancer|recurrent colon cancer
1711522|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
1711523|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
1711524|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
1711525|NCT00003838|Engraftment|engraftment
1711526|NCT00003838|Cyclophosphamide|cyclophosphamide
1711527|NCT00003838|Fludarabine|fludarabine
1711528|NCT00003838|Donor Apheresis|donor apheresis
1711529|NCT00003838|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
1711530|NCT00003838|Graft-Versus-Tumor|graft-versus-tumor
1711531|NCT00003838|Graft-Versus-Host Disease|graft-versus-host disease
1711532|NCT00003838|Multiple Myeloma|multiple myeloma
1711533|NCT00003838|Extramedullary Plasmacytoma|extramedullary plasmacytoma
1711534|NCT00003838|Chronic Disease|chronic disease
1711535|NCT00003838|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1711536|NCT00003838|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1711537|NCT00003838|Acute Myelogenous Leukemia|acute myelogenous leukemia
1711538|NCT00003838|Myeloproliferative Disease|myeloproliferative disease
1711539|NCT00003838|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1711540|NCT00003838|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1711541|NCT00003838|Aplastic Anemia|aplastic anemia
1711542|NCT00003838|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
1711543|NCT00003838|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
1711544|NCT00003838|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
1711545|NCT00003838|Hodgkin Disease|hodgkin disease
1711546|NCT00003838|Pure Red Cell Aplasia|pure red cell aplasia
1711547|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1711548|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1711549|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711551|NCT00003833|stage III colon cancer|stage iii colon cancer
1722553|NCT00002326|Adenine|adenine
1711553|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1711554|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1711555|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
1711556|NCT00003831|large cell lung cancer|large cell lung cancer
1711557|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
1711558|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1711559|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1711560|NCT00003816|Burkitt lymphoma|burkitt lymphoma
1711561|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1711562|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1711563|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1711564|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1711565|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1711566|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1711567|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1711568|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711569|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1711570|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1711571|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1711572|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1711573|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1711574|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1711575|NCT00003816|polycythemia vera|polycythemia vera
1711576|NCT00003816|essential thrombocythemia|essential thrombocythemia
1711577|NCT00003816|refractory anemia|refractory anemia
1711578|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
1711579|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1711580|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711581|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1711582|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
1711583|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711584|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711585|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1711586|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711587|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711588|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711589|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711590|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711591|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711592|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1711593|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1711594|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711595|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1711596|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711597|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
1711598|NCT00003816|intraocular lymphoma|intraocular lymphoma
1711599|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1711600|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1711601|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711602|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1711603|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711604|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1711605|NCT00003816|primary myelofibrosis|primary myelofibrosis
1711606|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1711607|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1711608|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1711609|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1711610|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711611|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1711612|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1711613|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1711614|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1711615|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1711616|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1711617|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1711618|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1711619|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1711620|NCT00003816|aplastic anemia|aplastic anemia
1711621|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711622|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1711623|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1711624|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1711625|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1711626|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1711627|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1711628|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1711629|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1711630|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1711631|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711632|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711633|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711634|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1711635|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1711636|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1711637|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1711638|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1711639|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1711640|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1711641|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1711642|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1711643|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1711644|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1711645|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1711646|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1711647|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1711648|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
1720826|NCT00016588|Adenine|adenine
1711649|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
1711650|NCT00003800|testicular teratoma|testicular teratoma
1711651|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
1711652|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1711653|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1711654|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1711655|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1711656|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1711657|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1711658|NCT00003796|stage IV breast cancer|stage iv breast cancer
1711659|NCT00003796|recurrent breast cancer|recurrent breast cancer
1711660|NCT00003796|male breast cancer|male breast cancer
1711661|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1711662|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711663|NCT00003793|localized osteosarcoma|localized osteosarcoma
1711664|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
1711665|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1711666|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1711667|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1711668|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
1711669|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
1711670|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1711671|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1711672|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1711673|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1711674|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
1711675|NCT00003788|adult glioblastoma|adult glioblastoma
1711676|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1711677|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
1711678|NCT00003788|adult gliosarcoma|adult gliosarcoma
1711679|NCT00003782|stage I breast cancer|stage i breast cancer
1711680|NCT00003782|stage II breast cancer|stage ii breast cancer
1720198|NCT00026676|Selenium|selenium
1711681|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
1711682|NCT00003771|menopausal symptoms|menopausal symptoms
1711683|NCT00003771|stage I breast cancer|stage i breast cancer
1711684|NCT00003771|stage II breast cancer|stage ii breast cancer
1711685|NCT00003771|breast cancer in situ|breast cancer in situ
1711686|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
1711687|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1711688|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1711689|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711690|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711691|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1711692|NCT00003753|stage IV colon cancer|stage iv colon cancer
1711693|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
1711694|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
1711695|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1711696|NCT00003753|liver metastases|liver metastases
1711697|NCT00003753|recurrent colon cancer|recurrent colon cancer
1711698|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
1711699|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
1711700|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
1711701|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
1711702|NCT00003750|recurrent melanoma|recurrent melanoma
1711703|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1711704|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1711705|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1711706|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
1711707|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
1711708|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1711709|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1711710|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
1711711|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1711712|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
1711713|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1711714|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
1711715|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1711716|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1711717|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1711718|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
1711719|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1711720|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
1711721|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
1711722|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1711723|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
1711724|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
1711725|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
1711726|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
1711727|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
1711728|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
1711729|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
1711730|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
1711731|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1711732|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711733|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1711734|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
1711735|NCT00003739|neutropenia|neutropenia
1711736|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
1711737|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
1711738|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
1711739|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
1711740|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
1711741|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
1711742|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1711743|NCT00003730|stage IV breast cancer|stage iv breast cancer
1711744|NCT00003730|recurrent breast cancer|recurrent breast cancer
1711745|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1711746|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1711747|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1711748|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1711749|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1711750|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
1711751|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
1711752|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
1711753|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
1711754|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
1711755|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1711756|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711757|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1711758|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1711759|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1711760|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1711761|NCT00003690|stage IV breast cancer|stage iv breast cancer
1711762|NCT00003690|recurrent breast cancer|recurrent breast cancer
1711763|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
1711764|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
1711765|NCT00003690|stage IV melanoma|stage iv melanoma
1711766|NCT00003690|recurrent melanoma|recurrent melanoma
1711767|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711768|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
1711769|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
1711770|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
1711771|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1711772|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1711773|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
1711774|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1711775|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1711776|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1711777|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1711778|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
1711779|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
1711780|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
1711781|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1711782|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
1711783|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711784|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711785|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1711786|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1712522|NCT00003422|stage III rectal cancer|stage iii rectal cancer
1711787|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1711788|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1711789|NCT00003687|small intestine lymphoma|small intestine lymphoma
1711790|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1711791|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1711792|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1711793|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1711794|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1711795|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1711796|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1711797|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1711798|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1711799|NCT00003687|polycythemia vera|polycythemia vera
1711800|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1711801|NCT00003687|essential thrombocythemia|essential thrombocythemia
1711802|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
1711803|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1711804|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
1711805|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711806|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1711807|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
1711808|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1711809|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1711810|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1711811|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1711812|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1711813|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1711814|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1711815|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1711816|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1711817|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1711818|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1711819|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1711820|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1711821|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1711822|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1711823|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1711824|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1711825|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1711826|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711827|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711828|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1711829|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1711830|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1711831|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1711832|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1711833|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1711834|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1711835|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1711836|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1711837|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1711838|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1711839|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711840|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1711841|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711842|NCT00003687|pain|pain
1711843|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
1711844|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1711845|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1711846|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
1711847|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
1711848|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1711849|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1711850|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1711851|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1711852|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1711853|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1711854|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1711855|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1711856|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
1711857|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
1711858|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1711859|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711860|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1711861|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1711862|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1711863|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1711864|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1711865|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1711866|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1711867|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1711868|NCT00003678|stage I breast cancer|stage i breast cancer
1711869|NCT00003678|stage II breast cancer|stage ii breast cancer
1711870|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1711871|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711872|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711873|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
1711874|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1711875|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1711876|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1711877|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1711878|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
1711879|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1711880|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1711881|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1711882|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1711883|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1711884|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1711885|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1711886|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1711887|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1711888|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1711889|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1711890|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1711891|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1711892|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1711893|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1711894|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1711895|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1711896|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1711897|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
1711898|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
1711899|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1711900|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
1711901|NCT00003652|stage II anal cancer|stage ii anal cancer
1711902|NCT00003652|stage III anal cancer|stage iii anal cancer
1711903|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1711904|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1711905|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1711906|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1711907|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1711908|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1711909|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1711910|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1711911|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1711912|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1711913|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1711914|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1711915|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1711916|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1711917|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1711918|NCT00003644|Brenner tumor|brenner tumor
1711919|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1711920|NCT00003643|testicular seminoma|testicular seminoma
1711921|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
1711922|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
1711923|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
1711924|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1711925|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1711926|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1711927|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1711928|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1711929|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1711930|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1711931|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1711932|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1711933|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1711934|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1711935|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1711936|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1711937|NCT00003643|testicular immature teratoma|testicular immature teratoma
1711938|NCT00003643|testicular mature teratoma|testicular mature teratoma
1711939|NCT00003643|adult teratoma|adult teratoma
1711940|NCT00003641|stage II melanoma|stage ii melanoma
1711941|NCT00003641|stage III melanoma|stage iii melanoma
1711942|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1711943|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1711944|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1711945|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1711946|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1711947|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1711948|NCT00003636|fallopian tube cancer|fallopian tube cancer
1711949|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1711950|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1711951|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
1711952|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
1711953|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1711954|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1711955|NCT00003612|stage IV breast cancer|stage iv breast cancer
1711956|NCT00003612|recurrent breast cancer|recurrent breast cancer
1711957|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1711958|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1711959|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1711960|NCT00003607|stage I prostate cancer|stage i prostate cancer
1711961|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
1711962|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
1711963|NCT00003607|stage III prostate cancer|stage iii prostate cancer
1711964|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
1711965|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
1711966|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
1711967|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
1711968|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1711969|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
1711970|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1711971|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1711972|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711973|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711974|NCT00003596|stage II anal cancer|stage ii anal cancer
1711975|NCT00003596|stage III anal cancer|stage iii anal cancer
1711976|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
1711977|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
1711978|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
1711979|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1711980|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1711981|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1711982|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1711983|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1711984|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1711985|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1711986|NCT00003593|refractory anemia|refractory anemia
1711987|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1711988|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
1711989|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1711990|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1711991|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1711992|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1711993|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1711994|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1711995|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1711996|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1711997|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1711998|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
1711999|NCT00003590|adult grade I meningioma|adult grade i meningioma
1712000|NCT00003577|stage I breast cancer|stage i breast cancer
1712001|NCT00003577|stage II breast cancer|stage ii breast cancer
1712002|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1712003|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1712004|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1712005|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1712006|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1712007|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1712008|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1712009|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1712010|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1712011|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1712012|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1712013|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1712014|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1712015|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712016|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1712017|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1712018|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1712019|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1712020|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1712021|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1712022|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1712023|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1712024|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1712025|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1712026|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1712027|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1712028|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1712029|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1712030|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1712031|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1712032|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1712033|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1712034|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1712035|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1712036|NCT00003569|neurotoxicity|neurotoxicity
1712037|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
1712038|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
1712039|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
1712040|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
1712041|NCT00003568|stage IV melanoma|stage iv melanoma
1712042|NCT00003568|recurrent melanoma|recurrent melanoma
1712043|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
1712044|NCT00003567|adult brain stem glioma|adult brain stem glioma
1712045|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1712046|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1712047|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1712661|NCT00003329|stage I prostate cancer|stage i prostate cancer
1712048|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1712049|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1712050|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1712051|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1712052|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1712053|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1712054|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1712055|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1712056|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1712057|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1712058|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712059|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712060|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1712061|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1712062|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1712063|NCT00003567|adult mixed glioma|adult mixed glioma
1712064|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1712065|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1712066|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1712067|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712068|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1712069|NCT00003567|adult glioblastoma|adult glioblastoma
1712070|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712071|NCT00003567|adult subependymoma|adult subependymoma
1712072|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
1712073|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1712074|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
1712075|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1712076|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1712077|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1712078|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1712079|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1712080|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1712081|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1712082|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
1712083|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
1712084|NCT00003567|adult gliosarcoma|adult gliosarcoma
1712085|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
1712086|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1712087|NCT00003565|stage IV breast cancer|stage iv breast cancer
1712088|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
1712089|NCT00003565|recurrent breast cancer|recurrent breast cancer
1712090|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
1712091|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
1712092|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1712093|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1712094|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
1712095|NCT00003565|stage III bladder cancer|stage iii bladder cancer
1712096|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
1712097|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
1712098|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
1712099|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1712100|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1712101|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1712102|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1712103|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
1712104|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
1712105|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1712106|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1712107|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
1712108|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
1712109|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
1712110|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
1712111|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1712112|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
1712113|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
1712114|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
1712115|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
1712116|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
1712117|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
1712118|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
1712119|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
1712120|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
1712121|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1712122|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
1712123|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1712124|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
1712125|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
1712126|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
1712127|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
1712128|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
1712129|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1712130|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1712131|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1712132|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1712133|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1712134|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1712135|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
1712136|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1712137|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
1712138|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1712139|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
1712140|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
1712141|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
1712142|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1712143|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
1712144|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1712145|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1712146|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1712147|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
1712148|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1712149|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1712150|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1712151|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
1712152|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1712153|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1712154|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
1712155|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
1712156|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
1712157|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1712158|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712159|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
1712160|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1712161|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
1712162|NCT00003560|fallopian tube cancer|fallopian tube cancer
1712163|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1712164|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
1712165|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
1712166|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
1712167|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
1712168|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1712169|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1712170|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1712171|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1712172|NCT00003538|stage IV breast cancer|stage iv breast cancer
1712173|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
1712174|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
1712175|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1712176|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1712177|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1712178|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1712179|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1712180|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712181|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1712182|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
1712183|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
1712184|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1712185|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
1712186|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
1712187|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
1712188|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
1712189|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1712190|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1714095|NCT00051142|Glaucoma|glaucoma
1712191|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1712192|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1712193|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1712194|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1712195|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1712196|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1712197|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1712198|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1712199|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1712200|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1712201|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1712202|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
1712203|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1712204|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1712205|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1712206|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1712207|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1712208|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1712209|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
1712210|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1712211|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1712212|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
1712213|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
1712214|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
1712215|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1712216|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1712217|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1712218|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1712219|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1712220|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1712221|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1712222|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1712223|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1712224|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1712225|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1712226|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1712227|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1712228|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1712229|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1712230|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1712231|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
1712232|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1712233|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1712234|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1712235|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1712236|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1712237|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1712238|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1712239|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1712240|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1712241|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1712242|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1712243|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1712244|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1712245|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1712246|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1712247|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1712248|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1712249|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1712250|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1712251|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1712252|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1712253|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1712254|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1712255|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712256|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712257|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1712258|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1712259|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1712260|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1712261|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1712262|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1712263|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1722554|NCT00002325|Mycoses|mycoses
1712264|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1712265|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
1712266|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1712267|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1712268|NCT00003538|anemia|anemia
1712269|NCT00003538|graft versus host disease|graft versus host disease
1712270|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
1712271|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1712272|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1712273|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1712274|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1712275|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1712276|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1712277|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1712278|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1712279|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
1712280|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1712281|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1712282|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1714096|NCT00051142|POAG|poag
1712283|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1712284|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1712285|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1712286|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1712287|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1712288|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1712289|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1712290|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1712291|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1712292|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1712293|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1712294|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1712295|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1712296|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1712297|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1712298|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1712299|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1712300|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1712301|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1712302|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1712303|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1712304|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
1712305|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1712306|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1712307|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1712308|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1712309|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1712310|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1712311|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1712312|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1712313|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1712314|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1712315|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1712316|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1712317|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1712318|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1712319|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1712320|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1712321|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1712322|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712323|NCT00003535|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
1720199|NCT00026663|Assays|assays
1712324|NCT00003535|childhood glioblastoma multiforme|childhood glioblastoma multiforme
1712325|NCT00003534|Refractory stage IV prostate cancer|refractory stage iv prostate cancer
1712326|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1712327|NCT00003532|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1712328|NCT00003532|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712329|NCT00003532|Stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1712330|NCT00003532|Stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1712331|NCT00003531|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1712332|NCT00003530|Childhood primary liver cancer|childhood primary liver cancer
1712333|NCT00003530|Adult primary liver cancer|adult primary liver cancer
1712334|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
1712335|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
1712336|NCT00003524|Stage III and IV Stomach (Gastric) Cancer|stage iii and iv stomach (gastric) cancer
1712337|NCT00003524|Recurrent Stomach (Gastric) Cancer|recurrent stomach (gastric) cancer
1712338|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
1712339|NCT00003521|Stage III and IV Soft Tissue Sarcoma|stage iii and iv soft tissue sarcoma
1712340|NCT00003521|Recurrent Soft Tissue Sarcoma|recurrent soft tissue sarcoma
1712341|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
1712342|NCT00003516|Stage III or Stage IV Prostate Cancer Stage III|stage iii or stage iv prostate cancer stage iii
1712343|NCT00003516|Stage III or Stage IV Prostate Cancer Stage IV|stage iii or stage iv prostate cancer stage iv
1712344|NCT00003515|Metastatic Primitive Neuroectodermal Tumor|metastatic primitive neuroectodermal tumor
1712345|NCT00003515|Recurrent Primitive Neuroectodermal Tumor|recurrent primitive neuroectodermal tumor
1712346|NCT00003515|Refractory Primitive Neuroectodermal Tumor|refractory primitive neuroectodermal tumor
1712347|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
1712348|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
1712349|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
1712350|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
1712351|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
1712352|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
1712353|NCT00003514|somatostatinoma|somatostatinoma
1712354|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
1712355|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
1712356|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
1712357|NCT00003513|Metastatic Neuroblastoma|metastatic neuroblastoma
1712358|NCT00003513|Recurrent Neuroblastoma|recurrent neuroblastoma
1712359|NCT00003513|Refractory Neuroblastoma|refractory neuroblastoma
1712360|NCT00003512|Waldenstrom Macroglobulinemia Recurrent|waldenstrom macroglobulinemia recurrent
1712361|NCT00003512|Waldenstrom Macroglobulinemia Refractory|waldenstrom macroglobulinemia refractory
1712362|NCT00003511|Stage I multiple myeloma|stage i multiple myeloma
1712363|NCT00003511|Stage II multiple myeloma|stage ii multiple myeloma
1712364|NCT00003511|Stage III multiple myeloma|stage iii multiple myeloma
1712365|NCT00003509|Stage IV melanoma of the skin|stage iv melanoma of the skin
1712366|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
1712367|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1712368|NCT00003501|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
1712369|NCT00003501|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
1712370|NCT00003501|High-Grade Stage II - IV Non-Hodgkin's Lymphoma|high-grade stage ii - iv non-hodgkin's lymphoma
1712371|NCT00003500|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
1712372|NCT00003500|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
1712373|NCT00003500|Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|intermediate-grade stage ii - iv non-hodgkin's lymphoma
1712374|NCT00003499|Low-grade non-Hodgkin's lymphoma|low-grade non-hodgkin's lymphoma
1712375|NCT00003498|Non Hodgkin Lymphoma Recurrent|non hodgkin lymphoma recurrent
1712376|NCT00003498|Non Hodgkin Lymphoma Refractory|non hodgkin lymphoma refractory
1712377|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1712378|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
1712379|NCT00003495|recurrent lung cancer|recurrent lung cancer
1712380|NCT00003494|Bronchial Alveolar Cancer Recurrent|bronchial alveolar cancer recurrent
1712381|NCT00003494|Bronchial Alveolar Cancer Stage IV|bronchial alveolar cancer stage iv
1712382|NCT00003492|Stage IV large cell lung cancer|stage iv large cell lung cancer
1712383|NCT00003492|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1712384|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
1712385|NCT00003489|Advanced Head and Neck Cancer|advanced head and neck cancer
1712386|NCT00003489|Recurrent Head and Neck Cancer|recurrent head and neck cancer
1712387|NCT00003489|Oral Cavity Cancer|oral cavity cancer
1712388|NCT00003489|Nasopharyngeal Cancer|nasopharyngeal cancer
1712389|NCT00003489|Hypopharyngeal Cancer|hypopharyngeal cancer
1712390|NCT00003489|Laryngeal Cancer|laryngeal cancer
1712391|NCT00003489|Nasal Cavity Cancer|nasal cavity cancer
1712392|NCT00003489|Paranasal Sinus Cancer|paranasal sinus cancer
1712393|NCT00003489|Oropharyngeal Cancer|oropharyngeal cancer
1712394|NCT00003489|Salivary Gland Cancer|salivary gland cancer
1712395|NCT00003489|Stage IV Head and Neck Cancer|stage iv head and neck cancer
1712396|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
1720200|NCT00026663|Resistance|resistance
1712397|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
1712398|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1712399|NCT00003485|stage IV colon cancer|stage iv colon cancer
1712400|NCT00003485|unresectable colon cancer|unresectable colon cancer
1712401|NCT00003483|adult meningioma|adult meningioma
1712402|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
1712403|NCT00003479|Ependymoma|ependymoma
1712404|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
1712405|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
1712406|NCT00003478|adult brain stem glioma|adult brain stem glioma
1712407|NCT00003478|adult medulloblastoma|adult medulloblastoma
1712408|NCT00003478|adult glioblastoma|adult glioblastoma
1712409|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712410|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
1712411|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1712412|NCT00003478|adult mixed glioma|adult mixed glioma
1712413|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
1712414|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
1712415|NCT00003478|adult gliosarcoma|adult gliosarcoma
1712416|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
1712417|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
1712418|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
1712419|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1712420|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
1712421|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
1712422|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
1712423|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
1712424|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
1712425|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
1712426|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
1712427|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712428|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
1712429|NCT00003474|adult glioblastoma|adult glioblastoma
1712430|NCT00003474|recurrent glioblastoma|recurrent glioblastoma
1712431|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
1712432|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
1712433|NCT00003472|Recurrent/progressive adult oligodendroglioma|recurrent/progressive adult oligodendroglioma
1712434|NCT00003472|Recurrent/progressive adult anaplastic oligodendroglioma|recurrent/progressive adult anaplastic oligodendroglioma
1712435|NCT00003471|Recurrent/progressive adult low grade astrocytoma|recurrent/progressive adult low grade astrocytoma
1712436|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
1712437|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
1712438|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712439|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
1712440|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
1712441|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
1712442|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
1712443|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
1712444|NCT00003467|adult brain stem glioma|adult brain stem glioma
1712445|NCT00003467|adult mixed glioma|adult mixed glioma
1712446|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712447|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712448|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
1712449|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
1712450|NCT00003466|adult mixed glioma|adult mixed glioma
1712451|NCT00003466|childhood mixed glioma|childhood mixed glioma
1712452|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712453|NCT00003466|adult subependymoma|adult subependymoma
1712454|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1712455|NCT00003466|adult brain stem glioma|adult brain stem glioma
1712456|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1712457|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1712458|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1712459|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
1712460|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
1712461|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
1712462|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
1712463|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
1712464|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
1712465|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
1712466|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
1712467|NCT00003461|adult medulloblastoma|adult medulloblastoma
1712468|NCT00003461|adult meningioma|adult meningioma
1712469|NCT00003461|adult glioblastoma|adult glioblastoma
1712470|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
1712471|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
1712472|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712473|NCT00003461|adult mixed glioma|adult mixed glioma
1712474|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
1712475|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1712476|NCT00003461|adult grade III meningioma|adult grade iii meningioma
1712477|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712478|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
1712479|NCT00003461|adult gliosarcoma|adult gliosarcoma
1712480|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1712481|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
1712482|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
1712483|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
1712484|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
1712485|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1712486|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
1712487|NCT00003458|Anaplastic glioma|anaplastic glioma
1712488|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
1712489|NCT00003458|Astrocytoma|astrocytoma
1712490|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
1712491|NCT00003458|Brain stem glioma|brain stem glioma
1712492|NCT00003458|Craniopharyngioma|craniopharyngioma
1712493|NCT00003458|Ganglioglioma|ganglioglioma
1712494|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
1712495|NCT00003458|Gliosarcoma|gliosarcoma
1712496|NCT00003458|Medulloepithelioma|medulloepithelioma
1712497|NCT00003458|Neurocytoma|neurocytoma
1712498|NCT00003458|Oligodendroglioma|oligodendroglioma
1712499|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
1712500|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
1712501|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
1712502|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
1712503|NCT00003457|Astrocytoma|astrocytoma
1712504|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
1712505|NCT00003457|Brainstem glioma|brainstem glioma
1712506|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
1712507|NCT00003457|Glioma|glioma
1712508|NCT00003457|Neurocytoma|neurocytoma
1712509|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
1712510|NCT00003457|Tectal glioma|tectal glioma
1712511|NCT00003456|adult glioblastoma|adult glioblastoma
1712512|NCT00003454|recurrent breast cancer|recurrent breast cancer
1712513|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1712514|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
1712515|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1712516|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1712517|NCT00003429|stage I cervical cancer|stage i cervical cancer
1712518|NCT00003429|stage II cervical cancer|stage ii cervical cancer
1712519|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
1712520|NCT00003422|stage I rectal cancer|stage i rectal cancer
1712521|NCT00003422|stage II rectal cancer|stage ii rectal cancer
1712523|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1712524|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
1712525|NCT00003420|testicular teratoma|testicular teratoma
1712526|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
1712527|NCT00003417|adult glioblastoma|adult glioblastoma
1712528|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
1712529|NCT00003417|adult gliosarcoma|adult gliosarcoma
1712530|NCT00003404|recurrent breast cancer|recurrent breast cancer
1712531|NCT00003404|phyllodes tumor|phyllodes tumor
1712532|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1712533|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1712534|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1712535|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1712536|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1712537|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1712538|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1712539|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
1712540|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
1712541|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1712542|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712543|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
1712544|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
1712545|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
1712546|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
1712547|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
1712548|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
1712549|NCT00003385|fallopian tube cancer|fallopian tube cancer
1712550|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1712551|NCT00003385|Brenner tumor|brenner tumor
1712552|NCT00003379|stage III cervical cancer|stage iii cervical cancer
1712553|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
1712554|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
1712555|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
1712556|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
1712557|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1712558|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
1712559|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1712560|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
1712561|NCT00003377|stage III cervical cancer|stage iii cervical cancer
1712562|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
1712563|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1712564|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
1712565|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1712566|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
1712567|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
1712568|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712569|NCT00003354|stage I colon cancer|stage i colon cancer
1712570|NCT00003354|stage II colon cancer|stage ii colon cancer
1712571|NCT00003354|stage III colon cancer|stage iii colon cancer
1712572|NCT00003354|stage IV colon cancer|stage iv colon cancer
1712573|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
1712574|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
1712575|NCT00003354|stage I rectal cancer|stage i rectal cancer
1712576|NCT00003354|stage II rectal cancer|stage ii rectal cancer
1712577|NCT00003354|stage III rectal cancer|stage iii rectal cancer
1712578|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
1712579|NCT00003342|stage III bladder cancer|stage iii bladder cancer
1712580|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
1712581|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1712582|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1712583|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
1712584|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1712585|NCT00003336|refractory anemia|refractory anemia
1712586|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1712587|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1712588|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1712589|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1712590|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1712591|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1712592|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1712593|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1712594|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1712595|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1712596|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1712597|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1712598|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1712599|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1712600|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1712601|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1712602|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1712603|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1712604|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1712605|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1712606|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1712607|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1712608|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
1712609|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1712610|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1712611|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1712612|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1712613|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1712614|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712615|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712616|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1712617|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1712618|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1712619|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1712620|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1720621|NCT00023374|efficacy|efficacy
1712621|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1712622|NCT00003335|graft versus host disease|graft versus host disease
1712623|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1712624|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1712625|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1712626|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1712627|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1712628|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1712629|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1712630|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1712631|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1712632|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1712633|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1712634|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1712635|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1712636|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1712637|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1712638|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1712639|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1712640|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1712641|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1712642|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
1712643|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
1712644|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
1712645|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1712646|NCT00003329|stage I colon cancer|stage i colon cancer
1712647|NCT00003329|stage II colon cancer|stage ii colon cancer
1712648|NCT00003329|stage III colon cancer|stage iii colon cancer
1712649|NCT00003329|stage IV colon cancer|stage iv colon cancer
1712650|NCT00003329|stage I breast cancer|stage i breast cancer
1712651|NCT00003329|stage II breast cancer|stage ii breast cancer
1712652|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
1712653|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
1712654|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
1712655|NCT00003329|stage IV breast cancer|stage iv breast cancer
1712656|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1712657|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1712658|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
1712659|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
1712660|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1712662|NCT00003329|stage II prostate cancer|stage ii prostate cancer
1712663|NCT00003329|stage III prostate cancer|stage iii prostate cancer
1712664|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
1712665|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1712666|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
1712667|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
1712668|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
1712669|NCT00003309|adult medulloblastoma|adult medulloblastoma
1712670|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
1712671|NCT00003309|adult ependymoma|adult ependymoma
1712672|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1712673|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
1712674|NCT00003308|chondrosarcoma|chondrosarcoma
1712675|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
1712676|NCT00003308|stage IV melanoma|stage iv melanoma
1712677|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
1712678|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
1712679|NCT00003308|ovarian sarcoma|ovarian sarcoma
1712680|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1712681|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1712682|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1712683|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
1712684|NCT00003278|intraocular lymphoma|intraocular lymphoma
1712685|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1712686|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1712687|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
1712688|NCT00003273|regional neuroblastoma|regional neuroblastoma
1712689|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
1712690|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
1712691|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
1712692|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
1712693|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1712694|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1712695|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1712696|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1712697|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
1712698|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
1712699|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
1712700|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
1712701|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
1712702|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
1712703|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
1712704|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
1712705|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1712706|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
1712707|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
1712708|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1712709|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1712710|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1712711|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1712712|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1712713|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1712714|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1712715|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1712716|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
1712717|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712718|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712719|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1712720|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1712721|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1712722|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1712723|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1712724|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1712725|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1712726|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1712727|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1712728|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1712729|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
1712730|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
1712731|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
1712732|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1712733|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
1712734|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1712735|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1712736|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1712737|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1712738|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1712739|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1712740|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1712741|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1712742|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1712743|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1712744|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1712745|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1712746|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1712747|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1712748|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1712749|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1712750|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1712751|NCT00003179|endometrial cancer|endometrial cancer
1712752|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1712822|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1712823|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1712753|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1712754|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1712755|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
1712756|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1712757|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1712758|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1712759|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1712760|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1712761|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1712762|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
1712763|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
1712764|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
1712765|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
1712766|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1712767|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1712768|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1712769|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1712770|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1712771|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
1712772|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
1712773|NCT00003140|stage I breast cancer|stage i breast cancer
1712774|NCT00003140|stage II breast cancer|stage ii breast cancer
1712775|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
1712776|NCT00003138|anemia|anemia
1712777|NCT00003138|refractory anemia|refractory anemia
1712778|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
1712779|NCT00003138|erythropoietin|erythropoietin
1712780|NCT00003138|filgrastim|filgrastim
1712781|NCT00003135|stage IV breast cancer|stage iv breast cancer
1712782|NCT00003135|recurrent breast cancer|recurrent breast cancer
1712783|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
1712784|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
1712785|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
1712786|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1712787|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1712788|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
1712789|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
1712790|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1712791|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1712792|NCT00003135|male breast cancer|male breast cancer
1712793|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
1712794|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
1712795|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
1712796|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
1712797|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
1712798|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1712799|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
1712800|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
1712801|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1712802|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1712803|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
1712804|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1712805|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1712806|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1712807|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1712808|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1712809|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1712810|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1712811|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1712812|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1712813|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1712814|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1712815|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1712816|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1712817|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712818|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712819|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1712820|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1712821|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1712824|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1712825|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1712826|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1712827|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1712828|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1712829|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1712830|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1712831|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1712832|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1712833|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1712834|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1712835|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1712836|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1712837|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1712838|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1712839|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1712840|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1712841|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1712842|NCT00003105|stage III bladder cancer|stage iii bladder cancer
1712843|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
1712844|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
1712845|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1712846|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
1712847|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
1712848|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
1712849|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1712850|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
1712851|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
1712852|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
1712853|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
1712854|NCT00003093|regional neuroblastoma|regional neuroblastoma
1712855|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
1712856|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
1712857|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1712858|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1712859|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
1712860|NCT00003067|adult glioblastoma|adult glioblastoma
1712861|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712862|NCT00003067|adult mixed glioma|adult mixed glioma
1712863|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
1712864|NCT00003067|adult gliosarcoma|adult gliosarcoma
1712865|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
1712866|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
1712867|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
1712868|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1712869|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
1712870|NCT00003063|stage II colon cancer|stage ii colon cancer
1712871|NCT00003063|stage III colon cancer|stage iii colon cancer
1712872|NCT00003063|stage II rectal cancer|stage ii rectal cancer
1712873|NCT00003063|stage III rectal cancer|stage iii rectal cancer
1712874|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1712875|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1712876|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1712877|NCT00003052|adult angiosarcoma|adult angiosarcoma
1712878|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
1712879|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
1712880|NCT00003052|adult liposarcoma|adult liposarcoma
1712881|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
1712882|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
1712883|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1712884|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1712885|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
1712886|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1712887|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1712888|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1712889|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1712890|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
1712891|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
1712892|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
1712893|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1722555|NCT00002325|Fluconazole|fluconazole
1712894|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
1712895|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
1712896|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
1712897|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
1712898|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1712899|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
1712900|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1712901|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
1712902|NCT00003027|stage IV melanoma|stage iv melanoma
1712903|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1712904|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
1712905|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1712906|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
1712907|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
1712908|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
1712909|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
1712910|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1712911|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1712912|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1712913|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
1712914|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1712915|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1712916|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1712917|NCT00003022|regional neuroblastoma|regional neuroblastoma
1712918|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
1712919|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
1712920|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
1712921|NCT00003022|retinoblastoma|retinoblastoma
1712922|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
1712923|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
1712924|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
1712925|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1712926|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
1712927|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
1712928|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
1712929|NCT00003022|iris melanoma|iris melanoma
1712930|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
1712931|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
1712932|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
1712933|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
1712934|NCT00003022|adult brain stem glioma|adult brain stem glioma
1712935|NCT00003022|adult medulloblastoma|adult medulloblastoma
1712936|NCT00003022|stage IV melanoma|stage iv melanoma
1712937|NCT00003022|recurrent melanoma|recurrent melanoma
1712938|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1712939|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1712940|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1712941|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
1712942|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1712943|NCT00003022|adult mixed glioma|adult mixed glioma
1712944|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
1712945|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
1712946|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1712947|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1712948|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1712949|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1712950|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1712951|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
1712952|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1712953|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1712954|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1712955|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
1712956|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
1712957|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1712958|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1712959|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
1712960|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1712961|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
1712962|NCT00003022|adult glioblastoma|adult glioblastoma
1712963|NCT00003022|adult gliosarcoma|adult gliosarcoma
1712964|NCT00003016|stage I breast cancer|stage i breast cancer
1712965|NCT00003016|stage II breast cancer|stage ii breast cancer
1720622|NCT00023374|toxicity|toxicity
1712966|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
1712967|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
1712968|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
1712969|NCT00003013|stage II breast cancer|stage ii breast cancer
1712970|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
1712971|NCT00002996|pain|pain
1712972|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1712973|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1712974|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1712975|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1712976|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
1712977|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1712978|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1712979|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1712980|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1712981|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
1712982|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
1712983|NCT00002990|stage I bladder cancer|stage i bladder cancer
1712984|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1712985|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
1712986|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1712987|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1712988|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1712989|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1712990|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1712991|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
1712992|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1712993|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
1712994|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
1712995|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
1712996|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
1712997|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
1712998|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1712999|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1713000|NCT00002975|actinic keratosis|actinic keratosis
1713001|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
1713002|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
1713003|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
1713004|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
1713005|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
1713006|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
1713007|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
1713008|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
1713009|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
1713010|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
1713011|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
1713012|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
1713013|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
1713014|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
1713015|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
1713016|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
1713017|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1713018|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1713019|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1713020|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1713021|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1713022|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
1713023|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1713024|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1713025|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1713026|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1713027|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
1713028|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1713029|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1713030|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
1713031|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1713032|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1713033|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1713034|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1713180|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
1713181|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
1713035|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1713036|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1713037|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
1713038|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1713039|NCT00002931|testicular seminoma|testicular seminoma
1713040|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
1713041|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
1713042|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
1713043|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1713044|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1713045|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1713046|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1713047|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1713048|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1713049|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1713050|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1713051|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1713052|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1713053|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1713054|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1713055|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
1713056|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
1713057|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
1713058|NCT00002931|adult teratoma|adult teratoma
1713059|NCT00002931|testicular immature teratoma|testicular immature teratoma
1713060|NCT00002931|testicular mature teratoma|testicular mature teratoma
1713061|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
1713062|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
1713063|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
1713064|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1713065|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1713066|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
1713067|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
1713068|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1713069|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1713070|NCT00002926|refractory anemia|refractory anemia
1713071|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1713072|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
1713073|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1713074|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1713075|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1713076|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1713077|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1713078|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
1713079|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1713080|NCT00002920|endometrial cancer|endometrial cancer
1713081|NCT00002920|stage I breast cancer|stage i breast cancer
1713082|NCT00002920|stage II breast cancer|stage ii breast cancer
1713083|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
1713084|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
1713085|NCT00002920|Paget disease of the breast|paget disease of the breast
1713086|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
1713087|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
1713088|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
1713089|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
1713090|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
1713091|NCT00002900|stage I breast cancer|stage i breast cancer
1713092|NCT00002900|stage II breast cancer|stage ii breast cancer
1713093|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
1713094|NCT00002900|cardiac toxicity|cardiac toxicity
1713095|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
1713096|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
1713097|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1713098|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
1713099|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
1713100|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
1713101|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
1713102|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
1713103|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
1713104|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
1713105|NCT00002898|childhood liposarcoma|childhood liposarcoma
1713106|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
1713107|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
1713108|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
1713109|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
1713110|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
1713111|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
1713112|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
1713113|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
1713114|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1713115|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
1713116|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1713117|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1713118|NCT00002895|fallopian tube cancer|fallopian tube cancer
1713119|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1713120|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
1713121|NCT00002883|stage I gastric cancer|stage i gastric cancer
1713122|NCT00002883|stage II gastric cancer|stage ii gastric cancer
1713123|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
1713124|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
1713125|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1713126|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1713127|NCT00002882|stage III melanoma|stage iii melanoma
1713128|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
1713129|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
1713130|NCT00002874|stage III prostate cancer|stage iii prostate cancer
1713131|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
1713132|NCT00002860|stage IV melanoma|stage iv melanoma
1713133|NCT00002860|recurrent melanoma|recurrent melanoma
1713134|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1713135|NCT00002855|stage III prostate cancer|stage iii prostate cancer
1713136|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
1713137|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
1713138|NCT00002854|stage IV colon cancer|stage iv colon cancer
1713139|NCT00002854|stage II breast cancer|stage ii breast cancer
1713140|NCT00002854|stage IV breast cancer|stage iv breast cancer
1713141|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
1713142|NCT00002854|recurrent breast cancer|recurrent breast cancer
1713143|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
1713144|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
1713145|NCT00002854|localized osteosarcoma|localized osteosarcoma
1713146|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
1713147|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
1713148|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
1713149|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
1720927|NCT00013585|Selegiline|selegiline
1713150|NCT00002854|recurrent colon cancer|recurrent colon cancer
1713151|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
1713152|NCT00002854|stage IV anal cancer|stage iv anal cancer
1713153|NCT00002854|recurrent anal cancer|recurrent anal cancer
1713154|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
1713155|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
1713156|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1713157|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1713158|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1713159|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1713160|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1713161|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1713162|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
1713163|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1713164|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
1713165|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
1713166|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
1713167|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
1713168|NCT00002854|stage II melanoma|stage ii melanoma
1713169|NCT00002854|stage III melanoma|stage iii melanoma
1713170|NCT00002854|stage IV melanoma|stage iv melanoma
1713171|NCT00002854|recurrent melanoma|recurrent melanoma
1713172|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
1713173|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1713174|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1713175|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
1713176|NCT00002851|stage I breast cancer|stage i breast cancer
1713177|NCT00002851|stage II breast cancer|stage ii breast cancer
1713178|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
1713179|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
1713183|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
1713184|NCT00002848|stage I prostate cancer|stage i prostate cancer
1713185|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
1713186|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
1713187|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
1713188|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
1713189|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
1713190|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
1713191|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
1713192|NCT00002842|stage IV colon cancer|stage iv colon cancer
1713193|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
1713194|NCT00002842|recurrent colon cancer|recurrent colon cancer
1713195|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
1713196|NCT00002842|liver metastases|liver metastases
1713197|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
1713198|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
1713199|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
1713200|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
1713201|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
1713202|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
1713203|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
1713204|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
1713205|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
1713206|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
1713207|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1713208|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1713209|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
1713210|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1713211|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1713212|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1713213|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1713214|NCT00002809|refractory anemia|refractory anemia
1713215|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
1713216|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1713217|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1713218|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1713219|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1713220|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1713221|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
1713222|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
1713223|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
1713224|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
1713225|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
1713226|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
1713227|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
1713228|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
1713229|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
1713230|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
1713231|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
1713232|NCT00002792|polycythemia vera|polycythemia vera
1713233|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
1713234|NCT00002792|essential thrombocythemia|essential thrombocythemia
1713235|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1713236|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
1713237|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1713238|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1713239|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1713240|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
1713241|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1713242|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
1713243|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1713244|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1713245|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
1713246|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1720818|NCT00016601|Indinavir|indinavir
1713247|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1713248|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1713249|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
1713250|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
1713251|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
1713252|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1713253|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
1713254|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1713255|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1713256|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1713257|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1713258|NCT00002762|stage I breast cancer|stage i breast cancer
1713259|NCT00002762|stage II breast cancer|stage ii breast cancer
1713260|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
1713261|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
1713262|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1713263|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
1713264|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1713265|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1713266|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1713267|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1713268|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1713269|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1713270|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1713271|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1714098|NCT00051142|OHT|oht
1713272|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
1713273|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
1713274|NCT00002746|refractory anemia|refractory anemia
1713275|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
1713276|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
1713277|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1713278|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1713279|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1713280|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1713281|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1713282|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1713283|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1721130|NCT00007202|Didanosine|didanosine
1713284|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1713285|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1713286|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
1713287|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1713288|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1713289|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
1713290|NCT00002720|stage I breast cancer|stage i breast cancer
1713291|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
1713292|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1713293|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1713294|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
1713295|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1713296|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
1713297|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1713298|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1713299|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
1713300|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1713301|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1713302|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1713303|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1713304|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1713305|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1713306|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
1713307|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1713308|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
1713309|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
1713310|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
1713311|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
1713312|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1713313|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
1713314|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1713315|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1713316|NCT00002716|stage IV colon cancer|stage iv colon cancer
1713317|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
1713318|NCT00002716|recurrent colon cancer|recurrent colon cancer
1713319|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
1713320|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
1713321|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1713322|NCT00002716|liver metastases|liver metastases
1713323|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1713324|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1713325|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1713326|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1713327|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
1713328|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
1713329|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
1713330|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
1713331|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
1713332|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
1713333|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
1713334|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
1713335|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
1713336|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
1713337|NCT00002702|tongue cancer|tongue cancer
1713338|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
1713339|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1713340|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1713341|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1713342|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1713343|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1713344|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1713345|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1713346|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1713347|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1713348|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1713349|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1713350|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1713351|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1713352|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1713353|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1713354|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1713355|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1713356|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
1713357|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
1713358|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
1713359|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
1713360|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
1713361|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
1713362|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
1713363|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1713364|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1713365|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1713366|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1713367|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1713368|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1713369|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1713370|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1713371|NCT00002684|stage III bladder cancer|stage iii bladder cancer
1713372|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
1713373|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
1713374|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
1713375|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
1713376|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
1713377|NCT00002684|distal urethral cancer|distal urethral cancer
1713378|NCT00002684|proximal urethral cancer|proximal urethral cancer
1713379|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
1713380|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1713381|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
1713382|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1713383|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
1713384|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
1713385|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
1713386|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
1713387|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
1713388|NCT00002668|stage IV breast cancer|stage iv breast cancer
1713389|NCT00002668|recurrent breast cancer|recurrent breast cancer
1713390|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
1713391|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
1713392|NCT00002668|pain|pain
1713393|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1713394|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1713395|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1713396|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1713397|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1713398|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
1713399|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
1713400|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
1713401|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
1713402|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
1713403|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
1713404|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
1713405|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
1713406|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
1713407|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1713408|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1713409|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
1713410|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
1713411|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
1713412|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
1713413|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
1713414|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
1713540|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
1713415|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
1713416|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
1713417|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
1713418|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
1713419|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1713420|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1713421|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1713422|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1713423|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1713424|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1713425|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
1713426|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
1713427|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
1713428|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
1713429|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1713430|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1713431|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1713432|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1713433|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1713434|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1713435|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
1713436|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
1713437|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
1713438|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1713844|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
1713439|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1713569|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
1713440|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1713441|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1713442|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1713443|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1713444|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
1713445|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
1713446|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
1713447|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1713448|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1713449|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1713450|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1713451|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1713452|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1713453|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
1713454|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
1713455|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
1713456|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
1713457|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
1713458|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
1713459|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
1713460|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
1713461|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
1713462|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
1713463|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
1713464|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
1713465|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
1713466|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1713467|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1713468|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1713469|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1713470|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
1713471|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
1713472|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
1713473|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
1713474|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1713475|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
1713476|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1713477|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1713478|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1713479|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1713480|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1713481|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
1713482|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
1713483|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
1713484|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1713485|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
1713486|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1713487|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1713488|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1713489|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1713490|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1713491|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
1713492|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
1713493|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
1713494|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
1713495|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
1713496|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
1713497|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
1713498|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
1713568|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
1713499|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
1713500|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
1713501|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
1713502|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
1713503|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
1713504|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
1713505|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
1713506|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
1713507|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
1713508|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
1713509|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
1713510|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
1713511|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
1713512|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
1713513|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
1713514|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
1713515|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
1713516|NCT00002662|stage IV breast cancer|stage iv breast cancer
1713517|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
1713518|NCT00002662|recurrent breast cancer|recurrent breast cancer
1713519|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
1713520|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
1713521|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1713522|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
1713523|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
1713524|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
1713525|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
1713526|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1713527|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
1713528|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
1713529|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
1713530|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1713531|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1713532|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
1713533|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
1713534|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
1713535|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
1713536|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
1713537|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
1713538|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
1713539|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
1713541|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
1713542|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
1713543|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
1713544|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
1713545|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1713546|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
1713547|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
1713548|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
1713549|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1713550|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
1713551|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
1713552|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1713553|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
1713554|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
1713555|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1713556|NCT00002647|adult brain stem glioma|adult brain stem glioma
1713557|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1713558|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
1713559|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
1713560|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
1713561|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
1713562|NCT00002647|adult ependymoma|adult ependymoma
1713563|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
1713564|NCT00002647|adult glioblastoma|adult glioblastoma
1713565|NCT00002647|adult gliosarcoma|adult gliosarcoma
1713566|NCT00002647|adult medulloblastoma|adult medulloblastoma
1713567|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
1713570|NCT00002647|adult papillary meningioma|adult papillary meningioma
1713571|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1713572|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
1713573|NCT00002647|adult pineoblastoma|adult pineoblastoma
1713574|NCT00002647|adult pineocytoma|adult pineocytoma
1713575|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
1713576|NCT00002647|adult subependymoma|adult subependymoma
1713577|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
1713578|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
1713579|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
1713580|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
1713581|NCT00002647|adult grade III meningioma|adult grade iii meningioma
1713582|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1713583|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
1713584|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
1713585|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1713586|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1713587|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
1713588|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1713589|NCT00002641|adult angiosarcoma|adult angiosarcoma
1713590|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
1713591|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
1713592|NCT00002641|adult liposarcoma|adult liposarcoma
1713593|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
1713594|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
1713595|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
1713596|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1713597|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
1713598|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
1713599|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
1713600|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
1713601|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
1713602|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
1713603|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
1713604|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
1713605|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
1713606|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
1713607|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
1713608|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
1713609|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
1713610|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
1713611|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
1713612|NCT00002641|ovarian sarcoma|ovarian sarcoma
1713613|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1713614|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
1713615|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1713616|NCT00002633|stage II prostate cancer|stage ii prostate cancer
1713617|NCT00002633|stage III prostate cancer|stage iii prostate cancer
1713618|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
1713619|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1713620|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
1713621|NCT00002624|large cell lung cancer|large cell lung cancer
1713622|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
1713623|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1713624|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
1713625|NCT00002623|large cell lung cancer|large cell lung cancer
1713626|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1713627|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
1713628|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
1713629|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
1713630|NCT00002615|stage II gastric cancer|stage ii gastric cancer
1713631|NCT00002615|stage III gastric cancer|stage iii gastric cancer
1713632|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
1713633|NCT00002611|stage I Wilms tumor|stage i wilms tumor
1713634|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
1713635|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
1713636|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
1713637|NCT00002611|stage V Wilms tumor|stage v wilms tumor
1713638|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1713639|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1713640|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
1713641|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
1713642|NCT00002608|childhood brain tumor|childhood brain tumor
1713643|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
1713644|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
1714027|NCT00051545|cancer|cancer
1713645|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
1713846|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
1713646|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
1713647|NCT00002608|childhood liver cancer|childhood liver cancer
1713648|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
1713649|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
1713650|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
1713651|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1713652|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
1713653|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
1713654|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
1713655|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
1713656|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
1713657|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
1713658|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
1713659|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
1713660|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
1713661|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
1713662|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
1713663|NCT00002608|adult brain stem glioma|adult brain stem glioma
1713664|NCT00002608|adult medulloblastoma|adult medulloblastoma
1713665|NCT00002608|adult glioblastoma|adult glioblastoma
1713666|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
1713667|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
1713668|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
1713669|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
1713670|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1713671|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
1713672|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
1713673|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1713674|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
1713675|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
1713676|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1713677|NCT00002608|adult mixed glioma|adult mixed glioma
1713678|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
1713679|NCT00002608|adult subependymoma|adult subependymoma
1713680|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
1713681|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
1713682|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
1713683|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1713684|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
1713685|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
1713686|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
1713687|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
1713688|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
1713689|NCT00002608|adult gliosarcoma|adult gliosarcoma
1713690|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
1721228|NCT00006443|Genotype|genotype
1713691|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
1713692|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
1713693|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
1713694|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
1713695|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
1713696|NCT00002596|testicular seminoma|testicular seminoma
1713697|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
1713698|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
1713699|NCT00002596|testicular teratoma|testicular teratoma
1713700|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
1713701|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
1713702|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
1713703|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
1713704|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
1713705|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
1713706|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
1713707|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
1713708|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
1713709|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
1713710|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
1713711|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
1713712|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
1713713|NCT00002596|childhood teratoma|childhood teratoma
1714028|NCT00051545|hepatocellular|hepatocellular
1713714|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
1713715|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
1713716|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
1713717|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1713718|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
1713719|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
1713720|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
1713721|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
1713722|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
1713723|NCT00002586|small cell lung cancer|small cell lung cancer
1713724|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
1713725|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1713726|NCT00002569|adult mixed glioma|adult mixed glioma
1713727|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
1713728|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1713729|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1713730|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
1713731|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
1713732|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
1713733|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
1713734|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
1713735|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
1713736|NCT00002544|stage IV breast cancer|stage iv breast cancer
1713737|NCT00002544|recurrent breast cancer|recurrent breast cancer
1713738|NCT00002528|stage I breast cancer|stage i breast cancer
1713739|NCT00002528|stage II breast cancer|stage ii breast cancer
1713740|NCT00002523|stage II rectal cancer|stage ii rectal cancer
1713741|NCT00002523|stage III rectal cancer|stage iii rectal cancer
1713742|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
1713743|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
1713744|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
1713745|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
1713746|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
1713747|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
1713748|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
1713749|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
1713750|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
1713751|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
1713752|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
1713753|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
1713754|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
1713755|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
1713756|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
1713757|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
1713758|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
1713759|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
1713760|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
1713761|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
1713762|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
1713763|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
1713764|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
1713765|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
1713766|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
1713767|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
1713768|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
1713769|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
1713770|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
1713771|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
1713772|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
1713773|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
1713774|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
1713775|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
1713776|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
1713777|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
1713778|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
1713779|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
1714029|NCT00051545|carcinoma|carcinoma
1713780|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
1713781|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
1713782|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
1713783|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
1713784|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
1713785|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
1713786|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
1713787|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
1713788|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
1713789|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
1713790|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
1713791|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
1713792|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
1713793|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
1713794|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
1713795|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1713796|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
1713797|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
1713798|NCT00002515|chondrosarcoma|chondrosarcoma
1713799|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
1713800|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
1713801|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
1713802|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
1713803|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
1713804|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
1713805|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
1713806|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
1713807|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
1713808|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
1713809|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
1713810|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
1713811|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
1713812|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
1713813|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
1713814|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
1713815|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
1713816|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
1713817|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
1713818|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
1713819|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
1713893|NCT00051818|chronic HIV infection|chronic hiv infection
1713820|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
1713821|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
1713822|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1713823|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
1713824|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
1713825|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
1713826|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
1713827|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1713828|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
1713829|NCT00002511|stage I prostate cancer|stage i prostate cancer
1713830|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
1713831|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
1713832|NCT00002511|stage III prostate cancer|stage iii prostate cancer
1713833|NCT00002490|stage I bladder cancer|stage i bladder cancer
1713834|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
1713835|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
1713836|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
1713837|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1713838|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1713839|NCT00002475|stage III colon cancer|stage iii colon cancer
1713840|NCT00002475|stage IV colon cancer|stage iv colon cancer
1713841|NCT00002475|stage IV breast cancer|stage iv breast cancer
1713842|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
1713843|NCT00002475|recurrent breast cancer|recurrent breast cancer
1714565|NCT00001886|Ischemia|ischemia
1713845|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
1713847|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
1713848|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
1713849|NCT00002475|recurrent colon cancer|recurrent colon cancer
1713850|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
1713851|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
1713852|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
1713853|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
1713854|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
1713855|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
1713856|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
1713857|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
1713858|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
1713859|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1713860|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
1713861|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
1713862|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
1713863|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
1713864|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
1713865|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
1713866|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
1713867|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
1713868|NCT00002472|childhood teratoma|childhood teratoma
1713869|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
1713870|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
1713871|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
1713872|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
1713873|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
1713874|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
1713875|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
1713876|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
1713877|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
1713878|NCT00002455|stage I colon cancer|stage i colon cancer
1713879|NCT00002455|stage II colon cancer|stage ii colon cancer
1713880|NCT00002455|stage III colon cancer|stage iii colon cancer
1713881|NCT00002455|stage I breast cancer|stage i breast cancer
1713882|NCT00002455|stage II breast cancer|stage ii breast cancer
1713883|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
1713884|NCT00002455|recurrent breast cancer|recurrent breast cancer
1713885|NCT00002455|recurrent colon cancer|recurrent colon cancer
1713886|NCT00002455|stage I melanoma|stage i melanoma
1713887|NCT00002455|stage II melanoma|stage ii melanoma
1713888|NCT00002455|stage III melanoma|stage iii melanoma
1713889|NCT00002455|recurrent melanoma|recurrent melanoma
1713890|NCT00052143|Huntington's disease|huntington's disease
1713891|NCT00052143|HD|hd
1713892|NCT00052143|Huntington disease|huntington disease
1714206|NCT00050804|Anxiety|anxiety
1713894|NCT00051818|treatment interruption|treatment interruption
1713895|NCT00051818|HIV-specific immune response|hiv-specific immune response
1713896|NCT00051818|immune response|immune response
1713897|NCT00051818|virological response|virological response
1713898|NCT00051818|treatment experienced|treatment experienced
1713899|NCT00052091|Geriatrics|geriatrics
1713900|NCT00052078|Phobic Disorders|phobic disorders
1713901|NCT00052078|Anxiety, Separation|anxiety, separation
1713902|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1713904|NCT00052026|Adolescent|adolescent
1713905|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
1713906|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
1713907|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
1713908|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
1713909|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
1713910|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
1713911|NCT00052026|Age Factors|age factors
1713912|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
1713913|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
1713914|NCT00052026|Child|child
1713915|NCT00052026|Child, Preschool|child, preschool
1713916|NCT00052026|Drug Administration Schedule|drug administration schedule
1713917|NCT00052026|Female|female
1713918|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
1713919|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
1713920|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
1713921|NCT00052026|Human|human
1713922|NCT00052026|Infant|infant
1713923|NCT00052026|Infant, Newborn|infant, newborn
1713924|NCT00052026|Male|male
1713925|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
1713926|NCT00052026|Placebos|placebos
1713927|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
1713928|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
1713929|NCT00052026|Prospective Studies|prospective studies
1713930|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
1713931|NCT00052026|Treatment Outcome|treatment outcome
1713932|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
1713933|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
1713934|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
1713935|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
1713936|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
1713937|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
1713938|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
1713939|NCT00052013|CNS,|cns,
1713940|NCT00052013|hemangioblastoma,|hemangioblastoma,
1713941|NCT00052013|retinal|retinal
1713942|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
1713943|NCT00051935|GSD-II|gsd-ii
1713944|NCT00051935|Pompe Disease|pompe disease
1713945|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
1713946|NCT00051922|HIV Seronegativity|hiv seronegativity
1713947|NCT00051961|Dopamine|dopamine
1713948|NCT00051961|Spinal Physiology|spinal physiology
1713949|NCT00051961|Flexor Reflex|flexor reflex
1713950|NCT00051961|Ropinirole|ropinirole
1713951|NCT00051961|Motor Control|motor control
1713952|NCT00051961|Dopaminergic|dopaminergic
1713953|NCT00051961|Restless Legs|restless legs
1713954|NCT00051909|Alzheimer's Disease|alzheimer's disease
1713955|NCT00051844|HIV|hiv
1713956|NCT00051844|NNRTI Failure|nnrti failure
1713957|NCT00051844|HIV Infections|hiv infections
1713958|NCT00051831|Treatment Naive|treatment naive
1713959|NCT00051831|HIV-1|hiv-1
1713961|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1713962|NCT00051831|Immunologic Memory|immunologic memory
1713963|NCT00051831|Pentafuside|pentafuside
1713964|NCT00051831|Anti-HIV Agents|anti-hiv agents
1713965|NCT00051831|Drug Therapy, Combination|drug therapy, combination
1713966|NCT00051831|Saquinavir|saquinavir
1713967|NCT00051831|Ritonavir|ritonavir
1713968|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1713969|NCT00051831|RNA, Viral|rna, viral
1713970|NCT00051831|Viral Load|viral load
1713971|NCT00051831|Fusion Inhibitors|fusion inhibitors
1713972|NCT00051831|Entry Inhibitors|entry inhibitors
1713973|NCT00051870|Verbal Memory|verbal memory
1713974|NCT00051870|Inhibition|inhibition
1713975|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1713976|NCT00051870|Cortical Excitability|cortical excitability
1713977|NCT00051870|Nonverbal Memory|nonverbal memory
1713978|NCT00051857|Magnetic Resonance Imaging|magnetic resonance imaging
1713979|NCT00051857|Muscle|muscle
1713980|NCT00051857|Bone|bone
1713981|NCT00051857|Dynamics|dynamics
1713982|NCT00051857|Visualization|visualization
1713983|NCT00051805|Patient Compliance|patient compliance
1713984|NCT00051805|Adherence|adherence
1713985|NCT00051805|Treatment Experienced|treatment experienced
1713986|NCT00051779|CAL|cal
1713987|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
1713988|NCT00051779|Breast Cancer|breast cancer
1713989|NCT00051779|Bone Metastasis|bone metastasis
1713990|NCT00051779|Hypercalcemia|hypercalcemia
1713991|NCT00051766|compliance|compliance
1713992|NCT00051766|medication|medication
1713993|NCT00051766|antiretroviral|antiretroviral
1713994|NCT00051766|adherence|adherence
1713995|NCT00051766|intervention|intervention
1713996|NCT00051766|treatment experienced|treatment experienced
1713997|NCT00051753|Otitis Media|otitis media
1713998|NCT00051753|Acute Otitis Media|acute otitis media
1713999|NCT00051753|ear infection|ear infection
1714000|NCT00051753|levofloxacin|levofloxacin
1714001|NCT00051753|amoxicillin|amoxicillin
1714002|NCT00051753|clavulanate|clavulanate
1714003|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
1714005|NCT00051701|Campath|campath
1714006|NCT00051701|alemtuzumab|alemtuzumab
1714007|NCT00051675|adenocarcinoma|adenocarcinoma
1714008|NCT00051675|monoclonal antibody|monoclonal antibody
1714009|NCT00051636|Bisphosphonate|bisphosphonate
1714010|NCT00051636|SAP|sap
1714011|NCT00051636|SAP excess|sap excess
1714012|NCT00051636|non-inferiority|non-inferiority
1714013|NCT00051636|therapeutic response|therapeutic response
1714014|NCT00051636|extended observation period|extended observation period
1714015|NCT00051623|Psoriatic arthritis|psoriatic arthritis
1714016|NCT00051623|Infliximab|infliximab
1714017|NCT00051623|Remicade|remicade
1714018|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
1714019|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
1714020|NCT00051415|Flaxseed|flaxseed
1714021|NCT00051415|Cholesterol|cholesterol
1714022|NCT00051402|Postmenopausal|postmenopausal
1714023|NCT00051402|Memory Loss|memory loss
1714024|NCT00051402|Cognition|cognition
1714025|NCT00051402|Phytoestrogens|phytoestrogens
1714026|NCT00051545|liver|liver
1714030|NCT00051532|hepatocellular|hepatocellular
1714031|NCT00051532|carcinoma|carcinoma
1714034|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
1714035|NCT00051493|Lung Cancer|lung cancer
1714036|NCT00051493|NSCLC|nsclc
1714037|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
1714038|NCT00051519|HIV|hiv
1714039|NCT00051519|AIDS|aids
1714040|NCT00051519|Vaccine|vaccine
1714041|NCT00051519|HIV-positive|hiv-positive
1714042|NCT00051519|Therapy|therapy
1714043|NCT00051454|HIV Seronegativity|hiv seronegativity
1714044|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
1714045|NCT00051441|stomatitis|stomatitis
1714046|NCT00051441|radiation effects|radiation effects
1714047|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
1714048|NCT00051337|Kinesiogenic|kinesiogenic
1714049|NCT00051337|Psychogenic|psychogenic
1714050|NCT00051337|Channelopathy|channelopathy
1714051|NCT00051337|Ictal|ictal
1714052|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
1714053|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
1714054|NCT00051337|Single Photon Emission|single photon emission
1714055|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
1714056|NCT00051324|Huntington's disease|huntington's disease
1714057|NCT00051324|Huntington disease|huntington disease
1714058|NCT00051324|HD|hd
1714059|NCT00051285|CHF|chf
1714060|NCT00051285|heart|heart
1714061|NCT00051285|failure|failure
1714062|NCT00051285|congestive|congestive
1714063|NCT00051285|enoximone|enoximone
1714064|NCT00051285|phosphodiesterase|phosphodiesterase
1714065|NCT00051285|inhibitor|inhibitor
1714066|NCT00051311|Lymphoma|lymphoma
1714067|NCT00051311|Leukemia|leukemia
1714068|NCT00051311|Hodgkin's Disease|hodgkin's disease
1714069|NCT00051311|Multiple Myeloma|multiple myeloma
1714070|NCT00051311|Immunotherapy|immunotherapy
1714071|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
1714072|NCT00051259|depression|depression
1714073|NCT00051259|MDD|mdd
1714074|NCT00051259|sexual dysfunction|sexual dysfunction
1714075|NCT00051259|orgasm disorder|orgasm disorder
1714076|NCT00051207|Mood Disorders|mood disorders
1714077|NCT00051207|Psychotherapy|psychotherapy
1714078|NCT00051207|Comorbidity|comorbidity
1714079|NCT00051194|Glaucoma|glaucoma
1714080|NCT00051194|POAG|poag
1714081|NCT00051194|OAG|oag
1714082|NCT00051194|OHT|oht
1714083|NCT00051181|Glaucoma|glaucoma
1714084|NCT00051181|POAG|poag
1714085|NCT00051181|OAG|oag
1714086|NCT00051181|OHT|oht
1714087|NCT00051168|Glaucoma|glaucoma
1714088|NCT00051168|POAG|poag
1714089|NCT00051168|OAG|oag
1714090|NCT00051168|OHT|oht
1714091|NCT00051155|Glaucoma|glaucoma
1714092|NCT00051155|POAG|poag
1714100|NCT00051129|anecortave acetate|anecortave acetate
1714101|NCT00051129|wet AMD|wet amd
1714102|NCT00051129|age-related macular degeneration|age-related macular degeneration
1714103|NCT00051129|Macular Degeneration|macular degeneration
1714104|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
1714105|NCT00051129|Age-Related Maculopathies|age-related maculopathies
1714106|NCT00051129|Age-Related Maculopathy|age-related maculopathy
1714107|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
1714108|NCT00051116|Multiple Myeloma|multiple myeloma
1714109|NCT00051116|Revimid|revimid
1714110|NCT00051116|CC5013|cc5013
1714111|NCT00051116|CC-5013|cc-5013
1714112|NCT00051103|Refractory|refractory
1714113|NCT00051090|Hepatitis B|hepatitis b
1714114|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
1714115|NCT00051090|HIV Infections|hiv infections
1714116|NCT00051090|Lamivudine|lamivudine
1714117|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1714118|NCT00051090|Antiviral Agents|antiviral agents
1714119|NCT00051090|Drug Therapy, Combination|drug therapy, combination
1714120|NCT00051090|Treatment Naive|treatment naive
1714121|NCT00051077|HIV Infections|hiv infections
1714122|NCT00051077|Hepatitis B|hepatitis b
1714123|NCT00051077|Hepatitis C|hepatitis c
1714124|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
1714125|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
1714126|NCT00051077|Ribavirin|ribavirin
1714127|NCT00051077|Antiviral Agents|antiviral agents
1714128|NCT00051077|Drug Resistance, Viral|drug resistance, viral
1714129|NCT00051077|Treatment Experienced|treatment experienced
1714130|NCT00050986|Brain Neoplasms|brain neoplasms
1714131|NCT00050986|CNS Diseases|cns diseases
1714132|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
1714133|NCT00050986|Temozolomide|temozolomide
1714134|NCT00050986|Temodar|temodar
1714135|NCT00050986|R115777|r115777
1714136|NCT00050986|Zarnestra|zarnestra
1714137|NCT00050973|NSCLC|nsclc
1714138|NCT00050973|Targretin|targretin
1714139|NCT00050973|Retinoid|retinoid
1714140|NCT00050973|Bexarotene|bexarotene
1714141|NCT00050960|NSCLC|nsclc
1714142|NCT00050960|Targretin|targretin
1714143|NCT00050960|Retinoid|retinoid
1714144|NCT00050960|Bexarotene|bexarotene
1714566|NCT00001886|Ultrasound|ultrasound
1714145|NCT00050947|partial seizures|partial seizures
1714146|NCT00050934|partial seizures|partial seizures
1714147|NCT00050921|HIV Infections|hiv infections
1714148|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
1714149|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1714150|NCT00050921|Growth Hormone|growth hormone
1714151|NCT00050921|Cell Division|cell division
1714152|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1714153|NCT00050921|Treatment Experienced|treatment experienced
1714154|NCT00050908|Brachial Artery|brachial artery
1714155|NCT00050908|Endothelium, Vascular|endothelium, vascular
1714156|NCT00050908|Vasodilation|vasodilation
1714157|NCT00050908|Nitroglycerin|nitroglycerin
1714158|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1714159|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
1714160|NCT00050908|Drug Therapy, Combination|drug therapy, combination
1714161|NCT00050908|Ritonavir|ritonavir
1714162|NCT00050908|efavirenz|efavirenz
1714163|NCT00050908|lopinavir|lopinavir
1714164|NCT00050908|stavudine|stavudine
1714165|NCT00050908|lamivudine|lamivudine
1714166|NCT00050908|zidovudine|zidovudine
1714167|NCT00050908|Treatment Naive|treatment naive
1714168|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1714169|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
1714170|NCT00050895|Drug Therapy, Combination|drug therapy, combination
1714171|NCT00050895|Delayed Action Preparations|delayed action preparations
1714172|NCT00050895|Treatment Naive|treatment naive
1714173|NCT00050895|HIV-1|hiv-1
1714174|NCT00050882|GM-611|gm-611
1714175|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
1714176|NCT00050882|Bloating|bloating
1714177|NCT00050882|Delayed gastric emptying|delayed gastric emptying
1714178|NCT00050882|Mitemcinal|mitemcinal
1714179|NCT00050869|Mirror Neurons|mirror neurons
1714180|NCT00050869|Performance|performance
1714181|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
1714182|NCT00050869|Attention|attention
1714183|NCT00050869|Premotor Cortex|premotor cortex
1714184|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
1714185|NCT00050856|Salvage|salvage
1714186|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
1714187|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
1714188|NCT00050856|Subcutaneous Injection|subcutaneous injection
1714189|NCT00050817|Embolism|embolism
1714190|NCT00050791|Obesity|obesity
1714191|NCT00050791|Weightloss|weightloss
1714192|NCT00050791|Leptin|leptin
1714193|NCT00050791|Diet|diet
1714194|NCT00050791|Reducing|reducing
1714195|NCT00050791|Overweight|overweight
1714196|NCT00050791|Fat|fat
1714197|NCT00050778|Multiple Sclerosis|multiple sclerosis
1714198|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
1714199|NCT00050804|Acute Stress Disorder|acute stress disorder
1714200|NCT00050804|PTSD|ptsd
1714201|NCT00050804|Treatment|treatment
1714202|NCT00050804|SSRI|ssri
1714203|NCT00050804|Startle|startle
1714204|NCT00050804|Psychophysiology|psychophysiology
1714205|NCT00050804|Trauma|trauma
1714208|NCT00050765|Myocardial Infarction|myocardial infarction
1714209|NCT00050765|Heart disease|heart disease
1714210|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
1714211|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
1714212|NCT00050765|CABG|cabg
1714213|NCT00050765|ICD|icd
1714214|NCT00050765|Heart failure|heart failure
1714215|NCT00050752|Renal Cancer|renal cancer
1714216|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
1714217|NCT00050752|Uterine Fibroid|uterine fibroid
1714218|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
1714219|NCT00050726|Interleukin-2|interleukin-2
1714220|NCT00050726|Immunotherapy|immunotherapy
1714221|NCT00050726|HIV|hiv
1714222|NCT00050726|IL-2|il-2
1714223|NCT00050713|Kidney Disease|kidney disease
1714224|NCT00050713|Glomerulonephritis|glomerulonephritis
1714225|NCT00050713|Lupus Nephritis|lupus nephritis
1714226|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
1714227|NCT00050713|Hyperlipidemia|hyperlipidemia
1714228|NCT00050700|PET|pet
1714229|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
1714230|NCT00050700|Bipolar Disorder|bipolar disorder
1714231|NCT00050700|Major Depressive Disorder|major depressive disorder
1714232|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
1714233|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
1714234|NCT00050661|psoriasis|psoriasis
1714235|NCT00050661|Cyclosporine|cyclosporine
1714236|NCT00050661|Daclizamub|daclizamub
1714237|NCT00050661|anti-TAC|anti-tac
1714238|NCT00050661|dermatology|dermatology
1714239|NCT00050661|skin|skin
1714240|NCT00050661|lesions|lesions
1714241|NCT00050648|psoriasis|psoriasis
1714242|NCT00050648|Daclizumab|daclizumab
1714243|NCT00050648|Cyclosporin|cyclosporin
1714244|NCT00050648|anti-TAC|anti-tac
1714245|NCT00050648|dermatology|dermatology
1714246|NCT00050648|skin|skin
1714247|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
1714248|NCT00050635|diarrhea|diarrhea
1714249|NCT00050635|CTID|ctid
1714250|NCT00050635|colorectal cancer|colorectal cancer
1714251|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
1714252|NCT00050635|Sandostatin|sandostatin
1714253|NCT00050635|adverse events|adverse events
1714254|NCT00050635|side effects|side effects
1714255|NCT00050427|Trabectedin|trabectedin
1714256|NCT00050427|Yondelis|yondelis
1714257|NCT00050427|ET743|et743
1714258|NCT00050427|Advanced breast cancer|advanced breast cancer
1714259|NCT00050427|Breast|breast
1714260|NCT00050427|Cancer|cancer
1714261|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
1714262|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1714263|NCT00050518|Smallpox|smallpox
1714264|NCT00050518|Aventis Pasteur|aventis pasteur
1714265|NCT00050518|Vaccine|vaccine
1714266|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
1714267|NCT00050492|Ocular|ocular
1714268|NCT00050492|Cytokine|cytokine
1714269|NCT00050492|Chemokine|chemokine
1714270|NCT00050492|Viruses|viruses
1714271|NCT00050492|Autoantibody|autoantibody
1714272|NCT00050492|Retina|retina
1714273|NCT00050492|Vasculitis|vasculitis
1714274|NCT00050492|Adhesion Molecules|adhesion molecules
1714275|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
1714276|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
1714277|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
1714278|NCT00050466|Normal Volunteers|normal volunteers
1714279|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
1714280|NCT00050466|Corneal Opacities|corneal opacities
1714281|NCT00050466|Cornea|cornea
1714282|NCT00050466|Transparency|transparency
1714283|NCT00050466|Vision|vision
1714284|NCT00050440|Endometrial|endometrial
1714285|NCT00050440|Cancer|cancer
1714286|NCT00050440|Carcinoma|carcinoma
1714287|NCT00050440|Trabectedin|trabectedin
1714288|NCT00050440|Ecteinascidin 743|ecteinascidin 743
1714289|NCT00050440|ET743|et743
1714290|NCT00050440|Antineoplastic Agents|antineoplastic agents
1714291|NCT00050440|Alkylating Agents|alkylating agents
1714292|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
1714293|NCT00050414|Ovarian cancer|ovarian cancer
1714294|NCT00050414|Ovary|ovary
1714295|NCT00050414|Cancer|cancer
1714296|NCT00050414|Trabectedin|trabectedin
1714297|NCT00050414|Yondelis|yondelis
1714298|NCT00050414|ET743|et743
1714299|NCT00050414|Ecteinascidin 743|ecteinascidin 743
1714300|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1714301|NCT00050414|Alkylating Agents|alkylating agents
1714302|NCT00050401|ventilator-associated|ventilator-associated
1714303|NCT00050401|nosocomial|nosocomial
1714304|NCT00011635|Caffeine|caffeine
1714305|NCT00011635|Cytochrome P 450|cytochrome p 450
1714306|NCT00011635|Dextromethorphan|dextromethorphan
1714307|NCT00011635|Drug Interaction|drug interaction
1714308|NCT00011635|Metabolism|metabolism
1714309|NCT00011635|Drug Metabolism|drug metabolism
1721229|NCT00006443|Phenotype|phenotype
1714310|NCT00011635|Healthy Volunteer|healthy volunteer
1714311|NCT00011635|Milk Thistle|milk thistle
1714312|NCT00011063|Anti-Epileptic|anti-epileptic
1714313|NCT00011063|CYP2C9|cyp2c9
1714314|NCT00011063|Herbal|herbal
1714315|NCT00011063|Interaction|interaction
1714316|NCT00011063|Metabolism|metabolism
1714317|NCT00011063|Drug Interaction|drug interaction
1714318|NCT00011063|Drug Metabolism|drug metabolism
1714319|NCT00011063|Ginko Biloba|ginko biloba
1714320|NCT00011063|Healthy Volunteer|healthy volunteer
1714321|NCT00009542|Caffeine|caffeine
1714322|NCT00009542|Cytochrome P 450|cytochrome p 450
1714323|NCT00009542|Dextromethorphan|dextromethorphan
1714324|NCT00009542|Herbal|herbal
1714325|NCT00009542|Interactions|interactions
1714326|NCT00009542|Alternative Therapy|alternative therapy
1714327|NCT00009542|Healthy Volunteer|healthy volunteer
1714328|NCT00009542|Kava|kava
1714329|NCT00006395|Antiepileptic|antiepileptic
1714330|NCT00006395|CYP3A4|cyp3a4
1714331|NCT00006395|Herbal|herbal
1714332|NCT00006395|Induction|induction
1714333|NCT00006395|Interaction|interaction
1714334|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
1714335|NCT00006191|Motor Cortex|motor cortex
1714336|NCT00006191|Myoclonus|myoclonus
1714337|NCT00006191|Healthy Volunteer|healthy volunteer
1714338|NCT00006155|DNA Damage|dna damage
1714339|NCT00006155|DNA Repair|dna repair
1714340|NCT00006155|FLK-1|flk-1
1714341|NCT00006155|Pharmacokinetics|pharmacokinetics
1714342|NCT00006155|VEGF|vegf
1714343|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
1714344|NCT00006155|Ovarian Cancer|ovarian cancer
1714345|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
1714346|NCT00006071|Brachial Reactivity|brachial reactivity
1714347|NCT00006071|Endothelial Function|endothelial function
1714348|NCT00006071|Endothelial Markers|endothelial markers
1714349|NCT00006071|Forearm Flow|forearm flow
1714350|NCT00006071|Insulin Resistance|insulin resistance
1714351|NCT00006071|Elevated Cholesterol|elevated cholesterol
1714352|NCT00006071|Hypertension|hypertension
1714353|NCT00006062|Liver Impairment|liver impairment
1714354|NCT00006062|Pharmacokinetics|pharmacokinetics
1714355|NCT00006062|Platinum Analogues|platinum analogues
1714360|NCT00005926|Radiotherapy|radiotherapy
1714361|NCT00005926|Pancreatic Cancer|pancreatic cancer
1714362|NCT00005912|Aspergillosis|aspergillosis
1714363|NCT00005912|Candidiasis|candidiasis
1714364|NCT00005912|Fungal Infections|fungal infections
1714365|NCT00005912|Fungemia|fungemia
1714366|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
1714367|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
1714368|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
1714369|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
1714370|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
1714371|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
1714372|NCT00005783|Sickle Cell Anemia|sickle cell anemia
1714373|NCT00005783|Sickle Cell Disease|sickle cell disease
1714374|NCT00005783|Sickle Cell Disorder|sickle cell disorder
1714375|NCT00005781|Epidemiology|epidemiology
1714376|NCT00005781|NHANES|nhanes
1714377|NCT00005781|Photography|photography
1714378|NCT00005781|Prevalence|prevalence
1714379|NCT00005781|Skin Disease|skin disease
1714380|NCT00005781|Healthy Volunteer|healthy volunteer
1714381|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
1714382|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
1714383|NCT00005574|Muscle Disease|muscle disease
1714384|NCT00005574|Myopathy|myopathy
1714385|NCT00005570|Bleeding|bleeding
1714386|NCT00005570|Cytokines|cytokines
1714387|NCT00005570|Immune Response|immune response
1714388|NCT00005570|Pharmacogenomic|pharmacogenomic
1714389|NCT00005570|Serum Antibodies|serum antibodies
1714390|NCT00005570|ITP|itp
1714391|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
1714392|NCT00005111|Blood Flow|blood flow
1714393|NCT00005111|Glucose|glucose
1714394|NCT00005111|Lysosomal Disease|lysosomal disease
1714395|NCT00005111|Metabolic|metabolic
1714396|NCT00005111|Uptake|uptake
1714397|NCT00005111|Fabry Disease|fabry disease
1714398|NCT00005016|Fetal Anomaly|fetal anomaly
1714399|NCT00005016|Genetic Counseling|genetic counseling
1714400|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
1714401|NCT00005016|Psychosocial Issues|psychosocial issues
1714402|NCT00005016|Qualitative|qualitative
1714403|NCT00005016|HPE|hpe
1714404|NCT00005016|Holoprosencephaly|holoprosencephaly
1714405|NCT00004851|HCV Antibody Library|hcv antibody library
1714406|NCT00004848|AIDS|aids
1714407|NCT00004848|Autologous Blood|autologous blood
1714408|NCT00004848|Cardiac Surgery|cardiac surgery
1714409|NCT00004848|HIV|hiv
1714410|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
1714411|NCT00004848|Liver Biopsy|liver biopsy
1714412|NCT00004848|Long Term Sera Storage|long term sera storage
1714413|NCT00004848|Non-A Hepatitis|non-a hepatitis
1714414|NCT00004848|Non-B Hepatitis|non-b hepatitis
1714415|NCT00004576|Dyskinesias|dyskinesias
1714418|NCT00004576|Parkinson's Disease|parkinson's disease
1714419|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
1714420|NCT00004574|Ataxia|ataxia
1714421|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
1714422|NCT00004574|Vitamin A|vitamin a
1714423|NCT00004574|Vitamin E|vitamin e
1714424|NCT00004557|Attention|attention
1714425|NCT00004557|Cognition|cognition
1714426|NCT00004557|Dementia|dementia
1714427|NCT00004557|Memory|memory
1714428|NCT00004557|Object Recognition|object recognition
1714429|NCT00004557|Spatial Processes|spatial processes
1714430|NCT00001986|Alcohol|alcohol
1714431|NCT00001986|Octanol|octanol
1714432|NCT00001986|Treatment|treatment
1714433|NCT00001986|Tremor|tremor
1714434|NCT00001982|Aminotransferases|aminotransferases
1714435|NCT00001982|Anti-HCV|anti-hcv
1714436|NCT00001982|Blood Donors|blood donors
1714437|NCT00001982|HCV RNA|hcv rna
1714438|NCT00001982|Hepatitis C|hepatitis c
1714439|NCT00001982|Liver Biopsy|liver biopsy
1714440|NCT00001982|Serum Aminotransferases|serum aminotransferases
1714441|NCT00001982|Transfusion|transfusion
1714442|NCT00001977|Alzheimer's Disease|alzheimer's disease
1714443|NCT00001977|Attention|attention
1714444|NCT00001977|Brain|brain
1714445|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1714446|NCT00001977|Physostigmine|physostigmine
1714447|NCT00001977|Positron Emission Tomography|positron emission tomography
1714448|NCT00001977|Working Memory|working memory
1714449|NCT00001968|AIDS|aids
1714450|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
1714451|NCT00001968|Drug Interactions|drug interactions
1714452|NCT00001968|HIV|hiv
1714453|NCT00001968|Protease Inhibitor|protease inhibitor
1714454|NCT00001966|Adjustment|adjustment
1714455|NCT00001966|Alternative|alternative
1714456|NCT00001966|Anxiety|anxiety
1714457|NCT00001966|Guided-Imagery|guided-imagery
1714458|NCT00001966|Meditation|meditation
1714459|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1714460|NCT00001965|Calcineurin|calcineurin
1714461|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
1714462|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1714463|NCT00001963|Blood Flow|blood flow
1714464|NCT00001963|Exercise|exercise
1714465|NCT00001963|Microcirculation|microcirculation
1714466|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
1722647|NCT00002305|Meningitis|meningitis
1714467|NCT00001963|Vasodilation|vasodilation
1714468|NCT00001963|Healthy Volunteer|healthy volunteer
1714469|NCT00001944|Drug Resistance|drug resistance
1714470|NCT00001944|MDR-1|mdr-1
1714471|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
1714473|NCT00001944|Resistance Reversal|resistance reversal
1714474|NCT00001940|Antifungal Agent|antifungal agent
1714475|NCT00001940|Aspergillosis|aspergillosis
1714476|NCT00001940|Candidemia|candidemia
1714477|NCT00001940|Fungemia|fungemia
1714478|NCT00001937|Aspergillosis|aspergillosis
1714479|NCT00001937|Candidiasis|candidiasis
1714480|NCT00001937|Fungal Infections|fungal infections
1714481|NCT00001937|Fungemia|fungemia
1714482|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
1714483|NCT00001931|Continuous Stimulation|continuous stimulation
1714484|NCT00001931|Dose Finding|dose finding
1714485|NCT00001931|Skin Patch|skin patch
1714486|NCT00001930|Amantadine|amantadine
1714487|NCT00001930|Chorea|chorea
1714488|NCT00001930|Glutamate Antagonist|glutamate antagonist
1714489|NCT00001929|Dyskinesias|dyskinesias
1714490|NCT00001929|Glutamate Antagonist|glutamate antagonist
1714491|NCT00001929|Levodopa|levodopa
1714492|NCT00001928|Diagnosis|diagnosis
1714493|NCT00001928|Infusion|infusion
1714494|NCT00001928|Parkinsonism|parkinsonism
1714495|NCT00001918|Cognitive Function|cognitive function
1714496|NCT00001918|Depression|depression
1714497|NCT00001918|EMG|emg
1714498|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
1714499|NCT00001918|Impurities|impurities
1714500|NCT00001918|L-5-HTP|l-5-htp
1714501|NCT00001918|Memory Impairment|memory impairment
1714502|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
1714503|NCT00001918|Sleep Disorders|sleep disorders
1714504|NCT00001916|Bone Remodeling|bone remodeling
1714505|NCT00001916|Corticosteroids|corticosteroids
1714506|NCT00001916|Cytokine|cytokine
1714507|NCT00001916|Depression|depression
1714508|NCT00001916|Glucocorticoids|glucocorticoids
1714509|NCT00001916|Osteopenia|osteopenia
1714510|NCT00001916|Osteoporosis|osteoporosis
1714511|NCT00001916|Primary Affective Disorder|primary affective disorder
1714512|NCT00001909|Allergy|allergy
1714513|NCT00001909|Immunomodulator|immunomodulator
1714514|NCT00001909|Inflammation|inflammation
1714515|NCT00001909|Interleukin|interleukin
1714516|NCT00001909|Th2|th2
1714517|NCT00001909|Asthma|asthma
1714518|NCT00001906|Alum|alum
1714519|NCT00001906|Antigen|antigen
1714520|NCT00001906|Cytokine|cytokine
1714521|NCT00001906|Parasitic Infection|parasitic infection
1714522|NCT00001906|Phase I|phase i
1714523|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
1714524|NCT00001904|Atherosclerosis|atherosclerosis
1714525|NCT00001904|Cardiovascular Disease|cardiovascular disease
1721230|NCT00006443|Cytokines|cytokines
1714526|NCT00001904|Computerized Edge Reader|computerized edge reader
1714527|NCT00001904|Myocardial Infarction|myocardial infarction
1714528|NCT00001904|Risk Factor|risk factor
1714529|NCT00001903|Immunization|immunization
1714530|NCT00001903|Immunocompromised|immunocompromised
1714531|NCT00001903|Immunoglobulin|immunoglobulin
1714532|NCT00001903|Prophylaxis|prophylaxis
1714533|NCT00001903|Respiratory Virus|respiratory virus
1714534|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
1714535|NCT00001903|Mini-Transplantation|mini-transplantation
1714536|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
1714537|NCT00001891|CABG|cabg
1714538|NCT00001891|Hibernation|hibernation
1714539|NCT00001891|LV Function|lv function
1714540|NCT00001891|Microbubbles|microbubbles
1714541|NCT00001891|Revascularization|revascularization
1714542|NCT00001891|Coronary Artery Disease|coronary artery disease
1714543|NCT00001890|Cellular Immunity|cellular immunity
1714544|NCT00001890|Cytokines|cytokines
1714545|NCT00001890|Estrogen|estrogen
1714546|NCT00001890|Humoral Immunity|humoral immunity
1714547|NCT00001890|Progesterone|progesterone
1714548|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
1714549|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
1714550|NCT00001890|Postmenopause|postmenopause
1714551|NCT00001889|Microbubbles|microbubbles
1714552|NCT00001889|Myocardial Blood Flow|myocardial blood flow
1714553|NCT00001889|Myocardial Ischemia|myocardial ischemia
1714554|NCT00001889|Second Harmonics|second harmonics
1714555|NCT00001889|Ultrasound|ultrasound
1714556|NCT00001889|Coronary Artery Disease|coronary artery disease
1714557|NCT00001887|Airway Inflammation|airway inflammation
1714558|NCT00001887|Allergen Challenge|allergen challenge
1714559|NCT00001887|Bronchoscopy|bronchoscopy
1714560|NCT00001887|Cytokines|cytokines
1714561|NCT00001887|Receptors|receptors
1714562|NCT00001887|Asthma|asthma
1714563|NCT00001887|Normal Volunteer|normal volunteer
1714564|NCT00001886|Coronary Artery Disease|coronary artery disease
1714567|NCT00001886|Ventricular Function|ventricular function
1714568|NCT00001886|Wall Motion|wall motion
1714569|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
1714570|NCT00001881|Genetics|genetics
1714571|NCT00001881|Phenotypes|phenotypes
1714572|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1714573|NCT00001879|Liver Disease|liver disease
1714574|NCT00001879|Novel Agents|novel agents
1714575|NCT00001879|Serum|serum
1714576|NCT00001879|Viruses|viruses
1714577|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
1714578|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
1714579|NCT00001871|Genetic Mutations|genetic mutations
1714580|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1714581|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
1714582|NCT00001867|Cytokine|cytokine
1714583|NCT00001867|Gestation|gestation
1714584|NCT00001867|Postpartum|postpartum
1714585|NCT00001867|Pregnancy|pregnancy
1714586|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
1714587|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
1714588|NCT00001867|Uveitis|uveitis
1714589|NCT00001857|Costimulation|costimulation
1714590|NCT00001857|Immunosuppression|immunosuppression
1714591|NCT00001857|Tolerance|tolerance
1714592|NCT00001840|Infarct|infarct
1714593|NCT00001840|Ischemia|ischemia
1714594|NCT00001840|MRI|mri
1714595|NCT00001840|Natural History|natural history
1714596|NCT00001840|Stroke|stroke
1714597|NCT00001840|Treatment|treatment
1714598|NCT00001840|Brain Stroke|brain stroke
1714599|NCT00001839|Anemia|anemia
1714600|NCT00001839|Immunosuppressive|immunosuppressive
1714601|NCT00001839|Phase II Trial|phase ii trial
1714602|NCT00001839|Pre-Leukemia|pre-leukemia
1714603|NCT00001839|Therapy|therapy
1714604|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
1714605|NCT00001816|Anger|anger
1714606|NCT00001816|Loneliness|loneliness
1714607|NCT00001816|Mood|mood
1714608|NCT00001816|Psychosocial|psychosocial
1714609|NCT00001816|Virtual Network|virtual network
1714610|NCT00001814|Hereditary|hereditary
1714611|NCT00001814|Kidney|kidney
1714612|NCT00001814|MET|met
1714613|NCT00001814|Oncocytoma|oncocytoma
1714614|NCT00001814|VHL|vhl
1714615|NCT00001812|Mucositis|mucositis
1714616|NCT00001812|Oral Candidiasis|oral candidiasis
1714617|NCT00001812|Prophylaxis|prophylaxis
1714618|NCT00001812|Stomatitis|stomatitis
1714619|NCT00001812|Swish and Swallow|swish and swallow
1714620|NCT00001810|Antifungal Agent|antifungal agent
1714621|NCT00001810|Aspergillosis|aspergillosis
1714622|NCT00001810|Candidiasis|candidiasis
1714623|NCT00001810|Fungemia|fungemia
1714624|NCT00001805|Breast Cancer|breast cancer
1714625|NCT00001805|Colon Cancer|colon cancer
1714626|NCT00001805|Gastric Cancer|gastric cancer
1714627|NCT00001805|Lung Cancer|lung cancer
1714628|NCT00001805|Pancreatic Cancer|pancreatic cancer
1714629|NCT00001797|Cytokines|cytokines
1714630|NCT00001797|Immunomodulation|immunomodulation
1714631|NCT00001797|Inflammation|inflammation
1714632|NCT00001797|Skin|skin
1714634|NCT00001790|Aspergillosis|aspergillosis
1714635|NCT00001790|Candidiasis|candidiasis
1714636|NCT00001790|Empiric Therapy|empiric therapy
1714637|NCT00001790|Fungal Infection|fungal infection
1714638|NCT00001790|Fungemia|fungemia
1714639|NCT00001789|Autoantibody|autoantibody
1714640|NCT00001789|Autoimmunity|autoimmunity
1714641|NCT00001789|Inflammation|inflammation
1714642|NCT00001789|Kidney|kidney
1714643|NCT00001789|Lymphocyte|lymphocyte
1714644|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
1714645|NCT00001789|SLE-GN|sle-gn
1714646|NCT00001782|Deafness|deafness
1714647|NCT00001782|Hemisphere Dominance|hemisphere dominance
1714648|NCT00001782|Language|language
1714649|NCT00001782|Plasticity|plasticity
1714650|NCT00001782|Speech|speech
1714651|NCT00001782|rTMS|rtms
1714652|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
1714653|NCT00001777|Serotonergic Transmission|serotonergic transmission
1714654|NCT00001774|Acetylcholine|acetylcholine
1714655|NCT00001774|Blood Flow|blood flow
1714656|NCT00001774|Blood vessel|blood vessel
1714657|NCT00001774|Resistance|resistance
1714658|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
1714659|NCT00001774|Fabry Disease|fabry disease
1714660|NCT00001774|Normal Volunteer|normal volunteer
1714661|NCT00001772|Bipolar Disorder|bipolar disorder
1714662|NCT00001772|Rapid Cycling|rapid cycling
1714663|NCT00001772|Screening|screening
1714664|NCT00001768|Autoimmunity|autoimmunity
1714665|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
1714666|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
1714667|NCT00001763|AIDS|aids
1714668|NCT00001763|Cell Mediated Immunity|cell mediated immunity
1714669|NCT00001763|Cytokine|cytokine
1714671|NCT00001763|Thl Response|thl response
1714672|NCT00001761|Autoimmunity|autoimmunity
1714673|NCT00001761|Cytokine|cytokine
1714674|NCT00001761|Inflammation|inflammation
1714675|NCT00001761|Interleukin|interleukin
1714676|NCT00001761|Vasculitis|vasculitis
1714888|NCT00001639|Gene Dosage|gene dosage
1714677|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
1714678|NCT00001759|Allergy|allergy
1714679|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
1714680|NCT00001759|Imaging|imaging
1714681|NCT00001759|PET|pet
1714682|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
1714683|NCT00001759|Asthma|asthma
1714684|NCT00001757|Azole|azole
1714685|NCT00001757|Immunocompromised|immunocompromised
1714686|NCT00001757|Mycosis|mycosis
1714687|NCT00001757|Invasive Fungal Infection|invasive fungal infection
1714688|NCT00001757|Systemic Fungal Infection|systemic fungal infection
1714689|NCT00001754|Dwarfism|dwarfism
1714690|NCT00001754|Gene Mapping|gene mapping
1714691|NCT00001754|Linkage|linkage
1714692|NCT00001754|Mutation Analysis|mutation analysis
1714693|NCT00001754|Skeletal Biology|skeletal biology
1714694|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
1714695|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
1714696|NCT00001754|Ellis Van Crevald|ellis van crevald
1714697|NCT00001754|FgFR-3|fgfr-3
1714698|NCT00001754|Proximal Symphalangism|proximal symphalangism
1714699|NCT00001754|Pyknodysotosis|pyknodysotosis
1714700|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
1714701|NCT00001754|Short Stature|short stature
1714702|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
1714703|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
1714704|NCT00001753|Exercise|exercise
1714705|NCT00001753|MRI|mri
1714706|NCT00001753|MRS|mrs
1714707|NCT00001753|Normal Volunteer|normal volunteer
1714708|NCT00001753|Tibialix Anterior|tibialix anterior
1714709|NCT00001752|Adhesion Molecules|adhesion molecules
1714710|NCT00001752|Endothelial Function|endothelial function
1714711|NCT00001752|Inflammation|inflammation
1714712|NCT00001752|Lipoproteins|lipoproteins
1714713|NCT00001752|Nitric Oxide|nitric oxide
1714714|NCT00001752|Hormone Therapy|hormone therapy
1714715|NCT00001752|Postmenopausal Women|postmenopausal women
1714716|NCT00001748|Cyclophosphamide|cyclophosphamide
1714717|NCT00001748|Donor Apheresis|donor apheresis
1714718|NCT00001748|Graft vs. Host Disease|graft vs. host disease
1714719|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
1714720|NCT00001748|Leukemic Relapse|leukemic relapse
1714721|NCT00001748|Myeloma|myeloma
1714722|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
1714723|NCT00001748|Whole Body Irradiation|whole body irradiation
1714724|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
1714725|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1714726|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
1714727|NCT00001748|Hematological Malignancies|hematological malignancies
1714728|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
1714729|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
1714730|NCT00001747|Brachial Artery|brachial artery
1714731|NCT00001747|Doppler|doppler
1714732|NCT00001747|Endothelium|endothelium
1714733|NCT00001747|Nitric Oxide|nitric oxide
1714734|NCT00001747|Nitroglycerin|nitroglycerin
1714735|NCT00001747|Normal Volunteer|normal volunteer
1714736|NCT00001742|Acetylcholine|acetylcholine
1714737|NCT00001742|Aspirin|aspirin
1714738|NCT00001742|Nitric Oxide|nitric oxide
1714739|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
1714740|NCT00001742|Hypercholesterolemia|hypercholesterolemia
1714741|NCT00001742|Hypertension|hypertension
1714742|NCT00001740|Cardiac|cardiac
1714743|NCT00001740|Function|function
1714744|NCT00001740|MRI|mri
1714745|NCT00001740|Reconstruction|reconstruction
1714746|NCT00001740|Ultrasound|ultrasound
1714747|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
1714748|NCT00001738|Intermediate Uveitis|intermediate uveitis
1714749|NCT00001738|Pars Planitis|pars planitis
1714750|NCT00001738|Retinal Vasculature|retinal vasculature
1714751|NCT00001738|Uveitis|uveitis
1714752|NCT00001738|Vascular Permeability|vascular permeability
1714753|NCT00001738|Vitreous|vitreous
1714754|NCT00001736|Corneal Crystals|corneal crystals
1714755|NCT00001736|Cysteamine|cysteamine
1714756|NCT00001736|Cystinosis|cystinosis
1714757|NCT00001736|Eye|eye
1714758|NCT00001735|Gene Therapy|gene therapy
1714759|NCT00001735|Graft|graft
1714760|NCT00001735|Ornithine|ornithine
1714761|NCT00001735|Retina|retina
1714762|NCT00001735|Retinovirus|retinovirus
1714763|NCT00001735|Retrovirus|retrovirus
1714764|NCT00001735|Skin|skin
1714765|NCT00001735|Gyrate Atrophy|gyrate atrophy
1714766|NCT00001731|Conjunctiva|conjunctiva
1714767|NCT00001731|Dry Eyes|dry eyes
1714768|NCT00001731|Inflammation|inflammation
1714769|NCT00001731|Lacrimal Gland|lacrimal gland
1714770|NCT00001731|T Lymphocyte|t lymphocyte
1714771|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
1714772|NCT00001730|Ablation|ablation
1714773|NCT00001730|Activity-Time Curves|activity-time curves
1714774|NCT00001730|Iodine Biokinetics|iodine biokinetics
1714775|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
1714776|NCT00001730|Thyroid Remnant|thyroid remnant
1714777|NCT00001718|Biofeedback|biofeedback
1714778|NCT00001718|Swallowing|swallowing
1714779|NCT00001718|Swallowing Therapy|swallowing therapy
1714780|NCT00001718|Tongue/Palate|tongue/palate
1714781|NCT00001718|Ultrasound|ultrasound
1714782|NCT00001718|Dysphagia|dysphagia
1714783|NCT00001717|Compensation|compensation
1714784|NCT00001717|Motivations|motivations
1714785|NCT00001717|Volunteers|volunteers
1714786|NCT00001717|HIV|hiv
1714787|NCT00001714|MRI|mri
1714788|NCT00001714|Macromolecules|macromolecules
1714789|NCT00001714|Magnetization Transfer|magnetization transfer
1714790|NCT00001714|Metabolites|metabolites
1714791|NCT00001714|Tissue Characterization|tissue characterization
1714792|NCT00001714|Normal Volunteer|normal volunteer
1714793|NCT00001705|Antigen|antigen
1714794|NCT00001705|Cancer|cancer
1714795|NCT00001705|Immunotherapy|immunotherapy
1714796|NCT00001699|AIDS|aids
1714797|NCT00001699|Compliance|compliance
1714798|NCT00001699|HIV|hiv
1714799|NCT00001699|Medication|medication
1714800|NCT00001699|Perceived Threat|perceived threat
1714801|NCT00001699|Teenagers|teenagers
1714802|NCT00001696|Anti-metastatic|anti-metastatic
1714803|NCT00001696|Chemoprevention|chemoprevention
1714804|NCT00001696|Isoflavinoid|isoflavinoid
1714805|NCT00001696|Prostate Cancer|prostate cancer
1714806|NCT00001696|Signal Transduction|signal transduction
1714807|NCT00001685|Cancer|cancer
1714808|NCT00001685|IL-12|il-12
1714809|NCT00001685|IL-2|il-2
1714810|NCT00001685|Immunotherapy|immunotherapy
1714811|NCT00001685|Vaccine|vaccine
1714812|NCT00001681|Cytokines|cytokines
1714813|NCT00001681|Gene Regulation|gene regulation
1714814|NCT00001681|Immunization|immunization
1714815|NCT00001681|Influenza|influenza
1714816|NCT00001681|Pathogenesis|pathogenesis
1714817|NCT00001680|Double-masked|double-masked
1714818|NCT00001680|Neuropathy|neuropathy
1714819|NCT00001680|Occlusive Dressing|occlusive dressing
1714820|NCT00001680|Pilot|pilot
1714821|NCT00001680|Placebo|placebo
1714822|NCT00001679|Immunogenetics|immunogenetics
1714823|NCT00001679|Joint Damage|joint damage
1714824|NCT00001679|Reactive Arthritis|reactive arthritis
1714825|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
1714826|NCT00001679|Synovium|synovium
1714827|NCT00001679|Synovitis|synovitis
1714828|NCT00001677|Immunosuppression|immunosuppression
1714829|NCT00001677|Lymphocytes|lymphocytes
1714830|NCT00001677|Magnetic Resonance|magnetic resonance
1714831|NCT00001677|Synovial Biopsy|synovial biopsy
1714832|NCT00001677|Synovitis|synovitis
1714833|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
1714834|NCT00001672|Brain Mapping|brain mapping
1714835|NCT00001672|Cognition|cognition
1714836|NCT00001672|Noninvasive|noninvasive
1714837|NCT00001672|Temporal Lobe|temporal lobe
1714838|NCT00001672|Visual Naming|visual naming
1714839|NCT00001669|EAE|eae
1714840|NCT00001669|EDSS|edss
1714841|NCT00001669|MRI|mri
1714842|NCT00001669|SNRS|snrs
1714843|NCT00001669|Multiple Sclerosis|multiple sclerosis
1714844|NCT00001668|Deafness|deafness
1714845|NCT00001668|Hemangioblastoma|hemangioblastoma
1714846|NCT00001668|Papillary Carcinoma|papillary carcinoma
1714847|NCT00001668|VHL Gene|vhl gene
1714848|NCT00001668|Vestibular Function|vestibular function
1714849|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
1714850|NCT00001667|Family Studies|family studies
1714851|NCT00001667|Genetic|genetic
1714852|NCT00001667|Myoclonus|myoclonus
1714853|NCT00001667|Tics|tics
1714854|NCT00001667|Tremor|tremor
1714855|NCT00001667|Movement Disorders|movement disorders
1714856|NCT00001667|Neurological Disease|neurological disease
1714857|NCT00001665|Magnetic Stimulation|magnetic stimulation
1714858|NCT00001665|Motor Skills|motor skills
1714859|NCT00001665|Parkinson's Disease|parkinson's disease
1714860|NCT00001665|rTMS|rtms
1714861|NCT00001658|Amoxicillin|amoxicillin
1714862|NCT00001658|Antibiotics|antibiotics
1714863|NCT00001658|Cytokines|cytokines
1714864|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
1714865|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
1714866|NCT00001658|Streptococcal Infection|streptococcal infection
1714867|NCT00001658|Tic Disorders|tic disorders
1714868|NCT00001657|15 O PET Scanning|15 o pet scanning
1714869|NCT00001657|Anxiety|anxiety
1714870|NCT00001657|Cerebral Blood Flow|cerebral blood flow
1714871|NCT00001657|Depression|depression
1714872|NCT00001657|Domestic Abuse|domestic abuse
1714873|NCT00001657|Neuroendocrine|neuroendocrine
1714874|NCT00001657|PET Scanning|pet scanning
1714875|NCT00001657|Police Officers|police officers
1714876|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
1714877|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1714878|NCT00001646|Aspergillus|aspergillus
1714879|NCT00001646|Azole|azole
1714880|NCT00001646|Immunocompromise|immunocompromise
1714881|NCT00001642|Chromosomal Deletion|chromosomal deletion
1714882|NCT00001642|Mutations|mutations
1714883|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
1714884|NCT00001642|Physical Map|physical map
1714885|NCT00001642|Transcript Identification|transcript identification
1714886|NCT00001642|Alagille Syndrome|alagille syndrome
1714887|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
1714889|NCT00001639|Haploinsufficiency|haploinsufficiency
1714890|NCT00001639|Karyotype|karyotype
1714891|NCT00001639|Malformations|malformations
1714892|NCT00001639|Mental Retardation|mental retardation
1714893|NCT00001633|Contrast Media|contrast media
1714894|NCT00001633|Coronary Artery Disease|coronary artery disease
1714895|NCT00001633|Coronary Vessels|coronary vessels
1722830|NCT00002272|Acyclovir|acyclovir
1714896|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
1714897|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
1714898|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
1714899|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
1714900|NCT00001629|Atherosclerosis|atherosclerosis
1714901|NCT00001629|Blood Flow|blood flow
1714902|NCT00001629|Cold Pressor Test|cold pressor test
1714903|NCT00001629|Endothelium|endothelium
1714904|NCT00001629|Exercise|exercise
1714905|NCT00001629|Coronary Artery Disease|coronary artery disease
1714906|NCT00001629|Heart Failure|heart failure
1714907|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
1714908|NCT00001628|Atherosclerosis|atherosclerosis
1714909|NCT00001628|Blood Flow|blood flow
1714910|NCT00001628|Endothelium|endothelium
1714911|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
1714913|NCT00001624|Endothelin|endothelin
1714914|NCT00001624|Insulin|insulin
1714915|NCT00001624|Plethysmography|plethysmography
1714916|NCT00001624|Vasoconstriction|vasoconstriction
1714917|NCT00001624|Healthy Volunteer|healthy volunteer
1714918|NCT00001622|Endothelium|endothelium
1714919|NCT00001622|Hypercholesterolemia|hypercholesterolemia
1714920|NCT00001622|Hypertension|hypertension
1714921|NCT00001622|Microvessels|microvessels
1714922|NCT00001622|Vasodilation|vasodilation
1714923|NCT00001622|Normal Volunteer|normal volunteer
1714924|NCT00001617|Aging|aging
1714925|NCT00001617|Cataract|cataract
1714926|NCT00001617|Eye|eye
1714927|NCT00001617|Human Lens|human lens
1714928|NCT00001617|Normal Volunteer|normal volunteer
1714929|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
1714930|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
1714931|NCT00001615|Disciform|disciform
1714932|NCT00001615|Drusen|drusen
1714933|NCT00001615|Natural History|natural history
1714934|NCT00001615|Periocular|periocular
1714935|NCT00001615|Quality of Life|quality of life
1714936|NCT00001615|Steroids|steroids
1714937|NCT00001615|Corticosteroid|corticosteroid
1714938|NCT00001614|Eye|eye
1714939|NCT00001614|Immunosuppression|immunosuppression
1714940|NCT00001614|Inflammation|inflammation
1714941|NCT00001614|Iritis|iritis
1714942|NCT00001614|Joint|joint
1714943|NCT00001614|Oral Tolerance|oral tolerance
1714944|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
1714945|NCT00001614|Uveitis|uveitis
1714946|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
1714947|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
1714948|NCT00001612|Photocoagulation|photocoagulation
1714949|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
1714950|NCT00001605|Conjugate Vaccine|conjugate vaccine
1714951|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
1714952|NCT00001605|Tetanus Toxoid|tetanus toxoid
1714953|NCT00001605|Normal Volunteers|normal volunteers
1714954|NCT00001587|Hyperthermia|hyperthermia
1714955|NCT00001587|Metastases|metastases
1714956|NCT00001587|Organ Perfusion|organ perfusion
1714957|NCT00001587|Regional Therapy|regional therapy
1714958|NCT00001584|Pathogenesis|pathogenesis
1714959|NCT00001584|Resistance|resistance
1714960|NCT00001584|Sanctuary Sites|sanctuary sites
1714961|NCT00001584|Semen|semen
1714962|NCT00001584|Sexual Transmission|sexual transmission
1714963|NCT00001579|Biochemical Modulation|biochemical modulation
1714964|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
1714965|NCT00001579|Oral Administration|oral administration
1714966|NCT00001579|Pharmacokinetics|pharmacokinetics
1714967|NCT00001577|Chemotherapy|chemotherapy
1714968|NCT00001577|Hyperthermia|hyperthermia
1714969|NCT00001577|Isolation perfusion|isolation perfusion
1714970|NCT00001577|Regional Therapy|regional therapy
1714971|NCT00001573|Glioma|glioma
1714972|NCT00001573|PDGF|pdgf
1714973|NCT00001573|Pharmacokinetics|pharmacokinetics
1714974|NCT00001573|Sarcoma|sarcoma
1714975|NCT00001573|Toxicity|toxicity
1714976|NCT00001571|Cancer|cancer
1714977|NCT00001571|DDT, PCB|ddt, pcb
1714978|NCT00001571|Epidemiology|epidemiology
1714979|NCT00001571|Pesticides|pesticides
1714980|NCT00001571|Serum|serum
1714981|NCT00001570|Cytochrome P 450|cytochrome p 450
1714982|NCT00001570|Multi-Drug Resistance|multi-drug resistance
1714983|NCT00001570|P-Glycoprotein|p-glycoprotein
1714984|NCT00001570|Pharmacokinetics|pharmacokinetics
1714985|NCT00001565|Brain Tumors|brain tumors
1714986|NCT00001565|Differentiation|differentiation
1714987|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
1714988|NCT00001565|Neuroblastoma|neuroblastoma
1714989|NCT00001565|Phenylacetate|phenylacetate
1714990|NCT00001554|Cortical Localization|cortical localization
1714991|NCT00001554|Optical Imaging|optical imaging
1714992|NCT00001554|Thermal Imaging|thermal imaging
1714993|NCT00001553|Plasticity|plasticity
1714994|NCT00001553|Recovery|recovery
1714995|NCT00001553|Stroke|stroke
1714996|NCT00001553|Use|use
1714997|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
1714998|NCT00001546|Biochemical Screening|biochemical screening
1714999|NCT00001546|Body Temperature|body temperature
1715000|NCT00001546|Consent Form|consent form
1715005|NCT00001546|Physical Examination|physical examination
1715006|NCT00001546|Psychiatric Examination|psychiatric examination
1715007|NCT00001546|Sleep Duration|sleep duration
1715008|NCT00001546|Sleep Disorders|sleep disorders
1715009|NCT00001540|Diagnostic|diagnostic
1715010|NCT00001540|Immune Function|immune function
1715011|NCT00001540|Immunization|immunization
1715012|NCT00001540|Immunodeficiency|immunodeficiency
1715013|NCT00001540|Quantitative|quantitative
1715014|NCT00001538|AIDS|aids
1715015|NCT00001538|DNA Vaccine|dna vaccine
1715016|NCT00001538|Naked DNA|naked dna
1715017|NCT00001538|Plasmid|plasmid
1715018|NCT00001538|gp 160|gp 160
1715019|NCT00001536|Disability|disability
1715020|NCT00001536|Dwarfism|dwarfism
1715021|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
1715022|NCT00001536|Quality of Life|quality of life
1715023|NCT00001536|Reproductive Issues|reproductive issues
1715024|NCT00001536|Support Groups|support groups
1715025|NCT00001536|Achondroplasia|achondroplasia
1715026|NCT00001533|Anemia|anemia
1715027|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
1715028|NCT00001533|Immunosuppression|immunosuppression
1715029|NCT00001533|Neutropenia|neutropenia
1715030|NCT00001533|T-LGL Leukemia|t-lgl leukemia
1715031|NCT00001531|Atherogenesis|atherogenesis
1715032|NCT00001531|Cell Mediated Immunity|cell mediated immunity
1715033|NCT00001531|Coronary Artery Disease|coronary artery disease
1715034|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
1715035|NCT00001530|Drug-Refractory|drug-refractory
1715036|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
1715037|NCT00001530|Obstruction|obstruction
1715038|NCT00001530|Pacemaker Therapy|pacemaker therapy
1715039|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1715040|NCT00001528|Coronary Artery Disease|coronary artery disease
1715041|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
1715042|NCT00001528|Myocardial Blood Flow|myocardial blood flow
1715043|NCT00001528|Myocardial Stunning|myocardial stunning
1715044|NCT00001528|Positron Emission Tomography|positron emission tomography
1715045|NCT00001527|BQ-123|bq-123
1715046|NCT00001527|BQ-788|bq-788
1715047|NCT00001527|Endothelin|endothelin
1715048|NCT00001527|Endothelium|endothelium
1715049|NCT00001527|Plethysmography|plethysmography
1715050|NCT00001527|Essential Hypertension|essential hypertension
1715051|NCT00001523|Cytology|cytology
1715052|NCT00001523|Diagnostic Imaging|diagnostic imaging
1715053|NCT00001523|Radiation Damage|radiation damage
1715054|NCT00001523|Saliva|saliva
1715059|NCT00001520|Endotracheal Intubation|endotracheal intubation
1715060|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
1715061|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
1715062|NCT00001520|Paralysis|paralysis
1715063|NCT00001520|Reversal Agents|reversal agents
1715064|NCT00001519|Exercise|exercise
1715065|NCT00001519|Exercise Intensity|exercise intensity
1715066|NCT00001519|Non-Linear Regression|non-linear regression
1715067|NCT00001519|Oxygen Uptake|oxygen uptake
1715068|NCT00001519|Recovery|recovery
1715069|NCT00001519|Subject Comparison|subject comparison
1715070|NCT00001519|Time Constant|time constant
1715071|NCT00001519|VO2|vo2
1715072|NCT00001518|Groshong Catheter|groshong catheter
1715073|NCT00001518|Heparinized Flush Solution|heparinized flush solution
1715074|NCT00001518|Intraluminal Clot|intraluminal clot
1715075|NCT00001518|Urokinase|urokinase
1715076|NCT00001518|Venous Access Device|venous access device
1715077|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
1715078|NCT00001509|Differentiation|differentiation
1715079|NCT00001509|N-myc Expression|n-myc expression
1715080|NCT00001509|Retinoid|retinoid
1715081|NCT00001509|Solid Tumor|solid tumor
1715082|NCT00001509|Trk Expression|trk expression
1715083|NCT00001502|Blood-Brain Barrier|blood-brain barrier
1715084|NCT00001502|Bradykinin|bradykinin
1715085|NCT00001502|Children|children
1715086|NCT00001502|Glioma|glioma
1715087|NCT00001502|Medulloblastoma|medulloblastoma
1715088|NCT00001499|Carcinoma|carcinoma
1715089|NCT00001499|Combination Chemotherapy|combination chemotherapy
1715090|NCT00001499|Combined Modality Therapy|combined modality therapy
1715091|NCT00001499|Infusion|infusion
1715092|NCT00001499|Intravenous|intravenous
1715093|NCT00001499|Lung Neoplasm|lung neoplasm
1715094|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
1715095|NCT00001498|5-Fluorouracil|5-fluorouracil
1715096|NCT00001498|Cyclophosphamide|cyclophosphamide
1715097|NCT00001498|Methotrexate|methotrexate
1715098|NCT00001498|Thiotepa|thiotepa
1715099|NCT00001497|Brain Imaging|brain imaging
1715100|NCT00001497|Encephalopathy|encephalopathy
1715101|NCT00001497|Hyperactivity|hyperactivity
1715102|NCT00001497|Neuroimmunology|neuroimmunology
1715103|NCT00001497|Reaction Time Tasks|reaction time tasks
1715104|NCT00001495|Camptothecin|camptothecin
1715105|NCT00001495|Cancer|cancer
1715106|NCT00001495|Chemotherapy|chemotherapy
1715107|NCT00001495|Natural Products|natural products
1715108|NCT00001495|Neoplasms|neoplasms
1715109|NCT00001493|Dose Intensity|dose intensity
1715110|NCT00001493|Gene Therapy|gene therapy
1715111|NCT00001493|Multidrug Resistance|multidrug resistance
1715112|NCT00001489|Cerebral Metabolism|cerebral metabolism
1715113|NCT00001489|Complex Partial Seizures|complex partial seizures
1715114|NCT00001489|Epilepsy|epilepsy
1715115|NCT00001485|Chemical Mediators|chemical mediators
1715116|NCT00001485|Circadian Rhythms|circadian rhythms
1715117|NCT00001485|Gender Differences|gender differences
1715118|NCT00001485|Melatonin|melatonin
1715119|NCT00001485|Photoperiodism|photoperiodism
1715120|NCT00001485|Seasonal Changes|seasonal changes
1715121|NCT00001482|Anticonvulsants|anticonvulsants
1715122|NCT00001482|Bipolar Disorder|bipolar disorder
1715123|NCT00001482|Depression|depression
1715124|NCT00001482|Gabapentin|gabapentin
1715125|NCT00001482|Lamotrigine|lamotrigine
1715126|NCT00001482|Mania|mania
1715127|NCT00001482|Mood Disorders|mood disorders
1715128|NCT00001479|ACTH|acth
1715129|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
1715130|NCT00001479|Antidepressant Treatment|antidepressant treatment
1715131|NCT00001479|Chaos Theory|chaos theory
1715132|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
1715133|NCT00001479|Major Depression|major depression
1715134|NCT00001479|Normal Volunteer|normal volunteer
1715135|NCT00001479|Primary Affective Disorder|primary affective disorder
1715136|NCT00001478|Bupropion|bupropion
1715137|NCT00001478|Carbamazepine|carbamazepine
1715138|NCT00001478|Cerebral Blood Flow|cerebral blood flow
1715139|NCT00001478|Gabapentin|gabapentin
1715140|NCT00001478|Lamotrigine|lamotrigine
1715141|NCT00001478|Mood Disorders|mood disorders
1715142|NCT00001478|Nimodipine|nimodipine
1715143|NCT00001478|Oxygen-15|oxygen-15
1715144|NCT00001478|Positron Emission Tomography|positron emission tomography
1715145|NCT00001478|Venlafaxine|venlafaxine
1715146|NCT00001477|Communicable Infection|communicable infection
1715147|NCT00001477|Monitoring|monitoring
1715148|NCT00001477|Non-Invasive Tests|non-invasive tests
1715149|NCT00001477|Opportunistic Infection|opportunistic infection
1715150|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
1715151|NCT00001468|Breast Cancer|breast cancer
1715152|NCT00001468|High Risk Families|high risk families
1715153|NCT00001468|Inherited Susceptibility|inherited susceptibility
1715154|NCT00001468|Psychological Responses to Risk|psychological responses to risk
1715155|NCT00001466|Clinical Genetics|clinical genetics
1715156|NCT00001466|Etiology|etiology
1715157|NCT00001466|Medical Screening|medical screening
1715158|NCT00001466|Prognosis|prognosis
1715159|NCT00001466|Genetic Disorders|genetic disorders
1715160|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
1715162|NCT00001462|Genetic Diseases|genetic diseases
1715163|NCT00001462|Inflammation|inflammation
1715164|NCT00001462|Nitric Oxide|nitric oxide
1715165|NCT00001462|Protease|protease
1715166|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
1715167|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
1715168|NCT00001461|Bradykinin|bradykinin
1715169|NCT00001461|Endothelial Function|endothelial function
1715170|NCT00001461|Nitric Oxide|nitric oxide
1715171|NCT00001461|Coronary Artery Disease|coronary artery disease
1715172|NCT00001459|Gated Blood Pool|gated blood pool
1715173|NCT00001459|SPECT Scan|spect scan
1715174|NCT00001459|Coronary Artery Disease|coronary artery disease
1715175|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1715176|NCT00001459|Microvascular Angina|microvascular angina
1715177|NCT00001455|Genetics|genetics
1715178|NCT00001455|Hemochromatosis|hemochromatosis
1715179|NCT00001455|Iron Metabolism|iron metabolism
1715180|NCT00001455|Iron Storage Disorder|iron storage disorder
1715181|NCT00001455|Pedigree|pedigree
1715182|NCT00001455|Iron Overload|iron overload
1715183|NCT00001450|Chemotherapy|chemotherapy
1715184|NCT00001450|In Vitro Testing|in vitro testing
1715185|NCT00001450|Infusional|infusional
1715186|NCT00001450|Lung Neoplasm|lung neoplasm
1715187|NCT00001450|Pharmacokinetics|pharmacokinetics
1715188|NCT00001449|Anti-Cancer Agents|anti-cancer agents
1715189|NCT00001449|Antimetabolite|antimetabolite
1715190|NCT00001449|Palliation|palliation
1715191|NCT00001449|Pharmacodynamics|pharmacodynamics
1715192|NCT00001449|Pharmacokinetics|pharmacokinetics
1715193|NCT00001448|Antifungal Therapy|antifungal therapy
1715194|NCT00001448|Articulation|articulation
1715195|NCT00001448|Behavior|behavior
1715196|NCT00001448|Expressive Language|expressive language
1715197|NCT00001448|Thrush|thrush
1715198|NCT00001446|Angiogenesis|angiogenesis
1715199|NCT00001446|Malignancy|malignancy
1715200|NCT00001446|Neuropathy|neuropathy
1715201|NCT00001446|Pharmacokinetics|pharmacokinetics
1715203|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
1715204|NCT00001445|Double Blind Randomization|double blind randomization
1715205|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
1715206|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
1715208|NCT00001443|Bioavailability|bioavailability
1715209|NCT00001443|Immunologic Evaluations|immunologic evaluations
1715210|NCT00001443|Pharmacokinetics|pharmacokinetics
1715211|NCT00001443|Toxicity|toxicity
1715212|NCT00001439|Cancer|cancer
1715213|NCT00001439|Immunotherapy|immunotherapy
1715214|NCT00001438|HIV Infection|hiv infection
1715215|NCT00001438|Immune Response|immune response
1715216|NCT00001438|Pediatric|pediatric
1715217|NCT00001438|Pharmacokinetics|pharmacokinetics
1715218|NCT00001438|Toxicity|toxicity
1715219|NCT00001437|Cytokines|cytokines
1715220|NCT00001437|Fibrosis Intensity|fibrosis intensity
1715221|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
1715222|NCT00001437|Radiation Injury|radiation injury
1715223|NCT00001437|Trental|trental
1715224|NCT00001436|Hormone Interactions|hormone interactions
1715225|NCT00001436|IGF-I|igf-i
1715226|NCT00001436|Metastatic|metastatic
1715227|NCT00001436|Pediatric|pediatric
1715228|NCT00001436|Recurrent|recurrent
1715229|NCT00001435|Anxiety|anxiety
1715230|NCT00001435|Depression|depression
1715231|NCT00001435|Family Functioning|family functioning
1715232|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
1715233|NCT00001435|Social Support|social support
1715234|NCT00001431|Combined Modality|combined modality
1715235|NCT00001431|GI Cancer|gi cancer
1715236|NCT00001431|Pancreatic Cancer|pancreatic cancer
1715237|NCT00001431|Radiotherapy|radiotherapy
1715238|NCT00001428|Chemotherapy|chemotherapy
1715239|NCT00001428|Cytokine|cytokine
1715240|NCT00001428|Efficacy|efficacy
1715241|NCT00001428|Palliation|palliation
1715242|NCT00001428|Solid Tumor|solid tumor
1715243|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
1715244|NCT00001427|Pharmacokinetics|pharmacokinetics
1715245|NCT00001424|AIDS|aids
1715246|NCT00001424|Children|children
1715247|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
1715248|NCT00001422|Adenine Analogue|adenine analogue
1715249|NCT00001422|Apoptosis|apoptosis
1715250|NCT00001422|Cytokines|cytokines
1715251|NCT00001422|Psoriasis|psoriasis
1715252|NCT00001422|Synovium|synovium
1715253|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
1715254|NCT00001421|Cytotoxicity|cytotoxicity
1715255|NCT00001421|HLA Class I|hla class i
1715256|NCT00001421|Lymphocytes|lymphocytes
1715257|NCT00001421|Muscle|muscle
1715258|NCT00001421|Myositis|myositis
1715259|NCT00001421|Thionamides|thionamides
1715260|NCT00001421|Dermatomyositis|dermatomyositis
1715261|NCT00001421|Polymyositis|polymyositis
1715262|NCT00001416|Bone Disease|bone disease
1715263|NCT00001416|Calcitriol|calcitriol
1715264|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
1715265|NCT00001416|Gaucher's Disease|gaucher's disease
1715266|NCT00001416|Vitamin D|vitamin d
1715269|NCT00001415|Immune Response|immune response
1715270|NCT00001415|Inflammation|inflammation
1715271|NCT00001415|Steroids|steroids
1715272|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
1715273|NCT00001415|Depression|depression
1715274|NCT00001415|Fibromyalgia|fibromyalgia
1715275|NCT00001415|Normal Volunteer|normal volunteer
1715276|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
1715277|NCT00001402|Hibernating Myocardium|hibernating myocardium
1715278|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
1715279|NCT00001402|Metoprolol|metoprolol
1715280|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
1715281|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
1715282|NCT00001402|Congestive Heart Failure|congestive heart failure
1715283|NCT00001402|Heart Failure|heart failure
1715284|NCT00001395|Cataracts|cataracts
1715285|NCT00001395|Complications|complications
1715286|NCT00001395|Rates of Progression|rates of progression
1715287|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
1715288|NCT00001387|Paclitaxel|paclitaxel
1715289|NCT00001387|Pediatric|pediatric
1715290|NCT00001387|Pharmacokinetics|pharmacokinetics
1715291|NCT00001387|Phase I|phase i
1715292|NCT00001387|Toxicity|toxicity
1715293|NCT00001385|Cancer Diagnosis|cancer diagnosis
1715294|NCT00001385|Cancer Metabolism|cancer metabolism
1715295|NCT00001385|FDG|fdg
1715296|NCT00001385|FDG Breast Imaging|fdg breast imaging
1715297|NCT00001385|PET|pet
1715298|NCT00001385|Positron Emission Mammography|positron emission mammography
1715299|NCT00001385|Radiopharmaceutical|radiopharmaceutical
1715300|NCT00001385|Scintimammography|scintimammography
1715301|NCT00001384|14-Day Cycle|14-day cycle
1715302|NCT00001384|Dose Intensity|dose intensity
1715303|NCT00001384|Filgrastim|filgrastim
1715304|NCT00001384|Lymph Node Positive|lymph node positive
1715305|NCT00001384|Non-Cross Resistant|non-cross resistant
1715306|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
1715307|NCT00001383|Multidrug Resistance|multidrug resistance
1715308|NCT00001383|Pgp Blocker|pgp blocker
1715309|NCT00001383|Pump Blocker|pump blocker
1715310|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
1715311|NCT00001382|Immunotherapy|immunotherapy
1715312|NCT00001382|Vaccine|vaccine
1715313|NCT00001381|Adult|adult
1715314|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
1715315|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
1715316|NCT00001378|Biomarkers|biomarkers
1715317|NCT00001378|Chemoprevention|chemoprevention
1715318|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
1715319|NCT00001378|TGF Beta|tgf beta
1715320|NCT00001377|Familial|familial
1715321|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
1715323|NCT00001377|Prostate Cancer|prostate cancer
1715324|NCT00001376|Androgens|androgens
1715325|NCT00001376|Female|female
1715326|NCT00001376|Immunology|immunology
1715327|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
1715328|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
1715329|NCT00001376|Postpartum|postpartum
1715330|NCT00001376|Pregnancy|pregnancy
1715331|NCT00001375|Infection|infection
1715332|NCT00001375|Reactive Arthritis|reactive arthritis
1715333|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
1715334|NCT00001375|Synovial Biopsy|synovial biopsy
1715335|NCT00001375|Synovial Fluid|synovial fluid
1715336|NCT00001375|Synovitis|synovitis
1715337|NCT00001371|Inflammation|inflammation
1715338|NCT00001371|Lipocortin|lipocortin
1715339|NCT00001371|Phospholipase A-2|phospholipase a-2
1715340|NCT00001371|Skin|skin
1715341|NCT00001371|Uteroglobin|uteroglobin
1715342|NCT00001371|Psoriasis|psoriasis
1715343|NCT00001365|Dextromethorphan|dextromethorphan
1715344|NCT00001365|Dextrorphan|dextrorphan
1715345|NCT00001365|Glutamate Antagonist|glutamate antagonist
1715346|NCT00001365|Parkinson's Disease|parkinson's disease
1715347|NCT00001363|Blood Flow|blood flow
1715348|NCT00001363|Chess Play|chess play
1715349|NCT00001363|Frontal Lobe|frontal lobe
1715350|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
1715351|NCT00001363|Neuropsychology|neuropsychology
1715352|NCT00001363|Positron Emission Tomography|positron emission tomography
1715353|NCT00001363|Prefrontal Cortex|prefrontal cortex
1715354|NCT00001346|Diabetic Macular Edema|diabetic macular edema
1715355|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
1715356|NCT00001346|Macular Edema|macular edema
1715357|NCT00001346|Photocoagulation|photocoagulation
1715358|NCT00001346|Psychophysical Testing|psychophysical testing
1715359|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
1715360|NCT00001344|Diabetes Mellitus|diabetes mellitus
1715361|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
1715362|NCT00001344|Memantine|memantine
1715363|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
1715364|NCT00001344|Neuropathic Pain|neuropathic pain
1715365|NCT00001344|Neuropathy|neuropathy
1715366|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
1715367|NCT00001344|Shingles|shingles
1715368|NCT00001342|Electrooculography|electrooculography
1715369|NCT00001342|Electroretinogram|electroretinogram
1715370|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
1715371|NCT00001342|Glycogen Storage Disease|glycogen storage disease
1715372|NCT00001341|Antifolate|antifolate
1715373|NCT00001341|Inhibitor|inhibitor
1715374|NCT00001341|Pharmacokinetics|pharmacokinetics
1715375|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
1715376|NCT00001341|Toxicity|toxicity
1715377|NCT00001338|Fusion Protein|fusion protein
1715378|NCT00001333|Intraventricular|intraventricular
1715379|NCT00001333|Meningeal Malignancy|meningeal malignancy
1715380|NCT00001333|NSC 609699|nsc 609699
1715381|NCT00001333|SKF 104864|skf 104864
1715382|NCT00001333|Topoisomerase 1|topoisomerase 1
1715383|NCT00001332|Cancer Treatment|cancer treatment
1715384|NCT00001332|Chemotherapy|chemotherapy
1715385|NCT00001332|Regional Therapy|regional therapy
1715386|NCT00001332|Surgery|surgery
1715387|NCT00001330|Autoimmune Diseases|autoimmune diseases
1715388|NCT00001330|Connective Tissue Disease|connective tissue disease
1715389|NCT00001330|Scleroderma|scleroderma
1715390|NCT00001330|Silicone Device Implants|silicone device implants
1715391|NCT00001330|Silicone Injection|silicone injection
1715392|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
1715393|NCT00001330|Myositis|myositis
1715394|NCT00001330|Systemic Sclerosis|systemic sclerosis
1715395|NCT00001324|Ataxia|ataxia
1715396|NCT00001324|Brain|brain
1715397|NCT00001324|Motor Learning|motor learning
1715398|NCT00001324|Parkinson's Disease|parkinson's disease
1715399|NCT00001324|Physiology|physiology
1715400|NCT00001324|Positron Emission Tomography|positron emission tomography
1715401|NCT00001324|Stroke|stroke
1715402|NCT00001324|Tremor|tremor
1715403|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
1715404|NCT00001324|Movement Disorders|movement disorders
1715405|NCT00001324|Normal Volunteer|normal volunteer
1715406|NCT00001318|Immune Adjuvant|immune adjuvant
1715407|NCT00001318|Phagocytes|phagocytes
1715408|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
1715409|NCT00001317|Children|children
1715410|NCT00001317|Gamma Interferon|gamma interferon
1715411|NCT00001317|Hospitalizations|hospitalizations
1715412|NCT00001317|Infection|infection
1715413|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
1715414|NCT00001314|Aortic Regurgitation|aortic regurgitation
1715415|NCT00001314|Dobutamine Stress|dobutamine stress
1715416|NCT00001314|Left Ventricular Function|left ventricular function
1715417|NCT00001314|Mitral Regurgitation|mitral regurgitation
1715418|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
1715419|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
1715420|NCT00001311|Cell/Flare Meter|cell/flare meter
1715421|NCT00001311|Heparin Coating|heparin coating
1715422|NCT00001311|Inflammation|inflammation
1715423|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
1715424|NCT00001311|Multicentric|multicentric
1715425|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
1715426|NCT00001311|Specular Micrography|specular micrography
1715427|NCT00001311|Specular Microscopy|specular microscopy
1715428|NCT00001301|Adverse Effects|adverse effects
1715429|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
1715430|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
1715431|NCT00001301|Extended Remission|extended remission
1715432|NCT00001301|Health Status|health status
1715433|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
1715434|NCT00001301|Molecular Studies|molecular studies
1715435|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
1715436|NCT00001300|Ifosfamide|ifosfamide
1715437|NCT00001300|Randomized Study|randomized study
1715438|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
1715439|NCT00001298|Antibody|antibody
1715441|NCT00001298|Enzyme|enzyme
1715442|NCT00001298|Kidney|kidney
1715443|NCT00001298|Pharmacokinetics|pharmacokinetics
1715444|NCT00001298|Thymidine|thymidine
1715445|NCT00001298|Toxicity|toxicity
1715446|NCT00001296|Interferon-Gamma|interferon-gamma
1715447|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
1715448|NCT00001296|Melanoma|melanoma
1715449|NCT00001296|Melphalan|melphalan
1715450|NCT00001296|TNF|tnf
1715451|NCT00001292|DNA Markers|dna markers
1715452|NCT00001292|Family Studies|family studies
1715453|NCT00001292|Gene Mapping|gene mapping
1715454|NCT00001292|Ichthyosis|ichthyosis
1715455|NCT00001292|Keratin|keratin
1715456|NCT00001292|Linkage Analysis|linkage analysis
1715457|NCT00001292|Scaling Disorders|scaling disorders
1715458|NCT00001292|Skin|skin
1715459|NCT00001291|Osteoarthritis|osteoarthritis
1715460|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
1715461|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
1715462|NCT00001291|Synovial Biopsy|synovial biopsy
1715463|NCT00001291|Synovitis|synovitis
1715464|NCT00001291|Synovium|synovium
1715465|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
1715466|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
1715467|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
1715468|NCT00001287|CIDP|cidp
1715469|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
1721231|NCT00006443|Nelfinavir|nelfinavir
1715470|NCT00001285|Circadian Rhythms|circadian rhythms
1715471|NCT00001285|Environmental Light|environmental light
1715472|NCT00001285|Estrogen|estrogen
1715473|NCT00001285|Melatonin|melatonin
1715474|NCT00001285|Progesterone|progesterone
1715475|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
1715476|NCT00001285|Sleep|sleep
1715477|NCT00001285|Testosterone|testosterone
1715478|NCT00001285|Depression|depression
1715479|NCT00001285|Hypomania|hypomania
1715480|NCT00001285|Mania|mania
1715481|NCT00001280|Aspergillosis|aspergillosis
1715482|NCT00001280|Phagocyte Defect|phagocyte defect
1715483|NCT00001280|Torulopsis|torulopsis
1715484|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
1715485|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
1715486|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
1715487|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
1715488|NCT00001278|Sarcoidosis|sarcoidosis
1715489|NCT00001278|Conjunctiva|conjunctiva
1715490|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
1715491|NCT00001272|Adult|adult
1715492|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
1715493|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
1715494|NCT00001271|Antigen Modulation|antigen modulation
1715495|NCT00001271|Pharmacokinetics|pharmacokinetics
1715496|NCT00001271|Ricin A Chain|ricin a chain
1715497|NCT00001270|Chemotherapy|chemotherapy
1715498|NCT00001270|High Dose|high dose
1715499|NCT00001270|Protection|protection
1715500|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
1715501|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
1715502|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
1715503|NCT00001267|Anti-Viral|anti-viral
1715504|NCT00001267|Dideoxynucleosides|dideoxynucleosides
1715505|NCT00001267|HIV|hiv
1715506|NCT00001267|Retrovirus|retrovirus
1715507|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
1715508|NCT00001239|5-Fluorouracil|5-fluorouracil
1715509|NCT00001239|Adriamycin|adriamycin
1715510|NCT00001239|Breast Carcinoma|breast carcinoma
1715511|NCT00001239|Leucovorin|leucovorin
1715512|NCT00001239|Phase II|phase ii
1715513|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
1715514|NCT00001237|GM-CSF|gm-csf
1715515|NCT00001237|High-Grade|high-grade
1715516|NCT00001233|Adolescence|adolescence
1715517|NCT00001233|Aggressivity|aggressivity
1715518|NCT00001233|Anger|anger
1715519|NCT00001233|Developmental Psychopathology|developmental psychopathology
1715520|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
1715521|NCT00001233|Early Onset Aggression|early onset aggression
1715522|NCT00001233|Emotion Regulation|emotion regulation
1715523|NCT00001233|Family Violence|family violence
1715524|NCT00001233|Preschool Conduct Problems|preschool conduct problems
1715530|NCT00001232|Menstrual Cycle|menstrual cycle
1715531|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
1715532|NCT00001229|Clonidine|clonidine
1715533|NCT00001229|Glucagon|glucagon
1715534|NCT00001229|Pheochromocytoma|pheochromocytoma
1715535|NCT00001218|Baseline Data|baseline data
1715536|NCT00001218|Curve Averaging|curve averaging
1715537|NCT00001218|Curve Fitting|curve fitting
1715538|NCT00001218|Movement Patterns|movement patterns
1715539|NCT00001218|Normative Data|normative data
1715540|NCT00001218|Polar Distribution|polar distribution
1715541|NCT00001218|Tongue|tongue
1715542|NCT00001218|Tongue Shape|tongue shape
1715543|NCT00001218|Ultrasound|ultrasound
1715544|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
1715545|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
1715546|NCT00001216|Amputations|amputations
1715547|NCT00001216|Brainstem Stimulation|brainstem stimulation
1715548|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
1715549|NCT00001216|Cortical Motor Physiology|cortical motor physiology
1715550|NCT00001216|Electrical Stimulation|electrical stimulation
1715551|NCT00001216|Motor Cortex|motor cortex
1715552|NCT00001216|Plasticity|plasticity
1715553|NCT00001216|Spinal Cord Injury|spinal cord injury
1715554|NCT00001216|Stroke|stroke
1715555|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
1715556|NCT00001211|Edentulous|edentulous
1715557|NCT00001211|Endosseous|endosseous
1715558|NCT00001211|Implants|implants
1715559|NCT00001211|Mandibular Atrophy|mandibular atrophy
1715560|NCT00001211|Oral|oral
1715561|NCT00001211|Titanium|titanium
1715562|NCT00001210|Blood Donors|blood donors
1715563|NCT00001210|Epitopes|epitopes
1715564|NCT00001210|HIV|hiv
1715565|NCT00001209|Combined Chemotherapy|combined chemotherapy
1715566|NCT00001209|Irradiation|irradiation
1715567|NCT00001209|Unresectable|unresectable
1715568|NCT00001194|Helium Cryogen|helium cryogen
1715569|NCT00001194|Magnetic Field|magnetic field
1715570|NCT00001194|Multi-Institute|multi-institute
1715571|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
1715572|NCT00001194|Radiofrequency|radiofrequency
1715573|NCT00001193|Autologous|autologous
1715574|NCT00001193|Melphalan|melphalan
1715576|NCT00001193|Transplantation|transplantation
1715577|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
1715578|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
1715579|NCT00001189|Radiotherapy|radiotherapy
1715580|NCT00001189|Randomized Study|randomized study
1715581|NCT00001189|Sarcoma|sarcoma
1715582|NCT00001189|Surgery|surgery
1715583|NCT00001188|Chemotherapy|chemotherapy
1715584|NCT00001188|Radiation Therapy|radiation therapy
1715585|NCT00001188|Sarcoma|sarcoma
1715586|NCT00001188|Surgery|surgery
1715587|NCT00001173|B Cells|b cells
1715588|NCT00001173|Humoral Immunity|humoral immunity
1715589|NCT00001173|Lymphocytes|lymphocytes
1715590|NCT00001173|Tetanus Toxoid|tetanus toxoid
1715591|NCT00001169|Chemotherapy|chemotherapy
1715592|NCT00001169|Cytokines|cytokines
1715593|NCT00001169|Immunology|immunology
1715594|NCT00001169|Kala-Azar|kala-azar
1715595|NCT00001169|Leishmaniasis|leishmaniasis
1715596|NCT00001164|Genetic Evaluation|genetic evaluation
1715597|NCT00001164|Immunologic Evaluations|immunologic evaluations
1715598|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
1715599|NCT00001164|Muscular Dystrophies|muscular dystrophies
1715600|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
1715601|NCT00001164|Neuronal Degenerations|neuronal degenerations
1715602|NCT00001164|Retinal Degenerations|retinal degenerations
1715603|NCT00001164|Viral Diseases|viral diseases
1715604|NCT00001158|Cellular Immunity|cellular immunity
1715605|NCT00001158|Humoral Immunity|humoral immunity
1715606|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
1715607|NCT00001153|Albinism|albinism
1715608|NCT00001153|Ocular Albinism|ocular albinism
1715609|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
1715610|NCT00001153|Tyrosinase Negative|tyrosinase negative
1715611|NCT00001153|Tyrosinase Positive|tyrosinase positive
1715612|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
1715613|NCT00001152|Glaucoma|glaucoma
1715614|NCT00001152|Ocular Hypertension|ocular hypertension
1715615|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
1715616|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
1715617|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
1715618|NCT00001142|Body Fat|body fat
1715620|NCT00001142|HAART|haart
1715621|NCT00001142|Hyperlipidemia|hyperlipidemia
1715622|NCT00001142|Insulin Resistance|insulin resistance
1715623|NCT00001142|Lipodystrophy|lipodystrophy
1715624|NCT00001142|MRI|mri
1715625|NCT00001142|Protease Inhibitor|protease inhibitor
1715626|NCT00001142|Side-Effects|side-effects
1715627|NCT00001142|Visceral Fat|visceral fat
1715628|NCT00001142|Chronic Infection|chronic infection
1715629|NCT00001142|HIV|hiv
1715630|NCT00001142|Healthy Volunteer|healthy volunteer
1715631|NCT00050388|Cancer|cancer
1715632|NCT00050388|Carcinoma|carcinoma
1715633|NCT00050388|Neoplasm|neoplasm
1715634|NCT00050388|Head cancer|head cancer
1715635|NCT00050388|Neck cancer|neck cancer
1715636|NCT00050388|Tongue cancer|tongue cancer
1715642|NCT00050388|Squamous Cell|squamous cell
1715643|NCT00050388|Salivary Glands|salivary glands
1715644|NCT00050388|Tumor|tumor
1715645|NCT00050388|Lesion|lesion
1715646|NCT00050388|Cancer treatment|cancer treatment
1715647|NCT00050388|Clinical trial|clinical trial
1715648|NCT00050388|Allovectin-7®|allovectin-7®
1715649|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
1715650|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
1715651|NCT00050388|Gene therapy|gene therapy
1715652|NCT00050388|Immunotherapy|immunotherapy
1715653|NCT00050388|Cancer research|cancer research
1715654|NCT00050388|Cancer vaccine|cancer vaccine
1715655|NCT00050388|Cancer cells|cancer cells
1715656|NCT00050375|OvaRex|ovarex
1715657|NCT00050375|ovarian|ovarian
1715658|NCT00050375|CA125|ca125
1715659|NCT00050375|murine|murine
1715660|NCT00050375|antibody|antibody
1715661|NCT00050375|immunotherapy|immunotherapy
1715662|NCT00050362|Pain|pain
1715663|NCT00050362|NSAID|nsaid
1715664|NCT00050362|Oral Surgery|oral surgery
1715665|NCT00050362|Hyperalgesia|hyperalgesia
1715666|NCT00050362|Preemptive Analgesia|preemptive analgesia
1715667|NCT00050349|cancer|cancer
1715668|NCT00050349|tumor|tumor
1715669|NCT00050349|tumour|tumour
1715670|NCT00050349|neoplasm|neoplasm
1715671|NCT00050349|carcinoma|carcinoma
1715672|NCT00050349|carcinoid|carcinoid
1715673|NCT00050349|neuroendocrine|neuroendocrine
1715674|NCT00050349|Islet cell|islet cell
1715675|NCT00050349|Gastrinoma|gastrinoma
1715676|NCT00050349|VIPoma|vipoma
1715677|NCT00050349|metastatic|metastatic
1715678|NCT00050349|intravenous|intravenous
1715679|NCT00050349|epothilone|epothilone
1715680|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
1715681|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
1715682|NCT00050323|Kidney Cancer|kidney cancer
1715683|NCT00050323|Cancer (General)|cancer (general)
1715684|NCT00050310|Confirmed|confirmed
1715685|NCT00050310|Suspected|suspected
1715686|NCT00050310|Pathogenesis|pathogenesis
1715687|NCT00050310|Bronchoscopy|bronchoscopy
1715688|NCT00050310|Cultures|cultures
1715689|NCT00050310|Anthrax|anthrax
1715690|NCT00050310|Natural History|natural history
1715691|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
1715692|NCT00050284|Treatment Experienced|treatment experienced
1715693|NCT00050284|Disease Progression|disease progression
1715694|NCT00050284|Anti-HIV Agents|anti-hiv agents
1715695|NCT00050284|Treatment Interruption|treatment interruption
1715696|NCT00050271|Acetylcarnitine|acetylcarnitine
1715697|NCT00050271|Dideoxynucleosides|dideoxynucleosides
1715698|NCT00050271|Epidermis|epidermis
1715699|NCT00050271|Biopsy|biopsy
1715700|NCT00050271|Immunohistochemistry|immunohistochemistry
1715701|NCT00050271|Nerve Fibers|nerve fibers
1715702|NCT00050271|Treatment Experienced|treatment experienced
1715703|NCT00050245|Neuropathy|neuropathy
1715704|NCT00050245|B Cells|b cells
1715705|NCT00050245|Anti-MAG|anti-mag
1715706|NCT00050245|Demyelination|demyelination
1715707|NCT00050245|MAG|mag
1715708|NCT00050245|RITUXAN|rituxan
1715709|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
1715710|NCT00050245|Retuximab|retuximab
1715711|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
1715712|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
1715713|NCT00050232|Uncontrolled|uncontrolled
1715714|NCT00050232|Laughing|laughing
1715715|NCT00050232|Crying|crying
1715716|NCT00050219|Raclopride|raclopride
1715717|NCT00050219|D2 Receptors|d2 receptors
1715718|NCT00050219|Striatum|striatum
1715719|NCT00050219|Low-Response|low-response
1715720|NCT00050219|Alcoholism|alcoholism
1715721|NCT00050219|Alcohol|alcohol
1715722|NCT00050219|Dopamine|dopamine
1715723|NCT00050219|Response|response
1715724|NCT00050141|Breast cancer|breast cancer
1715725|NCT00050141|ZARNESTRA|zarnestra
1715726|NCT00050141|tipifarnib|tipifarnib
1715728|NCT00050141|Estrogen receptor positive|estrogen receptor positive
1715729|NCT00050141|Progesterone receptor positive|progesterone receptor positive
1715730|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
1715731|NCT00050167|Breast Cancer|breast cancer
1715732|NCT00050167|Capecitabine|capecitabine
1715733|NCT00050167|Docetaxel|docetaxel
1715734|NCT00050167|Paclitaxel|paclitaxel
1715735|NCT00050167|Taxotere|taxotere
1715736|NCT00050167|Taxol|taxol
1715737|NCT00050167|Xeloda|xeloda
1715738|NCT00050167|Taxanes|taxanes
1715739|NCT00050167|Operable Breast Cancer|operable breast cancer
1715740|NCT00050193|Children|children
1715741|NCT00050193|Mast Cells|mast cells
1715742|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
1715743|NCT00050193|Bone Marrow|bone marrow
1715744|NCT00050193|Severe|severe
1715745|NCT00050193|Mastocytosis|mastocytosis
1715746|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
1715747|NCT00050180|P-Glycoprotein|p-glycoprotein
1715748|NCT00050180|Protease Inhibitor|protease inhibitor
1715749|NCT00050180|Antiretrovirals|antiretrovirals
1715750|NCT00050180|Cytochrome P450|cytochrome p450
1715751|NCT00050180|Drug Transporters|drug transporters
1715752|NCT00050180|Healthy Volunteer|healthy volunteer
1715753|NCT00050180|HV|hv
1715754|NCT00050154|R115777|r115777
1715755|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
1715756|NCT00050154|Tipifarnib|tipifarnib
1715757|NCT00050154|Zarnestra|zarnestra
1715758|NCT00050128|Rehabilitation|rehabilitation
1715759|NCT00050128|Plasticity|plasticity
1715760|NCT00050128|Frequency|frequency
1715761|NCT00050128|Inhibition|inhibition
1715762|NCT00050128|Pinch|pinch
1715763|NCT00050128|Stroke|stroke
1715764|NCT00050089|AIDS|aids
1715765|NCT00050089|antiretrovirals|antiretrovirals
1715766|NCT00050089|ART|art
1715767|NCT00050089|drug-free period|drug-free period
1715768|NCT00050089|HAART|haart
1715769|NCT00050089|HIV|hiv
1715770|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
1715771|NCT00050089|randomized|randomized
1715772|NCT00050089|structured treatment interruptions|structured treatment interruptions
1715773|NCT00050076|Congestive Heart Failure|congestive heart failure
1715774|NCT00050076|Cardiac Failure|cardiac failure
1715775|NCT00050076|Heart Decompensation|heart decompensation
1715776|NCT00050076|Drug Therapy|drug therapy
1715777|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1715778|NCT00050063|Treatment Experienced|treatment experienced
1715779|NCT00050063|AIDS Vaccines|aids vaccines
1715780|NCT00050063|Treatment Interruption|treatment interruption
1715781|NCT00050063|Viral Load|viral load
1715782|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1715783|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1715784|NCT00050050|Adult|adult
1715785|NCT00050050|ADHD|adhd
1715786|NCT00050050|ADD|add
1715787|NCT00050115|Bone Marrow Failure|bone marrow failure
1715788|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
1715789|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
1715790|NCT00050115|Hepatitis|hepatitis
1715791|NCT00050115|Aplastic Anemia|aplastic anemia
1715792|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
1715793|NCT00050024|TMS|tms
1715794|NCT00050024|Afferent Stimulation|afferent stimulation
1715795|NCT00050024|Motor Cortex|motor cortex
1715796|NCT00050024|Writer's Cramp|writer's cramp
1715797|NCT00050024|Surround Inhibition|surround inhibition
1715798|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
1715799|NCT00050024|Focal Dystonia|focal dystonia
1715800|NCT00050024|Writer Cramp|writer cramp
1715801|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
1715802|NCT00050011|postmenopausal women|postmenopausal women
1715803|NCT00050011|breast cancer|breast cancer
1715804|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
1715805|NCT00050011|adjuvant therapy|adjuvant therapy
1715806|NCT00050011|hormonal therapy|hormonal therapy
1715807|NCT00050011|bone loss|bone loss
1715808|NCT00050011|bisphosphonates|bisphosphonates
1715809|NCT00050011|ZFAST|zfast
1715810|NCT00050011|Letrozole|letrozole
1715811|NCT00050011|Zoledronic Acid|zoledronic acid
1715812|NCT00050011|US32|us32
1715813|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
1715814|NCT00049998|advanced|advanced
1715815|NCT00049998|Second-line|second-line
1715816|NCT00049998|topotecan|topotecan
1715817|NCT00049998|Hycamtin|hycamtin
1715818|NCT00049998|oral|oral
1715819|NCT00049998|docetaxel|docetaxel
1715820|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
1715821|NCT00049959|Verteporfin PDT|verteporfin pdt
1715822|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
1715823|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
1715824|NCT00049946|Talnetant|talnetant
1715825|NCT00049946|schizophrenia|schizophrenia
1715826|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
1715827|NCT00049946|psychosis|psychosis
1715828|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
1715829|NCT00049829|Osteoporosis|osteoporosis
1715831|NCT00049816|aerobic exercise|aerobic exercise
1715832|NCT00049816|walking|walking
1715833|NCT00049816|cycling|cycling
1715834|NCT00049816|gait|gait
1715835|NCT00049816|MRI|mri
1715836|NCT00049803|Narcolepsy|narcolepsy
1715837|NCT00049803|Sodium Oxybate|sodium oxybate
1715838|NCT00049803|Cataplexy|cataplexy
1715839|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
1715840|NCT00049803|GHB|ghb
1715841|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
1715842|NCT00049803|Orphan Medical|orphan medical
1715843|NCT00049803|Orphan Drug|orphan drug
1715844|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
1715845|NCT00049738|Psychosis|psychosis
1715846|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
1715847|NCT00049738|Schizophrenia|schizophrenia
1715848|NCT00049738|Schizoaffective|schizoaffective
1715849|NCT00049738|Psychotic Disorder|psychotic disorder
1715850|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
1715851|NCT00049725|Autoimmune Disease|autoimmune disease
1715852|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
1715853|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
1715855|NCT00049725|Monoclonal Antibody|monoclonal antibody
1715856|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
1715857|NCT00049725|ITP|itp
1715858|NCT00048841|Male|male
1715859|NCT00048841|Osteoporosis|osteoporosis
1715860|NCT00048841|Prostate cancer|prostate cancer
1715861|NCT00048841|Hypogonadism|hypogonadism
1715862|NCT00048841|Bisphosphonates|bisphosphonates
1715863|NCT00048841|Bone mineral density|bone mineral density
1715864|NCT00048815|Minor Depression|minor depression
1715865|NCT00048815|St. John's Wart|st. john's wart
1715866|NCT00048802|Adolescence|adolescence
1715867|NCT00048906|Pharmacokinetics|pharmacokinetics
1715868|NCT00048906|Enzyme|enzyme
1715869|NCT00048906|Lysosomal|lysosomal
1715870|NCT00048906|Kidney|kidney
1715871|NCT00048906|Stroke|stroke
1715872|NCT00048906|Fabry Disease|fabry disease
1715873|NCT00048906|Fabrys|fabrys
1715874|NCT00048906|Fabry's|fabry's
1715875|NCT00048893|CEA vaccine|cea vaccine
1715876|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
1715877|NCT00048893|T- Cell Repertoire|t- cell repertoire
1715878|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
1715879|NCT00048893|Breast Cancer|breast cancer
1715880|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1715881|NCT00048880|Monoclonal Antibody|monoclonal antibody
1715882|NCT00048880|CD30|cd30
1715883|NCT00048880|Antibody Saturation|antibody saturation
1715884|NCT00048880|Apoptosis|apoptosis
1715885|NCT00048880|Flow Cytometry|flow cytometry
1715886|NCT00048880|Cancer|cancer
1715887|NCT00048776|Secondary Raynaud's|secondary raynaud's
1715888|NCT00048776|circulatory|circulatory
1715889|NCT00048776|vascular|vascular
1715890|NCT00048776|scleroderma|scleroderma
1715891|NCT00048776|lupus|lupus
1715892|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
1715898|NCT00048789|Transplantation|transplantation
1715899|NCT00048789|Stem Cell|stem cell
1715900|NCT00048789|UVA|uva
1715901|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
1715902|NCT00048789|GVHD|gvhd
1715903|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
1715904|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
1715905|NCT00048750|Invasive Fungal Infection|invasive fungal infection
1715906|NCT00048750|Micafungin|micafungin
1715907|NCT00048750|ICU|icu
1715908|NCT00048737|Leukemia|leukemia
1715909|NCT00048737|Lymphoma|lymphoma
1715910|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
1715911|NCT00048737|Cyclophosphamide|cyclophosphamide
1715912|NCT00048737|Cytoxan|cytoxan
1715913|NCT00048737|Neosar|neosar
1715914|NCT00048737|Fludarabine|fludarabine
1715915|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
1715916|NCT00048737|Fludara|fludara
1715917|NCT00048737|Rituximab|rituximab
1715918|NCT00048737|Rituxan|rituxan
1715919|NCT00048737|Zevalin|zevalin
1715920|NCT00048737|Indium Zevalin|indium zevalin
1715921|NCT00048737|90Y Zevalin|90y zevalin
1715922|NCT00048737|CD-20-positive|cd-20-positive
1715923|NCT00048737|B-cell Lymphoma|b-cell lymphoma
1715924|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
1715925|NCT00048737|NHL|nhl
1715926|NCT00048737|CLL|cll
1715927|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1715928|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
1715929|NCT00048737|ASCT|asct
1715930|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
1715931|NCT00048698|Frontal Lobe|frontal lobe
1715932|NCT00048698|Motor Cortex|motor cortex
1715933|NCT00048698|Dementia|dementia
1715934|NCT00048698|Cognition|cognition
1715935|NCT00048698|Healthy Volunteer|healthy volunteer
1715936|NCT00048698|HV|hv
1715937|NCT00048685|Caries|caries
1715938|NCT00048685|Bacteria|bacteria
1715939|NCT00048685|Saliva|saliva
1715940|NCT00048685|Teeth|teeth
1715941|NCT00048685|Autoimmune|autoimmune
1715942|NCT00048685|Dry Mouth|dry mouth
1720819|NCT00016601|Nelfinavir|nelfinavir
1715943|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
1715944|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
1715945|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
1715946|NCT00048672|Leukemia|leukemia
1715947|NCT00048672|Gleevec|gleevec
1715948|NCT00048672|STI571|sti571
1715949|NCT00048672|Imatinib mesylate|imatinib mesylate
1715950|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
1715951|NCT00048646|TBI|tbi
1715952|NCT00048646|ProTECT|protect
1715953|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
1715954|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
1715955|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
1715956|NCT00048503|Zarnestra|zarnestra
1715957|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
1715958|NCT00048503|Tipifarnib|tipifarnib
1715959|NCT00048464|Immunotherapy|immunotherapy
1715960|NCT00048464|T Cell Therapy|t cell therapy
1715961|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
1715962|NCT00048464|Bone marrow transplant|bone marrow transplant
1715963|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
1715965|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
1715966|NCT00048490|Seizures|seizures
1715967|NCT00048490|Magnetism|magnetism
1715968|NCT00048490|Brain|brain
1715969|NCT00048490|Stimulation|stimulation
1715970|NCT00048490|Therapy|therapy
1715971|NCT00048490|Epilepsy|epilepsy
1715972|NCT00048477|Endothelium|endothelium
1715973|NCT00048477|Vasodilation|vasodilation
1715974|NCT00048477|Exercise|exercise
1715975|NCT00048477|Hemoglobin|hemoglobin
1715976|NCT00048477|Blood Flow|blood flow
1715977|NCT00048477|Healthy Volunteer|healthy volunteer
1715978|NCT00048477|HV|hv
1715979|NCT00048373|LANGERHANS|langerhans
1715980|NCT00048373|HISTIOCYTOSIS|histiocytosis
1715981|NCT00048360|ADD|add
1715982|NCT00048360|ADHD|adhd
1715983|NCT00048360|attention deficit|attention deficit
1715984|NCT00048360|hyperactivity|hyperactivity
1715985|NCT00048308|CABG|cabg
1715986|NCT00048347|Lymphocyte|lymphocyte
1715987|NCT00048347|Monocyte|monocyte
1715988|NCT00048347|Inflammation|inflammation
1715989|NCT00048347|Th2|th2
1715990|NCT00048347|Colonoscopy|colonoscopy
1715991|NCT00048347|Ulcerative Colitis|ulcerative colitis
1715992|NCT00048334|Histone Acetylation|histone acetylation
1715993|NCT00048334|Cancer|cancer
1715994|NCT00048282|Incidence|incidence
1715995|NCT00048282|HIV Seroprevalence|hiv seroprevalence
1715996|NCT00048282|Vagina|vagina
1715997|NCT00048282|Anti-Infective Agents|anti-infective agents
1715998|NCT00048282|Administration, Topical|administration, topical
1715999|NCT00048282|Gels|gels
1716000|NCT00048282|HIV Seronegativity|hiv seronegativity
1716001|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
1716002|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
1716003|NCT00048217|Treatment Experienced|treatment experienced
1716006|NCT00048204|Major Depressive Disorder|major depressive disorder
1716007|NCT00048256|Cancer|cancer
1716008|NCT00048256|Personality Assessment|personality assessment
1716009|NCT00048256|Coping Styles|coping styles
1716010|NCT00048256|Psychological Distress|psychological distress
1716011|NCT00048256|Bone Marrow Transplants|bone marrow transplants
1716012|NCT00048256|Bone Marrow Transplant|bone marrow transplant
1716013|NCT00048113|Crohn's|crohn's
1716014|NCT00048100|Dendritic cells|dendritic cells
1716015|NCT00048100|Lymphocytes|lymphocytes
1716016|NCT00048100|AML|aml
1716017|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
1716018|NCT00047983|Kidney Transplantation|kidney transplantation
1716019|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
1716020|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
1716021|NCT00047983|Graft Survival|graft survival
1716022|NCT00047970|Breast Cancer|breast cancer
1716023|NCT00047970|Sisters|sisters
1716024|NCT00047827|Aspergillus|aspergillus
1716025|NCT00047827|Aspergillosis|aspergillosis
1716026|NCT00047827|Anti-Fungal|anti-fungal
1716027|NCT00047827|AmBisome|ambisome
1716028|NCT00047827|Micafungin|micafungin
1716029|NCT00047814|HCV|hcv
1716030|NCT00047957|Transcranial|transcranial
1716031|NCT00047957|Magnetic|magnetic
1716032|NCT00047957|Stimulation|stimulation
1716033|NCT00047957|Motor|motor
1716034|NCT00047957|Cortex|cortex
1716035|NCT00047957|Motor Cortex|motor cortex
1716036|NCT00047957|Afferent Stimulation|afferent stimulation
1716037|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1716038|NCT00047957|Healthy Volunteer|healthy volunteer
1716039|NCT00047957|HV|hv
1716040|NCT00047944|Attention|attention
1716042|NCT00047944|Amygdala|amygdala
1716043|NCT00047944|Prefrontal Cortex|prefrontal cortex
1716044|NCT00047944|Facial Expression|facial expression
1716045|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
1716046|NCT00047944|fMRI|fmri
1716047|NCT00047944|Depression|depression
1716048|NCT00047944|Anxiety|anxiety
1716049|NCT00047944|Adolescence|adolescence
1716050|NCT00047944|Children|children
1716052|NCT00047931|HIV-Negative|hiv-negative
1716053|NCT00047931|Placebo-Controlled|placebo-controlled
1716054|NCT00047931|Volunteer|volunteer
1716055|NCT00047931|Dose-Escalation|dose-escalation
1716056|NCT00047931|HIV Seronegativity|hiv seronegativity
1716057|NCT00047931|Healthy Volunteer|healthy volunteer
1716058|NCT00047931|HV|hv
1716059|NCT00047918|Mast Cells|mast cells
1716060|NCT00047918|Bone Marrow|bone marrow
1716061|NCT00047918|Flushing|flushing
1716062|NCT00047918|Mutations|mutations
1716063|NCT00047918|Mastocytosis|mastocytosis
1716064|NCT00047918|Anaphylaxis|anaphylaxis
1716065|NCT00047905|Qualitative|qualitative
1716066|NCT00047905|Communication Analysis|communication analysis
1716067|NCT00047905|RIAS|rias
1716068|NCT00047905|Counseling Models|counseling models
1716069|NCT00047905|Videotaping|videotaping
1716070|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
1716071|NCT00047905|Counseling Process|counseling process
1716072|NCT00047905|Video Tape Study|video tape study
1716073|NCT00047905|Simulated Clients|simulated clients
1716074|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
1716075|NCT00047879|Brain Tumors|brain tumors
1716076|NCT00047879|Experimental|experimental
1716079|NCT00047879|Progression-Free|progression-free
1716080|NCT00047879|Brain Tumor|brain tumor
1716081|NCT00047879|Glioma|glioma
1716082|NCT00047866|Limbic System|limbic system
1716083|NCT00047866|Amphetamine|amphetamine
1716084|NCT00047866|Dopamine|dopamine
1716085|NCT00047866|Brain Imaging|brain imaging
1716086|NCT00047866|Cerebral Blood Flow|cerebral blood flow
1716087|NCT00047866|Cerebral Blood Volume|cerebral blood volume
1716088|NCT00047866|Alcoholism|alcoholism
1716089|NCT00047866|Tyrosine Depletion|tyrosine depletion
1716090|NCT00047866|Amino Acids|amino acids
1716091|NCT00047866|Affect|affect
1716092|NCT00047866|Healthy Volunteer|healthy volunteer
1716093|NCT00047866|HV|hv
1716094|NCT00047853|Anxiety|anxiety
1716095|NCT00047853|Neuroimaging|neuroimaging
1716096|NCT00047853|Affective Neuroscience|affective neuroscience
1716097|NCT00047853|Healthy Volunteer|healthy volunteer
1716098|NCT00047853|HV|hv
1716099|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
1716100|NCT00047554|open-angle|open-angle
1716101|NCT00047554|glaucoma|glaucoma
1716102|NCT00047554|ocular|ocular
1716103|NCT00047554|hypertension|hypertension
1716104|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
1716105|NCT00047554|iris|iris
1716106|NCT00047554|pigmentation|pigmentation
1716107|NCT00047541|open-angle|open-angle
1716108|NCT00047541|glaucoma|glaucoma
1716109|NCT00047541|ocular|ocular
1716110|NCT00047541|hypertension|hypertension
1716111|NCT00047541|POAG|poag
1716112|NCT00047528|open-angle|open-angle
1716113|NCT00047528|glaucoma|glaucoma
1716114|NCT00047528|ocular|ocular
1716115|NCT00047528|hypertension|hypertension
1716116|NCT00047528|POAG|poag
1716120|NCT00047515|hypertension|hypertension
1716121|NCT00047515|POAG|poag
1716122|NCT00047749|pain|pain
1716123|NCT00047749|ziconotide|ziconotide
1716124|NCT00047749|Prialt|prialt
1716125|NCT00047749|intrathecal|intrathecal
1716126|NCT00047749|Synchromed|synchromed
1716127|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
1716128|NCT00047723|ALS|als
1716129|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1716130|NCT00047723|minocycline|minocycline
1716131|NCT00047710|pancreatic cancer|pancreatic cancer
1716132|NCT00047710|pancreas cancer|pancreas cancer
1716133|NCT00047710|pancreas|pancreas
1716134|NCT00047684|Child Abuse, Sexual|child abuse, sexual
1716135|NCT00047671|Depressive Disorder|depressive disorder
1716136|NCT00047645|lung|lung
1716137|NCT00047645|IPF|ipf
1716138|NCT00047632|ovarian|ovarian
1716139|NCT00047632|carcinoma|carcinoma
1716140|NCT00047632|peritoneal|peritoneal
1716141|NCT00047632|cancer|cancer
1716142|NCT00047632|ovary|ovary
1716143|NCT00047632|interferon gamma|interferon gamma
1716144|NCT00047606|open-angle|open-angle
1716145|NCT00047606|glaucoma|glaucoma
1716146|NCT00047606|ocular|ocular
1716147|NCT00047606|hypertension|hypertension
1716148|NCT00047606|POAG|poag
1716149|NCT00047606|Iris|iris
1716150|NCT00047606|Pigmentation|pigmentation
1716151|NCT00047606|Japanese|japanese
1716152|NCT00047593|open-angle|open-angle
1716153|NCT00047593|glaucoma|glaucoma
1716154|NCT00047593|ocular|ocular
1716155|NCT00047593|hypertension|hypertension
1716156|NCT00047593|POAG|poag
1716157|NCT00047593|Iris|iris
1716158|NCT00047593|Pigmentation|pigmentation
1716159|NCT00047593|Japanese|japanese
1716160|NCT00047619|Decubitus Ulcers|decubitus ulcers
1716161|NCT00047619|Pulsatile Lavage|pulsatile lavage
1716162|NCT00047619|SCI|sci
1716163|NCT00047619|Spinal Cord Injury|spinal cord injury
1716164|NCT00047619|Wound healing|wound healing
1716165|NCT00047619|pressure ulcer|pressure ulcer
1716166|NCT00047580|Spasticity|spasticity
1720921|NCT00013663|aldesleukin|aldesleukin
1716167|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
1716168|NCT00047580|Spinal Cord Injury|spinal cord injury
1716170|NCT00047567|ZONISAMIDE|zonisamide
1716171|NCT00047567|BIPOLAR|bipolar
1716172|NCT00046371|Cancer Vaccines|cancer vaccines
1716173|NCT00046371|Aromatase|aromatase
1716174|NCT00046371|Receptors, Estrogen|receptors, estrogen
1716175|NCT00046371|Receptors, Progesterone|receptors, progesterone
1716176|NCT00047476|neurobehavioral function|neurobehavioral function
1716177|NCT00047476|chemobrain|chemobrain
1716178|NCT00047476|chemo brain|chemo brain
1716179|NCT00047476|fatigue|fatigue
1716180|NCT00047476|memory loss|memory loss
1716181|NCT00047476|exhausted|exhausted
1716182|NCT00047476|trouble concentrating|trouble concentrating
1716183|NCT00047463|epilepsy|epilepsy
1716184|NCT00047463|sleep apnea|sleep apnea
1716185|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
1716186|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
1716187|NCT00047463|CPAP|cpap
1716188|NCT00047450|Psychotic Disorders|psychotic disorders
1716189|NCT00047411|CPR, AED|cpr, aed
1716190|NCT00046800|Ovarian Cancer|ovarian cancer
1716191|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
1716192|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
1716193|NCT00046774|Safety|safety
1716195|NCT00046774|Biologic Therapy|biologic therapy
1716196|NCT00046774|Lymphocytes|lymphocytes
1716197|NCT00046774|Response|response
1716198|NCT00046774|Lupus|lupus
1716199|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
1716200|NCT00046774|SLE|sle
1716201|NCT00046735|solid tumors|solid tumors
1716202|NCT00046735|Revimid|revimid
1716203|NCT00046735|CC5013|cc5013
1716204|NCT00046735|CC-5013|cc-5013
1716205|NCT00046722|treatment experienced|treatment experienced
1716206|NCT00046722|complementary therapies|complementary therapies
1716207|NCT00046722|Neuropathy|neuropathy
1716208|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
1716209|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
1716210|NCT00046722|HIV|hiv
1716211|NCT00046527|Metastatic breast cancer|metastatic breast cancer
1716212|NCT00046527|Taxol|taxol
1716213|NCT00046527|Taxane|taxane
1716214|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
1716215|NCT00046514|Taxol|taxol
1716216|NCT00046423|Cancer|cancer
1716217|NCT00046423|solid tumor|solid tumor
1716218|NCT00046423|Advanced malignancy|advanced malignancy
1716219|NCT00046423|Taxane therapy|taxane therapy
1716220|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
1716221|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
1716222|NCT00046709|Cancer pain|cancer pain
1716223|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
1716224|NCT00046696|Cancer|cancer
1716225|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
1716226|NCT00046696|Living with Cancer|living with cancer
1716227|NCT00046683|Adult acute leukemia|adult acute leukemia
1716228|NCT00046683|Adult chronic leukemia|adult chronic leukemia
1716229|NCT00046683|Childhood leukemia|childhood leukemia
1716230|NCT00046683|Campath|campath
1716231|NCT00046683|Alemtuzumab|alemtuzumab
1716232|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
1716233|NCT00046540|Irinotecan|irinotecan
1716234|NCT00046540|CPT-11|cpt-11
1716235|NCT00046540|Malignant Tumors|malignant tumors
1716236|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
1716237|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
1716238|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1716239|NCT00046488|CLL|cll
1716240|NCT00046631|built environment|built environment
1716241|NCT00046631|parks|parks
1716242|NCT00046631|retail outlets|retail outlets
1716243|NCT00046631|adolescent girls|adolescent girls
1716244|NCT00046631|physical activity|physical activity
1716245|NCT00046553|Cortisol|cortisol
1716246|NCT00046553|CRH|crh
1716247|NCT00046553|HPA Axis|hpa axis
1716248|NCT00046553|Hypothalamus|hypothalamus
1716249|NCT00046553|Hippocampus|hippocampus
1716250|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1716251|NCT00046553|PTSD|ptsd
1716252|NCT00046553|Healthy Volunteer|healthy volunteer
1716253|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
1716254|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
1716255|NCT00046436|Anti-HIV Agents|anti-hiv agents
1716256|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
1716257|NCT00046410|MRI|mri
1716258|NCT00046410|Diffusion|diffusion
1716259|NCT00046410|Cognitive|cognitive
1716260|NCT00046410|Stroke|stroke
1716261|NCT00046410|Heart|heart
1716262|NCT00046410|Coronary Artery Disease|coronary artery disease
1716263|NCT00046410|Heart Disease|heart disease
1716264|NCT00046397|Smallpox|smallpox
1716265|NCT00046397|Vaccine|vaccine
1716266|NCT00046397|Vaccination|vaccination
1716267|NCT00046397|Variola|variola
1716268|NCT00046397|Adults|adults
1716269|NCT00046397|Smallpox Vaccine|smallpox vaccine
1716270|NCT00046397|Healthy Volunteer|healthy volunteer
1716271|NCT00046397|Small Pox|small pox
1716272|NCT00046345|treatment experienced|treatment experienced
1716273|NCT00046332|Integrase inhibitors|integrase inhibitors
1716274|NCT00046332|Monotherapy|monotherapy
1716275|NCT00046332|HIV-1 infection|hiv-1 infection
1716276|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
1716277|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
1716278|NCT00046306|Oxidative Stress|oxidative stress
1716279|NCT00046306|Cardiovascular Disease|cardiovascular disease
1716280|NCT00046306|Cancer|cancer
1716281|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
1716282|NCT00046358|Cholesterol|cholesterol
1716283|NCT00046358|Statin|statin
1716284|NCT00046358|NSAID|nsaid
1716285|NCT00046358|Antiinflammatory|antiinflammatory
1716286|NCT00046358|Dementia|dementia
1716287|NCT00046358|Alzheimer's Disease|alzheimer's disease
1716288|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
1716289|NCT00046358|Healthy Volunteer|healthy volunteer
1716290|NCT00046293|Stroke|stroke
1716291|NCT00046293|Abciximab|abciximab
1716292|NCT00046293|Retavase|retavase
1716293|NCT00046293|MRI|mri
1716294|NCT00046293|Cerebral Blood Flow|cerebral blood flow
1716295|NCT00046267|Delayed-Action Preparations|delayed-action preparations
1716296|NCT00046267|Blood Glucose|blood glucose
1716297|NCT00046267|Insulin|insulin
1716298|NCT00046267|Alanine Transaminase|alanine transaminase
1716299|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
1716300|NCT00046267|Fructosamine|fructosamine
1716301|NCT00046267|Glucose Tolerance Test|glucose tolerance test
1716302|NCT00046267|Treatment Experienced|treatment experienced
1716303|NCT00046254|hip fracture|hip fracture
1716304|NCT00046254|recurrent fracture|recurrent fracture
1716305|NCT00046254|fracture|fracture
1716306|NCT00046254|bone loss|bone loss
1716307|NCT00046254|bisphosphonate|bisphosphonate
1716308|NCT00046254|bone mineral density|bone mineral density
1716309|NCT00046254|osteoporosis|osteoporosis
1716310|NCT00046254|zoledronic acid|zoledronic acid
1716311|NCT00046254|geriatrics|geriatrics
1716312|NCT00046254|rehabilitation|rehabilitation
1716313|NCT00046254|elderly|elderly
1716314|NCT00046254|nursing home|nursing home
1716315|NCT00046254|orthopedic|orthopedic
1716316|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
1716317|NCT00046228|Myocardial infarction|myocardial infarction
1716318|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
1716319|NCT00046228|abciximab|abciximab
1716320|NCT00046228|reteplase|reteplase
1716321|NCT00046228|safety and efficacy|safety and efficacy
1716322|NCT00046215|Virtual Lesion Study|virtual lesion study
1716323|NCT00046215|Motor Imagery|motor imagery
1716324|NCT00046215|Primary Motor Cortex|primary motor cortex
1716325|NCT00046215|Motor Inhibition|motor inhibition
1716326|NCT00046215|Motor Execution|motor execution
1716327|NCT00046215|Healthy Volunteer|healthy volunteer
1716328|NCT00046202|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1716329|NCT00046202|Sterol|sterol
1716330|NCT00046202|Mutations|mutations
1716331|NCT00046202|Dysmorphology|dysmorphology
1716332|NCT00046202|Mental Retardation|mental retardation
1716333|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
1716334|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
1716335|NCT00046202|Lathosterolosis|lathosterolosis
1716336|NCT00046202|Desmosterols|desmosterols
1716337|NCT00046202|CHILD Syndrome|child syndrome
1716338|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
1716339|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
1716340|NCT00046189|Sun Exposure|sun exposure
1716341|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
1716342|NCT00046189|Skin Cancer|skin cancer
1716343|NCT00046189|Family History|family history
1716344|NCT00046189|HETEROZYGOTE|heterozygote
1716345|NCT00046189|XP|xp
1716346|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
1716347|NCT00046163|Neurology|neurology
1716348|NCT00046163|Cardiology|cardiology
1716349|NCT00046111|oral|oral
1716350|NCT00046111|Bioequivalence|bioequivalence
1716351|NCT00046111|Hycamtin|hycamtin
1716352|NCT00046111|Topotecan|topotecan
1716353|NCT00046085|Schizophrenia|schizophrenia
1716354|NCT00046085|Family|family
1716355|NCT00046085|Psychoeducation|psychoeducation
1716356|NCT00046085|Internet|internet
1716357|NCT00046072|Sepsis|sepsis
1716358|NCT00046072|Shock|shock
1716359|NCT00046072|Septic|septic
1716360|NCT00046072|Sepsis Syndrome|sepsis syndrome
1716361|NCT00046072|Septicemia|septicemia
1716362|NCT00046072|Endotoxins|endotoxins
1716363|NCT00046072|Endotoxemia|endotoxemia
1716364|NCT00046072|Infection|infection
1716365|NCT00046059|Linkage|linkage
1716366|NCT00046059|Gene Identification|gene identification
1716367|NCT00046059|ADHD|adhd
1716368|NCT00046059|Hyperactivity|hyperactivity
1716369|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1716370|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
1716371|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
1716372|NCT00046033|Salvage Therapy|salvage therapy
1716373|NCT00046033|Viral Load|viral load
1716374|NCT00046033|RNA, Viral|rna, viral
1716375|NCT00046033|Drug Therapy, Combination|drug therapy, combination
1716376|NCT00046020|Depression|depression
1716377|NCT00045994|cardiovascular|cardiovascular
1716378|NCT00045994|aged|aged
1716379|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
1716380|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
1716381|NCT00045994|blood pressure|blood pressure
1716382|NCT00045981|cardiovascular|cardiovascular
1716383|NCT00045981|aged|aged
1716384|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
1716385|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
1716386|NCT00045981|blood pressure|blood pressure
1716387|NCT00045968|oncology|oncology
1716388|NCT00045968|neurology|neurology
1716389|NCT00045968|glioma|glioma
1716390|NCT00045968|brain tumor|brain tumor
1716391|NCT00045968|brain cancer|brain cancer
1716392|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
1716393|NCT00045968|glioblastoma|glioblastoma
1716394|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
1716395|NCT00045968|immunotherapy|immunotherapy
1716396|NCT00045968|dendritic cells|dendritic cells
1716397|NCT00045968|immune therapy|immune therapy
1716398|NCT00045968|GBM|gbm
1723598|NCT00002136|Neoplasms|neoplasms
1716399|NCT00045968|Brain cancer, primary|brain cancer, primary
1716400|NCT00045968|tumor vaccine|tumor vaccine
1716401|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
1716402|NCT00045968|DCVax|dcvax
1716403|NCT00045968|Grade IV brain cancer|grade iv brain cancer
1716404|NCT00045942|AML|aml
1716405|NCT00045942|MDS|mds
1716406|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
1716407|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
1716408|NCT00045916|Antidepressive Agents|antidepressive agents
1716409|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
1716410|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
1716411|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
1716412|NCT00045838|Healthy|healthy
1716413|NCT00045838|HIV-Negative|hiv-negative
1716414|NCT00045838|Placebo Controlled|placebo controlled
1716415|NCT00045838|Volunteer|volunteer
1716416|NCT00045838|Dose-Escalation|dose-escalation
1716417|NCT00045838|Healthy Volunteers|healthy volunteers
1716418|NCT00045838|HV|hv
1716419|NCT00045838|HIV Seronegativity|hiv seronegativity
1716420|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
1716421|NCT00045812|Cholesterol|cholesterol
1716422|NCT00045812|Sitosterol|sitosterol
1716423|NCT00045812|Atherosclerosis|atherosclerosis
1716424|NCT00045812|Intestine|intestine
1716425|NCT00045812|Absorption|absorption
1716426|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
1716427|NCT00045812|Sterol Metabolism|sterol metabolism
1716428|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
1716429|NCT00044928|Abdominal Infections|abdominal infections
1716430|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
1716434|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
1716435|NCT00044837|Lopinavir|lopinavir
1716436|NCT00044837|HIV-1|hiv-1
1716437|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
1716438|NCT00044837|Ritonavir|ritonavir
1716439|NCT00044837|Postmenopause|postmenopause
1716440|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1716441|NCT00044837|Pharmacokinetics|pharmacokinetics
1716442|NCT00044837|Area Under Curve|area under curve
1716443|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
1716444|NCT00044837|efavirenz|efavirenz
1716445|NCT00044837|estradiol|estradiol
1716446|NCT00044876|Endometrium|endometrium
1716447|NCT00044876|Progesterone|progesterone
1716448|NCT00044876|Estrogen|estrogen
1716449|NCT00044876|Leiomyoma|leiomyoma
1716450|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
1716451|NCT00044876|Uterine Fibroids|uterine fibroids
1716452|NCT00044876|Fibroids|fibroids
1716453|NCT00044798|Aged|aged
1716454|NCT00044785|colorectal cancer|colorectal cancer
1716455|NCT00044785|gastric cancer|gastric cancer
1716456|NCT00044785|breast cancer|breast cancer
1716457|NCT00044772|Panic|panic
1716458|NCT00044772|Disorder|disorder
1716459|NCT00044759|Hematologic|hematologic
1716460|NCT00044759|Neoplasms|neoplasms
1716461|NCT00044746|Diabetes|diabetes
1716462|NCT00044733|Leukemia|leukemia
1716463|NCT00044733|Stem Cell Transplant|stem cell transplant
1716464|NCT00044720|Kidney Transplant|kidney transplant
1716465|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1716466|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
1716467|NCT00044681|Risperidone|risperidone
1716468|NCT00044681|depression|depression
1716469|NCT00044681|melancholia|melancholia
1716470|NCT00044681|depressive disorder|depressive disorder
1716471|NCT00044681|antipsychotic agents|antipsychotic agents
1716472|NCT00044668|exenatide|exenatide
1716473|NCT00044668|exendin-4|exendin-4
1716474|NCT00044668|diabetes|diabetes
1716475|NCT00044668|Amylin|amylin
1716478|NCT00044629|Sleep Deprivation|sleep deprivation
1716479|NCT00044629|Insomnia|insomnia
1716480|NCT00044629|Sleep Disorders|sleep disorders
1716481|NCT00044603|Pregnancy|pregnancy
1716482|NCT00044590|Parkinson's disease|parkinson's disease
1716483|NCT00044590|Pesticides|pesticides
1716484|NCT00044590|Genetic susceptibility|genetic susceptibility
1716485|NCT00044590|Polymorphisms|polymorphisms
1716486|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
1716487|NCT00044564|Taxane|taxane
1716488|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
1716489|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
1716490|NCT00044551|Taxane|taxane
1716491|NCT00044551|Lymphoma|lymphoma
1716492|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1716493|NCT00044538|Taxane|taxane
1716494|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
1716495|NCT00044538|NSCLC|nsclc
1716496|NCT00044525|Taxane|taxane
1716497|NCT00044525|Breast Cancer|breast cancer
1716498|NCT00044525|Metastasis|metastasis
1716499|NCT00044512|Cancer|cancer
1716500|NCT00044512|Liver Cancer|liver cancer
1716501|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
1716502|NCT00044486|Prophylaxis|prophylaxis
1716503|NCT00044486|neutropenia|neutropenia
1716504|NCT00044486|AML|aml
1716505|NCT00044486|MDS|mds
1723779|NCT00002095|Ganciclovir|ganciclovir
1716506|NCT00044486|fungal infections|fungal infections
1716507|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
1716508|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
1716509|NCT00044473|Otitis Media|otitis media
1716510|NCT00044473|Ear Diaeases|ear diaeases
1716511|NCT00044473|Levofloxacin|levofloxacin
1716512|NCT00044473|Quinolones|quinolones
1716513|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
1716514|NCT00044382|Revimid|revimid
1716515|NCT00044382|CC5013|cc5013
1716516|NCT00044382|CC-5013|cc-5013
1716517|NCT00044369|Varicocele|varicocele
1716518|NCT00044369|environmental toxins|environmental toxins
1716519|NCT00044369|male infertility|male infertility
1716520|NCT00044369|cadmium|cadmium
1716521|NCT00044356|Melanoma|melanoma
1716522|NCT00044356|Metastatic Melanoma|metastatic melanoma
1716523|NCT00044356|Malignant Melanoma|malignant melanoma
1716524|NCT00044356|Skin Cancer|skin cancer
1716525|NCT00044356|Tumor|tumor
1716526|NCT00044356|Experimental Treatment|experimental treatment
1716527|NCT00044356|Clinical Trial|clinical trial
1716528|NCT00044356|Gene Therapy|gene therapy
1716529|NCT00044356|Gene Delivery|gene delivery
1716530|NCT00044356|Gene Transfer|gene transfer
1716531|NCT00044356|Immunotherapy|immunotherapy
1716532|NCT00044356|Cancer|cancer
1716533|NCT00044356|Neoplasm|neoplasm
1716534|NCT00044356|Lesion|lesion
1716535|NCT00044356|Metastasis|metastasis
1716536|NCT00044356|Cancerous mole|cancerous mole
1716537|NCT00044356|Melanoma vaccine|melanoma vaccine
1716538|NCT00044356|Cancer research|cancer research
1716539|NCT00044356|Cancer cells|cancer cells
1716540|NCT00044356|Allovectin-7®|allovectin-7®
1716541|NCT00044343|colorectal cancer|colorectal cancer
1716542|NCT00044343|EGFR inhibitor|egfr inhibitor
1716543|NCT00044343|lapatinib|lapatinib
1716544|NCT00044343|metastatic|metastatic
1716545|NCT00044317|FEV|fev
1716546|NCT00044317|Smoking|smoking
1716547|NCT00044317|antioxidents|antioxidents
1716548|NCT00044317|lung growth|lung growth
1716549|NCT00044291|Atamestane|atamestane
1716550|NCT00044291|Toremifene|toremifene
1716551|NCT00044291|Letrozole|letrozole
1716552|NCT00044291|Aromatase inhibitor|aromatase inhibitor
1716553|NCT00044291|Receptor-positive|receptor-positive
1716554|NCT00044291|First line therapy|first line therapy
1716555|NCT00044291|Estrogen blocker|estrogen blocker
1716556|NCT00044291|Metastatic breast cancer|metastatic breast cancer
1716557|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
1716558|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
1716559|NCT00044291|stage IV breast cancer|stage iv breast cancer
1716560|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
1716561|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
1716562|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
1716563|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
1716564|NCT00044291|recurrent breast cancer|recurrent breast cancer
1716565|NCT00044304|Treatment|treatment
1716566|NCT00044304|Eosinophil|eosinophil
1716567|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1716568|NCT00044304|Hypereosinophilia|hypereosinophilia
1716569|NCT00044304|Biologicals|biologicals
1716570|NCT00044304|Chemotherapy|chemotherapy
1716571|NCT00044304|Gleevec|gleevec
1716572|NCT00044304|Eosinophils|eosinophils
1716573|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1716575|NCT00044278|epilepsy|epilepsy
1716576|NCT00044278|pediatric|pediatric
1716577|NCT00044278|partial seizures|partial seizures
1716578|NCT00044265|ACE inhibitor|ace inhibitor
1716579|NCT00044265|high blood pressure|high blood pressure
1716580|NCT00044265|pediatric|pediatric
1716581|NCT00044252|Neurosteroids|neurosteroids
1716582|NCT00044252|Complex Partial Seizure|complex partial seizure
1716583|NCT00044252|Menstrual Cycle|menstrual cycle
1716584|NCT00044252|Allopregnanolone|allopregnanolone
1716585|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
1716586|NCT00044252|Seizures|seizures
1716587|NCT00044252|Epilepsy|epilepsy
1716588|NCT00044252|Healthy Volunteer|healthy volunteer
1716589|NCT00044252|HV|hv
1716590|NCT00044252|Normal Control|normal control
1716591|NCT00044239|Tic Disorders|tic disorders
1716592|NCT00044239|Neurophyschological|neurophyschological
1716593|NCT00044239|Immunology|immunology
1716594|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
1716595|NCT00044239|Basal Ganglia|basal ganglia
1716596|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1716597|NCT00044239|Children|children
1716598|NCT00044239|Adolescents|adolescents
1716599|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1716600|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
1716601|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
1716602|NCT00044239|OCD|ocd
1716603|NCT00044239|Healthy Volunteers|healthy volunteers
1716604|NCT00044239|HV|hv
1716605|NCT00044226|BPH|bph
1716606|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1716607|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1716608|NCT00044226|Enlarged Prostate|enlarged prostate
1716609|NCT00044187|schizoaffective disorder|schizoaffective disorder
1716610|NCT00044187|schizophreniform disorder|schizophreniform disorder
1716611|NCT00044187|bipolar I disorder|bipolar i disorder
1716612|NCT00044200|Phospholipase A2|phospholipase a2
1716613|NCT00044200|Arachidonic Acid|arachidonic acid
1716614|NCT00044200|Blood Flow|blood flow
1716615|NCT00044200|Coupling|coupling
1716616|NCT00044200|Neurotransmission|neurotransmission
1716617|NCT00044200|PET|pet
1716618|NCT00044200|Signal Transduction|signal transduction
1716619|NCT00044200|Activation|activation
1716620|NCT00044200|Brain|brain
1716621|NCT00044200|[15O]H20|[15o]h20
1716622|NCT00044174|Depression|depression
1716623|NCT00044174|Mother-Infant Interaction|mother-infant interaction
1716624|NCT00044174|Still-face|still-face
1716625|NCT00044174|Socioemotional Development|socioemotional development
1716626|NCT00044174|Cognitive Development|cognitive development
1716627|NCT00044174|Healthy|healthy
1716628|NCT00044174|Mothers|mothers
1716629|NCT00044174|Postpartum|postpartum
1716630|NCT00044174|Postpartum Depression|postpartum depression
1716631|NCT00044148|Persistent Albuminuria|persistent albuminuria
1716632|NCT00044135|clevudine|clevudine
1716633|NCT00044135|hepatitis B|hepatitis b
1716634|NCT00044070|ARTIST|artist
1716635|NCT00044070|Acute ischemic stroke|acute ischemic stroke
1716636|NCT00044057|ARTIST|artist
1716637|NCT00044044|Schizophrenia|schizophrenia
1716638|NCT00044044|Latuda|latuda
1716639|NCT00044044|Lurasidone|lurasidone
1716640|NCT00044031|pancreatic cancer|pancreatic cancer
1716641|NCT00044031|G17DT|g17dt
1716642|NCT00044031|gemcitabine|gemcitabine
1716643|NCT00044018|Revimid|revimid
1716644|NCT00044018|CC5013|cc5013
1716645|NCT00044005|Schizophrenia|schizophrenia
1716647|NCT00044005|Lurasidone|lurasidone
1716648|NCT00043329|Registry|registry
1716649|NCT00043329|Actimmune|actimmune
1716650|NCT00043329|osteopetrosis|osteopetrosis
1716651|NCT00044122|Mastocytosis|mastocytosis
1716652|NCT00044122|Urticaria Pigmentosa|urticaria pigmentosa
1716653|NCT00044122|Classification|classification
1716654|NCT00044122|Tryptase|tryptase
1716655|NCT00044122|Mutations|mutations
1716656|NCT00044109|Pain|pain
1716657|NCT00044109|Low Back|low back
1716658|NCT00044109|Radiculopathy|radiculopathy
1716659|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
1716660|NCT00044109|Back Device|back device
1716661|NCT00044109|Sciatica|sciatica
1716662|NCT00044109|Low Back Pain|low back pain
1716663|NCT00044096|SSRI|ssri
1716664|NCT00044096|Anxiety|anxiety
1716665|NCT00044096|Stress|stress
1716666|NCT00044096|Citalopram|citalopram
1716667|NCT00044096|Benadryl|benadryl
1716668|NCT00044096|Diphenhydramine|diphenhydramine
1716669|NCT00044096|Startle|startle
1716670|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
1716671|NCT00044096|Fear|fear
1716672|NCT00044096|Normal Volunteers|normal volunteers
1716673|NCT00044096|Healthy Volunteers|healthy volunteers
1716674|NCT00044096|HV|hv
1716675|NCT00044083|Catecholamines|catecholamines
1716676|NCT00044083|Dopamine|dopamine
1716677|NCT00044083|Clinical Trial|clinical trial
1716678|NCT00044083|fMRI|fmri
1716679|NCT00044083|PFC|pfc
1716680|NCT00044083|Vitamin B2|vitamin b2
1716681|NCT00044083|Riboflavin|riboflavin
1716682|NCT00044083|Tolcapone|tolcapone
1716683|NCT00044083|Placebo|placebo
1716684|NCT00044083|Normal Volunteers|normal volunteers
1716685|NCT00044083|Schizophrenia|schizophrenia
1716686|NCT00044083|Healthy Volunteers|healthy volunteers
1716687|NCT00044083|HV|hv
1716688|NCT00043992|Asthma|asthma
1716689|NCT00043992|Allergens|allergens
1716690|NCT00043966|treatment naive|treatment naive
1716691|NCT00043953|treatment naive|treatment naive
1716692|NCT00043888|fosamprenavir|fosamprenavir
1716700|NCT00043888|protease inhibitors|protease inhibitors
1716701|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
1716702|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
1716703|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
1716705|NCT00043979|Ewing Sarcoma|ewing sarcoma
1716706|NCT00043940|thrombosis|thrombosis
1716707|NCT00043940|bivalirudin|bivalirudin
1716708|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
1716709|NCT00043940|HIT|hit
1716710|NCT00043940|HITTS|hitts
1716711|NCT00043940|HIT/HITTS|hit/hitts
1716712|NCT00043927|Chemotherapy-naive|chemotherapy-naive
1716713|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
1716714|NCT00043927|SCLC|sclc
1716715|NCT00043927|Extensive disease|extensive disease
1716716|NCT00043927|ED|ed
1716717|NCT00043927|topotecan|topotecan
1716718|NCT00043927|Hycamtin|hycamtin
1716719|NCT00043927|oral|oral
1716720|NCT00043914|epilepsy|epilepsy
1716721|NCT00043914|monotherapy conversion|monotherapy conversion
1716722|NCT00043901|PGTC|pgtc
1716723|NCT00043901|Lamotrigine|lamotrigine
1716724|NCT00043901|epilepsy|epilepsy
1716725|NCT00043901|seizures|seizures
1716726|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
1716727|NCT00043875|partial seizures|partial seizures
1716728|NCT00043875|pediatric|pediatric
1716732|NCT00043862|Radiation Sensitization|radiation sensitization
1716733|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
1716734|NCT00043862|newly diagnosed|newly diagnosed
1716735|NCT00043862|limited stage|limited stage
1716736|NCT00043862|topotecan|topotecan
1716737|NCT00043849|Psychosis|psychosis
1716738|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
1716739|NCT00043836|ejection fraction|ejection fraction
1716740|NCT00043836|exercise tolerance|exercise tolerance
1716741|NCT00043836|heart failure, congestive|heart failure, congestive
1716742|NCT00043836|quality of life|quality of life
1716743|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
1716744|NCT00043823|NSCLC|nsclc
1716745|NCT00043823|Lung Cancer|lung cancer
1716746|NCT00043823|Avastin|avastin
1716747|NCT00043823|Bevacizumab|bevacizumab
1716748|NCT00043823|rhuMAb VEGF|rhumab vegf
1716749|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
1716750|NCT00043823|Tarceva|tarceva
1716751|NCT00043823|OSI-774|osi-774
1716752|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
1716753|NCT00043810|AML|aml
1716754|NCT00043810|MDS|mds
1716755|NCT00043810|Gelonin|gelonin
1716756|NCT00043810|Purging|purging
1716758|NCT00043810|Peripheral Stem Cell|peripheral stem cell
1716759|NCT00043797|ARI|ari
1716760|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
1716761|NCT00043797|Diabetic complications|diabetic complications
1716762|NCT00043784|Acute coronary syndromes|acute coronary syndromes
1716763|NCT00043784|non-ST-segment elevation|non-st-segment elevation
1716764|NCT00043693|Psychotic Disorders|psychotic disorders
1716765|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
1716766|NCT00043693|Substance Abuse|substance abuse
1716767|NCT00043771|CHF|chf
1716768|NCT00043758|CHF|chf
1716769|NCT00043745|soy|soy
1716770|NCT00043745|isoflavones|isoflavones
1716771|NCT00043745|alternative hormone therapy|alternative hormone therapy
1716772|NCT00043745|bone loss|bone loss
1716773|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
1716774|NCT00043732|Scio-469|scio-469
1716775|NCT00043719|Human Female|human female
1716776|NCT00043719|Osteoporosis|osteoporosis
1716777|NCT00043719|Postmenopausal|postmenopausal
1716778|NCT00043719|Nitric Oxide|nitric oxide
1716779|NCT00043719|Nitroglycerin|nitroglycerin
1716780|NCT00043719|Calcium|calcium
1716781|NCT00043719|Vitamin D|vitamin d
1716782|NCT00043589|Memory|memory
1716783|NCT00043576|Prostate Cancer|prostate cancer
1716784|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
1716785|NCT00043680|Classic|classic
1716786|NCT00043680|Occult|occult
1716787|NCT00043680|Neovascular|neovascular
1716788|NCT00043680|Celecoxib|celecoxib
1716789|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
1716790|NCT00043680|Photodynamic Therapy|photodynamic therapy
1716791|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
1716792|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
1716793|NCT00043680|Macular Degeneration|macular degeneration
1716794|NCT00043680|AMD|amd
1716795|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
1716796|NCT00043667|Interleukin 2|interleukin 2
1716797|NCT00043667|IL-2 Receptor|il-2 receptor
1716798|NCT00043667|Anti-CD25|anti-cd25
1716799|NCT00043667|Anti-Tac|anti-tac
1716800|NCT00043667|Anti-IL-2R|anti-il-2r
1716801|NCT00043667|Uveitis|uveitis
1716802|NCT00043667|Daclizumab|daclizumab
1716803|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
1716804|NCT00043654|Antidepressant|antidepressant
1716805|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
1716806|NCT00043654|Cortisol|cortisol
1716807|NCT00043654|Neuroendocrine|neuroendocrine
1716808|NCT00043654|Cognition|cognition
1716809|NCT00043654|Bipolar|bipolar
1716810|NCT00043654|Bipolar Disorder|bipolar disorder
1716811|NCT00043654|BPD|bpd
1716812|NCT00043654|HV|hv
1716813|NCT00043641|RT PCR|rt pcr
1716814|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
1716815|NCT00043641|Drug Intensification|drug intensification
1716816|NCT00043641|Ultra-low|ultra-low
1716817|NCT00043641|Sequence|sequence
1716818|NCT00043641|HIV|hiv
1716819|NCT00043641|Treatment Experienced|treatment experienced
1716820|NCT00043628|Progenitor Cells|progenitor cells
1716821|NCT00043628|MRI|mri
1716822|NCT00043628|Coronary Blood Flow|coronary blood flow
1716823|NCT00043628|Hematopoiesis|hematopoiesis
1716824|NCT00043628|Myocardial Contractility|myocardial contractility
1716825|NCT00043628|Coronary Artery Disease|coronary artery disease
1716826|NCT00043628|CAD|cad
1716827|NCT00043628|Heart Disease|heart disease
1716828|NCT00043615|Angiogenesis|angiogenesis
1716829|NCT00043615|Drug Resistance|drug resistance
1716830|NCT00043615|Signal Transduction|signal transduction
1716831|NCT00043615|EGFR|egfr
1716832|NCT00043615|Survival Factors|survival factors
1716833|NCT00043615|Malignancy|malignancy
1716834|NCT00043615|Pre-Cancer Condition|pre-cancer condition
1716835|NCT00043615|Cancer Risk|cancer risk
1716836|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
1716837|NCT00043563|Minimal Attention Control|minimal attention control
1724606|NCT00001085|Lamivudine|lamivudine
1716838|NCT00043550|Major Depressive Disorder|major depressive disorder
1716839|NCT00043537|Phobic Disorders|phobic disorders
1716840|NCT00043537|Mutism|mutism
1716841|NCT00043511|Injections, Intramuscular|injections, intramuscular
1716842|NCT00043511|HIV Seronegativity|hiv seronegativity
1716843|NCT00043511|Plasmids|plasmids
1716844|NCT00043511|Vaccines, DNA|vaccines, dna
1716845|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
1716846|NCT00043498|Pollutants|pollutants
1716847|NCT00043459|NHL|nhl
1716848|NCT00043433|HCC|hcc
1716849|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
1716850|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
1716851|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
1716852|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
1716853|NCT00043381|MDS|mds
1716854|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
1716855|NCT00043381|CMML|cmml
1716856|NCT00043381|decitabine|decitabine
1716857|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
1716858|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
1716859|NCT00043355|pulmonary|pulmonary
1716860|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
1716861|NCT00043355|MAC|mac
1716862|NCT00043355|nontuberculous|nontuberculous
1716863|NCT00043355|mycobacteria|mycobacteria
1716864|NCT00043355|lung|lung
1716865|NCT00043342|cystic fibrosis|cystic fibrosis
1716866|NCT00043342|pulmonary impairment|pulmonary impairment
1716867|NCT00043472|Screening|screening
1716868|NCT00043472|Oophorectomy|oophorectomy
1716869|NCT00043472|Hereditary|hereditary
1716870|NCT00043472|Genetics|genetics
1716871|NCT00043472|Cancer|cancer
1716872|NCT00043472|Ovarian Cancer|ovarian cancer
1716873|NCT00043472|Ovarian Cancer Risk|ovarian cancer risk
1716874|NCT00043316|cystic fibrosis|cystic fibrosis
1716875|NCT00043316|pulmonary impairment|pulmonary impairment
1716876|NCT00043303|hepatitis C|hepatitis c
1716877|NCT00043303|liver fibrosis|liver fibrosis
1716878|NCT00043303|liver cirrhosis|liver cirrhosis
1716879|NCT00043277|neonates|neonates
1716880|NCT00043277|thrombosis|thrombosis
1716881|NCT00043277|bivalirudin|bivalirudin
1716882|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
1716883|NCT00043238|PCBs|pcbs
1716884|NCT00043238|Thyroid|thyroid
1716885|NCT00043238|Hyperactivity|hyperactivity
1716886|NCT00043238|School Performance|school performance
1716887|NCT00043238|Mohawk Tribe|mohawk tribe
1716888|NCT00043212|prostate cancer|prostate cancer
1716889|NCT00043212|oncology|oncology
1716890|NCT00043212|urology|urology
1716891|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
1716892|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
1716893|NCT00043199|Colorectal Cancer|colorectal cancer
1716894|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
1716895|NCT00043199|Colorectal Tumor|colorectal tumor
1716896|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
1716897|NCT00043199|Unresectable|unresectable
1716898|NCT00043199|Metastatic|metastatic
1716899|NCT00043199|Refractory|refractory
1716900|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
1716901|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
1716902|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
1716903|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
1716904|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
1716905|NCT00043225|SCID|scid
1716906|NCT00043225|ADA-SCID|ada-scid
1716907|NCT00043225|Immune Deficiency|immune deficiency
1716909|NCT00043186|osteoporosis|osteoporosis
1716910|NCT00042718|Chronic Bronchitis|chronic bronchitis
1716911|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
1716912|NCT00042705|asthma|asthma
1716913|NCT00042705|indoor allergens|indoor allergens
1716914|NCT00042692|catechol thioethers|catechol thioethers
1716915|NCT00042692|Parkinson's disease|parkinson's disease
1716916|NCT00042692|neurodegenerative disease|neurodegenerative disease
1716917|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
1716918|NCT00042679|Adenocarcinoma|adenocarcinoma
1716919|NCT00042679|Carcinoma Squamous|carcinoma squamous
1716920|NCT00042679|Adult Lung Cancer|adult lung cancer
1716921|NCT00042588|Safety and Efficacy|safety and efficacy
1716922|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
1716923|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
1716924|NCT00042562|Depressed|depressed
1716925|NCT00042562|blues|blues
1716926|NCT00042562|sadness|sadness
1716927|NCT00042562|feelings of guilt|feelings of guilt
1716928|NCT00042562|hopelessness|hopelessness
1716929|NCT00042562|lack of energy|lack of energy
1716930|NCT00042549|Gallstones|gallstones
1716931|NCT00042549|Gallstone|gallstone
1716932|NCT00042549|Biliary stones|biliary stones
1716933|NCT00042549|Gallbladder stones|gallbladder stones
1716934|NCT00042549|Gallbladder|gallbladder
1716935|NCT00042549|Lithotripsy|lithotripsy
1716936|NCT00042549|Cholelithiasis|cholelithiasis
1716943|NCT00042627|Granulocytapheresis|granulocytapheresis
1716944|NCT00042627|Granulocyte Donors|granulocyte donors
1716945|NCT00042614|Genes|genes
1716946|NCT00042614|Heart|heart
1716947|NCT00042614|Lymphocytes|lymphocytes
1716948|NCT00042614|Proteomics|proteomics
1716949|NCT00042614|Transplant|transplant
1716950|NCT00042614|Heart Transplant|heart transplant
1716951|NCT00042614|Healthy Volunteer|healthy volunteer
1716952|NCT00042614|HV|hv
1716953|NCT00042614|Normal Control|normal control
1716954|NCT00042536|Yohimbine|yohimbine
1716955|NCT00042536|Naltrexone|naltrexone
1716956|NCT00042536|Sexual Function|sexual function
1716957|NCT00042536|Erectile Dysfunction|erectile dysfunction
1716958|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
1716959|NCT00042536|Opiate Receptor|opiate receptor
1716960|NCT00042536|Male Impotence|male impotence
1716961|NCT00042536|ED|ed
1716962|NCT00042536|Healthy Volunteer|healthy volunteer
1716964|NCT00042536|Normal Control|normal control
1716965|NCT00042523|Autoantibody|autoantibody
1716966|NCT00042523|Anti-DNA Antibody|anti-dna antibody
1716967|NCT00042523|Cross-Reactivity|cross-reactivity
1716968|NCT00042523|Neuron Loss|neuron loss
1716969|NCT00042523|Imaging|imaging
1716970|NCT00042523|Lupus|lupus
1716971|NCT00042523|SLE|sle
1716972|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
1716973|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
1716974|NCT00042510|Gastric cancer|gastric cancer
1716975|NCT00042484|Asthma|asthma
1716976|NCT00042484|Children's Health|children's health
1716977|NCT00042484|Community Based Research|community based research
1716978|NCT00042445|Neoplasm|neoplasm
1716979|NCT00042445|Petrochemical|petrochemical
1716980|NCT00042445|Leukemia|leukemia
1716981|NCT00042445|Taiwan|taiwan
1716982|NCT00042419|Industrial Injuries|industrial injuries
1716983|NCT00042419|Tendonitis|tendonitis
1716984|NCT00042419|Assembly Line|assembly line
1716985|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
1716986|NCT00042354|CLO222|clo222
1716987|NCT00042354|clolar|clolar
1716988|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
1716989|NCT00042341|CLO212|clo212
1716990|NCT00042341|clolar|clolar
1716991|NCT00042341|pediatric ALL|pediatric all
1716992|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
1716993|NCT00042328|Cancer|cancer
1716994|NCT00042289|Pregnancy|pregnancy
1716995|NCT00042289|Pharmacokinetics|pharmacokinetics
1716996|NCT00042289|Treatment Experienced|treatment experienced
1716997|NCT00041483|AMD|amd
1716998|NCT00041483|age-related macular degeneration|age-related macular degeneration
1716999|NCT00041483|Anecortave|anecortave
1717000|NCT00041483|Acetate|acetate
1717001|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
1717002|NCT00042380|Antidepressant|antidepressant
1717003|NCT00042380|Anxiety|anxiety
1717004|NCT00042380|Dopamine|dopamine
1717005|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
1717006|NCT00042380|Affective Disorder|affective disorder
1717007|NCT00042380|Phytoestrogen|phytoestrogen
1717008|NCT00042380|Genistein|genistein
1717009|NCT00042380|Major Depression|major depression
1717010|NCT00042380|Depression|depression
1717011|NCT00042276|Pressure Pain Threshold|pressure pain threshold
1717012|NCT00042276|MTrP|mtrp
1717013|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
1717014|NCT00042276|Soft Tissue Pain|soft tissue pain
1717015|NCT00042276|Pathophysiology|pathophysiology
1717016|NCT00042276|Myofascial Pain|myofascial pain
1717017|NCT00042276|Microdialysis|microdialysis
1717018|NCT00042276|Myofascial Trigger Points|myofascial trigger points
1717019|NCT00042276|Rehabilitation|rehabilitation
1717020|NCT00042276|Muscle Pain|muscle pain
1717021|NCT00042276|Neck Pain|neck pain
1717022|NCT00042276|Healthy Volunteer|healthy volunteer
1717023|NCT00042276|HV|hv
1717024|NCT00042276|Normal Control|normal control
1717025|NCT00042263|health disparities|health disparities
1717026|NCT00042263|social environment|social environment
1717027|NCT00042263|physical environment|physical environment
1717028|NCT00042263|racial health disparities|racial health disparities
1717029|NCT00042250|Cell Cycle Interphase|cell cycle interphase
1717030|NCT00042250|G0|g0
1717031|NCT00042250|G1|g1
1717032|NCT00042250|G2|g2
1717033|NCT00042250|S Phase|s phase
1717034|NCT00042237|Child Abuse, Sexual|child abuse, sexual
1717035|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
1717036|NCT00042211|Depressive Disorder|depressive disorder
1717037|NCT00042211|Blindness|blindness
1717038|NCT00042211|Aged|aged
1717039|NCT00042198|Cognitive therapy|cognitive therapy
1717040|NCT00042198|Relaxation techniques|relaxation techniques
1717041|NCT00042185|Adolescence|adolescence
1717042|NCT00042185|Prevention and Control|prevention and control
1717043|NCT00042185|Bulimia|bulimia
1717044|NCT00042172|Cognition|cognition
1717045|NCT00042172|Memory|memory
1717046|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
1717047|NCT00042146|Insomnia|insomnia
1717048|NCT00042146|Sleep Disorders|sleep disorders
1717049|NCT00042146|Sleep Deprivation|sleep deprivation
1717052|NCT00042133|longitudinal studies|longitudinal studies
1717053|NCT00042133|neighborhood factors|neighborhood factors
1717054|NCT00042133|socio-economic status|socio-economic status
1717055|NCT00042133|race|race
1717056|NCT00042120|Parkinson's disease|parkinson's disease
1717057|NCT00042120|Movement Disorders|movement disorders
1717058|NCT00042120|Epidemiological Study|epidemiological study
1717059|NCT00042107|Parkinson Disease|parkinson disease
1717060|NCT00042107|Neurodegenerative|neurodegenerative
1717061|NCT00042094|Smallpox|smallpox
1717062|NCT00042094|Smallpox Vaccine|smallpox vaccine
1717063|NCT00042094|Vaccinia|vaccinia
1717064|NCT00042081|CABG|cabg
1717065|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
1717066|NCT00042081|coronary artery disease|coronary artery disease
1717067|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
1717068|NCT00042081|coronary stenosis|coronary stenosis
1717069|NCT00042081|coronary occlusion|coronary occlusion
1717070|NCT00042055|Crohn's Disease|crohn's disease
1717071|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
1717072|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
1717074|NCT00042016|CML-CP|cml-cp
1717075|NCT00042016|Chronic phase|chronic phase
1717076|NCT00042016|Decitabine|decitabine
1717077|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
1717078|NCT00042016|Methylation|methylation
1717079|NCT00042016|STI 571|sti 571
1717080|NCT00042016|Imatinib mesylate|imatinib mesylate
1717081|NCT00042016|Gleevec|gleevec
1717082|NCT00042016|BCR/ABL|bcr/abl
1717083|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
1717084|NCT00042003|CML|cml
1717085|NCT00042003|CML-BP|cml-bp
1717086|NCT00042003|Blast phase|blast phase
1717087|NCT00042003|Decitabine|decitabine
1717088|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
1717089|NCT00042003|Methylation|methylation
1717090|NCT00042003|STI 571|sti 571
1717091|NCT00042003|Imatinib mesylate|imatinib mesylate
1717092|NCT00042003|Gleevec|gleevec
1717093|NCT00042003|BCR/ABL|bcr/abl
1717094|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
1717095|NCT00041990|CML|cml
1717096|NCT00041990|CML-AP|cml-ap
1717097|NCT00041990|Accelerated phase|accelerated phase
1717098|NCT00041990|Decitabine|decitabine
1717099|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
1717100|NCT00041990|Methylation|methylation
1717101|NCT00041990|STI 571|sti 571
1717102|NCT00041990|Imatinib mesylate|imatinib mesylate
1717103|NCT00041990|Gleevec|gleevec
1717104|NCT00041990|BCR/ABL|bcr/abl
1717105|NCT00041977|Rosacea|rosacea
1717106|NCT00041964|Lopinavir|lopinavir
1717107|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
1717108|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
1717109|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
1717110|NCT00041964|Ritonavir|ritonavir
1717111|NCT00041964|Nelfinavir|nelfinavir
1717112|NCT00041964|Viral Load|viral load
1717113|NCT00041964|puerperium|puerperium
1717114|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
1717115|NCT00041951|CAE|cae
1717116|NCT00041951|Petit Mal|petit mal
1717117|NCT00041951|Epilepsy|epilepsy
1717118|NCT00041951|Seizures|seizures
1717119|NCT00041951|Genes|genes
1717120|NCT00041951|Inheritance|inheritance
1717121|NCT00041951|Genetics|genetics
1717122|NCT00041951|Genetic Linkage|genetic linkage
1717123|NCT00041938|heart disease|heart disease
1717124|NCT00041938|stroke|stroke
1717125|NCT00041938|ischemic heart disease|ischemic heart disease
1717126|NCT00041938|myocardial infarction|myocardial infarction
1717127|NCT00041938|atrial fibrillation|atrial fibrillation
1717128|NCT00041938|low ejection fraction|low ejection fraction
1717129|NCT00041938|cardiac failure|cardiac failure
1717130|NCT00041938|aspirin|aspirin
1717131|NCT00041938|Warfarin|warfarin
1717132|NCT00041938|anticoagulant|anticoagulant
1717133|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
1717134|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
1717135|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
1717136|NCT00041925|peripheral vein bypass|peripheral vein bypass
1717137|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
1717138|NCT00041925|graft stenosis|graft stenosis
1717139|NCT00041925|occluded grafts|occluded grafts
1717140|NCT00041860|Benzene|benzene
1717141|NCT00041860|Air pollution|air pollution
1717142|NCT00041847|gene|gene
1717143|NCT00041847|environment|environment
1717144|NCT00041847|occupation|occupation
1717145|NCT00041847|diet|diet
1717146|NCT00041847|interaction|interaction
1717147|NCT00041834|childhood asthma|childhood asthma
1717148|NCT00041834|traffic|traffic
1717149|NCT00041821|rhinitis|rhinitis
1717150|NCT00041821|irritation|irritation
1717151|NCT00041821|trigeminal|trigeminal
1717152|NCT00041899|Progesterone|progesterone
1717153|NCT00041899|Cortisol|cortisol
1717154|NCT00041899|Menstrual Cycle|menstrual cycle
1717155|NCT00041899|Formulation|formulation
1717156|NCT00041899|Endometrium|endometrium
1717157|NCT00041899|Estrogen|estrogen
1717158|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
1717159|NCT00041886|Percutaneous|percutaneous
1717160|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
1717161|NCT00041886|Soft Tissue Metastases|soft tissue metastases
1717162|NCT00041886|Thermal Ablation|thermal ablation
1717163|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
1717164|NCT00041886|Tumor|tumor
1717165|NCT00041808|Metastatic liver cancer|metastatic liver cancer
1717166|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
1717167|NCT00041808|colorectal cancer|colorectal cancer
1717168|NCT00041808|esophageal cancer|esophageal cancer
1717169|NCT00041808|gastric cancer|gastric cancer
1717170|NCT00041808|pancreatic cancer|pancreatic cancer
1717171|NCT00041808|breast cancer|breast cancer
1717172|NCT00041808|malignant melanoma|malignant melanoma
1717173|NCT00041808|sarcoma|sarcoma
1717174|NCT00041808|GIST|gist
1717175|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
1717176|NCT00041808|lung cancer|lung cancer
1717177|NCT00041808|liver cancer|liver cancer
1717178|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
1717179|NCT00041769|Drug Therapy, Combination|drug therapy, combination
1717180|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
1717181|NCT00041769|Salvage Therapy|salvage therapy
1717182|NCT00041769|Viral Load|viral load
1717183|NCT00041769|Treatment Experienced|treatment experienced
1717184|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
1717185|NCT00041730|lymphoma|lymphoma
1717186|NCT00041730|vaccine|vaccine
1717187|NCT00041730|idiotype|idiotype
1717189|NCT00041730|GM-CSF|gm-csf
1717190|NCT00041730|FavId|favid
1717191|NCT00041717|spinal cord injury|spinal cord injury
1717192|NCT00041717|muscle spasticity|muscle spasticity
1717193|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
1717194|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
1717195|NCT00041691|Colorectal Cancer|colorectal cancer
1717196|NCT00041691|Colon Cancer|colon cancer
1717197|NCT00041691|Rectal Cancer|rectal cancer
1717198|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
1717199|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
1717200|NCT00041691|Colorectal Tumor|colorectal tumor
1717201|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
1717202|NCT00041652|Colorectal Cancer|colorectal cancer
1717203|NCT00041652|Colon Cancer|colon cancer
1717204|NCT00041652|Rectal Cancer|rectal cancer
1717205|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
1717206|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
1717207|NCT00041652|Breast Cancer|breast cancer
1717208|NCT00041652|Breast Neoplasms|breast neoplasms
1717209|NCT00041639|Pancreatic Cancer|pancreatic cancer
1717210|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
1717211|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
1717212|NCT00041639|Pancreas Cancer|pancreas cancer
1717213|NCT00041639|Pancreatic Tumor|pancreatic tumor
1717214|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
1717215|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
1717216|NCT00041600|epilepsy|epilepsy
1717217|NCT00041600|seizures|seizures
1717218|NCT00041600|disorders of human cognition|disorders of human cognition
1717219|NCT00041600|neuronal migration|neuronal migration
1717430|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
1717220|NCT00041600|neuronal migration disorders|neuronal migration disorders
1717221|NCT00041600|lissencephaly|lissencephaly
1717222|NCT00041600|schizencephaly|schizencephaly
1717223|NCT00041600|polymicrogyria|polymicrogyria
1717224|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
1717225|NCT00041600|heterotopia|heterotopia
1717226|NCT00041587|Cancer|cancer
1717227|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
1717228|NCT00041509|venous thromboembolism|venous thromboembolism
1717229|NCT00041509|thromboembolism|thromboembolism
1717230|NCT00041509|pulmonary embolism|pulmonary embolism
1717231|NCT00041509|deep vein thrombosis|deep vein thrombosis
1717232|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
1717233|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
1717234|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
1717235|NCT00041535|Eye Movements|eye movements
1717236|NCT00041535|Saccades|saccades
1717237|NCT00041535|Metabolic|metabolic
1717238|NCT00041535|Lysosomal|lysosomal
1717239|NCT00041535|Myoclonus|myoclonus
1717240|NCT00041535|Gaucher Disease|gaucher disease
1717241|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
1717242|NCT00040677|sickle cell anemia|sickle cell anemia
1717243|NCT00040677|sickle cell disease|sickle cell disease
1717244|NCT00040677|anemia|anemia
1717245|NCT00040677|ICA-17043|ica-17043
1717246|NCT00040677|senicapoc|senicapoc
1717247|NCT00040664|pediatrics|pediatrics
1717248|NCT00040664|HIV|hiv
1717249|NCT00040664|protease inhibitors|protease inhibitors
1717250|NCT00040664|ritonavir|ritonavir
1717251|NCT00040664|fosamprenavir|fosamprenavir
1717252|NCT00040664|LEXIVA|lexiva
1717253|NCT00040664|AGENERASE|agenerase
1717254|NCT00040664|amprenavir|amprenavir
1717255|NCT00040651|Systemic Sclerosis|systemic sclerosis
1717256|NCT00040651|Chemotherapy|chemotherapy
1717257|NCT00040651|Cyclophosphamide|cyclophosphamide
1717258|NCT00040651|Fludarabine|fludarabine
1717259|NCT00040651|Leukapheresis|leukapheresis
1717260|NCT00040651|Mesna|mesna
1717261|NCT00040651|Stem Cell|stem cell
1717262|NCT00040651|T-Cell|t-cell
1717263|NCT00040651|Thymoglobulin|thymoglobulin
1717264|NCT00040651|Scleroderma|scleroderma
1717265|NCT00040027|hepatitis C|hepatitis c
1717266|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
1717267|NCT00040599|Colon Cancer|colon cancer
1717268|NCT00040599|Rectal Cancer|rectal cancer
1717269|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
1717270|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
1717271|NCT00040599|Colorectal Tumor|colorectal tumor
1717272|NCT00040586|hormone-refractory|hormone-refractory
1717273|NCT00040573|Brain neoplasm|brain neoplasm
1717274|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
1717275|NCT00040560|Lung Cancer|lung cancer
1717276|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
1717277|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
1717278|NCT00040534|Advanced Cancer|advanced cancer
1717279|NCT00040521|Crohn's Disease|crohn's disease
1717280|NCT00040521|Active Crohns Disease|active crohns disease
1717281|NCT00040495|Peptic|peptic
1717282|NCT00040495|Ulcer|ulcer
1717283|NCT00040495|Hemorrhage|hemorrhage
1717284|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
1717285|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
1717286|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
1717287|NCT00040443|Memory Loss|memory loss
1717288|NCT00040443|Alzheimer's Disease|alzheimer's disease
1717289|NCT00040443|Brain Aging|brain aging
1717290|NCT00040443|Ampalex®|ampalex®
1717291|NCT00040443|CX516|cx516
1717292|NCT00040508|Proteinuria|proteinuria
1717293|NCT00040508|Renal Failure|renal failure
1717294|NCT00040508|Fibrosis|fibrosis
1717295|NCT00040508|Rapamycin|rapamycin
1717296|NCT00040508|Immunosuppression|immunosuppression
1717297|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1717298|NCT00040508|FSGS|fsgs
1717299|NCT00040404|Parkinson's disease|parkinson's disease
1717300|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
1717301|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
1717302|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
1717303|NCT00040391|Pharmacia|pharmacia
1717304|NCT00040378|Alzheimer Disease|alzheimer disease
1717305|NCT00040378|Vitamin E|vitamin e
1717306|NCT00040378|Selenium|selenium
1717307|NCT00040365|Prostate Cancer|prostate cancer
1717308|NCT00040365|Radiation Therapy|radiation therapy
1717309|NCT00040365|Rectal Toxicity|rectal toxicity
1717310|NCT00040365|Amifostine|amifostine
1717311|NCT00040365|Radioprotector|radioprotector
1717312|NCT00040352|Genetics|genetics
1717313|NCT00040352|Risk Factors|risk factors
1717314|NCT00040352|Natural History|natural history
1717315|NCT00040352|Melanoma Precursors|melanoma precursors
1717316|NCT00040352|Skin Cancer|skin cancer
1717317|NCT00040352|Melanoma|melanoma
1717318|NCT00040339|brain injury|brain injury
1717319|NCT00040339|hypothermia|hypothermia
1717320|NCT00040339|body cooling|body cooling
1717321|NCT00040339|body temperature|body temperature
1717322|NCT00040326|epilepsy|epilepsy
1717323|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
1717324|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
1717325|NCT00040326|MTLE|mtle
1717326|NCT00040326|seizures|seizures
1717327|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
1717328|NCT00040326|surgery|surgery
1717329|NCT00040326|antiepileptic drugs|antiepileptic drugs
1717330|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
1717331|NCT00040300|treatment experienced|treatment experienced
1717332|NCT00040300|HIV|hiv
1717333|NCT00040300|Phase I|phase i
1717334|NCT00040300|Combination Therapy|combination therapy
1717335|NCT00040287|smoking|smoking
1717336|NCT00040287|obesity|obesity
1717337|NCT00040287|weight loss|weight loss
1717338|NCT00040287|smoking cessation|smoking cessation
1717339|NCT00040287|weight control|weight control
1717340|NCT00040274|HIV|hiv
1717341|NCT00040274|Phase I|phase i
1717342|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
1717343|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
1717344|NCT00040157|treatment experienced,|treatment experienced,
1717345|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
1717346|NCT00040157|Achillion|achillion
1717347|NCT00040144|E-Antigen positive,|e-antigen positive,
1717348|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
1717349|NCT00040144|Achillion|achillion
1717350|NCT00040261|Antiglutamatergic|antiglutamatergic
1717351|NCT00040261|Neuroprotective|neuroprotective
1717352|NCT00040261|Unipolar Depression|unipolar depression
1717353|NCT00040261|Treatment|treatment
1717354|NCT00040261|Antidepressant|antidepressant
1717355|NCT00040261|Depression|depression
1717356|NCT00040261|Glutamate|glutamate
1717358|NCT00040261|Pathophysiology|pathophysiology
1717359|NCT00040261|Positron Emission Tomography|positron emission tomography
1717360|NCT00040261|Major Depression|major depression
1717361|NCT00040248|Relapse|relapse
1717362|NCT00040248|Monoclonal Antibody|monoclonal antibody
1717363|NCT00040248|Biologic Agent|biologic agent
1717364|NCT00040248|Anti-CD25|anti-cd25
1717365|NCT00040248|Activated Lymphocyte|activated lymphocyte
1717366|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
1717367|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
1717368|NCT00040248|WG|wg
1717369|NCT00040235|Leukapheresis|leukapheresis
1717370|NCT00040235|Hypomagnesemia|hypomagnesemia
1717371|NCT00040235|Plateletpheresis|plateletpheresis
1717372|NCT00040235|Hypocalcemia|hypocalcemia
1717373|NCT00040235|Citrate|citrate
1717374|NCT00040235|Healthy Volunteer|healthy volunteer
1717375|NCT00040235|HV|hv
1717376|NCT00040235|Normal Control|normal control
1717377|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
1717378|NCT00040222|Gene discovery|gene discovery
1717379|NCT00040222|Cancer prevention|cancer prevention
1717380|NCT00040222|Risk-reduction|risk-reduction
1717381|NCT00040222|Hereditary|hereditary
1717382|NCT00040222|Breast Cancer|breast cancer
1717383|NCT00040222|Ovarian Cancer|ovarian cancer
1717384|NCT00040222|Cowden Syndrome|cowden syndrome
1717385|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
1717386|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
1717387|NCT00040209|JP 1730|jp 1730
1717388|NCT00040209|Dyskinesias|dyskinesias
1717389|NCT00040209|Levodopa Infusion|levodopa infusion
1717390|NCT00040209|Apomorphine Infusion|apomorphine infusion
1717391|NCT00040209|Clinical Trial|clinical trial
1717392|NCT00040209|Parkinson Disease|parkinson disease
1717393|NCT00040209|PD|pd
1717394|NCT00040196|Parkinson's Disease|parkinson's disease
1717395|NCT00040196|Levodopa|levodopa
1717396|NCT00040196|Perfusion fMRI|perfusion fmri
1717397|NCT00040196|Aging|aging
1717398|NCT00040196|Motor Control|motor control
1717399|NCT00040196|PD|pd
1717400|NCT00040196|Healthy Volunteer|healthy volunteer
1717401|NCT00040196|HV|hv
1717402|NCT00040196|Normal Control|normal control
1717403|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
1717404|NCT00040105|R115777|r115777
1717405|NCT00040105|Zarnestra|zarnestra
1717406|NCT00040105|Tipifarnib|tipifarnib
1717407|NCT00040105|Imatinib Mesylate|imatinib mesylate
1717408|NCT00040105|Gleevec|gleevec
1717409|NCT00040105|Imatinib|imatinib
1717410|NCT00040105|STI571|sti571
1717411|NCT00040105|NSC-716051|nsc-716051
1717412|NCT00040092|Virulizin|virulizin
1717413|NCT00040092|Immunotherapy|immunotherapy
1717414|NCT00040092|Pancreas|pancreas
1717415|NCT00040092|Pancreatic Cancer|pancreatic cancer
1717416|NCT00040092|clinical trial|clinical trial
1717417|NCT00039988|Treatment Outcome|treatment outcome
1717418|NCT00039988|Multiple Sclerosis|multiple sclerosis
1717419|NCT00039988|Albuterol|albuterol
1717420|NCT00039988|Copolymer 1|copolymer 1
1717421|NCT00039975|Drug Interactions|drug interactions
1717422|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
1717423|NCT00039975|Ritonavir|ritonavir
1717424|NCT00039975|Indinavir|indinavir
1717425|NCT00039975|Calcium Channel Blockers|calcium channel blockers
1717426|NCT00039975|Pharmacokinetics|pharmacokinetics
1717431|NCT00039962|cirrhosis, liver|cirrhosis, liver
1717432|NCT00039936|Binge Eating|binge eating
1717433|NCT00039936|Obesity|obesity
1717434|NCT00039936|Cognitive|cognitive
1717435|NCT00039936|Behavior|behavior
1717436|NCT00040053|amphetamine dependence|amphetamine dependence
1717437|NCT00039923|Hemolysis|hemolysis
1717438|NCT00039923|CD55|cd55
1717439|NCT00039923|CD59|cd59
1717440|NCT00039923|Transfusion|transfusion
1717441|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1717443|NCT00039884|Cervical cancer|cervical cancer
1717444|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
1717445|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
1717446|NCT00039858|HIT|hit
1717447|NCT00039858|HITTS|hitts
1717448|NCT00039858|anticoagulation|anticoagulation
1717449|NCT00039845|Brain|brain
1717450|NCT00039845|Imaging|imaging
1717451|NCT00039845|Pediatrics|pediatrics
1717452|NCT00039845|Mapping|mapping
1717453|NCT00039845|Development|development
1717454|NCT00039845|fMRI|fmri
1717455|NCT00039845|Children|children
1717456|NCT00039845|Language|language
1717457|NCT00039845|Healthy Volunteer|healthy volunteer
1717458|NCT00039845|HV|hv
1717459|NCT00039845|Normal Control|normal control
1717460|NCT00039832|Stroke|stroke
1717461|NCT00039832|Abciximab|abciximab
1717462|NCT00039832|Reteplase|reteplase
1717463|NCT00039832|MRI|mri
1717464|NCT00039832|Cerebral Blood Flow|cerebral blood flow
1717465|NCT00039793|Cancer-related fatigue|cancer-related fatigue
1717466|NCT00039793|alternative medicine|alternative medicine
1717467|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
1717468|NCT00039793|fatigue|fatigue
1717469|NCT00039793|human therapy evaluation|human therapy evaluation
1717470|NCT00039793|physical therapy|physical therapy
1717471|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
1717472|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
1717473|NCT00039780|Breast|breast
1717474|NCT00039780|Cancer|cancer
1717475|NCT00039780|Metastatic|metastatic
1717476|NCT00039780|Paclitaxel|paclitaxel
1717477|NCT00039780|Peripheral|peripheral
1717478|NCT00039780|Taxol|taxol
1717479|NCT00039780|Neuropathy|neuropathy
1717480|NCT00039780|Neurotoxicity|neurotoxicity
1717481|NCT00039780|Paresthesias|paresthesias
1717488|NCT00039819|Sensory Stimulation|sensory stimulation
1717489|NCT00039819|Locomotion|locomotion
1717490|NCT00039819|Magnetic Stimulation|magnetic stimulation
1717491|NCT00039819|Reflexes|reflexes
1717492|NCT00039819|Healthy Volunteer|healthy volunteer
1717493|NCT00039819|HV|hv
1717494|NCT00039819|Normal Control|normal control
1717495|NCT00039754|Multiple myeloma|multiple myeloma
1717496|NCT00039754|Transplant|transplant
1717497|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
1717498|NCT00039754|Holmium|holmium
1717499|NCT00039741|Drug Therapy, Combination|drug therapy, combination
1717500|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
1717501|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1717502|NCT00039741|Viral Load|viral load
1717503|NCT00039741|Treatment Naive|treatment naive
1717504|NCT00039767|Fibrin Sleeves|fibrin sleeves
1717505|NCT00039767|Anticoagulants|anticoagulants
1717506|NCT00039767|Catheters|catheters
1717507|NCT00039767|Thrombosis|thrombosis
1717508|NCT00039767|Hirudin|hirudin
1717509|NCT00039767|Lepirudin|lepirudin
1717510|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
1717511|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
1717512|NCT00038987|Smallpox|smallpox
1717513|NCT00038987|APSV|apsv
1717514|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
1717515|NCT00038987|vaccinia-naive|vaccinia-naive
1717516|NCT00038974|Hepatitis C|hepatitis c
1717517|NCT00038974|Interferon|interferon
1717518|NCT00038974|Ribavirin|ribavirin
1717519|NCT00038974|Efficacy|efficacy
1717520|NCT00038974|Viral load|viral load
1717521|NCT00038974|Genetics|genetics
1717522|NCT00038974|Cytokines|cytokines
1717523|NCT00038974|Immunology|immunology
1717524|NCT00038961|fondaparinux sodium|fondaparinux sodium
1717525|NCT00038961|DVT Prevention|dvt prevention
1717526|NCT00038961|abdominal surgery|abdominal surgery
1717527|NCT00038961|VTE prevention|vte prevention
1717528|NCT00038961|venous thromboembolism|venous thromboembolism
1717529|NCT00038961|pulmonary embolism|pulmonary embolism
1717530|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
1717531|NCT00039715|Traumatic Reminders|traumatic reminders
1717532|NCT00039715|Stress|stress
1717533|NCT00039715|Hippocampus|hippocampus
1717534|NCT00039715|Flashbacks|flashbacks
1717535|NCT00039715|PTSD|ptsd
1717536|NCT00039715|Type II GR Receptor|type ii gr receptor
1717537|NCT00039715|Hydrocortisone|hydrocortisone
1717538|NCT00039715|Memory|memory
1717539|NCT00039715|Major Depression|major depression
1717540|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1717541|NCT00039715|Healthy Volunteer|healthy volunteer
1717542|NCT00039715|HV|hv
1717543|NCT00039715|Normal Control|normal control
1717544|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
1717545|NCT00039702|Alzheimer's Disease|alzheimer's disease
1717546|NCT00039702|SPECT|spect
1717547|NCT00039702|AD|ad
1717548|NCT00039702|Healthy Volunteer|healthy volunteer
1717549|NCT00039702|HV|hv
1717550|NCT00039702|Normal Control|normal control
1717551|NCT00039689|Primary HIV Infection|primary hiv infection
1717552|NCT00039689|Chronic HIV Infection|chronic hiv infection
1717553|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
1717554|NCT00039689|Innate Immunity|innate immunity
1717555|NCT00039689|B Cell|b cell
1717556|NCT00039689|HIV Infection|hiv infection
1717557|NCT00039689|Acute Infection|acute infection
1717558|NCT00039689|Treatment Naive|treatment naive
1717559|NCT00039676|Genetics|genetics
1717560|NCT00039676|Risk Factors|risk factors
1717561|NCT00039676|Natural History|natural history
1717562|NCT00039676|Lymphoma|lymphoma
1717563|NCT00039676|Leukemia|leukemia
1717564|NCT00039676|Lymph Node Cancer|lymph node cancer
1717565|NCT00039663|Hyperlipidemia|hyperlipidemia
1717566|NCT00039663|Insulin Resistance|insulin resistance
1717567|NCT00039663|Coronary Artery Disease|coronary artery disease
1717568|NCT00039663|Lipodystrophy|lipodystrophy
1717569|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
1717570|NCT00039663|HIV Infection|hiv infection
1717571|NCT00039663|Treatment Experienced|treatment experienced
1717572|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1717573|NCT00039650|T Cells|t cells
1717574|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
1717575|NCT00039650|Apheresis|apheresis
1717576|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
1717577|NCT00039650|Healthy Volunteer|healthy volunteer
1717578|NCT00039650|HV|hv
1717579|NCT00039650|Normal Control|normal control
1717580|NCT00039624|Radiation Therapy|radiation therapy
1717581|NCT00039624|Prostate|prostate
1717582|NCT00039624|MRI|mri
1717583|NCT00039624|Brachytherapy|brachytherapy
1717584|NCT00039624|Phase II|phase ii
1717585|NCT00039624|Prostate Cancer|prostate cancer
1717586|NCT00038948|Renal|renal
1717587|NCT00038948|Allograft|allograft
1717588|NCT00038948|Recipients|recipients
1717589|NCT00038935|Hemophilia|hemophilia
1717590|NCT00038922|Left-Sided|left-sided
1717591|NCT00038922|Ulcerative|ulcerative
1717592|NCT00038922|Colitis|colitis
1717595|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
1717596|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1717597|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1717598|NCT00038883|Low grade Lymphoma|low grade lymphoma
1717599|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
1717600|NCT00038870|AML|aml
1717601|NCT00038870|CML|cml
1717602|NCT00038870|Dendritic Cells|dendritic cells
1717603|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
1717604|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1717605|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
1717606|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1717607|NCT00038857|Leukemia|leukemia
1717608|NCT00038857|Lymphoma|lymphoma
1717609|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
1717610|NCT00038857|T cell depletion|t cell depletion
1717611|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
1717612|NCT00038857|GVHD|gvhd
1717613|NCT00038844|Lymphoma|lymphoma
1717614|NCT00038844|Leukemia|leukemia
1717615|NCT00038844|Campath-1 H|campath-1 h
1717616|NCT00038844|Campath|campath
1717617|NCT00038844|Alemtuzumab|alemtuzumab
1717618|NCT00038844|Fludarabine|fludarabine
1717619|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
1717620|NCT00038844|Fludara|fludara
1717621|NCT00038844|Cyclophosphamide|cyclophosphamide
1717622|NCT00038844|Cytoxan|cytoxan
1717623|NCT00038844|Neosar|neosar
1717624|NCT00038844|Rituxan|rituxan
1717625|NCT00038844|Rituximab|rituximab
1717626|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
1717627|NCT00038831|AML|aml
1717628|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
1717629|NCT00038831|MDS|mds
1717630|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1717631|NCT00038831|CML|cml
1717632|NCT00038831|Mylotarg|mylotarg
1717633|NCT00038831|Gemtuzumab|gemtuzumab
1717634|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
1717635|NCT00038831|Melphalan|melphalan
1717636|NCT00038831|Alkeran|alkeran
1717637|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
1717638|NCT00038831|Fludarabine|fludarabine
1717639|NCT00038831|Fludara|fludara
1717640|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
1717641|NCT00038831|ATG|atg
1717642|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
1717643|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
1717644|NCT00038831|Allo PBSCT|allo pbsct
1717645|NCT00038831|Allogeneic transplantation|allogeneic transplantation
1717646|NCT00038818|CML|cml
1717647|NCT00038818|MM|mm
1717648|NCT00038818|NHL|nhl
1717649|NCT00038818|HD|hd
1717651|NCT00038818|CD8 Depleted|cd8 depleted
1717652|NCT00038818|Donor Lymphocyte|donor lymphocyte
1717653|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
1717654|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
1717655|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
1717656|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
1717658|NCT00038805|AML|aml
1717659|NCT00038805|MDS|mds
1717660|NCT00038805|CML|cml
1717661|NCT00038805|CMML|cmml
1717662|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
1717663|NCT00038805|Mylotarg|mylotarg
1717664|NCT00038805|CMA-676|cma-676
1717665|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
1717666|NCT00038792|Refractory|refractory
1717667|NCT00038779|Lymphoma|lymphoma
1717668|NCT00038779|CML|cml
1717669|NCT00038779|CLL|cll
1717670|NCT00038779|AML|aml
1717671|NCT00038779|ALL|all
1717672|NCT00038779|MDS|mds
1717673|NCT00038779|AA|aa
1717674|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
1717675|NCT00038753|vision screening|vision screening
1717676|NCT00038727|DPP|dpp
1717677|NCT00038727|IGT|igt
1717678|NCT00038727|Prediabetes|prediabetes
1717679|NCT00038727|Type 2 diabetes|type 2 diabetes
1717680|NCT00038727|Macrovascular disease|macrovascular disease
1717681|NCT00038727|Microvascular disease|microvascular disease
1717682|NCT00038727|Lifestyle|lifestyle
1717683|NCT00038727|Metformin|metformin
1717684|NCT00038727|Obesity|obesity
1717685|NCT00038714|HPV|hpv
1717686|NCT00038714|Papilloma|papilloma
1717687|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
1717688|NCT00038688|Health Education|health education
1717689|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
1717690|NCT00038688|Program Evaluation|program evaluation
1717693|NCT00038688|HIV Seronegativity|hiv seronegativity
1717694|NCT00038688|Substance-related Disorders|substance-related disorders
1717695|NCT00038675|Leukemia|leukemia
1717696|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1717697|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
1717698|NCT00038675|Polycythemia Vera|polycythemia vera
1717699|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1717700|NCT00038675|Mastocytosis|mastocytosis
1717701|NCT00038675|Imatinib Mesylate|imatinib mesylate
1717702|NCT00038675|Gleevec|gleevec
1717703|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
1717704|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
1717705|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
1717706|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1717708|NCT00038649|Gleevec|gleevec
1717709|NCT00038649|STI571|sti571
1717710|NCT00038636|HIV|hiv
1717711|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
1717712|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
1717713|NCT00038623|Zevalin|zevalin
1717714|NCT00038610|Leukemia|leukemia
1717715|NCT00038610|Lymphoblastic|lymphoblastic
1717716|NCT00038610|Acute|acute
1717717|NCT00038610|Philadelphia-Positive|philadelphia-positive
1717718|NCT00038610|Imatinib Mesylate|imatinib mesylate
1717719|NCT00038610|Gleevec|gleevec
1717720|NCT00038610|Glivec|glivec
1717721|NCT00038610|Imatinib|imatinib
1717722|NCT00038610|STI571|sti571
1717723|NCT00038610|STI-571|sti-571
1717724|NCT00038610|CGP-57148B|cgp-57148b
1717725|NCT00038610|NSC-716051|nsc-716051
1717726|NCT00038610|Cyclophosphamide|cyclophosphamide
1717727|NCT00038610|Cytoxan®,|cytoxan®,
1717728|NCT00038610|Neosar®|neosar®
1717729|NCT00038610|Doxorubicin|doxorubicin
1717730|NCT00038610|Adriamycin ®|adriamycin ®
1717731|NCT00038610|Rubex ®|rubex ®
1717732|NCT00038610|Adriamycin PFS|adriamycin pfs
1717733|NCT00038610|Adriamycin RDF|adriamycin rdf
1717734|NCT00038610|Vincristine|vincristine
1717735|NCT00038610|Dexamethasone|dexamethasone
1717736|NCT00038610|Decadron|decadron
1717737|NCT00038610|Methotrexate|methotrexate
1717738|NCT00038610|Cytarabine|cytarabine
1717739|NCT00038610|Ara-C|ara-c
1717740|NCT00038610|Cytosar|cytosar
1717741|NCT00038610|DepoCyt|depocyt
1717742|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
1717743|NCT00038610|Mesna|mesna
1717744|NCT00038610|Mesnex|mesnex
1717745|NCT00038610|G-CSF|g-csf
1717746|NCT00038610|Filgrastim|filgrastim
1717747|NCT00038610|Neupogen|neupogen
1717748|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
1717749|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
1717750|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
1717751|NCT00038571|Cancer|cancer
1717752|NCT00038571|Relapsed|relapsed
1717753|NCT00038571|Refractory|refractory
1717754|NCT00038571|B cell lymphoma|b cell lymphoma
1717755|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
1717756|NCT00038571|PS-341|ps-341
1717757|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
1717758|NCT00038558|Dacarbazine|dacarbazine
1717760|NCT00038558|DTIC-Dome|dtic-dome
1717761|NCT00038558|Vinblastine|vinblastine
1717762|NCT00038558|Velban|velban
1717763|NCT00038558|Bleomycin sulfate|bleomycin sulfate
1717764|NCT00038558|Blenoxane|blenoxane
1717765|NCT00038558|BLM|blm
1717766|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
1717767|NCT00038558|Adriamycin|adriamycin
1717768|NCT00038558|Filgrastim|filgrastim
1717769|NCT00038558|G-CSF|g-csf
1717770|NCT00038558|Neupogen|neupogen
1717771|NCT00038558|Pegfilgrastim|pegfilgrastim
1717772|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
1717773|NCT00038545|LYMPHOMA|lymphoma
1717774|NCT00038545|NON-HODGKINS|non-hodgkins
1717775|NCT00038545|AGGRESSIVE|aggressive
1717776|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
1717777|NCT00038532|treatment experienced|treatment experienced
1717778|NCT00038532|HIV|hiv
1717779|NCT00038519|treatment experienced|treatment experienced
1717780|NCT00038519|HIV|hiv
1717781|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
1717782|NCT00038493|GBM|gbm
1717783|NCT00038493|Glioma|glioma
1717784|NCT00038493|Brain Tumor|brain tumor
1717785|NCT00038480|Lopinavir|lopinavir
1717786|NCT00038480|HIV-1|hiv-1
1717787|NCT00038480|Drug Therapy, Combination|drug therapy, combination
1717788|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
1717789|NCT00038480|Ritonavir|ritonavir
1717790|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1717791|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
1717792|NCT00038454|CABG|cabg
1717793|NCT00038454|Transfusion|transfusion
1717794|NCT00038441|Malignant Glioma|malignant glioma
1717795|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1717796|NCT00038415|CLL|cll
1717797|NCT00038415|Binet Stage A|binet stage a
1717798|NCT00038415|Vaccination|vaccination
1717801|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
1717802|NCT00038415|DNA|dna
1717803|NCT00038402|Breast Cancer|breast cancer
1717804|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
1717805|NCT00038402|Operable Breast Cancer|operable breast cancer
1717806|NCT00038402|Herceptin|herceptin
1717809|NCT00038402|Fluorouracil|fluorouracil
1717810|NCT00038402|Cyclophosphamide|cyclophosphamide
1717811|NCT00038402|Epirubicin|epirubicin
1717812|NCT00038402|Trastuzumab|trastuzumab
1717813|NCT00038402|Paclitaxel|paclitaxel
1717814|NCT00038402|Neosar|neosar
1717815|NCT00038389|Brain Stem Tumor|brain stem tumor
1717816|NCT00038376|T-cell lymphoma|t-cell lymphoma
1717817|NCT00038376|accutane|accutane
1717818|NCT00038376|isotretinoin|isotretinoin
1717819|NCT00038376|mycosis fungoides|mycosis fungoides
1717820|NCT00038376|T-cell malignancies|t-cell malignancies
1717821|NCT00038363|Frail|frail
1717822|NCT00038363|Disable|disable
1717823|NCT00038363|Disabled Persons|disabled persons
1717824|NCT00038363|Physically disabled|physically disabled
1717825|NCT00038363|Elderly|elderly
1717826|NCT00038363|Rehabilitation|rehabilitation
1717827|NCT00038363|Subacute care|subacute care
1717828|NCT00038350|Age|age
1717829|NCT00038350|Dysphagia|dysphagia
1717830|NCT00038350|Swallowing|swallowing
1717831|NCT00038337|Health Literacy|health literacy
1717832|NCT00038337|Visual|visual
1717833|NCT00038337|Cognitive|cognitive
1717834|NCT00038285|Amputation|amputation
1717835|NCT00038285|Cardiovascular Disease|cardiovascular disease
1717836|NCT00038285|PVD|pvd
1717837|NCT00038272|Placebos|placebos
1717838|NCT00038272|Drug Therapy, Combination|drug therapy, combination
1717839|NCT00038272|Anti-HIV Agents|anti-hiv agents
1717840|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
1717841|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
1717842|NCT00038272|Treatment Experienced|treatment experienced
1717843|NCT00038272|DAPD|dapd
1717844|NCT00038272|MMF|mmf
1717845|NCT00038259|Interleukin-2|interleukin-2
1717846|NCT00038259|Drug Administration Schedule|drug administration schedule
1717847|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
1717848|NCT00038259|Anti-HIV Agents|anti-hiv agents
1717849|NCT00038259|Viral Load|viral load
1717850|NCT00038259|Treatment Interruption|treatment interruption
1717851|NCT00038259|Treatment Experienced|treatment experienced
1717852|NCT00038259|STI|sti
1717853|NCT00038246|Prostate Cancer|prostate cancer
1717854|NCT00038233|myeloma|myeloma
1717855|NCT00038220|HIV|hiv
1717856|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
1717857|NCT00038207|Bone sarcomas|bone sarcomas
1717858|NCT00038194|Prostate Cancer|prostate cancer
1717859|NCT00038194|bone metastasis|bone metastasis
1717860|NCT00038181|Prostate Cancer|prostate cancer
1717861|NCT00038168|Prostate Cancer|prostate cancer
1717862|NCT00038155|Ambulation|ambulation
1717863|NCT00038155|Difficulties in ambulation|difficulties in ambulation
1717864|NCT00038155|Geriatric|geriatric
1717865|NCT00038155|Rehabilitation|rehabilitation
1717866|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
1717871|NCT00038142|Cyclophosphamide|cyclophosphamide
1717872|NCT00038142|Dexrazoxane|dexrazoxane
1717873|NCT00038142|Zinecard|zinecard
1717874|NCT00038142|VACdxr|vacdxr
1717875|NCT00038142|ImmTher|immther
1717876|NCT00038116|Parkinson's disease|parkinson's disease
1717877|NCT00038116|PD|pd
1717878|NCT00038116|dopamine|dopamine
1717879|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
1717880|NCT00038116|tissue implants|tissue implants
1717881|NCT00038090|Myeloma|myeloma
1717882|NCT00038090|Thalidomide|thalidomide
1717883|NCT00038090|Thalomid|thalomid
1717884|NCT00038090|Dexamethasone|dexamethasone
1717885|NCT00038090|Decadron|decadron
1717886|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
1717887|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
1717888|NCT00038064|Drug Therapy|drug therapy
1717889|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
1717890|NCT00038051|AML|aml
1717891|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
1717892|NCT00038051|CMML|cmml
1717893|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
1717894|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
1717895|NCT00038051|RAEB-t|raeb-t
1717896|NCT00038051|RAEB|raeb
1717897|NCT00038051|Hum-195/rGel|hum-195/rgel
1717898|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
1717899|NCT00038025|Mycosis Fungoides|mycosis fungoides
1717900|NCT00038025|Lymphoma|lymphoma
1717901|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
1717902|NCT00038025|Deoxycoformycin|deoxycoformycin
1717903|NCT00038025|Pentostatin|pentostatin
1717904|NCT00038025|All other lymphomas|all other lymphomas
1717905|NCT00038025|Nucleoside analogue|nucleoside analogue
1717906|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
1717907|NCT00038025|T-cells|t-cells
1717908|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
1717909|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
1717910|NCT00038012|thrombopoietin|thrombopoietin
1717911|NCT00038012|Gynecologic malignancy|gynecologic malignancy
1717912|NCT00037999|Muscle strength|muscle strength
1717913|NCT00037999|Testosterone|testosterone
1717914|NCT00037999|Rehabilitation|rehabilitation
1717915|NCT00037999|Impaired muscle strength|impaired muscle strength
1717916|NCT00037986|Audiology|audiology
1717917|NCT00037986|Hearing|hearing
1717918|NCT00037986|Hearing Aids|hearing aids
1717919|NCT00037986|Quality of Life|quality of life
1717920|NCT00037973|COPD|copd
1717921|NCT00037973|Ventilation|ventilation
1717922|NCT00037960|Constrained Induced|constrained induced
1717923|NCT00037960|CI therapy|ci therapy
1717925|NCT00037960|Strokes|strokes
1717926|NCT00037947|Multiple Sclerosis|multiple sclerosis
1717927|NCT00037947|MS|ms
1717928|NCT00037947|Hearing|hearing
1717929|NCT00037934|Robot|robot
1717930|NCT00037934|Stroke|stroke
1717931|NCT00037934|Upper Extremity|upper extremity
1717932|NCT00037921|SCI|sci
1717933|NCT00037921|UTI|uti
1717934|NCT00037908|Stroke|stroke
1717935|NCT00037908|Hemiparesis|hemiparesis
1717936|NCT00037908|Upper limb function|upper limb function
1717937|NCT00037908|Strength training|strength training
1717938|NCT00037895|Stroke|stroke
1717939|NCT00037895|Ambulation Training|ambulation training
1717940|NCT00037895|Rehabilitation|rehabilitation
1717941|NCT00037895|Treadmill|treadmill
1717942|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1717943|NCT00037882|Interferon alpha|interferon alpha
1717944|NCT00037882|Roferon|roferon
1717945|NCT00037882|Intron|intron
1717946|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
1717947|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
1717948|NCT00037843|adrenal diseases|adrenal diseases
1717949|NCT00037830|Parkinson's disease|parkinson's disease
1717950|NCT00037830|PD|pd
1717951|NCT00037830|GM1 Ganglioside|gm1 ganglioside
1717952|NCT00037830|Sygen|sygen
1717953|NCT00037817|Toxicity Evaluation|toxicity evaluation
1717954|NCT00037817|Pharmacokinetics|pharmacokinetics
1717955|NCT00037817|Apoptosis|apoptosis
1717956|NCT00037817|Gene Induction|gene induction
1717957|NCT00037817|Gene Expression|gene expression
1717958|NCT00037817|Lung Cancer|lung cancer
1717959|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
1717960|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
1717961|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
1717962|NCT00037804|Pharmacia|pharmacia
1717963|NCT00004575|Endothelium|endothelium
1717964|NCT00004575|Vasodilation|vasodilation
1717965|NCT00004575|Vascular Biology|vascular biology
1717966|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
1717967|NCT00001908|Allergy|allergy
1717968|NCT00001908|Interleukin|interleukin
1717969|NCT00001908|Immunomodulator|immunomodulator
1717970|NCT00001908|Th2|th2
1717971|NCT00001908|Inflammation|inflammation
1717972|NCT00001908|Asthma|asthma
1717973|NCT00001866|Eye Movements|eye movements
1717974|NCT00001866|Eye Oscillations|eye oscillations
1717975|NCT00001866|Extraocular Muscles|extraocular muscles
1717976|NCT00001866|Eye Development|eye development
1717977|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
1717978|NCT00001866|Congenital Nystagmus|congenital nystagmus
1717979|NCT00001864|Lazy Eye|lazy eye
1717980|NCT00001864|Atropine Penalization|atropine penalization
1717981|NCT00001864|Patching|patching
1717982|NCT00001864|Vision Loss|vision loss
1717983|NCT00001864|Amblyopia|amblyopia
1717984|NCT00001818|Antiretrovirals|antiretrovirals
1717985|NCT00001818|Resistant Virus|resistant virus
1717986|NCT00001818|T-cell activation|t-cell activation
1717987|NCT00001818|Immune Suppression|immune suppression
1717988|NCT00001818|Cytotoxic Agent|cytotoxic agent
1717989|NCT00001688|CD4 Cells|cd4 cells
1717990|NCT00001688|Cytokines|cytokines
1717991|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
1717992|NCT00001688|V Beta Repertoire|v beta repertoire
1717993|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
1717994|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
1717995|NCT00001542|Candidiasis|candidiasis
1717996|NCT00001542|Azole|azole
1717997|NCT00001542|Resistance|resistance
1717998|NCT00001542|Candida Albicans|candida albicans
1717999|NCT00001542|Oropharynx|oropharynx
1718000|NCT00001190|Growth|growth
1718001|NCT00001190|Adolescence|adolescence
1718002|NCT00001190|Children|children
1718003|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
1718004|NCT00037713|BEC2, vaccine|bec2, vaccine
1718005|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
1718006|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
1718007|NCT00037687|Severe sepsis|severe sepsis
1718008|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
1718009|NCT00037674|Bipolar Disorder|bipolar disorder
1718010|NCT00037674|Bipolar|bipolar
1718011|NCT00037674|Mania|mania
1718012|NCT00037674|Topiramate|topiramate
1718013|NCT00037674|Lithium|lithium
1718014|NCT00037661|dry eye|dry eye
1718129|NCT00036582|Normal Control|normal control
1718130|NCT00036569|Brainstem Glioma|brainstem glioma
1718131|NCT00036569|Pediatric|pediatric
1718015|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
1718016|NCT00037609|Metastatic breast cancer|metastatic breast cancer
1718023|NCT00037557|Hemophilia B|hemophilia b
1718024|NCT00037544|Severe|severe
1718025|NCT00037544|Hemophilia|hemophilia
1718026|NCT00037544|A|a
1718027|NCT00037531|Transplant|transplant
1718028|NCT00037531|Kidney|kidney
1718029|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
1718030|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
1718031|NCT00037492|stroke|stroke
1718032|NCT00037492|recovery|recovery
1718033|NCT00037479|neurologic Lyme disease|neurologic lyme disease
1718034|NCT00037479|Lyme disease|lyme disease
1718035|NCT00037479|ceftriaxone|ceftriaxone
1718036|NCT00037479|Rocephin|rocephin
1718037|NCT00037479|PET scans|pet scans
1718038|NCT00037479|Lyme encephalopathy|lyme encephalopathy
1718039|NCT00037479|neuroborreliosis|neuroborreliosis
1718040|NCT00037479|borreliosis|borreliosis
1718041|NCT00037219|Anidulafungin|anidulafungin
1718042|NCT00037219|Candidemia|candidemia
1718043|NCT00037219|Invasive Candidiasis|invasive candidiasis
1718044|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
1718045|NCT00037167|Fall-Prevention|fall-prevention
1718046|NCT00037167|Balance|balance
1718047|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
1718048|NCT00037167|Protective Devices|protective devices
1718049|NCT00037167|Gait|gait
1718050|NCT00037167|Equilibrium|equilibrium
1718051|NCT00037167|Accidental Falls|accidental falls
1718052|NCT00037167|Frail Elderly|frail elderly
1718053|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1718054|NCT00037154|Herbal Therapies|herbal therapies
1718055|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
1718056|NCT00037154|Men's Health|men's health
1718057|NCT00037141|Prostate|prostate
1718058|NCT00037141|BPH|bph
1718059|NCT00037141|Prostatitis|prostatitis
1718060|NCT00037128|Lupus|lupus
1718061|NCT00037128|SLE|sle
1718062|NCT00037128|DHEA|dhea
1718063|NCT00037128|GL701|gl701
1718064|NCT00037115|Demyelinating|demyelinating
1718065|NCT00037115|Multiple Sclerosis|multiple sclerosis
1718066|NCT00037115|Myelitis|myelitis
1718067|NCT00037115|Neuritis|neuritis
1718068|NCT00037115|Optic Neuritis|optic neuritis
1718069|NCT00037115|AVONEX|avonex
1718070|NCT00037115|methotrexate|methotrexate
1718071|NCT00037115|methylprednisolone|methylprednisolone
1718072|NCT00037115|interferon beta 1a|interferon beta 1a
1718073|NCT00037115|demyelination|demyelination
1718074|NCT00037115|central nervous system|central nervous system
1718075|NCT00037115|brain|brain
1718076|NCT00037115|nerve|nerve
1718077|NCT00037115|lesions|lesions
1718078|NCT00037115|enhancement|enhancement
1718079|NCT00037115|enhancing|enhancing
1718080|NCT00037102|Multiple Sclerosis|multiple sclerosis
1718081|NCT00037102|Relapsing|relapsing
1718082|NCT00037102|Methotrexate|methotrexate
1718083|NCT00037102|AVONEX|avonex
1718084|NCT00037102|interferon beta 1a|interferon beta 1a
1718085|NCT00037102|demyelinating|demyelinating
1718087|NCT00037076|HIV Seropositivity|hiv seropositivity
1718088|NCT00037076|Hepatitis C|hepatitis c
1718089|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
1718090|NCT00037076|RNA, Viral|rna, viral
1718091|NCT00037076|Prevalence|prevalence
1718092|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
1718093|NCT00037076|Hepacivirus|hepacivirus
1718094|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
1718095|NCT00037076|GB virus C|gb virus c
1718096|NCT00037063|Pilot Projects|pilot projects
1718097|NCT00037063|Recurrence|recurrence
1718098|NCT00037063|Antioxidants|antioxidants
1718099|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1718100|NCT00037063|Anti-HIV Agents|anti-hiv agents
1718101|NCT00037063|Ascorbic Acid|ascorbic acid
1718102|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
1718103|NCT00037063|Riboflavin|riboflavin
1718104|NCT00037063|Thiamine|thiamine
1718105|NCT00037063|Lactic Acid|lactic acid
1718106|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
1718107|NCT00036647|Tarceva|tarceva
1718108|NCT00036647|EGFR|egfr
1718109|NCT00036647|erlotinib|erlotinib
1718110|NCT00036634|treatment naive|treatment naive
1718111|NCT00036595|Subdural|subdural
1718112|NCT00036595|Epilepsy|epilepsy
1718113|NCT00036595|Motor Function|motor function
1718114|NCT00036595|Desynchronization|desynchronization
1718115|NCT00036595|Coherence|coherence
1718116|NCT00036595|Motor Control|motor control
1718117|NCT00036582|Psychophysiology|psychophysiology
1718118|NCT00036582|Structural MRI|structural mri
1718119|NCT00036582|Genetics|genetics
1718120|NCT00036582|Bipolar Disorder|bipolar disorder
1718121|NCT00036582|Children and Adolescents|children and adolescents
1718122|NCT00036582|Clozapine|clozapine
1718123|NCT00036582|Placebo|placebo
1718124|NCT00036582|Treatment-Refractory|treatment-refractory
1718125|NCT00036582|Bipolar|bipolar
1718126|NCT00036582|Healthy Volunteer|healthy volunteer
1718127|NCT00036582|HV|hv
1718134|NCT00036569|Angiogenesis|angiogenesis
1718135|NCT00036569|Brain Tumor|brain tumor
1718136|NCT00036569|Glioma|glioma
1718137|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
1718138|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
1718139|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
1718140|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
1718141|NCT00036517|diarrhea|diarrhea
1718142|NCT00036517|reduce|reduce
1718143|NCT00036517|alleviate|alleviate
1718144|NCT00036517|modulate|modulate
1718145|NCT00036517|Saltz regimen|saltz regimen
1718146|NCT00036517|CPT-11|cpt-11
1718147|NCT00036517|irinotecan|irinotecan
1718148|NCT00036517|camptosar|camptosar
1718149|NCT00036517|5-fluorouracil|5-fluorouracil
1718150|NCT00036517|leucovorin|leucovorin
1718151|NCT00036517|5-FU|5-fu
1718152|NCT00036517|LV|lv
1718153|NCT00036517|chemotherapy|chemotherapy
1718154|NCT00036517|side effect|side effect
1718155|NCT00036517|toxicity|toxicity
1718156|NCT00036517|botanical drug|botanical drug
1718157|NCT00036517|herbal medicine|herbal medicine
1718158|NCT00036517|chinese herbal medicine|chinese herbal medicine
1718159|NCT00036517|traditional chinese medicine|traditional chinese medicine
1718160|NCT00036517|TCM|tcm
1718161|NCT00036517|oral dose|oral dose
1718162|NCT00036517|oral administration|oral administration
1718163|NCT00036517|concomitant use|concomitant use
1718164|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
1718165|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
1718166|NCT00036491|SLE|sle
1718167|NCT00036491|B-Lymphocytes|b-lymphocytes
1718168|NCT00036491|anti-CD20|anti-cd20
1718169|NCT00036491|rituximab|rituximab
1718170|NCT00036478|Pilot Projects|pilot projects
1718171|NCT00036478|Exercise|exercise
1718172|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
1718173|NCT00036478|Mitochondria|mitochondria
1718174|NCT00036478|Lactates|lactates
1718175|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1718176|NCT00036465|Pilot Projects|pilot projects
1718177|NCT00036465|HIV-1|hiv-1
1718178|NCT00036465|RNA, Viral|rna, viral
1718179|NCT00036465|Genotype|genotype
1718180|NCT00036465|Viral Load|viral load
1718181|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1718182|NCT00036465|Treatment Experienced|treatment experienced
1718183|NCT00036452|Lopinavir|lopinavir
1718184|NCT00036452|HIV-1|hiv-1
1718185|NCT00036452|Drug Administration Schedule|drug administration schedule
1718186|NCT00036452|Stavudine|stavudine
1718187|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
1718188|NCT00036452|Ritonavir|ritonavir
1718189|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1718190|NCT00036452|Self Care|self care
1718191|NCT00036452|Viral Load|viral load
1718192|NCT00036452|Emtricitabine|emtricitabine
1718193|NCT00036452|Directly Observed Therapy|directly observed therapy
1718194|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
1718195|NCT00036452|Treatment Naive|treatment naive
1718196|NCT00036439|ulcerative colitis|ulcerative colitis
1718197|NCT00036439|infliximab|infliximab
1718198|NCT00036439|Remicade|remicade
1718199|NCT00036439|infusion|infusion
1718200|NCT00036426|lymphoma|lymphoma
1718201|NCT00036426|vaccine|vaccine
1718202|NCT00036426|idiotype|idiotype
1718203|NCT00036426|KLH|klh
1718204|NCT00036426|GM-CSF|gm-csf
1718205|NCT00036413|(ALS)|(als)
1718206|NCT00036400|Anemia|anemia
1718207|NCT00036400|Gastric Cancer|gastric cancer
1718208|NCT00036400|Rectal Cancer|rectal cancer
1718209|NCT00036400|Epoetin Alfa|epoetin alfa
1718210|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
1718211|NCT00036387|infliximab|infliximab
1718212|NCT00036387|anti-TNF|anti-tnf
1718213|NCT00036387|methotrexate|methotrexate
1718214|NCT00036387|safety and efficacy|safety and efficacy
1718215|NCT00036387|Remicade|remicade
1718216|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1718217|NCT00036374|Infliximab|infliximab
1718218|NCT00036374|Methotrexate|methotrexate
1718219|NCT00036374|remicade|remicade
1718220|NCT00036348|Bipolar I disorder|bipolar i disorder
1718221|NCT00036335|depression|depression
1718222|NCT00036335|pain|pain
1718223|NCT00036335|blues|blues
1718224|NCT00036335|sadness|sadness
1718225|NCT00036335|aches|aches
1718226|NCT00036309|Major Depressive Disorder|major depressive disorder
1718227|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
1718228|NCT00036296|Involuntary Movements|involuntary movements
1718229|NCT00036296|Abnormal Movements|abnormal movements
1718230|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
1718231|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
1718232|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1718233|NCT00036257|Leukemia|leukemia
1718234|NCT00036257|CLL|cll
1718235|NCT00036179|Candidemia|candidemia
1718239|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
1718240|NCT00036140|Pharmacia|pharmacia
1718241|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
1718242|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
1718243|NCT00036101|Bipolar I Disorder|bipolar i disorder
1718244|NCT00036075|prostate cancer|prostate cancer
1718245|NCT00036075|prostate|prostate
1718246|NCT00036062|Sivelestat|sivelestat
1718247|NCT00036062|acute lung injury|acute lung injury
1718248|NCT00036036|renal|renal
1718249|NCT00036036|renal cell cancer|renal cell cancer
1718250|NCT00036036|renal cell carcinoma|renal cell carcinoma
1718251|NCT00036036|kidney cancer|kidney cancer
1718252|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
1718253|NCT00035997|Prostate Cancer|prostate cancer
1718254|NCT00035997|Bone Metastasis|bone metastasis
1718255|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
1718256|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
1718257|NCT00035958|Pediatric|pediatric
1718258|NCT00035958|Randomized Clinical Trial|randomized clinical trial
1718259|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
1718260|NCT00035919|Colon cancer|colon cancer
1718261|NCT00035919|Targeted Injectable Vector|targeted injectable vector
1718262|NCT00035919|Gene Transfer|gene transfer
1718263|NCT00035919|Gene Therapy|gene therapy
1718264|NCT00035919|Retroviral vector|retroviral vector
1718265|NCT00035906|Diabetes|diabetes
1718266|NCT00035906|Macular Edema|macular edema
1718267|NCT00035906|Diabetic Macular Edema|diabetic macular edema
1718268|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
1718269|NCT00035906|Cystoid Macular Edema|cystoid macular edema
1718270|NCT00035906|Uveitis|uveitis
1718271|NCT00035906|Vision|vision
1718272|NCT00035906|Eye|eye
1718273|NCT00035906|Retina|retina
1718274|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
1718275|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
1718276|NCT00035893|treatment interruption|treatment interruption
1718277|NCT00035893|HIV Infections|hiv infections
1718278|NCT00035880|Acute graft versus host disease|acute graft versus host disease
1718279|NCT00035880|Stem Cell Transplantation|stem cell transplantation
1718280|NCT00035854|Pharmacia|pharmacia
1718281|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
1718282|NCT00035828|COPD|copd
1718283|NCT00035828|Chronic bronchitis|chronic bronchitis
1718284|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1718285|NCT00035828|Shortness of breath|shortness of breath
1718286|NCT00035828|Dyspnea|dyspnea
1718287|NCT00035828|Bronchitis|bronchitis
1718288|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1718289|NCT00035815|ALS|als
1718290|NCT00035815|progressive weakness|progressive weakness
1718291|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
1718292|NCT00035815|IGF-I|igf-i
1718293|NCT00035815|Myotrophin|myotrophin
1718294|NCT00035802|Bipolar|bipolar
1718295|NCT00035802|Mania|mania
1718300|NCT00035802|Anticonvulsants|anticonvulsants
1718301|NCT00035802|Central Nervous System Agents|central nervous system agents
1718302|NCT00035802|Protective Agents|protective agents
1718303|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
1718304|NCT00035620|Bone cancer|bone cancer
1718305|NCT00035620|Sarcoma|sarcoma
1718306|NCT00035620|Neutropenia|neutropenia
1718307|NCT00035620|Chemotherapy|chemotherapy
1718308|NCT00035594|Breast cancer|breast cancer
1718309|NCT00035594|Neutropenia|neutropenia
1718310|NCT00035594|Chemotherapy|chemotherapy
1718311|NCT00035581|treatment experienced|treatment experienced
1718312|NCT00035581|HIV Infections|hiv infections
1718313|NCT00035581|HIV|hiv
1718314|NCT00035581|HAART|haart
1718315|NCT00035581|early virologic failure|early virologic failure
1718316|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1718317|NCT00035555|kidney|kidney
1718318|NCT00035555|transplant|transplant
1718319|NCT00035555|rejection|rejection
1718320|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
1718321|NCT00035529|MS|ms
1718322|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
1718323|NCT00035438|ocd|ocd
1718324|NCT00035438|Anxiety|anxiety
1718325|NCT00035438|St. John’s Wort|st. john’s wort
1718326|NCT00035438|Wisconsin|wisconsin
1718327|NCT00035438|Psychiatric|psychiatric
1718328|NCT00035438|Mental health|mental health
1718329|NCT00035412|Social phobia|social phobia
1718330|NCT00035412|Social anxiety|social anxiety
1718331|NCT00035412|Anxiety|anxiety
1718332|NCT00035412|St. John’ Wort|st. john’ wort
1718333|NCT00035412|Wisconsin|wisconsin
1718334|NCT00035412|Psychiatric|psychiatric
1718335|NCT00035412|Mental health|mental health
1718336|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
1718337|NCT00035399|alternative medicine|alternative medicine
1718338|NCT00035399|arthritis therapy|arthritis therapy
1718339|NCT00035399|combination therapy|combination therapy
1721232|NCT00006443|Macrophages|macrophages
1718340|NCT00035399|human therapy evaluation|human therapy evaluation
1718341|NCT00035399|knee|knee
1718342|NCT00035399|osteoarthritis|osteoarthritis
1718343|NCT00035399|physical therapy|physical therapy
1718344|NCT00035399|chronic pain|chronic pain
1718345|NCT00035399|clinical trial|clinical trial
1718346|NCT00035399|functional ability|functional ability
1718347|NCT00035360|PEG-Intron|peg-intron
1718348|NCT00035360|treatment experienced|treatment experienced
1718349|NCT00035386|Outflow Obstruction|outflow obstruction
1718350|NCT00035386|ICE|ice
1718351|NCT00035386|HCM|hcm
1718352|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1718353|NCT00035386|OHC|ohc
1718354|NCT00035386|Obstructive HCM|obstructive hcm
1718355|NCT00035386|Cardiomyopathy|cardiomyopathy
1718356|NCT00035373|Tumor|tumor
1718357|NCT00035373|Brain|brain
1718358|NCT00035373|Chemotherapy|chemotherapy
1718359|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
1718360|NCT00035373|Radiation Therapy|radiation therapy
1718361|NCT00035373|CNS Tumor|cns tumor
1718362|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
1718363|NCT00035334|Amyloidosis|amyloidosis
1718364|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
1718365|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
1718366|NCT00035308|Immunologic Diseases|immunologic diseases
1718367|NCT00035308|Autoimmune Diseases|autoimmune diseases
1718368|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
1718370|NCT00035308|Lupus Nephritis|lupus nephritis
1718371|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
1718372|NCT00035269|Pharmacia|pharmacia
1718373|NCT00035243|kidney cancer|kidney cancer
1718374|NCT00035243|renal cancer|renal cancer
1718375|NCT00035243|cancer|cancer
1718376|NCT00035243|tumor|tumor
1718377|NCT00035243|tumour|tumour
1718378|NCT00035243|neoplasm|neoplasm
1718379|NCT00035243|carcinoma|carcinoma
1718380|NCT00035243|clear cell|clear cell
1718381|NCT00035243|sarcomatoid|sarcomatoid
1718382|NCT00035243|papillary|papillary
1718383|NCT00035243|medullary|medullary
1718384|NCT00035243|collecting duct|collecting duct
1718385|NCT00035243|chromophobe|chromophobe
1718386|NCT00035243|intravenous|intravenous
1718387|NCT00035243|epothilone|epothilone
1718388|NCT00035230|Bipolar disorders|bipolar disorders
1718389|NCT00035230|Bipolar|bipolar
1718390|NCT00035230|mania|mania
1718391|NCT00035230|Topiramate|topiramate
1718392|NCT00035230|Lithium|lithium
1718393|NCT00035204|Donepezil|donepezil
1718394|NCT00035204|Alzheimer's|alzheimer's
1718395|NCT00035204|Dementia|dementia
1718396|NCT00035204|Cognitive impairment|cognitive impairment
1718397|NCT00035204|Aricept|aricept
1718398|NCT00035204|Alzheimer's disease|alzheimer's disease
1718399|NCT00035204|Razadyne|razadyne
1718400|NCT00035204|Galantamine|galantamine
1718401|NCT00035191|Dementia|dementia
1718402|NCT00035191|vascular dementia|vascular dementia
1718403|NCT00035191|cerebral vascular disease|cerebral vascular disease
1718404|NCT00035178|ESRD|esrd
1718405|NCT00035178|End-stage renal disease|end-stage renal disease
1718406|NCT00035178|Hemodialysis|hemodialysis
1718407|NCT00035165|melanoma|melanoma
1718415|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
1718416|NCT00035126|breast|breast
1718417|NCT00035126|cancer|cancer
1718418|NCT00035126|tumor|tumor
1718419|NCT00035126|tumour|tumour
1718420|NCT00035126|intravenous|intravenous
1718421|NCT00035126|epothilone|epothilone
1718422|NCT00035126|taxane|taxane
1718423|NCT00035126|anthracycline|anthracycline
1718424|NCT00035113|prostate cancer|prostate cancer
1718425|NCT00035113|prostate|prostate
1718426|NCT00035113|androgen independent|androgen independent
1718427|NCT00035113|cancer|cancer
1718428|NCT00035113|tumor|tumor
1718429|NCT00035113|tumour|tumour
1718430|NCT00035113|neoplasm|neoplasm
1718431|NCT00035113|carcinoma|carcinoma
1718432|NCT00035113|intravenous|intravenous
1718433|NCT00035113|epothilone|epothilone
1718434|NCT00035100|ovarian|ovarian
1718435|NCT00035100|ovary|ovary
1718436|NCT00035100|peritoneal cancer|peritoneal cancer
1718437|NCT00035100|fallopian cancer|fallopian cancer
1718438|NCT00035100|cancer|cancer
1718439|NCT00035100|tumor|tumor
1718440|NCT00035100|tumour|tumour
1718441|NCT00035100|neoplasm|neoplasm
1718442|NCT00035100|carcinoma|carcinoma
1718443|NCT00035100|intravenous|intravenous
1718444|NCT00035100|epothilone|epothilone
1718445|NCT00035087|colon|colon
1718446|NCT00035087|rectum|rectum
1718447|NCT00035087|colorectal|colorectal
1718448|NCT00035087|rectal|rectal
1718449|NCT00035087|cancer|cancer
1718450|NCT00035087|tumor|tumor
1718451|NCT00035087|tumour|tumour
1718452|NCT00035087|neoplasm|neoplasm
1718453|NCT00035087|carcinoma|carcinoma
1718454|NCT00035087|intravenous|intravenous
1718456|NCT00035061|Bladder Cancer|bladder cancer
1718457|NCT00035061|Metastatic|metastatic
1718458|NCT00035061|Recurrent|recurrent
1718459|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
1718460|NCT00035035|Pancreas|pancreas
1718461|NCT00035035|Cancer|cancer
1718462|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
1718463|NCT00035035|Alimta|alimta
1718464|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
1718465|NCT00034970|alternative medicine|alternative medicine
1718466|NCT00034970|art|art
1718467|NCT00034970|cancer|cancer
1718468|NCT00034970|combination cancer therapy|combination cancer therapy
1718469|NCT00034970|creative-expression|creative-expression
1718470|NCT00034970|group therapy|group therapy
1718471|NCT00034970|holistic|holistic
1718472|NCT00034970|human therapy evaluation|human therapy evaluation
1718473|NCT00034970|meditation|meditation
1718474|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
1718475|NCT00034970|coping|coping
1718476|NCT00034970|gender difference|gender difference
1718477|NCT00034970|outcomes research|outcomes research
1718478|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
1718479|NCT00034970|psychological stressor|psychological stressor
1718480|NCT00034970|quality of life|quality of life
1718481|NCT00034970|racial /ethnic difference|racial /ethnic difference
1718482|NCT00034970|stress management|stress management
1718483|NCT00034970|support|support
1718484|NCT00034970|behavioral /social science research|behavioral /social science research
1718485|NCT00034970|patient oriented research|patient oriented research
1718486|NCT00034957|Pharmacia|pharmacia
1718487|NCT00034918|Metastatic breast cancer|metastatic breast cancer
1718488|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
1718489|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
1718490|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
1718491|NCT00034866|HIV|hiv
1718492|NCT00034866|treatment experienced|treatment experienced
1718493|NCT00034866|Boehringer|boehringer
1718494|NCT00034866|tipranavir|tipranavir
1718495|NCT00034866|ritonavir|ritonavir
1718496|NCT00034840|hypertension|hypertension
1718497|NCT00034840|telmisartan|telmisartan
1718498|NCT00034840|valsartan|valsartan
1718499|NCT00034840|boehringer|boehringer
1718500|NCT00034801|Depression|depression
1718501|NCT00034801|Comorbid Depression|comorbid depression
1718502|NCT00034801|Schizophrenia|schizophrenia
1718503|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
1718504|NCT00034788|Regranex|regranex
1718505|NCT00034788|Foot ulcers|foot ulcers
1718506|NCT00034788|Diabetes|diabetes
1718507|NCT00034788|Diabetes mellitus|diabetes mellitus
1718508|NCT00034788|Diabetic foot|diabetic foot
1718509|NCT00034775|Schizophrenia|schizophrenia
1718510|NCT00034775|intramuscular injection|intramuscular injection
1718511|NCT00034775|antipsychotic agents|antipsychotic agents
1718512|NCT00034775|risperidone|risperidone
1718513|NCT00034762|Alzheimer's disease|alzheimer's disease
1718514|NCT00034762|psychosis|psychosis
1718515|NCT00034762|elderly|elderly
1718516|NCT00034762|dementia|dementia
1718517|NCT00034762|risperidone|risperidone
1718518|NCT00034762|antipsychotic agents|antipsychotic agents
1718519|NCT00034749|Adolescents|adolescents
1718520|NCT00034749|Schizophrenia|schizophrenia
1718521|NCT00034749|risperidone|risperidone
1718523|NCT00034736|Bacterial pneumonia|bacterial pneumonia
1718524|NCT00034736|Community acquired pneumonia|community acquired pneumonia
1718525|NCT00034736|Lung Inflammation|lung inflammation
1718526|NCT00034736|Quinolones|quinolones
1718527|NCT00034736|Levofloxacin|levofloxacin
1718528|NCT00034736|Ceftriaxone|ceftriaxone
1718529|NCT00034736|Erythromycin|erythromycin
1718530|NCT00034736|Clarithromycin|clarithromycin
1718531|NCT00034723|DTI|dti
1718532|NCT00034723|MRSI|mrsi
1718533|NCT00034723|MTR|mtr
1718534|NCT00034723|NAWN|nawn
1718535|NCT00034723|Fiber-Tract|fiber-tract
1718536|NCT00034723|Normal Control|normal control
1718537|NCT00034723|Healthy Volunteer|healthy volunteer
1718538|NCT00034723|HV|hv
1718539|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
1718540|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
1718541|NCT00034723|HAM/TSP|ham/tsp
1718542|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
1718543|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
1718544|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
1718545|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
1718546|NCT00034710|Pain|pain
1718547|NCT00034710|Capsicum|capsicum
1718548|NCT00034710|Pepper|pepper
1718549|NCT00034710|Dermal assessment|dermal assessment
1718550|NCT00034710|Pain measurement|pain measurement
1718551|NCT00034710|Diary|diary
1718552|NCT00034710|PHN|phn
1718553|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
1718554|NCT00034710|allodynia|allodynia
1718555|NCT00034710|hyperalgesia|hyperalgesia
1718559|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
1718560|NCT00034684|Leukemia|leukemia
1718561|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
1718562|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
1718563|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
1718564|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
1718565|NCT00034671|Invasive Fungal Infections|invasive fungal infections
1718665|NCT00034281|Cancer|cancer
1718566|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
1718567|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
1718568|NCT00034645|Fungal infections|fungal infections
1718569|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
1718570|NCT00034632|Invasive Fungal Infections|invasive fungal infections
1718571|NCT00034606|Lung cancer|lung cancer
1718572|NCT00034606|cancer|cancer
1718573|NCT00034606|neoplasm|neoplasm
1718574|NCT00034606|non-small|non-small
1718575|NCT00034606|chemotherapy|chemotherapy
1718576|NCT00034593|Bladder cancer|bladder cancer
1718577|NCT00034593|metastatic|metastatic
1718578|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
1718579|NCT00034580|Bipolar I Disorder|bipolar i disorder
1718580|NCT00034567|Prevention|prevention
1718581|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
1718582|NCT00034554|melanoma|melanoma
1718583|NCT00034554|gp75|gp75
1718584|NCT00034554|DNA vaccine|dna vaccine
1718585|NCT00034541|cetuximab|cetuximab
1718586|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
1718587|NCT00034541|antibody|antibody
1718588|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
1718589|NCT00034541|carboplatin|carboplatin
1718590|NCT00034541|paclitaxel|paclitaxel
1718591|NCT00034489|metastatic breast cancer|metastatic breast cancer
1718592|NCT00034489|combination therapy|combination therapy
1718593|NCT00034489|Alimta|alimta
1718594|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
1718595|NCT00034463|metastatic cancer|metastatic cancer
1718596|NCT00034463|chemotherapy|chemotherapy
1718597|NCT00034450|Terminal Cancer|terminal cancer
1718598|NCT00034437|Normal Volunteer|normal volunteer
1718599|NCT00034437|Phlebotomy|phlebotomy
1718600|NCT00034437|Cytomegalovirus|cytomegalovirus
1718601|NCT00034437|CMV|cmv
1718602|NCT00034437|CMV Seropositve|cmv seropositve
1718603|NCT00034424|Genetics|genetics
1718604|NCT00034424|Hereditary|hereditary
1718605|NCT00034424|Screening|screening
1718606|NCT00034424|Behavioral|behavioral
1718607|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
1718608|NCT00034424|Testicular Cancer|testicular cancer
1718609|NCT00034398|Basal Ganglia|basal ganglia
1718610|NCT00034398|Neuroimaging|neuroimaging
1718611|NCT00034398|Inhibitory Neurons|inhibitory neurons
1718612|NCT00034398|Disinhibition|disinhibition
1718613|NCT00034398|Tics|tics
1718614|NCT00034398|Tourette's Syndrome|tourette's syndrome
1718615|NCT00034398|Tourette Syndrome|tourette syndrome
1718616|NCT00034398|Healthy Volunteer|healthy volunteer
1718617|NCT00034398|HV|hv
1718618|NCT00034398|Normal Control|normal control
1718619|NCT00034385|Cytomegalovirus|cytomegalovirus
1718620|NCT00034385|Prophylaxis|prophylaxis
1718621|NCT00034385|Renal Transplant|renal transplant
1718622|NCT00034385|Valcyte|valcyte
1718623|NCT00034385|Kidney Transplant|kidney transplant
1718624|NCT00034372|immunotherapy|immunotherapy
1718627|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1718628|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1718629|NCT00034359|E-antigen positive|e-antigen positive
1718630|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
1718631|NCT00017862|Eosinophils|eosinophils
1718632|NCT00017862|Monoclonal Antibody|monoclonal antibody
1718633|NCT00017862|Hypereosinophilia|hypereosinophilia
1718634|NCT00017862|Biologicals|biologicals
1718635|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
1718636|NCT00034346|Advanced|advanced
1718637|NCT00034346|Non-Small-Cell|non-small-cell
1718638|NCT00034346|Lung|lung
1718639|NCT00034346|Cancer|cancer
1718640|NCT00034346|NSCLC|nsclc
1718641|NCT00034346|Carcinoma|carcinoma
1718642|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
1718643|NCT00034333|Hepatoma|hepatoma
1718644|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
1718645|NCT00034333|liver cancer|liver cancer
1718646|NCT00034333|HCC|hcc
1718647|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
1718648|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
1718649|NCT00034294|CDAD|cdad
1718650|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
1718651|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
1718652|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
1718653|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
1718654|NCT00034294|infectious diarrhea|infectious diarrhea
1718655|NCT00034294|chronic diarrhea|chronic diarrhea
1718656|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
1718657|NCT00034281|Gene, HER2|gene, her2
1718658|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
1718659|NCT00034281|Breast neoplasm|breast neoplasm
1718660|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
1718661|NCT00034281|Ovarian neoplasm|ovarian neoplasm
1718662|NCT00034281|Colorectal neoplasm|colorectal neoplasm
1718663|NCT00034281|Renal neoplasm|renal neoplasm
1718664|NCT00034281|Prostate neoplasm|prostate neoplasm
1718666|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
1718667|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
1718668|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
1718669|NCT00034242|Ataxia|ataxia
1718670|NCT00034242|Treatment|treatment
1718671|NCT00034242|IVIG|ivig
1718672|NCT00034242|SCA|sca
1718673|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
1718674|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
1718675|NCT00034242|Cerebellum|cerebellum
1718676|NCT00034229|Antidepressant|antidepressant
1718677|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
1718678|NCT00034229|Bipolar Disorder|bipolar disorder
1718679|NCT00034229|Depression|depression
1718680|NCT00034229|Treatment Refractory|treatment refractory
1718681|NCT00034229|Felbamate|felbamate
1718682|NCT00034229|Glutamate|glutamate
1718683|NCT00034229|Treatment-Resistant|treatment-resistant
1718684|NCT00034229|Bipolar|bipolar
1718685|NCT00034229|BPD|bpd
1718686|NCT00034229|Bipolar Depression|bipolar depression
1718687|NCT00034216|Suppressor Cells|suppressor cells
1718688|NCT00034216|T-cells|t-cells
1718689|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
1718690|NCT00034216|Cancer|cancer
1718691|NCT00034216|Malignancy|malignancy
1718692|NCT00034216|Blood Sample|blood sample
1718693|NCT00034138|immunotherapy|immunotherapy
1718694|NCT00034138|monoclonal|monoclonal
1718695|NCT00034138|antibody|antibody
1718696|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
1718697|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
1718698|NCT00034125|cancer|cancer
1718699|NCT00034125|metastatic breast cancer|metastatic breast cancer
1718700|NCT00034125|hormonal therapy|hormonal therapy
1718701|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
1718702|NCT00034112|combination therapy,|combination therapy,
1718703|NCT00034112|emphysema|emphysema
1718704|NCT00034112|exercise|exercise
1718705|NCT00034112|human therapy evaluation|human therapy evaluation
1718706|NCT00034112|rehabilitation|rehabilitation
1718707|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
1718708|NCT00034112|respiratory function|respiratory function
1718709|NCT00034112|biomechanics|biomechanics
1718710|NCT00034112|body movement|body movement
1718711|NCT00034112|diaphragm|diaphragm
1718712|NCT00034112|dyspnea|dyspnea
1718713|NCT00034112|muscle tension|muscle tension
1718714|NCT00034112|musculoskeletal system|musculoskeletal system
1718715|NCT00034112|outcomes research|outcomes research
1718716|NCT00034112|quality of life|quality of life
1718717|NCT00034112|somatic reflex|somatic reflex
1718718|NCT00034086|Lopinavir|lopinavir
1718719|NCT00034086|OspA Protein|ospa protein
1718720|NCT00034086|HIV-1|hiv-1
1718721|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
1718722|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
1718724|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
1718725|NCT00034086|HAART|haart
1718726|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
1718727|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
1718728|NCT00034073|Imaging|imaging
1718729|NCT00034073|Pediatrics|pediatrics
1718730|NCT00034073|Brain|brain
1718731|NCT00034073|Mapping|mapping
1718732|NCT00034073|Development|development
1718733|NCT00034073|Healthy Volunteer|healthy volunteer
1718734|NCT00034073|HV|hv
1718735|NCT00034073|Normal Control|normal control
1718736|NCT00034060|Cytokines|cytokines
1718737|NCT00034060|Exanercept|exanercept
1718738|NCT00034060|Cachexia|cachexia
1718739|NCT00034060|Body Composition|body composition
1718740|NCT00034060|Vascular Endothelial System|vascular endothelial system
1718741|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
1718742|NCT00034060|RA|ra
1718743|NCT00034060|Women|women
1718744|NCT00034060|Healthy Volunteer|healthy volunteer
1718745|NCT00034060|HV|hv
1718746|NCT00034060|Normal Control|normal control
1718747|NCT00034047|Endometriosis|endometriosis
1718748|NCT00034047|Pelvic pain|pelvic pain
1718749|NCT00034047|Acupuncture|acupuncture
1718750|NCT00034047|Chinese herbs|chinese herbs
1718751|NCT00034047|Hormone therapy|hormone therapy
1718752|NCT00034047|Nafarelin|nafarelin
1718753|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
1718754|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
1718755|NCT00034034|anxiety|anxiety
1718756|NCT00034034|colorectal neoplasm|colorectal neoplasm
1718757|NCT00034034|human therapy evaluation|human therapy evaluation
1718758|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
1718759|NCT00034034|quality of life|quality of life
1718760|NCT00034034|terminal patient care|terminal patient care
1718761|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
1718762|NCT00034034|pain|pain
1718763|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
1718764|NCT00034034|stress management|stress management
1718765|NCT00034034|alternative medicine|alternative medicine
1718766|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
1718767|NCT00034034|human subject|human subject
1718768|NCT00034034|patient oriented research|patient oriented research
1718769|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
1718770|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
1718771|NCT00034021|ginkgo biloba|ginkgo biloba
1718772|NCT00034021|human therapy evaluation|human therapy evaluation
1718773|NCT00034021|sex behavior|sex behavior
1718774|NCT00034021|antidepressant|antidepressant
1718775|NCT00034021|blood flow|blood flow
1718776|NCT00034021|clinical trial|clinical trial
1718777|NCT00034021|drug adverse effect|drug adverse effect
1718778|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
1718779|NCT00034021|relaxation|relaxation
1718780|NCT00034021|smooth muscle|smooth muscle
1718781|NCT00034021|alternative medicine|alternative medicine
1718782|NCT00034021|blood flow measurement|blood flow measurement
1718783|NCT00034021|female|female
1718784|NCT00034021|placebo|placebo
1718785|NCT00034021|women's health|women's health
1718786|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
1718787|NCT00034008|Energy Medicine|energy medicine
1718788|NCT00034008|Healing Touch|healing touch
1718789|NCT00034008|CAM Research|cam research
1718790|NCT00034008|Neonates|neonates
1718791|NCT00034008|Stress|stress
1718792|NCT00034008|Conditions resulting from stress|conditions resulting from stress
1718793|NCT00034008|Neonatal intensive care|neonatal intensive care
1718794|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
1718795|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
1718796|NCT00034008|Therapeutic Touch|therapeutic touch
1718797|NCT00034008|Touch therapies|touch therapies
1718798|NCT00034008|Energy therapies|energy therapies
1718799|NCT00034008|Infant touch|infant touch
1718800|NCT00034008|Infant stimulation|infant stimulation
1718801|NCT00033995|Tics|tics
1718802|NCT00033995|Basal Ganglia|basal ganglia
1718803|NCT00033995|Neuroimaging|neuroimaging
1718804|NCT00033995|Sleep|sleep
1718805|NCT00033995|Suppression of Tics|suppression of tics
1718806|NCT00033995|Tourette Syndrome|tourette syndrome
1718807|NCT00033995|Tourette's Syndrome|tourette's syndrome
1718808|NCT00033995|Tic Disorder|tic disorder
1718809|NCT00033995|Healthy Volunteer|healthy volunteer
1718810|NCT00033995|HV|hv
1718811|NCT00033995|Normal Control|normal control
1718812|NCT00033982|Triazole|triazole
1718813|NCT00033982|Refractory|refractory
1718814|NCT00033982|Antifungal|antifungal
1718815|NCT00033982|Fungal Infection|fungal infection
1718816|NCT00033969|CRPS|crps
1718817|NCT00033969|RSD|rsd
1718818|NCT00033969|Causalgia|causalgia
1718819|NCT00033969|Chronic Pain|chronic pain
1718820|NCT00033969|Neuropathic Pain|neuropathic pain
1718821|NCT00033969|Normal Control|normal control
1718822|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
1718823|NCT00033969|Healthy Volunteer|healthy volunteer
1718825|NCT00033956|Metastatic Melanoma|metastatic melanoma
1718826|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
1718827|NCT00033956|IL-2|il-2
1718828|NCT00033956|Interleukin-2|interleukin-2
1718829|NCT00033956|Hypotension|hypotension
1718830|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
1718831|NCT00033917|bleeding in the brain|bleeding in the brain
1718832|NCT00033917|indomethacin|indomethacin
1718833|NCT00033917|prematurity|prematurity
1718834|NCT00033917|very low birth weight infants|very low birth weight infants
1718835|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
1718836|NCT00033891|Muscle Weakness|muscle weakness
1718837|NCT00033891|Muscle Biopsy|muscle biopsy
1718838|NCT00033891|Gene Expression Profiling|gene expression profiling
1718839|NCT00033891|MRI|mri
1718840|NCT00033891|Inflammation|inflammation
1718841|NCT00033891|Polymyositis|polymyositis
1718842|NCT00033891|Dermatomyositis|dermatomyositis
1718843|NCT00033878|Advanced Cancer|advanced cancer
1718844|NCT00033865|Insomnia|insomnia
1718845|NCT00033865|Yoga|yoga
1718846|NCT00033865|Meditation|meditation
1718847|NCT00033865|Behavioral treatment|behavioral treatment
1718848|NCT00033852|complementary therapies|complementary therapies
1718849|NCT00033852|Depression|depression
1718850|NCT00033852|HIV|hiv
1718851|NCT00033852|Massage Therapy|massage therapy
1718852|NCT00033852|Alternative Treatments|alternative treatments
1718853|NCT00033839|Headache|headache
1718854|NCT00033839|Cluster|cluster
1718856|NCT00033839|Episodic Cluster|episodic cluster
1718857|NCT00033826|Vitamin D|vitamin d
1718858|NCT00033826|Adipose tissue|adipose tissue
1718859|NCT00033826|Metabolism|metabolism
1718860|NCT00033813|Duchenne|duchenne
1718861|NCT00033813|muscular|muscular
1718862|NCT00033813|dystrophy|dystrophy
1718863|NCT00033813|controlled clinical trial|controlled clinical trial
1718864|NCT00033813|CINRG|cinrg
1718865|NCT00033787|Depression|depression
1718866|NCT00033787|Tryptophan Depletion|tryptophan depletion
1718867|NCT00033787|PET|pet
1718868|NCT00033787|Serotonin|serotonin
1718869|NCT00033787|Pathophysiology|pathophysiology
1718870|NCT00033787|Emotional Stimuli|emotional stimuli
1718871|NCT00033787|GABA MRS|gaba mrs
1718872|NCT00033787|MDD|mdd
1718873|NCT00033787|Healthy Volunteer|healthy volunteer
1718874|NCT00033787|HV|hv
1718875|NCT00033787|Normal Control|normal control
1718876|NCT00033774|Leukapheresis|leukapheresis
1718877|NCT00033774|G-CSF|g-csf
1718878|NCT00033774|Mobilization|mobilization
1718879|NCT00033774|Stem Cells|stem cells
1718880|NCT00033774|Adult|adult
1718881|NCT00033774|Healthy Volunteer|healthy volunteer
1718883|NCT00033774|Normal Control|normal control
1718884|NCT00033215|neovascularization|neovascularization
1718885|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
1718886|NCT00033215|antiangiogenesis|antiangiogenesis
1718887|NCT00033215|type IV collagenases|type iv collagenases
1718888|NCT00033202|Solid Tumor|solid tumor
1718889|NCT00033202|Camptothecin|camptothecin
1718890|NCT00033202|Pharmacokinetics|pharmacokinetics
1718891|NCT00033189|duchenne|duchenne
1718892|NCT00033189|dystrophy|dystrophy
1718893|NCT00033189|DMD|dmd
1718894|NCT00033189|clinical trial|clinical trial
1718895|NCT00033189|CINRG|cinrg
1718896|NCT00033176|complementary therapies|complementary therapies
1718897|NCT00033176|Immune restoration|immune restoration
1718898|NCT00033176|HIV infection|hiv infection
1718899|NCT00033176|AIDS|aids
1718900|NCT00033176|HAART non-responsiveness|haart non-responsiveness
1718901|NCT00033176|glutathione restoration|glutathione restoration
1718902|NCT00033176|lipoic acid|lipoic acid
1718903|NCT00033176|dithiol|dithiol
1718904|NCT00033163|Antiviral Agents|antiviral agents
1718905|NCT00033163|Hepatitis B|hepatitis b
1718906|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
1718907|NCT00033163|Lamivudine|lamivudine
1718908|NCT00033163|DNA, Viral|dna, viral
1718909|NCT00033163|Hepatitis B Virus|hepatitis b virus
1718910|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
1718911|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
1718912|NCT00033163|Treatment Experienced|treatment experienced
1718913|NCT00033150|Specific Language Impairment|specific language impairment
1718914|NCT00033150|Fast ForWord|fast forword
1718915|NCT00033150|Language therapy|language therapy
1718916|NCT00033150|Auditory processing|auditory processing
1718917|NCT00033137|Pneumothorax|pneumothorax
1718918|NCT00033137|Kidney|kidney
1718919|NCT00033137|Fibrofolliculoma|fibrofolliculoma
1718920|NCT00033137|BHD|bhd
1718921|NCT00033137|Neoplasms|neoplasms
1718922|NCT00033137|Kidney Cancer|kidney cancer
1718923|NCT00033137|Birt Hogg Dube Syndrome|birt hogg dube syndrome
1718924|NCT00033137|Skin Papules|skin papules
1718925|NCT00033085|cocaine dependence|cocaine dependence
1718926|NCT00033033|cocaine dependence|cocaine dependence
1718927|NCT00033020|substance use disorders|substance use disorders
1718928|NCT00033007|substance use disorders|substance use disorders
1718929|NCT00032994|substance use disorders|substance use disorders
1718930|NCT00032981|substance use disorder|substance use disorder
1718931|NCT00032968|opiate dependence|opiate dependence
1718932|NCT00032955|opiate addiction|opiate addiction
1718933|NCT00032955|morphine addiction|morphine addiction
1718934|NCT00032942|opiate dependence|opiate dependence
1718935|NCT00032929|Cocaine Dependence|cocaine dependence
1718936|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
1718937|NCT00032890|osteoarthritis|osteoarthritis
1718938|NCT00032890|knee pain|knee pain
1718939|NCT00032877|Linkage Study|linkage study
1718940|NCT00032877|Gene Identification Study|gene identification study
1718941|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
1718942|NCT00032877|Fraser Syndrome|fraser syndrome
1718943|NCT00032877|Cryptophthalmos|cryptophthalmos
1718944|NCT00032877|Fryns Syndrome|fryns syndrome
1718945|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
1718946|NCT00032877|Positional Cloning|positional cloning
1718947|NCT00032864|amputations, diabetes,|amputations, diabetes,
1718948|NCT00032838|Hydrocortisone|hydrocortisone
1718949|NCT00032838|Yohimbine|yohimbine
1718950|NCT00032838|Cognition|cognition
1718951|NCT00032838|Norepinephrine|norepinephrine
1718952|NCT00032838|Cortisol|cortisol
1718953|NCT00032838|Emotion|emotion
1718954|NCT00032838|Healthy Volunteer|healthy volunteer
1718955|NCT00032838|HV|hv
1718956|NCT00032838|Normal Control|normal control
1718957|NCT00032825|Combination|combination
1718958|NCT00032825|Microtubule|microtubule
1718959|NCT00032825|Hormonal|hormonal
1718960|NCT00032825|Chemotherapy|chemotherapy
1722215|NCT00002391|Viral Load|viral load
1718961|NCT00032825|Pharmacokinetics|pharmacokinetics
1718962|NCT00032825|Prostate Cancer|prostate cancer
1718963|NCT00032825|Prostate|prostate
1718964|NCT00032773|acute graft versus host disease|acute graft versus host disease
1718965|NCT00032773|aGVHD|agvhd
1718966|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
1718967|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
1718968|NCT00032773|cord blood transplant|cord blood transplant
1718969|NCT00032773|pentostatin|pentostatin
1718970|NCT00032773|Nipent|nipent
1718971|NCT00032773|deoxycoformycin|deoxycoformycin
1718972|NCT00032812|Motor Learning|motor learning
1718973|NCT00032812|Sequencing|sequencing
1718974|NCT00032812|Functional Imaging|functional imaging
1718975|NCT00032812|Raclopride|raclopride
1718976|NCT00032812|Connectivity|connectivity
1718977|NCT00032812|Parkinson Disease|parkinson disease
1718978|NCT00032812|Parkinson's Disease|parkinson's disease
1718979|NCT00032812|PD|pd
1718980|NCT00032812|Healthy Volunteer|healthy volunteer
1718981|NCT00032812|HV|hv
1718982|NCT00032812|Normal Control|normal control
1718983|NCT00032760|binge eating disorder|binge eating disorder
1718984|NCT00032760|human therapy evaluation|human therapy evaluation
1718985|NCT00032760|meditation|meditation
1718986|NCT00032760|obesity|obesity
1718987|NCT00032760|nutrition education|nutrition education
1718988|NCT00032760|psychotherapy|psychotherapy
1718989|NCT00032760|racial /ethnic difference|racial /ethnic difference
1718990|NCT00032760|adult human|adult human
1718991|NCT00032760|alternative medicine|alternative medicine
1718992|NCT00032760|patient oriented research|patient oriented research
1718993|NCT00032747|Chronic Heart Failure|chronic heart failure
1718994|NCT00032747|Heart Disease|heart disease
1718995|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
1718996|NCT00032734|SIADH|siadh
1718997|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
1718998|NCT00032721|complementary therapies|complementary therapies
1718999|NCT00032721|Alternative medicine|alternative medicine
1719000|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
1719001|NCT00032721|Subtle energy therapy|subtle energy therapy
1719002|NCT00032721|Reiki|reiki
1719003|NCT00032721|HIV/AIDS|hiv/aids
1719004|NCT00032695|myelopathy|myelopathy
1719005|NCT00032695|AIDS-myelopathy|aids-myelopathy
1719006|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
1719007|NCT00032695|methionine|methionine
1719008|NCT00032682|Bowel Movement|bowel movement
1719009|NCT00032682|Children|children
1719010|NCT00032682|Stool|stool
1719011|NCT00032682|Symptom Management|symptom management
1719012|NCT00032682|Cancer|cancer
1719013|NCT00032682|Constipation|constipation
1719014|NCT00032669|Antiretrovirals|antiretrovirals
1719015|NCT00032669|Adherence|adherence
1719016|NCT00032669|Dose Adjustments|dose adjustments
1719017|NCT00032669|Genotypic Resistance|genotypic resistance
1719018|NCT00032669|Phenotypic Resistance|phenotypic resistance
1719019|NCT00032656|Adolescents|adolescents
1719020|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
1719021|NCT00032656|Health services utilization|health services utilization
1719022|NCT00032656|Communication|communication
1719023|NCT00032656|Quality of care|quality of care
1719024|NCT00032617|PTSD|ptsd
1719025|NCT00032617|Stress Disorder|stress disorder
1719026|NCT00032617|Trauma|trauma
1719027|NCT00032591|AF|af
1719028|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
1719029|NCT00032539|Informed Consent|informed consent
1719030|NCT00032513|Herpesvirus|herpesvirus
1719031|NCT00032513|Hemophagocytosis|hemophagocytosis
1719032|NCT00032513|Lymphoproliferative|lymphoproliferative
1719033|NCT00032513|Epstein-Barr|epstein-barr
1719034|NCT00032513|Mononucleosis|mononucleosis
1719035|NCT00032513|EBV|ebv
1719036|NCT00032513|CAEBV|caebv
1719037|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
1719038|NCT00032513|Virus|virus
1719039|NCT00032500|common cold|common cold
1719040|NCT00032500|Echinacea|echinacea
1719041|NCT00032487|DM|dm
1719042|NCT00032487|glycemic control|glycemic control
1719043|NCT00032487|insulin|insulin
1719044|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
1719045|NCT00032474|Ginkgo biloba|ginkgo biloba
1719046|NCT00032474|type 2 diabetes|type 2 diabetes
1719047|NCT00032474|platelet function|platelet function
1719048|NCT00032474|antioxidant|antioxidant
1719049|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
1719050|NCT00032461|fibromyalgia|fibromyalgia
1719051|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
1719052|NCT00032461|neurologic abnormalities|neurologic abnormalities
1719053|NCT00032448|Hernia|hernia
1719054|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
1719055|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
1719056|NCT00032435|folate|folate
1719057|NCT00032435|pyridoxine|pyridoxine
1719058|NCT00032435|vitamin B6|vitamin b6
1719059|NCT00032435|cyanocobalamin|cyanocobalamin
1719060|NCT00032435|homoc|homoc
1719061|NCT00032422|Acupuncture|acupuncture
1719062|NCT00032422|Heart Failure|heart failure
1719063|NCT00032422|Autonomic nervous system|autonomic nervous system
1719064|NCT00032409|Music Therapy|music therapy
1719065|NCT00032409|Relaxation Therapy|relaxation therapy
1719066|NCT00032409|Stress Reduction|stress reduction
1719067|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
1719068|NCT00032409|Stem Cell Transplantation|stem cell transplantation
1719070|NCT00032396|ARMD|armd
1719071|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
1719072|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
1719073|NCT00032396|CNV|cnv
1719074|NCT00032383|Rehabilitation|rehabilitation
1719076|NCT00032370|myocardial infarction|myocardial infarction
1719077|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
1719078|NCT00032357|Ferritin reduction|ferritin reduction
1719079|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
1719080|NCT00032357|phlebotomy|phlebotomy
1719081|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
1719082|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
1719083|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
1719084|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
1719085|NCT00032305|Colitis|colitis
1719086|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
1719087|NCT00032305|Digestive System Disease|digestive system disease
1719088|NCT00032305|Intestinal Disease|intestinal disease
1719089|NCT00032305|Colonic Disease|colonic disease
1719090|NCT00032240|Biomechanics|biomechanics
1719091|NCT00032227|Carpal Tunnel Release|carpal tunnel release
1719092|NCT00032227|MR Nerve Imaging|mr nerve imaging
1719093|NCT00032227|Wrist MRI|wrist mri
1719094|NCT00032201|Surgery|surgery
1719095|NCT00032201|Tissue Sample|tissue sample
1719096|NCT00032201|Gene Expression Profiling|gene expression profiling
1719097|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
1719098|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
1719099|NCT00032201|Breast Cancer|breast cancer
1719100|NCT00032201|Breast Cancer Risk|breast cancer risk
1719101|NCT00032201|Breast|breast
1719102|NCT00031551|Stomatitis|stomatitis
1719103|NCT00031551|Oropharyngeal pain|oropharyngeal pain
1719104|NCT00031551|TNF|tnf
1719105|NCT00031551|Etanercept|etanercept
1719106|NCT00031551|Bone marrow transplantation|bone marrow transplantation
1719107|NCT00031551|Chemotherapy|chemotherapy
1719108|NCT00031551|Cancer|cancer
1719109|NCT00031551|Oral cavity|oral cavity
1719110|NCT00031551|Oral mucous membranes|oral mucous membranes
1719111|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
1719112|NCT00031551|Inflammation|inflammation
1719113|NCT00031538|Brain Tumor|brain tumor
1719114|NCT00031538|Surgery|surgery
1719115|NCT00031538|Molecular|molecular
1719116|NCT00031538|Glioma|glioma
1719117|NCT00031538|Intraoperative|intraoperative
1719118|NCT00031538|Gliomas|gliomas
1719119|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
1719120|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
1719121|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
1719122|NCT00031473|Ribavirin|ribavirin
1719123|NCT00031473|RSV|rsv
1719124|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
1719125|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
1719126|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
1719232|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
1719127|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
1719128|NCT00031408|Specimen Handling|specimen handling
1719130|NCT00031408|Informed Consent|informed consent
1719131|NCT00031408|Genetic Screening|genetic screening
1719132|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1719133|NCT00031395|ADHD|adhd
1719134|NCT00031395|clonidine|clonidine
1719135|NCT00031395|methylphenidate|methylphenidate
1719136|NCT00031395|MPH|mph
1719137|NCT00031382|Functional MRI|functional mri
1719138|NCT00031382|Dual Task|dual task
1719139|NCT00031382|Neural Activation|neural activation
1719140|NCT00031382|Basal Ganglia|basal ganglia
1719141|NCT00031382|Cerebellum|cerebellum
1719142|NCT00031382|Healthy Volunteer|healthy volunteer
1719143|NCT00031382|HV|hv
1719144|NCT00031382|Normal Control|normal control
1719145|NCT00031369|MRI|mri
1719146|NCT00031369|Writer's Cramp|writer's cramp
1719147|NCT00031369|Movement Disorder|movement disorder
1719148|NCT00031369|Gray Matter|gray matter
1719149|NCT00031369|Brain Morphology|brain morphology
1719150|NCT00031369|Dystonia|dystonia
1719151|NCT00031369|Focal Hand Dystonia|focal hand dystonia
1719152|NCT00031369|Healthy Volunteer|healthy volunteer
1719153|NCT00031369|HV|hv
1719154|NCT00031369|Normal Control|normal control
1719155|NCT00031343|Liver Disease|liver disease
1719156|NCT00031343|Virologic Response|virologic response
1719157|NCT00031343|Immune Mechanisms|immune mechanisms
1719159|NCT00031343|Antiviral Therapy|antiviral therapy
1719160|NCT00031343|HIV|hiv
1719161|NCT00031343|Hepatitis C|hepatitis c
1719162|NCT00031343|HCV|hcv
1719163|NCT00031343|Coinfection|coinfection
1719164|NCT00031317|Depression|depression
1719165|NCT00031317|Treatment|treatment
1719166|NCT00031317|Antidepressant|antidepressant
1719167|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
1719168|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
1719169|NCT00031317|Combined Treatment|combined treatment
1719170|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
1719171|NCT00031317|Panic Disorder|panic disorder
1719172|NCT00031317|PD|pd
1719173|NCT00031304|HIV|hiv
1719179|NCT00031304|Healthy Volunteer|healthy volunteer
1719180|NCT00031304|Volunteer|volunteer
1719181|NCT00031304|HIV Seronegativity|hiv seronegativity
1719182|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
1719183|NCT00031291|Anthrax|anthrax
1719184|NCT00031291|Immune Globulin|immune globulin
1719185|NCT00031291|Plasmapheresis|plasmapheresis
1719186|NCT00031291|Vaccine|vaccine
1719187|NCT00031278|Metastatic|metastatic
1719188|NCT00031278|Breast|breast
1719189|NCT00031278|Cancer|cancer
1719190|NCT00031278|immunotherapy|immunotherapy
1719191|NCT00031278|CPG 7909|cpg 7909
1719192|NCT00031265|stroke|stroke
1719193|NCT00031265|telephone|telephone
1719194|NCT00031265|intervention|intervention
1719195|NCT00031187|Prostate|prostate
1719196|NCT00031187|Lewis Blood-Group System|lewis blood-group system
1719197|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
1719198|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
1719199|NCT00031187|Antineoplastic Agents|antineoplastic agents
1719200|NCT00031174|Apheresis|apheresis
1719201|NCT00031174|Healthy Volunteer|healthy volunteer
1719202|NCT00031174|Rheumatoid Disease|rheumatoid disease
1719203|NCT00031174|Rheumatic Disease|rheumatic disease
1719204|NCT00031174|Lupus|lupus
1719205|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
1719206|NCT00031174|Myositis|myositis
1719207|NCT00031174|HV|hv
1719208|NCT00031174|Normal Control|normal control
1719209|NCT00031161|Tyrosine|tyrosine
1719210|NCT00031161|Diet|diet
1719211|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
1719212|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
1719213|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
1719214|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
1719215|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
1719216|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
1719217|NCT00031148|HLA Antigens|hla antigens
1719218|NCT00031148|Transplantation, Homologous|transplantation, homologous
1719219|NCT00031148|Recombinant Proteins|recombinant proteins
1719220|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
1719221|NCT00031135|Lipotropic Agents|lipotropic agents
1719222|NCT00031135|Choline|choline
1719223|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
1719224|NCT00031122|Environmental Exposure|environmental exposure
1719225|NCT00031122|Chromosome Mapping|chromosome mapping
1719226|NCT00031122|Data Collection|data collection
1719227|NCT00031109|HIV Antibodies|hiv antibodies
1719228|NCT00031109|HIV-1|hiv-1
1719229|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
1719230|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
1719231|NCT00031109|AIDS Vaccines|aids vaccines
1719233|NCT00031109|Disease Models, Animal|disease models, animal
1719234|NCT00031109|Antibody Formation|antibody formation
1719235|NCT00031109|Macaca|macaca
1719236|NCT00031109|Neutralization Tests|neutralization tests
1719237|NCT00031109|Viral Load|viral load
1719238|NCT00031109|aluminum hydroxide|aluminum hydroxide
1719239|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
1719240|NCT00031096|Acne Vulgaris|acne vulgaris
1719241|NCT00031096|Propionibacterium acnes|propionibacterium acnes
1719242|NCT00031083|Glioma|glioma
1719243|NCT00031083|Brain Tumor|brain tumor
1719244|NCT00031083|Adenovirus|adenovirus
1719245|NCT00031083|Gene Therapy|gene therapy
1719246|NCT00031083|Biogen|biogen
1719247|NCT00031070|Zidovudine|zidovudine
1719248|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
1719249|NCT00031070|Lamivudine|lamivudine
1719250|NCT00031070|Cyclosporine|cyclosporine
1719251|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
1719252|NCT00031070|Rabies Vaccine|rabies vaccine
1719253|NCT00031070|abacavir|abacavir
1719254|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1719255|NCT00031070|efavirenz|efavirenz
1719256|NCT00031070|Treatment Naive|treatment naive
1719257|NCT00031057|Administration, Oral|administration, oral
1719258|NCT00031057|Blood|blood
1719259|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719260|NCT00031057|Riboflavin|riboflavin
1719261|NCT00031057|Thiamine|thiamine
1719262|NCT00031057|Vitamin B Complex|vitamin b complex
1719265|NCT00031044|Drug Therapy, Combination|drug therapy, combination
1719266|NCT00031044|RNA, Viral|rna, viral
1719267|NCT00031044|Salvage Therapy|salvage therapy
1719268|NCT00031044|Anti-HIV Agents|anti-hiv agents
1719269|NCT00031044|Viral Load|viral load
1719270|NCT00031044|Purines|purines
1719271|NCT00031044|T-20 Peptide|t-20 peptide
1719272|NCT00031044|ABT 378|abt 378
1719273|NCT00031044|Treatment Experienced|treatment experienced
1719274|NCT00031031|MTD|mtd
1719275|NCT00031031|Safety|safety
1719276|NCT00031031|Pharmacokinetics|pharmacokinetics
1719277|NCT00031031|Efficacy|efficacy
1719278|NCT00031018|Inflammation|inflammation
1719279|NCT00031018|immunosenescence|immunosenescence
1719280|NCT00031018|autoimmunity|autoimmunity
1719281|NCT00031018|atherosclerosis|atherosclerosis
1719282|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
1719283|NCT00031018|Hayflick phenomenon|hayflick phenomenon
1719284|NCT00031005|Non-Myeloablative|non-myeloablative
1719285|NCT00031005|Campath 1-H|campath 1-h
1719286|NCT00031005|Fludarabine|fludarabine
1719287|NCT00031005|Immunodeficiency|immunodeficiency
1719288|NCT00031005|Infection|infection
1719289|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
1719290|NCT00031005|LAD|lad
1719291|NCT00030992|Epothilone B|epothilone b
1719292|NCT00030992|Ixabepilone|ixabepilone
1719293|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
1719294|NCT00030992|Kidney Cancer|kidney cancer
1719295|NCT00030979|Mild Dementia|mild dementia
1719296|NCT00030979|Acetylcholine|acetylcholine
1719297|NCT00030979|Memory|memory
1719298|NCT00030979|Hallucinations|hallucinations
1719299|NCT00030979|Washout|washout
1719300|NCT00030979|Parkinson Disease|parkinson disease
1719301|NCT00030979|Parkinson's Disease|parkinson's disease
1719302|NCT00030979|PD|pd
1719303|NCT00030979|Dementia|dementia
1719304|NCT00030966|Multiple Sclerosis|multiple sclerosis
1719305|NCT00030966|MS|ms
1719306|NCT00030953|Tourette's Syndrome|tourette's syndrome
1719307|NCT00030953|GABA|gaba
1719308|NCT00030953|NAA|naa
1719309|NCT00030953|Choline|choline
1719310|NCT00030953|Creatine|creatine
1719311|NCT00030953|Tourette Syndrome|tourette syndrome
1719312|NCT00030953|Healthy Volunteer|healthy volunteer
1719313|NCT00030953|HV|hv
1719314|NCT00030953|Normal Control|normal control
1719315|NCT00030940|Antigenic Epitopes|antigenic epitopes
1719316|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
1719317|NCT00030940|Auto-antibodies|auto-antibodies
1719318|NCT00030940|Stiffness Index|stiffness index
1719319|NCT00030940|SPS|sps
1719320|NCT00030940|Anti-GAD|anti-gad
1719321|NCT00030940|MR Spectroscopy|mr spectroscopy
1719322|NCT00030940|GAD|gad
1719323|NCT00030940|Stiff Person Syndrome|stiff person syndrome
1719324|NCT00030238|Body Fat|body fat
1719325|NCT00030238|Weight Gain|weight gain
1719326|NCT00030238|Adult|adult
1719327|NCT00030238|Hypertension|hypertension
1719328|NCT00030238|Dietary Supplements|dietary supplements
1719329|NCT00030238|Healthy Volunteer|healthy volunteer
1719330|NCT00030238|HIV|hiv
1719331|NCT00030238|Body Weight|body weight
1719332|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
1719333|NCT00030212|T Cell|t cell
1719334|NCT00030212|IBM|ibm
1719335|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
1719336|NCT00030212|Antigenic Epitopes|antigenic epitopes
1719337|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
1719338|NCT00030212|Myositis|myositis
1719339|NCT00030212|Inclusion Body Myositis|inclusion body myositis
1719340|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
1719341|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
1719342|NCT00030199|Eletromyography|eletromyography
1719343|NCT00030199|Needle Electrode|needle electrode
1719344|NCT00030199|Facial Muscles|facial muscles
1719345|NCT00030199|Blink Reflex|blink reflex
1719346|NCT00030199|Motor Cortex|motor cortex
1719347|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1719348|NCT00030199|Healthy Volunteer|healthy volunteer
1719350|NCT00030199|Normal Control|normal control
1719351|NCT00030186|AML|aml
1719352|NCT00030186|FLT-3 mutation|flt-3 mutation
1719353|NCT00030173|Epothilone D|epothilone d
1719354|NCT00030173|tubulin polymerization|tubulin polymerization
1719355|NCT00030160|Obesity|obesity
1719356|NCT00030160|Prevention|prevention
1719357|NCT00030160|Exercise|exercise
1719358|NCT00030147|Gonadal Steroids|gonadal steroids
1719359|NCT00030147|Estrogen Receptor|estrogen receptor
1719360|NCT00030147|Mood Disorders|mood disorders
1719361|NCT00030147|Perimenopause|perimenopause
1719362|NCT00030147|Estradiol|estradiol
1719363|NCT00030147|Depression|depression
1719364|NCT00030147|Estrogen Response Element|estrogen response element
1719365|NCT00030147|Perimenopausal|perimenopausal
1719366|NCT00030147|Perimenopausal Depression|perimenopausal depression
1719367|NCT00030134|Natural History|natural history
1719368|NCT00030134|Female Carrier|female carrier
1719369|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
1719370|NCT00030134|Lysosomal Disease|lysosomal disease
1719371|NCT00030134|X-Linked|x-linked
1719372|NCT00030134|Fabry|fabry
1719373|NCT00030134|Fabry Disease|fabry disease
1719374|NCT00030121|Acute Respiratory Distress|acute respiratory distress
1719375|NCT00030121|Acute Lung Injury|acute lung injury
1719376|NCT00030069|Hematopoiesis|hematopoiesis
1719377|NCT00030069|Apoptosis|apoptosis
1719378|NCT00030069|Cell Differentiation|cell differentiation
1719379|NCT00030069|Bone Marrow Cells|bone marrow cells
1719380|NCT00030056|Sargramostim|sargramostim
1719381|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
1719382|NCT00030043|Electric Stimulation|electric stimulation
1719383|NCT00030043|Implants, Artificial|implants, artificial
1719384|NCT00030043|Brainstem|brainstem
1719385|NCT00030043|Electrodes|electrodes
1719386|NCT00030043|Speech Perception|speech perception
1719387|NCT00029991|Leg pain|leg pain
1719388|NCT00029991|Peripheral angiopathies|peripheral angiopathies
1719389|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
1719390|NCT00029965|Tay-Sachs|tay-sachs
1719391|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
1719392|NCT00029965|Sandhoff|sandhoff
1719393|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
1719394|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
1719395|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
1719396|NCT00029965|Gaucher|gaucher
1719397|NCT00029952|Cortisol|cortisol
1719398|NCT00029952|Bone Density|bone density
1719399|NCT00029952|Cushing Syndrome|cushing syndrome
1719400|NCT00029952|Postoperative|postoperative
1719401|NCT00029939|Preparation|preparation
1719402|NCT00029939|Subconscious|subconscious
1719403|NCT00029939|Healthy Volunteer|healthy volunteer
1719405|NCT00029939|Normal Control|normal control
1719406|NCT00029926|Imaging|imaging
1719407|NCT00029926|Immune System|immune system
1719408|NCT00029926|Autoimmune Disease|autoimmune disease
1719409|NCT00029926|Lymphonodes|lymphonodes
1719410|NCT00029926|Spleen|spleen
1719411|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
1719412|NCT00029926|Lupus|lupus
1719413|NCT00029926|SLE|sle
1719414|NCT00029913|Placebos|placebos
1719415|NCT00029913|AIDS Vaccines|aids vaccines
1719416|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
1719417|NCT00029913|Disease Progression|disease progression
1719418|NCT00029913|Viral Load|viral load
1719419|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
1719420|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
1719421|NCT00029900|Polyethylene Glycol|polyethylene glycol
1719422|NCT00029900|Arginine Deiminase|arginine deiminase
1719423|NCT00029874|Tetracyclines|tetracyclines
1719424|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
1719425|NCT00029861|Weight Loss|weight loss
1719426|NCT00029861|Obesity|obesity
1719427|NCT00029861|Weight Reduction|weight reduction
1719428|NCT00029861|Overweight|overweight
1719429|NCT00029848|Diabetes|diabetes
1719430|NCT00029848|Obesity|obesity
1719431|NCT00029835|Obesity|obesity
1719432|NCT00029822|Acute Urinary Retention|acute urinary retention
1719433|NCT00029822|AUR|aur
1719434|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
1719435|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
1719436|NCT00029822|BPH|bph
1719437|NCT00029822|Enlarged Prostate|enlarged prostate
1719438|NCT00029809|Parkinsons Disease|parkinsons disease
1719439|NCT00029809|Chinese exercise|chinese exercise
1719440|NCT00029783|Glioblastoma|glioblastoma
1719441|NCT00029783|Brain tumor|brain tumor
1719442|NCT00029783|Distant healing|distant healing
1719443|NCT00029783|Distance healing|distance healing
1719444|NCT00029757|Surgical menopause|surgical menopause
1719445|NCT00029744|AIDS Vaccines|aids vaccines
1719446|NCT00029744|Clinical Protocols|clinical protocols
1719447|NCT00029744|HIV Seronegativity|hiv seronegativity
1719448|NCT00029744|Patient Selection|patient selection
1719449|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
1719450|NCT00029744|Demography|demography
1719451|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
1719452|NCT00029731|Nitric Oxide|nitric oxide
1719453|NCT00029731|Administration, Oral|administration, oral
1719454|NCT00029718|Chronic Stroke|chronic stroke
1719455|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
1719456|NCT00029718|Motor Cortex|motor cortex
1719457|NCT00029718|Motor Control|motor control
1719458|NCT00029718|Motor Recovery|motor recovery
1719459|NCT00029718|Healthy Volunteer|healthy volunteer
1719460|NCT00029718|HV|hv
1719461|NCT00029718|Normal Control|normal control
1719462|NCT00029666|Motor Cortex|motor cortex
1719463|NCT00029666|Sham Stimulation|sham stimulation
1719464|NCT00029666|Prefrontal Cortex|prefrontal cortex
1719465|NCT00029666|Brain Stimulation|brain stimulation
1719466|NCT00029666|Gait|gait
1719467|NCT00029666|Parkinson|parkinson
1719468|NCT00029666|Parkinson's|parkinson's
1719469|NCT00029666|PD|pd
1719470|NCT00029653|Frontal Lobe|frontal lobe
1719471|NCT00029653|Reaction Time|reaction time
1719472|NCT00029653|Movement Preparation|movement preparation
1719473|NCT00029653|Motor Threshold|motor threshold
1719474|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1719475|NCT00029653|Motor Cortex|motor cortex
1719476|NCT00029653|Healthy Volunteer|healthy volunteer
1719477|NCT00029653|Normal Control|normal control
1719478|NCT00029653|HV|hv
1719479|NCT00029640|MRI|mri
1719480|NCT00029640|MRS|mrs
1719481|NCT00029640|SSRI|ssri
1719482|NCT00029640|Children|children
1719483|NCT00029640|Depression|depression
1719484|NCT00029640|Augmentation|augmentation
1719485|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
1719486|NCT00029640|Major Depression|major depression
1719487|NCT00029640|MDD|mdd
1719488|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
1719489|NCT00029627|Polymorphisms|polymorphisms
1719490|NCT00029627|Challenge Study|challenge study
1719491|NCT00029627|Yohimbine|yohimbine
1719492|NCT00029627|Clonidine|clonidine
1719493|NCT00029627|Subtypes|subtypes
1719494|NCT00029627|Normal Control|normal control
1719495|NCT00029627|HV|hv
1719496|NCT00029627|Healthy Volunteer|healthy volunteer
1719497|NCT00029614|ADHD|adhd
1719498|NCT00029614|Substance Use|substance use
1719499|NCT00029601|Magnetic Stimulation|magnetic stimulation
1719500|NCT00029601|Intracortical Inhibition|intracortical inhibition
1719501|NCT00029601|Intracortical Facilitation|intracortical facilitation
1719502|NCT00029601|Motor Evoked Potential|motor evoked potential
1719503|NCT00029601|Reaction Time|reaction time
1719504|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1719505|NCT00029601|Dystonia|dystonia
1719506|NCT00029601|Focal Dystonia|focal dystonia
1719507|NCT00029601|Healthy Volunteer|healthy volunteer
1719508|NCT00029601|HV|hv
1719509|NCT00029601|Normal Control|normal control
1719510|NCT00029588|fMRI|fmri
1719511|NCT00029588|Adolescents and Adults|adolescents and adults
1719512|NCT00029588|Depression|depression
1719513|NCT00029588|Anxiety|anxiety
1719514|NCT00029588|Anxiety Disorder|anxiety disorder
1719515|NCT00029588|GAD|gad
1719516|NCT00029588|Adolescents|adolescents
1719517|NCT00029588|Healthy Volunteer|healthy volunteer
1719518|NCT00029588|HV|hv
1719519|NCT00029588|Normal Control|normal control
1719520|NCT00029575|Atherosclerotic|atherosclerotic
1719521|NCT00029575|Plaque|plaque
1719522|NCT00029575|Resolution|resolution
1719523|NCT00029575|Adventitia|adventitia
1719524|NCT00029575|Ultrasound|ultrasound
1719525|NCT00029575|Cardiac Catheterization|cardiac catheterization
1719526|NCT00029575|Arteriosclerosis|arteriosclerosis
1719527|NCT00029575|Coronary Artery Disease|coronary artery disease
1719528|NCT00029536|Epilepsy|epilepsy
1719529|NCT00029536|Seizure|seizure
1719530|NCT00029536|Hormone|hormone
1719531|NCT00029536|Progesterone|progesterone
1719532|NCT00029536|Catamenial|catamenial
1719533|NCT00029523|neoplastic|neoplastic
1719534|NCT00029523|meningitis|meningitis
1719535|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
1719536|NCT00029523|CSF|csf
1719537|NCT00029523|meningeal|meningeal
1719538|NCT00029523|meninges|meninges
1719539|NCT00029523|CNS|cns
1719540|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
1719541|NCT00029458|Placebo Controlled|placebo controlled
1719542|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
1719543|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
1719544|NCT00029458|Positron Emission Tomography|positron emission tomography
1719545|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
1719546|NCT00029458|Antimanic|antimanic
1719547|NCT00029458|Mania|mania
1719548|NCT00029458|Pathophysiology|pathophysiology
1719549|NCT00029458|Treatment-Resistant|treatment-resistant
1719550|NCT00029458|Mood Disorder|mood disorder
1719551|NCT00029458|BPD|bpd
1719552|NCT00029458|Bipolar|bipolar
1719553|NCT00029445|HLA B5701|hla b5701
1719555|NCT00029445|Neutralizing Antibodies|neutralizing antibodies
1719556|NCT00029445|CTL|ctl
1719557|NCT00029445|Virus Restriction|virus restriction
1719558|NCT00029445|HIV|hiv
1719559|NCT00029445|HIV-Infected Long Term Nonprogressors|hiv-infected long term nonprogressors
1719560|NCT00029341|Drug Therapy, Combination|drug therapy, combination
1719561|NCT00029341|Drug Administration Schedule|drug administration schedule
1719562|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
1719563|NCT00029341|Genotype|genotype
1719564|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719565|NCT00029341|Anti-HIV Agents|anti-hiv agents
1719566|NCT00029341|Viral Load|viral load
1719567|NCT00029341|Pharmacokinetics|pharmacokinetics
1719568|NCT00029341|Efavirenz|efavirenz
1719569|NCT00029341|Treatment Interruption|treatment interruption
1719570|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
1719571|NCT00029328|Stem Cell Transplantation|stem cell transplantation
1719572|NCT00029328|Transplantation, Homologous|transplantation, homologous
1719573|NCT00029328|Respiratory Function Tests|respiratory function tests
1719574|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
1719575|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
1719576|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
1719577|NCT00029315|Pharmacokinetics|pharmacokinetics
1719578|NCT00029315|Recombinant Proteins|recombinant proteins
1719579|NCT00029315|Anticoagulants|anticoagulants
1719580|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
1719581|NCT00029315|Pharmacology|pharmacology
1719582|NCT00029315|Catheters, Indwelling|catheters, indwelling
1719583|NCT00029315|Cerebral Ventricles|cerebral ventricles
1719584|NCT00029302|fMRI|fmri
1719585|NCT00029302|Voluntary Movement|voluntary movement
1719586|NCT00029302|Healthy Volunteer|healthy volunteer
1719587|NCT00029302|HV|hv
1719588|NCT00029302|Normal Control|normal control
1719589|NCT00029276|Parkinson's|parkinson's
1719590|NCT00029276|Depression|depression
1719591|NCT00029276|Magnetic Stimulation|magnetic stimulation
1719592|NCT00029250|complementary therapies|complementary therapies
1719593|NCT00029250|garlic|garlic
1719594|NCT00029250|Allium sativum|allium sativum
1719595|NCT00029250|metabolic diseases|metabolic diseases
1719596|NCT00029250|HAART|haart
1719597|NCT00029250|Protease inhibitors|protease inhibitors
1719598|NCT00029237|Behavioral intervention|behavioral intervention
1719599|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
1719600|NCT00029237|Complementary therapy|complementary therapy
1719601|NCT00029237|Stress and coping|stress and coping
1719602|NCT00029237|complementary therapies|complementary therapies
1719603|NCT00029224|bone lesions|bone lesions
1719604|NCT00029224|breast cancer|breast cancer
1719605|NCT00029224|multiple myeloma|multiple myeloma
1719606|NCT00029224|prostate cancer|prostate cancer
1719607|NCT00029224|bone metastases|bone metastases
1719608|NCT00029224|pain|pain
1719609|NCT00029198|Massage Therapy|massage therapy
1719610|NCT00029198|Preterm Infants|preterm infants
1719611|NCT00029198|Weight Gain|weight gain
1719612|NCT00029198|Vagal Tone|vagal tone
1719613|NCT00029198|IGF-1|igf-1
1719614|NCT00029198|Oxytocin|oxytocin
1719615|NCT00029198|Brazelton|brazelton
1719616|NCT00029185|Corneal Erosion|corneal erosion
1719617|NCT00029185|Dextrans|dextrans
1719618|NCT00029185|Administration, Topical|administration, topical
1719619|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
1719620|NCT00029185|Thimerosal|thimerosal
1719621|NCT00029172|stroke|stroke
1719622|NCT00029172|depression|depression
1719623|NCT00029159|Turner syndrome|turner syndrome
1719624|NCT00029159|estrogen|estrogen
1719625|NCT00029159|androgen|androgen
1719626|NCT00029159|growth hormone|growth hormone
1719627|NCT00029146|stroke|stroke
1719628|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
1719629|NCT00029146|carotid arteries|carotid arteries
1719630|NCT00029146|cerebral infarction|cerebral infarction
1719631|NCT00029133|aneurysm|aneurysm
1719632|NCT00029133|hypothermia|hypothermia
1719633|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
1719634|NCT00028431|Stage III melanoma|stage iii melanoma
1719635|NCT00028431|Stage IV melanoma|stage iv melanoma
1719636|NCT00028431|Interleukin-12|interleukin-12
1719637|NCT00028431|Cancer Vaccines|cancer vaccines
1719638|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
1719639|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
1719640|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
1719641|NCT00028431|Mannitol|mannitol
1719642|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
1719643|NCT00028431|Melan-A Protein|melan-a protein
1719644|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
1719645|NCT00028431|Antibodies|antibodies
1719646|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
1719647|NCT00028431|CTLA-4|ctla-4
1719648|NCT00028418|Acute Leukemia|acute leukemia
1719649|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1719650|NCT00028418|Antineoplastic Agents|antineoplastic agents
1719651|NCT00028418|Nucleosides|nucleosides
1719652|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
1719653|NCT00028418|Cladribine|cladribine
1719655|NCT00028405|Photodynamic Therapy|photodynamic therapy
1719656|NCT00028405|Bulky Tumor|bulky tumor
1719657|NCT00028405|Refractory Tumor|refractory tumor
1719658|NCT00028405|Head and Neck Cancer|head and neck cancer
1719659|NCT00028405|Breast Cancer|breast cancer
1719660|NCT00028405|Pelvic Tumors|pelvic tumors
1719661|NCT00028405|Liver Metastasis|liver metastasis
1719662|NCT00028405|Colorectal Cancer|colorectal cancer
1719663|NCT00028405|Sarcoma|sarcoma
1719664|NCT00028405|Anal Cancer|anal cancer
1719665|NCT00028405|Oral Cancer|oral cancer
1719666|NCT00028405|Recurrent|recurrent
1719667|NCT00028405|Lymphadenopathy|lymphadenopathy
1719668|NCT00028405|Ovarian Cancer|ovarian cancer
1719669|NCT00028405|Cervical Cancer|cervical cancer
1719670|NCT00029120|Alzheimer's Disease|alzheimer's disease
1719671|NCT00029120|Spectroscopy|spectroscopy
1719672|NCT00029120|Longitudinal|longitudinal
1719673|NCT00029120|Perfusion|perfusion
1719674|NCT00029120|Hippocampus|hippocampus
1719675|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
1719676|NCT00029120|Cerebral Blood Flow|cerebral blood flow
1719677|NCT00029120|Aging|aging
1719678|NCT00029120|Dementia|dementia
1719679|NCT00029120|Alzheimer's|alzheimer's
1719680|NCT00029120|Memory Disorder|memory disorder
1719681|NCT00029120|Memory|memory
1719682|NCT00029120|Healthy Volunteer|healthy volunteer
1719683|NCT00029120|HV|hv
1719684|NCT00029120|Normal Control|normal control
1719688|NCT00029107|Cryoglobulinemia|cryoglobulinemia
1719689|NCT00029107|Hepatitis C|hepatitis c
1719690|NCT00029107|HcV-cV|hcv-cv
1719691|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
1719692|NCT00029068|Neurophysiology|neurophysiology
1719693|NCT00029068|Tourette Syndrome|tourette syndrome
1719694|NCT00029068|Anorexia|anorexia
1719695|NCT00029068|SRIs|sris
1719696|NCT00029068|Personality|personality
1719697|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
1719698|NCT00029068|Cortical Excitability|cortical excitability
1719699|NCT00029068|Motor Cortex|motor cortex
1719700|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1719701|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
1719702|NCT00029068|Obsessive Compulsive|obsessive compulsive
1719703|NCT00029068|OCD|ocd
1719704|NCT00029068|Healthy Volunteer|healthy volunteer
1719705|NCT00029068|Normal Control|normal control
1719706|NCT00029068|HV|hv
1719707|NCT00029042|MRI|mri
1719708|NCT00029042|Inflammation|inflammation
1719709|NCT00029042|Joint Disability|joint disability
1719710|NCT00029042|Imaging|imaging
1719711|NCT00029042|Biologic Therapy|biologic therapy
1719712|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
1719713|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
1719714|NCT00029042|JRA|jra
1719715|NCT00029042|Children|children
1719716|NCT00029042|Joints|joints
1719717|NCT00029042|Joint Inflammation|joint inflammation
1719718|NCT00028379|Plasticity|plasticity
1719719|NCT00028379|Motor Cortex|motor cortex
1719720|NCT00028379|Stroke|stroke
1719721|NCT00028379|Somatosensory|somatosensory
1719722|NCT00028379|Hemiparesis|hemiparesis
1719723|NCT00028366|HIV-1|hiv-1
1719724|NCT00028366|Drug Therapy, Combination|drug therapy, combination
1719725|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
1719726|NCT00028366|Ritonavir|ritonavir
1719727|NCT00028366|RNA, Viral|rna, viral
1719728|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719729|NCT00028366|Viral Load|viral load
1719730|NCT00028366|ABT 378|abt 378
1719731|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
1719732|NCT00028366|VX-175|vx-175
1719733|NCT00028366|Treatment Experienced|treatment experienced
1719734|NCT00028353|PIN|pin
1719735|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
1719736|NCT00028340|Breast Cancer|breast cancer
1719737|NCT00028340|Post Menopausal|post menopausal
1719738|NCT00028340|Breast Duct|breast duct
1719739|NCT00028340|Healthy Volunteer|healthy volunteer
1719740|NCT00028340|HV|hv
1719741|NCT00028340|Normal Control|normal control
1719742|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1719743|NCT00028327|Zidovudine|zidovudine
1719744|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
1719745|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
1719746|NCT00028327|Lamivudine|lamivudine
1719747|NCT00028327|Pneumonia|pneumonia
1719748|NCT00028327|Nelfinavir|nelfinavir
1719749|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719750|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1719751|NCT00028327|Efavirenz|efavirenz
1719752|NCT00028327|Intensive Care Units|intensive care units
1719753|NCT00028327|Sepsis|sepsis
1719754|NCT00028314|HIV-1|hiv-1
1719755|NCT00028314|Abacavir|abacavir
1719756|NCT00028314|Nevirapine|nevirapine
1719757|NCT00028314|Ritonavir|ritonavir
1719758|NCT00028314|RNA, Viral|rna, viral
1719759|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
1719760|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719761|NCT00028314|Anti-HIV Agents|anti-hiv agents
1719762|NCT00028314|Viral Load|viral load
1719763|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
1719764|NCT00028314|ABT 378|abt 378
1719765|NCT00028314|Treatment Experienced|treatment experienced
1719766|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
1719767|NCT00028301|RNA, Viral|rna, viral
1719768|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1719769|NCT00028301|Anti-HIV Agents|anti-hiv agents
1719770|NCT00028301|Viral Load|viral load
1719771|NCT00028301|Lipids|lipids
1719772|NCT00028301|ABT 378|abt 378
1719773|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1719774|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
1719775|NCT00028288|Asthma|asthma
1719776|NCT00028288|Daclizumab|daclizumab
1719777|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
1719778|NCT00028288|anti-IL-2|anti-il-2
1719779|NCT00028288|Zenapax|zenapax
1719780|NCT00028275|Hepatitis C Virus|hepatitis c virus
1719781|NCT00028275|Cirrhosis|cirrhosis
1719782|NCT00028275|Antiviral Agents|antiviral agents
1719783|NCT00028275|Viral Resistance|viral resistance
1719784|NCT00028275|Alpha Interferon|alpha interferon
1719785|NCT00028275|Hepatitis C|hepatitis c
1719786|NCT00028275|Hepatitis|hepatitis
1719787|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
1719788|NCT00028262|Lysosomes|lysosomes
1719789|NCT00028262|Batten Disease|batten disease
1719790|NCT00028262|Encephalopathy|encephalopathy
1719791|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
1719792|NCT00028262|CLN 1|cln 1
1719793|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
1719794|NCT00028262|Cystagon|cystagon
1719795|NCT00028249|Patient Satisfaction|patient satisfaction
1719796|NCT00028249|Self Efficacy|self efficacy
1719797|NCT00028249|Social Support|social support
1719798|NCT00028249|Symptom Management|symptom management
1719799|NCT00028249|Advanced Malignancies|advanced malignancies
1719800|NCT00028249|Pain Intervention|pain intervention
1719801|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
1719802|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
1719803|NCT00028236|Immune Reconstitution|immune reconstitution
1719804|NCT00028236|T Lymphocytes|t lymphocytes
1719805|NCT00028236|B Lymphocytes|b lymphocytes
1719806|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
1719807|NCT00028236|Gene Therapy|gene therapy
1719808|NCT00028236|NK Cell|nk cell
1719809|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
1719810|NCT00028236|Engraftment|engraftment
1719811|NCT00028236|XSCID|xscid
1719812|NCT00028236|Immune Deficiency|immune deficiency
1719813|NCT00028236|Immune System|immune system
1719814|NCT00028210|Amputee|amputee
1719815|NCT00028210|Plasticity|plasticity
1719816|NCT00028210|Somatosensory|somatosensory
1719817|NCT00028210|Upper Limb Amputation|upper limb amputation
1719818|NCT00028210|Tactile Performance|tactile performance
1719819|NCT00028210|Cortical Reorganization|cortical reorganization
1719820|NCT00028210|Healthy Volunteer|healthy volunteer
1719821|NCT00028210|HV|hv
1719822|NCT00028210|Normal Control|normal control
1719823|NCT00028197|Voluntary Movement|voluntary movement
1719824|NCT00028197|Functional MRI|functional mri
1719825|NCT00028197|Sensorimotor Integration|sensorimotor integration
1719826|NCT00028197|Superior Parietal Lobe|superior parietal lobe
1719827|NCT00028197|Supplementary Motor Area|supplementary motor area
1719828|NCT00028197|Normal Control|normal control
1719829|NCT00028197|HV|hv
1719830|NCT00028197|Healthy Volunteer|healthy volunteer
1719831|NCT00028184|Chronic Stroke|chronic stroke
1719832|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
1719833|NCT00028184|Motor Control|motor control
1719834|NCT00028184|Motor Recovery|motor recovery
1719835|NCT00028184|Stroke|stroke
1719836|NCT00028184|Healthy Volunteer|healthy volunteer
1719837|NCT00028184|HV|hv
1719838|NCT00028184|Healthy Control|healthy control
1719839|NCT00028158|Antineoplastic agents|antineoplastic agents
1719840|NCT00028158|Herpes virus|herpes virus
1719841|NCT00028158|Brain tumor|brain tumor
1719842|NCT00028158|Oncolytic virs|oncolytic virs
1719843|NCT00028145|Women's Health|women's health
1719844|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
1719845|NCT00028145|Preventive Medicine|preventive medicine
1719846|NCT00028145|Treatment Experienced|treatment experienced
1719847|NCT00028132|Risk Factors|risk factors
1719848|NCT00028132|Mucous Membrane|mucous membrane
1719849|NCT00028132|Anti-Infective Agents|anti-infective agents
1719850|NCT00028132|Cervix Uteri|cervix uteri
1719851|NCT00028132|Vagina|vagina
1719852|NCT00028132|Anti-HIV Agents|anti-hiv agents
1719853|NCT00028132|Pharmacokinetics|pharmacokinetics
1719854|NCT00028132|Vulva|vulva
1719855|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
1719856|NCT00028132|HIV Seronegativity|hiv seronegativity
1719857|NCT00028119|Clinical Trials|clinical trials
1719858|NCT00028119|Sexual Partners|sexual partners
1719859|NCT00028119|Risk Factors|risk factors
1719860|NCT00028119|Incidence|incidence
1719861|NCT00028119|HIV Seronegativity|hiv seronegativity
1719862|NCT00028119|India|india
1721326|NCT00006326|Indinavir|indinavir
1719863|NCT00028119|Patient Compliance|patient compliance
1719864|NCT00028119|Preventive Health Services|preventive health services
1719865|NCT00028106|Cancer|cancer
1719866|NCT00028106|Metastasis|metastasis
1719867|NCT00028106|Fluorodopamine|fluorodopamine
1719869|NCT00028106|Methylprednisolone|methylprednisolone
1719870|NCT00028106|Catecholamines|catecholamines
1719871|NCT00028106|Metanephrines|metanephrines
1719872|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
1719873|NCT00028106|Retinoic Acid|retinoic acid
1719874|NCT00028106|Carbidopa|carbidopa
1719875|NCT00028093|Chronic Hepatitis|chronic hepatitis
1719876|NCT00028093|Cirrhosis|cirrhosis
1719877|NCT00028093|Hepatitis C Virus|hepatitis c virus
1719878|NCT00028093|Hemolysis|hemolysis
1719879|NCT00028093|Ribavirin|ribavirin
1719880|NCT00028093|Alpha Interferon|alpha interferon
1719881|NCT00028093|Peginterferon|peginterferon
1719882|NCT00028093|Antiviral Agents|antiviral agents
1719883|NCT00028093|Viral Hepatitis|viral hepatitis
1719884|NCT00028093|Hemolytic Anemia|hemolytic anemia
1719885|NCT00028093|Renal Failure|renal failure
1719886|NCT00028093|Renal Dialysis|renal dialysis
1719887|NCT00028093|Hepatitis|hepatitis
1719888|NCT00028093|Hepatitis C|hepatitis c
1719889|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
1719890|NCT00028080|Lyme Disease|lyme disease
1719891|NCT00028080|Infection|infection
1719892|NCT00028080|Therapy|therapy
1719903|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
1719904|NCT00027482|Thymus|thymus
1719905|NCT00027482|HIV|hiv
1719906|NCT00027482|Immunity|immunity
1719907|NCT00027482|Lymphocytes|lymphocytes
1719908|NCT00027482|Monocytes|monocytes
1719909|NCT00027482|Healthy Volunteer|healthy volunteer
1719910|NCT00027482|HV|hv
1719911|NCT00027482|Normal Control|normal control
1719912|NCT00027469|Atheroembolism|atheroembolism
1719913|NCT00027469|Atherosclerosis|atherosclerosis
1719914|NCT00027469|MRI|mri
1719915|NCT00027469|Renal Artery Stenosis|renal artery stenosis
1719916|NCT00027469|Renovascular Hypertension|renovascular hypertension
1719917|NCT00027469|ARAS|aras
1719918|NCT00027469|Renovascular Disease|renovascular disease
1719919|NCT00027469|Renal Artery Stenting|renal artery stenting
1719920|NCT00027469|PTRAS|ptras
1719921|NCT00027456|Insulin Resistance|insulin resistance
1719922|NCT00027456|Diabetes Mellitus|diabetes mellitus
1719923|NCT00027456|Adipocytes|adipocytes
1719924|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
1719925|NCT00027456|Leprechaunism|leprechaunism
1719926|NCT00027456|Leptin|leptin
1719927|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
1719928|NCT00027417|Congenital heart defects|congenital heart defects
1719929|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
1719930|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
1719931|NCT00027417|Triostat|triostat
1719932|NCT00027417|Cardiac surgery|cardiac surgery
1719933|NCT00027404|Adult, Autism|adult, autism
1719934|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
1719935|NCT00027378|fluoxetine,|fluoxetine,
1719936|NCT00027378|adolescents,|adolescents,
1719937|NCT00027378|alcohol dependence,|alcohol dependence,
1719938|NCT00027378|major depression|major depression
1719939|NCT00027378|Alcoholism|alcoholism
1719940|NCT00027365|HIV Seronegativity|hiv seronegativity
1719941|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
1719942|NCT00027365|Injections, Intramuscular|injections, intramuscular
1719943|NCT00027365|HIV Antibodies|hiv antibodies
1719944|NCT00027365|HIV-1|hiv-1
1719945|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
1719946|NCT00027365|Gene Products, tat|gene products, tat
1719947|NCT00027365|AIDS Vaccines|aids vaccines
1719948|NCT00027365|Neutralization Tests|neutralization tests
1719949|NCT00027365|Vaccines, Combined|vaccines, combined
1719950|NCT00027365|AIDS Seronegativity|aids seronegativity
1719951|NCT00027365|Gene Products, nef|gene products, nef
1719952|NCT00027352|Physician's Practice Patterns|physician's practice patterns
1719953|NCT00027352|Anti-HIV Agents|anti-hiv agents
1719954|NCT00027339|HIV-1|hiv-1
1719955|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
1719956|NCT00027339|RNA, Viral|rna, viral
1719957|NCT00027339|Phenotype|phenotype
1719958|NCT00027339|Viral Load|viral load
1719959|NCT00027339|Pharmacokinetics|pharmacokinetics
1719960|NCT00027339|Treatment Experienced|treatment experienced
1719961|NCT00027326|Blood|blood
1719962|NCT00027326|Samples|samples
1719963|NCT00027326|Radiation|radiation
1719964|NCT00027326|Urine|urine
1719965|NCT00027326|Cancer|cancer
1719966|NCT00027326|Radiation Therapy|radiation therapy
1719967|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
1719968|NCT00027287|Type I Diabetes|type i diabetes
1719969|NCT00027287|Type 2 Diabetes|type 2 diabetes
1719970|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
1719971|NCT00027287|Vitamin E|vitamin e
1719972|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
1719973|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
1719974|NCT00027287|Macular Edema|macular edema
1719975|NCT00027287|Type II Diabetes|type ii diabetes
1719985|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
1719986|NCT00027261|HIV-1|hiv-1
1719987|NCT00027261|AIDS Vaccines|aids vaccines
1719988|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1719989|NCT00027261|HIV Seronegativity|hiv seronegativity
1719990|NCT00027261|Avipoxvirus|avipoxvirus
1719991|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1719992|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
1719993|NCT00027248|central venous catheter|central venous catheter
1719994|NCT00027248|bloodstream infection|bloodstream infection
1719995|NCT00027248|CVC|cvc
1719996|NCT00027248|catheter colonization|catheter colonization
1719997|NCT00027248|local catheter site infection|local catheter site infection
1719998|NCT00027209|seizures|seizures
1719999|NCT00027209|epilepsy|epilepsy
1720000|NCT00027209|menopause|menopause
1720001|NCT00027196|Genetics|genetics
1720002|NCT00027196|Cardiac Diseases|cardiac diseases
1720003|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
1720004|NCT00027196|Sudden Death|sudden death
1720005|NCT00027196|Arrhythmias|arrhythmias
1720006|NCT00027183|Cystic Fibrosis|cystic fibrosis
1720007|NCT00027183|Effector Proteins|effector proteins
1720008|NCT00027183|Cytotoxin|cytotoxin
1720009|NCT00027183|Lung Injury|lung injury
1720010|NCT00027183|Genetic Screen|genetic screen
1720011|NCT00027170|Myocardial Infarction|myocardial infarction
1720012|NCT00027170|Myocardial Viability|myocardial viability
1720013|NCT00027170|Myocardial Perfusion|myocardial perfusion
1720014|NCT00027170|Myocardial Ischemia|myocardial ischemia
1720015|NCT00027170|Atherosclerosis|atherosclerosis
1720016|NCT00027170|Cardiovascular Disease|cardiovascular disease
1720017|NCT00027170|Coronary Artery Disease|coronary artery disease
1720018|NCT00027157|Coronary Spasm|coronary spasm
1720019|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
1720020|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
1720021|NCT00027157|Susceptibility Genes|susceptibility genes
1720022|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
1720023|NCT00027144|Leukemia|leukemia
1720024|NCT00027144|Vaccine|vaccine
1720025|NCT00027131|vaccine|vaccine
1720026|NCT00027131|immunotherapy|immunotherapy
1720027|NCT00027118|Shoulder|shoulder
1720028|NCT00027118|Breast Cancer|breast cancer
1720029|NCT00027118|Physical Therapy|physical therapy
1720030|NCT00027118|Lymphedema|lymphedema
1720031|NCT00027118|Quality of Life|quality of life
1720032|NCT00027118|Breast Cancer Surgery|breast cancer surgery
1720033|NCT00027118|Healthy Volunteer|healthy volunteer
1720034|NCT00027118|HV|hv
1720035|NCT00027118|Normal Control|normal control
1720036|NCT00027105|Fatigue|fatigue
1720037|NCT00027105|Shoulder function|shoulder function
1720038|NCT00027105|Lymphedema|lymphedema
1720039|NCT00027105|Breast Cancer|breast cancer
1720040|NCT00027105|Breast Cancer Surgery|breast cancer surgery
1720041|NCT00027105|Quality of Life|quality of life
1720042|NCT00027092|Infusions, Intravenous|infusions, intravenous
1720043|NCT00027092|Testosterone|testosterone
1720044|NCT00027092|Insulin Resistance|insulin resistance
1720045|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
1720046|NCT00027092|Glucose Tolerance Test|glucose tolerance test
1720047|NCT00027066|stroke|stroke
1720048|NCT00027066|aspirin|aspirin
1720049|NCT00027066|warfarin|warfarin
1720050|NCT00027053|alcoholism|alcoholism
1720051|NCT00027053|alcohol dependence|alcohol dependence
1720052|NCT00027053|trazadone|trazadone
1720053|NCT00027053|sleep|sleep
1720054|NCT00027040|AIDS Dementia Complex|aids dementia complex
1720055|NCT00027040|Selegiline|selegiline
1720056|NCT00027040|Oxidative Stress|oxidative stress
1720057|NCT00027040|Cognition|cognition
1720058|NCT00027040|Neuroprotective Agents|neuroprotective agents
1720059|NCT00027040|Brain Injuries|brain injuries
1720060|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1720061|NCT00027040|Protons|protons
1720062|NCT00027014|opioid|opioid
1720063|NCT00027014|St. John's wort|st. john's wort
1720064|NCT00027014|analgesia|analgesia
1720065|NCT00027014|metabolism|metabolism
1720066|NCT00027014|transporter|transporter
1720067|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
1720068|NCT00026988|Huntington's disease|huntington's disease
1720069|NCT00026988|creatine|creatine
1720070|NCT00026988|energy depletion|energy depletion
1720071|NCT00026975|Laryngeal Cancer|laryngeal cancer
1720072|NCT00026975|Laryngectomy|laryngectomy
1720073|NCT00026975|Tissue Oxygenation|tissue oxygenation
1720074|NCT00026975|Irradiated Tissue|irradiated tissue
1720075|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
1720076|NCT00026975|Angiogenesis|angiogenesis
1720077|NCT00026975|EF5|ef5
1720078|NCT00026962|Breast|breast
1720079|NCT00026962|Hormones|hormones
1720080|NCT00026962|Prevention|prevention
1720081|NCT00026962|Saliva|saliva
1720082|NCT00026962|Serum|serum
1720083|NCT00026949|Etoposide|etoposide
1720084|NCT00026949|Breast Cancer|breast cancer
1720085|NCT00026949|Pharmacokinetics|pharmacokinetics
1720086|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
1720087|NCT00026936|TCP|tcp
1720090|NCT00026936|3-D Programming|3-d programming
1720091|NCT00026923|Laparoscopy|laparoscopy
1720092|NCT00026923|Telemedicine|telemedicine
1720093|NCT00026923|Surgery|surgery
1720094|NCT00026923|Endoscopy|endoscopy
1720095|NCT00026910|Cell-Cycle|cell-cycle
1720096|NCT00026910|Apoptosis|apoptosis
1720097|NCT00026910|Molecular Prognosis|molecular prognosis
1720098|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
1720099|NCT00026897|Cellular Therapy|cellular therapy
1720100|NCT00026897|Lymphocyte Migration|lymphocyte migration
1720101|NCT00026897|Tumor Imaging|tumor imaging
1720102|NCT00026884|Serum|serum
1720103|NCT00026884|Collection of Tissue|collection of tissue
1720104|NCT00026884|Malignant Disease|malignant disease
1720105|NCT00026884|Molecular Basis|molecular basis
1720106|NCT00026884|Genome Sequencing|genome sequencing
1720107|NCT00026871|Non-Therapeutic|non-therapeutic
1720108|NCT00026871|Radiation Therapy|radiation therapy
1720109|NCT00026871|Dosimetry|dosimetry
1720110|NCT00026871|Dose-Rate|dose-rate
1720111|NCT00026871|Fiberoptic|fiberoptic
1720112|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
1720113|NCT00026858|Leukemia|leukemia
1720114|NCT00026858|Breast Cancer|breast cancer
1720115|NCT00026858|Multiple Myeloma|multiple myeloma
1720116|NCT00026858|Total Body Irradiation|total body irradiation
1720118|NCT00026832|Major Depression|major depression
1720119|NCT00026832|MRI|mri
1720120|NCT00026832|Cerebral Blood Flow|cerebral blood flow
1720121|NCT00026832|Neuroendocrine|neuroendocrine
1720122|NCT00026832|Bipolar Disorder|bipolar disorder
1720123|NCT00026832|Serotonin1A|serotonin1a
1720124|NCT00026832|Mood Disorder|mood disorder
1720125|NCT00026832|Major Depressive Disorder|major depressive disorder
1720126|NCT00026832|MDD|mdd
1720127|NCT00026832|Depression|depression
1720128|NCT00026832|Healthy Volunteer|healthy volunteer
1720129|NCT00026832|HV|hv
1720130|NCT00026832|Normal Control|normal control
1720131|NCT00026819|NSAID|nsaid
1720132|NCT00026819|Acute Pain Model|acute pain model
1720133|NCT00026819|Hyperalgesia|hyperalgesia
1720134|NCT00026819|Central Sensitization|central sensitization
1720135|NCT00026819|Wisdom Teeth|wisdom teeth
1720136|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
1720137|NCT00026819|Third Molar|third molar
1720138|NCT00026806|HIV Infection|hiv infection
1720139|NCT00026806|Mental Health|mental health
1720140|NCT00026806|Risk Behaviors|risk behaviors
1720141|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1720142|NCT00026806|Youth|youth
1720143|NCT00026806|HIV|hiv
1720144|NCT00026806|Long Term Survivor|long term survivor
1720145|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
1720146|NCT00026793|Doppler|doppler
1720147|NCT00026793|Infrared|infrared
1720148|NCT00026793|HIV|hiv
1720149|NCT00026793|Imaging|imaging
1720150|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
1720151|NCT00026793|Laser Imaging|laser imaging
1720152|NCT00026793|Infrared Imaging|infrared imaging
1720153|NCT00026780|CT Scan|ct scan
1720154|NCT00026780|MRI Scan|mri scan
1720155|NCT00026780|Childhood Cancer|childhood cancer
1720156|NCT00026780|Eligibility Screening|eligibility screening
1720157|NCT00026780|Tissue Procurement|tissue procurement
1720158|NCT00026780|Pediatric|pediatric
1720159|NCT00026780|Children|children
1720160|NCT00026780|Screening|screening
1720161|NCT00026767|Risk Factors|risk factors
1720162|NCT00026767|Epidemiology|epidemiology
1720163|NCT00026767|BMT/SCT|bmt/sct
1720164|NCT00026767|Fungal Infection|fungal infection
1720165|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
1720166|NCT00026767|Organ Transplant|organ transplant
1720167|NCT00026754|Screening|screening
1720168|NCT00026754|Cancer|cancer
1720169|NCT00026754|HIV Infection|hiv infection
1720170|NCT00026754|Scans|scans
1720171|NCT00026754|Laboratory Tests|laboratory tests
1720172|NCT00026754|HIV|hiv
1720173|NCT00026754|Skin Disorders|skin disorders
1720174|NCT00026741|Cytokine|cytokine
1720175|NCT00026741|Inflammation|inflammation
1720176|NCT00026741|Lymphocyte|lymphocyte
1720177|NCT00026741|T Cell|t cell
1720178|NCT00026741|Migration|migration
1720179|NCT00026741|Healthy Volunteer|healthy volunteer
1720180|NCT00026741|Skin Biopsy|skin biopsy
1720181|NCT00026728|Human Herpesvirus B|human herpesvirus b
1720182|NCT00026728|NHANES|nhanes
1720183|NCT00026728|Epidemiology|epidemiology
1720184|NCT00026728|Population-Based Study|population-based study
1720185|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
1720186|NCT00026715|Renal Function|renal function
1720187|NCT00026715|Iothalamate|iothalamate
1720188|NCT00026702|Acute Renal Failure|acute renal failure
1720189|NCT00026702|Biomarkers|biomarkers
1720190|NCT00026689|Evaluation|evaluation
1720191|NCT00026689|Screening|screening
1720192|NCT00026689|Cancer|cancer
1720193|NCT00026689|Radiation|radiation
1720194|NCT00026689|Eligibility|eligibility
1720195|NCT00026676|Surrogate Markers|surrogate markers
1720196|NCT00026676|Genotypic Resistance|genotypic resistance
1720197|NCT00026676|Phenotypic Resistance|phenotypic resistance
1720201|NCT00026663|Biopsy Samples|biopsy samples
1720202|NCT00026663|Specimen Acquisition|specimen acquisition
1720203|NCT00026663|Cancer Cells|cancer cells
1720204|NCT00026650|Late Effects|late effects
1720205|NCT00026650|Radiation Therapy|radiation therapy
1720206|NCT00026650|Cancer|cancer
1720207|NCT00026637|depression|depression
1720208|NCT00026637|epilepsy|epilepsy
1720210|NCT00026624|Virus Replication|virus replication
1720211|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
1720212|NCT00026624|HIV-1|hiv-1
1720213|NCT00026624|AIDS Vaccines|aids vaccines
1720214|NCT00026624|Dendritic Cells|dendritic cells
1720215|NCT00026624|Adoptive Transfer|adoptive transfer
1720216|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
1720217|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1720218|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
1720219|NCT00026598|Basal Ganglia|basal ganglia
1720220|NCT00026598|Cerebral Cortex|cerebral cortex
1720221|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
1720222|NCT00026598|Bradykinesia|bradykinesia
1720223|NCT00026598|Bradyphrenia|bradyphrenia
1720224|NCT00026598|Parkinson's Disease|parkinson's disease
1720225|NCT00026598|Parkinson Disease|parkinson disease
1720227|NCT00026598|Healthy Volunteer|healthy volunteer
1720228|NCT00026598|HV|hv
1720229|NCT00026598|Normal Control|normal control
1720230|NCT00026585|Bipolar Disorder|bipolar disorder
1720231|NCT00026585|Antimanic|antimanic
1720232|NCT00026585|Placebo Controlled|placebo controlled
1720233|NCT00026585|Randomized|randomized
1720234|NCT00026585|Cytochrome P450|cytochrome p450
1720235|NCT00026585|Mania|mania
1720236|NCT00026585|PKC Inhibitor|pkc inhibitor
1720237|NCT00026585|Tamoxifen|tamoxifen
1720238|NCT00026585|Bipolar|bipolar
1720239|NCT00026585|Manic|manic
1720240|NCT00026585|BPD|bpd
1720241|NCT00026559|Classical Conditioning|classical conditioning
1720242|NCT00026559|Fear Conditioning|fear conditioning
1720243|NCT00026559|Stress|stress
1720244|NCT00026559|Anxiety|anxiety
1720245|NCT00026559|Learning|learning
1720246|NCT00026559|Normal Volunteers|normal volunteers
1720247|NCT00026559|Adults|adults
1720248|NCT00026559|Healthy Volunteer|healthy volunteer
1720249|NCT00026559|Normal Control|normal control
1720250|NCT00026546|Stop Task|stop task
1720251|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
1720252|NCT00026546|Developmental|developmental
1720253|NCT00026546|Inhibitory Control|inhibitory control
1720254|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1720255|NCT00026546|ADHD|adhd
1720256|NCT00026546|Impulsivity|impulsivity
1720257|NCT00026546|Healthy Volunteer|healthy volunteer
1720258|NCT00026546|Normal Volunteer|normal volunteer
1720259|NCT00026546|HV|hv
1720260|NCT00026065|Hypertension|hypertension
1720261|NCT00026065|BIofeedback|biofeedback
1720262|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
1720263|NCT00026065|Prediction|prediction
1720264|NCT00026052|Riluzole|riluzole
1720265|NCT00026052|Neuroprotective|neuroprotective
1720266|NCT00026052|Open-Label Study|open-label study
1720267|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
1720268|NCT00026052|Unipolar Depression|unipolar depression
1720269|NCT00026052|Antidepressant|antidepressant
1720270|NCT00026052|Depression|depression
1720271|NCT00026052|Major Depression|major depression
1720272|NCT00026039|stroke|stroke
1720273|NCT00026039|estrogen|estrogen
1720274|NCT00026026|Human tooth agenesis|human tooth agenesis
1720275|NCT00026013|contraception|contraception
1720276|NCT00026013|hormonal contraception|hormonal contraception
1720277|NCT00026013|herbal remedies|herbal remedies
1720278|NCT00026013|hypericum perforatum|hypericum perforatum
1720279|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
1720280|NCT00026000|Voluntary Movement|voluntary movement
1720281|NCT00026000|Basal Ganglia|basal ganglia
1720282|NCT00026000|Frontal Lobe|frontal lobe
1720283|NCT00026000|Motor Cortex|motor cortex
1720284|NCT00026000|Motor Tic Disorder|motor tic disorder
1720285|NCT00026000|Tourette's Syndrome|tourette's syndrome
1720286|NCT00026000|Vocal Tic Disorder|vocal tic disorder
1720287|NCT00026000|Tic|tic
1720288|NCT00026000|Healthy Volunteer|healthy volunteer
1720289|NCT00026000|HV|hv
1720290|NCT00026000|Normal Control|normal control
1720291|NCT00025987|Brain|brain
1720292|NCT00025987|Temperature|temperature
1720293|NCT00025987|Lower|lower
1720294|NCT00025987|Tympanic|tympanic
1720295|NCT00025987|Rectal|rectal
1720296|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
1720297|NCT00025987|Control|control
1720298|NCT00025987|Epilepsy|epilepsy
1720299|NCT00025987|Healthy Volunteer|healthy volunteer
1720300|NCT00025987|HV|hv
1720301|NCT00025974|PET|pet
1720302|NCT00025974|5-HT1A Receptors|5-ht1a receptors
1720303|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
1720304|NCT00025974|Panic Disorder|panic disorder
1720305|NCT00025974|PTSD|ptsd
1720306|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
1720307|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1720308|NCT00025974|Major Depression|major depression
1720309|NCT00025974|Anxiety|anxiety
1720310|NCT00025974|Depression|depression
1720311|NCT00025974|Healthy Volunteer|healthy volunteer
1720312|NCT00025974|HV|hv
1720313|NCT00025974|Normal Control|normal control
1720314|NCT00025935|Mood Disorders|mood disorders
1720315|NCT00025935|Bipolar Disorder|bipolar disorder
1722505|NCT00002337|vesnarinone|vesnarinone
1720316|NCT00025935|Neuroimaging|neuroimaging
1720317|NCT00025935|Psychophysiology|psychophysiology
1720318|NCT00025935|Frustration|frustration
1720319|NCT00025935|Emotional Dysregulation|emotional dysregulation
1720320|NCT00025935|Lithium|lithium
1720321|NCT00025935|Conduct Disorder|conduct disorder
1720322|NCT00025935|Children and Adolescents|children and adolescents
1720323|NCT00025935|Affective Neuroscience|affective neuroscience
1720324|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
1720325|NCT00025935|Mood Disorder|mood disorder
1720326|NCT00025935|Behavior|behavior
1720327|NCT00025935|Children|children
1720328|NCT00025935|Adolescent|adolescent
1720329|NCT00025935|Healthy Volunteer|healthy volunteer
1720330|NCT00025935|HV|hv
1720331|NCT00025935|Normal Control|normal control
1720332|NCT00025922|Immunization|immunization
1720333|NCT00025922|Titers|titers
1720334|NCT00025922|Immune Activation|immune activation
1720335|NCT00025922|Antibody|antibody
1720336|NCT00025922|CD4 Cell Count|cd4 cell count
1720337|NCT00025922|HIV|hiv
1720338|NCT00025909|Therapy|therapy
1720339|NCT00025909|Antiretrovirals|antiretrovirals
1720340|NCT00025909|Interruption|interruption
1720341|NCT00025909|CD4+ T Cell|cd4+ t cell
1720342|NCT00025909|Plasma Viremia|plasma viremia
1720343|NCT00025909|HIV|hiv
1720344|NCT00025909|Treatment Experienced|treatment experienced
1720345|NCT00025909|Treatment Interuption|treatment interuption
1720346|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
1720347|NCT00025883|Diabetes Mellitus|diabetes mellitus
1720348|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
1720349|NCT00025883|NASH|nash
1720350|NCT00025883|Lipodystrophy|lipodystrophy
1720351|NCT00025883|Leptin|leptin
1720352|NCT00025883|Diabetes|diabetes
1720353|NCT00025870|Genetics|genetics
1720354|NCT00025870|Metabolic|metabolic
1720355|NCT00025870|Dysmorphology|dysmorphology
1720356|NCT00025870|Training|training
1720357|NCT00025870|DNA|dna
1720358|NCT00025870|DNA Testing|dna testing
1720359|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
1720360|NCT00025870|Developmental Delay|developmental delay
1720361|NCT00025870|Genetic Counseling|genetic counseling
1720362|NCT00025870|Molecular Genetics|molecular genetics
1720363|NCT00025857|fMRI|fmri
1720364|NCT00025857|Depression|depression
1720365|NCT00025857|PTSD|ptsd
1720366|NCT00025857|Emotion|emotion
1720367|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
1720368|NCT00025857|Anxiety|anxiety
1720369|NCT00025857|Normal Volunteers|normal volunteers
1720370|NCT00025857|Adolescence|adolescence
1720371|NCT00025857|Memory|memory
1720372|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
1720373|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1720374|NCT00025857|Adolescent|adolescent
1720375|NCT00025857|Healthy Volunteer|healthy volunteer
1720376|NCT00025857|HV|hv
1720377|NCT00025857|Normal Control|normal control
1720378|NCT00025844|Stress|stress
1720379|NCT00025844|Anxiety|anxiety
1720380|NCT00025844|Adults|adults
1720381|NCT00025844|Fear Conditioning|fear conditioning
1720382|NCT00025844|Normal Volunteers|normal volunteers
1720383|NCT00025844|Associative Learning|associative learning
1720384|NCT00025844|Virtual Reality|virtual reality
1720385|NCT00025844|Context Conditioning|context conditioning
1720386|NCT00025844|Healthy Volunteer|healthy volunteer
1720387|NCT00025844|HV|hv
1720388|NCT00025844|Normal Control|normal control
1720389|NCT00025831|Buccal|buccal
1720390|NCT00025831|DNA|dna
1720391|NCT00025831|Pooling|pooling
1720392|NCT00025831|Genotyping|genotyping
1720393|NCT00025831|Mouthwash|mouthwash
1720394|NCT00025831|Healthy Volunteer|healthy volunteer
1720395|NCT00025831|HV|hv
1720396|NCT00025831|Normal Control|normal control
1720397|NCT00025818|dry eyes|dry eyes
1720398|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
1720399|NCT00025818|Lupus|lupus
1720400|NCT00025818|Sjogren's syndrome|sjogren's syndrome
1720401|NCT00025818|myositis|myositis
1720402|NCT00025818|scleroderma|scleroderma
1720403|NCT00025818|autoimmune disorder|autoimmune disorder
1720404|NCT00025805|Cytokines|cytokines
1720405|NCT00025805|Th1 Th2 Response|th1 th2 response
1720406|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
1720407|NCT00025805|Lymphocyte|lymphocyte
1720408|NCT00025805|Colonoscopy|colonoscopy
1720409|NCT00025805|Crohn's Disease|crohn's disease
1720410|NCT00025805|Crohn's|crohn's
1720411|NCT00025792|Pramipexole|pramipexole
1720412|NCT00025792|Neuroprotective|neuroprotective
1720413|NCT00025792|Placebo Controlled|placebo controlled
1720414|NCT00025792|Depression|depression
1720415|NCT00025792|Brain Imaging|brain imaging
1720416|NCT00025792|Antidepressant|antidepressant
1720417|NCT00025792|Bipolar Disorder|bipolar disorder
1720418|NCT00025792|Bipolar|bipolar
1720419|NCT00025792|BPD|bpd
1720420|NCT00025792|Bipolar Depression|bipolar depression
1720421|NCT00025779|Hyperactivity|hyperactivity
1720422|NCT00025779|Distractibility|distractibility
1720423|NCT00025779|Impulsiveness|impulsiveness
1720424|NCT00025779|Pervasive Development Disorders|pervasive development disorders
1723160|NCT00002208|HIV-1|hiv-1
1720425|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
1720426|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
1720427|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
1720428|NCT00025740|Combined Treatment|combined treatment
1720429|NCT00025740|Rapid Treatment|rapid treatment
1720430|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1720431|NCT00025740|PTSD|ptsd
1720432|NCT00025727|HIV-1|hiv-1
1720433|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
1720434|NCT00025727|Ritonavir|ritonavir
1720435|NCT00025727|RNA, Viral|rna, viral
1720436|NCT00025727|Anti-HIV Agents|anti-hiv agents
1720437|NCT00025727|Viral Load|viral load
1720438|NCT00025727|ABT 378|abt 378
1720439|NCT00025727|VX-175|vx-175
1720440|NCT00025714|Serotonin Receptor|serotonin receptor
1720441|NCT00025714|Cell Culture|cell culture
1720442|NCT00025714|Temporal Lobe|temporal lobe
1720443|NCT00025714|Endothelial Cells|endothelial cells
1720444|NCT00025714|Superficial Temporal Artery|superficial temporal artery
1720445|NCT00025714|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1720446|NCT00025714|Epilepsy|epilepsy
1720447|NCT00025714|Intractable Epilepsy|intractable epilepsy
1720448|NCT00025701|Cortex|cortex
1720449|NCT00025701|Inhibition|inhibition
1720450|NCT00025701|Motor Control|motor control
1720451|NCT00025701|Event-Related Synchronization|event-related synchronization
1720452|NCT00025701|Event-Related Desynchronization|event-related desynchronization
1720453|NCT00025701|Focal Hand Dystonia|focal hand dystonia
1720454|NCT00025701|Focal Dystonia|focal dystonia
1720455|NCT00025701|Dystonia|dystonia
1720456|NCT00025701|Hand|hand
1720457|NCT00025701|Healthy Volunteer|healthy volunteer
1720458|NCT00025701|HV|hv
1720459|NCT00024999|Movement|movement
1720460|NCT00024999|Coordination|coordination
1720461|NCT00024999|Correlation|correlation
1720462|NCT00024999|Coherence|coherence
1720463|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
1720464|NCT00024999|Apraxia|apraxia
1720465|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
1720466|NCT00024999|Healthy Volunteer|healthy volunteer
1720467|NCT00024999|HV|hv
1720468|NCT00024999|Normal Control|normal control
1720469|NCT00024986|HAART|haart
1720470|NCT00024986|Genotypic Resistance|genotypic resistance
1720471|NCT00024986|Phenotypic Resistance|phenotypic resistance
1720472|NCT00024986|Immune Reconstitution|immune reconstitution
1720473|NCT00024986|Bone Density|bone density
1720474|NCT00024986|HIV|hiv
1720475|NCT00024986|Children|children
1720476|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
1720477|NCT00024960|Speech|speech
1720478|NCT00024960|Motor Control|motor control
1720479|NCT00024960|Phenotype|phenotype
1720480|NCT00024960|Dysfluency|dysfluency
1720481|NCT00024960|Fluency|fluency
1720482|NCT00024960|Stuttering|stuttering
1720483|NCT00024960|Healthy Volunteer|healthy volunteer
1720484|NCT00024960|HV|hv
1720485|NCT00024960|Normal Control|normal control
1720486|NCT00024934|Immunodeficiency|immunodeficiency
1720487|NCT00024934|Primary|primary
1720488|NCT00024934|Cancer|cancer
1720489|NCT00024934|Genetics|genetics
1720490|NCT00024934|IGA Deficiency|iga deficiency
1720491|NCT00024934|Immune Deficiency|immune deficiency
1720492|NCT00024908|Cognition|cognition
1720493|NCT00024908|Frontal Lobes|frontal lobes
1720494|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
1720495|NCT00024908|Focal Lesions|focal lesions
1720496|NCT00024908|Executive Functions|executive functions
1720497|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
1720498|NCT00024908|Frontal Lobe|frontal lobe
1720499|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
1720500|NCT00024908|Healthy Volunteer|healthy volunteer
1720501|NCT00024908|HV|hv
1720502|NCT00024908|Normal Control|normal control
1720503|NCT00024804|SKELETAL DISEASE|skeletal disease
1720504|NCT00024804|Osteoporosis|osteoporosis
1720505|NCT00024804|Dysplasia|dysplasia
1720506|NCT00024804|Osteomalacia|osteomalacia
1720507|NCT00024804|Bone Diseases|bone diseases
1720508|NCT00024791|Cerebral Palsy|cerebral palsy
1720509|NCT00024791|Pediatric|pediatric
1720510|NCT00024791|Cognition|cognition
1720511|NCT00024791|Motor Learning|motor learning
1720512|NCT00024791|Visuomotor Integration|visuomotor integration
1720513|NCT00024791|Corticospinal Tracts|corticospinal tracts
1720514|NCT00024791|Cortical Re-Organization|cortical re-organization
1720515|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
1720516|NCT00024791|Spastic Diplegia|spastic diplegia
1720517|NCT00024791|Functional Outcome|functional outcome
1720518|NCT00024791|Children|children
1720519|NCT00024791|Healthy Volunteer|healthy volunteer
1720520|NCT00024791|HV|hv
1721327|NCT00006326|Delavirdine|delavirdine
1720521|NCT00024791|Normal Control|normal control
1720522|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
1720523|NCT00024687|advanced malignancy|advanced malignancy
1720524|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
1720525|NCT00024674|SS1P|ss1p
1720526|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
1720527|NCT00024674|advanced malignancy|advanced malignancy
1720528|NCT00024661|recurrent solid tumors|recurrent solid tumors
1720529|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
1720530|NCT00024648|advanced malignancy|advanced malignancy
1720531|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
1720532|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
1720533|NCT00024648|LErafAON|lerafaon
1720534|NCT00024622|Familial|familial
1720535|NCT00024622|Genetic|genetic
1720536|NCT00024622|Symptomatic|symptomatic
1720537|NCT00024622|Equivocally Affected|equivocally affected
1720538|NCT00024622|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
1720539|NCT00024622|O-15 Labelled Water|o-15 labelled water
1720540|NCT00024622|Carbidopa|carbidopa
1720541|NCT00024622|Adult|adult
1720542|NCT00024622|Schizophrenia|schizophrenia
1720543|NCT00024622|Parkinson's Disease|parkinson's disease
1720544|NCT00024622|PD|pd
1720545|NCT00024622|Parkinson|parkinson
1720546|NCT00024622|Healthy Control|healthy control
1720547|NCT00024622|HV|hv
1720548|NCT00024622|Normal Control|normal control
1720549|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
1720550|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
1720551|NCT00024570|CNS interstitial infusion|cns interstitial infusion
1720552|NCT00024570|recombinant toxins|recombinant toxins
1720553|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
1720554|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
1720555|NCT00024570|intratumoral therapy|intratumoral therapy
1720556|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
1720557|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
1720558|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
1720559|NCT00024557|CNS interstitial infusion|cns interstitial infusion
1720560|NCT00024557|recombinant toxins|recombinant toxins
1720561|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
1720562|NCT00024557|intratumoral therapy|intratumoral therapy
1720563|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
1720564|NCT00024544|asthma|asthma
1720565|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
1720566|NCT00024544|pascolizumab|pascolizumab
1720567|NCT00024531|Alzheimer disease|alzheimer disease
1720568|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
1720569|NCT00024518|Diabetes|diabetes
1720570|NCT00024518|Immunotherapy|immunotherapy
1720571|NCT00024518|Study Drug|study drug
1720572|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
1720573|NCT00024518|Diabetes Mellitus|diabetes mellitus
1720574|NCT00024518|TIBM|tibm
1720575|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
1720576|NCT00024492|solid tumors|solid tumors
1720577|NCT00024479|Minorities|minorities
1720578|NCT00024479|Rheumatic Disease|rheumatic disease
1720579|NCT00024479|Community Based|community based
1720580|NCT00024479|Ethnicity|ethnicity
1720581|NCT00024479|Health Disparities|health disparities
1720582|NCT00023582|Syphilis|syphilis
1720583|NCT00023582|Herpes Genitalis|herpes genitalis
1720584|NCT00023582|Risk Factors|risk factors
1720585|NCT00023582|Incidence|incidence
1720586|NCT00023582|Prevalence|prevalence
1720587|NCT00023582|Homosexuality, Male|homosexuality, male
1720588|NCT00023582|Informed Consent|informed consent
1720589|NCT00023582|Peru|peru
1720590|NCT00023582|HIV Seronegativity|hiv seronegativity
1720591|NCT00023569|TMS|tms
1720592|NCT00023569|Conjoint Movement|conjoint movement
1720593|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
1720594|NCT00023569|Brain Plasticity|brain plasticity
1720595|NCT00023569|Electrical Stimulation|electrical stimulation
1720596|NCT00023569|Stroke|stroke
1720597|NCT00023569|CVA|cva
1720598|NCT00023504|Immunization|immunization
1720599|NCT00023504|Antibody|antibody
1720600|NCT00023504|Immunodeficiency|immunodeficiency
1720601|NCT00023504|Pneumococcal Vaccines|pneumococcal vaccines
1720602|NCT00023504|Phi-X 174|phi-x 174
1720603|NCT00023504|Primary Immune Disorders|primary immune disorders
1720604|NCT00023452|Latent TB infection|latent tb infection
1720605|NCT00023439|tuberculosis|tuberculosis
1720606|NCT00023439|TB|tb
1720607|NCT00023426|tuberculosis|tuberculosis
1720608|NCT00023426|tb|tb
1720609|NCT00023426|rifapentine|rifapentine
1720610|NCT00023426|safety|safety
1720611|NCT00023426|dose|dose
1720612|NCT00023413|tuberculosis|tuberculosis
1720613|NCT00023413|TB|tb
1720614|NCT00023400|tuberculosis|tuberculosis
1720615|NCT00023400|TB|tb
1720616|NCT00023374|tuberculosis|tuberculosis
1720617|NCT00023374|TB|tb
1720618|NCT00023374|isoniazid resistance|isoniazid resistance
1720619|NCT00023374|isoniazid intolerance|isoniazid intolerance
1720620|NCT00023374|treatment|treatment
1720623|NCT00023361|tuberculosis|tuberculosis
1720624|NCT00023361|TB|tb
1720625|NCT00023348|Tuberculosis|tuberculosis
1720626|NCT00023348|TB|tb
1720627|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
1720628|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
1720629|NCT00023491|Tissue Regeneration|tissue regeneration
1723261|NCT00002193|VX 478|vx 478
1720630|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
1720631|NCT00023491|Head and Neck Cancer|head and neck cancer
1720632|NCT00023491|Salivary Gland|salivary gland
1720633|NCT00023491|Saliva Gland|saliva gland
1720634|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
1720635|NCT00023322|Cirrhosis|cirrhosis
1720636|NCT00023322|Chronic Hepatitis|chronic hepatitis
1720637|NCT00023322|Alpha Interferon|alpha interferon
1720638|NCT00023322|Hepatitis D Virus|hepatitis d virus
1720639|NCT00023322|Delta Hepatitis|delta hepatitis
1720640|NCT00023322|Viral Hepatitis|viral hepatitis
1720641|NCT00023322|Antiviral Agents|antiviral agents
1720642|NCT00023322|Hepatitis D|hepatitis d
1720643|NCT00023322|HDV|hdv
1720644|NCT00023322|Liver|liver
1720645|NCT00023322|Hepatitis|hepatitis
1720646|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
1720647|NCT00023309|Lamivudine|lamivudine
1720648|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
1720649|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
1720650|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
1720651|NCT00023309|Liver Biopsy|liver biopsy
1720652|NCT00023309|Hepatitis B|hepatitis b
1720653|NCT00023309|Hepatitis|hepatitis
1720654|NCT00023309|HBV|hbv
1720655|NCT00023309|Liver|liver
1720656|NCT00023296|Acute Chest Syndrome|acute chest syndrome
1720657|NCT00023296|Blood Flow|blood flow
1720658|NCT00023296|Nitric Oxide|nitric oxide
1720659|NCT00023296|NO Therapy|no therapy
1720660|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
1720661|NCT00023296|Sickle Cell Anemia|sickle cell anemia
1720662|NCT00023296|Sickle Cell|sickle cell
1720663|NCT00023296|ACS|acs
1720664|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
1720665|NCT00023218|Liver|liver
1720666|NCT00023218|HIV-1|hiv-1
1720667|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
1720668|NCT00023218|Ritonavir|ritonavir
1720669|NCT00023218|Biopsy|biopsy
1720670|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720671|NCT00023218|Anti-HIV Agents|anti-hiv agents
1720672|NCT00023218|ABT 378|abt 378
1720673|NCT00023218|Acidosis, Lactic|acidosis, lactic
1720674|NCT00023218|efavirenz|efavirenz
1720675|NCT00023218|Alanine Transaminase|alanine transaminase
1720676|NCT00023205|Arthritis|arthritis
1720677|NCT00023205|Health literacy|health literacy
1720678|NCT00023205|Patient education|patient education
1720679|NCT00023205|Self-efficacy|self-efficacy
1720680|NCT00022763|Anti-HIV Agents|anti-hiv agents
1720681|NCT00022763|pentafuside|pentafuside
1720682|NCT00021775|Risk Factors|risk factors
1720683|NCT00021775|Incidence|incidence
1720684|NCT00021775|Patient Selection|patient selection
1720685|NCT00021775|HIV Seronegativity|hiv seronegativity
1720686|NCT00021762|Virus Replication|virus replication
1720687|NCT00021762|HIV-1|hiv-1
1720688|NCT00021762|Drug Administration Schedule|drug administration schedule
1720689|NCT00021762|AIDS Vaccines|aids vaccines
1720690|NCT00021762|RNA, Viral|rna, viral
1720691|NCT00021762|Viral Load|viral load
1720692|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
1720693|NCT00021762|Treatment Interruption|treatment interruption
1720694|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1720695|NCT00021671|Drug Therapy, Combination|drug therapy, combination
1720696|NCT00021671|Ampicillin|ampicillin
1720697|NCT00021671|Nevirapine|nevirapine
1720698|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
1720699|NCT00021671|Anti-Infective Agents|anti-infective agents
1720700|NCT00021671|Erythromycin|erythromycin
1720701|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720702|NCT00021671|Metronidazole|metronidazole
1720703|NCT00021671|Anti-HIV Agents|anti-hiv agents
1720704|NCT00021671|Chorioamnionitis|chorioamnionitis
1720705|NCT00021671|HIV Seronegativity|hiv seronegativity
1720706|NCT00021632|Ribavirin|ribavirin
1720707|NCT00021632|Drug Interactions|drug interactions
1720708|NCT00021632|Drug Therapy, Combination|drug therapy, combination
1720709|NCT00021632|Zidovudine|zidovudine
1720710|NCT00021632|Stavudine|stavudine
1720711|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720712|NCT00021632|Anti-HIV Agents|anti-hiv agents
1720713|NCT00021632|Pharmacokinetics|pharmacokinetics
1720714|NCT00021632|Area Under Curve|area under curve
1720715|NCT00021554|HIV-1|hiv-1
1720716|NCT00021554|Drug Therapy, Combination|drug therapy, combination
1720717|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
1720718|NCT00021554|RNA, Viral|rna, viral
1720719|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720720|NCT00021554|Anti-HIV Agents|anti-hiv agents
1720721|NCT00021554|Viral Load|viral load
1720722|NCT00021554|pentafuside|pentafuside
1720723|NCT00021489|Placebos|placebos
1721624|NCT00005018|HIV-1|hiv-1
1720724|NCT00021489|Drug Therapy, Combination|drug therapy, combination
1720725|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720726|NCT00021489|Anti-HIV Agents|anti-hiv agents
1720727|NCT00021489|abacavir|abacavir
1720728|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
1720729|NCT00021463|Nevirapine|nevirapine
1720730|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720731|NCT00021463|Anti-HIV Agents|anti-hiv agents
1720732|NCT00021463|Triglycerides|triglycerides
1720733|NCT00021463|abacavir|abacavir
1720734|NCT00021463|efavirenz|efavirenz
1720735|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
1720736|NCT00017992|HIV-1|hiv-1
1720737|NCT00017992|Drug Administration Schedule|drug administration schedule
1720738|NCT00017992|Stavudine|stavudine
1720739|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
1720740|NCT00017992|Ritonavir|ritonavir
1720741|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720742|NCT00017992|Anti-HIV Agents|anti-hiv agents
1720743|NCT00017992|Pharmacokinetics|pharmacokinetics
1720744|NCT00017992|ABT 378|abt 378
1720745|NCT00017992|emtricitabine|emtricitabine
1720746|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
1720747|NCT00017797|HIV-1|hiv-1
1720748|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
1720749|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720750|NCT00017797|Anti-HIV Agents|anti-hiv agents
1720751|NCT00017797|Glucose Intolerance|glucose intolerance
1720752|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1720753|NCT00017784|Infusions, Intravenous|infusions, intravenous
1720754|NCT00017784|Antiviral Agents|antiviral agents
1720755|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1720756|NCT00017784|valganciclovir|valganciclovir
1720757|NCT00017771|HIV-1|hiv-1
1720758|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
1720759|NCT00017771|Risk Factors|risk factors
1720760|NCT00017771|Hydroxyurea|hydroxyurea
1720761|NCT00017771|Disease Progression|disease progression
1720762|NCT00017771|Alcohol Drinking|alcohol drinking
1720763|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720764|NCT00017771|Anti-HIV Agents|anti-hiv agents
1720765|NCT00017771|Viral Load|viral load
1720766|NCT00017771|Polyneuropathies|polyneuropathies
1720767|NCT00017771|Treatment Experienced|treatment experienced
1720768|NCT00017758|Drug Interactions|drug interactions
1720770|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720771|NCT00017758|Anti-HIV Agents|anti-hiv agents
1720772|NCT00017758|Pharmacokinetics|pharmacokinetics
1720773|NCT00017758|Pravastatin|pravastatin
1720774|NCT00017758|efavirenz|efavirenz
1720775|NCT00017758|Simvastatin|simvastatin
1720776|NCT00017758|atorvastatin|atorvastatin
1720777|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
1720778|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
1720779|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
1720780|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720781|NCT00017719|Anti-HIV Agents|anti-hiv agents
1720782|NCT00017719|Viral Load|viral load
1720783|NCT00017719|Combivir|combivir
1720784|NCT00017719|Treatment Naive|treatment naive
1720785|NCT00017693|Recombinant Proteins|recombinant proteins
1720786|NCT00017693|Aerosols|aerosols
1720787|NCT00017693|Asthma|asthma
1720788|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
1720789|NCT00017693|Forced Expiratory Volume|forced expiratory volume
1720790|NCT00016783|Drug Therapy, Combination|drug therapy, combination
1720791|NCT00016783|Drug Administration Schedule|drug administration schedule
1720792|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
1720793|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
1720794|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1720795|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720796|NCT00016783|Anti-HIV Agents|anti-hiv agents
1720797|NCT00016783|Viral Load|viral load
1720798|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1720799|NCT00016783|Treatment Experienced|treatment experienced
1720800|NCT00016783|Treatment Interruption|treatment interruption
1720801|NCT00016718|Didanosine|didanosine
1720802|NCT00016718|Drug Therapy, Combination|drug therapy, combination
1720803|NCT00016718|Drug Administration Schedule|drug administration schedule
1720804|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720805|NCT00016718|Anti-HIV Agents|anti-hiv agents
1720806|NCT00016718|Pharmacokinetics|pharmacokinetics
1720807|NCT00016718|Deoxycytidine|deoxycytidine
1720808|NCT00016718|Efavirenz|efavirenz
1720809|NCT00016718|Treatment Naive|treatment naive
1720810|NCT00016692|Drug tolerance|drug tolerance
1720811|NCT00016692|Acute Infection|acute infection
1720812|NCT00016601|Delayed-Action Preparations|delayed-action preparations
1720813|NCT00016601|Drug Interactions|drug interactions
1720814|NCT00016601|Drug Therapy, Combination|drug therapy, combination
1720815|NCT00016601|Nevirapine|nevirapine
1720816|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
1720817|NCT00016601|Ritonavir|ritonavir
1720820|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720821|NCT00016601|Anti-HIV Agents|anti-hiv agents
1720822|NCT00016601|Pharmacokinetics|pharmacokinetics
1720823|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
1720824|NCT00016601|efavirenz|efavirenz
1720825|NCT00016588|HIV-1|hiv-1
1720827|NCT00016588|Anti-HIV Agents|anti-hiv agents
1720828|NCT00016588|Viral Load|viral load
1720829|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
1720830|NCT00016536|Antiviral Agents|antiviral agents
1720831|NCT00016536|Mucous Membrane|mucous membrane
1720832|NCT00016536|Spermatocidal Agents|spermatocidal agents
1720833|NCT00016536|Penis|penis
1720834|NCT00016536|Epithelium|epithelium
1720835|NCT00016536|PRO 2000|pro 2000
1720836|NCT00016536|Urethra|urethra
1720837|NCT00016536|HIV Seronegativity|hiv seronegativity
1720838|NCT00015704|Treatment Experienced|treatment experienced
1720839|NCT00015704|Treatment Interruption|treatment interruption
1720840|NCT00015704|Drug Administration Schedule|drug administration schedule
1720841|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
1720842|NCT00015704|Anti-HIV Agents|anti-hiv agents
1720843|NCT00015704|Tetanus Toxoid|tetanus toxoid
1720844|NCT00015704|Aldesleukin|aldesleukin
1720845|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
1720846|NCT00015691|Drug Therapy, Combination|drug therapy, combination
1720847|NCT00015691|Adipose Tissue|adipose tissue
1720848|NCT00015691|Area Under Curve|area under curve
1720849|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
1720850|NCT00015691|Anthropometry|anthropometry
1720851|NCT00015691|Hyperinsulinemia|hyperinsulinemia
1720852|NCT00015691|Metformin|metformin
1720853|NCT00015691|BRL 49653|brl 49653
1720854|NCT00015691|Insulin|insulin
1720855|NCT00015691|Glucose Tolerance Test|glucose tolerance test
1720856|NCT00015652|Ribavirin|ribavirin
1720857|NCT00015652|Polyethylene Glycols|polyethylene glycols
1720858|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
1720859|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
1720860|NCT00015652|Drug Therapy, Combination|drug therapy, combination
1720861|NCT00015652|Antiviral Agents|antiviral agents
1720862|NCT00015652|Hepatitis C|hepatitis c
1720863|NCT00015652|Aldesleukin|aldesleukin
1720864|NCT00015652|Peginterferon|peginterferon
1720865|NCT00014937|HIV-1|hiv-1
1720866|NCT00014937|Didanosine|didanosine
1720867|NCT00014937|Drug Therapy, Combination|drug therapy, combination
1720868|NCT00014937|Zidovudine|zidovudine
1720871|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
1720872|NCT00014937|Ritonavir|ritonavir
1720873|NCT00014937|Lamivudine|lamivudine
1720874|NCT00014937|RNA, Viral|rna, viral
1720875|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720876|NCT00014937|Anti-HIV Agents|anti-hiv agents
1720877|NCT00014937|Viral Load|viral load
1720878|NCT00014937|ABT 378|abt 378
1720879|NCT00014937|Combivir|combivir
1720880|NCT00014937|Efavirenz|efavirenz
1720881|NCT00014937|Treatment Experienced|treatment experienced
1720882|NCT00014053|Reference Values|reference values
1720883|NCT00014053|HIV Seropositivity|hiv seropositivity
1720884|NCT00014053|Immune System|immune system
1720885|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1720886|NCT00014053|HIV Seronegativity|hiv seronegativity
1720887|NCT00014053|Antigens, CD|antigens, cd
1720888|NCT00014014|Zidovudine|zidovudine
1720889|NCT00014014|Phosphorylation|phosphorylation
1720890|NCT00014014|Drug Administration Schedule|drug administration schedule
1720891|NCT00014014|Lamivudine|lamivudine
1720892|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720893|NCT00014014|Anti-HIV Agents|anti-hiv agents
1720894|NCT00014014|Pharmacokinetics|pharmacokinetics
1720895|NCT00014014|Combivir|combivir
1720896|NCT00013897|Placebos|placebos
1720897|NCT00013897|Drug Therapy, Combination|drug therapy, combination
1720898|NCT00013897|Zidovudine|zidovudine
1720899|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
1720900|NCT00013897|Lamivudine|lamivudine
1720901|NCT00013897|RNA, Viral|rna, viral
1720902|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720903|NCT00013897|Anti-HIV Agents|anti-hiv agents
1720904|NCT00013897|Viral Load|viral load
1720905|NCT00013897|BMS 232632|bms 232632
1720906|NCT00013897|efavirenz|efavirenz
1720907|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
1720908|NCT00013871|Antibodies, Viral|antibodies, viral
1720909|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
1720910|NCT00013871|Immunization, Secondary|immunization, secondary
1720911|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
1720912|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1720913|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
1720914|NCT00013663|Virus Replication|virus replication
1720915|NCT00013663|HIV-1|hiv-1
1720916|NCT00013663|AIDS Vaccines|aids vaccines
1720917|NCT00013663|RNA, Viral|rna, viral
1720918|NCT00013663|Avipoxvirus|avipoxvirus
1720919|NCT00013663|Genetic Vectors|genetic vectors
1720920|NCT00013663|Viral Load|viral load
1720922|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
1720923|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1720924|NCT00013663|Treatment Interruption|treatment interruption
1720925|NCT00013585|Cognitive Disorders|cognitive disorders
1720926|NCT00013585|AIDS Dementia Complex|aids dementia complex
1720928|NCT00013585|Administration, Cutaneous|administration, cutaneous
1720929|NCT00013585|Neuroprotective Agents|neuroprotective agents
1720930|NCT00013572|Injections, Intramuscular|injections, intramuscular
1720931|NCT00013572|Injections, Intradermal|injections, intradermal
1720932|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
1720933|NCT00013572|HIV-1|hiv-1
1720934|NCT00013572|AIDS Vaccines|aids vaccines
1720935|NCT00013572|Dendritic Cells|dendritic cells
1720936|NCT00013572|HIV Seronegativity|hiv seronegativity
1720937|NCT00013572|Genes, env|genes, env
1720938|NCT00013572|Genes, pol|genes, pol
1720939|NCT00013572|Genes, gag|genes, gag
1720940|NCT00013572|Transfection|transfection
1720941|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
1720942|NCT00013520|HIV-1|hiv-1
1720943|NCT00013520|Didanosine|didanosine
1720944|NCT00013520|Drug Therapy, Combination|drug therapy, combination
1720945|NCT00013520|Zidovudine|zidovudine
1720946|NCT00013520|Nevirapine|nevirapine
1720947|NCT00013520|Stavudine|stavudine
1720948|NCT00013520|Lamivudine|lamivudine
1720949|NCT00013520|RNA, Viral|rna, viral
1720950|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720951|NCT00013520|Anti-HIV Agents|anti-hiv agents
1720952|NCT00013520|Viral Load|viral load
1720953|NCT00013520|Combivir|combivir
1720954|NCT00013520|BMS 232632|bms 232632
1720955|NCT00013520|Efavirenz|efavirenz
1720956|NCT00013520|Treatment Naive|treatment naive
1720957|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
1720958|NCT00012519|Drug Therapy, Combination|drug therapy, combination
1720959|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
1720960|NCT00012519|Ritonavir|ritonavir
1720961|NCT00012519|Indinavir|indinavir
1720962|NCT00012519|Anti-HIV Agents|anti-hiv agents
1720963|NCT00012519|Viral Load|viral load
1720964|NCT00012519|Pharmacokinetics|pharmacokinetics
1720965|NCT00012519|Treatment Experienced|treatment experienced
1720966|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1720967|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
1720968|NCT00012467|Itraconazole|itraconazole
1720969|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
1720970|NCT00012467|Fluconazole|fluconazole
1720971|NCT00012467|Flucytosine|flucytosine
1720972|NCT00012467|Antifungal Agents|antifungal agents
1720973|NCT00012467|Amphotericin B|amphotericin b
1720974|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
1720975|NCT00011895|HIV-1|hiv-1
1720976|NCT00011895|Drug Therapy, Combination|drug therapy, combination
1720977|NCT00011895|Zidovudine|zidovudine
1720978|NCT00011895|Lamivudine|lamivudine
1720979|NCT00011895|Drug Combinations|drug combinations
1720980|NCT00011895|RNA, Viral|rna, viral
1720981|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720982|NCT00011895|Anti-HIV Agents|anti-hiv agents
1720983|NCT00011895|Viral Load|viral load
1720984|NCT00011895|abacavir|abacavir
1720985|NCT00011895|efavirenz|efavirenz
1720986|NCT00011479|Administration, Oral|administration, oral
1720987|NCT00011479|Drug Administration Schedule|drug administration schedule
1720988|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1720989|NCT00011479|Anti-HIV Agents|anti-hiv agents
1720990|NCT00011479|Pharmacokinetics|pharmacokinetics
1720991|NCT00011479|abacavir|abacavir
1720992|NCT00011128|HIV-1|hiv-1
1720993|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
1720994|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
1720995|NCT00011128|Salvage Therapy|salvage therapy
1720996|NCT00011128|Anti-HIV Agents|anti-hiv agents
1720997|NCT00011128|Viral Load|viral load
1720998|NCT00011128|Treatment Experienced|treatment experienced
1720999|NCT00011089|HIV-1|hiv-1
1721000|NCT00011089|Disease Progression|disease progression
1721001|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721002|NCT00011089|Anti-HIV Agents|anti-hiv agents
1721003|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
1721004|NCT00011050|Specimen Handling|specimen handling
1721005|NCT00011050|Blood|blood
1721006|NCT00011050|Cryopreservation|cryopreservation
1721007|NCT00011050|Lactic Acid|lactic acid
1721008|NCT00011050|Sodium Fluoride|sodium fluoride
1721009|NCT00011050|Oxalates|oxalates
1721010|NCT00011037|HIV Antibodies|hiv antibodies
1721011|NCT00011037|HIV Antigens|hiv antigens
1721012|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
1721013|NCT00011037|AIDS Vaccines|aids vaccines
1721014|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721015|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1721016|NCT00011037|Neutralization Tests|neutralization tests
1721017|NCT00011037|Haiti|haiti
1721018|NCT00011037|Brazil|brazil
1721019|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
1721020|NCT00011037|Epitopes|epitopes
1721021|NCT00011037|Viral Proteins|viral proteins
1721022|NCT00011037|Trinidad and Tobago|trinidad and tobago
1721023|NCT00011037|Peru|peru
1721024|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
1721025|NCT00011037|HIV Seronegativity|hiv seronegativity
1721026|NCT00011011|HIV-1|hiv-1
1721027|NCT00011011|Drug Administration Schedule|drug administration schedule
1721028|NCT00011011|AIDS Vaccines|aids vaccines
1721029|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
1721030|NCT00011011|RNA, Viral|rna, viral
1721031|NCT00011011|Anti-HIV Agents|anti-hiv agents
1721032|NCT00011011|Viral Load|viral load
1721033|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721034|NCT00011011|Treatment Interruption|treatment interruption
1721035|NCT00009555|Testosterone|testosterone
1721036|NCT00009555|Anthropometry|anthropometry
1721037|NCT00009555|Obesity|obesity
1721038|NCT00009555|Abdomen|abdomen
1721039|NCT00009061|HIV-1|hiv-1
1721040|NCT00009061|Drug Therapy, Combination|drug therapy, combination
1721041|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
1721042|NCT00009061|Ritonavir|ritonavir
1721043|NCT00009061|Lamivudine|lamivudine
1721044|NCT00009061|Nelfinavir|nelfinavir
1721045|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721046|NCT00009061|Anti-HIV Agents|anti-hiv agents
1721047|NCT00009061|abacavir|abacavir
1721048|NCT00008866|HIV-1|hiv-1
1721049|NCT00008866|Didanosine|didanosine
1721050|NCT00008866|Drug Therapy, Combination|drug therapy, combination
1721051|NCT00008866|Drug Administration Schedule|drug administration schedule
1721052|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721053|NCT00008866|Hydroxyurea|hydroxyurea
1721054|NCT00008866|RNA, Viral|rna, viral
1721055|NCT00008866|Genotype|genotype
1721056|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721057|NCT00008866|Anti-HIV Agents|anti-hiv agents
1721058|NCT00008866|Viral Load|viral load
1721059|NCT00008853|Clinical Evaluation|clinical evaluation
1721060|NCT00008554|HIV-1|hiv-1
1721061|NCT00008554|Drug Therapy, Combination|drug therapy, combination
1721062|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
1721063|NCT00008554|Lamivudine|lamivudine
1721064|NCT00008554|Nelfinavir|nelfinavir
1721065|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721066|NCT00008554|Anti-HIV Agents|anti-hiv agents
1721067|NCT00008554|abacavir|abacavir
1721068|NCT00008528|HIV-1|hiv-1
1721069|NCT00008528|Drug Therapy, Combination|drug therapy, combination
1721070|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
1721071|NCT00008528|RNA, Viral|rna, viral
1721072|NCT00008528|Membrane Fusion|membrane fusion
1721073|NCT00008528|Anti-HIV Agents|anti-hiv agents
1721074|NCT00008528|Viral Load|viral load
1721075|NCT00008489|Didanosine|didanosine
1721076|NCT00008489|Gastrointestinal System|gastrointestinal system
1721077|NCT00008489|Tablets|tablets
1721078|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721079|NCT00008489|Anti-HIV Agents|anti-hiv agents
1721080|NCT00008489|Capsules|capsules
1721081|NCT00008463|Ribavirin|ribavirin
1721082|NCT00008463|Polyethylene Glycols|polyethylene glycols
1721083|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
1721084|NCT00008463|HIV-1|hiv-1
1721085|NCT00008463|Antiviral Agents|antiviral agents
1721086|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
1721087|NCT00007488|HIV-1|hiv-1
1721088|NCT00007488|Lymphoid Tissue|lymphoid tissue
1721089|NCT00007488|Viremia|viremia
1721090|NCT00007488|RNA, Viral|rna, viral
1721091|NCT00007488|Saliva|saliva
1721092|NCT00007488|Anti-HIV Agents|anti-hiv agents
1721093|NCT00007488|Viral Load|viral load
1721094|NCT00007488|Genitalia, Female|genitalia, female
1721095|NCT00007488|Genitalia, Male|genitalia, male
1721096|NCT00007449|HIV-1|hiv-1
1721097|NCT00007449|Drug Therapy, Combination|drug therapy, combination
1721098|NCT00007449|RNA, Viral|rna, viral
1721099|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721100|NCT00007449|Anti-HIV Agents|anti-hiv agents
1721101|NCT00007449|Viral Load|viral load
1721102|NCT00007436|HIV-1|hiv-1
1721103|NCT00007436|Drug Therapy, Combination|drug therapy, combination
1721104|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721105|NCT00007436|Anti-HIV Agents|anti-hiv agents
1721106|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
1721107|NCT00007423|HIV Antibodies|hiv antibodies
1721108|NCT00007423|HIV-1|hiv-1
1721109|NCT00007423|AIDS Vaccines|aids vaccines
1721110|NCT00007423|HIV Seronegativity|hiv seronegativity
1721111|NCT00007423|Uganda|uganda
1721112|NCT00007423|Cross Reactions|cross reactions
1721113|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
1721114|NCT00007332|Drug Therapy, Combination|drug therapy, combination
1721115|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
1721116|NCT00007332|AIDS Vaccines|aids vaccines
1721117|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1721118|NCT00007332|HIV Seronegativity|hiv seronegativity
1721119|NCT00007332|AIDSVAX|aidsvax
1721120|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
1721121|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
1721122|NCT00007319|Risk Factors|risk factors
1721123|NCT00007319|HIV Seronegativity|hiv seronegativity
1721124|NCT00007319|Anti-HIV Agents|anti-hiv agents
1721125|NCT00007319|Carotid Artery|carotid artery
1721126|NCT00007319|Tunica Intima|tunica intima
1721127|NCT00007319|Atherosclerosis|atherosclerosis
1721128|NCT00007202|Virus Replication|virus replication
1721129|NCT00007202|HIV-1|hiv-1
1721131|NCT00007202|Drug Therapy, Combination|drug therapy, combination
1721132|NCT00007202|Stavudine|stavudine
1721133|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
1721134|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
1721135|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721136|NCT00007202|Anti-HIV Agents|anti-hiv agents
1721137|NCT00007202|Viral Load|viral load
1721138|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
1721139|NCT00007202|Acute Infection|acute infection
1721140|NCT00006643|Liver|liver
1721141|NCT00006643|Hepatitis C|hepatitis c
1721142|NCT00006643|Biopsy|biopsy
1721143|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
1721144|NCT00006630|Smallpox Vaccine|smallpox vaccine
1721145|NCT00006630|Injections, Intramuscular|injections, intramuscular
1721146|NCT00006630|Immunoglobulins|immunoglobulins
1721147|NCT00006630|Orthopoxvirus|orthopoxvirus
1721148|NCT00006617|HIV-1|hiv-1
1721149|NCT00006617|Drug Therapy, Combination|drug therapy, combination
1721150|NCT00006617|Zidovudine|zidovudine
1721151|NCT00006617|Lymphoid Tissue|lymphoid tissue
1721152|NCT00006617|Gastrointestinal System|gastrointestinal system
1721153|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
1721154|NCT00006617|Lamivudine|lamivudine
1721155|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
1721156|NCT00006617|VX 478|vx 478
1721157|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721158|NCT00006617|Anti-HIV Agents|anti-hiv agents
1721159|NCT00006617|Viral Load|viral load
1721160|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
1721161|NCT00006617|abacavir|abacavir
1721162|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
1721163|NCT00006604|Drug Therapy, Combination|drug therapy, combination
1721164|NCT00006604|Drug Administration Schedule|drug administration schedule
1721165|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
1721166|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721167|NCT00006604|Anti-HIV Agents|anti-hiv agents
1721168|NCT00006604|Pharmacokinetics|pharmacokinetics
1721169|NCT00006604|Treatment Experienced|treatment experienced
1721170|NCT00006604|Treatment Naive|treatment naive
1724607|NCT00001085|RNA, Viral|rna, viral
1721171|NCT00006591|Drug Therapy, Combination|drug therapy, combination
1721172|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
1721173|NCT00006591|Ritonavir|ritonavir
1721174|NCT00006591|VX 478|vx 478
1721175|NCT00006591|Salvage Therapy|salvage therapy
1721176|NCT00006591|Anti-HIV Agents|anti-hiv agents
1721177|NCT00006591|Drug Monitoring|drug monitoring
1721178|NCT00006591|Nelfinavir|nelfinavir
1721179|NCT00006591|Treatment Experienced|treatment experienced
1721180|NCT00006578|Drug Therapy, Combination|drug therapy, combination
1721181|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1721182|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
1721183|NCT00006578|Ritonavir|ritonavir
1721184|NCT00006578|Lamivudine|lamivudine
1721185|NCT00006578|Stem Cells|stem cells
1721186|NCT00006578|VX 478|vx 478
1721187|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721188|NCT00006578|Anti-HIV Agents|anti-hiv agents
1721189|NCT00006578|Antigens, CD34|antigens, cd34
1721190|NCT00006578|abacavir|abacavir
1721191|NCT00006578|Treatment Naive|treatment naive
1721192|NCT00006509|Recombinant Proteins|recombinant proteins
1721193|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
1721194|NCT00006509|AIDS Vaccines|aids vaccines
1721195|NCT00006509|Anti-HIV Agents|anti-hiv agents
1721196|NCT00006509|Treatment Experienced|treatment experienced
1721197|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721198|NCT00006495|Placebos|placebos
1721199|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1721200|NCT00006495|AIDS Vaccines|aids vaccines
1721201|NCT00006495|RNA, Viral|rna, viral
1721202|NCT00006495|HIV Core Protein p24|hiv core protein p24
1721203|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1721204|NCT00006495|Anti-HIV Agents|anti-hiv agents
1721205|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721206|NCT00006490|HIV-1|hiv-1
1721207|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
1721208|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
1721209|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
1721210|NCT00006490|Genotype|genotype
1721211|NCT00006490|Phenotype|phenotype
1721212|NCT00006490|Anti-HIV Agents|anti-hiv agents
1721213|NCT00006444|Drug Therapy, Combination|drug therapy, combination
1721214|NCT00006444|Papillomavirus, Human|papillomavirus, human
1721215|NCT00006444|DNA, Viral|dna, viral
1721216|NCT00006444|Anti-HIV Agent|anti-hiv agent
1721217|NCT00006444|Treatment Naive|treatment naive
1721218|NCT00006443|T-Lymphocytes|t-lymphocytes
1721219|NCT00006443|HIV-1|hiv-1
1721220|NCT00006443|Lymphoid Tissue|lymphoid tissue
1721221|NCT00006443|Stavudine|stavudine
1721625|NCT00005018|Didanosine|didanosine
1721222|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
1721223|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
1721224|NCT00006443|Biological Markers|biological markers
1721225|NCT00006443|Lamivudine|lamivudine
1721226|NCT00006443|Indinavir|indinavir
1721227|NCT00006443|RNA, Viral|rna, viral
1721233|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721234|NCT00006443|In Situ Hybridization|in situ hybridization
1721235|NCT00006443|Anti-HIV Agents|anti-hiv agents
1721236|NCT00006443|Viral Load|viral load
1721237|NCT00006443|Cell Membrane|cell membrane
1721238|NCT00006443|Acute Infection|acute infection
1721239|NCT00006443|Treatment Naive|treatment naive
1721240|NCT00006442|Lymphocytes|lymphocytes
1721242|NCT00006442|Lymphoid Tissue|lymphoid tissue
1721243|NCT00006442|Blood|blood
1721244|NCT00006442|Anti-HIV Agents|anti-hiv agents
1721245|NCT00006442|Viral Load|viral load
1721246|NCT00006441|Virus Replication|virus replication
1721247|NCT00006441|HIV-1|hiv-1
1721248|NCT00006441|Interleukin-2|interleukin-2
1721249|NCT00006441|Drug Therapy, Combination|drug therapy, combination
1721250|NCT00006441|Zidovudine|zidovudine
1721251|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
1721252|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721253|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1721254|NCT00006441|Biological Markers|biological markers
1721255|NCT00006441|Lamivudine|lamivudine
1721256|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721257|NCT00006441|Anti-HIV Agents|anti-hiv agents
1721258|NCT00006441|Nelfinavir|nelfinavir
1721259|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
1721260|NCT00006441|Acute Infection|acute infection
1721261|NCT00006440|Risk Factors|risk factors
1721262|NCT00006440|Behavior Therapy|behavior therapy
1721263|NCT00006440|Substance-Related Disorders|substance-related disorders
1721264|NCT00006440|Feasibility Studies|feasibility studies
1721265|NCT00006415|Virus Replication|virus replication
1721266|NCT00006415|HIV-1|hiv-1
1721267|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
1721268|NCT00006415|DNA, Viral|dna, viral
1721269|NCT00006415|RNA, Viral|rna, viral
1721270|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
1721271|NCT00006415|Anti-HIV Agents|anti-hiv agents
1721272|NCT00006415|Viral Load|viral load
1721273|NCT00006415|Proviruses|proviruses
1721274|NCT00006415|Acute Infection|acute infection
1721275|NCT00006412|Hyperlipidemia|hyperlipidemia
1721276|NCT00006412|Procetofen|procetofen
1721278|NCT00006412|Antilipemic Agents|antilipemic agents
1721279|NCT00006397|Didanosine|didanosine
1721280|NCT00006397|Drug Therapy, Combination|drug therapy, combination
1721281|NCT00006397|Stavudine|stavudine
1721282|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
1721283|NCT00006397|Sex Factors|sex factors
1721284|NCT00006397|Ritonavir|ritonavir
1721285|NCT00006397|Indinavir|indinavir
1721286|NCT00006397|Dosage Forms|dosage forms
1721287|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721288|NCT00006397|Anti-HIV Agents|anti-hiv agents
1721289|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
1721290|NCT00006396|HIV-1|hiv-1
1721291|NCT00006396|Administration, Oral|administration, oral
1721292|NCT00006396|Zidovudine|zidovudine
1721293|NCT00006396|Nevirapine|nevirapine
1721294|NCT00006396|RNA, Viral|rna, viral
1721295|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
1721296|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
1721297|NCT00006396|Blotting, Western|blotting, western
1721298|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721299|NCT00006396|Anti-HIV Agents|anti-hiv agents
1721300|NCT00006396|Viral Load|viral load
1721301|NCT00006396|HIV Seronegativity|hiv seronegativity
1721302|NCT00006339|Prospective Studies|prospective studies
1721303|NCT00006339|HIV-1|hiv-1
1721304|NCT00006339|Didanosine|didanosine
1721305|NCT00006339|Drug Therapy, Combination|drug therapy, combination
1721306|NCT00006339|Stavudine|stavudine
1721307|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
1721308|NCT00006339|Hydroxyurea|hydroxyurea
1721309|NCT00006339|Ritonavir|ritonavir
1721310|NCT00006339|Indinavir|indinavir
1721311|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721312|NCT00006339|Anti-HIV Agents|anti-hiv agents
1721313|NCT00006339|Viral Load|viral load
1721314|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
1721315|NCT00006327|Recombinant Proteins|recombinant proteins
1721316|NCT00006327|HIV-1|hiv-1
1721317|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
1721318|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
1721319|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
1721320|NCT00006327|Blotting, Western|blotting, western
1721321|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
1721322|NCT00006327|AIDSVAX|aidsvax
1721323|NCT00006326|Drug Therapy, Combination|drug therapy, combination
1721324|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
1721325|NCT00006326|Ritonavir|ritonavir
1721328|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721329|NCT00006326|Salvage Therapy|salvage therapy
1721330|NCT00006326|Anti-HIV Agents|anti-hiv agents
1721331|NCT00006326|Viral Load|viral load
1721332|NCT00006326|Nelfinavir|nelfinavir
1721333|NCT00006325|Polyethylene Glycols|polyethylene glycols
1721334|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
1721335|NCT00006325|HIV-1|hiv-1
1721336|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
1721337|NCT00006325|Drug Therapy, Combination|drug therapy, combination
1721338|NCT00006325|Virus Inhibitors|virus inhibitors
1721339|NCT00006325|Anti-HIV Agents|anti-hiv agents
1721340|NCT00006325|Pharmacokinetics|pharmacokinetics
1721341|NCT00006324|HIV Seronegativity|hiv seronegativity
1721342|NCT00006324|Delayed-Action Preparations|delayed-action preparations
1721343|NCT00006324|Risk Factors|risk factors
1721344|NCT00006324|Prevalence|prevalence
1721345|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
1721346|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
1721347|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
1721348|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721349|NCT00006316|Histoplasmosis|histoplasmosis
1721350|NCT00006316|Antifungal Agents|antifungal agents
1721351|NCT00006316|Recurrence|recurrence
1721352|NCT00006316|Anti-HIV Agents|anti-hiv agents
1721353|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721354|NCT00006304|AIDS-Related Complex|aids-related complex
1721355|NCT00006298|HIV Antibodies|hiv antibodies
1721356|NCT00006298|HIV-1|hiv-1
1721357|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
1721358|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1721359|NCT00006298|Genotype|genotype
1721360|NCT00006298|Species Specificity|species specificity
1721361|NCT00006298|Neutralization Tests|neutralization tests
1721362|NCT00006298|Viral Load|viral load
1721363|NCT00006298|Alleles|alleles
1721364|NCT00006298|HLA Antigens|hla antigens
1721365|NCT00006298|Cross Reactions|cross reactions
1721366|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
1721367|NCT00006298|Haplotypes|haplotypes
1721368|NCT00006291|Virus Replication|virus replication
1721369|NCT00006291|T-Lymphocytes|t-lymphocytes
1721370|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
1721371|NCT00006291|AIDS Vaccines|aids vaccines
1721372|NCT00006291|Anti-HIV Agents|anti-hiv agents
1721373|NCT00006291|Viral Load|viral load
1721374|NCT00006291|Aldesleukin|aldesleukin
1721375|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1724608|NCT00001085|VX 478|vx 478
1721376|NCT00006290|Drug Therapy, Combination|drug therapy, combination
1721377|NCT00006290|Questionnaires|questionnaires
1721378|NCT00006290|Quality of Life|quality of life
1721379|NCT00006290|Patient Compliance|patient compliance
1721380|NCT00006290|Body Composition|body composition
1721381|NCT00006290|Anti-HIV Agents|anti-hiv agents
1721382|NCT00006290|Adipose Tissue|adipose tissue
1721383|NCT00006290|Body Image|body image
1721384|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
1721385|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
1721386|NCT00006279|Drug Administration Schedule|drug administration schedule
1721387|NCT00006279|Nevirapine|nevirapine
1721388|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
1721389|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721390|NCT00006279|Anti-HIV Agents|anti-hiv agents
1721391|NCT00006279|Breast Feeding|breast feeding
1721392|NCT00006211|Drug Therapy, Combination|drug therapy, combination
1721393|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
1721394|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721395|NCT00006211|Anti-HIV Agents|anti-hiv agents
1721396|NCT00006211|Viral Load|viral load
1721397|NCT00006211|Nelfinavir|nelfinavir
1721398|NCT00006209|HIV-1|hiv-1
1721399|NCT00006209|Immunity, Cellular|immunity, cellular
1721400|NCT00006209|Drug Therapy, Combination|drug therapy, combination
1721401|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721402|NCT00006209|Antigens|antigens
1721403|NCT00006209|Anti-HIV Agents|anti-hiv agents
1721404|NCT00006209|Viral Load|viral load
1721405|NCT00006209|tucaresol|tucaresol
1721406|NCT00006208|HIV-1|hiv-1
1721407|NCT00006208|Didanosine|didanosine
1721408|NCT00006208|Drug Therapy, Combination|drug therapy, combination
1721409|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721410|NCT00006208|Anti-HIV Agents|anti-hiv agents
1721411|NCT00006208|Deoxycytidine|deoxycytidine
1721412|NCT00006208|efavirenz|efavirenz
1721413|NCT00006207|HIV Seropositivity|hiv seropositivity
1721414|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
1721415|NCT00006207|HIV Seronegativity|hiv seronegativity
1721416|NCT00006207|Mucous Membrane|mucous membrane
1721417|NCT00006207|Ulcer|ulcer
1721418|NCT00006207|Vagina|vagina
1721419|NCT00006207|Anti-HIV Agents|anti-hiv agents
1721420|NCT00006207|Sexual Abstinence|sexual abstinence
1721421|NCT00006207|Irritants|irritants
1721422|NCT00006207|PRO 2000|pro 2000
1721423|NCT00006154|Interleukin-2|interleukin-2
1721424|NCT00006154|Didanosine|didanosine
1721727|NCT00004985|Nelfinavir|nelfinavir
1721425|NCT00006154|Drug Therapy, Combination|drug therapy, combination
1721426|NCT00006154|Stavudine|stavudine
1721427|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
1721428|NCT00006154|Ritonavir|ritonavir
1721429|NCT00006154|Indinavir|indinavir
1721430|NCT00006154|Virus Latency|virus latency
1721431|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721432|NCT00006154|Anti-HIV Agents|anti-hiv agents
1721433|NCT00006154|abacavir|abacavir
1721434|NCT00006154|efavirenz|efavirenz
1721435|NCT00006154|Acute Infection|acute infection
1721436|NCT00006153|HIV Antibodies|hiv antibodies
1721437|NCT00006153|Immunity, Cellular|immunity, cellular
1721438|NCT00006153|Drug Therapy, Combination|drug therapy, combination
1721439|NCT00006153|Anti-HIV Agents|anti-hiv agents
1721441|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721442|NCT00006152|Drug Therapy, Combination|drug therapy, combination
1721443|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
1721444|NCT00006152|Ritonavir|ritonavir
1721445|NCT00006152|VX 478|vx 478
1721446|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721447|NCT00006152|Anti-HIV Agents|anti-hiv agents
1721448|NCT00006152|Viral Load|viral load
1721449|NCT00006152|abacavir|abacavir
1721450|NCT00006145|Ganciclovir|ganciclovir
1721451|NCT00006145|Cytomegalovirus|cytomegalovirus
1721452|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
1721453|NCT00006145|Administration, Oral|administration, oral
1721454|NCT00006145|Antiviral Agents|antiviral agents
1721455|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
1721456|NCT00006145|Viremia|viremia
1721457|NCT00006145|DNA, Viral|dna, viral
1721458|NCT00006144|Drug Therapy, Combination|drug therapy, combination
1721459|NCT00006144|Stavudine|stavudine
1721460|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
1721461|NCT00006144|Cohort Studies|cohort studies
1721462|NCT00006144|Ritonavir|ritonavir
1721463|NCT00006144|Disease Progression|disease progression
1721464|NCT00006144|Antigens, CD|antigens, cd
1721465|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721466|NCT00006144|Anti-HIV Agents|anti-hiv agents
1721467|NCT00006144|Immunophenotyping|immunophenotyping
1721468|NCT00006144|Deoxycytidine|deoxycytidine
1721469|NCT00006143|Treatment Outcome|treatment outcome
1721470|NCT00006143|serostim|serostim
1721471|NCT00006143|Developmental Disabilities|developmental disabilities
1721472|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
1721473|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
1721474|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
1721475|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
1721476|NCT00006075|Labor|labor
1721477|NCT00006075|Disinfectants|disinfectants
1721478|NCT00006075|Vagina|vagina
1721479|NCT00006075|Chlorhexidine|chlorhexidine
1721480|NCT00006075|Irrigation|irrigation
1721481|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
1721482|NCT00006066|Interleukin-2|interleukin-2
1721483|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
1721484|NCT00006066|Drug Therapy, Combination|drug therapy, combination
1721485|NCT00006066|Immunocompromised Host|immunocompromised host
1721486|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
1721487|NCT00006066|Anti-HIV Agents|anti-hiv agents
1721488|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
1721489|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
1721490|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
1721491|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
1721492|NCT00006064|RNA, Messenger|rna, messenger
1721493|NCT00006064|Interleukin-1|interleukin-1
1721494|NCT00006064|Body Composition|body composition
1721495|NCT00006064|Anti-HIV Agents|anti-hiv agents
1721496|NCT00006064|Viral Load|viral load
1721497|NCT00006064|Age Factors|age factors
1721498|NCT00006064|Anthropometry|anthropometry
1721499|NCT00005931|Skin Neoplasms|skin neoplasms
1721500|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
1721501|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721502|NCT00005931|Antineoplastic Agents|antineoplastic agents
1721503|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
1721504|NCT00005931|SU 5416|su 5416
1721505|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
1721506|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
1721507|NCT00005921|Antifungal Agents|antifungal agents
1721508|NCT00005921|Candidiasis|candidiasis
1721509|NCT00005921|Esophageal Diseases|esophageal diseases
1721510|NCT00005921|MK 0991|mk 0991
1721511|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721512|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
1721513|NCT00005920|Fluconazole|fluconazole
1721514|NCT00005920|Antifungal Agents|antifungal agents
1721515|NCT00005920|Candidiasis, Oral|candidiasis, oral
1721516|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
1721517|NCT00005920|MK 0991|mk 0991
1721518|NCT00005918|Drug Therapy, Combination|drug therapy, combination
1721519|NCT00005918|Stavudine|stavudine
1721520|NCT00005918|Lamivudine|lamivudine
1721521|NCT00005918|RNA, Viral|rna, viral
1721522|NCT00005918|Dosage Forms|dosage forms
1721523|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721524|NCT00005918|Anti-HIV Agents|anti-hiv agents
1721525|NCT00005918|Viral Load|viral load
1721526|NCT00005918|efavirenz|efavirenz
1721527|NCT00005915|HIV-1|hiv-1
1721528|NCT00005915|Drug Administration Schedule|drug administration schedule
1721529|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
1721530|NCT00005915|Disease Progression|disease progression
1721531|NCT00005915|Genotype|genotype
1721532|NCT00005915|Phenotype|phenotype
1721533|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
1721534|NCT00005915|Anti-HIV Agents|anti-hiv agents
1721535|NCT00005915|Treatment Experienced|treatment experienced
1721536|NCT00005779|Virus Replication|virus replication
1721537|NCT00005779|HIV-1|hiv-1
1721538|NCT00005779|AIDS Vaccines|aids vaccines
1721539|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
1721540|NCT00005779|Cohort Studies|cohort studies
1721541|NCT00005779|Interleukin-12|interleukin-12
1721542|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721543|NCT00005764|HIV-1|hiv-1
1721544|NCT00005764|Zalcitabine|zalcitabine
1721545|NCT00005764|Didanosine|didanosine
1721546|NCT00005764|Drug Therapy, Combination|drug therapy, combination
1721547|NCT00005764|Zidovudine|zidovudine
1721548|NCT00005764|Stavudine|stavudine
1721549|NCT00005764|Lamivudine|lamivudine
1721550|NCT00005764|Blood|blood
1721551|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721552|NCT00005764|Anti-HIV Agents|anti-hiv agents
1721553|NCT00005764|Lipodystrophy|lipodystrophy
1721554|NCT00005764|Combivir|combivir
1721555|NCT00005764|Lactic Acid|lactic acid
1721556|NCT00005764|abacavir|abacavir
1721557|NCT00005762|Drug Interactions|drug interactions
1721558|NCT00005762|Drug Therapy, Combination|drug therapy, combination
1721559|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
1721560|NCT00005762|Ritonavir|ritonavir
1721561|NCT00005762|Dosage Forms|dosage forms
1721562|NCT00005762|Saquinavir|saquinavir
1721563|NCT00005762|VX 478|vx 478
1721564|NCT00005762|Anti-HIV Agents|anti-hiv agents
1721565|NCT00005762|Nelfinavir|nelfinavir
1721566|NCT00005762|Pharmacokinetics|pharmacokinetics
1721567|NCT00005762|efavirenz|efavirenz
1721568|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1721569|NCT00005758|Combined Modality Therapy|combined modality therapy
1721570|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
1721571|NCT00005758|AIDS Vaccines|aids vaccines
1721572|NCT00005758|RNA, Viral|rna, viral
1724704|NCT00001071|Stem Cells|stem cells
1721573|NCT00005758|HIV Core Protein p24|hiv core protein p24
1721574|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1721575|NCT00005758|Anti-HIV Agents|anti-hiv agents
1721576|NCT00005758|Viral Load|viral load
1721577|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1721578|NCT00005663|Herpes Simplex|herpes simplex
1721579|NCT00005663|Antiviral Agents|antiviral agents
1721580|NCT00005663|Anus Diseases|anus diseases
1721581|NCT00005663|Herpes Genitalis|herpes genitalis
1721582|NCT00005663|Recurrence|recurrence
1721583|NCT00005663|valacyclovir|valacyclovir
1721584|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721585|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1721586|NCT00005572|Lymphocytes|lymphocytes
1721587|NCT00005572|Histoplasmosis|histoplasmosis
1721588|NCT00005572|Recurrence|recurrence
1721589|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1721590|NCT00005572|Cell Division|cell division
1721591|NCT00005572|Immunocompetence|immunocompetence
1721592|NCT00005572|Anti-HIV Agents|anti-hiv agents
1721593|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
1721594|NCT00005120|Biological Markers|biological markers
1721595|NCT00005120|Anti-HIV Agents|anti-hiv agents
1721596|NCT00005120|Viral Load|viral load
1721597|NCT00005120|Pharmacokinetics|pharmacokinetics
1721598|NCT00005120|calanolide A|calanolide a
1721599|NCT00005118|HIV-1|hiv-1
1721600|NCT00005118|Drug Therapy, Combination|drug therapy, combination
1721601|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
1721602|NCT00005118|Ritonavir|ritonavir
1721603|NCT00005118|Indinavir|indinavir
1721604|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721605|NCT00005118|Anti-HIV Agents|anti-hiv agents
1721606|NCT00005118|Viral Load|viral load
1721607|NCT00005118|Nelfinavir|nelfinavir
1721608|NCT00005106|Drug Therapy, Combination|drug therapy, combination
1721609|NCT00005106|Zidovudine|zidovudine
1721610|NCT00005106|Stavudine|stavudine
1721611|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
1721612|NCT00005106|Lamivudine|lamivudine
1721613|NCT00005106|Nelfinavir|nelfinavir
1721614|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721615|NCT00005106|Anti-HIV Agents|anti-hiv agents
1721616|NCT00005106|Adipose Tissue|adipose tissue
1721617|NCT00005106|Lipodystrophy|lipodystrophy
1721618|NCT00005106|abacavir|abacavir
1721619|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
1721620|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721621|NCT00005020|Phenotype|phenotype
1721622|NCT00005020|Viral Load|viral load
1721623|NCT00005020|Acute Infection|acute infection
1721626|NCT00005018|Drug Therapy, Combination|drug therapy, combination
1721627|NCT00005018|Zidovudine|zidovudine
1721628|NCT00005018|Stavudine|stavudine
1723359|NCT00002179|RNA, Viral|rna, viral
1721629|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
1721630|NCT00005018|Hydroxyurea|hydroxyurea
1721631|NCT00005018|RNA, Viral|rna, viral
1721632|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721633|NCT00005018|Anti-HIV Agents|anti-hiv agents
1721634|NCT00005018|Viral Load|viral load
1721635|NCT00005018|abacavir|abacavir
1721636|NCT00005018|efavirenz|efavirenz
1721637|NCT00005017|HIV-1|hiv-1
1721638|NCT00005017|Drug Therapy, Combination|drug therapy, combination
1721639|NCT00005017|Stavudine|stavudine
1721640|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
1721641|NCT00005017|Ritonavir|ritonavir
1721642|NCT00005017|Lamivudine|lamivudine
1721643|NCT00005017|VX 478|vx 478
1721644|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721645|NCT00005017|Anti-HIV Agents|anti-hiv agents
1721646|NCT00005017|abacavir|abacavir
1721647|NCT00005017|efavirenz|efavirenz
1721648|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
1721649|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
1721650|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
1721651|NCT00005012|RNA, Viral|rna, viral
1721652|NCT00005012|Virus Inhibitors|virus inhibitors
1721653|NCT00005012|Anti-HIV Agents|anti-hiv agents
1721654|NCT00005012|Viral Load|viral load
1721655|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
1721656|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
1721657|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
1721658|NCT00005009|VZV susceptible|vzv susceptible
1721659|NCT00005009|safety|safety
1721660|NCT00005009|immunogenicity|immunogenicity
1721661|NCT00005002|HIV-1|hiv-1
1721662|NCT00005002|Drug Therapy, Combination|drug therapy, combination
1721663|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
1721664|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
1721665|NCT00005002|Nelfinavir|nelfinavir
1721666|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721667|NCT00005002|Anti-HIV Agents|anti-hiv agents
1721668|NCT00005002|Viral Load|viral load
1721669|NCT00005002|remune|remune
1721670|NCT00005002|Combivir|combivir
1721671|NCT00005001|HIV-1|hiv-1
1721672|NCT00005001|Drug Therapy, Combination|drug therapy, combination
1721673|NCT00005001|RNA, Viral|rna, viral
1721674|NCT00005001|Anti-HIV Agents|anti-hiv agents
1721678|NCT00005000|Drug Therapy, Combination|drug therapy, combination
1721679|NCT00005000|Lymphoid Tissue|lymphoid tissue
1721680|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
1721681|NCT00005000|Genotype|genotype
1721682|NCT00005000|Phenotype|phenotype
1721683|NCT00005000|Nelfinavir|nelfinavir
1721684|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721685|NCT00005000|Anti-HIV Agents|anti-hiv agents
1721686|NCT00005000|Viral Load|viral load
1721687|NCT00005000|Adipose Tissue|adipose tissue
1721688|NCT00005000|Glucose|glucose
1721689|NCT00005000|Lipids|lipids
1721690|NCT00005000|Immunophenotyping|immunophenotyping
1721691|NCT00005000|efavirenz|efavirenz
1721692|NCT00004999|Drug Therapy, Combination|drug therapy, combination
1721693|NCT00004999|Zidovudine|zidovudine
1721694|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
1721695|NCT00004999|Lamivudine|lamivudine
1721696|NCT00004999|Disease Progression|disease progression
1721697|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721698|NCT00004999|Anti-HIV Agents|anti-hiv agents
1721699|NCT00004999|Viral Load|viral load
1721700|NCT00004999|Nelfinavir|nelfinavir
1721701|NCT00004999|Combivir|combivir
1721702|NCT00004998|Drug Therapy, Combination|drug therapy, combination
1721703|NCT00004998|Zidovudine|zidovudine
1721704|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
1721705|NCT00004998|Lamivudine|lamivudine
1721706|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721707|NCT00004998|Anti-HIV Agents|anti-hiv agents
1721708|NCT00004998|Nelfinavir|nelfinavir
1721709|NCT00004998|Combivir|combivir
1721710|NCT00004987|Anti-HIV Agents|anti-hiv agents
1721711|NCT00004987|Viral Load|viral load
1721712|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
1721713|NCT00004987|Infusions, Parenteral|infusions, parenteral
1721714|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721715|NCT00004986|Cryptosporidiosis|cryptosporidiosis
1721716|NCT00004986|Drug Evaluation|drug evaluation
1721717|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
1721718|NCT00004986|Treatment Failure|treatment failure
1721719|NCT00004986|nitazoxanide|nitazoxanide
1721720|NCT00004985|HIV-1|hiv-1
1721721|NCT00004985|Drug Therapy, Combination|drug therapy, combination
1721722|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
1721723|NCT00004985|RNA, Viral|rna, viral
1721724|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721725|NCT00004985|Anti-HIV Agents|anti-hiv agents
1721726|NCT00004985|Viral Load|viral load
1721728|NCT00004981|Drug Therapy, Combination|drug therapy, combination
1721729|NCT00004981|Zidovudine|zidovudine
1724086|NCT00002033|Zidovudine|zidovudine
1721730|NCT00004981|Drug Administration Schedule|drug administration schedule
1721731|NCT00004981|Lamivudine|lamivudine
1721732|NCT00004981|RNA, Viral|rna, viral
1721733|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721734|NCT00004981|Anti-HIV Agents|anti-hiv agents
1721735|NCT00004981|Viral Load|viral load
1721736|NCT00004981|Combivir|combivir
1721737|NCT00004981|abacavir|abacavir
1721738|NCT00004978|Recombinant Proteins|recombinant proteins
1721739|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
1721740|NCT00004978|HIV-1|hiv-1
1721741|NCT00004978|Interleukin-2|interleukin-2
1721742|NCT00004978|Drug Therapy, Combination|drug therapy, combination
1721743|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
1721744|NCT00004978|Disease Progression|disease progression
1721745|NCT00004978|Follow-Up Studies|follow-up studies
1721746|NCT00004978|Anti-HIV Agents|anti-hiv agents
1721747|NCT00004855|Drug Therapy, Combination|drug therapy, combination
1721748|NCT00004855|Nevirapine|nevirapine
1721749|NCT00004855|Stavudine|stavudine
1721750|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
1721751|NCT00004855|Ritonavir|ritonavir
1721752|NCT00004855|Lamivudine|lamivudine
1721753|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721754|NCT00004855|Anti-HIV Agents|anti-hiv agents
1721755|NCT00004855|ABT 378|abt 378
1721756|NCT00004855|abacavir|abacavir
1721757|NCT00004852|HIV-1|hiv-1
1721758|NCT00004852|Drug Therapy, Combination|drug therapy, combination
1721759|NCT00004852|Zidovudine|zidovudine
1721760|NCT00004852|Drug Administration Schedule|drug administration schedule
1721761|NCT00004852|Lamivudine|lamivudine
1721762|NCT00004852|Genotype|genotype
1721763|NCT00004852|Phenotype|phenotype
1721764|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721765|NCT00004852|Anti-HIV Agents|anti-hiv agents
1721766|NCT00004852|Viral Load|viral load
1721767|NCT00004852|efavirenz|efavirenz
1721768|NCT00004736|Tuberculosis|tuberculosis
1721769|NCT00004736|Rifabutin|rifabutin
1721770|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721771|NCT00004736|Drug Therapy, Combination|drug therapy, combination
1721772|NCT00004736|Antitubercular Agents|antitubercular agents
1721773|NCT00004736|Anti-HIV Agents|anti-hiv agents
1721774|NCT00004735|Viral Vaccines|viral vaccines
1721775|NCT00004735|Drug Therapy, Combination|drug therapy, combination
1721776|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1721777|NCT00004735|Immunologic Memory|immunologic memory
1721778|NCT00004735|Antibody Formation|antibody formation
1721779|NCT00004735|Anti-HIV Agents|anti-hiv agents
1721780|NCT00004735|Tetanus Toxoid|tetanus toxoid
1721781|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
1721782|NCT00004735|Enfuvirtide|enfuvirtide
1721783|NCT00004735|T-20|t-20
1721784|NCT00004735|Treatment Naive|treatment naive
1721785|NCT00004735|Treatment Experienced|treatment experienced
1721786|NCT00004585|Drug Therapy, Combination|drug therapy, combination
1721787|NCT00004585|Zidovudine|zidovudine
1721788|NCT00004585|Lamivudine|lamivudine
1721789|NCT00004585|RNA, Viral|rna, viral
1721790|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721791|NCT00004585|Anti-HIV Agents|anti-hiv agents
1721792|NCT00004585|Viral Load|viral load
1721793|NCT00004585|abacavir|abacavir
1721794|NCT00004585|efavirenz|efavirenz
1721795|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
1721796|NCT00004584|Drug Therapy, Combination|drug therapy, combination
1721797|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
1721798|NCT00004584|Ritonavir|ritonavir
1721799|NCT00004584|Saquinavir|saquinavir
1721800|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721801|NCT00004584|Anti-HIV Agents|anti-hiv agents
1721802|NCT00004583|Drug Therapy, Combination|drug therapy, combination
1721803|NCT00004583|Administration, Oral|administration, oral
1721804|NCT00004583|Stavudine|stavudine
1721805|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
1721806|NCT00004583|Lamivudine|lamivudine
1721807|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721808|NCT00004583|Anti-HIV Agents|anti-hiv agents
1721809|NCT00004583|Nelfinavir|nelfinavir
1721810|NCT00004583|ABT 378|abt 378
1721811|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
1721812|NCT00004582|Ritonavir|ritonavir
1721813|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721814|NCT00004582|Anti-HIV Agents|anti-hiv agents
1721815|NCT00004582|Viral Load|viral load
1721816|NCT00004582|ABT 378|abt 378
1721817|NCT00004582|efavirenz|efavirenz
1721818|NCT00004581|Drug Therapy, Combination|drug therapy, combination
1721819|NCT00004581|Nevirapine|nevirapine
1721820|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
1721821|NCT00004581|Ritonavir|ritonavir
1721822|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721823|NCT00004581|Anti-HIV Agents|anti-hiv agents
1721824|NCT00004581|ABT 378|abt 378
1721825|NCT00004580|Drug Therapy, Combination|drug therapy, combination
1721827|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
1721828|NCT00004580|Ritonavir|ritonavir
1721829|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721830|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
1721831|NCT00004579|Viral Vaccines|viral vaccines
1721832|NCT00004579|HIV-1|hiv-1
1721833|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
1721834|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
1721835|NCT00004579|AIDS Vaccines|aids vaccines
1721836|NCT00004579|HIV Seronegativity|hiv seronegativity
1721837|NCT00004579|Avipoxvirus|avipoxvirus
1721838|NCT00004579|Immunization|immunization
1721839|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
1721840|NCT00004579|Recombination, Genetic|recombination, genetic
1721841|NCT00004578|Stavudine|stavudine
1721842|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
1721843|NCT00004578|Ritonavir|ritonavir
1721844|NCT00004578|Lamivudine|lamivudine
1721845|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721846|NCT00002453|HIV-1|hiv-1
1721847|NCT00002453|Drug Therapy, Combination|drug therapy, combination
1721848|NCT00002453|Disease Progression|disease progression
1721849|NCT00002453|Anti-HIV Agents|anti-hiv agents
1721850|NCT00002452|Drug Therapy, Combination|drug therapy, combination
1721851|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
1721852|NCT00002452|Indinavir|indinavir
1721853|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721854|NCT00002452|Anti-HIV Agents|anti-hiv agents
1721855|NCT00002452|Viral Load|viral load
1721856|NCT00002451|Drug Therapy, Combination|drug therapy, combination
1721857|NCT00002451|Stavudine|stavudine
1721858|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
1721859|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
1721860|NCT00002451|Ritonavir|ritonavir
1721861|NCT00002451|Lamivudine|lamivudine
1721862|NCT00002451|Indinavir|indinavir
1721863|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721864|NCT00002451|Anti-HIV Agents|anti-hiv agents
1721865|NCT00002451|Viral Load|viral load
1721866|NCT00002450|HIV-1|hiv-1
1721867|NCT00002450|Drug Therapy, Combination|drug therapy, combination
1721868|NCT00002450|Drug Administration Schedule|drug administration schedule
1721869|NCT00002450|RNA, Viral|rna, viral
1721870|NCT00002450|Anti-HIV Agents|anti-hiv agents
1721871|NCT00002450|Viral Load|viral load
1721872|NCT00002449|Recombinant Proteins|recombinant proteins
1721873|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
1721874|NCT00002449|Interleukin-2|interleukin-2
1721875|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
1721876|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
1721877|NCT00002449|Anti-HIV Agents|anti-hiv agents
1721878|NCT00002449|Viral Load|viral load
1721879|NCT00002449|Pharmacokinetics|pharmacokinetics
1721880|NCT00002448|Drug Therapy, Combination|drug therapy, combination
1721881|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
1721882|NCT00002448|Ritonavir|ritonavir
1721883|NCT00002448|Dosage Forms|dosage forms
1721884|NCT00002448|Saquinavir|saquinavir
1721885|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721886|NCT00002448|Anti-HIV Agents|anti-hiv agents
1721887|NCT00002448|efavirenz|efavirenz
1721888|NCT00002447|Drug Therapy, Combination|drug therapy, combination
1721889|NCT00002447|Saquinavir|saquinavir
1721890|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
1721891|NCT00002447|Ritonavir|ritonavir
1721892|NCT00002447|Dosage Forms|dosage forms
1721893|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721894|NCT00002447|Anti-HIV Agents|anti-hiv agents
1721895|NCT00002447|efavirenz|efavirenz
1721896|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721897|NCT00002446|Fluconazole|fluconazole
1721898|NCT00002446|Administration, Oral|administration, oral
1721899|NCT00002446|Antifungal Agents|antifungal agents
1721900|NCT00002446|Candidiasis, Oral|candidiasis, oral
1721901|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
1721902|NCT00002446|posaconazole|posaconazole
1721903|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721904|NCT00002445|Placebos|placebos
1721905|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
1721906|NCT00002445|Antineoplastic Agents|antineoplastic agents
1721907|NCT00002445|Treatment Outcome|treatment outcome
1721908|NCT00002445|Quality of Life|quality of life
1721909|NCT00002442|Drug Therapy, Combination|drug therapy, combination
1721910|NCT00002442|Zidovudine|zidovudine
1721911|NCT00002442|Drug Administration Schedule|drug administration schedule
1721912|NCT00002442|Stavudine|stavudine
1721913|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
1721914|NCT00002442|Lamivudine|lamivudine
1721915|NCT00002442|Indinavir|indinavir
1721916|NCT00002442|Dosage Forms|dosage forms
1721917|NCT00002442|Nelfinavir|nelfinavir
1721918|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721919|NCT00002442|Anti-HIV Agents|anti-hiv agents
1721920|NCT00002441|HIV-1|hiv-1
1721921|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
1721922|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721923|NCT00002441|AIDS Vaccines|aids vaccines
1721924|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
1721925|NCT00002441|Risk Factors|risk factors
1721926|NCT00002441|HIV Seronegativity|hiv seronegativity
1721927|NCT00002441|Antigens, Viral|antigens, viral
1721928|NCT00002441|Alum Compounds|alum compounds
1721929|NCT00002440|HIV-1|hiv-1
1721930|NCT00002440|Drug Therapy, Combination|drug therapy, combination
1721931|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
1721932|NCT00002440|Mutation|mutation
1721933|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
1721934|NCT00002440|HIV Protease|hiv protease
1721935|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721936|NCT00002440|Anti-HIV Agents|anti-hiv agents
1721937|NCT00002440|abacavir|abacavir
1721938|NCT00002438|Itraconazole|itraconazole
1721939|NCT00002438|Histoplasmosis|histoplasmosis
1721940|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721941|NCT00002437|Retinitis|retinitis
1721942|NCT00002437|Probenecid|probenecid
1721943|NCT00002437|Drug Therapy, Combination|drug therapy, combination
1721944|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
1721945|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721946|NCT00002437|Antiviral Agents|antiviral agents
1721947|NCT00002437|cidofovir|cidofovir
1721948|NCT00002436|Zalcitabine|zalcitabine
1721949|NCT00002436|Drug Therapy, Combination|drug therapy, combination
1721950|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721951|NCT00002436|AIDS-Related Complex|aids-related complex
1721952|NCT00002436|Antiviral Agents|antiviral agents
1721953|NCT00002436|Zidovudine|zidovudine
1721954|NCT00002435|Drug Therapy, Combination|drug therapy, combination
1721955|NCT00002435|Antiviral Agents|antiviral agents
1721956|NCT00002435|Zidovudine|zidovudine
1721957|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
1721958|NCT00002434|Trimetrexate|trimetrexate
1721959|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1721960|NCT00002434|Leucovorin|leucovorin
1721961|NCT00002434|Drug Therapy, Combination|drug therapy, combination
1721962|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721963|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
1721964|NCT00002433|Macrophage Activation|macrophage activation
1721965|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1721966|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
1721967|NCT00002433|Aerosols|aerosols
1721968|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721969|NCT00002432|Retinitis|retinitis
1721970|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721972|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
1721973|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721974|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1721975|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
1721976|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1721977|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
1721978|NCT00002431|AIDS-Related Complex|aids-related complex
1721979|NCT00002431|Candidiasis, Oral|candidiasis, oral
1721980|NCT00002430|Drug Therapy, Combination|drug therapy, combination
1721981|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
1721982|NCT00002430|Lamivudine|lamivudine
1721983|NCT00002430|Indinavir|indinavir
1721984|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721985|NCT00002430|Anti-HIV Agents|anti-hiv agents
1721986|NCT00002430|Nelfinavir|nelfinavir
1721987|NCT00002429|Didanosine|didanosine
1721988|NCT00002429|Drug Therapy, Combination|drug therapy, combination
1721989|NCT00002429|Stavudine|stavudine
1721990|NCT00002429|RNA, Viral|rna, viral
1721991|NCT00002429|Nelfinavir|nelfinavir
1721992|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1721993|NCT00002429|Anti-HIV Agents|anti-hiv agents
1721994|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
1721995|NCT00002428|HIV-1|hiv-1
1721996|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
1721997|NCT00002428|AIDS Vaccines|aids vaccines
1721998|NCT00002428|HIV Seronegativity|hiv seronegativity
1721999|NCT00002427|Didanosine|didanosine
1722000|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
1722001|NCT00002427|Drug Therapy, Combination|drug therapy, combination
1722002|NCT00002427|Stavudine|stavudine
1722003|NCT00002427|Hydroxyurea|hydroxyurea
1722004|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722005|NCT00002427|Anti-HIV Agents|anti-hiv agents
1722006|NCT00002426|HIV-1|hiv-1
1722007|NCT00002426|RNA, Viral|rna, viral
1722008|NCT00002426|VX 478|vx 478
1722009|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722010|NCT00002426|Anti-HIV Agents|anti-hiv agents
1722011|NCT00002426|Viral Load|viral load
1722012|NCT00002425|Drug Therapy, Combination|drug therapy, combination
1722013|NCT00002425|Saquinavir|saquinavir
1722014|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
1722015|NCT00002425|Dosage Forms|dosage forms
1722016|NCT00002425|Anti-HIV Agents|anti-hiv agents
1722017|NCT00002424|Drug Therapy, Combination|drug therapy, combination
1724933|NCT00001032|Zalcitabine|zalcitabine
1722018|NCT00002424|Drug Administration Schedule|drug administration schedule
1722019|NCT00002424|Stavudine|stavudine
1722020|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
1722021|NCT00002424|Lamivudine|lamivudine
1722022|NCT00002424|Indinavir|indinavir
1722023|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722024|NCT00002424|Anti-HIV Agents|anti-hiv agents
1722025|NCT00002423|Drug Therapy, Combination|drug therapy, combination
1722026|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
1722027|NCT00002423|Lamivudine|lamivudine
1722028|NCT00002423|Indinavir|indinavir
1722029|NCT00002423|Nelfinavir|nelfinavir
1722030|NCT00002423|VX 478|vx 478
1722031|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722032|NCT00002423|Anti-HIV Agents|anti-hiv agents
1722033|NCT00002423|Viral Load|viral load
1722034|NCT00002423|abacavir|abacavir
1722035|NCT00002422|Injections, Intramuscular|injections, intramuscular
1722036|NCT00002422|Drug Interactions|drug interactions
1722037|NCT00002422|Salvage Therapy|salvage therapy
1722038|NCT00002422|Anti-HIV Agents|anti-hiv agents
1722039|NCT00002420|Drug Therapy, Combination|drug therapy, combination
1722040|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722041|NCT00002420|Anti-HIV Agents|anti-hiv agents
1722042|NCT00002419|Drug Therapy, Combination|drug therapy, combination
1722043|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
1722044|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722045|NCT00002419|Anti-HIV Agents|anti-hiv agents
1722046|NCT00002418|Drug Therapy, Combination|drug therapy, combination
1722047|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722048|NCT00002418|Anti-HIV Agents|anti-hiv agents
1722049|NCT00002418|Viral Load|viral load
1722050|NCT00002417|Drug Therapy, Combination|drug therapy, combination
1722051|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
1722052|NCT00002417|VX 478|vx 478
1722053|NCT00002417|Lipodystrophy|lipodystrophy
1722054|NCT00002417|Hyperlipidemia|hyperlipidemia
1722055|NCT00002416|HIV-1|hiv-1
1722056|NCT00002416|Zalcitabine|zalcitabine
1722057|NCT00002416|Zidovudine|zidovudine
1722058|NCT00002416|Stavudine|stavudine
1722059|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
1722060|NCT00002416|Lamivudine|lamivudine
1722061|NCT00002416|RNA, Viral|rna, viral
1722062|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722063|NCT00002416|Anti-HIV Agents|anti-hiv agents
1722064|NCT00002415|Drug Therapy, Combination|drug therapy, combination
1722065|NCT00002415|Prodrugs|prodrugs
1722066|NCT00002415|Anti-HIV Agents|anti-hiv agents
1722067|NCT00002414|AIDS Dementia Complex|aids dementia complex
1722068|NCT00002414|Anti-HIV Agents|anti-hiv agents
1722069|NCT00002413|Anti-HIV Agents|anti-hiv agents
1722070|NCT00002413|Viral Load|viral load
1722071|NCT00002413|MKC 442|mkc 442
1722072|NCT00002412|Didanosine|didanosine
1722073|NCT00002412|Drug Therapy, Combination|drug therapy, combination
1722074|NCT00002412|Stavudine|stavudine
1722075|NCT00002412|Hydroxyurea|hydroxyurea
1722076|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722077|NCT00002412|Anti-HIV Agents|anti-hiv agents
1722078|NCT00002412|Viral Load|viral load
1722079|NCT00002412|MKC 442|mkc 442
1722080|NCT00002411|HIV-1|hiv-1
1722081|NCT00002411|Didanosine|didanosine
1722082|NCT00002411|Drug Therapy, Combination|drug therapy, combination
1722083|NCT00002411|Zidovudine|zidovudine
1722084|NCT00002411|Stavudine|stavudine
1722085|NCT00002411|Lamivudine|lamivudine
1722086|NCT00002411|RNA, Viral|rna, viral
1722087|NCT00002411|Nelfinavir|nelfinavir
1722088|NCT00002411|Anti-HIV Agents|anti-hiv agents
1722089|NCT00002411|Viral Load|viral load
1722090|NCT00002410|HIV-1|hiv-1
1722091|NCT00002410|Drug Therapy, Combination|drug therapy, combination
1722092|NCT00002410|Zidovudine|zidovudine
1722093|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
1722094|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
1722095|NCT00002410|Lamivudine|lamivudine
1722096|NCT00002410|Indinavir|indinavir
1722097|NCT00002410|Genotype|genotype
1722098|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722099|NCT00002410|efavirenz|efavirenz
1722100|NCT00002409|Drug Therapy, Combination|drug therapy, combination
1722101|NCT00002409|Zidovudine|zidovudine
1722102|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
1722103|NCT00002409|Lamivudine|lamivudine
1722104|NCT00002409|Patient Education|patient education
1722105|NCT00002409|Patient Compliance|patient compliance
1722106|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722107|NCT00002409|Anti-HIV Agents|anti-hiv agents
1722108|NCT00002409|Viral Load|viral load
1722109|NCT00002409|abacavir|abacavir
1722110|NCT00002408|Diarrhea|diarrhea
1722111|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722112|NCT00002406|HIV-1|hiv-1
1722113|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
1722114|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
1722115|NCT00002406|Indinavir|indinavir
1722117|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722118|NCT00002405|Drug Therapy, Combination|drug therapy, combination
1722119|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
1722120|NCT00002405|VX 478|vx 478
1722121|NCT00002405|Anti-HIV Agents|anti-hiv agents
1722122|NCT00002404|HIV-1|hiv-1
1722123|NCT00002404|Antiviral Agents|antiviral agents
1722124|NCT00002404|Herpes Genitalis|herpes genitalis
1722125|NCT00002404|Recurrence|recurrence
1722126|NCT00002404|DNA, Viral|dna, viral
1722127|NCT00002404|RNA, Viral|rna, viral
1722128|NCT00002404|valacyclovir|valacyclovir
1722129|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
1722130|NCT00002403|HIV-1|hiv-1
1722131|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
1722132|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
1722133|NCT00002403|HIV Integrase|hiv integrase
1722134|NCT00002402|HIV-1|hiv-1
1722135|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
1722136|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722137|NCT00002402|AIDS Vaccines|aids vaccines
1722138|NCT00002402|HIV Seronegativity|hiv seronegativity
1722139|NCT00002402|Antigens, Viral|antigens, viral
1722140|NCT00002402|Alum Compounds|alum compounds
1722141|NCT00002401|HIV-1|hiv-1
1722142|NCT00002401|Zidovudine|zidovudine
1722143|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
1722144|NCT00002401|Lamivudine|lamivudine
1722145|NCT00002401|Indinavir|indinavir
1722146|NCT00002401|RNA, Viral|rna, viral
1722147|NCT00002401|Delavirdine|delavirdine
1722148|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722149|NCT00002401|Viral Load|viral load
1722150|NCT00002400|HIV-1|hiv-1
1722151|NCT00002400|Drug Therapy, Combination|drug therapy, combination
1722152|NCT00002400|Zidovudine|zidovudine
1722153|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
1722154|NCT00002400|Lamivudine|lamivudine
1722155|NCT00002400|Indinavir|indinavir
1722156|NCT00002400|RNA, Viral|rna, viral
1722157|NCT00002400|Delavirdine|delavirdine
1722158|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722159|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722160|NCT00002399|Fluconazole|fluconazole
1722161|NCT00002399|Antifungal Agents|antifungal agents
1722162|NCT00002399|Candidiasis|candidiasis
1722163|NCT00002399|Triazoles|triazoles
1722164|NCT00002398|HIV-1|hiv-1
1722165|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722166|NCT00002398|Adenine|adenine
1722167|NCT00002398|Anti-HIV Agents|anti-hiv agents
1722168|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
1722169|NCT00002397|HIV-1|hiv-1
1722170|NCT00002397|Drug Therapy, Combination|drug therapy, combination
1722171|NCT00002397|Stavudine|stavudine
1722172|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
1722173|NCT00002397|Lamivudine|lamivudine
1722174|NCT00002397|Saquinavir|saquinavir
1722175|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
1722176|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722177|NCT00002397|Viral Load|viral load
1722178|NCT00002397|Nelfinavir|nelfinavir
1722179|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
1722180|NCT00002396|Adenine|adenine
1722181|NCT00002396|Anti-HIV Agents|anti-hiv agents
1722182|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722183|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
1722184|NCT00002395|Infusions, Intravenous|infusions, intravenous
1722185|NCT00002395|Drug Administration Schedule|drug administration schedule
1722186|NCT00002395|Topotecan|topotecan
1722187|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722188|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
1722189|NCT00002394|Fluconazole|fluconazole
1722190|NCT00002394|Antifungal Agents|antifungal agents
1722191|NCT00002394|Candidiasis, Oral|candidiasis, oral
1722192|NCT00002394|Drug Administration Schedule|drug administration schedule
1722193|NCT00002394|terbinafine|terbinafine
1722194|NCT00002393|Placebos|placebos
1722195|NCT00002393|Drug Therapy, Combination|drug therapy, combination
1722196|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
1722197|NCT00002393|Indinavir|indinavir
1722198|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722199|NCT00002393|efavirenz|efavirenz
1722200|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
1722201|NCT00002392|Immunity, Cellular|immunity, cellular
1722202|NCT00002392|Drug Therapy, Combination|drug therapy, combination
1722203|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
1722204|NCT00002392|Thalidomide|thalidomide
1722205|NCT00002392|Immunologic Memory|immunologic memory
1722206|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
1722207|NCT00002392|Tetanus Toxoid|tetanus toxoid
1722208|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
1722209|NCT00002391|HIV-1|hiv-1
1722210|NCT00002391|Drug Therapy, Combination|drug therapy, combination
1722211|NCT00002391|Zidovudine|zidovudine
1722212|NCT00002391|Lamivudine|lamivudine
1722213|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722214|NCT00002391|Anti-HIV Agents|anti-hiv agents
1722216|NCT00002391|Child Development|child development
1722217|NCT00002391|abacavir|abacavir
1722219|NCT00002389|Drug Therapy, Combination|drug therapy, combination
1722220|NCT00002389|Antiviral Agents|antiviral agents
1722221|NCT00002389|Zidovudine|zidovudine
1722222|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
1722223|NCT00002389|Lamivudine|lamivudine
1722224|NCT00002389|RNA, Viral|rna, viral
1722225|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722226|NCT00002389|Anti-HIV Agents|anti-hiv agents
1722227|NCT00002389|Viral Load|viral load
1722228|NCT00002389|abacavir|abacavir
1722229|NCT00002388|HIV-1|hiv-1
1722230|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722231|NCT00002388|Anti-HIV Agents|anti-hiv agents
1722232|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722233|NCT00002387|Drug Administration Schedule|drug administration schedule
1722234|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
1722235|NCT00002387|Indinavir|indinavir
1722236|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722237|NCT00002387|Anti-HIV Agents|anti-hiv agents
1722238|NCT00002387|efavirenz|efavirenz
1722239|NCT00002386|Drug Therapy, Combination|drug therapy, combination
1722240|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
1722241|NCT00002386|Indinavir|indinavir
1722242|NCT00002386|Factor VIII|factor viii
1722243|NCT00002386|Factor IX|factor ix
1722244|NCT00002386|Half-Life|half-life
1722245|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722246|NCT00002386|Anti-HIV Agents|anti-hiv agents
1722247|NCT00002386|Platelet Aggregation|platelet aggregation
1722248|NCT00002386|Hemophilia A|hemophilia a
1722249|NCT00002386|Hemophilia B|hemophilia b
1722250|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
1722251|NCT00002385|Cohort Studies|cohort studies
1722252|NCT00002385|Anti-HIV Agents|anti-hiv agents
1722253|NCT00002383|Drug Administration Schedule|drug administration schedule
1722254|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
1722255|NCT00002383|Dosage Forms|dosage forms
1722256|NCT00002383|Saquinavir|saquinavir
1722257|NCT00002383|Anti-HIV Agents|anti-hiv agents
1722258|NCT00002382|Zalcitabine|zalcitabine
1722259|NCT00002382|Didanosine|didanosine
1722260|NCT00002382|Drug Therapy, Combination|drug therapy, combination
1722261|NCT00002382|Zidovudine|zidovudine
1722262|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
1722263|NCT00002382|Saquinavir|saquinavir
1722264|NCT00002382|Patient Selection|patient selection
1722265|NCT00002382|Anti-HIV Agents|anti-hiv agents
1722266|NCT00002381|HIV-1|hiv-1
1724800|NCT00001054|Chickenpox|chickenpox
1722267|NCT00002381|Drug Therapy, Combination|drug therapy, combination
1722268|NCT00002381|Nevirapine|nevirapine
1722269|NCT00002381|Stavudine|stavudine
1722270|NCT00002381|RNA, Viral|rna, viral
1722271|NCT00002381|Nelfinavir|nelfinavir
1722272|NCT00002381|Anti-HIV Agents|anti-hiv agents
1722273|NCT00002381|Viral Load|viral load
1722274|NCT00002380|Drug Therapy, Combination|drug therapy, combination
1722275|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
1722276|NCT00002380|Dosage Forms|dosage forms
1722277|NCT00002380|Saquinavir|saquinavir
1722278|NCT00002380|Nelfinavir|nelfinavir
1722279|NCT00002380|Anti-HIV Agents|anti-hiv agents
1722280|NCT00002379|HIV-1|hiv-1
1722281|NCT00002379|Drug Therapy, Combination|drug therapy, combination
1722282|NCT00002379|Administration, Oral|administration, oral
1722283|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722284|NCT00002379|Zidovudine|zidovudine
1722285|NCT00002379|Stavudine|stavudine
1722286|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
1722287|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
1722288|NCT00002379|Lamivudine|lamivudine
1722289|NCT00002379|Indinavir|indinavir
1722290|NCT00002379|RNA, Viral|rna, viral
1722291|NCT00002379|Adenine|adenine
1722292|NCT00002379|Anti-HIV Agents|anti-hiv agents
1722293|NCT00002379|Viral Load|viral load
1722294|NCT00002378|HIV-1|hiv-1
1722295|NCT00002378|Drug Therapy, Combination|drug therapy, combination
1722296|NCT00002378|Zidovudine|zidovudine
1722297|NCT00002378|Stavudine|stavudine
1722298|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
1722299|NCT00002378|Lamivudine|lamivudine
1722300|NCT00002378|RNA, Viral|rna, viral
1722301|NCT00002378|Dosage Forms|dosage forms
1722302|NCT00002378|Saquinavir|saquinavir
1722303|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722304|NCT00002378|Anti-HIV Agents|anti-hiv agents
1722305|NCT00002378|Viral Load|viral load
1722306|NCT00002378|Nelfinavir|nelfinavir
1722307|NCT00002376|HIV-1|hiv-1
1722308|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
1722309|NCT00002376|RNA, Viral|rna, viral
1722310|NCT00002376|Anti-HIV Agents|anti-hiv agents
1722311|NCT00002376|Viral Load|viral load
1722312|NCT00002375|Drug Therapy, Combination|drug therapy, combination
1722313|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
1722314|NCT00002375|Indinavir|indinavir
1722315|NCT00002375|Nelfinavir|nelfinavir
1722316|NCT00002375|Anti-HIV Agents|anti-hiv agents
1722317|NCT00002374|HIV-1|hiv-1
1722318|NCT00002374|Drug Therapy, Combination|drug therapy, combination
1722319|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722320|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
1722321|NCT00002374|RNA, Viral|rna, viral
1722322|NCT00002374|Saquinavir|saquinavir
1722323|NCT00002374|Anti-HIV Agents|anti-hiv agents
1722324|NCT00002374|Viral Load|viral load
1722325|NCT00002373|Cytomegalovirus|cytomegalovirus
1722326|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
1722327|NCT00002373|Administration, Oral|administration, oral
1722328|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722329|NCT00002373|Antiviral Agents|antiviral agents
1722330|NCT00002373|Virus Shedding|virus shedding
1722331|NCT00002373|Viral Load|viral load
1722332|NCT00002372|Drug Therapy, Combination|drug therapy, combination
1722333|NCT00002372|Administration, Oral|administration, oral
1722334|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
1722335|NCT00002372|Indinavir|indinavir
1722336|NCT00002372|Saquinavir|saquinavir
1722337|NCT00002372|Nelfinavir|nelfinavir
1722338|NCT00002372|VX 478|vx 478
1722339|NCT00002371|HIV-1|hiv-1
1722340|NCT00002371|Drug Therapy, Combination|drug therapy, combination
1722341|NCT00002371|Stavudine|stavudine
1722342|NCT00002371|Lamivudine|lamivudine
1722343|NCT00002371|RNA, Viral|rna, viral
1722344|NCT00002371|Anti-HIV Agents|anti-hiv agents
1722345|NCT00002371|Viral Load|viral load
1722346|NCT00002370|Itraconazole|itraconazole
1722347|NCT00002370|Administration, Oral|administration, oral
1722348|NCT00002370|Antifungal Agents|antifungal agents
1722349|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722350|NCT00002370|Drug Administration Schedule|drug administration schedule
1722351|NCT00002369|Drug Therapy, Combination|drug therapy, combination
1722352|NCT00002369|Zidovudine|zidovudine
1722353|NCT00002369|Stavudine|stavudine
1722354|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
1722355|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
1722356|NCT00002369|Lamivudine|lamivudine
1722357|NCT00002369|Indinavir|indinavir
1722358|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722359|NCT00002369|Anti-HIV Agents|anti-hiv agents
1722360|NCT00002369|Viral Load|viral load
1722361|NCT00002368|Drug Therapy, Combination|drug therapy, combination
1722362|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722363|NCT00002368|Nevirapine|nevirapine
1722364|NCT00002368|Lamivudine|lamivudine
1722365|NCT00002368|Disease Progression|disease progression
1722366|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722367|NCT00002368|Anti-HIV Agents|anti-hiv agents
1725258|NCT00000981|Retinitis|retinitis
1722368|NCT00002367|Drug Therapy, Combination|drug therapy, combination
1722369|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722370|NCT00002367|Zidovudine|zidovudine
1722371|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
1722372|NCT00002367|Lamivudine|lamivudine
1722373|NCT00002367|Saquinavir|saquinavir
1722374|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722375|NCT00002367|Anti-HIV Agents|anti-hiv agents
1722376|NCT00002366|Skin Neoplasms|skin neoplasms
1722377|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
1722378|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722379|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
1722380|NCT00002366|Ritonavir|ritonavir
1722381|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
1722382|NCT00002365|Administration, Oral|administration, oral
1722383|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722384|NCT00002365|Anti-HIV Agents|anti-hiv agents
1722385|NCT00002364|Drug Therapy, Combination|drug therapy, combination
1722386|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722387|NCT00002364|AIDS-Related Complex|aids-related complex
1722388|NCT00002364|Antiviral Agents|antiviral agents
1722389|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722390|NCT00002363|AIDS-Related Complex|aids-related complex
1722391|NCT00002363|Antiviral Agents|antiviral agents
1722392|NCT00002362|Dideoxynucleosides|dideoxynucleosides
1722393|NCT00002362|Drug Therapy, Combination|drug therapy, combination
1722394|NCT00002362|Stavudine|stavudine
1722395|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722396|NCT00002362|abacavir|abacavir
1722397|NCT00002362|efavirenz|efavirenz
1722398|NCT00002361|Drug Therapy, Combination|drug therapy, combination
1722399|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
1722400|NCT00002361|Ritonavir|ritonavir
1722401|NCT00002361|Indinavir|indinavir
1722402|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722403|NCT00002361|Anti-HIV Agents|anti-hiv agents
1722404|NCT00002361|Viral Load|viral load
1722405|NCT00002360|Didanosine|didanosine
1722406|NCT00002360|Tablets|tablets
1722407|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722408|NCT00002360|Anti-HIV Agents|anti-hiv agents
1722409|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
1722410|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
1722411|NCT00002359|Viral Vaccines|viral vaccines
1722412|NCT00002359|HIV-1|hiv-1
1722413|NCT00002359|AIDS-Related Complex|aids-related complex
1722414|NCT00002359|AIDS Vaccines|aids vaccines
1722415|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
1722416|NCT00002358|Herpes Zoster|herpes zoster
1722417|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722418|NCT00002358|AIDS-Related Complex|aids-related complex
1722419|NCT00002358|Antiviral Agents|antiviral agents
1722420|NCT00002358|sorivudine|sorivudine
1722421|NCT00002358|Chickenpox|chickenpox
1722422|NCT00002357|Drug Therapy, Combination|drug therapy, combination
1722423|NCT00002357|AIDS-Related Complex|aids-related complex
1722424|NCT00002357|Antiviral Agents|antiviral agents
1722425|NCT00002357|Zidovudine|zidovudine
1722426|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722427|NCT00002356|Antiviral Agents|antiviral agents
1722428|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1722429|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722430|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722431|NCT00002355|Antiviral Agents|antiviral agents
1722432|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1722433|NCT00002354|Drug Therapy, Combination|drug therapy, combination
1722434|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722435|NCT00002354|AIDS-Related Complex|aids-related complex
1722436|NCT00002354|Stavudine|stavudine
1722437|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
1722438|NCT00002354|Indinavir|indinavir
1722439|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
1722440|NCT00002353|AIDS Vaccines|aids vaccines
1722441|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
1722442|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722443|NCT00002352|Antiviral Agents|antiviral agents
1722444|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722445|NCT00002351|AIDS-Related Complex|aids-related complex
1722446|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
1722447|NCT00002351|Indinavir|indinavir
1722448|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
1722449|NCT00002350|AIDS Vaccines|aids vaccines
1722450|NCT00002350|DNA, Viral|dna, viral
1722451|NCT00002349|AIDS-Related Complex|aids-related complex
1722452|NCT00002349|Stavudine|stavudine
1722453|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1722454|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722455|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
1722456|NCT00002348|Mitoguazone|mitoguazone
1722457|NCT00002347|Zalcitabine|zalcitabine
1722458|NCT00002347|Drug Therapy, Combination|drug therapy, combination
1722459|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722460|NCT00002347|AIDS-Related Complex|aids-related complex
1722461|NCT00002347|Zidovudine|zidovudine
1722462|NCT00002347|Nevirapine|nevirapine
1722463|NCT00002347|Saquinavir|saquinavir
1722464|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722465|NCT00002346|AIDS-Related Complex|aids-related complex
1722466|NCT00002346|Antiviral Agents|antiviral agents
1722467|NCT00002346|Adenine|adenine
1722468|NCT00002345|Megestrol|megestrol
1722469|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722470|NCT00002345|Anorexia|anorexia
1722471|NCT00002345|Cachexia|cachexia
1722472|NCT00002345|Suspensions|suspensions
1722473|NCT00002344|Azithromycin|azithromycin
1722474|NCT00002344|Bacterial Infections|bacterial infections
1722475|NCT00002343|Rifabutin|rifabutin
1722476|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1722477|NCT00002343|Drug Therapy, Combination|drug therapy, combination
1722478|NCT00002343|Ethambutol|ethambutol
1722479|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722480|NCT00002342|Neoplasms|neoplasms
1722481|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
1722482|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722483|NCT00002342|Antineoplastic Agents|antineoplastic agents
1722484|NCT00002342|tecogalan|tecogalan
1722485|NCT00002341|Itraconazole|itraconazole
1722486|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722487|NCT00002341|AIDS-Related Complex|aids-related complex
1722488|NCT00002341|Candidiasis, Oral|candidiasis, oral
1722489|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722490|NCT00002340|Pentamidine|pentamidine
1722491|NCT00002340|Antifungal Agents|antifungal agents
1722492|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722493|NCT00002340|AIDS-Related Complex|aids-related complex
1722494|NCT00002340|atovaquone|atovaquone
1722495|NCT00002339|Esophagitis|esophagitis
1722496|NCT00002339|Fluconazole|fluconazole
1722497|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722498|NCT00002339|Candidiasis|candidiasis
1722499|NCT00002339|Immunocompromised Host|immunocompromised host
1722500|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722501|NCT00002338|AIDS-Related Complex|aids-related complex
1722502|NCT00002338|Antiviral Agents|antiviral agents
1722503|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722504|NCT00002337|Antiviral Agents|antiviral agents
1722506|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
1722507|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722508|NCT00002336|Clarithromycin|clarithromycin
1722509|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722510|NCT00002335|AIDS-Related Complex|aids-related complex
1722511|NCT00002335|Antiviral Agents|antiviral agents
1722512|NCT00002334|Drug Therapy, Combination|drug therapy, combination
1722513|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722514|NCT00002334|AIDS-Related Complex|aids-related complex
1722515|NCT00002334|Zidovudine|zidovudine
1722516|NCT00002334|Saquinavir|saquinavir
1722517|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
1722518|NCT00002333|Zalcitabine|zalcitabine
1722519|NCT00002333|Drug Therapy, Combination|drug therapy, combination
1722520|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722521|NCT00002333|AIDS-Related Complex|aids-related complex
1722522|NCT00002333|Saquinavir|saquinavir
1722523|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
1722524|NCT00002332|Thymopentin|thymopentin
1722525|NCT00002332|AIDS-Related Complex|aids-related complex
1722526|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
1722527|NCT00002331|Drug Therapy, Combination|drug therapy, combination
1722528|NCT00002331|Ethambutol|ethambutol
1722529|NCT00002331|Clofazimine|clofazimine
1722530|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722531|NCT00002331|Clarithromycin|clarithromycin
1722532|NCT00002330|Retinitis|retinitis
1722533|NCT00002330|Ganciclovir|ganciclovir
1722534|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
1722535|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722536|NCT00002329|MDL 28574|mdl 28574
1722537|NCT00002328|Antidiarrheals|antidiarrheals
1722538|NCT00002328|Cryptosporidiosis|cryptosporidiosis
1722539|NCT00002328|Diarrhea|diarrhea
1722540|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722541|NCT00002328|Azithromycin|azithromycin
1722542|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722543|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722544|NCT00002327|AIDS-Related Complex|aids-related complex
1722545|NCT00002327|Antiviral Agents|antiviral agents
1722546|NCT00002327|Condylomata Acuminata|condylomata acuminata
1722547|NCT00002327|cidofovir|cidofovir
1722548|NCT00002326|Drug Therapy, Combination|drug therapy, combination
1722549|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722550|NCT00002326|AIDS-Related Complex|aids-related complex
1722551|NCT00002326|Antiviral Agents|antiviral agents
1722556|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722557|NCT00002325|AIDS-Related Complex|aids-related complex
1722558|NCT00002325|Coccidioidomycosis|coccidioidomycosis
1722559|NCT00002324|Drug Therapy, Combination|drug therapy, combination
1722560|NCT00002324|AIDS-Related Complex|aids-related complex
1722561|NCT00002324|Zidovudine|zidovudine
1722562|NCT00002324|Nevirapine|nevirapine
1722563|NCT00002323|Drug Therapy, Combination|drug therapy, combination
1722564|NCT00002323|Zidovudine|zidovudine
1722565|NCT00002323|Nevirapine|nevirapine
1722566|NCT00002322|Drug Therapy, Combination|drug therapy, combination
1722567|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722568|NCT00002322|AIDS-Related Complex|aids-related complex
1722569|NCT00002322|Antiviral Agents|antiviral agents
1722570|NCT00002321|Retinitis|retinitis
1722571|NCT00002321|Interleukin-2|interleukin-2
1722572|NCT00002321|Ganciclovir|ganciclovir
1722573|NCT00002321|Drug Therapy, Combination|drug therapy, combination
1722574|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722575|NCT00002321|Antiviral Agents|antiviral agents
1722576|NCT00002320|Drug Therapy, Combination|drug therapy, combination
1722577|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722578|NCT00002320|AIDS-Related Complex|aids-related complex
1722579|NCT00002320|Antiviral Agents|antiviral agents
1722580|NCT00002320|Zidovudine|zidovudine
1722581|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
1722582|NCT00002319|Liposomes|liposomes
1722583|NCT00002319|Doxorubicin|doxorubicin
1722584|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722585|NCT00002319|Drug Carriers|drug carriers
1722586|NCT00002318|Vincristine|vincristine
1722587|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
1722588|NCT00002318|Liposomes|liposomes
1722589|NCT00002318|Doxorubicin|doxorubicin
1722590|NCT00002318|Drug Therapy, Combination|drug therapy, combination
1722591|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722592|NCT00002318|Bleomycin|bleomycin
1722593|NCT00002318|Drug Carriers|drug carriers
1722594|NCT00002317|Trimetrexate|trimetrexate
1722595|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722596|NCT00002317|Leucovorin|leucovorin
1722597|NCT00002317|Drug Therapy, Combination|drug therapy, combination
1725028|NCT00001016|Leucovorin|leucovorin
1722598|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722599|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722600|NCT00002316|Meningitis|meningitis
1722601|NCT00002316|Drug Therapy, Combination|drug therapy, combination
1722602|NCT00002316|Antifungal Agents|antifungal agents
1722603|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722604|NCT00002316|Amphotericin B|amphotericin b
1722605|NCT00002315|Herpes Zoster|herpes zoster
1722606|NCT00002315|Acyclovir|acyclovir
1722607|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722608|NCT00002315|AIDS-Related Complex|aids-related complex
1722609|NCT00002315|Antiviral Agents|antiviral agents
1722610|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
1722611|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722612|NCT00002314|Antineoplastic Agents|antineoplastic agents
1722613|NCT00002314|Gene Products, tat|gene products, tat
1722614|NCT00002313|Nystatin|nystatin
1722615|NCT00002313|Didanosine|didanosine
1722616|NCT00002313|Drug Therapy, Combination|drug therapy, combination
1722617|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722618|NCT00002313|AIDS-Related Complex|aids-related complex
1722619|NCT00002312|Drug Interactions|drug interactions
1722620|NCT00002312|Antiviral Agents|antiviral agents
1722621|NCT00002312|Zidovudine|zidovudine
1722622|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722623|NCT00002311|AIDS-Related Complex|aids-related complex
1722624|NCT00002311|Wobenzym|wobenzym
1722625|NCT00002311|Hydrolases|hydrolases
1722626|NCT00002310|Herpes Simplex|herpes simplex
1722627|NCT00002310|HIV-1|hiv-1
1722628|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722629|NCT00002310|Antiviral Agents|antiviral agents
1722630|NCT00002310|Administration, Topical|administration, topical
1722631|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1722632|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722633|NCT00002309|AIDS-Related Complex|aids-related complex
1722634|NCT00002309|Azithromycin|azithromycin
1722635|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722636|NCT00002308|AIDS-Related Complex|aids-related complex
1722637|NCT00002308|Stavudine|stavudine
1722638|NCT00002307|Zidovudine|zidovudine
1722639|NCT00002307|Stavudine|stavudine
1722640|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722641|NCT00002306|Meningitis|meningitis
1722642|NCT00002306|Cryptococcosis|cryptococcosis
1722643|NCT00002306|Fluconazole|fluconazole
1722644|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722645|NCT00002306|Amphotericin B|amphotericin b
1722646|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722648|NCT00002305|Cryptococcosis|cryptococcosis
1722649|NCT00002305|Drug Therapy, Combination|drug therapy, combination
1722650|NCT00002305|Fluconazole|fluconazole
1722651|NCT00002305|Flucytosine|flucytosine
1722888|NCT00002258|AIDS-Related Complex|aids-related complex
1722652|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722653|NCT00002305|Amphotericin B|amphotericin b
1722654|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722655|NCT00002304|Immune Tolerance|immune tolerance
1722656|NCT00002304|Ketoconazole|ketoconazole
1722657|NCT00002304|Esophagitis|esophagitis
1722658|NCT00002304|Fluconazole|fluconazole
1722659|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722660|NCT00002304|Candidiasis, Oral|candidiasis, oral
1722661|NCT00002303|Recombinant Proteins|recombinant proteins
1722662|NCT00002303|Erythropoietin|erythropoietin
1722663|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722664|NCT00002303|Anemia|anemia
1722665|NCT00002303|AIDS-Related Complex|aids-related complex
1722666|NCT00002303|Zidovudine|zidovudine
1722667|NCT00002302|Recombinant Proteins|recombinant proteins
1722668|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
1722669|NCT00002302|Erythropoietin|erythropoietin
1722670|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722671|NCT00002302|Anemia|anemia
1722672|NCT00002302|Zidovudine|zidovudine
1722673|NCT00002301|Retinitis|retinitis
1722674|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722675|NCT00002301|Ganciclovir|ganciclovir
1722676|NCT00002301|Foscarnet|foscarnet
1722677|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
1722678|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722679|NCT00002301|Antiviral Agents|antiviral agents
1722680|NCT00002300|T-Lymphocytes|t-lymphocytes
1722681|NCT00002300|Megestrol|megestrol
1722682|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
1722683|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722684|NCT00002300|Anorexia|anorexia
1722685|NCT00002300|Cachexia|cachexia
1722686|NCT00002299|Retinitis|retinitis
1722687|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722688|NCT00002299|Ganciclovir|ganciclovir
1722689|NCT00002299|Drug Therapy, Combination|drug therapy, combination
1722690|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
1722691|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722692|NCT00002299|Interferon Type I|interferon type i
1722693|NCT00002298|Ribavirin|ribavirin
1722694|NCT00002298|AIDS-Related Complex|aids-related complex
1722695|NCT00002297|Inosine Pranobex|inosine pranobex
1722696|NCT00002297|AIDS-Related Complex|aids-related complex
1722697|NCT00002296|T-Lymphocytes|t-lymphocytes
1722698|NCT00002296|Immune Tolerance|immune tolerance
1722699|NCT00002296|Inosine Pranobex|inosine pranobex
1722700|NCT00002296|Killer Cells|killer cells
1722701|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1722702|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722703|NCT00002296|AIDS-Related Complex|aids-related complex
1722704|NCT00002295|Infusions, Intravenous|infusions, intravenous
1722705|NCT00002295|Drug Evaluation|drug evaluation
1722706|NCT00002295|Administration, Oral|administration, oral
1722707|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722708|NCT00002295|AIDS-Related Complex|aids-related complex
1722709|NCT00002295|Zidovudine|zidovudine
1722710|NCT00002295|Biological Availability|biological availability
1722711|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722712|NCT00002294|Meningitis|meningitis
1722713|NCT00002294|Cryptococcosis|cryptococcosis
1722714|NCT00002294|Fluconazole|fluconazole
1722715|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722716|NCT00002293|Nystatin|nystatin
1722717|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722718|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722719|NCT00002293|AIDS-Related Complex|aids-related complex
1722720|NCT00002293|Candidiasis, Oral|candidiasis, oral
1722721|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722722|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722723|NCT00002292|Pentamidine|pentamidine
1722724|NCT00002292|Injections, Intravenous|injections, intravenous
1722725|NCT00002292|Administration, Inhalation|administration, inhalation
1722726|NCT00002292|Aerosols|aerosols
1722727|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722728|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722729|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722730|NCT00002291|Pentamidine|pentamidine
1722731|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
1722732|NCT00002291|Aerosols|aerosols
1722733|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722734|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722735|NCT00002290|Drug Therapy, Combination|drug therapy, combination
1722736|NCT00002290|Acyclovir|acyclovir
1722737|NCT00002290|AIDS-Related Complex|aids-related complex
1722738|NCT00002290|Zidovudine|zidovudine
1722739|NCT00002289|Semen|semen
1722740|NCT00002289|Thymopentin|thymopentin
1722741|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
1722742|NCT00002289|HIV Seropositivity|hiv seropositivity
1722743|NCT00002289|AIDS-Related Complex|aids-related complex
1722744|NCT00002288|Neuropsychological Tests|neuropsychological tests
1722745|NCT00002288|AIDS-Related Complex|aids-related complex
1722746|NCT00002288|Zidovudine|zidovudine
1722747|NCT00002287|Health Manpower|health manpower
1722748|NCT00002287|Accidents, Occupational|accidents, occupational
1722749|NCT00002287|Zidovudine|zidovudine
1722750|NCT00002286|Pilot Projects|pilot projects
1722751|NCT00002286|Psoriasis|psoriasis
1722752|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722753|NCT00002286|Zidovudine|zidovudine
1722754|NCT00002285|Virus Replication|virus replication
1722755|NCT00002285|Pilot Projects|pilot projects
1722756|NCT00002285|Immune Tolerance|immune tolerance
1722757|NCT00002285|Lymphocytes|lymphocytes
1722758|NCT00002285|Drug Evaluation|drug evaluation
1722759|NCT00002285|Combined Modality Therapy|combined modality therapy
1722760|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722761|NCT00002285|Transplantation, Homologous|transplantation, homologous
1722762|NCT00002285|Zidovudine|zidovudine
1722763|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
1722764|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722765|NCT00002284|AIDS-Related Complex|aids-related complex
1722766|NCT00002284|Zidovudine|zidovudine
1722767|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
1722768|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1722889|NCT00002258|Thrombocytopenia|thrombocytopenia
1722769|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722770|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722771|NCT00002283|Dapsone|dapsone
1722772|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722773|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722774|NCT00002282|Fluconazole|fluconazole
1722775|NCT00002282|Clotrimazole|clotrimazole
1722776|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722777|NCT00002282|Candidiasis, Oral|candidiasis, oral
1722778|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
1722779|NCT00002281|Erythropoietin|erythropoietin
1722780|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722781|NCT00002281|AIDS-Related Complex|aids-related complex
1722782|NCT00002281|Zidovudine|zidovudine
1722783|NCT00002280|Didanosine|didanosine
1722784|NCT00002280|Drugs, Investigational|drugs, investigational
1722785|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722786|NCT00002280|Zidovudine|zidovudine
1722787|NCT00002279|Zalcitabine|zalcitabine
1722788|NCT00002279|Didanosine|didanosine
1722789|NCT00002279|Drugs, Investigational|drugs, investigational
1722790|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722791|NCT00002279|AIDS-Related Complex|aids-related complex
1722792|NCT00002279|Zidovudine|zidovudine
1722793|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722794|NCT00002278|Cryptosporidiosis|cryptosporidiosis
1722795|NCT00002278|Diarrhea|diarrhea
1722796|NCT00002278|diclazuril|diclazuril
1722797|NCT00002278|Coccidiostats|coccidiostats
1722798|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722799|NCT00002277|Mycoses|mycoses
1722800|NCT00002277|Neoplasms|neoplasms
1722801|NCT00002277|Neutropenia|neutropenia
1722802|NCT00002277|Fluconazole|fluconazole
1722803|NCT00002277|Amphotericin B|amphotericin b
1722804|NCT00002276|Blood Platelets|blood platelets
1722805|NCT00002276|Ibuprofen|ibuprofen
1722806|NCT00002276|Drug Interactions|drug interactions
1722807|NCT00002276|Zidovudine|zidovudine
1722808|NCT00002276|Hemophilia A|hemophilia a
1722809|NCT00002275|Weight Loss|weight loss
1722810|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1722811|NCT00002275|Parenteral Nutrition|parenteral nutrition
1722812|NCT00002275|Liposyn|liposyn
1722813|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722814|NCT00002274|Didanosine|didanosine
1722815|NCT00002274|Drugs, Investigational|drugs, investigational
1722816|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722817|NCT00002274|Zidovudine|zidovudine
1722818|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722819|NCT00002273|Ganciclovir|ganciclovir
1722820|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
1722821|NCT00002273|Colitis|colitis
1722822|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722823|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722824|NCT00002272|Immune Tolerance|immune tolerance
1722825|NCT00002272|Injections, Intravenous|injections, intravenous
1722826|NCT00002272|Herpes Simplex|herpes simplex
1722827|NCT00002272|Immunity, Cellular|immunity, cellular
1722828|NCT00002272|Drug Resistance|drug resistance
1722829|NCT00002272|Foscarnet|foscarnet
1722831|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722832|NCT00002272|Antiviral Agents|antiviral agents
1722833|NCT00002271|Thymidine|thymidine
1722834|NCT00002271|Nucleosides|nucleosides
1722835|NCT00002271|Antiviral Agents|antiviral agents
1722836|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
1722837|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
1722838|NCT00002270|Drug Evaluation|drug evaluation
1722839|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722840|NCT00002270|Zidovudine|zidovudine
1722841|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722842|NCT00002269|ampligen|ampligen
1722843|NCT00002269|AIDS-Related Complex|aids-related complex
1722844|NCT00002269|Zidovudine|zidovudine
1722845|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722846|NCT00002268|Immunotherapy|immunotherapy
1722847|NCT00002268|Drug Evaluation|drug evaluation
1722848|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
1722849|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
1722850|NCT00002267|Rifabutin|rifabutin
1722851|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722852|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1722853|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722854|NCT00002267|Antitubercular Agents|antitubercular agents
1722855|NCT00002266|Drug Therapy, Combination|drug therapy, combination
1722856|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722857|NCT00002266|AIDS-Related Complex|aids-related complex
1722858|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
1722859|NCT00002265|Zalcitabine|zalcitabine
1722860|NCT00002265|Drug Evaluation|drug evaluation
1722861|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722862|NCT00002265|AIDS-Related Complex|aids-related complex
1722863|NCT00002265|Zidovudine|zidovudine
1722864|NCT00002263|Pilot Projects|pilot projects
1722865|NCT00002263|Neutropenia|neutropenia
1722866|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1722867|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722868|NCT00002263|Zidovudine|zidovudine
1722869|NCT00002262|Skin Neoplasms|skin neoplasms
1722870|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
1722871|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722872|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
1722873|NCT00002261|Vaccinia Virus|vaccinia virus
1722874|NCT00002261|Viral Vaccines|viral vaccines
1722875|NCT00002261|Smallpox Vaccine|smallpox vaccine
1722876|NCT00002261|HIV-1|hiv-1
1722877|NCT00002261|AIDS Vaccines|aids vaccines
1722878|NCT00002261|HIV Seronegativity|hiv seronegativity
1722879|NCT00002260|Biological Availability|biological availability
1722880|NCT00002260|alovudine|alovudine
1722881|NCT00002260|Food|food
1722882|NCT00002259|Mitoxantrone|mitoxantrone
1722883|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722884|NCT00002258|Interleukin-3|interleukin-3
1722885|NCT00002258|Recombinant Proteins|recombinant proteins
1722886|NCT00002258|Leukopenia|leukopenia
1722887|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722890|NCT00002257|Retinitis|retinitis
1722891|NCT00002257|Ganciclovir|ganciclovir
1722892|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
1722893|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722894|NCT00002256|Zalcitabine|zalcitabine
1722895|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722896|NCT00002256|AIDS-Related Complex|aids-related complex
1722897|NCT00002256|Zidovudine|zidovudine
1722898|NCT00002255|Erythropoietin|erythropoietin
1722899|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1722900|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722901|NCT00002255|AIDS-Related Complex|aids-related complex
1722902|NCT00002255|Zidovudine|zidovudine
1722903|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722904|NCT00002253|Octreotide|octreotide
1722905|NCT00002253|Diarrhea|diarrhea
1722906|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722907|NCT00002253|AIDS-Related Complex|aids-related complex
1722908|NCT00002252|Octreotide|octreotide
1722909|NCT00002252|Diarrhea|diarrhea
1722910|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722911|NCT00002252|AIDS-Related Complex|aids-related complex
1722912|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1722913|NCT00002251|Ganciclovir|ganciclovir
1722914|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
1722915|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722916|NCT00002251|Biological Availability|biological availability
1722917|NCT00002250|Recombinant Proteins|recombinant proteins
1722918|NCT00002250|IgG|igg
1722919|NCT00002250|Drug Evaluation|drug evaluation
1722920|NCT00002250|Antigens, CD4|antigens, cd4
1722921|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
1722922|NCT00002249|Ofloxacin|ofloxacin
1722923|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722924|NCT00002248|Antidiarrheals|antidiarrheals
1722925|NCT00002248|Cryptosporidiosis|cryptosporidiosis
1722926|NCT00002248|Diarrhea|diarrhea
1722927|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722928|NCT00002248|Cryptosporidium|cryptosporidium
1722929|NCT00002248|Immunization, Passive|immunization, passive
1722930|NCT00002247|Retinitis|retinitis
1722931|NCT00002247|Ganciclovir|ganciclovir
1722932|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
1722933|NCT00002247|Administration, Oral|administration, oral
1722934|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722935|NCT00002246|AIDS Dementia Complex|aids dementia complex
1722936|NCT00002246|Zidovudine|zidovudine
1722937|NCT00002246|Stavudine|stavudine
1722938|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722939|NCT00002245|Drug Therapy, Combination|drug therapy, combination
1722940|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
1722941|NCT00002245|Lamivudine|lamivudine
1722942|NCT00002245|Carbohydrates|carbohydrates
1722943|NCT00002245|VX 478|vx 478
1722944|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722945|NCT00002245|Anti-HIV Agents|anti-hiv agents
1722946|NCT00002245|Lipids|lipids
1722947|NCT00002245|Insulin Resistance|insulin resistance
1722948|NCT00002245|abacavir|abacavir
1722949|NCT00002244|Placebos|placebos
1722950|NCT00002244|Infusions, Intravenous|infusions, intravenous
1722951|NCT00002244|Quality of Life|quality of life
1722952|NCT00002244|Anti-HIV Agents|anti-hiv agents
1722953|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
1722954|NCT00002243|Anti-HIV Agents|anti-hiv agents
1722955|NCT00002241|Drug Therapy, Combination|drug therapy, combination
1722956|NCT00002241|Stavudine|stavudine
1722957|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
1722958|NCT00002241|Ritonavir|ritonavir
1722959|NCT00002241|Lamivudine|lamivudine
1722960|NCT00002241|Indinavir|indinavir
1722961|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722962|NCT00002241|Anti-HIV Agents|anti-hiv agents
1722963|NCT00002241|Viral Load|viral load
1722964|NCT00002240|Didanosine|didanosine
1722965|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
1722966|NCT00002240|Drug Therapy, Combination|drug therapy, combination
1722967|NCT00002240|Stavudine|stavudine
1722968|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
1722969|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722970|NCT00002240|Anti-HIV Agents|anti-hiv agents
1722971|NCT00002240|Nelfinavir|nelfinavir
1722972|NCT00002239|HIV-1|hiv-1
1722973|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
1722974|NCT00002239|Drug Therapy, Combination|drug therapy, combination
1722975|NCT00002239|VX 478|vx 478
1722976|NCT00002239|Anti-HIV Agents|anti-hiv agents
1722977|NCT00002239|pentafuside|pentafuside
1722978|NCT00002239|abacavir|abacavir
1722979|NCT00002239|efavirenz|efavirenz
1722980|NCT00002238|Drug Therapy, Combination|drug therapy, combination
1722981|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1722982|NCT00002238|AIDS-Related Complex|aids-related complex
1722983|NCT00002238|Zidovudine|zidovudine
1722984|NCT00002238|Interferon Type I|interferon type i
1722985|NCT00002237|Placebos|placebos
1722986|NCT00002237|Administration, Oral|administration, oral
1722987|NCT00002237|Anti-HIV Agents|anti-hiv agents
1722988|NCT00002237|Viral Load|viral load
1722989|NCT00002237|peldesine|peldesine
1722990|NCT00002236|Drug Therapy, Combination|drug therapy, combination
1722991|NCT00002236|Zidovudine|zidovudine
1722992|NCT00002236|Drug Administration Schedule|drug administration schedule
1722993|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
1722994|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
1722995|NCT00002236|Indinavir|indinavir
1722996|NCT00002236|Delavirdine|delavirdine
1722997|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1722998|NCT00002236|Anti-HIV Agents|anti-hiv agents
1722999|NCT00002236|Viral Load|viral load
1723000|NCT00002235|Drug Therapy, Combination|drug therapy, combination
1723001|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
1723002|NCT00002235|Indinavir|indinavir
1723003|NCT00002235|Nelfinavir|nelfinavir
1723004|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723005|NCT00002235|Anti-HIV Agents|anti-hiv agents
1723006|NCT00002235|efavirenz|efavirenz
1723007|NCT00002234|Drug Therapy, Combination|drug therapy, combination
1723008|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723009|NCT00002234|Anti-HIV Agents|anti-hiv agents
1723010|NCT00002233|Drug Therapy, Combination|drug therapy, combination
1723011|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
1723012|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
1723013|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723014|NCT00002233|Anti-HIV Agents|anti-hiv agents
1723015|NCT00002233|Viral Load|viral load
1723016|NCT00002232|Injections, Intradermal|injections, intradermal
1723017|NCT00002232|Injections, Intramuscular|injections, intramuscular
1723018|NCT00002232|HIV Antibodies|hiv antibodies
1723019|NCT00002232|Immunity, Cellular|immunity, cellular
1723020|NCT00002232|AIDS Vaccines|aids vaccines
1723021|NCT00002232|HIV Seronegativity|hiv seronegativity
1723022|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1723023|NCT00002232|Vaccines, DNA|vaccines, dna
1723024|NCT00002232|Immunity, Mucosal|immunity, mucosal
1723025|NCT00002231|Injections, Intramuscular|injections, intramuscular
1723026|NCT00002231|HIV Antibodies|hiv antibodies
1723027|NCT00002231|Immunity, Cellular|immunity, cellular
1723028|NCT00002231|AIDS Vaccines|aids vaccines
1723029|NCT00002231|HIV Seronegativity|hiv seronegativity
1723030|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1723031|NCT00002231|Vaccines, DNA|vaccines, dna
1723032|NCT00002230|Didanosine|didanosine
1723033|NCT00002230|Drug Therapy, Combination|drug therapy, combination
1723034|NCT00002230|Stavudine|stavudine
1723035|NCT00002230|Hydroxyurea|hydroxyurea
1723036|NCT00002230|Anti-HIV Agents|anti-hiv agents
1723037|NCT00002229|Drug Therapy, Combination|drug therapy, combination
1723038|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
1723039|NCT00002229|Dosage Forms|dosage forms
1723040|NCT00002229|Saquinavir|saquinavir
1723041|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723042|NCT00002229|Anti-HIV Agents|anti-hiv agents
1723043|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
1723044|NCT00002228|HIV-1|hiv-1
1723045|NCT00002228|Anti-HIV Agents|anti-hiv agents
1723046|NCT00002228|peptide T20|peptide t20
1723047|NCT00002227|Drug Therapy, Combination|drug therapy, combination
1723048|NCT00002227|Stavudine|stavudine
1723049|NCT00002227|Lamivudine|lamivudine
1723050|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723051|NCT00002227|efavirenz|efavirenz
1723052|NCT00002226|Skin Neoplasms|skin neoplasms
1723053|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
1723054|NCT00002226|Antineoplastic Agents|antineoplastic agents
1723055|NCT00002225|Didanosine|didanosine
1723056|NCT00002225|Drug Therapy, Combination|drug therapy, combination
1723057|NCT00002225|Stavudine|stavudine
1723058|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723059|NCT00002225|efavirenz|efavirenz
1723060|NCT00002224|Didanosine|didanosine
1723061|NCT00002224|Drug Therapy, Combination|drug therapy, combination
1723062|NCT00002224|Drug Administration Schedule|drug administration schedule
1723063|NCT00002224|Stavudine|stavudine
1723064|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
1723065|NCT00002224|Nelfinavir|nelfinavir
1723066|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723067|NCT00002224|Anti-HIV Agents|anti-hiv agents
1723068|NCT00002224|Viral Load|viral load
1723069|NCT00002223|Drug Therapy, Combination|drug therapy, combination
1723070|NCT00002223|Adolescent Behavior|adolescent behavior
1723071|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
1723072|NCT00002223|Ritonavir|ritonavir
1723073|NCT00002223|Indinavir|indinavir
1723074|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723075|NCT00002222|Ganciclovir|ganciclovir
1723076|NCT00002222|Antiviral Agents|antiviral agents
1723077|NCT00002222|Drug Administration Schedule|drug administration schedule
1723078|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1723079|NCT00002222|Prodrugs|prodrugs
1723080|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
1723081|NCT00002221|Bone Marrow|bone marrow
1723082|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
1723083|NCT00002221|HIV-1|hiv-1
1723084|NCT00002221|Retroviridae|retroviridae
1723085|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
1723086|NCT00002221|Genetic Vectors|genetic vectors
1723087|NCT00002221|Transduction, Genetic|transduction, genetic
1723088|NCT00002221|Gene Transfer Techniques|gene transfer techniques
1723089|NCT00002220|Drug Resistance|drug resistance
1723090|NCT00002220|Drug Therapy, Combination|drug therapy, combination
1723091|NCT00002220|Antiviral Agents|antiviral agents
1723092|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
1723093|NCT00002220|Indinavir|indinavir
1723094|NCT00002220|RNA, Viral|rna, viral
1723095|NCT00002220|Adenine|adenine
1723096|NCT00002220|efavirenz|efavirenz
1723097|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
1723098|NCT00002219|Antiviral Agents|antiviral agents
1723099|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
1723100|NCT00002219|Disease Progression|disease progression
1723101|NCT00002219|RNA, Viral|rna, viral
1723102|NCT00002219|Adenine|adenine
1723103|NCT00002219|Viral Load|viral load
1723104|NCT00002219|Age Factors|age factors
1723105|NCT00002219|Nelfinavir|nelfinavir
1723106|NCT00002218|HIV-1|hiv-1
1723107|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
1723108|NCT00002218|Anti-HIV Agents|anti-hiv agents
1723109|NCT00002217|Drug Therapy, Combination|drug therapy, combination
1723110|NCT00002217|Patient Compliance|patient compliance
1723111|NCT00002217|Anti-HIV Agents|anti-hiv agents
1723112|NCT00002217|abacavir|abacavir
1723113|NCT00002216|Drug Therapy, Combination|drug therapy, combination
1723114|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
1723115|NCT00002216|VX 478|vx 478
1725543|NCT00000941|Nelfinavir|nelfinavir
1723116|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723117|NCT00002216|Anti-HIV Agents|anti-hiv agents
1723118|NCT00002216|abacavir|abacavir
1723119|NCT00002215|Drug Therapy, Combination|drug therapy, combination
1723120|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
1723121|NCT00002215|RNA, Viral|rna, viral
1723122|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723123|NCT00002215|Viral Load|viral load
1723124|NCT00002215|Nelfinavir|nelfinavir
1723125|NCT00002215|Uracil|uracil
1723126|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
1723127|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723128|NCT00002213|HIV-1|hiv-1
1723129|NCT00002213|Drug Therapy, Combination|drug therapy, combination
1723130|NCT00002213|Antiviral Agents|antiviral agents
1723131|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
1723132|NCT00002213|RNA, Viral|rna, viral
1723133|NCT00002213|VX 478|vx 478
1723134|NCT00002213|Anti-HIV Agents|anti-hiv agents
1723135|NCT00002213|abacavir|abacavir
1723136|NCT00002213|efavirenz|efavirenz
1723137|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
1723138|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723139|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
1723140|NCT00002211|HIV-1|hiv-1
1723141|NCT00002211|Didanosine|didanosine
1723142|NCT00002211|Stavudine|stavudine
1723143|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
1723144|NCT00002211|RNA, Viral|rna, viral
1723145|NCT00002211|Delavirdine|delavirdine
1723146|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723147|NCT00002211|Viral Load|viral load
1723148|NCT00002211|Nelfinavir|nelfinavir
1723149|NCT00002210|HIV-1|hiv-1
1723150|NCT00002210|Drug Therapy, Combination|drug therapy, combination
1723151|NCT00002210|Delavirdine|delavirdine
1723152|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723153|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
1723154|NCT00002209|Drug Therapy, Combination|drug therapy, combination
1723155|NCT00002209|AIDS Dementia Complex|aids dementia complex
1723156|NCT00002209|Zidovudine|zidovudine
1723157|NCT00002209|Lamivudine|lamivudine
1723158|NCT00002209|Indinavir|indinavir
1723159|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723161|NCT00002208|Drug Therapy, Combination|drug therapy, combination
1723162|NCT00002208|Zidovudine|zidovudine
1723163|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
1723164|NCT00002208|Lamivudine|lamivudine
1723165|NCT00002208|Indinavir|indinavir
1723166|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723167|NCT00002207|Didanosine|didanosine
1723168|NCT00002207|Drug Therapy, Combination|drug therapy, combination
1723169|NCT00002207|Stavudine|stavudine
1723170|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723171|NCT00002206|HIV-1|hiv-1
1723172|NCT00002206|Adenine|adenine
1723173|NCT00002206|Anti-HIV Agents|anti-hiv agents
1723174|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
1723175|NCT00002205|VX 478|vx 478
1723176|NCT00002205|Anti-HIV Agents|anti-hiv agents
1723177|NCT00002205|abacavir|abacavir
1723178|NCT00002204|Reference Values|reference values
1723179|NCT00002204|Placebos|placebos
1723180|NCT00002204|AIDS Vaccines|aids vaccines
1723181|NCT00002204|HIV Core Protein p24|hiv core protein p24
1723182|NCT00002204|HIV Seronegativity|hiv seronegativity
1723183|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
1723184|NCT00002203|Drug Therapy, Combination|drug therapy, combination
1723185|NCT00002203|Zidovudine|zidovudine
1723186|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
1723187|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
1723188|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
1723189|NCT00002203|Lamivudine|lamivudine
1723190|NCT00002203|Patient Compliance|patient compliance
1723191|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723192|NCT00002203|Anti-HIV Agents|anti-hiv agents
1723193|NCT00002203|Viral Load|viral load
1723194|NCT00002202|HIV-1|hiv-1
1723195|NCT00002202|Drug Therapy, Combination|drug therapy, combination
1723196|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
1723197|NCT00002202|Indinavir|indinavir
1723198|NCT00002202|RNA, Viral|rna, viral
1723199|NCT00002202|VX 478|vx 478
1723200|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723201|NCT00002202|Anti-HIV Agents|anti-hiv agents
1723202|NCT00002202|Viral Load|viral load
1723203|NCT00002201|Drug Therapy, Combination|drug therapy, combination
1723204|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
1723205|NCT00002201|Ritonavir|ritonavir
1723206|NCT00002201|Nelfinavir|nelfinavir
1723207|NCT00002201|Anti-HIV Agents|anti-hiv agents
1723208|NCT00002200|HIV-1|hiv-1
1723209|NCT00002200|Administration, Oral|administration, oral
1723210|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
1723211|NCT00002200|RNA, Viral|rna, viral
1723212|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723213|NCT00002200|Anti-HIV Agents|anti-hiv agents
1723214|NCT00002200|Viral Load|viral load
1723215|NCT00002200|abacavir|abacavir
1723216|NCT00002199|HIV-1|hiv-1
1723217|NCT00002199|Drug Therapy, Combination|drug therapy, combination
1723218|NCT00002199|Zidovudine|zidovudine
1723219|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
1723220|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
1723221|NCT00002199|Lamivudine|lamivudine
1723222|NCT00002199|Indinavir|indinavir
1723223|NCT00002199|Genotype|genotype
1723224|NCT00002199|Phenotype|phenotype
1723225|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723226|NCT00002199|Anti-HIV Agents|anti-hiv agents
1723227|NCT00002199|abacavir|abacavir
1723228|NCT00002198|Drug Interactions|drug interactions
1723229|NCT00002198|Antiviral Agents|antiviral agents
1723230|NCT00002198|Ethanol|ethanol
1723231|NCT00002198|abacavir|abacavir
1723232|NCT00002197|HIV-1|hiv-1
1723233|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
1723234|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723235|NCT00002197|Anti-HIV Agents|anti-hiv agents
1723236|NCT00002197|Viral Load|viral load
1723237|NCT00002197|abacavir|abacavir
1723238|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
1723239|NCT00002196|Administration, Oral|administration, oral
1723240|NCT00002196|Drug Administration Schedule|drug administration schedule
1723241|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
1723242|NCT00002196|Anti-HIV Agents|anti-hiv agents
1723243|NCT00002195|Drug Therapy, Combination|drug therapy, combination
1723244|NCT00002195|Zidovudine|zidovudine
1723245|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
1723246|NCT00002195|Lamivudine|lamivudine
1723247|NCT00002195|VX 478|vx 478
1723248|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723249|NCT00002195|Anti-HIV Agents|anti-hiv agents
1723250|NCT00002195|Viral Load|viral load
1723251|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
1723252|NCT00002194|Clarithromycin|clarithromycin
1723253|NCT00002194|Nevirapine|nevirapine
1723254|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723255|NCT00002194|Cytochrome P-450|cytochrome p-450
1723256|NCT00002194|Anti-HIV Agents|anti-hiv agents
1723257|NCT00002193|HIV-1|hiv-1
1723258|NCT00002193|Drug Therapy, Combination|drug therapy, combination
1723259|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
1723260|NCT00002193|RNA, Viral|rna, viral
1723262|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723263|NCT00002193|Anti-HIV Agents|anti-hiv agents
1723264|NCT00002193|Viral Load|viral load
1723265|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723266|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723267|NCT00002192|Drug Therapy, Combination|drug therapy, combination
1723268|NCT00002192|Antitubercular Agents|antitubercular agents
1723269|NCT00002192|Azithromycin|azithromycin
1723270|NCT00002192|Clarithromycin|clarithromycin
1723271|NCT00002192|Bacteremia|bacteremia
1723272|NCT00002192|rifapentine|rifapentine
1723273|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723274|NCT00002191|Placebos|placebos
1723275|NCT00002191|Protozoan Infections|protozoan infections
1723276|NCT00002191|Intestinal Diseases|intestinal diseases
1723277|NCT00002191|Albendazole|albendazole
1723278|NCT00002191|Microsporida|microsporida
1723279|NCT00002191|Anthelmintics|anthelmintics
1723280|NCT00002190|Drug Therapy, Combination|drug therapy, combination
1723281|NCT00002190|Zidovudine|zidovudine
1723282|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
1723283|NCT00002190|Lamivudine|lamivudine
1723284|NCT00002190|Saquinavir|saquinavir
1723285|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723286|NCT00002190|Anti-HIV Agents|anti-hiv agents
1723287|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
1723288|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723289|NCT00002189|Paclitaxel|paclitaxel
1723290|NCT00002189|Treatment Outcome|treatment outcome
1723291|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
1723292|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723293|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
1723294|NCT00002188|Antineoplastic Agents|antineoplastic agents
1723295|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723296|NCT00002187|Antiviral Agents|antiviral agents
1723297|NCT00002187|Drug Administration Schedule|drug administration schedule
1723298|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1723299|NCT00002187|fomivirsen|fomivirsen
1723300|NCT00002187|Vitreous Body|vitreous body
1723301|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723302|NCT00002186|Herpes Simplex|herpes simplex
1723303|NCT00002186|Drug Therapy, Combination|drug therapy, combination
1723304|NCT00002186|Acyclovir|acyclovir
1723305|NCT00002186|Antiviral Agents|antiviral agents
1723306|NCT00002186|Gels|gels
1723307|NCT00002186|SP 303|sp 303
1723308|NCT00002185|Skin Neoplasms|skin neoplasms
1723309|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723310|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
1723311|NCT00002185|Drug Therapy, Combination|drug therapy, combination
1723312|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
1723313|NCT00002185|Mucous Membrane|mucous membrane
1723314|NCT00002185|Nelfinavir|nelfinavir
1723315|NCT00002185|Anti-HIV Agents|anti-hiv agents
1723316|NCT00002184|HIV-1|hiv-1
1723317|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
1723318|NCT00002184|Drug Therapy, Combination|drug therapy, combination
1723319|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723320|NCT00002184|Zidovudine|zidovudine
1723321|NCT00002184|Stavudine|stavudine
1723322|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
1723323|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
1723324|NCT00002184|Lamivudine|lamivudine
1723325|NCT00002184|RNA, Viral|rna, viral
1723326|NCT00002184|Saquinavir|saquinavir
1723327|NCT00002184|Nelfinavir|nelfinavir
1723328|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723329|NCT00002184|Adenine|adenine
1723330|NCT00002184|Anti-HIV Agents|anti-hiv agents
1723331|NCT00002184|Viral Load|viral load
1723332|NCT00002183|Drug Therapy, Combination|drug therapy, combination
1723333|NCT00002183|Drug Administration Schedule|drug administration schedule
1723334|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
1723335|NCT00002183|VX 478|vx 478
1723336|NCT00002183|Anti-HIV Agents|anti-hiv agents
1723337|NCT00002182|Placebos|placebos
1723338|NCT00002182|Appetite Stimulants|appetite stimulants
1723339|NCT00002182|Megestrol Acetate|megestrol acetate
1723340|NCT00002182|Failure to Thrive|failure to thrive
1723341|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723342|NCT00002181|Herpes Simplex|herpes simplex
1723343|NCT00002181|Acyclovir|acyclovir
1723344|NCT00002181|Antiviral Agents|antiviral agents
1723345|NCT00002181|Gels|gels
1723346|NCT00002181|cidofovir|cidofovir
1723347|NCT00002180|Placebos|placebos
1723348|NCT00002180|Anti-HIV Agents|anti-hiv agents
1723349|NCT00002180|Adenine|adenine
1723350|NCT00002179|Semen|semen
1723351|NCT00002179|Monocytes|monocytes
1723352|NCT00002179|HIV-1|hiv-1
1723353|NCT00002179|Drug Therapy, Combination|drug therapy, combination
1723354|NCT00002179|Zidovudine|zidovudine
1723355|NCT00002179|Lymph Nodes|lymph nodes
1723356|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
1723357|NCT00002179|Lamivudine|lamivudine
1723358|NCT00002179|Indinavir|indinavir
1723360|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723361|NCT00002179|Anti-HIV Agents|anti-hiv agents
1723362|NCT00002179|Viral Load|viral load
1723363|NCT00002178|HIV-1|hiv-1
1723364|NCT00002178|Drug Therapy, Combination|drug therapy, combination
1723365|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
1723366|NCT00002178|RNA, Viral|rna, viral
1723367|NCT00002178|Dosage Forms|dosage forms
1723368|NCT00002178|Saquinavir|saquinavir
1723369|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723370|NCT00002178|Anti-HIV Agents|anti-hiv agents
1723371|NCT00002178|Viral Load|viral load
1723372|NCT00002177|Pilot Projects|pilot projects
1723373|NCT00002177|HIV-1|hiv-1
1723374|NCT00002177|Didanosine|didanosine
1723375|NCT00002177|Drug Therapy, Combination|drug therapy, combination
1723376|NCT00002177|Stavudine|stavudine
1723377|NCT00002177|Hydroxyurea|hydroxyurea
1723378|NCT00002177|RNA, Viral|rna, viral
1723379|NCT00002177|Nelfinavir|nelfinavir
1723380|NCT00002177|Anti-HIV Agents|anti-hiv agents
1723381|NCT00002177|Viral Load|viral load
1723382|NCT00002176|Pilot Projects|pilot projects
1723383|NCT00002176|Didanosine|didanosine
1723384|NCT00002176|Drug Therapy, Combination|drug therapy, combination
1723385|NCT00002176|Stavudine|stavudine
1723386|NCT00002176|Hydroxyurea|hydroxyurea
1723387|NCT00002176|Nelfinavir|nelfinavir
1723388|NCT00002176|Anti-HIV Agents|anti-hiv agents
1723389|NCT00002176|Viral Load|viral load
1723390|NCT00002175|Cohort Studies|cohort studies
1723391|NCT00002175|RNA, Viral|rna, viral
1723392|NCT00002175|Administration, Cutaneous|administration, cutaneous
1723393|NCT00002175|Anti-HIV Agents|anti-hiv agents
1723394|NCT00002175|Dinitrobenzenes|dinitrobenzenes
1723395|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
1723396|NCT00002174|Thalidomide|thalidomide
1723397|NCT00002174|Cytokines|cytokines
1723398|NCT00002174|Viral Load|viral load
1723399|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723400|NCT00002173|AIDS Vaccines|aids vaccines
1723401|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
1723402|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
1723403|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723404|NCT00002172|AIDS Vaccines|aids vaccines
1723405|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
1723406|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
1723407|NCT00002171|Placebos|placebos
1723408|NCT00002171|Drug Therapy, Combination|drug therapy, combination
1723409|NCT00002171|Stavudine|stavudine
1723410|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
1723411|NCT00002171|Lamivudine|lamivudine
1723412|NCT00002171|Nelfinavir|nelfinavir
1723413|NCT00002171|Anti-HIV Agents|anti-hiv agents
1723414|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723415|NCT00002170|Placebos|placebos
1726870|NCT00000726|Retinitis|retinitis
1723416|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723417|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723418|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
1723419|NCT00002170|Nelfinavir|nelfinavir
1723420|NCT00002170|Anti-Infective Agents|anti-infective agents
1723421|NCT00002170|Anti-HIV Agents|anti-hiv agents
1723422|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723423|NCT00002169|Placebos|placebos
1723424|NCT00002169|Antiviral Agents|antiviral agents
1723425|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1723426|NCT00002169|Treatment Outcome|treatment outcome
1723427|NCT00002169|Nelfinavir|nelfinavir
1723428|NCT00002168|Didanosine|didanosine
1723429|NCT00002168|Drug Therapy, Combination|drug therapy, combination
1723430|NCT00002168|Zidovudine|zidovudine
1723431|NCT00002168|Stavudine|stavudine
1723432|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
1723433|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
1723434|NCT00002168|Lamivudine|lamivudine
1723435|NCT00002168|Indinavir|indinavir
1723436|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723437|NCT00002168|Anti-HIV Agents|anti-hiv agents
1723438|NCT00002168|Viral Load|viral load
1723439|NCT00002167|Skin Neoplasms|skin neoplasms
1723440|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
1723441|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723442|NCT00002167|Photochemotherapy|photochemotherapy
1723443|NCT00002167|tin etiopurpurin|tin etiopurpurin
1723444|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
1723445|NCT00002166|Nevirapine|nevirapine
1723446|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723447|NCT00002166|Anti-HIV Agents|anti-hiv agents
1723448|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723449|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
1723450|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
1723451|NCT00002165|Nelfinavir|nelfinavir
1723452|NCT00002165|Anti-HIV Agents|anti-hiv agents
1723453|NCT00002164|Biological Availability|biological availability
1723454|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
1723455|NCT00002164|Dosage Forms|dosage forms
1723456|NCT00002164|Nelfinavir|nelfinavir
1723457|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723458|NCT00002163|AIDS Dementia Complex|aids dementia complex
1723459|NCT00002163|Antiviral Agents|antiviral agents
1723460|NCT00002163|abacavir|abacavir
1723461|NCT00002162|Drug Therapy, Combination|drug therapy, combination
1723462|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723463|NCT00002162|AIDS-Related Complex|aids-related complex
1723464|NCT00002162|Antiviral Agents|antiviral agents
1723465|NCT00002162|Saquinavir|saquinavir
1723466|NCT00002161|Drug Therapy, Combination|drug therapy, combination
1723467|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723468|NCT00002161|AIDS-Related Complex|aids-related complex
1723469|NCT00002161|Antiviral Agents|antiviral agents
1723470|NCT00002161|Adenine|adenine
1723471|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723472|NCT00002160|AIDS-Related Complex|aids-related complex
1723473|NCT00002160|Pain|pain
1723474|NCT00002160|Palliative Care|palliative care
1723475|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
1723476|NCT00002160|Calcium Channel Blockers|calcium channel blockers
1723477|NCT00002159|Itraconazole|itraconazole
1723478|NCT00002159|Histoplasmosis|histoplasmosis
1723479|NCT00002159|Antifungal Agents|antifungal agents
1723480|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723481|NCT00002159|Amphotericin B|amphotericin b
1723482|NCT00002159|AIDS-Related Complex|aids-related complex
1723483|NCT00002159|Blastomycosis|blastomycosis
1723484|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
1723485|NCT00002158|Cryptosporidiosis|cryptosporidiosis
1723486|NCT00002158|Diarrhea|diarrhea
1723487|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723488|NCT00002158|nitazoxanide|nitazoxanide
1723489|NCT00002158|Antiparasitic Agents|antiparasitic agents
1723490|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723491|NCT00002157|Cachexia|cachexia
1723492|NCT00002157|Thalidomide|thalidomide
1723493|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723494|NCT00002156|Ganciclovir|ganciclovir
1723495|NCT00002156|Drug Therapy, Combination|drug therapy, combination
1723496|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723497|NCT00002156|Antiviral Agents|antiviral agents
1723498|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1723499|NCT00002156|Injections|injections
1723500|NCT00002155|Drug Therapy, Combination|drug therapy, combination
1723501|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723502|NCT00002155|Antiviral Agents|antiviral agents
1723503|NCT00002155|Zidovudine|zidovudine
1723504|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
1723505|NCT00002155|Lamivudine|lamivudine
1723506|NCT00002155|Indinavir|indinavir
1723507|NCT00002154|Drug Therapy, Combination|drug therapy, combination
1723508|NCT00002154|Cognition Disorders|cognition disorders
1723509|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723510|NCT00002154|AIDS-Related Complex|aids-related complex
1723511|NCT00002154|Thioctic Acid|thioctic acid
1723512|NCT00002154|Selegiline|selegiline
1723513|NCT00002153|Skin Neoplasms|skin neoplasms
1723514|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
1723515|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723516|NCT00002153|Antineoplastic Agents|antineoplastic agents
1723517|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723518|NCT00002152|Antiviral Agents|antiviral agents
1723519|NCT00002151|Drug Therapy, Combination|drug therapy, combination
1723520|NCT00002151|AIDS-Related Complex|aids-related complex
1723521|NCT00002151|Zidovudine|zidovudine
1723522|NCT00002151|MDL 28574|mdl 28574
1723523|NCT00002150|Drug Therapy, Combination|drug therapy, combination
1723524|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723525|NCT00002150|AIDS-Related Complex|aids-related complex
1723526|NCT00002150|Zidovudine|zidovudine
1723527|NCT00002150|MDL 28574|mdl 28574
1723528|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723529|NCT00002149|Drug Therapy, Combination|drug therapy, combination
1723530|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723531|NCT00002149|AIDS-Related Complex|aids-related complex
1723532|NCT00002149|Sinusitis|sinusitis
1723533|NCT00002149|Ephedrine|ephedrine
1723534|NCT00002149|Acupuncture Therapy|acupuncture therapy
1723535|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
1723536|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
1723537|NCT00002149|Drug Combinations|drug combinations
1723538|NCT00002149|Antibiotics, Combined|antibiotics, combined
1723539|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
1723540|NCT00002148|Cognition Disorders|cognition disorders
1723541|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723542|NCT00002148|AIDS-Related Complex|aids-related complex
1723543|NCT00002148|Free Radical Scavengers|free radical scavengers
1723544|NCT00002148|Antioxidants|antioxidants
1723545|NCT00002148|OPC 14117|opc 14117
1723546|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
1723547|NCT00002147|Liposomes|liposomes
1723548|NCT00002147|Doxorubicin|doxorubicin
1725486|NCT00000947|Placebos|placebos
1723549|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723550|NCT00002147|Drug Carriers|drug carriers
1723551|NCT00002146|Infusions, Intravenous|infusions, intravenous
1723552|NCT00002146|Foscarnet|foscarnet
1723553|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
1723554|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723555|NCT00002146|Magnesium Sulfate|magnesium sulfate
1723556|NCT00002146|Magnesium Deficiency|magnesium deficiency
1723557|NCT00002146|Hypocalcemia|hypocalcemia
1723558|NCT00002145|Foscarnet|foscarnet
1723559|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
1723560|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723561|NCT00002144|Herpes Simplex|herpes simplex
1723562|NCT00002144|Foscarnet|foscarnet
1723563|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723564|NCT00002143|Psoriasis|psoriasis
1723565|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723566|NCT00002143|AIDS-Related Complex|aids-related complex
1723567|NCT00002143|Acitretin|acitretin
1723568|NCT00002142|Retinitis|retinitis
1723569|NCT00002142|Probenecid|probenecid
1723570|NCT00002142|Drug Therapy, Combination|drug therapy, combination
1723571|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
1723572|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723573|NCT00002142|Antiviral Agents|antiviral agents
1723574|NCT00002142|cidofovir|cidofovir
1723575|NCT00002141|Biological Availability|biological availability
1723576|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1723577|NCT00002141|Food-Drug Interactions|food-drug interactions
1723578|NCT00002141|abacavir|abacavir
1723579|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723580|NCT00002140|Drug Therapy, Combination|drug therapy, combination
1723581|NCT00002140|Ethambutol|ethambutol
1723582|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723583|NCT00002140|Azithromycin|azithromycin
1723584|NCT00002140|Clarithromycin|clarithromycin
1723585|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723586|NCT00002139|Azithromycin|azithromycin
1723587|NCT00002139|Bacterial Infections|bacterial infections
1723588|NCT00002138|Neoplasms|neoplasms
1723589|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
1723590|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723591|NCT00002138|Antineoplastic Agents|antineoplastic agents
1723592|NCT00002138|tecogalan|tecogalan
1723593|NCT00002137|Neoplasms|neoplasms
1723594|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
1723595|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723596|NCT00002137|Antineoplastic Agents|antineoplastic agents
1723597|NCT00002137|tecogalan|tecogalan
1723599|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
1723600|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723601|NCT00002136|Antineoplastic Agents|antineoplastic agents
1723602|NCT00002136|tecogalan|tecogalan
1723603|NCT00002135|Retinitis|retinitis
1723604|NCT00002135|Ganciclovir|ganciclovir
1723605|NCT00002135|Administration, Oral|administration, oral
1723606|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723607|NCT00002134|Retinitis|retinitis
1723608|NCT00002134|Ganciclovir|ganciclovir
1723609|NCT00002134|Administration, Oral|administration, oral
1723610|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723611|NCT00002133|Itraconazole|itraconazole
1723612|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723613|NCT00002133|AIDS-Related Complex|aids-related complex
1723614|NCT00002133|Candidiasis, Oral|candidiasis, oral
1723615|NCT00002132|Itraconazole|itraconazole
1723616|NCT00002132|Fluconazole|fluconazole
1723617|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723618|NCT00002132|Candidiasis|candidiasis
1723619|NCT00002132|Immunocompromised Host|immunocompromised host
1723620|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
1723621|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723622|NCT00002131|Antiviral Agents|antiviral agents
1723623|NCT00002131|vesnarinone|vesnarinone
1723624|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723625|NCT00002130|Antiviral Agents|antiviral agents
1723626|NCT00002130|vesnarinone|vesnarinone
1723627|NCT00002129|vesnarinone|vesnarinone
1723628|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723629|NCT00002128|AIDS-Related Complex|aids-related complex
1723630|NCT00002128|Antiviral Agents|antiviral agents
1723631|NCT00002128|Adenine|adenine
1723632|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723633|NCT00002127|Cachexia|cachexia
1723634|NCT00002127|Thalidomide|thalidomide
1723635|NCT00002126|Neutropenia|neutropenia
1723636|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1723637|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723638|NCT00002125|Retinitis|retinitis
1723639|NCT00002125|Infusions, Intravenous|infusions, intravenous
1723640|NCT00002125|Foscarnet|foscarnet
1725582|NCT00000932|Genotype|genotype
1723641|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
1723642|NCT00002125|Administration, Oral|administration, oral
1723643|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723644|NCT00002125|Fluid Therapy|fluid therapy
1723645|NCT00002124|Drug Therapy, Combination|drug therapy, combination
1723646|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723647|NCT00002124|AIDS-Related Complex|aids-related complex
1723648|NCT00002124|Antiviral Agents|antiviral agents
1723649|NCT00002124|Zidovudine|zidovudine
1723650|NCT00002123|Didanosine|didanosine
1723651|NCT00002123|Drug Therapy, Combination|drug therapy, combination
1723652|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723653|NCT00002123|AIDS-Related Complex|aids-related complex
1723654|NCT00002123|Antiviral Agents|antiviral agents
1723655|NCT00002122|Rifabutin|rifabutin
1723656|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723657|NCT00002122|Mycoses|mycoses
1723658|NCT00002122|Drug Therapy, Combination|drug therapy, combination
1723659|NCT00002122|Fluconazole|fluconazole
1723660|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723661|NCT00002122|Azithromycin|azithromycin
1723662|NCT00002121|Antidiarrheals|antidiarrheals
1723663|NCT00002121|Diarrhea|diarrhea
1723664|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723665|NCT00002121|AIDS-Related Complex|aids-related complex
1723666|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
1723667|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1723668|NCT00002120|Trimetrexate|trimetrexate
1723669|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723670|NCT00002120|Leucovorin|leucovorin
1723671|NCT00002120|Dapsone|dapsone
1723672|NCT00002120|Drug Therapy, Combination|drug therapy, combination
1723673|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723674|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723675|NCT00002119|AIDS-Related Complex|aids-related complex
1723676|NCT00002119|Antiviral Agents|antiviral agents
1723677|NCT00002118|Zalcitabine|zalcitabine
1723678|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723679|NCT00002118|AIDS-Related Complex|aids-related complex
1723680|NCT00002117|Zalcitabine|zalcitabine
1723681|NCT00002117|Drug Therapy, Combination|drug therapy, combination
1723682|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723683|NCT00002117|AIDS-Related Complex|aids-related complex
1723684|NCT00002117|Zidovudine|zidovudine
1723685|NCT00002116|Herpes Simplex|herpes simplex
1723686|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723687|NCT00002116|Antiviral Agents|antiviral agents
1723688|NCT00002116|cidofovir|cidofovir
1723689|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723690|NCT00002115|Antiviral Agents|antiviral agents
1723691|NCT00002115|Adenine|adenine
1723692|NCT00002113|Meningitis|meningitis
1723693|NCT00002113|Cryptococcosis|cryptococcosis
1723694|NCT00002113|Drug Therapy, Combination|drug therapy, combination
1723695|NCT00002113|Fluconazole|fluconazole
1723696|NCT00002113|Flucytosine|flucytosine
1723697|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723698|NCT00002112|Nystatin|nystatin
1723699|NCT00002112|Fluconazole|fluconazole
1723700|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723701|NCT00002112|AIDS-Related Complex|aids-related complex
1723702|NCT00002112|Candidiasis, Oral|candidiasis, oral
1723703|NCT00002111|AIDS-Related Complex|aids-related complex
1723704|NCT00002111|Saquinavir|saquinavir
1723705|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
1723706|NCT00002110|Drug Therapy, Combination|drug therapy, combination
1723707|NCT00002110|AIDS-Related Complex|aids-related complex
1723708|NCT00002110|Zidovudine|zidovudine
1723709|NCT00002110|Cysteamine|cysteamine
1723710|NCT00002109|Thymopentin|thymopentin
1723711|NCT00002109|Zalcitabine|zalcitabine
1723712|NCT00002109|Didanosine|didanosine
1723713|NCT00002109|Drug Therapy, Combination|drug therapy, combination
1723714|NCT00002109|Zidovudine|zidovudine
1723715|NCT00002109|Stavudine|stavudine
1723716|NCT00002108|Drug Therapy, Combination|drug therapy, combination
1723717|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723718|NCT00002108|AIDS-Related Complex|aids-related complex
1723719|NCT00002108|Antiviral Agents|antiviral agents
1723720|NCT00002108|Zidovudine|zidovudine
1723721|NCT00002107|Interleukin-2|interleukin-2
1723722|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723723|NCT00002107|AIDS-Related Complex|aids-related complex
1723724|NCT00002106|Ranitidine|ranitidine
1723725|NCT00002105|Vincristine|vincristine
1723726|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
1723727|NCT00002105|Liposomes|liposomes
1723728|NCT00002105|Doxorubicin|doxorubicin
1723729|NCT00002105|Drug Therapy, Combination|drug therapy, combination
1723730|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723731|NCT00002105|Bleomycin|bleomycin
1723732|NCT00002105|Drug Carriers|drug carriers
1725683|NCT00000912|Viral Load|viral load
1723733|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
1723734|NCT00002104|Mycobacterium Infections|mycobacterium infections
1723735|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723736|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723737|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723738|NCT00002104|AIDS-Related Complex|aids-related complex
1724087|NCT00002032|Rifabutin|rifabutin
1723739|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
1723740|NCT00002104|Thalidomide|thalidomide
1723741|NCT00002103|Trimetrexate|trimetrexate
1723742|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723743|NCT00002103|Leucovorin|leucovorin
1723744|NCT00002103|Drug Therapy, Combination|drug therapy, combination
1723745|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723746|NCT00002102|Trimetrexate|trimetrexate
1723747|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723748|NCT00002102|Leucovorin|leucovorin
1723749|NCT00002102|Drug Therapy, Combination|drug therapy, combination
1723750|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723751|NCT00002101|Rifabutin|rifabutin
1723752|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723753|NCT00002101|Drug Therapy, Combination|drug therapy, combination
1723754|NCT00002101|Ethambutol|ethambutol
1723755|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723756|NCT00002101|Clarithromycin|clarithromycin
1723757|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723758|NCT00002100|AIDS-Related Complex|aids-related complex
1723759|NCT00002100|curdlan sulfate|curdlan sulfate
1723760|NCT00002099|Didanosine|didanosine
1723761|NCT00002099|Drug Therapy, Combination|drug therapy, combination
1723762|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723763|NCT00002099|AIDS-Related Complex|aids-related complex
1723764|NCT00002099|Lentinan|lentinan
1723765|NCT00002098|Didanosine|didanosine
1723766|NCT00002098|Drug Therapy, Combination|drug therapy, combination
1723767|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723768|NCT00002098|AIDS-Related Complex|aids-related complex
1723769|NCT00002098|Lentinan|lentinan
1723770|NCT00002097|Nystatin|nystatin
1723771|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723772|NCT00002097|AIDS-Related Complex|aids-related complex
1723773|NCT00002096|Didanosine|didanosine
1723774|NCT00002096|Ganciclovir|ganciclovir
1723775|NCT00002096|Drug Interactions|drug interactions
1723776|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
1723777|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723778|NCT00002096|Zidovudine|zidovudine
1723780|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
1723781|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723782|NCT00002094|Virus Replication|virus replication
1723783|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723784|NCT00002094|Antiviral Agents|antiviral agents
1723785|NCT00002093|Vincristine|vincristine
1723786|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
1723787|NCT00002093|Liposomes|liposomes
1723788|NCT00002093|Doxorubicin|doxorubicin
1723789|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723790|NCT00002093|Bleomycin|bleomycin
1723791|NCT00002093|Daunorubicin|daunorubicin
1723792|NCT00002093|Drug Carriers|drug carriers
1723793|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723794|NCT00002092|AIDS-Related Complex|aids-related complex
1723795|NCT00002092|Cimetidine|cimetidine
1723796|NCT00002091|Pentoxifylline|pentoxifylline
1723797|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723798|NCT00002091|AIDS-Related Complex|aids-related complex
1723799|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723800|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723801|NCT00002090|Azithromycin|azithromycin
1723802|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723803|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723804|NCT00002089|Azithromycin|azithromycin
1723805|NCT00002088|Diarrhea|diarrhea
1723806|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723807|NCT00002088|AIDS-Related Complex|aids-related complex
1723808|NCT00002088|Saccharomyces|saccharomyces
1723809|NCT00002087|Recombinant Proteins|recombinant proteins
1723810|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723811|NCT00002087|Antigens, CD4|antigens, cd4
1723812|NCT00002087|AIDS-Related Complex|aids-related complex
1723813|NCT00002086|Zalcitabine|zalcitabine
1723814|NCT00002086|Drug Therapy, Combination|drug therapy, combination
1723815|NCT00002086|AIDS-Related Complex|aids-related complex
1723816|NCT00002086|Zidovudine|zidovudine
1723817|NCT00002086|Interferon-alpha|interferon-alpha
1723818|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724177|NCT00002014|Drug Evaluation|drug evaluation
1723819|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723820|NCT00002085|Azithromycin|azithromycin
1723821|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
1723822|NCT00002084|Acyclovir|acyclovir
1723823|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723824|NCT00002084|AIDS-Related Complex|aids-related complex
1723825|NCT00002084|Antiviral Agents|antiviral agents
1723826|NCT00002084|Anus Diseases|anus diseases
1723827|NCT00002084|Herpes Genitalis|herpes genitalis
1723828|NCT00002083|Peptide T|peptide t
1723829|NCT00002083|HIV-1|hiv-1
1723830|NCT00002083|Administration, Intranasal|administration, intranasal
1723831|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723832|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
1723833|NCT00002082|Cryptosporidiosis|cryptosporidiosis
1723834|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723835|NCT00002082|Azithromycin|azithromycin
1723836|NCT00002081|Zalcitabine|zalcitabine
1723837|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723838|NCT00002081|AIDS-Related Complex|aids-related complex
1723839|NCT00002081|Zidovudine|zidovudine
1723840|NCT00002080|Rifabutin|rifabutin
1723841|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723842|NCT00002080|AIDS-Related Complex|aids-related complex
1723843|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
1723844|NCT00002080|Bacteremia|bacteremia
1723845|NCT00002079|Zidovudine|zidovudine
1723846|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
1723847|NCT00002078|Drug Evaluation|drug evaluation
1723848|NCT00002078|Interferon-alpha|interferon-alpha
1723849|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723850|NCT00002077|Meningitis|meningitis
1723851|NCT00002077|Injections, Intravenous|injections, intravenous
1723852|NCT00002077|Cryptococcosis|cryptococcosis
1723853|NCT00002077|Fluconazole|fluconazole
1723854|NCT00002077|Administration, Oral|administration, oral
1723855|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723856|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723857|NCT00002076|Meningitis|meningitis
1723858|NCT00002076|Cryptococcosis|cryptococcosis
1723859|NCT00002076|Fluconazole|fluconazole
1723860|NCT00002076|Administration, Oral|administration, oral
1723861|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723862|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723863|NCT00002075|Meningitis|meningitis
1723864|NCT00002075|Cryptococcosis|cryptococcosis
1723865|NCT00002075|Drug Therapy, Combination|drug therapy, combination
1723866|NCT00002075|Fluconazole|fluconazole
1723867|NCT00002075|Flucytosine|flucytosine
1723868|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723869|NCT00002075|Amphotericin B|amphotericin b
1723870|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723871|NCT00002074|Meningitis|meningitis
1723872|NCT00002074|Cryptococcosis|cryptococcosis
1723873|NCT00002074|Fluconazole|fluconazole
1723874|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723875|NCT00002074|Amphotericin B|amphotericin b
1723876|NCT00002073|Recombinant Proteins|recombinant proteins
1723877|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
1723878|NCT00002073|Erythropoietin|erythropoietin
1723879|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723880|NCT00002073|Anemia|anemia
1723881|NCT00002073|Zidovudine|zidovudine
1723882|NCT00002072|Recombinant Proteins|recombinant proteins
1723883|NCT00002072|Erythropoietin|erythropoietin
1723884|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723885|NCT00002072|Anemia|anemia
1723886|NCT00002072|Zidovudine|zidovudine
1723887|NCT00002071|Recombinant Proteins|recombinant proteins
1723888|NCT00002071|Erythropoietin|erythropoietin
1723889|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723890|NCT00002071|Anemia|anemia
1723891|NCT00002071|Zidovudine|zidovudine
1723892|NCT00002070|Recombinant Proteins|recombinant proteins
1723893|NCT00002070|Retinitis|retinitis
1723894|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723895|NCT00002070|Neutropenia|neutropenia
1723896|NCT00002070|Ganciclovir|ganciclovir
1723897|NCT00002070|Drug Therapy, Combination|drug therapy, combination
1723898|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1723899|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
1723900|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723901|NCT00002069|Ditiocarb|ditiocarb
1723902|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723903|NCT00002069|AIDS-Related Complex|aids-related complex
1723904|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723905|NCT00002068|Meningitis|meningitis
1723906|NCT00002068|Cryptococcosis|cryptococcosis
1723907|NCT00002068|Drug Therapy, Combination|drug therapy, combination
1723908|NCT00002068|Fluconazole|fluconazole
1723909|NCT00002068|Flucytosine|flucytosine
1724178|NCT00002014|Zidovudine|zidovudine
1723910|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723911|NCT00002068|Amphotericin B|amphotericin b
1723912|NCT00002067|Body Weight|body weight
1723913|NCT00002067|T-Lymphocytes|t-lymphocytes
1723914|NCT00002067|Nutritional Status|nutritional status
1723915|NCT00002067|Megestrol|megestrol
1723916|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723917|NCT00002067|Anorexia|anorexia
1723918|NCT00002067|Cachexia|cachexia
1723919|NCT00002067|Energy Intake|energy intake
1723920|NCT00002066|Thymopentin|thymopentin
1723921|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723922|NCT00002065|Delayed-Action Preparations|delayed-action preparations
1723923|NCT00002065|Disulfiram|disulfiram
1723924|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723925|NCT00002065|AIDS-Related Complex|aids-related complex
1723926|NCT00002064|Sulfonamides|sulfonamides
1723927|NCT00002064|Toxoplasmosis|toxoplasmosis
1723928|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723929|NCT00002064|Pyrimethamine|pyrimethamine
1723930|NCT00002064|Drug Therapy, Combination|drug therapy, combination
1723931|NCT00002064|Encephalitis|encephalitis
1723932|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723933|NCT00002064|Clindamycin|clindamycin
1723934|NCT00002063|Immune Tolerance|immune tolerance
1723935|NCT00002063|AIDS-Related Complex|aids-related complex
1723936|NCT00002063|Zidovudine|zidovudine
1723937|NCT00002062|Spiramycin|spiramycin
1723938|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723939|NCT00002062|Immune Tolerance|immune tolerance
1723940|NCT00002062|Cryptosporidiosis|cryptosporidiosis
1723941|NCT00002062|Diarrhea|diarrhea
1723942|NCT00002062|Drugs, Investigational|drugs, investigational
1723943|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723944|NCT00002061|T-Lymphocytes|t-lymphocytes
1723945|NCT00002061|Immune Tolerance|immune tolerance
1723946|NCT00002061|Inosine Pranobex|inosine pranobex
1723947|NCT00002061|Killer Cells|killer cells
1723948|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1723949|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723950|NCT00002061|AIDS-Related Complex|aids-related complex
1723951|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723952|NCT00002060|Inosine Pranobex|inosine pranobex
1723953|NCT00002060|Homosexuality|homosexuality
1723954|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723955|NCT00002060|AIDS-Related Complex|aids-related complex
1723956|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
1723957|NCT00002059|Neoplasms|neoplasms
1723958|NCT00002059|Inosine Pranobex|inosine pranobex
1723959|NCT00002059|Killer Cells|killer cells
1723960|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
1723961|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723962|NCT00002059|AIDS-Related Complex|aids-related complex
1723963|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723964|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1723965|NCT00002058|Clofazimine|clofazimine
1723966|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723967|NCT00002057|Nystatin|nystatin
1723968|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723969|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723970|NCT00002057|AIDS-Related Complex|aids-related complex
1723971|NCT00002057|Candidiasis, Oral|candidiasis, oral
1723972|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1723973|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723974|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723975|NCT00002056|Pentamidine|pentamidine
1723976|NCT00002056|Injections, Intravenous|injections, intravenous
1723977|NCT00002056|Administration, Oral|administration, oral
1723978|NCT00002056|Aerosols|aerosols
1723979|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723980|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723981|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723982|NCT00002055|Pentamidine|pentamidine
1723983|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
1723984|NCT00002055|Aerosols|aerosols
1723985|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723986|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723987|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723988|NCT00002054|Pentamidine|pentamidine
1723989|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
1723990|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723991|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723992|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1723993|NCT00002053|Pentamidine|pentamidine
1723994|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723995|NCT00002052|Salmonella Infections|salmonella infections
1723996|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1723997|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1723998|NCT00002052|Amoxicillin|amoxicillin
1723999|NCT00002052|Ceftriaxone|ceftriaxone
1724000|NCT00002051|Thymopentin|thymopentin
1724001|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724002|NCT00002050|Semen|semen
1724003|NCT00002050|Thymopentin|thymopentin
1724004|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
1724005|NCT00002050|AIDS-Related Complex|aids-related complex
1724006|NCT00002049|Semen|semen
1724007|NCT00002049|Thymopentin|thymopentin
1724008|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
1724009|NCT00002049|HIV Seropositivity|hiv seropositivity
1724010|NCT00002049|AIDS-Related Complex|aids-related complex
1724011|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724012|NCT00002048|Zidovudine|zidovudine
1724013|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
1724014|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724015|NCT00002047|AIDS-Related Complex|aids-related complex
1724016|NCT00002047|Zidovudine|zidovudine
1724017|NCT00002047|Renal Dialysis|renal dialysis
1724018|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724019|NCT00002046|AIDS-Related Complex|aids-related complex
1724020|NCT00002046|Zidovudine|zidovudine
1724021|NCT00002045|Prospective Studies|prospective studies
1724022|NCT00002045|Zidovudine|zidovudine
1724023|NCT00002044|Pilot Projects|pilot projects
1724024|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
1724025|NCT00002044|Drug Evaluation|drug evaluation
1724026|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724027|NCT00002044|AIDS Dementia Complex|aids dementia complex
1724028|NCT00002044|AIDS-Related Complex|aids-related complex
1724029|NCT00002044|Zidovudine|zidovudine
1724030|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724031|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724032|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
1724033|NCT00002043|Dapsone|dapsone
1724034|NCT00002043|AIDS-Related Complex|aids-related complex
1724035|NCT00002043|Candidiasis, Oral|candidiasis, oral
1724036|NCT00002042|Recombinant Proteins|recombinant proteins
1724037|NCT00002042|Erythropoietin|erythropoietin
1724038|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724039|NCT00002042|Anemia|anemia
1724040|NCT00002042|AIDS-Related Complex|aids-related complex
1724041|NCT00002042|Zidovudine|zidovudine
1724042|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724043|NCT00002041|Esophagitis|esophagitis
1724044|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724045|NCT00002041|Amphotericin B|amphotericin b
1724046|NCT00002041|Candidiasis, Oral|candidiasis, oral
1724047|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724048|NCT00002040|Meningitis|meningitis
1724049|NCT00002040|Injections, Intravenous|injections, intravenous
1724050|NCT00002040|Cryptococcosis|cryptococcosis
1724051|NCT00002040|Fluconazole|fluconazole
1724052|NCT00002040|Administration, Oral|administration, oral
1724053|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724054|NCT00002039|Retinitis|retinitis
1724055|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724056|NCT00002039|Drug Therapy, Combination|drug therapy, combination
1724057|NCT00002039|Foscarnet|foscarnet
1724058|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
1724059|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724060|NCT00002039|Antiviral Agents|antiviral agents
1724061|NCT00002039|Zidovudine|zidovudine
1724062|NCT00002038|Mycoses|mycoses
1724063|NCT00002038|Drugs, Investigational|drugs, investigational
1724064|NCT00002038|Fluconazole|fluconazole
1724065|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724066|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724067|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1724068|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724069|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724070|NCT00002036|AIDS-Related Complex|aids-related complex
1724071|NCT00002036|Immunization, Passive|immunization, passive
1724072|NCT00002035|Didanosine|didanosine
1724073|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724074|NCT00002035|AIDS-Related Complex|aids-related complex
1724075|NCT00002035|Zidovudine|zidovudine
1724076|NCT00002034|Retinitis|retinitis
1724077|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724078|NCT00002034|Ganciclovir|ganciclovir
1724079|NCT00002034|Drug Interactions|drug interactions
1724080|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
1724081|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724082|NCT00002034|Zidovudine|zidovudine
1724083|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724084|NCT00002033|AIDS-Related Complex|aids-related complex
1724085|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
1724088|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724089|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724090|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724091|NCT00002032|Antitubercular Agents|antitubercular agents
1724092|NCT00002031|Langerhans Cells|langerhans cells
1724093|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
1724094|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724095|NCT00002031|AIDS-Related Complex|aids-related complex
1724096|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724097|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724098|NCT00002030|Pentamidine|pentamidine
1724099|NCT00002030|Aerosols|aerosols
1724100|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724101|NCT00002029|Weight Loss|weight loss
1724102|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
1724103|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724104|NCT00002029|Liposyn|liposyn
1724105|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724106|NCT00002028|Didanosine|didanosine
1724107|NCT00002028|Drugs, Investigational|drugs, investigational
1724108|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724109|NCT00002028|AIDS-Related Complex|aids-related complex
1724110|NCT00002028|Zidovudine|zidovudine
1724111|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724112|NCT00002027|Cryptosporidiosis|cryptosporidiosis
1724113|NCT00002027|Diarrhea|diarrhea
1724114|NCT00002027|diclazuril|diclazuril
1724115|NCT00002027|Coccidiostats|coccidiostats
1724116|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724117|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724118|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
1724119|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
1724120|NCT00002026|Acyclovir|acyclovir
1724121|NCT00002026|AIDS-Related Complex|aids-related complex
1724122|NCT00002025|Retinitis|retinitis
1724123|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724124|NCT00002025|Immune Tolerance|immune tolerance
1724125|NCT00002025|Injections, Intravenous|injections, intravenous
1724126|NCT00002025|Ganciclovir|ganciclovir
1724127|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
1724128|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724129|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724130|NCT00002024|Immune Tolerance|immune tolerance
1724131|NCT00002024|Ganciclovir|ganciclovir
1724132|NCT00002024|Drugs, Investigational|drugs, investigational
1724133|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
1724313|NCT00001136|Genetic Vectors|genetic vectors
1724134|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724135|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
1724136|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724137|NCT00002023|AIDS-Related Complex|aids-related complex
1724138|NCT00002023|Zidovudine|zidovudine
1724139|NCT00002022|Recombinant Proteins|recombinant proteins
1724140|NCT00002022|Drugs, Investigational|drugs, investigational
1724141|NCT00002022|Erythropoietin|erythropoietin
1724142|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724143|NCT00002022|Anemia|anemia
1724144|NCT00002022|Zidovudine|zidovudine
1724145|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724146|NCT00002021|Immune Tolerance|immune tolerance
1724147|NCT00002021|Injections, Intravenous|injections, intravenous
1724148|NCT00002021|Herpes Simplex|herpes simplex
1724149|NCT00002021|Immunity, Cellular|immunity, cellular
1724150|NCT00002021|Foscarnet|foscarnet
1724151|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724152|NCT00002021|Antiviral Agents|antiviral agents
1724153|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724154|NCT00002020|AIDS-Related Complex|aids-related complex
1724155|NCT00002020|Zidovudine|zidovudine
1724156|NCT00002019|Meningitis|meningitis
1724157|NCT00002019|Liposomes|liposomes
1724158|NCT00002019|Cryptococcosis|cryptococcosis
1724159|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724160|NCT00002019|Amphotericin B|amphotericin b
1724161|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
1724162|NCT00002018|Interferon Type I|interferon type i
1724163|NCT00002017|Polyethylene Glycols|polyethylene glycols
1724164|NCT00002017|Interleukin-2|interleukin-2
1724165|NCT00002016|Retinitis|retinitis
1724166|NCT00002016|Ganciclovir|ganciclovir
1724167|NCT00002016|Cytomegalovirus|cytomegalovirus
1724168|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
1724169|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724170|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
1724171|NCT00002015|Retinitis|retinitis
1724172|NCT00002015|Ganciclovir|ganciclovir
1724173|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
1724174|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724175|NCT00002015|Immunocompromised Host|immunocompromised host
1724176|NCT00002014|Didanosine|didanosine
1724179|NCT00002013|Drug Therapy, Combination|drug therapy, combination
1724180|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724181|NCT00002013|AIDS-Related Complex|aids-related complex
1724182|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
1724183|NCT00002013|Zidovudine|zidovudine
1724184|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724185|NCT00002012|AIDS-Related Complex|aids-related complex
1724186|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
1724187|NCT00002011|PUVA Therapy|puva therapy
1724188|NCT00002011|Methoxsalen|methoxsalen
1724189|NCT00002011|AIDS-Related Complex|aids-related complex
1724190|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724191|NCT00002010|Meningitis|meningitis
1724192|NCT00002010|Fluconazole|fluconazole
1724193|NCT00002010|Coccidioidin|coccidioidin
1724194|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724195|NCT00002010|Coccidioidomycosis|coccidioidomycosis
1724196|NCT00002009|Leukopenia|leukopenia
1724197|NCT00002009|Drug Evaluation|drug evaluation
1724198|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1724199|NCT00002008|Leukopenia|leukopenia
1724200|NCT00002008|Drug Evaluation|drug evaluation
1724201|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1724202|NCT00002007|Leukopenia|leukopenia
1724441|NCT00001113|Interferon Type I|interferon type i
1724203|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1724204|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724205|NCT00002007|Zidovudine|zidovudine
1724206|NCT00002006|Neutropenia|neutropenia
1724207|NCT00002006|Drug Interactions|drug interactions
1724208|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1724209|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724210|NCT00002006|Zidovudine|zidovudine
1724211|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724212|NCT00002005|Antigens, CD4|antigens, cd4
1724213|NCT00002005|AIDS-Related Complex|aids-related complex
1724214|NCT00002004|Recombinant Proteins|recombinant proteins
1724215|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724216|NCT00002004|Antigens, CD4|antigens, cd4
1724217|NCT00002004|AIDS-Related Complex|aids-related complex
1724218|NCT00002003|Mitoxantrone|mitoxantrone
1724219|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
1724220|NCT00002003|Etoposide|etoposide
1724221|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724222|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1724223|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724224|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724225|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724226|NCT00002001|Zalcitabine|zalcitabine
1724227|NCT00002001|Didanosine|didanosine
1724228|NCT00002001|Drug Therapy, Combination|drug therapy, combination
1724229|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724230|NCT00002001|Zidovudine|zidovudine
1724231|NCT00002000|Acyclovir|acyclovir
1724232|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724233|NCT00002000|AIDS-Related Complex|aids-related complex
1724234|NCT00002000|Antiviral Agents|antiviral agents
1724235|NCT00002000|Anus Diseases|anus diseases
1724236|NCT00002000|Herpes Genitalis|herpes genitalis
1724237|NCT00001999|Retinitis|retinitis
1724238|NCT00001999|Gamma-Globulins|gamma-globulins
1724239|NCT00001999|Ganciclovir|ganciclovir
1724240|NCT00001999|Drug Therapy, Combination|drug therapy, combination
1724241|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
1724242|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724243|NCT00001999|Immunization, Passive|immunization, passive
1724244|NCT00001998|Nystatin|nystatin
1724245|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724246|NCT00001998|AIDS-Related Complex|aids-related complex
1724247|NCT00001997|Recombinant Proteins|recombinant proteins
1724248|NCT00001997|Polyethylene Glycols|polyethylene glycols
1724249|NCT00001997|Interleukin-2|interleukin-2
1724250|NCT00001997|Didanosine|didanosine
1724251|NCT00001997|Zidovudine|zidovudine
1724252|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1724253|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724254|NCT00001996|Pentamidine|pentamidine
1724255|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724256|NCT00001996|atovaquone|atovaquone
1724257|NCT00001995|Rifabutin|rifabutin
1724258|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724259|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724260|NCT00001994|Toxoplasmosis|toxoplasmosis
1724261|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724262|NCT00001994|Naphthoquinones|naphthoquinones
1724263|NCT00001994|Encephalitis|encephalitis
1724453|NCT00001111|AIDS-Related Complex|aids-related complex
1724264|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724265|NCT00001993|Drug Therapy, Combination|drug therapy, combination
1724266|NCT00001993|Zidovudine|zidovudine
1724267|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
1724268|NCT00001992|Drug Evaluation|drug evaluation
1724269|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724270|NCT00001992|AIDS Vaccines|aids vaccines
1724271|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1724272|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724273|NCT00001991|Antifungal Agents|antifungal agents
1724274|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724275|NCT00001991|atovaquone|atovaquone
1724276|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1724277|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724278|NCT00001990|Pentamidine|pentamidine
1724279|NCT00001990|Antifungal Agents|antifungal agents
1724280|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724281|NCT00001990|atovaquone|atovaquone
1724282|NCT00001989|Trichosanthin|trichosanthin
1724283|NCT00001989|Drug Evaluation|drug evaluation
1724284|NCT00001989|Drug Therapy, Combination|drug therapy, combination
1724285|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724286|NCT00001989|AIDS-Related Complex|aids-related complex
1724287|NCT00001989|Antiviral Agents|antiviral agents
1724288|NCT00001989|Zidovudine|zidovudine
1724289|NCT00001137|Treatment Experienced|treatment experienced
1724290|NCT00001137|Treatment Naive|treatment naive
1724291|NCT00001137|Virus Replication|virus replication
1724292|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724293|NCT00001137|HIV-1|hiv-1
1724294|NCT00001137|Risk Factors|risk factors
1724295|NCT00001137|Incidence|incidence
1724296|NCT00001137|RNA, Viral|rna, viral
1724297|NCT00001137|Anti-HIV Agents|anti-hiv agents
1724298|NCT00001137|Viral Load|viral load
1724299|NCT00001137|Lipodystrophy|lipodystrophy
1724300|NCT00001137|Nervous System|nervous system
1724301|NCT00001137|Cardiovascular System|cardiovascular system
1724302|NCT00001137|Neurologic Symptoms|neurologic symptoms
1724303|NCT00001136|Injections, Intramuscular|injections, intramuscular
1724304|NCT00001136|HIV-1|hiv-1
1724305|NCT00001136|AIDS Vaccines|aids vaccines
1724306|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1724307|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1724308|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1724309|NCT00001136|Gene Products, gag|gene products, gag
1724310|NCT00001136|HIV Seronegativity|hiv seronegativity
1724311|NCT00001136|Immunologic Memory|immunologic memory
1724312|NCT00001136|Antibodies, Viral|antibodies, viral
1724314|NCT00001136|Gene Products, env|gene products, env
1724315|NCT00001136|Poxviridae|poxviridae
1724316|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
1724317|NCT00001135|Placebos|placebos
1724318|NCT00001135|Pregnancy|pregnancy
1724442|NCT00001112|Monocytes|monocytes
1724319|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
1724320|NCT00001135|Nevirapine|nevirapine
1724321|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
1724322|NCT00001135|Labor|labor
1724323|NCT00001135|Anti-HIV Agents|anti-hiv agents
1724324|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
1724325|NCT00001133|Drug Therapy, Combination|drug therapy, combination
1724326|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
1724327|NCT00001133|Ritonavir|ritonavir
1724328|NCT00001133|Indinavir|indinavir
1724329|NCT00001133|Anti-HIV Agents|anti-hiv agents
1724330|NCT00001133|Pharmacokinetics|pharmacokinetics
1724331|NCT00001133|Treatment Experienced|treatment experienced
1724332|NCT00001132|Placebos|placebos
1724333|NCT00001132|HIV-1|hiv-1
1724334|NCT00001132|Drug Therapy, Combination|drug therapy, combination
1724335|NCT00001132|RNA, Viral|rna, viral
1724336|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724337|NCT00001132|Anti-HIV Agents|anti-hiv agents
1724338|NCT00001132|Viral Load|viral load
1724339|NCT00001132|abacavir|abacavir
1724340|NCT00001131|Interleukin-2|interleukin-2
1724341|NCT00001131|Drug Therapy, Combination|drug therapy, combination
1724342|NCT00001131|Drug Administration Schedule|drug administration schedule
1724343|NCT00001131|Viremia|viremia
1724344|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1724345|NCT00001131|Anti-HIV Agents|anti-hiv agents
1724346|NCT00001131|Treatment Experienced|treatment experienced
1724347|NCT00001130|Questionnaires|questionnaires
1724348|NCT00001130|Antibodies, Viral|antibodies, viral
1724349|NCT00001130|Emergency Service, Hospital|emergency service, hospital
1724350|NCT00001129|Drug Therapy, Combination|drug therapy, combination
1724351|NCT00001129|RNA, Viral|rna, viral
1724352|NCT00001129|Patient Compliance|patient compliance
1724353|NCT00001129|Anti-HIV Agents|anti-hiv agents
1724354|NCT00001129|Viral Load|viral load
1724355|NCT00001129|Reminder Systems|reminder systems
1724356|NCT00001129|Treatment Experienced|treatment experienced
1724357|NCT00001129|Treatment Naive|treatment naive
1724358|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724359|NCT00001128|Cryptosporidiosis|cryptosporidiosis
1724360|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724361|NCT00001128|Azithromycin|azithromycin
1724362|NCT00001128|Paromomycin|paromomycin
1724363|NCT00001128|Interleukin-12|interleukin-12
1724364|NCT00001125|Antibodies, Viral|antibodies, viral
1724365|NCT00001125|Chickenpox|chickenpox
1724366|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
1724367|NCT00001122|Didanosine|didanosine
1724368|NCT00001122|Drug Therapy, Combination|drug therapy, combination
1724369|NCT00001122|Stavudine|stavudine
1724370|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
1724371|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
1724372|NCT00001122|Nelfinavir|nelfinavir
1724373|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724374|NCT00001122|Self Care|self care
1724375|NCT00001122|Anti-HIV Agents|anti-hiv agents
1724376|NCT00001122|Viral Load|viral load
1724377|NCT00001122|efavirenz|efavirenz
1724378|NCT00001122|Treatment Naive|treatment naive
1724379|NCT00001121|Placebos|placebos
1724380|NCT00001121|AIDS Vaccines|aids vaccines
1724381|NCT00001121|Follow-Up Studies|follow-up studies
1724382|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1724383|NCT00001120|Prospective Studies|prospective studies
1724384|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
1724385|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
1724386|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724387|NCT00001120|Cohort Studies|cohort studies
1724388|NCT00001120|Risk Factors|risk factors
1724389|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
1724390|NCT00001120|Antibodies, Viral|antibodies, viral
1724391|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
1724392|NCT00001120|Viral Load|viral load
1724393|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
1724394|NCT00001120|Translocation (Genetics)|translocation (genetics)
1724395|NCT00001119|Immunity, Cellular|immunity, cellular
1724396|NCT00001119|Drug Therapy, Combination|drug therapy, combination
1724397|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
1724398|NCT00001119|Antibody Formation|antibody formation
1724399|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724400|NCT00001119|Anti-HIV Agents|anti-hiv agents
1724401|NCT00001119|Viral Load|viral load
1724402|NCT00001119|Tetanus Toxoid|tetanus toxoid
1724403|NCT00001119|Case-Control Studies|case-control studies
1724404|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
1724405|NCT00001119|Acute Infection|acute infection
1724406|NCT00001118|Injections, Intravenous|injections, intravenous
1724407|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
1724408|NCT00001118|Drug Therapy, Combination|drug therapy, combination
1724409|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
1724410|NCT00001118|Membrane Fusion|membrane fusion
1724411|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724412|NCT00001118|Anti-HIV Agents|anti-hiv agents
1724413|NCT00001118|Viral Load|viral load
1724414|NCT00001118|peptide T20|peptide t20
1724415|NCT00001117|HIV-1|hiv-1
1724416|NCT00001117|Drug Therapy, Combination|drug therapy, combination
1724417|NCT00001117|Hepatitis C|hepatitis c
1724418|NCT00001117|RNA, Viral|rna, viral
1724419|NCT00001117|Anti-HIV Agents|anti-hiv agents
1724420|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
1724421|NCT00001116|Interleukin-2|interleukin-2
1724422|NCT00001116|Immunity, Cellular|immunity, cellular
1724423|NCT00001116|Antiviral Agents|antiviral agents
1724424|NCT00001116|Interleukin-6|interleukin-6
1724425|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
1724426|NCT00001115|Herpes Simplex|herpes simplex
1724427|NCT00001115|Acyclovir|acyclovir
1724428|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724429|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
1724430|NCT00001114|Didanosine|didanosine
1724431|NCT00001114|Drug Interactions|drug interactions
1724432|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724433|NCT00001114|Interferon-alpha|interferon-alpha
1724434|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
1724435|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
1724436|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
1724437|NCT00001113|Drug Evaluation|drug evaluation
1724438|NCT00001113|Drug Therapy, Combination|drug therapy, combination
1724439|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724440|NCT00001113|Zidovudine|zidovudine
1724443|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1724444|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
1724445|NCT00001112|Immune System|immune system
1724446|NCT00001112|Drug Evaluation|drug evaluation
1724447|NCT00001112|Drug Therapy, Combination|drug therapy, combination
1724448|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724449|NCT00001112|Zidovudine|zidovudine
1724450|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
1724451|NCT00001111|Drug Therapy, Combination|drug therapy, combination
1724452|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724840|NCT00001046|Pregnancy|pregnancy
1724454|NCT00001111|Antiviral Agents|antiviral agents
1724455|NCT00001111|Zidovudine|zidovudine
1724456|NCT00001111|Nevirapine|nevirapine
1724457|NCT00001110|Lung|lung
1724458|NCT00001110|HIV-1|hiv-1
1724459|NCT00001110|Viremia|viremia
1724460|NCT00001110|Anti-HIV Agents|anti-hiv agents
1724461|NCT00001110|Viral Load|viral load
1724462|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
1724463|NCT00001109|Monocytes|monocytes
1724464|NCT00001109|Flow Cytometry|flow cytometry
1724465|NCT00001109|HIV Seronegativity|hiv seronegativity
1724466|NCT00001109|Phenotype|phenotype
1724467|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
1724468|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
1724469|NCT00001108|Drug Therapy, Combination|drug therapy, combination
1724470|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
1724471|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724472|NCT00001108|Salvage Therapy|salvage therapy
1724473|NCT00001108|Anti-HIV Agents|anti-hiv agents
1724474|NCT00001106|Pregnancy|pregnancy
1724475|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
1724476|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
1724477|NCT00001106|Drug Evaluation|drug evaluation
1724478|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724479|NCT00001106|Zidovudine|zidovudine
1724480|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
1724481|NCT00001105|AIDS-Related Complex|aids-related complex
1724482|NCT00001105|Immunization, Passive|immunization, passive
1724483|NCT00001104|Sex Behavior|sex behavior
1724484|NCT00001104|T-Lymphocytes|t-lymphocytes
1724485|NCT00001104|HIV Antibodies|hiv antibodies
1724486|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724487|NCT00001104|AIDS-Related Complex|aids-related complex
1724488|NCT00001104|Zidovudine|zidovudine
1724489|NCT00001104|Hemophilia A|hemophilia a
1724490|NCT00001103|Neuropsychological Tests|neuropsychological tests
1724491|NCT00001103|HIV-1|hiv-1
1724492|NCT00001103|RNA, Viral|rna, viral
1724493|NCT00001103|Anti-HIV Agents|anti-hiv agents
1724494|NCT00001103|Viral Load|viral load
1724495|NCT00001102|Drug Therapy, Combination|drug therapy, combination
1724496|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
1724497|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724498|NCT00001102|Body Composition|body composition
1724499|NCT00001102|Anti-HIV Agents|anti-hiv agents
1724500|NCT00001102|Cholesterol|cholesterol
1724501|NCT00001102|Triglycerides|triglycerides
1724502|NCT00001097|Drug Therapy, Combination|drug therapy, combination
1724503|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
1724504|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724505|NCT00001097|Anti-HIV Agents|anti-hiv agents
1724506|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
1724507|NCT00001096|HIV Antibodies|hiv antibodies
1724508|NCT00001096|HIV Antigens|hiv antigens
1724509|NCT00001096|HIV-1|hiv-1
1724510|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
1724511|NCT00001096|AIDS Vaccines|aids vaccines
1724512|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1724513|NCT00001096|HIV Seronegativity|hiv seronegativity
1724514|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
1724515|NCT00001096|Alum Compounds|alum compounds
1724516|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
1724517|NCT00001095|Drug Therapy, Combination|drug therapy, combination
1724518|NCT00001095|Zidovudine|zidovudine
1724519|NCT00001095|Nevirapine|nevirapine
1724520|NCT00001095|Stavudine|stavudine
1724521|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
1724522|NCT00001095|Lamivudine|lamivudine
1724523|NCT00001095|VX 478|vx 478
1724524|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724525|NCT00001095|Anti-HIV Agents|anti-hiv agents
1724526|NCT00001095|Viral Load|viral load
1724527|NCT00001094|HIV-1|hiv-1
1724528|NCT00001094|Drug Therapy, Combination|drug therapy, combination
1724529|NCT00001094|Zidovudine|zidovudine
1724530|NCT00001094|Lamivudine|lamivudine
1724531|NCT00001094|RNA, Viral|rna, viral
1724532|NCT00001094|Saquinavir|saquinavir
1724533|NCT00001094|Delavirdine|delavirdine
1724534|NCT00001094|Anti-HIV Agents|anti-hiv agents
1724535|NCT00001094|Nelfinavir|nelfinavir
1724536|NCT00001093|Immunity, Cellular|immunity, cellular
1724537|NCT00001093|Sexual Partners|sexual partners
1724538|NCT00001093|Treatment Outcome|treatment outcome
1724539|NCT00001093|Anti-HIV Agents|anti-hiv agents
1724540|NCT00001093|Viral Load|viral load
1724541|NCT00001093|Acute Infection|acute infection
1724542|NCT00001092|Semen|semen
1724543|NCT00001092|HIV-1|hiv-1
1724544|NCT00001092|Sexual Partners|sexual partners
1724545|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
1724546|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1724547|NCT00001092|Saliva|saliva
1724548|NCT00001092|Blood|blood
1724549|NCT00001092|Cervix Uteri|cervix uteri
1724550|NCT00001092|Vagina|vagina
1724551|NCT00001092|Acute Infection|acute infection
1724552|NCT00001091|Drug Therapy, Combination|drug therapy, combination
1724553|NCT00001091|Nevirapine|nevirapine
1724554|NCT00001091|Stavudine|stavudine
1724555|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
1724556|NCT00001091|Ritonavir|ritonavir
1724557|NCT00001091|Lamivudine|lamivudine
1724558|NCT00001091|Nelfinavir|nelfinavir
1724559|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724560|NCT00001090|Reference Values|reference values
1724561|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1724562|NCT00001090|AIDS Vaccines|aids vaccines
1724563|NCT00001090|HIV Seronegativity|hiv seronegativity
1724564|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1724565|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
1724566|NCT00001089|Prospective Studies|prospective studies
1724567|NCT00001089|HIV-1|hiv-1
1724568|NCT00001089|Cytomegalovirus|cytomegalovirus
1724569|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
1724570|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724571|NCT00001089|Anti-HIV Agents|anti-hiv agents
1724572|NCT00001089|Viral Load|viral load
1724573|NCT00001089|Multiple Organ Failure|multiple organ failure
1724574|NCT00001088|Injections, Intramuscular|injections, intramuscular
1724575|NCT00001088|AIDS Vaccines|aids vaccines
1724576|NCT00001088|HIV Seronegativity|hiv seronegativity
1724577|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
1724578|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
1724579|NCT00001088|Vaccines, DNA|vaccines, dna
1724580|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
1724581|NCT00001087|Drug Therapy, Combination|drug therapy, combination
1724582|NCT00001087|Antiviral Agents|antiviral agents
1724583|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
1724584|NCT00001087|Ritonavir|ritonavir
1724585|NCT00001087|Saquinavir|saquinavir
1724586|NCT00001087|Nelfinavir|nelfinavir
1724587|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724588|NCT00001087|Adenine|adenine
1724589|NCT00001087|Anti-HIV Agents|anti-hiv agents
1724590|NCT00001087|efavirenz|efavirenz
1724591|NCT00001086|Placebos|placebos
1724592|NCT00001086|HIV-1|hiv-1
1724593|NCT00001086|Drug Therapy, Combination|drug therapy, combination
1724594|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
1724595|NCT00001086|Indinavir|indinavir
1724596|NCT00001086|RNA, Viral|rna, viral
1724597|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724598|NCT00001086|Anti-HIV Agents|anti-hiv agents
1724599|NCT00001086|Viral Load|viral load
1724600|NCT00001086|efavirenz|efavirenz
1724601|NCT00001085|HIV-1|hiv-1
1724602|NCT00001085|Drug Therapy, Combination|drug therapy, combination
1724603|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724604|NCT00001085|Zidovudine|zidovudine
1724605|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
1724609|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724610|NCT00001085|Anti-HIV Agents|anti-hiv agents
1724611|NCT00001085|Viral Load|viral load
1724612|NCT00001084|Prospective Studies|prospective studies
1724613|NCT00001084|Drug Therapy, Combination|drug therapy, combination
1724614|NCT00001084|Zidovudine|zidovudine
1724615|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
1724616|NCT00001084|Lamivudine|lamivudine
1724617|NCT00001084|Indinavir|indinavir
1724618|NCT00001084|RNA, Viral|rna, viral
1724619|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724620|NCT00001084|Anti-HIV Agents|anti-hiv agents
1724621|NCT00001084|Viral Load|viral load
1724622|NCT00001083|HIV-1|hiv-1
1724623|NCT00001083|Drug Therapy, Combination|drug therapy, combination
1724624|NCT00001083|Zidovudine|zidovudine
1724625|NCT00001083|Nevirapine|nevirapine
1724626|NCT00001083|Stavudine|stavudine
1724627|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
1724628|NCT00001083|Ritonavir|ritonavir
1724629|NCT00001083|Lamivudine|lamivudine
1724630|NCT00001083|Indinavir|indinavir
1724631|NCT00001083|RNA, Viral|rna, viral
1724632|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1724633|NCT00001083|Anti-HIV Agents|anti-hiv agents
1724634|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
1724635|NCT00001082|Antiviral Agents|antiviral agents
1724636|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
1724637|NCT00001082|Prodrugs|prodrugs
1724638|NCT00001082|Survival|survival
1724639|NCT00001082|Adenine|adenine
1724640|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724641|NCT00001081|Cryptosporidiosis|cryptosporidiosis
1724642|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
1724643|NCT00001081|nitazoxanide|nitazoxanide
1724644|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
1724645|NCT00001080|HIV-1|hiv-1
1724646|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
1724647|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1724648|NCT00001080|Lamivudine|lamivudine
1724649|NCT00001080|Influenza Vaccine|influenza vaccine
1724650|NCT00001080|RNA, Viral|rna, viral
1724651|NCT00001080|Bacterial Vaccines|bacterial vaccines
1724652|NCT00001080|Anti-HIV Agents|anti-hiv agents
1724653|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
1724654|NCT00001080|Viral Load|viral load
1724655|NCT00001079|Placebos|placebos
1724656|NCT00001079|Drug Therapy, Combination|drug therapy, combination
1724657|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724658|NCT00001079|AIDS-Related Complex|aids-related complex
1724659|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
1724660|NCT00001079|Megestrol Acetate|megestrol acetate
1724661|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
1724662|NCT00001078|Viral Vaccines|viral vaccines
1724663|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724664|NCT00001078|Anti-HIV Agents|anti-hiv agents
1724665|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
1724666|NCT00001077|Weight Loss|weight loss
1724667|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724668|NCT00001077|Nutritional Support|nutritional support
1724669|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
1724670|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
1724671|NCT00001076|AIDS Vaccines|aids vaccines
1724672|NCT00001076|HIV Seronegativity|hiv seronegativity
1724673|NCT00001076|Avipoxvirus|avipoxvirus
1724674|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
1724675|NCT00001075|Drug Therapy, Combination|drug therapy, combination
1724676|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724677|NCT00001075|AIDS-Related Complex|aids-related complex
1724678|NCT00001075|Antiviral Agents|antiviral agents
1724679|NCT00001075|Zidovudine|zidovudine
1724680|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
1724681|NCT00001075|Ritonavir|ritonavir
1724682|NCT00001075|Lamivudine|lamivudine
1724683|NCT00001074|Didanosine|didanosine
1724684|NCT00001074|Drug Therapy, Combination|drug therapy, combination
1724685|NCT00001074|Antiviral Agents|antiviral agents
1724686|NCT00001074|Hydroxyurea|hydroxyurea
1724687|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724688|NCT00001073|AIDS-Related Complex|aids-related complex
1724689|NCT00001073|Cervix Dysplasia|cervix dysplasia
1724690|NCT00001073|Cervix Diseases|cervix diseases
1724691|NCT00001073|Isotretinoin|isotretinoin
1724692|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
1724693|NCT00001073|Cervix Neoplasms|cervix neoplasms
1724694|NCT00001073|Keratolytic Agents|keratolytic agents
1724695|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
1724696|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
1724697|NCT00001072|AIDS Vaccines|aids vaccines
1724698|NCT00001072|HIV Seronegativity|hiv seronegativity
1724699|NCT00001072|Avipoxvirus|avipoxvirus
1724700|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
1724701|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1724702|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724703|NCT00001071|AIDS-Related Complex|aids-related complex
1724705|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724706|NCT00001069|AIDS-Related Complex|aids-related complex
1724707|NCT00001069|Antiviral Agents|antiviral agents
1724708|NCT00001069|Decision Making|decision making
1724709|NCT00001069|Physician's Practice Patterns|physician's practice patterns
1724710|NCT00001068|Zalcitabine|zalcitabine
1724711|NCT00001068|Didanosine|didanosine
1724712|NCT00001068|Drug Therapy, Combination|drug therapy, combination
1724713|NCT00001068|AIDS-Related Complex|aids-related complex
1724714|NCT00001068|Antiviral Agents|antiviral agents
1724715|NCT00001068|Zidovudine|zidovudine
1724716|NCT00001068|Lamivudine|lamivudine
1724717|NCT00001067|Drug Therapy, Combination|drug therapy, combination
1724718|NCT00001067|AIDS-Related Complex|aids-related complex
1724719|NCT00001067|Zidovudine|zidovudine
1724720|NCT00001067|Stavudine|stavudine
1724721|NCT00001067|Lamivudine|lamivudine
1724722|NCT00001066|Didanosine|didanosine
1724723|NCT00001066|Drug Therapy, Combination|drug therapy, combination
1724724|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724725|NCT00001066|AIDS-Related Complex|aids-related complex
1724726|NCT00001066|Zidovudine|zidovudine
1724727|NCT00001066|Lamivudine|lamivudine
1724728|NCT00001065|Administration, Oral|administration, oral
1724729|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724730|NCT00001065|Amphotericin B|amphotericin b
1724731|NCT00001065|AIDS-Related Complex|aids-related complex
1724732|NCT00001065|Candidiasis, Oral|candidiasis, oral
1724733|NCT00001065|Suspensions|suspensions
1724734|NCT00001064|HIV Antigens|hiv antigens
1724735|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
1724736|NCT00001064|Dendritic Cells|dendritic cells
1724737|NCT00001063|Didanosine|didanosine
1724738|NCT00001063|Drug Therapy, Combination|drug therapy, combination
1724739|NCT00001063|AIDS-Related Complex|aids-related complex
1724740|NCT00001063|Zidovudine|zidovudine
1724741|NCT00001063|Stavudine|stavudine
1724742|NCT00001062|Infusions, Intravenous|infusions, intravenous
1724743|NCT00001062|Ganciclovir|ganciclovir
1724744|NCT00001062|Administration, Oral|administration, oral
1724745|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724746|NCT00001062|Antiviral Agents|antiviral agents
1724747|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1724748|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724749|NCT00001061|Ganciclovir|ganciclovir
1724750|NCT00001061|Foscarnet|foscarnet
1724751|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724752|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
1724753|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1724754|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
1724755|NCT00001060|HIV-1|hiv-1
1724756|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724757|NCT00001060|AIDS-Related Complex|aids-related complex
1724758|NCT00001060|AIDS Vaccines|aids vaccines
1724759|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1724760|NCT00001059|Vincristine|vincristine
1724761|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
1724762|NCT00001059|Liposomes|liposomes
1724763|NCT00001059|Doxorubicin|doxorubicin
1724764|NCT00001059|Drug Therapy, Combination|drug therapy, combination
1724765|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1724766|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724767|NCT00001059|Bleomycin|bleomycin
1724768|NCT00001059|Drug Carriers|drug carriers
1724769|NCT00001058|Rifabutin|rifabutin
1724770|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724771|NCT00001058|Drug Therapy, Combination|drug therapy, combination
1724772|NCT00001058|Ethambutol|ethambutol
1724773|NCT00001058|Clofazimine|clofazimine
1724774|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724775|NCT00001058|Ciprofloxacin|ciprofloxacin
1724776|NCT00001058|Clarithromycin|clarithromycin
1724777|NCT00001057|Didanosine|didanosine
1724778|NCT00001057|Drug Therapy, Combination|drug therapy, combination
1724779|NCT00001057|Zidovudine|zidovudine
1724780|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
1724781|NCT00001056|Vaccinia Virus|vaccinia virus
1724782|NCT00001056|Viral Vaccines|viral vaccines
1724783|NCT00001056|HIV-1|hiv-1
1724784|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
1724785|NCT00001056|AIDS Vaccines|aids vaccines
1724786|NCT00001056|HIV Seronegativity|hiv seronegativity
1724787|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
1724788|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
1724789|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
1724790|NCT00001055|AIDS Vaccines|aids vaccines
1724791|NCT00001055|HIV Seronegativity|hiv seronegativity
1724792|NCT00001055|Avipoxvirus|avipoxvirus
1724793|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
1724794|NCT00001054|Herpes Zoster|herpes zoster
1724795|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724796|NCT00001054|Herpes Simplex|herpes simplex
1724797|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724798|NCT00001054|AIDS-Related Complex|aids-related complex
1724799|NCT00001054|valacyclovir|valacyclovir
1724801|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
1724802|NCT00001053|Recombinant Proteins|recombinant proteins
1724803|NCT00001053|HIV-1|hiv-1
1724804|NCT00001053|AIDS Vaccines|aids vaccines
1724805|NCT00001053|HIV Core Protein p24|hiv core protein p24
1724806|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
1724807|NCT00001053|Gene Products, gag|gene products, gag
1724808|NCT00001053|HIV Seronegativity|hiv seronegativity
1724809|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
1724810|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
1724811|NCT00001052|Drug Therapy, Combination|drug therapy, combination
1724812|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
1724813|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
1724814|NCT00001052|AIDS Vaccines|aids vaccines
1724815|NCT00001052|HIV Seronegativity|hiv seronegativity
1724816|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
1724817|NCT00001049|Didanosine|didanosine
1724818|NCT00001049|Drug Therapy, Combination|drug therapy, combination
1724819|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724820|NCT00001049|AIDS-Related Complex|aids-related complex
1724821|NCT00001049|Zidovudine|zidovudine
1724822|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
1724823|NCT00001048|Infusions, Intravenous|infusions, intravenous
1724824|NCT00001048|Cytarabine|cytarabine
1724825|NCT00001048|Zalcitabine|zalcitabine
1724826|NCT00001048|Didanosine|didanosine
1724827|NCT00001048|Drug Therapy, Combination|drug therapy, combination
1724828|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1724829|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724830|NCT00001048|Zidovudine|zidovudine
1724831|NCT00001048|Injections, Spinal|injections, spinal
1724832|NCT00001047|Rifabutin|rifabutin
1724833|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724834|NCT00001047|Drug Therapy, Combination|drug therapy, combination
1724835|NCT00001047|Ethambutol|ethambutol
1724836|NCT00001047|Clofazimine|clofazimine
1724837|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724838|NCT00001047|Clarithromycin|clarithromycin
1724839|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
1724841|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
1724842|NCT00001046|AIDS-Related Complex|aids-related complex
1724843|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
1724844|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
1724845|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1724846|NCT00001045|Didanosine|didanosine
1724847|NCT00001045|Drug Therapy, Combination|drug therapy, combination
1724848|NCT00001045|Zidovudine|zidovudine
1724849|NCT00001045|Nevirapine|nevirapine
1724850|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
1724851|NCT00001044|Drug Therapy, Combination|drug therapy, combination
1724852|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
1724853|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
1724854|NCT00001044|AIDS Vaccines|aids vaccines
1724855|NCT00001044|HIV Seronegativity|hiv seronegativity
1724856|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
1724857|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
1724858|NCT00001043|Vaccinia Virus|vaccinia virus
1724859|NCT00001043|Viral Vaccines|viral vaccines
1724860|NCT00001043|Smallpox Vaccine|smallpox vaccine
1724861|NCT00001043|HIV-1|hiv-1
1724862|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
1724863|NCT00001043|AIDS Vaccines|aids vaccines
1724864|NCT00001043|HIV Seronegativity|hiv seronegativity
1724865|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
1724866|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
1724867|NCT00001042|Drug Therapy, Combination|drug therapy, combination
1724868|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
1724869|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
1724870|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
1724871|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
1724872|NCT00001042|AIDS Vaccines|aids vaccines
1724873|NCT00001042|HIV Seronegativity|hiv seronegativity
1724874|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
1724875|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
1724876|NCT00001041|Pregnancy|pregnancy
1724877|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
1724878|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
1724879|NCT00001041|AIDS Vaccines|aids vaccines
1724880|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1724881|NCT00001040|Zalcitabine|zalcitabine
1724882|NCT00001040|Drug Therapy, Combination|drug therapy, combination
1724883|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724884|NCT00001040|AIDS-Related Complex|aids-related complex
1724885|NCT00001040|Zidovudine|zidovudine
1724886|NCT00001040|Saquinavir|saquinavir
1724887|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
1724888|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724889|NCT00001039|Drug Therapy, Combination|drug therapy, combination
1724890|NCT00001039|Ethambutol|ethambutol
1724891|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724892|NCT00001039|Clarithromycin|clarithromycin
1727234|NCT00000670|Probenecid|probenecid
1724893|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
1724894|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724895|NCT00001038|Antiviral Agents|antiviral agents
1724896|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
1724897|NCT00001037|HIV-1|hiv-1
1724898|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
1724899|NCT00001037|AIDS Vaccines|aids vaccines
1724900|NCT00001037|HIV Seronegativity|hiv seronegativity
1724901|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
1724902|NCT00001036|T-Lymphocytes|t-lymphocytes
1724903|NCT00001036|Polyethylene Glycols|polyethylene glycols
1724904|NCT00001036|Interleukin-2|interleukin-2
1724905|NCT00001036|Drug Therapy, Combination|drug therapy, combination
1724906|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
1724907|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724908|NCT00001036|Zidovudine|zidovudine
1724909|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
1724910|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724911|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
1724912|NCT00001035|Zalcitabine|zalcitabine
1724913|NCT00001035|Didanosine|didanosine
1724914|NCT00001035|Drug Therapy, Combination|drug therapy, combination
1724915|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724916|NCT00001035|Zidovudine|zidovudine
1724917|NCT00001035|Hepatitis C|hepatitis c
1724918|NCT00001034|Retinitis|retinitis
1724919|NCT00001034|Ganciclovir|ganciclovir
1724920|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
1724921|NCT00001034|Administration, Oral|administration, oral
1724922|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724923|NCT00001034|Gastrointestinal System|gastrointestinal system
1724924|NCT00001033|Isoniazid|isoniazid
1724925|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1724926|NCT00001033|Pyrazinamide|pyrazinamide
1724927|NCT00001033|Pyridoxine|pyridoxine
1724928|NCT00001033|Ofloxacin|ofloxacin
1724929|NCT00001033|Rifampin|rifampin
1724930|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1724931|NCT00001033|Ethambutol|ethambutol
1724932|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724934|NCT00001032|Drug Therapy, Combination|drug therapy, combination
1724935|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724936|NCT00001032|AIDS-Related Complex|aids-related complex
1724937|NCT00001032|Zidovudine|zidovudine
1724938|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
1724939|NCT00001031|HIV-1|hiv-1
1724940|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
1724941|NCT00001031|AIDS Vaccines|aids vaccines
1724942|NCT00001031|HIV Seronegativity|hiv seronegativity
1724943|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
1724944|NCT00001030|Rifabutin|rifabutin
1724945|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724946|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724947|NCT00001030|Clarithromycin|clarithromycin
1724948|NCT00001029|Zalcitabine|zalcitabine
1724949|NCT00001029|Didanosine|didanosine
1724950|NCT00001029|Drug Therapy, Combination|drug therapy, combination
1724951|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724952|NCT00001029|Zidovudine|zidovudine
1724953|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724954|NCT00001028|Pentamidine|pentamidine
1724955|NCT00001028|Dapsone|dapsone
1724956|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724957|NCT00001028|AIDS-Related Complex|aids-related complex
1724958|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1724959|NCT00001027|Pentamidine|pentamidine
1724960|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724961|NCT00001027|AIDS-Related Complex|aids-related complex
1724962|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
1724963|NCT00001026|Vaccinia Virus|vaccinia virus
1724964|NCT00001026|Viral Vaccines|viral vaccines
1724965|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
1724966|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
1724967|NCT00001026|AIDS Vaccines|aids vaccines
1724968|NCT00001026|HIV Seronegativity|hiv seronegativity
1724969|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
1724970|NCT00001025|Virus Replication|virus replication
1724971|NCT00001025|Didanosine|didanosine
1724972|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724973|NCT00001025|AIDS-Related Complex|aids-related complex
1724974|NCT00001025|Zidovudine|zidovudine
1724975|NCT00001024|Didanosine|didanosine
1724976|NCT00001024|AIDS-Related Complex|aids-related complex
1724977|NCT00001024|Zidovudine|zidovudine
1724978|NCT00001024|Lymph Nodes|lymph nodes
1724979|NCT00001024|Lymphoid Tissue|lymphoid tissue
1724980|NCT00001023|Rifabutin|rifabutin
1724981|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1724982|NCT00001023|Drug Interactions|drug interactions
1724983|NCT00001023|Azithromycin|azithromycin
1724984|NCT00001023|Clarithromycin|clarithromycin
1724985|NCT00001022|Zalcitabine|zalcitabine
1724986|NCT00001022|Didanosine|didanosine
1724987|NCT00001022|Drug Therapy, Combination|drug therapy, combination
1724988|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1724989|NCT00001022|AIDS-Related Complex|aids-related complex
1724990|NCT00001022|Zidovudine|zidovudine
1724991|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
1724992|NCT00001021|HIV-1|hiv-1
1724993|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
1724994|NCT00001021|AIDS Vaccines|aids vaccines
1724995|NCT00001021|HIV Seronegativity|hiv seronegativity
1724996|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
1724997|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
1724998|NCT00001020|Viral Vaccines|viral vaccines
1724999|NCT00001020|HIV-1|hiv-1
1725000|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
1725001|NCT00001020|AIDS Vaccines|aids vaccines
1725002|NCT00001020|HIV Seronegativity|hiv seronegativity
1725003|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
1725004|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
1725005|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
1725006|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
1725007|NCT00001019|AIDS Vaccines|aids vaccines
1725008|NCT00001019|HIV Seronegativity|hiv seronegativity
1725009|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
1725010|NCT00001018|Cryptosporidiosis|cryptosporidiosis
1725011|NCT00001018|Diarrhea|diarrhea
1725012|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725013|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
1725014|NCT00001018|Triazines|triazines
1725015|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725016|NCT00001017|Meningitis|meningitis
1725017|NCT00001017|Injections, Intravenous|injections, intravenous
1725018|NCT00001017|Cryptococcosis|cryptococcosis
1725019|NCT00001017|Fluconazole|fluconazole
1725020|NCT00001017|Administration, Oral|administration, oral
1725021|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725022|NCT00001017|Amphotericin B|amphotericin b
1725023|NCT00001016|Trimetrexate|trimetrexate
1725024|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725025|NCT00001016|Quinazolines|quinazolines
1725026|NCT00001016|Infusions, Intravenous|infusions, intravenous
1725027|NCT00001016|Injections, Intravenous|injections, intravenous
1725029|NCT00001016|Drug Evaluation|drug evaluation
1725030|NCT00001016|Drug Therapy, Combination|drug therapy, combination
1725031|NCT00001016|Administration, Oral|administration, oral
1725032|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725033|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
1725034|NCT00001016|AIDS-Related Complex|aids-related complex
1725035|NCT00001015|Ribavirin|ribavirin
1725036|NCT00001015|T-Lymphocytes|t-lymphocytes
1725037|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725038|NCT00001015|AIDS-Related Complex|aids-related complex
1725039|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1725040|NCT00001014|Trimetrexate|trimetrexate
1725041|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725042|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725043|NCT00001014|Infusions, Intravenous|infusions, intravenous
1725044|NCT00001014|Leucovorin|leucovorin
1725045|NCT00001014|Drug Therapy, Combination|drug therapy, combination
1725046|NCT00001014|Administration, Oral|administration, oral
1725281|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
1725047|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725048|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
1725049|NCT00001014|AIDS-Related Complex|aids-related complex
1725050|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1725051|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1725052|NCT00001013|Trimetrexate|trimetrexate
1725053|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725054|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725055|NCT00001013|Pentamidine|pentamidine
1725056|NCT00001013|Infusions, Intravenous|infusions, intravenous
1725057|NCT00001013|Leucovorin|leucovorin
1725058|NCT00001013|Drug Therapy, Combination|drug therapy, combination
1725059|NCT00001013|Folic Acid Antagonists|folic acid antagonists
1725060|NCT00001013|Aerosols|aerosols
1725061|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725062|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
1725063|NCT00001013|AIDS-Related Complex|aids-related complex
1725064|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1725065|NCT00001012|Virus Replication|virus replication
1725066|NCT00001012|T-Lymphocytes|t-lymphocytes
1725067|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
1725068|NCT00001012|Drug Evaluation|drug evaluation
1725069|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725070|NCT00001012|AL 721|al 721
1725071|NCT00001012|AIDS-Related Complex|aids-related complex
1725072|NCT00001012|Antiviral Agents|antiviral agents
1725073|NCT00001011|Virus Replication|virus replication
1725074|NCT00001011|AIDS-Related Complex|aids-related complex
1725075|NCT00001011|Zidovudine|zidovudine
1725076|NCT00001010|Immune Tolerance|immune tolerance
1725077|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
1725078|NCT00001010|Drug Evaluation|drug evaluation
1725079|NCT00001010|Drug Therapy, Combination|drug therapy, combination
1725080|NCT00001010|Acyclovir|acyclovir
1725081|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725082|NCT00001010|AIDS-Related Complex|aids-related complex
1725083|NCT00001010|Zidovudine|zidovudine
1725084|NCT00001009|T-Lymphocytes|t-lymphocytes
1725085|NCT00001009|HIV Antigens|hiv antigens
1725086|NCT00001009|Dextran Sulfate|dextran sulfate
1725087|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
1725088|NCT00001009|Drug Evaluation|drug evaluation
1725089|NCT00001009|Drug Therapy, Combination|drug therapy, combination
1725090|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725091|NCT00001009|AIDS-Related Complex|aids-related complex
1725092|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
1725093|NCT00001008|Methadone|methadone
1725094|NCT00001008|Opioid-Related Disorders|opioid-related disorders
1725095|NCT00001008|Drug Evaluation|drug evaluation
1725096|NCT00001008|Drug Interactions|drug interactions
1725097|NCT00001008|Drug Therapy, Combination|drug therapy, combination
1725098|NCT00001008|Administration, Oral|administration, oral
1725099|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725100|NCT00001008|AIDS-Related Complex|aids-related complex
1725101|NCT00001008|Zidovudine|zidovudine
1725102|NCT00001007|Pregnancy|pregnancy
1725103|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725104|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
1725105|NCT00001007|Infusions, Intravenous|infusions, intravenous
1725106|NCT00001007|Drug Evaluation|drug evaluation
1725107|NCT00001007|Administration, Oral|administration, oral
1725108|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725109|NCT00001007|Zidovudine|zidovudine
1725110|NCT00001006|Infusions, Intravenous|infusions, intravenous
1725111|NCT00001006|Immunologic Surveillance|immunologic surveillance
1725112|NCT00001006|Drug Evaluation|drug evaluation
1725113|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
1725114|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725115|NCT00001006|AIDS-Related Complex|aids-related complex
1725116|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
1725117|NCT00001005|Recombinant Proteins|recombinant proteins
1725118|NCT00001005|HIV Seropositivity|hiv seropositivity
1725119|NCT00001005|Interleukin-2|interleukin-2
1725120|NCT00001005|Drug Evaluation|drug evaluation
1725121|NCT00001005|Drug Therapy, Combination|drug therapy, combination
1725122|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725123|NCT00001005|AIDS-Related Complex|aids-related complex
1725124|NCT00001005|Zidovudine|zidovudine
1725125|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
1725126|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1725127|NCT00001004|HIV Antigens|hiv antigens
1725128|NCT00001004|Immunologic Surveillance|immunologic surveillance
1725129|NCT00001004|Drug Therapy, Combination|drug therapy, combination
1725130|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725131|NCT00001004|AIDS-Related Complex|aids-related complex
1725132|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725133|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725134|NCT00001003|Pentamidine|pentamidine
1725135|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
1725136|NCT00001003|Lung|lung
1725137|NCT00001003|Administration, Inhalation|administration, inhalation
1725138|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725139|NCT00001003|Zidovudine|zidovudine
1725140|NCT00001002|Drug Therapy, Combination|drug therapy, combination
1725141|NCT00001002|Foscarnet|foscarnet
1725142|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725143|NCT00001002|AIDS-Related Complex|aids-related complex
1725144|NCT00001002|Antiviral Agents|antiviral agents
1725145|NCT00001002|Zidovudine|zidovudine
1725146|NCT00001001|Liver|liver
1725147|NCT00001001|Liver Diseases|liver diseases
1725148|NCT00001001|Liver Function Tests|liver function tests
1725149|NCT00001001|HIV Seropositivity|hiv seropositivity
1725150|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725151|NCT00001001|Zidovudine|zidovudine
1725152|NCT00001001|Biological Availability|biological availability
1725153|NCT00001000|Macrophage Activation|macrophage activation
1725154|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
1725155|NCT00001000|Immunologic Surveillance|immunologic surveillance
1725156|NCT00001000|ampligen|ampligen
1725157|NCT00001000|Antiviral Agents|antiviral agents
1725158|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725159|NCT00000999|AIDS-Related Complex|aids-related complex
1725160|NCT00000999|Zidovudine|zidovudine
1725161|NCT00000998|Trimetrexate|trimetrexate
1725162|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725163|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725164|NCT00000998|Injections, Intravenous|injections, intravenous
1725165|NCT00000998|Leucovorin|leucovorin
1725166|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
1725167|NCT00000998|Drug Therapy, Combination|drug therapy, combination
1725168|NCT00000998|Folic Acid Antagonists|folic acid antagonists
1725169|NCT00000998|Administration, Oral|administration, oral
1725170|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725171|NCT00000998|Antineoplastic Agents|antineoplastic agents
1725172|NCT00000997|Zalcitabine|zalcitabine
1725173|NCT00000997|Drug Evaluation|drug evaluation
1725174|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725175|NCT00000997|AIDS-Related Complex|aids-related complex
1725176|NCT00000997|Biological Availability|biological availability
1725177|NCT00000996|Doxorubicin|doxorubicin
1725178|NCT00000996|Drug Evaluation|drug evaluation
1725179|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725180|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725181|NCT00000995|Ganciclovir|ganciclovir
1725182|NCT00000995|Drug Evaluation|drug evaluation
1725183|NCT00000995|Drug Therapy, Combination|drug therapy, combination
1725184|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
1725185|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725186|NCT00000995|Zidovudine|zidovudine
1725187|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725188|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
1725189|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725190|NCT00000994|Zidovudine|zidovudine
1725191|NCT00000993|HIV-1|hiv-1
1725192|NCT00000993|Drug Evaluation|drug evaluation
1725193|NCT00000993|Accidents|accidents
1725194|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725195|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
1725196|NCT00000993|Zidovudine|zidovudine
1725197|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725198|NCT00000992|Ketoconazole|ketoconazole
1725199|NCT00000992|Histoplasmosis|histoplasmosis
1725200|NCT00000992|Drug Evaluation|drug evaluation
1725201|NCT00000992|Antifungal Agents|antifungal agents
1725202|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725203|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1725204|NCT00000991|Toxoplasmosis|toxoplasmosis
1725205|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725206|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725207|NCT00000991|Pentamidine|pentamidine
1725208|NCT00000991|Dapsone|dapsone
1725209|NCT00000991|Drug Evaluation|drug evaluation
1725210|NCT00000991|Drug Therapy, Combination|drug therapy, combination
1725211|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725212|NCT00000991|Zidovudine|zidovudine
1725213|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1725214|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725215|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
1725216|NCT00000990|Zidovudine|zidovudine
1725217|NCT00000989|Retinitis|retinitis
1725218|NCT00000989|Ganciclovir|ganciclovir
1725219|NCT00000989|Drug Evaluation|drug evaluation
1725220|NCT00000989|Drug Therapy, Combination|drug therapy, combination
1725221|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
1725222|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725223|NCT00000989|Zidovudine|zidovudine
1725224|NCT00000988|Injections, Intravenous|injections, intravenous
1725225|NCT00000988|Drug Evaluation|drug evaluation
1725226|NCT00000988|Administration, Oral|administration, oral
1725227|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725228|NCT00000988|AIDS-Related Complex|aids-related complex
1725229|NCT00000988|Antiviral Agents|antiviral agents
1725230|NCT00000987|Vincristine|vincristine
1725231|NCT00000987|Doxorubicin|doxorubicin
1725232|NCT00000987|Drug Therapy, Combination|drug therapy, combination
1725233|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725234|NCT00000987|Zidovudine|zidovudine
1725235|NCT00000987|Bleomycin|bleomycin
1725236|NCT00000986|Recombinant Proteins|recombinant proteins
1725237|NCT00000986|Interleukin-2|interleukin-2
1725238|NCT00000986|Drug Interactions|drug interactions
1725239|NCT00000986|Drug Therapy, Combination|drug therapy, combination
1725240|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725241|NCT00000986|AIDS-Related Complex|aids-related complex
1725242|NCT00000986|Zidovudine|zidovudine
1725243|NCT00000985|Vidarabine|vidarabine
1725244|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
1725245|NCT00000985|Herpes Simplex|herpes simplex
1725246|NCT00000985|Foscarnet|foscarnet
1725247|NCT00000985|Acyclovir|acyclovir
1725248|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725249|NCT00000984|Recombinant Proteins|recombinant proteins
1725250|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725251|NCT00000984|Antigens, CD4|antigens, cd4
1725252|NCT00000984|Antiviral Agents|antiviral agents
1725253|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725254|NCT00000983|Zidovudine|zidovudine
1725255|NCT00000982|Central Nervous System Diseases|central nervous system diseases
1725256|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725257|NCT00000982|Zidovudine|zidovudine
1725259|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725260|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
1725261|NCT00000981|Drug Evaluation|drug evaluation
1725262|NCT00000981|fiacitabine|fiacitabine
1725263|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
1725264|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725265|NCT00000981|Antiviral Agents|antiviral agents
1725266|NCT00000980|Single-Blind Method|single-blind method
1725267|NCT00000980|Spiramycin|spiramycin
1725268|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725269|NCT00000980|Injections, Intravenous|injections, intravenous
1725270|NCT00000980|Cryptosporidiosis|cryptosporidiosis
1725271|NCT00000980|Diarrhea|diarrhea
1725272|NCT00000980|Drug Evaluation|drug evaluation
1725273|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725274|NCT00000979|Didanosine|didanosine
1725275|NCT00000979|Zidovudine|zidovudine
1725276|NCT00000978|Zalcitabine|zalcitabine
1725277|NCT00000978|Drug Therapy, Combination|drug therapy, combination
1725278|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725279|NCT00000978|AIDS-Related Complex|aids-related complex
1725280|NCT00000978|Zidovudine|zidovudine
1725282|NCT00000977|HIV Seropositivity|hiv seropositivity
1725283|NCT00000977|HIV-1|hiv-1
1725284|NCT00000977|Drug Evaluation|drug evaluation
1725285|NCT00000977|AIDS Vaccines|aids vaccines
1725286|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1725287|NCT00000976|Recombinant Proteins|recombinant proteins
1725288|NCT00000976|Injections, Intravenous|injections, intravenous
1725289|NCT00000976|IgG|igg
1725290|NCT00000976|Drug Evaluation|drug evaluation
1725291|NCT00000976|Administration, Oral|administration, oral
1725292|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725293|NCT00000976|Antigens, CD4|antigens, cd4
1725294|NCT00000976|Zidovudine|zidovudine
1725295|NCT00000976|Carrier Proteins|carrier proteins
1725296|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725297|NCT00000975|Histoplasmosis|histoplasmosis
1725298|NCT00000975|Drug Evaluation|drug evaluation
1725299|NCT00000975|Antifungal Agents|antifungal agents
1725300|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725301|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725302|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725303|NCT00000974|Pentamidine|pentamidine
1725304|NCT00000974|Injections, Intravenous|injections, intravenous
1725305|NCT00000974|Drug Evaluation|drug evaluation
1725306|NCT00000974|Aerosols|aerosols
1725307|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725308|NCT00000973|Toxoplasmosis|toxoplasmosis
1725309|NCT00000973|Toxoplasma|toxoplasma
1725310|NCT00000973|Pyrimethamine|pyrimethamine
1725311|NCT00000973|Leucovorin|leucovorin
1725312|NCT00000973|Drug Evaluation|drug evaluation
1725313|NCT00000973|Encephalitis|encephalitis
1725314|NCT00000973|Zidovudine|zidovudine
1725315|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
1725316|NCT00000972|Drug Evaluation|drug evaluation
1725317|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
1725318|NCT00000972|AIDS Vaccines|aids vaccines
1725319|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
1725320|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725321|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725322|NCT00000971|Didanosine|didanosine
1725323|NCT00000971|Drug Evaluation|drug evaluation
1725324|NCT00000971|Drug Interactions|drug interactions
1725325|NCT00000971|Drug Therapy, Combination|drug therapy, combination
1725326|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725327|NCT00000971|Zidovudine|zidovudine
1725328|NCT00000970|Retinitis|retinitis
1725329|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725330|NCT00000970|Ganciclovir|ganciclovir
1725331|NCT00000970|Drug Evaluation|drug evaluation
1725332|NCT00000970|Drug Therapy, Combination|drug therapy, combination
1725333|NCT00000970|Foscarnet|foscarnet
1725334|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
1725335|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725336|NCT00000969|Zalcitabine|zalcitabine
1725337|NCT00000969|Didanosine|didanosine
1725338|NCT00000969|Drug Evaluation|drug evaluation
1725339|NCT00000969|Zidovudine|zidovudine
1725340|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
1725341|NCT00000968|Drug Evaluation|drug evaluation
1725342|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
1725343|NCT00000968|AIDS Vaccines|aids vaccines
1725344|NCT00000968|HIV Seronegativity|hiv seronegativity
1725345|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
1725346|NCT00000967|Drug Therapy, Combination|drug therapy, combination
1725347|NCT00000967|AIDS-Related Complex|aids-related complex
1725348|NCT00000967|Zidovudine|zidovudine
1725349|NCT00000967|Interferon Type I|interferon type i
1725350|NCT00000966|Toxoplasmosis|toxoplasmosis
1725351|NCT00000966|Toxoplasma|toxoplasma
1725352|NCT00000966|Pyrimethamine|pyrimethamine
1725353|NCT00000966|Leucovorin|leucovorin
1725354|NCT00000966|Drug Evaluation|drug evaluation
1725355|NCT00000966|Drug Therapy, Combination|drug therapy, combination
1725356|NCT00000966|Encephalitis|encephalitis
1725357|NCT00000966|Administration, Oral|administration, oral
1725358|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725359|NCT00000966|Azithromycin|azithromycin
1725360|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
1725361|NCT00000965|Drug Evaluation|drug evaluation
1725362|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725363|NCT00000965|AIDS-Related Complex|aids-related complex
1725364|NCT00000965|Zidovudine|zidovudine
1725365|NCT00000965|Phosphorylation|phosphorylation
1725366|NCT00000964|Ranitidine|ranitidine
1725367|NCT00000964|Phosphorus Acids|phosphorus acids
1725368|NCT00000964|Drug Evaluation|drug evaluation
1725369|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725370|NCT00000963|Didanosine|didanosine
1725371|NCT00000963|Drug Evaluation|drug evaluation
1725372|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725373|NCT00000963|AIDS-Related Complex|aids-related complex
1725374|NCT00000963|Zidovudine|zidovudine
1725375|NCT00000962|Drug Evaluation|drug evaluation
1725376|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725377|NCT00000962|AIDS-Related Complex|aids-related complex
1725378|NCT00000962|Nevirapine|nevirapine
1725379|NCT00000961|Drug Therapy, Combination|drug therapy, combination
1725380|NCT00000961|Zidovudine|zidovudine
1725381|NCT00000960|Pregnancy|pregnancy
1725382|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725383|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
1725384|NCT00000960|Administration, Oral|administration, oral
1725385|NCT00000960|AIDS-Related Complex|aids-related complex
1725386|NCT00000960|Zidovudine|zidovudine
1725387|NCT00000959|Tuberculosis|tuberculosis
1725388|NCT00000959|Isoniazid|isoniazid
1725389|NCT00000959|Pyridoxine|pyridoxine
1725390|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725391|NCT00000959|Drug Evaluation|drug evaluation
1725392|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725393|NCT00000959|Antitubercular Agents|antitubercular agents
1725394|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
1725395|NCT00000958|Recombinant Proteins|recombinant proteins
1725396|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
1725397|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725398|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
1725399|NCT00000958|AIDS Vaccines|aids vaccines
1725400|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1725401|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
1725402|NCT00000957|Vaccinia Virus|vaccinia virus
1725403|NCT00000957|Viral Vaccines|viral vaccines
1725404|NCT00000957|HIV-1|hiv-1
1725405|NCT00000957|Drug Evaluation|drug evaluation
1725406|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
1725407|NCT00000957|Drug Administration Schedule|drug administration schedule
1725408|NCT00000957|AIDS Vaccines|aids vaccines
1725409|NCT00000957|HIV Seronegativity|hiv seronegativity
1725410|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
1725411|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
1725412|NCT00000956|Vaccinia Virus|vaccinia virus
1725413|NCT00000956|HIV-1|hiv-1
1725414|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
1725415|NCT00000956|AIDS Vaccines|aids vaccines
1725416|NCT00000956|HIV Seronegativity|hiv seronegativity
1725417|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
1725418|NCT00000955|Tuberculosis|tuberculosis
1725419|NCT00000955|Immunologic Tests|immunologic tests
1725420|NCT00000955|Tuberculin|tuberculin
1725421|NCT00000955|Tuberculin Test|tuberculin test
1725422|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725423|NCT00000955|Injections, Intradermal|injections, intradermal
1725424|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725425|NCT00000955|AIDS-Related Complex|aids-related complex
1725426|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
1725427|NCT00000954|Vincristine|vincristine
1725428|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
1725429|NCT00000954|Zalcitabine|zalcitabine
1725430|NCT00000954|Didanosine|didanosine
1725431|NCT00000954|Doxorubicin|doxorubicin
1725432|NCT00000954|Drug Evaluation|drug evaluation
1725433|NCT00000954|Drug Interactions|drug interactions
1725434|NCT00000954|Drug Therapy, Combination|drug therapy, combination
1725435|NCT00000954|Combined Modality Therapy|combined modality therapy
1725436|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725437|NCT00000954|Antineoplastic Agents|antineoplastic agents
1725438|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
1725439|NCT00000954|Antiviral Agents|antiviral agents
1725440|NCT00000954|Bleomycin|bleomycin
1725441|NCT00000953|Herpes Zoster|herpes zoster
1725442|NCT00000953|Acyclovir|acyclovir
1725443|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725444|NCT00000953|AIDS-Related Complex|aids-related complex
1725445|NCT00000953|Antiviral Agents|antiviral agents
1725446|NCT00000953|sorivudine|sorivudine
1725447|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
1725448|NCT00000952|Drug Therapy, Combination|drug therapy, combination
1725449|NCT00000952|Zidovudine|zidovudine
1725450|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
1725451|NCT00000952|Ritonavir|ritonavir
1725452|NCT00000952|Lamivudine|lamivudine
1725453|NCT00000952|Anti-HIV Agents|anti-hiv agents
1725454|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725455|NCT00000951|Fluconazole|fluconazole
1725456|NCT00000951|Antifungal Agents|antifungal agents
1725457|NCT00000951|Candidiasis, Oral|candidiasis, oral
1725458|NCT00000951|Drug Administration Schedule|drug administration schedule
1725459|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
1725460|NCT00000950|Tuberculosis|tuberculosis
1725461|NCT00000950|Isoniazid|isoniazid
1725462|NCT00000950|Pyrazinamide|pyrazinamide
1725463|NCT00000950|Pyridoxine|pyridoxine
1725464|NCT00000950|Rifampin|rifampin
1725465|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725466|NCT00000950|Drug Therapy, Combination|drug therapy, combination
1725467|NCT00000950|Ethambutol|ethambutol
1725468|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725469|NCT00000950|Antitubercular Agents|antitubercular agents
1725470|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725471|NCT00000949|Interleukin-2|interleukin-2
1725472|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
1725473|NCT00000949|Adolescent Behavior|adolescent behavior
1725474|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
1725475|NCT00000949|RNA, Viral|rna, viral
1725476|NCT00000949|Quality of Life|quality of life
1725477|NCT00000949|Anti-HIV Agents|anti-hiv agents
1725478|NCT00000949|Viral Load|viral load
1725479|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
1725480|NCT00000948|Interleukin-2|interleukin-2
1725481|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
1725482|NCT00000948|Drug Therapy, Combination|drug therapy, combination
1725483|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
1725484|NCT00000948|Anti-HIV Agents|anti-hiv agents
1725485|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725487|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725488|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725489|NCT00000947|Antitubercular Agents|antitubercular agents
1725490|NCT00000947|Azithromycin|azithromycin
1725491|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
1725492|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
1725493|NCT00000947|Antibiotics|antibiotics
1725494|NCT00000947|Time Factors|time factors
1725495|NCT00000947|Anti-HIV Agents|anti-hiv agents
1725496|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
1725497|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
1725498|NCT00000946|Drug Evaluation|drug evaluation
1725499|NCT00000946|Drug Therapy, Combination|drug therapy, combination
1725500|NCT00000946|AIDS Vaccines|aids vaccines
1725501|NCT00000946|HIV Seronegativity|hiv seronegativity
1725502|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
1725503|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
1725504|NCT00000945|Probenecid|probenecid
1725505|NCT00000945|HIV-1|hiv-1
1725506|NCT00000945|Central Nervous System Diseases|central nervous system diseases
1725507|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725508|NCT00000945|DNA, Viral|dna, viral
1725509|NCT00000945|cidofovir|cidofovir
1725510|NCT00000945|Anti-HIV Agents|anti-hiv agents
1725511|NCT00000945|Neurologic Examination|neurologic examination
1725512|NCT00000945|Renal Agents|renal agents
1725513|NCT00000944|Pregnancy|pregnancy
1725514|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725515|NCT00000944|Drug Therapy, Combination|drug therapy, combination
1725516|NCT00000944|Zidovudine|zidovudine
1725517|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
1725518|NCT00000944|Lamivudine|lamivudine
1725519|NCT00000944|Indinavir|indinavir
1725520|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
1725521|NCT00000944|Anti-HIV Agents|anti-hiv agents
1725522|NCT00000943|Lymphocytes|lymphocytes
1725523|NCT00000943|Interleukin-2|interleukin-2
1725524|NCT00000943|Drug Therapy, Combination|drug therapy, combination
1725525|NCT00000943|AIDS Vaccines|aids vaccines
1725526|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
1725527|NCT00000943|Cell Division|cell division
1725528|NCT00000943|HIV Core Protein p24|hiv core protein p24
1725529|NCT00000943|Anti-HIV Agents|anti-hiv agents
1725530|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1725531|NCT00000942|Placebos|placebos
1725532|NCT00000942|Pregnancy|pregnancy
1725533|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725534|NCT00000942|Nevirapine|nevirapine
1725535|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
1725536|NCT00000942|Labor|labor
1725537|NCT00000942|Anti-HIV Agents|anti-hiv agents
1725538|NCT00000941|Drug Interactions|drug interactions
1725539|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
1725540|NCT00000941|Ritonavir|ritonavir
1725541|NCT00000941|HIV Seronegativity|hiv seronegativity
1725542|NCT00000941|Saquinavir|saquinavir
1725544|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
1725545|NCT00000940|Drug Therapy, Combination|drug therapy, combination
1725546|NCT00000940|Stavudine|stavudine
1725547|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
1725548|NCT00000940|Protease Inhibitors|protease inhibitors
1725549|NCT00000940|Lamivudine|lamivudine
1725550|NCT00000940|VX 478|vx 478
1725551|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725552|NCT00000940|Anti-HIV Agents|anti-hiv agents
1725553|NCT00000940|Viral Load|viral load
1725554|NCT00000940|Abacavir Sulfate|abacavir sulfate
1725555|NCT00000940|Acute Infection|acute infection
1725556|NCT00000940|Treatment Interruption|treatment interruption
1725557|NCT00000939|Didanosine|didanosine
1725558|NCT00000939|Drug Therapy, Combination|drug therapy, combination
1725559|NCT00000939|Stavudine|stavudine
1725560|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
1725561|NCT00000939|Hydroxyurea|hydroxyurea
1725562|NCT00000939|RNA, Viral|rna, viral
1725563|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725564|NCT00000939|Anti-HIV Agents|anti-hiv agents
1725565|NCT00000939|Viral Load|viral load
1725566|NCT00000939|efavirenz|efavirenz
1725567|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725568|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725569|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
1725570|NCT00000933|Azithromycin|azithromycin
1725571|NCT00000933|Drug Administration Schedule|drug administration schedule
1725572|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
1725573|NCT00000933|Carrier State|carrier state
1725574|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
1725575|NCT00000932|Prospective Studies|prospective studies
1725576|NCT00000932|HIV-1|hiv-1
1725577|NCT00000932|Drug Therapy, Combination|drug therapy, combination
1725578|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
1725579|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
1725580|NCT00000932|Disease Progression|disease progression
1725581|NCT00000932|Treatment Outcome|treatment outcome
1725583|NCT00000932|Anti-HIV Agents|anti-hiv agents
1725584|NCT00000932|Viral Load|viral load
1725585|NCT00000931|Homosexuality, Male|homosexuality, male
1725586|NCT00000931|Risk-Taking|risk-taking
1725587|NCT00000931|Behavior Therapy|behavior therapy
1725588|NCT00000931|HIV Seronegativity|hiv seronegativity
1725589|NCT00000930|Sexual Partners|sexual partners
1725590|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
1725591|NCT00000930|Cohort Studies|cohort studies
1725592|NCT00000930|Risk Factors|risk factors
1725593|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
1725594|NCT00000930|Disease Progression|disease progression
1725595|NCT00000930|Homosexuality, Male|homosexuality, male
1725596|NCT00000930|Genotype|genotype
1725597|NCT00000930|Phenotype|phenotype
1725598|NCT00000929|Sexual Partners|sexual partners
1725599|NCT00000929|Homosexuality, Male|homosexuality, male
1725600|NCT00000929|Anti-Infective Agents|anti-infective agents
1725601|NCT00000929|Patient Compliance|patient compliance
1725602|NCT00000929|Nonoxynol|nonoxynol
1725603|NCT00000929|Rectum|rectum
1725604|NCT00000928|Sexual Partners|sexual partners
1725605|NCT00000928|Condoms|condoms
1725606|NCT00000928|Counseling|counseling
1725607|NCT00000927|Administration, Topical|administration, topical
1725608|NCT00000927|Mucous Membrane|mucous membrane
1725609|NCT00000927|Anti-Infective Agents|anti-infective agents
1725610|NCT00000927|Cervix Uteri|cervix uteri
1725611|NCT00000927|Vagina|vagina
1725612|NCT00000927|Vulva|vulva
1725613|NCT00000927|Buffers|buffers
1725614|NCT00000926|Nonoxynol|nonoxynol
1725615|NCT00000925|Dietary Proteins|dietary proteins
1725616|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
1725617|NCT00000924|Drug Therapy, Combination|drug therapy, combination
1725618|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
1725619|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725620|NCT00000924|Anti-HIV Agents|anti-hiv agents
1725621|NCT00000923|Interleukin-2|interleukin-2
1725622|NCT00000923|Drug Therapy, Combination|drug therapy, combination
1725623|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
1725624|NCT00000923|Anti-HIV Agents|anti-hiv agents
1725625|NCT00000923|Viral Load|viral load
1725626|NCT00000922|Drug Therapy, Combination|drug therapy, combination
1725627|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
1725628|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725629|NCT00000922|Anti-HIV Agents|anti-hiv agents
1725630|NCT00000922|Treatment Naive|treatment naive
1725631|NCT00000921|Drug Therapy, Combination|drug therapy, combination
1725632|NCT00000921|Prednisone|prednisone
1725633|NCT00000921|Anti-HIV Agents|anti-hiv agents
1725634|NCT00000920|Pregnancy|pregnancy
1725635|NCT00000920|Drug Therapy, Combination|drug therapy, combination
1725636|NCT00000920|Zidovudine|zidovudine
1725637|NCT00000920|Pregnancy Complications|pregnancy complications
1725638|NCT00000920|Ritonavir|ritonavir
1725639|NCT00000920|Lamivudine|lamivudine
1725640|NCT00000920|Saquinavir|saquinavir
1725641|NCT00000920|Anti-HIV Agents|anti-hiv agents
1725642|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
1725643|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725644|NCT00000919|Anti-HIV Agents|anti-hiv agents
1725645|NCT00000919|Viral Load|viral load
1725646|NCT00000918|Drug Therapy, Combination|drug therapy, combination
1725647|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
1725648|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725649|NCT00000918|Salvage Therapy|salvage therapy
1725650|NCT00000918|Anti-HIV Agents|anti-hiv agents
1725651|NCT00000918|Viral Load|viral load
1725652|NCT00000917|Gene Therapy|gene therapy
1725653|NCT00000917|Specimen Handling|specimen handling
1725654|NCT00000917|Blood Banks|blood banks
1725655|NCT00000917|Fetal Blood|fetal blood
1725656|NCT00000916|Drug Therapy, Combination|drug therapy, combination
1725657|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
1725658|NCT00000916|Hydroxyurea|hydroxyurea
1725659|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725660|NCT00000916|Anti-HIV Agents|anti-hiv agents
1725661|NCT00000916|Viral Load|viral load
1725662|NCT00000915|AIDS Vaccines|aids vaccines
1725663|NCT00000915|Incidence|incidence
1725664|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
1725665|NCT00000915|Risk-Taking|risk-taking
1725666|NCT00000914|Drug Therapy, Combination|drug therapy, combination
1725667|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
1725668|NCT00000914|Ritonavir|ritonavir
1725669|NCT00000914|Indinavir|indinavir
1725670|NCT00000914|Saquinavir|saquinavir
1725671|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725672|NCT00000914|Viral Load|viral load
1725673|NCT00000914|Nelfinavir|nelfinavir
1725674|NCT00000913|Saquinavir|saquinavir
1725675|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725676|NCT00000913|Anti-HIV Agents|anti-hiv agents
1725677|NCT00000913|Viral Load|viral load
1725678|NCT00000912|Placebos|placebos
1725679|NCT00000912|Drug Therapy, Combination|drug therapy, combination
1725680|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
1725681|NCT00000912|VX 478|vx 478
1725682|NCT00000912|Anti-HIV Agents|anti-hiv agents
1725687|NCT00000911|Immunity, Cellular|immunity, cellular
1725688|NCT00000911|Lymph Nodes|lymph nodes
1725689|NCT00000911|Viremia|viremia
1725690|NCT00000911|Antibodies, Viral|antibodies, viral
1725691|NCT00000911|Vagina|vagina
1725692|NCT00000911|Viral Load|viral load
1725693|NCT00000911|Acute Infection|acute infection
1725694|NCT00000910|Pregnancy|pregnancy
1725695|NCT00000910|Anti-HIV Agents|anti-hiv agents
1725696|NCT00000909|Interleukin-2|interleukin-2
1725697|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
1725698|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
1725699|NCT00000909|RNA, Viral|rna, viral
1725700|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725701|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1725702|NCT00000908|Antiviral Agents|antiviral agents
1725703|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
1725704|NCT00000908|RNA, Viral|rna, viral
1725705|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725706|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725707|NCT00000907|Immunity, Cellular|immunity, cellular
1725708|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
1725709|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
1725710|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
1725711|NCT00000907|Disease Progression|disease progression
1725712|NCT00000907|Anti-HIV Agents|anti-hiv agents
1725713|NCT00000906|Methadone|methadone
1725714|NCT00000906|HIV-1|hiv-1
1725715|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
1725716|NCT00000906|Drug Interactions|drug interactions
1725717|NCT00000906|Drug Therapy, Combination|drug therapy, combination
1725718|NCT00000906|Saquinavir|saquinavir
1725719|NCT00000906|Adolescent Behavior|adolescent behavior
1725720|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
1725721|NCT00000906|Ritonavir|ritonavir
1725722|NCT00000906|Narcotics|narcotics
1725723|NCT00000906|Substance-Related Disorders|substance-related disorders
1725724|NCT00000905|Immunity, Cellular|immunity, cellular
1725725|NCT00000905|Disease Progression|disease progression
1725726|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1725727|NCT00000905|DNA, Viral|dna, viral
1725728|NCT00000905|Prognosis|prognosis
1725729|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
1725730|NCT00000904|Viral Vaccines|viral vaccines
1725731|NCT00000904|HIV Antibodies|hiv antibodies
1725732|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
1725733|NCT00000904|AIDS Vaccines|aids vaccines
1725734|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1725735|NCT00000904|HIV Seronegativity|hiv seronegativity
1725736|NCT00000904|Antibody Formation|antibody formation
1725737|NCT00000904|Risk-Taking|risk-taking
1725738|NCT00000904|Avipoxvirus|avipoxvirus
1725739|NCT00000904|Genetic Vectors|genetic vectors
1725740|NCT00000904|Immunization|immunization
1725741|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
1725742|NCT00000903|Drug Therapy, Combination|drug therapy, combination
1725743|NCT00000903|Zidovudine|zidovudine
1727517|NCT00023166|Phase I|phase i
1725744|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
1725745|NCT00000903|Lamivudine|lamivudine
1725746|NCT00000903|Indinavir|indinavir
1725747|NCT00000903|RNA, Viral|rna, viral
1725748|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725749|NCT00000903|Nelfinavir|nelfinavir
1725750|NCT00000903|efavirenz|efavirenz
1725751|NCT00000902|Zalcitabine|zalcitabine
1725752|NCT00000902|Didanosine|didanosine
1725753|NCT00000902|Drug Therapy, Combination|drug therapy, combination
1725754|NCT00000902|Zidovudine|zidovudine
1725755|NCT00000902|Nevirapine|nevirapine
1725756|NCT00000902|Stavudine|stavudine
1725757|NCT00000902|Ritonavir|ritonavir
1725758|NCT00000902|Lamivudine|lamivudine
1725759|NCT00000902|RNA, Viral|rna, viral
1725760|NCT00000902|Anti-HIV Agents|anti-hiv agents
1725761|NCT00000902|Nelfinavir|nelfinavir
1725762|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
1725763|NCT00000901|Drug Therapy, Combination|drug therapy, combination
1725764|NCT00000901|Stavudine|stavudine
1725765|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
1725766|NCT00000901|Lamivudine|lamivudine
1725767|NCT00000901|Indinavir|indinavir
1725768|NCT00000901|RNA, Viral|rna, viral
1725769|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725770|NCT00000901|Viral Load|viral load
1725771|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725772|NCT00000900|HIV-1|hiv-1
1725773|NCT00000900|Antiviral Agents|antiviral agents
1725774|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
1725775|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
1725776|NCT00000900|RNA, Viral|rna, viral
1725777|NCT00000900|Fever|fever
1725778|NCT00000900|Viral Load|viral load
1725779|NCT00000899|Cyclophosphamide|cyclophosphamide
1725780|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
1725781|NCT00000899|Drug Therapy, Combination|drug therapy, combination
1725879|NCT00000888|Drug Therapy, Combination|drug therapy, combination
1725782|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1725881|NCT00000888|Zidovudine|zidovudine
1725783|NCT00000899|Combined Modality Therapy|combined modality therapy
1725784|NCT00000899|Antineoplastic Agents|antineoplastic agents
1725785|NCT00000899|Lymph Nodes|lymph nodes
1725786|NCT00000899|Stavudine|stavudine
1725787|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
1725788|NCT00000899|Lamivudine|lamivudine
1725789|NCT00000899|DNA, Viral|dna, viral
1725790|NCT00000899|RNA, Viral|rna, viral
1725791|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725792|NCT00000899|Anti-HIV Agents|anti-hiv agents
1725793|NCT00000899|Nelfinavir|nelfinavir
1725794|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
1725795|NCT00000898|Drug Interactions|drug interactions
1725796|NCT00000898|Drug Therapy, Combination|drug therapy, combination
1725797|NCT00000898|Saquinavir|saquinavir
1725798|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
1725799|NCT00000898|Ritonavir|ritonavir
1725800|NCT00000898|Nelfinavir|nelfinavir
1725801|NCT00000897|Drug Interactions|drug interactions
1725802|NCT00000897|Zidovudine|zidovudine
1725803|NCT00000897|Sex Factors|sex factors
1725804|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725805|NCT00000897|Contraceptives, Oral|contraceptives, oral
1725806|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
1725807|NCT00000897|Anti-HIV Agents|anti-hiv agents
1725808|NCT00000897|Viral Load|viral load
1725809|NCT00000897|Estrogens|estrogens
1725810|NCT00000896|HIV-1|hiv-1
1725811|NCT00000896|Drug Therapy, Combination|drug therapy, combination
1725812|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1725813|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725814|NCT00000896|Zidovudine|zidovudine
1725815|NCT00000896|Nevirapine|nevirapine
1725816|NCT00000896|Stavudine|stavudine
1725817|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
1725818|NCT00000896|Lamivudine|lamivudine
1725819|NCT00000896|Indinavir|indinavir
1725820|NCT00000896|Interleukin-12|interleukin-12
1725821|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725822|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725823|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725824|NCT00000895|HIV-1|hiv-1
1725825|NCT00000895|Drug Therapy, Combination|drug therapy, combination
1725826|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725827|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
1725828|NCT00000895|Bacteremia|bacteremia
1725829|NCT00000895|Nevirapine|nevirapine
1725830|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
1725831|NCT00000895|Risk Factors|risk factors
1725832|NCT00000895|RNA, Viral|rna, viral
1725833|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725834|NCT00000895|Nelfinavir|nelfinavir
1725835|NCT00000894|Infusions, Intravenous|infusions, intravenous
1725836|NCT00000894|Ganciclovir|ganciclovir
1725837|NCT00000894|Drug Therapy, Combination|drug therapy, combination
1725838|NCT00000894|Administration, Oral|administration, oral
1725839|NCT00000894|Antiviral Agents|antiviral agents
1725840|NCT00000894|Drug Implants|drug implants
1725841|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1725842|NCT00000894|Eye|eye
1725843|NCT00000894|cidofovir|cidofovir
1725844|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
1725845|NCT00000893|Drug Therapy, Combination|drug therapy, combination
1725846|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
1725847|NCT00000893|Nelfinavir|nelfinavir
1725848|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725849|NCT00000893|Area Under Curve|area under curve
1725850|NCT00000893|efavirenz|efavirenz
1725851|NCT00000892|HIV-1|hiv-1
1725852|NCT00000892|Drug Therapy, Combination|drug therapy, combination
1725853|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
1725854|NCT00000892|Ritonavir|ritonavir
1725855|NCT00000892|Indinavir|indinavir
1725856|NCT00000892|RNA, Viral|rna, viral
1725857|NCT00000892|Saquinavir|saquinavir
1725858|NCT00000892|Delavirdine|delavirdine
1725859|NCT00000892|Nelfinavir|nelfinavir
1725860|NCT00000892|Adenine|adenine
1725861|NCT00000892|Anti-HIV Agents|anti-hiv agents
1725862|NCT00000892|Viral Load|viral load
1725863|NCT00000891|Drug Therapy, Combination|drug therapy, combination
1725864|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
1725865|NCT00000891|Follow-Up Studies|follow-up studies
1725866|NCT00000891|Anti-HIV Agents|anti-hiv agents
1725867|NCT00000891|Viral Load|viral load
1725868|NCT00000890|HIV-1|hiv-1
1725869|NCT00000890|Muscles|muscles
1725870|NCT00000890|RNA, Viral|rna, viral
1725871|NCT00000890|Body Composition|body composition
1725872|NCT00000890|Anti-HIV Agents|anti-hiv agents
1725873|NCT00000890|Viral Load|viral load
1725874|NCT00000889|Interleukin-2|interleukin-2
1725875|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
1725876|NCT00000889|Anti-HIV Agents|anti-hiv agents
1725877|NCT00000888|Pregnancy|pregnancy
1725878|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725977|NCT00000878|Lamivudine|lamivudine
1725880|NCT00000888|Administration, Oral|administration, oral
1725882|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
1725883|NCT00000888|Ritonavir|ritonavir
1725884|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
1725885|NCT00000888|Anti-HIV Agents|anti-hiv agents
1725886|NCT00000888|Fetal Blood|fetal blood
1725887|NCT00000887|Pregnancy|pregnancy
1725888|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725889|NCT00000887|Drug Therapy, Combination|drug therapy, combination
1725890|NCT00000887|Zidovudine|zidovudine
1725891|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
1725892|NCT00000887|Lamivudine|lamivudine
1725893|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
1725894|NCT00000887|Nelfinavir|nelfinavir
1725895|NCT00000887|Anti-HIV Agents|anti-hiv agents
1725896|NCT00000886|HIV Antibodies|hiv antibodies
1725897|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
1725898|NCT00000886|Drug Carriers|drug carriers
1725899|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
1725900|NCT00000886|AIDS Vaccines|aids vaccines
1725901|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1725902|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
1725903|NCT00000886|HIV Seronegativity|hiv seronegativity
1725904|NCT00000886|Neutralization Tests|neutralization tests
1725905|NCT00000886|Mineral Oil|mineral oil
1725906|NCT00000886|Oleic Acids|oleic acids
1725908|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
1725909|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
1725910|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
1725912|NCT00000885|Drug Therapy, Combination|drug therapy, combination
1725913|NCT00000885|Zidovudine|zidovudine
1725914|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
1725915|NCT00000885|Lamivudine|lamivudine
1725916|NCT00000885|Indinavir|indinavir
1725917|NCT00000885|RNA, Viral|rna, viral
1725918|NCT00000885|Treatment Failure|treatment failure
1725919|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725920|NCT00000885|Anti-HIV Agents|anti-hiv agents
1725921|NCT00000885|Viral Load|viral load
1725922|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
1725923|NCT00000884|Injections, Intramuscular|injections, intramuscular
1725925|NCT00000884|Immunity, Cellular|immunity, cellular
1725926|NCT00000884|AIDS Vaccines|aids vaccines
1725927|NCT00000884|HIV Seronegativity|hiv seronegativity
1725928|NCT00000884|Mucous Membrane|mucous membrane
1725929|NCT00000884|Antibodies, Viral|antibodies, viral
1725930|NCT00000884|Avipoxvirus|avipoxvirus
1725931|NCT00000884|Genetic Vectors|genetic vectors
1725932|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
1725933|NCT00000884|Immunity, Mucosal|immunity, mucosal
1725934|NCT00000884|Rabies Vaccines|rabies vaccines
1725935|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
1725936|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725937|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1725938|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
1725939|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1725940|NCT00000883|Azithromycin|azithromycin
1725941|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
1725942|NCT00000883|Anti-HIV Agents|anti-hiv agents
1725943|NCT00000882|HIV-1|hiv-1
1725944|NCT00000882|Drug Therapy, Combination|drug therapy, combination
1725945|NCT00000882|Stavudine|stavudine
1725946|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
1725947|NCT00000882|Lamivudine|lamivudine
1725948|NCT00000882|Indinavir|indinavir
1725949|NCT00000882|RNA, Viral|rna, viral
1725950|NCT00000882|Delavirdine|delavirdine
1725951|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725952|NCT00000882|Anti-HIV Agents|anti-hiv agents
1725953|NCT00000882|Viral Load|viral load
1725954|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1725955|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
1725956|NCT00000881|Antiviral Agents|antiviral agents
1725957|NCT00000881|cidofovir|cidofovir
1725958|NCT00000880|T-Lymphocytes|t-lymphocytes
1725959|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
1725960|NCT00000880|HIV-1|hiv-1
1725961|NCT00000880|Drug Therapy, Combination|drug therapy, combination
1725962|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
1725963|NCT00000880|Apoptosis|apoptosis
1725964|NCT00000880|Cyclosporine|cyclosporine
1725965|NCT00000880|Anti-HIV Agents|anti-hiv agents
1725966|NCT00000879|Pregnancy|pregnancy
1725967|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725968|NCT00000879|AIDS Vaccines|aids vaccines
1725969|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
1725970|NCT00000879|Avipoxvirus|avipoxvirus
1725971|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
1725972|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1725973|NCT00000878|Pregnancy|pregnancy
1725974|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
1725975|NCT00000878|Drug Therapy, Combination|drug therapy, combination
1725976|NCT00000878|Stavudine|stavudine
1725978|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
1725979|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1725980|NCT00000878|Anti-HIV Agents|anti-hiv agents
1725981|NCT00000878|Viral Load|viral load
1725982|NCT00000877|Rifabutin|rifabutin
1725983|NCT00000877|Drug Therapy, Combination|drug therapy, combination
1725984|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
1725985|NCT00000877|Indinavir|indinavir
1725986|NCT00000877|HIV Seronegativity|hiv seronegativity
1725987|NCT00000877|Anti-HIV Agents|anti-hiv agents
1725988|NCT00000876|Antiviral Agents|antiviral agents
1725989|NCT00000876|CD4-IgG(2)|cd4-igg(2)
1725991|NCT00000875|Drug Therapy, Combination|drug therapy, combination
1725992|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
1725993|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1725994|NCT00000875|Anti-HIV Agents|anti-hiv agents
1725995|NCT00000875|Viral Load|viral load
1725996|NCT00000874|HIV-1|hiv-1
1725997|NCT00000874|Drug Therapy, Combination|drug therapy, combination
1725998|NCT00000874|Zidovudine|zidovudine
1725999|NCT00000874|Stavudine|stavudine
1726000|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
1726001|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
1726002|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
1726003|NCT00000874|Ritonavir|ritonavir
1726004|NCT00000874|Lamivudine|lamivudine
1726005|NCT00000874|Indinavir|indinavir
1726006|NCT00000874|RNA, Viral|rna, viral
1726007|NCT00000874|Genotype|genotype
1726008|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726009|NCT00000874|Anti-HIV Agents|anti-hiv agents
1726010|NCT00000874|Viral Load|viral load
1726011|NCT00000873|Nutritional Status|nutritional status
1726012|NCT00000873|HIV Seronegativity|hiv seronegativity
1726013|NCT00000873|Infant Food|infant food
1726014|NCT00000872|Virus Replication|virus replication
1726015|NCT00000872|HIV-1|hiv-1
1726016|NCT00000872|Drug Therapy, Combination|drug therapy, combination
1726017|NCT00000872|Zidovudine|zidovudine
1726018|NCT00000872|Nevirapine|nevirapine
1726019|NCT00000872|Stavudine|stavudine
1726020|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
1726021|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
1726022|NCT00000872|Lamivudine|lamivudine
1726023|NCT00000872|RNA, Viral|rna, viral
1726024|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726025|NCT00000872|Anti-HIV Agents|anti-hiv agents
1726026|NCT00000872|Viral Load|viral load
1726027|NCT00000872|Nelfinavir|nelfinavir
1726028|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
1726029|NCT00000871|AIDS Vaccines|aids vaccines
1726030|NCT00000871|HIV Seronegativity|hiv seronegativity
1726031|NCT00000871|Avipoxvirus|avipoxvirus
1726032|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
1726033|NCT00000870|Recombinant Proteins|recombinant proteins
1726034|NCT00000870|Infusions, Intravenous|infusions, intravenous
1726035|NCT00000870|Injections, Intravenous|injections, intravenous
1726036|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
1726037|NCT00000870|Interleukin-2|interleukin-2
1726038|NCT00000870|Drug Administration Schedule|drug administration schedule
1726039|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
1726040|NCT00000870|Quality of Life|quality of life
1726041|NCT00000870|Anti-HIV Agents|anti-hiv agents
1726042|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
1726043|NCT00000869|Placebos|placebos
1726044|NCT00000869|Pregnancy|pregnancy
1726045|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726046|NCT00000869|Administration, Oral|administration, oral
1726047|NCT00000869|Nevirapine|nevirapine
1726048|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
1726049|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726050|NCT00000869|Anti-HIV Agents|anti-hiv agents
1726051|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
1726052|NCT00000868|HIV-1|hiv-1
1726053|NCT00000868|Administration, Oral|administration, oral
1726054|NCT00000868|AIDS Vaccines|aids vaccines
1726055|NCT00000868|HIV Seronegativity|hiv seronegativity
1726056|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
1726057|NCT00000868|Recombination, Genetic|recombination, genetic
1726058|NCT00000868|Salmonella typhi|salmonella typhi
1726059|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
1726060|NCT00000867|Drug Therapy, Combination|drug therapy, combination
1726061|NCT00000867|Administration, Oral|administration, oral
1726062|NCT00000867|AIDS Dementia Complex|aids dementia complex
1726063|NCT00000867|Zidovudine|zidovudine
1726064|NCT00000867|Anti-HIV Agents|anti-hiv agents
1726065|NCT00000867|Memantine|memantine
1726066|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
1726067|NCT00000866|Vaccinia Virus|vaccinia virus
1726068|NCT00000866|Placebos|placebos
1726069|NCT00000866|HIV-1|hiv-1
1726070|NCT00000866|AIDS Vaccines|aids vaccines
1726071|NCT00000866|HIV Seronegativity|hiv seronegativity
1726072|NCT00000866|Genes, env|genes, env
1726073|NCT00000866|Genes, pol|genes, pol
1726074|NCT00000866|Genes, gag|genes, gag
1726075|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
1726076|NCT00000865|Drug Therapy, Combination|drug therapy, combination
1726077|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726078|NCT00000865|Anti-HIV Agents|anti-hiv agents
1726080|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726081|NCT00000864|HIV-1|hiv-1
1726082|NCT00000864|Drug Therapy, Combination|drug therapy, combination
1726083|NCT00000864|Zidovudine|zidovudine
1726084|NCT00000864|Drug Administration Schedule|drug administration schedule
1726085|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
1726086|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726087|NCT00000864|Anti-HIV Agents|anti-hiv agents
1726088|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726089|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726090|NCT00000863|Administration, Oral|administration, oral
1726091|NCT00000863|WR 6026|wr 6026
1726092|NCT00000862|Pregnancy|pregnancy
1726093|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726094|NCT00000862|Administration, Oral|administration, oral
1726095|NCT00000862|Zidovudine|zidovudine
1726096|NCT00000862|Delivery|delivery
1726097|NCT00000862|Labor|labor
1726098|NCT00000862|Anti-HIV Agents|anti-hiv agents
1726099|NCT00000861|Drug Administration Schedule|drug administration schedule
1726100|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
1726101|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
1726102|NCT00000861|Indinavir|indinavir
1726103|NCT00000861|RNA, Viral|rna, viral
1726104|NCT00000861|Anti-HIV Agents|anti-hiv agents
1726105|NCT00000861|Viral Load|viral load
1726106|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
1726107|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726108|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1726109|NCT00000860|Drug Therapy, Combination|drug therapy, combination
1726110|NCT00000860|Anti-HIV Agents|anti-hiv agents
1726111|NCT00000859|HIV-1|hiv-1
1726112|NCT00000859|Drug Resistance|drug resistance
1726113|NCT00000859|Drug Therapy, Combination|drug therapy, combination
1726114|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
1726115|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
1726116|NCT00000859|Ritonavir|ritonavir
1726117|NCT00000859|Indinavir|indinavir
1726118|NCT00000859|Disease Progression|disease progression
1726119|NCT00000859|RNA, Viral|rna, viral
1726120|NCT00000859|Genotype|genotype
1726121|NCT00000859|Nelfinavir|nelfinavir
1726122|NCT00000859|Anti-HIV Agents|anti-hiv agents
1726123|NCT00000859|Viral Load|viral load
1726124|NCT00000858|HIV-1|hiv-1
1726125|NCT00000858|Vagina|vagina
1726126|NCT00000857|Recombinant Proteins|recombinant proteins
1726127|NCT00000857|T-Lymphocytes|t-lymphocytes
1726128|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
1726129|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
1726130|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
1726131|NCT00000857|Interleukin-12|interleukin-12
1726132|NCT00000857|Killer Cells, Natural|killer cells, natural
1726133|NCT00000857|Th1 Cells|th1 cells
1726134|NCT00000857|Interferon Type II|interferon type ii
1726135|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726136|NCT00000856|Ganciclovir|ganciclovir
1726137|NCT00000856|Drug Therapy, Combination|drug therapy, combination
1726138|NCT00000856|Encephalitis|encephalitis
1726139|NCT00000856|Foscarnet|foscarnet
1726140|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
1726141|NCT00000856|Antiviral Agents|antiviral agents
1726142|NCT00000856|Radiculopathy|radiculopathy
1726143|NCT00000855|Zidovudine|zidovudine
1726144|NCT00000855|Anti-HIV Agents|anti-hiv agents
1726145|NCT00000854|Placebos|placebos
1726146|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726147|NCT00000854|AIDS-Related Complex|aids-related complex
1726148|NCT00000854|Anabolic Steroids|anabolic steroids
1726149|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
1726150|NCT00000854|nandrolone decanoate|nandrolone decanoate
1726151|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
1726152|NCT00000853|HIV-1|hiv-1
1726153|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
1726154|NCT00000853|AIDS Vaccines|aids vaccines
1726155|NCT00000853|HIV Seronegativity|hiv seronegativity
1726156|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
1726157|NCT00000852|T-Lymphocytes|t-lymphocytes
1726158|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726159|NCT00000852|Transplantation, Homologous|transplantation, homologous
1726160|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
1726161|NCT00000851|Didanosine|didanosine
1726162|NCT00000851|Drug Therapy, Combination|drug therapy, combination
1726163|NCT00000851|Antiviral Agents|antiviral agents
1726164|NCT00000851|Stavudine|stavudine
1726165|NCT00000850|HIV-1|hiv-1
1726166|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1726167|NCT00000850|RNA, Viral|rna, viral
1726168|NCT00000850|Anti-HIV Agents|anti-hiv agents
1726169|NCT00000850|Viral Load|viral load
1726170|NCT00000850|Receptors, Chemokine|receptors, chemokine
1726171|NCT00000849|Interleukin-2|interleukin-2
1726172|NCT00000849|Immunity, Cellular|immunity, cellular
1726173|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
1726267|NCT00000833|Antiviral Agents|antiviral agents
1726174|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726175|NCT00000849|AIDS-Related Complex|aids-related complex
1726176|NCT00000849|Viral Load|viral load
1726177|NCT00000848|Administration, Oral|administration, oral
1726178|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726179|NCT00000848|AIDS-Related Complex|aids-related complex
1726180|NCT00000848|Antiviral Agents|antiviral agents
1726181|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
1726182|NCT00000848|Biological Markers|biological markers
1726183|NCT00000848|Indinavir|indinavir
1726184|NCT00000848|Viremia|viremia
1726185|NCT00000848|RNA, Viral|rna, viral
1726186|NCT00000848|Saquinavir|saquinavir
1726187|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
1726188|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
1726189|NCT00000847|AIDS Vaccines|aids vaccines
1726190|NCT00000847|HIV Seronegativity|hiv seronegativity
1726191|NCT00000847|Avipoxvirus|avipoxvirus
1726192|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
1726193|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
1726194|NCT00000846|HIV-1|hiv-1
1726195|NCT00000846|AIDS Vaccines|aids vaccines
1726196|NCT00000846|HIV Seronegativity|hiv seronegativity
1726197|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
1726198|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
1726199|NCT00000845|AIDS Vaccines|aids vaccines
1726200|NCT00000845|HIV Seronegativity|hiv seronegativity
1726201|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
1726202|NCT00000844|Drug Therapy, Combination|drug therapy, combination
1726203|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
1726204|NCT00000844|Administration, Oral|administration, oral
1726205|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726206|NCT00000844|AIDS-Related Complex|aids-related complex
1726207|NCT00000844|Interferon-alpha|interferon-alpha
1726208|NCT00000843|Antiviral Agents|antiviral agents
1726209|NCT00000843|Adenine|adenine
1726210|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726211|NCT00000842|AIDS-Related Complex|aids-related complex
1726212|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
1726213|NCT00000842|Nerve Growth Factors|nerve growth factors
1726214|NCT00000842|Growth Substances|growth substances
1726215|NCT00000841|Drug Therapy, Combination|drug therapy, combination
1726216|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726217|NCT00000841|Antiviral Agents|antiviral agents
1726218|NCT00000841|Zidovudine|zidovudine
1726219|NCT00000841|Stavudine|stavudine
1726220|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
1726221|NCT00000841|Lamivudine|lamivudine
1726222|NCT00000841|Indinavir|indinavir
1726223|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726224|NCT00000840|AIDS-Related Complex|aids-related complex
1726225|NCT00000840|Antiviral Agents|antiviral agents
1726226|NCT00000840|Zidovudine|zidovudine
1726227|NCT00000840|Biological Markers|biological markers
1726228|NCT00000840|Viremia|viremia
1726229|NCT00000840|RNA, Viral|rna, viral
1726230|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
1726231|NCT00000839|Pregnancy|pregnancy
1726232|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726233|NCT00000839|Didanosine|didanosine
1726234|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726235|NCT00000839|AIDS-Related Complex|aids-related complex
1726236|NCT00000838|Didanosine|didanosine
1726237|NCT00000838|Drug Therapy, Combination|drug therapy, combination
1726238|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726239|NCT00000838|AIDS-Related Complex|aids-related complex
1726240|NCT00000838|Antiviral Agents|antiviral agents
1726241|NCT00000838|Zidovudine|zidovudine
1726242|NCT00000838|Stavudine|stavudine
1726243|NCT00000838|Lamivudine|lamivudine
1726244|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
1726245|NCT00000837|Viral Vaccines|viral vaccines
1726246|NCT00000837|AIDS-Related Complex|aids-related complex
1726247|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
1726248|NCT00000837|Chickenpox|chickenpox
1726249|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
1726250|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726251|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726252|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
1726253|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
1726254|NCT00000834|Methotrexate|methotrexate
1726255|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726256|NCT00000834|AIDS-Related Complex|aids-related complex
1726257|NCT00000834|Zidovudine|zidovudine
1726258|NCT00000834|Lamivudine|lamivudine
1726259|NCT00000834|Disease Progression|disease progression
1726260|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
1726261|NCT00000834|Anti-HIV Agents|anti-hiv agents
1726262|NCT00000833|Ribavirin|ribavirin
1726263|NCT00000833|Didanosine|didanosine
1726264|NCT00000833|Drug Therapy, Combination|drug therapy, combination
1726446|NCT00000799|Antiviral Agents|antiviral agents
1726265|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726266|NCT00000833|AIDS-Related Complex|aids-related complex
1726268|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
1726269|NCT00000832|HIV-1|hiv-1
1726270|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
1726271|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
1726272|NCT00000832|AIDS Vaccines|aids vaccines
1726273|NCT00000832|HIV Seronegativity|hiv seronegativity
1726274|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
1726275|NCT00000831|Didanosine|didanosine
1726276|NCT00000831|Drug Therapy, Combination|drug therapy, combination
1726277|NCT00000831|AIDS-Related Complex|aids-related complex
1726278|NCT00000831|Antiviral Agents|antiviral agents
1726279|NCT00000831|Zidovudine|zidovudine
1726280|NCT00000831|Stavudine|stavudine
1726281|NCT00000831|Lamivudine|lamivudine
1726282|NCT00000831|Drug Combinations|drug combinations
1726283|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
1726284|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726285|NCT00000829|AIDS-Related Complex|aids-related complex
1726286|NCT00000829|Pneumococcal Infections|pneumococcal infections
1726287|NCT00000829|Bacterial Vaccines|bacterial vaccines
1726288|NCT00000828|Pregnancy|pregnancy
1726289|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726290|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726291|NCT00000828|AIDS-Related Complex|aids-related complex
1726292|NCT00000828|Zidovudine|zidovudine
1726293|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
1726294|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
1726295|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726296|NCT00000827|AIDS-Related Complex|aids-related complex
1726297|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1726298|NCT00000827|Immunization, Passive|immunization, passive
1726299|NCT00000826|Rifabutin|rifabutin
1726300|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726301|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726302|NCT00000826|Dapsone|dapsone
1726303|NCT00000826|Drug Interactions|drug interactions
1726304|NCT00000826|Fluconazole|fluconazole
1726305|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726306|NCT00000826|AIDS-Related Complex|aids-related complex
1726307|NCT00000826|Clarithromycin|clarithromycin
1726308|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726309|NCT00000825|HIV-1|hiv-1
1726310|NCT00000825|Interleukin-2|interleukin-2
1726311|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
1726312|NCT00000825|Antiviral Agents|antiviral agents
1726313|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
1726314|NCT00000825|DNA, Viral|dna, viral
1726315|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
1726316|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
1726317|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
1726318|NCT00000824|Dendritic Cells|dendritic cells
1726319|NCT00000823|Didanosine|didanosine
1726320|NCT00000823|Drug Therapy, Combination|drug therapy, combination
1726321|NCT00000823|Zidovudine|zidovudine
1726322|NCT00000823|Drug Administration Schedule|drug administration schedule
1727518|NCT00023166|Open label|open label
1726323|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
1726324|NCT00000822|Didanosine|didanosine
1726325|NCT00000822|Drug Therapy, Combination|drug therapy, combination
1726326|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
1726327|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726328|NCT00000822|AIDS-Related Complex|aids-related complex
1726329|NCT00000822|Stavudine|stavudine
1726330|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
1726331|NCT00000822|AIDS Vaccines|aids vaccines
1726332|NCT00000822|Ritonavir|ritonavir
1726333|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
1726334|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726335|NCT00000821|Interleukin-2|interleukin-2
1726336|NCT00000821|AIDS-Related Complex|aids-related complex
1726337|NCT00000820|Interleukin-2|interleukin-2
1726338|NCT00000820|Drug Therapy, Combination|drug therapy, combination
1726339|NCT00000820|AIDS-Related Complex|aids-related complex
1726340|NCT00000820|Antiviral Agents|antiviral agents
1726341|NCT00000819|AIDS-Related Complex|aids-related complex
1726342|NCT00000819|Prednisone|prednisone
1726343|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
1726344|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726345|NCT00000818|AIDS-Related Complex|aids-related complex
1726346|NCT00000818|Zidovudine|zidovudine
1726347|NCT00000818|Lymph Nodes|lymph nodes
1726348|NCT00000818|Lymphoid Tissue|lymphoid tissue
1726349|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726350|NCT00000817|AIDS-Related Complex|aids-related complex
1726351|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
1726352|NCT00000817|Amitriptyline|amitriptyline
1726353|NCT00000817|Pain|pain
1726354|NCT00000817|Acupuncture Therapy|acupuncture therapy
1726355|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726356|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726357|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726358|NCT00000816|AIDS-Related Complex|aids-related complex
1726359|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726360|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726361|NCT00000815|AIDS-Related Complex|aids-related complex
1726362|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
1726363|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
1726364|NCT00000815|Measles Vaccine|measles vaccine
1726365|NCT00000815|Immunization Schedule|immunization schedule
1726366|NCT00000815|Measles Virus|measles virus
1726367|NCT00000815|Measles|measles
1726368|NCT00000814|Didanosine|didanosine
1726369|NCT00000814|Drug Therapy, Combination|drug therapy, combination
1726370|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726371|NCT00000814|AIDS-Related Complex|aids-related complex
1726372|NCT00000814|Zidovudine|zidovudine
1726373|NCT00000814|Nevirapine|nevirapine
1726374|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
1726375|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
1726376|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
1726377|NCT00000813|AIDS Vaccines|aids vaccines
1726378|NCT00000813|HIV Seronegativity|hiv seronegativity
1726379|NCT00000813|Avipoxvirus|avipoxvirus
1726380|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
1726381|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726382|NCT00000812|AIDS-Related Complex|aids-related complex
1726383|NCT00000812|Thalidomide|thalidomide
1726384|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726385|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726386|NCT00000811|Drug Therapy, Combination|drug therapy, combination
1726387|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726388|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
1726389|NCT00000811|AIDS-Related Complex|aids-related complex
1726390|NCT00000811|Azithromycin|azithromycin
1726391|NCT00000811|Bacterial Infections|bacterial infections
1726392|NCT00000811|atovaquone|atovaquone
1726393|NCT00000810|Didanosine|didanosine
1726394|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726395|NCT00000810|AIDS-Related Complex|aids-related complex
1726396|NCT00000810|Antiviral Agents|antiviral agents
1726397|NCT00000810|Zidovudine|zidovudine
1726398|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
1726399|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726400|NCT00000808|Pregnancy|pregnancy
1726401|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726402|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726403|NCT00000808|AIDS-Related Complex|aids-related complex
1726404|NCT00000808|Nevirapine|nevirapine
1726405|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
1726406|NCT00000807|Etoposide|etoposide
1726407|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726408|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726409|NCT00000806|AIDS-Related Complex|aids-related complex
1726410|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
1726411|NCT00000805|Ganciclovir|ganciclovir
1726412|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
1726413|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726414|NCT00000803|Didanosine|didanosine
1726415|NCT00000803|Drug Therapy, Combination|drug therapy, combination
1726416|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726417|NCT00000803|AIDS-Related Complex|aids-related complex
1726418|NCT00000803|Antiviral Agents|antiviral agents
1726419|NCT00000803|Zidovudine|zidovudine
1726420|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726422|NCT00000802|Antifungal Agents|antifungal agents
1726423|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726424|NCT00000802|atovaquone|atovaquone
1726425|NCT00000801|Vincristine|vincristine
1726426|NCT00000801|Cyclophosphamide|cyclophosphamide
1726427|NCT00000801|Cytarabine|cytarabine
1726428|NCT00000801|Dexamethasone|dexamethasone
1726429|NCT00000801|Doxorubicin|doxorubicin
1726430|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1726431|NCT00000801|Combined Modality Therapy|combined modality therapy
1726432|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726433|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
1726434|NCT00000801|Brain Neoplasms|brain neoplasms
1726435|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
1726436|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
1726437|NCT00000800|Methadone|methadone
1726438|NCT00000800|Drug Interactions|drug interactions
1726439|NCT00000800|Drug Therapy, Combination|drug therapy, combination
1726440|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726441|NCT00000800|AIDS-Related Complex|aids-related complex
1726442|NCT00000800|Zidovudine|zidovudine
1726443|NCT00000799|Retinitis|retinitis
1726444|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
1726445|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726447|NCT00000799|cidofovir|cidofovir
1726448|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
1726449|NCT00000798|HIV-1|hiv-1
1726450|NCT00000798|Administration, Oral|administration, oral
1726451|NCT00000798|AIDS Vaccines|aids vaccines
1726452|NCT00000798|HIV Seronegativity|hiv seronegativity
1726453|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
1726454|NCT00000796|Isoniazid|isoniazid
1726455|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1726456|NCT00000796|Pyrazinamide|pyrazinamide
1726457|NCT00000796|Pyridoxine|pyridoxine
1726458|NCT00000796|Ofloxacin|ofloxacin
1726459|NCT00000796|Rifampin|rifampin
1726460|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726461|NCT00000796|Drug Therapy, Combination|drug therapy, combination
1726462|NCT00000796|Ethambutol|ethambutol
1726463|NCT00000796|Clofazimine|clofazimine
1726464|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726465|NCT00000796|Amikacin|amikacin
1726466|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
1726467|NCT00000796|Cycloserine|cycloserine
1726468|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
1726469|NCT00000796|Ethionamide|ethionamide
1726470|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
1726471|NCT00000796|Streptomycin|streptomycin
1726472|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
1726473|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
1726474|NCT00000795|HIV-1|hiv-1
1726475|NCT00000795|AIDS Vaccines|aids vaccines
1726476|NCT00000795|HIV Seronegativity|hiv seronegativity
1726477|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
1726478|NCT00000794|Pyrimethamine|pyrimethamine
1726479|NCT00000794|Leucovorin|leucovorin
1726480|NCT00000794|Drug Therapy, Combination|drug therapy, combination
1726481|NCT00000794|Encephalitis|encephalitis
1726482|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726483|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
1726484|NCT00000794|Clarithromycin|clarithromycin
1726485|NCT00000794|atovaquone|atovaquone
1726486|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
1726487|NCT00000794|Sulfadiazine|sulfadiazine
1726488|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726489|NCT00000793|AIDS-Related Complex|aids-related complex
1726490|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
1726491|NCT00000793|Amitriptyline|amitriptyline
1726492|NCT00000793|Pain|pain
1726493|NCT00000793|Mexiletine|mexiletine
1726494|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
1726495|NCT00000793|Parasympatholytics|parasympatholytics
1726496|NCT00000792|Administration, Oral|administration, oral
1726497|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726498|NCT00000792|AIDS-Related Complex|aids-related complex
1726499|NCT00000792|Antiviral Agents|antiviral agents
1726500|NCT00000791|Drug Therapy, Combination|drug therapy, combination
1726501|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726502|NCT00000791|AIDS-Related Complex|aids-related complex
1726503|NCT00000791|Antiviral Agents|antiviral agents
1726504|NCT00000791|Zidovudine|zidovudine
1726505|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726506|NCT00000790|AIDS-Related Complex|aids-related complex
1726507|NCT00000790|Thalidomide|thalidomide
1726508|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
1726509|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726510|NCT00000789|AIDS-Related Complex|aids-related complex
1726511|NCT00000789|Zidovudine|zidovudine
1726512|NCT00000789|Stavudine|stavudine
1726513|NCT00000788|Methadone|methadone
1726514|NCT00000788|Drug Interactions|drug interactions
1726515|NCT00000788|Drug Therapy, Combination|drug therapy, combination
1726516|NCT00000788|Fluconazole|fluconazole
1726517|NCT00000788|Antifungal Agents|antifungal agents
1726518|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726519|NCT00000788|AIDS-Related Complex|aids-related complex
1726520|NCT00000787|Sex Behavior|sex behavior
1726521|NCT00000785|Tuberculosis|tuberculosis
1726522|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
1726523|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726524|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726525|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
1726526|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726527|NCT00000784|AIDS-Related Complex|aids-related complex
1726528|NCT00000783|Sex Behavior|sex behavior
1726529|NCT00000783|Sexual Partners|sexual partners
1726530|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
1726531|NCT00000782|Injections, Intradermal|injections, intradermal
1726532|NCT00000782|HIV Antigens|hiv antigens
1726533|NCT00000782|HIV-1|hiv-1
1726534|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
1726535|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726536|NCT00000782|AIDS-Related Complex|aids-related complex
1726537|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
1726538|NCT00000782|AIDS Vaccines|aids vaccines
1726539|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726540|NCT00000781|Zalcitabine|zalcitabine
1726541|NCT00000781|Didanosine|didanosine
1726542|NCT00000781|Drug Therapy, Combination|drug therapy, combination
1726543|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726546|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726547|NCT00000780|AIDS-Related Complex|aids-related complex
1726548|NCT00000780|Adolescent Behavior|adolescent behavior
1726549|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
1726550|NCT00000779|HIV-1|hiv-1
1726551|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
1726552|NCT00000779|AIDS-Related Complex|aids-related complex
1726553|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
1726554|NCT00000779|AIDS Vaccines|aids vaccines
1726555|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726556|NCT00000778|Isoniazid|isoniazid
1726557|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
1726558|NCT00000778|Pyridoxine|pyridoxine
1726559|NCT00000778|Ofloxacin|ofloxacin
1726560|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726561|NCT00000778|Drug Evaluation|drug evaluation
1726562|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726563|NCT00000778|Sputum|sputum
1726564|NCT00000778|Colony Count, Microbial|colony count, microbial
1726565|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
1726566|NCT00000777|Pregnancy|pregnancy
1726567|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726568|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
1726569|NCT00000777|AIDS Vaccines|aids vaccines
1726570|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
1726571|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726572|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726573|NCT00000776|Meningitis|meningitis
1726574|NCT00000776|Cryptococcosis|cryptococcosis
1726575|NCT00000776|Dexamethasone|dexamethasone
1726576|NCT00000776|Drug Therapy, Combination|drug therapy, combination
1726577|NCT00000776|Fluconazole|fluconazole
1726578|NCT00000776|Flucytosine|flucytosine
1726579|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726580|NCT00000776|Amphotericin B|amphotericin b
1726581|NCT00000776|Brain Diseases|brain diseases
1726582|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
1726583|NCT00000775|HIV-1|hiv-1
1726584|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
1726585|NCT00000775|AIDS Vaccines|aids vaccines
1726586|NCT00000775|HIV Seronegativity|hiv seronegativity
1726587|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
1726588|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
1726589|NCT00000774|Virus Replication|virus replication
1726590|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
1726591|NCT00000774|AIDS Vaccines|aids vaccines
1726592|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
1726593|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726594|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726595|NCT00000773|Antifungal Agents|antifungal agents
1726596|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726597|NCT00000773|AIDS-Related Complex|aids-related complex
1726598|NCT00000773|Biological Availability|biological availability
1726599|NCT00000773|atovaquone|atovaquone
1726600|NCT00000772|Ribavirin|ribavirin
1726601|NCT00000772|Didanosine|didanosine
1727628|NCT00022971|CLL|cll
1726602|NCT00000772|Drug Therapy, Combination|drug therapy, combination
1726603|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726604|NCT00000772|AIDS-Related Complex|aids-related complex
1726605|NCT00000771|Cryptosporidiosis|cryptosporidiosis
1726606|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726607|NCT00000771|Paromomycin|paromomycin
1726608|NCT00000770|Didanosine|didanosine
1726609|NCT00000770|Drug Therapy, Combination|drug therapy, combination
1726610|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726611|NCT00000770|AIDS-Related Complex|aids-related complex
1726612|NCT00000770|Zidovudine|zidovudine
1726613|NCT00000770|Nevirapine|nevirapine
1726614|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
1726615|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726616|NCT00000769|Interleukin-4|interleukin-4
1726617|NCT00000768|Intestinal Absorption|intestinal absorption
1726618|NCT00000768|Ganciclovir|ganciclovir
1726619|NCT00000768|Drug Therapy, Combination|drug therapy, combination
1726620|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
1726621|NCT00000768|Colitis|colitis
1726622|NCT00000768|Administration, Oral|administration, oral
1726623|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726624|NCT00000768|Biological Availability|biological availability
1726625|NCT00000768|Glutamic Acid|glutamic acid
1726626|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
1726627|NCT00000767|Vaccinia Virus|vaccinia virus
1726628|NCT00000767|Viral Vaccines|viral vaccines
1726629|NCT00000767|Smallpox Vaccine|smallpox vaccine
1726630|NCT00000767|HIV-1|hiv-1
1726631|NCT00000767|AIDS Vaccines|aids vaccines
1726632|NCT00000767|HIV Seronegativity|hiv seronegativity
1726633|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
1726634|NCT00000766|Retinitis|retinitis
1726635|NCT00000766|Ganciclovir|ganciclovir
1726636|NCT00000766|Foscarnet|foscarnet
1726637|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
1726638|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726639|NCT00000765|Zidovudine|zidovudine
1726640|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
1726641|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726642|NCT00000764|AIDS-Related Complex|aids-related complex
1726643|NCT00000764|Anus Neoplasms|anus neoplasms
1726644|NCT00000764|Papillomavirus, Human|papillomavirus, human
1726645|NCT00000764|Papovaviridae Infections|papovaviridae infections
1726646|NCT00000764|Tumor Virus Infections|tumor virus infections
1726647|NCT00000764|Isotretinoin|isotretinoin
1726648|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
1726649|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726650|NCT00000763|Antineoplastic Agents|antineoplastic agents
1726651|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
1726652|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
1726653|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
1726654|NCT00000762|AIDS Vaccines|aids vaccines
1726655|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726656|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
1726657|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726658|NCT00000761|AIDS-Related Complex|aids-related complex
1726659|NCT00000760|Didanosine|didanosine
1726660|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726661|NCT00000760|AIDS-Related Complex|aids-related complex
1726662|NCT00000760|Antiviral Agents|antiviral agents
1726663|NCT00000760|Zidovudine|zidovudine
1726664|NCT00000760|Gene Products, tat|gene products, tat
1726665|NCT00000759|Central Nervous System Diseases|central nervous system diseases
1726666|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726667|NCT00000759|AIDS-Related Complex|aids-related complex
1726668|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
1726669|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726670|NCT00000758|AIDS-Related Complex|aids-related complex
1726671|NCT00000758|Fluorouracil|fluorouracil
1726672|NCT00000758|Cervix Dysplasia|cervix dysplasia
1726673|NCT00000758|Cervix Diseases|cervix diseases
1726674|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
1726675|NCT00000757|Vaccinia Virus|vaccinia virus
1726676|NCT00000757|HIV-1|hiv-1
1726677|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
1726678|NCT00000757|AIDS Vaccines|aids vaccines
1726679|NCT00000757|HIV Seronegativity|hiv seronegativity
1726680|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
1726681|NCT00000756|T-Lymphocytes|t-lymphocytes
1726682|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726683|NCT00000756|AIDS-Related Complex|aids-related complex
1726684|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
1726685|NCT00000756|Transplantation, Autologous|transplantation, autologous
1726686|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
1726687|NCT00000755|HIV-1|hiv-1
1726688|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726689|NCT00000755|AIDS-Related Complex|aids-related complex
1726690|NCT00000755|Zidovudine|zidovudine
1726691|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
1726692|NCT00000755|AIDS Vaccines|aids vaccines
1727629|NCT00022971|Leukemia|leukemia
1726693|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1726694|NCT00000754|Zalcitabine|zalcitabine
1726695|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726696|NCT00000754|AIDS-Related Complex|aids-related complex
1726697|NCT00000754|Zidovudine|zidovudine
1726698|NCT00000754|Interferon-alpha|interferon-alpha
1726699|NCT00000753|Zalcitabine|zalcitabine
1726700|NCT00000753|Didanosine|didanosine
1726701|NCT00000753|Drug Therapy, Combination|drug therapy, combination
1726702|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726703|NCT00000753|AIDS-Related Complex|aids-related complex
1726704|NCT00000753|Antiviral Agents|antiviral agents
1726705|NCT00000753|Zidovudine|zidovudine
1726706|NCT00000752|Drug Therapy, Combination|drug therapy, combination
1726707|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726708|NCT00000752|AIDS-Related Complex|aids-related complex
1726709|NCT00000752|cefuroxime axetil|cefuroxime axetil
1726710|NCT00000752|Beclomethasone|beclomethasone
1726711|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
1726712|NCT00000752|Sinusitis|sinusitis
1726713|NCT00000752|Ephedrine|ephedrine
1726714|NCT00000751|Pregnancy|pregnancy
1726715|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
1726716|NCT00000751|Drug Therapy, Combination|drug therapy, combination
1726717|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726718|NCT00000751|AIDS-Related Complex|aids-related complex
1726719|NCT00000751|Zidovudine|zidovudine
1726720|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
1726721|NCT00000751|Immunization, Passive|immunization, passive
1726722|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726723|NCT00000750|AIDS-Related Complex|aids-related complex
1726724|NCT00000750|Zidovudine|zidovudine
1726725|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
1726726|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
1726727|NCT00000749|AIDS Vaccines|aids vaccines
1726728|NCT00000749|HIV Seronegativity|hiv seronegativity
1726729|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
1727177|NCT00000681|Zidovudine|zidovudine
1726730|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726731|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726732|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726733|NCT00000748|AIDS-Related Complex|aids-related complex
1726734|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726735|NCT00000747|Drug Resistance|drug resistance
1726736|NCT00000747|AIDS-Related Complex|aids-related complex
1726737|NCT00000747|Antiviral Agents|antiviral agents
1726738|NCT00000747|Nevirapine|nevirapine
1726739|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
1726740|NCT00000746|Vaccinia Virus|vaccinia virus
1726741|NCT00000746|Viral Vaccines|viral vaccines
1726742|NCT00000746|HIV-1|hiv-1
1726743|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
1726744|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
1726745|NCT00000746|AIDS Vaccines|aids vaccines
1726746|NCT00000746|HIV Seronegativity|hiv seronegativity
1726747|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
1726748|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
1726749|NCT00000745|Vaccinia Virus|vaccinia virus
1726750|NCT00000745|Viral Vaccines|viral vaccines
1726751|NCT00000745|HIV-1|hiv-1
1726752|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
1726753|NCT00000745|AIDS Vaccines|aids vaccines
1726754|NCT00000745|HIV Seronegativity|hiv seronegativity
1726755|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
1726756|NCT00000744|Fluconazole|fluconazole
1726757|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726758|NCT00000744|AIDS-Related Complex|aids-related complex
1726759|NCT00000744|Candidiasis|candidiasis
1726760|NCT00000743|Recombinant Proteins|recombinant proteins
1726761|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726762|NCT00000743|Antigens, CD4|antigens, cd4
1726763|NCT00000743|AIDS-Related Complex|aids-related complex
1726764|NCT00000743|Zidovudine|zidovudine
1726765|NCT00000742|Didanosine|didanosine
1726766|NCT00000742|Drug Therapy, Combination|drug therapy, combination
1726767|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726768|NCT00000742|AIDS-Related Complex|aids-related complex
1726769|NCT00000742|Antiviral Agents|antiviral agents
1726770|NCT00000742|Zidovudine|zidovudine
1726771|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726772|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726773|NCT00000741|Methylprednisolone|methylprednisolone
1726774|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726775|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726776|NCT00000740|AIDS-Related Complex|aids-related complex
1726777|NCT00000740|WR 6026|wr 6026
1726778|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726779|NCT00000739|Dapsone|dapsone
1726780|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726781|NCT00000739|AIDS-Related Complex|aids-related complex
1726782|NCT00000739|Drug Administration Schedule|drug administration schedule
1726783|NCT00000738|Central Nervous System Diseases|central nervous system diseases
1726784|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726785|NCT00000738|AIDS Dementia Complex|aids dementia complex
1726786|NCT00000738|AIDS-Related Complex|aids-related complex
1726787|NCT00000738|Zidovudine|zidovudine
1726788|NCT00000738|Nimodipine|nimodipine
1726789|NCT00000737|Weight Loss|weight loss
1726790|NCT00000737|Megestrol|megestrol
1726791|NCT00000737|Cachexia|cachexia
1726792|NCT00000737|Eating Disorders|eating disorders
1726793|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
1726794|NCT00000737|Appetite|appetite
1726795|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726796|NCT00000736|AIDS-Related Complex|aids-related complex
1726797|NCT00000736|Zidovudine|zidovudine
1726798|NCT00000735|Virus Replication|virus replication
1726799|NCT00000735|T-Lymphocytes|t-lymphocytes
1726800|NCT00000735|Infusions, Intravenous|infusions, intravenous
1726801|NCT00000735|Immunologic Surveillance|immunologic surveillance
1726802|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726803|NCT00000735|ampligen|ampligen
1726804|NCT00000735|AIDS-Related Complex|aids-related complex
1726805|NCT00000735|Antiviral Agents|antiviral agents
1726806|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726807|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726808|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726809|NCT00000734|Drug Interactions|drug interactions
1726810|NCT00000734|Drug Therapy, Combination|drug therapy, combination
1726811|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726812|NCT00000734|AIDS-Related Complex|aids-related complex
1726813|NCT00000734|Zidovudine|zidovudine
1726814|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726815|NCT00000733|Ribavirin|ribavirin
1726816|NCT00000733|T-Lymphocytes|t-lymphocytes
1726817|NCT00000733|Infusions, Intravenous|infusions, intravenous
1726818|NCT00000733|Immunologic Surveillance|immunologic surveillance
1726819|NCT00000733|Administration, Oral|administration, oral
1727178|NCT00000681|Bleomycin|bleomycin
1726820|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726821|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726822|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726823|NCT00000732|Drug Interactions|drug interactions
1726824|NCT00000732|Drug Therapy, Combination|drug therapy, combination
1726825|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726826|NCT00000732|AIDS-Related Complex|aids-related complex
1726827|NCT00000732|Zidovudine|zidovudine
1726828|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726829|NCT00000731|Acetaminophen|acetaminophen
1726830|NCT00000731|Drug Interactions|drug interactions
1726831|NCT00000731|Drug Therapy, Combination|drug therapy, combination
1726832|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726833|NCT00000731|AIDS-Related Complex|aids-related complex
1726834|NCT00000731|Zidovudine|zidovudine
1726835|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726836|NCT00000730|Trimetrexate|trimetrexate
1726837|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726838|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726839|NCT00000730|Leucovorin|leucovorin
1726840|NCT00000730|Folic Acid Antagonists|folic acid antagonists
1726841|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726842|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
1726843|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726844|NCT00000729|Virus Replication|virus replication
1726845|NCT00000729|Infusions, Intravenous|infusions, intravenous
1726846|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
1726847|NCT00000729|Foscarnet|foscarnet
1726848|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726849|NCT00000729|AIDS-Related Complex|aids-related complex
1726850|NCT00000729|Antiviral Agents|antiviral agents
1726851|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1726852|NCT00000728|Immune Tolerance|immune tolerance
1726853|NCT00000728|Interleukin-2|interleukin-2
1726854|NCT00000728|Drug Therapy, Combination|drug therapy, combination
1726855|NCT00000728|AIDS-Related Complex|aids-related complex
1726856|NCT00000728|Zidovudine|zidovudine
1726857|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1726858|NCT00000727|Sulfadoxine|sulfadoxine
1726859|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726860|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726861|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726862|NCT00000727|Pentamidine|pentamidine
1726863|NCT00000727|Pyrimethamine|pyrimethamine
1726864|NCT00000727|Drug Evaluation|drug evaluation
1726865|NCT00000727|Administration, Inhalation|administration, inhalation
1726866|NCT00000727|Administration, Oral|administration, oral
1726867|NCT00000727|Aerosols|aerosols
1726868|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726869|NCT00000727|Zidovudine|zidovudine
1726871|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726872|NCT00000726|Foscarnet|foscarnet
1726873|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
1726874|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726875|NCT00000726|Antiviral Agents|antiviral agents
1726876|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
1726877|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
1726878|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
1726879|NCT00000725|Drug Therapy, Combination|drug therapy, combination
1726880|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726881|NCT00000725|Zidovudine|zidovudine
1726882|NCT00000725|Interferon Type I|interferon type i
1726883|NCT00000724|Trimetrexate|trimetrexate
1726884|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726885|NCT00000724|Injections, Intravenous|injections, intravenous
1726886|NCT00000724|Leucovorin|leucovorin
1726887|NCT00000724|Drug Evaluation|drug evaluation
1726888|NCT00000724|Drug Therapy, Combination|drug therapy, combination
1726889|NCT00000724|Folic Acid Antagonists|folic acid antagonists
1726890|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726891|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
1726892|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726893|NCT00000723|Lymphoma|lymphoma
1726894|NCT00000723|Methotrexate|methotrexate
1726895|NCT00000723|Leucovorin|leucovorin
1726896|NCT00000723|Dexamethasone|dexamethasone
1726897|NCT00000723|Drug Evaluation|drug evaluation
1726898|NCT00000723|Drug Therapy, Combination|drug therapy, combination
1726899|NCT00000723|Combined Modality Therapy|combined modality therapy
1726900|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726901|NCT00000723|Zidovudine|zidovudine
1726902|NCT00000723|Brain Neoplasms|brain neoplasms
1726903|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726904|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726905|NCT00000722|Pentamidine|pentamidine
1726906|NCT00000722|Injections, Intravenous|injections, intravenous
1726907|NCT00000722|Lung|lung
1726908|NCT00000722|Administration, Inhalation|administration, inhalation
1726909|NCT00000722|Aerosols|aerosols
1726910|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726911|NCT00000721|Recombinant Proteins|recombinant proteins
1726912|NCT00000721|Infusions, Intravenous|infusions, intravenous
1726913|NCT00000721|Injections, Intramuscular|injections, intramuscular
1726914|NCT00000721|Injections, Intravenous|injections, intravenous
1726915|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
1726916|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
1726917|NCT00000721|Drug Evaluation|drug evaluation
1726918|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726919|NCT00000721|Antigens, CD4|antigens, cd4
1726920|NCT00000721|AIDS-Related Complex|aids-related complex
1726921|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726922|NCT00000720|Placebos|placebos
1726923|NCT00000720|Infusions, Intravenous|infusions, intravenous
1726924|NCT00000720|Gamma-Globulins|gamma-globulins
1726925|NCT00000720|Combined Modality Therapy|combined modality therapy
1726926|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726927|NCT00000720|Zidovudine|zidovudine
1726928|NCT00000720|Bacterial Infections|bacterial infections
1726929|NCT00000720|Immunization, Passive|immunization, passive
1726930|NCT00000719|Zalcitabine|zalcitabine
1726931|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726932|NCT00000719|Zidovudine|zidovudine
1726933|NCT00000718|Zalcitabine|zalcitabine
1726934|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
1726935|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726936|NCT00000718|AIDS-Related Complex|aids-related complex
1726937|NCT00000718|Zidovudine|zidovudine
1726938|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726939|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726940|NCT00000717|Primaquine|primaquine
1726941|NCT00000717|Infusions, Intravenous|infusions, intravenous
1726942|NCT00000717|Drug Evaluation|drug evaluation
1726943|NCT00000717|Drug Therapy, Combination|drug therapy, combination
1726944|NCT00000717|Administration, Oral|administration, oral
1726945|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726946|NCT00000717|Clindamycin|clindamycin
1726947|NCT00000716|Drug Evaluation|drug evaluation
1726948|NCT00000716|Administration, Oral|administration, oral
1726949|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726950|NCT00000716|Zidovudine|zidovudine
1726951|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1726952|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726953|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726954|NCT00000715|Pentamidine|pentamidine
1726955|NCT00000715|Infusions, Intravenous|infusions, intravenous
1726956|NCT00000715|Administration, Inhalation|administration, inhalation
1726957|NCT00000715|Aerosols|aerosols
1726958|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726959|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1726960|NCT00000714|Trimetrexate|trimetrexate
1726961|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726962|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1726963|NCT00000714|Leucovorin|leucovorin
1726964|NCT00000714|Drug Evaluation|drug evaluation
1726965|NCT00000714|Drug Therapy, Combination|drug therapy, combination
1726966|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726967|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
1726968|NCT00000713|Polyribonucleotides|polyribonucleotides
1726969|NCT00000713|HIV Seropositivity|hiv seropositivity
1726970|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
1726971|NCT00000713|Drug Evaluation|drug evaluation
1726972|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726973|NCT00000713|ampligen|ampligen
1726974|NCT00000713|AIDS-Related Complex|aids-related complex
1726975|NCT00000713|Antiviral Agents|antiviral agents
1726976|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1726977|NCT00000712|Herpesviridae Infections|herpesviridae infections
1726978|NCT00000712|Drug Evaluation|drug evaluation
1726979|NCT00000712|Drug Therapy, Combination|drug therapy, combination
1726980|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
1726981|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
1726982|NCT00000712|Acyclovir|acyclovir
1726983|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726984|NCT00000712|Antiviral Agents|antiviral agents
1726985|NCT00000712|Zidovudine|zidovudine
1726986|NCT00000711|Neutropenia|neutropenia
1726987|NCT00000711|Drug Evaluation|drug evaluation
1726988|NCT00000711|Drug Therapy, Combination|drug therapy, combination
1726989|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1726990|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726991|NCT00000711|AIDS-Related Complex|aids-related complex
1726992|NCT00000711|Zidovudine|zidovudine
1726993|NCT00000710|Injections, Intravenous|injections, intravenous
1726994|NCT00000710|Didanosine|didanosine
1726995|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
1726996|NCT00000710|Drug Evaluation|drug evaluation
1726997|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1726998|NCT00000710|AIDS-Related Complex|aids-related complex
1726999|NCT00000709|Neuropsychological Tests|neuropsychological tests
1727000|NCT00000709|AIDS Dementia Complex|aids dementia complex
1727001|NCT00000709|Zidovudine|zidovudine
1727002|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1727003|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727004|NCT00000708|Meningitis|meningitis
1727005|NCT00000708|Injections, Intravenous|injections, intravenous
1727006|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
1727007|NCT00000708|Cryptococcosis|cryptococcosis
1727008|NCT00000708|Drug Therapy, Combination|drug therapy, combination
1727009|NCT00000708|Fluconazole|fluconazole
1727010|NCT00000708|Administration, Oral|administration, oral
1727011|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727012|NCT00000708|Amphotericin B|amphotericin b
1727013|NCT00000707|Respiratory Function Tests|respiratory function tests
1727014|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727015|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1727016|NCT00000707|Pentamidine|pentamidine
1727017|NCT00000707|Lung|lung
1727018|NCT00000707|HIV Seropositivity|hiv seropositivity
1727019|NCT00000707|Drug Evaluation|drug evaluation
1727020|NCT00000707|Administration, Inhalation|administration, inhalation
1727021|NCT00000707|Aerosols|aerosols
1727022|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727023|NCT00000706|Quinine|quinine
1727024|NCT00000706|Probenecid|probenecid
1727025|NCT00000706|Drug Therapy, Combination|drug therapy, combination
1727026|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727027|NCT00000706|AIDS-Related Complex|aids-related complex
1727028|NCT00000706|Zidovudine|zidovudine
1727029|NCT00000705|Drug Evaluation|drug evaluation
1727030|NCT00000705|Zidovudine|zidovudine
1727031|NCT00000705|Hemophilia A|hemophilia a
1727032|NCT00000704|HIV Antigens|hiv antigens
1727033|NCT00000704|Immunologic Surveillance|immunologic surveillance
1727034|NCT00000704|Zalcitabine|zalcitabine
1727035|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
1727036|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727037|NCT00000704|AIDS-Related Complex|aids-related complex
1727038|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
1727039|NCT00000703|Vincristine|vincristine
1727040|NCT00000703|Lymphoma|lymphoma
1727041|NCT00000703|Methotrexate|methotrexate
1727042|NCT00000703|Cyclophosphamide|cyclophosphamide
1727043|NCT00000703|Cytarabine|cytarabine
1727044|NCT00000703|Dexamethasone|dexamethasone
1727045|NCT00000703|Doxorubicin|doxorubicin
1727046|NCT00000703|Drug Therapy, Combination|drug therapy, combination
1727047|NCT00000703|Combined Modality Therapy|combined modality therapy
1727048|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727049|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
1727050|NCT00000703|Zidovudine|zidovudine
1727051|NCT00000703|Bleomycin|bleomycin
1727052|NCT00000702|AIDS Dementia Complex|aids dementia complex
1727053|NCT00000702|Zidovudine|zidovudine
1727054|NCT00000701|Drug Evaluation|drug evaluation
1727055|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727056|NCT00000701|AIDS-Related Complex|aids-related complex
1727057|NCT00000701|Zidovudine|zidovudine
1727058|NCT00000700|United States|united states
1727059|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727060|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1727061|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727062|NCT00000700|Zidovudine|zidovudine
1727063|NCT00000699|Ribavirin|ribavirin
1727064|NCT00000699|Inosine Pranobex|inosine pranobex
1727065|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
1727066|NCT00000699|Drug Evaluation|drug evaluation
1727067|NCT00000699|Drug Therapy, Combination|drug therapy, combination
1727068|NCT00000699|AIDS-Related Complex|aids-related complex
1727069|NCT00000698|Retinitis|retinitis
1727070|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727071|NCT00000698|Ganciclovir|ganciclovir
1727072|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
1727073|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727074|NCT00000697|Retinitis|retinitis
1727075|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727076|NCT00000697|Bone Marrow|bone marrow
1727077|NCT00000697|Ganciclovir|ganciclovir
1727078|NCT00000697|Foscarnet|foscarnet
1727079|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
1727080|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727081|NCT00000697|Antiviral Agents|antiviral agents
1727082|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
1727083|NCT00000696|Drug Therapy, Combination|drug therapy, combination
1727084|NCT00000696|AIDS-Related Complex|aids-related complex
1727085|NCT00000696|Zidovudine|zidovudine
1727086|NCT00000695|Drug Evaluation|drug evaluation
1727087|NCT00000695|Drug Therapy, Combination|drug therapy, combination
1727088|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727089|NCT00000695|Zidovudine|zidovudine
1727090|NCT00000695|Interferon Type I|interferon type i
1727091|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
1727092|NCT00000694|Immune System|immune system
1727093|NCT00000694|Drug Evaluation|drug evaluation
1727094|NCT00000694|Drug Therapy, Combination|drug therapy, combination
1727095|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1727096|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727097|NCT00000694|Zidovudine|zidovudine
1727098|NCT00000693|Retinitis|retinitis
1727099|NCT00000693|Drug Evaluation|drug evaluation
1727100|NCT00000693|Drug Therapy, Combination|drug therapy, combination
1727101|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
1727102|NCT00000693|Acyclovir|acyclovir
1727103|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727104|NCT00000693|Zidovudine|zidovudine
1727105|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727106|NCT00000692|AIDS-Related Complex|aids-related complex
1727107|NCT00000692|Antiviral Agents|antiviral agents
1727108|NCT00000692|Biological Availability|biological availability
1727109|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
1727110|NCT00000691|Retinitis|retinitis
1727111|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727112|NCT00000691|Ganciclovir|ganciclovir
1727113|NCT00000691|Drug Evaluation|drug evaluation
1727114|NCT00000691|Foscarnet|foscarnet
1727115|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
1727116|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727117|NCT00000691|Antiviral Agents|antiviral agents
1727118|NCT00000690|Reference Values|reference values
1727119|NCT00000690|Infusions, Intravenous|infusions, intravenous
1727120|NCT00000690|Intestinal Absorption|intestinal absorption
1727121|NCT00000690|Dextran Sulfate|dextran sulfate
1727122|NCT00000690|Administration, Oral|administration, oral
1727123|NCT00000690|Blood Coagulation|blood coagulation
1727124|NCT00000689|M-BACOD protocol|m-bacod protocol
1727125|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
1727126|NCT00000689|Infusions, Intravenous|infusions, intravenous
1727127|NCT00000689|Injections, Intravenous|injections, intravenous
1727128|NCT00000689|Leucovorin|leucovorin
1727129|NCT00000689|Cytarabine|cytarabine
1727130|NCT00000689|Drug Evaluation|drug evaluation
1727131|NCT00000689|Drug Therapy, Combination|drug therapy, combination
1727132|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1727133|NCT00000689|Administration, Oral|administration, oral
1727134|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727135|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
1727136|NCT00000688|Retinitis|retinitis
1727137|NCT00000688|Injections, Intravenous|injections, intravenous
1727138|NCT00000688|Ganciclovir|ganciclovir
1728165|NCT00016679|Metabolism|metabolism
1727139|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
1727140|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727141|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
1727142|NCT00000687|Drug Evaluation|drug evaluation
1727143|NCT00000687|Drug Therapy, Combination|drug therapy, combination
1727144|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727145|NCT00000687|Zidovudine|zidovudine
1727146|NCT00000686|Drug Evaluation|drug evaluation
1727147|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727148|NCT00000686|AIDS-Related Complex|aids-related complex
1727149|NCT00000686|Antiviral Agents|antiviral agents
1727150|NCT00000686|Zidovudine|zidovudine
1727151|NCT00000685|Kidney Diseases|kidney diseases
1727152|NCT00000685|Drug Evaluation|drug evaluation
1727153|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727154|NCT00000685|Zidovudine|zidovudine
1727155|NCT00000685|Renal Dialysis|renal dialysis
1727156|NCT00000684|Infusions, Intravenous|infusions, intravenous
1727157|NCT00000684|Dextran Sulfate|dextran sulfate
1727158|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727159|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
1727160|NCT00000683|Vaccinia Virus|vaccinia virus
1727161|NCT00000683|Viral Envelope Proteins|viral envelope proteins
1727162|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727163|NCT00000683|AIDS Vaccines|aids vaccines
1727164|NCT00000683|HIV Seronegativity|hiv seronegativity
1727165|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
1727166|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727167|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1727168|NCT00000682|Zalcitabine|zalcitabine
1727169|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727170|NCT00000682|Zidovudine|zidovudine
1727171|NCT00000681|Vincristine|vincristine
1727172|NCT00000681|Doxorubicin|doxorubicin
1727173|NCT00000681|Drug Evaluation|drug evaluation
1727174|NCT00000681|Drug Therapy, Combination|drug therapy, combination
1727175|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1727176|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727179|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
1727180|NCT00000680|Indium Radioisotopes|indium radioisotopes
1727181|NCT00000680|Leukapheresis|leukapheresis
1727182|NCT00000680|Interleukin-2|interleukin-2
1727183|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727184|NCT00000680|AIDS-Related Complex|aids-related complex
1727185|NCT00000680|Zidovudine|zidovudine
1727186|NCT00000680|Immunization, Passive|immunization, passive
1727187|NCT00000679|Zalcitabine|zalcitabine
1727188|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727189|NCT00000679|AIDS-Related Complex|aids-related complex
1727190|NCT00000679|Zidovudine|zidovudine
1727191|NCT00000678|Zalcitabine|zalcitabine
1727192|NCT00000678|Drug Evaluation|drug evaluation
1727193|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727194|NCT00000678|AIDS-Related Complex|aids-related complex
1727195|NCT00000678|Zidovudine|zidovudine
1727196|NCT00000677|Sch 39304|sch 39304
1727197|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727198|NCT00000677|Meningitis|meningitis
1727199|NCT00000677|Cryptococcosis|cryptococcosis
1727200|NCT00000677|Drug Evaluation|drug evaluation
1727201|NCT00000677|Antifungal Agents|antifungal agents
1727202|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727203|NCT00000676|Mycoses|mycoses
1727204|NCT00000676|Fluconazole|fluconazole
1727205|NCT00000676|Clotrimazole|clotrimazole
1727206|NCT00000676|Antifungal Agents|antifungal agents
1727207|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727208|NCT00000676|AIDS-Related Complex|aids-related complex
1727209|NCT00000675|Recombinant Proteins|recombinant proteins
1727211|NCT00000675|Drug Evaluation|drug evaluation
1727212|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727213|NCT00000675|Antigens, CD4|antigens, cd4
1727214|NCT00000675|AIDS-Related Complex|aids-related complex
1727215|NCT00000675|Carrier Proteins|carrier proteins
1727216|NCT00000674|Toxoplasmosis|toxoplasmosis
1727217|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727218|NCT00000674|Pyrimethamine|pyrimethamine
1727219|NCT00000674|Leucovorin|leucovorin
1727220|NCT00000674|Drug Evaluation|drug evaluation
1727221|NCT00000674|Drug Therapy, Combination|drug therapy, combination
1727222|NCT00000674|Encephalitis|encephalitis
1727223|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727224|NCT00000674|Clindamycin|clindamycin
1727225|NCT00000673|Retinitis|retinitis
1727226|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727227|NCT00000673|Ganciclovir|ganciclovir
1727228|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
1727229|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727230|NCT00000672|Didanosine|didanosine
1727231|NCT00000672|Zidovudine|zidovudine
1727232|NCT00000671|Didanosine|didanosine
1727233|NCT00000671|Zidovudine|zidovudine
1727235|NCT00000670|Drug Evaluation|drug evaluation
1727236|NCT00000670|Drug Interactions|drug interactions
1727237|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727238|NCT00000670|Zidovudine|zidovudine
1727239|NCT00000669|Didanosine|didanosine
1727240|NCT00000669|Drug Evaluation|drug evaluation
1727241|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727242|NCT00000669|AIDS-Related Complex|aids-related complex
1727243|NCT00000668|Retinitis|retinitis
1727244|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727245|NCT00000668|Ganciclovir|ganciclovir
1727246|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
1727247|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727248|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
1727249|NCT00000667|Injections, Intradermal|injections, intradermal
1727250|NCT00000667|HIV Antigens|hiv antigens
1727251|NCT00000667|HIV Seropositivity|hiv seropositivity
1727252|NCT00000667|HIV-1|hiv-1
1727253|NCT00000667|Drug Evaluation|drug evaluation
1727254|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
1727255|NCT00000667|AIDS Vaccines|aids vaccines
1727256|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1727257|NCT00000666|Toxoplasmosis|toxoplasmosis
1727258|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727259|NCT00000666|Pyrimethamine|pyrimethamine
1727260|NCT00000666|Drug Evaluation|drug evaluation
1727261|NCT00000666|Encephalitis|encephalitis
1727262|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727263|NCT00000665|Retinitis|retinitis
1727264|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727265|NCT00000665|Ganciclovir|ganciclovir
1727266|NCT00000665|Foscarnet|foscarnet
1727267|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
1727268|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727269|NCT00000665|Antiviral Agents|antiviral agents
1727270|NCT00000664|Polyethylene Glycols|polyethylene glycols
1727271|NCT00000664|Interleukin-2|interleukin-2
1727272|NCT00000664|Drug Evaluation|drug evaluation
1727274|NCT00000663|Recombinant Proteins|recombinant proteins
1727275|NCT00000663|Injections, Intravenous|injections, intravenous
1727276|NCT00000663|IgG|igg
1727277|NCT00000663|Drug Evaluation|drug evaluation
1727278|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727279|NCT00000663|Antigens, CD4|antigens, cd4
1727280|NCT00000663|Carrier Proteins|carrier proteins
1727281|NCT00000662|Drugs, Investigational|drugs, investigational
1727282|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727283|NCT00000662|AIDS-Related Complex|aids-related complex
1727284|NCT00000662|Zidovudine|zidovudine
1727285|NCT00000661|Oxazepam|oxazepam
1727286|NCT00000661|Drug Evaluation|drug evaluation
1727287|NCT00000661|Drug Interactions|drug interactions
1727288|NCT00000661|Zidovudine|zidovudine
1727289|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
1727290|NCT00000660|Drug Evaluation|drug evaluation
1727291|NCT00000660|Etoposide|etoposide
1727292|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727293|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727294|NCT00000659|Antigens, CD4|antigens, cd4
1727295|NCT00000659|AIDS-Related Complex|aids-related complex
1727296|NCT00000659|Zidovudine|zidovudine
1727297|NCT00000658|M-BACOD protocol|m-bacod protocol
1727298|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
1727299|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727300|NCT00000658|Allopurinol|allopurinol
1727301|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
1727302|NCT00000657|Didanosine|didanosine
1727303|NCT00000657|Drug Evaluation|drug evaluation
1727304|NCT00000657|Drugs, Investigational|drugs, investigational
1727305|NCT00000657|AIDS Dementia Complex|aids dementia complex
1727306|NCT00000657|Zidovudine|zidovudine
1727307|NCT00000656|Didanosine|didanosine
1727308|NCT00000656|Drug Therapy, Combination|drug therapy, combination
1727309|NCT00000656|Zidovudine|zidovudine
1727310|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1727311|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727312|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1727313|NCT00000655|Naphthoquinones|naphthoquinones
1727314|NCT00000655|Antifungal Agents|antifungal agents
1727315|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727316|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1727317|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727318|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
1727319|NCT00000654|Herpesviridae Infections|herpesviridae infections
1727320|NCT00000654|Drug Evaluation|drug evaluation
1727321|NCT00000654|Antiviral Agents|antiviral agents
1727322|NCT00000654|Hepatitis B|hepatitis b
1727323|NCT00000653|Zalcitabine|zalcitabine
1727324|NCT00000653|Drug Evaluation|drug evaluation
1727325|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727326|NCT00000653|AIDS-Related Complex|aids-related complex
1727327|NCT00000652|Didanosine|didanosine
1727328|NCT00000652|Drug Evaluation|drug evaluation
1727329|NCT00000652|Drug Therapy, Combination|drug therapy, combination
1727330|NCT00000652|Zidovudine|zidovudine
1727331|NCT00000651|Zalcitabine|zalcitabine
1727332|NCT00000651|Antiviral Agents|antiviral agents
1727333|NCT00000651|Zidovudine|zidovudine
1727334|NCT00000650|Drug Evaluation|drug evaluation
1727335|NCT00000650|Ditiocarb|ditiocarb
1727336|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727337|NCT00000649|Drug Therapy, Combination|drug therapy, combination
1727338|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727339|NCT00000649|AIDS-Related Complex|aids-related complex
1727340|NCT00000649|Zidovudine|zidovudine
1727341|NCT00000649|Nevirapine|nevirapine
1727342|NCT00000648|Penicillin G|penicillin g
1727343|NCT00000648|Neurosyphilis|neurosyphilis
1727344|NCT00000648|Drug Evaluation|drug evaluation
1727345|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727346|NCT00000648|AIDS-Related Complex|aids-related complex
1727347|NCT00000648|Ceftriaxone|ceftriaxone
1727348|NCT00000647|Recombinant Proteins|recombinant proteins
1727350|NCT00000647|Drug Evaluation|drug evaluation
1727351|NCT00000647|Drug Therapy, Combination|drug therapy, combination
1727352|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727353|NCT00000647|Antigens, CD4|antigens, cd4
1727354|NCT00000647|Zidovudine|zidovudine
1727355|NCT00000647|Carrier Proteins|carrier proteins
1727356|NCT00000647|Interferon Type I|interferon type i
1727357|NCT00000646|Pentoxifylline|pentoxifylline
1727358|NCT00000646|Virus Replication|virus replication
1727359|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
1727360|NCT00000646|Drug Evaluation|drug evaluation
1727361|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727362|NCT00000646|Cachexia|cachexia
1727363|NCT00000646|Drug Synergism|drug synergism
1727364|NCT00000645|Drug Evaluation|drug evaluation
1727365|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727366|NCT00000645|AIDS-Related Complex|aids-related complex
1727367|NCT00000645|Antiviral Agents|antiviral agents
1727368|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727369|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1727370|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727371|NCT00000644|Clarithromycin|clarithromycin
1727372|NCT00000643|Toxoplasmosis|toxoplasmosis
1727373|NCT00000643|Pyrimethamine|pyrimethamine
1727374|NCT00000643|Leucovorin|leucovorin
1727375|NCT00000643|Drug Evaluation|drug evaluation
1727376|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727377|NCT00000643|AIDS-Related Complex|aids-related complex
1727378|NCT00000643|Brain Diseases|brain diseases
1727379|NCT00000642|Recombinant Proteins|recombinant proteins
1727380|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
1727381|NCT00000642|Pregnancy|pregnancy
1727382|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
1727383|NCT00000642|IgG|igg
1727384|NCT00000642|Drug Evaluation|drug evaluation
1727385|NCT00000642|Antigens, CD4|antigens, cd4
1727386|NCT00000642|AIDS-Related Complex|aids-related complex
1727387|NCT00000642|Immunization, Passive|immunization, passive
1727388|NCT00000641|Rifampin|rifampin
1727389|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
1727390|NCT00000641|Drug Evaluation|drug evaluation
1727391|NCT00000641|Drug Therapy, Combination|drug therapy, combination
1727392|NCT00000641|Ethambutol|ethambutol
1727393|NCT00000641|Clofazimine|clofazimine
1727394|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727395|NCT00000641|Amikacin|amikacin
1727396|NCT00000641|Azithromycin|azithromycin
1727397|NCT00000641|Ciprofloxacin|ciprofloxacin
1727398|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
1727399|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
1727400|NCT00000640|Primaquine|primaquine
1727401|NCT00000640|Dapsone|dapsone
1727402|NCT00000640|Drug Therapy, Combination|drug therapy, combination
1727403|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727404|NCT00000640|Clindamycin|clindamycin
1727405|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
1727406|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727407|NCT00000639|Meningitis|meningitis
1727408|NCT00000639|Cryptococcosis|cryptococcosis
1727409|NCT00000639|Drug Evaluation|drug evaluation
1727410|NCT00000639|Drug Therapy, Combination|drug therapy, combination
1727411|NCT00000639|Fluconazole|fluconazole
1727412|NCT00000639|Flucytosine|flucytosine
1727413|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727414|NCT00000639|Amphotericin B|amphotericin b
1727415|NCT00000639|Brain Diseases|brain diseases
1727416|NCT00000638|Tuberculosis|tuberculosis
1727417|NCT00000638|Isoniazid|isoniazid
1727418|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
1727419|NCT00000638|Pyrazinamide|pyrazinamide
1727420|NCT00000638|Pyridoxine|pyridoxine
1727421|NCT00000638|Rifampin|rifampin
1727422|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727423|NCT00000638|Drug Therapy, Combination|drug therapy, combination
1727424|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727425|NCT00000638|Antitubercular Agents|antitubercular agents
1727426|NCT00000638|AIDS-Related Complex|aids-related complex
1727427|NCT00000637|Didanosine|didanosine
1727428|NCT00000637|Drug Evaluation|drug evaluation
1727429|NCT00000637|Drug Therapy, Combination|drug therapy, combination
1727430|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727431|NCT00000637|AIDS-Related Complex|aids-related complex
1727432|NCT00000637|Zidovudine|zidovudine
1727433|NCT00000636|Tuberculosis|tuberculosis
1727434|NCT00000636|Isoniazid|isoniazid
1727435|NCT00000636|Pyrazinamide|pyrazinamide
1727436|NCT00000636|Pyridoxine|pyridoxine
1727437|NCT00000636|Rifampin|rifampin
1727438|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727439|NCT00000636|Drug Therapy, Combination|drug therapy, combination
1727440|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727441|NCT00000636|Antitubercular Agents|antitubercular agents
1727442|NCT00000636|AIDS-Related Complex|aids-related complex
1727443|NCT00000635|Bacitracin|bacitracin
1727444|NCT00000635|Polymyxin B|polymyxin b
1727445|NCT00000635|Trifluridine|trifluridine
1727446|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
1727447|NCT00000635|Herpesviridae Infections|herpesviridae infections
1727448|NCT00000635|Drug Evaluation|drug evaluation
1727449|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727450|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
1727451|NCT00000635|Antiviral Agents|antiviral agents
1727452|NCT00000634|Benzodiazepines|benzodiazepines
1727453|NCT00000634|Drug Evaluation|drug evaluation
1727454|NCT00000634|Drugs, Investigational|drugs, investigational
1727455|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727456|NCT00000634|Antiviral Agents|antiviral agents
1727457|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
1727458|NCT00000633|Vaccinia Virus|vaccinia virus
1727459|NCT00000633|Viral Vaccines|viral vaccines
1727461|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
1727462|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727463|NCT00000633|AIDS-Related Complex|aids-related complex
1727464|NCT00000633|AIDS Vaccines|aids vaccines
1727465|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
1727466|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
1727467|NCT00000632|Drug Evaluation|drug evaluation
1727468|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
1727469|NCT00000632|AIDS Vaccines|aids vaccines
1727470|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
1727471|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
1727472|NCT00000631|Vaccinia Virus|vaccinia virus
1727473|NCT00000631|Viral Envelope Proteins|viral envelope proteins
1727474|NCT00000631|Viral Vaccines|viral vaccines
1727475|NCT00000631|AIDS Vaccines|aids vaccines
1727476|NCT00000631|HIV Seronegativity|hiv seronegativity
1727477|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
1727478|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
1727479|NCT00000630|Vaccinia Virus|vaccinia virus
1727480|NCT00000630|Viral Envelope Proteins|viral envelope proteins
1727481|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727482|NCT00000630|AIDS Vaccines|aids vaccines
1727483|NCT00000630|HIV Seronegativity|hiv seronegativity
1727484|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
1727485|NCT00000629|Valproic Acid|valproic acid
1727486|NCT00000629|Zidovudine|zidovudine
1727487|NCT00000628|Drug Evaluation|drug evaluation
1727488|NCT00000628|Drugs, Investigational|drugs, investigational
1727489|NCT00000628|Drug Therapy, Combination|drug therapy, combination
1727490|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727491|NCT00000628|AIDS-Related Complex|aids-related complex
1727492|NCT00000628|Antiviral Agents|antiviral agents
1727493|NCT00000627|Pilot Projects|pilot projects
1727494|NCT00000627|Histoplasmosis|histoplasmosis
1727495|NCT00000627|Drug Evaluation|drug evaluation
1727496|NCT00000627|Fluconazole|fluconazole
1727497|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727498|NCT00000627|Recurrence|recurrence
1727499|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1727500|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1727501|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
1727502|NCT00000626|AIDS-Related Complex|aids-related complex
1727503|NCT00000626|Hodgkin Disease|hodgkin disease
1727504|NCT00000626|ABVD protocol|abvd protocol
1727505|NCT00000625|Zalcitabine|zalcitabine
1727506|NCT00000625|Didanosine|didanosine
1727507|NCT00000625|Drug Therapy, Combination|drug therapy, combination
1727508|NCT00000625|AIDS-Related Complex|aids-related complex
1727509|NCT00000625|Antiviral Agents|antiviral agents
1727510|NCT00000625|Zidovudine|zidovudine
1727511|NCT00023192|Campath 1-H|campath 1-h
1727512|NCT00023192|T-Cell Depletion|t-cell depletion
1727513|NCT00023192|Therapy|therapy
1727514|NCT00023192|Stem Cell Transplantation|stem cell transplantation
1727515|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
1727516|NCT00023192|CGD|cgd
1727519|NCT00023166|Safety/efficacy|safety/efficacy
1727520|NCT00023166|Lymphomas|lymphomas
1727521|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
1727522|NCT00023166|Neoplasms|neoplasms
1727523|NCT00023166|Neoplasm metastasis|neoplasm metastasis
1727524|NCT00023153|Drug Resistance|drug resistance
1727525|NCT00023153|Viral Load|viral load
1727526|NCT00023153|Liver|liver
1727527|NCT00023153|Immunology|immunology
1727528|NCT00023153|Liver Histology|liver histology
1727529|NCT00023153|Hepatitis B|hepatitis b
1727530|NCT00023153|HBV|hbv
1727531|NCT00023153|HIV|hiv
1727532|NCT00023140|biomarkers|biomarkers
1727533|NCT00023140|exposure|exposure
1727534|NCT00023140|adducts|adducts
1727535|NCT00023140|metabolites|metabolites
1727536|NCT00023140|butadiene|butadiene
1727537|NCT00023127|Asthma|asthma
1727538|NCT00023127|Allergen|allergen
1727539|NCT00023127|Cockroach|cockroach
1727540|NCT00023114|lung function|lung function
1727541|NCT00023114|smoking|smoking
1727542|NCT00023114|metabolism|metabolism
1727543|NCT00023101|lead|lead
1727544|NCT00023101|endocrine dysfunction|endocrine dysfunction
1727545|NCT00023088|Rehabilitation|rehabilitation
1727546|NCT00023088|Functional Level|functional level
1727547|NCT00023088|Activity of Daily Living|activity of daily living
1727548|NCT00023088|Mobility|mobility
1727549|NCT00023088|Normal Volunteer|normal volunteer
1727550|NCT00023075|MRI|mri
1727551|NCT00023075|Neuromuscular Disease|neuromuscular disease
1727552|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
1727553|NCT00023075|Choline|choline
1727554|NCT00023075|Creatine|creatine
1727555|NCT00023075|Spasms|spasms
1727556|NCT00023075|Spasticity|spasticity
1727557|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
1727558|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
1727559|NCT00023075|Spastic Paraparesis|spastic paraparesis
1727560|NCT00023075|Healthy Volunteer|healthy volunteer
1727562|NCT00023075|Normal Control|normal control
1727563|NCT00023062|Natural History|natural history
1727564|NCT00023062|Motor Cortex|motor cortex
1727565|NCT00023062|Behavior|behavior
1727566|NCT00023062|Healthy Volunteers|healthy volunteers
1727567|NCT00023062|Motor Control|motor control
1727568|NCT00023062|Parkinson Disease|parkinson disease
1727569|NCT00023062|Parkinson's|parkinson's
1727570|NCT00023062|Healthy Volunteer|healthy volunteer
1727571|NCT00023062|HV|hv
1727572|NCT00023062|Normal Control|normal control
1727573|NCT00023049|Deafness|deafness
1727574|NCT00023049|Genes|genes
1727575|NCT00023049|Impairment|impairment
1727576|NCT00023049|Auditory|auditory
1727577|NCT00023049|Vestibular|vestibular
1727578|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
1727579|NCT00023049|Hearing Impairment|hearing impairment
1727580|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
1727581|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
1727582|NCT00023049|SNHL|snhl
1727583|NCT00023036|Genetics|genetics
1727584|NCT00023036|Deafness|deafness
1727585|NCT00023036|EVA|eva
1727586|NCT00023036|Pendred|pendred
1727587|NCT00023036|Hearing|hearing
1727588|NCT00023036|Hearing Impairment|hearing impairment
1727589|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
1727590|NCT00023036|SNHL|snhl
1727591|NCT00023036|Inner Ear|inner ear
1727592|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
1727593|NCT00023023|Hepatitis|hepatitis
1727594|NCT00023023|Blood Bank|blood bank
1727595|NCT00023023|Viruses|viruses
1727596|NCT00023023|Blood Donors|blood donors
1727597|NCT00023023|Blood Recipients|blood recipients
1727598|NCT00023010|CD18|cd18
1727599|NCT00023010|Retrovirus|retrovirus
1727600|NCT00023010|RCR|rcr
1727601|NCT00023010|Stem Cell|stem cell
1727602|NCT00023010|Gene Transfer|gene transfer
1727603|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
1727604|NCT00023010|LAD|lad
1727605|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
1727606|NCT00022997|Phlebotomy|phlebotomy
1727607|NCT00022997|Chemoreceptors|chemoreceptors
1727608|NCT00022997|Population Associations|population associations
1727609|NCT00022997|Non-Tasters|non-tasters
1727610|NCT00022997|Taste|taste
1727611|NCT00022997|Healthy Volunteer|healthy volunteer
1727612|NCT00022997|HV|hv
1727613|NCT00022997|Normal Control|normal control
1727614|NCT00022984|Attitudes Towards Technology|attitudes towards technology
1727615|NCT00022984|Cardiovascular Disease|cardiovascular disease
1727616|NCT00022984|Illness Representation|illness representation
1727617|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
1727618|NCT00022984|Symptom Distress|symptom distress
1727619|NCT00022984|Heart Disease|heart disease
1727620|NCT00022984|ICD|icd
1727621|NCT00022971|Monoclonal Antibody|monoclonal antibody
1727622|NCT00022971|Lymphoma|lymphoma
1727623|NCT00022971|Rituximab|rituximab
1727624|NCT00022971|Hu1D10|hu1d10
1727625|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1727626|NCT00022971|NHL|nhl
1727627|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1727630|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1727631|NCT00022958|Radioimmunotherapy|radioimmunotherapy
1727632|NCT00022958|Monoclonal Antibody|monoclonal antibody
1727633|NCT00022958|Corixa|corixa
1727634|NCT00022958|Bexxar|bexxar
1727635|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
1727636|NCT00022958|Tositumomab|tositumomab
1727637|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727638|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727639|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
1727640|NCT00022945|Radioimmunotherapy|radioimmunotherapy
1727641|NCT00022945|Monoclonal Antibody|monoclonal antibody
1727642|NCT00022945|Corixa|corixa
1727643|NCT00022945|Bexxar|bexxar
1727644|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
1727645|NCT00022945|Tositumomab|tositumomab
1727646|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727647|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727648|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1727649|NCT00022932|Radioimmunotherapy|radioimmunotherapy
1727650|NCT00022932|Monoclonal Antibody|monoclonal antibody
1727651|NCT00022932|Corixa|corixa
1727652|NCT00022932|Bexxar|bexxar
1727653|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
1727654|NCT00022932|Tositumomab|tositumomab
1727655|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727656|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727657|NCT00022919|Microdissection|microdissection
1727658|NCT00022919|Chromosome|chromosome
1727659|NCT00022919|Karyotype|karyotype
1727660|NCT00022919|Tumor|tumor
1727661|NCT00022919|Malignancy|malignancy
1727662|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
1727663|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
1727664|NCT00022919|Prostate Cancer|prostate cancer
1727665|NCT00022919|Prostate|prostate
1727666|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1727667|NCT00022906|Radioimmunotherapy|radioimmunotherapy
1727668|NCT00022906|Monoclonal Antibody|monoclonal antibody
1727669|NCT00022906|Corixa|corixa
1727670|NCT00022906|Bexxar|bexxar
1727671|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
1727672|NCT00022906|Tositumomab|tositumomab
1727673|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727674|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727675|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1727676|NCT00022893|Radioimmunotherapy|radioimmunotherapy
1727677|NCT00022893|Monoclonal Antibody|monoclonal antibody
1727678|NCT00022893|Corixa|corixa
1727679|NCT00022893|Bexxar|bexxar
1727680|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
1727681|NCT00022893|Tositumomab|tositumomab
1727682|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727683|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727684|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1727685|NCT00022880|Dose-Escalation|dose-escalation
1727686|NCT00022880|Radioimmunotherapy|radioimmunotherapy
1727687|NCT00022880|Monoclonal Antibody|monoclonal antibody
1727688|NCT00022880|Corixa|corixa
1727689|NCT00022880|Bexxar|bexxar
1727690|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
1727691|NCT00022880|Tositumomab|tositumomab
1727692|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
1727693|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
1727694|NCT00022867|Bone growth|bone growth
1727695|NCT00022867|Calcium|calcium
1727696|NCT00022867|Children|children
1727697|NCT00022867|Diet|diet
1727698|NCT00022867|Puberty|puberty
1727699|NCT00022854|ACL|acl
1727700|NCT00022854|Nerve block|nerve block
1727701|NCT00022854|Knee|knee
1727702|NCT00022854|Outcome survey|outcome survey
1727703|NCT00022854|Anesthesia|anesthesia
1727704|NCT00022854|Analgesia|analgesia
1727705|NCT00022854|Pain|pain
1727706|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
1727707|NCT00022841|Children|children
1727708|NCT00022841|Glucocorticoids|glucocorticoids
1727709|NCT00022841|Osteoporosis|osteoporosis
1727710|NCT00022841|Pediatric|pediatric
1727711|NCT00022841|Pamidronate|pamidronate
1727712|NCT00022841|Steroids|steroids
1727713|NCT00022828|Laser|laser
1727714|NCT00022828|Cervical|cervical
1727715|NCT00022828|Spinal|spinal
1727716|NCT00022828|Spine|spine
1727717|NCT00022828|Neck|neck
1727718|NCT00022828|Illinois|illinois
1727719|NCT00022815|Compartment syndrome|compartment syndrome
1727720|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
1727721|NCT00022815|Reperfusion injury|reperfusion injury
1727722|NCT00022815|Ischemia|ischemia
1727723|NCT00022802|Biomedical equipment development|biomedical equipment development
1727724|NCT00022802|Computer assisted patient care|computer assisted patient care
1727725|NCT00022802|Digital imaging|digital imaging
1727726|NCT00022802|Hip surgery|hip surgery
1727727|NCT00022802|Orthopedics|orthopedics
1727728|NCT00022802|Trauma|trauma
1727729|NCT00022802|Radiography|radiography
1727730|NCT00022802|Biomedical imaging|biomedical imaging
1727731|NCT00022776|Human therapy evaluation|human therapy evaluation
1727732|NCT00022776|Orthopedics|orthopedics
1727733|NCT00022776|Physical therapy|physical therapy
1727734|NCT00022776|Nonsurgical treatment|nonsurgical treatment
1727735|NCT00022776|Surgical decompression|surgical decompression
1727736|NCT00022776|Surgery|surgery
1727737|NCT00022776|Lumbar|lumbar
1727738|NCT00022776|Spine disorder|spine disorder
1727739|NCT00022776|Spinal stenosis|spinal stenosis
1727740|NCT00022776|Gender difference|gender difference
1727741|NCT00022776|Medical rehabilitation|medical rehabilitation
1727742|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
1727743|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
1727744|NCT00022750|Nurse Case Manager|nurse case manager
1727745|NCT00022750|Community Health Worker|community health worker
1727746|NCT00022750|Behavioral Interventions|behavioral interventions
1727747|NCT00022750|Cost-effectiveness|cost-effectiveness
1727748|NCT00022750|Randomized trial|randomized trial
1727749|NCT00021866|epilepsy|epilepsy
1727750|NCT00021866|seizure|seizure
1727751|NCT00021866|pregnancy|pregnancy
1727752|NCT00021866|antiepileptic|antiepileptic
1727753|NCT00021866|AED|aed
1727754|NCT00021866|carbamazepine|carbamazepine
1727755|NCT00021866|phenytoin|phenytoin
1727756|NCT00021866|valproate|valproate
1727757|NCT00021866|lamotrigine|lamotrigine
1727758|NCT00021866|child|child
1727759|NCT00021866|behavior|behavior
1727760|NCT00021853|Individualized|individualized
1727761|NCT00021853|Finger|finger
1727762|NCT00021853|Training|training
1727763|NCT00021853|Splinting|splinting
1727764|NCT00021853|TMS|tms
1727765|NCT00021853|Dystonia|dystonia
1727972|NCT00018200|sciatica|sciatica
1727766|NCT00021853|Focal Dystonia|focal dystonia
1727767|NCT00021853|Movement Disorder|movement disorder
1727768|NCT00021853|Focal Hand Dystonia|focal hand dystonia
1727769|NCT00021853|Writer's Cramp|writer's cramp
1727770|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
1727771|NCT00021827|parathyroid hormone|parathyroid hormone
1727772|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
1727773|NCT00021827|postmenopausal women|postmenopausal women
1727774|NCT00021814|BPH progression|bph progression
1727775|NCT00021814|Medical Therapy|medical therapy
1727776|NCT00021814|Finasteride|finasteride
1727777|NCT00021814|Doxazosin|doxazosin
1727778|NCT00021814|Randomized|randomized
1727779|NCT00021814|Multi-center|multi-center
1727780|NCT00021814|Clinical Trial|clinical trial
1727781|NCT00021814|Proscar|proscar
1727782|NCT00021814|Cardura|cardura
1727783|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
1727784|NCT00021801|Immunosuppression|immunosuppression
1727785|NCT00021801|Islet Cell Transplant|islet cell transplant
1727786|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
1727787|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
1727788|NCT00021788|Immunosuppression|immunosuppression
1727789|NCT00021788|Islet Cell Transplantation|islet cell transplantation
1727790|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
1727791|NCT00021749|CLL|cll
1727792|NCT00021749|Leukemia|leukemia
1727793|NCT00021749|Chronic|chronic
1727794|NCT00021749|Cancer|cancer
1727795|NCT00021749|Adult|adult
1727796|NCT00021749|Lymphocytic|lymphocytic
1727797|NCT00021749|Genasense|genasense
1727798|NCT00021749|G3139|g3139
1727799|NCT00021749|Genta|genta
1727800|NCT00021749|Bcl-2|bcl-2
1727801|NCT00021749|Antisense|antisense
1727802|NCT00021749|Oligonucleotide|oligonucleotide
1727803|NCT00021749|oblimerson|oblimerson
1727804|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
1727805|NCT00021736|subretinal neovascularization|subretinal neovascularization
1727806|NCT00021723|Alzheimer's|alzheimer's
1727807|NCT00021723|AN-1792|an-1792
1727808|NCT00021723|AIP-001|aip-001
1727809|NCT00021710|Stroke|stroke
1727810|NCT00021710|Learning|learning
1727811|NCT00021710|Plasticity|plasticity
1727812|NCT00021710|Motor|motor
1727813|NCT00021710|Rehabilitation|rehabilitation
1727814|NCT00021710|Premotor|premotor
1727815|NCT00021710|Normal Control|normal control
1727816|NCT00021710|Healthy Volunteer|healthy volunteer
1727817|NCT00021710|HV|hv
1727818|NCT00021710|Motor Learning|motor learning
1727819|NCT00021697|AVP-923|avp-923
1727820|NCT00021697|Dextromethorphan|dextromethorphan
1727821|NCT00021697|Quinidine|quinidine
1727822|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
1727823|NCT00021658|Epidemiology|epidemiology
1727824|NCT00021658|pesticide|pesticide
1727825|NCT00021658|asthma|asthma
1727826|NCT00021658|children|children
1727827|NCT00021658|exposure|exposure
1727828|NCT00021645|Corticosteroids|corticosteroids
1727829|NCT00021645|Immunosuppressives|immunosuppressives
1727830|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
1727831|NCT00021645|Uveitis|uveitis
1727832|NCT00021645|Macular Edema|macular edema
1727833|NCT00021567|Pneumonia|pneumonia
1727834|NCT00021567|Cytokine|cytokine
1727835|NCT00021567|Aerosol|aerosol
1727836|NCT00021567|Therapy|therapy
1727837|NCT00021567|Mycobacteria|mycobacteria
1727838|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
1727839|NCT00021567|MAC|mac
1728166|NCT00016679|Toxicity|toxicity
1727840|NCT00021567|Pulmonary Infection|pulmonary infection
1727841|NCT00021567|Lung Infection|lung infection
1727842|NCT00021541|Surrogate Markers|surrogate markers
1727843|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
1727844|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
1727845|NCT00021541|Tumor Tissue Bank|tumor tissue bank
1727846|NCT00021541|Neurofibromatosis|neurofibromatosis
1727847|NCT00021541|NF1|nf1
1727848|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
1727849|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
1727850|NCT00021541|Neurofibroma|neurofibroma
1727851|NCT00021528|Sequential Treatment|sequential treatment
1727852|NCT00021528|Major Depression|major depression
1727853|NCT00021528|Treatment Resistant Depression|treatment resistant depression
1727854|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
1727855|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
1727856|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
1727857|NCT00021502|Shock|shock
1727858|NCT00021476|Whiplash|whiplash
1727859|NCT00021476|Chronic pain|chronic pain
1727860|NCT00021476|Motor vehicle accidents|motor vehicle accidents
1727861|NCT00021437|Bloom syndrome protein|bloom syndrome protein
1727862|NCT00018902|Depressive Disorder|depressive disorder
1727863|NCT00018902|Adolescents|adolescents
1727864|NCT00018902|Teenagers|teenagers
1727865|NCT00018902|Teens|teens
1727866|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
1727867|NCT00018889|Clinical Evaluation|clinical evaluation
1727868|NCT00018889|Genetic Study|genetic study
1727869|NCT00018889|Essential Tremor|essential tremor
1727870|NCT00018889|Familial Myoclonus|familial myoclonus
1727871|NCT00018889|Hereditary Ataxia|hereditary ataxia
1727872|NCT00018889|Movement Disorder|movement disorder
1727873|NCT00018889|Inherited Movement Disorder|inherited movement disorder
1727874|NCT00018876|Epidural fibrosis|epidural fibrosis
1727875|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
1727876|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
1727877|NCT00018876|Lumbar laminectomy|lumbar laminectomy
1727878|NCT00018876|Radiotherapy|radiotherapy
1727879|NCT00018876|Radiation|radiation
1727880|NCT00018876|Perineural scar formation|perineural scar formation
1727881|NCT00018876|Peridural fibrosis|peridural fibrosis
1727882|NCT00018876|Back surgery|back surgery
1727883|NCT00018863|ADHD|adhd
1727884|NCT00018850|schizophrenia|schizophrenia
1727885|NCT00018850|ondansetron|ondansetron
1727886|NCT00018850|nicotine|nicotine
1727887|NCT00018850|haloperidol|haloperidol
1727888|NCT00018811|Relaxation Techniques|relaxation techniques
1727889|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
1727890|NCT00018811|Psychophysiology|psychophysiology
1727891|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
1727892|NCT00018785|kidney transplantation|kidney transplantation
1727893|NCT00018785|immunosuppression|immunosuppression
1727894|NCT00018785|bone marrow|bone marrow
1727895|NCT00018772|coagulation|coagulation
1727896|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
1727897|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
1727898|NCT00018733|Depression|depression
1727899|NCT00018720|triglyceride|triglyceride
1727900|NCT00018720|bile acids|bile acids
1727901|NCT00018720|cholelithias|cholelithias
1727902|NCT00018694|bile acid synthesis|bile acid synthesis
1727903|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
1727904|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
1727905|NCT00018668|Antipsychotics|antipsychotics
1727906|NCT00018668|schizophrenia|schizophrenia
1727907|NCT00018668|motor retardation|motor retardation
1727908|NCT00018668|bradykinesia|bradykinesia
1727909|NCT00018655|Mood Disorders|mood disorders
1727910|NCT00018655|Substance-Related Disorders|substance-related disorders
1727911|NCT00018642|quetiapine|quetiapine
1727912|NCT00018642|haloperidol decanoate|haloperidol decanoate
1727913|NCT00018629|Aging|aging
1727914|NCT00018629|Neuropsychology|neuropsychology
1727915|NCT00018629|Psychotherapy|psychotherapy
1727916|NCT00018629|Rehabilitation|rehabilitation
1727917|NCT00018629|Schizophrenia|schizophrenia
1727918|NCT00018616|compliance|compliance
1727919|NCT00018616|MEMS|mems
1727920|NCT00018616|metformin|metformin
1727921|NCT00018603|PTSD|ptsd
1727922|NCT00018590|Vascular Diseases|vascular diseases
1727923|NCT00018538|vitamin D|vitamin d
1727924|NCT00018538|prostatic neoplasms|prostatic neoplasms
1727925|NCT00018538|neoplasm recurrence|neoplasm recurrence
1727926|NCT00018512|dental implant|dental implant
1727927|NCT00018499|Traumatic Brain Injury|traumatic brain injury
1727928|NCT00018473|Risk Factors|risk factors
1727929|NCT00018473|Genes|genes
1727930|NCT00018473|Epidemiology|epidemiology
1727931|NCT00018473|Apolipoproteins E|apolipoproteins e
1727932|NCT00018473|Alzheimer's Disease|alzheimer's disease
1727933|NCT00018460|geriatrics|geriatrics
1727934|NCT00018460|vitamin B complex|vitamin b complex
1727935|NCT00018460|thrombomodulin|thrombomodulin
1727936|NCT00018460|anticoagulants|anticoagulants
1728893|NCT00011193|Sedentary|sedentary
1727937|NCT00018447|osteoporosis|osteoporosis
1727938|NCT00018434|Infection|infection
1727939|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
1727940|NCT00018421|Exercise|exercise
1727941|NCT00018421|Rehabilitation|rehabilitation
1727942|NCT00018408|COPD|copd
1727943|NCT00018408|Smoking|smoking
1727944|NCT00018395|Calcium Metabolism|calcium metabolism
1727945|NCT00018369|Aging|aging
1727946|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
1727947|NCT00018356|Aging|aging
1727948|NCT00018356|nutrition|nutrition
1727949|NCT00018356|rehabilitation|rehabilitation
1727950|NCT00018330|Behavioral|behavioral
1727951|NCT00018330|Weight Loss|weight loss
1727952|NCT00018330|Genetics|genetics
1727953|NCT00018330|Lipoprotein lipase|lipoprotein lipase
1727954|NCT00018330|Visceral fat|visceral fat
1727955|NCT00018330|Lipoprotein|lipoprotein
1727956|NCT00018317|Diet|diet
1727957|NCT00018317|exercise|exercise
1727958|NCT00018304|blood pressure|blood pressure
1727959|NCT00018304|insulin sensitivity|insulin sensitivity
1727960|NCT00018304|blood flow|blood flow
1727961|NCT00018291|Dementia|dementia
1727962|NCT00018291|Agitated Behavior|agitated behavior
1727963|NCT00018291|Behavioral disturbance|behavioral disturbance
1727964|NCT00018265|Rehabilitation|rehabilitation
1727965|NCT00018265|exercise test|exercise test
1727966|NCT00018265|aging|aging
1727967|NCT00018213|Naltrexone|naltrexone
1727968|NCT00018213|Nicotine patch|nicotine patch
1727969|NCT00018213|Tobacco dependence|tobacco dependence
1727970|NCT00018200|analgesia|analgesia
1727971|NCT00018200|Back pain|back pain
1727973|NCT00018187|smoking cessation|smoking cessation
1727974|NCT00018187|bupropion|bupropion
1727975|NCT00018187|mecamylamine|mecamylamine
1727976|NCT00018187|nicotine|nicotine
1727977|NCT00018174|Depression|depression
1727978|NCT00018174|Fluoxetine|fluoxetine
1727979|NCT00018174|Nicotine dependence|nicotine dependence
1727980|NCT00018161|Nicotine|nicotine
1727982|NCT00018161|cigarette smoking|cigarette smoking
1727983|NCT00018148|smoking cessation|smoking cessation
1727984|NCT00018135|high iPTH levels|high ipth levels
1727985|NCT00018122|Islet cell transplant|islet cell transplant
1727986|NCT00018096|Genetics|genetics
1727987|NCT00018096|Lipopolysaccharide|lipopolysaccharide
1727988|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
1727989|NCT00018070|Choroid|choroid
1727990|NCT00018070|Blood Vessels|blood vessels
1727991|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
1727992|NCT00018070|Laser|laser
1727993|NCT00018070|Macular Degeneration|macular degeneration
1727995|NCT00018057|fMRI|fmri
1727996|NCT00018057|SSRI|ssri
1727997|NCT00018057|Neuropsychological|neuropsychological
1727998|NCT00018057|Evaluative Learning|evaluative learning
1727999|NCT00018057|Adolescent|adolescent
1728000|NCT00018057|Normal Volunteers|normal volunteers
1728001|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
1728002|NCT00018057|CBT|cbt
1728003|NCT00018057|IPT|ipt
1728004|NCT00018057|Anxiety|anxiety
1728005|NCT00018057|Anxiety Disorder|anxiety disorder
1728006|NCT00018057|Mood Disorder|mood disorder
1728007|NCT00018057|Depression|depression
1728008|NCT00018057|Healthy Volunteer|healthy volunteer
1728009|NCT00018057|Normal Control|normal control
1728010|NCT00018044|Morphotype|morphotype
1728011|NCT00018044|Pulmonary|pulmonary
1728012|NCT00018044|Infection|infection
1728013|NCT00018044|Mycobacterium|mycobacterium
1728014|NCT00018044|Nontuberculous|nontuberculous
1728015|NCT00018044|Mycobacterial Infection|mycobacterial infection
1728016|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
1728017|NCT00018044|NTM|ntm
1728018|NCT00018044|Job's Syndrome|job's syndrome
1728019|NCT00018044|Job Syndrome|job syndrome
1728020|NCT00018044|Cystic Fibrosis|cystic fibrosis
1728021|NCT00018044|CF|cf
1728022|NCT00018031|Liver Disease|liver disease
1728023|NCT00018031|Virologic Response|virologic response
1728024|NCT00018031|Immune Mechanisms|immune mechanisms
1728025|NCT00018031|Cirrhosis|cirrhosis
1728026|NCT00018031|Eradication|eradication
1728027|NCT00018031|HIV|hiv
1728028|NCT00018031|Hepatitis C|hepatitis c
1728029|NCT00018018|Gene Therapy|gene therapy
1728030|NCT00018018|ADA-SCID|ada-scid
1728031|NCT00018018|Stem Cells|stem cells
1728032|NCT00018018|Retroviruses|retroviruses
1728033|NCT00018018|Immune Deficiency Disease|immune deficiency disease
1728034|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
1728035|NCT00018018|ADA-Deficiency|ada-deficiency
1728036|NCT00018018|Retroviral Vectors|retroviral vectors
1728037|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
1728038|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
1728039|NCT00018018|SCID|scid
1728040|NCT00018018|Immune Deficiency|immune deficiency
1728041|NCT00018005|Heart Failure|heart failure
1728042|NCT00018005|Self-Management|self-management
1728043|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
1728044|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1728045|NCT00017979|Motor Cortex|motor cortex
1728046|NCT00017979|Motor Imagery|motor imagery
1728047|NCT00017979|Reaction Time|reaction time
1728048|NCT00017979|Cerebral Inhibition|cerebral inhibition
1728049|NCT00017979|Healthy Volunteer|healthy volunteer
1728050|NCT00017979|Normal Control|normal control
1728051|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1728052|NCT00017966|Motor Cortex|motor cortex
1728053|NCT00017966|Cerebral Inhibition|cerebral inhibition
1728054|NCT00017966|Corpus Callosum|corpus callosum
1728055|NCT00017966|Evoked Potential|evoked potential
1728056|NCT00017966|Healthy Volunteer|healthy volunteer
1728057|NCT00017966|Normal Control|normal control
1728058|NCT00017940|Gene Therapy|gene therapy
1728059|NCT00017953|Diabetes|diabetes
1728060|NCT00017953|Weight loss|weight loss
1728061|NCT00017953|Heart Attack|heart attack
1728062|NCT00017953|Heart disease|heart disease
1728063|NCT00017953|Lifestyle Intervention|lifestyle intervention
1728064|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
1728065|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
1728066|NCT00017953|Bone Density|bone density
1728067|NCT00017927|Acromegaly|acromegaly
1728068|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
1728069|NCT00017927|IGF-1|igf-1
1728070|NCT00017927|Adenoma|adenoma
1728071|NCT00017927|Hyperplasia|hyperplasia
1728072|NCT00017927|MAS|mas
1728073|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
1728074|NCT00017927|PFD|pfd
1728075|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
1728585|NCT00013598|Cirrhosis|cirrhosis
1728084|NCT00017875|Focal Dystonia|focal dystonia
1728085|NCT00017875|Dystonic Disorder|dystonic disorder
1728086|NCT00017875|DYTI Dystonia|dyti dystonia
1728087|NCT00017875|Movement Disorder|movement disorder
1728088|NCT00017875|Generalized Dystonia|generalized dystonia
1728089|NCT00017875|Healthy Control|healthy control
1728090|NCT00017875|Normal Volunteer|normal volunteer
1728091|NCT00017823|complementary therapies|complementary therapies
1728093|NCT00017823|HIV Infections|hiv infections
1728094|NCT00017823|Nausea|nausea
1728095|NCT00017823|Vomiting|vomiting
1728096|NCT00017810|complementary therapies|complementary therapies
1728097|NCT00017810|Behavior Therapy|behavior therapy
1728098|NCT00017810|Diarrhea|diarrhea
1728099|NCT00017810|Diet Therapy|diet therapy
1728100|NCT00017810|Food|food
1728101|NCT00017810|HIV Seropositivity|hiv seropositivity
1728103|NCT00017745|Hereditary Myopathies|hereditary myopathies
1728104|NCT00017745|Intermediate Filaments|intermediate filaments
1728105|NCT00017745|Cardiomyopathies|cardiomyopathies
1728106|NCT00017745|Genetic Testing|genetic testing
1728107|NCT00017745|Myopathy|myopathy
1728108|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
1728109|NCT00017732|Malformations|malformations
1728110|NCT00017732|Ethnicity|ethnicity
1728111|NCT00017732|Mutations|mutations
1728112|NCT00017732|Cholesterol|cholesterol
1728113|NCT00017732|Metabolism|metabolism
1728114|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
1728115|NCT00017732|SLOS|slos
1728116|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
1728117|NCT00017706|physician education|physician education
1728118|NCT00017706|behavioral weight control|behavioral weight control
1728119|NCT00017706|physician intervention|physician intervention
1728120|NCT00017706|obesity counseling|obesity counseling
1728121|NCT00016848|Obesity|obesity
1728122|NCT00016848|Endocrine|endocrine
1728123|NCT00016848|Diet|diet
1728124|NCT00016848|Metabolism|metabolism
1728125|NCT00016848|Macronutrients|macronutrients
1728126|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
1728127|NCT00016835|Glycemic control|glycemic control
1728128|NCT00016835|Periodontal therapy|periodontal therapy
1728129|NCT00017680|amyloidosis|amyloidosis
1728130|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1728131|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1728132|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1728133|NCT00017680|oncologic disorders|oncologic disorders
1728134|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
1728135|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
1728136|NCT00017680|rare disease|rare disease
1728137|NCT00017654|aplastic anemia|aplastic anemia
1728138|NCT00017654|disease-related problem/condition|disease-related problem/condition
1728139|NCT00017654|graft versus host disease|graft versus host disease
1728140|NCT00017654|hematologic disorders|hematologic disorders
1728141|NCT00017654|rare disease|rare disease
1728142|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1728143|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1728144|NCT00017641|rare disease|rare disease
1728145|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
1728146|NCT00017628|multiple sclerosis|multiple sclerosis
1728147|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1728148|NCT00017628|rare disease|rare disease
1728149|NCT00016796|Reading|reading
1728150|NCT00016796|Naming|naming
1728164|NCT00016679|Pharmacokinetics|pharmacokinetics
1728167|NCT00016679|Side Effects|side effects
1728168|NCT00016679|Essential Tremor|essential tremor
1728169|NCT00016679|Tremor|tremor
1728170|NCT00016679|Movement Disorder|movement disorder
1728171|NCT00016666|Season|season
1728172|NCT00016666|Light|light
1728173|NCT00016666|Propranolol|propranolol
1728174|NCT00016666|Photoperiod|photoperiod
1728175|NCT00016666|Pharmacokinetics|pharmacokinetics
1728176|NCT00016666|Circadian Rhythm|circadian rhythm
1728177|NCT00016666|Seasonal Rhythm|seasonal rhythm
1728178|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
1728179|NCT00016666|Pineal Gland|pineal gland
1728180|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
1728181|NCT00016666|Healthy Volunteer|healthy volunteer
1728182|NCT00016666|HV|hv
1728183|NCT00016666|Winter Depression|winter depression
1728184|NCT00016666|SAD|sad
1728185|NCT00016653|Duchenne|duchenne
1728186|NCT00016653|muscular|muscular
1728187|NCT00016653|dystrophy|dystrophy
1728188|NCT00016653|treatment|treatment
1728189|NCT00016562|Genetic|genetic
1728190|NCT00016562|Degenerative|degenerative
1728191|NCT00016562|Lysosomal|lysosomal
1728192|NCT00016562|Brain|brain
1728193|NCT00016562|Mental Retardation|mental retardation
1728194|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
1728195|NCT00016562|Neurometabolic|neurometabolic
1728196|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
1728197|NCT00016562|Abnormal Metabolism|abnormal metabolism
1728198|NCT00016549|Endothelial Proliferation|endothelial proliferation
1728199|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
1728200|NCT00016549|VEGF|vegf
1728201|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
1728202|NCT00016549|Molecular Targets|molecular targets
1728203|NCT00016549|Breast Cancer|breast cancer
1728204|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
1728205|NCT00016549|IBC|ibc
1728530|NCT00013767|Insecticide|insecticide
1728206|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
1728207|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1728208|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
1728209|NCT00016523|Prematurity|prematurity
1728210|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
1728211|NCT00016523|Aspiration syndrome|aspiration syndrome
1728212|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
1728213|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
1728214|NCT00016510|Bilingualism|bilingualism
1728215|NCT00016510|Fluency|fluency
1728216|NCT00016510|Age at Acquisition|age at acquisition
1728217|NCT00016510|Words and Sentences|words and sentences
1728218|NCT00016510|Cortical Area|cortical area
1728219|NCT00016510|Healthy Volunteer|healthy volunteer
1728220|NCT00016510|HV|hv
1728221|NCT00016510|Bilingual|bilingual
1728222|NCT00016510|Second Language|second language
1728223|NCT00016497|otitis media with effusion|otitis media with effusion
1728224|NCT00016497|children|children
1728225|NCT00016497|tympanostomy tubes|tympanostomy tubes
1728226|NCT00016497|adenoidectomy|adenoidectomy
1728227|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1728228|NCT00016458|rare disease|rare disease
1728229|NCT00016458|systemic sclerosis|systemic sclerosis
1728230|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1728231|NCT00016445|cystic fibrosis|cystic fibrosis
1728232|NCT00016445|disease-related problem/condition|disease-related problem/condition
1728233|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1728234|NCT00016445|quality of life|quality of life
1728235|NCT00016445|rare disease|rare disease
1728236|NCT00015808|Neurodegeneration|neurodegeneration
1728237|NCT00015808|Anti-Oxidant|anti-oxidant
1728238|NCT00015808|Neuropathy|neuropathy
1728239|NCT00015808|Hereditary|hereditary
1728240|NCT00015808|Spinocerebellar|spinocerebellar
1728241|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
1728242|NCT00015808|Friedreich Ataxia|friedreich ataxia
1728243|NCT00015808|FRDA|frda
1728244|NCT00015795|Pressure|pressure
1728245|NCT00015795|Botulinum Toxin|botulinum toxin
1728246|NCT00015795|Voice|voice
1728247|NCT00015795|Dystonia|dystonia
1728248|NCT00015795|Pathophysiology|pathophysiology
1728249|NCT00015795|Healthy Volunteer|healthy volunteer
1728250|NCT00015795|HV|hv
1728251|NCT00015795|ABSD|absd
1728252|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
1728253|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
1728254|NCT00015782|Metabolic|metabolic
1728255|NCT00015782|Genetic|genetic
1728256|NCT00015782|Storage|storage
1728257|NCT00015782|Retinal Disease|retinal disease
1728258|NCT00015782|Degenerative|degenerative
1728259|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
1728260|NCT00015782|ML-IV|ml-iv
1728261|NCT00015769|Mania|mania
1728262|NCT00015769|Depression|depression
1728263|NCT00015769|Anticonvulsants|anticonvulsants
1728264|NCT00015769|Mood Stabilizers|mood stabilizers
1728265|NCT00015769|Bipolar|bipolar
1728266|NCT00015769|Mood Stabilizer|mood stabilizer
1728267|NCT00015756|Apheresis|apheresis
1728268|NCT00015756|Transplantation|transplantation
1728269|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
1728270|NCT00015756|Exotoxins|exotoxins
1728271|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
1728272|NCT00015756|Cystic Fibrosis|cystic fibrosis
1728273|NCT00015756|CF|cf
1728274|NCT00015717|Imaging|imaging
1728275|NCT00015717|Complications|complications
1728276|NCT00015717|Stenosis|stenosis
1728277|NCT00015717|Treatment|treatment
1728278|NCT00015717|Strokes|strokes
1728279|NCT00015717|Cerebral Ischemia|cerebral ischemia
1728280|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
1728281|NCT00015678|Motor Cortex|motor cortex
1728282|NCT00015678|Drug|drug
1728283|NCT00015678|GABA|gaba
1728284|NCT00015678|Cortical Modulation|cortical modulation
1728285|NCT00015678|Magnetic Stimulation|magnetic stimulation
1728286|NCT00015678|Healthy Volunteer|healthy volunteer
1728287|NCT00015665|Fungal|fungal
1728288|NCT00015665|Immunodeficiency|immunodeficiency
1728289|NCT00015665|Infection|infection
1728290|NCT00015665|Refractory|refractory
1728291|NCT00015665|Severe|severe
1728292|NCT00015665|Fungal Infections|fungal infections
1728293|NCT00015639|Blood Donors|blood donors
1728294|NCT00015639|Employees|employees
1728295|NCT00015639|Heparin|heparin
1728296|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
1728297|NCT00015639|Membrane|membrane
1728298|NCT00015639|Healthy Volunteer|healthy volunteer
1728299|NCT00015613|Hispanics|hispanics
1728300|NCT00015613|Acculturation|acculturation
1728301|NCT00015613|Maternal Exposure|maternal exposure
1728302|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
1728303|NCT00015613|Infant, Premature|infant, premature
1728304|NCT00015613|Organophosphates|organophosphates
1728305|NCT00015613|Pesticides|pesticides
1728306|NCT00015613|Stress|stress
1728307|NCT00015613|Nutrition|nutrition
1728308|NCT00015600|Pesticide|pesticide
1728309|NCT00015600|Farmworker|farmworker
1728310|NCT00015600|Occupational health|occupational health
1728311|NCT00015587|Molecular Epidemiology|molecular epidemiology
1728312|NCT00015587|Case Control|case control
1728313|NCT00015574|arrhythmia|arrhythmia
1728314|NCT00015574|cardiac|cardiac
1728315|NCT00015574|air pollution|air pollution
1728316|NCT00015574|time series|time series
1728317|NCT00015561|population studies|population studies
1728318|NCT00015561|laboratory evaluation|laboratory evaluation
1728319|NCT00015561|hormone analysis|hormone analysis
1728320|NCT00015561|semen analysis|semen analysis
1728321|NCT00015561|chromosome studies|chromosome studies
1728322|NCT00015548|antipsychotic treatment|antipsychotic treatment
1728323|NCT00015548|Alzheimer's disease|alzheimer's disease
1728324|NCT00015548|agitation|agitation
1728325|NCT00015548|dementia|dementia
1728326|NCT00015548|psychosis|psychosis
1728327|NCT00015548|behavioral symptoms|behavioral symptoms
1728328|NCT00015548|hallucinations|hallucinations
1728329|NCT00015548|delusions|delusions
1728330|NCT00015483|Hematotoxicity|hematotoxicity
1728331|NCT00015483|Benzene|benzene
1728332|NCT00015483|Bone Marrow|bone marrow
1728333|NCT00015470|Myopathy|myopathy
1728334|NCT00015470|Dystrophy|dystrophy
1728335|NCT00015470|Neuropathy|neuropathy
1728336|NCT00015470|Muscle Weakness|muscle weakness
1728337|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
1728338|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
1728339|NCT00015457|Writer's Cramp|writer's cramp
1728340|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
1728341|NCT00015457|Torticollis|torticollis
1728342|NCT00015457|Chemodenervation|chemodenervation
1728343|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
1728344|NCT00015444|Spasticity|spasticity
1728345|NCT00015444|Motor Neuron Disease|motor neuron disease
1728346|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1728347|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
1728348|NCT00015444|Muscle Stiffness|muscle stiffness
1728349|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
1728350|NCT00015444|Isaacs Syndrome|isaacs syndrome
1728351|NCT00015431|Malabsorption|malabsorption
1728352|NCT00015431|Endoscopy|endoscopy
1728353|NCT00015431|Cytokine|cytokine
1728354|NCT00015431|Immunophenotype|immunophenotype
1728355|NCT00015431|Lymphocyte|lymphocyte
1728356|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
1728357|NCT00015431|Gastrointestinal|gastrointestinal
1728358|NCT00015015|Dichloroacetate|dichloroacetate
1728359|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
1728360|NCT00015015|Genetic disease|genetic disease
1728361|NCT00015015|Toxicology|toxicology
1728362|NCT00015015|Biotransformation|biotransformation
1728363|NCT00015340|Opioid Dependence|opioid dependence
1728364|NCT00015249|cocaine dependence|cocaine dependence
1728365|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
1728366|NCT00015171|opioid dependence|opioid dependence
1728367|NCT00015132|cocaine dependence|cocaine dependence
1728368|NCT00015106|cocaine dependence|cocaine dependence
1728369|NCT00015080|cocaine dependence|cocaine dependence
1728370|NCT00015054|cocaine dependence|cocaine dependence
1728371|NCT00015041|opiate dependence|opiate dependence
1728372|NCT00015028|opioid dependence|opioid dependence
1728373|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
1728374|NCT00015002|Preterm delivery|preterm delivery
1728375|NCT00014989|Preterm delivery|preterm delivery
1728376|NCT00014989|Cerebral palsy|cerebral palsy
1728377|NCT00014989|Magnesium sulfate|magnesium sulfate
1728378|NCT00014976|Pyramidal Tract|pyramidal tract
1728379|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
1728380|NCT00014976|Spastic Paraparesis|spastic paraparesis
1728382|NCT00014976|Magnetic Stimulation|magnetic stimulation
1728383|NCT00014976|Muscle Spasticity|muscle spasticity
1728384|NCT00014976|Healthy Volunteer|healthy volunteer
1728385|NCT00014963|benzene|benzene
1728386|NCT00014963|biomarkers|biomarkers
1728387|NCT00014963|air pollution|air pollution
1728388|NCT00014963|muconic acid|muconic acid
1728389|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
1728390|NCT00014950|Cystic Fibrosis|cystic fibrosis
1728391|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
1728392|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
1728393|NCT00014950|newborn screening|newborn screening
1728394|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
1728395|NCT00014950|nutrition|nutrition
1728396|NCT00014950|pulmonary status|pulmonary status
1728397|NCT00014950|meconium ileus|meconium ileus
1728398|NCT00014950|growth|growth
1728399|NCT00014950|Genetic counseling|genetic counseling
1728400|NCT00014950|risk communication|risk communication
1728401|NCT00014898|Lead exposure|lead exposure
1728402|NCT00014898|Bone lead|bone lead
1728403|NCT00014898|Attention deficit|attention deficit
1728404|NCT00014885|Lead exposure|lead exposure
1728405|NCT00014885|Bone lead|bone lead
1728406|NCT00014885|Cognitive function|cognitive function
1728407|NCT00014885|Academic achievement|academic achievement
1728408|NCT00014885|Neurobehavior|neurobehavior
1728409|NCT00014859|Pulmonary surfactant|pulmonary surfactant
1728410|NCT00014859|Surfactant protein B|surfactant protein b
1728411|NCT00014859|Surfactant protein C|surfactant protein c
1728412|NCT00014859|ABCA3|abca3
1728413|NCT00014859|NKX2-1|nkx2-1
1728414|NCT00014807|Pesticide exposure|pesticide exposure
1728415|NCT00014807|Organophosphate|organophosphate
1728416|NCT00014807|Biomarkers of exposure|biomarkers of exposure
1728417|NCT00014807|Poisoning|poisoning
1728418|NCT00014807|Occupational Health|occupational health
1728419|NCT00014794|Arthritis|arthritis
1728420|NCT00014794|Vascularity|vascularity
1728421|NCT00014794|Angiogenesis|angiogenesis
1728422|NCT00014794|Imaging|imaging
1728423|NCT00014794|MRI|mri
1728424|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
1728425|NCT00014794|PET Scan|pet scan
1728426|NCT00014794|Synovitis|synovitis
1728427|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1728428|NCT00014781|cystic fibrosis|cystic fibrosis
1728429|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1728430|NCT00014781|rare disease|rare disease
1728431|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1728432|NCT00014768|cystic fibrosis|cystic fibrosis
1728433|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1728434|NCT00014768|rare disease|rare disease
1728435|NCT00014755|multiple sclerosis|multiple sclerosis
1728436|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1728437|NCT00014755|rare disease|rare disease
1728438|NCT00014742|Dupuytren's disease|dupuytren's disease
1728439|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1728440|NCT00014742|rare disease|rare disease
1728441|NCT00014729|dermatologic disorders|dermatologic disorders
1728442|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
1728443|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1728444|NCT00014729|rare disease|rare disease
1728445|NCT00014040|Angina Pectoris|angina pectoris
1728446|NCT00014040|Endothelium|endothelium
1728447|NCT00014040|Platelets|platelets
1728448|NCT00014040|Inflammation|inflammation
1728449|NCT00014040|Atherosclerosis|atherosclerosis
1728450|NCT00014040|Coronary Artery Disease|coronary artery disease
1728451|NCT00014040|Chest Pain|chest pain
1728452|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
1728453|NCT00014040|Treadmill Exercise|treadmill exercise
1728454|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
1728455|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
1728456|NCT00014027|Neurotransmitters|neurotransmitters
1728457|NCT00014027|Cardiovascular|cardiovascular
1728458|NCT00014027|Reactivity|reactivity
1728459|NCT00014027|Healthy Volunteer|healthy volunteer
1728460|NCT00014027|Lumbar Puncture|lumbar puncture
1728461|NCT00014027|MRI|mri
1728462|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
1728463|NCT00014001|Effectiveness|effectiveness
1728464|NCT00013975|Framingham Risk Scoring|framingham risk scoring
1728465|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
1728466|NCT00013975|EPC Colony Assay|epc colony assay
1728467|NCT00013975|Healthy Volunteer|healthy volunteer
1728468|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
1728469|NCT00013975|Cholesterol|cholesterol
1729322|NCT00006565|ETS|ets
1728470|NCT00013975|Hypertension|hypertension
1728471|NCT00013975|Smoking|smoking
1728472|NCT00013975|Diabetes|diabetes
1728473|NCT00013975|Postmenopausal|postmenopausal
1728474|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
1728475|NCT00013975|Risk Factors|risk factors
1728476|NCT00013949|Holter monitoring|holter monitoring
1728477|NCT00013949|ECG|ecg
1728478|NCT00013949|Cardiac|cardiac
1728488|NCT00013936|Modified Binary Search|modified binary search
1728489|NCT00013936|Visual Acuity Test|visual acuity test
1728490|NCT00013923|Nutritional Supplement|nutritional supplement
1728491|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
1728492|NCT00013858|methylmercury|methylmercury
1728493|NCT00013858|PCBs|pcbs
1728494|NCT00013858|lead|lead
1728495|NCT00013858|fish consumption|fish consumption
1728496|NCT00013858|breast-feeding|breast-feeding
1728498|NCT00013884|T20|t20
1728499|NCT00013884|HAART|haart
1728500|NCT00013884|Interruption|interruption
1728501|NCT00013884|Therapy|therapy
1728502|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
1728503|NCT00013884|Treatment Interuption|treatment interuption
1728514|NCT00013832|Pressure|pressure
1728515|NCT00013832|Swallowing|swallowing
1728516|NCT00013832|Tongue|tongue
1728517|NCT00013832|Healthy Volunteer|healthy volunteer
1728518|NCT00013832|Dysphagia|dysphagia
1728519|NCT00013819|lead poisoning|lead poisoning
1728520|NCT00013819|central nervous system|central nervous system
1728521|NCT00013819|peripheral nervous system|peripheral nervous system
1728522|NCT00013819|occupational health|occupational health
1728523|NCT00013819|genetic susceptibility|genetic susceptibility
1728524|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
1728525|NCT00013780|ozone uptake|ozone uptake
1728526|NCT00013780|inhalation toxicology|inhalation toxicology
1728527|NCT00013780|nasal cavities|nasal cavities
1728528|NCT00013780|antioxidants|antioxidants
1728529|NCT00013767|Pesticide|pesticide
1728531|NCT00013767|Organophosphate|organophosphate
1728532|NCT00013767|Child Health|child health
1728533|NCT00013767|Exposure Prevention|exposure prevention
1728534|NCT00013754|pesticide|pesticide
1728535|NCT00013754|insecticide|insecticide
1728536|NCT00013754|organophosphate|organophosphate
1728537|NCT00013754|exposure|exposure
1728538|NCT00013754|child health|child health
1728539|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
1728540|NCT00013741|Diabetes Mellitus|diabetes mellitus
1728541|NCT00013741|Renal Dialysis|renal dialysis
1728542|NCT00013741|Heart Attack|heart attack
1728543|NCT00013741|Coronary Heart Disease|coronary heart disease
1728544|NCT00013728|asthma|asthma
1728545|NCT00013728|particulate matter|particulate matter
1728546|NCT00013715|Asthma|asthma
1728547|NCT00013715|Rhinovirus|rhinovirus
1728548|NCT00013715|Ozone|ozone
1728549|NCT00013702|Immunology|immunology
1728550|NCT00013702|Cirrhosis|cirrhosis
1728551|NCT00013702|Ascites|ascites
1728552|NCT00013702|Open-Label|open-label
1728553|NCT00013702|Chronic|chronic
1728554|NCT00013702|HIV|hiv
1728555|NCT00013702|Hepatitis B|hepatitis b
1728556|NCT00013689|Lymphadenopathy|lymphadenopathy
1728557|NCT00013689|Splenomegaly|splenomegaly
1728558|NCT00013689|Children|children
1728559|NCT00013689|Tomography|tomography
1728560|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
1728561|NCT00013650|Alzheimer's Disease|alzheimer's disease
1728562|NCT00013650|Immunomodulatory|immunomodulatory
1728563|NCT00013650|Antiinflammatory|antiinflammatory
1728564|NCT00013650|Cyclophosphamide|cyclophosphamide
1728565|NCT00013650|Non-steroidal|non-steroidal
1728566|NCT00013650|Complement|complement
1728567|NCT00013650|Immune Function|immune function
1728568|NCT00013650|Immunotherapy|immunotherapy
1728569|NCT00013637|Osteoporosis|osteoporosis
1728570|NCT00013637|Lead|lead
1728571|NCT00013624|Riluzole|riluzole
1728572|NCT00013624|Dyskinesias|dyskinesias
1728573|NCT00013624|L-Dopa Infusion|l-dopa infusion
1728574|NCT00013624|Parkinson's Disease|parkinson's disease
1728575|NCT00013611|HIV|hiv
1728576|NCT00013611|Proleukin|proleukin
1728577|NCT00013611|IL-2|il-2
1728578|NCT00013611|Adult|adult
1728579|NCT00013611|HAART|haart
1728580|NCT00013611|Treatment Experienced|treatment experienced
1728581|NCT00013598|Insulin Resistance|insulin resistance
1728582|NCT00013598|Obesity|obesity
1728583|NCT00013598|Diabetes|diabetes
1728584|NCT00013598|Fatty Liver|fatty liver
1728586|NCT00013598|Thiazolidinediones|thiazolidinediones
1728587|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
1728588|NCT00013598|PPARgamma|ppargamma
1728589|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
1728590|NCT00013598|Pioglitazone|pioglitazone
1728591|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1728592|NCT00013598|Liver Biopsy|liver biopsy
1728593|NCT00013598|Pharmacotherapy|pharmacotherapy
1728594|NCT00013559|Sleep Disturbance|sleep disturbance
1728595|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
1728596|NCT00013559|Deletion 17p11.2|deletion 17p11.2
1728597|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
1728598|NCT00013559|Behavioral Phenotype|behavioral phenotype
1728599|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
1728600|NCT00013559|Genetics|genetics
1728601|NCT00013546|Osteoporosis|osteoporosis
1728602|NCT00013546|Body Composition|body composition
1728603|NCT00013546|Estrogen|estrogen
1728604|NCT00013546|Androgen|androgen
1728605|NCT00013546|Ovarian Failure|ovarian failure
1728606|NCT00013546|Turner's Syndrome|turner's syndrome
1728607|NCT00013546|Hormone Replacement|hormone replacement
1728609|NCT00013546|Turner's|turner's
1728610|NCT00013546|TS|ts
1728611|NCT00013533|Leukemia|leukemia
1728612|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
1728613|NCT00013533|Bone Marrow Transplant|bone marrow transplant
1728614|NCT00013533|Pediatric Oncology|pediatric oncology
1728615|NCT00013533|Lymphoma|lymphoma
1728616|NCT00013533|Efficacy|efficacy
1728617|NCT00013533|Safety|safety
1728618|NCT00013533|Childhood Cancer|childhood cancer
1728619|NCT00013507|Frail|frail
1728620|NCT00013507|FIT|fit
1728621|NCT00013507|transfer|transfer
1728622|NCT00013507|continence|continence
1728623|NCT00013507|ambulation|ambulation
1728624|NCT00013507|balance|balance
1728625|NCT00013507|fall risk|fall risk
1728626|NCT00013507|strength,endurance|strength,endurance
1728627|NCT00013494|Hemiplegia|hemiplegia
1728628|NCT00013494|elderly|elderly
1728629|NCT00013494|Video|video
1728630|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
1728631|NCT00013494|digitized videoclips|digitized videoclips
1728632|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
1728633|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
1728634|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
1728635|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
1728636|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
1728637|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
1728638|NCT00013403|Vision, quality of life|vision, quality of life
1728639|NCT00013390|Auditory, tinnitus|auditory, tinnitus
1728640|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
1728641|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
1728642|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
1728643|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
1728644|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
1728645|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
1728646|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
1728647|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
1728648|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
1728649|NCT00013260|Case management|case management
1728650|NCT00013260|Nurse intervention|nurse intervention
1728651|NCT00013195|Telephone|telephone
1728652|NCT00013026|Congestive Heart Failure|congestive heart failure
1728653|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
1728654|NCT00012844|Patient Lifting|patient lifting
1728655|NCT00012844|Occupational Accidents|occupational accidents
1728656|NCT00012779|Health Care Education|health care education
1728657|NCT00012779|Health Care Cost|health care cost
1728658|NCT00012558|Psychotic Disorders|psychotic disorders
1728659|NCT00012558|Mood Disorders|mood disorders
1728660|NCT00012558|Manic-Depressive Illness|manic-depressive illness
1728661|NCT00012558|Hypomania|hypomania
1728662|NCT00012558|Mania|mania
1728663|NCT00012558|Mood Stabilizer|mood stabilizer
1728664|NCT00012545|Stem Cells|stem cells
1728665|NCT00012545|Sickle Cell Disease|sickle cell disease
1728666|NCT00012545|Umbilical Cord Blood|umbilical cord blood
1728667|NCT00012493|Cardiac event|cardiac event
1728668|NCT00012493|Heart disease|heart disease
1728669|NCT00012493|Particulate Matter|particulate matter
1728670|NCT00012480|Lead|lead
1728671|NCT00012480|Male infertility|male infertility
1728672|NCT00012480|Gene expression|gene expression
1728673|NCT00012480|Economics, Medical|economics, medical
1728674|NCT00012441|Renal Dialysis|renal dialysis
1728675|NCT00012428|Cognitive development|cognitive development
1728676|NCT00012428|Prenatal exposure|prenatal exposure
1728677|NCT00012428|PCBs|pcbs
1728678|NCT00011908|Safety|safety
1728679|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
1728680|NCT00011908|Anti-CD22|anti-cd22
1728681|NCT00011908|Response|response
1728682|NCT00011908|Efficacy|efficacy
1728683|NCT00011908|Lupus|lupus
1728684|NCT00011908|Immunotherapy|immunotherapy
1728685|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
1728686|NCT00011856|Cerebral|cerebral
1728687|NCT00011856|Loci|loci
1728688|NCT00011856|Susceptibility Genes|susceptibility genes
1728689|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
1728690|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
1728691|NCT00011856|Genetics|genetics
1728692|NCT00011843|X-Linked|x-linked
1728693|NCT00011843|Heterogeneous|heterogeneous
1728694|NCT00011843|Embryologic Development|embryologic development
1728695|NCT00011843|Mental Retardation|mental retardation
1728696|NCT00011843|Brain Development|brain development
1728697|NCT00011843|Microphthalmia|microphthalmia
1728698|NCT00011843|Anophthalmia|anophthalmia
1728699|NCT00011843|Malformations|malformations
1728700|NCT00011843|Lenz Dysplasia|lenz dysplasia
1728701|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
1728702|NCT00011843|Mutation Screening|mutation screening
1728703|NCT00011843|Gene Characterization|gene characterization
1728704|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
1728705|NCT00011830|Leukapheresis|leukapheresis
1728706|NCT00011817|Evaluation and Treatment|evaluation and treatment
1728707|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
1728708|NCT00011817|Genetic Testing|genetic testing
1728709|NCT00011817|Genetic Eye Diseases|genetic eye diseases
1728710|NCT00011817|Evaluation|evaluation
1728711|NCT00011804|Low Back Pain|low back pain
1728712|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
1728713|NCT00011804|Anticonvulsants|anticonvulsants
1728714|NCT00011804|Neuropathic Pain|neuropathic pain
1728715|NCT00011804|Analgesia|analgesia
1728716|NCT00011804|Sciatica|sciatica
1728718|NCT00011791|Catecholamines|catecholamines
1728719|NCT00011791|Adrenal Medulla|adrenal medulla
1728720|NCT00011791|Endocrine|endocrine
1728721|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1728722|NCT00011791|Exercise|exercise
1728723|NCT00011791|Healthy Volunteer|healthy volunteer
1728724|NCT00011778|Cell Cycle|cell cycle
1728725|NCT00011778|NFKB|nfkb
1728726|NCT00011778|Combined Modality|combined modality
1728727|NCT00011778|Radiosensitizer|radiosensitizer
1728728|NCT00011778|Ubiquitin|ubiquitin
1728729|NCT00011778|Head and Neck Cancer|head and neck cancer
1728730|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
1728731|NCT00011778|Radiation Therapy|radiation therapy
1728732|NCT00011778|Protease Inhibitor|protease inhibitor
1728733|NCT00011765|Aggression|aggression
1728734|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
1728735|NCT00011765|Rage|rage
1728736|NCT00011765|Fear|fear
1728737|NCT00011765|Violence|violence
1728738|NCT00011765|Domestic Violence|domestic violence
1728739|NCT00011765|Physical Aggression|physical aggression
1728740|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
1728741|NCT00011752|Serotonin Reuptake|serotonin reuptake
1728742|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
1728743|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
1728744|NCT00011752|Alcoholism|alcoholism
1728746|NCT00011752|TRP|trp
1728747|NCT00011752|Tryptophan Depletion|tryptophan depletion
1728748|NCT00011752|Healthy Volunteer|healthy volunteer
1728749|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
1728750|NCT00011726|Pregnancy|pregnancy
1728751|NCT00011726|Lead Exposure|lead exposure
1728752|NCT00011726|Lactation|lactation
1728753|NCT00011726|Bone Mineralization|bone mineralization
1728754|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
1728755|NCT00011713|Semen|semen
1728756|NCT00011713|Infertility|infertility
1728757|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
1728758|NCT00011713|Phthalates|phthalates
1728759|NCT00011713|Bisphenol A|bisphenol a
1728760|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
1728761|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
1728762|NCT00011687|Fertility|fertility
1728763|NCT00011687|Hormones|hormones
1728764|NCT00011687|Semen|semen
1728765|NCT00011687|Reproductive Health|reproductive health
1728766|NCT00011674|Lead|lead
1728767|NCT00011674|Prenatal|prenatal
1728768|NCT00011674|Development|development
1728769|NCT00011674|Children|children
1728770|NCT00011674|Psychology|psychology
1728771|NCT00011674|Toxicology|toxicology
1728772|NCT00011674|Teratology|teratology
1728773|NCT00011661|Lead poisoning|lead poisoning
1728774|NCT00011661|Native Americans|native americans
1728775|NCT00011648|Echocardiogram|echocardiogram
1728776|NCT00011648|Morbidity|morbidity
1728777|NCT00011648|Mortality|mortality
1728778|NCT00011648|Sickle Cell Anemia|sickle cell anemia
1728779|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
1728878|NCT00011245|Meningitis|meningitis
1728780|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
1728781|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
1728782|NCT00011583|Cerebrovascular|cerebrovascular
1728783|NCT00011583|Hemiplegia|hemiplegia
1728784|NCT00011583|Robotics|robotics
1728785|NCT00011570|defecation|defecation
1728786|NCT00011570|electrical stimulation|electrical stimulation
1728787|NCT00011570|penile erection|penile erection
1728788|NCT00011570|Spinal cord injury|spinal cord injury
1728789|NCT00011570|urology|urology
1728790|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
1728791|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
1728792|NCT00011531|Decubitus Ulcers|decubitus ulcers
1728793|NCT00011531|dehiscence|dehiscence
1728794|NCT00011531|SCI|sci
1728795|NCT00011531|wound healing|wound healing
1728796|NCT00011518|Arsenic|arsenic
1728797|NCT00011518|Bladder Cancer|bladder cancer
1728798|NCT00011518|Drinking Water|drinking water
1728799|NCT00011505|G-CSF|g-csf
1728800|NCT00011505|Leukapheresis|leukapheresis
1728801|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
1728802|NCT00011505|Central Line Placement|central line placement
1728803|NCT00011505|G-CSF Administration|g-csf administration
1728804|NCT00011505|Stem Cell Preservation|stem cell preservation
1728805|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
1728806|NCT00011505|Healthy Volunteer|healthy volunteer
1728807|NCT00011492|Oral Cancer|oral cancer
1728808|NCT00011492|Squamous Cell Cancer|squamous cell cancer
1728809|NCT00011492|Head and Neck Cancer|head and neck cancer
1728810|NCT00011492|Laryngeal Cancer|laryngeal cancer
1728811|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
1728812|NCT00011492|Squamous Cell Carcinoma|squamous cell carcinoma
1728813|NCT00011466|ADHD|adhd
1728814|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1728815|NCT00011466|Carbohydrate Craving|carbohydrate craving
1728816|NCT00011453|NQO1|nqo1
1728817|NCT00011453|DT-diaphorase|dt-diaphorase
1728818|NCT00011453|Benzene|benzene
1728819|NCT00011453|Leukemia|leukemia
1728820|NCT00011453|Aplastic anemia|aplastic anemia
1728821|NCT00011440|Allergy|allergy
1728822|NCT00011440|Air pollution|air pollution
1728823|NCT00011440|Lung function|lung function
1728824|NCT00011440|Inflammation|inflammation
1728825|NCT00011414|Drug Resistance|drug resistance
1728826|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
1728827|NCT00011414|Chemotherapy|chemotherapy
1728828|NCT00011414|p-glycoprotien|p-glycoprotien
1728829|NCT00011414|Brain Tumors|brain tumors
1728830|NCT00011414|Childhood Cancer|childhood cancer
1728831|NCT00011414|Brain Tumor|brain tumor
1728832|NCT00011388|Organochlorine compounds|organochlorine compounds
1728833|NCT00011388|Endocrine disruptors|endocrine disruptors
1728834|NCT00011388|Sex Hormones|sex hormones
1728835|NCT00011388|Reproductive function|reproductive function
1728836|NCT00011388|Menstrual Disturbances|menstrual disturbances
1728837|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
1728838|NCT00011375|Immunology|immunology
1728839|NCT00011375|Immunomodulation|immunomodulation
1728840|NCT00011375|Antidepressant|antidepressant
1728841|NCT00011375|Therapy|therapy
1728842|NCT00011375|Multiple Sclerosis|multiple sclerosis
1728843|NCT00011375|Immunotherapy|immunotherapy
1728844|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
1728845|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1728846|NCT00011362|Prematurity|prematurity
1728847|NCT00011362|Dexamethasone|dexamethasone
1728848|NCT00011362|Glucocorticoids|glucocorticoids
1728849|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
1728850|NCT00011362|Respiratory insufficiency|respiratory insufficiency
1728851|NCT00011362|Steroids|steroids
1728852|NCT00011349|Prostate Cancer|prostate cancer
1728853|NCT00011336|SCI|sci
1728854|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
1728855|NCT00011336|measures of pulmonary function|measures of pulmonary function
1728856|NCT00011336|respiratory illness|respiratory illness
1728857|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
1728858|NCT00011310|Particulates|particulates
1728859|NCT00011310|Air Pollution|air pollution
1728860|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
1728861|NCT00011310|Lung|lung
1728862|NCT00011310|Inflammation|inflammation
1728863|NCT00011284|Liver|liver
1728864|NCT00011284|Inflammation|inflammation
1728865|NCT00011284|Endotoxin|endotoxin
1728866|NCT00011284|Neutrophils|neutrophils
1728867|NCT00011284|Hepatocytes|hepatocytes
1728868|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
1728869|NCT00011258|stroke|stroke
1728870|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
1728871|NCT00011258|paraoxonase|paraoxonase
1728872|NCT00011245|Arachnoiditis|arachnoiditis
1728873|NCT00011245|Myelography|myelography
1728874|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
1728875|NCT00011245|Magnetic Resonance|magnetic resonance
1728876|NCT00011245|CSF Pressure|csf pressure
1728877|NCT00011245|Trauma|trauma
1728879|NCT00011245|Paralysis|paralysis
1728880|NCT00011245|Spondylosis|spondylosis
1728881|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
1728882|NCT00011245|Presyringomyelia|presyringomyelia
1728883|NCT00011245|Spinal Cord Edema|spinal cord edema
1728884|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
1728885|NCT00011245|Intraoperative Radiation|intraoperative radiation
1728886|NCT00011245|Ultrasonography|ultrasonography
1728887|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
1728888|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
1728889|NCT00011193|Hypertension|hypertension
1728890|NCT00011193|Postmenopausal|postmenopausal
1728891|NCT00011193|Overweight or Obese|overweight or obese
1728892|NCT00011193|Women|women
1728894|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
1728895|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
1728896|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
1728897|NCT00011076|Deskar|deskar
1728898|NCT00011076|Fibrosis|fibrosis
1728899|NCT00011076|Myocardium|myocardium
1728900|NCT00011076|Scarring|scarring
1728901|NCT00011076|Arrhythmia|arrhythmia
1728902|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1728903|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
1728904|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
1728905|NCT00011115|overweight|overweight
1728906|NCT00011102|weight gain|weight gain
1728907|NCT00010998|Multiple Sclerosis|multiple sclerosis
1728908|NCT00010998|Yoga|yoga
1728909|NCT00010985|Backpain|backpain
1728910|NCT00010985|Pain|pain
1728911|NCT00010985|Alternative Medicine|alternative medicine
1728912|NCT00010985|Acupuncture|acupuncture
1728913|NCT00010985|Chiropractic|chiropractic
1728914|NCT00010985|Massage Therapy|massage therapy
1728915|NCT00010959|menopause|menopause
1728916|NCT00010959|hot flashes|hot flashes
1728917|NCT00010959|botanicals|botanicals
1728918|NCT00010946|acupuncture|acupuncture
1728919|NCT00010946|osteoarthritis|osteoarthritis
1728920|NCT00010946|elderly|elderly
1728921|NCT00010868|bipolar disorder|bipolar disorder
1728922|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
1728923|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
1728924|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
1728925|NCT00010855|hypnosis|hypnosis
1728926|NCT00010855|relaxation|relaxation
1728927|NCT00010855|invasive medical procedures|invasive medical procedures
1728928|NCT00010855|interventional radiology|interventional radiology
1728929|NCT00010855|conscious sedation|conscious sedation
1728931|NCT00010855|complications|complications
1728932|NCT00010855|cost analysis|cost analysis
1728933|NCT00010855|Interventional procedures, complications|interventional procedures, complications
1728934|NCT00010855|Angiography|angiography
1728935|NCT00010855|Nephrostomy|nephrostomy
1728936|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
1728937|NCT00010855|Fibroid Embolization|fibroid embolization
1728938|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
1728939|NCT00010829|Osteoporosis|osteoporosis
1728940|NCT00010829|Breast Cancer|breast cancer
1728941|NCT00010829|Endometrial Cancer|endometrial cancer
1728943|NCT00010712|Menopause|menopause
1728944|NCT00010712|Hot Flashes|hot flashes
1728945|NCT00010712|Osteoporosis|osteoporosis
1728946|NCT00010712|Postmenopausal|postmenopausal
1728947|NCT00010699|cvd|cvd
1728948|NCT00010608|CVD|cvd
1728949|NCT00010530|CVD|cvd
1728950|NCT00010504|acupuncture|acupuncture
1728951|NCT00010504|fibromyalgia|fibromyalgia
1728952|NCT00010504|pain|pain
1728953|NCT00010504|analgesia|analgesia
1728954|NCT00010491|Diarrhea|diarrhea
1728955|NCT00010491|complementary therapies|complementary therapies
1728956|NCT00009685|Vaccine|vaccine
1728957|NCT00009685|HIV|hiv
1728958|NCT00009685|Codon-Optimized|codon-optimized
1728959|NCT00009685|HIV Vaccine|hiv vaccine
1728960|NCT00009685|Healthy Volunteer|healthy volunteer
1728961|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
1728962|NCT00009685|HIV Seronegativity|hiv seronegativity
1728963|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
1728964|NCT00009672|Low Back Pain|low back pain
1728965|NCT00009672|Opioid|opioid
1728966|NCT00009672|Antidepressant|antidepressant
1728967|NCT00009672|Randomized Controlled Trial|randomized controlled trial
1728968|NCT00009672|Analgesic|analgesic
1728969|NCT00009672|Sciatica|sciatica
1728970|NCT00009659|Endometrium|endometrium
1728971|NCT00009659|Estrogen|estrogen
1728972|NCT00009659|Antihormone|antihormone
1728973|NCT00009659|Menopause|menopause
1728974|NCT00009659|Progesterone|progesterone
1728975|NCT00009659|Postmenopausal Women|postmenopausal women
1728976|NCT00009659|Hormone Replacement|hormone replacement
1728977|NCT00009646|Chronic lung disease|chronic lung disease
1728978|NCT00009646|Indocin|indocin
1728979|NCT00009646|Indomethacin|indomethacin
1728980|NCT00009646|Infants, very low birth weight|infants, very low birth weight
1728981|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
1728982|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
1728988|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
1728989|NCT00009633|Follow up studies|follow up studies
1728990|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
1728991|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1728993|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
1728994|NCT00009620|Phenobarbital|phenobarbital
1728995|NCT00009620|Pregnancy|pregnancy
1728996|NCT00009620|Prenatal care|prenatal care
1728997|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
1728998|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
1728999|NCT00009620|Brain injury|brain injury
1729000|NCT00009620|Brain hemorrhage|brain hemorrhage
1729001|NCT00010452|cystic hygroma|cystic hygroma
1729002|NCT00010452|lymphangiomas|lymphangiomas
1729003|NCT00010452|lymphatic malformations|lymphatic malformations
1729424|NCT00006437|Adhesion|adhesion
1729004|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729005|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
1729006|NCT00010439|rare disease|rare disease
1729007|NCT00010426|cystinosis|cystinosis
1729008|NCT00010426|rare disease|rare disease
1729009|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
1729010|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729011|NCT00010413|pemphigus|pemphigus
1729012|NCT00010413|rare disease|rare disease
1729013|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
1729014|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729015|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729016|NCT00010400|rare disease|rare disease
1729017|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
1729018|NCT00010387|Felty syndrome|felty syndrome
1729019|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
1729020|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
1729021|NCT00010387|hematologic disorders|hematologic disorders
1729022|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1729023|NCT00010387|rare disease|rare disease
1729024|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
1729025|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
1729026|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1729027|NCT00010374|rare disease|rare disease
1729028|NCT00010374|spinal cord injury|spinal cord injury
1729029|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729030|NCT00010335|dermatomyositis|dermatomyositis
1729031|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729032|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1729033|NCT00010335|rare disease|rare disease
1729034|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
1729035|NCT00010335|systemic sclerosis|systemic sclerosis
1729036|NCT00009581|Endothelial Function|endothelial function
1729037|NCT00009581|Hydroxyurea|hydroxyurea
1729038|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
1729039|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
1729040|NCT00009581|Sickle Cell Anemia|sickle cell anemia
1729041|NCT00009581|Nitric Oxide|nitric oxide
1729042|NCT00009568|Antidepressants|antidepressants
1729043|NCT00009568|Platelet Function|platelet function
1729044|NCT00009568|SSRI|ssri
1729045|NCT00009568|Depression|depression
1729046|NCT00009568|Bleeding Time|bleeding time
1729047|NCT00009256|Quasispecies Variation|quasispecies variation
1729048|NCT00009256|Genotyping|genotyping
1729049|NCT00009256|Phenotyping|phenotyping
1729050|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
1729051|NCT00009256|Drug Naive Patients|drug naive patients
1729052|NCT00009256|HIV|hiv
1729053|NCT00009256|Treatment Naive|treatment naive
1729061|NCT00009230|Age associated memory impairment|age associated memory impairment
1729062|NCT00009230|Mild cognitive impairment|mild cognitive impairment
1729063|NCT00009217|Alzheimer's disease|alzheimer's disease
1729064|NCT00009217|psychosis|psychosis
1729065|NCT00009217|agitation|agitation
1729066|NCT00009217|haloperidol|haloperidol
1729067|NCT00009204|Behavioral problems|behavioral problems
1729068|NCT00009204|Agitation|agitation
1729069|NCT00009048|Dyskinesias|dyskinesias
1729070|NCT00009048|L-Dopa Infusion|l-dopa infusion
1729071|NCT00009048|Clinical Trial|clinical trial
1729072|NCT00009048|Motor Function|motor function
1729073|NCT00009048|Psychosis|psychosis
1729074|NCT00009048|Parkinson's Disease|parkinson's disease
1729092|NCT00009009|Kidney Transplant|kidney transplant
1729093|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
1729094|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
1729096|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1729097|NCT00008892|Normal Volunteers|normal volunteers
1729098|NCT00008814|Cognition|cognition
1729099|NCT00008814|Infant Development|infant development
1729100|NCT00008814|MRI, Functional|mri, functional
1729101|NCT00008736|Feeding intolerance|feeding intolerance
1729102|NCT00008736|Infant, premature|infant, premature
1729103|NCT00008827|Obesity|obesity
1729104|NCT00008827|Behavioral weight control|behavioral weight control
1729105|NCT00008827|Internet|internet
1729106|NCT00008541|Keratitis|keratitis
1729107|NCT00008541|Conjunctivitis|conjunctivitis
1729108|NCT00008541|Meibomitis|meibomitis
1729109|NCT00008541|Corneal Infiltrates|corneal infiltrates
1729110|NCT00008541|Dacryocystitis|dacryocystitis
1729111|NCT00008541|Blepharitis|blepharitis
1729112|NCT00008541|Dacryoadenitis|dacryoadenitis
1729113|NCT00008541|Corneal Eye Disease|corneal eye disease
1729114|NCT00008515|Steroids|steroids
1729115|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
1729116|NCT00008515|Implant|implant
1729117|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
1729118|NCT00008515|Sustained Release Implant|sustained release implant
1729119|NCT00008502|Genetics|genetics
1729120|NCT00008502|African Americans|african americans
1729121|NCT00008502|Skin|skin
1729122|NCT00008502|Keloids|keloids
1729123|NCT00008502|Familial Disposition|familial disposition
1729124|NCT00008476|Preemptive Analgesia|preemptive analgesia
1729125|NCT00008476|Vanilloid|vanilloid
1729126|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
1729127|NCT00008476|Capsaicin|capsaicin
1729128|NCT00008476|Acute Pain|acute pain
1729129|NCT00008476|Orofacial|orofacial
1729130|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
1729131|NCT00008476|Resiniferatoxin|resiniferatoxin
1729132|NCT00008476|Healthy Volunteer|healthy volunteer
1729133|NCT00008476|Wisdom Teeth|wisdom teeth
1729134|NCT00008476|Pain|pain
1729135|NCT00007800|obesity treatment|obesity treatment
1729136|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
1729137|NCT00007800|type 2 diabetes|type 2 diabetes
1729138|NCT00007800|behavioral weight control|behavioral weight control
1729139|NCT00007800|motivational interviewing|motivational interviewing
1729140|NCT00007800|motivational enhancement|motivational enhancement
1729141|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
1729142|NCT00007670|gabapentin|gabapentin
1729143|NCT00007670|lamotrigine|lamotrigine
1729144|NCT00007670|seizures in the elderly|seizures in the elderly
1729145|NCT00007670|Carbamazepine|carbamazepine
1729146|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
1729147|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
1729148|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
1729149|NCT00007748|aerobic exercise|aerobic exercise
1729150|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
1729151|NCT00007748|CBT|cbt
1729152|NCT00007748|Gulf War Illnesses|gulf war illnesses
1729153|NCT00007748|GWI|gwi
1729154|NCT00007735|antibiotic treatment|antibiotic treatment
1729155|NCT00007735|mycoplasma species|mycoplasma species
1729156|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
1729157|NCT00007735|mycoplasma positive|mycoplasma positive
1729158|NCT00007735|Gulf War Syndrome|gulf war syndrome
1729159|NCT00007722|ALS|als
1729160|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1729161|NCT00007722|Gulf War Veterans|gulf war veterans
1729162|NCT00007709|Hepatitis C|hepatitis c
1729163|NCT00007709|HIV|hiv
1729164|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
1729165|NCT00007683|aspirin|aspirin
1729166|NCT00007683|clopidogrel|clopidogrel
1729167|NCT00007683|embolic events|embolic events
1729168|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
1729169|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
1729170|NCT00007683|symptomatic CHF|symptomatic chf
1729171|NCT00007683|warfarin|warfarin
1729172|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
1729173|NCT00007644|cancer treatment|cancer treatment
1729174|NCT00007644|chronic diseases|chronic diseases
1729886|NCT00006150|Fractures|fractures
1729175|NCT00007644|expectant management|expectant management
1729176|NCT00007644|genitourinary|genitourinary
1729177|NCT00007644|prostate|prostate
1729178|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
1729179|NCT00007644|radical prostatectomy|radical prostatectomy
1729180|NCT00007631|NMSC|nmsc
1729181|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
1729182|NCT00007631|topical tretinoin cream|topical tretinoin cream
1729183|NCT00007618|colorectal cancer|colorectal cancer
1729184|NCT00007605|amiodarone|amiodarone
1729185|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
1729186|NCT00007605|cardiac mortality|cardiac mortality
1729187|NCT00007605|major and minor bleeds|major and minor bleeds
1729188|NCT00007605|sinus rhythm|sinus rhythm
1729189|NCT00007605|sotalol|sotalol
1729190|NCT00007592|Hypertension|hypertension
1729191|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
1729192|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
1729193|NCT00007579|prostate cancer|prostate cancer
1729194|NCT00007540|Prostate cancer|prostate cancer
1729195|NCT00007540|CAG repeat sequence|cag repeat sequence
1729196|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
1729197|NCT00007527|opiate dependence|opiate dependence
1729198|NCT00007527|narcotic treatment|narcotic treatment
1729199|NCT00007514|olfactory functioning|olfactory functioning
1729200|NCT00007514|neurotoxic exposure|neurotoxic exposure
1729201|NCT00007514|Gulf War-era veterans|gulf war-era veterans
1729202|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
1729203|NCT00007475|Plasma Exchange|plasma exchange
1729204|NCT00007475|Cyclophosphamide|cyclophosphamide
1729205|NCT00007475|Proteinuria|proteinuria
1729206|NCT00007475|Hemodialysis|hemodialysis
1729207|NCT00007475|Expression Profiling|expression profiling
1729208|NCT00007358|Dexamethasone|dexamethasone
1729209|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
1729210|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
1729211|NCT00007358|Ultrasound|ultrasound
1729212|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
1729213|NCT00007358|Echocardiograms|echocardiograms
1729214|NCT00007358|Mothers|mothers
1729215|NCT00007345|Histone Acetylase|histone acetylase
1729216|NCT00007345|Differentiation|differentiation
1729217|NCT00007345|Sezary Syndrome|sezary syndrome
1729218|NCT00007345|Mycosis Fungoides|mycosis fungoides
1729219|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
1729220|NCT00007306|Parathyroid hormone|parathyroid hormone
1729221|NCT00007306|Psoriasis|psoriasis
1729222|NCT00007306|Lesions|lesions
1729223|NCT00007306|Topical medications|topical medications
1729224|NCT00007306|Ointment|ointment
1729225|NCT00007306|Calcium metabolism|calcium metabolism
1729226|NCT00007306|Skin biopsy|skin biopsy
1729227|NCT00007293|Phototherapy|phototherapy
1729228|NCT00007293|Psoriasis|psoriasis
1729229|NCT00007293|Scalp psoriasis|scalp psoriasis
1729230|NCT00007293|Fiber optic|fiber optic
1729231|NCT00007293|Light comb|light comb
1729232|NCT00007293|UV source|uv source
1729233|NCT00007280|Bioengineered skin|bioengineered skin
1729234|NCT00007280|Venous leg ulcer|venous leg ulcer
1729235|NCT00007267|Scleroderma|scleroderma
1729236|NCT00007267|Systemic sclerosis|systemic sclerosis
1729237|NCT00007267|Depression|depression
1729238|NCT00007267|Pain|pain
1729239|NCT00007267|Disfigurement|disfigurement
1729240|NCT00007267|Body image dissatisfaction|body image dissatisfaction
1729241|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
1729242|NCT00007267|Self-help|self-help
1729243|NCT00007267|Psychological intervention|psychological intervention
1729244|NCT00007254|Analgesia|analgesia
1729245|NCT00007254|Bedsore|bedsore
1729246|NCT00007254|Morphine gel|morphine gel
1729247|NCT00007254|Pressure ulcer|pressure ulcer
1729248|NCT00007254|Pain|pain
1729249|NCT00007254|Ulcer|ulcer
1729250|NCT00007241|Osteoarthritis|osteoarthritis
1729251|NCT00007241|Knee|knee
1729253|NCT00007241|Isometric|isometric
1729255|NCT00007241|Strengthening|strengthening
1729256|NCT00007241|Joint-related pain|joint-related pain
1729257|NCT00007228|Chorea|chorea
1729258|NCT00007228|DCM|dcm
1729259|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1729260|NCT00007228|Sudden Death|sudden death
1729261|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
1729262|NCT00007215|Cataract|cataract
1729263|NCT00007215|Early Lens Changes|early lens changes
1729264|NCT00007215|Protein Aggregation|protein aggregation
1729265|NCT00007215|Blindness|blindness
1729266|NCT00007215|Vision|vision
1729267|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
1729268|NCT00007215|Age-Related Changes|age-related changes
1729269|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
1729270|NCT00007215|Normal Volunteers|normal volunteers
1729271|NCT00007215|Lens|lens
1729272|NCT00007215|Healthy Volunteer|healthy volunteer
1729273|NCT00007189|Alzheimer disease|alzheimer disease
1729274|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
1729275|NCT00007163|Immunosuppression|immunosuppression
1729887|NCT00006150|Pneumonia|pneumonia
1729278|NCT00007163|Interferon Gamma|interferon gamma
1729279|NCT00007163|Colonoscopy|colonoscopy
1729280|NCT00007163|Crohn's Disease|crohn's disease
1729281|NCT00007163|Immunotherapy|immunotherapy
1729282|NCT00007163|IL-12|il-12
1729283|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
1729284|NCT00007150|Hemochromatosis|hemochromatosis
1729285|NCT00007150|Iron Overload|iron overload
1729286|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
1729287|NCT00007150|Blood Donation|blood donation
1729288|NCT00007137|3D MRI|3d mri
1729289|NCT00007137|Diffusion Tensor|diffusion tensor
1729290|NCT00007137|Tongue|tongue
1729291|NCT00007137|Ultrasound|ultrasound
1729292|NCT00007137|Volume|volume
1729293|NCT00007137|Healthy Volunteer|healthy volunteer
1729294|NCT00007137|Swallowing|swallowing
1729295|NCT00007137|Tongue Weakness|tongue weakness
1729296|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
1729297|NCT00007124|Myoclonus|myoclonus
1729298|NCT00007124|Epilepsy|epilepsy
1729299|NCT00007124|Dementia|dementia
1729300|NCT00007124|Polyglucosan|polyglucosan
1729301|NCT00007124|Insulin|insulin
1729302|NCT00007124|Lafora Disease|lafora disease
1729303|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
1729304|NCT00007059|disease-related problem/condition|disease-related problem/condition
1729305|NCT00007059|graft versus host disease|graft versus host disease
1729306|NCT00007059|rare disease|rare disease
1729307|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729308|NCT00007046|bone cancer|bone cancer
1729309|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
1729310|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729311|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
1729312|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
1729313|NCT00007046|oncologic disorders|oncologic disorders
1729314|NCT00007046|rare disease|rare disease
1729315|NCT00007033|Alagille syndrome|alagille syndrome
1729316|NCT00007033|biliary atresia|biliary atresia
1729317|NCT00007033|cholestasis|cholestasis
1729318|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
1729319|NCT00007033|rare disease|rare disease
1729320|NCT00006565|asthma|asthma
1729321|NCT00006565|HEPA|hepa
1729323|NCT00006519|Pharmacokinetic|pharmacokinetic
1729324|NCT00006519|Pediatric AIDS|pediatric aids
1729325|NCT00006519|Resistance Testing|resistance testing
1729326|NCT00006519|Combination Therapy|combination therapy
1729327|NCT00006519|Viral Drug Dynamics|viral drug dynamics
1729328|NCT00006519|Treatment Experienced|treatment experienced
1729329|NCT00006518|Tumor|tumor
1729330|NCT00006518|Viruses|viruses
1729331|NCT00006518|HIV|hiv
1729332|NCT00006518|KSHV|kshv
1729333|NCT00006518|AIDS|aids
1729334|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
1729335|NCT00006517|Winter Depression|winter depression
1729336|NCT00006517|Mood disorders|mood disorders
1729337|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
1729338|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
1729339|NCT00006517|Light therapy|light therapy
1729340|NCT00006517|Phototherapy|phototherapy
1729341|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
1729342|NCT00006517|Negative air ionization therapy|negative air ionization therapy
1729343|NCT00006517|Chronobiology|chronobiology
1729344|NCT00006517|Biological rhythms|biological rhythms
1729345|NCT00006516|Neonatal brain injury|neonatal brain injury
1729346|NCT00006516|Brain Hypoxia|brain hypoxia
1729347|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
1729348|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
1729349|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
1729350|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
1729351|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
1729352|NCT00006516|Environmental enrichment|environmental enrichment
1729353|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
1729867|NCT00006158|weight loss|weight loss
1729354|NCT00006516|Parent-infant interactions|parent-infant interactions
1729355|NCT00006516|Prenatal hypoxia|prenatal hypoxia
1729356|NCT00006515|Pediatric|pediatric
1729357|NCT00006515|Sarcoma|sarcoma
1729358|NCT00006515|Effects|effects
1729359|NCT00006515|Survivors|survivors
1729360|NCT00006515|Pilot|pilot
1729363|NCT00006494|AIDS|aids
1729364|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
1729365|NCT00006494|Drug Resistance|drug resistance
1729366|NCT00006494|Phenotype|phenotype
1729367|NCT00006494|HIV|hiv
1729368|NCT00006494|Genotype|genotype
1729369|NCT00006494|Treatment Experienced|treatment experienced
1729370|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
1729371|NCT00006492|Celiac Disease|celiac disease
1729372|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
1729373|NCT00006492|Gluten-Free Diet|gluten-free diet
1729374|NCT00006489|Alcoholism|alcoholism
1729375|NCT00006489|Alcohol Dependence|alcohol dependence
1729376|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
1729377|NCT00006489|Naltrexone|naltrexone
1729378|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
1729379|NCT00006450|Children|children
1729380|NCT00006450|Brain|brain
1729381|NCT00006450|Maturation|maturation
1729382|NCT00006450|Phenylacetate|phenylacetate
1729383|NCT00006450|Differentiation|differentiation
1729384|NCT00006507|Sensory integration|sensory integration
1729385|NCT00006507|Occupational therapy|occupational therapy
1729386|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
1729387|NCT00006448|Spinal cord injury|spinal cord injury
1729388|NCT00006448|Amputation|amputation
1729389|NCT00006448|Pain management|pain management
1729390|NCT00006447|Brain Injuries|brain injuries
1729391|NCT00006447|Trauma|trauma
1729392|NCT00006447|Caregivers|caregivers
1729393|NCT00006447|Burden and Dependency|burden and dependency
1729394|NCT00006447|Rehabilitation|rehabilitation
1729395|NCT00006447|Support, social|support, social
1729396|NCT00006447|Information System|information system
1729397|NCT00006447|Information Resources (PT)|information resources (pt)
1729398|NCT00006447|Disability, persons with|disability, persons with
1729399|NCT00006446|Behavioral disorders|behavioral disorders
1729400|NCT00006446|Parenting skills and communication|parenting skills and communication
1729401|NCT00006446|Parent-child interactions|parent-child interactions
1729402|NCT00006446|At-risk preschooler|at-risk preschooler
1729403|NCT00006446|Head Start|head start
1729404|NCT00006445|Pregnancy|pregnancy
1729405|NCT00006445|Ultrasound|ultrasound
1729406|NCT00006445|Serum screen|serum screen
1729407|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
1729408|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
1729409|NCT00006445|Alpha fetoprotein|alpha fetoprotein
1729410|NCT00006445|Unconjugated estriol|unconjugated estriol
1729411|NCT00006445|Inhibin-A|inhibin-a
1729412|NCT00006445|Down syndrome|down syndrome
1729413|NCT00006445|Aneuploidy|aneuploidy
1729414|NCT00006439|HIV|hiv
1729415|NCT00006438|Rocker sole|rocker sole
1729416|NCT00006438|Plantar pressure|plantar pressure
1729417|NCT00006438|Diabetic feet|diabetic feet
1729418|NCT00006438|Insensate feet|insensate feet
1729419|NCT00006438|gait analysis|gait analysis
1729420|NCT00006438|Pedorthics|pedorthics
1729421|NCT00006438|Gait abnormalities|gait abnormalities
1729422|NCT00006437|MMP|mmp
1729423|NCT00006437|Proteases|proteases
1729425|NCT00006437|Migration|migration
1729426|NCT00006437|Extracellular Matrix|extracellular matrix
1729427|NCT00006436|AIDS|aids
1729428|NCT00006436|Malignancy|malignancy
1729429|NCT00006436|Antiretroviral|antiretroviral
1729430|NCT00006436|Chemotherapy|chemotherapy
1729431|NCT00006436|Monoclonal|monoclonal
1729432|NCT00006435|Tissue Repository|tissue repository
1729433|NCT00006435|Growth Rate|growth rate
1729434|NCT00006435|Volumetric MRI|volumetric mri
1729435|NCT00006434|Dendritic cells|dendritic cells
1729436|NCT00006429|Spinal Cord Injury|spinal cord injury
1729437|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
1729438|NCT00006429|Treadmill Training|treadmill training
1729439|NCT00006429|Physical therapy|physical therapy
1729440|NCT00006429|Gait|gait
1729441|NCT00006429|Assisted Ambulation|assisted ambulation
1729442|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
1729443|NCT00006428|Chronic Pain|chronic pain
1729444|NCT00006428|Amitriptyline|amitriptyline
1729445|NCT00006427|Amputation|amputation
1729446|NCT00006427|Chronic Pain|chronic pain
1729447|NCT00006427|Amitriptyline|amitriptyline
1729448|NCT00006426|Foot ulcers|foot ulcers
1729449|NCT00006426|Diabetes|diabetes
1729450|NCT00006426|Peripheral neuropathy|peripheral neuropathy
1729451|NCT00006426|Casting|casting
1729452|NCT00006426|Achilles Lengthening|achilles lengthening
1729453|NCT00006426|Ambulatory surgery|ambulatory surgery
1729454|NCT00006426|Foot deformity|foot deformity
1729455|NCT00006425|Breast MRI|breast mri
1729456|NCT00006425|Ductal lavage|ductal lavage
1729457|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
1729961|NCT00006070|Swelling|swelling
1729458|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
1729459|NCT00006425|Healthy Volunteer|healthy volunteer
1729460|NCT00006424|Plasticity|plasticity
1729461|NCT00006424|Motor|motor
1729462|NCT00006424|Stroke|stroke
1729463|NCT00006424|Amphetamine|amphetamine
1729464|NCT00006424|fMRI|fmri
1729465|NCT00006424|Cortical Reorganization|cortical reorganization
1729466|NCT00006424|Spectroscopy|spectroscopy
1729467|NCT00006422|Lazy Eye|lazy eye
1729468|NCT00006422|Amblyopia|amblyopia
1729469|NCT00006422|Nystagmus|nystagmus
1729470|NCT00006422|Eye Movements|eye movements
1729471|NCT00006422|Child Vision|child vision
1729472|NCT00006421|Breast MRI|breast mri
1729473|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
1729474|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
1729475|NCT00006421|Ductal lavage|ductal lavage
1729476|NCT00006418|Schizophrenia|schizophrenia
1729477|NCT00006418|Genetics|genetics
1729478|NCT00006417|Fludarabine|fludarabine
1729479|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
1729480|NCT00006417|Immunodeficiency|immunodeficiency
1729481|NCT00006417|Neutrophils|neutrophils
1729482|NCT00006417|Oxidase|oxidase
1729483|NCT00006417|Engraftment|engraftment
1729484|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
1729485|NCT00006417|Cyclophosphamide|cyclophosphamide
1729486|NCT00006417|Donor Apheresis|donor apheresis
1729487|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
1729488|NCT00006417|Therapy|therapy
1729489|NCT00006414|Anesthesia|anesthesia
1729490|NCT00006414|Magnetic Stimulation|magnetic stimulation
1729491|NCT00006414|Motor|motor
1729492|NCT00006414|Neuroplasticity|neuroplasticity
1729493|NCT00006414|Practice|practice
1729494|NCT00006414|Rehabilitation|rehabilitation
1729495|NCT00006414|Stroke|stroke
1729496|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
1729497|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
1729498|NCT00006413|Engraftment|engraftment
1729499|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
1729500|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
1729501|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
1729502|NCT00006413|Cyclophosphamide|cyclophosphamide
1729503|NCT00006413|Fludarabine|fludarabine
1729504|NCT00006413|Donor Apheresis|donor apheresis
1729505|NCT00006413|Mast Cells|mast cells
1729506|NCT00006411|cornea transplant|cornea transplant
1729507|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
1729508|NCT00006411|moderate risk corneal diseases requiring corneal transplantation|moderate risk corneal diseases requiring corneal transplantation
1729509|NCT00006411|corneal transplantation|corneal transplantation
1729510|NCT00006400|Blood Diseases|blood diseases
1729511|NCT00006400|Sickle Cell Anemia|sickle cell anemia
1729512|NCT00006398|cirrhosis|cirrhosis
1729513|NCT00006398|esophageal varices|esophageal varices
1729514|NCT00006398|variceal hemorrhage|variceal hemorrhage
1729515|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
1729516|NCT00006394|disease-related problem/condition|disease-related problem/condition
1729517|NCT00006394|endocrine disorders|endocrine disorders
1729518|NCT00006394|growth hormone deficiency|growth hormone deficiency
1729519|NCT00006394|osteoporosis|osteoporosis
1729520|NCT00006394|quality of life|quality of life
1729521|NCT00006394|rare disease|rare disease
1729522|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729523|NCT00006393|rare disease|rare disease
1729524|NCT00006393|systemic sclerosis|systemic sclerosis
1729525|NCT00006337|Clinical Trial|clinical trial
1729526|NCT00006337|Dyskinesias|dyskinesias
1729527|NCT00006337|Levodopa Infusion|levodopa infusion
1729528|NCT00006336|Gap Detection Test|gap detection test
1729529|NCT00006336|Fahn-Scale|fahn-scale
1729530|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
1729531|NCT00006336|Writing Standard Paragraph|writing standard paragraph
1729532|NCT00006336|Braille Reading Grade I|braille reading grade i
1729533|NCT00006335|Genetic|genetic
1729534|NCT00006335|Analysis|analysis
1729535|NCT00006335|Immune|immune
1729536|NCT00006335|Teenage|teenage
1729537|NCT00006335|Girls|girls
1729538|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
1729539|NCT00006335|XSCID|xscid
1729540|NCT00006335|Carrier Testing|carrier testing
1729541|NCT00006335|X-Linked Disease|x-linked disease
1729542|NCT00006335|Adolescent|adolescent
1729543|NCT00006334|Genes|genes
1729544|NCT00006334|X-Chromosome|x-chromosome
1729545|NCT00006334|Osteoporosis|osteoporosis
1729546|NCT00006334|Ovarian Failure|ovarian failure
1729547|NCT00006334|Imprinting|imprinting
1729548|NCT00006334|Turner's|turner's
1729549|NCT00006334|Turner|turner
1729550|NCT00006334|TS|ts
1729551|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
1729552|NCT00006333|Inflammation|inflammation
1729553|NCT00006333|Synovitis|synovitis
1729554|NCT00006333|Genetics|genetics
1729555|NCT00006333|Synovial Biopsy|synovial biopsy
1729556|NCT00006333|Arthritis|arthritis
1729557|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
1729558|NCT00006333|JRA|jra
1729559|NCT00006332|Molybdenum|molybdenum
1729560|NCT00006331|Kidney transplantation|kidney transplantation
1729561|NCT00006331|Immunology|immunology
1729562|NCT00006330|Digoxin|digoxin
1729563|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
1729564|NCT00006330|Rosales|rosales
1729565|NCT00006330|Drug Interaction|drug interaction
1729566|NCT00006329|Radionuclide imaging|radionuclide imaging
1729567|NCT00006329|Surgery|surgery
1729568|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
1729569|NCT00006328|Transplantation immunology|transplantation immunology
1729570|NCT00006328|Genetics|genetics
1729571|NCT00006328|Graft Rejection|graft rejection
1729572|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
1729573|NCT00006320|Protease Inhibitor|protease inhibitor
1729574|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
1729575|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
1729576|NCT00006319|Jak-3 SCID|jak-3 scid
1729577|NCT00006319|X-Linked SCID|x-linked scid
1729888|NCT00006150|Scoliosis|scoliosis
1729578|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
1729579|NCT00006319|Primary Immunodeficiencies|primary immunodeficiencies
1729580|NCT00006319|ADA-SCID|ada-scid
1729581|NCT00006318|Cerebral Blood Flow|cerebral blood flow
1729582|NCT00006318|CO2 Inhalation|co2 inhalation
1729583|NCT00006318|Imaging|imaging
1729584|NCT00006318|MRI|mri
1729585|NCT00006318|Perfusion|perfusion
1729586|NCT00006318|Functional Activation|functional activation
1729587|NCT00006301|Hepatitis C|hepatitis c
1729588|NCT00006301|Viral Sequence|viral sequence
1729589|NCT00006301|PCR|pcr
1729590|NCT00006301|T Cell|t cell
1729591|NCT00006301|Seroconversion|seroconversion
1729592|NCT00006301|Cytokines|cytokines
1729593|NCT00006300|Immunosuppression|immunosuppression
1729594|NCT00006300|Treatment Recommendations|treatment recommendations
1729595|NCT00006300|Pancytopenia|pancytopenia
1729596|NCT00006300|Schizophrenia|schizophrenia
1729597|NCT00006300|Inpatient Population|inpatient population
1729598|NCT00006299|Celecoxib|celecoxib
1729599|NCT00006299|Thromboxane B2|thromboxane b2
1729600|NCT00006299|Prostaglandin E2|prostaglandin e2
1729601|NCT00006299|Microdialysis|microdialysis
1729602|NCT00006299|Ibuprofen|ibuprofen
1729603|NCT00006292|Biologic Therapy|biologic therapy
1729604|NCT00006292|Bone Erosion|bone erosion
1729605|NCT00006292|CT|ct
1729606|NCT00006292|MRI|mri
1729607|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
1729608|NCT00006292|RA|ra
1729609|NCT00006289|Analgesia|analgesia
1729610|NCT00006289|Causalgia|causalgia
1729611|NCT00006289|CRPS|crps
1729612|NCT00006289|Neuropathic Pain|neuropathic pain
1729613|NCT00006289|Oral Surgery|oral surgery
1729614|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
1729615|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
1729616|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
1729617|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1729618|NCT00006285|Parietal Lobe|parietal lobe
1729619|NCT00006285|fMRI|fmri
1729620|NCT00006285|Cognition|cognition
1729621|NCT00006285|Perception|perception
1729622|NCT00006285|Cortical Stimulation|cortical stimulation
1729623|NCT00006285|Spatial Attention|spatial attention
1729624|NCT00006286|Depression|depression
1729625|NCT00006286|Major Depressive Disorder|major depressive disorder
1729626|NCT00006286|Fluoxetine|fluoxetine
1729627|NCT00006286|Prozac|prozac
1729628|NCT00006286|SSRI|ssri
1729629|NCT00006286|Psychotherapy|psychotherapy
1729630|NCT00006286|CBT|cbt
1729631|NCT00006286|Teenagers|teenagers
1729632|NCT00006286|Adolescents|adolescents
1729633|NCT00006286|Teens|teens
1729634|NCT00006278|Cushing's Syndrome|cushing's syndrome
1729635|NCT00006278|Adrenal Glands|adrenal glands
1729636|NCT00006278|Proteomics|proteomics
1729637|NCT00006278|Cortisol|cortisol
1729638|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
1729639|NCT00006276|Skin Disease|skin disease
1729640|NCT00006276|Blood Vessels|blood vessels
1729641|NCT00006276|Cytokines|cytokines
1729642|NCT00006276|Autoimmune Disease|autoimmune disease
1729643|NCT00006280|Cystic Fibrosis|cystic fibrosis
1729644|NCT00006275|dermatologic disorders|dermatologic disorders
1729645|NCT00006275|psoriasis|psoriasis
1729646|NCT00006275|rare disease|rare disease
1729647|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1729648|NCT00006274|neonatal disorders|neonatal disorders
1729649|NCT00006274|rare disease|rare disease
1729650|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
1729651|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1729652|NCT00006273|cystic fibrosis|cystic fibrosis
1729653|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729654|NCT00006273|rare disease|rare disease
1729655|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1729656|NCT00006272|heart defects|heart defects
1729657|NCT00006272|rare disease|rare disease
1729658|NCT00006271|brain injury|brain injury
1729659|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1729660|NCT00006271|rare disease|rare disease
1729661|NCT00006270|brain injury|brain injury
1729662|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1729663|NCT00006270|rare disease|rare disease
1729664|NCT00006205|alcoholism|alcoholism
1729665|NCT00006205|alcohol addiction|alcohol addiction
1729666|NCT00006204|Alcoholism|alcoholism
1729667|NCT00006204|Alcohol Dependence|alcohol dependence
1729668|NCT00006204|Depression|depression
1729669|NCT00006204|Naltrexone|naltrexone
1729670|NCT00006204|Fluoxetine|fluoxetine
1729671|NCT00006202|Serum levels of Lutein|serum levels of lutein
1729672|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
1729673|NCT00006202|Safety|safety
1729674|NCT00006202|Toxicity|toxicity
1729675|NCT00006199|solid tumor|solid tumor
1729676|NCT00006196|Vitamin D resistance|vitamin d resistance
1729677|NCT00006194|sarcopenia|sarcopenia
1729678|NCT00006190|Lipoproteins|lipoproteins
1729679|NCT00006190|Insulin resistance|insulin resistance
1729680|NCT00006190|Adipose tissue|adipose tissue
1729681|NCT00006188|Behcet's Disease|behcet's disease
1729682|NCT00006188|Sarcoidosis|sarcoidosis
1729683|NCT00006188|Iritis|iritis
1729684|NCT00006188|Choroiditis|choroiditis
1729685|NCT00006188|Iridocyclitis|iridocyclitis
1729686|NCT00006188|Retinal Disease|retinal disease
1729687|NCT00006188|Cystoid Macular Edema|cystoid macular edema
1729688|NCT00006188|Uveitis|uveitis
1729689|NCT00006188|Intraocular Inflammation|intraocular inflammation
1729690|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
1729691|NCT00006187|Investigational Drug|investigational drug
1729692|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
1729693|NCT00006184|Immunoablative|immunoablative
1729694|NCT00006184|Mobilization|mobilization
1729695|NCT00006184|Apheresis|apheresis
1729696|NCT00006184|Multiple Myeloma|multiple myeloma
1729697|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
1729698|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
1729699|NCT00006185|peripheral fat wasting|peripheral fat wasting
1729700|NCT00006185|truncal adiposity|truncal adiposity
1729701|NCT00006185|fat biopsy|fat biopsy
1729702|NCT00006185|muscle biopsy|muscle biopsy
1729703|NCT00006185|intravenous lines|intravenous lines
1729704|NCT00006185|blood draws|blood draws
1729705|NCT00006185|insulin administration|insulin administration
1729706|NCT00006185|sugar water|sugar water
1729707|NCT00006185|screening|screening
1729708|NCT00006399|Alzheimer disease|alzheimer disease
1729709|NCT00006399|Estrogen therapy|estrogen therapy
1729710|NCT00006399|Post-menopausal women|post-menopausal women
1729711|NCT00006181|Health behavior change|health behavior change
1729712|NCT00006181|Motivational interviewing|motivational interviewing
1729713|NCT00006181|Motivational enhancement|motivational enhancement
1729714|NCT00006181|Health counseling|health counseling
1729715|NCT00006181|Team intervention|team intervention
1729716|NCT00006181|One-on-one intervention|one-on-one intervention
1729717|NCT00006181|Physical activity|physical activity
1729718|NCT00006181|Exercise|exercise
1729719|NCT00006181|Nutrition|nutrition
1729720|NCT00006181|Health assessments|health assessments
1729721|NCT00006181|Strength|strength
1729722|NCT00006181|Flexibility|flexibility
1729723|NCT00006181|Percent body fat|percent body fat
1729724|NCT00006181|Social-learning theory|social-learning theory
1729725|NCT00006181|PHLAME|phlame
1729726|NCT00006181|Fire fighters|fire fighters
1729727|NCT00006181|Fire stations|fire stations
1729728|NCT00006181|Cancer|cancer
1729729|NCT00006181|Cardiovascular diseases|cardiovascular diseases
1729730|NCT00006180|Preventive Medicine|preventive medicine
1729731|NCT00006180|Women's Health|women's health
1729732|NCT00006180|Bone Formation|bone formation
1729733|NCT00006180|Mood Disorders|mood disorders
1729734|NCT00006180|Bone Resorption|bone resorption
1729735|NCT00006180|Major Depression|major depression
1729736|NCT00006180|Osteopenia|osteopenia
1729737|NCT00006180|Osteoporosis|osteoporosis
1729738|NCT00006180|Bone Fracture|bone fracture
1729739|NCT00006180|Bisphosphonate|bisphosphonate
1729740|NCT00006180|Depression|depression
1729741|NCT00006180|Bone Density|bone density
1729742|NCT00006180|Healthy Volunteer|healthy volunteer
1729743|NCT00006180|HV|hv
1729744|NCT00006180|Normal Control|normal control
1729745|NCT00006178|Renal Failure|renal failure
1729746|NCT00006178|Anti-rejection|anti-rejection
1729747|NCT00006178|Apoptosis|apoptosis
1729748|NCT00006178|Polyclonal Antibody|polyclonal antibody
1729749|NCT00006178|Kidney Transplant|kidney transplant
1729750|NCT00006177|Emotion|emotion
1729751|NCT00006177|Children and Adolescents|children and adolescents
1729752|NCT00006177|Affective Neuroscience|affective neuroscience
1729753|NCT00006177|Bipolar Disorder|bipolar disorder
1729754|NCT00006177|Child|child
1729755|NCT00006177|Child Bipolar|child bipolar
1729756|NCT00006177|BPD|bpd
1729757|NCT00006177|Adolescent Bipolar|adolescent bipolar
1729758|NCT00006176|FENIB|fenib
1729759|NCT00006176|Presenile Dementia|presenile dementia
1729760|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
1729761|NCT00006176|Dementia|dementia
1729762|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
1729962|NCT00006070|Pain|pain
1729763|NCT00006176|Familial Presenile Dementia|familial presenile dementia
1729764|NCT00006176|FDNIB|fdnib
1729765|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
1729766|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
1729767|NCT00006175|Cyclooxygenase|cyclooxygenase
1729768|NCT00006175|COX-1|cox-1
1729769|NCT00006175|COX-2|cox-2
1729770|NCT00006175|Prostanoids|prostanoids
1729771|NCT00006175|P.C.R.|p.c.r.
1729772|NCT00006175|Healthy Volunteer|healthy volunteer
1729773|NCT00006174|Precocious Puberty|precocious puberty
1729774|NCT00006174|Polyostotic|polyostotic
1729775|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
1729776|NCT00006174|PFD|pfd
1729777|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
1729778|NCT00006173|Atherosclerosis|atherosclerosis
1729779|NCT00006173|Hypertension|hypertension
1729780|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
1729781|NCT00006172|Antidepressive Agents|antidepressive agents
1729782|NCT00006172|Chronobiology|chronobiology
1729783|NCT00006172|Chronotherapy|chronotherapy
1729784|NCT00006172|Circadian rhythms|circadian rhythms
1729785|NCT00006172|Depressive Disorder|depressive disorder
1729786|NCT00006172|Ions|ions
1729787|NCT00006172|Light|light
1729788|NCT00006172|Lighting|lighting
1729789|NCT00006172|Mood disorders|mood disorders
1729790|NCT00006172|Phototherapy.|phototherapy.
1729791|NCT00006171|HHV-8|hhv-8
1729792|NCT00006171|Pathophysiology|pathophysiology
1729793|NCT00006171|AIDS|aids
1729794|NCT00006171|Cancer|cancer
1729795|NCT00006171|Anti-Retroviral|anti-retroviral
1729796|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
1729797|NCT00006171|HIV|hiv
1729798|NCT00006170|smoking cessation|smoking cessation
1729799|NCT00006170|Women|women
1729800|NCT00006170|bupropion|bupropion
1729801|NCT00006170|weight concerns|weight concerns
1729802|NCT00006170|weight|weight
1729803|NCT00006156|Ovarian Failure|ovarian failure
1729804|NCT00006156|Ovary|ovary
1729805|NCT00006156|Aging|aging
1729806|NCT00006156|Healthy Volunteer|healthy volunteer
1729807|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
1729808|NCT00006156|Premature Menopause|premature menopause
1729809|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
1729810|NCT00006169|Nutrition|nutrition
1729811|NCT00006169|Behavior Therapy|behavior therapy
1729812|NCT00006169|Cystic Fibrosis|cystic fibrosis
1729813|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
1729814|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
1729815|NCT00006168|UDCA|udca
1729816|NCT00006168|MTX|mtx
1729817|NCT00006168|Hepatology|hepatology
1729818|NCT00006168|methotrexate|methotrexate
1729819|NCT00006168|liver|liver
1729820|NCT00006167|oxandrolone|oxandrolone
1729821|NCT00006167|AIDS wasting|aids wasting
1729822|NCT00006167|strength training|strength training
1729823|NCT00006167|progressive resistance training|progressive resistance training
1729824|NCT00006167|exercise|exercise
1729825|NCT00006167|dietary intervention|dietary intervention
1729826|NCT00006166|refractory ascites|refractory ascites
1729827|NCT00006166|paracenteses|paracenteses
1729828|NCT00006165|Native Hawaiian|native hawaiian
1729829|NCT00006165|Diabetes Mellitus|diabetes mellitus
1729830|NCT00006165|Lifestyle Intervention|lifestyle intervention
1729831|NCT00006165|Family Support|family support
1729832|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
1729833|NCT00006164|liver disease|liver disease
1729834|NCT00006164|hepatitis c virus|hepatitis c virus
1729835|NCT00006164|antiviral agent|antiviral agent
1729836|NCT00006164|cirrhosis|cirrhosis
1729837|NCT00006163|diabetes|diabetes
1729838|NCT00006163|self-management|self-management
1729839|NCT00006163|randomized trial|randomized trial
1729840|NCT00006163|RE-AIM evaluation|re-aim evaluation
1729841|NCT00006163|participation|participation
1729842|NCT00006163|maintenance|maintenance
1729843|NCT00006163|community resources|community resources
1729844|NCT00006163|dietary change|dietary change
1729845|NCT00006162|low fat diet|low fat diet
1729846|NCT00006162|aerobic exercise|aerobic exercise
1729847|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
1729848|NCT00006162|Japanese Americans|japanese americans
1729849|NCT00006162|metabolic risk factors|metabolic risk factors
1729850|NCT00006161|TIPS|tips
1729851|NCT00006161|DSRS|dsrs
1729852|NCT00006161|Varices|varices
1729853|NCT00006161|Variceal bleeding|variceal bleeding
1729854|NCT00006161|Splenorenal Shunt|splenorenal shunt
1729855|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
1729856|NCT00006161|Cirrhosis|cirrhosis
1729857|NCT00006161|Portal hypertension|portal hypertension
1729858|NCT00006161|Liver disease|liver disease
1729859|NCT00006159|diabetes|diabetes
1729860|NCT00006159|lifestyle intervention|lifestyle intervention
1729861|NCT00006159|Native American|native american
1729862|NCT00006159|community intervention|community intervention
1729863|NCT00006159|diet|diet
1729864|NCT00006159|exercise|exercise
1729865|NCT00006158|AIDS|aids
1729866|NCT00006158|HIV|hiv
1729868|NCT00006158|Wasting Syndrome|wasting syndrome
1729869|NCT00006158|testosterone|testosterone
1729870|NCT00006158|androgen levels|androgen levels
1729871|NCT00006158|hormones|hormones
1729872|NCT00006157|Functional bowel disorder|functional bowel disorder
1729873|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
1729874|NCT00006157|Painful constipation|painful constipation
1729875|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
1729876|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
1729877|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
1729878|NCT00006157|IBS|ibs
1729879|NCT00006157|CFAP|cfap
1729880|NCT00006151|nicotine fading|nicotine fading
1729881|NCT00006151|Accu Drop|accu drop
1729882|NCT00006151|cigarette tapering|cigarette tapering
1729883|NCT00006151|smoking cessation|smoking cessation
1729884|NCT00006151|motivational interviewing|motivational interviewing
1729885|NCT00006150|IgE|ige
1729889|NCT00006150|Eczema|eczema
1729890|NCT00006150|Job's Syndrome|job's syndrome
1729891|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
1729892|NCT00006150|HIE Syndrome|hie syndrome
1729893|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
1729894|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
1729895|NCT00006148|Splenomegaly|splenomegaly
1729896|NCT00006077|Clinical Trial|clinical trial
1729897|NCT00006077|Dyskinesias|dyskinesias
1729898|NCT00006077|Levodopa Infusion|levodopa infusion
1729899|NCT00006077|Parkinson's Disease|parkinson's disease
1729900|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
1729901|NCT00006142|phenylketonuria|phenylketonuria
1729902|NCT00006142|rare disease|rare disease
1729903|NCT00006138|disease-related problem/condition|disease-related problem/condition
1729904|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729905|NCT00006138|hematologic disorders|hematologic disorders
1729906|NCT00006138|osteoporosis|osteoporosis
1729907|NCT00006138|rare disease|rare disease
1729908|NCT00006138|thalassemia major|thalassemia major
1729909|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
1729910|NCT00006137|rare disease|rare disease
1729911|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
1729912|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729913|NCT00006136|hematologic disorders|hematologic disorders
1729914|NCT00006136|rare disease|rare disease
1729915|NCT00006136|thalassemia intermedia|thalassemia intermedia
1729916|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
1729917|NCT00006135|herpesvirus infection|herpesvirus infection
1729918|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729919|NCT00006135|rare disease|rare disease
1729920|NCT00006135|viral infection|viral infection
1729921|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729922|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729923|NCT00006134|rare disease|rare disease
1729924|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
1729925|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729926|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729927|NCT00006133|rare disease|rare disease
1729928|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
1729929|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
1729930|NCT00006132|herpes virus infection|herpes virus infection
1729931|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1729932|NCT00006132|rare disease|rare disease
1729933|NCT00006132|viral infection|viral infection
1729934|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1729935|NCT00006130|avascular necrosis|avascular necrosis
1729936|NCT00006130|disease-related problem/condition|disease-related problem/condition
1729937|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729938|NCT00006130|hematologic disorders|hematologic disorders
1729939|NCT00006130|pain|pain
1729940|NCT00006130|rare disease|rare disease
1729941|NCT00006130|sickle cell anemia|sickle cell anemia
1729942|NCT00006129|burns|burns
1729943|NCT00006129|dermatologic disorders|dermatologic disorders
1729944|NCT00006129|rare disease|rare disease
1729945|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1729946|NCT00006128|rare disease|rare disease
1729947|NCT00006127|Fanconi's anemia|fanconi's anemia
1729948|NCT00006127|aplastic anemia|aplastic anemia
1729949|NCT00006127|hematologic disorders|hematologic disorders
1729950|NCT00006127|rare disease|rare disease
1729951|NCT00006076|Hearing|hearing
1729952|NCT00006076|Auditory Processing|auditory processing
1729953|NCT00006076|Pitch Recognition|pitch recognition
1729954|NCT00006076|Tone Deafness|tone deafness
1729955|NCT00006076|Tune Deafness|tune deafness
1729956|NCT00006076|HV|hv
1729957|NCT00006076|Deafness|deafness
1729958|NCT00006076|Congenital Amusia|congenital amusia
1729959|NCT00006076|Healthy Volunteer|healthy volunteer
1729960|NCT00006070|Oral Surgery|oral surgery
1729966|NCT00005937|Immunosuppression|immunosuppression
1729967|NCT00005937|ATG|atg
1729968|NCT00005937|Cyclosporine|cyclosporine
1729969|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
1729970|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
1729971|NCT00005936|Parvovirus|parvovirus
1729972|NCT00005936|Hepatitis|hepatitis
1729973|NCT00005936|Biopsy|biopsy
1729974|NCT00005936|Control|control
1729975|NCT00005936|Liver Biopsy|liver biopsy
1729976|NCT00005935|Immunosuppression|immunosuppression
1729977|NCT00005935|T Cells|t cells
1729978|NCT00005935|Autoimmunity|autoimmunity
1729979|NCT00005935|Bone Marrow Failure|bone marrow failure
1729980|NCT00005935|Hematopoiesis|hematopoiesis
1729981|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
1730341|NCT00005774|Survanta|survanta
1729982|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
1729983|NCT00005934|5-Azacytidine|5-azacytidine
1729984|NCT00005934|Phenylbutyrate|phenylbutyrate
1729985|NCT00005934|Thalassemia|thalassemia
1729986|NCT00005934|Hemoglobin|hemoglobin
1729987|NCT00005934|Anemia|anemia
1729988|NCT00005934|Blood|blood
1729989|NCT00005934|Thalassemia Major|thalassemia major
1729990|NCT00005934|Beta Thalassemia|beta thalassemia
1729991|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1729992|NCT00006063|cystic fibrosis|cystic fibrosis
1729993|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729994|NCT00006063|rare disease|rare disease
1729995|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1729996|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
1729997|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
1729998|NCT00006061|rare disease|rare disease
1729999|NCT00006060|multiple sclerosis|multiple sclerosis
1730000|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730001|NCT00006060|rare disease|rare disease
1730002|NCT00006059|epilepsy|epilepsy
1730003|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730004|NCT00006059|rare disease|rare disease
1730005|NCT00006059|seizures|seizures
1730006|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1730007|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730008|NCT00006058|neonatal disorders|neonatal disorders
1730009|NCT00006058|rare disease|rare disease
1730010|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
1730011|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
1730012|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
1730013|NCT00006056|disease-related problem/condition|disease-related problem/condition
1730014|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
1730015|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730016|NCT00006056|graft versus host disease|graft versus host disease
1730017|NCT00006056|hematologic disorders|hematologic disorders
1730018|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1730019|NCT00006056|histiocytosis|histiocytosis
1730020|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730021|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
1730022|NCT00006056|rare disease|rare disease
1730023|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
1730024|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
1730025|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
1730026|NCT00006055|Takayasu arteritis|takayasu arteritis
1730027|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
1730028|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1730029|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
1730030|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730031|NCT00006055|disease-related problem/condition|disease-related problem/condition
1730032|NCT00006055|giant cell arteritis|giant cell arteritis
1730033|NCT00006055|graft versus host disease|graft versus host disease
1730034|NCT00006055|hematologic disorders|hematologic disorders
1730035|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
1730036|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1730037|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730038|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1730039|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
1730040|NCT00006055|pure red cell aplasia|pure red cell aplasia
1730041|NCT00006055|rare disease|rare disease
1730042|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
1730043|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
1730044|NCT00006055|vasculitis|vasculitis
1730045|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
1730046|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
1730047|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
1730048|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
1730049|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
1730050|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
1730148|NCT00005910|Pancreas|pancreas
1730051|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
1730052|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
1730053|NCT00006054|complement deficiency|complement deficiency
1730054|NCT00006054|disease-related problem/condition|disease-related problem/condition
1730055|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
1730056|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730057|NCT00006054|graft versus host disease|graft versus host disease
1730058|NCT00006054|hematologic disorders|hematologic disorders
1730059|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
1730060|NCT00006054|histiocytosis|histiocytosis
1730061|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730164|NCT00005908|Fine Needle Aspirate|fine needle aspirate
1730062|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
1730063|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
1730064|NCT00006054|rare disease|rare disease
1730065|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
1730066|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
1730067|NCT00005933|Chronic Disease|chronic disease
1730068|NCT00005933|Pediatric|pediatric
1730069|NCT00005933|Pulmonary|pulmonary
1730070|NCT00005933|Intelligence|intelligence
1730071|NCT00005933|Coping|coping
1730072|NCT00005933|Chronic Illness|chronic illness
1730073|NCT00005933|Learning|learning
1730074|NCT00005928|ACE Inhibitor|ace inhibitor
1730075|NCT00005928|Vascular Inflammation|vascular inflammation
1730076|NCT00005928|Vascular Compliance|vascular compliance
1730077|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
1730078|NCT00005928|Coronary Artery Disease|coronary artery disease
1730079|NCT00005927|Adrenal Adenoma|adrenal adenoma
1730080|NCT00005927|Adrenal Cancer|adrenal cancer
1730081|NCT00005927|Macronodular Adrenals|macronodular adrenals
1730082|NCT00005927|Ectopic Receptors|ectopic receptors
1730083|NCT00005927|Gene Profiling|gene profiling
1730084|NCT00005927|Adrenocortical Carcinoma|adrenocortical carcinoma
1730085|NCT00005927|Cushing Syndrome|cushing syndrome
1730086|NCT00005927|Virilizing Adrenal Tumor|virilizing adrenal tumor
1730087|NCT00005927|Feminizing Adrenal Tumor|feminizing adrenal tumor
1730088|NCT00005927|Massive Macronodular Adrenocortical Disease|massive macronodular adrenocortical disease
1730089|NCT00005927|Adrenal Gland Tumor|adrenal gland tumor
1730090|NCT00005925|Video-EEG|video-eeg
1730091|NCT00005925|Muscimol|muscimol
1730092|NCT00005925|Depth Electrode|depth electrode
1730093|NCT00005925|Brain Catheter|brain catheter
1730094|NCT00005925|Pharmacology|pharmacology
1730095|NCT00005925|Epilepsy|epilepsy
1730096|NCT00005925|Infusion|infusion
1730097|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
1730098|NCT00005924|B Cell|b cell
1730099|NCT00005924|Epstein-Barr Virus|epstein-barr virus
1730100|NCT00005923|Joint Instability|joint instability
1730101|NCT00005922|Conditioning|conditioning
1730102|NCT00005922|Corticosteroid|corticosteroid
1730103|NCT00005922|Lesions|lesions
1730104|NCT00005922|Pharmacotherapy|pharmacotherapy
1730105|NCT00005922|Placebo effect|placebo effect
1730106|NCT00005922|Psoriasis|psoriasis
1730107|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
1730108|NCT00005919|Pigment Dispersion|pigment dispersion
1730109|NCT00005919|Ocular Hypertension|ocular hypertension
1730110|NCT00005919|Glaucoma|glaucoma
1730111|NCT00005919|Pupil Reaction|pupil reaction
1730112|NCT00005919|Natural History|natural history
1730113|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
1730114|NCT00005919|Gene Mutation|gene mutation
1730115|NCT00005917|Albinism|albinism
1730116|NCT00005917|Giant Granules|giant granules
1730117|NCT00005917|Infection|infection
1730118|NCT00005917|Melanosomes|melanosomes
1730119|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
1730120|NCT00005916|Immunotherapy|immunotherapy
1730121|NCT00005916|Radiation|radiation
1730122|NCT00005916|Immunology|immunology
1730123|NCT00005916|Prostvac|prostvac
1730124|NCT00005916|Prostate Cancer|prostate cancer
1730125|NCT00005914|Depression|depression
1730126|NCT00005914|Depressive Disorder|depressive disorder
1730127|NCT00005914|Family|family
1730128|NCT00005914|Genes|genes
1730129|NCT00005914|Genetic Techniques|genetic techniques
1730130|NCT00005914|Genetics|genetics
1730131|NCT00005914|Linkage (Genetics)|linkage (genetics)
1730132|NCT00005914|Nuclear Family|nuclear family
1730133|NCT00005914|Recurrence|recurrence
1730134|NCT00005914|Severity of Illness Index|severity of illness index
1730135|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
1730136|NCT00005911|Human Eye|human eye
1730137|NCT00005911|Lens|lens
1730138|NCT00005911|Normal Volunteers|normal volunteers
1730139|NCT00005911|Cataract|cataract
1730140|NCT00005911|Human Lens|human lens
1730141|NCT00005911|Healthy Volunteer|healthy volunteer
1730142|NCT00005910|Islet Cell Tumors|islet cell tumors
1730143|NCT00005910|Surgery|surgery
1730144|NCT00005910|Ultrasound|ultrasound
1730145|NCT00005910|Insulin|insulin
1730146|NCT00005910|Rapid Assay|rapid assay
1730147|NCT00005910|Arteriogram|arteriogram
1730151|NCT00005910|Localization|localization
1730152|NCT00005910|Hypoglycemia|hypoglycemia
1730153|NCT00005909|Homogentisic Acid|homogentisic acid
1730154|NCT00005909|Ochronosis|ochronosis
1730155|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
1730156|NCT00005909|Arthritis|arthritis
1730157|NCT00005909|Enzyme Defect|enzyme defect
1730158|NCT00005909|Alkaptonuria|alkaptonuria
1730159|NCT00005909|Homogentisic Acid Oxidase|homogentisic acid oxidase
1730160|NCT00005908|cDNA Microarray|cdna microarray
1730161|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
1730162|NCT00005908|Biological Response|biological response
1730163|NCT00005908|Molecular Profiling|molecular profiling
1730165|NCT00005908|Breast Cancer|breast cancer
1730167|NCT00005907|Reconstitution|reconstitution
1730169|NCT00005907|Transplant|transplant
1730170|NCT00005907|Vaccine|vaccine
1730171|NCT00005906|Chylous Ascites|chylous ascites
1730172|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
1730173|NCT00005906|Inhibitory Effects|inhibitory effects
1730174|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
1730175|NCT00005906|Somatostatin|somatostatin
1730176|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
1730177|NCT00005905|Adipocyte - Development|adipocyte - development
1730178|NCT00005905|Insulin Resistance|insulin resistance
1730179|NCT00005905|Dyslipidemia|dyslipidemia
1730180|NCT00005905|Diabetes Mellitus|diabetes mellitus
1730181|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1730182|NCT00005905|Leptin Replacement|leptin replacement
1730183|NCT00005903|Parkinsonism|parkinsonism
1730184|NCT00005903|Trophic Factor|trophic factor
1730185|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
1730186|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
1730187|NCT00005902|Brain|brain
1730188|NCT00005902|Brainstem|brainstem
1730189|NCT00005902|Cyst|cyst
1730190|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
1730191|NCT00005902|Spinal Cord|spinal cord
1730192|NCT00005902|von Hippel-Lindau|von hippel-lindau
1730193|NCT00005901|Bisphosphonates|bisphosphonates
1730194|NCT00005901|Growth Hormone|growth hormone
1730195|NCT00005901|Bone Density|bone density
1730196|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
1730197|NCT00005900|Gaucher's disease|gaucher's disease
1730198|NCT00005900|I cell disease|i cell disease
1730199|NCT00005900|Niemann-Pick disease|niemann-pick disease
1730200|NCT00005900|Wolman disease|wolman disease
1730201|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
1730202|NCT00005900|disease-related problem/condition|disease-related problem/condition
1730203|NCT00005900|fucosidosis|fucosidosis
1730204|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730205|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
1730206|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
1730207|NCT00005900|mannosidosis|mannosidosis
1730444|NCT00005654|hyperinsulinism|hyperinsulinism
1730208|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
1730209|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
1730210|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
1730211|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
1730212|NCT00005900|oncologic disorders|oncologic disorders
1730213|NCT00005900|pulmonary complications|pulmonary complications
1730214|NCT00005900|rare disease|rare disease
1730215|NCT00005900|sphingolipidoses|sphingolipidoses
1730216|NCT00005896|Fanconi's anemia|fanconi's anemia
1730217|NCT00005896|aplastic anemia|aplastic anemia
1730218|NCT00005896|hematologic disorders|hematologic disorders
1730219|NCT00005896|rare disease|rare disease
1730220|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
1730221|NCT00005893|chronic neutropenia|chronic neutropenia
1730222|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
1730223|NCT00005893|disease-related problem/condition|disease-related problem/condition
1730224|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730225|NCT00005893|hematologic disorders|hematologic disorders
1730226|NCT00005893|neutropenia|neutropenia
1730227|NCT00005893|pure red cell aplasia|pure red cell aplasia
1730228|NCT00005893|rare disease|rare disease
1730229|NCT00005893|sickle cell anemia|sickle cell anemia
1730230|NCT00005893|thalassemia major|thalassemia major
1730231|NCT00005892|Fanconi's anemia|fanconi's anemia
1730232|NCT00005892|acute leukemia|acute leukemia
1730233|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
1730234|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
1730235|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
1730236|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
1730237|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
1730238|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
1730239|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
1730240|NCT00005892|aplastic anemia|aplastic anemia
1730241|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
1730242|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
1730243|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
1730244|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
1730245|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
1730246|NCT00005892|hematologic disorders|hematologic disorders
1730247|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
1730248|NCT00005892|leukemia|leukemia
1730249|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
1730250|NCT00005892|oncologic disorders|oncologic disorders
1730251|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
1730252|NCT00005892|rare disease|rare disease
1730253|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
1730254|NCT00005891|Fanconi's Anemia|fanconi's anemia
1730255|NCT00005891|aplastic anemia|aplastic anemia
1730256|NCT00005891|hematologic disorders|hematologic disorders
1730257|NCT00005891|rare disease|rare disease
1730258|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730259|NCT00005890|rare disease|rare disease
1730260|NCT00005890|sepsis|sepsis
1730261|NCT00005890|septic shock|septic shock
1730262|NCT00005889|endocrine disorders|endocrine disorders
1730263|NCT00005889|hyperglycemia|hyperglycemia
1730264|NCT00005889|low birth weight|low birth weight
1730265|NCT00005889|neonatal disorders|neonatal disorders
1730266|NCT00005889|rare disease|rare disease
1730267|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
1730268|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730269|NCT00005888|low birth weight|low birth weight
1730270|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
1730271|NCT00005888|neonatal disorders|neonatal disorders
1730272|NCT00005888|rare disease|rare disease
1730273|NCT00005888|sepsis|sepsis
1730274|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
1730275|NCT00005785|Engraftment|engraftment
1730276|NCT00005785|Graft vs. Host Disease|graft vs. host disease
1730277|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
1730278|NCT00005785|Donor Apheresis|donor apheresis
1730279|NCT00005785|Cyclophosphamide|cyclophosphamide
1730280|NCT00005785|Fludarabine|fludarabine
1730282|NCT00005785|AIDS|aids
1730283|NCT00005785|Gene Therapy|gene therapy
1730284|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1730285|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1730286|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
1730287|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1730288|NCT00005784|Macular Degeneration|macular degeneration
1730289|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
1730290|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
1730291|NCT00005784|Central Serous Retinopathy|central serous retinopathy
1730292|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
1730293|NCT00005784|Retinal Disease|retinal disease
1730294|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
1730295|NCT00005782|Donor Apheresis|donor apheresis
1730296|NCT00005782|Sickle Cell Trait|sickle cell trait
1730297|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
1730298|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
1730299|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
1730300|NCT00005780|Molecular Complete Remissions|molecular complete remissions
1730301|NCT00005780|Novel Treatment Approach|novel treatment approach
1730302|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
1730303|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
1730304|NCT00005778|Cytoxan|cytoxan
1730305|NCT00005778|Cyclophosphamide|cyclophosphamide
1730306|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
1730307|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
1730308|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
1730309|NCT00005777|Prematurity|prematurity
1730310|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
1730311|NCT00005777|Dexamethasone|dexamethasone
1730312|NCT00005777|Glucocorticoids|glucocorticoids
1730313|NCT00005777|Respiration, Artificial|respiration, artificial
1730314|NCT00005777|Mechanical ventilation|mechanical ventilation
1730315|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
1730316|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
1730317|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
1730318|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
1730319|NCT00005776|Meconium aspiration|meconium aspiration
1730320|NCT00005776|Methemoglobinemia|methemoglobinemia
1730321|NCT00005776|Nitric oxide|nitric oxide
1730322|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
1730323|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
1730324|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
1730325|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
1730326|NCT00005776|Respiratory insufficiency|respiratory insufficiency
1730327|NCT00005776|Severe respiratory failure|severe respiratory failure
1730328|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
1730329|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
1730330|NCT00005775|Prematurity|prematurity
1730332|NCT00005775|Total parenteral nutrition|total parenteral nutrition
1730333|NCT00005775|Nutrition|nutrition
1730334|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
1730335|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
1730336|NCT00005774|Pulmonary ventilation|pulmonary ventilation
1730337|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
1730338|NCT00005774|Respiratory insufficiency|respiratory insufficiency
1730339|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
1730340|NCT00005774|Mechanical Ventilation|mechanical ventilation
1730342|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
1730343|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
1730344|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
1730345|NCT00005773|Meconium aspiration|meconium aspiration
1730346|NCT00005773|Methemoglobinemia|methemoglobinemia
1730347|NCT00005773|Nitric oxide|nitric oxide
1730348|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
1730349|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
1730350|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
1730351|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
1730352|NCT00005773|Respiratory insufficiency|respiratory insufficiency
1730353|NCT00005773|Severe respiratory failure|severe respiratory failure
1730354|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
1730355|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
1730356|NCT00005772|Hypothermia|hypothermia
1730357|NCT00005772|Neonatal depression|neonatal depression
1730358|NCT00005772|Perinatal asphyxia|perinatal asphyxia
1730359|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
1730360|NCT00005770|elastic property of skin|elastic property of skin
1730361|NCT00005767|Amino Acid Metabolism|amino acid metabolism
1730362|NCT00005766|ALS|als
1730363|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
1730364|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
1730365|NCT00005761|Chemokines|chemokines
1730366|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
1730367|NCT00005761|Cross-Sectional|cross-sectional
1730368|NCT00005761|Serum Levels|serum levels
1730369|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
1730370|NCT00005760|Dyslipidemia|dyslipidemia
1730371|NCT00005760|Hypertension|hypertension
1730372|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
1730373|NCT00005760|Obesity|obesity
1730374|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
1730375|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
1730376|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
1730377|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
1730378|NCT00005675|Multicenter|multicenter
1730379|NCT00005727|Nutrition|nutrition
1730380|NCT00005727|Education|education
1730381|NCT00005520|Hypertension|hypertension
1730382|NCT00005520|Pharmacogenetics|pharmacogenetics
1730383|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
1730384|NCT00005520|Candesartan|candesartan
1730385|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
1730386|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
1730387|NCT00005487|Heart Failure, Congestive|heart failure, congestive
1730388|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
1730389|NCT00005673|HIV|hiv
1730390|NCT00005673|Antiretroviral|antiretroviral
1730391|NCT00005673|NNRTI|nnrti
1730392|NCT00005671|Angina|angina
1730393|NCT00005671|Condition Specific|condition specific
1730394|NCT00005671|Heart Failure|heart failure
1730395|NCT00005671|Symptom Distress|symptom distress
1730396|NCT00005671|Revascularization|revascularization
1730397|NCT00005671|Coronary Artery Disease|coronary artery disease
1730398|NCT00005671|Ischemic Heart Disease|ischemic heart disease
1730399|NCT00005669|Child|child
1730400|NCT00005669|Body Fat|body fat
1730401|NCT00005669|Food Intake|food intake
1730402|NCT00005669|Diabetes Mellitus|diabetes mellitus
1730403|NCT00005669|Dyslipidemia|dyslipidemia
1730404|NCT00005669|Vitamin B12|vitamin b12
1730405|NCT00005669|Childhood Obesity|childhood obesity
1730406|NCT00005667|liver transplantation|liver transplantation
1730407|NCT00005667|vancomycin resistance|vancomycin resistance
1730408|NCT00005666|Diagnostic imaging|diagnostic imaging
1730409|NCT00005664|Healthy Volunteers|healthy volunteers
1730410|NCT00005664|Endocrine Related Conditions|endocrine related conditions
1730411|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
1730412|NCT00005664|Early Pubertal Development|early pubertal development
1730413|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
1730414|NCT00005660|Teratogenicity|teratogenicity
1730415|NCT00005660|Ichthyosis|ichthyosis
1730416|NCT00005660|Darier's Disease|darier's disease
1730417|NCT00005660|Retinoids|retinoids
1730418|NCT00005660|Skin|skin
1730419|NCT00005660|Psoriasis|psoriasis
1730420|NCT00005660|Basal cell carcinoma|basal cell carcinoma
1730421|NCT00005660|Skin Cancer|skin cancer
1730422|NCT00005658|Biochemical|biochemical
1730423|NCT00005658|Schizophrenia|schizophrenia
1730424|NCT00005658|NMDA|nmda
1730425|NCT00005658|Adolescence|adolescence
1730426|NCT00005658|Psychosis|psychosis
1730427|NCT00005658|Child Psychosis|child psychosis
1730428|NCT00005658|Biochemical Correlates|biochemical correlates
1730429|NCT00005658|Brain Imaging|brain imaging
1730430|NCT00005658|Glycine|glycine
1730431|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
1730432|NCT00005657|Cytokines|cytokines
1730433|NCT00005657|Treatment|treatment
1730434|NCT00005657|Genetic Polymorphism|genetic polymorphism
1730435|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
1730436|NCT00005657|Mononuclear Cells|mononuclear cells
1730437|NCT00005655|Gene Expression|gene expression
1730438|NCT00005655|Neovascularization|neovascularization
1730439|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
1730440|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
1730441|NCT00005655|Immunotherapy|immunotherapy
1730442|NCT00005655|Tumor|tumor
1730443|NCT00005654|endocrine disorders|endocrine disorders
1730445|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
1730446|NCT00005654|rare disease|rare disease
1730447|NCT00005652|hematologic disorders|hematologic disorders
1730448|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
1730449|NCT00005652|rare disease|rare disease
1730450|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730451|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730452|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
1730453|NCT00005650|rare disease|rare disease
1730454|NCT00005575|Imipramine|imipramine
1730455|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
1730456|NCT00005571|Skin|skin
1730457|NCT00005571|Humoral Immunity|humoral immunity
1730458|NCT00005571|Myositis|myositis
1730459|NCT00005571|Complement|complement
1730460|NCT00005571|Antibody|antibody
1730461|NCT00005571|Dermatomyositis|dermatomyositis
1730462|NCT00005569|Elastase|elastase
1730463|NCT00005569|Inflammation|inflammation
1730465|NCT00005569|Gender|gender
1730466|NCT00005569|Cytokine|cytokine
1730467|NCT00005569|Healthy Volunteer|healthy volunteer
1730468|NCT00005566|Suicide|suicide
1730469|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
1730470|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
1730471|NCT00005119|Calcium metabolism|calcium metabolism
1730472|NCT00005119|Vitamin D|vitamin d
1730473|NCT00005119|Bone Markers|bone markers
1730474|NCT00005119|Premenopausal|premenopausal
1730475|NCT00005119|Menstrual Cycle|menstrual cycle
1730476|NCT00005117|endothelial dysfunction|endothelial dysfunction
1730477|NCT00005116|depression|depression
1730478|NCT00005108|Menopause|menopause
1730479|NCT00005108|Atherosclerosis|atherosclerosis
1730480|NCT00005108|Estrogen|estrogen
1730481|NCT00005108|MRI|mri
1730482|NCT00005108|Ultrasound|ultrasound
1730483|NCT00005105|endocrine disorders|endocrine disorders
1730484|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
1730485|NCT00005105|rare disease|rare disease
1730486|NCT00005104|endocrine disorders|endocrine disorders
1730487|NCT00005104|hyperinsulinism|hyperinsulinism
1730488|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
1730489|NCT00005104|rare disease|rare disease
1730490|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
1730491|NCT00005103|porphyria|porphyria
1730492|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
1730493|NCT00005103|rare disease|rare disease
1730494|NCT00005102|DiGeorge syndrome|digeorge syndrome
1730495|NCT00005102|Shprintzen syndrome|shprintzen syndrome
1730496|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730497|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
1730498|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730499|NCT00005102|rare disease|rare disease
1730500|NCT00005101|disease-related problem/condition|disease-related problem/condition
1730501|NCT00005101|osteoporosis|osteoporosis
1730502|NCT00005101|rare disease|rare disease
1730503|NCT00005100|acromegaly|acromegaly
1730504|NCT00005100|endocrine disorders|endocrine disorders
1730505|NCT00005100|rare disease|rare disease
1730506|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
1730507|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730508|NCT00005098|rare disease|rare disease
1730509|NCT00005015|Bipolar Disorder|bipolar disorder
1730510|NCT00005015|Depression|depression
1730511|NCT00005015|Fluoxetine|fluoxetine
1730512|NCT00005014|Autistic Disorder|autistic disorder
1730513|NCT00005014|Risperidone|risperidone
1730514|NCT00005013|Antidepressive Agents|antidepressive agents
1730515|NCT00005013|Depression|depression
1730516|NCT00005013|Depressive Disorder|depressive disorder
1730517|NCT00005013|Herbs|herbs
1730518|NCT00005013|Hypericum|hypericum
1730519|NCT00005013|Medicine, Herbal|medicine, herbal
1730520|NCT00005013|Plant Extracts|plant extracts
1730521|NCT00005013|Alternative Medicine|alternative medicine
1730522|NCT00005011|Depression|depression
1730523|NCT00005011|Menstrual Cycle|menstrual cycle
1730524|NCT00005011|Gonadal Steroids|gonadal steroids
1730525|NCT00005011|GnRH Agonist|gnrh agonist
1730526|NCT00005011|PMS|pms
1730527|NCT00005011|Estradiol|estradiol
1730528|NCT00005011|Progesterone|progesterone
1730532|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
1730533|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
1730534|NCT00005007|Vasculitis|vasculitis
1730535|NCT00005007|Etanercept|etanercept
1730536|NCT00005007|Tumor necrosis factor|tumor necrosis factor
1730537|NCT00005006|Anabolic agent|anabolic agent
1730538|NCT00005006|hPTH|hpth
1730539|NCT00005006|PTH|pth
1730540|NCT00005006|Parathyroid hormone|parathyroid hormone
1730541|NCT00005006|Bone mass|bone mass
1730542|NCT00005006|Bone turnover|bone turnover
1730543|NCT00005006|Bone formation|bone formation
1730544|NCT00005006|Alendronate|alendronate
1730545|NCT00005006|Osteoporosis|osteoporosis
1730546|NCT00005006|Cyclical therapy|cyclical therapy
1730547|NCT00005005|PTH|pth
1730548|NCT00005005|Alendronate|alendronate
1730549|NCT00005005|Parathyroid hormone|parathyroid hormone
1730550|NCT00005005|Osteoporosis|osteoporosis
1730551|NCT00005005|Postmenopausal|postmenopausal
1730552|NCT00005004|Cognitive Processes|cognitive processes
1730553|NCT00005004|Inferential Ambiguities|inferential ambiguities
1730554|NCT00005004|Language Processes|language processes
1730555|NCT00005004|Lexical Ambiguities|lexical ambiguities
1730556|NCT00005004|Suppression Mechanism|suppression mechanism
1730557|NCT00005004|Discourse Processes|discourse processes
1730558|NCT00005004|Discourse Production Analysis|discourse production analysis
1730559|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
1730560|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
1730561|NCT00005004|Aging Effects|aging effects
1730562|NCT00005004|Garden Path Phenomena|garden path phenomena
1730563|NCT00005004|Text Integration|text integration
1730564|NCT00005003|Handedness|handedness
1730565|NCT00005003|Laterality|laterality
1730566|NCT00005003|Linkage|linkage
1730567|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
1730568|NCT00005003|Dinucleotide|dinucleotide
1730569|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
1730570|NCT00004997|Hematopoietic|hematopoietic
1730571|NCT00004997|DHFR Enzyme|dhfr enzyme
1730572|NCT00004997|Anemia|anemia
1730573|NCT00004997|Folic Acid|folic acid
1730574|NCT00004997|MDS|mds
1730575|NCT00004997|Myelodysplasia|myelodysplasia
1730576|NCT00004997|Myelodysplastic|myelodysplastic
1730577|NCT00004996|Antigen Presentation|antigen presentation
1730578|NCT00004996|Cytokines|cytokines
1730579|NCT00004996|Helminth|helminth
1730580|NCT00004996|Healthy Volunteer|healthy volunteer
1730581|NCT00004996|Cross-Over Study|cross-over study
1730582|NCT00004996|Helminth Infection|helminth infection
1730583|NCT00004994|Allogeneic Transplant|allogeneic transplant
1730584|NCT00004994|Function|function
1730585|NCT00004994|Mini-Transplant|mini-transplant
1730586|NCT00004994|Physical Symptoms|physical symptoms
1730587|NCT00004994|Symptom Distress|symptom distress
1730588|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
1730589|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
1730590|NCT00004993|Postmenopausal women|postmenopausal women
1730591|NCT00004993|osteoporotic fractures|osteoporotic fractures
1730592|NCT00004992|clinical trial|clinical trial
1730593|NCT00004992|multi-center|multi-center
1730594|NCT00004992|NIDDM|niddm
1730595|NCT00004992|NIDDK|niddk
1730596|NCT00004992|Diabetes Prevention Program (DPP)|diabetes prevention program (dpp)
1730597|NCT00004992|diabetes risk factors|diabetes risk factors
1730598|NCT00004992|diabetes|diabetes
1730599|NCT00004992|glycemia|glycemia
1730600|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
1730601|NCT00004992|quality of life|quality of life
1730602|NCT00004992|physical activity and nutrition|physical activity and nutrition
1730603|NCT00004992|occurrence of adverse events|occurrence of adverse events
1730604|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
1730605|NCT00004992|prevention|prevention
1730606|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
1730607|NCT00004992|lifestyle intervention|lifestyle intervention
1730608|NCT00004992|drug intervention|drug intervention
1730609|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1730610|NCT00004991|Stuttering|stuttering
1730611|NCT00004991|Speech Perception|speech perception
1730612|NCT00004991|Speech Production|speech production
1730613|NCT00004991|Phonology|phonology
1730614|NCT00004991|Development|development
1730615|NCT00004991|Motor Control|motor control
1730616|NCT00004991|Neural Networks|neural networks
1730617|NCT00004991|Phonological Disorders|phonological disorders
1730618|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
1730619|NCT00004990|Steroids|steroids
1730620|NCT00004990|Osteoporosis|osteoporosis
1730621|NCT00004990|Adrenal Suppression|adrenal suppression
1730622|NCT00004990|Proteinuria|proteinuria
1730623|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1730624|NCT00004988|Anti-Tumor Effects|anti-tumor effects
1730625|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
1730626|NCT00004988|Metastatic Cancer|metastatic cancer
1730627|NCT00004988|Pharmacokinetics|pharmacokinetics
1730628|NCT00004988|Solid Tumors|solid tumors
1730629|NCT00004988|Tumor|tumor
1730630|NCT00004984|diabetes|diabetes
1730631|NCT00004984|insulin|insulin
1730634|NCT00004984|C-peptide levels|c-peptide levels
1730635|NCT00004984|insulin autoantibodies|insulin autoantibodies
1730636|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
1730637|NCT00004984|cellular immune responses|cellular immune responses
1730638|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
1730639|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
1730640|NCT00004983|diabetes self-management education|diabetes self-management education
1730641|NCT00004983|diabetes self-care|diabetes self-care
1730642|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
1730643|NCT00004983|health education|health education
1730644|NCT00004983|patient education|patient education
1730645|NCT00004982|chelation therapy|chelation therapy
1730646|NCT00004982|combination chemotherapy|combination chemotherapy
1730647|NCT00004982|iron poisoning|iron poisoning
1730648|NCT00004982|thalassemia|thalassemia
1730649|NCT00004982|chelating agent|chelating agent
1730650|NCT00004982|deferoxamine|deferoxamine
1730651|NCT00004982|drug screening /evaluation|drug screening /evaluation
1730652|NCT00004982|therapy evaluation|therapy evaluation
1730653|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730654|NCT00004980|rare disease|rare disease
1730655|NCT00004980|schizophrenia|schizophrenia
1730656|NCT00004854|moderate heart failure|moderate heart failure
1730657|NCT00004853|AMGEN|amgen
1730658|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
1730659|NCT00004853|MPNST|mpnst
1730660|NCT00004853|Randomized|randomized
1730661|NCT00004853|Sarcoma|sarcoma
1730662|NCT00004853|Tumor|tumor
1730663|NCT00004850|Hepatitis C Virus|hepatitis c virus
1730664|NCT00004850|Blood Donors|blood donors
1730665|NCT00004850|Liver Biopsy|liver biopsy
1730666|NCT00004850|ALT|alt
1730667|NCT00004850|Natural History|natural history
1730668|NCT00004847|Neurofibromatosis|neurofibromatosis
1730669|NCT00004847|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
1730670|NCT00004847|Von Hippel-Lindau Disease|von hippel-lindau disease
1730671|NCT00004847|Norepinephrine|norepinephrine
1730672|NCT00004847|Epinephrine|epinephrine
1730673|NCT00004847|Metanephrines|metanephrines
1730674|NCT00004847|PET|pet
1730675|NCT00004847|Paraganglioma|paraganglioma
1730676|NCT00004847|Pheochromocytoma|pheochromocytoma
1730677|NCT00004846|Viral Gene Amplification|viral gene amplification
1730678|NCT00004846|Blood Transmitted Infections|blood transmitted infections
1730679|NCT00004846|Transfusion Risks|transfusion risks
1730680|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
1730681|NCT00004846|Viral Detection Assays|viral detection assays
1730682|NCT00004846|HIV Seronegativity|hiv seronegativity
1730683|NCT00004739|Pediatric HIV infection|pediatric hiv infection
1730684|NCT00004845|Anti-inflammatory|anti-inflammatory
1730685|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
1730686|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
1730687|NCT00004738|Syringomyelia|syringomyelia
1730688|NCT00004738|Genetics|genetics
1730689|NCT00004738|Chiari I Malformation|chiari i malformation
1730690|NCT00004734|stroke|stroke
1730691|NCT00004734|cerebral infarction|cerebral infarction
1730692|NCT00004734|homocysteine|homocysteine
1730693|NCT00004734|vitamin|vitamin
1730694|NCT00004734|folic acid|folic acid
1730695|NCT00004734|pyridoxine|pyridoxine
1730696|NCT00004734|vitamin B6|vitamin b6
1730697|NCT00004734|cyanocobalamin|cyanocobalamin
1730698|NCT00004734|vitamin B12|vitamin b12
1730699|NCT00004734|multivitamin|multivitamin
1730700|NCT00004733|Parkinson's|parkinson's
1730701|NCT00004733|ELLDOPA|elldopa
1730702|NCT00004733|L-dopa|l-dopa
1730703|NCT00004733|levodopa|levodopa
1730704|NCT00004733|Sinemet|sinemet
1730705|NCT00004733|tremor|tremor
1730706|NCT00004732|angioplasty|angioplasty
1730707|NCT00004732|asymptomatic|asymptomatic
1730708|NCT00004732|atherosclerosis|atherosclerosis
1730709|NCT00004732|carotid endarterectomy|carotid endarterectomy
1730710|NCT00004732|carotid stenting|carotid stenting
1730711|NCT00004732|CREST|crest
1730712|NCT00004732|Cerebral Infarction|cerebral infarction
1730713|NCT00004732|device|device
1730714|NCT00004732|intervention|intervention
1730715|NCT00004732|restenosis|restenosis
1730716|NCT00004732|revascularization|revascularization
1730717|NCT00004732|stenosis|stenosis
1730718|NCT00004732|stent|stent
1730719|NCT00004732|stroke|stroke
1730720|NCT00004732|symptomatic|symptomatic
1730721|NCT00004732|surgery|surgery
1730722|NCT00004732|transient ischemic attack|transient ischemic attack
1730723|NCT00004731|Parkinson's disease|parkinson's disease
1730724|NCT00004731|coenzyme Q10|coenzyme q10
1730725|NCT00004730|head injury|head injury
1730726|NCT00004730|traumatic brain injury|traumatic brain injury
1730727|NCT00004730|concussion|concussion
1730728|NCT00004730|magnesium sulfate|magnesium sulfate
1730729|NCT00004730|neuroprotection|neuroprotection
1730730|NCT00004729|child|child
1730731|NCT00004729|children|children
1730732|NCT00004729|epilepsy|epilepsy
1730733|NCT00004729|seizure|seizure
1730734|NCT00004729|ketogenic|ketogenic
1730735|NCT00004729|diet|diet
1730736|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
1730739|NCT00004728|cerebral infarction|cerebral infarction
1730740|NCT00004728|warfarin|warfarin
1730741|NCT00004728|coumadin|coumadin
1730742|NCT00004728|aspirin|aspirin
1730743|NCT00004728|ASA|asa
1731582|NCT00000390|Female|female
1730744|NCT00004728|acetysalicylic acid|acetysalicylic acid
1730745|NCT00004728|atherosclerosis|atherosclerosis
1730746|NCT00004728|stenosis|stenosis
1730747|NCT00004728|intracranial|intracranial
1730748|NCT00004728|artery|artery
1730749|NCT00004728|arteries|arteries
1730750|NCT00004728|transient ischemic attack|transient ischemic attack
1730751|NCT00004728|TIA|tia
1730752|NCT00004728|minorities|minorities
1730753|NCT00004727|African American|african american
1730754|NCT00004727|antiplatelet|antiplatelet
1730755|NCT00004727|aspirin|aspirin
1730756|NCT00004727|ASA|asa
1730757|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
1730758|NCT00004727|ticlopidine|ticlopidine
1730759|NCT00004727|prevention|prevention
1730760|NCT00004727|stroke|stroke
1730761|NCT00004727|cerebral infarction|cerebral infarction
1730762|NCT00004727|Chicago|chicago
1730763|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
1730764|NCT00004941|Crohn's disease|crohn's disease
1730765|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
1730766|NCT00004941|rare disease|rare disease
1730767|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
1730768|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
1730769|NCT00004940|porphyria|porphyria
1730770|NCT00004940|rare disease|rare disease
1730771|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
1730772|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730773|NCT00004939|rare disease|rare disease
1730774|NCT00004938|fungal infection|fungal infection
1730775|NCT00004938|rare disease|rare disease
1730776|NCT00004938|sporotrichosis|sporotrichosis
1730777|NCT00004844|Parkinson Disease|parkinson disease
1730778|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730779|NCT00004844|rare disease|rare disease
1730780|NCT00004843|disease-related problem/condition|disease-related problem/condition
1730781|NCT00004843|endocrine disorders|endocrine disorders
1730782|NCT00004843|hyperparathyroidism|hyperparathyroidism
1730783|NCT00004843|quality of life|quality of life
1730784|NCT00004843|rare disease|rare disease
1730785|NCT00004842|cirrhosis|cirrhosis
1730786|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
1730787|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
1730788|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
1730789|NCT00004842|rare disease|rare disease
1730790|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730791|NCT00004840|neonatal disorders|neonatal disorders
1730792|NCT00004840|rare disease|rare disease
1730793|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
1730794|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
1730795|NCT00004838|lead poisoning|lead poisoning
1730796|NCT00004838|rare disease|rare disease
1730797|NCT00004834|anxiety disorder|anxiety disorder
1730798|NCT00004834|disease-related problem/condition|disease-related problem/condition
1730799|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730800|NCT00004834|panic disorder|panic disorder
1730801|NCT00004834|rare disease|rare disease
1730802|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
1730803|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
1730804|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730805|NCT00004833|rare disease|rare disease
1730806|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
1730807|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730808|NCT00004832|rare disease|rare disease
1730809|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
1730810|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
1730811|NCT00004831|porphyria|porphyria
1730812|NCT00004831|rare disease|rare disease
1730813|NCT00004829|bacterial infection|bacterial infection
1730814|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730815|NCT00004829|cystic fibrosis|cystic fibrosis
1730816|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730817|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730818|NCT00004829|rare disease|rare disease
1730819|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730820|NCT00004828|heart defects|heart defects
1730821|NCT00004828|rare disease|rare disease
1730822|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
1730823|NCT00004827|rare disease|rare disease
1730824|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
1730825|NCT00004826|Parkinson disease|parkinson disease
1730826|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730827|NCT00004826|rare disease|rare disease
1730828|NCT00004825|endocrine disorders|endocrine disorders
1730829|NCT00004825|hyperinsulinism|hyperinsulinism
1730830|NCT00004825|rare disease|rare disease
1730917|NCT00004793|constitutional growth delay|constitutional growth delay
1730831|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730832|NCT00004817|rare disease|rare disease
1730833|NCT00004817|seizures|seizures
1730834|NCT00004816|multiple sclerosis|multiple sclerosis
1730835|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730836|NCT00004816|rare disease|rare disease
1730837|NCT00004815|Werner's syndrome|werner's syndrome
1730838|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730839|NCT00004815|rare disease|rare disease
1730840|NCT00004814|multiple sclerosis|multiple sclerosis
1730841|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730842|NCT00004814|rare disease|rare disease
1730843|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
1730844|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730845|NCT00004812|rare disease|rare disease
1730846|NCT00004812|spinal cord injury|spinal cord injury
1730847|NCT00004811|blastomycosis|blastomycosis
1730848|NCT00004811|fungal infection|fungal infection
1730849|NCT00004811|histoplasmosis|histoplasmosis
1730850|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730851|NCT00004811|rare disease|rare disease
1730852|NCT00004811|sporotrichosis|sporotrichosis
1730853|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
1730854|NCT00004810|rare disease|rare disease
1730855|NCT00004810|ulcerative colitis|ulcerative colitis
1730856|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
1730857|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
1730858|NCT00004809|rare disease|rare disease
1730859|NCT00004808|blastomycosis|blastomycosis
1730860|NCT00004808|fungal infection|fungal infection
1730861|NCT00004808|histoplasmosis|histoplasmosis
1730862|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730863|NCT00004808|rare disease|rare disease
1730864|NCT00004808|sporotrichosis|sporotrichosis
1730865|NCT00004807|Rett syndrome|rett syndrome
1730866|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730867|NCT00004807|rare disease|rare disease
1730868|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730869|NCT00004806|cystic fibrosis|cystic fibrosis
1730870|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730871|NCT00004806|rare disease|rare disease
1730872|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1730873|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730874|NCT00004805|disease-related problem/condition|disease-related problem/condition
1730875|NCT00004805|educational needs|educational needs
1730876|NCT00004805|hypertensive disorder|hypertensive disorder
1730877|NCT00004805|neonatal disorders|neonatal disorders
1730878|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
1730879|NCT00004805|rare disease|rare disease
1730880|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
1730881|NCT00004804|hepatitis C|hepatitis c
1730882|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730883|NCT00004804|rare disease|rare disease
1730884|NCT00004804|viral infection|viral infection
1730885|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730886|NCT00004802|periodic paralysis|periodic paralysis
1730887|NCT00004802|rare disease|rare disease
1730888|NCT00004801|hematologic disorders|hematologic disorders
1730889|NCT00004801|rare disease|rare disease
1730890|NCT00004800|bacterial infection|bacterial infection
1730891|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730892|NCT00004800|pertussis|pertussis
1730893|NCT00004800|rare disease|rare disease
1730894|NCT00004799|bacterial infection|bacterial infection
1730895|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730896|NCT00004799|pertussis|pertussis
1730897|NCT00004799|rare disease|rare disease
1730898|NCT00004797|disease-related problem/condition|disease-related problem/condition
1730899|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730900|NCT00004797|hematologic disorders|hematologic disorders
1730901|NCT00004797|pain|pain
1730902|NCT00004797|rare disease|rare disease
1730903|NCT00004797|sickle cell anemia|sickle cell anemia
1730904|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730905|NCT00004796|cirrhosis|cirrhosis
1730906|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
1730907|NCT00004796|hypertensive disorder|hypertensive disorder
1730908|NCT00004796|portal hypertension|portal hypertension
1730909|NCT00004796|rare disease|rare disease
1730910|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1730911|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730912|NCT00004795|rare disease|rare disease
1730913|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
1730914|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
1730915|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
1730916|NCT00004794|rare disease|rare disease
1731265|NCT00004565|Genetics|genetics
1730918|NCT00004793|endocrine disorders|endocrine disorders
1730919|NCT00004793|rare disease|rare disease
1730920|NCT00004791|dermatologic disorders|dermatologic disorders
1730921|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
1731010|NCT00004759|rare disease|rare disease
1730922|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730923|NCT00004791|rare disease|rare disease
1730924|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
1730925|NCT00004789|acute porphyria|acute porphyria
1730926|NCT00004789|rare disease|rare disease
1730927|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
1730928|NCT00004788|porphyria|porphyria
1730929|NCT00004788|rare disease|rare disease
1730930|NCT00004787|Fanconi's anemia|fanconi's anemia
1730931|NCT00004787|Shwachman syndrome|shwachman syndrome
1730932|NCT00004787|aplastic anemia|aplastic anemia
1730933|NCT00004787|dermatologic disorders|dermatologic disorders
1730934|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
1730935|NCT00004787|hematologic disorders|hematologic disorders
1730936|NCT00004787|rare disease|rare disease
1730937|NCT00004787|thrombocytopenia|thrombocytopenia
1730938|NCT00004786|Raynaud's syndrome|raynaud's syndrome
1730939|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1730940|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730941|NCT00004786|rare disease|rare disease
1730942|NCT00004786|systemic sclerosis|systemic sclerosis
1730943|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1730944|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730945|NCT00004785|neonatal disorders|neonatal disorders
1730946|NCT00004785|rare disease|rare disease
1730947|NCT00004784|cirrhosis|cirrhosis
1730948|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
1730949|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
1730950|NCT00004784|rare disease|rare disease
1730951|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
1730952|NCT00004781|candidiasis|candidiasis
1730953|NCT00004781|disease-related problem/condition|disease-related problem/condition
1730954|NCT00004781|fungal infection|fungal infection
1730955|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1730956|NCT00004781|infection|infection
1730957|NCT00004781|rare disease|rare disease
1730958|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730959|NCT00004779|cystic fibrosis|cystic fibrosis
1730960|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1730961|NCT00004779|rare disease|rare disease
1730962|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1730963|NCT00004778|neonatal disorders|neonatal disorders
1730964|NCT00004778|rare disease|rare disease
1730965|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
1730966|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
1730967|NCT00004776|epilepsy|epilepsy
1730968|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730969|NCT00004776|rare disease|rare disease
1730970|NCT00004776|seizures|seizures
1730971|NCT00004773|Rett syndrome|rett syndrome
1730972|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730973|NCT00004773|rare disease|rare disease
1730974|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
1730975|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730976|NCT00004772|rare disease|rare disease
1730977|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1730978|NCT00004771|motor neuron disease|motor neuron disease
1730979|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1730980|NCT00004771|rare disease|rare disease
1730981|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
1730982|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
1730983|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
1730984|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
1730985|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
1730986|NCT00004770|rare disease|rare disease
1730987|NCT00004769|Genetic diseases|genetic diseases
1730988|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
1730989|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
1730990|NCT00004769|CMT|cmt
1730991|NCT00004769|Rare disease|rare disease
1730992|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
1730993|NCT00004767|rare disease|rare disease
1730994|NCT00004767|urea cycle disorder|urea cycle disorder
1730995|NCT00004763|endocrine disorders|endocrine disorders
1730996|NCT00004763|hyperandrogenism|hyperandrogenism
1730997|NCT00004763|rare disease|rare disease
1730998|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
1730999|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
1731000|NCT00004762|rare disease|rare disease
1731001|NCT00004761|dermatologic disorders|dermatologic disorders
1731002|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
1731003|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731004|NCT00004761|rare disease|rare disease
1731005|NCT00004760|Parkinson disease|parkinson disease
1731006|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731007|NCT00004760|Rare disease|rare disease
1731008|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
1731009|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731011|NCT00004759|spinal cord injury|spinal cord injury
1731012|NCT00004758|infantile spasms|infantile spasms
1731013|NCT00004758|epilepsy|epilepsy
1731014|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731015|NCT00004758|rare disease|rare disease
1731016|NCT00004758|seizures|seizures
1731017|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
1731018|NCT00004757|herpesvirus infection|herpesvirus infection
1731019|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731020|NCT00004757|rare disease|rare disease
1731021|NCT00004757|viral infection|viral infection
1731022|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1731023|NCT00004756|disease-related problem/condition|disease-related problem/condition
1731024|NCT00004756|educational needs|educational needs
1731025|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731026|NCT00004756|rare disease|rare disease
1731027|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
1731028|NCT00004755|dermatologic disorders|dermatologic disorders
1731029|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
1731030|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731031|NCT00004755|leishmaniasis|leishmaniasis
1731032|NCT00004755|rare disease|rare disease
1731033|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731034|NCT00004754|hypertensive disorder|hypertensive disorder
1731035|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
1731036|NCT00004754|rare disease|rare disease
1731037|NCT00004753|Huntington's disease|huntington's disease
1731038|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731039|NCT00004753|rare disease|rare disease
1731040|NCT00004751|cerebral palsy|cerebral palsy
1731041|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731042|NCT00004751|rare disease|rare disease
1731043|NCT00004751|spastic diplegia|spastic diplegia
1731044|NCT00004748|cirrhosis|cirrhosis
1731045|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
1731046|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
1731047|NCT00004748|rare disease|rare disease
1731048|NCT00004747|bacterial infections|bacterial infections
1731049|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731050|NCT00004747|cystic fibrosis|cystic fibrosis
1731051|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731052|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731053|NCT00004747|rare disease|rare disease
1731054|NCT00004744|multiple sclerosis|multiple sclerosis
1731055|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731056|NCT00004744|rare disease|rare disease
1731057|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731058|NCT00004740|rare disease|rare disease
1731059|NCT00004740|tuberculosis|tuberculosis
1731060|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731061|NCT00004705|cystic fibrosis|cystic fibrosis
1731062|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731063|NCT00004705|rare disease|rare disease
1731064|NCT00004700|endocrine disorders|endocrine disorders
1731065|NCT00004700|hyperinsulinism|hyperinsulinism
1731066|NCT00004700|rare disease|rare disease
1731067|NCT00004699|endocrine disorders|endocrine disorders
1731068|NCT00004699|hyperinsulinism|hyperinsulinism
1731069|NCT00004699|rare disease|rare disease
1731070|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
1731071|NCT00004697|hepatic steatosis|hepatic steatosis
1731072|NCT00004697|rare disease|rare disease
1731073|NCT00004696|disease-related problem/condition|disease-related problem/condition
1731074|NCT00004696|pain|pain
1731075|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
1731076|NCT00004696|rare disease|rare disease
1731077|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
1731078|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731079|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
1731080|NCT00004695|rare disease|rare disease
1731081|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731082|NCT00004694|hereditary angioedema|hereditary angioedema
1731083|NCT00004694|rare disease|rare disease
1731084|NCT00004690|dermatologic disorders|dermatologic disorders
1731085|NCT00004690|ichthyosis|ichthyosis
1731086|NCT00004690|rare disease|rare disease
1731087|NCT00004689|bacterial infection|bacterial infection
1731088|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731089|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
1731090|NCT00004689|mycobacterium infection|mycobacterium infection
1731266|NCT00004565|High Risk|high risk
1731091|NCT00004689|rare disease|rare disease
1731092|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
1731093|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
1731094|NCT00004688|adult brain stem glioma|adult brain stem glioma
1731095|NCT00004688|adult brain tumor|adult brain tumor
1731096|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
1731097|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
1731098|NCT00004688|brain tumor|brain tumor
1731099|NCT00004688|genetic condition|genetic condition
1731100|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
1731101|NCT00004688|mixed gliomas|mixed gliomas
1731102|NCT00004688|nervous tissue tumors|nervous tissue tumors
1731103|NCT00004688|oncologic disorders|oncologic disorders
1731104|NCT00004688|rare disease|rare disease
1731105|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
1731106|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731107|NCT00004686|giant cell arteritis|giant cell arteritis
1731108|NCT00004686|rare disease|rare disease
1731109|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731110|NCT00004685|muscular dystrophy|muscular dystrophy
1731111|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731112|NCT00004685|rare disease|rare disease
1731113|NCT00004682|myasthenia gravis|myasthenia gravis
1731114|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731115|NCT00004682|rare disease|rare disease
1731116|NCT00004670|Parkinson disease|parkinson disease
1731117|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731118|NCT00004670|rare disease|rare disease
1731119|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
1731120|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731121|NCT00004669|neonatal disorders|neonatal disorders
1731122|NCT00004669|rare disease|rare disease
1731123|NCT00004667|hematologic disorders|hematologic disorders
1731124|NCT00004667|rare disease|rare disease
1731125|NCT00004667|von Willebrand's disease|von willebrand's disease
1731126|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1731127|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731128|NCT00004665|rare disease|rare disease
1731129|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
1731130|NCT00004664|disease-related problem/condition|disease-related problem/condition
1731131|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
1731132|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731133|NCT00004664|nutrition|nutrition
1731134|NCT00004664|rare disease|rare disease
1731135|NCT00004664|viral infection|viral infection
1731136|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1731137|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731138|NCT00004663|rare disease|rare disease
1731139|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
1731140|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1731141|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731142|NCT00004662|rare disease|rare disease
1731143|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
1731144|NCT00004661|endocrine disorders|endocrine disorders
1731145|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
1731146|NCT00004661|rare disease|rare disease
1731147|NCT00004660|Graves' disease|graves' disease
1731148|NCT00004660|thyroid disease|thyroid disease
1731149|NCT00004660|endocrine disorders|endocrine disorders
1731150|NCT00004660|rare disease|rare disease
1731151|NCT00004659|adult brain tumor|adult brain tumor
1731152|NCT00004659|brain tumor|brain tumor
1731153|NCT00004659|childhood brain tumor|childhood brain tumor
1731154|NCT00004659|genetic condition|genetic condition
1731155|NCT00004659|nervous tissue tumors|nervous tissue tumors
1731156|NCT00004659|oncologic disorders|oncologic disorders
1731157|NCT00004659|rare disease|rare disease
1731158|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
1731159|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
1731160|NCT00004658|rare disease|rare disease
1731161|NCT00004656|Rett syndrome|rett syndrome
1731162|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731163|NCT00004656|rare disease|rare disease
1731164|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731165|NCT00004654|hematologic disorders|hematologic disorders
1731166|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1731167|NCT00004654|rare disease|rare disease
1731168|NCT00004652|Tourette syndrome|tourette syndrome
1731169|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731170|NCT00004652|rare disease|rare disease
1731171|NCT00004650|disease-related problem/condition|disease-related problem/condition
1731172|NCT00004650|osteoporosis|osteoporosis
1731173|NCT00004650|rare disease|rare disease
1731174|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731175|NCT00004649|hematologic disorders|hematologic disorders
1731176|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1731177|NCT00004649|rare disease|rare disease
1731178|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731179|NCT00004648|hematologic disorders|hematologic disorders
1731581|NCT00000390|Depression|depression
1731180|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1731181|NCT00004648|rare disease|rare disease
1731182|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
1731183|NCT00004647|diabetic neuropathy|diabetic neuropathy
1731184|NCT00004647|disease-related problem/condition|disease-related problem/condition
1731185|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731186|NCT00004647|pain|pain
1731187|NCT00004647|rare disease|rare disease
1731188|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
1731189|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731190|NCT00004646|muscular dystrophy|muscular dystrophy
1731191|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731192|NCT00004646|rare disease|rare disease
1731193|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
1731194|NCT00004645|Devic's syndrome|devic's syndrome
1731195|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
1731196|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
1731197|NCT00004645|acute transverse myelitis|acute transverse myelitis
1731198|NCT00004645|multiple sclerosis|multiple sclerosis
1731199|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1731200|NCT00004645|rare disease|rare disease
1731201|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
1731202|NCT00004644|herpesvirus infection|herpesvirus infection
1731203|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731204|NCT00004644|rare disease|rare disease
1731205|NCT00004644|viral infection|viral infection
1731206|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1731207|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731208|NCT00004643|rare disease|rare disease
1731209|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
1731210|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
1731211|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
1731212|NCT00004642|herpesvirus infection|herpesvirus infection
1731213|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1731214|NCT00004642|neonatal disorders|neonatal disorders
1731215|NCT00004642|rare disease|rare disease
1731216|NCT00004642|viral infection|viral infection
1731217|NCT00004638|chronic sinusitis|chronic sinusitis
1731218|NCT00004635|Angiogenesis|angiogenesis
1731219|NCT00004635|Cancer|cancer
1731220|NCT00004635|Hormonal Therapy|hormonal therapy
1731221|NCT00004635|Prostate|prostate
1731222|NCT00004635|Thalidomide|thalidomide
1731223|NCT00004635|Prostate Cancer|prostate cancer
1731224|NCT00004577|BOLD Effect|bold effect
1731225|NCT00004577|Cerebral Blood Flow|cerebral blood flow
1731226|NCT00004577|Cerebral Blood Volume|cerebral blood volume
1731227|NCT00004577|Functional Imaging|functional imaging
1731228|NCT00004577|Magnetic Resonance Imaging|magnetic resonance imaging
1731229|NCT00004577|Technical Developments|technical developments
1731230|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
1731231|NCT00004572|Type 2 Diabetes|type 2 diabetes
1731232|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
1731233|NCT00004571|Brain Metabolism|brain metabolism
1731234|NCT00004571|Brain Physiology|brain physiology
1731235|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
1731236|NCT00004571|Cognitition|cognitition
1731237|NCT00004570|Temporal Processing|temporal processing
1731238|NCT00004570|Language Impairment|language impairment
1731239|NCT00004570|Linkage Analysis|linkage analysis
1731240|NCT00004570|Inheritance|inheritance
1731241|NCT00004570|Language Delay|language delay
1731242|NCT00004570|Healthy|healthy
1731243|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
1731244|NCT00004570|Speech Impediment|speech impediment
1731245|NCT00004568|Peripheral Neuropathies|peripheral neuropathies
1731246|NCT00004568|Myopathy|myopathy
1731247|NCT00004568|Muscular Dystrophy|muscular dystrophy
1731248|NCT00004568|Motor Neuron Disease|motor neuron disease
1731249|NCT00004568|Neurological Disorders|neurological disorders
1731250|NCT00004567|Relapse|relapse
1731251|NCT00004567|Immunosuppressive|immunosuppressive
1731252|NCT00004567|Toxicity|toxicity
1731253|NCT00004567|Purineantimetabolite|purineantimetabolite
1731254|NCT00004567|Alternative Agents|alternative agents
1731255|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
1731256|NCT00004567|Wegener's Disease|wegener's disease
1731257|NCT00004567|Blood Vessel Disorder|blood vessel disorder
1731258|NCT00004567|Systemic Vasculitis|systemic vasculitis
1731259|NCT00004566|3D Imaging|3d imaging
1731260|NCT00004566|Swallowing|swallowing
1731261|NCT00004566|Fetal Development|fetal development
1731262|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
1731263|NCT00004566|Ultrasound|ultrasound
1731264|NCT00004565|Breast Cancer|breast cancer
1731267|NCT00004565|Polymorphisms|polymorphisms
1731268|NCT00004565|Susceptibility|susceptibility
1731269|NCT00004565|Biomarkers|biomarkers
1731270|NCT00004565|Estrogen|estrogen
1731271|NCT00004565|Genes|genes
1731272|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
1731273|NCT00004564|Cerebrovascular accident|cerebrovascular accident
1731274|NCT00004563|Lung Diseases|lung diseases
1731275|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
1731276|NCT00004563|Systemic Scleroderma|systemic scleroderma
1731277|NCT00004563|Scleroderma, systemic|scleroderma, systemic
1731278|NCT00004556|Stimulants|stimulants
1731280|NCT00004556|Cognition|cognition
1731281|NCT00004556|Brain Physiology|brain physiology
1731282|NCT00004556|Brain Metabolism|brain metabolism
1731283|NCT00004556|Catecholamines|catecholamines
1731284|NCT00004556|Brain Imaging|brain imaging
1731285|NCT00004556|Cognitive Efficiency|cognitive efficiency
1731286|NCT00004556|Dopamine Genes|dopamine genes
1731287|NCT00004553|Single Fiber EMG|single fiber emg
1731288|NCT00004553|Macro-EMG|macro-emg
1731289|NCT00004553|Myasthenia|myasthenia
1731290|NCT00004553|Post-Polio Syndrome|post-polio syndrome
1731291|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
1731292|NCT00004553|Motor Dysfunction|motor dysfunction
1731293|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
1731294|NCT00004550|Screening|screening
1731295|NCT00004550|Longitudinal|longitudinal
1731296|NCT00004550|Transition|transition
1731297|NCT00004550|Treatment|treatment
1731298|NCT00004550|Comorbidity|comorbidity
1731299|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
1731300|NCT00004550|Evaluation|evaluation
1731301|NCT00004550|Follow-Up|follow-up
1731302|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
1731303|NCT00004550|OCD|ocd
1731304|NCT00004549|Atherosclerosis|atherosclerosis
1731305|NCT00004549|Endothelium|endothelium
1731306|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
1731307|NCT00004549|Markers of Inflammation|markers of inflammation
1731308|NCT00004549|Claudication|claudication
1731309|NCT00004547|Surgery|surgery
1731310|NCT00004547|Mesothelioma|mesothelioma
1731311|NCT00004547|Pseudomyxoma|pseudomyxoma
1731312|NCT00004547|Colon Cancer|colon cancer
1731313|NCT00004547|Chemotherapy|chemotherapy
1731314|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1731315|NCT00004533|cystic fibrosis|cystic fibrosis
1731316|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1731317|NCT00004533|rare disease|rare disease
1731318|NCT00001987|Diabetes Mellitus|diabetes mellitus
1731319|NCT00001987|Severe Insulin Resistance|severe insulin resistance
1731320|NCT00001987|Type B Insulin Resistance|type b insulin resistance
1731321|NCT00000436|Hip fracture|hip fracture
1731322|NCT00000436|Self-efficacy|self-efficacy
1731323|NCT00000436|Strength training|strength training
1731324|NCT00000436|Rehabilitation|rehabilitation
1731325|NCT00000436|Postoperative|postoperative
1731326|NCT00001985|Diabetes|diabetes
1731327|NCT00001985|Gene|gene
1731328|NCT00001984|Immunosuppression|immunosuppression
1731329|NCT00001984|Tolerance|tolerance
1731330|NCT00001984|DSG|dsg
1731331|NCT00001984|Alemtuzumab|alemtuzumab
1731332|NCT00001983|Questionnaires|questionnaires
1731333|NCT00001983|Eligibility|eligibility
1731334|NCT00001983|History|history
1731335|NCT00001983|Physical Examination|physical examination
1731336|NCT00001983|Tests|tests
1731337|NCT00001983|Fibromyalgia|fibromyalgia
1731338|NCT00001981|Somatostatin Analogue|somatostatin analogue
1731339|NCT00001981|Acromegaly|acromegaly
1731340|NCT00001981|TSH Producing Tumor|tsh producing tumor
1731341|NCT00001981|Islet Cell Tumor|islet cell tumor
1731342|NCT00001981|Ursodeoxycholate|ursodeoxycholate
1731343|NCT00001981|Pituitary|pituitary
1731344|NCT00001981|Irradiation|irradiation
1731345|NCT00001981|Treatment|treatment
1731346|NCT00000435|RA|ra
1731347|NCT00000435|Immune Modulation|immune modulation
1731348|NCT00000435|Oral Tolerance|oral tolerance
1731349|NCT00000435|Peptide|peptide
1731350|NCT00000435|dnaJ|dnaj
1731351|NCT00000434|Osteoarthritis|osteoarthritis
1731352|NCT00000434|Health education|health education
1731353|NCT00000434|Aerobic exercise|aerobic exercise
1731354|NCT00000434|Self-efficacy|self-efficacy
1731355|NCT00000434|Muscle strength|muscle strength
1731356|NCT00000434|Outcomes research|outcomes research
1731357|NCT00000434|Longitudinal study|longitudinal study
1731358|NCT00001979|Kidney Disease|kidney disease
1731359|NCT00001979|Autoimmune Diseases|autoimmune diseases
1731360|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
1731361|NCT00001978|Kidney Disease|kidney disease
1731362|NCT00001978|Kidney Function Tests|kidney function tests
1731363|NCT00001978|Proteinuria|proteinuria
1731364|NCT00001976|CMV|cmv
1731365|NCT00001976|Infection|infection
1731366|NCT00001976|Comparison|comparison
1731367|NCT00001976|Observational|observational
1731368|NCT00001976|Cytomegalovirus|cytomegalovirus
1731369|NCT00001976|RT-PCR|rt-pcr
1731370|NCT00001975|Skin Biopsy|skin biopsy
1731371|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
1731372|NCT00001975|Cell Growth|cell growth
1731373|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
1731374|NCT00001975|Cytokines|cytokines
1731375|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
1731376|NCT00001973|G Protein Mutation|g protein mutation
1731377|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
1731378|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
1731379|NCT00001973|Mutation|mutation
1731380|NCT00001973|Pathology|pathology
1731381|NCT00001973|Immunohistochemistry|immunohistochemistry
1731382|NCT00001973|PCR|pcr
1731383|NCT00001973|In Situ Hybridization|in situ hybridization
1731384|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
1731385|NCT00001973|Calcinosis|calcinosis
1731386|NCT00001972|Alzheimer's Disease|alzheimer's disease
1731387|NCT00001972|Positron Emission Tomography|positron emission tomography
1731388|NCT00001972|Brain Phospholipid|brain phospholipid
1731389|NCT00001972|Fatty Acids|fatty acids
1731390|NCT00001972|11C Arachidonate|11c arachidonate
1731391|NCT00001972|Signal Transduction|signal transduction
1731392|NCT00001972|Brain|brain
1731393|NCT00001971|Hepatitis B|hepatitis b
1731394|NCT00001971|Hepatitis C|hepatitis c
1731395|NCT00001971|Hepatitis D|hepatitis d
1731396|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
1731397|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
1731398|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
1731399|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
1731400|NCT00001971|Wilson's Disease|wilson's disease
1731401|NCT00001971|Hemochromatosis|hemochromatosis
1731402|NCT00001971|Liver Biopsy|liver biopsy
1731403|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
1731404|NCT00001971|Liver Disease|liver disease
1731405|NCT00001969|Cardiovascular Disease|cardiovascular disease
1731406|NCT00001969|Glucose Clamp|glucose clamp
1731407|NCT00001969|Hypercortisolism|hypercortisolism
1731408|NCT00001969|Insulin Sensitivity|insulin sensitivity
1731409|NCT00001969|Major Depression Disorder|major depression disorder
1731410|NCT00001969|Inflammation|inflammation
1731411|NCT00001969|Coagulation|coagulation
1731412|NCT00001969|Metabolic|metabolic
1731413|NCT00001969|Insulin|insulin
1731414|NCT00001969|Cytokine|cytokine
1731415|NCT00001969|Depression|depression
1731416|NCT00001969|Volunteer|volunteer
1731417|NCT00001969|Healthy Volunteer|healthy volunteer
1731419|NCT00001967|HAART|haart
1731420|NCT00001967|Immunity|immunity
1731421|NCT00001967|Toxicity|toxicity
1731422|NCT00001967|Resistance|resistance
1731423|NCT00001967|Treatment Interruption|treatment interruption
1731424|NCT00001964|Hematopoiesis|hematopoiesis
1731425|NCT00001964|Bone Marrow Failure|bone marrow failure
1731426|NCT00001964|Aplastic Anemia|aplastic anemia
1731427|NCT00001962|Immunosuppression|immunosuppression
1731428|NCT00001962|T-cells|t-cells
1731429|NCT00001962|Hematopoiesis|hematopoiesis
1731430|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
1731431|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
1731432|NCT00001962|Aplastic Anemia|aplastic anemia
1731433|NCT00001961|Myocardial Infarction|myocardial infarction
1731434|NCT00001961|Coronary Artery Disease|coronary artery disease
1731435|NCT00001961|Adenosine|adenosine
1731436|NCT00001961|Stress Testing|stress testing
1731437|NCT00001961|Perfusion|perfusion
1731438|NCT00001960|HCM|hcm
1731439|NCT00001960|Pediatric|pediatric
1731440|NCT00001960|Pacemaker|pacemaker
1731441|NCT00001960|Treatment|treatment
1731442|NCT00001960|Symptoms|symptoms
1731443|NCT00001959|Fibrosis|fibrosis
1731444|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
1731445|NCT00001959|Proteinuria|proteinuria
1731446|NCT00001959|Renal Failure|renal failure
1731447|NCT00001959|TGF-Beta|tgf-beta
1731448|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
1731449|NCT00001959|FSGS|fsgs
1731450|NCT00001958|Gamma Gene|gamma gene
1731451|NCT00001958|Hemoglobin Switching|hemoglobin switching
1731452|NCT00001958|Erythropoiesis|erythropoiesis
1731453|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
1731454|NCT00001958|Cooley's Anemia|cooley's anemia
1731455|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
1731456|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
1731457|NCT00001957|Central Auditory Processing|central auditory processing
1731458|NCT00001957|CAPD|capd
1731459|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
1731460|NCT00001957|Speech Impediment|speech impediment
1731461|NCT00001956|Genetic Markers|genetic markers
1731462|NCT00001956|Thermal Pain|thermal pain
1731463|NCT00001956|Hyperalgesia|hyperalgesia
1731464|NCT00001956|Oral Surgery|oral surgery
1731465|NCT00001956|Cold Pain|cold pain
1731466|NCT00001956|Peripheral Nerve|peripheral nerve
1731467|NCT00001956|Allodynia|allodynia
1731468|NCT00001956|Spinal Cord|spinal cord
1731469|NCT00001956|Personality Traits|personality traits
1731470|NCT00001956|Pain Ratings|pain ratings
1731471|NCT00001955|Clinical Trial|clinical trial
1731472|NCT00001955|Temporomandibular Joints|temporomandibular joints
1731473|NCT00001955|Celecoxib|celecoxib
1731474|NCT00001955|Etanercept|etanercept
1731475|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
1731478|NCT00001954|Clinical Trial|clinical trial
1731479|NCT00001954|Autoimmune|autoimmune
1731480|NCT00001954|Disease Activity|disease activity
1731481|NCT00001954|Cytokine|cytokine
1731482|NCT00001954|Saliva|saliva
1731483|NCT00001954|Xerostomia|xerostomia
1731484|NCT00001954|Salivary Glands|salivary glands
1731485|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
1731486|NCT00001953|Endocrine System|endocrine system
1731487|NCT00001953|Autoimmunity|autoimmunity
1731488|NCT00001953|Salivary Glands|salivary glands
1731489|NCT00001953|Glucose Tolerance Test|glucose tolerance test
1731490|NCT00001953|Growth Hormone|growth hormone
1731491|NCT00001953|Somatostatin|somatostatin
1731492|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
1731493|NCT00001952|Fentanyl|fentanyl
1731494|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
1731495|NCT00001952|Endodontics|endodontics
1731496|NCT00001952|Denti Patch|denti patch
1731497|NCT00001952|Pain|pain
1731498|NCT00001952|Chronic Inflammation|chronic inflammation
1731499|NCT00001951|Bone|bone
1731500|NCT00001951|Cognition|cognition
1731501|NCT00001951|Estrogen|estrogen
1731502|NCT00001951|Mood|mood
1731503|NCT00001951|Testosterone|testosterone
1731504|NCT00001951|Osteoporosis|osteoporosis
1731505|NCT00001951|Ovarian Failure|ovarian failure
1731506|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
1731507|NCT00001951|POF|pof
1731508|NCT00001951|Premature Ovarian Failure|premature ovarian failure
1731509|NCT00001950|Cognition|cognition
1731510|NCT00001950|Infancy|infancy
1731511|NCT00001950|Perception|perception
1731512|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
1731513|NCT00001948|Symptom Distress|symptom distress
1731514|NCT00001948|Immune Function|immune function
1731515|NCT00001948|Medication Trial|medication trial
1731516|NCT00001948|Physical Symptoms|physical symptoms
1731517|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
1731518|NCT00001946|Gadolinium|gadolinium
1731519|NCT00001946|Suburban Hospital|suburban hospital
1731520|NCT00001946|Atherosclerosis|atherosclerosis
1731521|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
1731522|NCT00001941|Interleukin-2|interleukin-2
1731523|NCT00001941|HTLV-I|htlv-i
1731524|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
1731525|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
1731526|NCT00001938|Ovarian Cancer|ovarian cancer
1731527|NCT00001938|Proteomics|proteomics
1731528|NCT00000433|Spondylitis|spondylitis
1731529|NCT00000433|Etanercept|etanercept
1731530|NCT00000433|ENBREL|enbrel
1731531|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
1731532|NCT00000432|Lyme disease|lyme disease
1731533|NCT00000432|Education evaluation|education evaluation
1731534|NCT00000432|Communicable disease control|communicable disease control
1731535|NCT00000432|Outcomes research|outcomes research
1731536|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
1731537|NCT00000431|Venous leg ulcer|venous leg ulcer
1731538|NCT00000431|Wound healing|wound healing
1731539|NCT00000431|Somatic gene therapy|somatic gene therapy
1731540|NCT00000431|PDGF-B|pdgf-b
1731541|NCT00000430|Osteoporosis|osteoporosis
1731542|NCT00000430|Osteopenia|osteopenia
1732665|NCT00001603|Neck|neck
1731543|NCT00000430|Postmenopausal women|postmenopausal women
1731544|NCT00000430|Hormone replacement therapy|hormone replacement therapy
1731545|NCT00000430|Alendronate|alendronate
1731546|NCT00000429|JRA|jra
1731547|NCT00000429|Osteopenia|osteopenia
1731548|NCT00000429|Dietary calcium|dietary calcium
1731549|NCT00000429|Diet therapy|diet therapy
1731550|NCT00000429|Bone density|bone density
1731551|NCT00000429|Ossification|ossification
1731552|NCT00000429|Biomarker|biomarker
1731553|NCT00000429|Dietary supplement|dietary supplement
1731554|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
1731555|NCT00000428|Amitriptyline|amitriptyline
1731556|NCT00000428|Fluoxetine|fluoxetine
1731557|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
1731558|NCT00000427|Alendronate|alendronate
1731559|NCT00000427|Bone metabolism|bone metabolism
1731560|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
1731561|NCT00000427|Bone loss|bone loss
1731562|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
1731563|NCT00000427|Osteoporosis in men|osteoporosis in men
1731564|NCT00000111|mouth mucosa|mouth mucosa
1731565|NCT00000111|transplants|transplants
1731566|NCT00000110|exercise|exercise
1731567|NCT00000110|exertion|exertion
1731568|NCT00000110|physical fitness|physical fitness
1731569|NCT00000110|lipids|lipids
1731570|NCT00000110|nutrition|nutrition
1731571|NCT00000108|exercise|exercise
1731572|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
1731573|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
1731574|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1731575|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1731576|NCT00000392|AIDS-Related Complex|aids-related complex
1731577|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1731578|NCT00000391|AIDS-Related Complex|aids-related complex
1731579|NCT00000390|Adult|adult
1731580|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
1731584|NCT00000390|Imipramine|imipramine
1731585|NCT00000390|Male|male
1731586|NCT00000390|Middle Age|middle age
1731587|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
1731588|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
1731589|NCT00000390|Depression -- etiology|depression -- etiology
1731590|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
1731591|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
1731592|NCT00001936|Laryngeal Elevation|laryngeal elevation
1731593|NCT00001936|Dysphagia|dysphagia
1731594|NCT00001936|Stroke|stroke
1731595|NCT00001936|Neuroprosthesis|neuroprosthesis
1731596|NCT00001936|Dysphonia|dysphonia
1731597|NCT00001936|Aspiration|aspiration
1731598|NCT00001936|Motor Control|motor control
1731599|NCT00001936|Videofluoroscopy|videofluoroscopy
1731600|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
1731601|NCT00001936|Healthy Volunteer|healthy volunteer
1731602|NCT00001936|Swallowing Disorders|swallowing disorders
1731603|NCT00001934|Multiple Sclerosis|multiple sclerosis
1731604|NCT00001934|Immunotherapy|immunotherapy
1731605|NCT00001934|MRI|mri
1731606|NCT00001933|Acetylcholine|acetylcholine
1731607|NCT00001933|Clinical Trial|clinical trial
1731608|NCT00001933|GABA|gaba
1731609|NCT00001933|Cognition|cognition
1731610|NCT00001933|Nicotine|nicotine
1731611|NCT00001932|Epilepsy|epilepsy
1731612|NCT00001932|Temporal Lobe|temporal lobe
1731613|NCT00001932|Blood Flow|blood flow
1731614|NCT00001932|Metabolism|metabolism
1731615|NCT00001932|Localization|localization
1731616|NCT00001927|Factor V Leiden|factor v leiden
1731617|NCT00001927|Prothrombin Mutation|prothrombin mutation
1731618|NCT00001927|Antiphospholipids|antiphospholipids
1731619|NCT00001927|Cerebral Infarction|cerebral infarction
1731620|NCT00001927|Thrombophilia|thrombophilia
1731621|NCT00001927|Porencephaly|porencephaly
1731622|NCT00001927|Perinatal Stroke|perinatal stroke
1731623|NCT00001927|Healthy Mothers|healthy mothers
1731624|NCT00001927|Healthy Children|healthy children
1731625|NCT00001926|Plasticity|plasticity
1731626|NCT00001926|Magnetic Stimulation|magnetic stimulation
1731627|NCT00001926|PET|pet
1731628|NCT00001926|Blind|blind
1731629|NCT00001926|Braille|braille
1731630|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
1731631|NCT00001925|Inferior Olives|inferior olives
1731632|NCT00001925|Calcium Channels|calcium channels
1731633|NCT00001925|Accelerometry|accelerometry
1731634|NCT00001925|Electromyography|electromyography
1731635|NCT00001925|Palatal Tremor|palatal tremor
1731636|NCT00001923|Pain|pain
1731637|NCT00001923|Amputee|amputee
1731638|NCT00001923|Phantom Limb|phantom limb
1731639|NCT00001923|Amputation|amputation
1731640|NCT00001923|Magnetic Stimulation|magnetic stimulation
1731641|NCT00001923|Phantom|phantom
1731642|NCT00001922|Evoked Response|evoked response
1731643|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
1731644|NCT00001922|Aerodynamic|aerodynamic
1731645|NCT00001922|Vibration|vibration
1731646|NCT00001922|Laryngeal|laryngeal
1731647|NCT00001922|Voice Disorders|voice disorders
1731648|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
1731649|NCT00001922|Long-latency Responses|long-latency responses
1731650|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
1731651|NCT00001921|Functional Connectivity|functional connectivity
1731652|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
1731653|NCT00001921|Electrophysiology|electrophysiology
1731654|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1731655|NCT00001921|Healthy Subjects|healthy subjects
1731656|NCT00001921|Schizophrenia|schizophrenia
1731657|NCT00001921|MEG|meg
1731658|NCT00001921|Neuroimaging|neuroimaging
1731659|NCT00001921|EEG|eeg
1731660|NCT00001921|MRI|mri
1731661|NCT00001920|Schizophrenia|schizophrenia
1731662|NCT00001920|Eyeblink|eyeblink
1731663|NCT00001920|Evoked Potentials|evoked potentials
1731664|NCT00001920|Learning|learning
1731665|NCT00001920|Normal Volunteer|normal volunteer
1731666|NCT00001920|Healthy Volunteer|healthy volunteer
1731667|NCT00001919|Mechanism of Action|mechanism of action
1731668|NCT00001919|BCIT-SPECT|bcit-spect
1731669|NCT00001919|St. John's Wort|st. john's wort
1731670|NCT00001919|Hypericum Perforatum|hypericum perforatum
1731671|NCT00001919|Depression|depression
1731672|NCT00001919|Serotonin|serotonin
1731673|NCT00001919|Dopamine Transporter|dopamine transporter
1731674|NCT00001919|SPECT|spect
1731675|NCT00001919|Brain Disorders|brain disorders
1731676|NCT00001917|Positron Emission Tomography|positron emission tomography
1731677|NCT00001917|Physostigmine|physostigmine
1731678|NCT00001917|Visual Stimulation|visual stimulation
1731679|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
1731680|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
1731681|NCT00001917|Aging|aging
1731682|NCT00001917|Alzheimer's Disease|alzheimer's disease
1731683|NCT00001917|Visual Activation|visual activation
1731684|NCT00001915|Cortical Stimulation|cortical stimulation
1731685|NCT00001915|Motor Control|motor control
1731686|NCT00001915|Neuromotor Maturation|neuromotor maturation
1731687|NCT00001915|Magnetic Stimulation|magnetic stimulation
1731688|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1731689|NCT00001915|Hearing Loss|hearing loss
1731690|NCT00001915|Hearing Conservation|hearing conservation
1731691|NCT00001915|Hearing Protective Devices|hearing protective devices
1731692|NCT00001915|Safety Study|safety study
1731693|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
1731694|NCT00001915|Normal Volunteer|normal volunteer
1731695|NCT00001913|Visual Processing|visual processing
1731696|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
1731697|NCT00001913|Maternal Behavior|maternal behavior
1731698|NCT00001913|Attachment|attachment
1731699|NCT00001913|Bereavement|bereavement
1731700|NCT00001912|Cysticercosis|cysticercosis
1731701|NCT00001912|T. Solium|t. solium
1731703|NCT00001912|Seizures|seizures
1731704|NCT00001912|Calcified Cysts|calcified cysts
1731705|NCT00001912|Taenia|taenia
1731706|NCT00001911|Cytokine|cytokine
1731707|NCT00001911|Interferon Gamma|interferon gamma
1731708|NCT00001911|Pulmonary|pulmonary
1731709|NCT00001911|Disseminated|disseminated
1731710|NCT00001911|Refractory|refractory
1731711|NCT00001911|Mycobacterial Infection|mycobacterial infection
1731712|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
1731713|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
1731714|NCT00001910|T Cells|t cells
1731715|NCT00001910|Allergy|allergy
1731716|NCT00001910|Asthma|asthma
1731717|NCT00001910|Cytokine|cytokine
1731718|NCT00001910|Vaccine|vaccine
1731719|NCT00001905|Neutrophil|neutrophil
1731720|NCT00001905|Immunodeficiency|immunodeficiency
1731721|NCT00001905|Cytokine|cytokine
1731722|NCT00001905|Treatment|treatment
1731723|NCT00001905|Trafficking|trafficking
1731724|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
1731725|NCT00001905|LAD I|lad i
1731726|NCT00001901|Vasculitis|vasculitis
1731727|NCT00001901|Prednisone-sparing|prednisone-sparing
1731728|NCT00001901|Methotrexate|methotrexate
1731729|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
1731730|NCT00001901|Remission|remission
1731731|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
1731732|NCT00001899|Viral Suppression|viral suppression
1731733|NCT00001899|Latency|latency
1731734|NCT00001899|AIDS Therapy|aids therapy
1731735|NCT00001899|Viral Relapse|viral relapse
1731736|NCT00001899|Immunodeficiency|immunodeficiency
1731737|NCT00001899|HIV|hiv
1731738|NCT00001899|Treatment Interruption|treatment interruption
1731739|NCT00001898|Melanoma|melanoma
1731740|NCT00001898|Breast Cancer|breast cancer
1731741|NCT00001898|Gene Expression|gene expression
1731742|NCT00001898|DNA Chip Technology|dna chip technology
1731743|NCT00001898|Expressed Sequence Tags|expressed sequence tags
1731744|NCT00001895|Electromechanical Mapping|electromechanical mapping
1731745|NCT00001895|Myocardial Viability|myocardial viability
1731746|NCT00001895|Myocardial Ischemia|myocardial ischemia
1731747|NCT00001895|Positron Emission Tomography|positron emission tomography
1732772|NCT00001569|Taxol|taxol
1731748|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
1731749|NCT00001894|HCM|hcm
1731750|NCT00001894|Alcohol|alcohol
1731751|NCT00001894|Septal Ablation|septal ablation
1731752|NCT00001894|Pacemaker|pacemaker
1731753|NCT00001893|Bronchoprovocation|bronchoprovocation
1731754|NCT00001893|Airway Inflammation|airway inflammation
1731755|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
1731756|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
1731757|NCT00001893|Pulmonary Function Test|pulmonary function test
1731758|NCT00001893|Asthma|asthma
1731759|NCT00001888|Induced Sputum|induced sputum
1731760|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
1731761|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
1731762|NCT00001888|Bronchoscopy|bronchoscopy
1731763|NCT00001888|mRNA|mrna
1731764|NCT00001888|Asthma|asthma
1731765|NCT00001888|Normal Volunteer|normal volunteer
1731766|NCT00001885|Interstitial Lung Disease|interstitial lung disease
1731767|NCT00001885|Inherited Disease|inherited disease
1731768|NCT00001885|Genetic Markers|genetic markers
1731769|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
1731770|NCT00001885|DNA Mutations|dna mutations
1731771|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
1731772|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
1731773|NCT00001885|Normal Volunteer|normal volunteer
1731774|NCT00001884|Bronchoscopy|bronchoscopy
1731775|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1731776|NCT00001884|Proteases|proteases
1731777|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
1731778|NCT00001884|Reactive Proteins|reactive proteins
1731779|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
1731780|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
1731781|NCT00001883|Treadmill|treadmill
1731782|NCT00001883|Bicycle|bicycle
1731783|NCT00001883|Lung Function|lung function
1731784|NCT00001883|Physiology|physiology
1731785|NCT00001883|Quality Control|quality control
1731790|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
1731792|NCT00001880|Cyclophosphamide|cyclophosphamide
1731793|NCT00001880|Fludarabine|fludarabine
1731794|NCT00001880|Donor Apheresis|donor apheresis
1731795|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
1731796|NCT00001880|Cancer|cancer
1731797|NCT00001880|Tumor|tumor
1731798|NCT00001878|Growth Hormone|growth hormone
1731799|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
1731800|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1731801|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
1731802|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
1731803|NCT00001877|Corticosteroids|corticosteroids
1731804|NCT00001877|Macrophages|macrophages
1731805|NCT00001877|Phosphodiesterase|phosphodiesterase
1731806|NCT00001877|Autoimmune|autoimmune
1731807|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
1731808|NCT00001876|Interstitial Lung Disease|interstitial lung disease
1731809|NCT00001876|Collagen Vascular Disease|collagen vascular disease
1731810|NCT00001876|Extracellular Matrix|extracellular matrix
1731811|NCT00001876|Pulmonary Function|pulmonary function
1731812|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
1731813|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
1731814|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
1731815|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
1731816|NCT00001874|Imaging|imaging
1731817|NCT00001874|Spectroscopy|spectroscopy
1731818|NCT00001874|MRI|mri
1731819|NCT00001874|Cardiovascular|cardiovascular
1731820|NCT00001874|Technical Development|technical development
1731821|NCT00001874|Safety|safety
1731822|NCT00001874|Gadolinium|gadolinium
1731823|NCT00001874|Heart|heart
1731824|NCT00001874|Toxicity|toxicity
1731825|NCT00001874|Adverse Events|adverse events
1731826|NCT00001874|Normal Volunteer|normal volunteer
1731827|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
1731828|NCT00001873|Cyclosporine|cyclosporine
1731829|NCT00001873|Cyclosphosphamide|cyclosphosphamide
1731830|NCT00001873|Whole Body Irradiation|whole body irradiation
1731831|NCT00001873|Donor Apheresis|donor apheresis
1731832|NCT00001873|Leukemic Relapse|leukemic relapse
1731833|NCT00001873|Graft vs. Host Disease|graft vs. host disease
1731834|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
1731835|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
1731836|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1731837|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
1731838|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
1731839|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
1731840|NCT00001873|Multiple Myeloma|multiple myeloma
1731841|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1731842|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
1731848|NCT00001870|Insulin Resistance|insulin resistance
1731849|NCT00001870|Oxidative Stress|oxidative stress
1731850|NCT00001870|Antioxidant|antioxidant
1731851|NCT00001870|Endothelial Function|endothelial function
1731852|NCT00001870|Glucose Clamp|glucose clamp
1731853|NCT00001870|Type 2 Diabetes|type 2 diabetes
1731854|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
1731855|NCT00001869|Progesterone|progesterone
1731856|NCT00001869|Pulmonary Function Tests|pulmonary function tests
1731857|NCT00001869|Pneumothorax|pneumothorax
1731858|NCT00001869|Oopherectomy|oopherectomy
1731859|NCT00001869|High Resolution CT|high resolution ct
1731860|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
1731861|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
1731862|NCT00001865|Behcet's|behcet's
1731863|NCT00001865|Monoclonal Antibody|monoclonal antibody
1731864|NCT00001865|Uveitis|uveitis
1731865|NCT00001865|Interleukin 2|interleukin 2
1731866|NCT00001865|Retinal Vasculitis|retinal vasculitis
1731867|NCT00001865|Hyopyon|hyopyon
1731868|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
1731869|NCT00001865|Bechet's Disease|bechet's disease
1731870|NCT00001865|Ocular Disease|ocular disease
1731871|NCT00001863|Immunosuppression|immunosuppression
1731872|NCT00001863|Inflammation|inflammation
1731873|NCT00001863|Eye|eye
1731874|NCT00001863|Vision|vision
1731875|NCT00001863|Medication|medication
1731876|NCT00001863|Uveitis|uveitis
1731877|NCT00001863|Leflunomide|leflunomide
1731878|NCT00001863|Vitritis|vitritis
1731879|NCT00001862|Ocular Inflammation|ocular inflammation
1731880|NCT00001862|Children|children
1731881|NCT00001862|Immunotherapy|immunotherapy
1731882|NCT00001862|Cytokine|cytokine
1731883|NCT00001862|Clinical Trial|clinical trial
1731884|NCT00001862|Uveitis|uveitis
1731888|NCT00001861|Eye Movements|eye movements
1731889|NCT00001861|Amblyopia|amblyopia
1731890|NCT00001861|Orthoptics|orthoptics
1731891|NCT00001861|Lazy Eye|lazy eye
1731892|NCT00001861|Eye Development|eye development
1731893|NCT00001861|Nystagmus|nystagmus
1731894|NCT00001861|Strabismus|strabismus
1731895|NCT00001861|Screening Protocol|screening protocol
1731896|NCT00001861|Eye Movement Disorders|eye movement disorders
1731897|NCT00001860|Growth Hormone|growth hormone
1731898|NCT00001860|Somatostatin|somatostatin
1731899|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
1731900|NCT00001860|Acromegaly|acromegaly
1731901|NCT00001860|Macroadenoma|macroadenoma
1731902|NCT00001859|Evaluation|evaluation
1731903|NCT00001859|Diabetes|diabetes
1731904|NCT00001859|Renal Failure|renal failure
1731905|NCT00001858|Biopsy|biopsy
1731906|NCT00001858|Immune System|immune system
1731907|NCT00001858|Renal|renal
1731908|NCT00001856|Living Donor|living donor
1731909|NCT00001856|Transplantation|transplantation
1731910|NCT00001856|Nephrectomy|nephrectomy
1731911|NCT00001854|Ribavirin|ribavirin
1731912|NCT00001854|Liver Disease|liver disease
1731913|NCT00001854|Antiviral Agent|antiviral agent
1731914|NCT00001854|Cirrhosis|cirrhosis
1731915|NCT00001854|Chronic Hepatitis|chronic hepatitis
1731916|NCT00001854|Iron|iron
1731917|NCT00001854|Viral Hepatitis|viral hepatitis
1731918|NCT00001854|Hepatitis C Virus|hepatitis c virus
1731919|NCT00001854|Hemolytic Anemia|hemolytic anemia
1731920|NCT00001854|Hemolysis|hemolysis
1731921|NCT00001853|Healthy Volunteers|healthy volunteers
1731922|NCT00001853|Health Disparities|health disparities
1731923|NCT00001853|Diabetes|diabetes
1731924|NCT00001853|Cardiovascular Disease|cardiovascular disease
1731928|NCT00001851|Marrow|marrow
1731929|NCT00001851|Grafting|grafting
1731930|NCT00001851|Imaging|imaging
1731931|NCT00001851|Injection|injection
1731932|NCT00001851|Aspiration|aspiration
1731933|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
1731934|NCT00001851|Bone Grafting|bone grafting
1731935|NCT00001851|Bone Graft Substitutes|bone graft substitutes
1731936|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
1731937|NCT00001850|Training|training
1731938|NCT00001850|Reproduction|reproduction
1731939|NCT00001850|Infertility|infertility
1731940|NCT00001850|Women's Health|women's health
1731941|NCT00001850|Hormone|hormone
1731942|NCT00001849|PET|pet
1731943|NCT00001849|(18F)-DOPA|(18f)-dopa
1731944|NCT00001849|Pentetreotide|pentetreotide
1731945|NCT00001849|ACTH|acth
1731946|NCT00001849|Octreotide|octreotide
1731947|NCT00001849|Cushing's Syndrome|cushing's syndrome
1731948|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
1731949|NCT00001848|Estrogen Receptor|estrogen receptor
1731950|NCT00001848|Laparoscopy|laparoscopy
1731951|NCT00001848|Surgical Excision|surgical excision
1731952|NCT00001848|Raloxifene|raloxifene
1731953|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
1731954|NCT00001848|Estrogen|estrogen
1731955|NCT00001848|Endometriosis|endometriosis
1731956|NCT00001848|Pelvic Pain|pelvic pain
1731957|NCT00001846|Volunteer Donor|volunteer donor
1731958|NCT00001846|Research Samples|research samples
1731959|NCT00001846|Leukapheresis|leukapheresis
1731960|NCT00001846|Plateletpheresis|plateletpheresis
1731961|NCT00001846|Plasmapheresis|plasmapheresis
1731962|NCT00001846|Healthy Volunteer|healthy volunteer
1731963|NCT00001846|Normal Volunteer|normal volunteer
1731964|NCT00001845|MRI|mri
1731965|NCT00001845|Cerebral Blood Flow|cerebral blood flow
1731966|NCT00001845|CO2 Inhalation|co2 inhalation
1731967|NCT00001845|Acetazolamide|acetazolamide
1731968|NCT00001845|Perfusion|perfusion
1731969|NCT00001845|Healthy Volunteer|healthy volunteer
1731970|NCT00001844|MRI/MRS|mri/mrs
1731971|NCT00001844|Functional MRI|functional mri
1731972|NCT00001844|Metabolic Imaging|metabolic imaging
1731973|NCT00001844|Brain|brain
1731974|NCT00001844|Healthy Volunteer|healthy volunteer
1731975|NCT00001842|Granulocytes|granulocytes
1731976|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
1731977|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
1731978|NCT00001842|Apheresis|apheresis
1731979|NCT00001842|Blood Donors|blood donors
1731980|NCT00001842|Healthy Volunteer|healthy volunteer
1731981|NCT00001841|Arteriosclerosis|arteriosclerosis
1731982|NCT00001841|Imaging|imaging
1731983|NCT00001841|MRA|mra
1731984|NCT00001841|Narrowing of Vessels|narrowing of vessels
1731985|NCT00001841|Hardening of Arteries|hardening of arteries
1731986|NCT00001837|Sonohysterography|sonohysterography
1731987|NCT00001837|Color Doppler Sonography|color doppler sonography
1731988|NCT00001837|Endometrium|endometrium
1731989|NCT00001837|Gynecologic|gynecologic
1731990|NCT00001837|Menstrual Cycle|menstrual cycle
1732002|NCT00001832|Immunotherapy|immunotherapy
1732003|NCT00001832|Adoptive Transfer|adoptive transfer
1732004|NCT00001832|IL-2|il-2
1732005|NCT00001832|Toxicity|toxicity
1732006|NCT00001832|Clinical Response|clinical response
1732007|NCT00001832|Breast Cancer|breast cancer
1732008|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
1732009|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
1732010|NCT00001830|Immunotherapy|immunotherapy
1732011|NCT00001830|Lymphoma|lymphoma
1732012|NCT00001830|Multiple Myeloma|multiple myeloma
1732013|NCT00001830|Graft vs. Host Disease|graft vs. host disease
1732014|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
1732015|NCT00001830|Leukemia|leukemia
1732016|NCT00001827|Immunotherapy|immunotherapy
1732017|NCT00001827|Cancer|cancer
1732018|NCT00001827|Oncogenes|oncogenes
1732019|NCT00001827|T-cells|t-cells
1732020|NCT00001827|Vaccine Therapy|vaccine therapy
1732022|NCT00001827|Ovarian Cancer|ovarian cancer
1732023|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
1732024|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
1732025|NCT00001826|Antiviral Activity|antiviral activity
1732026|NCT00001826|VB Repertoire|vb repertoire
1732027|NCT00001826|Immunizations|immunizations
1732028|NCT00001826|HIV|hiv
1732029|NCT00001826|Treatment Experienced|treatment experienced
1732030|NCT00001823|Cancer|cancer
1732031|NCT00001823|Gene Therapy|gene therapy
1732032|NCT00001823|Immunotherapy|immunotherapy
1732033|NCT00001823|Melanoma|melanoma
1732034|NCT00001823|Clinical Trial|clinical trial
1732035|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
1732036|NCT00001813|Trichothiodystrophy|trichothiodystrophy
1732037|NCT00001813|Cockayne Syndrome|cockayne syndrome
1732038|NCT00001813|Skin Cancer|skin cancer
1732039|NCT00001813|DNA Repair|dna repair
1732052|NCT00001803|Gene-Environment Interaction|gene-environment interaction
1732053|NCT00001803|Kidney Cancer|kidney cancer
1732054|NCT00001803|VHL|vhl
1732055|NCT00001803|Genetic Epidemiology|genetic epidemiology
1732056|NCT00001788|Cytokine|cytokine
1732057|NCT00001788|Stat|stat
1732058|NCT00001788|Jak|jak
1732059|NCT00001788|IL-12|il-12
1732060|NCT00001788|Mutation|mutation
1732061|NCT00001788|Immunodeficiency|immunodeficiency
1732062|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
1732063|NCT00001785|Virus|virus
1732064|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
1732065|NCT00001784|Blepharospasm|blepharospasm
1732066|NCT00001784|Writer's Cramp|writer's cramp
1732067|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
1732068|NCT00001784|Sodium Channels|sodium channels
1732069|NCT00001784|Sensorimotor Integration|sensorimotor integration
1732070|NCT00001784|Focal Dystonia|focal dystonia
1732071|NCT00001783|Rehabilitation|rehabilitation
1732072|NCT00001783|Plasticity|plasticity
1732073|NCT00001783|Stroke|stroke
1732074|NCT00001783|Amphetamine|amphetamine
1732075|NCT00001783|Motor|motor
1732076|NCT00001783|Hemiparetic|hemiparetic
1732077|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
1732078|NCT00001781|Multiple Sclerosis|multiple sclerosis
1732079|NCT00001781|Immunology|immunology
1732080|NCT00001781|Treatment|treatment
1732081|NCT00001780|Myelopathy|myelopathy
1732082|NCT00001780|Demyelination|demyelination
1732083|NCT00001780|Leukodystrophy|leukodystrophy
1732084|NCT00001780|Motor Neuron Disease|motor neuron disease
1732085|NCT00001780|Movement Disorders|movement disorders
1732086|NCT00001780|Normal Volunteer|normal volunteer
1732087|NCT00001778|Immune Response|immune response
1732088|NCT00001778|Sero-Indeterminant|sero-indeterminant
1732089|NCT00001778|Transmission|transmission
1732090|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
1732091|NCT00001778|Viral Load|viral load
1732092|NCT00001778|HTLV-I|htlv-i
1732093|NCT00001778|HAM/TSP|ham/tsp
1732094|NCT00001776|Magnetic Stimulation|magnetic stimulation
1732095|NCT00001776|Plasticity|plasticity
1732096|NCT00001776|SRTT|srtt
1732097|NCT00001776|Sequence|sequence
1732098|NCT00001776|Implicit Memory|implicit memory
1732099|NCT00001776|Explicit Memory|explicit memory
1732100|NCT00001776|Memory|memory
1732101|NCT00001776|Parkinson's Disease|parkinson's disease
1732102|NCT00001776|Cerebellar Deficit|cerebellar deficit
1732103|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
1732104|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
1732105|NCT00001776|Normal Volunteer|normal volunteer
1732106|NCT00001771|Receptors|receptors
1732107|NCT00001771|Re-Uptake|re-uptake
1732108|NCT00001771|Neurotransmitters|neurotransmitters
1732109|NCT00001771|Neuroimaging|neuroimaging
1732110|NCT00001771|Drug Abuse|drug abuse
1732111|NCT00001771|Serotonin|serotonin
1732112|NCT00001771|Brain Scan|brain scan
1732113|NCT00001771|Tourette's Syndrome|tourette's syndrome
1732114|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
1732115|NCT00001771|Schizophrenia|schizophrenia
1732116|NCT00001771|Normal Volunteer|normal volunteer
1732117|NCT00001770|Depression|depression
1732118|NCT00001770|Estrogen|estrogen
1732119|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
1732120|NCT00001770|Mood|mood
1732121|NCT00001770|Progestin|progestin
1732122|NCT00001770|Progesterone|progesterone
1732123|NCT00001770|Anxiety|anxiety
1732124|NCT00001766|Abacavir|abacavir
1732125|NCT00001766|Salvage|salvage
1732126|NCT00001766|Drug Interaction|drug interaction
1732127|NCT00001766|Drug Levels|drug levels
1732128|NCT00001766|Anti-Viral|anti-viral
1732129|NCT00001766|HIV|hiv
1732130|NCT00001765|Engraftment|engraftment
1732131|NCT00001765|Minitransplant|minitransplant
1732132|NCT00001765|Fludarabine|fludarabine
1732133|NCT00001765|Neutrophil|neutrophil
1732134|NCT00001765|Allogenic|allogenic
1732135|NCT00001765|Donor Apheresis|donor apheresis
1732136|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
1732137|NCT00001765|Cyclophosphamide|cyclophosphamide
1732138|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
1732139|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
1732140|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
1732141|NCT00001764|Alternative agent|alternative agent
1732142|NCT00001764|Purine Antimetabolite|purine antimetabolite
1732143|NCT00001764|Immunosuppressive|immunosuppressive
1732144|NCT00001764|Previous relapse|previous relapse
1732145|NCT00001764|Drug Intolerance|drug intolerance
1732146|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
1732147|NCT00001762|Protease Inhibitor|protease inhibitor
1732148|NCT00001762|HIV Infection|hiv infection
1732149|NCT00001762|Appearance|appearance
1732150|NCT00001762|Subcutaneous Fat|subcutaneous fat
1732151|NCT00001762|Facial Wasting|facial wasting
1732152|NCT00001760|Stem Cell Factor|stem cell factor
1732153|NCT00001760|Cytokine|cytokine
1732154|NCT00001760|Chemokines|chemokines
1732155|NCT00001760|Chemotaxis|chemotaxis
1732156|NCT00001760|Mast Cells|mast cells
1732157|NCT00001760|Normal Volunteer|normal volunteer
1732158|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
1732159|NCT00001760|Atopic Dermatitis|atopic dermatitis
1732160|NCT00001758|Antiretroviral|antiretroviral
1732161|NCT00001758|HIV-1|hiv-1
1732162|NCT00001758|1592U89|1592u89
1732163|NCT00001758|141W94|141w94
1732164|NCT00001758|DMP 266|dmp 266
1732165|NCT00001756|Leukapheresis|leukapheresis
1732166|NCT00001756|Mastocytosis|mastocytosis
1732167|NCT00001756|G-CSF|g-csf
1732168|NCT00001756|Mast Cells|mast cells
1732169|NCT00001756|Normal Volunteer|normal volunteer
1732170|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
1732171|NCT00001750|G-CSF|g-csf
1732172|NCT00001750|Cell-Cycle|cell-cycle
1732173|NCT00001750|Stem Cell|stem cell
1732174|NCT00001750|Apheresis|apheresis
1732175|NCT00001750|Melphalan|melphalan
1732176|NCT00001750|Gene Transfer|gene transfer
1732177|NCT00001750|Retroviral Receptor|retroviral receptor
1732178|NCT00001750|Stem Cell Expansion|stem cell expansion
1732179|NCT00001750|Multiple Myeloma|multiple myeloma
1732180|NCT00001749|Immune Suppression|immune suppression
1732181|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
1732182|NCT00001749|Congenital Anemia|congenital anemia
1732183|NCT00001749|Reticulocytopenia|reticulocytopenia
1732184|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
1732185|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1732187|NCT00001746|Evaluation for Research|evaluation for research
1732188|NCT00001746|Medical Advice|medical advice
1732189|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
1732190|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
1732191|NCT00001741|Vascular Tone|vascular tone
1732192|NCT00001741|Angiotensin II|angiotensin ii
1732193|NCT00001741|Losartan|losartan
1732195|NCT00001737|Immunosuppression|immunosuppression
1732196|NCT00001737|Inflammation|inflammation
1732197|NCT00001737|Therapy|therapy
1732198|NCT00001737|Vitreous|vitreous
1732199|NCT00001737|Uveitis|uveitis
1732200|NCT00001734|Uveitis|uveitis
1732201|NCT00001734|Conjunctivitis|conjunctivitis
1732202|NCT00001734|Iritis|iritis
1732208|NCT00001734|Eye Inflammation|eye inflammation
1732209|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
1732210|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
1732211|NCT00001733|Neovascularization|neovascularization
1732212|NCT00001733|Macular Degeneration|macular degeneration
1732213|NCT00001733|Retinal Disease|retinal disease
1732214|NCT00001733|Diabetes|diabetes
1732215|NCT00001732|Genetics|genetics
1732216|NCT00001732|Diagnosis|diagnosis
1732217|NCT00001732|Screening Protocol|screening protocol
1732218|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
1732219|NCT00001732|Genetic Testing|genetic testing
1732220|NCT00001732|Family Studies|family studies
1732221|NCT00001729|Cirrhosis|cirrhosis
1732222|NCT00001729|Liver Disease|liver disease
1732223|NCT00001729|Hemolytic Anemia|hemolytic anemia
1732224|NCT00001729|Liver Biopsy|liver biopsy
1732225|NCT00001729|Ribavirin|ribavirin
1732226|NCT00001729|Alpha Interferon|alpha interferon
1732227|NCT00001729|Viral Hepatitis|viral hepatitis
1732228|NCT00001729|Hepatitis C Virus|hepatitis c virus
1732229|NCT00001729|Chronic Hepatitis|chronic hepatitis
1732230|NCT00001729|Antiviral Agents|antiviral agents
1732231|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
1732232|NCT00001728|Bone Turnover|bone turnover
1732233|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
1732234|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
1732235|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
1732236|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
1732237|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
1732238|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
1732239|NCT00001726|Bacterial Colonization|bacterial colonization
1732240|NCT00001726|Plaque|plaque
1732241|NCT00001726|Mouth|mouth
1732242|NCT00001726|Saliva|saliva
1732243|NCT00001726|Adhesion|adhesion
1732244|NCT00001726|Dental Plaque Formation|dental plaque formation
1732245|NCT00001726|Dental Caries|dental caries
1732246|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
1732247|NCT00001725|Dextromethorphan|dextromethorphan
1732249|NCT00001725|Orofacial Pain|orofacial pain
1732250|NCT00001725|Neuropathic Pain|neuropathic pain
1732251|NCT00001725|Facial Neuralgia|facial neuralgia
1732252|NCT00001724|Pain|pain
1732253|NCT00001724|Microencapsulated Drug|microencapsulated drug
1732254|NCT00001724|NSAID|nsaid
1732255|NCT00001724|Acute Inflammation|acute inflammation
1732256|NCT00001724|Peripheral Administration|peripheral administration
1732257|NCT00001724|Dose-Response|dose-response
1732258|NCT00001724|Relative Potency Assay|relative potency assay
1732259|NCT00001724|Pharmacokinetics|pharmacokinetics
1732260|NCT00001723|Dyslipidemia|dyslipidemia
1732261|NCT00001723|Race|race
1732262|NCT00001723|Body Fat|body fat
1732263|NCT00001723|Visceral Fat|visceral fat
1732264|NCT00001723|Sleep Apnea|sleep apnea
1732265|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
1732266|NCT00001723|Type 2 Diabetes|type 2 diabetes
1732267|NCT00001723|Obesity|obesity
1732268|NCT00001723|Childhood Obesity|childhood obesity
1732269|NCT00001722|Obesity|obesity
1732270|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
1732271|NCT00001722|Fat Tissue|fat tissue
1732272|NCT00001722|Metabolism|metabolism
1732273|NCT00001722|Adipose Tissue|adipose tissue
1732274|NCT00001722|Microdialysis|microdialysis
1732275|NCT00001722|Leptin|leptin
1732276|NCT00001722|Lipolysis|lipolysis
1732277|NCT00001722|Normal Volunteer|normal volunteer
1732278|NCT00001721|Dysmorphology|dysmorphology
1732279|NCT00001721|Cholesterol|cholesterol
1732280|NCT00001721|Endocrine|endocrine
1732281|NCT00001721|MRI|mri
1732282|NCT00001721|Demyelination|demyelination
1732283|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
1732284|NCT00001720|Glucocorticoids|glucocorticoids
1732285|NCT00001720|Bone Mineral Density|bone mineral density
1732286|NCT00001720|Bisphosphonates|bisphosphonates
1732287|NCT00001720|Vertebral Fracture|vertebral fracture
1732288|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
1732289|NCT00001719|Blood Flow|blood flow
1732290|NCT00001719|Hepatic Disease|hepatic disease
1732291|NCT00001719|Liver|liver
1732292|NCT00001719|Modeling|modeling
1732293|NCT00001719|Rheology|rheology
1732294|NCT00001719|Normal Volunteer|normal volunteer
1732295|NCT00001716|Hemoglobin|hemoglobin
1732296|NCT00001716|P50|p50
1732297|NCT00001716|Microvascular|microvascular
1732298|NCT00001716|Perfusion|perfusion
1732299|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
1732300|NCT00001716|Sickle Cell Anemia|sickle cell anemia
1732308|NCT00001713|Catheter Directed|catheter directed
1732309|NCT00001713|Thrombolysis|thrombolysis
1732310|NCT00001713|Anticoagulation|anticoagulation
1732311|NCT00001713|Emboli|emboli
1732312|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
1732313|NCT00001713|TPA|tpa
1732314|NCT00001713|DVT|dvt
1732315|NCT00001712|Healthcare Worker|healthcare worker
1732316|NCT00001712|Bloodborne Diseases|bloodborne diseases
1732317|NCT00001712|Hepatitis B|hepatitis b
1732318|NCT00001712|Hepatitis C|hepatitis c
1732319|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
1732320|NCT00001712|Parenteral Exposure|parenteral exposure
1732321|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
1732322|NCT00001712|Blood and Body Substances|blood and body substances
1732323|NCT00001712|Universal Precautions|universal precautions
1732324|NCT00001712|HIV Seronegativity|hiv seronegativity
1732325|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
1732326|NCT00001711|Gadolinium|gadolinium
1732327|NCT00001711|Magnetic Resonance Angiography|magnetic resonance angiography
1732328|NCT00001711|Normal Volunteer|normal volunteer
1732329|NCT00001703|Immunotherapy|immunotherapy
1732330|NCT00001703|Kidney|kidney
1732331|NCT00001703|Genes|genes
1732332|NCT00001703|Vaccine Therapy|vaccine therapy
1732333|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
1732334|NCT00001702|Genetic|genetic
1732335|NCT00001702|Variant Alleles|variant alleles
1732336|NCT00001702|Risk Factor|risk factor
1732337|NCT00001702|Cancer|cancer
1732338|NCT00001702|Transplantation|transplantation
1732339|NCT00001701|Risk Factor|risk factor
1732340|NCT00001701|Genetic|genetic
1732341|NCT00001701|Variant Alleles|variant alleles
1732342|NCT00001701|Cancer|cancer
1732343|NCT00001701|Transplantation|transplantation
1732344|NCT00001698|Chemoprevention|chemoprevention
1732345|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
1732346|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
1732347|NCT00001698|Field Cancerization|field cancerization
1732348|NCT00001695|Complementary Medicine|complementary medicine
1732349|NCT00001695|Unproven Treatments|unproven treatments
1732350|NCT00001695|Herbal|herbal
1732351|NCT00001693|Chemoprevention|chemoprevention
1732352|NCT00001693|Biomarkers|biomarkers
1732353|NCT00001693|Endoscopy|endoscopy
1732354|NCT00001693|Colorectal|colorectal
1732355|NCT00001693|Celecoxib|celecoxib
1732356|NCT00001689|Neurotoxicity|neurotoxicity
1732357|NCT00001689|A.L.L.|a.l.l.
1732358|NCT00001689|Limited Sampling|limited sampling
1732359|NCT00001689|Dose Individualization|dose individualization
1732360|NCT00001689|Vinca Alkaloids|vinca alkaloids
1732361|NCT00001686|Leukemia|leukemia
1732362|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
1732363|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
1732364|NCT00001686|Lymphoma, Osteosarcoma|lymphoma, osteosarcoma
1732365|NCT00001686|Brain Tumors, Rhabdomyosarcoma|brain tumors, rhabdomyosarcoma
1732366|NCT00001686|Lymphoma|lymphoma
1732367|NCT00001686|Neoplasm|neoplasm
1732368|NCT00001686|Sarcoma|sarcoma
1732369|NCT00001683|Collagen Breakdown|collagen breakdown
1732370|NCT00001683|Pharmacokinetics|pharmacokinetics
1732371|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
1732372|NCT00001683|Angiogenesis|angiogenesis
1732373|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
1732374|NCT00001678|Autoimmunity|autoimmunity
1732375|NCT00001678|Sibling Pairs|sibling pairs
1732376|NCT00001678|Genes|genes
1732377|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
1732378|NCT00001678|Bone Erosion|bone erosion
1732379|NCT00001676|Remission|remission
1732380|NCT00001676|Renal Function|renal function
1732381|NCT00001676|Infection|infection
1732382|NCT00001676|Germinal Center|germinal center
1732383|NCT00001676|Immunoglobulin|immunoglobulin
1732384|NCT00001676|Glomerulonephritis|glomerulonephritis
1732385|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
1732386|NCT00001676|Lupus Nephritis|lupus nephritis
1732387|NCT00001671|White Matter|white matter
1732388|NCT00001671|Myelin|myelin
1732389|NCT00001671|Degenerative Diseases|degenerative diseases
1732390|NCT00001671|Genetic|genetic
1732391|NCT00001671|Oligodendrocytes|oligodendrocytes
1732392|NCT00001671|Leukodystrophy|leukodystrophy
1732393|NCT00001666|Seizures|seizures
1732394|NCT00001666|Partial Epilepsy|partial epilepsy
1732395|NCT00001666|Intractable|intractable
1732397|NCT00001664|Narcolepsy|narcolepsy
1732398|NCT00001664|Polysomnography|polysomnography
1732399|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
1732400|NCT00001664|Sleep Disorders|sleep disorders
1732401|NCT00001664|Hypersomnia|hypersomnia
1732402|NCT00001664|Periodic Leg Movements|periodic leg movements
1732403|NCT00001663|Neurological Disorders|neurological disorders
1732404|NCT00001663|Movement Disorders|movement disorders
1732405|NCT00001663|Physiology|physiology
1732406|NCT00001663|Noninvasive|noninvasive
1732407|NCT00001663|Brain Stimulation|brain stimulation
1732408|NCT00001663|Cortical Myoclonus|cortical myoclonus
1732409|NCT00001662|Dementia|dementia
1732410|NCT00001662|Glutamate|glutamate
1732411|NCT00001662|Clinical Trial|clinical trial
1732412|NCT00001662|Neurotransmitter|neurotransmitter
1732413|NCT00001662|Alzheimer's Disease|alzheimer's disease
1732414|NCT00001661|Plasticity|plasticity
1732415|NCT00001661|Use|use
1732416|NCT00001661|Stroke|stroke
1732417|NCT00001661|Spinal Cord Injury|spinal cord injury
1732418|NCT00001661|Amputation|amputation
1732419|NCT00001661|Intracortical Inhibition|intracortical inhibition
1732420|NCT00001659|Bereavement|bereavement
1732421|NCT00001659|Depression|depression
1732422|NCT00001659|Suicide|suicide
1732423|NCT00001659|Activity of Daily Living|activity of daily living
1732424|NCT00001659|Immune Function|immune function
1732425|NCT00001659|Occupational Performance|occupational performance
1732426|NCT00001659|Sleep Disorders|sleep disorders
1732427|NCT00001659|Mood Changes|mood changes
1732428|NCT00001656|Clozapine|clozapine
1732429|NCT00001656|Olanzapine|olanzapine
1732430|NCT00001656|Drug Response|drug response
1732431|NCT00001656|Safety|safety
1732432|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
1732433|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
1732434|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
1732435|NCT00001656|Phenomenology|phenomenology
1732436|NCT00001656|Biochemical Correlates|biochemical correlates
1732437|NCT00001656|Brain Imaging|brain imaging
1732438|NCT00001656|Schizophrenia|schizophrenia
1732439|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
1732440|NCT00001656|Psychosis|psychosis
1732441|NCT00001654|Adolescence|adolescence
1732442|NCT00001654|Comorbid Disorders|comorbid disorders
1732443|NCT00001654|Physiology|physiology
1732444|NCT00001654|Socialization|socialization
1732445|NCT00001654|Gender|gender
1732446|NCT00001654|Conduct Problems|conduct problems
1732447|NCT00001654|Anxiety|anxiety
1732448|NCT00001654|Sadness|sadness
1732449|NCT00001654|Emotion|emotion
1732450|NCT00001654|Psychophysiology|psychophysiology
1732451|NCT00001652|Life-Charting|life-charting
1732452|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
1732453|NCT00001652|Diagnostic Tests|diagnostic tests
1732454|NCT00001652|Cognitive Testing|cognitive testing
1732455|NCT00001652|Course of Illness|course of illness
1732456|NCT00001652|Bipolar Disorder|bipolar disorder
1732457|NCT00001651|Deuterium|deuterium
1732458|NCT00001651|HIV|hiv
1732459|NCT00001651|Labeling|labeling
1732460|NCT00001651|CD4 Cells|cd4 cells
1732461|NCT00001651|Immunodeficiency|immunodeficiency
1732462|NCT00001650|BrDU|brdu
1732463|NCT00001650|HIV|hiv
1732464|NCT00001650|Labeling|labeling
1732465|NCT00001650|CD4 Cells|cd4 cells
1732466|NCT00001650|Immunodeficiency|immunodeficiency
1732467|NCT00001649|Clinical Trial|clinical trial
1732468|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
1732469|NCT00001649|Phase III|phase iii
1732470|NCT00001649|HSV|hsv
1732471|NCT00001649|Valtrex|valtrex
1732472|NCT00001649|Valaciclovir|valaciclovir
1732473|NCT00001649|HS2A/B3009|hs2a/b3009
1732474|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
1732475|NCT00001649|Heterosexual Couples|heterosexual couples
1732476|NCT00001648|HVEM Gene|hvem gene
1732477|NCT00001648|HSV|hsv
1732478|NCT00001648|Herpes Simplex Virus|herpes simplex virus
1732479|NCT00001647|AIDS|aids
1732480|NCT00001647|Immunotherapy|immunotherapy
1732481|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
1732482|NCT00001647|T Cell Repertoire|t cell repertoire
1732483|NCT00001647|Identical Twins|identical twins
1732484|NCT00001645|Chagas' Disease|chagas' disease
1732485|NCT00001645|Trypanosomiasis|trypanosomiasis
1732486|NCT00001645|Malaria|malaria
1732487|NCT00001645|Parasitic Infection|parasitic infection
1732488|NCT00001644|Immunodeficiency|immunodeficiency
1732489|NCT00001644|Latency|latency
1732490|NCT00001644|T Cell Turnover|t cell turnover
1732491|NCT00001644|Infected Cell Turnover|infected cell turnover
1732492|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
1732493|NCT00001643|Lewy Body|lewy body
1732494|NCT00001643|Mutation|mutation
1732495|NCT00001643|Hereditary|hereditary
1732496|NCT00001643|Dominant|dominant
1732497|NCT00001643|Sporadic|sporadic
1732498|NCT00001643|Parkinson's Disease|parkinson's disease
1732499|NCT00001641|Fibrillin|fibrillin
1732500|NCT00001641|Collagen|collagen
1732501|NCT00001641|Marfan Syndrome|marfan syndrome
1732502|NCT00001641|Stickler Syndrome|stickler syndrome
1732503|NCT00001641|Aortic Dissection|aortic dissection
1732504|NCT00001641|Ehlers-Danlos|ehlers-danlos
1732505|NCT00001641|Connective Tissue Disorders|connective tissue disorders
1732506|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
1732507|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
1732508|NCT00001640|Parkinson's Disease|parkinson's disease
1732509|NCT00001638|Echocardiography|echocardiography
1732510|NCT00001638|Heart|heart
1732511|NCT00001638|Gadolinium|gadolinium
1732512|NCT00001638|Dobutamine|dobutamine
1732513|NCT00001638|Toxicity|toxicity
1732514|NCT00001638|Adverse Events|adverse events
1732515|NCT00001638|Myocardial Infarction|myocardial infarction
1732516|NCT00001638|Myocardial Viability|myocardial viability
1732531|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
1732532|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
1732533|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
1732534|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
1732535|NCT00001632|Hypertrophy|hypertrophy
1732536|NCT00001632|Integrated|integrated
1732537|NCT00001632|Backscatter|backscatter
1732538|NCT00001632|Cyclic|cyclic
1732539|NCT00001632|Echocardiography|echocardiography
1732540|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1732541|NCT00001631|Gadolinium|gadolinium
1732542|NCT00001631|Ischemia|ischemia
1732543|NCT00001631|Coronary Artery Disease|coronary artery disease
1732773|NCT00001568|Tumors|tumors
1732544|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1732545|NCT00001631|Dipyridamole|dipyridamole
1732546|NCT00001630|Immunosuppression|immunosuppression
1732547|NCT00001630|Thrombocytopenia|thrombocytopenia
1732548|NCT00001630|Autoimmune Disease|autoimmune disease
1732549|NCT00001630|Evan's Syndrome|evan's syndrome
1732550|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
1732551|NCT00001630|Episodic Bleeding|episodic bleeding
1732552|NCT00001627|Bone Marrow|bone marrow
1732553|NCT00001627|Hematopoiesis|hematopoiesis
1732554|NCT00001627|DNA|dna
1732555|NCT00001627|RNA|rna
1732556|NCT00001627|Viruses|viruses
1732557|NCT00001627|Normal Volunteer|normal volunteer
1732558|NCT00001627|Aplastic Anemia|aplastic anemia
1732559|NCT00001627|Myelodysplasia|myelodysplasia
1732560|NCT00001627|Fanconi's Anemia|fanconi's anemia
1732561|NCT00001627|Single Lineage Cytopenia|single lineage cytopenia
1732562|NCT00001626|Cytopenia|cytopenia
1732563|NCT00001626|Randomized|randomized
1732564|NCT00001626|Immunosuppression|immunosuppression
1732565|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
1732566|NCT00001625|Insulin Resistance|insulin resistance
1732567|NCT00001625|Obesity|obesity
1732568|NCT00001625|Hypertension|hypertension
1732569|NCT00001625|Diabetes|diabetes
1732570|NCT00001625|Mathematical Modeling|mathematical modeling
1732571|NCT00001625|Normal Volunteer|normal volunteer
1732586|NCT00001621|Teaching|teaching
1732587|NCT00001621|Pulmonary Disease|pulmonary disease
1732588|NCT00001621|Routine Testing|routine testing
1732589|NCT00001621|Medically Indicated|medically indicated
1732590|NCT00001621|Pulmonary Function Test|pulmonary function test
1732591|NCT00001620|Thrombocytopenia|thrombocytopenia
1732592|NCT00001620|Anemia|anemia
1732593|NCT00001620|Neutropenia|neutropenia
1732594|NCT00001620|Dysplasia|dysplasia
1732595|NCT00001620|Cytopenia|cytopenia
1732596|NCT00001620|Hematologic Malignancy|hematologic malignancy
1732597|NCT00001619|Imaging|imaging
1732598|NCT00001619|Spectroscopy|spectroscopy
1732600|NCT00001619|Cardiovascular|cardiovascular
1732601|NCT00001619|Technical Development|technical development
1732602|NCT00001619|Heart|heart
1732603|NCT00001619|Safety|safety
1732604|NCT00001619|Toxicity|toxicity
1732605|NCT00001619|Gadolinium|gadolinium
1732606|NCT00001619|Adverse Events|adverse events
1732607|NCT00001619|Normal Volunteer|normal volunteer
1732608|NCT00001618|Cystic Fibrosis|cystic fibrosis
1732609|NCT00001618|Healthy Volunteers|healthy volunteers
1732610|NCT00001618|Asthma|asthma
1732611|NCT00001618|Normal Volunteer|normal volunteer
1732612|NCT00001618|Chronic Lung Disease|chronic lung disease
1732613|NCT00001613|Cataract Surgery|cataract surgery
1732614|NCT00001613|Human Lens|human lens
1732615|NCT00001613|Crystallins|crystallins
1732616|NCT00001613|Post-Translational|post-translational
1732617|NCT00001613|Protein Modification|protein modification
1732618|NCT00001613|Nuclear Cataract|nuclear cataract
1732619|NCT00001613|Cataract Extraction|cataract extraction
1732620|NCT00001611|AIDS|aids
1732621|NCT00001611|Eye|eye
1732622|NCT00001611|Treatment|treatment
1732623|NCT00001611|Opportunistic Infection|opportunistic infection
1732624|NCT00001611|Immunology|immunology
1732625|NCT00001611|Retinitis|retinitis
1732626|NCT00001610|Standing Potential|standing potential
1732627|NCT00001610|Fast Oscillation|fast oscillation
1732628|NCT00001610|Slow Oscillation|slow oscillation
1732629|NCT00001610|Retinal Pigment|retinal pigment
1732630|NCT00001610|Epithelium|epithelium
1732631|NCT00001610|Electro-oculogram|electro-oculogram
1732632|NCT00001610|Cellular Immune Response|cellular immune response
1732633|NCT00001610|Retinal Antigens|retinal antigens
1732634|NCT00001610|IRBP|irbp
1732635|NCT00001610|S-Antigen|s-antigen
1732636|NCT00001610|Normal Volunteer|normal volunteer
1732637|NCT00001609|Linkage|linkage
1732638|NCT00001609|Genetic Analysis|genetic analysis
1732639|NCT00001609|Lens|lens
1732640|NCT00001609|Opacity|opacity
1732641|NCT00001609|Inherited|inherited
1732642|NCT00001609|Linkage Analysis|linkage analysis
1732643|NCT00001609|Genomic DNA|genomic dna
1732644|NCT00001609|Risk Prediction|risk prediction
1732645|NCT00001609|Pedigree Analysis|pedigree analysis
1732646|NCT00001609|Congenital Cataracts|congenital cataracts
1732647|NCT00001609|Hereditary Cataracts|hereditary cataracts
1732648|NCT00001606|Linkage Analysis|linkage analysis
1732649|NCT00001606|Positional Cloning|positional cloning
1732650|NCT00001606|Mutation Screening|mutation screening
1732651|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
1732652|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
1732653|NCT00001604|DNA Samples|dna samples
1732654|NCT00001604|Buccal Swab|buccal swab
1732655|NCT00001604|Genotyping|genotyping
1732656|NCT00001604|Statistical Analysis|statistical analysis
1732657|NCT00001604|Computers|computers
1732658|NCT00001604|Stuttering|stuttering
1732659|NCT00001603|Cytokines|cytokines
1732660|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
1732661|NCT00001603|Papilloma|papilloma
1732662|NCT00001603|Communication|communication
1732663|NCT00001603|Immunity|immunity
1732664|NCT00001603|Head|head
1732666|NCT00001603|Head and Neck Cancer|head and neck cancer
1732667|NCT00001602|Dysfluency|dysfluency
1732668|NCT00001602|Polymorphism|polymorphism
1732669|NCT00001602|Stuttering|stuttering
1732670|NCT00001602|Dopamine|dopamine
1732671|NCT00001602|Family Studies|family studies
1732672|NCT00001602|Receptors|receptors
1732673|NCT00001602|Serotonin|serotonin
1732674|NCT00001602|Enzymes|enzymes
1732675|NCT00001602|Genetics|genetics
1732676|NCT00001602|Linkage Analysis|linkage analysis
1732677|NCT00001601|Oral Medicine|oral medicine
1732678|NCT00001601|Clinical Experience|clinical experience
1732679|NCT00001601|Therapy|therapy
1732680|NCT00001601|Educational Training|educational training
1732681|NCT00001601|Pathogenesis|pathogenesis
1732682|NCT00001601|Oral Lesions|oral lesions
1732683|NCT00001601|Aphthous Ulcers|aphthous ulcers
1732684|NCT00001601|Lichen Planus|lichen planus
1732685|NCT00001601|Burning Mouth|burning mouth
1732686|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
1732687|NCT00001601|Oral Disease|oral disease
1732688|NCT00001601|Oral Manifestations|oral manifestations
1732689|NCT00001600|Screening Protocol|screening protocol
1732690|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
1732691|NCT00001600|Oral Surgery|oral surgery
1732692|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
1732693|NCT00001599|Xerostomia|xerostomia
1732694|NCT00001599|Autoimmunity|autoimmunity
1732695|NCT00001599|Salivary Glands|salivary glands
1732696|NCT00001599|Lacrimal Function|lacrimal function
1732697|NCT00001599|Immunomodulator|immunomodulator
1732698|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
1732699|NCT00001599|Dry Mouth|dry mouth
1732700|NCT00001598|Xerostomia|xerostomia
1732701|NCT00001598|Autoimmunity|autoimmunity
1732702|NCT00001598|Salivary Glands|salivary glands
1732703|NCT00001598|Androgen Therapy|androgen therapy
1732704|NCT00001598|Lacrimal Function|lacrimal function
1732705|NCT00001598|DHEA|dhea
1732706|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
1732707|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
1732708|NCT00001597|Psychophysics|psychophysics
1732709|NCT00001597|Validation|validation
1732710|NCT00001597|Fentanyl|fentanyl
1732711|NCT00001597|Normal Volunteer|normal volunteer
1732712|NCT00001597|Pain|pain
1732713|NCT00001596|Albinism|albinism
1732714|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
1732715|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
1732716|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
1732717|NCT00001595|Oncogenesis|oncogenesis
1732718|NCT00001595|Adenoma|adenoma
1732719|NCT00001595|Craniopharyngioma|craniopharyngioma
1732725|NCT00001594|Basilar Invagination|basilar invagination
1732726|NCT00001591|Central Nervous System|central nervous system
1732727|NCT00001591|Technical Development|technical development
1732728|NCT00001591|Activation Studies|activation studies
1732729|NCT00001591|Pulse Sequences|pulse sequences
1732730|NCT00001591|Metabolites|metabolites
1732731|NCT00001591|Normal Volunteer|normal volunteer
1732732|NCT00001589|Ferritin|ferritin
1732733|NCT00001589|Atherosclerosis|atherosclerosis
1732734|NCT00001589|Myocardial Infarction|myocardial infarction
1732735|NCT00001589|Blood Donors|blood donors
1732736|NCT00001589|Low Density Lipoprotein|low density lipoprotein
1732737|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
1732738|NCT00001586|Genetics|genetics
1732739|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
1732740|NCT00001586|Immunosuppression|immunosuppression
1732741|NCT00001586|T Lymphocytes|t lymphocytes
1732742|NCT00001586|Marrow Purging|marrow purging
1732743|NCT00001582|Autoimmune Disorder|autoimmune disorder
1732744|NCT00001582|Immune System Evaluation|immune system evaluation
1732745|NCT00001582|Human Response Investigation|human response investigation
1732746|NCT00001582|Tissue Acquisition|tissue acquisition
1732747|NCT00001580|Molecular Diagnostics|molecular diagnostics
1732748|NCT00001580|Ovary|ovary
1732749|NCT00001580|Tissue Acquisition|tissue acquisition
1732750|NCT00001580|cDNA Library|cdna library
1732751|NCT00001580|CGAP|cgap
1732752|NCT00001576|Regional Therapy|regional therapy
1732753|NCT00001576|Organ Perfusion|organ perfusion
1732754|NCT00001576|Metastases|metastases
1732755|NCT00001576|Hyperthermia|hyperthermia
1732756|NCT00001575|Yttrium 90|yttrium 90
1732757|NCT00001575|Radiolabeled|radiolabeled
1732758|NCT00001575|Anti -Tac|anti -tac
1732759|NCT00001575|Calcium DTPA|calcium dtpa
1732760|NCT00001574|Metabolites|metabolites
1732761|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
1732762|NCT00001574|Scans|scans
1732763|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
1732764|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
1732765|NCT00001572|Immunization|immunization
1732766|NCT00001572|Induction Chemotherapy|induction chemotherapy
1732767|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
1732768|NCT00001572|Follicular Lymphoma|follicular lymphoma
1732769|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
1732770|NCT00001569|Gastrointestinal|gastrointestinal
1732771|NCT00001569|Adenocarcinoma|adenocarcinoma
1732774|NCT00001568|Detection|detection
1732775|NCT00001568|Follow-Up|follow-up
1732776|NCT00001568|Markers|markers
1732777|NCT00001568|Radiolabeled|radiolabeled
1732778|NCT00001567|Follow-Up Study|follow-up study
1732779|NCT00001567|Relapse-Free Survival|relapse-free survival
1732780|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
1732781|NCT00001567|Hematologic Malignancy|hematologic malignancy
1732782|NCT00001567|Chronic Therapy|chronic therapy
1732783|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
1732784|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
1732785|NCT00001566|Immunotherapy|immunotherapy
1732786|NCT00001566|Tumor Vaccine|tumor vaccine
1732787|NCT00001566|Interleukin-2|interleukin-2
1732788|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
1732789|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
1732790|NCT00001564|Immunotherapy|immunotherapy
1732791|NCT00001564|Tumor Vaccine|tumor vaccine
1732792|NCT00001564|Fusion Protein|fusion protein
1732797|NCT00001561|Multiple Myeloma|multiple myeloma
1732798|NCT00001561|Vaccine|vaccine
1732799|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
1732800|NCT00001561|Immune Transfer|immune transfer
1732801|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
1732802|NCT00001560|AIDS|aids
1732803|NCT00001560|Multidisciplinary|multidisciplinary
1732804|NCT00001560|Leukemia|leukemia
1732805|NCT00001560|Lymphoma|lymphoma
1732806|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
1732807|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
1732808|NCT00001552|Pedigree|pedigree
1732809|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
1732810|NCT00001552|Voice Disorder|voice disorder
1732811|NCT00001551|Stuttering|stuttering
1732812|NCT00001551|Linkage|linkage
1732813|NCT00001551|Pedigree|pedigree
1732814|NCT00001551|Speech Articulation|speech articulation
1732815|NCT00001551|Phonological Processing Disorders|phonological processing disorders
1732816|NCT00001551|Speech Disorder|speech disorder
1732817|NCT00001550|Immunotherapy|immunotherapy
1732818|NCT00001550|Muscle Stiffness|muscle stiffness
1732824|NCT00001549|Movement Disorders|movement disorders
1732825|NCT00001549|Parkinson's|parkinson's
1732826|NCT00001549|Alzheimer's|alzheimer's
1732827|NCT00001549|Screening|screening
1732828|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
1732829|NCT00001549|Alzheimer Disease|alzheimer disease
1732830|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
1732832|NCT00001549|Restless Leg Syndrome|restless leg syndrome
1732833|NCT00001549|RLS|rls
1732834|NCT00001549|Parkinsonism|parkinsonism
1732835|NCT00001549|PD|pd
1732836|NCT00001548|Genetic|genetic
1732837|NCT00001548|Psychiatric Disorder|psychiatric disorder
1732838|NCT00001548|Affected Sib Pairs|affected sib pairs
1732839|NCT00001548|Obsessions|obsessions
1732840|NCT00001548|Compulsions|compulsions
1732841|NCT00001548|Family Study|family study
1732842|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
1732843|NCT00001548|Trichotillomania|trichotillomania
1732844|NCT00001548|Tourette's Syndrome|tourette's syndrome
1732845|NCT00001547|Drug|drug
1732846|NCT00001547|Imaging|imaging
1732847|NCT00001547|Brain|brain
1732848|NCT00001547|Metabolism|metabolism
1732849|NCT00001547|Organic Mental Syndrome|organic mental syndrome
1732850|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
1732851|NCT00001547|Spectroscopy|spectroscopy
1732852|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
1732853|NCT00001547|Drug Effects|drug effects
1732854|NCT00001547|Interferon-alpha|interferon-alpha
1732855|NCT00001545|Affective Disorders|affective disorders
1732856|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
1732857|NCT00001545|Mania|mania
1732858|NCT00001545|Bipolar Disorder|bipolar disorder
1732859|NCT00001545|Depression|depression
1732860|NCT00001545|Unipolar Disorder|unipolar disorder
1732861|NCT00001545|Unipolar Depression|unipolar depression
1732862|NCT00001544|DNA Probes|dna probes
1732863|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
1732864|NCT00001544|Family Studies|family studies
1732865|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
1732866|NCT00001544|Genotyping|genotyping
1732867|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
1732868|NCT00001544|Schizophrenia|schizophrenia
1732869|NCT00001544|Mental Retardation|mental retardation
1732870|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
1732871|NCT00001543|Major Depression|major depression
1732872|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
1732873|NCT00001543|Pulsatility|pulsatility
1732874|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
1732875|NCT00001543|Cortisol|cortisol
1732876|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
1732877|NCT00001543|Pharmacokinetics|pharmacokinetics
1732878|NCT00001543|Half-Life|half-life
1732879|NCT00001543|Bioavailability|bioavailability
1732880|NCT00001543|Cushing's Syndrome|cushing's syndrome
1732881|NCT00001541|Vasculitis|vasculitis
1732882|NCT00001541|Inflammation|inflammation
1732883|NCT00001541|Bronchoscopy|bronchoscopy
1732884|NCT00001541|Cytokines|cytokines
1732885|NCT00001541|Inflammatory Mediators|inflammatory mediators
1732886|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
1732887|NCT00001539|Central Nervous System|central nervous system
1732888|NCT00001539|Lyme Disease|lyme disease
1732889|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
1732890|NCT00001539|Neuroborreliosis|neuroborreliosis
1732891|NCT00001539|Chronic Symptoms|chronic symptoms
1732892|NCT00001535|Intracellular Immunization|intracellular immunization
1732893|NCT00001535|Immune Based Therapy|immune based therapy
1732894|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
1732895|NCT00001535|Identical Twins|identical twins
1732896|NCT00001535|HIV/AIDS|hiv/aids
1732897|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
1732898|NCT00001534|Genetics|genetics
1732899|NCT00001534|Myocardial Ischemia|myocardial ischemia
1732900|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
1732901|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
1732902|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1732903|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
1732904|NCT00001532|Genetic Polymorphism|genetic polymorphism
1732905|NCT00001532|Nitric Oxide Synthase|nitric oxide synthase
1732906|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
1732907|NCT00001532|Candidate Genes|candidate genes
1732908|NCT00001532|Lung Pathology|lung pathology
1732909|NCT00001532|Asthma|asthma
1732910|NCT00001532|Lung Disease|lung disease
1732911|NCT00001532|Cystic Fibrosis|cystic fibrosis
1732922|NCT00001526|Daclizumab|daclizumab
1732923|NCT00001526|HAT|hat
1732924|NCT00001526|Zenapax|zenapax
1732925|NCT00001526|Interleukin 2|interleukin 2
1732926|NCT00001524|Thalidomide|thalidomide
1732927|NCT00001524|Clinical Trial|clinical trial
1732928|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
1732929|NCT00001524|Delayed Healing|delayed healing
1732930|NCT00001524|Painful Oral Lesions|painful oral lesions
1732931|NCT00001524|HIV/AIDS|hiv/aids
1732932|NCT00001524|Mouth Ulcers|mouth ulcers
1732933|NCT00001524|Aphthous Ulcers|aphthous ulcers
1732934|NCT00001524|Healing|healing
1732935|NCT00001524|Cytokines|cytokines
1732936|NCT00001522|Insulin Resistance|insulin resistance
1732937|NCT00001522|Race|race
1732938|NCT00001522|Body Fat|body fat
1732939|NCT00001522|Body Composition|body composition
1732940|NCT00001522|Obesity|obesity
1732941|NCT00001521|21-Hydroxylase Deficiency|21-hydroxylase deficiency
1732942|NCT00001521|11-Hydroxylase Deficiency|11-hydroxylase deficiency
1732943|NCT00001521|Antiandrogen|antiandrogen
1732944|NCT00001521|Aromatase Inhibitor|aromatase inhibitor
1732945|NCT00001521|Growth Disorder|growth disorder
1732946|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
1732947|NCT00001516|Case Study Design|case study design
1732948|NCT00001516|Rehabilitation|rehabilitation
1732949|NCT00001516|Treatment Efficacy|treatment efficacy
1732950|NCT00001516|Occupational Therapy Process|occupational therapy process
1732951|NCT00001516|Reflection|reflection
1732952|NCT00001516|Occupational Therapy|occupational therapy
1732953|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
1732954|NCT00001515|Computer Assisted Visualization|computer assisted visualization
1732955|NCT00001515|Lung Cavities|lung cavities
1732956|NCT00001515|Endobronchial Lesions|endobronchial lesions
1732957|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
1732958|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
1732959|NCT00001512|ProMace Chemotherapy|promace chemotherapy
1732960|NCT00001512|Indolent Lymphoma|indolent lymphoma
1732961|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
1732963|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
1732964|NCT00001507|T-cells|t-cells
1732965|NCT00001507|CD34+ Selection|cd34+ selection
1732966|NCT00001507|T-Cell Depletion|t-cell depletion
1732967|NCT00001507|Apheresis|apheresis
1732968|NCT00001507|Mobilization|mobilization
1732969|NCT00001506|Training Protocol|training protocol
1732970|NCT00001506|Natural History|natural history
1732971|NCT00001506|Consultation|consultation
1732972|NCT00001506|Standard Therapy|standard therapy
1732973|NCT00001506|Standard Tests|standard tests
1732974|NCT00001506|Training|training
1732975|NCT00001505|Biopsy|biopsy
1732976|NCT00001505|Research|research
1732977|NCT00001505|Autoimmune|autoimmune
1732978|NCT00001505|Blistering|blistering
1732979|NCT00001505|Compensation|compensation
1732980|NCT00001504|Retinoids|retinoids
1732981|NCT00001504|Biomarkers|biomarkers
1732982|NCT00001503|Cancer|cancer
1732983|NCT00001503|Late Effects|late effects
1732984|NCT00001503|Survival|survival
1732985|NCT00001503|Follow-Up|follow-up
1732986|NCT00001500|Smoking|smoking
1732987|NCT00001500|Alcohol|alcohol
1732988|NCT00001500|HIV|hiv
1732989|NCT00001500|AIDS|aids
1732990|NCT00001500|DNA Markers|dna markers
1732991|NCT00001500|Personality|personality
1732992|NCT00001500|Healthy Volunteers|healthy volunteers
1732993|NCT00001500|Normal Volunteer|normal volunteer
1732994|NCT00001496|BRCA-1|brca-1
1732995|NCT00001496|Familial Breast Cancer|familial breast cancer
1732996|NCT00001496|Breast Cell Culture|breast cell culture
1732997|NCT00001496|High Risk|high risk
1732998|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
1732999|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
1733000|NCT00001491|Nerve Conduction Studies|nerve conduction studies
1733001|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
1733002|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
1733003|NCT00001491|Fabry Disease|fabry disease
1733004|NCT00001491|Fabrys|fabrys
1733005|NCT00001491|Fabry's|fabry's
1733006|NCT00001487|Menopause|menopause
1733007|NCT00001487|Andropause|andropause
1733008|NCT00001487|Depression|depression
1733009|NCT00001487|DHEA|dhea
1733010|NCT00001487|Steroids|steroids
1733011|NCT00001487|Mid-Life Depression|mid-life depression
1733012|NCT00001487|Mid Life|mid life
1733013|NCT00001487|Perimenopause|perimenopause
1733014|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
1733015|NCT00001486|Paranoia|paranoia
1733016|NCT00001486|Schizophrenic Research|schizophrenic research
1733017|NCT00001486|Hallucinations|hallucinations
1733018|NCT00001486|Delusions|delusions
1733019|NCT00001486|Brain Scans|brain scans
1733020|NCT00001486|Negative Symptoms|negative symptoms
1733021|NCT00001486|Symptoms of Schizophrenia|symptoms of schizophrenia
1733022|NCT00001486|Causes of Schizophrenia|causes of schizophrenia
1733036|NCT00001483|Bupropion|bupropion
1733037|NCT00001483|Sertraline|sertraline
1733038|NCT00001481|Postpartum Disorders|postpartum disorders
1733039|NCT00001481|Depression|depression
1733041|NCT00001481|Postpartum Depression|postpartum depression
1733042|NCT00001481|Hormones|hormones
1733043|NCT00001481|Pregnancy|pregnancy
1733044|NCT00001481|Estrogen|estrogen
1733045|NCT00001481|Progesterone|progesterone
1733046|NCT00001481|Gonadal Steroids|gonadal steroids
1733047|NCT00001481|GnRH Agonist|gnrh agonist
1733048|NCT00001481|Postpartum|postpartum
1733049|NCT00001481|Mood Disorder|mood disorder
1733050|NCT00001480|Dementia|dementia
1733051|NCT00001480|Alzheimer's Disease|alzheimer's disease
1733052|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
1733053|NCT00001480|Diagnostic Test|diagnostic test
1733054|NCT00001480|Cognitive Testing|cognitive testing
1733055|NCT00001480|Memory Disorder|memory disorder
1733056|NCT00001480|Normal Volunteer|normal volunteer
1733057|NCT00001476|CD34+ Progenitor|cd34+ progenitor
1733058|NCT00001476|Retrovirus|retrovirus
1733059|NCT00001476|Leukapheresis|leukapheresis
1733060|NCT00001476|Transduction|transduction
1733061|NCT00001476|Granulocytes|granulocytes
1733062|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
1733063|NCT00001475|AIDS|aids
1733064|NCT00001475|Cytokines|cytokines
1733065|NCT00001475|Thalidomide|thalidomide
1733066|NCT00001475|Monoclonal Antibody|monoclonal antibody
1733067|NCT00001475|Immunomodulator|immunomodulator
1733068|NCT00001474|Cytokines|cytokines
1733069|NCT00001474|Immunoregulation|immunoregulation
1733070|NCT00001474|Infusion Duration|infusion duration
1733071|NCT00001474|CD4 Cells|cd4 cells
1733072|NCT00001473|Vasculitis|vasculitis
1733073|NCT00001473|Remission|remission
1733074|NCT00001473|Relapse|relapse
1733075|NCT00001473|Toxicity|toxicity
1733076|NCT00001473|ANCA|anca
1733077|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
1733078|NCT00001471|AIDS|aids
1733080|NCT00001471|Retrovirus|retrovirus
1733081|NCT00001471|Therapy|therapy
1733082|NCT00001471|Response|response
1733083|NCT00001469|Cancer Susceptibility Alleles|cancer susceptibility alleles
1733084|NCT00001469|Prostate Cancer|prostate cancer
1733085|NCT00001469|Cancer Genetics|cancer genetics
1733086|NCT00001469|Cancer|cancer
1733087|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
1733088|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
1733089|NCT00001467|Immunologic Disorders|immunologic disorders
1733090|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
1733091|NCT00001465|Bronchoscopy|bronchoscopy
1733092|NCT00001465|Female|female
1733093|NCT00001465|Pneumothorax|pneumothorax
1733094|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
1733095|NCT00001465|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
1733096|NCT00001464|Oxygen|oxygen
1733097|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
1733098|NCT00001464|DNA Repair|dna repair
1733099|NCT00001464|Carbonyl Groups|carbonyl groups
1733100|NCT00001464|Serum|serum
1733101|NCT00001464|ADP-ribosylation|adp-ribosylation
1733102|NCT00001464|Defensin|defensin
1733103|NCT00001464|Protein Oxidation|protein oxidation
1733104|NCT00001464|Human Volunteers|human volunteers
1733105|NCT00001460|Training Protocol|training protocol
1733106|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
1733107|NCT00001460|Congenital Heart Disease|congenital heart disease
1733108|NCT00001460|Acquired Heart Disease|acquired heart disease
1733109|NCT00001460|Arrhythmias|arrhythmias
1733123|NCT00001457|Nucleoside Analogues|nucleoside analogues
1733124|NCT00001457|Delta Hepatitis|delta hepatitis
1733125|NCT00001457|Glomerulonephritis|glomerulonephritis
1733126|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
1733127|NCT00001457|Hepatitis Mutants|hepatitis mutants
1733128|NCT00001457|3TC|3tc
1733129|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
1733230|NCT00001413|DEXA Scan|dexa scan
1733130|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
1733131|NCT00001457|Cirrhosis|cirrhosis
1733132|NCT00001457|Lamivudine|lamivudine
1733133|NCT00001456|Albinism|albinism
1733134|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
1733135|NCT00001456|Metabolic Disease|metabolic disease
1733136|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
1733137|NCT00001454|Estrogen|estrogen
1733138|NCT00001454|Progesterone|progesterone
1733139|NCT00001454|Menses|menses
1733140|NCT00001454|Endometrium|endometrium
1733141|NCT00001454|Normal Volunteer|normal volunteer
1733142|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
1733143|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
1733144|NCT00001453|Cushing Syndrome|cushing syndrome
1733145|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
1733146|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
1733147|NCT00001452|Cushing Syndrome|cushing syndrome
1733148|NCT00001452|Gene Mapping|gene mapping
1733149|NCT00001452|Linkage|linkage
1733150|NCT00001452|Oncogene|oncogene
1733151|NCT00001452|Linkage Analysis|linkage analysis
1733152|NCT00001452|Gene Identification|gene identification
1733153|NCT00001452|Tumors|tumors
1733154|NCT00001452|Familial Neoplasia|familial neoplasia
1733155|NCT00001452|Adrenal Gland|adrenal gland
1733156|NCT00001452|Lentigines|lentigines
1733157|NCT00001452|Carney Complex|carney complex
1733158|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
1733159|NCT00001451|Bone Marrow Donor|bone marrow donor
1733160|NCT00001451|Marrow Transplant|marrow transplant
1733161|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
1733162|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
1733163|NCT00001451|Healthy Volunteer|healthy volunteer
1733164|NCT00001444|Pharmacokinetics|pharmacokinetics
1733165|NCT00001444|Natural Products|natural products
1733166|NCT00001444|Salvage Therapy|salvage therapy
1733167|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
1733169|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
1733170|NCT00001442|Radiosensitizer|radiosensitizer
1733171|NCT00001442|Radiotherapy|radiotherapy
1733172|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
1733173|NCT00001440|p53|p53
1733174|NCT00001440|Interleukin-2|interleukin-2
1733175|NCT00001440|T-Cell Repopulation|t-cell repopulation
1733176|NCT00001440|Apheresis|apheresis
1733177|NCT00001440|RAS|ras
1733178|NCT00001432|Purging|purging
1733179|NCT00001432|Apheresis|apheresis
1733180|NCT00001432|Long Term Culture|long term culture
1733181|NCT00001432|T Cells|t cells
1733182|NCT00001432|Stem Cell|stem cell
1733183|NCT00001430|IL-2|il-2
1733184|NCT00001430|Drug Resistance|drug resistance
1733185|NCT00001430|Continuous Infusion|continuous infusion
1733186|NCT00001430|Peripheral Stem Cells|peripheral stem cells
1733187|NCT00001430|MDR|mdr
1733188|NCT00001426|Ovarian Cancer|ovarian cancer
1733189|NCT00001426|Initial Therapy|initial therapy
1733190|NCT00001426|Paclitaxel|paclitaxel
1733191|NCT00001426|Cisplatin|cisplatin
1733192|NCT00001426|Cyclophosphamide|cyclophosphamide
1733193|NCT00001420|Lymphocytes|lymphocytes
1733194|NCT00001420|Cytokines|cytokines
1733195|NCT00001420|Apoptosis|apoptosis
1733196|NCT00001420|Psoriasis|psoriasis
1733197|NCT00001420|Genetics|genetics
1733198|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
1733199|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
1733200|NCT00001418|Dysautonomias|dysautonomias
1733201|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
1733202|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
1733203|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
1733204|NCT00001418|Sympathectomy|sympathectomy
1733205|NCT00001418|Fluorodopamine|fluorodopamine
1733206|NCT00001418|Positron Emission Tomography|positron emission tomography
1733207|NCT00001418|Norepinephrine|norepinephrine
1733208|NCT00001418|Dopamine|dopamine
1733209|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
1733210|NCT00001417|Needle Biopsy|needle biopsy
1733211|NCT00001417|Computed Tomography|computed tomography
1733212|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
1733213|NCT00001417|Spinal Angiography|spinal angiography
1733214|NCT00001417|Intratumoral Pressure|intratumoral pressure
1733215|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
1733216|NCT00001417|Spinal Metastasis|spinal metastasis
1733217|NCT00001417|Absolute Ethanol|absolute ethanol
1733218|NCT00001417|Spinal Tumor|spinal tumor
1733219|NCT00001417|Vertebral Tumor|vertebral tumor
1733220|NCT00001414|Behavior Genetics|behavior genetics
1733221|NCT00001414|Normal Personality|normal personality
1733222|NCT00001414|Intelligence|intelligence
1733223|NCT00001414|Siblings|siblings
1733224|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
1733329|NCT00001386|Retrovirus|retrovirus
1733225|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
1733226|NCT00001414|X-Chromosome|x-chromosome
1733227|NCT00001413|Corticosteroids|corticosteroids
1733228|NCT00001413|Osteoporosis|osteoporosis
1733229|NCT00001413|Depression|depression
1733231|NCT00001413|Body Mass|body mass
1733232|NCT00001413|Dual X-Ray|dual x-ray
1733233|NCT00001413|Energy Absorptiometry|energy absorptiometry
1733234|NCT00001413|Normal Volunteer|normal volunteer
1733235|NCT00001412|Gonadal Steroids|gonadal steroids
1733236|NCT00001412|Central Nervous System Function|central nervous system function
1733237|NCT00001412|GnRH Agonist|gnrh agonist
1733238|NCT00001412|Testosterone|testosterone
1733239|NCT00001412|Leuprolide Acetate|leuprolide acetate
1733240|NCT00001412|Mood|mood
1733241|NCT00001412|Behavior|behavior
1733242|NCT00001412|Cognitive Function|cognitive function
1733243|NCT00001410|Recombinant Production|recombinant production
1733244|NCT00001410|Inherited Disease|inherited disease
1733245|NCT00001410|Lysosomal Disorder|lysosomal disorder
1733246|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
1733247|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
1733248|NCT00001410|Glucocerebrosidase|glucocerebrosidase
1733249|NCT00001410|Polyethylene Glycol|polyethylene glycol
1733250|NCT00001410|Gaucher Disease|gaucher disease
1733251|NCT00001410|Recombinant Enzyme|recombinant enzyme
1733252|NCT00001409|AIDS|aids
1733253|NCT00001409|Gene Therapy|gene therapy
1733254|NCT00001409|T Cell Universal Receptor|t cell universal receptor
1733255|NCT00001409|Ex Vivo Activation|ex vivo activation
1733256|NCT00001408|Lymphocytes|lymphocytes
1733257|NCT00001408|Asthma|asthma
1733258|NCT00001408|Cytokines|cytokines
1733259|NCT00001408|Interleukin-5|interleukin-5
1733260|NCT00001408|Late Phase Response|late phase response
1733261|NCT00001407|Cytokines|cytokines
1733262|NCT00001407|Mycobacteria|mycobacteria
1733263|NCT00001407|Pneumonia|pneumonia
1733264|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
1733266|NCT00001406|Helminth Parasites|helminth parasites
1733267|NCT00001406|Hypereosinophilia|hypereosinophilia
1733268|NCT00001406|Allergy|allergy
1733269|NCT00001406|Asthma|asthma
1733270|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
1733271|NCT00001405|Apheresis|apheresis
1733272|NCT00001405|CD34 Cells|cd34 cells
1733273|NCT00001405|Infection|infection
1733274|NCT00001405|Nadph Oxidase|nadph oxidase
1733275|NCT00001405|Normal Volunteer|normal volunteer
1733276|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
1733277|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
1733278|NCT00001404|Polysyndactyly|polysyndactyly
1733279|NCT00001404|Autosomal Dominant|autosomal dominant
1733280|NCT00001404|Mutation|mutation
1733281|NCT00001404|Gelastic|gelastic
1733282|NCT00001404|Gelastic Seizure|gelastic seizure
1733283|NCT00001404|Hypothalamic|hypothalamic
1733284|NCT00001404|Malformations|malformations
1733285|NCT00001404|Polydactyly|polydactyly
1733286|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
1733287|NCT00001403|Proteus Syndrome|proteus syndrome
1733288|NCT00001403|Overgrowth|overgrowth
1733289|NCT00001400|Heart Disease|heart disease
1733290|NCT00001400|Screening|screening
1733291|NCT00001400|Follow-Up|follow-up
1733292|NCT00001399|Gene Therapy|gene therapy
1733293|NCT00001399|Stem Cell Rescue|stem cell rescue
1733294|NCT00001399|Bone Marrow Failure|bone marrow failure
1733295|NCT00001399|Fanconi Anemia|fanconi anemia
1733296|NCT00001398|Hematopoiesis|hematopoiesis
1733297|NCT00001398|Stem Cell Cycling|stem cell cycling
1733298|NCT00001398|Bone Marrow Failure|bone marrow failure
1733299|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
1733300|NCT00001397|Hematologic Malignancies|hematologic malignancies
1733301|NCT00001396|Pacemaker|pacemaker
1733302|NCT00001396|Pediatric|pediatric
1733303|NCT00001396|Obstructive HCM|obstructive hcm
1733304|NCT00001394|Hyperparathyroidism|hyperparathyroidism
1733305|NCT00001394|Arterial Stimulation|arterial stimulation
1733306|NCT00001394|Venous Sampling|venous sampling
1733307|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
1733308|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
1733309|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
1733310|NCT00001393|Renal Disease|renal disease
1733311|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
1733312|NCT00001392|Retrovirus|retrovirus
1733313|NCT00001392|PCR|pcr
1733314|NCT00001392|Renal Failure|renal failure
1733315|NCT00001392|HIV|hiv
1733316|NCT00001392|Rituximab|rituximab
1733317|NCT00001391|Augmentation|augmentation
1733318|NCT00001391|Osteogenesis|osteogenesis
1733319|NCT00001391|Stem Cells|stem cells
1733320|NCT00001391|Bone Formation|bone formation
1733321|NCT00001391|Bone Induction|bone induction
1733322|NCT00001390|Saliva|saliva
1733323|NCT00001390|Parotid|parotid
1733324|NCT00001390|Lip Biopsy|lip biopsy
1733325|NCT00001390|Health|health
1733326|NCT00001390|Exocrine|exocrine
1733327|NCT00001390|Normal Volunteer|normal volunteer
1733328|NCT00001386|AIDS|aids
1733330|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
1733331|NCT00001386|Vaccine|vaccine
1733332|NCT00001386|Helper T Cells|helper t cells
1733333|NCT00001379|Epstein-Barr Virus|epstein-barr virus
1733334|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
1733335|NCT00001379|Viral|viral
1733336|NCT00001379|Immunosuppression|immunosuppression
1733337|NCT00001379|Lymphoma|lymphoma
1733338|NCT00001373|Auto-Inflammation|auto-inflammation
1733339|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
1733340|NCT00001373|Genetics|genetics
1733341|NCT00001373|Periodic Fever|periodic fever
1733342|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
1733343|NCT00001372|Natural History|natural history
1733344|NCT00001372|Lupus Nephritis|lupus nephritis
1733345|NCT00001372|Lupus|lupus
1733346|NCT00001372|Systemic Lupus|systemic lupus
1733347|NCT00001372|SLE|sle
1733348|NCT00001368|Cerebral Ischemia|cerebral ischemia
1733349|NCT00001368|Hypertension|hypertension
1733350|NCT00001368|Immune Response|immune response
1733351|NCT00001368|Carotid Stenosis|carotid stenosis
1733352|NCT00001368|Atherosclerosis|atherosclerosis
1733353|NCT00001367|Human|human
1733354|NCT00001367|Movement|movement
1733355|NCT00001367|Non-Investigational to Diagnostic Puzzle|non-investigational to diagnostic puzzle
1733356|NCT00001367|Parkinson's|parkinson's
1733357|NCT00001367|Dystonia|dystonia
1733358|NCT00001367|Cerebellar|cerebellar
1733359|NCT00001367|Puzzles|puzzles
1733360|NCT00001367|Neurological Disorders|neurological disorders
1733361|NCT00001367|Movement Disorders|movement disorders
1733362|NCT00001366|Neuroimaging|neuroimaging
1733363|NCT00001366|Seizures|seizures
1733364|NCT00001366|Cerebral Localization|cerebral localization
1733365|NCT00001366|Partial Epilepsy|partial epilepsy
1733366|NCT00001366|Epilepsy|epilepsy
1733367|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
1733368|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
1733369|NCT00001364|Surgery|surgery
1733370|NCT00001364|Embolization|embolization
1733791|NCT00001246|Triple X|triple x
1733371|NCT00001364|Spinal Arteriography|spinal arteriography
1733372|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
1733373|NCT00001362|Contrast Enhancement|contrast enhancement
1733374|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
1733375|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
1733376|NCT00001362|Neurological Disorders|neurological disorders
1733377|NCT00001362|Blood Flow|blood flow
1733378|NCT00001362|Blood Volume|blood volume
1733379|NCT00001362|Normal Volunteer|normal volunteer
1733380|NCT00001361|Movement Disorders|movement disorders
1733381|NCT00001361|Sensory Processing|sensory processing
1733382|NCT00001361|Stroke|stroke
1733383|NCT00001361|Spinal Cord Injury|spinal cord injury
1733384|NCT00001361|Blood Flow|blood flow
1733385|NCT00001361|Blood Volume|blood volume
1733386|NCT00001361|Cognitive Function|cognitive function
1733387|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
1733388|NCT00001361|Neurological Disorders|neurological disorders
1733389|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
1733390|NCT00001361|Plasticity|plasticity
1733391|NCT00001361|Normal Volunteer|normal volunteer
1733392|NCT00001360|Cognition|cognition
1733393|NCT00001360|Vision|vision
1733394|NCT00001360|Cortex|cortex
1733395|NCT00001360|Visual Processing|visual processing
1733396|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
1733397|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
1733398|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
1733399|NCT00001359|Adolescents|adolescents
1733400|NCT00001359|Autoimmune Illness|autoimmune illness
1733401|NCT00001359|Children|children
1733402|NCT00001359|Tic Disorders|tic disorders
1733403|NCT00001359|Streptococcal Infections|streptococcal infections
1733404|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
1733405|NCT00001357|Cytokines|cytokines
1733406|NCT00001357|Immunoregulation|immunoregulation
1733407|NCT00001357|CD4 Cells|cd4 cells
1733408|NCT00001356|IL-3|il-3
1733409|NCT00001356|Stem Cell Factor|stem cell factor
1733410|NCT00001356|Cytokines|cytokines
1733411|NCT00001356|Cell Differentiation|cell differentiation
1733412|NCT00001356|Receptors|receptors
1733413|NCT00001356|Bone Marrow|bone marrow
1733414|NCT00001356|Mastocytosis|mastocytosis
1733415|NCT00001355|Immunodeficiency|immunodeficiency
1733416|NCT00001355|Infections|infections
1733417|NCT00001355|Phagocytes|phagocytes
1733418|NCT00001355|Cytokines|cytokines
1733419|NCT00001355|Genetics|genetics
1733420|NCT00001354|AIDS|aids
1733421|NCT00001354|Immunotherapy|immunotherapy
1733422|NCT00001354|CD4 Cells|cd4 cells
1733423|NCT00001354|Immunomodulator|immunomodulator
1733424|NCT00001354|Cytokines|cytokines
1733425|NCT00001353|AIDS|aids
1733426|NCT00001353|Immune Based Therapy|immune based therapy
1733427|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
1733428|NCT00001353|Lymphapheresis|lymphapheresis
1733429|NCT00001353|Ex Vivo Activation|ex vivo activation
1733430|NCT00001353|HIV|hiv
1733431|NCT00001353|Gene Therapy|gene therapy
1733438|NCT00001351|Chronic Infection|chronic infection
1733439|NCT00001351|Infectious Diseases|infectious diseases
1733440|NCT00001351|Host Response|host response
1733441|NCT00001351|Immunologic Disorders|immunologic disorders
1733442|NCT00001351|Acute Infection|acute infection
1734372|NCT00000410|MRI|mri
1733443|NCT00001350|Immunoregulation|immunoregulation
1733444|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
1733445|NCT00001350|Lymphadenopathy|lymphadenopathy
1733446|NCT00001350|ALPS|alps
1733447|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
1733448|NCT00001349|Plasmapheresis|plasmapheresis
1733449|NCT00001349|Lymphocytes|lymphocytes
1733450|NCT00001349|Eosinophils|eosinophils
1733451|NCT00001349|Neutrophils|neutrophils
1733452|NCT00001347|Linkage Analysis|linkage analysis
1733453|NCT00001347|Genomic DNA|genomic dna
1733454|NCT00001347|Pedigree Analysis|pedigree analysis
1733455|NCT00001347|Usher Syndrome|usher syndrome
1733456|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
1733457|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
1733463|NCT00001343|Turner's Syndrome|turner's syndrome
1733464|NCT00001343|Short Stature|short stature
1733465|NCT00001343|Cognitive Function|cognitive function
1733466|NCT00001343|Sex Steroids|sex steroids
1733467|NCT00001343|Turner Syndrome|turner syndrome
1733468|NCT00001343|TS|ts
1733469|NCT00001339|Multidrug Resistance|multidrug resistance
1733470|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
1733471|NCT00001339|P-Glycoprotein|p-glycoprotein
1733472|NCT00001339|MDR-1|mdr-1
1733473|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
1733474|NCT00001337|CD20 +|cd20 +
1733475|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
1733476|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
1733477|NCT00001337|De Novo|de novo
1733478|NCT00001336|Transplantation|transplantation
1733479|NCT00001336|Cancer|cancer
1733480|NCT00001336|Cellular Immunity|cellular immunity
1733481|NCT00001336|Stem Cell Function|stem cell function
1733482|NCT00001336|Immunodeficiency|immunodeficiency
1733483|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
1733484|NCT00001335|Up-Front Phase II Window|up-front phase ii window
1733485|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
1733486|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
1733487|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
1733488|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
1733489|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
1733490|NCT00001331|Myopathy|myopathy
1733491|NCT00001331|Phosphofructokinase|phosphofructokinase
1733492|NCT00001331|Acid Maltase|acid maltase
1733493|NCT00001331|Pompe|pompe
1733494|NCT00001331|Muscle Diseases|muscle diseases
1733495|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
1733496|NCT00001329|Yohimbine|yohimbine
1733497|NCT00001329|Catecholamines|catecholamines
1733498|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
1733499|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
1733500|NCT00001329|Stress|stress
1733501|NCT00001329|Hypertension|hypertension
1733502|NCT00001329|Autonomic Failure|autonomic failure
1733503|NCT00001328|Cancer|cancer
1733504|NCT00001328|Gene Transfer|gene transfer
1733505|NCT00001328|Recurrent Tumors|recurrent tumors
1733506|NCT00001328|Primary Tumors|primary tumors
1733507|NCT00001328|Metastases|metastases
1733508|NCT00001328|Anti-Viral Drugs|anti-viral drugs
1733509|NCT00001328|Chemosensitization|chemosensitization
1733510|NCT00001328|Brain Tumors|brain tumors
1733511|NCT00001328|Gene Therapy|gene therapy
1733512|NCT00001328|Ganciclovir|ganciclovir
1733513|NCT00001327|Syringomyelia|syringomyelia
1733514|NCT00001327|Chiari Malformation|chiari malformation
1733515|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
1733516|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
1733517|NCT00001327|Hydrocephalus|hydrocephalus
1733518|NCT00001327|Spinal Cord|spinal cord
1733519|NCT00001327|Ventriculostomy|ventriculostomy
1733520|NCT00001327|Lumbar Puncture|lumbar puncture
1733521|NCT00001327|Pressure Measurement|pressure measurement
1733522|NCT00001325|Positron|positron
1733523|NCT00001325|Tomography|tomography
1733524|NCT00001325|Seizures|seizures
1733525|NCT00001325|Epileptic Focus|epileptic focus
1733526|NCT00001325|Electroencephalography|electroencephalography
1733527|NCT00001325|Metabolism|metabolism
1733528|NCT00001325|Glucose|glucose
1733529|NCT00001325|Cerebral|cerebral
1733530|NCT00001325|Positron Emission Tomography|positron emission tomography
1733531|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
1733532|NCT00001323|Cognition|cognition
1733533|NCT00001323|Neuropsychology|neuropsychology
1733534|NCT00001323|Neuropsychological Tests|neuropsychological tests
1733535|NCT00001323|Neurological Exam|neurological exam
1733536|NCT00001323|Psychiatric|psychiatric
1733537|NCT00001323|Attention|attention
1733538|NCT00001323|Schizophrenic|schizophrenic
1733539|NCT00001323|Schizoaffective|schizoaffective
1733540|NCT00001323|Working Memory|working memory
1733541|NCT00001323|Memory|memory
1733542|NCT00001322|Gonadal Steroids|gonadal steroids
1733543|NCT00001322|Mood|mood
1733544|NCT00001322|Menstrual Cycle|menstrual cycle
1733545|NCT00001322|Neuropsychological Testing|neuropsychological testing
1733546|NCT00001322|Estrogen|estrogen
1733547|NCT00001322|Dexamethasone|dexamethasone
1733548|NCT00001322|Progesterone|progesterone
1733549|NCT00001322|Central Nervous System Function|central nervous system function
1733550|NCT00001322|Estradiol|estradiol
1733551|NCT00001322|GnRH Agonist|gnrh agonist
1733552|NCT00001320|Parkinson's Disease|parkinson's disease
1733553|NCT00001320|Schizophrenia|schizophrenia
1733554|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
1733555|NCT00001320|Brain Imaging|brain imaging
1733556|NCT00001320|SPECT|spect
1733557|NCT00001320|Equilibrium|equilibrium
1733558|NCT00001320|Brain Scan|brain scan
1733559|NCT00001320|Brain Research|brain research
1733560|NCT00001320|Brain Disorders|brain disorders
1733561|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
1733562|NCT00001320|Normal Volunteer|normal volunteer
1733563|NCT00001319|HIV Negative|hiv negative
1733564|NCT00001319|CD4 Deficiency|cd4 deficiency
1733565|NCT00001319|Retrovirus|retrovirus
1733566|NCT00001316|Lymph Node|lymph node
1733567|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
1733568|NCT00001316|In Situ Hybridization|in situ hybridization
1733569|NCT00001316|AIDS|aids
1733570|NCT00001316|Excisional Biopsy|excisional biopsy
1733571|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
1733572|NCT00001313|Chest Pain|chest pain
1733573|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1733574|NCT00001313|Coronary Artery Disease|coronary artery disease
1733575|NCT00001313|Microvascular Angina|microvascular angina
1733576|NCT00001313|Cardiac Investigation|cardiac investigation
1733577|NCT00001313|Follow-up|follow-up
1733578|NCT00001313|Heart Disease|heart disease
1733579|NCT00001310|Retinal Disease|retinal disease
1733580|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
1733581|NCT00001310|Uveitis|uveitis
1733582|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
1733583|NCT00001310|Corneal Disease|corneal disease
1733584|NCT00001310|Ocular Disease|ocular disease
1733585|NCT00001309|Pharmacokinetics|pharmacokinetics
1733586|NCT00001309|Biodistribution|biodistribution
1733587|NCT00001309|Ascorbic Acid|ascorbic acid
1733588|NCT00001308|Stuttering|stuttering
1733589|NCT00001308|Tourette's Syndrome|tourette's syndrome
1733590|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
1733591|NCT00001308|Dysarthria|dysarthria
1733592|NCT00001308|Parkinson's Disease|parkinson's disease
1733593|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
1733594|NCT00001308|Aphasia|aphasia
1733595|NCT00001308|Speech|speech
1733596|NCT00001308|Motor Control|motor control
1733597|NCT00001307|Analgesia|analgesia
1733599|NCT00001307|Positron Emission|positron emission
1733600|NCT00001307|Functional Brain Imaging|functional brain imaging
1733601|NCT00001307|Allodynia|allodynia
1733602|NCT00001307|Thalamus|thalamus
1733603|NCT00001307|Somatosensory Cortex|somatosensory cortex
1733604|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
1733605|NCT00001307|Normal Volunteer|normal volunteer
1733606|NCT00001307|Chronic Pain|chronic pain
1733607|NCT00001306|Infertility|infertility
1733608|NCT00001306|Ovulation|ovulation
1733609|NCT00001306|Autoimmune|autoimmune
1733610|NCT00001306|Follicle|follicle
1733611|NCT00001306|Menopause|menopause
1733612|NCT00001306|Biopsy|biopsy
1733613|NCT00001306|Glucocorticoids|glucocorticoids
1733614|NCT00001306|Premature Ovarian Failure|premature ovarian failure
1733615|NCT00001306|Amenorrhea|amenorrhea
1733616|NCT00001306|Ovarian Failure|ovarian failure
1733617|NCT00001306|POF|pof
1733618|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
1733619|NCT00001304|Hypoparathyroidism|hypoparathyroidism
1733620|NCT00001304|Parathyroid Hormone|parathyroid hormone
1733621|NCT00001304|Vitamin D|vitamin d
1733622|NCT00001304|Calcium Metabolism|calcium metabolism
1733623|NCT00001304|PTH 1-34|pth 1-34
1733624|NCT00001304|Bone|bone
1733625|NCT00001303|Hemodynamics|hemodynamics
1733626|NCT00001303|Lung Permeability|lung permeability
1733627|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
1733628|NCT00001303|Bronchoscopy|bronchoscopy
1733629|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
1733630|NCT00001303|Normal Volunteer|normal volunteer
1733631|NCT00001302|Vinblastine|vinblastine
1733632|NCT00001302|Multidrug Resistance|multidrug resistance
1733633|NCT00001302|Resistance Reversal|resistance reversal
1733634|NCT00001302|Pgp Blocker|pgp blocker
1733635|NCT00001302|Pharmacokinetics|pharmacokinetics
1733636|NCT00001302|Cyclosporine|cyclosporine
1733637|NCT00001302|Drug Interactions|drug interactions
1733638|NCT00001295|Follow-Up|follow-up
1733639|NCT00001295|Treatment|treatment
1733640|NCT00001294|Genetic Linkage|genetic linkage
1733641|NCT00001294|Sex Behavior|sex behavior
1733642|NCT00001294|AIDS|aids
1733643|NCT00001294|Alcohol Dependence|alcohol dependence
1733644|NCT00001294|HLA System|hla system
1733645|NCT00001294|Cancer|cancer
1733646|NCT00001289|Enzyme Replacement|enzyme replacement
1733647|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
1733648|NCT00001289|Lysosomal Storage|lysosomal storage
1733649|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
1733650|NCT00001289|Seizures|seizures
1733651|NCT00001289|Mental Retardation|mental retardation
1733652|NCT00001289|Gaucher Disease|gaucher disease
1733653|NCT00001288|Positron Emission Tomography|positron emission tomography
1733654|NCT00001288|Epilepsy|epilepsy
1733655|NCT00001288|Stroke|stroke
1733656|NCT00001284|Cognition|cognition
1733657|NCT00001284|Schizophrenia|schizophrenia
1733658|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
1733659|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
1733660|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
1733661|NCT00001282|HIV|hiv
1733662|NCT00001282|Immunomodulator|immunomodulator
1733663|NCT00001282|Anti-Viral|anti-viral
1733664|NCT00001281|Lymphocytes|lymphocytes
1733665|NCT00001281|Venipuncture|venipuncture
1733666|NCT00001281|Mononuclear Cells|mononuclear cells
1733667|NCT00001277|Hypoglycemia|hypoglycemia
1733668|NCT00001277|Genetics|genetics
1733669|NCT00001277|Hyperparathyroidism|hyperparathyroidism
1733670|NCT00001276|Hypoglycemia|hypoglycemia
1733671|NCT00001276|Insulinoma|insulinoma
1733672|NCT00001275|Menopause|menopause
1733673|NCT00001275|Estrogen|estrogen
1733674|NCT00001275|Infertility|infertility
1733675|NCT00001275|Ovulation|ovulation
1733676|NCT00001275|Amenorrhea|amenorrhea
1733677|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
1733678|NCT00001275|Young Women|young women
1733679|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
1733680|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
1733681|NCT00001275|Premature Ovarian Failure|premature ovarian failure
1733682|NCT00001275|POF|pof
1733683|NCT00001266|Bayesian|bayesian
1733684|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
1733685|NCT00001266|Combined Androgen Ablation|combined androgen ablation
1733686|NCT00001266|Prostate Specific Antigen|prostate specific antigen
1733687|NCT00001265|Autoimmune Diseases|autoimmune diseases
1733688|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
1733689|NCT00001265|Polymyositis|polymyositis
1733690|NCT00001265|Dermatomyositis|dermatomyositis
1733691|NCT00001265|Inclusion Body Myositis|inclusion body myositis
1733692|NCT00001265|Pathogenesis|pathogenesis
1733693|NCT00001265|Connective Tissue Diseases|connective tissue diseases
1733694|NCT00001262|Menkes|menkes
1733695|NCT00001262|Copper|copper
1733696|NCT00001262|X-Linked|x-linked
1733697|NCT00001262|Neurodegeneration|neurodegeneration
1733698|NCT00001262|ATP7A|atp7a
1733699|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
1733700|NCT00001261|Muscle Immunopathology|muscle immunopathology
1733701|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
1733702|NCT00001261|Inclusion Body Myositis|inclusion body myositis
1733703|NCT00001260|Schizophrenia|schizophrenia
1733704|NCT00001260|Neuropathology|neuropathology
1733705|NCT00001260|Neurochemistry|neurochemistry
1733706|NCT00001260|Substance Abuse|substance abuse
1733707|NCT00001260|Bipolar Disorder|bipolar disorder
1733708|NCT00001260|Aging|aging
1733709|NCT00001260|Normal Development|normal development
1733710|NCT00001260|Depression|depression
1733711|NCT00001260|Anxiety Disorders|anxiety disorders
1733712|NCT00001260|Suicide|suicide
1733713|NCT00001260|Dementia|dementia
1733714|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
1733715|NCT00001260|Tourette's Syndrome|tourette's syndrome
1733716|NCT00001260|Normal Controls|normal controls
1733717|NCT00001259|Depression|depression
1733718|NCT00001259|Menstrual Cycle|menstrual cycle
1733719|NCT00001259|Gonadal Steroids|gonadal steroids
1733720|NCT00001259|GnRH Agonist|gnrh agonist
1733721|NCT00001259|Mood Disorders|mood disorders
1733722|NCT00001258|Neuropsychology|neuropsychology
1733723|NCT00001258|Cerebral Blood Flow|cerebral blood flow
1733724|NCT00001258|Cognitive Disorders|cognitive disorders
1733725|NCT00001258|Prefrontal Cortex|prefrontal cortex
1733726|NCT00001258|Hormones|hormones
1733727|NCT00001258|Psychosis|psychosis
1733728|NCT00001258|Neuroimaging|neuroimaging
1733729|NCT00001258|Brain Scan|brain scan
1733730|NCT00001258|Healthy Volunteers|healthy volunteers
1733731|NCT00001258|Schizophrenia|schizophrenia
1733732|NCT00001257|Lymphokines|lymphokines
1733733|NCT00001257|LTB4|ltb4
1733734|NCT00001257|Inflammation|inflammation
1733735|NCT00001257|Normal Volunteer|normal volunteer
1733736|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
1733737|NCT00001256|Vasculitis|vasculitis
1733738|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
1733739|NCT00001256|Inflammation|inflammation
1733740|NCT00001256|Glomerulonephritis|glomerulonephritis
1733741|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
1733742|NCT00001255|Retroviral Vector|retroviral vector
1733743|NCT00001255|Gene Therapy|gene therapy
1733744|NCT00001255|PEG-ADA|peg-ada
1733745|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
1733746|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
1733747|NCT00001254|Islet Cell Tumors|islet cell tumors
1733748|NCT00001253|Turner's Syndrome|turner's syndrome
1733749|NCT00001253|Estrogen|estrogen
1733750|NCT00001253|Ethinyl estradiol|ethinyl estradiol
1733751|NCT00001253|Learning|learning
1733752|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
1733753|NCT00001252|Biomechanics|biomechanics
1733754|NCT00001252|Kinesiology|kinesiology
1733755|NCT00001252|Walking|walking
1733756|NCT00001252|ACL|acl
1733757|NCT00001252|Stroke|stroke
1733758|NCT00001252|Leg Weakness|leg weakness
1733759|NCT00001252|Paralysis|paralysis
1733760|NCT00001252|Anterior Cruciate Ligament|anterior cruciate ligament
1733761|NCT00001252|Gait Degicit|gait degicit
1733762|NCT00001251|Meningeal Malignancy|meningeal malignancy
1733763|NCT00001251|Pediatric|pediatric
1733764|NCT00001251|Alkylating Agents|alkylating agents
1733765|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
1733766|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
1733767|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
1733768|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
1733769|NCT00001248|Multiple Sclerosis|multiple sclerosis
1733770|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
1733771|NCT00001247|Schizophrenia|schizophrenia
1733772|NCT00001247|Psychosis|psychosis
1733773|NCT00001247|Neuroleptics|neuroleptics
1733774|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
1733775|NCT00001246|Cognitive|cognitive
1733776|NCT00001246|Genetics|genetics
1733777|NCT00001246|Development|development
1733778|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
1733779|NCT00001246|Jacob Syndrome|jacob syndrome
1733780|NCT00001246|Trisomy X|trisomy x
1733781|NCT00001246|Healthy Volunteer|healthy volunteer
1733782|NCT00001246|XXY|xxy
1733783|NCT00001246|XXXY|xxxy
1733784|NCT00001246|XXXXY|xxxxy
1733785|NCT00001246|XYY|xyy
1733786|NCT00001246|XXYY|xxyy
1733787|NCT00001246|XO|xo
1733788|NCT00001246|XXXX|xxxx
1733789|NCT00001246|XXX|xxx
1733790|NCT00001246|XXXXX|xxxxx
1733792|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
1733793|NCT00001246|Twin|twin
1733794|NCT00001245|Strongyloidiasis|strongyloidiasis
1733795|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
1733796|NCT00001245|IgE|ige
1733797|NCT00001245|Nematode|nematode
1733798|NCT00001245|Immunosuppression|immunosuppression
1733799|NCT00001245|Skin Test|skin test
1733800|NCT00001245|Diagnosis|diagnosis
1733801|NCT00001245|Intestinal Helminth|intestinal helminth
1733802|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
1733803|NCT00001244|Agammaglobulinemia|agammaglobulinemia
1733804|NCT00001244|Primary Immune Deficiency|primary immune deficiency
1733805|NCT00001244|Immune Response|immune response
1733806|NCT00001243|AIDS|aids
1733807|NCT00001243|Myeloid Progenitors|myeloid progenitors
1733808|NCT00001243|Monocytes|monocytes
1733809|NCT00001243|Plasmid Libraries|plasmid libraries
1733810|NCT00001243|Cytokines|cytokines
1733811|NCT00001242|Calcium|calcium
1733812|NCT00001242|Vitamin D|vitamin d
1733813|NCT00001242|Calcitriol|calcitriol
1733814|NCT00001242|Parathyroid|parathyroid
1733815|NCT00001242|Cyclic AMP|cyclic amp
1733816|NCT00001242|Rickets|rickets
1733817|NCT00001241|Gastric Acid Secretion|gastric acid secretion
1733818|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
1733819|NCT00001240|Stomach|stomach
1733820|NCT00001240|Hypersecretion|hypersecretion
1733821|NCT00001240|Hyposecretion|hyposecretion
1733822|NCT00001240|Gastrinoma|gastrinoma
1733823|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
1733824|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
1733825|NCT00001238|Birt Hogg Dube|birt hogg dube
1733826|NCT00001238|Von Hippel Lindau|von hippel lindau
1733827|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
1733828|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
1733829|NCT00001235|Genetics|genetics
1733830|NCT00001235|Neurotransmitters|neurotransmitters
1733831|NCT00001235|DNA|dna
1733832|NCT00001235|Lymphoblasts|lymphoblasts
1733833|NCT00001235|Skin Fibroblast|skin fibroblast
1733834|NCT00001235|Alzheimer's Disease|alzheimer's disease
1733835|NCT00001234|Bone Marrow|bone marrow
1733836|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
1733837|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
1733838|NCT00001231|Mood|mood
1733839|NCT00001231|Behavior|behavior
1733840|NCT00001231|Cognition|cognition
1733841|NCT00001231|Climacteric|climacteric
1733842|NCT00001231|Menopause|menopause
1733843|NCT00001231|Perimenopause|perimenopause
1733844|NCT00001231|Midlife|midlife
1733845|NCT00001231|Depression|depression
1733846|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
1733847|NCT00001230|Loa Loa|loa loa
1733848|NCT00001230|Brugia Malayi|brugia malayi
1733849|NCT00001230|Brugia Timori|brugia timori
1733850|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
1733851|NCT00001230|Mansonella Perstans|mansonella perstans
1733852|NCT00001230|Mansonella Ozzardi|mansonella ozzardi
1733853|NCT00001230|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
1733854|NCT00001230|Suramin|suramin
1733855|NCT00001230|Ivermectin|ivermectin
1733856|NCT00001230|Filarial Infection|filarial infection
1733857|NCT00001228|Interferon|interferon
1733858|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
1733859|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
1733860|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
1733861|NCT00001226|Apolipoproteins|apolipoproteins
1733862|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
1733863|NCT00001226|Healthy Volunteers|healthy volunteers
1733864|NCT00001225|DNA Polymorphisms|dna polymorphisms
1733865|NCT00001225|Echocardiography|echocardiography
1733866|NCT00001225|Gene Mapping|gene mapping
1733867|NCT00001225|Linkage Analysis|linkage analysis
1733868|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
1733869|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
1733870|NCT00001224|Cataracts|cataracts
1733871|NCT00001224|Vitrectomy|vitrectomy
1733872|NCT00001224|Extracapsular|extracapsular
1733873|NCT00001224|Cataract Surgery|cataract surgery
1733874|NCT00001224|Uveitis|uveitis
1733875|NCT00001224|Lenticular Opacity|lenticular opacity
1733876|NCT00001224|Vitreal Opacity|vitreal opacity
1733877|NCT00001223|Cystic Fibrosis|cystic fibrosis
1733878|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
1733879|NCT00001223|Bronchiectasis|bronchiectasis
1733880|NCT00001221|Growth|growth
1733881|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
1733882|NCT00001221|Estrogen|estrogen
1733883|NCT00001221|Somatotropin|somatotropin
1733884|NCT00001221|Turner's Syndrome|turner's syndrome
1733885|NCT00001221|Growth Hormone|growth hormone
1733886|NCT00001220|Swallowing Disorders|swallowing disorders
1733887|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
1733888|NCT00001220|Aspiration|aspiration
1733889|NCT00001220|Imaging|imaging
1733890|NCT00001219|Magnetic Resonance Imaging|magnetic resonance imaging
1733891|NCT00001219|Pulse Sequences|pulse sequences
1733892|NCT00001215|Lysosomal Storage Disorders|lysosomal storage disorders
1733893|NCT00001215|Variants|variants
1733894|NCT00001215|Chemical Phenotype|chemical phenotype
1733895|NCT00001215|Proteins|proteins
1733896|NCT00001215|Genes|genes
1733897|NCT00001215|Phenotype|phenotype
1733898|NCT00001215|Mutations|mutations
1733899|NCT00001215|Parkinsonism|parkinsonism
1733900|NCT00001214|Bone Marrow Failure|bone marrow failure
1733901|NCT00001214|Lymphocytapheresis|lymphocytapheresis
1733902|NCT00001214|Pancytopenia|pancytopenia
1733903|NCT00001214|Aplastic Anemia|aplastic anemia
1733904|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
1733905|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
1733906|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
1733907|NCT00001213|Corneal Crystals|corneal crystals
1733908|NCT00001213|Benzalkonium|benzalkonium
1733909|NCT00001213|Toxicity|toxicity
1733910|NCT00001213|Efficacy|efficacy
1733911|NCT00001213|Cystinosis|cystinosis
1733912|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
1733913|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
1733914|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
1733915|NCT00001212|Prednisone|prednisone
1733916|NCT00001212|Methylprednisolone|methylprednisolone
1733917|NCT00001212|Cyclophosphamide|cyclophosphamide
1733918|NCT00001212|Cyclosporine|cyclosporine
1733919|NCT00001212|Cyclosporin A|cyclosporin a
1733920|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
1733921|NCT00001208|Writer's Cramp|writer's cramp
1733922|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
1733923|NCT00001208|Stuttering|stuttering
1733924|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
1733925|NCT00001208|Palatal Myoclonus|palatal myoclonus
1733926|NCT00001208|Dystonia|dystonia
1733927|NCT00001208|Essential Tremor|essential tremor
1733928|NCT00001208|Movement Disorders|movement disorders
1733929|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
1733930|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
1733931|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
1733932|NCT00001206|Lumbar Puncture|lumbar puncture
1733934|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
1733935|NCT00001206|Psychosocial Functioning|psychosocial functioning
1733936|NCT00001206|Risk Factors|risk factors
1733937|NCT00001206|Genetics|genetics
1733938|NCT00001205|Taenia Solium|taenia solium
1733939|NCT00001205|Cysticercosis|cysticercosis
1733940|NCT00001205|Praziquantel|praziquantel
1733941|NCT00001204|Dyslipoprotein|dyslipoprotein
1733949|NCT00001203|Cardiac Disease|cardiac disease
1733950|NCT00001203|Acquired Anemia|acquired anemia
1733951|NCT00001202|Luteinizing Hormone|luteinizing hormone
1733952|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
1733953|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
1733954|NCT00001202|LHRH|lhrh
1733955|NCT00001202|Precocious Puberty|precocious puberty
1733956|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
1733957|NCT00001201|Nerve Conduction Studies|nerve conduction studies
1733959|NCT00001201|Normal Volunteer|normal volunteer
1733960|NCT00001201|Electrophysiology|electrophysiology
1733961|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
1733962|NCT00001201|Myopathies|myopathies
1733963|NCT00001198|Schizophrenia|schizophrenia
1733964|NCT00001198|Observational|observational
1733965|NCT00001197|Gene Expression Therapy|gene expression therapy
1733966|NCT00001197|Gamma Globin Gene|gamma globin gene
1733967|NCT00001197|Hemoglobin Switching|hemoglobin switching
1733968|NCT00001197|Bone Marrow|bone marrow
1733969|NCT00001197|Sickle Cell Anemia|sickle cell anemia
1733970|NCT00001196|Salivary Function|salivary function
1733971|NCT00001196|Salivary Gland|salivary gland
1733972|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
1733973|NCT00001196|Dry Mouth|dry mouth
1733974|NCT00001195|Development|development
1733975|NCT00001195|Hormones|hormones
1733976|NCT00001195|Growth|growth
1733977|NCT00001195|Metabolism|metabolism
1733978|NCT00001195|Eating Behavior|eating behavior
1733979|NCT00001195|Body Composition|body composition
1733980|NCT00001195|Normal Volunteer|normal volunteer
1733981|NCT00001192|Executive Functions|executive functions
1733982|NCT00001192|Language|language
1733983|NCT00001192|Attention|attention
1733984|NCT00001192|Visual-Spatial Ability|visual-spatial ability
1733985|NCT00001192|Memory|memory
1733986|NCT00001192|Motor Behavior|motor behavior
1733987|NCT00001192|Intelligence|intelligence
1733988|NCT00001192|Personality|personality
1733989|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
1733990|NCT00001192|Hand and Eye Dominance|hand and eye dominance
1733991|NCT00001192|Normal Volunteer|normal volunteer
1733992|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
1733993|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
1733994|NCT00001191|Gastrinoma|gastrinoma
1733995|NCT00001191|Acid Hypersecretion|acid hypersecretion
1733996|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
1733997|NCT00001186|Psychosocial|psychosocial
1733998|NCT00001186|Self Esteem|self esteem
1733999|NCT00001186|Oncology|oncology
1734000|NCT00001186|Well-Being|well-being
1734001|NCT00001186|Pediatrics|pediatrics
1734002|NCT00001185|Poliomyelitis|poliomyelitis
1734003|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
1734004|NCT00001185|Motor Neurons|motor neurons
1734005|NCT00001185|Late Viral Infection|late viral infection
1734006|NCT00001185|Motor Neuron Firing|motor neuron firing
1734007|NCT00001185|Immune Defects|immune defects
1734008|NCT00001185|Post-polio Syndrome|post-polio syndrome
1734009|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
1734010|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
1734011|NCT00001184|Regional Enteritis|regional enteritis
1734012|NCT00001184|Crohn's Disease|crohn's disease
1734013|NCT00001184|Ulcerative Colitis|ulcerative colitis
1734021|NCT00001182|General Dental|general dental
1734022|NCT00001182|Diagnostic|diagnostic
1734023|NCT00001182|Therapeutic|therapeutic
1734024|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
1734025|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
1734026|NCT00001181|Teslac|teslac
1734027|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
1734028|NCT00001180|Cushing Syndrome|cushing syndrome
1734029|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
1734030|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
1734031|NCT00001180|Normal Volunteer|normal volunteer
1734032|NCT00001178|Alzheimer's Disease|alzheimer's disease
1734033|NCT00001178|Cerebral Metabolism|cerebral metabolism
1734034|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
1734035|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
1734036|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
1734037|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
1734038|NCT00001178|Positron Emission Tomography|positron emission tomography
1734536|NCT00000386|Child|child
1734039|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
1734040|NCT00001178|Senile Dementia|senile dementia
1734041|NCT00001178|Down Syndrome|down syndrome
1734042|NCT00001178|Trisomy 21|trisomy 21
1734043|NCT00001177|Mood|mood
1734044|NCT00001177|Depression|depression
1734045|NCT00001177|Cognition|cognition
1734046|NCT00001177|Menstrual|menstrual
1734047|NCT00001177|Neuroendocrine|neuroendocrine
1734048|NCT00001177|Genetics|genetics
1734049|NCT00001177|PMDD|pmdd
1734050|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
1734051|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
1734052|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
1734053|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
1734054|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
1734055|NCT00001176|Hypertension|hypertension
1734056|NCT00001176|Primary Aldosteronism|primary aldosteronism
1734057|NCT00001174|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
1734058|NCT00001174|Affective Disorder|affective disorder
1734059|NCT00001174|Depression|depression
1734060|NCT00001174|Genetic|genetic
1734061|NCT00001174|DNA|dna
1734062|NCT00001174|Mania|mania
1734063|NCT00001174|Affected Sibling Pairs|affected sibling pairs
1734064|NCT00001174|Family Study|family study
1734065|NCT00001174|Genome-Wide Scan|genome-wide scan
1734066|NCT00001174|Lymphoblastoid Cell Lines|lymphoblastoid cell lines
1734067|NCT00001174|Diagnostic Interview for Genetic Studies (DIGS)|diagnostic interview for genetic studies (digs)
1734068|NCT00001174|Panic Disorder|panic disorder
1734069|NCT00001174|Bipolar Disorder|bipolar disorder
1734070|NCT00001172|Vision|vision
1734071|NCT00001172|Eye Movement|eye movement
1734072|NCT00001172|Perception|perception
1734073|NCT00001172|Healthy Volunteer|healthy volunteer
1734074|NCT00001171|Brain Tumors|brain tumors
1734075|NCT00001171|Glioma|glioma
1734076|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
1734077|NCT00001171|Pituitary Adenoma|pituitary adenoma
1734078|NCT00001170|Parental Psychopathology|parental psychopathology
1734079|NCT00001170|Child Rearing|child rearing
1734080|NCT00001170|Depression|depression
1734081|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
1734082|NCT00001170|Manic-Depression|manic-depression
1734083|NCT00001170|Social-Emotional Development|social-emotional development
1734084|NCT00001170|Cognitive Development|cognitive development
1734085|NCT00001170|Child Psychopathology|child psychopathology
1734086|NCT00001170|Affective Disorder|affective disorder
1734087|NCT00001170|Children at Risk|children at risk
1734088|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
1734089|NCT00001168|Hypercholesterolemia|hypercholesterolemia
1734090|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
1734091|NCT00001168|hypoalphalipoproteinemia|hypoalphalipoproteinemia
1734092|NCT00001168|Atherosclerosis|atherosclerosis
1734093|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
1734094|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
1734095|NCT00001167|Dysphagia|dysphagia
1734096|NCT00001167|Dysarthria|dysarthria
1734097|NCT00001167|Tongue Motion|tongue motion
1734098|NCT00001167|Xerostomia|xerostomia
1734099|NCT00001167|Swallowing|swallowing
1734100|NCT00001167|Speech|speech
1734101|NCT00001167|Polymyositis|polymyositis
1734102|NCT00001167|Speech Disorders|speech disorders
1734103|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
1734104|NCT00001167|Ultrasound|ultrasound
1734105|NCT00001166|Hyperornithinemia|hyperornithinemia
1734106|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
1734107|NCT00001166|Tissue Culture|tissue culture
1734108|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
1734109|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
1734110|NCT00001166|Arginine|arginine
1734111|NCT00001166|Skin Fibroblast|skin fibroblast
1734112|NCT00001166|Gyrate Atrophy|gyrate atrophy
1734113|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
1734114|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
1734115|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
1734116|NCT00001165|Gastrinoma|gastrinoma
1734117|NCT00001165|Acid Secretion|acid secretion
1734118|NCT00001165|Toxicity|toxicity
1734119|NCT00001163|Cancer|cancer
1734120|NCT00001163|Genes/Genetics|genes/genetics
1734121|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
1734122|NCT00001163|Environment|environment
1734123|NCT00001162|Giardia|giardia
1734124|NCT00001162|Helminth|helminth
1734125|NCT00001162|Cryptosporidium|cryptosporidium
1734126|NCT00001162|Hookworms|hookworms
1734127|NCT00001162|Trichuris|trichuris
1734128|NCT00001162|Strongyloides|strongyloides
1734129|NCT00001162|Protozoa|protozoa
1734130|NCT00001162|Small Bowel Biopsy|small bowel biopsy
1734131|NCT00001162|E. Histolytica|e. histolytica
1734132|NCT00001162|Duodenal Aspiration|duodenal aspiration
1734133|NCT00001162|Coccidiosis|coccidiosis
1734134|NCT00001162|Clonorchis|clonorchis
1734135|NCT00001162|Amebiasis|amebiasis
1734136|NCT00001162|Parasitic Disease|parasitic disease
1734137|NCT00001162|Tapeworm|tapeworm
1734138|NCT00001162|Trichinosis|trichinosis
1734139|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
1734140|NCT00001162|Opisthorchis|opisthorchis
1734141|NCT00001162|Paragonimiasis|paragonimiasis
1734142|NCT00001162|Echinococcus|echinococcus
1734143|NCT00001161|Irido Corneal Angle|irido corneal angle
1734144|NCT00001161|Mesothelium|mesothelium
1734145|NCT00001161|Congenital Anomalies|congenital anomalies
1734146|NCT00001161|Neural Crest|neural crest
1734147|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
1734148|NCT00001161|Glaucoma|glaucoma
1734149|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
1734150|NCT00001161|Rieger's Anomaly|rieger's anomaly
1734151|NCT00001161|Peter's Anomaly|peter's anomaly
1734152|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
1734153|NCT00001161|Aniridia|aniridia
1734154|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
1734155|NCT00001161|Megalocornea|megalocornea
1734156|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
1734157|NCT00001160|Radioiodine|radioiodine
1734158|NCT00001160|Dosimetry|dosimetry
1734159|NCT00001159|Hyperthyroidism|hyperthyroidism
1734160|NCT00001159|Hypothyroidism|hypothyroidism
1734161|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
1734162|NCT00001156|Immunogenetics|immunogenetics
1734163|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
1734164|NCT00001156|Twins|twins
1734165|NCT00001156|Epstein-Barr Virus|epstein-barr virus
1734166|NCT00001156|HTLV-I|htlv-i
1734167|NCT00001156|Vasculitis|vasculitis
1734168|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
1734169|NCT00001156|Immunity to Viruses|immunity to viruses
1734170|NCT00001156|Multiple Sclerosis|multiple sclerosis
1734171|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
1734172|NCT00001155|Vasculitis|vasculitis
1734173|NCT00001155|Prednisone|prednisone
1734174|NCT00001155|Granuloma|granuloma
1734175|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
1734176|NCT00001155|Cyclophosphamide|cyclophosphamide
1734177|NCT00001155|Renal Biopsy|renal biopsy
1734178|NCT00001154|Cholesterol|cholesterol
1734179|NCT00001154|Apolipoproteins|apolipoproteins
1734180|NCT00001154|Kinetics|kinetics
1734181|NCT00001151|Calciferol|calciferol
1734182|NCT00001151|Hypocalcemia|hypocalcemia
1734183|NCT00001151|Rickets|rickets
1734184|NCT00001150|Blister Formation|blister formation
1734185|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
1734186|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
1734187|NCT00001149|Anticonvulsants|anticonvulsants
1734188|NCT00001149|Intensive Monitoring|intensive monitoring
1734189|NCT00001149|Epilepsy|epilepsy
1734190|NCT00001148|Metastasis|metastasis
1734191|NCT00001148|Glioma|glioma
1734192|NCT00001148|Venous|venous
1734193|NCT00001148|Sampling|sampling
1734194|NCT00001148|p53 Mutation|p53 mutation
1734195|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
1734196|NCT00001148|Circulating Tumor Cells|circulating tumor cells
1734197|NCT00001148|Mutation|mutation
1734198|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
1734199|NCT00001147|Dopamine|dopamine
1734200|NCT00001147|Metanephrine|metanephrine
1734201|NCT00001147|Norepinephrine|norepinephrine
1734202|NCT00001147|Epinephrine|epinephrine
1734203|NCT00001147|Catecholamines|catecholamines
1734204|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
1734205|NCT00001147|Monoamine Oxidase|monoamine oxidase
1734206|NCT00001147|Phenosulfotransferase|phenosulfotransferase
1734207|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
1734208|NCT00001147|Normetanephrine|normetanephrine
1734209|NCT00001146|Bipolar Disorder|bipolar disorder
1734210|NCT00001146|Clinical Trial|clinical trial
1734211|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
1734212|NCT00001146|Life Chart Methodology|life chart methodology
1734213|NCT00001146|Mood Disorders|mood disorders
1734214|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
1734215|NCT00001146|Rapid Cycling|rapid cycling
1734216|NCT00001146|Treatment|treatment
1734217|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
1734218|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
1734220|NCT00001145|Phi-X 174|phi-x 174
1734221|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
1734222|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
1734223|NCT00001144|Engraftment|engraftment
1734224|NCT00001144|Graft vs. Host Disease|graft vs. host disease
1734225|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
1734226|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
1734227|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
1734228|NCT00001143|Eye Movements|eye movements
1734229|NCT00001143|Strabismus|strabismus
1734230|NCT00001143|Infants|infants
1734231|NCT00001143|Development|development
1734232|NCT00001143|Ocular Motor System|ocular motor system
1734233|NCT00000426|Calcium deficiency|calcium deficiency
1734234|NCT00000426|Dietary calcium|dietary calcium
1734235|NCT00000426|Dietary protein|dietary protein
1734236|NCT00000426|Osteoporosis|osteoporosis
1734237|NCT00000426|Calcium supplement|calcium supplement
1734238|NCT00000426|Bone density|bone density
1734239|NCT00000426|Bone mass|bone mass
1734240|NCT00000426|Bone mass accumulation|bone mass accumulation
1734241|NCT00000425|Osteoarthritis|osteoarthritis
1734242|NCT00000425|Skeletal disorder|skeletal disorder
1734243|NCT00000425|Chemotherapy|chemotherapy
1734244|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
1734245|NCT00000425|Arthroplasty|arthroplasty
1734246|NCT00000425|Cartilage metabolism|cartilage metabolism
1734247|NCT00000425|Hip|hip
1734248|NCT00000425|Knee|knee
1734249|NCT00000425|Outcomes research|outcomes research
1734250|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
1734251|NCT00000424|Knee|knee
1734252|NCT00000424|Sham lavage|sham lavage
1734253|NCT00000424|Tidal lavage|tidal lavage
1734254|NCT00000424|Lavage therapy|lavage therapy
1734255|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
1734256|NCT00000424|Placebo|placebo
1734257|NCT00000424|Radiography|radiography
1734258|NCT00000424|Human therapy evaluation|human therapy evaluation
1734259|NCT00000424|WOMAC|womac
1734260|NCT00000423|Fibromyalgia|fibromyalgia
1734261|NCT00000423|Health education|health education
1734262|NCT00000423|Program evaluation|program evaluation
1734263|NCT00000423|Social support|social support
1734264|NCT00000423|Managed care|managed care
1734265|NCT00000423|Quality of well-being|quality of well-being
1734266|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
1734267|NCT00000422|Physical therapy|physical therapy
1734268|NCT00000422|Psychotherapy|psychotherapy
1734269|NCT00000422|Group counseling|group counseling
1734270|NCT00000422|Human therapy relations|human therapy relations
1734271|NCT00000422|Interpersonal relations|interpersonal relations
1734272|NCT00000422|Chronic pain|chronic pain
1734273|NCT00000422|Cognition|cognition
1734274|NCT00000422|Emotion|emotion
1734275|NCT00000422|Memory|memory
1734276|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
1734277|NCT00000422|Psychological stressor|psychological stressor
1734278|NCT00000422|Psychological adaptation|psychological adaptation
1734279|NCT00000422|Outcomes research|outcomes research
1734280|NCT00000421|SLE|sle
1734281|NCT00000421|Lupus|lupus
1734282|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
1734283|NCT00000421|Corticosteroid treatment|corticosteroid treatment
1734284|NCT00000421|Hormone therapy|hormone therapy
1734285|NCT00000421|Complement|complement
1734286|NCT00000421|Hypertension|hypertension
1734287|NCT00000421|Estrogen|estrogen
1734288|NCT00000421|SELENA|selena
1734289|NCT00000420|SLE|sle
1734290|NCT00000420|SELENA|selena
1734291|NCT00000420|Oral contraceptives|oral contraceptives
1734292|NCT00000420|The pill|the pill
1734293|NCT00000420|Birth control|birth control
1734294|NCT00000420|Condom|condom
1734295|NCT00000420|Diaphragm|diaphragm
1734296|NCT00000420|Estrogen|estrogen
1734297|NCT00000420|Lupus|lupus
1734298|NCT00000420|Placebo|placebo
1734299|NCT00000419|SLE|sle
1734300|NCT00000419|SELENA|selena
1734301|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
1734302|NCT00000419|Postmenopause|postmenopause
1734303|NCT00000419|Osteoporosis|osteoporosis
1734304|NCT00000419|Estrogens|estrogens
1734305|NCT00000419|Steroids|steroids
1734306|NCT00000419|Progestin|progestin
1734307|NCT00000419|Placebo|placebo
1734308|NCT00000418|OA|oa
1734309|NCT00000418|Patient education|patient education
1734310|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
1734311|NCT00000418|Social support systems|social support systems
1734312|NCT00000417|SLE|sle
1734313|NCT00000417|Lupus|lupus
1734314|NCT00000417|Educational intervention|educational intervention
1734315|NCT00000417|Health education|health education
1734316|NCT00000417|Social support network|social support network
1734317|NCT00000417|Outcomes research|outcomes research
1734318|NCT00000417|Self-help|self-help
1734319|NCT00000416|Arthritis|arthritis
1734320|NCT00000416|Rheumatic disorders|rheumatic disorders
1734321|NCT00000416|Work-related disability|work-related disability
1734322|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
1734323|NCT00000416|Job retention services|job retention services
1734324|NCT00000416|Work limitations|work limitations
1734325|NCT00000416|Work instability|work instability
1734326|NCT00000415|Calcium|calcium
1734327|NCT00000415|Physical activity|physical activity
1734328|NCT00000415|Children|children
1734329|NCT00000415|Bone mass accretion|bone mass accretion
1734330|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
1734331|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
1734332|NCT00000415|Placebo|placebo
1734333|NCT00000415|Bone growth|bone growth
1734334|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
1734335|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
1734336|NCT00000414|Arthritis education|arthritis education
1734337|NCT00000414|Health care service evaluation|health care service evaluation
1734338|NCT00000414|Outcomes research|outcomes research
1734339|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
1734340|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
1734341|NCT00000413|Osteoporosis prevention|osteoporosis prevention
1734342|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
1734343|NCT00000413|Preadolescent|preadolescent
1734344|NCT00000413|Calcium|calcium
1734345|NCT00000413|Exercise|exercise
1734346|NCT00000413|Peak bone mass|peak bone mass
1734347|NCT00000413|Bone density|bone density
1734348|NCT00000412|Osteoporosis|osteoporosis
1734349|NCT00000412|Osteopenia|osteopenia
1734350|NCT00000412|Heart transplant|heart transplant
1734351|NCT00000412|Bone fracture|bone fracture
1734352|NCT00000412|Bone density|bone density
1734353|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
1734354|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
1734355|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
1734356|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
1734357|NCT00000411|Low back pain (LBP)|low back pain (lbp)
1734358|NCT00000411|Surgical therapy|surgical therapy
1734359|NCT00000411|Nonsurgical therapy|nonsurgical therapy
1734360|NCT00000411|Randomized study|randomized study
1734361|NCT00000411|Multicenter|multicenter
1734363|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
1734364|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
1734365|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
1734366|NCT00000410|Low back pain (LBP)|low back pain (lbp)
1734367|NCT00000410|Leg pain|leg pain
1734368|NCT00000410|Surgical therapy|surgical therapy
1734369|NCT00000410|Non-surgical therapy|non-surgical therapy
1734370|NCT00000410|Randomized study|randomized study
1734371|NCT00000410|Multicenter|multicenter
1734373|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
1734374|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
1734375|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
1734376|NCT00000409|Low back pain (LBP)|low back pain (lbp)
1734377|NCT00000409|Leg pain|leg pain
1734378|NCT00000409|Surgical therapy|surgical therapy
1734379|NCT00000409|Randomized study|randomized study
1734380|NCT00000409|Multicenter|multicenter
1734381|NCT00000409|MRI|mri
1734382|NCT00000409|Nonsurgical therapy|nonsurgical therapy
1734383|NCT00000408|Health education|health education
1734384|NCT00000408|Back injury|back injury
1734385|NCT00000408|Chronic pain|chronic pain
1734386|NCT00000408|Education/evaluation planning|education/evaluation planning
1734387|NCT00000408|Outcomes research|outcomes research
1734388|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
1734389|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
1734390|NCT00000407|Agency enhancement intervention|agency enhancement intervention
1734391|NCT00000407|Health care service evaluation|health care service evaluation
1734392|NCT00000407|Musculoskeletal disability|musculoskeletal disability
1734393|NCT00000407|Return to work|return to work
1734394|NCT00000407|Outcomes research|outcomes research
1734395|NCT00000407|Unemployment|unemployment
1734396|NCT00000407|Work disability|work disability
1734397|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
1734398|NCT00000406|Knee|knee
1734399|NCT00000406|Radiographic OA|radiographic oa
1734400|NCT00000406|Strength training|strength training
1734401|NCT00000406|Physical therapy|physical therapy
1734402|NCT00000406|Exercise|exercise
1734403|NCT00000406|Body composition|body composition
1734404|NCT00000406|Striated muscle|striated muscle
1734406|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
1734407|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
1734408|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
1734409|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
1734410|NCT00000405|Osteoporosis|osteoporosis
1734411|NCT00000405|Bone fractures|bone fractures
1734412|NCT00000405|Bone mass|bone mass
1734413|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
1734414|NCT00000405|Ossification|ossification
1734415|NCT00000405|Biomechanics|biomechanics
1734416|NCT00000405|Exercise|exercise
1734417|NCT00000405|Diet|diet
1734418|NCT00000405|Spine|spine
1734419|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
1734420|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
1734421|NCT00000404|Knee|knee
1734422|NCT00000404|HMO|hmo
1734423|NCT00000404|Comprehensive care|comprehensive care
1734424|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
1734425|NCT00000403|Knee|knee
1734426|NCT00000403|Doxycycline|doxycycline
1734427|NCT00000403|Skeletal disorder|skeletal disorder
1734428|NCT00000403|Placebo|placebo
1734429|NCT00000403|Urinalysis|urinalysis
1734430|NCT00000403|NSAIDs|nsaids
1734431|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
1734432|NCT00000403|WOMAC|womac
1734433|NCT00000402|Osteoporosis|osteoporosis
1734434|NCT00000402|Dietary calcium|dietary calcium
1734435|NCT00000402|Puberty|puberty
1734436|NCT00000402|Bone density|bone density
1734437|NCT00000402|Bone mass|bone mass
1734438|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
1734439|NCT00000401|NSAIDs|nsaids
1734440|NCT00000401|Oral Tolerance|oral tolerance
1734441|NCT00000401|Drug Interaction|drug interaction
1734442|NCT00000401|Oral Administration|oral administration
1734443|NCT00000401|Interleukin 10|interleukin 10
1734444|NCT00000401|Collagen|collagen
1734445|NCT00000401|Chemotherapy|chemotherapy
1734446|NCT00000401|Human Therapy Evaluation|human therapy evaluation
1734447|NCT00000401|DMARDs|dmards
1734448|NCT00000401|RA|ra
1734449|NCT00000401|IL-10|il-10
1734450|NCT00000400|Osteoporosis|osteoporosis
1734451|NCT00000400|Bone formation|bone formation
1734452|NCT00000400|Bone resorption|bone resorption
1734453|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
1734454|NCT00000400|Postmenopause|postmenopause
1734455|NCT00000399|Estrogen|estrogen
1734456|NCT00000399|Hormone therapy|hormone therapy
1734457|NCT00000399|Strength training|strength training
1734458|NCT00000399|Exercise|exercise
1734459|NCT00000399|Postmenopause|postmenopause
1734460|NCT00000399|Disorder prevention|disorder prevention
1734461|NCT00000399|Osteoporosis|osteoporosis
1734462|NCT00000399|Bone mineral density|bone mineral density
1734463|NCT00000399|Bone mass|bone mass
1734464|NCT00000399|Cholesterol|cholesterol
1734465|NCT00000399|Body composition|body composition
1734466|NCT00000398|Fibromyalgia|fibromyalgia
1734467|NCT00000398|Pain|pain
1734468|NCT00000398|Coping skills training|coping skills training
1734469|NCT00000398|Physical exercise training|physical exercise training
1734470|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
1734471|NCT00000397|Fibromyalgia|fibromyalgia
1734472|NCT00000397|Insomnia|insomnia
1734473|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
1734474|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
1734475|NCT00000396|Arthritis|arthritis
1734476|NCT00000396|Arthritis education|arthritis education
1734477|NCT00000396|African Americans|african americans
1734478|NCT00000396|Self-help|self-help
1734479|NCT00000396|Self-management|self-management
1734480|NCT00000396|Cultural beliefs|cultural beliefs
1734481|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
1734482|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
1734483|NCT00000395|Antifolate efficacy|antifolate efficacy
1734484|NCT00000395|Autoimmunity|autoimmunity
1734485|NCT00000395|Adenosine metabolism|adenosine metabolism
1734486|NCT00000395|Methotrexate therapy|methotrexate therapy
1734487|NCT00000395|Skeletal disorder|skeletal disorder
1734488|NCT00000395|Dietary supplement|dietary supplement
1734489|NCT00000395|Antiarthritic agent|antiarthritic agent
1734490|NCT00000395|Folic acid|folic acid
1734491|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
1734492|NCT00000394|Acupuncture|acupuncture
1734493|NCT00000394|Median nerve|median nerve
1734494|NCT00000394|Single-blind mute methodology|single-blind mute methodology
1734495|NCT00000104|lead overburden|lead overburden
1734496|NCT00000456|Alcoholism|alcoholism
1734497|NCT00000456|Alcohol Dependence|alcohol dependence
1734498|NCT00000456|Naltrexone|naltrexone
1734499|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
1734500|NCT00000451|Alcoholism|alcoholism
1734501|NCT00000451|Alcohol Dependence|alcohol dependence
1734502|NCT00000389|Adolescence|adolescence
1734503|NCT00000389|Anxiety Disorders|anxiety disorders
1734504|NCT00000389|Child|child
1734505|NCT00000389|Female|female
1734506|NCT00000389|Fluvoxamine|fluvoxamine
1734507|NCT00000389|Human|human
1734509|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734510|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
1734511|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
1734512|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
1734513|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
1734514|NCT00000388|Adolescence|adolescence
1734515|NCT00000388|Child|child
1734516|NCT00000388|Cognition|cognition
1734517|NCT00000388|Combined Modality Therapy|combined modality therapy
1734518|NCT00000388|Female|female
1734519|NCT00000388|Human|human
1734520|NCT00000388|Male|male
1734521|NCT00000388|Peer Group|peer group
1734522|NCT00000388|Risk Factors|risk factors
1734523|NCT00000388|Treatment Outcome|treatment outcome
1734524|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
1734525|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
1734526|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
1734527|NCT00000387|Adolescence|adolescence
1734528|NCT00000387|Family|family
1734529|NCT00000387|Female|female
1734530|NCT00000387|Human|human
1734531|NCT00000387|Male|male
1734532|NCT00000387|Schizophrenia|schizophrenia
1734533|NCT00000387|Self Care|self care
1734534|NCT00000387|Community Health Services|community health services
1734535|NCT00000386|Adolescence|adolescence
1734537|NCT00000386|Comparative Study|comparative study
1734538|NCT00000386|Family|family
1734539|NCT00000386|Female|female
1734540|NCT00000386|Human|human
1734541|NCT00000386|Male|male
1734542|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1734543|NCT00000386|Relaxation Techniques|relaxation techniques
1734544|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
1734545|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
1734546|NCT00000385|Adolescence|adolescence
1734547|NCT00000385|Child|child
1734548|NCT00000385|Conduct Disorder|conduct disorder
1734549|NCT00000385|Female|female
1734550|NCT00000385|Lithium|lithium
1734551|NCT00000385|Male|male
1734552|NCT00000385|Placebos|placebos
1734553|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
1734554|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
1734555|NCT00000384|Adolescence|adolescence
1734556|NCT00000384|Child|child
1734557|NCT00000384|Cognitive Therapy|cognitive therapy
1734558|NCT00000384|Combined Modality Therapy|combined modality therapy
1734559|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1734560|NCT00000384|Placebos|placebos
1734561|NCT00000384|Sertraline|sertraline
1734562|NCT00000384|Patient Education|patient education
1734563|NCT00000384|Psychotherapy|psychotherapy
1734564|NCT00000383|Adolescence|adolescence
1734565|NCT00000383|Child|child
1734566|NCT00000383|Cognitive Therapy|cognitive therapy
1734567|NCT00000383|Comparative Study|comparative study
1734568|NCT00000383|Female|female
1734569|NCT00000383|Human|human
1734570|NCT00000383|Male|male
1734571|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1734572|NCT00000383|Child Abuse, Sexual|child abuse, sexual
1734573|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
1734574|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
1734575|NCT00000382|Child Abuse|child abuse
1734576|NCT00000382|Female|female
1734577|NCT00000382|Human|human
1734578|NCT00000382|Infant|infant
1734579|NCT00000382|Male|male
1734580|NCT00000382|Caregivers|caregivers
1734581|NCT00000382|Patient Education|patient education
1734582|NCT00000382|Psychotherapy|psychotherapy
1734583|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
1734584|NCT00000381|Adolescence|adolescence
1734585|NCT00000381|Anxiety Disorders|anxiety disorders
1734586|NCT00000381|Child|child
1734587|NCT00000381|Female|female
1734588|NCT00000381|Fluoxetine|fluoxetine
1734589|NCT00000381|Male|male
1734590|NCT00000381|Placebos|placebos
1734591|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734592|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
1734593|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
1734594|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
1734595|NCT00000380|Adult|adult
1734596|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
1734597|NCT00000380|Female|female
1734598|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
1734599|NCT00000380|Human|human
1734600|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
1734601|NCT00000380|Male|male
1734602|NCT00000380|Placebos|placebos
1734603|NCT00000380|Sleep Disorders|sleep disorders
1734604|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
1734605|NCT00000380|Somatotropin|somatotropin
1734606|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
1734607|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
1734608|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
1734609|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
1734610|NCT00000379|Adult|adult
1734611|NCT00000379|Comparative Study|comparative study
1734612|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
1734613|NCT00000379|Eye Movements|eye movements
1734614|NCT00000379|Female|female
1734615|NCT00000379|Fluoxetine|fluoxetine
1734616|NCT00000379|Human|human
1734617|NCT00000379|Male|male
1734618|NCT00000379|Placebos|placebos
1734619|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
1734620|NCT00000379|Treatment Outcome|treatment outcome
1734621|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
1734622|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
1734623|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
1734624|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
1734625|NCT00000378|Aged|aged
1734626|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
1734627|NCT00000378|Depression|depression
1734628|NCT00000378|Female|female
1734629|NCT00000378|Human|human
1734630|NCT00000378|Male|male
1734631|NCT00000378|Middle Age|middle age
1734632|NCT00000378|Nortriptyline|nortriptyline
1734633|NCT00000378|Sertraline|sertraline
1734634|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734635|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
1734636|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
1734637|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
1734638|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
1734639|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
1734640|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
1734641|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
1734642|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
1734643|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
1734644|NCT00000377|Aged|aged
1734645|NCT00000377|Antidepressive Agents|antidepressive agents
1734646|NCT00000377|Depression|depression
1734647|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
1734648|NCT00000377|Female|female
1734649|NCT00000377|Human|human
1734650|NCT00000377|Male|male
1734651|NCT00000377|Middle Age|middle age
1734652|NCT00000377|Nortriptyline|nortriptyline
1734653|NCT00000377|Placebos|placebos
1734654|NCT00000377|Recurrence|recurrence
1734655|NCT00000377|Aged, 80 and over|aged, 80 and over
1734656|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
1734657|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
1734658|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
1734659|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
1734660|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
1734661|NCT00000376|Adult|adult
1734662|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
1734663|NCT00000376|Anxiety Disorders|anxiety disorders
1734664|NCT00000376|Cognitive Therapy|cognitive therapy
1734665|NCT00000376|Combined Modality Therapy|combined modality therapy
1734666|NCT00000376|Depression|depression
1734667|NCT00000376|Desipramine|desipramine
1734668|NCT00000376|Female|female
1734669|NCT00000376|Human|human
1734670|NCT00000376|Male|male
1734671|NCT00000376|Personality Disorders|personality disorders
1734672|NCT00000376|Pilot Projects|pilot projects
1734673|NCT00000376|Patient Care Team|patient care team
1734674|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
1734675|NCT00000376|Depression -- *therapy|depression -- *therapy
1734676|NCT00000376|Depression -- drug therapy|depression -- drug therapy
1734677|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
1734678|NCT00000375|Adult|adult
1734679|NCT00000375|Antidepressive Agents|antidepressive agents
1734680|NCT00000375|Depressive Disorder|depressive disorder
1734681|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
1734682|NCT00000375|Female|female
1734683|NCT00000375|Human|human
1734684|NCT00000375|Lithium|lithium
1734685|NCT00000375|Male|male
1734686|NCT00000375|Nortriptyline|nortriptyline
1734687|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734688|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
1734689|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
1734690|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
1734691|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
1734692|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
1734693|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
1734694|NCT00000374|Adolescence|adolescence
1734695|NCT00000374|Adult|adult
1734696|NCT00000374|Antipsychotic Agents|antipsychotic agents
1734697|NCT00000374|Female|female
1734698|NCT00000374|Human|human
1734699|NCT00000374|Male|male
1734700|NCT00000374|olanzapine|olanzapine
1734701|NCT00000374|Risperidone|risperidone
1734702|NCT00000374|Schizophrenia|schizophrenia
1734703|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
1734704|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
1734705|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
1734830|NCT00000179|Behavioral symptoms|behavioral symptoms
1734706|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
1734707|NCT00000373|Adolescence|adolescence
1734708|NCT00000373|Adult|adult
1734709|NCT00000373|Antipsychotic Agents|antipsychotic agents
1734710|NCT00000373|Dopamine Antagonists|dopamine antagonists
1734711|NCT00000373|Female|female
1734712|NCT00000373|Fluvoxamine|fluvoxamine
1734713|NCT00000373|Haloperidol|haloperidol
1734714|NCT00000373|Human|human
1734715|NCT00000373|Male|male
1734716|NCT00000373|Middle Age|middle age
1734717|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
1734718|NCT00000373|Placebos|placebos
1734719|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734720|NCT00000373|Tourette Syndrome|tourette syndrome
1734721|NCT00000373|Tryptophan|tryptophan
1734722|NCT00000373|Drug Combinations|drug combinations
1734723|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
1734724|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
1734725|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
1734726|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
1734727|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
1734728|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
1734729|NCT00000372|Adult|adult
1734730|NCT00000372|Amino Acids|amino acids
1734731|NCT00000372|Cycloserine|cycloserine
1734732|NCT00000372|Female|female
1734733|NCT00000372|Glycine|glycine
1734734|NCT00000372|Human|human
1734735|NCT00000372|Male|male
1734736|NCT00000372|N-Methylaspartate|n-methylaspartate
1734737|NCT00000372|Placebos|placebos
1734738|NCT00000372|Schizophrenia|schizophrenia
1734739|NCT00000372|Amino Acids -- blood|amino acids -- blood
1734740|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
1734741|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
1734742|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
1734743|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
1734744|NCT00000371|Adult|adult
1734745|NCT00000371|Cognition|cognition
1734746|NCT00000371|Cycloserine|cycloserine
1734747|NCT00000371|Dopamine|dopamine
1734748|NCT00000371|Female|female
1734749|NCT00000371|Glutamic Acid|glutamic acid
1734750|NCT00000371|Human|human
1734751|NCT00000371|Male|male
1734752|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
1734753|NCT00000371|Schizophrenia|schizophrenia
1734754|NCT00000371|Serotonin|serotonin
1734755|NCT00000371|Quality of Life|quality of life
1734756|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
1734757|NCT00000371|Dopamine -- blood|dopamine -- blood
1734758|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
1734759|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
1734760|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
1734761|NCT00000371|Serotonin -- blood|serotonin -- blood
1734762|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
1734763|NCT00000370|Cognitive Therapy|cognitive therapy
1734764|NCT00000370|Cost of Illness|cost of illness
1734765|NCT00000370|Female|female
1734766|NCT00000370|Human|human
1734767|NCT00000370|Male|male
1734768|NCT00000370|Phobic Disorders|phobic disorders
1734769|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
1734770|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
1734771|NCT00000369|Adult|adult
1734772|NCT00000369|Antidepressive Agents|antidepressive agents
1734773|NCT00000369|Bipolar Disorder|bipolar disorder
1734774|NCT00000369|Combined Modality Therapy|combined modality therapy
1734775|NCT00000369|Female|female
1734776|NCT00000369|Human|human
1734777|NCT00000369|Lithium Carbonate|lithium carbonate
1734778|NCT00000369|Male|male
1734779|NCT00000369|Psychotherapy|psychotherapy
1734780|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
1734781|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
1734782|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
1734783|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
1734784|NCT00000368|Adult|adult
1734785|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
1734786|NCT00000368|Pharmacotherapy|pharmacotherapy
1734787|NCT00000368|Long term treatment|long term treatment
1734788|NCT00000368|Remission and relapse|remission and relapse
1734789|NCT00000368|Male|male
1734790|NCT00000368|Panic Disorder|panic disorder
1734792|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
1734793|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
1734794|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
1734795|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
1734796|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
1734797|NCT00000367|Depression|depression
1734798|NCT00000367|Family|family
1734799|NCT00000367|Female|female
1734800|NCT00000367|Human|human
1734801|NCT00000367|Male|male
1734802|NCT00000367|Practice Guidelines|practice guidelines
1734803|NCT00000367|Education, Medical, Continuing|education, medical, continuing
1734804|NCT00000367|Patient Education|patient education
1734805|NCT00000367|Suicide|suicide
1734806|NCT00000363|Antibiotics|antibiotics
1734807|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
1734808|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
1734809|NCT00000363|Infant|infant
1734810|NCT00000363|Otitis Media|otitis media
1734811|NCT00000362|Deglutition Disorders|deglutition disorders
1734812|NCT00000362|Dementia|dementia
1734813|NCT00000362|Parkinson Disease|parkinson disease
1734814|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
1734815|NCT00000361|Autoimmune Diseases|autoimmune diseases
1734816|NCT00000361|Cyclophosphamide|cyclophosphamide
1734817|NCT00000361|Hearing|hearing
1734818|NCT00000361|Labyrinth Diseases|labyrinth diseases
1734819|NCT00000361|Methotrexate|methotrexate
1734820|NCT00000361|Prednisone|prednisone
1735089|NCT00004416|achalasia|achalasia
1734821|NCT00000359|Physical Therapy|physical therapy
1734822|NCT00000359|Vertigo|vertigo
1734823|NCT00000359|rehabilitation|rehabilitation
1734824|NCT00000359|occupational therapy|occupational therapy
1734825|NCT00000180|Memory|memory
1734826|NCT00000180|Mild cognitive impairment|mild cognitive impairment
1734827|NCT00000180|Nerve growth factors|nerve growth factors
1734828|NCT00000179|Alzheimer's disease|alzheimer's disease
1734829|NCT00000179|Psychomotor agitation|psychomotor agitation
1734831|NCT00000179|Haloperidol|haloperidol
1734832|NCT00000179|Trazodone|trazodone
1734833|NCT00000179|Anti-psychotic agents|anti-psychotic agents
1734834|NCT00000179|Anti-depressant agents|anti-depressant agents
1734835|NCT00000178|Alzheimer's disease|alzheimer's disease
1734836|NCT00000178|Prednisone|prednisone
1734837|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
1734838|NCT00000177|Alzheimer's disease|alzheimer's disease
1734839|NCT00000177|Estrogen|estrogen
1734840|NCT00000176|Alzheimer's disease|alzheimer's disease
1734841|NCT00000176|memory loss|memory loss
1734842|NCT00000176|Estrogen|estrogen
1734843|NCT00000175|Emotions|emotions
1734844|NCT00000175|Cognition|cognition
1734845|NCT00000175|Aging|aging
1734846|NCT00000175|Memory|memory
1734847|NCT00000174|Mild cognitive impairment|mild cognitive impairment
1734848|NCT00000174|Alzheimer's disease|alzheimer's disease
1734849|NCT00000174|Memory|memory
1734850|NCT00000174|Cholinergic agents|cholinergic agents
1734851|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
1734852|NCT00000173|Mild cognitive impairment|mild cognitive impairment
1734853|NCT00000173|Alzheimer's disease|alzheimer's disease
1734854|NCT00000173|Memory|memory
1734855|NCT00000173|Donepezil|donepezil
1734856|NCT00000173|Vitamin E|vitamin e
1734857|NCT00000173|Antioxidants|antioxidants
1734858|NCT00000173|Cholinergic agents|cholinergic agents
1734859|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
1734860|NCT00000172|Alzheimer's disease|alzheimer's disease
1734861|NCT00000172|Cholinergic agents|cholinergic agents
1734862|NCT00000172|Cholinergic agonists|cholinergic agonists
1734863|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
1734864|NCT00000171|Alzheimer's disease|alzheimer's disease
1734865|NCT00000171|Sleep disorders|sleep disorders
1734866|NCT00000171|Melatonin|melatonin
1734867|NCT00000623|chelator|chelator
1734868|NCT00000623|iron|iron
1734869|NCT00000623|transfusion|transfusion
1734870|NCT00000623|anemia|anemia
1734871|NCT00000623|thalassemia|thalassemia
1734872|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
1734873|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734874|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
1734875|NCT00004500|rare disease|rare disease
1734876|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1734877|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
1734878|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
1734879|NCT00004498|rare disease|rare disease
1734880|NCT00004498|urea cycle disorder|urea cycle disorder
1734881|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734882|NCT00004497|hypertensive disorder|hypertensive disorder
1734883|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
1734884|NCT00004497|rare disease|rare disease
1734885|NCT00004496|acute renal failure|acute renal failure
1734886|NCT00004496|rare disease|rare disease
1734887|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
1734888|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734889|NCT00004495|end stage renal disease|end stage renal disease
1734890|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
1734891|NCT00004495|rare disease|rare disease
1734892|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
1734893|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734894|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1734895|NCT00004494|neonatal disorders|neonatal disorders
1734896|NCT00004494|rare disease|rare disease
1734897|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
1734898|NCT00004494|sepsis|sepsis
1734899|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
1734900|NCT00004493|lactic acidosis|lactic acidosis
1734901|NCT00004493|rare disease|rare disease
1734902|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1734903|NCT00004492|hematologic disorders|hematologic disorders
1734904|NCT00004492|rare disease|rare disease
1734905|NCT00004492|sickle cell anemia|sickle cell anemia
1734906|NCT00004490|disease-related problem/condition|disease-related problem/condition
1734907|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
1734908|NCT00004490|lactic acidosis|lactic acidosis
1734909|NCT00004490|quality of life|quality of life
1734910|NCT00004490|rare disease|rare disease
1734911|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734912|NCT00004489|cystic fibrosis|cystic fibrosis
1734913|NCT00004489|disease-related problem/condition|disease-related problem/condition
1735090|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
1734914|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1734915|NCT00004489|osteoporosis|osteoporosis
1734916|NCT00004489|rare disease|rare disease
1734917|NCT00004488|Gaucher's disease|gaucher's disease
1734918|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
1734919|NCT00004488|rare disease|rare disease
1734920|NCT00004488|sphingolipidoses|sphingolipidoses
1734921|NCT00004487|rare disease|rare disease
1734922|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
1734923|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
1734924|NCT00004486|autism|autism
1734925|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734926|NCT00004486|rare disease|rare disease
1734927|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1734928|NCT00004485|hematologic disorders|hematologic disorders
1734929|NCT00004485|rare disease|rare disease
1734930|NCT00004485|sickle cell anemia|sickle cell anemia
1734931|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734932|NCT00004482|giant cell myocarditis|giant cell myocarditis
1734933|NCT00004482|rare disease|rare disease
1734934|NCT00004481|endocrine disorders|endocrine disorders
1734935|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
1734936|NCT00004481|rare disease|rare disease
1734937|NCT00004481|sitosterolemia|sitosterolemia
1734938|NCT00004480|dermatologic disorders|dermatologic disorders
1734939|NCT00004480|hyperhidrosis|hyperhidrosis
1734940|NCT00004480|rare disease|rare disease
1734941|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734942|NCT00004479|rare disease|rare disease
1734943|NCT00004479|syncope|syncope
1734944|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
1734945|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734946|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734947|NCT00004478|orthostatic hypotension|orthostatic hypotension
1734948|NCT00004478|rare disease|rare disease
1734949|NCT00004474|Hematologic Disorders|hematologic disorders
1734950|NCT00004474|Rare Disease|rare disease
1734951|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734952|NCT00004471|cystic fibrosis|cystic fibrosis
1734953|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1734954|NCT00004471|rare disease|rare disease
1734955|NCT00004468|dermatologic disorders|dermatologic disorders
1734956|NCT00004468|psoriasis|psoriasis
1734957|NCT00004468|rare disease|rare disease
1734958|NCT00004467|acute liver failure|acute liver failure
1734959|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
1734960|NCT00004467|rare disease|rare disease
1734961|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1734962|NCT00004466|hyperlipidemia|hyperlipidemia
1734963|NCT00004466|nephrotic syndrome|nephrotic syndrome
1734964|NCT00004466|rare disease|rare disease
1734965|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
1734966|NCT00004465|E. coli infection|e. coli infection
1734967|NCT00004465|bacterial infection|bacterial infection
1734968|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
1734969|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1734970|NCT00004465|rare disease|rare disease
1734971|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
1734972|NCT00004464|aplastic anemia|aplastic anemia
1734973|NCT00004464|hematologic disorders|hematologic disorders
1734974|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
1734975|NCT00004464|rare disease|rare disease
1734977|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
1734978|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734979|NCT00004458|rare disease|rare disease
1734980|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
1734981|NCT00004457|motor neuron disease|motor neuron disease
1734982|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734983|NCT00004457|rare disease|rare disease
1734984|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
1734985|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
1734986|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
1734987|NCT00004454|rare disease|rare disease
1734988|NCT00004451|Parkinson disease|parkinson disease
1734989|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734990|NCT00004451|rare disease|rare disease
1734991|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
1734992|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
1734993|NCT00004450|rare disease|rare disease
1734994|NCT00004450|sphingolipidoses|sphingolipidoses
1734996|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1734997|NCT00004449|rare disease|rare disease
1734998|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
1734999|NCT00004448|rare disease|rare disease
1735000|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
1735001|NCT00004446|depersonalization disorder|depersonalization disorder
1735002|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735003|NCT00004446|rare disease|rare disease
1735004|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
1735005|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735006|NCT00004445|rare disease|rare disease
1735007|NCT00004445|spinal cord injury|spinal cord injury
1735008|NCT00004444|bacterial infection|bacterial infection
1735009|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735010|NCT00004444|mycobacterium infection|mycobacterium infection
1735011|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
1735012|NCT00004444|rare disease|rare disease
1735013|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
1735014|NCT00004443|rare disease|rare disease
1735015|NCT00004443|tyrosinemia I|tyrosinemia i
1735016|NCT00004442|Zellweger syndrome|zellweger syndrome
1735017|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
1735018|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
1735019|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
1735020|NCT00004442|infantile Refsum's disease|infantile refsum's disease
1735021|NCT00004442|peroxisomal disorders|peroxisomal disorders
1735022|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
1735023|NCT00004442|rare disease|rare disease
1735024|NCT00004442|sphingolipidoses|sphingolipidoses
1735025|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735026|NCT00004441|cystic fibrosis|cystic fibrosis
1735027|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735028|NCT00004441|rare disease|rare disease
1735029|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735030|NCT00004440|cystic fibrosis|cystic fibrosis
1735031|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735032|NCT00004440|rare disease|rare disease
1735033|NCT00004438|endocrine disorders|endocrine disorders
1735034|NCT00004438|hypogonadism|hypogonadism
1735035|NCT00004438|rare disease|rare disease
1735036|NCT00004437|acoustic neuroma|acoustic neuroma
1735037|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735038|NCT00004437|hearing loss|hearing loss
1735039|NCT00004437|neurofibromatosis|neurofibromatosis
1735040|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735041|NCT00004437|rare disease|rare disease
1735042|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735043|NCT00004436|hemangioma|hemangioma
1735044|NCT00004436|rare disease|rare disease
1735045|NCT00004433|Tourette syndrome|tourette syndrome
1735046|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735047|NCT00004433|rare disease|rare disease
1735048|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735049|NCT00004431|rare disease|rare disease
1735050|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
1735051|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735052|NCT00004430|corneal neovascularization|corneal neovascularization
1735053|NCT00004430|rare disease|rare disease
1735054|NCT00004429|end stage renal disease|end stage renal disease
1735055|NCT00004429|rare disease|rare disease
1735056|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
1735057|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735058|NCT00004428|cystic fibrosis|cystic fibrosis
1735059|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735060|NCT00004428|rare disease|rare disease
1735061|NCT00004426|endocrine disorders|endocrine disorders
1735062|NCT00004426|hypogonadism|hypogonadism
1735063|NCT00004426|rare disease|rare disease
1735064|NCT00004424|disease-related problem/condition|disease-related problem/condition
1735065|NCT00004424|oncologic disorders|oncologic disorders
1735066|NCT00004424|pulmonary complications|pulmonary complications
1735067|NCT00004424|rare disease|rare disease
1735068|NCT00004424|Respiration, Artificial|respiration, artificial
1735069|NCT00004423|Crohn's disease|crohn's disease
1735070|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
1735071|NCT00004423|rare disease|rare disease
1735072|NCT00004422|bacterial infection|bacterial infection
1735073|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735074|NCT00004422|pertussis|pertussis
1735075|NCT00004422|rare disease|rare disease
1735076|NCT00004421|dystonia|dystonia
1735077|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735078|NCT00004421|rare disease|rare disease
1735079|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735080|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
1735081|NCT00004420|rare disease|rare disease
1735082|NCT00004419|endocrine disorders|endocrine disorders
1735083|NCT00004419|insulin resistance|insulin resistance
1735084|NCT00004419|rare disease|rare disease
1735085|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
1735086|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
1735087|NCT00004418|rare disease|rare disease
1735088|NCT00004418|sphingolipidoses|sphingolipidoses
1735091|NCT00004416|rare disease|rare disease
1735092|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
1735093|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735094|NCT00004415|rare disease|rare disease
1735095|NCT00004415|spinal cord injury|spinal cord injury
1735096|NCT00004414|cholestasis|cholestasis
1735097|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
1735098|NCT00004414|rare disease|rare disease
1735099|NCT00004412|dermatologic disorders|dermatologic disorders
1735100|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735101|NCT00004412|hematologic disorders|hematologic disorders
1735102|NCT00004412|rare disease|rare disease
1735103|NCT00004412|sickle cell anemia|sickle cell anemia
1735104|NCT00004412|skin ulcers|skin ulcers
1735105|NCT00004412|thalassemia major|thalassemia major
1735106|NCT00004410|cholestasis|cholestasis
1735107|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
1735108|NCT00004410|rare disease|rare disease
1735109|NCT00004409|Dupuytren's disease|dupuytren's disease
1735110|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735111|NCT00004409|rare disease|rare disease
1735112|NCT00004408|disease-related problem/condition|disease-related problem/condition
1735113|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735114|NCT00004408|hematologic disorders|hematologic disorders
1735115|NCT00004408|pain|pain
1735116|NCT00004408|rare disease|rare disease
1735117|NCT00004408|sickle cell anemia|sickle cell anemia
1735118|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
1735119|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
1735120|NCT00004407|diabetic neuropathy|diabetic neuropathy
1735121|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
1735210|NCT00004378|sphingolipidoses|sphingolipidoses
1735122|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735123|NCT00004407|rare disease|rare disease
1735124|NCT00004406|disease-related problem/condition|disease-related problem/condition
1735125|NCT00004406|osteoporosis|osteoporosis
1735126|NCT00004406|rare disease|rare disease
1735127|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735128|NCT00004404|hematologic disorders|hematologic disorders
1735129|NCT00004404|rare disease|rare disease
1735130|NCT00004404|sickle cell anemia|sickle cell anemia
1735131|NCT00004403|cysticercosis|cysticercosis
1735132|NCT00004403|epilepsy|epilepsy
1735133|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735134|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735135|NCT00004403|parasitic infection|parasitic infection
1735136|NCT00004403|rare disease|rare disease
1735137|NCT00004403|seizures|seizures
1735138|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735139|NCT00004402|osteopetrosis|osteopetrosis
1735140|NCT00004402|rare disease|rare disease
1735141|NCT00004401|bacterial infection|bacterial infection
1735142|NCT00004401|clostridium infection|clostridium infection
1735143|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735144|NCT00004401|infant botulism|infant botulism
1735145|NCT00004401|rare disease|rare disease
1735146|NCT00004400|cachexia|cachexia
1735147|NCT00004400|disease-related problem/condition|disease-related problem/condition
1735148|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
1735149|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735150|NCT00004400|nutrition|nutrition
1735151|NCT00004400|quality of life|quality of life
1735152|NCT00004400|rare disease|rare disease
1735153|NCT00004400|viral infection|viral infection
1735154|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735155|NCT00004399|hypertensive disorder|hypertensive disorder
1735156|NCT00004399|pre-eclampsia|pre-eclampsia
1735157|NCT00004399|rare disease|rare disease
1735158|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
1735159|NCT00004398|porphyria|porphyria
1735160|NCT00004398|rare disease|rare disease
1735161|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
1735162|NCT00004397|porphyria|porphyria
1735163|NCT00004397|rare disease|rare disease
1735164|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
1735165|NCT00004396|porphyria|porphyria
1735166|NCT00004396|rare disease|rare disease
1735167|NCT00004393|Tourette syndrome|tourette syndrome
1735168|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735169|NCT00004393|rare disease|rare disease
1735170|NCT00004392|apnea|apnea
1735171|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735172|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735173|NCT00004392|rare disease|rare disease
1735174|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
1735175|NCT00004390|disease-related problem/condition|disease-related problem/condition
1735176|NCT00004390|herpes zoster infection|herpes zoster infection
1735177|NCT00004390|herpesvirus infection|herpesvirus infection
1735178|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735179|NCT00004390|pain|pain
1735180|NCT00004390|rare disease|rare disease
1735181|NCT00004390|viral infection|viral infection
1735182|NCT00004387|Parkinson disease|parkinson disease
1735183|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735184|NCT00004387|rare disease|rare disease
1735185|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
1735186|NCT00004386|rare disease|rare disease
1735187|NCT00004386|urea cycle disorder|urea cycle disorder
1735188|NCT00004382|hematologic disorders|hematologic disorders
1735189|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
1735190|NCT00004382|rare disease|rare disease
1735191|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
1735192|NCT00004381|hematologic disorders|hematologic disorders
1735193|NCT00004381|hemolytic disease|hemolytic disease
1735194|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
1735195|NCT00004381|neonatal disorders|neonatal disorders
1735196|NCT00004381|rare disease|rare disease
1735197|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735198|NCT00004380|rare disease|rare disease
1735199|NCT00004380|systemic sclerosis|systemic sclerosis
1735200|NCT00004378|Fanconi's anemia|fanconi's anemia
1735201|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
1735202|NCT00004378|aplastic anemia|aplastic anemia
1735203|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
1735204|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735205|NCT00004378|hematologic disorders|hematologic disorders
1735206|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
1735207|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
1735208|NCT00004378|pure red cell aplasia|pure red cell aplasia
1735209|NCT00004378|rare disease|rare disease
1735211|NCT00004378|thalassemia major|thalassemia major
1735212|NCT00004376|Tourette syndrome|tourette syndrome
1735213|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735214|NCT00004376|rare disease|rare disease
1735215|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735216|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735217|NCT00004375|rare disease|rare disease
1735218|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
1735219|NCT00004374|amyloidosis|amyloidosis
1735220|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735221|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735222|NCT00004374|rare disease|rare disease
1735223|NCT00004373|anxiety disorder|anxiety disorder
1735224|NCT00004373|disease-related problem/condition|disease-related problem/condition
1735225|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735226|NCT00004373|panic disorder|panic disorder
1735227|NCT00004373|rare disease|rare disease
1735228|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
1735229|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
1735230|NCT00004368|rare disease|rare disease
1735231|NCT00004367|anxiety disorder|anxiety disorder
1735232|NCT00004367|disease-related problem/condition|disease-related problem/condition
1735233|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735234|NCT00004367|panic disorder|panic disorder
1735235|NCT00004367|rare disease|rare disease
1735236|NCT00004366|agoraphobia|agoraphobia
1735237|NCT00004366|anxiety disorder|anxiety disorder
1735238|NCT00004366|disease-related problem/condition|disease-related problem/condition
1735239|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735240|NCT00004366|panic disorder|panic disorder
1735241|NCT00004366|rare disease|rare disease
1735242|NCT00004366|vestibular diseases|vestibular diseases
1735243|NCT00004365|endocrine disorders|endocrine disorders
1735244|NCT00004365|growth hormone deficiency|growth hormone deficiency
1735245|NCT00004365|rare disease|rare disease
1735246|NCT00004364|diabetes insipidus|diabetes insipidus
1735247|NCT00004364|endocrine disorders|endocrine disorders
1735248|NCT00004364|rare disease|rare disease
1735249|NCT00004363|diabetes insipidus|diabetes insipidus
1735250|NCT00004363|endocrine disorders|endocrine disorders
1735251|NCT00004363|rare disease|rare disease
1735252|NCT00004361|DiGeorge syndrome|digeorge syndrome
1735253|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735254|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
1735255|NCT00004361|endocrine disorders|endocrine disorders
1735256|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735257|NCT00004361|hypoparathyroidism|hypoparathyroidism
1735258|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
1735259|NCT00004361|rare disease|rare disease
1735260|NCT00004361|tetralogy of Fallot|tetralogy of fallot
1735261|NCT00004360|diabetes insipidus|diabetes insipidus
1735262|NCT00004360|endocrine disorders|endocrine disorders
1735263|NCT00004360|rare disease|rare disease
1735264|NCT00004359|dermatologic disorders|dermatologic disorders
1735265|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
1735266|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735267|NCT00004359|rare disease|rare disease
1735268|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
1735269|NCT00004358|rare disease|rare disease
1735270|NCT00004358|tumoral calcinosis|tumoral calcinosis
1735271|NCT00004357|Cardiovascular Disease|cardiovascular disease
1735272|NCT00004357|Respiratory Disease|respiratory disease
1735273|NCT00004357|Rare Diseases|rare diseases
1735274|NCT00004357|Vasculitis|vasculitis
1735275|NCT00004356|homocystinuria|homocystinuria
1735276|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
1735277|NCT00004356|rare disease|rare disease
1735278|NCT00004354|endocrine disorders|endocrine disorders
1735279|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735280|NCT00004354|hyperaldosteronism|hyperaldosteronism
1735281|NCT00004354|rare disease|rare disease
1735282|NCT00004353|MELAS syndrome|melas syndrome
1735283|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
1735284|NCT00004353|lactic acidosis|lactic acidosis
1735285|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
1735286|NCT00004353|rare disease|rare disease
1735287|NCT00004351|Angelman syndrome|angelman syndrome
1735288|NCT00004351|DiGeorge syndrome|digeorge syndrome
1735289|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
1735290|NCT00004351|Shprintzen syndrome|shprintzen syndrome
1735291|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
1735292|NCT00004351|Williams syndrome|williams syndrome
1735293|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735294|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735295|NCT00004351|rare disease|rare disease
1735296|NCT00004350|Fanconi syndrome|fanconi syndrome
1735297|NCT00004350|cystinosis|cystinosis
1735298|NCT00004350|rare disease|rare disease
1735299|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
1735300|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
1735301|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
1735302|NCT00004348|rare disease|rare disease
1735303|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
1735304|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735305|NCT00004347|rare disease|rare disease
1735306|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
1735307|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
1735308|NCT00004346|rare disease|rare disease
1735309|NCT00004345|Usher syndrome|usher syndrome
1735310|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
1735311|NCT00004345|rare disease|rare disease
1735312|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
1735313|NCT00004344|endocrine disorders|endocrine disorders
1735314|NCT00004344|precocious puberty|precocious puberty
1735315|NCT00004344|rare disease|rare disease
1735316|NCT00004343|Cushing's syndrome|cushing's syndrome
1735317|NCT00004343|endocrine disorders|endocrine disorders
1735318|NCT00004343|rare disease|rare disease
1735319|NCT00004342|chronic neutropenia|chronic neutropenia
1735320|NCT00004342|disease-related problem/condition|disease-related problem/condition
1735321|NCT00004342|hematologic disorders|hematologic disorders
1735322|NCT00004342|neutropenia|neutropenia
1735323|NCT00004342|rare disease|rare disease
1735324|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
1735325|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
1735326|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
1735327|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
1735328|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735329|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735330|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
1735331|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
1735332|NCT00004341|rare disease|rare disease
1735333|NCT00004340|end stage renal disease|end stage renal disease
1735334|NCT00004340|rare disease|rare disease
1735335|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
1735336|NCT00004340|renal osteodystrophy|renal osteodystrophy
1735337|NCT00004339|Wilson disease|wilson disease
1735338|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
1735339|NCT00004339|rare disease|rare disease
1735340|NCT00004338|Wilson disease|wilson disease
1735341|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
1735342|NCT00004338|rare disease|rare disease
1735343|NCT00004336|Mondini dysplasia|mondini dysplasia
1735344|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735345|NCT00004336|rare disease|rare disease
1735346|NCT00004335|endocrine disorders|endocrine disorders
1735347|NCT00004335|growth hormone deficiency|growth hormone deficiency
1735348|NCT00004335|hypogonadism|hypogonadism
1735349|NCT00004335|precocious puberty|precocious puberty
1735350|NCT00004335|rare disease|rare disease
1735351|NCT00004334|Cushing's syndrome|cushing's syndrome
1735352|NCT00004334|endocrine disorders|endocrine disorders
1735353|NCT00004334|rare disease|rare disease
1735354|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
1735355|NCT00004333|rare disease|rare disease
1735356|NCT00004333|tyrosinemia I|tyrosinemia i
1735357|NCT00004332|acromegaly|acromegaly
1735358|NCT00004332|endocrine disorders|endocrine disorders
1735359|NCT00004332|rare disease|rare disease
1735360|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
1735361|NCT00004331|porphyria|porphyria
1735362|NCT00004331|rare disease|rare disease
1735363|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
1735364|NCT00004330|porphyria|porphyria
1735365|NCT00004330|rare disease|rare disease
1735366|NCT00004329|endocrine disorders|endocrine disorders
1735367|NCT00004329|rare disease|rare disease
1735368|NCT00004328|endocrine disorders|endocrine disorders
1735369|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
1735370|NCT00004328|rare disease|rare disease
1735371|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735372|NCT00004327|hematologic disorders|hematologic disorders
1735373|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
1735374|NCT00004327|rare disease|rare disease
1735375|NCT00004327|senile ectasia|senile ectasia
1735376|NCT00004326|Cushing's syndrome|cushing's syndrome
1735377|NCT00004326|endocrine disorders|endocrine disorders
1735378|NCT00004326|rare disease|rare disease
1735379|NCT00004325|Tourette syndrome|tourette syndrome
1735380|NCT00004325|anxiety disorder|anxiety disorder
1735381|NCT00004325|disease-related problem/condition|disease-related problem/condition
1735382|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735383|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
1735384|NCT00004325|oncologic disorders|oncologic disorders
1735385|NCT00004325|rare disease|rare disease
1735386|NCT00004324|Tourette syndrome|tourette syndrome
1735387|NCT00004324|anxiety disorder|anxiety disorder
1735388|NCT00004324|disease-related problem/condition|disease-related problem/condition
1735389|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735390|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
1735391|NCT00004324|oncologic disorders|oncologic disorders
1735392|NCT00004324|rare disease|rare disease
1735393|NCT00004323|aplastic anemia|aplastic anemia
1735394|NCT00004323|hematologic disorders|hematologic disorders
1735395|NCT00004323|rare disease|rare disease
1735396|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735397|NCT00004317|rare disease|rare disease
1735398|NCT00004317|toxoplasmosis|toxoplasmosis
1735399|NCT00004316|interstitial cystitis|interstitial cystitis
1735400|NCT00004316|rare disease|rare disease
1735401|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
1735402|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
1735403|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735404|NCT00004315|cholestasis|cholestasis
1735405|NCT00004315|cystic fibrosis|cystic fibrosis
1735406|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
1735407|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735408|NCT00004315|rare disease|rare disease
1735409|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
1735410|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
1735411|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735412|NCT00004314|rare disease|rare disease
1735413|NCT00004313|Addison's disease|addison's disease
1735414|NCT00004313|endocrine disorders|endocrine disorders
1735415|NCT00004313|rare disease|rare disease
1735416|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
1735417|NCT00004312|cystinosis|cystinosis
1735418|NCT00004312|rare disease|rare disease
1735419|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
1735420|NCT00004311|acanthosis nigricans|acanthosis nigricans
1735421|NCT00004311|dermatologic disorders|dermatologic disorders
1735422|NCT00004311|endocrine disorders|endocrine disorders
1735423|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
1735424|NCT00004311|rare disease|rare disease
1735425|NCT00004310|anxiety disorder|anxiety disorder
1735426|NCT00004310|disease-related problem/condition|disease-related problem/condition
1735427|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735428|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
1735429|NCT00004310|oncologic disorders|oncologic disorders
1735430|NCT00004310|rare disease|rare disease
1735431|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
1735432|NCT00004307|rare disease|rare disease
1735433|NCT00004307|urea cycle disorder|urea cycle disorder
1735434|NCT00004306|hereditary ataxia|hereditary ataxia
1735435|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735436|NCT00004306|rare disease|rare disease
1735437|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
1735438|NCT00004305|rare disease|rare disease
1735439|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
1735440|NCT00004300|mental retardation|mental retardation
1735441|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735442|NCT00004300|rare disease|rare disease
1735443|NCT00004300|stereotyped behavior|stereotyped behavior
1735444|NCT00004297|epilepsy|epilepsy
1735445|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735446|NCT00004297|rare disease|rare disease
1735447|NCT00004297|seizures|seizures
1735448|NCT00004297|status epilepticus|status epilepticus
1735449|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
1735450|NCT00004296|bacterial infection|bacterial infection
1735451|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735452|NCT00004296|cystic fibrosis|cystic fibrosis
1735453|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735454|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735455|NCT00004296|mycobacterium infection|mycobacterium infection
1735456|NCT00004296|rare disease|rare disease
1735457|NCT00004294|Gaucher's disease|gaucher's disease
1735458|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
1735459|NCT00004294|rare disease|rare disease
1735460|NCT00004294|sphingolipidoses|sphingolipidoses
1735461|NCT00004293|Gaucher's disease|gaucher's disease
1735462|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
1735463|NCT00004293|rare disease|rare disease
1735464|NCT00004293|sphingolipidoses|sphingolipidoses
1735465|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
1735466|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735467|NCT00004288|rare disease|rare disease
1735468|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735469|NCT00004287|cystic fibrosis|cystic fibrosis
1735470|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735471|NCT00004287|rare disease|rare disease
1735472|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
1735473|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
1735474|NCT00004286|rare disease|rare disease
1735475|NCT00004285|end stage renal disease|end stage renal disease
1735476|NCT00004285|rare disease|rare disease
1735477|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
1735478|NCT00004284|hypercalciuria|hypercalciuria
1735479|NCT00004284|nephrolithiasis|nephrolithiasis
1735480|NCT00004284|rare disease|rare disease
1735481|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
1735482|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
1735483|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
1735484|NCT00004278|herpesvirus infection|herpesvirus infection
1735485|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735486|NCT00004278|neonatal disorders|neonatal disorders
1735487|NCT00004278|rare disease|rare disease
1735488|NCT00004278|viral infection|viral infection
1735489|NCT00004276|bacterial infection|bacterial infection
1735490|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
1735491|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
1735492|NCT00004276|mycobacterium infection|mycobacterium infection
1735493|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
1735494|NCT00004276|rare disease|rare disease
1735495|NCT00004276|viral infection|viral infection
1735496|NCT00004275|Turner's syndrome|turner's syndrome
1735497|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735498|NCT00004275|rare disease|rare disease
1735499|NCT00004274|Turner's syndrome|turner's syndrome
1735500|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
1735501|NCT00004274|rare disease|rare disease
1735502|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
1735503|NCT00004268|disease-related problem/condition|disease-related problem/condition
1735504|NCT00004268|orthostatic hypotension|orthostatic hypotension
1735505|NCT00004268|quality of life|quality of life
1735506|NCT00004268|rare disease|rare disease
1735507|NCT00004266|diabetic nephropathy|diabetic nephropathy
1735508|NCT00004266|rare disease|rare disease
1735509|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
1735510|NCT00000170|Amblyopia|amblyopia
1735511|NCT00000170|patching|patching
1735512|NCT00000170|atropine|atropine
1735513|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
1735514|NCT00000163|Congenital Esotropia|congenital esotropia
1735515|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
1735516|NCT00000160|Vision Loss|vision loss
1735517|NCT00000158|photocoagulation|photocoagulation
1735518|NCT00000158|argon blue-green laser|argon blue-green laser
1735519|NCT00000158|krypton red laser|krypton red laser
1735520|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
1735521|NCT00000153|Optic Disk|optic disk
1735522|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
1735523|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
1735524|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
1735525|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
1735526|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
1735527|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
1735528|NCT00000131|Central Vein Occlusion|central vein occlusion
1735529|NCT00000131|Ischemic Retina|ischemic retina
1735530|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
1735531|NCT00000128|Near-point Esophoria|near-point esophoria
1735532|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
1735533|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
1735534|NCT00000124|Choroidal Melanoma|choroidal melanoma
1735535|NCT00000124|Ocular Melanoma|ocular melanoma
1735536|NCT00000121|strabismus|strabismus
1735537|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
1735538|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
1735539|NCT00000114|vitamin supplements|vitamin supplements
1735540|NCT00000113|myopia|myopia
1735541|NCT00000113|nearsightedness|nearsightedness
1735542|NCT00000357|opiate dependence|opiate dependence
1735543|NCT00000356|opiate dependence|opiate dependence
1735544|NCT00000355|opiate dependence|opiate dependence
1735545|NCT00000354|opiate dependence|opiate dependence
1735546|NCT00000353|opiate dependence|opiate dependence
1735547|NCT00000352|opiate dependence|opiate dependence
1735548|NCT00000350|amphetamine dependence|amphetamine dependence
1735549|NCT00000349|cocaine dependence|cocaine dependence
1735550|NCT00000348|cocaine dependence|cocaine dependence
1735551|NCT00000347|cocaine dependence|cocaine dependence
1735552|NCT00000346|amphetamine dependence|amphetamine dependence
1735553|NCT00000345|opioid dependence|opioid dependence
1735554|NCT00000344|opioid dependence|opioid dependence
1735555|NCT00000343|stimulant dependence|stimulant dependence
1735556|NCT00000342|cocaine dependence|cocaine dependence
1735557|NCT00000341|opioid dependence|opioid dependence
1735558|NCT00000340|cocaine dependence|cocaine dependence
1735559|NCT00000339|cocaine dependence|cocaine dependence
1735560|NCT00000338|cocaine dependence|cocaine dependence
1735561|NCT00000337|cocaine dependence|cocaine dependence
1735562|NCT00000336|cocaine dependence|cocaine dependence
1735563|NCT00000335|opioid dependence|opioid dependence
1735564|NCT00000331|Heroin Dependence|heroin dependence
1735565|NCT00000330|Heroin Dependence|heroin dependence
1735566|NCT00000329|drug dependence|drug dependence
1735567|NCT00000328|drug dependence|drug dependence
1735568|NCT00000327|drug dependence|drug dependence
1735569|NCT00000326|Heroin Dependence|heroin dependence
1735570|NCT00000325|cocaine dependence|cocaine dependence
1735571|NCT00000323|cocaine dependence|cocaine dependence
1735572|NCT00000322|amphetamine dependence|amphetamine dependence
1735573|NCT00000321|methamphetamine dependence|methamphetamine dependence
1735574|NCT00000320|opioid dependence|opioid dependence
1735575|NCT00000318|opioid dependence|opioid dependence
1735576|NCT00000317|Cocaine|cocaine
1735577|NCT00000317|METHADONE PATIENTS|methadone patients
1735578|NCT00000317|RISPERIDONE|risperidone
1735579|NCT00000316|cocaine dependence|cocaine dependence
1735580|NCT00000315|cocaine dependence|cocaine dependence
1735581|NCT00000314|cocaine dependence|cocaine dependence
1735582|NCT00000313|cocaine dependence|cocaine dependence
1735583|NCT00000311|Cocaine-Related Disorders|cocaine-related disorders
1735584|NCT00000311|Opioid-Related Disorders|opioid-related disorders
1735585|NCT00000311|Substance-Related Disorders|substance-related disorders
1735586|NCT00000310|cocaine dependence|cocaine dependence
1735587|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
1735588|NCT00000308|cocaine dependence|cocaine dependence
1735589|NCT00000307|alcohol dependence|alcohol dependence
1735590|NCT00000306|cocaine dependence|cocaine dependence
1735591|NCT00000304|cocaine dependence|cocaine dependence
1735592|NCT00000303|Cocaine dependence|cocaine dependence
1735593|NCT00000301|Amantadine|amantadine
1735594|NCT00000301|Cocaine|cocaine
1735595|NCT00000301|Pharmacotherapy|pharmacotherapy
1735596|NCT00000301|Outpatient|outpatient
1735597|NCT00000300|opiate|opiate
1735598|NCT00000300|dependence|dependence
1735599|NCT00000299|Opioid-Related Disorders|opioid-related disorders
1735600|NCT00000296|nicotine dependence|nicotine dependence
1735601|NCT00000293|cocaine dependence|cocaine dependence
1735602|NCT00000291|cocaine dependence|cocaine dependence
1735603|NCT00000290|cocaine dependence|cocaine dependence
1735604|NCT00000288|nicotine dependence|nicotine dependence
1735605|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
1735606|NCT00000286|cocaine dependence|cocaine dependence
1735607|NCT00000285|cocaine dependence|cocaine dependence
1735608|NCT00000284|nicotine dependence|nicotine dependence
1735609|NCT00000282|pemoline|pemoline
1735610|NCT00000281|anti psychotic agents|anti psychotic agents
1735611|NCT00000280|cocaine|cocaine
1735612|NCT00000275|cocaine dependence|cocaine dependence
1735613|NCT00000274|cocaine dependence|cocaine dependence
1735614|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
1735615|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
1735616|NCT00000270|cocaine|cocaine
1735617|NCT00000269|cocaine dependence|cocaine dependence
1735618|NCT00000268|cocaine dependence|cocaine dependence
1735619|NCT00000267|cocaine dependence|cocaine dependence
1735620|NCT00000266|cocaine dependence|cocaine dependence
1735621|NCT00000265|nitrous oxide|nitrous oxide
1735622|NCT00000265|anxiety|anxiety
1735623|NCT00000265|subjective effects|subjective effects
1735624|NCT00000265|dental|dental
1735625|NCT00000265|patients|patients
1735626|NCT00000264|nitrous oxide|nitrous oxide
1735627|NCT00000264|inhalant|inhalant
1735628|NCT00000264|ethanol|ethanol
1735629|NCT00000264|subjective effects|subjective effects
1735630|NCT00000264|psychomotor effects|psychomotor effects
1735631|NCT00000264|healthy volunteer|healthy volunteer
1735632|NCT00000263|nitrous oxide|nitrous oxide
1735633|NCT00000263|ethanol|ethanol
1735634|NCT00000263|drug interaction|drug interaction
1735635|NCT00000263|subjective effects|subjective effects
1735636|NCT00000263|healthy volunteer|healthy volunteer
1735637|NCT00000262|nitrous oxide|nitrous oxide
1735638|NCT00000262|sevoflurane|sevoflurane
1735639|NCT00000262|drug interaction|drug interaction
1735640|NCT00000262|subjective effects|subjective effects
1735641|NCT00000262|analgesia|analgesia
1735642|NCT00000262|healthy volunteers|healthy volunteers
1735643|NCT00000261|nitrous oxide|nitrous oxide
1735644|NCT00000261|sevoflurane|sevoflurane
1735645|NCT00000261|ethanol|ethanol
1735646|NCT00000261|subjective effects|subjective effects
1735647|NCT00000261|healthy volunteer|healthy volunteer
1735648|NCT00000260|nitrous oxide|nitrous oxide
1735649|NCT00000260|subjective effects|subjective effects
1735650|NCT00000260|reinforcer|reinforcer
1735651|NCT00000260|inhalant|inhalant
1735652|NCT00000260|healthy volunteer|healthy volunteer
1735653|NCT00000259|sevoflurane|sevoflurane
1735654|NCT00000259|nitrous oxide|nitrous oxide
1735655|NCT00000259|subjective effects|subjective effects
1735656|NCT00000259|healthy volunteer|healthy volunteer
1735657|NCT00000258|nitrous oxide|nitrous oxide
1735658|NCT00000258|instruction|instruction
1735659|NCT00000258|subjective effects|subjective effects
1735660|NCT00000258|reinforcer|reinforcer
1735661|NCT00000258|healthy volunteer|healthy volunteer
1735662|NCT00000257|nitrous oxide|nitrous oxide
1735663|NCT00000257|subjective effects|subjective effects
1735664|NCT00000257|ethanol|ethanol
1735665|NCT00000257|healthy volunteer|healthy volunteer
1735666|NCT00000256|nitrous oxide|nitrous oxide
1735667|NCT00000256|reinforcer|reinforcer
1735668|NCT00000256|subjective effects|subjective effects
1735669|NCT00000256|healthy volunteer|healthy volunteer
1735670|NCT00000255|nitrous oxide|nitrous oxide
1735671|NCT00000255|acute tolerance|acute tolerance
1735672|NCT00000255|subjective effects|subjective effects
1735673|NCT00000255|analgesia|analgesia
1735674|NCT00000255|psychomotor|psychomotor
1735675|NCT00000255|healthy volunteer|healthy volunteer
1735676|NCT00000254|isoflurane|isoflurane
1735677|NCT00000254|general anesthetic|general anesthetic
1735678|NCT00000254|inhalant|inhalant
1735679|NCT00000254|subjective effects|subjective effects
1735680|NCT00000254|healthy volunteer|healthy volunteer
1735681|NCT00000253|nitrous oxide|nitrous oxide
1735682|NCT00000253|inhalant|inhalant
1735683|NCT00000253|subjective effects|subjective effects
1735684|NCT00000253|healthy volunteer|healthy volunteer
1735685|NCT00000252|nitrous oxide|nitrous oxide
1735686|NCT00000252|acute tolerance|acute tolerance
1735687|NCT00000252|subjective effects|subjective effects
1735688|NCT00000252|psychomotor|psychomotor
1735689|NCT00000252|analgesia|analgesia
1735690|NCT00000252|healthy volunteer|healthy volunteer
1735691|NCT00000251|nitrous oxide|nitrous oxide
1735692|NCT00000251|isoflurane|isoflurane
1735693|NCT00000251|subjective effects|subjective effects
1735694|NCT00000251|psychomotor|psychomotor
1735695|NCT00000251|healthy volunteer|healthy volunteer
1735696|NCT00000251|drug interaction|drug interaction
1735697|NCT00000250|nitrous oxide|nitrous oxide
1735698|NCT00000250|choice|choice
1735699|NCT00000250|subjective effects|subjective effects
1735700|NCT00000250|pain|pain
1735701|NCT00000250|analgesia|analgesia
1735702|NCT00000250|reinforcer|reinforcer
1735703|NCT00000250|healthy volunteer|healthy volunteer
1735704|NCT00000249|nitrous oxide|nitrous oxide
1735705|NCT00000249|subjective effects|subjective effects
1735706|NCT00000249|healthy volunteer|healthy volunteer
1735707|NCT00000246|Substance-Related Disorders|substance-related disorders
1735708|NCT00000245|cocaine dependence|cocaine dependence
1735709|NCT00000244|addiction|addiction
1735710|NCT00000244|opiate|opiate
1735711|NCT00000244|heroin|heroin
1735712|NCT00000244|dynorphin|dynorphin
1735713|NCT00000243|opioid dependence|opioid dependence
1735714|NCT00000242|Cocaine|cocaine
1735715|NCT00000242|Substance Abuse|substance abuse
1735716|NCT00000241|methamphetamine dependence|methamphetamine dependence
1735717|NCT00000218|cocaine dependence|cocaine dependence
1735718|NCT00000217|drug abuse|drug abuse
1735719|NCT00000215|cocaine dependence|cocaine dependence
1735720|NCT00000214|intravenous abuse|intravenous abuse
1735721|NCT00000213|intravenous abuse|intravenous abuse
1735722|NCT00000212|crack cocaine|crack cocaine
1735723|NCT00000210|opioid addiction|opioid addiction
1735724|NCT00000210|cocaine addiction|cocaine addiction
1735725|NCT00000207|Buprenorphine|buprenorphine
1735726|NCT00000207|Opioid|opioid
1735727|NCT00000206|Opioid|opioid
1735728|NCT00000201|cocaine dependence|cocaine dependence
1735729|NCT00000200|self-administration|self-administration
1735730|NCT00000199|cocaine|cocaine
1735731|NCT00000198|cocaine|cocaine
1735732|NCT00000197|cocaine|cocaine
1735733|NCT00000195|opioid disorders|opioid disorders
1735734|NCT00000194|opioid disorders|opioid disorders
1735735|NCT00000193|Opioid disorders|opioid disorders
1735736|NCT00000192|opioid disorders|opioid disorders
1735737|NCT00000191|Cocaine Dependence|cocaine dependence
1735738|NCT00000191|Carbamazepine|carbamazepine
1735739|NCT00000190|Cocaine Detection|cocaine detection
1735740|NCT00000190|Parotid Saliva|parotid saliva
1735741|NCT00000189|Cocaine Dependence|cocaine dependence
1735742|NCT00000189|Gepirone|gepirone
1735743|NCT00000188|Cocaine Dependence|cocaine dependence
1735744|NCT00000188|Selegiline|selegiline
1735745|NCT00000187|Cocaine Dependence|cocaine dependence
1735746|NCT00000187|ritanserin|ritanserin
1735747|NCT00004640|Aging|aging
1735748|NCT00004640|Elderly|elderly
1735749|NCT00004640|Periodontal Disease|periodontal disease
1735750|NCT00004640|Dental Caries|dental caries
1735751|NCT00004640|Fluoride|fluoride
1735752|NCT00004640|Antibacterial rinse|antibacterial rinse
1735753|NCT00004640|Chlorhexidine|chlorhexidine
1735754|NCT00004640|Tooth Mortality|tooth mortality
1735755|NCT00004639|cleft lip and palate|cleft lip and palate
1735756|NCT00004639|children|children
1735757|NCT00004639|speech|speech
1735758|NCT00004639|velopharyngeal function|velopharyngeal function
1735759|NCT00004639|congenital facial malformation|congenital facial malformation
1735760|NCT00004639|von Langenbeck procedure|von langenbeck procedure
1735761|NCT00004639|Furlow procedure|furlow procedure
1735762|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
1735763|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
